data_2aff_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2aff _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 65.7 p . . . . . 0 N--CA 1.462 0.149 0 CA-C-O 120.848 0.356 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.8 mtt85 -89.0 126.91 35.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.647 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -127.48 138.52 52.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.795 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 24.3 tp -117.21 131.63 56.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.023 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.2 t -108.98 131.9 58.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.681 0.276 . . . . 0.0 110.708 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.6 m -82.15 133.18 35.25 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.395 0.617 . . . . 0.0 112.206 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 92.8 mt -103.78 137.61 31.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.619 177.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -97.83 160.03 14.56 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.99 -178.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -58.14 -25.57 61.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.299 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.1 p -79.64 -13.69 59.32 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.582 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.81 19.73 33.44 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.002 -0.618 . . . . 0.0 111.772 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.5 m -115.94 135.67 55.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -76.1 141.06 42.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.828 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -123.25 -118.17 2.41 Favored Glycine 0 CA--C 1.542 1.728 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.795 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -72.04 147.96 49.88 Favored 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 122.415 2.077 . . . . 0.0 112.8 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -108.06 150.07 27.64 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.172 0.51 . . . . 0.0 110.768 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -119.56 111.64 36.13 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.898 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.12 123.64 6.27 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.555 1.503 . . . . 0.0 111.259 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 82.1 mt -77.65 52.49 1.0 Allowed 'General case' 0 C--O 1.233 0.196 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.665 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.6 t -62.06 -42.16 98.9 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.101 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.6 mt -69.1 146.51 52.5 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 58.4 p -67.45 -16.57 64.3 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.496 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 90.2 m -131.23 133.89 45.91 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.414 -0.514 . . . . 0.0 111.542 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.8 t -124.33 116.05 21.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.446 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 56.9 tp -114.66 124.86 52.89 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.85 0.357 . . . . 0.0 111.422 -178.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.537 ' O ' ' O ' ' A' ' 47' ' ' GLN . 22.7 m-85 -104.5 141.31 36.61 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.518 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 156.59 -173.08 34.36 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.25 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.545 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 27.2 mtm180 -80.0 -27.74 39.55 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.055 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.532 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -56.18 137.78 46.58 Favored Glycine 0 CA--C 1.521 0.453 0 C-N-CA 120.186 -1.007 . . . . 0.0 110.695 -178.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.402 ' C ' ' H ' ' A' ' 35' ' ' CYS . 10.6 tp -65.18 -40.12 87.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.671 -0.412 . . . . 0.0 109.99 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -53.99 -13.54 0.81 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.256 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.532 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 37.8 m -71.24 138.25 49.3 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.513 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.496 ' OD2' ' O ' ' A' ' 26' ' ' THR . 56.0 m-20 -61.55 -34.28 75.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.443 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 94.2 mt -127.59 122.56 59.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 13.2 ttp180 -111.86 137.25 50.07 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.418 -178.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 94.6 mt -120.63 130.31 74.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.9 pt20 -81.74 38.4 0.51 Allowed 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.607 ' CD1' ' CZ ' ' A' ' 93' ' ' ARG . 39.9 mt -103.08 132.72 20.86 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.91 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.89 -11.37 30.54 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.459 2.106 . . . . 0.0 113.214 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.1 m -96.32 4.56 9.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.898 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.545 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 44.1 t -96.23 133.97 35.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.975 0.417 . . . . 0.0 110.562 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.2 m -70.93 165.51 23.19 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.825 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.0 mttm -63.23 -39.18 93.87 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.661 -178.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.695 ' O ' ' N ' ' A' ' 49' ' ' CYS . 86.4 mt-30 -113.92 -16.08 12.25 Favored 'General case' 0 C--O 1.227 -0.128 0 O-C-N 123.31 0.381 . . . . 0.0 111.247 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 28.7 t60 34.26 -74.13 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.695 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.52 138.96 46.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.129 0.49 . . . . 0.0 111.962 -179.025 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -127.56 130.93 49.96 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.877 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.9 mt -114.62 132.81 62.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.602 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -118.65 123.27 44.54 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.8 mt -106.44 117.06 51.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.019 -0.672 . . . . 0.0 112.345 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.431 ' O ' ' C ' ' A' ' 55' ' ' GLU . 81.0 m-70 -114.15 145.17 42.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.233 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 54' ' ' HIS . 96.3 mt-10 -40.5 -31.8 0.17 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.339 0.59 . . . . 0.0 109.471 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.516 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 58.6 tt0 -63.9 -68.6 0.33 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.162 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.516 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 5.1 tp10 -157.38 -170.24 3.17 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.287 -178.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.424 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -109.45 125.97 53.0 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.6 mt -116.63 130.21 71.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.235 0.54 . . . . 0.0 111.857 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 19.4 tp -101.39 126.25 48.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.841 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -110.14 136.64 49.06 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.966 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.439 HD22 ' HA ' ' A' ' 68' ' ' PRO . 64.7 t-20 -96.48 105.48 17.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.684 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -97.63 -7.47 31.01 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.56 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 t -77.01 99.64 5.37 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.012 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.4 m -86.83 -18.18 31.6 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.88 -43.35 11.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.52 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -135.31 91.64 18.73 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.803 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.439 ' HA ' HD22 ' A' ' 62' ' ' ASN . 47.3 Cg_exo -56.24 145.51 76.78 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.193 1.929 . . . . 0.0 113.408 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 18.9 m -79.39 137.17 37.19 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.84 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -102.0 141.37 34.95 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.017 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 93.1 t -132.21 134.33 59.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.425 HD22 ' CG ' ' A' ' 86' ' ' ASP . 75.1 m-20 50.92 32.87 7.89 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.219 0.533 . . . . 0.0 109.593 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.93 29.56 60.69 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.135 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 31.0 t -148.97 143.83 26.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 117.439 0.619 . . . . 0.0 111.335 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 62.1 t -69.38 143.16 15.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.465 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.1 pt -113.89 68.46 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.223 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -52.12 -27.69 15.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.662 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -120.74 169.57 8.6 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.549 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -60.28 143.14 99.51 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 122.354 2.036 . . . . 0.0 112.23 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.9 m -139.57 139.31 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-O 120.83 0.348 . . . . 0.0 111.223 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -75.51 131.82 40.34 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 92.3 mt -79.51 139.79 37.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.089 0.471 . . . . 0.0 111.086 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -127.87 144.9 51.09 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.748 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.443 ' CE1' ' H ' ' A' ' 99' ' ' ASN . 3.4 t-160 -54.54 117.67 3.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.924 0.392 . . . . 0.0 110.088 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.67 -14.75 27.06 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.074 -0.811 . . . . 0.0 111.074 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.425 ' CG ' HD22 ' A' ' 72' ' ' ASN . 17.3 m-20 -74.84 133.47 41.88 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.049 0.452 . . . . 0.0 110.316 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 49.4 t -112.38 133.68 57.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.676 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 89.6 mt -93.09 129.99 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 177.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 51.6 m -118.17 125.37 50.07 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.717 0.77 . . . . 0.0 112.43 -178.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.57 ' N ' ' O ' ' A' ' 93' ' ' ARG . 87.0 mt -116.62 123.08 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 114.505 -1.225 . . . . 0.0 108.505 178.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.453 ' CG2' ' N ' ' A' ' 92' ' ' ASP . 94.6 mt 33.24 -101.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.463 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.453 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 82.6 m-20 -105.86 7.02 32.06 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.64 0.257 . . . . 0.0 111.599 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.607 ' CZ ' ' CD1' ' A' ' 41' ' ' LEU . 40.7 mtm-85 -125.07 142.21 51.63 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.716 -178.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 51.0 m -139.51 157.32 46.04 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.499 -0.481 . . . . 0.0 110.617 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -125.96 120.47 30.45 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.655 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 44.4 ttm180 -80.35 127.08 31.96 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.251 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -92.56 125.7 37.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.805 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -121.6 127.41 50.85 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.263 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.443 ' H ' ' CE1' ' A' ' 84' ' ' HIS . 49.4 t-20 . . . . . 0 C--N 1.324 -0.54 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.654 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo . . . . . 0 N--CA 1.485 1.028 0 CA-C-O 121.651 0.605 . . . . 0.0 112.809 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 53.5 t -57.79 142.83 12.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.659 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 5.1 t . . . . . 0 C--N 1.327 -0.396 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.29 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo . . . . . 0 N--CA 1.5 1.881 0 N-CA-C 112.838 0.284 . . . . 0.0 112.838 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 70.2 m -69.37 -47.17 65.09 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.526 -0.47 . . . . 0.0 109.787 178.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -59.97 -46.67 88.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.624 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 94.5 mt -63.27 -41.29 99.01 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.821 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -65.18 -39.66 93.19 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.009 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -61.97 -41.8 98.41 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.074 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.528 ' NH2' ' CD2' ' A' ' 41' ' ' LEU . 24.9 mmt180 -63.3 -43.15 98.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.676 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -62.68 -41.98 99.39 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.482 -0.487 . . . . 0.0 109.863 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 5.3 t -65.15 -44.86 87.21 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 69.4 tp60 -57.43 -41.16 79.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.778 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--N 1.326 -0.415 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.91 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 . . . . . 0 C--O 1.236 0.348 0 CA-C-O 120.697 0.284 . . . . 0.0 110.255 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 56.5 mt -112.74 134.5 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 53.4 t -122.86 133.32 69.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -96.84 119.54 35.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.243 0.544 . . . . 0.0 111.018 -178.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -67.34 -45.67 75.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.249 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.68 158.18 34.82 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.437 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -60.58 150.32 82.37 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 122.873 2.382 . . . . 0.0 112.478 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 42.9 pt . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 121.581 0.705 . . . . 0.0 111.587 -179.319 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.0 p . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.834 0.349 . . . . 0.0 110.707 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 89.2 mtm-85 -87.18 121.77 30.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.346 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -126.26 134.75 51.09 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.679 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 36.4 tp -115.81 130.94 57.04 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.3 t -108.9 131.77 58.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.474 -179.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 m -92.21 114.01 26.43 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 121.13 0.49 . . . . 0.0 111.819 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.425 HG23 HD11 ' A' ' 10' ' ' ILE . 96.8 mt -81.32 146.09 7.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.151 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -92.71 157.7 16.31 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.768 HH12 HE21 ' B' ' 248' ' ' GLN . 87.8 mtm180 -59.91 -21.97 61.79 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.741 -0.383 . . . . 0.0 110.469 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.1 m -80.76 -12.01 59.52 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.1 35.51 8.11 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.9 t -120.72 134.31 64.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.667 0.27 . . . . 0.0 110.869 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -66.41 118.77 10.53 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.409 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -108.29 -130.84 6.31 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.196 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.03 148.34 39.88 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 122.546 2.164 . . . . 0.0 113.321 -178.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 65.0 m170 -104.03 140.0 38.36 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.115 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -111.7 97.87 38.89 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.505 -0.771 . . . . 0.0 108.958 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.46 127.04 12.11 Favored 'Trans proline' 0 C--N 1.314 -1.24 0 C-N-CA 121.194 1.263 . . . . 0.0 110.922 -178.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 92.8 mt -84.51 81.33 8.89 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.625 0.726 . . . . 0.0 110.563 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 91.1 p -86.72 -9.29 56.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.467 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.0 mt -102.6 145.35 29.77 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.008 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.6 t -65.09 -16.2 63.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.333 -178.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.07 132.63 42.0 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.972 0.415 . . . . 0.0 111.803 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.8 t -123.35 117.58 25.55 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.658 178.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 39.3 tp -115.55 127.4 55.24 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 120.702 0.287 . . . . 0.0 111.35 -178.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.488 ' O ' ' O ' ' A' ' 47' ' ' GLN . 8.4 m-85 -107.62 142.69 37.17 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.504 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 153.97 -170.36 32.58 Favored Glycine 0 N--CA 1.467 0.75 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.966 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.631 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 81.4 mtm-85 -84.0 -31.34 25.53 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.952 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.562 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -53.48 148.65 15.28 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.142 -178.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.436 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 10.1 tp -68.38 -42.82 84.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.801 0.334 . . . . 0.0 110.454 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.436 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 51.6 tp10 -53.09 -19.89 3.23 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.562 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 5.3 m -66.8 124.95 24.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.821 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -59.5 -27.41 66.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.312 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.454 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 97.7 mt -128.45 121.14 54.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.831 178.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 74.1 mtm180 -100.4 135.45 41.82 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.492 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.431 HG23 ' NE ' ' A' ' 93' ' ' ARG . 99.4 mt -119.99 131.8 71.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.458 0.647 . . . . 0.0 110.57 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -78.78 28.22 0.21 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.999 -1.0 . . . . 0.0 112.987 -178.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.434 ' HG ' ' HE ' ' A' ' 93' ' ' ARG . 7.3 mt -105.97 104.69 50.48 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 120.539 -0.465 . . . . 0.0 109.804 178.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -53.84 -8.74 0.96 Allowed 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 122.417 2.078 . . . . 0.0 113.254 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.9 m -95.62 3.69 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.637 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.631 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 5.9 p -95.45 138.23 21.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.88 162.54 18.8 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.487 0.66 . . . . 0.0 111.527 -179.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt -62.94 -40.55 97.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.433 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.676 ' O ' ' N ' ' A' ' 49' ' ' CYS . 15.1 mm100 -109.47 -13.28 14.6 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.381 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 25.8 t60 35.88 -73.31 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.288 -0.869 . . . . 0.0 113.163 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.676 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -149.35 149.76 31.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.19 0.519 . . . . 0.0 111.661 -179.564 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -135.85 134.9 39.32 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.675 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 89.4 mt -105.81 133.39 50.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.024 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -111.71 120.37 41.79 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 91.3 mt -104.46 110.02 29.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.581 0.705 . . . . 0.0 111.613 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.468 ' O ' ' N ' ' A' ' 56' ' ' GLN . 95.0 m-70 -112.19 144.37 41.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.644 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 54' ' ' HIS . 83.7 tt0 -41.18 -28.35 0.09 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.468 ' N ' ' O ' ' A' ' 54' ' ' HIS . 99.7 mm-40 -66.53 -68.82 0.34 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.151 178.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -158.75 -169.69 2.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.479 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -108.43 124.61 50.67 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.509 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 98.9 mt -115.58 129.32 72.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.084 0.468 . . . . 0.0 112.059 -178.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 43.9 tp -94.51 124.18 38.38 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.973 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -108.82 132.1 54.33 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.865 0.364 . . . . 0.0 110.019 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.407 HD22 ' HA ' ' A' ' 68' ' ' PRO . 33.5 t-20 -94.32 105.04 17.02 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.813 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -96.31 -6.56 37.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.033 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.2 t -85.58 97.58 10.16 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.199 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 77.5 p -78.09 -33.59 50.61 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 177.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.7 m -63.68 -46.25 86.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.817 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -142.48 95.98 6.41 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.777 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.407 ' HA ' HD22 ' A' ' 62' ' ' ASN . 52.7 Cg_exo -54.49 144.45 62.47 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 121.877 1.718 . . . . 0.0 112.122 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 33.0 m -72.09 138.07 47.52 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.128 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -100.98 139.28 36.88 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.642 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 70.8 t -129.97 135.42 61.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 52.43 32.87 11.98 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 119.774 -0.77 . . . . 0.0 109.063 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.23 27.85 69.25 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.611 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 34.4 t -142.23 137.32 30.65 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 117.671 0.736 . . . . 0.0 111.91 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -69.18 143.6 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.511 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.562 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 1.2 pt -113.47 108.1 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 121.564 0.697 . . . . 0.0 110.553 178.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -70.8 -31.62 68.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.282 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.485 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -129.38 -179.35 0.98 Allowed Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.752 -179.588 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 24.7 Cg_exo -62.6 146.94 95.41 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 122.779 2.32 . . . . 0.0 112.061 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.8 p -140.12 141.69 33.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.019 0.438 . . . . 0.0 111.164 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -76.56 133.44 39.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.724 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 98.3 mt -88.93 139.14 30.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.206 0.527 . . . . 0.0 111.501 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.405 ' N ' ' OD2' ' A' ' 86' ' ' ASP . 99.4 mttt -123.2 149.76 44.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.803 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.772 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 8.1 t60 -54.39 121.92 9.33 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.125 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.8 -13.24 38.41 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.405 ' OD2' ' N ' ' A' ' 83' ' ' LYS . 84.3 m-20 -68.88 136.58 52.85 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.056 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.401 ' CG1' ' OG ' ' A' ' 94' ' ' SER . 70.3 t -109.14 131.56 59.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.422 -178.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 25.7 mm -93.37 129.58 43.62 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 178.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.0 m -120.42 123.88 44.1 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.104 -0.639 . . . . 0.0 112.205 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.655 ' CG2' HH12 ' A' ' 93' ' ' ARG . 94.9 mt -122.61 126.75 74.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.367 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.454 ' C ' ' O ' ' A' ' 90' ' ' ILE . 47.9 mm 35.34 -105.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 121.041 -0.264 . . . . 0.0 111.246 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.477 ' OD1' ' CD2' ' B' ' 242' ' ' LEU . 87.8 m-20 -109.12 16.4 22.55 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.747 0.308 . . . . 0.0 111.064 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.655 HH12 ' CG2' ' A' ' 90' ' ' ILE . 1.8 mtm105 -126.39 144.57 50.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.073 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.401 ' OG ' ' CG1' ' A' ' 87' ' ' VAL . 47.4 t -138.7 148.73 44.31 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 178.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.48 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 27.3 m-85 -125.6 125.11 42.63 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.659 -179.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 78.4 mtp85 -85.91 128.02 34.74 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.433 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.559 ' CZ ' ' OD1' ' A' ' 99' ' ' ASN . 92.0 t80 -95.41 127.17 41.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.945 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -138.67 124.6 19.96 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.222 -0.591 . . . . 0.0 111.969 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.772 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 96.9 m-20 . . . . . 0 N--CA 1.463 0.217 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.107 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo . . . . . 0 N--CA 1.483 0.882 0 CA-C-O 121.826 0.678 . . . . 0.0 113.115 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -67.37 139.89 20.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.327 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 6.3 t . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.016 -179.941 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo . . . . . 0 N--CA 1.504 2.093 0 N-CA-C 113.842 0.67 . . . . 0.0 113.842 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 35.4 m -74.61 -43.21 56.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.314 0.578 . . . . 0.0 109.851 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . 0.606 ' CZ ' ' NE ' ' B' ' 245' ' ' ARG . 68.7 t80 -59.18 -45.96 89.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.926 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . 0.477 ' CD2' ' OD1' ' A' ' 92' ' ' ASP . 81.6 mt -62.47 -41.73 98.99 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.777 -0.192 . . . . 0.0 111.382 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -65.86 -36.9 84.72 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.676 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -59.63 -42.85 93.63 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.682 ' NH1' HE22 ' B' ' 248' ' ' GLN . 2.4 mpt_? -60.64 -41.77 95.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.193 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -60.83 -40.45 92.82 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 16.5 m -64.26 -46.55 83.22 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.622 178.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . 0.768 HE21 HH12 ' A' ' 12' ' ' ARG . 27.1 mt-30 -61.62 -36.48 80.87 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.12 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 42.1 t . . . . . 0 C--N 1.329 -0.29 0 C-N-CA 120.347 -0.541 . . . . 0.0 110.099 179.611 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 57.8 mp0 . . . . . 0 CA--C 1.529 0.162 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 70.8 mt -117.36 134.28 61.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 54.2 t -127.74 135.06 64.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.295 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -95.28 117.69 30.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.217 0.532 . . . . 0.0 111.151 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -65.13 -44.18 89.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.08 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -91.55 150.43 41.1 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.658 -178.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -67.03 146.07 75.85 Favored 'Trans proline' 0 N--CA 1.497 1.678 0 C-N-CA 122.644 2.229 . . . . 0.0 112.697 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 25.1 pt . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.114 179.282 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.9 p . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.511 0.196 . . . . 0.0 111.487 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 87.8 mtm-85 -104.38 125.79 50.91 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.076 0.465 . . . . 0.0 111.638 -178.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -134.04 138.67 45.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.922 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 31.4 tp -113.29 129.62 56.48 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.6 m -107.58 133.52 52.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-O 121.085 0.469 . . . . 0.0 110.681 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.2 m -90.68 115.39 27.74 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.457 -0.792 . . . . 0.0 113.136 -177.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.4 mt -79.02 142.1 14.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 178.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -88.74 157.64 18.44 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.753 HH12 ' NE2' ' B' ' 248' ' ' GLN . 84.2 mtp180 -59.04 -33.07 70.33 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.021 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.7 t -69.91 -18.6 63.39 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.267 0.556 . . . . 0.0 109.849 178.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.82 34.75 4.24 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.6 t -124.95 134.16 67.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.13 0.49 . . . . 0.0 111.517 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -70.11 131.31 44.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.253 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -113.13 -128.04 4.8 Favored Glycine 0 CA--C 1.539 1.545 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.586 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -73.74 154.76 49.2 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.35 2.033 . . . . 0.0 112.625 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.498 ' O ' ' CG2' ' B' ' 267' ' ' ILE . 7.6 m170 -110.01 139.98 44.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.269 0.557 . . . . 0.0 111.177 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -108.6 99.38 33.27 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.014 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.87 128.14 15.51 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 121.19 1.26 . . . . 0.0 111.334 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 72.5 mt -79.06 47.86 0.81 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.301 -178.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 99.5 p -59.1 -24.87 63.32 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 71.0 mt -78.35 139.52 38.8 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.417 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.8 t -66.15 -18.45 65.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.354 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.479 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 85.1 m -133.02 135.17 45.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.813 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.8 t -127.06 115.34 19.03 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.2 tp -114.93 129.88 56.8 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.195 0.522 . . . . 0.0 110.915 -178.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.515 ' O ' ' O ' ' A' ' 47' ' ' GLN . 14.3 m-85 -110.96 135.16 51.89 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.146 -0.933 . . . . 0.0 109.576 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 160.21 -172.06 36.59 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.704 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -81.2 -31.6 33.86 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.705 0.288 . . . . 0.0 110.998 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.529 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -54.9 150.31 18.75 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 111.714 -0.554 . . . . 0.0 111.714 -178.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.404 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 10.9 tp -66.44 -40.05 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-O 120.791 0.329 . . . . 0.0 110.158 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.404 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 96.9 mt-10 -51.72 -27.87 13.27 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.338 -0.545 . . . . 0.0 109.542 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.529 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 14.2 m -57.16 110.99 0.93 Allowed 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.934 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.479 ' OD2' ' O ' ' A' ' 26' ' ' THR . 97.5 m-20 -51.18 -18.75 0.96 Allowed 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.455 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 76.2 mt -134.06 125.77 48.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.94 177.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 71.5 mtm180 -103.46 135.06 45.76 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.612 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 99.2 mt -117.17 129.1 74.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -77.25 25.48 0.17 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -177.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 67.2 mt -96.81 128.06 37.08 Favored Pre-proline 0 N--CA 1.466 0.35 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.554 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -73.22 -9.75 23.58 Favored 'Trans proline' 0 N--CA 1.487 1.132 0 C-N-CA 122.052 1.835 . . . . 0.0 112.848 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.416 HG23 ' CZ ' ' B' ' 241' ' ' PHE . 28.9 m -96.71 4.2 9.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 120.758 0.313 . . . . 0.0 110.582 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 38.1 t -93.08 135.71 27.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.871 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.9 m -70.67 173.01 7.69 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.473 0.654 . . . . 0.0 111.584 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 40.7 mtmt -63.73 -41.66 98.02 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.527 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.614 ' O ' ' N ' ' A' ' 49' ' ' CYS . 86.1 mt-30 -114.52 -20.95 10.55 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.919 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 27.5 t60 37.75 -76.13 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 113.971 1.101 . . . . 0.0 113.971 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.614 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -128.78 133.27 48.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.926 0.393 . . . . 0.0 111.516 -178.621 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -125.66 127.95 47.07 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.31 178.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 94.5 mt -110.25 132.41 58.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -114.5 120.3 39.78 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.3 mt -102.93 114.94 43.95 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 C-N-CA 119.714 -0.794 . . . . 0.0 111.968 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.55 ' O ' ' N ' ' A' ' 56' ' ' GLN . 97.0 m-70 -112.57 141.16 46.66 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.221 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.469 ' C ' ' O ' ' A' ' 54' ' ' HIS . 95.1 mt-10 -39.73 -26.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 -178.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.55 ' N ' ' O ' ' A' ' 54' ' ' HIS . 84.6 mt-30 -66.05 -67.98 0.4 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.948 177.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -161.84 -158.27 0.53 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.479 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -116.71 129.76 56.32 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.575 0.226 . . . . 0.0 110.66 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.438 HG21 HD11 ' A' ' 59' ' ' ILE . 98.2 mt -119.55 131.59 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 121.046 0.451 . . . . 0.0 111.762 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 28.7 tp -99.27 129.34 45.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.977 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -116.48 138.22 51.55 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.825 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 38.2 p-10 -101.89 107.33 18.47 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.629 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -94.27 -11.61 29.82 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.896 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.3 p -77.19 100.75 5.9 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.286 178.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.7 p -73.43 -34.27 65.35 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.11 -40.29 71.55 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.699 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -144.07 90.95 6.63 Favored Pre-proline 0 N--CA 1.467 0.412 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -64.81 149.45 89.61 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 C-N-CA 120.988 1.126 . . . . 0.0 112.089 -179.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.8 m -71.11 151.51 44.4 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.386 0.612 . . . . 0.0 111.776 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -106.7 147.06 30.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.833 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.501 ' CG2' ' OD1' ' A' ' 86' ' ' ASP . 4.8 p -132.88 134.86 57.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 51.75 32.11 9.02 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.185 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.88 27.64 70.26 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.878 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 68.6 m -139.26 142.35 37.78 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.2 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.7 t -75.45 133.3 31.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.381 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.3 pt -101.84 102.12 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.516 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -64.1 -34.42 78.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.492 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.402 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 1.3 mt-10 -129.74 178.49 1.68 Allowed Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.79 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.402 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 31.3 Cg_exo -60.09 143.63 99.53 Favored 'Trans proline' 0 N--CA 1.504 2.09 0 C-N-CA 122.742 2.295 . . . . 0.0 112.469 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.5 p -135.91 138.46 47.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.371 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 83.3 mtm-85 -73.17 129.88 39.02 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.5 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 97.0 mt -83.77 137.41 33.74 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.161 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -129.17 152.98 48.16 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.363 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.609 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 7.5 t60 -53.36 119.18 4.48 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.264 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.64 -14.46 29.73 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 87' ' ' VAL . 59.4 t0 -66.25 130.41 43.14 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.229 0.538 . . . . 0.0 110.623 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.531 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 71.1 t -109.27 130.85 61.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.001 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 87.6 mt -105.78 134.1 48.27 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.6 m -118.21 124.33 47.65 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 121.191 0.519 . . . . 0.0 111.64 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.576 ' N ' ' O ' ' A' ' 93' ' ' ARG . 97.4 mt -114.82 126.08 72.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.417 ' C ' ' O ' ' A' ' 90' ' ' ILE . 36.2 mm 38.28 -109.3 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.697 -179.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.537 ' OD1' ' CD2' ' B' ' 242' ' ' LEU . 98.1 m-20 -107.77 14.61 25.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.501 0.667 . . . . 0.0 110.011 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.576 ' O ' ' N ' ' A' ' 90' ' ' ILE . 18.8 mtp85 -126.86 146.95 50.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.298 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 66.4 m -137.69 150.65 47.5 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 121.235 0.54 . . . . 0.0 110.778 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -124.39 122.28 37.23 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.69 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -89.79 135.84 33.39 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 119.378 -0.929 . . . . 0.0 110.685 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -96.75 124.72 40.81 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.431 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -124.79 122.08 36.41 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.609 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 46.3 t30 . . . . . 0 C--N 1.333 -0.136 0 C-N-CA 120.671 -0.411 . . . . 0.0 111.257 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo . . . . . 0 N--CA 1.494 1.545 0 CA-C-O 121.835 0.681 . . . . 0.0 113.767 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 24.0 t -67.99 135.08 29.16 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.921 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 16.0 t . . . . . 0 C--N 1.325 -0.482 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.391 179.839 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo . . . . . 0 N--CA 1.506 2.236 0 N-CA-C 113.905 0.694 . . . . 0.0 113.905 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 21.2 m -71.64 -45.93 60.55 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.202 0.525 . . . . 0.0 109.933 178.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . 0.416 ' CZ ' HG23 ' A' ' 43' ' ' VAL . 45.9 t80 -58.09 -44.89 87.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.068 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . 0.537 ' CD2' ' OD1' ' A' ' 92' ' ' ASP . 93.7 mt -62.21 -40.81 97.35 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.566 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -61.62 -45.17 95.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.362 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 -62.4 -43.07 99.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.733 0.301 . . . . 0.0 110.995 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.523 ' CZ ' ' NE ' ' A' ' 12' ' ' ARG . 16.1 mmm180 -58.67 -44.88 90.34 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.76 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -63.27 -39.24 94.05 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.874 0.369 . . . . 0.0 110.175 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 38.8 t -65.48 -44.77 86.09 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 122.0 0.905 . . . . 0.0 109.137 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . 0.753 ' NE2' HH12 ' A' ' 12' ' ' ARG . 57.8 tt0 -59.62 -39.76 85.34 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.74 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 26.0 t . . . . . 0 CA--C 1.519 -0.25 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.659 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . 0.472 ' OE1' ' NH1' ' B' ' 245' ' ' ARG . 98.5 mt-10 . . . . . 0 N--CA 1.465 0.299 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 78.7 mt -112.38 132.01 62.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 46.0 t -127.5 134.18 66.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.193 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -99.09 123.58 43.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.341 0.591 . . . . 0.0 110.897 -178.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -64.28 -40.6 96.3 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.414 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -95.81 164.67 18.21 Favored Pre-proline 0 N--CA 1.463 0.224 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.254 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -61.27 145.13 98.81 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 122.283 1.989 . . . . 0.0 110.916 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . 0.498 ' CG2' ' O ' ' A' ' 19' ' ' HIS . 2.6 mt . . . . . 0 C--N 1.321 -0.657 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.425 -178.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.4 p . . . . . 0 CA--C 1.531 0.243 0 CA-C-O 120.79 0.329 . . . . 0.0 111.471 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.5 mtt85 -88.28 129.81 35.27 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.249 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -126.09 136.18 52.61 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.27 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 30.6 tp -115.82 132.58 56.6 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.9 t -110.2 132.37 58.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.063 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 m -88.72 114.2 25.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.024 -0.534 . . . . 0.0 112.118 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 95.5 mt -85.13 144.02 10.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -96.09 160.33 14.5 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.503 HH12 ' CD ' ' B' ' 260' ' ' GLU . 94.7 mtm-85 -62.38 -20.2 64.18 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.901 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.0 p -78.58 -16.25 57.63 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 120.592 -0.443 . . . . 0.0 109.909 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.41 17.72 30.56 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.369 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.0 m -115.14 135.63 54.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 117.191 0.496 . . . . 0.0 110.169 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -72.52 142.86 48.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.341 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -126.72 -117.72 2.14 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.499 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.63 146.77 44.26 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.161 1.907 . . . . 0.0 112.129 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.595 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -108.03 138.98 43.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.06 0.457 . . . . 0.0 110.909 -179.69 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -110.1 104.85 56.45 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.955 -178.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.83 130.19 14.29 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.211 1.274 . . . . 0.0 112.016 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.4 mt -83.74 60.27 5.65 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.603 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.3 t -62.83 -40.67 98.15 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 69.9 mt -71.6 144.1 49.59 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.149 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 92.3 p -69.41 -14.06 62.7 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.055 -0.521 . . . . 0.0 112.101 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.407 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 62.6 m -130.42 133.65 46.51 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.38 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.5 t -124.95 115.94 21.39 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 58.5 tp -113.56 130.26 56.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.911 0.386 . . . . 0.0 110.928 -178.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.522 ' O ' ' O ' ' A' ' 47' ' ' GLN . 59.2 m-85 -110.17 136.33 49.56 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.219 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 160.83 -174.26 37.45 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.284 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.581 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 82.3 mtm-85 -79.93 -30.48 39.98 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.552 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -53.4 149.18 13.67 Favored Glycine 0 N--CA 1.467 0.718 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.496 -177.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.437 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 10.5 tp -67.65 -43.24 86.93 Favored 'Isoleucine or valine' 0 C--N 1.341 0.2 0 CA-C-O 120.868 0.366 . . . . 0.0 111.008 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.437 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 81.3 tt0 -56.09 -19.39 12.9 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.825 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.552 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 9.6 m -63.02 126.44 27.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.607 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.407 ' OD2' ' O ' ' A' ' 26' ' ' THR . 89.8 m-20 -61.41 -32.6 72.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.337 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 50.5 mm -123.38 114.58 42.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.195 178.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 47.0 mtm180 -99.72 137.14 38.62 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 121.169 -0.212 . . . . 0.0 110.667 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.441 HG23 HD12 ' A' ' 39' ' ' ILE . 82.2 mt -120.06 131.27 72.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 120.184 -0.606 . . . . 0.0 111.093 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -73.22 28.31 0.06 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.332 -0.849 . . . . 0.0 113.001 -177.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.568 ' CD1' ' NH1' ' A' ' 93' ' ' ARG . 65.9 mt -113.06 130.92 23.1 Favored Pre-proline 0 C--N 1.323 -0.564 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.692 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.84 -9.67 23.98 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 122.262 1.974 . . . . 0.0 112.184 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.1 m -90.86 2.6 7.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.026 0.441 . . . . 0.0 110.017 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.581 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 55.2 t -94.51 132.3 38.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.7 m -71.22 169.2 15.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.562 0.696 . . . . 0.0 111.932 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -62.46 -41.78 99.0 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.442 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.639 ' O ' ' N ' ' A' ' 49' ' ' CYS . 96.3 mt-30 -116.34 -15.26 10.99 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.281 0.363 . . . . 0.0 110.834 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.0 t60 31.08 -74.25 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.639 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.5 138.34 47.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.212 0.529 . . . . 0.0 112.126 -178.67 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -127.99 133.35 49.16 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.443 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.6 mt -118.25 133.94 63.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.026 0.441 . . . . 0.0 110.705 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.58 ' CD ' ' HE2' ' A' ' 54' ' ' HIS . 85.1 tt0 -121.03 124.07 43.93 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.0 mt -106.54 117.26 51.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.661 0.743 . . . . 0.0 112.914 -178.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.58 ' HE2' ' CD ' ' A' ' 52' ' ' GLU . 94.3 m-70 -110.66 143.3 41.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.098 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 54' ' ' HIS . 83.2 tt0 -40.39 -30.32 0.1 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.278 -0.569 . . . . 0.0 109.807 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.434 ' N ' ' O ' ' A' ' 54' ' ' HIS . 59.9 tt0 -64.11 -67.62 0.42 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -157.21 -169.44 2.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.071 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.75 125.95 54.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.767 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.411 HD11 HG21 ' A' ' 59' ' ' ILE . 96.6 mt -115.48 128.52 72.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.31 0.576 . . . . 0.0 111.933 -178.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 24.9 tp -99.07 132.1 44.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.968 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -115.4 135.83 53.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.528 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.59 ' ND2' ' H ' ' A' ' 69' ' ' THR . 12.3 t-20 -97.17 108.58 21.34 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.929 0.395 . . . . 0.0 111.185 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -100.88 -8.57 22.43 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.263 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.7 t -74.64 98.84 3.5 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.092 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.2 m -74.51 -40.38 61.81 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.25 0.547 . . . . 0.0 110.236 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.54 -43.38 94.16 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.264 -178.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -144.34 97.36 5.17 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.011 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -57.25 149.4 64.54 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.977 1.785 . . . . 0.0 111.858 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.59 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 85.4 m -76.41 156.34 33.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.324 0.583 . . . . 0.0 110.933 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -114.84 139.36 49.82 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.61 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 55.3 t -128.42 136.23 60.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.54 ' ND2' ' OD1' ' A' ' 86' ' ' ASP . 82.2 m-20 53.25 33.36 15.29 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 119.777 -0.769 . . . . 0.0 109.1 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.04 27.38 73.93 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 115.106 -0.952 . . . . 0.0 112.032 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 74.3 m -141.56 136.37 31.02 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 117.29 0.545 . . . . 0.0 111.31 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.7 p -63.46 144.01 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.803 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.3 pt -118.78 90.96 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.091 0 CA-C-O 121.065 0.459 . . . . 0.0 110.538 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -67.46 -26.94 66.64 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.443 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -122.58 169.34 9.9 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.063 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.79 144.23 99.48 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.075 1.85 . . . . 0.0 111.773 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.3 m -136.47 138.43 46.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.22 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -73.88 134.48 43.25 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.498 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.7 mt -86.09 135.81 33.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.03 0.443 . . . . 0.0 111.324 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -127.79 148.33 50.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.502 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.479 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 5.3 t60 -48.86 116.16 1.54 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.081 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.01 -13.87 40.85 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.161 -0.775 . . . . 0.0 111.161 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.54 ' OD1' ' ND2' ' A' ' 72' ' ' ASN . 34.4 t70 -66.23 133.7 51.16 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 70.8 t -114.19 133.29 60.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.354 -0.538 . . . . 0.0 111.517 -178.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 71.1 mt -100.02 131.77 46.83 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 89.4 m -123.97 125.9 45.39 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.83 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.504 ' O ' ' N ' ' A' ' 92' ' ' ASP . 94.2 mt -112.5 123.65 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.591 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.44 ' C ' ' O ' ' A' ' 90' ' ' ILE . 94.5 mt 38.61 -94.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.028 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 90' ' ' ILE . 52.1 t0 -121.71 16.35 11.08 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 120.941 -0.303 . . . . 0.0 111.564 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.568 ' NH1' ' CD1' ' A' ' 41' ' ' LEU . 44.3 mtm-85 -128.43 139.05 52.56 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.0 m -133.69 152.14 51.81 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 119.979 -0.689 . . . . 0.0 111.169 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -123.85 121.74 36.16 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.088 178.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -85.21 131.75 34.38 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.113 0.483 . . . . 0.0 111.304 -178.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -95.63 124.73 39.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.003 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -125.6 122.31 36.09 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.967 0.413 . . . . 0.0 110.702 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.479 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 55.3 t-20 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.957 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo . . . . . 0 N--CA 1.486 1.057 0 CA-C-O 121.474 0.531 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 24.1 t -111.08 132.55 59.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.273 -179.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 40.1 t . . . . . 0 C--N 1.332 -0.188 0 CA-C-O 120.97 0.414 . . . . 0.0 110.046 179.639 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo . . . . . 0 N--CA 1.496 1.66 0 CA-C-O 120.795 0.248 . . . . 0.0 112.043 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 18.8 m -74.16 -44.35 53.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.316 0.579 . . . . 0.0 109.806 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . 0.485 ' CE1' ' NH2' ' B' ' 245' ' ' ARG . 82.1 t80 -58.14 -46.55 85.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.0 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 95.0 mt -64.5 -39.62 94.12 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.154 0.502 . . . . 0.0 109.993 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -61.33 -41.7 97.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.577 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -60.9 -42.24 97.66 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.326 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.485 ' NH2' ' CE1' ' B' ' 241' ' ' PHE . 47.8 mmt-85 -61.17 -40.49 94.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.93 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -61.34 -39.27 89.96 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 24.0 m -65.76 -43.73 88.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -60.48 -37.65 81.73 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 114.511 -1.222 . . . . 0.0 110.426 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 46.8 t . . . . . 0 CA--C 1.531 0.229 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.051 179.003 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . 0.503 ' CD ' HH12 ' A' ' 12' ' ' ARG . 97.5 mt-10 . . . . . 0 N--CA 1.462 0.143 0 CA-C-O 120.426 0.155 . . . . 0.0 111.053 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 61.5 mt -112.34 135.06 52.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 43.6 t -123.86 133.3 69.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.202 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -94.79 117.46 30.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.988 0.423 . . . . 0.0 110.976 -178.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -65.39 -47.01 77.81 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.275 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -82.34 160.89 61.31 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.201 -0.908 . . . . 0.0 110.257 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -60.37 141.65 96.18 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.162 1.908 . . . . 0.0 111.753 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . 0.494 ' CD1' ' O ' ' A' ' 19' ' ' HIS . 13.8 tt . . . . . 0 C--N 1.324 -0.532 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.919 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 35.3 p . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.734 0.302 . . . . 0.0 111.267 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.643 HH22 ' CB ' ' A' ' 99' ' ' ASN . 7.0 mmp_? -90.52 118.0 29.64 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -178.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.664 ' NH2' ' ND1' ' A' ' 19' ' ' HIS . 77.8 ttt-85 -127.36 127.23 43.9 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.696 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 77.6 mt -113.67 144.71 42.47 Favored 'General case' 0 C--N 1.339 0.139 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 51.2 t -121.12 130.94 74.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.47 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.1 m -81.37 142.17 33.28 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.579 0.704 . . . . 0.0 112.432 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.402 ' CD1' ' OD1' ' A' ' 16' ' ' ASP . 47.0 mm -108.59 134.35 50.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.62 177.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -90.15 156.58 18.24 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.998 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.679 ' NH1' ' NH2' ' B' ' 245' ' ' ARG . 88.8 mtm180 -58.85 -25.91 63.7 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.247 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.9 p -78.26 -10.11 59.52 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.78 37.85 9.14 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.7 t -122.1 134.3 65.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.674 0.273 . . . . 0.0 110.658 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.402 ' OD1' ' CD1' ' A' ' 10' ' ' ILE . 96.8 m-20 -71.4 133.39 45.9 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.34 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -122.41 -118.02 2.46 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 120.806 -0.711 . . . . 0.0 111.887 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -74.65 145.04 32.38 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.265 1.976 . . . . 0.0 112.812 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.664 ' ND1' ' NH2' ' A' ' 6' ' ' ARG . 17.9 m170 -101.73 140.69 35.67 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.66 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -114.42 97.03 45.1 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.441 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -79.67 139.22 14.01 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 121.836 1.691 . . . . 0.0 110.66 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 92.8 mt -101.43 124.08 46.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.747 0.784 . . . . 0.0 110.529 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.6 p -124.18 -1.31 8.22 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.261 -1.336 . . . . 0.0 108.683 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 42.2 mt -104.67 147.99 27.06 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 114.508 -1.224 . . . . 0.0 109.732 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 96.1 p -65.98 -17.26 64.56 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.345 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 85.2 m -132.37 133.77 44.36 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.246 0.546 . . . . 0.0 112.122 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.573 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 2.9 t -126.4 121.51 32.68 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.4 tp -120.9 132.22 54.84 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.824 0.345 . . . . 0.0 111.922 -177.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.573 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 8.9 m-85 -109.22 140.79 42.38 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 151.44 -177.78 29.17 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.447 178.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.456 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 46.0 mtm180 -74.19 -33.52 63.45 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.501 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -48.12 148.44 4.07 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.808 -0.71 . . . . 0.0 111.587 -178.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.503 ' CD1' ' NH1' ' A' ' 38' ' ' ARG . 9.9 tp -66.53 -41.96 89.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-O 120.9 0.381 . . . . 0.0 110.438 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.443 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 79.2 tt0 -58.55 -25.83 62.92 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 17.9 m -52.73 115.45 1.82 Allowed 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -53.05 -25.0 11.1 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.538 -178.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.481 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 96.2 mt -129.71 122.06 54.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.503 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 83.8 mtp180 -106.06 135.53 47.35 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.015 0.435 . . . . 0.0 110.853 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 95.5 mt -118.09 129.55 74.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.059 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -73.73 34.24 0.08 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -177.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 55.9 mt -111.24 129.04 24.44 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.684 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.76 -10.25 24.76 Favored 'Trans proline' 0 N--CA 1.489 1.237 0 C-N-CA 122.445 2.096 . . . . 0.0 113.101 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.9 m -94.15 1.12 9.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.562 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.456 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 42.6 t -89.75 136.05 24.65 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.24 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.072 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.6 m -69.8 164.79 22.84 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.424 0.63 . . . . 0.0 111.297 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -62.65 -43.26 99.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.287 -179.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.594 ' O ' ' N ' ' A' ' 49' ' ' CYS . 92.7 mm-40 -111.34 -24.15 10.38 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.318 0.58 . . . . 0.0 110.002 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.0 t60 39.22 -78.05 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.251 -0.886 . . . . 0.0 113.382 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.594 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -129.53 133.73 47.39 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.385 0.612 . . . . 0.0 112.225 -178.663 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -126.83 132.44 50.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.307 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 93.7 mt -117.54 135.41 58.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.568 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.584 ' CD ' ' HE2' ' A' ' 54' ' ' HIS . 79.7 tt0 -120.48 124.62 45.87 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.441 HD11 HG23 ' A' ' 53' ' ' ILE . 84.9 mt -102.04 117.83 47.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.324 0.583 . . . . 0.0 111.57 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.584 ' HE2' ' CD ' ' A' ' 52' ' ' GLU . 97.5 m-70 -112.94 141.01 47.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.258 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 54' ' ' HIS . 94.1 mt-10 -39.75 -28.85 0.05 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -178.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.49 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 58.1 tt0 -63.55 -67.67 0.41 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.301 178.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.49 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 3.7 tp10 -158.16 -164.43 1.5 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.336 -178.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -111.49 129.96 55.88 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.9 mt -118.87 128.09 75.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.386 0.612 . . . . 0.0 112.157 -178.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.437 ' CD1' ' HG ' ' A' ' 49' ' ' CYS . 28.1 tp -97.29 127.87 43.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.934 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -113.23 136.47 52.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.127 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.431 HD22 ' HA ' ' A' ' 68' ' ' PRO . 58.5 t-20 -97.12 104.61 16.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.188 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -96.51 -9.7 29.03 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 120.757 0.313 . . . . 0.0 110.747 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.506 ' H ' ' HG ' ' A' ' 64' ' ' SER . 0.7 OUTLIER -70.15 101.44 1.85 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.101 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 79.0 p -87.73 -10.13 52.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.206 0.527 . . . . 0.0 109.591 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.92 -43.22 6.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.249 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -135.85 94.86 14.31 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.025 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.431 ' HA ' HD22 ' A' ' 62' ' ' ASN . 50.4 Cg_exo -57.17 142.9 94.51 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 121.966 1.777 . . . . 0.0 113.014 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 95.9 m -74.49 144.1 44.3 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.401 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -104.88 139.47 39.57 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.056 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 68.8 t -131.02 133.11 63.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 53.65 32.11 13.92 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.149 -0.621 . . . . 0.0 110.065 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.45 26.88 68.9 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-N 115.606 -0.724 . . . . 0.0 112.129 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 43.4 t -142.68 139.93 31.37 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 117.36 0.58 . . . . 0.0 111.08 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.2 p -70.25 140.85 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.486 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.8 pt -113.96 90.72 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.82 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -68.43 -28.94 67.51 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.478 ' N ' ' CD ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -116.49 162.18 28.0 Favored Pre-proline 0 C--O 1.232 0.168 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.582 179.129 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -66.56 150.54 83.94 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.571 2.181 . . . . 0.0 112.466 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.4 m -141.78 141.76 29.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.142 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -70.52 129.92 40.49 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.077 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.3 mt -79.64 140.17 37.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.175 0.512 . . . . 0.0 111.13 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -131.84 151.23 51.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.729 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.667 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 6.1 t60 -53.78 120.14 5.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.052 0.453 . . . . 0.0 111.162 -179.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.81 -17.67 32.54 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -67.51 135.06 52.44 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 120.184 -0.607 . . . . 0.0 110.258 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.5 t -113.67 132.51 62.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.115 -178.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.451 ' O ' ' OG ' ' A' ' 94' ' ' SER . 84.5 mt -103.78 132.78 49.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 90.1 m -122.63 128.97 51.35 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.48 0.657 . . . . 0.0 112.646 -178.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.488 ' O ' ' N ' ' A' ' 93' ' ' ARG . 81.2 mt -113.91 126.02 71.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.499 178.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.458 ' C ' ' O ' ' A' ' 90' ' ' ILE . 41.2 mm 35.99 -98.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.746 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 90' ' ' ILE . 41.3 p-10 -116.13 12.11 15.44 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.04 0.448 . . . . 0.0 110.918 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.731 HH22 ' NH2' ' B' ' 245' ' ' ARG . 53.9 mtt85 -123.07 140.44 53.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.334 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' A' ' 88' ' ' ILE . 29.4 t -137.27 151.15 48.38 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 120.319 -0.553 . . . . 0.0 110.722 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -123.6 122.21 37.57 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -84.65 136.35 33.79 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.167 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.61 ' CZ ' ' CZ ' ' A' ' 5' ' ' ARG . 60.0 t80 -94.48 118.02 31.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.742 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -125.47 125.71 43.75 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 111.971 0.359 . . . . 0.0 111.971 -178.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.667 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 12.1 t-20 . . . . . 0 C--N 1.333 -0.142 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo . . . . . 0 N--CA 1.487 1.138 0 CA-C-O 121.499 0.541 . . . . 0.0 112.922 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 54.9 t -64.71 139.82 20.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.716 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 7.3 t . . . . . 0 C--N 1.329 -0.312 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 179.188 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo . . . . . 0 N--CA 1.496 1.666 0 N-CA-C 112.83 0.281 . . . . 0.0 112.83 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 90.9 m -73.61 -45.19 54.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.546 0.689 . . . . 0.0 109.668 178.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -58.33 -46.22 86.61 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.622 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 94.9 mt -62.67 -41.64 99.2 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 120.981 0.419 . . . . 0.0 110.481 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -59.29 -37.06 76.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.415 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -62.92 -43.4 98.91 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.012 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.731 ' NH2' HH22 ' A' ' 93' ' ' ARG . 26.5 mmm180 -58.59 -41.65 86.24 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -64.21 -43.22 95.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.349 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 27.9 t -64.08 -44.98 90.7 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -57.38 -40.31 77.93 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.29 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 54.3 t . . . . . 0 C--N 1.328 -0.358 0 C-N-CA 120.658 -0.417 . . . . 0.0 109.916 178.957 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . 0.57 ' OE1' ' NH2' ' B' ' 245' ' ' ARG . 96.4 mt-10 . . . . . 0 N--CA 1.467 0.421 0 CA-C-O 120.793 0.33 . . . . 0.0 111.163 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . 0.4 HG21 HD13 ' B' ' 261' ' ' ILE . 89.6 mt -109.78 133.08 56.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 41.5 t -124.32 133.71 68.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.945 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -98.77 121.29 40.53 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.299 0.571 . . . . 0.0 110.818 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . 0.43 ' HZ2' ' HA ' ' A' ' 34' ' ' GLU . 88.5 tttt -65.92 -39.2 90.32 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.905 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . 0.414 ' CB ' ' CD ' ' B' ' 266' ' ' PRO . 0.6 OUTLIER -103.2 179.47 0.96 Allowed Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.099 -178.461 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . 0.414 ' CD ' ' CB ' ' B' ' 265' ' ' GLN . 24.4 Cg_exo -62.25 149.81 89.27 Favored 'Trans proline' 0 N--CA 1.498 1.742 0 C-N-CA 122.822 2.348 . . . . 0.0 113.536 -178.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 15.8 pt . . . . . 0 N--CA 1.465 0.308 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.051 179.535 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.0 p . . . . . 0 CA--C 1.524 -0.027 0 CA-C-O 120.864 0.364 . . . . 0.0 110.373 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.72 HH11 ' HH ' ' A' ' 97' ' ' TYR . 94.3 mtt-85 -97.25 115.01 26.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.957 -178.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.735 HH21 ' ND1' ' A' ' 19' ' ' HIS . 73.5 ttt180 -128.24 130.8 48.49 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.667 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 34.2 tp -113.17 133.25 55.14 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.0 t -109.87 131.57 60.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.851 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.1 m -92.17 113.86 26.25 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.942 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.8 mt -79.15 143.69 12.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.901 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -87.99 159.37 18.33 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.153 0.502 . . . . 0.0 110.64 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.429 ' HD2' HH21 ' A' ' 93' ' ' ARG . 82.1 mtp180 -53.27 -32.42 48.46 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.066 -178.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 91.1 p -79.37 -7.39 58.33 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.954 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.15 31.96 11.25 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.7 t -117.86 132.71 66.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -75.11 138.91 42.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.556 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -131.94 -114.89 1.63 Allowed Glycine 0 CA--C 1.538 1.479 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.321 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -74.07 148.31 39.65 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.46 2.107 . . . . 0.0 112.56 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.735 ' ND1' HH21 ' A' ' 6' ' ' ARG . 0.0 OUTLIER -111.37 160.82 16.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.479 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -131.21 103.51 15.29 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.706 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.98 135.83 17.77 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 121.346 1.364 . . . . 0.0 111.627 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 64.7 mt -85.22 51.83 2.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.228 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.2 p -64.25 -24.85 67.81 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.7 mt -80.33 141.82 35.07 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.678 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.8 t -63.14 -20.73 65.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.563 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 94.4 m -134.88 135.64 41.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.106 0.479 . . . . 0.0 111.577 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.2 t -127.99 120.7 28.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.591 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.418 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 56.3 tp -118.51 131.65 56.23 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.262 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.521 ' O ' ' O ' ' A' ' 47' ' ' GLN . 3.8 m-85 -108.83 141.78 40.38 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.291 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 158.15 -170.92 35.01 Favored Glycine 0 N--CA 1.469 0.894 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.219 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.578 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 81.9 mtm-85 -84.42 -27.91 27.24 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 122.447 -0.443 . . . . 0.0 110.821 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -54.66 146.07 27.19 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.051 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 31.2 mm -64.54 -43.57 96.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.014 0.435 . . . . 0.0 110.291 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -57.17 -19.86 23.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.048 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 81.7 m -62.77 131.97 50.65 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.491 -0.483 . . . . 0.0 110.171 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.418 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 64.8 m-20 -61.48 -34.79 76.06 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.222 -178.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 99.4 mt -125.16 125.88 70.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 44.4 mtm-85 -119.39 145.14 46.48 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.879 -177.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.429 ' C ' ' H ' ' A' ' 41' ' ' LEU . 80.9 mt -123.2 133.16 69.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.422 -178.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -75.88 25.64 0.12 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.973 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.429 ' H ' ' C ' ' A' ' 39' ' ' ILE . 30.4 mt -96.81 129.41 32.78 Favored Pre-proline 0 C--N 1.324 -0.528 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.087 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.403 ' O ' ' HD2' ' B' ' 235' ' ' PRO . 42.8 Cg_endo -71.09 -13.09 31.1 Favored 'Trans proline' 0 N--CA 1.489 1.225 0 C-N-CA 122.029 1.819 . . . . 0.0 112.618 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.439 ' CG2' ' CZ ' ' B' ' 241' ' ' PHE . 26.9 m -98.06 3.22 10.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.619 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.578 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 35.4 t -89.88 135.69 25.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.15 160.62 20.86 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.373 0.606 . . . . 0.0 111.782 -178.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -62.46 -42.31 99.38 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.071 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.614 ' O ' ' N ' ' A' ' 49' ' ' CYS . 86.7 mt-30 -114.97 -14.4 11.87 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 123.609 0.568 . . . . 0.0 110.069 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.414 ' O ' ' OG ' ' A' ' 64' ' ' SER . 19.7 t60 31.1 -73.75 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.614 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.85 137.19 44.87 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -177.631 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -125.16 132.33 53.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.909 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.9 mt -118.57 133.03 66.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.832 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -119.99 127.38 52.57 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 177.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.407 HG22 HD12 ' A' ' 53' ' ' ILE . 86.7 mt -108.36 124.15 64.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -177.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.517 ' CD2' ' N ' ' A' ' 54' ' ' HIS . 2.7 m-70 -117.5 141.02 48.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.538 -1.21 . . . . 0.0 109.479 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 54' ' ' HIS . 96.3 mt-10 -39.91 -29.5 0.07 Allowed 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.993 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.458 ' N ' ' O ' ' A' ' 54' ' ' HIS . 69.0 tp60 -64.38 -65.93 0.61 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -158.5 -155.44 0.49 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.099 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -120.5 131.41 54.71 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.208 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.7 mm -112.58 123.62 68.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.668 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 30.9 tp -97.67 127.21 43.45 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -115.01 136.18 53.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.956 0.408 . . . . 0.0 110.847 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.427 HD22 ' HA ' ' A' ' 68' ' ' PRO . 39.8 t30 -97.29 106.22 18.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.48 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -98.74 -8.18 26.47 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.086 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' A' ' 48' ' ' HIS . 1.2 m -69.74 101.33 1.66 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 95.4 p -83.57 -13.23 54.88 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.123 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -91.35 -46.81 7.82 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.199 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -139.67 101.51 7.26 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.916 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.427 ' HA ' HD22 ' A' ' 62' ' ' ASN . 36.6 Cg_exo -57.07 147.66 73.82 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 121.986 1.791 . . . . 0.0 112.884 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.7 m -74.66 145.83 42.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.543 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -107.54 140.34 40.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.256 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.1 t -129.66 133.91 64.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 53.59 32.93 15.29 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 119.899 -0.72 . . . . 0.0 109.284 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.45 27.57 71.14 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.702 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 21.3 t -141.99 138.79 32.14 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 117.133 0.466 . . . . 0.0 112.003 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.3 t -68.76 140.3 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.143 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.9 pt -113.36 93.86 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-O 120.983 0.42 . . . . 0.0 110.808 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -65.04 -28.98 69.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.63 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.462 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.2 OUTLIER -126.34 178.96 1.3 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.178 -179.313 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.462 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 36.5 Cg_exo -59.36 143.05 99.85 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 122.68 2.253 . . . . 0.0 111.45 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.2 p -137.69 140.78 40.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.464 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.436 HH11 ' HD3' ' A' ' 81' ' ' ARG . 34.0 mmt-85 -79.29 129.4 34.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.221 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 98.4 mt -85.21 136.58 33.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.985 0.421 . . . . 0.0 111.381 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -125.85 152.2 45.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.459 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.407 ' CD2' ' C ' ' A' ' 84' ' ' HIS . 6.9 t60 -53.37 115.78 2.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.79 0.329 . . . . 0.0 110.422 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.7 -16.7 25.99 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -69.01 135.2 50.52 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.215 -0.594 . . . . 0.0 109.958 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.1 t -112.39 131.29 64.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.138 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 91.6 mt -94.62 131.37 41.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.464 ' OG1' ' OG ' ' A' ' 94' ' ' SER . 25.6 m -122.79 128.18 50.11 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -177.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.474 ' O ' ' C ' ' A' ' 91' ' ' ILE . 79.5 mt -113.79 125.14 71.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.01 178.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.474 ' C ' ' O ' ' A' ' 90' ' ' ILE . 97.9 mt 33.64 -96.36 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.074 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.593 ' OD1' ' NH1' ' A' ' 93' ' ' ARG . 47.9 p-10 -114.74 12.24 17.02 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.593 ' NH1' ' OD1' ' A' ' 92' ' ' ASP . 70.6 mtt85 -124.62 140.05 53.3 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.683 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.464 ' OG ' ' OG1' ' A' ' 89' ' ' THR . 56.6 m -136.09 151.1 49.46 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.45 0.643 . . . . 0.0 111.137 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -121.95 120.74 35.3 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.851 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -81.65 129.21 34.62 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.616 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.72 ' HH ' HH11 ' A' ' 5' ' ' ARG . 87.1 t80 -94.9 124.31 38.88 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.722 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -123.3 122.01 37.27 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.617 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 47.7 t30 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.373 179.685 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . 0.403 ' HD2' ' O ' ' A' ' 42' ' ' PRO . 26.8 Cg_exo . . . . . 0 N--CA 1.491 1.382 0 CA-C-O 121.532 0.555 . . . . 0.0 112.779 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -78.76 133.17 30.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.87 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 34.7 t . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.963 -179.093 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo . . . . . 0 N--CA 1.494 1.537 0 CA-C-O 120.551 0.146 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 79.8 m -74.38 -43.0 58.35 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.29 0.567 . . . . 0.0 109.62 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . 0.488 ' CE1' ' NH2' ' B' ' 245' ' ' ARG . 73.6 t80 -55.54 -46.65 77.06 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.693 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 98.4 mt -64.75 -39.49 93.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.108 0.48 . . . . 0.0 110.331 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 51.2 tp10 -61.12 -42.52 98.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.761 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -63.72 -39.43 94.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.307 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.488 ' NH2' ' CE1' ' B' ' 241' ' ' PHE . 40.3 mmt-85 -61.74 -40.74 96.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.706 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -62.18 -41.38 98.28 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.412 -0.515 . . . . 0.0 109.95 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 37.3 t -65.04 -45.38 85.66 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . 0.409 ' HB2' ' NH2' ' A' ' 12' ' ' ARG . 74.8 mt-30 -61.2 -35.41 77.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.554 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 39.4 t . . . . . 0 C--N 1.33 -0.247 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.43 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . 0.452 ' OE1' ' NH2' ' A' ' 93' ' ' ARG . 95.2 mt-10 . . . . . 0 CA--C 1.529 0.159 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 76.5 mt -111.61 134.0 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 54.8 t -125.58 132.85 70.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.738 0.304 . . . . 0.0 111.098 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -98.33 120.36 38.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.312 0.577 . . . . 0.0 111.626 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -66.85 -44.61 80.58 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.203 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.42 159.2 30.13 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.033 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.02 154.4 67.39 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 123.051 2.501 . . . . 0.0 111.864 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 47.0 pt . . . . . 0 C--N 1.327 -0.393 0 CA-C-O 121.309 0.576 . . . . 0.0 111.819 -178.931 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.5 p . . . . . 0 CA--C 1.529 0.152 0 CA-C-O 120.901 0.381 . . . . 0.0 110.716 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.4 mtt85 -94.87 124.93 39.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.908 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -133.53 140.25 47.09 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.343 -0.543 . . . . 0.0 111.521 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 79.2 mt -113.0 138.45 49.86 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.502 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 54.7 t -112.78 131.34 64.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.3 m -85.38 136.32 33.51 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.595 0.712 . . . . 0.0 112.32 -178.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 95.0 mt -108.89 138.03 38.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.185 178.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -91.4 158.36 16.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.191 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.46 ' CD ' HH21 ' B' ' 245' ' ' ARG . 87.5 mtm180 -59.26 -23.51 62.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.044 0.45 . . . . 0.0 110.271 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.2 t -79.05 -16.83 56.26 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.358 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.05 36.62 5.93 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.6 t -119.46 134.18 63.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 121.191 0.519 . . . . 0.0 112.052 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.401 ' C ' ' OD1' ' A' ' 16' ' ' ASP . 60.5 t0 -76.96 120.1 21.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.38 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -115.48 -124.75 3.82 Favored Glycine 0 CA--C 1.539 1.583 0 C-N-CA 120.919 -0.657 . . . . 0.0 111.665 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.24 153.25 40.52 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.551 2.167 . . . . 0.0 113.192 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -111.61 156.58 21.58 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.029 0.442 . . . . 0.0 110.563 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -123.58 100.91 37.54 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.066 -179.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.53 134.44 20.49 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 C-N-CA 121.344 1.363 . . . . 0.0 111.928 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.3 mt -88.55 71.74 8.86 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.844 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 89.2 p -79.9 -8.22 59.18 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.8 mt -97.4 142.5 29.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.801 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.9 p -66.2 -21.69 66.32 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.099 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 86.0 m -133.68 136.23 44.58 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.006 0.431 . . . . 0.0 110.775 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.561 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -134.81 129.53 34.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.486 178.632 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 48.1 tp -119.71 131.22 55.34 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.745 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.561 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 38.1 m-85 -104.98 140.78 37.68 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.702 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 149.3 -166.4 29.53 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 120.299 -0.953 . . . . 0.0 112.574 178.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 44.5 mtm180 -86.0 -32.01 21.72 Favored 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.415 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -49.33 151.16 3.84 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 -178.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.422 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 11.3 tp -66.41 -40.5 86.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.422 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 85.1 tt0 -54.8 -23.96 20.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.022 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.415 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 59.5 m -56.79 115.02 2.32 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.827 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -57.82 -21.41 42.09 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.435 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 97.6 mt -129.99 120.98 50.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.278 -0.874 . . . . 0.0 108.912 177.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 84.7 mtp180 -105.54 133.66 49.93 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.514 -179.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.0 mt -118.49 128.07 75.47 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -80.25 43.59 0.64 Allowed 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -177.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.476 ' CD1' ' NH1' ' A' ' 93' ' ' ARG . 59.0 mt -111.14 134.06 21.16 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.379 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.81 -9.76 21.2 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 122.223 1.948 . . . . 0.0 111.965 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.0 m -101.11 2.28 10.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.772 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 25.1 t -93.34 135.84 26.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.278 0.561 . . . . 0.0 109.945 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.4 m -68.25 159.94 30.24 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.377 -178.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -61.47 -42.46 98.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.928 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.675 ' O ' ' N ' ' A' ' 49' ' ' CYS . 82.9 mt-30 -114.58 -16.37 11.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.459 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.2 t60 32.81 -73.82 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.675 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -134.8 138.13 43.98 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -178.221 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -125.5 136.76 53.69 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.42 -0.809 . . . . 0.0 108.909 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 14.9 tt -126.5 140.72 48.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.074 0.464 . . . . 0.0 110.89 -178.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -122.59 135.56 54.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.393 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.8 mt -110.6 114.62 47.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.283 0.564 . . . . 0.0 111.355 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.47 ' O ' ' N ' ' A' ' 56' ' ' GLN . 92.3 m-70 -115.76 143.89 44.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.571 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 54' ' ' HIS . 96.1 mt-10 -40.06 -29.36 0.07 Allowed 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.308 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.47 ' N ' ' O ' ' A' ' 54' ' ' HIS . 87.9 mt-30 -63.48 -69.66 0.26 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -160.57 -164.1 1.18 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.555 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -108.42 131.91 54.3 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.163 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 89.2 mt -122.0 132.27 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -178.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 57.9 tp -99.35 128.83 45.51 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.825 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -115.53 134.95 54.58 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.405 HD22 ' HA ' ' A' ' 68' ' ' PRO . 36.3 t30 -95.74 103.53 15.42 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -95.25 -8.25 36.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.427 178.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.44 98.42 8.88 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.989 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.9 p -79.57 -31.82 41.97 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.5 m -65.32 -49.08 70.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.917 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.441 HD22 ' HA ' ' B' ' 236' ' ' VAL . 73.8 m-20 -138.96 95.9 9.39 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.742 -179.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.405 ' HA ' HD22 ' A' ' 62' ' ' ASN . 47.3 Cg_exo -54.04 144.32 58.0 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 121.901 1.734 . . . . 0.0 112.74 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.3 m -71.11 132.29 44.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.783 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -97.56 140.64 31.67 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.071 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.5 p -133.25 137.68 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 49.85 32.38 5.38 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.3 29.35 70.3 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.901 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 58.3 m -135.13 124.77 25.17 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 117.364 0.582 . . . . 0.0 112.086 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.7 m -69.27 137.0 25.12 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.526 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 1.6 pt -116.26 120.17 64.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 C-N-CA 120.659 -0.417 . . . . 0.0 110.726 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -85.29 -18.93 32.42 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.02 167.07 17.96 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.2 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.88 151.46 73.91 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.697 2.265 . . . . 0.0 112.807 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.5 m -141.2 148.81 20.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.193 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -79.09 133.7 36.76 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.331 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 97.0 mt -85.57 144.34 27.95 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.238 0.542 . . . . 0.0 111.304 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -128.47 151.1 49.79 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.913 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.796 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 7.0 t60 -53.72 118.34 3.85 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.059 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.28 -17.33 31.61 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.994 -0.843 . . . . 0.0 110.994 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -67.16 135.38 53.43 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.227 0.537 . . . . 0.0 110.214 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.5 p -113.54 133.47 59.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.877 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.411 ' O ' ' OG ' ' A' ' 94' ' ' SER . 97.1 mt -99.67 131.7 46.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 177.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 98.6 m -122.91 125.67 45.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.642 0.735 . . . . 0.0 112.527 -178.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.591 ' O ' ' N ' ' A' ' 92' ' ' ASP . 96.6 mt -111.03 125.26 68.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 114.519 -1.218 . . . . 0.0 108.198 178.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.492 ' CG2' ' NH1' ' B' ' 245' ' ' ARG . 23.4 mm 35.17 -90.23 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -178.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.591 ' N ' ' O ' ' A' ' 90' ' ' ILE . 1.0 OUTLIER -125.44 5.81 7.65 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.14 0.495 . . . . 0.0 110.735 178.793 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.741 ' NH1' ' NH2' ' B' ' 245' ' ' ARG . 71.4 mtt85 -108.4 137.01 47.09 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.186 178.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 88' ' ' ILE . 31.0 t -139.21 151.27 46.42 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.167 -179.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -124.81 126.02 44.94 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -87.06 135.99 33.08 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.99 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -97.82 123.0 41.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.358 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -139.62 130.69 26.42 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.158 -0.617 . . . . 0.0 112.069 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.796 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 77.8 m-20 . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.626 178.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo . . . . . 0 N--CA 1.484 0.96 0 CA-C-O 121.038 0.349 . . . . 0.0 111.949 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . 0.441 ' HA ' HD22 ' A' ' 67' ' ' ASN . 3.5 m -65.75 147.55 12.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 8.5 t . . . . . 0 C--N 1.328 -0.354 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.246 -179.427 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo . . . . . 0 N--CA 1.503 2.068 0 N-CA-C 113.254 0.444 . . . . 0.0 113.254 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 42.9 m -72.11 -43.39 64.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.051 0.453 . . . . 0.0 110.214 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . 0.43 ' CE2' ' HD2' ' B' ' 245' ' ' ARG . 63.6 t80 -58.11 -46.76 85.0 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.097 -178.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 82.7 mt -63.79 -41.66 97.88 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.85 -39.67 90.99 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.565 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -61.74 -40.72 96.09 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.237 -0.585 . . . . 0.0 109.617 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.741 ' NH2' ' NH1' ' A' ' 93' ' ' ARG . 77.9 mtp180 -63.35 -42.53 98.92 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.289 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -62.99 -41.06 99.46 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.382 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 33.5 p -67.62 -44.27 78.4 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.285 0.564 . . . . 0.0 109.905 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -63.49 -32.85 74.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.42 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 75.8 t . . . . . 0 C--N 1.328 -0.361 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.856 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 . . . . . 0 CA--C 1.529 0.14 0 CA-C-O 120.741 0.305 . . . . 0.0 111.371 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 75.6 mt -110.84 134.1 54.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 79.1 t -126.22 135.04 65.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.766 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -95.25 120.41 35.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.145 -178.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 40.5 tttp -65.33 -45.52 83.93 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.034 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -91.54 160.92 35.67 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.714 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.46 148.54 67.22 Favored 'Trans proline' 0 C--N 1.301 -1.923 0 C-N-CA 122.698 2.265 . . . . 0.0 112.829 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 42.7 pt . . . . . 0 C--N 1.332 -0.165 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.759 179.384 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.3 p . . . . . 0 CA--C 1.523 -0.066 0 CA-C-O 120.665 0.269 . . . . 0.0 110.834 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.836 HH11 ' HH ' ' A' ' 97' ' ' TYR . 93.5 mtt-85 -93.84 120.74 34.49 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.546 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -130.09 137.08 49.99 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.057 0.456 . . . . 0.0 111.782 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 43.8 tp -110.49 130.57 55.53 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.7 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 43.3 t -107.37 130.23 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 120.744 0.307 . . . . 0.0 110.72 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 m -90.91 116.4 28.69 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -177.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.6 mt -83.72 142.89 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.21 178.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -93.32 157.85 16.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.265 0.555 . . . . 0.0 111.147 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.583 HH22 ' CG ' ' B' ' 248' ' ' GLN . 59.1 mtp180 -57.97 -31.9 67.34 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.232 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.4 p -71.59 -15.62 62.27 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.064 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.03 37.18 5.76 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 46.3 t -124.81 133.6 69.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.181 -0.509 . . . . 0.0 111.328 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -77.22 136.9 38.57 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.87 -120.25 2.22 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.486 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -71.53 151.52 58.98 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.273 1.982 . . . . 0.0 113.147 -178.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -108.01 158.59 17.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.178 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -129.22 94.98 31.99 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.22 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -57.93 124.9 17.05 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.038 1.825 . . . . 0.0 111.862 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 89.3 mt -87.39 46.94 1.43 Allowed 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.676 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.5 t -59.81 -20.21 55.42 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 71.7 mt -77.78 139.44 39.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.02 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.1 p -64.62 -20.98 66.59 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.906 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.5 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 28.2 m -132.45 132.98 43.3 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.716 -0.393 . . . . 0.0 110.769 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.2 t -124.98 117.92 25.09 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.3 tp -115.99 129.05 56.2 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.278 -178.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.492 ' O ' ' O ' ' A' ' 47' ' ' GLN . 4.9 m-85 -108.56 139.96 42.59 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.056 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.76 -178.11 29.24 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.479 178.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 46.5 mtm180 -70.96 -33.3 70.33 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.685 0.278 . . . . 0.0 111.264 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.452 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -47.15 143.62 5.47 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.447 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 10.3 tp -67.1 -41.11 86.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.447 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 79.7 mm-40 -55.79 -19.25 10.73 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.899 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.452 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 86.0 m -55.96 122.13 10.88 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.232 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.5 ' OD2' ' O ' ' A' ' 26' ' ' THR . 63.8 m-20 -58.15 -29.2 65.39 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 79.4 mt -128.38 119.09 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 176.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 68.8 ttp85 -106.47 135.85 47.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.319 -178.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.408 ' C ' ' H ' ' A' ' 41' ' ' LEU . 95.1 mt -116.17 129.93 71.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-O 121.168 0.508 . . . . 0.0 110.853 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -75.92 25.46 0.12 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.415 -178.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.408 ' H ' ' C ' ' A' ' 39' ' ' ILE . 29.7 mt -92.22 128.85 43.47 Favored Pre-proline 0 C--N 1.326 -0.43 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.403 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.19 -8.21 21.7 Favored 'Trans proline' 0 C--N 1.316 -1.18 0 C-N-CA 122.083 1.856 . . . . 0.0 111.905 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.2 m -104.58 5.33 10.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.496 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.7 t -90.64 137.81 20.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.8 m -66.68 168.06 10.07 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.295 0.569 . . . . 0.0 112.035 -178.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -63.15 -45.71 90.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.237 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.651 ' O ' ' N ' ' A' ' 49' ' ' CYS . 86.9 mt-30 -115.02 -16.82 11.6 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.193 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.7 t60 35.97 -74.81 0.0 OUTLIER 'General case' 0 C--O 1.236 0.373 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.651 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.4 134.35 47.07 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -177.971 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -127.46 126.8 42.99 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.852 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.7 mt -111.52 134.26 54.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.332 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.581 ' CD ' ' HE2' ' A' ' 54' ' ' HIS . 82.7 tt0 -116.66 122.63 45.11 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 178.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 74.3 mt -103.46 118.7 50.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.008 -0.677 . . . . 0.0 112.276 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.581 ' HE2' ' CD ' ' A' ' 52' ' ' GLU . 99.3 m-70 -114.25 139.91 49.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.14 178.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.459 ' C ' ' O ' ' A' ' 54' ' ' HIS . 97.3 mt-10 -39.79 -25.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.465 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.56 ' N ' ' O ' ' A' ' 54' ' ' HIS . 60.4 tt0 -64.99 -67.55 0.43 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.672 ' CB ' ' HE ' ' A' ' 81' ' ' ARG . 4.7 tp10 -158.37 -159.14 0.77 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.104 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.407 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -118.25 128.36 54.61 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 87.7 mt -118.68 129.68 74.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.895 -178.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.7 tp -99.59 129.65 45.76 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.857 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -110.97 135.93 50.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.147 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.476 HD22 ' CB ' ' A' ' 68' ' ' PRO . 36.7 t-20 -97.26 109.45 22.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.835 0.35 . . . . 0.0 111.748 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -99.83 -9.66 22.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.692 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.9 t -78.74 119.81 22.5 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.106 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 95.2 p -101.04 -29.92 11.9 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.404 ' O ' ' OD1' ' A' ' 67' ' ' ASN . 0.6 OUTLIER -66.57 -42.06 87.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.608 178.67 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.404 ' OD1' ' O ' ' A' ' 66' ' ' THR . 1.4 m-20 -147.97 101.13 3.65 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.162 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.476 ' CB ' HD22 ' A' ' 62' ' ' ASN . 39.1 Cg_endo -66.2 154.22 75.0 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 121.624 1.549 . . . . 0.0 112.753 -178.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.1 m -75.24 149.9 38.75 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.612 -178.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -112.84 140.18 47.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.663 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 41.1 t -129.08 135.66 61.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 52.22 31.81 9.76 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -178.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.42 25.81 71.76 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.893 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 63.4 m -136.78 135.94 38.47 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 120.324 -0.55 . . . . 0.0 112.031 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 43.5 t -66.63 135.84 27.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.233 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.0 pt -106.62 98.82 7.4 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.088 0 CA-C-O 121.322 0.582 . . . . 0.0 111.001 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -63.13 -33.26 75.07 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.39 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.498 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.2 OUTLIER -129.58 -178.71 0.85 Allowed Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.262 -179.531 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.498 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 31.5 Cg_exo -60.5 146.53 96.71 Favored 'Trans proline' 0 N--CA 1.504 2.1 0 C-N-CA 123.297 2.665 . . . . 0.0 112.459 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.4 p -140.01 139.65 36.69 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 CA-C-O 120.93 0.395 . . . . 0.0 111.626 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.672 ' HE ' ' CB ' ' A' ' 57' ' ' GLU . 70.5 ttt180 -75.34 127.65 33.63 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.687 178.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 92.4 mt -84.12 141.26 31.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.167 0.508 . . . . 0.0 111.206 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -130.73 149.36 52.41 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.882 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.779 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 7.8 t60 -52.39 117.99 3.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.64 -179.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.36 -16.97 34.61 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -66.37 139.72 58.04 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 121.213 0.53 . . . . 0.0 110.308 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.4 p -111.09 133.01 58.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.869 -178.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.7 mt -101.14 129.65 51.81 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 76.8 m -124.48 122.29 37.22 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.642 0.734 . . . . 0.0 112.445 -178.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.57 ' O ' ' N ' ' A' ' 93' ' ' ARG . 76.5 mt -108.34 125.24 65.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.511 ' C ' ' O ' ' A' ' 90' ' ' ILE . 94.5 mt 34.73 -97.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.063 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.569 ' OD2' ' CZ ' ' B' ' 245' ' ' ARG . 54.4 p-10 -117.41 6.8 12.66 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.919 0.39 . . . . 0.0 111.196 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.57 ' N ' ' O ' ' A' ' 90' ' ' ILE . 23.1 mmt180 -110.53 134.27 52.53 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 71.6 p -137.55 150.95 47.89 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 119.661 -0.815 . . . . 0.0 110.429 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -125.43 124.6 41.79 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.408 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 69.4 mtp85 -87.12 134.11 33.55 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.316 -0.554 . . . . 0.0 110.951 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.836 ' HH ' HH11 ' A' ' 5' ' ' ARG . 92.6 t80 -99.25 126.67 45.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.15 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -143.5 125.98 15.8 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.967 0.413 . . . . 0.0 111.668 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.779 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 97.5 m-20 . . . . . 0 N--CA 1.464 0.266 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.308 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo . . . . . 0 N--CA 1.492 1.416 0 CA-C-O 121.391 0.496 . . . . 0.0 112.411 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 14.6 p -87.2 127.81 40.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.22 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.6 t . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.662 -179.531 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo . . . . . 0 N--CA 1.494 1.526 0 CA-C-O 120.637 0.182 . . . . 0.0 111.819 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 20.4 m -68.14 -44.97 74.84 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 177.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -58.67 -45.62 89.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.144 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 84.0 mt -63.35 -41.66 98.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.917 0.389 . . . . 0.0 111.49 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -63.3 -42.07 99.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.151 -178.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 77.8 ttt-85 -61.44 -43.46 98.83 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.934 0.397 . . . . 0.0 110.572 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.569 ' CZ ' ' OD2' ' A' ' 92' ' ' ASP . 8.4 tpp85 -59.82 -42.4 93.45 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.849 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.98 -39.86 96.0 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 58.2 m -64.98 -44.28 89.82 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 177.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . 0.583 ' CG ' HH22 ' A' ' 12' ' ' ARG . 60.9 tt0 -58.67 -38.36 78.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.437 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 42.1 t . . . . . 0 C--N 1.329 -0.283 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.95 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . 0.484 ' N ' ' OE1' ' B' ' 260' ' ' GLU . 50.7 mp0 . . . . . 0 N--CA 1.467 0.383 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 53.2 mt -116.02 135.6 55.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 61.7 t -129.08 135.54 61.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.865 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -95.19 119.46 33.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.435 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -64.63 -47.15 79.59 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.838 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -93.67 159.15 35.39 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.038 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -69.44 148.1 66.41 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.818 2.345 . . . . 0.0 112.754 -179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 44.8 pt . . . . . 0 C--N 1.326 -0.451 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.54 179.007 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.48 ' O ' ' O ' ' A' ' 99' ' ' ASN . 80.5 m . . . . . 0 CA--C 1.529 0.149 0 CA-C-O 120.731 0.3 . . . . 0.0 111.214 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.3 mtt85 -86.58 137.23 32.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.136 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -129.33 131.52 46.93 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.372 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 32.7 tp -109.64 131.66 54.85 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.4 t -113.27 131.17 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 121.172 0.511 . . . . 0.0 111.002 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.2 m -80.18 145.51 32.25 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.429 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.537 ' CD1' ' OD1' ' A' ' 16' ' ' ASP . 46.2 mm -112.83 136.24 49.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.579 177.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -88.3 151.74 22.42 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.758 HH11 ' NH2' ' A' ' 93' ' ' ARG . 79.0 mtm-85 -58.17 -21.8 48.77 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.175 -178.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 93.9 p -78.12 -10.9 59.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.767 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.98 31.8 11.67 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.184 -1.167 . . . . 0.0 110.184 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 51.2 t -118.34 132.64 67.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.796 0.332 . . . . 0.0 110.325 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.537 ' OD1' ' CD1' ' A' ' 10' ' ' ILE . 79.8 m-20 -75.85 137.51 40.51 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -130.89 -116.59 1.83 Allowed Glycine 0 CA--C 1.537 1.433 0 C-N-CA 120.364 -0.922 . . . . 0.0 112.597 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.63 146.84 44.39 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.337 2.025 . . . . 0.0 112.755 -178.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -109.21 155.15 21.43 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.012 0.435 . . . . 0.0 110.004 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -127.94 104.38 20.78 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.993 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.58 134.78 19.03 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 C-N-CA 121.371 1.381 . . . . 0.0 111.388 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 90.7 mt -87.23 59.61 5.66 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.374 -178.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.672 ' HG ' HE22 ' B' ' 265' ' ' GLN . 88.2 p -65.39 -33.08 75.12 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.8 mt -76.43 142.44 41.04 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.705 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 77.4 p -65.17 -17.6 64.61 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.417 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 92.0 m -135.31 136.96 41.99 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.725 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.0 t -128.12 119.73 25.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.056 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 38.6 tp -117.27 128.1 54.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.856 -178.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.543 ' O ' ' O ' ' A' ' 47' ' ' GLN . 4.7 m-85 -106.13 138.56 42.1 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 123.594 0.559 . . . . 0.0 109.834 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 160.8 -164.62 34.78 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.147 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.62 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 83.3 mtm-85 -86.82 -26.63 23.96 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.483 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.569 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -55.82 149.66 24.74 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-N 116.249 -0.432 . . . . 0.0 112.912 -178.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.468 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 10.5 tp -70.35 -42.77 78.67 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 CA-C-O 121.118 0.485 . . . . 0.0 109.823 178.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.468 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 21.6 pt-20 -54.78 -20.15 7.91 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.498 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.569 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 13.3 m -61.63 128.15 34.9 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.205 -179.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.417 ' OD2' ' O ' ' A' ' 26' ' ' THR . 55.0 m-20 -61.88 -32.76 73.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.447 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 98.6 mt -128.62 125.51 63.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.692 178.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 70.8 mtm180 -106.57 138.17 43.25 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.931 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.522 ' C ' ' H ' ' A' ' 41' ' ' LEU . 94.2 mt -117.81 127.66 75.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -72.83 32.83 0.07 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.696 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.522 ' H ' ' C ' ' A' ' 39' ' ' ILE . 25.9 mt -98.44 120.99 58.08 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.667 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.1 -9.27 23.26 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.309 2.006 . . . . 0.0 112.45 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.1 m -103.5 10.71 8.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.664 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.62 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 11.0 t -100.8 138.1 26.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.616 ' CB ' ' HG ' ' A' ' 64' ' ' SER . 68.5 m -69.91 172.17 8.19 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.577 0.703 . . . . 0.0 112.11 -178.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -63.98 -40.91 97.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.393 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.663 ' O ' ' N ' ' A' ' 49' ' ' CYS . 86.8 mt-30 -112.73 -20.03 11.8 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 123.172 0.295 . . . . 0.0 110.766 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 26.0 t60 37.12 -73.57 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.663 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.46 136.83 48.26 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.017 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -126.85 129.59 48.56 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.357 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.8 mt -115.01 133.75 60.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.584 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -115.2 128.68 56.32 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 52.0 mm -98.28 115.83 39.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.214 0.531 . . . . 0.0 110.959 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.486 ' O ' ' N ' ' A' ' 56' ' ' GLN . 97.2 m-70 -119.4 135.0 54.94 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.159 179.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 54' ' ' HIS . 51.6 tp10 -40.26 -28.69 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.041 -0.663 . . . . 0.0 109.375 -179.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.486 ' N ' ' O ' ' A' ' 54' ' ' HIS . 50.7 tt0 -65.39 -67.87 0.41 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.113 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.431 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 5.8 tp10 -158.8 -159.72 0.8 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.049 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.431 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -120.73 130.46 54.06 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.5 mt -116.92 128.8 74.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.191 0.519 . . . . 0.0 111.514 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.454 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 22.6 tp -96.96 127.05 42.54 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.403 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -110.88 136.44 49.92 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.22 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -95.63 106.97 19.12 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.291 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -99.97 -12.03 20.11 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.31 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.616 ' HG ' ' CB ' ' A' ' 45' ' ' SER . 0.2 OUTLIER -83.44 100.44 10.72 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.779 -179.776 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.8 m -73.31 -34.7 65.84 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.999 0.428 . . . . 0.0 110.491 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.71 -37.09 81.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.096 -179.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -145.05 92.37 5.73 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.171 -178.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -56.65 146.42 76.53 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.205 1.937 . . . . 0.0 112.735 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.3 m -72.84 136.96 45.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.61 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -102.43 140.15 37.09 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.668 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 51.7 t -131.78 133.25 61.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.581 ' ND2' ' OD1' ' A' ' 86' ' ' ASP . 83.8 m-20 53.01 32.16 12.34 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.488 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.99 28.29 64.9 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.905 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 66.1 m -142.71 138.95 30.91 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 117.048 0.424 . . . . 0.0 111.214 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -71.39 141.47 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.399 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.1 pt -112.41 90.09 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.848 178.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -65.37 -26.97 68.25 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -121.63 168.09 12.07 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.544 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -56.51 142.46 89.69 Favored 'Trans proline' 0 N--CA 1.501 1.935 0 C-N-CA 122.312 2.008 . . . . 0.0 112.272 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.7 p -134.3 138.87 49.2 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 CA-C-O 121.072 0.463 . . . . 0.0 111.255 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -78.3 131.29 36.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.507 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 89.9 mt -83.14 131.22 35.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.261 0.553 . . . . 0.0 111.06 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -119.91 143.59 47.87 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.048 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -48.81 118.04 2.37 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.384 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.66 -12.84 42.58 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.581 ' OD1' ' ND2' ' A' ' 72' ' ' ASN . 26.3 t70 -69.71 132.2 45.76 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.3 t -108.27 133.53 52.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.19 -178.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 87.8 mt -102.21 131.79 49.55 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 54.1 m -120.89 127.4 51.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.535 0.683 . . . . 0.0 112.749 -178.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.543 ' N ' ' O ' ' A' ' 93' ' ' ARG . 88.9 mt -112.35 121.96 65.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.588 178.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.47 ' C ' ' O ' ' A' ' 90' ' ' ILE . 75.3 mt 31.71 -95.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.522 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 92' ' ' ASP . 38.7 p-10 -107.87 6.71 27.62 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -178.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.758 ' NH2' HH11 ' A' ' 12' ' ' ARG . 91.0 mtt-85 -129.98 147.95 51.78 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.458 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.3 t -136.77 154.18 50.63 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.626 0.727 . . . . 0.0 111.241 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -125.46 120.93 32.33 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.893 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -83.5 132.53 34.94 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.106 -0.638 . . . . 0.0 110.551 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -94.04 123.55 37.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.302 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -125.46 117.08 22.89 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.48 ' O ' ' O ' ' A' ' 4' ' ' THR . 7.2 t-20 . . . . . 0 C--N 1.326 -0.43 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.543 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo . . . . . 0 N--CA 1.485 1.009 0 CA-C-O 121.676 0.615 . . . . 0.0 113.032 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 9.7 p -77.47 128.31 38.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.403 -178.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.425 179.926 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo . . . . . 0 N--CA 1.498 1.751 0 N-CA-C 113.057 0.368 . . . . 0.0 113.057 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 18.6 m -72.88 -43.81 62.08 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -58.14 -46.72 85.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.577 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 87.4 mt -65.16 -41.91 94.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.973 0.416 . . . . 0.0 110.988 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 50.3 tp10 -65.22 -44.82 87.03 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.065 -179.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -64.34 -44.1 92.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.049 0.452 . . . . 0.0 111.046 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.593 ' NH1' ' OE2' ' B' ' 260' ' ' GLU . 54.5 ttm-85 -65.53 -41.06 93.52 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.709 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -60.86 -36.78 80.04 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 40.2 t -66.11 -43.24 87.76 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 177.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 67.4 tp60 -61.04 -36.46 79.61 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.286 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . 0.441 ' CG2' ' HE ' ' A' ' 12' ' ' ARG . 47.5 t . . . . . 0 CA--C 1.519 -0.225 0 CA-C-O 120.959 0.409 . . . . 0.0 109.988 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . 0.593 ' OE2' ' NH1' ' B' ' 245' ' ' ARG . 97.7 mt-10 . . . . . 0 CA--C 1.523 -0.073 0 CA-C-O 120.973 0.416 . . . . 0.0 110.361 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 85.0 mt -115.25 135.15 56.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.569 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 45.5 t -125.83 133.7 68.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.082 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -98.95 120.71 39.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.555 0.693 . . . . 0.0 112.421 -177.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -67.29 -41.59 85.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.623 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . 0.672 HE22 ' HG ' ' A' ' 23' ' ' SER . 0.0 OUTLIER -105.12 159.39 29.53 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.576 -178.165 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -61.01 153.76 61.74 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 123.128 2.552 . . . . 0.0 112.598 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 45.4 pt . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.872 -179.347 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.553 ' O ' ' O ' ' A' ' 99' ' ' ASN . 25.0 m . . . . . 0 C--O 1.227 -0.116 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.7 mtt85 -92.94 138.54 31.39 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.632 -178.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -133.42 141.83 48.04 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.729 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 65.7 mt -116.57 139.04 50.93 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.6 t -110.81 132.61 58.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 C-N-CA 120.349 -0.541 . . . . 0.0 110.158 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 m -91.58 116.79 29.16 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -177.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.6 mt -84.11 142.51 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.057 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -94.85 155.82 16.62 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.272 0.558 . . . . 0.0 111.266 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.523 ' CD ' ' NH2' ' B' ' 245' ' ' ARG . 83.4 mtm180 -59.05 -32.15 69.5 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.159 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 93.9 p -70.49 -22.51 62.64 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.49 30.05 5.73 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.329 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.3 t -118.04 131.03 71.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.107 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -78.26 138.64 38.72 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.89 -113.83 1.48 Allowed Glycine 0 CA--C 1.53 0.988 0 C-N-CA 120.041 -1.076 . . . . 0.0 112.426 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.6 149.42 55.31 Favored 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 121.953 1.769 . . . . 0.0 112.006 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -114.51 144.65 43.01 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.094 0.473 . . . . 0.0 110.304 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -105.87 102.74 40.67 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.344 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -77.74 132.6 12.1 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 121.95 1.766 . . . . 0.0 111.415 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.9 mt -84.56 76.63 10.16 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -177.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 61.5 p -79.9 -12.17 59.76 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 177.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.5 mt -102.61 146.81 27.62 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.521 -178.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -68.89 -15.31 63.46 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.832 0.348 . . . . 0.0 111.397 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.454 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 92.1 m -132.48 134.96 45.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.017 0.437 . . . . 0.0 111.295 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.1 t -127.3 118.91 25.12 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.05 178.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 33.6 tp -118.2 125.51 50.32 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.814 -178.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.509 ' O ' ' O ' ' A' ' 47' ' ' GLN . 5.1 m-85 -102.61 135.94 43.34 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 123.669 0.606 . . . . 0.0 109.679 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 154.91 -179.9 30.61 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 120.353 -0.927 . . . . 0.0 112.568 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 31' ' ' ARG . 47.1 mtm180 -70.9 -33.48 70.59 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 122.653 -0.322 . . . . 0.0 111.552 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.551 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -43.94 140.18 3.52 Favored Glycine 0 N--CA 1.464 0.553 0 N-CA-C 111.306 -0.717 . . . . 0.0 111.306 -178.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.51 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 9.7 tp -65.51 -41.99 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.51 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 50.6 tp10 -56.92 -18.82 14.77 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.805 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.551 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 20.2 m -62.54 128.06 34.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.29 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.454 ' OD2' ' O ' ' A' ' 26' ' ' THR . 95.5 m-20 -60.4 -28.97 68.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.621 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.476 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 92.1 mt -128.32 118.56 48.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 177.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -104.97 138.12 41.67 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.463 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.428 ' C ' ' H ' ' A' ' 41' ' ' LEU . 88.6 mt -120.32 129.35 75.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 120.536 -0.465 . . . . 0.0 110.318 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -73.79 34.63 0.09 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.143 -178.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.572 ' CD1' ' NH2' ' A' ' 93' ' ' ARG . 32.3 mt -109.25 129.54 23.79 Favored Pre-proline 0 C--N 1.326 -0.435 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.06 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.12 -9.11 21.77 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 C-N-CA 121.975 1.784 . . . . 0.0 112.634 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.405 HG22 ' CE2' ' B' ' 241' ' ' PHE . 27.6 m -96.74 -0.67 10.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.627 0.251 . . . . 0.0 110.866 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 37.2 t -87.95 136.93 22.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.0 m -69.7 167.54 16.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.294 0.568 . . . . 0.0 111.553 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -64.46 -42.17 96.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.446 -178.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.656 ' O ' ' N ' ' A' ' 49' ' ' CYS . 86.5 mt-30 -115.13 -19.51 10.82 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.384 178.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 24.6 t60 37.3 -76.5 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.656 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -129.1 133.24 47.58 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.27 0.557 . . . . 0.0 111.722 -178.649 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -125.12 126.2 44.94 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.231 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 98.3 mt -112.86 134.55 55.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.578 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.568 ' CD ' ' HE2' ' A' ' 54' ' ' HIS . 84.6 tt0 -122.29 127.06 49.4 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.43 122.95 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 CA-C-O 121.754 0.788 . . . . 0.0 112.754 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.568 ' HE2' ' CD ' ' A' ' 52' ' ' GLU . 98.0 m-70 -114.02 139.42 49.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.388 -1.278 . . . . 0.0 109.308 179.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.473 ' C ' ' O ' ' A' ' 54' ' ' HIS . 83.3 tt0 -38.96 -26.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.55 ' N ' ' O ' ' A' ' 54' ' ' HIS . 91.2 mt-30 -67.36 -67.64 0.44 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.871 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.452 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 3.3 tp10 -155.2 -165.18 1.95 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.826 -179.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -114.33 133.38 55.72 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.527 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.2 mt -121.72 127.54 75.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.005 0.431 . . . . 0.0 111.561 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 28.9 tp -100.26 127.43 46.55 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.223 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -113.53 138.71 49.75 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.041 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.479 ' ND2' ' H ' ' A' ' 69' ' ' THR . 8.6 t-20 -100.65 108.78 20.75 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.389 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -100.88 -9.82 21.25 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.335 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -75.98 99.15 4.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.098 0.475 . . . . 0.0 110.307 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.8 t -73.04 -36.52 66.96 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.519 0.676 . . . . 0.0 109.354 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.5 m -65.31 -48.14 74.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.81 -1.086 . . . . 0.0 111.789 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -142.81 95.11 6.37 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.546 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -55.17 146.78 57.93 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 122.18 1.92 . . . . 0.0 112.287 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.479 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 59.0 m -74.57 140.45 44.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.284 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -99.18 142.51 30.57 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.647 179.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 54.5 t -131.12 134.73 61.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 51.07 30.25 5.32 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 119.321 -0.951 . . . . 0.0 108.601 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.07 26.13 69.5 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.221 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.4 p -137.85 137.34 38.02 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.98 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.7 t -70.99 136.07 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.312 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.4 pt -109.4 93.99 2.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.729 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -67.81 -29.43 68.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.087 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -125.46 174.65 3.73 Favored Pre-proline 0 CA--C 1.536 0.419 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.172 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -61.36 144.58 98.48 Favored 'Trans proline' 0 N--CA 1.501 1.936 0 C-N-CA 122.871 2.38 . . . . 0.0 112.745 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.7 m -144.03 143.06 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.352 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 92.4 mtt-85 -75.36 129.88 38.1 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.61 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 88.1 mt -83.77 139.24 32.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.705 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -126.9 151.16 48.8 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.489 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.495 ' C ' ' CD2' ' A' ' 84' ' ' HIS . 6.1 t60 -58.06 122.39 12.93 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.91 0.385 . . . . 0.0 110.388 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.49 -13.67 32.97 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.574 -0.61 . . . . 0.0 111.574 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -75.0 136.82 41.24 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.728 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.3 t -108.28 131.98 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.068 -178.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.426 HD12 HG22 ' A' ' 88' ' ' ILE . 96.7 mt -97.09 132.07 42.44 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.477 ' CB ' ' HG ' ' A' ' 94' ' ' SER . 84.5 m -124.68 126.7 46.13 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -177.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.437 HG22 HH11 ' A' ' 93' ' ' ARG . 93.2 mt -114.79 122.03 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.523 ' HB ' HH12 ' A' ' 93' ' ' ARG . 89.7 mt 36.29 -103.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.401 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 88.3 m-20 -103.77 9.02 37.22 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -178.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.614 HH21 ' CZ ' ' B' ' 245' ' ' ARG . 2.5 ptp85 -132.46 148.16 52.39 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.509 -0.477 . . . . 0.0 111.194 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.477 ' HG ' ' CB ' ' A' ' 89' ' ' THR . 65.2 m -135.15 152.33 51.5 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.349 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -119.32 121.56 39.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.25 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -81.56 131.05 35.26 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 119.821 -0.751 . . . . 0.0 111.391 -179.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -93.24 120.28 33.34 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.247 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -136.4 122.29 20.02 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.727 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.553 ' O ' ' O ' ' A' ' 4' ' ' THR . 90.6 m-20 . . . . . 0 N--CA 1.455 -0.176 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 178.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo . . . . . 0 N--CA 1.491 1.335 0 CA-C-O 121.68 0.616 . . . . 0.0 112.83 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -73.12 137.65 22.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 114.559 -1.2 . . . . 0.0 109.713 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.33 -0.276 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.444 -179.245 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo . . . . . 0 N--CA 1.495 1.606 0 N-CA-C 112.986 0.341 . . . . 0.0 112.986 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 40.1 p -73.99 -39.46 63.65 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . 0.412 ' CE2' ' HD2' ' B' ' 245' ' ' ARG . 81.7 t80 -57.45 -45.7 84.44 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.427 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 90.9 mt -62.89 -40.16 96.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.991 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.77 -43.02 97.64 Favored 'General case' 0 CA--C 1.522 -0.105 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.794 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -61.4 -42.82 99.34 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.839 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.614 ' CZ ' HH21 ' A' ' 93' ' ' ARG . 70.6 mtp85 -61.3 -43.89 98.12 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.484 0.549 . . . . 0.0 112.484 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -62.87 -39.61 94.96 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.099 -0.64 . . . . 0.0 109.298 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 39.7 t -67.23 -46.56 73.43 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.025 178.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -59.27 -37.21 77.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.36 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 40.7 t . . . . . 0 C--N 1.33 -0.268 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.798 -179.969 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . 0.436 ' OE2' ' NH1' ' A' ' 12' ' ' ARG . 97.3 mt-10 . . . . . 0 CA--C 1.54 0.569 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 82.6 mt -117.61 132.88 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 43.2 t -126.97 135.35 63.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.495 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -96.91 120.58 37.52 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.194 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -65.48 -46.11 81.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.539 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -96.9 164.95 16.85 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.277 -178.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -64.32 152.58 80.83 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.351 2.034 . . . . 0.0 111.91 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 42.6 pt . . . . . 0 C--N 1.328 -0.328 0 CA-C-O 121.307 0.575 . . . . 0.0 112.103 -178.553 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.7 p . . . . . 0 CA--C 1.529 0.159 0 CA-C-O 120.823 0.344 . . . . 0.0 111.258 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 88.0 mtm-85 -86.09 127.49 34.7 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -128.48 144.28 51.12 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.83 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 82.0 mt -113.89 142.62 45.89 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.5 t -114.14 126.76 71.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.0 m -77.4 140.68 39.95 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.505 0.669 . . . . 0.0 111.52 -178.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.2 mm -109.95 135.31 49.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.088 178.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -94.6 158.29 15.6 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.339 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -57.9 -20.97 41.06 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.89 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.7 p -81.23 -11.65 59.33 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.969 179.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.23 16.55 57.29 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-N 116.086 -0.506 . . . . 0.0 113.094 178.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.5 m -109.05 147.31 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 117.434 0.617 . . . . 0.0 111.533 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.431 ' C ' ' OD1' ' A' ' 16' ' ' ASP . 58.9 t0 -69.74 126.42 29.67 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.18 -178.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.402 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -115.86 -132.35 5.06 Favored Glycine 0 CA--C 1.542 1.751 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -74.18 153.36 46.06 Favored 'Trans proline' 0 N--CA 1.5 1.868 0 C-N-CA 122.509 2.139 . . . . 0.0 112.952 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -109.7 162.51 14.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.006 0.431 . . . . 0.0 110.615 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -132.43 106.76 13.24 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.047 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -73.58 127.37 11.66 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 121.903 1.736 . . . . 0.0 112.603 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.5 mt -92.05 48.26 1.41 Allowed 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.8 p -64.82 -13.05 54.45 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 119.559 -0.856 . . . . 0.0 109.222 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 75.4 mt -81.29 141.6 33.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.222 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 87.8 p -62.19 -21.65 65.27 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.971 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 57.6 m -139.54 138.84 36.63 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 119.827 -0.749 . . . . 0.0 112.164 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.7 t -128.6 123.92 34.57 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.849 178.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.6 tp -117.43 128.18 54.76 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.979 -178.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.483 ' O ' ' O ' ' A' ' 47' ' ' GLN . 4.4 m-85 -107.35 139.61 41.56 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.703 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 155.8 -173.37 33.84 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.196 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.629 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 83.9 mtm-85 -79.79 -31.03 40.76 Favored 'General case' 0 CA--C 1.527 0.079 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.561 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -52.38 146.08 16.52 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 121.003 -0.618 . . . . 0.0 111.695 -178.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.2 mm -63.8 -43.61 97.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.877 0.37 . . . . 0.0 110.078 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -53.0 -18.11 1.82 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.989 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.561 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 59.6 m -61.18 123.39 17.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.982 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -60.18 -31.73 70.4 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.442 HG23 HD12 ' A' ' 37' ' ' ILE . 81.0 mt -124.65 119.33 55.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 176.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -102.41 137.31 40.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.723 -178.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 98.2 mt -122.99 131.62 72.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.521 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -80.3 26.0 0.38 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.529 -178.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 34.8 mt -90.11 132.62 35.48 Favored Pre-proline 0 C--N 1.325 -0.477 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.377 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -71.4 -12.65 29.88 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 121.904 1.736 . . . . 0.0 111.53 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.6 m -102.14 7.59 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.629 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 11.4 t -93.51 129.95 43.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.401 ' HB3' ' HG ' ' A' ' 64' ' ' SER . 0.1 OUTLIER -64.28 168.04 6.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.272 0.558 . . . . 0.0 110.894 -179.453 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -63.25 -43.32 98.32 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.1 -178.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.626 ' O ' ' N ' ' A' ' 49' ' ' CYS . 86.3 mt-30 -111.18 -11.83 14.19 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.55 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 18.6 t60 30.23 -76.68 0.0 OUTLIER 'General case' 0 C--O 1.237 0.402 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.626 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.95 136.04 47.04 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.266 0.555 . . . . 0.0 112.061 -178.549 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -127.38 127.09 43.62 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.064 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 95.8 mt -111.6 133.13 58.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.208 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -114.4 131.69 56.49 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.5 mm -103.51 115.37 45.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.296 0.57 . . . . 0.0 111.269 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.426 ' O ' ' C ' ' A' ' 55' ' ' GLU . 93.2 m-70 -117.04 137.57 52.16 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.959 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 54' ' ' HIS . 80.1 mm-40 -40.18 -35.39 0.39 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.256 0.551 . . . . 0.0 109.777 -179.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.478 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 98.5 mm-40 -64.13 -67.11 0.46 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.983 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.478 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 6.1 tp10 -155.64 -166.08 2.14 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.534 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.45 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -119.88 127.93 53.17 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 91.3 mt -116.02 130.54 70.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.11 0.481 . . . . 0.0 111.496 -178.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 19.6 tp -96.88 127.36 42.78 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.145 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -110.58 136.19 50.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.803 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.586 ' ND2' ' H ' ' A' ' 69' ' ' THR . 20.5 t-20 -97.15 111.66 23.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.856 0.36 . . . . 0.0 111.575 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.444 ' CD2' ' OE1' ' A' ' 47' ' ' GLN . 32.8 m-85 -99.8 -8.22 24.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.667 178.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.401 ' HG ' ' HB3' ' A' ' 45' ' ' SER . 1.8 t -70.59 99.26 1.62 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 88.3 p -85.08 -6.12 59.32 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.324 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.04 -38.04 7.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.286 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -144.68 97.49 5.0 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.032 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.4 147.71 55.62 Favored 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 122.504 2.136 . . . . 0.0 113.376 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.586 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 11.1 m -72.08 138.06 47.55 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.56 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -101.54 139.04 37.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.533 179.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 25.5 t -130.5 134.17 62.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 54.94 32.46 18.01 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.288 0.566 . . . . 0.0 109.696 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.13 27.35 70.36 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.895 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.8 m -138.06 131.66 30.95 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.785 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -67.47 142.42 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 121.101 0.476 . . . . 0.0 111.123 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.525 ' CG2' ' O ' ' A' ' 78' ' ' GLU . 75.1 mt -114.51 123.79 70.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.845 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -96.14 -24.09 16.45 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.981 179.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.525 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 3.7 mm-40 -129.27 172.42 7.16 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.785 -178.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -60.6 146.49 96.98 Favored 'Trans proline' 0 N--CA 1.501 1.943 0 C-N-CA 122.285 1.99 . . . . 0.0 112.652 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.1 p -140.15 144.97 26.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.209 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -77.85 129.66 35.68 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.157 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.9 mt -86.56 135.94 33.25 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.249 0.547 . . . . 0.0 111.107 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -131.1 154.25 48.49 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.629 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.723 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 8.2 t60 -53.44 117.37 3.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.626 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 113.87 -25.38 10.9 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.1 -0.572 . . . . 0.0 112.157 178.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -66.8 137.0 56.3 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.871 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 68.4 t -113.38 132.68 61.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.7 -178.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.0 mt -93.4 130.79 41.9 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 N-CA-C 107.994 -1.114 . . . . 0.0 107.994 178.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 51.4 m -118.52 128.26 54.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.639 0.733 . . . . 0.0 112.575 -178.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.458 ' O ' ' C ' ' A' ' 91' ' ' ILE . 95.3 mt -118.03 124.63 73.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.682 178.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.458 ' C ' ' O ' ' A' ' 90' ' ' ILE . 42.6 mm 34.14 -95.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.944 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 90' ' ' ILE . 47.9 t0 -117.65 15.36 14.53 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.727 0.298 . . . . 0.0 111.336 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.571 ' NH2' ' OE1' ' B' ' 260' ' ' GLU . 55.6 mtt85 -127.13 143.44 51.27 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.09 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 38.2 m -135.69 154.53 51.25 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.531 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -127.56 121.58 30.98 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -88.58 133.62 34.12 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.984 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -93.07 122.98 36.0 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.166 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -124.51 118.81 27.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.838 0.351 . . . . 0.0 110.294 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.723 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 58.5 t-20 . . . . . 0 C--N 1.33 -0.265 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo . . . . . 0 N--CA 1.484 0.954 0 CA-C-O 121.038 0.349 . . . . 0.0 111.712 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 27.9 t -112.84 133.6 58.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.375 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 2.3 t . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.438 179.996 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo . . . . . 0 N--CA 1.499 1.796 0 N-CA-C 113.795 0.652 . . . . 0.0 113.795 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 18.1 p -76.04 -42.57 47.33 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.735 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -58.08 -45.0 87.87 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.837 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 95.6 mt -64.54 -41.87 96.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.781 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -63.95 -36.92 85.53 Favored 'General case' 0 C--N 1.334 -0.093 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.38 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' B' ' 244' ' ' ARG . 78.2 mtt85 -61.74 -43.25 99.21 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.628 -0.429 . . . . 0.0 109.981 179.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -63.2 -41.88 99.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.427 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -63.53 -39.36 94.23 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 11.2 t -64.28 -46.59 83.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.129 178.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -61.42 -35.87 78.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.611 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 77.3 t . . . . . 0 C--N 1.328 -0.328 0 CA-C-O 120.903 0.382 . . . . 0.0 110.188 179.035 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . 0.571 ' OE1' ' NH2' ' A' ' 93' ' ' ARG . 96.0 mt-10 . . . . . 0 CA--C 1.53 0.179 0 CA-C-O 120.611 0.244 . . . . 0.0 111.461 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 68.5 mt -107.77 134.5 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 178.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 77.3 t -128.07 136.76 59.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.369 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -95.49 118.18 31.74 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.296 0.57 . . . . 0.0 111.499 -178.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -65.05 -44.02 90.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.289 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 10.4 mm-40 -96.73 154.01 38.53 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.57 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -61.65 146.24 96.94 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.326 2.017 . . . . 0.0 112.355 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 45.6 pt . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.872 -179.637 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 96.4 m . . . . . 0 CA--C 1.521 -0.172 0 CA-C-O 120.769 0.318 . . . . 0.0 111.382 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.6 mtt85 -87.51 129.74 34.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.436 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -133.93 139.55 46.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.611 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 34.5 tp -114.59 129.2 56.65 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.764 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.7 t -108.19 131.11 59.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.29 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.8 m -81.76 148.23 29.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.287 0.565 . . . . 0.0 111.711 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 92.6 mt -117.93 138.06 49.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 114.979 -1.01 . . . . 0.0 108.74 178.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -91.14 160.73 15.41 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.045 0.45 . . . . 0.0 111.408 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.522 HH12 ' CD ' ' B' ' 248' ' ' GLN . 89.9 mtm180 -58.63 -28.82 66.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.781 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.5 p -78.41 -7.61 57.56 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.636 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.67 33.17 9.38 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -178.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.5 t -123.78 135.27 64.02 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 CA-C-O 121.385 0.612 . . . . 0.0 111.55 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -76.27 138.11 40.34 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.547 179.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -126.29 -121.62 2.5 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 111.404 -0.678 . . . . 0.0 111.404 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.24 152.92 45.47 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.281 1.988 . . . . 0.0 112.829 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -110.34 153.81 24.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.16 0.505 . . . . 0.0 110.658 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.426 ' CD2' HD12 ' A' ' 37' ' ' ILE . 43.8 t80 -122.58 94.9 47.26 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.335 -179.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -59.36 127.03 22.47 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 121.349 1.366 . . . . 0.0 111.254 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.4 mt -84.77 50.17 1.86 Allowed 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.448 -178.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 72.4 m -60.86 -33.83 73.67 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.2 0.524 . . . . 0.0 109.845 179.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 66.7 mt -69.97 139.96 52.91 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.369 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.0 t -65.69 -18.83 65.61 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.405 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.9 m -134.51 133.53 40.45 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.246 -0.582 . . . . 0.0 111.444 -178.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.2 t -129.54 120.37 25.24 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.313 0.578 . . . . 0.0 110.249 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 48.4 tp -117.37 131.74 56.72 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.994 -178.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.462 ' O ' ' O ' ' A' ' 47' ' ' GLN . 37.3 m-85 -109.7 140.5 43.5 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.848 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 153.86 -175.49 32.14 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 120.783 -0.723 . . . . 0.0 111.686 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 45.0 mtm180 -75.15 -32.29 61.27 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.609 0.242 . . . . 0.0 111.428 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.589 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -45.04 140.04 4.76 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.1 tp -66.91 -41.07 87.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.374 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -61.41 -15.73 39.66 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.205 0.526 . . . . 0.0 110.149 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.589 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 8.8 m -61.17 131.62 51.05 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.289 -0.564 . . . . 0.0 109.752 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -60.67 -33.43 72.82 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.426 HD12 ' CD2' ' A' ' 20' ' ' PHE . 44.1 mm -121.4 115.12 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.061 177.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 88.3 mtm-85 -100.72 133.08 45.71 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.475 ' CG2' ' NH1' ' A' ' 93' ' ' ARG . 96.2 mt -119.24 129.8 74.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.689 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -74.92 24.14 0.09 Allowed 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -177.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.46 ' CD2' ' NH2' ' A' ' 93' ' ' ARG . 95.6 mt -97.87 126.71 39.64 Favored Pre-proline 0 C--N 1.324 -0.512 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.384 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -70.97 -9.67 26.13 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.682 2.254 . . . . 0.0 113.232 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.1 m -97.71 5.33 9.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.393 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.4 t -94.96 136.79 25.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.692 0.282 . . . . 0.0 110.38 179.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.404 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 1.2 t -67.52 165.62 16.44 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.164 0.507 . . . . 0.0 110.857 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 41.1 mtmt -62.51 -41.99 99.21 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.36 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.605 ' O ' ' N ' ' A' ' 49' ' ' CYS . 84.2 mt-30 -111.46 -17.72 13.02 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.954 0.407 . . . . 0.0 111.111 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.404 ' H ' ' HB3' ' A' ' 45' ' ' SER . 26.8 t60 34.06 -75.92 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.605 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.81 136.94 49.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.321 0.581 . . . . 0.0 112.559 -177.785 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -127.09 129.0 47.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.979 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 93.5 mt -114.83 133.31 61.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.43 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -117.1 126.98 53.67 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 77.5 mt -108.81 113.78 45.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.705 0.765 . . . . 0.0 111.714 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.582 ' O ' ' N ' ' A' ' 56' ' ' GLN . 86.4 m-70 -114.27 146.79 40.0 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.806 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 54' ' ' HIS . 57.7 mp0 -40.58 -22.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.653 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.582 ' N ' ' O ' ' A' ' 54' ' ' HIS . 14.8 mm100 -72.57 -69.38 0.41 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -160.58 -164.89 1.3 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.191 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.8 124.26 50.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.663 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.403 HG21 ' NE2' ' A' ' 61' ' ' HIS . 96.6 mt -113.5 130.02 68.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.026 0.441 . . . . 0.0 111.751 -179.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 25.6 tp -99.76 128.3 45.87 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.011 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.403 ' NE2' HG21 ' A' ' 59' ' ' ILE . 94.7 m-70 -113.15 136.04 53.15 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.147 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -93.48 107.97 19.73 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.642 0.258 . . . . 0.0 111.67 -178.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -101.19 -11.51 19.48 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.714 179.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.6 t -72.45 98.43 2.27 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.9 t -82.69 -17.33 44.84 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.806 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.32 -43.21 8.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.287 -178.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -133.31 97.35 16.35 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -57.62 144.33 92.88 Favored 'Trans proline' 0 N--CA 1.5 1.894 0 C-N-CA 122.183 1.922 . . . . 0.0 113.224 -178.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.6 m -72.51 150.01 43.6 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.372 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -114.42 141.25 47.9 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.482 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 44.6 t -127.72 134.1 66.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 54.84 32.02 16.85 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.139 -0.625 . . . . 0.0 110.12 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.12 23.28 77.99 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.124 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.7 t -138.33 143.95 40.16 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 117.011 0.405 . . . . 0.0 110.99 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 44.2 t -67.08 132.33 32.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.502 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.409 HG12 ' O ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -118.56 79.29 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.426 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -65.96 -21.35 66.41 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.117 -178.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.409 ' O ' HG12 ' A' ' 76' ' ' ILE . 0.6 OUTLIER -110.35 159.95 30.2 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -179.562 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.41 145.87 92.83 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 C-N-CA 121.148 1.232 . . . . 0.0 111.196 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.42 145.73 21.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 89.9 mtm180 -75.29 132.05 40.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.795 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 92.0 mt -80.77 141.27 34.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.066 0.46 . . . . 0.0 110.927 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -129.02 149.84 50.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.779 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.471 ' C ' ' CD2' ' A' ' 84' ' ' HIS . 7.7 t60 -54.67 119.91 5.99 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.376 -0.529 . . . . 0.0 110.57 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.07 -8.32 41.94 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.43 ' C ' ' OD1' ' A' ' 86' ' ' ASP . 45.6 t0 -71.62 127.54 32.9 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.45 ' CG1' ' OG ' ' A' ' 94' ' ' SER . 76.6 t -105.56 134.62 46.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.401 -178.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.416 ' O ' ' OG ' ' A' ' 94' ' ' SER . 11.6 mm -98.16 128.55 49.49 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.7 m -122.48 129.06 51.61 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.841 0.829 . . . . 0.0 112.875 -178.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.476 ' O ' ' C ' ' A' ' 91' ' ' ILE . 74.1 mt -121.01 127.03 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 114.445 -1.252 . . . . 0.0 108.429 178.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.476 ' C ' ' O ' ' A' ' 90' ' ' ILE . 37.5 mm 35.91 -99.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 C-N-CA 120.576 -0.449 . . . . 0.0 110.252 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.504 ' O ' ' OD1' ' A' ' 92' ' ' ASP . 39.0 t0 -118.07 17.6 14.03 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.989 0.424 . . . . 0.0 110.91 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.535 ' NH2' ' OE1' ' B' ' 260' ' ' GLU . 97.7 mtt180 -125.67 142.17 51.65 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.759 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.45 ' OG ' ' CG1' ' A' ' 87' ' ' VAL . 16.6 t -140.12 152.85 46.44 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 120.184 -0.607 . . . . 0.0 110.781 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -126.07 125.12 42.07 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.617 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -88.03 134.09 33.82 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 120.351 -0.539 . . . . 0.0 111.605 -178.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -97.64 125.92 42.66 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.858 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -131.03 124.28 30.56 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.216 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 45.5 p-10 . . . . . 0 N--CA 1.466 0.339 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.841 -179.844 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo . . . . . 0 N--CA 1.485 1.005 0 CA-C-O 121.201 0.417 . . . . 0.0 112.765 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 39.8 t -67.78 136.56 26.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.72 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 10.4 t . . . . . 0 CA--C 1.52 -0.206 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.594 -179.795 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo . . . . . 0 N--CA 1.494 1.533 0 CA-C-O 120.596 0.165 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 24.7 m -71.41 -42.95 67.68 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -58.33 -46.61 85.88 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.221 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 88.0 mt -62.97 -41.17 99.46 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.491 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -61.34 -38.76 88.08 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.408 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . 0.451 ' O ' ' OG ' ' B' ' 247' ' ' SER . 42.1 ttm180 -63.79 -42.77 97.67 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.419 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -60.88 -40.27 92.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.259 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -64.17 -38.45 91.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.863 0.364 . . . . 0.0 110.763 179.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 247' ' ' SER . . . . . 0.576 ' HG ' ' N ' ' B' ' 248' ' ' GLN . 80.8 p -68.61 -40.56 80.37 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . 0.576 ' N ' ' HG ' ' B' ' 247' ' ' SER . 59.8 tt0 -60.53 -38.27 83.9 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.442 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 24.4 t . . . . . 0 N--CA 1.452 -0.335 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.986 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . 0.535 ' OE1' ' NH2' ' A' ' 93' ' ' ARG . 91.1 mt-10 . . . . . 0 N--CA 1.464 0.242 0 CA-C-O 120.485 0.183 . . . . 0.0 111.347 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 64.6 mt -108.59 141.45 23.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 54.3 t -127.27 135.62 62.93 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 CA-C-O 121.065 0.459 . . . . 0.0 110.957 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -98.81 124.06 43.44 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.519 -178.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . 0.416 ' HB3' ' NE2' ' B' ' 265' ' ' GLN . 88.6 tttt -64.69 -47.1 79.61 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.705 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . 0.724 ' N ' HE21 ' B' ' 265' ' ' GLN . 0.0 OUTLIER -96.74 159.1 32.42 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.547 -179.344 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -68.05 143.51 60.19 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 122.998 2.465 . . . . 0.0 113.395 -179.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 47.9 pt . . . . . 0 C--N 1.326 -0.438 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.535 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.8 m . . . . . 0 CA--C 1.522 -0.116 0 CA-C-O 121.399 0.619 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.791 HH11 ' HH ' ' A' ' 97' ' ' TYR . 93.9 mtt-85 -92.39 130.81 37.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.309 -178.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.568 ' HE ' ' CE1' ' A' ' 19' ' ' HIS . 85.6 mtp180 -128.7 141.4 51.34 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.106 0.479 . . . . 0.0 111.343 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 41.7 tp -117.8 136.46 53.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.065 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.7 t -114.26 130.01 69.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 CA-C-O 120.775 0.321 . . . . 0.0 111.353 -178.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 m -94.87 116.16 28.37 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.553 -178.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 66.9 mt -84.93 150.93 3.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.99 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -92.93 161.15 14.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.714 0.292 . . . . 0.0 110.358 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.755 HH11 HH11 ' B' ' 245' ' ' ARG . 91.0 mtm180 -57.22 -29.3 63.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.917 -179.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 75.4 p -77.28 -11.09 59.79 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.831 -0.347 . . . . 0.0 110.818 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.88 29.28 11.95 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.1 t -114.49 133.69 59.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.735 0.303 . . . . 0.0 110.668 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' A' ' 17' ' ' GLY . 64.8 t0 -69.34 127.64 33.77 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.809 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.409 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -119.31 -123.67 3.19 Favored Glycine 0 CA--C 1.537 1.42 0 C-N-CA 121.083 -0.579 . . . . 0.0 112.166 -179.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -74.34 149.08 39.45 Favored 'Trans proline' 0 N--CA 1.497 1.709 0 C-N-CA 122.492 2.128 . . . . 0.0 113.338 -178.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.568 ' CE1' ' HE ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -109.28 151.72 26.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.902 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -121.29 104.5 40.57 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.906 -178.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.437 ' O ' ' NE2' ' B' ' 265' ' ' GLN . 60.2 Cg_endo -77.48 127.37 8.9 Favored 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 121.767 1.645 . . . . 0.0 111.722 -179.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 79.3 mt -77.23 80.36 3.75 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.369 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.632 ' H ' HE22 ' B' ' 265' ' ' GLN . 66.4 p -82.91 -10.99 58.54 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.8 mt -108.07 148.93 29.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.574 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 94.7 p -72.19 -13.4 61.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.845 -178.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 29.0 m -129.57 131.34 46.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.185 0.517 . . . . 0.0 110.777 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.684 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -128.0 119.64 25.88 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.579 179.191 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.507 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 49.2 tp -120.02 125.29 47.99 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.737 -178.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.684 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 19.5 m-85 -98.96 124.36 43.86 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -176.98 -156.77 16.53 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 119.894 -1.146 . . . . 0.0 112.503 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.622 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 84.7 mtm-85 -107.9 -24.31 11.69 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 120.354 -0.539 . . . . 0.0 110.599 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.28 165.06 36.06 Favored Glycine 0 CA--C 1.524 0.644 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.135 -178.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.5 tp -67.14 -40.01 84.34 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 CA-C-N 115.529 -0.336 . . . . 0.0 110.713 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -57.62 -32.64 67.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.533 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 68.9 m -49.52 116.18 1.64 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.936 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.572 ' OD1' ' N ' ' A' ' 37' ' ' ILE . 6.6 p-10 -58.16 -29.65 65.76 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.572 ' N ' ' OD1' ' A' ' 36' ' ' ASP . 80.2 mt -129.23 117.11 42.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 177.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -101.28 138.74 37.9 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.871 0.367 . . . . 0.0 111.459 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.479 ' C ' ' H ' ' A' ' 41' ' ' LEU . 91.6 mt -119.71 130.6 73.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.473 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.431 ' OE1' ' OE1' ' B' ' 260' ' ' GLU . 73.8 mt-30 -73.53 21.9 0.08 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.396 -178.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.534 ' CD2' ' NH2' ' B' ' 245' ' ' ARG . 20.1 mt -90.65 123.52 64.94 Favored Pre-proline 0 C--N 1.326 -0.426 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.165 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.31 -8.52 22.02 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 121.671 1.581 . . . . 0.0 112.128 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.4 m -101.42 4.77 10.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 C-N-CA 120.43 -0.508 . . . . 0.0 111.451 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.622 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 38.0 t -96.72 106.77 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.297 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.533 ' O ' ' O ' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -33.84 162.91 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.963 0.887 . . . . 0.0 112.385 -179.143 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -61.66 -41.06 97.0 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.354 -1.294 . . . . 0.0 111.461 -178.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.616 ' O ' ' N ' ' A' ' 49' ' ' CYS . 89.7 mm-40 -109.57 -17.45 13.73 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 123.728 0.642 . . . . 0.0 110.303 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.494 ' O ' ' OG ' ' A' ' 64' ' ' SER . 19.1 t60 36.87 -78.51 0.0 OUTLIER 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.072 -0.967 . . . . 0.0 113.02 -179.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.616 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -135.93 139.75 43.5 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.616 -178.588 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -126.41 131.68 51.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.843 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 87.9 mt -115.38 131.91 66.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.176 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -118.07 129.36 55.51 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.9 mt -110.49 121.85 64.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.548 0.689 . . . . 0.0 112.852 -178.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.464 ' O ' ' C ' ' A' ' 55' ' ' GLU . 97.3 m-70 -116.49 140.33 49.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.406 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 54' ' ' HIS . 92.1 mt-10 -39.92 -30.32 0.08 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.462 ' N ' ' O ' ' A' ' 54' ' ' HIS . 88.4 mt-30 -64.57 -68.79 0.33 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.798 178.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -152.21 -171.45 3.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.404 0.621 . . . . 0.0 110.748 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -111.91 124.63 52.78 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.507 178.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 91.0 mt -114.21 131.22 66.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.179 0.514 . . . . 0.0 112.128 -178.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.456 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 16.2 tp -104.1 129.6 51.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.191 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -115.2 138.09 51.31 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.167 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.571 ' ND2' ' H ' ' A' ' 69' ' ' THR . 23.3 t-20 -102.02 110.6 22.6 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.965 179.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -98.4 -5.35 32.8 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.157 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.494 ' OG ' ' O ' ' A' ' 48' ' ' HIS . 1.4 m -71.64 100.64 2.34 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.277 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.7 m -84.11 -20.48 32.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.119 0.485 . . . . 0.0 109.963 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.76 -40.85 11.58 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.619 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -138.94 95.16 9.7 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.872 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -57.77 143.65 95.0 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 122.287 1.991 . . . . 0.0 112.552 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.571 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 4.5 m -77.08 154.79 32.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.58 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.402 ' N ' ' CG2' ' A' ' 69' ' ' THR . 75.3 mt-30 -114.87 140.45 48.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.921 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 50.6 t -128.43 135.72 61.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 50.27 33.56 7.55 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.38 28.41 67.9 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.775 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.4 t -142.47 139.45 31.56 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.173 -0.611 . . . . 0.0 112.197 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.7 t -67.51 137.54 24.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.282 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 10.9 pt -108.6 81.33 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.154 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -60.85 -33.54 73.22 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.542 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.471 ' N ' ' CD ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -117.05 165.4 15.54 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.873 179.754 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.54 142.39 98.82 Favored 'Trans proline' 0 N--CA 1.502 1.979 0 C-N-CA 122.346 2.031 . . . . 0.0 112.162 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.5 m -135.6 138.17 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-O 120.961 0.41 . . . . 0.0 111.904 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.7 mtm180 -72.39 131.18 42.27 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.7 mt -80.02 136.61 36.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.266 0.555 . . . . 0.0 111.436 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -126.41 146.79 49.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.935 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.729 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 3.5 t-160 -54.41 121.88 9.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.146 0.498 . . . . 0.0 110.909 -178.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.73 -10.84 38.37 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -71.86 136.71 47.06 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.49 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.7 p -114.12 132.21 63.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.182 -178.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 69.1 mt -101.65 132.9 46.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 53.0 m -118.65 128.72 54.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.686 0.755 . . . . 0.0 112.121 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.555 ' O ' ' N ' ' A' ' 93' ' ' ARG . 98.1 mt -118.81 131.26 72.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 177.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.496 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 88.9 mt -24.43 98.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.547 ' OD1' ' CD2' ' B' ' 242' ' ' LEU . 2.7 m-20 89.01 -15.78 0.31 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 177.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.57 HH21 ' CG ' ' B' ' 260' ' ' GLU . 69.6 mtt85 -132.5 141.89 48.97 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.159 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.6 t -135.98 149.98 49.07 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.436 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 36.7 m-85 -126.57 123.63 38.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.785 -179.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -84.42 129.09 34.9 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.599 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.791 ' HH ' HH11 ' A' ' 5' ' ' ARG . 87.8 t80 -91.78 124.67 36.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.137 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -123.76 132.42 53.8 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.737 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.729 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 41.5 t-20 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.137 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo . . . . . 0 N--CA 1.488 1.173 0 CA-C-O 121.151 0.396 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 44.1 t -112.61 132.5 61.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.644 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 2.5 t . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.159 -179.417 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo . . . . . 0 N--CA 1.501 1.945 0 N-CA-C 113.611 0.581 . . . . 0.0 113.611 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 19.0 p -82.76 -38.9 22.58 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.347 -0.541 . . . . 0.0 109.886 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -57.9 -46.48 84.87 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.726 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . 0.547 ' CD2' ' OD1' ' A' ' 92' ' ' ASP . 97.3 mt -66.23 -42.43 88.64 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.386 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -63.39 -43.27 98.04 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.996 -178.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -63.43 -43.32 97.8 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.858 0.361 . . . . 0.0 111.04 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.755 HH11 HH11 ' A' ' 12' ' ' ARG . 58.0 ttm-85 -61.4 -42.28 98.47 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.797 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -63.17 -37.85 88.85 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.205 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 67.3 m -67.46 -43.8 80.15 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 177.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 63.5 tp60 -59.58 -39.85 85.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.979 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 77.6 t . . . . . 0 C--N 1.331 -0.231 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.921 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . 0.57 ' CG ' HH21 ' A' ' 93' ' ' ARG . 49.9 mm-40 . . . . . 0 CA--C 1.531 0.215 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . 0.41 HG22 HD12 ' B' ' 261' ' ' ILE . 89.4 mt -110.1 135.09 50.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 69.2 t -127.5 132.06 69.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.927 0.394 . . . . 0.0 110.204 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -96.35 120.7 37.13 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.241 0.543 . . . . 0.0 111.493 -178.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -67.96 -41.35 82.59 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.417 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . 0.632 HE22 ' H ' ' A' ' 23' ' ' SER . 0.0 OUTLIER -93.59 161.41 30.54 Favored Pre-proline 0 N--CA 1.463 0.202 0 CA-C-N 116.62 -0.263 . . . . 0.0 111.419 -177.797 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -59.31 143.55 99.7 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.227 1.951 . . . . 0.0 111.181 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . 0.55 ' CG2' ' O ' ' A' ' 19' ' ' HIS . 2.1 mt . . . . . 0 N--CA 1.449 -0.477 0 C-N-CA 120.304 -0.559 . . . . 0.0 110.55 -178.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.1 m . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.977 0.417 . . . . 0.0 110.665 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -98.56 135.38 40.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.037 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -137.89 150.4 47.06 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.498 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 86.2 mt -116.5 139.22 50.71 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.455 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 65.5 t -110.92 127.98 67.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.8 m -79.04 142.06 36.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.387 0.613 . . . . 0.0 112.386 -178.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.9 mt -114.17 135.88 52.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.467 176.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -86.91 160.01 18.85 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 90.9 mtm180 -57.84 -29.31 64.86 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.578 -178.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 42.8 m -80.81 -9.49 59.81 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.712 0.291 . . . . 0.0 110.928 179.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.68 40.67 5.58 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.6 t -121.09 133.02 69.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.919 0.39 . . . . 0.0 110.74 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -75.19 125.45 28.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.154 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -120.54 -121.01 2.82 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.062 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -74.89 150.78 39.25 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.464 2.109 . . . . 0.0 112.777 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.97 155.85 22.1 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -122.29 93.24 48.65 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.2 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.467 ' O ' ' NE2' ' B' ' 265' ' ' GLN . 27.3 Cg_exo -61.66 130.47 31.62 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.159 1.906 . . . . 0.0 111.74 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.7 mt -85.79 82.22 8.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.426 0.631 . . . . 0.0 110.396 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.7 p -86.78 -8.14 57.62 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.002 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 42.7 mt -108.08 147.99 30.42 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.964 -178.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.9 t -65.39 -18.25 65.17 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -178.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 21.6 m -136.65 136.96 39.56 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.463 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.7 t -129.73 123.4 30.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.514 178.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 52.5 tp -116.69 129.69 56.28 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.037 0.446 . . . . 0.0 111.642 -178.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.51 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 3.2 m-85 -109.16 144.47 37.18 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.99 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 146.97 -170.12 27.94 Favored Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.764 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 47.9 mtm180 -78.53 -32.3 47.91 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.491 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -50.83 146.77 9.15 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.63 -178.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.445 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 7.6 tp -67.17 -41.78 87.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.445 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 70.3 mm-40 -53.33 -17.65 1.98 Allowed 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.813 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 59.8 m -62.27 121.42 13.11 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.749 -179.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -57.83 -29.71 65.15 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.407 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 92.5 mt -128.23 121.93 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.107 176.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -106.97 137.94 44.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.092 -178.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 95.5 mt -120.53 129.32 75.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -78.2 26.99 0.2 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.4 mt -92.73 126.84 50.33 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.808 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.79 -12.41 30.89 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.499 2.133 . . . . 0.0 113.632 -179.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.416 ' CG2' ' CE2' ' B' ' 241' ' ' PHE . 35.2 m -99.92 5.83 9.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.791 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.7 t -89.32 136.61 23.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.986 179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.2 m -67.84 161.33 26.48 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.52 0.676 . . . . 0.0 111.548 -178.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -61.65 -42.99 99.67 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.112 -178.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.603 ' O ' ' N ' ' A' ' 49' ' ' CYS . 95.5 mt-30 -115.72 -6.26 12.13 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 123.652 0.595 . . . . 0.0 111.064 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.463 ' C ' ' O ' ' A' ' 47' ' ' GLN . 15.2 t60 15.9 -73.43 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 -178.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.603 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -128.48 132.67 48.38 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.483 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -126.85 126.57 43.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.179 179.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 85.6 mt -106.71 130.32 58.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.048 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -116.81 119.83 36.62 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.5 mt -103.62 116.55 47.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.02 -0.672 . . . . 0.0 112.285 -178.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.551 ' O ' ' N ' ' A' ' 56' ' ' GLN . 87.0 m-70 -114.88 142.91 45.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.303 179.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.4 mm-40 -39.52 -26.35 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -178.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.551 ' N ' ' O ' ' A' ' 54' ' ' HIS . 77.7 mt-30 -69.47 -68.73 0.39 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.891 178.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.409 ' CD ' ' N ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -157.68 -166.13 1.93 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.321 -179.174 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.9 130.2 56.2 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.2 mt -119.8 130.78 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.46 ' CD1' ' HG ' ' A' ' 49' ' ' CYS . 29.0 tp -100.14 125.83 46.32 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.291 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -107.53 137.57 45.32 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.575 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -99.92 106.95 18.82 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -99.35 -5.35 29.8 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.662 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.585 ' HG ' ' C ' ' A' ' 67' ' ' ASN . 23.1 t -86.77 99.88 12.11 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 120.401 -0.52 . . . . 0.0 112.014 -178.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.5 m -73.68 -37.6 65.17 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 177.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.7 p -65.66 -36.24 83.09 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.636 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.585 ' C ' ' HG ' ' A' ' 64' ' ' SER . 36.3 m-80 -153.05 97.92 2.8 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.547 -179.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -59.28 147.01 92.87 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.063 1.842 . . . . 0.0 112.758 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 60.4 m -65.62 133.58 51.46 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 177.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -96.82 141.55 29.88 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.223 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.525 ' CG2' ' OD1' ' A' ' 86' ' ' ASP . 5.2 p -129.66 134.67 62.93 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 50.96 32.97 8.08 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 119.694 -0.802 . . . . 0.0 109.15 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.05 28.53 66.38 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.443 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.2 t -140.24 139.43 35.58 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 117.308 0.554 . . . . 0.0 110.743 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -68.05 144.1 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 120.903 0.382 . . . . 0.0 111.48 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.511 ' CG2' ' O ' ' A' ' 78' ' ' GLU . 85.9 mt -106.28 108.73 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.693 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -76.18 -39.17 55.48 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.1 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.511 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 1.5 mt-10 -128.64 172.99 6.11 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.737 -178.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -57.54 143.57 94.29 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 122.16 1.907 . . . . 0.0 112.57 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.1 t -133.0 138.03 52.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.425 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -74.32 131.35 41.07 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 178.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.4 mt -82.84 136.73 34.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.982 0.42 . . . . 0.0 111.491 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -132.61 154.95 49.55 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.301 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.405 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 5.2 t60 -54.94 117.28 3.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.894 0.378 . . . . 0.0 111.596 -179.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.39 -14.03 30.51 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.525 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 52.5 t0 -69.44 127.8 34.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.089 0.471 . . . . 0.0 110.445 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.424 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 72.5 t -108.79 132.64 56.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.359 -178.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.481 ' O ' ' OG ' ' A' ' 94' ' ' SER . 97.1 mt -102.48 131.13 51.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 89.7 m -119.49 129.49 54.74 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.643 0.735 . . . . 0.0 112.119 -178.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.623 ' O ' ' N ' ' A' ' 93' ' ' ARG . 92.0 mt -118.35 133.08 66.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 114.615 -1.175 . . . . 0.0 108.769 178.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.543 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 70.3 mt -20.77 91.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.637 ' OD2' ' NE ' ' B' ' 245' ' ' ARG . 21.3 t0 93.36 -21.73 0.07 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 177.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.623 ' N ' ' O ' ' A' ' 90' ' ' ILE . 87.8 mtt-85 -130.4 146.01 51.9 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.103 -0.639 . . . . 0.0 111.029 -179.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.481 ' OG ' ' O ' ' A' ' 88' ' ' ILE . 32.7 t -138.9 151.77 47.21 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.149 0.5 . . . . 0.0 110.317 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.445 ' N ' ' HG ' ' A' ' 94' ' ' SER . 91.6 m-85 -125.65 127.27 46.02 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -89.06 138.02 31.79 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.745 -179.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -94.91 119.37 33.34 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.512 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -123.18 120.96 34.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.852 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.405 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 64.1 t-20 . . . . . 0 C--N 1.325 -0.476 0 C-N-CA 120.679 -0.409 . . . . 0.0 110.141 179.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo . . . . . 0 N--CA 1.495 1.608 0 CA-C-O 121.333 0.472 . . . . 0.0 112.982 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 10.7 p -78.39 128.87 38.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.254 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.328 -0.339 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.184 -179.316 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo . . . . . 0 N--CA 1.491 1.377 0 CA-C-O 120.711 0.213 . . . . 0.0 111.981 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 20.0 m -68.72 -46.89 67.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.442 0.639 . . . . 0.0 109.774 178.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . 0.744 ' CD2' ' NH1' ' B' ' 245' ' ' ARG . 77.2 t80 -58.65 -44.0 89.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.767 -179.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . 0.654 ' CD2' HH22 ' B' ' 245' ' ' ARG . 60.6 mt -61.34 -43.87 98.14 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.214 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -64.69 -37.7 88.49 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . 0.415 ' O ' ' OG ' ' B' ' 247' ' ' SER . 76.4 ttt180 -62.68 -47.2 84.69 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.632 -178.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.744 ' NH1' ' CD2' ' B' ' 241' ' ' PHE . 27.8 mtm-85 -63.93 -37.55 87.84 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.773 -179.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -62.49 -41.2 98.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.809 0.338 . . . . 0.0 110.443 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 247' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 76.7 p -66.16 -41.12 90.82 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -62.08 -38.98 90.88 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.111 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 52.5 t . . . . . 0 N--CA 1.451 -0.4 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.52 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 . . . . . 0 C--O 1.231 0.124 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 66.7 mt -107.32 133.6 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 56.5 t -125.86 132.94 70.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.109 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -96.23 118.78 33.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.401 0.62 . . . . 0.0 111.969 -177.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -66.23 -44.65 83.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.767 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . 0.467 ' NE2' ' O ' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -95.83 156.15 37.6 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.09 -179.462 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -64.93 144.21 82.03 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 C-N-CA 122.674 2.249 . . . . 0.0 112.926 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 47.3 pt . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.912 179.463 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.0 p . . . . . 0 CA--C 1.528 0.129 0 CA-C-O 120.912 0.387 . . . . 0.0 110.851 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.517 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 96.8 mtt-85 -90.24 122.39 33.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.87 -178.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -130.69 138.08 49.85 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.918 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 83.3 mt -115.26 139.42 49.97 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.57 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.6 t -112.1 127.65 69.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.3 m -87.62 111.83 21.67 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.234 0.54 . . . . 0.0 111.43 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 90.9 mt -82.82 145.52 8.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.717 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -92.0 158.19 16.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.783 0.325 . . . . 0.0 110.754 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -58.01 -24.75 59.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.529 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.2 m -80.94 -10.05 59.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.033 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.07 39.81 6.81 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.1 t -123.31 134.62 65.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.849 0.356 . . . . 0.0 111.328 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' A' ' 17' ' ' GLY . 62.6 t0 -73.93 127.24 32.36 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.931 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.428 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -123.8 -122.73 2.73 Favored Glycine 0 CA--C 1.542 1.746 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.217 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.95 148.63 45.75 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 122.671 2.247 . . . . 0.0 113.626 -178.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -107.39 154.83 20.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.166 0.508 . . . . 0.0 110.832 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -130.76 103.2 16.03 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.582 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -78.05 138.62 16.49 Favored 'Trans proline' 0 N--CA 1.488 1.191 0 C-N-CA 121.911 1.74 . . . . 0.0 112.635 -179.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 94.0 mt -92.65 54.42 2.24 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.225 -0.443 . . . . 0.0 112.188 -178.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.6 p -59.67 -29.03 67.78 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 63.1 mt -75.43 142.11 43.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.609 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.32 -16.65 64.22 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -178.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 30.3 m -140.5 140.29 35.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.021 0.438 . . . . 0.0 111.16 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.617 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -136.28 134.2 37.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.382 178.545 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 47.5 tp -121.73 127.38 50.63 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.214 -178.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.617 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 21.0 m-85 -101.86 131.99 47.89 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.663 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.62 -177.79 38.61 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 120.274 -0.965 . . . . 0.0 112.285 179.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.671 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 73.0 mtm-85 -77.9 -31.95 51.47 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.764 0.316 . . . . 0.0 110.554 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.435 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -52.45 149.21 10.34 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -178.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.45 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 8.1 tp -66.44 -42.04 89.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 C-N-CA 120.759 -0.377 . . . . 0.0 110.272 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.45 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 80.0 mm-40 -53.16 -18.87 2.5 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.435 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 57.1 m -63.25 121.88 14.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.533 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -57.94 -29.41 65.14 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.434 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 93.4 mt -122.64 119.78 59.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 176.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 87.9 mtm-85 -104.0 133.67 48.56 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.355 -178.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 98.9 mt -117.53 129.36 74.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.148 0.499 . . . . 0.0 110.24 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -77.92 24.1 0.24 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.857 -177.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.566 ' CD1' ' NH1' ' A' ' 93' ' ' ARG . 38.3 mt -105.02 128.24 27.1 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.912 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.47 -12.93 30.02 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.434 2.089 . . . . 0.0 113.309 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.5 m -88.45 -2.21 8.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.871 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.671 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 55.8 t -92.86 134.55 30.39 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.255 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 178.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.1 162.04 17.74 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.291 0.567 . . . . 0.0 111.793 -178.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -59.86 -43.6 94.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.19 -178.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.67 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.5 mt-30 -111.5 -18.08 12.93 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.5 t60 32.59 -71.93 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.467 -1.242 . . . . 0.0 114.108 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.67 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.19 136.21 45.53 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.296 0.57 . . . . 0.0 112.263 -177.847 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -125.68 135.76 52.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.333 178.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.0 tt -124.29 136.39 60.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.03 0.443 . . . . 0.0 110.14 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -122.46 132.57 54.41 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.981 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 95.6 mt -106.99 112.25 39.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.823 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.501 ' O ' ' N ' ' A' ' 56' ' ' GLN . 81.4 m-70 -112.92 145.96 39.83 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.156 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' A' ' 54' ' ' HIS . 99.1 mt-10 -40.2 -27.02 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.894 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.501 ' N ' ' O ' ' A' ' 54' ' ' HIS . 85.7 mt-30 -67.04 -68.92 0.34 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.608 178.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -158.68 -168.22 2.35 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.209 0.528 . . . . 0.0 110.945 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -104.04 120.74 41.72 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 177.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.6 mt -110.99 128.89 67.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 56.5 tp -97.82 129.78 44.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.682 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -114.86 136.95 52.54 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.731 0.3 . . . . 0.0 111.147 -179.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -94.35 106.55 18.53 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -102.75 -10.18 19.37 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.311 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.5 t -74.27 101.59 4.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.381 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 92.2 p -82.61 -12.69 57.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.01 0.434 . . . . 0.0 110.035 179.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.15 -35.64 9.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.434 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -145.33 92.75 5.54 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.39 -179.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -55.57 146.19 65.67 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 122.648 2.232 . . . . 0.0 112.721 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 61.8 m -77.03 138.65 39.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.585 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -102.68 141.15 35.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.088 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.4 t -129.79 135.18 61.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 52.42 32.13 10.77 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.2 24.72 70.48 Favored Glycine 0 CA--C 1.535 1.281 0 CA-C-N 115.131 -0.941 . . . . 0.0 112.885 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 47.6 t -141.66 140.85 33.33 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 118.053 0.927 . . . . 0.0 112.057 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 43.0 t -68.03 139.43 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.343 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.2 pt -114.59 89.36 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.25 178.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -63.72 -24.0 67.6 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -123.62 166.74 17.36 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.128 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -65.55 150.64 86.43 Favored 'Trans proline' 0 N--CA 1.5 1.86 0 C-N-CA 122.845 2.364 . . . . 0.0 113.441 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 29.7 m -143.1 143.92 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.59 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -75.27 138.56 41.95 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 178.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 92.0 mt -96.67 134.83 39.42 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.249 0.547 . . . . 0.0 111.571 -178.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -121.45 157.3 30.88 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.769 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.55 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 4.5 t60 -55.46 120.71 7.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.354 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.38 -19.3 26.93 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -68.14 135.94 52.91 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.307 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.499 ' CG1' ' HG ' ' A' ' 94' ' ' SER . 42.2 t -114.6 133.54 60.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.524 -178.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.474 ' O ' ' OG ' ' A' ' 94' ' ' SER . 80.9 mt -100.61 132.49 46.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.248 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.6 m -125.56 130.09 51.02 Favored 'General case' 0 C--N 1.334 -0.097 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -179.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.43 ' O ' ' N ' ' A' ' 92' ' ' ASP . 84.0 mt -119.32 127.59 75.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.28 178.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.441 ' CG2' ' NH2' ' B' ' 245' ' ' ARG . 36.0 mm 42.26 -97.82 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -178.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.506 ' O ' ' OD1' ' A' ' 92' ' ' ASP . 48.0 t0 -126.85 23.92 6.57 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.283 0.564 . . . . 0.0 110.02 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.601 HH12 ' NH1' ' B' ' 245' ' ' ARG . 54.5 mtm-85 -126.45 139.75 53.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.001 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.499 ' HG ' ' CG1' ' A' ' 87' ' ' VAL . 15.9 t -139.75 150.57 44.94 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.223 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -118.83 119.38 34.21 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 39.2 ttp-105 -82.23 130.58 35.13 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.33 -179.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.517 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 61.6 t80 -97.74 124.85 42.25 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.059 0.456 . . . . 0.0 111.271 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -128.52 123.65 34.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.523 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.55 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 58.3 t-20 . . . . . 0 C--N 1.329 -0.317 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.361 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo . . . . . 0 N--CA 1.491 1.328 0 CA-C-O 121.959 0.733 . . . . 0.0 112.95 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 4.0 p -65.25 136.55 26.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 114.572 -1.195 . . . . 0.0 110.446 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 20.2 t . . . . . 0 C--N 1.327 -0.412 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.214 -179.764 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo . . . . . 0 N--CA 1.5 1.86 0 N-CA-C 112.595 0.19 . . . . 0.0 112.595 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 19.5 m -70.28 -45.29 66.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.657 0.742 . . . . 0.0 109.038 178.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . 0.43 ' CE2' ' NE ' ' B' ' 245' ' ' ARG . 87.7 t80 -58.15 -43.94 87.62 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.585 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . 0.554 ' CD2' HH21 ' B' ' 245' ' ' ARG . 75.8 mt -61.76 -41.96 98.37 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.767 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.44 -39.28 91.88 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.49 -179.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -60.02 -45.71 91.9 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.566 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.601 ' NH1' HH12 ' A' ' 93' ' ' ARG . 64.3 mtm180 -63.3 -38.22 90.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.468 -179.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.3 -39.08 91.79 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 120.101 -0.64 . . . . 0.0 109.652 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 18.0 m -63.98 -44.15 93.56 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -60.23 -35.84 76.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.517 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 38.0 t . . . . . 0 N--CA 1.453 -0.286 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.572 179.717 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 . . . . . 0 CA--C 1.534 0.358 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 66.1 mt -114.57 134.8 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 41.2 t -127.57 136.2 61.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -95.5 117.24 30.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.171 0.51 . . . . 0.0 110.865 -178.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -63.65 -47.11 82.64 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.448 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 4.2 mm100 -96.63 154.42 38.47 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.853 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.29 147.65 59.93 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 123.015 2.477 . . . . 0.0 113.639 -178.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 29.9 pt . . . . . 0 C--N 1.33 -0.244 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.203 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 69.6 p . . . . . 0 N--CA 1.463 0.19 0 CA-C-O 120.719 0.295 . . . . 0.0 111.507 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.483 ' CD ' ' HH ' ' A' ' 97' ' ' TYR . 85.1 mtt85 -87.74 120.24 28.86 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.264 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -124.22 135.86 53.75 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.134 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 33.2 tp -116.05 131.91 56.81 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.605 -0.438 . . . . 0.0 109.853 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 53.8 t -109.04 132.55 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.328 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 m -88.68 112.57 23.28 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.958 0.409 . . . . 0.0 112.043 -178.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 79.4 mt -80.75 141.85 14.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -97.42 160.87 14.07 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.021 0.439 . . . . 0.0 109.852 178.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -59.69 -19.86 52.52 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.983 -179.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.5 t -78.71 -16.48 57.2 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.282 178.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.85 24.49 22.88 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.5 m -119.77 135.83 58.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -70.89 139.46 50.77 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.238 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -125.1 -121.99 2.59 Favored Glycine 0 CA--C 1.534 1.246 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.4 148.14 54.03 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 121.869 1.712 . . . . 0.0 112.888 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -108.34 143.85 36.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.29 0.567 . . . . 0.0 111.139 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -114.68 98.82 50.55 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.358 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.55 132.01 18.29 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 121.101 1.2 . . . . 0.0 111.359 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.2 mt -84.5 56.12 3.68 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.07 -178.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.672 ' HG ' HE22 ' B' ' 265' ' ' GLN . 79.8 p -64.48 -22.39 66.95 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.416 ' HG ' HE22 ' B' ' 265' ' ' GLN . 92.1 mt -84.96 141.91 30.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.545 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 45.3 t -61.8 -18.1 58.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.524 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.514 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 33.5 m -133.93 132.93 40.82 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.593 -0.443 . . . . 0.0 112.008 -179.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.5 t -122.09 114.59 21.11 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.42 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 53.8 tp -113.95 131.37 56.34 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.523 -178.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.404 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 12.5 m-85 -109.76 127.18 54.46 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.051 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 173.63 -173.6 45.86 Favored Glycine 0 N--CA 1.474 1.199 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.492 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.649 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 85.9 mtm-85 -86.29 -26.72 24.79 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.463 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.547 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -58.31 154.52 25.01 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.99 -178.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.465 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 10.5 tp -66.57 -41.81 88.97 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-O 120.746 0.308 . . . . 0.0 111.002 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.465 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 83.1 tt0 -57.63 -20.27 32.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.776 -179.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.547 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 7.5 m -60.69 129.41 41.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.234 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.514 ' OD2' ' O ' ' A' ' 26' ' ' THR . 54.3 m-20 -61.93 -34.35 75.93 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 87.9 mt -126.3 121.39 58.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 178.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.413 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 83.5 mtp180 -103.53 134.28 47.15 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.631 -178.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 89.9 mt -117.34 129.72 73.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.074 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -78.47 39.35 0.33 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -177.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.539 ' CD1' ' NH2' ' A' ' 93' ' ' ARG . 75.9 mt -119.94 137.72 26.12 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.844 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -72.78 -11.93 26.15 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 122.608 2.206 . . . . 0.0 112.455 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.8 m -92.04 4.15 7.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.517 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.649 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 48.0 t -98.69 130.35 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.3 m -73.05 172.32 11.24 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.747 0.784 . . . . 0.0 112.642 -178.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -64.63 -40.32 95.26 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.091 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.649 ' O ' ' N ' ' A' ' 49' ' ' CYS . 84.0 mm-40 -114.12 -19.25 11.43 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.921 0.391 . . . . 0.0 110.345 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.7 t60 31.37 -77.41 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.649 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -128.05 133.25 49.06 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.605 -178.931 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -129.2 128.84 44.15 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.401 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 85.9 mt -114.04 133.15 60.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.416 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.569 ' CD ' ' HE2' ' A' ' 54' ' ' HIS . 81.3 tt0 -113.53 125.07 53.79 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.9 mm -93.99 123.98 46.29 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 121.602 0.715 . . . . 0.0 112.088 -178.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.569 ' HE2' ' CD ' ' A' ' 52' ' ' GLU . 96.5 m-70 -124.75 131.03 53.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.386 178.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 54' ' ' HIS . 47.9 tp10 -42.73 -32.2 0.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -64.12 -67.57 0.42 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.213 -0.903 . . . . 0.0 108.914 178.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.545 ' OE2' ' CD ' ' A' ' 81' ' ' ARG . 0.2 OUTLIER -152.3 -175.36 5.23 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.639 179.808 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.55 129.04 56.63 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.704 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.4 mt -116.77 131.55 69.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -178.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 50.1 tp -94.38 125.69 39.18 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.322 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -110.33 132.52 54.1 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.11 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.427 ' ND2' ' O ' ' A' ' 76' ' ' ILE . 41.5 t30 -94.05 106.23 18.21 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.25 0.548 . . . . 0.0 111.705 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -100.57 -9.45 21.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.397 179.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.0 t -76.75 98.18 4.71 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 120.036 -0.666 . . . . 0.0 109.831 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.4 p -74.99 -32.82 61.75 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.377 178.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.28 -43.24 57.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.461 -179.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -140.57 97.77 7.34 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -55.51 145.01 71.39 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.295 1.997 . . . . 0.0 112.532 -178.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 13.2 m -71.79 137.15 47.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.157 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -101.02 140.73 34.91 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.666 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.7 p -135.17 136.08 51.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 50.11 30.93 4.52 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.96 28.86 65.88 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.972 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.4 m -135.3 124.55 24.6 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.826 -179.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.6 m -71.87 140.75 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.427 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 46.2 pt -121.0 141.88 39.56 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-O 121.203 0.525 . . . . 0.0 111.281 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.489 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 21.5 p-10 -104.29 -14.32 15.84 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 178.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -128.66 166.77 22.36 Favored Pre-proline 0 CA--C 1.528 0.098 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.148 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -64.12 146.88 91.35 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 122.673 2.249 . . . . 0.0 112.772 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.7 t -133.95 140.47 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.837 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.545 ' CD ' ' OE2' ' A' ' 57' ' ' GLU . 88.6 mtm180 -71.95 128.99 37.49 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.659 -0.417 . . . . 0.0 110.952 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 92.8 mt -84.37 131.23 34.72 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.341 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -124.53 153.2 42.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.702 178.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.628 ' HD1' ' N ' ' A' ' 99' ' ' ASN . 12.4 t60 -56.94 122.52 12.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.956 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.22 -19.96 33.74 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.05 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -66.27 139.26 58.06 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 77.1 t -112.03 129.99 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.326 -178.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.2 mt -95.66 131.21 43.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 42.3 m -120.69 124.53 45.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.494 0.664 . . . . 0.0 111.82 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 86.0 mt -119.57 121.06 65.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.173 179.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 36.0 mm 52.45 -112.51 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -178.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -116.25 24.25 11.53 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.337 0.589 . . . . 0.0 110.371 179.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.539 ' NH2' ' CD1' ' A' ' 41' ' ' LEU . 47.5 mtm-85 -131.26 146.72 52.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.224 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.3 p -140.65 158.58 43.78 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.318 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -126.37 124.24 39.78 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.238 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -85.14 127.68 34.35 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 121.075 0.464 . . . . 0.0 111.053 -179.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.483 ' HH ' ' CD ' ' A' ' 5' ' ' ARG . 92.3 t80 -96.09 125.64 40.77 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.885 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -130.5 122.38 27.53 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.428 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.628 ' N ' ' HD1' ' A' ' 84' ' ' HIS . 49.2 t-20 . . . . . 0 C--N 1.331 -0.215 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.967 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo . . . . . 0 N--CA 1.485 1.015 0 CA-C-O 121.417 0.507 . . . . 0.0 112.263 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 76.3 t -59.09 139.85 18.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.215 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . 0.603 ' SG ' ' CD1' ' B' ' 241' ' ' PHE . 4.9 t . . . . . 0 C--N 1.331 -0.211 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo . . . . . 0 N--CA 1.5 1.863 0 N-CA-C 113.222 0.431 . . . . 0.0 113.222 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 98.7 m -73.27 -45.72 54.05 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.631 0.729 . . . . 0.0 109.541 178.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . 0.603 ' CD1' ' SG ' ' B' ' 237' ' ' CYS . 54.4 t80 -57.31 -45.63 84.02 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.102 -178.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 89.0 mt -65.24 -42.23 93.53 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -61.67 -38.75 88.93 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.404 -0.519 . . . . 0.0 110.357 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . 0.563 ' O ' ' OG ' ' B' ' 247' ' ' SER . 82.7 mtp180 -64.12 -40.72 96.79 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.544 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.449 ' NH2' ' CD2' ' A' ' 41' ' ' LEU . 22.0 mmt180 -64.73 -41.4 95.98 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.382 -179.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.46 -38.05 88.27 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 247' ' ' SER . . . . . 0.563 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 77.8 p -67.46 -42.78 82.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.441 179.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -61.56 -36.2 79.95 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.838 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 34.9 t . . . . . 0 C--N 1.326 -0.447 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.358 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . 0.503 ' N ' ' OE1' ' B' ' 260' ' ' GLU . 44.5 mp0 . . . . . 0 C--O 1.223 -0.335 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 74.5 mt -118.62 133.67 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 75.5 t -129.25 137.19 57.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.987 0.423 . . . . 0.0 110.884 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -97.31 119.56 36.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.595 -178.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -67.87 -45.89 73.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.364 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . 0.672 HE22 ' HG ' ' A' ' 23' ' ' SER . 0.0 OUTLIER -92.57 156.17 41.47 Favored Pre-proline 0 C--N 1.332 -0.16 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.049 -179.006 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -63.65 148.28 92.32 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.995 2.464 . . . . 0.0 112.17 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 33.9 pt . . . . . 0 C--N 1.326 -0.439 0 CA-C-O 121.416 0.627 . . . . 0.0 111.185 -179.535 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 63.3 p . . . . . 0 C--O 1.232 0.147 0 CA-C-O 121.027 0.442 . . . . 0.0 110.308 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.534 ' CD ' ' HH ' ' A' ' 97' ' ' TYR . 86.0 mtt85 -97.43 132.42 43.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.219 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -134.37 145.31 48.85 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.844 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.5 mt -114.07 142.95 45.55 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.049 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.9 t -115.82 129.9 71.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 m -90.74 119.32 30.87 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.485 0.66 . . . . 0.0 112.776 -177.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.1 mm -81.33 135.48 24.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.496 178.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -85.86 156.3 20.6 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.792 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.413 ' NE ' ' HD2' ' B' ' 245' ' ' ARG . 83.7 mtp180 -58.36 -34.61 70.85 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.3 p -70.25 -18.88 63.15 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.202 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.65 34.38 5.78 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.0 t -121.15 133.09 68.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 114.992 -0.604 . . . . 0.0 110.922 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -73.26 136.38 44.59 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -135.52 -114.56 1.4 Allowed Glycine 0 CA--C 1.534 1.276 0 C-N-CA 119.752 -1.213 . . . . 0.0 112.827 -179.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.67 144.09 43.5 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.33 2.02 . . . . 0.0 113.653 -177.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 63.8 m170 -107.9 137.94 45.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.678 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -106.12 96.51 13.32 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.6 134.59 22.51 Favored 'Trans proline' 0 C--N 1.315 -1.231 0 C-N-CA 121.283 1.322 . . . . 0.0 110.745 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.9 mt -86.06 74.16 10.14 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.663 -178.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.1 p -79.6 -10.24 59.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.41 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.1 mt -105.86 148.0 28.06 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.108 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.2 t -68.22 -16.16 63.86 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.5 m -134.41 136.97 43.69 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.419 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.664 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 4.1 t -131.69 124.47 29.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.923 178.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 47.7 tp -118.38 129.61 55.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.532 -178.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.664 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 6.8 m-85 -106.06 134.72 48.74 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.422 179.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 156.5 -177.91 33.24 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 120.451 -0.88 . . . . 0.0 112.322 179.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.407 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 45.5 mtm105 -75.1 -32.44 61.42 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.48 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -50.34 150.85 5.25 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.778 -178.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.461 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 9.8 tp -66.11 -41.66 89.9 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-O 121.021 0.439 . . . . 0.0 110.1 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.461 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 97.7 mt-10 -56.07 -24.3 39.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.806 -179.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.48 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 32.0 m -55.8 117.2 3.44 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.685 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -57.37 -29.15 63.8 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 98.7 mt -125.64 118.66 52.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.417 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 84.1 mtp180 -104.06 136.73 43.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.689 -178.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 97.6 mt -118.08 129.82 73.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 121.29 0.567 . . . . 0.0 110.771 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -74.96 35.19 0.1 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 114.975 -1.011 . . . . 0.0 113.092 -177.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.654 ' CD1' ' HE ' ' A' ' 93' ' ' ARG . 28.3 mt -118.94 130.93 24.56 Favored Pre-proline 0 C--N 1.323 -0.561 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.457 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.436 ' O ' ' HD2' ' B' ' 235' ' ' PRO . 44.2 Cg_endo -67.84 -18.97 47.23 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.379 2.052 . . . . 0.0 113.454 -179.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.2 m -83.87 -0.08 5.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.836 -0.345 . . . . 0.0 110.896 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.407 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 56.8 t -88.08 133.0 31.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.926 0.393 . . . . 0.0 110.124 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.9 m -67.89 162.49 24.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.426 0.631 . . . . 0.0 111.325 -179.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -60.88 -41.53 96.19 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.591 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.629 ' O ' ' N ' ' A' ' 49' ' ' CYS . 97.9 mm-40 -115.33 -25.32 8.04 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.436 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.8 t60 36.54 -76.07 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.629 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.53 134.04 46.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.37 0.605 . . . . 0.0 112.177 -178.091 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -126.8 131.62 51.22 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.196 179.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 91.6 mt -115.41 133.32 62.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.507 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -119.34 126.55 51.7 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 89.1 mt -106.38 118.18 53.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.555 0.693 . . . . 0.0 111.83 -179.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.453 ' O ' ' N ' ' A' ' 56' ' ' GLN . 86.5 m-70 -113.86 142.66 45.82 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.331 179.366 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 54' ' ' HIS . 80.0 mm-40 -40.21 -29.46 0.08 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.453 ' N ' ' O ' ' A' ' 54' ' ' HIS . 88.5 mt-30 -63.7 -66.98 0.47 Allowed 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.447 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 5.5 tp10 -158.36 -163.32 1.26 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.138 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.447 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -112.8 129.16 56.53 Favored 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.1 mt -119.29 128.88 75.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.385 0.612 . . . . 0.0 112.145 -178.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.4 tp -97.79 126.58 43.22 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.054 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -110.97 136.36 50.09 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.843 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -97.33 104.44 16.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.575 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -99.07 -10.06 23.07 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.891 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.52 99.03 3.48 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.248 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.7 m -73.55 -39.82 64.44 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.377 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.66 -47.46 81.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.818 -178.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -142.9 99.03 5.6 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.38 148.35 33.66 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.361 2.04 . . . . 0.0 113.26 -179.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.5 m -69.32 139.54 54.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.862 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -100.33 141.93 32.5 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.431 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.495 ' CG2' ' OD1' ' A' ' 86' ' ' ASP . 8.5 p -130.79 135.17 60.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 44.99 33.71 1.09 Allowed 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.082 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.05 29.28 62.93 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.837 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.485 ' N ' ' O ' ' A' ' 71' ' ' VAL . 15.8 m -140.65 139.43 34.82 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 120.576 -0.449 . . . . 0.0 111.239 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.2 t -72.59 137.93 22.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.243 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.0 pt -109.38 91.99 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.707 178.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -65.41 -30.29 71.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.56 179.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -122.86 168.7 11.37 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.458 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -60.71 148.87 90.3 Favored 'Trans proline' 0 N--CA 1.501 1.917 0 C-N-CA 122.41 2.073 . . . . 0.0 112.26 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.6 p -142.72 142.89 26.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.42 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.7 mtm180 -75.58 131.43 39.99 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 93.0 mt -78.42 140.33 38.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.128 0.49 . . . . 0.0 111.471 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -128.4 148.13 50.69 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.534 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.557 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 5.0 t60 -55.36 117.21 3.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.213 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.07 -8.71 31.38 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.495 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 60.6 t0 -73.7 128.18 34.81 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.73 0.3 . . . . 0.0 110.441 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.457 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 48.3 t -109.9 132.64 57.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.463 -178.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.8 mt -105.37 134.01 48.06 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 97.6 m -121.53 126.65 49.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.33 0.586 . . . . 0.0 111.898 -178.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.8 mt -115.71 124.81 72.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 177.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.4 mm 40.81 -101.66 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 -178.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -118.39 23.56 11.47 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.096 0.475 . . . . 0.0 110.615 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.654 ' HE ' ' CD1' ' A' ' 41' ' ' LEU . 7.9 mtm105 -128.2 146.5 50.71 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.095 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.1 t -137.06 147.16 45.96 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.469 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -120.13 121.0 37.83 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -84.87 135.07 34.24 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.344 -178.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.534 ' HH ' ' CD ' ' A' ' 5' ' ' ARG . 86.8 t80 -95.16 120.36 35.25 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.524 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -122.26 123.8 42.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.319 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.557 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 62.5 t-20 . . . . . 0 C--N 1.33 -0.282 0 CA-C-O 120.832 0.348 . . . . 0.0 110.576 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . 0.436 ' HD2' ' O ' ' A' ' 42' ' ' PRO . 31.3 Cg_exo . . . . . 0 N--CA 1.488 1.199 0 CA-C-O 121.756 0.648 . . . . 0.0 112.726 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 25.5 t -68.56 133.66 31.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 114.572 -1.195 . . . . 0.0 109.406 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.403 0 C-N-CA 120.218 -0.593 . . . . 0.0 110.199 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo . . . . . 0 N--CA 1.493 1.447 0 CA-C-O 120.948 0.312 . . . . 0.0 111.76 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 21.4 m -74.21 -46.2 43.35 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.79 177.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -57.84 -44.87 86.77 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.276 -179.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 79.2 mt -63.76 -39.76 95.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.406 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -60.34 -42.42 95.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.317 -0.401 . . . . 0.0 109.96 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -65.67 -39.47 91.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.203 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.413 ' HD2' ' NE ' ' A' ' 12' ' ' ARG . 3.1 tpp85 -57.5 -43.69 84.38 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -64.4 -41.52 96.6 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 68.1 m -60.93 -45.51 94.39 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -62.53 -34.21 76.45 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.339 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 19.0 t . . . . . 0 CA--C 1.519 -0.234 0 C-N-CA 120.409 -0.516 . . . . 0.0 109.92 179.544 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 . . . . . 0 CA--C 1.53 0.19 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 59.3 mt -116.35 132.19 66.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 42.9 t -125.3 134.42 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.094 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -95.54 118.01 31.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.296 0.569 . . . . 0.0 111.038 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -65.02 -44.24 89.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.463 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -100.84 157.83 32.96 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.039 -178.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.23 153.47 69.7 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.777 2.318 . . . . 0.0 111.883 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 41.9 pt . . . . . 0 C--N 1.328 -0.355 0 CA-C-O 121.65 0.738 . . . . 0.0 111.995 -178.877 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.2 m . . . . . 0 N--CA 1.467 0.393 0 CA-C-O 120.666 0.27 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.595 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 95.2 mtt-85 -97.76 112.31 24.26 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.556 -179.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 60.7 ttp180 -124.73 131.5 53.45 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.862 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 43.8 tp -109.32 132.63 53.94 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 37.1 t -109.81 131.41 60.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.809 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.6 m -91.45 113.49 25.77 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -177.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.567 ' CD1' ' HG ' ' A' ' 94' ' ' SER . 97.0 mt -81.91 143.59 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.648 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -89.79 158.42 17.51 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.039 0.447 . . . . 0.0 110.97 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -57.28 -32.21 66.39 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.994 -178.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.4 p -79.76 -7.9 58.92 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.419 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.82 40.29 4.99 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.2 t -122.59 131.16 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 O-C-N 122.753 -0.263 . . . . 0.0 111.446 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -73.59 134.29 43.7 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -126.97 -123.52 2.65 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.036 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -74.37 153.16 44.94 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 122.362 2.042 . . . . 0.0 112.167 -178.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.571 ' O ' ' CG2' ' B' ' 267' ' ' ILE . 0.2 OUTLIER -108.16 159.88 16.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.971 0.415 . . . . 0.0 110.842 -179.516 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.412 ' CD2' HD12 ' A' ' 37' ' ' ILE . 43.8 t80 -128.38 92.3 41.55 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.64 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.23 125.55 18.84 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.026 1.817 . . . . 0.0 111.292 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.466 ' CD2' ' SG ' ' A' ' 27' ' ' CYS . 93.1 mt -87.92 42.25 1.04 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.896 0.379 . . . . 0.0 111.404 -178.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.7 t -59.37 -23.35 62.49 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.678 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.0 mt -76.62 143.9 39.87 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 82.2 p -66.66 -20.31 65.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.676 -178.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.512 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 93.8 m -128.74 128.96 45.06 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.379 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.466 ' SG ' ' CD2' ' A' ' 22' ' ' LEU . 6.5 t -121.94 112.57 18.46 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.02 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 52.6 tp -113.47 126.07 54.92 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.233 -177.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.501 ' O ' ' O ' ' A' ' 47' ' ' GLN . 6.6 m-85 -106.44 136.66 45.8 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.454 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 160.37 -173.11 36.91 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.284 -0.96 . . . . 0.0 112.421 178.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.571 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 39.3 mtm180 -79.38 -29.21 41.99 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.575 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -61.89 151.03 45.09 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.523 -177.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 33' ' ' ILE . 78.2 mt -64.87 -42.92 96.15 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.337 0 CA-C-N 115.564 -0.318 . . . . 0.0 110.916 179.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -52.64 -26.03 12.49 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 119.657 -0.817 . . . . 0.0 108.893 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.575 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 11.4 m -57.81 118.74 5.63 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.295 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.512 ' OD2' ' O ' ' A' ' 26' ' ' THR . 98.5 m-20 -56.09 -24.07 37.9 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.222 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.459 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 96.9 mt -131.66 122.75 50.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.838 178.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 32.2 mtm180 -107.71 140.47 40.71 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.016 0.436 . . . . 0.0 111.5 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.443 ' C ' ' H ' ' A' ' 41' ' ' LEU . 78.0 mt -121.04 128.79 76.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -70.57 32.3 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -177.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.568 ' CD1' ' CZ ' ' A' ' 93' ' ' ARG . 64.7 mt -110.79 133.68 21.15 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.956 -179.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.7 -8.92 24.07 Favored 'Trans proline' 0 N--CA 1.501 1.959 0 C-N-CA 123.478 2.785 . . . . 0.0 113.863 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.6 m -101.13 2.65 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.032 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.571 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 18.4 t -89.54 100.98 11.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.649 -179.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.521 ' O ' ' O ' ' A' ' 44' ' ' VAL . 3.6 t -34.99 164.29 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.936 -179.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -63.59 -43.55 96.61 Favored 'General case' 0 C--O 1.238 0.447 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.776 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.609 ' O ' ' N ' ' A' ' 49' ' ' CYS . 94.5 mm-40 -111.21 -23.51 10.81 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.007 0.432 . . . . 0.0 110.421 -179.285 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 16.5 t60 41.29 -78.3 0.0 OUTLIER 'General case' 0 C--O 1.24 0.576 0 CA-C-N 115.421 -0.808 . . . . 0.0 112.679 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.609 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.45 136.93 48.37 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.914 -178.861 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -129.81 129.51 44.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.181 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 89.0 mt -114.61 138.41 44.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.313 -179.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -118.0 122.51 43.4 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.426 HG21 HD11 ' A' ' 53' ' ' ILE . 89.3 mt -103.47 114.09 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 C-N-CA 120.104 -0.639 . . . . 0.0 111.285 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.5 ' O ' ' N ' ' A' ' 56' ' ' GLN . 96.6 m-70 -111.41 139.9 46.44 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.828 179.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 54' ' ' HIS . 81.2 tt0 -39.56 -28.43 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.5 ' N ' ' O ' ' A' ' 54' ' ' HIS . 99.6 mm-40 -64.19 -68.14 0.38 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.164 178.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -157.98 -168.02 2.39 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.865 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.54 128.4 56.34 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.24 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 87.6 mt -118.64 129.89 74.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 121.175 0.512 . . . . 0.0 111.963 -178.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 25.1 tp -96.31 128.38 43.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.671 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -113.13 138.57 49.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.295 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.567 HD22 ' CB ' ' A' ' 68' ' ' PRO . 61.1 t-20 -99.8 107.01 18.95 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -98.68 -8.03 26.86 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.803 0.335 . . . . 0.0 110.444 179.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.05 100.68 12.33 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.781 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.6 p -88.31 -30.34 19.67 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.215 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.7 -46.37 85.78 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -142.49 101.89 5.55 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 115.174 -0.921 . . . . 0.0 108.693 178.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.567 ' CB ' HD22 ' A' ' 62' ' ' ASN . 60.0 Cg_endo -69.44 152.25 70.97 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.097 1.865 . . . . 0.0 114.032 -177.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.425 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 11.4 m -70.94 145.57 50.03 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.286 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -106.82 143.61 34.66 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.7 179.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.505 ' CG2' ' OD1' ' A' ' 86' ' ' ASP . 6.3 p -131.67 136.26 57.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 48.5 32.27 3.29 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.85 27.52 68.77 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.341 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.46 ' N ' ' O ' ' A' ' 71' ' ' VAL . 31.3 m -137.67 133.2 33.98 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.322 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 54.7 t -60.97 136.52 24.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.858 0.361 . . . . 0.0 110.57 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.505 ' CG1' ' O ' ' A' ' 78' ' ' GLU . 14.0 tt -103.1 89.73 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.892 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -63.43 -35.84 81.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.746 179.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.505 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 0.8 OUTLIER -128.69 167.52 19.05 Favored Pre-proline 0 N--CA 1.464 0.233 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.372 -179.214 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -56.74 141.78 91.93 Favored 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 122.27 1.98 . . . . 0.0 112.674 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 73.0 t -131.72 137.8 54.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.617 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 83.1 mtt85 -70.24 129.16 38.61 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 97.0 mt -82.53 137.12 34.7 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.456 -0.497 . . . . 0.0 111.394 -178.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -129.29 152.73 48.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.107 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.698 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 7.2 t60 -54.19 118.34 3.99 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.734 0.302 . . . . 0.0 110.428 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.73 -13.15 24.95 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.505 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 59.8 t0 -71.43 128.41 35.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.845 0.355 . . . . 0.0 110.464 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.405 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 69.3 t -110.83 129.05 66.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.674 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 93.8 mt -97.28 132.58 41.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 94.0 m -122.8 127.74 49.51 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 120.026 -0.67 . . . . 0.0 112.553 -178.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 82.2 mt -120.31 125.37 74.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 114.944 -1.026 . . . . 0.0 108.26 178.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 25.1 mm 43.22 -116.33 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -178.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -102.74 14.47 31.87 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.854 0.359 . . . . 0.0 110.849 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.804 HH11 ' NH2' ' B' ' 245' ' ' ARG . 37.2 mtm-85 -123.37 145.13 49.0 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.427 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.567 ' HG ' ' CD1' ' A' ' 10' ' ' ILE . 38.3 p -140.99 151.86 44.46 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 120.687 -0.405 . . . . 0.0 109.927 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -120.07 121.65 39.34 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 79.6 mtp85 -81.56 130.3 35.0 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.471 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.595 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 86.7 t80 -96.62 123.05 40.17 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.198 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -127.41 131.62 50.26 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.007 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.698 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 64.9 t-20 . . . . . 0 CA--C 1.52 -0.206 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.412 -179.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo . . . . . 0 N--CA 1.486 1.076 0 CA-C-O 121.21 0.421 . . . . 0.0 112.17 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 41.1 t -70.13 133.02 32.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.441 -178.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 4.8 t . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.751 179.059 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo . . . . . 0 N--CA 1.497 1.713 0 N-CA-C 113.419 0.507 . . . . 0.0 113.419 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 96.6 m -74.03 -44.65 53.65 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.307 -0.557 . . . . 0.0 109.579 178.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -59.71 -46.54 88.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.263 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 88.3 mt -63.87 -42.36 97.54 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.092 0.472 . . . . 0.0 110.569 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -61.81 -38.89 89.81 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.255 -179.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -62.36 -44.75 95.74 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.4 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.804 ' NH2' HH11 ' A' ' 93' ' ' ARG . 72.6 mtp85 -61.18 -39.7 91.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.894 -179.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -63.67 -41.74 98.14 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 120.375 -0.53 . . . . 0.0 109.683 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 62.6 m -66.17 -45.36 81.17 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -58.03 -39.3 78.04 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.879 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 54.7 t . . . . . 0 C--N 1.33 -0.282 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.633 179.52 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 . . . . . 0 C--O 1.231 0.116 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 74.6 mt -103.22 136.64 34.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 72.0 t -125.96 135.76 62.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.45 0.643 . . . . 0.0 111.359 -178.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -97.46 116.55 29.88 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.781 -178.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -67.58 -39.6 84.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.505 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.56 159.46 32.57 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.344 -178.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -61.2 147.61 95.15 Favored 'Trans proline' 0 C--N 1.302 -1.891 0 C-N-CA 122.27 1.98 . . . . 0.0 111.925 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . 0.571 ' CG2' ' O ' ' A' ' 19' ' ' HIS . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.904 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.6 m . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.59 0.233 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.5 mtm-85 -95.91 117.46 30.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.012 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.613 ' NH2' ' HD1' ' A' ' 19' ' ' HIS . 76.1 ttt180 -128.31 134.92 49.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.864 0.364 . . . . 0.0 110.251 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 24.2 tp -113.87 132.85 55.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.989 -179.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 51.5 t -108.49 130.86 60.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 m -90.79 121.34 32.58 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.356 0.598 . . . . 0.0 112.124 -178.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 98.2 mt -89.18 141.06 14.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.23 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -91.03 162.87 14.52 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.696 HH22 ' NE2' ' B' ' 248' ' ' GLN . 87.4 mtm180 -55.83 -27.56 52.04 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.075 -178.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 92.6 p -84.87 -6.26 59.34 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.791 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.51 42.17 7.49 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.436 -1.065 . . . . 0.0 110.436 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.2 t -118.57 132.99 66.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.797 0.332 . . . . 0.0 110.996 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.506 ' CG ' ' HE2' ' A' ' 19' ' ' HIS . 63.9 t0 -74.17 120.24 19.47 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.872 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -117.37 -120.76 3.12 Favored Glycine 0 CA--C 1.539 1.582 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.748 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -74.34 147.45 37.07 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 122.413 2.075 . . . . 0.0 112.703 -179.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.613 ' HD1' ' NH2' ' A' ' 6' ' ' ARG . 65.2 m170 -109.66 143.87 38.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.083 0.468 . . . . 0.0 110.818 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -112.28 104.14 55.81 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.71 -178.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -74.02 128.18 12.06 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 121.34 1.36 . . . . 0.0 111.106 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.3 mt -85.07 47.32 1.39 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.811 -177.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 97.2 p -59.07 -28.44 66.47 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.3 mt -74.29 141.78 45.26 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.8 m -70.95 -16.29 62.64 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.972 -0.291 . . . . 0.0 111.724 -178.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.9 m -134.07 135.88 43.58 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.97 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.676 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 2.4 t -131.05 123.05 27.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.945 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.3 tp -117.51 130.24 56.31 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.686 0.279 . . . . 0.0 110.92 -178.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.676 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 59.3 m-85 -108.02 143.63 36.45 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.823 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 147.84 -177.61 25.99 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.035 178.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 46.6 mtm180 -70.83 -32.67 69.79 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.924 0.392 . . . . 0.0 111.042 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.535 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -48.67 143.92 7.56 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 -178.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.474 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 10.8 tp -66.22 -41.59 89.49 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.151 0 CA-C-O 121.046 0.45 . . . . 0.0 110.078 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.474 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 97.9 mt-10 -54.88 -22.1 13.67 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.519 179.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.535 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 50.0 m -56.73 118.39 4.85 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.348 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -59.54 -26.89 65.74 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.411 HG21 HD13 ' A' ' 37' ' ' ILE . 47.5 mm -123.54 108.54 21.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 176.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -102.28 132.95 47.92 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.843 -177.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 84.0 mt -123.42 131.51 73.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.537 HE21 ' CA ' ' B' ' 260' ' ' GLU . 2.5 pp0? -88.56 43.71 1.15 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 119.626 -0.83 . . . . 0.0 112.558 -178.112 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.471 ' CD1' ' NH1' ' A' ' 93' ' ' ARG . 36.6 mt -95.36 128.87 36.83 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.27 178.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -70.78 -13.34 32.04 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 122.095 1.863 . . . . 0.0 113.534 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 18.6 m -100.61 5.67 10.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.028 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 34.5 t -95.7 139.07 19.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.123 0.487 . . . . 0.0 111.086 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.468 ' HG ' ' N ' ' A' ' 46' ' ' LYS . 0.4 OUTLIER -65.87 166.04 11.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.548 -179.37 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.468 ' N ' ' HG ' ' A' ' 45' ' ' SER . 91.7 mttt -63.87 -44.12 94.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.003 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.625 ' O ' ' N ' ' A' ' 49' ' ' CYS . 98.2 mt-30 -113.4 -12.08 13.04 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.885 0.374 . . . . 0.0 111.049 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 26.1 t60 34.48 -74.77 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 178.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.625 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -135.53 139.54 44.04 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.405 0.622 . . . . 0.0 112.095 -177.938 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -127.66 131.09 49.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.78 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.8 mt -113.24 132.95 60.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.107 179.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.58 ' CD ' ' HE2' ' A' ' 54' ' ' HIS . 83.4 tt0 -117.89 123.32 45.57 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 85.1 mt -107.22 117.11 52.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 119.968 -0.693 . . . . 0.0 112.559 -178.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.58 ' HE2' ' CD ' ' A' ' 52' ' ' GLU . 97.7 m-70 -110.93 139.67 46.06 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.968 178.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.5 tt0 -40.77 -32.55 0.23 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.5 -0.48 . . . . 0.0 109.802 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -66.3 -65.97 0.61 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.99 -173.23 4.43 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.098 0.475 . . . . 0.0 111.797 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.84 129.22 56.61 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.698 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 91.3 mt -118.14 130.87 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 121.609 0.719 . . . . 0.0 112.76 -178.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 43.1 tp -98.69 128.06 44.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.456 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -115.06 136.03 53.56 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.948 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.409 HD22 ' HA ' ' A' ' 68' ' ' PRO . 64.0 t-20 -97.32 104.72 16.77 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.25 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -96.44 -11.66 25.31 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.865 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.503 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 85.1 p -74.71 98.4 3.44 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.098 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.8 m -78.67 -32.85 47.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.345 179.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.19 -42.72 55.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.595 -179.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.503 ' O ' ' OG ' ' A' ' 64' ' ' SER . 79.5 m-20 -135.88 95.06 14.07 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.919 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.409 ' HA ' HD22 ' A' ' 62' ' ' ASN . 40.1 Cg_exo -54.92 143.33 72.77 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.383 2.055 . . . . 0.0 113.242 -178.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.408 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 12.2 m -70.94 152.87 43.18 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.309 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.463 ' O ' ' N ' ' A' ' 89' ' ' THR . 72.9 mt-30 -115.54 141.24 48.33 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.535 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.547 ' CG2' ' OD1' ' A' ' 86' ' ' ASP . 4.4 p -130.9 137.51 55.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 49.26 32.16 4.17 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.05 28.79 69.8 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.959 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.464 ' N ' ' O ' ' A' ' 71' ' ' VAL . 9.0 t -140.24 137.3 34.16 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.914 0.388 . . . . 0.0 111.363 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.7 t -64.9 135.97 27.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.673 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 11.9 pt -110.49 77.93 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.12 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.318 179.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -59.93 -33.02 71.33 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -112.9 159.35 34.84 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.785 178.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.55 154.27 71.97 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.413 2.075 . . . . 0.0 111.67 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.0 m -148.15 149.02 15.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.873 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -73.1 132.15 42.95 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-O 120.983 0.42 . . . . 0.0 110.449 179.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 97.6 mt -80.95 140.97 34.95 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.198 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -133.63 154.6 50.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.767 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.666 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 6.1 t60 -55.15 116.46 2.81 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.259 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.17 -18.39 18.58 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.547 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 56.9 t0 -66.08 123.36 19.67 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.271 0.557 . . . . 0.0 109.508 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.502 ' CG2' ' OG ' ' A' ' 94' ' ' SER . 7.4 p -104.37 132.94 49.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.078 -178.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 29.4 mm -92.48 130.47 41.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 178.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.463 ' N ' ' O ' ' A' ' 70' ' ' GLN . 22.6 m -121.96 126.44 48.6 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 119.364 -0.934 . . . . 0.0 112.9 -178.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.579 ' O ' ' N ' ' A' ' 93' ' ' ARG . 98.0 mt -120.39 127.69 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 113.988 -1.46 . . . . 0.0 107.996 177.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.553 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 44.0 mt -21.21 101.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 O-C-N 123.612 0.57 . . . . 0.0 112.243 -179.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.553 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 11.3 t0 89.87 -19.81 0.16 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 177.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.59 HH21 ' CB ' ' B' ' 260' ' ' GLU . 71.7 mtt85 -131.44 139.85 49.48 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.806 -178.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.502 ' OG ' ' CG2' ' A' ' 87' ' ' VAL . 15.8 t -135.04 146.91 49.43 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 120.894 0.378 . . . . 0.0 110.09 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -123.78 124.52 42.87 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.752 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -88.29 133.47 34.05 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 119.568 -0.853 . . . . 0.0 110.932 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -95.28 124.34 39.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.875 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -123.12 127.62 48.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.421 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.666 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 62.6 t-20 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.385 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo . . . . . 0 N--CA 1.492 1.386 0 CA-C-O 121.306 0.461 . . . . 0.0 112.635 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 72.8 t -66.2 133.26 31.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.818 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 2.0 t . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.113 179.651 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo . . . . . 0 N--CA 1.495 1.598 0 CA-C-O 120.64 0.184 . . . . 0.0 112.263 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 98.9 m -67.25 -48.0 69.08 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -59.31 -47.57 84.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.13 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 85.9 mt -65.36 -40.13 93.18 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.14 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -62.16 -42.4 99.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.896 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 79.2 ttt-85 -61.19 -42.48 98.65 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.078 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -62.72 -42.33 99.6 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.749 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -62.11 -43.12 99.53 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 54.3 m -65.35 -44.05 88.93 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . 0.696 ' NE2' HH22 ' A' ' 12' ' ' ARG . 57.0 tt0 -57.26 -41.29 79.4 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.521 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 55.1 t . . . . . 0 C--N 1.331 -0.232 0 CA-C-O 120.75 0.309 . . . . 0.0 110.649 179.323 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . 0.59 ' CB ' HH21 ' A' ' 93' ' ' ARG . 51.1 mp0 . . . . . 0 C--O 1.237 0.437 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 78.1 mt -110.81 136.21 47.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 76.7 t -122.91 131.19 73.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.999 0.428 . . . . 0.0 110.254 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -94.23 117.48 30.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.202 0.525 . . . . 0.0 110.958 -178.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.32 -44.81 90.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.543 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.75 160.36 28.07 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.801 -179.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -57.07 152.87 41.8 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.987 2.458 . . . . 0.0 111.716 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 39.8 pt . . . . . 0 C--N 1.327 -0.383 0 CA-C-O 121.622 0.725 . . . . 0.0 111.978 -178.921 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.503 ' O ' ' O ' ' A' ' 99' ' ' ASN . 2.9 m . . . . . 0 CA--C 1.529 0.16 0 CA-C-O 120.795 0.331 . . . . 0.0 111.318 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.443 ' HE ' HD12 ' A' ' 53' ' ' ILE . 82.5 mtm-85 -89.98 130.68 36.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.958 -179.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -131.06 148.04 52.69 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.155 0.502 . . . . 0.0 111.921 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 94.1 mt -115.4 141.7 47.68 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.257 179.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.9 t -113.14 128.22 70.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.7 m -91.69 113.73 26.08 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.8 mt -77.58 138.77 19.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -86.32 157.04 19.99 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.425 179.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -58.01 -30.84 66.41 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.782 -179.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 87.0 p -78.55 -9.74 59.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.871 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.56 34.78 6.81 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.756 -0.937 . . . . 0.0 110.756 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 52.3 t -121.51 133.84 66.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.574 0.226 . . . . 0.0 110.813 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.403 ' C ' ' OD1' ' A' ' 16' ' ' ASP . 62.3 t0 -66.24 120.15 12.75 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.934 0.397 . . . . 0.0 110.383 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -104.43 -136.12 8.7 Favored Glycine 0 CA--C 1.535 1.337 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.374 -178.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.97 151.54 45.15 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.581 2.187 . . . . 0.0 112.693 -178.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -107.85 128.93 55.04 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.965 -179.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -97.67 106.36 32.83 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.053 -178.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.85 128.13 9.87 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 121.703 1.602 . . . . 0.0 111.405 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.5 mt -83.39 84.0 7.67 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.381 -0.528 . . . . 0.0 111.552 -178.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 57.2 p -83.44 -13.66 54.27 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 58.6 mt -99.55 142.57 30.85 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.963 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 27.1 m -69.48 -10.44 58.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.646 -178.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 29.2 m -132.16 132.56 43.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.757 0.313 . . . . 0.0 110.57 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.6 t -128.1 123.68 35.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.508 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.411 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 54.7 tp -117.45 131.67 56.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.017 -179.058 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.414 ' CE2' HG13 ' A' ' 37' ' ' ILE . 32.1 m-85 -110.33 135.91 50.32 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 155.81 -164.38 32.18 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 120.367 -0.921 . . . . 0.0 112.328 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.62 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 47.6 ptt85 -119.18 19.54 12.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.651 -0.275 . . . . 0.0 110.352 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.63 ' O ' ' N ' ' A' ' 34' ' ' GLU . . . -88.32 29.74 5.53 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.591 ' C ' ' H ' ' A' ' 35' ' ' CYS . 1.7 tp 55.63 -61.85 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 O-C-N 123.849 0.382 . . . . 0.0 111.163 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.63 ' N ' ' O ' ' A' ' 32' ' ' GLY . 49.8 tp10 -50.46 -9.64 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.415 0.626 . . . . 0.0 109.514 179.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.591 ' H ' ' C ' ' A' ' 33' ' ' ILE . 35.1 m -65.42 124.74 23.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.39 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.411 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 60.5 m-20 -60.34 -31.66 70.51 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.414 HG13 ' CE2' ' A' ' 29' ' ' PHE . 42.6 mm -118.95 114.08 43.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 177.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.74 HH22 ' NZ ' ' B' ' 264' ' ' LYS . 77.3 mtt85 -103.64 136.09 43.99 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.448 -177.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 97.8 mt -122.58 132.23 71.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 121.006 0.432 . . . . 0.0 110.439 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -77.27 33.0 0.15 Allowed 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -176.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.553 ' CD1' ' NH1' ' A' ' 93' ' ' ARG . 47.4 mt -109.81 134.75 20.54 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 120.091 -0.643 . . . . 0.0 111.546 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.55 -8.23 21.36 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.456 2.104 . . . . 0.0 113.517 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.6 m -100.56 3.23 10.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.468 179.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.62 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 37.2 t -88.96 132.74 32.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.482 -0.487 . . . . 0.0 109.713 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.8 t -66.02 155.86 35.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.498 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.516 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 40.3 mtmt -63.04 -40.76 98.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.027 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.646 ' O ' ' N ' ' A' ' 49' ' ' CYS . 87.5 mt-30 -115.94 -7.57 11.96 Favored 'General case' 0 N--CA 1.464 0.23 0 O-C-N 123.319 0.387 . . . . 0.0 111.334 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.469 ' C ' ' O ' ' A' ' 47' ' ' GLN . 17.0 t60 15.7 -71.4 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -178.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.646 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.46 133.42 45.15 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -178.49 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -125.36 129.02 49.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.784 178.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 90.5 mt -115.1 134.86 56.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.042 0.449 . . . . 0.0 111.732 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.578 ' CD ' ' HE2' ' A' ' 54' ' ' HIS . 81.5 tt0 -117.59 126.15 52.05 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.443 HD12 ' HE ' ' A' ' 5' ' ' ARG . 94.9 mt -108.14 118.87 56.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 113.086 0.772 . . . . 0.0 113.086 -178.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.578 ' HE2' ' CD ' ' A' ' 52' ' ' GLU . 98.4 m-70 -111.23 138.28 47.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.015 178.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 54' ' ' HIS . 78.6 tt0 -40.72 -33.87 0.33 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -179.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -63.79 -67.14 0.45 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.696 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.51 ' OE2' ' CD ' ' A' ' 81' ' ' ARG . 0.1 OUTLIER -148.56 -178.97 6.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.203 0.525 . . . . 0.0 111.519 -179.373 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -106.51 126.47 52.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.189 178.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 86.6 mt -116.9 128.6 74.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.429 0.633 . . . . 0.0 112.351 -178.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 24.8 tp -99.85 130.57 46.06 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.499 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -112.61 132.9 54.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.098 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 63.9 t-20 -92.16 106.77 18.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.353 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -98.25 -7.57 28.91 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.44 102.06 4.33 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.039 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.5 m -89.42 -6.52 56.48 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.2 -40.14 6.92 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.126 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 56.9 m-20 -142.69 99.04 5.72 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.107 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -55.36 146.2 63.25 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.286 1.991 . . . . 0.0 113.546 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.9 m -76.01 144.95 40.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.837 178.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.441 ' O ' ' N ' ' A' ' 89' ' ' THR . 87.5 mt-30 -105.63 139.16 40.64 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.795 179.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 54.9 t -130.1 134.44 62.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 52.67 33.78 14.54 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.6 27.91 71.8 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.233 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 68.2 m -142.77 138.26 30.32 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 117.626 0.713 . . . . 0.0 111.853 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.4 t -68.12 140.8 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.853 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.5 pt -114.16 105.99 19.79 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.063 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.67 178.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 20.5 p-10 -74.37 -26.54 60.18 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.131 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.442 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.3 OUTLIER -130.4 178.52 1.69 Allowed Pre-proline 0 C--N 1.33 -0.258 0 C-N-CA 120.866 -0.333 . . . . 0.0 110.62 -179.794 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 31.2 Cg_exo -59.91 141.87 97.42 Favored 'Trans proline' 0 N--CA 1.502 1.985 0 C-N-CA 122.687 2.258 . . . . 0.0 113.158 -179.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 47.1 t -133.77 135.92 54.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.725 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.51 ' CD ' ' OE2' ' A' ' 57' ' ' GLU . 88.9 mtm180 -71.91 132.98 45.11 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.1 mt -86.86 136.82 32.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.257 0.551 . . . . 0.0 111.615 -178.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -121.31 148.79 43.85 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.613 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.577 ' HD1' ' H ' ' A' ' 99' ' ' ASN . 7.9 t60 -58.55 125.76 24.73 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.029 0.442 . . . . 0.0 110.291 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.57 -17.44 42.91 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.809 -0.917 . . . . 0.0 110.809 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -67.74 140.39 56.72 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.101 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.1 p -112.33 127.96 69.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.476 -178.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 88.0 mt -92.81 130.59 41.67 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 177.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.441 ' N ' ' O ' ' A' ' 70' ' ' GLN . 52.1 m -125.85 128.9 48.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.975 0.893 . . . . 0.0 113.111 -178.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.546 ' O ' ' C ' ' A' ' 91' ' ' ILE . 95.9 mt -114.44 137.81 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 114.004 -1.453 . . . . 0.0 108.217 178.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.546 ' C ' ' O ' ' A' ' 90' ' ' ILE . 87.4 mt 17.02 -85.74 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 O-C-N 123.645 0.591 . . . . 0.0 111.771 -178.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.499 ' N ' ' O ' ' A' ' 90' ' ' ILE . 53.9 t0 -121.63 14.33 10.97 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 120.315 -0.554 . . . . 0.0 112.023 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.553 ' NH1' ' CD1' ' A' ' 41' ' ' LEU . 45.1 mtm-85 -129.31 140.75 51.3 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.642 -0.423 . . . . 0.0 109.974 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 55.0 p -139.14 153.96 48.04 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.124 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -127.13 126.84 43.6 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.746 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -84.34 129.36 34.88 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.85 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.557 ' CE2' ' OD1' ' A' ' 99' ' ' ASN . 88.8 t80 -89.63 123.86 34.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.951 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -134.12 113.24 11.85 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.076 0.465 . . . . 0.0 111.146 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.577 ' H ' ' HD1' ' A' ' 84' ' ' HIS . 99.1 m-20 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.152 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 N--CA 1.487 1.14 0 CA-C-O 121.588 0.578 . . . . 0.0 113.098 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 55.0 t -65.22 137.14 25.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 114.585 -1.189 . . . . 0.0 111.156 -179.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 5.9 t . . . . . 0 C--N 1.331 -0.214 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 179.817 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo . . . . . 0 N--CA 1.492 1.425 0 CA-C-O 120.443 0.101 . . . . 0.0 112.266 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 21.9 p -74.18 -41.19 61.85 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 121.188 0.518 . . . . 0.0 109.835 178.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -58.22 -45.56 87.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.964 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 89.1 mt -64.18 -40.46 96.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.658 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -61.81 -40.55 95.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.027 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 80.4 mtt85 -62.16 -42.52 99.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.168 0.509 . . . . 0.0 109.994 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.444 ' O ' ' CG2' ' B' ' 249' ' ' VAL . 78.0 mtp85 -61.98 -41.95 98.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.657 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -61.92 -43.32 99.09 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.274 -0.57 . . . . 0.0 110.398 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 46.9 t -65.97 -45.22 82.48 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -63.43 -34.49 77.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.012 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . 0.444 ' CG2' ' O ' ' B' ' 245' ' ' ARG . 59.8 t . . . . . 0 C--N 1.33 -0.278 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.127 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . 0.425 ' OE1' ' CD2' ' A' ' 41' ' ' LEU . 97.1 mt-10 . . . . . 0 N--CA 1.457 -0.077 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 61.6 mt -109.33 132.41 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 75.2 t -127.87 137.08 58.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.282 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -98.61 120.48 39.11 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.052 -177.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . 0.74 ' NZ ' HH22 ' A' ' 38' ' ' ARG . 64.6 tttp -65.18 -48.07 74.73 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.924 178.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -85.5 172.04 9.48 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.281 -178.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -58.08 143.98 95.62 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.343 2.029 . . . . 0.0 112.943 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 18.5 tt . . . . . 0 N--CA 1.448 -0.569 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.361 179.216 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.9 p . . . . . 0 N--CA 1.456 -0.136 0 CA-C-O 120.874 0.369 . . . . 0.0 111.014 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.4 mtm-85 -99.76 124.43 45.02 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.02 -178.641 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -133.74 144.81 49.32 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.261 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 69.4 mt -111.73 138.96 47.61 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.855 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.8 t -112.29 125.88 69.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.3 m -74.93 138.65 42.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.916 -178.693 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.614 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 98.5 mt -109.89 132.86 56.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.547 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -90.38 157.25 17.71 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.479 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.53 ' NH1' ' CD ' ' B' ' 260' ' ' GLU . 93.2 mtm-85 -61.31 -23.49 65.75 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.048 -179.28 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.5 m -76.08 -16.6 59.89 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.552 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.06 33.26 7.03 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.596 -1.001 . . . . 0.0 110.596 -179.331 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 37.0 t -117.64 131.82 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-O 120.573 0.225 . . . . 0.0 111.499 -179.521 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -74.02 136.65 43.14 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 178.376 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -130.46 -119.95 2.17 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.308 -179.169 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -72.95 150.16 48.46 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 122.464 2.109 . . . . 0.0 112.646 -178.748 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -112.38 156.96 21.63 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.306 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -123.13 103.99 35.67 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.143 -179.261 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -71.49 127.24 13.01 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 121.622 1.548 . . . . 0.0 111.929 -179.414 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.3 mt -84.31 48.83 1.55 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -178.295 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 94.3 p -61.35 -24.33 66.38 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.484 ' CD1' ' NE2' ' B' ' 265' ' ' GLN . 73.3 mt -77.36 139.76 39.81 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.667 179.485 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 91.8 p -66.18 -18.96 65.67 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.165 -179.302 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.428 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 40.4 m -132.8 132.83 42.63 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.024 -179.777 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.7 t -125.27 118.33 25.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.847 178.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 39.7 tp -116.82 128.55 55.38 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.055 -178.646 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.465 ' O ' ' O ' ' A' ' 47' ' ' GLN . 4.5 m-85 -107.58 141.06 39.62 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.158 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 158.13 -168.76 34.65 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 120.033 -1.079 . . . . 0.0 112.615 179.016 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.6 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 86.5 mtm-85 -81.23 -31.1 33.99 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-O 121.005 0.431 . . . . 0.0 110.185 179.687 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.485 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -50.56 142.07 16.37 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 115.745 -0.662 . . . . 0.0 112.39 -177.979 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.471 ' CD1' ' CZ ' ' A' ' 38' ' ' ARG . 38.8 mm -65.67 -43.65 93.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.276 0.56 . . . . 0.0 109.492 179.087 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.3 tp10 -57.8 -19.38 28.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.973 -179.637 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 34.9 m -59.69 130.9 49.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.42 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.428 ' OD2' ' O ' ' A' ' 26' ' ' THR . 54.6 m-20 -60.78 -33.83 73.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.838 -179.351 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 89.7 mt -127.84 120.66 54.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 177.48 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.471 ' CZ ' ' CD1' ' A' ' 33' ' ' ILE . 81.4 mtp180 -103.12 137.02 41.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.824 -178.722 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.436 ' C ' ' H ' ' A' ' 41' ' ' LEU . 98.4 mt -118.26 127.55 75.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.805 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -73.16 31.92 0.07 Allowed 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -177.405 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.455 ' CD2' ' OE1' ' B' ' 260' ' ' GLU . 88.2 mt -108.45 132.09 21.34 Favored Pre-proline 0 C--N 1.325 -0.482 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.012 179.657 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.37 -9.79 23.38 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.459 2.106 . . . . 0.0 112.797 179.742 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.2 m -95.03 2.62 9.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.512 -0.475 . . . . 0.0 109.801 179.51 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.6 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 21.0 t -88.57 131.6 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.602 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.632 ' OG ' ' N ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -66.42 167.48 10.57 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.325 0.583 . . . . 0.0 111.798 -177.897 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.485 ' N ' ' HG ' ' A' ' 45' ' ' SER . 95.8 mttt -61.37 -45.84 92.68 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.423 -178.746 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.622 ' O ' ' N ' ' A' ' 49' ' ' CYS . 86.1 mt-30 -113.62 -15.71 12.47 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.557 178.825 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.632 ' N ' ' OG ' ' A' ' 45' ' ' SER . 16.8 t60 34.93 -76.61 0.0 OUTLIER 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.067 -0.969 . . . . 0.0 113.604 179.765 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.622 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -129.56 134.41 47.72 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.367 0.603 . . . . 0.0 112.294 -178.433 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -125.67 132.23 52.46 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.845 178.67 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.2 mt -116.46 134.26 60.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.927 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -117.83 122.97 44.78 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.562 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 72.7 mt -105.27 115.8 47.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.419 0.628 . . . . 0.0 111.476 -178.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.46 ' O ' ' N ' ' A' ' 56' ' ' GLN . 87.2 m-70 -114.79 144.86 42.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.816 -1.083 . . . . 0.0 109.868 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.8 mm-40 -40.84 -27.15 0.05 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.07 0.462 . . . . 0.0 110.156 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.46 ' N ' ' O ' ' A' ' 54' ' ' HIS . 86.9 mm-40 -68.96 -67.61 0.46 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.151 179.094 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -158.99 -166.37 1.83 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.37 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.34 129.35 55.77 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.195 -179.853 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 90.0 mt -120.48 130.18 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 121.166 0.508 . . . . 0.0 112.338 -178.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 36.0 tp -97.71 129.25 44.77 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.156 179.852 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -114.61 136.41 53.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.206 179.677 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -97.42 104.87 16.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.97 0.414 . . . . 0.0 111.614 -179.613 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -94.2 -10.5 32.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.68 178.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.8 t -76.95 102.94 6.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.225 179.237 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 88.8 p -86.76 -8.7 57.13 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.574 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.84 -37.91 10.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.117 0.484 . . . . 0.0 110.019 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -146.2 95.57 4.71 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.961 179.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.0 148.57 76.03 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 122.363 2.042 . . . . 0.0 112.526 -179.652 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 57.1 m -70.29 141.23 52.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.469 179.197 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -98.53 146.71 25.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.562 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.513 ' CG2' ' OD1' ' A' ' 86' ' ' ASP . 6.1 p -130.55 135.99 59.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.2 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 48.3 32.37 3.14 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 -179.694 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.12 29.57 62.34 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 111.414 -0.674 . . . . 0.0 111.414 -179.836 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.415 ' N ' ' O ' ' A' ' 71' ' ' VAL . 15.0 m -138.87 136.32 35.43 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.817 0.308 . . . . 0.0 111.052 -179.62 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.8 p -64.38 143.81 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 120.931 0.396 . . . . 0.0 111.835 -179.194 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.527 ' CG2' ' O ' ' A' ' 78' ' ' GLU . 95.5 mt -107.64 103.51 15.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.036 179.672 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -64.58 -41.84 96.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.519 179.082 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.527 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.4 OUTLIER -137.38 -177.46 0.71 Allowed Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.456 -178.362 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.506 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 35.7 Cg_exo -58.69 145.71 94.71 Favored 'Trans proline' 0 N--CA 1.5 1.885 0 C-N-CA 122.838 2.359 . . . . 0.0 112.779 -179.598 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.3 m -144.48 147.25 19.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.556 179.808 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -77.53 131.82 38.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.807 178.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.0 mt -84.76 140.52 31.19 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.08 0.467 . . . . 0.0 111.482 -179.396 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -129.32 151.36 50.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.646 179.58 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.633 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 5.2 t60 -54.42 120.87 7.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.482 -179.656 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.82 -13.8 41.66 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 -179.269 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.513 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 55.1 t0 -70.05 126.38 29.53 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.363 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 71.4 t -103.88 135.02 43.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.625 -178.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.518 ' O ' ' OG ' ' A' ' 94' ' ' SER . 84.7 mt -103.91 129.52 55.92 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.769 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 87.5 m -124.53 124.69 42.81 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 119.861 -0.736 . . . . 0.0 112.675 -178.269 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.582 ' O ' ' N ' ' A' ' 93' ' ' ARG . 98.4 mt -111.93 131.54 63.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 114.697 -1.138 . . . . 0.0 107.944 177.942 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.504 ' C ' ' O ' ' A' ' 90' ' ' ILE . 66.0 mt -21.9 97.61 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.585 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.502 ' CG ' ' NE ' ' B' ' 245' ' ' ARG . 3.3 m-20 89.2 -24.9 0.08 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 178.098 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.614 ' NH2' ' O ' ' A' ' 10' ' ' ILE . 6.2 mmm180 -124.15 140.05 53.34 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.532 -179.288 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.518 ' OG ' ' O ' ' A' ' 88' ' ' ILE . 46.0 t -141.22 151.59 43.89 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.768 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -128.24 123.14 33.44 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.267 179.323 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -80.08 134.09 36.16 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.289 179.22 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -94.83 123.69 38.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.669 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -124.63 122.19 36.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.785 -179.874 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.633 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 59.9 t-20 . . . . . 0 C--N 1.33 -0.244 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.038 179.61 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo . . . . . 0 N--CA 1.493 1.478 0 N-CA-C 113.759 0.638 . . . . 0.0 113.759 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 19.0 t -78.21 131.5 34.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.019 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 3.3 t . . . . . 0 C--N 1.33 -0.25 0 CA-C-O 120.807 0.337 . . . . 0.0 111.268 -179.353 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo . . . . . 0 N--CA 1.494 1.552 0 N-CA-C 113.306 0.464 . . . . 0.0 113.306 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 6.7 p -77.29 -38.25 51.15 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 120.187 -0.605 . . . . 0.0 109.528 177.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -58.63 -45.47 89.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.327 179.78 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . 0.456 HD22 HH21 ' B' ' 245' ' ' ARG . 95.3 mt -62.6 -41.54 99.03 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 121.161 0.505 . . . . 0.0 110.537 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -67.9 -38.4 82.92 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.571 -179.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -61.12 -48.02 83.57 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.502 -178.593 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.502 ' NE ' ' CG ' ' A' ' 92' ' ' ASP . 52.0 ptt85 -64.64 -37.37 87.36 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.613 -179.303 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -61.21 -39.72 91.28 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.294 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 14.0 t -66.75 -42.3 86.42 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.364 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -58.07 -39.88 79.6 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.853 179.674 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 42.9 t . . . . . 0 CA--C 1.52 -0.21 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.918 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . 0.53 ' CD ' ' NH1' ' A' ' 12' ' ' ARG . 97.6 mt-10 . . . . . 0 N--CA 1.462 0.163 0 CA-C-O 120.519 0.2 . . . . 0.0 110.84 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 47.6 mt -115.37 137.92 47.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -179.555 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 55.3 t -127.23 133.93 67.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.897 179.223 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -97.31 122.6 40.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.051 0.453 . . . . 0.0 111.348 -178.411 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -66.18 -44.08 85.04 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.359 179.568 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . 0.484 ' NE2' ' CD1' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -99.87 170.0 7.32 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.554 -178.723 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.77 154.56 67.56 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.414 2.076 . . . . 0.0 112.017 -179.83 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 45.0 pt . . . . . 0 C--N 1.328 -0.362 0 CA-C-O 121.484 0.659 . . . . 0.0 111.936 -179.147 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 37.1 m . . . . . 0 CA--C 1.52 -0.2 0 CA-C-O 121.017 0.437 . . . . 0.0 110.667 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.54 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 95.9 mtt-85 -90.76 125.4 35.69 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.749 -178.425 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -134.73 143.93 47.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.871 -179.243 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 73.1 mt -116.75 142.06 47.41 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.775 179.667 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.7 t -117.19 128.31 74.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.968 0.413 . . . . 0.0 110.279 179.536 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.2 m -74.68 140.8 44.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.354 0.597 . . . . 0.0 112.325 -179.187 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.604 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 90.0 mt -112.47 134.06 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.838 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -91.6 158.08 16.63 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.193 0.52 . . . . 0.0 111.77 -179.311 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.732 HH11 HH11 ' B' ' 245' ' ' ARG . 86.4 mtm180 -58.21 -30.99 66.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.505 -178.952 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.5 p -78.15 -10.2 59.52 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.601 178.96 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.81 36.17 7.42 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 179.951 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.5 t -118.07 132.74 67.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.01 0.433 . . . . 0.0 111.579 -179.615 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -73.22 128.86 36.68 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.003 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -125.45 -120.68 2.46 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 120.139 -1.029 . . . . 0.0 112.709 -178.797 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -72.01 146.67 47.53 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 122.242 1.962 . . . . 0.0 112.517 -178.202 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -108.71 147.33 32.11 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.94 179.372 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -116.87 102.8 52.87 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.578 -179.375 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.61 133.84 17.75 Favored 'Trans proline' 0 N--CA 1.486 1.049 0 C-N-CA 121.122 1.215 . . . . 0.0 110.504 -179.357 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 92.3 mt -87.64 62.87 7.27 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.723 -177.822 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 80.6 p -70.71 -21.0 62.61 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 177.79 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 71.0 mt -85.03 138.34 32.5 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.339 -179.61 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -62.4 -20.9 64.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.612 -179.12 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.1 m -134.17 135.49 43.11 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.821 -179.827 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.661 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -129.88 122.92 29.57 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.187 178.883 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.507 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 35.0 tp -120.98 126.8 50.87 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.7 -178.688 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.661 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 36.3 m-85 -99.74 127.16 45.88 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.134 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -176.39 -156.16 14.77 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.448 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -115.46 -17.67 11.17 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 117.174 0.487 . . . . 0.0 110.415 179.13 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.23 161.88 47.35 Favored Glycine 0 CA--C 1.519 0.337 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -179.656 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.449 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 10.8 tp -66.04 -41.63 90.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.408 179.585 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.449 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 15.0 pt-20 -56.86 -22.77 39.41 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.801 -179.727 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.7 m -63.23 126.3 26.96 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.874 0.369 . . . . 0.0 110.706 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.611 ' OD1' ' N ' ' A' ' 37' ' ' ILE . 11.0 p-10 -61.97 -28.89 69.87 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.096 -179.316 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.611 ' N ' ' OD1' ' A' ' 36' ' ' ASP . 97.5 mt -130.55 122.42 52.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 177.724 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 75.0 mtm180 -103.82 136.24 43.88 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.198 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.472 ' C ' ' H ' ' A' ' 41' ' ' LEU . 97.2 mt -117.66 129.23 74.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.857 179.748 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -70.52 32.4 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.814 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.577 ' CD2' ' NH2' ' B' ' 245' ' ' ARG . 43.4 mt -110.33 121.77 40.52 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 120.446 -0.502 . . . . 0.0 109.668 179.043 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.02 -1.47 10.92 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.244 1.963 . . . . 0.0 112.351 -178.809 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 18.3 m -99.2 6.73 9.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.323 179.813 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.448 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 29.6 t -89.96 133.94 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.25 178.797 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.04 159.56 28.43 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.02 0.438 . . . . 0.0 110.551 179.514 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -61.77 -39.16 90.67 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.273 -178.817 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.606 ' O ' ' N ' ' A' ' 49' ' ' CYS . 96.3 mm-40 -111.53 -18.22 12.88 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.46 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.4 t60 29.96 -78.85 0.0 OUTLIER 'General case' 0 C--O 1.236 0.377 0 CA-C-N 114.716 -1.129 . . . . 0.0 113.124 -179.683 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.606 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -129.47 134.21 47.69 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.914 -179.342 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -125.66 128.49 47.91 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.223 179.364 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 93.0 mt -114.54 133.31 61.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.787 -179.849 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -113.27 133.68 54.98 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.807 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.485 HG23 HD11 ' A' ' 53' ' ' ILE . 47.9 mm -103.14 114.5 42.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.558 -179.462 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.44 ' O ' ' C ' ' A' ' 55' ' ' GLU . 95.0 m-70 -115.47 132.8 56.51 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.473 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 54' ' ' HIS . 95.4 mt-10 -40.47 -34.13 0.32 Allowed 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 121.195 0.522 . . . . 0.0 109.92 -178.673 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -62.75 -67.32 0.43 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.233 179.418 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -152.43 -164.38 1.94 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.333 -179.63 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.462 ' CB ' ' NH1' ' A' ' 5' ' ' ARG . . . -127.28 131.18 50.56 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.011 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 91.7 mt -112.32 129.9 67.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.255 0.55 . . . . 0.0 112.205 -178.237 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 44.3 tp -94.46 120.22 34.37 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.224 179.028 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -107.85 135.05 49.9 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.962 0.41 . . . . 0.0 111.336 -178.823 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -96.14 104.91 16.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.246 179.627 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -99.31 -10.84 21.82 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.614 179.549 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.4 t -69.61 100.87 1.52 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.538 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.9 p -85.01 -15.96 42.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.038 0.447 . . . . 0.0 109.924 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.24 -46.13 8.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.752 -179.852 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.41 HD22 ' HA ' ' B' ' 236' ' ' VAL . 65.5 m-20 -135.08 97.71 13.38 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.283 -0.872 . . . . 0.0 109.456 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -56.74 144.64 86.22 Favored 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 122.501 2.134 . . . . 0.0 113.612 -178.838 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.0 m -75.36 140.39 43.0 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.264 178.756 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -104.3 141.42 36.34 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.321 179.938 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.424 ' O ' ' OG ' ' A' ' 74' ' ' SER . 53.0 t -131.92 135.29 58.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.739 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 51.92 31.96 9.26 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -178.399 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.31 27.48 69.79 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.095 -179.924 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 15.5 p -140.39 140.83 35.57 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 117.608 0.704 . . . . 0.0 111.696 179.776 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 41.5 t -68.87 135.83 27.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.041 179.451 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.4 pt -113.34 82.22 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.974 0.416 . . . . 0.0 110.696 178.588 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -61.62 -24.69 66.87 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.441 179.885 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -118.79 167.36 11.88 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.997 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -62.46 145.54 95.6 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 122.386 2.058 . . . . 0.0 112.568 179.63 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.34 140.01 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 120.822 0.344 . . . . 0.0 110.996 179.291 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -74.77 133.18 42.01 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.456 179.519 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.6 mt -79.23 134.9 36.66 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.196 0.522 . . . . 0.0 110.92 -179.596 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -129.52 150.18 50.98 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.385 179.479 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -52.32 113.63 1.1 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.501 -179.852 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.29 -11.16 19.69 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.437 ' C ' ' OD1' ' A' ' 86' ' ' ASP . 52.4 t0 -68.96 123.6 21.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.205 0.526 . . . . 0.0 110.998 -179.713 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.6 t -108.94 130.89 61.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.71 -179.572 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 83.9 mt -104.46 133.2 49.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.726 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 82.8 m -120.61 129.45 53.74 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.6 0.714 . . . . 0.0 112.491 -178.53 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.485 ' O ' ' N ' ' A' ' 93' ' ' ARG . 89.5 mt -121.13 122.59 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 114.501 -1.227 . . . . 0.0 108.1 178.235 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.424 ' C ' ' O ' ' A' ' 90' ' ' ILE . 36.8 mm 40.73 -112.45 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.016 -178.831 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -103.16 10.88 37.62 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.544 0.211 . . . . 0.0 111.05 179.079 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.604 ' NH2' ' O ' ' A' ' 10' ' ' ILE . 6.5 mmm180 -120.76 143.97 48.53 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.674 -179.123 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.1 p -142.26 155.76 45.25 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.904 0.383 . . . . 0.0 110.838 -179.96 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -128.0 124.99 38.56 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.273 179.35 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -86.95 133.67 33.57 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.505 0.193 . . . . 0.0 110.827 -179.737 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.54 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 69.6 t80 -93.96 123.79 37.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.893 179.886 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -123.85 128.83 50.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.42 -179.923 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 . . . . . 0 C--N 1.326 -0.447 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.147 178.992 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo . . . . . 0 N--CA 1.49 1.28 0 CA-C-O 121.485 0.535 . . . . 0.0 112.784 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . 0.41 ' HA ' HD22 ' A' ' 67' ' ' ASN . 27.8 t -72.08 137.29 23.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.782 -179.771 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 8.0 t . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.175 -179.628 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo . . . . . 0 N--CA 1.499 1.829 0 CA-C-O 120.881 0.284 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 99.8 m -73.04 -45.16 59.13 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.714 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -55.17 -45.31 75.74 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.875 -179.575 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 89.6 mt -63.11 -42.6 99.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.791 -179.185 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -65.3 -42.18 93.32 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.368 -179.024 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -61.98 -44.88 95.8 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.167 0.508 . . . . 0.0 110.509 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.732 HH11 HH11 ' A' ' 12' ' ' ARG . 49.5 ttm-85 -64.78 -41.49 95.81 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.682 -179.345 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -60.74 -38.17 84.26 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.708 0.29 . . . . 0.0 110.532 179.398 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 88.3 p -69.29 -40.56 77.65 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.528 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -58.64 -37.53 76.13 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.66 178.78 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 54.1 t . . . . . 0 CA--C 1.528 0.105 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.262 178.824 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 . . . . . 0 CA--C 1.544 0.727 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . 0.406 HD11 HG23 ' B' ' 261' ' ' ILE . 2.7 mm -114.05 133.28 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-N 119.334 0.97 . . . . 0.0 110.223 178.854 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 52.6 t -126.5 133.23 69.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.159 178.894 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -100.41 122.02 42.47 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.191 0.52 . . . . 0.0 111.266 -178.637 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . 0.406 ' HZ2' ' HA ' ' A' ' 34' ' ' GLU . 87.5 tttt -63.3 -47.62 81.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.222 179.432 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -96.47 161.57 26.38 Favored Pre-proline 0 N--CA 1.453 -0.314 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.474 -179.79 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.98 150.18 37.87 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 123.035 2.49 . . . . 0.0 112.585 -178.877 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 28.5 pt . . . . . 0 C--N 1.325 -0.497 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.248 178.926 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.8 p . . . . . 0 C--O 1.231 0.105 0 CA-C-O 121.013 0.435 . . . . 0.0 110.108 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.63 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 94.6 mtt-85 -98.02 113.53 25.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.136 -179.585 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -127.62 138.18 52.77 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.92 0.39 . . . . 0.0 111.331 -179.711 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 42.3 tp -117.41 129.94 56.17 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.586 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.1 t -106.15 130.8 57.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.911 -179.536 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 m -92.2 114.81 27.45 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.253 -179.635 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.404 HG23 HD12 ' A' ' 10' ' ' ILE . 96.2 mt -80.96 145.66 8.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.516 179.359 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -88.13 161.69 17.16 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.076 0.465 . . . . 0.0 111.169 -179.866 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.702 HH11 ' NH2' ' A' ' 93' ' ' ARG . 58.0 mtp85 -55.21 -32.59 62.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.458 -179.445 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 42.9 t -80.74 -6.67 58.77 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.859 179.502 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.57 33.86 12.72 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -179.527 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.8 t -114.16 132.75 62.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.724 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 63.0 t0 -65.31 120.69 13.23 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.865 -179.448 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -107.88 -133.56 7.12 Favored Glycine 0 CA--C 1.536 1.366 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 -179.279 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.73 149.88 49.26 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 122.106 1.87 . . . . 0.0 112.341 -179.21 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -105.78 139.23 40.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.891 0.377 . . . . 0.0 109.991 179.493 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -111.45 103.5 55.1 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.684 -179.614 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.69 132.16 16.91 Favored 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 121.437 1.425 . . . . 0.0 111.972 -179.216 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 75.5 mt -87.5 45.98 1.33 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.887 -178.728 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 79.2 p -65.22 -17.82 64.81 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.276 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.5 mt -81.38 143.0 32.48 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.27 178.518 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.0 t -64.8 -23.65 67.3 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -178.872 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 66.3 m -135.03 136.87 42.44 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.56 -179.505 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.8 t -130.02 121.78 27.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.066 178.924 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.6 tp -116.78 127.65 54.54 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.579 -179.269 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.521 ' O ' ' O ' ' A' ' 47' ' ' GLN . 7.6 m-85 -104.86 141.3 36.77 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.291 178.915 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 156.33 -174.24 34.15 Favored Glycine 0 N--CA 1.469 0.867 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.415 178.922 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.636 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 83.2 mtm-85 -78.62 -29.3 45.86 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.168 179.56 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.553 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -54.47 148.98 19.94 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.643 -178.759 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.459 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 11.1 tp -67.78 -40.81 84.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.084 0.469 . . . . 0.0 110.023 179.512 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.459 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 80.1 mm-40 -54.4 -21.8 10.69 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.773 179.546 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.553 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 58.8 m -55.64 118.62 4.68 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.93 179.553 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -55.89 -29.69 60.38 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 179.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 73.0 mt -128.48 120.55 53.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.36 176.226 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 78.2 ttt-85 -108.35 137.26 46.61 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.602 -177.898 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.2 mt -121.45 132.09 71.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.4 -179.54 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -80.94 32.21 0.32 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -177.962 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.439 HD13 ' NH1' ' A' ' 93' ' ' ARG . 16.4 mt -97.2 133.54 23.87 Favored Pre-proline 0 C--N 1.32 -0.691 0 C-N-CA 120.049 -0.661 . . . . 0.0 110.711 -179.938 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.12 -10.41 25.88 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 122.364 2.043 . . . . 0.0 112.221 -179.746 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.2 m -105.47 4.05 10.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.269 -179.384 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.636 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 17.4 t -88.77 131.15 36.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 177.714 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.77 163.16 19.87 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.082 0.467 . . . . 0.0 110.812 -178.858 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -61.38 -40.9 96.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.013 -178.8 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.608 ' O ' ' N ' ' A' ' 49' ' ' CYS . 12.3 mm100 -110.31 -17.0 13.6 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 123.573 0.546 . . . . 0.0 110.299 -179.852 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 21.7 t60 33.09 -75.73 0.0 OUTLIER 'General case' 0 C--O 1.239 0.525 0 CA-C-N 114.943 -1.026 . . . . 0.0 113.634 -179.601 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.608 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -135.48 139.77 44.3 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -178.299 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -127.57 133.52 49.76 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.633 179.707 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.0 mt -119.04 134.14 63.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.082 -179.855 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -116.63 127.75 54.75 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.065 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.3 mt -109.46 111.52 36.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.473 0.654 . . . . 0.0 111.218 -179.756 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.548 ' O ' ' N ' ' A' ' 56' ' ' GLN . 94.8 m-70 -110.51 143.18 41.25 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.801 -1.09 . . . . 0.0 108.984 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.561 ' OE1' ' N ' ' A' ' 55' ' ' GLU . 55.1 mp0 -40.65 -24.44 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.853 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.548 ' N ' ' O ' ' A' ' 54' ' ' HIS . 88.8 mm-40 -68.16 -69.26 0.33 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.07 179.044 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.438 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 5.5 tp10 -158.91 -168.31 2.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.987 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.462 ' CB ' ' NH1' ' A' ' 5' ' ' ARG . . . -109.73 126.09 53.36 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.099 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.29 130.25 70.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.467 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.6 tp -98.66 130.21 45.16 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.429 179.724 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -117.47 137.65 52.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.857 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.544 HD22 ' CB ' ' A' ' 68' ' ' PRO . 64.1 t-20 -98.08 104.68 16.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.08 179.805 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -96.27 -7.28 35.88 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.864 179.342 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.38 100.81 10.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.984 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.1 m -87.08 -37.69 17.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.677 179.75 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.08 -44.11 97.86 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.418 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -141.23 101.23 6.24 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.119 179.415 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.544 ' CB ' HD22 ' A' ' 62' ' ' ASN . 44.5 Cg_endo -67.76 152.32 77.76 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 121.676 1.584 . . . . 0.0 113.602 -178.242 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.5 m -77.38 149.11 35.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.775 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -111.99 140.53 46.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.345 179.404 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.5 t -128.5 136.32 60.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.598 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 53.65 32.97 15.52 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.225 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.98 25.93 74.88 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.437 -179.759 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 66.7 m -141.14 141.78 34.12 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 117.114 0.457 . . . . 0.0 111.856 -179.564 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 75.2 t -67.91 139.14 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.687 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 9.2 pt -111.2 82.63 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-O 121.126 0.488 . . . . 0.0 111.049 178.55 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -62.56 -32.79 73.82 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.98 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -113.95 156.95 43.21 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.834 178.676 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.6 152.39 80.55 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.18 1.92 . . . . 0.0 111.582 178.928 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.1 m -146.89 149.0 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 121.28 0.562 . . . . 0.0 112.03 179.89 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -72.4 133.68 45.02 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.871 179.678 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.4 mt -77.26 137.94 39.11 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.098 0.475 . . . . 0.0 110.767 179.9 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -128.56 147.12 50.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.514 179.535 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.749 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 6.8 t60 -56.06 118.99 5.17 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.579 -179.525 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.27 -20.04 23.9 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -179.801 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -66.44 131.18 45.49 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.595 179.305 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.6 t -114.86 131.35 67.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.159 -178.501 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 84.6 mt -95.05 133.75 34.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.725 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.0 m -120.7 128.38 52.9 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.62 0.724 . . . . 0.0 112.574 -178.833 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.543 ' O ' ' N ' ' A' ' 92' ' ' ASP . 97.5 mt -115.06 123.4 70.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 114.559 -1.2 . . . . 0.0 108.664 178.54 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.457 ' CG2' ' CZ ' ' B' ' 245' ' ' ARG . 32.2 mm 38.71 -93.25 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.35 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.72 ' H ' ' NH1' ' B' ' 245' ' ' ARG . 16.9 t0 -125.97 20.16 7.68 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.011 0.434 . . . . 0.0 110.86 179.139 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.702 ' NH2' HH11 ' A' ' 12' ' ' ARG . 75.5 mtt85 -124.85 142.57 51.35 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.351 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 30.2 p -139.61 154.73 47.64 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.96 179.763 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.502 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 17.1 m-85 -125.16 121.96 35.72 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.035 179.54 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 39.1 ttp-105 -85.08 130.67 34.57 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.125 -0.63 . . . . 0.0 110.713 -179.256 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.63 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 87.7 t80 -94.66 123.67 38.24 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.962 -179.556 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -121.41 122.88 40.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.962 179.647 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.749 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 54.7 t-20 . . . . . 0 C--N 1.328 -0.37 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.976 179.001 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 N--CA 1.491 1.38 0 N-CA-C 113.997 0.73 . . . . 0.0 113.997 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 39.4 t -76.0 133.62 30.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 114.781 -1.1 . . . . 0.0 110.998 -179.454 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 7.6 t . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.675 179.367 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo . . . . . 0 N--CA 1.496 1.63 0 N-CA-C 112.671 0.219 . . . . 0.0 112.671 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 97.2 m -74.08 -42.52 60.04 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.857 0.361 . . . . 0.0 110.161 178.664 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . 0.412 ' HA ' ' HE ' ' B' ' 244' ' ' ARG . 64.1 t80 -58.02 -45.75 86.41 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -179.54 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 87.2 mt -62.61 -40.86 98.3 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.177 179.964 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -61.52 -39.72 92.04 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.713 179.609 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . 0.419 ' O ' ' OG ' ' B' ' 247' ' ' SER . 88.7 mtm180 -62.08 -40.38 95.62 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.77 179.69 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.72 ' NH1' ' H ' ' A' ' 92' ' ' ASP . 89.4 mtt180 -60.1 -42.48 94.79 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.224 179.084 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -64.23 -42.79 96.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.016 0.436 . . . . 0.0 110.488 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 247' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 35.8 p -63.86 -44.86 91.85 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.73 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -58.58 -40.29 82.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.965 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 55.3 t . . . . . 0 C--N 1.327 -0.372 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.267 -179.885 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . 0.514 ' OE1' ' NH2' ' A' ' 93' ' ' ARG . 94.6 mt-10 . . . . . 0 CA--C 1.531 0.236 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 68.6 mt -108.24 132.16 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.757 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 53.4 t -128.25 134.39 65.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.805 -178.609 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -99.54 121.92 41.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.51 0.671 . . . . 0.0 111.176 -178.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -67.06 -44.88 79.0 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.902 178.874 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -92.76 150.63 39.91 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.706 -178.235 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.84 143.98 47.1 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 122.86 2.373 . . . . 0.0 112.581 179.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 33.3 pt . . . . . 0 C--N 1.33 -0.265 0 CA-C-O 121.04 0.448 . . . . 0.0 110.7 179.209 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.425 ' HG1' ' H ' ' A' ' 5' ' ' ARG . 17.2 p . . . . . 0 C--O 1.231 0.122 0 CA-C-O 121.165 0.507 . . . . 0.0 110.064 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.425 ' H ' ' HG1' ' A' ' 4' ' ' THR . 96.3 mtt-85 -89.47 124.5 34.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.922 -179.858 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -134.43 139.39 45.52 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.287 -0.565 . . . . 0.0 112.322 -179.342 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.7 mt -113.55 143.56 44.33 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.072 178.718 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.48 ' CG1' ' OD1' ' A' ' 16' ' ' ASP . 70.3 t -117.03 128.93 74.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.224 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.5 m -92.87 113.87 26.26 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.132 0.492 . . . . 0.0 112.076 -178.436 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 86.8 mt -79.19 143.86 11.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.784 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -89.54 161.6 16.12 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.223 0.535 . . . . 0.0 110.9 179.64 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.744 HH12 ' NE2' ' B' ' 248' ' ' GLN . 80.9 mtp180 -58.19 -33.41 69.23 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.802 -179.326 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.7 t -76.02 -13.11 60.23 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.706 179.218 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.39 35.05 5.83 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 -178.878 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.0 t -119.04 132.42 68.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.092 0.472 . . . . 0.0 110.966 -179.9 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.48 ' OD1' ' CG1' ' A' ' 8' ' ' VAL . 43.6 t0 -68.5 124.98 25.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.749 179.581 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -117.58 -126.41 3.72 Favored Glycine 0 CA--C 1.541 1.673 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.225 -178.916 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.29 147.88 42.76 Favored 'Trans proline' 0 N--CA 1.504 2.107 0 C-N-CA 122.741 2.294 . . . . 0.0 114.523 -177.808 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 60.1 m170 -104.77 144.73 31.34 Favored 'General case' 0 C--N 1.335 -0.059 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.08 179.37 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.405 ' CD2' HD11 ' A' ' 37' ' ' ILE . 72.1 t80 -121.82 105.44 37.99 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.996 -179.579 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -75.63 132.84 15.02 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 C-N-CA 121.682 1.588 . . . . 0.0 112.292 -179.14 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 89.6 mt -81.3 54.73 2.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.834 0.349 . . . . 0.0 110.935 -179.253 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.7 t -59.8 -37.58 79.53 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.877 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 66.0 mt -74.02 141.6 45.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.666 179.519 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 m -66.76 -15.23 63.41 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.075 -0.512 . . . . 0.0 112.271 -178.029 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.49 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 40.4 m -136.24 137.87 41.24 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.017 0.437 . . . . 0.0 110.724 179.504 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.668 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 4.3 t -131.58 122.87 26.81 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.908 179.65 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 42.4 tp -119.77 128.16 53.47 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.896 -178.98 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.668 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 14.1 m-85 -104.23 140.33 38.0 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.179 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.95 -171.79 38.81 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 119.647 -1.263 . . . . 0.0 112.764 179.1 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.623 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 85.4 mtm-85 -80.37 -28.08 38.07 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.418 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.55 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -60.68 141.22 48.06 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.3 -0.476 . . . . 0.0 112.287 -178.168 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.443 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 11.0 tp -66.06 -41.43 89.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.095 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.443 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 82.5 tt0 -54.52 -16.41 2.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.125 179.839 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.55 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 33.5 m -66.01 135.93 55.35 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.265 179.862 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.49 ' OD2' ' O ' ' A' ' 26' ' ' THR . 56.0 m-20 -61.42 -33.32 73.51 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.38 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.422 HG21 HD12 ' A' ' 37' ' ' ILE . 93.4 mt -127.66 122.46 59.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 177.17 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 76.8 ttt-85 -111.26 137.99 48.29 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.607 -178.317 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.444 ' C ' ' H ' ' A' ' 41' ' ' LEU . 92.9 mt -119.11 131.87 70.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.846 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -75.13 20.69 0.13 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.686 -178.693 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.444 ' H ' ' C ' ' A' ' 39' ' ' ILE . 22.7 mt -93.52 124.44 57.21 Favored Pre-proline 0 C--N 1.321 -0.66 0 C-N-CA 120.261 -0.575 . . . . 0.0 111.105 -179.449 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.47 -14.25 27.79 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 C-N-CA 121.901 1.734 . . . . 0.0 112.375 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 18.0 m -88.67 0.62 7.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.135 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.623 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 72.6 t -95.33 136.11 27.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.186 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.4 m -69.39 171.16 9.09 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.322 0.582 . . . . 0.0 111.699 -178.749 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -61.84 -42.11 98.63 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.671 -178.13 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.679 ' O ' ' N ' ' A' ' 49' ' ' CYS . 87.8 mt-30 -113.75 -14.99 12.51 Favored 'General case' 0 CA--C 1.521 -0.155 0 O-C-N 123.365 0.416 . . . . 0.0 110.337 179.873 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 30.1 t60 33.44 -73.11 0.0 OUTLIER 'General case' 0 C--O 1.236 0.393 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 179.654 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.679 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.68 135.35 45.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.06 0.457 . . . . 0.0 111.921 -178.649 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -123.85 128.66 49.82 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.389 179.3 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.4 mt -115.16 134.46 58.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.351 -179.686 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.556 ' CD ' ' HE2' ' A' ' 54' ' ' HIS . 83.9 tt0 -120.01 128.29 53.4 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.782 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.0 mt -108.18 118.8 56.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.471 0.653 . . . . 0.0 112.611 -178.549 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.556 ' HE2' ' CD ' ' A' ' 52' ' ' GLU . 99.0 m-70 -115.3 141.23 48.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.326 178.859 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.6 mm-40 -40.12 -25.94 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.906 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.545 ' N ' ' O ' ' A' ' 54' ' ' HIS . 85.9 mt-30 -65.71 -68.3 0.38 Allowed 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.2 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -159.94 -162.77 1.04 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.905 179.614 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -114.29 126.44 55.03 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.398 179.147 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.7 mt -112.68 127.9 69.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.441 0.638 . . . . 0.0 111.95 -178.923 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 40.1 tp -95.44 128.85 42.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.955 -179.74 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -115.33 135.8 53.77 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.549 -179.748 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.4 ' OD1' ' C ' ' A' ' 62' ' ' ASN . 51.1 t-20 -95.12 106.22 18.21 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.897 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -100.86 -10.05 21.05 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 179.279 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.3 t -78.85 100.61 7.26 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.269 -179.619 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.4 p -76.95 -33.84 57.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.042 0.448 . . . . 0.0 110.636 178.918 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.82 -40.65 65.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.485 -178.86 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -141.29 93.52 7.96 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.163 -179.726 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.06 145.67 51.94 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.344 2.029 . . . . 0.0 113.053 -179.488 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.2 m -72.65 139.54 47.39 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.338 179.533 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -102.89 139.77 38.03 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.662 179.641 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.405 ' CG1' ' OD1' ' A' ' 86' ' ' ASP . 75.3 t -133.46 134.43 56.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.097 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.4 m120 54.79 26.92 8.18 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -178.397 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.53 24.13 66.05 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-N 115.039 -0.982 . . . . 0.0 112.048 179.585 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.2 t -138.48 140.4 39.2 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 117.371 0.585 . . . . 0.0 111.28 179.695 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -70.99 140.38 18.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.183 179.918 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.2 pt -115.42 91.95 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.122 179.941 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -66.87 -25.72 66.54 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.653 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.19 162.19 27.41 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.505 179.484 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.13 154.16 66.53 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.62 2.213 . . . . 0.0 112.247 179.899 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.9 m -145.65 148.62 17.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.833 -179.781 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.2 mtm-85 -75.65 134.83 40.5 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.158 179.531 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 90.0 mt -89.7 134.02 34.37 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.138 0.495 . . . . 0.0 111.161 -179.677 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -125.1 156.62 37.99 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.052 179.143 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.519 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 4.2 t60 -54.1 120.02 5.87 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.546 -0.461 . . . . 0.0 111.089 -178.701 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.07 -15.65 28.11 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 179.797 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.436 ' OD1' ' N ' ' A' ' 87' ' ' VAL . 59.1 t0 -65.41 128.21 34.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.882 0.372 . . . . 0.0 110.422 179.988 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.436 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 53.6 t -112.13 130.93 64.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.291 -179.382 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.7 mt -101.64 134.02 43.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.383 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 76.9 m -124.33 129.22 50.34 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -178.53 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.585 ' O ' ' N ' ' A' ' 92' ' ' ASP . 95.0 mt -112.18 126.67 69.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 114.516 -1.22 . . . . 0.0 108.159 177.57 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.45 ' C ' ' O ' ' A' ' 90' ' ' ILE . 45.4 mm 40.19 -92.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 C-N-CA 120.269 -0.572 . . . . 0.0 109.716 -179.257 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.585 ' N ' ' O ' ' A' ' 90' ' ' ILE . 0.7 OUTLIER -129.43 20.48 5.69 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.928 0.395 . . . . 0.0 110.87 179.732 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.657 ' HE ' HH12 ' B' ' 245' ' ' ARG . 98.5 mtt180 -124.31 142.09 51.54 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.326 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 75.6 m -137.55 151.36 48.31 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.203 -179.725 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -121.95 122.33 39.13 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.534 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -84.95 133.96 34.26 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 119.638 -0.825 . . . . 0.0 111.375 -178.581 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -95.8 120.08 35.43 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.158 179.532 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -122.31 119.67 31.8 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.263 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.519 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 64.8 t-20 . . . . . 0 C--N 1.326 -0.453 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.333 179.7 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo . . . . . 0 N--CA 1.486 1.05 0 CA-C-O 120.933 0.306 . . . . 0.0 111.607 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 4.9 p -116.85 132.75 65.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.328 -179.664 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 45.9 t . . . . . 0 N--CA 1.465 0.294 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.532 -179.256 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo . . . . . 0 N--CA 1.498 1.736 0 N-CA-C 113.53 0.55 . . . . 0.0 113.53 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 5.2 p -73.29 -41.6 63.39 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.026 -0.669 . . . . 0.0 109.305 178.28 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -58.24 -46.65 85.56 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.12 -179.524 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 94.4 mt -62.79 -40.45 97.35 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.605 -179.674 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -63.9 -37.37 87.14 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.271 179.545 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -62.4 -41.75 98.91 Favored 'General case' 0 C--N 1.334 -0.1 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.488 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.657 HH12 ' HE ' ' A' ' 93' ' ' ARG . 60.9 ttm-85 -58.07 -44.19 87.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.006 -179.495 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -63.33 -40.4 97.22 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.029 0.442 . . . . 0.0 110.759 -179.475 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 41.8 m -69.0 -46.13 68.81 Favored 'General case' 0 C--N 1.334 -0.104 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.65 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . 0.744 ' NE2' HH12 ' A' ' 12' ' ' ARG . 59.5 tt0 -61.78 -36.94 82.52 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.818 -179.55 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 75.4 t . . . . . 0 N--CA 1.453 -0.288 0 C-N-CA 120.257 -0.577 . . . . 0.0 109.513 179.42 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . 0.637 ' OE1' ' NH2' ' A' ' 93' ' ' ARG . 95.1 mt-10 . . . . . 0 N--CA 1.462 0.137 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 79.4 mt -106.78 132.31 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 177.589 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 47.6 t -126.4 133.09 69.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 120.904 0.383 . . . . 0.0 111.014 -179.15 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -97.88 124.13 42.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.12 -179.297 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -69.36 -45.42 69.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.261 179.457 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.22 155.79 40.73 Favored Pre-proline 0 CA--C 1.521 -0.16 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.201 -179.428 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.85 144.26 70.18 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 122.584 2.189 . . . . 0.0 113.052 -179.664 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 45.0 pt . . . . . 0 C--N 1.331 -0.206 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.87 178.835 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.484 ' HG1' ' H ' ' A' ' 5' ' ' ARG . 25.0 p . . . . . 0 CA--C 1.521 -0.156 0 CA-C-O 120.976 0.417 . . . . 0.0 110.505 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.484 ' H ' ' HG1' ' A' ' 4' ' ' THR . 85.3 mtt85 -100.12 123.42 44.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.171 -179.616 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -130.01 144.35 51.29 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.685 -179.84 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 83.9 mt -113.18 135.45 53.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.392 179.045 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.6 m -110.79 132.06 60.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-O 120.95 0.405 . . . . 0.0 110.019 179.254 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.7 m -79.97 142.53 34.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.495 -0.775 . . . . 0.0 113.044 -178.193 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.5 mt -112.15 136.67 47.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.024 176.611 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -90.32 158.94 16.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.842 0.353 . . . . 0.0 110.432 179.754 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -58.45 -30.92 67.3 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.088 -178.875 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.3 p -76.44 -11.58 59.91 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.199 179.594 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.08 35.57 6.02 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -179.635 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 54.0 t -120.14 132.04 70.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.935 0.398 . . . . 0.0 110.816 -179.81 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -81.21 138.41 35.81 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.805 179.624 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -133.42 -116.15 1.68 Allowed Glycine 0 CA--C 1.538 1.517 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.124 -179.718 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.36 153.1 61.35 Favored 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 122.473 2.116 . . . . 0.0 112.849 -178.83 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -116.04 161.68 18.52 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.604 -179.832 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -122.88 91.84 49.5 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.417 -179.563 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -59.96 127.63 23.96 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 121.957 1.772 . . . . 0.0 110.564 179.346 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.6 mt -82.02 57.56 3.56 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.566 -0.454 . . . . 0.0 111.233 -179.002 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 89.8 p -67.84 -22.97 65.12 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.576 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 80.2 mt -83.63 138.9 33.13 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.233 179.79 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 92.9 p -64.22 -18.09 64.19 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.03 -179.48 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.495 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 88.0 m -134.37 134.82 42.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.985 179.91 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.675 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 1.4 t -128.21 118.11 22.75 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.235 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.448 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 40.8 tp -117.47 128.73 55.27 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.22 -177.699 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.675 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 19.8 m-85 -104.89 135.8 45.57 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.657 179.045 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 164.22 178.62 37.86 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 120.283 -0.961 . . . . 0.0 112.778 179.034 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.424 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 42.3 mtm180 -75.44 -31.1 60.2 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.903 0.382 . . . . 0.0 110.503 178.654 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -50.48 144.86 10.58 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.19 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.6 tp -66.92 -41.05 87.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.908 -179.585 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -58.03 -20.83 41.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.869 0.366 . . . . 0.0 110.813 -179.92 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 62.4 m -57.63 131.52 50.48 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.878 -179.512 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.495 ' OD2' ' O ' ' A' ' 26' ' ' THR . 56.0 m-20 -60.25 -33.56 72.47 Favored 'General case' 0 C--N 1.334 -0.097 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -178.781 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 84.8 mt -126.12 123.8 64.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 176.65 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 84.2 mtm-85 -105.45 135.04 47.58 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.439 -0.505 . . . . 0.0 110.609 -178.246 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.432 HG23 HD13 ' A' ' 39' ' ' ILE . 95.8 mt -118.78 131.02 72.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 120.304 -0.559 . . . . 0.0 111.36 -179.82 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -75.45 32.26 0.11 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.52 -0.763 . . . . 0.0 112.318 -178.794 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 61.0 mt -106.18 127.07 29.02 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.65 179.378 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.33 -8.49 22.79 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 122.406 2.071 . . . . 0.0 113.117 -179.42 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.5 m -95.38 6.77 7.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.39 179.737 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.424 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 36.1 t -96.86 135.36 31.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.331 179.475 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.1 m -73.02 173.68 8.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.205 -178.883 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -63.02 -40.35 97.49 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.819 179.476 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.64 ' O ' ' N ' ' A' ' 49' ' ' CYS . 9.8 mm100 -113.24 -23.3 10.02 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.974 -0.291 . . . . 0.0 110.519 -179.712 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.4 t60 43.58 -77.69 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.894 -179.735 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.64 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -134.03 136.97 44.41 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.991 -179.517 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -125.77 133.13 52.16 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.485 179.75 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 98.6 mt -115.98 131.43 68.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.058 179.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.587 ' OE2' ' NE2' ' A' ' 54' ' ' HIS . 79.4 tt0 -118.11 125.73 50.85 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.765 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 86.2 mt -108.06 123.17 63.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.896 0.855 . . . . 0.0 112.992 -177.826 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.587 ' NE2' ' OE2' ' A' ' 52' ' ' GLU . 98.5 m-70 -117.57 136.92 52.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 113.989 -1.459 . . . . 0.0 109.056 178.902 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 54' ' ' HIS . 96.2 mt-10 -41.18 -32.23 0.26 Allowed 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.156 -0.617 . . . . 0.0 109.89 -179.571 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -64.22 -67.93 0.39 Allowed 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.291 -0.564 . . . . 0.0 109.893 179.224 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.603 ' CG ' ' H ' ' A' ' 58' ' ' ALA . 52.9 tt0 -150.56 -179.35 7.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.863 -178.593 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.603 ' H ' ' CG ' ' A' ' 57' ' ' GLU . . . -108.83 131.86 54.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.052 -179.697 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.8 mt -119.85 129.5 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -178.33 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 38.6 tp -97.39 129.03 44.67 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.041 -0.982 . . . . 0.0 110.051 179.47 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -115.92 136.32 53.15 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 179.595 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.599 HD22 ' CB ' ' A' ' 68' ' ' PRO . 62.7 t-20 -100.32 105.24 16.74 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 120.965 0.412 . . . . 0.0 111.134 -179.477 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -97.52 -9.57 26.85 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.229 179.855 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.87 98.55 7.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.021 0.438 . . . . 0.0 110.271 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.4 t -76.27 -42.65 44.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.844 179.396 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.28 -45.43 94.52 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.293 -178.68 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -139.36 94.84 9.4 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 115.503 -0.771 . . . . 0.0 108.958 -179.503 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.599 ' CB ' HD22 ' A' ' 62' ' ' ASN . 35.6 Cg_endo -64.86 150.52 88.01 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 121.528 1.485 . . . . 0.0 112.507 -178.173 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.8 m -73.01 142.11 47.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.7 -178.883 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -99.51 148.04 24.68 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.788 179.84 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.6 p -132.61 135.47 57.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.239 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 50.85 33.02 7.91 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.455 -179.861 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.69 27.69 70.5 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -179.442 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 10.4 t -138.12 139.42 39.43 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.462 -179.501 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 77.8 t -69.22 134.0 30.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.031 0.443 . . . . 0.0 111.636 -179.715 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.16 95.58 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.482 179.266 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -81.92 -16.62 49.95 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.666 -179.209 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -110.01 156.91 39.21 Favored Pre-proline 0 C--O 1.222 -0.372 0 C-N-CA 121.099 -0.241 . . . . 0.0 110.481 -179.733 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -64.57 145.98 88.26 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.369 2.046 . . . . 0.0 112.669 -179.807 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.9 m -147.61 148.08 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.106 -179.463 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 91.2 mtm180 -73.97 132.36 42.33 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.403 179.391 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 77.8 mt -79.39 141.2 37.09 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.996 0.427 . . . . 0.0 111.417 179.693 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -132.75 151.29 52.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.775 179.55 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.536 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 5.5 t60 -56.23 116.82 3.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.024 -179.801 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.92 -14.32 26.55 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.061 179.235 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -74.48 134.97 42.26 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.229 179.867 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.0 t -108.07 132.13 56.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.749 -178.891 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.49 ' O ' ' OG ' ' A' ' 94' ' ' SER . 88.8 mt -104.99 131.87 53.12 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.769 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 65.2 m -120.78 130.01 53.83 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 119.745 -0.782 . . . . 0.0 112.778 -177.96 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.597 ' O ' ' N ' ' A' ' 93' ' ' ARG . 96.6 mt -114.58 131.19 67.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 114.29 -1.323 . . . . 0.0 108.611 178.335 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.554 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 95.6 mt -20.38 95.26 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -179.565 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.554 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 10.5 t0 90.42 -23.55 0.09 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 178.084 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.597 ' N ' ' O ' ' A' ' 90' ' ' ILE . 88.2 mtt-85 -130.0 147.02 51.71 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.03 -179.621 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.49 ' OG ' ' O ' ' A' ' 88' ' ' ILE . 38.7 t -139.1 152.27 47.37 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.384 0.611 . . . . 0.0 110.598 -179.911 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -125.07 121.36 34.08 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.649 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -87.51 140.27 29.69 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 119.453 -0.899 . . . . 0.0 109.976 -179.561 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -96.65 123.17 40.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.031 -178.292 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -126.03 120.77 31.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.781 179.711 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.536 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 64.4 t-20 . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.259 179.817 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo . . . . . 0 N--CA 1.489 1.244 0 N-CA-C 113.722 0.624 . . . . 0.0 113.722 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 50.1 t -64.42 132.46 30.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.036 179.231 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.324 -0.511 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.063 -179.693 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo . . . . . 0 N--CA 1.499 1.835 0 N-CA-C 113.009 0.35 . . . . 0.0 113.009 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 86.0 m -74.84 -45.99 39.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.949 0.404 . . . . 0.0 110.881 179.234 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . 0.641 ' CE2' ' CZ ' ' B' ' 245' ' ' ARG . 57.2 t80 -58.37 -48.31 81.0 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.033 -178.31 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 44.7 mt -64.73 -42.62 95.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.252 0.548 . . . . 0.0 110.757 179.681 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -62.99 -43.09 99.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.016 -178.72 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -61.55 -45.56 93.65 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.692 -179.041 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.641 ' CZ ' ' CE2' ' B' ' 241' ' ' PHE . 89.7 mtm180 -63.86 -37.05 85.96 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.904 -178.771 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.7 -39.7 92.42 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.305 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 70.2 m -63.49 -44.09 95.38 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.606 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 93.9 mm-40 -61.11 -37.11 81.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.281 -179.779 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 47.1 t . . . . . 0 C--N 1.327 -0.39 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.914 179.792 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 . . . . . 0 CA--C 1.523 -0.085 0 CA-C-O 121.446 0.641 . . . . 0.0 109.694 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 82.6 mt -115.91 133.55 61.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.79 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 55.0 t -126.6 133.13 69.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.979 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -96.12 121.95 38.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.204 0.526 . . . . 0.0 111.219 -178.53 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . 0.443 ' CB ' ' O ' ' A' ' 36' ' ' ASP . 87.6 tttt -63.78 -43.45 96.34 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.477 179.551 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.24 160.14 31.37 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.327 -179.398 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -61.17 145.42 98.74 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.686 2.257 . . . . 0.0 111.031 178.464 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . 0.578 ' O ' ' CD1' ' B' ' 267' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.49 0 C-N-CA 120.151 -0.62 . . . . 0.0 111.28 -179.415 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.55 ' O ' ' O ' ' A' ' 99' ' ' ASN . 2.4 t . . . . . 0 N--CA 1.474 0.743 0 CA-C-O 120.6 0.238 . . . . 0.0 110.592 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.569 ' NH1' ' HH ' ' A' ' 97' ' ' TYR . 92.9 mtt-85 -86.08 130.54 34.5 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.635 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -135.0 142.38 46.43 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.536 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.8 mt -111.7 132.74 54.41 Favored 'General case' 0 CA--C 1.523 -0.076 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.29 179.405 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.6 t -109.01 125.89 66.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.988 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.1 m -77.17 140.94 40.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.679 -178.779 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.3 mt -110.27 135.19 50.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.125 178.578 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -90.68 159.51 16.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.202 0.525 . . . . 0.0 110.947 -179.809 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.588 HH11 ' NH1' ' B' ' 245' ' ' ARG . 91.1 mtm180 -56.95 -29.35 63.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.601 -178.546 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.3 p -81.44 -8.49 59.74 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.279 -179.734 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.29 33.27 7.74 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 179.676 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.7 t -120.38 134.7 63.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.572 0.225 . . . . 0.0 111.518 -179.59 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -72.4 136.4 46.07 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.105 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -124.84 -119.41 2.39 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.679 -179.893 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.62 148.3 36.93 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 122.52 2.147 . . . . 0.0 113.318 -178.989 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -109.55 138.31 46.1 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.515 179.853 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -111.54 104.04 55.69 Favored Pre-proline 0 N--CA 1.469 0.477 0 N-CA-C 110.056 -0.349 . . . . 0.0 110.056 -179.746 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -76.15 138.43 20.34 Favored 'Trans proline' 0 N--CA 1.489 1.235 0 C-N-CA 121.949 1.766 . . . . 0.0 112.217 -179.133 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 93.4 mt -88.83 92.06 9.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.143 0.497 . . . . 0.0 111.106 -178.878 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 88.6 p -93.55 -8.07 42.36 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.728 179.017 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 67.3 mt -109.58 150.07 28.74 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.859 -179.424 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.9 m -68.97 -16.39 63.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.734 0.302 . . . . 0.0 111.311 -179.148 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 78.4 m -128.59 132.01 48.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.058 0.456 . . . . 0.0 111.464 -179.766 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.631 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 5.2 t -128.1 119.19 24.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.451 178.816 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 31.6 tp -117.68 130.34 56.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.41 -178.496 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.631 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 17.5 m-85 -107.72 137.23 46.1 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.666 179.441 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 156.91 -177.48 33.79 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 120.384 -0.912 . . . . 0.0 112.425 178.899 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -74.91 -32.55 61.84 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.581 0.229 . . . . 0.0 111.48 179.202 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.489 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -53.04 145.68 20.58 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.264 -178.514 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.459 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 11.1 tp -66.36 -41.93 89.71 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-O 120.856 0.36 . . . . 0.0 110.204 179.873 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.459 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 49.9 tp10 -52.3 -22.1 4.16 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.605 179.511 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.489 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 9.9 m -65.46 126.03 26.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.064 -179.791 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -57.67 -27.5 62.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.023 -179.551 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 78.7 mt -130.26 123.71 56.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.484 178.295 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 75.2 mtm180 -101.61 135.33 43.31 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.317 179.979 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.506 ' C ' ' H ' ' A' ' 41' ' ' LEU . 97.3 mt -117.56 129.58 73.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.131 0.491 . . . . 0.0 109.97 179.068 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -74.24 29.1 0.08 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.205 -178.952 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.547 ' CD2' ' NH2' ' B' ' 245' ' ' ARG . 26.9 mt -93.72 121.36 64.75 Favored Pre-proline 0 CA--C 1.533 0.303 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.204 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.4 -8.45 20.73 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 121.779 1.653 . . . . 0.0 111.676 -179.642 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 m -102.53 9.88 8.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.906 -179.981 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.9 t -96.59 141.36 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 121.077 0.465 . . . . 0.0 110.595 179.324 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.8 m -71.64 165.59 23.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.517 -179.24 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -62.17 -40.83 97.34 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.665 -179.426 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.634 ' O ' ' N ' ' A' ' 49' ' ' CYS . 85.7 mt-30 -113.59 -25.0 8.93 Favored 'General case' 0 C--O 1.226 -0.133 0 CA-C-O 121.102 0.477 . . . . 0.0 110.27 -179.907 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.8 t60 37.08 -76.01 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 179.405 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.634 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -127.34 133.54 50.07 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.243 0.544 . . . . 0.0 112.187 -178.128 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -130.88 129.18 41.95 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.051 179.993 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 94.4 mt -113.07 133.8 57.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.561 179.842 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -118.94 126.96 52.98 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.641 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.2 mt -104.67 113.72 42.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.049 -0.66 . . . . 0.0 111.215 -179.398 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.559 ' O ' ' N ' ' A' ' 56' ' ' GLN . 95.3 m-70 -113.4 145.4 41.19 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.569 179.789 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 54' ' ' HIS . 77.3 tt0 -39.85 -24.59 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -179.694 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.559 ' N ' ' O ' ' A' ' 54' ' ' HIS . 87.0 mt-30 -71.14 -68.69 0.42 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.222 178.9 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.496 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 2.5 tp10 -158.62 -169.17 2.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.234 0.54 . . . . 0.0 111.025 -178.962 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -105.71 121.89 44.94 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 177.961 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.7 mt -114.66 129.42 70.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.223 0.535 . . . . 0.0 112.093 -178.443 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 29.5 tp -96.64 127.48 42.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.47 179.706 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -112.01 135.32 52.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.857 0.36 . . . . 0.0 110.404 -179.821 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.449 ' ND2' ' H ' ' A' ' 69' ' ' THR . 10.7 t-20 -93.46 106.5 18.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.635 -179.847 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -98.38 -12.57 21.29 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.72 179.056 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 t -73.98 100.51 3.58 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.204 179.749 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.2 p -86.09 -20.76 28.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.897 0.38 . . . . 0.0 110.761 179.768 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.62 -44.65 12.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.213 -179.612 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 -135.1 94.17 16.3 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.175 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.419 ' HA ' HD22 ' A' ' 62' ' ' ASN . 41.7 Cg_exo -55.38 145.11 69.31 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.393 2.062 . . . . 0.0 113.57 -178.435 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.449 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 53.1 m -74.03 142.59 45.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.332 179.176 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -104.6 140.97 37.24 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.663 179.765 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.0 t -128.52 131.46 68.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.83 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 51.09 32.03 7.26 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.149 -0.621 . . . . 0.0 109.489 -179.06 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.56 26.33 67.9 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.861 179.749 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.9 p -136.78 133.93 36.5 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 122.451 -0.44 . . . . 0.0 111.061 -179.989 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -68.03 138.12 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.494 179.821 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.9 pt -116.28 92.34 2.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.659 179.729 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -68.2 -20.89 64.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.075 0.464 . . . . 0.0 109.841 178.933 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.86 168.2 11.96 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.726 -179.533 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.65 152.43 69.9 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.778 2.319 . . . . 0.0 112.255 179.601 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.4 p -143.09 145.11 23.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.866 -179.742 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.8 mtm-85 -73.24 128.16 34.7 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.483 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.7 mt -80.4 137.37 36.52 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.203 -179.345 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -130.6 153.42 48.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.429 179.767 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -58.17 118.87 5.93 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.011 0.434 . . . . 0.0 110.505 -179.542 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.59 -7.24 26.22 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.746 -0.941 . . . . 0.0 110.746 -179.472 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.438 ' C ' ' OD1' ' A' ' 86' ' ' ASP . 52.2 t0 -81.12 123.85 28.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.092 0.472 . . . . 0.0 110.365 179.792 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 42.9 t -104.05 134.17 46.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.648 -179.162 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.1 mt -103.32 129.94 54.39 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 178.104 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 29.4 m -119.08 128.09 53.99 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.531 0.682 . . . . 0.0 111.832 -178.616 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.411 ' O ' ' C ' ' A' ' 91' ' ' ILE . 94.6 mt -118.1 125.29 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.954 179.295 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.469 HG21 HD12 ' A' ' 91' ' ' ILE . 38.2 mm 38.36 -105.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.991 -179.117 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.54 ' CG ' ' NE ' ' B' ' 245' ' ' ARG . 1.1 p30 -108.24 12.07 26.84 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -178.808 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.591 ' HE ' ' CG1' ' B' ' 261' ' ' ILE . 53.4 mtp85 -132.91 147.9 52.29 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.068 179.616 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 38.1 m -138.8 158.27 44.53 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.233 -179.064 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -125.89 122.95 37.53 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.354 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 79.4 mtp85 -81.35 135.53 35.69 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.491 179.471 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.569 ' HH ' ' NH1' ' A' ' 5' ' ' ARG . 80.6 t80 -95.15 122.07 37.44 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.997 179.952 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -134.64 119.96 18.97 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.999 -179.257 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.55 ' O ' ' O ' ' A' ' 4' ' ' THR . 91.9 m-20 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.758 179.381 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo . . . . . 0 N--CA 1.49 1.295 0 CA-C-O 121.467 0.528 . . . . 0.0 112.944 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 74.3 t -76.22 132.72 32.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.898 -179.381 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 37.5 t . . . . . 0 C--N 1.331 -0.22 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.776 -179.728 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo . . . . . 0 N--CA 1.499 1.795 0 N-CA-C 113.189 0.419 . . . . 0.0 113.189 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 21.8 m -73.18 -45.58 55.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.261 0.553 . . . . 0.0 109.89 178.829 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -58.59 -47.23 85.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.362 -179.381 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 98.8 mt -66.53 -39.79 88.78 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.832 0.348 . . . . 0.0 111.251 -179.805 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 51.5 tp10 -62.87 -45.09 94.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.171 -179.372 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -62.09 -40.8 97.08 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.258 0.552 . . . . 0.0 109.915 179.807 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.588 ' NH1' HH11 ' A' ' 12' ' ' ARG . 56.2 ttm-85 -60.13 -42.98 95.99 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.423 -179.229 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -62.23 -38.46 89.3 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.563 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 47.8 t -64.8 -44.21 90.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.433 177.849 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -60.94 -36.32 79.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.344 179.933 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 22.3 t . . . . . 0 N--CA 1.454 -0.228 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.932 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 . . . . . 0 N--CA 1.463 0.224 0 CA-C-O 121.223 0.535 . . . . 0.0 110.065 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . 0.591 ' CG1' ' HE ' ' A' ' 93' ' ' ARG . 58.6 mt -115.3 147.22 18.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.73 179.52 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 78.7 t -128.91 136.38 59.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.39 179.468 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -98.18 120.92 39.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.259 0.552 . . . . 0.0 111.567 -178.74 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . 0.417 ' HZ3' ' HA ' ' A' ' 34' ' ' GLU . 87.8 tttt -68.55 -46.2 70.11 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.783 -179.684 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -96.37 176.65 2.05 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.055 -178.715 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -59.54 146.13 96.02 Favored 'Trans proline' 0 N--CA 1.5 1.879 0 C-N-CA 122.644 2.229 . . . . 0.0 113.252 -178.938 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 1.1 tt . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.451 -179.829 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.41 ' HG1' ' HG3' ' A' ' 5' ' ' ARG . 6.4 p . . . . . 0 N--CA 1.462 0.164 0 CA-C-O 120.609 0.242 . . . . 0.0 110.873 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.41 ' HG3' ' HG1' ' A' ' 4' ' ' THR . 85.2 mtt85 -97.2 127.23 42.98 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.783 -178.679 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 94.5 mtm-85 -129.6 135.44 48.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.993 179.816 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 39.9 tp -108.79 134.11 51.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.301 -179.47 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 54.9 t -114.98 130.7 69.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.128 -179.704 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.1 m -79.51 142.29 35.93 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.81 -179.605 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.622 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 90.0 mt -109.32 135.51 48.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.39 -0.823 . . . . 0.0 108.857 177.769 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.65 ' CA ' HH22 ' A' ' 93' ' ' ARG . 97.4 mttt -87.25 153.68 21.3 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.766 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.581 ' NH1' ' OE2' ' B' ' 260' ' ' GLU . 88.8 mtm180 -58.11 -23.81 56.33 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.414 -0.515 . . . . 0.0 110.474 -179.357 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.0 m -80.38 -10.72 59.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.385 179.524 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.67 30.28 9.19 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 179.644 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.9 t -121.21 132.12 71.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.795 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -73.55 140.01 46.01 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.362 179.418 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -122.42 -121.46 2.72 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 121.031 -0.604 . . . . 0.0 111.916 -179.041 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.05 149.74 53.16 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 122.094 1.863 . . . . 0.0 112.489 -179.059 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.56 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -109.95 140.44 43.94 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.925 -179.092 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -112.86 104.71 55.97 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.614 -178.807 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -72.63 131.36 17.2 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.103 1.202 . . . . 0.0 111.579 -178.488 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 92.2 mt -86.21 48.68 1.65 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.926 -178.189 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.6 p -65.33 -22.31 66.8 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.918 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.8 mt -80.28 141.47 35.49 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.018 179.965 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.7 m -62.48 -21.6 65.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.985 -179.206 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 74.7 m -138.15 135.77 36.04 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.693 -179.404 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.0 t -126.73 122.09 33.87 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 177.888 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.429 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 44.1 tp -118.01 127.35 53.72 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.104 0.478 . . . . 0.0 111.163 -178.386 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.52 ' O ' ' O ' ' A' ' 47' ' ' GLN . 9.3 m-85 -105.36 132.45 51.53 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.904 179.83 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.79 -175.93 39.13 Favored Glycine 0 N--CA 1.467 0.749 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.158 179.425 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.601 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 78.9 mtm-85 -77.73 -30.12 51.51 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.873 0.368 . . . . 0.0 110.338 179.262 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -50.62 149.2 6.78 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.923 -0.471 . . . . 0.0 111.923 -178.208 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.429 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 10.9 tp -67.05 -40.57 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.458 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.429 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 96.5 mt-10 -57.2 -25.4 58.98 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.885 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.439 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 47.7 m -53.59 118.41 3.88 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.995 179.824 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.429 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 55.3 m-20 -58.56 -28.26 65.35 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.155 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 90.4 mt -129.0 124.62 61.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 176.494 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.41 ' O ' ' N ' ' B' ' 262' ' ' VAL . 84.5 mtp180 -107.72 136.6 47.19 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.636 -178.61 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.431 ' C ' ' H ' ' A' ' 41' ' ' LEU . 92.5 mt -118.0 130.31 73.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 179.501 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -73.44 30.54 0.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.441 -177.747 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.431 ' H ' ' C ' ' A' ' 39' ' ' ILE . 82.3 mt -100.85 127.85 31.23 Favored Pre-proline 0 C--N 1.326 -0.417 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.521 179.865 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.24 -8.09 20.49 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 122.267 1.978 . . . . 0.0 111.77 179.636 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.4 m -100.21 6.37 9.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.008 -179.776 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.601 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 9.4 t -97.25 138.0 23.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 179.151 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.7 m -68.75 165.16 20.15 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.502 0.668 . . . . 0.0 111.496 -178.882 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.439 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 9.6 mtmt -61.94 -40.06 94.21 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.825 -179.459 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.639 ' O ' ' N ' ' A' ' 49' ' ' CYS . 85.8 mt-30 -118.06 -20.28 8.75 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.91 0.386 . . . . 0.0 111.322 179.742 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 33.7 t60 32.57 -73.97 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 178.887 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.639 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -124.83 131.52 53.43 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.157 0.503 . . . . 0.0 112.213 -178.305 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -126.82 127.89 45.7 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.229 179.914 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.1 mt -113.48 131.13 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.532 179.883 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.569 ' OE2' ' NE2' ' A' ' 54' ' ' HIS . 81.2 tt0 -118.34 128.06 54.29 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.742 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 88.6 mt -106.87 117.14 52.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 121.597 0.713 . . . . 0.0 112.19 -178.017 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.569 ' NE2' ' OE2' ' A' ' 52' ' ' GLU . 96.6 m-70 -112.24 141.11 46.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.628 179.759 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 54' ' ' HIS . 96.9 mt-10 -40.44 -29.92 0.1 Allowed 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.381 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' ' 54' ' ' HIS . 89.0 mt-30 -67.33 -67.1 0.48 Allowed 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.461 178.654 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.432 ' OE1' ' N ' ' A' ' 58' ' ' ALA . 1.3 mm-40 -155.49 -177.28 6.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.486 0.66 . . . . 0.0 112.212 -178.263 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.432 ' N ' ' OE1' ' A' ' 57' ' ' GLU . . . -106.38 118.85 37.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.456 178.585 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 94.2 mt -110.63 131.57 61.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.541 0.686 . . . . 0.0 111.804 -178.775 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 23.8 tp -98.99 128.69 45.19 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.59 179.519 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -115.27 135.84 53.73 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.021 -179.773 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.618 ' ND2' ' H ' ' A' ' 69' ' ' THR . 13.4 t-20 -97.76 108.49 21.22 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.423 179.859 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -96.82 -8.06 32.02 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.649 179.413 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.481 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 6.7 t -71.19 97.83 1.6 Allowed 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.343 179.808 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.0 m -74.15 -43.29 57.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.292 0.568 . . . . 0.0 110.068 178.819 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -65.04 -43.23 93.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.808 -178.82 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.481 ' O ' ' OG ' ' A' ' 64' ' ' SER . 36.7 m-20 -140.16 99.95 7.2 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.189 -179.386 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -56.77 146.29 78.55 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 122.281 1.987 . . . . 0.0 112.871 -179.593 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.618 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 10.3 m -75.28 142.6 43.28 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.419 179.391 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -104.65 138.44 40.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.64 179.694 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 72.2 t -128.74 134.14 65.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.464 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 52.4 34.86 16.0 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.346 -179.425 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.86 26.47 69.07 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.541 179.212 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 41.8 m -146.46 141.29 26.95 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 117.563 0.681 . . . . 0.0 112.031 179.93 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.9 t -68.56 138.11 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.454 179.764 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.5 pt -113.48 89.09 1.23 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-O 121.158 0.504 . . . . 0.0 111.147 178.739 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -65.51 -27.2 68.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.567 179.114 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -120.01 166.08 16.08 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.067 -179.723 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.76 144.32 99.47 Favored 'Trans proline' 0 N--CA 1.501 1.936 0 C-N-CA 122.581 2.187 . . . . 0.0 112.197 -179.72 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.5 m -136.92 138.25 46.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.999 179.767 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.9 mtm180 -73.25 132.74 43.5 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.259 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.1 mt -81.5 133.79 35.44 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.113 -179.051 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -125.88 149.57 48.59 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.834 179.96 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -52.6 112.51 0.84 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.156 0.503 . . . . 0.0 111.062 -179.268 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.6 -11.43 25.69 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.799 179.233 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -70.36 132.48 45.71 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 117.289 0.545 . . . . 0.0 110.679 -179.823 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.0 t -108.16 132.69 55.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.929 -178.877 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.449 ' O ' ' OG ' ' A' ' 94' ' ' SER . 96.7 mt -104.32 130.92 54.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.759 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 87.0 m -122.8 123.59 41.39 Favored 'General case' 0 CA--C 1.523 -0.086 0 CA-C-O 121.628 0.728 . . . . 0.0 112.003 -178.83 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.56 ' N ' ' O ' ' A' ' 93' ' ' ARG . 78.9 mt -110.91 123.93 67.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.658 178.852 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.51 ' C ' ' O ' ' A' ' 90' ' ' ILE . 96.8 mt 31.78 -95.63 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.896 179.044 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.505 ' OD1' ' N ' ' A' ' 92' ' ' ASP . 24.1 p-10 -114.29 7.51 16.47 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.517 -179.763 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.65 HH22 ' CA ' ' A' ' 11' ' ' LYS . 1.7 mmp_? -119.41 137.22 53.9 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.651 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 88' ' ' ILE . 44.9 t -138.26 150.17 46.42 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.234 179.951 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -129.22 134.14 47.85 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.839 179.581 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -95.05 134.05 38.16 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.353 -179.406 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -93.51 121.54 35.03 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.914 -179.541 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -134.41 127.39 31.48 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 120.453 -0.499 . . . . 0.0 112.071 -179.915 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 . . . . . 0 C--N 1.333 -0.118 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.875 179.395 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo . . . . . 0 N--CA 1.486 1.076 0 CA-C-O 121.782 0.659 . . . . 0.0 112.662 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 30.5 t -64.86 131.42 30.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 114.429 -1.26 . . . . 0.0 109.856 -179.76 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 2.0 t . . . . . 0 C--N 1.327 -0.379 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.88 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo . . . . . 0 N--CA 1.5 1.867 0 CA-C-O 120.695 0.206 . . . . 0.0 112.208 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 23.6 m -73.29 -44.11 59.75 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.818 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . 0.703 ' CD1' ' NH2' ' B' ' 245' ' ' ARG . 77.2 t80 -57.57 -46.41 84.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.839 -179.63 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 91.6 mt -63.09 -40.65 98.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.424 0.63 . . . . 0.0 110.143 -179.945 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -62.4 -41.41 98.64 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.158 -179.663 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . 0.462 ' O ' ' OG ' ' B' ' 247' ' ' SER . 94.4 mtt-85 -61.44 -43.16 99.36 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.882 0.372 . . . . 0.0 111.039 -179.465 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.703 ' NH2' ' CD1' ' B' ' 241' ' ' PHE . 0.3 OUTLIER -61.24 -38.27 86.04 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.834 -179.921 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.11 -39.13 91.46 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.492 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 247' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 64.5 p -68.81 -41.41 78.7 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.293 178.164 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -58.86 -38.57 79.07 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.899 179.014 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 48.5 t . . . . . 0 N--CA 1.451 -0.411 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.003 179.297 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . 0.581 ' OE2' ' NH1' ' A' ' 12' ' ' ARG . 98.7 mt-10 . . . . . 0 CA--C 1.537 0.475 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 80.1 mt -115.58 134.71 57.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.422 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . 0.41 ' N ' ' O ' ' A' ' 38' ' ' ARG . 40.3 t -127.69 132.87 68.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.529 179.014 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -97.11 120.14 36.92 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.213 -179.46 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -63.98 -46.27 85.35 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.508 179.148 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -97.99 151.96 37.81 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.565 -179.42 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -66.99 146.84 78.81 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.929 2.42 . . . . 0.0 113.055 -178.932 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 27.5 pt . . . . . 0 C--N 1.327 -0.387 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.514 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 69.5 p . . . . . 0 C--O 1.233 0.198 0 CA-C-O 121.029 0.443 . . . . 0.0 110.583 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.611 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 94.5 mtt-85 -91.89 113.4 25.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.458 -179.321 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -126.31 133.72 51.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.379 -179.747 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 31.8 tp -113.62 133.85 55.05 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.781 -179.816 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.9 t -110.21 129.22 65.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.868 0.366 . . . . 0.0 111.116 -179.425 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.8 m -83.43 137.44 33.91 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.084 -178.864 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.6 mt -104.64 135.65 41.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.583 177.623 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -88.97 158.9 17.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.569 179.916 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.605 ' CD ' HH22 ' A' ' 93' ' ' ARG . 77.5 mtp180 -56.5 -29.27 61.61 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.076 179.881 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.9 m -79.25 -7.79 58.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.847 179.599 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.96 28.97 24.43 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -179.21 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.3 t -113.7 132.67 62.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.505 -0.347 . . . . 0.0 110.467 -179.695 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -77.61 138.71 39.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.407 179.944 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -133.87 -119.66 2.01 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 120.348 -0.93 . . . . 0.0 112.748 -179.141 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -66.44 143.12 68.3 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.144 1.896 . . . . 0.0 113.499 -177.828 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.435 ' O ' ' CD1' ' B' ' 267' ' ' ILE . 0.6 OUTLIER -108.04 130.56 55.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.576 -179.728 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -101.26 107.65 51.46 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.304 -179.181 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -74.64 128.9 12.16 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 121.753 1.636 . . . . 0.0 111.679 -179.562 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 86.6 mt -86.43 51.24 2.17 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -178.063 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.7 p -62.41 -22.37 66.11 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.456 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.6 mt -79.15 137.95 37.68 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.209 179.043 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 81.0 p -66.57 -17.46 64.83 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.925 -179.424 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.433 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 86.4 m -129.98 131.03 45.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.066 0.46 . . . . 0.0 111.046 179.616 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.6 t -123.54 115.25 21.21 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.292 178.155 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.8 tp -112.01 124.55 52.64 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.928 -179.219 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.484 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 3.9 m-85 -106.42 143.51 34.44 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.763 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 157.49 -170.55 34.59 Favored Glycine 0 C--O 1.225 -0.408 0 C-N-CA 120.005 -1.093 . . . . 0.0 111.715 178.852 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.0 ttp85 -87.49 -27.41 22.67 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.84 -0.18 . . . . 0.0 111.212 -179.903 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.564 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -59.19 151.13 35.71 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 179.99 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.442 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 10.5 tp -66.24 -40.41 86.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.218 -0.593 . . . . 0.0 110.298 179.854 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.442 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 79.4 mm-40 -53.98 -15.68 1.52 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.353 -179.884 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.564 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 34.1 m -64.48 123.63 19.72 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 120.162 -0.615 . . . . 0.0 109.394 179.631 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.433 ' OD2' ' O ' ' A' ' 26' ' ' THR . 98.6 m-20 -56.95 -25.0 57.06 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -179.501 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.419 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 99.0 mt -129.82 120.83 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.367 176.761 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 68.9 ttp85 -108.22 133.94 51.76 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.791 -178.648 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 97.6 mt -116.31 130.08 71.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.875 -179.825 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -75.24 34.59 0.11 Allowed 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -178.205 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 57.8 mt -110.84 127.55 26.75 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.753 179.651 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.81 -8.45 22.39 Favored 'Trans proline' 0 N--CA 1.498 1.742 0 C-N-CA 122.684 2.256 . . . . 0.0 114.063 -179.024 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.2 m -100.61 1.8 10.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.317 179.711 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.487 ' O ' ' O ' ' A' ' 45' ' ' SER . 91.2 t -97.26 103.35 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.034 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.487 ' O ' ' O ' ' A' ' 44' ' ' VAL . 12.5 t -32.71 157.54 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.785 0.803 . . . . 0.0 111.961 -178.688 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -64.25 -38.38 90.83 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.963 -179.695 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.577 ' O ' ' N ' ' A' ' 49' ' ' CYS . 95.6 mm-40 -113.22 -6.67 13.6 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 123.474 0.484 . . . . 0.0 111.055 -179.015 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.465 ' CD2' ' OG1' ' A' ' 69' ' ' THR . 20.8 t60 14.28 -71.66 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 -178.982 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.577 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.3 136.06 45.22 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -177.352 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -125.99 125.56 42.87 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.69 178.827 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.6 mt -110.72 132.79 58.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.978 179.894 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.418 ' CD ' ' CE1' ' A' ' 54' ' ' HIS . 75.6 tt0 -115.64 124.78 51.78 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.487 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.6 mt -103.16 120.68 53.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 119.913 -0.715 . . . . 0.0 112.422 -178.309 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.592 ' O ' ' N ' ' A' ' 56' ' ' GLN . 2.4 m-70 -114.91 138.4 50.86 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.084 178.723 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.462 ' C ' ' O ' ' A' ' 54' ' ' HIS . 96.5 mt-10 -39.86 -23.88 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 -179.655 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.592 ' N ' ' O ' ' A' ' 54' ' ' HIS . 66.2 tp60 -68.49 -67.93 0.43 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.142 178.257 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -159.2 -163.38 1.2 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.74 -179.529 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.42 131.7 54.82 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.401 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 41.2 mm -112.23 125.08 69.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.068 -178.801 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.433 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 28.9 tp -100.43 125.63 46.73 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.805 0.336 . . . . 0.0 110.097 -179.849 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -115.68 136.96 52.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.157 179.456 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.731 ' ND2' ' H ' ' A' ' 69' ' ' THR . 14.6 t-20 -100.54 106.73 18.28 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.4 -179.856 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -97.58 -6.93 32.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.587 179.462 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.48 100.6 0.87 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.886 179.563 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.2 m -83.25 -14.95 52.11 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.276 -0.569 . . . . 0.0 109.677 179.374 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.5 -43.5 9.65 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.594 179.964 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 44.0 m-20 -146.97 101.66 3.88 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.452 -179.485 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.404 ' HA ' HD22 ' A' ' 62' ' ' ASN . 32.5 Cg_exo -56.04 150.53 46.97 Favored 'Trans proline' 0 N--CA 1.499 1.824 0 C-N-CA 122.664 2.243 . . . . 0.0 113.998 -178.795 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.731 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 11.3 m -71.57 136.99 47.68 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.794 178.987 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.556 ' O ' ' N ' ' A' ' 89' ' ' THR . 70.2 mt-30 -99.64 146.04 26.92 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.597 179.947 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.544 ' CG2' ' OD1' ' A' ' 86' ' ' ASP . 4.1 p -133.75 139.73 48.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.499 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 48.24 33.13 3.5 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -179.63 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.23 29.79 65.96 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.299 -179.549 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.442 ' N ' ' O ' ' A' ' 71' ' ' VAL . 18.2 t -140.67 137.32 33.46 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.975 -179.199 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 38.9 t -66.76 139.09 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.375 -179.321 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.455 ' CG2' ' O ' ' A' ' 78' ' ' GLU . 89.8 mt -107.64 116.21 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.528 179.055 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.465 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 24.5 p-10 -87.75 -33.54 18.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.661 0.267 . . . . 0.0 111.064 179.274 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.455 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 5.0 pt-20 -128.88 174.05 4.95 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.949 -179.292 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -58.8 144.48 98.35 Favored 'Trans proline' 0 N--CA 1.501 1.929 0 C-N-CA 122.305 2.003 . . . . 0.0 112.513 -179.4 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.6 p -141.6 144.26 26.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.308 0.575 . . . . 0.0 111.689 179.747 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -77.6 132.98 38.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.095 179.611 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.2 mt -88.02 140.26 29.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.922 0.392 . . . . 0.0 111.146 -179.451 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -129.69 154.45 47.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.576 -179.87 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.563 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 7.6 t60 -54.46 117.81 3.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.038 0.447 . . . . 0.0 110.654 -179.502 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.81 -16.73 30.72 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 -179.396 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.544 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 45.3 t0 -69.94 126.52 29.94 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.185 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 49.7 t -102.5 135.58 38.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.006 -178.981 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 28.3 mm -92.59 129.03 43.77 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.605 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 177.485 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.556 ' N ' ' O ' ' A' ' 70' ' ' GLN . 98.8 m -121.23 125.15 46.4 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 122.031 0.919 . . . . 0.0 112.597 -178.245 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.591 ' O ' ' N ' ' A' ' 93' ' ' ARG . 97.0 mt -117.38 132.47 67.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 113.993 -1.458 . . . . 0.0 107.924 177.919 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.515 ' C ' ' O ' ' A' ' 90' ' ' ILE . 69.7 mt -26.78 104.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 O-C-N 123.448 0.467 . . . . 0.0 111.257 -179.225 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.509 ' CG ' ' NE ' ' B' ' 245' ' ' ARG . 90.9 m-20 79.37 -16.51 0.66 Allowed 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 179.147 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.605 HH22 ' CD ' ' A' ' 12' ' ' ARG . 23.5 mtt85 -130.62 137.36 49.59 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.661 -0.415 . . . . 0.0 110.84 179.028 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.2 m -138.82 152.42 47.85 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.156 0.503 . . . . 0.0 109.888 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -126.16 122.95 37.13 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.094 -179.61 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -83.69 132.05 34.9 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.82 -179.59 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.611 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 72.5 t80 -96.87 127.16 42.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.691 -179.525 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -124.94 120.95 33.07 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.271 179.533 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.563 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 59.4 t-20 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.044 179.988 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo . . . . . 0 N--CA 1.488 1.201 0 CA-C-O 121.582 0.576 . . . . 0.0 112.358 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 36.8 t -63.06 141.67 17.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.226 179.511 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.464 0.249 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.193 -179.72 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo . . . . . 0 N--CA 1.498 1.769 0 N-CA-C 112.834 0.282 . . . . 0.0 112.834 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 18.8 m -72.15 -44.96 62.3 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.212 0.529 . . . . 0.0 109.897 178.618 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -55.92 -47.13 78.08 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.6 -179.439 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . 0.437 ' CD2' ' OD1' ' A' ' 92' ' ' ASP . 93.3 mt -65.39 -41.49 93.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.776 -179.653 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -60.59 -40.68 92.64 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.738 -179.242 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -61.76 -42.44 98.99 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.785 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.509 ' NE ' ' CG ' ' A' ' 92' ' ' ASP . 70.4 ttp85 -60.77 -43.56 97.88 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.559 -179.739 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.98 -42.11 97.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.986 0.422 . . . . 0.0 109.957 -179.548 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 73.9 m -66.64 -45.09 80.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.542 0.687 . . . . 0.0 109.292 178.303 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . 0.424 ' HG2' HH22 ' A' ' 12' ' ' ARG . 68.8 tp60 -59.84 -35.44 74.75 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.325 -179.992 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 71.4 t . . . . . 0 C--N 1.33 -0.273 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.063 179.887 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 . . . . . 0 CA--C 1.533 0.291 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 73.1 mt -109.87 132.86 56.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.183 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 54.9 t -123.18 131.57 72.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.187 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -94.46 119.93 33.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.038 0.447 . . . . 0.0 111.723 -178.576 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -63.29 -48.45 78.08 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.899 179.74 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -89.34 160.3 42.71 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.609 -179.067 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -60.04 140.64 93.61 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.194 1.93 . . . . 0.0 111.727 179.867 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . 0.435 ' CD1' ' O ' ' A' ' 19' ' ' HIS . 3.2 tt . . . . . 0 C--N 1.324 -0.508 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.169 -179.249 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.6 m . . . . . 0 C--O 1.234 0.257 0 CA-C-O 120.945 0.402 . . . . 0.0 110.464 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.563 ' CD ' ' HH ' ' A' ' 97' ' ' TYR . 87.0 mtm-85 -100.51 131.51 46.38 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.026 -179.209 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -130.87 154.37 48.14 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.202 0.525 . . . . 0.0 111.995 -179.364 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.1 mt -119.96 141.93 49.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.625 179.387 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 45.9 t -115.53 129.83 71.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.787 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.0 m -88.46 111.98 22.42 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.426 0.631 . . . . 0.0 112.079 -178.14 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 35.5 mm -79.57 142.86 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.215 178.539 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -95.28 160.47 14.52 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.414 0.626 . . . . 0.0 111.189 -179.547 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.434 ' NH2' ' HA ' ' B' ' 245' ' ' ARG . 82.7 mtp180 -58.84 -27.53 65.21 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.94 179.41 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 93.8 p -74.11 -18.48 60.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.0 178.833 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.67 21.2 12.85 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-N 116.213 -0.449 . . . . 0.0 112.134 179.266 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.0 p -125.57 139.72 50.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.977 0.417 . . . . 0.0 110.189 179.897 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.447 ' OD1' ' N ' ' A' ' 16' ' ' ASP . 33.4 p-10 -84.72 149.14 25.99 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.463 -179.696 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -138.54 -97.85 0.42 Allowed Glycine 0 CA--C 1.53 1.021 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.768 -179.817 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.84 141.39 27.08 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.198 1.932 . . . . 0.0 112.395 -179.087 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -106.95 146.67 30.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.985 0.421 . . . . 0.0 110.375 -179.482 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -114.74 98.63 50.18 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.334 -179.931 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.32 133.52 14.75 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.872 1.715 . . . . 0.0 112.069 -178.411 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 92.2 mt -87.71 86.27 7.16 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.062 -178.806 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 89.5 p -83.65 -11.34 57.38 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.566 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.1 mt -109.15 154.86 21.74 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.378 -179.697 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 59.9 m -79.56 -8.53 59.23 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -178.648 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.477 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 24.2 m -126.43 129.14 48.14 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.827 -179.637 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.1 t -123.78 114.52 20.01 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.991 178.505 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 45.4 tp -112.25 128.49 56.27 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.451 -178.39 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.466 ' O ' ' O ' ' A' ' 47' ' ' GLN . 7.0 m-85 -110.36 130.9 55.46 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.482 -179.953 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 165.2 -176.65 40.84 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.411 178.692 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.639 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 81.5 mtm-85 -75.51 -30.96 59.98 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 122.483 -0.422 . . . . 0.0 112.032 -179.346 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -54.6 143.66 31.41 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 121.387 -0.435 . . . . 0.0 112.181 -178.131 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.444 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 11.1 tp -64.43 -41.09 91.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.252 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.444 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 80.8 tt0 -54.44 -15.95 2.0 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.357 179.5 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.7 m -69.16 133.13 47.59 Favored 'General case' 0 N--CA 1.461 0.1 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.989 -179.319 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.477 ' OD2' ' O ' ' A' ' 26' ' ' THR . 91.2 m-20 -59.95 -31.2 69.65 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.922 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.46 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 98.8 mt -126.68 124.59 65.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 177.008 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 70.1 ttt180 -110.64 133.49 53.27 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.54 -178.566 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 94.6 mt -118.17 131.4 71.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 121.073 0.463 . . . . 0.0 110.736 -179.148 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -75.89 32.79 0.12 Allowed 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -178.168 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.6 ' CD1' ' NH1' ' A' ' 93' ' ' ARG . 52.9 mt -113.45 128.19 25.97 Favored Pre-proline 0 N--CA 1.471 0.581 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.306 179.571 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.84 -15.03 29.86 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.239 1.959 . . . . 0.0 113.269 -179.034 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.444 ' O ' ' CG2' ' A' ' 43' ' ' VAL . 2.9 p -86.05 -1.41 7.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.103 179.729 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.639 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 5.3 p -95.1 139.28 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.958 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.79 171.91 7.18 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.563 0.697 . . . . 0.0 112.456 -178.09 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 44.7 mttm -64.26 -45.36 88.45 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.592 -179.369 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.662 ' O ' ' N ' ' A' ' 49' ' ' CYS . 84.6 mt-30 -113.05 -12.75 13.16 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.781 -179.607 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 21.3 t60 33.86 -75.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.238 -0.892 . . . . 0.0 113.385 179.52 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.662 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.2 134.77 46.8 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.759 -178.466 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -127.67 127.55 43.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.422 179.769 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 92.8 mt -109.73 133.06 56.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.868 -179.635 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -115.72 117.47 30.35 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.012 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 90.1 mt -101.1 112.72 34.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 119.972 -0.691 . . . . 0.0 111.328 -178.691 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.427 ' O ' ' C ' ' A' ' 55' ' ' GLU . 92.7 m-70 -110.05 141.06 43.41 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.483 -1.235 . . . . 0.0 109.561 -179.685 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 54' ' ' HIS . 99.2 mt-10 -41.23 -36.05 0.71 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.234 0.54 . . . . 0.0 109.693 -179.895 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -60.38 -66.23 0.56 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.371 179.637 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -154.0 -174.01 4.8 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.13 -179.369 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.56 123.18 48.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.292 179.152 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.9 mt -117.42 131.42 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -178.679 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 24.2 tp -100.76 127.87 47.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.209 179.267 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -109.22 135.48 50.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.054 179.817 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 61.1 t-20 -96.71 108.34 20.96 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.999 0.428 . . . . 0.0 111.261 -179.263 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -101.25 -7.29 23.19 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.668 179.855 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.7 t -76.71 97.79 4.57 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.883 -179.877 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.1 p -78.39 -33.01 49.11 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.092 179.113 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.39 -44.47 51.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.044 -179.213 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.414 ' ND2' HG21 ' A' ' 43' ' ' VAL . 79.0 m-20 -139.54 94.78 9.24 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.082 -179.693 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -54.48 147.23 48.59 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.522 2.148 . . . . 0.0 113.465 -179.725 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 59.3 m -77.05 149.06 35.83 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.115 179.095 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -110.08 141.06 43.46 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.711 -179.61 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 55.0 t -132.37 135.48 57.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.316 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 52.99 33.34 14.51 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -178.711 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.6 28.98 70.17 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.153 179.495 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.2 t -143.74 142.83 31.12 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 117.037 0.419 . . . . 0.0 111.138 179.51 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 52.9 t -68.0 138.64 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.066 -0.516 . . . . 0.0 112.062 -179.193 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.6 pt -112.46 92.75 2.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-O 121.274 0.559 . . . . 0.0 109.899 178.369 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -63.98 -28.45 69.82 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.628 -179.743 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.439 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.8 OUTLIER -130.81 179.46 1.34 Allowed Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.801 -179.67 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.439 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 31.9 Cg_exo -60.58 146.19 97.48 Favored 'Trans proline' 0 N--CA 1.501 1.951 0 C-N-CA 123.137 2.558 . . . . 0.0 113.244 179.898 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.4 137.95 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.381 179.484 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 68.2 ttp85 -73.12 129.07 37.25 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.904 -0.319 . . . . 0.0 110.77 179.925 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 97.4 mt -81.2 139.58 35.44 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.355 0.598 . . . . 0.0 110.946 179.936 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -136.71 152.19 50.09 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.352 -179.748 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.552 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 6.3 t60 -52.15 114.82 1.45 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.927 0.394 . . . . 0.0 110.366 -179.797 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.81 -18.34 22.13 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.034 -0.827 . . . . 0.0 111.034 -179.718 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 87' ' ' VAL . 53.3 t0 -66.21 129.49 40.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.276 0.56 . . . . 0.0 110.021 179.153 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.501 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 9.3 p -109.16 133.91 52.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.687 -179.051 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.1 mt -99.88 129.47 50.47 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.204 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.6 m -123.58 127.74 48.72 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.699 0.761 . . . . 0.0 112.761 -178.456 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.483 ' O ' ' N ' ' A' ' 93' ' ' ARG . 96.5 mt -117.37 125.82 74.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 114.44 -1.255 . . . . 0.0 108.551 177.626 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.44 ' C ' ' O ' ' A' ' 90' ' ' ILE . 82.4 mt 36.55 -103.3 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.929 179.949 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.404 ' HB2' HH21 ' B' ' 245' ' ' ARG . 89.8 m-20 -109.32 7.82 25.32 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.571 179.715 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.6 ' NH1' ' CD1' ' A' ' 41' ' ' LEU . 40.9 mtm-85 -121.94 140.85 51.94 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -179.208 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.5 t -138.03 152.26 48.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.297 0.57 . . . . 0.0 111.091 -179.698 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -121.99 120.96 35.92 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.417 179.081 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 53.6 ttt85 -84.87 129.98 34.73 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.871 -179.197 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.563 ' HH ' ' CD ' ' A' ' 5' ' ' ARG . 69.0 t80 -93.74 122.84 36.61 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.208 -179.242 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -123.0 124.19 42.58 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.88 179.967 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.552 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 63.2 t-20 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.055 -179.711 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo . . . . . 0 N--CA 1.493 1.451 0 CA-C-O 121.138 0.391 . . . . 0.0 112.667 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 24.4 t -57.74 137.33 20.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.798 -179.61 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 7.0 t . . . . . 0 C--N 1.327 -0.376 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.257 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo . . . . . 0 N--CA 1.49 1.317 0 CA-C-O 120.338 0.057 . . . . 0.0 112.159 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 91.3 m -73.57 -47.52 40.0 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-O 121.132 0.492 . . . . 0.0 109.732 178.894 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -59.83 -45.66 91.69 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.71 -179.29 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 91.9 mt -64.5 -40.56 95.87 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.86 0.362 . . . . 0.0 110.887 -179.728 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -60.14 -42.11 94.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.351 -179.2 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . 0.511 ' O ' ' OG ' ' B' ' 247' ' ' SER . 89.4 mtm180 -65.3 -39.29 92.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.594 179.276 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.488 ' NH2' HH11 ' A' ' 93' ' ' ARG . 16.8 mmm180 -60.72 -43.66 97.57 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.863 -178.471 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -63.92 -40.19 95.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.208 0.528 . . . . 0.0 109.819 179.353 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 247' ' ' SER . . . . . 0.511 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 67.9 p -64.03 -44.72 91.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.625 179.182 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . 0.424 ' HB2' HH22 ' A' ' 12' ' ' ARG . 87.3 mt-30 -61.1 -33.79 73.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.68 179.665 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 55.4 t . . . . . 0 C--N 1.332 -0.185 0 C-N-CA 120.259 -0.577 . . . . 0.0 109.754 179.139 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 . . . . . 0 CA--C 1.522 -0.102 0 CA-C-O 120.472 0.177 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 66.8 mt -115.96 135.35 56.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.765 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 72.7 t -127.39 135.39 63.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.113 179.543 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -96.84 118.18 32.71 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.396 0.617 . . . . 0.0 110.769 -179.163 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -66.85 -46.72 74.18 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.066 -179.917 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -75.31 168.5 27.09 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.588 -179.083 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -64.64 144.17 83.45 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 121.356 1.371 . . . . 0.0 111.024 179.275 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 10.6 tt . . . . . 0 C--N 1.322 -0.613 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.534 -178.936 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.4 m . . . . . 0 N--CA 1.463 0.185 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.432 ' NE ' ' CD1' ' A' ' 53' ' ' ILE . 86.2 mtm-85 -90.83 130.68 36.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.068 0.461 . . . . 0.0 111.328 -178.407 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -135.41 143.0 45.74 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.966 179.677 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 10.9 mp -120.08 139.33 52.71 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.93 0.395 . . . . 0.0 110.937 179.773 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.5 t -111.88 132.02 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.102 -179.729 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.0 m -84.21 139.37 32.43 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -178.286 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.429 HG23 HD12 ' A' ' 10' ' ' ILE . 49.2 mm -108.31 135.11 48.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.821 177.324 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -90.8 159.93 16.03 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 177.802 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.532 ' CZ ' ' OE2' ' B' ' 260' ' ' GLU . 90.9 mtm180 -56.2 -20.98 20.41 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.149 -179.42 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.9 m -83.62 -13.16 54.92 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.12 179.876 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.25 31.49 11.75 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.102 179.634 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.1 m -118.78 142.54 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 120.982 0.42 . . . . 0.0 111.77 -179.793 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -73.21 119.12 17.01 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.237 -179.151 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -110.96 -128.21 5.3 Favored Glycine 0 CA--C 1.54 1.654 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 -179.752 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -74.8 149.53 37.83 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 122.538 2.159 . . . . 0.0 113.209 -178.854 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 47.8 m170 -101.72 143.55 31.52 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.126 -179.665 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.404 ' CD2' HD12 ' A' ' 37' ' ' ILE . 39.0 t80 -113.42 92.52 23.48 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.192 179.53 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -77.67 138.19 16.87 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 121.878 1.719 . . . . 0.0 111.767 -179.415 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 82.9 mt -101.65 125.54 48.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.454 0.645 . . . . 0.0 111.465 -179.007 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 82.9 p -120.34 -1.03 10.28 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.329 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 45.4 mt -111.37 152.83 26.86 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 114.402 -1.272 . . . . 0.0 109.398 -178.921 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.9 m -77.27 -11.76 59.87 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -177.818 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 20.7 m -127.31 130.92 50.4 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 120.131 -0.628 . . . . 0.0 112.03 -179.617 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.5 t -126.15 117.97 24.24 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.851 178.841 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.411 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 31.9 tp -113.57 134.97 54.4 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 120.838 0.351 . . . . 0.0 111.215 -178.851 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.511 ' O ' ' O ' ' A' ' 47' ' ' GLN . 79.0 m-85 -112.44 135.82 52.68 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.682 179.244 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 165.39 -164.94 37.56 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 120.617 -0.801 . . . . 0.0 111.422 179.784 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 31.1 ptt-85 -103.41 -26.19 12.99 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.544 -0.462 . . . . 0.0 111.24 179.996 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -50.29 158.55 1.71 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 179.859 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.564 ' O ' ' NH2' ' A' ' 38' ' ' ARG . 7.9 tp -66.94 -41.87 88.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 117.644 0.722 . . . . 0.0 110.588 -179.22 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.448 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 80.4 tt0 -60.13 -19.68 54.72 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 -178.914 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 55.8 m -59.84 130.98 49.42 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.276 -0.57 . . . . 0.0 111.002 -179.238 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.565 ' CG ' ' NE2' ' B' ' 265' ' ' GLN . 74.2 m-20 -61.5 -32.65 72.69 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.907 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.416 HG13 ' CE2' ' A' ' 29' ' ' PHE . 46.6 mm -119.83 112.84 38.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.102 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.564 ' NH2' ' O ' ' A' ' 33' ' ' ILE . 74.0 mtt85 -98.95 131.16 45.22 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.579 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.421 HD12 HH11 ' A' ' 93' ' ' ARG . 91.8 mt -121.76 132.13 71.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.882 0.373 . . . . 0.0 110.711 -178.265 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -75.46 33.02 0.11 Allowed 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -177.664 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.4 HD13 ' NH2' ' A' ' 93' ' ' ARG . 88.5 mt -115.19 123.76 31.21 Favored Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 120.261 -0.575 . . . . 0.0 110.159 179.138 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.95 -7.21 19.68 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.291 1.994 . . . . 0.0 113.427 -178.986 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.9 m -87.26 1.24 6.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 119.791 -0.763 . . . . 0.0 109.129 178.69 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.4 p -96.29 138.39 21.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.262 178.533 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.7 t -75.22 173.36 10.93 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.592 0.71 . . . . 0.0 111.86 -178.348 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 43.6 mttp -64.13 -41.77 97.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.043 179.954 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.647 ' O ' ' N ' ' A' ' 49' ' ' CYS . 10.7 mm100 -109.72 -20.69 12.72 Favored 'General case' 0 C--N 1.334 -0.068 0 CA-C-O 120.766 0.317 . . . . 0.0 110.952 -179.691 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.1 t60 37.54 -77.81 0.0 OUTLIER 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.647 -179.862 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.647 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.65 135.31 45.76 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.331 0.586 . . . . 0.0 111.581 -179.337 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -126.02 131.83 52.12 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.157 179.844 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 99.2 mt -118.27 133.45 65.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.267 179.912 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.603 ' CD ' ' HE2' ' A' ' 61' ' ' HIS . 21.8 pt-20 -116.62 128.43 55.38 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.48 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.432 ' CD1' ' NE ' ' A' ' 5' ' ' ARG . 83.4 mt -107.53 114.92 47.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.506 -178.074 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.522 ' O ' ' N ' ' A' ' 56' ' ' GLN . 99.5 m-70 -113.28 144.7 42.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.983 179.894 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 54' ' ' HIS . 84.6 tt0 -39.62 -27.58 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -179.717 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.522 ' N ' ' O ' ' A' ' 54' ' ' HIS . 89.1 mt-30 -65.66 -68.99 0.32 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.534 178.798 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -161.25 -161.83 0.85 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.92 0.39 . . . . 0.0 111.073 179.23 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -111.35 125.15 53.55 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.781 179.42 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.7 mt -113.91 128.34 70.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.997 0.427 . . . . 0.0 111.39 -179.076 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.1 tp -98.19 128.35 44.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.928 -179.798 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.603 ' HE2' ' CD ' ' A' ' 52' ' ' GLU . 99.6 m-70 -116.3 138.11 51.59 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.711 -179.268 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -103.13 105.36 15.65 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 179.944 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -96.94 -4.41 40.01 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.93 178.988 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.65 100.83 11.1 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.044 179.355 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.2 m -87.64 -14.47 39.93 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.089 179.852 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.71 -41.19 15.35 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.499 -179.849 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -144.2 95.05 5.64 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.486 179.702 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -64.65 150.86 87.51 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 121.28 1.32 . . . . 0.0 112.988 -178.483 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.6 m -72.73 137.45 45.93 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.829 -179.705 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -97.2 140.19 32.05 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.506 -0.478 . . . . 0.0 109.842 178.997 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.457 ' O ' ' N ' ' A' ' 74' ' ' SER . 7.3 p -129.43 135.95 60.47 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.504 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.131 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 48.86 29.83 2.46 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -178.78 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 76.11 25.07 67.29 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-N 115.045 -0.98 . . . . 0.0 112.18 179.94 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 71' ' ' VAL . 12.9 t -137.37 139.16 40.59 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 117.383 0.591 . . . . 0.0 111.733 -179.874 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.4 m -73.57 138.32 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.055 179.985 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.6 pt -105.15 94.25 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 121.184 0.516 . . . . 0.0 111.274 179.611 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -65.33 -33.62 76.4 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.226 179.285 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -121.16 167.35 13.42 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.404 -179.129 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -60.32 142.81 99.03 Favored 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 121.842 1.695 . . . . 0.0 112.104 -179.304 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 24.2 m -137.04 137.57 46.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.094 0.473 . . . . 0.0 110.834 179.237 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -71.56 133.09 45.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.947 179.705 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 92.8 mt -85.74 139.59 31.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.219 0.533 . . . . 0.0 110.604 179.872 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -123.97 151.23 43.89 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.319 179.824 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.715 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 5.6 t60 -57.56 122.64 13.19 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.653 -179.67 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.47 -15.84 35.05 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 179.616 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -69.27 137.74 53.32 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.415 -179.766 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 40.6 t -110.17 130.56 63.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.964 0.411 . . . . 0.0 110.829 -179.239 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 88.0 mt -98.71 130.64 47.26 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 178.373 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 94.5 m -123.14 124.54 43.3 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 119.816 -0.754 . . . . 0.0 112.187 -178.866 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.496 ' O ' ' C ' ' A' ' 91' ' ' ILE . 92.1 mt -115.46 130.89 69.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.129 178.284 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.579 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 84.7 mt -15.68 98.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -178.059 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.453 ' OD1' ' NE ' ' B' ' 245' ' ' ARG . 23.7 m-20 85.23 -22.11 0.21 Allowed 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 177.617 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.579 ' NH2' ' O ' ' A' ' 91' ' ' ILE . 0.2 OUTLIER -130.59 144.1 51.19 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.985 -179.676 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 66.8 p -137.96 153.97 49.41 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.177 0.513 . . . . 0.0 110.072 -179.859 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -125.15 122.73 37.92 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.481 179.792 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -84.69 132.16 34.49 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.619 -179.627 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.619 ' CZ ' ' OD1' ' A' ' 99' ' ' ASN . 88.0 t80 -97.12 123.93 41.01 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.775 -179.525 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -134.49 127.52 31.58 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.673 179.954 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.715 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 70.1 m-20 . . . . . 0 N--CA 1.467 0.378 0 CA-C-O 120.916 0.389 . . . . 0.0 110.854 179.296 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo . . . . . 0 N--CA 1.491 1.331 0 CA-C-O 121.159 0.399 . . . . 0.0 112.899 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 78.6 t -61.48 139.4 20.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.184 -179.591 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 3.8 t . . . . . 0 C--N 1.33 -0.242 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.279 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo . . . . . 0 N--CA 1.498 1.745 0 CA-C-O 120.744 0.227 . . . . 0.0 112.455 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 28.4 m -69.07 -48.83 61.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.234 0.54 . . . . 0.0 110.194 178.557 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -60.15 -46.64 88.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.788 -178.62 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . 0.421 ' CD2' ' OD1' ' A' ' 92' ' ' ASP . 97.3 mt -63.92 -41.19 97.72 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.761 -0.375 . . . . 0.0 111.964 -178.59 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -66.32 -39.96 89.62 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.167 -179.635 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -62.18 -48.96 77.74 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.162 -0.615 . . . . 0.0 112.274 -178.754 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.497 ' HB2' HH11 ' A' ' 12' ' ' ARG . 3.9 ppt_? -65.72 -37.61 86.89 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.074 -178.515 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . 0.443 ' N ' ' HG3' ' B' ' 245' ' ' ARG . 36.7 ttmt -62.73 -40.44 97.22 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.519 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 50.5 m -65.73 -41.79 91.81 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.945 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -56.79 -39.47 74.16 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.934 179.486 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 58.1 t . . . . . 0 N--CA 1.452 -0.343 0 CA-C-O 121.079 0.466 . . . . 0.0 110.201 179.206 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . 0.532 ' OE2' ' CZ ' ' A' ' 12' ' ' ARG . 97.6 mt-10 . . . . . 0 CA--C 1.523 -0.086 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 58.2 mt -114.77 137.51 47.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.947 -179.865 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 48.8 t -124.43 133.95 68.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.883 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -93.01 117.3 29.91 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.768 -178.262 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -67.33 -44.88 78.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.623 179.411 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . 0.565 ' NE2' ' CG ' ' A' ' 36' ' ' ASP . 33.6 mt-30 -88.84 152.41 48.69 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.039 -178.957 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -62.22 141.36 87.75 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.44 2.093 . . . . 0.0 113.259 179.878 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 20.5 pt . . . . . 0 N--CA 1.463 0.209 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.827 179.026 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.7 p . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.852 0.358 . . . . 0.0 110.675 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.5 mtt85 -99.46 131.49 45.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.014 -179.731 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -135.66 144.71 46.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.343 179.27 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 83.2 mt -112.13 141.19 46.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.125 179.007 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 31.1 t -114.84 129.13 71.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.576 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.1 m -92.07 114.99 27.68 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -177.943 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.458 ' CD1' ' HG ' ' A' ' 94' ' ' SER . 96.7 mt -81.68 144.73 9.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.543 178.205 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.9 mttt -94.48 162.27 13.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.892 0.377 . . . . 0.0 110.436 179.221 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -57.89 -30.04 65.53 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.531 -178.969 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.2 p -76.28 -20.56 57.22 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.649 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.7 32.62 4.4 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.903 179.649 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.7 m -128.07 134.47 65.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.881 0.372 . . . . 0.0 110.85 179.399 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -71.45 139.01 49.48 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.321 179.276 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -127.08 -118.1 2.15 Favored Glycine 0 CA--C 1.536 1.345 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -179.89 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.02 147.7 43.7 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 121.951 1.768 . . . . 0.0 112.619 -179.331 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -111.52 153.54 26.06 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.779 179.801 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -122.45 94.01 48.06 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.199 -178.598 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.52 127.99 25.67 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.145 1.897 . . . . 0.0 111.601 179.426 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.9 mt -82.77 56.42 3.39 Favored 'General case' 0 CA--C 1.522 -0.134 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.949 -179.733 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 91.9 p -62.74 -16.16 56.41 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.028 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.4 mt -91.92 143.15 26.79 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 114.761 -1.108 . . . . 0.0 110.676 -179.794 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.9 m -69.1 -17.02 63.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.697 -179.303 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.2 m -134.61 137.52 43.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.048 -179.874 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.615 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.6 OUTLIER -130.82 124.23 30.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.012 178.554 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.529 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 52.4 tp -118.36 128.72 54.91 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.966 0.412 . . . . 0.0 112.03 -177.758 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.615 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 60.5 m-85 -103.49 124.25 48.4 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.951 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 176.35 -178.23 47.74 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 119.822 -1.18 . . . . 0.0 112.965 179.449 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.41 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 46.2 mtm180 -80.05 -28.53 39.22 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.807 0.337 . . . . 0.0 110.6 179.034 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -54.66 143.35 32.22 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 -178.985 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.3 mm -64.92 -43.17 96.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.177 0.513 . . . . 0.0 109.816 179.166 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -55.91 -20.3 15.36 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.086 -179.851 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 38.5 m -63.95 131.05 46.49 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.509 -179.918 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 37' ' ' ILE . 6.6 p-10 -59.47 -30.39 68.5 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.838 -178.956 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.535 ' N ' ' OD1' ' A' ' 36' ' ' ASP . 96.5 mt -126.14 121.43 59.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.528 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 77.1 ttt-85 -110.51 136.89 48.95 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.061 -178.377 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.482 ' C ' ' H ' ' A' ' 41' ' ' LEU . 82.9 mt -119.61 131.35 72.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.922 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -75.56 24.0 0.12 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.246 -179.1 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.482 ' H ' ' C ' ' A' ' 39' ' ' ILE . 24.6 mt -89.31 122.96 68.09 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.365 179.808 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.73 -14.86 30.17 Favored 'Trans proline' 0 N--CA 1.488 1.177 0 C-N-CA 121.783 1.655 . . . . 0.0 112.594 -179.72 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.1 m -93.65 3.41 8.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.087 179.913 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.41 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 25.0 t -89.44 137.02 22.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 120.441 -0.504 . . . . 0.0 109.945 179.069 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.3 m -68.61 171.98 6.87 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.568 0.699 . . . . 0.0 111.504 -179.596 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -63.4 -43.58 97.15 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.659 -179.802 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.623 ' O ' ' N ' ' A' ' 49' ' ' CYS . 89.9 mt-30 -116.94 -20.53 9.36 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.805 179.904 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.3 t60 36.21 -78.58 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 179.491 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.623 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -125.89 133.82 51.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.217 0.532 . . . . 0.0 112.194 -178.847 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -126.51 129.91 49.56 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.688 179.827 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.6 mt -113.71 132.91 61.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.984 0.421 . . . . 0.0 110.419 179.01 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.461 ' OE2' ' CE1' ' A' ' 54' ' ' HIS . 83.4 tt0 -118.08 125.35 50.14 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 178.62 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.438 HD11 HG21 ' A' ' 53' ' ' ILE . 93.4 mt -108.63 123.04 64.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.808 0.813 . . . . 0.0 112.855 -178.155 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.554 ' O ' ' N ' ' A' ' 56' ' ' GLN . 98.0 m-70 -115.85 139.05 50.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.258 -1.337 . . . . 0.0 109.285 179.143 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.482 ' C ' ' O ' ' A' ' 54' ' ' HIS . 83.5 tt0 -39.99 -26.25 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -179.666 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.554 ' N ' ' O ' ' A' ' 54' ' ' HIS . 91.5 mt-30 -64.46 -68.97 0.31 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.027 177.812 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -159.7 -161.89 0.96 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.578 179.81 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -118.41 131.79 56.27 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.517 179.99 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.0 mt -117.57 129.21 74.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-O 121.387 0.613 . . . . 0.0 111.727 -179.301 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 28.2 tp -98.68 127.31 44.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.338 -179.782 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -111.79 135.48 52.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.21 179.858 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 62.7 t-20 -94.77 106.99 19.01 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.42 179.995 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -99.38 -10.38 22.33 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 179.53 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.4 t -76.22 98.62 4.49 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.727 -179.565 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.9 p -80.71 -35.16 33.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.143 0.497 . . . . 0.0 109.768 178.671 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.5 m -65.16 -49.65 69.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.692 179.859 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -136.57 96.35 12.17 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.461 179.535 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -55.38 144.73 71.15 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.105 1.87 . . . . 0.0 112.082 -179.204 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.7 m -73.76 146.81 44.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.332 179.831 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -110.29 141.25 43.54 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.782 179.955 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 42.0 t -127.92 134.27 65.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.426 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.2 m120 52.54 30.53 8.6 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -179.447 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.65 25.47 69.85 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.74 179.792 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 58.3 m -136.52 138.48 41.38 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.452 -179.642 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 44.4 t -68.94 138.28 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.433 179.982 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.9 pt -116.19 85.88 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.202 179.502 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.524 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 15.4 p-10 -66.47 -26.57 67.25 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.538 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -114.04 159.54 35.83 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.333 179.7 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -66.75 149.45 83.61 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.772 2.315 . . . . 0.0 111.822 179.278 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.2 m -141.45 144.42 26.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.692 -179.427 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -71.68 130.72 41.85 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.281 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.9 mt -81.89 138.82 34.95 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.096 0.474 . . . . 0.0 111.93 -178.738 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -130.91 151.65 51.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.715 179.585 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.555 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 4.2 t60 -57.0 121.1 9.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.893 0.378 . . . . 0.0 111.145 -179.228 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.13 -17.28 19.68 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 179.48 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -71.4 134.68 46.83 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.269 0.557 . . . . 0.0 111.082 -179.784 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 68.1 t -111.02 133.86 55.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.713 -179.361 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 79.1 mt -103.58 133.4 47.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.366 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 84.8 m -121.59 131.24 54.01 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.789 0.804 . . . . 0.0 112.589 -178.53 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 76.5 mt -123.47 126.46 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 114.29 -1.323 . . . . 0.0 108.783 179.247 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 44.9 mm 43.42 -107.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.002 -179.253 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.504 ' HB3' ' HE ' ' B' ' 245' ' ' ARG . 45.7 t0 -114.89 16.59 17.22 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.943 0.402 . . . . 0.0 111.048 -179.795 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 17.4 mtp180 -130.78 148.22 52.54 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.067 179.4 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.458 ' HG ' ' CD1' ' A' ' 10' ' ' ILE . 19.4 p -138.64 157.35 46.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.966 0.412 . . . . 0.0 110.839 -179.23 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -124.0 121.62 35.73 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.563 179.086 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -80.2 131.67 35.74 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.306 -179.78 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -96.62 121.28 38.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.955 -179.865 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -121.49 122.87 40.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.118 -179.89 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.555 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 60.4 t-20 . . . . . 0 CA--C 1.521 -0.152 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.324 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo . . . . . 0 N--CA 1.494 1.532 0 CA-C-O 121.026 0.344 . . . . 0.0 112.38 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 4.4 p -101.72 129.5 52.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.945 179.381 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 53.2 t . . . . . 0 C--N 1.325 -0.462 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.143 -179.341 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo . . . . . 0 N--CA 1.498 1.753 0 CA-C-O 120.732 0.222 . . . . 0.0 112.589 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 96.3 m -73.5 -46.75 46.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.48 179.3 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . 0.413 ' CE2' ' HD2' ' B' ' 245' ' ' ARG . 72.2 t80 -59.91 -45.35 92.84 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.588 -179.123 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 93.9 mt -64.71 -39.25 93.33 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.018 0.437 . . . . 0.0 110.218 179.397 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -61.75 -42.83 99.48 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.339 -179.368 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -62.37 -40.67 97.21 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.231 179.903 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.504 ' HE ' ' HB3' ' A' ' 92' ' ' ASP . 77.6 mtp85 -60.84 -41.97 96.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.166 -179.943 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.22 -40.8 98.49 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 179.247 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 10.9 t -65.26 -46.71 79.44 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.855 178.448 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -60.12 -39.11 85.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.247 -179.549 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 45.3 t . . . . . 0 C--N 1.327 -0.398 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.291 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 . . . . . 0 N--CA 1.461 0.086 0 CA-C-O 120.706 0.289 . . . . 0.0 110.7 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 78.5 mt -101.89 137.58 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 178.312 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 64.6 t -126.64 134.3 66.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.79 -178.95 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -96.73 119.54 35.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.111 0.481 . . . . 0.0 111.231 -178.672 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -64.66 -40.66 95.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.454 179.532 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . 0.728 ' N ' HE21 ' B' ' 265' ' ' GLN . 0.0 OUTLIER -101.96 160.82 25.3 Favored Pre-proline 0 N--CA 1.464 0.247 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.431 -179.242 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -70.94 145.76 51.13 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 122.595 2.197 . . . . 0.0 113.221 -179.105 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.4 pt . . . . . 0 C--N 1.326 -0.434 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.197 178.86 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.7 p . . . . . 0 N--CA 1.452 -0.359 0 CA-C-O 121.282 0.563 . . . . 0.0 109.636 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.596 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 92.4 mtt-85 -88.17 131.49 34.71 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.951 -179.526 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.5 mtp180 -133.27 141.03 47.8 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 120.312 -0.555 . . . . 0.0 112.389 -179.274 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 40.0 tp -117.42 132.97 56.47 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.243 179.488 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 53.0 t -108.37 131.07 59.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.897 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 m -93.71 117.45 30.1 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.346 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.489 ' CD1' ' OD1' ' A' ' 16' ' ' ASP . 48.3 mm -82.27 143.28 12.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.645 179.649 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -90.97 160.48 15.62 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 177.701 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.409 ' CG ' ' NH1' ' A' ' 93' ' ' ARG . 83.4 mtm180 -57.0 -24.48 53.93 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.962 -178.442 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 68.6 p -83.9 -8.26 59.23 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.922 179.754 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.21 35.12 9.03 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 179.887 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 32.2 t -117.3 132.49 66.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 -179.997 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.489 ' OD1' ' CD1' ' A' ' 10' ' ' ILE . 92.4 m-20 -70.04 133.46 47.23 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.656 -0.418 . . . . 0.0 109.952 179.762 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -126.03 -122.26 2.57 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.593 -179.547 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -72.91 145.92 41.18 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.002 1.801 . . . . 0.0 112.575 -179.036 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 54.5 m170 -107.83 143.44 36.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.132 0.491 . . . . 0.0 111.126 -179.331 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -115.04 93.96 36.8 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.069 -179.207 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -56.79 124.4 16.15 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 121.896 1.731 . . . . 0.0 111.681 179.136 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.7 mt -87.79 41.73 1.01 Allowed 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.384 -179.781 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.8 p -64.7 -20.44 66.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.788 179.594 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.8 mt -74.04 142.09 45.73 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.568 179.778 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 73.8 p -61.42 -25.15 67.02 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.362 -179.21 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 45.3 m -134.69 134.33 40.97 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.221 -0.592 . . . . 0.0 111.534 179.917 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.692 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -128.37 120.2 26.51 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.069 178.345 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.522 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 43.4 tp -120.03 124.96 47.18 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.999 -177.02 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.692 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 38.8 m-85 -101.37 140.83 35.12 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.23 179.282 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 158.67 -173.58 35.67 Favored Glycine 0 N--CA 1.464 0.536 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.156 178.269 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.63 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 72.2 mtm-85 -83.29 -30.74 27.33 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.876 0.37 . . . . 0.0 110.21 179.895 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.561 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -56.29 152.08 21.15 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 121.126 -0.559 . . . . 0.0 111.728 -178.26 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.1 tp -66.7 -40.51 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.677 179.958 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -53.69 -21.39 6.92 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.293 179.972 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.561 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 4.2 m -63.88 115.78 5.17 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.118 -179.974 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.594 ' OD1' ' N ' ' A' ' 37' ' ' ILE . 39.2 p-10 -50.97 -24.59 3.79 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.758 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.594 ' N ' ' OD1' ' A' ' 36' ' ' ASP . 94.2 mt -130.67 123.49 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.223 178.062 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.427 HH12 ' HA ' ' B' ' 264' ' ' LYS . 88.2 mtm-85 -103.97 134.66 46.88 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.4 -0.52 . . . . 0.0 109.801 -179.434 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.421 ' C ' ' H ' ' A' ' 41' ' ' LEU . 98.1 mt -117.91 130.54 72.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.064 0.459 . . . . 0.0 109.796 -179.809 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -79.23 30.37 0.22 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.201 -179.043 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.421 ' H ' ' C ' ' A' ' 39' ' ' ILE . 33.9 mt -94.8 123.24 58.44 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.476 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.99 -10.76 26.59 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 121.856 1.704 . . . . 0.0 112.047 -179.386 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.6 m -100.51 8.31 8.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.771 -179.211 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.63 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 42.2 t -100.63 136.75 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.459 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.7 m -67.66 169.47 9.4 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.317 0.579 . . . . 0.0 111.478 -179.179 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -62.26 -40.35 95.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.455 -179.474 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.697 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.1 mt-30 -114.59 -11.19 12.42 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 123.348 0.405 . . . . 0.0 111.357 -179.933 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.8 t60 31.86 -73.45 0.0 OUTLIER 'General case' 0 C--O 1.237 0.423 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 179.649 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.697 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -134.95 139.5 44.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.284 0.564 . . . . 0.0 112.324 -178.621 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -125.42 128.68 48.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.049 179.323 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 94.6 mt -115.45 133.3 62.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.016 -179.552 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -115.5 127.25 55.17 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.859 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.423 HG21 HD13 ' A' ' 53' ' ' ILE . 75.9 mt -108.36 111.99 38.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.95 -179.386 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.538 ' O ' ' N ' ' A' ' 56' ' ' GLN . 82.3 m-70 -110.8 143.94 40.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.541 -179.598 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 54' ' ' HIS . 96.9 mt-10 -41.06 -24.84 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.532 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.538 ' N ' ' O ' ' A' ' 54' ' ' HIS . 94.2 mm-40 -68.8 -68.8 0.37 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.463 178.712 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.554 ' CB ' ' HE ' ' A' ' 81' ' ' ARG . 5.1 tp10 -159.17 -167.76 2.16 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.328 179.895 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.433 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -110.67 125.33 53.34 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.937 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.14 129.54 71.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.353 0.596 . . . . 0.0 112.391 -177.757 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.416 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 49.3 tp -94.72 123.45 38.17 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.38 -179.431 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -111.68 136.47 50.87 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.362 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.41 HD22 ' HA ' ' A' ' 68' ' ' PRO . 48.8 t30 -97.94 105.41 17.55 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.734 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -96.08 -7.32 36.44 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.682 178.976 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.555 ' HG ' ' H ' ' A' ' 67' ' ' ASN . 10.1 t -79.46 100.8 7.85 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.279 178.798 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.0 m -84.74 -17.77 37.26 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.084 0.469 . . . . 0.0 110.025 179.577 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.05 -36.61 15.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.602 -179.845 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.555 ' H ' ' HG ' ' A' ' 64' ' ' SER . 79.5 m-20 -144.12 95.24 5.64 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.398 179.765 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.41 ' HA ' HD22 ' A' ' 62' ' ' ASN . 31.5 Cg_exo -57.96 146.78 85.49 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.128 1.885 . . . . 0.0 112.658 -179.098 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.5 m -70.71 134.89 47.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.278 178.792 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -99.71 139.77 34.89 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.57 179.989 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 31.4 t -130.49 135.93 59.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 178.706 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 53.42 31.72 12.63 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -178.613 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.37 29.5 70.04 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.152 -179.866 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 81.1 p -137.63 130.5 30.16 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 120.446 -0.502 . . . . 0.0 111.999 -179.283 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.4 t -63.7 141.43 18.16 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.935 179.581 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.584 ' CG2' ' O ' ' A' ' 78' ' ' GLU . 96.3 mt -112.14 111.15 34.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.352 179.511 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -76.31 -34.34 59.04 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.801 179.579 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.584 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.1 OUTLIER -131.51 178.13 1.9 Allowed Pre-proline 0 N--CA 1.468 0.445 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.874 -179.734 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 35.5 Cg_exo -57.13 141.5 94.31 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 122.522 2.148 . . . . 0.0 112.739 -179.079 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.4 t -133.19 138.07 52.17 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.132 179.75 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.554 ' HE ' ' CB ' ' A' ' 57' ' ' GLU . 73.3 ttt180 -74.62 131.46 40.94 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.633 179.28 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.2 mt -87.25 140.97 29.01 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.16 0.505 . . . . 0.0 112.272 -178.645 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -134.4 156.12 49.09 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.406 179.59 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.58 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 6.3 t60 -56.77 120.17 7.41 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.868 0.366 . . . . 0.0 111.44 -179.359 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.33 -21.23 22.25 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.52 179.316 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -65.84 135.54 54.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.254 0.55 . . . . 0.0 110.341 -179.788 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.2 t -113.37 133.79 58.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.233 -178.213 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.7 mt -98.35 130.17 47.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.678 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 55.1 m -120.02 124.64 46.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.531 0.682 . . . . 0.0 112.26 -178.818 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 93.3 mt -115.54 124.0 71.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.091 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 27.5 mm 43.89 -106.49 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -178.812 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.608 ' OD1' ' NH2' ' B' ' 245' ' ' ARG . 40.6 p-10 -114.93 12.73 16.9 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.076 0.465 . . . . 0.0 110.473 179.273 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.409 ' NH1' ' CG ' ' A' ' 12' ' ' ARG . 6.1 ttp180 -120.39 143.62 48.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.577 179.732 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 38.2 t -137.7 152.83 49.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.353 0.596 . . . . 0.0 111.371 -178.76 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -120.42 120.73 36.8 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.803 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -84.04 131.69 34.79 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.363 -178.562 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.596 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 84.0 t80 -94.26 124.2 38.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.65 179.813 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -129.92 123.26 30.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.009 0.433 . . . . 0.0 111.638 -179.702 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.58 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 65.0 t-20 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.841 179.121 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 N--CA 1.487 1.097 0 CA-C-O 121.283 0.451 . . . . 0.0 112.889 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 31.3 t -59.63 134.78 24.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.794 -179.672 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 8.6 t . . . . . 0 C--N 1.328 -0.359 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -179.861 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo . . . . . 0 N--CA 1.492 1.428 0 CA-C-O 120.444 0.102 . . . . 0.0 112.165 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 76.0 m -72.88 -44.46 61.28 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 178.337 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . 0.426 ' CE2' ' HD2' ' B' ' 245' ' ' ARG . 63.3 t80 -58.75 -47.64 83.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.29 -179.465 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 89.2 mt -64.59 -42.49 95.55 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -179.386 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -65.52 -38.72 90.49 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.521 -0.472 . . . . 0.0 111.136 -179.08 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -61.77 -44.08 97.59 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.855 179.78 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.608 ' NH2' ' OD1' ' A' ' 92' ' ' ASP . 82.2 mtp180 -63.16 -37.66 88.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.089 -179.028 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.82 -39.4 91.65 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.359 -0.537 . . . . 0.0 109.99 179.225 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 61.9 m -67.49 -43.79 80.1 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.571 0.701 . . . . 0.0 109.516 178.274 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -60.82 -37.35 81.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.699 -179.863 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 50.0 t . . . . . 0 N--CA 1.447 -0.587 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.185 179.61 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 121.0 0.429 . . . . 0.0 110.408 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 74.0 mt -112.93 137.64 45.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.684 179.978 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . 0.402 ' CG1' ' NH2' ' A' ' 38' ' ' ARG . 41.3 t -126.86 134.15 66.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.906 0.384 . . . . 0.0 110.579 179.891 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -97.55 122.26 40.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.979 0.418 . . . . 0.0 111.961 -178.528 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . 0.427 ' HA ' HH12 ' A' ' 38' ' ' ARG . 87.4 tttt -62.56 -44.9 95.2 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.663 179.578 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -99.52 164.97 15.59 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.01 179.977 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.72 153.13 51.63 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.392 2.062 . . . . 0.0 112.099 179.567 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 36.4 pt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.089 -178.576 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.611 ' HG1' ' H ' ' A' ' 5' ' ' ARG . 51.0 p . . . . . 0 CA--C 1.522 -0.127 0 CA-C-O 120.902 0.382 . . . . 0.0 110.858 . . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.611 ' H ' ' HG1' ' A' ' 4' ' ' THR . 99.2 mtt180 -99.52 129.73 45.71 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.556 -178.78 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -129.23 143.08 50.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.495 -179.726 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 90.9 mt -113.29 136.37 52.82 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.697 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 50.0 t -112.94 131.92 63.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.839 -0.345 . . . . 0.0 110.303 -179.384 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.2 m -90.07 115.88 27.67 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 -177.722 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.413 HD11 HG23 ' A' ' 10' ' ' ILE . 96.8 mt -85.09 142.22 13.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.292 178.153 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -91.42 159.98 15.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.97 0.414 . . . . 0.0 110.515 179.36 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 88.9 mtm180 -58.05 -29.53 65.45 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.792 -179.229 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.1 p -76.75 -17.3 59.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.86 0.362 . . . . 0.0 110.544 179.471 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.93 32.75 5.5 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -179.679 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.4 t -121.35 132.46 70.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.054 0.454 . . . . 0.0 111.106 -179.994 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -78.23 138.44 38.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.667 178.883 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.7 -115.72 1.67 Allowed Glycine 0 CA--C 1.533 1.162 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.467 179.936 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.11 148.56 56.63 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 121.841 1.694 . . . . 0.0 112.433 -179.392 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.467 ' CD2' ' C ' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -113.13 158.05 20.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.016 0.436 . . . . 0.0 109.921 179.701 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -120.53 101.31 46.32 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.164 -179.044 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -75.2 131.41 14.04 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.016 1.811 . . . . 0.0 111.891 -179.617 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 83.8 mt -86.71 85.32 7.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.158 0.504 . . . . 0.0 112.043 -178.486 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 92.6 p -89.01 -9.68 50.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.194 178.058 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 47.2 mt -104.45 148.12 26.81 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.071 -179.816 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.5 m -70.83 -16.23 62.7 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.498 -179.463 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.421 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 55.8 m -131.31 134.11 46.03 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.752 -179.916 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.6 t -129.63 120.54 25.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.955 178.179 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.431 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 35.3 tp -116.4 129.82 56.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.887 -179.078 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.528 ' O ' ' O ' ' A' ' 47' ' ' GLN . 9.8 m-85 -108.95 139.11 44.26 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.697 179.904 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.94 -178.71 29.05 Favored Glycine 0 N--CA 1.47 0.925 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.161 178.316 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 46.9 mtm180 -67.14 -33.29 75.12 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 179.381 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.54 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -46.78 131.8 12.29 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 -178.812 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.437 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 9.3 tp -64.79 -42.03 93.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 O-C-N 122.434 -0.451 . . . . 0.0 110.024 179.387 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.437 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 7.9 pt-20 -56.4 -13.01 1.93 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.228 179.292 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.54 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 31.3 m -70.16 139.15 52.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.595 -179.301 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.431 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 57.2 m-20 -63.77 -34.74 78.58 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.329 -179.505 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.423 HG22 HD12 ' A' ' 37' ' ' ILE . 40.6 mm -122.22 112.82 36.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 177.978 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 15.9 ttp180 -101.83 130.88 48.38 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.596 -178.636 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.431 ' C ' ' H ' ' A' ' 41' ' ' LEU . 93.2 mt -118.68 131.85 70.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.157 -179.395 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -76.03 32.45 0.12 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.606 -179.528 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.686 ' CD1' HH21 ' A' ' 93' ' ' ARG . 20.3 mt -95.55 118.46 66.14 Favored Pre-proline 0 CA--C 1.534 0.355 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.507 179.499 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -73.36 -11.4 24.7 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 121.908 1.739 . . . . 0.0 111.985 -179.922 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.1 m -95.39 5.26 8.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.207 179.431 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.0 t -98.69 139.84 19.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.577 -179.464 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.406 ' OG ' ' OG ' ' A' ' 64' ' ' SER . 75.3 m -68.73 175.18 3.71 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.682 0.753 . . . . 0.0 111.315 -179.589 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -65.12 -43.17 92.82 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.958 -179.699 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.616 ' O ' ' N ' ' A' ' 49' ' ' CYS . 81.9 mt-30 -113.77 -12.72 12.72 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.542 -179.682 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.9 t60 38.7 -76.89 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 178.873 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.616 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -135.58 140.32 44.56 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.252 0.548 . . . . 0.0 111.812 -178.657 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -125.51 132.65 52.58 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.788 179.891 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.5 mt -116.42 134.1 60.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.918 179.49 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.438 ' CG ' ' NE2' ' A' ' 54' ' ' HIS . 47.2 tp10 -119.96 128.6 53.73 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.369 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.463 ' CG2' ' NH1' ' A' ' 5' ' ' ARG . 96.8 mt -105.57 123.54 60.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.591 0.71 . . . . 0.0 112.159 -178.678 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.569 ' O ' ' N ' ' A' ' 56' ' ' GLN . 3.3 m-70 -120.54 139.9 52.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.452 -179.752 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.467 ' C ' ' O ' ' A' ' 54' ' ' HIS . 83.9 tt0 -39.3 -25.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.73 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' A' ' 54' ' ' HIS . 67.9 tp60 -69.11 -68.2 0.42 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.096 178.301 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.443 ' HA ' HH22 ' A' ' 5' ' ' ARG . 8.8 pt-20 -160.03 -157.52 0.56 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.708 179.64 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.73 132.3 55.87 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.505 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.448 ' CG2' ' NE2' ' A' ' 61' ' ' HIS . 45.5 mm -111.08 127.54 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 121.051 -0.26 . . . . 0.0 111.636 -178.65 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 28.8 tp -103.51 125.3 49.99 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.955 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.448 ' NE2' ' CG2' ' A' ' 59' ' ' ILE . 97.9 m-70 -118.37 139.49 51.3 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.486 -179.211 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -102.7 107.86 18.91 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.596 179.741 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -94.83 -7.8 39.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.66 179.142 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.406 ' OG ' ' OG ' ' A' ' 45' ' ' SER . 0.1 OUTLIER -86.09 99.7 11.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.856 0.36 . . . . 0.0 110.878 -179.861 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.6 p -77.39 -32.91 55.15 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.885 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.7 m -63.55 -49.35 73.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.221 -179.405 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -136.55 91.92 15.6 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.957 -179.626 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.77 143.55 69.99 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.157 1.904 . . . . 0.0 112.568 -179.599 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.8 m -74.71 138.07 42.51 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.839 179.246 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -100.12 140.48 34.28 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.271 179.636 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.453 ' O ' ' N ' ' A' ' 74' ' ' SER . 5.1 p -131.59 136.42 57.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 178.939 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 48.35 31.98 3.0 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -178.675 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.84 29.48 63.05 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.437 -179.831 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.453 ' N ' ' O ' ' A' ' 71' ' ' VAL . 19.5 m -140.34 133.5 29.56 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 120.58 -0.448 . . . . 0.0 112.112 -179.479 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.0 t -70.43 139.06 20.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.475 179.152 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.7 pt -112.26 94.37 3.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.117 0.484 . . . . 0.0 111.266 179.814 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -65.22 -29.08 69.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.974 178.956 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.0 176.1 2.85 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.392 -179.979 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -59.93 144.08 99.51 Favored 'Trans proline' 0 N--CA 1.5 1.899 0 C-N-CA 122.515 2.143 . . . . 0.0 112.591 -179.776 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.1 p -136.7 141.26 41.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.521 179.679 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -81.02 130.21 34.91 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.473 179.377 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.5 mt -83.61 141.3 31.64 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.039 0.447 . . . . 0.0 111.642 -179.791 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -130.75 151.16 51.49 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.909 179.171 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.468 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 4.3 t60 -52.12 118.66 3.65 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.001 0.429 . . . . 0.0 111.587 -178.637 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.03 -13.57 37.53 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 179.455 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -67.99 135.37 52.23 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.19 179.831 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.4 t -112.44 133.29 58.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.81 -178.205 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 92.8 mt -104.53 132.35 51.36 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.643 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 58.8 m -119.39 128.0 53.66 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.325 -0.55 . . . . 0.0 112.112 -178.766 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 98.2 mt -122.08 124.83 72.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.846 178.588 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 26.0 mm 41.45 -114.99 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 121.068 -0.253 . . . . 0.0 110.629 -178.837 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -101.56 12.94 36.38 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.767 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.686 HH21 ' CD1' ' A' ' 41' ' ' LEU . 11.4 mtm180 -131.46 149.07 52.67 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.382 -179.497 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 71.7 m -135.49 154.15 51.51 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.008 0.432 . . . . 0.0 111.337 -179.631 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -120.49 120.52 36.12 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.539 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 78.1 mtp85 -85.22 136.79 33.37 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 120.308 -0.557 . . . . 0.0 111.059 -179.238 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 92.2 t80 -96.5 118.81 33.79 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.402 -179.625 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -122.7 122.95 40.0 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.755 0.312 . . . . 0.0 111.0 179.549 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.468 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 52.7 t-20 . . . . . 0 C--O 1.231 0.097 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.717 179.733 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 N--CA 1.49 1.294 0 N-CA-C 113.652 0.597 . . . . 0.0 113.652 . . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -68.48 140.27 19.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.648 -179.74 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 19.4 t . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.734 -179.858 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo . . . . . 0 N--CA 1.498 1.775 0 N-CA-C 113.431 0.512 . . . . 0.0 113.431 . . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 59.5 m -73.9 -43.51 58.24 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.18 0.514 . . . . 0.0 109.698 178.358 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -58.93 -45.81 89.49 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.558 -179.243 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 91.1 mt -64.77 -40.87 95.99 Favored 'General case' 0 CA--C 1.521 -0.161 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.192 -179.429 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -59.96 -40.72 89.99 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.05 -179.638 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 62.0 ttp180 -62.39 -43.32 99.11 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.792 0.33 . . . . 0.0 110.794 179.786 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.594 ' NH1' ' OE1' ' B' ' 248' ' ' GLN . 1.9 mpt_? -59.32 -43.73 92.64 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.111 -179.307 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.7 -40.96 98.77 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.838 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 65.6 m -64.38 -45.21 88.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.411 0.624 . . . . 0.0 109.327 178.194 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . 0.594 ' OE1' ' NH1' ' B' ' 245' ' ' ARG . 80.4 mt-30 -60.36 -37.38 80.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.116 -179.81 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 48.7 t . . . . . 0 C--N 1.328 -0.364 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.325 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . 0.498 ' OE1' ' NH2' ' A' ' 93' ' ' ARG . 93.6 mt-10 . . . . . 0 N--CA 1.463 0.186 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 . . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 81.0 mt -109.77 131.97 59.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.194 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 40.4 t -124.06 132.67 70.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.348 -179.807 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -94.42 117.23 29.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.104 0.478 . . . . 0.0 111.108 -178.509 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -67.87 -46.59 71.28 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.513 179.949 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.17 163.43 23.44 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.223 -178.96 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -60.33 149.59 85.0 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.177 1.918 . . . . 0.0 112.031 179.857 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.3 pt . . . . . 0 C--N 1.328 -0.344 0 CA-C-O 121.485 0.66 . . . . 0.0 111.886 -178.396 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 CA--C 1.517 -0.29 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.422 ' HG2' ' HH ' ' A' ' 97' ' ' TYR . 87.2 mtm-85 -93.5 111.3 22.94 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.098 0.475 . . . . 0.0 110.392 -179.372 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.747 ' NH2' ' HD1' ' A' ' 19' ' ' HIS . 79.5 ttt180 -127.44 131.22 50.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.184 -179.776 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 80.0 mt -110.12 135.64 50.6 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.832 179.952 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.506 ' CG2' ' NH2' ' A' ' 96' ' ' ARG . 89.0 t -106.74 120.38 57.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.479 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.509 ' OG1' ' O ' ' A' ' 18' ' ' PRO . 70.0 p -77.45 140.81 39.91 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.576 0.703 . . . . 0.0 110.99 -179.05 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 51.0 mm -103.76 130.18 54.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.619 -179.791 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.44 ' HA ' HH12 ' A' ' 93' ' ' ARG . 95.9 mttt -83.98 154.99 23.01 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.889 178.001 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.528 HH22 ' CB ' ' B' ' 248' ' ' GLN . 75.8 mtp180 -56.61 -34.3 67.09 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.532 -179.214 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.43 ' HG ' HG12 ' B' ' 249' ' ' VAL . 67.4 m -76.76 -6.13 50.98 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.428 179.093 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.32 32.09 10.92 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.529 179.482 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.0 t -113.53 132.25 62.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.794 0.331 . . . . 0.0 110.639 -179.998 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -73.13 136.28 44.81 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.503 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -130.75 -115.98 1.78 Allowed Glycine 0 CA--C 1.534 1.279 0 C-N-CA 120.18 -1.009 . . . . 0.0 112.886 -178.855 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.509 ' O ' ' OG1' ' A' ' 9' ' ' THR . 61.2 Cg_endo -70.81 143.18 45.1 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 122.24 1.96 . . . . 0.0 112.937 -177.952 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.747 ' HD1' ' NH2' ' A' ' 6' ' ' ARG . 57.4 m170 -110.29 123.08 49.15 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.446 179.591 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -98.04 109.07 50.1 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.907 -179.513 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -79.03 139.09 14.95 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 121.344 1.363 . . . . 0.0 111.707 179.373 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.426 ' CD2' ' SG ' ' A' ' 27' ' ' CYS . 74.3 mt -91.66 50.13 1.67 Allowed 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.205 -178.967 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.8 t -63.82 -17.44 63.12 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 119.45 -0.9 . . . . 0.0 108.692 178.968 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 46.2 mt -78.65 138.45 38.32 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.875 179.951 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.15 -23.05 65.27 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.608 -179.274 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 94.5 m -133.78 134.91 43.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.561 179.147 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.426 ' SG ' ' CD2' ' A' ' 22' ' ' LEU . 6.1 t -124.37 118.43 26.71 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.536 179.008 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 44.4 tp -115.49 131.63 56.87 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.224 0.535 . . . . 0.0 111.78 -178.421 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.543 ' O ' ' O ' ' A' ' 47' ' ' GLN . 2.3 m-85 -111.2 138.96 46.99 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.572 179.865 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 150.85 179.21 26.4 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.539 178.68 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 45.7 mtm180 -70.22 -33.04 71.19 Favored 'General case' 0 C--O 1.227 -0.123 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 179.795 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.616 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -51.32 148.05 9.21 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.193 -179.065 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.406 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 11.0 tp -67.5 -39.72 83.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.217 -0.593 . . . . 0.0 109.508 179.54 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.406 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 98.4 mt-10 -53.06 -21.55 4.79 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.261 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.616 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 48.3 m -55.84 118.51 4.66 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.706 -179.597 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -59.72 -32.79 70.86 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -179.924 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 91.1 mt -123.5 120.96 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 176.256 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -109.04 135.33 50.38 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.949 -177.326 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.45 ' C ' ' H ' ' A' ' 41' ' ' LEU . 95.1 mt -119.87 130.27 74.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.618 -179.652 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -75.17 25.67 0.1 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.473 -179.099 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.45 ' H ' ' C ' ' A' ' 39' ' ' ILE . 24.3 mt -88.9 123.26 67.97 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.184 -179.915 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -73.28 -10.15 23.87 Favored 'Trans proline' 0 N--CA 1.49 1.285 0 C-N-CA 121.877 1.718 . . . . 0.0 112.548 179.714 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.0 m -97.97 8.26 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.114 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.555 179.442 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 25.5 t -101.26 139.56 22.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.449 179.068 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.1 m -74.11 171.85 12.8 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.061 0.458 . . . . 0.0 111.444 -178.974 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.6 mttp -61.37 -42.46 98.75 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.245 -178.778 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.62 ' O ' ' N ' ' A' ' 49' ' ' CYS . 95.5 mt-30 -112.81 -15.96 12.83 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.575 0.226 . . . . 0.0 111.162 -179.163 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 18.5 t60 37.25 -75.64 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 179.071 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.62 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.76 137.82 48.34 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.266 0.555 . . . . 0.0 111.366 -177.661 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -129.71 134.05 47.41 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.156 -179.983 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.4 mt -118.34 135.57 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.682 -179.688 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -112.78 127.84 56.26 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.638 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.4 mm -100.55 125.76 54.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 119.674 -0.81 . . . . 0.0 110.712 -179.668 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.456 ' O ' ' N ' ' A' ' 56' ' ' GLN . 94.7 m-70 -130.35 136.22 48.87 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.307 179.806 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 54' ' ' HIS . 42.7 tt0 -40.74 -28.85 0.08 Allowed 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.217 -0.593 . . . . 0.0 109.845 -179.272 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.456 ' N ' ' O ' ' A' ' 54' ' ' HIS . 55.0 tt0 -65.99 -68.28 0.38 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.301 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -158.37 -164.55 1.5 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.801 179.737 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -118.3 135.13 54.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.983 0.42 . . . . 0.0 110.394 179.775 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.05 130.27 74.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.564 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 50.1 tp -93.17 126.69 38.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.546 178.923 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -113.91 134.32 54.89 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.236 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 31.5 t30 -97.59 104.27 16.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.955 -179.481 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -96.44 -9.69 29.22 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.677 178.86 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.2 m -72.19 98.17 2.1 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.693 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.5 p -77.34 -36.1 54.15 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.705 0.765 . . . . 0.0 109.231 178.644 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.8 m -65.23 -48.57 72.83 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.387 -1.279 . . . . 0.0 110.78 -179.147 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -142.04 100.76 5.87 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.201 -179.128 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.18 145.75 85.11 Favored 'Trans proline' 0 N--CA 1.5 1.872 0 C-N-CA 122.022 1.815 . . . . 0.0 111.858 -179.564 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.3 m -72.49 141.87 48.56 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.199 0.523 . . . . 0.0 110.548 -179.642 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -101.0 141.61 33.64 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.805 -179.606 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.5 t -131.27 136.52 57.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 177.25 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 54.04 31.41 13.6 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -178.795 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.85 24.01 76.83 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.004 179.65 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 44.1 t -134.99 137.26 42.85 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.325 0.583 . . . . 0.0 111.527 -179.737 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.3 t -68.04 139.87 20.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.076 -179.544 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.585 ' CG2' ' O ' ' A' ' 78' ' ' GLU . 95.9 mt -113.88 116.77 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.986 179.407 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -90.74 -24.15 20.47 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.712 179.054 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.585 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.2 OUTLIER -128.9 168.18 16.91 Favored Pre-proline 0 C--O 1.222 -0.388 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.879 -178.669 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -66.28 148.02 84.09 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 122.463 2.109 . . . . 0.0 112.7 -179.941 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.1 m -141.18 151.93 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.164 179.976 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -78.53 129.23 34.6 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.485 179.345 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.9 mt -82.42 140.56 33.37 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.931 0.396 . . . . 0.0 110.736 -179.114 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -129.92 151.94 49.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.552 179.745 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.447 ' C ' ' CD2' ' A' ' 84' ' ' HIS . 7.5 t60 -56.5 119.98 6.96 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.165 -178.89 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.17 -18.13 23.79 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 121.155 -0.545 . . . . 0.0 111.767 179.128 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -69.51 133.23 47.44 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.331 179.912 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.0 t -107.76 136.9 41.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.45 -178.6 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.463 ' O ' ' OG ' ' A' ' 94' ' ' SER . 95.3 mt -103.07 129.1 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 178.167 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 96.2 m -120.33 127.32 52.23 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 119.913 -0.715 . . . . 0.0 112.025 -178.532 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.566 ' N ' ' O ' ' A' ' 93' ' ' ARG . 90.7 mt -116.5 134.86 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 CA-C-N 115.023 -0.989 . . . . 0.0 108.961 178.229 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.507 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 47.1 mt -29.13 97.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.415 -178.807 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.507 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 1.4 m-20 92.05 -22.4 0.08 Allowed 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 112.872 0.694 . . . . 0.0 112.872 178.047 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.721 HH21 ' CD1' ' B' ' 261' ' ' ILE . 25.2 mmm180 -131.04 143.73 50.92 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.17 -179.734 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 88' ' ' ILE . 43.2 t -138.38 152.25 48.24 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.975 0.417 . . . . 0.0 110.421 -179.901 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.408 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 71.4 m-85 -127.26 123.36 36.29 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.353 179.659 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.506 ' NH2' ' CG2' ' A' ' 8' ' ' VAL . 38.3 ttp-105 -90.31 135.58 33.59 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.487 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.422 ' HH ' ' HG2' ' A' ' 5' ' ' ARG . 81.4 t80 -98.93 127.89 44.96 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -178.489 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -134.0 120.68 20.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.28 179.552 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.44 ' OD1' ' ND1' ' A' ' 84' ' ' HIS . 43.1 p-10 . . . . . 0 C--N 1.332 -0.168 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.338 -179.949 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo . . . . . 0 N--CA 1.489 1.213 0 N-CA-C 113.936 0.706 . . . . 0.0 113.936 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.19 139.62 20.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.7 179.854 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 4.0 t . . . . . 0 C--N 1.323 -0.582 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.569 -178.575 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo . . . . . 0 N--CA 1.496 1.646 0 N-CA-C 112.735 0.244 . . . . 0.0 112.735 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 2.8 m -74.78 -43.65 53.66 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 177.898 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . 0.57 ' CZ ' ' NH2' ' B' ' 245' ' ' ARG . 79.0 t80 -58.36 -46.91 85.39 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.499 -179.374 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 95.9 mt -67.78 -39.3 84.07 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.058 179.384 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 73.3 tt0 -61.07 -41.56 96.86 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.539 179.906 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . 0.625 ' NH1' ' NE2' ' B' ' 248' ' ' GLN . 78.4 ttt-85 -64.12 -40.98 97.36 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.245 0.545 . . . . 0.0 109.653 179.538 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.57 ' NH2' ' CZ ' ' B' ' 241' ' ' PHE . 10.1 tpp180 -57.33 -42.7 82.42 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.054 -179.525 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.48 -41.45 98.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.445 179.824 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 47.1 t -63.27 -45.07 93.2 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.468 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . 0.625 ' NE2' ' NH1' ' B' ' 244' ' ' ARG . 84.6 mt-30 -60.67 -32.53 71.73 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.473 179.655 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . 0.43 HG12 ' HG ' ' A' ' 13' ' ' SER . 72.5 t . . . . . 0 N--CA 1.451 -0.381 0 C-N-CA 119.977 -0.689 . . . . 0.0 109.477 179.52 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 . . . . . 0 N--CA 1.467 0.389 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . 0.721 ' CD1' HH21 ' A' ' 93' ' ' ARG . 66.0 mt -112.97 133.93 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.254 179.888 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 45.9 t -124.18 132.63 71.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.743 178.918 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -97.13 118.66 34.04 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.377 0.608 . . . . 0.0 111.909 -178.131 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -62.41 -44.19 97.02 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.767 178.813 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -84.55 162.31 51.13 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.366 -179.809 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -65.59 144.96 80.69 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.095 1.863 . . . . 0.0 112.44 179.9 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.536 0.435 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.551 -179.896 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 72.3 p . . . . . 0 C--O 1.234 0.265 0 CA-C-O 120.914 0.388 . . . . 0.0 110.446 . . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.8 mtt85 -88.57 132.0 34.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.554 179.718 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 19.5 ptp180 -139.02 148.67 43.72 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 120.029 -0.668 . . . . 0.0 111.717 179.877 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 67.1 mt -115.26 144.8 43.18 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.766 179.676 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.6 t -117.37 124.83 73.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.475 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.1 m -73.73 138.12 44.44 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.927 0.394 . . . . 0.0 111.846 -179.079 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.426 HD11 HG22 ' A' ' 10' ' ' ILE . 78.8 mt -111.31 137.11 45.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.377 178.079 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -92.76 155.11 17.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.663 179.868 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.825 HH11 HH11 ' B' ' 245' ' ' ARG . 90.6 mtm180 -58.1 -23.73 55.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.505 -179.126 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.8 p -81.97 -10.15 59.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.1 0.476 . . . . 0.0 109.736 179.031 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.55 34.58 7.83 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 -179.819 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.6 t -122.45 133.31 69.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.706 0.288 . . . . 0.0 110.903 -179.959 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -74.99 141.06 44.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.861 179.844 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.04 -118.96 2.13 Favored Glycine 0 CA--C 1.542 1.727 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.369 -179.309 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.11 145.53 44.55 Favored 'Trans proline' 0 N--CA 1.501 1.918 0 C-N-CA 122.517 2.145 . . . . 0.0 114.065 -177.932 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 57.8 m170 -105.56 139.08 40.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.248 179.842 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -112.15 104.6 56.12 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 108.957 -0.756 . . . . 0.0 108.957 179.505 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -75.47 133.42 15.88 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 C-N-CA 121.404 1.403 . . . . 0.0 110.772 -178.983 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.2 mt -87.81 59.18 5.25 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 119.879 -0.728 . . . . 0.0 111.784 -178.187 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.2 p -67.61 -21.13 65.41 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.473 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.549 ' CD1' ' NE2' ' B' ' 265' ' ' GLN . 70.2 mt -84.01 140.69 31.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.628 -179.686 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 77.7 p -62.56 -21.31 65.49 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.78 -179.507 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.505 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 65.5 m -131.94 132.82 43.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.848 0.356 . . . . 0.0 111.748 -179.234 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.1 t -124.86 118.51 26.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.302 178.242 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 45.5 tp -115.95 128.45 55.76 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.439 -178.908 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.469 ' O ' ' O ' ' A' ' 47' ' ' GLN . 6.3 m-85 -106.51 136.0 47.04 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.335 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 159.02 -169.64 35.29 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 119.727 -1.225 . . . . 0.0 112.402 178.854 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.525 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 42.1 mtm180 -87.34 -31.1 20.34 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.418 179.376 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.416 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -50.82 148.18 7.89 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -179.735 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 36.9 mm -63.98 -43.73 97.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 O-C-N 122.611 -0.346 . . . . 0.0 111.046 -179.409 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -53.69 -18.12 2.8 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.82 -179.511 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.416 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 70.3 m -59.68 123.47 17.04 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 121.13 0.49 . . . . 0.0 111.189 -179.449 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.505 ' OD2' ' O ' ' A' ' 26' ' ' THR . 71.1 m-20 -60.77 -29.95 69.73 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.804 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.428 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 95.6 mt -127.17 123.95 63.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.241 -0.89 . . . . 0.0 108.822 177.492 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 38' ' ' ARG . 26.8 mtm180 -107.18 138.11 43.99 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.283 -179.107 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.435 ' C ' ' H ' ' A' ' 41' ' ' LEU . 95.9 mt -119.26 128.63 75.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.445 -179.911 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -73.16 30.72 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.123 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.435 ' H ' ' C ' ' A' ' 39' ' ' ILE . 94.0 mt -108.19 128.31 25.95 Favored Pre-proline 0 N--CA 1.464 0.257 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.649 179.137 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.75 -8.87 21.99 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.488 2.125 . . . . 0.0 112.107 179.953 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.7 m -93.13 4.22 7.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 121.209 0.528 . . . . 0.0 110.274 179.293 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.525 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 20.4 t -95.13 133.7 35.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.512 -0.767 . . . . 0.0 108.941 178.332 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.455 ' HG ' ' H ' ' A' ' 46' ' ' LYS . 8.2 t -70.41 170.52 11.78 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.287 0.565 . . . . 0.0 111.506 -178.266 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.455 ' H ' ' HG ' ' A' ' 45' ' ' SER . 52.2 mttp -62.97 -42.57 99.87 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.132 -179.444 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.607 ' O ' ' N ' ' A' ' 49' ' ' CYS . 87.1 mt-30 -114.49 -22.9 9.59 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 123.436 0.46 . . . . 0.0 110.709 -179.808 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.3 t60 37.13 -75.83 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 179.502 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.607 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -128.36 134.04 48.77 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.101 0.477 . . . . 0.0 111.955 -177.817 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -128.87 136.94 51.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.608 -179.932 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.7 mt -121.93 135.94 60.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.978 -179.932 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -113.85 127.1 55.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.634 178.973 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 48.8 mm -96.1 114.3 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-O 121.174 0.512 . . . . 0.0 111.555 -179.522 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.463 ' O ' ' N ' ' A' ' 56' ' ' GLN . 94.6 m-70 -117.54 134.61 54.68 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.622 178.684 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.512 ' OE1' ' N ' ' A' ' 55' ' ' GLU . 57.6 mp0 -39.72 -29.72 0.06 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -179.718 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.463 ' N ' ' O ' ' A' ' 54' ' ' HIS . 87.7 mt-30 -66.55 -67.87 0.42 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.545 178.735 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.11 -165.18 1.77 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.698 -179.275 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -120.28 129.46 54.04 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.569 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.4 mt -114.05 130.66 67.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -178.493 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 51.2 tp -94.59 124.54 38.69 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.884 179.585 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -112.84 137.6 50.94 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.099 -179.232 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.558 ' ND2' ' O ' ' A' ' 76' ' ' ILE . 50.7 p-10 -98.33 104.57 16.61 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.866 -179.841 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -93.88 -7.28 43.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.162 0.506 . . . . 0.0 109.825 178.328 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.43 ' HG ' ' H ' ' A' ' 67' ' ' ASN . 4.4 t -75.21 100.9 4.45 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.013 179.531 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.9 m -87.46 -9.31 54.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.234 -179.962 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.16 -41.92 8.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.09 0.472 . . . . 0.0 109.829 -179.85 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.43 ' H ' ' HG ' ' A' ' 64' ' ' SER . 40.9 m-20 -140.59 101.29 6.65 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.746 179.586 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -56.02 143.32 83.54 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 121.996 1.797 . . . . 0.0 112.24 -179.466 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 92.4 m -70.78 138.33 50.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.27 178.763 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -98.3 139.63 33.79 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.058 -179.999 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 55.5 t -133.5 132.38 57.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.288 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 53.22 34.31 17.31 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.612 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.5 29.02 66.51 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 114.958 -1.019 . . . . 0.0 112.53 179.928 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 47.3 t -145.72 142.42 28.94 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.924 179.763 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.0 m -74.75 140.24 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.515 179.278 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.558 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 4.6 pt -105.34 98.91 7.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.618 0.723 . . . . 0.0 109.901 178.781 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -63.86 -34.66 78.44 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.573 -179.705 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.458 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 1.2 mt-10 -128.9 -178.78 0.85 Allowed Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.748 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.458 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 25.0 Cg_exo -61.42 142.43 95.49 Favored 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 122.192 1.928 . . . . 0.0 113.03 -178.813 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 78.0 t -132.72 137.53 53.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.159 179.736 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -75.99 128.51 35.2 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.576 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.6 mt -84.01 136.43 34.05 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.99 -179.702 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -120.53 149.94 41.63 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.767 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.59 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 6.1 t60 -55.31 123.88 15.25 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.995 -178.603 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.05 -13.55 52.46 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.513 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -71.24 136.91 48.22 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.49 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.4 p -105.5 140.42 23.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.776 -0.37 . . . . 0.0 111.38 -178.815 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 72.1 mt -108.25 130.81 60.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.092 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 53.5 m -126.39 128.8 47.6 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -177.355 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.428 ' N ' ' O ' ' A' ' 93' ' ' ARG . 91.4 mt -112.66 121.67 65.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 114.228 -1.351 . . . . 0.0 107.354 177.197 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.418 ' CG2' ' N ' ' A' ' 92' ' ' ASP . 97.0 mt 35.57 -99.01 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.751 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.418 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 94.5 m-20 -110.38 8.62 23.37 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -178.982 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.493 HH21 HG13 ' B' ' 261' ' ' ILE . 50.3 mtp85 -127.12 144.26 51.07 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -179.846 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.4 ' OG ' ' CD1' ' A' ' 10' ' ' ILE . 19.4 p -141.28 159.28 42.54 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.37 0.605 . . . . 0.0 112.217 -178.458 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -129.24 125.01 35.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.084 178.231 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -82.12 135.16 35.34 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 119.769 -0.773 . . . . 0.0 110.49 179.967 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -97.2 122.92 40.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.323 0.582 . . . . 0.0 111.091 -179.271 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -124.31 117.16 23.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.533 179.455 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.59 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 64.7 t-20 . . . . . 0 C--N 1.322 -0.619 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.704 -179.747 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo . . . . . 0 N--CA 1.488 1.17 0 CA-C-O 121.42 0.508 . . . . 0.0 112.067 . . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 53.3 t -62.61 135.42 27.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.559 179.666 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 14.9 t . . . . . 0 CA--C 1.518 -0.259 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.413 -179.511 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo . . . . . 0 N--CA 1.495 1.597 0 N-CA-C 112.476 0.145 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 17.4 p -73.65 -40.74 63.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.017 0.436 . . . . 0.0 110.006 178.371 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -56.6 -46.53 80.8 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.871 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 93.6 mt -62.57 -43.52 98.6 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.941 -179.335 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -64.73 -40.01 94.61 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.07 -178.861 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . 0.47 ' O ' ' OG ' ' B' ' 247' ' ' SER . 95.0 mtt-85 -64.51 -42.01 96.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.218 0.532 . . . . 0.0 110.071 179.649 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.825 HH11 HH11 ' A' ' 12' ' ' ARG . 25.0 ttm-85 -61.79 -42.19 98.68 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.765 -179.339 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -61.56 -36.4 80.51 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.809 0.337 . . . . 0.0 110.285 179.113 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 247' ' ' SER . . . . . 0.47 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 78.6 p -69.94 -40.39 75.52 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 177.958 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -57.61 -40.18 78.55 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.024 179.324 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 56.9 t . . . . . 0 C--N 1.327 -0.376 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 178.627 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . 0.535 ' OE2' ' NH1' ' A' ' 12' ' ' ARG . 96.9 mt-10 . . . . . 0 N--CA 1.466 0.327 0 CA-C-O 120.759 0.314 . . . . 0.0 111.187 . . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . 0.493 HG13 HH21 ' A' ' 93' ' ' ARG . 71.6 mt -116.93 135.2 58.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.609 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 50.0 t -123.78 132.32 71.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.541 179.309 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -95.57 119.52 34.21 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.264 0.554 . . . . 0.0 111.781 -178.234 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -64.9 -45.3 86.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.354 179.769 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . 0.549 ' NE2' ' CD1' ' A' ' 24' ' ' LEU . 0.3 OUTLIER -100.78 163.96 17.07 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.284 -179.831 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -61.41 156.86 43.93 Favored 'Trans proline' 0 N--CA 1.503 2.051 0 C-N-CA 122.992 2.462 . . . . 0.0 113.062 -179.604 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 25.9 pt . . . . . 0 N--CA 1.465 0.285 0 CA-C-O 121.312 0.577 . . . . 0.0 111.775 -178.986 . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.7 m . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.897 0.379 . . . . 0.0 111.477 . . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.608 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 85.1 mtt-85 -100.25 148.75 24.31 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.492 -177.995 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -134.55 141.68 46.76 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.516 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 98.5 mt -113.8 139.74 48.88 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 178.73 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 67.9 t -113.89 129.46 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.407 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 m -93.22 116.62 29.19 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.402 0.62 . . . . 0.0 112.516 -178.258 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 81.7 mt -85.67 147.66 5.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.111 179.149 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -93.61 157.87 15.97 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.479 179.092 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.595 ' NH2' ' OE2' ' B' ' 260' ' ' GLU . 91.1 mtm180 -60.98 -27.56 68.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.304 -0.407 . . . . 0.0 109.997 179.859 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 91.1 p -70.6 -22.69 62.52 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.755 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.73 6.94 37.27 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-N 115.72 -0.673 . . . . 0.0 113.699 178.576 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.8 m -104.82 142.92 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 117.995 0.898 . . . . 0.0 111.568 -179.693 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 17' ' ' GLY . 61.8 t0 -69.15 127.85 34.55 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.063 -179.397 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.437 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -115.72 -127.94 4.26 Favored Glycine 0 CA--C 1.535 1.325 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 -179.814 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.93 155.88 38.78 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.483 2.122 . . . . 0.0 112.788 -178.872 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -112.78 158.78 19.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.985 0.421 . . . . 0.0 111.191 -178.591 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -128.35 98.61 25.69 Favored Pre-proline 0 N--CA 1.467 0.403 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.578 -179.727 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.28 139.57 26.48 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 121.587 1.525 . . . . 0.0 112.508 -178.905 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.2 mt -88.33 86.01 6.99 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.203 -179.331 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 59.7 p -86.39 -7.95 58.04 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.515 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.0 mt -108.69 148.82 29.86 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.041 -179.184 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.3 m -68.73 -15.06 63.4 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.127 -179.117 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 57.0 m -130.02 134.63 47.54 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.452 -0.499 . . . . 0.0 112.143 -179.975 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.7 t -127.96 118.76 24.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.914 178.573 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.3 tp -118.46 130.8 56.15 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 120.954 0.406 . . . . 0.0 111.031 -179.056 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.446 ' O ' ' O ' ' A' ' 47' ' ' GLN . 18.3 m-85 -110.25 141.6 42.99 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.988 -179.893 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 153.67 -174.88 32.19 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.883 178.795 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.473 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 45.1 mtm180 -74.82 -32.53 61.98 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 122.704 -0.291 . . . . 0.0 111.722 179.348 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.594 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -58.14 149.57 34.59 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.579 -177.714 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.461 HD11 HG22 ' A' ' 33' ' ' ILE . 82.4 mt -66.37 -43.06 91.49 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 178.247 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -49.9 -25.28 3.07 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.222 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.594 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 3.6 m -65.69 115.01 5.4 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.723 179.47 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -52.76 -21.09 3.71 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.166 -178.135 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.417 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 85.4 mt -131.4 123.92 53.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.657 177.809 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 47.3 mtm180 -107.3 138.5 43.38 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.836 -179.865 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.483 ' CG2' ' NH1' ' A' ' 93' ' ' ARG . 63.9 mt -120.56 132.44 70.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.419 -0.512 . . . . 0.0 110.48 179.762 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -75.41 24.08 0.11 Allowed 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -178.068 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 25.7 mt -105.48 128.67 26.09 Favored Pre-proline 0 C--N 1.323 -0.56 0 C-N-CA 119.591 -0.844 . . . . 0.0 109.855 179.341 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.07 -10.27 25.75 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.523 2.149 . . . . 0.0 112.566 -178.773 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.8 m -87.11 -0.21 7.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.622 179.927 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.473 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 48.0 t -91.38 131.64 37.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.131 0.491 . . . . 0.0 111.006 -179.223 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.05 160.64 20.54 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.987 179.77 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 28.2 mtmt -59.93 -42.54 94.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.702 -178.839 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.629 ' O ' ' N ' ' A' ' 49' ' ' CYS . 12.4 mm100 -111.49 -16.52 13.28 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 123.481 0.488 . . . . 0.0 110.048 -179.549 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.2 t60 35.62 -76.37 0.0 OUTLIER 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.076 -0.966 . . . . 0.0 113.348 -179.763 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.629 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -137.09 140.18 41.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.941 0.401 . . . . 0.0 111.799 -178.622 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -127.01 131.91 50.89 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.511 179.728 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.9 mt -114.87 135.93 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-O 121.098 0.475 . . . . 0.0 110.738 179.54 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -113.75 125.55 54.23 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.067 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 93.9 mt -108.2 113.62 44.36 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.461 -179.856 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.582 ' O ' ' N ' ' A' ' 56' ' ' GLN . 91.5 m-70 -115.42 141.36 48.15 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.125 179.974 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.467 ' C ' ' O ' ' A' ' 54' ' ' HIS . 84.1 tt0 -38.92 -25.18 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 120.293 -0.563 . . . . 0.0 109.527 -179.109 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.582 ' N ' ' O ' ' A' ' 54' ' ' HIS . 57.3 tt0 -67.51 -67.31 0.47 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.386 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -160.65 -163.66 1.11 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.193 -179.586 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.79 127.16 55.9 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.577 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 89.2 mt -113.89 128.76 70.67 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 CA-C-O 121.297 0.57 . . . . 0.0 111.688 -179.228 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 43.4 tp -97.39 126.91 42.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.883 -179.975 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -114.7 138.01 51.22 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.962 179.105 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.519 ' ND2' ' H ' ' A' ' 69' ' ' THR . 16.8 t-20 -101.12 109.62 21.53 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.067 0.461 . . . . 0.0 111.602 -179.564 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -94.89 -4.59 46.65 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.254 179.108 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.0 t -90.42 101.06 13.79 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.728 -179.712 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.4 p -87.59 -24.21 24.06 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.388 -0.525 . . . . 0.0 109.996 178.087 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.74 -43.29 72.61 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.6 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -142.97 100.9 5.36 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.69 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -66.28 150.85 84.52 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.264 1.309 . . . . 0.0 113.532 -177.831 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.519 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 33.7 m -69.93 137.95 51.96 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.912 179.555 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -101.38 142.43 32.79 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.662 179.906 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.544 ' CG2' ' OD1' ' A' ' 86' ' ' ASP . 5.0 p -129.5 137.2 57.47 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.14 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 49.57 32.8 5.18 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.583 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.51 27.85 64.65 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.057 -179.903 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 62.8 m -141.06 138.8 33.86 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 117.549 0.675 . . . . 0.0 112.098 -179.473 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.4 m -65.62 137.45 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.527 179.734 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.497 ' CG2' ' O ' ' A' ' 78' ' ' GLU . 96.2 mt -99.57 96.39 4.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.594 179.856 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -65.15 -41.49 94.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.853 0.359 . . . . 0.0 110.867 179.645 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.497 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.1 OUTLIER -126.72 166.05 24.65 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.492 -179.343 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -57.24 143.32 93.87 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.174 1.916 . . . . 0.0 112.565 -179.052 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.6 t -133.32 137.49 53.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.654 -179.894 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 87.7 mtm-85 -68.98 134.43 49.48 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.535 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 80.3 mt -81.08 137.28 36.0 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.472 0.653 . . . . 0.0 111.589 -179.22 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -125.64 147.08 49.44 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.656 179.724 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.751 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 4.8 t60 -57.19 124.97 20.67 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.578 -179.318 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.73 -24.22 26.03 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -179.151 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.544 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 41.4 t0 -64.57 134.48 54.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.991 0.424 . . . . 0.0 110.198 179.347 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.544 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 9.9 p -110.9 132.9 58.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.509 -178.157 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 79.0 mt -99.09 130.18 48.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.857 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 17.7 m -116.85 123.73 47.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.514 0.673 . . . . 0.0 111.405 179.895 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.634 ' O ' ' N ' ' A' ' 93' ' ' ARG . 96.8 mt -117.36 129.04 74.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.062 178.306 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.494 ' C ' ' O ' ' A' ' 90' ' ' ILE . 85.5 mt -14.97 96.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -178.876 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 79.06 -11.23 1.24 Allowed 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 177.963 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.634 ' N ' ' O ' ' A' ' 90' ' ' ILE . 17.7 mtm180 -130.95 134.28 46.59 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.349 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.2 m -133.81 147.95 51.28 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.6 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -122.81 120.13 32.62 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.549 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.429 ' NE ' ' OE2' ' A' ' 98' ' ' GLU . 37.8 ttp-105 -79.97 130.92 35.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.061 0.458 . . . . 0.0 110.989 -179.362 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.608 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 46.0 t80 -98.5 122.97 42.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.413 -179.704 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.429 ' OE2' ' NE ' ' A' ' 96' ' ' ARG . 96.3 mt-10 -139.07 129.31 25.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.188 0.518 . . . . 0.0 111.333 179.832 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.751 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 91.4 m-20 . . . . . 0 C--N 1.324 -0.543 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.356 179.734 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo . . . . . 0 N--CA 1.487 1.139 0 CA-C-O 121.226 0.427 . . . . 0.0 111.843 . . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 37.7 t -112.73 134.07 56.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.83 179.871 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 3.7 t . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.553 -179.539 . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo . . . . . 0 N--CA 1.489 1.255 0 N-CA-C 111.622 -0.184 . . . . 0.0 111.622 . . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 18.5 m -71.92 -46.78 56.39 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 120.606 -0.437 . . . . 0.0 110.421 179.092 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . 0.5 ' CZ ' ' NH1' ' B' ' 245' ' ' ARG . 80.5 t80 -58.7 -45.73 88.86 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.616 -178.846 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 93.9 mt -64.16 -40.16 95.55 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.04 -179.178 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -60.98 -45.16 95.92 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.489 -179.689 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -66.91 -38.67 86.65 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.598 179.744 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.576 ' CA ' ' HE ' ' B' ' 245' ' ' ARG . 0.0 OUTLIER -60.11 -44.62 94.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.97 -179.029 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.59 -40.77 97.8 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.353 0.597 . . . . 0.0 109.473 179.117 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 26.8 m -60.44 -45.74 92.57 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.44 179.226 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . 0.561 HE22 ' NH2' ' B' ' 245' ' ' ARG . 74.1 mt-30 -58.23 -37.93 75.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.416 179.793 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 54.6 t . . . . . 0 C--N 1.329 -0.287 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.013 179.35 . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . 0.595 ' OE2' ' NH2' ' A' ' 12' ' ' ARG . 56.6 mp0 . . . . . 0 C--O 1.225 -0.231 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 . . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 66.3 mt -112.77 135.45 52.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.671 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 55.1 t -130.16 134.88 62.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.124 0.488 . . . . 0.0 111.048 -178.657 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -95.06 118.81 32.5 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.551 0.691 . . . . 0.0 111.277 -178.503 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -66.01 -47.52 74.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.159 179.424 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -89.06 151.45 46.92 Favored Pre-proline 0 N--CA 1.449 -0.494 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.185 -178.981 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.9 149.46 72.32 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.919 2.412 . . . . 0.0 112.838 179.747 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 44.1 pt . . . . . 0 C--N 1.33 -0.262 0 CA-C-O 121.313 0.578 . . . . 0.0 110.09 179.042 . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.41 ' H ' ' HG1' ' A' ' 4' ' ' THR . 2.0 p . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.883 0.373 . . . . 0.0 110.41 . . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 88.6 mtm-85 -90.26 126.4 35.83 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.28 179.913 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -129.79 135.37 48.35 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.095 0.474 . . . . 0.0 111.032 179.826 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 29.5 tp -115.3 133.82 55.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.136 -179.38 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 45.0 t -109.15 131.98 58.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.407 -179.95 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 m -90.99 118.39 30.34 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.34 0.59 . . . . 0.0 112.541 -178.408 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.0 mt -85.85 142.14 13.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.536 179.248 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -89.31 160.68 16.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.027 0.441 . . . . 0.0 110.919 179.262 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.571 HH11 HH11 ' B' ' 245' ' ' ARG . 90.5 mtm180 -55.94 -33.07 64.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.662 -178.902 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.6 t -77.75 -8.54 58.12 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.234 179.837 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.92 31.14 9.49 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -179.924 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.0 t -116.8 132.69 65.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.857 0.36 . . . . 0.0 110.081 179.681 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 45.4 p-10 -84.19 142.8 30.06 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.978 179.612 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -133.89 -108.05 1.02 Allowed Glycine 0 CA--C 1.532 1.098 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.733 -179.531 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -73.29 148.57 43.91 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 122.347 2.032 . . . . 0.0 112.028 -179.454 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -111.94 147.58 35.57 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.149 -179.844 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -115.05 104.72 53.73 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.981 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.42 133.14 15.63 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.164 1.242 . . . . 0.0 110.992 -178.81 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 82.9 mt -87.61 51.76 2.31 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -177.51 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.5 m -59.28 -34.1 71.87 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.879 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.9 mt -71.62 144.75 49.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.45 -179.845 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.6 m -68.18 -16.38 63.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.415 -179.355 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.448 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 95.5 m -133.77 134.42 42.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.834 0.35 . . . . 0.0 111.664 -179.806 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.9 t -125.78 116.66 21.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.902 178.424 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 58.2 tp -113.71 127.83 56.18 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.794 -178.924 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.506 ' O ' ' O ' ' A' ' 47' ' ' GLN . 9.4 m-85 -106.93 139.23 41.67 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.851 179.65 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 146.5 -175.93 25.67 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 120.982 -0.628 . . . . 0.0 111.622 178.972 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 47.6 mtm180 -75.46 -33.72 60.88 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -179.851 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.505 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -44.45 142.95 2.75 Favored Glycine 0 C--O 1.223 -0.535 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 -178.465 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.411 ' CD1' ' CZ ' ' A' ' 38' ' ' ARG . 32.5 mm -62.6 -43.13 98.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 117.194 0.497 . . . . 0.0 110.033 179.957 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -54.81 -20.73 9.24 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.51 -0.476 . . . . 0.0 109.865 179.551 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.505 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 60.0 m -56.63 119.61 6.4 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-O 120.968 0.413 . . . . 0.0 111.141 -179.47 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.448 ' OD2' ' O ' ' A' ' 26' ' ' THR . 80.0 m-20 -58.09 -26.63 62.81 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -179.817 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.432 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 95.1 mt -129.18 118.97 47.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.235 177.381 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.411 ' CZ ' ' CD1' ' A' ' 33' ' ' ILE . 84.7 mtp180 -103.34 133.5 48.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.634 -179.106 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.428 ' C ' ' H ' ' A' ' 41' ' ' LEU . 83.6 mt -118.13 129.94 73.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 120.511 -0.475 . . . . 0.0 110.021 179.744 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -75.24 36.71 0.12 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.85 -178.057 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.611 ' CD1' ' CZ ' ' A' ' 93' ' ' ARG . 70.0 mt -111.74 119.32 44.98 Favored Pre-proline 0 C--N 1.325 -0.457 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.061 -179.678 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -71.29 -12.77 30.27 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 121.835 1.69 . . . . 0.0 112.824 -179.987 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.448 ' CG2' ' CZ ' ' B' ' 241' ' ' PHE . 31.1 m -86.76 -3.51 8.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.949 -0.301 . . . . 0.0 110.716 179.657 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.3 p -96.62 146.76 6.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.103 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.9 m -74.65 166.14 24.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.469 0.652 . . . . 0.0 112.519 -178.478 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 45.6 mttp -63.23 -40.05 96.34 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.03 -0.987 . . . . 0.0 111.737 179.975 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.669 ' O ' ' N ' ' A' ' 49' ' ' CYS . 89.7 mt-30 -113.36 -19.83 11.58 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.385 179.858 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.0 t60 34.83 -75.93 0.0 OUTLIER 'General case' 0 C--O 1.234 0.274 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 179.048 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.669 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.1 134.45 47.36 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.248 0.547 . . . . 0.0 112.253 -178.948 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -127.01 128.65 46.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.257 179.021 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.3 mt -111.56 133.74 56.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.189 179.845 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -116.79 126.55 53.26 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.463 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 84.8 mt -106.15 112.91 41.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.404 -179.067 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.504 ' O ' ' N ' ' A' ' 56' ' ' GLN . 95.0 m-70 -112.78 144.03 43.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.399 179.54 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 54' ' ' HIS . 84.1 tt0 -39.9 -27.21 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.358 -0.537 . . . . 0.0 109.992 -178.839 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.504 ' N ' ' O ' ' A' ' 54' ' ' HIS . 75.8 mt-30 -69.08 -66.99 0.51 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.949 179.132 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -157.92 -169.2 2.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.347 -179.11 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -111.85 125.32 53.89 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.741 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.5 mt -114.73 132.05 65.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -178.203 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 44.0 tp -94.8 122.54 37.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.8 179.266 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -109.08 136.35 48.73 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.159 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.432 HD22 ' HA ' ' A' ' 68' ' ' PRO . 63.5 t-20 -97.54 109.54 22.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.068 0.461 . . . . 0.0 112.241 -178.422 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.405 ' CD2' ' OE1' ' A' ' 47' ' ' GLN . 28.3 m-85 -100.91 -9.87 21.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.121 179.326 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.409 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 2.7 t -76.22 98.62 4.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.805 0.336 . . . . 0.0 110.844 -179.389 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 34.2 t -79.09 -40.79 30.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.323 0.582 . . . . 0.0 109.744 178.683 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.75 -47.02 79.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.02 -179.112 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.409 ' O ' ' OG ' ' A' ' 64' ' ' SER . 42.3 m-20 -136.97 97.91 10.77 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.452 179.894 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.432 ' HA ' HD22 ' A' ' 62' ' ' ASN . 36.2 Cg_exo -56.45 145.05 81.55 Favored 'Trans proline' 0 N--CA 1.494 1.5 0 C-N-CA 121.799 1.666 . . . . 0.0 112.612 -179.121 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.3 m -73.83 140.01 45.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.393 -179.992 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -104.59 141.79 35.79 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.749 -179.188 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.509 ' CG1' ' OD1' ' A' ' 86' ' ' ASP . 55.3 t -130.96 136.23 58.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.491 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 52.26 33.3 12.33 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -179.394 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.58 29.48 72.88 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.284 179.726 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.468 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 30.7 p -141.66 136.65 31.11 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.714 -0.395 . . . . 0.0 110.867 -179.974 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 78.6 t -66.01 135.82 27.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.087 -179.907 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.08 96.65 3.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.409 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -84.56 -16.69 41.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.536 -0.757 . . . . 0.0 112.014 -178.583 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -111.47 162.6 20.3 Favored Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.557 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -58.96 142.24 99.1 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 121.45 1.433 . . . . 0.0 111.693 179.684 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.5 p -140.48 139.1 35.89 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 CA-C-O 120.957 0.408 . . . . 0.0 110.758 179.814 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.62 HH21 ' CE ' ' A' ' 83' ' ' LYS . 61.9 ttp180 -73.39 127.71 33.44 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.461 179.616 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 98.2 mt -78.78 138.16 38.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.79 -180.0 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.62 ' CE ' HH21 ' A' ' 81' ' ' ARG . 97.7 mttt -130.29 151.93 50.26 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.342 179.237 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.603 ' HD1' ' CG ' ' A' ' 99' ' ' ASN . 3.7 t-160 -55.59 120.95 8.02 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.287 -179.334 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.08 -15.06 36.89 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -179.58 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.509 ' OD1' ' CG1' ' A' ' 71' ' ' VAL . 35.2 t70 -68.79 126.54 30.07 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.312 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.9 t -109.51 127.09 66.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.578 -178.922 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 90.7 mt -93.27 133.54 34.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.896 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 53.7 m -124.19 123.08 39.5 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.592 0.71 . . . . 0.0 112.387 -178.555 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.451 ' N ' ' O ' ' A' ' 93' ' ' ARG . 93.1 mt -107.91 124.27 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 177.498 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.443 ' C ' ' O ' ' A' ' 90' ' ' ILE . 93.9 mt 39.47 -98.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.171 -178.445 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.613 ' OD1' ' NH1' ' A' ' 93' ' ' ARG . 28.9 p-10 -119.71 16.54 12.76 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.015 0.436 . . . . 0.0 110.837 179.365 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.613 ' NH1' ' OD1' ' A' ' 92' ' ' ASP . 45.0 mtm-85 -120.0 138.12 53.68 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.765 179.877 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 66.9 m -137.44 152.41 49.55 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 119.886 -0.726 . . . . 0.0 111.283 -179.871 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -123.79 121.45 35.45 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.098 179.413 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -81.95 129.08 34.67 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.75 -179.045 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -99.0 126.99 44.82 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.832 179.876 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -137.22 127.88 26.98 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.653 179.996 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.603 ' CG ' ' HD1' ' A' ' 84' ' ' HIS . 41.2 p30 . . . . . 0 N--CA 1.463 0.223 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.532 -179.965 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo . . . . . 0 N--CA 1.49 1.314 0 CA-C-O 121.212 0.422 . . . . 0.0 112.657 . . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 31.4 t -64.09 135.5 27.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.391 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-O 121.093 0.473 . . . . 0.0 110.805 -178.741 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo . . . . . 0 N--CA 1.492 1.389 0 CA-C-O 120.495 0.123 . . . . 0.0 111.806 . . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 52.0 m -73.03 -46.19 53.38 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.05 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . 0.448 ' CZ ' ' CG2' ' A' ' 43' ' ' VAL . 71.3 t80 -56.6 -48.15 78.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.757 -179.793 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 85.8 mt -66.18 -43.6 86.4 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -179.887 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -65.48 -45.14 84.8 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.447 -178.228 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -62.68 -44.53 96.02 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.435 179.626 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.571 HH11 HH11 ' A' ' 12' ' ' ARG . 52.2 ttm-85 -63.56 -44.09 95.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.98 -179.627 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -63.97 -36.89 85.45 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.554 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 32.7 m -64.08 -43.78 94.38 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.47 178.022 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -61.64 -34.59 75.96 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.877 -179.962 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 43.4 t . . . . . 0 C--N 1.332 -0.192 0 C-N-CA 120.774 -0.371 . . . . 0.0 110.232 179.098 . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 . . . . . 0 CA--C 1.527 0.069 0 CA-C-O 120.66 0.267 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 66.9 mt -109.69 134.56 51.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 178.945 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 61.9 t -125.23 133.88 68.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.746 -179.311 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -94.43 118.95 32.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.043 -178.986 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -68.2 -41.16 81.79 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.281 179.392 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -103.56 163.69 16.92 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.814 -178.878 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -62.27 153.27 71.26 Favored 'Trans proline' 0 N--CA 1.5 1.856 0 C-N-CA 123.202 2.601 . . . . 0.0 113.08 -179.429 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 42.5 pt . . . . . 0 C--N 1.33 -0.253 0 CA-C-O 121.693 0.759 . . . . 0.0 112.328 -179.02 . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.7 m . . . . . 0 CA--C 1.531 0.234 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 . . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.7 mtt85 -97.76 137.22 36.97 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.918 0.389 . . . . 0.0 111.997 -177.494 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -137.62 145.98 43.41 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.518 179.576 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.439 ' CD2' ' N ' ' A' ' 7' ' ' LEU . 3.0 mm? -112.96 141.54 46.68 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.94 178.395 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.0 t -114.09 127.02 71.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.852 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 50.0 m -78.64 139.68 38.51 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -177.998 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 99.6 mt -109.22 136.47 45.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.185 177.494 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -88.8 158.46 18.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.006 0.431 . . . . 0.0 110.926 179.942 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.487 ' CD ' HH11 ' B' ' 245' ' ' ARG . 86.3 mtm180 -57.16 -30.59 64.59 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.801 -178.611 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 88.6 p -80.93 -7.07 59.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.192 179.988 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.88 34.44 6.85 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.692 179.527 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.2 t -119.64 132.73 68.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.748 0.308 . . . . 0.0 111.111 -179.988 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -74.84 138.23 42.39 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.73 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -131.65 -118.89 2.02 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 120.533 -0.842 . . . . 0.0 112.616 -178.939 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -73.79 149.12 42.32 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.414 2.076 . . . . 0.0 113.066 -178.427 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -110.58 157.46 19.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.697 -179.962 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.424 ' CD2' ' CD1' ' A' ' 37' ' ' ILE . 35.2 t80 -124.64 99.83 35.36 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.924 -179.553 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -74.81 135.52 19.58 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 121.374 1.383 . . . . 0.0 112.48 -179.499 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.5 mt -87.65 81.98 7.54 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 120.872 0.367 . . . . 0.0 111.093 -179.24 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.474 ' OG ' ' NE2' ' B' ' 265' ' ' GLN . 77.9 p -86.33 -8.68 57.51 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.164 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.5 mt -103.82 146.22 28.96 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.611 179.917 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.6 m -67.81 -14.82 63.27 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -179.219 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 39.7 m -131.03 132.6 45.06 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.694 -179.948 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.1 t -126.96 120.21 28.55 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.653 178.835 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 35.1 tp -117.22 130.86 56.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.779 0.323 . . . . 0.0 111.42 -178.561 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.446 ' O ' ' O ' ' A' ' 47' ' ' GLN . 54.1 m-85 -107.43 133.44 51.94 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.615 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 179.42 -173.46 45.39 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.186 -1.007 . . . . 0.0 112.718 -179.967 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.2 ttp-105 -93.75 -23.4 18.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.234 -0.483 . . . . 0.0 110.349 179.746 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.467 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -72.2 163.96 54.49 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.932 -179.095 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.56 ' CD1' ' NH1' ' A' ' 38' ' ' ARG . 10.4 tp -68.17 -43.25 85.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.948 0.404 . . . . 0.0 111.582 -179.846 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.513 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 52.1 tp10 -54.19 -19.81 5.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.862 -178.594 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.467 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 3.5 m -67.77 129.01 38.59 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.275 -179.777 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -61.58 -33.84 74.58 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.961 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.424 ' CD1' ' CD2' ' A' ' 20' ' ' PHE . 36.9 mm -120.11 116.6 50.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.097 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.56 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 83.2 mtp180 -105.63 134.85 48.07 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.681 -178.404 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 78.6 mt -121.13 129.13 75.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.35 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -77.22 27.72 0.15 Allowed 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -177.921 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.402 ' CD2' ' OE1' ' B' ' 260' ' ' GLU . 78.9 mt -99.09 139.18 20.81 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.121 179.55 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.45 -14.73 20.1 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.492 2.128 . . . . 0.0 112.277 -179.395 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.1 m -91.19 7.87 4.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.534 179.868 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 55.6 t -100.36 132.11 46.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.359 179.09 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.4 m -74.11 170.32 15.73 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.768 0.794 . . . . 0.0 111.655 -179.52 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -64.83 -38.54 91.32 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.093 179.799 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.642 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.0 mt-30 -114.74 -19.2 11.15 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.167 179.875 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 14.8 t60 32.61 -76.58 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 179.805 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.642 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.82 134.16 46.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.3 0.571 . . . . 0.0 112.066 -178.662 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -125.34 132.55 52.82 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.189 179.08 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.8 mt -116.46 133.78 61.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.986 -179.563 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -113.87 123.76 50.58 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.513 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.6 mt -105.87 111.6 35.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.659 -179.484 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.458 ' O ' ' N ' ' A' ' 56' ' ' GLN . 81.4 m-70 -113.77 142.85 45.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.313 179.834 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 54' ' ' HIS . 99.2 mt-10 -40.67 -28.46 0.07 Allowed 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.266 -0.574 . . . . 0.0 109.826 -179.771 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.488 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 95.1 mt-30 -63.78 -68.55 0.34 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.546 178.866 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.488 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 3.4 tp10 -157.24 -168.32 2.58 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.585 -179.671 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.12 124.71 52.02 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 178.473 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 98.0 mt -115.83 130.28 70.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.283 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 47.1 tp -97.98 127.98 44.26 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.249 179.258 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -114.94 138.24 51.06 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.467 -179.995 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.426 HD22 ' CA ' ' A' ' 68' ' ' PRO . 57.8 t-20 -98.69 106.83 19.15 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.903 0.383 . . . . 0.0 111.961 -179.692 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -102.33 -9.5 20.29 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.032 179.406 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.38 100.14 4.35 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.173 -179.932 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 85.0 p -84.24 -32.11 24.65 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.341 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.7 m -64.43 -51.46 63.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.699 -179.745 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -138.79 95.96 9.58 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.673 179.825 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.426 ' CA ' HD22 ' A' ' 62' ' ' ASN . 52.0 Cg_exo -55.0 146.7 56.46 Favored 'Trans proline' 0 N--CA 1.499 1.809 0 C-N-CA 122.286 1.99 . . . . 0.0 113.328 -178.957 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 44.3 m -75.06 145.16 42.58 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.289 -179.984 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -108.11 143.37 36.95 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.808 -179.733 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.435 ' O ' ' N ' ' A' ' 74' ' ' SER . 5.4 p -131.99 135.97 57.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.77 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 49.16 33.17 4.69 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.238 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.69 29.09 69.92 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.317 -179.577 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 71' ' ' VAL . 66.8 m -138.65 136.06 35.51 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.906 0.353 . . . . 0.0 111.161 -179.616 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -66.32 141.75 17.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.176 -179.806 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.2 pt -118.71 78.99 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.677 179.107 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -63.34 -24.02 67.67 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.768 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -116.84 158.71 43.14 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.838 179.559 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -64.97 148.62 89.81 Favored 'Trans proline' 0 N--CA 1.5 1.884 0 C-N-CA 122.859 2.373 . . . . 0.0 113.044 -179.6 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 65.9 t -138.41 138.99 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.088 179.815 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -69.33 132.11 45.89 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 178.817 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 90.0 mt -78.85 138.38 38.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.304 0.574 . . . . 0.0 111.113 -179.985 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -132.36 150.14 52.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.075 179.949 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.741 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 4.9 t60 -58.17 119.12 6.29 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.874 0.369 . . . . 0.0 110.401 -179.674 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.51 -23.04 16.19 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 -179.66 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 87' ' ' VAL . 57.7 t0 -67.93 132.11 46.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.029 0.442 . . . . 0.0 110.939 179.736 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.526 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 50.0 t -110.63 132.15 59.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.512 -179.038 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 87.3 mt -95.75 131.26 43.01 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 177.957 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 44.6 m -121.99 128.97 52.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.989 0.899 . . . . 0.0 113.314 -177.244 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.617 ' O ' ' N ' ' A' ' 93' ' ' ARG . 97.9 mt -116.42 129.94 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-N 113.926 -1.488 . . . . 0.0 108.379 178.453 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.523 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 70.4 mt -21.49 98.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.415 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.566 ' OD2' ' NH1' ' B' ' 245' ' ' ARG . 0.8 OUTLIER 88.46 -23.8 0.11 Allowed 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 178.171 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.617 ' N ' ' O ' ' A' ' 90' ' ' ILE . 83.4 mtt-85 -128.35 145.02 51.2 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.273 -179.53 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.3 t -140.7 153.76 46.08 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.325 0.583 . . . . 0.0 110.576 -179.9 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -124.96 121.49 34.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.464 179.363 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -81.6 131.68 35.28 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.342 -179.937 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.584 ' CZ ' ' OD1' ' A' ' 99' ' ' ASN . 85.8 t80 -94.66 126.22 39.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.691 -179.647 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -136.4 128.59 29.84 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 120.572 -0.451 . . . . 0.0 112.001 -179.531 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.741 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 93.7 m-20 . . . . . 0 CA--C 1.531 0.219 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.827 179.083 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo . . . . . 0 N--CA 1.494 1.505 0 N-CA-C 114.474 0.913 . . . . 0.0 114.474 . . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 26.8 m -72.43 143.35 14.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 114.279 -1.328 . . . . 0.0 109.174 179.34 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 10.3 t . . . . . 0 C--N 1.322 -0.599 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.705 -179.028 . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo . . . . . 0 N--CA 1.494 1.518 0 CA-C-O 120.607 0.169 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 99.3 m -73.22 -45.09 58.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.905 0.384 . . . . 0.0 111.023 179.376 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -57.08 -47.84 80.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.251 -179.29 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 87.1 mt -63.5 -42.56 98.5 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.412 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -63.67 -41.88 98.12 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.892 -179.547 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 62.9 ttm-85 -64.31 -44.21 92.29 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.009 0.433 . . . . 0.0 110.422 179.938 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.566 ' NH1' ' OD2' ' A' ' 92' ' ' ASP . 4.0 tpp85 -61.43 -42.9 99.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.773 -179.61 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -59.48 -40.09 85.81 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.825 0.345 . . . . 0.0 110.271 -179.734 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 78.0 p -70.31 -39.88 74.55 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.816 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 63.7 tp60 -59.25 -38.53 80.3 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.699 179.823 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 38.3 t . . . . . 0 C--N 1.332 -0.18 0 CA-C-O 120.734 0.302 . . . . 0.0 110.35 179.029 . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . 0.58 ' CD ' HH21 ' A' ' 93' ' ' ARG . 98.2 mt-10 . . . . . 0 N--CA 1.465 0.312 0 CA-C-O 120.767 0.318 . . . . 0.0 110.173 . . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 67.6 mt -114.11 134.19 57.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.655 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 44.4 t -124.99 134.53 66.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.168 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -96.17 117.72 31.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.275 0.559 . . . . 0.0 111.578 -178.222 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -65.96 -46.29 78.66 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.163 179.611 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . 0.474 ' NE2' ' OG ' ' A' ' 23' ' ' SER . 0.0 OUTLIER -96.0 155.51 38.2 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.336 -179.192 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -64.31 148.86 90.99 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 123.212 2.608 . . . . 0.0 113.42 -179.222 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 47.1 pt . . . . . 0 C--N 1.332 -0.157 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.761 178.693 . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.8 p . . . . . 0 N--CA 1.456 -0.164 0 CA-C-O 121.096 0.474 . . . . 0.0 110.549 . . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.409 HH11 HD11 ' A' ' 53' ' ' ILE . 99.9 mtt180 -98.84 135.34 40.44 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.212 -179.736 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.497 ' NE ' ' OE1' ' A' ' 98' ' ' GLU . 33.4 ptt180 -140.85 155.44 46.34 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.27 -0.572 . . . . 0.0 112.034 -179.569 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 78.5 mt -118.91 145.19 45.94 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.747 179.703 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.6 t -114.43 129.88 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 178.177 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.4 m -91.64 118.27 30.49 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -177.553 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 98.1 mt -84.67 142.87 12.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.436 178.284 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -94.99 167.89 11.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.845 0.355 . . . . 0.0 110.942 179.566 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.442 ' HG2' HH11 ' B' ' 245' ' ' ARG . 83.5 mtm180 -56.49 -32.44 65.02 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.465 -178.407 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.5 m -80.25 -7.61 59.09 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.47 179.893 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.71 39.83 6.98 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 -179.545 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.3 t -119.58 130.85 73.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.959 0.409 . . . . 0.0 110.869 -179.403 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -77.16 136.68 38.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.558 179.305 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -137.59 -114.86 1.32 Allowed Glycine 0 CA--C 1.535 1.297 0 C-N-CA 120.2 -1.0 . . . . 0.0 111.746 -179.9 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -71.92 149.0 52.62 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.088 1.859 . . . . 0.0 112.502 -178.994 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -113.45 157.6 21.75 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.793 179.932 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -118.13 97.71 50.94 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.487 179.864 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -74.17 131.76 15.74 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 121.39 1.393 . . . . 0.0 111.342 -179.328 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 82.0 mt -83.51 80.63 9.04 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.632 -178.791 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 87.9 p -84.55 -11.15 56.6 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.867 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 67.5 mt -107.16 149.18 27.96 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.191 -179.885 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 28.5 t -67.88 -15.79 63.78 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.811 -179.408 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.531 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 58.8 m -127.16 130.04 49.01 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.594 -0.442 . . . . 0.0 112.181 -179.192 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.7 t -123.76 113.46 18.61 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 177.799 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.408 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 41.0 tp -115.68 131.09 57.04 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.619 -178.232 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.54 ' O ' ' O ' ' A' ' 47' ' ' GLN . 6.9 m-85 -108.51 131.1 55.16 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.706 179.796 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 166.59 -175.25 41.99 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 119.934 -1.127 . . . . 0.0 112.862 179.386 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.503 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 76.4 mtm-85 -80.1 -32.11 39.17 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-O 120.876 0.369 . . . . 0.0 110.594 179.95 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.563 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -51.3 146.23 11.4 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.512 -178.147 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.51 ' CD1' ' CZ ' ' A' ' 38' ' ' ARG . 36.9 mm -64.44 -43.46 96.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.74 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -54.91 -21.24 10.93 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.633 -179.769 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.563 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 17.2 m -59.08 129.07 40.37 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.155 0.503 . . . . 0.0 110.521 -179.672 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.531 ' OD2' ' O ' ' A' ' 26' ' ' THR . 59.0 m-20 -60.9 -33.35 72.99 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.457 -179.109 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.413 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 89.4 mt -125.97 119.78 55.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 177.998 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.51 ' CZ ' ' CD1' ' A' ' 33' ' ' ILE . 83.3 mtp180 -103.75 137.84 41.22 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.889 -178.497 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.435 HG23 HD13 ' A' ' 39' ' ' ILE . 90.3 mt -121.08 131.76 72.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.267 179.551 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -75.24 26.35 0.1 Allowed 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -178.319 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.587 ' CD1' ' CZ ' ' A' ' 93' ' ' ARG . 81.9 mt -102.2 131.74 22.27 Favored Pre-proline 0 C--N 1.326 -0.42 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.301 179.947 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.69 -13.18 27.05 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 122.292 1.995 . . . . 0.0 112.47 -179.535 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.8 m -92.81 2.04 8.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.159 -179.621 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.503 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 38.0 t -91.7 133.8 32.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 177.875 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.0 m -72.64 175.0 6.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.501 0.667 . . . . 0.0 111.586 -178.285 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -63.35 -42.58 98.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.736 -179.787 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.629 ' O ' ' N ' ' A' ' 49' ' ' CYS . 89.0 mt-30 -116.98 -17.01 10.48 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.426 0.454 . . . . 0.0 111.335 -179.948 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.1 t60 34.05 -76.52 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 179.665 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.629 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -127.8 135.1 49.63 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.225 0.536 . . . . 0.0 112.222 -178.766 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -126.74 133.08 50.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.896 179.476 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.3 mt -119.37 132.04 70.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.63 179.107 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -115.21 126.09 54.14 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.944 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.409 HD11 HH11 ' A' ' 5' ' ' ARG . 47.4 mm -93.68 122.66 45.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.326 0.584 . . . . 0.0 111.356 -178.029 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.463 ' O ' ' C ' ' A' ' 55' ' ' GLU . 11.0 m-70 -117.76 127.42 53.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.168 179.104 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' A' ' 54' ' ' HIS . 97.5 mt-10 -40.96 -31.33 0.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.967 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.428 ' N ' ' C ' ' A' ' 54' ' ' HIS . 85.7 mt-30 -67.0 -67.61 0.44 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.664 178.046 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.405 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 3.5 tp10 -149.77 -172.79 4.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.157 -179.63 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.405 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -115.01 132.19 56.68 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.951 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.452 HG22 HD11 ' A' ' 59' ' ' ILE . 47.6 mm -113.21 128.11 70.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 120.493 -0.483 . . . . 0.0 112.022 -178.286 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 22.9 tp -98.65 126.61 44.3 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.545 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -117.92 139.09 51.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.739 0.304 . . . . 0.0 110.595 -179.724 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.551 ' ND2' ' H ' ' A' ' 69' ' ' THR . 16.0 t-20 -101.58 113.93 27.51 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.85 0.357 . . . . 0.0 111.493 -179.728 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -102.45 -7.92 21.54 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.653 179.878 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.42 99.16 11.01 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.423 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.9 m -76.25 -32.31 58.79 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.246 0.546 . . . . 0.0 109.938 179.064 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.0 m -63.48 -45.97 88.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.598 -179.309 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -142.93 93.15 6.73 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.597 179.208 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -56.93 148.89 64.8 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.056 1.837 . . . . 0.0 111.859 -179.721 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.551 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 41.7 m -70.66 156.43 39.48 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.106 -179.589 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -114.6 140.98 48.36 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.915 179.683 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.498 ' O ' ' OG ' ' A' ' 74' ' ' SER . 55.6 t -130.21 135.68 60.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.762 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 52.81 32.38 12.19 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 119.857 -0.737 . . . . 0.0 109.359 -179.142 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.25 29.17 68.84 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.511 179.99 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.498 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 11.3 p -142.03 140.15 32.55 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.286 179.965 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.2 p -63.0 143.27 15.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.698 -179.433 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.418 ' CG1' ' O ' ' A' ' 78' ' ' GLU . 10.5 tt -113.88 87.28 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.577 -179.849 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 20.5 p-10 -66.4 -33.03 74.79 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.952 179.891 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.418 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 2.7 mt-10 -124.65 167.41 15.96 Favored Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.27 -179.053 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -60.3 144.87 99.5 Favored 'Trans proline' 0 N--CA 1.502 2.001 0 C-N-CA 122.582 2.188 . . . . 0.0 112.891 179.647 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.1 m -138.77 152.81 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 CA-C-O 121.618 0.723 . . . . 0.0 111.962 178.665 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -79.45 127.31 31.95 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.835 179.548 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 98.1 mt -83.41 129.49 34.99 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.28 0.562 . . . . 0.0 110.434 -179.623 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -121.91 150.45 41.96 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.283 -179.881 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.428 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 6.1 t60 -49.63 118.35 2.75 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.955 -179.397 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.15 -20.35 28.55 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 179.685 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 87' ' ' VAL . 56.7 t0 -61.54 132.49 53.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.17 0.509 . . . . 0.0 110.437 179.864 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.503 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 56.7 t -109.48 129.75 63.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.278 -179.03 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.8 mt -98.09 131.56 44.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.613 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.474 ' OG1' ' OG ' ' A' ' 94' ' ' SER . 74.7 m -126.05 127.92 46.6 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.624 0.726 . . . . 0.0 112.405 -178.42 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.569 ' O ' ' N ' ' A' ' 92' ' ' ASP . 97.8 mt -110.13 125.4 67.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.009 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.473 ' CD1' HH22 ' A' ' 93' ' ' ARG . 88.6 mt 40.0 -91.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 120.584 -0.447 . . . . 0.0 110.315 -178.7 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.569 ' N ' ' O ' ' A' ' 90' ' ' ILE . 33.9 t70 -128.06 20.05 6.43 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.04 0.448 . . . . 0.0 111.238 -179.776 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.633 ' NH1' ' NH2' ' B' ' 245' ' ' ARG . 45.8 mtm-85 -126.65 140.41 52.43 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.541 -179.798 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.474 ' OG ' ' OG1' ' A' ' 89' ' ' THR . 57.4 m -138.89 153.31 48.27 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 119.602 -0.839 . . . . 0.0 112.2 -179.154 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -121.92 122.44 39.4 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.705 178.864 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -81.55 130.11 34.93 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 119.884 -0.726 . . . . 0.0 110.449 -179.108 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -94.27 124.24 38.17 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.272 -179.283 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.497 ' OE1' ' NE ' ' A' ' 6' ' ' ARG . 80.3 tt0 -124.5 123.44 40.13 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.97 179.868 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.428 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 64.0 t-20 . . . . . 0 N--CA 1.463 0.193 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.668 -179.959 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo . . . . . 0 N--CA 1.484 0.925 0 CA-C-O 120.947 0.311 . . . . 0.0 111.59 . . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 5.9 p -113.91 133.2 60.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.799 179.704 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 4.6 t . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.48 -178.923 . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo . . . . . 0 N--CA 1.495 1.584 0 CA-C-O 120.621 0.176 . . . . 0.0 112.003 . . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 94.4 m -71.88 -45.84 59.91 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.147 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -58.79 -47.05 86.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.101 -179.376 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 95.3 mt -63.56 -41.1 98.42 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -179.046 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -63.12 -38.87 92.91 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.967 -179.792 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -63.49 -41.85 98.56 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.126 0.489 . . . . 0.0 110.002 179.613 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.633 ' NH2' ' NH1' ' A' ' 93' ' ' ARG . 62.4 ttm-85 -60.05 -44.72 94.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.008 -179.168 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -64.77 -40.05 94.62 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.752 179.467 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 66.6 m -63.77 -45.42 89.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.499 179.509 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -60.7 -39.47 88.65 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.259 -179.461 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 21.0 t . . . . . 0 N--CA 1.452 -0.351 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.445 . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 . . . . . 0 CA--C 1.531 0.247 0 CA-C-O 120.481 0.181 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 73.5 mt -106.39 138.73 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.783 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 54.1 t -129.05 136.66 59.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.274 -178.765 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -97.4 117.12 30.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.318 0.58 . . . . 0.0 111.126 -179.397 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 43.3 tttp -67.05 -43.41 82.8 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.502 178.99 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 53.8 mm-40 -94.0 155.2 40.43 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.721 -179.014 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -61.31 154.1 60.82 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.103 1.869 . . . . 0.0 111.036 178.561 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 40.3 pt . . . . . 0 C--N 1.324 -0.539 0 CA-C-O 121.702 0.763 . . . . 0.0 112.372 -178.328 . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 68.5 p . . . . . 0 CA--C 1.521 -0.152 0 CA-C-O 120.787 0.327 . . . . 0.0 110.58 . . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.449 ' NH1' ' CG2' ' A' ' 53' ' ' ILE . 99.9 mtt180 -94.72 130.73 41.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.941 179.924 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -128.27 137.85 52.16 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.424 179.514 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 45.0 tp -106.88 130.88 54.49 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.47 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.6 t -110.04 129.31 65.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.475 -178.991 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 m -90.9 111.9 23.52 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.461 -178.971 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.7 mt -83.13 148.03 5.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.599 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -94.15 168.6 10.83 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.383 0.611 . . . . 0.0 111.434 179.705 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.421 ' HD3' HH12 ' A' ' 93' ' ' ARG . 87.9 mtm180 -58.06 -29.74 65.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.886 -179.038 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.8 p -80.54 -6.24 57.93 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.687 179.796 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.04 23.6 37.6 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.163 179.159 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.1 m -109.54 140.86 26.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.535 179.742 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.41 ' C ' ' OD1' ' A' ' 16' ' ' ASP . 57.3 t0 -69.32 122.75 19.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.682 -179.6 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -108.74 -131.91 6.49 Favored Glycine 0 CA--C 1.538 1.506 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 -179.344 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -74.71 153.95 43.64 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.342 2.028 . . . . 0.0 112.031 -179.258 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -109.15 155.92 20.45 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.148 -179.536 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -126.12 92.28 46.13 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.477 179.927 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.94 126.72 22.53 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 121.865 1.71 . . . . 0.0 111.551 -179.789 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.2 mt -80.02 54.3 1.88 Allowed 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 120.808 0.337 . . . . 0.0 110.708 -179.351 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.6 t -62.46 -40.62 97.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.802 179.587 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 46.8 mt -70.54 144.49 51.29 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.178 -179.77 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.6 t -66.01 -17.84 64.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.444 -178.84 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.549 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 50.2 m -132.53 134.13 44.61 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.996 -179.777 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.654 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 2.7 t -127.66 116.81 20.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.111 0.481 . . . . 0.0 109.798 178.585 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.403 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 44.7 tp -114.82 130.14 56.82 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.631 -178.291 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.654 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 27.1 m-85 -108.7 139.18 43.86 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.171 -179.894 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.87 -175.38 30.65 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.405 178.574 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.6 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 81.5 mtm-85 -74.04 -32.96 63.54 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.911 0.386 . . . . 0.0 110.868 -179.961 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.428 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -46.86 139.8 7.46 Favored Glycine 0 N--CA 1.465 0.584 0 N-CA-C 111.554 -0.619 . . . . 0.0 111.554 -178.582 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.547 ' CD1' ' CZ ' ' A' ' 38' ' ' ARG . 36.3 mm -64.99 -44.71 96.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.805 0.336 . . . . 0.0 110.975 -179.951 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.462 ' HA ' ' HZ1' ' B' ' 264' ' ' LYS . 15.4 pt-20 -57.98 -13.91 5.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.45 -179.173 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.428 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 60.0 m -63.02 131.23 47.91 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.524 -179.877 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.549 ' OD2' ' O ' ' A' ' 26' ' ' THR . 58.9 m-20 -61.24 -30.79 70.66 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.288 -179.326 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 77.9 mt -128.44 119.34 50.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.019 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.547 ' CZ ' ' CD1' ' A' ' 33' ' ' ILE . 83.8 mtp180 -100.04 135.54 41.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.518 -179.052 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 95.2 mt -121.28 128.96 76.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.55 -0.46 . . . . 0.0 109.907 179.98 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -79.36 31.26 0.22 Allowed 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -178.318 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.2 mt -97.85 128.48 33.92 Favored Pre-proline 0 CA--C 1.535 0.366 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.763 179.544 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -72.51 -12.69 27.27 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.487 2.125 . . . . 0.0 113.272 -179.276 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.1 m -100.29 6.99 9.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.316 -0.554 . . . . 0.0 110.432 179.525 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.6 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 32.0 t -95.43 134.99 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.934 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.615 ' HG ' ' N ' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -67.67 164.47 19.2 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.502 0.668 . . . . 0.0 111.94 -178.691 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.615 ' N ' ' HG ' ' A' ' 45' ' ' SER . 95.7 mttt -63.56 -42.31 98.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.056 -179.375 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.638 ' O ' ' N ' ' A' ' 49' ' ' CYS . 95.3 mm-40 -109.2 -23.04 11.81 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.591 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.473 ' O ' ' OG ' ' A' ' 64' ' ' SER . 17.1 t60 38.18 -76.04 0.0 OUTLIER 'General case' 0 C--O 1.235 0.336 0 CA-C-N 114.621 -1.172 . . . . 0.0 113.086 179.135 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.638 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.59 136.79 45.13 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.347 -0.541 . . . . 0.0 112.04 -178.218 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -128.17 130.39 47.98 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.394 179.431 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 95.8 mt -112.36 133.36 58.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.043 -179.934 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 73.3 tt0 -116.92 125.32 51.29 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.864 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.449 ' CG2' ' NH1' ' A' ' 5' ' ' ARG . 91.8 mt -104.33 123.81 58.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.666 0.746 . . . . 0.0 112.913 -177.796 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.494 ' O ' ' N ' ' A' ' 56' ' ' GLN . 2.0 m-70 -118.21 137.19 53.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.506 -1.225 . . . . 0.0 109.437 179.06 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.466 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.9 mm-40 -39.38 -29.57 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -179.508 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.494 ' N ' ' O ' ' A' ' 54' ' ' HIS . 98.6 mm-40 -65.22 -66.52 0.53 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.955 178.656 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -157.49 -166.03 1.93 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.198 -179.65 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -108.95 130.79 55.46 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.699 179.129 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.46 HG21 HD12 ' A' ' 59' ' ' ILE . 37.1 mm -112.43 125.84 69.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.902 -179.473 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.1 tp -99.72 123.41 43.95 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.723 0.297 . . . . 0.0 110.53 -179.888 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -111.23 134.6 52.69 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.152 179.853 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.408 ' ND2' ' O ' ' A' ' 76' ' ' ILE . 46.6 p-10 -99.89 108.3 20.51 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 121.0 0.429 . . . . 0.0 111.537 -179.845 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -97.52 -9.65 26.72 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.7 -179.937 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.473 ' OG ' ' O ' ' A' ' 48' ' ' HIS . 0.3 OUTLIER -77.25 99.88 5.64 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 120.95 0.405 . . . . 0.0 110.764 -179.689 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 86.5 p -79.08 -31.44 44.37 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.875 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.6 m -64.41 -47.99 77.08 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.764 -179.796 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -147.61 99.17 3.85 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.25 -179.699 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -56.27 149.66 53.93 Favored 'Trans proline' 0 N--CA 1.499 1.794 0 C-N-CA 122.117 1.878 . . . . 0.0 113.215 -178.489 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 50.3 m -68.06 138.7 56.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.174 178.849 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -100.45 144.54 29.33 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.731 -179.745 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.43 ' O ' ' N ' ' A' ' 74' ' ' SER . 5.1 p -131.21 136.28 58.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.167 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 51.12 30.93 6.01 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -178.967 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.41 26.2 70.76 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.936 -179.86 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 71' ' ' VAL . 12.0 t -135.65 137.8 42.21 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.194 0.521 . . . . 0.0 111.534 -179.511 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.5 t -66.68 136.43 26.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.813 -179.784 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.515 ' CG2' ' O ' ' A' ' 78' ' ' GLU . 97.0 mt -101.27 100.86 11.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.561 179.383 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -64.44 -41.15 96.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.875 179.872 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.515 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.9 OUTLIER -132.54 -178.07 0.79 Allowed Pre-proline 0 N--CA 1.464 0.227 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.346 -178.656 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 31.3 Cg_exo -59.38 143.8 99.6 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.49 2.127 . . . . 0.0 111.642 -179.815 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.2 p -141.01 147.65 22.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-O 121.186 0.517 . . . . 0.0 112.078 -179.041 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -79.7 128.16 33.08 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.283 179.27 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.0 mt -83.33 139.15 33.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.22 -179.84 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.484 ' N ' ' OD2' ' A' ' 86' ' ' ASP . 99.2 mttt -128.81 153.67 47.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.795 179.166 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.538 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 3.6 t-160 -55.54 119.4 5.6 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.892 0.377 . . . . 0.0 110.383 -179.661 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.0 -13.66 31.65 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.687 179.606 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.523 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 2.4 p30 -72.06 133.2 45.11 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.406 -0.517 . . . . 0.0 109.894 179.564 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 45.7 t -109.21 130.12 62.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.583 -178.309 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 89.4 mt -98.21 131.29 45.56 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 178.401 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.6 m -119.27 127.91 53.67 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.951 0.882 . . . . 0.0 112.628 -178.066 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.587 ' O ' ' N ' ' A' ' 93' ' ' ARG . 98.4 mt -115.28 134.11 59.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.471 178.496 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.484 ' C ' ' O ' ' A' ' 90' ' ' ILE . 53.9 mt -31.73 100.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 O-C-N 123.028 0.205 . . . . 0.0 111.295 -179.857 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 91' ' ' ILE . 83.8 m-20 86.67 -16.11 0.42 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.132 0.973 . . . . 0.0 113.259 179.169 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.587 ' N ' ' O ' ' A' ' 90' ' ' ILE . 81.1 mmt-85 -130.43 141.53 50.53 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.902 179.517 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.5 m -139.02 148.58 43.6 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.611 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.472 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 18.8 m-85 -126.8 125.37 41.59 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.544 -179.804 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 49.0 ttt85 -84.5 131.18 34.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.885 0.374 . . . . 0.0 110.893 -179.647 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -94.73 122.2 37.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.917 -179.781 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -124.1 120.73 33.22 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.637 -179.679 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.538 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 43.9 t-20 . . . . . 0 C--N 1.332 -0.17 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.199 179.364 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo . . . . . 0 N--CA 1.49 1.319 0 CA-C-O 121.631 0.596 . . . . 0.0 113.289 . . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 35.1 m -76.44 135.42 26.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 114.66 -1.154 . . . . 0.0 109.989 179.799 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 5.1 t . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.403 -178.732 . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo . . . . . 0 N--CA 1.492 1.387 0 CA-C-O 120.922 0.301 . . . . 0.0 111.579 . . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 60.4 m -75.27 -43.01 53.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.599 177.445 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -59.18 -45.11 91.9 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.031 -179.949 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 98.2 mt -63.8 -39.32 93.95 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.091 0.472 . . . . 0.0 110.124 179.899 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -62.25 -41.71 98.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.768 179.985 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -62.36 -37.2 84.77 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.178 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.593 ' NH2' ' OE1' ' B' ' 248' ' ' GLN . 0.0 OUTLIER -58.5 -43.14 88.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.875 179.684 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -61.16 -38.48 86.6 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.587 -0.524 . . . . 0.0 109.587 178.95 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 38.0 t -64.1 -43.08 96.43 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 177.601 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . 0.593 ' OE1' ' NH2' ' B' ' 245' ' ' ARG . 36.7 mt-30 -58.49 -37.9 76.53 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.419 179.881 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 38.5 t . . . . . 0 N--CA 1.454 -0.238 0 C-N-CA 120.546 -0.461 . . . . 0.0 110.345 179.859 . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . 0.41 ' HB2' ' NH2' ' A' ' 93' ' ' ARG . 95.5 mt-10 . . . . . 0 N--CA 1.462 0.161 0 N-CA-C 111.366 0.136 . . . . 0.0 111.366 . . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 82.8 mt -111.47 132.28 60.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.838 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 54.9 t -127.98 136.03 61.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.149 -179.873 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -96.99 121.97 39.46 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.41 0.624 . . . . 0.0 111.258 -179.029 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . 0.462 ' HZ1' ' HA ' ' A' ' 34' ' ' GLU . 88.3 tttt -66.25 -46.16 78.07 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.037 179.473 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . 0.521 ' OE1' ' O ' ' B' ' 266' ' ' PRO . 0.0 OUTLIER -94.8 157.22 37.18 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.036 -179.418 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . 0.521 ' O ' ' OE1' ' B' ' 265' ' ' GLN . 57.2 Cg_endo -65.72 145.26 80.73 Favored 'Trans proline' 0 N--CA 1.5 1.882 0 C-N-CA 123.15 2.566 . . . . 0.0 113.118 -178.852 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 43.9 pt . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.224 178.95 . . . . . . . . 0 0 . 1 . 041 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 34.2 p . . . . . 0 N--CA 1.456 -0.148 0 CA-C-O 120.975 0.417 . . . . 0.0 110.528 . . . . . . . . . 0 0 . 1 . 041 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.733 ' NE ' ' HH ' ' A' ' 97' ' ' TYR . 83.5 mtp180 -85.17 129.89 34.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.155 -179.418 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.75 HH21 ' HD1' ' A' ' 19' ' ' HIS . 79.5 ttt180 -124.42 131.38 53.5 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -178.783 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 40.3 tp -109.81 132.36 54.22 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.208 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.7 t -109.79 128.45 65.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.467 -178.952 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.6 m -89.93 115.04 26.93 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.565 -179.429 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.4 mt -79.87 140.14 17.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.151 179.393 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -89.93 160.41 16.43 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.182 0.515 . . . . 0.0 111.046 179.071 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.597 ' NH2' ' N ' ' B' ' 249' ' ' VAL . 73.5 mtp180 -57.52 -31.96 66.57 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.779 -179.757 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 99.7 p -77.38 -11.59 59.86 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.634 -179.634 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.93 31.68 9.72 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 -179.682 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.7 t -115.86 133.37 62.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.432 -0.384 . . . . 0.0 110.427 -179.68 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.436 ' C ' ' OD1' ' A' ' 16' ' ' ASP . 49.0 t0 -62.02 120.33 10.61 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.6 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -103.31 -134.81 8.42 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 120.892 -0.67 . . . . 0.0 111.808 -178.7 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -75.14 150.7 37.94 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.526 2.151 . . . . 0.0 112.534 -178.945 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.75 ' HD1' HH21 ' A' ' 6' ' ' ARG . 0.6 OUTLIER -108.51 131.08 55.18 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.64 -179.541 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -100.84 100.38 12.59 Favored Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.347 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.28 134.74 21.45 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 121.095 1.197 . . . . 0.0 111.581 -178.303 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 68.2 mt -99.38 124.17 44.28 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.627 0.727 . . . . 0.0 111.574 -178.118 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.6 p -137.09 -19.7 1.27 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.404 -1.271 . . . . 0.0 109.284 178.714 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 58.7 mt -79.15 144.92 34.02 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.355 179.41 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 90.9 p -61.82 -21.3 64.5 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -178.248 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.441 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 53.9 m -135.08 134.79 40.69 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.213 -0.595 . . . . 0.0 112.561 -178.618 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.9 t -124.81 116.23 21.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.602 178.119 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 49.6 tp -116.73 132.86 56.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.957 0.408 . . . . 0.0 112.042 -178.337 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.441 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 10.8 m-85 -110.49 140.6 44.6 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.233 178.973 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 154.13 -176.29 32.06 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.044 178.735 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.646 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 80.2 mtm-85 -75.48 -30.72 59.99 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 120.956 0.407 . . . . 0.0 110.111 179.562 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.556 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -51.06 145.07 11.69 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.848 -178.608 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.403 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 10.7 tp -68.12 -41.0 83.86 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 120.872 0.368 . . . . 0.0 110.095 179.271 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.403 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 80.6 tt0 -55.67 -22.09 21.36 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.47 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.556 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 19.0 m -58.82 121.41 11.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.837 179.369 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.441 ' OD2' ' O ' ' A' ' 26' ' ' THR . 96.2 m-20 -58.65 -25.05 62.36 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -178.767 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 82.1 mt -131.21 122.74 51.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.565 177.27 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 60.6 mtm180 -101.08 134.22 44.41 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.491 179.658 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.404 ' C ' ' H ' ' A' ' 41' ' ' LEU . 96.4 mt -116.47 127.87 73.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.484 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -74.66 28.21 0.09 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.23 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.404 ' H ' ' C ' ' A' ' 39' ' ' ILE . 40.7 mt -98.31 129.54 30.34 Favored Pre-proline 0 CA--C 1.538 0.508 0 C-N-CA 119.924 -0.711 . . . . 0.0 110.737 179.922 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.59 -7.53 20.35 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.607 2.205 . . . . 0.0 112.072 -179.523 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.4 m -102.06 6.79 9.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.112 -179.355 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.646 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 17.4 t -95.08 136.43 26.17 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.268 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.864 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.5 m -69.43 167.48 16.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.054 0.454 . . . . 0.0 111.147 -179.384 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 47.3 mttp -63.5 -38.6 91.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.966 -179.53 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.676 ' O ' ' N ' ' A' ' 49' ' ' CYS . 91.7 mm-40 -113.66 -17.99 12.0 Favored 'General case' 0 C--O 1.223 -0.338 0 O-C-N 123.474 0.484 . . . . 0.0 111.371 -179.159 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 23.2 t60 29.63 -74.97 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.52 0.934 . . . . 0.0 113.52 -179.608 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.676 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.11 133.83 46.0 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.427 0.632 . . . . 0.0 112.402 -178.287 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -128.55 128.37 44.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.2 179.537 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 85.2 mt -109.47 132.37 57.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.422 179.667 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -114.63 124.24 51.33 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.11 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 64.5 mt -107.46 116.59 51.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 120.02 -0.672 . . . . 0.0 112.727 -177.661 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.455 ' O ' ' C ' ' A' ' 55' ' ' GLU . 97.4 m-70 -111.49 139.26 47.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.905 178.654 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 54' ' ' HIS . 84.0 tt0 -41.21 -30.05 0.15 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 119.926 -0.709 . . . . 0.0 109.306 -179.943 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.431 ' N ' ' O ' ' A' ' 54' ' ' HIS . 84.8 mt-30 -61.08 -68.09 0.34 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.622 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -156.19 -174.04 4.77 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.1 -179.772 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.512 ' CB ' HH22 ' A' ' 5' ' ' ARG . . . -108.32 125.3 51.54 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.022 179.732 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.1 mt -119.23 130.77 73.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.369 0.604 . . . . 0.0 112.471 -178.55 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 18.4 tp -97.86 127.94 44.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.367 179.503 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -109.0 134.81 51.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.891 179.621 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.417 HD22 ' HA ' ' A' ' 68' ' ' PRO . 64.5 t-20 -94.49 105.49 17.46 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.39 -178.866 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -98.75 -8.28 26.28 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.689 179.497 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.6 m -71.52 101.93 2.58 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.304 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 89.7 p -87.84 -24.13 23.8 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.107 179.821 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.27 -42.1 32.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.312 0.577 . . . . 0.0 109.769 179.323 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 36.7 m-20 -143.13 99.31 5.46 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.875 -179.498 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.417 ' HA ' HD22 ' A' ' 62' ' ' ASN . 52.7 Cg_exo -54.77 148.17 46.95 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.197 1.931 . . . . 0.0 113.41 -179.578 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.1 m -75.04 142.07 43.81 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.293 179.457 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -108.2 139.9 42.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.928 179.688 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 54.8 t -131.75 135.33 59.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.579 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 51.81 31.72 8.63 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.28 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.51 25.06 68.79 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-N 114.957 -1.02 . . . . 0.0 112.132 179.743 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 66.1 m -142.93 142.52 31.71 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 117.725 0.762 . . . . 0.0 112.57 -179.576 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.8 t -69.85 142.08 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.312 179.424 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.3 pt -110.98 77.08 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.478 179.221 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -52.55 -29.56 26.14 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.4 179.943 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.56 171.25 6.34 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.145 179.366 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -60.63 148.44 91.4 Favored 'Trans proline' 0 N--CA 1.499 1.84 0 C-N-CA 122.276 1.984 . . . . 0.0 111.832 179.631 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.8 p -138.15 140.83 39.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.995 0.426 . . . . 0.0 111.625 -179.391 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.9 mtm180 -75.12 128.53 35.73 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.025 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.5 mt -84.4 138.96 32.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.958 0.409 . . . . 0.0 111.054 -179.449 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -131.83 155.63 47.46 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.583 179.987 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.728 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 5.7 t60 -56.92 115.13 2.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.446 179.944 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.3 -12.49 26.15 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 -179.462 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.464 ' OD1' ' N ' ' A' ' 87' ' ' VAL . 58.7 t0 -70.01 129.79 40.41 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 179.615 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.464 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 60.9 t -110.96 131.82 61.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.228 -179.237 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 94.4 mt -97.63 129.79 47.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.379 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 77.7 m -120.46 125.71 48.59 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.69 0.757 . . . . 0.0 112.777 -178.231 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.47 ' N ' ' O ' ' A' ' 93' ' ' ARG . 95.7 mt -112.2 123.47 67.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.347 178.079 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.464 ' C ' ' O ' ' A' ' 90' ' ' ILE . 96.0 mt 34.33 -98.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 121.201 -0.2 . . . . 0.0 110.972 -178.883 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.587 ' OD2' ' CZ ' ' B' ' 245' ' ' ARG . 50.1 p-10 -114.43 15.03 17.97 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.913 0.387 . . . . 0.0 111.544 -179.99 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.47 ' O ' ' N ' ' A' ' 90' ' ' ILE . 84.6 mtt-85 -124.89 142.48 51.43 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.765 179.058 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 53.8 p -141.0 154.43 46.02 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.715 179.549 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -124.32 125.46 44.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.555 179.757 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 79.4 mtp85 -88.48 132.4 34.5 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.83 -179.494 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.733 ' HH ' ' NE ' ' A' ' 5' ' ' ARG . 88.3 t80 -95.21 127.87 41.6 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.197 -179.609 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -131.24 116.43 17.64 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.303 -179.613 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.728 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 61.9 t-20 . . . . . 0 N--CA 1.464 0.243 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.963 -179.806 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo . . . . . 0 N--CA 1.486 1.043 0 CA-C-O 121.624 0.594 . . . . 0.0 113.44 . . . . . . . . . 0 0 . 1 . 041 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 53.7 t -63.91 136.32 26.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.542 -179.355 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 14.8 t . . . . . 0 C--N 1.332 -0.187 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.764 . . . . . . . . 0 0 . 1 . 041 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo . . . . . 0 N--CA 1.493 1.473 0 CA-C-O 120.656 0.19 . . . . 0.0 111.986 . . . . . . . . . 0 0 . 1 . 041 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 19.9 m -68.3 -44.42 75.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.321 0.581 . . . . 0.0 109.67 178.001 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -58.47 -47.26 84.62 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.411 -179.296 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 93.8 mt -63.32 -40.68 97.99 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.146 -179.501 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -64.42 -41.25 96.71 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.115 -179.42 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -62.0 -41.86 98.52 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.016 -179.653 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.587 ' CZ ' ' OD2' ' A' ' 92' ' ' ASP . 8.2 tpp85 -61.28 -42.02 97.94 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.277 179.595 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -61.39 -41.38 97.04 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.412 179.891 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 58.5 m -68.75 -41.91 78.27 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.305 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . 0.434 ' HB3' HH22 ' A' ' 12' ' ' ARG . 62.1 tt0 -61.1 -39.67 90.84 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.119 -179.422 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . 0.597 ' N ' ' NH2' ' A' ' 12' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.465 0.297 0 C-N-CA 119.932 -0.707 . . . . 0.0 109.25 179.165 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . 0.422 ' CD ' HH21 ' A' ' 93' ' ' ARG . 97.0 mt-10 . . . . . 0 CA--C 1.535 0.402 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 . . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 65.0 mt -118.4 133.44 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 120.604 -0.438 . . . . 0.0 109.839 179.703 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 49.6 t -128.46 135.91 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 120.786 0.327 . . . . 0.0 110.836 -179.693 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -97.42 119.64 36.32 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.298 0.57 . . . . 0.0 112.156 -178.641 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . 0.403 ' HZ1' ' HA ' ' A' ' 34' ' ' GLU . 87.5 tttt -64.93 -45.37 86.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.292 178.552 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -89.9 157.84 45.48 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.393 -179.002 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -60.71 144.15 99.5 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 C-N-CA 122.055 1.837 . . . . 0.0 111.139 179.173 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . 0.498 ' CD1' ' O ' ' A' ' 19' ' ' HIS . 2.5 tt . . . . . 0 C--N 1.324 -0.514 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.549 -178.555 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.7 p . . . . . 0 C--O 1.232 0.164 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 . . . . . . . . . 0 0 . 1 . 042 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.4 mtm-85 -93.4 121.61 34.97 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.282 -178.725 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.747 HH21 ' ND1' ' A' ' 19' ' ' HIS . 80.5 ttt180 -130.23 132.01 45.78 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.757 -179.566 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 26.0 tp -112.84 133.33 54.88 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -179.928 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.6 t -110.49 131.98 60.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 121.071 -0.251 . . . . 0.0 110.903 -179.492 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 m -93.24 114.38 26.84 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.317 0.58 . . . . 0.0 112.026 -178.713 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.425 HG22 HD13 ' A' ' 10' ' ' ILE . 98.2 mt -83.73 146.63 6.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.712 178.538 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -90.49 158.77 16.86 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.903 0.382 . . . . 0.0 110.028 179.063 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' B' ' 245' ' ' ARG . 89.7 mtm180 -57.55 -25.54 60.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.03 -179.608 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 90.3 p -79.94 -10.67 59.8 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.838 179.56 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.59 34.69 7.74 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 -179.738 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.3 t -121.03 135.28 61.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.988 0.423 . . . . 0.0 111.381 -179.681 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -74.06 123.49 24.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.278 179.39 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -118.36 -119.97 2.95 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 120.894 -0.67 . . . . 0.0 111.724 -179.327 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -76.21 149.81 32.37 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.137 1.891 . . . . 0.0 111.549 -179.321 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.747 ' ND1' HH21 ' A' ' 6' ' ' ARG . 0.3 OUTLIER -111.79 156.66 21.61 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.787 179.93 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -121.76 101.97 42.06 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.03 -179.025 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -73.72 129.59 13.72 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 121.515 1.476 . . . . 0.0 111.359 -179.907 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 93.7 mt -82.12 52.64 2.04 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 120.779 0.324 . . . . 0.0 111.745 -178.567 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.401 ' OG ' ' OE1' ' B' ' 265' ' ' GLN . 91.5 p -62.69 -17.67 61.04 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.415 0.626 . . . . 0.0 109.947 179.22 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.0 mt -90.38 142.17 28.0 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.605 -179.545 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.1 m -66.08 -20.04 66.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.256 -179.847 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.5 m -130.41 131.96 45.51 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.516 -179.816 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.6 t -124.77 116.44 22.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.368 178.655 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 36' ' ' ASP . 50.9 tp -114.41 125.35 53.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.85 -178.753 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.52 ' O ' ' O ' ' A' ' 47' ' ' GLN . 6.9 m-85 -108.11 142.1 38.81 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.789 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 163.86 -165.98 37.24 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.197 -1.002 . . . . 0.0 112.336 178.71 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 28.8 ttp-105 -91.48 -31.0 16.14 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.8 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.576 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -60.75 156.63 31.68 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -179.659 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.7 tp -69.06 -39.27 79.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.872 -179.988 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -52.41 -23.46 6.07 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.969 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.576 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 6.1 m -61.25 118.84 7.39 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.118 -179.586 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.549 ' N ' ' O ' ' A' ' 28' ' ' LEU . 99.0 m-20 -58.53 -25.02 61.99 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.448 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 47.5 mm -123.63 108.57 21.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 177.021 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 45.0 mtm180 -100.36 135.08 42.34 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -177.969 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.417 HG22 ' NH2' ' A' ' 93' ' ' ARG . 96.8 mt -122.03 132.46 70.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.401 0.62 . . . . 0.0 111.477 -178.851 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -68.84 13.37 0.1 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 114.929 -1.032 . . . . 0.0 112.974 -178.579 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.714 ' CD1' HH21 ' A' ' 93' ' ' ARG . 17.5 mt -94.18 124.87 54.57 Favored Pre-proline 0 C--N 1.32 -0.712 0 C-N-CA 118.973 -1.091 . . . . 0.0 110.166 179.87 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -73.91 -8.97 21.92 Favored 'Trans proline' 0 C--N 1.315 -1.207 0 C-N-CA 122.165 1.91 . . . . 0.0 111.715 179.939 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.0 m -90.29 -0.1 8.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.193 179.302 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.0 p -91.03 139.32 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-O 121.123 0.487 . . . . 0.0 110.205 -179.986 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.8 t -68.88 161.86 27.77 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.226 0.536 . . . . 0.0 111.354 -178.768 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.468 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 79.9 mttt -61.22 -42.37 98.49 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.614 -178.383 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.672 ' O ' ' N ' ' A' ' 49' ' ' CYS . 90.1 mt-30 -115.44 -12.45 11.7 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 121.061 -0.256 . . . . 0.0 111.246 179.512 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.452 ' CD2' ' OG1' ' A' ' 69' ' ' THR . 20.1 t60 30.76 -73.37 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 179.49 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.672 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -135.56 140.51 44.72 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 119.91 -0.716 . . . . 0.0 112.324 -178.6 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -129.24 130.7 46.59 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.769 179.876 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.7 mt -111.83 131.96 61.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.989 179.717 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -113.34 124.56 52.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.863 179.032 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.456 HD13 HG23 ' A' ' 53' ' ' ILE . 48.3 mm -99.45 108.17 22.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.533 -179.895 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.458 ' O ' ' C ' ' A' ' 55' ' ' GLU . 94.7 m-70 -106.48 133.21 51.51 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.681 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 54' ' ' HIS . 95.7 mt-10 -42.32 -31.17 0.37 Allowed 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 119.585 -0.846 . . . . 0.0 108.974 -179.599 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.416 ' N ' ' C ' ' A' ' 54' ' ' HIS . 88.2 mt-30 -67.99 -68.83 0.36 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.759 178.831 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -146.86 176.16 10.1 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.13 0.491 . . . . 0.0 111.603 -179.128 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -111.33 123.2 49.73 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.678 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 93.1 mt -117.06 135.25 58.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -177.631 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 24.9 tp -100.59 125.64 46.98 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.876 -179.932 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -111.34 137.4 49.14 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.197 -179.539 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 64.0 t-20 -98.66 106.22 18.47 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.243 179.478 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -97.26 -10.68 25.29 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 179.865 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.98 106.86 3.36 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 179.955 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 85.7 p -91.88 -15.04 28.69 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.166 -0.613 . . . . 0.0 110.03 179.229 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.2 -46.12 7.55 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.567 -179.83 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -132.48 92.93 26.33 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.729 179.724 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -56.15 140.89 87.87 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.226 1.95 . . . . 0.0 112.821 -179.378 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.452 ' OG1' ' CD2' ' A' ' 48' ' ' HIS . 86.9 m -72.5 140.32 48.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.388 179.143 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -101.71 140.65 35.72 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.943 178.896 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.445 ' CG1' ' OD1' ' A' ' 86' ' ' ASP . 75.1 t -134.04 133.11 56.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.436 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.59 ' ND2' ' OD1' ' A' ' 86' ' ' ASP . 89.1 m-20 53.8 33.08 16.15 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 119.909 -0.716 . . . . 0.0 109.128 -179.264 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.63 28.68 68.86 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.077 179.587 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 43.3 t -145.61 143.94 30.16 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 117.242 0.521 . . . . 0.0 111.615 179.942 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 50.9 t -70.28 135.19 28.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.024 179.744 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 9.1 pt -108.36 70.47 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.16 179.048 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -56.17 -30.65 62.52 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.949 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.32 157.75 37.22 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.487 178.605 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -64.05 149.59 90.13 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.314 2.009 . . . . 0.0 112.202 -179.841 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.7 m -139.03 142.93 32.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.202 -179.645 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 60.2 ttp180 -72.69 125.32 27.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.394 179.25 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 98.0 mt -77.33 138.7 39.5 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.362 0.601 . . . . 0.0 110.779 179.299 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -136.35 155.15 50.46 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.93 -179.411 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.481 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 3.6 t-160 -55.83 113.16 1.38 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.358 -179.647 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.79 -6.76 22.16 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 121.169 -0.539 . . . . 0.0 111.767 179.977 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.59 ' OD1' ' ND2' ' A' ' 72' ' ' ASN . 37.9 t0 -76.73 124.34 27.53 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.249 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 45.8 t -108.12 129.5 62.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.328 -178.476 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 81.9 mt -97.13 132.2 42.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.842 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.9 m -116.41 126.23 53.15 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.072 0.463 . . . . 0.0 111.605 -179.448 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.4 ' CG2' HH12 ' A' ' 93' ' ' ARG . 87.8 mt -122.2 123.14 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.465 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 45.0 mm 40.31 -106.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 121.065 -0.254 . . . . 0.0 110.506 -179.609 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.562 ' O ' ' OD1' ' A' ' 92' ' ' ASP . 66.3 t0 -110.48 18.93 19.28 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.06 0.457 . . . . 0.0 110.677 -179.863 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.714 HH21 ' CD1' ' A' ' 41' ' ' LEU . 8.5 mtm105 -125.44 142.95 51.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.369 -179.985 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 75.2 m -134.43 147.36 50.42 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 120.355 -0.538 . . . . 0.0 109.713 178.296 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -125.28 124.29 41.31 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.931 -179.566 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -90.58 131.76 36.11 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.292 -179.116 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -93.4 123.76 36.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.372 179.269 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -120.04 126.48 50.9 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.213 -179.855 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.481 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 11.5 t-20 . . . . . 0 C--N 1.331 -0.212 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.612 179.732 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo . . . . . 0 N--CA 1.491 1.346 0 CA-C-O 121.334 0.473 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 042 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 39.4 t -61.81 138.59 22.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.271 -179.757 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 10.4 t . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.433 -179.428 . . . . . . . . 0 0 . 1 . 042 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo . . . . . 0 N--CA 1.495 1.607 0 N-CA-C 112.945 0.325 . . . . 0.0 112.945 . . . . . . . . . 0 0 . 1 . 042 nuclear orig core ' B' B ' 240' ' ' THR . . . . . 0.438 ' H ' ' HG1' ' B' ' 240' ' ' THR . 2.9 p -73.65 -40.67 63.55 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.908 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -57.25 -46.9 82.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.115 179.976 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 95.7 mt -64.12 -41.4 97.25 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.884 -179.758 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -62.1 -39.72 93.43 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.757 -179.457 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -63.0 -41.3 99.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.889 0.376 . . . . 0.0 110.688 179.407 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.421 ' HD2' HH11 ' A' ' 12' ' ' ARG . 22.7 mmt180 -62.61 -39.01 92.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.026 -179.605 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.32 -39.58 93.5 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.007 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 46.1 t -64.75 -45.01 88.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.488 177.629 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -60.4 -38.15 83.07 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.793 -179.348 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 40.3 t . . . . . 0 N--CA 1.448 -0.533 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.514 -179.791 . . . . . . . . 0 0 . 1 . 042 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . 0.57 ' N ' ' OE1' ' B' ' 260' ' ' GLU . 44.1 mp0 . . . . . 0 C--O 1.226 -0.146 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 . . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 44.6 mt -114.48 134.58 56.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.609 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 74.0 t -126.4 130.77 71.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.114 0.483 . . . . 0.0 110.18 179.6 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -90.62 116.38 28.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.467 -178.403 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -64.91 -44.41 89.67 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.18 179.688 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . 0.401 ' OE1' ' OG ' ' A' ' 23' ' ' SER . 0.0 OUTLIER -92.97 156.34 40.56 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.421 -179.144 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -61.74 145.66 97.18 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.843 2.362 . . . . 0.0 112.146 -179.944 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 27.2 pt . . . . . 0 C--N 1.321 -0.65 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.99 -179.695 . . . . . . . . 0 0 . 1 . 043 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.0 p . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.948 0.404 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 043 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 90.9 mtm-85 -98.7 124.98 43.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.489 -179.624 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 88.6 mtm-85 -129.0 137.85 51.59 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.903 -179.995 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 33.9 tp -109.96 129.52 55.65 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.986 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 52.8 t -109.76 131.15 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 120.942 0.401 . . . . 0.0 110.662 -179.463 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 m -79.78 140.33 36.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.449 -179.097 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.436 ' CD1' ' OD1' ' A' ' 16' ' ' ASP . 50.6 mm -108.69 135.52 47.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.509 177.505 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.7 mttm -86.86 156.4 19.87 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.258 179.185 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.496 ' CD ' ' OD2' ' A' ' 92' ' ' ASP . 89.3 mtm180 -57.1 -29.57 63.63 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.64 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.4 t -78.11 -14.54 59.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.674 179.303 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.75 35.57 5.83 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.208 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.1 t -119.98 130.45 74.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.963 0.411 . . . . 0.0 110.958 -179.623 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.436 ' OD1' ' CD1' ' A' ' 10' ' ' ILE . 97.7 m-20 -72.25 136.36 46.3 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.193 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -127.85 -122.74 2.54 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 120.533 -0.841 . . . . 0.0 111.971 -178.887 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -74.12 151.03 43.69 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.33 2.02 . . . . 0.0 112.779 -178.616 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -110.76 149.79 30.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.621 -179.712 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -122.19 102.7 39.91 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.475 -179.395 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.43 134.41 22.54 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.551 1.501 . . . . 0.0 112.105 -178.485 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 91.1 mt -81.62 56.53 3.02 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.129 -179.285 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.586 ' HG ' HE22 ' B' ' 265' ' ' GLN . 6.0 p -68.09 -23.09 64.89 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.142 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.5 mt -86.21 142.26 28.73 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.599 178.737 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 70.3 p -67.8 -16.17 63.98 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.484 -179.108 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.504 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 66.8 m -133.17 135.29 45.03 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.489 179.973 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.676 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 2.1 t -127.85 114.94 17.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.068 178.675 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.427 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 46.1 tp -110.96 128.16 55.74 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.588 -178.873 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.676 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 35.1 m-85 -104.75 137.57 42.35 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.788 178.933 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 158.55 -171.29 35.29 Favored Glycine 0 N--CA 1.471 1.022 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.809 179.091 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.591 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 83.2 mtm-85 -86.82 -29.61 22.13 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.442 -179.67 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -54.3 157.96 5.93 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 -178.355 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.9 tp -68.89 -40.26 80.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 O-C-N 122.639 -0.33 . . . . 0.0 110.539 179.65 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -57.05 -25.68 59.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.284 -179.825 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.418 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 75.9 m -50.84 115.07 1.34 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.349 179.709 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.504 ' OD2' ' O ' ' A' ' 26' ' ' THR . 94.2 m-20 -58.57 -31.86 68.39 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -179.594 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.435 HG21 HD13 ' A' ' 37' ' ' ILE . 95.2 mt -126.13 122.22 61.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 176.381 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 50.3 mtm180 -105.6 138.85 41.12 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.168 -0.613 . . . . 0.0 112.484 -178.721 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 90.5 mt -122.94 129.28 75.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.937 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -77.33 29.47 0.15 Allowed 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -177.894 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 78.5 mt -90.96 122.11 67.12 Favored Pre-proline 0 C--N 1.323 -0.581 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.671 179.455 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.7 -7.91 22.09 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 122.032 1.821 . . . . 0.0 112.061 -179.252 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.6 m -101.56 5.98 10.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.024 179.673 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.591 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 54.3 t -107.0 114.19 45.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.63 179.682 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.8 t -42.75 170.88 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 122.208 1.004 . . . . 0.0 113.303 -178.208 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.418 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 50.3 mttp -63.21 -40.32 97.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.475 -1.238 . . . . 0.0 112.003 -179.763 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.637 ' O ' ' N ' ' A' ' 49' ' ' CYS . 89.0 mt-30 -112.61 -13.34 13.31 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.217 -179.604 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.401 ' ND1' HG13 ' A' ' 44' ' ' VAL . 34.6 t60 36.73 -74.88 0.0 OUTLIER 'General case' 0 C--O 1.237 0.407 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 179.132 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.637 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -134.84 139.63 45.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.141 -178.336 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -128.94 132.77 47.66 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.603 179.927 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 95.5 mt -117.07 134.48 60.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.38 179.892 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -121.54 127.62 51.16 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.467 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 95.8 mt -102.22 118.32 48.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.368 0.604 . . . . 0.0 112.283 -178.473 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.536 ' O ' ' N ' ' A' ' 56' ' ' GLN . 1.9 m-70 -112.89 139.86 48.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.264 178.992 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.9 mm-40 -39.91 -26.48 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -179.586 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.536 ' N ' ' O ' ' A' ' 54' ' ' HIS . 88.5 mt-30 -65.08 -67.32 0.45 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.086 -0.961 . . . . 0.0 108.662 178.028 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -160.9 -162.7 0.95 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.806 0.336 . . . . 0.0 111.377 179.733 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -106.45 127.46 53.31 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.617 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.407 HG22 HD13 ' A' ' 59' ' ' ILE . 44.4 mm -110.51 125.96 67.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.432 -178.781 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 35.7 tp -99.82 126.84 45.99 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.615 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -117.12 136.71 52.8 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.614 0.245 . . . . 0.0 111.377 -179.328 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.477 HD22 ' CB ' ' A' ' 68' ' ' PRO . 48.5 t30 -98.33 106.41 18.69 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.384 179.573 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -98.59 -8.58 26.18 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 179.664 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.2 t -81.07 98.85 8.18 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.274 -179.799 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.4 t -77.87 -39.61 42.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.243 0.544 . . . . 0.0 109.651 178.238 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.09 -46.33 87.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.745 -179.49 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -137.23 93.86 12.76 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.26 -179.809 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.477 ' CB ' HD22 ' A' ' 62' ' ' ASN . 39.2 Cg_endo -64.57 148.76 90.56 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.4 1.4 . . . . 0.0 112.733 -177.76 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 89.2 m -75.42 153.62 37.57 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.6 -179.29 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -115.47 140.59 49.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.852 -179.572 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 50.4 t -129.46 136.15 59.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.679 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 52.32 32.55 11.19 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.522 0.677 . . . . 0.0 109.484 -179.784 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.06 25.04 74.61 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 114.909 -1.041 . . . . 0.0 112.523 178.973 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.8 t -139.31 141.38 37.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 117.444 0.622 . . . . 0.0 110.631 179.131 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 68.7 t -66.4 136.32 26.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.628 -179.559 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.1 pt -108.32 80.06 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.102 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.474 178.963 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -63.93 -31.63 72.88 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.361 0.601 . . . . 0.0 109.744 179.396 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -111.35 155.83 42.16 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.362 179.024 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -63.52 147.43 93.11 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 122.309 2.006 . . . . 0.0 112.209 -179.707 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.3 m -140.25 145.24 26.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.267 0.556 . . . . 0.0 111.534 -179.884 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -74.4 135.64 42.41 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.171 179.79 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.2 mt -81.02 134.19 35.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.921 0.391 . . . . 0.0 111.134 -179.552 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -128.49 149.29 50.65 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.778 179.119 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.403 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 8.3 t60 -52.01 118.3 3.36 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.873 0.368 . . . . 0.0 111.164 -178.669 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.42 -15.27 30.02 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.184 -0.767 . . . . 0.0 111.184 -179.844 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -69.6 131.93 45.42 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.681 179.975 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 71.4 t -113.78 133.85 58.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.94 -178.531 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.8 mt -102.91 132.87 48.16 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.985 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 96.7 m -120.35 126.91 51.68 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 120.027 -0.669 . . . . 0.0 111.669 -179.497 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.583 ' O ' ' N ' ' A' ' 93' ' ' ARG . 89.4 mt -116.07 130.37 70.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.329 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.556 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 84.5 mt -20.93 94.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -178.202 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.556 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 12.9 t0 94.44 -24.78 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 177.847 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.583 ' N ' ' O ' ' A' ' 90' ' ' ILE . 18.2 mtp85 -131.22 146.67 52.41 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.819 -179.949 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 93.9 p -140.04 156.28 46.68 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.95 0.405 . . . . 0.0 110.251 179.739 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -130.64 128.21 40.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.234 -179.631 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 73.7 mtp85 -89.43 134.69 33.98 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.503 -179.606 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -95.37 124.55 39.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.515 179.698 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -125.23 127.8 47.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.488 -179.9 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.403 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 59.8 t-20 . . . . . 0 C--N 1.331 -0.203 0 CA-C-O 120.82 0.343 . . . . 0.0 110.686 179.999 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo . . . . . 0 N--CA 1.491 1.376 0 CA-C-O 121.469 0.529 . . . . 0.0 112.998 . . . . . . . . . 0 0 . 1 . 043 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 55.3 t -60.56 138.31 21.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.279 -179.958 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 2.0 t . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.066 179.821 . . . . . . . . 0 0 . 1 . 043 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo . . . . . 0 N--CA 1.491 1.356 0 N-CA-C 112.379 0.107 . . . . 0.0 112.379 . . . . . . . . . 0 0 . 1 . 043 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 99.2 m -73.33 -46.07 51.5 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.042 178.513 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -58.3 -47.3 84.12 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.907 -178.47 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.8 -42.6 97.68 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.719 -0.393 . . . . 0.0 111.8 -179.392 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -65.48 -44.06 88.28 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.183 -179.197 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . 0.533 ' NH1' ' OE1' ' B' ' 248' ' ' GLN . 71.0 ttp85 -65.06 -43.49 92.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.999 0.428 . . . . 0.0 110.3 179.16 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . . . . . . . . . 14.5 tpp180 -61.68 -43.81 98.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.542 -179.604 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -65.49 -38.17 88.98 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.046 178.845 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 47.1 t -63.62 -45.15 91.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.464 179.257 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . 0.533 ' OE1' ' NH1' ' B' ' 244' ' ' ARG . 26.1 mt-30 -61.75 -36.13 80.12 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.758 -179.431 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 77.5 t . . . . . 0 C--N 1.327 -0.391 0 CA-C-O 121.025 0.44 . . . . 0.0 110.458 179.197 . . . . . . . . 0 0 . 1 . 043 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 . . . . . 0 N--CA 1.454 -0.255 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 . . . . . . . . . 0 0 . 1 . 043 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . 0.576 ' CD1' ' NE ' ' A' ' 93' ' ' ARG . 60.9 mt -107.2 134.01 50.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.691 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 62.3 t -126.56 131.69 71.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.454 -179.545 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -95.06 120.52 35.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.693 -178.361 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -65.46 -45.24 84.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.659 179.137 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . 0.586 HE22 ' HG ' ' A' ' 23' ' ' SER . 0.0 OUTLIER -89.5 152.77 47.73 Favored Pre-proline 0 C--O 1.231 0.117 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.606 -179.107 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -64.04 141.86 78.71 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.494 2.129 . . . . 0.0 112.116 -179.876 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.1 pt . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.818 179.052 . . . . . . . . 0 0 . 1 . 044 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.469 ' O ' ' O ' ' A' ' 99' ' ' ASN . 26.8 m . . . . . 0 N--CA 1.46 0.071 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 . . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.6 mtt85 -92.49 137.26 32.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.229 -178.208 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.7 mtt85 -130.5 139.62 50.51 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.187 -0.46 . . . . 0.0 112.032 -179.655 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 27.3 tp -113.42 130.84 56.21 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.479 179.862 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.5 ' CG1' ' OD1' ' A' ' 16' ' ' ASP . 41.0 t -109.43 129.61 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.215 -178.867 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.9 m -80.2 145.31 32.33 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.797 -178.798 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.7 mt -116.19 137.64 49.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 114.66 -1.155 . . . . 0.0 109.42 178.244 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.1 mttt -88.43 160.21 17.64 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.402 179.854 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.574 ' HG3' HH11 ' A' ' 93' ' ' ARG . 90.0 mtm180 -57.82 -32.33 67.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.428 -179.329 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.1 t -79.82 -5.87 56.24 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.356 179.358 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.45 38.17 7.25 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.933 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.5 t -115.0 132.57 63.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.298 0.57 . . . . 0.0 111.324 -179.799 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.5 ' OD1' ' CG1' ' A' ' 8' ' ' VAL . 67.1 t0 -77.15 122.84 25.57 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.106 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -118.3 -120.1 2.97 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.173 -178.509 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -74.46 152.56 43.81 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.317 2.011 . . . . 0.0 112.395 -178.893 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -111.17 147.74 34.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.057 0.456 . . . . 0.0 110.18 179.913 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -117.54 101.68 52.35 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.075 -179.255 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -73.08 136.54 24.87 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.279 1.32 . . . . 0.0 111.696 -179.592 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.0 mt -86.57 65.78 9.18 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.527 -178.307 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.594 ' OG ' ' NE2' ' B' ' 265' ' ' GLN . 18.0 p -68.8 -22.43 64.26 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.693 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 76.2 mt -87.53 142.19 28.05 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.378 179.977 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 61.4 p -66.21 -15.6 63.3 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.658 -179.322 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.507 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 35.6 m -133.02 134.04 43.89 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.988 0.423 . . . . 0.0 110.902 -179.558 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.8 t -126.56 118.13 24.24 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.275 179.911 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 44.6 tp -116.87 128.96 55.76 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.05 -179.071 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.539 ' O ' ' O ' ' A' ' 47' ' ' GLN . 5.8 m-85 -105.94 131.02 53.75 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.868 179.717 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.8 179.9 37.65 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 120.253 -0.975 . . . . 0.0 112.368 179.267 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.471 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 45.3 mtm105 -73.39 -32.53 64.51 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 179.573 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.567 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -48.44 149.28 3.97 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -178.548 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.533 ' CD1' ' NH1' ' A' ' 38' ' ' ARG . 10.4 tp -68.06 -41.99 84.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.339 0.59 . . . . 0.0 110.109 179.676 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.439 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 80.8 tt0 -56.74 -20.71 23.46 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.386 -179.823 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.567 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 14.8 m -58.12 128.41 37.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.129 -179.819 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.507 ' OD2' ' O ' ' A' ' 26' ' ' THR . 54.0 m-20 -62.4 -33.47 74.82 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.127 -179.712 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 93.2 mt -125.55 118.57 52.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 177.45 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.533 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 82.9 mtp180 -103.36 139.65 38.49 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.137 -178.762 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.458 ' C ' ' H ' ' A' ' 41' ' ' LEU . 80.5 mt -121.54 129.28 75.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.37 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -74.58 34.93 0.1 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.737 -178.367 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.458 ' H ' ' C ' ' A' ' 39' ' ' ILE . 38.2 mt -102.35 122.66 45.78 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.63 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.1 -6.11 18.45 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 122.415 2.077 . . . . 0.0 112.729 -178.802 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.436 ' CG2' ' CZ ' ' B' ' 241' ' ' PHE . 2.9 m -107.3 6.26 9.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.328 -179.749 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.48 ' O ' ' O ' ' A' ' 45' ' ' SER . 11.8 t -98.27 110.42 25.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.296 0.569 . . . . 0.0 110.693 -179.673 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.48 ' O ' ' O ' ' A' ' 44' ' ' VAL . 1.2 t -33.85 160.25 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.112 -0.949 . . . . 0.0 112.266 -178.94 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -62.04 -42.01 98.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.107 -179.416 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.653 ' O ' ' N ' ' A' ' 49' ' ' CYS . 90.0 mt-30 -114.75 -17.7 11.54 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.696 179.659 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 29.5 t60 35.98 -72.59 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 179.293 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.653 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.71 137.86 47.05 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.067 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -126.84 128.62 46.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.557 179.401 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.3 mt -116.67 135.19 57.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.73 0.3 . . . . 0.0 110.231 179.202 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -113.23 136.79 52.35 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.232 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.8 mm -104.19 124.24 58.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.078 -179.245 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.444 ' O ' ' C ' ' A' ' 55' ' ' GLU . 97.4 m-70 -128.63 135.76 49.75 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.967 179.348 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 54' ' ' HIS . 51.7 tp10 -40.26 -30.37 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.022 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.463 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 92.2 mt-30 -66.34 -67.89 0.41 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.255 178.266 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.508 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 8.3 tp10 -157.93 -158.07 0.7 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.726 -179.352 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.508 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -124.2 130.93 53.38 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.738 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.407 HG23 ' CE1' ' A' ' 61' ' ' HIS . 92.2 mt -119.55 130.67 73.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.188 0.518 . . . . 0.0 111.48 -179.109 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 25.1 tp -95.71 132.23 41.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.845 -179.753 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.407 ' CE1' HG23 ' A' ' 59' ' ' ILE . 98.0 m-70 -117.02 137.38 52.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.075 179.519 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.414 HD22 ' HA ' ' A' ' 68' ' ' PRO . 62.5 t-20 -95.45 106.44 18.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.046 -178.508 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -97.15 -13.54 22.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.972 179.201 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.12 101.21 4.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.46 179.869 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.6 m -87.2 -16.53 35.06 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.118 179.628 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.8 -45.64 10.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.16 179.453 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -135.96 95.67 13.54 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.373 -179.988 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.414 ' HA ' HD22 ' A' ' 62' ' ' ASN . 50.0 Cg_exo -55.16 142.8 77.15 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.227 1.951 . . . . 0.0 113.124 -179.934 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.415 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 5.3 m -70.41 140.85 52.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.008 179.181 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -102.1 140.72 36.01 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.507 -0.477 . . . . 0.0 109.953 179.57 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 51.8 t -129.78 134.64 62.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.52 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 50.28 32.84 6.61 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -179.585 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.37 25.7 67.6 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.628 179.532 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 29.6 t -140.74 141.23 34.89 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 117.606 0.703 . . . . 0.0 111.207 179.573 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -68.19 140.46 19.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.191 -179.878 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.462 ' CG1' ' O ' ' A' ' 78' ' ' GLU . 9.4 tt -106.74 94.03 2.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.43 179.59 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.5 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 16.2 p-10 -68.24 -34.33 76.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.43 179.844 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.462 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 0.1 OUTLIER -130.65 174.88 4.15 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.115 -178.838 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -61.0 142.89 98.86 Favored 'Trans proline' 0 N--CA 1.501 1.954 0 C-N-CA 122.678 2.252 . . . . 0.0 112.775 -179.615 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.2 m -140.33 143.67 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.402 179.857 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -75.05 126.65 31.47 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.812 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.6 mt -79.42 139.26 37.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.917 -179.677 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -126.36 150.12 48.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.445 179.956 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.811 ' HD1' ' H ' ' A' ' 99' ' ' ASN . 9.7 t60 -58.03 121.34 10.37 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.13 -179.561 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.84 -13.82 26.91 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -179.711 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -68.58 134.69 50.36 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.421 179.841 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 74.2 t -108.65 131.84 58.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.68 -178.794 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.465 ' O ' ' OG ' ' A' ' 94' ' ' SER . 83.0 mt -105.6 132.09 53.41 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.1 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.926 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 94.5 m -121.0 125.64 47.88 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 120.305 -0.558 . . . . 0.0 112.044 -178.261 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.454 ' O ' ' C ' ' A' ' 91' ' ' ILE . 92.4 mt -119.05 124.88 73.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 178.716 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.454 ' C ' ' O ' ' A' ' 90' ' ' ILE . 45.0 mm 35.17 -107.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.729 -178.761 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 92' ' ' ASP . 31.3 p-10 -106.04 12.07 30.82 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.385 -179.825 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.574 HH11 ' HG3' ' A' ' 12' ' ' ARG . 19.6 mmm180 -125.85 144.12 50.79 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.593 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' A' ' 88' ' ' ILE . 26.4 t -137.59 155.52 49.11 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.896 -179.858 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -130.13 130.96 45.45 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.559 -0.292 . . . . 0.0 110.739 179.889 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -94.65 134.1 37.59 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.157 179.441 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.459 ' OH ' ' OD1' ' A' ' 99' ' ' ASN . 64.2 t80 -97.63 126.51 42.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.853 179.727 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -134.88 125.69 27.27 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.177 179.849 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.811 ' H ' ' HD1' ' A' ' 84' ' ' HIS . 91.1 m-20 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.512 178.849 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo . . . . . 0 N--CA 1.49 1.29 0 CA-C-O 121.348 0.478 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 044 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 47.6 t -76.05 131.42 34.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.107 -0.951 . . . . 0.0 112.009 -178.334 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 4.0 t . . . . . 0 CA--C 1.518 -0.283 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 178.165 . . . . . . . . 0 0 . 1 . 044 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo . . . . . 0 N--CA 1.497 1.707 0 N-CA-C 112.694 0.229 . . . . 0.0 112.694 . . . . . . . . . 0 0 . 1 . 044 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 86.3 m -73.56 -44.09 58.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.224 0.535 . . . . 0.0 109.61 178.259 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . 0.717 ' CE1' ' NE ' ' B' ' 245' ' ' ARG . 53.4 t80 -56.85 -46.93 81.42 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.705 -178.911 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 95.7 mt -64.01 -40.57 96.63 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 121.076 0.465 . . . . 0.0 110.517 -179.856 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -64.1 -39.9 95.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.649 -179.303 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 44.2 ttm180 -60.84 -44.77 96.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.876 0.369 . . . . 0.0 110.209 -179.69 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.717 ' NE ' ' CE1' ' B' ' 241' ' ' PHE . 2.2 mtm-85 -63.26 -40.67 98.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.011 179.858 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.36 -41.42 98.83 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.268 179.117 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 31.3 t -65.93 -45.88 80.25 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.464 0.65 . . . . 0.0 109.674 178.959 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -63.43 -34.53 77.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.261 -179.792 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 51.7 t . . . . . 0 C--N 1.327 -0.405 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.687 179.743 . . . . . . . . 0 0 . 1 . 044 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 CA--C 1.529 0.17 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 . . . . . . . . . 0 0 . 1 . 044 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . 0.462 ' CD1' ' HE ' ' A' ' 93' ' ' ARG . 73.3 mt -109.78 140.44 28.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.913 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 78.7 t -128.34 136.38 60.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.865 -178.904 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -97.93 121.01 39.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.362 0.601 . . . . 0.0 111.71 -179.027 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -66.26 -42.79 88.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.194 179.479 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . 0.594 ' NE2' ' OG ' ' A' ' 23' ' ' SER . 0.0 OUTLIER -99.44 161.64 23.9 Favored Pre-proline 0 N--CA 1.465 0.322 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.274 -178.73 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -60.95 149.69 87.56 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.531 2.154 . . . . 0.0 112.14 178.875 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 44.5 pt . . . . . 0 C--N 1.331 -0.201 0 CA-C-O 121.534 0.683 . . . . 0.0 112.295 -179.091 . . . . . . . . 0 0 . 1 . 045 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.1 p . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.746 0.308 . . . . 0.0 110.663 . . . . . . . . . 0 0 . 1 . 045 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.423 ' HE ' ' CD1' ' A' ' 53' ' ' ILE . 87.7 mtm-85 -98.06 121.6 40.18 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.595 -179.711 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -129.98 137.9 50.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.072 179.839 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.455 ' CD2' ' N ' ' A' ' 7' ' ' LEU . 1.1 mm? -111.12 135.37 51.74 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.512 179.416 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.0 t -111.09 126.41 68.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.642 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 m -82.86 112.83 20.03 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.124 -178.337 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 98.1 mt -81.83 139.78 17.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.914 179.242 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -90.44 153.37 20.45 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.286 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.569 ' NH1' ' OD2' ' A' ' 92' ' ' ASP . 30.2 mtp85 -59.75 -26.46 65.69 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.709 179.82 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.3 p -72.53 -19.0 61.59 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.993 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.74 31.3 6.09 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 -179.646 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 51.9 t -121.06 132.37 70.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.928 0.394 . . . . 0.0 111.02 -179.814 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -76.85 139.87 40.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.062 179.262 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -130.9 -115.11 1.7 Allowed Glycine 0 CA--C 1.538 1.524 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.165 -179.378 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -70.21 144.89 52.95 Favored 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 122.2 1.933 . . . . 0.0 113.054 -178.538 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 59.0 m170 -109.14 135.15 50.74 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.586 -179.543 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -106.92 102.57 43.31 Favored Pre-proline 0 N--CA 1.467 0.385 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.043 -179.149 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.47 132.49 16.23 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 121.422 1.414 . . . . 0.0 111.971 -179.986 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 73.3 mt -85.8 58.48 5.07 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -178.745 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 86.5 p -66.76 -17.31 64.8 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 178.842 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.1 mt -86.68 139.67 30.54 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.475 -179.76 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.4 t -63.6 -18.61 64.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.717 -179.905 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.15 140.93 36.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.626 -179.19 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.666 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -137.37 132.57 33.73 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.093 178.875 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 56.3 tp -125.45 123.16 38.64 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.805 -179.067 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.666 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 46.5 m-85 -95.82 141.33 29.4 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.811 179.683 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 147.44 -176.8 26.11 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.066 178.685 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 45.5 mtm180 -70.8 -33.11 70.38 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 179.285 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.577 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -42.62 140.31 2.24 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -179.35 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.0 tp -67.0 -39.29 83.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.936 -179.694 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -58.81 -20.58 51.58 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.189 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.577 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 66.8 m -50.24 119.9 4.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.971 179.632 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -61.75 -31.77 71.98 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 179.736 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.4 HG13 ' CE2' ' A' ' 29' ' ' PHE . 27.1 mm -120.85 105.0 16.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 177.044 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.403 HH12 ' HG2' ' A' ' 40' ' ' GLN . 68.2 ttp85 -98.21 135.98 39.08 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.559 -178.457 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.52 ' CG2' ' NH1' ' A' ' 93' ' ' ARG . 94.5 mt -121.58 131.59 72.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.902 -179.683 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.403 ' HG2' HH12 ' A' ' 38' ' ' ARG . 74.5 mt-30 -78.26 31.78 0.18 Allowed 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -177.693 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 87.1 mt -96.34 122.93 56.4 Favored Pre-proline 0 C--N 1.326 -0.454 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.727 179.586 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.08 -8.29 21.92 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 122.261 1.974 . . . . 0.0 112.601 -179.361 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.5 m -102.17 4.76 10.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.191 179.997 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.0 p -97.32 150.3 4.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.348 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.2 163.43 27.85 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.805 0.812 . . . . 0.0 112.186 -178.869 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.9 mtmt -63.76 -38.1 89.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.131 -179.558 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.621 ' O ' ' N ' ' A' ' 49' ' ' CYS . 10.4 mm100 -110.58 -20.33 12.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.024 0.44 . . . . 0.0 109.967 179.897 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.8 t60 38.3 -77.32 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 179.021 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.621 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -134.73 137.73 43.73 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.42 -0.512 . . . . 0.0 112.085 -178.038 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -123.65 131.57 53.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.886 179.225 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.2 tt -120.13 134.62 63.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.716 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -120.75 128.42 52.9 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.35 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.423 ' CD1' ' HE ' ' A' ' 5' ' ' ARG . 78.4 mt -106.43 122.37 60.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 119.774 -0.77 . . . . 0.0 112.262 -178.754 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.51 ' CD2' ' N ' ' A' ' 54' ' ' HIS . 2.4 m-70 -114.42 137.95 51.18 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.785 179.666 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.466 ' C ' ' O ' ' A' ' 54' ' ' HIS . 97.7 mt-10 -40.93 -29.77 0.11 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.75 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.452 ' N ' ' C ' ' A' ' 54' ' ' HIS . 59.4 tt0 -64.31 -68.21 0.37 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.798 178.294 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -156.82 -168.31 2.63 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.202 -179.853 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -105.52 133.23 50.61 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.532 -179.747 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.419 HG21 HD13 ' A' ' 59' ' ' ILE . 41.4 mm -118.86 125.55 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 120.511 -0.475 . . . . 0.0 111.502 -179.491 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 57.3 tp -104.65 130.48 52.66 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.836 -179.954 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.9 m-70 -121.55 140.41 52.26 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.741 179.923 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.714 ' ND2' ' H ' ' A' ' 69' ' ' THR . 25.2 t-20 -104.62 110.77 23.21 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.892 0.377 . . . . 0.0 111.957 179.743 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -96.66 -4.33 41.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.417 179.18 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.44 100.65 9.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.518 179.97 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 86.5 p -84.87 -29.11 25.53 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.285 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.42 ' O ' ' OD1' ' A' ' 67' ' ' ASN . 2.1 m -64.3 -49.27 72.43 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.078 179.388 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.421 ' OD1' ' CG2' ' B' ' 236' ' ' VAL . 2.7 m-20 -145.75 100.37 4.33 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.563 179.623 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.79 153.23 78.88 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 121.308 1.338 . . . . 0.0 112.038 -178.933 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.714 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 28.3 m -75.14 150.41 38.76 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.642 -179.5 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -108.48 141.18 40.74 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.933 179.307 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 48.8 t -128.2 134.4 65.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.309 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 53.66 31.4 12.63 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -178.622 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.76 29.16 67.82 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.051 179.522 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 67.0 m -139.67 138.52 36.12 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 117.076 0.438 . . . . 0.0 111.213 -179.967 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.7 t -69.94 133.98 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.707 179.527 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.3 pt -101.38 94.14 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 CA-C-O 121.241 0.543 . . . . 0.0 110.506 179.338 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -63.95 -34.47 78.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.123 179.714 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -124.44 172.64 5.6 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.922 179.978 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.61 143.21 99.72 Favored 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 122.151 1.901 . . . . 0.0 112.549 -179.709 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 48.1 t -131.36 138.97 51.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.075 179.905 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 95.8 mtm-85 -76.38 128.82 35.59 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.777 179.174 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 93.7 mt -86.04 134.04 33.87 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.245 0.545 . . . . 0.0 111.277 -179.333 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -124.45 154.41 40.51 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.244 178.954 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.579 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 4.5 t60 -53.63 118.9 4.27 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.32 -179.504 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.44 -11.66 28.31 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.823 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.425 ' C ' ' OD1' ' A' ' 86' ' ' ASP . 50.2 t0 -71.73 126.09 28.82 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.407 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 43.7 t -107.86 129.08 62.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.493 -179.203 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.523 ' O ' ' OG ' ' A' ' 94' ' ' SER . 94.3 mt -94.29 132.52 38.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.315 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.8 m -123.47 123.26 40.24 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.49 0.662 . . . . 0.0 112.572 -178.775 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.511 ' O ' ' N ' ' A' ' 93' ' ' ARG . 90.0 mt -109.51 123.82 65.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.197 177.845 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.487 ' C ' ' O ' ' A' ' 90' ' ' ILE . 86.8 mt 35.2 -96.82 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.509 -0.477 . . . . 0.0 110.613 179.746 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.569 ' OD2' ' NH1' ' A' ' 12' ' ' ARG . 20.8 p-10 -115.03 12.19 16.65 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.736 179.999 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.692 HH21 ' NH2' ' B' ' 245' ' ' ARG . 98.9 mtt180 -124.02 142.13 51.44 Favored 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.444 179.938 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.523 ' OG ' ' O ' ' A' ' 88' ' ' ILE . 38.9 t -138.5 147.62 43.38 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.583 179.834 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -121.78 120.64 35.21 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.095 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -79.7 131.79 36.04 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.343 -178.656 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -95.41 122.18 37.86 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.606 179.855 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -124.56 124.57 42.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.706 -179.708 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.579 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 59.0 t-20 . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.213 -179.929 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo . . . . . 0 N--CA 1.486 1.051 0 CA-C-O 121.714 0.631 . . . . 0.0 112.799 . . . . . . . . . 0 0 . 1 . 045 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . 0.421 ' CG2' ' OD1' ' A' ' 67' ' ' ASN . 1.0 OUTLIER -64.44 136.9 25.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.01 -179.473 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 7.7 t . . . . . 0 C--N 1.332 -0.186 0 CA-C-O 120.843 0.354 . . . . 0.0 110.488 -179.079 . . . . . . . . 0 0 . 1 . 045 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo . . . . . 0 N--CA 1.495 1.578 0 N-CA-C 112.866 0.295 . . . . 0.0 112.866 . . . . . . . . . 0 0 . 1 . 045 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 35.8 p -75.47 -40.69 57.07 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.316 -0.553 . . . . 0.0 109.704 178.603 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -57.17 -47.36 81.42 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.677 -179.592 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 91.6 mt -62.65 -41.11 98.87 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.635 179.93 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -65.26 -41.49 94.2 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.76 -179.29 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 80.9 mtt85 -62.18 -43.04 99.72 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.093 179.495 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.692 ' NH2' HH21 ' A' ' 93' ' ' ARG . 24.1 mmm180 -61.19 -39.76 91.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.082 -178.622 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.43 -38.71 90.8 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 179.057 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 71.1 m -62.9 -43.66 98.19 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 177.413 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -59.15 -36.6 75.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.194 179.761 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 63.3 t . . . . . 0 N--CA 1.453 -0.297 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.393 179.646 . . . . . . . . 0 0 . 1 . 045 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . 0.627 ' OE1' ' NH2' ' A' ' 93' ' ' ARG . 98.3 mt-10 . . . . . 0 CA--C 1.531 0.214 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 . . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 77.9 mt -118.31 133.84 63.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 177.225 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 68.3 t -126.24 133.04 69.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.381 -178.494 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -93.42 116.64 29.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.802 -179.307 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -64.49 -42.33 95.94 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.207 179.212 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -101.84 169.77 7.26 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.875 -179.398 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -62.29 149.68 89.81 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 121.752 1.635 . . . . 0.0 113.495 -179.281 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 19.8 pt . . . . . 0 N--CA 1.462 0.151 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.912 -179.175 . . . . . . . . 0 0 . 1 . 046 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.6 p . . . . . 0 CA--C 1.521 -0.137 0 CA-C-O 120.619 0.247 . . . . 0.0 111.311 . . . . . . . . . 0 0 . 1 . 046 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -96.52 122.08 39.04 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.094 -179.417 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -128.35 142.61 51.07 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.184 0.516 . . . . 0.0 111.339 -179.14 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 45.2 tp -113.38 133.09 55.34 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.304 -179.362 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.0 t -109.01 131.11 60.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.32 -179.617 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.5 m -92.3 115.55 28.18 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.514 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.422 HG21 HD12 ' A' ' 10' ' ' ILE . 98.4 mt -83.13 145.43 8.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.242 179.014 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -91.44 162.08 14.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.163 0.506 . . . . 0.0 110.863 178.928 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.572 ' NH1' ' OE2' ' B' ' 260' ' ' GLU . 88.6 mtm180 -57.95 -30.07 65.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.792 -179.638 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.2 m -78.35 -8.61 58.63 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.813 0.339 . . . . 0.0 110.591 179.759 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.3 29.38 12.51 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -179.89 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.8 t -120.02 133.72 65.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.841 0.353 . . . . 0.0 110.075 179.95 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.488 ' O ' ' OD1' ' A' ' 16' ' ' ASP . 43.3 p30 -79.7 141.59 36.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.553 -179.978 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -128.42 -112.29 1.65 Allowed Glycine 0 CA--C 1.535 1.327 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 -179.923 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -75.02 150.05 37.51 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 122.627 2.218 . . . . 0.0 112.978 -179.329 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -111.24 148.97 31.69 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.415 179.694 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -117.44 104.58 49.67 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.66 -179.817 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.83 131.43 15.76 Favored 'Trans proline' 0 N--CA 1.489 1.229 0 C-N-CA 121.371 1.381 . . . . 0.0 111.942 -178.905 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 83.4 mt -88.97 46.03 1.35 Allowed 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.082 -178.67 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -55.99 -32.01 63.55 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.668 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 69.4 mt -69.75 142.78 53.2 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.654 179.436 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 97.8 p -63.5 -16.86 61.91 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.327 -178.917 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.5 m -145.15 145.42 31.36 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.694 -0.403 . . . . 0.0 110.845 179.61 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.677 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -136.54 127.82 28.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.662 179.327 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.449 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 40.0 tp -114.39 123.92 50.68 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -178.156 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.677 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 54.3 m-85 -97.39 133.59 41.78 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.987 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 177.09 -177.7 48.25 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 119.533 -1.318 . . . . 0.0 112.871 179.609 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 23.6 ttp85 -89.25 -23.79 22.25 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.946 -0.627 . . . . 0.0 110.994 179.944 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.71 152.16 45.59 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 -179.823 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.48 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 10.6 tp -64.12 -41.26 91.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.104 0.478 . . . . 0.0 110.195 179.45 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.48 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 83.1 tt0 -51.37 -17.49 0.77 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.972 -179.764 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 24.0 m -75.08 139.08 42.55 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.493 179.986 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.449 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 57.1 m-20 -61.13 -32.81 72.5 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 -179.445 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 94.2 mt -123.03 116.98 50.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 177.44 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.1 ttp180 -103.95 131.95 50.68 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.397 -178.425 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 80.0 mt -117.34 132.26 67.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.086 0.47 . . . . 0.0 110.012 -179.41 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -76.71 30.93 0.13 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.77 -177.857 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.455 ' CD1' ' HE ' ' A' ' 93' ' ' ARG . 33.3 mt -103.2 131.84 21.72 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.727 179.247 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.96 -10.01 24.22 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.531 2.154 . . . . 0.0 112.642 -179.519 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.1 m -97.62 7.22 8.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.872 -179.989 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.499 ' CG2' ' NH2' ' A' ' 93' ' ' ARG . 28.6 t -95.09 134.61 31.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.202 179.236 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.3 t -73.44 171.16 13.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.409 0.623 . . . . 0.0 111.54 -179.152 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -63.5 -42.88 98.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.8 -179.053 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.652 ' O ' ' N ' ' A' ' 49' ' ' CYS . 98.3 mt-30 -113.89 -21.19 10.76 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.384 -179.612 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.0 t60 41.04 -74.94 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.957 179.621 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.652 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -140.29 141.75 35.75 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.537 -179.201 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -128.02 133.03 49.08 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.639 178.795 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.5 tt -112.06 134.46 54.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -179.872 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -118.15 132.81 56.31 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 -179.875 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 98.3 mt -112.21 117.89 56.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.664 0.745 . . . . 0.0 112.613 -179.135 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.452 ' O ' ' N ' ' A' ' 56' ' ' GLN . 91.4 m-70 -116.65 139.63 50.31 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.211 178.808 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 54' ' ' HIS . 82.6 tt0 -40.13 -30.0 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.252 0.548 . . . . 0.0 109.634 -179.295 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.477 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 60.1 tt0 -65.34 -68.21 0.38 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.053 179.118 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.477 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 3.4 tp10 -154.15 -172.95 4.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.833 -178.976 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -107.24 130.02 54.8 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.827 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.6 mt -120.05 129.65 75.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.437 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 45.2 tp -100.17 127.88 46.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.209 179.532 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -114.97 137.79 51.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.502 -179.877 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.661 ' ND2' ' H ' ' A' ' 69' ' ' THR . 28.9 t-20 -100.27 108.24 20.26 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.755 0.312 . . . . 0.0 111.825 179.802 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -99.21 -7.39 26.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.995 179.454 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.36 102.22 13.81 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.733 0.301 . . . . 0.0 111.112 -179.742 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.1 m -83.99 -27.69 28.25 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.643 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.3 m -64.24 -48.66 74.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.604 179.769 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -140.13 95.31 8.47 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.02 -179.899 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -56.78 144.6 86.73 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.173 1.915 . . . . 0.0 112.534 -179.765 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.661 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 18.3 m -75.79 141.79 42.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.473 179.248 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -103.57 140.98 36.8 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.523 -179.73 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 55.7 t -129.57 132.44 66.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.966 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 51.38 31.72 7.58 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.184 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.9 28.13 63.29 Favored Glycine 0 CA--C 1.534 1.25 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.088 179.636 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 35.0 t -142.35 141.65 32.36 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 117.274 0.537 . . . . 0.0 111.451 179.945 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 54.1 t -69.79 141.5 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.109 179.946 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.1 pt -116.22 75.83 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.557 179.233 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -65.67 -26.22 67.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.84 0.352 . . . . 0.0 110.26 179.832 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -112.18 160.98 28.08 Favored Pre-proline 0 CA--C 1.532 0.26 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.376 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.8 140.24 94.24 Favored 'Trans proline' 0 N--CA 1.499 1.827 0 C-N-CA 121.46 1.44 . . . . 0.0 111.994 179.852 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.3 t -133.61 136.32 54.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.999 179.944 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -74.9 130.44 39.41 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 178.764 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.0 mt -84.1 140.64 31.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.161 0.505 . . . . 0.0 111.611 -179.607 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -129.33 151.24 50.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.371 179.69 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.701 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 6.3 t60 -54.69 119.0 4.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.704 -179.225 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.66 -13.33 35.47 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 179.873 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -68.85 134.22 49.36 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.337 -0.545 . . . . 0.0 109.762 179.631 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.3 t -109.38 132.23 58.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.139 -178.425 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 81.6 mt -103.82 131.06 53.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.844 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.43 ' HG1' ' HG ' ' A' ' 94' ' ' SER . 2.5 m -118.72 125.73 50.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.468 0.651 . . . . 0.0 111.823 -179.607 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.522 ' O ' ' N ' ' A' ' 93' ' ' ARG . 89.3 mt -118.1 123.7 72.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.535 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.45 ' C ' ' O ' ' A' ' 90' ' ' ILE . 46.7 mm 40.78 -108.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.205 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -111.28 12.68 21.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.253 0.549 . . . . 0.0 110.132 178.829 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.522 ' N ' ' O ' ' A' ' 90' ' ' ILE . 18.8 mtm105 -112.28 139.6 47.7 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.862 179.715 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.43 ' HG ' ' HG1' ' A' ' 89' ' ' THR . 37.4 t -135.54 145.54 47.13 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.775 178.976 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -124.15 122.6 38.26 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.87 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -86.35 132.74 33.89 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.2 -0.6 . . . . 0.0 111.387 -179.324 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.516 ' CZ ' ' OD1' ' A' ' 99' ' ' ASN . 93.8 t80 -95.5 124.16 39.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.969 179.485 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -139.81 127.18 21.38 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.257 -0.577 . . . . 0.0 111.51 -179.161 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.701 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 92.3 m-20 . . . . . 0 CA--C 1.529 0.144 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.977 -179.754 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo . . . . . 0 N--CA 1.494 1.528 0 N-CA-C 114.41 0.888 . . . . 0.0 114.41 . . . . . . . . . 0 0 . 1 . 046 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -69.28 137.73 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 114.38 -1.282 . . . . 0.0 110.445 179.991 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 6.8 t . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.384 -179.687 . . . . . . . . 0 0 . 1 . 046 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo . . . . . 0 N--CA 1.503 2.043 0 N-CA-C 114.31 0.85 . . . . 0.0 114.31 . . . . . . . . . 0 0 . 1 . 046 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 7.7 p -74.76 -38.89 62.08 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.154 -0.619 . . . . 0.0 110.02 179.071 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . 0.485 ' CZ ' ' NH2' ' B' ' 245' ' ' ARG . 66.6 t80 -58.71 -45.3 89.85 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.696 -179.294 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 95.6 mt -64.91 -40.66 95.42 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.838 0.351 . . . . 0.0 111.209 179.681 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -64.33 -44.06 92.71 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.088 -179.025 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 62.8 ttm-85 -60.49 -42.53 96.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.264 0.554 . . . . 0.0 109.886 179.556 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.485 ' NH2' ' CZ ' ' B' ' 241' ' ' PHE . 48.5 ttm-85 -60.62 -43.18 97.78 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.127 -178.965 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.02 -38.64 89.44 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.35 -179.516 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 15.6 t -65.91 -42.99 89.46 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 177.536 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 69.2 tp60 -59.4 -38.02 79.5 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.61 179.845 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 43.3 t . . . . . 0 C--N 1.331 -0.213 0 C-N-CA 120.614 -0.435 . . . . 0.0 109.873 179.315 . . . . . . . . 0 0 . 1 . 046 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . 0.572 ' OE2' ' NH1' ' A' ' 12' ' ' ARG . 97.0 mt-10 . . . . . 0 CA--C 1.529 0.138 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 . . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 64.5 mt -118.4 134.01 63.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.078 -179.743 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 40.7 t -128.24 134.85 64.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.996 -179.705 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -96.03 119.0 33.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.554 -178.904 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -65.22 -44.46 88.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.924 178.871 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -97.35 158.38 33.28 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.382 -179.728 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -69.53 145.74 59.42 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 123.022 2.481 . . . . 0.0 113.398 -179.264 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 48.6 pt . . . . . 0 C--N 1.332 -0.155 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.434 179.061 . . . . . . . . 0 0 . 1 . 047 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 77.0 p . . . . . 0 C--O 1.232 0.177 0 CA-C-O 121.032 0.444 . . . . 0.0 110.439 . . . . . . . . . 0 0 . 1 . 047 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.4 mtt85 -96.46 119.59 35.22 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.784 179.875 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.9 mtm180 -132.85 141.42 48.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.936 0.398 . . . . 0.0 111.323 -179.292 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 64.0 mt -114.35 142.37 46.41 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.669 -179.375 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 76.6 t -117.05 130.55 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.651 178.833 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.8 m -87.28 113.58 23.13 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -178.163 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 95.1 mt -80.9 140.05 17.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.404 177.781 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -88.21 155.42 19.77 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 178.36 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.675 HH12 ' NH1' ' B' ' 245' ' ' ARG . 75.1 mtp85 -59.29 -26.5 65.01 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.235 -178.899 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.0 m -76.9 -18.75 58.1 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.034 0.445 . . . . 0.0 110.667 179.328 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.08 33.99 4.73 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.196 -1.161 . . . . 0.0 110.196 -179.718 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.2 t -124.13 129.91 73.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.478 0.18 . . . . 0.0 110.533 179.991 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -73.3 138.02 45.19 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.439 179.265 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -125.96 -117.03 2.13 Favored Glycine 0 CA--C 1.541 1.688 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.323 -179.298 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -75.95 147.67 30.77 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 122.765 2.31 . . . . 0.0 112.384 -178.505 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -108.36 148.66 29.78 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.414 179.913 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -118.69 101.28 50.72 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.284 -179.876 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.31 135.04 23.92 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.012 1.808 . . . . 0.0 111.629 -179.266 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.6 mt -91.03 49.49 1.65 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.069 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 34.4 t -61.71 -19.1 62.02 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.508 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 80.7 mt -80.14 138.0 36.83 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.057 -179.895 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.1 m -64.76 -19.79 66.0 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.994 -179.486 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.505 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 39.0 m -135.45 135.2 40.34 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.618 -179.405 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.683 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 5.4 t -130.38 120.75 24.76 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.163 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.8 tp -118.99 128.77 54.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.308 -178.723 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.683 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 3.9 m-85 -105.05 142.59 34.56 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -179.875 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 146.83 -174.36 26.69 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.887 178.587 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.426 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 46.3 mtm180 -74.03 -33.03 63.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 179.42 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.504 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -41.85 144.81 0.8 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 -179.05 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.466 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 10.3 tp -67.42 -41.86 86.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 O-C-N 122.219 -0.577 . . . . 0.0 109.824 179.483 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.466 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 76.4 mm-40 -58.15 -23.3 54.78 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.178 179.374 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.504 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 57.4 m -50.9 118.24 3.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.077 179.969 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.505 ' OD2' ' O ' ' A' ' 26' ' ' THR . 57.6 m-20 -57.52 -30.6 65.29 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.817 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.414 HG21 HD11 ' A' ' 37' ' ' ILE . 87.8 mt -125.15 118.86 54.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.239 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -104.74 134.74 47.39 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.913 -178.962 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.42 HG21 HD11 ' A' ' 39' ' ' ILE . 95.7 mt -114.57 127.23 72.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 121.2 0.524 . . . . 0.0 110.788 179.294 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -70.74 39.37 0.05 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.289 -0.869 . . . . 0.0 113.115 -178.322 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.493 ' CD1' ' NH2' ' A' ' 93' ' ' ARG . 79.3 mt -117.02 130.99 24.21 Favored Pre-proline 0 C--N 1.326 -0.449 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.369 179.738 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -72.7 -9.19 23.58 Favored 'Trans proline' 0 N--CA 1.489 1.235 0 C-N-CA 122.122 1.881 . . . . 0.0 112.162 179.522 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.0 m -99.11 1.98 10.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.894 179.808 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.426 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 6.3 t -86.92 134.93 26.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.268 0.556 . . . . 0.0 110.315 179.412 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.8 m -65.06 160.02 21.95 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.742 -178.987 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -63.72 -43.63 95.98 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.276 -179.085 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.636 ' O ' ' N ' ' A' ' 49' ' ' CYS . 12.1 mm100 -112.75 -23.43 10.17 Favored 'General case' 0 C--O 1.227 -0.123 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.424 179.929 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.3 t60 37.14 -76.75 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.078 -0.964 . . . . 0.0 112.932 179.855 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.636 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.0 136.1 47.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.337 0.589 . . . . 0.0 112.28 -178.539 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -125.39 129.09 49.2 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.781 179.683 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 93.8 mt -114.11 133.71 59.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.181 178.781 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -115.25 128.89 56.43 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.532 179.013 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 51.8 mm -99.0 118.66 45.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.989 -179.807 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.435 ' O ' ' C ' ' A' ' 55' ' ' GLU . 99.5 m-70 -120.31 135.09 55.13 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.33 179.646 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 54' ' ' HIS . 82.6 tt0 -40.46 -32.03 0.18 Allowed 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -179.675 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.434 ' N ' ' C ' ' A' ' 54' ' ' HIS . 88.7 mt-30 -67.53 -68.48 0.38 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.041 179.236 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.476 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 5.1 tp10 -153.84 -167.05 2.55 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.369 -179.067 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.476 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -119.44 130.4 55.25 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.435 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.441 HD12 HG22 ' A' ' 59' ' ' ILE . 99.5 mt -117.97 131.16 71.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.634 0.731 . . . . 0.0 111.981 -178.433 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.7 tp -99.78 127.53 45.93 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.213 179.624 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -110.16 133.64 53.01 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.208 -178.881 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 61.4 t-20 -93.25 104.57 16.74 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.948 179.889 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -100.93 -11.93 19.35 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 120.995 -0.282 . . . . 0.0 111.594 179.812 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 m -68.29 99.78 0.96 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.421 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 87.9 p -85.38 -10.11 56.7 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.525 -179.774 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.19 -43.12 6.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.117 179.88 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -133.84 95.61 17.17 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.991 -179.709 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.0 141.2 86.72 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.395 2.063 . . . . 0.0 112.882 -179.735 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.2 m -74.07 136.63 43.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.283 179.174 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -100.6 139.31 36.47 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.212 179.362 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.7 t -131.62 133.37 61.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 178.76 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 54.52 32.68 17.34 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -178.844 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.3 27.22 72.02 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.115 179.487 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 28.5 t -141.29 136.96 32.11 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 117.377 0.589 . . . . 0.0 111.501 -179.966 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -70.06 138.58 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.862 179.652 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.3 pt -114.08 91.57 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 121.208 0.528 . . . . 0.0 111.401 179.664 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -66.49 -26.86 67.38 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.823 178.494 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.495 ' N ' ' OE1' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -119.21 162.07 33.66 Favored Pre-proline 0 N--CA 1.465 0.295 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.81 179.71 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.29 151.09 86.84 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.694 2.263 . . . . 0.0 112.388 -179.388 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 36.0 m -142.05 148.69 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.107 0 CA-C-O 121.273 0.559 . . . . 0.0 112.107 -179.483 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -75.86 127.54 33.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.018 178.865 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 92.9 mt -75.55 140.06 42.5 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.488 179.609 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -130.51 146.08 51.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.2 179.515 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.559 ' HD1' ' C ' ' A' ' 99' ' ' ASN . 7.2 t60 -51.4 119.62 4.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.133 -179.178 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.81 -12.19 49.8 Favored Glycine 0 CA--C 1.522 0.51 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.938 179.463 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -69.66 137.22 51.99 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.316 -0.553 . . . . 0.0 110.204 179.705 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.42 ' O ' ' CG1' ' A' ' 87' ' ' VAL . 8.7 p -106.89 134.86 47.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.876 -178.667 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 93.4 mt -103.27 129.48 55.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 177.696 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 47.5 m -123.98 124.81 43.4 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.577 0.704 . . . . 0.0 112.783 -178.171 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.425 ' O ' ' N ' ' A' ' 92' ' ' ASP . 94.0 mt -111.6 124.2 68.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.005 178.102 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.465 ' CG2' ' NH2' ' B' ' 245' ' ' ARG . 64.4 mt 39.36 -96.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.987 -179.201 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.49 ' CB ' ' NH2' ' B' ' 245' ' ' ARG . 52.8 t0 -120.51 18.15 12.08 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.792 0.33 . . . . 0.0 111.888 -178.791 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.808 HH22 ' NH1' ' B' ' 245' ' ' ARG . 1.1 ptp85 -131.25 144.29 51.19 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.067 178.679 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 38.1 m -136.14 152.83 51.23 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.298 0.571 . . . . 0.0 111.232 -179.913 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -122.95 122.09 37.71 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.629 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 45.2 ttm180 -78.95 131.77 36.47 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.216 -178.726 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -95.93 119.62 34.75 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.76 179.924 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -122.5 122.21 38.39 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.262 -179.969 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.559 ' C ' ' HD1' ' A' ' 84' ' ' HIS . 59.4 t-20 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.615 -179.651 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo . . . . . 0 N--CA 1.489 1.21 0 CA-C-O 121.316 0.465 . . . . 0.0 113.156 . . . . . . . . . 0 0 . 1 . 047 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 67.9 t -66.93 133.27 31.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.771 179.836 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.332 -0.188 0 CA-C-O 121.036 0.445 . . . . 0.0 110.555 -179.468 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo . . . . . 0 N--CA 1.491 1.35 0 CA-C-O 120.488 0.12 . . . . 0.0 112.018 . . . . . . . . . 0 0 . 1 . 047 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 2.8 m -75.96 -42.39 48.64 Favored 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.532 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -58.16 -46.11 86.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.143 -179.788 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . 0.525 ' CD2' HH21 ' B' ' 245' ' ' ARG . 92.9 mt -63.82 -41.95 97.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.171 0.51 . . . . 0.0 110.851 179.874 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -63.04 -43.0 99.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.979 -179.092 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -61.51 -43.89 98.04 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.271 179.935 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.808 ' NH1' HH22 ' A' ' 93' ' ' ARG . 75.6 mtm180 -63.54 -40.04 95.99 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.881 -178.926 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -61.31 -39.01 88.91 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.263 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 13.5 t -65.91 -45.37 82.18 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.711 0.767 . . . . 0.0 109.496 178.051 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -62.17 -33.63 74.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.558 179.872 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 54.0 t . . . . . 0 N--CA 1.452 -0.338 0 C-N-CA 119.986 -0.686 . . . . 0.0 109.335 178.761 . . . . . . . . 0 0 . 1 . 047 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 53.5 mp0 . . . . . 0 N--CA 1.463 0.188 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 . . . . . . . . . 0 0 . 1 . 047 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 56.6 mt -119.29 130.2 74.26 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 177.89 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 54.1 t -122.69 133.83 67.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.427 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -95.27 122.14 37.66 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.263 0.554 . . . . 0.0 110.685 -178.7 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -62.53 -46.06 90.11 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.564 -179.889 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -94.85 160.71 30.58 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.82 -179.403 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.41 147.49 58.83 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.478 2.119 . . . . 0.0 112.94 -179.695 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 47.9 pt . . . . . 0 N--CA 1.466 0.346 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.666 179.13 . . . . . . . . 0 0 . 1 . 048 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 121.008 0.433 . . . . 0.0 110.481 . . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.571 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 94.9 mtt-85 -98.6 122.09 41.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.128 -179.381 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.578 ' NH2' ' OE2' ' A' ' 98' ' ' GLU . 33.6 ptt-85 -146.01 158.38 43.87 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.103 -0.639 . . . . 0.0 112.009 179.937 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.3 mt -118.86 144.85 46.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.261 179.604 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.414 ' CG1' ' NE2' ' A' ' 19' ' ' HIS . 67.0 t -114.31 125.46 71.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.568 -0.453 . . . . 0.0 109.903 179.446 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.2 m -74.21 134.16 42.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.019 0.438 . . . . 0.0 111.313 -179.689 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.0 mt -104.0 133.98 46.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.759 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -86.71 154.25 21.11 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.279 -0.568 . . . . 0.0 109.881 179.307 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 89.9 mtm180 -54.99 -27.74 46.44 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.581 -178.983 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.4 m -81.1 -5.67 57.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.759 0.314 . . . . 0.0 110.589 179.809 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.82 34.09 9.35 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 -179.959 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.8 t -121.08 135.59 60.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.86 0.362 . . . . 0.0 110.91 -179.852 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.463 ' O ' ' OD1' ' A' ' 16' ' ' ASP . 48.7 p-10 -75.97 133.36 40.47 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.459 179.727 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -121.39 -121.15 2.76 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.794 -179.327 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.48 147.24 40.78 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.131 1.888 . . . . 0.0 112.8 -178.871 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.414 ' NE2' ' CG1' ' A' ' 8' ' ' VAL . 62.0 m170 -109.76 143.37 39.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.635 -179.664 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -112.52 99.83 48.4 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.849 -179.717 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -70.6 131.51 20.18 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 C-N-CA 120.912 1.075 . . . . 0.0 110.787 -179.638 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 75.8 mt -85.39 77.36 9.95 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 120.261 -0.575 . . . . 0.0 110.784 -178.749 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 97.3 p -85.56 -10.61 55.68 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.077 178.744 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 52.2 mt -102.57 146.19 28.51 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.312 -179.047 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 94.9 p -65.91 -20.02 66.07 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -178.488 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 27.6 m -133.25 133.06 42.18 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.481 -0.487 . . . . 0.0 111.359 -179.777 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.0 t -122.71 116.84 24.44 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.589 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 56.8 tp -113.61 129.37 56.57 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -177.673 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.499 ' O ' ' O ' ' A' ' 47' ' ' GLN . 72.6 m-85 -109.77 131.51 55.0 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.449 179.804 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 160.46 -173.41 37.02 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.882 179.072 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.627 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 75.9 mtm-85 -80.89 -28.52 35.9 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.243 179.364 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.553 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -46.35 146.41 3.16 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -178.645 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.448 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 9.9 tp -67.72 -41.91 85.78 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 CA-C-O 120.843 0.354 . . . . 0.0 110.285 179.823 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.448 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 81.7 tt0 -59.03 -21.34 58.92 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.462 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.553 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 22.4 m -55.84 123.46 14.32 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.401 -179.96 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -62.08 -30.96 71.36 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.397 -179.71 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.409 HG23 HD13 ' A' ' 37' ' ' ILE . 47.1 mm -124.61 121.13 60.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.17 178.649 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.412 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 60.0 mtm180 -108.81 137.25 47.05 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 120.279 -0.569 . . . . 0.0 111.386 -179.977 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 89.6 mt -121.19 129.31 75.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.047 179.349 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -74.89 32.34 0.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -177.941 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 25.8 mt -98.27 129.07 31.47 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.317 179.272 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -73.14 -5.32 16.97 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 122.317 2.012 . . . . 0.0 112.368 -179.941 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.9 m -107.63 8.71 9.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.356 179.81 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.627 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 13.7 t -95.15 137.6 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.601 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.7 m -69.05 167.28 16.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.479 0.657 . . . . 0.0 112.381 -178.095 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.3 mttp -63.99 -41.65 97.45 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.033 -179.577 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.639 ' O ' ' N ' ' A' ' 49' ' ' CYS . 96.2 mt-30 -115.62 -25.24 7.93 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.098 0.475 . . . . 0.0 110.245 179.864 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 32.1 t60 38.39 -72.44 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 178.912 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.639 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -134.83 139.26 44.93 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -177.967 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.9 ttpp -132.95 133.95 43.88 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.539 178.827 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 92.3 mt -113.27 135.7 51.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.883 179.683 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.567 ' CD ' ' HE2' ' A' ' 54' ' ' HIS . 79.8 tt0 -117.32 132.12 56.67 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.255 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.1 mm -103.6 118.55 50.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.403 -0.519 . . . . 0.0 112.295 -177.924 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.567 ' HE2' ' CD ' ' A' ' 52' ' ' GLU . 97.9 m-70 -117.66 134.22 55.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.11 178.052 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 54' ' ' HIS . 84.6 tt0 -40.15 -35.47 0.4 Allowed 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.038 -179.085 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -64.27 -66.7 0.51 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.945 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.404 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 4.2 tp10 -150.43 -167.96 2.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.286 -179.718 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.404 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -119.2 134.61 55.11 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.536 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 98.0 mt -120.2 130.77 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 121.385 0.612 . . . . 0.0 112.615 -178.729 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 21.7 tp -98.72 128.44 44.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.084 179.624 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -109.84 134.62 51.85 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.051 -179.346 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.484 HD22 ' CA ' ' A' ' 68' ' ' PRO . 62.7 t-20 -95.65 104.62 16.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.802 -178.848 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -97.19 -10.46 25.82 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.373 179.535 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 10.3 t -78.01 98.93 5.88 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.666 -179.477 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.2 m -76.09 -40.26 53.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.249 0.547 . . . . 0.0 110.055 178.509 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.37 -41.35 85.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.451 -179.671 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.442 ' O ' ' OG ' ' A' ' 64' ' ' SER . 59.8 m-20 -140.51 93.29 8.81 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.718 -179.895 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.484 ' CA ' HD22 ' A' ' 62' ' ' ASN . 40.6 Cg_exo -56.56 147.55 69.15 Favored 'Trans proline' 0 N--CA 1.498 1.784 0 C-N-CA 122.551 2.167 . . . . 0.0 113.029 -179.064 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.425 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 3.9 m -72.25 136.83 46.44 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.472 179.227 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -100.43 141.56 33.11 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.578 179.49 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.489 ' O ' ' OG ' ' A' ' 74' ' ' SER . 56.1 t -128.54 135.97 61.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.236 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 50.97 31.87 6.79 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.464 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.94 29.27 63.18 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.028 179.569 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.489 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 12.1 p -141.34 141.0 33.87 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 117.139 0.469 . . . . 0.0 111.412 179.878 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 53.5 t -74.76 136.5 25.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-O 121.115 0.483 . . . . 0.0 111.74 -179.854 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.535 ' CD1' ' O ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -137.15 119.45 19.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.824 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.41 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 38.3 p-10 -101.17 -0.42 36.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.922 -178.038 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.535 ' O ' ' CD1' ' A' ' 76' ' ' ILE . 5.2 pt-20 -119.93 165.09 18.87 Favored Pre-proline 0 C--N 1.331 -0.225 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.256 179.965 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.98 141.86 96.36 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 121.747 1.632 . . . . 0.0 111.866 179.772 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.7 p -140.21 140.31 35.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.725 -179.879 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -78.96 130.3 35.41 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.961 179.542 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.8 mt -78.87 140.19 38.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.01 0.433 . . . . 0.0 110.728 179.96 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -129.7 149.38 51.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.329 179.978 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.441 ' C ' ' CD2' ' A' ' 84' ' ' HIS . 7.3 t60 -55.62 116.6 2.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.012 0.434 . . . . 0.0 110.885 -179.168 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.44 -16.41 37.88 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -179.751 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 87' ' ' VAL . 53.7 t0 -67.68 131.07 44.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.717 0.294 . . . . 0.0 110.231 179.314 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.48 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 76.7 t -104.92 135.54 42.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.937 0.399 . . . . 0.0 111.298 -178.8 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 88.4 mt -104.13 130.28 55.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.443 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.8 m -122.53 123.58 41.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.828 0.823 . . . . 0.0 112.836 -178.884 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.571 ' O ' ' N ' ' A' ' 93' ' ' ARG . 86.9 mt -109.38 125.95 66.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 114.236 -1.347 . . . . 0.0 108.281 178.274 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.493 ' CG2' ' N ' ' A' ' 92' ' ' ASP . 97.8 mt 29.42 -101.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.932 0.396 . . . . 0.0 111.578 -179.165 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.493 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 35.6 p-10 -105.54 11.42 32.45 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.137 -179.035 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.571 ' N ' ' O ' ' A' ' 90' ' ' ILE . 8.7 mtp85 -130.2 145.2 51.71 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.045 -179.55 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.1 p -140.64 153.24 45.95 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.178 0.513 . . . . 0.0 110.699 179.747 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -129.77 127.41 40.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.953 179.814 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -82.9 133.64 35.11 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.376 -0.529 . . . . 0.0 110.182 179.979 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.571 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 85.0 t80 -94.61 126.21 39.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.485 -179.24 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.578 ' OE2' ' NH2' ' A' ' 6' ' ' ARG . 82.5 tt0 -135.5 118.88 16.77 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.823 179.546 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.42 ' C ' ' OD1' ' A' ' 99' ' ' ASN . 55.5 p30 . . . . . 0 C--N 1.333 -0.136 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.67 -179.998 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo . . . . . 0 N--CA 1.486 1.047 0 CA-C-O 121.509 0.545 . . . . 0.0 111.971 . . . . . . . . . 0 0 . 1 . 048 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 4.8 p -64.73 141.51 18.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.548 -179.606 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . 0.465 ' SG ' ' CD2' ' B' ' 241' ' ' PHE . 2.8 t . . . . . 0 C--N 1.333 -0.113 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.217 -179.594 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo . . . . . 0 N--CA 1.495 1.607 0 CA-C-O 120.825 0.26 . . . . 0.0 112.062 . . . . . . . . . 0 0 . 1 . 048 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 87.8 m -64.34 -46.42 83.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.433 0.635 . . . . 0.0 109.317 178.771 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . 0.465 ' CD2' ' SG ' ' B' ' 237' ' ' CYS . 85.4 t80 -58.02 -47.5 82.87 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.546 -179.378 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 96.9 mt -62.8 -41.92 99.49 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.89 -178.584 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -65.09 -39.02 92.58 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.224 -179.271 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . 0.466 ' O ' ' OG ' ' B' ' 247' ' ' SER . 99.5 mtt180 -63.41 -40.24 96.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.085 0.469 . . . . 0.0 109.835 179.884 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . . . . . . . . . 71.2 ttp85 -61.21 -43.16 99.32 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.845 -179.505 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.37 -40.62 97.05 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.321 -179.652 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' B' B ' 247' ' ' SER . . . . . 0.466 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 79.4 p -64.51 -42.84 95.55 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.726 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -61.66 -39.12 90.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.193 -179.991 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 54.3 t . . . . . 0 N--CA 1.456 -0.157 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.303 179.059 . . . . . . . . 0 0 . 1 . 048 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 . . . . . 0 CA--C 1.534 0.363 0 N-CA-C 115.316 1.598 . . . . 0.0 115.316 . . . . . . . . . 0 0 . 1 . 048 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . 0.46 ' CD1' ' NE ' ' A' ' 93' ' ' ARG . 74.2 mt -118.21 132.89 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 119.434 1.016 . . . . 0.0 109.274 178.388 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 55.9 t -125.11 135.21 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-O 120.932 0.396 . . . . 0.0 111.191 -179.625 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -98.79 119.12 37.01 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.278 0.561 . . . . 0.0 110.581 -179.761 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -66.24 -43.89 85.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.045 179.934 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -103.13 157.98 32.68 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.355 -179.1 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -63.89 155.54 63.45 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 122.949 2.432 . . . . 0.0 112.703 -179.833 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.0 pt . . . . . 0 C--N 1.331 -0.217 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.117 -178.745 . . . . . . . . 0 0 . 1 . 049 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.1 p . . . . . 0 C--O 1.233 0.201 0 CA-C-O 120.591 0.234 . . . . 0.0 111.035 . . . . . . . . . 0 0 . 1 . 049 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.6 mtt85 -83.71 123.12 29.52 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.26 -179.865 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -127.45 136.52 51.92 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.23 -179.404 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 25.3 tp -112.67 130.6 55.99 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.836 -179.755 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.0 t -108.07 129.15 62.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.914 -179.479 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.0 m -81.05 143.83 32.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.471 0.653 . . . . 0.0 111.921 -179.606 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.8 mm -111.81 135.15 51.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.613 178.729 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -89.9 157.27 17.95 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.01 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.478 HH11 ' CD ' ' B' ' 245' ' ' ARG . 84.5 mtm180 -58.6 -22.57 56.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.059 -179.466 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.2 m -85.08 -9.45 57.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.991 -179.63 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.49 40.24 6.47 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.189 -0.765 . . . . 0.0 111.189 179.716 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 54.6 t -125.89 135.36 64.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.726 0.298 . . . . 0.0 111.627 -179.265 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.402 ' CG ' ' HE2' ' A' ' 19' ' ' HIS . 62.8 t0 -67.68 124.55 23.59 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.163 179.115 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -115.62 -124.8 3.81 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 120.959 -0.639 . . . . 0.0 111.863 -179.18 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -75.82 146.61 30.0 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.31 2.006 . . . . 0.0 113.334 -178.688 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.402 ' HE2' ' CG ' ' A' ' 16' ' ' ASP . 59.4 m170 -106.1 142.17 36.23 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.563 -179.935 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -117.74 106.85 45.35 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.096 179.977 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.29 127.49 12.71 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 121.541 1.494 . . . . 0.0 112.03 -178.382 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 56.3 mt -89.01 43.92 1.18 Allowed 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.35 -178.361 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 65.3 p -67.54 -19.85 65.34 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.554 -0.458 . . . . 0.0 109.849 179.381 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.9 mt -74.39 144.06 44.54 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.61 179.954 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 92.8 p -58.07 -26.08 62.08 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.035 -178.39 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 97.8 m -141.22 138.63 33.44 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.206 -0.598 . . . . 0.0 111.839 -179.113 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.655 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 2.5 t -128.77 121.7 28.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.053 178.393 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.407 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 52.1 tp -119.74 129.33 54.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.377 -178.167 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.655 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 3.0 m-85 -104.68 137.17 42.9 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.473 179.495 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 163.55 -167.46 37.74 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.419 178.883 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.636 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 86.3 mtm-85 -88.05 -27.99 21.64 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.767 0.318 . . . . 0.0 110.263 179.97 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.408 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -55.64 149.87 23.36 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 121.133 -0.556 . . . . 0.0 111.837 -178.168 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.543 ' CD1' ' NH1' ' A' ' 38' ' ' ARG . 10.5 tp -68.09 -41.6 84.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 CA-C-O 120.864 0.364 . . . . 0.0 110.518 179.92 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -57.4 -23.34 48.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.226 0.536 . . . . 0.0 110.099 179.77 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.408 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 33.3 m -56.0 126.12 24.47 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.185 179.683 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.407 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 55.0 m-20 -61.04 -33.14 72.82 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.602 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.463 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 94.8 mt -123.98 121.9 63.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 177.314 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.543 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 83.1 mtp180 -109.84 139.1 45.29 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.405 -178.544 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.414 HG23 HD12 ' A' ' 39' ' ' ILE . 97.4 mt -120.36 130.58 74.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.987 179.004 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.409 ' NE2' ' HA ' ' B' ' 260' ' ' GLU . 19.9 pt20 -79.75 35.67 0.31 Allowed 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -177.768 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.589 ' CD1' ' NH1' ' A' ' 93' ' ' ARG . 60.5 mt -112.95 135.17 21.67 Favored Pre-proline 0 C--N 1.328 -0.328 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.112 178.191 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.67 -9.78 26.49 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.629 2.22 . . . . 0.0 113.22 -178.717 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.432 ' CG2' ' CZ ' ' B' ' 241' ' ' PHE . 1.8 m -96.52 2.0 10.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.444 -179.828 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.636 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 53.2 t -88.3 131.96 34.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.614 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.6 m -63.99 158.39 22.57 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.159 0.504 . . . . 0.0 111.328 -179.106 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -61.42 -42.08 98.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.663 -179.086 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.612 ' O ' ' N ' ' A' ' 49' ' ' CYS . 10.8 mm100 -115.43 -20.23 10.35 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.919 179.677 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.5 t60 33.21 -74.54 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 179.082 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.612 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -129.54 133.94 47.49 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -177.608 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -123.93 133.07 53.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.663 179.284 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 98.1 mt -119.49 134.38 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.679 -179.218 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -115.92 127.99 55.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.402 179.154 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.3 mm -100.49 109.86 26.15 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 CA-C-O 121.251 0.548 . . . . 0.0 110.861 -179.481 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.445 ' O ' ' C ' ' A' ' 55' ' ' GLU . 97.8 m-70 -111.36 135.22 52.22 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.512 179.247 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 54' ' ' HIS . 93.1 mt-10 -41.8 -34.32 0.63 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -179.396 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 73.5 tp60 -63.72 -67.2 0.45 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.373 178.572 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -155.68 -169.52 3.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.691 -179.829 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -117.47 129.94 56.14 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.592 -179.729 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 87.9 mt -117.51 130.51 72.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 121.324 0.583 . . . . 0.0 112.416 -178.902 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.428 HD12 ' HG ' ' A' ' 49' ' ' CYS . 50.5 tp -95.27 129.19 42.49 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.931 179.81 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -115.19 133.44 56.03 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.799 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.695 ' ND2' ' H ' ' A' ' 69' ' ' THR . 11.3 t-20 -96.57 108.3 20.87 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.266 -179.684 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -97.51 -7.02 32.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.256 179.532 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.629 ' HG ' ' ND2' ' A' ' 62' ' ' ASN . 78.7 p -76.25 97.93 4.31 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.306 179.579 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.3 m -80.39 -32.95 37.49 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.2 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.1 m -65.55 -48.07 73.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.293 179.597 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.543 ' O ' ' OG ' ' A' ' 64' ' ' SER . 1.5 m-20 -137.72 102.02 8.68 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.032 -179.663 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -55.14 146.05 61.62 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 121.752 1.635 . . . . 0.0 112.326 -179.85 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.695 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 10.2 m -74.68 140.64 44.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.595 179.075 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -104.61 139.02 40.07 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.14 179.673 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 56.4 t -132.02 132.96 61.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.879 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 54.38 33.48 18.66 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.025 -0.67 . . . . 0.0 109.622 -179.391 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.7 29.29 65.7 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.77 178.921 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.1 t -148.08 140.39 24.3 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 117.492 0.646 . . . . 0.0 111.342 179.342 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -68.65 144.0 14.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.379 -179.485 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.1 pt -118.19 94.35 3.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 121.034 0.445 . . . . 0.0 110.585 179.068 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.58 ' OD1' ' N ' ' A' ' 78' ' ' GLU . 37.0 p-10 -69.4 -23.96 63.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.281 179.727 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.58 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 2.6 mt-10 -124.28 170.04 9.53 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.459 179.656 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -60.73 147.27 95.51 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 122.485 2.123 . . . . 0.0 112.601 179.283 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 29.3 m -138.32 138.71 42.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.473 179.626 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.558 HH21 ' CE ' ' A' ' 83' ' ' LYS . 61.7 ttp180 -72.8 130.44 40.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.632 179.281 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 97.0 mt -81.58 136.02 35.57 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.015 0.436 . . . . 0.0 111.7 -179.386 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.558 ' CE ' HH21 ' A' ' 81' ' ' ARG . 99.1 mttt -129.05 149.0 51.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.409 179.426 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.66 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 7.2 t60 -54.58 116.81 2.88 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.162 179.897 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 113.09 -15.35 23.28 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.572 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -67.96 135.67 52.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.29 0.567 . . . . 0.0 110.672 -179.569 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 77.0 t -112.48 131.57 63.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.752 -178.652 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.473 ' O ' ' OG ' ' A' ' 94' ' ' SER . 81.0 mt -104.29 131.14 53.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.081 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 38.8 m -123.26 128.24 49.7 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -177.807 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.427 ' O ' ' C ' ' A' ' 91' ' ' ILE . 91.4 mt -115.76 124.17 71.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.051 178.679 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.431 HG21 ' HG ' ' B' ' 237' ' ' CYS . 76.6 mt 39.72 -100.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.445 179.989 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.601 ' OD1' ' NH1' ' A' ' 93' ' ' ARG . 24.2 p-10 -116.21 13.4 15.68 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.779 0.323 . . . . 0.0 111.482 -179.919 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.601 ' NH1' ' OD1' ' A' ' 92' ' ' ASP . 57.0 mtm-85 -125.07 143.45 50.91 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.878 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.473 ' OG ' ' O ' ' A' ' 88' ' ' ILE . 36.2 t -138.75 156.18 47.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.628 0.728 . . . . 0.0 111.887 -179.413 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -128.32 124.62 36.93 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.454 179.294 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -89.6 134.54 34.08 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.951 -0.7 . . . . 0.0 110.959 -179.316 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.471 ' CZ ' ' OD1' ' A' ' 99' ' ' ASN . 85.7 t80 -98.0 123.27 41.93 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.046 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -141.11 126.91 19.14 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.093 -179.617 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.66 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 95.0 m-20 . . . . . 0 N--CA 1.462 0.153 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.434 179.214 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo . . . . . 0 N--CA 1.49 1.276 0 CA-C-O 121.506 0.544 . . . . 0.0 112.015 . . . . . . . . . 0 0 . 1 . 049 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 8.2 p -109.9 135.07 50.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.248 -179.767 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . 0.472 ' SG ' ' CD1' ' B' ' 241' ' ' PHE . 19.9 t . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.289 -179.426 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo . . . . . 0 N--CA 1.494 1.543 0 CA-C-O 120.854 0.272 . . . . 0.0 111.884 . . . . . . . . . 0 0 . 1 . 049 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 77.6 m -73.3 -46.69 48.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.566 178.834 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . 0.472 ' CD1' ' SG ' ' B' ' 237' ' ' CYS . 57.5 t80 -58.19 -45.84 86.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.693 -178.999 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 78.4 mt -64.27 -40.46 96.02 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.478 179.85 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -61.67 -40.63 95.63 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.951 0.405 . . . . 0.0 110.206 179.922 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -61.8 -43.1 99.52 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.628 179.601 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.478 ' CD ' HH11 ' A' ' 12' ' ' ARG . 40.0 mmt-85 -62.19 -39.79 93.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.605 -179.514 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.08 -40.2 96.96 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.238 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 11.2 t -62.84 -44.06 97.15 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 177.693 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -60.0 -38.11 81.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.785 -179.917 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 25.0 t . . . . . 0 C--N 1.327 -0.374 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.797 179.724 . . . . . . . . 0 0 . 1 . 049 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . 0.409 ' HA ' ' NE2' ' A' ' 40' ' ' GLN . 98.5 mt-10 . . . . . 0 CA--C 1.52 -0.174 0 CA-C-O 121.029 0.443 . . . . 0.0 110.037 . . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 66.7 mt -113.3 141.12 30.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.303 -178.799 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 56.0 t -127.63 134.04 66.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.329 -179.812 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -99.43 122.92 43.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.441 0.639 . . . . 0.0 111.238 -179.208 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -64.78 -44.88 88.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.42 179.772 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -98.5 155.29 36.98 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.796 -178.901 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.74 149.71 83.6 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.776 2.318 . . . . 0.0 111.791 179.202 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 25.1 pt . . . . . 0 C--N 1.325 -0.481 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.271 -179.425 . . . . . . . . 0 0 . 1 . 050 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 74.8 p . . . . . 0 N--CA 1.461 0.098 0 CA-C-O 120.929 0.395 . . . . 0.0 111.218 . . . . . . . . . 0 0 . 1 . 050 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.722 ' NH1' ' HH ' ' A' ' 97' ' ' TYR . 93.7 mtt-85 -92.72 126.22 37.7 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.305 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 89.6 mtm-85 -134.5 151.45 51.14 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.247 0.546 . . . . 0.0 112.255 -179.075 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 85.5 mt -119.16 146.97 44.71 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.875 -179.55 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.0 t -118.55 129.79 74.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.816 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 53.5 m -89.07 112.74 23.76 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -178.126 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.414 HD11 ' HG ' ' A' ' 94' ' ' SER . 95.8 mt -83.64 143.13 12.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 177.748 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.1 tttm -92.33 167.64 11.86 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.108 -0.637 . . . . 0.0 111.063 -179.735 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.601 ' NH1' ' OE2' ' B' ' 260' ' ' GLU . 90.5 mtm180 -58.25 -31.54 67.52 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.517 -179.165 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 90.5 p -83.35 -6.13 59.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.962 0.41 . . . . 0.0 110.024 179.136 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.2 39.78 7.23 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.89 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.1 t -117.26 134.19 61.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.029 0.442 . . . . 0.0 111.617 -179.198 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -73.09 116.68 13.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.702 -179.839 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -110.95 -124.24 4.57 Favored Glycine 0 CA--C 1.54 1.596 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 179.416 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.93 147.58 39.19 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 122.41 2.073 . . . . 0.0 113.518 -179.219 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.551 ' O ' ' CD1' ' B' ' 267' ' ' ILE . 0.4 OUTLIER -110.59 131.01 55.42 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.234 179.333 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -99.58 101.01 12.04 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.533 -179.098 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.97 135.63 23.55 Favored 'Trans proline' 0 C--N 1.315 -1.204 0 C-N-CA 121.332 1.355 . . . . 0.0 111.36 -179.69 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 79.8 mt -85.95 76.58 9.82 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.965 -178.542 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 95.5 p -82.67 -10.34 58.97 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.757 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.2 mt -102.16 146.02 28.55 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.611 -179.682 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.8 m -66.19 -14.8 62.46 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.929 -0.308 . . . . 0.0 111.514 -179.255 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.426 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 75.0 m -135.49 136.48 41.29 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.912 0.387 . . . . 0.0 111.875 -179.539 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.2 t -126.2 117.18 22.57 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.911 178.626 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 58.4 tp -113.57 127.88 56.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.602 0.239 . . . . 0.0 110.861 -179.171 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.587 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 6.0 m-85 -107.4 141.81 38.21 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.741 179.473 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 149.64 -178.5 27.1 Favored Glycine 0 N--CA 1.467 0.751 0 C-N-CA 120.175 -1.012 . . . . 0.0 112.418 178.676 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.494 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 45.8 mtm180 -73.56 -32.92 64.43 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 179.787 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.535 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -50.13 141.68 15.36 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 120.474 -0.87 . . . . 0.0 111.317 -178.579 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.571 ' CD1' ' CZ ' ' A' ' 38' ' ' ARG . 34.4 mm -63.17 -43.62 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-O 120.874 0.369 . . . . 0.0 110.029 179.529 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -53.81 -19.25 4.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.962 179.806 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.535 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 39.6 m -61.6 129.27 40.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.396 -179.923 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.426 ' OD2' ' O ' ' A' ' 26' ' ' THR . 91.4 m-20 -60.73 -30.38 69.94 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.645 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.455 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 82.7 mt -126.93 119.96 54.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.482 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.571 ' CZ ' ' CD1' ' A' ' 33' ' ' ILE . 82.0 mtp180 -99.95 133.75 43.87 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.029 -178.822 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.8 mt -118.44 128.81 75.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-O 121.131 0.491 . . . . 0.0 110.339 179.991 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -76.67 26.87 0.13 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.253 -178.683 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 26.3 mt -94.84 124.76 53.56 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.554 179.731 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.88 -10.84 26.88 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 122.371 2.047 . . . . 0.0 112.542 -179.443 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.1 m -100.86 8.88 8.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.941 0.4 . . . . 0.0 111.27 179.996 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.494 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 21.9 t -97.44 136.31 28.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.329 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.3 m -70.45 170.45 11.97 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.635 0.731 . . . . 0.0 111.921 -178.467 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -62.28 -41.41 98.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.039 -179.144 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.607 ' O ' ' N ' ' A' ' 49' ' ' CYS . 13.9 mm100 -110.91 -20.95 12.26 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.265 0.555 . . . . 0.0 110.403 -179.849 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.0 t60 39.74 -78.34 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.006 -0.997 . . . . 0.0 113.209 179.087 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.607 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.16 137.69 46.32 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.216 0.531 . . . . 0.0 111.791 -178.886 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -129.15 135.36 48.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.217 179.661 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.6 mt -121.27 136.95 56.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.142 -179.11 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -117.01 123.89 47.99 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.755 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.4 mt -102.37 116.05 45.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.528 0.68 . . . . 0.0 111.521 -178.714 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.492 ' O ' ' N ' ' A' ' 56' ' ' GLN . 90.8 m-70 -117.67 144.57 45.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.143 179.932 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 54' ' ' HIS . 80.7 tt0 -39.2 -29.16 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -179.626 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.492 ' N ' ' O ' ' A' ' 54' ' ' HIS . 86.5 mt-30 -66.59 -68.59 0.36 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.733 178.944 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.439 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 6.1 tp10 -157.65 -158.99 0.79 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.562 -179.67 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.439 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -118.42 128.77 54.94 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.064 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.9 mt -118.38 129.3 74.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.304 0.573 . . . . 0.0 112.248 -178.477 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 49.2 tp -95.31 129.19 42.53 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.584 -179.954 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -114.23 134.71 54.73 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.154 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.647 HD22 ' CB ' ' A' ' 68' ' ' PRO . 63.7 t-20 -97.84 105.8 18.0 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -178.078 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -98.24 -8.55 27.12 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.911 179.568 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.3 t -81.06 99.23 8.37 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.694 0.283 . . . . 0.0 110.983 179.684 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.4 t -83.99 -32.74 24.81 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.804 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.6 m -61.29 -47.46 85.85 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.918 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -144.17 108.62 4.96 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.714 178.587 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.647 ' CB ' HD22 ' A' ' 62' ' ' ASN . 40.1 Cg_endo -68.6 152.64 74.56 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 121.535 1.49 . . . . 0.0 113.019 -178.473 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.9 m -70.66 138.97 51.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.22 -179.636 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -101.76 140.28 36.26 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.833 -179.682 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.9 t -134.89 136.29 52.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 178.13 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 56.91 33.51 23.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.993 0.425 . . . . 0.0 110.064 -179.581 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.97 30.64 67.66 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.173 179.219 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 36.0 m -148.18 146.39 28.7 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 117.359 0.58 . . . . 0.0 111.348 -179.661 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.4 m -72.78 147.36 10.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-O 121.015 0.436 . . . . 0.0 111.002 -179.703 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.545 ' CG2' ' O ' ' A' ' 78' ' ' GLU . 98.3 mt -107.2 107.21 22.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.406 -179.474 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -66.09 -42.25 89.58 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.64 179.233 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.545 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.4 OUTLIER -136.71 -177.55 0.72 Allowed Pre-proline 0 N--CA 1.466 0.346 0 CA-C-O 120.666 0.269 . . . . 0.0 111.298 -178.737 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.509 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 45.2 Cg_exo -58.69 145.22 96.57 Favored 'Trans proline' 0 N--CA 1.5 1.895 0 C-N-CA 122.842 2.361 . . . . 0.0 113.199 -179.753 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.8 m -143.76 143.07 24.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.985 179.634 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.411 ' HE ' ' HE2' ' A' ' 83' ' ' LYS . 59.6 ttp180 -76.25 133.59 40.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.107 179.449 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 98.4 mt -82.35 143.87 30.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.151 0.501 . . . . 0.0 111.675 -179.153 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.411 ' HE2' ' HE ' ' A' ' 81' ' ' ARG . 73.3 mmtt -132.72 151.68 51.92 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.489 179.556 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.702 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 5.4 t60 -56.26 117.8 4.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.421 -178.847 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.67 -18.58 24.58 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 111.189 -0.765 . . . . 0.0 111.189 179.527 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -69.61 135.08 49.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.163 0.506 . . . . 0.0 110.554 -179.899 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 49.7 t -110.16 132.78 57.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.91 -179.178 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.1 mt -101.12 130.22 50.89 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 177.676 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 49.6 m -120.1 126.42 50.71 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 119.876 -0.73 . . . . 0.0 112.209 -178.663 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.591 ' O ' ' N ' ' A' ' 93' ' ' ARG . 99.1 mt -114.78 129.91 70.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 114.798 -1.092 . . . . 0.0 108.25 177.993 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.501 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 75.6 mt -23.04 95.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -178.612 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.501 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 3.8 m-20 92.88 -27.19 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 178.551 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.591 ' N ' ' O ' ' A' ' 90' ' ' ILE . 7.9 mmm180 -125.93 143.21 51.18 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.418 -179.3 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.414 ' HG ' HD11 ' A' ' 10' ' ' ILE . 87.0 p -138.81 154.36 48.46 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.6 -0.44 . . . . 0.0 109.995 179.345 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -129.12 126.79 40.1 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.32 -179.539 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 41.7 ttp-105 -90.91 135.69 33.57 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.661 -0.415 . . . . 0.0 110.429 -179.605 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.722 ' HH ' ' NH1' ' A' ' 5' ' ' ARG . 89.1 t80 -92.39 121.34 33.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.905 -179.759 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -121.63 123.43 41.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.831 -179.568 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.702 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 60.3 t-20 . . . . . 0 C--N 1.333 -0.118 0 CA-C-O 120.921 0.391 . . . . 0.0 110.285 179.923 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo . . . . . 0 N--CA 1.485 1.023 0 CA-C-O 121.413 0.506 . . . . 0.0 112.708 . . . . . . . . . 0 0 . 1 . 050 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 2.1 p -107.72 132.4 55.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.058 179.071 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 3.2 t . . . . . 0 C--N 1.329 -0.305 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.03 -179.282 . . . . . . . . 0 0 . 1 . 050 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo . . . . . 0 N--CA 1.502 2.003 0 N-CA-C 113.078 0.376 . . . . 0.0 113.078 . . . . . . . . . 0 0 . 1 . 050 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 98.9 m -74.47 -46.39 39.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.064 0.459 . . . . 0.0 110.357 178.894 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . 0.423 ' CZ ' ' NH2' ' B' ' 245' ' ' ARG . 88.1 t80 -59.63 -45.34 92.26 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.82 -178.8 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . 0.417 ' CD2' ' OD1' ' A' ' 92' ' ' ASP . 89.9 mt -65.79 -39.96 91.47 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 119.86 -0.736 . . . . 0.0 110.563 179.398 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -60.67 -41.84 95.86 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.854 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -65.81 -37.58 86.64 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.314 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.456 HH11 ' NH1' ' A' ' 12' ' ' ARG . 10.7 tpp180 -62.62 -44.52 96.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.334 -179.68 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -63.08 -36.62 84.19 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.978 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 10.2 t -63.53 -44.65 93.6 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.629 177.974 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 66.6 mm-40 -57.83 -37.63 74.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.919 -179.952 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 C--N 1.326 -0.426 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.576 178.934 . . . . . . . . 0 0 . 1 . 050 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . 0.601 ' OE2' ' NH1' ' A' ' 12' ' ' ARG . 92.4 mt-10 . . . . . 0 N--CA 1.448 -0.528 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 . . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 3.0 mm -112.72 131.36 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 114.31 -1.314 . . . . 0.0 109.407 -179.109 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 39.2 t -124.95 132.31 71.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.629 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -98.56 122.05 41.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.2 0.524 . . . . 0.0 111.889 -178.302 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -65.06 -45.9 83.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.694 179.326 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -92.47 163.9 24.75 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.436 -179.882 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.86 146.92 92.23 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.21 1.94 . . . . 0.0 112.56 -179.89 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . 0.551 ' CD1' ' O ' ' A' ' 19' ' ' HIS . 4.9 tt . . . . . 0 C--N 1.323 -0.582 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.246 -179.607 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.1 m . . . . . 0 C--O 1.237 0.411 0 CA-C-O 120.813 0.34 . . . . 0.0 111.745 . . . . . . . . . 0 0 . 1 . 051 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -91.4 138.66 31.4 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.949 -178.011 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -139.0 147.23 41.87 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 179.761 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 42.4 tp -117.82 133.61 55.76 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.258 179.241 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 53.7 t -110.8 132.02 60.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.265 -178.668 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 m -96.6 115.84 28.1 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.874 -179.249 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 87.2 mt -83.41 150.96 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.578 179.888 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -86.17 154.09 21.58 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 178.527 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.533 ' NH2' ' OE2' ' B' ' 260' ' ' GLU . 87.7 mtm180 -58.22 -25.47 61.7 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.373 179.776 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.2 m -79.49 -8.25 59.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.843 179.84 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.01 31.84 8.89 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -179.893 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.8 t -118.65 133.64 64.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.611 0.243 . . . . 0.0 110.898 -179.949 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -72.89 133.02 44.22 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.524 -0.546 . . . . 0.0 109.524 179.141 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -127.54 -118.63 2.17 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 120.403 -0.903 . . . . 0.0 111.931 -179.54 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -76.17 149.06 31.62 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.56 2.173 . . . . 0.0 112.593 -179.028 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -110.81 151.08 28.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.339 0.59 . . . . 0.0 111.246 -179.432 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -112.54 91.75 17.87 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.304 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.47 133.53 22.64 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 121.226 1.284 . . . . 0.0 111.269 -178.329 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.594 ' O ' ' CB ' ' A' ' 23' ' ' SER . 72.0 mt -73.45 -149.56 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.976 -178.429 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.594 ' CB ' ' O ' ' A' ' 22' ' ' LEU . 6.9 p 135.98 -40.16 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -179.181 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.3 mt -77.52 142.84 38.86 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.55 -1.204 . . . . 0.0 109.769 179.746 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 m -65.26 -17.13 64.25 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -178.766 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.1 m -133.86 133.56 41.69 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.619 0.599 . . . . 0.0 112.619 -179.2 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.662 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.4 OUTLIER -126.15 119.44 27.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.185 178.146 . . . . . . . . 3 3 . 1 . 051 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 36.7 tp -119.7 128.07 53.45 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.826 -178.391 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.662 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 25.1 m-85 -100.73 128.18 46.88 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.262 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -173.35 -165.04 29.61 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 120.057 -1.068 . . . . 0.0 112.876 -179.79 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.499 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 38.0 ttp-105 -105.75 -8.5 17.78 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.169 -0.515 . . . . 0.0 111.694 -179.138 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -91.52 170.05 33.49 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.66 -178.865 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.475 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 11.0 tp -68.45 -41.7 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 115.638 -0.281 . . . . 0.0 111.301 -179.884 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.475 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 48.8 tt0 -56.76 -29.46 62.62 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.458 -179.429 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.9 m -63.5 129.94 42.28 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.479 -179.975 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -60.51 -31.3 70.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.383 -178.768 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.404 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 97.6 mt -127.25 118.65 50.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 178.258 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 59.9 mtm180 -102.29 137.2 40.86 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.57 179.9 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.47 ' C ' ' H ' ' A' ' 41' ' ' LEU . 75.8 mt -119.38 131.94 70.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.617 -179.583 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -67.2 18.82 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -177.934 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.47 ' H ' ' C ' ' A' ' 39' ' ' ILE . 15.5 mt -104.64 127.73 28.34 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.87 179.96 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.67 -5.89 17.8 Favored 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 122.368 2.046 . . . . 0.0 112.326 -179.737 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.0 m -91.8 5.51 6.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.065 179.462 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.499 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 54.7 t -96.51 135.52 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.882 178.885 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.2 m -74.27 167.99 20.51 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.747 0.784 . . . . 0.0 112.951 -178.377 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.7 mtmt -64.13 -37.97 89.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.689 179.588 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.612 ' O ' ' N ' ' A' ' 49' ' ' CYS . 92.1 mm-40 -115.16 -32.26 5.75 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.135 0.493 . . . . 0.0 110.103 -179.984 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 18.7 t60 41.74 -77.2 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.764 179.636 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.612 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.37 134.74 47.38 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.793 -178.916 . . . . . . . . 3 3 . 1 . 051 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -126.05 129.25 48.79 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.359 -179.972 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 95.5 mt -114.89 131.98 65.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.208 -179.736 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -116.93 125.8 52.0 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.552 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 98.0 mt -106.73 114.5 46.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 119.975 -0.69 . . . . 0.0 112.022 -178.585 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.426 ' O ' ' C ' ' A' ' 55' ' ' GLU . 86.2 m-70 -113.27 146.32 39.55 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.719 179.804 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 54' ' ' HIS . 52.8 tp10 -40.66 -33.39 0.28 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.527 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -61.39 -68.94 0.27 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.744 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -161.35 -160.58 0.73 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.145 178.723 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.11 128.15 56.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.365 -179.926 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 91.2 mt -116.59 129.88 72.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.036 0.446 . . . . 0.0 111.892 -179.013 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 28.5 tp -100.0 130.39 46.16 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.896 -179.14 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -115.92 136.17 53.29 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.718 179.849 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -97.09 106.54 18.89 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -178.994 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -100.58 -7.47 24.01 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.213 178.73 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.99 100.97 7.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.187 179.789 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.3 m -88.47 -10.92 47.42 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.999 179.606 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.98 -43.6 9.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.284 -179.724 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -140.05 101.26 7.03 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.08 -179.877 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -56.7 143.11 90.83 Favored 'Trans proline' 0 N--CA 1.501 1.929 0 C-N-CA 122.297 1.998 . . . . 0.0 113.355 -179.312 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.9 m -72.27 140.35 48.57 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.096 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 89' ' ' THR . 72.8 mt-30 -104.57 140.35 38.12 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.327 -0.549 . . . . 0.0 111.39 -179.005 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 55.8 t -131.61 133.43 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.982 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 54.21 33.06 17.25 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.976 179.947 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.5 24.29 70.89 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.993 178.932 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.7 t -142.79 143.52 32.21 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 117.585 0.692 . . . . 0.0 111.058 179.844 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.5 m -69.22 144.11 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.311 179.945 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.486 ' CG1' ' O ' ' A' ' 78' ' ' GLU . 8.2 tt -106.42 91.39 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.259 179.191 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -64.11 -37.27 86.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.966 179.925 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.486 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 3.5 mt-10 -126.89 168.7 13.85 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.254 -179.044 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -59.74 145.38 98.31 Favored 'Trans proline' 0 N--CA 1.501 1.912 0 C-N-CA 122.042 1.828 . . . . 0.0 112.705 -179.56 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.2 m -145.48 151.58 14.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.801 178.922 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -78.83 132.94 37.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.762 179.552 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.1 mt -89.39 140.92 29.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.16 0.505 . . . . 0.0 111.281 -179.681 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -123.13 151.94 41.61 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.852 179.351 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -53.82 121.69 8.45 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.403 -179.861 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.15 -13.99 37.01 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -179.888 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -68.71 135.59 51.55 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.575 -0.45 . . . . 0.0 109.937 179.671 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.495 ' CG1' ' OG ' ' A' ' 94' ' ' SER . 91.4 t -107.06 132.28 54.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.213 -179.024 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 45.2 mm -91.05 128.28 42.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.768 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.526 ' N ' ' O ' ' A' ' 70' ' ' GLN . 63.5 m -124.26 123.35 40.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.505 0.669 . . . . 0.0 112.531 -178.02 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.443 ' O ' ' C ' ' A' ' 91' ' ' ILE . 85.1 mt -121.55 129.06 75.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.432 179.295 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.443 ' C ' ' O ' ' A' ' 90' ' ' ILE . 95.8 mt 34.2 -99.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.454 -179.797 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.5 ' O ' ' OD1' ' A' ' 92' ' ' ASP . 36.7 t0 -114.05 16.87 18.1 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.703 0.287 . . . . 0.0 111.33 -179.216 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.444 ' NH2' ' CG2' ' A' ' 44' ' ' VAL . 4.8 mtm105 -124.71 139.18 54.09 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.812 -179.298 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.495 ' OG ' ' CG1' ' A' ' 87' ' ' VAL . 41.7 t -132.72 141.81 48.74 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.103 0.478 . . . . 0.0 110.128 179.606 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.458 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 27.2 m-85 -125.06 123.26 39.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.886 -179.993 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -82.53 126.42 32.25 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.508 -179.855 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.585 ' CE2' ' OD1' ' A' ' 99' ' ' ASN . 74.7 t80 -90.59 124.27 34.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.658 179.607 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -128.52 113.5 15.56 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.801 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.585 ' OD1' ' CE2' ' A' ' 97' ' ' TYR . 87.2 m-20 . . . . . 0 C--N 1.327 -0.41 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.544 179.961 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo . . . . . 0 N--CA 1.491 1.331 0 CA-C-O 121.531 0.555 . . . . 0.0 113.159 . . . . . . . . . 0 0 . 1 . 051 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 1.8 t -61.03 138.9 21.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.306 -179.882 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.243 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.288 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo . . . . . 0 N--CA 1.497 1.733 0 N-CA-C 112.7 0.231 . . . . 0.0 112.7 . . . . . . . . . 0 0 . 1 . 051 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 25.9 m -74.52 -42.6 58.61 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.073 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . 0.422 ' CZ ' ' NE ' ' B' ' 245' ' ' ARG . 73.1 t80 -57.17 -47.41 81.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.585 -179.219 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 91.0 mt -65.31 -39.47 92.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.039 0.447 . . . . 0.0 110.206 179.634 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -62.35 -41.25 98.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.757 -179.615 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -64.33 -40.78 96.58 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.65 179.85 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.422 ' NE ' ' CZ ' ' B' ' 241' ' ' PHE . 25.9 mmt180 -61.37 -42.69 99.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.33 -179.354 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.4 -39.76 95.36 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.304 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 11.0 t -66.04 -45.89 79.77 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.849 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -55.11 -40.87 70.96 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.693 179.996 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 44.3 t . . . . . 0 C--N 1.332 -0.175 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.857 . . . . . . . . 0 0 . 1 . 051 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . 0.533 ' OE2' ' NH2' ' A' ' 12' ' ' ARG . 53.5 mp0 . . . . . 0 C--O 1.226 -0.174 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 . . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 64.5 mt -111.7 134.28 54.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.48 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 77.1 t -128.02 135.27 63.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.761 -179.225 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -96.53 119.25 34.67 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.072 -178.224 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -66.42 -46.82 75.23 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.156 178.976 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.37 156.2 51.17 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.859 -178.543 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -62.23 149.19 91.54 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 C-N-CA 122.46 2.107 . . . . 0.0 111.071 179.261 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 30.1 pt . . . . . 0 C--N 1.325 -0.489 0 CA-C-O 121.47 0.652 . . . . 0.0 111.964 -178.42 . . . . . . . . 0 0 . 1 . 052 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 69.1 p . . . . . 0 N--CA 1.455 -0.214 0 CA-C-O 120.919 0.39 . . . . 0.0 110.556 . . . . . . . . . 0 0 . 1 . 052 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.5 mtt85 -94.2 132.76 38.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.248 -179.808 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.484 HH21 ' CD ' ' A' ' 98' ' ' GLU . 39.5 ptt180 -143.57 153.43 42.55 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 120.311 -0.556 . . . . 0.0 111.784 -179.943 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 68.5 mt -117.98 138.71 52.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.817 -179.757 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.6 t -112.03 130.3 65.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.524 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.5 m -79.27 141.24 37.23 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -178.389 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.428 HD11 ' NH1' ' A' ' 96' ' ' ARG . 47.9 mm -106.2 132.4 53.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.096 -0.957 . . . . 0.0 109.035 177.547 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -87.74 154.42 20.58 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.406 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.426 ' HG2' HH12 ' B' ' 245' ' ' ARG . 80.8 mtm180 -57.78 -23.67 53.46 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -178.806 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.4 m -82.89 -9.5 59.28 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.623 179.653 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.27 32.58 10.34 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -179.746 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.1 t -120.53 132.09 71.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.875 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.589 ' OD2' ' NH2' ' A' ' 96' ' ' ARG . 98.2 m-20 -69.8 137.96 52.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.438 -179.649 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -124.77 -121.23 2.54 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.28 -179.093 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -75.93 146.62 29.66 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.578 2.185 . . . . 0.0 113.192 -178.486 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -106.65 143.69 34.39 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.154 0.502 . . . . 0.0 110.461 179.754 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -112.35 96.22 34.63 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.371 -179.707 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -68.89 129.35 18.36 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 121.369 1.379 . . . . 0.0 112.332 -178.422 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 94.4 mt -83.88 78.05 9.79 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.114 0.483 . . . . 0.0 111.052 -178.922 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.7 p -82.29 -13.14 57.45 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.176 178.93 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.2 mt -102.86 148.22 25.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.428 -179.312 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 80.0 p -69.95 -14.78 62.87 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.568 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 58.3 m -129.48 131.48 46.69 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.315 -179.985 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.3 t -124.55 112.7 17.15 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 178.63 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.441 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 40.6 tp -110.01 124.58 51.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.524 -178.749 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.434 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 5.5 m-85 -104.76 140.77 37.59 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.175 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -179.97 -176.08 47.12 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.001 -1.095 . . . . 0.0 112.428 179.507 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 37.2 ttp180 -91.27 -10.01 43.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.928 0.394 . . . . 0.0 109.959 -179.933 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.434 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -93.86 154.53 21.64 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.763 -179.652 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.445 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 11.3 tp -66.92 -40.84 86.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 179.435 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.445 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 80.9 tt0 -46.92 -16.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.478 -179.968 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.435 ' H ' ' C ' ' A' ' 33' ' ' ILE . 2.8 m -83.19 145.14 29.34 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.764 -179.983 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.441 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 54.8 m-20 -58.85 -32.81 69.77 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -179.539 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 85.3 mt -129.04 124.54 60.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.314 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 36.0 ttp180 -108.47 138.71 44.32 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.541 -0.464 . . . . 0.0 111.228 -179.514 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 98.3 mt -121.23 132.54 70.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.125 0.488 . . . . 0.0 110.418 -179.915 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -76.38 29.19 0.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.35 -178.803 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 38.2 mt -98.72 128.87 31.35 Favored Pre-proline 0 C--N 1.324 -0.523 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.476 179.736 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.89 -9.59 22.44 Favored 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 122.135 1.89 . . . . 0.0 111.345 179.316 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.4 m -97.43 5.5 9.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.804 -179.917 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 24.8 t -96.46 133.12 38.96 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-O 121.134 0.492 . . . . 0.0 110.058 179.272 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 28.7 m -72.21 160.93 31.6 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.944 -179.291 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.27 -39.31 89.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.832 -178.891 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.534 ' O ' ' N ' ' A' ' 49' ' ' CYS . 99.4 mm-40 -111.45 -9.81 14.21 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.903 0.382 . . . . 0.0 110.966 -179.549 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.575 ' ND1' ' OG ' ' A' ' 64' ' ' SER . 15.1 t60 15.36 -76.05 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -178.16 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.534 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.65 135.09 46.64 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 -177.613 . . . . . . . . 3 3 . 1 . 052 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -128.55 128.73 44.83 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.648 179.57 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.9 mt -112.84 133.5 58.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.364 179.796 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -116.81 125.27 51.34 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.34 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 87.5 mt -107.27 113.56 43.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.62 0.724 . . . . 0.0 111.812 -179.117 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.433 ' C ' ' N ' ' A' ' 56' ' ' GLN . 86.7 m-70 -109.68 141.77 41.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.442 -179.941 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 54' ' ' HIS . 94.3 mt-10 -42.72 -28.35 0.23 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.729 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.487 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 86.7 mt-30 -65.0 -69.44 0.29 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.642 178.791 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.487 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 4.4 tp10 -154.79 -174.56 5.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.762 -179.064 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -108.62 127.92 54.39 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.252 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.461 HG23 HD12 ' A' ' 59' ' ' ILE . 91.6 mt -119.18 132.17 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -178.512 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.1 tp -100.85 129.58 46.74 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.693 178.934 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -114.35 137.72 51.45 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.787 -179.601 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -98.42 104.28 16.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.266 -0.424 . . . . 0.0 112.11 -179.568 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -101.22 -5.31 25.72 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.518 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.575 ' OG ' ' ND1' ' A' ' 48' ' ' HIS . 0.2 OUTLIER -77.03 99.51 5.33 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.917 -179.844 . . . . . . . . 3 3 . 1 . 052 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.0 m -78.74 -31.72 46.43 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.311 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.5 m -63.45 -49.0 75.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.596 -179.808 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.412 HD22 ' HA ' ' B' ' 236' ' ' VAL . 49.7 m-80 -150.61 100.93 3.1 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.002 -179.487 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -52.34 149.1 23.74 Favored 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 122.468 2.112 . . . . 0.0 112.843 -179.823 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 31.3 m -72.83 137.07 45.5 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.774 179.877 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -100.15 142.02 32.19 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.098 -179.972 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.418 ' O ' ' OG ' ' A' ' 74' ' ' SER . 54.6 t -130.36 134.04 63.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.932 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 51.59 33.01 9.88 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 119.684 -0.806 . . . . 0.0 109.497 179.99 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.68 29.51 67.5 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.344 179.402 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 24.0 p -140.92 133.49 28.6 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 117.486 0.643 . . . . 0.0 111.424 -179.96 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.1 t -69.93 139.18 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.092 179.978 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.55 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 1.2 pt -108.63 107.41 22.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.454 0.645 . . . . 0.0 111.213 179.551 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.432 ' O ' ' OE1' ' A' ' 78' ' ' GLU . 58.3 m-20 -65.64 -33.87 76.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.851 179.051 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.513 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.1 OUTLIER -128.45 -177.72 0.68 Allowed Pre-proline 0 N--CA 1.465 0.282 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.318 179.988 . . . . . . . . 3 3 . 1 . 052 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.513 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 39.7 Cg_exo -61.56 145.08 98.07 Favored 'Trans proline' 0 N--CA 1.499 1.822 0 C-N-CA 122.705 2.27 . . . . 0.0 112.441 179.75 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.2 t -133.21 136.55 54.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.587 179.426 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -73.24 131.19 41.66 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.161 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 90.3 mt -87.46 136.65 32.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.035 0.445 . . . . 0.0 111.279 -179.006 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.537 ' N ' ' OD2' ' A' ' 86' ' ' ASP . 99.2 mttt -125.36 152.26 45.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.953 -179.929 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.498 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 6.1 t60 -52.08 114.73 1.41 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.829 -179.317 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.95 -12.09 29.42 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 179.634 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.537 ' OD2' ' N ' ' A' ' 83' ' ' LYS . 97.5 m-20 -69.98 137.71 51.67 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.086 179.767 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 88.6 t -111.41 134.15 54.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.418 -178.573 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 37.5 mm -93.31 126.53 45.73 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 178.291 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 51.2 m -125.4 127.44 46.57 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.944 0.878 . . . . 0.0 113.08 -178.125 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.531 ' O ' ' C ' ' A' ' 91' ' ' ILE . 89.0 mt -111.76 133.95 55.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 113.933 -1.485 . . . . 0.0 108.043 178.739 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.531 ' C ' ' O ' ' A' ' 90' ' ' ILE . 74.3 mt 16.17 -83.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 O-C-N 123.65 0.594 . . . . 0.0 112.171 -177.333 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' A' ' 90' ' ' ILE . 46.6 t0 -120.7 8.18 10.59 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.593 -179.515 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.734 ' NH1' HH22 ' B' ' 245' ' ' ARG . 2.4 tpp180 -124.65 137.92 54.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.085 -179.784 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 91.0 p -140.79 158.7 43.58 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.577 0.703 . . . . 0.0 112.343 -178.711 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -130.05 128.8 42.68 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.483 179.573 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.589 ' NH2' ' OD2' ' A' ' 16' ' ' ASP . 92.4 mtm-85 -87.55 132.97 33.86 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 119.591 -0.844 . . . . 0.0 111.168 -179.812 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -95.48 125.15 39.89 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.46 179.369 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.484 ' CD ' HH21 ' A' ' 6' ' ' ARG . 83.4 tt0 -126.52 121.68 33.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.623 179.931 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.498 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 64.7 t-20 . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.996 179.764 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo . . . . . 0 N--CA 1.482 0.821 0 CA-C-O 121.376 0.49 . . . . 0.0 112.892 . . . . . . . . . 0 0 . 1 . 052 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . 0.412 ' HA ' HD22 ' A' ' 67' ' ' ASN . 24.8 m -65.67 153.31 8.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.602 -179.263 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 8.6 t . . . . . 0 C--N 1.328 -0.337 0 CA-C-O 121.214 0.531 . . . . 0.0 111.122 -178.629 . . . . . . . . 0 0 . 1 . 052 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo . . . . . 0 N--CA 1.498 1.769 0 N-CA-C 112.826 0.279 . . . . 0.0 112.826 . . . . . . . . . 0 0 . 1 . 052 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 84.2 m -74.21 -40.21 62.6 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.202 0.525 . . . . 0.0 109.595 178.017 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -58.5 -48.06 82.04 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.751 -179.227 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 86.9 mt -63.5 -42.27 98.53 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 120.858 0.361 . . . . 0.0 111.32 179.86 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -66.17 -36.72 83.83 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.451 -179.471 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -61.24 -44.06 97.86 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.454 -0.499 . . . . 0.0 109.808 179.416 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.734 HH22 ' NH1' ' A' ' 93' ' ' ARG . 2.9 mtt-85 -59.9 -41.13 90.97 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.871 0.367 . . . . 0.0 110.432 179.776 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -61.77 -43.05 99.62 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.354 179.505 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 10.5 t -64.26 -45.41 88.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.284 0.564 . . . . 0.0 109.687 178.958 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 28.7 mm100 -62.01 -35.69 79.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.977 -179.363 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 44.8 t . . . . . 0 C--N 1.331 -0.22 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.677 179.357 . . . . . . . . 0 0 . 1 . 052 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 . . . . . 0 CA--C 1.531 0.245 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 . . . . . . . . . 0 0 . 1 . 052 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 75.1 mt -118.23 131.37 71.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.061 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 53.6 t -125.23 132.37 71.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.575 179.81 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -96.18 115.75 27.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.2 -178.927 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -65.53 -46.7 78.57 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.747 179.289 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -87.25 150.39 49.27 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.13 -178.957 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.13 142.98 63.26 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.327 2.018 . . . . 0.0 112.254 -179.745 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 44.5 pt . . . . . 0 C--N 1.327 -0.396 0 CA-C-O 121.148 0.499 . . . . 0.0 109.841 179.114 . . . . . . . . 0 0 . 1 . 053 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.0 p . . . . . 0 N--CA 1.456 -0.173 0 CA-C-O 120.953 0.406 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 053 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.56 ' NH2' ' CD1' ' A' ' 53' ' ' ILE . 15.0 mtm180 -93.69 128.84 40.08 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.564 -179.086 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.7 mtp180 -126.94 139.15 53.27 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.155 0.502 . . . . 0.0 111.456 179.74 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 32.3 tp -112.51 132.83 54.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.057 -179.6 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.0 t -109.45 129.68 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.822 0.344 . . . . 0.0 110.648 179.982 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.8 m -86.28 111.93 20.91 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.715 -179.368 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 79.5 mt -80.42 142.76 13.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.15 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -93.56 159.02 15.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.992 0.425 . . . . 0.0 111.587 179.994 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 89.9 mtm180 -59.12 -29.8 67.66 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.417 179.682 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.4 m -75.51 -15.41 60.4 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.43 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.8 31.83 7.18 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -179.86 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.7 t -119.66 131.17 72.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.835 0.35 . . . . 0.0 110.911 -179.496 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -74.96 139.42 42.98 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.436 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.84 -115.57 1.65 Allowed Glycine 0 CA--C 1.534 1.227 0 C-N-CA 120.118 -1.039 . . . . 0.0 112.11 -179.355 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.71 146.68 43.65 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.264 1.976 . . . . 0.0 112.909 -178.717 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -109.77 146.9 34.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.031 -179.622 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.413 ' CD2' HD12 ' A' ' 37' ' ' ILE . 40.3 t80 -117.27 101.29 53.03 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.584 -179.813 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -72.47 127.35 12.44 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 121.714 1.61 . . . . 0.0 111.546 -178.743 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.416 ' CD1' ' NH2' ' A' ' 5' ' ' ARG . 62.6 mt -78.02 52.29 1.06 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.985 -178.555 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.6 p -61.83 -33.28 73.87 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.398 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 68.6 mt -74.06 141.87 45.69 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.818 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 94.7 p -67.07 -16.61 64.45 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.879 0.371 . . . . 0.0 110.814 -179.35 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 56.4 m -130.83 132.46 45.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.962 -179.992 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.666 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 2.6 t -128.25 120.04 26.38 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.828 179.471 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 27.6 tp -120.15 130.98 54.85 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.541 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.666 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 35.6 m-85 -108.15 144.29 35.75 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.826 179.92 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 149.23 -178.92 26.44 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 120.928 -0.654 . . . . 0.0 112.074 177.929 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 45.6 mtm180 -69.72 -32.88 71.68 Favored 'General case' 0 CA--C 1.522 -0.119 0 CA-C-O 120.936 0.398 . . . . 0.0 111.256 178.76 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.562 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -52.78 135.68 38.26 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -178.813 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.435 ' C ' ' N ' ' A' ' 35' ' ' CYS . 80.1 mt -63.89 -43.45 97.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.48 179.419 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -51.48 -18.9 1.2 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.406 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.562 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 13.9 m -68.79 129.13 39.04 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.718 179.037 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -60.42 -28.63 68.42 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.689 -179.103 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.413 HD12 ' CD2' ' A' ' 20' ' ' PHE . 48.2 mm -122.5 116.0 47.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.9 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -100.79 131.44 46.68 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.678 -179.39 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.416 ' C ' ' H ' ' A' ' 41' ' ' LEU . 91.8 mt -119.52 130.36 74.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.205 -0.598 . . . . 0.0 109.798 -179.549 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -78.04 27.81 0.18 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.207 -178.594 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.416 ' H ' ' C ' ' A' ' 39' ' ' ILE . 16.0 mt -95.3 110.73 52.1 Favored Pre-proline 0 C--N 1.325 -0.483 0 C-N-CA 120.592 -0.443 . . . . 0.0 109.827 179.769 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -56.55 -12.05 7.79 Favored 'Trans proline' 0 N--CA 1.499 1.809 0 C-N-CA 122.115 1.877 . . . . 0.0 113.223 -179.266 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.6 m -102.64 9.14 9.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -178.888 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.532 ' O ' ' O ' ' A' ' 45' ' ' SER . 8.8 p -103.3 106.59 20.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.021 179.894 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.532 ' O ' ' O ' ' A' ' 44' ' ' VAL . 0.4 OUTLIER -34.05 167.08 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 114.911 -1.04 . . . . 0.0 113.122 -178.109 . . . . . . . . 3 3 . 1 . 053 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -62.37 -42.82 99.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.471 -178.723 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.639 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.0 mm-40 -111.97 -20.03 12.14 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.421 -179.445 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 24.6 t60 36.55 -75.26 0.0 OUTLIER 'General case' 0 C--O 1.236 0.361 0 CA-C-N 114.89 -1.05 . . . . 0.0 113.493 179.685 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.639 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.27 135.91 45.21 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.759 -178.118 . . . . . . . . 3 3 . 1 . 053 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -128.56 134.82 48.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.776 179.809 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.0 mt -117.05 132.73 65.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.21 179.701 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -118.56 127.24 53.43 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.647 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.56 ' CD1' ' NH2' ' A' ' 5' ' ' ARG . 86.7 mt -102.72 116.27 46.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.487 0.66 . . . . 0.0 111.593 -179.562 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.448 ' O ' ' C ' ' A' ' 55' ' ' GLU . 79.6 m-70 -111.83 139.04 47.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.114 -179.921 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 54' ' ' HIS . 97.6 mt-10 -40.55 -34.69 0.38 Allowed 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.654 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -60.73 -67.96 0.35 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.832 178.599 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -155.63 -171.89 3.94 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.286 0.565 . . . . 0.0 111.571 -179.03 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.18 128.17 54.81 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.668 179.18 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.404 HD13 HG23 ' A' ' 59' ' ' ILE . 96.4 mt -125.48 133.53 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -178.77 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.415 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 16.5 tp -97.89 131.68 44.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.138 179.024 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -113.35 136.2 53.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.959 179.992 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -97.97 104.1 16.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.37 -179.921 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -95.99 -8.7 33.0 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.17 179.636 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.09 109.58 7.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.933 0.397 . . . . 0.0 111.364 -179.579 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.7 p -90.44 -18.07 26.05 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.07 179.022 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.91 -40.88 13.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.221 -179.901 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -145.67 99.1 4.45 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.47 -179.766 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -57.86 147.49 81.02 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 122.049 1.833 . . . . 0.0 112.779 179.99 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.0 m -68.08 137.17 54.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.884 179.519 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -98.52 143.62 28.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.977 179.353 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.414 ' O ' ' N ' ' A' ' 74' ' ' SER . 5.1 p -130.82 137.9 54.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.342 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 50.58 31.84 6.11 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.946 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.91 28.68 68.29 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.355 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.414 ' N ' ' O ' ' A' ' 71' ' ' VAL . 14.8 t -137.97 135.29 35.86 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.846 0.355 . . . . 0.0 111.357 -179.726 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.4 p -61.73 143.03 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.914 -179.207 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.55 ' CG2' ' O ' ' A' ' 78' ' ' GLU . 96.5 mt -108.3 106.01 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.931 -179.855 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -68.74 -42.04 78.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.428 179.067 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.55 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.7 OUTLIER -135.01 -179.92 1.21 Allowed Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.522 -178.774 . . . . . . . . 3 3 . 1 . 053 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.473 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 32.1 Cg_exo -57.48 146.94 81.25 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.631 2.221 . . . . 0.0 112.699 -179.595 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 18.2 m -139.67 142.81 31.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.48 -179.315 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.52 HH21 ' CE ' ' A' ' 83' ' ' LYS . 61.2 ttp180 -76.07 131.28 39.37 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.579 179.013 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.3 mt -80.61 135.5 36.07 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-O 121.148 0.499 . . . . 0.0 111.69 -179.413 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.52 ' CE ' HH21 ' A' ' 81' ' ' ARG . 99.0 mttt -129.07 150.57 50.41 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.868 178.937 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.665 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 6.3 t60 -55.3 115.72 2.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.831 0.348 . . . . 0.0 111.748 -179.172 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.24 -18.75 18.09 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.936 -0.65 . . . . 0.0 111.595 179.016 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -69.52 136.37 51.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.34 0.591 . . . . 0.0 110.608 179.913 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.8 t -114.5 131.24 67.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.04 -179.014 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 92.8 mt -97.23 132.26 42.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.645 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.8 m -118.55 124.92 48.71 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.338 -178.544 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.474 ' O ' ' N ' ' A' ' 92' ' ' ASP . 78.0 mt -112.38 126.96 69.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.134 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.495 ' CG2' ' NH2' ' B' ' 245' ' ' ARG . 33.8 mm 38.74 -97.09 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -178.749 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.543 ' CB ' ' NH2' ' B' ' 245' ' ' ARG . 44.2 t0 -123.09 17.45 10.0 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.097 0.475 . . . . 0.0 110.494 178.883 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.459 ' O ' ' N ' ' A' ' 90' ' ' ILE . 29.7 mmm-85 -122.96 138.78 54.59 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.855 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.3 m -135.04 151.59 50.92 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.87 -179.248 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -122.62 120.83 34.9 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.246 179.271 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 38.9 ttp-105 -81.16 130.55 35.07 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.831 -179.671 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -97.69 125.55 42.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.035 -179.917 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -128.15 129.25 46.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.327 -179.956 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.665 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 60.5 t-20 . . . . . 0 N--CA 1.464 0.227 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.778 -179.411 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo . . . . . 0 N--CA 1.485 0.972 0 CA-C-O 121.179 0.408 . . . . 0.0 111.846 . . . . . . . . . 0 0 . 1 . 053 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 15.7 t -98.84 128.38 50.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.206 -179.744 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 5.7 t . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.548 -179.848 . . . . . . . . 0 0 . 1 . 053 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo . . . . . 0 N--CA 1.495 1.577 0 N-CA-C 113.115 0.39 . . . . 0.0 113.115 . . . . . . . . . 0 0 . 1 . 053 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 96.0 m -72.88 -45.66 57.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.288 0.566 . . . . 0.0 109.779 179.123 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . 0.433 ' CE2' ' NE ' ' B' ' 245' ' ' ARG . 80.3 t80 -57.38 -44.42 84.42 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.968 -179.722 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . 0.418 HD23 HH21 ' B' ' 245' ' ' ARG . 97.0 mt -63.51 -41.83 98.5 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.641 -179.796 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -66.31 -37.23 84.91 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.707 0.289 . . . . 0.0 111.108 -179.497 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 78.2 ttt-85 -63.1 -47.62 82.07 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.636 -179.429 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.543 ' NH2' ' CB ' ' A' ' 92' ' ' ASP . 55.9 mtm180 -65.53 -39.3 91.62 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.621 -179.585 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -59.79 -40.3 87.85 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.325 179.991 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 28.2 m -68.22 -42.83 79.19 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.5 0.667 . . . . 0.0 109.587 178.301 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -62.54 -36.26 82.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.862 179.731 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 95.0 t . . . . . 0 N--CA 1.451 -0.387 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.961 . . . . . . . . 0 0 . 1 . 053 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 . . . . . 0 CA--C 1.536 0.432 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 . . . . . . . . . 0 0 . 1 . 053 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . 0.42 HD11 ' NH2' ' A' ' 93' ' ' ARG . 76.7 mt -112.18 134.6 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 119.101 0.864 . . . . 0.0 109.571 178.814 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 40.4 t -127.74 134.11 66.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.993 -179.74 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -94.33 115.14 27.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.662 -179.016 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -66.3 -46.92 75.31 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.628 179.78 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.09 155.16 43.19 Favored Pre-proline 0 N--CA 1.454 -0.267 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.708 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -63.0 141.77 85.24 Favored 'Trans proline' 0 C--N 1.302 -1.906 0 C-N-CA 122.86 2.373 . . . . 0.0 113.085 179.965 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 37.4 pt . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.607 178.355 . . . . . . . . 0 0 . 1 . 054 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.489 ' O ' ' O ' ' A' ' 99' ' ' ASN . 23.8 m . . . . . 0 N--CA 1.464 0.258 0 N-CA-C 111.787 0.292 . . . . 0.0 111.787 . . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 86.2 mtt85 -82.31 134.24 35.26 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.906 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -131.14 139.06 49.74 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 120.266 -0.573 . . . . 0.0 111.984 -179.075 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 34.2 mt -115.75 133.65 55.81 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.958 179.948 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 76.3 t -107.25 127.61 62.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.349 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 m -91.01 114.75 27.35 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 112.943 0.719 . . . . 0.0 112.943 -177.31 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 92.6 mt -80.99 141.9 14.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.645 179.242 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -90.43 159.54 16.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.063 0.458 . . . . 0.0 110.748 179.157 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.479 ' HG2' HH21 ' B' ' 245' ' ' ARG . 81.3 mtp180 -58.77 -32.75 69.58 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.405 -179.426 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.7 p -74.45 -13.62 60.73 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.584 179.674 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.26 29.91 7.28 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -179.745 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.3 t -117.58 130.17 72.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.721 0.296 . . . . 0.0 111.205 -179.494 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -73.62 139.26 45.37 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 177.773 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.2 -112.8 1.43 Allowed Glycine 0 CA--C 1.53 0.978 0 C-N-CA 120.161 -1.018 . . . . 0.0 112.232 -179.088 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -73.45 144.8 36.91 Favored 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 122.138 1.892 . . . . 0.0 113.009 -178.524 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 66.1 m170 -104.0 135.58 45.26 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.453 179.662 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.419 ' CD2' HD11 ' A' ' 37' ' ' ILE . 47.4 t80 -106.07 91.97 6.05 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.024 -179.274 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -72.95 139.27 29.83 Favored 'Trans proline' 0 N--CA 1.488 1.193 0 C-N-CA 121.634 1.556 . . . . 0.0 111.352 -179.33 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 86.2 mt -101.31 124.03 46.36 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.423 -178.592 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 65.3 p -117.37 -8.93 10.99 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.602 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 54.9 mt -101.73 149.78 23.81 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.587 -179.083 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 97.3 p -70.18 -12.14 61.39 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.27 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.434 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 41.9 m -132.35 133.98 44.64 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.257 -0.577 . . . . 0.0 111.89 -179.544 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 10.0 t -125.25 116.46 22.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.323 -0.853 . . . . 0.0 108.901 178.384 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.402 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 52.1 tp -116.88 132.8 56.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.997 -178.04 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.499 ' O ' ' O ' ' A' ' 47' ' ' GLN . 42.1 m-85 -110.16 136.67 49.02 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.366 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 164.48 -166.79 38.04 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 120.111 -1.042 . . . . 0.0 112.344 179.541 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.645 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 85.4 mtm-85 -89.27 -29.03 19.5 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 115.606 -0.297 . . . . 0.0 110.462 179.581 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.461 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -57.23 153.1 23.49 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 121.273 -0.489 . . . . 0.0 112.715 -177.73 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.525 ' CD1' ' NH1' ' A' ' 38' ' ' ARG . 9.4 tp -66.55 -41.87 89.12 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 N-CA-C 110.356 -0.238 . . . . 0.0 110.356 179.389 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -56.49 -27.07 56.16 Favored 'General case' 0 N--CA 1.461 0.124 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.647 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.461 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 19.3 m -54.54 122.75 11.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.693 179.701 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.434 ' OD2' ' O ' ' A' ' 26' ' ' THR . 55.5 m-20 -60.87 -33.35 72.95 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -179.566 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.428 HG22 HD13 ' A' ' 37' ' ' ILE . 44.0 mm -119.1 109.91 28.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 177.792 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.525 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 84.9 mtp180 -98.21 134.83 40.71 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -179.097 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.43 ' C ' ' H ' ' A' ' 41' ' ' LEU . 98.1 mt -120.42 132.34 70.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.028 -179.922 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -76.11 29.11 0.11 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.498 -0.773 . . . . 0.0 112.113 -178.495 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.485 ' CD1' ' CZ ' ' A' ' 93' ' ' ARG . 44.9 mt -106.12 130.07 23.56 Favored Pre-proline 0 CA--C 1.534 0.348 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.448 178.973 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.25 -12.65 25.49 Favored 'Trans proline' 0 N--CA 1.49 1.268 0 C-N-CA 122.448 2.099 . . . . 0.0 112.736 -179.455 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.7 m -92.57 -0.61 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.695 179.851 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.645 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 46.1 t -86.71 132.83 31.36 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.452 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.014 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.6 m -70.15 167.96 16.67 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.331 0.586 . . . . 0.0 111.22 -178.588 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt -62.64 -40.55 97.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.703 -178.872 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.652 ' O ' ' N ' ' A' ' 49' ' ' CYS . 95.4 mm-40 -115.38 -20.9 10.09 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.928 0.394 . . . . 0.0 110.483 -179.568 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.3 t60 34.05 -74.52 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -179.947 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.652 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.99 136.92 46.33 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -177.97 . . . . . . . . 3 3 . 1 . 054 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -128.23 132.2 48.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.861 179.558 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.9 mt -116.59 134.09 61.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.69 179.901 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -111.21 129.01 56.09 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.957 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.9 mm -100.16 118.6 47.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.304 0.573 . . . . 0.0 111.253 -179.138 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.452 ' O ' ' C ' ' A' ' 55' ' ' GLU . 98.0 m-70 -119.86 130.79 55.04 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.915 179.296 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' A' ' 54' ' ' HIS . 81.8 tt0 -40.83 -31.35 0.16 Allowed 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -179.866 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.458 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 98.4 mm-40 -64.82 -67.76 0.41 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.94 178.649 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.459 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 5.5 tp10 -153.49 -170.51 3.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.0 -179.481 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.459 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -118.43 128.41 54.59 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.513 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.0 mt -114.51 130.67 68.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.134 0.492 . . . . 0.0 112.23 -178.732 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.7 tp -99.56 128.88 45.68 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.471 179.996 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -112.7 136.7 51.98 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.742 179.649 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.499 HD22 ' CA ' ' A' ' 68' ' ' PRO . 59.5 t-20 -95.96 110.32 22.55 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.403 -178.763 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -103.94 -7.92 20.03 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 179.84 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.559 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 97.9 p -81.37 98.48 8.21 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.18 -179.419 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.3 m -74.64 -38.86 62.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.449 0.642 . . . . 0.0 109.482 178.427 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p -65.46 -39.21 91.74 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.342 -179.629 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.559 ' O ' ' OG ' ' A' ' 64' ' ' SER . 54.2 m-80 -146.18 92.79 5.2 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.424 -179.53 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.499 ' CA ' HD22 ' A' ' 62' ' ' ASN . 46.8 Cg_exo -54.22 145.98 52.14 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.541 2.16 . . . . 0.0 111.873 -179.072 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.7 m -70.87 150.6 45.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.956 179.665 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -117.23 140.16 49.88 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.777 -179.768 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 48.9 t -130.92 134.86 61.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.353 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 51.79 32.32 9.44 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -179.37 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.27 27.06 68.86 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.957 179.688 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.9 t -140.15 138.05 34.9 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 117.359 0.579 . . . . 0.0 111.599 179.864 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 10.9 t -68.67 140.68 18.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.685 179.958 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.0 pt -112.08 84.33 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.949 179.403 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -61.91 -32.17 72.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.449 179.532 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -118.46 168.21 10.01 Favored Pre-proline 0 CA--C 1.531 0.249 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.534 179.587 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.71 145.09 99.09 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 122.205 1.936 . . . . 0.0 112.52 179.965 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.2 p -138.9 140.0 39.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.986 179.652 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.6 mtm-85 -73.25 131.46 41.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.846 179.243 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.8 mt -84.95 137.57 33.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.114 0.483 . . . . 0.0 111.58 -179.136 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -126.95 151.06 49.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.563 179.028 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.462 ' C ' ' CD2' ' A' ' 84' ' ' HIS . 4.9 t60 -56.94 123.28 14.56 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.849 -179.736 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.26 -21.76 28.29 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 179.592 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -69.24 138.47 53.99 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.023 0.44 . . . . 0.0 110.513 179.784 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.2 t -111.75 131.1 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.85 -177.928 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.7 mt -93.01 134.32 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.117 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 94.5 m -126.55 126.5 43.78 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 119.933 -0.707 . . . . 0.0 112.492 -179.026 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.577 ' O ' ' N ' ' A' ' 92' ' ' ASP . 89.6 mt -110.48 125.66 67.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.085 -0.961 . . . . 0.0 108.695 178.367 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.435 ' C ' ' O ' ' A' ' 90' ' ' ILE . 89.2 mt 38.85 -91.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.113 -179.087 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.577 ' N ' ' O ' ' A' ' 90' ' ' ILE . 42.7 t0 -126.8 21.17 7.0 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.385 179.82 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.628 ' NH1' HH12 ' B' ' 245' ' ' ARG . 50.4 mtm-85 -129.01 143.39 50.85 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.321 -179.607 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 28.9 p -139.61 153.87 47.45 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 119.796 -0.762 . . . . 0.0 111.729 179.634 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -123.38 121.6 36.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.623 178.439 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -74.24 126.57 30.91 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.373 -179.534 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.507 ' OH ' ' OD1' ' A' ' 99' ' ' ASN . 92.0 t80 -94.51 121.42 36.04 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.929 0.395 . . . . 0.0 110.719 -179.972 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.427 ' HG3' ' CE1' ' A' ' 84' ' ' HIS . 84.7 tt0 -131.63 116.57 17.54 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.725 -179.959 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.507 ' OD1' ' OH ' ' A' ' 97' ' ' TYR . 91.5 m-20 . . . . . 0 C--N 1.33 -0.244 0 CA-C-O 120.974 0.416 . . . . 0.0 111.044 179.905 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo . . . . . 0 N--CA 1.489 1.231 0 CA-C-O 121.706 0.628 . . . . 0.0 112.814 . . . . . . . . . 0 0 . 1 . 054 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 13.1 p -79.5 125.29 38.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.716 179.26 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.9 t . . . . . 0 C--N 1.331 -0.226 0 C-N-CA 120.502 -0.479 . . . . 0.0 109.845 -179.795 . . . . . . . . 0 0 . 1 . 054 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo . . . . . 0 N--CA 1.491 1.371 0 N-CA-C 111.284 -0.314 . . . . 0.0 111.284 . . . . . . . . . 0 0 . 1 . 054 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 79.8 m -74.79 -43.85 52.59 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 177.764 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . 0.426 ' CE2' ' HD2' ' B' ' 245' ' ' ARG . 88.3 t80 -57.52 -46.54 83.69 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.994 -179.584 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 92.5 mt -64.0 -41.62 97.42 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.259 -179.938 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.8 -39.5 87.77 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.99 -179.901 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . 0.511 ' O ' ' OG ' ' B' ' 247' ' ' SER . 62.8 ttp180 -60.51 -43.97 96.5 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.943 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.628 HH12 ' NH1' ' A' ' 93' ' ' ARG . 79.3 mtp180 -61.77 -40.1 93.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.553 -179.508 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.21 -38.22 85.81 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 120.504 -0.478 . . . . 0.0 109.853 179.127 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' B' B ' 247' ' ' SER . . . . . 0.511 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 80.2 p -68.62 -42.57 77.9 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 178.389 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . 0.47 ' HB2' HH22 ' A' ' 12' ' ' ARG . 82.5 mt-30 -61.89 -35.59 78.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.536 179.568 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 22.5 t . . . . . 0 C--N 1.33 -0.25 0 CA-C-O 120.941 0.401 . . . . 0.0 110.159 179.221 . . . . . . . . 0 0 . 1 . 054 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 . . . . . 0 CA--C 1.537 0.451 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 . . . . . . . . . 0 0 . 1 . 054 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 60.0 mt -110.42 137.19 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 120.516 -0.474 . . . . 0.0 109.867 179.722 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 44.7 t -126.89 134.63 65.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.731 179.465 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -94.14 117.25 29.84 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.462 -178.85 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -67.93 -47.99 67.17 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.15 -179.985 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -82.62 157.99 66.36 Favored Pre-proline 0 CA--C 1.516 -0.354 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.681 -179.123 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.82 138.54 49.01 Favored 'Trans proline' 0 C--N 1.301 -1.933 0 C-N-CA 122.5 2.133 . . . . 0.0 112.641 179.586 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 1.4 pt . . . . . 0 C--N 1.325 -0.491 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.259 178.522 . . . . . . . . 0 0 . 1 . 055 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 78.9 p . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.933 0.397 . . . . 0.0 110.73 . . . . . . . . . 0 0 . 1 . 055 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.561 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 96.0 mtt-85 -96.24 117.77 31.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.594 -179.53 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.569 ' HE ' ' CE1' ' A' ' 19' ' ' HIS . 85.6 mtp180 -131.37 139.02 49.4 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.054 0.454 . . . . 0.0 111.601 179.877 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 37.1 tp -114.26 128.88 56.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.486 179.519 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 64.4 t -108.68 131.6 58.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.694 -0.403 . . . . 0.0 110.026 -179.684 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.3 m -82.56 152.23 26.06 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.601 0.715 . . . . 0.0 112.181 -178.714 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.5 mt -120.08 140.2 44.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.101 177.46 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 73.0 mttt -89.05 157.12 18.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.17 0.509 . . . . 0.0 110.501 179.551 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.562 ' NH2' ' O ' ' B' ' 245' ' ' ARG . 79.3 mtp180 -56.35 -31.03 63.39 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.665 -179.758 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.3 m -77.83 -9.33 58.99 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.764 -0.375 . . . . 0.0 110.339 179.589 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.83 38.98 5.35 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 179.878 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.4 t -124.09 133.42 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 120.92 0.39 . . . . 0.0 111.64 -179.692 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -76.71 138.66 40.12 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.078 178.939 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -134.47 -116.43 1.65 Allowed Glycine 0 CA--C 1.538 1.508 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.965 -179.521 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.95 152.09 45.95 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 122.499 2.133 . . . . 0.0 113.096 -179.163 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.569 ' CE1' ' HE ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -116.14 158.77 22.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.935 0.397 . . . . 0.0 110.48 179.904 . . . . . . . . 3 3 . 1 . 055 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -124.15 108.38 29.9 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.589 -179.382 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -75.58 127.95 10.67 Favored 'Trans proline' 0 N--CA 1.488 1.201 0 C-N-CA 121.605 1.537 . . . . 0.0 111.361 -179.196 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 61.6 mt -82.86 49.41 1.5 Allowed 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.137 -178.808 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.6 t -63.1 -32.5 73.9 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 178.75 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.452 ' HG ' HE22 ' B' ' 265' ' ' GLN . 68.5 mt -70.77 142.25 51.4 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.831 179.711 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.5 m -63.87 -22.96 67.16 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.507 -179.289 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.3 m -133.27 133.93 43.27 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.953 -179.761 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.676 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 3.0 t -127.14 114.87 18.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.81 179.664 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.2 tp -111.55 125.69 54.19 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.228 -178.741 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.676 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 18.4 m-85 -100.69 128.51 46.71 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 177.93 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 179.26 -155.86 17.01 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 120.027 -1.082 . . . . 0.0 112.309 -179.588 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.599 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 81.8 mtm-85 -109.98 -25.23 10.37 Favored 'General case' 0 N--CA 1.46 0.067 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.074 179.902 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.48 161.29 21.92 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.194 -0.763 . . . . 0.0 111.194 -179.13 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.455 ' CD1' ' NH1' ' A' ' 38' ' ' ARG . 10.9 tp -67.38 -39.44 82.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.949 0.404 . . . . 0.0 110.418 179.959 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.4 ' H ' HG21 ' A' ' 33' ' ' ILE . 97.7 mt-10 -57.48 -31.58 66.11 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.109 -179.981 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.3 m -50.81 120.64 4.97 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.022 179.803 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -60.71 -33.4 72.83 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.406 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 96.4 mt -124.94 116.92 48.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.395 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.455 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 83.9 mtp180 -103.31 137.26 41.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.507 -177.927 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.507 ' C ' ' H ' ' A' ' 41' ' ' LEU . 92.7 mt -120.22 131.34 72.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.534 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -73.83 25.98 0.07 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.651 -178.234 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.507 ' H ' ' C ' ' A' ' 39' ' ' ILE . 15.1 mt -101.68 122.95 45.84 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.647 179.947 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.9 -8.68 21.57 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 122.295 1.997 . . . . 0.0 112.144 -179.753 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.2 m -92.91 0.74 9.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.656 179.325 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.599 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 93.7 t -98.27 103.47 14.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.858 179.449 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.538 ' O ' ' O ' ' A' ' 44' ' ' VAL . 1.4 t -34.11 162.11 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.451 0.643 . . . . 0.0 112.022 -178.846 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -60.69 -41.85 95.97 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.019 -0.992 . . . . 0.0 112.175 -178.371 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.584 ' O ' ' N ' ' A' ' 49' ' ' CYS . 90.8 mm-40 -107.67 -18.04 13.94 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.556 0.693 . . . . 0.0 109.902 179.589 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.0 t60 37.22 -78.16 0.0 OUTLIER 'General case' 0 C--O 1.239 0.53 0 CA-C-N 114.541 -1.209 . . . . 0.0 113.738 179.901 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.584 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -134.54 139.23 45.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.115 0.483 . . . . 0.0 112.072 -178.455 . . . . . . . . 3 3 . 1 . 055 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -129.15 125.26 36.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.555 179.594 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.5 mt -109.32 133.79 53.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.102 179.863 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.592 ' CD ' ' HE2' ' A' ' 54' ' ' HIS . 74.5 tt0 -113.17 126.37 55.37 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.324 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.8 mm -98.63 118.61 45.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.325 0.583 . . . . 0.0 112.141 -178.201 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.592 ' HE2' ' CD ' ' A' ' 52' ' ' GLU . 96.5 m-70 -119.46 132.22 55.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.375 178.411 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.469 ' C ' ' O ' ' A' ' 54' ' ' HIS . 76.0 tt0 -40.72 -28.37 0.07 Allowed 'General case' 0 CA--C 1.518 -0.25 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.719 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.492 ' N ' ' O ' ' A' ' 54' ' ' HIS . 86.0 mt-30 -66.41 -68.47 0.37 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.329 178.387 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.461 ' CB ' ' HE ' ' A' ' 81' ' ' ARG . 1.4 pt-20 -156.12 -168.81 2.86 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.843 -179.307 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -114.52 128.66 56.45 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.039 179.474 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.2 mt -116.85 127.94 74.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.2 0.524 . . . . 0.0 111.157 -179.748 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.2 tp -95.92 129.18 43.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.507 -179.69 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -115.68 136.32 53.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.984 179.636 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.665 ' ND2' ' H ' ' A' ' 69' ' ' THR . 12.8 t-20 -99.4 110.53 23.01 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.121 179.935 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -99.59 -8.38 24.56 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 120.856 0.36 . . . . 0.0 110.55 179.365 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.0 t -76.17 99.05 4.57 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.063 179.964 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 45.9 t -75.09 -44.59 46.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.663 0.744 . . . . 0.0 109.527 178.463 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.83 -43.36 98.99 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.495 -1.23 . . . . 0.0 111.021 -179.17 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -143.39 97.07 5.65 Favored Pre-proline 0 N--CA 1.468 0.436 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.216 -179.792 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.84 146.3 86.75 Favored 'Trans proline' 0 N--CA 1.499 1.844 0 C-N-CA 122.294 1.996 . . . . 0.0 112.963 179.553 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.665 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 29.1 m -69.34 137.05 52.58 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.068 178.927 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -98.69 140.16 33.32 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.548 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 25.2 t -132.96 137.12 54.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.359 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 54.61 33.59 19.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.136 0.494 . . . . 0.0 109.914 -179.34 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.73 30.24 66.42 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.952 179.473 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.2 m -145.16 140.35 27.9 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 117.464 0.632 . . . . 0.0 112.193 -179.505 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.2 t -70.44 136.23 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.677 179.944 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.562 ' CG2' ' O ' ' A' ' 78' ' ' GLU . 88.6 mt -107.81 117.69 53.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.495 179.943 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -89.16 -29.13 19.55 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.68 178.928 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.562 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.0 OUTLIER -126.03 166.61 20.49 Favored Pre-proline 0 N--CA 1.467 0.401 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.122 -178.947 . . . . . . . . 3 3 . 1 . 055 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.07 148.96 91.36 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 122.469 2.112 . . . . 0.0 112.354 -179.946 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.2 m -141.41 151.55 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 121.354 0.597 . . . . 0.0 112.605 -179.559 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.461 ' HE ' ' CB ' ' A' ' 57' ' ' GLU . 74.6 ttt180 -78.13 128.31 33.6 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.543 179.066 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.9 mt -81.64 134.03 35.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.119 0.485 . . . . 0.0 111.229 -179.625 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -128.39 152.12 48.56 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.117 179.265 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.7 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 5.1 t60 -53.8 117.76 3.42 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.489 -179.535 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.62 -3.41 27.71 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -179.248 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.404 ' C ' ' OD1' ' A' ' 86' ' ' ASP . 45.7 t0 -80.34 121.29 25.49 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.083 -0.339 . . . . 0.0 110.083 179.628 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 74.5 t -108.43 132.68 55.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.042 -178.249 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 84.8 mt -99.11 131.98 45.35 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.682 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.3 m -115.93 125.04 52.05 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.345 0.593 . . . . 0.0 111.061 -179.179 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.484 ' O ' ' N ' ' A' ' 93' ' ' ARG . 92.0 mt -118.85 123.31 71.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.898 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.468 ' C ' ' O ' ' A' ' 90' ' ' ILE . 46.7 mm 35.13 -104.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.972 -179.727 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 92' ' ' ASP . 37.1 p-10 -105.91 11.11 32.13 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -179.555 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.544 HH21 ' CG ' ' B' ' 260' ' ' GLU . 86.0 mtt-85 -127.58 147.31 50.34 Favored 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.193 -179.426 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 29.0 t -137.18 153.22 50.5 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.079 0.466 . . . . 0.0 110.331 179.271 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -126.64 129.14 47.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.426 179.76 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -94.15 135.07 35.92 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.26 -179.003 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.561 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 83.8 t80 -99.91 124.2 44.97 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.357 179.912 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -124.89 127.53 47.25 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.728 179.508 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.7 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 63.5 t-20 . . . . . 0 C--N 1.331 -0.222 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.171 179.436 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo . . . . . 0 N--CA 1.484 0.958 0 CA-C-O 121.02 0.342 . . . . 0.0 111.936 . . . . . . . . . 0 0 . 1 . 055 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 37.0 t -114.08 133.4 60.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.751 179.952 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 2.6 t . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.668 179.43 . . . . . . . . 0 0 . 1 . 055 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo . . . . . 0 N--CA 1.492 1.4 0 N-CA-C 112.571 0.181 . . . . 0.0 112.571 . . . . . . . . . 0 0 . 1 . 055 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 99.2 m -73.21 -46.02 52.81 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.375 0.607 . . . . 0.0 109.709 178.067 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -57.65 -45.36 85.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.485 -179.433 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 95.8 mt -64.17 -41.4 97.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.548 -179.25 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -63.19 -41.5 99.2 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.225 -179.951 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -62.49 -43.44 98.82 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.976 0.417 . . . . 0.0 110.055 179.533 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.562 ' O ' ' NH2' ' A' ' 12' ' ' ARG . 24.4 mmt180 -61.26 -43.02 99.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.64 -179.473 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.66 -38.99 92.49 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.803 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 11.1 t -64.72 -46.22 83.2 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 177.696 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . 0.416 ' HB2' HH22 ' A' ' 12' ' ' ARG . 83.6 mt-30 -60.39 -37.74 81.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.123 179.709 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 61.9 t . . . . . 0 CA--C 1.519 -0.22 0 C-N-CA 120.217 -0.593 . . . . 0.0 109.744 179.898 . . . . . . . . 0 0 . 1 . 055 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . 0.544 ' CG ' HH21 ' A' ' 93' ' ' ARG . 97.6 mt-10 . . . . . 0 C--O 1.231 0.121 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 . . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 60.3 mt -111.11 138.07 40.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.867 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 48.6 t -128.55 136.08 60.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.682 0.277 . . . . 0.0 110.296 179.502 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -99.2 122.03 41.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.276 0.56 . . . . 0.0 111.791 -178.465 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -65.71 -44.3 86.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.021 179.233 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . 0.452 HE22 ' HG ' ' A' ' 24' ' ' LEU . 0.3 OUTLIER -103.77 162.14 20.86 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.737 -178.831 . . . . . . . . 3 3 . 1 . 055 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -60.75 152.79 67.02 Favored 'Trans proline' 0 N--CA 1.499 1.836 0 C-N-CA 123.17 2.58 . . . . 0.0 112.702 179.376 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 40.1 pt . . . . . 0 C--N 1.327 -0.39 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.55 -179.844 . . . . . . . . 0 0 . 1 . 056 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 52.9 p . . . . . 0 CA--C 1.517 -0.318 0 CA-C-O 121.142 0.496 . . . . 0.0 111.016 . . . . . . . . . 0 0 . 1 . 056 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.5 mtt85 -100.43 122.06 42.56 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.972 -178.919 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -132.14 142.08 49.35 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.173 179.909 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 40.0 tp -114.68 125.25 53.52 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.493 179.494 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 32.0 m -104.85 132.82 50.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.701 -179.413 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.1 m -79.68 142.83 35.16 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.386 -179.119 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.439 HD13 HG23 ' A' ' 10' ' ' ILE . 86.0 mt -111.49 135.94 49.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 177.492 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -89.2 157.73 18.15 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.627 179.291 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.426 ' HD3' HH22 ' A' ' 93' ' ' ARG . 87.8 mtm180 -57.2 -26.57 60.88 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.151 -179.191 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 44.9 m -80.48 -12.53 59.54 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 179.541 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.23 35.89 5.87 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.955 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.6 t -124.21 133.56 68.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 120.803 0.335 . . . . 0.0 110.793 -179.101 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -72.26 130.33 40.54 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.546 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -119.98 -122.68 3.03 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.282 -178.826 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.58 145.17 51.65 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 121.357 1.372 . . . . 0.0 112.402 -179.458 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 61.6 m170 -103.72 140.34 37.73 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.642 -179.975 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.4 ' CD2' HD12 ' A' ' 37' ' ' ILE . 59.3 t80 -114.39 96.19 42.16 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.073 -179.466 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -59.28 125.88 19.27 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.93 1.754 . . . . 0.0 112.497 -179.01 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 89.0 mt -85.62 44.91 1.14 Allowed 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.533 -179.893 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 66.3 p -60.17 -30.69 69.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.979 0.419 . . . . 0.0 109.943 179.57 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 68.5 mt -72.54 144.98 47.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.22 178.987 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.09 -20.64 65.83 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.568 -178.343 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.499 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 23.0 m -133.05 136.95 46.25 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.655 -179.321 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.621 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 3.7 t -129.43 118.36 22.03 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.794 178.052 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 49.5 tp -114.55 130.61 56.78 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.173 -178.859 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.621 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 9.1 m-85 -109.21 138.28 45.81 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.195 -0.911 . . . . 0.0 108.91 179.174 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.42 -166.72 36.67 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.145 179.105 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.574 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 81.7 mtm-85 -89.81 -29.62 18.52 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 179.8 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.562 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -52.96 148.77 12.28 Favored Glycine 0 CA--C 1.521 0.458 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.314 -179.413 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.498 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 11.1 tp -66.01 -39.83 85.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.874 0.369 . . . . 0.0 110.191 -179.98 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.498 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 78.3 mm-40 -58.78 -21.99 57.13 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.217 -178.373 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.562 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 14.3 m -56.86 121.05 8.96 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.829 -179.804 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.499 ' OD2' ' O ' ' A' ' 26' ' ' THR . 95.3 m-20 -57.93 -26.06 61.72 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.17 179.807 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.432 HG23 HD13 ' A' ' 37' ' ' ILE . 86.3 mt -130.06 122.08 53.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 176.848 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.466 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 83.9 mtp180 -105.6 135.15 47.54 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.358 -178.737 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.407 ' C ' ' H ' ' A' ' 41' ' ' LEU . 96.9 mt -119.97 129.56 75.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.945 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -75.74 24.65 0.12 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -177.771 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.563 ' CD2' ' NH2' ' B' ' 245' ' ' ARG . 34.0 mt -92.49 125.55 55.58 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 119.841 -0.744 . . . . 0.0 110.848 179.667 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -72.62 -8.93 23.31 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.048 1.832 . . . . 0.0 112.558 -179.151 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.6 m -101.55 5.13 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.393 -179.648 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.574 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 40.7 t -99.09 106.65 19.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.152 -179.843 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.551 ' O ' ' O ' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -31.96 162.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.554 -178.762 . . . . . . . . 3 3 . 1 . 056 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -59.22 -47.39 85.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.3 -178.933 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.63 ' O ' ' N ' ' A' ' 49' ' ' CYS . 98.4 mt-30 -107.25 -12.44 15.36 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.491 0.662 . . . . 0.0 110.071 179.592 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.403 ' ND1' HG11 ' A' ' 44' ' ' VAL . 20.0 t60 37.99 -75.51 0.0 OUTLIER 'General case' 0 C--O 1.239 0.539 0 CA-C-N 114.812 -1.085 . . . . 0.0 113.765 179.744 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.63 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -139.1 140.72 38.06 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.584 -178.664 . . . . . . . . 3 3 . 1 . 056 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -128.04 127.61 43.47 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.893 179.51 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 91.4 mt -110.16 135.02 50.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.319 -179.951 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -117.97 128.42 54.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.513 178.149 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 94.2 mt -111.95 117.73 55.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.498 0.666 . . . . 0.0 111.603 -179.225 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.588 ' O ' ' N ' ' A' ' 56' ' ' GLN . 89.3 m-70 -117.59 144.86 44.73 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.94 179.63 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 54' ' ' HIS . 80.0 mm-40 -38.94 -23.91 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.215 -0.594 . . . . 0.0 109.928 -179.825 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.588 ' N ' ' O ' ' A' ' 54' ' ' HIS . 56.3 tt0 -67.76 -68.78 0.36 Allowed 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.267 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -161.66 -158.27 0.54 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.034 179.337 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.81 131.43 55.7 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.059 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.448 HG23 HD12 ' A' ' 59' ' ' ILE . 80.0 mt -120.78 131.03 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 121.061 0.457 . . . . 0.0 112.231 -179.354 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.434 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 28.8 tp -102.29 131.43 48.88 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.635 -179.376 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -112.81 133.44 54.8 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.593 179.132 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.598 HD22 ' CB ' ' A' ' 68' ' ' PRO . 57.4 t-20 -95.0 107.84 19.89 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -178.675 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -98.75 -11.58 21.75 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.401 179.693 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 3.9 t -84.1 100.26 11.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.236 179.593 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.6 p -83.55 -40.7 18.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.528 0.68 . . . . 0.0 109.393 179.298 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.64 -43.15 97.89 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.012 -0.994 . . . . 0.0 109.986 -179.984 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.436 ' O ' ' OG ' ' A' ' 64' ' ' SER . 8.4 m-80 -141.41 97.32 6.8 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.088 178.695 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.598 ' CB ' HD22 ' A' ' 62' ' ' ASN . 52.9 Cg_endo -66.4 152.73 80.28 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 121.932 1.754 . . . . 0.0 113.165 -178.19 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.418 ' CG2' ' N ' ' A' ' 70' ' ' GLN . 18.5 m -73.98 153.99 39.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.572 -179.25 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.47 ' O ' ' N ' ' A' ' 89' ' ' THR . 74.0 mt-30 -113.82 140.09 48.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.527 178.947 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.4 t -128.63 135.42 62.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.344 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 52.07 32.94 11.11 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -178.96 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.02 28.23 68.91 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.783 179.707 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 69.9 m -140.6 140.53 35.11 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.997 179.884 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 52.1 t -65.23 136.87 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.589 179.827 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.47 ' CG1' ' O ' ' A' ' 78' ' ' GLU . 7.5 tt -104.57 89.64 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.779 178.793 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -63.88 -35.19 79.83 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.722 -179.483 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.47 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 1.7 mt-10 -128.02 168.46 15.33 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.803 -179.475 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.84 143.75 80.07 Favored 'Trans proline' 0 N--CA 1.501 1.967 0 C-N-CA 122.282 1.988 . . . . 0.0 112.815 -178.747 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.7 p -139.87 142.95 31.18 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 121.329 0.585 . . . . 0.0 111.782 179.571 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -75.17 133.65 41.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.701 179.782 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 56.9 mt -92.5 134.33 35.07 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.801 -179.098 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.518 ' O ' ' OD2' ' A' ' 86' ' ' ASP . 99.8 mttt -120.14 153.07 36.72 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.904 -179.825 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.715 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 9.3 t60 -51.1 119.13 3.71 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.243 -179.317 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.89 -14.61 34.38 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -179.614 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.518 ' OD2' ' O ' ' A' ' 83' ' ' LYS . 2.1 p30 -69.28 131.1 44.33 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.15 179.422 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 13.5 p -105.31 140.55 22.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.56 -179.198 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 38.6 mm -102.99 128.94 55.45 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 177.851 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.47 ' N ' ' O ' ' A' ' 70' ' ' GLN . 41.1 m -121.91 130.21 53.16 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -177.654 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.532 ' O ' ' N ' ' A' ' 93' ' ' ARG . 97.5 mt -115.9 129.74 71.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 113.881 -1.509 . . . . 0.0 107.398 177.442 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.513 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 23.5 mt -31.74 107.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.022 0.439 . . . . 0.0 111.118 -178.37 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.513 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 2.2 t70 88.89 -25.66 0.08 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 178.691 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 90' ' ' ILE . 55.6 mtt85 -130.09 139.85 50.89 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 121.329 -0.149 . . . . 0.0 110.618 -178.658 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 34.0 p -142.51 158.56 43.55 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.222 0.534 . . . . 0.0 110.474 -179.997 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -132.06 133.65 44.61 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.79 179.414 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 78.3 mtp85 -95.75 136.89 35.57 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 119.767 -0.773 . . . . 0.0 109.988 179.0 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -95.46 125.7 40.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.227 -179.116 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -122.09 122.19 38.69 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.265 179.062 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.715 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 49.4 t-20 . . . . . 0 C--N 1.324 -0.507 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.708 -179.976 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo . . . . . 0 N--CA 1.492 1.425 0 N-CA-C 111.702 -0.153 . . . . 0.0 111.702 . . . . . . . . . 0 0 . 1 . 056 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 25.6 t -110.3 133.2 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-O 120.949 0.404 . . . . 0.0 110.505 -179.509 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 3.5 t . . . . . 0 CA--C 1.515 -0.403 0 CA-C-O 121.157 0.503 . . . . 0.0 110.608 -179.643 . . . . . . . . 0 0 . 1 . 056 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo . . . . . 0 N--CA 1.491 1.379 0 N-CA-C 112.605 0.194 . . . . 0.0 112.605 . . . . . . . . . 0 0 . 1 . 056 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 99.9 m -72.73 -43.97 62.28 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.628 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -56.91 -47.68 80.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.264 -179.679 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 92.7 mt -62.61 -41.2 98.85 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.927 -179.173 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -63.63 -40.0 95.76 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.517 -0.473 . . . . 0.0 109.749 179.886 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . 0.55 ' O ' ' OG ' ' B' ' 247' ' ' SER . 72.9 ttt180 -59.84 -43.6 94.53 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.176 179.35 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.563 ' NH2' ' CD2' ' A' ' 41' ' ' LEU . 22.2 mmt180 -62.44 -41.41 98.7 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.675 -179.279 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.71 -39.06 90.16 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.261 0.553 . . . . 0.0 109.769 179.658 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' B' B ' 247' ' ' SER . . . . . 0.55 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 57.6 p -67.15 -42.87 83.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.141 178.306 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -61.33 -35.84 78.52 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.028 179.789 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 49.8 t . . . . . 0 C--N 1.328 -0.347 0 O-C-N 121.595 -0.691 . . . . 0.0 110.118 178.638 . . . . . . . . 0 0 . 1 . 056 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . 0.475 ' OE1' ' NH2' ' A' ' 93' ' ' ARG . 96.6 mt-10 . . . . . 0 CA--C 1.531 0.231 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 . . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . 0.403 HG23 HD13 ' B' ' 261' ' ' ILE . 82.7 mt -112.06 130.95 64.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.821 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 60.8 t -126.4 134.34 66.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.16 -179.434 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -94.95 119.81 34.11 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.329 0.585 . . . . 0.0 110.975 -179.334 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.99 -43.92 97.45 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.071 179.48 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -100.98 155.31 36.45 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.619 -179.227 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -68.43 143.98 59.77 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 123.099 2.533 . . . . 0.0 113.659 -179.029 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 43.6 pt . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.047 178.35 . . . . . . . . 0 0 . 1 . 057 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.8 p . . . . . 0 CA--C 1.528 0.131 0 CA-C-O 120.756 0.312 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 057 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.641 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 95.7 mtt-85 -97.65 115.51 28.05 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.09 -178.877 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.6 mtt85 -129.44 138.54 51.51 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.997 0.427 . . . . 0.0 111.897 -179.874 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 32.5 tp -115.01 136.89 52.62 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.999 179.29 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 53.9 t -112.91 132.22 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.606 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 m -94.91 117.69 30.56 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.821 0.675 . . . . 0.0 112.821 -178.136 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 95.6 mt -82.97 143.71 11.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.85 179.569 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -90.6 159.89 16.21 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.042 178.419 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.583 HH12 ' CD ' ' B' ' 260' ' ' GLU . 55.0 mtm-85 -58.51 -28.29 65.28 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.403 -179.397 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.6 p -77.87 -8.6 58.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.876 0.37 . . . . 0.0 110.457 179.907 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.68 34.05 8.08 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.94 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.6 t -118.91 132.8 67.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.866 0.365 . . . . 0.0 111.065 -179.81 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -72.07 136.03 46.48 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.315 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -127.7 -121.77 2.45 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 120.541 -0.837 . . . . 0.0 111.94 -179.135 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -73.12 149.57 46.5 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.313 2.009 . . . . 0.0 112.865 -178.601 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -106.45 152.9 23.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.638 179.868 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -121.36 92.92 48.78 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.017 179.789 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -59.51 125.95 19.33 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.636 1.558 . . . . 0.0 110.713 -179.595 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.2 mt -90.83 45.83 1.28 Allowed 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.558 -178.242 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 94.5 p -60.53 -23.4 64.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.216 0.532 . . . . 0.0 109.635 179.545 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.7 mt -77.1 144.44 38.5 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.323 179.494 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.7 m -67.81 -18.75 64.94 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -178.373 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 59.3 m -134.72 135.16 41.75 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.671 -179.559 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.6 t -127.2 119.47 26.48 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.059 178.871 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.424 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 35.9 tp -113.45 128.12 56.34 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 121.178 -0.209 . . . . 0.0 111.537 -178.609 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.511 ' O ' ' O ' ' A' ' 47' ' ' GLN . 13.5 m-85 -107.69 130.48 54.92 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.532 179.181 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -176.26 -171.3 39.89 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.707 179.883 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.558 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 39.7 ttp-105 -93.9 -9.31 37.6 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.249 -0.476 . . . . 0.0 111.298 -179.422 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.485 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -93.93 158.88 23.44 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.671 -178.651 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.423 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 11.1 tp -66.81 -40.22 85.41 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 115.078 -0.561 . . . . 0.0 110.496 179.82 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.423 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 85.2 tt0 -53.15 -22.43 6.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.035 0.445 . . . . 0.0 110.053 -179.695 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 2.7 m -71.52 139.31 49.46 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.762 179.839 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.424 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 99.6 m-20 -60.8 -31.26 70.64 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.145 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.43 HG23 HD12 ' A' ' 37' ' ' ILE . 84.5 mt -129.27 120.33 50.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.489 177.34 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 77.2 ttt-85 -107.41 135.1 49.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.843 -178.981 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.417 ' C ' ' H ' ' A' ' 41' ' ' LEU . 99.7 mt -117.45 130.72 71.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.902 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -73.65 34.98 0.08 Allowed 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -177.588 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.653 ' CD1' ' HE ' ' A' ' 93' ' ' ARG . 37.6 mt -114.41 132.18 22.94 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.582 179.478 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.47 -12.01 26.87 Favored 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 122.574 2.182 . . . . 0.0 112.997 -179.036 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.2 m -88.11 0.9 6.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.416 179.743 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.645 ' CG2' ' NH2' ' A' ' 93' ' ' ARG . 55.7 t -90.54 131.77 36.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.156 179.331 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 46.4 t -70.75 165.31 23.32 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.345 -179.107 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 70.2 mttt -61.9 -39.97 93.83 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.142 -179.26 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.679 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.9 mt-30 -120.5 -21.54 6.76 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.046 179.772 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 16.6 t60 36.15 -75.05 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 178.991 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.679 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -128.52 132.66 48.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.104 0.478 . . . . 0.0 111.677 -178.891 . . . . . . . . 3 3 . 1 . 057 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -128.51 125.25 37.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.138 179.234 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.0 mt -107.07 133.38 51.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.526 -179.529 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.544 ' CD ' ' HE2' ' A' ' 54' ' ' HIS . 82.4 tt0 -117.24 126.06 52.15 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.562 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.5 119.72 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -177.625 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.553 ' O ' ' N ' ' A' ' 56' ' ' GLN . 97.4 m-70 -114.46 141.28 47.89 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.628 178.813 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 54' ' ' HIS . 58.8 mp0 -40.71 -24.46 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.801 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.553 ' N ' ' O ' ' A' ' 54' ' ' HIS . 99.8 mm-40 -71.86 -69.16 0.41 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.548 178.848 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.452 ' OE2' ' NE ' ' A' ' 81' ' ' ARG . 2.3 pt-20 -152.61 -174.71 5.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.294 0.568 . . . . 0.0 111.602 -178.95 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.47 130.18 55.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.672 179.156 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 86.2 mt -121.08 131.04 74.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.162 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 24.0 tp -100.01 129.16 46.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.318 179.442 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -113.51 135.38 53.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.149 179.573 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.444 ' ND2' ' H ' ' A' ' 69' ' ' THR . 9.1 t-20 -95.09 105.62 17.56 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.866 -0.333 . . . . 0.0 111.338 -179.988 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -98.07 -6.96 30.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.209 178.847 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.403 ' HB2' HD22 ' A' ' 62' ' ' ASN . 1.0 OUTLIER -69.36 102.28 1.72 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.401 179.846 . . . . . . . . 3 3 . 1 . 057 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.6 p -89.51 -6.51 56.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.788 0.328 . . . . 0.0 110.484 179.397 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.28 -42.12 6.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.332 0.587 . . . . 0.0 109.637 179.928 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -141.21 99.87 6.45 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.668 -179.919 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.404 ' HA ' HD22 ' A' ' 62' ' ' ASN . 48.8 Cg_exo -55.53 146.44 63.87 Favored 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 122.595 2.197 . . . . 0.0 112.982 -179.282 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.444 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 48.3 m -72.67 139.17 47.12 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.167 179.278 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -105.88 140.45 38.89 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.754 -179.589 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.441 ' O ' ' OG ' ' A' ' 74' ' ' SER . 54.9 t -132.23 132.9 60.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.041 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 52.91 32.93 13.44 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.049 -0.66 . . . . 0.0 109.332 -179.079 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.75 27.98 69.87 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.892 179.858 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 28.9 p -141.02 140.78 34.34 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 117.206 0.503 . . . . 0.0 111.22 179.895 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 13.4 t -72.4 142.48 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.804 -179.79 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.9 pt -115.67 88.69 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.66 178.967 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -63.67 -25.64 68.3 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.361 179.396 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.52 173.62 4.3 Favored Pre-proline 0 C--O 1.233 0.221 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.959 -179.704 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -61.66 142.37 94.14 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.401 2.067 . . . . 0.0 111.812 179.349 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 79.2 t -135.38 136.7 50.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.615 179.631 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.452 ' NE ' ' OE2' ' A' ' 57' ' ' GLU . 84.0 mtp180 -73.99 131.91 41.87 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.768 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.2 mt -82.45 139.94 33.68 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.954 0.407 . . . . 0.0 110.939 -179.38 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -131.12 151.35 51.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.698 -179.836 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.612 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 4.1 t60 -54.06 114.94 1.79 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.391 179.982 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.81 -6.39 29.42 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 -179.382 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.435 ' C ' ' OD1' ' A' ' 86' ' ' ASP . 26.7 t0 -79.4 125.28 29.33 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.306 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 42.6 t -110.03 130.54 63.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.604 -178.341 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 95.6 mt -92.46 130.62 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.804 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 25.7 m -121.65 126.75 49.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.449 0.643 . . . . 0.0 112.277 -178.124 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.623 ' CG2' HH12 ' A' ' 93' ' ' ARG . 70.8 mt -121.69 127.54 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.442 178.977 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 82.9 mt 38.59 -101.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.629 -179.511 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -115.88 15.72 16.28 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 120.666 -0.413 . . . . 0.0 111.693 -179.183 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.653 ' HE ' ' CD1' ' A' ' 41' ' ' LEU . 4.5 ptt85 -131.64 146.32 52.13 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.839 179.125 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 53.0 m -139.24 155.48 47.74 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.572 -179.388 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -122.22 121.04 35.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.657 179.775 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -83.7 130.95 34.97 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.878 0.371 . . . . 0.0 111.59 -178.872 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.641 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 76.6 t80 -96.37 123.62 40.08 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.23 -179.47 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -123.53 126.29 46.44 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.895 179.801 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.612 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 59.7 t-20 . . . . . 0 N--CA 1.464 0.231 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.243 179.43 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo . . . . . 0 N--CA 1.491 1.361 0 CA-C-O 121.519 0.55 . . . . 0.0 113.406 . . . . . . . . . 0 0 . 1 . 057 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 31.2 t -65.29 136.6 26.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.864 179.102 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 5.7 t . . . . . 0 C--N 1.327 -0.41 0 C-N-CA 120.626 -0.429 . . . . 0.0 110.099 -179.685 . . . . . . . . 0 0 . 1 . 057 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo . . . . . 0 N--CA 1.494 1.506 0 N-CA-C 112.609 0.196 . . . . 0.0 112.609 . . . . . . . . . 0 0 . 1 . 057 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 96.2 m -73.33 -44.9 58.03 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.515 0.674 . . . . 0.0 109.334 178.551 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -56.11 -44.8 79.43 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.826 -179.861 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 92.1 mt -62.81 -40.86 98.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 179.818 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -64.42 -39.94 94.8 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.419 -179.26 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 59.8 ttm-85 -60.01 -44.86 94.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.044 0.45 . . . . 0.0 109.962 179.781 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.448 HH21 ' HG2' ' A' ' 12' ' ' ARG . 58.1 mtp180 -63.32 -41.55 98.93 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.749 -179.823 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -62.85 -40.76 98.46 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.239 -0.585 . . . . 0.0 109.806 179.376 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 38.5 t -64.38 -45.05 89.4 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 122.052 0.929 . . . . 0.0 108.679 178.167 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -59.52 -37.28 77.93 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.41 -179.973 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 21.8 t . . . . . 0 C--N 1.33 -0.267 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.753 . . . . . . . . 0 0 . 1 . 057 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . 0.583 ' CD ' HH12 ' A' ' 12' ' ' ARG . 53.5 mp0 . . . . . 0 N--CA 1.461 0.119 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 . . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 69.4 mt -108.58 135.53 47.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.738 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 55.0 t -127.45 134.0 66.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.947 0.404 . . . . 0.0 110.896 -178.384 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -97.38 119.75 36.48 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.557 -179.331 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.85 -43.84 94.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.924 179.038 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -95.79 153.78 39.24 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.362 -179.598 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.85 147.05 80.13 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 123.087 2.525 . . . . 0.0 113.288 -179.273 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.4 pt . . . . . 0 C--N 1.331 -0.223 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.678 178.455 . . . . . . . . 0 0 . 1 . 058 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.444 ' HG1' ' N ' ' A' ' 5' ' ' ARG . 50.0 p . . . . . 0 N--CA 1.453 -0.277 0 CA-C-O 121.238 0.542 . . . . 0.0 110.25 . . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.444 ' N ' ' HG1' ' A' ' 4' ' ' THR . 84.9 mtt85 -89.39 122.27 32.45 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.493 -179.449 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -124.79 139.44 53.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.24 -179.922 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 29.4 tp -116.39 132.83 56.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.133 -179.4 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.477 ' CG1' ' NH2' ' A' ' 96' ' ' ARG . 67.6 t -108.18 130.19 61.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.36 -179.676 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.581 ' OG1' ' O ' ' A' ' 18' ' ' PRO . 59.2 p -91.28 114.22 26.69 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.455 0.645 . . . . 0.0 112.485 -178.83 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 95.5 mt -79.71 140.9 16.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.396 178.953 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -87.69 158.19 18.89 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.15 0.5 . . . . 0.0 111.008 179.179 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.592 ' NH1' ' OE2' ' B' ' 260' ' ' GLU . 81.3 mtp180 -58.3 -31.03 67.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.554 -179.305 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 93.2 p -74.82 -12.79 60.47 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.933 179.275 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.34 25.93 10.57 Favored Glycine 0 CA--C 1.531 1.045 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -179.566 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.2 t -119.27 134.98 61.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.695 0.283 . . . . 0.0 110.541 179.981 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.633 ' CG ' HH22 ' A' ' 96' ' ' ARG . 90.6 m-20 -67.6 139.23 56.86 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.426 -179.837 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -127.04 -123.71 2.66 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.068 -179.023 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.581 ' O ' ' OG1' ' A' ' 9' ' ' THR . 61.1 Cg_endo -72.43 146.34 44.51 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 122.321 2.014 . . . . 0.0 113.184 -178.426 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.61 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -111.08 131.01 55.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.094 0.473 . . . . 0.0 111.049 -179.561 . . . . . . . . 3 3 . 1 . 058 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -101.35 107.7 51.93 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.014 -179.602 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -73.64 127.45 11.68 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 121.129 1.219 . . . . 0.0 111.645 -179.748 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.9 mt -87.87 50.58 2.02 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.139 -178.769 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 97.4 p -65.97 -19.07 65.74 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.051 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 68.0 mt -79.03 140.57 37.9 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.283 179.848 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.7 t -62.43 -25.5 68.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.866 179.916 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 66.0 m -129.79 130.96 46.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.193 -179.768 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.61 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 8.6 t -129.3 124.17 33.69 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.605 178.903 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 42.8 tp -119.28 132.05 55.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.928 0.394 . . . . 0.0 111.184 -178.747 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.61 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 10.0 m-85 -108.97 139.98 43.09 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.022 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 167.76 -155.7 26.77 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 119.942 -1.123 . . . . 0.0 112.069 179.846 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.538 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 37.6 ttp-105 -111.2 -21.64 11.8 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.88 -0.16 . . . . 0.0 110.855 -179.459 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.458 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -73.77 163.59 54.69 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.553 -179.161 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.514 ' CD1' ' NH1' ' A' ' 38' ' ' ARG . 46.2 mm -64.52 -45.67 94.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 O-C-N 122.746 -0.267 . . . . 0.0 110.944 -179.876 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -49.78 -21.95 1.27 Allowed 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.503 179.962 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.572 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 4.8 m -67.75 121.87 16.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.11 -179.513 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -59.41 -25.9 64.7 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.757 -179.494 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.452 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 98.1 mt -128.77 124.16 60.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.086 177.64 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.514 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 56.6 mtm180 -110.34 141.43 43.38 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 120.634 -0.427 . . . . 0.0 111.237 -179.704 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.478 HD12 HH21 ' A' ' 93' ' ' ARG . 81.0 mt -121.17 132.65 70.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.034 179.916 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -74.75 29.81 0.09 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.569 -177.762 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.663 ' CD1' ' NH1' ' A' ' 93' ' ' ARG . 51.5 mt -109.34 133.55 20.77 Favored Pre-proline 0 C--N 1.325 -0.494 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.643 -179.559 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.2 -12.92 25.74 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.741 2.294 . . . . 0.0 112.016 179.598 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.4 m -88.61 3.71 5.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.069 179.448 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.538 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 55.1 t -98.99 130.88 47.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 C-N-CA 120.434 -0.507 . . . . 0.0 109.699 178.432 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 75.6 m -70.74 172.62 8.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.632 -179.077 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.572 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 10.5 mttm -63.79 -41.87 97.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.259 179.939 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.658 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.2 mt-30 -117.48 -16.15 10.21 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 123.337 0.398 . . . . 0.0 111.732 -179.315 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.5 t60 33.78 -72.58 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 179.081 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.658 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -135.99 140.32 43.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.067 0.461 . . . . 0.0 112.036 -178.752 . . . . . . . . 3 3 . 1 . 058 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -126.63 135.51 51.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.556 179.918 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 92.3 mt -121.52 134.17 65.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.013 -179.483 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -116.14 127.34 54.75 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.849 179.036 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.423 HG23 HD12 ' A' ' 53' ' ' ILE . 82.1 mt -106.57 113.27 42.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 119.853 -0.739 . . . . 0.0 112.288 -179.606 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.426 ' O ' ' C ' ' A' ' 55' ' ' GLU . 98.0 m-70 -113.25 143.89 43.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.742 179.426 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 54' ' ' HIS . 41.3 tt0 -40.9 -30.68 0.14 Allowed 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.028 -0.669 . . . . 0.0 109.4 -179.407 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.47 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 85.7 mt-30 -60.79 -68.88 0.26 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.37 179.131 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.47 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 4.2 tp10 -157.91 -164.95 1.63 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.809 179.775 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.44 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -111.59 126.77 55.36 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 178.317 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.412 HD12 HG22 ' A' ' 59' ' ' ILE . 94.4 mt -115.36 131.56 67.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.247 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.443 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 22.0 tp -101.05 131.24 47.04 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.835 179.773 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -114.26 134.71 54.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.499 -179.779 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 56.6 t-20 -92.84 105.06 17.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.933 0.397 . . . . 0.0 111.434 -179.309 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -101.82 -9.56 20.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.277 179.417 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.92 98.2 10.21 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.717 -179.581 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.5 m -76.69 -38.41 54.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.359 0.599 . . . . 0.0 109.854 178.996 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.49 -44.66 95.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.832 -178.688 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.421 HD22 ' HA ' ' B' ' 236' ' ' VAL . 85.4 m-20 -139.16 95.86 9.21 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.624 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -54.8 144.29 66.79 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 121.787 1.658 . . . . 0.0 112.542 -179.038 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 97.0 m -73.42 138.38 45.19 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.625 178.76 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -99.96 137.81 37.91 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.272 179.881 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 54.2 t -131.89 133.21 61.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 178.517 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 53.71 32.1 14.06 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.218 -179.121 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.4 27.66 67.38 Favored Glycine 0 CA--C 1.536 1.38 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.225 179.691 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 58.6 m -144.35 140.45 29.11 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 117.319 0.56 . . . . 0.0 111.657 -179.964 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.6 m -74.28 146.8 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.748 179.515 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.8 pt -116.43 98.5 6.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.262 0.553 . . . . 0.0 111.549 179.837 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -67.14 -26.58 66.74 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 178.465 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.31 166.36 17.51 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.602 -179.868 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -64.22 150.5 88.18 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.684 2.256 . . . . 0.0 112.183 179.249 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.4 m -141.63 141.99 29.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.347 -179.482 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -74.91 135.22 41.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.966 179.18 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 98.2 mt -83.82 137.53 33.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.236 0.541 . . . . 0.0 110.838 -179.631 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -129.27 154.85 46.42 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.808 179.974 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -56.99 116.19 3.06 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.843 -178.901 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.06 -12.8 29.06 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -179.743 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.409 ' C ' ' OD1' ' A' ' 86' ' ' ASP . 43.6 t0 -67.78 128.47 36.59 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.963 0.411 . . . . 0.0 110.283 179.651 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.3 p -109.11 134.87 49.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.559 -179.053 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 81.2 mt -106.8 131.17 57.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.275 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.8 m -119.9 123.67 44.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.446 0.641 . . . . 0.0 111.479 -179.033 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 84.8 mt -116.74 124.47 72.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.914 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.462 HG22 HD12 ' A' ' 91' ' ' ILE . 44.8 mm 44.61 -103.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.773 -179.607 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.664 ' OD1' ' NH1' ' A' ' 93' ' ' ARG . 12.3 p-10 -117.49 17.58 14.5 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.995 0.426 . . . . 0.0 110.488 -179.803 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.664 ' NH1' ' OD1' ' A' ' 92' ' ' ASP . 34.2 mtm-85 -127.1 142.68 51.46 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.024 -179.366 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.407 ' HG ' ' N ' ' A' ' 95' ' ' PHE . 41.2 t -135.25 150.26 50.02 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.564 -179.826 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.505 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 19.2 m-85 -124.97 124.02 41.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.581 -179.892 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.633 HH22 ' CG ' ' A' ' 16' ' ' ASP . 89.8 mtm-85 -85.66 128.41 34.77 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.932 -178.915 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -92.12 124.53 36.28 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.193 179.083 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -127.69 118.55 24.03 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.549 -179.547 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 61.4 t-20 . . . . . 0 C--N 1.326 -0.431 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.009 179.589 . . . . . . . . 0 0 . 1 . 058 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo . . . . . 0 N--CA 1.483 0.874 0 CA-C-O 121.66 0.608 . . . . 0.0 113.019 . . . . . . . . . 0 0 . 1 . 058 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . 0.421 ' HA ' HD22 ' A' ' 67' ' ' ASN . 17.5 t -57.56 141.09 15.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.485 -179.597 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 16.5 t . . . . . 0 C--N 1.332 -0.154 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.455 . . . . . . . . 0 0 . 1 . 058 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo . . . . . 0 N--CA 1.498 1.758 0 N-CA-C 113.057 0.368 . . . . 0.0 113.057 . . . . . . . . . 0 0 . 1 . 058 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 13.7 p -73.96 -39.2 63.9 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.218 179.044 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -57.42 -46.34 83.65 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.357 -179.872 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 94.9 mt -63.45 -40.76 98.0 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.215 179.95 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -58.18 -41.77 84.64 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.14 179.558 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -64.34 -38.8 92.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.447 179.844 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.494 ' NE ' ' CB ' ' A' ' 92' ' ' ASP . 10.1 ttm180 -57.8 -44.93 86.65 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.56 -179.511 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -61.65 -41.23 97.23 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.758 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 10.2 t -63.8 -45.97 87.25 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.323 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . 0.418 ' HG2' HH12 ' A' ' 12' ' ' ARG . 67.0 tp60 -58.51 -41.15 84.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.688 -1.142 . . . . 0.0 111.406 -179.531 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 55.0 t . . . . . 0 C--N 1.332 -0.158 0 C-N-CA 120.559 -0.457 . . . . 0.0 109.792 179.897 . . . . . . . . 0 0 . 1 . 058 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . 0.592 ' OE2' ' NH1' ' A' ' 12' ' ' ARG . 95.7 mt-10 . . . . . 0 N--CA 1.464 0.239 0 N-CA-C 113.982 1.105 . . . . 0.0 113.982 . . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 73.9 mt -109.41 134.11 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 118.644 0.656 . . . . 0.0 109.691 179.684 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . 0.421 ' N ' ' O ' ' A' ' 38' ' ' ARG . 56.1 t -123.9 131.94 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.052 -179.532 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -98.77 120.64 39.56 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.21 0.528 . . . . 0.0 111.174 -178.683 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -63.05 -48.3 79.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.332 -179.681 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -88.78 161.86 40.3 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.029 -179.068 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -62.28 143.54 94.13 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.276 1.984 . . . . 0.0 112.279 -179.963 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . 0.428 ' CD1' ' O ' ' A' ' 19' ' ' HIS . 4.2 tt . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.877 -179.647 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.452 ' HG1' ' N ' ' A' ' 5' ' ' ARG . 73.8 p . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.99 0.424 . . . . 0.0 110.409 . . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.452 ' N ' ' HG1' ' A' ' 4' ' ' THR . 89.9 mtm-85 -91.24 125.75 36.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.151 -179.75 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 86.5 mtm-85 -131.43 137.14 48.52 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.849 179.522 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 40.8 tp -113.32 131.38 55.97 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.983 -179.905 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.6 t -109.07 131.71 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 120.947 0.403 . . . . 0.0 110.984 -179.586 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 m -90.65 112.64 24.45 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.748 -179.341 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.7 mt -79.72 144.67 10.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.405 178.646 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -90.6 158.32 17.03 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.142 0.496 . . . . 0.0 110.588 179.17 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.729 HH12 ' NE2' ' B' ' 248' ' ' GLN . 87.2 mtm180 -58.39 -28.39 65.13 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.727 -178.846 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 93.6 p -80.36 -11.22 59.73 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.473 179.795 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.55 31.34 7.16 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.108 179.212 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.1 t -122.61 133.45 68.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.789 0.328 . . . . 0.0 110.729 179.623 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -73.64 138.64 44.93 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.207 179.479 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.66 -118.34 1.93 Allowed Glycine 0 CA--C 1.534 1.225 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.764 -179.899 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.42 146.14 55.29 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 121.912 1.741 . . . . 0.0 112.332 -179.112 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -110.83 158.54 18.58 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.157 0.503 . . . . 0.0 110.649 -179.337 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -125.74 102.0 29.32 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.617 -179.491 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -69.8 128.56 16.16 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 121.279 1.32 . . . . 0.0 111.468 -178.947 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.8 mt -85.72 49.48 1.78 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.543 -178.183 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 92.2 p -61.55 -24.93 66.97 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.055 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 65.7 mt -78.64 141.27 38.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.076 179.779 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 91.9 p -65.33 -19.99 66.2 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.811 179.962 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.409 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 61.8 m -130.28 131.46 45.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.6 -178.852 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.2 t -125.0 112.71 16.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.429 178.385 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.7 tp -109.36 127.74 54.57 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.923 -178.593 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.453 ' CE2' ' CD1' ' A' ' 37' ' ' ILE . 2.5 m-85 -110.07 143.41 40.16 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.745 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 150.98 -166.82 30.5 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.233 178.468 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.531 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 46.2 mtm105 -82.62 -30.98 29.07 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 179.946 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.544 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -50.84 139.08 24.31 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 120.556 -0.83 . . . . 0.0 111.298 -178.854 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 31.3 mm -63.92 -43.79 97.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 121.064 0.459 . . . . 0.0 110.332 179.396 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -55.72 -14.41 2.25 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.132 179.879 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.544 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 56.6 m -64.43 135.2 55.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.93 179.954 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.409 ' OD2' ' O ' ' A' ' 26' ' ' THR . 58.5 m-20 -61.23 -33.84 74.15 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.646 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.453 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 88.2 mt -127.32 122.58 60.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 177.471 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 77.5 ttt-85 -111.42 138.6 47.71 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.516 -178.187 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 83.8 mt -119.86 131.48 72.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-O 120.88 0.371 . . . . 0.0 110.409 -179.89 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -78.06 33.82 0.19 Allowed 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 -178.49 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.529 ' CD1' ' CZ ' ' A' ' 93' ' ' ARG . 33.4 mt -109.09 131.86 21.56 Favored Pre-proline 0 C--N 1.325 -0.461 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.293 -179.651 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.79 -15.41 29.94 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.392 2.061 . . . . 0.0 112.874 -179.681 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.2 m -90.27 1.01 8.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.281 179.592 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.531 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 45.3 t -93.25 133.74 33.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.061 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.9 m -71.53 164.09 26.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.4 0.619 . . . . 0.0 112.02 -178.609 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -63.73 -43.3 96.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.187 -178.834 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.623 ' O ' ' N ' ' A' ' 49' ' ' CYS . 93.1 mm-40 -111.95 -17.88 12.78 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.966 0.412 . . . . 0.0 110.148 -179.791 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 14.9 t60 30.66 -76.15 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 179.908 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.623 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.52 137.25 47.09 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -178.43 . . . . . . . . 3 3 . 1 . 059 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -128.69 126.69 40.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.876 179.809 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 91.8 mt -108.71 133.71 52.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.129 0.49 . . . . 0.0 110.738 179.868 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.448 ' OE2' ' CE1' ' A' ' 54' ' ' HIS . 81.0 tt0 -118.23 123.83 46.42 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.354 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 92.5 mt -107.5 119.25 56.78 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 CA-C-O 122.013 0.911 . . . . 0.0 112.858 -178.531 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.461 ' O ' ' C ' ' A' ' 55' ' ' GLU . 98.7 m-70 -108.02 134.14 51.34 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 113.871 -1.513 . . . . 0.0 108.865 179.075 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.461 ' C ' ' O ' ' A' ' 54' ' ' HIS . 97.3 mt-10 -42.5 -33.13 0.63 Allowed 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.524 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.408 ' N ' ' C ' ' A' ' 54' ' ' HIS . 78.6 mt-30 -64.53 -68.33 0.36 Allowed 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.071 -0.968 . . . . 0.0 108.835 177.722 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -143.82 179.12 7.36 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.562 0.696 . . . . 0.0 112.404 -178.567 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.9 120.59 41.96 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.095 178.429 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.7 mt -118.34 133.03 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.994 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.427 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 15.7 tp -99.29 129.45 45.51 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.317 179.487 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -110.8 136.89 49.16 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.559 -179.945 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -98.9 106.97 19.29 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.007 0.432 . . . . 0.0 111.905 -179.052 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -100.21 -6.06 26.67 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.779 179.402 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.7 99.18 8.06 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.376 -179.667 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.7 p -88.53 -20.42 25.12 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.738 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.6 m -74.18 -50.91 17.22 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.467 179.189 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.452 HD22 ' HA ' ' B' ' 236' ' ' VAL . 72.2 m-20 -137.43 99.42 9.66 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 114.698 -1.137 . . . . 0.0 108.923 179.766 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -54.0 144.62 56.18 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 121.954 1.769 . . . . 0.0 113.403 -178.762 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 26.8 m -72.12 139.87 48.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.493 178.581 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -105.1 140.53 38.13 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.166 -0.614 . . . . 0.0 110.648 179.932 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.2 p -134.06 134.22 55.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.707 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 51.6 31.89 8.33 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -179.065 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.92 27.39 68.91 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.887 -179.751 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.7 t -139.07 136.73 35.55 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 117.497 0.649 . . . . 0.0 111.804 -179.839 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.5 m -73.75 143.25 13.87 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.151 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.048 179.667 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 9.9 pt -117.07 100.61 10.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.411 0.624 . . . . 0.0 111.028 179.795 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -71.0 -21.97 62.22 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.072 179.46 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.438 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.3 OUTLIER -130.19 177.21 2.31 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.736 179.78 . . . . . . . . 3 3 . 1 . 059 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.438 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 36.7 Cg_exo -59.96 142.32 98.24 Favored 'Trans proline' 0 N--CA 1.5 1.906 0 C-N-CA 122.865 2.377 . . . . 0.0 112.708 -179.335 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 61.4 t -133.03 139.32 49.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.065 179.602 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.527 HH21 ' CE ' ' A' ' 83' ' ' LYS . 62.5 ttp180 -76.61 126.73 31.49 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.955 179.043 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 94.4 mt -82.78 138.45 34.0 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.942 0.401 . . . . 0.0 111.703 -179.285 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.527 ' CE ' HH21 ' A' ' 81' ' ' ARG . 99.3 mttt -128.38 150.95 49.89 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.035 179.712 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.432 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 6.1 t60 -55.43 122.31 10.92 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.068 0.461 . . . . 0.0 111.174 -179.18 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.96 -16.64 42.73 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 -179.894 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -65.82 136.54 56.32 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.62 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 42.0 t -114.5 132.76 62.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.427 -178.364 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 91.6 mt -95.51 131.43 42.33 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.43 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.7 m -123.98 124.96 43.74 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.6 0.714 . . . . 0.0 112.634 -178.319 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.5 ' O ' ' N ' ' A' ' 92' ' ' ASP . 93.7 mt -113.15 125.91 70.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 114.695 -1.139 . . . . 0.0 108.427 178.432 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.425 ' C ' ' O ' ' A' ' 90' ' ' ILE . 73.9 mt 39.5 -94.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 C-N-CA 120.716 -0.393 . . . . 0.0 110.53 -179.458 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.517 ' O ' ' OD1' ' A' ' 92' ' ' ASP . 62.3 t0 -124.94 19.0 8.49 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.071 0.463 . . . . 0.0 110.905 -179.78 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.676 ' NH1' ' NH2' ' B' ' 245' ' ' ARG . 58.0 mtm-85 -127.62 141.98 51.48 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.472 -179.841 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 25.8 p -139.27 154.2 47.91 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 119.59 -0.844 . . . . 0.0 111.426 -179.798 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -123.22 121.79 36.77 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.078 179.702 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 -80.14 127.65 32.57 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.953 -179.148 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -95.1 125.13 39.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.111 -179.825 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -124.87 121.62 35.06 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.636 179.651 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.432 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 53.2 t-20 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.012 179.453 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 N--CA 1.482 0.818 0 CA-C-O 121.501 0.542 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 059 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . 0.452 ' HA ' HD22 ' A' ' 67' ' ' ASN . 10.9 m -67.39 147.75 12.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.191 -178.919 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 3.0 t . . . . . 0 C--N 1.323 -0.546 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.847 179.891 . . . . . . . . 0 0 . 1 . 059 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo . . . . . 0 N--CA 1.498 1.787 0 N-CA-C 113.585 0.571 . . . . 0.0 113.585 . . . . . . . . . 0 0 . 1 . 059 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 97.3 m -73.61 -44.21 57.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.179 0.514 . . . . 0.0 109.844 179.074 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -58.31 -46.11 86.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.652 -179.516 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 94.7 mt -63.54 -40.13 96.2 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.852 0.358 . . . . 0.0 110.284 -179.834 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 51.9 tp10 -60.77 -43.73 97.65 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.496 -179.749 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -60.04 -41.74 92.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.175 0.512 . . . . 0.0 109.841 179.548 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.676 ' NH2' ' NH1' ' A' ' 93' ' ' ARG . 61.3 ttm-85 -60.04 -44.75 94.46 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.718 -179.544 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -61.87 -40.9 96.98 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.056 0.455 . . . . 0.0 110.141 -179.719 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 61.4 m -66.94 -44.01 81.73 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 177.949 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . 0.729 ' NE2' HH12 ' A' ' 12' ' ' ARG . 59.0 tt0 -60.87 -37.8 83.38 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.201 179.867 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 53.6 t . . . . . 0 N--CA 1.455 -0.177 0 C-N-CA 119.926 -0.709 . . . . 0.0 110.037 -179.966 . . . . . . . . 0 0 . 1 . 059 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 . . . . . 0 N--CA 1.465 0.319 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 . . . . . . . . . 0 0 . 1 . 059 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 75.2 mt -113.11 134.9 54.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 179.065 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 59.2 t -124.22 133.27 69.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.924 0.392 . . . . 0.0 110.842 -179.564 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -96.48 118.5 33.11 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.141 0.496 . . . . 0.0 110.928 -179.424 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -65.32 -47.95 74.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.857 -179.945 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -95.15 164.84 18.22 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.143 -178.436 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -64.34 149.63 89.78 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 122.91 2.406 . . . . 0.0 112.696 -179.575 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 47.7 pt . . . . . 0 C--N 1.33 -0.243 0 CA-C-O 121.366 0.603 . . . . 0.0 111.436 -179.851 . . . . . . . . 0 0 . 1 . 060 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.2 m . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.915 0.388 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 060 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.1 mtt85 -90.08 136.45 33.04 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.657 -178.559 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -127.59 137.35 52.55 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.787 179.482 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 40.6 tp -115.67 134.0 55.48 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.651 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.0 t -111.76 130.98 64.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -179.799 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.2 m -90.45 111.76 23.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.393 0.616 . . . . 0.0 112.09 -178.644 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 95.2 mt -79.97 142.13 14.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.703 178.64 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -91.42 159.97 15.7 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.021 0.439 . . . . 0.0 111.368 -179.832 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 91.3 mtm180 -57.68 -29.38 64.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.282 -179.68 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.7 t -80.69 -11.01 59.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.339 179.557 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.63 34.82 6.42 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.356 -0.697 . . . . 0.0 111.356 -179.985 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.4 t -121.65 131.33 73.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.604 0.24 . . . . 0.0 110.696 179.531 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -73.27 135.7 44.49 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.146 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -124.82 -117.08 2.21 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.145 -179.288 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -73.62 144.55 35.83 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.153 1.902 . . . . 0.0 113.056 -178.581 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.424 ' O ' ' CG2' ' B' ' 267' ' ' ILE . 6.3 m170 -102.63 149.36 24.51 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.93 179.602 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -127.22 104.37 22.44 Favored Pre-proline 0 CA--C 1.536 0.437 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.538 -178.759 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.51 ' O ' ' NE2' ' B' ' 265' ' ' GLN . 61.5 Cg_endo -75.25 134.91 17.98 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.359 1.373 . . . . 0.0 112.433 -179.399 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 68.2 mt -88.98 54.27 2.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.341 -178.714 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.3 p -61.21 -20.53 62.89 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.984 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 80.8 mt -84.91 141.08 30.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.451 179.165 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.9 p -67.81 -15.9 63.85 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -178.595 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.513 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 85.6 m -132.52 134.72 45.35 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.071 179.905 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.7 t -127.8 115.78 19.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.226 179.409 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.1 tp -114.5 128.68 56.46 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.487 -178.991 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.518 ' O ' ' O ' ' A' ' 47' ' ' GLN . 3.4 m-85 -107.11 136.48 46.88 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.205 179.297 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 163.7 -175.87 39.85 Favored Glycine 0 N--CA 1.467 0.766 0 C-N-CA 120.094 -1.05 . . . . 0.0 112.591 178.88 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.626 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 84.1 mtm-85 -72.34 -30.2 64.52 Favored 'General case' 0 CA--C 1.522 -0.111 0 CA-C-O 121.035 0.445 . . . . 0.0 110.06 179.311 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.511 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -55.77 138.78 43.91 Favored Glycine 0 CA--C 1.523 0.54 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.401 -177.98 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.4 tp -69.09 -41.15 81.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.84 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 -54.04 -18.24 3.41 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 178.767 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.511 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 18.7 m -66.81 139.18 57.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.577 -179.769 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.513 ' OD2' ' O ' ' A' ' 26' ' ' THR . 60.5 m-20 -62.47 -34.73 77.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.613 -179.13 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.438 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 96.8 mt -127.18 120.84 56.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 177.796 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 51.3 ttt180 -108.39 133.94 51.87 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.26 -179.026 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 79.5 mt -117.49 133.93 62.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.439 -179.657 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -79.45 29.91 0.23 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.466 -178.096 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 24.1 mt -98.49 125.82 41.57 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.915 179.39 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.94 -9.07 24.13 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.369 2.046 . . . . 0.0 113.326 -178.749 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.0 m -98.94 7.34 8.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.633 -179.797 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.626 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 53.6 t -96.7 135.75 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.809 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.0 m -70.01 171.33 9.68 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.114 0.483 . . . . 0.0 111.638 -179.234 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -61.67 -41.55 97.69 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.405 -179.044 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.633 ' O ' ' N ' ' A' ' 49' ' ' CYS . 97.1 mt-30 -112.5 -18.88 12.31 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 123.384 0.428 . . . . 0.0 110.757 -179.92 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 16.0 t60 36.93 -76.23 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 179.513 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.633 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.12 136.23 48.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.317 0.58 . . . . 0.0 112.121 -178.856 . . . . . . . . 3 3 . 1 . 060 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -126.27 127.98 46.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.259 179.623 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 95.5 mt -116.29 134.36 59.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.998 -179.916 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.562 ' CD ' ' HE2' ' A' ' 61' ' ' HIS . 14.5 pt-20 -114.71 140.3 48.97 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.331 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 50.1 mm -107.66 120.41 58.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.185 -0.606 . . . . 0.0 111.821 -179.11 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.515 ' HE2' ' CD ' ' A' ' 52' ' ' GLU . 98.5 m-70 -123.68 133.36 53.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.661 178.488 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 54' ' ' HIS . 98.7 mt-10 -39.56 -31.81 0.11 Allowed 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.415 -0.514 . . . . 0.0 109.938 -178.261 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.422 ' N ' ' O ' ' A' ' 54' ' ' HIS . 85.9 mt-30 -63.2 -67.82 0.39 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.476 178.894 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.414 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 7.1 tp10 -152.22 -153.54 0.49 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.529 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.414 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -131.71 134.14 45.59 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.644 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.3 mt -119.14 130.61 73.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -178.262 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.412 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 26.3 tp -95.7 127.46 41.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.754 179.201 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.562 ' HE2' ' CD ' ' A' ' 52' ' ' GLU . 99.0 m-70 -114.4 138.23 50.82 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.596 -179.409 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.428 ' C ' ' OD1' ' A' ' 62' ' ' ASN . 55.6 t-20 -96.08 106.2 18.35 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -178.54 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -101.56 -12.16 18.7 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.947 0.403 . . . . 0.0 110.038 178.425 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.13 104.78 3.72 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.369 179.613 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.5 p -88.29 -19.49 26.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.164 0.506 . . . . 0.0 109.831 179.648 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.66 -44.49 12.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.783 -179.874 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 -140.62 98.3 7.18 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.181 -179.715 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -54.91 143.99 69.51 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.279 1.986 . . . . 0.0 112.673 -179.614 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.1 m -70.28 136.57 49.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.117 179.32 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -101.72 141.1 35.1 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.442 179.937 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 51.6 t -126.15 136.21 61.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.649 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 51.27 33.61 10.06 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -179.821 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.41 28.42 71.27 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.162 -179.968 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.5 t -140.18 138.34 35.08 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.259 -179.727 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 64.1 t -69.3 131.82 33.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.896 -179.34 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.3 100.39 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.765 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -84.33 -16.42 43.02 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.972 -179.013 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.23 160.82 29.82 Favored Pre-proline 0 C--O 1.219 -0.524 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.238 179.866 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -58.24 142.27 97.24 Favored 'Trans proline' 0 N--CA 1.502 1.989 0 C-N-CA 121.932 1.755 . . . . 0.0 112.968 -179.151 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.3 p -142.15 141.08 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 120.996 0.427 . . . . 0.0 111.459 179.575 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -74.52 131.05 40.67 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.41 179.492 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.7 mt -83.46 136.86 34.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.171 0.51 . . . . 0.0 110.96 -179.984 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -128.22 151.2 49.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.152 -179.785 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.717 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 4.6 t60 -53.45 120.21 5.8 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.383 -179.209 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.13 -15.7 27.92 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -179.34 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -73.75 124.9 26.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.007 0.432 . . . . 0.0 110.245 179.753 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.2 t -104.57 133.38 48.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.127 -178.953 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 33.1 mm -90.08 130.91 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.1 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.5 m -121.56 126.28 48.76 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -177.84 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.524 ' O ' ' N ' ' A' ' 92' ' ' ASP . 91.9 mt -115.75 125.3 72.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.843 178.612 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.456 ' C ' ' O ' ' A' ' 90' ' ' ILE . 42.1 mm 35.66 -93.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.974 179.261 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 90' ' ' ILE . 28.1 t70 -122.85 19.29 10.18 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.745 0.307 . . . . 0.0 111.294 -179.711 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.475 ' HG3' HH22 ' B' ' 245' ' ' ARG . 99.1 mtt180 -129.75 145.22 51.56 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.443 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 60.8 p -140.63 157.04 46.04 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 119.634 -0.826 . . . . 0.0 111.35 -179.95 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 46.6 m-85 -125.87 122.13 35.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.894 179.893 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 52.2 ttt85 -82.49 128.5 34.34 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.582 -179.757 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -96.54 127.79 42.86 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.739 179.871 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -134.22 124.52 26.1 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.639 179.888 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.717 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 46.6 p30 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.71 -179.863 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo . . . . . 0 N--CA 1.485 1.024 0 CA-C-O 121.173 0.406 . . . . 0.0 112.562 . . . . . . . . . 0 0 . 1 . 060 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . 0.456 ' O ' ' CG1' ' B' ' 236' ' ' VAL . 3.0 p -101.55 125.95 55.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.722 -179.814 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 32.1 t . . . . . 0 N--CA 1.453 -0.314 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.533 179.689 . . . . . . . . 0 0 . 1 . 060 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo . . . . . 0 N--CA 1.494 1.533 0 CA-C-O 120.75 0.229 . . . . 0.0 111.801 . . . . . . . . . 0 0 . 1 . 060 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 96.7 m -71.95 -43.89 64.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.582 0.706 . . . . 0.0 109.334 178.13 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . 0.411 ' CE2' ' HD2' ' B' ' 245' ' ' ARG . 80.8 t80 -57.85 -46.15 85.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.172 -179.44 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 89.0 mt -63.73 -42.19 97.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.541 -179.634 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -64.85 -40.01 94.48 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.412 -179.254 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -61.71 -44.98 95.89 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.073 -179.458 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.475 HH22 ' HG3' ' A' ' 93' ' ' ARG . 79.9 mtp180 -63.2 -40.42 97.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.36 -179.475 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.95 -39.69 95.4 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.924 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 75.2 m -64.06 -45.03 90.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.35 177.942 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 -61.58 -37.31 83.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.786 -179.761 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 39.1 t . . . . . 0 C--N 1.332 -0.17 0 C-N-CA 119.951 -0.699 . . . . 0.0 109.263 178.644 . . . . . . . . 0 0 . 1 . 060 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 . . . . . 0 CA--C 1.53 0.196 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 . . . . . . . . . 0 0 . 1 . 060 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 95.7 mt -103.76 137.42 32.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 177.909 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 69.2 t -125.38 132.44 71.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 120.421 -0.511 . . . . 0.0 110.544 -178.715 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -97.71 122.61 40.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.2 0.524 . . . . 0.0 111.734 -178.365 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -69.26 -42.8 75.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.551 179.899 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . 0.51 ' NE2' ' O ' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -88.06 161.21 44.41 Favored Pre-proline 0 CA--C 1.518 -0.269 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.933 -178.328 . . . . . . . . 3 3 . 1 . 060 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -59.23 145.68 97.0 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 121.973 1.782 . . . . 0.0 109.924 178.633 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . 0.424 ' CG2' ' O ' ' A' ' 19' ' ' HIS . 4.3 mt . . . . . 0 C--N 1.326 -0.443 0 C-N-CA 119.946 -0.702 . . . . 0.0 110.953 -178.081 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 26.0 m . . . . . 0 N--CA 1.463 0.177 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 . . . . . . . . . 0 0 . 1 . 061 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -98.33 136.34 38.64 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.21 -177.667 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.1 mtm-85 -138.25 150.19 46.45 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.808 -179.807 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.5 mt -115.0 143.43 45.2 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.744 -179.908 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.4 t -115.97 127.66 73.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.338 179.07 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 m -77.85 134.16 38.02 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.647 0.737 . . . . 0.0 112.156 -178.888 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.515 ' CD1' ' OD1' ' A' ' 16' ' ' ASP . 50.5 mm -104.47 134.23 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 114.653 -1.158 . . . . 0.0 107.943 177.086 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -96.67 159.81 14.73 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.197 0.522 . . . . 0.0 111.103 -179.246 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 84.7 mtt-85 -57.52 -31.1 65.71 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.111 -178.84 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.2 p -72.97 -15.15 61.55 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.808 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.7 17.04 46.42 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.647 179.948 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.3 m -108.15 139.72 29.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.127 0.489 . . . . 0.0 110.632 -179.845 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.515 ' OD1' ' CD1' ' A' ' 10' ' ' ILE . 99.0 m-20 -76.76 138.5 39.95 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.953 179.849 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -128.48 -117.72 2.04 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 120.193 -1.003 . . . . 0.0 111.653 -179.774 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -74.73 151.58 41.16 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.6 2.2 . . . . 0.0 112.635 -179.126 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -111.17 144.32 40.5 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.265 179.28 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -108.28 94.64 13.76 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.582 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.83 137.3 29.4 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 121.169 1.246 . . . . 0.0 111.855 -178.795 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.9 mt -93.18 107.75 19.5 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.144 0.497 . . . . 0.0 111.419 -178.755 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.477 ' HG ' ' NE2' ' B' ' 265' ' ' GLN . 94.4 p -111.53 -6.34 14.43 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.348 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 70.7 mt -104.32 146.69 28.44 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.764 -179.739 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 83.8 p -66.32 -16.56 64.14 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.75 -178.754 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 29.8 m -132.9 134.16 44.22 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.939 -179.43 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.629 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 9.2 t -127.39 120.77 29.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.881 178.839 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 32.0 tp -118.5 128.46 54.61 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.788 0.328 . . . . 0.0 111.38 -178.428 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.629 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 14.5 m-85 -105.15 140.15 38.75 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.561 179.12 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 153.38 -179.58 29.63 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 119.944 -1.122 . . . . 0.0 112.637 178.537 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.499 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 45.3 mtm180 -70.04 -33.05 71.47 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.03 0.443 . . . . 0.0 110.637 178.516 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.57 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -52.96 141.31 29.44 Favored Glycine 0 CA--C 1.521 0.449 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.95 -178.401 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.434 HG22 HD13 ' A' ' 33' ' ' ILE . 78.7 mt -63.05 -43.05 98.8 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.162 178.974 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.407 ' HA ' ' NZ ' ' B' ' 264' ' ' LYS . 97.2 mt-10 -51.1 -18.85 0.93 Allowed 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.403 -0.519 . . . . 0.0 109.666 179.67 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.57 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 23.0 m -67.26 122.58 18.18 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.163 -179.527 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -57.05 -22.86 42.39 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -179.534 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 84.2 mt -130.98 118.28 40.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.987 177.904 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 57.4 mtt180 -99.74 133.5 44.0 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.29 -179.022 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 97.4 mt -116.81 126.93 74.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 120.417 -0.513 . . . . 0.0 109.999 179.339 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -75.27 42.64 0.2 Allowed 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -177.104 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.626 ' CD1' ' CZ ' ' A' ' 93' ' ' ARG . 85.4 mt -118.43 131.48 24.22 Favored Pre-proline 0 C--N 1.326 -0.451 0 C-N-CA 120.521 -0.472 . . . . 0.0 111.098 179.657 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.41 -10.32 23.81 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 122.235 1.957 . . . . 0.0 111.892 179.786 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.4 m -96.02 2.69 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.056 179.724 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.499 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 37.3 t -99.44 104.02 15.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.916 0.388 . . . . 0.0 111.262 -179.621 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.471 ' O ' ' O ' ' A' ' 44' ' ' VAL . 5.0 m -37.92 161.35 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.301 0.572 . . . . 0.0 111.108 -179.797 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.3 mttp -63.5 -38.71 92.18 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.82 -179.096 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.599 ' O ' ' N ' ' A' ' 49' ' ' CYS . 96.2 mm-40 -108.9 -25.53 10.71 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.264 0.554 . . . . 0.0 110.417 -179.482 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 18.2 t60 38.67 -76.33 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 179.467 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.599 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.57 135.41 46.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.132 0.492 . . . . 0.0 112.018 -178.162 . . . . . . . . 3 3 . 1 . 061 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -130.14 131.0 45.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.808 179.89 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 91.1 mt -115.53 136.03 53.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.222 179.65 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -118.82 128.9 54.9 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.412 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.0 mt -105.67 114.26 44.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.626 -179.508 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.558 ' O ' ' N ' ' A' ' 56' ' ' GLN . 79.7 m-70 -112.22 143.53 43.12 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.336 179.385 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.459 ' C ' ' O ' ' A' ' 54' ' ' HIS . 98.5 mt-10 -40.09 -25.48 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -179.699 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.558 ' N ' ' O ' ' A' ' 54' ' ' HIS . 82.8 mt-30 -67.73 -68.96 0.35 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.407 178.519 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.452 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 4.1 tp10 -160.4 -162.91 1.02 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.724 179.957 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.422 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -111.19 124.41 52.16 Favored 'General case' 0 N--CA 1.461 0.119 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.326 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 79.4 mt -116.58 131.15 70.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.802 -178.36 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.3 tp -96.86 129.83 44.24 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.487 179.836 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -113.13 133.48 55.01 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.235 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -96.26 108.48 20.98 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.496 -179.374 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -99.75 -9.53 22.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.425 179.896 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.9 t -74.17 100.56 3.7 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.508 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.4 m -84.17 -22.7 30.88 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.428 -179.767 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.415 ' O ' ' OD1' ' A' ' 67' ' ' ASN . 0.2 OUTLIER -78.34 -43.72 27.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.147 0.498 . . . . 0.0 110.222 179.993 . . . . . . . . 3 3 . 1 . 061 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.415 ' OD1' ' O ' ' A' ' 66' ' ' THR . 22.8 m-20 -140.88 100.41 6.57 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.749 -179.833 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.48 147.24 79.56 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 121.954 1.77 . . . . 0.0 112.438 -179.656 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.3 m -74.61 151.74 39.33 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.182 179.234 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -111.23 140.67 45.6 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.267 179.932 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.421 ' CG1' ' OD1' ' A' ' 86' ' ' ASP . 55.8 t -129.99 134.39 62.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.962 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 52.08 32.0 9.72 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -179.024 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.89 29.12 67.59 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.528 -179.834 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.7 m -141.82 138.5 32.24 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.583 -179.64 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.5 t -68.22 140.5 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.208 -179.275 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 9.2 pt -113.0 92.18 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 121.272 0.558 . . . . 0.0 110.164 178.306 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -64.83 -29.37 70.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.98 -179.779 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.423 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.8 OUTLIER -125.28 177.78 1.74 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.986 179.383 . . . . . . . . 3 3 . 1 . 061 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.423 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 36.0 Cg_exo -60.43 145.68 98.24 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 122.527 2.152 . . . . 0.0 112.097 179.814 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.8 p -137.73 141.22 39.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-O 121.166 0.507 . . . . 0.0 111.365 -179.778 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 45.3 ttm180 -79.88 131.97 35.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.711 179.68 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 89.3 mt -84.54 138.39 32.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.899 -179.043 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -130.84 152.57 50.03 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.75 179.065 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.435 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 6.9 t60 -55.88 119.09 5.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.84 0.352 . . . . 0.0 110.817 -179.451 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.57 -9.0 35.01 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.824 -0.911 . . . . 0.0 110.824 -179.675 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.421 ' OD1' ' CG1' ' A' ' 71' ' ' VAL . 61.0 t0 -75.61 126.58 31.28 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.727 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 39.9 t -107.35 131.07 58.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.788 -179.032 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.496 ' O ' ' OG ' ' A' ' 94' ' ' SER . 87.4 mt -97.0 131.51 43.62 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.396 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.9 m -122.46 125.38 45.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.566 0.698 . . . . 0.0 112.033 -178.429 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.455 ' O ' ' C ' ' A' ' 91' ' ' ILE . 95.7 mt -113.25 124.35 69.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.471 178.912 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.455 ' C ' ' O ' ' A' ' 90' ' ' ILE . 95.0 mt 35.09 -99.95 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 121.166 -0.213 . . . . 0.0 110.527 -178.612 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -116.41 20.22 14.3 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.025 0.441 . . . . 0.0 110.929 179.745 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.626 ' CZ ' ' CD1' ' A' ' 41' ' ' LEU . 29.9 mtm-85 -130.13 142.34 50.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.473 -179.783 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.496 ' OG ' ' O ' ' A' ' 88' ' ' ILE . 30.2 t -140.48 152.4 45.59 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.637 -179.037 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -123.31 122.0 37.24 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.157 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -83.98 134.13 34.66 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.827 -179.496 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -92.81 120.82 33.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.579 179.807 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -123.2 116.54 23.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.018 179.735 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.435 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 50.9 t-20 . . . . . 0 C--N 1.329 -0.305 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.329 179.768 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo . . . . . 0 N--CA 1.488 1.182 0 CA-C-O 121.032 0.347 . . . . 0.0 111.707 . . . . . . . . . 0 0 . 1 . 061 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 42.7 t -61.35 136.36 24.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.628 179.612 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 14.9 t . . . . . 0 C--N 1.328 -0.343 0 C-N-CA 120.493 -0.483 . . . . 0.0 109.737 -179.787 . . . . . . . . 0 0 . 1 . 061 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo . . . . . 0 N--CA 1.499 1.802 0 N-CA-C 113.25 0.442 . . . . 0.0 113.25 . . . . . . . . . 0 0 . 1 . 061 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 20.7 m -72.93 -49.2 30.95 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.299 -0.561 . . . . 0.0 110.091 179.16 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -58.08 -47.49 83.01 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.324 -179.066 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 86.8 mt -64.48 -42.18 96.04 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -179.177 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -65.54 -39.36 91.65 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.201 -0.6 . . . . 0.0 111.099 -179.539 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . 0.42 ' O ' ' OG ' ' B' ' 247' ' ' SER . 81.7 mtp180 -61.84 -42.88 99.57 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.167 -0.613 . . . . 0.0 109.591 179.784 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -63.07 -41.23 99.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.717 -179.846 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -62.1 -42.66 99.45 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.45 0.643 . . . . 0.0 109.89 179.41 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' B' B ' 247' ' ' SER . . . . . 0.42 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 67.3 p -67.83 -43.99 78.27 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.245 -0.888 . . . . 0.0 109.129 178.652 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . 0.417 ' H ' ' HG ' ' B' ' 247' ' ' SER . 52.5 tt0 -61.39 -39.49 90.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.388 179.882 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.087 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.872 179.674 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 . . . . . 0 CA--C 1.531 0.242 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 . . . . . . . . . 0 0 . 1 . 061 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 80.8 mt -119.46 132.33 69.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.35 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 51.1 t -126.79 135.61 63.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.021 0.439 . . . . 0.0 110.874 -179.69 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -94.59 117.44 30.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.186 0.517 . . . . 0.0 110.78 -179.176 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . 0.407 ' NZ ' ' HA ' ' A' ' 34' ' ' GLU . 88.8 tttt -70.53 -44.23 67.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.79 -179.69 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . 0.477 ' NE2' ' HG ' ' A' ' 23' ' ' SER . 0.1 OUTLIER -94.68 162.18 26.39 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.771 -179.032 . . . . . . . . 3 3 . 1 . 061 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -59.94 151.74 69.52 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.9 2.4 . . . . 0.0 111.588 179.364 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 47.8 pt . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 121.44 0.638 . . . . 0.0 111.827 -178.708 . . . . . . . . 0 0 . 1 . 062 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 30.3 p . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 120.951 0.405 . . . . 0.0 110.629 . . . . . . . . . 0 0 . 1 . 062 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.436 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 93.7 mtt-85 -91.68 131.2 37.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.819 -179.27 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -135.23 144.62 47.0 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.452 179.312 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 69.3 mt -119.64 146.46 45.54 Favored 'General case' 0 CA--C 1.527 0.083 0 CA-C-O 121.025 0.44 . . . . 0.0 111.451 -179.389 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.2 t -117.87 129.79 73.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.584 178.9 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 m -91.35 114.46 27.0 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.933 0.397 . . . . 0.0 111.067 -179.631 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 92.9 mt -81.11 144.66 10.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.282 179.508 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -84.78 150.76 24.83 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.339 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.606 ' NH1' ' NH1' ' B' ' 245' ' ' ARG . 87.8 mtm180 -58.28 -24.99 61.26 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -179.888 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.1 t -76.73 -13.03 60.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.876 178.738 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.97 35.27 6.82 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 179.946 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.0 t -121.39 135.6 61.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.734 0.302 . . . . 0.0 110.888 -179.861 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -71.29 118.67 14.38 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.886 179.384 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -111.38 -126.43 4.87 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 120.976 -0.631 . . . . 0.0 111.751 -179.017 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.63 148.68 42.38 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.236 1.958 . . . . 0.0 112.196 -179.239 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -105.77 154.57 20.3 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.647 179.801 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.416 ' CD2' HD13 ' A' ' 37' ' ' ILE . 51.5 t80 -122.44 92.37 49.01 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.1 -179.33 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -74.16 139.92 27.3 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 121.331 1.354 . . . . 0.0 111.557 -179.517 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.3 mt -102.54 125.29 49.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.22 0.533 . . . . 0.0 111.798 -178.176 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 61.6 p -121.71 -2.73 9.31 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.381 -0.827 . . . . 0.0 108.806 178.292 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.9 mt -104.82 147.17 28.02 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.154 -179.203 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 90.6 p -68.63 -17.15 64.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.001 -178.912 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 44.2 m -128.53 131.78 48.27 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.365 0.603 . . . . 0.0 111.997 -179.121 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.683 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -128.52 121.6 29.22 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.188 178.896 . . . . . . . . 3 3 . 1 . 062 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.516 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 42.8 tp -120.76 126.43 50.13 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -178.208 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.683 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 66.0 m-85 -103.08 145.14 30.35 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 178.616 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 155.64 -169.87 33.49 Favored Glycine 0 C--N 1.321 -0.27 0 C-N-CA 119.886 -1.15 . . . . 0.0 112.273 178.611 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 33.2 ttp-105 -86.64 -31.11 21.28 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -179.624 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -57.09 152.09 25.24 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-N 116.217 -0.447 . . . . 0.0 112.168 -178.977 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.421 ' CD1' ' CZ ' ' A' ' 38' ' ' ARG . 37.5 mm -63.93 -44.04 97.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-O 120.766 0.317 . . . . 0.0 110.93 179.93 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -55.74 -17.5 6.14 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.095 -179.075 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 83.2 m -64.05 119.65 10.53 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.662 -179.71 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.589 ' OD2' ' SG ' ' A' ' 27' ' ' CYS . 12.0 p-10 -56.54 -24.07 44.26 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.97 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.449 ' N ' ' OD1' ' A' ' 36' ' ' ASP . 45.2 mm -126.17 116.33 45.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.1 -0.955 . . . . 0.0 108.761 176.803 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.421 ' CZ ' ' CD1' ' A' ' 33' ' ' ILE . 84.5 mtp180 -100.97 132.24 46.48 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -179.195 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.417 HG23 HD12 ' A' ' 39' ' ' ILE . 96.6 mt -123.08 131.53 73.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.173 0.511 . . . . 0.0 111.058 -179.341 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -81.75 35.18 0.41 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.642 -178.628 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.58 ' CD2' ' CZ ' ' B' ' 245' ' ' ARG . 40.3 mt -100.17 115.72 65.21 Favored Pre-proline 0 C--N 1.325 -0.494 0 C-N-CA 120.388 -0.525 . . . . 0.0 110.391 179.502 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -56.22 -15.4 14.42 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 121.944 1.763 . . . . 0.0 112.421 178.794 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.9 m -98.24 8.32 7.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.556 -179.583 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.7 t -99.21 132.51 44.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.103 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.2 m -71.96 169.06 16.7 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.585 0.707 . . . . 0.0 111.775 -178.829 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -64.78 -40.69 95.67 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.671 -1.15 . . . . 0.0 111.457 -179.076 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.602 ' O ' ' N ' ' A' ' 49' ' ' CYS . 93.7 mm-40 -106.91 -23.86 12.22 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.259 0.552 . . . . 0.0 110.036 179.821 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.6 t60 38.17 -78.46 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.144 -0.935 . . . . 0.0 112.975 179.487 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.602 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.1 OUTLIER -135.36 137.0 41.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.226 0.536 . . . . 0.0 111.767 -178.428 . . . . . . . . 3 3 . 1 . 062 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -124.74 128.22 48.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.603 179.155 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 82.4 mt -111.07 131.49 62.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.852 179.303 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -114.29 132.49 56.15 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.371 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.448 HG22 HD13 ' A' ' 53' ' ' ILE . 43.4 mm -103.33 114.32 42.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 120.161 -0.616 . . . . 0.0 111.106 -179.278 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.449 ' O ' ' C ' ' A' ' 55' ' ' GLU . 96.9 m-70 -116.71 137.17 52.39 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.633 179.195 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 54' ' ' HIS . 80.2 mm-40 -39.95 -35.73 0.39 Allowed 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.057 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -60.27 -68.63 0.28 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.013 178.804 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.582 ' OE2' ' NH1' ' A' ' 81' ' ' ARG . 9.5 pt-20 -160.37 -158.46 0.62 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.327 178.88 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -120.95 133.96 55.29 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.764 0.316 . . . . 0.0 110.917 -179.648 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 87.6 mt -116.83 131.4 69.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.3 0.571 . . . . 0.0 112.457 -178.837 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.465 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 37.5 tp -95.22 126.91 40.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.695 179.833 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -116.0 134.34 55.07 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.668 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -98.96 105.23 17.35 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.787 -179.369 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -96.83 -7.89 32.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.301 179.134 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.96 99.47 6.85 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.069 0.461 . . . . 0.0 110.627 179.906 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 91.5 p -78.39 -33.09 49.04 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.945 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.2 m -66.9 -46.09 75.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.072 -179.351 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -146.05 97.27 4.51 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.835 -179.118 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.6 146.67 52.58 Favored 'Trans proline' 0 N--CA 1.501 1.958 0 C-N-CA 122.625 2.217 . . . . 0.0 113.585 -179.965 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 93.4 m -72.14 138.74 47.91 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.463 178.669 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -102.35 140.73 36.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.092 -179.918 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.6 t -131.36 139.69 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.118 178.568 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 8.9 m120 52.36 32.4 11.04 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.346 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.09 30.23 65.64 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.51 179.185 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.7 m -146.2 143.76 29.47 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 117.659 0.729 . . . . 0.0 111.798 -179.825 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 74.8 t -69.8 138.35 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.235 -179.376 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.536 ' CG2' ' O ' ' A' ' 78' ' ' GLU . 95.6 mt -105.15 100.31 10.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.569 179.744 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -65.94 -39.56 90.58 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.599 179.57 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.536 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.1 OUTLIER -129.63 177.48 2.16 Favored Pre-proline 0 N--CA 1.466 0.374 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.405 -178.989 . . . . . . . . 3 3 . 1 . 062 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.423 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 33.8 Cg_exo -58.93 145.05 98.53 Favored 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 122.56 2.173 . . . . 0.0 112.54 -179.45 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.4 p -142.68 141.32 27.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.508 -179.778 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.582 ' NH1' ' OE2' ' A' ' 57' ' ' GLU . 93.9 mtt-85 -73.85 133.09 43.12 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.613 -179.507 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 94.3 mt -87.15 139.24 30.77 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.356 0.598 . . . . 0.0 111.76 -179.17 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -130.89 155.36 46.88 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.727 -179.566 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.507 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 5.9 t60 -56.22 118.51 4.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.803 0.335 . . . . 0.0 110.229 -179.748 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.31 -12.52 26.13 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.367 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.405 ' C ' ' OD1' ' A' ' 86' ' ' ASP . 48.1 t0 -68.99 128.19 35.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.851 0.358 . . . . 0.0 110.605 179.762 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 53.6 t -109.81 131.84 59.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.78 -178.81 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.499 ' O ' ' OG ' ' A' ' 94' ' ' SER . 5.4 mm -94.65 127.79 46.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.091 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 53.1 m -118.14 124.93 49.21 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.881 -179.558 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.444 ' O ' ' C ' ' A' ' 91' ' ' ILE . 96.0 mt -122.19 126.18 73.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.26 179.321 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.445 HG21 HD13 ' A' ' 91' ' ' ILE . 31.8 mm 35.87 -109.55 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.01 -179.464 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -103.1 11.59 36.94 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.755 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.555 ' NH2' ' OE1' ' B' ' 260' ' ' GLU . 17.4 ptp180 -130.88 147.25 52.51 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.827 179.822 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.499 ' OG ' ' O ' ' A' ' 88' ' ' ILE . 29.8 t -137.07 152.75 50.4 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.736 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -121.35 121.47 37.72 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.73 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -85.18 129.54 34.78 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.004 -0.679 . . . . 0.0 110.515 -179.112 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.565 ' HH ' ' ND2' ' A' ' 99' ' ' ASN . 24.3 t80 -97.37 122.83 40.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.093 0.473 . . . . 0.0 110.236 179.869 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -121.86 123.26 41.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.062 179.849 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.565 ' ND2' ' HH ' ' A' ' 97' ' ' TYR . 20.6 t-20 . . . . . 0 C--N 1.327 -0.401 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.888 -179.51 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo . . . . . 0 N--CA 1.494 1.517 0 CA-C-O 122.292 0.872 . . . . 0.0 114.041 . . . . . . . . . 0 0 . 1 . 062 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -75.1 139.38 19.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 113.939 -1.482 . . . . 0.0 111.017 -179.244 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.9 t . . . . . 0 C--O 1.232 0.152 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.225 -179.975 . . . . . . . . 0 0 . 1 . 062 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo . . . . . 0 N--CA 1.496 1.619 0 N-CA-C 113.164 0.409 . . . . 0.0 113.164 . . . . . . . . . 0 0 . 1 . 062 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 16.7 m -73.14 -47.27 45.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.258 0.551 . . . . 0.0 110.434 179.385 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -57.88 -46.81 84.32 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.633 -178.932 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 96.7 mt -63.55 -42.32 98.37 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.669 -179.241 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -66.1 -39.1 89.71 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.338 -179.668 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . 0.535 ' NH1' ' OE1' ' B' ' 248' ' ' GLN . 78.4 ttt-85 -59.83 -45.72 91.52 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.953 -179.593 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.606 ' NH1' ' NH1' ' A' ' 12' ' ' ARG . 95.6 mtt-85 -65.81 -37.14 85.45 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.483 -179.5 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -60.28 -40.65 91.16 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.817 179.667 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 78.2 p -69.97 -43.02 72.36 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.108 0.48 . . . . 0.0 110.103 178.948 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . 0.535 ' OE1' ' NH1' ' B' ' 244' ' ' ARG . 88.0 mt-30 -64.19 -36.69 84.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.321 -179.768 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 60.4 t . . . . . 0 C--N 1.329 -0.299 0 C-N-CA 120.356 -0.538 . . . . 0.0 109.912 179.444 . . . . . . . . 0 0 . 1 . 062 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . 0.57 ' CD ' HH12 ' B' ' 245' ' ' ARG . 97.0 mt-10 . . . . . 0 CA--C 1.537 0.457 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 . . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . 0.41 ' CG1' HH11 ' A' ' 93' ' ' ARG . 69.8 mt -118.43 132.37 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 178.079 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 52.3 t -124.89 132.74 70.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.232 179.46 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -93.42 117.11 29.68 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.135 0.493 . . . . 0.0 110.897 -178.259 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -67.4 -45.97 74.61 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.393 -179.87 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 25.6 mm100 -88.6 153.34 50.25 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.887 -178.729 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -61.28 147.19 96.25 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.448 2.099 . . . . 0.0 112.253 179.362 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.4 pt . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.282 -179.329 . . . . . . . . 0 0 . 1 . 063 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 46.0 p . . . . . 0 N--CA 1.471 0.599 0 CA-C-O 121.238 0.542 . . . . 0.0 110.368 . . . . . . . . . 0 0 . 1 . 063 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.8 mtt85 -85.92 131.05 34.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.324 -179.592 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -129.09 139.41 52.0 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.348 179.975 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 32.7 tp -116.49 133.31 56.16 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.836 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 70.7 t -112.42 131.06 64.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.068 0.461 . . . . 0.0 110.174 -179.293 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.8 m -80.99 144.5 31.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.769 0.795 . . . . 0.0 112.472 -178.236 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.534 ' CD1' ' OD1' ' A' ' 16' ' ' ASP . 48.5 mm -111.86 135.78 50.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.54 178.389 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -93.48 157.95 15.96 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.318 0.58 . . . . 0.0 110.31 178.433 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.451 ' HD3' HH21 ' B' ' 245' ' ' ARG . 88.5 mtm180 -58.02 -23.49 54.42 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.435 -179.514 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 87.7 p -80.08 -13.13 59.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.329 179.913 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.19 20.06 34.07 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.56 179.228 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.4 m -115.65 138.21 46.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.166 179.301 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.534 ' OD1' ' CD1' ' A' ' 10' ' ' ILE . 83.1 m-20 -70.3 139.97 52.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.11 -179.91 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -126.22 -120.21 2.37 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 121.063 -0.589 . . . . 0.0 111.634 -179.638 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.38 146.1 39.33 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.018 1.812 . . . . 0.0 113.117 -178.621 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -104.82 145.64 30.1 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.09 179.468 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -119.45 103.5 46.67 Favored Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.496 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -73.64 130.06 14.34 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 121.617 1.544 . . . . 0.0 112.588 -178.433 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.2 mt -85.87 57.05 4.25 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.104 -178.666 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.59 -33.07 74.22 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.479 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.7 mt -74.91 142.5 44.01 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.139 179.791 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.59 -14.98 63.37 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.186 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.529 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 54.4 m -132.13 132.13 42.96 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.842 -179.798 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.5 t -124.57 117.16 23.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.804 178.683 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 32.6 tp -115.44 126.23 54.08 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.447 -178.96 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.493 ' O ' ' O ' ' A' ' 47' ' ' GLN . 4.8 m-85 -107.11 138.92 42.39 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.831 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.13 -168.78 37.29 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 120.071 -1.061 . . . . 0.0 112.577 179.424 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.711 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 83.9 mtm-85 -82.54 -26.68 32.24 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.744 0.307 . . . . 0.0 110.585 -179.753 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.474 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -61.69 134.62 47.13 Favored Glycine 0 N--CA 1.466 0.644 0 C-N-CA 121.354 -0.45 . . . . 0.0 112.349 -178.018 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.431 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 10.7 tp -62.79 -41.43 92.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.101 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.431 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 83.8 tt0 -51.87 -16.09 0.64 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.883 179.137 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.474 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 40.8 m -70.54 142.4 51.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.751 179.709 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.529 ' OD2' ' O ' ' A' ' 26' ' ' THR . 59.1 m-20 -60.96 -34.08 74.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.703 -179.736 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.438 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 85.1 mt -129.89 124.31 58.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.031 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 70.6 ttp85 -109.63 138.45 45.98 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.18 -179.407 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 97.7 mt -116.6 131.36 69.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.687 -179.433 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -74.82 30.78 0.09 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -178.083 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.616 ' CD1' ' CZ ' ' A' ' 93' ' ' ARG . 17.3 mt -110.36 129.81 23.55 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 120.132 -0.627 . . . . 0.0 111.954 179.921 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.48 -10.38 26.76 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.567 2.178 . . . . 0.0 112.971 -179.878 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.7 m -95.83 -1.88 10.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 121.056 -0.258 . . . . 0.0 111.407 -179.827 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.711 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 53.4 t -87.24 135.85 24.34 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.54 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.994 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.427 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 0.6 OUTLIER -62.55 162.39 10.49 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.248 0.547 . . . . 0.0 111.551 -179.183 . . . . . . . . 3 3 . 1 . 063 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -62.57 -45.1 94.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.857 -178.861 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.642 ' O ' ' N ' ' A' ' 49' ' ' CYS . 85.8 mt-30 -113.81 -12.69 12.69 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 123.937 0.773 . . . . 0.0 110.243 179.397 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.427 ' H ' ' HB3' ' A' ' 45' ' ' SER . 10.3 t60 31.01 -72.7 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 179.305 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.642 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.5 135.26 46.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.396 0.617 . . . . 0.0 112.196 -178.233 . . . . . . . . 3 3 . 1 . 063 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -126.92 128.85 47.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.054 179.307 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.2 mt -115.18 134.54 57.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.971 -179.808 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -111.98 131.35 55.45 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.039 179.036 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 51.5 mm -101.55 110.4 28.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 120.144 -0.622 . . . . 0.0 111.015 179.617 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.465 ' O ' ' C ' ' A' ' 55' ' ' GLU . 97.7 m-70 -113.54 135.33 54.01 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.267 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.465 ' C ' ' O ' ' A' ' 54' ' ' HIS . 93.2 mt-10 -41.2 -32.0 0.25 Allowed 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -179.998 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.454 ' N ' ' C ' ' A' ' 54' ' ' HIS . 99.8 mm-40 -65.23 -68.26 0.38 Allowed 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.638 178.402 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.478 ' HG3' ' NE ' ' A' ' 81' ' ' ARG . 1.0 OUTLIER -155.13 -171.84 3.96 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.539 0.685 . . . . 0.0 111.499 -179.638 . . . . . . . . 3 3 . 1 . 063 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -115.24 122.53 46.27 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.477 178.781 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.0 mt -114.55 133.58 60.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.258 0.551 . . . . 0.0 111.675 -178.423 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 21.5 tp -97.6 128.3 44.22 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.779 -179.751 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -110.45 133.61 53.12 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.09 179.689 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.411 HD22 ' HA ' ' A' ' 68' ' ' PRO . 60.8 t-20 -90.88 106.98 18.89 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.193 -179.589 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -97.95 -11.08 23.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.376 179.202 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 54.1 p -74.15 100.74 3.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.043 0.449 . . . . 0.0 110.923 179.82 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.1 p -86.2 -14.26 44.47 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.249 179.542 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.72 -42.98 8.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.954 -179.886 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.462 ' O ' ' OG ' ' A' ' 64' ' ' SER . 34.4 m-80 -136.93 99.3 10.18 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.369 179.887 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.411 ' HA ' HD22 ' A' ' 62' ' ' ASN . 49.2 Cg_exo -54.39 143.86 64.13 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.15 1.9 . . . . 0.0 112.985 -179.585 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.3 m -77.16 141.5 40.11 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.824 179.192 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -107.3 138.8 42.82 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.435 0.636 . . . . 0.0 110.821 179.975 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 66.8 t -131.4 135.07 60.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.494 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 53.84 32.35 14.89 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.035 -0.666 . . . . 0.0 110.398 -179.469 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.18 29.63 66.29 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.8 178.296 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 73.3 m -146.51 138.2 24.64 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.496 -0.482 . . . . 0.0 111.05 179.302 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -69.42 144.26 14.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.974 179.739 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.8 pt -119.14 95.09 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.133 179.048 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 78' ' ' GLU . 49.0 p-10 -71.09 -24.01 62.23 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.254 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.491 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 5.5 mt-10 -118.92 163.96 23.49 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.745 179.545 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -62.23 150.1 88.17 Favored 'Trans proline' 0 N--CA 1.501 1.943 0 C-N-CA 122.656 2.237 . . . . 0.0 112.483 179.78 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.0 p -140.54 143.87 28.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-O 121.478 0.656 . . . . 0.0 112.352 -179.003 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.478 ' NE ' ' HG3' ' A' ' 57' ' ' GLU . 68.2 ttt180 -73.33 126.79 30.95 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.558 179.245 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.0 mt -82.13 132.43 35.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.956 0.407 . . . . 0.0 110.955 -179.623 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -123.57 149.22 45.55 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.706 179.284 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.45 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 5.2 t60 -52.44 121.01 6.22 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.962 -179.249 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.01 -13.67 45.02 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.529 -0.629 . . . . 0.0 111.529 179.676 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -71.21 139.22 50.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.954 0.407 . . . . 0.0 111.095 -179.939 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.7 t -117.92 130.18 73.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.468 -178.5 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 92.7 mt -94.0 131.93 39.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.225 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.8 m -115.91 127.6 55.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.307 0.575 . . . . 0.0 112.252 -178.568 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.534 ' O ' ' N ' ' A' ' 93' ' ' ARG . 93.5 mt -125.87 124.8 67.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.176 178.346 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.537 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 72.2 mt -3.61 89.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -179.856 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.537 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 8.9 t0 86.84 -15.44 0.44 Allowed 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 177.158 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.73 ' NH1' HH22 ' B' ' 245' ' ' ARG . 23.3 mtm-85 -131.27 145.82 52.05 Favored 'General case' 0 CA--C 1.512 -0.519 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.698 -179.127 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.8 p -138.0 156.13 48.15 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 121.134 0.493 . . . . 0.0 110.164 179.567 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -130.08 122.12 27.71 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.536 -179.292 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 44.5 ttm180 -84.66 128.62 34.7 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 120.446 -0.502 . . . . 0.0 111.202 -179.616 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 92.9 t80 -91.88 125.33 36.54 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.616 179.947 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -126.5 121.22 31.73 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.807 179.539 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.45 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 64.8 t-20 . . . . . 0 C--N 1.329 -0.292 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.393 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo . . . . . 0 N--CA 1.492 1.392 0 CA-C-O 121.028 0.345 . . . . 0.0 111.787 . . . . . . . . . 0 0 . 1 . 063 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 2.4 p -114.03 135.74 52.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.129 179.746 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 121.18 0.514 . . . . 0.0 110.071 -179.878 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo . . . . . 0 N--CA 1.49 1.287 0 N-CA-C 112.257 0.06 . . . . 0.0 112.257 . . . . . . . . . 0 0 . 1 . 063 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 27.4 p -77.08 -39.67 48.92 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.24 178.274 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -58.99 -47.04 86.58 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.934 -179.798 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 80.2 mt -67.27 -39.63 86.08 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.127 179.033 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -65.22 -40.88 94.69 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.824 -178.903 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 78.1 ttt-85 -63.01 -43.67 98.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 120.431 -0.507 . . . . 0.0 110.557 -179.553 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.73 HH22 ' NH1' ' A' ' 93' ' ' ARG . 85.6 mtp180 -64.53 -37.32 87.15 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.678 -178.894 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.27 -40.15 96.59 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.095 178.811 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 44.6 t -64.07 -44.18 93.18 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.701 0.763 . . . . 0.0 109.211 178.499 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -62.41 -36.32 81.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.263 179.727 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 60.0 t . . . . . 0 C--N 1.327 -0.382 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.307 179.708 . . . . . . . . 0 0 . 1 . 063 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 . . . . . 0 C--O 1.227 -0.127 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 . . . . . . . . . 0 0 . 1 . 063 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 64.1 mt -108.46 135.13 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.735 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 78.4 t -127.98 136.45 60.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.913 0.387 . . . . 0.0 109.961 -179.684 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -99.68 121.11 40.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.42 -178.398 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -66.52 -45.51 79.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.932 179.217 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.41 152.2 47.21 Favored Pre-proline 0 CA--C 1.52 -0.199 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.283 -179.448 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -62.5 140.51 82.21 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.754 2.303 . . . . 0.0 112.234 -179.831 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 41.8 pt . . . . . 0 C--N 1.322 -0.599 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.01 179.14 . . . . . . . . 0 0 . 1 . 064 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 60.1 p . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.858 0.361 . . . . 0.0 110.642 . . . . . . . . . 0 0 . 1 . 064 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.9 mtt85 -90.65 126.84 36.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.505 -179.676 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -135.95 146.43 47.27 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.384 -0.526 . . . . 0.0 111.688 -179.646 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 73.3 mt -114.41 142.83 45.85 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.021 179.358 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.2 t -118.31 130.34 73.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.195 179.686 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 50.0 m -79.22 135.44 36.79 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.294 0.569 . . . . 0.0 111.956 -178.843 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.6 mt -112.51 138.11 42.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.301 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -91.71 157.15 17.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.089 0.471 . . . . 0.0 111.507 -179.009 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 85.7 mtm-85 -58.27 -24.42 59.36 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.6 -178.623 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 86.2 p -84.78 -7.92 59.02 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.261 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.44 38.8 6.53 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.82 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.9 t -122.14 134.54 65.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.897 0.38 . . . . 0.0 111.416 -179.709 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -77.09 122.53 25.1 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.705 179.824 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -114.75 -122.85 3.68 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.657 -179.435 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.38 148.99 34.56 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.406 2.071 . . . . 0.0 112.914 -178.985 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -103.97 153.8 20.4 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.919 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -124.23 91.15 49.96 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.245 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.0 139.71 36.5 Favored 'Trans proline' 0 C--N 1.315 -1.191 0 C-N-CA 121.253 1.302 . . . . 0.0 111.785 -179.299 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 83.1 mt -101.23 122.53 43.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.265 0.555 . . . . 0.0 111.187 -178.866 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.6 p -117.76 -6.74 11.05 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.47 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 67.2 mt -102.79 148.31 25.77 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.555 -179.623 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.9 m -72.53 -14.49 61.66 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.438 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.417 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 31.5 m -127.92 129.42 46.81 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.411 -179.799 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.2 t -123.91 119.34 29.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.272 178.268 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.5 tp -116.3 130.23 56.67 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.94 0.4 . . . . 0.0 111.355 -178.084 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.654 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 5.7 m-85 -109.4 138.98 44.94 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.011 -179.897 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 148.08 -171.83 28.48 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.081 178.944 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 47.6 mtm180 -79.1 -32.75 44.74 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 -179.919 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.557 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -45.32 147.63 1.85 Allowed Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 -178.751 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 36.2 mm -63.88 -43.51 97.82 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 CA-C-O 120.921 0.391 . . . . 0.0 110.149 179.958 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -56.87 -21.25 28.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.955 -179.654 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.557 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 59.7 m -52.87 115.16 1.69 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.133 -179.667 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.417 ' OD2' ' O ' ' A' ' 26' ' ' THR . 79.3 m-20 -57.16 -21.6 34.07 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -179.697 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.454 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 98.9 mt -132.25 122.24 47.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.124 -0.943 . . . . 0.0 109.334 177.037 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -104.77 135.94 45.22 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 -179.791 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 95.1 mt -115.26 127.72 72.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.615 -179.99 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -69.94 40.08 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -177.361 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.64 ' CD1' ' NH1' ' A' ' 93' ' ' ARG . 20.5 mt -124.18 132.32 24.29 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.957 -179.934 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.08 -7.2 19.57 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.679 2.252 . . . . 0.0 112.931 -179.509 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.2 m -99.8 2.25 10.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.685 179.53 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 29.4 t -87.94 136.54 22.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.345 179.526 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.2 m -65.9 157.2 31.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.182 0.515 . . . . 0.0 111.179 -179.659 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -62.74 -43.65 98.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.161 -178.888 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.638 ' O ' ' N ' ' A' ' 49' ' ' CYS . 96.7 mt-30 -113.99 -15.0 12.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.957 0.408 . . . . 0.0 110.511 179.677 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 18.3 t60 28.38 -74.86 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 178.875 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.654 ' SG ' ' CD1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -128.23 133.96 48.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.258 0.552 . . . . 0.0 112.436 -178.666 . . . . . . . . 3 3 . 1 . 064 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -127.63 131.05 49.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.122 179.17 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.4 mt -115.39 133.63 61.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.894 -179.56 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -113.84 123.01 48.77 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.345 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.0 mt -105.62 113.8 43.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.448 0.642 . . . . 0.0 111.778 -178.662 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.422 ' O ' ' N ' ' A' ' 56' ' ' GLN . 82.2 m-70 -114.6 144.44 43.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.592 179.783 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 54' ' ' HIS . 78.2 mm-40 -41.07 -29.5 0.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.02 -179.02 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.422 ' N ' ' O ' ' A' ' 54' ' ' HIS . 95.7 mt-30 -64.73 -68.93 0.32 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.031 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.1 -166.1 1.99 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.061 179.86 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.29 127.89 56.29 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.324 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.404 HG21 HD12 ' A' ' 59' ' ' ILE . 95.5 mt -115.52 127.88 72.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.098 0.475 . . . . 0.0 111.795 -179.211 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 24.8 tp -97.42 126.95 42.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.043 179.596 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -111.2 135.33 51.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.858 179.925 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.521 ' ND2' ' H ' ' A' ' 69' ' ' THR . 22.0 t-20 -98.83 106.9 19.22 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.974 -179.705 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -95.09 -6.64 41.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.534 178.994 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.5 t -71.65 99.84 2.18 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.493 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 79.0 p -87.21 -16.52 35.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.275 179.823 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.72 -42.82 10.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.278 -179.806 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 56.8 m-20 -139.25 97.96 8.42 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.983 -179.802 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -56.67 146.0 78.95 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 122.321 2.014 . . . . 0.0 113.156 -179.435 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.521 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 2.9 m -76.68 149.95 36.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.59 179.492 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -110.77 140.03 45.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.154 -179.653 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.42 ' CG1' ' OD1' ' A' ' 86' ' ' ASP . 60.6 t -131.09 135.3 60.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.386 -0.824 . . . . 0.0 108.87 179.624 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 51.59 33.35 10.51 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 119.834 -0.747 . . . . 0.0 109.103 -179.835 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.3 25.96 71.65 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.066 179.531 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 67.6 m -142.18 139.91 32.22 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 117.503 0.651 . . . . 0.0 111.561 179.948 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -68.13 143.91 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.185 179.897 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.4 pt -116.05 94.38 3.08 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-O 121.166 0.507 . . . . 0.0 110.479 179.111 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -67.21 -25.83 66.31 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.739 179.762 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.478 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.1 OUTLIER -129.98 179.73 1.24 Allowed Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.818 -179.876 . . . . . . . . 3 3 . 1 . 064 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.478 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 23.8 Cg_exo -62.06 146.83 96.02 Favored 'Trans proline' 0 N--CA 1.5 1.878 0 C-N-CA 123.087 2.524 . . . . 0.0 112.703 -179.379 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.4 m -142.41 137.97 29.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.813 -179.748 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 85.2 mtt85 -73.33 129.35 37.83 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.258 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.3 mt -83.17 137.6 33.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.942 0.401 . . . . 0.0 110.493 179.987 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -131.49 156.7 45.2 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.614 -179.883 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.585 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 3.6 t-160 -59.07 118.64 6.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.029 0.442 . . . . 0.0 110.115 -179.899 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.12 -8.0 35.61 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 -179.046 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.42 ' OD1' ' CG1' ' A' ' 71' ' ' VAL . 64.4 t0 -77.2 126.99 31.84 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.478 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 13.0 p -107.16 137.47 37.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.471 -178.897 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.49 ' O ' ' OG ' ' A' ' 94' ' ' SER . 83.3 mt -103.9 128.22 57.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.502 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.5 m -123.17 126.56 47.23 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 121.624 0.726 . . . . 0.0 112.82 -178.243 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.474 ' O ' ' C ' ' A' ' 91' ' ' ILE . 97.9 mt -117.51 126.88 74.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.988 178.547 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.474 ' C ' ' O ' ' A' ' 90' ' ' ILE . 96.8 mt 32.79 -98.73 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.669 -179.499 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -112.13 12.1 20.45 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -179.84 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.64 ' NH1' ' CD1' ' A' ' 41' ' ' LEU . 39.6 mtm-85 -126.19 142.55 51.48 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 120.984 -0.287 . . . . 0.0 110.441 -179.499 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.49 ' OG ' ' O ' ' A' ' 88' ' ' ILE . 43.7 t -138.55 149.57 45.46 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.706 179.92 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.406 ' N ' ' HG ' ' A' ' 94' ' ' SER . 96.8 m-85 -121.0 121.2 37.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.038 178.558 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 55.3 ttt85 -84.45 131.03 34.71 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.546 -0.462 . . . . 0.0 109.766 -179.774 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -90.38 122.52 33.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.402 -179.753 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -124.24 120.64 32.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.843 0.354 . . . . 0.0 110.836 179.893 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.585 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 62.8 t-20 . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.221 179.688 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo . . . . . 0 N--CA 1.486 1.054 0 CA-C-O 121.248 0.436 . . . . 0.0 112.331 . . . . . . . . . 0 0 . 1 . 064 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 49.8 t -65.5 135.68 27.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.714 -179.623 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.7 t . . . . . 0 CA--C 1.52 -0.191 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.723 . . . . . . . . 0 0 . 1 . 064 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo . . . . . 0 N--CA 1.5 1.867 0 N-CA-C 113.668 0.603 . . . . 0.0 113.668 . . . . . . . . . 0 0 . 1 . 064 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 39.8 p -73.47 -38.59 65.39 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.977 179.182 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -58.09 -48.14 81.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.845 -179.004 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 98.0 mt -67.71 -42.36 82.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.884 0.373 . . . . 0.0 111.674 -179.687 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -63.25 -45.16 92.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.884 -178.62 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -63.53 -43.82 96.05 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.841 0.353 . . . . 0.0 111.141 -179.527 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . . . . . . . . . 48.5 ttm-85 -65.27 -41.9 93.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.469 -179.334 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -63.4 -39.02 93.36 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.179 179.159 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 20.3 m -65.12 -42.64 93.74 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 177.895 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 63.6 tp60 -59.63 -35.41 74.31 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.53 -1.213 . . . . 0.0 110.179 179.493 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 49.9 t . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.873 0.368 . . . . 0.0 110.227 178.926 . . . . . . . . 0 0 . 1 . 064 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 . . . . . 0 N--CA 1.455 -0.181 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 064 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 70.6 mt -115.47 134.48 58.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.168 179.94 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 54.6 t -124.16 132.91 70.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.725 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -94.54 119.02 32.57 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.387 0.613 . . . . 0.0 111.612 -177.88 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -66.83 -46.48 74.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.287 179.68 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -72.85 166.44 43.05 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.181 -179.25 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -64.26 141.26 74.65 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 121.569 1.513 . . . . 0.0 111.282 179.878 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 11.9 tt . . . . . 0 C--N 1.324 -0.517 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.34 -178.869 . . . . . . . . 0 0 . 1 . 065 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.408 ' OG1' ' N ' ' A' ' 5' ' ' ARG . 6.6 p . . . . . 0 CA--C 1.518 -0.256 0 CA-C-O 121.302 0.572 . . . . 0.0 110.326 . . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.408 ' N ' ' OG1' ' A' ' 4' ' ' THR . 85.3 mtt85 -94.21 128.24 40.54 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.816 -179.885 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -132.86 144.33 50.12 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.389 -0.525 . . . . 0.0 111.354 -179.345 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 79.9 mt -115.41 145.59 42.4 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.669 179.633 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.7 t -118.48 130.18 73.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.855 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 m -90.66 117.04 29.0 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.308 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.0 mt -86.94 142.36 13.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.305 177.724 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -95.16 169.73 9.89 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.869 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 88.9 mtm180 -56.96 -29.6 63.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.8 -178.784 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.6 t -81.11 -7.35 59.54 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.757 179.295 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.27 40.19 8.67 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 -178.892 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.8 t -116.64 134.06 61.32 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.076 0 CA-C-O 120.832 0.349 . . . . 0.0 111.602 -178.713 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.468 ' C ' ' OD1' ' A' ' 16' ' ' ASP . 39.4 t0 -77.64 124.36 27.84 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.138 179.448 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -124.09 -115.56 2.16 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 120.655 -0.784 . . . . 0.0 111.408 179.94 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -72.95 144.21 37.94 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.153 1.902 . . . . 0.0 113.621 -178.808 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 50.9 m170 -106.05 142.41 35.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.275 179.781 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -114.2 93.02 29.12 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.221 -179.571 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -69.07 135.15 31.31 Favored 'Trans proline' 0 N--CA 1.488 1.187 0 C-N-CA 121.51 1.474 . . . . 0.0 111.668 -179.537 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 92.4 mt -84.84 80.31 9.32 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.187 -178.699 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 85.6 p -82.33 -10.85 58.93 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.078 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 58.0 mt -103.85 144.66 31.21 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.401 -179.202 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.8 t -67.5 -14.84 63.29 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.968 -179.856 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.548 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 89.2 m -131.38 133.69 45.52 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 120.696 -0.401 . . . . 0.0 111.395 -179.809 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.601 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 13.2 t -125.27 116.14 21.48 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.632 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.4 tp -115.23 131.29 56.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.29 -178.161 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.601 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 23.3 m-85 -109.38 136.91 48.04 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.632 178.943 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 154.22 -177.19 31.76 Favored Glycine 0 C--O 1.221 -0.677 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.778 178.804 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.477 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 46.4 mtm180 -77.47 -31.08 53.48 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.646 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.508 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -51.33 150.55 6.85 Favored Glycine 0 N--CA 1.465 0.582 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.395 -178.327 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.472 ' CD1' ' NH1' ' A' ' 38' ' ' ARG . 11.0 tp -66.44 -41.62 89.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.646 0.26 . . . . 0.0 110.533 179.967 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.47 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 81.0 mm-40 -55.72 -24.23 33.61 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.347 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.508 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 39.0 m -53.3 118.04 3.51 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.823 179.971 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.548 ' OD2' ' O ' ' A' ' 26' ' ' THR . 93.2 m-20 -59.14 -27.99 66.15 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.855 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.409 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 97.9 mt -127.53 119.12 51.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 176.479 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.472 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 82.9 mtp180 -102.2 134.82 44.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.901 0.382 . . . . 0.0 111.901 -178.439 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.0 mt -122.02 130.05 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.114 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.693 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -82.93 34.36 0.45 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.001 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 31.3 mt -95.65 129.03 35.71 Favored Pre-proline 0 C--N 1.325 -0.477 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.33 179.458 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.17 -12.16 27.62 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 C-N-CA 122.218 1.945 . . . . 0.0 112.361 -179.616 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.4 m -98.08 5.73 9.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.872 0.368 . . . . 0.0 110.495 -179.949 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.477 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 37.4 t -98.82 135.11 35.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.414 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.632 ' HG ' ' H ' ' A' ' 46' ' ' LYS . 6.9 t -70.34 174.68 5.37 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.229 0.538 . . . . 0.0 111.233 -179.031 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.632 ' H ' ' HG ' ' A' ' 45' ' ' SER . 50.4 mttp -64.03 -41.01 97.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.1 -179.926 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.628 ' O ' ' N ' ' A' ' 49' ' ' CYS . 85.6 mt-30 -112.85 -20.08 11.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.919 -179.272 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 28.2 t60 39.17 -76.8 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 179.751 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.628 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.2 133.46 46.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.306 -178.548 . . . . . . . . 3 3 . 1 . 065 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -127.35 130.57 49.69 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.541 179.34 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 86.2 mt -115.98 134.86 57.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.812 -179.826 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.568 ' CD ' ' HE2' ' A' ' 54' ' ' HIS . 74.6 tt0 -120.47 125.8 48.81 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.791 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 93.9 mt -106.56 119.08 55.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.567 0.698 . . . . 0.0 112.26 -179.009 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.568 ' HE2' ' CD ' ' A' ' 52' ' ' GLU . 99.6 m-70 -112.36 140.34 47.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.605 -1.179 . . . . 0.0 108.959 178.961 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.9 mm-40 -40.78 -28.02 0.07 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 -179.86 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.462 ' N ' ' O ' ' A' ' 54' ' ' HIS . 82.3 mt-30 -65.88 -68.04 0.4 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.434 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -154.14 -171.51 3.9 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.382 -179.613 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.16 128.99 55.78 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.497 -0.556 . . . . 0.0 109.497 179.021 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 98.0 mt -119.02 130.96 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -178.752 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 32.1 tp -99.33 131.7 45.17 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.003 179.277 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -114.55 136.44 53.02 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.072 179.197 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.407 HD22 ' HA ' ' A' ' 68' ' ' PRO . 57.9 t-20 -97.81 111.09 23.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.187 0.518 . . . . 0.0 111.651 -179.543 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -104.8 -10.37 17.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.484 179.91 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.4 101.46 12.02 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.491 -179.813 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 77.8 p -76.19 -35.57 59.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.257 0.551 . . . . 0.0 109.903 179.244 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.01 -43.02 99.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.285 -178.827 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -147.25 99.77 3.9 Favored Pre-proline 0 C--N 1.317 -0.834 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.484 -179.034 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.407 ' HA ' HD22 ' A' ' 62' ' ' ASN . 33.6 Cg_exo -57.55 146.46 84.02 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 C-N-CA 121.783 1.656 . . . . 0.0 112.681 -178.78 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 18.2 m -70.24 136.17 49.68 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.351 178.316 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -96.94 143.9 27.37 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.171 -0.612 . . . . 0.0 111.229 -179.162 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.48 ' CG2' ' OD1' ' A' ' 86' ' ' ASP . 5.4 p -129.5 133.88 64.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.837 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 49.17 30.12 2.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.157 0.503 . . . . 0.0 109.952 -179.331 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 78.2 27.47 57.85 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.393 179.064 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.6 t -138.0 139.59 39.73 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.997 0.398 . . . . 0.0 110.46 179.739 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -67.78 142.29 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.846 179.907 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.528 ' CG2' ' O ' ' A' ' 78' ' ' GLU . 96.6 mt -101.72 103.72 15.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.936 -179.742 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -67.63 -40.97 84.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.989 179.028 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.528 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.6 OUTLIER -134.68 179.37 1.4 Allowed Pre-proline 0 CA--C 1.53 0.186 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.727 -178.35 . . . . . . . . 3 3 . 1 . 065 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.467 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 31.8 Cg_exo -59.37 144.59 99.36 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 122.804 2.336 . . . . 0.0 112.648 -179.585 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.8 m -143.1 141.24 26.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.995 -179.806 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 91.7 mtm180 -71.68 131.39 43.09 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.526 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.4 mt -80.19 139.99 36.51 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.838 0.351 . . . . 0.0 110.978 -179.538 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -131.44 150.2 52.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.426 -179.903 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.641 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 5.8 t60 -55.92 123.09 13.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.908 0.385 . . . . 0.0 110.982 -179.304 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.12 -14.19 48.42 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 -179.472 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.48 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 64.9 t0 -71.4 129.75 39.6 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.028 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.447 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 95.0 t -109.36 130.55 62.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.265 -178.819 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.4 mt -97.0 131.57 43.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.984 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 63.9 m -127.97 127.63 43.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.713 0.768 . . . . 0.0 113.002 -178.512 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.607 ' O ' ' N ' ' A' ' 92' ' ' ASP . 82.2 mt -107.03 123.06 61.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 177.682 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.437 ' C ' ' O ' ' A' ' 90' ' ' ILE . 70.3 mt 38.87 -88.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 120.511 -0.475 . . . . 0.0 110.646 -179.467 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.607 ' N ' ' O ' ' A' ' 90' ' ' ILE . 32.4 t70 -128.18 16.17 6.69 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -179.746 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.625 ' HE ' HH12 ' B' ' 245' ' ' ARG . 98.3 mtt180 -123.01 139.91 53.59 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.115 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 31.7 p -138.84 151.87 47.37 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 119.23 -0.988 . . . . 0.0 112.011 -179.684 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -122.1 121.61 37.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.554 -1.203 . . . . 0.0 108.364 178.958 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -83.56 133.32 34.87 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.176 -0.609 . . . . 0.0 111.48 -178.52 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -96.83 122.47 39.82 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.234 -179.615 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -123.67 124.58 43.08 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.864 179.947 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.641 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 62.9 t-20 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.787 179.478 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 N--CA 1.487 1.104 0 CA-C-O 121.785 0.66 . . . . 0.0 113.307 . . . . . . . . . 0 0 . 1 . 065 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 12.2 p -58.35 135.73 22.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.135 -179.642 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 10.0 t . . . . . 0 C--N 1.329 -0.311 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.742 -179.502 . . . . . . . . 0 0 . 1 . 065 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo . . . . . 0 N--CA 1.502 1.999 0 N-CA-C 114.085 0.764 . . . . 0.0 114.085 . . . . . . . . . 0 0 . 1 . 065 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 97.4 m -67.45 -47.09 71.15 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.379 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . 0.415 ' CE2' ' HD2' ' B' ' 245' ' ' ARG . 91.7 t80 -57.93 -46.21 85.4 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.335 -179.459 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 87.6 mt -65.43 -38.83 91.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.842 0.353 . . . . 0.0 110.64 179.962 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -60.77 -41.11 94.83 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.077 0.465 . . . . 0.0 110.044 -179.98 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 62.0 ttp180 -61.45 -43.17 99.34 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.195 179.877 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.625 HH12 ' HE ' ' A' ' 93' ' ' ARG . 76.0 mtp85 -60.07 -42.09 93.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.866 -179.689 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.29 -41.34 96.81 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.28 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 8.6 t -63.4 -46.13 87.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.738 178.381 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -59.33 -38.45 80.35 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.808 -178.989 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 25.1 t . . . . . 0 N--CA 1.455 -0.207 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.677 178.846 . . . . . . . . 0 0 . 1 . 065 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . 0.544 ' OE1' ' NH2' ' A' ' 93' ' ' ARG . 97.8 mt-10 . . . . . 0 N--CA 1.456 -0.155 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 . . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 76.3 mt -114.51 128.98 71.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.178 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 54.4 t -126.85 133.9 67.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.137 0.494 . . . . 0.0 110.973 -179.203 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -96.38 120.36 36.54 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.99 -179.299 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -64.07 -42.72 96.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.533 0.682 . . . . 0.0 110.045 179.24 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . 0.534 ' N ' HE21 ' B' ' 265' ' ' GLN . 0.0 OUTLIER -103.26 171.52 5.09 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.006 -178.604 . . . . . . . . 3 3 . 1 . 065 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -54.52 149.73 37.79 Favored 'Trans proline' 0 N--CA 1.501 1.953 0 C-N-CA 123.143 2.562 . . . . 0.0 114.154 -179.728 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 33.0 pt . . . . . 0 C--O 1.232 0.178 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.001 179.907 . . . . . . . . 0 0 . 1 . 066 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 68.2 p . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.952 0.406 . . . . 0.0 110.543 . . . . . . . . . 0 0 . 1 . 066 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.549 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 95.1 mtt-85 -95.5 122.11 37.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.128 -179.644 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.411 ' NE ' ' OE1' ' A' ' 98' ' ' GLU . 31.1 ptt180 -138.48 145.34 40.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.072 0.463 . . . . 0.0 111.298 -179.86 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 36.9 tp -118.93 136.47 54.05 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.359 179.007 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.0 t -110.35 131.6 60.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.822 -178.548 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.5 m -93.47 114.73 27.19 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.156 0.503 . . . . 0.0 112.12 -179.144 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 45.7 mm -79.63 144.93 10.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.611 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -90.52 158.92 16.77 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.181 178.595 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.55 ' NE ' ' NH2' ' B' ' 245' ' ' ARG . 84.7 mtp180 -54.87 -27.84 45.6 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.801 -178.825 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 85.9 p -79.19 -10.71 59.89 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 120.876 -0.329 . . . . 0.0 111.626 179.982 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.69 33.36 7.96 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 -179.223 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.6 t -120.6 134.61 63.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.87 0.367 . . . . 0.0 110.969 -179.531 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -71.22 129.28 38.49 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.818 179.58 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -125.35 -121.53 2.54 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.527 -179.076 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.21 144.62 42.13 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.16 1.907 . . . . 0.0 113.019 -178.104 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 59.2 m170 -104.22 145.78 29.73 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.647 -179.443 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -116.21 91.37 32.19 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.992 -179.924 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -60.35 125.36 17.26 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 121.779 1.652 . . . . 0.0 111.135 179.52 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.0 mt -84.48 50.51 1.9 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.292 -178.762 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.4 p -61.21 -23.69 65.8 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.962 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.3 mt -83.53 141.84 31.33 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.173 -179.832 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.2 m -67.25 -17.84 64.97 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.834 -178.696 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.74 133.73 40.23 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.252 -0.579 . . . . 0.0 112.029 -178.977 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.5 t -128.19 119.96 26.29 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.25 179.207 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 38.5 tp -111.75 128.54 56.12 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.88 -178.938 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.478 ' O ' ' O ' ' A' ' 47' ' ' GLN . 57.6 m-85 -108.35 134.86 50.57 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.329 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 156.83 -170.7 34.25 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 119.904 -1.141 . . . . 0.0 112.449 179.344 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.603 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 10.4 mtp180 -85.6 -31.45 22.61 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -179.779 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -51.45 155.45 3.77 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 -178.648 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.489 ' CD1' HH12 ' A' ' 38' ' ' ARG . 1.1 tp -66.16 -42.69 91.66 Favored 'Isoleucine or valine' 0 C--N 1.34 0.195 0 CA-C-N 117.149 0.475 . . . . 0.0 111.01 -179.707 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.406 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 73.6 mm-40 -58.06 -16.82 14.27 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.409 -179.64 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 68.6 m -59.8 120.34 9.36 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.838 -179.485 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -60.89 -32.27 71.73 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.73 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.425 HG13 ' CE2' ' A' ' 29' ' ' PHE . 48.9 mm -120.13 113.77 41.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.554 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.489 HH12 ' CD1' ' A' ' 33' ' ' ILE . 77.4 mtt180 -101.06 132.77 46.33 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.028 -0.669 . . . . 0.0 111.287 -177.876 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 95.9 mt -123.73 129.85 74.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.283 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -83.56 43.74 0.92 Allowed 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -176.98 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.578 ' CD1' ' CZ ' ' A' ' 93' ' ' ARG . 39.9 mt -109.4 126.58 28.91 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 120.403 -0.519 . . . . 0.0 111.781 179.885 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -68.86 -13.84 37.63 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.174 1.916 . . . . 0.0 112.779 179.709 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.2 m -90.68 4.43 6.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.891 0.377 . . . . 0.0 110.701 179.996 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.603 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 54.7 t -107.03 136.43 42.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.23 -179.698 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.3 m -70.68 168.31 16.8 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.527 0.68 . . . . 0.0 111.281 -179.386 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.5 mttm -62.07 -38.77 90.06 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.109 -179.293 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.708 ' O ' ' N ' ' A' ' 49' ' ' CYS . 99.0 mt-30 -109.58 -14.98 14.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.532 -179.077 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 23.5 t60 37.13 -72.75 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -179.836 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.708 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -151.69 151.92 32.09 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.997 179.943 . . . . . . . . 3 3 . 1 . 066 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -138.36 143.57 39.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.96 -179.96 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.8 mt -114.39 133.06 61.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.483 179.934 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -114.67 124.58 52.18 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.494 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.4 mt -105.89 118.59 53.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -177.356 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.423 ' O ' ' C ' ' A' ' 55' ' ' GLU . 97.7 m-70 -112.97 138.43 49.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.267 -1.333 . . . . 0.0 108.718 178.055 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 54' ' ' HIS . 94.8 mt-10 -39.47 -35.67 0.31 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.186 0.517 . . . . 0.0 109.807 -178.822 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -60.26 -68.17 0.32 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.649 179.071 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.522 ' CD ' ' NH1' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -151.99 -171.26 3.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.11 0.481 . . . . 0.0 111.063 179.523 . . . . . . . . 3 3 . 1 . 066 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.04 129.15 55.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.398 179.505 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.4 mt -116.84 129.14 73.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.234 0.54 . . . . 0.0 112.39 -178.555 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 25.4 tp -98.38 128.29 44.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.439 179.669 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -112.84 134.61 54.27 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.151 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.648 HD22 ' CB ' ' A' ' 68' ' ' PRO . 61.6 t-20 -98.4 109.59 22.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.925 -178.429 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -98.71 -3.89 34.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.094 179.726 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.1 t -92.8 110.36 21.8 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.085 -179.274 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 56.3 p -93.59 -28.75 15.85 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.577 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.447 ' O ' ' OD1' ' A' ' 67' ' ' ASN . 0.3 OUTLIER -65.52 -43.68 89.29 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.834 179.734 . . . . . . . . 3 3 . 1 . 066 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.447 ' OD1' ' O ' ' A' ' 66' ' ' THR . 33.2 m-20 -149.2 103.91 3.33 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.884 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.648 ' CB ' HD22 ' A' ' 62' ' ' ASN . 68.0 Cg_endo -71.03 158.21 55.83 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 121.657 1.571 . . . . 0.0 113.337 -177.424 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.1 m -73.04 140.03 46.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.296 179.656 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.539 ' O ' ' N ' ' A' ' 89' ' ' THR . 89.3 mt-30 -102.76 142.42 33.94 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.34 -179.507 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.566 ' CG2' ' OD1' ' A' ' 86' ' ' ASP . 8.9 p -132.04 138.63 52.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.766 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 50.39 31.81 5.78 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 -179.616 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.68 30.03 64.63 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.493 179.962 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 65.6 m -140.7 136.35 32.53 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 117.151 0.475 . . . . 0.0 111.847 -179.235 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.8 t -63.8 137.2 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.732 179.758 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.551 ' CG2' ' O ' ' A' ' 78' ' ' GLU . 92.6 mt -101.91 110.87 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 178.631 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.474 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 18.6 p-10 -75.45 -37.15 60.52 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.13 179.546 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.551 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.8 OUTLIER -133.15 -177.95 0.78 Allowed Pre-proline 0 N--CA 1.465 0.316 0 CA-C-O 120.895 0.379 . . . . 0.0 111.823 -178.938 . . . . . . . . 3 3 . 1 . 066 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.516 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 32.5 Cg_exo -59.51 144.78 99.33 Favored 'Trans proline' 0 N--CA 1.499 1.822 0 C-N-CA 122.84 2.36 . . . . 0.0 112.545 -179.653 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 23.5 m -142.22 141.39 28.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.566 -179.627 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.522 ' NH1' ' CD ' ' A' ' 57' ' ' GLU . 96.7 mtt-85 -74.97 136.71 41.31 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.785 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 97.7 mt -92.31 136.43 33.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.461 0.648 . . . . 0.0 111.173 -179.579 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -125.31 155.53 40.08 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.824 179.965 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.455 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 10.4 t60 -57.43 121.88 11.28 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.954 -179.451 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.21 -22.44 20.59 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.962 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.566 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 64.9 t0 -64.32 131.27 46.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.712 0.292 . . . . 0.0 110.835 179.656 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.503 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 39.7 t -108.88 130.86 61.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.906 -179.463 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.5 mt -91.46 128.88 42.93 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.165 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.539 ' N ' ' O ' ' A' ' 70' ' ' GLN . 53.3 m -123.78 125.51 44.85 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.677 0.751 . . . . 0.0 112.002 -178.853 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 95.2 mt -115.97 123.0 70.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.588 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.444 HD11 HH22 ' A' ' 93' ' ' ARG . 96.6 mt 43.53 -102.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.934 -178.768 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.62 ' OD1' ' NH1' ' A' ' 93' ' ' ARG . 46.0 p-10 -118.39 14.67 13.8 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.166 0.508 . . . . 0.0 110.972 179.938 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.62 ' NH1' ' OD1' ' A' ' 92' ' ' ASP . 51.2 mtm-85 -122.57 143.76 49.53 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.533 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 29.0 p -139.63 153.01 47.23 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 119.499 -0.881 . . . . 0.0 111.732 -179.137 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -122.51 120.78 34.87 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 114.786 -1.097 . . . . 0.0 108.686 178.906 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 44.4 ttm180 -82.85 128.7 34.66 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.144 -0.622 . . . . 0.0 111.455 -178.657 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.549 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 83.3 t80 -97.78 127.95 44.08 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.92 179.736 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.411 ' OE1' ' NE ' ' A' ' 6' ' ' ARG . 98.2 mt-10 -130.7 123.78 30.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.048 179.637 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.455 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 63.8 t-20 . . . . . 0 C--N 1.327 -0.386 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.028 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo . . . . . 0 N--CA 1.49 1.304 0 CA-C-O 121.798 0.666 . . . . 0.0 113.494 . . . . . . . . . 0 0 . 1 . 066 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . 0.407 ' HA ' HD22 ' A' ' 67' ' ' ASN . 23.0 t -57.44 140.81 15.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.843 -179.067 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 49.0 t . . . . . 0 C--N 1.331 -0.211 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.599 . . . . . . . . 0 0 . 1 . 066 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo . . . . . 0 N--CA 1.498 1.767 0 N-CA-C 113.406 0.502 . . . . 0.0 113.406 . . . . . . . . . 0 0 . 1 . 066 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 16.9 m -73.13 -47.7 41.83 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 119.953 -0.699 . . . . 0.0 109.394 178.972 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -57.49 -44.84 85.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.192 179.911 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 92.9 mt -65.32 -39.1 92.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.811 179.816 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -62.87 -42.15 99.65 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.296 -179.053 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . 0.48 ' O ' ' OG ' ' B' ' 247' ' ' SER . 95.1 mtm-85 -62.84 -42.23 99.65 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.231 -179.429 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.55 ' NH2' ' NE ' ' A' ' 12' ' ' ARG . 77.2 mtp85 -63.54 -40.57 97.37 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.5 -0.48 . . . . 0.0 112.095 -179.33 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.42 -38.84 88.56 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 120.205 -0.598 . . . . 0.0 109.682 179.658 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' B' B ' 247' ' ' SER . . . . . 0.48 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 70.7 p -67.17 -42.5 84.16 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 177.959 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 75.5 mm-40 -62.7 -33.1 74.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.757 179.641 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 37.5 t . . . . . 0 N--CA 1.453 -0.308 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.978 179.583 . . . . . . . . 0 0 . 1 . 066 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 35.3 tp10 . . . . . 0 CA--C 1.534 0.335 0 N-CA-C 111.552 0.205 . . . . 0.0 111.552 . . . . . . . . . 0 0 . 1 . 066 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 63.5 mt -111.97 135.85 49.98 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 CA-C-O 120.811 0.339 . . . . 0.0 110.517 -179.719 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 38.2 t -127.63 134.2 66.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.053 179.447 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -96.69 121.02 38.07 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.991 0.424 . . . . 0.0 111.544 -178.597 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -65.15 -48.09 74.76 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.711 179.583 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -95.63 157.87 35.37 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.286 -178.891 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -64.47 154.67 70.48 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 123.209 2.606 . . . . 0.0 112.575 178.987 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 36.0 pt . . . . . 0 C--N 1.332 -0.156 0 CA-C-O 121.594 0.711 . . . . 0.0 112.401 -179.346 . . . . . . . . 0 0 . 1 . 067 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.9 p . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.739 0.304 . . . . 0.0 111.414 . . . . . . . . . 0 0 . 1 . 067 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.693 ' NE ' ' CZ ' ' A' ' 97' ' ' TYR . 2.6 mmp_? -90.9 118.2 30.11 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.781 -178.805 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.6 mtp180 -129.08 137.1 51.06 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.202 0.525 . . . . 0.0 111.541 179.522 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 22.6 tp -114.49 131.05 56.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.268 179.807 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 76.6 t -108.91 130.89 61.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.072 -179.602 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.6 m -77.71 142.93 38.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.683 -179.341 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.439 ' CD1' ' OD1' ' A' ' 16' ' ' ASP . 50.4 mm -111.11 136.16 48.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.954 178.85 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -89.91 155.64 18.99 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.53 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.494 ' HD3' HH21 ' B' ' 245' ' ' ARG . 89.7 mtm180 -59.78 -24.45 64.1 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.039 -178.951 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.4 p -82.97 -6.97 59.7 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.447 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.77 38.11 7.65 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 179.691 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.6 t -122.84 133.63 68.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.662 0.267 . . . . 0.0 110.565 179.533 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.439 ' OD1' ' CD1' ' A' ' 10' ' ' ILE . 90.9 m-20 -73.7 135.15 43.66 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.271 179.64 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -124.84 -121.57 2.57 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 120.596 -0.811 . . . . 0.0 111.897 -179.633 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.59 145.32 41.69 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.139 1.892 . . . . 0.0 112.888 -178.709 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -104.56 143.76 32.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.711 179.995 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.417 ' CD2' HD13 ' A' ' 37' ' ' ILE . 38.7 t80 -115.36 107.21 49.69 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.19 179.374 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -74.78 127.5 10.89 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 121.373 1.382 . . . . 0.0 111.758 -179.159 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 82.2 mt -84.12 48.81 1.53 Allowed 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.29 -179.383 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 93.6 p -60.72 -25.36 66.37 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.467 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 66.8 mt -76.04 139.02 41.24 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.383 179.986 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.2 m -63.21 -19.25 64.35 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.286 -179.489 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.467 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 22.8 m -136.81 135.0 37.58 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.478 -179.723 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.9 t -126.43 118.49 25.08 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.058 0.456 . . . . 0.0 110.182 178.104 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 53.5 tp -114.17 132.42 56.09 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.121 -179.016 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.515 ' O ' ' O ' ' A' ' 47' ' ' GLN . 34.1 m-85 -112.04 137.34 50.2 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.376 -179.341 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 152.93 -177.96 30.3 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.304 179.17 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 45.4 mtm180 -70.6 -32.03 69.25 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 179.772 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.568 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -51.79 148.04 10.64 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 121.133 -0.556 . . . . 0.0 112.477 -178.084 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.444 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 11.0 tp -66.71 -41.47 88.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 120.886 0.374 . . . . 0.0 110.152 179.315 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.444 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 77.5 tt0 -57.33 -24.08 52.83 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.497 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.568 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 16.5 m -56.6 120.36 7.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.93 179.343 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.467 ' OD2' ' O ' ' A' ' 26' ' ' THR . 95.7 m-20 -61.87 -25.5 67.58 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.537 0.684 . . . . 0.0 109.155 -179.692 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.417 HD13 ' CD2' ' A' ' 20' ' ' PHE . 39.5 mm -126.88 117.11 46.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.888 178.848 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 62.0 mtm180 -104.1 135.24 45.96 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.614 -179.871 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.2 mt -120.13 127.95 75.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.521 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -75.05 34.58 0.1 Allowed 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -177.108 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.414 HD11 ' NH2' ' B' ' 245' ' ' ARG . 96.2 mt -103.37 127.88 28.71 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.986 179.588 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.79 -9.83 24.23 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.491 2.128 . . . . 0.0 112.197 -179.915 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.8 m -96.77 9.96 6.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.613 179.818 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 20.1 t -103.31 135.72 39.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.428 179.71 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.501 ' OG ' ' OG ' ' A' ' 64' ' ' SER . 13.2 m -70.04 170.15 11.98 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.357 0.599 . . . . 0.0 111.048 -179.895 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -64.3 -40.16 95.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.698 -179.685 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.616 ' O ' ' N ' ' A' ' 49' ' ' CYS . 69.5 mm-40 -110.07 -25.07 10.42 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.131 0.491 . . . . 0.0 110.676 -179.158 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.5 t60 40.08 -74.69 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 179.119 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.616 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.48 136.86 45.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.406 0.622 . . . . 0.0 112.396 -177.834 . . . . . . . . 3 3 . 1 . 067 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -127.1 128.05 45.61 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.938 179.011 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.8 mt -116.85 134.59 59.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.84 -179.737 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -115.75 135.8 53.68 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.662 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 49.9 mm -102.08 114.2 40.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 120.169 -0.613 . . . . 0.0 110.62 -179.945 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -115.4 134.39 55.14 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.078 179.01 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -42.13 -32.9 0.51 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.01 -179.487 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -63.04 -66.23 0.57 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.739 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -157.69 -160.33 0.92 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.131 179.671 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -121.29 133.83 55.14 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.561 -179.926 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.9 mt -118.27 128.48 75.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.266 0.555 . . . . 0.0 112.099 -179.265 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.4 tp -95.69 125.01 39.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.623 179.575 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -112.02 136.06 51.85 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.69 0.281 . . . . 0.0 110.444 -179.794 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.752 ' ND2' ' H ' ' A' ' 69' ' ' THR . 21.2 t-20 -97.88 107.7 20.24 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.529 -179.808 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -98.66 -10.65 22.95 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.222 179.37 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.501 ' OG ' ' OG ' ' A' ' 45' ' ' SER . 0.1 OUTLIER -80.73 97.96 7.53 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.233 179.954 . . . . . . . . 3 3 . 1 . 067 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.0 p -71.67 -32.56 68.01 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.78 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.0 m -64.0 -47.07 81.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.504 -178.956 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -141.99 97.41 6.42 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.888 -178.984 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -56.06 146.76 68.09 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.009 1.806 . . . . 0.0 111.63 179.696 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.752 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 6.7 m -73.91 146.16 44.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.291 0.567 . . . . 0.0 111.151 -179.698 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -104.81 140.9 37.43 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.996 179.791 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.499 ' O ' ' OG ' ' A' ' 74' ' ' SER . 43.0 t -129.02 135.53 61.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.214 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 51.94 33.48 11.77 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.209 -0.596 . . . . 0.0 109.533 -179.733 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.33 29.84 71.71 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.431 179.703 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.499 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 16.5 p -141.55 136.14 30.83 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.754 0.311 . . . . 0.0 110.895 179.987 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.1 p -68.42 139.14 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 CA-C-O 121.083 0.468 . . . . 0.0 111.678 -179.753 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.7 109.45 21.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.092 179.492 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -90.46 -17.55 26.93 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.845 -179.201 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -116.01 164.88 16.2 Favored Pre-proline 0 N--CA 1.469 0.505 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.824 179.77 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -56.78 142.97 91.93 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 C-N-CA 121.59 1.526 . . . . 0.0 111.562 179.296 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.0 p -139.9 138.91 38.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.983 0.42 . . . . 0.0 110.989 -178.909 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.2 mtm180 -77.94 133.03 38.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.482 -179.982 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 93.4 mt -86.72 139.84 30.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.143 0.497 . . . . 0.0 111.074 -179.445 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -133.31 155.51 49.3 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.697 -179.501 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.496 ' CE1' ' O ' ' A' ' 99' ' ' ASN . 3.4 t-160 -55.36 113.3 1.36 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.899 -179.458 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.66 -17.54 18.12 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 121.068 -0.587 . . . . 0.0 111.921 179.475 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -70.94 133.3 46.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.998 0.428 . . . . 0.0 110.371 -179.901 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.418 ' CG2' ' OG ' ' A' ' 94' ' ' SER . 14.2 p -107.87 132.76 54.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.008 -179.217 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 91.3 mt -97.68 130.3 46.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.372 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 51.6 m -122.14 126.23 47.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.735 0.779 . . . . 0.0 112.561 -178.417 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.491 ' O ' ' N ' ' A' ' 92' ' ' ASP . 80.7 mt -113.04 120.07 62.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 114.509 -1.223 . . . . 0.0 108.186 178.661 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.41 ' C ' ' O ' ' A' ' 90' ' ' ILE . 57.1 mt 38.09 -92.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.715 -0.221 . . . . 0.0 111.144 -179.533 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 90' ' ' ILE . 10.3 t0 -119.35 14.75 12.95 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.572 -179.254 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.42 ' HG2' HH11 ' A' ' 93' ' ' ARG . 79.6 mtt-85 -128.89 146.73 50.86 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.148 179.726 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.418 ' OG ' ' CG2' ' A' ' 87' ' ' VAL . 12.8 t -139.45 153.98 47.67 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.651 0.739 . . . . 0.0 111.701 -179.73 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -126.65 121.88 33.39 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.109 179.061 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -82.42 131.29 35.22 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.226 -178.944 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.693 ' CZ ' ' NE ' ' A' ' 5' ' ' ARG . 67.5 t80 -92.25 121.39 33.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.031 179.95 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.463 ' C ' ' NH2' ' A' ' 5' ' ' ARG . 93.5 mt-10 -126.57 131.37 51.55 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -177.886 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.61 ' CG ' HH12 ' A' ' 5' ' ' ARG . 63.1 t-20 . . . . . 0 C--N 1.333 -0.119 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.179 178.591 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo . . . . . 0 N--CA 1.483 0.909 0 CA-C-O 121.222 0.426 . . . . 0.0 112.621 . . . . . . . . . 0 0 . 1 . 067 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 31.4 m -59.25 142.74 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.618 -179.72 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 2.4 t . . . . . 0 C--N 1.322 -0.604 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.789 179.926 . . . . . . . . 0 0 . 1 . 067 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo . . . . . 0 N--CA 1.494 1.548 0 N-CA-C 113.039 0.361 . . . . 0.0 113.039 . . . . . . . . . 0 0 . 1 . 067 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 26.2 p -74.16 -40.02 62.85 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 120.421 -0.511 . . . . 0.0 109.696 178.401 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -59.96 -46.67 88.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.109 -179.358 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 90.6 mt -65.25 -41.43 94.32 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -179.561 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -65.47 -40.62 93.37 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.422 -179.374 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . 0.489 ' O ' ' OG ' ' B' ' 247' ' ' SER . 82.3 mtp180 -62.04 -42.71 99.46 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.52 -179.886 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.494 HH21 ' HD3' ' A' ' 12' ' ' ARG . 85.3 mtp180 -65.9 -39.95 91.07 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.579 -179.912 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -62.16 -40.81 97.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.167 0.508 . . . . 0.0 110.106 178.887 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' B' B ' 247' ' ' SER . . . . . 0.489 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 73.5 p -66.19 -41.69 89.85 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.463 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -61.27 -36.19 79.36 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.116 179.431 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 27.8 t . . . . . 0 C--N 1.326 -0.449 0 C-N-CA 120.166 -0.614 . . . . 0.0 109.49 178.769 . . . . . . . . 0 0 . 1 . 067 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 . . . . . 0 N--CA 1.462 0.152 0 CA-C-O 120.558 0.218 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 067 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 68.2 mt -115.62 136.99 50.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -179.312 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 55.2 t -124.89 132.56 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 121.102 0.477 . . . . 0.0 110.769 -179.837 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -94.6 118.45 31.71 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.875 -179.101 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -64.23 -46.53 83.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.273 179.974 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -97.2 158.79 32.67 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.417 -179.3 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -65.94 149.2 86.44 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 123.486 2.791 . . . . 0.0 113.664 -179.716 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 42.3 pt . . . . . 0 CA--C 1.529 0.163 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.3 179.014 . . . . . . . . 0 0 . 1 . 068 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.7 m . . . . . 0 N--CA 1.457 -0.079 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 . . . . . . . . . 0 0 . 1 . 068 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 86.0 mtt85 -90.57 127.54 36.29 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -177.677 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.5 mtp180 -127.88 136.84 51.94 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.207 179.982 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 43.3 tp -114.79 135.2 54.45 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 179.55 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.8 t -113.85 129.65 69.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.281 -179.404 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.4 m -93.61 112.61 24.53 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -178.209 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.587 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 97.0 mt -78.22 144.4 11.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 177.419 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.468 ' C ' HH12 ' A' ' 93' ' ' ARG . 96.6 mttt -91.83 165.99 12.97 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 119.841 -0.744 . . . . 0.0 109.915 178.584 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.749 HH11 HH11 ' B' ' 245' ' ' ARG . 86.2 mtm180 -57.51 -27.95 63.03 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.635 -178.769 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.7 m -79.21 -10.47 59.83 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.433 -179.522 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.61 25.66 19.99 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.018 179.551 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.5 m -117.58 138.83 46.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.597 179.803 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -64.56 127.36 31.21 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.059 -179.717 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -114.88 -128.55 4.51 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 121.146 -0.55 . . . . 0.0 112.054 -179.062 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -75.67 148.84 33.28 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.416 2.077 . . . . 0.0 112.29 -179.14 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -102.77 165.37 11.1 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.6 -179.933 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -139.57 103.74 7.06 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.325 -179.778 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -72.45 126.7 11.81 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 121.446 1.431 . . . . 0.0 111.566 -178.757 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 69.2 mt -85.27 50.75 2.01 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.722 -178.924 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 99.1 p -60.4 -28.63 68.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.1 179.778 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.1 mt -74.61 143.12 44.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.359 -179.732 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 91.5 p -63.91 -17.39 63.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.907 -178.484 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.405 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 31.9 m -133.55 133.54 42.24 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.135 179.857 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.4 t -124.81 116.72 22.73 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.443 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.401 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 36.0 tp -113.98 126.26 54.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.139 -179.218 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.491 ' O ' ' O ' ' A' ' 47' ' ' GLN . 12.7 m-85 -104.88 137.96 41.86 Favored 'General case' 0 C--N 1.334 -0.091 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.652 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 175.57 -174.21 46.71 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 119.95 -1.119 . . . . 0.0 112.011 179.66 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 27.9 ttp85 -91.59 -16.12 27.59 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.623 -0.288 . . . . 0.0 111.263 179.843 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -81.7 154.35 34.1 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 121.068 -0.587 . . . . 0.0 111.782 -179.43 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.409 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 10.5 tp -66.46 -41.67 89.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.754 0.311 . . . . 0.0 110.459 179.436 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.409 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 80.7 tt0 -50.3 -18.65 0.65 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.912 0.387 . . . . 0.0 110.106 -179.613 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.425 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 82.3 m -73.83 140.72 45.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.207 179.685 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.405 ' OD2' ' O ' ' A' ' 26' ' ' THR . 94.6 m-20 -60.48 -32.78 71.74 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -179.552 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 84.1 mt -126.95 122.5 60.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 176.559 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 67.8 ttp85 -106.36 133.56 50.86 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.461 -179.476 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.458 ' C ' ' H ' ' A' ' 41' ' ' LEU . 79.7 mt -114.37 131.71 65.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.71 -179.55 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -74.5 25.37 0.08 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.962 -178.281 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.458 ' H ' ' C ' ' A' ' 39' ' ' ILE . 50.5 mt -100.29 128.21 31.08 Favored Pre-proline 0 C--N 1.326 -0.427 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.407 179.144 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -73.1 -9.2 23.18 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.347 2.031 . . . . 0.0 111.858 179.678 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.2 m -92.18 5.46 6.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.656 179.829 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 36.1 t -96.84 131.8 42.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.2 179.574 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.9 t -70.17 173.02 7.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.26 -179.052 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.425 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 64.2 mttp -62.77 -42.21 99.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.814 -179.529 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.65 ' O ' ' N ' ' A' ' 49' ' ' CYS . 99.5 mt-30 -114.33 -18.23 11.61 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.203 -179.399 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.4 t60 35.14 -76.53 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 179.8 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.65 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.42 134.58 47.22 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.157 0.503 . . . . 0.0 111.956 -178.521 . . . . . . . . 3 3 . 1 . 068 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -127.16 134.07 50.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.849 -179.966 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.6 mt -119.68 133.42 66.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.96 -179.749 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -108.77 127.48 54.04 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.591 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.7 mm -101.35 115.44 43.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 119.995 -0.682 . . . . 0.0 111.33 -178.726 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.469 ' O ' ' C ' ' A' ' 55' ' ' GLU . 95.8 m-70 -119.1 134.13 55.38 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.731 179.155 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.469 ' C ' ' O ' ' A' ' 54' ' ' HIS . 84.9 tt0 -40.75 -30.71 0.13 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.91 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.453 ' N ' ' C ' ' A' ' 54' ' ' HIS . 94.1 mm-40 -66.19 -68.63 0.36 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.034 178.705 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.53 ' OE1' ' CZ ' ' A' ' 81' ' ' ARG . 2.0 pt-20 -153.92 -172.99 4.41 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.334 -178.823 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -116.46 128.0 55.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.622 179.313 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.2 mt -115.8 130.48 70.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.296 0.57 . . . . 0.0 112.023 -178.279 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 23.4 tp -97.43 129.03 44.68 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.09 179.876 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -113.19 137.04 52.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.882 -179.644 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 62.0 t-20 -93.56 105.62 17.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.468 -179.132 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -101.96 -10.59 19.65 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.324 179.319 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 60.4 p -72.99 102.41 3.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.603 179.742 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.7 p -82.11 -19.0 41.02 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.677 179.742 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.98 -41.29 14.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.001 -179.077 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.443 ' O ' ' OG ' ' A' ' 64' ' ' SER . 47.3 m-20 -143.32 106.93 5.18 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.36 -179.47 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -56.49 143.4 87.8 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 121.606 1.537 . . . . 0.0 112.142 -179.927 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.8 m -69.85 137.35 51.65 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.726 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -97.82 138.34 35.33 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.997 -179.761 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.9 t -133.93 134.52 55.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.994 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 9.9 m120 52.97 30.03 8.76 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 -178.836 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.34 27.49 69.71 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.134 -179.513 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.4 t -140.48 138.82 34.93 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.906 0.384 . . . . 0.0 111.756 -179.606 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.2 m -73.82 141.69 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.996 -179.97 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 10.3 pt -108.36 96.39 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 121.238 0.542 . . . . 0.0 111.462 179.67 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -64.39 -35.62 81.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.777 179.263 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -121.48 171.77 5.72 Favored Pre-proline 0 CA--C 1.533 0.301 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.989 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -60.08 147.25 93.84 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.165 1.91 . . . . 0.0 111.917 179.854 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.9 p -139.2 141.99 34.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.376 0.608 . . . . 0.0 111.755 -179.512 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.53 ' CZ ' ' OE1' ' A' ' 57' ' ' GLU . 79.5 ttt180 -74.78 128.66 36.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.176 179.224 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.2 mt -79.91 135.35 36.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.026 0.441 . . . . 0.0 110.897 -179.888 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -124.47 147.79 48.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.733 179.203 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.557 ' ND1' ' OD1' ' A' ' 99' ' ' ASN . 10.5 t60 -53.36 122.48 9.71 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.005 -179.074 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.93 -16.91 42.54 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.976 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -66.76 135.25 53.69 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.483 -0.487 . . . . 0.0 109.821 179.77 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 53.2 t -109.84 131.93 59.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.011 -178.305 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.1 mt -98.98 130.93 47.14 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.426 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.1 m -121.29 127.52 51.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.632 0.729 . . . . 0.0 112.226 -178.722 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.646 ' O ' ' N ' ' A' ' 93' ' ' ARG . 97.6 mt -119.93 125.21 74.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 178.001 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.525 ' C ' ' O ' ' A' ' 90' ' ' ILE . 62.2 mt -11.15 97.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -178.129 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 78.17 -9.71 1.47 Allowed 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 177.938 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.72 HH12 ' N ' ' A' ' 12' ' ' ARG . 20.0 mmm180 -130.09 133.07 46.42 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.669 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 89.0 p -138.54 153.5 48.73 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.176 179.299 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -130.03 132.23 46.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.268 -179.324 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 92.0 mtm-85 -88.51 130.39 35.24 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.539 -179.825 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -95.58 126.49 40.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.502 -179.452 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -134.8 118.13 16.69 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.192 179.489 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.557 ' OD1' ' ND1' ' A' ' 84' ' ' HIS . 53.4 p-10 . . . . . 0 C--N 1.332 -0.175 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.336 -179.489 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo . . . . . 0 N--CA 1.494 1.535 0 N-CA-C 114.032 0.743 . . . . 0.0 114.032 . . . . . . . . . 0 0 . 1 . 068 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 68.0 t -63.65 135.42 27.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.483 179.097 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 2.0 t . . . . . 0 C--N 1.328 -0.367 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.294 -179.842 . . . . . . . . 0 0 . 1 . 068 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo . . . . . 0 N--CA 1.496 1.619 0 CA-C-O 120.63 0.179 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 068 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 21.6 p -76.37 -45.63 31.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.897 0.379 . . . . 0.0 110.39 179.035 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -58.9 -48.41 81.53 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.32 -178.742 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 80.1 mt -65.45 -42.11 92.69 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.09 -179.892 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -61.28 -43.64 98.53 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.555 -178.87 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 77.0 ttt-85 -63.41 -43.68 96.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.903 0.382 . . . . 0.0 111.312 -179.14 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.749 HH11 HH11 ' A' ' 12' ' ' ARG . 52.8 ttm-85 -64.08 -40.52 96.43 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.862 -179.262 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -60.13 -36.99 78.74 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.744 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 20.2 m -66.15 -42.8 88.54 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 177.189 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . 0.516 ' CD ' HH12 ' A' ' 12' ' ' ARG . 56.7 tt0 -60.27 -34.36 73.61 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.097 179.662 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 55.7 t . . . . . 0 N--CA 1.454 -0.234 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.118 178.974 . . . . . . . . 0 0 . 1 . 068 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 . . . . . 0 CA--C 1.531 0.242 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 . . . . . . . . . 0 0 . 1 . 068 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . 0.643 ' CD1' HH21 ' A' ' 93' ' ' ARG . 42.5 mt -110.17 138.3 38.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.101 -179.811 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 43.0 t -125.61 132.33 71.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.005 0.431 . . . . 0.0 110.221 179.262 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -96.39 120.52 36.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.877 -178.94 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -66.01 -47.32 74.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.387 -179.315 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.8 151.99 44.22 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.445 -179.018 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -64.55 147.71 90.34 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.754 2.303 . . . . 0.0 112.31 179.613 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.1 pt . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.448 179.82 . . . . . . . . 0 0 . 1 . 069 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 99.2 m . . . . . 0 N--CA 1.461 0.112 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 . . . . . . . . . 0 0 . 1 . 069 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.722 ' NH1' ' HH ' ' A' ' 97' ' ' TYR . 95.5 mtt-85 -88.04 128.85 35.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.671 -178.579 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -129.33 140.37 51.42 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 120.471 -0.492 . . . . 0.0 112.13 -179.242 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 34.0 tp -116.25 134.38 54.97 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.843 178.966 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.3 t -110.78 130.83 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.016 -179.945 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 m -94.14 116.86 29.32 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.678 -178.77 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.458 ' CD1' ' HG ' ' A' ' 94' ' ' SER . 96.8 mt -80.18 143.55 12.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.32 179.061 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -91.22 158.88 16.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.022 0.439 . . . . 0.0 110.268 178.637 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.811 HH12 ' NE2' ' B' ' 248' ' ' GLN . 80.9 mtp180 -58.2 -32.07 67.93 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.539 -179.854 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.2 m -77.23 -9.95 59.11 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.006 -179.947 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.71 33.67 7.33 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.446 -0.662 . . . . 0.0 111.446 179.877 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.0 t -119.57 134.22 63.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.733 0.301 . . . . 0.0 110.79 -179.823 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -63.17 122.41 16.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.26 179.942 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -106.89 -139.58 9.38 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.553 -179.266 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.79 155.49 62.43 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.215 1.944 . . . . 0.0 112.082 -179.164 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -107.29 146.8 31.06 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.975 -179.05 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -115.16 101.68 54.52 Favored Pre-proline 0 CA--C 1.536 0.437 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.898 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.72 131.78 17.7 Favored 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 121.398 1.399 . . . . 0.0 111.475 -179.392 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 83.4 mt -86.48 52.44 2.5 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 119.961 -0.695 . . . . 0.0 111.197 -178.44 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.8 p -61.8 -29.87 70.43 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.797 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 67.5 mt -79.06 142.45 36.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.187 179.757 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 72.6 p -66.39 -20.17 66.0 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.969 -0.293 . . . . 0.0 111.713 -179.494 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.416 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 53.2 m -127.04 128.9 47.03 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.292 0.568 . . . . 0.0 112.011 -179.633 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.545 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 11.8 t -123.57 113.54 18.85 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.774 178.697 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.565 ' O ' ' N ' ' A' ' 36' ' ' ASP . 63.4 tp -110.42 125.33 53.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.185 0.517 . . . . 0.0 110.786 -179.555 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.545 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 4.5 m-85 -107.06 140.02 40.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.282 179.583 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 170.38 -160.22 32.88 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.377 179.388 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 27.4 ptt-85 -107.22 -8.92 16.25 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.411 179.817 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.478 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -85.37 167.24 40.93 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.286 -179.945 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.495 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 10.9 tp -67.29 -42.41 87.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.719 0.295 . . . . 0.0 110.779 -179.814 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.495 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 78.4 mm-40 -53.14 -25.55 13.76 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.144 0.497 . . . . 0.0 110.021 -178.908 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.478 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 3.7 m -62.38 124.21 20.32 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.402 179.521 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.565 ' N ' ' O ' ' A' ' 28' ' ' LEU . 63.7 m-20 -58.54 -29.03 66.02 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -179.055 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.459 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 93.6 mt -126.56 122.32 60.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 176.237 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 72.0 ttp85 -106.57 135.81 47.44 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.116 -178.511 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 98.6 mt -115.68 129.1 72.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.009 -179.573 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -74.09 31.5 0.08 Allowed 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 -177.918 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.49 ' CG ' HH21 ' A' ' 93' ' ' ARG . 86.2 mt -107.49 135.88 19.67 Favored Pre-proline 0 C--N 1.323 -0.559 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.888 179.539 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.56 -10.13 24.89 Favored 'Trans proline' 0 C--N 1.315 -1.216 0 C-N-CA 122.067 1.845 . . . . 0.0 111.428 179.215 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.7 m -97.22 6.62 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.216 -179.936 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.0 t -92.78 128.48 44.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.045 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 41.2 t -66.71 172.76 3.96 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.51 0.671 . . . . 0.0 111.628 -178.59 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -65.83 -43.24 89.12 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.96 -179.631 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.628 ' O ' ' N ' ' A' ' 49' ' ' CYS . 86.8 mt-30 -119.36 -5.34 10.37 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.847 -179.002 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.503 ' C ' ' O ' ' A' ' 47' ' ' GLN . 17.8 t60 14.05 -73.37 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 -178.852 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.628 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -126.08 129.53 49.29 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 119.716 -0.793 . . . . 0.0 112.876 -179.069 . . . . . . . . 3 3 . 1 . 069 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -126.58 128.66 47.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.013 178.508 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.425 HG22 HD11 ' A' ' 51' ' ' ILE . 97.2 mt -116.41 134.3 60.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.685 -179.292 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -112.18 122.12 46.86 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.603 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.442 HG21 HD13 ' A' ' 53' ' ' ILE . 95.7 mt -101.8 116.49 45.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 119.543 -0.863 . . . . 0.0 111.847 -178.638 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.485 ' O ' ' N ' ' A' ' 56' ' ' GLN . 94.1 m-70 -114.19 141.52 47.43 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.922 -179.828 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.475 ' OE1' ' N ' ' A' ' 55' ' ' GLU . 51.7 mp0 -40.15 -29.37 0.07 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 179.852 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.485 ' N ' ' O ' ' A' ' 54' ' ' HIS . 56.1 tt0 -65.34 -68.14 0.39 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.241 -0.89 . . . . 0.0 108.997 178.192 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.488 ' OE1' ' O ' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -159.53 -166.28 1.74 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.257 0.551 . . . . 0.0 111.868 -179.531 . . . . . . . . 3 3 . 1 . 069 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.488 ' O ' ' OE1' ' A' ' 57' ' ' GLU . . . -112.88 125.48 54.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.313 179.633 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 99.0 mt -116.08 129.55 72.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -177.924 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.414 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 50.9 tp -96.3 128.87 43.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.642 179.706 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -111.57 135.31 52.33 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.74 179.722 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -100.57 106.84 18.39 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -178.749 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -99.89 -1.44 37.36 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.994 179.031 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.46 100.04 12.46 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.404 -179.553 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.0 p -81.7 -15.16 55.35 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.214 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.92 -35.57 14.65 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.213 -179.86 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -150.7 89.0 4.47 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.24 -179.815 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -57.12 148.9 66.46 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.68 2.253 . . . . 0.0 112.717 -179.665 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 38.1 m -71.99 138.37 47.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.324 179.327 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -96.63 144.54 26.58 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.101 -179.664 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.404 ' O ' ' N ' ' A' ' 74' ' ' SER . 3.9 p -127.87 135.74 62.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.956 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 8.3 m120 48.71 31.46 3.06 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.287 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.56 27.44 63.29 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.686 179.87 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 71' ' ' VAL . 21.1 t -136.67 134.53 37.36 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.998 0.399 . . . . 0.0 110.907 179.784 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -60.64 143.95 13.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.342 -179.911 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.536 ' CG2' ' O ' ' A' ' 78' ' ' GLU . 97.2 mt -107.97 102.93 14.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.456 179.565 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -64.92 -42.31 94.81 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.716 0.294 . . . . 0.0 111.556 179.365 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.536 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.3 OUTLIER -133.67 -179.41 1.06 Allowed Pre-proline 0 CA--C 1.532 0.28 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.597 -178.581 . . . . . . . . 3 3 . 1 . 069 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.471 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 52.3 Cg_exo -55.18 138.05 78.25 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 122.331 2.021 . . . . 0.0 112.779 -178.687 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 72.7 t -134.48 136.68 52.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.792 -179.576 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -73.84 135.49 43.43 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.608 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 97.4 mt -84.89 137.56 33.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.284 0.564 . . . . 0.0 111.466 -179.225 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -126.74 151.04 48.72 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.219 -179.963 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.472 ' ND1' ' OD1' ' A' ' 99' ' ' ASN . 15.0 t60 -60.46 125.76 24.92 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.041 0.448 . . . . 0.0 110.774 -179.43 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.11 -17.88 47.18 Favored Glycine 0 CA--C 1.519 0.289 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.516 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 87' ' ' VAL . 66.4 t0 -72.52 133.05 44.59 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.041 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.512 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 33.6 t -109.36 133.3 54.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.1 0.476 . . . . 0.0 110.998 -179.119 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.4 mt -93.33 131.46 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 178.841 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.3 m -122.44 124.54 43.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.495 0.664 . . . . 0.0 112.311 -178.321 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.575 ' O ' ' N ' ' A' ' 93' ' ' ARG . 98.0 mt -117.84 133.46 64.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.752 178.725 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.49 ' C ' ' O ' ' A' ' 90' ' ' ILE . 80.8 mt -23.7 97.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -178.614 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.473 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 3.2 m-20 89.73 -20.07 0.16 Allowed 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.801 1.038 . . . . 0.0 113.801 177.792 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.603 ' NH2' ' OE1' ' B' ' 260' ' ' GLU . 54.3 mtt-85 -130.33 140.81 50.62 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.6 -179.114 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.458 ' HG ' ' CD1' ' A' ' 10' ' ' ILE . 11.2 p -137.53 150.71 47.73 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.712 0.291 . . . . 0.0 110.241 -179.931 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.541 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 15.4 m-85 -129.53 123.78 32.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.077 -179.038 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -79.37 127.7 32.42 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.137 0.494 . . . . 0.0 111.337 -179.464 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.722 ' HH ' ' NH1' ' A' ' 5' ' ' ARG . 67.9 t80 -94.26 127.68 40.27 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.997 -179.707 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -141.26 116.96 10.33 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.702 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.472 ' OD1' ' ND1' ' A' ' 84' ' ' HIS . 52.4 p30 . . . . . 0 C--N 1.331 -0.234 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.48 179.72 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo . . . . . 0 N--CA 1.481 0.754 0 CA-C-O 121.241 0.434 . . . . 0.0 112.082 . . . . . . . . . 0 0 . 1 . 069 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 2.9 p -115.18 133.64 60.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.914 179.864 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 2.3 t . . . . . 0 C--N 1.326 -0.448 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.635 -179.418 . . . . . . . . 0 0 . 1 . 069 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo . . . . . 0 N--CA 1.496 1.645 0 N-CA-C 113.175 0.413 . . . . 0.0 113.175 . . . . . . . . . 0 0 . 1 . 069 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 14.5 m -69.11 -45.68 69.59 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.582 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -57.3 -45.93 83.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.364 -179.327 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 90.6 mt -64.53 -41.37 96.41 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -179.91 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -64.09 -39.11 93.35 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.967 -178.95 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -61.82 -41.64 98.03 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.544 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . . . . . . . . . 71.3 ttp85 -60.9 -42.51 98.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.981 179.847 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.18 -40.59 90.52 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.097 -179.506 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 68.6 m -68.07 -42.99 79.61 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.481 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . 0.811 ' NE2' HH12 ' A' ' 12' ' ' ARG . 56.0 tt0 -62.37 -38.07 88.13 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.61 -179.18 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 77.8 t . . . . . 0 N--CA 1.454 -0.267 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.108 . . . . . . . . 0 0 . 1 . 069 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . 0.603 ' OE1' ' NH2' ' A' ' 93' ' ' ARG . 90.8 mt-10 . . . . . 0 N--CA 1.456 -0.163 0 CA-C-O 121.237 0.541 . . . . 0.0 110.702 . . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 50.5 mt -107.87 139.42 29.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.762 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 61.1 t -126.73 135.27 64.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.511 -179.741 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -98.97 121.54 41.05 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.302 0.572 . . . . 0.0 111.089 -178.833 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -64.66 -46.72 81.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.952 179.913 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -93.15 150.09 38.57 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.956 -179.269 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.7 148.54 65.7 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.549 2.166 . . . . 0.0 112.678 -179.869 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.3 pt . . . . . 0 C--N 1.327 -0.39 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.535 179.589 . . . . . . . . 0 0 . 1 . 070 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 41.4 p . . . . . 0 CA--C 1.523 -0.076 0 CA-C-O 120.78 0.324 . . . . 0.0 110.699 . . . . . . . . . 0 0 . 1 . 070 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 89.7 mtm-85 -88.66 123.68 33.35 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.751 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -130.79 138.48 49.93 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -178.393 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 68.2 mt -112.98 133.52 54.9 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.088 178.645 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 66.4 t -108.77 128.37 64.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.415 179.672 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.9 m -92.17 114.45 27.0 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.729 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.435 ' CD1' ' HG ' ' A' ' 94' ' ' SER . 96.4 mt -78.39 141.88 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.766 178.605 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.74 155.37 20.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.316 179.827 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -57.57 -31.96 66.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.682 -179.515 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.0 p -78.21 -8.3 58.16 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.146 0.498 . . . . 0.0 110.61 -179.877 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.76 38.2 6.21 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 -179.547 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 52.9 t -121.52 132.74 70.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.716 -0.393 . . . . 0.0 111.153 -179.49 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -68.54 116.61 9.28 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.795 -0.816 . . . . 0.0 108.795 179.53 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -107.53 -131.32 6.58 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.994 -178.975 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.58 149.45 61.7 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 121.945 1.763 . . . . 0.0 112.816 -178.63 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -106.85 145.0 32.68 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.598 179.351 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -115.17 96.45 45.41 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.184 -178.805 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.3 134.03 20.27 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.337 1.358 . . . . 0.0 112.311 -179.048 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.5 mt -84.54 83.02 8.15 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.017 -179.172 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 24.3 p -87.31 -12.03 47.73 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.535 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 58.9 mt -99.47 142.41 30.98 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.178 -179.732 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 77.9 p -66.82 -14.92 63.21 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.283 -178.953 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.0 m -130.73 131.98 45.08 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.973 0.416 . . . . 0.0 111.147 -179.721 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.9 t -125.71 119.44 28.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.453 178.992 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 50.5 tp -116.15 131.11 57.03 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.837 0.351 . . . . 0.0 111.408 -178.27 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.562 ' O ' ' O ' ' A' ' 47' ' ' GLN . 10.8 m-85 -108.8 143.29 38.16 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.63 179.704 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 156.74 -152.98 24.32 Favored Glycine 0 C--O 1.223 -0.536 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.262 179.448 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.609 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 32.9 mtm180 -108.0 -26.48 10.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.806 0.336 . . . . 0.0 110.414 179.251 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.562 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -58.29 155.39 22.95 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 121.205 -0.521 . . . . 0.0 111.917 -178.639 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 35.9 mm -63.4 -42.56 96.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.753 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -55.06 -29.6 57.85 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.147 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.562 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 5.7 m -53.99 113.82 1.37 Allowed 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.085 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -59.08 -23.93 62.49 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -178.558 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.451 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 91.1 mt -128.4 121.95 56.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 177.197 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.432 ' O ' ' N ' ' B' ' 262' ' ' VAL . 43.4 mtm180 -110.64 136.81 49.17 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.359 -179.151 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.446 ' C ' ' H ' ' A' ' 41' ' ' LEU . 93.3 mt -115.66 128.91 72.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.688 179.397 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -71.71 33.72 0.06 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.704 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.618 ' CD1' ' NH1' ' A' ' 93' ' ' ARG . 41.6 mt -115.39 131.57 23.54 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 120.189 -0.604 . . . . 0.0 111.14 179.739 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.26 -15.11 31.69 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.345 2.03 . . . . 0.0 113.321 -179.637 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.2 m -84.25 -0.49 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-O 121.009 0.433 . . . . 0.0 110.534 179.61 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.609 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 66.4 t -94.65 133.07 36.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.6 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 38.4 t -71.85 170.73 13.05 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.465 0.65 . . . . 0.0 111.962 -178.335 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.558 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 51.7 mttp -62.48 -40.43 96.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.424 -179.874 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.695 ' O ' ' N ' ' A' ' 49' ' ' CYS . 86.2 mt-30 -119.55 -15.01 9.06 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 123.239 0.337 . . . . 0.0 111.65 -179.249 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.6 t60 32.41 -71.91 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 179.534 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.695 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -134.44 137.34 43.91 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.952 -178.582 . . . . . . . . 3 3 . 1 . 070 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -127.41 131.04 50.36 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.045 179.416 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.6 mt -116.74 135.32 57.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.441 -179.606 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -117.28 124.76 49.79 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.765 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 80.9 mt -104.72 115.75 47.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.724 0.773 . . . . 0.0 112.096 -178.788 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.588 ' O ' ' N ' ' A' ' 56' ' ' GLN . 96.9 m-70 -112.59 141.59 46.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.547 -1.206 . . . . 0.0 108.844 179.129 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 54' ' ' HIS . 50.6 tp10 -39.36 -24.57 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -179.336 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.588 ' N ' ' O ' ' A' ' 54' ' ' HIS . 49.8 tt0 -64.93 -68.2 0.38 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.123 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.93 -155.15 0.4 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.484 178.476 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -116.86 126.04 52.43 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.711 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 99.2 mt -114.92 131.09 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 121.152 0.501 . . . . 0.0 112.064 -178.628 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.409 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 23.9 tp -101.5 129.29 47.54 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.389 -179.451 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -113.23 136.0 53.21 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.577 -179.896 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.456 HD22 ' HA ' ' A' ' 68' ' ' PRO . 41.0 t30 -95.87 105.34 17.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.559 179.998 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -99.12 -10.11 22.95 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.803 179.56 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.41 98.49 11.04 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.865 179.709 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.8 m -75.55 -30.29 59.67 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.407 178.998 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.4 m -61.01 -45.42 94.88 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.856 -179.296 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.2 m-20 -144.07 102.18 4.84 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.982 -179.659 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.456 ' HA ' HD22 ' A' ' 62' ' ' ASN . 32.4 Cg_exo -56.39 146.01 75.81 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 121.479 1.452 . . . . 0.0 112.343 179.554 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.7 m -73.07 144.39 47.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.144 179.17 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -102.8 138.68 39.37 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.491 179.399 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 52.2 t -132.78 131.63 59.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.185 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 54.3 34.12 19.83 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.131 -0.628 . . . . 0.0 109.978 -179.43 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.52 25.56 72.2 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.647 178.901 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 29.1 t -145.55 142.49 29.21 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 117.524 0.662 . . . . 0.0 111.34 179.751 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -73.2 141.63 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.838 179.749 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 11.4 pt -108.13 98.51 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-O 121.43 0.633 . . . . 0.0 110.888 179.0 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -66.23 -32.06 73.26 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.322 179.406 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -123.61 172.84 5.1 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.454 -179.283 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.63 146.72 94.53 Favored 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 122.468 2.112 . . . . 0.0 112.276 179.927 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.7 p -139.97 140.39 35.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.137 0.494 . . . . 0.0 111.304 -179.86 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -75.39 131.94 40.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.573 179.691 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 93.2 mt -87.27 138.39 31.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.274 0.559 . . . . 0.0 111.449 -179.645 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -130.1 156.43 44.55 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.665 179.368 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.751 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 4.7 t60 -59.86 123.83 18.25 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.604 -179.574 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.84 -13.86 45.64 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.877 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -69.7 136.99 51.72 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.472 -0.491 . . . . 0.0 109.864 179.728 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 50.7 t -113.61 130.64 67.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.837 -178.797 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 98.7 mt -103.84 133.33 48.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.734 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 95.8 m -128.58 129.89 46.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.907 0.861 . . . . 0.0 113.217 -178.379 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.465 ' O ' ' N ' ' A' ' 92' ' ' ASP . 92.8 mt -113.2 124.96 70.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.106 -1.406 . . . . 0.0 107.918 178.135 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.452 ' C ' ' O ' ' A' ' 90' ' ' ILE . 52.6 mt 34.68 -94.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.73 -178.719 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.623 ' OD1' ' NH1' ' A' ' 93' ' ' ARG . 31.5 p-10 -116.79 10.3 14.19 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.927 -179.754 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.623 ' NH1' ' OD1' ' A' ' 92' ' ' ASP . 53.4 mtm-85 -122.39 139.43 53.85 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -179.581 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.435 ' HG ' ' CD1' ' A' ' 10' ' ' ILE . 58.5 p -140.31 155.33 46.86 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.961 -179.78 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -124.67 121.96 36.18 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.501 179.711 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -81.18 132.54 35.36 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 119.651 -0.819 . . . . 0.0 110.249 -179.901 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.626 ' OH ' ' ND2' ' A' ' 99' ' ' ASN . 87.2 t80 -102.02 124.98 48.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.494 -178.873 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -140.49 127.7 21.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.045 179.148 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.751 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 94.3 m-20 . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.166 178.996 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo . . . . . 0 N--CA 1.487 1.109 0 CA-C-O 121.914 0.714 . . . . 0.0 112.26 . . . . . . . . . 0 0 . 1 . 070 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 3.6 m -66.76 138.69 22.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 114.552 -1.204 . . . . 0.0 110.263 -178.996 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.5 t . . . . . 0 C--N 1.323 -0.556 0 C-N-CA 120.392 -0.523 . . . . 0.0 109.7 179.918 . . . . . . . . 0 0 . 1 . 070 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_exo . . . . . 0 N--CA 1.498 1.779 0 CA-C-O 120.69 0.204 . . . . 0.0 112.137 . . . . . . . . . 0 0 . 1 . 070 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 71.4 m -68.88 -44.77 72.6 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.004 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . 0.713 ' CD1' ' NH2' ' B' ' 245' ' ' ARG . 62.7 t80 -58.07 -46.1 86.0 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.503 -179.4 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 71.9 mt -62.11 -41.04 97.82 Favored 'General case' 0 N--CA 1.462 0.127 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 179.972 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.83 -39.36 93.45 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.208 -179.471 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -59.47 -44.24 93.06 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.659 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.713 ' NH2' ' CD1' ' B' ' 241' ' ' PHE . 0.6 OUTLIER -62.22 -40.9 97.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.44 179.423 . . . . . . . . 3 3 . 1 . 070 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -61.98 -43.74 98.2 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.477 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 38.9 t -63.13 -44.19 96.25 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.529 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -61.35 -33.66 73.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.355 179.764 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 51.3 t . . . . . 0 C--N 1.333 -0.132 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.013 179.548 . . . . . . . . 0 0 . 1 . 070 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 . . . . . 0 N--CA 1.455 -0.176 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 . . . . . . . . . 0 0 . 1 . 070 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 73.6 mt -109.57 132.88 56.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.335 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . 0.432 ' N ' ' O ' ' A' ' 38' ' ' ARG . 53.7 t -124.37 133.19 70.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.605 -178.775 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -98.91 121.59 41.07 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.135 0.493 . . . . 0.0 111.936 -178.382 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -65.59 -44.04 87.84 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.621 179.417 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.23 158.51 83.85 Favored Pre-proline 0 CA--C 1.517 -0.312 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.828 -179.102 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -57.79 139.47 90.41 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 C-N-CA 122.2 1.933 . . . . 0.0 111.302 179.444 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 19.1 tt . . . . . 0 N--CA 1.441 -0.876 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.206 -179.313 . . . . . . . . 0 0 . 1 . 071 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 99' ' ' ASN . 2.5 t . . . . . 0 N--CA 1.454 -0.237 0 CA-C-O 120.986 0.422 . . . . 0.0 109.881 . . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.603 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 94.9 mtt-85 -81.64 135.7 35.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.038 179.894 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.4 mtp180 -130.54 140.37 50.47 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 121.504 0.669 . . . . 0.0 112.469 -178.63 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 44.4 tp -117.16 133.56 55.85 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.154 179.391 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.2 t -109.33 130.97 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.264 -178.752 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.7 m -89.96 115.59 27.37 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 121.316 0.579 . . . . 0.0 112.357 -178.842 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 94.1 mt -83.9 143.37 11.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.641 178.725 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -86.95 155.0 20.37 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.4 178.364 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.741 HH11 HH11 ' B' ' 245' ' ' ARG . 91.1 mtm180 -52.92 -26.99 16.73 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.848 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 91.6 p -81.36 -6.26 58.72 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.292 179.309 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.63 36.95 9.91 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.322 -179.267 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 36.1 t -120.62 137.09 55.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.953 0.406 . . . . 0.0 111.453 -178.883 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -76.56 121.26 22.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.149 -179.504 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -117.18 -123.79 3.44 Favored Glycine 0 CA--C 1.542 1.739 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -179.786 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -74.8 148.88 36.89 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 122.48 2.12 . . . . 0.0 113.134 -179.359 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -102.96 165.97 10.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.293 179.03 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.44 ' CD2' HD12 ' A' ' 37' ' ' ILE . 52.8 t80 -134.63 97.44 14.23 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.206 -179.248 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.79 122.66 10.81 Favored 'Trans proline' 0 N--CA 1.501 1.943 0 C-N-CA 122.441 2.094 . . . . 0.0 112.694 -179.896 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.6 mt -83.94 49.53 1.65 Allowed 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 121.126 -0.23 . . . . 0.0 111.375 -179.477 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 91.6 p -65.23 -22.55 66.89 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.051 0.453 . . . . 0.0 109.789 179.396 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 80.5 mt -77.58 139.48 39.54 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.991 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.458 ' H ' ' HG ' ' A' ' 25' ' ' SER . 0.8 OUTLIER -63.81 -17.52 63.19 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.223 -0.444 . . . . 0.0 112.047 -178.28 . . . . . . . . 3 3 . 1 . 071 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 86.2 m -133.26 133.97 43.34 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.444 -179.613 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.7 t -122.98 114.79 20.88 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.107 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.41 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 31.4 tp -111.09 128.43 55.88 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.489 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.52 ' O ' ' O ' ' A' ' 47' ' ' GLN . 55.8 m-85 -108.44 137.05 47.05 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.939 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 165.77 -170.94 40.79 Favored Glycine 0 C--O 1.224 -0.52 0 C-N-CA 119.833 -1.175 . . . . 0.0 112.555 179.786 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 37.4 ttp85 -90.19 -30.04 17.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.078 -0.561 . . . . 0.0 111.489 179.843 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.495 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -57.26 155.25 17.92 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.714 -0.555 . . . . 0.0 111.714 -179.226 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.504 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 10.2 tp -66.71 -42.43 89.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.594 -179.704 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.504 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 16.2 pt-20 -58.95 -13.42 6.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.362 -179.418 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.58 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 6.6 m -68.27 128.54 36.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.979 0.418 . . . . 0.0 110.414 -179.507 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.41 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 61.9 m-20 -60.18 -32.84 71.45 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.469 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.44 HD12 ' CD2' ' A' ' 20' ' ' PHE . 47.1 mm -119.59 111.29 32.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 177.275 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 88.4 mtm-85 -100.47 133.57 44.7 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.722 -178.327 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.7 mt -118.91 129.64 74.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.317 0.58 . . . . 0.0 109.813 178.839 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -72.44 33.82 0.06 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.221 -0.9 . . . . 0.0 112.782 -177.381 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.553 ' CD1' ' CZ ' ' A' ' 93' ' ' ARG . 49.6 mt -110.48 133.23 21.19 Favored Pre-proline 0 N--CA 1.468 0.44 0 C-N-CA 119.81 -0.756 . . . . 0.0 111.834 -179.855 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -71.35 -9.38 25.2 Favored 'Trans proline' 0 N--CA 1.488 1.164 0 C-N-CA 122.363 2.042 . . . . 0.0 113.107 -179.11 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.1 m -102.6 6.11 10.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.018 179.864 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 24.1 t -90.91 133.7 31.86 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.956 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.3 m -68.46 158.07 34.52 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.127 -178.83 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.58 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 9.2 mtmp? -63.39 -39.29 94.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.24 -179.506 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.652 ' O ' ' N ' ' A' ' 49' ' ' CYS . 97.9 mt-30 -114.13 -21.43 10.51 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-O 120.885 0.374 . . . . 0.0 110.318 179.559 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.4 t60 33.06 -74.17 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -179.711 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.652 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -129.82 133.28 46.85 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.121 0.486 . . . . 0.0 111.909 -179.001 . . . . . . . . 3 3 . 1 . 071 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -125.27 126.67 45.51 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.809 179.668 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 94.8 mt -113.4 132.51 62.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.606 -179.766 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -112.3 134.87 53.6 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 178.74 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 49.8 mm -104.43 112.86 39.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.752 -179.471 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.443 ' C ' ' N ' ' A' ' 56' ' ' GLN . 97.5 m-70 -116.07 135.36 54.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.944 179.163 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.489 ' OE1' ' N ' ' A' ' 55' ' ' GLU . 53.8 mp0 -41.2 -29.6 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.546 0.689 . . . . 0.0 109.454 -179.58 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.443 ' N ' ' C ' ' A' ' 54' ' ' HIS . 24.4 mt-30 -67.83 -67.75 0.44 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.394 178.526 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.453 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 4.3 tp10 -155.51 -168.46 2.83 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.742 -179.404 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.453 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -116.09 124.47 50.48 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.388 179.121 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.4 HG21 HD12 ' A' ' 59' ' ' ILE . 92.8 mt -110.52 128.8 66.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 120.867 0.365 . . . . 0.0 111.936 -178.928 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 32.2 tp -94.97 124.56 39.09 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.875 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -110.09 134.24 52.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.958 -179.392 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -93.08 108.41 20.0 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.227 -179.234 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -103.36 -11.62 17.77 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.516 179.331 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.474 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 2.1 t -73.77 99.0 3.05 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.452 -179.676 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.5 t -77.22 -43.01 35.14 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.102 0.477 . . . . 0.0 110.552 178.691 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.1 p -66.8 -39.76 87.85 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.865 -179.001 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.474 ' O ' ' OG ' ' A' ' 64' ' ' SER . 39.6 m-80 -142.84 97.43 5.88 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.672 -179.361 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.2 144.21 60.25 Favored 'Trans proline' 0 N--CA 1.502 2.005 0 C-N-CA 122.636 2.224 . . . . 0.0 113.5 -179.813 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 16.4 m -69.65 134.85 49.19 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.547 178.413 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -102.62 138.49 39.46 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.054 -0.658 . . . . 0.0 109.987 179.71 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 75.9 t -131.44 133.97 61.35 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.473 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.831 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 53.91 33.75 17.96 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -178.767 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.54 29.46 72.92 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.335 -179.666 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 73.4 m -141.11 136.14 31.63 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.007 0.432 . . . . 0.0 111.577 -179.633 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.3 p -68.74 142.51 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.681 179.929 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.7 pt -119.46 88.28 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.139 178.729 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -68.01 -26.23 65.79 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.411 0.624 . . . . 0.0 109.588 178.329 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -113.8 159.07 37.23 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 114.935 -1.029 . . . . 0.0 109.889 179.532 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.32 155.1 71.9 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.147 1.898 . . . . 0.0 111.5 179.916 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.0 m -149.65 146.51 16.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.874 -179.222 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.6 mtm-85 -72.19 131.53 42.89 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.366 179.494 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 99.7 mt -82.63 139.09 33.95 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.423 0.63 . . . . 0.0 110.255 179.75 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -124.34 150.17 45.78 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.221 -179.906 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.756 ' HD1' ' H ' ' A' ' 99' ' ' ASN . 5.9 t60 -63.25 126.04 26.11 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 119.719 -0.793 . . . . 0.0 109.495 -179.764 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.07 -18.94 33.2 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.207 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -69.16 143.26 54.12 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.428 179.586 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.4 p -112.57 134.81 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.781 -178.528 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 85.9 mt -103.06 131.15 52.0 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.526 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 53.6 m -121.18 127.85 51.9 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.616 0.722 . . . . 0.0 112.312 -179.106 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.453 ' O ' ' N ' ' A' ' 92' ' ' ASP . 98.0 mt -121.05 128.32 76.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.211 179.886 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.445 ' C ' ' O ' ' A' ' 90' ' ' ILE . 39.4 mm 39.26 -98.58 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.685 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.534 ' O ' ' OD1' ' A' ' 92' ' ' ASP . 65.5 t0 -125.04 23.07 7.85 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.546 0.688 . . . . 0.0 110.642 179.387 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.553 ' CZ ' ' CD1' ' A' ' 41' ' ' LEU . 38.0 mtm-85 -129.52 142.44 50.77 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.147 -0.933 . . . . 0.0 108.865 179.862 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.8 m -135.21 151.22 50.42 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.031 -179.414 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -126.93 120.42 29.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.594 179.179 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -83.12 129.55 35.03 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.151 -0.619 . . . . 0.0 110.644 179.846 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.603 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 93.8 t80 -94.38 126.85 39.9 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.814 179.748 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -142.82 122.46 13.32 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.015 0.436 . . . . 0.0 111.274 -179.879 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.756 ' H ' ' HD1' ' A' ' 84' ' ' HIS . 86.8 m-20 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.502 179.813 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo . . . . . 0 N--CA 1.489 1.226 0 CA-C-O 121.448 0.52 . . . . 0.0 112.929 . . . . . . . . . 0 0 . 1 . 071 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 14.7 p -62.28 134.95 27.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.49 -179.869 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 7.4 t . . . . . 0 C--N 1.329 -0.298 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.541 . . . . . . . . 0 0 . 1 . 071 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo . . . . . 0 N--CA 1.493 1.443 0 CA-C-O 120.947 0.311 . . . . 0.0 111.427 . . . . . . . . . 0 0 . 1 . 071 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 95.6 m -68.47 -45.23 72.97 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.352 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -58.59 -48.6 80.42 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.182 179.737 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 86.8 mt -64.69 -42.0 95.62 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.916 0.389 . . . . 0.0 110.971 -179.917 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -66.04 -47.06 75.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.282 -179.287 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -62.55 -41.85 99.16 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.167 -179.743 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.741 HH11 HH11 ' A' ' 12' ' ' ARG . 52.1 ttm-85 -64.17 -39.45 94.03 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.188 -179.727 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -59.28 -38.44 80.16 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.361 0.601 . . . . 0.0 109.468 179.923 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 15.9 m -67.14 -42.21 84.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.778 177.974 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -64.04 -31.14 72.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.46 179.881 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 55.6 t . . . . . 0 N--CA 1.456 -0.138 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.065 178.513 . . . . . . . . 0 0 . 1 . 071 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 . . . . . 0 N--CA 1.452 -0.354 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 . . . . . . . . . 0 0 . 1 . 071 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 66.3 mt -107.94 136.41 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 177.845 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 55.2 t -127.59 135.34 63.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.88 -178.618 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -94.74 117.16 29.69 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.907 -178.744 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -64.5 -46.11 84.37 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.264 179.935 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.68 158.24 36.95 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.657 -179.53 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -61.24 147.43 95.63 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 C-N-CA 123.041 2.494 . . . . 0.0 112.609 179.47 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.4 pt . . . . . 0 C--N 1.326 -0.427 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.073 -179.783 . . . . . . . . 0 0 . 1 . 072 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.4 p . . . . . 0 CA--C 1.531 0.224 0 CA-C-O 120.598 0.237 . . . . 0.0 111.501 . . . . . . . . . 0 0 . 1 . 072 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.7 mtm-85 -100.72 115.5 30.41 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 121.031 -0.268 . . . . 0.0 110.761 -179.57 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -131.65 141.23 49.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.277 0.56 . . . . 0.0 111.427 179.769 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 36.4 tp -114.47 127.7 55.95 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.413 179.908 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 75.8 t -103.15 127.86 56.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.521 -0.471 . . . . 0.0 110.268 -179.406 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 m -92.85 114.45 27.01 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 121.113 0.482 . . . . 0.0 111.398 -179.52 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 85.9 mt -80.86 146.78 6.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.419 179.746 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -90.3 154.17 19.91 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 177.811 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.48 ' NH1' ' OD2' ' A' ' 92' ' ' ASP . 38.4 mtp85 -58.04 -28.71 64.75 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.547 -179.245 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 86.0 p -74.81 -14.9 60.74 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.606 -0.437 . . . . 0.0 110.142 178.949 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.54 36.44 4.84 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 -179.518 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.6 t -123.72 133.78 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-O 120.848 0.356 . . . . 0.0 111.68 -179.447 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -66.02 125.87 26.83 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.364 179.512 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -117.28 -126.98 3.83 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.458 -178.951 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -73.76 147.33 39.61 Favored 'Trans proline' 0 N--CA 1.5 1.874 0 C-N-CA 122.604 2.203 . . . . 0.0 112.955 -178.446 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 62.7 m170 -109.23 132.17 54.37 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.913 0.387 . . . . 0.0 110.705 -179.955 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -102.22 105.42 42.76 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.936 -179.893 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -74.93 128.66 11.72 Favored 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 121.464 1.443 . . . . 0.0 111.529 -179.418 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 64.9 mt -89.99 44.17 1.19 Allowed 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.387 -178.472 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 84.8 p -59.23 -21.94 60.31 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.408 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 73.6 mt -76.92 146.05 37.82 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.326 179.836 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.0 m -64.24 -23.18 67.21 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.23 -178.981 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 61.2 m -136.26 136.45 39.84 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.897 -179.039 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.1 t -128.01 120.05 26.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.062 179.063 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.4 tp -114.81 132.34 56.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.641 0.258 . . . . 0.0 111.112 -178.749 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.506 ' O ' ' O ' ' A' ' 47' ' ' GLN . 5.9 m-85 -111.92 139.8 47.11 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.902 179.715 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.44 -167.56 30.84 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 120.564 -0.826 . . . . 0.0 112.164 178.755 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.502 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 45.8 mtm180 -84.5 -32.0 24.19 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.867 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.572 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -49.49 143.69 9.65 Favored Glycine 0 CA--C 1.519 0.323 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 -178.662 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.0 tp -65.99 -41.1 89.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 120.248 -0.581 . . . . 0.0 109.932 179.995 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.407 ' HA ' ' HZ2' ' B' ' 264' ' ' LYS . 82.5 tt0 -54.71 -20.48 8.42 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.228 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.572 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 34.2 m -59.65 126.54 28.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.924 -179.834 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -59.83 -31.98 70.24 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.249 0.547 . . . . 0.0 109.547 -179.623 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.455 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 97.4 mt -123.83 116.56 48.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.148 177.761 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 25.9 mtp85 -100.86 132.39 46.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.434 -178.197 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 92.8 mt -121.7 131.11 73.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.987 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -79.53 34.16 0.26 Allowed 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -177.849 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.563 ' CD1' HH21 ' A' ' 93' ' ' ARG . 23.6 mt -104.76 127.88 27.96 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.895 178.92 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -73.42 -9.49 23.03 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 122.303 2.002 . . . . 0.0 112.277 -179.997 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.0 m -91.73 1.09 8.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.73 0.3 . . . . 0.0 110.677 179.798 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.502 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 42.8 t -98.35 138.02 24.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.989 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 64.0 m -72.38 170.58 13.91 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.101 0.477 . . . . 0.0 111.364 -178.794 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -62.48 -41.41 98.77 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.884 -179.099 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.626 ' O ' ' N ' ' A' ' 49' ' ' CYS . 89.6 mt-30 -111.44 -18.5 12.85 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.631 0.253 . . . . 0.0 111.489 -179.698 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.6 t60 36.61 -77.06 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 179.262 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.626 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.66 136.08 47.41 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.067 0.461 . . . . 0.0 111.559 -178.475 . . . . . . . . 3 3 . 1 . 072 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -129.45 132.17 46.89 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.477 179.774 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.7 mt -115.13 134.31 58.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.855 -179.745 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -116.65 124.22 49.22 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.783 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 98.0 mt -107.25 114.69 46.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.483 -179.668 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.459 ' O ' ' N ' ' A' ' 56' ' ' GLN . 89.5 m-70 -114.22 145.95 41.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.831 179.924 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 54' ' ' HIS . 53.4 tp10 -40.7 -28.63 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.603 -179.819 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.459 ' N ' ' O ' ' A' ' 54' ' ' HIS . 84.1 mt-30 -63.53 -68.79 0.32 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.962 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.468 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 6.1 tp10 -159.9 -163.48 1.15 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.996 179.379 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.468 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -110.3 127.49 55.04 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.659 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.7 mt -117.22 130.2 72.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.371 0.605 . . . . 0.0 112.099 -178.911 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.8 tp -99.17 129.12 45.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.292 -179.74 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -114.53 137.48 51.81 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.618 179.975 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.446 HD22 ' HA ' ' A' ' 68' ' ' PRO . 54.1 t30 -97.61 107.55 20.08 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.374 -179.757 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -98.9 -10.1 23.29 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 179.918 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.2 t -74.98 102.71 4.9 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.548 179.429 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.7 p -82.28 -17.7 44.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.98 0.419 . . . . 0.0 110.382 179.764 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.24 -39.96 11.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.009 -179.102 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.414 HD22 ' HA ' ' B' ' 236' ' ' VAL . 71.2 m-20 -140.65 94.52 8.22 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.555 -179.936 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.446 ' HA ' HD22 ' A' ' 62' ' ' ASN . 32.2 Cg_exo -57.01 146.34 80.91 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.005 1.804 . . . . 0.0 112.028 -179.404 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.1 m -72.93 137.48 45.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.496 179.967 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -100.76 141.27 33.87 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.104 -179.827 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 46.0 t -127.2 136.95 59.24 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.155 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 51.29 32.31 8.13 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.714 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.96 29.92 68.52 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 -179.965 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.3 p -140.25 134.76 31.52 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 120.641 -0.423 . . . . 0.0 111.644 -179.3 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 52.9 t -67.8 132.89 32.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-O 121.248 0.547 . . . . 0.0 110.929 179.708 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.13 111.39 25.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.807 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -96.25 -10.62 27.54 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.734 -0.387 . . . . 0.0 111.772 -178.592 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -117.25 158.12 45.36 Favored Pre-proline 0 C--N 1.329 -0.3 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.627 -179.412 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -56.12 142.49 86.31 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 121.919 1.746 . . . . 0.0 112.216 179.522 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 18.9 m -144.57 139.96 23.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.623 179.306 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 89.3 mtm-85 -72.91 133.07 44.22 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.876 0.37 . . . . 0.0 110.176 179.758 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 93.7 mt -81.45 138.98 35.48 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.169 -179.434 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -126.78 148.91 49.89 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.466 179.429 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.692 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 12.4 t60 -58.48 124.89 21.14 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.886 0.374 . . . . 0.0 111.209 -178.667 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.07 -20.96 34.69 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.444 -0.662 . . . . 0.0 111.444 179.967 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -66.87 138.44 57.32 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 120.491 -0.483 . . . . 0.0 110.023 179.731 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 79.5 t -110.36 132.69 58.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.25 -178.747 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 82.5 mt -100.63 132.6 45.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.324 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 93.7 m -120.82 125.52 47.76 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.032 -0.667 . . . . 0.0 112.172 -178.203 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.422 ' O ' ' C ' ' A' ' 91' ' ' ILE . 96.2 mt -116.25 123.96 71.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.019 -0.991 . . . . 0.0 108.61 178.694 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.422 ' C ' ' O ' ' A' ' 90' ' ' ILE . 48.8 mm 39.72 -106.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.618 -179.318 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.48 ' OD2' ' NH1' ' A' ' 12' ' ' ARG . 32.8 p-10 -110.1 13.09 23.34 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.787 0.327 . . . . 0.0 111.698 -179.346 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.563 HH21 ' CD1' ' A' ' 41' ' ' LEU . 9.5 mtm105 -118.51 140.4 49.94 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.198 179.732 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.0 m -128.88 144.8 51.28 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.006 179.007 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 41.7 m-85 -126.73 123.53 37.69 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.497 -179.782 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -85.95 128.49 34.85 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 119.953 -0.699 . . . . 0.0 109.721 -179.754 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -93.98 127.98 40.07 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 120.897 0.38 . . . . 0.0 110.495 -179.995 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -126.56 128.79 47.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.56 -179.323 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.692 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 43.8 t30 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.538 179.485 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 N--CA 1.488 1.184 0 CA-C-O 121.071 0.363 . . . . 0.0 112.763 . . . . . . . . . 0 0 . 1 . 072 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . 0.414 ' HA ' HD22 ' A' ' 67' ' ' ASN . 77.5 t -59.83 134.98 24.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.664 -179.625 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 4.5 t . . . . . 0 C--N 1.327 -0.412 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.493 -179.117 . . . . . . . . 0 0 . 1 . 072 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo . . . . . 0 N--CA 1.489 1.207 0 N-CA-C 111.736 -0.14 . . . . 0.0 111.736 . . . . . . . . . 0 0 . 1 . 072 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 73.5 m -75.07 -45.36 41.97 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 176.956 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -57.07 -47.52 80.8 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.265 -179.106 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 93.0 mt -66.07 -39.85 90.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.15 -179.611 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -62.4 -42.18 99.23 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.577 -179.257 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -63.39 -42.0 98.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.019 0.438 . . . . 0.0 110.058 179.523 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.497 ' CA ' ' HE ' ' B' ' 245' ' ' ARG . 0.0 OUTLIER -63.19 -43.15 99.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.81 -179.348 . . . . . . . . 3 3 . 1 . 072 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.76 -37.71 87.7 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.66 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 39.0 t -64.71 -42.61 95.13 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 177.29 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -59.26 -36.88 76.31 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.073 179.997 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 46.3 t . . . . . 0 C--O 1.23 0.057 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.129 178.829 . . . . . . . . 0 0 . 1 . 072 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 . . . . . 0 N--CA 1.453 -0.32 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 . . . . . . . . . 0 0 . 1 . 072 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 16.8 mt -115.84 135.85 54.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.51 -179.627 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 45.2 t -127.23 133.72 67.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.537 179.272 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -96.37 119.93 35.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.151 0.5 . . . . 0.0 111.711 -178.638 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . 0.407 ' HZ2' ' HA ' ' A' ' 34' ' ' GLU . 88.4 tttt -65.45 -44.51 87.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.335 178.964 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -100.25 157.35 33.97 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.979 -179.171 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.4 157.51 54.22 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.945 2.43 . . . . 0.0 112.0 178.763 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 45.3 pt . . . . . 0 C--N 1.33 -0.258 0 CA-C-O 121.336 0.588 . . . . 0.0 112.306 -178.868 . . . . . . . . 0 0 . 1 . 073 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.4 t . . . . . 0 C--O 1.235 0.291 0 CA-C-O 120.843 0.354 . . . . 0.0 110.145 . . . . . . . . . 0 0 . 1 . 073 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -94.07 123.1 37.23 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.918 -179.57 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 -128.23 137.14 51.89 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.214 -179.903 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 39.6 tp -112.87 130.98 55.91 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.845 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 66.7 t -109.53 130.99 61.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.325 -179.439 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 m -90.87 118.56 30.37 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.163 -178.765 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.598 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 96.0 mt -81.63 140.54 16.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.063 179.282 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.461 ' HA ' HH22 ' A' ' 93' ' ' ARG . 41.5 mmtt -83.71 158.91 21.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.955 0.407 . . . . 0.0 110.058 178.89 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.563 ' N ' HH12 ' A' ' 93' ' ' ARG . 85.4 mtp180 -57.74 -35.48 70.76 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.12 -178.646 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.4 t -76.08 -8.52 57.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.739 0.304 . . . . 0.0 111.414 -179.787 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.66 35.07 5.76 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 -179.184 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.6 t -121.84 132.9 69.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.785 0.326 . . . . 0.0 111.189 -179.72 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -77.71 137.12 38.31 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.313 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.95 -118.34 2.03 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 120.617 -0.802 . . . . 0.0 111.492 -179.63 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.53 151.96 48.03 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.216 1.944 . . . . 0.0 112.274 -179.25 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.459 ' CD2' ' C ' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -117.1 156.62 27.28 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.309 179.814 . . . . . . . . 3 3 . 1 . 073 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -124.04 107.03 30.83 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.924 -179.13 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.24 135.16 22.2 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 121.546 1.497 . . . . 0.0 111.961 -179.282 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 62.2 mt -96.44 40.95 1.12 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.166 -178.512 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.8 p -63.07 -18.47 63.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.146 0.498 . . . . 0.0 109.957 179.541 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.9 mt -75.53 149.49 38.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.504 179.219 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 26.3 m -62.99 -25.52 68.42 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.494 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.478 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 95.7 m -139.25 139.66 37.48 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 120.1 -0.64 . . . . 0.0 112.541 -179.59 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.0 t -128.09 116.63 20.27 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.852 179.027 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.9 tp -113.81 128.91 56.6 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.84 0.352 . . . . 0.0 110.976 -179.073 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.503 ' O ' ' O ' ' A' ' 47' ' ' GLN . 5.1 m-85 -108.07 137.04 46.75 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.171 -179.511 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 152.54 -172.79 31.67 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.216 -0.992 . . . . 0.0 112.267 178.756 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 48.1 mtm180 -76.98 -32.57 57.35 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 179.851 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.498 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -48.23 144.95 6.2 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 120.674 -0.775 . . . . 0.0 111.263 -178.693 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.469 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 9.9 tp -65.64 -41.16 89.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.824 0.345 . . . . 0.0 110.12 -179.99 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.469 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 80.3 mm-40 -57.06 -19.54 19.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.959 -179.987 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 62.8 m -56.05 122.69 12.23 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.703 -179.751 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.478 ' OD2' ' O ' ' A' ' 26' ' ' THR . 56.0 m-20 -58.88 -30.72 67.97 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -179.947 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.435 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 85.6 mt -127.01 120.51 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.361 177.333 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 84.4 mtp180 -102.46 135.15 44.59 Favored 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.472 -179.354 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.427 ' C ' ' H ' ' A' ' 41' ' ' LEU . 97.1 mt -116.12 126.31 73.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.145 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -75.05 30.62 0.09 Allowed 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -177.87 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.427 ' H ' ' C ' ' A' ' 39' ' ' ILE . 45.9 mt -98.27 126.22 40.57 Favored Pre-proline 0 C--N 1.325 -0.49 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.3 179.259 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -72.4 -8.22 22.27 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 C-N-CA 122.315 2.01 . . . . 0.0 112.853 -179.719 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.5 m -101.73 6.32 10.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.069 0.462 . . . . 0.0 110.422 179.52 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.1 t -91.01 137.41 21.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.431 178.747 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.8 m -68.72 169.24 11.63 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.613 0.72 . . . . 0.0 112.214 -178.332 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -62.78 -43.93 97.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.177 -179.041 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.586 ' O ' ' N ' ' A' ' 49' ' ' CYS . 95.2 mm-40 -113.65 -25.75 8.56 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.95 -179.532 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.1 t60 40.42 -78.74 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.878 -1.056 . . . . 0.0 113.43 179.661 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.586 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -129.05 136.03 49.72 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.025 . . . . . . . . 3 3 . 1 . 073 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -129.53 126.82 39.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.798 -179.931 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.1 mt -112.04 134.72 53.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.341 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -119.77 127.67 53.02 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.624 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 83.6 mt -105.67 121.52 58.02 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 CA-C-O 121.694 0.759 . . . . 0.0 111.609 -178.904 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.548 ' O ' ' N ' ' A' ' 56' ' ' GLN . 92.5 m-70 -117.11 142.81 46.52 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.105 -179.504 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 54' ' ' HIS . 92.4 mt-10 -39.0 -26.75 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -179.295 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.548 ' N ' ' O ' ' A' ' 54' ' ' HIS . 87.7 mt-30 -68.63 -67.39 0.47 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.679 179.045 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.485 ' CD ' HH21 ' A' ' 81' ' ' ARG . 5.3 tp10 -159.66 -156.98 0.54 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.221 179.802 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -120.88 131.17 54.24 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.039 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 93.5 mt -120.77 131.22 73.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.031 0.443 . . . . 0.0 112.027 -178.455 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 34.7 tp -94.48 125.2 38.98 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.042 179.566 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -111.21 138.22 47.93 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.16 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.617 HD22 ' CB ' ' A' ' 68' ' ' PRO . 63.5 t-20 -101.74 107.82 19.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.43 . . . . 0.0 112.013 -178.53 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -99.33 -9.87 23.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.43 -179.991 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.49 99.93 9.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.691 0.281 . . . . 0.0 110.295 -179.634 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.2 p -82.34 -35.9 27.42 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.963 179.811 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.69 -48.19 81.9 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.182 0.515 . . . . 0.0 109.902 -179.517 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -139.63 100.63 7.45 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.683 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.617 ' CB ' HD22 ' A' ' 62' ' ' ASN . 44.7 Cg_endo -66.9 151.22 82.64 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 121.56 1.507 . . . . 0.0 113.662 -177.79 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.41 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 16.6 m -68.38 144.02 54.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.116 -179.835 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -103.73 140.6 37.38 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.85 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.9 p -129.27 135.85 60.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.621 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 49.83 34.34 7.58 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.628 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.04 28.19 70.83 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.529 -179.838 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.0 m -139.64 139.69 36.76 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.796 -179.421 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.3 t -68.56 135.93 27.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 120.909 0.385 . . . . 0.0 111.231 179.661 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.518 ' CG1' ' O ' ' A' ' 78' ' ' GLU . 9.6 tt -105.45 96.56 4.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.332 179.906 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -64.57 -35.59 81.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.67 179.736 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.518 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 0.0 OUTLIER -133.55 177.22 2.36 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 120.596 -0.441 . . . . 0.0 111.722 -179.157 . . . . . . . . 3 3 . 1 . 073 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.433 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 48.8 Cg_exo -56.22 141.72 87.84 Favored 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 122.842 2.362 . . . . 0.0 112.944 -179.661 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 42.1 t -134.58 141.26 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.027 -179.636 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.485 HH21 ' CD ' ' A' ' 57' ' ' GLU . 60.2 ttt180 -74.03 122.83 23.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.022 178.353 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 98.5 mt -75.02 140.44 43.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.174 0.511 . . . . 0.0 111.3 -179.144 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -133.17 147.7 52.06 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.58 179.701 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.516 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 7.8 t60 -52.66 114.4 1.38 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.316 179.38 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 113.85 -14.67 21.82 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.179 -0.769 . . . . 0.0 111.179 179.997 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -69.42 131.32 44.59 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.028 179.684 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 66.8 t -110.55 129.4 65.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.369 -178.95 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 89.7 mt -101.71 133.9 43.78 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.51 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 66.5 m -121.71 121.85 38.23 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.583 0.706 . . . . 0.0 111.529 -179.135 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.632 ' O ' ' N ' ' A' ' 93' ' ' ARG . 86.6 mt -110.32 128.98 66.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.533 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.539 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 61.8 mt -15.42 92.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -178.519 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.539 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 2.7 t70 88.73 -22.33 0.13 Allowed 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 177.595 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.632 ' N ' ' O ' ' A' ' 90' ' ' ILE . 19.6 mmm180 -122.94 138.74 54.59 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.789 -0.365 . . . . 0.0 110.349 -179.603 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 69.4 m -134.88 150.0 50.38 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.707 179.688 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.409 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 55.3 m-85 -127.56 121.35 30.39 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.361 -179.917 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 96' ' ' ARG . 42.1 ttp-105 -84.77 133.51 34.35 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.906 0.384 . . . . 0.0 110.257 -179.834 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -94.3 121.34 35.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.199 -179.327 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -127.56 123.08 34.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.616 179.971 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.516 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 7.8 p-10 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.047 179.4 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo . . . . . 0 N--CA 1.497 1.691 0 CA-C-O 120.967 0.319 . . . . 0.0 112.7 . . . . . . . . . 0 0 . 1 . 073 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 28.3 t -89.48 131.08 37.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.038 178.89 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 8.0 t . . . . . 0 C--N 1.325 -0.474 0 CA-C-O 120.984 0.421 . . . . 0.0 110.965 -179.264 . . . . . . . . 0 0 . 1 . 073 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo . . . . . 0 N--CA 1.493 1.46 0 CA-C-O 120.687 0.203 . . . . 0.0 111.712 . . . . . . . . . 0 0 . 1 . 073 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 3.1 m -74.05 -41.8 61.22 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 177.259 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -57.49 -47.24 82.44 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.238 -179.69 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 99.3 mt -65.55 -39.87 92.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.778 -179.787 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -61.28 -42.05 97.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.425 -179.801 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -62.0 -43.41 98.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.64 179.512 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.417 ' NH1' ' OE1' ' B' ' 248' ' ' GLN . 2.6 mpt_? -60.33 -40.74 91.7 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.292 -179.927 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -63.5 -43.01 98.49 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.375 0.607 . . . . 0.0 109.76 179.089 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 72.3 m -62.71 -44.38 96.37 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.646 179.094 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . 0.417 ' OE1' ' NH1' ' B' ' 245' ' ' ARG . 86.5 mt-30 -61.11 -36.68 80.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.572 -179.887 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 22.9 t . . . . . 0 C--N 1.33 -0.273 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.139 179.301 . . . . . . . . 0 0 . 1 . 073 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . 0.658 ' CD ' ' H ' ' B' ' 260' ' ' GLU . 1.3 pm0 . . . . . 0 C--O 1.226 -0.162 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 . . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . 0.463 HD12 HH21 ' A' ' 93' ' ' ARG . 60.1 mt -118.67 131.69 70.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.146 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 50.8 t -128.88 134.81 63.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.057 -179.515 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -94.45 119.92 33.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.174 0.511 . . . . 0.0 111.206 -178.582 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.26 -44.72 94.35 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.507 179.56 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -102.19 159.93 27.91 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.408 -179.086 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -65.88 161.45 39.37 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.602 2.201 . . . . 0.0 111.723 179.68 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.4 pt . . . . . 0 C--N 1.33 -0.258 0 CA-C-O 121.435 0.636 . . . . 0.0 111.952 -179.03 . . . . . . . . 0 0 . 1 . 074 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 54.2 m . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.836 0.351 . . . . 0.0 110.494 . . . . . . . . . 0 0 . 1 . 074 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.507 ' NH2' ' O ' ' A' ' 22' ' ' LEU . 82.9 mtm-85 -81.72 132.61 35.29 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.41 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 91.0 mtm-85 -127.1 131.42 50.84 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.295 -179.768 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 29.8 tp -117.22 126.24 52.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.409 179.348 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.8 m -101.3 133.65 43.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.903 -179.277 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.7 m -92.2 113.87 26.26 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.072 -178.874 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.3 mt -81.78 144.53 10.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.683 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -101.02 164.02 12.01 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.618 179.965 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.432 ' HD3' HH12 ' A' ' 93' ' ' ARG . 87.4 mtm180 -59.35 -31.56 69.31 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.569 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.1 t -70.35 -20.59 62.97 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.484 179.239 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.39 17.3 20.24 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.727 179.36 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.5 m -110.23 135.49 49.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.991 0.424 . . . . 0.0 111.198 -179.733 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 17' ' ' GLY . 64.0 t0 -76.55 135.75 39.28 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.029 179.602 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.511 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -126.63 -114.03 1.88 Allowed Glycine 0 CA--C 1.537 1.428 0 C-N-CA 120.361 -0.924 . . . . 0.0 111.961 -179.897 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.91 147.64 50.06 Favored 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 122.434 2.089 . . . . 0.0 113.488 -178.678 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -109.83 142.1 41.58 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.148 179.325 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -113.32 106.14 54.75 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.041 -179.829 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.62 129.46 13.67 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 121.419 1.413 . . . . 0.0 111.831 -179.432 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.507 ' O ' ' NH2' ' A' ' 5' ' ' ARG . 25.8 mt -94.77 39.94 1.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.858 -178.556 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.9 t -63.12 -15.82 57.99 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.405 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.8 mt -73.7 145.36 45.27 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.327 179.891 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 86.6 p -58.44 -26.38 63.26 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.049 -178.42 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 87.3 m -141.41 139.99 33.56 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.487 -179.584 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.665 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 6.6 t -129.29 119.88 24.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.668 178.856 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 50.1 tp -114.7 130.49 56.83 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.373 -178.422 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.665 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 7.0 m-85 -107.68 141.02 39.84 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.807 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 153.39 -171.39 32.27 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 119.95 -1.119 . . . . 0.0 112.538 179.053 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.5 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 45.0 mtm180 -85.8 -32.57 21.72 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 111.497 0.184 . . . . 0.0 111.497 179.564 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -47.36 150.05 2.55 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 -178.977 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.545 ' O ' ' NH2' ' A' ' 38' ' ' ARG . 8.2 tp -64.54 -41.52 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 O-C-N 122.442 -0.446 . . . . 0.0 110.574 -179.579 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.464 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 95.5 mt-10 -59.08 -18.82 38.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.898 -179.315 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 71.4 m -57.11 118.94 5.53 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.119 -179.869 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -56.4 -29.89 62.1 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.328 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.445 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 75.1 mt -124.37 118.81 54.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 177.01 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.545 ' NH2' ' O ' ' A' ' 33' ' ' ILE . 72.0 mtt85 -103.86 134.38 47.25 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.469 -178.427 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.432 ' C ' ' H ' ' A' ' 41' ' ' LEU . 77.6 mt -117.96 129.61 74.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.877 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -76.84 29.99 0.13 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.749 -178.974 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.432 ' H ' ' C ' ' A' ' 39' ' ' ILE . 7.3 mt -99.66 127.14 34.87 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.188 179.902 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.16 -13.27 31.05 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.278 1.986 . . . . 0.0 113.438 -179.202 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.4 p -96.13 5.06 8.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.114 179.73 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.5 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 42.4 t -88.68 133.45 30.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.275 179.431 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.15 162.69 19.21 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.213 0.53 . . . . 0.0 110.576 179.965 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -60.6 -42.14 96.2 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.944 -178.512 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.615 ' O ' ' N ' ' A' ' 49' ' ' CYS . 97.6 mm-40 -109.33 -16.07 14.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.11 179.837 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.6 t60 34.88 -77.82 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.686 -179.316 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.615 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.11 136.64 45.95 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.113 0.483 . . . . 0.0 111.364 -178.931 . . . . . . . . 3 3 . 1 . 074 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -127.86 129.54 47.08 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.867 179.855 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.8 mt -112.18 133.03 59.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.14 179.663 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.527 ' CD ' ' HE2' ' A' ' 54' ' ' HIS . 81.7 tt0 -115.61 124.03 49.92 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.048 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.445 HG23 HD12 ' A' ' 53' ' ' ILE . 48.4 mm -96.33 117.61 40.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.155 0.502 . . . . 0.0 111.886 -178.345 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.527 ' HE2' ' CD ' ' A' ' 52' ' ' GLU . 95.8 m-70 -115.42 132.52 56.59 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.116 179.065 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 54' ' ' HIS . 96.9 mt-10 -42.54 -30.16 0.33 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.375 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.457 ' N ' ' C ' ' A' ' 54' ' ' HIS . 59.3 tt0 -67.09 -68.37 0.38 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.602 178.216 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -151.16 -174.83 4.93 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.475 0.655 . . . . 0.0 111.905 -179.66 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.35 122.16 46.54 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.978 178.372 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 98.5 mt -117.2 132.35 67.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -178.505 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.1 tp -98.76 130.16 45.21 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.173 179.302 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -110.35 135.43 51.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.785 179.585 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 64.2 t-20 -95.31 105.97 17.97 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.915 179.983 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -98.34 -9.81 24.8 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.581 179.52 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.1 m -72.99 100.63 3.02 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 178.988 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.2 p -87.11 -21.55 25.93 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.114 179.95 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.72 -44.86 11.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.215 -179.73 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -132.34 93.14 26.35 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.285 179.75 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -56.25 142.71 87.18 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.45 2.1 . . . . 0.0 112.84 -178.6 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 45.6 m -75.74 152.99 37.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.819 179.607 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -116.08 140.67 49.04 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.835 -179.278 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 55.6 t -129.25 134.5 63.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.336 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 53.29 33.41 15.5 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -179.163 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.9 28.62 70.32 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.696 179.944 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 45.0 t -141.65 140.05 33.16 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 117.04 0.42 . . . . 0.0 111.39 -179.972 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.1 t -66.66 136.38 26.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.685 -179.86 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.7 pt -111.88 79.19 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.617 179.276 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -62.27 -26.94 68.67 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.355 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.08 162.04 26.27 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.837 179.187 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.41 146.43 89.66 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.544 2.163 . . . . 0.0 111.561 179.724 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.7 m -137.77 142.95 34.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.17 0.51 . . . . 0.0 111.555 -179.6 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -72.32 127.52 32.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.585 -179.759 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.0 mt -78.52 139.19 38.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.185 0.517 . . . . 0.0 111.185 -179.596 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -135.72 150.06 49.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.209 -178.68 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.412 ' HD1' ' HB2' ' A' ' 99' ' ' ASN . 3.5 t-160 -53.35 113.21 1.07 Allowed 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.73 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.32 -10.89 26.43 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -179.784 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.42 ' OD1' ' C ' ' A' ' 86' ' ' ASP . 49.0 t0 -74.19 127.24 32.44 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.41 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 13.1 p -108.78 132.64 56.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.639 -178.493 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 94.9 mt -98.66 130.37 47.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.11 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.1 m -117.38 127.25 53.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.725 0.774 . . . . 0.0 112.177 -178.669 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.595 ' O ' ' N ' ' A' ' 93' ' ' ARG . 94.7 mt -116.39 132.86 64.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 114.46 -1.245 . . . . 0.0 108.436 178.536 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.534 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 89.1 mt -25.64 99.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 -179.098 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.534 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 6.9 t0 90.06 -21.88 0.12 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 178.08 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.595 ' N ' ' O ' ' A' ' 90' ' ' ILE . 63.2 mtt85 -131.27 146.09 52.16 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.215 -179.289 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 44.8 p -140.67 154.56 46.44 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.026 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -128.26 128.51 44.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.033 -179.825 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -94.81 135.07 36.74 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 119.461 -0.896 . . . . 0.0 110.66 -179.948 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.461 ' CE2' ' OD1' ' A' ' 99' ' ' ASN . 88.0 t80 -95.04 125.89 40.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.707 -179.705 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.521 ' N ' ' OE1' ' A' ' 98' ' ' GLU . 55.7 mp0 -134.94 126.94 29.64 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.423 -179.652 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.461 ' OD1' ' CE2' ' A' ' 97' ' ' TYR . 98.3 m-20 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.867 179.122 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo . . . . . 0 N--CA 1.492 1.39 0 CA-C-O 120.966 0.319 . . . . 0.0 112.415 . . . . . . . . . 0 0 . 1 . 074 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 40.2 t -114.03 136.5 50.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.933 -179.764 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.008 -179.207 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo . . . . . 0 N--CA 1.501 1.921 0 N-CA-C 114.241 0.824 . . . . 0.0 114.241 . . . . . . . . . 0 0 . 1 . 074 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 44.8 p -79.52 -34.62 41.0 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.321 179.423 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . 0.544 ' CE2' ' CZ ' ' B' ' 245' ' ' ARG . 78.9 t80 -57.9 -47.86 81.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.702 -179.572 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . 0.408 HD22 ' NH2' ' B' ' 245' ' ' ARG . 72.0 mt -65.36 -43.16 91.68 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.005 0.431 . . . . 0.0 110.774 179.276 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -65.8 -39.43 90.91 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.463 -179.245 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -61.67 -47.23 86.27 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.962 -179.719 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.544 ' CZ ' ' CE2' ' B' ' 241' ' ' PHE . 78.1 mtm180 -65.95 -37.99 87.44 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.39 -179.275 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -59.57 -42.17 91.84 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.994 0.426 . . . . 0.0 111.006 179.703 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' B' B ' 247' ' ' SER . . . . . 0.606 ' HG ' ' N ' ' B' ' 248' ' ' GLN . 81.2 p -68.95 -42.98 75.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.664 0.745 . . . . 0.0 109.112 178.981 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . 0.606 ' N ' ' HG ' ' B' ' 247' ' ' SER . 94.7 mt-30 -62.97 -37.92 89.03 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.783 179.749 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 55.1 t . . . . . 0 N--CA 1.454 -0.261 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.112 . . . . . . . . 0 0 . 1 . 074 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . 0.446 ' OE1' ' NH2' ' A' ' 93' ' ' ARG . 99.0 mt-10 . . . . . 0 N--CA 1.455 -0.2 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 . . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 70.5 mt -112.88 134.89 54.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -179.999 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 48.8 t -126.51 134.35 66.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.122 179.47 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -94.79 120.94 35.84 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.155 0.502 . . . . 0.0 110.993 -179.457 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . 0.417 ' HG3' HH22 ' A' ' 38' ' ' ARG . 88.2 tttt -62.93 -45.7 91.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.016 179.414 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 5.7 mm100 -97.68 152.7 38.29 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.336 -179.803 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -69.88 148.98 65.51 Favored 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 122.906 2.404 . . . . 0.0 113.305 -179.279 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 18.7 pt . . . . . 0 N--CA 1.462 0.146 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.313 178.9 . . . . . . . . 0 0 . 1 . 075 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 59.6 p . . . . . 0 N--CA 1.463 0.219 0 CA-C-O 120.904 0.383 . . . . 0.0 111.451 . . . . . . . . . 0 0 . 1 . 075 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.726 HH11 ' HH ' ' A' ' 97' ' ' TYR . 91.5 mtt-85 -92.49 129.77 38.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.071 -177.941 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -136.47 141.99 43.54 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.362 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 26.1 mt -116.48 142.12 47.29 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.87 179.207 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.7 t -114.76 129.32 71.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.138 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 m -94.57 118.54 31.84 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -177.725 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 91.0 mt -81.39 143.58 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.804 179.587 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 69.9 mttt -87.51 160.73 18.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.374 178.671 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.522 HH21 ' HG3' ' B' ' 245' ' ' ARG . 81.3 mtp180 -56.18 -33.14 64.99 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.693 -178.76 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 99.8 p -79.82 -8.29 59.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.311 -179.314 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.64 39.75 5.82 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 179.831 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 37.1 t -123.15 133.96 67.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.237 0.542 . . . . 0.0 111.261 -179.454 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -68.9 123.23 20.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.128 179.905 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -115.38 -125.31 3.92 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.507 -179.577 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -74.32 150.08 41.13 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.139 1.893 . . . . 0.0 112.363 -179.342 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -107.21 150.91 26.11 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.9 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -119.24 90.98 43.11 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.286 -178.585 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -63.94 130.82 28.69 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.509 2.14 . . . . 0.0 111.36 178.708 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.1 mt -96.05 122.37 38.81 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.738 -179.671 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.4 p -121.87 -26.38 4.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.126 179.284 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.3 mt -78.3 143.72 36.73 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.054 179.008 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.0 p -69.93 -13.82 62.42 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.307 -179.389 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.443 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 20.3 m -127.75 130.39 48.68 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 120.599 -0.441 . . . . 0.0 110.905 179.452 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.8 t -126.67 119.03 25.98 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.595 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' A' ' 36' ' ' ASP . 52.9 tp -117.57 124.35 48.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.901 0.382 . . . . 0.0 111.667 -178.776 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.442 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 4.7 m-85 -100.39 142.55 31.71 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 178.768 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 155.55 -177.14 32.86 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 119.972 -1.109 . . . . 0.0 112.265 178.709 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.61 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 87.8 mtm-85 -75.34 -32.18 60.81 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.139 0.495 . . . . 0.0 110.007 179.388 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.546 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -53.0 146.5 18.22 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.112 -178.434 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.44 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 10.2 tp -66.88 -41.57 87.83 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.158 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.44 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 78.2 mm-40 -54.07 -19.55 5.06 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.758 179.818 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.546 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 38.6 m -60.67 124.61 20.93 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.072 179.917 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.443 ' OD2' ' O ' ' A' ' 26' ' ' THR . 56.1 m-20 -59.11 -32.41 69.81 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -179.793 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 85.5 mt -124.04 120.82 60.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 175.724 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -108.43 136.0 48.79 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.209 -0.596 . . . . 0.0 111.242 -179.189 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 76.8 mt -115.67 132.0 66.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.99 -179.879 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -80.31 25.62 0.39 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.124 -178.476 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 36.2 mt -99.04 129.14 30.22 Favored Pre-proline 0 C--N 1.328 -0.333 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.266 179.332 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.45 -13.53 33.03 Favored 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 122.184 1.922 . . . . 0.0 112.798 -179.638 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -91.58 1.25 8.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.499 -0.48 . . . . 0.0 111.75 -179.542 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.61 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 66.0 t -93.22 132.32 37.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.352 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.454 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 0.3 OUTLIER -61.69 164.7 5.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.241 0.543 . . . . 0.0 111.551 -178.585 . . . . . . . . 3 3 . 1 . 075 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.473 ' CG ' ' NH2' ' A' ' 31' ' ' ARG . 96.6 mttt -61.99 -45.08 95.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.825 -179.142 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.589 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.2 mt-30 -110.53 -12.34 14.38 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-O 121.519 0.676 . . . . 0.0 109.548 179.315 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.454 ' H ' ' HB3' ' A' ' 45' ' ' SER . 25.1 t60 28.8 -75.45 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.219 -1.355 . . . . 0.0 114.255 179.277 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.589 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.43 135.87 46.37 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -177.688 . . . . . . . . 3 3 . 1 . 075 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -126.78 130.49 50.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.616 179.36 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 98.3 mt -115.22 133.31 61.86 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.135 179.537 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -112.48 122.47 47.81 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.309 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 94.7 mt -104.13 113.57 41.41 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 C-N-CA 119.726 -0.79 . . . . 0.0 111.943 -179.004 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.441 ' C ' ' N ' ' A' ' 56' ' ' GLN . 89.9 m-70 -113.5 141.21 47.4 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.592 179.274 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 54' ' ' HIS . 94.8 mt-10 -40.67 -31.87 0.18 Allowed 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -179.365 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.441 ' N ' ' C ' ' A' ' 54' ' ' HIS . 54.7 mt-30 -63.4 -67.75 0.4 Allowed 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.359 -0.837 . . . . 0.0 108.78 178.623 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -154.99 -174.77 5.12 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.785 0.803 . . . . 0.0 112.611 -179.285 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.65 119.54 39.71 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 114.457 -1.247 . . . . 0.0 108.198 177.689 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.2 mt -110.48 130.12 64.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.842 0.353 . . . . 0.0 111.823 -178.467 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 28.0 tp -97.05 128.24 43.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.464 179.88 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -113.43 138.77 49.61 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.535 179.746 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -96.44 111.09 23.31 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -179.233 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -104.5 -8.49 19.04 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.762 178.698 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.7 t -75.23 104.61 5.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.765 0.316 . . . . 0.0 110.303 179.281 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 94.7 p -87.59 -8.33 56.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.021 0.439 . . . . 0.0 110.331 179.843 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.4 ' HB ' ' ND2' ' A' ' 67' ' ' ASN . 0.2 OUTLIER -101.94 -37.26 8.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.207 -179.213 . . . . . . . . 3 3 . 1 . 075 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.4 ' ND2' ' HB ' ' A' ' 66' ' ' THR . 6.3 m-80 -145.07 98.87 4.68 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.489 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -57.29 145.84 85.3 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 121.8 1.667 . . . . 0.0 112.258 -178.782 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 28.8 m -67.7 137.34 55.44 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.291 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -102.42 140.78 36.24 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.399 179.576 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 55.7 t -130.95 133.22 63.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.675 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 54.59 30.51 13.32 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.671 -178.922 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.98 23.97 73.12 Favored Glycine 0 CA--C 1.534 1.27 0 CA-C-N 115.307 -0.861 . . . . 0.0 112.711 179.001 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 58.5 m -139.09 145.65 39.77 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 117.522 0.661 . . . . 0.0 110.742 179.478 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.9 m -71.03 142.74 15.21 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-O 121.138 0.494 . . . . 0.0 111.87 -179.351 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.478 ' CG1' ' O ' ' A' ' 78' ' ' GLU . 6.7 tt -109.54 92.35 2.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.196 179.155 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -65.89 -34.98 79.37 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.746 -179.685 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.478 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 0.2 OUTLIER -126.04 175.06 3.44 Favored Pre-proline 0 N--CA 1.464 0.259 0 C-N-CA 120.414 -0.515 . . . . 0.0 111.481 -179.578 . . . . . . . . 3 3 . 1 . 075 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.421 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 35.5 Cg_exo -57.68 140.98 95.28 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.509 2.139 . . . . 0.0 112.396 -179.881 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 72.1 t -137.43 137.83 45.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.181 -179.671 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 91.9 mtm-85 -74.29 132.02 41.7 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.713 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 97.8 mt -87.95 139.27 30.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.174 0.512 . . . . 0.0 111.852 -178.72 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -129.63 154.18 47.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.487 -179.43 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.623 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 7.6 t60 -57.0 120.69 8.4 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.84 0.353 . . . . 0.0 111.462 -179.29 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.15 -16.48 27.43 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.651 -0.58 . . . . 0.0 111.651 179.299 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -69.94 136.99 51.15 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.105 0.478 . . . . 0.0 110.276 179.812 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 53.3 t -111.88 132.07 61.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.169 -178.936 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.463 HG21 HD13 ' A' ' 88' ' ' ILE . 96.1 mt -99.1 130.94 47.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.559 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.5 m -122.82 126.41 47.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.293 0.568 . . . . 0.0 111.816 -178.387 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.495 ' O ' ' N ' ' A' ' 93' ' ' ARG . 96.2 mt -113.31 124.18 69.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.291 178.164 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.456 ' C ' ' O ' ' A' ' 90' ' ' ILE . 48.5 mm 35.03 -98.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.796 -179.533 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.578 ' OD2' ' NE ' ' B' ' 245' ' ' ARG . 85.3 m-20 -110.44 5.14 21.16 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -179.517 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.495 ' N ' ' O ' ' A' ' 90' ' ' ILE . 84.6 mtt-85 -120.39 145.48 47.13 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.943 -179.129 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.5 p -140.64 152.87 45.74 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.199 0.523 . . . . 0.0 111.196 179.789 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -123.95 123.17 39.81 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.841 179.592 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -80.6 129.19 34.37 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.287 -179.87 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.726 ' HH ' HH11 ' A' ' 5' ' ' ARG . 86.8 t80 -96.15 125.45 40.68 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.792 0.33 . . . . 0.0 111.267 -179.645 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -130.85 123.17 28.44 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 121.064 0.459 . . . . 0.0 111.532 -179.882 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.623 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 58.4 t-20 . . . . . 0 C--N 1.327 -0.386 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.445 179.845 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo . . . . . 0 N--CA 1.49 1.312 0 CA-C-O 121.028 0.345 . . . . 0.0 112.213 . . . . . . . . . 0 0 . 1 . 075 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 2.7 p -118.99 137.14 53.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.557 -179.729 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 3.0 t . . . . . 0 C--N 1.332 -0.171 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.514 -179.74 . . . . . . . . 0 0 . 1 . 075 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo . . . . . 0 N--CA 1.494 1.541 0 CA-C-O 120.547 0.144 . . . . 0.0 112.446 . . . . . . . . . 0 0 . 1 . 075 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 97.8 m -73.21 -44.89 58.96 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.271 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -57.88 -45.77 85.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.855 -179.493 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . 0.53 ' CD2' ' OD1' ' A' ' 92' ' ' ASP . 97.2 mt -63.46 -41.08 98.63 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 120.746 -0.381 . . . . 0.0 110.466 -179.634 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -60.28 -42.89 96.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.351 -179.476 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -64.04 -39.9 95.13 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.353 -179.997 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.578 ' NE ' ' OD2' ' A' ' 92' ' ' ASP . 57.9 ttm-85 -59.49 -44.13 93.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.862 -179.978 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -60.8 -42.95 98.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.039 0.447 . . . . 0.0 111.033 -179.472 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 67.8 p -69.68 -44.12 71.1 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.608 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . 0.441 ' HG2' HH22 ' A' ' 12' ' ' ARG . 66.3 tp60 -59.19 -39.2 81.85 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.474 179.758 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 73.4 t . . . . . 0 C--N 1.332 -0.161 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.495 179.682 . . . . . . . . 0 0 . 1 . 075 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 . . . . . 0 N--CA 1.463 0.197 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 . . . . . . . . . 0 0 . 1 . 075 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 65.7 mt -111.74 134.97 52.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.915 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 42.2 t -125.35 132.76 70.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.909 0.385 . . . . 0.0 110.467 179.464 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -98.6 121.02 40.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.938 -178.648 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -69.21 -47.1 65.74 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.276 -179.368 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -67.31 165.69 26.67 Favored Pre-proline 0 N--CA 1.464 0.266 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.904 -179.237 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -62.42 143.58 93.65 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.472 2.115 . . . . 0.0 111.603 179.217 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 19.8 tt . . . . . 0 N--CA 1.446 -0.649 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.056 -179.413 . . . . . . . . 0 0 . 1 . 076 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 95.9 m . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.692 0.282 . . . . 0.0 111.598 . . . . . . . . . 0 0 . 1 . 076 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.6 mtt85 -93.63 125.69 38.39 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.538 -178.145 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -124.19 140.5 52.9 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.015 -179.4 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 38.0 tp -113.66 131.34 56.19 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.792 179.704 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.2 m -110.55 130.73 63.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 121.13 0.491 . . . . 0.0 111.334 -179.393 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.1 m -78.45 141.97 37.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.297 -179.182 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.5 mm -109.97 136.43 45.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.033 177.296 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -91.42 154.77 18.93 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.435 179.54 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.477 ' CD ' ' OD2' ' A' ' 92' ' ' ASP . 89.1 mtm180 -54.56 -27.23 37.3 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.301 -179.684 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 91.8 p -80.48 -7.37 59.15 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.926 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.19 39.65 7.82 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 179.938 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.9 t -125.15 137.54 57.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -178.835 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.44 ' CG ' ' HE2' ' A' ' 19' ' ' HIS . 67.4 t0 -69.96 127.49 33.04 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.086 179.827 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -113.6 -127.51 4.6 Favored Glycine 0 CA--C 1.54 1.606 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 179.735 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -75.36 154.19 40.63 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 122.345 2.03 . . . . 0.0 112.311 -179.51 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.44 ' HE2' ' CG ' ' A' ' 16' ' ' ASP . 64.3 m170 -109.37 140.65 42.8 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.234 0.54 . . . . 0.0 111.888 -178.267 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -112.66 106.14 55.64 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.918 179.771 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -74.59 126.23 10.08 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 121.635 1.557 . . . . 0.0 111.563 -179.538 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.452 ' CD2' ' SG ' ' A' ' 27' ' ' CYS . 87.7 mt -82.8 52.66 2.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.899 0.38 . . . . 0.0 110.905 -179.263 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.6 t -64.66 -27.61 69.04 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.929 179.607 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.6 mt -79.11 142.96 35.97 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.705 179.568 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 44.0 t -63.67 -18.47 64.01 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 121.17 -0.212 . . . . 0.0 111.422 -179.341 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 40.7 m -131.13 131.6 44.23 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.867 -179.321 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.452 ' SG ' ' CD2' ' A' ' 22' ' ' LEU . 4.0 t -124.15 115.24 20.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.197 178.908 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.431 ' O ' ' N ' ' A' ' 36' ' ' ASP . 53.1 tp -112.26 122.79 48.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.162 0.506 . . . . 0.0 111.825 -178.849 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.525 ' O ' ' O ' ' A' ' 47' ' ' GLN . 5.4 m-85 -102.28 139.42 37.91 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.403 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 167.09 -171.56 41.9 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 118.699 -1.715 . . . . 0.0 113.513 179.304 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.563 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 36.7 ttp-105 -89.57 -31.54 17.54 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 114.549 -0.826 . . . . 0.0 109.377 179.585 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.46 151.62 39.48 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.767 -0.533 . . . . 0.0 111.767 -179.465 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.564 ' CD1' ' CZ ' ' A' ' 38' ' ' ARG . 39.5 mm -63.31 -44.41 99.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 121.106 0.479 . . . . 0.0 110.314 -179.965 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -52.95 -18.98 2.25 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.628 -179.208 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.55 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 78.6 m -62.78 128.19 34.77 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.247 -179.882 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 28' ' ' LEU . 62.2 m-20 -59.41 -31.3 69.14 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -179.56 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.441 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 93.3 mt -124.81 116.02 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.59 177.683 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.564 ' CZ ' ' CD1' ' A' ' 33' ' ' ILE . 83.7 mtp180 -99.25 137.63 37.5 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.928 -178.48 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.501 ' C ' ' H ' ' A' ' 41' ' ' LEU . 96.6 mt -119.82 129.02 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 121.335 0.588 . . . . 0.0 110.166 179.044 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -68.92 23.64 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.402 -178.156 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.65 ' CD1' ' NH1' ' A' ' 93' ' ' ARG . 36.6 mt -106.0 129.68 24.2 Favored Pre-proline 0 C--N 1.324 -0.527 0 C-N-CA 120.015 -0.674 . . . . 0.0 111.247 -179.451 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.69 -10.4 25.04 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 C-N-CA 122.085 1.857 . . . . 0.0 112.589 179.714 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.2 m -91.55 1.42 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.213 179.183 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.563 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 51.4 t -90.83 136.01 25.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.03 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.3 m -71.78 168.34 18.03 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.492 0.663 . . . . 0.0 111.461 -178.783 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.55 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 97.9 mttt -60.15 -42.03 94.04 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.832 -1.077 . . . . 0.0 111.454 -179.257 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.665 ' O ' ' N ' ' A' ' 49' ' ' CYS . 87.2 mt-30 -116.29 -17.68 10.7 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 123.246 0.341 . . . . 0.0 110.976 179.789 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 31.6 t60 34.58 -74.81 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -179.691 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.665 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.29 137.44 46.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.326 0.584 . . . . 0.0 112.455 -178.831 . . . . . . . . 3 3 . 1 . 076 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -128.96 133.14 47.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.011 -179.749 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 88.2 mt -116.62 134.44 60.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.384 179.89 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -115.54 123.48 48.61 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 177.719 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 76.4 mt -103.75 114.11 42.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.287 -178.954 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.595 ' O ' ' N ' ' A' ' 56' ' ' GLN . 92.6 m-70 -111.8 141.75 45.02 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.007 179.233 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.48 ' OE1' ' N ' ' A' ' 55' ' ' GLU . 56.0 mp0 -39.47 -24.12 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.495 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.595 ' N ' ' O ' ' A' ' 54' ' ' HIS . 58.1 tt0 -67.95 -69.25 0.33 Allowed 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.177 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.69 ' CB ' ' HE ' ' A' ' 81' ' ' ARG . 2.8 tp10 -158.02 -163.11 1.25 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.334 179.914 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -115.98 125.42 52.48 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.012 -0.995 . . . . 0.0 108.531 178.347 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.4 mt -113.76 129.91 68.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.848 -178.413 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 50.5 tp -94.11 126.62 39.45 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.483 179.761 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -112.67 136.61 52.04 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.246 179.798 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -98.63 108.75 21.51 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.134 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -100.11 -11.24 20.67 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.432 179.473 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.1 t -69.64 103.35 2.09 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.596 179.106 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.0 p -84.51 -12.47 54.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.288 0.566 . . . . 0.0 109.548 178.856 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.19 -37.27 9.76 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.756 179.956 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -144.18 90.27 6.79 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.847 179.741 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -56.23 146.33 72.3 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.21 1.94 . . . . 0.0 112.264 -179.862 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 56.8 m -73.32 144.02 46.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.159 179.913 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -102.97 141.04 36.44 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.694 179.639 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.8 t -130.34 134.67 62.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.553 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 53.71 34.73 19.58 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.27 -179.431 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.29 29.4 70.27 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.499 179.217 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.9 t -143.64 136.75 27.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 117.355 0.577 . . . . 0.0 110.783 179.314 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.8 p -70.72 139.96 19.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.692 -179.401 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.568 ' CD1' ' O ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -132.76 125.56 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.931 179.31 . . . . . . . . 3 3 . 1 . 076 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -97.73 -9.27 26.95 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.755 -179.382 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.568 ' O ' ' CD1' ' A' ' 76' ' ' ILE . 0.4 OUTLIER -125.19 170.33 9.42 Favored Pre-proline 0 N--CA 1.469 0.482 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.162 -179.431 . . . . . . . . 3 3 . 1 . 076 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -61.41 143.29 97.52 Favored 'Trans proline' 0 N--CA 1.501 1.915 0 C-N-CA 122.442 2.095 . . . . 0.0 113.271 -179.601 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 42.7 t -136.21 136.9 48.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.329 178.403 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.69 ' HE ' ' CB ' ' A' ' 57' ' ' GLU . 72.1 ttt180 -75.63 131.95 40.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.872 179.98 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.6 mt -84.89 136.73 33.51 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.369 0.604 . . . . 0.0 112.417 -178.369 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.528 ' HZ3' ' CZ ' ' A' ' 81' ' ' ARG . 74.0 mmtt -125.73 149.21 48.71 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.494 179.495 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.463 ' CE1' ' O ' ' A' ' 99' ' ' ASN . 5.3 t-160 -54.48 113.81 1.43 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.837 0.351 . . . . 0.0 110.989 -179.934 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.3 -15.67 25.06 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.018 178.938 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -68.3 137.22 54.5 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.099 -0.64 . . . . 0.0 109.403 179.534 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 23.3 t -110.04 134.26 52.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.868 -178.728 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 86.2 mt -103.76 129.42 55.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.1 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.9 m -116.36 129.35 56.2 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.515 -178.958 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.58 ' O ' ' N ' ' A' ' 93' ' ' ARG . 94.3 mt -119.65 128.85 75.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.53 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.509 ' O ' ' NH1' ' A' ' 93' ' ' ARG . 94.5 mt -20.41 95.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -178.984 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.477 ' OD2' ' CD ' ' A' ' 12' ' ' ARG . 5.2 t0 90.07 -22.12 0.11 Allowed 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 177.985 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.65 ' NH1' ' CD1' ' A' ' 41' ' ' LEU . 14.7 mtm-85 -130.58 145.84 51.97 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.235 -179.69 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.8 p -138.01 155.79 48.49 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.038 0.447 . . . . 0.0 110.781 -179.361 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -131.65 129.44 40.81 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.643 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 44.4 ttm180 -96.83 136.34 37.51 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 119.836 -0.745 . . . . 0.0 110.229 179.83 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -89.68 125.48 35.28 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.682 -179.724 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -125.65 127.3 46.07 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.5 -179.366 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.463 ' O ' ' CE1' ' A' ' 84' ' ' HIS . 55.5 t-20 . . . . . 0 N--CA 1.463 0.225 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.199 179.601 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo . . . . . 0 N--CA 1.486 1.069 0 CA-C-O 121.187 0.411 . . . . 0.0 111.923 . . . . . . . . . 0 0 . 1 . 076 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 6.6 p -115.19 137.28 49.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.762 -179.893 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 5.7 t . . . . . 0 CA--C 1.52 -0.189 0 CA-C-O 120.876 0.37 . . . . 0.0 110.958 -178.52 . . . . . . . . 0 0 . 1 . 076 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo . . . . . 0 N--CA 1.494 1.506 0 CA-C-O 120.518 0.132 . . . . 0.0 112.292 . . . . . . . . . 0 0 . 1 . 076 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 94.6 m -75.51 -42.75 51.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.043 0.449 . . . . 0.0 110.352 178.813 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -57.54 -47.34 82.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.761 -179.832 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 90.1 mt -63.72 -41.19 98.1 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.086 0.47 . . . . 0.0 109.781 179.439 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -60.93 -41.31 95.95 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.873 179.789 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 73.6 ttt-85 -63.05 -43.23 99.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.668 -179.78 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.482 ' NH2' ' CD2' ' A' ' 41' ' ' LEU . 24.0 mmt180 -59.9 -43.27 94.91 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.55 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.48 -41.93 98.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.818 179.215 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 11.8 t -65.73 -44.05 87.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.725 0.774 . . . . 0.0 108.957 179.512 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -60.89 -37.5 82.42 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.938 -179.447 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 62.7 t . . . . . 0 C--N 1.33 -0.272 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.614 179.647 . . . . . . . . 0 0 . 1 . 076 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 . . . . . 0 N--CA 1.462 0.151 0 CA-C-O 120.891 0.377 . . . . 0.0 110.546 . . . . . . . . . 0 0 . 1 . 076 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 65.9 mt -113.9 133.8 58.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.852 -179.856 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 43.5 t -126.91 134.23 66.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.508 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -97.38 123.65 41.28 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.137 0.494 . . . . 0.0 111.495 -178.255 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -64.07 -41.49 97.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.572 179.697 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -105.53 173.14 3.43 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.547 -178.956 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -57.26 150.78 55.97 Favored 'Trans proline' 0 N--CA 1.502 1.973 0 C-N-CA 122.824 2.349 . . . . 0.0 114.219 -179.614 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 41.4 pt . . . . . 0 C--O 1.232 0.16 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.501 179.823 . . . . . . . . 0 0 . 1 . 077 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.9 m . . . . . 0 N--CA 1.465 0.289 0 CA-C-O 121.076 0.465 . . . . 0.0 111.663 . . . . . . . . . 0 0 . 1 . 077 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.505 ' NH1' ' CG2' ' A' ' 53' ' ' ILE . 85.0 mtt85 -89.57 134.21 34.23 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.355 -178.549 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -134.82 144.3 47.53 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.292 179.982 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 85.1 mt -114.94 135.65 53.98 Favored 'General case' 0 C--N 1.334 -0.097 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.635 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 76.7 t -111.83 130.36 65.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.562 -0.455 . . . . 0.0 109.994 -179.363 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.1 m -80.3 140.24 36.25 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -178.132 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.412 HG22 HD13 ' A' ' 10' ' ' ILE . 96.6 mt -106.13 132.47 53.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 176.673 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.644 ' C ' HH22 ' A' ' 93' ' ' ARG . 97.3 mttt -86.25 154.2 21.45 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.189 0.518 . . . . 0.0 109.729 179.134 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.637 ' N ' HH22 ' A' ' 93' ' ' ARG . 84.9 mtp180 -56.15 -28.8 59.39 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.186 -179.263 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 86.1 p -80.7 -8.83 59.77 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.641 179.747 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.55 33.17 8.72 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.721 -0.551 . . . . 0.0 111.721 179.367 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 54.3 t -119.82 135.33 60.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.784 0.326 . . . . 0.0 110.414 179.818 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -65.03 125.99 26.65 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.776 179.81 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -111.19 -133.33 6.26 Favored Glycine 0 CA--C 1.539 1.575 0 C-N-CA 120.722 -0.752 . . . . 0.0 111.942 -179.184 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.85 151.88 40.86 Favored 'Trans proline' 0 N--CA 1.499 1.827 0 C-N-CA 122.571 2.181 . . . . 0.0 113.037 -178.624 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.501 ' H ' ' CD2' ' A' ' 19' ' ' HIS . 0.1 OUTLIER -106.02 147.87 28.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.363 179.508 . . . . . . . . 3 3 . 1 . 077 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -117.26 95.24 46.96 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.353 -179.571 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -64.15 127.32 19.01 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 122.613 2.209 . . . . 0.0 111.96 -179.468 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 93.3 mt -85.61 83.33 7.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.086 0.469 . . . . 0.0 111.357 -179.485 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 92.2 p -88.17 -14.17 39.3 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.488 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 66.9 mt -95.52 138.39 33.26 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.091 -179.688 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 27.5 t -64.37 -17.67 63.94 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.058 -179.742 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 46.8 m -128.67 129.53 45.94 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.563 179.582 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.9 t -121.38 115.63 23.29 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.128 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.404 ' O ' ' N ' ' A' ' 36' ' ' ASP . 53.9 tp -113.38 122.02 46.11 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.466 -178.857 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.434 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 18.3 m-85 -100.07 141.34 33.03 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.455 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 169.35 -161.08 34.56 Favored Glycine 0 C--O 1.226 -0.392 0 C-N-CA 119.541 -1.314 . . . . 0.0 112.467 179.238 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 29.5 ttp85 -108.0 -9.84 15.59 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -178.372 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -89.21 170.62 37.66 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.798 -178.714 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.409 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 10.7 tp -66.88 -41.45 87.66 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 O-C-N 122.759 -0.259 . . . . 0.0 110.562 179.861 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.409 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 72.3 mm-40 -54.27 -26.66 30.3 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.055 0.455 . . . . 0.0 110.721 -179.19 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.548 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 79.2 m -64.2 121.31 13.92 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.485 -179.982 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 28' ' ' LEU . 87.4 m-20 -59.7 -28.2 67.09 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.342 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.418 HG22 HD11 ' A' ' 37' ' ' ILE . 89.4 mt -127.08 123.04 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.175 177.726 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 -104.24 136.05 44.57 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.242 -179.595 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.486 ' C ' ' H ' ' A' ' 41' ' ' LEU . 97.4 mt -117.5 128.93 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.912 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -72.39 34.0 0.06 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.244 -178.199 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.531 ' CD2' ' CZ ' ' B' ' 245' ' ' ARG . 32.2 mt -102.87 126.5 32.43 Favored Pre-proline 0 C--N 1.322 -0.624 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.428 179.339 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -73.03 -7.12 20.17 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.147 1.898 . . . . 0.0 112.655 -179.418 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.7 m -102.99 13.23 7.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.499 179.394 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 29.1 t -99.76 133.26 43.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.172 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 33.2 t -72.49 175.05 6.61 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.439 0.638 . . . . 0.0 112.538 -178.329 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.548 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 61.0 mttp -65.18 -40.64 94.54 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.797 -179.455 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.659 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.1 mt-30 -112.86 -18.06 12.36 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.211 -179.853 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 23.9 t60 32.73 -74.48 0.0 OUTLIER 'General case' 0 C--O 1.236 0.357 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 179.882 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.659 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.48 134.0 46.73 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.998 0.428 . . . . 0.0 111.594 -179.578 . . . . . . . . 3 3 . 1 . 077 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -125.77 130.36 51.29 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.465 179.183 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.6 mt -117.43 134.01 62.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.226 179.611 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -114.52 131.03 56.79 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.396 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.505 ' CG2' ' NH1' ' A' ' 5' ' ' ARG . 48.3 mm -99.45 120.29 48.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.46 -178.449 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.462 ' O ' ' C ' ' A' ' 55' ' ' GLU . 94.0 m-70 -119.73 132.36 55.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.262 179.103 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.462 ' C ' ' O ' ' A' ' 54' ' ' HIS . 98.4 mt-10 -40.31 -37.17 0.62 Allowed 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.728 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.456 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 84.3 mt-30 -62.76 -67.25 0.44 Allowed 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.379 179.028 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.456 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 6.1 tp10 -151.03 -166.62 2.58 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.2 -179.039 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.453 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -125.48 135.71 52.59 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 -179.957 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.9 mt -119.04 131.49 71.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -178.311 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.431 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 32.7 tp -97.94 125.93 43.09 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 114.827 -1.079 . . . . 0.0 108.846 178.471 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -112.71 136.79 51.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.743 -179.058 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 26.0 t30 -96.31 105.61 17.7 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.788 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.422 ' CD2' ' OE1' ' A' ' 47' ' ' GLN . 27.0 m-85 -96.48 -9.21 30.21 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.066 178.613 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.515 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 42.2 t -73.83 100.22 3.41 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.477 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.9 m -83.18 -16.61 45.94 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.383 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.42 -38.95 15.68 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.252 -179.782 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.515 ' O ' ' OG ' ' A' ' 64' ' ' SER . 77.4 m-20 -146.62 98.73 4.17 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.343 -179.86 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.38 147.78 55.09 Favored 'Trans proline' 0 N--CA 1.501 1.961 0 C-N-CA 122.392 2.062 . . . . 0.0 113.688 -179.423 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 89.1 m -71.41 136.09 47.55 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.695 179.1 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -98.88 140.89 32.38 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.642 -179.722 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.455 ' CG1' ' OD1' ' A' ' 86' ' ' ASP . 71.5 t -129.43 134.71 63.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.07 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 51.28 34.78 12.17 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.604 -0.838 . . . . 0.0 109.655 -179.773 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.23 30.11 69.78 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.933 179.64 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.6 p -142.22 133.7 26.59 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.469 -179.693 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -67.6 142.37 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.309 -179.964 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.465 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 2.9 pt -119.02 121.27 66.39 Favored 'Isoleucine or valine' 0 C--N 1.343 0.285 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.109 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -87.2 -24.09 24.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.401 -179.894 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -127.04 172.98 5.81 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.907 -179.585 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.51 144.1 99.5 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 122.434 2.09 . . . . 0.0 112.58 179.514 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.7 t -132.16 138.57 52.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.737 178.922 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -73.31 131.17 41.6 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.442 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 97.3 mt -84.26 135.49 34.31 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.079 0.466 . . . . 0.0 111.536 -179.912 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -127.12 149.58 49.88 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.811 179.796 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.723 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 6.7 t60 -55.6 116.63 3.01 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.423 179.819 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.1 -18.77 23.45 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 -179.416 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.455 ' OD1' ' CG1' ' A' ' 71' ' ' VAL . 36.4 t70 -66.81 132.28 47.71 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.535 0.207 . . . . 0.0 110.449 179.151 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 53.4 t -106.86 132.19 54.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.194 -178.927 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.457 ' O ' ' OG ' ' A' ' 94' ' ' SER . 80.0 mt -101.33 129.79 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 177.914 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.3 m -120.42 126.09 49.58 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.531 0.681 . . . . 0.0 112.353 -178.875 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.599 ' O ' ' N ' ' A' ' 93' ' ' ARG . 91.7 mt -113.18 133.26 59.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 177.746 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.526 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 68.0 mt -30.9 102.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 O-C-N 123.112 0.257 . . . . 0.0 111.66 -178.759 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 4.8 t70 87.67 -22.18 0.15 Allowed 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 178.743 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.644 HH22 ' C ' ' A' ' 11' ' ' LYS . 2.0 mmp_? -127.73 139.62 52.57 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.564 -179.337 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 88' ' ' ILE . 34.7 t -141.1 148.66 40.48 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.929 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -129.19 130.47 46.38 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.397 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -89.03 134.36 34.02 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.325 -179.488 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.506 ' CZ ' ' OD1' ' A' ' 99' ' ' ASN . 91.1 t80 -94.45 124.52 38.53 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.142 -179.991 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -139.2 123.96 18.58 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.513 -179.173 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.723 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 79.5 m-20 . . . . . 0 C--N 1.328 -0.339 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.621 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo . . . . . 0 N--CA 1.487 1.112 0 CA-C-O 121.77 0.654 . . . . 0.0 112.909 . . . . . . . . . 0 0 . 1 . 077 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 25.0 t -60.05 138.64 20.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.766 -179.808 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 4.1 t . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.562 -179.659 . . . . . . . . 0 0 . 1 . 077 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo . . . . . 0 N--CA 1.497 1.731 0 N-CA-C 113.576 0.568 . . . . 0.0 113.576 . . . . . . . . . 0 0 . 1 . 077 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 17.2 p -73.54 -41.25 63.25 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 119.836 -0.746 . . . . 0.0 109.268 177.981 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . 0.505 ' CZ ' ' NE ' ' B' ' 245' ' ' ARG . 75.7 t80 -56.86 -47.37 80.56 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.752 -179.415 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 90.7 mt -67.08 -40.14 86.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.515 179.172 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -63.4 -43.06 98.6 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.399 -178.653 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -61.72 -42.57 99.12 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.093 0.473 . . . . 0.0 110.637 179.69 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.531 ' CZ ' ' CD2' ' A' ' 41' ' ' LEU . 95.6 mtt-85 -64.0 -39.05 93.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.12 -179.637 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.02 -39.01 93.46 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.061 179.495 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 32.8 t -67.55 -42.18 83.08 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.22 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -58.24 -36.77 73.71 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.903 179.205 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 41.3 t . . . . . 0 N--CA 1.453 -0.321 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.501 179.259 . . . . . . . . 0 0 . 1 . 077 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 . . . . . 0 N--CA 1.464 0.235 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 . . . . . . . . . 0 0 . 1 . 077 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 64.6 mt -119.26 132.35 69.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.398 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 56.1 t -126.9 135.9 62.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.366 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -99.32 120.22 39.21 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.901 -177.885 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -65.48 -43.48 90.09 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.571 0.701 . . . . 0.0 109.916 179.451 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -100.78 172.6 4.36 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.255 -178.951 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.0 150.05 66.85 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 121.985 1.79 . . . . 0.0 112.599 179.742 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 42.5 pt . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.741 178.996 . . . . . . . . 0 0 . 1 . 078 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 46.1 m . . . . . 0 N--CA 1.455 -0.211 0 CA-C-O 121.129 0.49 . . . . 0.0 110.78 . . . . . . . . . 0 0 . 1 . 078 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.466 HH11 HD11 ' A' ' 53' ' ' ILE . 99.1 mtt180 -99.79 127.03 45.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.517 -179.016 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.792 ' HE ' ' CE1' ' A' ' 19' ' ' HIS . 83.2 mtp180 -129.3 148.67 51.25 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.877 -179.075 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 99.6 mt -112.87 142.23 45.77 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.557 178.872 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.459 HG12 HH21 ' A' ' 96' ' ' ARG . 72.8 t -116.24 128.38 73.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.59 -0.444 . . . . 0.0 109.996 179.855 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 m -81.57 141.09 34.06 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.456 0.646 . . . . 0.0 112.674 -178.293 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 83.1 mt -113.93 135.93 52.02 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.056 178.133 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.6 mttp -86.91 158.29 19.34 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.101 178.792 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.608 ' CD ' HH21 ' B' ' 245' ' ' ARG . 89.3 mtm180 -58.75 -27.46 64.98 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.193 -179.86 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 99.0 p -83.56 -8.87 59.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.825 179.771 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.43 37.73 6.49 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.863 179.819 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.1 t -118.76 131.3 71.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-O 120.835 0.35 . . . . 0.0 111.11 179.811 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -75.72 124.34 27.1 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.671 179.83 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -113.41 -122.52 3.88 Favored Glycine 0 CA--C 1.543 1.806 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.721 -179.84 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -76.4 155.54 36.58 Favored 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 123.043 2.495 . . . . 0.0 112.267 -178.702 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.792 ' CE1' ' HE ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -117.67 149.28 40.98 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.829 . . . . . . . . 3 3 . 1 . 078 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -115.5 100.49 53.64 Favored Pre-proline 0 N--CA 1.468 0.438 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.748 -177.658 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.407 ' HG3' ' NE2' ' A' ' 19' ' ' HIS . 3.0 Cg_exo -65.04 129.96 24.47 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 121.367 1.378 . . . . 0.0 111.557 179.48 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 90.6 mt -83.85 71.32 10.47 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.834 -179.896 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 80.6 p -78.66 -15.27 58.69 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.754 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 80.3 mt -93.64 140.78 29.23 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.211 -179.866 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 80.4 p -66.64 -17.51 64.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.959 -179.72 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.484 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 94.9 m -130.7 132.77 45.57 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.907 179.69 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.8 t -125.26 116.65 22.31 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.015 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 44.1 tp -114.16 129.02 56.63 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 121.169 -0.213 . . . . 0.0 111.181 -178.506 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.417 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 13.9 m-85 -109.25 140.8 42.43 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.285 179.649 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 156.78 -178.35 33.26 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 119.932 -1.128 . . . . 0.0 112.069 178.603 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.518 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 43.7 mtm180 -74.72 -27.12 60.24 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.457 178.773 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.465 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -57.58 148.38 34.61 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.406 -177.771 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.432 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 11.1 tp -66.9 -41.47 87.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.097 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.432 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 92.8 mt-10 -52.49 -21.82 4.16 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.744 178.767 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.465 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 13.8 m -64.85 120.73 13.07 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.597 -179.492 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.484 ' OD2' ' O ' ' A' ' 26' ' ' THR . 99.4 m-20 -54.89 -25.21 27.43 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.316 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.414 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 96.8 mt -130.73 124.78 57.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.229 176.837 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 40.4 ttp180 -115.73 139.24 50.34 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.973 -179.386 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.432 ' C ' ' H ' ' A' ' 41' ' ' LEU . 89.2 mt -117.88 133.47 64.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.704 -178.927 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -73.49 20.38 0.09 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.106 -178.527 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.432 ' H ' ' C ' ' A' ' 39' ' ' ILE . 30.3 mt -91.2 128.41 47.47 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.924 179.488 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.14 -6.55 19.12 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 122.757 2.305 . . . . 0.0 113.143 -179.118 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.2 m -105.23 4.9 10.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.91 179.615 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.518 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 19.8 t -85.91 133.16 30.29 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.931 178.853 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.3 m -64.27 157.96 24.6 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.199 -179.496 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.405 ' HG2' ' H ' ' A' ' 47' ' ' GLN . 10.4 ptmt -60.71 -46.34 90.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.476 -178.815 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.695 ' O ' ' N ' ' A' ' 49' ' ' CYS . 78.6 mt-30 -113.39 -12.31 13.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.553 179.578 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 24.1 t60 28.36 -70.27 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 179.712 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.695 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -146.67 149.57 33.72 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.699 0.762 . . . . 0.0 112.522 -179.064 . . . . . . . . 3 3 . 1 . 078 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -139.07 131.12 27.94 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.517 -1.22 . . . . 0.0 111.237 179.945 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.6 mt -106.41 135.25 45.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.796 179.875 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -112.76 135.72 53.18 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.062 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.466 HD11 HH11 ' A' ' 5' ' ' ARG . 38.8 mm -101.08 124.8 54.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 119.744 -0.782 . . . . 0.0 110.877 -179.646 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.437 ' O ' ' N ' ' A' ' 56' ' ' GLN . 95.6 m-70 -128.45 133.42 48.52 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.41 178.902 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 54' ' ' HIS . 97.8 mt-10 -39.97 -29.98 0.08 Allowed 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 120.492 -0.483 . . . . 0.0 109.761 -179.154 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.437 ' N ' ' O ' ' A' ' 54' ' ' HIS . 69.8 tp60 -64.91 -67.37 0.44 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.041 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.432 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 9.6 tp10 -155.3 -152.05 0.38 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.92 -179.572 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.432 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -127.74 134.72 49.53 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.576 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.1 mt -120.99 132.71 69.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.027 -0.669 . . . . 0.0 112.306 -178.274 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 21.1 tp -101.57 128.05 48.01 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.897 -179.558 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -110.95 136.85 49.35 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.733 -179.973 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -97.09 107.69 20.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.206 0.527 . . . . 0.0 111.745 -179.813 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -98.9 -10.29 23.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.2 179.676 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.09 101.66 7.09 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.28 -179.179 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.7 m -83.15 -43.41 16.22 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.187 0.518 . . . . 0.0 110.363 178.958 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.49 -46.83 88.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.858 -179.042 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -133.52 93.81 20.77 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.617 -179.724 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.442 ' O ' ' NE2' ' A' ' 70' ' ' GLN . 53.1 Cg_exo -52.11 140.3 50.8 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.222 1.948 . . . . 0.0 112.819 -179.325 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.1 m -69.79 146.25 51.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.622 179.281 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.446 ' OE1' ' CG2' ' A' ' 75' ' ' VAL . 81.5 mm-40 -109.7 141.5 42.2 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.121 -179.765 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.451 ' O ' ' N ' ' A' ' 74' ' ' SER . 3.6 p -129.94 135.55 60.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.901 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 49.13 31.5 3.53 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -179.043 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.04 29.12 65.26 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.638 -179.429 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.451 ' N ' ' O ' ' A' ' 71' ' ' VAL . 22.3 m -139.61 139.46 36.75 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 120.454 -0.498 . . . . 0.0 112.046 179.99 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.446 ' CG2' ' OE1' ' A' ' 70' ' ' GLN . 58.7 t -61.14 137.37 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.018 -179.706 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.4 pt -117.34 72.53 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 120.661 -0.415 . . . . 0.0 109.927 178.498 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.486 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 21.3 p-10 -61.59 -27.6 68.76 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.689 179.974 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -112.89 159.48 34.37 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.431 178.979 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.84 144.42 88.49 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.014 1.809 . . . . 0.0 112.329 179.776 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 51.4 t -131.84 138.89 51.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.88 -179.57 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -73.82 130.87 40.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.296 179.447 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.8 mt -80.85 135.48 35.94 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.592 0.711 . . . . 0.0 111.569 -178.97 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -128.11 151.15 49.54 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.955 179.028 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.792 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 7.0 t60 -55.03 117.25 3.29 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.938 -178.847 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 113.32 -15.18 22.83 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.089 179.4 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -70.0 133.31 47.1 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 117.139 0.47 . . . . 0.0 110.7 -179.921 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.5 p -108.91 137.31 41.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.674 -179.469 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 88.2 mt -104.96 129.81 57.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 177.908 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.509 ' OG1' ' OG ' ' A' ' 94' ' ' SER . 2.5 m -121.42 129.34 52.94 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -177.45 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.414 ' N ' ' O ' ' A' ' 93' ' ' ARG . 89.2 mt -116.63 122.95 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 114.306 -1.315 . . . . 0.0 109.151 178.335 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 38.8 mm 40.05 -98.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.064 -179.562 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -117.68 17.0 14.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.213 0.53 . . . . 0.0 109.978 -179.787 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.414 ' O ' ' N ' ' A' ' 90' ' ' ILE . 39.3 ttm180 -130.26 144.05 51.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.176 -179.671 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.509 ' OG ' ' OG1' ' A' ' 89' ' ' THR . 36.7 m -140.62 158.9 43.3 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.793 0.806 . . . . 0.0 111.855 -179.494 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -128.35 123.24 33.42 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.304 179.434 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.459 HH21 HG12 ' A' ' 8' ' ' VAL . 95.2 mtm-85 -86.24 135.59 33.5 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.957 -179.407 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -93.33 122.8 36.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.826 178.745 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -125.72 126.29 44.38 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.252 -178.907 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.792 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 28.9 t-20 . . . . . 0 C--N 1.332 -0.195 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.725 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo . . . . . 0 N--CA 1.49 1.303 0 CA-C-O 121.11 0.379 . . . . 0.0 111.937 . . . . . . . . . 0 0 . 1 . 078 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 52.5 t -77.95 131.86 33.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.215 -178.545 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 2.5 t . . . . . 0 N--CA 1.463 0.211 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.99 179.224 . . . . . . . . 0 0 . 1 . 078 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo . . . . . 0 N--CA 1.491 1.344 0 N-CA-C 112.471 0.143 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 078 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 27.5 m -72.74 -46.02 55.64 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.296 178.545 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . 0.415 ' CE2' ' HD2' ' B' ' 245' ' ' ARG . 71.6 t80 -58.21 -45.7 87.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.743 -179.243 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 88.9 mt -64.35 -42.53 96.18 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 120.829 0.347 . . . . 0.0 111.003 179.345 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -62.9 -43.23 99.35 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.289 -178.68 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 87.8 mtm180 -63.29 -42.03 99.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.986 0.422 . . . . 0.0 110.631 -179.005 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.608 HH21 ' CD ' ' A' ' 12' ' ' ARG . 75.9 mtp180 -61.52 -42.07 98.27 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.255 179.955 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -64.56 -40.2 95.13 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.379 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 15.3 t -65.56 -44.96 85.16 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.558 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -60.21 -37.89 81.67 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.025 -179.945 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 37.4 t . . . . . 0 N--CA 1.462 0.169 0 CA-C-O 120.811 0.338 . . . . 0.0 110.52 178.93 . . . . . . . . 0 0 . 1 . 078 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . 0.552 ' OE2' ' CZ ' ' A' ' 12' ' ' ARG . 98.3 mt-10 . . . . . 0 N--CA 1.444 -0.725 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 . . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 2.8 mt -116.0 140.84 36.02 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.537 -179.795 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 62.3 t -127.81 136.21 60.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.376 179.354 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . 0.446 ' CG ' ' CG2' ' B' ' 267' ' ' ILE . 68.3 m-85 -99.59 124.64 44.98 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.395 0.616 . . . . 0.0 111.615 -178.271 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -62.09 -40.79 97.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.744 179.572 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -107.05 173.6 3.02 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 114.838 -1.073 . . . . 0.0 110.232 -179.336 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.77 150.45 62.38 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 122.63 2.22 . . . . 0.0 113.535 -179.63 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . 0.446 ' CG2' ' CG ' ' B' ' 263' ' ' PHE . 41.1 pt . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.813 179.576 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.2 t . . . . . 0 N--CA 1.462 0.146 0 CA-C-O 121.186 0.517 . . . . 0.0 110.397 . . . . . . . . . 0 0 . 1 . 079 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.421 HH12 HG22 ' A' ' 53' ' ' ILE . 99.9 mtt180 -88.7 139.08 30.83 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.506 -179.822 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.7 mtm180 -130.97 136.21 48.34 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.429 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 83.3 mt -112.47 138.9 48.56 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-O 120.778 0.323 . . . . 0.0 110.624 179.515 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 43.5 t -112.34 128.36 69.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.25 178.988 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.593 ' OG1' ' O ' ' A' ' 18' ' ' PRO . 74.8 p -83.14 138.94 33.46 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.49 0.662 . . . . 0.0 112.023 -178.815 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.415 HG23 HD12 ' A' ' 10' ' ' ILE . 47.0 mm -105.66 134.07 48.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.656 179.38 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.4 mttt -86.79 153.86 21.36 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.054 178.266 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 91.8 mtm180 -57.22 -25.87 59.77 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.446 -0.502 . . . . 0.0 109.968 -179.556 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.1 m -79.48 -10.48 59.81 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.771 179.158 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.64 40.09 7.9 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.066 -1.213 . . . . 0.0 110.066 -178.946 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.8 t -120.48 131.08 73.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 114.996 -0.602 . . . . 0.0 109.894 -179.992 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -71.38 125.24 26.49 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.18 179.679 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -120.64 -120.85 2.8 Favored Glycine 0 CA--C 1.54 1.643 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.214 -179.23 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.593 ' O ' ' OG1' ' A' ' 9' ' ' THR . 74.1 Cg_endo -72.87 145.26 40.18 Favored 'Trans proline' 0 N--CA 1.503 2.087 0 C-N-CA 122.848 2.365 . . . . 0.0 114.307 -177.769 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -110.65 129.17 55.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.011 -179.784 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -100.1 102.38 17.71 Favored Pre-proline 0 N--CA 1.465 0.323 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.817 -179.995 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -78.21 139.09 16.57 Favored 'Trans proline' 0 C--N 1.314 -1.242 0 C-N-CA 121.608 1.538 . . . . 0.0 111.957 -179.45 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 87.8 mt -101.39 130.26 47.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.255 0.55 . . . . 0.0 111.498 -179.109 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 45.1 p -139.54 4.03 2.14 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.875 177.725 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.1 mt -107.35 151.25 25.75 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.332 -179.654 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.457 ' H ' ' HG ' ' A' ' 25' ' ' SER . 1.2 m -62.93 -24.29 67.79 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.369 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 87.1 m -133.97 135.42 43.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.428 0.632 . . . . 0.0 111.948 -179.483 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.599 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 3.1 t -126.19 117.19 22.58 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 177.769 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 49.2 tp -115.41 131.31 56.97 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.807 -176.842 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.599 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 11.2 m-85 -107.44 128.48 54.52 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.719 -179.913 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 165.01 -176.18 40.8 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 119.918 -1.134 . . . . 0.0 113.549 178.14 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 48.6 mtm180 -74.67 -31.91 62.07 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.746 0.308 . . . . 0.0 110.63 179.129 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.526 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -51.14 145.45 11.68 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.033 -178.568 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 32.4 mm -65.78 -43.87 93.26 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.102 0 CA-C-O 120.81 0.338 . . . . 0.0 110.913 179.305 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -55.64 -23.51 28.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.028 0.442 . . . . 0.0 109.831 -179.682 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.526 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 35.2 m -54.46 126.61 24.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.287 -179.369 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -61.35 -33.22 73.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.872 -179.459 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 77.9 mt -126.54 122.87 61.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 177.38 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.424 ' O ' ' N ' ' B' ' 262' ' ' VAL . 39.6 mtm180 -106.23 137.63 43.83 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -179.602 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.515 ' C ' ' H ' ' A' ' 41' ' ' LEU . 80.3 mt -117.42 125.9 74.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.918 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -71.34 29.33 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.894 -178.604 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.515 ' H ' ' C ' ' A' ' 39' ' ' ILE . 13.0 mt -100.73 127.61 32.02 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.955 -179.942 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.07 -9.17 24.15 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.096 1.864 . . . . 0.0 112.722 -179.385 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 18.1 m -99.07 7.86 8.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.089 -0.644 . . . . 0.0 111.301 -179.723 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 42.8 t -91.86 135.88 25.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.799 178.677 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.7 m -68.94 166.97 16.76 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.207 -179.476 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -61.21 -42.57 98.83 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.208 -0.906 . . . . 0.0 111.045 -179.055 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.627 ' O ' ' N ' ' A' ' 49' ' ' CYS . 12.5 mm100 -115.57 -26.84 7.33 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 123.853 0.721 . . . . 0.0 109.825 -179.518 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.44 ' O ' ' OG ' ' A' ' 64' ' ' SER . 21.3 t60 44.95 -74.86 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.493 179.556 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.627 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -134.81 139.59 45.21 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.703 -179.195 . . . . . . . . 3 3 . 1 . 079 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 21.7 ttpt -130.61 129.52 42.83 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.0 179.007 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 91.5 mt -107.56 130.47 59.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.34 179.615 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -114.52 123.15 48.65 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 177.598 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.421 HG22 HH12 ' A' ' 5' ' ' ARG . 95.3 mt -103.04 115.91 45.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 119.816 -0.753 . . . . 0.0 111.626 -179.195 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.52 ' O ' ' N ' ' A' ' 56' ' ' GLN . 84.7 m-70 -113.24 141.19 47.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.162 179.551 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.1 tt0 -39.97 -26.13 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.446 0.641 . . . . 0.0 109.528 -178.827 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.52 ' N ' ' O ' ' A' ' 54' ' ' HIS . 63.2 tt0 -68.13 -67.98 0.42 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.816 -1.083 . . . . 0.0 109.628 179.104 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -157.58 -168.48 2.58 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.607 -179.426 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -107.5 127.09 53.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.615 179.24 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.1 mt -120.28 129.67 75.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.213 0.53 . . . . 0.0 111.979 -179.618 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.481 ' CD1' ' HG ' ' A' ' 49' ' ' CYS . 23.5 tp -101.42 128.51 47.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.152 -179.907 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -113.8 138.57 50.09 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.882 -179.296 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.518 HD22 ' CA ' ' A' ' 68' ' ' PRO . 55.3 t-20 -100.39 108.34 20.33 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.825 0.345 . . . . 0.0 111.649 -179.934 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -98.03 -9.45 25.99 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.538 -179.89 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -78.82 117.11 19.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.971 0.415 . . . . 0.0 111.107 -179.818 . . . . . . . . 3 3 . 1 . 079 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.7 p -101.2 -14.6 17.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.64 179.351 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.73 -44.44 10.55 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.346 0.593 . . . . 0.0 109.421 -179.596 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -138.85 95.47 9.69 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.137 -0.938 . . . . 0.0 108.584 178.286 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.518 ' CA ' HD22 ' A' ' 62' ' ' ASN . 37.5 Cg_endo -66.4 150.11 84.52 Favored 'Trans proline' 0 C--N 1.316 -1.156 0 C-N-CA 121.18 1.253 . . . . 0.0 113.029 -177.918 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.447 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 5.3 m -72.13 140.26 48.76 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.949 -179.401 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -103.33 140.9 36.81 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.514 178.547 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.495 ' CG2' ' OD1' ' A' ' 86' ' ' ASP . 5.6 p -128.48 135.5 62.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.043 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 48.37 31.03 2.54 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 119.415 -0.914 . . . . 0.0 108.629 -178.628 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.08 24.73 73.01 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.683 -179.583 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.459 ' N ' ' O ' ' A' ' 71' ' ' VAL . 35.9 t -136.24 139.55 42.81 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.94 0.37 . . . . 0.0 111.11 -179.711 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 79.3 t -68.02 140.7 18.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.169 179.807 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.9 pt -111.77 70.97 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 120.927 0.394 . . . . 0.0 110.437 179.021 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -54.95 -32.72 61.67 Favored 'General case' 0 N--CA 1.461 0.096 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.313 179.578 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -118.88 163.05 28.11 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.96 179.399 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -59.46 144.57 99.37 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.886 1.724 . . . . 0.0 112.829 -179.158 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.0 m -138.14 138.39 43.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.176 -179.68 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -73.12 129.08 37.27 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 120.646 -0.422 . . . . 0.0 109.919 179.47 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 94.6 mt -80.51 141.27 35.32 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.994 0.426 . . . . 0.0 110.631 179.717 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.42 ' HG2' ' N ' ' A' ' 84' ' ' HIS . 88.3 tttt -136.03 157.78 46.01 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.952 -179.56 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.74 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 6.2 t60 -57.3 118.41 5.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.924 0.392 . . . . 0.0 110.834 -179.36 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.68 -7.67 29.89 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -179.989 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.495 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 50.5 t0 -74.76 124.88 27.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.023 0.439 . . . . 0.0 110.115 179.316 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.409 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 75.0 t -108.02 131.36 58.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.658 -178.685 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 80.3 mt -99.47 130.67 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.341 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.652 ' HG1' ' HG ' ' A' ' 94' ' ' SER . 2.2 m -118.46 124.78 48.45 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.409 0.623 . . . . 0.0 112.494 -179.121 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.461 ' O ' ' C ' ' A' ' 91' ' ' ILE . 96.9 mt -114.0 124.68 70.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 177.902 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.472 HD11 HG22 ' A' ' 91' ' ' ILE . 34.5 mm 36.09 -99.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 -178.764 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.509 ' CG ' ' NH2' ' B' ' 245' ' ' ARG . 37.7 p-10 -116.08 14.01 15.93 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.247 179.425 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.432 ' O ' ' N ' ' A' ' 90' ' ' ILE . 84.7 mtt-85 -121.96 145.52 48.04 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.282 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.652 ' HG ' ' HG1' ' A' ' 89' ' ' THR . 73.7 m -136.72 154.96 50.45 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.009 179.766 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -126.59 120.65 30.11 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.333 179.378 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -85.42 136.58 33.39 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.39 -178.936 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -98.18 122.81 41.8 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.302 -179.521 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -134.76 129.33 34.47 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.275 0.56 . . . . 0.0 112.004 -179.601 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.74 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 13.3 p30 . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.762 179.399 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo . . . . . 0 N--CA 1.488 1.205 0 CA-C-O 121.291 0.454 . . . . 0.0 112.372 . . . . . . . . . 0 0 . 1 . 079 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 11.4 t -85.4 129.26 38.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.127 -179.568 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.243 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.59 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo . . . . . 0 N--CA 1.493 1.446 0 N-CA-C 113.222 0.432 . . . . 0.0 113.222 . . . . . . . . . 0 0 . 1 . 079 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 23.4 m -74.17 -44.6 52.88 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.273 179.008 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . 0.43 ' CE2' ' NE ' ' B' ' 245' ' ' ARG . 89.1 t80 -56.35 -46.92 79.77 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.634 -179.436 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . 0.483 HD21 HH21 ' B' ' 245' ' ' ARG . 93.3 mt -63.02 -42.27 99.75 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.846 0.355 . . . . 0.0 110.634 179.869 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -67.6 -40.24 84.75 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -179.425 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -60.97 -45.0 96.53 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.328 -178.832 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.509 ' NH2' ' CG ' ' A' ' 92' ' ' ASP . 60.5 mtm180 -65.36 -38.55 90.42 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.626 -0.429 . . . . 0.0 111.513 -179.662 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -61.49 -41.15 96.84 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.41 -179.845 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 62.9 m -64.91 -41.07 95.89 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.052 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -62.13 -37.48 85.3 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.797 179.882 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 27.3 t . . . . . 0 N--CA 1.456 -0.156 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.255 179.359 . . . . . . . . 0 0 . 1 . 079 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 . . . . . 0 C--O 1.233 0.225 0 CA-C-O 121.352 0.596 . . . . 0.0 110.275 . . . . . . . . . 0 0 . 1 . 079 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 81.3 mt -114.42 136.8 49.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.324 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . 0.424 ' N ' ' O ' ' A' ' 38' ' ' ARG . 88.1 t -124.51 132.0 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 120.816 -0.353 . . . . 0.0 110.424 -179.202 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -96.93 118.55 33.59 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.192 0.52 . . . . 0.0 112.193 -178.18 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -67.2 -46.01 75.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.553 179.057 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 62.6 mm-40 -91.77 160.78 35.51 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.622 -178.168 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -62.51 154.3 65.51 Favored 'Trans proline' 0 N--CA 1.501 1.942 0 C-N-CA 122.664 2.243 . . . . 0.0 111.082 179.11 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.1 pt . . . . . 0 CA--C 1.519 -0.238 0 CA-C-O 121.497 0.665 . . . . 0.0 112.139 -178.771 . . . . . . . . 0 0 . 1 . 080 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 74.1 m . . . . . 0 N--CA 1.457 -0.12 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 . . . . . . . . . 0 0 . 1 . 080 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.695 ' NH1' ' HH ' ' A' ' 97' ' ' TYR . 95.5 mtt-85 -93.62 118.12 30.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.718 0.294 . . . . 0.0 111.205 -178.671 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.8 mtp180 -133.51 138.16 45.98 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.397 -0.521 . . . . 0.0 111.509 179.468 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 35.8 tp -113.85 133.62 55.31 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.331 179.876 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.4 t -109.69 130.96 61.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.865 0.364 . . . . 0.0 110.106 -179.966 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.483 HG23 HH21 ' A' ' 93' ' ' ARG . 1.5 m -88.33 115.65 25.98 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.092 -0.503 . . . . 0.0 112.046 -178.698 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.652 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 95.4 mt -84.04 141.5 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.245 178.712 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -94.78 157.17 16.06 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.332 0.586 . . . . 0.0 111.812 179.526 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.473 ' CD ' ' OD2' ' A' ' 92' ' ' ASP . 89.9 mtm180 -57.85 -27.67 63.44 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.459 -178.92 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.0 t -75.72 -16.36 60.16 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.449 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.22 26.88 11.52 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -179.441 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 49.7 t -117.26 133.59 63.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.75 0.31 . . . . 0.0 110.632 179.865 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -75.47 138.56 41.68 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 178.835 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.5 -113.94 1.69 Allowed Glycine 0 CA--C 1.534 1.237 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.316 -179.292 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -72.1 143.01 39.29 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.18 1.92 . . . . 0.0 113.015 -178.415 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 55.0 m170 -102.76 143.35 32.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.028 179.863 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -117.08 92.43 39.36 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.297 -179.49 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -60.8 127.49 22.65 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.162 1.908 . . . . 0.0 111.755 179.965 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.6 mt -90.01 51.01 1.96 Allowed 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.739 -0.384 . . . . 0.0 111.126 -179.156 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.6 p -63.33 -20.14 65.24 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.21 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.3 mt -81.45 141.89 33.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.501 179.266 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.9 m -66.51 -20.44 66.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.665 -178.742 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 83.9 m -129.32 131.01 46.84 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.048 0.451 . . . . 0.0 111.332 179.551 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.8 t -127.08 123.34 36.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.804 178.898 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 40.8 tp -120.32 127.46 52.37 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.36 -178.782 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 11.2 m-85 -104.36 130.77 52.21 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.773 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 178.37 -159.24 24.48 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 111.424 -0.671 . . . . 0.0 111.424 -179.771 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 29.3 ptt-85 -108.48 -15.88 14.34 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.955 -179.87 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -77.0 165.59 53.58 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.017 -178.852 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 30.9 mm -64.5 -43.07 96.86 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.843 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.9 mp0 -52.27 -29.14 21.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.168 -179.887 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 58.6 m -60.88 121.08 11.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.846 179.831 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -55.36 -29.35 58.23 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.958 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.423 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 99.3 mt -129.49 124.43 59.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.247 -0.888 . . . . 0.0 108.868 177.505 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 45.7 mtm180 -101.8 134.25 45.27 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.703 -179.905 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.556 ' C ' ' H ' ' A' ' 41' ' ' LEU . 92.1 mt -119.37 129.04 75.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.813 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -70.24 35.19 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.921 -178.88 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.556 ' H ' ' C ' ' A' ' 39' ' ' ILE . 23.6 mt -103.65 115.93 62.74 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.267 -179.75 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -74.64 -7.78 19.78 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.145 1.896 . . . . 0.0 111.771 -179.847 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.9 m -100.36 8.2 8.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.59 179.843 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.5 p -96.72 140.86 16.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.455 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.0 m -70.98 166.63 20.89 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.336 0.589 . . . . 0.0 111.612 -178.728 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -63.38 -40.84 98.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.01 -179.696 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.582 ' O ' ' N ' ' A' ' 49' ' ' CYS . 87.7 mt-30 -116.93 -6.65 11.45 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.405 -179.89 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.478 ' C ' ' O ' ' A' ' 47' ' ' GLN . 13.1 t60 15.21 -74.88 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -179.568 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.582 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -125.48 130.15 51.22 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.885 -0.726 . . . . 0.0 112.061 -178.435 . . . . . . . . 3 3 . 1 . 080 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -127.67 126.42 41.92 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.102 179.979 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 83.5 mt -110.23 133.56 55.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.912 -179.309 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -115.18 126.54 54.71 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.497 178.931 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.3 mm -97.84 113.3 32.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 119.675 -0.81 . . . . 0.0 111.085 -179.694 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.437 ' O ' ' C ' ' A' ' 55' ' ' GLU . 97.4 m-70 -114.85 136.3 53.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.432 179.114 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 54' ' ' HIS . 98.4 mt-10 -40.31 -38.68 0.83 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.42 -0.512 . . . . 0.0 109.741 -179.428 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.495 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 50.8 tt0 -62.34 -66.43 0.54 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.035 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.495 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 4.0 tp10 -155.58 -169.42 3.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.334 -179.377 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.415 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -114.52 129.42 56.66 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.61 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 93.9 mt -115.4 131.83 66.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.408 0.623 . . . . 0.0 111.913 -178.796 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.487 ' CD1' ' HG ' ' A' ' 49' ' ' CYS . 28.2 tp -100.61 130.8 46.72 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.196 179.994 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -111.3 131.52 55.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.819 -179.343 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 62.6 t-20 -94.74 106.16 18.13 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.819 0.343 . . . . 0.0 111.429 -179.673 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -97.52 -7.74 30.71 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.178 -179.683 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.8 p -84.06 108.21 16.86 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 119.997 -0.681 . . . . 0.0 111.3 -179.334 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 89.6 p -91.27 -16.25 27.87 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.783 178.874 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.23 -42.53 13.72 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.128 179.95 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -139.82 97.64 8.02 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.085 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -56.08 143.22 84.54 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 121.974 1.782 . . . . 0.0 112.781 -178.501 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.5 m -69.83 138.25 52.45 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.349 178.588 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -102.73 140.29 37.2 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.272 0.558 . . . . 0.0 111.091 -179.561 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.401 ' O ' ' N ' ' A' ' 74' ' ' SER . 4.0 p -133.14 135.66 56.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.92 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 50.09 31.79 5.26 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.361 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.13 26.51 68.38 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.769 179.91 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.401 ' N ' ' O ' ' A' ' 71' ' ' VAL . 7.6 t -140.6 138.23 34.27 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 117.266 0.533 . . . . 0.0 111.929 -179.546 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.6 m -72.39 141.94 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.789 179.374 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.9 pt -113.68 94.16 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.203 0.525 . . . . 0.0 111.148 179.461 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -65.35 -29.05 69.74 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.752 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -122.12 165.02 22.18 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.219 179.909 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.14 152.28 81.6 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.647 2.231 . . . . 0.0 112.6 -179.819 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.3 m -143.33 143.46 24.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.466 -179.424 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -72.01 133.33 45.25 Favored 'General case' 0 C--O 1.231 0.098 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.036 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 98.1 mt -82.34 141.57 32.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.026 0.441 . . . . 0.0 111.564 -179.487 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -131.38 151.9 51.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.425 179.682 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.491 ' HD1' ' C ' ' A' ' 99' ' ' ASN . 7.4 t60 -54.37 117.7 3.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.712 0.291 . . . . 0.0 110.813 -179.785 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.5 -15.43 27.15 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.196 -0.526 . . . . 0.0 111.821 179.515 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -67.4 134.46 51.48 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.345 -0.542 . . . . 0.0 110.545 -179.741 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 74.3 t -109.74 135.91 47.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.244 -178.225 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.474 ' O ' ' OG ' ' A' ' 94' ' ' SER . 6.5 mm -99.26 128.74 50.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.761 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.4 m -119.98 121.22 38.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.686 0.755 . . . . 0.0 111.976 -178.989 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.613 ' O ' ' N ' ' A' ' 93' ' ' ARG . 96.2 mt -115.87 127.75 73.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.002 178.667 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.537 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 72.5 mt -18.64 99.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -178.763 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.537 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 2.6 t70 88.68 -21.96 0.14 Allowed 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 178.031 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.652 ' NH2' ' O ' ' A' ' 10' ' ' ILE . 8.0 mmm180 -130.06 146.02 51.7 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.0 -179.609 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.474 ' OG ' ' O ' ' A' ' 88' ' ' ILE . 32.6 t -139.45 148.83 43.28 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.991 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -126.92 122.14 33.75 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 -179.992 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 79.0 mtp85 -82.07 130.31 35.05 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.89 0.376 . . . . 0.0 111.249 -179.184 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.695 ' HH ' ' NH1' ' A' ' 5' ' ' ARG . 82.8 t80 -96.23 124.92 40.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.554 179.498 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -122.39 127.04 49.22 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.6 179.852 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.491 ' C ' ' HD1' ' A' ' 84' ' ' HIS . 61.6 t-20 . . . . . 0 C--N 1.328 -0.342 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.217 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo . . . . . 0 N--CA 1.489 1.235 0 CA-C-O 121.357 0.482 . . . . 0.0 113.015 . . . . . . . . . 0 0 . 1 . 080 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 25.6 t -110.28 133.37 55.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.998 -179.396 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.6 t . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.867 -179.902 . . . . . . . . 0 0 . 1 . 080 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo . . . . . 0 N--CA 1.493 1.495 0 CA-C-O 120.769 0.237 . . . . 0.0 111.926 . . . . . . . . . 0 0 . 1 . 080 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 16.8 m -73.74 -44.92 54.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.203 0.525 . . . . 0.0 110.29 178.357 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -58.17 -45.54 87.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.873 -178.724 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 94.0 mt -63.64 -39.76 95.16 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.328 -0.549 . . . . 0.0 109.575 179.568 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -62.04 -42.75 99.51 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.258 179.988 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -64.89 -40.64 95.42 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.126 -179.713 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.434 ' NE ' ' OD2' ' A' ' 92' ' ' ASP . 13.6 mmm180 -61.05 -38.92 87.88 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.298 -178.778 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -65.06 -38.82 92.05 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.38 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 30.4 m -62.39 -45.8 91.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.497 178.475 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -61.08 -35.35 76.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.457 -179.739 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 24.2 t . . . . . 0 C--N 1.328 -0.342 0 C-N-CA 120.39 -0.524 . . . . 0.0 109.697 179.423 . . . . . . . . 0 0 . 1 . 080 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 . . . . . 0 CA--C 1.54 0.584 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 . . . . . . . . . 0 0 . 1 . 080 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . 0.4 HG13 ' NH2' ' A' ' 93' ' ' ARG . 4.6 mm -110.46 130.78 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-N 119.113 0.87 . . . . 0.0 109.945 179.537 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 53.5 t -124.48 131.77 72.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.032 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -99.73 122.51 42.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.064 0.459 . . . . 0.0 111.613 -178.257 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -63.85 -46.78 83.46 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.358 0.599 . . . . 0.0 110.135 179.927 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.55 157.34 34.92 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.654 -179.367 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -60.3 145.23 99.02 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.893 2.395 . . . . 0.0 113.059 -179.647 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 14.5 pt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.178 179.483 . . . . . . . . 0 0 . 1 . 081 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.6 p . . . . . 0 N--CA 1.45 -0.461 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 081 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.511 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 96.1 mtt-85 -91.99 118.7 31.02 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.274 -179.882 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.581 HH21 ' ND1' ' A' ' 19' ' ' HIS . 76.7 ttt180 -128.29 129.78 46.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.926 0.394 . . . . 0.0 111.56 -179.476 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 33.9 tp -112.91 130.06 56.25 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.581 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.8 t -109.06 134.29 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-O 120.835 0.35 . . . . 0.0 110.795 -179.39 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.7 m -91.96 120.93 33.07 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.502 -178.521 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.495 ' CD1' ' OD1' ' A' ' 16' ' ' ASP . 49.4 mm -82.15 138.68 19.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.539 179.651 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -91.6 159.65 15.79 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 121.331 0.586 . . . . 0.0 111.561 179.115 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.57 ' NH2' ' OE1' ' B' ' 248' ' ' GLN . 77.3 mtp180 -54.72 -33.07 60.53 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.32 -179.109 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.8 p -78.4 -12.78 60.03 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.76 -179.594 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.59 13.56 40.65 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.973 178.899 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.3 m -109.71 141.49 24.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.317 179.947 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.495 ' OD1' ' CD1' ' A' ' 10' ' ' ILE . 86.4 m-20 -73.6 139.26 45.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.56 -179.327 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.43 -117.33 1.96 Allowed Glycine 0 CA--C 1.535 1.295 0 C-N-CA 120.383 -0.913 . . . . 0.0 111.638 179.94 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.17 143.28 43.74 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 122.096 1.864 . . . . 0.0 113.319 -178.73 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.581 ' ND1' HH21 ' A' ' 6' ' ' ARG . 1.0 OUTLIER -106.85 157.6 17.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.402 -179.861 . . . . . . . . 3 3 . 1 . 081 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.439 ' CZ ' ' OE1' ' B' ' 265' ' ' GLN . 48.3 t80 -131.52 102.19 15.44 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.773 179.918 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.08 132.73 17.09 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 121.728 1.619 . . . . 0.0 112.061 -179.037 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.9 mt -83.36 55.4 3.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.901 0.381 . . . . 0.0 111.46 -178.535 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 52.4 p -68.04 -25.39 65.34 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.558 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.0 mt -80.65 139.65 36.09 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.539 -0.755 . . . . 0.0 108.966 179.083 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 80.3 p -65.5 -19.38 65.91 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.408 -179.224 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.52 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 44.6 m -131.95 131.49 42.67 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.175 -179.446 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.1 t -125.15 117.18 23.32 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.711 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.429 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 52.0 tp -113.93 126.06 54.73 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.915 -179.6 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.494 ' O ' ' O ' ' A' ' 47' ' ' GLN . 7.8 m-85 -104.7 141.09 37.08 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.944 179.465 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 153.34 -174.24 32.03 Favored Glycine 0 N--CA 1.469 0.864 0 C-N-CA 120.288 -0.958 . . . . 0.0 112.328 178.481 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.628 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 80.7 mtm-85 -77.39 -32.51 54.89 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-O 120.93 0.395 . . . . 0.0 110.842 -179.982 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.485 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -46.04 144.63 3.65 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 -179.057 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.449 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 10.0 tp -65.96 -41.41 89.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-O 120.883 0.373 . . . . 0.0 110.056 179.667 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.449 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 79.4 mm-40 -57.63 -15.65 8.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.861 -179.845 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 80.2 m -56.87 124.4 18.42 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.587 -179.628 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.52 ' OD2' ' O ' ' A' ' 26' ' ' THR . 57.0 m-20 -60.2 -33.15 71.83 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 179.443 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.41 HD12 ' CZ ' ' A' ' 29' ' ' PHE . 87.1 mt -127.57 120.33 54.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 176.346 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 76.8 ttt-85 -105.85 135.53 47.11 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.352 -177.923 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 94.5 mt -117.32 130.09 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 121.045 0.45 . . . . 0.0 110.888 -179.537 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -81.09 30.62 0.33 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.496 -179.216 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 20.8 mt -91.32 112.8 55.94 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.758 179.262 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -57.38 -14.24 15.43 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.347 2.032 . . . . 0.0 113.343 179.636 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.4 m -103.78 11.15 8.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.748 -178.988 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.628 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 6.0 p -98.56 138.39 23.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.018 179.629 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.0 m -68.91 167.87 14.8 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.616 0.722 . . . . 0.0 111.983 -179.138 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -63.02 -43.79 97.75 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 114.768 -1.106 . . . . 0.0 111.997 -178.394 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.649 ' O ' ' N ' ' A' ' 49' ' ' CYS . 21.6 mp0 -110.74 -14.55 14.0 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.935 0.398 . . . . 0.0 110.035 179.966 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 25.7 t60 32.45 -75.31 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.083 -0.962 . . . . 0.0 113.551 179.633 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.649 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.82 137.82 45.3 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -178.594 . . . . . . . . 3 3 . 1 . 081 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -125.02 131.83 53.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.016 179.599 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 88.3 mt -114.12 130.54 68.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.337 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -117.98 121.35 40.42 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.422 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 86.3 mt -103.82 116.04 46.86 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-O 121.572 0.701 . . . . 0.0 111.649 -178.854 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.454 ' O ' ' N ' ' A' ' 56' ' ' GLN . 53.0 m-70 -111.84 146.08 38.31 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.864 -179.837 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 54' ' ' HIS . 95.5 mt-10 -39.83 -30.45 0.08 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.128 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.465 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 89.6 mt-30 -63.97 -68.74 0.32 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.991 179.213 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.465 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 4.6 tp10 -159.13 -161.82 0.99 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.668 179.401 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.432 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -116.63 122.31 44.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.578 179.158 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 91.4 mt -113.59 130.48 67.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.266 0.555 . . . . 0.0 112.132 -178.926 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.3 tp -92.37 125.39 37.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.15 179.47 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -111.36 136.28 50.71 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.635 0.255 . . . . 0.0 110.921 179.73 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.682 ' ND2' ' H ' ' A' ' 69' ' ' THR . 8.1 t-20 -97.76 104.48 16.51 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.133 179.114 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -95.99 -8.87 32.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.026 179.447 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.25 101.01 2.73 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.941 179.423 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.9 p -84.58 -10.17 57.64 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.438 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.39 -44.3 6.92 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.881 179.519 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.404 HD22 ' HA ' ' B' ' 236' ' ' VAL . 74.8 m-20 -137.45 91.62 14.05 Favored Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.57 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.68 144.29 54.02 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.422 2.081 . . . . 0.0 112.46 -179.055 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.682 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 20.4 m -72.17 138.29 47.53 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.786 179.164 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -100.98 141.22 34.19 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.36 -179.867 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 54.5 t -130.3 134.27 62.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.101 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 52.13 32.48 10.56 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.13 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.93 29.72 66.7 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.781 179.68 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.7 m -139.02 130.65 27.35 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.521 -0.472 . . . . 0.0 111.425 -179.599 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -69.56 138.26 22.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.619 179.844 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.544 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 1.2 pt -118.54 112.39 37.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-O 121.37 0.605 . . . . 0.0 111.501 -179.763 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -80.32 -20.52 44.09 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.583 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -121.55 160.2 47.25 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.394 179.741 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -61.99 148.49 93.05 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.901 1.734 . . . . 0.0 112.444 179.69 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 76.9 t -130.35 138.13 54.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.021 -179.469 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.462 ' HE ' ' HG2' ' A' ' 57' ' ' GLU . 72.5 ttt180 -70.77 129.48 39.21 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.713 178.948 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.4 mt -80.68 135.29 36.0 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.309 0.576 . . . . 0.0 111.276 -179.921 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -133.06 151.75 52.01 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.51 -179.912 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.552 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 4.6 t60 -52.04 116.44 2.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.168 -179.16 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.16 -14.79 36.73 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 121.234 -0.508 . . . . 0.0 111.953 179.551 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -68.89 134.94 50.28 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.953 -179.512 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.9 t -114.13 132.68 62.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.647 -178.207 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.5 mt -100.54 131.81 47.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.317 -0.856 . . . . 0.0 108.79 178.888 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.9 m -120.91 124.2 44.35 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.343 0.592 . . . . 0.0 112.064 -178.431 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.578 ' O ' ' N ' ' A' ' 92' ' ' ASP . 82.2 mt -111.15 122.59 65.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 178.099 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.475 ' C ' ' O ' ' A' ' 90' ' ' ILE . 43.8 mm 36.89 -92.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.02 -179.471 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.578 ' N ' ' O ' ' A' ' 90' ' ' ILE . 59.2 t0 -121.48 7.46 10.09 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.881 0.372 . . . . 0.0 111.296 179.649 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.73 HH12 HH22 ' B' ' 245' ' ' ARG . 48.5 mmt-85 -111.59 135.01 52.76 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.101 178.9 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.6 m -133.5 148.18 51.67 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.96 179.466 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -124.81 124.66 42.59 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.429 -179.684 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 77.1 mtp85 -86.99 131.75 33.99 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 119.687 -0.805 . . . . 0.0 110.976 -179.109 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.511 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 71.2 t80 -96.62 125.55 41.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.492 179.674 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -126.26 123.16 37.5 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.382 179.835 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.552 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 63.7 t-20 . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.078 179.371 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo . . . . . 0 N--CA 1.487 1.146 0 CA-C-O 121.71 0.629 . . . . 0.0 113.621 . . . . . . . . . 0 0 . 1 . 081 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . 0.404 ' HA ' HD22 ' A' ' 67' ' ' ASN . 1.2 m -68.86 147.84 12.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.079 -178.876 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 4.3 t . . . . . 0 N--CA 1.466 0.359 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.897 -179.966 . . . . . . . . 0 0 . 1 . 081 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo . . . . . 0 N--CA 1.5 1.893 0 N-CA-C 112.772 0.258 . . . . 0.0 112.772 . . . . . . . . . 0 0 . 1 . 081 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 51.6 m -70.91 -45.72 63.79 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.864 179.239 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -58.4 -46.5 86.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.523 -178.928 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 82.8 mt -63.11 -41.79 99.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.277 -179.061 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -67.0 -38.67 86.44 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.113 -179.652 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -61.61 -43.91 97.98 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.313 179.539 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.73 HH22 HH12 ' A' ' 93' ' ' ARG . 37.9 mtp85 -61.38 -40.98 96.31 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.018 -179.881 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -60.89 -41.19 95.54 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 178.122 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 48.0 t -62.87 -44.27 96.57 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 177.916 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . 0.57 ' OE1' ' NH2' ' A' ' 12' ' ' ARG . 87.5 mt-30 -60.02 -37.15 78.9 Favored 'General case' 0 CA--C 1.523 -0.074 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.051 179.598 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 55.8 t . . . . . 0 C--N 1.33 -0.252 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.663 179.689 . . . . . . . . 0 0 . 1 . 081 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 . . . . . 0 N--CA 1.462 0.155 0 CA-C-O 120.574 0.226 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 081 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 66.8 mt -123.13 132.91 70.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.891 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 55.6 t -125.84 134.08 67.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.888 0.375 . . . . 0.0 110.631 -179.932 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -96.17 117.67 31.2 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.155 0.503 . . . . 0.0 110.968 -179.25 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -66.88 -45.48 77.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.89 179.555 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . 0.439 ' OE1' ' CZ ' ' A' ' 20' ' ' PHE . 0.3 OUTLIER -93.85 157.82 37.43 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.309 -179.61 . . . . . . . . 3 3 . 1 . 081 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -64.49 150.42 88.27 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 C-N-CA 123.006 2.471 . . . . 0.0 112.436 -179.892 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 30.3 pt . . . . . 0 C--N 1.328 -0.369 0 CA-C-O 121.247 0.546 . . . . 0.0 111.048 179.762 . . . . . . . . 0 0 . 1 . 082 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.1 m . . . . . 0 C--O 1.233 0.191 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 . . . . . . . . . 0 0 . 1 . 082 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 86.0 mtt85 -89.6 129.68 36.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.041 179.318 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -128.4 141.77 51.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.071 0.462 . . . . 0.0 111.545 -179.93 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 28.1 tp -114.44 130.46 56.72 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.354 179.696 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 52.3 t -106.04 129.26 59.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.554 -0.459 . . . . 0.0 110.474 -179.429 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.573 ' OG1' ' O ' ' A' ' 18' ' ' PRO . 77.6 p -81.89 140.79 33.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.458 -178.243 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.453 HG22 HD13 ' A' ' 10' ' ' ILE . 96.6 mt -110.88 136.41 47.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.098 178.653 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.1 mttm -87.96 160.08 18.05 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.36 179.224 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.474 ' HD3' HH21 ' B' ' 245' ' ' ARG . 89.7 mtm180 -58.44 -29.41 66.11 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.962 -179.259 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 87.1 p -81.24 -7.28 59.54 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.005 179.936 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.0 35.72 6.64 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 179.696 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.6 t -119.03 132.44 68.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.693 0.282 . . . . 0.0 111.076 -179.978 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -77.45 135.56 38.28 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.637 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -128.11 -114.04 1.78 Allowed Glycine 0 CA--C 1.535 1.31 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.052 -179.098 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.573 ' O ' ' OG1' ' A' ' 9' ' ' THR . 61.4 Cg_endo -72.24 145.71 44.27 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 122.445 2.097 . . . . 0.0 113.378 -178.657 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -108.79 129.52 55.38 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.384 179.776 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -98.63 99.85 8.34 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.604 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.76 134.4 20.02 Favored 'Trans proline' 0 C--N 1.315 -1.229 0 C-N-CA 121.12 1.214 . . . . 0.0 111.099 -179.347 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.9 mt -94.15 118.42 31.53 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.547 -178.982 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.4 p -125.03 -4.36 7.49 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.509 179.328 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 49.8 mt -104.47 148.77 26.09 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.545 -179.032 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.36 -22.43 66.26 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.11 -178.906 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 88.0 m -128.34 130.06 47.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.282 0.563 . . . . 0.0 111.76 -179.433 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.628 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -127.96 121.75 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.878 178.565 . . . . . . . . 3 3 . 1 . 082 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.527 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 53.7 tp -123.87 124.16 42.03 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -177.649 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.628 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 46.5 m-85 -97.4 141.28 30.67 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.091 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 168.69 -164.44 38.05 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.109 -1.044 . . . . 0.0 112.423 179.582 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.509 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 33.9 ttp-105 -96.99 -28.91 13.95 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.684 -0.758 . . . . 0.0 110.186 -179.611 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.9 162.08 53.99 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.777 -178.439 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.0 tp -64.47 -39.45 85.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.056 -0.572 . . . . 0.0 110.153 179.342 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -53.31 -28.08 26.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.435 -179.643 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.3 m -64.37 116.71 6.34 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.434 -179.969 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.527 ' OD1' ' O ' ' A' ' 28' ' ' LEU . 12.5 p-10 -58.02 -26.24 62.18 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.539 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 34.6 mm -122.33 113.96 40.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.361 177.636 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -105.36 136.67 44.47 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.784 179.479 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.52 ' C ' ' H ' ' A' ' 41' ' ' LEU . 91.3 mt -119.61 132.13 70.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.36 -0.836 . . . . 0.0 108.976 179.603 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -71.29 29.4 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.669 -178.808 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.52 ' H ' ' C ' ' A' ' 39' ' ' ILE . 31.4 mt -91.1 122.73 66.1 Favored Pre-proline 0 C--N 1.323 -0.549 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.037 179.805 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.44 -7.47 20.95 Favored 'Trans proline' 0 N--CA 1.49 1.298 0 C-N-CA 122.12 1.88 . . . . 0.0 111.64 -179.161 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.2 m -107.54 9.97 9.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.844 -179.164 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.509 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 9.6 p -92.16 141.85 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.061 179.835 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.0 m -71.26 159.43 34.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.714 0.769 . . . . 0.0 112.215 -178.659 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -61.89 -39.72 92.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.814 -1.084 . . . . 0.0 110.797 -179.602 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.595 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.3 mt-30 -117.14 -8.76 11.13 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.678 0.275 . . . . 0.0 111.047 179.445 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.471 ' CG ' ' HG ' ' A' ' 64' ' ' SER . 24.3 t60 16.19 -73.88 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 114.633 1.345 . . . . 0.0 114.633 -178.527 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.595 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.8 134.64 47.03 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 119.966 -0.693 . . . . 0.0 112.72 -177.724 . . . . . . . . 3 3 . 1 . 082 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -126.02 131.16 52.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.638 179.742 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.9 mt -116.0 133.38 62.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.166 0.508 . . . . 0.0 110.728 179.649 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -118.67 122.58 42.87 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.371 -0.832 . . . . 0.0 108.774 179.051 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 92.1 mt -105.2 116.09 48.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.561 0.696 . . . . 0.0 111.653 -178.974 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.439 ' O ' ' C ' ' A' ' 55' ' ' GLU . 87.6 m-70 -114.42 144.78 42.75 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.604 -179.848 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 54' ' ' HIS . 92.1 mt-10 -39.77 -33.11 0.17 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.318 -0.553 . . . . 0.0 109.911 -179.037 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.449 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 82.7 mt-30 -61.73 -68.38 0.32 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.788 179.227 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.449 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 4.5 tp10 -158.2 -166.35 1.92 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.393 -179.492 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.433 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -110.1 130.13 55.59 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.921 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.5 mt -119.4 129.07 75.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.226 0.536 . . . . 0.0 112.24 -178.549 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.449 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 17.4 tp -99.27 126.25 45.06 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.216 179.535 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -113.22 137.1 51.97 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.928 -179.886 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.506 ' ND2' ' O ' ' A' ' 76' ' ' ILE . 22.3 p-10 -100.66 111.19 23.39 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.992 0.425 . . . . 0.0 111.929 -179.246 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -102.61 -6.84 22.33 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.352 179.73 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.471 ' HG ' ' CG ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -78.44 100.12 6.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.81 0.338 . . . . 0.0 111.579 -179.476 . . . . . . . . 3 3 . 1 . 082 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.9 p -75.6 -32.17 60.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.207 178.288 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.4 m -65.25 -49.24 70.39 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.108 -179.069 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -145.4 103.95 4.32 Favored Pre-proline 0 N--CA 1.466 0.348 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.831 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -54.68 145.14 61.44 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 121.446 1.43 . . . . 0.0 112.004 -179.096 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.9 m -68.8 138.73 55.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.867 178.872 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -99.32 139.98 34.17 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.991 -179.764 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 55.0 t -134.38 134.47 54.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.735 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.573 ' ND2' ' OD1' ' A' ' 86' ' ' ASP . 74.1 m-20 53.8 32.12 14.34 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.611 -179.5 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.65 28.34 63.4 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.736 179.251 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.5 m -147.98 144.85 28.26 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 117.74 0.77 . . . . 0.0 111.734 179.902 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.4 m -75.88 139.54 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.435 179.247 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.506 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 4.5 pt -104.99 101.61 12.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.411 0.624 . . . . 0.0 111.319 -179.912 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -65.01 -34.86 79.45 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.808 179.431 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.457 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.7 OUTLIER -126.15 178.52 1.48 Allowed Pre-proline 0 CA--C 1.53 0.176 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.52 179.803 . . . . . . . . 3 3 . 1 . 082 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.457 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 21.7 Cg_exo -63.26 146.89 94.13 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 C-N-CA 122.826 2.351 . . . . 0.0 112.174 -179.899 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.5 p -141.64 140.96 30.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.067 179.668 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -72.6 129.86 39.25 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.121 179.41 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 93.0 mt -86.63 135.84 33.26 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.344 -179.926 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -126.83 155.0 43.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.811 -179.554 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.612 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 6.1 t60 -53.96 116.64 2.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.441 -179.597 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.55 -14.48 27.41 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -179.509 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.573 ' OD1' ' ND2' ' A' ' 72' ' ' ASN . 26.2 t70 -69.12 129.7 40.62 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 179.551 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.0 t -109.24 135.64 47.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.312 -178.761 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 89.3 mt -103.43 132.29 50.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.25 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.843 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.0 m -122.15 127.59 50.26 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.762 0.791 . . . . 0.0 112.799 -178.342 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.611 ' O ' ' N ' ' A' ' 93' ' ' ARG . 97.4 mt -121.26 122.94 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 114.369 -1.287 . . . . 0.0 108.492 177.953 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.508 ' C ' ' O ' ' A' ' 90' ' ' ILE . 56.6 mt -3.74 95.62 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -179.77 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.589 ' CG ' ' HE ' ' B' ' 245' ' ' ARG . 1.4 t70 78.73 -13.42 0.97 Allowed 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 177.69 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.611 ' N ' ' O ' ' A' ' 90' ' ' ILE . 1.6 tpp180 -130.78 139.41 50.22 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.628 -179.192 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.9 p -140.15 157.08 46.18 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.283 0.563 . . . . 0.0 111.436 -179.204 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -130.04 125.97 36.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.207 -179.584 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -88.78 132.19 34.73 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.945 -179.231 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -96.94 125.43 41.36 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.498 -179.811 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -127.2 119.73 27.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.082 179.114 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.612 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 58.9 t-20 . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.504 179.583 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo . . . . . 0 N--CA 1.494 1.543 0 CA-C-O 121.573 0.572 . . . . 0.0 113.282 . . . . . . . . . 0 0 . 1 . 082 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 6.0 p -97.1 132.8 40.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.11 179.641 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . 0.403 ' HG ' ' CG2' ' A' ' 91' ' ' ILE . 10.7 t . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.201 -179.221 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo . . . . . 0 N--CA 1.494 1.542 0 N-CA-C 112.592 0.189 . . . . 0.0 112.592 . . . . . . . . . 0 0 . 1 . 082 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 42.5 p -74.37 -36.62 63.56 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.577 -0.449 . . . . 0.0 109.793 178.762 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . 0.611 ' CZ ' ' NH1' ' B' ' 245' ' ' ARG . 85.9 t80 -59.39 -48.04 83.15 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.261 -179.153 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 94.3 mt -64.64 -42.28 95.56 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.445 -179.892 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -69.37 -42.13 75.6 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.867 -179.439 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 62.2 ttp180 -61.87 -46.66 88.43 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.703 -178.799 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.611 ' NH1' ' CZ ' ' B' ' 241' ' ' PHE . 10.7 ptm85 -71.47 -38.89 71.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.292 -179.476 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -61.54 -39.99 93.05 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.504 179.737 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 23.0 t -69.35 -42.77 74.83 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.289 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 64.1 tp60 -58.21 -40.14 80.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.838 179.758 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 89.0 t . . . . . 0 N--CA 1.452 -0.348 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.698 179.826 . . . . . . . . 0 0 . 1 . 082 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 . . . . . 0 N--CA 1.461 0.119 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 . . . . . . . . . 0 0 . 1 . 082 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 54.9 mt -103.84 134.65 44.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.75 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 77.7 t -123.18 132.37 71.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.43 -179.163 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -95.03 111.92 23.67 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.88 -177.677 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -61.93 -45.52 93.32 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.33 179.19 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -98.99 156.77 35.12 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.308 -179.472 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.28 152.94 71.77 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 123.158 2.572 . . . . 0.0 113.427 -178.866 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 26.3 pt . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.196 179.112 . . . . . . . . 0 0 . 1 . 083 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 67.3 p . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.917 0.389 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 083 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.835 HH11 ' HH ' ' A' ' 97' ' ' TYR . 94.0 mtt-85 -93.11 119.99 32.92 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.228 -179.286 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -131.14 139.25 49.76 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.436 179.937 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 46.9 tp -115.25 131.88 56.79 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.979 179.749 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 73.8 t -110.65 133.07 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.597 -178.759 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 m -84.42 143.23 29.56 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.717 0.77 . . . . 0.0 112.475 -179.094 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 50.6 mm -109.39 137.08 43.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 114.238 -1.346 . . . . 0.0 108.807 177.794 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -91.58 160.84 15.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.302 0.573 . . . . 0.0 111.127 179.877 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.44 HH22 ' CB ' ' B' ' 248' ' ' GLN . 82.0 mtp180 -54.1 -32.29 54.53 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.015 -178.949 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 97.7 p -81.64 -6.27 58.85 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.281 -179.958 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.03 38.2 6.92 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -179.869 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.5 t -123.74 133.73 68.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.02 0.438 . . . . 0.0 110.519 179.964 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.481 ' O ' ' OD1' ' A' ' 16' ' ' ASP . 50.8 p-10 -80.19 136.9 36.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.292 179.695 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -131.76 -110.63 1.3 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 120.3 -0.953 . . . . 0.0 112.169 -179.613 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.17 144.08 41.24 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.288 1.992 . . . . 0.0 113.25 -178.608 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -109.06 148.79 30.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.372 179.909 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -118.48 94.69 47.72 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.633 -179.262 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -60.69 126.57 20.15 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 121.926 1.751 . . . . 0.0 111.638 179.653 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 63.5 mt -91.18 47.81 1.44 Allowed 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -178.576 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.9 m -66.28 -16.77 64.3 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.701 179.629 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.2 mt -78.43 141.3 38.4 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.163 179.496 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 94.3 p -61.17 -21.98 64.29 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.756 -0.657 . . . . 0.0 112.054 -178.488 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 44.5 m -137.42 136.45 37.83 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 120.397 -0.521 . . . . 0.0 112.081 -179.435 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.2 t -129.43 122.6 29.72 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.035 178.315 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 47.6 tp -117.08 130.63 56.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.197 -179.23 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.45 ' CE2' ' CD1' ' A' ' 37' ' ' ILE . 7.9 m-85 -107.41 125.67 51.51 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.562 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 172.72 178.64 42.94 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 120.297 -0.954 . . . . 0.0 112.303 179.831 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.652 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 81.2 mtm-85 -77.6 -31.48 53.0 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.016 179.362 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -52.49 150.2 9.29 Favored Glycine 0 N--CA 1.464 0.553 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 -178.872 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.479 ' CD1' ' NH1' ' A' ' 38' ' ' ARG . 8.8 tp -66.76 -42.77 89.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.815 -179.514 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.436 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 83.8 tt0 -53.44 -18.28 2.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.386 179.406 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.9 m -62.38 127.05 29.5 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.537 -179.742 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -61.09 -31.64 71.31 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -179.459 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.45 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 98.5 mt -126.14 120.98 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 176.539 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.479 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 83.7 mtp180 -100.41 128.55 46.44 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.739 -178.951 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 89.5 mt -112.94 128.08 69.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.205 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -80.93 26.74 0.41 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.976 -0.557 . . . . 0.0 112.382 -177.432 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.616 ' CD1' ' HE ' ' A' ' 93' ' ' ARG . 68.4 mt -94.98 131.73 29.64 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.185 179.263 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.93 -12.1 31.91 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.098 1.865 . . . . 0.0 112.897 -179.676 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.5 m -98.27 12.67 5.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.278 -179.796 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.652 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 14.3 t -100.89 130.86 49.59 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 C-N-CA 120.577 -0.449 . . . . 0.0 109.893 178.695 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.715 ' HG ' ' H ' ' A' ' 46' ' ' LYS . 29.6 t -71.38 173.42 7.87 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.448 0.642 . . . . 0.0 112.125 -178.559 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.715 ' H ' ' HG ' ' A' ' 45' ' ' SER . 46.6 mttp -64.51 -41.39 96.46 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.89 179.919 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.588 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.2 mt-30 -116.45 -7.32 11.69 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 121.111 -0.235 . . . . 0.0 111.338 -179.566 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.474 ' C ' ' O ' ' A' ' 47' ' ' GLN . 14.9 t60 15.91 -74.88 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -178.695 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.588 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -129.24 133.27 47.44 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.088 -0.645 . . . . 0.0 112.341 -178.335 . . . . . . . . 3 3 . 1 . 083 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -128.47 131.15 48.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.293 179.763 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.4 mt -117.35 133.67 63.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.008 -179.697 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.518 ' CD ' ' HE2' ' A' ' 54' ' ' HIS . 81.7 tt0 -112.41 133.26 54.6 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.51 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.4 mm -101.96 124.28 55.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.448 0.642 . . . . 0.0 111.661 -178.637 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.57 ' O ' ' N ' ' A' ' 56' ' ' GLN . 96.9 m-70 -124.92 132.35 53.31 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.488 178.747 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.47 ' C ' ' O ' ' A' ' 54' ' ' HIS . 77.9 tt0 -39.79 -25.34 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.894 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.57 ' N ' ' O ' ' A' ' 54' ' ' HIS . 91.3 mt-30 -66.59 -68.34 0.38 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.018 178.018 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.46 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 5.3 tp10 -158.71 -160.75 0.9 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.209 179.942 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.46 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -118.69 127.89 54.0 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.224 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.7 mt -115.65 129.56 71.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.476 0.655 . . . . 0.0 111.523 -178.927 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.8 tp -96.62 128.86 43.96 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.383 -179.62 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -110.63 132.89 53.8 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.764 179.82 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -94.47 103.95 15.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.299 -179.391 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -97.07 -7.9 31.62 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.741 -0.383 . . . . 0.0 111.015 179.209 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.49 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 12.9 t -72.17 100.92 2.67 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-O 120.779 0.323 . . . . 0.0 110.169 179.256 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.7 p -82.99 -13.85 55.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.874 179.641 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.27 -38.3 10.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.181 -179.534 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.49 ' O ' ' OG ' ' A' ' 64' ' ' SER . 76.1 m-20 -143.11 101.23 5.28 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.772 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.01 146.39 87.55 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 121.509 1.473 . . . . 0.0 112.436 179.951 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.7 m -73.61 143.53 46.31 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.906 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -104.37 140.94 37.19 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.041 -179.355 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 43.9 t -132.26 135.54 57.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.372 -0.831 . . . . 0.0 108.82 179.562 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 14.0 m120 52.8 26.95 4.91 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -179.235 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.28 29.1 62.72 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.651 -179.634 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.3 m -142.46 140.47 31.92 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.865 0.365 . . . . 0.0 110.827 179.875 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -73.22 142.75 14.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.013 -179.21 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.5 pt -109.88 92.62 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-O 121.224 0.535 . . . . 0.0 110.911 179.115 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -63.95 -30.95 71.99 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.715 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -121.31 169.49 8.99 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.362 179.865 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -59.06 144.89 99.18 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 121.918 1.745 . . . . 0.0 111.751 179.429 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.2 p -135.21 140.94 44.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.108 0.48 . . . . 0.0 111.445 -179.627 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.437 HH21 ' CE ' ' A' ' 83' ' ' LYS . 62.7 ttp180 -78.2 132.64 37.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.881 179.085 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.8 mt -87.67 137.12 32.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.933 -178.541 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.437 ' CE ' HH21 ' A' ' 81' ' ' ARG . 99.2 mttt -124.86 151.23 45.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.432 179.532 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.495 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 6.8 t60 -54.62 121.3 8.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.771 -179.377 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.28 -18.99 35.2 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.034 -0.827 . . . . 0.0 111.034 -179.942 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -69.05 136.69 52.74 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.551 -0.46 . . . . 0.0 109.86 179.735 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.0 t -113.24 133.53 58.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.543 -178.305 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 89.2 mt -98.32 133.72 39.54 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.684 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 97.4 m -123.2 127.67 48.96 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 119.605 -0.838 . . . . 0.0 112.36 -179.195 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.612 ' O ' ' N ' ' A' ' 93' ' ' ARG . 96.8 mt -116.45 129.64 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 114.123 -1.399 . . . . 0.0 108.41 178.418 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.517 ' C ' ' O ' ' A' ' 90' ' ' ILE . 79.4 mt -18.98 101.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 O-C-N 123.744 0.652 . . . . 0.0 112.279 -179.246 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.496 ' OD1' ' NE ' ' B' ' 245' ' ' ARG . 73.8 m-20 80.37 -18.27 0.51 Allowed 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 178.919 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.616 ' HE ' ' CD1' ' A' ' 41' ' ' LEU . 59.4 mtt-85 -129.51 141.59 50.96 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.61 179.93 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 30.7 p -138.27 152.83 48.92 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.169 0.509 . . . . 0.0 110.027 179.901 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -128.79 121.93 29.41 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.623 -179.563 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -80.52 128.78 33.99 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.711 -0.395 . . . . 0.0 111.2 -179.705 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.835 ' HH ' HH11 ' A' ' 5' ' ' ARG . 89.4 t80 -94.62 124.97 38.97 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.597 179.632 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -127.66 122.84 34.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.937 0.399 . . . . 0.0 111.32 -179.89 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.495 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 61.6 t-20 . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.085 179.095 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo . . . . . 0 N--CA 1.487 1.105 0 CA-C-O 121.266 0.444 . . . . 0.0 112.71 . . . . . . . . . 0 0 . 1 . 083 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . 0.452 ' HA ' HD22 ' A' ' 67' ' ' ASN . 53.1 t -57.46 141.99 13.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.456 179.687 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 17.4 t . . . . . 0 C--N 1.328 -0.345 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.782 -179.263 . . . . . . . . 0 0 . 1 . 083 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo . . . . . 0 N--CA 1.496 1.641 0 N-CA-C 112.851 0.289 . . . . 0.0 112.851 . . . . . . . . . 0 0 . 1 . 083 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 54.6 m -74.05 -44.22 55.03 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 121.029 0.443 . . . . 0.0 109.849 178.198 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -56.84 -47.12 81.08 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.894 -178.989 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . 0.405 ' CD2' ' OD1' ' A' ' 92' ' ' ASP . 97.1 mt -66.99 -40.82 87.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.734 179.541 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -60.73 -43.19 98.18 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.854 -179.812 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -60.43 -42.86 96.95 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.505 179.739 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.496 ' NE ' ' OD1' ' A' ' 92' ' ' ASP . 71.7 ttp85 -61.64 -40.61 95.52 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.604 -0.439 . . . . 0.0 111.253 -179.524 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -60.54 -40.16 90.53 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.46 -179.718 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 80.8 p -69.85 -42.22 73.85 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.058 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . 0.44 ' CB ' HH22 ' A' ' 12' ' ' ARG . 87.4 mt-30 -63.55 -32.41 73.86 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.209 179.778 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 54.9 t . . . . . 0 C--O 1.233 0.232 0 C-N-CA 120.113 -0.635 . . . . 0.0 109.64 178.477 . . . . . . . . 0 0 . 1 . 083 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 52.8 mp0 . . . . . 0 CA--C 1.518 -0.279 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 . . . . . . . . . 0 0 . 1 . 083 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 67.0 mt -113.98 132.17 63.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.202 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 53.2 t -127.12 131.43 70.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.786 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -93.07 120.66 33.61 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.222 0.534 . . . . 0.0 110.335 -178.49 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -64.82 -44.94 88.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.989 -179.416 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.74 158.56 31.9 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.786 -179.221 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -65.16 153.82 76.47 Favored 'Trans proline' 0 N--CA 1.503 2.039 0 C-N-CA 123.278 2.652 . . . . 0.0 111.846 -179.979 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 47.0 pt . . . . . 0 C--O 1.232 0.153 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -178.514 . . . . . . . . 0 0 . 1 . 084 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.5 m . . . . . 0 N--CA 1.454 -0.23 0 CA-C-O 121.223 0.535 . . . . 0.0 110.351 . . . . . . . . . 0 0 . 1 . 084 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.3 mtt85 -91.8 129.35 37.78 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.433 -178.728 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.5 mtt85 -130.83 138.0 49.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.276 -179.973 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 39.4 tp -115.11 128.35 56.16 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.619 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.3 m -109.49 132.49 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 121.155 0.502 . . . . 0.0 111.413 -179.078 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 m -80.36 138.56 36.7 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.246 -179.437 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.5 mt -107.83 138.23 35.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.695 177.715 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -89.14 155.97 19.1 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.014 0.435 . . . . 0.0 109.849 178.434 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.557 HH11 ' CZ ' ' A' ' 93' ' ' ARG . 72.7 mtp85 -58.05 -24.17 57.37 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.429 -179.04 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.2 p -82.47 -8.63 59.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.037 0.446 . . . . 0.0 110.16 178.982 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.76 36.16 6.94 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -179.834 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.6 t -121.88 133.5 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.801 0.334 . . . . 0.0 111.069 -179.993 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 17' ' ' GLY . 61.6 t0 -78.43 132.58 37.38 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.236 179.397 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.461 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -125.72 -113.56 1.92 Allowed Glycine 0 CA--C 1.537 1.458 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.954 -179.736 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -71.68 143.9 43.0 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 122.324 2.016 . . . . 0.0 113.298 -178.568 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.541 ' O ' ' CD1' ' B' ' 267' ' ' ILE . 0.3 OUTLIER -111.29 135.81 51.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.135 0.493 . . . . 0.0 111.119 -179.89 . . . . . . . . 3 3 . 1 . 084 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -105.81 105.76 54.25 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.405 179.976 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -74.31 129.49 13.04 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 121.33 1.353 . . . . 0.0 111.911 -178.899 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 74.5 mt -83.97 47.04 1.25 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.859 -178.777 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.0 p -64.08 -21.57 66.58 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.969 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.3 mt -83.31 143.71 30.19 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.007 179.796 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.7 t -64.14 -21.73 66.66 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.947 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.415 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 56.2 m -135.63 135.54 40.28 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.181 -0.608 . . . . 0.0 112.369 -179.012 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.551 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 16.9 t -127.9 119.83 26.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.324 178.4 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 49.1 tp -118.07 130.89 56.41 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.229 -178.546 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.551 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 5.5 m-85 -108.53 140.78 41.38 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.2 179.852 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 152.21 -176.28 30.55 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.249 178.393 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.695 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 76.8 mtm-85 -75.89 -32.23 59.57 Favored 'General case' 0 C--N 1.338 0.068 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.197 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.582 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -48.08 143.37 7.04 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 -178.471 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.512 ' CD1' ' CZ ' ' A' ' 38' ' ' ARG . 32.2 mm -65.79 -43.91 93.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.647 179.803 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -54.28 -17.74 3.25 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.789 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.582 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 39.4 m -60.16 121.47 11.99 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.218 179.851 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.415 ' OD2' ' O ' ' A' ' 26' ' ' THR . 99.0 m-20 -60.69 -28.64 68.77 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.238 -179.264 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.446 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 96.7 mt -126.13 120.54 57.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 176.798 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.512 ' CZ ' ' CD1' ' A' ' 33' ' ' ILE . 84.0 mtp180 -103.99 132.53 50.15 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.938 -178.199 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 84.8 mt -121.49 130.79 74.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 121.03 0.443 . . . . 0.0 109.961 179.491 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -78.44 41.5 0.4 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.232 -178.495 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 77.8 mt -105.88 104.99 51.71 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.44 179.41 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -57.61 -15.39 20.22 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.117 1.878 . . . . 0.0 112.148 179.532 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.0 m -91.11 4.89 6.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.237 -179.632 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.695 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 24.9 t -104.18 140.32 22.62 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.354 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.128 180.0 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.4 m -71.05 168.09 17.84 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.284 0.564 . . . . 0.0 112.276 -179.236 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -61.8 -39.29 91.2 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.271 -179.678 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.643 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.6 mt-30 -111.17 -19.43 12.7 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.904 179.813 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.3 t60 35.85 -75.86 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 179.015 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.643 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.83 134.45 46.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.266 0.555 . . . . 0.0 112.106 -177.871 . . . . . . . . 3 3 . 1 . 084 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -127.43 131.71 50.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.458 179.668 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 98.0 mt -118.03 133.88 63.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.175 179.933 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -117.69 134.37 54.96 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.102 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 48.3 mm -98.56 119.71 46.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.831 179.819 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.483 ' O ' ' N ' ' A' ' 56' ' ' GLN . 98.4 m-70 -123.85 135.53 53.8 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.137 -179.989 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 54' ' ' HIS . 92.8 mt-10 -41.28 -25.97 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -179.396 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.483 ' N ' ' O ' ' A' ' 54' ' ' HIS . 47.9 tt0 -67.3 -68.87 0.35 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.75 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -156.95 -163.44 1.41 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.399 179.094 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -108.92 126.09 52.71 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 177.47 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.9 mt -114.9 129.52 70.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.243 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.1 tp -100.14 129.2 46.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.135 179.634 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -113.24 135.56 53.7 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.877 -179.713 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.4 HD22 ' HA ' ' A' ' 68' ' ' PRO . 47.6 t30 -94.35 104.7 16.67 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.403 179.708 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -96.75 -10.78 26.06 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.194 179.397 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.4 t -68.18 101.47 1.18 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.046 179.653 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.5 p -84.35 -7.22 59.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.066 0.46 . . . . 0.0 110.024 179.895 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.44 -43.85 5.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.836 -179.131 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -140.23 99.39 7.25 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.646 -179.769 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.4 ' HA ' HD22 ' A' ' 62' ' ' ASN . 52.9 Cg_exo -55.19 145.95 62.7 Favored 'Trans proline' 0 N--CA 1.5 1.904 0 C-N-CA 122.359 2.039 . . . . 0.0 113.236 -179.348 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.2 m -73.11 137.96 45.52 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.869 178.796 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -99.24 140.77 32.91 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.517 179.82 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 55.9 t -128.82 135.34 62.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.685 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 52.04 31.44 8.76 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.124 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.8 28.18 69.42 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.489 179.921 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.1 p -140.69 139.22 34.71 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 120.774 -0.371 . . . . 0.0 111.48 -179.735 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 38.8 t -70.37 138.32 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.16 -179.6 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.7 pt -112.73 96.68 4.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.1 178.321 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -66.65 -26.14 66.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.189 -179.76 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.437 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.3 OUTLIER -130.93 178.55 1.68 Allowed Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.312 -179.086 . . . . . . . . 3 3 . 1 . 084 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.437 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 36.1 Cg_exo -59.99 146.27 96.38 Favored 'Trans proline' 0 N--CA 1.505 2.155 0 C-N-CA 123.09 2.527 . . . . 0.0 112.802 -179.775 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.6 p -144.37 141.65 24.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.634 179.984 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -78.89 133.95 36.93 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.52 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 89.0 mt -91.18 140.44 29.8 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.991 0.424 . . . . 0.0 111.522 -179.074 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -128.2 157.5 40.68 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.981 179.165 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.532 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 5.8 t60 -53.99 115.71 2.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.523 -178.553 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.3 -10.65 26.52 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.142 179.16 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -67.67 135.34 52.65 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.018 -179.836 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.41 HG22 ' NH1' ' A' ' 96' ' ' ARG . 48.9 t -109.44 126.57 66.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.43 -179.665 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 84.8 mt -100.42 131.25 48.31 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 178.514 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 75.3 m -122.84 129.1 51.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.715 0.769 . . . . 0.0 112.584 -178.189 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.462 ' O ' ' C ' ' A' ' 91' ' ' ILE . 95.0 mt -116.53 128.07 73.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 114.493 -1.23 . . . . 0.0 108.621 178.537 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.462 ' C ' ' O ' ' A' ' 90' ' ' ILE . 42.4 mm 34.02 -99.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.166 -179.428 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.504 ' O ' ' OD1' ' A' ' 92' ' ' ASP . 61.7 t0 -115.55 16.49 16.55 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 120.94 0.4 . . . . 0.0 110.847 -179.576 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.571 HH21 ' CD ' ' B' ' 260' ' ' GLU . 73.1 mtt-85 -127.93 144.5 51.1 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.67 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.6 p -140.92 156.81 46.01 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.391 0.615 . . . . 0.0 111.637 -179.551 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -132.54 133.58 43.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.412 179.617 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.41 ' NH1' HG22 ' A' ' 87' ' ' VAL . 70.4 mtp85 -98.48 137.78 36.66 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 119.881 -0.727 . . . . 0.0 110.361 179.906 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 93.9 t80 -93.24 122.99 36.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.689 -179.881 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -123.93 119.48 29.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.166 179.397 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.532 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 47.5 t-20 . . . . . 0 C--N 1.327 -0.412 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.64 180.0 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo . . . . . 0 N--CA 1.483 0.87 0 CA-C-O 121.324 0.468 . . . . 0.0 112.288 . . . . . . . . . 0 0 . 1 . 084 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 54.7 t -60.58 140.53 18.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.383 -179.541 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 6.5 t . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.235 -179.747 . . . . . . . . 0 0 . 1 . 084 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo . . . . . 0 N--CA 1.494 1.542 0 N-CA-C 112.962 0.331 . . . . 0.0 112.962 . . . . . . . . . 0 0 . 1 . 084 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 40.9 p -75.95 -40.27 54.35 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.289 -0.564 . . . . 0.0 109.909 178.441 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . 0.561 ' CZ ' ' NE ' ' B' ' 245' ' ' ARG . 81.6 t80 -57.3 -48.04 79.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.415 -179.626 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 89.4 mt -65.91 -42.09 90.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.018 179.964 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -67.94 -39.87 83.39 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.798 -179.463 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -60.88 -46.63 89.88 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.444 -179.154 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.561 ' NE ' ' CZ ' ' B' ' 241' ' ' PHE . 94.0 mtt-85 -67.78 -38.53 83.51 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.615 179.806 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -60.78 -40.28 91.99 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.101 -179.45 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 9.7 t -65.53 -45.62 82.73 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.656 0.741 . . . . 0.0 109.56 177.911 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -64.91 -31.44 72.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.539 -179.914 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 93.8 t . . . . . 0 C--N 1.331 -0.212 0 CA-C-O 120.966 0.412 . . . . 0.0 110.538 179.363 . . . . . . . . 0 0 . 1 . 084 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . 0.571 ' CD ' HH21 ' A' ' 93' ' ' ARG . 94.8 mt-10 . . . . . 0 N--CA 1.463 0.224 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 . . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 68.2 mt -113.77 131.05 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.34 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 40.4 t -128.46 135.86 61.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.829 0.347 . . . . 0.0 111.308 -179.076 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -97.24 119.01 34.97 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.221 0.534 . . . . 0.0 111.651 -179.31 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -62.98 -46.45 87.62 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.986 178.984 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -90.15 156.39 46.38 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.191 -179.554 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -60.17 142.59 98.63 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 C-N-CA 122.226 1.951 . . . . 0.0 112.183 -179.845 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . 0.541 ' CD1' ' O ' ' A' ' 19' ' ' HIS . 3.9 tt . . . . . 0 C--N 1.325 -0.494 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.946 -179.72 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.1 m . . . . . 0 N--CA 1.463 0.176 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 . . . . . . . . . 0 0 . 1 . 085 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.457 ' CD ' ' OH ' ' A' ' 97' ' ' TYR . 82.0 mtt85 -102.04 134.34 45.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.832 0.349 . . . . 0.0 111.218 -178.782 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.453 HH21 ' CD ' ' A' ' 98' ' ' GLU . 36.8 ptt180 -142.48 157.42 44.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.866 179.722 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 74.0 mt -120.83 147.19 45.71 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.033 -179.811 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.7 t -116.21 126.77 73.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.377 178.658 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.3 m -78.66 138.48 38.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.487 0.661 . . . . 0.0 111.801 -178.692 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.6 mm -103.37 132.61 49.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.63 178.208 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -86.75 155.86 20.17 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.12 179.5 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.59 ' CD ' HH11 ' B' ' 245' ' ' ARG . 87.4 mtm180 -58.39 -30.28 66.69 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.052 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.6 t -74.62 -15.06 60.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.805 179.246 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.0 30.75 7.7 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 -179.431 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.1 t -119.09 133.99 64.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.94 0.4 . . . . 0.0 111.121 -179.964 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -74.75 136.98 41.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.838 178.981 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.51 -120.31 2.24 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 120.558 -0.829 . . . . 0.0 111.782 -179.905 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -73.54 152.84 49.09 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.173 1.915 . . . . 0.0 112.428 -179.111 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -114.1 156.07 24.84 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.015 179.471 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -119.97 104.04 44.63 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.451 -179.946 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.3 130.43 16.29 Favored 'Trans proline' 0 N--CA 1.488 1.19 0 C-N-CA 121.356 1.371 . . . . 0.0 112.59 -178.913 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.1 mt -83.88 45.7 1.11 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.749 -179.431 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.8 m -59.29 -28.73 67.02 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.666 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.3 mt -77.84 143.12 38.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.622 179.976 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 95.7 p -64.44 -21.08 66.54 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.219 -179.567 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 90.9 m -135.48 136.04 40.96 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.053 0.454 . . . . 0.0 112.153 -179.593 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.643 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 3.4 t -131.72 124.05 28.98 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.515 178.361 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.409 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 31.4 tp -116.36 130.49 56.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.934 -178.982 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.643 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 14.4 m-85 -107.34 141.07 39.28 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.436 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 160.21 -164.34 34.33 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 119.566 -1.302 . . . . 0.0 112.979 179.198 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.8 ttp85 -98.85 -32.11 11.51 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 114.977 -0.612 . . . . 0.0 111.88 -179.268 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -57.56 156.25 17.11 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.509 -1.037 . . . . 0.0 110.509 -179.795 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.584 ' O ' ' NE ' ' A' ' 38' ' ' ARG . 8.7 tp -63.97 -42.37 95.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 117.327 0.563 . . . . 0.0 112.235 -178.616 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.541 ' OE1' ' N ' ' A' ' 34' ' ' GLU . 57.9 mp0 -56.89 -17.41 9.38 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.267 -178.699 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.585 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 89.5 m -59.86 122.74 14.99 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.244 -0.583 . . . . 0.0 110.087 179.522 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.448 ' O ' ' CB ' ' B' ' 264' ' ' LYS . 71.5 m-20 -59.9 -31.18 69.57 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.273 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.45 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 94.6 mt -122.03 115.52 46.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 176.384 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.584 ' NE ' ' O ' ' A' ' 33' ' ' ILE . 74.5 mtt85 -104.43 138.22 41.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.006 -177.267 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 80.1 mt -119.5 130.49 73.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.839 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -73.7 38.79 0.1 Allowed 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -177.867 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.579 ' CD1' HH21 ' A' ' 93' ' ' ARG . 39.7 mt -125.04 129.64 24.47 Favored Pre-proline 0 C--N 1.325 -0.487 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.938 179.771 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.06 -11.83 27.58 Favored 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 122.404 2.069 . . . . 0.0 113.392 -178.973 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.411 ' CG2' ' CZ ' ' B' ' 241' ' ' PHE . 27.5 m -83.94 -4.32 8.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.411 179.549 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 40.8 t -87.38 133.13 30.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.209 179.578 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.5 t -65.25 161.16 19.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.779 -179.198 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.585 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 93.7 mttt -62.02 -44.35 96.9 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.485 -178.951 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.643 ' O ' ' N ' ' A' ' 49' ' ' CYS . 89.5 mt-30 -116.9 -18.23 10.22 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.921 0.391 . . . . 0.0 111.014 179.682 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.434 ' CE1' ' HG ' ' A' ' 64' ' ' SER . 16.7 t60 33.66 -72.21 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 179.415 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.643 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.11 137.18 46.22 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -177.726 . . . . . . . . 3 3 . 1 . 085 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -125.32 126.78 45.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.686 179.176 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 88.0 mt -110.36 131.73 60.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.995 -179.933 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -115.38 131.29 56.98 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.925 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.1 mm -100.39 122.24 52.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.841 -179.312 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.454 ' O ' ' C ' ' A' ' 55' ' ' GLU . 97.1 m-70 -122.42 132.15 54.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.199 179.25 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 54' ' ' HIS . 76.6 mt-10 -40.68 -36.71 0.64 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -178.457 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.487 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 88.7 mt-30 -62.85 -66.7 0.5 Allowed 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.401 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.487 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 3.8 tp10 -153.74 -168.3 2.93 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.678 -179.658 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.41 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -118.4 132.87 56.24 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.099 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.1 mt -118.59 129.89 74.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.392 0.615 . . . . 0.0 111.956 -178.666 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 40.1 tp -95.13 129.07 42.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.046 179.997 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -113.76 136.12 53.21 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 179.956 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.584 ' ND2' ' H ' ' A' ' 69' ' ' THR . 17.1 t-20 -97.41 107.64 20.19 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.988 0.423 . . . . 0.0 111.787 -179.582 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -98.65 -10.77 22.8 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.622 179.162 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.434 ' HG ' ' CE1' ' A' ' 48' ' ' HIS . 1.3 t -69.78 101.03 1.61 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.443 179.914 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 90.3 p -84.34 -14.27 50.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.972 0.415 . . . . 0.0 110.039 179.614 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.45 -40.8 8.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.161 -179.004 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -137.09 93.79 13.0 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.053 -179.687 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -56.75 144.03 88.33 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.256 1.97 . . . . 0.0 112.226 -179.822 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.584 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 95.1 m -71.29 137.13 48.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.056 179.707 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -98.32 141.29 31.4 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.614 178.982 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 55.5 t -130.15 136.55 58.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.251 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 53.37 32.33 13.6 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.252 -179.691 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.11 27.5 72.86 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.48 -179.99 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.1 m -138.37 137.51 37.38 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.383 -179.634 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.9 p -71.05 135.51 27.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.017 0.437 . . . . 0.0 111.897 -179.67 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.543 ' CD1' ' O ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -136.18 121.95 29.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.727 178.545 . . . . . . . . 3 3 . 1 . 085 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.7 p-10 -103.22 -5.02 23.56 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 120.801 -0.359 . . . . 0.0 111.475 -179.273 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.543 ' O ' ' CD1' ' A' ' 76' ' ' ILE . 21.4 mt-10 -116.13 151.49 46.71 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.747 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -60.35 146.23 97.03 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.016 1.811 . . . . 0.0 112.422 -179.12 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.6 m -141.32 147.26 22.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.325 -179.644 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -73.87 131.12 41.16 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 178.858 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.7 mt -78.46 134.76 37.3 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.257 179.965 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -124.9 148.83 48.12 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 178.848 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.523 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 6.1 t60 -55.1 121.42 8.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.393 -178.944 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.32 -19.13 34.86 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 179.975 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -67.61 134.79 51.82 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.385 179.919 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.5 t -110.04 132.48 58.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.811 -179.257 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.516 ' O ' ' OG ' ' A' ' 94' ' ' SER . 86.6 mt -101.33 132.16 47.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 178.697 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.458 ' HG1' ' HG ' ' A' ' 94' ' ' SER . 55.7 m -124.89 124.1 41.34 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 119.953 -0.699 . . . . 0.0 112.054 -178.543 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.461 ' O ' ' C ' ' A' ' 91' ' ' ILE . 86.6 mt -109.74 127.84 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.058 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.493 ' CG2' ' N ' ' A' ' 92' ' ' ASP . 95.3 mt 37.32 -100.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.583 -179.149 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.493 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 1.6 t70 -118.36 15.93 13.9 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.816 0.341 . . . . 0.0 110.963 -179.827 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.579 HH21 ' CD1' ' A' ' 41' ' ' LEU . 3.4 mtm105 -124.04 138.69 54.41 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.916 -179.588 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.516 ' OG ' ' O ' ' A' ' 88' ' ' ILE . 47.0 t -137.7 151.85 48.65 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.917 -179.405 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -127.21 123.33 36.35 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.582 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -82.85 135.98 34.77 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.048 -178.304 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.457 ' OH ' ' CD ' ' A' ' 5' ' ' ARG . 88.4 t80 -93.97 122.83 36.87 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.337 -179.854 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.453 ' CD ' HH21 ' A' ' 6' ' ' ARG . 76.1 tt0 -126.93 122.25 34.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.779 179.911 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.523 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 62.0 t-20 . . . . . 0 C--N 1.327 -0.377 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.588 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo . . . . . 0 N--CA 1.49 1.293 0 CA-C-O 121.287 0.453 . . . . 0.0 112.872 . . . . . . . . . 0 0 . 1 . 085 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 40.4 t -66.78 135.35 28.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.225 -0.898 . . . . 0.0 108.72 178.662 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 35.9 t . . . . . 0 C--N 1.323 -0.545 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.085 -179.027 . . . . . . . . 0 0 . 1 . 085 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo . . . . . 0 N--CA 1.496 1.665 0 CA-C-O 120.39 0.079 . . . . 0.0 112.199 . . . . . . . . . 0 0 . 1 . 085 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 24.7 m -73.34 -44.81 58.15 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.238 0.542 . . . . 0.0 109.552 178.286 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . 0.411 ' CZ ' ' CG2' ' A' ' 43' ' ' VAL . 83.4 t80 -56.67 -45.71 81.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.79 -179.963 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 88.8 mt -64.08 -41.65 97.24 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.559 179.871 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -60.69 -40.78 93.46 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.429 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -64.29 -42.32 96.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.423 179.094 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.59 HH11 ' CD ' ' A' ' 12' ' ' ARG . 58.1 ttm-85 -58.06 -42.9 86.48 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.168 -179.895 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -60.71 -39.94 90.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.167 -179.977 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 59.2 m -65.14 -44.49 88.46 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.025 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -60.41 -37.45 80.9 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.802 -179.895 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 38.7 t . . . . . 0 N--CA 1.452 -0.357 0 C-N-CA 119.864 -0.734 . . . . 0.0 109.805 178.908 . . . . . . . . 0 0 . 1 . 085 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . 0.538 ' N ' ' OE1' ' B' ' 260' ' ' GLU . 51.7 mp0 . . . . . 0 CA--C 1.534 0.358 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 . . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 75.4 mt -114.21 136.46 50.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.086 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . 0.459 ' N ' ' O ' ' A' ' 38' ' ' ARG . 50.2 t -128.18 137.92 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.86 0.362 . . . . 0.0 110.939 -179.565 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -100.86 122.64 43.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.117 0.484 . . . . 0.0 111.386 -179.117 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . 0.448 ' CB ' ' O ' ' A' ' 36' ' ' ASP . 89.2 tttt -64.35 -45.88 85.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.309 179.238 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 5.0 mp0 -99.82 163.63 18.07 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.976 -179.008 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.59 156.47 65.46 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.836 2.357 . . . . 0.0 111.459 178.916 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 37.6 pt . . . . . 0 C--N 1.325 -0.461 0 CA-C-O 121.267 0.556 . . . . 0.0 112.085 -178.832 . . . . . . . . 0 0 . 1 . 086 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.404 ' O ' ' OG1' ' A' ' 4' ' ' THR . 1.8 t . . . . . 0 C--O 1.233 0.229 0 CA-C-O 120.807 0.336 . . . . 0.0 110.854 . . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.405 ' HG2' ' HH ' ' A' ' 97' ' ' TYR . 83.9 mtt85 -85.63 122.11 29.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.341 -179.589 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -126.73 137.46 53.25 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.537 179.847 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 30.6 tp -114.67 127.54 55.82 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.617 179.98 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.48 ' CG1' ' OD1' ' A' ' 16' ' ' ASP . 64.2 t -104.53 134.19 46.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.105 179.684 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 m -94.42 118.93 32.38 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.247 0.546 . . . . 0.0 112.141 -178.516 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.612 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 95.3 mt -83.02 141.8 14.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.999 179.541 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.431 ' HA ' HH22 ' A' ' 93' ' ' ARG . 98.0 mttt -88.44 159.26 18.07 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 178.856 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.583 HH12 ' CD ' ' B' ' 248' ' ' GLN . 84.5 mtp180 -57.22 -29.63 63.92 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 121.059 -0.257 . . . . 0.0 111.139 -178.764 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.4 m -81.18 -6.21 58.59 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.605 179.393 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.97 36.85 7.5 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 -179.557 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.3 t -119.1 132.64 68.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.836 0.351 . . . . 0.0 110.633 -179.535 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.48 ' OD1' ' CG1' ' A' ' 8' ' ' VAL . 68.4 t0 -76.21 130.81 38.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.65 -179.549 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.17 -116.08 1.87 Allowed Glycine 0 CA--C 1.539 1.579 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.737 -179.438 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.5 145.91 38.53 Favored 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 122.797 2.331 . . . . 0.0 113.867 -178.301 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -109.23 150.12 28.41 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.12 0.486 . . . . 0.0 110.807 179.544 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -120.42 106.06 40.79 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.02 179.577 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -73.21 125.91 10.66 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 C-N-CA 121.459 1.439 . . . . 0.0 112.137 -178.583 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.0 mt -88.27 43.5 1.13 Allowed 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.108 -178.796 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 80.0 p -66.24 -19.55 65.86 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.564 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 90.0 mt -73.46 142.71 46.83 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.678 179.575 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 71.5 p -59.41 -24.95 63.9 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.474 -179.135 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 39.1 m -136.93 134.05 36.35 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.918 -179.6 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.5 t -126.03 122.24 35.31 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.335 178.169 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 41.7 tp -118.09 129.79 55.76 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.478 -178.441 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 4.7 m-85 -108.29 139.57 42.8 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 123.425 0.453 . . . . 0.0 110.06 179.395 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 178.22 -170.34 42.44 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 178.861 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 27.9 ptt-85 -100.11 -3.23 32.27 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.543 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -81.87 166.29 46.66 Favored Glycine 0 CA--C 1.52 0.371 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -179.326 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 19.3 tt -96.16 5.73 8.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.216 0.532 . . . . 0.0 110.308 179.969 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -95.64 -7.96 36.13 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.989 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.2 m -91.44 151.1 20.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.137 -179.94 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -60.77 -32.36 71.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.186 -179.641 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 98.4 mt -128.12 127.29 67.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.463 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -113.42 136.85 52.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.894 -178.775 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.422 ' C ' ' H ' ' A' ' 41' ' ' LEU . 85.6 mt -118.34 130.64 72.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.685 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -73.02 35.43 0.08 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.29 -178.035 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.422 ' H ' ' C ' ' A' ' 39' ' ' ILE . 59.7 mt -109.97 129.07 24.34 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.017 -179.83 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.5 -6.86 19.85 Favored 'Trans proline' 0 N--CA 1.49 1.292 0 C-N-CA 122.314 2.009 . . . . 0.0 112.623 -179.798 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.1 m -102.41 7.21 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.035 179.368 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 37.1 t -93.3 134.11 32.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.817 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.9 m -68.14 160.37 29.16 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.639 0.733 . . . . 0.0 112.481 -178.782 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -63.56 -41.3 98.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.088 -179.445 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.641 ' O ' ' N ' ' A' ' 49' ' ' CYS . 98.3 mm-40 -113.84 -19.22 11.58 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.005 -179.971 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.505 ' CG ' ' HG ' ' A' ' 64' ' ' SER . 21.7 t60 26.83 -74.65 0.0 OUTLIER 'General case' 0 C--O 1.235 0.335 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 179.969 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.641 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.19 134.48 46.53 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.6 0.714 . . . . 0.0 112.727 -178.206 . . . . . . . . 3 3 . 1 . 086 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -127.36 129.63 47.95 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.313 179.865 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 98.1 mt -113.92 132.25 63.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.438 179.859 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -111.19 126.38 54.8 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 178.088 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.445 HG22 HD11 ' A' ' 53' ' ' ILE . 82.2 mt -104.22 115.18 45.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.819 0.819 . . . . 0.0 111.952 -179.002 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.428 ' O ' ' C ' ' A' ' 55' ' ' GLU . 98.3 m-70 -117.55 142.57 47.03 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.265 -1.334 . . . . 0.0 110.165 179.844 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 54' ' ' HIS . 87.3 tt0 -40.5 -33.16 0.24 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.673 179.539 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.502 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 64.6 tp60 -61.72 -68.03 0.36 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.55 179.417 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.502 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 6.5 tp10 -156.41 -168.71 2.8 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.463 -178.641 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.449 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -110.46 126.81 54.73 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.412 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.8 mt -115.09 131.15 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -177.689 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 21.6 tp -101.59 127.78 48.15 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.769 179.862 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -110.92 135.58 51.24 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.737 179.876 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.466 ' ND2' ' O ' ' A' ' 76' ' ' ILE . 48.6 t-20 -94.92 104.5 16.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.296 -179.196 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -99.53 -9.65 23.04 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.307 179.729 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.505 ' HG ' ' CG ' ' A' ' 48' ' ' HIS . 0.8 OUTLIER -69.05 102.75 1.69 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.478 . . . . . . . . 3 3 . 1 . 086 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 81.6 p -88.91 -15.94 33.12 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.225 179.911 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.97 -42.78 10.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.261 -179.805 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 46.4 m-20 -141.2 103.45 6.1 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.483 -179.729 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -56.25 144.85 80.13 Favored 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 121.9 1.733 . . . . 0.0 113.188 -179.097 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.5 m -73.3 140.05 46.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.593 178.459 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -101.26 139.61 36.7 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.15 0.5 . . . . 0.0 111.532 -179.874 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 45.1 t -136.4 133.79 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.956 178.63 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 8.0 m120 54.49 32.31 16.52 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.075 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.67 29.16 63.9 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-N 115.14 -0.936 . . . . 0.0 112.212 179.388 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 64.1 m -149.87 147.47 27.99 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 117.401 0.601 . . . . 0.0 111.674 -179.742 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.8 m -75.82 149.48 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.103 0.477 . . . . 0.0 111.733 -179.695 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.466 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 4.0 pt -120.97 97.94 5.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.663 179.312 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -69.25 -23.34 63.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.719 179.724 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -129.85 177.25 2.28 Favored Pre-proline 0 N--CA 1.469 0.506 0 C-N-CA 121.191 -0.203 . . . . 0.0 111.324 -179.84 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -61.02 146.7 97.41 Favored 'Trans proline' 0 N--CA 1.503 2.071 0 C-N-CA 123.042 2.495 . . . . 0.0 112.744 179.649 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.4 p -143.67 138.99 25.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.696 179.884 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 88.9 mtm180 -74.84 133.05 41.94 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.176 179.475 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 93.3 mt -89.23 129.09 35.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.963 0.411 . . . . 0.0 110.696 179.77 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -117.22 156.15 28.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.243 179.594 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.407 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 6.4 t60 -56.01 118.41 4.62 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.178 179.978 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.35 -17.42 18.99 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -179.775 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.45 ' OD1' ' N ' ' A' ' 87' ' ' VAL . 54.3 t0 -65.63 127.57 32.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.256 0.55 . . . . 0.0 110.851 179.725 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.45 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 56.0 t -109.14 132.99 55.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.43 -179.226 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 77.2 mt -101.05 130.54 50.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.843 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 51.5 m -122.54 122.88 39.95 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.608 0.718 . . . . 0.0 112.221 -178.629 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.519 ' O ' ' N ' ' A' ' 93' ' ' ARG . 96.7 mt -113.9 124.66 70.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 114.642 -1.163 . . . . 0.0 108.592 178.24 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.437 ' C ' ' O ' ' A' ' 90' ' ' ILE . 46.3 mm 39.17 -96.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.323 -179.27 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.531 ' CB ' ' HE ' ' B' ' 245' ' ' ARG . 54.7 t0 -119.95 5.07 10.9 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.978 0.418 . . . . 0.0 110.742 -179.826 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.617 HH21 ' CD1' ' B' ' 261' ' ' ILE . 17.9 mmm180 -106.89 134.97 49.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.699 179.925 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 47.1 t -132.12 144.07 50.45 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.838 -179.872 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -123.19 120.26 32.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.1 179.766 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 44.2 ttm180 -84.47 127.35 33.98 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.142 -179.8 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.724 ' HH ' ' ND2' ' A' ' 99' ' ' ASN . 88.9 t80 -95.73 129.05 43.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.462 179.854 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -142.66 128.63 19.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.973 0.416 . . . . 0.0 111.938 -179.445 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.724 ' ND2' ' HH ' ' A' ' 97' ' ' TYR . 89.1 m-20 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.987 179.228 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo . . . . . 0 N--CA 1.488 1.175 0 CA-C-O 121.568 0.57 . . . . 0.0 113.095 . . . . . . . . . 0 0 . 1 . 086 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 55.6 t -67.75 136.02 27.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 114.612 -1.176 . . . . 0.0 111.803 -179.357 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.9 t . . . . . 0 C--N 1.331 -0.22 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.644 178.774 . . . . . . . . 0 0 . 1 . 086 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo . . . . . 0 N--CA 1.504 2.091 0 N-CA-C 113.609 0.58 . . . . 0.0 113.609 . . . . . . . . . 0 0 . 1 . 086 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 37.2 m -72.28 -45.52 59.74 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.201 0.524 . . . . 0.0 110.341 179.135 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -56.61 -45.41 81.49 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.659 -179.733 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 98.6 mt -64.31 -41.31 96.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.31 179.82 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -64.99 -37.42 87.61 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.642 179.903 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -60.36 -43.41 96.57 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.616 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.531 ' HE ' ' CB ' ' A' ' 92' ' ' ASP . 75.1 mtp85 -62.34 -37.48 85.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.75 -179.966 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -62.04 -41.37 98.05 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.238 179.809 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 10.2 t -65.63 -44.07 87.58 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.757 0.789 . . . . 0.0 108.932 177.812 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . 0.583 ' CD ' HH12 ' A' ' 12' ' ' ARG . 64.5 tt0 -62.11 -32.2 72.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.454 179.455 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 55.6 t . . . . . 0 N--CA 1.456 -0.173 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 179.109 . . . . . . . . 0 0 . 1 . 086 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 . . . . . 0 N--CA 1.462 0.168 0 CA-C-O 120.7 0.286 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 086 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . 0.617 ' CD1' HH21 ' A' ' 93' ' ' ARG . 39.7 mt -118.09 138.34 49.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -179.734 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 52.9 t -126.56 135.28 64.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.431 -179.847 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -98.23 118.62 35.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.135 0.493 . . . . 0.0 111.242 -178.903 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.86 -47.35 78.22 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.446 179.273 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -92.48 150.6 40.21 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.253 -179.22 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -66.44 147.76 83.04 Favored 'Trans proline' 0 N--CA 1.499 1.828 0 C-N-CA 123.169 2.579 . . . . 0.0 113.34 -179.488 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 19.7 pt . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.128 178.722 . . . . . . . . 0 0 . 1 . 087 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.6 p . . . . . 0 C--O 1.236 0.361 0 CA-C-O 120.726 0.298 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 087 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.45 119.95 33.95 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.247 0.546 . . . . 0.0 110.719 -179.894 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 83.9 mtp180 -133.48 143.57 48.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.309 179.107 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -112.32 127.48 56.0 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.416 179.067 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.9 t -98.77 125.67 52.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.058 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 m -76.84 138.08 39.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.473 0.654 . . . . 0.0 112.2 -178.923 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.611 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 48.1 mm -105.19 132.45 51.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.625 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -87.73 156.8 19.27 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.09 -0.644 . . . . 0.0 110.994 179.918 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.63 ' NH2' HE21 ' B' ' 248' ' ' GLN . 73.2 mtp180 -54.02 -33.56 57.54 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.612 -179.286 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.7 m -78.73 -5.41 53.13 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.42 179.008 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.42 35.02 9.78 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -179.343 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.3 t -119.15 134.6 62.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.66 0.267 . . . . 0.0 110.284 -179.84 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.403 ' OD1' ' CD1' ' A' ' 10' ' ' ILE . 86.7 m-20 -76.15 137.97 40.42 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.862 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.25 -118.15 2.05 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.514 -179.176 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.43 147.9 47.47 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.215 1.943 . . . . 0.0 113.002 -178.217 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 64.7 m170 -105.45 132.76 51.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.236 179.577 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -104.61 97.52 12.58 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.115 179.784 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -71.37 129.11 15.42 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 121.326 1.351 . . . . 0.0 111.675 -179.859 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 49.6 mt -96.92 54.12 1.25 Allowed 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.421 -179.131 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 92.0 p -61.78 -17.94 57.97 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.855 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 76.7 mt -77.15 142.21 39.8 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.293 178.88 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.7 t -63.61 -20.83 65.99 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -178.866 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 72.1 m -132.92 133.43 43.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.137 0.494 . . . . 0.0 111.739 -179.652 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.567 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 9.6 t -126.34 119.09 26.43 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.493 179.291 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.461 ' O ' ' N ' ' A' ' 36' ' ' ASP . 34.0 tp -115.55 126.57 54.41 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.566 -0.453 . . . . 0.0 111.854 -178.084 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.567 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 10.5 m-85 -104.12 139.86 38.6 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.994 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 171.82 -171.83 44.33 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 119.812 -1.185 . . . . 0.0 112.063 179.738 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 31.2 ttp85 -100.26 -8.73 23.16 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.114 -0.543 . . . . 0.0 111.778 -179.444 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.451 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -88.78 167.31 34.83 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 120.688 -0.767 . . . . 0.0 111.284 -179.996 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.433 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 9.9 tp -64.71 -42.06 93.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 O-C-N 122.551 -0.382 . . . . 0.0 110.975 -179.732 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.433 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 93.0 mt-10 -53.7 -22.23 8.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.766 0.317 . . . . 0.0 111.047 -179.334 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 4.0 m -65.96 124.83 23.59 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.438 -179.873 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 28' ' ' LEU . 53.1 m-20 -60.31 -30.65 69.63 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.349 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 79.7 mt -123.93 121.41 62.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 176.825 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.439 HH12 ' HA ' ' B' ' 264' ' ' LYS . 89.2 mtm-85 -103.84 133.93 48.0 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.006 -178.228 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.451 ' C ' ' H ' ' A' ' 41' ' ' LEU . 97.9 mt -116.9 128.95 74.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.289 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -73.23 26.46 0.06 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.014 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.451 ' H ' ' C ' ' A' ' 39' ' ' ILE . 51.5 mt -95.64 127.44 41.6 Favored Pre-proline 0 C--N 1.324 -0.543 0 C-N-CA 120.478 -0.489 . . . . 0.0 109.921 179.022 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.91 -7.96 22.08 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 122.186 1.924 . . . . 0.0 111.964 -179.628 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.8 m -97.92 10.97 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.299 179.982 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 33.5 t -99.0 133.52 41.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-O 120.675 0.274 . . . . 0.0 110.846 179.467 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.0 m -74.45 170.69 15.17 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.255 0.55 . . . . 0.0 111.927 -178.934 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -64.53 -41.45 96.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.202 -179.301 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.617 ' O ' ' N ' ' A' ' 49' ' ' CYS . 97.8 mm-40 -109.58 -27.41 9.41 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.164 0.507 . . . . 0.0 110.025 -179.578 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.441 ' O ' ' OG ' ' A' ' 64' ' ' SER . 18.8 t60 38.94 -77.52 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.666 -1.152 . . . . 0.0 112.661 179.623 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.617 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.45 133.68 46.5 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.259 0.552 . . . . 0.0 111.114 -179.066 . . . . . . . . 3 3 . 1 . 087 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -128.76 131.45 47.84 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.494 -179.819 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 94.7 mt -116.88 133.21 64.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.183 0.516 . . . . 0.0 110.744 179.633 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -115.81 125.92 53.33 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.704 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 95.5 mt -105.02 113.67 42.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.482 0.658 . . . . 0.0 111.77 -178.938 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.475 ' O ' ' N ' ' A' ' 56' ' ' GLN . 90.7 m-70 -112.11 142.94 43.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.316 -179.883 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 54' ' ' HIS . 78.4 tt0 -40.9 -27.48 0.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.298 0.57 . . . . 0.0 109.897 -179.317 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.475 ' N ' ' O ' ' A' ' 54' ' ' HIS . 70.0 tp60 -65.86 -67.88 0.41 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.727 179.715 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.464 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 5.8 tp10 -158.12 -168.17 2.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.042 -0.527 . . . . 0.0 109.676 -179.257 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.464 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -108.87 122.63 47.6 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.909 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.0 mt -114.56 131.43 66.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -177.763 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.406 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 24.5 tp -103.07 127.22 50.41 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.216 -179.417 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -111.05 136.78 49.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.141 179.335 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.468 HD22 ' HA ' ' A' ' 68' ' ' PRO . 58.9 t-20 -97.92 106.95 19.33 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.693 -178.954 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -101.43 -7.3 23.01 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.471 179.606 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 48' ' ' HIS . 0.7 OUTLIER -74.36 99.48 3.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.484 -178.794 . . . . . . . . 3 3 . 1 . 087 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 76.7 p -81.08 -32.41 33.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.059 0.457 . . . . 0.0 109.863 179.337 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.8 m -62.92 -49.97 72.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.683 -179.935 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 -144.15 106.33 4.83 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.933 -179.854 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.468 ' HA ' HD22 ' A' ' 62' ' ' ASN . 45.4 Cg_exo -54.08 146.89 46.2 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 121.923 1.748 . . . . 0.0 112.949 -179.231 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.4 m -74.98 138.95 42.6 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.924 178.885 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -101.78 140.67 35.75 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.95 179.841 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.455 ' O ' ' OG ' ' A' ' 74' ' ' SER . 64.8 t -131.8 133.17 61.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.052 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 53.74 32.39 14.69 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.007 -178.611 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.12 29.09 67.18 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.417 -179.73 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 4.9 p -145.42 140.4 27.6 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.953 -179.682 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.1 t -65.82 139.85 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.456 179.741 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.3 pt -110.2 78.13 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.089 0 CA-C-O 121.021 0.439 . . . . 0.0 110.214 178.587 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -57.59 -31.69 66.43 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.004 179.993 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -118.81 168.85 8.91 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.55 179.762 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.3 141.99 98.51 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.019 1.813 . . . . 0.0 111.941 179.607 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 61.2 t -135.78 136.57 50.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.188 -179.913 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -72.64 131.55 42.57 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.614 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 93.3 mt -83.25 138.59 33.53 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.761 -179.836 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -130.71 154.46 47.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.024 -179.661 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.414 ' CD2' ' C ' ' A' ' 84' ' ' HIS . 7.7 t60 -54.35 116.42 2.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.372 179.88 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.72 -19.15 31.23 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -179.846 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.434 ' C ' ' OD1' ' A' ' 86' ' ' ASP . 45.5 t0 -65.54 126.95 29.93 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.144 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 52.8 t -109.94 134.55 51.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.432 -0.507 . . . . 0.0 111.312 -178.386 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 79.5 mt -100.96 130.17 50.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.172 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 68.3 m -122.44 123.05 40.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.514 0.673 . . . . 0.0 111.545 -178.762 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.632 ' O ' ' N ' ' A' ' 93' ' ' ARG . 79.6 mt -107.08 121.02 59.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 178.382 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.49 ' C ' ' O ' ' A' ' 90' ' ' ILE . 96.7 mt 33.99 -91.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.818 -179.707 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.576 ' N ' ' O ' ' A' ' 90' ' ' ILE . 46.6 p-10 -118.49 2.7 11.82 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.899 0.381 . . . . 0.0 111.118 179.654 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.738 ' NH2' ' H ' ' A' ' 94' ' ' SER . 0.5 OUTLIER -111.87 132.49 54.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.31 -179.98 . . . . . . . . 3 3 . 1 . 087 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.738 ' H ' ' NH2' ' A' ' 93' ' ' ARG . 16.7 m -135.7 152.28 51.02 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.612 0.72 . . . . 0.0 112.019 -179.455 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.449 ' CZ ' ' NH1' ' A' ' 93' ' ' ARG . 84.4 m-85 -129.67 126.29 37.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.901 179.06 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 96' ' ' ARG . 37.9 ttp-105 -88.11 133.33 34.02 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.612 179.662 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -93.42 125.77 38.2 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.926 -179.73 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -124.47 131.02 53.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.612 179.93 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 59.8 t-20 . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.042 -179.741 . . . . . . . . 0 0 . 1 . 087 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo . . . . . 0 N--CA 1.487 1.091 0 CA-C-O 121.37 0.487 . . . . 0.0 112.167 . . . . . . . . . 0 0 . 1 . 087 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.58 137.61 22.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.074 179.817 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 3.7 t . . . . . 0 C--N 1.331 -0.223 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.223 -178.701 . . . . . . . . 0 0 . 1 . 087 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo . . . . . 0 N--CA 1.498 1.768 0 CA-C-O 120.929 0.304 . . . . 0.0 111.888 . . . . . . . . . 0 0 . 1 . 087 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 98.3 m -72.91 -44.65 60.98 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.314 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -57.99 -45.06 87.42 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.865 -179.415 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 97.1 mt -64.81 -40.9 95.97 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -179.426 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -61.22 -42.89 99.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.786 179.964 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -63.21 -39.43 94.6 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.44 -0.504 . . . . 0.0 109.682 179.946 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.616 HH11 ' CZ ' ' A' ' 12' ' ' ARG . 14.5 tpp180 -59.04 -42.42 90.22 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 179.604 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -60.4 -43.03 97.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.403 179.131 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 16.5 t -65.1 -44.88 87.39 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.948 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . 0.63 HE21 ' NH2' ' A' ' 12' ' ' ARG . 27.4 mt-30 -60.84 -32.84 72.23 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.465 -179.825 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 54.1 t . . . . . 0 CA--C 1.52 -0.183 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.046 . . . . . . . . 0 0 . 1 . 087 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . 0.568 ' OE2' ' NH1' ' A' ' 12' ' ' ARG . 92.7 mt-10 . . . . . 0 C--O 1.226 -0.145 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 . . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 59.1 mt -116.53 134.12 60.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.958 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 52.9 t -126.5 134.03 67.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.946 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -93.95 117.86 30.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.479 0.657 . . . . 0.0 111.97 -178.412 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . 0.439 ' HA ' HH12 ' A' ' 38' ' ' ARG . 87.5 tttt -63.34 -43.86 96.51 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.981 179.128 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 9.3 mp0 -100.65 157.43 33.74 Favored Pre-proline 0 N--CA 1.449 -0.492 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.548 -179.686 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -70.2 143.57 49.13 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 C-N-CA 122.847 2.364 . . . . 0.0 113.312 -179.157 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 29.5 pt . . . . . 0 N--CA 1.451 -0.378 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.072 178.564 . . . . . . . . 0 0 . 1 . 088 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.598 ' HG1' ' H ' ' A' ' 5' ' ' ARG . 37.2 p . . . . . 0 N--CA 1.462 0.137 0 CA-C-O 120.772 0.32 . . . . 0.0 111.3 . . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.598 ' H ' ' HG1' ' A' ' 4' ' ' THR . 82.6 mtm-85 -99.71 134.93 41.89 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.902 -179.366 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -138.82 144.9 39.51 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 120.222 -0.591 . . . . 0.0 111.626 -179.859 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.4 mt -108.73 140.62 41.88 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.003 178.58 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.4 t -112.54 129.21 68.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.616 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 m -93.45 117.77 30.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.272 0.558 . . . . 0.0 112.299 -178.049 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.5 mt -83.07 143.04 12.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.785 179.582 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -95.94 164.31 12.77 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.967 179.498 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.435 ' HG3' ' NH1' ' A' ' 93' ' ' ARG . 82.7 mtp180 -58.36 -30.09 66.49 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.281 -179.366 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 88.0 p -73.25 -15.08 61.43 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.229 179.561 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.93 11.09 44.3 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -179.869 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.4 m -112.02 138.73 39.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.956 0.408 . . . . 0.0 110.484 179.931 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.419 ' O ' ' OD1' ' A' ' 16' ' ' ASP . 54.2 p-10 -80.19 146.85 31.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.006 179.446 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.21 -106.09 1.01 Allowed Glycine 0 CA--C 1.537 1.447 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 179.822 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.1 146.92 37.39 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 122.963 2.442 . . . . 0.0 112.248 -179.994 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -112.97 153.18 28.43 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.194 179.901 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.422 ' CD2' HD11 ' A' ' 37' ' ' ILE . 62.5 t80 -117.53 89.21 31.59 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.665 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -61.3 132.62 42.12 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.556 2.171 . . . . 0.0 111.089 179.914 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.7 mt -87.97 82.23 7.29 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.653 -178.847 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 86.0 p -86.59 -11.14 52.32 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 178.379 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 63.4 mt -101.92 144.06 31.03 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.526 -179.186 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.1 m -67.86 -21.2 65.19 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.779 0.323 . . . . 0.0 111.199 -179.724 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 63.1 m -127.52 133.31 49.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.708 179.619 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.657 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 9.8 t -129.78 122.13 28.2 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.463 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 49.8 tp -118.08 132.5 56.35 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.149 -178.246 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.657 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 38.0 m-85 -110.49 142.46 42.22 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.8 0.334 . . . . 0.0 110.197 179.837 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 150.13 -176.16 28.89 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 179.406 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 46.6 mtm180 -77.76 -31.68 52.19 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.64 179.605 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.578 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -47.8 149.37 3.27 Favored Glycine 0 N--CA 1.466 0.688 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 -179.012 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.0 tp -68.58 -41.04 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.583 -179.918 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -55.07 -21.98 14.51 Favored 'General case' 0 C--O 1.231 0.096 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -179.995 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.578 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 19.0 m -57.34 113.01 1.57 Allowed 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.771 178.812 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -58.36 -26.72 63.47 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 -179.99 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.422 HD11 ' CD2' ' A' ' 20' ' ' PHE . 50.5 mm -122.4 113.48 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.476 177.289 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 42.2 mtm180 -98.02 131.63 44.27 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.829 -179.662 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.401 ' C ' ' H ' ' A' ' 41' ' ' LEU . 99.2 mt -118.17 131.25 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 121.465 0.65 . . . . 0.0 111.31 179.79 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -79.79 32.39 0.25 Allowed 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.159 -178.631 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.401 ' H ' ' C ' ' A' ' 39' ' ' ILE . 31.9 mt -98.22 121.56 56.73 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.484 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -72.33 -13.0 27.92 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 121.552 1.501 . . . . 0.0 111.499 -179.823 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.2 m -96.2 7.73 7.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.505 -179.451 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.457 HG23 ' ND1' ' A' ' 48' ' ' HIS . 5.0 p -101.86 142.5 16.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.533 179.958 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.8 m -71.95 170.35 13.95 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.363 0.602 . . . . 0.0 111.129 -179.391 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -63.81 -41.2 97.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.986 -179.764 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.637 ' O ' ' N ' ' A' ' 49' ' ' CYS . 87.7 mt-30 -108.96 -9.92 15.08 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 121.086 -0.246 . . . . 0.0 110.994 -179.958 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.457 ' ND1' HG23 ' A' ' 44' ' ' VAL . 30.0 t60 31.41 -76.32 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 179.635 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.637 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.51 137.37 45.58 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.132 0.491 . . . . 0.0 111.685 -178.472 . . . . . . . . 3 3 . 1 . 088 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -123.75 131.56 53.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.899 178.733 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.5 mt -116.05 133.46 62.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.197 -179.109 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -117.85 125.63 50.89 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.02 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.456 HD13 ' HE ' ' A' ' 5' ' ' ARG . 67.7 mt -103.29 116.6 47.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 C-N-CA 119.853 -0.739 . . . . 0.0 111.207 -179.488 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.503 ' O ' ' N ' ' A' ' 56' ' ' GLN . 6.3 m-70 -111.72 135.8 51.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.182 179.637 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.0 mm-40 -41.51 -26.58 0.07 Allowed 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.477 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.503 ' N ' ' O ' ' A' ' 54' ' ' HIS . 82.4 mt-30 -68.39 -68.55 0.38 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.215 178.679 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.468 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 5.2 tp10 -151.0 -178.3 6.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.557 -179.357 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.468 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -102.41 128.7 48.89 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.554 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.464 HG21 HD12 ' A' ' 59' ' ' ILE . 40.9 mm -111.89 126.57 69.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.886 -178.117 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.428 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 23.0 tp -101.37 124.24 46.75 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.923 178.878 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -114.81 137.04 52.42 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.419 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.636 ' ND2' ' H ' ' A' ' 69' ' ' THR . 21.5 t-20 -102.21 108.28 19.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.03 0.443 . . . . 0.0 111.288 179.49 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -94.43 -3.03 50.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.805 179.298 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.8 t -82.31 100.98 10.26 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.446 -0.501 . . . . 0.0 110.081 179.521 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.9 m -82.76 -17.2 45.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.62 179.954 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.52 -36.09 17.8 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.376 -179.338 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -146.05 100.58 4.22 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.873 -179.54 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -57.81 144.09 94.25 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 121.736 1.624 . . . . 0.0 112.708 -179.336 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.636 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 37.2 m -70.21 134.55 48.17 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.171 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -96.08 141.1 29.87 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.635 -178.909 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.5 t -134.32 134.07 55.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.321 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 53.49 31.89 13.09 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 119.84 -0.744 . . . . 0.0 109.023 -179.104 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.04 25.68 72.98 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.26 179.852 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 37.8 t -141.72 143.57 33.6 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 117.297 0.549 . . . . 0.0 111.528 -179.993 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.8 m -76.69 139.13 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.884 179.984 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.414 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 1.1 pt -104.08 104.05 16.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.622 179.106 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.428 ' C ' ' OE1' ' A' ' 78' ' ' GLU . 57.9 m-20 -63.24 -35.88 81.8 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-O 121.191 0.519 . . . . 0.0 109.911 179.964 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.428 ' OE1' ' C ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -125.79 177.95 1.7 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.345 -179.128 . . . . . . . . 3 3 . 1 . 088 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.418 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 34.6 Cg_exo -60.48 142.64 98.5 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 122.302 2.001 . . . . 0.0 111.914 179.966 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 42.9 t -132.7 138.19 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 120.946 0.403 . . . . 0.0 111.665 179.722 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -75.32 132.83 41.25 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.679 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 86.1 mt -87.41 137.2 32.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.326 0.584 . . . . 0.0 111.318 -179.121 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -126.02 151.85 46.54 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.321 -179.704 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.724 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 9.1 t60 -55.12 122.98 12.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.227 0.537 . . . . 0.0 111.246 -178.973 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 103.35 -13.22 54.89 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.143 -179.657 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -70.72 139.06 51.04 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 117.079 0.44 . . . . 0.0 110.696 179.687 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 8.7 p -111.69 135.81 49.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.411 -0.515 . . . . 0.0 111.841 -178.996 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 81.2 mt -102.4 128.99 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 177.606 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 95.3 m -123.93 125.07 43.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.702 0.763 . . . . 0.0 111.759 -178.438 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.63 ' O ' ' N ' ' A' ' 93' ' ' ARG . 96.1 mt -113.99 121.65 66.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 114.547 -1.206 . . . . 0.0 108.062 178.324 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.555 ' C ' ' O ' ' A' ' 90' ' ' ILE . 66.5 mt -3.44 95.31 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -179.833 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.427 ' CB ' ' NH1' ' B' ' 245' ' ' ARG . 2.0 t0 77.83 -20.3 0.39 Allowed 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 178.18 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.709 ' HE ' ' CD1' ' B' ' 261' ' ' ILE . 6.8 tpt180 -120.31 130.08 54.29 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 110.465 -0.198 . . . . 0.0 110.465 -178.372 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 64.3 m -134.62 151.11 50.83 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -178.486 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -122.63 120.74 34.62 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.308 178.551 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 37.7 ttp-105 -87.86 134.95 33.59 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 119.914 -0.715 . . . . 0.0 110.727 -179.652 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -96.93 123.86 40.75 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.124 -178.14 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -125.12 120.26 30.9 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.234 179.415 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.724 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 15.9 t-20 . . . . . 0 N--CA 1.472 0.657 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.507 -179.225 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo . . . . . 0 N--CA 1.49 1.275 0 N-CA-C 113.388 0.495 . . . . 0.0 113.388 . . . . . . . . . 0 0 . 1 . 088 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 60.5 t -60.82 137.61 22.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.48 179.667 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 2.7 t . . . . . 0 C--N 1.321 -0.651 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.038 -179.559 . . . . . . . . 0 0 . 1 . 088 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo . . . . . 0 N--CA 1.496 1.655 0 CA-C-O 120.775 0.24 . . . . 0.0 112.241 . . . . . . . . . 0 0 . 1 . 088 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 86.2 m -72.24 -44.05 63.46 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.439 0.638 . . . . 0.0 109.417 178.485 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -58.47 -51.01 71.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.324 -178.624 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 97.2 mt -63.51 -42.04 98.49 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.183 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -64.29 -42.24 96.49 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -178.734 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -62.2 -41.8 98.7 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.344 -179.591 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.427 ' NH1' ' CB ' ' A' ' 92' ' ' ASP . 83.5 mtp180 -63.21 -39.32 94.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.636 -178.495 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -62.01 -38.46 88.73 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.016 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 21.0 m -65.49 -42.61 91.97 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.499 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -62.33 -32.92 73.75 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.156 179.705 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 53.1 t . . . . . 0 N--CA 1.45 -0.439 0 C-N-CA 120.121 -0.632 . . . . 0.0 109.419 178.74 . . . . . . . . 0 0 . 1 . 088 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 . . . . . 0 C--O 1.23 0.075 0 N-CA-C 111.838 0.311 . . . . 0.0 111.838 . . . . . . . . . 0 0 . 1 . 088 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . 0.709 ' CD1' ' HE ' ' A' ' 93' ' ' ARG . 64.9 mt -117.6 134.36 61.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -179.883 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 47.8 t -123.4 130.65 74.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.162 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -93.47 117.07 29.63 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.272 0.558 . . . . 0.0 111.106 -177.924 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -64.48 -46.6 82.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.687 -179.781 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -92.49 165.78 18.59 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.069 -178.465 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -69.07 148.01 68.6 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 122.122 1.882 . . . . 0.0 112.739 -178.93 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 32.1 pt . . . . . 0 C--N 1.321 -0.646 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.15 -179.876 . . . . . . . . 0 0 . 1 . 089 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.0 p . . . . . 0 N--CA 1.455 -0.183 0 CA-C-O 121.133 0.492 . . . . 0.0 110.294 . . . . . . . . . 0 0 . 1 . 089 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.55 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 80.5 mtp85 -87.69 126.73 35.14 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.064 -179.465 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -129.62 133.53 47.19 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.013 -179.863 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 35.1 tp -117.1 128.38 55.08 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.748 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.6 m -106.16 136.09 41.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.419 -179.768 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 m -95.29 117.84 30.99 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.142 -0.936 . . . . 0.0 112.589 -178.589 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.7 mt -84.65 145.59 7.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.386 179.02 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -96.4 162.3 13.55 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.95 0.405 . . . . 0.0 110.773 179.315 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.593 ' NH1' ' OE2' ' B' ' 260' ' ' GLU . 87.6 mtm180 -58.45 -27.38 64.32 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.558 -178.636 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 89.3 p -81.82 -9.77 59.52 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.093 -0.643 . . . . 0.0 109.697 179.646 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.3 36.75 6.47 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.61 179.8 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.3 t -118.38 132.37 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-O 120.787 0.327 . . . . 0.0 111.42 179.993 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -69.64 124.48 24.06 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.862 179.274 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -116.08 -128.89 4.34 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.271 -178.937 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -70.61 148.07 58.76 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.031 1.821 . . . . 0.0 112.816 -178.623 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -106.51 144.87 32.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.814 -179.572 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.408 ' CD2' HD13 ' A' ' 37' ' ' ILE . 34.6 t80 -112.25 100.98 51.19 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.321 179.862 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.414 ' CD ' ' O ' ' B' ' 267' ' ' ILE . 57.8 Cg_endo -75.79 128.82 11.15 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 121.47 1.446 . . . . 0.0 111.42 -179.632 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 88.0 mt -83.8 81.17 8.88 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.855 -178.871 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 87.8 p -86.01 -13.7 46.72 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.987 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 73.8 mt -100.03 145.36 28.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.422 -179.967 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 54.2 p -68.56 -15.77 63.64 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.506 -178.804 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 85.6 m -128.61 131.48 48.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.237 0.541 . . . . 0.0 111.778 -179.691 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.9 t -128.11 122.15 31.34 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.304 178.543 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.8 tp -115.27 130.58 56.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.956 0.408 . . . . 0.0 111.002 -179.074 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.55 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 44.8 m-85 -111.36 140.47 45.92 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.796 179.718 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 152.64 -168.4 31.63 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 120.886 -0.673 . . . . 0.0 111.504 179.394 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.578 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 49.5 ptt85 -118.29 17.27 13.92 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 122.76 -0.259 . . . . 0.0 111.034 179.901 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.629 ' O ' ' N ' ' A' ' 34' ' ' GLU . . . -88.05 32.96 4.16 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.814 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.68 ' C ' ' H ' ' A' ' 35' ' ' CYS . 2.0 tt 52.03 -62.09 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 123.28 0.632 . . . . 0.0 112.587 -179.609 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.629 ' N ' ' O ' ' A' ' 32' ' ' GLY . 72.0 tt0 -52.26 2.21 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 O-C-N 121.974 -0.454 . . . . 0.0 110.899 -178.934 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.68 ' H ' ' C ' ' A' ' 33' ' ' ILE . 3.9 m -82.77 133.81 35.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.891 0.377 . . . . 0.0 111.027 179.82 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -61.88 -26.81 68.37 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.88 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.419 HG22 HD12 ' A' ' 37' ' ' ILE . 49.0 mm -123.41 117.09 50.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 177.267 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 82.1 mtt180 -100.33 132.92 45.43 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.85 -179.133 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 80.9 mt -120.31 130.98 73.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.469 -0.493 . . . . 0.0 110.446 -179.727 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -79.11 33.97 0.23 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.507 -179.046 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 17.9 mt -102.06 108.74 57.85 Favored Pre-proline 0 C--N 1.326 -0.427 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.78 -179.974 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -57.56 -13.81 14.91 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.21 1.94 . . . . 0.0 112.406 179.159 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.6 m -97.31 9.7 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.858 -179.893 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.578 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 15.7 t -102.17 135.88 37.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.092 0.473 . . . . 0.0 110.957 -179.744 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.53 162.23 21.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.204 -179.12 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -62.89 -42.42 99.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.702 -179.392 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.595 ' O ' ' N ' ' A' ' 49' ' ' CYS . 87.6 mt-30 -112.34 -2.58 14.76 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.916 0.389 . . . . 0.0 110.579 178.882 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.456 ' C ' ' O ' ' A' ' 47' ' ' GLN . 14.8 t60 15.88 -73.51 0.0 OUTLIER 'General case' 0 C--O 1.235 0.29 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -179.287 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.595 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.91 134.69 44.9 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.331 -0.548 . . . . 0.0 112.094 -178.127 . . . . . . . . 3 3 . 1 . 089 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -127.41 132.36 50.13 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.399 179.793 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.2 mt -115.93 133.24 62.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.977 0.417 . . . . 0.0 111.432 -179.491 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -117.41 127.93 54.52 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.428 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 93.0 mt -105.53 118.36 52.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 119.941 -0.703 . . . . 0.0 112.231 -179.089 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.454 ' O ' ' N ' ' A' ' 56' ' ' GLN . 92.9 m-70 -116.39 144.01 44.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.692 -179.522 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 54' ' ' HIS . 95.3 mt-10 -40.28 -29.69 0.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.857 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.483 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 53.4 tt0 -63.87 -68.31 0.36 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.411 178.733 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.483 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 5.5 tp10 -160.09 -159.44 0.71 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.047 179.371 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.448 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -116.04 124.97 51.79 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.213 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.417 HG22 HD11 ' A' ' 59' ' ' ILE . 96.5 mt -116.69 132.43 66.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.243 0.545 . . . . 0.0 112.22 -178.329 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.1 tp -100.54 129.03 46.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.319 -179.971 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -110.22 135.65 50.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.704 -179.66 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.438 HD22 ' HA ' ' A' ' 68' ' ' PRO . 47.2 t-20 -95.95 105.22 17.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.729 -179.247 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -98.0 -5.74 33.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.815 179.086 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.23 101.39 3.98 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.702 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.6 p -87.37 -11.13 50.2 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.699 -179.877 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.1 -36.08 9.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.169 -179.272 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 60.2 m-80 -142.78 97.72 5.87 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.664 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.438 ' HA ' HD22 ' A' ' 62' ' ' ASN . 32.6 Cg_exo -55.92 146.08 70.21 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 122.299 2.0 . . . . 0.0 113.633 -178.358 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.3 m -69.23 133.19 47.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.023 178.641 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -97.78 141.78 30.37 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.224 -0.59 . . . . 0.0 111.347 -179.287 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.3 p -133.46 133.58 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.801 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 50.64 32.96 7.43 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 119.921 -0.712 . . . . 0.0 109.219 -179.321 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.21 29.27 62.62 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.943 179.788 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.5 m -142.33 135.31 28.55 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.233 -0.587 . . . . 0.0 111.962 -179.727 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -72.84 139.23 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.471 179.277 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.547 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 1.1 pt -107.07 111.81 37.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-O 121.719 0.771 . . . . 0.0 111.023 179.721 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -67.3 -31.98 72.64 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.993 179.303 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.615 ' N ' ' OE1' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -133.13 -179.19 1.0 Allowed Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.847 -179.322 . . . . . . . . 3 3 . 1 . 089 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.496 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 31.3 Cg_exo -60.77 146.72 96.92 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 122.973 2.449 . . . . 0.0 113.08 179.828 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.9 m -137.4 140.53 41.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.857 179.018 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 52.3 ttp180 -73.15 129.96 39.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.317 179.3 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.0 mt -81.92 140.82 33.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.374 0.607 . . . . 0.0 111.694 -179.227 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.66 152.23 51.62 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.94 179.599 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.626 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 5.6 t60 -56.85 121.11 9.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.991 0.424 . . . . 0.0 110.916 -179.477 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.61 -18.75 37.46 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 179.924 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -67.48 135.57 53.27 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.963 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.4 t -113.71 132.73 61.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.329 -177.671 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.431 ' O ' ' OG ' ' A' ' 94' ' ' SER . 97.9 mt -96.52 129.3 46.78 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 177.801 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 43.1 m -121.71 124.96 45.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.622 0.725 . . . . 0.0 112.133 -178.0 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.572 ' O ' ' N ' ' A' ' 93' ' ' ARG . 95.4 mt -113.07 128.84 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 114.708 -1.133 . . . . 0.0 107.987 178.404 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.527 ' C ' ' O ' ' A' ' 90' ' ' ILE . 61.3 mt -20.88 102.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -178.673 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.461 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 5.1 m-20 87.17 -23.72 0.13 Allowed 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 177.881 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.572 ' N ' ' O ' ' A' ' 90' ' ' ILE . 17.3 mmm-85 -129.24 144.6 51.28 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.413 179.926 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 88' ' ' ILE . 41.5 t -140.24 152.87 46.29 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.249 0.547 . . . . 0.0 110.814 179.979 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.4 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 51.7 m-85 -123.2 122.06 37.47 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.985 -179.768 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -88.49 130.98 35.08 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 119.655 -0.818 . . . . 0.0 109.959 179.591 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.55 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 41.0 t80 -93.83 127.71 39.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.168 -179.941 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -123.94 122.29 37.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.689 179.56 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.626 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 27.5 t-20 . . . . . 0 C--N 1.328 -0.368 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.32 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo . . . . . 0 N--CA 1.492 1.409 0 N-CA-C 114.27 0.834 . . . . 0.0 114.27 . . . . . . . . . 0 0 . 1 . 089 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 55.4 t -65.38 142.07 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.301 179.529 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 3.5 t . . . . . 0 N--CA 1.464 0.227 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.378 179.892 . . . . . . . . 0 0 . 1 . 089 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo . . . . . 0 N--CA 1.499 1.817 0 N-CA-C 113.07 0.373 . . . . 0.0 113.07 . . . . . . . . . 0 0 . 1 . 089 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 30.4 m -68.62 -46.69 68.59 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.077 0.465 . . . . 0.0 110.031 178.73 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -59.52 -46.31 89.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.483 -178.607 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 84.7 mt -63.72 -42.65 97.88 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -178.907 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -65.56 -40.02 92.34 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.406 -0.517 . . . . 0.0 111.093 -178.931 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 63.7 ttm-85 -63.62 -44.12 94.86 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.441 -0.503 . . . . 0.0 109.849 179.649 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . . . . . . . . . 70.6 ttp85 -61.28 -42.53 98.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.757 -179.928 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -59.17 -37.95 78.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.019 -179.675 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 49.0 m -68.92 -41.66 77.84 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 177.454 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 70.2 tp60 -61.16 -38.38 86.26 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.515 179.954 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 38.6 t . . . . . 0 C--N 1.331 -0.227 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.119 179.232 . . . . . . . . 0 0 . 1 . 089 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . 0.593 ' OE2' ' NH1' ' A' ' 12' ' ' ARG . 98.1 mt-10 . . . . . 0 N--CA 1.461 0.108 0 CA-C-O 120.487 0.184 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 81.1 mt -116.41 138.06 48.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.86 0.362 . . . . 0.0 110.18 179.972 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 43.9 t -127.07 136.44 60.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.363 179.739 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -97.72 118.02 33.33 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.249 0.547 . . . . 0.0 110.979 -178.748 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -64.7 -46.53 81.94 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.599 179.509 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . 0.413 ' CB ' ' CD ' ' B' ' 266' ' ' PRO . 1.1 mm-40 -98.73 177.74 1.5 Allowed Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.467 -179.111 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . 0.413 ' CD ' ' CB ' ' B' ' 265' ' ' GLN . 38.8 Cg_exo -60.75 143.36 99.38 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.544 2.162 . . . . 0.0 113.193 -178.895 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . 0.414 ' O ' ' CD ' ' A' ' 21' ' ' PRO . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.314 179.296 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.4 p . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.786 0.327 . . . . 0.0 110.503 . . . . . . . . . 0 0 . 1 . 090 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.587 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 93.6 mtt-85 -100.21 117.12 33.78 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.89 -179.092 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 32.3 ptt-85 -132.96 141.78 48.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.25 179.871 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 33.2 tp -118.24 136.18 53.82 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.899 -179.805 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.0 t -112.56 131.2 64.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 -179.784 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.8 m -91.08 113.62 25.93 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.548 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 84.6 mt -81.63 145.01 9.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.666 178.477 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -89.9 157.89 17.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.083 0.468 . . . . 0.0 111.066 178.949 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.628 ' NH1' HH11 ' B' ' 245' ' ' ARG . 90.4 mtm180 -58.61 -32.07 68.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.93 -179.454 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.5 m -75.64 -13.49 60.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.917 0.389 . . . . 0.0 110.381 179.675 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.06 35.54 5.51 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.363 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.4 t -121.66 133.17 68.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.849 0.357 . . . . 0.0 111.551 -179.12 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -72.43 122.62 21.54 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.767 179.415 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -114.63 -129.26 4.69 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.529 -179.354 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.49 156.18 54.42 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.301 2.001 . . . . 0.0 112.859 -178.969 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.482 ' CD2' ' C ' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -112.91 156.0 23.75 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.128 0.49 . . . . 0.0 110.762 -179.336 . . . . . . . . 3 3 . 1 . 090 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -126.19 104.39 25.72 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.517 -179.436 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -74.01 132.8 17.29 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 C-N-CA 121.07 1.18 . . . . 0.0 111.472 -179.363 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 73.9 mt -89.98 49.97 1.8 Allowed 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.196 -178.351 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 93.9 p -63.13 -19.65 64.65 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.893 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 87.0 mt -77.48 140.2 39.76 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.069 179.592 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 77.9 p -61.57 -21.38 64.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.593 -178.973 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.488 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 20.8 m -136.27 135.7 39.21 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.786 -0.365 . . . . 0.0 111.304 -179.752 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.0 t -124.84 116.65 22.59 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.46 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.1 tp -113.73 127.8 56.17 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.906 0.384 . . . . 0.0 110.87 -179.052 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.641 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 9.6 m-85 -106.33 132.5 52.3 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.666 179.773 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 163.24 -173.53 39.41 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 119.724 -1.227 . . . . 0.0 112.879 179.144 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.635 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 87.3 mtm-85 -77.44 -31.02 53.65 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-O 120.907 0.384 . . . . 0.0 110.167 179.51 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.498 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -52.81 148.1 13.53 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.365 -178.075 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.461 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 8.2 tp -67.36 -40.6 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.417 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.461 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 79.5 mm-40 -54.45 -24.93 22.21 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.221 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 61.6 m -51.85 120.65 5.52 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.122 -179.786 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.488 ' OD2' ' O ' ' A' ' 26' ' ' THR . 68.0 m-20 -57.56 -27.3 62.54 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 179.932 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.42 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 84.4 mt -129.35 121.26 53.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.92 177.367 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 66.7 ttp85 -112.13 138.23 49.08 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.857 -179.177 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.46 ' CD1' ' NH1' ' A' ' 93' ' ' ARG . 78.0 mt -117.66 132.53 67.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.975 0.417 . . . . 0.0 110.312 -179.54 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -72.45 32.49 0.06 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.478 -178.168 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.542 ' CD1' HH21 ' A' ' 93' ' ' ARG . 78.7 mt -118.64 128.1 26.16 Favored Pre-proline 0 CA--C 1.535 0.392 0 C-N-CA 120.249 -0.58 . . . . 0.0 111.95 -179.722 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.85 -11.35 25.67 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 122.46 2.107 . . . . 0.0 113.222 -179.85 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 m -87.63 -5.58 10.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.344 179.403 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.635 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 55.3 t -84.51 133.17 29.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 177.541 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.34 161.37 9.26 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.127 0.489 . . . . 0.0 111.265 -179.086 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -61.99 -44.66 96.26 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.704 -178.988 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.604 ' O ' ' N ' ' A' ' 49' ' ' CYS . 95.1 mt-30 -113.94 -15.03 12.4 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.17 179.904 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 24.1 t60 31.35 -76.51 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 179.394 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.641 ' SG ' ' CD1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -130.26 135.87 48.57 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.28 0.562 . . . . 0.0 112.193 -178.194 . . . . . . . . 3 3 . 1 . 090 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -128.16 126.84 41.85 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.246 179.534 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.4 mt -113.19 136.3 49.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.753 -179.659 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -115.62 132.84 56.51 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.917 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 51.5 mm -102.51 119.67 51.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.171 -0.612 . . . . 0.0 111.445 -178.948 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.451 ' O ' ' N ' ' A' ' 56' ' ' GLN . 96.5 m-70 -121.44 134.07 55.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.14 179.398 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 54' ' ' HIS . 81.0 tt0 -40.3 -29.82 0.09 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -179.765 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.451 ' N ' ' O ' ' A' ' 54' ' ' HIS . 60.0 tt0 -67.58 -67.29 0.47 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.544 179.083 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.433 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 5.3 tp10 -154.72 -161.56 1.23 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.125 -179.185 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.433 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -124.96 132.17 53.32 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.143 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.5 mt -116.99 129.21 73.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.175 0.512 . . . . 0.0 112.339 -179.097 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 34.7 tp -96.92 128.53 43.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.184 179.121 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -111.82 136.04 51.63 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.497 -179.58 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -94.63 106.86 18.85 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.441 -179.671 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -99.87 -10.72 21.42 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.342 179.292 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.7 t -71.65 100.78 2.38 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.297 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.7 m -87.66 -19.27 27.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.083 0.468 . . . . 0.0 110.405 -179.858 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.85 -43.0 10.92 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.105 179.809 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -133.23 91.94 26.29 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.497 179.994 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -54.8 143.5 70.48 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.15 1.9 . . . . 0.0 112.702 -178.986 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.4 m -74.84 141.47 44.24 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.812 -1.086 . . . . 0.0 111.005 -179.781 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -104.32 142.05 35.24 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.396 179.527 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.493 ' CG2' ' OD1' ' A' ' 86' ' ' ASP . 4.9 p -128.55 134.13 65.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.207 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 46.65 34.7 2.6 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 -179.426 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.05 26.53 68.51 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.916 179.802 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.454 ' N ' ' O ' ' A' ' 71' ' ' VAL . 14.5 m -138.43 135.41 35.21 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 117.164 0.482 . . . . 0.0 111.499 179.928 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 43.3 t -64.72 136.36 26.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.422 179.965 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 pt -116.64 83.87 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.588 179.036 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -66.28 -22.26 66.3 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.88 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.401 ' H ' ' CD ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -118.45 163.43 25.46 Favored Pre-proline 0 C--N 1.333 -0.146 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.841 178.994 . . . . . . . . 3 3 . 1 . 090 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -67.93 152.0 77.46 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.65 2.234 . . . . 0.0 112.685 -179.685 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.6 m -144.3 146.22 20.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.597 -179.719 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 91.5 mtm180 -73.48 131.3 41.63 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.78 179.179 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.4 mt -84.06 133.72 34.64 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.016 0.436 . . . . 0.0 110.939 -179.696 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -130.68 157.03 43.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.763 179.879 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -58.13 117.51 4.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.903 0.382 . . . . 0.0 110.526 -179.72 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.77 -11.46 20.88 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -179.449 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.493 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 61.7 t0 -79.18 120.11 23.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.984 0.421 . . . . 0.0 110.185 179.586 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.8 t -108.21 130.79 60.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.92 -178.985 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.2 mt -94.73 132.18 39.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.108 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.9 m -116.61 127.16 54.21 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 121.53 0.681 . . . . 0.0 111.477 -179.831 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.47 ' O ' ' C ' ' A' ' 91' ' ' ILE . 96.6 mt -122.86 125.15 71.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.001 179.044 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.47 ' C ' ' O ' ' A' ' 90' ' ' ILE . 87.4 mt 33.09 -101.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.155 -179.455 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.498 ' O ' ' OD1' ' A' ' 92' ' ' ASP . 56.9 t0 -109.69 14.98 23.11 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 121.067 -0.253 . . . . 0.0 111.615 -179.123 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.604 HH22 ' CG2' ' A' ' 44' ' ' VAL . 8.9 mtm105 -127.87 143.02 51.12 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.806 -179.449 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.3 m -134.8 148.48 50.2 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.945 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -126.94 126.97 44.12 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.884 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -89.77 131.04 35.93 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.812 179.857 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.587 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 88.9 t80 -97.99 129.2 44.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.938 0.399 . . . . 0.0 110.127 179.569 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -133.14 123.91 26.54 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.222 -179.514 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 54.3 t30 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.818 -179.682 . . . . . . . . 0 0 . 1 . 090 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo . . . . . 0 N--CA 1.486 1.072 0 N-CA-C 110.958 -0.439 . . . . 0.0 110.958 . . . . . . . . . 0 0 . 1 . 090 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 4.1 p -118.14 136.48 55.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 120.976 0.417 . . . . 0.0 111.026 -179.277 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 11.9 t . . . . . 0 CA--C 1.52 -0.197 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.377 -179.939 . . . . . . . . 0 0 . 1 . 090 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo . . . . . 0 N--CA 1.499 1.812 0 N-CA-C 112.881 0.3 . . . . 0.0 112.881 . . . . . . . . . 0 0 . 1 . 090 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 36.2 m -73.58 -44.76 56.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.229 0.538 . . . . 0.0 109.837 178.224 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -57.28 -46.31 83.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.448 -179.413 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 97.9 mt -63.61 -41.2 98.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.919 0.39 . . . . 0.0 110.06 -179.871 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -62.75 -45.05 94.51 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.099 179.736 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . 0.518 ' O ' ' OG ' ' B' ' 247' ' ' SER . 73.6 ttt180 -65.03 -41.85 94.9 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.045 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.628 HH11 ' NH1' ' A' ' 12' ' ' ARG . 9.0 tpp180 -58.91 -43.95 91.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.543 -179.122 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -64.93 -42.05 95.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.122 0.487 . . . . 0.0 109.874 178.796 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' B' B ' 247' ' ' SER . . . . . 0.521 ' HG ' ' N ' ' B' ' 248' ' ' GLN . 78.3 p -62.05 -46.32 89.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.037 179.774 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . 0.521 ' N ' ' HG ' ' B' ' 247' ' ' SER . 84.4 mt-30 -62.61 -39.02 92.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.278 -179.575 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 42.6 t . . . . . 0 C--N 1.329 -0.32 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.303 -179.946 . . . . . . . . 0 0 . 1 . 090 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . 0.587 ' OE2' ' NH1' ' B' ' 245' ' ' ARG . 95.7 mt-10 . . . . . 0 C--O 1.228 -0.042 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 . . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 55.0 mt -111.12 139.91 32.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.554 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 58.9 t -128.25 135.71 61.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.129 179.765 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -97.41 120.8 38.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.252 0.549 . . . . 0.0 111.9 -178.178 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -63.88 -46.63 84.08 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.231 179.267 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -94.01 161.78 28.77 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.903 -179.674 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.93 146.36 58.88 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 122.854 2.369 . . . . 0.0 112.768 -179.64 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 45.3 pt . . . . . 0 C--N 1.328 -0.342 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.679 . . . . . . . . 0 0 . 1 . 091 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 68.2 p . . . . . 0 CA--C 1.516 -0.34 0 CA-C-O 121.017 0.437 . . . . 0.0 110.469 . . . . . . . . . 0 0 . 1 . 091 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.8 mtt85 -93.08 129.19 39.13 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.37 -0.532 . . . . 0.0 109.589 -179.743 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -133.99 145.44 49.5 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 120.641 -0.423 . . . . 0.0 111.363 -179.476 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 66.0 mt -115.34 136.31 53.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.316 179.635 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.489 ' CG1' ' NH2' ' A' ' 96' ' ' ARG . 27.4 t -109.71 127.06 66.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.715 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.0 m -77.26 142.04 39.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.356 -178.493 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.5 mt -110.43 134.15 53.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.871 177.261 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -88.51 158.77 18.22 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.06 0.457 . . . . 0.0 110.815 179.99 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.422 ' NH2' ' HB3' ' B' ' 248' ' ' GLN . 82.1 mtp180 -57.25 -32.82 66.95 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.901 -178.824 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 65.2 m -77.31 -6.78 54.5 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.201 178.767 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.07 31.63 10.7 Favored Glycine 0 CA--C 1.519 0.302 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 -179.595 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.1 t -113.5 133.04 60.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.987 0.423 . . . . 0.0 111.451 -178.924 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.631 ' CG ' HH22 ' A' ' 96' ' ' ARG . 97.5 m-20 -74.03 137.03 43.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.874 179.651 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.47 -122.91 2.49 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 120.459 -0.877 . . . . 0.0 113.029 -178.633 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -71.78 149.93 55.12 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.463 2.109 . . . . 0.0 113.235 -177.965 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -111.29 127.39 55.61 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.688 179.962 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.411 ' CD2' HD11 ' A' ' 37' ' ' ILE . 55.9 t80 -99.29 105.55 33.49 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.854 179.903 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -75.82 135.29 17.45 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 121.112 1.208 . . . . 0.0 111.255 -179.516 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.5 mt -85.94 58.94 5.33 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.484 -178.528 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 90.8 p -64.17 -34.5 78.21 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.003 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 66.2 mt -75.77 144.94 41.13 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.53 179.423 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.8 m -68.63 -17.09 64.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.873 -178.624 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.483 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 58.1 m -133.22 134.22 43.73 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.666 -0.413 . . . . 0.0 112.024 -179.198 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.5 t -126.23 116.2 20.91 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.64 179.14 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 63.2 tp -113.2 128.9 56.62 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 121.006 -0.277 . . . . 0.0 111.087 -179.486 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.429 ' CE2' HG13 ' A' ' 37' ' ' ILE . 19.3 m-85 -107.1 129.04 54.88 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.783 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 172.46 -175.44 45.6 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.455 179.96 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.623 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 83.8 mtm-85 -80.28 -26.55 38.88 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.98 0.419 . . . . 0.0 110.33 179.363 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -55.44 144.45 33.29 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.132 -178.041 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.464 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 11.1 tp -64.91 -41.77 93.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.17 0.509 . . . . 0.0 109.634 179.334 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.464 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 17.3 pt-20 -57.19 -16.74 8.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.331 -179.874 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 45.8 m -66.21 134.01 51.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.204 0.526 . . . . 0.0 111.096 -178.84 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.483 ' OD2' ' O ' ' A' ' 26' ' ' THR . 60.9 m-20 -63.17 -36.34 83.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.316 -179.461 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.463 HG23 HD13 ' A' ' 37' ' ' ILE . 49.1 mm -121.14 117.4 52.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.483 177.693 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.43 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 81.4 mtp180 -107.2 134.7 49.91 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 120.374 -0.531 . . . . 0.0 111.018 -179.259 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 85.3 mt -120.92 131.34 73.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 120.126 -0.63 . . . . 0.0 109.711 178.916 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -77.84 24.93 0.21 Allowed 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -177.492 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 32.8 mt -94.23 132.61 28.84 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.973 179.433 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.57 -12.26 29.04 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.121 1.881 . . . . 0.0 113.584 -179.239 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.0 m -97.41 9.53 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 120.034 -0.666 . . . . 0.0 110.787 179.309 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.623 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 33.8 t -94.84 131.79 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 177.918 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.9 m -76.1 173.49 11.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.579 0.704 . . . . 0.0 111.865 -178.755 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -64.75 -38.62 91.6 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.477 -179.862 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.649 ' O ' ' N ' ' A' ' 49' ' ' CYS . 93.8 mm-40 -113.34 -23.52 9.84 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.993 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.7 t60 34.26 -77.42 0.0 OUTLIER 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.63 179.978 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.649 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.72 135.74 47.08 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.981 0.42 . . . . 0.0 111.62 -179.385 . . . . . . . . 3 3 . 1 . 091 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -128.82 127.32 41.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.506 179.911 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 85.7 mt -111.6 132.85 59.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.599 -179.451 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -115.59 125.66 53.22 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.434 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.412 HG23 HD11 ' A' ' 53' ' ' ILE . 97.7 mt -107.3 115.13 47.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.029 -179.497 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.466 ' C ' ' N ' ' A' ' 56' ' ' GLN . 94.1 m-70 -112.45 144.75 41.37 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.771 -179.711 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 54' ' ' HIS . 94.9 mt-10 -41.62 -27.52 0.1 Allowed 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.152 -179.908 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.466 ' N ' ' C ' ' A' ' 54' ' ' HIS . 88.1 mt-30 -65.0 -68.89 0.33 Allowed 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.157 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -159.34 -164.9 1.46 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.954 179.489 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -108.97 130.75 55.47 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.608 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.4 mt -121.15 130.53 74.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -177.961 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.405 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 22.7 tp -101.15 126.93 47.9 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.66 179.514 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -109.77 135.71 50.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.697 178.726 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.599 HD22 ' CA ' ' A' ' 68' ' ' PRO . 56.2 t-20 -98.14 103.71 15.68 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.76 -179.159 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -98.86 -7.24 27.59 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -179.693 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 26.2 t -76.6 99.58 5.05 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.998 179.954 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.7 p -74.95 -38.46 61.72 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.993 0.425 . . . . 0.0 109.902 178.999 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.0 p -67.18 -39.35 86.39 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.538 179.859 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.454 ' O ' ' OG ' ' A' ' 64' ' ' SER . 46.3 m-20 -147.47 97.51 4.04 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.44 -179.277 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.599 ' CA ' HD22 ' A' ' 62' ' ' ASN . 37.3 Cg_exo -56.55 148.11 65.66 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 121.988 1.792 . . . . 0.0 112.574 179.544 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.556 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 8.3 m -74.36 137.43 42.78 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.36 179.718 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -99.03 140.12 33.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.427 179.827 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 25.2 t -130.49 134.69 61.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.65 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 53.12 35.94 21.06 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 120.127 -0.629 . . . . 0.0 109.399 -179.716 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 66.56 30.15 75.96 Favored Glycine 0 CA--C 1.523 0.557 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.204 179.484 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 83.4 p -138.44 125.86 21.84 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.625 -179.141 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.3 p -63.01 140.78 19.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.104 0.478 . . . . 0.0 111.57 -179.657 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.549 ' CG2' ' O ' ' A' ' 78' ' ' GLU . 97.1 mt -116.17 124.27 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.085 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.044 -179.883 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.454 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 30.6 p-10 -96.76 -24.58 15.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.974 179.198 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.549 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 2.5 mt-10 -129.54 169.91 12.12 Favored Pre-proline 0 N--CA 1.468 0.451 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.092 -179.055 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -56.8 143.25 91.3 Favored 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 121.994 1.796 . . . . 0.0 112.581 -179.95 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 78.0 t -136.4 138.22 47.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.756 179.975 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 85.4 mtt85 -74.17 134.68 42.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.629 179.199 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.1 mt -86.02 136.61 33.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.388 0.613 . . . . 0.0 111.393 -179.754 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -126.95 151.46 48.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.967 179.764 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.718 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 7.8 t60 -56.58 120.14 7.27 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.963 0.411 . . . . 0.0 111.296 -179.447 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.7 -17.73 30.17 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 179.465 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -71.06 134.54 47.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.943 0.401 . . . . 0.0 110.47 -179.85 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.8 p -106.59 135.93 43.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.825 -178.859 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.9 mt -105.95 131.44 55.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 179.0 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 99.9 m -122.51 127.75 49.93 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -178.314 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.519 ' N ' ' O ' ' A' ' 93' ' ' ARG . 96.9 mt -112.67 132.27 61.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 177.428 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.579 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 2.5 mp -37.74 101.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.777 -178.766 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.579 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 37.5 t0 101.49 -30.94 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.732 0 O-C-N 124.225 0.953 . . . . 0.0 112.496 179.01 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 90' ' ' ILE . 36.0 mmt180 -128.99 143.18 50.79 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.951 -178.647 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.1 p -138.26 151.25 47.45 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.474 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -130.76 125.05 32.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.736 -179.351 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.631 HH22 ' CG ' ' A' ' 16' ' ' ASP . 92.8 mtm-85 -84.35 138.39 32.91 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.113 178.869 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -96.2 116.59 29.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.488 -179.392 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -120.64 122.59 40.83 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.777 0.322 . . . . 0.0 110.362 179.743 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.718 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 21.5 t-20 . . . . . 0 C--N 1.327 -0.38 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.372 179.897 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo . . . . . 0 N--CA 1.491 1.334 0 CA-C-O 121.113 0.38 . . . . 0.0 112.803 . . . . . . . . . 0 0 . 1 . 091 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 8.9 p -80.44 124.64 38.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.277 179.969 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.608 -179.354 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo . . . . . 0 N--CA 1.489 1.26 0 N-CA-C 111.395 -0.271 . . . . 0.0 111.395 . . . . . . . . . 0 0 . 1 . 091 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 73.8 m -71.35 -45.53 62.71 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.194 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -57.89 -46.72 84.49 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.336 179.588 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 90.0 mt -64.58 -40.07 94.88 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.667 179.026 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -61.41 -40.81 95.77 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 120.778 0.323 . . . . 0.0 110.686 -179.979 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -60.04 -42.07 93.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.569 179.466 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . . . . . . . . . 67.9 ttp85 -59.92 -42.97 95.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.538 179.878 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -62.83 -41.66 99.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.211 -179.225 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 59.5 p -69.53 -41.55 75.83 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.879 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . 0.422 ' HB3' ' NH2' ' A' ' 12' ' ' ARG . 67.2 tp60 -60.95 -38.22 85.12 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.424 -179.937 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 39.3 t . . . . . 0 C--N 1.331 -0.207 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.547 179.543 . . . . . . . . 0 0 . 1 . 091 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . 0.449 ' HB2' HH21 ' A' ' 93' ' ' ARG . 77.2 mt-10 . . . . . 0 C--O 1.226 -0.141 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 . . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 83.2 mt -107.59 132.07 56.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.949 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 54.9 t -124.78 132.37 71.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.082 -179.947 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -94.3 118.35 31.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.052 -178.636 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -67.13 -44.8 78.93 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.606 179.276 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . 0.508 ' OE1' ' O ' ' B' ' 266' ' ' PRO . 0.0 OUTLIER -87.42 162.12 43.64 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.999 -179.621 . . . . . . . . 3 3 . 1 . 091 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . 0.508 ' O ' ' OE1' ' B' ' 265' ' ' GLN . 36.6 Cg_endo -62.15 144.07 95.32 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 121.974 1.783 . . . . 0.0 111.91 -179.85 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 11.8 tt . . . . . 0 C--N 1.322 -0.589 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.623 -178.925 . . . . . . . . 0 0 . 1 . 092 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.6 m . . . . . 0 N--CA 1.463 0.204 0 N-CA-C 111.426 0.158 . . . . 0.0 111.426 . . . . . . . . . 0 0 . 1 . 092 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.612 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 95.3 mtt-85 -90.97 122.98 34.1 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.457 -179.665 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -133.08 140.21 47.55 Favored 'General case' 0 CA--C 1.522 -0.105 0 CA-C-O 121.246 0.546 . . . . 0.0 112.134 -179.65 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 37.3 tp -114.57 135.81 53.72 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.347 -179.883 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.8 t -111.66 130.1 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 120.683 0.278 . . . . 0.0 110.487 -179.735 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 m -88.93 118.47 28.67 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -177.837 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.437 ' CD1' ' HG ' ' A' ' 94' ' ' SER . 97.0 mt -83.32 139.07 18.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.37 178.935 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -88.97 160.46 17.12 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.981 179.275 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.504 ' NE ' ' NH2' ' B' ' 245' ' ' ARG . 84.4 mtp180 -56.3 -30.97 63.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.269 -179.27 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 84.3 p -79.22 -7.27 58.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.424 -179.803 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.61 28.08 22.81 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 -179.817 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.7 t -112.01 133.03 59.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.829 0.347 . . . . 0.0 110.629 -179.625 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -77.02 141.24 40.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.732 179.317 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -133.3 -114.91 1.56 Allowed Glycine 0 CA--C 1.536 1.396 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.64 -179.319 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -74.45 149.56 39.68 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.406 2.071 . . . . 0.0 113.324 -179.171 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -112.52 148.88 33.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.986 179.941 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -114.58 105.4 53.62 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.714 179.983 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.17 122.41 8.37 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 C-N-CA 121.123 1.215 . . . . 0.0 110.895 -179.678 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 74.2 mt -78.51 46.11 0.62 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.256 -0.578 . . . . 0.0 110.442 -179.2 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.9 p -59.53 -30.25 68.46 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.333 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 73.3 mt -72.86 142.91 47.96 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.996 179.532 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.5 m -62.94 -22.97 67.15 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.255 -179.382 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 86.3 m -135.43 137.89 42.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.504 -179.606 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.687 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 3.5 t -132.57 123.83 27.23 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.825 0.345 . . . . 0.0 110.266 178.227 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.409 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 41.0 tp -112.72 130.3 56.11 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.957 -179.228 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.687 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 6.9 m-85 -108.88 140.03 42.91 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.768 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 167.63 -169.05 40.98 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 118.84 -1.647 . . . . 0.0 113.436 179.203 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.451 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 36.9 ttp-105 -90.77 -28.47 18.23 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 114.53 -0.835 . . . . 0.0 110.537 -179.966 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.08 152.35 49.03 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.517 -179.344 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.635 ' O ' ' NE ' ' A' ' 38' ' ' ARG . 7.0 tp -66.42 -42.28 90.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.449 0.642 . . . . 0.0 110.273 179.506 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.486 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 79.9 tt0 -54.62 -13.87 1.13 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.874 -178.925 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 83.4 m -67.58 133.32 49.21 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.497 179.801 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.431 ' O ' ' CB ' ' B' ' 264' ' ' LYS . 51.3 m-20 -58.69 -32.34 69.05 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.473 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.466 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 92.4 mt -125.33 120.61 58.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 177.228 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.635 ' NE ' ' O ' ' A' ' 33' ' ' ILE . 71.0 mtt85 -107.01 135.84 47.88 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.064 -177.34 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.438 ' C ' ' H ' ' A' ' 41' ' ' LEU . 89.4 mt -118.12 133.55 64.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.069 0.461 . . . . 0.0 110.593 179.019 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -75.16 23.42 0.1 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.966 -178.864 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.508 HD13 ' HE ' ' A' ' 93' ' ' ARG . 21.0 mt -92.23 123.77 61.58 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.248 178.831 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -71.99 -8.27 22.61 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 121.821 1.681 . . . . 0.0 112.713 -179.503 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.8 m -101.14 7.83 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.58 -179.736 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.451 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 21.0 t -91.12 137.19 22.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 120.394 -0.522 . . . . 0.0 109.838 179.674 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.606 ' HG ' ' N ' ' A' ' 46' ' ' LYS . 0.4 OUTLIER -65.66 164.78 13.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.167 0.508 . . . . 0.0 111.192 -179.451 . . . . . . . . 3 3 . 1 . 092 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.606 ' N ' ' HG ' ' A' ' 45' ' ' SER . 97.2 mttt -62.54 -44.53 96.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.221 -178.822 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.644 ' O ' ' N ' ' A' ' 49' ' ' CYS . 83.4 mt-30 -113.8 -20.59 11.06 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 123.526 0.516 . . . . 0.0 110.376 179.092 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.513 ' O ' ' OG ' ' A' ' 64' ' ' SER . 24.5 t60 35.52 -73.27 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 179.846 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.644 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -129.91 134.18 47.32 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -178.381 . . . . . . . . 3 3 . 1 . 092 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -125.74 129.95 50.51 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.41 178.67 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.2 mt -113.9 134.66 56.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.015 -179.421 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -119.08 124.93 48.1 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.917 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 94.2 mt -104.27 114.13 43.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.483 0.659 . . . . 0.0 111.447 -179.326 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.44 ' O ' ' C ' ' A' ' 55' ' ' GLU . 94.8 m-70 -114.26 142.23 46.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.638 -1.165 . . . . 0.0 109.93 -179.681 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 54' ' ' HIS . 97.5 mt-10 -40.11 -31.14 0.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -179.703 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.433 ' N ' ' O ' ' A' ' 54' ' ' HIS . 89.1 mt-30 -62.35 -67.98 0.37 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.491 178.604 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.435 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 4.8 tp10 -159.21 -162.98 1.13 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.902 179.742 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.435 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -114.19 127.24 55.8 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.009 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.6 mt -116.44 130.9 70.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.21 0.529 . . . . 0.0 112.369 -177.952 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 25.6 tp -98.62 130.29 45.15 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.464 179.442 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -116.58 137.52 52.12 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.548 -179.437 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.667 ' ND2' ' H ' ' A' ' 69' ' ' THR . 16.1 t-20 -98.88 106.7 19.0 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.935 179.496 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -98.14 -7.24 29.88 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.001 178.453 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.513 ' OG ' ' O ' ' A' ' 48' ' ' HIS . 0.7 OUTLIER -70.29 100.93 1.8 Allowed 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.698 179.456 . . . . . . . . 3 3 . 1 . 092 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.3 m -86.05 -8.7 57.73 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.031 0.443 . . . . 0.0 110.268 179.917 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.67 -39.52 8.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.226 179.817 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 67.3 m-20 -142.63 93.79 6.82 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.111 179.569 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.403 ' HA ' HD22 ' A' ' 62' ' ' ASN . 42.4 Cg_exo -55.07 148.59 47.7 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 122.384 2.056 . . . . 0.0 112.13 -179.782 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.667 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 33.5 m -73.4 149.64 42.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.301 -179.761 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -114.11 140.56 48.4 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.405 -179.911 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.445 ' O ' ' N ' ' A' ' 74' ' ' SER . 4.2 p -128.78 134.8 63.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.671 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 48.8 30.49 2.68 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.086 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.09 27.9 67.55 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.569 -179.984 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.445 ' N ' ' O ' ' A' ' 71' ' ' VAL . 71.5 m -134.81 134.91 41.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.674 0.273 . . . . 0.0 110.434 179.935 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.5 p -68.51 145.19 13.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -178.748 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.1 pt -122.36 86.08 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.839 179.801 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 46.4 p-10 -67.21 -21.89 65.74 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.846 0.355 . . . . 0.0 110.406 179.68 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -122.5 170.28 8.24 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.446 179.918 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -62.96 144.53 93.29 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 122.298 1.999 . . . . 0.0 112.21 -179.888 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.9 p -139.28 139.68 39.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.858 -179.831 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -74.71 132.88 42.01 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.791 -0.363 . . . . 0.0 110.449 179.452 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 97.7 mt -83.0 138.48 33.74 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.643 179.925 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -128.47 149.42 50.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.36 179.697 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.753 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 6.2 t60 -54.15 119.71 5.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.057 0.456 . . . . 0.0 111.105 -179.426 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.97 -15.73 36.73 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 179.208 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -70.15 137.56 51.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.836 0.35 . . . . 0.0 110.616 179.821 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.0 t -111.08 132.73 58.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.14 -178.728 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.457 HG21 HD13 ' A' ' 88' ' ' ILE . 97.3 mt -100.52 132.22 46.58 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.829 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.2 m -120.7 121.71 38.86 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 119.862 -0.735 . . . . 0.0 112.027 -179.136 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.535 ' N ' ' O ' ' A' ' 93' ' ' ARG . 97.4 mt -108.12 119.63 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 177.74 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.429 ' C ' ' O ' ' A' ' 90' ' ' ILE . 91.7 mt 35.16 -96.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.486 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.633 ' OD2' ' NE ' ' B' ' 245' ' ' ARG . 31.5 p-10 -110.1 10.82 23.95 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -178.323 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.535 ' O ' ' N ' ' A' ' 90' ' ' ILE . 80.1 mtt-85 -130.04 145.56 51.67 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.624 -179.785 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.437 ' HG ' ' CD1' ' A' ' 10' ' ' ILE . 54.3 p -139.72 151.94 46.26 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.389 0.614 . . . . 0.0 110.133 179.392 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.4 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 54.8 m-85 -125.38 126.2 44.63 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.953 -179.924 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -85.57 131.94 34.27 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.971 -179.351 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.681 ' HH ' HD22 ' A' ' 99' ' ' ASN . 88.4 t80 -100.53 125.54 46.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.916 -179.659 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -145.1 132.79 20.99 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.066 0.46 . . . . 0.0 111.912 -179.961 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.753 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 98.7 m-20 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.714 179.57 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo . . . . . 0 N--CA 1.497 1.703 0 CA-C-O 120.837 0.265 . . . . 0.0 112.357 . . . . . . . . . 0 0 . 1 . 092 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 12.0 m -101.78 130.21 51.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.836 179.615 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.7 t . . . . . 0 CA--C 1.52 -0.19 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.198 -179.705 . . . . . . . . 0 0 . 1 . 092 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo . . . . . 0 N--CA 1.495 1.575 0 CA-C-O 120.565 0.152 . . . . 0.0 112.243 . . . . . . . . . 0 0 . 1 . 092 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 19.8 m -70.33 -43.14 70.87 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.096 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -57.94 -49.06 78.08 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.801 179.825 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 97.1 mt -63.66 -41.76 98.17 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.569 -179.193 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -65.12 -40.91 95.15 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -178.829 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -61.59 -43.77 98.24 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.183 -179.59 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.633 ' NE ' ' OD2' ' A' ' 92' ' ' ASP . 76.3 mtp85 -65.14 -40.49 94.49 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.765 -179.6 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -61.6 -39.55 91.65 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.008 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 14.4 t -65.14 -43.86 90.53 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.416 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . 0.4 ' OE1' ' NH2' ' A' ' 12' ' ' ARG . 55.9 tt0 -61.07 -37.83 84.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.254 179.689 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 70.5 t . . . . . 0 N--CA 1.453 -0.287 0 C-N-CA 120.526 -0.47 . . . . 0.0 109.833 178.768 . . . . . . . . 0 0 . 1 . 092 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . 0.427 ' HB2' ' NH2' ' A' ' 93' ' ' ARG . 98.3 mt-10 . . . . . 0 CA--C 1.529 0.147 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 . . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 69.2 mt -108.91 134.69 50.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.848 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 59.1 t -128.88 134.79 63.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.918 0.39 . . . . 0.0 110.621 -179.684 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -97.21 122.08 39.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.661 -178.898 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . 0.459 ' HG3' HH22 ' A' ' 38' ' ' ARG . 86.9 tttt -66.81 -44.51 81.01 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.293 179.424 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 9.7 mp0 -100.87 160.31 27.1 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.482 -177.935 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -62.3 151.38 82.81 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 123.423 2.748 . . . . 0.0 112.803 -179.336 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 40.8 pt . . . . . 0 C--N 1.33 -0.261 0 CA-C-O 121.844 0.83 . . . . 0.0 112.431 -178.722 . . . . . . . . 0 0 . 1 . 093 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.7 m . . . . . 0 N--CA 1.463 0.192 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 . . . . . . . . . 0 0 . 1 . 093 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.603 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 96.3 mtt-85 -88.12 118.01 27.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.916 0.388 . . . . 0.0 110.743 -178.844 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.645 HH21 ' ND1' ' A' ' 19' ' ' HIS . 75.6 ttt180 -125.99 126.42 44.28 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.288 -179.499 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 22.5 tp -109.13 130.98 55.49 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.467 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 76.5 t -106.82 127.46 62.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.355 179.97 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.5 m -80.23 144.75 32.66 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.375 0.607 . . . . 0.0 111.674 -179.047 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.409 HD13 HG22 ' A' ' 10' ' ' ILE . 98.1 mt -116.1 138.41 46.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.235 178.451 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -91.26 156.36 17.87 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.361 179.013 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.437 ' NH2' ' OE2' ' B' ' 260' ' ' GLU . 89.9 mtm180 -60.02 -28.75 67.99 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.615 -179.852 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 84.0 p -74.3 -14.47 60.9 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.524 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.34 35.42 5.73 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 -179.699 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 49.6 t -120.55 130.95 73.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.747 0.308 . . . . 0.0 111.049 -179.797 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -77.08 138.28 39.44 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.632 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.17 -118.24 2.06 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.936 -179.301 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -69.85 148.07 63.71 Favored 'Trans proline' 0 N--CA 1.501 1.938 0 C-N-CA 122.317 2.011 . . . . 0.0 113.685 -178.468 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.645 ' ND1' HH21 ' A' ' 6' ' ' ARG . 0.9 OUTLIER -111.95 130.27 55.9 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.376 -179.863 . . . . . . . . 3 3 . 1 . 093 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -107.02 105.43 55.53 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.15 -179.108 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.05 135.17 22.59 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 120.717 0.944 . . . . 0.0 111.306 -179.9 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 74.9 mt -87.13 48.14 1.61 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.754 -178.899 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.9 m -60.46 -29.91 69.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.91 178.829 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 73.1 mt -71.12 143.42 50.6 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.372 -179.939 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.3 m -58.94 -25.99 64.0 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.918 -179.143 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 78.0 m -138.77 141.17 38.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.182 0.515 . . . . 0.0 111.431 -179.862 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.8 t -130.42 121.85 26.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.694 178.683 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 41.2 tp -117.12 126.61 53.09 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.63 -179.652 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.442 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 4.3 m-85 -101.92 125.78 48.68 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.441 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 172.12 178.39 42.33 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 119.75 -1.214 . . . . 0.0 113.016 179.624 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.422 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 45.8 mtm180 -73.33 -32.77 64.75 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.771 0.32 . . . . 0.0 111.308 179.01 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -48.9 147.02 5.75 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 -178.967 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.439 ' HA ' HH11 ' A' ' 38' ' ' ARG . 11.0 tp -67.02 -40.66 86.01 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 CA-C-O 121.249 0.547 . . . . 0.0 109.929 179.714 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -57.68 -19.83 29.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.387 -179.951 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 76.8 m -59.72 129.95 44.42 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.821 -179.399 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.41 ' O ' ' CB ' ' B' ' 264' ' ' LYS . 66.0 m-20 -61.82 -35.03 77.02 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 -179.589 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.417 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 93.6 mt -123.5 118.32 54.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 177.395 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.439 HH11 ' HA ' ' A' ' 33' ' ' ILE . 21.8 mtp85 -104.57 136.22 44.53 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.447 -178.375 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.467 ' C ' ' H ' ' A' ' 41' ' ' LEU . 94.0 mt -117.54 129.85 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 121.036 0.446 . . . . 0.0 110.595 -179.955 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -73.36 28.54 0.07 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.808 -178.42 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.568 ' CD1' ' HE ' ' A' ' 93' ' ' ARG . 49.0 mt -103.14 127.89 28.82 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 120.296 -0.561 . . . . 0.0 110.803 -179.985 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.9 -7.47 20.77 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.129 1.886 . . . . 0.0 112.673 -179.369 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.8 m -98.7 4.73 9.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 120.776 -0.369 . . . . 0.0 111.06 179.941 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.422 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 16.1 t -88.4 134.8 27.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.158 178.434 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.2 m -70.54 168.58 15.99 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.447 0.641 . . . . 0.0 111.93 -179.264 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -62.9 -43.67 98.17 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.285 -178.98 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.623 ' O ' ' N ' ' A' ' 49' ' ' CYS . 97.2 mt-30 -114.24 -25.03 8.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.575 179.472 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.6 t60 37.0 -77.21 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.076 -0.966 . . . . 0.0 113.023 179.064 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.623 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -127.39 132.86 50.07 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.228 0.537 . . . . 0.0 111.775 -178.279 . . . . . . . . 3 3 . 1 . 093 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -128.86 132.47 47.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.07 -179.578 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.1 mt -117.12 132.31 67.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.488 179.488 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -114.73 127.85 55.98 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.79 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.5 mm -100.27 111.81 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-O 121.105 0.479 . . . . 0.0 110.736 -179.22 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.448 ' O ' ' C ' ' A' ' 55' ' ' GLU . 88.6 m-70 -110.64 132.91 53.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.17 179.434 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 54' ' ' HIS . 76.9 tt0 -40.82 -32.17 0.21 Allowed 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.394 -179.945 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.409 ' N ' ' O ' ' A' ' 54' ' ' HIS . 98.4 mm-40 -69.16 -68.48 0.4 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.599 179.171 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -146.13 -178.59 6.21 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.706 0.765 . . . . 0.0 111.939 -178.354 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -116.16 122.0 43.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.788 178.206 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 94.0 mt -118.85 133.92 64.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.161 0.505 . . . . 0.0 111.825 -178.638 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 22.9 tp -98.25 131.53 44.51 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.718 -179.896 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -114.22 139.49 49.34 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 121.053 0.454 . . . . 0.0 111.448 -178.955 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 59.1 t-20 -98.31 106.12 18.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.822 -179.485 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -98.63 -12.23 21.3 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.728 179.379 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.0 t -70.69 103.43 2.55 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.533 179.892 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.4 p -88.97 -18.73 26.83 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.432 179.695 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.68 -44.27 11.96 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.285 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -137.13 97.9 10.6 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.803 179.425 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -57.09 145.31 86.82 Favored 'Trans proline' 0 N--CA 1.499 1.82 0 C-N-CA 122.173 1.916 . . . . 0.0 113.014 -179.426 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.3 m -73.78 141.69 46.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.64 179.365 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -102.16 147.77 26.22 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.146 -179.637 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.546 ' CG2' ' OD1' ' A' ' 86' ' ' ASP . 4.3 p -128.04 136.04 61.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.88 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 47.75 31.59 2.26 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.226 -0.59 . . . . 0.0 109.653 -179.352 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.66 28.37 61.34 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.669 179.887 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 71' ' ' VAL . 58.3 m -140.35 141.57 35.64 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.192 -179.729 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 71.0 t -68.18 132.37 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.125 0 CA-C-O 121.358 0.599 . . . . 0.0 112.0 -179.131 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.58 100.3 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.72 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -87.07 -13.91 42.94 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.98 -178.717 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -117.02 164.96 16.7 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.967 -179.177 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -60.22 143.58 99.51 Favored 'Trans proline' 0 N--CA 1.501 1.956 0 C-N-CA 121.827 1.684 . . . . 0.0 111.613 -179.775 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.3 p -139.62 139.46 38.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.066 0.46 . . . . 0.0 110.782 -178.856 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -72.08 125.65 27.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.006 179.931 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.3 mt -77.95 137.25 38.22 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.269 0.557 . . . . 0.0 110.889 -179.894 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -134.96 152.8 52.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.993 -179.696 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.724 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 5.1 t60 -57.28 113.3 1.69 Allowed 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.347 -179.745 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.85 1.67 22.59 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 -179.843 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.546 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 67.7 t0 -86.16 122.96 30.9 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.596 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 28.0 t -105.7 134.27 47.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.791 -179.286 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.7 mt -105.26 132.61 51.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 178.453 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 37.4 m -121.02 125.45 47.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.484 0.659 . . . . 0.0 111.866 -178.901 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.401 ' O ' ' C ' ' A' ' 91' ' ' ILE . 84.8 mt -117.01 125.22 73.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.49 179.096 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.401 ' C ' ' O ' ' A' ' 90' ' ' ILE . 44.5 mm 40.47 -105.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.586 -179.443 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.459 ' O ' ' OD1' ' A' ' 92' ' ' ASP . 56.5 t0 -114.86 19.55 15.79 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.921 0.391 . . . . 0.0 110.633 -179.679 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.568 ' HE ' ' CD1' ' A' ' 41' ' ' LEU . 73.7 mtt-85 -129.32 145.49 51.37 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 -179.856 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.4 p -140.94 157.4 45.41 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.241 -179.834 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -131.09 124.96 31.92 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.055 -179.772 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -90.82 136.31 33.16 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.531 -179.707 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.603 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 72.2 t80 -100.16 124.55 45.71 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.833 -179.574 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -141.13 132.08 26.06 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 121.256 0.55 . . . . 0.0 111.829 -179.908 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.724 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 97.9 m-20 . . . . . 0 C--N 1.327 -0.409 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.393 178.413 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo . . . . . 0 N--CA 1.484 0.917 0 CA-C-O 121.033 0.347 . . . . 0.0 111.722 . . . . . . . . . 0 0 . 1 . 093 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 25.6 t -113.36 134.1 57.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.787 -178.958 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 44.6 t . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.634 -179.905 . . . . . . . . 0 0 . 1 . 093 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo . . . . . 0 N--CA 1.496 1.643 0 N-CA-C 112.711 0.235 . . . . 0.0 112.711 . . . . . . . . . 0 0 . 1 . 093 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 71.6 m -73.67 -42.91 60.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.239 0.543 . . . . 0.0 109.757 178.008 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -57.0 -47.02 81.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.981 -179.186 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 89.2 mt -63.42 -40.06 96.16 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.66 -179.998 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.7 -40.5 96.95 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.742 -179.948 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -63.44 -42.53 98.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.227 0.537 . . . . 0.0 110.374 179.309 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.403 ' HD3' ' NH1' ' A' ' 12' ' ' ARG . 21.9 mmt180 -59.36 -41.53 89.46 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.404 -179.125 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -65.35 -40.54 93.74 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.112 -0.635 . . . . 0.0 109.997 178.038 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 48.7 m -61.36 -46.82 88.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.261 178.703 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -62.56 -36.01 81.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.117 -179.724 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 33.2 t . . . . . 0 C--N 1.329 -0.301 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.92 -179.928 . . . . . . . . 0 0 . 1 . 093 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . 0.437 ' OE2' ' NH2' ' A' ' 12' ' ' ARG . 53.3 mp0 . . . . . 0 N--CA 1.47 0.542 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 . . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 84.3 mt -110.18 133.26 56.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.927 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 55.3 t -127.31 131.13 70.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.444 0.64 . . . . 0.0 110.914 -179.347 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -93.61 122.73 36.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.219 -0.901 . . . . 0.0 112.165 -178.804 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . 0.41 ' CB ' ' O ' ' A' ' 36' ' ' ASP . 88.1 tttt -65.78 -46.74 77.59 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.306 179.929 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.98 160.99 45.3 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.285 -179.365 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -59.8 140.58 93.94 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.363 2.042 . . . . 0.0 111.905 179.278 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 3.4 tt . . . . . 0 C--N 1.321 -0.639 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.881 179.908 . . . . . . . . 0 0 . 1 . 094 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.498 ' O ' ' O ' ' A' ' 99' ' ' ASN . 1.8 t . . . . . 0 N--CA 1.471 0.594 0 CA-C-O 121.027 0.442 . . . . 0.0 110.281 . . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 80.4 mtt85 -86.22 124.58 32.77 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.76 -179.526 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -133.6 141.31 47.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.244 0.545 . . . . 0.0 111.773 -179.228 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 42.8 tp -117.34 130.71 56.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.053 179.014 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 63.8 t -108.96 132.7 56.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.754 -179.226 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.0 m -92.35 111.59 23.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.795 -178.874 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 86.7 mt -78.69 147.89 6.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.373 179.142 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -92.12 158.34 16.24 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.329 178.101 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.428 ' NH1' HH11 ' B' ' 245' ' ' ARG . 87.9 mtm180 -57.85 -26.43 62.05 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.266 -178.492 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 97.9 p -80.61 -11.76 59.6 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 120.324 -0.551 . . . . 0.0 111.049 -179.876 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.98 24.22 13.43 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.409 178.777 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.4 m -116.89 136.56 53.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.281 179.037 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -65.91 126.41 28.43 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.423 -179.984 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -113.0 -128.64 4.95 Favored Glycine 0 CA--C 1.535 1.336 0 N-CA-C 111.381 -0.687 . . . . 0.0 111.381 -179.255 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -74.13 150.63 43.03 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 121.979 1.786 . . . . 0.0 111.951 -179.445 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -108.18 162.68 13.85 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.156 0.503 . . . . 0.0 110.604 -179.654 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -129.51 88.93 48.64 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.403 -179.051 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -61.44 131.08 34.38 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.464 2.109 . . . . 0.0 110.993 179.106 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 87.7 mt -98.68 121.44 40.63 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 119.819 -0.752 . . . . 0.0 111.355 -178.559 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 82.8 p -114.84 -28.34 7.1 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.562 178.66 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.7 mt -78.59 145.74 34.58 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.856 -1.066 . . . . 0.0 109.952 179.799 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 57.1 m -71.65 -8.27 53.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 0.0 112.216 -178.558 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.5 m -135.59 135.84 40.59 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.331 -179.687 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.5 t -126.4 117.1 22.24 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.227 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.0 tp -113.65 131.97 55.94 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.249 -178.362 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.507 ' O ' ' O ' ' A' ' 47' ' ' GLN . 4.9 m-85 -110.89 134.02 52.89 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.95 -179.655 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.29 -172.12 38.32 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 119.963 -1.113 . . . . 0.0 112.468 178.687 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.663 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 82.2 mtm-85 -83.28 -32.53 26.33 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.644 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -49.8 149.91 5.2 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -178.86 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.559 ' O ' ' NH2' ' A' ' 38' ' ' ARG . 36.5 mm -64.03 -43.28 97.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.33 -179.823 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -53.68 -21.61 7.35 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.943 -179.234 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 71.5 m -56.6 118.52 4.93 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.717 -179.695 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -57.13 -31.05 64.95 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.864 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 96.3 mt -123.56 117.08 50.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 176.734 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.559 ' NH2' ' O ' ' A' ' 33' ' ' ILE . 72.0 mtt85 -102.91 134.33 46.52 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.571 -177.928 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 78.7 mt -118.74 131.22 72.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.2 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -80.71 24.66 0.47 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.084 -178.652 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 27.8 mt -89.61 126.51 57.78 Favored Pre-proline 0 C--N 1.323 -0.579 0 C-N-CA 120.377 -0.529 . . . . 0.0 109.595 179.953 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -68.77 -13.0 36.05 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.258 1.972 . . . . 0.0 113.668 -179.158 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.41 ' CG2' ' CZ ' ' B' ' 241' ' ' PHE . 2.9 m -99.83 6.47 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.925 179.969 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.663 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 24.1 t -90.52 132.1 36.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.988 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.518 ' OG ' ' N ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -64.79 169.38 5.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.219 0.533 . . . . 0.0 111.375 -178.674 . . . . . . . . 3 3 . 1 . 094 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -62.64 -44.88 95.16 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.292 -179.366 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.651 ' O ' ' N ' ' A' ' 49' ' ' CYS . 96.2 mt-30 -113.21 -13.05 13.02 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.424 178.983 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.518 ' N ' ' OG ' ' A' ' 45' ' ' SER . 14.7 t60 34.2 -75.97 0.0 OUTLIER 'General case' 0 C--O 1.235 0.29 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 179.066 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.651 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.81 136.74 47.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.173 0.511 . . . . 0.0 112.003 -178.773 . . . . . . . . 3 3 . 1 . 094 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -126.38 127.08 44.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.205 179.655 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 92.3 mt -110.85 134.07 54.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.313 -179.113 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -116.5 121.46 41.88 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.718 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.5 mt -107.15 112.57 40.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.139 -0.624 . . . . 0.0 111.653 -179.571 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.44 ' O ' ' C ' ' A' ' 55' ' ' GLU . 96.2 m-70 -111.52 144.66 40.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.847 179.936 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.2 tt0 -40.85 -32.26 0.21 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.308 -0.626 . . . . 0.0 109.308 -179.944 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.425 ' N ' ' C ' ' A' ' 54' ' ' HIS . 98.1 mt-30 -63.8 -68.15 0.37 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.452 178.805 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.438 ' CD ' ' CD ' ' A' ' 81' ' ' ARG . 14.7 pt-20 -157.4 -171.82 3.75 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.484 -178.626 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.26 123.33 49.09 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.679 179.51 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.417 HG22 HD11 ' A' ' 59' ' ' ILE . 84.2 mt -114.73 128.08 71.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 120.345 -0.542 . . . . 0.0 112.343 -178.93 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 47.3 tp -93.85 127.49 39.62 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.352 179.517 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -115.04 135.41 54.25 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 178.795 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.642 ' ND2' ' H ' ' A' ' 69' ' ' THR . 16.0 t-20 -101.65 112.13 24.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.182 0.515 . . . . 0.0 111.576 -179.369 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -102.44 -7.08 22.25 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.749 179.784 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.36 100.7 3.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.368 179.899 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.2 m -84.98 -9.2 58.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.941 0.4 . . . . 0.0 109.928 179.678 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.92 -39.02 9.59 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.26 179.895 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -149.19 98.32 3.52 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.344 179.987 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -56.04 147.36 64.53 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 122.36 2.04 . . . . 0.0 112.713 179.968 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.642 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 38.1 m -69.64 138.78 53.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.088 178.872 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 89' ' ' THR . 83.7 mt-30 -101.02 139.67 36.39 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.161 179.795 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.2 t -131.36 135.97 58.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.356 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 53.86 34.59 19.67 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.949 -179.733 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.23 30.38 71.72 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.031 179.251 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 41.0 m -143.63 134.88 25.83 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 117.105 0.453 . . . . 0.0 111.054 -179.907 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -68.99 137.77 23.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.505 179.897 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.573 ' CG2' ' O ' ' A' ' 78' ' ' GLU . 97.2 mt -102.65 105.16 17.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.888 -179.634 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -67.55 -40.87 84.95 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.849 178.751 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.573 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 1.9 mt-10 -127.64 170.91 9.21 Favored Pre-proline 0 N--CA 1.469 0.482 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.147 -178.514 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -59.54 148.71 86.06 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.181 1.921 . . . . 0.0 112.133 179.983 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.7 m -147.39 148.84 16.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.179 0.514 . . . . 0.0 111.869 179.708 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.438 ' CD ' ' CD ' ' A' ' 57' ' ' GLU . 61.4 ttp180 -72.81 128.86 36.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.518 179.779 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 94.9 mt -85.32 135.94 33.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.142 0.496 . . . . 0.0 110.94 179.712 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -119.94 148.93 42.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.79 179.561 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.437 ' C ' ' CD2' ' A' ' 84' ' ' HIS . 5.8 t60 -51.41 123.16 9.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.673 -179.396 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.69 -14.95 49.64 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 179.878 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -67.12 139.09 57.5 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.4 -0.52 . . . . 0.0 109.639 179.507 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 72.6 t -109.99 134.22 52.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.394 -178.195 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 30.5 mm -90.71 127.28 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 177.492 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.509 ' N ' ' O ' ' A' ' 70' ' ' GLN . 31.6 m -119.74 123.36 43.55 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.467 0.651 . . . . 0.0 111.148 -178.652 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 92' ' ' ASP . 89.2 mt -118.08 126.03 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.314 179.5 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.427 ' C ' ' O ' ' A' ' 90' ' ' ILE . 87.9 mt 37.1 -95.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.056 -179.956 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 90' ' ' ILE . 54.2 t0 -119.62 14.38 12.66 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.917 0.389 . . . . 0.0 111.453 -179.356 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.418 HH22 ' HB2' ' B' ' 260' ' ' GLU . 2.2 tpp180 -128.48 142.25 51.14 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.286 -179.555 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.0 m -133.45 150.08 51.76 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.428 0.632 . . . . 0.0 111.362 -179.847 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -121.58 123.24 41.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.422 -0.808 . . . . 0.0 108.907 178.895 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -81.33 126.68 31.88 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.52 -179.725 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.572 ' CE2' ' OD1' ' A' ' 99' ' ' ASN . 76.8 t80 -95.6 123.48 39.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.11 -179.193 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -126.24 115.88 20.41 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.118 179.061 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.572 ' OD1' ' CE2' ' A' ' 97' ' ' TYR . 86.1 m-20 . . . . . 0 C--N 1.327 -0.401 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.94 -179.643 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo . . . . . 0 N--CA 1.482 0.836 0 CA-C-O 121.02 0.342 . . . . 0.0 111.715 . . . . . . . . . 0 0 . 1 . 094 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 3.1 p -112.29 133.42 58.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.861 -179.498 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 5.6 t . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.892 179.834 . . . . . . . . 0 0 . 1 . 094 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo . . . . . 0 N--CA 1.492 1.409 0 CA-C-O 120.529 0.137 . . . . 0.0 111.989 . . . . . . . . . 0 0 . 1 . 094 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 4.6 p -75.93 -38.9 57.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 177.908 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . 0.41 ' CZ ' ' CG2' ' A' ' 43' ' ' VAL . 74.8 t80 -57.71 -46.61 84.14 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.837 -179.466 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 92.5 mt -64.67 -40.85 96.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.163 179.711 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -61.87 -43.48 98.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.379 179.565 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . 0.413 ' O ' ' OG ' ' B' ' 247' ' ' SER . 63.4 ttm-85 -63.71 -42.96 97.89 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.366 179.431 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.428 HH11 ' NH1' ' A' ' 12' ' ' ARG . 12.4 tpp180 -61.99 -44.6 96.4 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.117 -179.617 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -64.63 -38.97 92.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.453 178.712 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' B' B ' 247' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 69.7 p -68.22 -43.76 77.27 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.253 0.549 . . . . 0.0 109.795 179.057 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -58.76 -37.88 77.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.325 179.824 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 77.0 t . . . . . 0 C--N 1.327 -0.406 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.909 179.934 . . . . . . . . 0 0 . 1 . 094 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . 0.418 ' HB2' HH22 ' A' ' 93' ' ' ARG . 90.6 mt-10 . . . . . 0 CA--C 1.529 0.15 0 CA-C-O 120.606 0.241 . . . . 0.0 111.026 . . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 60.9 mt -106.62 137.24 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.877 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 69.8 t -127.54 134.48 65.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.031 -179.548 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -94.94 119.16 33.01 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.986 -177.367 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . 0.471 ' HG3' HH22 ' A' ' 38' ' ' ARG . 88.5 tttt -68.48 -44.63 74.35 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.252 179.612 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.69 156.98 49.9 Favored Pre-proline 0 C--O 1.236 0.353 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.374 -179.43 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -62.26 144.6 95.64 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.935 2.423 . . . . 0.0 112.713 -179.563 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 47.2 pt . . . . . 0 N--CA 1.455 -0.204 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.572 178.673 . . . . . . . . 0 0 . 1 . 095 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.5 p . . . . . 0 C--O 1.231 0.095 0 CA-C-O 121.02 0.438 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 095 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 76.5 mtm-85 -88.58 125.05 34.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.315 -178.95 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -130.91 144.43 51.46 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.216 179.35 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 69.7 mt -117.24 141.12 48.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.442 179.761 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.5 t -113.37 127.61 70.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.784 179.652 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.9 m -82.76 135.14 35.07 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.233 -178.29 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.421 HD13 HG21 ' A' ' 10' ' ' ILE . 98.9 mt -105.65 137.04 37.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.348 178.368 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.6 mttm -89.69 161.03 16.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.042 0.449 . . . . 0.0 110.348 179.389 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.504 ' CD ' ' NH1' ' B' ' 245' ' ' ARG . 87.7 mtm180 -54.55 -27.13 36.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.198 -179.018 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.4 m -82.71 -5.1 58.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.197 179.443 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.39 35.3 14.66 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 179.519 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.1 t -115.51 135.36 55.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.773 0.321 . . . . 0.0 110.474 -179.995 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -78.45 132.6 37.36 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.203 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -126.55 -114.95 1.94 Allowed Glycine 0 CA--C 1.537 1.416 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.967 -179.139 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -71.9 144.49 43.34 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 122.338 2.025 . . . . 0.0 112.631 -178.97 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -106.54 132.66 52.28 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.984 0.421 . . . . 0.0 110.701 -179.746 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.406 ' CD2' HD13 ' A' ' 37' ' ' ILE . 56.0 t80 -101.18 102.35 20.31 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.44 -179.41 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -76.22 129.92 11.66 Favored 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 121.67 1.58 . . . . 0.0 111.789 -179.75 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 89.8 mt -87.41 80.28 8.18 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.165 -179.07 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.587 ' HG ' ' NE2' ' B' ' 265' ' ' GLN . 35.6 p -84.73 -9.92 57.75 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.437 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 66.6 mt -100.16 143.23 30.61 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.96 -179.676 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 93.1 p -65.56 -15.91 63.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.131 -178.642 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.488 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 33.4 m -130.13 130.74 45.17 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.864 -179.407 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.618 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 2.2 t -124.9 118.85 27.21 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.979 178.921 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.8 tp -120.01 131.86 55.28 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.509 -178.142 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.618 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 54.8 m-85 -108.45 143.13 37.81 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.289 179.689 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 156.29 -151.04 22.51 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 179.156 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.666 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 84.2 mtm-85 -108.89 -23.45 11.72 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.634 179.326 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.469 ' N ' ' SG ' ' A' ' 35' ' ' CYS . . . -55.49 156.86 8.79 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 121.281 -0.485 . . . . 0.0 112.206 -178.584 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.448 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 11.0 tp -65.69 -41.93 91.55 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 CA-C-O 120.986 0.422 . . . . 0.0 110.061 179.606 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.448 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 96.4 mt-10 -60.11 -28.46 67.88 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.803 179.873 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.543 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 9.3 m -53.13 115.46 1.89 Allowed 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.071 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.488 ' OD2' ' O ' ' A' ' 26' ' ' THR . 99.5 m-20 -60.74 -26.71 67.39 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -179.245 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.406 HD13 ' CD2' ' A' ' 20' ' ' PHE . 47.5 mm -123.24 112.37 33.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.67 177.516 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -105.0 137.65 42.42 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.773 -179.832 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 98.2 mt -121.76 132.85 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.138 179.058 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -79.33 34.26 0.25 Allowed 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -177.588 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.545 ' CD1' ' HE ' ' A' ' 93' ' ' ARG . 9.7 mt -113.59 137.61 22.25 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.553 178.9 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.09 -10.79 29.1 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.836 2.358 . . . . 0.0 113.93 -178.138 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.4 m -95.51 3.34 9.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.223 -0.591 . . . . 0.0 111.206 -179.993 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.666 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 37.3 t -94.5 130.19 43.69 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.717 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.9 m -70.97 163.47 27.46 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -177.796 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.543 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 54.8 mttp -62.75 -41.62 99.29 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.486 -179.048 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.633 ' O ' ' N ' ' A' ' 49' ' ' CYS . 10.8 mm100 -113.98 -24.63 8.95 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.239 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 24.5 t60 35.26 -74.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 178.944 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.633 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.79 138.64 45.83 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -177.993 . . . . . . . . 3 3 . 1 . 095 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -128.6 127.83 43.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.789 179.817 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.8 mt -115.42 134.22 59.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.516 179.244 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -114.17 137.84 51.23 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.449 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.429 HG21 HD12 ' A' ' 53' ' ' ILE . 39.5 mm -98.15 120.01 46.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.307 0.575 . . . . 0.0 110.679 -179.367 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.454 ' O ' ' C ' ' A' ' 55' ' ' GLU . 38.0 m-70 -120.78 131.35 54.43 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.303 179.452 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 54' ' ' HIS . 99.5 mt-10 -40.07 -34.46 0.3 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -179.774 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -62.75 -66.85 0.48 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.845 -1.071 . . . . 0.0 108.953 178.358 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -160.05 -159.14 0.69 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.426 178.854 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.62 131.03 56.28 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.814 -0.355 . . . . 0.0 110.362 -179.938 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.453 HG22 HD11 ' A' ' 59' ' ' ILE . 37.6 mm -108.64 123.5 64.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.004 -179.25 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 38.9 tp -95.77 124.01 39.6 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.149 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -113.01 134.17 54.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.259 -179.547 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -95.33 104.65 16.55 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.951 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -99.26 -7.51 26.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.957 178.838 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.9 t -78.08 98.94 5.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.133 -179.175 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.8 m -77.64 -37.49 49.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.127 0.489 . . . . 0.0 109.955 178.599 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.56 -40.45 80.61 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.458 -179.705 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -146.68 96.98 4.33 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.963 -179.286 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -56.36 148.28 62.75 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.455 2.104 . . . . 0.0 112.467 179.505 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.4 m -74.68 143.06 44.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.313 -179.764 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.416 ' O ' ' N ' ' A' ' 89' ' ' THR . 87.5 mt-30 -104.12 140.39 37.86 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.225 179.385 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.9 t -130.08 135.77 60.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.024 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 52.98 37.14 23.83 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.38 -179.898 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.29 29.53 74.4 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.095 179.204 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.3 t -144.94 136.05 24.94 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.481 -179.983 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.1 p -72.2 138.59 21.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.16 -179.256 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.526 ' CD1' ' O ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -133.6 126.76 52.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.96 179.289 . . . . . . . . 3 3 . 1 . 095 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -99.4 -9.76 23.07 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.658 -179.308 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.526 ' O ' ' CD1' ' A' ' 76' ' ' ILE . 1.2 pm0 -118.47 161.05 37.37 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 120.776 -0.37 . . . . 0.0 111.035 -179.18 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -57.54 143.77 93.8 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 121.613 1.542 . . . . 0.0 111.859 179.696 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.8 p -139.63 141.61 34.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.353 -179.462 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -78.39 134.12 37.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.394 -179.867 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.1 mt -93.46 139.36 30.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.241 0.543 . . . . 0.0 111.622 -179.269 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -126.06 155.93 40.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.997 179.765 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.751 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 8.4 t60 -55.83 118.55 4.68 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.9 0.381 . . . . 0.0 110.235 -179.523 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.82 -17.1 27.9 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 -179.704 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -68.14 137.47 54.92 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.224 179.968 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.55 ' CG2' ' OG ' ' A' ' 94' ' ' SER . 7.7 p -111.55 134.18 54.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.061 0.457 . . . . 0.0 112.031 -178.557 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 47.5 mm -93.81 128.02 45.46 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.093 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 178.069 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.416 ' N ' ' O ' ' A' ' 70' ' ' GLN . 47.9 m -126.57 126.68 44.05 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -178.001 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.459 ' O ' ' C ' ' A' ' 91' ' ' ILE . 86.4 mt -116.07 126.63 73.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 114.225 -1.352 . . . . 0.0 108.259 178.57 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.459 ' C ' ' O ' ' A' ' 90' ' ' ILE . 94.6 mt 35.71 -96.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 121.024 -0.271 . . . . 0.0 110.922 -179.593 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 90' ' ' ILE . 26.5 m-20 -120.11 17.28 12.43 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.86 0.362 . . . . 0.0 111.432 179.802 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.774 HH21 ' NH2' ' B' ' 245' ' ' ARG . 0.6 OUTLIER -124.71 138.22 54.3 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.845 . . . . . . . . 3 3 . 1 . 095 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.55 ' OG ' ' CG2' ' A' ' 87' ' ' VAL . 8.1 t -139.97 151.1 45.25 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 119.826 -0.75 . . . . 0.0 111.751 -179.055 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -122.69 122.51 38.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.561 178.734 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -87.2 134.12 33.57 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.315 -178.865 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.518 ' OH ' ' OD1' ' A' ' 99' ' ' ASN . 75.0 t80 -97.59 125.8 42.53 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.518 179.79 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -143.72 130.07 19.91 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.779 -179.908 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.751 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 84.7 m-20 . . . . . 0 C--N 1.332 -0.18 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.411 179.112 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo . . . . . 0 N--CA 1.488 1.155 0 CA-C-O 121.082 0.367 . . . . 0.0 111.969 . . . . . . . . . 0 0 . 1 . 095 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 24.8 t -59.6 137.53 21.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.006 179.441 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.9 t . . . . . 0 C--N 1.325 -0.465 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.169 -179.324 . . . . . . . . 0 0 . 1 . 095 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo . . . . . 0 N--CA 1.492 1.433 0 N-CA-C 111.519 -0.224 . . . . 0.0 111.519 . . . . . . . . . 0 0 . 1 . 095 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 97.0 m -71.03 -45.35 64.05 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.967 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -58.38 -46.8 85.64 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.754 -179.601 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 92.6 mt -64.04 -42.1 97.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.878 -179.577 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -63.3 -43.21 98.51 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 120.871 -0.331 . . . . 0.0 111.076 -179.402 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -63.0 -40.11 96.79 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.699 179.8 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.774 ' NH2' HH21 ' A' ' 93' ' ' ARG . 61.2 ttm-85 -61.76 -44.54 96.69 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.084 179.574 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -62.52 -41.53 98.92 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.469 -179.618 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 57.9 m -66.97 -46.03 75.89 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.291 0.567 . . . . 0.0 110.521 179.122 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -62.92 -33.56 75.59 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.447 -179.46 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 61.4 t . . . . . 0 CA--C 1.532 0.259 0 CA-C-O 121.19 0.519 . . . . 0.0 111.55 179.867 . . . . . . . . 0 0 . 1 . 095 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . 0.501 ' OE1' ' N ' ' B' ' 260' ' ' GLU . 57.4 mp0 . . . . . 0 N--CA 1.461 0.109 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 . . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 66.4 mt -106.01 134.35 47.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 178.123 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 72.0 t -123.71 132.27 71.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.26 0.552 . . . . 0.0 110.238 -178.812 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -95.18 117.4 30.18 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.543 -177.869 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . 0.418 ' NZ ' ' HA ' ' A' ' 34' ' ' GLU . 88.5 tttt -65.17 -45.77 83.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.572 179.745 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . 0.587 ' NE2' ' HG ' ' A' ' 23' ' ' SER . 0.0 OUTLIER -80.26 158.9 71.34 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.144 -179.819 . . . . . . . . 3 3 . 1 . 095 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -60.1 140.59 93.2 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 C-N-CA 122.237 1.958 . . . . 0.0 111.733 179.499 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 13.8 tt . . . . . 0 C--N 1.326 -0.414 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.156 -179.541 . . . . . . . . 0 0 . 1 . 096 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.6 m . . . . . 0 C--O 1.231 0.107 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 . . . . . . . . . 0 0 . 1 . 096 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 88.1 mtm-85 -94.87 131.57 40.62 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.936 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -142.86 151.54 41.18 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 119.958 -0.697 . . . . 0.0 112.305 179.933 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 80.3 mt -115.25 131.52 56.9 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.14 178.653 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 73.0 t -103.65 128.21 57.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.942 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 m -87.82 120.9 29.6 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -177.377 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 91.1 mt -82.18 134.92 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.659 178.462 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -88.37 160.73 17.46 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.4 0.619 . . . . 0.0 111.394 179.365 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.638 ' CG ' HH12 ' A' ' 93' ' ' ARG . 76.7 mtp180 -53.9 -40.98 67.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.921 -178.759 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.5 t -72.2 -11.11 60.58 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.024 179.892 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.25 35.31 5.3 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 -179.513 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.7 t -123.66 135.96 61.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.103 0.478 . . . . 0.0 111.914 -179.474 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -70.07 136.43 50.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.809 179.504 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -122.0 -125.34 3.11 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.919 -179.332 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.65 150.26 56.45 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 122.051 1.834 . . . . 0.0 113.222 -178.469 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 53.3 m170 -110.28 132.91 53.76 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.52 -179.251 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -102.12 100.73 15.99 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.301 -179.506 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -73.37 127.69 12.11 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 C-N-CA 121.421 1.414 . . . . 0.0 110.855 179.979 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 99.3 mt -79.99 55.58 2.16 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.816 -0.353 . . . . 0.0 111.886 -178.345 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 87.1 p -67.13 -22.21 65.8 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.508 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 69.9 mt -83.52 139.8 32.67 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.563 179.573 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.9 m -67.42 -18.6 65.17 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.429 -178.965 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 36.4 m -129.23 130.91 46.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.238 0.542 . . . . 0.0 111.918 -179.717 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.671 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.7 OUTLIER -125.62 118.33 25.45 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.65 178.735 . . . . . . . . 3 3 . 1 . 096 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.519 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 56.0 tp -119.79 125.69 49.21 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.522 -178.424 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.671 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 48.2 m-85 -101.76 128.07 48.26 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.492 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 177.5 -176.84 48.23 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.282 -0.961 . . . . 0.0 111.762 179.101 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.655 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 84.6 mtm-85 -82.39 -28.07 31.68 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.12 0.486 . . . . 0.0 110.242 179.75 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.61 155.02 41.63 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.282 -178.368 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.1 tp -65.98 -39.38 84.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.489 -0.355 . . . . 0.0 110.56 179.23 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -55.17 -21.61 14.2 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.659 -179.795 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.8 m -64.03 119.86 10.93 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.088 -179.982 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.585 ' OD2' ' SG ' ' A' ' 27' ' ' CYS . 28.2 p-10 -54.26 -26.12 27.19 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.385 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.51 ' N ' ' OD1' ' A' ' 36' ' ' ASP . 94.9 mt -130.59 123.61 55.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.29 -0.868 . . . . 0.0 108.879 178.043 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 20.9 mtm180 -109.3 137.63 46.88 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.761 -179.099 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 92.8 mt -118.65 131.62 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.936 179.293 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -77.89 31.64 0.17 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -177.877 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 34.7 mt -102.88 130.64 23.37 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.742 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.53 -6.09 18.17 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 121.909 1.739 . . . . 0.0 112.534 -179.459 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.419 HG22 ' CE2' ' B' ' 241' ' ' PHE . 4.9 m -101.39 3.74 10.59 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.501 -179.686 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.655 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 34.3 t -90.57 133.48 32.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.632 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -69.74 170.22 11.39 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.779 0.799 . . . . 0.0 112.753 -177.5 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -64.04 -43.83 94.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.512 -179.324 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.636 ' O ' ' N ' ' A' ' 49' ' ' CYS . 90.5 mm-40 -111.69 -17.39 13.01 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.299 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.4 t60 32.56 -78.11 0.0 OUTLIER 'General case' 0 C--O 1.238 0.492 0 CA-C-N 114.686 -1.143 . . . . 0.0 112.985 179.765 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.636 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.66 135.97 46.16 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.482 -179.003 . . . . . . . . 3 3 . 1 . 096 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -125.89 131.4 52.36 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.702 179.003 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.1 mt -117.64 135.17 58.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.574 -179.967 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -114.18 135.57 53.89 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.669 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.0 mm -103.01 125.19 57.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.941 -179.398 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.473 ' O ' ' N ' ' A' ' 56' ' ' GLN . 33.3 m-70 -127.04 129.31 47.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.596 179.349 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' A' ' 54' ' ' HIS . 96.0 mt-10 -40.2 -29.74 0.08 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.216 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.473 ' N ' ' O ' ' A' ' 54' ' ' HIS . 88.3 mt-30 -67.08 -67.28 0.46 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.41 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -154.92 -168.1 2.78 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.707 -179.807 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.11 131.09 55.65 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.407 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.3 mm -108.66 125.2 65.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.869 -179.433 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 34.1 tp -99.44 126.3 45.33 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.258 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -115.76 137.61 51.92 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.579 -179.187 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -102.57 105.18 15.65 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.368 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -95.89 -4.28 43.84 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.513 178.997 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.52 104.45 15.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.553 -179.187 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.3 p -87.31 -35.89 18.17 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.698 179.124 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.6 -45.71 92.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.793 -179.714 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -145.58 104.43 4.27 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.07 179.248 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -67.04 151.43 81.88 Favored 'Trans proline' 0 N--CA 1.491 1.332 0 C-N-CA 121.74 1.627 . . . . 0.0 113.287 -177.87 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 33.9 m -70.79 146.93 49.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.598 179.95 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -110.87 139.92 45.77 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.758 -179.404 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 54.2 t -129.66 134.99 62.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.05 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 53.6 34.41 18.57 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.221 179.829 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.31 28.71 69.43 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.91 179.468 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.6 t -144.93 142.62 30.01 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 117.182 0.491 . . . . 0.0 110.986 179.758 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.4 m -68.97 143.71 14.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.496 -179.497 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.477 ' CG1' ' O ' ' A' ' 78' ' ' GLU . 10.0 tt -111.67 90.92 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.92 -179.801 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -65.55 -35.25 80.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.115 179.52 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.477 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 5.0 mt-10 -124.67 164.74 28.99 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.387 -178.402 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.74 138.87 77.12 Favored 'Trans proline' 0 N--CA 1.501 1.954 0 C-N-CA 122.102 1.868 . . . . 0.0 112.874 -179.879 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 73.2 t -132.37 137.39 54.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.781 179.956 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 84.6 mtt85 -71.38 129.32 38.52 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.487 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.6 mt -82.75 137.36 34.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.164 0.507 . . . . 0.0 111.072 -179.876 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -128.09 152.35 48.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.593 -179.621 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.516 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 7.7 t60 -55.86 117.77 3.99 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.431 179.948 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.85 -20.43 19.93 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 179.851 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -67.03 136.63 55.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.979 0.418 . . . . 0.0 110.216 179.948 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.1 t -109.43 133.87 53.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.684 -178.758 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 88.6 mt -102.86 129.93 53.75 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.514 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 178.275 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 61.5 m -123.41 128.43 49.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.799 0.809 . . . . 0.0 112.249 -178.014 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.678 ' O ' ' N ' ' A' ' 93' ' ' ARG . 93.9 mt -116.53 132.86 64.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.077 178.7 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.517 ' C ' ' O ' ' A' ' 90' ' ' ILE . 51.0 mt -22.5 98.82 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.067 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.535 ' CG ' ' HE ' ' B' ' 245' ' ' ARG . 0.7 OUTLIER 80.08 -17.57 0.57 Allowed 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 178.354 . . . . . . . . 3 3 . 1 . 096 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.678 ' N ' ' O ' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -122.52 132.64 54.42 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 119.64 -0.219 . . . . 0.0 110.868 -179.747 . . . . . . . . 3 3 . 1 . 096 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.1 t -136.28 146.88 47.16 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 118.488 0.586 . . . . 0.0 111.129 -179.781 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -125.74 122.06 35.19 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.647 179.593 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -84.43 134.85 34.45 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.399 -179.249 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -97.82 126.43 43.18 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.492 -179.598 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -143.12 128.38 18.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.644 179.827 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.539 ' O ' ' OD1' ' A' ' 99' ' ' ASN . 29.0 p30 . . . . . 0 C--N 1.333 -0.113 0 CA-C-O 121.483 0.658 . . . . 0.0 111.343 -179.898 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo . . . . . 0 N--CA 1.483 0.902 0 CA-C-O 121.084 0.369 . . . . 0.0 111.927 . . . . . . . . . 0 0 . 1 . 096 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 3.8 p -113.7 132.65 62.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.095 -179.719 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.515 -0.378 0 C-N-CA 120.248 -0.581 . . . . 0.0 109.493 179.943 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo . . . . . 0 N--CA 1.49 1.284 0 N-CA-C 111.349 -0.289 . . . . 0.0 111.349 . . . . . . . . . 0 0 . 1 . 096 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 2.5 p -74.35 -39.75 62.58 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 177.784 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . 0.419 ' CE2' HG22 ' A' ' 43' ' ' VAL . 71.0 t80 -58.04 -47.46 83.03 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.047 -179.264 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 98.0 mt -64.66 -40.18 94.97 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.043 0.449 . . . . 0.0 110.07 -179.823 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -63.61 -44.0 95.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.795 179.567 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . 0.411 ' HA ' ' HG ' ' B' ' 247' ' ' SER . 99.4 mtt180 -61.54 -41.24 97.07 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.109 -179.855 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.535 ' HE ' ' CG ' ' A' ' 92' ' ' ASP . 22.1 mmm180 -61.61 -40.37 94.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.348 -179.859 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -63.77 -42.43 97.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.801 0.334 . . . . 0.0 110.794 179.313 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' B' B ' 247' ' ' SER . . . . . 0.411 ' HG ' ' HA ' ' B' ' 244' ' ' ARG . 72.2 p -64.95 -43.19 93.51 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.729 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -62.36 -37.33 85.25 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.682 179.668 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 79.3 t . . . . . 0 N--CA 1.453 -0.29 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.2 179.019 . . . . . . . . 0 0 . 1 . 096 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 . . . . . 0 C--O 1.227 -0.11 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 . . . . . . . . . 0 0 . 1 . 096 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 41.0 mt -109.66 133.11 55.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 119.881 -0.728 . . . . 0.0 109.111 178.824 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 44.1 t -127.8 135.5 62.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.541 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -100.22 123.64 44.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.249 0.547 . . . . 0.0 112.415 -177.6 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -63.98 -47.35 80.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.111 178.59 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -96.84 163.76 19.48 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.477 179.972 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -60.76 156.74 41.35 Favored 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 122.941 2.427 . . . . 0.0 111.982 178.72 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 10.6 pt . . . . . 0 N--CA 1.466 0.35 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.893 -178.224 . . . . . . . . 0 0 . 1 . 097 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.5 p . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.858 0.361 . . . . 0.0 110.354 . . . . . . . . . 0 0 . 1 . 097 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.449 ' NH1' ' CG2' ' A' ' 53' ' ' ILE . 99.9 mtt180 -94.11 132.28 38.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.747 179.213 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 91.6 mtm180 -134.07 141.93 47.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.015 -179.911 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 42.3 tp -111.94 131.27 55.49 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.122 179.416 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.7 t -107.07 130.27 59.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.382 179.832 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 m -92.84 115.06 27.77 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.437 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 88.6 mt -80.93 142.74 13.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.667 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -84.81 156.04 21.52 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.562 178.823 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.429 ' HG3' ' NH2' ' B' ' 245' ' ' ARG . 58.0 ttp180 -58.16 -35.85 72.16 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.069 -179.795 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.1 t -68.21 -21.59 64.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.988 0.423 . . . . 0.0 110.13 178.638 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.57 29.02 4.6 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 111.156 -0.777 . . . . 0.0 111.156 179.993 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.8 t -117.78 132.9 66.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.869 0.366 . . . . 0.0 111.152 -179.804 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 17' ' ' GLY . 63.5 t0 -79.29 130.83 35.85 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.67 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.462 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -129.93 -108.71 1.31 Allowed Glycine 0 CA--C 1.532 1.133 0 C-N-CA 119.707 -1.235 . . . . 0.0 112.221 -179.66 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.1 145.19 48.88 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.496 2.131 . . . . 0.0 113.81 -178.333 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.451 ' O ' ' CD1' ' B' ' 267' ' ' ILE . 0.2 OUTLIER -110.56 145.62 37.49 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.475 178.871 . . . . . . . . 3 3 . 1 . 097 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -113.99 92.21 25.14 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.856 -179.084 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.83 130.02 34.86 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 122.037 1.825 . . . . 0.0 111.189 -179.602 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.5 mt -87.73 84.71 7.03 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.314 -179.483 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 51.4 p -89.85 -10.44 45.33 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.164 179.486 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.412 ' CD1' ' CD ' ' B' ' 265' ' ' GLN . 59.4 mt -102.24 146.6 27.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.289 -179.723 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 52.4 p -68.84 -17.36 63.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.564 -179.614 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.48 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 30.5 m -128.87 130.73 47.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.873 0.368 . . . . 0.0 110.992 -179.437 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.8 t -126.03 119.28 27.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.718 178.844 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.433 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 42.8 tp -116.77 130.17 56.55 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.155 -178.098 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.504 ' O ' ' O ' ' A' ' 47' ' ' GLN . 10.1 m-85 -109.01 140.41 42.57 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.41 179.921 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 153.88 -177.24 31.47 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.316 -0.945 . . . . 0.0 112.431 177.969 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -71.13 -32.51 69.07 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 111.725 0.268 . . . . 0.0 111.725 179.336 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.453 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -50.38 140.27 19.46 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.812 -178.0 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.464 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 11.0 tp -67.1 -41.87 87.6 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 C-N-CA 120.381 -0.527 . . . . 0.0 109.597 179.569 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.464 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 77.3 tt0 -55.6 -16.98 4.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.226 179.457 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 24.1 m -66.63 136.26 55.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.119 -179.79 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.48 ' OD2' ' O ' ' A' ' 26' ' ' THR . 68.8 m-20 -61.53 -33.72 74.3 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -178.999 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 98.3 mt -125.05 119.67 56.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 177.188 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -104.64 133.11 50.04 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.774 -177.999 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 98.9 mt -119.36 129.13 75.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.587 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -76.39 29.63 0.12 Allowed 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -178.082 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 30.4 mt -94.12 129.03 38.7 Favored Pre-proline 0 C--N 1.322 -0.613 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.91 -179.806 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -72.86 -10.34 24.72 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 122.58 2.187 . . . . 0.0 113.046 -178.996 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.447 HG23 ' CE2' ' B' ' 241' ' ' PHE . 29.4 m -109.66 4.19 9.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.589 179.804 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.449 ' O ' ' O ' ' A' ' 45' ' ' SER . 4.5 t -91.8 108.17 19.72 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 CA-C-O 121.454 0.645 . . . . 0.0 110.642 179.623 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.449 ' O ' ' O ' ' A' ' 44' ' ' VAL . 1.1 m -32.09 153.05 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.999 -1.0 . . . . 0.0 112.167 -179.523 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -62.0 -42.36 99.06 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 114.406 -1.27 . . . . 0.0 111.192 -179.104 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.698 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.7 mt-30 -113.1 -18.09 12.24 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.097 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.521 ' CG ' ' HG ' ' A' ' 64' ' ' SER . 35.5 t60 31.83 -71.42 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 114.902 -1.045 . . . . 0.0 113.23 179.879 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.698 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.66 135.41 47.82 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.282 . . . . . . . . 3 3 . 1 . 097 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -127.82 131.72 49.52 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.507 179.098 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.7 mt -116.28 136.2 54.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.536 -179.576 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -120.55 125.25 47.32 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.619 178.877 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.449 ' CG2' ' NH1' ' A' ' 5' ' ' ARG . 96.4 mt -105.24 114.27 44.34 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 CA-C-O 121.363 0.602 . . . . 0.0 111.569 -179.839 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.572 ' O ' ' N ' ' A' ' 56' ' ' GLN . 93.8 m-70 -112.22 144.46 41.59 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.671 179.641 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.474 ' C ' ' O ' ' A' ' 54' ' ' HIS . 81.8 tt0 -38.83 -26.42 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.81 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.572 ' N ' ' O ' ' A' ' 54' ' ' HIS . 68.9 tp60 -69.62 -68.11 0.43 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.676 178.32 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -160.82 -165.21 1.33 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.551 -179.695 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.41 124.93 52.65 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.013 179.468 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 98.5 mt -113.57 129.22 69.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.245 0.545 . . . . 0.0 112.445 -179.042 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 51.1 tp -95.17 126.73 40.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.355 179.227 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -113.94 135.93 53.45 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.402 -179.305 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -95.74 106.67 18.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.952 0.406 . . . . 0.0 111.897 -179.678 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -99.17 -9.52 23.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.602 179.095 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.521 ' HG ' ' CG ' ' A' ' 48' ' ' HIS . 0.7 OUTLIER -72.45 102.93 3.32 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.489 179.785 . . . . . . . . 3 3 . 1 . 097 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 99.1 p -87.45 -1.58 58.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.083 0.468 . . . . 0.0 109.92 179.445 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -112.11 -35.81 5.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.378 -179.916 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 31.4 m-20 -144.27 90.42 6.69 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.607 179.675 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.38 147.1 48.24 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 123.108 2.539 . . . . 0.0 113.445 -178.298 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 58.8 m -71.85 130.41 40.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.32 179.609 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -98.91 143.57 29.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.771 179.637 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.0 t -131.67 133.22 61.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 179.161 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 54.04 33.62 18.03 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 119.491 -0.884 . . . . 0.0 109.286 179.489 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.34 28.73 69.34 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.235 179.627 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.1 m -139.27 133.0 30.65 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 117.439 0.619 . . . . 0.0 112.227 -179.854 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -72.28 137.91 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.213 179.75 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.543 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 1.7 pt -119.07 115.85 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 121.194 0.521 . . . . 0.0 110.057 178.737 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -82.37 -18.5 41.83 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.165 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.558 ' CD ' ' H ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -124.89 164.71 29.67 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.875 -179.975 . . . . . . . . 3 3 . 1 . 097 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -63.54 153.4 75.09 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 C-N-CA 122.789 2.326 . . . . 0.0 112.473 179.816 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.3 p -142.76 147.59 20.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.719 -179.259 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -78.65 129.95 35.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.746 179.294 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.0 mt -85.44 137.92 32.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.15 0.5 . . . . 0.0 111.257 -179.085 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -128.45 150.87 49.95 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.106 179.578 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.622 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 8.5 t60 -53.13 120.65 6.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.979 0.418 . . . . 0.0 111.156 -179.505 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.14 -20.82 23.28 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 179.746 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -67.56 136.03 53.88 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.053 0.454 . . . . 0.0 110.812 -179.814 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.1 t -116.53 132.18 66.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.058 -178.796 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 93.3 mt -92.6 131.77 38.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.291 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 54.5 m -123.47 124.71 43.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.8 0.809 . . . . 0.0 112.817 -178.41 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.492 ' O ' ' C ' ' A' ' 91' ' ' ILE . 96.5 mt -110.68 124.07 67.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.35 177.874 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.492 ' C ' ' O ' ' A' ' 90' ' ' ILE . 73.1 mt 33.98 -95.5 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.724 179.575 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' A' ' 90' ' ' ILE . 97.9 m-20 -113.72 9.52 17.75 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.557 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.715 ' HE ' HH22 ' B' ' 245' ' ' ARG . 97.5 mtt180 -125.08 144.25 50.51 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.513 -179.114 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.5 m -139.89 152.47 46.46 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.522 0.677 . . . . 0.0 111.388 -179.125 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -125.62 121.98 35.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.572 179.81 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -80.3 128.2 33.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.072 0.463 . . . . 0.0 111.639 -178.957 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -97.35 123.86 41.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.315 179.478 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -126.44 125.66 42.51 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.796 179.984 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.622 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 61.5 t-20 . . . . . 0 CA--C 1.53 0.193 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.255 179.443 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo . . . . . 0 N--CA 1.488 1.197 0 CA-C-O 121.32 0.467 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 097 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 53.7 t -63.35 136.4 26.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.088 179.942 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 4.2 t . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.446 -179.743 . . . . . . . . 0 0 . 1 . 097 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo . . . . . 0 N--CA 1.495 1.582 0 CA-C-O 120.63 0.179 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 097 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 16.1 m -66.78 -45.12 79.46 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.35 0.595 . . . . 0.0 109.529 178.644 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . 0.447 ' CE2' HG23 ' A' ' 43' ' ' VAL . 79.6 t80 -59.18 -46.13 89.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.034 -178.827 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 99.7 mt -64.58 -40.06 94.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.736 0.303 . . . . 0.0 111.332 -178.978 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 -62.95 -39.62 95.21 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.735 -179.289 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 87.7 mtm180 -64.03 -42.19 97.17 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.334 179.942 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.715 HH22 ' HE ' ' A' ' 93' ' ' ARG . 75.9 mtp85 -61.12 -41.33 96.52 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.781 -179.196 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -62.75 -41.36 99.17 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.479 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 8.7 t -63.59 -45.67 89.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.364 177.979 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -60.14 -39.11 85.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.128 -179.378 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 74.3 t . . . . . 0 C--N 1.329 -0.301 0 C-N-CA 120.256 -0.578 . . . . 0.0 110.274 179.643 . . . . . . . . 0 0 . 1 . 097 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . 0.616 ' OE1' ' NH2' ' A' ' 93' ' ' ARG . 93.8 mt-10 . . . . . 0 N--CA 1.464 0.265 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 . . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 59.5 mt -108.87 133.28 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.95 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 44.7 t -127.69 134.91 64.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.975 0.416 . . . . 0.0 111.109 -178.959 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -95.57 119.45 34.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.627 -178.767 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -64.79 -48.47 74.34 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.472 -179.517 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . 0.412 ' CD ' ' CD1' ' A' ' 24' ' ' LEU . 2.3 mt-30 -82.42 167.96 26.68 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.291 -179.236 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.85 144.98 89.92 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 121.701 1.601 . . . . 0.0 111.904 -179.554 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . 0.451 ' CD1' ' O ' ' A' ' 19' ' ' HIS . 7.8 tt . . . . . 0 C--N 1.321 -0.635 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.302 -179.275 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.9 p . . . . . 0 N--CA 1.462 0.158 0 CA-C-O 121.03 0.443 . . . . 0.0 110.384 . . . . . . . . . 0 0 . 1 . 098 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 89.6 mtm-85 -92.53 131.91 37.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.786 -179.398 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -133.01 141.93 48.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.011 0.434 . . . . 0.0 111.693 -179.927 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 26.4 tp -114.92 130.0 56.82 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.787 179.729 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 56.1 t -106.58 128.95 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.288 -179.012 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 m -80.27 140.46 36.2 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.263 0.554 . . . . 0.0 111.365 -179.833 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.493 ' CD1' ' OD1' ' A' ' 16' ' ' ASP . 50.6 mm -113.19 137.95 44.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.549 179.609 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -90.66 156.71 17.91 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.716 179.367 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -59.36 -24.0 63.02 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.172 179.676 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 81.8 p -81.61 -10.92 59.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.069 0.461 . . . . 0.0 109.856 179.301 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.02 34.34 8.94 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 -179.975 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.2 t -118.06 131.75 69.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.742 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.493 ' OD1' ' CD1' ' A' ' 10' ' ' ILE . 89.4 m-20 -72.4 134.05 45.21 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.229 -0.589 . . . . 0.0 109.628 179.264 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -118.53 -125.37 3.46 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.48 -179.1 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.59 152.71 38.41 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.372 2.048 . . . . 0.0 112.537 -178.689 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 10.6 m80 -102.71 154.61 18.99 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.907 0.384 . . . . 0.0 110.627 179.549 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -124.71 91.21 49.81 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.829 179.557 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -60.6 129.66 30.32 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.206 1.937 . . . . 0.0 111.719 179.872 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 90.6 mt -88.81 84.25 6.67 Favored 'General case' 0 N--CA 1.461 0.119 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.974 -179.302 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.2 p -86.21 -10.53 54.51 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.653 179.411 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.445 ' CD1' ' CD ' ' B' ' 265' ' ' GLN . 66.4 mt -102.14 145.77 28.89 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.094 -179.405 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 81.9 p -68.33 -15.9 63.74 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.045 0.45 . . . . 0.0 110.833 -179.257 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 46.3 m -128.47 132.43 48.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.674 -179.201 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.9 t -126.23 114.17 17.95 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.765 178.611 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.414 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 57.6 tp -111.31 122.51 48.05 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.906 0.384 . . . . 0.0 111.413 -178.459 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.537 ' O ' ' O ' ' A' ' 47' ' ' GLN . 11.1 m-85 -101.95 142.56 33.06 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.404 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 156.04 -169.63 33.67 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 120.136 -1.031 . . . . 0.0 112.453 179.17 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 31.9 ttp85 -89.28 -32.5 17.35 Favored 'General case' 0 N--CA 1.461 0.096 0 CA-C-O 120.817 0.342 . . . . 0.0 110.824 -179.899 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.432 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -50.36 145.41 9.7 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 -179.879 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 35.7 mm -63.69 -43.93 98.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.555 -179.614 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -54.8 -18.14 4.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.473 179.778 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.432 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 51.2 m -62.1 128.55 36.68 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.162 179.944 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.414 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 61.7 m-20 -58.97 -30.7 68.13 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -178.9 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.437 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 79.4 mt -126.5 121.74 59.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 177.126 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 47.6 mtt180 -101.12 136.06 41.59 Favored 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.266 -178.724 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.446 ' C ' ' H ' ' A' ' 41' ' ' LEU . 91.7 mt -117.12 125.33 73.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.995 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -70.92 39.07 0.05 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.308 -177.686 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.446 ' H ' ' C ' ' A' ' 39' ' ' ILE . 43.3 mt -112.69 125.17 30.37 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 120.556 -0.458 . . . . 0.0 109.796 179.16 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.56 -2.75 12.61 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.224 1.949 . . . . 0.0 112.61 -179.143 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.41 HG22 ' CE2' ' B' ' 241' ' ' PHE . 33.3 m -109.1 2.97 9.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.767 179.088 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.463 ' O ' ' O ' ' A' ' 45' ' ' SER . 2.7 t -89.72 109.7 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 120.703 0.287 . . . . 0.0 110.592 -179.865 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.58 ' OG ' ' N ' ' A' ' 48' ' ' HIS . 1.1 t -31.79 152.08 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.384 0.611 . . . . 0.0 111.775 -178.771 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.567 ' N ' ' HG ' ' A' ' 45' ' ' SER . 95.4 mttt -63.26 -43.0 99.21 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.04 -179.194 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.605 ' O ' ' N ' ' A' ' 49' ' ' CYS . 13.3 mm100 -108.9 -26.43 10.24 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.635 0.731 . . . . 0.0 109.113 179.205 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.58 ' N ' ' OG ' ' A' ' 45' ' ' SER . 36.5 t60 39.68 -74.46 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.257 -1.338 . . . . 0.0 113.681 179.471 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.605 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.54 136.44 46.62 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -177.985 . . . . . . . . 3 3 . 1 . 098 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -128.07 127.67 43.53 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.803 179.317 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.3 mt -108.85 133.78 52.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.297 179.838 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.581 ' CD ' ' HE2' ' A' ' 54' ' ' HIS . 82.1 tt0 -118.73 123.81 45.78 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.006 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.0 mt -106.85 116.0 49.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -178.565 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.581 ' HE2' ' CD ' ' A' ' 52' ' ' GLU . 96.9 m-70 -111.32 143.51 42.0 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.123 178.366 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.9 mm-40 -39.35 -26.85 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.278 0.561 . . . . 0.0 109.761 -179.841 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.53 ' N ' ' O ' ' A' ' 54' ' ' HIS . 47.2 tp60 -67.89 -68.3 0.4 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.262 178.918 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -158.92 -165.79 1.71 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.25 179.734 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.88 131.52 54.99 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.013 179.843 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 93.5 mt -121.41 132.31 70.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.233 0.54 . . . . 0.0 112.003 -179.09 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 37.0 tp -101.53 125.69 48.22 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.758 -179.175 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -110.81 135.97 50.57 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.636 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -97.94 105.34 17.47 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -178.123 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -98.28 -8.6 26.9 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.624 179.13 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.4 ' OG ' ' ND1' ' A' ' 48' ' ' HIS . 0.2 OUTLIER -78.2 98.23 5.78 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.985 0.422 . . . . 0.0 110.557 -179.716 . . . . . . . . 3 3 . 1 . 098 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.7 m -84.55 -33.94 23.34 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.886 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.4 m -64.41 -50.64 66.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.843 179.64 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -136.28 96.74 12.34 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.831 -179.752 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -55.29 143.43 75.95 Favored 'Trans proline' 0 N--CA 1.499 1.822 0 C-N-CA 122.151 1.901 . . . . 0.0 112.856 -178.822 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 18.2 m -72.06 140.34 48.92 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.406 179.93 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -104.01 140.35 37.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.438 -179.96 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 49.3 t -130.1 137.09 57.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.907 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 7.9 m120 54.05 32.55 15.83 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.267 -0.573 . . . . 0.0 109.791 -179.643 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.22 29.18 72.13 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.05 179.623 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 49.8 m -141.28 135.65 30.84 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.163 -179.996 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.4 p -70.86 136.32 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 121.181 0.515 . . . . 0.0 111.681 -179.303 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.597 ' CD1' ' O ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -132.68 125.25 52.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.837 179.77 . . . . . . . . 3 3 . 1 . 098 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -99.32 -9.02 24.08 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.121 -179.713 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.597 ' O ' ' CD1' ' A' ' 76' ' ' ILE . 16.3 mt-10 -119.6 156.72 53.3 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.299 -179.082 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -62.52 148.15 93.76 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.48 2.12 . . . . 0.0 112.702 -179.951 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.5 m -143.76 145.4 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.427 -179.608 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 87.3 mtm-85 -73.35 130.2 39.66 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.529 179.349 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.0 mt -85.35 140.69 30.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.278 0.561 . . . . 0.0 111.274 -179.682 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -133.62 157.51 45.57 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.256 -179.661 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.562 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 5.5 t60 -58.81 117.19 4.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.242 -179.664 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.65 -1.29 29.06 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 -179.365 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.415 ' C ' ' OD1' ' A' ' 86' ' ' ASP . 60.7 t0 -86.17 125.36 33.46 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.027 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.409 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 9.5 p -103.38 135.37 41.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 C-N-CA 120.461 -0.495 . . . . 0.0 111.543 -178.875 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 33.2 mm -96.14 128.28 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 177.789 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 36.3 m -122.79 121.55 36.56 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 119.688 -0.805 . . . . 0.0 113.08 -178.27 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.467 ' O ' ' C ' ' A' ' 91' ' ' ILE . 93.3 mt -110.36 124.79 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 114.624 -1.171 . . . . 0.0 108.623 177.672 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.467 ' C ' ' O ' ' A' ' 90' ' ' ILE . 61.1 mt 33.54 -99.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 121.034 -0.267 . . . . 0.0 111.195 179.7 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.506 ' O ' ' OD1' ' A' ' 92' ' ' ASP . 59.3 t0 -112.98 15.61 19.61 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.489 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.511 HH21 ' CD ' ' B' ' 260' ' ' GLU . 87.3 mtt-85 -129.32 140.61 51.34 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.128 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 75.2 m -137.17 154.73 50.16 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 119.958 -0.697 . . . . 0.0 111.585 -179.491 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -125.17 121.43 34.16 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.209 179.689 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 79.1 mtp85 -85.82 134.05 33.94 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.617 -179.685 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -93.53 123.76 37.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.736 -179.825 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -125.09 119.24 28.05 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.778 -179.769 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.562 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 59.7 t-20 . . . . . 0 N--CA 1.469 0.482 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.266 -179.754 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo . . . . . 0 N--CA 1.492 1.433 0 CA-C-O 121.462 0.526 . . . . 0.0 112.69 . . . . . . . . . 0 0 . 1 . 098 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 3.3 p -69.22 138.11 22.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.558 -0.747 . . . . 0.0 111.275 -178.841 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.5 t . . . . . 0 CA--C 1.516 -0.33 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.168 . . . . . . . . 0 0 . 1 . 098 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo . . . . . 0 N--CA 1.502 2.001 0 N-CA-C 113.189 0.419 . . . . 0.0 113.189 . . . . . . . . . 0 0 . 1 . 098 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 89.4 m -72.21 -44.75 62.5 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.396 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . 0.5 ' CE2' ' NE ' ' B' ' 245' ' ' ARG . 80.8 t80 -57.33 -46.5 83.18 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.072 -179.777 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 91.2 mt -64.19 -43.09 96.15 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 -179.936 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -65.52 -39.93 92.39 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.061 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 53.8 ttt85 -62.97 -46.22 88.73 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.354 -179.563 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.5 ' NE ' ' CE2' ' B' ' 241' ' ' PHE . 45.4 mtm180 -66.97 -37.9 85.1 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.903 -179.801 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -60.43 -45.94 91.82 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.207 -179.423 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 11.6 t -64.78 -44.66 89.29 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.677 178.681 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -63.52 -32.22 73.61 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.868 179.884 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 71.9 t . . . . . 0 C--N 1.326 -0.443 0 C-N-CA 120.286 -0.566 . . . . 0.0 109.644 179.46 . . . . . . . . 0 0 . 1 . 098 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . 0.511 ' CD ' HH21 ' A' ' 93' ' ' ARG . 95.4 mt-10 . . . . . 0 CA--C 1.527 0.087 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 . . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 74.0 mt -111.96 134.69 53.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.269 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 73.9 t -127.1 133.72 67.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.955 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -94.97 121.23 36.36 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.132 0.491 . . . . 0.0 111.483 -177.303 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -64.51 -43.99 92.34 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.956 179.606 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . 0.445 ' CD ' ' CD1' ' A' ' 24' ' ' LEU . 2.1 mt-30 -89.05 167.14 18.82 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.191 -178.068 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.77 149.27 60.21 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.744 2.296 . . . . 0.0 112.115 -179.885 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . 0.418 ' CD1' ' N ' ' B' ' 267' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.394 0 CA-C-O 121.594 0.712 . . . . 0.0 109.448 179.568 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 36.1 p . . . . . 0 N--CA 1.465 0.314 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 . . . . . . . . . 0 0 . 1 . 099 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.58 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 94.6 mtt-85 -90.48 123.76 34.44 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.659 -0.417 . . . . 0.0 111.709 -178.034 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.7 mtm-85 -127.7 130.53 49.01 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 121.113 0.482 . . . . 0.0 110.497 179.155 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 51.7 tp -113.01 125.14 54.08 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.885 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.7 m -104.7 133.44 48.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.42 -178.94 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.9 m -83.03 143.81 30.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.771 -179.268 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.411 HG22 HD13 ' A' ' 10' ' ' ILE . 97.2 mt -116.88 140.98 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.464 177.687 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -92.32 156.54 17.18 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.587 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.04 -15.87 37.24 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.779 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.6 p -77.16 -19.53 56.7 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.103 178.131 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.57 14.02 42.32 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.48 178.984 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.4 m -113.15 144.48 20.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.023 0.44 . . . . 0.0 111.101 -179.891 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 17' ' ' GLY . 61.9 t0 -80.1 130.47 35.27 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.999 -179.363 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.462 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -116.84 -122.55 3.35 Favored Glycine 0 CA--C 1.535 1.334 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 -179.803 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -71.97 151.77 56.67 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 121.737 1.625 . . . . 0.0 112.653 -178.913 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -108.28 151.65 25.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.989 0.423 . . . . 0.0 110.344 -179.508 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -120.09 96.91 49.4 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.478 -179.066 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.57 137.26 20.28 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 121.024 1.15 . . . . 0.0 111.686 -179.252 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.1 mt -99.21 120.76 40.05 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 119.884 -0.726 . . . . 0.0 111.848 -178.717 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.7 p -122.4 -0.46 9.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.64 178.366 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 63.6 mt -105.85 149.34 26.6 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.994 -179.054 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.3 p -69.39 -21.0 63.81 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.984 -179.397 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 42.8 m -128.8 131.96 47.82 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.056 -179.829 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.486 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -132.85 126.38 32.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.274 178.205 . . . . . . . . 3 3 . 1 . 099 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 33.3 tp -122.23 133.23 54.71 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.973 -178.056 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.505 ' O ' ' O ' ' A' ' 47' ' ' GLN . 51.0 m-85 -106.06 138.19 42.68 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.323 -0.853 . . . . 0.0 108.925 178.808 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 155.04 -172.85 33.38 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 120.381 -0.914 . . . . 0.0 111.731 179.181 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.42 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 46.7 mtm105 -81.32 -31.27 33.61 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -179.467 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.506 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -48.06 148.36 4.05 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.706 -179.004 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.437 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 9.9 tp -65.79 -43.45 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 120.695 0.283 . . . . 0.0 111.037 179.733 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.437 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 81.8 tt0 -59.39 -18.38 38.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.416 -179.736 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 33.4 m -57.84 126.81 29.02 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.739 -179.327 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.524 ' CG ' HE22 ' B' ' 265' ' ' GLN . 50.1 m-20 -62.59 -33.9 75.9 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.523 -179.606 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 40.6 mm -119.87 111.33 32.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 177.312 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.407 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 85.2 mtp180 -99.23 132.45 44.54 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 120.681 -0.407 . . . . 0.0 110.225 -179.403 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 80.7 mt -122.71 131.76 72.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.803 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -82.31 32.95 0.4 Allowed 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -177.859 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 70.3 mt -96.1 131.11 29.49 Favored Pre-proline 0 N--CA 1.469 0.483 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.121 178.992 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -73.4 -14.46 25.23 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.169 1.913 . . . . 0.0 112.156 179.672 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.3 m -93.07 7.14 5.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.602 179.931 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.42 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 24.3 t -101.37 134.46 41.57 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.482 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.5 m -71.84 168.14 18.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.282 0.563 . . . . 0.0 111.14 -179.131 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -60.91 -39.15 88.26 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.114 -178.98 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.602 ' O ' ' N ' ' A' ' 49' ' ' CYS . 13.4 mm100 -112.47 -18.07 12.52 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.619 0.247 . . . . 0.0 110.725 -179.828 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 23.3 t60 36.66 -75.9 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 179.634 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.602 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.1 OUTLIER -136.68 139.19 41.8 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.796 -178.581 . . . . . . . . 3 3 . 1 . 099 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -124.65 139.11 54.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.848 179.572 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 17.3 tt -128.95 138.29 54.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.143 179.959 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -117.22 137.84 52.1 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.015 179.144 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.7 mm -103.36 124.26 57.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.514 0.673 . . . . 0.0 111.159 -179.318 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.474 ' O ' ' N ' ' A' ' 56' ' ' GLN . 50.3 m-70 -125.41 132.15 52.81 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.17 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.473 ' C ' ' O ' ' A' ' 54' ' ' HIS . 97.7 mt-10 -39.59 -30.56 0.07 Allowed 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.125 -178.8 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.474 ' N ' ' O ' ' A' ' 54' ' ' HIS . 98.6 mt-30 -65.37 -69.9 0.27 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.264 179.33 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -154.88 -159.47 0.95 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.691 -179.777 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -119.71 137.9 53.63 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.864 0.364 . . . . 0.0 110.601 -179.84 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.3 mm -111.61 120.6 62.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.11 179.936 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.7 tp -98.22 126.04 43.53 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.248 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -113.34 136.14 53.09 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.817 -179.412 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.429 HD22 ' HA ' ' A' ' 68' ' ' PRO . 61.2 t-20 -96.21 109.8 22.21 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.98 0.419 . . . . 0.0 111.683 179.915 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -102.38 -9.41 20.33 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.343 179.4 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.22 98.8 9.58 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.821 0.343 . . . . 0.0 111.185 -179.296 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.3 p -78.77 -38.5 38.44 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.967 0.413 . . . . 0.0 109.959 178.729 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.41 -44.57 90.83 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.647 -179.488 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.411 ' CG ' ' H ' ' B' ' 237' ' ' CYS . 89.9 m-20 -139.41 89.56 12.03 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.188 179.897 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.429 ' HA ' HD22 ' A' ' 62' ' ' ASN . 46.4 Cg_exo -54.14 145.59 53.17 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.427 2.085 . . . . 0.0 112.449 -179.675 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.5 m -75.91 143.81 41.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.907 -179.175 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -103.88 142.84 33.7 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.658 179.994 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.48 ' CG2' ' OD1' ' A' ' 86' ' ' ASP . 4.5 p -131.33 135.47 59.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.198 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 51.92 28.95 5.57 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -179.576 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.86 27.45 64.71 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.319 179.995 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.415 ' N ' ' O ' ' A' ' 71' ' ' VAL . 25.5 m -139.9 140.5 36.46 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.86 -179.498 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 51.1 t -68.42 136.96 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -179.309 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.3 pt -110.74 79.68 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.226 0 CA-C-O 121.118 0.485 . . . . 0.0 111.491 179.188 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -61.13 -31.76 71.46 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.918 179.326 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.585 ' N ' ' OE1' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -114.84 159.6 36.79 Favored Pre-proline 0 CA--C 1.517 -0.305 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.766 . . . . . . . . 3 3 . 1 . 099 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -62.49 144.51 94.78 Favored 'Trans proline' 0 C--N 1.294 -2.341 0 C-N-CA 122.462 2.108 . . . . 0.0 111.72 -179.343 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 44.1 t -135.09 138.21 49.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.94 -179.151 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -74.63 137.65 42.39 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.831 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 93.3 mt -91.46 141.0 29.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.177 0.513 . . . . 0.0 112.349 -178.782 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -129.91 154.42 47.34 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.076 179.293 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.626 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 5.8 t60 -53.03 117.21 2.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.71 -179.565 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.38 -22.03 12.42 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 179.56 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 87' ' ' VAL . 59.4 t0 -62.76 130.27 44.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.259 0.552 . . . . 0.0 111.292 -179.873 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.526 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 61.7 t -105.65 133.05 51.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.231 -179.247 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 86.4 mt -103.12 128.74 55.82 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.639 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.8 m -119.06 129.01 54.86 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -178.422 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.674 ' O ' ' N ' ' A' ' 93' ' ' ARG . 98.6 mt -115.84 133.96 60.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 113.974 -1.466 . . . . 0.0 107.826 177.121 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.514 ' C ' ' O ' ' A' ' 90' ' ' ILE . 77.5 mt -19.12 94.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.028 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.42 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 0.4 OUTLIER 80.34 -13.22 0.96 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 177.771 . . . . . . . . 3 3 . 1 . 099 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.674 ' N ' ' O ' ' A' ' 90' ' ' ILE . 88.2 mtt180 -128.4 137.92 52.1 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.564 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 62.6 p -139.27 156.7 46.88 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.396 0.617 . . . . 0.0 110.697 -179.549 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -130.63 127.33 38.73 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.496 -0.775 . . . . 0.0 108.995 179.596 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -94.91 138.15 33.05 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.832 -179.514 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.58 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 83.1 t80 -96.71 126.1 41.64 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.876 -179.087 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -124.81 119.73 29.72 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.828 179.521 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.626 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 59.7 t-20 . . . . . 0 N--CA 1.464 0.242 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.124 -179.462 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo . . . . . 0 N--CA 1.495 1.615 0 N-CA-C 113.654 0.598 . . . . 0.0 113.654 . . . . . . . . . 0 0 . 1 . 099 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 38.8 t -61.77 137.47 23.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.461 179.213 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . 0.411 ' H ' ' CG ' ' A' ' 67' ' ' ASN . 0.7 OUTLIER . . . . . 0 C--N 1.326 -0.452 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.263 -178.902 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo . . . . . 0 N--CA 1.49 1.305 0 N-CA-C 111.601 -0.192 . . . . 0.0 111.601 . . . . . . . . . 0 0 . 1 . 099 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 94.7 m -72.89 -46.05 54.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.952 179.095 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -59.33 -45.63 90.83 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.579 -178.528 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 77.4 mt -65.32 -44.31 88.22 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.992 -179.178 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -62.48 -41.01 98.49 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.558 -179.098 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -63.84 -46.33 85.55 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.311 -179.251 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . . . . . . . . . 57.1 ttm-85 -64.82 -42.95 94.57 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.133 -179.246 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -63.27 -39.11 93.68 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.37 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 38.7 t -63.53 -44.98 92.64 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.674 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -58.61 -37.23 75.42 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.815 -179.687 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.533 0.291 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.896 179.839 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . 0.538 ' OE1' ' N ' ' B' ' 260' ' ' GLU . 56.8 mp0 . . . . . 0 C--O 1.233 0.195 0 CA-C-O 121.146 0.498 . . . . 0.0 111.551 . . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 72.1 mt -109.81 137.98 39.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.705 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 55.2 t -127.42 134.45 65.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 C-N-CA 120.202 -0.599 . . . . 0.0 111.239 -178.506 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -93.7 118.01 30.83 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.379 -178.861 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -67.02 -46.94 72.94 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.61 179.751 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . 0.524 HE22 ' CG ' ' A' ' 36' ' ' ASP . 2.1 mp0 -81.6 162.64 57.43 Favored Pre-proline 0 CA--C 1.514 -0.422 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.934 -178.785 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.9 144.49 58.84 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 121.617 1.545 . . . . 0.0 111.643 179.088 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 43.3 pt . . . . . 0 C--N 1.32 -0.717 0 CA-C-O 121.386 0.613 . . . . 0.0 109.43 178.553 . . . . . . . . 0 0 . 1 . 100 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.459 ' H ' ' HG1' ' A' ' 4' ' ' THR . 11.0 p . . . . . 0 CA--C 1.528 0.107 0 CA-C-O 121.023 0.439 . . . . 0.0 109.943 . . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.742 ' NH1' ' HH ' ' A' ' 97' ' ' TYR . 92.2 mtt-85 -92.47 124.08 36.25 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.268 -179.177 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -130.15 139.57 50.86 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.551 -179.877 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 33.5 tp -115.95 130.91 57.03 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.274 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.3 m -111.25 134.32 53.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 C-N-CA 120.744 -0.383 . . . . 0.0 110.77 -179.779 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.5 m -95.02 117.87 30.89 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -177.817 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.6 mt -80.94 144.27 10.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.13 178.443 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -92.64 163.8 13.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.755 178.8 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.625 ' CZ ' HH11 ' B' ' 245' ' ' ARG . 83.1 mtp180 -55.47 -30.54 60.77 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.885 -179.191 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 95.8 p -79.95 -7.58 58.86 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 120.666 -0.413 . . . . 0.0 111.521 -179.983 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.39 35.11 8.16 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.853 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.6 t -121.46 133.62 67.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.86 0.362 . . . . 0.0 110.626 -179.671 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -73.95 135.48 43.23 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 178.788 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.5 -116.95 1.93 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 120.412 -0.899 . . . . 0.0 111.699 -179.603 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -68.37 142.13 53.65 Favored 'Trans proline' 0 N--CA 1.49 1.276 0 C-N-CA 121.593 1.528 . . . . 0.0 112.545 -178.665 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 49.4 m170 -106.15 142.68 35.43 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.269 -179.377 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -113.32 93.32 26.01 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.272 -179.673 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -62.45 126.82 19.28 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 121.713 1.608 . . . . 0.0 110.387 179.7 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.6 mt -86.75 51.75 2.32 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.406 -178.719 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 88.9 p -61.67 -23.64 66.22 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.198 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 92.6 mt -77.61 139.03 39.45 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.264 179.36 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 99.3 p -66.4 -16.86 64.41 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.837 -178.461 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 61.8 m -138.83 138.44 37.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.565 0.222 . . . . 0.0 110.669 179.998 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.682 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -138.2 133.53 33.36 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.987 0.423 . . . . 0.0 110.69 179.205 . . . . . . . . 3 3 . 1 . 100 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 34.7 tp -123.04 131.45 53.71 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.745 -178.056 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.682 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 8.2 m-85 -107.2 141.95 37.69 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.115 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 158.5 -175.66 35.56 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.92 179.169 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.601 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 86.8 mtm-85 -74.94 -27.34 60.16 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 122.659 -0.318 . . . . 0.0 110.928 -179.935 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.566 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -59.14 138.05 49.83 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.154 -177.925 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.437 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 10.0 tp -66.51 -41.56 88.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.721 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.437 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 84.4 tt0 -51.93 -19.0 1.55 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.376 178.854 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.566 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 13.8 m -67.91 137.77 55.48 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.568 179.209 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -60.74 -33.77 73.42 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -179.251 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 96.8 mt -127.26 124.72 64.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.247 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.406 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 78.4 ttt-85 -109.34 134.23 52.07 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.115 -178.579 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 82.0 mt -116.45 130.59 71.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.929 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -78.82 26.04 0.25 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.792 -178.056 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.439 ' CD2' ' OE1' ' B' ' 260' ' ' GLU . 31.5 mt -95.37 125.96 47.86 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.977 179.947 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.69 -14.33 33.06 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.555 2.17 . . . . 0.0 113.056 -179.786 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.3 m -93.83 6.05 6.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.92 0.39 . . . . 0.0 110.7 -179.698 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.601 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 57.5 t -100.71 134.57 40.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.429 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.45 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 0.2 OUTLIER -66.07 167.71 9.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.165 0.507 . . . . 0.0 112.023 -178.658 . . . . . . . . 3 3 . 1 . 100 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -60.21 -42.67 95.62 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.664 -179.676 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.728 ' O ' ' N ' ' A' ' 49' ' ' CYS . 85.0 mt-30 -111.64 -12.15 13.93 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.463 179.675 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.45 ' H ' ' HB3' ' A' ' 45' ' ' SER . 27.7 t60 32.94 -68.17 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -179.852 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.728 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -142.87 143.87 32.25 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.202 -0.599 . . . . 0.0 112.152 -179.464 . . . . . . . . 3 3 . 1 . 100 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -125.18 137.62 54.14 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.832 179.436 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.8 tt -125.09 138.08 55.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.072 0.463 . . . . 0.0 110.128 -179.724 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -122.8 135.07 54.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.284 -179.463 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.7 mt -109.88 117.04 53.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.61 0.719 . . . . 0.0 111.949 -179.602 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.555 ' O ' ' N ' ' A' ' 56' ' ' GLN . 94.9 m-70 -116.37 142.52 46.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.475 -1.239 . . . . 0.0 110.351 -179.981 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 54' ' ' HIS . 80.8 mm-40 -39.88 -24.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.993 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.555 ' N ' ' O ' ' A' ' 54' ' ' HIS . 59.5 tt0 -69.47 -67.57 0.47 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.272 178.613 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.494 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 6.0 tp10 -161.12 -158.87 0.61 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.23 179.237 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.429 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -114.39 125.06 53.42 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.816 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.2 mt -114.12 130.91 67.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.129 0.49 . . . . 0.0 111.883 -178.447 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 56.5 tp -99.85 129.05 45.9 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.717 -179.391 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -113.59 136.72 52.5 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.542 179.65 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.413 ' ND2' ' HB3' ' A' ' 68' ' ' PRO . 29.9 t30 -95.28 108.79 20.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.04 0.447 . . . . 0.0 111.777 -179.962 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -98.78 -8.51 25.83 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.739 179.182 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.7 t -81.2 105.84 12.72 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.263 179.721 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.7 p -87.36 -20.36 26.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.244 0.545 . . . . 0.0 109.668 179.567 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -86.32 -33.58 20.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.196 -179.642 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 -150.84 93.95 3.64 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.17 179.926 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.413 ' HB3' ' ND2' ' A' ' 62' ' ' ASN . 32.2 Cg_exo -56.73 149.29 60.38 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.165 1.91 . . . . 0.0 112.009 -179.801 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 51.9 m -73.57 137.41 44.31 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.04 178.846 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -98.0 141.16 31.3 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.59 -179.768 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 51.8 t -126.45 134.11 67.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.21 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 51.65 33.18 10.35 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.974 -0.69 . . . . 0.0 109.416 -179.099 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.66 29.97 69.06 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.659 179.81 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.4 m -140.6 135.37 31.69 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 117.001 0.401 . . . . 0.0 111.142 -179.912 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.7 t -69.1 136.74 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.725 -179.606 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.55 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 1.1 pt -104.96 100.4 10.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-O 121.361 0.6 . . . . 0.0 110.677 178.959 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -65.45 -35.47 81.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.311 179.166 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -123.66 175.99 2.48 Favored Pre-proline 0 CA--C 1.536 0.404 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.548 -179.008 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.01 145.34 96.74 Favored 'Trans proline' 0 N--CA 1.501 1.926 0 C-N-CA 122.575 2.183 . . . . 0.0 111.954 -179.443 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.5 m -136.01 138.93 46.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.995 0.426 . . . . 0.0 112.14 -179.235 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -76.36 133.14 40.03 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 178.819 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 89.9 mt -89.43 136.01 33.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.413 0.625 . . . . 0.0 112.009 -178.589 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -121.26 148.61 44.06 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.742 179.014 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.714 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 9.2 t60 -54.49 123.04 11.84 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.931 0.396 . . . . 0.0 110.279 -179.577 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.13 -20.28 31.07 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.67 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -66.11 137.62 57.17 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.728 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.2 t -112.6 133.16 59.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.521 -178.368 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 92.2 mt -99.22 130.68 47.82 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 178.7 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 65.9 m -122.45 124.91 44.71 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.067 -0.653 . . . . 0.0 112.067 -178.735 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.514 ' N ' ' O ' ' A' ' 93' ' ' ARG . 77.0 mt -109.53 121.5 62.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.255 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.432 ' C ' ' O ' ' A' ' 90' ' ' ILE . 77.4 mt 35.24 -97.76 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.493 -179.867 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.562 ' OD2' ' NE ' ' B' ' 245' ' ' ARG . 42.0 p-10 -110.73 7.68 22.24 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.666 0.269 . . . . 0.0 111.633 -179.219 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 90' ' ' ILE . 85.6 mtt-85 -124.01 144.4 49.85 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.667 179.916 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.7 p -137.9 151.02 47.59 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.49 0.662 . . . . 0.0 111.056 179.553 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.406 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 35.1 m-85 -124.01 122.11 37.04 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.324 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 74.7 mtp85 -87.85 135.22 33.49 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.851 -178.658 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.742 ' HH ' ' NH1' ' A' ' 5' ' ' ARG . 89.7 t80 -99.25 125.16 44.81 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.629 -179.669 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -143.77 125.46 15.03 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.475 179.472 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.714 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 95.4 m-20 . . . . . 0 C--N 1.331 -0.225 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.567 179.705 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo . . . . . 0 N--CA 1.495 1.614 0 N-CA-C 113.342 0.478 . . . . 0.0 113.342 . . . . . . . . . 0 0 . 1 . 100 nuclear orig core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 71.4 t -58.25 131.09 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.013 -179.806 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 4.5 t . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.644 -179.539 . . . . . . . . 0 0 . 1 . 100 nuclear orig core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo . . . . . 0 N--CA 1.494 1.558 0 CA-C-O 120.745 0.227 . . . . 0.0 111.945 . . . . . . . . . 0 0 . 1 . 100 nuclear orig core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 29.3 m -72.72 -45.76 57.12 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.079 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -58.69 -45.97 88.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.729 -179.872 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 82.1 mt -64.41 -39.04 93.08 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.012 0.434 . . . . 0.0 110.28 -179.899 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -64.08 -39.94 95.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.16 -179.239 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -62.47 -41.42 98.75 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.987 0.422 . . . . 0.0 110.212 179.831 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' B' B ' 245' ' ' ARG . . . . . 0.625 HH11 ' CZ ' ' A' ' 12' ' ' ARG . 14.9 tpp180 -60.86 -42.38 97.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.081 -179.735 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.39 -42.87 98.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.727 179.738 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' B' B ' 247' ' ' SER . . . . . 0.458 ' HG ' ' H ' ' B' ' 248' ' ' GLN . 43.8 p -65.37 -44.01 88.94 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.834 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' B' B ' 248' ' ' GLN . . . . . 0.487 ' HB3' HH22 ' A' ' 12' ' ' ARG . 84.5 mt-30 -64.42 -34.48 78.27 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.919 179.737 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 79.7 t . . . . . 0 N--CA 1.455 -0.219 0 C-N-CA 120.271 -0.572 . . . . 0.0 109.919 179.788 . . . . . . . . 0 0 . 1 . 100 nuclear orig core ' B' B ' 260' ' ' GLU . . . . . 0.439 ' OE1' ' CD2' ' A' ' 41' ' ' LEU . 96.8 mt-10 . . . . . 0 CA--C 1.532 0.257 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 . . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 75.7 mt -117.14 134.27 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 C-N-CA 120.544 -0.462 . . . . 0.0 109.911 179.587 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 45.8 t -127.06 133.61 67.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.066 179.549 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -98.76 122.15 41.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.088 0.471 . . . . 0.0 111.857 -178.499 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -66.17 -43.11 87.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.134 178.356 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -102.2 174.16 3.06 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.344 -179.699 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -56.56 150.62 50.92 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 122.825 2.35 . . . . 0.0 113.765 179.76 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 34.2 pt . . . . . 0 C--N 1.332 -0.165 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.164 179.153 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo . . . . . 0 N--CA 1.493 1.476 0 CA-C-O 120.956 0.315 . . . . 0.0 112.25 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 65.7 p -88.87 -42.86 11.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.839 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.8 mtt85 -89.0 126.91 35.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.647 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -127.48 138.52 52.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.795 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 24.3 tp -117.21 131.63 56.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.023 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.2 t -108.98 131.9 58.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.681 0.276 . . . . 0.0 110.708 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.6 m -82.15 133.18 35.25 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.395 0.617 . . . . 0.0 112.206 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 92.8 mt -103.78 137.61 31.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.619 177.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -97.83 160.03 14.56 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.99 -178.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -58.14 -25.57 61.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.299 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.1 p -79.64 -13.69 59.32 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.582 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.81 19.73 33.44 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.002 -0.618 . . . . 0.0 111.772 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.5 m -115.94 135.67 55.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -76.1 141.06 42.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.828 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -123.25 -118.17 2.41 Favored Glycine 0 CA--C 1.542 1.728 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.795 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -72.04 147.96 49.88 Favored 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 122.415 2.077 . . . . 0.0 112.8 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -108.06 150.07 27.64 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.172 0.51 . . . . 0.0 110.768 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -119.56 111.64 36.13 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.898 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.12 123.64 6.27 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.555 1.503 . . . . 0.0 111.259 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 82.1 mt -77.65 52.49 1.0 Allowed 'General case' 0 C--O 1.233 0.196 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.665 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.6 t -62.06 -42.16 98.9 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.101 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.6 mt -69.1 146.51 52.5 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 58.4 p -67.45 -16.57 64.3 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.496 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 90.2 m -131.23 133.89 45.91 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.414 -0.514 . . . . 0.0 111.542 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.8 t -124.33 116.05 21.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.446 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 56.9 tp -114.66 124.86 52.89 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.85 0.357 . . . . 0.0 111.422 -178.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.537 ' O ' ' O ' ' A' ' 47' ' ' GLN . 22.7 m-85 -104.5 141.31 36.61 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.518 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 156.59 -173.08 34.36 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.25 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.545 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 27.2 mtm180 -80.0 -27.74 39.55 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.055 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.532 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -56.18 137.78 46.58 Favored Glycine 0 CA--C 1.521 0.453 0 C-N-CA 120.186 -1.007 . . . . 0.0 110.695 -178.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.402 ' C ' ' H ' ' A' ' 35' ' ' CYS . 10.6 tp -65.18 -40.12 87.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.671 -0.412 . . . . 0.0 109.99 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -53.99 -13.54 0.81 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.256 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.532 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 37.8 m -71.24 138.25 49.3 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.513 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.496 ' OD2' ' O ' ' A' ' 26' ' ' THR . 56.0 m-20 -61.55 -34.28 75.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.443 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 94.2 mt -127.59 122.56 59.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 13.2 ttp180 -111.86 137.25 50.07 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.418 -178.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 94.6 mt -120.63 130.31 74.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.9 pt20 -81.74 38.4 0.51 Allowed 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.607 ' CD1' ' CZ ' ' A' ' 93' ' ' ARG . 39.9 mt -103.08 132.72 20.86 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.91 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.89 -11.37 30.54 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.459 2.106 . . . . 0.0 113.214 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.1 m -96.32 4.56 9.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.898 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.545 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 44.1 t -96.23 133.97 35.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.975 0.417 . . . . 0.0 110.562 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.2 m -70.93 165.51 23.19 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.825 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.0 mttm -63.23 -39.18 93.87 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.661 -178.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.695 ' O ' ' N ' ' A' ' 49' ' ' CYS . 86.4 mt-30 -113.92 -16.08 12.25 Favored 'General case' 0 C--O 1.227 -0.128 0 O-C-N 123.31 0.381 . . . . 0.0 111.247 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 28.7 t60 34.26 -74.13 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.695 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.52 138.96 46.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.129 0.49 . . . . 0.0 111.962 -179.025 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -127.56 130.93 49.96 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.877 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.9 mt -114.62 132.81 62.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.602 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -118.65 123.27 44.54 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.8 mt -106.44 117.06 51.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.019 -0.672 . . . . 0.0 112.345 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.431 ' O ' ' C ' ' A' ' 55' ' ' GLU . 81.0 m-70 -114.15 145.17 42.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.233 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 54' ' ' HIS . 96.3 mt-10 -40.5 -31.8 0.17 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.339 0.59 . . . . 0.0 109.471 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.516 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 58.6 tt0 -63.9 -68.6 0.33 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.162 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.516 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 5.1 tp10 -157.38 -170.24 3.17 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.287 -178.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.424 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -109.45 125.97 53.0 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.6 mt -116.63 130.21 71.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.235 0.54 . . . . 0.0 111.857 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 19.4 tp -101.39 126.25 48.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.841 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -110.14 136.64 49.06 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.966 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.439 HD22 ' HA ' ' A' ' 68' ' ' PRO . 64.7 t-20 -96.48 105.48 17.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.684 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -97.63 -7.47 31.01 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.56 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 t -77.01 99.64 5.37 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.012 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.4 m -86.83 -18.18 31.6 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.88 -43.35 11.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.52 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -135.31 91.64 18.73 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.803 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.439 ' HA ' HD22 ' A' ' 62' ' ' ASN . 47.3 Cg_exo -56.24 145.51 76.78 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.193 1.929 . . . . 0.0 113.408 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 18.9 m -79.39 137.17 37.19 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.84 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -102.0 141.37 34.95 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.017 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 93.1 t -132.21 134.33 59.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.425 HD22 ' CG ' ' A' ' 86' ' ' ASP . 75.1 m-20 50.92 32.87 7.89 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.219 0.533 . . . . 0.0 109.593 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.93 29.56 60.69 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.135 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 31.0 t -148.97 143.83 26.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 117.439 0.619 . . . . 0.0 111.335 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 62.1 t -69.38 143.16 15.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.465 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.1 pt -113.89 68.46 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.223 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -52.12 -27.69 15.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.662 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -120.74 169.57 8.6 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.549 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -60.28 143.14 99.51 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 122.354 2.036 . . . . 0.0 112.23 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.9 m -139.57 139.31 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-O 120.83 0.348 . . . . 0.0 111.223 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -75.51 131.82 40.34 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 92.3 mt -79.51 139.79 37.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.089 0.471 . . . . 0.0 111.086 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -127.87 144.9 51.09 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.748 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.443 ' CE1' ' H ' ' A' ' 99' ' ' ASN . 3.4 t-160 -54.54 117.67 3.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.924 0.392 . . . . 0.0 110.088 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.67 -14.75 27.06 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.074 -0.811 . . . . 0.0 111.074 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.425 ' CG ' HD22 ' A' ' 72' ' ' ASN . 17.3 m-20 -74.84 133.47 41.88 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.049 0.452 . . . . 0.0 110.316 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 49.4 t -112.38 133.68 57.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.676 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 89.6 mt -93.09 129.99 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 177.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 51.6 m -118.17 125.37 50.07 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.717 0.77 . . . . 0.0 112.43 -178.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.57 ' N ' ' O ' ' A' ' 93' ' ' ARG . 87.0 mt -116.62 123.08 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 114.505 -1.225 . . . . 0.0 108.505 178.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.453 ' CG2' ' N ' ' A' ' 92' ' ' ASP . 94.6 mt 33.24 -101.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.463 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.453 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 82.6 m-20 -105.86 7.02 32.06 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.64 0.257 . . . . 0.0 111.599 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.607 ' CZ ' ' CD1' ' A' ' 41' ' ' LEU . 40.7 mtm-85 -125.07 142.21 51.63 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.716 -178.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 51.0 m -139.51 157.32 46.04 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.499 -0.481 . . . . 0.0 110.617 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -125.96 120.47 30.45 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.655 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 44.4 ttm180 -80.35 127.08 31.96 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.251 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -92.56 125.7 37.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.805 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -121.6 127.41 50.85 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.263 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.443 ' H ' ' CE1' ' A' ' 84' ' ' HIS . 49.4 t-20 -101.96 111.72 24.09 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.654 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 . . . . . 0 C--N 1.322 -0.591 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.749 179.84 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 44.1 t . . . . . 0 N--CA 1.465 0.306 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.581 ' C ' ' H ' ' B' ' 231' ' ' GLN . 81.0 m-20 -65.78 142.18 58.06 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.237 0.541 . . . . 0.0 111.743 -178.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.581 ' H ' ' C ' ' B' ' 229' ' ' ASP . 78.0 mt-30 -128.53 30.04 5.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.615 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -111.06 -152.5 12.57 Favored Glycine 0 CA--C 1.533 1.211 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -76.9 161.28 33.32 Favored 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 123.067 2.512 . . . . 0.0 113.342 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -70.56 134.09 25.54 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 121.418 1.412 . . . . 0.0 112.809 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 53.5 t -57.79 142.83 12.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.659 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 5.1 t -71.82 129.89 39.74 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . 0.405 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . 0.405 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 52.5 Cg_exo -56.19 -29.22 74.63 Favored 'Trans proline' 0 N--CA 1.5 1.881 0 C-N-CA 123.011 2.474 . . . . 0.0 112.838 -178.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 70.2 m -69.37 -47.17 65.09 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.526 -0.47 . . . . 0.0 109.787 178.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -59.97 -46.67 88.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.624 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 94.5 mt -63.27 -41.29 99.01 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.821 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -65.18 -39.66 93.19 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.009 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -61.97 -41.8 98.41 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.074 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.528 ' NH2' ' CD2' ' A' ' 41' ' ' LEU . 24.9 mmt180 -63.3 -43.15 98.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.676 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -62.68 -41.98 99.39 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.482 -0.487 . . . . 0.0 109.863 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 5.3 t -65.15 -44.86 87.21 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 69.4 tp60 -57.43 -41.16 79.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.778 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 21.5 t -61.52 -42.89 95.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -63.18 -34.76 78.32 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.669 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -79.24 -10.71 59.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.459 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 82.4 mt -102.87 -177.55 3.41 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.568 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . 0.55 ' O ' ' N ' ' B' ' 255' ' ' ASP . 67.7 m-80 -154.89 -164.54 1.82 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.831 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -45.44 -14.58 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.264 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . 0.55 ' N ' ' O ' ' B' ' 253' ' ' ASN . 97.5 m-20 -65.09 -12.17 47.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.948 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.659 ' O ' ' N ' ' B' ' 258' ' ' ASP . 94.7 m-20 -48.76 -34.44 12.22 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.924 179.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . 0.498 ' C ' ' O ' ' B' ' 256' ' ' ASP . 88.5 tttt -20.19 -41.38 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 O-C-N 123.928 0.767 . . . . 0.0 111.486 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.659 ' N ' ' O ' ' B' ' 256' ' ' ASP . 93.0 m-20 -100.12 62.19 1.11 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 177.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.539 ' N ' ' O ' ' B' ' 256' ' ' ASP . 41.7 m-20 -50.61 -113.67 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.845 -177.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -151.72 22.54 0.69 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.255 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 56.5 mt -112.74 134.5 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 53.4 t -122.86 133.32 69.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -96.84 119.54 35.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.243 0.544 . . . . 0.0 111.018 -178.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -67.34 -45.67 75.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.249 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.68 158.18 34.82 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.437 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -60.58 150.32 82.37 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 122.873 2.382 . . . . 0.0 112.478 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 42.9 pt . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 121.581 0.705 . . . . 0.0 111.587 -179.319 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo . . . . . 0 N--CA 1.496 1.647 0 CA-C-O 120.734 0.222 . . . . 0.0 111.808 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.0 p -106.8 -42.23 5.0 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.707 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 89.2 mtm-85 -87.18 121.77 30.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.346 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -126.26 134.75 51.09 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.679 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 36.4 tp -115.81 130.94 57.04 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.3 t -108.9 131.77 58.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.474 -179.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 m -92.21 114.01 26.43 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 121.13 0.49 . . . . 0.0 111.819 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.425 HG23 HD11 ' A' ' 10' ' ' ILE . 96.8 mt -81.32 146.09 7.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.151 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -92.71 157.7 16.31 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.768 HH12 HE21 ' B' ' 248' ' ' GLN . 87.8 mtm180 -59.91 -21.97 61.79 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.741 -0.383 . . . . 0.0 110.469 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.1 m -80.76 -12.01 59.52 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.1 35.51 8.11 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.9 t -120.72 134.31 64.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.667 0.27 . . . . 0.0 110.869 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -66.41 118.77 10.53 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.409 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -108.29 -130.84 6.31 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.196 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.03 148.34 39.88 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 122.546 2.164 . . . . 0.0 113.321 -178.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 65.0 m170 -104.03 140.0 38.36 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.115 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -111.7 97.87 38.89 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.505 -0.771 . . . . 0.0 108.958 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.46 127.04 12.11 Favored 'Trans proline' 0 C--N 1.314 -1.24 0 C-N-CA 121.194 1.263 . . . . 0.0 110.922 -178.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 92.8 mt -84.51 81.33 8.89 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.625 0.726 . . . . 0.0 110.563 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 91.1 p -86.72 -9.29 56.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.467 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.0 mt -102.6 145.35 29.77 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.008 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.6 t -65.09 -16.2 63.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.333 -178.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.07 132.63 42.0 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.972 0.415 . . . . 0.0 111.803 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.8 t -123.35 117.58 25.55 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.658 178.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 39.3 tp -115.55 127.4 55.24 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 120.702 0.287 . . . . 0.0 111.35 -178.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.488 ' O ' ' O ' ' A' ' 47' ' ' GLN . 8.4 m-85 -107.62 142.69 37.17 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.504 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 153.97 -170.36 32.58 Favored Glycine 0 N--CA 1.467 0.75 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.966 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.631 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 81.4 mtm-85 -84.0 -31.34 25.53 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.952 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.562 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -53.48 148.65 15.28 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.142 -178.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.436 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 10.1 tp -68.38 -42.82 84.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.801 0.334 . . . . 0.0 110.454 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.436 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 51.6 tp10 -53.09 -19.89 3.23 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.562 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 5.3 m -66.8 124.95 24.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.821 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -59.5 -27.41 66.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.312 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.454 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 97.7 mt -128.45 121.14 54.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.831 178.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 74.1 mtm180 -100.4 135.45 41.82 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.492 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.431 HG23 ' NE ' ' A' ' 93' ' ' ARG . 99.4 mt -119.99 131.8 71.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.458 0.647 . . . . 0.0 110.57 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -78.78 28.22 0.21 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.999 -1.0 . . . . 0.0 112.987 -178.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.434 ' HG ' ' HE ' ' A' ' 93' ' ' ARG . 7.3 mt -105.97 104.69 50.48 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 120.539 -0.465 . . . . 0.0 109.804 178.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -53.84 -8.74 0.96 Allowed 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 122.417 2.078 . . . . 0.0 113.254 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.9 m -95.62 3.69 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.637 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.631 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 5.9 p -95.45 138.23 21.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.88 162.54 18.8 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.487 0.66 . . . . 0.0 111.527 -179.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt -62.94 -40.55 97.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.433 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.676 ' O ' ' N ' ' A' ' 49' ' ' CYS . 15.1 mm100 -109.47 -13.28 14.6 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.381 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 25.8 t60 35.88 -73.31 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.288 -0.869 . . . . 0.0 113.163 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.676 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -149.35 149.76 31.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.19 0.519 . . . . 0.0 111.661 -179.564 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -135.85 134.9 39.32 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.675 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 89.4 mt -105.81 133.39 50.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.024 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -111.71 120.37 41.79 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 91.3 mt -104.46 110.02 29.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.581 0.705 . . . . 0.0 111.613 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.468 ' O ' ' N ' ' A' ' 56' ' ' GLN . 95.0 m-70 -112.19 144.37 41.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.644 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 54' ' ' HIS . 83.7 tt0 -41.18 -28.35 0.09 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.468 ' N ' ' O ' ' A' ' 54' ' ' HIS . 99.7 mm-40 -66.53 -68.82 0.34 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.151 178.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -158.75 -169.69 2.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.479 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -108.43 124.61 50.67 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.509 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 98.9 mt -115.58 129.32 72.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.084 0.468 . . . . 0.0 112.059 -178.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 43.9 tp -94.51 124.18 38.38 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.973 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -108.82 132.1 54.33 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.865 0.364 . . . . 0.0 110.019 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.407 HD22 ' HA ' ' A' ' 68' ' ' PRO . 33.5 t-20 -94.32 105.04 17.02 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.813 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -96.31 -6.56 37.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.033 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.2 t -85.58 97.58 10.16 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.199 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 77.5 p -78.09 -33.59 50.61 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 177.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.7 m -63.68 -46.25 86.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.817 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -142.48 95.98 6.41 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.777 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.407 ' HA ' HD22 ' A' ' 62' ' ' ASN . 52.7 Cg_exo -54.49 144.45 62.47 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 121.877 1.718 . . . . 0.0 112.122 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 33.0 m -72.09 138.07 47.52 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.128 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -100.98 139.28 36.88 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.642 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 70.8 t -129.97 135.42 61.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 52.43 32.87 11.98 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 119.774 -0.77 . . . . 0.0 109.063 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.23 27.85 69.25 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.611 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 34.4 t -142.23 137.32 30.65 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 117.671 0.736 . . . . 0.0 111.91 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -69.18 143.6 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.511 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.562 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 1.2 pt -113.47 108.1 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 121.564 0.697 . . . . 0.0 110.553 178.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -70.8 -31.62 68.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.282 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.485 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -129.38 -179.35 0.98 Allowed Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.752 -179.588 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 24.7 Cg_exo -62.6 146.94 95.41 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 122.779 2.32 . . . . 0.0 112.061 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.8 p -140.12 141.69 33.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.019 0.438 . . . . 0.0 111.164 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -76.56 133.44 39.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.724 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 98.3 mt -88.93 139.14 30.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.206 0.527 . . . . 0.0 111.501 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.405 ' N ' ' OD2' ' A' ' 86' ' ' ASP . 99.4 mttt -123.2 149.76 44.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.803 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.772 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 8.1 t60 -54.39 121.92 9.33 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.125 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.8 -13.24 38.41 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.405 ' OD2' ' N ' ' A' ' 83' ' ' LYS . 84.3 m-20 -68.88 136.58 52.85 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.056 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.401 ' CG1' ' OG ' ' A' ' 94' ' ' SER . 70.3 t -109.14 131.56 59.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.422 -178.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 25.7 mm -93.37 129.58 43.62 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 178.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.0 m -120.42 123.88 44.1 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.104 -0.639 . . . . 0.0 112.205 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.655 ' CG2' HH12 ' A' ' 93' ' ' ARG . 94.9 mt -122.61 126.75 74.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.367 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.454 ' C ' ' O ' ' A' ' 90' ' ' ILE . 47.9 mm 35.34 -105.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 121.041 -0.264 . . . . 0.0 111.246 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.477 ' OD1' ' CD2' ' B' ' 242' ' ' LEU . 87.8 m-20 -109.12 16.4 22.55 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.747 0.308 . . . . 0.0 111.064 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.655 HH12 ' CG2' ' A' ' 90' ' ' ILE . 1.8 mtm105 -126.39 144.57 50.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.073 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.401 ' OG ' ' CG1' ' A' ' 87' ' ' VAL . 47.4 t -138.7 148.73 44.31 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 178.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.48 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 27.3 m-85 -125.6 125.11 42.63 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.659 -179.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 78.4 mtp85 -85.91 128.02 34.74 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.433 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.559 ' CZ ' ' OD1' ' A' ' 99' ' ' ASN . 92.0 t80 -95.41 127.17 41.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.945 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -138.67 124.6 19.96 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.222 -0.591 . . . . 0.0 111.969 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.772 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 96.9 m-20 -100.83 107.21 18.69 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.107 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.492 ' O ' ' O ' ' A' ' 99' ' ' ASN . 46.3 tt0 . . . . . 0 C--N 1.327 -0.371 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.531 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 14.4 p . . . . . 0 CA--C 1.53 0.185 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.464 ' C ' ' H ' ' B' ' 231' ' ' GLN . 67.1 t0 -45.64 128.37 8.37 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.982 0.42 . . . . 0.0 111.44 -179.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . 0.443 ' N ' ' OD1' ' B' ' 229' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.49 ' O ' ' O ' ' B' ' 232' ' ' GLY . 71.0 mt-30 -114.2 -27.38 7.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.155 0.502 . . . . 0.0 109.808 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . 0.49 ' O ' ' O ' ' B' ' 231' ' ' GLN . . . -45.44 -177.19 0.01 OUTLIER Glycine 0 CA--C 1.53 1.004 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.19 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -70.6 162.07 43.8 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 123.891 3.061 . . . . 0.0 113.136 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.22 138.22 24.75 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 121.679 1.586 . . . . 0.0 113.115 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -67.37 139.89 20.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.327 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 6.3 t -73.8 133.19 43.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.016 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . 0.441 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . 0.441 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 31.7 Cg_exo -60.1 -25.99 81.28 Favored 'Trans proline' 0 N--CA 1.504 2.093 0 C-N-CA 123.224 2.616 . . . . 0.0 113.842 -178.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 240' ' ' THR . . . . . 0.421 ' OG1' ' O3P' ' B' ' 238' ' ' TPO . 35.4 m -74.61 -43.21 56.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.314 0.578 . . . . 0.0 109.851 178.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . 0.606 ' CZ ' ' NE ' ' B' ' 245' ' ' ARG . 68.7 t80 -59.18 -45.96 89.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.926 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . 0.477 ' CD2' ' OD1' ' A' ' 92' ' ' ASP . 81.6 mt -62.47 -41.73 98.99 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.777 -0.192 . . . . 0.0 111.382 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -65.86 -36.9 84.72 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.676 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -59.63 -42.85 93.63 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.682 ' NH1' HE22 ' B' ' 248' ' ' GLN . 2.4 mpt_? -60.64 -41.77 95.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.193 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -60.83 -40.45 92.82 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 16.5 m -64.26 -46.55 83.22 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.622 178.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . 0.768 HE21 HH12 ' A' ' 12' ' ' ARG . 27.1 mt-30 -61.62 -36.48 80.87 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.12 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 42.1 t -61.11 -46.27 96.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.347 -0.541 . . . . 0.0 110.099 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -60.34 -28.98 68.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.962 0.41 . . . . 0.0 110.143 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -95.42 -13.68 24.43 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.794 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' B' ' 248' ' ' GLN . 46.9 tp -74.52 142.12 44.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.098 0.475 . . . . 0.0 111.865 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -101.06 140.04 35.91 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.523 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -64.35 -19.06 65.22 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.315 0.579 . . . . 0.0 109.527 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -65.58 -10.44 35.34 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.926 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.461 ' C ' ' H ' ' B' ' 258' ' ' ASP . 67.7 t0 -93.7 75.3 4.32 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.34 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -67.82 11.53 0.14 Allowed 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -178.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.661 ' O ' ' N ' ' B' ' 260' ' ' GLU . 91.9 m-20 -96.83 1.26 50.47 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.493 ' C ' ' H ' ' B' ' 261' ' ' ILE . 39.0 t70 4.92 54.25 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 114.393 -1.276 . . . . 0.0 113.284 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.661 ' N ' ' O ' ' B' ' 258' ' ' ASP . 57.8 mp0 55.46 4.37 0.1 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . 0.513 ' N ' ' O ' ' B' ' 258' ' ' ASP . 70.8 mt -117.36 134.28 61.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 54.2 t -127.74 135.06 64.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.295 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -95.28 117.69 30.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.217 0.532 . . . . 0.0 111.151 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -65.13 -44.18 89.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.08 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -91.55 150.43 41.1 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.658 -178.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -67.03 146.07 75.85 Favored 'Trans proline' 0 N--CA 1.497 1.678 0 C-N-CA 122.644 2.229 . . . . 0.0 112.697 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 25.1 pt . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.114 179.282 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo . . . . . 0 N--CA 1.497 1.728 0 CA-C-O 121.072 0.363 . . . . 0.0 113.005 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.9 p -110.34 -34.29 6.39 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 120.714 -0.395 . . . . 0.0 111.487 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 87.8 mtm-85 -104.38 125.79 50.91 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.076 0.465 . . . . 0.0 111.638 -178.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -134.04 138.67 45.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.922 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 31.4 tp -113.29 129.62 56.48 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.6 m -107.58 133.52 52.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-O 121.085 0.469 . . . . 0.0 110.681 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.2 m -90.68 115.39 27.74 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.457 -0.792 . . . . 0.0 113.136 -177.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.4 mt -79.02 142.1 14.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 178.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -88.74 157.64 18.44 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.753 HH12 ' NE2' ' B' ' 248' ' ' GLN . 84.2 mtp180 -59.04 -33.07 70.33 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.021 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.7 t -69.91 -18.6 63.39 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.267 0.556 . . . . 0.0 109.849 178.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.82 34.75 4.24 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.6 t -124.95 134.16 67.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.13 0.49 . . . . 0.0 111.517 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -70.11 131.31 44.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.253 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -113.13 -128.04 4.8 Favored Glycine 0 CA--C 1.539 1.545 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.586 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -73.74 154.76 49.2 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.35 2.033 . . . . 0.0 112.625 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.498 ' O ' ' CG2' ' B' ' 267' ' ' ILE . 7.6 m170 -110.01 139.98 44.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.269 0.557 . . . . 0.0 111.177 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -108.6 99.38 33.27 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.014 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.87 128.14 15.51 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 121.19 1.26 . . . . 0.0 111.334 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 72.5 mt -79.06 47.86 0.81 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.301 -178.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 99.5 p -59.1 -24.87 63.32 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 71.0 mt -78.35 139.52 38.8 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.417 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.8 t -66.15 -18.45 65.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.354 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.479 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 85.1 m -133.02 135.17 45.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.813 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.8 t -127.06 115.34 19.03 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.2 tp -114.93 129.88 56.8 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.195 0.522 . . . . 0.0 110.915 -178.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.515 ' O ' ' O ' ' A' ' 47' ' ' GLN . 14.3 m-85 -110.96 135.16 51.89 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.146 -0.933 . . . . 0.0 109.576 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 160.21 -172.06 36.59 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.704 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -81.2 -31.6 33.86 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.705 0.288 . . . . 0.0 110.998 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.529 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -54.9 150.31 18.75 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 111.714 -0.554 . . . . 0.0 111.714 -178.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.404 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 10.9 tp -66.44 -40.05 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-O 120.791 0.329 . . . . 0.0 110.158 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.404 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 96.9 mt-10 -51.72 -27.87 13.27 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.338 -0.545 . . . . 0.0 109.542 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.529 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 14.2 m -57.16 110.99 0.93 Allowed 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.934 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.479 ' OD2' ' O ' ' A' ' 26' ' ' THR . 97.5 m-20 -51.18 -18.75 0.96 Allowed 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.455 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 76.2 mt -134.06 125.77 48.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.94 177.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 71.5 mtm180 -103.46 135.06 45.76 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.612 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 99.2 mt -117.17 129.1 74.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -77.25 25.48 0.17 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -177.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 67.2 mt -96.81 128.06 37.08 Favored Pre-proline 0 N--CA 1.466 0.35 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.554 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -73.22 -9.75 23.58 Favored 'Trans proline' 0 N--CA 1.487 1.132 0 C-N-CA 122.052 1.835 . . . . 0.0 112.848 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.416 HG23 ' CZ ' ' B' ' 241' ' ' PHE . 28.9 m -96.71 4.2 9.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 120.758 0.313 . . . . 0.0 110.582 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 38.1 t -93.08 135.71 27.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.871 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.9 m -70.67 173.01 7.69 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.473 0.654 . . . . 0.0 111.584 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 40.7 mtmt -63.73 -41.66 98.02 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.527 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.614 ' O ' ' N ' ' A' ' 49' ' ' CYS . 86.1 mt-30 -114.52 -20.95 10.55 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.919 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 27.5 t60 37.75 -76.13 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 113.971 1.101 . . . . 0.0 113.971 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.614 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -128.78 133.27 48.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.926 0.393 . . . . 0.0 111.516 -178.621 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -125.66 127.95 47.07 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.31 178.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 94.5 mt -110.25 132.41 58.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -114.5 120.3 39.78 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.3 mt -102.93 114.94 43.95 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 C-N-CA 119.714 -0.794 . . . . 0.0 111.968 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.55 ' O ' ' N ' ' A' ' 56' ' ' GLN . 97.0 m-70 -112.57 141.16 46.66 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.221 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.469 ' C ' ' O ' ' A' ' 54' ' ' HIS . 95.1 mt-10 -39.73 -26.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 -178.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.55 ' N ' ' O ' ' A' ' 54' ' ' HIS . 84.6 mt-30 -66.05 -67.98 0.4 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.948 177.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -161.84 -158.27 0.53 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.479 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -116.71 129.76 56.32 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.575 0.226 . . . . 0.0 110.66 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.438 HG21 HD11 ' A' ' 59' ' ' ILE . 98.2 mt -119.55 131.59 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 121.046 0.451 . . . . 0.0 111.762 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 28.7 tp -99.27 129.34 45.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.977 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -116.48 138.22 51.55 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.825 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 38.2 p-10 -101.89 107.33 18.47 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.629 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -94.27 -11.61 29.82 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.896 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.3 p -77.19 100.75 5.9 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.286 178.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.7 p -73.43 -34.27 65.35 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.11 -40.29 71.55 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.699 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -144.07 90.95 6.63 Favored Pre-proline 0 N--CA 1.467 0.412 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -64.81 149.45 89.61 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 C-N-CA 120.988 1.126 . . . . 0.0 112.089 -179.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.8 m -71.11 151.51 44.4 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.386 0.612 . . . . 0.0 111.776 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -106.7 147.06 30.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.833 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.501 ' CG2' ' OD1' ' A' ' 86' ' ' ASP . 4.8 p -132.88 134.86 57.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 51.75 32.11 9.02 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.185 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.88 27.64 70.26 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.878 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 68.6 m -139.26 142.35 37.78 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.2 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.7 t -75.45 133.3 31.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.381 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.3 pt -101.84 102.12 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.516 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -64.1 -34.42 78.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.492 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.402 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 1.3 mt-10 -129.74 178.49 1.68 Allowed Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.79 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.402 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 31.3 Cg_exo -60.09 143.63 99.53 Favored 'Trans proline' 0 N--CA 1.504 2.09 0 C-N-CA 122.742 2.295 . . . . 0.0 112.469 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.5 p -135.91 138.46 47.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.371 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 83.3 mtm-85 -73.17 129.88 39.02 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.5 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 97.0 mt -83.77 137.41 33.74 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.161 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -129.17 152.98 48.16 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.363 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.609 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 7.5 t60 -53.36 119.18 4.48 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.264 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.64 -14.46 29.73 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 87' ' ' VAL . 59.4 t0 -66.25 130.41 43.14 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.229 0.538 . . . . 0.0 110.623 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.531 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 71.1 t -109.27 130.85 61.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.001 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 87.6 mt -105.78 134.1 48.27 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.6 m -118.21 124.33 47.65 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 121.191 0.519 . . . . 0.0 111.64 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.576 ' N ' ' O ' ' A' ' 93' ' ' ARG . 97.4 mt -114.82 126.08 72.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.417 ' C ' ' O ' ' A' ' 90' ' ' ILE . 36.2 mm 38.28 -109.3 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.697 -179.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.537 ' OD1' ' CD2' ' B' ' 242' ' ' LEU . 98.1 m-20 -107.77 14.61 25.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.501 0.667 . . . . 0.0 110.011 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.644 ' NH2' ' OD2' ' B' ' 259' ' ' ASP . 18.8 mtp85 -126.86 146.95 50.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.298 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 66.4 m -137.69 150.65 47.5 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 121.235 0.54 . . . . 0.0 110.778 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -124.39 122.28 37.23 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.69 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -89.79 135.84 33.39 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 119.378 -0.929 . . . . 0.0 110.685 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -96.75 124.72 40.81 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.431 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -124.79 122.08 36.41 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.609 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 46.3 t30 -118.49 103.87 10.16 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.671 -0.411 . . . . 0.0 111.257 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 . . . . . 0 C--N 1.326 -0.44 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.806 179.415 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . 0.53 ' O ' ' CG2' ' B' ' 228' ' ' VAL . 30.4 m . . . . . 0 CA--C 1.521 -0.142 0 CA-C-O 120.988 0.423 . . . . 0.0 110.876 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.545 ' O ' ' CB ' ' B' ' 230' ' ' SEP . 42.0 p-10 -102.58 3.02 36.9 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.367 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . 0.591 ' O ' ' NE2' ' B' ' 231' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.591 ' NE2' ' O ' ' B' ' 230' ' ' SEP . 87.5 mm-40 -124.98 62.56 1.16 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.251 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -135.35 175.32 20.77 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.684 -178.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.22 160.48 49.7 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 123.396 2.731 . . . . 0.0 112.847 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.29 137.91 45.06 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.258 1.972 . . . . 0.0 113.767 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 24.0 t -67.99 135.08 29.16 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.921 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 16.0 t -68.87 128.58 37.17 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.391 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . 0.439 ' O2P' ' OG1' ' B' ' 240' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . 0.42 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 51.0 Cg_exo -57.49 -26.86 73.72 Favored 'Trans proline' 0 N--CA 1.506 2.236 0 C-N-CA 123.517 2.811 . . . . 0.0 113.905 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 240' ' ' THR . . . . . 0.439 ' OG1' ' O2P' ' B' ' 238' ' ' TPO . 21.2 m -71.64 -45.93 60.55 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.202 0.525 . . . . 0.0 109.933 178.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . 0.416 ' CZ ' HG23 ' A' ' 43' ' ' VAL . 45.9 t80 -58.09 -44.89 87.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.068 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . 0.537 ' CD2' ' OD1' ' A' ' 92' ' ' ASP . 93.7 mt -62.21 -40.81 97.35 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.566 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -61.62 -45.17 95.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.362 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 -62.4 -43.07 99.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.733 0.301 . . . . 0.0 110.995 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.523 ' CZ ' ' NE ' ' A' ' 12' ' ' ARG . 16.1 mmm180 -58.67 -44.88 90.34 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.76 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -63.27 -39.24 94.05 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.874 0.369 . . . . 0.0 110.175 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 38.8 t -65.48 -44.77 86.09 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 122.0 0.905 . . . . 0.0 109.137 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . 0.753 ' NE2' HH12 ' A' ' 12' ' ' ARG . 57.8 tt0 -59.62 -39.76 85.34 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.74 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 26.0 t -59.93 -45.59 94.98 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -59.29 -27.74 66.12 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -86.2 -12.57 49.39 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.666 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 66.7 mt -77.51 148.72 35.15 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.401 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -77.41 163.96 25.91 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.353 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 51.7 p-10 -78.98 -7.88 58.44 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -108.13 20.1 19.12 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.737 -1.119 . . . . 0.0 110.31 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -60.11 136.48 58.03 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.391 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . 0.689 ' O ' ' N ' ' B' ' 259' ' ' ASP . 99.0 mttt -125.29 -137.68 0.27 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.318 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.61 ' C ' ' O ' ' B' ' 257' ' ' LYS . 99.1 m-20 -9.58 74.37 0.0 OUTLIER 'General case' 0 C--N 1.351 0.668 0 O-C-N 124.096 0.872 . . . . 0.0 109.944 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.689 ' N ' ' O ' ' B' ' 257' ' ' LYS . 51.2 p-10 -78.82 80.96 5.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.922 -176.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.472 ' OE1' ' NH1' ' B' ' 245' ' ' ARG . 98.5 mt-10 46.48 2.75 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . 0.573 ' H ' ' C ' ' B' ' 259' ' ' ASP . 78.7 mt -112.38 132.01 62.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 46.0 t -127.5 134.18 66.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.193 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -99.09 123.58 43.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.341 0.591 . . . . 0.0 110.897 -178.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -64.28 -40.6 96.3 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.414 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -95.81 164.67 18.21 Favored Pre-proline 0 N--CA 1.463 0.224 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.254 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -61.27 145.13 98.81 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 122.283 1.989 . . . . 0.0 110.916 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . 0.498 ' CG2' ' O ' ' A' ' 19' ' ' HIS . 2.6 mt . . . . . 0 C--N 1.321 -0.657 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.425 -178.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo . . . . . 0 N--CA 1.492 1.426 0 CA-C-O 120.932 0.305 . . . . 0.0 112.698 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.4 p -89.91 -45.24 9.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.471 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.5 mtt85 -88.28 129.81 35.27 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.249 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -126.09 136.18 52.61 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.27 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 30.6 tp -115.82 132.58 56.6 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.9 t -110.2 132.37 58.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.063 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 m -88.72 114.2 25.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.024 -0.534 . . . . 0.0 112.118 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 95.5 mt -85.13 144.02 10.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -96.09 160.33 14.5 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.503 HH12 ' CD ' ' B' ' 260' ' ' GLU . 94.7 mtm-85 -62.38 -20.2 64.18 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.901 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.0 p -78.58 -16.25 57.63 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 120.592 -0.443 . . . . 0.0 109.909 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.41 17.72 30.56 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.369 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.0 m -115.14 135.63 54.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 117.191 0.496 . . . . 0.0 110.169 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -72.52 142.86 48.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.341 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -126.72 -117.72 2.14 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.499 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.63 146.77 44.26 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.161 1.907 . . . . 0.0 112.129 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.595 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -108.03 138.98 43.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.06 0.457 . . . . 0.0 110.909 -179.69 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -110.1 104.85 56.45 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.955 -178.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.83 130.19 14.29 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.211 1.274 . . . . 0.0 112.016 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.4 mt -83.74 60.27 5.65 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.603 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.3 t -62.83 -40.67 98.15 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 69.9 mt -71.6 144.1 49.59 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.149 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 92.3 p -69.41 -14.06 62.7 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.055 -0.521 . . . . 0.0 112.101 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.407 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 62.6 m -130.42 133.65 46.51 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.38 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.5 t -124.95 115.94 21.39 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 58.5 tp -113.56 130.26 56.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.911 0.386 . . . . 0.0 110.928 -178.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.522 ' O ' ' O ' ' A' ' 47' ' ' GLN . 59.2 m-85 -110.17 136.33 49.56 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.219 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 160.83 -174.26 37.45 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.284 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.581 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 82.3 mtm-85 -79.93 -30.48 39.98 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.552 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -53.4 149.18 13.67 Favored Glycine 0 N--CA 1.467 0.718 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.496 -177.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.437 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 10.5 tp -67.65 -43.24 86.93 Favored 'Isoleucine or valine' 0 C--N 1.341 0.2 0 CA-C-O 120.868 0.366 . . . . 0.0 111.008 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.437 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 81.3 tt0 -56.09 -19.39 12.9 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.825 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.552 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 9.6 m -63.02 126.44 27.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.607 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.407 ' OD2' ' O ' ' A' ' 26' ' ' THR . 89.8 m-20 -61.41 -32.6 72.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.337 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 50.5 mm -123.38 114.58 42.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.195 178.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 47.0 mtm180 -99.72 137.14 38.62 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 121.169 -0.212 . . . . 0.0 110.667 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.441 HG23 HD12 ' A' ' 39' ' ' ILE . 82.2 mt -120.06 131.27 72.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 120.184 -0.606 . . . . 0.0 111.093 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -73.22 28.31 0.06 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.332 -0.849 . . . . 0.0 113.001 -177.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.568 ' CD1' ' NH1' ' A' ' 93' ' ' ARG . 65.9 mt -113.06 130.92 23.1 Favored Pre-proline 0 C--N 1.323 -0.564 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.692 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.84 -9.67 23.98 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 122.262 1.974 . . . . 0.0 112.184 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.1 m -90.86 2.6 7.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.026 0.441 . . . . 0.0 110.017 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.581 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 55.2 t -94.51 132.3 38.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.7 m -71.22 169.2 15.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.562 0.696 . . . . 0.0 111.932 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.48 ' NZ ' ' O ' ' B' ' 232' ' ' GLY . 55.8 mttp -62.46 -41.78 99.0 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.442 -179.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.639 ' O ' ' N ' ' A' ' 49' ' ' CYS . 96.3 mt-30 -116.34 -15.26 10.99 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.281 0.363 . . . . 0.0 110.834 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.0 t60 31.08 -74.25 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.639 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.5 138.34 47.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.212 0.529 . . . . 0.0 112.126 -178.67 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -127.99 133.35 49.16 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.443 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.6 mt -118.25 133.94 63.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.026 0.441 . . . . 0.0 110.705 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.58 ' CD ' ' HE2' ' A' ' 54' ' ' HIS . 85.1 tt0 -121.03 124.07 43.93 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.0 mt -106.54 117.26 51.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.661 0.743 . . . . 0.0 112.914 -178.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.58 ' HE2' ' CD ' ' A' ' 52' ' ' GLU . 94.3 m-70 -110.66 143.3 41.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.098 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 54' ' ' HIS . 83.2 tt0 -40.39 -30.32 0.1 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.278 -0.569 . . . . 0.0 109.807 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.434 ' N ' ' O ' ' A' ' 54' ' ' HIS . 59.9 tt0 -64.11 -67.62 0.42 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -157.21 -169.44 2.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.071 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.75 125.95 54.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.767 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.411 HD11 HG21 ' A' ' 59' ' ' ILE . 96.6 mt -115.48 128.52 72.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.31 0.576 . . . . 0.0 111.933 -178.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 24.9 tp -99.07 132.1 44.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.968 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -115.4 135.83 53.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.528 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.59 ' ND2' ' H ' ' A' ' 69' ' ' THR . 12.3 t-20 -97.17 108.58 21.34 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.929 0.395 . . . . 0.0 111.185 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -100.88 -8.57 22.43 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.263 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.7 t -74.64 98.84 3.5 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.092 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.2 m -74.51 -40.38 61.81 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.25 0.547 . . . . 0.0 110.236 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.54 -43.38 94.16 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.264 -178.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -144.34 97.36 5.17 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.011 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -57.25 149.4 64.54 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.977 1.785 . . . . 0.0 111.858 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.59 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 85.4 m -76.41 156.34 33.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.324 0.583 . . . . 0.0 110.933 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -114.84 139.36 49.82 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.61 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 55.3 t -128.42 136.23 60.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.54 ' ND2' ' OD1' ' A' ' 86' ' ' ASP . 82.2 m-20 53.25 33.36 15.29 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 119.777 -0.769 . . . . 0.0 109.1 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.04 27.38 73.93 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 115.106 -0.952 . . . . 0.0 112.032 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 74.3 m -141.56 136.37 31.02 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 117.29 0.545 . . . . 0.0 111.31 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.7 p -63.46 144.01 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.803 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.3 pt -118.78 90.96 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.091 0 CA-C-O 121.065 0.459 . . . . 0.0 110.538 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -67.46 -26.94 66.64 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.443 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -122.58 169.34 9.9 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.063 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.79 144.23 99.48 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.075 1.85 . . . . 0.0 111.773 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.3 m -136.47 138.43 46.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.22 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -73.88 134.48 43.25 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.498 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.7 mt -86.09 135.81 33.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.03 0.443 . . . . 0.0 111.324 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -127.79 148.33 50.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.502 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.479 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 5.3 t60 -48.86 116.16 1.54 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.081 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.01 -13.87 40.85 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.161 -0.775 . . . . 0.0 111.161 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.54 ' OD1' ' ND2' ' A' ' 72' ' ' ASN . 34.4 t70 -66.23 133.7 51.16 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 70.8 t -114.19 133.29 60.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.354 -0.538 . . . . 0.0 111.517 -178.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 71.1 mt -100.02 131.77 46.83 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 89.4 m -123.97 125.9 45.39 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.83 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.504 ' O ' ' N ' ' A' ' 92' ' ' ASP . 94.2 mt -112.5 123.65 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.591 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.44 ' C ' ' O ' ' A' ' 90' ' ' ILE . 94.5 mt 38.61 -94.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.028 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 90' ' ' ILE . 52.1 t0 -121.71 16.35 11.08 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 120.941 -0.303 . . . . 0.0 111.564 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.568 ' NH1' ' CD1' ' A' ' 41' ' ' LEU . 44.3 mtm-85 -128.43 139.05 52.56 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.0 m -133.69 152.14 51.81 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 119.979 -0.689 . . . . 0.0 111.169 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -123.85 121.74 36.16 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.088 178.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -85.21 131.75 34.38 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.113 0.483 . . . . 0.0 111.304 -178.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -95.63 124.73 39.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.003 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -125.6 122.31 36.09 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.967 0.413 . . . . 0.0 110.702 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.479 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 55.3 t-20 -104.38 105.56 15.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.957 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.854 179.585 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . 0.569 ' O ' ' CB ' ' B' ' 229' ' ' ASP . 34.0 m . . . . . 0 N--CA 1.455 -0.187 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.569 ' CB ' ' O ' ' B' ' 228' ' ' VAL . 22.1 t0 95.55 158.04 0.02 OUTLIER 'General case' 0 C--O 1.237 0.42 0 O-C-N 123.768 0.668 . . . . 0.0 111.282 179.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 170.41 23.88 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.614 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . 0.48 ' O ' ' NZ ' ' A' ' 46' ' ' LYS . . . -115.89 -167.89 15.12 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 111.518 -0.633 . . . . 0.0 111.518 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.52 159.5 53.35 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.694 2.263 . . . . 0.0 112.48 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -74.29 172.47 15.99 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 122.417 2.078 . . . . 0.0 112.478 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 24.1 t -111.08 132.55 59.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.273 -179.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 40.1 t -61.73 120.65 11.06 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.97 0.414 . . . . 0.0 110.046 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -56.67 -22.37 43.72 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 121.757 1.638 . . . . 0.0 112.043 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 18.8 m -74.16 -44.35 53.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.316 0.579 . . . . 0.0 109.806 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . 0.485 ' CE1' ' NH2' ' B' ' 245' ' ' ARG . 82.1 t80 -58.14 -46.55 85.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.0 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 95.0 mt -64.5 -39.62 94.12 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.154 0.502 . . . . 0.0 109.993 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -61.33 -41.7 97.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.577 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -60.9 -42.24 97.66 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.326 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.485 ' NH2' ' CE1' ' B' ' 241' ' ' PHE . 47.8 mmt-85 -61.17 -40.49 94.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.93 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -61.34 -39.27 89.96 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 24.0 m -65.76 -43.73 88.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -60.48 -37.65 81.73 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 114.511 -1.222 . . . . 0.0 110.426 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 46.8 t -61.73 -46.39 96.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.051 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -60.46 -27.52 67.61 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 121.272 0.558 . . . . 0.0 109.793 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -86.16 -11.82 51.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.917 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.567 ' O ' ' CB ' ' B' ' 253' ' ' ASN . 90.7 mt -114.7 -174.5 2.5 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.823 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . 0.567 ' CB ' ' O ' ' B' ' 252' ' ' LEU . 0.3 OUTLIER 91.39 27.4 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.116 179.889 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . 0.582 ' O ' ' CB ' ' B' ' 255' ' ' ASP . 96.6 m-20 -92.91 -6.87 47.63 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.798 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . 0.582 ' CB ' ' O ' ' B' ' 254' ' ' ASP . 32.1 t0 106.28 58.05 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 O-C-N 124.04 0.837 . . . . 0.0 108.839 -178.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.579 ' O ' ' C ' ' B' ' 257' ' ' LYS . 54.6 p-10 -120.23 19.07 12.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.124 -178.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . 0.6 ' O ' ' N ' ' B' ' 259' ' ' ASP . 99.2 mttt 20.52 -89.24 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.41 0.444 . . . . 0.0 110.729 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' B' ' 256' ' ' ASP . 94.6 m-20 -27.11 87.76 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 O-C-N 123.647 0.592 . . . . 0.0 110.105 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.6 ' N ' ' O ' ' B' ' 257' ' ' LYS . 87.7 m-20 -87.06 -93.09 0.1 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.235 -179.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.503 ' CD ' HH12 ' A' ' 12' ' ' ARG . 97.5 mt-10 -141.46 9.47 2.03 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.053 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 61.5 mt -112.34 135.06 52.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 43.6 t -123.86 133.3 69.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.202 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -94.79 117.46 30.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.988 0.423 . . . . 0.0 110.976 -178.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -65.39 -47.01 77.81 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.275 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -82.34 160.89 61.31 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.201 -0.908 . . . . 0.0 110.257 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -60.37 141.65 96.18 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.162 1.908 . . . . 0.0 111.753 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . 0.494 ' CD1' ' O ' ' A' ' 19' ' ' HIS . 13.8 tt . . . . . 0 C--N 1.324 -0.532 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.919 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo . . . . . 0 N--CA 1.489 1.238 0 CA-C-O 120.875 0.281 . . . . 0.0 111.829 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 35.3 p -66.73 -35.38 79.98 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.267 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.643 HH22 ' CB ' ' A' ' 99' ' ' ASN . 7.0 mmp_? -90.52 118.0 29.64 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -178.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.664 ' NH2' ' ND1' ' A' ' 19' ' ' HIS . 77.8 ttt-85 -127.36 127.23 43.9 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.696 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 77.6 mt -113.67 144.71 42.47 Favored 'General case' 0 C--N 1.339 0.139 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 51.2 t -121.12 130.94 74.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.47 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.1 m -81.37 142.17 33.28 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.579 0.704 . . . . 0.0 112.432 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.402 ' CD1' ' OD1' ' A' ' 16' ' ' ASP . 47.0 mm -108.59 134.35 50.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.62 177.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -90.15 156.58 18.24 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.998 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.679 ' NH1' ' NH2' ' B' ' 245' ' ' ARG . 88.8 mtm180 -58.85 -25.91 63.7 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.247 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.9 p -78.26 -10.11 59.52 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.78 37.85 9.14 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.7 t -122.1 134.3 65.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.674 0.273 . . . . 0.0 110.658 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.402 ' OD1' ' CD1' ' A' ' 10' ' ' ILE . 96.8 m-20 -71.4 133.39 45.9 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.34 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -122.41 -118.02 2.46 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 120.806 -0.711 . . . . 0.0 111.887 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -74.65 145.04 32.38 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.265 1.976 . . . . 0.0 112.812 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.664 ' ND1' ' NH2' ' A' ' 6' ' ' ARG . 17.9 m170 -101.73 140.69 35.67 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.66 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -114.42 97.03 45.1 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.441 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -79.67 139.22 14.01 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 121.836 1.691 . . . . 0.0 110.66 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 92.8 mt -101.43 124.08 46.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.747 0.784 . . . . 0.0 110.529 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.6 p -124.18 -1.31 8.22 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.261 -1.336 . . . . 0.0 108.683 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 42.2 mt -104.67 147.99 27.06 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 114.508 -1.224 . . . . 0.0 109.732 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 96.1 p -65.98 -17.26 64.56 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.345 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 85.2 m -132.37 133.77 44.36 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.246 0.546 . . . . 0.0 112.122 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.573 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 2.9 t -126.4 121.51 32.68 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.4 tp -120.9 132.22 54.84 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.824 0.345 . . . . 0.0 111.922 -177.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.573 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 8.9 m-85 -109.22 140.79 42.38 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 151.44 -177.78 29.17 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.447 178.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.456 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 46.0 mtm180 -74.19 -33.52 63.45 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.501 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -48.12 148.44 4.07 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.808 -0.71 . . . . 0.0 111.587 -178.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.503 ' CD1' ' NH1' ' A' ' 38' ' ' ARG . 9.9 tp -66.53 -41.96 89.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-O 120.9 0.381 . . . . 0.0 110.438 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.443 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 79.2 tt0 -58.55 -25.83 62.92 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 17.9 m -52.73 115.45 1.82 Allowed 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -53.05 -25.0 11.1 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.538 -178.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.481 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 96.2 mt -129.71 122.06 54.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.503 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 83.8 mtp180 -106.06 135.53 47.35 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.015 0.435 . . . . 0.0 110.853 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 95.5 mt -118.09 129.55 74.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.059 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -73.73 34.24 0.08 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -177.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 55.9 mt -111.24 129.04 24.44 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.684 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.76 -10.25 24.76 Favored 'Trans proline' 0 N--CA 1.489 1.237 0 C-N-CA 122.445 2.096 . . . . 0.0 113.101 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.9 m -94.15 1.12 9.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.562 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.456 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 42.6 t -89.75 136.05 24.65 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.24 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.072 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.424 ' HG ' HG22 ' B' ' 234' ' ' TPO . 4.6 m -69.8 164.79 22.84 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.424 0.63 . . . . 0.0 111.297 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -62.65 -43.26 99.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.287 -179.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.594 ' O ' ' N ' ' A' ' 49' ' ' CYS . 92.7 mm-40 -111.34 -24.15 10.38 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.318 0.58 . . . . 0.0 110.002 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.0 t60 39.22 -78.05 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.251 -0.886 . . . . 0.0 113.382 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.594 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -129.53 133.73 47.39 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.385 0.612 . . . . 0.0 112.225 -178.663 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -126.83 132.44 50.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.307 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 93.7 mt -117.54 135.41 58.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.568 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.584 ' CD ' ' HE2' ' A' ' 54' ' ' HIS . 79.7 tt0 -120.48 124.62 45.87 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.441 HD11 HG23 ' A' ' 53' ' ' ILE . 84.9 mt -102.04 117.83 47.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.324 0.583 . . . . 0.0 111.57 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.584 ' HE2' ' CD ' ' A' ' 52' ' ' GLU . 97.5 m-70 -112.94 141.01 47.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.258 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 54' ' ' HIS . 94.1 mt-10 -39.75 -28.85 0.05 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -178.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.49 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 58.1 tt0 -63.55 -67.67 0.41 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.301 178.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.49 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 3.7 tp10 -158.16 -164.43 1.5 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.336 -178.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -111.49 129.96 55.88 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.9 mt -118.87 128.09 75.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.386 0.612 . . . . 0.0 112.157 -178.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.437 ' CD1' ' HG ' ' A' ' 49' ' ' CYS . 28.1 tp -97.29 127.87 43.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.934 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -113.23 136.47 52.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.127 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.431 HD22 ' HA ' ' A' ' 68' ' ' PRO . 58.5 t-20 -97.12 104.61 16.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.188 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -96.51 -9.7 29.03 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 120.757 0.313 . . . . 0.0 110.747 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.506 ' H ' ' HG ' ' A' ' 64' ' ' SER . 0.7 OUTLIER -70.15 101.44 1.85 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.101 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 79.0 p -87.73 -10.13 52.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.206 0.527 . . . . 0.0 109.591 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.92 -43.22 6.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.249 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -135.85 94.86 14.31 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.025 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.431 ' HA ' HD22 ' A' ' 62' ' ' ASN . 50.4 Cg_exo -57.17 142.9 94.51 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 121.966 1.777 . . . . 0.0 113.014 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 95.9 m -74.49 144.1 44.3 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.401 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -104.88 139.47 39.57 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.056 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 68.8 t -131.02 133.11 63.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 53.65 32.11 13.92 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.149 -0.621 . . . . 0.0 110.065 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.45 26.88 68.9 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-N 115.606 -0.724 . . . . 0.0 112.129 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 43.4 t -142.68 139.93 31.37 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 117.36 0.58 . . . . 0.0 111.08 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.2 p -70.25 140.85 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.486 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.8 pt -113.96 90.72 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.82 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -68.43 -28.94 67.51 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.478 ' N ' ' CD ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -116.49 162.18 28.0 Favored Pre-proline 0 C--O 1.232 0.168 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.582 179.129 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -66.56 150.54 83.94 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.571 2.181 . . . . 0.0 112.466 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.4 m -141.78 141.76 29.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.142 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -70.52 129.92 40.49 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.077 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.3 mt -79.64 140.17 37.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.175 0.512 . . . . 0.0 111.13 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -131.84 151.23 51.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.729 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.667 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 6.1 t60 -53.78 120.14 5.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.052 0.453 . . . . 0.0 111.162 -179.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.81 -17.67 32.54 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -67.51 135.06 52.44 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 120.184 -0.607 . . . . 0.0 110.258 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.5 t -113.67 132.51 62.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.115 -178.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.451 ' O ' ' OG ' ' A' ' 94' ' ' SER . 84.5 mt -103.78 132.78 49.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 90.1 m -122.63 128.97 51.35 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.48 0.657 . . . . 0.0 112.646 -178.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.488 ' O ' ' N ' ' A' ' 93' ' ' ARG . 81.2 mt -113.91 126.02 71.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.499 178.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.458 ' C ' ' O ' ' A' ' 90' ' ' ILE . 41.2 mm 35.99 -98.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.746 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 90' ' ' ILE . 41.3 p-10 -116.13 12.11 15.44 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.04 0.448 . . . . 0.0 110.918 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.731 HH22 ' NH2' ' B' ' 245' ' ' ARG . 53.9 mtt85 -123.07 140.44 53.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.334 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' A' ' 88' ' ' ILE . 29.4 t -137.27 151.15 48.38 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 120.319 -0.553 . . . . 0.0 110.722 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -123.6 122.21 37.57 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -84.65 136.35 33.79 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.167 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.61 ' CZ ' ' CZ ' ' A' ' 5' ' ' ARG . 60.0 t80 -94.48 118.02 31.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.742 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -125.47 125.71 43.75 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 111.971 0.359 . . . . 0.0 111.971 -178.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.667 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 12.1 t-20 -96.46 131.5 42.98 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 . . . . . 0 C--N 1.323 -0.587 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.956 -178.996 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . 0.616 ' O ' ' N ' ' B' ' 230' ' ' SEP . 14.4 t . . . . . 0 CA--C 1.513 -0.457 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.528 ' C ' ' O ' ' B' ' 228' ' ' VAL . 61.9 t0 15.1 -78.7 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.129 0 O-C-N 124.66 1.225 . . . . 0.0 111.23 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . 0.616 ' N ' ' O ' ' B' ' 228' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.525 ' O ' ' O ' ' B' ' 232' ' ' GLY . 0.2 OUTLIER -116.48 -26.83 6.95 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.887 -179.007 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . 0.525 ' O ' ' O ' ' B' ' 231' ' ' GLN . . . -40.22 173.63 0.01 OUTLIER Glycine 0 CA--C 1.528 0.86 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.098 -178.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.42 161.94 43.89 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 123.91 3.074 . . . . 0.0 112.741 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . 0.424 HG22 ' HG ' ' A' ' 45' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.65 133.82 19.33 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 121.891 1.727 . . . . 0.0 112.922 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 54.9 t -64.71 139.82 20.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.716 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 7.3 t -73.62 132.18 42.5 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . 0.44 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . 0.44 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 35.5 Cg_exo -57.97 -27.45 79.15 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 122.877 2.385 . . . . 0.0 112.83 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 240' ' ' THR . . . . . 0.4 ' OG1' ' O1P' ' B' ' 238' ' ' TPO . 90.9 m -73.61 -45.19 54.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.546 0.689 . . . . 0.0 109.668 178.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -58.33 -46.22 86.61 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.622 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 94.9 mt -62.67 -41.64 99.2 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 120.981 0.419 . . . . 0.0 110.481 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -59.29 -37.06 76.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.415 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -62.92 -43.4 98.91 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.012 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.731 ' NH2' HH22 ' A' ' 93' ' ' ARG . 26.5 mmm180 -58.59 -41.65 86.24 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -64.21 -43.22 95.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.349 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 27.9 t -64.08 -44.98 90.7 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . 0.587 ' O ' ' N ' ' B' ' 252' ' ' LEU . 87.2 mt-30 -57.38 -40.31 77.93 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.29 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . 0.457 ' O ' ' O ' ' B' ' 252' ' ' LEU . 54.3 t -62.82 -42.91 98.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 120.658 -0.417 . . . . 0.0 109.916 178.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -61.37 -36.42 80.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.2 0.524 . . . . 0.0 109.625 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -90.81 -11.3 39.8 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.063 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.587 ' N ' ' O ' ' B' ' 248' ' ' GLN . 37.3 tp -124.22 109.87 13.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.067 179.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . 0.609 ' ND2' ' O ' ' B' ' 253' ' ' ASN . 0.2 OUTLIER -177.47 12.79 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 178.781 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . 0.417 ' O ' ' CB ' ' B' ' 255' ' ' ASP . 34.7 t70 -62.92 -44.34 96.33 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 119.519 -0.873 . . . . 0.0 109.513 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . 0.464 ' CG ' ' O ' ' B' ' 255' ' ' ASP . 4.3 t0 156.27 66.3 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.495 -1.229 . . . . 0.0 107.74 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.499 ' C ' ' H ' ' B' ' 258' ' ' ASP . 46.5 t0 -105.76 98.47 8.16 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.873 -178.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -66.2 8.29 0.23 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.352 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.499 ' H ' ' C ' ' B' ' 256' ' ' ASP . 59.6 t0 -91.22 106.19 18.33 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . . . . . . . . . 53.6 p-10 -102.46 17.51 23.41 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -177.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.57 ' OE1' ' NH2' ' B' ' 245' ' ' ARG . 96.4 mt-10 62.87 7.64 2.71 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.25 0.477 . . . . 0.0 111.163 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . 0.4 HG21 HD13 ' B' ' 261' ' ' ILE . 89.6 mt -109.78 133.08 56.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 41.5 t -124.32 133.71 68.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.945 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -98.77 121.29 40.53 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.299 0.571 . . . . 0.0 110.818 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . 0.43 ' HZ2' ' HA ' ' A' ' 34' ' ' GLU . 88.5 tttt -65.92 -39.2 90.32 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.905 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . 0.414 ' CB ' ' CD ' ' B' ' 266' ' ' PRO . 0.6 OUTLIER -103.2 179.47 0.96 Allowed Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.099 -178.461 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . 0.414 ' CD ' ' CB ' ' B' ' 265' ' ' GLN . 24.4 Cg_exo -62.25 149.81 89.27 Favored 'Trans proline' 0 N--CA 1.498 1.742 0 C-N-CA 122.822 2.348 . . . . 0.0 113.536 -178.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 15.8 pt . . . . . 0 N--CA 1.465 0.308 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.051 179.535 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo . . . . . 0 N--CA 1.495 1.606 0 CA-C-O 121.17 0.404 . . . . 0.0 113.063 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.0 p -100.86 -23.16 14.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.373 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.72 HH11 ' HH ' ' A' ' 97' ' ' TYR . 94.3 mtt-85 -97.25 115.01 26.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.957 -178.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.735 HH21 ' ND1' ' A' ' 19' ' ' HIS . 73.5 ttt180 -128.24 130.8 48.49 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.667 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 34.2 tp -113.17 133.25 55.14 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.0 t -109.87 131.57 60.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.851 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.1 m -92.17 113.86 26.25 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.942 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.8 mt -79.15 143.69 12.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.901 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -87.99 159.37 18.33 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.153 0.502 . . . . 0.0 110.64 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.429 ' HD2' HH21 ' A' ' 93' ' ' ARG . 82.1 mtp180 -53.27 -32.42 48.46 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.066 -178.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 91.1 p -79.37 -7.39 58.33 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.954 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.15 31.96 11.25 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.7 t -117.86 132.71 66.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -75.11 138.91 42.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.556 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -131.94 -114.89 1.63 Allowed Glycine 0 CA--C 1.538 1.479 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.321 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -74.07 148.31 39.65 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.46 2.107 . . . . 0.0 112.56 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.735 ' ND1' HH21 ' A' ' 6' ' ' ARG . 0.0 OUTLIER -111.37 160.82 16.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.479 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -131.21 103.51 15.29 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.706 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.98 135.83 17.77 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 121.346 1.364 . . . . 0.0 111.627 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 64.7 mt -85.22 51.83 2.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.228 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.2 p -64.25 -24.85 67.81 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.7 mt -80.33 141.82 35.07 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.678 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.8 t -63.14 -20.73 65.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.563 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 94.4 m -134.88 135.64 41.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.106 0.479 . . . . 0.0 111.577 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.2 t -127.99 120.7 28.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.591 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.418 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 56.3 tp -118.51 131.65 56.23 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.262 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.521 ' O ' ' O ' ' A' ' 47' ' ' GLN . 3.8 m-85 -108.83 141.78 40.38 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.291 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 158.15 -170.92 35.01 Favored Glycine 0 N--CA 1.469 0.894 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.219 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.578 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 81.9 mtm-85 -84.42 -27.91 27.24 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 122.447 -0.443 . . . . 0.0 110.821 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -54.66 146.07 27.19 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.051 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 31.2 mm -64.54 -43.57 96.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.014 0.435 . . . . 0.0 110.291 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -57.17 -19.86 23.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.048 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 81.7 m -62.77 131.97 50.65 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.491 -0.483 . . . . 0.0 110.171 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.418 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 64.8 m-20 -61.48 -34.79 76.06 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.222 -178.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 99.4 mt -125.16 125.88 70.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 44.4 mtm-85 -119.39 145.14 46.48 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.879 -177.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.429 ' C ' ' H ' ' A' ' 41' ' ' LEU . 80.9 mt -123.2 133.16 69.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.422 -178.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -75.88 25.64 0.12 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.973 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.429 ' H ' ' C ' ' A' ' 39' ' ' ILE . 30.4 mt -96.81 129.41 32.78 Favored Pre-proline 0 C--N 1.324 -0.528 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.087 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.403 ' O ' ' HD2' ' B' ' 235' ' ' PRO . 42.8 Cg_endo -71.09 -13.09 31.1 Favored 'Trans proline' 0 N--CA 1.489 1.225 0 C-N-CA 122.029 1.819 . . . . 0.0 112.618 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.439 ' CG2' ' CZ ' ' B' ' 241' ' ' PHE . 26.9 m -98.06 3.22 10.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.619 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.578 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 35.4 t -89.88 135.69 25.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.15 160.62 20.86 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.373 0.606 . . . . 0.0 111.782 -178.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -62.46 -42.31 99.38 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.071 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.614 ' O ' ' N ' ' A' ' 49' ' ' CYS . 86.7 mt-30 -114.97 -14.4 11.87 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 123.609 0.568 . . . . 0.0 110.069 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.414 ' O ' ' OG ' ' A' ' 64' ' ' SER . 19.7 t60 31.1 -73.75 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.614 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.85 137.19 44.87 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -177.631 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -125.16 132.33 53.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.909 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.9 mt -118.57 133.03 66.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.832 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -119.99 127.38 52.57 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 177.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.407 HG22 HD12 ' A' ' 53' ' ' ILE . 86.7 mt -108.36 124.15 64.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -177.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.517 ' CD2' ' N ' ' A' ' 54' ' ' HIS . 2.7 m-70 -117.5 141.02 48.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.538 -1.21 . . . . 0.0 109.479 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 54' ' ' HIS . 96.3 mt-10 -39.91 -29.5 0.07 Allowed 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.993 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.458 ' N ' ' O ' ' A' ' 54' ' ' HIS . 69.0 tp60 -64.38 -65.93 0.61 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -158.5 -155.44 0.49 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.099 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -120.5 131.41 54.71 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.208 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.7 mm -112.58 123.62 68.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.668 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 30.9 tp -97.67 127.21 43.45 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -115.01 136.18 53.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.956 0.408 . . . . 0.0 110.847 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.427 HD22 ' HA ' ' A' ' 68' ' ' PRO . 39.8 t30 -97.29 106.22 18.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.48 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -98.74 -8.18 26.47 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.086 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' A' ' 48' ' ' HIS . 1.2 m -69.74 101.33 1.66 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 95.4 p -83.57 -13.23 54.88 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.123 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -91.35 -46.81 7.82 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.199 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -139.67 101.51 7.26 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.916 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.427 ' HA ' HD22 ' A' ' 62' ' ' ASN . 36.6 Cg_exo -57.07 147.66 73.82 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 121.986 1.791 . . . . 0.0 112.884 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.7 m -74.66 145.83 42.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.543 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -107.54 140.34 40.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.256 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.1 t -129.66 133.91 64.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 53.59 32.93 15.29 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 119.899 -0.72 . . . . 0.0 109.284 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.45 27.57 71.14 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.702 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 21.3 t -141.99 138.79 32.14 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 117.133 0.466 . . . . 0.0 112.003 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.3 t -68.76 140.3 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.143 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.9 pt -113.36 93.86 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-O 120.983 0.42 . . . . 0.0 110.808 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -65.04 -28.98 69.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.63 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.462 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.2 OUTLIER -126.34 178.96 1.3 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.178 -179.313 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.462 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 36.5 Cg_exo -59.36 143.05 99.85 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 122.68 2.253 . . . . 0.0 111.45 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.2 p -137.69 140.78 40.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.464 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.436 HH11 ' HD3' ' A' ' 81' ' ' ARG . 34.0 mmt-85 -79.29 129.4 34.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.221 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 98.4 mt -85.21 136.58 33.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.985 0.421 . . . . 0.0 111.381 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -125.85 152.2 45.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.459 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.407 ' CD2' ' C ' ' A' ' 84' ' ' HIS . 6.9 t60 -53.37 115.78 2.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.79 0.329 . . . . 0.0 110.422 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.7 -16.7 25.99 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -69.01 135.2 50.52 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.215 -0.594 . . . . 0.0 109.958 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.1 t -112.39 131.29 64.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.138 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 91.6 mt -94.62 131.37 41.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.464 ' OG1' ' OG ' ' A' ' 94' ' ' SER . 25.6 m -122.79 128.18 50.11 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -177.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.474 ' O ' ' C ' ' A' ' 91' ' ' ILE . 79.5 mt -113.79 125.14 71.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.01 178.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.474 ' C ' ' O ' ' A' ' 90' ' ' ILE . 97.9 mt 33.64 -96.36 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.074 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.593 ' OD1' ' NH1' ' A' ' 93' ' ' ARG . 47.9 p-10 -114.74 12.24 17.02 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.593 ' NH1' ' OD1' ' A' ' 92' ' ' ASP . 70.6 mtt85 -124.62 140.05 53.3 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.683 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.464 ' OG ' ' OG1' ' A' ' 89' ' ' THR . 56.6 m -136.09 151.1 49.46 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.45 0.643 . . . . 0.0 111.137 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -121.95 120.74 35.3 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.851 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -81.65 129.21 34.62 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.616 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.72 ' HH ' HH11 ' A' ' 5' ' ' ARG . 87.1 t80 -94.9 124.31 38.88 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.722 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -123.3 122.01 37.27 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.617 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -125.53 115.83 20.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.373 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 . . . . . 0 C--N 1.329 -0.313 0 CA-C-O 120.771 0.32 . . . . 0.0 110.541 -179.875 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 3.7 t . . . . . 0 CA--C 1.517 -0.294 0 CA-C-O 121.204 0.526 . . . . 0.0 111.541 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.657 ' C ' ' H ' ' B' ' 231' ' ' GLN . 98.0 m-20 58.76 88.23 0.07 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.682 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . 0.6 ' O ' ' NE2' ' B' ' 231' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.657 ' H ' ' C ' ' B' ' 229' ' ' ASP . 95.5 mm-40 -137.32 51.0 1.96 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -116.25 -173.98 17.32 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.251 -0.74 . . . . 0.0 111.251 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.09 158.82 56.34 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.8 2.333 . . . . 0.0 112.517 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . 0.403 ' HD2' ' O ' ' A' ' 42' ' ' PRO . 26.8 Cg_exo -60.03 141.49 96.44 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.911 2.407 . . . . 0.0 112.779 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -78.76 133.17 30.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.87 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 34.7 t -68.18 126.39 29.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.963 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -59.38 -23.54 70.67 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.63 2.22 . . . . 0.0 112.458 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 79.8 m -74.38 -43.0 58.35 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.29 0.567 . . . . 0.0 109.62 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . 0.488 ' CE1' ' NH2' ' B' ' 245' ' ' ARG . 73.6 t80 -55.54 -46.65 77.06 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.693 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 98.4 mt -64.75 -39.49 93.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.108 0.48 . . . . 0.0 110.331 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 51.2 tp10 -61.12 -42.52 98.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.761 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -63.72 -39.43 94.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.307 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.488 ' NH2' ' CE1' ' B' ' 241' ' ' PHE . 40.3 mmt-85 -61.74 -40.74 96.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.706 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -62.18 -41.38 98.28 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.412 -0.515 . . . . 0.0 109.95 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 37.3 t -65.04 -45.38 85.66 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . 0.409 ' HB2' ' NH2' ' A' ' 12' ' ' ARG . 74.8 mt-30 -61.2 -35.41 77.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.554 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 39.4 t -60.34 -45.75 96.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -59.07 -27.38 65.48 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -86.47 -10.11 54.86 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.097 178.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.413 ' O ' ' CB ' ' B' ' 253' ' ' ASN . 96.2 mt -117.52 -176.19 2.97 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.61 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . 0.587 ' ND2' ' O ' ' B' ' 253' ' ' ASN . 0.2 OUTLIER 79.62 14.49 0.98 Allowed 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.11 179.509 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' B' ' 255' ' ' ASP . 96.8 m-20 -65.57 -31.0 71.81 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . 0.478 ' O ' ' CB ' ' B' ' 256' ' ' ASP . 91.3 m-20 -137.61 -80.94 0.36 Allowed 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.668 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.478 ' CB ' ' O ' ' B' ' 255' ' ' ASP . 1.9 p30 154.24 116.97 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -178.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . 0.559 ' O ' ' C ' ' B' ' 258' ' ' ASP . 62.2 pttt -174.32 151.87 1.68 Allowed 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.514 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.559 ' C ' ' O ' ' B' ' 257' ' ' LYS . 66.7 t0 -6.31 119.48 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 O-C-N 124.344 1.027 . . . . 0.0 111.449 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . . . . . . . . . 46.3 p-10 -105.55 61.19 0.67 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.26 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.452 ' OE1' ' NH2' ' A' ' 93' ' ' ARG . 95.2 mt-10 62.74 9.46 3.6 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 76.5 mt -111.61 134.0 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 54.8 t -125.58 132.85 70.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.738 0.304 . . . . 0.0 111.098 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -98.33 120.36 38.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.312 0.577 . . . . 0.0 111.626 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -66.85 -44.61 80.58 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.203 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.42 159.2 30.13 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.033 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.02 154.4 67.39 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 123.051 2.501 . . . . 0.0 111.864 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 47.0 pt . . . . . 0 C--N 1.327 -0.393 0 CA-C-O 121.309 0.576 . . . . 0.0 111.819 -178.931 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo . . . . . 0 N--CA 1.493 1.472 0 CA-C-O 120.961 0.317 . . . . 0.0 112.401 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.5 p -87.04 -36.01 18.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.716 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.4 mtt85 -94.87 124.93 39.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.908 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -133.53 140.25 47.09 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.343 -0.543 . . . . 0.0 111.521 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 79.2 mt -113.0 138.45 49.86 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.502 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 54.7 t -112.78 131.34 64.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.3 m -85.38 136.32 33.51 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.595 0.712 . . . . 0.0 112.32 -178.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 95.0 mt -108.89 138.03 38.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.185 178.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -91.4 158.36 16.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.191 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.702 ' NE ' ' HZ2' ' B' ' 257' ' ' LYS . 87.5 mtm180 -59.26 -23.51 62.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.044 0.45 . . . . 0.0 110.271 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.2 t -79.05 -16.83 56.26 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.358 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.05 36.62 5.93 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.6 t -119.46 134.18 63.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 121.191 0.519 . . . . 0.0 112.052 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.401 ' C ' ' OD1' ' A' ' 16' ' ' ASP . 60.5 t0 -76.96 120.1 21.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.38 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -115.48 -124.75 3.82 Favored Glycine 0 CA--C 1.539 1.583 0 C-N-CA 120.919 -0.657 . . . . 0.0 111.665 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.24 153.25 40.52 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.551 2.167 . . . . 0.0 113.192 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -111.61 156.58 21.58 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.029 0.442 . . . . 0.0 110.563 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -123.58 100.91 37.54 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.066 -179.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.53 134.44 20.49 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 C-N-CA 121.344 1.363 . . . . 0.0 111.928 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.3 mt -88.55 71.74 8.86 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.844 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 89.2 p -79.9 -8.22 59.18 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.8 mt -97.4 142.5 29.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.801 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.9 p -66.2 -21.69 66.32 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.099 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 86.0 m -133.68 136.23 44.58 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.006 0.431 . . . . 0.0 110.775 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.561 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -134.81 129.53 34.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.486 178.632 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 48.1 tp -119.71 131.22 55.34 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.745 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.561 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 38.1 m-85 -104.98 140.78 37.68 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.702 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 149.3 -166.4 29.53 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 120.299 -0.953 . . . . 0.0 112.574 178.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 44.5 mtm180 -86.0 -32.01 21.72 Favored 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.415 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -49.33 151.16 3.84 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 -178.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.422 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 11.3 tp -66.41 -40.5 86.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.422 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 85.1 tt0 -54.8 -23.96 20.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.022 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.415 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 59.5 m -56.79 115.02 2.32 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.827 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -57.82 -21.41 42.09 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.435 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 97.6 mt -129.99 120.98 50.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.278 -0.874 . . . . 0.0 108.912 177.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 84.7 mtp180 -105.54 133.66 49.93 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.514 -179.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.0 mt -118.49 128.07 75.47 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -80.25 43.59 0.64 Allowed 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -177.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.476 ' CD1' ' NH1' ' A' ' 93' ' ' ARG . 59.0 mt -111.14 134.06 21.16 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.379 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.81 -9.76 21.2 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 122.223 1.948 . . . . 0.0 111.965 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.0 m -101.11 2.28 10.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.772 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 25.1 t -93.34 135.84 26.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.278 0.561 . . . . 0.0 109.945 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.404 ' HG ' HG21 ' B' ' 234' ' ' TPO . 2.4 m -68.25 159.94 30.24 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.377 -178.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -61.47 -42.46 98.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.928 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.675 ' O ' ' N ' ' A' ' 49' ' ' CYS . 82.9 mt-30 -114.58 -16.37 11.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.459 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.2 t60 32.81 -73.82 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.675 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -134.8 138.13 43.98 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -178.221 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -125.5 136.76 53.69 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.42 -0.809 . . . . 0.0 108.909 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 14.9 tt -126.5 140.72 48.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.074 0.464 . . . . 0.0 110.89 -178.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -122.59 135.56 54.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.393 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.8 mt -110.6 114.62 47.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.283 0.564 . . . . 0.0 111.355 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.47 ' O ' ' N ' ' A' ' 56' ' ' GLN . 92.3 m-70 -115.76 143.89 44.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.571 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 54' ' ' HIS . 96.1 mt-10 -40.06 -29.36 0.07 Allowed 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.308 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.47 ' N ' ' O ' ' A' ' 54' ' ' HIS . 87.9 mt-30 -63.48 -69.66 0.26 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -160.57 -164.1 1.18 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.555 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -108.42 131.91 54.3 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.163 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 89.2 mt -122.0 132.27 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -178.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 57.9 tp -99.35 128.83 45.51 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.825 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -115.53 134.95 54.58 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.405 HD22 ' HA ' ' A' ' 68' ' ' PRO . 36.3 t30 -95.74 103.53 15.42 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -95.25 -8.25 36.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.427 178.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.44 98.42 8.88 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.989 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.9 p -79.57 -31.82 41.97 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.5 m -65.32 -49.08 70.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.917 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.441 HD22 ' HA ' ' B' ' 236' ' ' VAL . 73.8 m-20 -138.96 95.9 9.39 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.742 -179.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.405 ' HA ' HD22 ' A' ' 62' ' ' ASN . 47.3 Cg_exo -54.04 144.32 58.0 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 121.901 1.734 . . . . 0.0 112.74 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.3 m -71.11 132.29 44.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.783 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -97.56 140.64 31.67 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.071 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.5 p -133.25 137.68 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 49.85 32.38 5.38 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.3 29.35 70.3 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.901 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 58.3 m -135.13 124.77 25.17 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 117.364 0.582 . . . . 0.0 112.086 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.7 m -69.27 137.0 25.12 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.526 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 1.6 pt -116.26 120.17 64.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 C-N-CA 120.659 -0.417 . . . . 0.0 110.726 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -85.29 -18.93 32.42 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.02 167.07 17.96 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.2 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.88 151.46 73.91 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.697 2.265 . . . . 0.0 112.807 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.5 m -141.2 148.81 20.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.193 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -79.09 133.7 36.76 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.331 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 97.0 mt -85.57 144.34 27.95 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.238 0.542 . . . . 0.0 111.304 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -128.47 151.1 49.79 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.913 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.796 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 7.0 t60 -53.72 118.34 3.85 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.059 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.28 -17.33 31.61 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.994 -0.843 . . . . 0.0 110.994 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -67.16 135.38 53.43 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.227 0.537 . . . . 0.0 110.214 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.5 p -113.54 133.47 59.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.877 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.411 ' O ' ' OG ' ' A' ' 94' ' ' SER . 97.1 mt -99.67 131.7 46.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 177.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 98.6 m -122.91 125.67 45.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.642 0.735 . . . . 0.0 112.527 -178.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.591 ' O ' ' N ' ' A' ' 92' ' ' ASP . 96.6 mt -111.03 125.26 68.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 114.519 -1.218 . . . . 0.0 108.198 178.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.492 ' CG2' ' NH1' ' B' ' 245' ' ' ARG . 23.4 mm 35.17 -90.23 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -178.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.591 ' N ' ' O ' ' A' ' 90' ' ' ILE . 1.0 OUTLIER -125.44 5.81 7.65 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.14 0.495 . . . . 0.0 110.735 178.793 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.741 ' NH1' ' NH2' ' B' ' 245' ' ' ARG . 71.4 mtt85 -108.4 137.01 47.09 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.186 178.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 88' ' ' ILE . 31.0 t -139.21 151.27 46.42 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.167 -179.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -124.81 126.02 44.94 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -87.06 135.99 33.08 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.99 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -97.82 123.0 41.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.358 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -139.62 130.69 26.42 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.158 -0.617 . . . . 0.0 112.069 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.796 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 77.8 m-20 -97.79 127.21 43.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.626 178.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 . . . . . 0 C--N 1.324 -0.519 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.922 -179.975 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . 0.449 ' O ' ' C ' ' B' ' 229' ' ' ASP . 33.3 m . . . . . 0 N--CA 1.455 -0.206 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.449 ' C ' ' O ' ' B' ' 228' ' ' VAL . 67.1 t0 -34.33 -83.6 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.501 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -134.65 54.12 1.96 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.084 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -117.23 -169.22 14.92 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.559 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -65.83 153.41 78.26 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 123.598 2.865 . . . . 0.0 112.7 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . 0.404 HG21 ' HG ' ' A' ' 45' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -77.63 141.19 19.47 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 C-N-CA 121.815 1.677 . . . . 0.0 111.949 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . 0.441 ' HA ' HD22 ' A' ' 67' ' ' ASN . 3.5 m -65.75 147.55 12.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 8.5 t -67.7 133.26 48.99 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.246 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . 0.403 ' O3P' ' OG1' ' B' ' 240' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.1 -29.94 85.05 Favored 'Trans proline' 0 N--CA 1.503 2.068 0 C-N-CA 123.019 2.479 . . . . 0.0 113.254 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 240' ' ' THR . . . . . 0.403 ' OG1' ' O3P' ' B' ' 238' ' ' TPO . 42.9 m -72.11 -43.39 64.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.051 0.453 . . . . 0.0 110.214 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . 0.43 ' CE2' ' HD2' ' B' ' 245' ' ' ARG . 63.6 t80 -58.11 -46.76 85.0 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.097 -178.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 82.7 mt -63.79 -41.66 97.88 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.85 -39.67 90.99 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.565 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -61.74 -40.72 96.09 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.237 -0.585 . . . . 0.0 109.617 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.741 ' NH2' ' NH1' ' A' ' 93' ' ' ARG . 77.9 mtp180 -63.35 -42.53 98.92 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.289 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -62.99 -41.06 99.46 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.382 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 33.5 p -67.62 -44.27 78.4 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.285 0.564 . . . . 0.0 109.905 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -63.49 -32.85 74.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.42 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . 0.492 ' O ' ' O ' ' B' ' 252' ' ' LEU . 75.8 t -62.34 -45.75 98.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -61.45 -28.09 69.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.45 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -85.39 -10.45 56.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.81 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.492 ' O ' ' O ' ' B' ' 249' ' ' VAL . 96.2 mt -120.63 108.91 14.6 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.467 177.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . 0.589 ' ND2' ' O ' ' B' ' 253' ' ' ASN . 0.3 OUTLIER 178.88 18.7 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 121.116 -0.233 . . . . 0.0 111.018 179.475 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -63.32 -42.69 99.02 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.057 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . 0.57 ' O ' ' CB ' ' B' ' 256' ' ' ASP . 36.4 t0 170.21 63.29 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.758 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.57 ' CB ' ' O ' ' B' ' 255' ' ' ASP . 63.1 m-20 109.28 129.24 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 O-C-N 124.446 1.091 . . . . 0.0 110.72 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . 0.702 ' HZ2' ' NE ' ' A' ' 12' ' ' ARG . 11.7 ptmt -106.13 28.3 7.8 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.36 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.449 ' C ' ' O ' ' B' ' 257' ' ' LYS . 87.3 m-20 41.59 64.63 1.0 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -178.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.669 ' C ' ' H ' ' B' ' 261' ' ' ILE . 50.6 p-10 -32.67 114.42 0.16 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.676 -178.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -61.9 19.33 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.711 -1.131 . . . . 0.0 111.371 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . 0.669 ' H ' ' C ' ' B' ' 259' ' ' ASP . 75.6 mt -110.84 134.1 54.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 178.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 79.1 t -126.22 135.04 65.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.766 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -95.25 120.41 35.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.145 -178.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 40.5 tttp -65.33 -45.52 83.93 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.034 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -91.54 160.92 35.67 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.714 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.46 148.54 67.22 Favored 'Trans proline' 0 C--N 1.301 -1.923 0 C-N-CA 122.698 2.265 . . . . 0.0 112.829 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 42.7 pt . . . . . 0 C--N 1.332 -0.165 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.759 179.384 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo . . . . . 0 N--CA 1.492 1.431 0 N-CA-C 112.899 0.307 . . . . 0.0 112.899 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.3 p -122.22 -40.06 2.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.834 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.836 HH11 ' HH ' ' A' ' 97' ' ' TYR . 93.5 mtt-85 -93.84 120.74 34.49 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.546 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.557 ' NH1' ' OE2' ' A' ' 100' ' ' GLU . 99.5 mtt180 -130.09 137.08 49.99 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.057 0.456 . . . . 0.0 111.782 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 43.8 tp -110.49 130.57 55.53 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.7 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 43.3 t -107.37 130.23 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 120.744 0.307 . . . . 0.0 110.72 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 m -90.91 116.4 28.69 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -177.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.6 mt -83.72 142.89 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.21 178.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -93.32 157.85 16.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.265 0.555 . . . . 0.0 111.147 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.583 HH22 ' CG ' ' B' ' 248' ' ' GLN . 59.1 mtp180 -57.97 -31.9 67.34 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.232 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.4 p -71.59 -15.62 62.27 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.064 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.03 37.18 5.76 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 46.3 t -124.81 133.6 69.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.181 -0.509 . . . . 0.0 111.328 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -77.22 136.9 38.57 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.87 -120.25 2.22 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.486 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -71.53 151.52 58.98 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.273 1.982 . . . . 0.0 113.147 -178.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -108.01 158.59 17.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.178 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -129.22 94.98 31.99 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.22 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -57.93 124.9 17.05 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.038 1.825 . . . . 0.0 111.862 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 89.3 mt -87.39 46.94 1.43 Allowed 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.676 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.5 t -59.81 -20.21 55.42 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 71.7 mt -77.78 139.44 39.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.02 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.1 p -64.62 -20.98 66.59 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.906 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.5 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 28.2 m -132.45 132.98 43.3 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.716 -0.393 . . . . 0.0 110.769 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.2 t -124.98 117.92 25.09 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.3 tp -115.99 129.05 56.2 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.278 -178.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.492 ' O ' ' O ' ' A' ' 47' ' ' GLN . 4.9 m-85 -108.56 139.96 42.59 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.056 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.76 -178.11 29.24 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.479 178.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 46.5 mtm180 -70.96 -33.3 70.33 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.685 0.278 . . . . 0.0 111.264 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.452 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -47.15 143.62 5.47 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.447 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 10.3 tp -67.1 -41.11 86.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.447 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 79.7 mm-40 -55.79 -19.25 10.73 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.899 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.452 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 86.0 m -55.96 122.13 10.88 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.232 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.5 ' OD2' ' O ' ' A' ' 26' ' ' THR . 63.8 m-20 -58.15 -29.2 65.39 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 79.4 mt -128.38 119.09 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 176.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 68.8 ttp85 -106.47 135.85 47.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.319 -178.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.408 ' C ' ' H ' ' A' ' 41' ' ' LEU . 95.1 mt -116.17 129.93 71.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-O 121.168 0.508 . . . . 0.0 110.853 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -75.92 25.46 0.12 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.415 -178.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.408 ' H ' ' C ' ' A' ' 39' ' ' ILE . 29.7 mt -92.22 128.85 43.47 Favored Pre-proline 0 C--N 1.326 -0.43 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.403 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.19 -8.21 21.7 Favored 'Trans proline' 0 C--N 1.316 -1.18 0 C-N-CA 122.083 1.856 . . . . 0.0 111.905 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.2 m -104.58 5.33 10.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.496 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.7 t -90.64 137.81 20.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.8 m -66.68 168.06 10.07 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.295 0.569 . . . . 0.0 112.035 -178.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -63.15 -45.71 90.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.237 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.651 ' O ' ' N ' ' A' ' 49' ' ' CYS . 86.9 mt-30 -115.02 -16.82 11.6 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.193 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.7 t60 35.97 -74.81 0.0 OUTLIER 'General case' 0 C--O 1.236 0.373 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.651 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.4 134.35 47.07 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -177.971 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -127.46 126.8 42.99 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.852 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.7 mt -111.52 134.26 54.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.332 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.581 ' CD ' ' HE2' ' A' ' 54' ' ' HIS . 82.7 tt0 -116.66 122.63 45.11 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 178.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 74.3 mt -103.46 118.7 50.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.008 -0.677 . . . . 0.0 112.276 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.581 ' HE2' ' CD ' ' A' ' 52' ' ' GLU . 99.3 m-70 -114.25 139.91 49.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.14 178.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.459 ' C ' ' O ' ' A' ' 54' ' ' HIS . 97.3 mt-10 -39.79 -25.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.465 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.56 ' N ' ' O ' ' A' ' 54' ' ' HIS . 60.4 tt0 -64.99 -67.55 0.43 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.672 ' CB ' ' HE ' ' A' ' 81' ' ' ARG . 4.7 tp10 -158.37 -159.14 0.77 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.104 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.407 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -118.25 128.36 54.61 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 87.7 mt -118.68 129.68 74.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.895 -178.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.7 tp -99.59 129.65 45.76 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.857 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -110.97 135.93 50.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.147 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.476 HD22 ' CB ' ' A' ' 68' ' ' PRO . 36.7 t-20 -97.26 109.45 22.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.835 0.35 . . . . 0.0 111.748 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -99.83 -9.66 22.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.692 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.9 t -78.74 119.81 22.5 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.106 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 95.2 p -101.04 -29.92 11.9 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.404 ' O ' ' OD1' ' A' ' 67' ' ' ASN . 0.6 OUTLIER -66.57 -42.06 87.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.608 178.67 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.404 ' OD1' ' O ' ' A' ' 66' ' ' THR . 1.4 m-20 -147.97 101.13 3.65 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.162 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.476 ' CB ' HD22 ' A' ' 62' ' ' ASN . 39.1 Cg_endo -66.2 154.22 75.0 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 121.624 1.549 . . . . 0.0 112.753 -178.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.1 m -75.24 149.9 38.75 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.612 -178.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -112.84 140.18 47.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.663 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 41.1 t -129.08 135.66 61.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 52.22 31.81 9.76 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -178.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.42 25.81 71.76 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.893 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 63.4 m -136.78 135.94 38.47 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 120.324 -0.55 . . . . 0.0 112.031 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 43.5 t -66.63 135.84 27.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.233 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.0 pt -106.62 98.82 7.4 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.088 0 CA-C-O 121.322 0.582 . . . . 0.0 111.001 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -63.13 -33.26 75.07 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.39 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.498 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.2 OUTLIER -129.58 -178.71 0.85 Allowed Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.262 -179.531 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.498 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 31.5 Cg_exo -60.5 146.53 96.71 Favored 'Trans proline' 0 N--CA 1.504 2.1 0 C-N-CA 123.297 2.665 . . . . 0.0 112.459 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.4 p -140.01 139.65 36.69 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 CA-C-O 120.93 0.395 . . . . 0.0 111.626 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.672 ' HE ' ' CB ' ' A' ' 57' ' ' GLU . 70.5 ttt180 -75.34 127.65 33.63 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.687 178.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 92.4 mt -84.12 141.26 31.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.167 0.508 . . . . 0.0 111.206 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -130.73 149.36 52.41 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.882 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.779 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 7.8 t60 -52.39 117.99 3.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.64 -179.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.36 -16.97 34.61 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -66.37 139.72 58.04 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 121.213 0.53 . . . . 0.0 110.308 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.4 p -111.09 133.01 58.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.869 -178.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.7 mt -101.14 129.65 51.81 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 76.8 m -124.48 122.29 37.22 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.642 0.734 . . . . 0.0 112.445 -178.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.57 ' O ' ' N ' ' A' ' 93' ' ' ARG . 76.5 mt -108.34 125.24 65.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.511 ' C ' ' O ' ' A' ' 90' ' ' ILE . 94.5 mt 34.73 -97.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.063 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.569 ' OD2' ' CZ ' ' B' ' 245' ' ' ARG . 54.4 p-10 -117.41 6.8 12.66 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.919 0.39 . . . . 0.0 111.196 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.595 ' NH2' ' O ' ' B' ' 259' ' ' ASP . 23.1 mmt180 -110.53 134.27 52.53 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 71.6 p -137.55 150.95 47.89 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 119.661 -0.815 . . . . 0.0 110.429 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -125.43 124.6 41.79 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.408 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 69.4 mtp85 -87.12 134.11 33.55 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.316 -0.554 . . . . 0.0 110.951 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.836 ' HH ' HH11 ' A' ' 5' ' ' ARG . 92.6 t80 -99.25 126.67 45.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.15 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -143.5 125.98 15.8 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.967 0.413 . . . . 0.0 111.668 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.779 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 97.5 m-20 -104.61 127.73 52.43 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.308 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.557 ' OE2' ' NH1' ' A' ' 6' ' ' ARG . 96.8 mt-10 . . . . . 0 C--N 1.33 -0.269 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 43.1 t . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.943 0.402 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.597 ' O ' ' C ' ' B' ' 230' ' ' SEP . 59.6 t0 -89.85 110.84 21.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.953 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . 0.597 ' C ' ' O ' ' B' ' 229' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.484 ' N ' ' O ' ' B' ' 229' ' ' ASP . 33.7 mm-40 77.49 52.45 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.858 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' B' ' 229' ' ' ASP . . . -99.72 -124.69 5.29 Favored Glycine 0 CA--C 1.534 1.243 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -77.56 157.04 32.33 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 122.551 2.167 . . . . 0.0 112.867 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -58.68 145.71 94.69 Favored 'Trans proline' 0 C--N 1.301 -1.956 0 C-N-CA 122.443 2.095 . . . . 0.0 112.411 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 14.6 p -87.2 127.81 40.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.22 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.6 t -59.98 118.86 6.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.662 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -55.84 -22.97 39.89 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.845 1.697 . . . . 0.0 111.819 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 20.4 m -68.14 -44.97 74.84 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 177.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -58.67 -45.62 89.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.144 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 84.0 mt -63.35 -41.66 98.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.917 0.389 . . . . 0.0 111.49 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -63.3 -42.07 99.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.151 -178.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 77.8 ttt-85 -61.44 -43.46 98.83 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.934 0.397 . . . . 0.0 110.572 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.569 ' CZ ' ' OD2' ' A' ' 92' ' ' ASP . 8.4 tpp85 -59.82 -42.4 93.45 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.849 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.98 -39.86 96.0 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 58.2 m -64.98 -44.28 89.82 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 177.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . 0.583 ' CG ' HH22 ' A' ' 12' ' ' ARG . 60.9 tt0 -58.67 -38.36 78.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.437 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 42.1 t -61.79 -44.11 98.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -58.33 -29.79 66.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.645 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -97.88 -11.47 23.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.962 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.54 ' CD1' ' OD2' ' B' ' 256' ' ' ASP . 38.6 tp -120.89 110.92 16.89 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.44 -179.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 176.99 40.69 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . 0.595 ' O ' ' CB ' ' B' ' 255' ' ' ASP . 81.3 m-20 -93.72 -4.21 50.87 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.202 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . 0.595 ' CB ' ' O ' ' B' ' 254' ' ' ASP . 61.1 t0 111.57 60.62 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 O-C-N 124.478 1.111 . . . . 0.0 110.45 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.54 ' OD2' ' CD1' ' B' ' 252' ' ' LEU . 95.4 m-20 -72.73 -66.3 0.68 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.504 0.668 . . . . 0.0 109.628 178.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . 0.434 ' CB ' ' O ' ' B' ' 256' ' ' ASP . 34.4 tttt 80.87 -5.04 1.72 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.323 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.709 ' O ' ' N ' ' B' ' 260' ' ' GLU . 50.6 p-10 -98.42 6.02 47.61 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 177.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.595 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 7.3 p30 -0.36 53.39 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 113.437 -1.71 . . . . 0.0 113.993 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.709 ' N ' ' O ' ' B' ' 258' ' ' ASP . 50.7 mp0 50.39 7.56 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . 0.451 ' H ' ' C ' ' B' ' 259' ' ' ASP . 53.2 mt -116.02 135.6 55.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 61.7 t -129.08 135.54 61.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.865 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -95.19 119.46 33.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.435 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -64.63 -47.15 79.59 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.838 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -93.67 159.15 35.39 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.038 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -69.44 148.1 66.41 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.818 2.345 . . . . 0.0 112.754 -179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 44.8 pt . . . . . 0 C--N 1.326 -0.451 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.54 179.007 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo . . . . . 0 N--CA 1.497 1.711 0 CA-C-O 120.882 0.284 . . . . 0.0 112.241 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.48 ' O ' ' O ' ' A' ' 99' ' ' ASN . 80.5 m -100.52 -56.33 2.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.214 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.3 mtt85 -86.58 137.23 32.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.136 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -129.33 131.52 46.93 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.372 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 32.7 tp -109.64 131.66 54.85 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.4 t -113.27 131.17 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 121.172 0.511 . . . . 0.0 111.002 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.2 m -80.18 145.51 32.25 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.429 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.537 ' CD1' ' OD1' ' A' ' 16' ' ' ASP . 46.2 mm -112.83 136.24 49.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.579 177.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -88.3 151.74 22.42 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.758 HH11 ' NH2' ' A' ' 93' ' ' ARG . 79.0 mtm-85 -58.17 -21.8 48.77 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.175 -178.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 93.9 p -78.12 -10.9 59.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.767 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.98 31.8 11.67 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.184 -1.167 . . . . 0.0 110.184 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 51.2 t -118.34 132.64 67.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.796 0.332 . . . . 0.0 110.325 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.537 ' OD1' ' CD1' ' A' ' 10' ' ' ILE . 79.8 m-20 -75.85 137.51 40.51 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -130.89 -116.59 1.83 Allowed Glycine 0 CA--C 1.537 1.433 0 C-N-CA 120.364 -0.922 . . . . 0.0 112.597 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.63 146.84 44.39 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.337 2.025 . . . . 0.0 112.755 -178.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -109.21 155.15 21.43 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.012 0.435 . . . . 0.0 110.004 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -127.94 104.38 20.78 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.993 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.58 134.78 19.03 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 C-N-CA 121.371 1.381 . . . . 0.0 111.388 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 90.7 mt -87.23 59.61 5.66 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.374 -178.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.672 ' HG ' HE22 ' B' ' 265' ' ' GLN . 88.2 p -65.39 -33.08 75.12 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.8 mt -76.43 142.44 41.04 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.705 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 77.4 p -65.17 -17.6 64.61 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.417 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 92.0 m -135.31 136.96 41.99 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.725 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.0 t -128.12 119.73 25.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.056 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 38.6 tp -117.27 128.1 54.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.856 -178.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.543 ' O ' ' O ' ' A' ' 47' ' ' GLN . 4.7 m-85 -106.13 138.56 42.1 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 123.594 0.559 . . . . 0.0 109.834 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 160.8 -164.62 34.78 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.147 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.62 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 83.3 mtm-85 -86.82 -26.63 23.96 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.483 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.569 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -55.82 149.66 24.74 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-N 116.249 -0.432 . . . . 0.0 112.912 -178.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.468 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 10.5 tp -70.35 -42.77 78.67 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 CA-C-O 121.118 0.485 . . . . 0.0 109.823 178.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.468 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 21.6 pt-20 -54.78 -20.15 7.91 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.498 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.569 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 13.3 m -61.63 128.15 34.9 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.205 -179.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.417 ' OD2' ' O ' ' A' ' 26' ' ' THR . 55.0 m-20 -61.88 -32.76 73.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.447 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 98.6 mt -128.62 125.51 63.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.692 178.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 70.8 mtm180 -106.57 138.17 43.25 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.931 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.522 ' C ' ' H ' ' A' ' 41' ' ' LEU . 94.2 mt -117.81 127.66 75.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -72.83 32.83 0.07 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.696 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.522 ' H ' ' C ' ' A' ' 39' ' ' ILE . 25.9 mt -98.44 120.99 58.08 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.667 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.1 -9.27 23.26 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.309 2.006 . . . . 0.0 112.45 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.1 m -103.5 10.71 8.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.664 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.62 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 11.0 t -100.8 138.1 26.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.616 ' CB ' ' HG ' ' A' ' 64' ' ' SER . 68.5 m -69.91 172.17 8.19 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.577 0.703 . . . . 0.0 112.11 -178.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -63.98 -40.91 97.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.393 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.663 ' O ' ' N ' ' A' ' 49' ' ' CYS . 86.8 mt-30 -112.73 -20.03 11.8 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 123.172 0.295 . . . . 0.0 110.766 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 26.0 t60 37.12 -73.57 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.663 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.46 136.83 48.26 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.017 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -126.85 129.59 48.56 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.357 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.8 mt -115.01 133.75 60.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.584 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -115.2 128.68 56.32 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 52.0 mm -98.28 115.83 39.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.214 0.531 . . . . 0.0 110.959 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.486 ' O ' ' N ' ' A' ' 56' ' ' GLN . 97.2 m-70 -119.4 135.0 54.94 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.159 179.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 54' ' ' HIS . 51.6 tp10 -40.26 -28.69 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.041 -0.663 . . . . 0.0 109.375 -179.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.486 ' N ' ' O ' ' A' ' 54' ' ' HIS . 50.7 tt0 -65.39 -67.87 0.41 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.113 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.431 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 5.8 tp10 -158.8 -159.72 0.8 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.049 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.431 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -120.73 130.46 54.06 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.5 mt -116.92 128.8 74.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.191 0.519 . . . . 0.0 111.514 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.454 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 22.6 tp -96.96 127.05 42.54 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.403 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -110.88 136.44 49.92 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.22 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -95.63 106.97 19.12 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.291 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -99.97 -12.03 20.11 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.31 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.616 ' HG ' ' CB ' ' A' ' 45' ' ' SER . 0.2 OUTLIER -83.44 100.44 10.72 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.779 -179.776 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.8 m -73.31 -34.7 65.84 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.999 0.428 . . . . 0.0 110.491 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.71 -37.09 81.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.096 -179.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -145.05 92.37 5.73 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.171 -178.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -56.65 146.42 76.53 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.205 1.937 . . . . 0.0 112.735 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.3 m -72.84 136.96 45.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.61 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -102.43 140.15 37.09 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.668 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 51.7 t -131.78 133.25 61.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.581 ' ND2' ' OD1' ' A' ' 86' ' ' ASP . 83.8 m-20 53.01 32.16 12.34 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.488 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.99 28.29 64.9 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.905 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 66.1 m -142.71 138.95 30.91 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 117.048 0.424 . . . . 0.0 111.214 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -71.39 141.47 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.399 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.1 pt -112.41 90.09 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.848 178.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -65.37 -26.97 68.25 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -121.63 168.09 12.07 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.544 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -56.51 142.46 89.69 Favored 'Trans proline' 0 N--CA 1.501 1.935 0 C-N-CA 122.312 2.008 . . . . 0.0 112.272 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.7 p -134.3 138.87 49.2 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 CA-C-O 121.072 0.463 . . . . 0.0 111.255 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -78.3 131.29 36.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.507 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 89.9 mt -83.14 131.22 35.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.261 0.553 . . . . 0.0 111.06 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -119.91 143.59 47.87 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.048 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -48.81 118.04 2.37 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.384 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.66 -12.84 42.58 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.581 ' OD1' ' ND2' ' A' ' 72' ' ' ASN . 26.3 t70 -69.71 132.2 45.76 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.3 t -108.27 133.53 52.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.19 -178.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 87.8 mt -102.21 131.79 49.55 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 54.1 m -120.89 127.4 51.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.535 0.683 . . . . 0.0 112.749 -178.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.543 ' N ' ' O ' ' A' ' 93' ' ' ARG . 88.9 mt -112.35 121.96 65.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.588 178.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.47 ' C ' ' O ' ' A' ' 90' ' ' ILE . 75.3 mt 31.71 -95.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.522 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 92' ' ' ASP . 38.7 p-10 -107.87 6.71 27.62 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -178.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.758 ' NH2' HH11 ' A' ' 12' ' ' ARG . 91.0 mtt-85 -129.98 147.95 51.78 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.458 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.3 t -136.77 154.18 50.63 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.626 0.727 . . . . 0.0 111.241 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -125.46 120.93 32.33 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.893 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -83.5 132.53 34.94 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.106 -0.638 . . . . 0.0 110.551 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -94.04 123.55 37.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.302 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -125.46 117.08 22.89 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.48 ' O ' ' O ' ' A' ' 4' ' ' THR . 7.2 t-20 -64.27 -41.87 96.72 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.543 -178.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 . . . . . 0 C--N 1.332 -0.19 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.375 -179.758 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.455 -0.193 0 CA-C-O 120.747 0.308 . . . . 0.0 110.767 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -68.58 141.36 55.49 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.056 0.455 . . . . 0.0 111.292 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -125.94 36.47 4.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.732 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -110.14 -175.75 20.84 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.21 160.42 49.65 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 122.895 2.397 . . . . 0.0 111.889 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.12 147.21 47.99 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 121.672 1.582 . . . . 0.0 113.032 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 9.7 p -77.47 128.31 38.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.403 -178.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.8 t -72.78 124.12 24.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.425 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.81 -22.36 67.76 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.646 2.231 . . . . 0.0 113.057 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 18.6 m -72.88 -43.81 62.08 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -58.14 -46.72 85.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.577 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 87.4 mt -65.16 -41.91 94.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.973 0.416 . . . . 0.0 110.988 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 50.3 tp10 -65.22 -44.82 87.03 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.065 -179.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -64.34 -44.1 92.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.049 0.452 . . . . 0.0 111.046 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.593 ' NH1' ' OE2' ' B' ' 260' ' ' GLU . 54.5 ttm-85 -65.53 -41.06 93.52 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.709 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -60.86 -36.78 80.04 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 40.2 t -66.11 -43.24 87.76 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 177.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . 0.554 ' O ' ' N ' ' B' ' 252' ' ' LEU . 67.4 tp60 -61.04 -36.46 79.61 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.286 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . 0.441 ' CG2' ' HE ' ' A' ' 12' ' ' ARG . 47.5 t -62.78 -45.74 98.1 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 CA-C-O 120.959 0.409 . . . . 0.0 109.988 179.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -62.92 -23.67 67.48 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.505 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -101.6 -8.7 21.61 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.189 178.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.554 ' N ' ' O ' ' B' ' 248' ' ' GLN . 37.9 tp -76.58 154.61 34.29 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.533 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -55.9 160.28 2.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.691 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . 0.409 ' N ' ' OD1' ' B' ' 254' ' ' ASP . 36.9 p-10 -80.91 5.97 14.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.441 0.639 . . . . 0.0 109.497 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -83.08 -88.62 0.09 Allowed 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.525 ' OD1' ' CD2' ' B' ' 252' ' ' LEU . 71.4 m-20 60.51 31.05 20.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.12 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.28 -36.61 84.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.971 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.494 ' O ' ' C ' ' B' ' 259' ' ' ASP . 92.4 m-20 -103.25 -2.06 27.84 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.607 ' CG ' ' H ' ' B' ' 260' ' ' GLU . 8.3 p-10 27.39 -101.95 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 113.928 -1.487 . . . . 0.0 109.728 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.607 ' H ' ' CG ' ' B' ' 259' ' ' ASP . 97.7 mt-10 -144.13 19.39 1.76 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.361 179.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 85.0 mt -115.25 135.15 56.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.569 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 45.5 t -125.83 133.7 68.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.082 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -98.95 120.71 39.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.555 0.693 . . . . 0.0 112.421 -177.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -67.29 -41.59 85.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.623 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . 0.672 HE22 ' HG ' ' A' ' 23' ' ' SER . 0.0 OUTLIER -105.12 159.39 29.53 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.576 -178.165 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -61.01 153.76 61.74 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 123.128 2.552 . . . . 0.0 112.598 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 45.4 pt . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.872 -179.347 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo . . . . . 0 N--CA 1.496 1.667 0 N-CA-C 110.854 -0.479 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.553 ' O ' ' O ' ' A' ' 99' ' ' ASN . 25.0 m -73.71 -46.0 48.78 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -178.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.7 mtt85 -92.94 138.54 31.39 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.632 -178.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -133.42 141.83 48.04 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.729 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 65.7 mt -116.57 139.04 50.93 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.6 t -110.81 132.61 58.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 C-N-CA 120.349 -0.541 . . . . 0.0 110.158 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 m -91.58 116.79 29.16 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -177.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.6 mt -84.11 142.51 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.057 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -94.85 155.82 16.62 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.272 0.558 . . . . 0.0 111.266 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.523 ' CD ' ' NH2' ' B' ' 245' ' ' ARG . 83.4 mtm180 -59.05 -32.15 69.5 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.159 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 93.9 p -70.49 -22.51 62.64 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.49 30.05 5.73 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.329 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.3 t -118.04 131.03 71.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.107 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -78.26 138.64 38.72 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.89 -113.83 1.48 Allowed Glycine 0 CA--C 1.53 0.988 0 C-N-CA 120.041 -1.076 . . . . 0.0 112.426 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.6 149.42 55.31 Favored 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 121.953 1.769 . . . . 0.0 112.006 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -114.51 144.65 43.01 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.094 0.473 . . . . 0.0 110.304 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -105.87 102.74 40.67 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.344 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -77.74 132.6 12.1 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 121.95 1.766 . . . . 0.0 111.415 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.9 mt -84.56 76.63 10.16 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -177.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 61.5 p -79.9 -12.17 59.76 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 177.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.5 mt -102.61 146.81 27.62 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.521 -178.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -68.89 -15.31 63.46 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.832 0.348 . . . . 0.0 111.397 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.454 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 92.1 m -132.48 134.96 45.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.017 0.437 . . . . 0.0 111.295 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.1 t -127.3 118.91 25.12 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.05 178.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 33.6 tp -118.2 125.51 50.32 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.814 -178.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.509 ' O ' ' O ' ' A' ' 47' ' ' GLN . 5.1 m-85 -102.61 135.94 43.34 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 123.669 0.606 . . . . 0.0 109.679 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 154.91 -179.9 30.61 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 120.353 -0.927 . . . . 0.0 112.568 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.465 ' NH1' ' O ' ' B' ' 229' ' ' ASP . 47.1 mtm180 -70.9 -33.48 70.59 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 122.653 -0.322 . . . . 0.0 111.552 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.551 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -43.94 140.18 3.52 Favored Glycine 0 N--CA 1.464 0.553 0 N-CA-C 111.306 -0.717 . . . . 0.0 111.306 -178.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.51 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 9.7 tp -65.51 -41.99 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.51 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 50.6 tp10 -56.92 -18.82 14.77 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.805 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.551 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 20.2 m -62.54 128.06 34.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.29 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.454 ' OD2' ' O ' ' A' ' 26' ' ' THR . 95.5 m-20 -60.4 -28.97 68.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.621 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.476 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 92.1 mt -128.32 118.56 48.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 177.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -104.97 138.12 41.67 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.463 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.428 ' C ' ' H ' ' A' ' 41' ' ' LEU . 88.6 mt -120.32 129.35 75.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 120.536 -0.465 . . . . 0.0 110.318 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -73.79 34.63 0.09 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.143 -178.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.572 ' CD1' ' NH2' ' A' ' 93' ' ' ARG . 32.3 mt -109.25 129.54 23.79 Favored Pre-proline 0 C--N 1.326 -0.435 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.06 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.12 -9.11 21.77 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 C-N-CA 121.975 1.784 . . . . 0.0 112.634 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.405 HG22 ' CE2' ' B' ' 241' ' ' PHE . 27.6 m -96.74 -0.67 10.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.627 0.251 . . . . 0.0 110.866 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 37.2 t -87.95 136.93 22.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.0 m -69.7 167.54 16.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.294 0.568 . . . . 0.0 111.553 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -64.46 -42.17 96.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.446 -178.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.656 ' O ' ' N ' ' A' ' 49' ' ' CYS . 86.5 mt-30 -115.13 -19.51 10.82 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.384 178.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 24.6 t60 37.3 -76.5 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.656 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -129.1 133.24 47.58 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.27 0.557 . . . . 0.0 111.722 -178.649 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -125.12 126.2 44.94 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.231 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 98.3 mt -112.86 134.55 55.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.578 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.568 ' CD ' ' HE2' ' A' ' 54' ' ' HIS . 84.6 tt0 -122.29 127.06 49.4 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.43 122.95 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 CA-C-O 121.754 0.788 . . . . 0.0 112.754 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.568 ' HE2' ' CD ' ' A' ' 52' ' ' GLU . 98.0 m-70 -114.02 139.42 49.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.388 -1.278 . . . . 0.0 109.308 179.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.473 ' C ' ' O ' ' A' ' 54' ' ' HIS . 83.3 tt0 -38.96 -26.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.55 ' N ' ' O ' ' A' ' 54' ' ' HIS . 91.2 mt-30 -67.36 -67.64 0.44 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.871 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.452 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 3.3 tp10 -155.2 -165.18 1.95 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.826 -179.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -114.33 133.38 55.72 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.527 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.2 mt -121.72 127.54 75.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.005 0.431 . . . . 0.0 111.561 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 28.9 tp -100.26 127.43 46.55 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.223 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -113.53 138.71 49.75 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.041 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.479 ' ND2' ' H ' ' A' ' 69' ' ' THR . 8.6 t-20 -100.65 108.78 20.75 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.389 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -100.88 -9.82 21.25 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.335 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -75.98 99.15 4.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.098 0.475 . . . . 0.0 110.307 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.8 t -73.04 -36.52 66.96 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.519 0.676 . . . . 0.0 109.354 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.5 m -65.31 -48.14 74.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.81 -1.086 . . . . 0.0 111.789 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -142.81 95.11 6.37 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.546 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -55.17 146.78 57.93 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 122.18 1.92 . . . . 0.0 112.287 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.479 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 59.0 m -74.57 140.45 44.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.284 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -99.18 142.51 30.57 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.647 179.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 54.5 t -131.12 134.73 61.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 51.07 30.25 5.32 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 119.321 -0.951 . . . . 0.0 108.601 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.07 26.13 69.5 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.221 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.4 p -137.85 137.34 38.02 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.98 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.7 t -70.99 136.07 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.312 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.4 pt -109.4 93.99 2.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.729 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -67.81 -29.43 68.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.087 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -125.46 174.65 3.73 Favored Pre-proline 0 CA--C 1.536 0.419 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.172 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -61.36 144.58 98.48 Favored 'Trans proline' 0 N--CA 1.501 1.936 0 C-N-CA 122.871 2.38 . . . . 0.0 112.745 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.7 m -144.03 143.06 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.352 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 92.4 mtt-85 -75.36 129.88 38.1 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.61 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 88.1 mt -83.77 139.24 32.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.705 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -126.9 151.16 48.8 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.489 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.495 ' C ' ' CD2' ' A' ' 84' ' ' HIS . 6.1 t60 -58.06 122.39 12.93 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.91 0.385 . . . . 0.0 110.388 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.49 -13.67 32.97 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.574 -0.61 . . . . 0.0 111.574 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -75.0 136.82 41.24 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.728 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.3 t -108.28 131.98 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.068 -178.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.426 HD12 HG22 ' A' ' 88' ' ' ILE . 96.7 mt -97.09 132.07 42.44 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.477 ' CB ' ' HG ' ' A' ' 94' ' ' SER . 84.5 m -124.68 126.7 46.13 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -177.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.437 HG22 HH11 ' A' ' 93' ' ' ARG . 93.2 mt -114.79 122.03 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.523 ' HB ' HH12 ' A' ' 93' ' ' ARG . 89.7 mt 36.29 -103.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.401 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 88.3 m-20 -103.77 9.02 37.22 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -178.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.614 HH21 ' CZ ' ' B' ' 245' ' ' ARG . 2.5 ptp85 -132.46 148.16 52.39 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.509 -0.477 . . . . 0.0 111.194 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.477 ' HG ' ' CB ' ' A' ' 89' ' ' THR . 65.2 m -135.15 152.33 51.5 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.349 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -119.32 121.56 39.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.25 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -81.56 131.05 35.26 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 119.821 -0.751 . . . . 0.0 111.391 -179.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -93.24 120.28 33.34 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.247 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -136.4 122.29 20.02 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.727 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.553 ' O ' ' O ' ' A' ' 4' ' ' THR . 90.6 m-20 -63.59 -40.77 97.79 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 178.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.606 179.243 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 34.1 m . . . . . 0 N--CA 1.453 -0.299 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.491 ' C ' ' H ' ' B' ' 231' ' ' GLN . 75.4 m-20 -71.24 130.71 42.13 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.209 0.528 . . . . 0.0 110.868 -178.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . 0.509 ' P ' ' H ' ' B' ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.491 ' H ' ' C ' ' B' ' 229' ' ' ASP . 75.0 mt-30 -123.9 35.19 4.89 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.988 -1.006 . . . . 0.0 109.449 178.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -114.36 -177.87 19.05 Favored Glycine 0 CA--C 1.533 1.17 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.45 161.11 44.78 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 123.399 2.733 . . . . 0.0 113.04 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -61.5 138.7 77.62 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.637 2.225 . . . . 0.0 112.83 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -73.12 137.65 22.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 114.559 -1.2 . . . . 0.0 109.713 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.8 t -52.39 116.18 2.13 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.444 -179.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -50.7 -26.48 17.43 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.543 2.162 . . . . 0.0 112.986 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 40.1 p -73.99 -39.46 63.65 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . 0.412 ' CE2' ' HD2' ' B' ' 245' ' ' ARG . 81.7 t80 -57.45 -45.7 84.44 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.427 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 90.9 mt -62.89 -40.16 96.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.991 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.77 -43.02 97.64 Favored 'General case' 0 CA--C 1.522 -0.105 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.794 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -61.4 -42.82 99.34 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.839 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.614 ' CZ ' HH21 ' A' ' 93' ' ' ARG . 70.6 mtp85 -61.3 -43.89 98.12 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.484 0.549 . . . . 0.0 112.484 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -62.87 -39.61 94.96 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.099 -0.64 . . . . 0.0 109.298 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 39.7 t -67.23 -46.56 73.43 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.025 178.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . 0.633 ' O ' ' N ' ' B' ' 252' ' ' LEU . 73.4 mt-30 -59.27 -37.21 77.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.36 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 40.7 t -62.79 -46.19 96.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.798 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -58.15 -29.75 65.82 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -96.64 -16.1 21.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.499 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.633 ' N ' ' O ' ' B' ' 248' ' ' GLN . 63.4 tp -123.13 111.36 16.42 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 178.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . 0.596 ' ND2' ' O ' ' B' ' 253' ' ' ASN . 0.5 OUTLIER 179.49 24.3 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.669 179.188 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -99.45 -3.92 32.59 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . 0.453 ' C ' ' H ' ' B' ' 257' ' ' LYS . 67.7 t0 -177.54 55.06 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.586 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.583 ' N ' ' OD1' ' B' ' 256' ' ' ASP . 6.1 p-10 -78.26 31.6 0.18 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.892 0.377 . . . . 0.0 111.035 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . 0.453 ' H ' ' C ' ' B' ' 255' ' ' ASP . 98.5 mttt -60.74 -29.54 69.45 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.744 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.685 ' O ' ' N ' ' B' ' 260' ' ' GLU . 23.3 p-10 -99.82 3.0 44.5 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.977 0.418 . . . . 0.0 110.351 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.451 ' C ' ' O ' ' B' ' 258' ' ' ASP . 48.9 p30 1.12 54.13 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 114.52 -1.218 . . . . 0.0 114.128 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.685 ' N ' ' O ' ' B' ' 258' ' ' ASP . 97.3 mt-10 55.22 9.91 0.39 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 178.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 82.6 mt -117.61 132.88 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 43.2 t -126.97 135.35 63.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.495 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -96.91 120.58 37.52 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.194 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -65.48 -46.11 81.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.539 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -96.9 164.95 16.85 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.277 -178.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -64.32 152.58 80.83 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.351 2.034 . . . . 0.0 111.91 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 42.6 pt . . . . . 0 C--N 1.328 -0.328 0 CA-C-O 121.307 0.575 . . . . 0.0 112.103 -178.553 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo . . . . . 0 N--CA 1.494 1.504 0 N-CA-C 111.459 -0.247 . . . . 0.0 111.459 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.449 ' HG1' ' C ' ' A' ' 100' ' ' GLU . 1.7 p -127.79 26.36 5.88 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.814 -0.354 . . . . 0.0 111.258 -179.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 88.0 mtm-85 -86.09 127.49 34.7 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -128.48 144.28 51.12 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.83 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 82.0 mt -113.89 142.62 45.89 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.5 t -114.14 126.76 71.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.0 m -77.4 140.68 39.95 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.505 0.669 . . . . 0.0 111.52 -178.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.2 mm -109.95 135.31 49.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.088 178.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -94.6 158.29 15.6 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.339 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -57.9 -20.97 41.06 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.89 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.7 p -81.23 -11.65 59.33 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.969 179.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.23 16.55 57.29 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-N 116.086 -0.506 . . . . 0.0 113.094 178.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.5 m -109.05 147.31 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 117.434 0.617 . . . . 0.0 111.533 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.431 ' C ' ' OD1' ' A' ' 16' ' ' ASP . 58.9 t0 -69.74 126.42 29.67 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.18 -178.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.402 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -115.86 -132.35 5.06 Favored Glycine 0 CA--C 1.542 1.751 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -74.18 153.36 46.06 Favored 'Trans proline' 0 N--CA 1.5 1.868 0 C-N-CA 122.509 2.139 . . . . 0.0 112.952 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -109.7 162.51 14.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.006 0.431 . . . . 0.0 110.615 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -132.43 106.76 13.24 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.047 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -73.58 127.37 11.66 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 121.903 1.736 . . . . 0.0 112.603 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.5 mt -92.05 48.26 1.41 Allowed 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.8 p -64.82 -13.05 54.45 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 119.559 -0.856 . . . . 0.0 109.222 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 75.4 mt -81.29 141.6 33.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.222 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 87.8 p -62.19 -21.65 65.27 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.971 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 57.6 m -139.54 138.84 36.63 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 119.827 -0.749 . . . . 0.0 112.164 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.7 t -128.6 123.92 34.57 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.849 178.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.6 tp -117.43 128.18 54.76 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.979 -178.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.483 ' O ' ' O ' ' A' ' 47' ' ' GLN . 4.4 m-85 -107.35 139.61 41.56 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.703 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 155.8 -173.37 33.84 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.196 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.629 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 83.9 mtm-85 -79.79 -31.03 40.76 Favored 'General case' 0 CA--C 1.527 0.079 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.561 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -52.38 146.08 16.52 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 121.003 -0.618 . . . . 0.0 111.695 -178.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.2 mm -63.8 -43.61 97.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.877 0.37 . . . . 0.0 110.078 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -53.0 -18.11 1.82 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.989 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.561 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 59.6 m -61.18 123.39 17.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.982 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -60.18 -31.73 70.4 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.442 HG23 HD12 ' A' ' 37' ' ' ILE . 81.0 mt -124.65 119.33 55.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 176.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -102.41 137.31 40.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.723 -178.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 98.2 mt -122.99 131.62 72.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.521 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -80.3 26.0 0.38 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.529 -178.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 34.8 mt -90.11 132.62 35.48 Favored Pre-proline 0 C--N 1.325 -0.477 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.377 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -71.4 -12.65 29.88 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 121.904 1.736 . . . . 0.0 111.53 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.6 m -102.14 7.59 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.629 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 11.4 t -93.51 129.95 43.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.401 ' HB3' ' HG ' ' A' ' 64' ' ' SER . 0.1 OUTLIER -64.28 168.04 6.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.272 0.558 . . . . 0.0 110.894 -179.453 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -63.25 -43.32 98.32 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.1 -178.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.626 ' O ' ' N ' ' A' ' 49' ' ' CYS . 86.3 mt-30 -111.18 -11.83 14.19 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.55 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 18.6 t60 30.23 -76.68 0.0 OUTLIER 'General case' 0 C--O 1.237 0.402 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.626 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.95 136.04 47.04 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.266 0.555 . . . . 0.0 112.061 -178.549 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -127.38 127.09 43.62 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.064 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 95.8 mt -111.6 133.13 58.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.208 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -114.4 131.69 56.49 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.5 mm -103.51 115.37 45.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.296 0.57 . . . . 0.0 111.269 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.426 ' O ' ' C ' ' A' ' 55' ' ' GLU . 93.2 m-70 -117.04 137.57 52.16 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.959 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 54' ' ' HIS . 80.1 mm-40 -40.18 -35.39 0.39 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.256 0.551 . . . . 0.0 109.777 -179.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.478 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 98.5 mm-40 -64.13 -67.11 0.46 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.983 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.478 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 6.1 tp10 -155.64 -166.08 2.14 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.534 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.45 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -119.88 127.93 53.17 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 91.3 mt -116.02 130.54 70.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.11 0.481 . . . . 0.0 111.496 -178.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 19.6 tp -96.88 127.36 42.78 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.145 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -110.58 136.19 50.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.803 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.586 ' ND2' ' H ' ' A' ' 69' ' ' THR . 20.5 t-20 -97.15 111.66 23.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.856 0.36 . . . . 0.0 111.575 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.444 ' CD2' ' OE1' ' A' ' 47' ' ' GLN . 32.8 m-85 -99.8 -8.22 24.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.667 178.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.401 ' HG ' ' HB3' ' A' ' 45' ' ' SER . 1.8 t -70.59 99.26 1.62 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 88.3 p -85.08 -6.12 59.32 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.324 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.04 -38.04 7.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.286 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -144.68 97.49 5.0 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.032 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.4 147.71 55.62 Favored 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 122.504 2.136 . . . . 0.0 113.376 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.586 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 11.1 m -72.08 138.06 47.55 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.56 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -101.54 139.04 37.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.533 179.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 25.5 t -130.5 134.17 62.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 54.94 32.46 18.01 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.288 0.566 . . . . 0.0 109.696 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.13 27.35 70.36 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.895 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.8 m -138.06 131.66 30.95 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.785 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -67.47 142.42 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 121.101 0.476 . . . . 0.0 111.123 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.525 ' CG2' ' O ' ' A' ' 78' ' ' GLU . 75.1 mt -114.51 123.79 70.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.845 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -96.14 -24.09 16.45 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.981 179.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.525 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 3.7 mm-40 -129.27 172.42 7.16 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.785 -178.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -60.6 146.49 96.98 Favored 'Trans proline' 0 N--CA 1.501 1.943 0 C-N-CA 122.285 1.99 . . . . 0.0 112.652 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.1 p -140.15 144.97 26.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.209 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -77.85 129.66 35.68 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.157 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.9 mt -86.56 135.94 33.25 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.249 0.547 . . . . 0.0 111.107 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -131.1 154.25 48.49 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.629 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.723 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 8.2 t60 -53.44 117.37 3.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.626 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 113.87 -25.38 10.9 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.1 -0.572 . . . . 0.0 112.157 178.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -66.8 137.0 56.3 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.871 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 68.4 t -113.38 132.68 61.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.7 -178.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.0 mt -93.4 130.79 41.9 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 N-CA-C 107.994 -1.114 . . . . 0.0 107.994 178.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 51.4 m -118.52 128.26 54.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.639 0.733 . . . . 0.0 112.575 -178.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.458 ' O ' ' C ' ' A' ' 91' ' ' ILE . 95.3 mt -118.03 124.63 73.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.682 178.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.458 ' C ' ' O ' ' A' ' 90' ' ' ILE . 42.6 mm 34.14 -95.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.944 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 90' ' ' ILE . 47.9 t0 -117.65 15.36 14.53 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.727 0.298 . . . . 0.0 111.336 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.571 ' NH2' ' OE1' ' B' ' 260' ' ' GLU . 55.6 mtt85 -127.13 143.44 51.27 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.09 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 38.2 m -135.69 154.53 51.25 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.531 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -127.56 121.58 30.98 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -88.58 133.62 34.12 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.984 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -93.07 122.98 36.0 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.166 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -124.51 118.81 27.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.838 0.351 . . . . 0.0 110.294 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.723 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 58.5 t-20 -100.19 102.65 14.0 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.449 ' C ' ' HG1' ' A' ' 4' ' ' THR . 79.9 mm-40 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.641 -178.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 47.5 t . . . . . 0 N--CA 1.45 -0.465 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.506 ' C ' ' H ' ' B' ' 231' ' ' GLN . 87.3 m-20 -68.97 143.84 54.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.513 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . 0.466 ' N ' ' O3P' ' B' ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.506 ' H ' ' C ' ' B' ' 229' ' ' ASP . 75.0 mt-30 -130.16 33.34 4.37 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.5 -179.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -109.15 -157.7 18.09 Favored Glycine 0 CA--C 1.531 1.072 0 N-CA-C 111.582 -0.607 . . . . 0.0 111.582 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -77.86 160.2 30.81 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 123.002 2.468 . . . . 0.0 112.831 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -77.57 172.93 14.98 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.602 2.201 . . . . 0.0 111.712 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 27.9 t -112.84 133.6 58.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.375 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 2.3 t -78.17 121.46 24.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.438 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . 0.441 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . 0.441 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 42.3 Cg_exo -57.77 -24.98 66.46 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 122.995 2.463 . . . . 0.0 113.795 -179.02 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 240' ' ' THR . . . . . 0.438 ' OG1' ' P ' ' B' ' 238' ' ' TPO . 18.1 p -76.04 -42.57 47.33 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.735 178.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -58.08 -45.0 87.87 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.837 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 95.6 mt -64.54 -41.87 96.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.781 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -63.95 -36.92 85.53 Favored 'General case' 0 C--N 1.334 -0.093 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.38 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' B' ' 244' ' ' ARG . 78.2 mtt85 -61.74 -43.25 99.21 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.628 -0.429 . . . . 0.0 109.981 179.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -63.2 -41.88 99.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.427 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -63.53 -39.36 94.23 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 11.2 t -64.28 -46.59 83.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.129 178.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -61.42 -35.87 78.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.611 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . 0.469 ' O ' ' O ' ' B' ' 252' ' ' LEU . 77.3 t -64.92 -44.23 96.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.903 0.382 . . . . 0.0 110.188 179.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -60.22 -33.88 72.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.564 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -95.61 -5.51 42.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.305 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.469 ' O ' ' O ' ' B' ' 249' ' ' VAL . 54.5 tp -119.79 120.19 35.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.502 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -70.92 -179.86 2.43 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.916 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . 0.414 ' N ' ' OD1' ' B' ' 254' ' ' ASP . 36.3 p-10 -91.37 2.34 56.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.707 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -70.44 -9.45 56.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.979 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.47 ' OD1' ' OD1' ' B' ' 258' ' ' ASP . 25.9 t0 -84.33 90.17 7.51 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.134 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . 0.428 ' C ' ' H ' ' B' ' 259' ' ' ASP . 98.7 mttt -81.56 7.23 12.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.546 -178.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.524 ' O ' ' C ' ' B' ' 259' ' ' ASP . 12.7 p-10 -82.8 23.07 0.84 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.689 ' C ' ' H ' ' B' ' 261' ' ' ILE . 38.0 p30 -19.68 124.91 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 123.99 0.806 . . . . 0.0 111.603 -179.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.571 ' OE1' ' NH2' ' A' ' 93' ' ' ARG . 96.0 mt-10 -52.71 7.78 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.461 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . 0.689 ' H ' ' C ' ' B' ' 259' ' ' ASP . 68.5 mt -107.77 134.5 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 178.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 77.3 t -128.07 136.76 59.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.369 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -95.49 118.18 31.74 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.296 0.57 . . . . 0.0 111.499 -178.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -65.05 -44.02 90.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.289 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 10.4 mm-40 -96.73 154.01 38.53 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.57 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -61.65 146.24 96.94 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.326 2.017 . . . . 0.0 112.355 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 45.6 pt . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.872 -179.637 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo . . . . . 0 N--CA 1.494 1.556 0 CA-C-O 120.645 0.185 . . . . 0.0 112.171 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 96.4 m -96.61 -45.05 6.87 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.382 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.6 mtt85 -87.51 129.74 34.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.436 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -133.93 139.55 46.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.611 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 34.5 tp -114.59 129.2 56.65 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.764 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.7 t -108.19 131.11 59.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.29 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.8 m -81.76 148.23 29.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.287 0.565 . . . . 0.0 111.711 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 92.6 mt -117.93 138.06 49.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 114.979 -1.01 . . . . 0.0 108.74 178.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -91.14 160.73 15.41 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.045 0.45 . . . . 0.0 111.408 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.522 HH12 ' CD ' ' B' ' 248' ' ' GLN . 89.9 mtm180 -58.63 -28.82 66.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.781 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.5 p -78.41 -7.61 57.56 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.636 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.67 33.17 9.38 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -178.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.5 t -123.78 135.27 64.02 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 CA-C-O 121.385 0.612 . . . . 0.0 111.55 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -76.27 138.11 40.34 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.547 179.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -126.29 -121.62 2.5 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 111.404 -0.678 . . . . 0.0 111.404 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.24 152.92 45.47 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.281 1.988 . . . . 0.0 112.829 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -110.34 153.81 24.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.16 0.505 . . . . 0.0 110.658 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.426 ' CD2' HD12 ' A' ' 37' ' ' ILE . 43.8 t80 -122.58 94.9 47.26 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.335 -179.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -59.36 127.03 22.47 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 121.349 1.366 . . . . 0.0 111.254 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.4 mt -84.77 50.17 1.86 Allowed 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.448 -178.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 72.4 m -60.86 -33.83 73.67 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.2 0.524 . . . . 0.0 109.845 179.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 66.7 mt -69.97 139.96 52.91 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.369 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.0 t -65.69 -18.83 65.61 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.405 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.9 m -134.51 133.53 40.45 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.246 -0.582 . . . . 0.0 111.444 -178.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.2 t -129.54 120.37 25.24 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.313 0.578 . . . . 0.0 110.249 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 48.4 tp -117.37 131.74 56.72 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.994 -178.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.462 ' O ' ' O ' ' A' ' 47' ' ' GLN . 37.3 m-85 -109.7 140.5 43.5 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.848 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 153.86 -175.49 32.14 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 120.783 -0.723 . . . . 0.0 111.686 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 45.0 mtm180 -75.15 -32.29 61.27 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.609 0.242 . . . . 0.0 111.428 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.589 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -45.04 140.04 4.76 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.1 tp -66.91 -41.07 87.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.374 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -61.41 -15.73 39.66 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.205 0.526 . . . . 0.0 110.149 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.589 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 8.8 m -61.17 131.62 51.05 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.289 -0.564 . . . . 0.0 109.752 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -60.67 -33.43 72.82 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.426 HD12 ' CD2' ' A' ' 20' ' ' PHE . 44.1 mm -121.4 115.12 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.061 177.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 88.3 mtm-85 -100.72 133.08 45.71 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.475 ' CG2' ' NH1' ' A' ' 93' ' ' ARG . 96.2 mt -119.24 129.8 74.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.689 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -74.92 24.14 0.09 Allowed 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -177.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.46 ' CD2' ' NH2' ' A' ' 93' ' ' ARG . 95.6 mt -97.87 126.71 39.64 Favored Pre-proline 0 C--N 1.324 -0.512 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.384 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -70.97 -9.67 26.13 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.682 2.254 . . . . 0.0 113.232 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.1 m -97.71 5.33 9.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.393 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.4 t -94.96 136.79 25.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.692 0.282 . . . . 0.0 110.38 179.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.404 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 1.2 t -67.52 165.62 16.44 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.164 0.507 . . . . 0.0 110.857 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 41.1 mtmt -62.51 -41.99 99.21 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.36 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.605 ' O ' ' N ' ' A' ' 49' ' ' CYS . 84.2 mt-30 -111.46 -17.72 13.02 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.954 0.407 . . . . 0.0 111.111 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.404 ' H ' ' HB3' ' A' ' 45' ' ' SER . 26.8 t60 34.06 -75.92 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.605 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.81 136.94 49.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.321 0.581 . . . . 0.0 112.559 -177.785 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -127.09 129.0 47.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.979 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 93.5 mt -114.83 133.31 61.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.43 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -117.1 126.98 53.67 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 77.5 mt -108.81 113.78 45.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.705 0.765 . . . . 0.0 111.714 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.582 ' O ' ' N ' ' A' ' 56' ' ' GLN . 86.4 m-70 -114.27 146.79 40.0 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.806 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 54' ' ' HIS . 57.7 mp0 -40.58 -22.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.653 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.582 ' N ' ' O ' ' A' ' 54' ' ' HIS . 14.8 mm100 -72.57 -69.38 0.41 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -160.58 -164.89 1.3 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.191 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.8 124.26 50.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.663 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.403 HG21 ' NE2' ' A' ' 61' ' ' HIS . 96.6 mt -113.5 130.02 68.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.026 0.441 . . . . 0.0 111.751 -179.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 25.6 tp -99.76 128.3 45.87 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.011 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.403 ' NE2' HG21 ' A' ' 59' ' ' ILE . 94.7 m-70 -113.15 136.04 53.15 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.147 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -93.48 107.97 19.73 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.642 0.258 . . . . 0.0 111.67 -178.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -101.19 -11.51 19.48 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.714 179.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.6 t -72.45 98.43 2.27 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.9 t -82.69 -17.33 44.84 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.806 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.32 -43.21 8.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.287 -178.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -133.31 97.35 16.35 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -57.62 144.33 92.88 Favored 'Trans proline' 0 N--CA 1.5 1.894 0 C-N-CA 122.183 1.922 . . . . 0.0 113.224 -178.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.6 m -72.51 150.01 43.6 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.372 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -114.42 141.25 47.9 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.482 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 44.6 t -127.72 134.1 66.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 54.84 32.02 16.85 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.139 -0.625 . . . . 0.0 110.12 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.12 23.28 77.99 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.124 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.7 t -138.33 143.95 40.16 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 117.011 0.405 . . . . 0.0 110.99 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 44.2 t -67.08 132.33 32.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.502 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.409 HG12 ' O ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -118.56 79.29 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.426 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -65.96 -21.35 66.41 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.117 -178.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.409 ' O ' HG12 ' A' ' 76' ' ' ILE . 0.6 OUTLIER -110.35 159.95 30.2 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -179.562 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.41 145.87 92.83 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 C-N-CA 121.148 1.232 . . . . 0.0 111.196 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.42 145.73 21.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 89.9 mtm180 -75.29 132.05 40.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.795 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 92.0 mt -80.77 141.27 34.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.066 0.46 . . . . 0.0 110.927 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -129.02 149.84 50.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.779 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.471 ' C ' ' CD2' ' A' ' 84' ' ' HIS . 7.7 t60 -54.67 119.91 5.99 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.376 -0.529 . . . . 0.0 110.57 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.07 -8.32 41.94 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.43 ' C ' ' OD1' ' A' ' 86' ' ' ASP . 45.6 t0 -71.62 127.54 32.9 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.45 ' CG1' ' OG ' ' A' ' 94' ' ' SER . 76.6 t -105.56 134.62 46.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.401 -178.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.416 ' O ' ' OG ' ' A' ' 94' ' ' SER . 11.6 mm -98.16 128.55 49.49 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.7 m -122.48 129.06 51.61 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.841 0.829 . . . . 0.0 112.875 -178.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.476 ' O ' ' C ' ' A' ' 91' ' ' ILE . 74.1 mt -121.01 127.03 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 114.445 -1.252 . . . . 0.0 108.429 178.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.476 ' C ' ' O ' ' A' ' 90' ' ' ILE . 37.5 mm 35.91 -99.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 C-N-CA 120.576 -0.449 . . . . 0.0 110.252 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.504 ' O ' ' OD1' ' A' ' 92' ' ' ASP . 39.0 t0 -118.07 17.6 14.03 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.989 0.424 . . . . 0.0 110.91 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.535 ' NH2' ' OE1' ' B' ' 260' ' ' GLU . 97.7 mtt180 -125.67 142.17 51.65 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.759 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.45 ' OG ' ' CG1' ' A' ' 87' ' ' VAL . 16.6 t -140.12 152.85 46.44 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 120.184 -0.607 . . . . 0.0 110.781 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -126.07 125.12 42.07 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.617 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -88.03 134.09 33.82 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 120.351 -0.539 . . . . 0.0 111.605 -178.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -97.64 125.92 42.66 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.858 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -131.03 124.28 30.56 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.216 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 45.5 p-10 -102.52 9.94 39.19 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.841 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 . . . . . 0 C--N 1.323 -0.544 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.905 179.649 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 78.3 t . . . . . 0 CA--C 1.529 0.141 0 CA-C-O 120.577 0.227 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.475 ' C ' ' H ' ' B' ' 231' ' ' GLN . 86.6 m-20 -98.6 -4.1 34.74 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.81 0.338 . . . . 0.0 110.434 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . 0.65 ' O ' ' NE2' ' B' ' 231' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.65 ' NE2' ' O ' ' B' ' 230' ' ' SEP . 92.3 mm-40 -135.63 39.83 2.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.363 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -110.38 -162.51 18.61 Favored Glycine 0 CA--C 1.521 0.441 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.736 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -70.94 156.08 60.91 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 123.465 2.777 . . . . 0.0 112.176 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -78.12 140.22 17.62 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 121.768 1.645 . . . . 0.0 112.765 -179.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 39.8 t -67.78 136.56 26.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.72 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 10.4 t -62.55 126.81 28.62 Favored 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.594 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -57.77 -23.15 56.89 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 121.921 1.747 . . . . 0.0 112.5 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 24.7 m -71.41 -42.95 67.68 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -58.33 -46.61 85.88 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.221 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 88.0 mt -62.97 -41.17 99.46 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.491 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -61.34 -38.76 88.08 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.408 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . 0.451 ' O ' ' OG ' ' B' ' 247' ' ' SER . 42.1 ttm180 -63.79 -42.77 97.67 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.419 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -60.88 -40.27 92.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.259 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -64.17 -38.45 91.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.863 0.364 . . . . 0.0 110.763 179.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 247' ' ' SER . . . . . 0.576 ' HG ' ' N ' ' B' ' 248' ' ' GLN . 80.8 p -68.61 -40.56 80.37 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . 0.576 ' N ' ' HG ' ' B' ' 247' ' ' SER . 59.8 tt0 -60.53 -38.27 83.9 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.442 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 24.4 t -63.04 -44.96 99.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -59.96 -27.62 66.97 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.72 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -96.59 -12.44 23.97 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.748 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.443 ' N ' ' O ' ' B' ' 248' ' ' GLN . 54.3 tp -124.39 115.66 21.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.305 178.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 171.63 23.0 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.042 178.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' B' ' 255' ' ' ASP . 29.2 p-10 -65.89 -46.4 78.5 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . 0.535 ' N ' ' OD1' ' B' ' 254' ' ' ASP . 24.6 p-10 170.38 64.41 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.551 179.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -120.33 99.48 6.6 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 120.551 -0.459 . . . . 0.0 111.725 -178.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . 0.597 ' O ' ' N ' ' B' ' 259' ' ' ASP . 98.8 mttt -65.76 -84.14 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.98 0.419 . . . . 0.0 110.161 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.583 ' O ' ' N ' ' B' ' 260' ' ' GLU . 97.4 m-20 -33.97 -28.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.476 -178.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.597 ' N ' ' O ' ' B' ' 257' ' ' LYS . 61.3 t0 45.86 -79.3 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.448 178.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.583 ' N ' ' O ' ' B' ' 258' ' ' ASP . 91.1 mt-10 -148.22 10.42 0.88 Allowed 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.347 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 64.6 mt -108.59 141.45 23.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 54.3 t -127.27 135.62 62.93 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 CA-C-O 121.065 0.459 . . . . 0.0 110.957 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -98.81 124.06 43.44 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.519 -178.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . 0.416 ' HB3' ' NE2' ' B' ' 265' ' ' GLN . 88.6 tttt -64.69 -47.1 79.61 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.705 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . 0.724 ' N ' HE21 ' B' ' 265' ' ' GLN . 0.0 OUTLIER -96.74 159.1 32.42 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.547 -179.344 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -68.05 143.51 60.19 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 122.998 2.465 . . . . 0.0 113.395 -179.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 47.9 pt . . . . . 0 C--N 1.326 -0.438 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.535 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo . . . . . 0 N--CA 1.496 1.654 0 CA-C-O 120.588 0.162 . . . . 0.0 111.874 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.8 m -100.84 -55.47 2.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.399 0.619 . . . . 0.0 110.137 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.791 HH11 ' HH ' ' A' ' 97' ' ' TYR . 93.9 mtt-85 -92.39 130.81 37.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.309 -178.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.568 ' HE ' ' CE1' ' A' ' 19' ' ' HIS . 85.6 mtp180 -128.7 141.4 51.34 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.106 0.479 . . . . 0.0 111.343 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 41.7 tp -117.8 136.46 53.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.065 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.7 t -114.26 130.01 69.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 CA-C-O 120.775 0.321 . . . . 0.0 111.353 -178.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 m -94.87 116.16 28.37 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.553 -178.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 66.9 mt -84.93 150.93 3.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.99 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -92.93 161.15 14.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.714 0.292 . . . . 0.0 110.358 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.755 HH11 HH11 ' B' ' 245' ' ' ARG . 91.0 mtm180 -57.22 -29.3 63.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.917 -179.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 75.4 p -77.28 -11.09 59.79 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.831 -0.347 . . . . 0.0 110.818 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.88 29.28 11.95 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.1 t -114.49 133.69 59.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.735 0.303 . . . . 0.0 110.668 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' A' ' 17' ' ' GLY . 64.8 t0 -69.34 127.64 33.77 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.809 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.409 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -119.31 -123.67 3.19 Favored Glycine 0 CA--C 1.537 1.42 0 C-N-CA 121.083 -0.579 . . . . 0.0 112.166 -179.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -74.34 149.08 39.45 Favored 'Trans proline' 0 N--CA 1.497 1.709 0 C-N-CA 122.492 2.128 . . . . 0.0 113.338 -178.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.568 ' CE1' ' HE ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -109.28 151.72 26.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.902 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -121.29 104.5 40.57 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.906 -178.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.437 ' O ' ' NE2' ' B' ' 265' ' ' GLN . 60.2 Cg_endo -77.48 127.37 8.9 Favored 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 121.767 1.645 . . . . 0.0 111.722 -179.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 79.3 mt -77.23 80.36 3.75 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.369 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.632 ' H ' HE22 ' B' ' 265' ' ' GLN . 66.4 p -82.91 -10.99 58.54 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.8 mt -108.07 148.93 29.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.574 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 94.7 p -72.19 -13.4 61.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.845 -178.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 29.0 m -129.57 131.34 46.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.185 0.517 . . . . 0.0 110.777 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.684 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -128.0 119.64 25.88 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.579 179.191 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.507 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 49.2 tp -120.02 125.29 47.99 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.737 -178.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.684 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 19.5 m-85 -98.96 124.36 43.86 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -176.98 -156.77 16.53 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 119.894 -1.146 . . . . 0.0 112.503 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.622 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 84.7 mtm-85 -107.9 -24.31 11.69 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 120.354 -0.539 . . . . 0.0 110.599 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.28 165.06 36.06 Favored Glycine 0 CA--C 1.524 0.644 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.135 -178.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.5 tp -67.14 -40.01 84.34 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 CA-C-N 115.529 -0.336 . . . . 0.0 110.713 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -57.62 -32.64 67.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.533 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 68.9 m -49.52 116.18 1.64 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.936 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.572 ' OD1' ' N ' ' A' ' 37' ' ' ILE . 6.6 p-10 -58.16 -29.65 65.76 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.572 ' N ' ' OD1' ' A' ' 36' ' ' ASP . 80.2 mt -129.23 117.11 42.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 177.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -101.28 138.74 37.9 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.871 0.367 . . . . 0.0 111.459 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.479 ' C ' ' H ' ' A' ' 41' ' ' LEU . 91.6 mt -119.71 130.6 73.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.473 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.431 ' OE1' ' OE1' ' B' ' 260' ' ' GLU . 73.8 mt-30 -73.53 21.9 0.08 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.396 -178.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.534 ' CD2' ' NH2' ' B' ' 245' ' ' ARG . 20.1 mt -90.65 123.52 64.94 Favored Pre-proline 0 C--N 1.326 -0.426 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.165 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.31 -8.52 22.02 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 121.671 1.581 . . . . 0.0 112.128 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.4 m -101.42 4.77 10.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 C-N-CA 120.43 -0.508 . . . . 0.0 111.451 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.622 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 38.0 t -96.72 106.77 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.297 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.533 ' O ' ' O ' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -33.84 162.91 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.963 0.887 . . . . 0.0 112.385 -179.143 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.45 ' CE ' ' O ' ' B' ' 232' ' ' GLY . 96.3 mttt -61.66 -41.06 97.0 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.354 -1.294 . . . . 0.0 111.461 -178.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.616 ' O ' ' N ' ' A' ' 49' ' ' CYS . 89.7 mm-40 -109.57 -17.45 13.73 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 123.728 0.642 . . . . 0.0 110.303 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.494 ' O ' ' OG ' ' A' ' 64' ' ' SER . 19.1 t60 36.87 -78.51 0.0 OUTLIER 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.072 -0.967 . . . . 0.0 113.02 -179.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.616 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -135.93 139.75 43.5 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.616 -178.588 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -126.41 131.68 51.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.843 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 87.9 mt -115.38 131.91 66.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.176 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -118.07 129.36 55.51 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.9 mt -110.49 121.85 64.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.548 0.689 . . . . 0.0 112.852 -178.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.464 ' O ' ' C ' ' A' ' 55' ' ' GLU . 97.3 m-70 -116.49 140.33 49.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.406 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 54' ' ' HIS . 92.1 mt-10 -39.92 -30.32 0.08 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.462 ' N ' ' O ' ' A' ' 54' ' ' HIS . 88.4 mt-30 -64.57 -68.79 0.33 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.798 178.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -152.21 -171.45 3.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.404 0.621 . . . . 0.0 110.748 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -111.91 124.63 52.78 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.507 178.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 91.0 mt -114.21 131.22 66.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.179 0.514 . . . . 0.0 112.128 -178.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.456 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 16.2 tp -104.1 129.6 51.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.191 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -115.2 138.09 51.31 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.167 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.571 ' ND2' ' H ' ' A' ' 69' ' ' THR . 23.3 t-20 -102.02 110.6 22.6 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.965 179.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -98.4 -5.35 32.8 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.157 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.494 ' OG ' ' O ' ' A' ' 48' ' ' HIS . 1.4 m -71.64 100.64 2.34 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.277 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.7 m -84.11 -20.48 32.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.119 0.485 . . . . 0.0 109.963 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.76 -40.85 11.58 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.619 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -138.94 95.16 9.7 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.872 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -57.77 143.65 95.0 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 122.287 1.991 . . . . 0.0 112.552 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.571 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 4.5 m -77.08 154.79 32.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.58 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.402 ' N ' ' CG2' ' A' ' 69' ' ' THR . 75.3 mt-30 -114.87 140.45 48.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.921 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 50.6 t -128.43 135.72 61.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 50.27 33.56 7.55 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.38 28.41 67.9 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.775 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.4 t -142.47 139.45 31.56 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.173 -0.611 . . . . 0.0 112.197 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.7 t -67.51 137.54 24.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.282 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 10.9 pt -108.6 81.33 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.154 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -60.85 -33.54 73.22 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.542 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.471 ' N ' ' CD ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -117.05 165.4 15.54 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.873 179.754 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.54 142.39 98.82 Favored 'Trans proline' 0 N--CA 1.502 1.979 0 C-N-CA 122.346 2.031 . . . . 0.0 112.162 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.5 m -135.6 138.17 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-O 120.961 0.41 . . . . 0.0 111.904 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.7 mtm180 -72.39 131.18 42.27 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.7 mt -80.02 136.61 36.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.266 0.555 . . . . 0.0 111.436 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -126.41 146.79 49.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.935 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.729 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 3.5 t-160 -54.41 121.88 9.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.146 0.498 . . . . 0.0 110.909 -178.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.73 -10.84 38.37 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -71.86 136.71 47.06 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.49 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.7 p -114.12 132.21 63.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.182 -178.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 69.1 mt -101.65 132.9 46.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 53.0 m -118.65 128.72 54.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.686 0.755 . . . . 0.0 112.121 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.555 ' O ' ' N ' ' A' ' 93' ' ' ARG . 98.1 mt -118.81 131.26 72.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 177.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.496 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 88.9 mt -24.43 98.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.547 ' OD1' ' CD2' ' B' ' 242' ' ' LEU . 2.7 m-20 89.01 -15.78 0.31 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 177.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.57 HH21 ' CG ' ' B' ' 260' ' ' GLU . 69.6 mtt85 -132.5 141.89 48.97 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.159 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.6 t -135.98 149.98 49.07 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.436 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 36.7 m-85 -126.57 123.63 38.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.785 -179.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -84.42 129.09 34.9 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.599 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.791 ' HH ' HH11 ' A' ' 5' ' ' ARG . 87.8 t80 -91.78 124.67 36.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.137 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -123.76 132.42 53.8 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.737 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.729 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 41.5 t-20 -115.09 115.06 26.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.137 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 121.11 0.481 . . . . 0.0 110.281 179.926 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 121.134 0.492 . . . . 0.0 110.613 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.553 ' O ' ' CB ' ' B' ' 230' ' ' SEP . 98.0 m-20 -97.39 -12.07 23.19 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.503 179.252 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . 0.553 ' CB ' ' O ' ' B' ' 229' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -167.85 62.06 0.07 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.382 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . 0.45 ' O ' ' CE ' ' A' ' 46' ' ' LYS . . . -98.17 -140.77 11.61 Favored Glycine 0 CA--C 1.535 1.311 0 N-CA-C 110.926 -0.869 . . . . 0.0 110.926 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -76.09 160.13 36.8 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.29 1.993 . . . . 0.0 112.8 -179.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -69.8 167.78 23.5 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.144 1.896 . . . . 0.0 112.45 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 44.1 t -112.61 132.5 61.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.644 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 2.5 t -72.03 133.47 45.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.159 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . 0.566 ' P ' ' OG1' ' B' ' 240' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 31.4 Cg_exo -59.28 -23.43 69.78 Favored 'Trans proline' 0 N--CA 1.501 1.945 0 C-N-CA 123.289 2.659 . . . . 0.0 113.611 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 240' ' ' THR . . . . . 0.566 ' OG1' ' P ' ' B' ' 238' ' ' TPO . 19.0 p -82.76 -38.9 22.58 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.347 -0.541 . . . . 0.0 109.886 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -57.9 -46.48 84.87 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.726 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . 0.547 ' CD2' ' OD1' ' A' ' 92' ' ' ASP . 97.3 mt -66.23 -42.43 88.64 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.386 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -63.39 -43.27 98.04 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.996 -178.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -63.43 -43.32 97.8 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.858 0.361 . . . . 0.0 111.04 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.755 HH11 HH11 ' A' ' 12' ' ' ARG . 58.0 ttm-85 -61.4 -42.28 98.47 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.797 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -63.17 -37.85 88.85 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.205 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 67.3 m -67.46 -43.8 80.15 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 177.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 63.5 tp60 -59.58 -39.85 85.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.979 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 77.6 t -62.51 -44.18 99.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -61.18 -25.04 66.75 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -82.19 -8.6 59.65 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.41 178.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.546 ' CD1' ' NH2' ' A' ' 12' ' ' ARG . 85.7 mt -100.49 -179.75 4.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.82 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . 0.493 ' N ' ' OD1' ' B' ' 253' ' ' ASN . 7.1 p-10 -153.2 -170.96 3.77 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.836 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -49.63 -11.55 0.06 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.224 -178.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . 0.53 ' C ' ' H ' ' B' ' 257' ' ' LYS . 44.4 p-10 -84.11 7.83 17.53 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' B' ' 253' ' ' ASN . 53.8 p-10 -72.29 39.94 0.08 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.251 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . 0.53 ' H ' ' C ' ' B' ' 255' ' ' ASP . 98.8 mttt -69.91 153.12 43.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.87 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' B' ' 260' ' ' GLU . 99.7 m-20 59.58 55.99 3.84 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -178.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.423 ' O ' ' OD1' ' B' ' 259' ' ' ASP . 43.5 p30 -58.45 58.13 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.043 -0.981 . . . . 0.0 112.907 -177.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.575 ' N ' ' O ' ' B' ' 258' ' ' ASP . 49.9 mm-40 63.64 5.51 2.23 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 177.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . 0.41 HG22 HD12 ' B' ' 261' ' ' ILE . 89.4 mt -110.1 135.09 50.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 69.2 t -127.5 132.06 69.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.927 0.394 . . . . 0.0 110.204 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -96.35 120.7 37.13 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.241 0.543 . . . . 0.0 111.493 -178.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -67.96 -41.35 82.59 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.417 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . 0.632 HE22 ' H ' ' A' ' 23' ' ' SER . 0.0 OUTLIER -93.59 161.41 30.54 Favored Pre-proline 0 N--CA 1.463 0.202 0 CA-C-N 116.62 -0.263 . . . . 0.0 111.419 -177.797 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -59.31 143.55 99.7 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.227 1.951 . . . . 0.0 111.181 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . 0.55 ' CG2' ' O ' ' A' ' 19' ' ' HIS . 2.1 mt . . . . . 0 N--CA 1.449 -0.477 0 C-N-CA 120.304 -0.559 . . . . 0.0 110.55 -178.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo . . . . . 0 N--CA 1.491 1.378 0 CA-C-O 120.946 0.311 . . . . 0.0 112.294 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.1 m -126.74 -63.05 1.1 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.665 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -98.56 135.38 40.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.037 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -137.89 150.4 47.06 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.498 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 86.2 mt -116.5 139.22 50.71 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.455 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 65.5 t -110.92 127.98 67.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.8 m -79.04 142.06 36.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.387 0.613 . . . . 0.0 112.386 -178.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.9 mt -114.17 135.88 52.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.467 176.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -86.91 160.01 18.85 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 90.9 mtm180 -57.84 -29.31 64.86 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.578 -178.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 42.8 m -80.81 -9.49 59.81 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.712 0.291 . . . . 0.0 110.928 179.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.68 40.67 5.58 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.6 t -121.09 133.02 69.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.919 0.39 . . . . 0.0 110.74 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -75.19 125.45 28.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.154 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -120.54 -121.01 2.82 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.062 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -74.89 150.78 39.25 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.464 2.109 . . . . 0.0 112.777 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.97 155.85 22.1 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -122.29 93.24 48.65 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.2 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.467 ' O ' ' NE2' ' B' ' 265' ' ' GLN . 27.3 Cg_exo -61.66 130.47 31.62 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.159 1.906 . . . . 0.0 111.74 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.7 mt -85.79 82.22 8.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.426 0.631 . . . . 0.0 110.396 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.7 p -86.78 -8.14 57.62 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.002 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 42.7 mt -108.08 147.99 30.42 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.964 -178.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.9 t -65.39 -18.25 65.17 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -178.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 21.6 m -136.65 136.96 39.56 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.463 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.7 t -129.73 123.4 30.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.514 178.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 52.5 tp -116.69 129.69 56.28 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.037 0.446 . . . . 0.0 111.642 -178.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.51 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 3.2 m-85 -109.16 144.47 37.18 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.99 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 146.97 -170.12 27.94 Favored Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.764 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 47.9 mtm180 -78.53 -32.3 47.91 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.491 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -50.83 146.77 9.15 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.63 -178.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.445 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 7.6 tp -67.17 -41.78 87.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.445 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 70.3 mm-40 -53.33 -17.65 1.98 Allowed 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.813 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 59.8 m -62.27 121.42 13.11 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.749 -179.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -57.83 -29.71 65.15 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.407 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 92.5 mt -128.23 121.93 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.107 176.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -106.97 137.94 44.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.092 -178.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 95.5 mt -120.53 129.32 75.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -78.2 26.99 0.2 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.4 mt -92.73 126.84 50.33 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.808 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.79 -12.41 30.89 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.499 2.133 . . . . 0.0 113.632 -179.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.416 ' CG2' ' CE2' ' B' ' 241' ' ' PHE . 35.2 m -99.92 5.83 9.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.791 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.7 t -89.32 136.61 23.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.986 179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.2 m -67.84 161.33 26.48 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.52 0.676 . . . . 0.0 111.548 -178.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -61.65 -42.99 99.67 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.112 -178.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.603 ' O ' ' N ' ' A' ' 49' ' ' CYS . 95.5 mt-30 -115.72 -6.26 12.13 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 123.652 0.595 . . . . 0.0 111.064 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.463 ' C ' ' O ' ' A' ' 47' ' ' GLN . 15.2 t60 15.9 -73.43 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 -178.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.603 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -128.48 132.67 48.38 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.483 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -126.85 126.57 43.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.179 179.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 85.6 mt -106.71 130.32 58.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.048 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -116.81 119.83 36.62 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.5 mt -103.62 116.55 47.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.02 -0.672 . . . . 0.0 112.285 -178.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.551 ' O ' ' N ' ' A' ' 56' ' ' GLN . 87.0 m-70 -114.88 142.91 45.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.303 179.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.4 mm-40 -39.52 -26.35 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -178.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.551 ' N ' ' O ' ' A' ' 54' ' ' HIS . 77.7 mt-30 -69.47 -68.73 0.39 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.891 178.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.409 ' CD ' ' N ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -157.68 -166.13 1.93 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.321 -179.174 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.9 130.2 56.2 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.2 mt -119.8 130.78 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.46 ' CD1' ' HG ' ' A' ' 49' ' ' CYS . 29.0 tp -100.14 125.83 46.32 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.291 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -107.53 137.57 45.32 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.575 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -99.92 106.95 18.82 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -99.35 -5.35 29.8 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.662 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.585 ' HG ' ' C ' ' A' ' 67' ' ' ASN . 23.1 t -86.77 99.88 12.11 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 120.401 -0.52 . . . . 0.0 112.014 -178.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.5 m -73.68 -37.6 65.17 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 177.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.7 p -65.66 -36.24 83.09 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.636 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.585 ' C ' ' HG ' ' A' ' 64' ' ' SER . 36.3 m-80 -153.05 97.92 2.8 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.547 -179.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -59.28 147.01 92.87 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.063 1.842 . . . . 0.0 112.758 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 60.4 m -65.62 133.58 51.46 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 177.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -96.82 141.55 29.88 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.223 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.525 ' CG2' ' OD1' ' A' ' 86' ' ' ASP . 5.2 p -129.66 134.67 62.93 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 50.96 32.97 8.08 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 119.694 -0.802 . . . . 0.0 109.15 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.05 28.53 66.38 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.443 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.2 t -140.24 139.43 35.58 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 117.308 0.554 . . . . 0.0 110.743 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -68.05 144.1 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 120.903 0.382 . . . . 0.0 111.48 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.511 ' CG2' ' O ' ' A' ' 78' ' ' GLU . 85.9 mt -106.28 108.73 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.693 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -76.18 -39.17 55.48 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.1 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.511 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 1.5 mt-10 -128.64 172.99 6.11 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.737 -178.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -57.54 143.57 94.29 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 122.16 1.907 . . . . 0.0 112.57 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.1 t -133.0 138.03 52.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.425 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -74.32 131.35 41.07 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 178.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.4 mt -82.84 136.73 34.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.982 0.42 . . . . 0.0 111.491 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -132.61 154.95 49.55 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.301 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.405 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 5.2 t60 -54.94 117.28 3.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.894 0.378 . . . . 0.0 111.596 -179.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.39 -14.03 30.51 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.525 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 52.5 t0 -69.44 127.8 34.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.089 0.471 . . . . 0.0 110.445 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.424 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 72.5 t -108.79 132.64 56.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.359 -178.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.481 ' O ' ' OG ' ' A' ' 94' ' ' SER . 97.1 mt -102.48 131.13 51.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 89.7 m -119.49 129.49 54.74 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.643 0.735 . . . . 0.0 112.119 -178.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.623 ' O ' ' N ' ' A' ' 93' ' ' ARG . 92.0 mt -118.35 133.08 66.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 114.615 -1.175 . . . . 0.0 108.769 178.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.543 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 70.3 mt -20.77 91.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.637 ' OD2' ' NE ' ' B' ' 245' ' ' ARG . 21.3 t0 93.36 -21.73 0.07 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 177.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.623 ' N ' ' O ' ' A' ' 90' ' ' ILE . 87.8 mtt-85 -130.4 146.01 51.9 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.103 -0.639 . . . . 0.0 111.029 -179.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.481 ' OG ' ' O ' ' A' ' 88' ' ' ILE . 32.7 t -138.9 151.77 47.21 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.149 0.5 . . . . 0.0 110.317 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.445 ' N ' ' HG ' ' A' ' 94' ' ' SER . 91.6 m-85 -125.65 127.27 46.02 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -89.06 138.02 31.79 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.745 -179.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -94.91 119.37 33.34 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.512 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -123.18 120.96 34.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.852 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.405 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 64.1 t-20 -104.65 112.99 26.29 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.679 -0.409 . . . . 0.0 110.141 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 . . . . . 0 C--N 1.328 -0.361 0 CA-C-O 120.943 0.402 . . . . 0.0 110.012 179.861 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . 0.513 ' O ' ' O ' ' B' ' 229' ' ' ASP . 52.2 t . . . . . 0 N--CA 1.453 -0.289 0 CA-C-O 120.72 0.295 . . . . 0.0 110.638 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.513 ' O ' ' O ' ' B' ' 228' ' ' VAL . 83.1 m-20 39.68 -166.65 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.212 0.53 . . . . 0.0 110.529 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . 0.451 ' O1P' ' N ' ' B' ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -167.79 73.73 0.12 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.917 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -104.47 -156.85 23.62 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -63.73 155.08 65.57 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 123.156 2.57 . . . . 0.0 112.244 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.53 141.99 97.79 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.688 2.259 . . . . 0.0 112.982 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 10.7 p -78.39 128.87 38.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.254 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.8 t -60.76 119.82 8.91 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.184 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -56.3 -24.92 53.87 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 122.219 1.946 . . . . 0.0 111.981 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 20.0 m -68.72 -46.89 67.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.442 0.639 . . . . 0.0 109.774 178.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . 0.744 ' CD2' ' NH1' ' B' ' 245' ' ' ARG . 77.2 t80 -58.65 -44.0 89.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.767 -179.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . 0.654 ' CD2' HH22 ' B' ' 245' ' ' ARG . 60.6 mt -61.34 -43.87 98.14 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.214 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -64.69 -37.7 88.49 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . 0.415 ' O ' ' OG ' ' B' ' 247' ' ' SER . 76.4 ttt180 -62.68 -47.2 84.69 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.632 -178.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.744 ' NH1' ' CD2' ' B' ' 241' ' ' PHE . 27.8 mtm-85 -63.93 -37.55 87.84 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.773 -179.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -62.49 -41.2 98.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.809 0.338 . . . . 0.0 110.443 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 247' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 76.7 p -66.16 -41.12 90.82 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -62.08 -38.98 90.88 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.111 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 52.5 t -62.0 -43.87 98.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -61.23 -28.09 68.91 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -87.51 -8.32 56.53 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.684 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.405 ' HG ' ' H ' ' B' ' 253' ' ' ASN . 2.6 tp -102.81 -178.71 3.75 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.116 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . 0.405 ' H ' ' HG ' ' B' ' 252' ' ' LEU . 23.0 p30 -143.05 169.87 16.77 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.339 0.59 . . . . 0.0 112.142 -179.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -71.43 -20.9 62.05 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.417 179.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -70.11 -10.32 58.37 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.768 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -85.93 83.33 7.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.42 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . 0.4 ' C ' ' H ' ' B' ' 259' ' ' ASP . 99.8 mttt -82.79 6.51 17.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.543 -179.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.466 ' O ' ' C ' ' B' ' 259' ' ' ASP . 98.3 m-20 -87.09 30.94 0.73 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.63 ' C ' ' H ' ' B' ' 261' ' ' ILE . 50.9 p-10 -31.4 141.05 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.869 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -59.45 12.89 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.075 -178.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . 0.63 ' H ' ' C ' ' B' ' 259' ' ' ASP . 66.7 mt -107.32 133.6 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 56.5 t -125.86 132.94 70.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.109 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -96.23 118.78 33.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.401 0.62 . . . . 0.0 111.969 -177.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -66.23 -44.65 83.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.767 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . 0.467 ' NE2' ' O ' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -95.83 156.15 37.6 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.09 -179.462 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -64.93 144.21 82.03 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 C-N-CA 122.674 2.249 . . . . 0.0 112.926 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 47.3 pt . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.912 179.463 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo . . . . . 0 N--CA 1.494 1.52 0 CA-C-O 120.984 0.326 . . . . 0.0 112.746 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.0 p -93.22 -37.9 11.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.851 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.517 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 96.8 mtt-85 -90.24 122.39 33.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.87 -178.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -130.69 138.08 49.85 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.918 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 83.3 mt -115.26 139.42 49.97 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.57 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.6 t -112.1 127.65 69.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.3 m -87.62 111.83 21.67 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.234 0.54 . . . . 0.0 111.43 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 90.9 mt -82.82 145.52 8.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.717 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -92.0 158.19 16.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.783 0.325 . . . . 0.0 110.754 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -58.01 -24.75 59.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.529 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.2 m -80.94 -10.05 59.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.033 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.07 39.81 6.81 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.1 t -123.31 134.62 65.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.849 0.356 . . . . 0.0 111.328 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' A' ' 17' ' ' GLY . 62.6 t0 -73.93 127.24 32.36 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.931 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.428 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -123.8 -122.73 2.73 Favored Glycine 0 CA--C 1.542 1.746 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.217 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.95 148.63 45.75 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 122.671 2.247 . . . . 0.0 113.626 -178.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -107.39 154.83 20.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.166 0.508 . . . . 0.0 110.832 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -130.76 103.2 16.03 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.582 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -78.05 138.62 16.49 Favored 'Trans proline' 0 N--CA 1.488 1.191 0 C-N-CA 121.911 1.74 . . . . 0.0 112.635 -179.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 94.0 mt -92.65 54.42 2.24 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.225 -0.443 . . . . 0.0 112.188 -178.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.6 p -59.67 -29.03 67.78 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 63.1 mt -75.43 142.11 43.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.609 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.32 -16.65 64.22 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -178.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 30.3 m -140.5 140.29 35.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.021 0.438 . . . . 0.0 111.16 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.617 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -136.28 134.2 37.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.382 178.545 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 47.5 tp -121.73 127.38 50.63 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.214 -178.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.617 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 21.0 m-85 -101.86 131.99 47.89 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.663 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.62 -177.79 38.61 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 120.274 -0.965 . . . . 0.0 112.285 179.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.671 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 73.0 mtm-85 -77.9 -31.95 51.47 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.764 0.316 . . . . 0.0 110.554 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.435 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -52.45 149.21 10.34 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -178.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.45 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 8.1 tp -66.44 -42.04 89.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 C-N-CA 120.759 -0.377 . . . . 0.0 110.272 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.45 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 80.0 mm-40 -53.16 -18.87 2.5 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.435 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 57.1 m -63.25 121.88 14.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.533 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -57.94 -29.41 65.14 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.434 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 93.4 mt -122.64 119.78 59.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 176.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 87.9 mtm-85 -104.0 133.67 48.56 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.355 -178.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 98.9 mt -117.53 129.36 74.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.148 0.499 . . . . 0.0 110.24 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -77.92 24.1 0.24 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.857 -177.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.566 ' CD1' ' NH1' ' A' ' 93' ' ' ARG . 38.3 mt -105.02 128.24 27.1 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.912 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.47 -12.93 30.02 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.434 2.089 . . . . 0.0 113.309 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.5 m -88.45 -2.21 8.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.871 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.671 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 55.8 t -92.86 134.55 30.39 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.255 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 178.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.1 162.04 17.74 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.291 0.567 . . . . 0.0 111.793 -178.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -59.86 -43.6 94.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.19 -178.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.67 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.5 mt-30 -111.5 -18.08 12.93 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.5 t60 32.59 -71.93 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.467 -1.242 . . . . 0.0 114.108 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.67 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.19 136.21 45.53 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.296 0.57 . . . . 0.0 112.263 -177.847 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -125.68 135.76 52.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.333 178.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.0 tt -124.29 136.39 60.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.03 0.443 . . . . 0.0 110.14 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -122.46 132.57 54.41 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.981 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 95.6 mt -106.99 112.25 39.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.823 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.501 ' O ' ' N ' ' A' ' 56' ' ' GLN . 81.4 m-70 -112.92 145.96 39.83 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.156 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' A' ' 54' ' ' HIS . 99.1 mt-10 -40.2 -27.02 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.894 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.501 ' N ' ' O ' ' A' ' 54' ' ' HIS . 85.7 mt-30 -67.04 -68.92 0.34 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.608 178.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -158.68 -168.22 2.35 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.209 0.528 . . . . 0.0 110.945 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -104.04 120.74 41.72 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 177.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.6 mt -110.99 128.89 67.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 56.5 tp -97.82 129.78 44.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.682 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -114.86 136.95 52.54 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.731 0.3 . . . . 0.0 111.147 -179.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -94.35 106.55 18.53 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -102.75 -10.18 19.37 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.311 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.5 t -74.27 101.59 4.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.381 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 92.2 p -82.61 -12.69 57.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.01 0.434 . . . . 0.0 110.035 179.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.15 -35.64 9.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.434 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -145.33 92.75 5.54 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.39 -179.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -55.57 146.19 65.67 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 122.648 2.232 . . . . 0.0 112.721 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 61.8 m -77.03 138.65 39.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.585 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -102.68 141.15 35.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.088 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.4 t -129.79 135.18 61.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 52.42 32.13 10.77 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.2 24.72 70.48 Favored Glycine 0 CA--C 1.535 1.281 0 CA-C-N 115.131 -0.941 . . . . 0.0 112.885 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 47.6 t -141.66 140.85 33.33 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 118.053 0.927 . . . . 0.0 112.057 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 43.0 t -68.03 139.43 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.343 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.2 pt -114.59 89.36 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.25 178.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -63.72 -24.0 67.6 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -123.62 166.74 17.36 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.128 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -65.55 150.64 86.43 Favored 'Trans proline' 0 N--CA 1.5 1.86 0 C-N-CA 122.845 2.364 . . . . 0.0 113.441 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 29.7 m -143.1 143.92 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.59 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -75.27 138.56 41.95 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 178.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 92.0 mt -96.67 134.83 39.42 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.249 0.547 . . . . 0.0 111.571 -178.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -121.45 157.3 30.88 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.769 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.55 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 4.5 t60 -55.46 120.71 7.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.354 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.38 -19.3 26.93 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -68.14 135.94 52.91 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.307 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.499 ' CG1' ' HG ' ' A' ' 94' ' ' SER . 42.2 t -114.6 133.54 60.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.524 -178.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.474 ' O ' ' OG ' ' A' ' 94' ' ' SER . 80.9 mt -100.61 132.49 46.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.248 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.6 m -125.56 130.09 51.02 Favored 'General case' 0 C--N 1.334 -0.097 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -179.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.43 ' O ' ' N ' ' A' ' 92' ' ' ASP . 84.0 mt -119.32 127.59 75.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.28 178.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.441 ' CG2' ' NH2' ' B' ' 245' ' ' ARG . 36.0 mm 42.26 -97.82 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -178.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.506 ' O ' ' OD1' ' A' ' 92' ' ' ASP . 48.0 t0 -126.85 23.92 6.57 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.283 0.564 . . . . 0.0 110.02 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.601 HH12 ' NH1' ' B' ' 245' ' ' ARG . 54.5 mtm-85 -126.45 139.75 53.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.001 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.499 ' HG ' ' CG1' ' A' ' 87' ' ' VAL . 15.9 t -139.75 150.57 44.94 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.223 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -118.83 119.38 34.21 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 39.2 ttp-105 -82.23 130.58 35.13 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.33 -179.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.517 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 61.6 t80 -97.74 124.85 42.25 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.059 0.456 . . . . 0.0 111.271 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -128.52 123.65 34.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.523 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.55 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 58.3 t-20 -100.15 109.52 21.79 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.361 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.857 -179.932 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 98.6 t . . . . . 0 N--CA 1.457 -0.108 0 CA-C-O 120.697 0.284 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.553 ' OD1' ' N ' ' B' ' 232' ' ' GLY . 51.9 p-10 -156.56 176.17 13.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.768 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -124.03 40.38 3.74 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . 0.553 ' N ' ' OD1' ' B' ' 229' ' ' ASP . . . -114.54 -173.13 17.91 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.956 -178.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -61.81 156.84 46.09 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 123.506 2.804 . . . . 0.0 112.675 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -63.95 135.68 49.0 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 121.335 1.357 . . . . 0.0 112.95 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 4.0 p -65.25 136.55 26.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 114.572 -1.195 . . . . 0.0 110.446 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 20.2 t -64.2 123.1 18.22 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.214 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . 0.402 ' O3P' ' OG1' ' B' ' 240' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -55.55 -23.51 40.11 Favored 'Trans proline' 0 N--CA 1.5 1.86 0 C-N-CA 122.283 1.989 . . . . 0.0 112.595 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 240' ' ' THR . . . . . 0.402 ' OG1' ' O3P' ' B' ' 238' ' ' TPO . 19.5 m -70.28 -45.29 66.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.657 0.742 . . . . 0.0 109.038 178.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . 0.43 ' CE2' ' NE ' ' B' ' 245' ' ' ARG . 87.7 t80 -58.15 -43.94 87.62 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.585 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . 0.554 ' CD2' HH21 ' B' ' 245' ' ' ARG . 75.8 mt -61.76 -41.96 98.37 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.767 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.44 -39.28 91.88 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.49 -179.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -60.02 -45.71 91.9 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.566 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.601 ' NH1' HH12 ' A' ' 93' ' ' ARG . 64.3 mtm180 -63.3 -38.22 90.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.468 -179.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.3 -39.08 91.79 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 120.101 -0.64 . . . . 0.0 109.652 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 18.0 m -63.98 -44.15 93.56 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . 0.446 ' O ' ' N ' ' B' ' 252' ' ' LEU . 84.6 mt-30 -60.23 -35.84 76.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.517 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 38.0 t -62.07 -46.44 96.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.572 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -60.19 -30.08 69.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.21 0.528 . . . . 0.0 109.594 179.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -91.76 -10.4 40.12 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.515 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' B' ' 248' ' ' GLN . 63.9 tp -75.54 144.11 42.09 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.06 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -98.06 130.12 44.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.377 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . 0.605 ' C ' ' H ' ' B' ' 256' ' ' ASP . 38.7 t70 -62.59 -32.59 73.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.892 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -58.6 3.01 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.733 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.605 ' H ' ' C ' ' B' ' 254' ' ' ASP . 62.2 t0 -121.59 104.21 9.47 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.754 0.311 . . . . 0.0 110.846 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . 0.591 ' O ' ' N ' ' B' ' 259' ' ' ASP . 99.8 mttt -66.64 -85.77 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.38 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.528 ' C ' ' O ' ' B' ' 257' ' ' LYS . 65.0 t0 -14.02 79.06 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 O-C-N 124.077 0.861 . . . . 0.0 111.494 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.591 ' N ' ' O ' ' B' ' 257' ' ' LYS . 42.8 t0 -91.03 79.43 5.82 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.567 -179.136 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 56.05 2.44 0.08 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 178.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . 0.446 ' H ' ' C ' ' B' ' 259' ' ' ASP . 66.1 mt -114.57 134.8 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 41.2 t -127.57 136.2 61.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -95.5 117.24 30.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.171 0.51 . . . . 0.0 110.865 -178.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -63.65 -47.11 82.64 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.448 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 4.2 mm100 -96.63 154.42 38.47 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.853 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.29 147.65 59.93 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 123.015 2.477 . . . . 0.0 113.639 -178.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 29.9 pt . . . . . 0 C--N 1.33 -0.244 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.203 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo . . . . . 0 N--CA 1.497 1.683 0 N-CA-C 112.847 0.287 . . . . 0.0 112.847 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 69.6 p -125.89 -47.43 1.66 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.507 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.483 ' CD ' ' HH ' ' A' ' 97' ' ' TYR . 85.1 mtt85 -87.74 120.24 28.86 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.264 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -124.22 135.86 53.75 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.134 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 33.2 tp -116.05 131.91 56.81 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.605 -0.438 . . . . 0.0 109.853 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 53.8 t -109.04 132.55 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.328 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 m -88.68 112.57 23.28 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.958 0.409 . . . . 0.0 112.043 -178.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 79.4 mt -80.75 141.85 14.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -97.42 160.87 14.07 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.021 0.439 . . . . 0.0 109.852 178.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -59.69 -19.86 52.52 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.983 -179.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.5 t -78.71 -16.48 57.2 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.282 178.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.85 24.49 22.88 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.5 m -119.77 135.83 58.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -70.89 139.46 50.77 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.238 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -125.1 -121.99 2.59 Favored Glycine 0 CA--C 1.534 1.246 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.4 148.14 54.03 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 121.869 1.712 . . . . 0.0 112.888 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -108.34 143.85 36.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.29 0.567 . . . . 0.0 111.139 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -114.68 98.82 50.55 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.358 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.55 132.01 18.29 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 121.101 1.2 . . . . 0.0 111.359 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.2 mt -84.5 56.12 3.68 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.07 -178.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.672 ' HG ' HE22 ' B' ' 265' ' ' GLN . 79.8 p -64.48 -22.39 66.95 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.416 ' HG ' HE22 ' B' ' 265' ' ' GLN . 92.1 mt -84.96 141.91 30.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.545 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 45.3 t -61.8 -18.1 58.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.524 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.514 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 33.5 m -133.93 132.93 40.82 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.593 -0.443 . . . . 0.0 112.008 -179.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.5 t -122.09 114.59 21.11 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.42 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 53.8 tp -113.95 131.37 56.34 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.523 -178.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.404 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 12.5 m-85 -109.76 127.18 54.46 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.051 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 173.63 -173.6 45.86 Favored Glycine 0 N--CA 1.474 1.199 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.492 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.649 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 85.9 mtm-85 -86.29 -26.72 24.79 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.463 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.547 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -58.31 154.52 25.01 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.99 -178.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.465 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 10.5 tp -66.57 -41.81 88.97 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-O 120.746 0.308 . . . . 0.0 111.002 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.465 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 83.1 tt0 -57.63 -20.27 32.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.776 -179.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.547 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 7.5 m -60.69 129.41 41.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.234 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.514 ' OD2' ' O ' ' A' ' 26' ' ' THR . 54.3 m-20 -61.93 -34.35 75.93 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 87.9 mt -126.3 121.39 58.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 178.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.413 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 83.5 mtp180 -103.53 134.28 47.15 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.631 -178.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 89.9 mt -117.34 129.72 73.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.074 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -78.47 39.35 0.33 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -177.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.539 ' CD1' ' NH2' ' A' ' 93' ' ' ARG . 75.9 mt -119.94 137.72 26.12 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.844 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -72.78 -11.93 26.15 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 122.608 2.206 . . . . 0.0 112.455 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.8 m -92.04 4.15 7.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.517 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.649 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 48.0 t -98.69 130.35 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.3 m -73.05 172.32 11.24 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.747 0.784 . . . . 0.0 112.642 -178.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -64.63 -40.32 95.26 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.091 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.649 ' O ' ' N ' ' A' ' 49' ' ' CYS . 84.0 mm-40 -114.12 -19.25 11.43 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.921 0.391 . . . . 0.0 110.345 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.7 t60 31.37 -77.41 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.649 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -128.05 133.25 49.06 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.605 -178.931 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -129.2 128.84 44.15 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.401 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 85.9 mt -114.04 133.15 60.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.416 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.569 ' CD ' ' HE2' ' A' ' 54' ' ' HIS . 81.3 tt0 -113.53 125.07 53.79 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.9 mm -93.99 123.98 46.29 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 121.602 0.715 . . . . 0.0 112.088 -178.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.569 ' HE2' ' CD ' ' A' ' 52' ' ' GLU . 96.5 m-70 -124.75 131.03 53.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.386 178.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 54' ' ' HIS . 47.9 tp10 -42.73 -32.2 0.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -64.12 -67.57 0.42 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.213 -0.903 . . . . 0.0 108.914 178.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.545 ' OE2' ' CD ' ' A' ' 81' ' ' ARG . 0.2 OUTLIER -152.3 -175.36 5.23 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.639 179.808 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.55 129.04 56.63 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.704 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.4 mt -116.77 131.55 69.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -178.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 50.1 tp -94.38 125.69 39.18 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.322 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -110.33 132.52 54.1 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.11 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.427 ' ND2' ' O ' ' A' ' 76' ' ' ILE . 41.5 t30 -94.05 106.23 18.21 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.25 0.548 . . . . 0.0 111.705 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -100.57 -9.45 21.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.397 179.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.0 t -76.75 98.18 4.71 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 120.036 -0.666 . . . . 0.0 109.831 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.4 p -74.99 -32.82 61.75 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.377 178.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.28 -43.24 57.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.461 -179.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -140.57 97.77 7.34 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -55.51 145.01 71.39 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.295 1.997 . . . . 0.0 112.532 -178.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 13.2 m -71.79 137.15 47.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.157 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -101.02 140.73 34.91 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.666 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.7 p -135.17 136.08 51.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 50.11 30.93 4.52 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.96 28.86 65.88 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.972 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.4 m -135.3 124.55 24.6 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.826 -179.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.6 m -71.87 140.75 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.427 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 46.2 pt -121.0 141.88 39.56 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-O 121.203 0.525 . . . . 0.0 111.281 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.489 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 21.5 p-10 -104.29 -14.32 15.84 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 178.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -128.66 166.77 22.36 Favored Pre-proline 0 CA--C 1.528 0.098 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.148 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -64.12 146.88 91.35 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 122.673 2.249 . . . . 0.0 112.772 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.7 t -133.95 140.47 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.837 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.545 ' CD ' ' OE2' ' A' ' 57' ' ' GLU . 88.6 mtm180 -71.95 128.99 37.49 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.659 -0.417 . . . . 0.0 110.952 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 92.8 mt -84.37 131.23 34.72 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.341 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -124.53 153.2 42.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.702 178.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.628 ' HD1' ' N ' ' A' ' 99' ' ' ASN . 12.4 t60 -56.94 122.52 12.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.956 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.22 -19.96 33.74 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.05 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -66.27 139.26 58.06 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 77.1 t -112.03 129.99 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.326 -178.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.2 mt -95.66 131.21 43.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 42.3 m -120.69 124.53 45.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.494 0.664 . . . . 0.0 111.82 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 86.0 mt -119.57 121.06 65.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.173 179.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 36.0 mm 52.45 -112.51 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -178.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -116.25 24.25 11.53 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.337 0.589 . . . . 0.0 110.371 179.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.539 ' NH2' ' CD1' ' A' ' 41' ' ' LEU . 47.5 mtm-85 -131.26 146.72 52.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.224 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.3 p -140.65 158.58 43.78 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.318 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -126.37 124.24 39.78 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.238 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -85.14 127.68 34.35 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 121.075 0.464 . . . . 0.0 111.053 -179.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.483 ' HH ' ' CD ' ' A' ' 5' ' ' ARG . 92.3 t80 -96.09 125.64 40.77 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.885 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -130.5 122.38 27.53 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.428 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.628 ' N ' ' HD1' ' A' ' 84' ' ' HIS . 49.2 t-20 -111.05 90.62 3.38 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.967 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.401 ' OE2' ' CE1' ' A' ' 84' ' ' HIS . 96.0 mt-10 . . . . . 0 C--N 1.331 -0.213 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.777 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . 0.435 ' O ' ' N ' ' B' ' 230' ' ' SEP . 33.5 m . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' B' ' 228' ' ' VAL . 93.7 m-20 36.66 -96.85 0.02 OUTLIER 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.583 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . 0.435 ' N ' ' O ' ' B' ' 228' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -136.05 66.14 1.51 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.754 -178.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -132.51 -177.88 15.19 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.108 -0.567 . . . . 0.0 112.136 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.77 160.86 48.06 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 123.62 2.88 . . . . 0.0 112.982 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.39 142.93 37.95 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 121.284 1.323 . . . . 0.0 112.263 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 76.3 t -59.09 139.85 18.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.215 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . 0.603 ' SG ' ' CD1' ' B' ' 241' ' ' PHE . 4.9 t -72.36 133.32 44.88 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.062 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . 0.472 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . 0.472 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 32.7 Cg_exo -60.67 -25.0 80.03 Favored 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 123.119 2.546 . . . . 0.0 113.222 -179.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 98.7 m -73.27 -45.72 54.05 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.631 0.729 . . . . 0.0 109.541 178.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . 0.603 ' CD1' ' SG ' ' B' ' 237' ' ' CYS . 54.4 t80 -57.31 -45.63 84.02 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.102 -178.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 89.0 mt -65.24 -42.23 93.53 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -61.67 -38.75 88.93 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.404 -0.519 . . . . 0.0 110.357 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . 0.563 ' O ' ' OG ' ' B' ' 247' ' ' SER . 82.7 mtp180 -64.12 -40.72 96.79 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.544 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.449 ' NH2' ' CD2' ' A' ' 41' ' ' LEU . 22.0 mmt180 -64.73 -41.4 95.98 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.382 -179.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.46 -38.05 88.27 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 247' ' ' SER . . . . . 0.563 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 77.8 p -67.46 -42.78 82.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.441 179.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . 0.482 ' O ' ' N ' ' B' ' 252' ' ' LEU . 86.7 mt-30 -61.56 -36.2 79.95 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.838 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 34.9 t -65.76 -43.72 93.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -58.61 -29.85 66.8 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.155 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -105.8 -5.11 20.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.543 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' B' ' 248' ' ' GLN . 51.5 tp -111.03 115.65 29.82 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.047 0.451 . . . . 0.0 110.142 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -52.54 155.53 2.14 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.495 -178.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -74.55 -8.66 57.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.396 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . 0.409 ' OD1' ' C ' ' B' ' 255' ' ' ASP . 47.1 p-10 -86.66 1.54 51.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.328 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.481 ' CG ' ' O ' ' B' ' 256' ' ' ASP . 18.7 p-10 -69.78 91.81 0.65 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.375 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -70.85 162.54 29.06 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 58.79 71.72 0.57 Allowed 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -178.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.466 ' OD1' ' OE1' ' B' ' 260' ' ' GLU . 37.1 t0 -87.86 77.09 8.6 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.43 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.503 ' N ' ' OE1' ' B' ' 260' ' ' GLU . 44.5 mp0 57.52 6.03 0.37 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 178.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 74.5 mt -118.62 133.67 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 75.5 t -129.25 137.19 57.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.987 0.423 . . . . 0.0 110.884 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -97.31 119.56 36.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.595 -178.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -67.87 -45.89 73.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.364 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . 0.672 HE22 ' HG ' ' A' ' 23' ' ' SER . 0.0 OUTLIER -92.57 156.17 41.47 Favored Pre-proline 0 C--N 1.332 -0.16 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.049 -179.006 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -63.65 148.28 92.32 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.995 2.464 . . . . 0.0 112.17 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 33.9 pt . . . . . 0 C--N 1.326 -0.439 0 CA-C-O 121.416 0.627 . . . . 0.0 111.185 -179.535 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo . . . . . 0 N--CA 1.497 1.7 0 CA-C-O 121.179 0.408 . . . . 0.0 112.986 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 63.3 p -104.19 -48.43 3.87 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.308 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.534 ' CD ' ' HH ' ' A' ' 97' ' ' TYR . 86.0 mtt85 -97.43 132.42 43.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.219 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -134.37 145.31 48.85 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.844 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.5 mt -114.07 142.95 45.55 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.049 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.9 t -115.82 129.9 71.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 m -90.74 119.32 30.87 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.485 0.66 . . . . 0.0 112.776 -177.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.1 mm -81.33 135.48 24.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.496 178.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -85.86 156.3 20.6 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.792 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.413 ' NE ' ' HD2' ' B' ' 245' ' ' ARG . 83.7 mtp180 -58.36 -34.61 70.85 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.3 p -70.25 -18.88 63.15 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.202 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.65 34.38 5.78 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.0 t -121.15 133.09 68.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 114.992 -0.604 . . . . 0.0 110.922 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -73.26 136.38 44.59 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -135.52 -114.56 1.4 Allowed Glycine 0 CA--C 1.534 1.276 0 C-N-CA 119.752 -1.213 . . . . 0.0 112.827 -179.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.67 144.09 43.5 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.33 2.02 . . . . 0.0 113.653 -177.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 63.8 m170 -107.9 137.94 45.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.678 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -106.12 96.51 13.32 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.6 134.59 22.51 Favored 'Trans proline' 0 C--N 1.315 -1.231 0 C-N-CA 121.283 1.322 . . . . 0.0 110.745 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.9 mt -86.06 74.16 10.14 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.663 -178.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.1 p -79.6 -10.24 59.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.41 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.1 mt -105.86 148.0 28.06 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.108 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.2 t -68.22 -16.16 63.86 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.5 m -134.41 136.97 43.69 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.419 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.664 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 4.1 t -131.69 124.47 29.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.923 178.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 47.7 tp -118.38 129.61 55.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.532 -178.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.664 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 6.8 m-85 -106.06 134.72 48.74 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.422 179.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 156.5 -177.91 33.24 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 120.451 -0.88 . . . . 0.0 112.322 179.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.407 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 45.5 mtm105 -75.1 -32.44 61.42 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.48 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -50.34 150.85 5.25 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.778 -178.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.461 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 9.8 tp -66.11 -41.66 89.9 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-O 121.021 0.439 . . . . 0.0 110.1 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.461 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 97.7 mt-10 -56.07 -24.3 39.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.806 -179.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.48 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 32.0 m -55.8 117.2 3.44 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.685 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -57.37 -29.15 63.8 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 98.7 mt -125.64 118.66 52.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.417 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 84.1 mtp180 -104.06 136.73 43.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.689 -178.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 97.6 mt -118.08 129.82 73.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 121.29 0.567 . . . . 0.0 110.771 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -74.96 35.19 0.1 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 114.975 -1.011 . . . . 0.0 113.092 -177.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.654 ' CD1' ' HE ' ' A' ' 93' ' ' ARG . 28.3 mt -118.94 130.93 24.56 Favored Pre-proline 0 C--N 1.323 -0.561 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.457 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.436 ' O ' ' HD2' ' B' ' 235' ' ' PRO . 44.2 Cg_endo -67.84 -18.97 47.23 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.379 2.052 . . . . 0.0 113.454 -179.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.2 m -83.87 -0.08 5.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.836 -0.345 . . . . 0.0 110.896 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.407 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 56.8 t -88.08 133.0 31.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.926 0.393 . . . . 0.0 110.124 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.9 m -67.89 162.49 24.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.426 0.631 . . . . 0.0 111.325 -179.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -60.88 -41.53 96.19 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.591 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.629 ' O ' ' N ' ' A' ' 49' ' ' CYS . 97.9 mm-40 -115.33 -25.32 8.04 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.436 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.8 t60 36.54 -76.07 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.629 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.53 134.04 46.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.37 0.605 . . . . 0.0 112.177 -178.091 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -126.8 131.62 51.22 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.196 179.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 91.6 mt -115.41 133.32 62.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.507 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -119.34 126.55 51.7 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 89.1 mt -106.38 118.18 53.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.555 0.693 . . . . 0.0 111.83 -179.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.453 ' O ' ' N ' ' A' ' 56' ' ' GLN . 86.5 m-70 -113.86 142.66 45.82 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.331 179.366 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 54' ' ' HIS . 80.0 mm-40 -40.21 -29.46 0.08 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.453 ' N ' ' O ' ' A' ' 54' ' ' HIS . 88.5 mt-30 -63.7 -66.98 0.47 Allowed 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.447 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 5.5 tp10 -158.36 -163.32 1.26 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.138 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.447 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -112.8 129.16 56.53 Favored 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.1 mt -119.29 128.88 75.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.385 0.612 . . . . 0.0 112.145 -178.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.4 tp -97.79 126.58 43.22 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.054 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -110.97 136.36 50.09 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.843 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -97.33 104.44 16.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.575 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -99.07 -10.06 23.07 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.891 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.52 99.03 3.48 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.248 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.7 m -73.55 -39.82 64.44 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.377 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.66 -47.46 81.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.818 -178.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -142.9 99.03 5.6 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.38 148.35 33.66 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.361 2.04 . . . . 0.0 113.26 -179.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.5 m -69.32 139.54 54.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.862 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -100.33 141.93 32.5 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.431 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.495 ' CG2' ' OD1' ' A' ' 86' ' ' ASP . 8.5 p -130.79 135.17 60.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 44.99 33.71 1.09 Allowed 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.082 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.05 29.28 62.93 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.837 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.485 ' N ' ' O ' ' A' ' 71' ' ' VAL . 15.8 m -140.65 139.43 34.82 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 120.576 -0.449 . . . . 0.0 111.239 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.2 t -72.59 137.93 22.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.243 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.0 pt -109.38 91.99 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.707 178.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -65.41 -30.29 71.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.56 179.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -122.86 168.7 11.37 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.458 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -60.71 148.87 90.3 Favored 'Trans proline' 0 N--CA 1.501 1.917 0 C-N-CA 122.41 2.073 . . . . 0.0 112.26 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.6 p -142.72 142.89 26.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.42 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.7 mtm180 -75.58 131.43 39.99 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 93.0 mt -78.42 140.33 38.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.128 0.49 . . . . 0.0 111.471 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -128.4 148.13 50.69 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.534 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.557 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 5.0 t60 -55.36 117.21 3.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.213 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.07 -8.71 31.38 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.495 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 60.6 t0 -73.7 128.18 34.81 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.73 0.3 . . . . 0.0 110.441 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.457 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 48.3 t -109.9 132.64 57.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.463 -178.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.8 mt -105.37 134.01 48.06 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 97.6 m -121.53 126.65 49.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.33 0.586 . . . . 0.0 111.898 -178.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.8 mt -115.71 124.81 72.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 177.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.4 mm 40.81 -101.66 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 -178.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -118.39 23.56 11.47 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.096 0.475 . . . . 0.0 110.615 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.654 ' HE ' ' CD1' ' A' ' 41' ' ' LEU . 7.9 mtm105 -128.2 146.5 50.71 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.095 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.1 t -137.06 147.16 45.96 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.469 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -120.13 121.0 37.83 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -84.87 135.07 34.24 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.344 -178.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.534 ' HH ' ' CD ' ' A' ' 5' ' ' ARG . 86.8 t80 -95.16 120.36 35.25 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.524 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -122.26 123.8 42.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.319 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.557 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 62.5 t-20 -105.88 115.71 30.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.832 0.348 . . . . 0.0 110.576 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.029 -179.621 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 53.6 t . . . . . 0 C--O 1.231 0.093 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.458 ' O ' ' CB ' ' B' ' 230' ' ' SEP . 53.0 p30 -108.47 176.48 5.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.234 179.29 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . 0.63 ' O ' ' NE2' ' B' ' 231' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.63 ' NE2' ' O ' ' B' ' 230' ' ' SEP . 99.8 mm-40 -149.64 68.76 1.02 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 121.114 -0.234 . . . . 0.0 110.914 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -118.14 177.88 16.66 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.517 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -66.04 151.87 82.77 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 123.228 2.618 . . . . 0.0 112.194 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . 0.436 ' HD2' ' O ' ' A' ' 42' ' ' PRO . 31.3 Cg_exo -57.96 137.05 78.94 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 121.84 1.694 . . . . 0.0 112.726 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 25.5 t -68.56 133.66 31.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 114.572 -1.195 . . . . 0.0 109.406 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -59.71 118.79 6.55 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.218 -0.593 . . . . 0.0 110.199 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -59.49 -20.38 56.55 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.543 2.162 . . . . 0.0 111.76 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 21.4 m -74.21 -46.2 43.35 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.79 177.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -57.84 -44.87 86.77 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.276 -179.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 79.2 mt -63.76 -39.76 95.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.406 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -60.34 -42.42 95.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.317 -0.401 . . . . 0.0 109.96 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -65.67 -39.47 91.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.203 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.413 ' HD2' ' NE ' ' A' ' 12' ' ' ARG . 3.1 tpp85 -57.5 -43.69 84.38 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -64.4 -41.52 96.6 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 68.1 m -60.93 -45.51 94.39 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -62.53 -34.21 76.45 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.339 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 19.0 t -60.25 -45.74 95.77 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 C-N-CA 120.409 -0.516 . . . . 0.0 109.92 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -62.31 -35.0 77.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.284 0.564 . . . . 0.0 109.899 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -79.56 -16.27 56.22 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.725 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 87.1 mt -122.29 111.58 17.09 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.547 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . 0.421 ' O ' ' CG ' ' B' ' 253' ' ' ASN . 13.9 t-20 -175.57 29.26 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 120.499 -0.48 . . . . 0.0 111.684 179.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . 0.543 ' O ' ' CB ' ' B' ' 255' ' ' ASP . 80.6 m-20 -97.0 -2.65 43.04 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.044 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . 0.543 ' CB ' ' O ' ' B' ' 254' ' ' ASP . 4.8 p-10 105.08 59.35 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 O-C-N 124.271 0.982 . . . . 0.0 109.88 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.567 ' O ' ' CB ' ' B' ' 257' ' ' LYS . 96.3 m-20 -73.6 -70.99 0.34 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.8 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . 0.567 ' CB ' ' O ' ' B' ' 256' ' ' ASP . 70.9 tttt 96.72 167.22 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.334 -178.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.608 ' O ' ' N ' ' B' ' 260' ' ' GLU . 74.0 m-20 56.61 38.12 29.34 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -177.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.406 ' C ' ' H ' ' B' ' 261' ' ' ILE . 82.2 m-20 -49.96 77.22 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.536 -1.211 . . . . 0.0 111.43 -178.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.608 ' N ' ' O ' ' B' ' 258' ' ' ASP . 56.0 mm-40 54.92 5.23 0.09 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.085 -0.961 . . . . 0.0 112.788 178.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . 0.406 ' H ' ' C ' ' B' ' 259' ' ' ASP . 59.3 mt -116.35 132.19 66.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 42.9 t -125.3 134.42 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.094 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -95.54 118.01 31.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.296 0.569 . . . . 0.0 111.038 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -65.02 -44.24 89.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.463 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -100.84 157.83 32.96 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.039 -178.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.23 153.47 69.7 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.777 2.318 . . . . 0.0 111.883 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 41.9 pt . . . . . 0 C--N 1.328 -0.355 0 CA-C-O 121.65 0.738 . . . . 0.0 111.995 -178.877 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo . . . . . 0 N--CA 1.493 1.456 0 N-CA-C 110.884 -0.468 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.2 m -62.04 -43.39 98.93 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.14 -178.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.595 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 95.2 mtt-85 -97.76 112.31 24.26 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.556 -179.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 60.7 ttp180 -124.73 131.5 53.45 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.862 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 43.8 tp -109.32 132.63 53.94 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 37.1 t -109.81 131.41 60.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.809 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.6 m -91.45 113.49 25.77 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -177.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.567 ' CD1' ' HG ' ' A' ' 94' ' ' SER . 97.0 mt -81.91 143.59 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.648 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -89.79 158.42 17.51 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.039 0.447 . . . . 0.0 110.97 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.519 ' NH2' ' CD2' ' B' ' 252' ' ' LEU . 89.0 mtm180 -57.28 -32.21 66.39 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.994 -178.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.4 p -79.76 -7.9 58.92 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.419 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.82 40.29 4.99 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.2 t -122.59 131.16 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 O-C-N 122.753 -0.263 . . . . 0.0 111.446 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -73.59 134.29 43.7 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -126.97 -123.52 2.65 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.036 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -74.37 153.16 44.94 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 122.362 2.042 . . . . 0.0 112.167 -178.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.571 ' O ' ' CG2' ' B' ' 267' ' ' ILE . 0.2 OUTLIER -108.16 159.88 16.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.971 0.415 . . . . 0.0 110.842 -179.516 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.412 ' CD2' HD12 ' A' ' 37' ' ' ILE . 43.8 t80 -128.38 92.3 41.55 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.64 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.23 125.55 18.84 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.026 1.817 . . . . 0.0 111.292 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.466 ' CD2' ' SG ' ' A' ' 27' ' ' CYS . 93.1 mt -87.92 42.25 1.04 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.896 0.379 . . . . 0.0 111.404 -178.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.7 t -59.37 -23.35 62.49 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.678 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.0 mt -76.62 143.9 39.87 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 82.2 p -66.66 -20.31 65.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.676 -178.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.512 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 93.8 m -128.74 128.96 45.06 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.379 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.466 ' SG ' ' CD2' ' A' ' 22' ' ' LEU . 6.5 t -121.94 112.57 18.46 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.02 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 52.6 tp -113.47 126.07 54.92 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.233 -177.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.501 ' O ' ' O ' ' A' ' 47' ' ' GLN . 6.6 m-85 -106.44 136.66 45.8 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.454 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 160.37 -173.11 36.91 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.284 -0.96 . . . . 0.0 112.421 178.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.571 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 39.3 mtm180 -79.38 -29.21 41.99 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.575 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -61.89 151.03 45.09 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.523 -177.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 33' ' ' ILE . 78.2 mt -64.87 -42.92 96.15 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.337 0 CA-C-N 115.564 -0.318 . . . . 0.0 110.916 179.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -52.64 -26.03 12.49 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 119.657 -0.817 . . . . 0.0 108.893 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.575 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 11.4 m -57.81 118.74 5.63 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.295 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.512 ' OD2' ' O ' ' A' ' 26' ' ' THR . 98.5 m-20 -56.09 -24.07 37.9 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.222 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.459 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 96.9 mt -131.66 122.75 50.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.838 178.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 32.2 mtm180 -107.71 140.47 40.71 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.016 0.436 . . . . 0.0 111.5 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.443 ' C ' ' H ' ' A' ' 41' ' ' LEU . 78.0 mt -121.04 128.79 76.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -70.57 32.3 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -177.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.568 ' CD1' ' CZ ' ' A' ' 93' ' ' ARG . 64.7 mt -110.79 133.68 21.15 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.956 -179.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.7 -8.92 24.07 Favored 'Trans proline' 0 N--CA 1.501 1.959 0 C-N-CA 123.478 2.785 . . . . 0.0 113.863 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.6 m -101.13 2.65 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.032 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.571 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 18.4 t -89.54 100.98 11.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.649 -179.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.521 ' O ' ' O ' ' A' ' 44' ' ' VAL . 3.6 t -34.99 164.29 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.936 -179.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -63.59 -43.55 96.61 Favored 'General case' 0 C--O 1.238 0.447 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.776 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.609 ' O ' ' N ' ' A' ' 49' ' ' CYS . 94.5 mm-40 -111.21 -23.51 10.81 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.007 0.432 . . . . 0.0 110.421 -179.285 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 16.5 t60 41.29 -78.3 0.0 OUTLIER 'General case' 0 C--O 1.24 0.576 0 CA-C-N 115.421 -0.808 . . . . 0.0 112.679 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.609 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.45 136.93 48.37 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.914 -178.861 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -129.81 129.51 44.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.181 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 89.0 mt -114.61 138.41 44.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.313 -179.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -118.0 122.51 43.4 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.426 HG21 HD11 ' A' ' 53' ' ' ILE . 89.3 mt -103.47 114.09 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 C-N-CA 120.104 -0.639 . . . . 0.0 111.285 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.5 ' O ' ' N ' ' A' ' 56' ' ' GLN . 96.6 m-70 -111.41 139.9 46.44 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.828 179.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 54' ' ' HIS . 81.2 tt0 -39.56 -28.43 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.5 ' N ' ' O ' ' A' ' 54' ' ' HIS . 99.6 mm-40 -64.19 -68.14 0.38 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.164 178.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -157.98 -168.02 2.39 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.865 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.54 128.4 56.34 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.24 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 87.6 mt -118.64 129.89 74.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 121.175 0.512 . . . . 0.0 111.963 -178.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 25.1 tp -96.31 128.38 43.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.671 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -113.13 138.57 49.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.295 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.567 HD22 ' CB ' ' A' ' 68' ' ' PRO . 61.1 t-20 -99.8 107.01 18.95 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -98.68 -8.03 26.86 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.803 0.335 . . . . 0.0 110.444 179.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.05 100.68 12.33 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.781 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.6 p -88.31 -30.34 19.67 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.215 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.7 -46.37 85.78 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -142.49 101.89 5.55 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 115.174 -0.921 . . . . 0.0 108.693 178.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.567 ' CB ' HD22 ' A' ' 62' ' ' ASN . 60.0 Cg_endo -69.44 152.25 70.97 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.097 1.865 . . . . 0.0 114.032 -177.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.425 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 11.4 m -70.94 145.57 50.03 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.286 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -106.82 143.61 34.66 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.7 179.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.505 ' CG2' ' OD1' ' A' ' 86' ' ' ASP . 6.3 p -131.67 136.26 57.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 48.5 32.27 3.29 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.85 27.52 68.77 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.341 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.46 ' N ' ' O ' ' A' ' 71' ' ' VAL . 31.3 m -137.67 133.2 33.98 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.322 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 54.7 t -60.97 136.52 24.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.858 0.361 . . . . 0.0 110.57 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.505 ' CG1' ' O ' ' A' ' 78' ' ' GLU . 14.0 tt -103.1 89.73 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.892 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -63.43 -35.84 81.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.746 179.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.505 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 0.8 OUTLIER -128.69 167.52 19.05 Favored Pre-proline 0 N--CA 1.464 0.233 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.372 -179.214 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -56.74 141.78 91.93 Favored 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 122.27 1.98 . . . . 0.0 112.674 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 73.0 t -131.72 137.8 54.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.617 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 83.1 mtt85 -70.24 129.16 38.61 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 97.0 mt -82.53 137.12 34.7 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.456 -0.497 . . . . 0.0 111.394 -178.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -129.29 152.73 48.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.107 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.698 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 7.2 t60 -54.19 118.34 3.99 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.734 0.302 . . . . 0.0 110.428 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.73 -13.15 24.95 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.505 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 59.8 t0 -71.43 128.41 35.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.845 0.355 . . . . 0.0 110.464 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.405 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 69.3 t -110.83 129.05 66.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.674 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 93.8 mt -97.28 132.58 41.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 94.0 m -122.8 127.74 49.51 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 120.026 -0.67 . . . . 0.0 112.553 -178.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 82.2 mt -120.31 125.37 74.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 114.944 -1.026 . . . . 0.0 108.26 178.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 25.1 mm 43.22 -116.33 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -178.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -102.74 14.47 31.87 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.854 0.359 . . . . 0.0 110.849 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.804 HH11 ' NH2' ' B' ' 245' ' ' ARG . 37.2 mtm-85 -123.37 145.13 49.0 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.427 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.567 ' HG ' ' CD1' ' A' ' 10' ' ' ILE . 38.3 p -140.99 151.86 44.46 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 120.687 -0.405 . . . . 0.0 109.927 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -120.07 121.65 39.34 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 79.6 mtp85 -81.56 130.3 35.0 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.471 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.595 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 86.7 t80 -96.62 123.05 40.17 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.198 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -127.41 131.62 50.26 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.007 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.698 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 64.9 t-20 -126.46 121.21 31.75 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.412 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 . . . . . 0 C--N 1.323 -0.568 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.655 178.941 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 26.1 m . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.643 0.258 . . . . 0.0 110.801 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 52.2 p-10 -85.56 171.18 11.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.698 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . 0.551 ' OG ' ' N ' ' B' ' 231' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.551 ' N ' ' OG ' ' B' ' 230' ' ' SEP . 25.4 mp0 -148.65 65.49 1.06 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.884 0.373 . . . . 0.0 110.864 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . 0.455 ' C ' HH12 ' A' ' 31' ' ' ARG . . . -111.21 177.3 19.04 Favored Glycine 0 CA--C 1.532 1.1 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 -179.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.06 160.41 50.03 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 123.163 2.576 . . . . 0.0 112.705 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.9 141.72 30.55 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 122.211 1.941 . . . . 0.0 112.17 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 41.1 t -70.13 133.02 32.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.441 -178.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 4.8 t -72.19 134.79 45.87 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.751 179.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -58.67 -25.59 75.93 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 123.143 2.562 . . . . 0.0 113.419 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 96.6 m -74.03 -44.65 53.65 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.307 -0.557 . . . . 0.0 109.579 178.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -59.71 -46.54 88.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.263 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 88.3 mt -63.87 -42.36 97.54 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.092 0.472 . . . . 0.0 110.569 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -61.81 -38.89 89.81 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.255 -179.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -62.36 -44.75 95.74 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.4 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.804 ' NH2' HH11 ' A' ' 93' ' ' ARG . 72.6 mtp85 -61.18 -39.7 91.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.894 -179.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -63.67 -41.74 98.14 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 120.375 -0.53 . . . . 0.0 109.683 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 62.6 m -66.17 -45.36 81.17 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -58.03 -39.3 78.04 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.879 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 54.7 t -64.05 -45.32 96.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.633 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -65.73 -28.9 69.39 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.795 0.331 . . . . 0.0 110.772 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -89.29 -11.06 44.58 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.132 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.519 ' CD2' ' NH2' ' A' ' 12' ' ' ARG . 3.0 mp -88.11 173.26 8.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.983 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . 0.554 ' O ' ' N ' ' B' ' 255' ' ' ASP . 39.7 m-80 -153.35 -174.13 4.83 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.14 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -44.01 -14.29 0.02 OUTLIER 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.929 0.395 . . . . 0.0 111.164 -178.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' B' ' 253' ' ' ASN . 25.5 p-10 -76.29 -5.76 48.46 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.747 179.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 42.0 p-10 -103.75 13.09 33.78 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 120.739 0.304 . . . . 0.0 110.185 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -66.45 -11.67 53.21 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.112 178.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.494 ' O ' ' OD2' ' B' ' 259' ' ' ASP . 34.6 t70 -58.51 -44.85 89.62 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.549 ' C ' ' H ' ' B' ' 261' ' ' ILE . 0.0 OUTLIER 80.73 116.58 0.06 Allowed 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.99 179.501 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -63.44 10.71 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.107 -178.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . 0.549 ' H ' ' C ' ' B' ' 259' ' ' ASP . 74.6 mt -103.22 136.64 34.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.061 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 72.0 t -125.96 135.76 62.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.45 0.643 . . . . 0.0 111.359 -178.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -97.46 116.55 29.88 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.781 -178.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -67.58 -39.6 84.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.505 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.56 159.46 32.57 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.344 -178.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -61.2 147.61 95.15 Favored 'Trans proline' 0 C--N 1.302 -1.891 0 C-N-CA 122.27 1.98 . . . . 0.0 111.925 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . 0.571 ' CG2' ' O ' ' A' ' 19' ' ' HIS . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.904 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo . . . . . 0 N--CA 1.493 1.48 0 CA-C-O 120.82 0.258 . . . . 0.0 112.375 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.6 m -62.16 -44.87 95.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.1 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.5 mtm-85 -95.91 117.46 30.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.012 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.613 ' NH2' ' HD1' ' A' ' 19' ' ' HIS . 76.1 ttt180 -128.31 134.92 49.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.864 0.364 . . . . 0.0 110.251 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 24.2 tp -113.87 132.85 55.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.989 -179.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 51.5 t -108.49 130.86 60.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 m -90.79 121.34 32.58 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.356 0.598 . . . . 0.0 112.124 -178.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 98.2 mt -89.18 141.06 14.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.23 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -91.03 162.87 14.52 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.696 HH22 ' NE2' ' B' ' 248' ' ' GLN . 87.4 mtm180 -55.83 -27.56 52.04 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.075 -178.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 92.6 p -84.87 -6.26 59.34 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.791 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.51 42.17 7.49 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.436 -1.065 . . . . 0.0 110.436 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.2 t -118.57 132.99 66.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.797 0.332 . . . . 0.0 110.996 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.506 ' CG ' ' HE2' ' A' ' 19' ' ' HIS . 63.9 t0 -74.17 120.24 19.47 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.872 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -117.37 -120.76 3.12 Favored Glycine 0 CA--C 1.539 1.582 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.748 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -74.34 147.45 37.07 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 122.413 2.075 . . . . 0.0 112.703 -179.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.613 ' HD1' ' NH2' ' A' ' 6' ' ' ARG . 65.2 m170 -109.66 143.87 38.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.083 0.468 . . . . 0.0 110.818 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -112.28 104.14 55.81 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.71 -178.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -74.02 128.18 12.06 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 121.34 1.36 . . . . 0.0 111.106 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.3 mt -85.07 47.32 1.39 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.811 -177.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 97.2 p -59.07 -28.44 66.47 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.3 mt -74.29 141.78 45.26 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.8 m -70.95 -16.29 62.64 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.972 -0.291 . . . . 0.0 111.724 -178.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.9 m -134.07 135.88 43.58 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.97 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.676 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 2.4 t -131.05 123.05 27.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.945 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.3 tp -117.51 130.24 56.31 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.686 0.279 . . . . 0.0 110.92 -178.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.676 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 59.3 m-85 -108.02 143.63 36.45 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.823 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 147.84 -177.61 25.99 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.035 178.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.453 ' HB3' ' H ' ' B' ' 230' ' ' SEP . 46.6 mtm180 -70.83 -32.67 69.79 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.924 0.392 . . . . 0.0 111.042 179.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.535 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -48.67 143.92 7.56 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 -178.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.474 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 10.8 tp -66.22 -41.59 89.49 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.151 0 CA-C-O 121.046 0.45 . . . . 0.0 110.078 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.474 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 97.9 mt-10 -54.88 -22.1 13.67 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.519 179.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.535 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 50.0 m -56.73 118.39 4.85 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.348 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -59.54 -26.89 65.74 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.411 HG21 HD13 ' A' ' 37' ' ' ILE . 47.5 mm -123.54 108.54 21.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 176.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -102.28 132.95 47.92 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.843 -177.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 84.0 mt -123.42 131.51 73.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.537 HE21 ' CA ' ' B' ' 260' ' ' GLU . 2.5 pp0? -88.56 43.71 1.15 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 119.626 -0.83 . . . . 0.0 112.558 -178.112 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.471 ' CD1' ' NH1' ' A' ' 93' ' ' ARG . 36.6 mt -95.36 128.87 36.83 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.27 178.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -70.78 -13.34 32.04 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 122.095 1.863 . . . . 0.0 113.534 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 18.6 m -100.61 5.67 10.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.028 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 34.5 t -95.7 139.07 19.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.123 0.487 . . . . 0.0 111.086 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.468 ' HG ' ' N ' ' A' ' 46' ' ' LYS . 0.4 OUTLIER -65.87 166.04 11.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.548 -179.37 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.468 ' N ' ' HG ' ' A' ' 45' ' ' SER . 91.7 mttt -63.87 -44.12 94.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.003 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.625 ' O ' ' N ' ' A' ' 49' ' ' CYS . 98.2 mt-30 -113.4 -12.08 13.04 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.885 0.374 . . . . 0.0 111.049 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 26.1 t60 34.48 -74.77 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 178.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.625 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -135.53 139.54 44.04 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.405 0.622 . . . . 0.0 112.095 -177.938 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -127.66 131.09 49.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.78 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.8 mt -113.24 132.95 60.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.107 179.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.58 ' CD ' ' HE2' ' A' ' 54' ' ' HIS . 83.4 tt0 -117.89 123.32 45.57 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 85.1 mt -107.22 117.11 52.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 119.968 -0.693 . . . . 0.0 112.559 -178.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.58 ' HE2' ' CD ' ' A' ' 52' ' ' GLU . 97.7 m-70 -110.93 139.67 46.06 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.968 178.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.5 tt0 -40.77 -32.55 0.23 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.5 -0.48 . . . . 0.0 109.802 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -66.3 -65.97 0.61 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.99 -173.23 4.43 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.098 0.475 . . . . 0.0 111.797 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.84 129.22 56.61 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.698 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 91.3 mt -118.14 130.87 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 121.609 0.719 . . . . 0.0 112.76 -178.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 43.1 tp -98.69 128.06 44.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.456 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -115.06 136.03 53.56 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.948 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.409 HD22 ' HA ' ' A' ' 68' ' ' PRO . 64.0 t-20 -97.32 104.72 16.77 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.25 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -96.44 -11.66 25.31 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.865 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.503 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 85.1 p -74.71 98.4 3.44 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.098 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.8 m -78.67 -32.85 47.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.345 179.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.19 -42.72 55.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.595 -179.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.503 ' O ' ' OG ' ' A' ' 64' ' ' SER . 79.5 m-20 -135.88 95.06 14.07 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.919 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.409 ' HA ' HD22 ' A' ' 62' ' ' ASN . 40.1 Cg_exo -54.92 143.33 72.77 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.383 2.055 . . . . 0.0 113.242 -178.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.408 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 12.2 m -70.94 152.87 43.18 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.309 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.463 ' O ' ' N ' ' A' ' 89' ' ' THR . 72.9 mt-30 -115.54 141.24 48.33 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.535 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.547 ' CG2' ' OD1' ' A' ' 86' ' ' ASP . 4.4 p -130.9 137.51 55.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 49.26 32.16 4.17 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.05 28.79 69.8 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.959 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.464 ' N ' ' O ' ' A' ' 71' ' ' VAL . 9.0 t -140.24 137.3 34.16 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.914 0.388 . . . . 0.0 111.363 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.7 t -64.9 135.97 27.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.673 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 11.9 pt -110.49 77.93 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.12 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.318 179.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -59.93 -33.02 71.33 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -112.9 159.35 34.84 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.785 178.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.55 154.27 71.97 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.413 2.075 . . . . 0.0 111.67 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.0 m -148.15 149.02 15.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.873 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -73.1 132.15 42.95 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-O 120.983 0.42 . . . . 0.0 110.449 179.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 97.6 mt -80.95 140.97 34.95 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.198 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -133.63 154.6 50.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.767 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.666 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 6.1 t60 -55.15 116.46 2.81 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.259 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.17 -18.39 18.58 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.547 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 56.9 t0 -66.08 123.36 19.67 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.271 0.557 . . . . 0.0 109.508 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.502 ' CG2' ' OG ' ' A' ' 94' ' ' SER . 7.4 p -104.37 132.94 49.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.078 -178.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 29.4 mm -92.48 130.47 41.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 178.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.463 ' N ' ' O ' ' A' ' 70' ' ' GLN . 22.6 m -121.96 126.44 48.6 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 119.364 -0.934 . . . . 0.0 112.9 -178.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.579 ' O ' ' N ' ' A' ' 93' ' ' ARG . 98.0 mt -120.39 127.69 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 113.988 -1.46 . . . . 0.0 107.996 177.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.553 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 44.0 mt -21.21 101.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 O-C-N 123.612 0.57 . . . . 0.0 112.243 -179.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.553 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 11.3 t0 89.87 -19.81 0.16 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 177.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.59 HH21 ' CB ' ' B' ' 260' ' ' GLU . 71.7 mtt85 -131.44 139.85 49.48 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.806 -178.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.502 ' OG ' ' CG2' ' A' ' 87' ' ' VAL . 15.8 t -135.04 146.91 49.43 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 120.894 0.378 . . . . 0.0 110.09 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -123.78 124.52 42.87 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.752 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -88.29 133.47 34.05 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 119.568 -0.853 . . . . 0.0 110.932 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -95.28 124.34 39.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.875 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -123.12 127.62 48.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.421 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.666 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 62.6 t-20 -130.22 112.36 13.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.385 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.4 ' O ' ' O ' ' A' ' 99' ' ' ASN . 82.6 tt0 . . . . . 0 C--N 1.33 -0.246 0 CA-C-O 120.897 0.379 . . . . 0.0 110.05 -179.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 CA--C 1.528 0.114 0 CA-C-O 120.827 0.346 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.508 ' O ' ' N ' ' B' ' 231' ' ' GLN . 75.9 m-20 -70.57 140.29 51.68 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . 0.453 ' H ' ' HB3' ' A' ' 31' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.508 ' N ' ' O ' ' B' ' 229' ' ' ASP . 4.3 mt-30 -46.26 -47.27 18.17 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.136 -179.068 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' B' ' 231' ' ' GLN . . . -36.71 165.64 0.01 OUTLIER Glycine 0 CA--C 1.529 0.958 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.463 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.04 162.97 40.21 Favored 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 124.384 3.39 . . . . 0.0 112.813 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.44 141.63 42.93 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 121.902 1.735 . . . . 0.0 112.635 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 72.8 t -66.2 133.26 31.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.818 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 2.0 t -74.88 135.6 41.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.113 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . 0.466 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . 0.466 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 33.1 Cg_exo -59.17 -24.01 71.91 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.728 2.285 . . . . 0.0 112.263 -179.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 98.9 m -67.25 -48.0 69.08 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -59.31 -47.57 84.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.13 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 85.9 mt -65.36 -40.13 93.18 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.14 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -62.16 -42.4 99.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.896 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 79.2 ttt-85 -61.19 -42.48 98.65 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.078 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -62.72 -42.33 99.6 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.749 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -62.11 -43.12 99.53 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 54.3 m -65.35 -44.05 88.93 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . 0.696 ' NE2' HH22 ' A' ' 12' ' ' ARG . 57.0 tt0 -57.26 -41.29 79.4 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.521 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 55.1 t -65.51 -43.83 94.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.75 0.309 . . . . 0.0 110.649 179.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -55.33 -29.8 59.01 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -87.3 -3.78 59.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.856 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 94.9 mt -123.62 116.2 22.72 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.968 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -61.5 -174.96 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.019 0.438 . . . . 0.0 111.345 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -62.47 -13.33 29.04 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.18 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -70.98 -14.92 62.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.853 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.406 ' CG ' ' N ' ' B' ' 257' ' ' LYS . 38.9 t70 38.09 -114.99 0.14 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.71 179.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . 0.491 ' O ' ' OD1' ' B' ' 259' ' ' ASP . 55.8 pttt 178.22 -130.94 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.39 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.584 ' OD1' ' N ' ' B' ' 259' ' ' ASP . 43.7 p-10 -65.23 -26.73 68.24 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.361 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.584 ' N ' ' OD1' ' B' ' 258' ' ' ASP . 1.1 m-20 89.98 12.58 0.06 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.582 179.462 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.59 ' CB ' HH21 ' A' ' 93' ' ' ARG . 51.1 mp0 56.28 -3.0 0.03 OUTLIER 'General case' 0 C--O 1.237 0.437 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 178.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . 0.547 ' H ' ' C ' ' B' ' 259' ' ' ASP . 78.1 mt -110.81 136.21 47.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 76.7 t -122.91 131.19 73.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.999 0.428 . . . . 0.0 110.254 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -94.23 117.48 30.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.202 0.525 . . . . 0.0 110.958 -178.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.32 -44.81 90.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.543 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.75 160.36 28.07 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.801 -179.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -57.07 152.87 41.8 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.987 2.458 . . . . 0.0 111.716 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 39.8 pt . . . . . 0 C--N 1.327 -0.383 0 CA-C-O 121.622 0.725 . . . . 0.0 111.978 -178.921 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo . . . . . 0 N--CA 1.501 1.929 0 CA-C-O 121.105 0.377 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.503 ' O ' ' O ' ' A' ' 99' ' ' ASN . 2.9 m -93.18 -53.83 3.96 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.318 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.443 ' HE ' HD12 ' A' ' 53' ' ' ILE . 82.5 mtm-85 -89.98 130.68 36.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.958 -179.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -131.06 148.04 52.69 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.155 0.502 . . . . 0.0 111.921 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 94.1 mt -115.4 141.7 47.68 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.257 179.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.9 t -113.14 128.22 70.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.7 m -91.69 113.73 26.08 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.8 mt -77.58 138.77 19.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -86.32 157.04 19.99 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.425 179.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -58.01 -30.84 66.41 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.782 -179.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 87.0 p -78.55 -9.74 59.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.871 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.56 34.78 6.81 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.756 -0.937 . . . . 0.0 110.756 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 52.3 t -121.51 133.84 66.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.574 0.226 . . . . 0.0 110.813 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.403 ' C ' ' OD1' ' A' ' 16' ' ' ASP . 62.3 t0 -66.24 120.15 12.75 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.934 0.397 . . . . 0.0 110.383 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -104.43 -136.12 8.7 Favored Glycine 0 CA--C 1.535 1.337 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.374 -178.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.97 151.54 45.15 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.581 2.187 . . . . 0.0 112.693 -178.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -107.85 128.93 55.04 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.965 -179.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -97.67 106.36 32.83 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.053 -178.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.85 128.13 9.87 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 121.703 1.602 . . . . 0.0 111.405 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.5 mt -83.39 84.0 7.67 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.381 -0.528 . . . . 0.0 111.552 -178.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 57.2 p -83.44 -13.66 54.27 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 58.6 mt -99.55 142.57 30.85 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.963 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 27.1 m -69.48 -10.44 58.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.646 -178.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 29.2 m -132.16 132.56 43.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.757 0.313 . . . . 0.0 110.57 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.6 t -128.1 123.68 35.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.508 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.411 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 54.7 tp -117.45 131.67 56.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.017 -179.058 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.414 ' CE2' HG13 ' A' ' 37' ' ' ILE . 32.1 m-85 -110.33 135.91 50.32 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 155.81 -164.38 32.18 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 120.367 -0.921 . . . . 0.0 112.328 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.62 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 47.6 ptt85 -119.18 19.54 12.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.651 -0.275 . . . . 0.0 110.352 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.63 ' O ' ' N ' ' A' ' 34' ' ' GLU . . . -88.32 29.74 5.53 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.591 ' C ' ' H ' ' A' ' 35' ' ' CYS . 1.7 tp 55.63 -61.85 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 O-C-N 123.849 0.382 . . . . 0.0 111.163 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.63 ' N ' ' O ' ' A' ' 32' ' ' GLY . 49.8 tp10 -50.46 -9.64 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.415 0.626 . . . . 0.0 109.514 179.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.591 ' H ' ' C ' ' A' ' 33' ' ' ILE . 35.1 m -65.42 124.74 23.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.39 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.411 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 60.5 m-20 -60.34 -31.66 70.51 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.414 HG13 ' CE2' ' A' ' 29' ' ' PHE . 42.6 mm -118.95 114.08 43.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 177.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.74 HH22 ' NZ ' ' B' ' 264' ' ' LYS . 77.3 mtt85 -103.64 136.09 43.99 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.448 -177.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 97.8 mt -122.58 132.23 71.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 121.006 0.432 . . . . 0.0 110.439 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -77.27 33.0 0.15 Allowed 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -176.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.553 ' CD1' ' NH1' ' A' ' 93' ' ' ARG . 47.4 mt -109.81 134.75 20.54 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 120.091 -0.643 . . . . 0.0 111.546 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.55 -8.23 21.36 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.456 2.104 . . . . 0.0 113.517 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.6 m -100.56 3.23 10.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.468 179.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.62 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 37.2 t -88.96 132.74 32.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.482 -0.487 . . . . 0.0 109.713 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.8 t -66.02 155.86 35.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.498 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.516 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 40.3 mtmt -63.04 -40.76 98.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.027 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.646 ' O ' ' N ' ' A' ' 49' ' ' CYS . 87.5 mt-30 -115.94 -7.57 11.96 Favored 'General case' 0 N--CA 1.464 0.23 0 O-C-N 123.319 0.387 . . . . 0.0 111.334 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.469 ' C ' ' O ' ' A' ' 47' ' ' GLN . 17.0 t60 15.7 -71.4 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -178.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.646 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.46 133.42 45.15 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -178.49 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -125.36 129.02 49.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.784 178.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 90.5 mt -115.1 134.86 56.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.042 0.449 . . . . 0.0 111.732 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.578 ' CD ' ' HE2' ' A' ' 54' ' ' HIS . 81.5 tt0 -117.59 126.15 52.05 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.443 HD12 ' HE ' ' A' ' 5' ' ' ARG . 94.9 mt -108.14 118.87 56.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 113.086 0.772 . . . . 0.0 113.086 -178.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.578 ' HE2' ' CD ' ' A' ' 52' ' ' GLU . 98.4 m-70 -111.23 138.28 47.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.015 178.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 54' ' ' HIS . 78.6 tt0 -40.72 -33.87 0.33 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -179.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -63.79 -67.14 0.45 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.696 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.51 ' OE2' ' CD ' ' A' ' 81' ' ' ARG . 0.1 OUTLIER -148.56 -178.97 6.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.203 0.525 . . . . 0.0 111.519 -179.373 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -106.51 126.47 52.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.189 178.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 86.6 mt -116.9 128.6 74.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.429 0.633 . . . . 0.0 112.351 -178.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 24.8 tp -99.85 130.57 46.06 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.499 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -112.61 132.9 54.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.098 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 63.9 t-20 -92.16 106.77 18.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.353 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -98.25 -7.57 28.91 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.44 102.06 4.33 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.039 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.5 m -89.42 -6.52 56.48 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.2 -40.14 6.92 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.126 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 56.9 m-20 -142.69 99.04 5.72 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.107 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -55.36 146.2 63.25 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.286 1.991 . . . . 0.0 113.546 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.9 m -76.01 144.95 40.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.837 178.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.441 ' O ' ' N ' ' A' ' 89' ' ' THR . 87.5 mt-30 -105.63 139.16 40.64 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.795 179.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 54.9 t -130.1 134.44 62.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 52.67 33.78 14.54 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.6 27.91 71.8 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.233 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 68.2 m -142.77 138.26 30.32 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 117.626 0.713 . . . . 0.0 111.853 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.4 t -68.12 140.8 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.853 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.5 pt -114.16 105.99 19.79 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.063 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.67 178.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 20.5 p-10 -74.37 -26.54 60.18 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.131 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.442 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.3 OUTLIER -130.4 178.52 1.69 Allowed Pre-proline 0 C--N 1.33 -0.258 0 C-N-CA 120.866 -0.333 . . . . 0.0 110.62 -179.794 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 31.2 Cg_exo -59.91 141.87 97.42 Favored 'Trans proline' 0 N--CA 1.502 1.985 0 C-N-CA 122.687 2.258 . . . . 0.0 113.158 -179.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 47.1 t -133.77 135.92 54.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.725 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.51 ' CD ' ' OE2' ' A' ' 57' ' ' GLU . 88.9 mtm180 -71.91 132.98 45.11 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.1 mt -86.86 136.82 32.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.257 0.551 . . . . 0.0 111.615 -178.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -121.31 148.79 43.85 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.613 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.577 ' HD1' ' H ' ' A' ' 99' ' ' ASN . 7.9 t60 -58.55 125.76 24.73 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.029 0.442 . . . . 0.0 110.291 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.57 -17.44 42.91 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.809 -0.917 . . . . 0.0 110.809 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -67.74 140.39 56.72 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.101 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.1 p -112.33 127.96 69.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.476 -178.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 88.0 mt -92.81 130.59 41.67 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 177.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.441 ' N ' ' O ' ' A' ' 70' ' ' GLN . 52.1 m -125.85 128.9 48.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.975 0.893 . . . . 0.0 113.111 -178.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.546 ' O ' ' C ' ' A' ' 91' ' ' ILE . 95.9 mt -114.44 137.81 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 114.004 -1.453 . . . . 0.0 108.217 178.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.546 ' C ' ' O ' ' A' ' 90' ' ' ILE . 87.4 mt 17.02 -85.74 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 O-C-N 123.645 0.591 . . . . 0.0 111.771 -178.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.499 ' N ' ' O ' ' A' ' 90' ' ' ILE . 53.9 t0 -121.63 14.33 10.97 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 120.315 -0.554 . . . . 0.0 112.023 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.553 ' NH1' ' CD1' ' A' ' 41' ' ' LEU . 45.1 mtm-85 -129.31 140.75 51.3 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.642 -0.423 . . . . 0.0 109.974 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 55.0 p -139.14 153.96 48.04 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.124 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -127.13 126.84 43.6 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.746 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -84.34 129.36 34.88 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.85 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.557 ' CE2' ' OD1' ' A' ' 99' ' ' ASN . 88.8 t80 -89.63 123.86 34.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.951 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -134.12 113.24 11.85 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.076 0.465 . . . . 0.0 111.146 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.577 ' H ' ' HD1' ' A' ' 84' ' ' HIS . 99.1 m-20 -68.17 -40.42 82.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.152 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.91 -179.542 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 39.0 t . . . . . 0 N--CA 1.456 -0.127 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.573 ' CG ' ' H ' ' B' ' 230' ' ' SEP . 45.1 t0 61.98 -173.5 0.14 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.074 -179.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . 0.598 ' O ' ' NE2' ' B' ' 231' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.598 ' NE2' ' O ' ' B' ' 230' ' ' SEP . 99.0 mm-40 -145.41 75.64 1.44 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.03 179.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -123.26 -174.08 14.18 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 120.986 -0.626 . . . . 0.0 111.754 -178.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . 0.606 ' O ' ' NH2' ' A' ' 31' ' ' ARG . 87.9 Cg_endo -73.66 155.22 49.65 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 123.415 2.743 . . . . 0.0 112.85 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.46 136.47 33.87 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 121.735 1.624 . . . . 0.0 113.098 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 55.0 t -65.22 137.14 25.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 114.585 -1.189 . . . . 0.0 111.156 -179.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 5.9 t -63.68 125.05 23.03 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -52.6 -23.02 18.41 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.934 1.756 . . . . 0.0 112.266 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 21.9 p -74.18 -41.19 61.85 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 121.188 0.518 . . . . 0.0 109.835 178.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -58.22 -45.56 87.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.964 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 89.1 mt -64.18 -40.46 96.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.658 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -61.81 -40.55 95.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.027 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 80.4 mtt85 -62.16 -42.52 99.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.168 0.509 . . . . 0.0 109.994 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.444 ' O ' ' CG2' ' B' ' 249' ' ' VAL . 78.0 mtp85 -61.98 -41.95 98.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.657 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -61.92 -43.32 99.09 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.274 -0.57 . . . . 0.0 110.398 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 46.9 t -65.97 -45.22 82.48 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -63.43 -34.49 77.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.012 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . 0.444 ' CG2' ' O ' ' B' ' 245' ' ' ARG . 59.8 t -61.06 -47.03 95.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.127 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -65.52 -29.71 70.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.788 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -78.12 -13.95 59.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.471 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 99.0 mt -114.44 115.08 26.71 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.971 0.415 . . . . 0.0 110.528 178.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . 0.577 ' C ' ' H ' ' B' ' 255' ' ' ASP . 1.6 m-80 -83.47 -157.35 0.24 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.534 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -47.31 -5.74 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.565 -179.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . 0.577 ' H ' ' C ' ' B' ' 253' ' ' ASN . 44.7 p-10 -70.95 -1.89 13.44 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.272 0.558 . . . . 0.0 109.9 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.657 ' O ' ' N ' ' B' ' 258' ' ' ASP . 93.8 m-20 -58.61 -33.09 69.62 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . 0.501 ' C ' ' O ' ' B' ' 256' ' ' ASP . 87.8 tttt -25.06 -36.33 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 O-C-N 124.211 0.945 . . . . 0.0 110.951 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.657 ' N ' ' O ' ' B' ' 256' ' ' ASP . 96.6 m-20 -86.99 44.86 1.21 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.591 ' N ' ' O ' ' B' ' 256' ' ' ASP . 48.3 p30 -48.15 144.54 3.72 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.526 0.679 . . . . 0.0 111.952 -178.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.425 ' OE1' ' CD2' ' A' ' 41' ' ' LEU . 97.1 mt-10 -61.93 20.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.588 -1.187 . . . . 0.0 112.495 -178.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . 0.576 ' H ' ' C ' ' B' ' 259' ' ' ASP . 61.6 mt -109.33 132.41 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 75.2 t -127.87 137.08 58.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.282 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -98.61 120.48 39.11 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.052 -177.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . 0.74 ' NZ ' HH22 ' A' ' 38' ' ' ARG . 64.6 tttp -65.18 -48.07 74.73 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.924 178.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -85.5 172.04 9.48 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.281 -178.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -58.08 143.98 95.62 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.343 2.029 . . . . 0.0 112.943 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 18.5 tt . . . . . 0 N--CA 1.448 -0.569 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.361 179.216 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo . . . . . 0 N--CA 1.49 1.294 0 CA-C-O 120.743 0.226 . . . . 0.0 111.616 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.9 p -78.07 -36.48 48.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.014 179.641 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.4 mtm-85 -99.76 124.43 45.02 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.02 -178.641 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -133.74 144.81 49.32 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.261 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 69.4 mt -111.73 138.96 47.61 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.855 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.8 t -112.29 125.88 69.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.3 m -74.93 138.65 42.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.916 -178.693 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.614 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 98.5 mt -109.89 132.86 56.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.547 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -90.38 157.25 17.71 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.479 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.53 ' NH1' ' CD ' ' B' ' 260' ' ' GLU . 93.2 mtm-85 -61.31 -23.49 65.75 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.048 -179.28 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.5 m -76.08 -16.6 59.89 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.552 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.06 33.26 7.03 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.596 -1.001 . . . . 0.0 110.596 -179.331 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 37.0 t -117.64 131.82 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-O 120.573 0.225 . . . . 0.0 111.499 -179.521 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -74.02 136.65 43.14 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 178.376 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -130.46 -119.95 2.17 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.308 -179.169 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -72.95 150.16 48.46 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 122.464 2.109 . . . . 0.0 112.646 -178.748 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -112.38 156.96 21.63 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.306 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -123.13 103.99 35.67 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.143 -179.261 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -71.49 127.24 13.01 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 121.622 1.548 . . . . 0.0 111.929 -179.414 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.3 mt -84.31 48.83 1.55 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -178.295 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 94.3 p -61.35 -24.33 66.38 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.484 ' CD1' ' NE2' ' B' ' 265' ' ' GLN . 73.3 mt -77.36 139.76 39.81 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.667 179.485 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 91.8 p -66.18 -18.96 65.67 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.165 -179.302 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.428 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 40.4 m -132.8 132.83 42.63 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.024 -179.777 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.7 t -125.27 118.33 25.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.847 178.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 39.7 tp -116.82 128.55 55.38 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.055 -178.646 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.465 ' O ' ' O ' ' A' ' 47' ' ' GLN . 4.5 m-85 -107.58 141.06 39.62 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.158 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 158.13 -168.76 34.65 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 120.033 -1.079 . . . . 0.0 112.615 179.016 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.6 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 86.5 mtm-85 -81.23 -31.1 33.99 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-O 121.005 0.431 . . . . 0.0 110.185 179.687 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.485 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -50.56 142.07 16.37 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 115.745 -0.662 . . . . 0.0 112.39 -177.979 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.471 ' CD1' ' CZ ' ' A' ' 38' ' ' ARG . 38.8 mm -65.67 -43.65 93.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.276 0.56 . . . . 0.0 109.492 179.087 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.3 tp10 -57.8 -19.38 28.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.973 -179.637 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 34.9 m -59.69 130.9 49.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.42 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.428 ' OD2' ' O ' ' A' ' 26' ' ' THR . 54.6 m-20 -60.78 -33.83 73.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.838 -179.351 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 89.7 mt -127.84 120.66 54.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 177.48 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.471 ' CZ ' ' CD1' ' A' ' 33' ' ' ILE . 81.4 mtp180 -103.12 137.02 41.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.824 -178.722 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.436 ' C ' ' H ' ' A' ' 41' ' ' LEU . 98.4 mt -118.26 127.55 75.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.805 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -73.16 31.92 0.07 Allowed 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -177.405 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.455 ' CD2' ' OE1' ' B' ' 260' ' ' GLU . 88.2 mt -108.45 132.09 21.34 Favored Pre-proline 0 C--N 1.325 -0.482 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.012 179.657 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.37 -9.79 23.38 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.459 2.106 . . . . 0.0 112.797 179.742 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.2 m -95.03 2.62 9.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.512 -0.475 . . . . 0.0 109.801 179.51 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.6 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 21.0 t -88.57 131.6 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.602 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.632 ' OG ' ' N ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -66.42 167.48 10.57 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.325 0.583 . . . . 0.0 111.798 -177.897 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.485 ' N ' ' HG ' ' A' ' 45' ' ' SER . 95.8 mttt -61.37 -45.84 92.68 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.423 -178.746 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.622 ' O ' ' N ' ' A' ' 49' ' ' CYS . 86.1 mt-30 -113.62 -15.71 12.47 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.557 178.825 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.632 ' N ' ' OG ' ' A' ' 45' ' ' SER . 16.8 t60 34.93 -76.61 0.0 OUTLIER 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.067 -0.969 . . . . 0.0 113.604 179.765 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.622 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -129.56 134.41 47.72 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.367 0.603 . . . . 0.0 112.294 -178.433 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -125.67 132.23 52.46 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.845 178.67 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.2 mt -116.46 134.26 60.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.927 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -117.83 122.97 44.78 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.562 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 72.7 mt -105.27 115.8 47.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.419 0.628 . . . . 0.0 111.476 -178.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.46 ' O ' ' N ' ' A' ' 56' ' ' GLN . 87.2 m-70 -114.79 144.86 42.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.816 -1.083 . . . . 0.0 109.868 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.8 mm-40 -40.84 -27.15 0.05 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.07 0.462 . . . . 0.0 110.156 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.46 ' N ' ' O ' ' A' ' 54' ' ' HIS . 86.9 mm-40 -68.96 -67.61 0.46 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.151 179.094 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -158.99 -166.37 1.83 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.37 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.34 129.35 55.77 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.195 -179.853 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 90.0 mt -120.48 130.18 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 121.166 0.508 . . . . 0.0 112.338 -178.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 36.0 tp -97.71 129.25 44.77 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.156 179.852 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -114.61 136.41 53.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.206 179.677 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -97.42 104.87 16.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.97 0.414 . . . . 0.0 111.614 -179.613 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -94.2 -10.5 32.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.68 178.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.8 t -76.95 102.94 6.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.225 179.237 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 88.8 p -86.76 -8.7 57.13 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.574 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.84 -37.91 10.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.117 0.484 . . . . 0.0 110.019 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -146.2 95.57 4.71 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.961 179.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.0 148.57 76.03 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 122.363 2.042 . . . . 0.0 112.526 -179.652 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 57.1 m -70.29 141.23 52.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.469 179.197 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -98.53 146.71 25.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.562 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.513 ' CG2' ' OD1' ' A' ' 86' ' ' ASP . 6.1 p -130.55 135.99 59.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.2 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 48.3 32.37 3.14 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 -179.694 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.12 29.57 62.34 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 111.414 -0.674 . . . . 0.0 111.414 -179.836 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.415 ' N ' ' O ' ' A' ' 71' ' ' VAL . 15.0 m -138.87 136.32 35.43 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.817 0.308 . . . . 0.0 111.052 -179.62 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.8 p -64.38 143.81 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 120.931 0.396 . . . . 0.0 111.835 -179.194 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.527 ' CG2' ' O ' ' A' ' 78' ' ' GLU . 95.5 mt -107.64 103.51 15.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.036 179.672 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -64.58 -41.84 96.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.519 179.082 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.527 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.4 OUTLIER -137.38 -177.46 0.71 Allowed Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.456 -178.362 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.506 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 35.7 Cg_exo -58.69 145.71 94.71 Favored 'Trans proline' 0 N--CA 1.5 1.885 0 C-N-CA 122.838 2.359 . . . . 0.0 112.779 -179.598 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.3 m -144.48 147.25 19.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.556 179.808 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -77.53 131.82 38.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.807 178.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.0 mt -84.76 140.52 31.19 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.08 0.467 . . . . 0.0 111.482 -179.396 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -129.32 151.36 50.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.646 179.58 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.633 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 5.2 t60 -54.42 120.87 7.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.482 -179.656 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.82 -13.8 41.66 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 -179.269 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.513 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 55.1 t0 -70.05 126.38 29.53 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.363 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 71.4 t -103.88 135.02 43.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.625 -178.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.518 ' O ' ' OG ' ' A' ' 94' ' ' SER . 84.7 mt -103.91 129.52 55.92 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.769 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 87.5 m -124.53 124.69 42.81 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 119.861 -0.736 . . . . 0.0 112.675 -178.269 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.582 ' O ' ' N ' ' A' ' 93' ' ' ARG . 98.4 mt -111.93 131.54 63.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 114.697 -1.138 . . . . 0.0 107.944 177.942 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.504 ' C ' ' O ' ' A' ' 90' ' ' ILE . 66.0 mt -21.9 97.61 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.585 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.502 ' CG ' ' NE ' ' B' ' 245' ' ' ARG . 3.3 m-20 89.2 -24.9 0.08 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 178.098 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.614 ' NH2' ' O ' ' A' ' 10' ' ' ILE . 6.2 mmm180 -124.15 140.05 53.34 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.532 -179.288 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.518 ' OG ' ' O ' ' A' ' 88' ' ' ILE . 46.0 t -141.22 151.59 43.89 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.768 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -128.24 123.14 33.44 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.267 179.323 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -80.08 134.09 36.16 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.289 179.22 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -94.83 123.69 38.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.669 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -124.63 122.19 36.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.785 -179.874 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.633 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 59.9 t-20 -106.52 104.18 13.81 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.038 179.61 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 . . . . . 0 C--N 1.328 -0.341 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.035 179.795 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.766 0.317 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -86.48 120.2 27.55 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.64 -179.765 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 -126.19 45.78 2.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.401 -179.496 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -116.94 -174.57 17.21 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 121.061 -0.59 . . . . 0.0 111.736 -179.458 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.11 162.04 41.75 Favored 'Trans proline' 0 N--CA 1.497 1.678 0 C-N-CA 123.712 2.941 . . . . 0.0 113.002 -179.739 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.78 147.71 56.89 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.081 1.854 . . . . 0.0 113.759 -179.404 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 19.0 t -78.21 131.5 34.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.019 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 3.3 t -60.35 126.41 27.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.807 0.337 . . . . 0.0 111.268 -179.353 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . 0.531 ' P ' ' OG1' ' B' ' 240' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -60.75 -23.53 76.58 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.813 2.342 . . . . 0.0 113.306 -179.171 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 240' ' ' THR . . . . . 0.531 ' OG1' ' P ' ' B' ' 238' ' ' TPO . 6.7 p -77.29 -38.25 51.15 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 120.187 -0.605 . . . . 0.0 109.528 177.94 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -58.63 -45.47 89.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.327 179.78 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . 0.456 HD22 HH21 ' B' ' 245' ' ' ARG . 95.3 mt -62.6 -41.54 99.03 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 121.161 0.505 . . . . 0.0 110.537 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -67.9 -38.4 82.92 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.571 -179.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -61.12 -48.02 83.57 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.502 -178.593 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.502 ' NE ' ' CG ' ' A' ' 92' ' ' ASP . 52.0 ptt85 -64.64 -37.37 87.36 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.613 -179.303 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -61.21 -39.72 91.28 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.294 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 14.0 t -66.75 -42.3 86.42 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.364 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -58.07 -39.88 79.6 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.853 179.674 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 42.9 t -59.64 -45.42 94.29 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.21 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -63.35 -23.64 67.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.056 178.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -87.66 -12.74 44.56 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.821 -179.624 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 78.1 mt -71.16 148.34 47.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.129 0.49 . . . . 0.0 110.645 179.364 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -173.02 39.25 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.687 179.751 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . 0.549 ' O ' ' CB ' ' B' ' 255' ' ' ASP . 46.5 p-10 -99.03 -3.03 35.76 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.067 179.109 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . 0.579 ' O ' ' CB ' ' B' ' 256' ' ' ASP . 48.2 p-10 129.51 -25.67 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.792 0 O-C-N 124.668 1.23 . . . . 0.0 109.936 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.579 ' CB ' ' O ' ' B' ' 255' ' ' ASP . 28.2 t0 105.01 13.34 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 O-C-N 124.157 0.91 . . . . 0.0 110.726 -179.815 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -108.71 161.0 15.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.117 179.784 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 64.04 55.44 1.54 Allowed 'General case' 0 C--O 1.231 0.126 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.553 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.618 ' CG ' ' H ' ' B' ' 260' ' ' GLU . 17.1 p-10 -65.76 -99.4 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.639 -179.0 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.618 ' H ' ' CG ' ' B' ' 259' ' ' ASP . 97.6 mt-10 -145.05 16.88 1.57 Allowed 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 121.079 -0.248 . . . . 0.0 110.84 -179.66 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 47.6 mt -115.37 137.92 47.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -179.555 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 55.3 t -127.23 133.93 67.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.897 179.223 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -97.31 122.6 40.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.051 0.453 . . . . 0.0 111.348 -178.411 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -66.18 -44.08 85.04 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.359 179.568 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . 0.484 ' NE2' ' CD1' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -99.87 170.0 7.32 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.554 -178.723 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.77 154.56 67.56 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.414 2.076 . . . . 0.0 112.017 -179.83 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 45.0 pt . . . . . 0 C--N 1.328 -0.362 0 CA-C-O 121.484 0.659 . . . . 0.0 111.936 -179.147 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo . . . . . 0 N--CA 1.494 1.516 0 CA-C-O 120.678 0.199 . . . . 0.0 111.996 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 37.1 m -99.42 -43.16 6.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.017 0.437 . . . . 0.0 110.667 179.227 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.54 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 95.9 mtt-85 -90.76 125.4 35.69 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.749 -178.425 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -134.73 143.93 47.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.871 -179.243 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 73.1 mt -116.75 142.06 47.41 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.775 179.667 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.7 t -117.19 128.31 74.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.968 0.413 . . . . 0.0 110.279 179.536 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.2 m -74.68 140.8 44.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.354 0.597 . . . . 0.0 112.325 -179.187 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.604 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 90.0 mt -112.47 134.06 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.838 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -91.6 158.08 16.63 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.193 0.52 . . . . 0.0 111.77 -179.311 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.732 HH11 HH11 ' B' ' 245' ' ' ARG . 86.4 mtm180 -58.21 -30.99 66.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.505 -178.952 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.5 p -78.15 -10.2 59.52 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.601 178.96 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.81 36.17 7.42 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 179.951 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.5 t -118.07 132.74 67.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.01 0.433 . . . . 0.0 111.579 -179.615 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -73.22 128.86 36.68 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.003 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -125.45 -120.68 2.46 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 120.139 -1.029 . . . . 0.0 112.709 -178.797 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -72.01 146.67 47.53 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 122.242 1.962 . . . . 0.0 112.517 -178.202 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -108.71 147.33 32.11 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.94 179.372 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -116.87 102.8 52.87 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.578 -179.375 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.61 133.84 17.75 Favored 'Trans proline' 0 N--CA 1.486 1.049 0 C-N-CA 121.122 1.215 . . . . 0.0 110.504 -179.357 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 92.3 mt -87.64 62.87 7.27 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.723 -177.822 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 80.6 p -70.71 -21.0 62.61 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 177.79 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 71.0 mt -85.03 138.34 32.5 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.339 -179.61 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -62.4 -20.9 64.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.612 -179.12 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.1 m -134.17 135.49 43.11 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.821 -179.827 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.661 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -129.88 122.92 29.57 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.187 178.883 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.507 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 35.0 tp -120.98 126.8 50.87 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.7 -178.688 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.661 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 36.3 m-85 -99.74 127.16 45.88 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.134 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -176.39 -156.16 14.77 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.448 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -115.46 -17.67 11.17 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 117.174 0.487 . . . . 0.0 110.415 179.13 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.23 161.88 47.35 Favored Glycine 0 CA--C 1.519 0.337 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -179.656 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.449 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 10.8 tp -66.04 -41.63 90.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.408 179.585 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.449 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 15.0 pt-20 -56.86 -22.77 39.41 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.801 -179.727 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.7 m -63.23 126.3 26.96 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.874 0.369 . . . . 0.0 110.706 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.611 ' OD1' ' N ' ' A' ' 37' ' ' ILE . 11.0 p-10 -61.97 -28.89 69.87 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.096 -179.316 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.611 ' N ' ' OD1' ' A' ' 36' ' ' ASP . 97.5 mt -130.55 122.42 52.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 177.724 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 75.0 mtm180 -103.82 136.24 43.88 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.198 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.472 ' C ' ' H ' ' A' ' 41' ' ' LEU . 97.2 mt -117.66 129.23 74.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.857 179.748 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -70.52 32.4 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.814 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.577 ' CD2' ' NH2' ' B' ' 245' ' ' ARG . 43.4 mt -110.33 121.77 40.52 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 120.446 -0.502 . . . . 0.0 109.668 179.043 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.02 -1.47 10.92 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.244 1.963 . . . . 0.0 112.351 -178.809 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 18.3 m -99.2 6.73 9.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.323 179.813 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.448 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 29.6 t -89.96 133.94 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.25 178.797 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.04 159.56 28.43 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.02 0.438 . . . . 0.0 110.551 179.514 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -61.77 -39.16 90.67 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.273 -178.817 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.606 ' O ' ' N ' ' A' ' 49' ' ' CYS . 96.3 mm-40 -111.53 -18.22 12.88 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.46 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.4 t60 29.96 -78.85 0.0 OUTLIER 'General case' 0 C--O 1.236 0.377 0 CA-C-N 114.716 -1.129 . . . . 0.0 113.124 -179.683 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.606 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -129.47 134.21 47.69 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.914 -179.342 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -125.66 128.49 47.91 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.223 179.364 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 93.0 mt -114.54 133.31 61.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.787 -179.849 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -113.27 133.68 54.98 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.807 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.485 HG23 HD11 ' A' ' 53' ' ' ILE . 47.9 mm -103.14 114.5 42.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.558 -179.462 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.44 ' O ' ' C ' ' A' ' 55' ' ' GLU . 95.0 m-70 -115.47 132.8 56.51 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.473 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 54' ' ' HIS . 95.4 mt-10 -40.47 -34.13 0.32 Allowed 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 121.195 0.522 . . . . 0.0 109.92 -178.673 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -62.75 -67.32 0.43 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.233 179.418 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -152.43 -164.38 1.94 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.333 -179.63 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.462 ' CB ' ' NH1' ' A' ' 5' ' ' ARG . . . -127.28 131.18 50.56 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.011 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 91.7 mt -112.32 129.9 67.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.255 0.55 . . . . 0.0 112.205 -178.237 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 44.3 tp -94.46 120.22 34.37 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.224 179.028 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -107.85 135.05 49.9 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.962 0.41 . . . . 0.0 111.336 -178.823 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -96.14 104.91 16.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.246 179.627 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -99.31 -10.84 21.82 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.614 179.549 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.4 t -69.61 100.87 1.52 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.538 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.9 p -85.01 -15.96 42.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.038 0.447 . . . . 0.0 109.924 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.24 -46.13 8.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.752 -179.852 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.41 HD22 ' HA ' ' B' ' 236' ' ' VAL . 65.5 m-20 -135.08 97.71 13.38 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.283 -0.872 . . . . 0.0 109.456 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -56.74 144.64 86.22 Favored 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 122.501 2.134 . . . . 0.0 113.612 -178.838 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.0 m -75.36 140.39 43.0 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.264 178.756 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -104.3 141.42 36.34 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.321 179.938 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.424 ' O ' ' OG ' ' A' ' 74' ' ' SER . 53.0 t -131.92 135.29 58.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.739 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 51.92 31.96 9.26 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -178.399 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.31 27.48 69.79 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.095 -179.924 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 15.5 p -140.39 140.83 35.57 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 117.608 0.704 . . . . 0.0 111.696 179.776 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 41.5 t -68.87 135.83 27.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.041 179.451 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.4 pt -113.34 82.22 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.974 0.416 . . . . 0.0 110.696 178.588 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -61.62 -24.69 66.87 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.441 179.885 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -118.79 167.36 11.88 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.997 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -62.46 145.54 95.6 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 122.386 2.058 . . . . 0.0 112.568 179.63 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.34 140.01 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 120.822 0.344 . . . . 0.0 110.996 179.291 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -74.77 133.18 42.01 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.456 179.519 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.6 mt -79.23 134.9 36.66 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.196 0.522 . . . . 0.0 110.92 -179.596 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -129.52 150.18 50.98 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.385 179.479 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -52.32 113.63 1.1 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.501 -179.852 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.29 -11.16 19.69 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.437 ' C ' ' OD1' ' A' ' 86' ' ' ASP . 52.4 t0 -68.96 123.6 21.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.205 0.526 . . . . 0.0 110.998 -179.713 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.6 t -108.94 130.89 61.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.71 -179.572 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 83.9 mt -104.46 133.2 49.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.726 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 82.8 m -120.61 129.45 53.74 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.6 0.714 . . . . 0.0 112.491 -178.53 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.485 ' O ' ' N ' ' A' ' 93' ' ' ARG . 89.5 mt -121.13 122.59 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 114.501 -1.227 . . . . 0.0 108.1 178.235 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.424 ' C ' ' O ' ' A' ' 90' ' ' ILE . 36.8 mm 40.73 -112.45 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.016 -178.831 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -103.16 10.88 37.62 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.544 0.211 . . . . 0.0 111.05 179.079 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.604 ' NH2' ' O ' ' A' ' 10' ' ' ILE . 6.5 mmm180 -120.76 143.97 48.53 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.674 -179.123 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.1 p -142.26 155.76 45.25 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.904 0.383 . . . . 0.0 110.838 -179.96 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -128.0 124.99 38.56 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.273 179.35 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -86.95 133.67 33.57 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.505 0.193 . . . . 0.0 110.827 -179.737 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.54 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 69.6 t80 -93.96 123.79 37.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.893 179.886 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -123.85 128.83 50.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.42 -179.923 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -103.53 106.62 17.18 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.147 178.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 . . . . . 0 C--N 1.331 -0.231 0 CA-C-O 120.819 0.342 . . . . 0.0 110.877 -179.934 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . 0.584 ' O ' ' N ' ' B' ' 230' ' ' SEP . 55.3 t . . . . . 0 CA--C 1.533 0.297 0 CA-C-O 120.743 0.306 . . . . 0.0 111.445 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.474 ' C ' ' H ' ' B' ' 231' ' ' GLN . 93.8 m-20 41.8 13.11 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 179.542 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . 0.584 ' N ' ' O ' ' B' ' 228' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.515 ' O ' ' O ' ' B' ' 232' ' ' GLY . 7.6 mt-30 -120.46 -10.9 9.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.183 0.516 . . . . 0.0 110.648 -179.866 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . 0.515 ' O ' ' O ' ' B' ' 231' ' ' GLN . . . -39.91 -179.34 0.01 OUTLIER Glycine 0 CA--C 1.533 1.18 0 CA-C-N 115.097 -0.956 . . . . 0.0 113.901 -178.419 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.66 162.02 42.4 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 124.344 3.363 . . . . 0.0 112.62 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -65.99 135.57 41.36 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 121.66 1.574 . . . . 0.0 112.784 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . 0.41 ' HA ' HD22 ' A' ' 67' ' ' ASN . 27.8 t -72.08 137.29 23.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.782 -179.771 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 8.0 t -69.06 127.38 32.9 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.175 -179.628 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -56.67 -25.53 60.4 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 122.378 2.052 . . . . 0.0 112.51 179.626 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 99.8 m -73.04 -45.16 59.13 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.714 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -55.17 -45.31 75.74 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.875 -179.575 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 89.6 mt -63.11 -42.6 99.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.791 -179.185 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -65.3 -42.18 93.32 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.368 -179.024 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -61.98 -44.88 95.8 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.167 0.508 . . . . 0.0 110.509 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.732 HH11 HH11 ' A' ' 12' ' ' ARG . 49.5 ttm-85 -64.78 -41.49 95.81 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.682 -179.345 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -60.74 -38.17 84.26 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.708 0.29 . . . . 0.0 110.532 179.398 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 88.3 p -69.29 -40.56 77.65 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.528 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -58.64 -37.53 76.13 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.66 178.78 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . 0.517 ' O ' ' O ' ' B' ' 252' ' ' LEU . 54.1 t -63.96 -45.79 95.85 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.262 178.824 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -56.08 -24.14 38.17 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.055 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -98.65 -8.81 25.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.075 179.493 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.517 ' O ' ' O ' ' B' ' 249' ' ' VAL . 61.8 tp -125.54 116.53 21.91 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.448 177.886 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -179.66 15.08 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 119.66 -0.816 . . . . 0.0 112.879 179.474 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . 0.401 ' O ' ' CB ' ' B' ' 255' ' ' ASP . 38.8 t70 -61.19 -44.67 96.91 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 178.827 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . 0.471 ' O ' ' CG ' ' B' ' 255' ' ' ASP . 1.3 t70 164.56 69.8 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.589 -1.187 . . . . 0.0 108.632 179.921 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.542 ' OD1' ' OD1' ' B' ' 258' ' ' ASP . 51.5 t0 -86.19 81.45 8.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.697 -179.515 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -65.11 -9.42 22.5 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.059 -178.292 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.658 ' O ' ' N ' ' B' ' 260' ' ' GLU . 17.8 p-10 -114.66 16.26 17.53 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.363 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.587 ' O ' ' NH1' ' A' ' 93' ' ' ARG . 39.4 t0 -24.58 76.23 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 114.404 -1.271 . . . . 0.0 113.045 -179.106 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.658 ' N ' ' O ' ' B' ' 258' ' ' ASP . 47.4 mm-40 59.46 6.44 0.79 Allowed 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 177.606 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . 0.406 HD11 HG23 ' B' ' 261' ' ' ILE . 2.7 mm -114.05 133.28 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-N 119.334 0.97 . . . . 0.0 110.223 178.854 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 52.6 t -126.5 133.23 69.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.159 178.894 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -100.41 122.02 42.47 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.191 0.52 . . . . 0.0 111.266 -178.637 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . 0.406 ' HZ2' ' HA ' ' A' ' 34' ' ' GLU . 87.5 tttt -63.3 -47.62 81.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.222 179.432 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -96.47 161.57 26.38 Favored Pre-proline 0 N--CA 1.453 -0.314 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.474 -179.79 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.98 150.18 37.87 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 123.035 2.49 . . . . 0.0 112.585 -178.877 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 28.5 pt . . . . . 0 C--N 1.325 -0.497 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.248 178.926 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo . . . . . 0 N--CA 1.5 1.865 0 CA-C-O 120.86 0.275 . . . . 0.0 112.709 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.8 p -113.49 -30.63 6.79 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.108 179.14 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.63 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 94.6 mtt-85 -98.02 113.53 25.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.136 -179.585 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -127.62 138.18 52.77 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.92 0.39 . . . . 0.0 111.331 -179.711 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 42.3 tp -117.41 129.94 56.17 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.586 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.1 t -106.15 130.8 57.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.911 -179.536 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 m -92.2 114.81 27.45 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.253 -179.635 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.404 HG23 HD12 ' A' ' 10' ' ' ILE . 96.2 mt -80.96 145.66 8.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.516 179.359 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -88.13 161.69 17.16 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.076 0.465 . . . . 0.0 111.169 -179.866 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.702 HH11 ' NH2' ' A' ' 93' ' ' ARG . 58.0 mtp85 -55.21 -32.59 62.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.458 -179.445 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.426 ' OG ' ' OD1' ' B' ' 254' ' ' ASP . 42.9 t -80.74 -6.67 58.77 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.859 179.502 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.57 33.86 12.72 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -179.527 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.8 t -114.16 132.75 62.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.724 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 63.0 t0 -65.31 120.69 13.23 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.865 -179.448 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -107.88 -133.56 7.12 Favored Glycine 0 CA--C 1.536 1.366 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 -179.279 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.73 149.88 49.26 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 122.106 1.87 . . . . 0.0 112.341 -179.21 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -105.78 139.23 40.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.891 0.377 . . . . 0.0 109.991 179.493 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -111.45 103.5 55.1 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.684 -179.614 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.69 132.16 16.91 Favored 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 121.437 1.425 . . . . 0.0 111.972 -179.216 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 75.5 mt -87.5 45.98 1.33 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.887 -178.728 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 79.2 p -65.22 -17.82 64.81 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.276 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.5 mt -81.38 143.0 32.48 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.27 178.518 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.0 t -64.8 -23.65 67.3 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -178.872 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 66.3 m -135.03 136.87 42.44 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.56 -179.505 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.8 t -130.02 121.78 27.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.066 178.924 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.6 tp -116.78 127.65 54.54 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.579 -179.269 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.521 ' O ' ' O ' ' A' ' 47' ' ' GLN . 7.6 m-85 -104.86 141.3 36.77 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.291 178.915 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 156.33 -174.24 34.15 Favored Glycine 0 N--CA 1.469 0.867 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.415 178.922 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.636 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 83.2 mtm-85 -78.62 -29.3 45.86 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.168 179.56 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.553 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -54.47 148.98 19.94 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.643 -178.759 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.459 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 11.1 tp -67.78 -40.81 84.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.084 0.469 . . . . 0.0 110.023 179.512 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.459 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 80.1 mm-40 -54.4 -21.8 10.69 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.773 179.546 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.553 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 58.8 m -55.64 118.62 4.68 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.93 179.553 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -55.89 -29.69 60.38 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 179.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 73.0 mt -128.48 120.55 53.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.36 176.226 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 78.2 ttt-85 -108.35 137.26 46.61 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.602 -177.898 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.2 mt -121.45 132.09 71.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.4 -179.54 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -80.94 32.21 0.32 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -177.962 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.439 HD13 ' NH1' ' A' ' 93' ' ' ARG . 16.4 mt -97.2 133.54 23.87 Favored Pre-proline 0 C--N 1.32 -0.691 0 C-N-CA 120.049 -0.661 . . . . 0.0 110.711 -179.938 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.12 -10.41 25.88 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 122.364 2.043 . . . . 0.0 112.221 -179.746 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.2 m -105.47 4.05 10.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.269 -179.384 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.636 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 17.4 t -88.77 131.15 36.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 177.714 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.77 163.16 19.87 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.082 0.467 . . . . 0.0 110.812 -178.858 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -61.38 -40.9 96.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.013 -178.8 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.608 ' O ' ' N ' ' A' ' 49' ' ' CYS . 12.3 mm100 -110.31 -17.0 13.6 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 123.573 0.546 . . . . 0.0 110.299 -179.852 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 21.7 t60 33.09 -75.73 0.0 OUTLIER 'General case' 0 C--O 1.239 0.525 0 CA-C-N 114.943 -1.026 . . . . 0.0 113.634 -179.601 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.608 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -135.48 139.77 44.3 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -178.299 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -127.57 133.52 49.76 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.633 179.707 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.0 mt -119.04 134.14 63.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.082 -179.855 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -116.63 127.75 54.75 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.065 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.3 mt -109.46 111.52 36.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.473 0.654 . . . . 0.0 111.218 -179.756 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.548 ' O ' ' N ' ' A' ' 56' ' ' GLN . 94.8 m-70 -110.51 143.18 41.25 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.801 -1.09 . . . . 0.0 108.984 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.561 ' OE1' ' N ' ' A' ' 55' ' ' GLU . 55.1 mp0 -40.65 -24.44 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.853 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.548 ' N ' ' O ' ' A' ' 54' ' ' HIS . 88.8 mm-40 -68.16 -69.26 0.33 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.07 179.044 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.438 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 5.5 tp10 -158.91 -168.31 2.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.987 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.462 ' CB ' ' NH1' ' A' ' 5' ' ' ARG . . . -109.73 126.09 53.36 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.099 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.29 130.25 70.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.467 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.6 tp -98.66 130.21 45.16 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.429 179.724 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -117.47 137.65 52.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.857 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.544 HD22 ' CB ' ' A' ' 68' ' ' PRO . 64.1 t-20 -98.08 104.68 16.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.08 179.805 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -96.27 -7.28 35.88 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.864 179.342 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.38 100.81 10.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.984 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.1 m -87.08 -37.69 17.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.677 179.75 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.08 -44.11 97.86 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.418 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -141.23 101.23 6.24 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.119 179.415 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.544 ' CB ' HD22 ' A' ' 62' ' ' ASN . 44.5 Cg_endo -67.76 152.32 77.76 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 121.676 1.584 . . . . 0.0 113.602 -178.242 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.5 m -77.38 149.11 35.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.775 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -111.99 140.53 46.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.345 179.404 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.5 t -128.5 136.32 60.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.598 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 53.65 32.97 15.52 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.225 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.98 25.93 74.88 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.437 -179.759 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 66.7 m -141.14 141.78 34.12 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 117.114 0.457 . . . . 0.0 111.856 -179.564 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 75.2 t -67.91 139.14 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.687 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 9.2 pt -111.2 82.63 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-O 121.126 0.488 . . . . 0.0 111.049 178.55 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -62.56 -32.79 73.82 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.98 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -113.95 156.95 43.21 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.834 178.676 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.6 152.39 80.55 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.18 1.92 . . . . 0.0 111.582 178.928 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.1 m -146.89 149.0 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 121.28 0.562 . . . . 0.0 112.03 179.89 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -72.4 133.68 45.02 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.871 179.678 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.4 mt -77.26 137.94 39.11 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.098 0.475 . . . . 0.0 110.767 179.9 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -128.56 147.12 50.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.514 179.535 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.749 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 6.8 t60 -56.06 118.99 5.17 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.579 -179.525 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.27 -20.04 23.9 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -179.801 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -66.44 131.18 45.49 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.595 179.305 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.6 t -114.86 131.35 67.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.159 -178.501 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 84.6 mt -95.05 133.75 34.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.725 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.0 m -120.7 128.38 52.9 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.62 0.724 . . . . 0.0 112.574 -178.833 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.543 ' O ' ' N ' ' A' ' 92' ' ' ASP . 97.5 mt -115.06 123.4 70.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 114.559 -1.2 . . . . 0.0 108.664 178.54 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.457 ' CG2' ' CZ ' ' B' ' 245' ' ' ARG . 32.2 mm 38.71 -93.25 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.35 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.72 ' H ' ' NH1' ' B' ' 245' ' ' ARG . 16.9 t0 -125.97 20.16 7.68 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.011 0.434 . . . . 0.0 110.86 179.139 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.702 ' NH2' HH11 ' A' ' 12' ' ' ARG . 75.5 mtt85 -124.85 142.57 51.35 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.351 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 30.2 p -139.61 154.73 47.64 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.96 179.763 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.502 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 17.1 m-85 -125.16 121.96 35.72 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.035 179.54 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 39.1 ttp-105 -85.08 130.67 34.57 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.125 -0.63 . . . . 0.0 110.713 -179.256 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.63 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 87.7 t80 -94.66 123.67 38.24 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.962 -179.556 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -121.41 122.88 40.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.962 179.647 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.749 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 54.7 t-20 -117.72 110.8 18.29 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.976 179.001 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 . . . . . 0 C--N 1.328 -0.368 0 CA-C-O 121.008 0.432 . . . . 0.0 110.763 -179.241 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 29.0 m . . . . . 0 N--CA 1.455 -0.223 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.482 ' C ' ' H ' ' B' ' 231' ' ' GLN . 88.6 m-20 -68.11 142.24 55.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.112 -179.545 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.482 ' H ' ' C ' ' B' ' 229' ' ' ASP . 75.8 mt-30 -127.81 26.49 5.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.255 -179.631 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -114.32 -157.12 11.85 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 120.711 -0.756 . . . . 0.0 111.818 -178.882 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.78 151.27 71.93 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 123.755 2.97 . . . . 0.0 113.555 -179.294 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.91 141.84 49.96 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.14 1.893 . . . . 0.0 113.997 -178.183 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 39.4 t -76.0 133.62 30.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 114.781 -1.1 . . . . 0.0 110.998 -179.454 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 7.6 t -75.31 129.58 37.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.675 179.367 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -56.13 -27.6 66.09 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 122.889 2.393 . . . . 0.0 112.671 -179.643 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 97.2 m -74.08 -42.52 60.04 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.857 0.361 . . . . 0.0 110.161 178.664 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . 0.412 ' HA ' ' HE ' ' B' ' 244' ' ' ARG . 64.1 t80 -58.02 -45.75 86.41 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -179.54 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 87.2 mt -62.61 -40.86 98.3 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.177 179.964 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -61.52 -39.72 92.04 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.713 179.609 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . 0.419 ' O ' ' OG ' ' B' ' 247' ' ' SER . 88.7 mtm180 -62.08 -40.38 95.62 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.77 179.69 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.72 ' NH1' ' H ' ' A' ' 92' ' ' ASP . 89.4 mtt180 -60.1 -42.48 94.79 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.224 179.084 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -64.23 -42.79 96.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.016 0.436 . . . . 0.0 110.488 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 247' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 35.8 p -63.86 -44.86 91.85 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.73 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -58.58 -40.29 82.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.965 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 55.3 t -62.09 -44.0 98.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.267 -179.885 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -64.34 -33.77 76.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.677 178.837 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -76.26 -13.13 60.17 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.839 179.191 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 67.5 mt -104.23 -178.39 3.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.128 178.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -118.95 151.21 38.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.795 179.699 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . 0.426 ' OD1' ' OG ' ' A' ' 13' ' ' SER . 98.9 m-20 -65.18 -20.0 66.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.887 -179.641 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 42.0 p-10 -82.64 18.94 1.39 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.762 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -70.53 93.78 0.93 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.403 0.62 . . . . 0.0 111.066 -179.289 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -66.18 -31.28 72.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.01 -0.995 . . . . 0.0 112.564 179.962 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -103.57 129.66 50.84 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.995 0.426 . . . . 0.0 110.908 -179.766 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.65 ' OD1' ' N ' ' B' ' 260' ' ' GLU . 35.7 t0 -125.3 158.97 32.85 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.555 0.693 . . . . 0.0 109.928 179.621 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.65 ' N ' ' OD1' ' B' ' 259' ' ' ASP . 94.6 mt-10 -56.84 13.02 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.684 -1.144 . . . . 0.0 112.11 -179.354 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . 0.633 ' H ' ' C ' ' B' ' 259' ' ' ASP . 68.6 mt -108.24 132.16 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.757 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 53.4 t -128.25 134.39 65.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.805 -178.609 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -99.54 121.92 41.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.51 0.671 . . . . 0.0 111.176 -178.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -67.06 -44.88 79.0 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.902 178.874 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -92.76 150.63 39.91 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.706 -178.235 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.84 143.98 47.1 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 122.86 2.373 . . . . 0.0 112.581 179.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 33.3 pt . . . . . 0 C--N 1.33 -0.265 0 CA-C-O 121.04 0.448 . . . . 0.0 110.7 179.209 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo . . . . . 0 N--CA 1.496 1.628 0 CA-C-O 120.783 0.243 . . . . 0.0 112.564 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.425 ' HG1' ' H ' ' A' ' 5' ' ' ARG . 17.2 p -122.67 -52.27 1.91 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.064 179.013 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.425 ' H ' ' HG1' ' A' ' 4' ' ' THR . 96.3 mtt-85 -89.47 124.5 34.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.922 -179.858 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -134.43 139.39 45.52 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.287 -0.565 . . . . 0.0 112.322 -179.342 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.7 mt -113.55 143.56 44.33 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.072 178.718 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.48 ' CG1' ' OD1' ' A' ' 16' ' ' ASP . 70.3 t -117.03 128.93 74.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.224 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.5 m -92.87 113.87 26.26 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.132 0.492 . . . . 0.0 112.076 -178.436 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 86.8 mt -79.19 143.86 11.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.784 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -89.54 161.6 16.12 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.223 0.535 . . . . 0.0 110.9 179.64 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.744 HH12 ' NE2' ' B' ' 248' ' ' GLN . 80.9 mtp180 -58.19 -33.41 69.23 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.802 -179.326 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.7 t -76.02 -13.11 60.23 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.706 179.218 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.39 35.05 5.83 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 -178.878 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.0 t -119.04 132.42 68.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.092 0.472 . . . . 0.0 110.966 -179.9 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.48 ' OD1' ' CG1' ' A' ' 8' ' ' VAL . 43.6 t0 -68.5 124.98 25.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.749 179.581 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -117.58 -126.41 3.72 Favored Glycine 0 CA--C 1.541 1.673 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.225 -178.916 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.29 147.88 42.76 Favored 'Trans proline' 0 N--CA 1.504 2.107 0 C-N-CA 122.741 2.294 . . . . 0.0 114.523 -177.808 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 60.1 m170 -104.77 144.73 31.34 Favored 'General case' 0 C--N 1.335 -0.059 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.08 179.37 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.405 ' CD2' HD11 ' A' ' 37' ' ' ILE . 72.1 t80 -121.82 105.44 37.99 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.996 -179.579 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -75.63 132.84 15.02 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 C-N-CA 121.682 1.588 . . . . 0.0 112.292 -179.14 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 89.6 mt -81.3 54.73 2.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.834 0.349 . . . . 0.0 110.935 -179.253 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.7 t -59.8 -37.58 79.53 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.877 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 66.0 mt -74.02 141.6 45.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.666 179.519 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 m -66.76 -15.23 63.41 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.075 -0.512 . . . . 0.0 112.271 -178.029 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.49 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 40.4 m -136.24 137.87 41.24 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.017 0.437 . . . . 0.0 110.724 179.504 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.668 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 4.3 t -131.58 122.87 26.81 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.908 179.65 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 42.4 tp -119.77 128.16 53.47 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.896 -178.98 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.668 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 14.1 m-85 -104.23 140.33 38.0 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.179 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.95 -171.79 38.81 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 119.647 -1.263 . . . . 0.0 112.764 179.1 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.623 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 85.4 mtm-85 -80.37 -28.08 38.07 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.418 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.55 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -60.68 141.22 48.06 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.3 -0.476 . . . . 0.0 112.287 -178.168 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.443 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 11.0 tp -66.06 -41.43 89.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.095 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.443 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 82.5 tt0 -54.52 -16.41 2.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.125 179.839 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.55 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 33.5 m -66.01 135.93 55.35 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.265 179.862 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.49 ' OD2' ' O ' ' A' ' 26' ' ' THR . 56.0 m-20 -61.42 -33.32 73.51 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.38 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.422 HG21 HD12 ' A' ' 37' ' ' ILE . 93.4 mt -127.66 122.46 59.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 177.17 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 76.8 ttt-85 -111.26 137.99 48.29 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.607 -178.317 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.444 ' C ' ' H ' ' A' ' 41' ' ' LEU . 92.9 mt -119.11 131.87 70.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.846 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -75.13 20.69 0.13 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.686 -178.693 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.444 ' H ' ' C ' ' A' ' 39' ' ' ILE . 22.7 mt -93.52 124.44 57.21 Favored Pre-proline 0 C--N 1.321 -0.66 0 C-N-CA 120.261 -0.575 . . . . 0.0 111.105 -179.449 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.47 -14.25 27.79 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 C-N-CA 121.901 1.734 . . . . 0.0 112.375 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 18.0 m -88.67 0.62 7.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.135 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.623 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 72.6 t -95.33 136.11 27.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.186 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.4 m -69.39 171.16 9.09 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.322 0.582 . . . . 0.0 111.699 -178.749 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -61.84 -42.11 98.63 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.671 -178.13 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.679 ' O ' ' N ' ' A' ' 49' ' ' CYS . 87.8 mt-30 -113.75 -14.99 12.51 Favored 'General case' 0 CA--C 1.521 -0.155 0 O-C-N 123.365 0.416 . . . . 0.0 110.337 179.873 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 30.1 t60 33.44 -73.11 0.0 OUTLIER 'General case' 0 C--O 1.236 0.393 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 179.654 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.679 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.68 135.35 45.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.06 0.457 . . . . 0.0 111.921 -178.649 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -123.85 128.66 49.82 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.389 179.3 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.4 mt -115.16 134.46 58.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.351 -179.686 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.556 ' CD ' ' HE2' ' A' ' 54' ' ' HIS . 83.9 tt0 -120.01 128.29 53.4 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.782 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.0 mt -108.18 118.8 56.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.471 0.653 . . . . 0.0 112.611 -178.549 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.556 ' HE2' ' CD ' ' A' ' 52' ' ' GLU . 99.0 m-70 -115.3 141.23 48.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.326 178.859 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.6 mm-40 -40.12 -25.94 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.906 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.545 ' N ' ' O ' ' A' ' 54' ' ' HIS . 85.9 mt-30 -65.71 -68.3 0.38 Allowed 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.2 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -159.94 -162.77 1.04 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.905 179.614 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -114.29 126.44 55.03 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.398 179.147 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.7 mt -112.68 127.9 69.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.441 0.638 . . . . 0.0 111.95 -178.923 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 40.1 tp -95.44 128.85 42.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.955 -179.74 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -115.33 135.8 53.77 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.549 -179.748 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.4 ' OD1' ' C ' ' A' ' 62' ' ' ASN . 51.1 t-20 -95.12 106.22 18.21 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.897 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -100.86 -10.05 21.05 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 179.279 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.3 t -78.85 100.61 7.26 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.269 -179.619 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.4 p -76.95 -33.84 57.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.042 0.448 . . . . 0.0 110.636 178.918 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.82 -40.65 65.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.485 -178.86 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -141.29 93.52 7.96 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.163 -179.726 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.06 145.67 51.94 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.344 2.029 . . . . 0.0 113.053 -179.488 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.2 m -72.65 139.54 47.39 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.338 179.533 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -102.89 139.77 38.03 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.662 179.641 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.405 ' CG1' ' OD1' ' A' ' 86' ' ' ASP . 75.3 t -133.46 134.43 56.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.097 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.4 m120 54.79 26.92 8.18 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -178.397 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.53 24.13 66.05 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-N 115.039 -0.982 . . . . 0.0 112.048 179.585 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.2 t -138.48 140.4 39.2 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 117.371 0.585 . . . . 0.0 111.28 179.695 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -70.99 140.38 18.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.183 179.918 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.2 pt -115.42 91.95 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.122 179.941 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -66.87 -25.72 66.54 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.653 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.19 162.19 27.41 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.505 179.484 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.13 154.16 66.53 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.62 2.213 . . . . 0.0 112.247 179.899 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.9 m -145.65 148.62 17.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.833 -179.781 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.2 mtm-85 -75.65 134.83 40.5 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.158 179.531 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 90.0 mt -89.7 134.02 34.37 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.138 0.495 . . . . 0.0 111.161 -179.677 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -125.1 156.62 37.99 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.052 179.143 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.519 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 4.2 t60 -54.1 120.02 5.87 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.546 -0.461 . . . . 0.0 111.089 -178.701 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.07 -15.65 28.11 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 179.797 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.436 ' OD1' ' N ' ' A' ' 87' ' ' VAL . 59.1 t0 -65.41 128.21 34.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.882 0.372 . . . . 0.0 110.422 179.988 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.436 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 53.6 t -112.13 130.93 64.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.291 -179.382 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.7 mt -101.64 134.02 43.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.383 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 76.9 m -124.33 129.22 50.34 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -178.53 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.585 ' O ' ' N ' ' A' ' 92' ' ' ASP . 95.0 mt -112.18 126.67 69.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 114.516 -1.22 . . . . 0.0 108.159 177.57 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.45 ' C ' ' O ' ' A' ' 90' ' ' ILE . 45.4 mm 40.19 -92.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 C-N-CA 120.269 -0.572 . . . . 0.0 109.716 -179.257 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.585 ' N ' ' O ' ' A' ' 90' ' ' ILE . 0.7 OUTLIER -129.43 20.48 5.69 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.928 0.395 . . . . 0.0 110.87 179.732 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.657 ' HE ' HH12 ' B' ' 245' ' ' ARG . 98.5 mtt180 -124.31 142.09 51.54 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.326 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 75.6 m -137.55 151.36 48.31 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.203 -179.725 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -121.95 122.33 39.13 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.534 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -84.95 133.96 34.26 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 119.638 -0.825 . . . . 0.0 111.375 -178.581 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -95.8 120.08 35.43 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.158 179.532 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -122.31 119.67 31.8 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.263 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.519 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 64.8 t-20 -102.11 114.12 27.98 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.333 179.7 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 . . . . . 0 C--N 1.326 -0.425 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.834 179.469 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 28.3 m . . . . . 0 N--CA 1.453 -0.306 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.553 ' C ' ' H ' ' B' ' 231' ' ' GLN . 77.6 m-20 -72.56 141.03 48.43 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.699 179.785 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . 0.44 ' C ' ' CD ' ' B' ' 231' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.553 ' H ' ' C ' ' B' ' 229' ' ' ASP . 16.5 mp0 -136.86 31.28 2.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.599 179.608 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -115.02 -161.62 13.35 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -179.547 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -60.84 150.93 80.69 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 123.456 2.771 . . . . 0.0 112.685 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . 0.427 ' O2P' ' CG2' ' B' ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -74.62 172.04 16.99 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 122.262 1.975 . . . . 0.0 111.607 178.704 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 4.9 p -116.85 132.75 65.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.328 -179.664 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 45.9 t -69.9 126.24 29.11 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.532 -179.256 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . 0.508 ' P ' ' OG1' ' B' ' 240' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . 0.477 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 35.8 Cg_exo -58.22 -25.9 74.07 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 C-N-CA 122.876 2.384 . . . . 0.0 113.53 -178.993 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 240' ' ' THR . . . . . 0.508 ' OG1' ' P ' ' B' ' 238' ' ' TPO . 5.2 p -73.29 -41.6 63.39 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.026 -0.669 . . . . 0.0 109.305 178.28 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -58.24 -46.65 85.56 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.12 -179.524 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 94.4 mt -62.79 -40.45 97.35 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.605 -179.674 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -63.9 -37.37 87.14 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.271 179.545 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -62.4 -41.75 98.91 Favored 'General case' 0 C--N 1.334 -0.1 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.488 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.657 HH12 ' HE ' ' A' ' 93' ' ' ARG . 60.9 ttm-85 -58.07 -44.19 87.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.006 -179.495 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -63.33 -40.4 97.22 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.029 0.442 . . . . 0.0 110.759 -179.475 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 41.8 m -69.0 -46.13 68.81 Favored 'General case' 0 C--N 1.334 -0.104 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.65 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . 0.744 ' NE2' HH12 ' A' ' 12' ' ' ARG . 59.5 tt0 -61.78 -36.94 82.52 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.818 -179.55 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 75.4 t -61.12 -45.47 98.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 120.257 -0.577 . . . . 0.0 109.513 179.42 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -59.53 -29.69 68.07 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.806 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -91.96 -15.21 28.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.609 178.886 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.53 ' N ' ' O ' ' B' ' 248' ' ' GLN . 40.7 tp -75.07 139.56 42.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.442 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -103.07 136.74 42.31 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.39 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -67.04 -23.72 65.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.823 -179.616 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 49.6 p-10 -75.98 -0.27 20.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.099 -179.2 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.455 ' O ' ' C ' ' B' ' 257' ' ' LYS . 90.3 m-20 -93.32 -2.96 54.31 Favored 'General case' 0 C--N 1.334 -0.099 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.403 179.175 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . 0.564 ' O ' ' C ' ' B' ' 258' ' ' ASP . 88.1 tttt 32.82 -103.19 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.441 -179.699 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.564 ' C ' ' O ' ' B' ' 257' ' ' LYS . 99.3 m-20 -17.66 87.15 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.587 0.708 . . . . 0.0 110.652 -179.308 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' B' ' 257' ' ' LYS . 23.3 p-10 -86.78 59.41 5.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.576 -1.193 . . . . 0.0 112.078 -178.481 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.637 ' OE1' ' NH2' ' A' ' 93' ' ' ARG . 95.1 mt-10 62.54 4.72 1.43 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.317 -0.401 . . . . 0.0 112.035 179.15 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 79.4 mt -106.78 132.31 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 177.589 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 47.6 t -126.4 133.09 69.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 120.904 0.383 . . . . 0.0 111.014 -179.15 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -97.88 124.13 42.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.12 -179.297 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -69.36 -45.42 69.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.261 179.457 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.22 155.79 40.73 Favored Pre-proline 0 CA--C 1.521 -0.16 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.201 -179.428 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.85 144.26 70.18 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 122.584 2.189 . . . . 0.0 113.052 -179.664 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 45.0 pt . . . . . 0 C--N 1.331 -0.206 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.87 178.835 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo . . . . . 0 N--CA 1.494 1.552 0 CA-C-O 120.825 0.261 . . . . 0.0 112.064 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.484 ' HG1' ' H ' ' A' ' 5' ' ' ARG . 25.0 p -107.72 -46.59 3.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.976 0.417 . . . . 0.0 110.505 179.966 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.484 ' H ' ' HG1' ' A' ' 4' ' ' THR . 85.3 mtt85 -100.12 123.42 44.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.171 -179.616 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -130.01 144.35 51.29 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.685 -179.84 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 83.9 mt -113.18 135.45 53.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.392 179.045 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.6 m -110.79 132.06 60.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-O 120.95 0.405 . . . . 0.0 110.019 179.254 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.7 m -79.97 142.53 34.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.495 -0.775 . . . . 0.0 113.044 -178.193 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.5 mt -112.15 136.67 47.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.024 176.611 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -90.32 158.94 16.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.842 0.353 . . . . 0.0 110.432 179.754 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -58.45 -30.92 67.3 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.088 -178.875 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.3 p -76.44 -11.58 59.91 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.199 179.594 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.08 35.57 6.02 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -179.635 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 54.0 t -120.14 132.04 70.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.935 0.398 . . . . 0.0 110.816 -179.81 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -81.21 138.41 35.81 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.805 179.624 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -133.42 -116.15 1.68 Allowed Glycine 0 CA--C 1.538 1.517 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.124 -179.718 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.36 153.1 61.35 Favored 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 122.473 2.116 . . . . 0.0 112.849 -178.83 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -116.04 161.68 18.52 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.604 -179.832 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -122.88 91.84 49.5 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.417 -179.563 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -59.96 127.63 23.96 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 121.957 1.772 . . . . 0.0 110.564 179.346 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.6 mt -82.02 57.56 3.56 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.566 -0.454 . . . . 0.0 111.233 -179.002 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 89.8 p -67.84 -22.97 65.12 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.576 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 80.2 mt -83.63 138.9 33.13 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.233 179.79 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 92.9 p -64.22 -18.09 64.19 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.03 -179.48 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.495 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 88.0 m -134.37 134.82 42.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.985 179.91 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.675 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 1.4 t -128.21 118.11 22.75 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.235 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.448 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 40.8 tp -117.47 128.73 55.27 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.22 -177.699 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.675 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 19.8 m-85 -104.89 135.8 45.57 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.657 179.045 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 164.22 178.62 37.86 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 120.283 -0.961 . . . . 0.0 112.778 179.034 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.424 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 42.3 mtm180 -75.44 -31.1 60.2 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.903 0.382 . . . . 0.0 110.503 178.654 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -50.48 144.86 10.58 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.19 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.6 tp -66.92 -41.05 87.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.908 -179.585 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -58.03 -20.83 41.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.869 0.366 . . . . 0.0 110.813 -179.92 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 62.4 m -57.63 131.52 50.48 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.878 -179.512 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.495 ' OD2' ' O ' ' A' ' 26' ' ' THR . 56.0 m-20 -60.25 -33.56 72.47 Favored 'General case' 0 C--N 1.334 -0.097 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -178.781 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 84.8 mt -126.12 123.8 64.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 176.65 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 84.2 mtm-85 -105.45 135.04 47.58 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.439 -0.505 . . . . 0.0 110.609 -178.246 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.432 HG23 HD13 ' A' ' 39' ' ' ILE . 95.8 mt -118.78 131.02 72.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 120.304 -0.559 . . . . 0.0 111.36 -179.82 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -75.45 32.26 0.11 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.52 -0.763 . . . . 0.0 112.318 -178.794 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 61.0 mt -106.18 127.07 29.02 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.65 179.378 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.33 -8.49 22.79 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 122.406 2.071 . . . . 0.0 113.117 -179.42 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.5 m -95.38 6.77 7.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.39 179.737 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.424 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 36.1 t -96.86 135.36 31.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.331 179.475 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.415 ' HG ' HG21 ' B' ' 234' ' ' TPO . 4.1 m -73.02 173.68 8.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.205 -178.883 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -63.02 -40.35 97.49 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.819 179.476 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.64 ' O ' ' N ' ' A' ' 49' ' ' CYS . 9.8 mm100 -113.24 -23.3 10.02 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.974 -0.291 . . . . 0.0 110.519 -179.712 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.4 t60 43.58 -77.69 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.894 -179.735 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.64 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -134.03 136.97 44.41 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.991 -179.517 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -125.77 133.13 52.16 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.485 179.75 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 98.6 mt -115.98 131.43 68.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.058 179.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.587 ' OE2' ' NE2' ' A' ' 54' ' ' HIS . 79.4 tt0 -118.11 125.73 50.85 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.765 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 86.2 mt -108.06 123.17 63.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.896 0.855 . . . . 0.0 112.992 -177.826 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.587 ' NE2' ' OE2' ' A' ' 52' ' ' GLU . 98.5 m-70 -117.57 136.92 52.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 113.989 -1.459 . . . . 0.0 109.056 178.902 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 54' ' ' HIS . 96.2 mt-10 -41.18 -32.23 0.26 Allowed 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.156 -0.617 . . . . 0.0 109.89 -179.571 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -64.22 -67.93 0.39 Allowed 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.291 -0.564 . . . . 0.0 109.893 179.224 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.603 ' CG ' ' H ' ' A' ' 58' ' ' ALA . 52.9 tt0 -150.56 -179.35 7.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.863 -178.593 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.603 ' H ' ' CG ' ' A' ' 57' ' ' GLU . . . -108.83 131.86 54.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.052 -179.697 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.8 mt -119.85 129.5 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -178.33 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 38.6 tp -97.39 129.03 44.67 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.041 -0.982 . . . . 0.0 110.051 179.47 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -115.92 136.32 53.15 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 179.595 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.599 HD22 ' CB ' ' A' ' 68' ' ' PRO . 62.7 t-20 -100.32 105.24 16.74 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 120.965 0.412 . . . . 0.0 111.134 -179.477 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -97.52 -9.57 26.85 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.229 179.855 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.87 98.55 7.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.021 0.438 . . . . 0.0 110.271 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.4 t -76.27 -42.65 44.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.844 179.396 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.28 -45.43 94.52 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.293 -178.68 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -139.36 94.84 9.4 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 115.503 -0.771 . . . . 0.0 108.958 -179.503 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.599 ' CB ' HD22 ' A' ' 62' ' ' ASN . 35.6 Cg_endo -64.86 150.52 88.01 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 121.528 1.485 . . . . 0.0 112.507 -178.173 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.8 m -73.01 142.11 47.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.7 -178.883 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -99.51 148.04 24.68 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.788 179.84 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.6 p -132.61 135.47 57.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.239 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 50.85 33.02 7.91 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.455 -179.861 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.69 27.69 70.5 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -179.442 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 10.4 t -138.12 139.42 39.43 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.462 -179.501 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 77.8 t -69.22 134.0 30.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.031 0.443 . . . . 0.0 111.636 -179.715 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.16 95.58 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.482 179.266 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -81.92 -16.62 49.95 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.666 -179.209 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -110.01 156.91 39.21 Favored Pre-proline 0 C--O 1.222 -0.372 0 C-N-CA 121.099 -0.241 . . . . 0.0 110.481 -179.733 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -64.57 145.98 88.26 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.369 2.046 . . . . 0.0 112.669 -179.807 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.9 m -147.61 148.08 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.106 -179.463 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 91.2 mtm180 -73.97 132.36 42.33 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.403 179.391 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 77.8 mt -79.39 141.2 37.09 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.996 0.427 . . . . 0.0 111.417 179.693 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -132.75 151.29 52.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.775 179.55 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.536 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 5.5 t60 -56.23 116.82 3.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.024 -179.801 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.92 -14.32 26.55 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.061 179.235 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -74.48 134.97 42.26 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.229 179.867 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.0 t -108.07 132.13 56.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.749 -178.891 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.49 ' O ' ' OG ' ' A' ' 94' ' ' SER . 88.8 mt -104.99 131.87 53.12 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.769 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 65.2 m -120.78 130.01 53.83 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 119.745 -0.782 . . . . 0.0 112.778 -177.96 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.597 ' O ' ' N ' ' A' ' 93' ' ' ARG . 96.6 mt -114.58 131.19 67.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 114.29 -1.323 . . . . 0.0 108.611 178.335 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.554 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 95.6 mt -20.38 95.26 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -179.565 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.554 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 10.5 t0 90.42 -23.55 0.09 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 178.084 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.597 ' N ' ' O ' ' A' ' 90' ' ' ILE . 88.2 mtt-85 -130.0 147.02 51.71 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.03 -179.621 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.49 ' OG ' ' O ' ' A' ' 88' ' ' ILE . 38.7 t -139.1 152.27 47.37 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.384 0.611 . . . . 0.0 110.598 -179.911 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -125.07 121.36 34.08 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.649 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -87.51 140.27 29.69 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 119.453 -0.899 . . . . 0.0 109.976 -179.561 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -96.65 123.17 40.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.031 -178.292 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -126.03 120.77 31.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.781 179.711 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.536 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 64.4 t-20 -108.36 113.92 27.37 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.259 179.817 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.0 tp10 . . . . . 0 C--N 1.327 -0.405 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.58 -179.571 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 54.6 t . . . . . 0 N--CA 1.449 -0.482 0 CA-C-O 120.924 0.393 . . . . 0.0 109.946 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.434 ' C ' ' OD1' ' B' ' 229' ' ' ASP . 49.8 p30 -100.55 173.99 6.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.675 -179.813 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . 0.596 ' O ' ' NE2' ' B' ' 231' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.596 ' NE2' ' O ' ' B' ' 230' ' ' SEP . 97.0 mm-40 -140.82 62.08 1.49 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.405 -179.724 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -119.95 179.53 16.54 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -179.677 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.69 159.89 49.66 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 123.582 2.855 . . . . 0.0 113.127 -179.838 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . 0.415 HG21 ' HG ' ' A' ' 45' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.44 145.33 47.49 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 121.996 1.797 . . . . 0.0 113.722 -179.176 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 50.1 t -64.42 132.46 30.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.036 179.231 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -67.62 137.55 55.72 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.063 -179.693 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -57.71 -25.81 70.04 Favored 'Trans proline' 0 N--CA 1.499 1.835 0 C-N-CA 123.023 2.482 . . . . 0.0 113.009 -179.665 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 86.0 m -74.84 -45.99 39.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.949 0.404 . . . . 0.0 110.881 179.234 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . 0.641 ' CE2' ' CZ ' ' B' ' 245' ' ' ARG . 57.2 t80 -58.37 -48.31 81.0 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.033 -178.31 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 44.7 mt -64.73 -42.62 95.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.252 0.548 . . . . 0.0 110.757 179.681 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -62.99 -43.09 99.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.016 -178.72 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -61.55 -45.56 93.65 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.692 -179.041 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.641 ' CZ ' ' CE2' ' B' ' 241' ' ' PHE . 89.7 mtm180 -63.86 -37.05 85.96 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.904 -178.771 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.7 -39.7 92.42 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.305 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 70.2 m -63.49 -44.09 95.38 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.606 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 93.9 mm-40 -61.11 -37.11 81.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.281 -179.779 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 47.1 t -62.22 -44.61 99.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.914 179.792 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -61.37 -27.14 68.31 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.564 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 -82.85 -14.62 53.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.828 179.254 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 94.3 mt -101.21 -179.83 4.15 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.307 178.543 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . 0.589 ' O ' ' N ' ' B' ' 255' ' ' ASP . 18.3 m-80 -150.8 -173.07 4.37 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.838 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . 0.577 ' C ' ' H ' ' B' ' 256' ' ' ASP . 14.9 t70 -43.57 -15.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.237 -179.719 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . 0.589 ' N ' ' O ' ' B' ' 253' ' ' ASN . 87.8 m-20 -73.52 16.39 0.2 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.308 0.575 . . . . 0.0 109.707 179.371 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.751 ' O ' ' O ' ' B' ' 257' ' ' LYS . 94.3 m-20 -60.52 -36.4 78.3 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.544 -179.772 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . 0.751 ' O ' ' O ' ' B' ' 256' ' ' ASP . 99.0 mttt -2.1 138.8 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.113 0 O-C-N 124.604 1.19 . . . . 0.0 112.221 -179.425 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.533 ' O ' ' C ' ' B' ' 259' ' ' ASP . 98.8 m-20 59.1 -3.14 0.09 Allowed 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.67 ' H ' ' C ' ' B' ' 257' ' ' LYS . 0.1 OUTLIER 15.55 -90.37 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.021 179.902 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -146.7 18.66 1.3 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.446 0.641 . . . . 0.0 109.694 179.07 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 82.6 mt -115.91 133.55 61.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.79 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 55.0 t -126.6 133.13 69.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.979 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -96.12 121.95 38.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.204 0.526 . . . . 0.0 111.219 -178.53 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . 0.443 ' CB ' ' O ' ' A' ' 36' ' ' ASP . 87.6 tttt -63.78 -43.45 96.34 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.477 179.551 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.24 160.14 31.37 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.327 -179.398 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -61.17 145.42 98.74 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.686 2.257 . . . . 0.0 111.031 178.464 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . 0.578 ' O ' ' CD1' ' B' ' 267' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.49 0 C-N-CA 120.151 -0.62 . . . . 0.0 111.28 -179.415 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.517 ' O ' ' CB ' ' A' ' 4' ' ' THR . 52.9 Cg_endo . . . . . 0 N--CA 1.491 1.348 0 N-CA-C 111.969 -0.051 . . . . 0.0 111.969 . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.55 ' O ' ' O ' ' A' ' 99' ' ' ASN . 2.4 t 143.42 -7.86 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 O-C-N 124.269 0.981 . . . . 0.0 110.592 179.421 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.569 ' NH1' ' HH ' ' A' ' 97' ' ' TYR . 92.9 mtt-85 -86.08 130.54 34.5 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.635 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -135.0 142.38 46.43 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.536 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.8 mt -111.7 132.74 54.41 Favored 'General case' 0 CA--C 1.523 -0.076 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.29 179.405 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.6 t -109.01 125.89 66.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.988 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.1 m -77.17 140.94 40.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.679 -178.779 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.3 mt -110.27 135.19 50.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.125 178.578 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -90.68 159.51 16.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.202 0.525 . . . . 0.0 110.947 -179.809 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.588 HH11 ' NH1' ' B' ' 245' ' ' ARG . 91.1 mtm180 -56.95 -29.35 63.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.601 -178.546 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.3 p -81.44 -8.49 59.74 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.279 -179.734 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.29 33.27 7.74 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 179.676 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.7 t -120.38 134.7 63.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.572 0.225 . . . . 0.0 111.518 -179.59 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -72.4 136.4 46.07 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.105 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -124.84 -119.41 2.39 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.679 -179.893 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.62 148.3 36.93 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 122.52 2.147 . . . . 0.0 113.318 -178.989 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -109.55 138.31 46.1 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.515 179.853 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -111.54 104.04 55.69 Favored Pre-proline 0 N--CA 1.469 0.477 0 N-CA-C 110.056 -0.349 . . . . 0.0 110.056 -179.746 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -76.15 138.43 20.34 Favored 'Trans proline' 0 N--CA 1.489 1.235 0 C-N-CA 121.949 1.766 . . . . 0.0 112.217 -179.133 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 93.4 mt -88.83 92.06 9.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.143 0.497 . . . . 0.0 111.106 -178.878 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 88.6 p -93.55 -8.07 42.36 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.728 179.017 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 67.3 mt -109.58 150.07 28.74 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.859 -179.424 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.9 m -68.97 -16.39 63.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.734 0.302 . . . . 0.0 111.311 -179.148 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 78.4 m -128.59 132.01 48.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.058 0.456 . . . . 0.0 111.464 -179.766 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.631 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 5.2 t -128.1 119.19 24.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.451 178.816 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 31.6 tp -117.68 130.34 56.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.41 -178.496 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.631 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 17.5 m-85 -107.72 137.23 46.1 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.666 179.441 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 156.91 -177.48 33.79 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 120.384 -0.912 . . . . 0.0 112.425 178.899 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -74.91 -32.55 61.84 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.581 0.229 . . . . 0.0 111.48 179.202 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.489 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -53.04 145.68 20.58 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.264 -178.514 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.459 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 11.1 tp -66.36 -41.93 89.71 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-O 120.856 0.36 . . . . 0.0 110.204 179.873 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.459 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 49.9 tp10 -52.3 -22.1 4.16 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.605 179.511 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.489 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 9.9 m -65.46 126.03 26.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.064 -179.791 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -57.67 -27.5 62.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.023 -179.551 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 78.7 mt -130.26 123.71 56.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.484 178.295 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 75.2 mtm180 -101.61 135.33 43.31 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.317 179.979 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.506 ' C ' ' H ' ' A' ' 41' ' ' LEU . 97.3 mt -117.56 129.58 73.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.131 0.491 . . . . 0.0 109.97 179.068 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -74.24 29.1 0.08 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.205 -178.952 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.547 ' CD2' ' NH2' ' B' ' 245' ' ' ARG . 26.9 mt -93.72 121.36 64.75 Favored Pre-proline 0 CA--C 1.533 0.303 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.204 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.4 -8.45 20.73 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 121.779 1.653 . . . . 0.0 111.676 -179.642 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 m -102.53 9.88 8.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.906 -179.981 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.9 t -96.59 141.36 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 121.077 0.465 . . . . 0.0 110.595 179.324 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.8 m -71.64 165.59 23.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.517 -179.24 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -62.17 -40.83 97.34 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.665 -179.426 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.634 ' O ' ' N ' ' A' ' 49' ' ' CYS . 85.7 mt-30 -113.59 -25.0 8.93 Favored 'General case' 0 C--O 1.226 -0.133 0 CA-C-O 121.102 0.477 . . . . 0.0 110.27 -179.907 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.8 t60 37.08 -76.01 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 179.405 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.634 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -127.34 133.54 50.07 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.243 0.544 . . . . 0.0 112.187 -178.128 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -130.88 129.18 41.95 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.051 179.993 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 94.4 mt -113.07 133.8 57.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.561 179.842 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -118.94 126.96 52.98 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.641 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.2 mt -104.67 113.72 42.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.049 -0.66 . . . . 0.0 111.215 -179.398 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.559 ' O ' ' N ' ' A' ' 56' ' ' GLN . 95.3 m-70 -113.4 145.4 41.19 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.569 179.789 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 54' ' ' HIS . 77.3 tt0 -39.85 -24.59 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -179.694 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.559 ' N ' ' O ' ' A' ' 54' ' ' HIS . 87.0 mt-30 -71.14 -68.69 0.42 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.222 178.9 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.496 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 2.5 tp10 -158.62 -169.17 2.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.234 0.54 . . . . 0.0 111.025 -178.962 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -105.71 121.89 44.94 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 177.961 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.7 mt -114.66 129.42 70.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.223 0.535 . . . . 0.0 112.093 -178.443 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 29.5 tp -96.64 127.48 42.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.47 179.706 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -112.01 135.32 52.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.857 0.36 . . . . 0.0 110.404 -179.821 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.449 ' ND2' ' H ' ' A' ' 69' ' ' THR . 10.7 t-20 -93.46 106.5 18.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.635 -179.847 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -98.38 -12.57 21.29 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.72 179.056 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 t -73.98 100.51 3.58 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.204 179.749 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.2 p -86.09 -20.76 28.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.897 0.38 . . . . 0.0 110.761 179.768 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.62 -44.65 12.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.213 -179.612 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 -135.1 94.17 16.3 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.175 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.419 ' HA ' HD22 ' A' ' 62' ' ' ASN . 41.7 Cg_exo -55.38 145.11 69.31 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.393 2.062 . . . . 0.0 113.57 -178.435 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.449 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 53.1 m -74.03 142.59 45.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.332 179.176 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -104.6 140.97 37.24 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.663 179.765 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.0 t -128.52 131.46 68.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.83 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 51.09 32.03 7.26 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.149 -0.621 . . . . 0.0 109.489 -179.06 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.56 26.33 67.9 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.861 179.749 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.9 p -136.78 133.93 36.5 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 122.451 -0.44 . . . . 0.0 111.061 -179.989 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -68.03 138.12 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.494 179.821 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.9 pt -116.28 92.34 2.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.659 179.729 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -68.2 -20.89 64.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.075 0.464 . . . . 0.0 109.841 178.933 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.86 168.2 11.96 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.726 -179.533 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.65 152.43 69.9 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.778 2.319 . . . . 0.0 112.255 179.601 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.4 p -143.09 145.11 23.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.866 -179.742 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.8 mtm-85 -73.24 128.16 34.7 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.483 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.7 mt -80.4 137.37 36.52 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.203 -179.345 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -130.6 153.42 48.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.429 179.767 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -58.17 118.87 5.93 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.011 0.434 . . . . 0.0 110.505 -179.542 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.59 -7.24 26.22 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.746 -0.941 . . . . 0.0 110.746 -179.472 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.438 ' C ' ' OD1' ' A' ' 86' ' ' ASP . 52.2 t0 -81.12 123.85 28.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.092 0.472 . . . . 0.0 110.365 179.792 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 42.9 t -104.05 134.17 46.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.648 -179.162 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.1 mt -103.32 129.94 54.39 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 178.104 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 29.4 m -119.08 128.09 53.99 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.531 0.682 . . . . 0.0 111.832 -178.616 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.411 ' O ' ' C ' ' A' ' 91' ' ' ILE . 94.6 mt -118.1 125.29 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.954 179.295 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.469 HG21 HD12 ' A' ' 91' ' ' ILE . 38.2 mm 38.36 -105.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.991 -179.117 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.54 ' CG ' ' NE ' ' B' ' 245' ' ' ARG . 1.1 p30 -108.24 12.07 26.84 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -178.808 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.591 ' HE ' ' CG1' ' B' ' 261' ' ' ILE . 53.4 mtp85 -132.91 147.9 52.29 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.068 179.616 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 38.1 m -138.8 158.27 44.53 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.233 -179.064 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -125.89 122.95 37.53 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.354 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 79.4 mtp85 -81.35 135.53 35.69 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.491 179.471 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.569 ' HH ' ' NH1' ' A' ' 5' ' ' ARG . 80.6 t80 -95.15 122.07 37.44 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.997 179.952 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -134.64 119.96 18.97 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.999 -179.257 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.55 ' O ' ' O ' ' A' ' 4' ' ' THR . 91.9 m-20 -65.92 -40.33 91.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.758 179.381 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 . . . . . 0 C--N 1.326 -0.417 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.475 -179.274 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . 0.471 ' CG1' ' O ' ' B' ' 228' ' ' VAL . 48.6 t . . . . . 0 CA--C 1.533 0.306 0 CA-C-O 120.62 0.248 . . . . 0.0 110.937 . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.527 ' C ' ' H ' ' B' ' 231' ' ' GLN . 90.0 m-20 -67.03 143.11 56.95 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.725 0.298 . . . . 0.0 111.726 -179.333 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.527 ' H ' ' C ' ' B' ' 229' ' ' ASP . 11.8 mp0 -111.96 -26.69 8.76 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.231 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' B' ' 231' ' ' GLN . . . -36.55 164.84 0.01 OUTLIER Glycine 0 CA--C 1.526 0.754 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.899 -179.499 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.3 162.4 41.68 Favored 'Trans proline' 0 C--N 1.301 -1.957 0 C-N-CA 123.777 2.984 . . . . 0.0 112.925 179.758 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -70.91 143.53 45.53 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 121.726 1.617 . . . . 0.0 112.944 -179.067 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 74.3 t -76.22 132.72 32.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.898 -179.381 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 37.5 t -72.52 132.87 44.39 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.776 -179.728 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -58.24 -23.87 64.49 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 122.951 2.434 . . . . 0.0 113.189 179.915 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 21.8 m -73.18 -45.58 55.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.261 0.553 . . . . 0.0 109.89 178.829 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -58.59 -47.23 85.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.362 -179.381 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 98.8 mt -66.53 -39.79 88.78 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.832 0.348 . . . . 0.0 111.251 -179.805 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 51.5 tp10 -62.87 -45.09 94.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.171 -179.372 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -62.09 -40.8 97.08 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.258 0.552 . . . . 0.0 109.915 179.807 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.588 ' NH1' HH11 ' A' ' 12' ' ' ARG . 56.2 ttm-85 -60.13 -42.98 95.99 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.423 -179.229 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -62.23 -38.46 89.3 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.563 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 47.8 t -64.8 -44.21 90.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.433 177.849 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -60.94 -36.32 79.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.344 179.933 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 22.3 t -61.89 -45.1 99.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.932 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -61.63 -28.83 69.65 Favored 'General case' 0 C--O 1.231 0.092 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.83 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -85.13 -9.08 58.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.533 178.924 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.557 ' O ' ' CB ' ' B' ' 253' ' ' ASN . 2.0 mp -108.2 -175.76 2.87 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.888 179.385 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . 0.557 ' CB ' ' O ' ' B' ' 252' ' ' LEU . 0.3 OUTLIER 89.75 26.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.033 179.659 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . 0.541 ' O ' ' CB ' ' B' ' 255' ' ' ASP . 31.5 t70 -66.5 -39.26 88.6 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.671 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . 0.541 ' CB ' ' O ' ' B' ' 254' ' ' ASP . 46.0 m-20 138.01 73.6 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 O-C-N 124.605 1.19 . . . . 0.0 109.486 179.821 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' B' ' 257' ' ' LYS . 40.8 t0 -161.26 141.52 10.9 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.414 179.969 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . 0.462 ' N ' ' OD1' ' B' ' 256' ' ' ASP . 88.4 tttt -61.11 -103.82 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.499 -0.48 . . . . 0.0 109.906 179.708 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 19.7 t0 43.02 75.09 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.074 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.582 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 40.9 p-10 -81.79 14.22 2.8 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.686 -177.507 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 69.29 -3.12 1.64 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.223 0.535 . . . . 0.0 110.065 179.643 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . 0.591 ' CG1' ' HE ' ' A' ' 93' ' ' ARG . 58.6 mt -115.3 147.22 18.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.73 179.52 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 78.7 t -128.91 136.38 59.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.39 179.468 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -98.18 120.92 39.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.259 0.552 . . . . 0.0 111.567 -178.74 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . 0.417 ' HZ3' ' HA ' ' A' ' 34' ' ' GLU . 87.8 tttt -68.55 -46.2 70.11 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.783 -179.684 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -96.37 176.65 2.05 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.055 -178.715 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -59.54 146.13 96.02 Favored 'Trans proline' 0 N--CA 1.5 1.879 0 C-N-CA 122.644 2.229 . . . . 0.0 113.252 -178.938 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 1.1 tt . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.451 -179.829 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo . . . . . 0 N--CA 1.498 1.742 0 CA-C-O 120.515 0.131 . . . . 0.0 111.848 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.41 ' HG1' ' HG3' ' A' ' 5' ' ' ARG . 6.4 p -91.55 -36.83 13.48 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.873 179.721 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.41 ' HG3' ' HG1' ' A' ' 4' ' ' THR . 85.2 mtt85 -97.2 127.23 42.98 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.783 -178.679 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 94.5 mtm-85 -129.6 135.44 48.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.993 179.816 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 39.9 tp -108.79 134.11 51.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.301 -179.47 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 54.9 t -114.98 130.7 69.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.128 -179.704 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.1 m -79.51 142.29 35.93 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.81 -179.605 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.622 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 90.0 mt -109.32 135.51 48.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.39 -0.823 . . . . 0.0 108.857 177.769 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.65 ' CA ' HH22 ' A' ' 93' ' ' ARG . 97.4 mttt -87.25 153.68 21.3 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.766 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.581 ' NH1' ' OE2' ' B' ' 260' ' ' GLU . 88.8 mtm180 -58.11 -23.81 56.33 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.414 -0.515 . . . . 0.0 110.474 -179.357 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.0 m -80.38 -10.72 59.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.385 179.524 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.67 30.28 9.19 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 179.644 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.9 t -121.21 132.12 71.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.795 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -73.55 140.01 46.01 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.362 179.418 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -122.42 -121.46 2.72 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 121.031 -0.604 . . . . 0.0 111.916 -179.041 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.05 149.74 53.16 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 122.094 1.863 . . . . 0.0 112.489 -179.059 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.56 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -109.95 140.44 43.94 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.925 -179.092 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -112.86 104.71 55.97 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.614 -178.807 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -72.63 131.36 17.2 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.103 1.202 . . . . 0.0 111.579 -178.488 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 92.2 mt -86.21 48.68 1.65 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.926 -178.189 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.6 p -65.33 -22.31 66.8 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.918 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.8 mt -80.28 141.47 35.49 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.018 179.965 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.7 m -62.48 -21.6 65.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.985 -179.206 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 74.7 m -138.15 135.77 36.04 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.693 -179.404 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.0 t -126.73 122.09 33.87 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 177.888 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.429 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 44.1 tp -118.01 127.35 53.72 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.104 0.478 . . . . 0.0 111.163 -178.386 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.52 ' O ' ' O ' ' A' ' 47' ' ' GLN . 9.3 m-85 -105.36 132.45 51.53 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.904 179.83 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.79 -175.93 39.13 Favored Glycine 0 N--CA 1.467 0.749 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.158 179.425 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.601 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 78.9 mtm-85 -77.73 -30.12 51.51 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.873 0.368 . . . . 0.0 110.338 179.262 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -50.62 149.2 6.78 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.923 -0.471 . . . . 0.0 111.923 -178.208 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.429 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 10.9 tp -67.05 -40.57 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.458 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.429 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 96.5 mt-10 -57.2 -25.4 58.98 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.885 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.439 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 47.7 m -53.59 118.41 3.88 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.995 179.824 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.429 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 55.3 m-20 -58.56 -28.26 65.35 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.155 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 90.4 mt -129.0 124.62 61.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 176.494 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.41 ' O ' ' N ' ' B' ' 262' ' ' VAL . 84.5 mtp180 -107.72 136.6 47.19 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.636 -178.61 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.431 ' C ' ' H ' ' A' ' 41' ' ' LEU . 92.5 mt -118.0 130.31 73.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 179.501 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -73.44 30.54 0.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.441 -177.747 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.431 ' H ' ' C ' ' A' ' 39' ' ' ILE . 82.3 mt -100.85 127.85 31.23 Favored Pre-proline 0 C--N 1.326 -0.417 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.521 179.865 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.24 -8.09 20.49 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 122.267 1.978 . . . . 0.0 111.77 179.636 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.4 m -100.21 6.37 9.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.008 -179.776 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.601 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 9.4 t -97.25 138.0 23.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 179.151 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.7 m -68.75 165.16 20.15 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.502 0.668 . . . . 0.0 111.496 -178.882 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.439 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 9.6 mtmt -61.94 -40.06 94.21 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.825 -179.459 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.639 ' O ' ' N ' ' A' ' 49' ' ' CYS . 85.8 mt-30 -118.06 -20.28 8.75 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.91 0.386 . . . . 0.0 111.322 179.742 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 33.7 t60 32.57 -73.97 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 178.887 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.639 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -124.83 131.52 53.43 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.157 0.503 . . . . 0.0 112.213 -178.305 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -126.82 127.89 45.7 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.229 179.914 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.1 mt -113.48 131.13 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.532 179.883 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.569 ' OE2' ' NE2' ' A' ' 54' ' ' HIS . 81.2 tt0 -118.34 128.06 54.29 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.742 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 88.6 mt -106.87 117.14 52.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 121.597 0.713 . . . . 0.0 112.19 -178.017 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.569 ' NE2' ' OE2' ' A' ' 52' ' ' GLU . 96.6 m-70 -112.24 141.11 46.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.628 179.759 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 54' ' ' HIS . 96.9 mt-10 -40.44 -29.92 0.1 Allowed 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.381 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' ' 54' ' ' HIS . 89.0 mt-30 -67.33 -67.1 0.48 Allowed 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.461 178.654 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.432 ' OE1' ' N ' ' A' ' 58' ' ' ALA . 1.3 mm-40 -155.49 -177.28 6.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.486 0.66 . . . . 0.0 112.212 -178.263 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.432 ' N ' ' OE1' ' A' ' 57' ' ' GLU . . . -106.38 118.85 37.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.456 178.585 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 94.2 mt -110.63 131.57 61.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.541 0.686 . . . . 0.0 111.804 -178.775 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 23.8 tp -98.99 128.69 45.19 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.59 179.519 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -115.27 135.84 53.73 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.021 -179.773 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.618 ' ND2' ' H ' ' A' ' 69' ' ' THR . 13.4 t-20 -97.76 108.49 21.22 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.423 179.859 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -96.82 -8.06 32.02 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.649 179.413 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.481 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 6.7 t -71.19 97.83 1.6 Allowed 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.343 179.808 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.0 m -74.15 -43.29 57.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.292 0.568 . . . . 0.0 110.068 178.819 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -65.04 -43.23 93.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.808 -178.82 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.481 ' O ' ' OG ' ' A' ' 64' ' ' SER . 36.7 m-20 -140.16 99.95 7.2 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.189 -179.386 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -56.77 146.29 78.55 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 122.281 1.987 . . . . 0.0 112.871 -179.593 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.618 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 10.3 m -75.28 142.6 43.28 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.419 179.391 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -104.65 138.44 40.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.64 179.694 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 72.2 t -128.74 134.14 65.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.464 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 52.4 34.86 16.0 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.346 -179.425 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.86 26.47 69.07 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.541 179.212 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 41.8 m -146.46 141.29 26.95 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 117.563 0.681 . . . . 0.0 112.031 179.93 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.9 t -68.56 138.11 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.454 179.764 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.5 pt -113.48 89.09 1.23 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-O 121.158 0.504 . . . . 0.0 111.147 178.739 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -65.51 -27.2 68.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.567 179.114 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -120.01 166.08 16.08 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.067 -179.723 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.76 144.32 99.47 Favored 'Trans proline' 0 N--CA 1.501 1.936 0 C-N-CA 122.581 2.187 . . . . 0.0 112.197 -179.72 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.5 m -136.92 138.25 46.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.999 179.767 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.9 mtm180 -73.25 132.74 43.5 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.259 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.1 mt -81.5 133.79 35.44 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.113 -179.051 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -125.88 149.57 48.59 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.834 179.96 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -52.6 112.51 0.84 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.156 0.503 . . . . 0.0 111.062 -179.268 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.6 -11.43 25.69 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.799 179.233 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -70.36 132.48 45.71 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 117.289 0.545 . . . . 0.0 110.679 -179.823 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.0 t -108.16 132.69 55.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.929 -178.877 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.449 ' O ' ' OG ' ' A' ' 94' ' ' SER . 96.7 mt -104.32 130.92 54.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.759 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 87.0 m -122.8 123.59 41.39 Favored 'General case' 0 CA--C 1.523 -0.086 0 CA-C-O 121.628 0.728 . . . . 0.0 112.003 -178.83 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.56 ' N ' ' O ' ' A' ' 93' ' ' ARG . 78.9 mt -110.91 123.93 67.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.658 178.852 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.51 ' C ' ' O ' ' A' ' 90' ' ' ILE . 96.8 mt 31.78 -95.63 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.896 179.044 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.505 ' OD1' ' N ' ' A' ' 92' ' ' ASP . 24.1 p-10 -114.29 7.51 16.47 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.517 -179.763 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.65 HH22 ' CA ' ' A' ' 11' ' ' LYS . 1.7 mmp_? -119.41 137.22 53.9 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.651 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 88' ' ' ILE . 44.9 t -138.26 150.17 46.42 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.234 179.951 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -129.22 134.14 47.85 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.839 179.581 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -95.05 134.05 38.16 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.353 -179.406 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -93.51 121.54 35.03 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.914 -179.541 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -134.41 127.39 31.48 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 120.453 -0.499 . . . . 0.0 112.071 -179.915 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -94.24 170.33 9.59 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.875 179.395 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 . . . . . 0 C--N 1.329 -0.324 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.365 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 67.3 t . . . . . 0 N--CA 1.451 -0.386 0 CA-C-O 120.727 0.299 . . . . 0.0 111.312 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.461 ' O ' ' CD ' ' B' ' 231' ' ' GLN . 97.6 m-20 -45.3 98.62 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.018 0.437 . . . . 0.0 112.167 -179.396 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . 0.447 ' C ' ' O ' ' B' ' 229' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.461 ' CD ' ' O ' ' B' ' 229' ' ' ASP . 1.0 OUTLIER -148.62 -57.83 0.22 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.961 0.41 . . . . 0.0 109.961 179.163 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' B' ' 231' ' ' GLN . . . -42.79 170.44 0.01 OUTLIER Glycine 0 CA--C 1.525 0.658 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.891 -179.472 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -68.95 164.7 32.69 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 C-N-CA 124.341 3.361 . . . . 0.0 112.242 179.631 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.69 137.36 72.7 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 122.106 1.871 . . . . 0.0 112.662 -179.534 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 30.5 t -64.86 131.42 30.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 114.429 -1.26 . . . . 0.0 109.856 -179.76 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 2.0 t -62.54 122.15 15.06 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.88 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -56.57 -22.02 41.25 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 122.081 1.854 . . . . 0.0 112.208 -179.045 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 23.6 m -73.29 -44.11 59.75 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.818 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . 0.703 ' CD1' ' NH2' ' B' ' 245' ' ' ARG . 77.2 t80 -57.57 -46.41 84.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.839 -179.63 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 91.6 mt -63.09 -40.65 98.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.424 0.63 . . . . 0.0 110.143 -179.945 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -62.4 -41.41 98.64 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.158 -179.663 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . 0.462 ' O ' ' OG ' ' B' ' 247' ' ' SER . 94.4 mtt-85 -61.44 -43.16 99.36 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.882 0.372 . . . . 0.0 111.039 -179.465 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.703 ' NH2' ' CD1' ' B' ' 241' ' ' PHE . 0.3 OUTLIER -61.24 -38.27 86.04 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.834 -179.921 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.11 -39.13 91.46 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.492 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 247' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 64.5 p -68.81 -41.41 78.7 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.293 178.164 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -58.86 -38.57 79.07 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.899 179.014 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 48.5 t -61.78 -44.68 99.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.003 179.297 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -58.29 -28.05 64.62 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.08 179.331 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -93.37 -8.04 43.0 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.752 178.985 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.463 ' HG ' ' H ' ' B' ' 253' ' ' ASN . 5.0 tp -100.33 179.59 4.41 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.205 0.526 . . . . 0.0 110.953 -179.475 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . 0.489 ' ND2' ' OD2' ' B' ' 255' ' ' ASP . 16.1 p30 -140.66 172.38 12.79 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.099 179.861 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . 0.482 ' N ' ' OD1' ' B' ' 254' ' ' ASP . 27.7 p-10 -67.89 -4.2 12.12 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.764 0.316 . . . . 0.0 110.845 -179.593 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . 0.489 ' OD2' ' ND2' ' B' ' 253' ' ' ASN . 95.4 m-20 -66.95 -16.7 64.51 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.097 179.859 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 50.2 p-10 -73.08 57.71 0.47 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.358 -178.87 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.73 -11.52 18.06 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 121.104 -0.238 . . . . 0.0 111.313 -179.729 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.687 ' O ' ' N ' ' B' ' 260' ' ' GLU . 88.3 m-20 -97.15 -0.01 47.67 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 177.54 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.476 ' C ' ' O ' ' B' ' 258' ' ' ASP . 50.1 p-10 0.83 57.04 0.0 OUTLIER 'General case' 0 C--O 1.221 -0.409 0 O-C-N 124.932 1.395 . . . . 0.0 113.073 -179.921 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.687 ' N ' ' O ' ' B' ' 258' ' ' ASP . 98.7 mt-10 58.19 6.99 0.59 Allowed 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 178.509 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . 0.452 ' N ' ' O ' ' B' ' 258' ' ' ASP . 80.1 mt -115.58 134.71 57.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.422 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . 0.41 ' N ' ' O ' ' A' ' 38' ' ' ARG . 40.3 t -127.69 132.87 68.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.529 179.014 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -97.11 120.14 36.92 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.213 -179.46 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -63.98 -46.27 85.35 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.508 179.148 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -97.99 151.96 37.81 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.565 -179.42 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -66.99 146.84 78.81 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.929 2.42 . . . . 0.0 113.055 -178.932 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 27.5 pt . . . . . 0 C--N 1.327 -0.387 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.514 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo . . . . . 0 N--CA 1.486 1.062 0 N-CA-C 111.343 -0.291 . . . . 0.0 111.343 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 69.5 p -70.13 -35.72 74.29 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.583 -179.905 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.611 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 94.5 mtt-85 -91.89 113.4 25.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.458 -179.321 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -126.31 133.72 51.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.379 -179.747 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 31.8 tp -113.62 133.85 55.05 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.781 -179.816 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.9 t -110.21 129.22 65.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.868 0.366 . . . . 0.0 111.116 -179.425 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.8 m -83.43 137.44 33.91 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.084 -178.864 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.6 mt -104.64 135.65 41.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.583 177.623 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -88.97 158.9 17.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.569 179.916 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.605 ' CD ' HH22 ' A' ' 93' ' ' ARG . 77.5 mtp180 -56.5 -29.27 61.61 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.076 179.881 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.9 m -79.25 -7.79 58.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.847 179.599 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.96 28.97 24.43 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -179.21 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.3 t -113.7 132.67 62.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.505 -0.347 . . . . 0.0 110.467 -179.695 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -77.61 138.71 39.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.407 179.944 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -133.87 -119.66 2.01 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 120.348 -0.93 . . . . 0.0 112.748 -179.141 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -66.44 143.12 68.3 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.144 1.896 . . . . 0.0 113.499 -177.828 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.435 ' O ' ' CD1' ' B' ' 267' ' ' ILE . 0.6 OUTLIER -108.04 130.56 55.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.576 -179.728 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -101.26 107.65 51.46 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.304 -179.181 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -74.64 128.9 12.16 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 121.753 1.636 . . . . 0.0 111.679 -179.562 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 86.6 mt -86.43 51.24 2.17 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -178.063 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.7 p -62.41 -22.37 66.11 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.456 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.6 mt -79.15 137.95 37.68 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.209 179.043 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 81.0 p -66.57 -17.46 64.83 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.925 -179.424 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.433 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 86.4 m -129.98 131.03 45.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.066 0.46 . . . . 0.0 111.046 179.616 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.6 t -123.54 115.25 21.21 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.292 178.155 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.8 tp -112.01 124.55 52.64 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.928 -179.219 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.484 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 3.9 m-85 -106.42 143.51 34.44 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.763 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 157.49 -170.55 34.59 Favored Glycine 0 C--O 1.225 -0.408 0 C-N-CA 120.005 -1.093 . . . . 0.0 111.715 178.852 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.0 ttp85 -87.49 -27.41 22.67 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.84 -0.18 . . . . 0.0 111.212 -179.903 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.564 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -59.19 151.13 35.71 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 179.99 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.442 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 10.5 tp -66.24 -40.41 86.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.218 -0.593 . . . . 0.0 110.298 179.854 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.442 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 79.4 mm-40 -53.98 -15.68 1.52 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.353 -179.884 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.564 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 34.1 m -64.48 123.63 19.72 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 120.162 -0.615 . . . . 0.0 109.394 179.631 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.433 ' OD2' ' O ' ' A' ' 26' ' ' THR . 98.6 m-20 -56.95 -25.0 57.06 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -179.501 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.419 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 99.0 mt -129.82 120.83 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.367 176.761 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 68.9 ttp85 -108.22 133.94 51.76 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.791 -178.648 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 97.6 mt -116.31 130.08 71.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.875 -179.825 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -75.24 34.59 0.11 Allowed 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -178.205 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 57.8 mt -110.84 127.55 26.75 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.753 179.651 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.81 -8.45 22.39 Favored 'Trans proline' 0 N--CA 1.498 1.742 0 C-N-CA 122.684 2.256 . . . . 0.0 114.063 -179.024 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.2 m -100.61 1.8 10.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.317 179.711 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.487 ' O ' ' O ' ' A' ' 45' ' ' SER . 91.2 t -97.26 103.35 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.034 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.487 ' O ' ' O ' ' A' ' 44' ' ' VAL . 12.5 t -32.71 157.54 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.785 0.803 . . . . 0.0 111.961 -178.688 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -64.25 -38.38 90.83 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.963 -179.695 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.577 ' O ' ' N ' ' A' ' 49' ' ' CYS . 95.6 mm-40 -113.22 -6.67 13.6 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 123.474 0.484 . . . . 0.0 111.055 -179.015 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.465 ' CD2' ' OG1' ' A' ' 69' ' ' THR . 20.8 t60 14.28 -71.66 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 -178.982 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.577 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.3 136.06 45.22 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -177.352 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -125.99 125.56 42.87 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.69 178.827 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.6 mt -110.72 132.79 58.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.978 179.894 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.418 ' CD ' ' CE1' ' A' ' 54' ' ' HIS . 75.6 tt0 -115.64 124.78 51.78 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.487 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.6 mt -103.16 120.68 53.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 119.913 -0.715 . . . . 0.0 112.422 -178.309 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.592 ' O ' ' N ' ' A' ' 56' ' ' GLN . 2.4 m-70 -114.91 138.4 50.86 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.084 178.723 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.462 ' C ' ' O ' ' A' ' 54' ' ' HIS . 96.5 mt-10 -39.86 -23.88 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 -179.655 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.592 ' N ' ' O ' ' A' ' 54' ' ' HIS . 66.2 tp60 -68.49 -67.93 0.43 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.142 178.257 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -159.2 -163.38 1.2 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.74 -179.529 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.42 131.7 54.82 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.401 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 41.2 mm -112.23 125.08 69.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.068 -178.801 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.433 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 28.9 tp -100.43 125.63 46.73 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.805 0.336 . . . . 0.0 110.097 -179.849 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -115.68 136.96 52.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.157 179.456 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.731 ' ND2' ' H ' ' A' ' 69' ' ' THR . 14.6 t-20 -100.54 106.73 18.28 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.4 -179.856 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -97.58 -6.93 32.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.587 179.462 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.48 100.6 0.87 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.886 179.563 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.2 m -83.25 -14.95 52.11 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.276 -0.569 . . . . 0.0 109.677 179.374 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.5 -43.5 9.65 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.594 179.964 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 44.0 m-20 -146.97 101.66 3.88 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.452 -179.485 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.404 ' HA ' HD22 ' A' ' 62' ' ' ASN . 32.5 Cg_exo -56.04 150.53 46.97 Favored 'Trans proline' 0 N--CA 1.499 1.824 0 C-N-CA 122.664 2.243 . . . . 0.0 113.998 -178.795 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.731 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 11.3 m -71.57 136.99 47.68 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.794 178.987 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.556 ' O ' ' N ' ' A' ' 89' ' ' THR . 70.2 mt-30 -99.64 146.04 26.92 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.597 179.947 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.544 ' CG2' ' OD1' ' A' ' 86' ' ' ASP . 4.1 p -133.75 139.73 48.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.499 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 48.24 33.13 3.5 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -179.63 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.23 29.79 65.96 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.299 -179.549 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.442 ' N ' ' O ' ' A' ' 71' ' ' VAL . 18.2 t -140.67 137.32 33.46 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.975 -179.199 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 38.9 t -66.76 139.09 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.375 -179.321 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.455 ' CG2' ' O ' ' A' ' 78' ' ' GLU . 89.8 mt -107.64 116.21 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.528 179.055 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.465 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 24.5 p-10 -87.75 -33.54 18.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.661 0.267 . . . . 0.0 111.064 179.274 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.455 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 5.0 pt-20 -128.88 174.05 4.95 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.949 -179.292 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -58.8 144.48 98.35 Favored 'Trans proline' 0 N--CA 1.501 1.929 0 C-N-CA 122.305 2.003 . . . . 0.0 112.513 -179.4 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.6 p -141.6 144.26 26.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.308 0.575 . . . . 0.0 111.689 179.747 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -77.6 132.98 38.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.095 179.611 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.2 mt -88.02 140.26 29.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.922 0.392 . . . . 0.0 111.146 -179.451 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -129.69 154.45 47.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.576 -179.87 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.563 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 7.6 t60 -54.46 117.81 3.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.038 0.447 . . . . 0.0 110.654 -179.502 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.81 -16.73 30.72 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 -179.396 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.544 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 45.3 t0 -69.94 126.52 29.94 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.185 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 49.7 t -102.5 135.58 38.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.006 -178.981 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 28.3 mm -92.59 129.03 43.77 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.605 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 177.485 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.556 ' N ' ' O ' ' A' ' 70' ' ' GLN . 98.8 m -121.23 125.15 46.4 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 122.031 0.919 . . . . 0.0 112.597 -178.245 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.591 ' O ' ' N ' ' A' ' 93' ' ' ARG . 97.0 mt -117.38 132.47 67.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 113.993 -1.458 . . . . 0.0 107.924 177.919 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.515 ' C ' ' O ' ' A' ' 90' ' ' ILE . 69.7 mt -26.78 104.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 O-C-N 123.448 0.467 . . . . 0.0 111.257 -179.225 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.509 ' CG ' ' NE ' ' B' ' 245' ' ' ARG . 90.9 m-20 79.37 -16.51 0.66 Allowed 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 179.147 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.605 HH22 ' CD ' ' A' ' 12' ' ' ARG . 23.5 mtt85 -130.62 137.36 49.59 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.661 -0.415 . . . . 0.0 110.84 179.028 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.2 m -138.82 152.42 47.85 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.156 0.503 . . . . 0.0 109.888 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -126.16 122.95 37.13 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.094 -179.61 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -83.69 132.05 34.9 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.82 -179.59 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.611 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 72.5 t80 -96.87 127.16 42.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.691 -179.525 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -124.94 120.95 33.07 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.271 179.533 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.563 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 59.4 t-20 -116.82 110.11 17.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.044 179.988 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 . . . . . 0 C--N 1.331 -0.225 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.004 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 47.6 t . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.776 0.322 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.572 ' C ' ' H ' ' B' ' 231' ' ' GLN . 98.9 m-20 -74.13 145.64 44.14 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.875 0.369 . . . . 0.0 111.152 179.675 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.572 ' H ' ' C ' ' B' ' 229' ' ' ASP . 0.7 OUTLIER -115.84 -25.55 7.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.075 0.464 . . . . 0.0 110.625 179.898 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' B' ' 231' ' ' GLN . . . -41.01 172.14 0.01 OUTLIER Glycine 0 CA--C 1.527 0.814 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.416 -179.089 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.24 163.84 35.57 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 124.248 3.299 . . . . 0.0 112.731 179.73 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -79.52 142.97 16.74 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 121.645 1.563 . . . . 0.0 112.358 179.537 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 36.8 t -63.06 141.67 17.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.226 179.511 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 2.2 t -71.99 132.67 44.61 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.193 -179.72 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . 0.401 ' O3P' ' OG1' ' B' ' 240' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -57.5 -25.36 66.24 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 122.874 2.383 . . . . 0.0 112.834 -179.814 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 240' ' ' THR . . . . . 0.401 ' OG1' ' O3P' ' B' ' 238' ' ' TPO . 18.8 m -72.15 -44.96 62.3 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.212 0.529 . . . . 0.0 109.897 178.618 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -55.92 -47.13 78.08 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.6 -179.439 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . 0.437 ' CD2' ' OD1' ' A' ' 92' ' ' ASP . 93.3 mt -65.39 -41.49 93.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.776 -179.653 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -60.59 -40.68 92.64 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.738 -179.242 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -61.76 -42.44 98.99 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.785 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.509 ' NE ' ' CG ' ' A' ' 92' ' ' ASP . 70.4 ttp85 -60.77 -43.56 97.88 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.559 -179.739 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.98 -42.11 97.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.986 0.422 . . . . 0.0 109.957 -179.548 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 73.9 m -66.64 -45.09 80.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.542 0.687 . . . . 0.0 109.292 178.303 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . 0.451 ' O ' ' N ' ' B' ' 252' ' ' LEU . 68.8 tp60 -59.84 -35.44 74.75 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.325 -179.992 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 71.4 t -63.05 -47.58 91.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.063 179.887 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -60.85 -28.81 69.11 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 121.445 0.641 . . . . 0.0 109.404 179.685 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -90.7 -11.91 38.26 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.982 178.986 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.451 ' N ' ' O ' ' B' ' 248' ' ' GLN . 46.0 tp -76.51 145.55 39.05 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.581 -179.499 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -100.79 130.97 46.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.81 179.368 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . 0.518 ' C ' ' H ' ' B' ' 256' ' ' ASP . 37.8 t70 -63.44 -33.5 75.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.734 179.783 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -61.86 3.91 0.14 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.929 -179.726 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.518 ' H ' ' C ' ' B' ' 254' ' ' ASP . 27.9 t0 -93.71 86.39 5.13 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 120.24 -0.584 . . . . 0.0 110.781 -179.515 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -71.18 7.12 1.36 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.165 179.701 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.468 ' H ' ' C ' ' B' ' 256' ' ' ASP . 22.0 t0 -128.77 97.57 4.71 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.113 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.541 ' CG ' ' NH2' ' A' ' 93' ' ' ARG . 46.0 t0 -88.95 -90.69 0.13 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.339 -0.545 . . . . 0.0 111.23 -178.793 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -149.09 16.92 0.95 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.807 -179.186 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 73.1 mt -109.87 132.86 56.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.183 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 54.9 t -123.18 131.57 72.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.187 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -94.46 119.93 33.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.038 0.447 . . . . 0.0 111.723 -178.576 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -63.29 -48.45 78.08 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.899 179.74 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -89.34 160.3 42.71 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.609 -179.067 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -60.04 140.64 93.61 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.194 1.93 . . . . 0.0 111.727 179.867 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . 0.435 ' CD1' ' O ' ' A' ' 19' ' ' HIS . 3.2 tt . . . . . 0 C--N 1.324 -0.508 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.169 -179.249 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo . . . . . 0 N--CA 1.496 1.62 0 CA-C-O 120.574 0.156 . . . . 0.0 111.805 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.6 m -104.6 -55.92 2.27 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.945 0.402 . . . . 0.0 110.464 179.459 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.563 ' CD ' ' HH ' ' A' ' 97' ' ' TYR . 87.0 mtm-85 -100.51 131.51 46.38 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.026 -179.209 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -130.87 154.37 48.14 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.202 0.525 . . . . 0.0 111.995 -179.364 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.1 mt -119.96 141.93 49.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.625 179.387 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 45.9 t -115.53 129.83 71.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.787 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.0 m -88.46 111.98 22.42 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.426 0.631 . . . . 0.0 112.079 -178.14 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 35.5 mm -79.57 142.86 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.215 178.539 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.412 ' HZ3' ' HA ' ' B' ' 257' ' ' LYS . 98.7 mttt -95.28 160.47 14.52 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.414 0.626 . . . . 0.0 111.189 -179.547 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.434 ' NH2' ' HA ' ' B' ' 245' ' ' ARG . 82.7 mtp180 -58.84 -27.53 65.21 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.94 179.41 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 93.8 p -74.11 -18.48 60.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.0 178.833 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.67 21.2 12.85 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-N 116.213 -0.449 . . . . 0.0 112.134 179.266 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.0 p -125.57 139.72 50.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.977 0.417 . . . . 0.0 110.189 179.897 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.447 ' OD1' ' N ' ' A' ' 16' ' ' ASP . 33.4 p-10 -84.72 149.14 25.99 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.463 -179.696 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -138.54 -97.85 0.42 Allowed Glycine 0 CA--C 1.53 1.021 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.768 -179.817 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.84 141.39 27.08 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.198 1.932 . . . . 0.0 112.395 -179.087 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -106.95 146.67 30.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.985 0.421 . . . . 0.0 110.375 -179.482 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -114.74 98.63 50.18 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.334 -179.931 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.32 133.52 14.75 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.872 1.715 . . . . 0.0 112.069 -178.411 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 92.2 mt -87.71 86.27 7.16 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.062 -178.806 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 89.5 p -83.65 -11.34 57.38 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.566 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.1 mt -109.15 154.86 21.74 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.378 -179.697 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 59.9 m -79.56 -8.53 59.23 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -178.648 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.477 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 24.2 m -126.43 129.14 48.14 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.827 -179.637 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.1 t -123.78 114.52 20.01 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.991 178.505 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 45.4 tp -112.25 128.49 56.27 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.451 -178.39 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.466 ' O ' ' O ' ' A' ' 47' ' ' GLN . 7.0 m-85 -110.36 130.9 55.46 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.482 -179.953 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 165.2 -176.65 40.84 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.411 178.692 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.639 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 81.5 mtm-85 -75.51 -30.96 59.98 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 122.483 -0.422 . . . . 0.0 112.032 -179.346 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -54.6 143.66 31.41 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 121.387 -0.435 . . . . 0.0 112.181 -178.131 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.444 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 11.1 tp -64.43 -41.09 91.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.252 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.444 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 80.8 tt0 -54.44 -15.95 2.0 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.357 179.5 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.7 m -69.16 133.13 47.59 Favored 'General case' 0 N--CA 1.461 0.1 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.989 -179.319 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.477 ' OD2' ' O ' ' A' ' 26' ' ' THR . 91.2 m-20 -59.95 -31.2 69.65 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.922 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.46 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 98.8 mt -126.68 124.59 65.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 177.008 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 70.1 ttt180 -110.64 133.49 53.27 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.54 -178.566 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 94.6 mt -118.17 131.4 71.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 121.073 0.463 . . . . 0.0 110.736 -179.148 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -75.89 32.79 0.12 Allowed 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -178.168 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.6 ' CD1' ' NH1' ' A' ' 93' ' ' ARG . 52.9 mt -113.45 128.19 25.97 Favored Pre-proline 0 N--CA 1.471 0.581 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.306 179.571 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.84 -15.03 29.86 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.239 1.959 . . . . 0.0 113.269 -179.034 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.444 ' O ' ' CG2' ' A' ' 43' ' ' VAL . 2.9 p -86.05 -1.41 7.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.103 179.729 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.639 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 5.3 p -95.1 139.28 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.958 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.79 171.91 7.18 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.563 0.697 . . . . 0.0 112.456 -178.09 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.561 ' NZ ' ' O ' ' B' ' 231' ' ' GLN . 44.7 mttm -64.26 -45.36 88.45 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.592 -179.369 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.662 ' O ' ' N ' ' A' ' 49' ' ' CYS . 84.6 mt-30 -113.05 -12.75 13.16 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.781 -179.607 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 21.3 t60 33.86 -75.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.238 -0.892 . . . . 0.0 113.385 179.52 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.662 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.2 134.77 46.8 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.759 -178.466 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -127.67 127.55 43.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.422 179.769 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 92.8 mt -109.73 133.06 56.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.868 -179.635 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -115.72 117.47 30.35 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.012 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 90.1 mt -101.1 112.72 34.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 119.972 -0.691 . . . . 0.0 111.328 -178.691 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.427 ' O ' ' C ' ' A' ' 55' ' ' GLU . 92.7 m-70 -110.05 141.06 43.41 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.483 -1.235 . . . . 0.0 109.561 -179.685 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 54' ' ' HIS . 99.2 mt-10 -41.23 -36.05 0.71 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.234 0.54 . . . . 0.0 109.693 -179.895 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -60.38 -66.23 0.56 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.371 179.637 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -154.0 -174.01 4.8 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.13 -179.369 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.56 123.18 48.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.292 179.152 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.9 mt -117.42 131.42 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -178.679 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 24.2 tp -100.76 127.87 47.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.209 179.267 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -109.22 135.48 50.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.054 179.817 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 61.1 t-20 -96.71 108.34 20.96 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.999 0.428 . . . . 0.0 111.261 -179.263 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -101.25 -7.29 23.19 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.668 179.855 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.7 t -76.71 97.79 4.57 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.883 -179.877 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.1 p -78.39 -33.01 49.11 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.092 179.113 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.39 -44.47 51.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.044 -179.213 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.414 ' ND2' HG21 ' A' ' 43' ' ' VAL . 79.0 m-20 -139.54 94.78 9.24 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.082 -179.693 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -54.48 147.23 48.59 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.522 2.148 . . . . 0.0 113.465 -179.725 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 59.3 m -77.05 149.06 35.83 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.115 179.095 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -110.08 141.06 43.46 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.711 -179.61 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 55.0 t -132.37 135.48 57.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.316 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 52.99 33.34 14.51 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -178.711 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.6 28.98 70.17 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.153 179.495 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.2 t -143.74 142.83 31.12 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 117.037 0.419 . . . . 0.0 111.138 179.51 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 52.9 t -68.0 138.64 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.066 -0.516 . . . . 0.0 112.062 -179.193 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.6 pt -112.46 92.75 2.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-O 121.274 0.559 . . . . 0.0 109.899 178.369 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -63.98 -28.45 69.82 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.628 -179.743 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.439 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.8 OUTLIER -130.81 179.46 1.34 Allowed Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.801 -179.67 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.439 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 31.9 Cg_exo -60.58 146.19 97.48 Favored 'Trans proline' 0 N--CA 1.501 1.951 0 C-N-CA 123.137 2.558 . . . . 0.0 113.244 179.898 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.4 137.95 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.381 179.484 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 68.2 ttp85 -73.12 129.07 37.25 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.904 -0.319 . . . . 0.0 110.77 179.925 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 97.4 mt -81.2 139.58 35.44 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.355 0.598 . . . . 0.0 110.946 179.936 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -136.71 152.19 50.09 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.352 -179.748 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.552 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 6.3 t60 -52.15 114.82 1.45 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.927 0.394 . . . . 0.0 110.366 -179.797 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.81 -18.34 22.13 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.034 -0.827 . . . . 0.0 111.034 -179.718 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 87' ' ' VAL . 53.3 t0 -66.21 129.49 40.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.276 0.56 . . . . 0.0 110.021 179.153 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.501 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 9.3 p -109.16 133.91 52.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.687 -179.051 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.1 mt -99.88 129.47 50.47 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.204 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.6 m -123.58 127.74 48.72 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.699 0.761 . . . . 0.0 112.761 -178.456 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.483 ' O ' ' N ' ' A' ' 93' ' ' ARG . 96.5 mt -117.37 125.82 74.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 114.44 -1.255 . . . . 0.0 108.551 177.626 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.44 ' C ' ' O ' ' A' ' 90' ' ' ILE . 82.4 mt 36.55 -103.3 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.929 179.949 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.404 ' HB2' HH21 ' B' ' 245' ' ' ARG . 89.8 m-20 -109.32 7.82 25.32 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.571 179.715 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.6 ' NH1' ' CD1' ' A' ' 41' ' ' LEU . 40.9 mtm-85 -121.94 140.85 51.94 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -179.208 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.5 t -138.03 152.26 48.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.297 0.57 . . . . 0.0 111.091 -179.698 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -121.99 120.96 35.92 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.417 179.081 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 53.6 ttt85 -84.87 129.98 34.73 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.871 -179.197 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.563 ' HH ' ' CD ' ' A' ' 5' ' ' ARG . 69.0 t80 -93.74 122.84 36.61 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.208 -179.242 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -123.0 124.19 42.58 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.88 179.967 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.552 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 63.2 t-20 -105.42 102.78 12.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.055 -179.711 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 . . . . . 0 C--N 1.328 -0.357 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.785 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 88.8 t . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.77 0.319 . . . . 0.0 110.615 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.589 ' O ' ' CB ' ' B' ' 230' ' ' SEP . 85.4 m-20 -88.34 -2.02 58.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.799 179.64 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . 0.589 ' CB ' ' O ' ' B' ' 229' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.561 ' O ' ' NZ ' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -150.28 7.59 0.6 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.005 -179.873 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . 0.511 ' O ' ' O ' ' B' ' 231' ' ' GLN . . . -48.27 -166.58 0.01 OUTLIER Glycine 0 CA--C 1.531 1.041 0 CA-C-N 116.527 -0.306 . . . . 0.0 112.748 -179.029 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -60.37 152.96 63.5 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 123.806 3.004 . . . . 0.0 112.998 -179.186 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -74.44 130.88 14.35 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.446 1.431 . . . . 0.0 112.667 179.574 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 24.4 t -57.74 137.33 20.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.798 -179.61 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 7.0 t -65.8 122.57 17.61 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.257 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . 0.477 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . 0.477 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 34.0 Cg_exo -59.3 -24.51 74.59 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.558 2.172 . . . . 0.0 112.159 -179.612 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 91.3 m -73.57 -47.52 40.0 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-O 121.132 0.492 . . . . 0.0 109.732 178.894 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -59.83 -45.66 91.69 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.71 -179.29 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 91.9 mt -64.5 -40.56 95.87 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.86 0.362 . . . . 0.0 110.887 -179.728 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -60.14 -42.11 94.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.351 -179.2 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . 0.511 ' O ' ' OG ' ' B' ' 247' ' ' SER . 89.4 mtm180 -65.3 -39.29 92.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.594 179.276 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.488 ' NH2' HH11 ' A' ' 93' ' ' ARG . 16.8 mmm180 -60.72 -43.66 97.57 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.863 -178.471 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -63.92 -40.19 95.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.208 0.528 . . . . 0.0 109.819 179.353 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 247' ' ' SER . . . . . 0.511 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 67.9 p -64.03 -44.72 91.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.625 179.182 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . 0.424 ' HB2' HH22 ' A' ' 12' ' ' ARG . 87.3 mt-30 -61.1 -33.79 73.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.68 179.665 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 55.4 t -63.38 -44.86 99.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 120.259 -0.577 . . . . 0.0 109.754 179.139 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -64.4 -28.64 69.82 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.129 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -84.76 -13.53 50.94 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.792 179.959 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 86.4 mt -103.35 -179.42 3.95 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.3 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -118.83 149.22 41.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.888 0.375 . . . . 0.0 110.877 179.981 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -65.99 -19.15 65.76 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.556 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -81.7 10.33 6.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.786 179.797 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -79.01 92.42 4.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.258 0.551 . . . . 0.0 109.771 179.665 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . 0.412 ' HA ' ' HZ3' ' A' ' 11' ' ' LYS . 98.7 mttt -67.61 -12.9 61.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.135 -0.938 . . . . 0.0 112.052 -178.632 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -126.14 101.96 7.0 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.211 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.62 ' CG ' ' H ' ' B' ' 260' ' ' GLU . 19.7 p-10 -89.57 -92.22 0.13 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.143 -179.563 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.62 ' H ' ' CG ' ' B' ' 259' ' ' ASP . 97.4 mt-10 -147.35 20.76 1.2 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.916 -179.994 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 66.8 mt -115.96 135.35 56.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.765 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 72.7 t -127.39 135.39 63.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.113 179.543 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -96.84 118.18 32.71 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.396 0.617 . . . . 0.0 110.769 -179.163 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -66.85 -46.72 74.18 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.066 -179.917 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -75.31 168.5 27.09 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.588 -179.083 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -64.64 144.17 83.45 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 121.356 1.371 . . . . 0.0 111.024 179.275 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 10.6 tt . . . . . 0 C--N 1.322 -0.613 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.534 -178.936 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo . . . . . 0 N--CA 1.499 1.814 0 CA-C-O 120.805 0.252 . . . . 0.0 112.325 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.4 m -71.82 -44.52 63.76 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.136 -179.65 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.432 ' NE ' ' CD1' ' A' ' 53' ' ' ILE . 86.2 mtm-85 -90.83 130.68 36.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.068 0.461 . . . . 0.0 111.328 -178.407 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.403 ' CZ ' ' OE2' ' A' ' 100' ' ' GLU . 99.8 mtt180 -135.41 143.0 45.74 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.966 179.677 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 10.9 mp -120.08 139.33 52.71 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.93 0.395 . . . . 0.0 110.937 179.773 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.5 t -111.88 132.02 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.102 -179.729 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.0 m -84.21 139.37 32.43 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -178.286 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.429 HG23 HD12 ' A' ' 10' ' ' ILE . 49.2 mm -108.31 135.11 48.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.821 177.324 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -90.8 159.93 16.03 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 177.802 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.532 ' CZ ' ' OE2' ' B' ' 260' ' ' GLU . 90.9 mtm180 -56.2 -20.98 20.41 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.149 -179.42 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.9 m -83.62 -13.16 54.92 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.12 179.876 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.25 31.49 11.75 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.102 179.634 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.1 m -118.78 142.54 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 120.982 0.42 . . . . 0.0 111.77 -179.793 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -73.21 119.12 17.01 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.237 -179.151 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -110.96 -128.21 5.3 Favored Glycine 0 CA--C 1.54 1.654 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 -179.752 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -74.8 149.53 37.83 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 122.538 2.159 . . . . 0.0 113.209 -178.854 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 47.8 m170 -101.72 143.55 31.52 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.126 -179.665 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.404 ' CD2' HD12 ' A' ' 37' ' ' ILE . 39.0 t80 -113.42 92.52 23.48 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.192 179.53 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -77.67 138.19 16.87 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 121.878 1.719 . . . . 0.0 111.767 -179.415 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 82.9 mt -101.65 125.54 48.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.454 0.645 . . . . 0.0 111.465 -179.007 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 82.9 p -120.34 -1.03 10.28 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.329 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 45.4 mt -111.37 152.83 26.86 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 114.402 -1.272 . . . . 0.0 109.398 -178.921 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.9 m -77.27 -11.76 59.87 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -177.818 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 20.7 m -127.31 130.92 50.4 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 120.131 -0.628 . . . . 0.0 112.03 -179.617 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.5 t -126.15 117.97 24.24 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.851 178.841 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.411 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 31.9 tp -113.57 134.97 54.4 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 120.838 0.351 . . . . 0.0 111.215 -178.851 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.511 ' O ' ' O ' ' A' ' 47' ' ' GLN . 79.0 m-85 -112.44 135.82 52.68 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.682 179.244 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 165.39 -164.94 37.56 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 120.617 -0.801 . . . . 0.0 111.422 179.784 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.614 ' NH2' ' O ' ' B' ' 232' ' ' GLY . 31.1 ptt-85 -103.41 -26.19 12.99 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.544 -0.462 . . . . 0.0 111.24 179.996 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -50.29 158.55 1.71 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 179.859 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.564 ' O ' ' NH2' ' A' ' 38' ' ' ARG . 7.9 tp -66.94 -41.87 88.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 117.644 0.722 . . . . 0.0 110.588 -179.22 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.448 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 80.4 tt0 -60.13 -19.68 54.72 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 -178.914 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 55.8 m -59.84 130.98 49.42 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.276 -0.57 . . . . 0.0 111.002 -179.238 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.565 ' CG ' ' NE2' ' B' ' 265' ' ' GLN . 74.2 m-20 -61.5 -32.65 72.69 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.907 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.416 HG13 ' CE2' ' A' ' 29' ' ' PHE . 46.6 mm -119.83 112.84 38.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.102 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.564 ' NH2' ' O ' ' A' ' 33' ' ' ILE . 74.0 mtt85 -98.95 131.16 45.22 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.579 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.421 HD12 HH11 ' A' ' 93' ' ' ARG . 91.8 mt -121.76 132.13 71.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.882 0.373 . . . . 0.0 110.711 -178.265 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -75.46 33.02 0.11 Allowed 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -177.664 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.4 HD13 ' NH2' ' A' ' 93' ' ' ARG . 88.5 mt -115.19 123.76 31.21 Favored Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 120.261 -0.575 . . . . 0.0 110.159 179.138 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.95 -7.21 19.68 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.291 1.994 . . . . 0.0 113.427 -178.986 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.9 m -87.26 1.24 6.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 119.791 -0.763 . . . . 0.0 109.129 178.69 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.4 p -96.29 138.39 21.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.262 178.533 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.7 t -75.22 173.36 10.93 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.592 0.71 . . . . 0.0 111.86 -178.348 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 43.6 mttp -64.13 -41.77 97.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.043 179.954 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.647 ' O ' ' N ' ' A' ' 49' ' ' CYS . 10.7 mm100 -109.72 -20.69 12.72 Favored 'General case' 0 C--N 1.334 -0.068 0 CA-C-O 120.766 0.317 . . . . 0.0 110.952 -179.691 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.1 t60 37.54 -77.81 0.0 OUTLIER 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.647 -179.862 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.647 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.65 135.31 45.76 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.331 0.586 . . . . 0.0 111.581 -179.337 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -126.02 131.83 52.12 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.157 179.844 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 99.2 mt -118.27 133.45 65.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.267 179.912 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.603 ' CD ' ' HE2' ' A' ' 61' ' ' HIS . 21.8 pt-20 -116.62 128.43 55.38 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.48 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.432 ' CD1' ' NE ' ' A' ' 5' ' ' ARG . 83.4 mt -107.53 114.92 47.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.506 -178.074 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.522 ' O ' ' N ' ' A' ' 56' ' ' GLN . 99.5 m-70 -113.28 144.7 42.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.983 179.894 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 54' ' ' HIS . 84.6 tt0 -39.62 -27.58 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -179.717 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.522 ' N ' ' O ' ' A' ' 54' ' ' HIS . 89.1 mt-30 -65.66 -68.99 0.32 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.534 178.798 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -161.25 -161.83 0.85 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.92 0.39 . . . . 0.0 111.073 179.23 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -111.35 125.15 53.55 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.781 179.42 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.7 mt -113.91 128.34 70.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.997 0.427 . . . . 0.0 111.39 -179.076 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.1 tp -98.19 128.35 44.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.928 -179.798 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.603 ' HE2' ' CD ' ' A' ' 52' ' ' GLU . 99.6 m-70 -116.3 138.11 51.59 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.711 -179.268 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -103.13 105.36 15.65 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 179.944 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -96.94 -4.41 40.01 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.93 178.988 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.65 100.83 11.1 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.044 179.355 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.2 m -87.64 -14.47 39.93 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.089 179.852 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.71 -41.19 15.35 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.499 -179.849 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -144.2 95.05 5.64 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.486 179.702 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -64.65 150.86 87.51 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 121.28 1.32 . . . . 0.0 112.988 -178.483 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.6 m -72.73 137.45 45.93 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.829 -179.705 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -97.2 140.19 32.05 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.506 -0.478 . . . . 0.0 109.842 178.997 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.457 ' O ' ' N ' ' A' ' 74' ' ' SER . 7.3 p -129.43 135.95 60.47 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.504 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.131 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 48.86 29.83 2.46 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -178.78 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 76.11 25.07 67.29 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-N 115.045 -0.98 . . . . 0.0 112.18 179.94 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 71' ' ' VAL . 12.9 t -137.37 139.16 40.59 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 117.383 0.591 . . . . 0.0 111.733 -179.874 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.4 m -73.57 138.32 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.055 179.985 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.6 pt -105.15 94.25 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 121.184 0.516 . . . . 0.0 111.274 179.611 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -65.33 -33.62 76.4 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.226 179.285 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -121.16 167.35 13.42 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.404 -179.129 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -60.32 142.81 99.03 Favored 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 121.842 1.695 . . . . 0.0 112.104 -179.304 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 24.2 m -137.04 137.57 46.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.094 0.473 . . . . 0.0 110.834 179.237 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -71.56 133.09 45.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.947 179.705 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 92.8 mt -85.74 139.59 31.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.219 0.533 . . . . 0.0 110.604 179.872 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -123.97 151.23 43.89 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.319 179.824 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.715 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 5.6 t60 -57.56 122.64 13.19 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.653 -179.67 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.47 -15.84 35.05 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 179.616 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -69.27 137.74 53.32 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.415 -179.766 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 40.6 t -110.17 130.56 63.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.964 0.411 . . . . 0.0 110.829 -179.239 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 88.0 mt -98.71 130.64 47.26 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 178.373 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 94.5 m -123.14 124.54 43.3 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 119.816 -0.754 . . . . 0.0 112.187 -178.866 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.496 ' O ' ' C ' ' A' ' 91' ' ' ILE . 92.1 mt -115.46 130.89 69.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.129 178.284 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.579 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 84.7 mt -15.68 98.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -178.059 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.453 ' OD1' ' NE ' ' B' ' 245' ' ' ARG . 23.7 m-20 85.23 -22.11 0.21 Allowed 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 177.617 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.579 ' NH2' ' O ' ' A' ' 91' ' ' ILE . 0.2 OUTLIER -130.59 144.1 51.19 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.985 -179.676 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 66.8 p -137.96 153.97 49.41 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.177 0.513 . . . . 0.0 110.072 -179.859 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -125.15 122.73 37.92 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.481 179.792 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -84.69 132.16 34.49 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.619 -179.627 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.619 ' CZ ' ' OD1' ' A' ' 99' ' ' ASN . 88.0 t80 -97.12 123.93 41.01 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.775 -179.525 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -134.49 127.52 31.58 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.673 179.954 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.715 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 70.1 m-20 -103.32 128.09 50.48 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.916 0.389 . . . . 0.0 110.854 179.296 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.403 ' OE2' ' CZ ' ' A' ' 6' ' ' ARG . 95.9 mt-10 . . . . . 0 N--CA 1.464 0.24 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.126 -179.935 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 59.8 t . . . . . 0 N--CA 1.455 -0.199 0 CA-C-O 120.727 0.299 . . . . 0.0 111.538 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.547 ' O ' ' NE2' ' B' ' 231' ' ' GLN . 75.6 m-20 -60.85 151.21 30.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.151 0.5 . . . . 0.0 110.944 -179.773 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . 0.46 ' CB ' ' NE2' ' B' ' 231' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.547 ' NE2' ' O ' ' B' ' 229' ' ' ASP . 0.0 OUTLIER 179.16 61.9 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.443 179.529 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . 0.614 ' O ' ' NH2' ' A' ' 31' ' ' ARG . . . -132.68 161.44 24.02 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.905 -179.877 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -76.27 157.64 37.42 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 123.539 2.826 . . . . 0.0 112.49 179.031 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.53 136.05 16.99 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.438 2.092 . . . . 0.0 112.899 179.293 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 78.6 t -61.48 139.4 20.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.184 -179.591 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 3.8 t -67.86 136.06 53.49 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.279 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . 0.422 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . 0.422 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 45.2 Cg_exo -57.42 -27.46 76.08 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.979 2.452 . . . . 0.0 112.455 -179.918 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 240' ' ' THR . . . . . 0.416 ' OG1' ' O2P' ' B' ' 238' ' ' TPO . 28.4 m -69.07 -48.83 61.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.234 0.54 . . . . 0.0 110.194 178.557 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -60.15 -46.64 88.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.788 -178.62 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . 0.421 ' CD2' ' OD1' ' A' ' 92' ' ' ASP . 97.3 mt -63.92 -41.19 97.72 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.761 -0.375 . . . . 0.0 111.964 -178.59 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -66.32 -39.96 89.62 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.167 -179.635 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -62.18 -48.96 77.74 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.162 -0.615 . . . . 0.0 112.274 -178.754 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.497 ' HB2' HH11 ' A' ' 12' ' ' ARG . 3.9 ppt_? -65.72 -37.61 86.89 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.074 -178.515 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . 0.443 ' N ' ' HG3' ' B' ' 245' ' ' ARG . 36.7 ttmt -62.73 -40.44 97.22 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.519 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 50.5 m -65.73 -41.79 91.81 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.945 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -56.79 -39.47 74.16 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.934 179.486 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 58.1 t -63.18 -45.51 98.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-O 121.079 0.466 . . . . 0.0 110.201 179.206 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -64.96 -36.12 83.35 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.853 179.08 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -80.87 -6.96 59.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.987 179.585 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.402 HD21 ' N ' ' B' ' 256' ' ' ASP . 31.7 tp -63.45 135.72 57.11 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.268 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . 0.557 ' C ' HD21 ' B' ' 253' ' ' ASN . 0.3 OUTLIER -73.73 -46.06 48.27 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -176.967 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . 0.509 ' OD1' ' ND2' ' B' ' 253' ' ' ASN . 81.6 m-20 -96.32 3.32 53.06 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.479 -0.488 . . . . 0.0 109.936 -179.569 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . 0.522 ' O ' ' CG ' ' B' ' 256' ' ' ASP . 84.4 m-20 54.23 23.21 4.1 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.769 179.371 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.522 ' CG ' ' O ' ' B' ' 255' ' ' ASP . 7.8 m-20 178.03 -66.77 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 179.776 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . 0.476 ' C ' ' O ' ' B' ' 256' ' ' ASP . 13.3 ptmt 28.36 -110.41 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.715 -178.823 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -94.54 146.72 23.91 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.101 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.575 ' CG ' ' H ' ' B' ' 260' ' ' GLU . 33.1 t0 -91.37 -141.14 0.17 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.204 0.526 . . . . 0.0 110.763 -179.839 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.575 ' H ' ' CG ' ' B' ' 259' ' ' ASP . 97.6 mt-10 -139.34 13.76 2.58 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.755 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 58.2 mt -114.77 137.51 47.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.947 -179.865 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 48.8 t -124.43 133.95 68.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.883 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -93.01 117.3 29.91 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.768 -178.262 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -67.33 -44.88 78.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.623 179.411 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . 0.565 ' NE2' ' CG ' ' A' ' 36' ' ' ASP . 33.6 mt-30 -88.84 152.41 48.69 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.039 -178.957 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -62.22 141.36 87.75 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.44 2.093 . . . . 0.0 113.259 179.878 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 20.5 pt . . . . . 0 N--CA 1.463 0.209 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.827 179.026 . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.421 ' HG2' ' HE ' ' A' ' 6' ' ' ARG . 43.1 Cg_endo . . . . . 0 N--CA 1.494 1.558 0 CA-C-O 120.918 0.299 . . . . 0.0 112.498 . . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.7 p -100.01 -44.11 6.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.675 -179.754 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.5 mtt85 -99.46 131.49 45.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.014 -179.731 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.421 ' HE ' ' HG2' ' A' ' 3' ' ' PRO . 99.5 mtt180 -135.66 144.71 46.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.343 179.27 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 83.2 mt -112.13 141.19 46.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.125 179.007 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 31.1 t -114.84 129.13 71.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.576 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.1 m -92.07 114.99 27.68 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -177.943 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.458 ' CD1' ' HG ' ' A' ' 94' ' ' SER . 96.7 mt -81.68 144.73 9.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.543 178.205 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.9 mttt -94.48 162.27 13.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.892 0.377 . . . . 0.0 110.436 179.221 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.554 ' NH2' ' CD1' ' B' ' 252' ' ' LEU . 86.8 mtm180 -57.89 -30.04 65.53 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.531 -178.969 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.2 p -76.28 -20.56 57.22 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.649 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.7 32.62 4.4 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.903 179.649 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.7 m -128.07 134.47 65.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.881 0.372 . . . . 0.0 110.85 179.399 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -71.45 139.01 49.48 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.321 179.276 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -127.08 -118.1 2.15 Favored Glycine 0 CA--C 1.536 1.345 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -179.89 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.02 147.7 43.7 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 121.951 1.768 . . . . 0.0 112.619 -179.331 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -111.52 153.54 26.06 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.779 179.801 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -122.45 94.01 48.06 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.199 -178.598 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.52 127.99 25.67 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.145 1.897 . . . . 0.0 111.601 179.426 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.9 mt -82.77 56.42 3.39 Favored 'General case' 0 CA--C 1.522 -0.134 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.949 -179.733 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 91.9 p -62.74 -16.16 56.41 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.028 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.4 mt -91.92 143.15 26.79 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 114.761 -1.108 . . . . 0.0 110.676 -179.794 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.9 m -69.1 -17.02 63.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.697 -179.303 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.2 m -134.61 137.52 43.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.048 -179.874 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.615 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.6 OUTLIER -130.82 124.23 30.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.012 178.554 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.529 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 52.4 tp -118.36 128.72 54.91 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.966 0.412 . . . . 0.0 112.03 -177.758 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.615 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 60.5 m-85 -103.49 124.25 48.4 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.951 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 176.35 -178.23 47.74 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 119.822 -1.18 . . . . 0.0 112.965 179.449 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.41 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 46.2 mtm180 -80.05 -28.53 39.22 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.807 0.337 . . . . 0.0 110.6 179.034 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -54.66 143.35 32.22 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 -178.985 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.3 mm -64.92 -43.17 96.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.177 0.513 . . . . 0.0 109.816 179.166 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -55.91 -20.3 15.36 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.086 -179.851 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 38.5 m -63.95 131.05 46.49 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.509 -179.918 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 37' ' ' ILE . 6.6 p-10 -59.47 -30.39 68.5 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.838 -178.956 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.535 ' N ' ' OD1' ' A' ' 36' ' ' ASP . 96.5 mt -126.14 121.43 59.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.528 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 77.1 ttt-85 -110.51 136.89 48.95 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.061 -178.377 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.482 ' C ' ' H ' ' A' ' 41' ' ' LEU . 82.9 mt -119.61 131.35 72.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.922 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -75.56 24.0 0.12 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.246 -179.1 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.482 ' H ' ' C ' ' A' ' 39' ' ' ILE . 24.6 mt -89.31 122.96 68.09 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.365 179.808 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.73 -14.86 30.17 Favored 'Trans proline' 0 N--CA 1.488 1.177 0 C-N-CA 121.783 1.655 . . . . 0.0 112.594 -179.72 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.1 m -93.65 3.41 8.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.087 179.913 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.41 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 25.0 t -89.44 137.02 22.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 120.441 -0.504 . . . . 0.0 109.945 179.069 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.429 ' HG ' HG23 ' B' ' 234' ' ' TPO . 2.3 m -68.61 171.98 6.87 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.568 0.699 . . . . 0.0 111.504 -179.596 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -63.4 -43.58 97.15 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.659 -179.802 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.623 ' O ' ' N ' ' A' ' 49' ' ' CYS . 89.9 mt-30 -116.94 -20.53 9.36 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.805 179.904 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.3 t60 36.21 -78.58 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 179.491 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.623 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -125.89 133.82 51.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.217 0.532 . . . . 0.0 112.194 -178.847 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -126.51 129.91 49.56 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.688 179.827 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.6 mt -113.71 132.91 61.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.984 0.421 . . . . 0.0 110.419 179.01 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.461 ' OE2' ' CE1' ' A' ' 54' ' ' HIS . 83.4 tt0 -118.08 125.35 50.14 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 178.62 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.438 HD11 HG21 ' A' ' 53' ' ' ILE . 93.4 mt -108.63 123.04 64.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.808 0.813 . . . . 0.0 112.855 -178.155 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.554 ' O ' ' N ' ' A' ' 56' ' ' GLN . 98.0 m-70 -115.85 139.05 50.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.258 -1.337 . . . . 0.0 109.285 179.143 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.482 ' C ' ' O ' ' A' ' 54' ' ' HIS . 83.5 tt0 -39.99 -26.25 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -179.666 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.554 ' N ' ' O ' ' A' ' 54' ' ' HIS . 91.5 mt-30 -64.46 -68.97 0.31 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.027 177.812 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -159.7 -161.89 0.96 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.578 179.81 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -118.41 131.79 56.27 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.517 179.99 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.0 mt -117.57 129.21 74.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-O 121.387 0.613 . . . . 0.0 111.727 -179.301 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 28.2 tp -98.68 127.31 44.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.338 -179.782 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -111.79 135.48 52.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.21 179.858 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 62.7 t-20 -94.77 106.99 19.01 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.42 179.995 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -99.38 -10.38 22.33 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 179.53 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.4 t -76.22 98.62 4.49 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.727 -179.565 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.9 p -80.71 -35.16 33.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.143 0.497 . . . . 0.0 109.768 178.671 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.5 m -65.16 -49.65 69.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.692 179.859 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -136.57 96.35 12.17 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.461 179.535 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -55.38 144.73 71.15 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.105 1.87 . . . . 0.0 112.082 -179.204 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.7 m -73.76 146.81 44.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.332 179.831 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -110.29 141.25 43.54 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.782 179.955 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 42.0 t -127.92 134.27 65.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.426 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.2 m120 52.54 30.53 8.6 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -179.447 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.65 25.47 69.85 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.74 179.792 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 58.3 m -136.52 138.48 41.38 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.452 -179.642 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 44.4 t -68.94 138.28 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.433 179.982 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.9 pt -116.19 85.88 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.202 179.502 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.524 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 15.4 p-10 -66.47 -26.57 67.25 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.538 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -114.04 159.54 35.83 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.333 179.7 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -66.75 149.45 83.61 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.772 2.315 . . . . 0.0 111.822 179.278 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.2 m -141.45 144.42 26.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.692 -179.427 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -71.68 130.72 41.85 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.281 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.9 mt -81.89 138.82 34.95 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.096 0.474 . . . . 0.0 111.93 -178.738 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -130.91 151.65 51.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.715 179.585 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.555 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 4.2 t60 -57.0 121.1 9.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.893 0.378 . . . . 0.0 111.145 -179.228 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.13 -17.28 19.68 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 179.48 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -71.4 134.68 46.83 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.269 0.557 . . . . 0.0 111.082 -179.784 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 68.1 t -111.02 133.86 55.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.713 -179.361 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 79.1 mt -103.58 133.4 47.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.366 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 84.8 m -121.59 131.24 54.01 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.789 0.804 . . . . 0.0 112.589 -178.53 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 76.5 mt -123.47 126.46 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 114.29 -1.323 . . . . 0.0 108.783 179.247 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 44.9 mm 43.42 -107.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.002 -179.253 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.504 ' HB3' ' HE ' ' B' ' 245' ' ' ARG . 45.7 t0 -114.89 16.59 17.22 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.943 0.402 . . . . 0.0 111.048 -179.795 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 17.4 mtp180 -130.78 148.22 52.54 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.067 179.4 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.458 ' HG ' ' CD1' ' A' ' 10' ' ' ILE . 19.4 p -138.64 157.35 46.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.966 0.412 . . . . 0.0 110.839 -179.23 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -124.0 121.62 35.73 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.563 179.086 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -80.2 131.67 35.74 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.306 -179.78 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -96.62 121.28 38.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.955 -179.865 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -121.49 122.87 40.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.118 -179.89 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.555 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 60.4 t-20 -112.27 104.36 12.54 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.324 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 . . . . . 0 C--N 1.326 -0.43 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.583 -179.893 . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.462 0.158 0 CA-C-O 120.944 0.402 . . . . 0.0 111.102 . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.591 ' C ' ' H ' ' B' ' 231' ' ' GLN . 99.0 m-20 -70.56 142.39 51.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.186 179.536 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . 0.632 ' P ' ' H ' ' B' ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.591 ' H ' ' C ' ' B' ' 229' ' ' ASP . 77.2 mt-30 -135.43 26.57 3.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.12 179.664 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -111.3 -140.9 8.4 Favored Glycine 0 CA--C 1.539 1.54 0 N-CA-C 111.636 -0.586 . . . . 0.0 111.636 -179.618 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -77.32 161.61 31.73 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.742 2.295 . . . . 0.0 113.209 -178.943 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . 0.429 HG23 ' HG ' ' A' ' 45' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -60.6 152.07 71.23 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 122.95 2.433 . . . . 0.0 112.38 179.714 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 4.4 p -101.72 129.5 52.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.945 179.381 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 53.2 t -73.65 130.79 40.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.143 -179.341 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -57.48 -24.18 59.91 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 122.824 2.349 . . . . 0.0 112.589 179.77 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 96.3 m -73.5 -46.75 46.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.48 179.3 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . 0.413 ' CE2' ' HD2' ' B' ' 245' ' ' ARG . 72.2 t80 -59.91 -45.35 92.84 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.588 -179.123 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 93.9 mt -64.71 -39.25 93.33 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.018 0.437 . . . . 0.0 110.218 179.397 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -61.75 -42.83 99.48 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.339 -179.368 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -62.37 -40.67 97.21 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.231 179.903 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.504 ' HE ' ' HB3' ' A' ' 92' ' ' ASP . 77.6 mtp85 -60.84 -41.97 96.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.166 -179.943 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.22 -40.8 98.49 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 179.247 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 10.9 t -65.26 -46.71 79.44 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.855 178.448 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -60.12 -39.11 85.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.247 -179.549 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 45.3 t -60.81 -44.21 97.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.291 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -64.83 -30.83 71.85 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.479 179.252 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -83.24 -11.92 57.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.586 -179.775 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.554 ' CD1' ' NH2' ' A' ' 12' ' ' ARG . 77.2 mt -96.04 178.55 5.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.07 0.462 . . . . 0.0 110.091 179.05 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . 0.567 ' O ' ' N ' ' B' ' 255' ' ' ASP . 8.7 p-10 -155.56 -170.49 3.45 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.108 179.668 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . 0.407 ' C ' ' O ' ' B' ' 253' ' ' ASN . 28.7 t70 -39.39 -22.32 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.234 0.54 . . . . 0.0 110.515 -179.706 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' B' ' 253' ' ' ASN . 95.7 m-20 -63.42 -11.07 20.27 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.045 179.666 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' B' ' 253' ' ' ASN . 18.6 p-10 -80.25 20.84 0.64 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.351 -179.957 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . 0.416 ' H ' ' C ' ' B' ' 255' ' ' ASP . 86.4 tttt -58.9 -28.88 66.6 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.003 179.957 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -80.15 130.44 35.23 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 177.938 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.694 ' C ' ' H ' ' B' ' 261' ' ' ILE . 49.2 p-10 -103.39 128.9 50.4 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.37 0.605 . . . . 0.0 111.314 -178.858 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -54.93 5.41 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.7 179.026 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . 0.694 ' H ' ' C ' ' B' ' 259' ' ' ASP . 78.5 mt -101.89 137.58 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 178.312 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 64.6 t -126.64 134.3 66.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.79 -178.95 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -96.73 119.54 35.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.111 0.481 . . . . 0.0 111.231 -178.672 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -64.66 -40.66 95.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.454 179.532 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . 0.728 ' N ' HE21 ' B' ' 265' ' ' GLN . 0.0 OUTLIER -101.96 160.82 25.3 Favored Pre-proline 0 N--CA 1.464 0.247 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.431 -179.242 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -70.94 145.76 51.13 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 122.595 2.197 . . . . 0.0 113.221 -179.105 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.4 pt . . . . . 0 C--N 1.326 -0.434 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.197 178.86 . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo . . . . . 0 N--CA 1.494 1.507 0 CA-C-O 121.191 0.413 . . . . 0.0 112.998 . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.7 p -125.7 28.85 6.1 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.636 179.373 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.596 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 92.4 mtt-85 -88.17 131.49 34.71 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.951 -179.526 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.5 mtp180 -133.27 141.03 47.8 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 120.312 -0.555 . . . . 0.0 112.389 -179.274 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 40.0 tp -117.42 132.97 56.47 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.243 179.488 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 53.0 t -108.37 131.07 59.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.897 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 m -93.71 117.45 30.1 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.346 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.489 ' CD1' ' OD1' ' A' ' 16' ' ' ASP . 48.3 mm -82.27 143.28 12.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.645 179.649 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -90.97 160.48 15.62 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 177.701 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.409 ' CG ' ' NH1' ' A' ' 93' ' ' ARG . 83.4 mtm180 -57.0 -24.48 53.93 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.962 -178.442 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 68.6 p -83.9 -8.26 59.23 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.922 179.754 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.21 35.12 9.03 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 179.887 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 32.2 t -117.3 132.49 66.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 -179.997 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.489 ' OD1' ' CD1' ' A' ' 10' ' ' ILE . 92.4 m-20 -70.04 133.46 47.23 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.656 -0.418 . . . . 0.0 109.952 179.762 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -126.03 -122.26 2.57 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.593 -179.547 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -72.91 145.92 41.18 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.002 1.801 . . . . 0.0 112.575 -179.036 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 54.5 m170 -107.83 143.44 36.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.132 0.491 . . . . 0.0 111.126 -179.331 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -115.04 93.96 36.8 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.069 -179.207 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -56.79 124.4 16.15 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 121.896 1.731 . . . . 0.0 111.681 179.136 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.7 mt -87.79 41.73 1.01 Allowed 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.384 -179.781 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.8 p -64.7 -20.44 66.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.788 179.594 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.8 mt -74.04 142.09 45.73 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.568 179.778 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 73.8 p -61.42 -25.15 67.02 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.362 -179.21 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 45.3 m -134.69 134.33 40.97 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.221 -0.592 . . . . 0.0 111.534 179.917 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.692 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -128.37 120.2 26.51 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.069 178.345 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.522 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 43.4 tp -120.03 124.96 47.18 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.999 -177.02 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.692 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 38.8 m-85 -101.37 140.83 35.12 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.23 179.282 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 158.67 -173.58 35.67 Favored Glycine 0 N--CA 1.464 0.536 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.156 178.269 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.63 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 72.2 mtm-85 -83.29 -30.74 27.33 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.876 0.37 . . . . 0.0 110.21 179.895 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.561 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -56.29 152.08 21.15 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 121.126 -0.559 . . . . 0.0 111.728 -178.26 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.1 tp -66.7 -40.51 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.677 179.958 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -53.69 -21.39 6.92 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.293 179.972 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.561 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 4.2 m -63.88 115.78 5.17 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.118 -179.974 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.594 ' OD1' ' N ' ' A' ' 37' ' ' ILE . 39.2 p-10 -50.97 -24.59 3.79 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.758 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.594 ' N ' ' OD1' ' A' ' 36' ' ' ASP . 94.2 mt -130.67 123.49 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.223 178.062 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.427 HH12 ' HA ' ' B' ' 264' ' ' LYS . 88.2 mtm-85 -103.97 134.66 46.88 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.4 -0.52 . . . . 0.0 109.801 -179.434 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.421 ' C ' ' H ' ' A' ' 41' ' ' LEU . 98.1 mt -117.91 130.54 72.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.064 0.459 . . . . 0.0 109.796 -179.809 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -79.23 30.37 0.22 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.201 -179.043 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.421 ' H ' ' C ' ' A' ' 39' ' ' ILE . 33.9 mt -94.8 123.24 58.44 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.476 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.99 -10.76 26.59 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 121.856 1.704 . . . . 0.0 112.047 -179.386 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.6 m -100.51 8.31 8.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.771 -179.211 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.63 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 42.2 t -100.63 136.75 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.459 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.7 m -67.66 169.47 9.4 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.317 0.579 . . . . 0.0 111.478 -179.179 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -62.26 -40.35 95.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.455 -179.474 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.697 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.1 mt-30 -114.59 -11.19 12.42 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 123.348 0.405 . . . . 0.0 111.357 -179.933 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.8 t60 31.86 -73.45 0.0 OUTLIER 'General case' 0 C--O 1.237 0.423 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 179.649 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.697 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -134.95 139.5 44.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.284 0.564 . . . . 0.0 112.324 -178.621 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -125.42 128.68 48.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.049 179.323 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 94.6 mt -115.45 133.3 62.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.016 -179.552 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -115.5 127.25 55.17 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.859 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.423 HG21 HD13 ' A' ' 53' ' ' ILE . 75.9 mt -108.36 111.99 38.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.95 -179.386 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.538 ' O ' ' N ' ' A' ' 56' ' ' GLN . 82.3 m-70 -110.8 143.94 40.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.541 -179.598 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 54' ' ' HIS . 96.9 mt-10 -41.06 -24.84 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.532 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.538 ' N ' ' O ' ' A' ' 54' ' ' HIS . 94.2 mm-40 -68.8 -68.8 0.37 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.463 178.712 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.554 ' CB ' ' HE ' ' A' ' 81' ' ' ARG . 5.1 tp10 -159.17 -167.76 2.16 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.328 179.895 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.433 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -110.67 125.33 53.34 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.937 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.14 129.54 71.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.353 0.596 . . . . 0.0 112.391 -177.757 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.416 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 49.3 tp -94.72 123.45 38.17 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.38 -179.431 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -111.68 136.47 50.87 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.362 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.41 HD22 ' HA ' ' A' ' 68' ' ' PRO . 48.8 t30 -97.94 105.41 17.55 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.734 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -96.08 -7.32 36.44 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.682 178.976 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.555 ' HG ' ' H ' ' A' ' 67' ' ' ASN . 10.1 t -79.46 100.8 7.85 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.279 178.798 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.0 m -84.74 -17.77 37.26 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.084 0.469 . . . . 0.0 110.025 179.577 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.05 -36.61 15.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.602 -179.845 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.555 ' H ' ' HG ' ' A' ' 64' ' ' SER . 79.5 m-20 -144.12 95.24 5.64 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.398 179.765 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.41 ' HA ' HD22 ' A' ' 62' ' ' ASN . 31.5 Cg_exo -57.96 146.78 85.49 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.128 1.885 . . . . 0.0 112.658 -179.098 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.5 m -70.71 134.89 47.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.278 178.792 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -99.71 139.77 34.89 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.57 179.989 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 31.4 t -130.49 135.93 59.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 178.706 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 53.42 31.72 12.63 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -178.613 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.37 29.5 70.04 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.152 -179.866 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 81.1 p -137.63 130.5 30.16 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 120.446 -0.502 . . . . 0.0 111.999 -179.283 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.4 t -63.7 141.43 18.16 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.935 179.581 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.584 ' CG2' ' O ' ' A' ' 78' ' ' GLU . 96.3 mt -112.14 111.15 34.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.352 179.511 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -76.31 -34.34 59.04 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.801 179.579 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.584 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.1 OUTLIER -131.51 178.13 1.9 Allowed Pre-proline 0 N--CA 1.468 0.445 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.874 -179.734 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 35.5 Cg_exo -57.13 141.5 94.31 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 122.522 2.148 . . . . 0.0 112.739 -179.079 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.4 t -133.19 138.07 52.17 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.132 179.75 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.554 ' HE ' ' CB ' ' A' ' 57' ' ' GLU . 73.3 ttt180 -74.62 131.46 40.94 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.633 179.28 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.2 mt -87.25 140.97 29.01 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.16 0.505 . . . . 0.0 112.272 -178.645 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -134.4 156.12 49.09 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.406 179.59 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.58 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 6.3 t60 -56.77 120.17 7.41 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.868 0.366 . . . . 0.0 111.44 -179.359 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.33 -21.23 22.25 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.52 179.316 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -65.84 135.54 54.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.254 0.55 . . . . 0.0 110.341 -179.788 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.2 t -113.37 133.79 58.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.233 -178.213 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.7 mt -98.35 130.17 47.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.678 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 55.1 m -120.02 124.64 46.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.531 0.682 . . . . 0.0 112.26 -178.818 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 93.3 mt -115.54 124.0 71.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.091 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 27.5 mm 43.89 -106.49 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -178.812 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.608 ' OD1' ' NH2' ' B' ' 245' ' ' ARG . 40.6 p-10 -114.93 12.73 16.9 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.076 0.465 . . . . 0.0 110.473 179.273 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.409 ' NH1' ' CG ' ' A' ' 12' ' ' ARG . 6.1 ttp180 -120.39 143.62 48.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.577 179.732 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 38.2 t -137.7 152.83 49.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.353 0.596 . . . . 0.0 111.371 -178.76 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -120.42 120.73 36.8 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.803 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -84.04 131.69 34.79 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.363 -178.562 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.596 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 84.0 t80 -94.26 124.2 38.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.65 179.813 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -129.92 123.26 30.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.009 0.433 . . . . 0.0 111.638 -179.702 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.58 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 65.0 t-20 -112.56 110.95 21.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.841 179.121 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 99' ' ' ASN . 79.3 mm-40 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.819 0.342 . . . . 0.0 110.48 -179.357 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.453 -0.3 0 CA-C-O 121.25 0.548 . . . . 0.0 110.925 . . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.655 ' C ' ' H ' ' B' ' 231' ' ' GLN . 68.4 t0 -161.08 78.73 0.59 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.544 179.454 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . 0.623 ' O ' ' NE2' ' B' ' 231' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.655 ' H ' ' C ' ' B' ' 229' ' ' ASP . 88.1 mm-40 -131.57 76.77 1.73 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.392 -179.931 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . 0.527 ' O ' ' NH2' ' A' ' 31' ' ' ARG . . . -136.48 172.38 22.5 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.029 -179.476 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.48 159.84 48.15 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 123.983 3.122 . . . . 0.0 113.112 -179.832 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.15 140.37 27.92 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 121.903 1.735 . . . . 0.0 112.889 -178.933 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 31.3 t -59.63 134.78 24.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.794 -179.672 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 8.6 t -62.03 129.78 42.47 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -179.861 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . 0.4 ' O1P' ' OG1' ' B' ' 240' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -60.38 -20.77 64.79 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 121.912 1.742 . . . . 0.0 112.165 179.801 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 240' ' ' THR . . . . . 0.4 ' OG1' ' O1P' ' B' ' 238' ' ' TPO . 76.0 m -72.88 -44.46 61.28 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 178.337 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . 0.426 ' CE2' ' HD2' ' B' ' 245' ' ' ARG . 63.3 t80 -58.75 -47.64 83.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.29 -179.465 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 89.2 mt -64.59 -42.49 95.55 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -179.386 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -65.52 -38.72 90.49 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.521 -0.472 . . . . 0.0 111.136 -179.08 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -61.77 -44.08 97.59 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.855 179.78 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.608 ' NH2' ' OD1' ' A' ' 92' ' ' ASP . 82.2 mtp180 -63.16 -37.66 88.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.089 -179.028 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.82 -39.4 91.65 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.359 -0.537 . . . . 0.0 109.99 179.225 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 61.9 m -67.49 -43.79 80.1 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.571 0.701 . . . . 0.0 109.516 178.274 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -60.82 -37.35 81.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.699 -179.863 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 50.0 t -63.91 -44.7 98.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.185 179.61 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -59.29 -26.35 64.89 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.341 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -95.24 -7.1 39.94 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.153 178.666 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.407 HD23 HH21 ' A' ' 12' ' ' ARG . 58.0 tp -78.54 149.44 33.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.503 -179.44 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -103.7 142.14 34.86 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.083 179.221 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . 0.434 ' C ' ' H ' ' B' ' 256' ' ' ASP . 99.8 m-20 -64.82 -21.72 66.84 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.821 0.343 . . . . 0.0 111.082 -179.229 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -63.4 -5.48 3.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.21 0.529 . . . . 0.0 109.81 179.557 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.572 ' OD1' ' N ' ' B' ' 257' ' ' LYS . 55.5 t0 -66.64 147.95 52.57 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.636 -179.844 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . 0.572 ' N ' ' OD1' ' B' ' 256' ' ' ASP . 99.0 mttt -139.5 159.33 42.41 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.395 179.47 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.527 ' O ' ' C ' ' B' ' 259' ' ' ASP . 13.4 m-20 46.2 16.24 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.058 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.558 ' H ' ' C ' ' B' ' 257' ' ' LYS . 36.2 t0 5.52 -80.96 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 114.477 -1.238 . . . . 0.0 112.037 -179.468 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -141.67 13.14 2.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.0 0.429 . . . . 0.0 110.408 179.518 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 74.0 mt -112.93 137.64 45.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.684 179.978 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . 0.402 ' CG1' ' NH2' ' A' ' 38' ' ' ARG . 41.3 t -126.86 134.15 66.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.906 0.384 . . . . 0.0 110.579 179.891 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -97.55 122.26 40.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.979 0.418 . . . . 0.0 111.961 -178.528 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . 0.427 ' HA ' HH12 ' A' ' 38' ' ' ARG . 87.4 tttt -62.56 -44.9 95.2 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.663 179.578 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -99.52 164.97 15.59 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.01 179.977 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.72 153.13 51.63 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.392 2.062 . . . . 0.0 112.099 179.567 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 36.4 pt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.089 -178.576 . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.445 ' HG2' HH21 ' A' ' 6' ' ' ARG . 73.2 Cg_endo . . . . . 0 N--CA 1.495 1.566 0 CA-C-O 120.71 0.213 . . . . 0.0 112.468 . . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.611 ' HG1' ' H ' ' A' ' 5' ' ' ARG . 51.0 p -116.87 -52.05 2.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.858 179.89 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.611 ' H ' ' HG1' ' A' ' 4' ' ' THR . 99.2 mtt180 -99.52 129.73 45.71 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.556 -178.78 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.445 HH21 ' HG2' ' A' ' 3' ' ' PRO . 99.8 mtt180 -129.23 143.08 50.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.495 -179.726 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 90.9 mt -113.29 136.37 52.82 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.697 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 50.0 t -112.94 131.92 63.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.839 -0.345 . . . . 0.0 110.303 -179.384 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.2 m -90.07 115.88 27.67 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 -177.722 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.413 HD11 HG23 ' A' ' 10' ' ' ILE . 96.8 mt -85.09 142.22 13.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.292 178.153 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -91.42 159.98 15.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.97 0.414 . . . . 0.0 110.515 179.36 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 88.9 mtm180 -58.05 -29.53 65.45 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.792 -179.229 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.1 p -76.75 -17.3 59.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.86 0.362 . . . . 0.0 110.544 179.471 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.93 32.75 5.5 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -179.679 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.4 t -121.35 132.46 70.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.054 0.454 . . . . 0.0 111.106 -179.994 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -78.23 138.44 38.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.667 178.883 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.7 -115.72 1.67 Allowed Glycine 0 CA--C 1.533 1.162 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.467 179.936 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.11 148.56 56.63 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 121.841 1.694 . . . . 0.0 112.433 -179.392 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.467 ' CD2' ' C ' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -113.13 158.05 20.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.016 0.436 . . . . 0.0 109.921 179.701 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -120.53 101.31 46.32 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.164 -179.044 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -75.2 131.41 14.04 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.016 1.811 . . . . 0.0 111.891 -179.617 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 83.8 mt -86.71 85.32 7.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.158 0.504 . . . . 0.0 112.043 -178.486 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 92.6 p -89.01 -9.68 50.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.194 178.058 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 47.2 mt -104.45 148.12 26.81 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.071 -179.816 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.5 m -70.83 -16.23 62.7 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.498 -179.463 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.421 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 55.8 m -131.31 134.11 46.03 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.752 -179.916 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.6 t -129.63 120.54 25.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.955 178.179 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.431 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 35.3 tp -116.4 129.82 56.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.887 -179.078 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.528 ' O ' ' O ' ' A' ' 47' ' ' GLN . 9.8 m-85 -108.95 139.11 44.26 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.697 179.904 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.94 -178.71 29.05 Favored Glycine 0 N--CA 1.47 0.925 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.161 178.316 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 46.9 mtm180 -67.14 -33.29 75.12 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 179.381 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.54 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -46.78 131.8 12.29 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 -178.812 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.437 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 9.3 tp -64.79 -42.03 93.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 O-C-N 122.434 -0.451 . . . . 0.0 110.024 179.387 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.437 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 7.9 pt-20 -56.4 -13.01 1.93 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.228 179.292 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.54 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 31.3 m -70.16 139.15 52.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.595 -179.301 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.431 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 57.2 m-20 -63.77 -34.74 78.58 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.329 -179.505 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.423 HG22 HD12 ' A' ' 37' ' ' ILE . 40.6 mm -122.22 112.82 36.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 177.978 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 15.9 ttp180 -101.83 130.88 48.38 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.596 -178.636 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.431 ' C ' ' H ' ' A' ' 41' ' ' LEU . 93.2 mt -118.68 131.85 70.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.157 -179.395 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -76.03 32.45 0.12 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.606 -179.528 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.686 ' CD1' HH21 ' A' ' 93' ' ' ARG . 20.3 mt -95.55 118.46 66.14 Favored Pre-proline 0 CA--C 1.534 0.355 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.507 179.499 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -73.36 -11.4 24.7 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 121.908 1.739 . . . . 0.0 111.985 -179.922 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.1 m -95.39 5.26 8.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.207 179.431 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.0 t -98.69 139.84 19.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.577 -179.464 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.406 ' OG ' ' OG ' ' A' ' 64' ' ' SER . 75.3 m -68.73 175.18 3.71 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.682 0.753 . . . . 0.0 111.315 -179.589 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -65.12 -43.17 92.82 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.958 -179.699 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.616 ' O ' ' N ' ' A' ' 49' ' ' CYS . 81.9 mt-30 -113.77 -12.72 12.72 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.542 -179.682 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.9 t60 38.7 -76.89 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 178.873 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.616 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -135.58 140.32 44.56 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.252 0.548 . . . . 0.0 111.812 -178.657 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -125.51 132.65 52.58 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.788 179.891 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.5 mt -116.42 134.1 60.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.918 179.49 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.438 ' CG ' ' NE2' ' A' ' 54' ' ' HIS . 47.2 tp10 -119.96 128.6 53.73 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.369 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.463 ' CG2' ' NH1' ' A' ' 5' ' ' ARG . 96.8 mt -105.57 123.54 60.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.591 0.71 . . . . 0.0 112.159 -178.678 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.569 ' O ' ' N ' ' A' ' 56' ' ' GLN . 3.3 m-70 -120.54 139.9 52.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.452 -179.752 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.467 ' C ' ' O ' ' A' ' 54' ' ' HIS . 83.9 tt0 -39.3 -25.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.73 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' A' ' 54' ' ' HIS . 67.9 tp60 -69.11 -68.2 0.42 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.096 178.301 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.443 ' HA ' HH22 ' A' ' 5' ' ' ARG . 8.8 pt-20 -160.03 -157.52 0.56 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.708 179.64 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.73 132.3 55.87 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.505 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.448 ' CG2' ' NE2' ' A' ' 61' ' ' HIS . 45.5 mm -111.08 127.54 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 121.051 -0.26 . . . . 0.0 111.636 -178.65 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 28.8 tp -103.51 125.3 49.99 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.955 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.448 ' NE2' ' CG2' ' A' ' 59' ' ' ILE . 97.9 m-70 -118.37 139.49 51.3 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.486 -179.211 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -102.7 107.86 18.91 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.596 179.741 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -94.83 -7.8 39.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.66 179.142 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.406 ' OG ' ' OG ' ' A' ' 45' ' ' SER . 0.1 OUTLIER -86.09 99.7 11.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.856 0.36 . . . . 0.0 110.878 -179.861 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.6 p -77.39 -32.91 55.15 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.885 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.7 m -63.55 -49.35 73.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.221 -179.405 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -136.55 91.92 15.6 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.957 -179.626 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.77 143.55 69.99 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.157 1.904 . . . . 0.0 112.568 -179.599 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.8 m -74.71 138.07 42.51 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.839 179.246 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -100.12 140.48 34.28 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.271 179.636 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.453 ' O ' ' N ' ' A' ' 74' ' ' SER . 5.1 p -131.59 136.42 57.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 178.939 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 48.35 31.98 3.0 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -178.675 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.84 29.48 63.05 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.437 -179.831 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.453 ' N ' ' O ' ' A' ' 71' ' ' VAL . 19.5 m -140.34 133.5 29.56 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 120.58 -0.448 . . . . 0.0 112.112 -179.479 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.0 t -70.43 139.06 20.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.475 179.152 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.7 pt -112.26 94.37 3.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.117 0.484 . . . . 0.0 111.266 179.814 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -65.22 -29.08 69.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.974 178.956 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.0 176.1 2.85 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.392 -179.979 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -59.93 144.08 99.51 Favored 'Trans proline' 0 N--CA 1.5 1.899 0 C-N-CA 122.515 2.143 . . . . 0.0 112.591 -179.776 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.1 p -136.7 141.26 41.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.521 179.679 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -81.02 130.21 34.91 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.473 179.377 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.5 mt -83.61 141.3 31.64 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.039 0.447 . . . . 0.0 111.642 -179.791 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -130.75 151.16 51.49 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.909 179.171 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.468 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 4.3 t60 -52.12 118.66 3.65 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.001 0.429 . . . . 0.0 111.587 -178.637 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.03 -13.57 37.53 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 179.455 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -67.99 135.37 52.23 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.19 179.831 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.4 t -112.44 133.29 58.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.81 -178.205 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 92.8 mt -104.53 132.35 51.36 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.643 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 58.8 m -119.39 128.0 53.66 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.325 -0.55 . . . . 0.0 112.112 -178.766 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 98.2 mt -122.08 124.83 72.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.846 178.588 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 26.0 mm 41.45 -114.99 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 121.068 -0.253 . . . . 0.0 110.629 -178.837 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -101.56 12.94 36.38 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.767 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.686 HH21 ' CD1' ' A' ' 41' ' ' LEU . 11.4 mtm180 -131.46 149.07 52.67 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.382 -179.497 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 71.7 m -135.49 154.15 51.51 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.008 0.432 . . . . 0.0 111.337 -179.631 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -120.49 120.52 36.12 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.539 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 78.1 mtp85 -85.22 136.79 33.37 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 120.308 -0.557 . . . . 0.0 111.059 -179.238 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 92.2 t80 -96.5 118.81 33.79 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.402 -179.625 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -122.7 122.95 40.0 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.755 0.312 . . . . 0.0 111.0 179.549 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.468 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 52.7 t-20 -101.54 101.9 12.55 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.717 179.733 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.042 179.413 . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.152 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 . . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.501 ' O ' ' CB ' ' B' ' 230' ' ' SEP . 52.2 m-20 -64.61 -35.72 81.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.289 -179.825 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . 0.501 ' CB ' ' O ' ' B' ' 229' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.555 ' O ' ' O ' ' B' ' 232' ' ' GLY . 1.3 pt20 -140.04 0.14 1.72 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.99 179.997 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . 0.555 ' O ' ' O ' ' B' ' 231' ' ' GLN . . . -51.21 -153.07 0.01 OUTLIER Glycine 0 CA--C 1.532 1.111 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.088 -179.347 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -75.02 162.07 37.67 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 122.884 2.389 . . . . 0.0 113.053 -178.929 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.64 139.0 22.2 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.238 1.959 . . . . 0.0 113.652 -178.782 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -68.48 140.27 19.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.648 -179.74 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 19.4 t -69.51 135.98 50.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.734 -179.858 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . 0.453 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . 0.453 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 50.0 Cg_exo -58.48 -28.86 86.83 Favored 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 123.322 2.681 . . . . 0.0 113.431 -179.294 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 240' ' ' THR . . . . . 0.431 ' OG1' ' O3P' ' B' ' 238' ' ' TPO . 59.5 m -73.9 -43.51 58.24 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.18 0.514 . . . . 0.0 109.698 178.358 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -58.93 -45.81 89.49 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.558 -179.243 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 91.1 mt -64.77 -40.87 95.99 Favored 'General case' 0 CA--C 1.521 -0.161 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.192 -179.429 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -59.96 -40.72 89.99 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.05 -179.638 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 62.0 ttp180 -62.39 -43.32 99.11 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.792 0.33 . . . . 0.0 110.794 179.786 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.594 ' NH1' ' OE1' ' B' ' 248' ' ' GLN . 1.9 mpt_? -59.32 -43.73 92.64 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.111 -179.307 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.7 -40.96 98.77 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.838 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 65.6 m -64.38 -45.21 88.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.411 0.624 . . . . 0.0 109.327 178.194 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . 0.594 ' OE1' ' NH1' ' B' ' 245' ' ' ARG . 80.4 mt-30 -60.36 -37.38 80.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.116 -179.81 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 48.7 t -60.34 -45.21 96.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.325 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -60.68 -27.27 67.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.535 178.595 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -85.18 -11.57 54.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.573 179.933 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 96.3 mt -111.22 -179.37 3.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.344 179.398 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . 0.543 ' OD1' ' N ' ' B' ' 256' ' ' ASP . 46.2 p30 -138.33 171.48 14.32 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.219 0.533 . . . . 0.0 111.42 -179.753 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -68.37 -21.76 64.69 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.788 179.837 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -81.84 -6.76 59.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.089 179.921 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.543 ' N ' ' OD1' ' B' ' 253' ' ' ASN . 66.2 t0 -88.23 94.68 9.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.923 0.392 . . . . 0.0 110.39 179.951 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -76.73 -176.65 3.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.906 -178.69 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' B' ' 260' ' ' GLU . 90.3 m-20 62.09 50.42 4.03 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.879 -179.138 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . . . . . . . . . 46.4 p30 -63.21 63.69 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.699 -179.574 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.553 ' N ' ' O ' ' B' ' 258' ' ' ASP . 93.6 mt-10 59.35 5.6 0.63 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.215 179.574 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 81.0 mt -109.77 131.97 59.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.194 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 40.4 t -124.06 132.67 70.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.348 -179.807 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -94.42 117.23 29.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.104 0.478 . . . . 0.0 111.108 -178.509 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -67.87 -46.59 71.28 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.513 179.949 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.17 163.43 23.44 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.223 -178.96 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -60.33 149.59 85.0 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.177 1.918 . . . . 0.0 112.031 179.857 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.3 pt . . . . . 0 C--N 1.328 -0.344 0 CA-C-O 121.485 0.66 . . . . 0.0 111.886 -178.396 . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo . . . . . 0 N--CA 1.49 1.296 0 CA-C-O 120.956 0.315 . . . . 0.0 111.455 . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.1 p -115.32 -27.31 7.27 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.209 179.305 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.422 ' HG2' ' HH ' ' A' ' 97' ' ' TYR . 87.2 mtm-85 -93.5 111.3 22.94 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.098 0.475 . . . . 0.0 110.392 -179.372 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.747 ' NH2' ' HD1' ' A' ' 19' ' ' HIS . 79.5 ttt180 -127.44 131.22 50.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.184 -179.776 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 80.0 mt -110.12 135.64 50.6 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.832 179.952 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.506 ' CG2' ' NH2' ' A' ' 96' ' ' ARG . 89.0 t -106.74 120.38 57.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.479 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.509 ' OG1' ' O ' ' A' ' 18' ' ' PRO . 70.0 p -77.45 140.81 39.91 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.576 0.703 . . . . 0.0 110.99 -179.05 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 51.0 mm -103.76 130.18 54.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.619 -179.791 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.44 ' HA ' HH12 ' A' ' 93' ' ' ARG . 95.9 mttt -83.98 154.99 23.01 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.889 178.001 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.528 HH22 ' CB ' ' B' ' 248' ' ' GLN . 75.8 mtp180 -56.61 -34.3 67.09 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.532 -179.214 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.43 ' HG ' HG12 ' B' ' 249' ' ' VAL . 67.4 m -76.76 -6.13 50.98 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.428 179.093 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.32 32.09 10.92 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.529 179.482 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.0 t -113.53 132.25 62.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.794 0.331 . . . . 0.0 110.639 -179.998 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -73.13 136.28 44.81 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.503 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -130.75 -115.98 1.78 Allowed Glycine 0 CA--C 1.534 1.279 0 C-N-CA 120.18 -1.009 . . . . 0.0 112.886 -178.855 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.509 ' O ' ' OG1' ' A' ' 9' ' ' THR . 61.2 Cg_endo -70.81 143.18 45.1 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 122.24 1.96 . . . . 0.0 112.937 -177.952 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.747 ' HD1' ' NH2' ' A' ' 6' ' ' ARG . 57.4 m170 -110.29 123.08 49.15 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.446 179.591 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -98.04 109.07 50.1 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.907 -179.513 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -79.03 139.09 14.95 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 121.344 1.363 . . . . 0.0 111.707 179.373 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.426 ' CD2' ' SG ' ' A' ' 27' ' ' CYS . 74.3 mt -91.66 50.13 1.67 Allowed 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.205 -178.967 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.8 t -63.82 -17.44 63.12 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 119.45 -0.9 . . . . 0.0 108.692 178.968 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 46.2 mt -78.65 138.45 38.32 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.875 179.951 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.15 -23.05 65.27 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.608 -179.274 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 94.5 m -133.78 134.91 43.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.561 179.147 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.426 ' SG ' ' CD2' ' A' ' 22' ' ' LEU . 6.1 t -124.37 118.43 26.71 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.536 179.008 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 44.4 tp -115.49 131.63 56.87 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.224 0.535 . . . . 0.0 111.78 -178.421 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.543 ' O ' ' O ' ' A' ' 47' ' ' GLN . 2.3 m-85 -111.2 138.96 46.99 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.572 179.865 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 150.85 179.21 26.4 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.539 178.68 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 45.7 mtm180 -70.22 -33.04 71.19 Favored 'General case' 0 C--O 1.227 -0.123 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 179.795 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.616 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -51.32 148.05 9.21 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.193 -179.065 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.406 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 11.0 tp -67.5 -39.72 83.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.217 -0.593 . . . . 0.0 109.508 179.54 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.406 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 98.4 mt-10 -53.06 -21.55 4.79 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.261 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.616 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 48.3 m -55.84 118.51 4.66 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.706 -179.597 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -59.72 -32.79 70.86 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -179.924 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 91.1 mt -123.5 120.96 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 176.256 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -109.04 135.33 50.38 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.949 -177.326 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.45 ' C ' ' H ' ' A' ' 41' ' ' LEU . 95.1 mt -119.87 130.27 74.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.618 -179.652 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -75.17 25.67 0.1 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.473 -179.099 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.45 ' H ' ' C ' ' A' ' 39' ' ' ILE . 24.3 mt -88.9 123.26 67.97 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.184 -179.915 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -73.28 -10.15 23.87 Favored 'Trans proline' 0 N--CA 1.49 1.285 0 C-N-CA 121.877 1.718 . . . . 0.0 112.548 179.714 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.0 m -97.97 8.26 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.114 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.555 179.442 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 25.5 t -101.26 139.56 22.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.449 179.068 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.1 m -74.11 171.85 12.8 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.061 0.458 . . . . 0.0 111.444 -178.974 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.6 mttp -61.37 -42.46 98.75 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.245 -178.778 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.62 ' O ' ' N ' ' A' ' 49' ' ' CYS . 95.5 mt-30 -112.81 -15.96 12.83 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.575 0.226 . . . . 0.0 111.162 -179.163 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 18.5 t60 37.25 -75.64 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 179.071 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.62 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.76 137.82 48.34 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.266 0.555 . . . . 0.0 111.366 -177.661 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -129.71 134.05 47.41 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.156 -179.983 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.4 mt -118.34 135.57 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.682 -179.688 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -112.78 127.84 56.26 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.638 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.4 mm -100.55 125.76 54.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 119.674 -0.81 . . . . 0.0 110.712 -179.668 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.456 ' O ' ' N ' ' A' ' 56' ' ' GLN . 94.7 m-70 -130.35 136.22 48.87 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.307 179.806 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 54' ' ' HIS . 42.7 tt0 -40.74 -28.85 0.08 Allowed 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.217 -0.593 . . . . 0.0 109.845 -179.272 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.456 ' N ' ' O ' ' A' ' 54' ' ' HIS . 55.0 tt0 -65.99 -68.28 0.38 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.301 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -158.37 -164.55 1.5 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.801 179.737 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -118.3 135.13 54.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.983 0.42 . . . . 0.0 110.394 179.775 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.05 130.27 74.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.564 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 50.1 tp -93.17 126.69 38.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.546 178.923 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -113.91 134.32 54.89 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.236 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 31.5 t30 -97.59 104.27 16.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.955 -179.481 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -96.44 -9.69 29.22 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.677 178.86 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.2 m -72.19 98.17 2.1 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.693 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.5 p -77.34 -36.1 54.15 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.705 0.765 . . . . 0.0 109.231 178.644 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.8 m -65.23 -48.57 72.83 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.387 -1.279 . . . . 0.0 110.78 -179.147 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -142.04 100.76 5.87 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.201 -179.128 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.18 145.75 85.11 Favored 'Trans proline' 0 N--CA 1.5 1.872 0 C-N-CA 122.022 1.815 . . . . 0.0 111.858 -179.564 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.3 m -72.49 141.87 48.56 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.199 0.523 . . . . 0.0 110.548 -179.642 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -101.0 141.61 33.64 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.805 -179.606 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.5 t -131.27 136.52 57.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 177.25 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 54.04 31.41 13.6 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -178.795 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.85 24.01 76.83 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.004 179.65 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 44.1 t -134.99 137.26 42.85 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.325 0.583 . . . . 0.0 111.527 -179.737 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.3 t -68.04 139.87 20.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.076 -179.544 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.585 ' CG2' ' O ' ' A' ' 78' ' ' GLU . 95.9 mt -113.88 116.77 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.986 179.407 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -90.74 -24.15 20.47 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.712 179.054 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.585 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.2 OUTLIER -128.9 168.18 16.91 Favored Pre-proline 0 C--O 1.222 -0.388 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.879 -178.669 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -66.28 148.02 84.09 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 122.463 2.109 . . . . 0.0 112.7 -179.941 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.1 m -141.18 151.93 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.164 179.976 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -78.53 129.23 34.6 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.485 179.345 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.9 mt -82.42 140.56 33.37 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.931 0.396 . . . . 0.0 110.736 -179.114 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -129.92 151.94 49.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.552 179.745 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.447 ' C ' ' CD2' ' A' ' 84' ' ' HIS . 7.5 t60 -56.5 119.98 6.96 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.165 -178.89 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.17 -18.13 23.79 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 121.155 -0.545 . . . . 0.0 111.767 179.128 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -69.51 133.23 47.44 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.331 179.912 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.0 t -107.76 136.9 41.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.45 -178.6 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.463 ' O ' ' OG ' ' A' ' 94' ' ' SER . 95.3 mt -103.07 129.1 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 178.167 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 96.2 m -120.33 127.32 52.23 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 119.913 -0.715 . . . . 0.0 112.025 -178.532 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.566 ' N ' ' O ' ' A' ' 93' ' ' ARG . 90.7 mt -116.5 134.86 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 CA-C-N 115.023 -0.989 . . . . 0.0 108.961 178.229 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.507 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 47.1 mt -29.13 97.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.415 -178.807 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.507 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 1.4 m-20 92.05 -22.4 0.08 Allowed 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 112.872 0.694 . . . . 0.0 112.872 178.047 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.721 HH21 ' CD1' ' B' ' 261' ' ' ILE . 25.2 mmm180 -131.04 143.73 50.92 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.17 -179.734 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 88' ' ' ILE . 43.2 t -138.38 152.25 48.24 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.975 0.417 . . . . 0.0 110.421 -179.901 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.408 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 71.4 m-85 -127.26 123.36 36.29 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.353 179.659 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.506 ' NH2' ' CG2' ' A' ' 8' ' ' VAL . 38.3 ttp-105 -90.31 135.58 33.59 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.487 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.422 ' HH ' ' HG2' ' A' ' 5' ' ' ARG . 81.4 t80 -98.93 127.89 44.96 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -178.489 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -134.0 120.68 20.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.28 179.552 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.44 ' OD1' ' ND1' ' A' ' 84' ' ' HIS . 43.1 p-10 -96.22 3.3 53.23 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.338 -179.949 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.092 179.661 . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 34.8 m . . . . . 0 CA--C 1.521 -0.165 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.461 ' C ' ' H ' ' B' ' 231' ' ' GLN . 67.9 t0 -87.26 117.08 25.78 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.581 -0.447 . . . . 0.0 110.125 -179.968 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.461 ' H ' ' C ' ' B' ' 229' ' ' ASP . 20.6 mp0 -126.33 41.86 3.43 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.204 179.539 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -117.14 -177.02 17.71 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.101 -0.571 . . . . 0.0 111.749 -179.604 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -66.67 156.55 65.23 Favored 'Trans proline' 0 N--CA 1.5 1.896 0 C-N-CA 123.312 2.675 . . . . 0.0 112.817 179.499 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.08 140.22 34.1 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 121.467 1.445 . . . . 0.0 113.936 -178.79 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.19 139.62 20.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.7 179.854 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 4.0 t -62.61 125.25 23.31 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.569 -178.575 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -62.81 -21.08 72.77 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.489 2.126 . . . . 0.0 112.735 -178.61 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 2.8 m -74.78 -43.65 53.66 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 177.898 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . 0.57 ' CZ ' ' NH2' ' B' ' 245' ' ' ARG . 79.0 t80 -58.36 -46.91 85.39 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.499 -179.374 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 95.9 mt -67.78 -39.3 84.07 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.058 179.384 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 73.3 tt0 -61.07 -41.56 96.86 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.539 179.906 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . 0.625 ' NH1' ' NE2' ' B' ' 248' ' ' GLN . 78.4 ttt-85 -64.12 -40.98 97.36 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.245 0.545 . . . . 0.0 109.653 179.538 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.57 ' NH2' ' CZ ' ' B' ' 241' ' ' PHE . 10.1 tpp180 -57.33 -42.7 82.42 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.054 -179.525 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.48 -41.45 98.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.445 179.824 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 47.1 t -63.27 -45.07 93.2 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.468 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . 0.625 ' NE2' ' NH1' ' B' ' 244' ' ' ARG . 84.6 mt-30 -60.67 -32.53 71.73 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.473 179.655 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . 0.43 HG12 ' HG ' ' A' ' 13' ' ' SER . 72.5 t -62.29 -45.98 97.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 119.977 -0.689 . . . . 0.0 109.477 179.52 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -58.69 -29.71 66.84 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.441 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -91.43 -12.14 35.62 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.494 179.043 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.491 ' N ' ' O ' ' B' ' 248' ' ' GLN . 55.1 tp -73.83 136.32 43.5 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.915 0.388 . . . . 0.0 111.12 -179.123 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -99.27 124.28 44.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.211 -179.543 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . 0.455 ' C ' ' H ' ' B' ' 256' ' ' ASP . 44.2 m-20 -63.33 -33.43 75.51 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.331 0.586 . . . . 0.0 109.912 178.558 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -61.34 2.55 0.15 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.638 -179.223 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.669 ' O ' ' N ' ' B' ' 258' ' ' ASP . 88.4 m-20 -96.78 -8.04 32.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.192 0.52 . . . . 0.0 109.738 179.16 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt 37.46 15.52 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.101 179.572 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.669 ' N ' ' O ' ' B' ' 256' ' ' ASP . 49.2 t0 -138.1 108.12 6.37 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.613 -179.509 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.449 ' CB ' ' NH1' ' A' ' 93' ' ' ARG . 80.8 m-20 -87.37 -90.11 0.12 Allowed 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.241 -0.584 . . . . 0.0 111.384 179.631 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -146.49 20.58 1.34 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 119.794 -0.762 . . . . 0.0 112.357 -179.243 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . 0.721 ' CD1' HH21 ' A' ' 93' ' ' ARG . 66.0 mt -112.97 133.93 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.254 179.888 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 45.9 t -124.18 132.63 71.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.743 178.918 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -97.13 118.66 34.04 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.377 0.608 . . . . 0.0 111.909 -178.131 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -62.41 -44.19 97.02 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.767 178.813 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -84.55 162.31 51.13 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.366 -179.809 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -65.59 144.96 80.69 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.095 1.863 . . . . 0.0 112.44 179.9 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.536 0.435 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.551 -179.896 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo . . . . . 0 N--CA 1.495 1.595 0 CA-C-O 120.822 0.259 . . . . 0.0 112.236 . . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 72.3 p -108.07 -52.81 2.71 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.446 -179.7 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.8 mtt85 -88.57 132.0 34.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.554 179.718 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 19.5 ptp180 -139.02 148.67 43.72 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 120.029 -0.668 . . . . 0.0 111.717 179.877 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 67.1 mt -115.26 144.8 43.18 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.766 179.676 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.6 t -117.37 124.83 73.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.475 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.1 m -73.73 138.12 44.44 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.927 0.394 . . . . 0.0 111.846 -179.079 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.426 HD11 HG22 ' A' ' 10' ' ' ILE . 78.8 mt -111.31 137.11 45.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.377 178.079 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -92.76 155.11 17.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.663 179.868 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.825 HH11 HH11 ' B' ' 245' ' ' ARG . 90.6 mtm180 -58.1 -23.73 55.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.505 -179.126 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.8 p -81.97 -10.15 59.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.1 0.476 . . . . 0.0 109.736 179.031 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.55 34.58 7.83 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 -179.819 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.6 t -122.45 133.31 69.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.706 0.288 . . . . 0.0 110.903 -179.959 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -74.99 141.06 44.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.861 179.844 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.04 -118.96 2.13 Favored Glycine 0 CA--C 1.542 1.727 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.369 -179.309 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.11 145.53 44.55 Favored 'Trans proline' 0 N--CA 1.501 1.918 0 C-N-CA 122.517 2.145 . . . . 0.0 114.065 -177.932 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 57.8 m170 -105.56 139.08 40.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.248 179.842 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -112.15 104.6 56.12 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 108.957 -0.756 . . . . 0.0 108.957 179.505 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -75.47 133.42 15.88 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 C-N-CA 121.404 1.403 . . . . 0.0 110.772 -178.983 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.2 mt -87.81 59.18 5.25 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 119.879 -0.728 . . . . 0.0 111.784 -178.187 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.2 p -67.61 -21.13 65.41 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.473 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.549 ' CD1' ' NE2' ' B' ' 265' ' ' GLN . 70.2 mt -84.01 140.69 31.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.628 -179.686 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 77.7 p -62.56 -21.31 65.49 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.78 -179.507 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.505 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 65.5 m -131.94 132.82 43.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.848 0.356 . . . . 0.0 111.748 -179.234 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.1 t -124.86 118.51 26.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.302 178.242 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 45.5 tp -115.95 128.45 55.76 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.439 -178.908 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.469 ' O ' ' O ' ' A' ' 47' ' ' GLN . 6.3 m-85 -106.51 136.0 47.04 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.335 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 159.02 -169.64 35.29 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 119.727 -1.225 . . . . 0.0 112.402 178.854 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.525 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 42.1 mtm180 -87.34 -31.1 20.34 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.418 179.376 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.416 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -50.82 148.18 7.89 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -179.735 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 36.9 mm -63.98 -43.73 97.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 O-C-N 122.611 -0.346 . . . . 0.0 111.046 -179.409 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -53.69 -18.12 2.8 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.82 -179.511 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.416 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 70.3 m -59.68 123.47 17.04 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 121.13 0.49 . . . . 0.0 111.189 -179.449 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.505 ' OD2' ' O ' ' A' ' 26' ' ' THR . 71.1 m-20 -60.77 -29.95 69.73 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.804 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.428 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 95.6 mt -127.17 123.95 63.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.241 -0.89 . . . . 0.0 108.822 177.492 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 38' ' ' ARG . 26.8 mtm180 -107.18 138.11 43.99 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.283 -179.107 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.435 ' C ' ' H ' ' A' ' 41' ' ' LEU . 95.9 mt -119.26 128.63 75.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.445 -179.911 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -73.16 30.72 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.123 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.435 ' H ' ' C ' ' A' ' 39' ' ' ILE . 94.0 mt -108.19 128.31 25.95 Favored Pre-proline 0 N--CA 1.464 0.257 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.649 179.137 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.75 -8.87 21.99 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.488 2.125 . . . . 0.0 112.107 179.953 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.7 m -93.13 4.22 7.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 121.209 0.528 . . . . 0.0 110.274 179.293 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.525 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 20.4 t -95.13 133.7 35.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.512 -0.767 . . . . 0.0 108.941 178.332 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.455 ' HG ' ' H ' ' A' ' 46' ' ' LYS . 8.2 t -70.41 170.52 11.78 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.287 0.565 . . . . 0.0 111.506 -178.266 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.455 ' H ' ' HG ' ' A' ' 45' ' ' SER . 52.2 mttp -62.97 -42.57 99.87 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.132 -179.444 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.607 ' O ' ' N ' ' A' ' 49' ' ' CYS . 87.1 mt-30 -114.49 -22.9 9.59 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 123.436 0.46 . . . . 0.0 110.709 -179.808 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.3 t60 37.13 -75.83 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 179.502 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.607 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -128.36 134.04 48.77 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.101 0.477 . . . . 0.0 111.955 -177.817 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -128.87 136.94 51.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.608 -179.932 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.7 mt -121.93 135.94 60.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.978 -179.932 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -113.85 127.1 55.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.634 178.973 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 48.8 mm -96.1 114.3 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-O 121.174 0.512 . . . . 0.0 111.555 -179.522 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.463 ' O ' ' N ' ' A' ' 56' ' ' GLN . 94.6 m-70 -117.54 134.61 54.68 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.622 178.684 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.512 ' OE1' ' N ' ' A' ' 55' ' ' GLU . 57.6 mp0 -39.72 -29.72 0.06 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -179.718 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.463 ' N ' ' O ' ' A' ' 54' ' ' HIS . 87.7 mt-30 -66.55 -67.87 0.42 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.545 178.735 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.11 -165.18 1.77 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.698 -179.275 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -120.28 129.46 54.04 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.569 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.4 mt -114.05 130.66 67.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -178.493 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 51.2 tp -94.59 124.54 38.69 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.884 179.585 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -112.84 137.6 50.94 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.099 -179.232 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.558 ' ND2' ' O ' ' A' ' 76' ' ' ILE . 50.7 p-10 -98.33 104.57 16.61 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.866 -179.841 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -93.88 -7.28 43.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.162 0.506 . . . . 0.0 109.825 178.328 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.43 ' HG ' ' H ' ' A' ' 67' ' ' ASN . 4.4 t -75.21 100.9 4.45 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.013 179.531 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.9 m -87.46 -9.31 54.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.234 -179.962 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.16 -41.92 8.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.09 0.472 . . . . 0.0 109.829 -179.85 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.43 ' H ' ' HG ' ' A' ' 64' ' ' SER . 40.9 m-20 -140.59 101.29 6.65 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.746 179.586 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -56.02 143.32 83.54 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 121.996 1.797 . . . . 0.0 112.24 -179.466 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 92.4 m -70.78 138.33 50.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.27 178.763 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -98.3 139.63 33.79 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.058 -179.999 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 55.5 t -133.5 132.38 57.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.288 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 53.22 34.31 17.31 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.612 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.5 29.02 66.51 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 114.958 -1.019 . . . . 0.0 112.53 179.928 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 47.3 t -145.72 142.42 28.94 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.924 179.763 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.0 m -74.75 140.24 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.515 179.278 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.558 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 4.6 pt -105.34 98.91 7.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.618 0.723 . . . . 0.0 109.901 178.781 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -63.86 -34.66 78.44 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.573 -179.705 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.458 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 1.2 mt-10 -128.9 -178.78 0.85 Allowed Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.748 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.458 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 25.0 Cg_exo -61.42 142.43 95.49 Favored 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 122.192 1.928 . . . . 0.0 113.03 -178.813 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 78.0 t -132.72 137.53 53.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.159 179.736 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -75.99 128.51 35.2 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.576 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.6 mt -84.01 136.43 34.05 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.99 -179.702 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -120.53 149.94 41.63 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.767 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.59 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 6.1 t60 -55.31 123.88 15.25 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.995 -178.603 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.05 -13.55 52.46 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.513 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -71.24 136.91 48.22 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.49 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.4 p -105.5 140.42 23.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.776 -0.37 . . . . 0.0 111.38 -178.815 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 72.1 mt -108.25 130.81 60.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.092 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 53.5 m -126.39 128.8 47.6 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -177.355 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.428 ' N ' ' O ' ' A' ' 93' ' ' ARG . 91.4 mt -112.66 121.67 65.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 114.228 -1.351 . . . . 0.0 107.354 177.197 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.418 ' CG2' ' N ' ' A' ' 92' ' ' ASP . 97.0 mt 35.57 -99.01 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.751 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.418 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 94.5 m-20 -110.38 8.62 23.37 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -178.982 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.493 HH21 HG13 ' B' ' 261' ' ' ILE . 50.3 mtp85 -127.12 144.26 51.07 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -179.846 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.4 ' OG ' ' CD1' ' A' ' 10' ' ' ILE . 19.4 p -141.28 159.28 42.54 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.37 0.605 . . . . 0.0 112.217 -178.458 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -129.24 125.01 35.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.084 178.231 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -82.12 135.16 35.34 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 119.769 -0.773 . . . . 0.0 110.49 179.967 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -97.2 122.92 40.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.323 0.582 . . . . 0.0 111.091 -179.271 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -124.31 117.16 23.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.533 179.455 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.59 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 64.7 t-20 -93.81 120.18 33.74 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.704 -179.747 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 70.6 tt0 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.032 179.792 . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . 0.432 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 3.3 m . . . . . 0 C--O 1.237 0.404 0 CA-C-O 120.607 0.242 . . . . 0.0 110.938 . . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.552 ' O ' ' CB ' ' B' ' 230' ' ' SEP . 28.8 t0 -74.96 89.2 2.38 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.898 -178.27 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . 0.552 ' CB ' ' O ' ' B' ' 229' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.58 50.83 1.85 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.192 -179.948 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . 0.511 ' CA ' HH12 ' A' ' 31' ' ' ARG . . . -108.03 -173.25 21.88 Favored Glycine 0 CA--C 1.533 1.201 0 N-CA-C 111.689 -0.564 . . . . 0.0 111.689 179.429 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . 0.482 ' O ' ' NH2' ' A' ' 31' ' ' ARG . 85.0 Cg_endo -77.54 162.76 30.19 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 123.815 3.01 . . . . 0.0 112.485 179.843 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -57.43 137.97 83.97 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 121.946 1.764 . . . . 0.0 112.067 179.059 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 53.3 t -62.61 135.42 27.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.559 179.666 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 14.9 t -56.58 118.22 4.63 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.413 -179.511 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.71 -26.64 47.94 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.553 2.169 . . . . 0.0 112.476 179.91 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 17.4 p -73.65 -40.74 63.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.017 0.436 . . . . 0.0 110.006 178.371 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -56.6 -46.53 80.8 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.871 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 93.6 mt -62.57 -43.52 98.6 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.941 -179.335 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -64.73 -40.01 94.61 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.07 -178.861 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . 0.47 ' O ' ' OG ' ' B' ' 247' ' ' SER . 95.0 mtt-85 -64.51 -42.01 96.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.218 0.532 . . . . 0.0 110.071 179.649 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.825 HH11 HH11 ' A' ' 12' ' ' ARG . 25.0 ttm-85 -61.79 -42.19 98.68 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.765 -179.339 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -61.56 -36.4 80.51 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.809 0.337 . . . . 0.0 110.285 179.113 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 247' ' ' SER . . . . . 0.47 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 78.6 p -69.94 -40.39 75.52 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 177.958 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -57.61 -40.18 78.55 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.024 179.324 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 56.9 t -61.8 -44.94 99.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 178.627 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -59.23 -27.56 65.87 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.212 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -84.26 -11.6 56.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.928 179.449 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 3.5 mp -108.88 171.49 7.4 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.427 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . 0.679 ' C ' ' H ' ' B' ' 255' ' ' ASP . 0.5 OUTLIER -176.21 -142.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.932 179.661 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . 0.579 ' H ' ' CG ' ' B' ' 253' ' ' ASN . 52.8 p30 -50.53 5.71 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.026 -178.716 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . 0.679 ' H ' ' C ' ' B' ' 253' ' ' ASN . 99.6 m-20 -38.02 -30.26 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.299 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.577 ' CB ' ' O ' ' B' ' 255' ' ' ASP . 39.4 t0 105.98 -128.62 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 O-C-N 124.192 0.932 . . . . 0.0 111.722 178.509 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -94.35 -158.72 0.65 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.005 -178.868 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 63.89 37.39 9.61 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.731 -179.66 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.486 ' OD2' ' NH1' ' A' ' 93' ' ' ARG . 67.1 t0 -57.83 -96.59 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.738 179.007 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.535 ' OE2' ' NH1' ' A' ' 12' ' ' ARG . 96.9 mt-10 -139.02 15.91 2.64 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.187 178.969 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . 0.493 HG13 HH21 ' A' ' 93' ' ' ARG . 71.6 mt -116.93 135.2 58.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.609 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 50.0 t -123.78 132.32 71.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.541 179.309 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -95.57 119.52 34.21 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.264 0.554 . . . . 0.0 111.781 -178.234 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -64.9 -45.3 86.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.354 179.769 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . 0.549 ' NE2' ' CD1' ' A' ' 24' ' ' LEU . 0.3 OUTLIER -100.78 163.96 17.07 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.284 -179.831 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -61.41 156.86 43.93 Favored 'Trans proline' 0 N--CA 1.503 2.051 0 C-N-CA 122.992 2.462 . . . . 0.0 113.062 -179.604 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 25.9 pt . . . . . 0 N--CA 1.465 0.285 0 CA-C-O 121.312 0.577 . . . . 0.0 111.775 -178.986 . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo . . . . . 0 N--CA 1.499 1.825 0 CA-C-O 120.697 0.207 . . . . 0.0 112.071 . . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.7 m -74.91 -50.97 15.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.897 0.379 . . . . 0.0 111.477 -179.932 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.608 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 85.1 mtt-85 -100.25 148.75 24.31 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.492 -177.995 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -134.55 141.68 46.76 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.516 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 98.5 mt -113.8 139.74 48.88 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 178.73 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 67.9 t -113.89 129.46 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.407 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 m -93.22 116.62 29.19 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.402 0.62 . . . . 0.0 112.516 -178.258 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 81.7 mt -85.67 147.66 5.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.111 179.149 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.619 ' NZ ' ' O ' ' B' ' 256' ' ' ASP . 94.8 mttt -93.61 157.87 15.97 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.479 179.092 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.595 ' NH2' ' OE2' ' B' ' 260' ' ' GLU . 91.1 mtm180 -60.98 -27.56 68.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.304 -0.407 . . . . 0.0 109.997 179.859 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 91.1 p -70.6 -22.69 62.52 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.755 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.73 6.94 37.27 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-N 115.72 -0.673 . . . . 0.0 113.699 178.576 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.8 m -104.82 142.92 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 117.995 0.898 . . . . 0.0 111.568 -179.693 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 17' ' ' GLY . 61.8 t0 -69.15 127.85 34.55 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.063 -179.397 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.437 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -115.72 -127.94 4.26 Favored Glycine 0 CA--C 1.535 1.325 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 -179.814 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.93 155.88 38.78 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.483 2.122 . . . . 0.0 112.788 -178.872 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -112.78 158.78 19.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.985 0.421 . . . . 0.0 111.191 -178.591 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -128.35 98.61 25.69 Favored Pre-proline 0 N--CA 1.467 0.403 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.578 -179.727 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.28 139.57 26.48 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 121.587 1.525 . . . . 0.0 112.508 -178.905 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.2 mt -88.33 86.01 6.99 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.203 -179.331 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 59.7 p -86.39 -7.95 58.04 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.515 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.0 mt -108.69 148.82 29.86 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.041 -179.184 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.3 m -68.73 -15.06 63.4 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.127 -179.117 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 57.0 m -130.02 134.63 47.54 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.452 -0.499 . . . . 0.0 112.143 -179.975 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.7 t -127.96 118.76 24.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.914 178.573 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.3 tp -118.46 130.8 56.15 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 120.954 0.406 . . . . 0.0 111.031 -179.056 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.446 ' O ' ' O ' ' A' ' 47' ' ' GLN . 18.3 m-85 -110.25 141.6 42.99 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.988 -179.893 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 153.67 -174.88 32.19 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.883 178.795 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.473 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 45.1 mtm180 -74.82 -32.53 61.98 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 122.704 -0.291 . . . . 0.0 111.722 179.348 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.594 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -58.14 149.57 34.59 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.579 -177.714 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.461 HD11 HG22 ' A' ' 33' ' ' ILE . 82.4 mt -66.37 -43.06 91.49 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 178.247 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -49.9 -25.28 3.07 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.222 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.594 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 3.6 m -65.69 115.01 5.4 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.723 179.47 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -52.76 -21.09 3.71 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.166 -178.135 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.417 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 85.4 mt -131.4 123.92 53.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.657 177.809 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 47.3 mtm180 -107.3 138.5 43.38 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.836 -179.865 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.483 ' CG2' ' NH1' ' A' ' 93' ' ' ARG . 63.9 mt -120.56 132.44 70.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.419 -0.512 . . . . 0.0 110.48 179.762 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -75.41 24.08 0.11 Allowed 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -178.068 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 25.7 mt -105.48 128.67 26.09 Favored Pre-proline 0 C--N 1.323 -0.56 0 C-N-CA 119.591 -0.844 . . . . 0.0 109.855 179.341 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.07 -10.27 25.75 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.523 2.149 . . . . 0.0 112.566 -178.773 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.8 m -87.11 -0.21 7.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.622 179.927 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.473 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 48.0 t -91.38 131.64 37.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.131 0.491 . . . . 0.0 111.006 -179.223 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.426 ' HG ' ' P ' ' B' ' 234' ' ' TPO . 0.5 OUTLIER -65.05 160.64 20.54 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.987 179.77 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 28.2 mtmt -59.93 -42.54 94.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.702 -178.839 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.629 ' O ' ' N ' ' A' ' 49' ' ' CYS . 12.4 mm100 -111.49 -16.52 13.28 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 123.481 0.488 . . . . 0.0 110.048 -179.549 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.2 t60 35.62 -76.37 0.0 OUTLIER 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.076 -0.966 . . . . 0.0 113.348 -179.763 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.629 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -137.09 140.18 41.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.941 0.401 . . . . 0.0 111.799 -178.622 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -127.01 131.91 50.89 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.511 179.728 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.9 mt -114.87 135.93 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-O 121.098 0.475 . . . . 0.0 110.738 179.54 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -113.75 125.55 54.23 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.067 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 93.9 mt -108.2 113.62 44.36 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.461 -179.856 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.582 ' O ' ' N ' ' A' ' 56' ' ' GLN . 91.5 m-70 -115.42 141.36 48.15 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.125 179.974 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.467 ' C ' ' O ' ' A' ' 54' ' ' HIS . 84.1 tt0 -38.92 -25.18 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 120.293 -0.563 . . . . 0.0 109.527 -179.109 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.582 ' N ' ' O ' ' A' ' 54' ' ' HIS . 57.3 tt0 -67.51 -67.31 0.47 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.386 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -160.65 -163.66 1.11 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.193 -179.586 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.79 127.16 55.9 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.577 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 89.2 mt -113.89 128.76 70.67 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 CA-C-O 121.297 0.57 . . . . 0.0 111.688 -179.228 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 43.4 tp -97.39 126.91 42.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.883 -179.975 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -114.7 138.01 51.22 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.962 179.105 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.519 ' ND2' ' H ' ' A' ' 69' ' ' THR . 16.8 t-20 -101.12 109.62 21.53 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.067 0.461 . . . . 0.0 111.602 -179.564 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -94.89 -4.59 46.65 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.254 179.108 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.0 t -90.42 101.06 13.79 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.728 -179.712 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.4 p -87.59 -24.21 24.06 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.388 -0.525 . . . . 0.0 109.996 178.087 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.74 -43.29 72.61 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.6 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -142.97 100.9 5.36 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.69 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -66.28 150.85 84.52 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.264 1.309 . . . . 0.0 113.532 -177.831 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.519 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 33.7 m -69.93 137.95 51.96 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.912 179.555 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -101.38 142.43 32.79 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.662 179.906 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.544 ' CG2' ' OD1' ' A' ' 86' ' ' ASP . 5.0 p -129.5 137.2 57.47 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.14 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 49.57 32.8 5.18 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.583 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.51 27.85 64.65 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.057 -179.903 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 62.8 m -141.06 138.8 33.86 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 117.549 0.675 . . . . 0.0 112.098 -179.473 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.4 m -65.62 137.45 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.527 179.734 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.497 ' CG2' ' O ' ' A' ' 78' ' ' GLU . 96.2 mt -99.57 96.39 4.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.594 179.856 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -65.15 -41.49 94.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.853 0.359 . . . . 0.0 110.867 179.645 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.497 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.1 OUTLIER -126.72 166.05 24.65 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.492 -179.343 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -57.24 143.32 93.87 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.174 1.916 . . . . 0.0 112.565 -179.052 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.6 t -133.32 137.49 53.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.654 -179.894 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 87.7 mtm-85 -68.98 134.43 49.48 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.535 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 80.3 mt -81.08 137.28 36.0 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.472 0.653 . . . . 0.0 111.589 -179.22 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -125.64 147.08 49.44 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.656 179.724 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.751 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 4.8 t60 -57.19 124.97 20.67 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.578 -179.318 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.73 -24.22 26.03 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -179.151 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.544 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 41.4 t0 -64.57 134.48 54.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.991 0.424 . . . . 0.0 110.198 179.347 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.544 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 9.9 p -110.9 132.9 58.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.509 -178.157 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 79.0 mt -99.09 130.18 48.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.857 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 17.7 m -116.85 123.73 47.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.514 0.673 . . . . 0.0 111.405 179.895 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.634 ' O ' ' N ' ' A' ' 93' ' ' ARG . 96.8 mt -117.36 129.04 74.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.062 178.306 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.494 ' C ' ' O ' ' A' ' 90' ' ' ILE . 85.5 mt -14.97 96.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -178.876 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 79.06 -11.23 1.24 Allowed 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 177.963 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.634 ' N ' ' O ' ' A' ' 90' ' ' ILE . 17.7 mtm180 -130.95 134.28 46.59 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.349 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.2 m -133.81 147.95 51.28 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.6 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -122.81 120.13 32.62 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.549 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.429 ' NE ' ' OE2' ' A' ' 98' ' ' GLU . 37.8 ttp-105 -79.97 130.92 35.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.061 0.458 . . . . 0.0 110.989 -179.362 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.608 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 46.0 t80 -98.5 122.97 42.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.413 -179.704 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.429 ' OE2' ' NE ' ' A' ' 96' ' ' ARG . 96.3 mt-10 -139.07 129.31 25.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.188 0.518 . . . . 0.0 111.333 179.832 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.751 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 91.4 m-20 -91.32 141.04 29.2 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.356 179.734 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 . . . . . 0 C--N 1.325 -0.467 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.656 179.5 . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . 0.499 ' O ' ' OD1' ' B' ' 229' ' ' ASP . 70.5 t . . . . . 0 N--CA 1.453 -0.309 0 CA-C-O 121.0 0.429 . . . . 0.0 110.139 . . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.499 ' OD1' ' O ' ' B' ' 228' ' ' VAL . 68.5 m-20 -164.93 174.69 10.26 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.934 -179.919 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -144.04 46.97 1.43 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.377 -179.724 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -112.64 -159.44 14.23 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.474 -0.651 . . . . 0.0 111.474 -178.826 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.84 158.2 53.48 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 122.554 2.169 . . . . 0.0 113.163 -179.381 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . 0.426 ' P ' ' HG ' ' A' ' 45' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -64.71 169.24 11.81 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.711 2.274 . . . . 0.0 111.843 178.703 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 37.7 t -112.73 134.07 56.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.83 179.871 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 3.7 t -52.32 112.98 0.9 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.553 -179.539 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . 0.404 ' O3P' ' OG1' ' B' ' 240' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -58.71 -22.27 60.26 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 C-N-CA 121.162 1.241 . . . . 0.0 111.622 178.855 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 240' ' ' THR . . . . . 0.404 ' OG1' ' O3P' ' B' ' 238' ' ' TPO . 18.5 m -71.92 -46.78 56.39 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 120.606 -0.437 . . . . 0.0 110.421 179.092 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . 0.5 ' CZ ' ' NH1' ' B' ' 245' ' ' ARG . 80.5 t80 -58.7 -45.73 88.86 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.616 -178.846 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 93.9 mt -64.16 -40.16 95.55 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.04 -179.178 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -60.98 -45.16 95.92 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.489 -179.689 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -66.91 -38.67 86.65 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.598 179.744 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.576 ' CA ' ' HE ' ' B' ' 245' ' ' ARG . 0.0 OUTLIER -60.11 -44.62 94.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.97 -179.029 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.59 -40.77 97.8 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.353 0.597 . . . . 0.0 109.473 179.117 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 26.8 m -60.44 -45.74 92.57 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.44 179.226 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . 0.561 HE22 ' NH2' ' B' ' 245' ' ' ARG . 74.1 mt-30 -58.23 -37.93 75.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.416 179.793 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . 0.442 ' CG2' ' HZ1' ' B' ' 257' ' ' LYS . 54.6 t -61.41 -46.57 96.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.013 179.35 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -57.96 -27.97 63.91 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.84 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -86.45 -12.56 48.68 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.107 179.871 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.542 ' O ' ' CB ' ' B' ' 253' ' ' ASN . 92.5 mt -109.76 -176.67 3.07 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.085 178.58 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . 0.542 ' CB ' ' O ' ' B' ' 252' ' ' LEU . 0.2 OUTLIER 84.42 20.9 0.13 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.884 -179.414 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -66.35 -41.96 88.79 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.116 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . 0.482 ' O ' ' OD1' ' B' ' 256' ' ' ASP . 52.2 m-20 -111.86 -80.97 0.59 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.219 179.287 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.619 ' O ' ' NZ ' ' A' ' 11' ' ' LYS . 98.1 m-20 -142.3 3.35 1.53 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.198 -179.742 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . 0.543 ' HZ2' ' HB2' ' A' ' 12' ' ' ARG . 74.6 tttt 60.55 116.27 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 120.216 -0.593 . . . . 0.0 109.428 -179.151 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.419 ' O ' ' CB ' ' B' ' 259' ' ' ASP . 96.5 m-20 -61.61 -36.64 81.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.712 -178.456 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.632 ' C ' ' H ' ' B' ' 261' ' ' ILE . 27.4 t0 81.36 112.03 0.06 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.187 -178.924 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.595 ' OE2' ' NH2' ' A' ' 12' ' ' ARG . 56.6 mp0 -58.88 19.85 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.279 -179.56 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . 0.632 ' H ' ' C ' ' B' ' 259' ' ' ASP . 66.3 mt -112.77 135.45 52.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.671 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 55.1 t -130.16 134.88 62.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.124 0.488 . . . . 0.0 111.048 -178.657 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -95.06 118.81 32.5 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.551 0.691 . . . . 0.0 111.277 -178.503 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -66.01 -47.52 74.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.159 179.424 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -89.06 151.45 46.92 Favored Pre-proline 0 N--CA 1.449 -0.494 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.185 -178.981 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.9 149.46 72.32 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.919 2.412 . . . . 0.0 112.838 179.747 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 44.1 pt . . . . . 0 C--N 1.33 -0.262 0 CA-C-O 121.313 0.578 . . . . 0.0 110.09 179.042 . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 N--CA 1.489 1.227 0 CA-C-O 120.691 0.205 . . . . 0.0 111.883 . . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.41 ' H ' ' HG1' ' A' ' 4' ' ' THR . 2.0 p -103.13 -43.14 5.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.41 -179.892 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 88.6 mtm-85 -90.26 126.4 35.83 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.28 179.913 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -129.79 135.37 48.35 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.095 0.474 . . . . 0.0 111.032 179.826 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 29.5 tp -115.3 133.82 55.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.136 -179.38 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 45.0 t -109.15 131.98 58.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.407 -179.95 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 m -90.99 118.39 30.34 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.34 0.59 . . . . 0.0 112.541 -178.408 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.0 mt -85.85 142.14 13.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.536 179.248 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.555 ' NZ ' ' O ' ' B' ' 256' ' ' ASP . 97.8 mttt -89.31 160.68 16.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.027 0.441 . . . . 0.0 110.919 179.262 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.571 HH11 HH11 ' B' ' 245' ' ' ARG . 90.5 mtm180 -55.94 -33.07 64.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.662 -178.902 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.6 t -77.75 -8.54 58.12 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.234 179.837 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.92 31.14 9.49 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -179.924 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.0 t -116.8 132.69 65.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.857 0.36 . . . . 0.0 110.081 179.681 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 45.4 p-10 -84.19 142.8 30.06 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.978 179.612 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -133.89 -108.05 1.02 Allowed Glycine 0 CA--C 1.532 1.098 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.733 -179.531 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -73.29 148.57 43.91 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 122.347 2.032 . . . . 0.0 112.028 -179.454 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -111.94 147.58 35.57 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.149 -179.844 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -115.05 104.72 53.73 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.981 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.42 133.14 15.63 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.164 1.242 . . . . 0.0 110.992 -178.81 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 82.9 mt -87.61 51.76 2.31 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -177.51 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.5 m -59.28 -34.1 71.87 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.879 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.9 mt -71.62 144.75 49.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.45 -179.845 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.6 m -68.18 -16.38 63.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.415 -179.355 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.448 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 95.5 m -133.77 134.42 42.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.834 0.35 . . . . 0.0 111.664 -179.806 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.9 t -125.78 116.66 21.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.902 178.424 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 58.2 tp -113.71 127.83 56.18 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.794 -178.924 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.506 ' O ' ' O ' ' A' ' 47' ' ' GLN . 9.4 m-85 -106.93 139.23 41.67 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.851 179.65 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 146.5 -175.93 25.67 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 120.982 -0.628 . . . . 0.0 111.622 178.972 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 47.6 mtm180 -75.46 -33.72 60.88 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -179.851 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.505 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -44.45 142.95 2.75 Favored Glycine 0 C--O 1.223 -0.535 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 -178.465 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.411 ' CD1' ' CZ ' ' A' ' 38' ' ' ARG . 32.5 mm -62.6 -43.13 98.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 117.194 0.497 . . . . 0.0 110.033 179.957 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -54.81 -20.73 9.24 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.51 -0.476 . . . . 0.0 109.865 179.551 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.505 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 60.0 m -56.63 119.61 6.4 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-O 120.968 0.413 . . . . 0.0 111.141 -179.47 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.448 ' OD2' ' O ' ' A' ' 26' ' ' THR . 80.0 m-20 -58.09 -26.63 62.81 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -179.817 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.432 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 95.1 mt -129.18 118.97 47.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.235 177.381 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.411 ' CZ ' ' CD1' ' A' ' 33' ' ' ILE . 84.7 mtp180 -103.34 133.5 48.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.634 -179.106 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.428 ' C ' ' H ' ' A' ' 41' ' ' LEU . 83.6 mt -118.13 129.94 73.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 120.511 -0.475 . . . . 0.0 110.021 179.744 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -75.24 36.71 0.12 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.85 -178.057 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.611 ' CD1' ' CZ ' ' A' ' 93' ' ' ARG . 70.0 mt -111.74 119.32 44.98 Favored Pre-proline 0 C--N 1.325 -0.457 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.061 -179.678 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -71.29 -12.77 30.27 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 121.835 1.69 . . . . 0.0 112.824 -179.987 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.448 ' CG2' ' CZ ' ' B' ' 241' ' ' PHE . 31.1 m -86.76 -3.51 8.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.949 -0.301 . . . . 0.0 110.716 179.657 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.3 p -96.62 146.76 6.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.103 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.494 ' HG ' HG22 ' B' ' 234' ' ' TPO . 5.9 m -74.65 166.14 24.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.469 0.652 . . . . 0.0 112.519 -178.478 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 45.6 mttp -63.23 -40.05 96.34 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.03 -0.987 . . . . 0.0 111.737 179.975 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.669 ' O ' ' N ' ' A' ' 49' ' ' CYS . 89.7 mt-30 -113.36 -19.83 11.58 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.385 179.858 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.0 t60 34.83 -75.93 0.0 OUTLIER 'General case' 0 C--O 1.234 0.274 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 179.048 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.669 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.1 134.45 47.36 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.248 0.547 . . . . 0.0 112.253 -178.948 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -127.01 128.65 46.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.257 179.021 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.3 mt -111.56 133.74 56.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.189 179.845 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -116.79 126.55 53.26 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.463 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 84.8 mt -106.15 112.91 41.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.404 -179.067 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.504 ' O ' ' N ' ' A' ' 56' ' ' GLN . 95.0 m-70 -112.78 144.03 43.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.399 179.54 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 54' ' ' HIS . 84.1 tt0 -39.9 -27.21 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.358 -0.537 . . . . 0.0 109.992 -178.839 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.504 ' N ' ' O ' ' A' ' 54' ' ' HIS . 75.8 mt-30 -69.08 -66.99 0.51 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.949 179.132 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -157.92 -169.2 2.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.347 -179.11 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -111.85 125.32 53.89 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.741 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.5 mt -114.73 132.05 65.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -178.203 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 44.0 tp -94.8 122.54 37.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.8 179.266 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -109.08 136.35 48.73 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.159 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.432 HD22 ' HA ' ' A' ' 68' ' ' PRO . 63.5 t-20 -97.54 109.54 22.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.068 0.461 . . . . 0.0 112.241 -178.422 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.405 ' CD2' ' OE1' ' A' ' 47' ' ' GLN . 28.3 m-85 -100.91 -9.87 21.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.121 179.326 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.409 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 2.7 t -76.22 98.62 4.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.805 0.336 . . . . 0.0 110.844 -179.389 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 34.2 t -79.09 -40.79 30.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.323 0.582 . . . . 0.0 109.744 178.683 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.75 -47.02 79.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.02 -179.112 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.409 ' O ' ' OG ' ' A' ' 64' ' ' SER . 42.3 m-20 -136.97 97.91 10.77 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.452 179.894 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.432 ' HA ' HD22 ' A' ' 62' ' ' ASN . 36.2 Cg_exo -56.45 145.05 81.55 Favored 'Trans proline' 0 N--CA 1.494 1.5 0 C-N-CA 121.799 1.666 . . . . 0.0 112.612 -179.121 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.3 m -73.83 140.01 45.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.393 -179.992 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -104.59 141.79 35.79 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.749 -179.188 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.509 ' CG1' ' OD1' ' A' ' 86' ' ' ASP . 55.3 t -130.96 136.23 58.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.491 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 52.26 33.3 12.33 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -179.394 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.58 29.48 72.88 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.284 179.726 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.468 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 30.7 p -141.66 136.65 31.11 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.714 -0.395 . . . . 0.0 110.867 -179.974 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 78.6 t -66.01 135.82 27.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.087 -179.907 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.08 96.65 3.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.409 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -84.56 -16.69 41.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.536 -0.757 . . . . 0.0 112.014 -178.583 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -111.47 162.6 20.3 Favored Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.557 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -58.96 142.24 99.1 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 121.45 1.433 . . . . 0.0 111.693 179.684 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.5 p -140.48 139.1 35.89 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 CA-C-O 120.957 0.408 . . . . 0.0 110.758 179.814 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.62 HH21 ' CE ' ' A' ' 83' ' ' LYS . 61.9 ttp180 -73.39 127.71 33.44 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.461 179.616 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 98.2 mt -78.78 138.16 38.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.79 -180.0 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.62 ' CE ' HH21 ' A' ' 81' ' ' ARG . 97.7 mttt -130.29 151.93 50.26 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.342 179.237 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.603 ' HD1' ' CG ' ' A' ' 99' ' ' ASN . 3.7 t-160 -55.59 120.95 8.02 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.287 -179.334 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.08 -15.06 36.89 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -179.58 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.509 ' OD1' ' CG1' ' A' ' 71' ' ' VAL . 35.2 t70 -68.79 126.54 30.07 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.312 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.9 t -109.51 127.09 66.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.578 -178.922 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 90.7 mt -93.27 133.54 34.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.896 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 53.7 m -124.19 123.08 39.5 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.592 0.71 . . . . 0.0 112.387 -178.555 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.451 ' N ' ' O ' ' A' ' 93' ' ' ARG . 93.1 mt -107.91 124.27 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 177.498 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.443 ' C ' ' O ' ' A' ' 90' ' ' ILE . 93.9 mt 39.47 -98.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.171 -178.445 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.613 ' OD1' ' NH1' ' A' ' 93' ' ' ARG . 28.9 p-10 -119.71 16.54 12.76 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.015 0.436 . . . . 0.0 110.837 179.365 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.613 ' NH1' ' OD1' ' A' ' 92' ' ' ASP . 45.0 mtm-85 -120.0 138.12 53.68 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.765 179.877 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 66.9 m -137.44 152.41 49.55 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 119.886 -0.726 . . . . 0.0 111.283 -179.871 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -123.79 121.45 35.45 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.098 179.413 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -81.95 129.08 34.67 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.75 -179.045 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -99.0 126.99 44.82 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.832 179.876 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -137.22 127.88 26.98 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.653 179.996 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.603 ' CG ' ' HD1' ' A' ' 84' ' ' HIS . 41.2 p30 -82.54 -145.58 0.07 Allowed 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.532 -179.965 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.415 ' N ' ' OD1' ' A' ' 99' ' ' ASN . 22.5 pt-20 . . . . . 0 C--N 1.331 -0.233 0 CA-C-O 121.05 0.452 . . . . 0.0 111.11 -179.189 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 4.7 p . . . . . 0 CA--C 1.53 0.203 0 N-CA-C 111.475 0.176 . . . . 0.0 111.475 . . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.518 ' C ' ' H ' ' B' ' 231' ' ' GLN . 79.7 m-20 -61.1 139.24 58.13 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.347 -179.786 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.518 ' H ' ' C ' ' B' ' 229' ' ' ASP . 88.3 mm-40 -132.2 48.84 2.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.906 179.986 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -118.22 -170.74 15.04 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -179.468 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -76.72 161.65 33.47 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 123.655 2.903 . . . . 0.0 113.279 -179.355 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . 0.494 HG22 ' HG ' ' A' ' 45' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -58.31 132.7 50.41 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.32 2.013 . . . . 0.0 112.657 179.511 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 31.4 t -64.09 135.5 27.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.391 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -57.19 122.51 12.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.093 0.473 . . . . 0.0 110.805 -178.741 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -59.22 -21.45 60.0 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 121.844 1.696 . . . . 0.0 111.806 178.776 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 52.0 m -73.03 -46.19 53.38 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.05 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . 0.448 ' CZ ' ' CG2' ' A' ' 43' ' ' VAL . 71.3 t80 -56.6 -48.15 78.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.757 -179.793 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 85.8 mt -66.18 -43.6 86.4 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -179.887 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -65.48 -45.14 84.8 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.447 -178.228 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -62.68 -44.53 96.02 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.435 179.626 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.571 HH11 HH11 ' A' ' 12' ' ' ARG . 52.2 ttm-85 -63.56 -44.09 95.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.98 -179.627 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -63.97 -36.89 85.45 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.554 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 32.7 m -64.08 -43.78 94.38 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.47 178.022 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -61.64 -34.59 75.96 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.877 -179.962 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 43.4 t -63.94 -45.46 96.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 120.774 -0.371 . . . . 0.0 110.232 179.098 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -64.54 -29.77 70.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.273 0.559 . . . . 0.0 109.649 179.208 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -89.78 -7.32 54.67 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.303 -179.701 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 49.6 tp -67.88 144.61 55.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.917 -179.52 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . 0.492 ' ND2' ' O ' ' B' ' 253' ' ' ASN . 1.5 t-20 -153.77 29.03 0.47 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.07 -179.794 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . 0.561 ' O ' ' CB ' ' B' ' 255' ' ' ASP . 80.8 m-20 -96.26 3.83 52.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.453 -0.794 . . . . 0.0 108.994 178.851 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . 0.561 ' CB ' ' O ' ' B' ' 254' ' ' ASP . 4.8 t70 93.26 -23.66 0.06 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.564 -178.743 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.555 ' O ' ' NZ ' ' A' ' 11' ' ' LYS . 8.0 t0 77.34 13.53 1.96 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.281 -179.965 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -67.64 -37.63 82.72 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.098 0.475 . . . . 0.0 111.068 178.345 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -88.81 122.28 32.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.763 179.744 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.693 ' C ' ' H ' ' B' ' 261' ' ' ILE . 43.8 p30 -114.25 143.49 44.76 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.579 0.704 . . . . 0.0 110.694 -179.704 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -59.93 15.99 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.626 -1.17 . . . . 0.0 111.186 -179.804 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . 0.693 ' H ' ' C ' ' B' ' 259' ' ' ASP . 66.9 mt -109.69 134.56 51.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 178.945 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 61.9 t -125.23 133.88 68.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.746 -179.311 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -94.43 118.95 32.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.043 -178.986 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -68.2 -41.16 81.79 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.281 179.392 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -103.56 163.69 16.92 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.814 -178.878 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -62.27 153.27 71.26 Favored 'Trans proline' 0 N--CA 1.5 1.856 0 C-N-CA 123.202 2.601 . . . . 0.0 113.08 -179.429 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 42.5 pt . . . . . 0 C--N 1.33 -0.253 0 CA-C-O 121.693 0.759 . . . . 0.0 112.328 -179.02 . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo . . . . . 0 N--CA 1.496 1.62 0 CA-C-O 120.762 0.234 . . . . 0.0 112.395 . . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.7 m -74.78 -47.98 27.92 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.965 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.7 mtt85 -97.76 137.22 36.97 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.918 0.389 . . . . 0.0 111.997 -177.494 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.569 ' NE ' ' OE2' ' A' ' 100' ' ' GLU . 89.4 mtm180 -137.62 145.98 43.41 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.518 179.576 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.439 ' CD2' ' N ' ' A' ' 7' ' ' LEU . 3.0 mm? -112.96 141.54 46.68 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.94 178.395 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.0 t -114.09 127.02 71.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.852 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 50.0 m -78.64 139.68 38.51 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -177.998 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 99.6 mt -109.22 136.47 45.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.185 177.494 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -88.8 158.46 18.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.006 0.431 . . . . 0.0 110.926 179.942 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.711 HH21 ' CD2' ' B' ' 252' ' ' LEU . 86.3 mtm180 -57.16 -30.59 64.59 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.801 -178.611 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 88.6 p -80.93 -7.07 59.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.192 179.988 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.88 34.44 6.85 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.692 179.527 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.2 t -119.64 132.73 68.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.748 0.308 . . . . 0.0 111.111 -179.988 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -74.84 138.23 42.39 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.73 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -131.65 -118.89 2.02 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 120.533 -0.842 . . . . 0.0 112.616 -178.939 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -73.79 149.12 42.32 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.414 2.076 . . . . 0.0 113.066 -178.427 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -110.58 157.46 19.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.697 -179.962 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.424 ' CD2' ' CD1' ' A' ' 37' ' ' ILE . 35.2 t80 -124.64 99.83 35.36 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.924 -179.553 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -74.81 135.52 19.58 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 121.374 1.383 . . . . 0.0 112.48 -179.499 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.5 mt -87.65 81.98 7.54 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 120.872 0.367 . . . . 0.0 111.093 -179.24 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.474 ' OG ' ' NE2' ' B' ' 265' ' ' GLN . 77.9 p -86.33 -8.68 57.51 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.164 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.5 mt -103.82 146.22 28.96 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.611 179.917 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.6 m -67.81 -14.82 63.27 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -179.219 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 39.7 m -131.03 132.6 45.06 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.694 -179.948 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.1 t -126.96 120.21 28.55 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.653 178.835 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 35.1 tp -117.22 130.86 56.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.779 0.323 . . . . 0.0 111.42 -178.561 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.446 ' O ' ' O ' ' A' ' 47' ' ' GLN . 54.1 m-85 -107.43 133.44 51.94 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.615 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 179.42 -173.46 45.39 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.186 -1.007 . . . . 0.0 112.718 -179.967 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.2 ttp-105 -93.75 -23.4 18.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.234 -0.483 . . . . 0.0 110.349 179.746 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.467 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -72.2 163.96 54.49 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.932 -179.095 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.56 ' CD1' ' NH1' ' A' ' 38' ' ' ARG . 10.4 tp -68.17 -43.25 85.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.948 0.404 . . . . 0.0 111.582 -179.846 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.513 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 52.1 tp10 -54.19 -19.81 5.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.862 -178.594 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.467 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 3.5 m -67.77 129.01 38.59 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.275 -179.777 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -61.58 -33.84 74.58 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.961 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.424 ' CD1' ' CD2' ' A' ' 20' ' ' PHE . 36.9 mm -120.11 116.6 50.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.097 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.56 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 83.2 mtp180 -105.63 134.85 48.07 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.681 -178.404 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 78.6 mt -121.13 129.13 75.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.35 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -77.22 27.72 0.15 Allowed 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -177.921 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.402 ' CD2' ' OE1' ' B' ' 260' ' ' GLU . 78.9 mt -99.09 139.18 20.81 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.121 179.55 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.45 -14.73 20.1 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.492 2.128 . . . . 0.0 112.277 -179.395 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.1 m -91.19 7.87 4.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.534 179.868 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 55.6 t -100.36 132.11 46.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.359 179.09 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.4 m -74.11 170.32 15.73 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.768 0.794 . . . . 0.0 111.655 -179.52 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -64.83 -38.54 91.32 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.093 179.799 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.642 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.0 mt-30 -114.74 -19.2 11.15 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.167 179.875 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 14.8 t60 32.61 -76.58 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 179.805 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.642 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.82 134.16 46.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.3 0.571 . . . . 0.0 112.066 -178.662 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -125.34 132.55 52.82 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.189 179.08 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.8 mt -116.46 133.78 61.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.986 -179.563 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -113.87 123.76 50.58 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.513 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.6 mt -105.87 111.6 35.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.659 -179.484 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.458 ' O ' ' N ' ' A' ' 56' ' ' GLN . 81.4 m-70 -113.77 142.85 45.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.313 179.834 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 54' ' ' HIS . 99.2 mt-10 -40.67 -28.46 0.07 Allowed 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.266 -0.574 . . . . 0.0 109.826 -179.771 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.488 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 95.1 mt-30 -63.78 -68.55 0.34 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.546 178.866 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.488 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 3.4 tp10 -157.24 -168.32 2.58 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.585 -179.671 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.12 124.71 52.02 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 178.473 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 98.0 mt -115.83 130.28 70.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.283 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 47.1 tp -97.98 127.98 44.26 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.249 179.258 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -114.94 138.24 51.06 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.467 -179.995 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.426 HD22 ' CA ' ' A' ' 68' ' ' PRO . 57.8 t-20 -98.69 106.83 19.15 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.903 0.383 . . . . 0.0 111.961 -179.692 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -102.33 -9.5 20.29 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.032 179.406 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.38 100.14 4.35 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.173 -179.932 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 85.0 p -84.24 -32.11 24.65 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.341 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.7 m -64.43 -51.46 63.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.699 -179.745 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -138.79 95.96 9.58 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.673 179.825 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.426 ' CA ' HD22 ' A' ' 62' ' ' ASN . 52.0 Cg_exo -55.0 146.7 56.46 Favored 'Trans proline' 0 N--CA 1.499 1.809 0 C-N-CA 122.286 1.99 . . . . 0.0 113.328 -178.957 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 44.3 m -75.06 145.16 42.58 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.289 -179.984 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -108.11 143.37 36.95 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.808 -179.733 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.435 ' O ' ' N ' ' A' ' 74' ' ' SER . 5.4 p -131.99 135.97 57.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.77 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 49.16 33.17 4.69 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.238 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.69 29.09 69.92 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.317 -179.577 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 71' ' ' VAL . 66.8 m -138.65 136.06 35.51 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.906 0.353 . . . . 0.0 111.161 -179.616 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -66.32 141.75 17.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.176 -179.806 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.2 pt -118.71 78.99 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.677 179.107 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -63.34 -24.02 67.67 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.768 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -116.84 158.71 43.14 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.838 179.559 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -64.97 148.62 89.81 Favored 'Trans proline' 0 N--CA 1.5 1.884 0 C-N-CA 122.859 2.373 . . . . 0.0 113.044 -179.6 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 65.9 t -138.41 138.99 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.088 179.815 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -69.33 132.11 45.89 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 178.817 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 90.0 mt -78.85 138.38 38.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.304 0.574 . . . . 0.0 111.113 -179.985 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -132.36 150.14 52.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.075 179.949 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.741 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 4.9 t60 -58.17 119.12 6.29 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.874 0.369 . . . . 0.0 110.401 -179.674 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.51 -23.04 16.19 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 -179.66 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 87' ' ' VAL . 57.7 t0 -67.93 132.11 46.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.029 0.442 . . . . 0.0 110.939 179.736 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.526 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 50.0 t -110.63 132.15 59.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.512 -179.038 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 87.3 mt -95.75 131.26 43.01 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 177.957 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 44.6 m -121.99 128.97 52.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.989 0.899 . . . . 0.0 113.314 -177.244 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.617 ' O ' ' N ' ' A' ' 93' ' ' ARG . 97.9 mt -116.42 129.94 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-N 113.926 -1.488 . . . . 0.0 108.379 178.453 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.523 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 70.4 mt -21.49 98.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.415 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.566 ' OD2' ' NH1' ' B' ' 245' ' ' ARG . 0.8 OUTLIER 88.46 -23.8 0.11 Allowed 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 178.171 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.624 HH22 ' CG ' ' B' ' 259' ' ' ASP . 83.4 mtt-85 -128.35 145.02 51.2 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.273 -179.53 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.3 t -140.7 153.76 46.08 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.325 0.583 . . . . 0.0 110.576 -179.9 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -124.96 121.49 34.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.464 179.363 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -81.6 131.68 35.28 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.342 -179.937 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.584 ' CZ ' ' OD1' ' A' ' 99' ' ' ASN . 85.8 t80 -94.66 126.22 39.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.691 -179.647 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -136.4 128.59 29.84 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 120.572 -0.451 . . . . 0.0 112.001 -179.531 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.741 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 93.7 m-20 -96.04 136.0 37.06 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.827 179.083 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.569 ' OE2' ' NE ' ' A' ' 6' ' ' ARG . 96.9 mt-10 . . . . . 0 N--CA 1.464 0.229 0 CA-C-O 120.889 0.376 . . . . 0.0 111.369 -179.482 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 28.4 m . . . . . 0 N--CA 1.45 -0.429 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 . . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.475 ' C ' ' H ' ' B' ' 231' ' ' GLN . 99.2 m-20 -68.36 148.21 51.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.033 0.444 . . . . 0.0 111.365 -179.232 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.475 ' H ' ' C ' ' B' ' 229' ' ' ASP . 74.9 mt-30 -128.18 36.24 4.32 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.678 -179.638 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -116.85 -161.87 12.5 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.602 -178.514 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -60.88 153.18 65.11 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 123.858 3.039 . . . . 0.0 112.401 -179.835 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -65.68 138.56 54.45 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.739 1.626 . . . . 0.0 114.474 -178.954 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 26.8 m -72.43 143.35 14.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 114.279 -1.328 . . . . 0.0 109.174 179.34 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 10.3 t -72.24 129.31 38.13 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.705 -179.028 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . 0.431 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . 0.431 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 39.0 Cg_exo -57.26 -26.92 72.61 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.755 2.303 . . . . 0.0 112.493 -179.252 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 99.3 m -73.22 -45.09 58.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.905 0.384 . . . . 0.0 111.023 179.376 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -57.08 -47.84 80.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.251 -179.29 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 87.1 mt -63.5 -42.56 98.5 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.412 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -63.67 -41.88 98.12 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.892 -179.547 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 62.9 ttm-85 -64.31 -44.21 92.29 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.009 0.433 . . . . 0.0 110.422 179.938 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.566 ' NH1' ' OD2' ' A' ' 92' ' ' ASP . 4.0 tpp85 -61.43 -42.9 99.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.773 -179.61 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -59.48 -40.09 85.81 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.825 0.345 . . . . 0.0 110.271 -179.734 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 78.0 p -70.31 -39.88 74.55 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.816 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . 0.416 ' O ' ' N ' ' B' ' 252' ' ' LEU . 63.7 tp60 -59.25 -38.53 80.3 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.699 179.823 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 38.3 t -62.34 -46.91 95.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.734 0.302 . . . . 0.0 110.35 179.029 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -58.67 -26.7 64.07 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.254 0.55 . . . . 0.0 109.831 179.708 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -96.69 -12.07 24.3 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.531 179.727 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.711 ' CD2' HH21 ' A' ' 12' ' ' ARG . 40.7 tp -73.3 140.2 46.62 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.746 -179.289 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -95.54 129.98 42.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.345 178.855 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . 0.532 ' N ' ' OD1' ' B' ' 254' ' ' ASP . 12.9 p-10 -61.39 -19.54 62.02 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.849 -179.249 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -64.63 1.14 0.89 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.968 -179.682 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.479 ' C ' ' H ' ' B' ' 258' ' ' ASP . 55.2 p-10 -91.79 69.88 5.61 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.31 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -64.99 1.76 0.87 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.316 -178.963 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.48 ' O ' ' C ' ' B' ' 259' ' ' ASP . 96.2 m-20 -113.23 0.63 14.94 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 177.799 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.624 ' CG ' HH22 ' A' ' 93' ' ' ARG . 66.6 t0 21.86 -96.99 0.0 OUTLIER 'General case' 0 C--O 1.233 0.199 0 CA-C-N 113.869 -1.514 . . . . 0.0 110.976 -179.674 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.58 ' CD ' HH21 ' A' ' 93' ' ' ARG . 98.2 mt-10 -141.09 14.46 2.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.767 0.318 . . . . 0.0 110.173 178.958 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 67.6 mt -114.11 134.19 57.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.655 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 44.4 t -124.99 134.53 66.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.168 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -96.17 117.72 31.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.275 0.559 . . . . 0.0 111.578 -178.222 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -65.96 -46.29 78.66 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.163 179.611 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . 0.474 ' NE2' ' OG ' ' A' ' 23' ' ' SER . 0.0 OUTLIER -96.0 155.51 38.2 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.336 -179.192 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -64.31 148.86 90.99 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 123.212 2.608 . . . . 0.0 113.42 -179.222 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 47.1 pt . . . . . 0 C--N 1.332 -0.157 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.761 178.693 . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo . . . . . 0 N--CA 1.491 1.346 0 CA-C-O 120.699 0.208 . . . . 0.0 112.158 . . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.8 p -89.24 -50.67 6.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.096 0.474 . . . . 0.0 110.549 179.927 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.409 HH11 HD11 ' A' ' 53' ' ' ILE . 99.9 mtt180 -98.84 135.34 40.44 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.212 -179.736 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.497 ' NE ' ' OE1' ' A' ' 98' ' ' GLU . 33.4 ptt180 -140.85 155.44 46.34 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.27 -0.572 . . . . 0.0 112.034 -179.569 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 78.5 mt -118.91 145.19 45.94 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.747 179.703 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.6 t -114.43 129.88 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 178.177 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.4 m -91.64 118.27 30.49 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -177.553 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 98.1 mt -84.67 142.87 12.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.436 178.284 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.601 ' NZ ' ' CB ' ' B' ' 256' ' ' ASP . 98.3 mttt -94.99 167.89 11.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.845 0.355 . . . . 0.0 110.942 179.566 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.586 ' NH2' ' CD1' ' B' ' 252' ' ' LEU . 83.5 mtm180 -56.49 -32.44 65.02 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.465 -178.407 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.5 m -80.25 -7.61 59.09 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.47 179.893 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.71 39.83 6.98 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 -179.545 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.3 t -119.58 130.85 73.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.959 0.409 . . . . 0.0 110.869 -179.403 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -77.16 136.68 38.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.558 179.305 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -137.59 -114.86 1.32 Allowed Glycine 0 CA--C 1.535 1.297 0 C-N-CA 120.2 -1.0 . . . . 0.0 111.746 -179.9 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -71.92 149.0 52.62 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.088 1.859 . . . . 0.0 112.502 -178.994 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -113.45 157.6 21.75 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.793 179.932 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -118.13 97.71 50.94 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.487 179.864 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -74.17 131.76 15.74 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 121.39 1.393 . . . . 0.0 111.342 -179.328 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 82.0 mt -83.51 80.63 9.04 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.632 -178.791 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 87.9 p -84.55 -11.15 56.6 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.867 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 67.5 mt -107.16 149.18 27.96 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.191 -179.885 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 28.5 t -67.88 -15.79 63.78 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.811 -179.408 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.531 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 58.8 m -127.16 130.04 49.01 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.594 -0.442 . . . . 0.0 112.181 -179.192 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.7 t -123.76 113.46 18.61 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 177.799 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.408 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 41.0 tp -115.68 131.09 57.04 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.619 -178.232 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.54 ' O ' ' O ' ' A' ' 47' ' ' GLN . 6.9 m-85 -108.51 131.1 55.16 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.706 179.796 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 166.59 -175.25 41.99 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 119.934 -1.127 . . . . 0.0 112.862 179.386 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.503 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 76.4 mtm-85 -80.1 -32.11 39.17 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-O 120.876 0.369 . . . . 0.0 110.594 179.95 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.563 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -51.3 146.23 11.4 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.512 -178.147 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.51 ' CD1' ' CZ ' ' A' ' 38' ' ' ARG . 36.9 mm -64.44 -43.46 96.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.74 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -54.91 -21.24 10.93 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.633 -179.769 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.563 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 17.2 m -59.08 129.07 40.37 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.155 0.503 . . . . 0.0 110.521 -179.672 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.531 ' OD2' ' O ' ' A' ' 26' ' ' THR . 59.0 m-20 -60.9 -33.35 72.99 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.457 -179.109 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.413 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 89.4 mt -125.97 119.78 55.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 177.998 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.51 ' CZ ' ' CD1' ' A' ' 33' ' ' ILE . 83.3 mtp180 -103.75 137.84 41.22 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.889 -178.497 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.435 HG23 HD13 ' A' ' 39' ' ' ILE . 90.3 mt -121.08 131.76 72.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.267 179.551 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -75.24 26.35 0.1 Allowed 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -178.319 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.587 ' CD1' ' CZ ' ' A' ' 93' ' ' ARG . 81.9 mt -102.2 131.74 22.27 Favored Pre-proline 0 C--N 1.326 -0.42 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.301 179.947 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.69 -13.18 27.05 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 122.292 1.995 . . . . 0.0 112.47 -179.535 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.8 m -92.81 2.04 8.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.159 -179.621 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.503 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 38.0 t -91.7 133.8 32.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 177.875 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.0 m -72.64 175.0 6.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.501 0.667 . . . . 0.0 111.586 -178.285 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -63.35 -42.58 98.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.736 -179.787 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.629 ' O ' ' N ' ' A' ' 49' ' ' CYS . 89.0 mt-30 -116.98 -17.01 10.48 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.426 0.454 . . . . 0.0 111.335 -179.948 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.1 t60 34.05 -76.52 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 179.665 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.629 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -127.8 135.1 49.63 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.225 0.536 . . . . 0.0 112.222 -178.766 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -126.74 133.08 50.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.896 179.476 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.3 mt -119.37 132.04 70.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.63 179.107 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -115.21 126.09 54.14 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.944 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.409 HD11 HH11 ' A' ' 5' ' ' ARG . 47.4 mm -93.68 122.66 45.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.326 0.584 . . . . 0.0 111.356 -178.029 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.463 ' O ' ' C ' ' A' ' 55' ' ' GLU . 11.0 m-70 -117.76 127.42 53.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.168 179.104 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' A' ' 54' ' ' HIS . 97.5 mt-10 -40.96 -31.33 0.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.967 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.428 ' N ' ' C ' ' A' ' 54' ' ' HIS . 85.7 mt-30 -67.0 -67.61 0.44 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.664 178.046 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.405 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 3.5 tp10 -149.77 -172.79 4.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.157 -179.63 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.405 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -115.01 132.19 56.68 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.951 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.452 HG22 HD11 ' A' ' 59' ' ' ILE . 47.6 mm -113.21 128.11 70.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 120.493 -0.483 . . . . 0.0 112.022 -178.286 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 22.9 tp -98.65 126.61 44.3 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.545 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -117.92 139.09 51.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.739 0.304 . . . . 0.0 110.595 -179.724 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.551 ' ND2' ' H ' ' A' ' 69' ' ' THR . 16.0 t-20 -101.58 113.93 27.51 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.85 0.357 . . . . 0.0 111.493 -179.728 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -102.45 -7.92 21.54 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.653 179.878 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.42 99.16 11.01 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.423 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.9 m -76.25 -32.31 58.79 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.246 0.546 . . . . 0.0 109.938 179.064 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.0 m -63.48 -45.97 88.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.598 -179.309 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -142.93 93.15 6.73 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.597 179.208 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -56.93 148.89 64.8 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.056 1.837 . . . . 0.0 111.859 -179.721 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.551 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 41.7 m -70.66 156.43 39.48 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.106 -179.589 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -114.6 140.98 48.36 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.915 179.683 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.498 ' O ' ' OG ' ' A' ' 74' ' ' SER . 55.6 t -130.21 135.68 60.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.762 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 52.81 32.38 12.19 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 119.857 -0.737 . . . . 0.0 109.359 -179.142 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.25 29.17 68.84 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.511 179.99 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.498 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 11.3 p -142.03 140.15 32.55 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.286 179.965 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.2 p -63.0 143.27 15.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.698 -179.433 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.418 ' CG1' ' O ' ' A' ' 78' ' ' GLU . 10.5 tt -113.88 87.28 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.577 -179.849 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 20.5 p-10 -66.4 -33.03 74.79 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.952 179.891 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.418 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 2.7 mt-10 -124.65 167.41 15.96 Favored Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.27 -179.053 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -60.3 144.87 99.5 Favored 'Trans proline' 0 N--CA 1.502 2.001 0 C-N-CA 122.582 2.188 . . . . 0.0 112.891 179.647 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.1 m -138.77 152.81 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 CA-C-O 121.618 0.723 . . . . 0.0 111.962 178.665 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -79.45 127.31 31.95 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.835 179.548 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 98.1 mt -83.41 129.49 34.99 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.28 0.562 . . . . 0.0 110.434 -179.623 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -121.91 150.45 41.96 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.283 -179.881 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.428 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 6.1 t60 -49.63 118.35 2.75 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.955 -179.397 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.15 -20.35 28.55 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 179.685 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 87' ' ' VAL . 56.7 t0 -61.54 132.49 53.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.17 0.509 . . . . 0.0 110.437 179.864 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.503 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 56.7 t -109.48 129.75 63.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.278 -179.03 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.8 mt -98.09 131.56 44.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.613 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.474 ' OG1' ' OG ' ' A' ' 94' ' ' SER . 74.7 m -126.05 127.92 46.6 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.624 0.726 . . . . 0.0 112.405 -178.42 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.569 ' O ' ' N ' ' A' ' 92' ' ' ASP . 97.8 mt -110.13 125.4 67.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.009 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.473 ' CD1' HH22 ' A' ' 93' ' ' ARG . 88.6 mt 40.0 -91.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 120.584 -0.447 . . . . 0.0 110.315 -178.7 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.569 ' N ' ' O ' ' A' ' 90' ' ' ILE . 33.9 t70 -128.06 20.05 6.43 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.04 0.448 . . . . 0.0 111.238 -179.776 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.633 ' NH1' ' NH2' ' B' ' 245' ' ' ARG . 45.8 mtm-85 -126.65 140.41 52.43 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.541 -179.798 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.474 ' OG ' ' OG1' ' A' ' 89' ' ' THR . 57.4 m -138.89 153.31 48.27 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 119.602 -0.839 . . . . 0.0 112.2 -179.154 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -121.92 122.44 39.4 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.705 178.864 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -81.55 130.11 34.93 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 119.884 -0.726 . . . . 0.0 110.449 -179.108 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -94.27 124.24 38.17 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.272 -179.283 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.497 ' OE1' ' NE ' ' A' ' 6' ' ' ARG . 80.3 tt0 -124.5 123.44 40.13 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.97 179.868 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.428 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 64.0 t-20 -107.71 114.07 27.79 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.668 -179.959 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 . . . . . 0 C--O 1.233 0.202 0 CA-C-O 121.035 0.445 . . . . 0.0 110.679 -179.624 . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 2.1 p . . . . . 0 CA--C 1.517 -0.305 0 CA-C-O 120.957 0.408 . . . . 0.0 110.598 . . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -61.0 -104.72 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.927 179.67 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -156.28 39.58 0.35 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 120.955 0.407 . . . . 0.0 111.045 -179.531 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -105.37 -139.94 10.0 Favored Glycine 0 CA--C 1.534 1.252 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -179.984 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -75.46 153.47 39.67 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 122.327 2.018 . . . . 0.0 112.22 -179.366 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -76.5 172.0 17.03 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.312 2.008 . . . . 0.0 111.59 178.918 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 5.9 p -113.91 133.2 60.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.799 179.704 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 4.6 t -72.35 129.9 39.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.48 -178.923 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . 0.454 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . 0.454 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 37.2 Cg_exo -58.94 -22.25 62.13 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.862 2.375 . . . . 0.0 112.003 179.863 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 94.4 m -71.88 -45.84 59.91 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.147 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -58.79 -47.05 86.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.101 -179.376 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 95.3 mt -63.56 -41.1 98.42 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -179.046 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -63.12 -38.87 92.91 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.967 -179.792 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -63.49 -41.85 98.56 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.126 0.489 . . . . 0.0 110.002 179.613 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.633 ' NH2' ' NH1' ' A' ' 93' ' ' ARG . 62.4 ttm-85 -60.05 -44.72 94.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.008 -179.168 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -64.77 -40.05 94.62 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.752 179.467 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 66.6 m -63.77 -45.42 89.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.499 179.509 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -60.7 -39.47 88.65 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.259 -179.461 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 21.0 t -60.6 -44.1 96.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.445 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -61.84 -34.49 76.06 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.632 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -75.47 -9.67 58.77 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 178.374 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.586 ' CD1' ' NH2' ' A' ' 12' ' ' ARG . 96.3 mt -113.39 -175.15 2.61 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.834 178.925 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . 0.416 ' OD1' ' N ' ' B' ' 253' ' ' ASN . 19.6 p-10 -137.83 177.67 7.7 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.139 0.495 . . . . 0.0 110.629 -179.929 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . 0.428 ' C ' ' H ' ' B' ' 256' ' ' ASP . 35.9 t70 -63.84 -16.22 60.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.67 -179.722 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . 0.502 ' O ' ' O ' ' B' ' 256' ' ' ASP . 99.3 m-20 -60.62 -3.77 0.78 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.174 -179.373 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.601 ' CB ' ' NZ ' ' A' ' 11' ' ' LYS . 4.0 p30 43.19 -176.1 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.878 0.371 . . . . 0.0 111.332 179.159 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . 0.543 ' O ' ' C ' ' B' ' 258' ' ' ASP . 16.1 ptmt -176.31 124.78 0.18 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.318 179.849 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.543 ' C ' ' O ' ' B' ' 257' ' ' LYS . 82.1 m-20 14.95 57.75 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.864 -179.506 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.676 ' C ' ' H ' ' B' ' 261' ' ' ILE . 44.2 p-10 -19.96 129.53 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.657 0.741 . . . . 0.0 112.427 -179.327 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -50.95 1.93 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.209 179.537 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . 0.676 ' H ' ' C ' ' B' ' 259' ' ' ASP . 73.5 mt -106.39 138.73 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.783 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 54.1 t -129.05 136.66 59.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.274 -178.765 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -97.4 117.12 30.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.318 0.58 . . . . 0.0 111.126 -179.397 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 43.3 tttp -67.05 -43.41 82.8 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.502 178.99 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 53.8 mm-40 -94.0 155.2 40.43 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.721 -179.014 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -61.31 154.1 60.82 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.103 1.869 . . . . 0.0 111.036 178.561 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 40.3 pt . . . . . 0 C--N 1.324 -0.539 0 CA-C-O 121.702 0.763 . . . . 0.0 112.372 -178.328 . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo . . . . . 0 N--CA 1.496 1.624 0 CA-C-O 120.748 0.228 . . . . 0.0 112.114 . . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 68.5 p -101.14 -48.59 4.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.58 -179.968 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.449 ' NH1' ' CG2' ' A' ' 53' ' ' ILE . 99.9 mtt180 -94.72 130.73 41.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.941 179.924 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -128.27 137.85 52.16 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.424 179.514 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 45.0 tp -106.88 130.88 54.49 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.47 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.6 t -110.04 129.31 65.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.475 -178.991 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 m -90.9 111.9 23.52 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.461 -178.971 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.7 mt -83.13 148.03 5.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.599 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -94.15 168.6 10.83 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.383 0.611 . . . . 0.0 111.434 179.705 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.491 HH21 ' CD2' ' B' ' 252' ' ' LEU . 87.9 mtm180 -58.06 -29.74 65.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.886 -179.038 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.8 p -80.54 -6.24 57.93 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.687 179.796 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.04 23.6 37.6 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.163 179.159 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.1 m -109.54 140.86 26.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.535 179.742 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.41 ' C ' ' OD1' ' A' ' 16' ' ' ASP . 57.3 t0 -69.32 122.75 19.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.682 -179.6 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -108.74 -131.91 6.49 Favored Glycine 0 CA--C 1.538 1.506 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 -179.344 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -74.71 153.95 43.64 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.342 2.028 . . . . 0.0 112.031 -179.258 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -109.15 155.92 20.45 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.148 -179.536 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -126.12 92.28 46.13 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.477 179.927 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.94 126.72 22.53 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 121.865 1.71 . . . . 0.0 111.551 -179.789 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.2 mt -80.02 54.3 1.88 Allowed 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 120.808 0.337 . . . . 0.0 110.708 -179.351 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.6 t -62.46 -40.62 97.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.802 179.587 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 46.8 mt -70.54 144.49 51.29 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.178 -179.77 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.6 t -66.01 -17.84 64.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.444 -178.84 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.549 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 50.2 m -132.53 134.13 44.61 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.996 -179.777 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.654 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 2.7 t -127.66 116.81 20.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.111 0.481 . . . . 0.0 109.798 178.585 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.403 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 44.7 tp -114.82 130.14 56.82 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.631 -178.291 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.654 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 27.1 m-85 -108.7 139.18 43.86 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.171 -179.894 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.87 -175.38 30.65 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.405 178.574 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.6 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 81.5 mtm-85 -74.04 -32.96 63.54 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.911 0.386 . . . . 0.0 110.868 -179.961 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.428 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -46.86 139.8 7.46 Favored Glycine 0 N--CA 1.465 0.584 0 N-CA-C 111.554 -0.619 . . . . 0.0 111.554 -178.582 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.547 ' CD1' ' CZ ' ' A' ' 38' ' ' ARG . 36.3 mm -64.99 -44.71 96.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.805 0.336 . . . . 0.0 110.975 -179.951 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.462 ' HA ' ' HZ1' ' B' ' 264' ' ' LYS . 15.4 pt-20 -57.98 -13.91 5.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.45 -179.173 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.428 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 60.0 m -63.02 131.23 47.91 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.524 -179.877 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.549 ' OD2' ' O ' ' A' ' 26' ' ' THR . 58.9 m-20 -61.24 -30.79 70.66 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.288 -179.326 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 77.9 mt -128.44 119.34 50.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.019 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.547 ' CZ ' ' CD1' ' A' ' 33' ' ' ILE . 83.8 mtp180 -100.04 135.54 41.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.518 -179.052 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 95.2 mt -121.28 128.96 76.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.55 -0.46 . . . . 0.0 109.907 179.98 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -79.36 31.26 0.22 Allowed 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -178.318 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.2 mt -97.85 128.48 33.92 Favored Pre-proline 0 CA--C 1.535 0.366 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.763 179.544 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -72.51 -12.69 27.27 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.487 2.125 . . . . 0.0 113.272 -179.276 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.1 m -100.29 6.99 9.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.316 -0.554 . . . . 0.0 110.432 179.525 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.6 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 32.0 t -95.43 134.99 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.934 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.615 ' HG ' ' N ' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -67.67 164.47 19.2 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.502 0.668 . . . . 0.0 111.94 -178.691 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.615 ' N ' ' HG ' ' A' ' 45' ' ' SER . 95.7 mttt -63.56 -42.31 98.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.056 -179.375 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.638 ' O ' ' N ' ' A' ' 49' ' ' CYS . 95.3 mm-40 -109.2 -23.04 11.81 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.591 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.473 ' O ' ' OG ' ' A' ' 64' ' ' SER . 17.1 t60 38.18 -76.04 0.0 OUTLIER 'General case' 0 C--O 1.235 0.336 0 CA-C-N 114.621 -1.172 . . . . 0.0 113.086 179.135 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.638 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.59 136.79 45.13 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.347 -0.541 . . . . 0.0 112.04 -178.218 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -128.17 130.39 47.98 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.394 179.431 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 95.8 mt -112.36 133.36 58.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.043 -179.934 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 73.3 tt0 -116.92 125.32 51.29 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.864 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.449 ' CG2' ' NH1' ' A' ' 5' ' ' ARG . 91.8 mt -104.33 123.81 58.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.666 0.746 . . . . 0.0 112.913 -177.796 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.494 ' O ' ' N ' ' A' ' 56' ' ' GLN . 2.0 m-70 -118.21 137.19 53.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.506 -1.225 . . . . 0.0 109.437 179.06 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.466 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.9 mm-40 -39.38 -29.57 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -179.508 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.494 ' N ' ' O ' ' A' ' 54' ' ' HIS . 98.6 mm-40 -65.22 -66.52 0.53 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.955 178.656 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -157.49 -166.03 1.93 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.198 -179.65 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -108.95 130.79 55.46 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.699 179.129 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.46 HG21 HD12 ' A' ' 59' ' ' ILE . 37.1 mm -112.43 125.84 69.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.902 -179.473 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.1 tp -99.72 123.41 43.95 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.723 0.297 . . . . 0.0 110.53 -179.888 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -111.23 134.6 52.69 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.152 179.853 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.408 ' ND2' ' O ' ' A' ' 76' ' ' ILE . 46.6 p-10 -99.89 108.3 20.51 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 121.0 0.429 . . . . 0.0 111.537 -179.845 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -97.52 -9.65 26.72 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.7 -179.937 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.473 ' OG ' ' O ' ' A' ' 48' ' ' HIS . 0.3 OUTLIER -77.25 99.88 5.64 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 120.95 0.405 . . . . 0.0 110.764 -179.689 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 86.5 p -79.08 -31.44 44.37 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.875 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.6 m -64.41 -47.99 77.08 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.764 -179.796 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -147.61 99.17 3.85 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.25 -179.699 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -56.27 149.66 53.93 Favored 'Trans proline' 0 N--CA 1.499 1.794 0 C-N-CA 122.117 1.878 . . . . 0.0 113.215 -178.489 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 50.3 m -68.06 138.7 56.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.174 178.849 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -100.45 144.54 29.33 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.731 -179.745 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.43 ' O ' ' N ' ' A' ' 74' ' ' SER . 5.1 p -131.21 136.28 58.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.167 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 51.12 30.93 6.01 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -178.967 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.41 26.2 70.76 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.936 -179.86 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 71' ' ' VAL . 12.0 t -135.65 137.8 42.21 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.194 0.521 . . . . 0.0 111.534 -179.511 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.5 t -66.68 136.43 26.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.813 -179.784 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.515 ' CG2' ' O ' ' A' ' 78' ' ' GLU . 97.0 mt -101.27 100.86 11.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.561 179.383 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -64.44 -41.15 96.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.875 179.872 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.515 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.9 OUTLIER -132.54 -178.07 0.79 Allowed Pre-proline 0 N--CA 1.464 0.227 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.346 -178.656 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 31.3 Cg_exo -59.38 143.8 99.6 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.49 2.127 . . . . 0.0 111.642 -179.815 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.2 p -141.01 147.65 22.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-O 121.186 0.517 . . . . 0.0 112.078 -179.041 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -79.7 128.16 33.08 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.283 179.27 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.0 mt -83.33 139.15 33.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.22 -179.84 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.484 ' N ' ' OD2' ' A' ' 86' ' ' ASP . 99.2 mttt -128.81 153.67 47.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.795 179.166 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.538 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 3.6 t-160 -55.54 119.4 5.6 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.892 0.377 . . . . 0.0 110.383 -179.661 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.0 -13.66 31.65 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.687 179.606 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.523 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 2.4 p30 -72.06 133.2 45.11 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.406 -0.517 . . . . 0.0 109.894 179.564 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 45.7 t -109.21 130.12 62.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.583 -178.309 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 89.4 mt -98.21 131.29 45.56 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 178.401 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.6 m -119.27 127.91 53.67 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.951 0.882 . . . . 0.0 112.628 -178.066 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.587 ' O ' ' N ' ' A' ' 93' ' ' ARG . 98.4 mt -115.28 134.11 59.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.471 178.496 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.484 ' C ' ' O ' ' A' ' 90' ' ' ILE . 53.9 mt -31.73 100.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 O-C-N 123.028 0.205 . . . . 0.0 111.295 -179.857 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 91' ' ' ILE . 83.8 m-20 86.67 -16.11 0.42 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.132 0.973 . . . . 0.0 113.259 179.169 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.587 ' N ' ' O ' ' A' ' 90' ' ' ILE . 81.1 mmt-85 -130.43 141.53 50.53 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.902 179.517 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.5 m -139.02 148.58 43.6 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.611 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.472 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 18.8 m-85 -126.8 125.37 41.59 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.544 -179.804 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 49.0 ttt85 -84.5 131.18 34.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.885 0.374 . . . . 0.0 110.893 -179.647 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -94.73 122.2 37.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.917 -179.781 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -124.1 120.73 33.22 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.637 -179.679 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.538 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 43.9 t-20 -108.54 112.56 24.99 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.199 179.364 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 C--N 1.327 -0.404 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.281 -179.96 . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 2.3 p . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 . . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.547 ' C ' ' H ' ' B' ' 231' ' ' GLN . 86.8 m-20 -67.58 144.33 55.64 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.742 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . 0.408 ' O1P' ' N ' ' B' ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.547 ' H ' ' C ' ' B' ' 229' ' ' ASP . 74.9 mt-30 -128.68 29.49 5.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.484 -179.571 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -110.78 -156.59 14.72 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.89 -179.414 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -75.36 161.56 37.51 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 123.369 2.712 . . . . 0.0 113.505 -178.972 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -76.32 143.66 25.28 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 122.375 2.05 . . . . 0.0 113.289 -179.37 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 35.1 m -76.44 135.42 26.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 114.66 -1.154 . . . . 0.0 109.989 179.799 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 5.1 t -67.81 128.01 34.9 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.403 -178.732 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . 0.417 ' O1P' ' OG1' ' B' ' 240' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.82 -19.07 52.54 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.379 2.053 . . . . 0.0 111.579 -179.706 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 240' ' ' THR . . . . . 0.417 ' OG1' ' O1P' ' B' ' 238' ' ' TPO . 60.4 m -75.27 -43.01 53.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.599 177.445 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -59.18 -45.11 91.9 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.031 -179.949 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 98.2 mt -63.8 -39.32 93.95 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.091 0.472 . . . . 0.0 110.124 179.899 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -62.25 -41.71 98.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.768 179.985 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -62.36 -37.2 84.77 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.178 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.593 ' NH2' ' OE1' ' B' ' 248' ' ' GLN . 0.0 OUTLIER -58.5 -43.14 88.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.875 179.684 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -61.16 -38.48 86.6 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.587 -0.524 . . . . 0.0 109.587 178.95 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 38.0 t -64.1 -43.08 96.43 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 177.601 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . 0.593 ' OE1' ' NH2' ' B' ' 245' ' ' ARG . 36.7 mt-30 -58.49 -37.9 76.53 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.419 179.881 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 38.5 t -61.11 -46.72 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 120.546 -0.461 . . . . 0.0 110.345 179.859 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -58.89 -29.22 66.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.027 0.441 . . . . 0.0 109.837 179.503 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -91.87 -8.64 45.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.489 179.429 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.491 ' CD2' HH21 ' A' ' 12' ' ' ARG . 63.2 tp -77.33 139.42 39.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.64 -179.2 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -101.67 124.76 47.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.129 -0.942 . . . . 0.0 110.398 179.453 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . 0.522 ' C ' ' H ' ' B' ' 256' ' ' ASP . 95.6 m-20 -61.22 -35.48 77.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.443 -179.645 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -64.92 -0.4 1.52 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.556 179.699 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.522 ' H ' ' C ' ' B' ' 254' ' ' ASP . 42.0 t0 -107.03 96.51 6.48 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.564 179.255 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . 0.484 ' O ' ' C ' ' B' ' 258' ' ' ASP . 98.7 mttt -69.96 -81.65 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.582 -179.667 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.484 ' C ' ' O ' ' B' ' 257' ' ' LYS . 84.5 m-20 -28.31 112.78 0.07 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.693 -178.942 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.633 ' C ' ' H ' ' B' ' 261' ' ' ILE . 30.3 t0 -116.94 -177.12 3.12 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.309 0.575 . . . . 0.0 110.299 -179.502 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.452 ' H ' ' CG ' ' B' ' 259' ' ' ASP . 95.5 mt-10 -56.24 5.78 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.366 -179.501 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . 0.633 ' H ' ' C ' ' B' ' 259' ' ' ASP . 82.8 mt -111.47 132.28 60.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.838 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 54.9 t -127.98 136.03 61.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.149 -179.873 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -96.99 121.97 39.46 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.41 0.624 . . . . 0.0 111.258 -179.029 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . 0.462 ' HZ1' ' HA ' ' A' ' 34' ' ' GLU . 88.3 tttt -66.25 -46.16 78.07 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.037 179.473 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . 0.521 ' OE1' ' O ' ' B' ' 266' ' ' PRO . 0.0 OUTLIER -94.8 157.22 37.18 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.036 -179.418 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . 0.521 ' O ' ' OE1' ' B' ' 265' ' ' GLN . 57.2 Cg_endo -65.72 145.26 80.73 Favored 'Trans proline' 0 N--CA 1.5 1.882 0 C-N-CA 123.15 2.566 . . . . 0.0 113.118 -178.852 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 43.9 pt . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.224 178.95 . . . . . . . . 0 0 . 1 . 041 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo . . . . . 0 N--CA 1.494 1.525 0 CA-C-O 120.931 0.305 . . . . 0.0 111.85 . . . . . . . . . 0 0 . 1 . 041 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.511 ' OG1' ' O ' ' A' ' 100' ' ' GLU . 34.2 p -128.43 26.82 5.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.528 -179.855 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.733 ' NE ' ' HH ' ' A' ' 97' ' ' TYR . 83.5 mtp180 -85.17 129.89 34.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.155 -179.418 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.75 HH21 ' HD1' ' A' ' 19' ' ' HIS . 79.5 ttt180 -124.42 131.38 53.5 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -178.783 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 40.3 tp -109.81 132.36 54.22 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.208 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.7 t -109.79 128.45 65.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.467 -178.952 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.6 m -89.93 115.04 26.93 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.565 -179.429 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.4 mt -79.87 140.14 17.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.151 179.393 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -89.93 160.41 16.43 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.182 0.515 . . . . 0.0 111.046 179.071 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.597 ' NH2' ' N ' ' B' ' 249' ' ' VAL . 73.5 mtp180 -57.52 -31.96 66.57 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.779 -179.757 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 99.7 p -77.38 -11.59 59.86 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.634 -179.634 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.93 31.68 9.72 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 -179.682 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.7 t -115.86 133.37 62.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.432 -0.384 . . . . 0.0 110.427 -179.68 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.436 ' C ' ' OD1' ' A' ' 16' ' ' ASP . 49.0 t0 -62.02 120.33 10.61 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.6 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -103.31 -134.81 8.42 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 120.892 -0.67 . . . . 0.0 111.808 -178.7 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -75.14 150.7 37.94 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.526 2.151 . . . . 0.0 112.534 -178.945 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.75 ' HD1' HH21 ' A' ' 6' ' ' ARG . 0.6 OUTLIER -108.51 131.08 55.18 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.64 -179.541 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -100.84 100.38 12.59 Favored Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.347 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.28 134.74 21.45 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 121.095 1.197 . . . . 0.0 111.581 -178.303 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 68.2 mt -99.38 124.17 44.28 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.627 0.727 . . . . 0.0 111.574 -178.118 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.6 p -137.09 -19.7 1.27 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.404 -1.271 . . . . 0.0 109.284 178.714 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 58.7 mt -79.15 144.92 34.02 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.355 179.41 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 90.9 p -61.82 -21.3 64.5 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -178.248 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.441 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 53.9 m -135.08 134.79 40.69 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.213 -0.595 . . . . 0.0 112.561 -178.618 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.9 t -124.81 116.23 21.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.602 178.119 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 49.6 tp -116.73 132.86 56.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.957 0.408 . . . . 0.0 112.042 -178.337 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.441 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 10.8 m-85 -110.49 140.6 44.6 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.233 178.973 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 154.13 -176.29 32.06 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.044 178.735 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.646 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 80.2 mtm-85 -75.48 -30.72 59.99 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 120.956 0.407 . . . . 0.0 110.111 179.562 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.556 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -51.06 145.07 11.69 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.848 -178.608 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.403 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 10.7 tp -68.12 -41.0 83.86 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 120.872 0.368 . . . . 0.0 110.095 179.271 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.403 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 80.6 tt0 -55.67 -22.09 21.36 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.47 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.556 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 19.0 m -58.82 121.41 11.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.837 179.369 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.441 ' OD2' ' O ' ' A' ' 26' ' ' THR . 96.2 m-20 -58.65 -25.05 62.36 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -178.767 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 82.1 mt -131.21 122.74 51.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.565 177.27 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 60.6 mtm180 -101.08 134.22 44.41 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.491 179.658 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.404 ' C ' ' H ' ' A' ' 41' ' ' LEU . 96.4 mt -116.47 127.87 73.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.484 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -74.66 28.21 0.09 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.23 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.404 ' H ' ' C ' ' A' ' 39' ' ' ILE . 40.7 mt -98.31 129.54 30.34 Favored Pre-proline 0 CA--C 1.538 0.508 0 C-N-CA 119.924 -0.711 . . . . 0.0 110.737 179.922 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.59 -7.53 20.35 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.607 2.205 . . . . 0.0 112.072 -179.523 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.4 m -102.06 6.79 9.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.112 -179.355 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.646 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 17.4 t -95.08 136.43 26.17 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.268 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.864 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.5 m -69.43 167.48 16.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.054 0.454 . . . . 0.0 111.147 -179.384 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 47.3 mttp -63.5 -38.6 91.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.966 -179.53 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.676 ' O ' ' N ' ' A' ' 49' ' ' CYS . 91.7 mm-40 -113.66 -17.99 12.0 Favored 'General case' 0 C--O 1.223 -0.338 0 O-C-N 123.474 0.484 . . . . 0.0 111.371 -179.159 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 23.2 t60 29.63 -74.97 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.52 0.934 . . . . 0.0 113.52 -179.608 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.676 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.11 133.83 46.0 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.427 0.632 . . . . 0.0 112.402 -178.287 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -128.55 128.37 44.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.2 179.537 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 85.2 mt -109.47 132.37 57.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.422 179.667 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -114.63 124.24 51.33 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.11 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 64.5 mt -107.46 116.59 51.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 120.02 -0.672 . . . . 0.0 112.727 -177.661 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.455 ' O ' ' C ' ' A' ' 55' ' ' GLU . 97.4 m-70 -111.49 139.26 47.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.905 178.654 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 54' ' ' HIS . 84.0 tt0 -41.21 -30.05 0.15 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 119.926 -0.709 . . . . 0.0 109.306 -179.943 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.431 ' N ' ' O ' ' A' ' 54' ' ' HIS . 84.8 mt-30 -61.08 -68.09 0.34 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.622 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -156.19 -174.04 4.77 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.1 -179.772 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.512 ' CB ' HH22 ' A' ' 5' ' ' ARG . . . -108.32 125.3 51.54 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.022 179.732 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.1 mt -119.23 130.77 73.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.369 0.604 . . . . 0.0 112.471 -178.55 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 18.4 tp -97.86 127.94 44.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.367 179.503 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -109.0 134.81 51.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.891 179.621 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.417 HD22 ' HA ' ' A' ' 68' ' ' PRO . 64.5 t-20 -94.49 105.49 17.46 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.39 -178.866 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -98.75 -8.28 26.28 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.689 179.497 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.6 m -71.52 101.93 2.58 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.304 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 89.7 p -87.84 -24.13 23.8 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.107 179.821 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.27 -42.1 32.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.312 0.577 . . . . 0.0 109.769 179.323 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 36.7 m-20 -143.13 99.31 5.46 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.875 -179.498 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.417 ' HA ' HD22 ' A' ' 62' ' ' ASN . 52.7 Cg_exo -54.77 148.17 46.95 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.197 1.931 . . . . 0.0 113.41 -179.578 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.1 m -75.04 142.07 43.81 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.293 179.457 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -108.2 139.9 42.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.928 179.688 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 54.8 t -131.75 135.33 59.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.579 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 51.81 31.72 8.63 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.28 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.51 25.06 68.79 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-N 114.957 -1.02 . . . . 0.0 112.132 179.743 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 66.1 m -142.93 142.52 31.71 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 117.725 0.762 . . . . 0.0 112.57 -179.576 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.8 t -69.85 142.08 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.312 179.424 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.3 pt -110.98 77.08 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.478 179.221 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -52.55 -29.56 26.14 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.4 179.943 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.56 171.25 6.34 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.145 179.366 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -60.63 148.44 91.4 Favored 'Trans proline' 0 N--CA 1.499 1.84 0 C-N-CA 122.276 1.984 . . . . 0.0 111.832 179.631 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.8 p -138.15 140.83 39.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.995 0.426 . . . . 0.0 111.625 -179.391 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.9 mtm180 -75.12 128.53 35.73 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.025 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.5 mt -84.4 138.96 32.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.958 0.409 . . . . 0.0 111.054 -179.449 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -131.83 155.63 47.46 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.583 179.987 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.728 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 5.7 t60 -56.92 115.13 2.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.446 179.944 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.3 -12.49 26.15 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 -179.462 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.464 ' OD1' ' N ' ' A' ' 87' ' ' VAL . 58.7 t0 -70.01 129.79 40.41 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 179.615 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.464 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 60.9 t -110.96 131.82 61.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.228 -179.237 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 94.4 mt -97.63 129.79 47.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.379 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 77.7 m -120.46 125.71 48.59 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.69 0.757 . . . . 0.0 112.777 -178.231 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.47 ' N ' ' O ' ' A' ' 93' ' ' ARG . 95.7 mt -112.2 123.47 67.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.347 178.079 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.464 ' C ' ' O ' ' A' ' 90' ' ' ILE . 96.0 mt 34.33 -98.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 121.201 -0.2 . . . . 0.0 110.972 -178.883 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.587 ' OD2' ' CZ ' ' B' ' 245' ' ' ARG . 50.1 p-10 -114.43 15.03 17.97 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.913 0.387 . . . . 0.0 111.544 -179.99 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.47 ' O ' ' N ' ' A' ' 90' ' ' ILE . 84.6 mtt-85 -124.89 142.48 51.43 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.765 179.058 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 53.8 p -141.0 154.43 46.02 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.715 179.549 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -124.32 125.46 44.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.555 179.757 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 79.4 mtp85 -88.48 132.4 34.5 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.83 -179.494 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.733 ' HH ' ' NE ' ' A' ' 5' ' ' ARG . 88.3 t80 -95.21 127.87 41.6 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.197 -179.609 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -131.24 116.43 17.64 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.303 -179.613 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.728 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 61.9 t-20 -109.71 111.01 22.21 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.963 -179.806 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.511 ' O ' ' OG1' ' A' ' 4' ' ' THR . 79.6 tt0 . . . . . 0 C--N 1.331 -0.224 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.656 -179.598 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 37.3 t . . . . . 0 C--O 1.232 0.165 0 N-CA-C 111.542 0.201 . . . . 0.0 111.542 . . . . . . . . . 0 0 . 1 . 041 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.401 ' C ' ' H ' ' B' ' 231' ' ' GLN . 99.1 m-20 -65.12 141.73 58.61 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.404 0.621 . . . . 0.0 111.368 -178.92 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 041 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.401 ' H ' ' C ' ' B' ' 229' ' ' ASP . 98.4 mm-40 -121.88 40.14 3.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.301 -179.069 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -122.08 -179.26 15.91 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.679 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.48 161.14 47.08 Favored 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 123.575 2.85 . . . . 0.0 112.697 179.861 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 041 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -77.19 142.46 21.59 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 121.656 1.57 . . . . 0.0 113.44 -179.331 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 53.7 t -63.91 136.32 26.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.542 -179.355 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 14.8 t -57.64 123.51 15.89 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.764 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 041 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.15 -27.22 36.36 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.913 1.742 . . . . 0.0 111.986 179.519 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 19.9 m -68.3 -44.42 75.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.321 0.581 . . . . 0.0 109.67 178.001 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -58.47 -47.26 84.62 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.411 -179.296 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 93.8 mt -63.32 -40.68 97.99 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.146 -179.501 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -64.42 -41.25 96.71 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.115 -179.42 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -62.0 -41.86 98.52 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.016 -179.653 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.587 ' CZ ' ' OD2' ' A' ' 92' ' ' ASP . 8.2 tpp85 -61.28 -42.02 97.94 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.277 179.595 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -61.39 -41.38 97.04 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.412 179.891 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 58.5 m -68.75 -41.91 78.27 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.305 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . 0.621 ' O ' ' N ' ' B' ' 252' ' ' LEU . 62.1 tt0 -61.1 -39.67 90.84 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.119 -179.422 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . 0.597 ' N ' ' NH2' ' A' ' 12' ' ' ARG . 0.3 OUTLIER -64.68 -39.02 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 119.932 -0.707 . . . . 0.0 109.25 179.165 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . 0.45 ' N ' HG11 ' B' ' 249' ' ' VAL . . . -60.37 -32.0 70.87 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.067 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -100.12 -11.54 20.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.859 178.82 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.621 ' N ' ' O ' ' B' ' 248' ' ' GLN . 0.9 OUTLIER -122.3 113.83 19.95 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.127 179.994 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . 0.474 ' O ' ' CG ' ' B' ' 253' ' ' ASN . 9.9 t-20 175.31 42.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.796 179.952 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . 0.588 ' O ' ' CB ' ' B' ' 255' ' ' ASP . 38.3 p-10 -93.4 2.18 56.6 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.381 179.941 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . 0.588 ' CB ' ' O ' ' B' ' 254' ' ' ASP . 61.5 t0 113.51 57.98 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 O-C-N 124.492 1.12 . . . . 0.0 109.956 -179.775 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -86.88 79.22 8.86 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.802 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -64.28 -4.8 4.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.071 -178.943 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.74 ' O ' ' N ' ' B' ' 260' ' ' GLU . 95.7 m-20 -94.72 -2.36 51.26 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.138 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.463 ' C ' ' O ' ' B' ' 258' ' ' ASP . 48.7 p30 0.1 54.13 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 114.32 -1.309 . . . . 0.0 113.161 -179.807 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.74 ' N ' ' O ' ' B' ' 258' ' ' ASP . 97.0 mt-10 59.09 8.16 0.98 Allowed 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 178.97 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 65.0 mt -118.4 133.44 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 120.604 -0.438 . . . . 0.0 109.839 179.703 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 49.6 t -128.46 135.91 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 120.786 0.327 . . . . 0.0 110.836 -179.693 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -97.42 119.64 36.32 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.298 0.57 . . . . 0.0 112.156 -178.641 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . 0.403 ' HZ1' ' HA ' ' A' ' 34' ' ' GLU . 87.5 tttt -64.93 -45.37 86.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.292 178.552 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -89.9 157.84 45.48 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.393 -179.002 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -60.71 144.15 99.5 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 C-N-CA 122.055 1.837 . . . . 0.0 111.139 179.173 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . 0.498 ' CD1' ' O ' ' A' ' 19' ' ' HIS . 2.5 tt . . . . . 0 C--N 1.324 -0.514 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.549 -178.555 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo . . . . . 0 N--CA 1.499 1.848 0 CA-C-O 121.118 0.383 . . . . 0.0 112.608 . . . . . . . . . 0 0 . 1 . 042 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.7 p -117.19 -35.13 4.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.061 -178.592 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.4 mtm-85 -93.4 121.61 34.97 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.282 -178.725 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.747 HH21 ' ND1' ' A' ' 19' ' ' HIS . 80.5 ttt180 -130.23 132.01 45.78 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.757 -179.566 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 26.0 tp -112.84 133.33 54.88 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -179.928 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.6 t -110.49 131.98 60.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 121.071 -0.251 . . . . 0.0 110.903 -179.492 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 m -93.24 114.38 26.84 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.317 0.58 . . . . 0.0 112.026 -178.713 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.425 HG22 HD13 ' A' ' 10' ' ' ILE . 98.2 mt -83.73 146.63 6.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.712 178.538 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -90.49 158.77 16.86 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.903 0.382 . . . . 0.0 110.028 179.063 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' B' ' 245' ' ' ARG . 89.7 mtm180 -57.55 -25.54 60.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.03 -179.608 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 90.3 p -79.94 -10.67 59.8 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.838 179.56 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.59 34.69 7.74 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 -179.738 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.3 t -121.03 135.28 61.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.988 0.423 . . . . 0.0 111.381 -179.681 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -74.06 123.49 24.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.278 179.39 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -118.36 -119.97 2.95 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 120.894 -0.67 . . . . 0.0 111.724 -179.327 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -76.21 149.81 32.37 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.137 1.891 . . . . 0.0 111.549 -179.321 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.747 ' ND1' HH21 ' A' ' 6' ' ' ARG . 0.3 OUTLIER -111.79 156.66 21.61 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.787 179.93 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -121.76 101.97 42.06 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.03 -179.025 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -73.72 129.59 13.72 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 121.515 1.476 . . . . 0.0 111.359 -179.907 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 93.7 mt -82.12 52.64 2.04 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 120.779 0.324 . . . . 0.0 111.745 -178.567 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.401 ' OG ' ' OE1' ' B' ' 265' ' ' GLN . 91.5 p -62.69 -17.67 61.04 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.415 0.626 . . . . 0.0 109.947 179.22 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.0 mt -90.38 142.17 28.0 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.605 -179.545 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.1 m -66.08 -20.04 66.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.256 -179.847 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.5 m -130.41 131.96 45.51 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.516 -179.816 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.6 t -124.77 116.44 22.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.368 178.655 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 36' ' ' ASP . 50.9 tp -114.41 125.35 53.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.85 -178.753 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.52 ' O ' ' O ' ' A' ' 47' ' ' GLN . 6.9 m-85 -108.11 142.1 38.81 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.789 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 163.86 -165.98 37.24 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.197 -1.002 . . . . 0.0 112.336 178.71 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.472 ' NH2' ' O ' ' B' ' 232' ' ' GLY . 28.8 ttp-105 -91.48 -31.0 16.14 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.8 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.576 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -60.75 156.63 31.68 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -179.659 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.7 tp -69.06 -39.27 79.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.872 -179.988 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -52.41 -23.46 6.07 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.969 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.576 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 6.1 m -61.25 118.84 7.39 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.118 -179.586 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.549 ' N ' ' O ' ' A' ' 28' ' ' LEU . 99.0 m-20 -58.53 -25.02 61.99 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.448 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 47.5 mm -123.63 108.57 21.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 177.021 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 45.0 mtm180 -100.36 135.08 42.34 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -177.969 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.417 HG22 ' NH2' ' A' ' 93' ' ' ARG . 96.8 mt -122.03 132.46 70.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.401 0.62 . . . . 0.0 111.477 -178.851 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -68.84 13.37 0.1 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 114.929 -1.032 . . . . 0.0 112.974 -178.579 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.714 ' CD1' HH21 ' A' ' 93' ' ' ARG . 17.5 mt -94.18 124.87 54.57 Favored Pre-proline 0 C--N 1.32 -0.712 0 C-N-CA 118.973 -1.091 . . . . 0.0 110.166 179.87 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -73.91 -8.97 21.92 Favored 'Trans proline' 0 C--N 1.315 -1.207 0 C-N-CA 122.165 1.91 . . . . 0.0 111.715 179.939 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.0 m -90.29 -0.1 8.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.193 179.302 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.0 p -91.03 139.32 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-O 121.123 0.487 . . . . 0.0 110.205 -179.986 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.8 t -68.88 161.86 27.77 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.226 0.536 . . . . 0.0 111.354 -178.768 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.468 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 79.9 mttt -61.22 -42.37 98.49 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.614 -178.383 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.672 ' O ' ' N ' ' A' ' 49' ' ' CYS . 90.1 mt-30 -115.44 -12.45 11.7 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 121.061 -0.256 . . . . 0.0 111.246 179.512 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.452 ' CD2' ' OG1' ' A' ' 69' ' ' THR . 20.1 t60 30.76 -73.37 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 179.49 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.672 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -135.56 140.51 44.72 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 119.91 -0.716 . . . . 0.0 112.324 -178.6 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -129.24 130.7 46.59 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.769 179.876 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.7 mt -111.83 131.96 61.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.989 179.717 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -113.34 124.56 52.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.863 179.032 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.456 HD13 HG23 ' A' ' 53' ' ' ILE . 48.3 mm -99.45 108.17 22.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.533 -179.895 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.458 ' O ' ' C ' ' A' ' 55' ' ' GLU . 94.7 m-70 -106.48 133.21 51.51 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.681 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 54' ' ' HIS . 95.7 mt-10 -42.32 -31.17 0.37 Allowed 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 119.585 -0.846 . . . . 0.0 108.974 -179.599 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.416 ' N ' ' C ' ' A' ' 54' ' ' HIS . 88.2 mt-30 -67.99 -68.83 0.36 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.759 178.831 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -146.86 176.16 10.1 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.13 0.491 . . . . 0.0 111.603 -179.128 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -111.33 123.2 49.73 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.678 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 93.1 mt -117.06 135.25 58.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -177.631 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 24.9 tp -100.59 125.64 46.98 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.876 -179.932 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -111.34 137.4 49.14 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.197 -179.539 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 64.0 t-20 -98.66 106.22 18.47 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.243 179.478 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -97.26 -10.68 25.29 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 179.865 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.98 106.86 3.36 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 179.955 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 85.7 p -91.88 -15.04 28.69 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.166 -0.613 . . . . 0.0 110.03 179.229 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.2 -46.12 7.55 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.567 -179.83 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -132.48 92.93 26.33 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.729 179.724 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -56.15 140.89 87.87 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.226 1.95 . . . . 0.0 112.821 -179.378 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.452 ' OG1' ' CD2' ' A' ' 48' ' ' HIS . 86.9 m -72.5 140.32 48.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.388 179.143 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -101.71 140.65 35.72 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.943 178.896 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.445 ' CG1' ' OD1' ' A' ' 86' ' ' ASP . 75.1 t -134.04 133.11 56.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.436 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.59 ' ND2' ' OD1' ' A' ' 86' ' ' ASP . 89.1 m-20 53.8 33.08 16.15 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 119.909 -0.716 . . . . 0.0 109.128 -179.264 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.63 28.68 68.86 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.077 179.587 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 43.3 t -145.61 143.94 30.16 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 117.242 0.521 . . . . 0.0 111.615 179.942 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 50.9 t -70.28 135.19 28.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.024 179.744 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 9.1 pt -108.36 70.47 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.16 179.048 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -56.17 -30.65 62.52 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.949 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.32 157.75 37.22 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.487 178.605 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -64.05 149.59 90.13 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.314 2.009 . . . . 0.0 112.202 -179.841 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.7 m -139.03 142.93 32.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.202 -179.645 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 60.2 ttp180 -72.69 125.32 27.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.394 179.25 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 98.0 mt -77.33 138.7 39.5 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.362 0.601 . . . . 0.0 110.779 179.299 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -136.35 155.15 50.46 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.93 -179.411 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.481 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 3.6 t-160 -55.83 113.16 1.38 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.358 -179.647 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.79 -6.76 22.16 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 121.169 -0.539 . . . . 0.0 111.767 179.977 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.59 ' OD1' ' ND2' ' A' ' 72' ' ' ASN . 37.9 t0 -76.73 124.34 27.53 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.249 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 45.8 t -108.12 129.5 62.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.328 -178.476 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 81.9 mt -97.13 132.2 42.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.842 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.9 m -116.41 126.23 53.15 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.072 0.463 . . . . 0.0 111.605 -179.448 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.4 ' CG2' HH12 ' A' ' 93' ' ' ARG . 87.8 mt -122.2 123.14 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.465 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 45.0 mm 40.31 -106.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 121.065 -0.254 . . . . 0.0 110.506 -179.609 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.562 ' O ' ' OD1' ' A' ' 92' ' ' ASP . 66.3 t0 -110.48 18.93 19.28 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.06 0.457 . . . . 0.0 110.677 -179.863 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.714 HH21 ' CD1' ' A' ' 41' ' ' LEU . 8.5 mtm105 -125.44 142.95 51.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.369 -179.985 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 75.2 m -134.43 147.36 50.42 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 120.355 -0.538 . . . . 0.0 109.713 178.296 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -125.28 124.29 41.31 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.931 -179.566 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -90.58 131.76 36.11 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.292 -179.116 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -93.4 123.76 36.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.372 179.269 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -120.04 126.48 50.9 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.213 -179.855 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.481 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 11.5 t-20 -113.77 -163.7 0.88 Allowed 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.612 179.732 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 . . . . . 0 N--CA 1.465 0.307 0 CA-C-O 120.871 0.367 . . . . 0.0 110.342 179.885 . . . . . . . . 0 0 . 1 . 042 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . 0.417 ' CG1' ' O ' ' B' ' 228' ' ' VAL . 10.0 p . . . . . 0 CA--C 1.531 0.222 0 CA-C-O 121.193 0.521 . . . . 0.0 111.213 . . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.416 ' O ' ' OD1' ' B' ' 229' ' ' ASP . 56.5 t0 -112.33 22.0 15.16 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.521 179.69 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . 0.573 ' O ' ' NE2' ' B' ' 231' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.573 ' NE2' ' O ' ' B' ' 230' ' ' SEP . 1.0 OUTLIER 158.2 -23.77 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.592 0.557 . . . . 0.0 111.215 179.995 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . 0.472 ' O ' ' NH2' ' A' ' 31' ' ' ARG . . . -52.07 -163.46 0.01 OUTLIER Glycine 0 CA--C 1.533 1.203 0 C-N-CA 121.238 -0.506 . . . . 0.0 112.181 -178.63 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -65.06 161.0 38.92 Favored 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 124.149 3.233 . . . . 0.0 112.908 -179.512 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 042 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -68.94 133.8 28.03 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 121.598 1.532 . . . . 0.0 112.513 -179.206 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 39.4 t -61.81 138.59 22.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.271 -179.757 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 10.4 t -63.9 130.34 43.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.433 -179.428 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . 0.487 ' P ' ' OG1' ' B' ' 240' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -59.36 -24.88 76.39 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 122.975 2.45 . . . . 0.0 112.945 -180.0 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' B' B ' 240' ' ' THR . . . . . 0.487 ' OG1' ' P ' ' B' ' 238' ' ' TPO . 2.9 p -73.65 -40.67 63.55 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.908 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -57.25 -46.9 82.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.115 179.976 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 95.7 mt -64.12 -41.4 97.25 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.884 -179.758 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -62.1 -39.72 93.43 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.757 -179.457 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -63.0 -41.3 99.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.889 0.376 . . . . 0.0 110.688 179.407 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.421 ' HD2' HH11 ' A' ' 12' ' ' ARG . 22.7 mmt180 -62.61 -39.01 92.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.026 -179.605 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.32 -39.58 93.5 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.007 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 46.1 t -64.75 -45.01 88.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.488 177.629 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . 0.547 ' O ' ' N ' ' B' ' 252' ' ' LEU . 84.8 mt-30 -60.4 -38.15 83.07 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.793 -179.348 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 40.3 t -61.79 -45.67 98.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.514 -179.791 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -60.45 -28.48 68.34 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.566 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -98.6 -8.81 25.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.974 179.172 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.547 ' N ' ' O ' ' B' ' 248' ' ' GLN . 36.9 tp -76.2 144.36 40.52 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.962 -179.109 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -99.52 136.96 38.69 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.77 179.163 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -67.12 -21.01 65.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.221 -179.559 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 39.2 p-10 -75.45 -0.36 19.81 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.335 -179.135 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.426 ' O ' ' C ' ' B' ' 257' ' ' LYS . 88.5 m-20 -93.07 -7.46 45.57 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.818 0.342 . . . . 0.0 110.104 179.212 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . 0.559 ' O ' ' C ' ' B' ' 258' ' ' ASP . 99.4 mttt 35.34 -104.94 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.237 179.947 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.559 ' C ' ' O ' ' B' ' 257' ' ' LYS . 64.7 t0 -8.54 80.1 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 O-C-N 123.912 0.757 . . . . 0.0 111.626 179.523 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' B' ' 257' ' ' LYS . 66.3 t0 -82.69 72.92 9.76 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.829 -178.852 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.57 ' N ' ' OE1' ' B' ' 260' ' ' GLU . 44.1 mp0 56.41 5.84 0.22 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 178.426 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 44.6 mt -114.48 134.58 56.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.609 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 74.0 t -126.4 130.77 71.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.114 0.483 . . . . 0.0 110.18 179.6 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -90.62 116.38 28.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.467 -178.403 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -64.91 -44.41 89.67 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.18 179.688 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . 0.401 ' OE1' ' OG ' ' A' ' 23' ' ' SER . 0.0 OUTLIER -92.97 156.34 40.56 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.421 -179.144 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -61.74 145.66 97.18 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.843 2.362 . . . . 0.0 112.146 -179.944 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 27.2 pt . . . . . 0 C--N 1.321 -0.65 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.99 -179.695 . . . . . . . . 0 0 . 1 . 043 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo . . . . . 0 N--CA 1.494 1.52 0 CA-C-O 120.907 0.295 . . . . 0.0 111.743 . . . . . . . . . 0 0 . 1 . 043 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.0 p -118.95 -43.07 2.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.815 -179.607 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 90.9 mtm-85 -98.7 124.98 43.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.489 -179.624 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 88.6 mtm-85 -129.0 137.85 51.59 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.903 -179.995 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 33.9 tp -109.96 129.52 55.65 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.986 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 52.8 t -109.76 131.15 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 120.942 0.401 . . . . 0.0 110.662 -179.463 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 m -79.78 140.33 36.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.449 -179.097 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.436 ' CD1' ' OD1' ' A' ' 16' ' ' ASP . 50.6 mm -108.69 135.52 47.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.509 177.505 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.453 ' HZ2' ' CG ' ' B' ' 257' ' ' LYS . 47.7 mttm -86.86 156.4 19.87 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.258 179.185 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.764 ' H ' ' NZ ' ' B' ' 257' ' ' LYS . 89.3 mtm180 -57.1 -29.57 63.63 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.64 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.4 t -78.11 -14.54 59.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.674 179.303 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.75 35.57 5.83 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.208 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.1 t -119.98 130.45 74.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.963 0.411 . . . . 0.0 110.958 -179.623 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.436 ' OD1' ' CD1' ' A' ' 10' ' ' ILE . 97.7 m-20 -72.25 136.36 46.3 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.193 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -127.85 -122.74 2.54 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 120.533 -0.841 . . . . 0.0 111.971 -178.887 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -74.12 151.03 43.69 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.33 2.02 . . . . 0.0 112.779 -178.616 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -110.76 149.79 30.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.621 -179.712 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -122.19 102.7 39.91 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.475 -179.395 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.43 134.41 22.54 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.551 1.501 . . . . 0.0 112.105 -178.485 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 91.1 mt -81.62 56.53 3.02 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.129 -179.285 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.586 ' HG ' HE22 ' B' ' 265' ' ' GLN . 6.0 p -68.09 -23.09 64.89 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.142 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.5 mt -86.21 142.26 28.73 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.599 178.737 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 70.3 p -67.8 -16.17 63.98 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.484 -179.108 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.504 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 66.8 m -133.17 135.29 45.03 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.489 179.973 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.676 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 2.1 t -127.85 114.94 17.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.068 178.675 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.427 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 46.1 tp -110.96 128.16 55.74 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.588 -178.873 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.676 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 35.1 m-85 -104.75 137.57 42.35 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.788 178.933 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 158.55 -171.29 35.29 Favored Glycine 0 N--CA 1.471 1.022 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.809 179.091 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.591 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 83.2 mtm-85 -86.82 -29.61 22.13 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.442 -179.67 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -54.3 157.96 5.93 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 -178.355 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.9 tp -68.89 -40.26 80.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 O-C-N 122.639 -0.33 . . . . 0.0 110.539 179.65 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -57.05 -25.68 59.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.284 -179.825 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.418 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 75.9 m -50.84 115.07 1.34 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.349 179.709 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.504 ' OD2' ' O ' ' A' ' 26' ' ' THR . 94.2 m-20 -58.57 -31.86 68.39 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -179.594 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.435 HG21 HD13 ' A' ' 37' ' ' ILE . 95.2 mt -126.13 122.22 61.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 176.381 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 50.3 mtm180 -105.6 138.85 41.12 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.168 -0.613 . . . . 0.0 112.484 -178.721 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 90.5 mt -122.94 129.28 75.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.937 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -77.33 29.47 0.15 Allowed 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -177.894 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 78.5 mt -90.96 122.11 67.12 Favored Pre-proline 0 C--N 1.323 -0.581 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.671 179.455 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.7 -7.91 22.09 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 122.032 1.821 . . . . 0.0 112.061 -179.252 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.6 m -101.56 5.98 10.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.024 179.673 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.591 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 54.3 t -107.0 114.19 45.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.63 179.682 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.8 t -42.75 170.88 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 122.208 1.004 . . . . 0.0 113.303 -178.208 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.418 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 50.3 mttp -63.21 -40.32 97.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.475 -1.238 . . . . 0.0 112.003 -179.763 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.637 ' O ' ' N ' ' A' ' 49' ' ' CYS . 89.0 mt-30 -112.61 -13.34 13.31 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.217 -179.604 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.401 ' ND1' HG13 ' A' ' 44' ' ' VAL . 34.6 t60 36.73 -74.88 0.0 OUTLIER 'General case' 0 C--O 1.237 0.407 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 179.132 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.637 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -134.84 139.63 45.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.141 -178.336 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -128.94 132.77 47.66 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.603 179.927 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 95.5 mt -117.07 134.48 60.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.38 179.892 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -121.54 127.62 51.16 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.467 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 95.8 mt -102.22 118.32 48.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.368 0.604 . . . . 0.0 112.283 -178.473 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.536 ' O ' ' N ' ' A' ' 56' ' ' GLN . 1.9 m-70 -112.89 139.86 48.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.264 178.992 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.9 mm-40 -39.91 -26.48 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -179.586 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.536 ' N ' ' O ' ' A' ' 54' ' ' HIS . 88.5 mt-30 -65.08 -67.32 0.45 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.086 -0.961 . . . . 0.0 108.662 178.028 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -160.9 -162.7 0.95 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.806 0.336 . . . . 0.0 111.377 179.733 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -106.45 127.46 53.31 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.617 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.407 HG22 HD13 ' A' ' 59' ' ' ILE . 44.4 mm -110.51 125.96 67.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.432 -178.781 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 35.7 tp -99.82 126.84 45.99 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.615 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -117.12 136.71 52.8 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.614 0.245 . . . . 0.0 111.377 -179.328 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.477 HD22 ' CB ' ' A' ' 68' ' ' PRO . 48.5 t30 -98.33 106.41 18.69 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.384 179.573 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -98.59 -8.58 26.18 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 179.664 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.2 t -81.07 98.85 8.18 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.274 -179.799 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.4 t -77.87 -39.61 42.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.243 0.544 . . . . 0.0 109.651 178.238 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.09 -46.33 87.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.745 -179.49 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -137.23 93.86 12.76 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.26 -179.809 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.477 ' CB ' HD22 ' A' ' 62' ' ' ASN . 39.2 Cg_endo -64.57 148.76 90.56 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.4 1.4 . . . . 0.0 112.733 -177.76 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 89.2 m -75.42 153.62 37.57 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.6 -179.29 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -115.47 140.59 49.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.852 -179.572 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 50.4 t -129.46 136.15 59.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.679 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 52.32 32.55 11.19 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.522 0.677 . . . . 0.0 109.484 -179.784 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.06 25.04 74.61 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 114.909 -1.041 . . . . 0.0 112.523 178.973 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.8 t -139.31 141.38 37.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 117.444 0.622 . . . . 0.0 110.631 179.131 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 68.7 t -66.4 136.32 26.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.628 -179.559 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.1 pt -108.32 80.06 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.102 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.474 178.963 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -63.93 -31.63 72.88 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.361 0.601 . . . . 0.0 109.744 179.396 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -111.35 155.83 42.16 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.362 179.024 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -63.52 147.43 93.11 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 122.309 2.006 . . . . 0.0 112.209 -179.707 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.3 m -140.25 145.24 26.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.267 0.556 . . . . 0.0 111.534 -179.884 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -74.4 135.64 42.41 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.171 179.79 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.2 mt -81.02 134.19 35.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.921 0.391 . . . . 0.0 111.134 -179.552 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -128.49 149.29 50.65 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.778 179.119 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.403 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 8.3 t60 -52.01 118.3 3.36 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.873 0.368 . . . . 0.0 111.164 -178.669 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.42 -15.27 30.02 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.184 -0.767 . . . . 0.0 111.184 -179.844 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -69.6 131.93 45.42 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.681 179.975 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 71.4 t -113.78 133.85 58.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.94 -178.531 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.8 mt -102.91 132.87 48.16 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.985 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 96.7 m -120.35 126.91 51.68 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 120.027 -0.669 . . . . 0.0 111.669 -179.497 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.583 ' O ' ' N ' ' A' ' 93' ' ' ARG . 89.4 mt -116.07 130.37 70.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.329 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.556 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 84.5 mt -20.93 94.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -178.202 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.556 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 12.9 t0 94.44 -24.78 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 177.847 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.583 ' N ' ' O ' ' A' ' 90' ' ' ILE . 18.2 mtp85 -131.22 146.67 52.41 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.819 -179.949 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 93.9 p -140.04 156.28 46.68 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.95 0.405 . . . . 0.0 110.251 179.739 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -130.64 128.21 40.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.234 -179.631 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 73.7 mtp85 -89.43 134.69 33.98 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.503 -179.606 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -95.37 124.55 39.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.515 179.698 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -125.23 127.8 47.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.488 -179.9 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.403 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 59.8 t-20 -125.63 114.62 18.94 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.82 0.343 . . . . 0.0 110.686 179.999 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.646 -179.955 . . . . . . . . 0 0 . 1 . 043 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 27.8 m . . . . . 0 N--CA 1.454 -0.27 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 043 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.536 ' O ' ' CB ' ' B' ' 230' ' ' SEP . 46.8 p-10 -102.04 15.89 27.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.351 -179.422 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . 0.551 ' O ' ' NE2' ' B' ' 231' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.551 ' NE2' ' O ' ' B' ' 230' ' ' SEP . 90.7 mm-40 -125.03 63.05 1.15 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.697 179.239 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -131.96 -177.96 15.22 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.405 -179.281 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.16 161.56 40.53 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 123.404 2.736 . . . . 0.0 112.64 -179.889 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 043 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.19 135.77 23.32 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 121.319 1.346 . . . . 0.0 112.998 -179.094 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 55.3 t -60.56 138.31 21.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.279 -179.958 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 2.0 t -70.55 133.41 46.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.066 179.821 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 043 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -58.59 -23.21 64.04 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.482 2.122 . . . . 0.0 112.379 -179.748 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 99.2 m -73.33 -46.07 51.5 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.042 178.513 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -58.3 -47.3 84.12 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.907 -178.47 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.8 -42.6 97.68 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.719 -0.393 . . . . 0.0 111.8 -179.392 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -65.48 -44.06 88.28 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.183 -179.197 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . 0.533 ' NH1' ' OE1' ' B' ' 248' ' ' GLN . 71.0 ttp85 -65.06 -43.49 92.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.999 0.428 . . . . 0.0 110.3 179.16 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . . . . . . . . . 14.5 tpp180 -61.68 -43.81 98.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.542 -179.604 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -65.49 -38.17 88.98 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.046 178.845 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 47.1 t -63.62 -45.15 91.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.464 179.257 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . 0.533 ' OE1' ' NH1' ' B' ' 244' ' ' ARG . 26.1 mt-30 -61.75 -36.13 80.12 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.758 -179.431 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 77.5 t -64.35 -46.31 93.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.025 0.44 . . . . 0.0 110.458 179.197 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -63.68 -32.5 74.01 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.223 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -81.54 -7.57 59.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.482 178.774 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 39.2 tp -105.41 113.8 27.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.936 179.482 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -47.81 145.24 2.94 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.042 -178.367 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -62.62 -30.06 71.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.433 179.64 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . 0.417 ' OD1' ' C ' ' B' ' 255' ' ' ASP . 39.0 p-10 -87.07 9.01 21.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.308 179.752 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.48 ' O ' ' HB2' ' B' ' 257' ' ' LYS . 60.2 t0 -132.63 116.49 16.72 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.945 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . 0.764 ' NZ ' ' H ' ' A' ' 12' ' ' ARG . 86.0 tttt 165.95 97.97 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.458 0 O-C-N 124.063 0.852 . . . . 0.0 109.641 179.379 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' B' ' 258' ' ' ASP . 19.3 p-10 -69.19 -6.77 30.95 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.699 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.667 ' C ' ' H ' ' B' ' 261' ' ' ILE . 46.0 t0 74.44 106.78 0.07 Allowed 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.422 -179.478 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -57.56 12.51 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.303 -1.317 . . . . 0.0 111.982 -179.088 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . 0.667 ' H ' ' C ' ' B' ' 259' ' ' ASP . 60.9 mt -107.2 134.01 50.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.691 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 62.3 t -126.56 131.69 71.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.454 -179.545 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -95.06 120.52 35.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.693 -178.361 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -65.46 -45.24 84.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.659 179.137 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . 0.586 HE22 ' HG ' ' A' ' 23' ' ' SER . 0.0 OUTLIER -89.5 152.77 47.73 Favored Pre-proline 0 C--O 1.231 0.117 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.606 -179.107 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -64.04 141.86 78.71 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.494 2.129 . . . . 0.0 112.116 -179.876 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.1 pt . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.818 179.052 . . . . . . . . 0 0 . 1 . 044 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo . . . . . 0 N--CA 1.495 1.602 0 CA-C-O 121.083 0.368 . . . . 0.0 111.858 . . . . . . . . . 0 0 . 1 . 044 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.469 ' O ' ' O ' ' A' ' 99' ' ' ASN . 26.8 m -73.24 -46.46 50.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.299 -178.96 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.6 mtt85 -92.49 137.26 32.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.229 -178.208 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.7 mtt85 -130.5 139.62 50.51 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.187 -0.46 . . . . 0.0 112.032 -179.655 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 27.3 tp -113.42 130.84 56.21 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.479 179.862 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.5 ' CG1' ' OD1' ' A' ' 16' ' ' ASP . 41.0 t -109.43 129.61 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.215 -178.867 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.9 m -80.2 145.31 32.33 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.797 -178.798 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.7 mt -116.19 137.64 49.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 114.66 -1.155 . . . . 0.0 109.42 178.244 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.429 ' CE ' ' OD1' ' B' ' 259' ' ' ASP . 60.1 mttt -88.43 160.21 17.64 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.402 179.854 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.574 ' HG3' HH11 ' A' ' 93' ' ' ARG . 90.0 mtm180 -57.82 -32.33 67.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.428 -179.329 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.1 t -79.82 -5.87 56.24 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.356 179.358 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.45 38.17 7.25 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.933 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.5 t -115.0 132.57 63.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.298 0.57 . . . . 0.0 111.324 -179.799 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.5 ' OD1' ' CG1' ' A' ' 8' ' ' VAL . 67.1 t0 -77.15 122.84 25.57 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.106 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -118.3 -120.1 2.97 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.173 -178.509 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -74.46 152.56 43.81 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.317 2.011 . . . . 0.0 112.395 -178.893 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -111.17 147.74 34.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.057 0.456 . . . . 0.0 110.18 179.913 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -117.54 101.68 52.35 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.075 -179.255 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -73.08 136.54 24.87 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.279 1.32 . . . . 0.0 111.696 -179.592 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.0 mt -86.57 65.78 9.18 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.527 -178.307 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.594 ' OG ' ' NE2' ' B' ' 265' ' ' GLN . 18.0 p -68.8 -22.43 64.26 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.693 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 76.2 mt -87.53 142.19 28.05 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.378 179.977 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 61.4 p -66.21 -15.6 63.3 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.658 -179.322 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.507 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 35.6 m -133.02 134.04 43.89 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.988 0.423 . . . . 0.0 110.902 -179.558 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.8 t -126.56 118.13 24.24 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.275 179.911 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 44.6 tp -116.87 128.96 55.76 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.05 -179.071 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.539 ' O ' ' O ' ' A' ' 47' ' ' GLN . 5.8 m-85 -105.94 131.02 53.75 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.868 179.717 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.8 179.9 37.65 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 120.253 -0.975 . . . . 0.0 112.368 179.267 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.471 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 45.3 mtm105 -73.39 -32.53 64.51 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 179.573 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.567 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -48.44 149.28 3.97 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -178.548 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.533 ' CD1' ' NH1' ' A' ' 38' ' ' ARG . 10.4 tp -68.06 -41.99 84.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.339 0.59 . . . . 0.0 110.109 179.676 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.439 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 80.8 tt0 -56.74 -20.71 23.46 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.386 -179.823 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.567 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 14.8 m -58.12 128.41 37.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.129 -179.819 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.507 ' OD2' ' O ' ' A' ' 26' ' ' THR . 54.0 m-20 -62.4 -33.47 74.82 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.127 -179.712 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 93.2 mt -125.55 118.57 52.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 177.45 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.533 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 82.9 mtp180 -103.36 139.65 38.49 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.137 -178.762 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.458 ' C ' ' H ' ' A' ' 41' ' ' LEU . 80.5 mt -121.54 129.28 75.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.37 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -74.58 34.93 0.1 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.737 -178.367 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.458 ' H ' ' C ' ' A' ' 39' ' ' ILE . 38.2 mt -102.35 122.66 45.78 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.63 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.1 -6.11 18.45 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 122.415 2.077 . . . . 0.0 112.729 -178.802 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.436 ' CG2' ' CZ ' ' B' ' 241' ' ' PHE . 2.9 m -107.3 6.26 9.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.328 -179.749 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.48 ' O ' ' O ' ' A' ' 45' ' ' SER . 11.8 t -98.27 110.42 25.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.296 0.569 . . . . 0.0 110.693 -179.673 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.48 ' O ' ' O ' ' A' ' 44' ' ' VAL . 1.2 t -33.85 160.25 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.112 -0.949 . . . . 0.0 112.266 -178.94 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -62.04 -42.01 98.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.107 -179.416 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.653 ' O ' ' N ' ' A' ' 49' ' ' CYS . 90.0 mt-30 -114.75 -17.7 11.54 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.696 179.659 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 29.5 t60 35.98 -72.59 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 179.293 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.653 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.71 137.86 47.05 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.067 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -126.84 128.62 46.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.557 179.401 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.3 mt -116.67 135.19 57.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.73 0.3 . . . . 0.0 110.231 179.202 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -113.23 136.79 52.35 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.232 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.8 mm -104.19 124.24 58.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.078 -179.245 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.444 ' O ' ' C ' ' A' ' 55' ' ' GLU . 97.4 m-70 -128.63 135.76 49.75 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.967 179.348 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 54' ' ' HIS . 51.7 tp10 -40.26 -30.37 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.022 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.463 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 92.2 mt-30 -66.34 -67.89 0.41 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.255 178.266 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.508 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 8.3 tp10 -157.93 -158.07 0.7 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.726 -179.352 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.508 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -124.2 130.93 53.38 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.738 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.407 HG23 ' CE1' ' A' ' 61' ' ' HIS . 92.2 mt -119.55 130.67 73.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.188 0.518 . . . . 0.0 111.48 -179.109 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 25.1 tp -95.71 132.23 41.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.845 -179.753 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.407 ' CE1' HG23 ' A' ' 59' ' ' ILE . 98.0 m-70 -117.02 137.38 52.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.075 179.519 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.414 HD22 ' HA ' ' A' ' 68' ' ' PRO . 62.5 t-20 -95.45 106.44 18.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.046 -178.508 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -97.15 -13.54 22.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.972 179.201 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.12 101.21 4.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.46 179.869 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.6 m -87.2 -16.53 35.06 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.118 179.628 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.8 -45.64 10.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.16 179.453 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -135.96 95.67 13.54 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.373 -179.988 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.414 ' HA ' HD22 ' A' ' 62' ' ' ASN . 50.0 Cg_exo -55.16 142.8 77.15 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.227 1.951 . . . . 0.0 113.124 -179.934 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.415 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 5.3 m -70.41 140.85 52.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.008 179.181 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -102.1 140.72 36.01 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.507 -0.477 . . . . 0.0 109.953 179.57 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 51.8 t -129.78 134.64 62.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.52 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 50.28 32.84 6.61 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -179.585 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.37 25.7 67.6 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.628 179.532 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 29.6 t -140.74 141.23 34.89 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 117.606 0.703 . . . . 0.0 111.207 179.573 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -68.19 140.46 19.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.191 -179.878 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.462 ' CG1' ' O ' ' A' ' 78' ' ' GLU . 9.4 tt -106.74 94.03 2.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.43 179.59 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.5 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 16.2 p-10 -68.24 -34.33 76.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.43 179.844 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.462 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 0.1 OUTLIER -130.65 174.88 4.15 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.115 -178.838 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -61.0 142.89 98.86 Favored 'Trans proline' 0 N--CA 1.501 1.954 0 C-N-CA 122.678 2.252 . . . . 0.0 112.775 -179.615 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.2 m -140.33 143.67 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.402 179.857 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -75.05 126.65 31.47 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.812 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.6 mt -79.42 139.26 37.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.917 -179.677 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -126.36 150.12 48.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.445 179.956 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.811 ' HD1' ' H ' ' A' ' 99' ' ' ASN . 9.7 t60 -58.03 121.34 10.37 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.13 -179.561 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.84 -13.82 26.91 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -179.711 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -68.58 134.69 50.36 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.421 179.841 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 74.2 t -108.65 131.84 58.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.68 -178.794 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.465 ' O ' ' OG ' ' A' ' 94' ' ' SER . 83.0 mt -105.6 132.09 53.41 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.1 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.926 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 94.5 m -121.0 125.64 47.88 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 120.305 -0.558 . . . . 0.0 112.044 -178.261 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.454 ' O ' ' C ' ' A' ' 91' ' ' ILE . 92.4 mt -119.05 124.88 73.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 178.716 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.454 ' C ' ' O ' ' A' ' 90' ' ' ILE . 45.0 mm 35.17 -107.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.729 -178.761 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 92' ' ' ASP . 31.3 p-10 -106.04 12.07 30.82 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.385 -179.825 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.574 HH11 ' HG3' ' A' ' 12' ' ' ARG . 19.6 mmm180 -125.85 144.12 50.79 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.593 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' A' ' 88' ' ' ILE . 26.4 t -137.59 155.52 49.11 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.896 -179.858 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -130.13 130.96 45.45 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.559 -0.292 . . . . 0.0 110.739 179.889 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -94.65 134.1 37.59 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.157 179.441 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.459 ' OH ' ' OD1' ' A' ' 99' ' ' ASN . 64.2 t80 -97.63 126.51 42.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.853 179.727 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -134.88 125.69 27.27 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.177 179.849 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.811 ' H ' ' HD1' ' A' ' 84' ' ' HIS . 91.1 m-20 -63.74 -41.37 98.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.512 178.849 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 . . . . . 0 C--N 1.331 -0.204 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.414 -179.719 . . . . . . . . 0 0 . 1 . 044 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.458 -0.061 0 CA-C-O 120.826 0.346 . . . . 0.0 111.107 . . . . . . . . . 0 0 . 1 . 044 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.605 ' O ' ' N ' ' B' ' 231' ' ' GLN . 95.5 m-20 -89.47 147.59 23.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.014 -178.767 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 044 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.605 ' N ' ' O ' ' B' ' 229' ' ' ASP . 0.3 OUTLIER -114.54 57.38 0.71 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.671 -179.019 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -123.04 166.06 15.52 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.082 -0.58 . . . . 0.0 111.687 -179.828 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -73.79 158.33 46.85 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 123.823 3.015 . . . . 0.0 112.472 179.511 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 044 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -72.01 145.2 44.33 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.243 1.962 . . . . 0.0 112.501 179.879 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 47.6 t -76.05 131.42 34.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.107 -0.951 . . . . 0.0 112.009 -178.334 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 4.0 t -76.95 128.02 33.77 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 178.165 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . 0.465 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . 0.465 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 34.3 Cg_exo -59.14 -26.46 81.81 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.764 2.31 . . . . 0.0 112.694 -179.857 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' B' B ' 240' ' ' THR . . . . . 0.4 ' OG1' ' O3P' ' B' ' 238' ' ' TPO . 86.3 m -73.56 -44.09 58.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.224 0.535 . . . . 0.0 109.61 178.259 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . 0.717 ' CE1' ' NE ' ' B' ' 245' ' ' ARG . 53.4 t80 -56.85 -46.93 81.42 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.705 -178.911 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 95.7 mt -64.01 -40.57 96.63 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 121.076 0.465 . . . . 0.0 110.517 -179.856 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -64.1 -39.9 95.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.649 -179.303 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 44.2 ttm180 -60.84 -44.77 96.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.876 0.369 . . . . 0.0 110.209 -179.69 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.717 ' NE ' ' CE1' ' B' ' 241' ' ' PHE . 2.2 mtm-85 -63.26 -40.67 98.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.011 179.858 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.36 -41.42 98.83 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.268 179.117 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 31.3 t -65.93 -45.88 80.25 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.464 0.65 . . . . 0.0 109.674 178.959 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -63.43 -34.53 77.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.261 -179.792 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 51.7 t -63.66 -45.08 98.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.687 179.743 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -65.51 -26.54 67.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.101 0.476 . . . . 0.0 110.254 179.203 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -96.22 -9.35 30.62 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.983 -179.357 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.582 ' CD2' ' OD2' ' B' ' 256' ' ' ASP . 13.3 mt -83.09 143.78 30.33 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -179.346 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . 0.598 ' O ' ' N ' ' B' ' 255' ' ' ASP . 12.9 t-20 -101.96 161.68 13.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.685 178.926 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . 0.431 ' H ' ' ND2' ' B' ' 253' ' ' ASN . 39.1 t70 -42.47 -8.61 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -179.084 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . 0.598 ' N ' ' O ' ' B' ' 253' ' ' ASN . 95.8 m-20 -61.58 -12.82 17.27 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.86 -179.334 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.582 ' OD2' ' CD2' ' B' ' 252' ' ' LEU . 89.5 m-20 -93.42 15.13 16.54 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 120.719 0.295 . . . . 0.0 110.424 179.362 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . 0.461 ' O ' ' OD1' ' B' ' 259' ' ' ASP . 88.8 tttt -58.49 -19.77 39.98 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.354 -179.923 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.456 ' O ' ' CB ' ' B' ' 259' ' ' ASP . 90.7 m-20 -60.65 -41.72 95.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.73 179.107 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.687 ' C ' ' H ' ' B' ' 261' ' ' ILE . 0.6 OUTLIER 82.88 114.16 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.473 179.263 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -51.64 6.88 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.9 -179.36 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . 0.687 ' H ' ' C ' ' B' ' 259' ' ' ASP . 73.3 mt -109.78 140.44 28.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.913 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 78.7 t -128.34 136.38 60.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.865 -178.904 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -97.93 121.01 39.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.362 0.601 . . . . 0.0 111.71 -179.027 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -66.26 -42.79 88.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.194 179.479 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . 0.594 ' NE2' ' OG ' ' A' ' 23' ' ' SER . 0.0 OUTLIER -99.44 161.64 23.9 Favored Pre-proline 0 N--CA 1.465 0.322 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.274 -178.73 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -60.95 149.69 87.56 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.531 2.154 . . . . 0.0 112.14 178.875 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 44.5 pt . . . . . 0 C--N 1.331 -0.201 0 CA-C-O 121.534 0.683 . . . . 0.0 112.295 -179.091 . . . . . . . . 0 0 . 1 . 045 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo . . . . . 0 N--CA 1.491 1.382 0 CA-C-O 120.778 0.241 . . . . 0.0 111.924 . . . . . . . . . 0 0 . 1 . 045 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.1 p -115.5 -36.05 4.4 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.663 -179.8 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.423 ' HE ' ' CD1' ' A' ' 53' ' ' ILE . 87.7 mtm-85 -98.06 121.6 40.18 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.595 -179.711 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -129.98 137.9 50.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.072 179.839 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.455 ' CD2' ' N ' ' A' ' 7' ' ' LEU . 1.1 mm? -111.12 135.37 51.74 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.512 179.416 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.0 t -111.09 126.41 68.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.642 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 m -82.86 112.83 20.03 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.124 -178.337 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 98.1 mt -81.83 139.78 17.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.914 179.242 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -90.44 153.37 20.45 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.286 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.569 ' NH1' ' OD2' ' A' ' 92' ' ' ASP . 30.2 mtp85 -59.75 -26.46 65.69 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.709 179.82 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.3 p -72.53 -19.0 61.59 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.993 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.74 31.3 6.09 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 -179.646 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 51.9 t -121.06 132.37 70.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.928 0.394 . . . . 0.0 111.02 -179.814 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -76.85 139.87 40.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.062 179.262 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -130.9 -115.11 1.7 Allowed Glycine 0 CA--C 1.538 1.524 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.165 -179.378 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -70.21 144.89 52.95 Favored 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 122.2 1.933 . . . . 0.0 113.054 -178.538 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 59.0 m170 -109.14 135.15 50.74 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.586 -179.543 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -106.92 102.57 43.31 Favored Pre-proline 0 N--CA 1.467 0.385 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.043 -179.149 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.47 132.49 16.23 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 121.422 1.414 . . . . 0.0 111.971 -179.986 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 73.3 mt -85.8 58.48 5.07 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -178.745 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 86.5 p -66.76 -17.31 64.8 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 178.842 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.1 mt -86.68 139.67 30.54 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.475 -179.76 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.4 t -63.6 -18.61 64.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.717 -179.905 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.15 140.93 36.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.626 -179.19 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.666 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -137.37 132.57 33.73 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.093 178.875 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 56.3 tp -125.45 123.16 38.64 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.805 -179.067 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.666 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 46.5 m-85 -95.82 141.33 29.4 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.811 179.683 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 147.44 -176.8 26.11 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.066 178.685 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 45.5 mtm180 -70.8 -33.11 70.38 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 179.285 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.577 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -42.62 140.31 2.24 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -179.35 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.0 tp -67.0 -39.29 83.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.936 -179.694 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -58.81 -20.58 51.58 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.189 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.577 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 66.8 m -50.24 119.9 4.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.971 179.632 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -61.75 -31.77 71.98 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 179.736 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.4 HG13 ' CE2' ' A' ' 29' ' ' PHE . 27.1 mm -120.85 105.0 16.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 177.044 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.403 HH12 ' HG2' ' A' ' 40' ' ' GLN . 68.2 ttp85 -98.21 135.98 39.08 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.559 -178.457 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.52 ' CG2' ' NH1' ' A' ' 93' ' ' ARG . 94.5 mt -121.58 131.59 72.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.902 -179.683 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.403 ' HG2' HH12 ' A' ' 38' ' ' ARG . 74.5 mt-30 -78.26 31.78 0.18 Allowed 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -177.693 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 87.1 mt -96.34 122.93 56.4 Favored Pre-proline 0 C--N 1.326 -0.454 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.727 179.586 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.08 -8.29 21.92 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 122.261 1.974 . . . . 0.0 112.601 -179.361 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.5 m -102.17 4.76 10.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.191 179.997 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.0 p -97.32 150.3 4.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.348 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.2 163.43 27.85 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.805 0.812 . . . . 0.0 112.186 -178.869 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.9 mtmt -63.76 -38.1 89.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.131 -179.558 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.621 ' O ' ' N ' ' A' ' 49' ' ' CYS . 10.4 mm100 -110.58 -20.33 12.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.024 0.44 . . . . 0.0 109.967 179.897 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.8 t60 38.3 -77.32 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 179.021 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.621 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -134.73 137.73 43.73 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.42 -0.512 . . . . 0.0 112.085 -178.038 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -123.65 131.57 53.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.886 179.225 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.2 tt -120.13 134.62 63.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.716 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -120.75 128.42 52.9 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.35 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.423 ' CD1' ' HE ' ' A' ' 5' ' ' ARG . 78.4 mt -106.43 122.37 60.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 119.774 -0.77 . . . . 0.0 112.262 -178.754 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.51 ' CD2' ' N ' ' A' ' 54' ' ' HIS . 2.4 m-70 -114.42 137.95 51.18 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.785 179.666 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.466 ' C ' ' O ' ' A' ' 54' ' ' HIS . 97.7 mt-10 -40.93 -29.77 0.11 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.75 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.452 ' N ' ' C ' ' A' ' 54' ' ' HIS . 59.4 tt0 -64.31 -68.21 0.37 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.798 178.294 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -156.82 -168.31 2.63 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.202 -179.853 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -105.52 133.23 50.61 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.532 -179.747 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.419 HG21 HD13 ' A' ' 59' ' ' ILE . 41.4 mm -118.86 125.55 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 120.511 -0.475 . . . . 0.0 111.502 -179.491 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 57.3 tp -104.65 130.48 52.66 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.836 -179.954 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.9 m-70 -121.55 140.41 52.26 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.741 179.923 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.714 ' ND2' ' H ' ' A' ' 69' ' ' THR . 25.2 t-20 -104.62 110.77 23.21 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.892 0.377 . . . . 0.0 111.957 179.743 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -96.66 -4.33 41.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.417 179.18 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.44 100.65 9.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.518 179.97 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 86.5 p -84.87 -29.11 25.53 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.285 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.42 ' O ' ' OD1' ' A' ' 67' ' ' ASN . 2.1 m -64.3 -49.27 72.43 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.078 179.388 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.421 ' OD1' ' CG2' ' B' ' 236' ' ' VAL . 2.7 m-20 -145.75 100.37 4.33 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.563 179.623 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.79 153.23 78.88 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 121.308 1.338 . . . . 0.0 112.038 -178.933 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.714 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 28.3 m -75.14 150.41 38.76 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.642 -179.5 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -108.48 141.18 40.74 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.933 179.307 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 48.8 t -128.2 134.4 65.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.309 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 53.66 31.4 12.63 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -178.622 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.76 29.16 67.82 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.051 179.522 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 67.0 m -139.67 138.52 36.12 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 117.076 0.438 . . . . 0.0 111.213 -179.967 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.7 t -69.94 133.98 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.707 179.527 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.3 pt -101.38 94.14 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 CA-C-O 121.241 0.543 . . . . 0.0 110.506 179.338 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -63.95 -34.47 78.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.123 179.714 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -124.44 172.64 5.6 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.922 179.978 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.61 143.21 99.72 Favored 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 122.151 1.901 . . . . 0.0 112.549 -179.709 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 48.1 t -131.36 138.97 51.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.075 179.905 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 95.8 mtm-85 -76.38 128.82 35.59 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.777 179.174 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 93.7 mt -86.04 134.04 33.87 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.245 0.545 . . . . 0.0 111.277 -179.333 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -124.45 154.41 40.51 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.244 178.954 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.579 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 4.5 t60 -53.63 118.9 4.27 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.32 -179.504 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.44 -11.66 28.31 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.823 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.425 ' C ' ' OD1' ' A' ' 86' ' ' ASP . 50.2 t0 -71.73 126.09 28.82 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.407 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 43.7 t -107.86 129.08 62.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.493 -179.203 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.523 ' O ' ' OG ' ' A' ' 94' ' ' SER . 94.3 mt -94.29 132.52 38.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.315 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.8 m -123.47 123.26 40.24 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.49 0.662 . . . . 0.0 112.572 -178.775 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.511 ' O ' ' N ' ' A' ' 93' ' ' ARG . 90.0 mt -109.51 123.82 65.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.197 177.845 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.487 ' C ' ' O ' ' A' ' 90' ' ' ILE . 86.8 mt 35.2 -96.82 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.509 -0.477 . . . . 0.0 110.613 179.746 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.569 ' OD2' ' NH1' ' A' ' 12' ' ' ARG . 20.8 p-10 -115.03 12.19 16.65 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.736 179.999 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.692 HH21 ' NH2' ' B' ' 245' ' ' ARG . 98.9 mtt180 -124.02 142.13 51.44 Favored 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.444 179.938 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.523 ' OG ' ' O ' ' A' ' 88' ' ' ILE . 38.9 t -138.5 147.62 43.38 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.583 179.834 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -121.78 120.64 35.21 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.095 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -79.7 131.79 36.04 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.343 -178.656 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -95.41 122.18 37.86 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.606 179.855 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -124.56 124.57 42.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.706 -179.708 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.579 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 59.0 t-20 -118.29 116.34 26.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.213 -179.929 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 . . . . . 0 C--N 1.332 -0.157 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.271 -179.549 . . . . . . . . 0 0 . 1 . 045 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 2.3 m . . . . . 0 CA--C 1.529 0.163 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 . . . . . . . . . 0 0 . 1 . 045 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -62.16 -47.55 84.04 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.226 0.536 . . . . 0.0 110.146 -179.896 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . 0.537 ' C ' ' H ' ' B' ' 232' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -75.22 38.99 0.14 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.81 -179.817 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . 0.537 ' H ' ' C ' ' B' ' 230' ' ' SEP . . . -127.06 -179.89 16.02 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 179.978 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -72.43 161.13 45.11 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 123.624 2.883 . . . . 0.0 113.732 -179.531 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 045 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -72.04 140.58 34.85 Favored 'Trans proline' 0 C--N 1.301 -1.971 0 C-N-CA 121.24 1.293 . . . . 0.0 112.799 -179.352 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . 0.421 ' CG2' ' OD1' ' A' ' 67' ' ' ASN . 1.0 OUTLIER -64.44 136.9 25.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.01 -179.473 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 7.7 t -60.34 126.67 28.34 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.843 0.354 . . . . 0.0 110.488 -179.079 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 045 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -56.24 -23.04 43.54 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.111 1.874 . . . . 0.0 112.866 179.768 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 35.8 p -75.47 -40.69 57.07 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.316 -0.553 . . . . 0.0 109.704 178.603 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -57.17 -47.36 81.42 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.677 -179.592 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 91.6 mt -62.65 -41.11 98.87 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.635 179.93 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -65.26 -41.49 94.2 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.76 -179.29 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 80.9 mtt85 -62.18 -43.04 99.72 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.093 179.495 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.692 ' NH2' HH21 ' A' ' 93' ' ' ARG . 24.1 mmm180 -61.19 -39.76 91.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.082 -178.622 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.43 -38.71 90.8 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 179.057 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 71.1 m -62.9 -43.66 98.19 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 177.413 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -59.15 -36.6 75.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.194 179.761 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 63.3 t -61.59 -45.82 97.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.393 179.646 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -59.39 -30.53 68.5 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.586 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -90.47 -9.79 46.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.883 179.103 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 54.1 tp -78.66 144.23 35.57 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.566 179.641 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -107.3 141.51 38.52 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.891 178.521 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -61.45 -32.14 72.11 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.892 0.377 . . . . 0.0 110.798 -179.61 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -71.49 -1.32 12.88 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.593 -179.222 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.483 ' O ' ' C ' ' B' ' 257' ' ' LYS . 93.2 m-20 -88.59 -5.33 58.24 Favored 'General case' 0 N--CA 1.462 0.133 0 C-N-CA 120.709 -0.397 . . . . 0.0 110.638 179.923 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . 0.559 ' O ' ' C ' ' B' ' 258' ' ' ASP . 86.4 tttt 32.41 -106.35 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.331 179.917 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.559 ' C ' ' O ' ' B' ' 257' ' ' LYS . 99.4 m-20 -14.27 99.54 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 O-C-N 123.724 0.64 . . . . 0.0 111.138 -179.975 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . . . . . . . . . 49.9 p-10 -99.33 57.54 1.05 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.006 -178.62 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.627 ' OE1' ' NH2' ' A' ' 93' ' ' ARG . 98.3 mt-10 61.83 17.56 8.95 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 178.317 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 77.9 mt -118.31 133.84 63.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 177.225 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 68.3 t -126.24 133.04 69.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.381 -178.494 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -93.42 116.64 29.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.802 -179.307 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -64.49 -42.33 95.94 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.207 179.212 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -101.84 169.77 7.26 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.875 -179.398 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -62.29 149.68 89.81 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 121.752 1.635 . . . . 0.0 113.495 -179.281 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 19.8 pt . . . . . 0 N--CA 1.462 0.151 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.912 -179.175 . . . . . . . . 0 0 . 1 . 046 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo . . . . . 0 N--CA 1.493 1.494 0 N-CA-C 111.73 -0.142 . . . . 0.0 111.73 . . . . . . . . . 0 0 . 1 . 046 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.6 p -99.1 -44.42 6.29 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.311 -179.352 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -96.52 122.08 39.04 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.094 -179.417 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -128.35 142.61 51.07 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.184 0.516 . . . . 0.0 111.339 -179.14 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 45.2 tp -113.38 133.09 55.34 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.304 -179.362 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.0 t -109.01 131.11 60.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.32 -179.617 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.5 m -92.3 115.55 28.18 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.514 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.422 HG21 HD12 ' A' ' 10' ' ' ILE . 98.4 mt -83.13 145.43 8.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.242 179.014 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -91.44 162.08 14.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.163 0.506 . . . . 0.0 110.863 178.928 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.684 HH21 ' CD2' ' B' ' 252' ' ' LEU . 88.6 mtm180 -57.95 -30.07 65.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.792 -179.638 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.2 m -78.35 -8.61 58.63 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.813 0.339 . . . . 0.0 110.591 179.759 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.3 29.38 12.51 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -179.89 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.8 t -120.02 133.72 65.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.841 0.353 . . . . 0.0 110.075 179.95 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.488 ' O ' ' OD1' ' A' ' 16' ' ' ASP . 43.3 p30 -79.7 141.59 36.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.553 -179.978 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -128.42 -112.29 1.65 Allowed Glycine 0 CA--C 1.535 1.327 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 -179.923 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -75.02 150.05 37.51 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 122.627 2.218 . . . . 0.0 112.978 -179.329 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -111.24 148.97 31.69 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.415 179.694 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -117.44 104.58 49.67 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.66 -179.817 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.83 131.43 15.76 Favored 'Trans proline' 0 N--CA 1.489 1.229 0 C-N-CA 121.371 1.381 . . . . 0.0 111.942 -178.905 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 83.4 mt -88.97 46.03 1.35 Allowed 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.082 -178.67 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -55.99 -32.01 63.55 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.668 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 69.4 mt -69.75 142.78 53.2 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.654 179.436 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 97.8 p -63.5 -16.86 61.91 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.327 -178.917 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.5 m -145.15 145.42 31.36 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.694 -0.403 . . . . 0.0 110.845 179.61 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.677 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -136.54 127.82 28.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.662 179.327 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.449 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 40.0 tp -114.39 123.92 50.68 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -178.156 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.677 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 54.3 m-85 -97.39 133.59 41.78 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.987 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 177.09 -177.7 48.25 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 119.533 -1.318 . . . . 0.0 112.871 179.609 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.686 ' NH1' ' H ' ' B' ' 231' ' ' GLN . 23.6 ttp85 -89.25 -23.79 22.25 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.946 -0.627 . . . . 0.0 110.994 179.944 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.71 152.16 45.59 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 -179.823 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.48 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 10.6 tp -64.12 -41.26 91.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.104 0.478 . . . . 0.0 110.195 179.45 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.48 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 83.1 tt0 -51.37 -17.49 0.77 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.972 -179.764 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 24.0 m -75.08 139.08 42.55 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.493 179.986 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.449 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 57.1 m-20 -61.13 -32.81 72.5 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 -179.445 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 94.2 mt -123.03 116.98 50.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 177.44 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.1 ttp180 -103.95 131.95 50.68 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.397 -178.425 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 80.0 mt -117.34 132.26 67.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.086 0.47 . . . . 0.0 110.012 -179.41 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -76.71 30.93 0.13 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.77 -177.857 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.455 ' CD1' ' HE ' ' A' ' 93' ' ' ARG . 33.3 mt -103.2 131.84 21.72 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.727 179.247 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.96 -10.01 24.22 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.531 2.154 . . . . 0.0 112.642 -179.519 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.1 m -97.62 7.22 8.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.872 -179.989 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.499 ' CG2' ' NH2' ' A' ' 93' ' ' ARG . 28.6 t -95.09 134.61 31.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.202 179.236 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.3 t -73.44 171.16 13.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.409 0.623 . . . . 0.0 111.54 -179.152 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -63.5 -42.88 98.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.8 -179.053 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.652 ' O ' ' N ' ' A' ' 49' ' ' CYS . 98.3 mt-30 -113.89 -21.19 10.76 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.384 -179.612 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.0 t60 41.04 -74.94 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.957 179.621 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.652 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -140.29 141.75 35.75 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.537 -179.201 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -128.02 133.03 49.08 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.639 178.795 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.5 tt -112.06 134.46 54.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -179.872 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -118.15 132.81 56.31 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 -179.875 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 98.3 mt -112.21 117.89 56.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.664 0.745 . . . . 0.0 112.613 -179.135 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.452 ' O ' ' N ' ' A' ' 56' ' ' GLN . 91.4 m-70 -116.65 139.63 50.31 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.211 178.808 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 54' ' ' HIS . 82.6 tt0 -40.13 -30.0 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.252 0.548 . . . . 0.0 109.634 -179.295 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.477 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 60.1 tt0 -65.34 -68.21 0.38 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.053 179.118 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.477 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 3.4 tp10 -154.15 -172.95 4.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.833 -178.976 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -107.24 130.02 54.8 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.827 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.6 mt -120.05 129.65 75.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.437 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 45.2 tp -100.17 127.88 46.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.209 179.532 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -114.97 137.79 51.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.502 -179.877 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.661 ' ND2' ' H ' ' A' ' 69' ' ' THR . 28.9 t-20 -100.27 108.24 20.26 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.755 0.312 . . . . 0.0 111.825 179.802 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -99.21 -7.39 26.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.995 179.454 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.36 102.22 13.81 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.733 0.301 . . . . 0.0 111.112 -179.742 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.1 m -83.99 -27.69 28.25 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.643 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.3 m -64.24 -48.66 74.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.604 179.769 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -140.13 95.31 8.47 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.02 -179.899 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -56.78 144.6 86.73 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.173 1.915 . . . . 0.0 112.534 -179.765 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.661 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 18.3 m -75.79 141.79 42.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.473 179.248 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -103.57 140.98 36.8 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.523 -179.73 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 55.7 t -129.57 132.44 66.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.966 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 51.38 31.72 7.58 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.184 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.9 28.13 63.29 Favored Glycine 0 CA--C 1.534 1.25 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.088 179.636 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 35.0 t -142.35 141.65 32.36 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 117.274 0.537 . . . . 0.0 111.451 179.945 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 54.1 t -69.79 141.5 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.109 179.946 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.1 pt -116.22 75.83 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.557 179.233 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -65.67 -26.22 67.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.84 0.352 . . . . 0.0 110.26 179.832 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -112.18 160.98 28.08 Favored Pre-proline 0 CA--C 1.532 0.26 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.376 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.8 140.24 94.24 Favored 'Trans proline' 0 N--CA 1.499 1.827 0 C-N-CA 121.46 1.44 . . . . 0.0 111.994 179.852 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.3 t -133.61 136.32 54.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.999 179.944 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -74.9 130.44 39.41 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 178.764 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.0 mt -84.1 140.64 31.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.161 0.505 . . . . 0.0 111.611 -179.607 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -129.33 151.24 50.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.371 179.69 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.701 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 6.3 t60 -54.69 119.0 4.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.704 -179.225 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.66 -13.33 35.47 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 179.873 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -68.85 134.22 49.36 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.337 -0.545 . . . . 0.0 109.762 179.631 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.3 t -109.38 132.23 58.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.139 -178.425 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 81.6 mt -103.82 131.06 53.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.844 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.43 ' HG1' ' HG ' ' A' ' 94' ' ' SER . 2.5 m -118.72 125.73 50.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.468 0.651 . . . . 0.0 111.823 -179.607 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.522 ' O ' ' N ' ' A' ' 93' ' ' ARG . 89.3 mt -118.1 123.7 72.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.535 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.45 ' C ' ' O ' ' A' ' 90' ' ' ILE . 46.7 mm 40.78 -108.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.205 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -111.28 12.68 21.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.253 0.549 . . . . 0.0 110.132 178.829 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.522 ' N ' ' O ' ' A' ' 90' ' ' ILE . 18.8 mtm105 -112.28 139.6 47.7 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.862 179.715 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.43 ' HG ' ' HG1' ' A' ' 89' ' ' THR . 37.4 t -135.54 145.54 47.13 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.775 178.976 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -124.15 122.6 38.26 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.87 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -86.35 132.74 33.89 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.2 -0.6 . . . . 0.0 111.387 -179.324 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.516 ' CZ ' ' OD1' ' A' ' 99' ' ' ASN . 93.8 t80 -95.5 124.16 39.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.969 179.485 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -139.81 127.18 21.38 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.257 -0.577 . . . . 0.0 111.51 -179.161 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.701 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 92.3 m-20 -102.97 139.91 37.92 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.977 -179.754 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.448 179.462 . . . . . . . . 0 0 . 1 . 046 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 18.8 m . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.601 0.238 . . . . 0.0 111.259 . . . . . . . . . 0 0 . 1 . 046 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' B' ' 231' ' ' GLN . 64.2 t0 -62.07 116.94 5.36 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.211 179.925 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . 0.497 ' O ' ' CB ' ' B' ' 231' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.686 ' H ' ' NH1' ' A' ' 31' ' ' ARG . 4.0 mt-30 153.26 -21.34 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 O-C-N 123.723 0.639 . . . . 0.0 110.421 179.122 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' B' ' 231' ' ' GLN . . . -51.26 -160.58 0.01 OUTLIER Glycine 0 CA--C 1.529 0.928 0 CA-C-N 115.78 -0.646 . . . . 0.0 112.129 -179.283 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -61.29 153.3 66.39 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 123.759 2.972 . . . . 0.0 112.947 -179.769 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 046 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -71.77 141.24 37.05 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.368 2.045 . . . . 0.0 114.41 -178.752 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -69.28 137.73 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 114.38 -1.282 . . . . 0.0 110.445 179.991 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 6.8 t -72.86 134.74 44.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.384 -179.687 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . 0.53 ' P ' ' OG1' ' B' ' 240' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . 0.414 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 44.3 Cg_exo -56.83 -29.5 81.47 Favored 'Trans proline' 0 N--CA 1.503 2.043 0 C-N-CA 123.484 2.789 . . . . 0.0 114.31 -178.81 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' B' B ' 240' ' ' THR . . . . . 0.53 ' OG1' ' P ' ' B' ' 238' ' ' TPO . 7.7 p -74.76 -38.89 62.08 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.154 -0.619 . . . . 0.0 110.02 179.071 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . 0.485 ' CZ ' ' NH2' ' B' ' 245' ' ' ARG . 66.6 t80 -58.71 -45.3 89.85 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.696 -179.294 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 95.6 mt -64.91 -40.66 95.42 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.838 0.351 . . . . 0.0 111.209 179.681 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -64.33 -44.06 92.71 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.088 -179.025 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 62.8 ttm-85 -60.49 -42.53 96.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.264 0.554 . . . . 0.0 109.886 179.556 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.485 ' NH2' ' CZ ' ' B' ' 241' ' ' PHE . 48.5 ttm-85 -60.62 -43.18 97.78 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.127 -178.965 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.02 -38.64 89.44 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.35 -179.516 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 15.6 t -65.91 -42.99 89.46 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 177.536 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . 0.461 ' O ' ' N ' ' B' ' 252' ' ' LEU . 69.2 tp60 -59.4 -38.02 79.5 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.61 179.845 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 43.3 t -60.82 -46.01 96.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.614 -0.435 . . . . 0.0 109.873 179.315 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -60.46 -27.12 67.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.187 0.518 . . . . 0.0 109.748 179.376 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -94.95 -12.23 27.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.158 179.167 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.684 ' CD2' HH21 ' A' ' 12' ' ' ARG . 44.6 tp -73.4 137.57 44.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.695 -178.967 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -95.6 128.6 42.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.008 178.899 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -64.58 -23.28 67.22 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.979 -179.438 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 45.0 p-10 -75.42 0.78 15.83 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.636 -179.676 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.46 ' O ' ' C ' ' B' ' 257' ' ' LYS . 97.3 m-20 -89.87 -3.83 57.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.353 179.504 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . 0.608 ' O ' ' N ' ' B' ' 259' ' ' ASP . 86.6 tttt 34.34 -110.04 0.05 OUTLIER 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.015 -179.47 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.568 ' C ' ' O ' ' B' ' 257' ' ' LYS . 98.4 m-20 -12.57 79.26 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 O-C-N 123.885 0.741 . . . . 0.0 110.888 -179.889 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.608 ' N ' ' O ' ' B' ' 257' ' ' LYS . 58.9 t0 -84.62 83.09 8.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.534 -178.635 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.572 ' OE2' ' NH1' ' A' ' 12' ' ' ARG . 97.0 mt-10 55.68 3.68 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.685 178.198 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . 0.438 ' H ' ' C ' ' B' ' 259' ' ' ASP . 64.5 mt -118.4 134.01 63.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.078 -179.743 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 40.7 t -128.24 134.85 64.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.996 -179.705 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -96.03 119.0 33.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.554 -178.904 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -65.22 -44.46 88.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.924 178.871 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -97.35 158.38 33.28 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.382 -179.728 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -69.53 145.74 59.42 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 123.022 2.481 . . . . 0.0 113.398 -179.264 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 48.6 pt . . . . . 0 C--N 1.332 -0.155 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.434 179.061 . . . . . . . . 0 0 . 1 . 047 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo . . . . . 0 N--CA 1.496 1.64 0 CA-C-O 120.766 0.236 . . . . 0.0 111.963 . . . . . . . . . 0 0 . 1 . 047 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 77.0 p -106.03 -39.44 5.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.439 -179.783 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.4 mtt85 -96.46 119.59 35.22 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.784 179.875 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.448 ' NH2' ' OE2' ' A' ' 100' ' ' GLU . 90.9 mtm180 -132.85 141.42 48.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.936 0.398 . . . . 0.0 111.323 -179.292 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 64.0 mt -114.35 142.37 46.41 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.669 -179.375 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 76.6 t -117.05 130.55 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.651 178.833 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.8 m -87.28 113.58 23.13 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -178.163 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 95.1 mt -80.9 140.05 17.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.404 177.781 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -88.21 155.42 19.77 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 178.36 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.675 HH12 ' NH1' ' B' ' 245' ' ' ARG . 75.1 mtp85 -59.29 -26.5 65.01 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.235 -178.899 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.0 m -76.9 -18.75 58.1 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.034 0.445 . . . . 0.0 110.667 179.328 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.08 33.99 4.73 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.196 -1.161 . . . . 0.0 110.196 -179.718 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.2 t -124.13 129.91 73.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.478 0.18 . . . . 0.0 110.533 179.991 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -73.3 138.02 45.19 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.439 179.265 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -125.96 -117.03 2.13 Favored Glycine 0 CA--C 1.541 1.688 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.323 -179.298 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -75.95 147.67 30.77 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 122.765 2.31 . . . . 0.0 112.384 -178.505 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -108.36 148.66 29.78 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.414 179.913 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -118.69 101.28 50.72 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.284 -179.876 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.31 135.04 23.92 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.012 1.808 . . . . 0.0 111.629 -179.266 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.6 mt -91.03 49.49 1.65 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.069 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 34.4 t -61.71 -19.1 62.02 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.508 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 80.7 mt -80.14 138.0 36.83 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.057 -179.895 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.1 m -64.76 -19.79 66.0 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.994 -179.486 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.505 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 39.0 m -135.45 135.2 40.34 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.618 -179.405 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.683 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 5.4 t -130.38 120.75 24.76 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.163 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.8 tp -118.99 128.77 54.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.308 -178.723 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.683 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 3.9 m-85 -105.05 142.59 34.56 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -179.875 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 146.83 -174.36 26.69 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.887 178.587 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.429 ' NH2' ' O ' ' B' ' 233' ' ' PRO . 46.3 mtm180 -74.03 -33.03 63.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 179.42 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.504 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -41.85 144.81 0.8 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 -179.05 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.466 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 10.3 tp -67.42 -41.86 86.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 O-C-N 122.219 -0.577 . . . . 0.0 109.824 179.483 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.466 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 76.4 mm-40 -58.15 -23.3 54.78 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.178 179.374 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.504 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 57.4 m -50.9 118.24 3.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.077 179.969 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.505 ' OD2' ' O ' ' A' ' 26' ' ' THR . 57.6 m-20 -57.52 -30.6 65.29 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.817 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.414 HG21 HD11 ' A' ' 37' ' ' ILE . 87.8 mt -125.15 118.86 54.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.239 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -104.74 134.74 47.39 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.913 -178.962 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.42 HG21 HD11 ' A' ' 39' ' ' ILE . 95.7 mt -114.57 127.23 72.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 121.2 0.524 . . . . 0.0 110.788 179.294 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -70.74 39.37 0.05 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.289 -0.869 . . . . 0.0 113.115 -178.322 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.493 ' CD1' ' NH2' ' A' ' 93' ' ' ARG . 79.3 mt -117.02 130.99 24.21 Favored Pre-proline 0 C--N 1.326 -0.449 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.369 179.738 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -72.7 -9.19 23.58 Favored 'Trans proline' 0 N--CA 1.489 1.235 0 C-N-CA 122.122 1.881 . . . . 0.0 112.162 179.522 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.0 m -99.11 1.98 10.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.894 179.808 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.426 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 6.3 t -86.92 134.93 26.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.268 0.556 . . . . 0.0 110.315 179.412 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.418 ' HG ' HG21 ' B' ' 234' ' ' TPO . 3.8 m -65.06 160.02 21.95 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.742 -178.987 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -63.72 -43.63 95.98 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.276 -179.085 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.636 ' O ' ' N ' ' A' ' 49' ' ' CYS . 12.1 mm100 -112.75 -23.43 10.17 Favored 'General case' 0 C--O 1.227 -0.123 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.424 179.929 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.3 t60 37.14 -76.75 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.078 -0.964 . . . . 0.0 112.932 179.855 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.636 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.0 136.1 47.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.337 0.589 . . . . 0.0 112.28 -178.539 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -125.39 129.09 49.2 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.781 179.683 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 93.8 mt -114.11 133.71 59.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.181 178.781 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -115.25 128.89 56.43 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.532 179.013 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 51.8 mm -99.0 118.66 45.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.989 -179.807 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.435 ' O ' ' C ' ' A' ' 55' ' ' GLU . 99.5 m-70 -120.31 135.09 55.13 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.33 179.646 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 54' ' ' HIS . 82.6 tt0 -40.46 -32.03 0.18 Allowed 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -179.675 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.434 ' N ' ' C ' ' A' ' 54' ' ' HIS . 88.7 mt-30 -67.53 -68.48 0.38 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.041 179.236 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.476 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 5.1 tp10 -153.84 -167.05 2.55 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.369 -179.067 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.476 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -119.44 130.4 55.25 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.435 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.441 HD12 HG22 ' A' ' 59' ' ' ILE . 99.5 mt -117.97 131.16 71.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.634 0.731 . . . . 0.0 111.981 -178.433 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.7 tp -99.78 127.53 45.93 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.213 179.624 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -110.16 133.64 53.01 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.208 -178.881 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 61.4 t-20 -93.25 104.57 16.74 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.948 179.889 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -100.93 -11.93 19.35 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 120.995 -0.282 . . . . 0.0 111.594 179.812 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 m -68.29 99.78 0.96 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.421 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 87.9 p -85.38 -10.11 56.7 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.525 -179.774 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.19 -43.12 6.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.117 179.88 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -133.84 95.61 17.17 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.991 -179.709 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.0 141.2 86.72 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.395 2.063 . . . . 0.0 112.882 -179.735 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.2 m -74.07 136.63 43.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.283 179.174 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -100.6 139.31 36.47 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.212 179.362 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.7 t -131.62 133.37 61.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 178.76 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 54.52 32.68 17.34 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -178.844 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.3 27.22 72.02 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.115 179.487 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 28.5 t -141.29 136.96 32.11 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 117.377 0.589 . . . . 0.0 111.501 -179.966 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -70.06 138.58 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.862 179.652 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.3 pt -114.08 91.57 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 121.208 0.528 . . . . 0.0 111.401 179.664 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -66.49 -26.86 67.38 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.823 178.494 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.495 ' N ' ' OE1' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -119.21 162.07 33.66 Favored Pre-proline 0 N--CA 1.465 0.295 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.81 179.71 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.29 151.09 86.84 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.694 2.263 . . . . 0.0 112.388 -179.388 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 36.0 m -142.05 148.69 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.107 0 CA-C-O 121.273 0.559 . . . . 0.0 112.107 -179.483 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -75.86 127.54 33.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.018 178.865 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 92.9 mt -75.55 140.06 42.5 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.488 179.609 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -130.51 146.08 51.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.2 179.515 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.559 ' HD1' ' C ' ' A' ' 99' ' ' ASN . 7.2 t60 -51.4 119.62 4.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.133 -179.178 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.81 -12.19 49.8 Favored Glycine 0 CA--C 1.522 0.51 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.938 179.463 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -69.66 137.22 51.99 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.316 -0.553 . . . . 0.0 110.204 179.705 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.42 ' O ' ' CG1' ' A' ' 87' ' ' VAL . 8.7 p -106.89 134.86 47.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.876 -178.667 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 93.4 mt -103.27 129.48 55.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 177.696 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 47.5 m -123.98 124.81 43.4 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.577 0.704 . . . . 0.0 112.783 -178.171 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.425 ' O ' ' N ' ' A' ' 92' ' ' ASP . 94.0 mt -111.6 124.2 68.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.005 178.102 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.465 ' CG2' ' NH2' ' B' ' 245' ' ' ARG . 64.4 mt 39.36 -96.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.987 -179.201 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.49 ' CB ' ' NH2' ' B' ' 245' ' ' ARG . 52.8 t0 -120.51 18.15 12.08 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.792 0.33 . . . . 0.0 111.888 -178.791 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.808 HH22 ' NH1' ' B' ' 245' ' ' ARG . 1.1 ptp85 -131.25 144.29 51.19 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.067 178.679 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 38.1 m -136.14 152.83 51.23 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.298 0.571 . . . . 0.0 111.232 -179.913 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -122.95 122.09 37.71 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.629 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 45.2 ttm180 -78.95 131.77 36.47 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.216 -178.726 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -95.93 119.62 34.75 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.76 179.924 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -122.5 122.21 38.39 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.262 -179.969 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.559 ' C ' ' HD1' ' A' ' 84' ' ' HIS . 59.4 t-20 -121.67 105.32 10.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.615 -179.651 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.448 ' OE2' ' NH2' ' A' ' 6' ' ' ARG . 96.1 mt-10 . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.493 178.625 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . 0.515 ' O ' ' CB ' ' B' ' 229' ' ' ASP . 86.7 t . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.759 0.314 . . . . 0.0 111.437 . . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' B' ' 230' ' ' SEP . 10.0 t0 83.81 55.38 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.938 179.424 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . 0.53 ' CB ' ' O ' ' B' ' 229' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.425 ' NE2' ' P ' ' B' ' 230' ' ' SEP . 2.7 mt-30 -145.36 61.31 1.29 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.61 179.446 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . 0.406 ' C ' HH12 ' A' ' 31' ' ' ARG . . . -110.91 -177.04 20.57 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.874 -179.132 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . 0.429 ' O ' ' NH2' ' A' ' 31' ' ' ARG . 65.4 Cg_endo -71.7 161.14 46.13 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.985 2.457 . . . . 0.0 112.635 -179.643 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . 0.418 HG21 ' HG ' ' A' ' 45' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -74.08 141.49 29.64 Favored 'Trans proline' 0 C--N 1.299 -2.046 0 C-N-CA 121.845 1.697 . . . . 0.0 113.156 -179.555 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 67.9 t -66.93 133.27 31.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.771 179.836 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -64.35 131.63 47.81 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.036 0.445 . . . . 0.0 110.555 -179.468 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 047 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -62.11 -22.37 74.09 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.774 2.316 . . . . 0.0 112.018 179.707 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 2.8 m -75.96 -42.39 48.64 Favored 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.532 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -58.16 -46.11 86.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.143 -179.788 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . 0.525 ' CD2' HH21 ' B' ' 245' ' ' ARG . 92.9 mt -63.82 -41.95 97.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.171 0.51 . . . . 0.0 110.851 179.874 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -63.04 -43.0 99.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.979 -179.092 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -61.51 -43.89 98.04 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.271 179.935 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.808 ' NH1' HH22 ' A' ' 93' ' ' ARG . 75.6 mtm180 -63.54 -40.04 95.99 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.881 -178.926 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -61.31 -39.01 88.91 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.263 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 13.5 t -65.91 -45.37 82.18 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.711 0.767 . . . . 0.0 109.496 178.051 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . 0.434 ' O ' ' N ' ' B' ' 252' ' ' LEU . 83.0 mt-30 -62.17 -33.63 74.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.558 179.872 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 54.0 t -63.41 -44.43 98.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 119.986 -0.686 . . . . 0.0 109.335 178.761 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -60.91 -27.41 68.17 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.679 179.345 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -95.27 -10.93 28.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.173 179.474 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.434 ' N ' ' O ' ' B' ' 248' ' ' GLN . 44.5 tp -79.81 156.82 27.23 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.581 179.908 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -109.91 139.95 44.42 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.196 179.436 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -66.52 -27.79 68.04 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.769 0.318 . . . . 0.0 111.076 179.984 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -68.71 -2.72 9.89 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.816 0.341 . . . . 0.0 110.847 179.732 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.43 ' O ' ' C ' ' B' ' 257' ' ' LYS . 96.0 m-20 -86.98 -4.81 59.21 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.533 179.929 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . 0.579 ' O ' ' C ' ' B' ' 258' ' ' ASP . 87.1 tttt 35.83 -109.66 0.05 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.38 -179.883 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.579 ' C ' ' O ' ' B' ' 257' ' ' LYS . 67.1 t0 -13.08 92.81 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 O-C-N 123.691 0.619 . . . . 0.0 111.088 -179.051 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.45 ' C ' ' OE1' ' B' ' 260' ' ' GLU . 39.8 p-10 -91.55 62.26 4.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.2 -179.168 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.45 ' OE1' ' C ' ' B' ' 259' ' ' ASP . 53.5 mp0 63.78 12.96 7.09 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.029 179.443 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 56.6 mt -119.29 130.2 74.26 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 177.89 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 54.1 t -122.69 133.83 67.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.427 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -95.27 122.14 37.66 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.263 0.554 . . . . 0.0 110.685 -178.7 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -62.53 -46.06 90.11 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.564 -179.889 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -94.85 160.71 30.58 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.82 -179.403 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.41 147.49 58.83 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.478 2.119 . . . . 0.0 112.94 -179.695 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 47.9 pt . . . . . 0 N--CA 1.466 0.346 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.666 179.13 . . . . . . . . 0 0 . 1 . 048 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo . . . . . 0 N--CA 1.495 1.597 0 CA-C-O 120.848 0.27 . . . . 0.0 112.701 . . . . . . . . . 0 0 . 1 . 048 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.25 -40.18 0.74 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.481 179.651 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.571 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 94.9 mtt-85 -98.6 122.09 41.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.128 -179.381 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.578 ' NH2' ' OE2' ' A' ' 98' ' ' GLU . 33.6 ptt-85 -146.01 158.38 43.87 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.103 -0.639 . . . . 0.0 112.009 179.937 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.3 mt -118.86 144.85 46.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.261 179.604 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.414 ' CG1' ' NE2' ' A' ' 19' ' ' HIS . 67.0 t -114.31 125.46 71.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.568 -0.453 . . . . 0.0 109.903 179.446 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.2 m -74.21 134.16 42.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.019 0.438 . . . . 0.0 111.313 -179.689 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.0 mt -104.0 133.98 46.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.759 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -86.71 154.25 21.11 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.279 -0.568 . . . . 0.0 109.881 179.307 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.431 ' NH2' ' CD2' ' B' ' 252' ' ' LEU . 89.9 mtm180 -54.99 -27.74 46.44 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.581 -178.983 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.4 m -81.1 -5.67 57.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.759 0.314 . . . . 0.0 110.589 179.809 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.82 34.09 9.35 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 -179.959 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.8 t -121.08 135.59 60.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.86 0.362 . . . . 0.0 110.91 -179.852 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.463 ' O ' ' OD1' ' A' ' 16' ' ' ASP . 48.7 p-10 -75.97 133.36 40.47 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.459 179.727 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -121.39 -121.15 2.76 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.794 -179.327 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.48 147.24 40.78 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.131 1.888 . . . . 0.0 112.8 -178.871 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.414 ' NE2' ' CG1' ' A' ' 8' ' ' VAL . 62.0 m170 -109.76 143.37 39.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.635 -179.664 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -112.52 99.83 48.4 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.849 -179.717 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -70.6 131.51 20.18 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 C-N-CA 120.912 1.075 . . . . 0.0 110.787 -179.638 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 75.8 mt -85.39 77.36 9.95 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 120.261 -0.575 . . . . 0.0 110.784 -178.749 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 97.3 p -85.56 -10.61 55.68 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.077 178.744 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 52.2 mt -102.57 146.19 28.51 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.312 -179.047 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 94.9 p -65.91 -20.02 66.07 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -178.488 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 27.6 m -133.25 133.06 42.18 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.481 -0.487 . . . . 0.0 111.359 -179.777 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.0 t -122.71 116.84 24.44 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.589 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 56.8 tp -113.61 129.37 56.57 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -177.673 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.499 ' O ' ' O ' ' A' ' 47' ' ' GLN . 72.6 m-85 -109.77 131.51 55.0 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.449 179.804 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 160.46 -173.41 37.02 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.882 179.072 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.627 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 75.9 mtm-85 -80.89 -28.52 35.9 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.243 179.364 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.553 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -46.35 146.41 3.16 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -178.645 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.448 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 9.9 tp -67.72 -41.91 85.78 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 CA-C-O 120.843 0.354 . . . . 0.0 110.285 179.823 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.448 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 81.7 tt0 -59.03 -21.34 58.92 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.462 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.553 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 22.4 m -55.84 123.46 14.32 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.401 -179.96 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -62.08 -30.96 71.36 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.397 -179.71 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.409 HG23 HD13 ' A' ' 37' ' ' ILE . 47.1 mm -124.61 121.13 60.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.17 178.649 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.412 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 60.0 mtm180 -108.81 137.25 47.05 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 120.279 -0.569 . . . . 0.0 111.386 -179.977 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 89.6 mt -121.19 129.31 75.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.047 179.349 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -74.89 32.34 0.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -177.941 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 25.8 mt -98.27 129.07 31.47 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.317 179.272 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -73.14 -5.32 16.97 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 122.317 2.012 . . . . 0.0 112.368 -179.941 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.9 m -107.63 8.71 9.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.356 179.81 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.627 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 13.7 t -95.15 137.6 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.601 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.7 m -69.05 167.28 16.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.479 0.657 . . . . 0.0 112.381 -178.095 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.3 mttp -63.99 -41.65 97.45 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.033 -179.577 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.639 ' O ' ' N ' ' A' ' 49' ' ' CYS . 96.2 mt-30 -115.62 -25.24 7.93 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.098 0.475 . . . . 0.0 110.245 179.864 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 32.1 t60 38.39 -72.44 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 178.912 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.639 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -134.83 139.26 44.93 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -177.967 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.9 ttpp -132.95 133.95 43.88 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.539 178.827 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 92.3 mt -113.27 135.7 51.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.883 179.683 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.567 ' CD ' ' HE2' ' A' ' 54' ' ' HIS . 79.8 tt0 -117.32 132.12 56.67 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.255 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.1 mm -103.6 118.55 50.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.403 -0.519 . . . . 0.0 112.295 -177.924 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.567 ' HE2' ' CD ' ' A' ' 52' ' ' GLU . 97.9 m-70 -117.66 134.22 55.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.11 178.052 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 54' ' ' HIS . 84.6 tt0 -40.15 -35.47 0.4 Allowed 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.038 -179.085 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -64.27 -66.7 0.51 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.945 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.404 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 4.2 tp10 -150.43 -167.96 2.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.286 -179.718 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.404 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -119.2 134.61 55.11 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.536 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 98.0 mt -120.2 130.77 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 121.385 0.612 . . . . 0.0 112.615 -178.729 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 21.7 tp -98.72 128.44 44.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.084 179.624 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -109.84 134.62 51.85 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.051 -179.346 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.484 HD22 ' CA ' ' A' ' 68' ' ' PRO . 62.7 t-20 -95.65 104.62 16.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.802 -178.848 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -97.19 -10.46 25.82 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.373 179.535 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 10.3 t -78.01 98.93 5.88 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.666 -179.477 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.2 m -76.09 -40.26 53.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.249 0.547 . . . . 0.0 110.055 178.509 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.37 -41.35 85.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.451 -179.671 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.442 ' O ' ' OG ' ' A' ' 64' ' ' SER . 59.8 m-20 -140.51 93.29 8.81 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.718 -179.895 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.484 ' CA ' HD22 ' A' ' 62' ' ' ASN . 40.6 Cg_exo -56.56 147.55 69.15 Favored 'Trans proline' 0 N--CA 1.498 1.784 0 C-N-CA 122.551 2.167 . . . . 0.0 113.029 -179.064 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.425 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 3.9 m -72.25 136.83 46.44 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.472 179.227 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -100.43 141.56 33.11 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.578 179.49 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.489 ' O ' ' OG ' ' A' ' 74' ' ' SER . 56.1 t -128.54 135.97 61.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.236 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 50.97 31.87 6.79 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.464 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.94 29.27 63.18 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.028 179.569 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.489 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 12.1 p -141.34 141.0 33.87 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 117.139 0.469 . . . . 0.0 111.412 179.878 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 53.5 t -74.76 136.5 25.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-O 121.115 0.483 . . . . 0.0 111.74 -179.854 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.535 ' CD1' ' O ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -137.15 119.45 19.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.824 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.41 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 38.3 p-10 -101.17 -0.42 36.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.922 -178.038 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.535 ' O ' ' CD1' ' A' ' 76' ' ' ILE . 5.2 pt-20 -119.93 165.09 18.87 Favored Pre-proline 0 C--N 1.331 -0.225 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.256 179.965 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.98 141.86 96.36 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 121.747 1.632 . . . . 0.0 111.866 179.772 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.7 p -140.21 140.31 35.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.725 -179.879 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -78.96 130.3 35.41 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.961 179.542 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.8 mt -78.87 140.19 38.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.01 0.433 . . . . 0.0 110.728 179.96 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -129.7 149.38 51.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.329 179.978 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.441 ' C ' ' CD2' ' A' ' 84' ' ' HIS . 7.3 t60 -55.62 116.6 2.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.012 0.434 . . . . 0.0 110.885 -179.168 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.44 -16.41 37.88 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -179.751 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 87' ' ' VAL . 53.7 t0 -67.68 131.07 44.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.717 0.294 . . . . 0.0 110.231 179.314 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.48 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 76.7 t -104.92 135.54 42.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.937 0.399 . . . . 0.0 111.298 -178.8 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 88.4 mt -104.13 130.28 55.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.443 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.8 m -122.53 123.58 41.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.828 0.823 . . . . 0.0 112.836 -178.884 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.571 ' O ' ' N ' ' A' ' 93' ' ' ARG . 86.9 mt -109.38 125.95 66.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 114.236 -1.347 . . . . 0.0 108.281 178.274 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.493 ' CG2' ' N ' ' A' ' 92' ' ' ASP . 97.8 mt 29.42 -101.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.932 0.396 . . . . 0.0 111.578 -179.165 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.493 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 35.6 p-10 -105.54 11.42 32.45 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.137 -179.035 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.619 ' NH1' ' O ' ' B' ' 259' ' ' ASP . 8.7 mtp85 -130.2 145.2 51.71 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.045 -179.55 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.1 p -140.64 153.24 45.95 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.178 0.513 . . . . 0.0 110.699 179.747 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -129.77 127.41 40.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.953 179.814 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -82.9 133.64 35.11 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.376 -0.529 . . . . 0.0 110.182 179.979 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.571 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 85.0 t80 -94.61 126.21 39.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.485 -179.24 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.578 ' OE2' ' NH2' ' A' ' 6' ' ' ARG . 82.5 tt0 -135.5 118.88 16.77 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.823 179.546 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.42 ' C ' ' OD1' ' A' ' 99' ' ' ASN . 55.5 p30 -104.31 6.5 35.33 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.67 -179.998 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.507 ' O ' ' OE2' ' A' ' 98' ' ' GLU . 82.2 tt0 . . . . . 0 C--N 1.327 -0.377 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.84 179.633 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 40.6 t . . . . . 0 N--CA 1.454 -0.272 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 . . . . . . . . . 0 0 . 1 . 048 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.469 ' C ' ' H ' ' B' ' 231' ' ' GLN . 97.8 m-20 -50.83 114.16 1.09 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.303 -179.452 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 048 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.469 ' H ' ' C ' ' B' ' 229' ' ' ASP . 99.5 mm-40 -101.48 -25.19 14.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.057 -179.871 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -68.91 153.29 52.87 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -179.161 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.76 132.58 17.36 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.764 2.31 . . . . 0.0 112.343 179.785 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 048 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -77.23 146.55 25.26 Favored 'Trans proline' 0 C--N 1.317 -1.089 0 C-N-CA 121.719 1.613 . . . . 0.0 111.971 177.303 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 4.8 p -64.73 141.51 18.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.548 -179.606 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . 0.465 ' SG ' ' CD2' ' B' ' 241' ' ' PHE . 2.8 t -70.27 130.46 42.06 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.217 -179.594 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 048 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.38 -29.11 56.87 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.53 2.154 . . . . 0.0 112.062 178.961 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 87.8 m -64.34 -46.42 83.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.433 0.635 . . . . 0.0 109.317 178.771 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . 0.465 ' CD2' ' SG ' ' B' ' 237' ' ' CYS . 85.4 t80 -58.02 -47.5 82.87 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.546 -179.378 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 96.9 mt -62.8 -41.92 99.49 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.89 -178.584 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -65.09 -39.02 92.58 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.224 -179.271 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . 0.466 ' O ' ' OG ' ' B' ' 247' ' ' SER . 99.5 mtt180 -63.41 -40.24 96.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.085 0.469 . . . . 0.0 109.835 179.884 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . . . . . . . . . 71.2 ttp85 -61.21 -43.16 99.32 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.845 -179.505 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.37 -40.62 97.05 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.321 -179.652 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' B' B ' 247' ' ' SER . . . . . 0.466 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 79.4 p -64.51 -42.84 95.55 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.726 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -61.66 -39.12 90.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.193 -179.991 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 54.3 t -64.32 -44.55 97.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.303 179.059 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -60.75 -34.06 73.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.314 179.975 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -89.95 -4.79 57.29 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.546 179.525 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.431 ' CD2' ' NH2' ' A' ' 12' ' ' ARG . 56.1 tp -113.89 112.96 24.19 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.984 0.421 . . . . 0.0 110.926 179.933 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . 0.526 ' C ' ' H ' ' B' ' 255' ' ' ASP . 28.3 m-80 -82.42 -162.9 0.62 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.108 -178.837 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 39.3 p-10 -54.22 -5.15 0.07 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.192 -178.907 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . 0.526 ' H ' ' C ' ' B' ' 253' ' ' ASN . 99.5 m-20 -63.62 -11.54 25.91 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.011 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.74 ' O ' ' N ' ' B' ' 258' ' ' ASP . 27.7 t70 -51.12 -31.17 18.5 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 114.749 -1.114 . . . . 0.0 112.014 -179.556 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . 0.499 ' C ' ' O ' ' B' ' 256' ' ' ASP . 98.6 mttt -7.86 -48.62 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.265 0 O-C-N 123.896 0.747 . . . . 0.0 112.682 -178.635 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.74 ' N ' ' O ' ' B' ' 256' ' ' ASP . 50.6 t0 -104.53 85.38 2.33 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 176.215 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.619 ' O ' ' NH1' ' A' ' 93' ' ' ARG . 26.6 t0 -96.11 72.86 2.93 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -175.825 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 54.15 13.69 0.63 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 115.316 1.598 . . . . 0.0 115.316 176.11 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . 0.46 ' CD1' ' NE ' ' A' ' 93' ' ' ARG . 74.2 mt -118.21 132.89 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 119.434 1.016 . . . . 0.0 109.274 178.388 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 55.9 t -125.11 135.21 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-O 120.932 0.396 . . . . 0.0 111.191 -179.625 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -98.79 119.12 37.01 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.278 0.561 . . . . 0.0 110.581 -179.761 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -66.24 -43.89 85.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.045 179.934 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -103.13 157.98 32.68 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.355 -179.1 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -63.89 155.54 63.45 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 122.949 2.432 . . . . 0.0 112.703 -179.833 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.0 pt . . . . . 0 C--N 1.331 -0.217 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.117 -178.745 . . . . . . . . 0 0 . 1 . 049 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo . . . . . 0 N--CA 1.494 1.551 0 CA-C-O 120.888 0.287 . . . . 0.0 111.944 . . . . . . . . . 0 0 . 1 . 049 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.1 p -117.41 24.94 10.79 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.035 -179.394 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.6 mtt85 -83.71 123.12 29.52 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.26 -179.865 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -127.45 136.52 51.92 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.23 -179.404 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 25.3 tp -112.67 130.6 55.99 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.836 -179.755 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.0 t -108.07 129.15 62.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.914 -179.479 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.0 m -81.05 143.83 32.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.471 0.653 . . . . 0.0 111.921 -179.606 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.8 mm -111.81 135.15 51.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.613 178.729 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -89.9 157.27 17.95 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.01 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.514 ' NH2' ' CD1' ' B' ' 252' ' ' LEU . 84.5 mtm180 -58.6 -22.57 56.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.059 -179.466 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.2 m -85.08 -9.45 57.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.991 -179.63 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.49 40.24 6.47 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.189 -0.765 . . . . 0.0 111.189 179.716 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 54.6 t -125.89 135.36 64.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.726 0.298 . . . . 0.0 111.627 -179.265 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.402 ' CG ' ' HE2' ' A' ' 19' ' ' HIS . 62.8 t0 -67.68 124.55 23.59 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.163 179.115 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -115.62 -124.8 3.81 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 120.959 -0.639 . . . . 0.0 111.863 -179.18 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -75.82 146.61 30.0 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.31 2.006 . . . . 0.0 113.334 -178.688 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.402 ' HE2' ' CG ' ' A' ' 16' ' ' ASP . 59.4 m170 -106.1 142.17 36.23 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.563 -179.935 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -117.74 106.85 45.35 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.096 179.977 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.29 127.49 12.71 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 121.541 1.494 . . . . 0.0 112.03 -178.382 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 56.3 mt -89.01 43.92 1.18 Allowed 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.35 -178.361 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 65.3 p -67.54 -19.85 65.34 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.554 -0.458 . . . . 0.0 109.849 179.381 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.9 mt -74.39 144.06 44.54 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.61 179.954 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 92.8 p -58.07 -26.08 62.08 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.035 -178.39 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 97.8 m -141.22 138.63 33.44 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.206 -0.598 . . . . 0.0 111.839 -179.113 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.655 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 2.5 t -128.77 121.7 28.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.053 178.393 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.407 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 52.1 tp -119.74 129.33 54.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.377 -178.167 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.655 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 3.0 m-85 -104.68 137.17 42.9 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.473 179.495 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 163.55 -167.46 37.74 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.419 178.883 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.636 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 86.3 mtm-85 -88.05 -27.99 21.64 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.767 0.318 . . . . 0.0 110.263 179.97 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.408 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -55.64 149.87 23.36 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 121.133 -0.556 . . . . 0.0 111.837 -178.168 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.543 ' CD1' ' NH1' ' A' ' 38' ' ' ARG . 10.5 tp -68.09 -41.6 84.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 CA-C-O 120.864 0.364 . . . . 0.0 110.518 179.92 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -57.4 -23.34 48.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.226 0.536 . . . . 0.0 110.099 179.77 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.408 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 33.3 m -56.0 126.12 24.47 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.185 179.683 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.407 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 55.0 m-20 -61.04 -33.14 72.82 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.602 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.463 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 94.8 mt -123.98 121.9 63.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 177.314 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.543 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 83.1 mtp180 -109.84 139.1 45.29 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.405 -178.544 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.414 HG23 HD12 ' A' ' 39' ' ' ILE . 97.4 mt -120.36 130.58 74.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.987 179.004 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.409 ' NE2' ' HA ' ' B' ' 260' ' ' GLU . 19.9 pt20 -79.75 35.67 0.31 Allowed 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -177.768 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.589 ' CD1' ' NH1' ' A' ' 93' ' ' ARG . 60.5 mt -112.95 135.17 21.67 Favored Pre-proline 0 C--N 1.328 -0.328 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.112 178.191 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.67 -9.78 26.49 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.629 2.22 . . . . 0.0 113.22 -178.717 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.432 ' CG2' ' CZ ' ' B' ' 241' ' ' PHE . 1.8 m -96.52 2.0 10.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.444 -179.828 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.636 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 53.2 t -88.3 131.96 34.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.614 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.6 m -63.99 158.39 22.57 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.159 0.504 . . . . 0.0 111.328 -179.106 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -61.42 -42.08 98.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.663 -179.086 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.612 ' O ' ' N ' ' A' ' 49' ' ' CYS . 10.8 mm100 -115.43 -20.23 10.35 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.919 179.677 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.5 t60 33.21 -74.54 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 179.082 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.612 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -129.54 133.94 47.49 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -177.608 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -123.93 133.07 53.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.663 179.284 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 98.1 mt -119.49 134.38 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.679 -179.218 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -115.92 127.99 55.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.402 179.154 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.3 mm -100.49 109.86 26.15 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 CA-C-O 121.251 0.548 . . . . 0.0 110.861 -179.481 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.445 ' O ' ' C ' ' A' ' 55' ' ' GLU . 97.8 m-70 -111.36 135.22 52.22 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.512 179.247 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 54' ' ' HIS . 93.1 mt-10 -41.8 -34.32 0.63 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -179.396 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 73.5 tp60 -63.72 -67.2 0.45 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.373 178.572 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -155.68 -169.52 3.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.691 -179.829 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -117.47 129.94 56.14 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.592 -179.729 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 87.9 mt -117.51 130.51 72.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 121.324 0.583 . . . . 0.0 112.416 -178.902 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.428 HD12 ' HG ' ' A' ' 49' ' ' CYS . 50.5 tp -95.27 129.19 42.49 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.931 179.81 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -115.19 133.44 56.03 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.799 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.695 ' ND2' ' H ' ' A' ' 69' ' ' THR . 11.3 t-20 -96.57 108.3 20.87 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.266 -179.684 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -97.51 -7.02 32.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.256 179.532 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.629 ' HG ' ' ND2' ' A' ' 62' ' ' ASN . 78.7 p -76.25 97.93 4.31 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.306 179.579 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.3 m -80.39 -32.95 37.49 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.2 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.1 m -65.55 -48.07 73.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.293 179.597 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.543 ' O ' ' OG ' ' A' ' 64' ' ' SER . 1.5 m-20 -137.72 102.02 8.68 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.032 -179.663 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -55.14 146.05 61.62 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 121.752 1.635 . . . . 0.0 112.326 -179.85 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.695 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 10.2 m -74.68 140.64 44.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.595 179.075 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -104.61 139.02 40.07 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.14 179.673 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 56.4 t -132.02 132.96 61.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.879 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 54.38 33.48 18.66 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.025 -0.67 . . . . 0.0 109.622 -179.391 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.7 29.29 65.7 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.77 178.921 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.1 t -148.08 140.39 24.3 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 117.492 0.646 . . . . 0.0 111.342 179.342 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -68.65 144.0 14.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.379 -179.485 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.1 pt -118.19 94.35 3.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 121.034 0.445 . . . . 0.0 110.585 179.068 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.58 ' OD1' ' N ' ' A' ' 78' ' ' GLU . 37.0 p-10 -69.4 -23.96 63.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.281 179.727 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.58 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 2.6 mt-10 -124.28 170.04 9.53 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.459 179.656 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -60.73 147.27 95.51 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 122.485 2.123 . . . . 0.0 112.601 179.283 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 29.3 m -138.32 138.71 42.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.473 179.626 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.558 HH21 ' CE ' ' A' ' 83' ' ' LYS . 61.7 ttp180 -72.8 130.44 40.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.632 179.281 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 97.0 mt -81.58 136.02 35.57 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.015 0.436 . . . . 0.0 111.7 -179.386 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.558 ' CE ' HH21 ' A' ' 81' ' ' ARG . 99.1 mttt -129.05 149.0 51.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.409 179.426 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.66 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 7.2 t60 -54.58 116.81 2.88 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.162 179.897 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 113.09 -15.35 23.28 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.572 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -67.96 135.67 52.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.29 0.567 . . . . 0.0 110.672 -179.569 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 77.0 t -112.48 131.57 63.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.752 -178.652 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.473 ' O ' ' OG ' ' A' ' 94' ' ' SER . 81.0 mt -104.29 131.14 53.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.081 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 38.8 m -123.26 128.24 49.7 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -177.807 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.427 ' O ' ' C ' ' A' ' 91' ' ' ILE . 91.4 mt -115.76 124.17 71.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.051 178.679 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.431 HG21 ' HG ' ' B' ' 237' ' ' CYS . 76.6 mt 39.72 -100.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.445 179.989 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.601 ' OD1' ' NH1' ' A' ' 93' ' ' ARG . 24.2 p-10 -116.21 13.4 15.68 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.779 0.323 . . . . 0.0 111.482 -179.919 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.601 ' NH1' ' OD1' ' A' ' 92' ' ' ASP . 57.0 mtm-85 -125.07 143.45 50.91 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.878 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.473 ' OG ' ' O ' ' A' ' 88' ' ' ILE . 36.2 t -138.75 156.18 47.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.628 0.728 . . . . 0.0 111.887 -179.413 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -128.32 124.62 36.93 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.454 179.294 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -89.6 134.54 34.08 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.951 -0.7 . . . . 0.0 110.959 -179.316 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.471 ' CZ ' ' OD1' ' A' ' 99' ' ' ASN . 85.7 t80 -98.0 123.27 41.93 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.046 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -141.11 126.91 19.14 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.093 -179.617 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.66 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 95.0 m-20 -101.44 108.16 19.67 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.434 179.214 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 . . . . . 0 C--N 1.328 -0.362 0 C-N-CA 119.868 -0.733 . . . . 0.0 110.271 179.598 . . . . . . . . 0 0 . 1 . 049 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . 0.422 ' CG1' ' H ' ' B' ' 229' ' ' ASP . 3.2 t . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.743 0.306 . . . . 0.0 110.458 . . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.55 ' C ' ' H ' ' B' ' 231' ' ' GLN . 30.4 p-10 -113.54 -2.37 13.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.824 179.931 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 049 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.55 ' H ' ' C ' ' B' ' 229' ' ' ASP . 0.0 OUTLIER -138.4 44.73 2.1 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.054 -179.268 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . 0.492 ' N ' ' OD1' ' B' ' 229' ' ' ASP . . . -118.18 -156.55 10.3 Favored Glycine 0 CA--C 1.532 1.116 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 179.909 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.23 160.95 44.14 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.735 2.29 . . . . 0.0 112.679 -179.548 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 049 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -51.86 156.71 6.6 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.682 2.255 . . . . 0.0 112.015 178.536 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 8.2 p -109.9 135.07 50.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.248 -179.767 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . 0.472 ' SG ' ' CD1' ' B' ' 241' ' ' PHE . 19.9 t -78.85 121.59 25.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.289 -179.426 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . 0.431 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . 0.431 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 32.2 Cg_exo -57.72 -24.58 63.93 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.668 2.245 . . . . 0.0 111.884 -179.091 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 77.6 m -73.3 -46.69 48.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.566 178.834 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . 0.472 ' CD1' ' SG ' ' B' ' 237' ' ' CYS . 57.5 t80 -58.19 -45.84 86.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.693 -178.999 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 78.4 mt -64.27 -40.46 96.02 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.478 179.85 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -61.67 -40.63 95.63 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.951 0.405 . . . . 0.0 110.206 179.922 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -61.8 -43.1 99.52 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.628 179.601 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.478 ' CD ' HH11 ' A' ' 12' ' ' ARG . 40.0 mmt-85 -62.19 -39.79 93.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.605 -179.514 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.08 -40.2 96.96 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.238 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 11.2 t -62.84 -44.06 97.15 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 177.693 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -60.0 -38.11 81.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.785 -179.917 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 25.0 t -61.7 -46.53 96.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.797 179.724 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -61.76 -26.84 68.32 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 179.253 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -88.02 -9.46 53.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.412 179.218 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.514 ' CD1' ' NH2' ' A' ' 12' ' ' ARG . 90.2 mt -114.16 106.83 14.83 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.187 179.919 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . 0.553 ' ND2' ' CG ' ' B' ' 255' ' ' ASP . 6.6 p-10 -61.35 179.83 0.2 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.896 0.379 . . . . 0.0 110.361 179.671 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -66.63 -11.42 53.58 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.01 -179.341 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . 0.567 ' O ' ' N ' ' B' ' 257' ' ' LYS . 15.7 p-10 -68.96 -8.12 41.61 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.96 -178.996 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -65.57 60.33 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.971 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . 0.567 ' N ' ' O ' ' B' ' 255' ' ' ASP . 84.9 tttt -64.71 -24.46 67.58 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.047 179.752 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.422 ' O ' ' O ' ' B' ' 259' ' ' ASP . 94.7 m-20 -108.19 81.62 1.51 Allowed 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 178.591 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.598 ' CG ' ' H ' ' B' ' 260' ' ' GLU . 38.6 p30 -53.77 -109.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.662 -178.862 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.598 ' H ' ' CG ' ' B' ' 259' ' ' ASP . 98.5 mt-10 -145.8 23.18 1.41 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.029 0.443 . . . . 0.0 110.037 179.983 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 66.7 mt -113.3 141.12 30.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.303 -178.799 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 56.0 t -127.63 134.04 66.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.329 -179.812 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -99.43 122.92 43.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.441 0.639 . . . . 0.0 111.238 -179.208 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -64.78 -44.88 88.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.42 179.772 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -98.5 155.29 36.98 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.796 -178.901 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.74 149.71 83.6 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.776 2.318 . . . . 0.0 111.791 179.202 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 25.1 pt . . . . . 0 C--N 1.325 -0.481 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.271 -179.425 . . . . . . . . 0 0 . 1 . 050 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo . . . . . 0 N--CA 1.493 1.461 0 N-CA-C 113.226 0.433 . . . . 0.0 113.226 . . . . . . . . . 0 0 . 1 . 050 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 74.8 p -105.02 -46.89 4.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.218 -179.398 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.722 ' NH1' ' HH ' ' A' ' 97' ' ' TYR . 93.7 mtt-85 -92.72 126.22 37.7 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.305 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 89.6 mtm-85 -134.5 151.45 51.14 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.247 0.546 . . . . 0.0 112.255 -179.075 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 85.5 mt -119.16 146.97 44.71 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.875 -179.55 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.0 t -118.55 129.79 74.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.816 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 53.5 m -89.07 112.74 23.76 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -178.126 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.414 HD11 ' HG ' ' A' ' 94' ' ' SER . 95.8 mt -83.64 143.13 12.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 177.748 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.1 tttm -92.33 167.64 11.86 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.108 -0.637 . . . . 0.0 111.063 -179.735 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.601 ' NH1' ' OE2' ' B' ' 260' ' ' GLU . 90.5 mtm180 -58.25 -31.54 67.52 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.517 -179.165 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 90.5 p -83.35 -6.13 59.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.962 0.41 . . . . 0.0 110.024 179.136 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.2 39.78 7.23 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.89 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.1 t -117.26 134.19 61.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.029 0.442 . . . . 0.0 111.617 -179.198 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -73.09 116.68 13.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.702 -179.839 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -110.95 -124.24 4.57 Favored Glycine 0 CA--C 1.54 1.596 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 179.416 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.93 147.58 39.19 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 122.41 2.073 . . . . 0.0 113.518 -179.219 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.551 ' O ' ' CD1' ' B' ' 267' ' ' ILE . 0.4 OUTLIER -110.59 131.01 55.42 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.234 179.333 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -99.58 101.01 12.04 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.533 -179.098 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.97 135.63 23.55 Favored 'Trans proline' 0 C--N 1.315 -1.204 0 C-N-CA 121.332 1.355 . . . . 0.0 111.36 -179.69 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 79.8 mt -85.95 76.58 9.82 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.965 -178.542 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 95.5 p -82.67 -10.34 58.97 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.757 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.2 mt -102.16 146.02 28.55 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.611 -179.682 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.8 m -66.19 -14.8 62.46 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.929 -0.308 . . . . 0.0 111.514 -179.255 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.426 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 75.0 m -135.49 136.48 41.29 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.912 0.387 . . . . 0.0 111.875 -179.539 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.2 t -126.2 117.18 22.57 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.911 178.626 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 58.4 tp -113.57 127.88 56.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.602 0.239 . . . . 0.0 110.861 -179.171 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.587 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 6.0 m-85 -107.4 141.81 38.21 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.741 179.473 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 149.64 -178.5 27.1 Favored Glycine 0 N--CA 1.467 0.751 0 C-N-CA 120.175 -1.012 . . . . 0.0 112.418 178.676 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.494 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 45.8 mtm180 -73.56 -32.92 64.43 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 179.787 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.535 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -50.13 141.68 15.36 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 120.474 -0.87 . . . . 0.0 111.317 -178.579 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.571 ' CD1' ' CZ ' ' A' ' 38' ' ' ARG . 34.4 mm -63.17 -43.62 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-O 120.874 0.369 . . . . 0.0 110.029 179.529 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -53.81 -19.25 4.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.962 179.806 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.535 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 39.6 m -61.6 129.27 40.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.396 -179.923 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.426 ' OD2' ' O ' ' A' ' 26' ' ' THR . 91.4 m-20 -60.73 -30.38 69.94 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.645 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.455 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 82.7 mt -126.93 119.96 54.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.482 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.571 ' CZ ' ' CD1' ' A' ' 33' ' ' ILE . 82.0 mtp180 -99.95 133.75 43.87 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.029 -178.822 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.8 mt -118.44 128.81 75.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-O 121.131 0.491 . . . . 0.0 110.339 179.991 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -76.67 26.87 0.13 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.253 -178.683 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 26.3 mt -94.84 124.76 53.56 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.554 179.731 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.88 -10.84 26.88 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 122.371 2.047 . . . . 0.0 112.542 -179.443 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.1 m -100.86 8.88 8.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.941 0.4 . . . . 0.0 111.27 179.996 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.494 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 21.9 t -97.44 136.31 28.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.329 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.3 m -70.45 170.45 11.97 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.635 0.731 . . . . 0.0 111.921 -178.467 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -62.28 -41.41 98.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.039 -179.144 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.607 ' O ' ' N ' ' A' ' 49' ' ' CYS . 13.9 mm100 -110.91 -20.95 12.26 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.265 0.555 . . . . 0.0 110.403 -179.849 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.0 t60 39.74 -78.34 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.006 -0.997 . . . . 0.0 113.209 179.087 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.607 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.16 137.69 46.32 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.216 0.531 . . . . 0.0 111.791 -178.886 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -129.15 135.36 48.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.217 179.661 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.6 mt -121.27 136.95 56.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.142 -179.11 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -117.01 123.89 47.99 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.755 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.4 mt -102.37 116.05 45.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.528 0.68 . . . . 0.0 111.521 -178.714 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.492 ' O ' ' N ' ' A' ' 56' ' ' GLN . 90.8 m-70 -117.67 144.57 45.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.143 179.932 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 54' ' ' HIS . 80.7 tt0 -39.2 -29.16 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -179.626 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.492 ' N ' ' O ' ' A' ' 54' ' ' HIS . 86.5 mt-30 -66.59 -68.59 0.36 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.733 178.944 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.439 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 6.1 tp10 -157.65 -158.99 0.79 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.562 -179.67 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.439 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -118.42 128.77 54.94 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.064 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.9 mt -118.38 129.3 74.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.304 0.573 . . . . 0.0 112.248 -178.477 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 49.2 tp -95.31 129.19 42.53 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.584 -179.954 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -114.23 134.71 54.73 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.154 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.647 HD22 ' CB ' ' A' ' 68' ' ' PRO . 63.7 t-20 -97.84 105.8 18.0 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -178.078 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -98.24 -8.55 27.12 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.911 179.568 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.3 t -81.06 99.23 8.37 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.694 0.283 . . . . 0.0 110.983 179.684 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.4 t -83.99 -32.74 24.81 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.804 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.6 m -61.29 -47.46 85.85 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.918 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -144.17 108.62 4.96 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.714 178.587 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.647 ' CB ' HD22 ' A' ' 62' ' ' ASN . 40.1 Cg_endo -68.6 152.64 74.56 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 121.535 1.49 . . . . 0.0 113.019 -178.473 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.9 m -70.66 138.97 51.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.22 -179.636 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -101.76 140.28 36.26 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.833 -179.682 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.9 t -134.89 136.29 52.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 178.13 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 56.91 33.51 23.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.993 0.425 . . . . 0.0 110.064 -179.581 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.97 30.64 67.66 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.173 179.219 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 36.0 m -148.18 146.39 28.7 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 117.359 0.58 . . . . 0.0 111.348 -179.661 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.4 m -72.78 147.36 10.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-O 121.015 0.436 . . . . 0.0 111.002 -179.703 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.545 ' CG2' ' O ' ' A' ' 78' ' ' GLU . 98.3 mt -107.2 107.21 22.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.406 -179.474 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -66.09 -42.25 89.58 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.64 179.233 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.545 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.4 OUTLIER -136.71 -177.55 0.72 Allowed Pre-proline 0 N--CA 1.466 0.346 0 CA-C-O 120.666 0.269 . . . . 0.0 111.298 -178.737 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.509 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 45.2 Cg_exo -58.69 145.22 96.57 Favored 'Trans proline' 0 N--CA 1.5 1.895 0 C-N-CA 122.842 2.361 . . . . 0.0 113.199 -179.753 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.8 m -143.76 143.07 24.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.985 179.634 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.411 ' HE ' ' HE2' ' A' ' 83' ' ' LYS . 59.6 ttp180 -76.25 133.59 40.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.107 179.449 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 98.4 mt -82.35 143.87 30.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.151 0.501 . . . . 0.0 111.675 -179.153 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.411 ' HE2' ' HE ' ' A' ' 81' ' ' ARG . 73.3 mmtt -132.72 151.68 51.92 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.489 179.556 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.702 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 5.4 t60 -56.26 117.8 4.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.421 -178.847 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.67 -18.58 24.58 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 111.189 -0.765 . . . . 0.0 111.189 179.527 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -69.61 135.08 49.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.163 0.506 . . . . 0.0 110.554 -179.899 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 49.7 t -110.16 132.78 57.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.91 -179.178 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.1 mt -101.12 130.22 50.89 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 177.676 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 49.6 m -120.1 126.42 50.71 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 119.876 -0.73 . . . . 0.0 112.209 -178.663 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.591 ' O ' ' N ' ' A' ' 93' ' ' ARG . 99.1 mt -114.78 129.91 70.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 114.798 -1.092 . . . . 0.0 108.25 177.993 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.501 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 75.6 mt -23.04 95.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -178.612 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.501 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 3.8 m-20 92.88 -27.19 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 178.551 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.591 ' N ' ' O ' ' A' ' 90' ' ' ILE . 7.9 mmm180 -125.93 143.21 51.18 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.418 -179.3 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.414 ' HG ' HD11 ' A' ' 10' ' ' ILE . 87.0 p -138.81 154.36 48.46 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.6 -0.44 . . . . 0.0 109.995 179.345 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -129.12 126.79 40.1 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.32 -179.539 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 41.7 ttp-105 -90.91 135.69 33.57 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.661 -0.415 . . . . 0.0 110.429 -179.605 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.722 ' HH ' ' NH1' ' A' ' 5' ' ' ARG . 89.1 t80 -92.39 121.34 33.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.905 -179.759 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -121.63 123.43 41.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.831 -179.568 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.702 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 60.3 t-20 -105.28 118.31 36.22 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.921 0.391 . . . . 0.0 110.285 179.923 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 . . . . . 0 C--N 1.326 -0.42 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.492 -179.49 . . . . . . . . 0 0 . 1 . 050 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 47.1 t . . . . . 0 C--O 1.231 0.131 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 . . . . . . . . . 0 0 . 1 . 050 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.578 ' OD1' ' N ' ' B' ' 231' ' ' GLN . 48.5 t0 -81.81 115.77 21.18 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.022 0.439 . . . . 0.0 110.556 -179.849 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 050 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.578 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 75.3 mt-30 -123.25 -26.13 4.35 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.25 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' B' ' 231' ' ' GLN . . . -52.1 -160.22 0.01 OUTLIER Glycine 0 CA--C 1.531 1.085 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.978 -179.679 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -72.89 160.89 45.05 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.944 2.43 . . . . 0.0 114.369 -178.551 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 050 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -74.78 168.8 24.02 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 121.931 1.754 . . . . 0.0 112.708 -179.783 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 2.1 p -107.72 132.4 55.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.058 179.071 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 3.2 t -79.19 133.44 36.71 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.03 -179.282 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . 0.419 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . 0.419 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 31.6 Cg_exo -59.0 -23.29 67.82 Favored 'Trans proline' 0 N--CA 1.502 2.003 0 C-N-CA 122.992 2.461 . . . . 0.0 113.078 -179.777 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' B' B ' 240' ' ' THR . . . . . 0.415 ' OG1' ' O2P' ' B' ' 238' ' ' TPO . 98.9 m -74.47 -46.39 39.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.064 0.459 . . . . 0.0 110.357 178.894 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . 0.423 ' CZ ' ' NH2' ' B' ' 245' ' ' ARG . 88.1 t80 -59.63 -45.34 92.26 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.82 -178.8 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . 0.417 ' CD2' ' OD1' ' A' ' 92' ' ' ASP . 89.9 mt -65.79 -39.96 91.47 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 119.86 -0.736 . . . . 0.0 110.563 179.398 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -60.67 -41.84 95.86 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.854 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -65.81 -37.58 86.64 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.314 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.456 HH11 ' NH1' ' A' ' 12' ' ' ARG . 10.7 tpp180 -62.62 -44.52 96.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.334 -179.68 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -63.08 -36.62 84.19 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.978 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 10.2 t -63.53 -44.65 93.6 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.629 177.974 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 66.6 mm-40 -57.83 -37.63 74.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.919 -179.952 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 21.9 t -63.93 -45.21 97.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.576 178.934 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -59.61 -29.9 68.32 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.078 0.465 . . . . 0.0 110.262 -179.663 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -92.81 -7.17 47.15 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.116 179.613 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.405 HD23 HH21 ' A' ' 12' ' ' ARG . 38.5 tp -75.12 147.19 40.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.863 -179.558 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -105.07 132.24 51.56 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.213 -179.756 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . 0.475 ' N ' ' OD1' ' B' ' 254' ' ' ASP . 28.2 p-10 -65.13 -33.66 76.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.516 179.052 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . 0.475 ' N ' ' OD1' ' B' ' 254' ' ' ASP . 96.9 m-20 -69.51 -6.28 29.65 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.361 179.897 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.572 ' O ' ' N ' ' B' ' 258' ' ' ASP . 34.9 t70 -98.95 -44.19 6.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.379 0.609 . . . . 0.0 109.844 179.316 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' B' ' 259' ' ' ASP . 99.1 mttt 58.65 -72.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.244 -179.263 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.573 ' O ' ' CB ' ' B' ' 259' ' ' ASP . 90.3 m-20 38.71 -95.44 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -179.115 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.573 ' CB ' ' O ' ' B' ' 258' ' ' ASP . 30.2 p-10 116.95 -162.94 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.453 0 O-C-N 124.868 1.355 . . . . 0.0 108.564 179.263 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.601 ' OE2' ' NH1' ' A' ' 12' ' ' ARG . 92.4 mt-10 -137.74 16.21 2.89 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 177.486 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . 0.433 ' H ' ' CG ' ' B' ' 259' ' ' ASP . 3.0 mm -112.72 131.36 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 114.31 -1.314 . . . . 0.0 109.407 -179.109 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 39.2 t -124.95 132.31 71.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.629 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -98.56 122.05 41.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.2 0.524 . . . . 0.0 111.889 -178.302 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -65.06 -45.9 83.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.694 179.326 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -92.47 163.9 24.75 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.436 -179.882 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.86 146.92 92.23 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.21 1.94 . . . . 0.0 112.56 -179.89 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . 0.551 ' CD1' ' O ' ' A' ' 19' ' ' HIS . 4.9 tt . . . . . 0 C--N 1.323 -0.582 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.246 -179.607 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo . . . . . 0 N--CA 1.489 1.214 0 CA-C-O 121.094 0.372 . . . . 0.0 112.096 . . . . . . . . . 0 0 . 1 . 051 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.1 m -72.35 -44.02 63.21 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.745 -179.744 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -91.4 138.66 31.4 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.949 -178.011 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -139.0 147.23 41.87 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 179.761 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 42.4 tp -117.82 133.61 55.76 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.258 179.241 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 53.7 t -110.8 132.02 60.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.265 -178.668 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 m -96.6 115.84 28.1 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.874 -179.249 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 87.2 mt -83.41 150.96 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.578 179.888 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.58 ' HZ1' ' C ' ' B' ' 257' ' ' LYS . 72.8 mmtt -86.17 154.09 21.58 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 178.527 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.533 ' NH2' ' OE2' ' B' ' 260' ' ' GLU . 87.7 mtm180 -58.22 -25.47 61.7 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.373 179.776 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.2 m -79.49 -8.25 59.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.843 179.84 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.01 31.84 8.89 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -179.893 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.8 t -118.65 133.64 64.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.611 0.243 . . . . 0.0 110.898 -179.949 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -72.89 133.02 44.22 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.524 -0.546 . . . . 0.0 109.524 179.141 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -127.54 -118.63 2.17 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 120.403 -0.903 . . . . 0.0 111.931 -179.54 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -76.17 149.06 31.62 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.56 2.173 . . . . 0.0 112.593 -179.028 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -110.81 151.08 28.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.339 0.59 . . . . 0.0 111.246 -179.432 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -112.54 91.75 17.87 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.304 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.47 133.53 22.64 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 121.226 1.284 . . . . 0.0 111.269 -178.329 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.594 ' O ' ' CB ' ' A' ' 23' ' ' SER . 72.0 mt -73.45 -149.56 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.976 -178.429 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.594 ' CB ' ' O ' ' A' ' 22' ' ' LEU . 6.9 p 135.98 -40.16 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -179.181 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.3 mt -77.52 142.84 38.86 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.55 -1.204 . . . . 0.0 109.769 179.746 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 m -65.26 -17.13 64.25 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -178.766 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.1 m -133.86 133.56 41.69 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.619 0.599 . . . . 0.0 112.619 -179.2 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.662 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.4 OUTLIER -126.15 119.44 27.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.185 178.146 . . . . . . . . 3 3 . 1 . 051 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 36.7 tp -119.7 128.07 53.45 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.826 -178.391 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.662 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 25.1 m-85 -100.73 128.18 46.88 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.262 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -173.35 -165.04 29.61 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 120.057 -1.068 . . . . 0.0 112.876 -179.79 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.499 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 38.0 ttp-105 -105.75 -8.5 17.78 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.169 -0.515 . . . . 0.0 111.694 -179.138 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -91.52 170.05 33.49 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.66 -178.865 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.475 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 11.0 tp -68.45 -41.7 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 115.638 -0.281 . . . . 0.0 111.301 -179.884 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.475 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 48.8 tt0 -56.76 -29.46 62.62 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.458 -179.429 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.9 m -63.5 129.94 42.28 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.479 -179.975 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -60.51 -31.3 70.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.383 -178.768 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.404 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 97.6 mt -127.25 118.65 50.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 178.258 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 59.9 mtm180 -102.29 137.2 40.86 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.57 179.9 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.47 ' C ' ' H ' ' A' ' 41' ' ' LEU . 75.8 mt -119.38 131.94 70.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.617 -179.583 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -67.2 18.82 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -177.934 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.47 ' H ' ' C ' ' A' ' 39' ' ' ILE . 15.5 mt -104.64 127.73 28.34 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.87 179.96 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.67 -5.89 17.8 Favored 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 122.368 2.046 . . . . 0.0 112.326 -179.737 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.0 m -91.8 5.51 6.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.065 179.462 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.499 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 54.7 t -96.51 135.52 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.882 178.885 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.2 m -74.27 167.99 20.51 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.747 0.784 . . . . 0.0 112.951 -178.377 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.7 mtmt -64.13 -37.97 89.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.689 179.588 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.612 ' O ' ' N ' ' A' ' 49' ' ' CYS . 92.1 mm-40 -115.16 -32.26 5.75 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.135 0.493 . . . . 0.0 110.103 -179.984 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 18.7 t60 41.74 -77.2 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.764 179.636 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.612 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.37 134.74 47.38 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.793 -178.916 . . . . . . . . 3 3 . 1 . 051 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -126.05 129.25 48.79 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.359 -179.972 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 95.5 mt -114.89 131.98 65.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.208 -179.736 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -116.93 125.8 52.0 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.552 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 98.0 mt -106.73 114.5 46.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 119.975 -0.69 . . . . 0.0 112.022 -178.585 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.426 ' O ' ' C ' ' A' ' 55' ' ' GLU . 86.2 m-70 -113.27 146.32 39.55 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.719 179.804 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 54' ' ' HIS . 52.8 tp10 -40.66 -33.39 0.28 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.527 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -61.39 -68.94 0.27 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.744 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -161.35 -160.58 0.73 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.145 178.723 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.11 128.15 56.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.365 -179.926 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 91.2 mt -116.59 129.88 72.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.036 0.446 . . . . 0.0 111.892 -179.013 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 28.5 tp -100.0 130.39 46.16 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.896 -179.14 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -115.92 136.17 53.29 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.718 179.849 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -97.09 106.54 18.89 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -178.994 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -100.58 -7.47 24.01 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.213 178.73 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.99 100.97 7.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.187 179.789 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.3 m -88.47 -10.92 47.42 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.999 179.606 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.98 -43.6 9.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.284 -179.724 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -140.05 101.26 7.03 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.08 -179.877 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -56.7 143.11 90.83 Favored 'Trans proline' 0 N--CA 1.501 1.929 0 C-N-CA 122.297 1.998 . . . . 0.0 113.355 -179.312 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.9 m -72.27 140.35 48.57 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.096 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 89' ' ' THR . 72.8 mt-30 -104.57 140.35 38.12 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.327 -0.549 . . . . 0.0 111.39 -179.005 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 55.8 t -131.61 133.43 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.982 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 54.21 33.06 17.25 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.976 179.947 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.5 24.29 70.89 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.993 178.932 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.7 t -142.79 143.52 32.21 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 117.585 0.692 . . . . 0.0 111.058 179.844 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.5 m -69.22 144.11 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.311 179.945 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.486 ' CG1' ' O ' ' A' ' 78' ' ' GLU . 8.2 tt -106.42 91.39 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.259 179.191 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -64.11 -37.27 86.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.966 179.925 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.486 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 3.5 mt-10 -126.89 168.7 13.85 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.254 -179.044 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -59.74 145.38 98.31 Favored 'Trans proline' 0 N--CA 1.501 1.912 0 C-N-CA 122.042 1.828 . . . . 0.0 112.705 -179.56 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.2 m -145.48 151.58 14.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.801 178.922 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -78.83 132.94 37.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.762 179.552 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.1 mt -89.39 140.92 29.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.16 0.505 . . . . 0.0 111.281 -179.681 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -123.13 151.94 41.61 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.852 179.351 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -53.82 121.69 8.45 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.403 -179.861 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.15 -13.99 37.01 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -179.888 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -68.71 135.59 51.55 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.575 -0.45 . . . . 0.0 109.937 179.671 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.495 ' CG1' ' OG ' ' A' ' 94' ' ' SER . 91.4 t -107.06 132.28 54.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.213 -179.024 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 45.2 mm -91.05 128.28 42.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.768 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.526 ' N ' ' O ' ' A' ' 70' ' ' GLN . 63.5 m -124.26 123.35 40.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.505 0.669 . . . . 0.0 112.531 -178.02 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.443 ' O ' ' C ' ' A' ' 91' ' ' ILE . 85.1 mt -121.55 129.06 75.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.432 179.295 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.443 ' C ' ' O ' ' A' ' 90' ' ' ILE . 95.8 mt 34.2 -99.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.454 -179.797 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.5 ' O ' ' OD1' ' A' ' 92' ' ' ASP . 36.7 t0 -114.05 16.87 18.1 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.703 0.287 . . . . 0.0 111.33 -179.216 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.444 ' NH2' ' CG2' ' A' ' 44' ' ' VAL . 4.8 mtm105 -124.71 139.18 54.09 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.812 -179.298 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.495 ' OG ' ' CG1' ' A' ' 87' ' ' VAL . 41.7 t -132.72 141.81 48.74 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.103 0.478 . . . . 0.0 110.128 179.606 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.458 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 27.2 m-85 -125.06 123.26 39.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.886 -179.993 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -82.53 126.42 32.25 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.508 -179.855 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.585 ' CE2' ' OD1' ' A' ' 99' ' ' ASN . 74.7 t80 -90.59 124.27 34.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.658 179.607 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -128.52 113.5 15.56 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.801 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.585 ' OD1' ' CE2' ' A' ' 97' ' ' TYR . 87.2 m-20 -66.42 -41.13 89.71 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.544 179.961 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.092 -179.244 . . . . . . . . 0 0 . 1 . 051 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 4.7 p . . . . . 0 CA--C 1.527 0.068 0 CA-C-O 121.215 0.531 . . . . 0.0 109.809 . . . . . . . . . 0 0 . 1 . 051 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.643 ' O ' ' N ' ' B' ' 231' ' ' GLN . 62.6 t0 -88.05 124.15 33.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.04 179.831 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 051 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.643 ' N ' ' O ' ' B' ' 229' ' ' ASP . 5.7 pt20 156.8 -21.72 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.106 179.923 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . 0.509 ' O ' ' O ' ' B' ' 231' ' ' GLN . . . -48.89 -164.73 0.01 OUTLIER Glycine 0 CA--C 1.537 1.437 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.264 -179.417 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.51 158.72 55.14 Favored 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 122.863 2.375 . . . . 0.0 113.334 -178.989 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 051 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.3 140.92 38.03 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 121.655 1.57 . . . . 0.0 113.159 -178.943 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 1.8 t -61.03 138.9 21.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.306 -179.882 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -66.08 128.95 38.12 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.288 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . 0.424 ' O3P' ' OG1' ' B' ' 240' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.77 -29.44 71.75 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 122.995 2.463 . . . . 0.0 112.7 179.974 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' B' B ' 240' ' ' THR . . . . . 0.424 ' OG1' ' O3P' ' B' ' 238' ' ' TPO . 25.9 m -74.52 -42.6 58.61 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.073 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . 0.422 ' CZ ' ' NE ' ' B' ' 245' ' ' ARG . 73.1 t80 -57.17 -47.41 81.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.585 -179.219 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 91.0 mt -65.31 -39.47 92.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.039 0.447 . . . . 0.0 110.206 179.634 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -62.35 -41.25 98.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.757 -179.615 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -64.33 -40.78 96.58 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.65 179.85 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.422 ' NE ' ' CZ ' ' B' ' 241' ' ' PHE . 25.9 mmt180 -61.37 -42.69 99.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.33 -179.354 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.4 -39.76 95.36 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.304 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 11.0 t -66.04 -45.89 79.77 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.849 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -55.11 -40.87 70.96 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.693 179.996 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 44.3 t -60.96 -43.88 96.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.857 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -60.85 -26.59 67.47 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.539 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -86.62 -13.4 45.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.954 -179.557 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 69.0 mt -72.39 147.89 45.77 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.161 0.505 . . . . 0.0 110.454 179.472 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . 0.498 ' C ' ' H ' ' B' ' 255' ' ' ASP . 80.8 m-20 -73.48 174.86 7.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.012 179.583 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -65.84 0.84 1.57 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.843 179.563 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . 0.498 ' H ' ' C ' ' B' ' 253' ' ' ASN . 65.4 m-20 -89.34 -86.34 0.19 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.314 178.69 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.416 ' O ' ' NZ ' ' A' ' 11' ' ' LYS . 34.2 t0 64.13 26.74 13.97 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.907 -179.203 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . 0.58 ' C ' ' HZ1' ' A' ' 11' ' ' LYS . 99.6 mttt -80.47 -9.76 59.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.411 -179.546 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -70.99 -71.97 0.23 Allowed 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 120.531 -0.467 . . . . 0.0 109.885 179.093 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.656 ' C ' ' H ' ' B' ' 261' ' ' ILE . 47.0 t0 72.72 124.88 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.311 0.577 . . . . 0.0 111.412 -179.867 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.533 ' OE2' ' NH2' ' A' ' 12' ' ' ARG . 53.5 mp0 -56.42 17.94 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.357 -179.433 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . 0.656 ' H ' ' C ' ' B' ' 259' ' ' ASP . 64.5 mt -111.7 134.28 54.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.48 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 77.1 t -128.02 135.27 63.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.761 -179.225 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -96.53 119.25 34.67 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.072 -178.224 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -66.42 -46.82 75.23 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.156 178.976 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.37 156.2 51.17 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.859 -178.543 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -62.23 149.19 91.54 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 C-N-CA 122.46 2.107 . . . . 0.0 111.071 179.261 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 30.1 pt . . . . . 0 C--N 1.325 -0.489 0 CA-C-O 121.47 0.652 . . . . 0.0 111.964 -178.42 . . . . . . . . 0 0 . 1 . 052 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo . . . . . 0 N--CA 1.495 1.594 0 CA-C-O 120.823 0.259 . . . . 0.0 112.015 . . . . . . . . . 0 0 . 1 . 052 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 69.1 p -102.67 -47.84 4.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.556 179.904 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.5 mtt85 -94.2 132.76 38.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.248 -179.808 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.484 HH21 ' CD ' ' A' ' 98' ' ' GLU . 39.5 ptt180 -143.57 153.43 42.55 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 120.311 -0.556 . . . . 0.0 111.784 -179.943 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 68.5 mt -117.98 138.71 52.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.817 -179.757 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.6 t -112.03 130.3 65.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.524 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.5 m -79.27 141.24 37.23 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -178.389 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.428 HD11 ' NH1' ' A' ' 96' ' ' ARG . 47.9 mm -106.2 132.4 53.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.096 -0.957 . . . . 0.0 109.035 177.547 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -87.74 154.42 20.58 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.406 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.426 ' HG2' HH12 ' B' ' 245' ' ' ARG . 80.8 mtm180 -57.78 -23.67 53.46 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -178.806 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.4 m -82.89 -9.5 59.28 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.623 179.653 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.27 32.58 10.34 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -179.746 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.1 t -120.53 132.09 71.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.875 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.589 ' OD2' ' NH2' ' A' ' 96' ' ' ARG . 98.2 m-20 -69.8 137.96 52.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.438 -179.649 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -124.77 -121.23 2.54 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.28 -179.093 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -75.93 146.62 29.66 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.578 2.185 . . . . 0.0 113.192 -178.486 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -106.65 143.69 34.39 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.154 0.502 . . . . 0.0 110.461 179.754 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -112.35 96.22 34.63 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.371 -179.707 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -68.89 129.35 18.36 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 121.369 1.379 . . . . 0.0 112.332 -178.422 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 94.4 mt -83.88 78.05 9.79 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.114 0.483 . . . . 0.0 111.052 -178.922 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.7 p -82.29 -13.14 57.45 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.176 178.93 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.2 mt -102.86 148.22 25.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.428 -179.312 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 80.0 p -69.95 -14.78 62.87 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.568 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 58.3 m -129.48 131.48 46.69 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.315 -179.985 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.3 t -124.55 112.7 17.15 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 178.63 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.441 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 40.6 tp -110.01 124.58 51.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.524 -178.749 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.434 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 5.5 m-85 -104.76 140.77 37.59 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.175 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -179.97 -176.08 47.12 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.001 -1.095 . . . . 0.0 112.428 179.507 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 37.2 ttp180 -91.27 -10.01 43.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.928 0.394 . . . . 0.0 109.959 -179.933 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.434 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -93.86 154.53 21.64 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.763 -179.652 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.445 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 11.3 tp -66.92 -40.84 86.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 179.435 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.445 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 80.9 tt0 -46.92 -16.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.478 -179.968 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.435 ' H ' ' C ' ' A' ' 33' ' ' ILE . 2.8 m -83.19 145.14 29.34 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.764 -179.983 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.441 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 54.8 m-20 -58.85 -32.81 69.77 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -179.539 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 85.3 mt -129.04 124.54 60.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.314 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 36.0 ttp180 -108.47 138.71 44.32 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.541 -0.464 . . . . 0.0 111.228 -179.514 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 98.3 mt -121.23 132.54 70.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.125 0.488 . . . . 0.0 110.418 -179.915 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -76.38 29.19 0.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.35 -178.803 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 38.2 mt -98.72 128.87 31.35 Favored Pre-proline 0 C--N 1.324 -0.523 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.476 179.736 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.89 -9.59 22.44 Favored 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 122.135 1.89 . . . . 0.0 111.345 179.316 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.4 m -97.43 5.5 9.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.804 -179.917 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 24.8 t -96.46 133.12 38.96 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-O 121.134 0.492 . . . . 0.0 110.058 179.272 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 28.7 m -72.21 160.93 31.6 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.944 -179.291 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.27 -39.31 89.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.832 -178.891 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.534 ' O ' ' N ' ' A' ' 49' ' ' CYS . 99.4 mm-40 -111.45 -9.81 14.21 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.903 0.382 . . . . 0.0 110.966 -179.549 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.575 ' ND1' ' OG ' ' A' ' 64' ' ' SER . 15.1 t60 15.36 -76.05 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -178.16 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.534 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.65 135.09 46.64 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 -177.613 . . . . . . . . 3 3 . 1 . 052 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -128.55 128.73 44.83 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.648 179.57 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.9 mt -112.84 133.5 58.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.364 179.796 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -116.81 125.27 51.34 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.34 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 87.5 mt -107.27 113.56 43.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.62 0.724 . . . . 0.0 111.812 -179.117 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.433 ' C ' ' N ' ' A' ' 56' ' ' GLN . 86.7 m-70 -109.68 141.77 41.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.442 -179.941 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 54' ' ' HIS . 94.3 mt-10 -42.72 -28.35 0.23 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.729 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.487 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 86.7 mt-30 -65.0 -69.44 0.29 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.642 178.791 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.487 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 4.4 tp10 -154.79 -174.56 5.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.762 -179.064 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -108.62 127.92 54.39 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.252 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.461 HG23 HD12 ' A' ' 59' ' ' ILE . 91.6 mt -119.18 132.17 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -178.512 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.1 tp -100.85 129.58 46.74 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.693 178.934 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -114.35 137.72 51.45 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.787 -179.601 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -98.42 104.28 16.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.266 -0.424 . . . . 0.0 112.11 -179.568 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -101.22 -5.31 25.72 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.518 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.575 ' OG ' ' ND1' ' A' ' 48' ' ' HIS . 0.2 OUTLIER -77.03 99.51 5.33 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.917 -179.844 . . . . . . . . 3 3 . 1 . 052 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.0 m -78.74 -31.72 46.43 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.311 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.5 m -63.45 -49.0 75.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.596 -179.808 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.412 HD22 ' HA ' ' B' ' 236' ' ' VAL . 49.7 m-80 -150.61 100.93 3.1 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.002 -179.487 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -52.34 149.1 23.74 Favored 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 122.468 2.112 . . . . 0.0 112.843 -179.823 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 31.3 m -72.83 137.07 45.5 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.774 179.877 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -100.15 142.02 32.19 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.098 -179.972 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.418 ' O ' ' OG ' ' A' ' 74' ' ' SER . 54.6 t -130.36 134.04 63.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.932 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 51.59 33.01 9.88 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 119.684 -0.806 . . . . 0.0 109.497 179.99 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.68 29.51 67.5 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.344 179.402 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 24.0 p -140.92 133.49 28.6 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 117.486 0.643 . . . . 0.0 111.424 -179.96 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.1 t -69.93 139.18 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.092 179.978 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.55 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 1.2 pt -108.63 107.41 22.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.454 0.645 . . . . 0.0 111.213 179.551 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.432 ' O ' ' OE1' ' A' ' 78' ' ' GLU . 58.3 m-20 -65.64 -33.87 76.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.851 179.051 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.513 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.1 OUTLIER -128.45 -177.72 0.68 Allowed Pre-proline 0 N--CA 1.465 0.282 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.318 179.988 . . . . . . . . 3 3 . 1 . 052 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.513 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 39.7 Cg_exo -61.56 145.08 98.07 Favored 'Trans proline' 0 N--CA 1.499 1.822 0 C-N-CA 122.705 2.27 . . . . 0.0 112.441 179.75 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.2 t -133.21 136.55 54.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.587 179.426 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -73.24 131.19 41.66 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.161 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 90.3 mt -87.46 136.65 32.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.035 0.445 . . . . 0.0 111.279 -179.006 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.537 ' N ' ' OD2' ' A' ' 86' ' ' ASP . 99.2 mttt -125.36 152.26 45.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.953 -179.929 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.498 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 6.1 t60 -52.08 114.73 1.41 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.829 -179.317 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.95 -12.09 29.42 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 179.634 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.537 ' OD2' ' N ' ' A' ' 83' ' ' LYS . 97.5 m-20 -69.98 137.71 51.67 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.086 179.767 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 88.6 t -111.41 134.15 54.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.418 -178.573 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 37.5 mm -93.31 126.53 45.73 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 178.291 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 51.2 m -125.4 127.44 46.57 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.944 0.878 . . . . 0.0 113.08 -178.125 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.531 ' O ' ' C ' ' A' ' 91' ' ' ILE . 89.0 mt -111.76 133.95 55.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 113.933 -1.485 . . . . 0.0 108.043 178.739 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.531 ' C ' ' O ' ' A' ' 90' ' ' ILE . 74.3 mt 16.17 -83.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 O-C-N 123.65 0.594 . . . . 0.0 112.171 -177.333 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' A' ' 90' ' ' ILE . 46.6 t0 -120.7 8.18 10.59 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.593 -179.515 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.734 ' NH1' HH22 ' B' ' 245' ' ' ARG . 2.4 tpp180 -124.65 137.92 54.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.085 -179.784 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 91.0 p -140.79 158.7 43.58 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.577 0.703 . . . . 0.0 112.343 -178.711 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -130.05 128.8 42.68 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.483 179.573 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.589 ' NH2' ' OD2' ' A' ' 16' ' ' ASP . 92.4 mtm-85 -87.55 132.97 33.86 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 119.591 -0.844 . . . . 0.0 111.168 -179.812 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -95.48 125.15 39.89 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.46 179.369 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.484 ' CD ' HH21 ' A' ' 6' ' ' ARG . 83.4 tt0 -126.52 121.68 33.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.623 179.931 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.498 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 64.7 t-20 -100.54 107.13 18.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.996 179.764 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 . . . . . 0 C--N 1.326 -0.418 0 CA-C-O 120.908 0.385 . . . . 0.0 110.721 -179.687 . . . . . . . . 0 0 . 1 . 052 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 21.3 m . . . . . 0 N--CA 1.452 -0.354 0 CA-C-O 120.863 0.363 . . . . 0.0 110.453 . . . . . . . . . 0 0 . 1 . 052 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -66.48 131.19 45.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.98 -179.701 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 052 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -126.4 41.39 3.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.066 0.46 . . . . 0.0 110.187 179.743 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -118.82 -168.27 14.09 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.835 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -61.3 152.1 74.72 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 123.387 2.725 . . . . 0.0 112.643 179.856 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 052 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -81.22 143.8 14.27 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.24 1.96 . . . . 0.0 112.892 -179.478 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . 0.412 ' HA ' HD22 ' A' ' 67' ' ' ASN . 24.8 m -65.67 153.31 8.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.602 -179.263 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 8.6 t -60.03 120.99 10.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.214 0.531 . . . . 0.0 111.122 -178.629 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 052 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -60.64 -27.71 85.3 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 122.941 2.427 . . . . 0.0 112.826 -178.766 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 84.2 m -74.21 -40.21 62.6 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.202 0.525 . . . . 0.0 109.595 178.017 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -58.5 -48.06 82.04 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.751 -179.227 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 86.9 mt -63.5 -42.27 98.53 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 120.858 0.361 . . . . 0.0 111.32 179.86 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -66.17 -36.72 83.83 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.451 -179.471 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -61.24 -44.06 97.86 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.454 -0.499 . . . . 0.0 109.808 179.416 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.734 HH22 ' NH1' ' A' ' 93' ' ' ARG . 2.9 mtt-85 -59.9 -41.13 90.97 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.871 0.367 . . . . 0.0 110.432 179.776 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -61.77 -43.05 99.62 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.354 179.505 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 10.5 t -64.26 -45.41 88.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.284 0.564 . . . . 0.0 109.687 178.958 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 28.7 mm100 -62.01 -35.69 79.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.977 -179.363 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 44.8 t -64.87 -46.06 93.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.677 179.357 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -62.13 -25.99 68.05 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.399 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -88.68 -11.22 45.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.811 179.697 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.415 HD23 HH21 ' A' ' 12' ' ' ARG . 48.8 tp -118.27 114.43 22.98 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.919 0.39 . . . . 0.0 111.777 -179.432 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -53.4 160.67 1.13 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.345 0.593 . . . . 0.0 111.685 -179.298 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -76.41 -21.74 55.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.017 178.748 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -92.44 7.25 43.87 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.389 -179.56 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -98.86 115.97 30.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.567 -179.728 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . 0.563 ' O ' ' CB ' ' B' ' 258' ' ' ASP . 97.8 mttt -73.3 160.58 31.64 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.675 179.416 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.563 ' CB ' ' O ' ' B' ' 257' ' ' LYS . 25.4 p-10 119.72 72.1 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 O-C-N 124.965 1.415 . . . . 0.0 108.336 -179.337 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . . . . . . . . . 38.3 p-10 -89.59 8.48 31.1 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.773 -178.22 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 62.61 20.39 11.97 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 179.931 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 75.1 mt -118.23 131.37 71.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.061 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 53.6 t -125.23 132.37 71.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.575 179.81 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -96.18 115.75 27.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.2 -178.927 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -65.53 -46.7 78.57 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.747 179.289 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -87.25 150.39 49.27 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.13 -178.957 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.13 142.98 63.26 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.327 2.018 . . . . 0.0 112.254 -179.745 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 44.5 pt . . . . . 0 C--N 1.327 -0.396 0 CA-C-O 121.148 0.499 . . . . 0.0 109.841 179.114 . . . . . . . . 0 0 . 1 . 053 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 N--CA 1.489 1.258 0 CA-C-O 120.891 0.288 . . . . 0.0 111.96 . . . . . . . . . 0 0 . 1 . 053 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.0 p -101.68 -50.32 3.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.038 -179.79 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.56 ' NH2' ' CD1' ' A' ' 53' ' ' ILE . 15.0 mtm180 -93.69 128.84 40.08 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.564 -179.086 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.7 mtp180 -126.94 139.15 53.27 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.155 0.502 . . . . 0.0 111.456 179.74 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 32.3 tp -112.51 132.83 54.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.057 -179.6 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.0 t -109.45 129.68 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.822 0.344 . . . . 0.0 110.648 179.982 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.8 m -86.28 111.93 20.91 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.715 -179.368 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 79.5 mt -80.42 142.76 13.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.15 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -93.56 159.02 15.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.992 0.425 . . . . 0.0 111.587 179.994 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 89.9 mtm180 -59.12 -29.8 67.66 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.417 179.682 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.4 m -75.51 -15.41 60.4 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.43 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.8 31.83 7.18 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -179.86 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.7 t -119.66 131.17 72.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.835 0.35 . . . . 0.0 110.911 -179.496 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -74.96 139.42 42.98 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.436 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.84 -115.57 1.65 Allowed Glycine 0 CA--C 1.534 1.227 0 C-N-CA 120.118 -1.039 . . . . 0.0 112.11 -179.355 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.71 146.68 43.65 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.264 1.976 . . . . 0.0 112.909 -178.717 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -109.77 146.9 34.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.031 -179.622 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.413 ' CD2' HD12 ' A' ' 37' ' ' ILE . 40.3 t80 -117.27 101.29 53.03 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.584 -179.813 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -72.47 127.35 12.44 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 121.714 1.61 . . . . 0.0 111.546 -178.743 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.416 ' CD1' ' NH2' ' A' ' 5' ' ' ARG . 62.6 mt -78.02 52.29 1.06 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.985 -178.555 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.6 p -61.83 -33.28 73.87 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.398 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 68.6 mt -74.06 141.87 45.69 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.818 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 94.7 p -67.07 -16.61 64.45 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.879 0.371 . . . . 0.0 110.814 -179.35 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 56.4 m -130.83 132.46 45.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.962 -179.992 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.666 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 2.6 t -128.25 120.04 26.38 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.828 179.471 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 27.6 tp -120.15 130.98 54.85 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.541 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.666 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 35.6 m-85 -108.15 144.29 35.75 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.826 179.92 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 149.23 -178.92 26.44 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 120.928 -0.654 . . . . 0.0 112.074 177.929 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 45.6 mtm180 -69.72 -32.88 71.68 Favored 'General case' 0 CA--C 1.522 -0.119 0 CA-C-O 120.936 0.398 . . . . 0.0 111.256 178.76 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.562 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -52.78 135.68 38.26 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -178.813 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.435 ' C ' ' N ' ' A' ' 35' ' ' CYS . 80.1 mt -63.89 -43.45 97.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.48 179.419 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -51.48 -18.9 1.2 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.406 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.562 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 13.9 m -68.79 129.13 39.04 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.718 179.037 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -60.42 -28.63 68.42 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.689 -179.103 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.413 HD12 ' CD2' ' A' ' 20' ' ' PHE . 48.2 mm -122.5 116.0 47.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.9 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -100.79 131.44 46.68 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.678 -179.39 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.416 ' C ' ' H ' ' A' ' 41' ' ' LEU . 91.8 mt -119.52 130.36 74.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.205 -0.598 . . . . 0.0 109.798 -179.549 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -78.04 27.81 0.18 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.207 -178.594 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.416 ' H ' ' C ' ' A' ' 39' ' ' ILE . 16.0 mt -95.3 110.73 52.1 Favored Pre-proline 0 C--N 1.325 -0.483 0 C-N-CA 120.592 -0.443 . . . . 0.0 109.827 179.769 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -56.55 -12.05 7.79 Favored 'Trans proline' 0 N--CA 1.499 1.809 0 C-N-CA 122.115 1.877 . . . . 0.0 113.223 -179.266 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.6 m -102.64 9.14 9.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -178.888 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.532 ' O ' ' O ' ' A' ' 45' ' ' SER . 8.8 p -103.3 106.59 20.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.021 179.894 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.532 ' O ' ' O ' ' A' ' 44' ' ' VAL . 0.4 OUTLIER -34.05 167.08 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 114.911 -1.04 . . . . 0.0 113.122 -178.109 . . . . . . . . 3 3 . 1 . 053 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -62.37 -42.82 99.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.471 -178.723 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.639 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.0 mm-40 -111.97 -20.03 12.14 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.421 -179.445 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 24.6 t60 36.55 -75.26 0.0 OUTLIER 'General case' 0 C--O 1.236 0.361 0 CA-C-N 114.89 -1.05 . . . . 0.0 113.493 179.685 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.639 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.27 135.91 45.21 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.759 -178.118 . . . . . . . . 3 3 . 1 . 053 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -128.56 134.82 48.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.776 179.809 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.0 mt -117.05 132.73 65.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.21 179.701 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -118.56 127.24 53.43 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.647 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.56 ' CD1' ' NH2' ' A' ' 5' ' ' ARG . 86.7 mt -102.72 116.27 46.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.487 0.66 . . . . 0.0 111.593 -179.562 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.448 ' O ' ' C ' ' A' ' 55' ' ' GLU . 79.6 m-70 -111.83 139.04 47.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.114 -179.921 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 54' ' ' HIS . 97.6 mt-10 -40.55 -34.69 0.38 Allowed 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.654 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -60.73 -67.96 0.35 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.832 178.599 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -155.63 -171.89 3.94 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.286 0.565 . . . . 0.0 111.571 -179.03 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.18 128.17 54.81 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.668 179.18 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.404 HD13 HG23 ' A' ' 59' ' ' ILE . 96.4 mt -125.48 133.53 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -178.77 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.415 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 16.5 tp -97.89 131.68 44.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.138 179.024 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -113.35 136.2 53.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.959 179.992 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -97.97 104.1 16.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.37 -179.921 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -95.99 -8.7 33.0 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.17 179.636 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.09 109.58 7.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.933 0.397 . . . . 0.0 111.364 -179.579 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.7 p -90.44 -18.07 26.05 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.07 179.022 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.91 -40.88 13.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.221 -179.901 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -145.67 99.1 4.45 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.47 -179.766 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -57.86 147.49 81.02 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 122.049 1.833 . . . . 0.0 112.779 179.99 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.0 m -68.08 137.17 54.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.884 179.519 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -98.52 143.62 28.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.977 179.353 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.414 ' O ' ' N ' ' A' ' 74' ' ' SER . 5.1 p -130.82 137.9 54.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.342 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 50.58 31.84 6.11 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.946 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.91 28.68 68.29 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.355 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.414 ' N ' ' O ' ' A' ' 71' ' ' VAL . 14.8 t -137.97 135.29 35.86 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.846 0.355 . . . . 0.0 111.357 -179.726 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.4 p -61.73 143.03 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.914 -179.207 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.55 ' CG2' ' O ' ' A' ' 78' ' ' GLU . 96.5 mt -108.3 106.01 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.931 -179.855 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -68.74 -42.04 78.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.428 179.067 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.55 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.7 OUTLIER -135.01 -179.92 1.21 Allowed Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.522 -178.774 . . . . . . . . 3 3 . 1 . 053 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.473 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 32.1 Cg_exo -57.48 146.94 81.25 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.631 2.221 . . . . 0.0 112.699 -179.595 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 18.2 m -139.67 142.81 31.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.48 -179.315 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.52 HH21 ' CE ' ' A' ' 83' ' ' LYS . 61.2 ttp180 -76.07 131.28 39.37 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.579 179.013 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.3 mt -80.61 135.5 36.07 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-O 121.148 0.499 . . . . 0.0 111.69 -179.413 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.52 ' CE ' HH21 ' A' ' 81' ' ' ARG . 99.0 mttt -129.07 150.57 50.41 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.868 178.937 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.665 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 6.3 t60 -55.3 115.72 2.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.831 0.348 . . . . 0.0 111.748 -179.172 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.24 -18.75 18.09 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.936 -0.65 . . . . 0.0 111.595 179.016 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -69.52 136.37 51.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.34 0.591 . . . . 0.0 110.608 179.913 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.8 t -114.5 131.24 67.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.04 -179.014 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 92.8 mt -97.23 132.26 42.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.645 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.8 m -118.55 124.92 48.71 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.338 -178.544 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.474 ' O ' ' N ' ' A' ' 92' ' ' ASP . 78.0 mt -112.38 126.96 69.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.134 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.495 ' CG2' ' NH2' ' B' ' 245' ' ' ARG . 33.8 mm 38.74 -97.09 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -178.749 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.543 ' CB ' ' NH2' ' B' ' 245' ' ' ARG . 44.2 t0 -123.09 17.45 10.0 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.097 0.475 . . . . 0.0 110.494 178.883 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.527 ' NH1' ' O ' ' B' ' 259' ' ' ASP . 29.7 mmm-85 -122.96 138.78 54.59 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.855 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.3 m -135.04 151.59 50.92 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.87 -179.248 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -122.62 120.83 34.9 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.246 179.271 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 38.9 ttp-105 -81.16 130.55 35.07 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.831 -179.671 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -97.69 125.55 42.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.035 -179.917 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -128.15 129.25 46.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.327 -179.956 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.665 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 60.5 t-20 -118.03 112.95 20.92 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.778 -179.411 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 121.062 0.458 . . . . 0.0 110.586 179.559 . . . . . . . . 0 0 . 1 . 053 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 15.3 m . . . . . 0 N--CA 1.446 -0.66 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 . . . . . . . . . 0 0 . 1 . 053 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.58 ' C ' ' H ' ' B' ' 231' ' ' GLN . 50.7 t0 -80.95 124.05 28.82 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.607 -179.577 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . 0.412 ' N ' ' O1P' ' B' ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.58 ' H ' ' C ' ' B' ' 229' ' ' ASP . 3.9 pt20 -140.63 31.54 1.86 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.256 0.55 . . . . 0.0 110.048 178.888 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -110.42 -159.07 16.77 Favored Glycine 0 CA--C 1.531 1.078 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 179.986 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -58.1 152.63 50.64 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 C-N-CA 123.573 2.848 . . . . 0.0 113.089 179.593 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 053 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.25 160.03 42.9 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.61 1.54 . . . . 0.0 111.846 -179.787 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 15.7 t -98.84 128.38 50.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.206 -179.744 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 5.7 t -69.96 126.96 31.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.548 -179.848 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 053 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -58.45 -25.37 73.36 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.963 2.442 . . . . 0.0 113.115 -178.769 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 96.0 m -72.88 -45.66 57.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.288 0.566 . . . . 0.0 109.779 179.123 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . 0.433 ' CE2' ' NE ' ' B' ' 245' ' ' ARG . 80.3 t80 -57.38 -44.42 84.42 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.968 -179.722 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . 0.418 HD23 HH21 ' B' ' 245' ' ' ARG . 97.0 mt -63.51 -41.83 98.5 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.641 -179.796 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -66.31 -37.23 84.91 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.707 0.289 . . . . 0.0 111.108 -179.497 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 78.2 ttt-85 -63.1 -47.62 82.07 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.636 -179.429 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.543 ' NH2' ' CB ' ' A' ' 92' ' ' ASP . 55.9 mtm180 -65.53 -39.3 91.62 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.621 -179.585 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -59.79 -40.3 87.85 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.325 179.991 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 28.2 m -68.22 -42.83 79.19 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.5 0.667 . . . . 0.0 109.587 178.301 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -62.54 -36.26 82.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.862 179.731 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . 0.468 ' O ' ' N ' ' B' ' 252' ' ' LEU . 95.0 t -65.63 -43.49 93.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.961 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -55.19 -26.19 37.58 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.025 179.502 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -86.22 2.28 47.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.714 177.937 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.468 ' N ' ' O ' ' B' ' 249' ' ' VAL . 97.8 mt -113.21 -175.49 2.68 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.332 -179.585 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 38.7 p30 -134.1 169.86 16.52 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.789 179.733 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -68.59 -18.25 64.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.583 179.287 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -74.91 0.46 15.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.089 -178.998 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -77.0 86.01 3.52 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.386 179.564 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -66.6 -8.15 25.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.698 -178.503 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -127.0 104.61 8.09 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.184 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.527 ' O ' ' NH1' ' A' ' 93' ' ' ARG . 63.4 t0 -121.93 86.9 2.66 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.116 -0.634 . . . . 0.0 112.53 -178.746 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 51.08 2.63 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 177.992 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . 0.42 HD11 ' NH2' ' A' ' 93' ' ' ARG . 76.7 mt -112.18 134.6 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 119.101 0.864 . . . . 0.0 109.571 178.814 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 40.4 t -127.74 134.11 66.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.993 -179.74 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -94.33 115.14 27.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.662 -179.016 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -66.3 -46.92 75.31 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.628 179.78 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.09 155.16 43.19 Favored Pre-proline 0 N--CA 1.454 -0.267 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.708 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -63.0 141.77 85.24 Favored 'Trans proline' 0 C--N 1.302 -1.906 0 C-N-CA 122.86 2.373 . . . . 0.0 113.085 179.965 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 37.4 pt . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.607 178.355 . . . . . . . . 0 0 . 1 . 054 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo . . . . . 0 N--CA 1.494 1.504 0 CA-C-O 120.888 0.287 . . . . 0.0 112.133 . . . . . . . . . 0 0 . 1 . 054 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.489 ' O ' ' O ' ' A' ' 99' ' ' ASN . 23.8 m -140.73 -84.22 0.21 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.787 -179.526 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 86.2 mtt85 -82.31 134.24 35.26 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.906 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -131.14 139.06 49.74 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 120.266 -0.573 . . . . 0.0 111.984 -179.075 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 34.2 mt -115.75 133.65 55.81 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.958 179.948 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 76.3 t -107.25 127.61 62.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.349 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 m -91.01 114.75 27.35 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 112.943 0.719 . . . . 0.0 112.943 -177.31 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 92.6 mt -80.99 141.9 14.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.645 179.242 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -90.43 159.54 16.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.063 0.458 . . . . 0.0 110.748 179.157 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.479 ' HG2' HH21 ' B' ' 245' ' ' ARG . 81.3 mtp180 -58.77 -32.75 69.58 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.405 -179.426 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.7 p -74.45 -13.62 60.73 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.584 179.674 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.26 29.91 7.28 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -179.745 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.3 t -117.58 130.17 72.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.721 0.296 . . . . 0.0 111.205 -179.494 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -73.62 139.26 45.37 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 177.773 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.2 -112.8 1.43 Allowed Glycine 0 CA--C 1.53 0.978 0 C-N-CA 120.161 -1.018 . . . . 0.0 112.232 -179.088 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -73.45 144.8 36.91 Favored 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 122.138 1.892 . . . . 0.0 113.009 -178.524 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 66.1 m170 -104.0 135.58 45.26 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.453 179.662 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.419 ' CD2' HD11 ' A' ' 37' ' ' ILE . 47.4 t80 -106.07 91.97 6.05 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.024 -179.274 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -72.95 139.27 29.83 Favored 'Trans proline' 0 N--CA 1.488 1.193 0 C-N-CA 121.634 1.556 . . . . 0.0 111.352 -179.33 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 86.2 mt -101.31 124.03 46.36 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.423 -178.592 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 65.3 p -117.37 -8.93 10.99 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.602 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 54.9 mt -101.73 149.78 23.81 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.587 -179.083 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 97.3 p -70.18 -12.14 61.39 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.27 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.434 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 41.9 m -132.35 133.98 44.64 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.257 -0.577 . . . . 0.0 111.89 -179.544 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 10.0 t -125.25 116.46 22.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.323 -0.853 . . . . 0.0 108.901 178.384 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.402 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 52.1 tp -116.88 132.8 56.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.997 -178.04 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.499 ' O ' ' O ' ' A' ' 47' ' ' GLN . 42.1 m-85 -110.16 136.67 49.02 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.366 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 164.48 -166.79 38.04 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 120.111 -1.042 . . . . 0.0 112.344 179.541 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.645 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 85.4 mtm-85 -89.27 -29.03 19.5 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 115.606 -0.297 . . . . 0.0 110.462 179.581 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.461 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -57.23 153.1 23.49 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 121.273 -0.489 . . . . 0.0 112.715 -177.73 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.525 ' CD1' ' NH1' ' A' ' 38' ' ' ARG . 9.4 tp -66.55 -41.87 89.12 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 N-CA-C 110.356 -0.238 . . . . 0.0 110.356 179.389 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -56.49 -27.07 56.16 Favored 'General case' 0 N--CA 1.461 0.124 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.647 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.461 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 19.3 m -54.54 122.75 11.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.693 179.701 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.434 ' OD2' ' O ' ' A' ' 26' ' ' THR . 55.5 m-20 -60.87 -33.35 72.95 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -179.566 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.428 HG22 HD13 ' A' ' 37' ' ' ILE . 44.0 mm -119.1 109.91 28.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 177.792 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.525 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 84.9 mtp180 -98.21 134.83 40.71 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -179.097 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.43 ' C ' ' H ' ' A' ' 41' ' ' LEU . 98.1 mt -120.42 132.34 70.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.028 -179.922 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -76.11 29.11 0.11 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.498 -0.773 . . . . 0.0 112.113 -178.495 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.485 ' CD1' ' CZ ' ' A' ' 93' ' ' ARG . 44.9 mt -106.12 130.07 23.56 Favored Pre-proline 0 CA--C 1.534 0.348 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.448 178.973 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.25 -12.65 25.49 Favored 'Trans proline' 0 N--CA 1.49 1.268 0 C-N-CA 122.448 2.099 . . . . 0.0 112.736 -179.455 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.7 m -92.57 -0.61 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.695 179.851 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.645 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 46.1 t -86.71 132.83 31.36 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.452 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.014 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.6 m -70.15 167.96 16.67 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.331 0.586 . . . . 0.0 111.22 -178.588 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt -62.64 -40.55 97.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.703 -178.872 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.652 ' O ' ' N ' ' A' ' 49' ' ' CYS . 95.4 mm-40 -115.38 -20.9 10.09 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.928 0.394 . . . . 0.0 110.483 -179.568 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.3 t60 34.05 -74.52 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -179.947 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.652 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.99 136.92 46.33 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -177.97 . . . . . . . . 3 3 . 1 . 054 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -128.23 132.2 48.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.861 179.558 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.9 mt -116.59 134.09 61.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.69 179.901 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -111.21 129.01 56.09 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.957 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.9 mm -100.16 118.6 47.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.304 0.573 . . . . 0.0 111.253 -179.138 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.452 ' O ' ' C ' ' A' ' 55' ' ' GLU . 98.0 m-70 -119.86 130.79 55.04 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.915 179.296 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' A' ' 54' ' ' HIS . 81.8 tt0 -40.83 -31.35 0.16 Allowed 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -179.866 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.458 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 98.4 mm-40 -64.82 -67.76 0.41 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.94 178.649 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.459 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 5.5 tp10 -153.49 -170.51 3.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.0 -179.481 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.459 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -118.43 128.41 54.59 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.513 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.0 mt -114.51 130.67 68.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.134 0.492 . . . . 0.0 112.23 -178.732 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.7 tp -99.56 128.88 45.68 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.471 179.996 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -112.7 136.7 51.98 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.742 179.649 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.499 HD22 ' CA ' ' A' ' 68' ' ' PRO . 59.5 t-20 -95.96 110.32 22.55 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.403 -178.763 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -103.94 -7.92 20.03 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 179.84 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.559 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 97.9 p -81.37 98.48 8.21 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.18 -179.419 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.3 m -74.64 -38.86 62.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.449 0.642 . . . . 0.0 109.482 178.427 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p -65.46 -39.21 91.74 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.342 -179.629 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.559 ' O ' ' OG ' ' A' ' 64' ' ' SER . 54.2 m-80 -146.18 92.79 5.2 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.424 -179.53 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.499 ' CA ' HD22 ' A' ' 62' ' ' ASN . 46.8 Cg_exo -54.22 145.98 52.14 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.541 2.16 . . . . 0.0 111.873 -179.072 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.7 m -70.87 150.6 45.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.956 179.665 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -117.23 140.16 49.88 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.777 -179.768 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 48.9 t -130.92 134.86 61.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.353 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 51.79 32.32 9.44 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -179.37 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.27 27.06 68.86 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.957 179.688 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.9 t -140.15 138.05 34.9 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 117.359 0.579 . . . . 0.0 111.599 179.864 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 10.9 t -68.67 140.68 18.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.685 179.958 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.0 pt -112.08 84.33 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.949 179.403 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -61.91 -32.17 72.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.449 179.532 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -118.46 168.21 10.01 Favored Pre-proline 0 CA--C 1.531 0.249 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.534 179.587 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.71 145.09 99.09 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 122.205 1.936 . . . . 0.0 112.52 179.965 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.2 p -138.9 140.0 39.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.986 179.652 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.6 mtm-85 -73.25 131.46 41.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.846 179.243 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.8 mt -84.95 137.57 33.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.114 0.483 . . . . 0.0 111.58 -179.136 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -126.95 151.06 49.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.563 179.028 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.462 ' C ' ' CD2' ' A' ' 84' ' ' HIS . 4.9 t60 -56.94 123.28 14.56 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.849 -179.736 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.26 -21.76 28.29 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 179.592 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -69.24 138.47 53.99 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.023 0.44 . . . . 0.0 110.513 179.784 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.2 t -111.75 131.1 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.85 -177.928 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.7 mt -93.01 134.32 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.117 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 94.5 m -126.55 126.5 43.78 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 119.933 -0.707 . . . . 0.0 112.492 -179.026 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.577 ' O ' ' N ' ' A' ' 92' ' ' ASP . 89.6 mt -110.48 125.66 67.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.085 -0.961 . . . . 0.0 108.695 178.367 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.435 ' C ' ' O ' ' A' ' 90' ' ' ILE . 89.2 mt 38.85 -91.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.113 -179.087 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.577 ' N ' ' O ' ' A' ' 90' ' ' ILE . 42.7 t0 -126.8 21.17 7.0 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.385 179.82 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.628 ' NH1' HH12 ' B' ' 245' ' ' ARG . 50.4 mtm-85 -129.01 143.39 50.85 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.321 -179.607 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 28.9 p -139.61 153.87 47.45 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 119.796 -0.762 . . . . 0.0 111.729 179.634 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -123.38 121.6 36.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.623 178.439 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -74.24 126.57 30.91 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.373 -179.534 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.507 ' OH ' ' OD1' ' A' ' 99' ' ' ASN . 92.0 t80 -94.51 121.42 36.04 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.929 0.395 . . . . 0.0 110.719 -179.972 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.427 ' HG3' ' CE1' ' A' ' 84' ' ' HIS . 84.7 tt0 -131.63 116.57 17.54 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.725 -179.959 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.507 ' OD1' ' OH ' ' A' ' 97' ' ' TYR . 91.5 m-20 -65.17 -42.44 93.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.974 0.416 . . . . 0.0 111.044 179.905 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.168 179.822 . . . . . . . . 0 0 . 1 . 054 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 56.0 t . . . . . 0 N--CA 1.454 -0.232 0 CA-C-O 120.75 0.31 . . . . 0.0 110.84 . . . . . . . . . 0 0 . 1 . 054 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.496 ' O ' ' OD1' ' B' ' 229' ' ' ASP . 66.6 t0 -170.22 -26.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.945 179.621 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . 0.552 ' O ' ' NE2' ' B' ' 231' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.552 ' NE2' ' O ' ' B' ' 230' ' ' SEP . 1.0 OUTLIER 160.57 40.76 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.201 -179.485 . . . . . . . . 3 3 . 1 . 054 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -121.95 -168.99 13.45 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 -179.611 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.35 157.15 57.48 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.822 2.348 . . . . 0.0 112.637 -179.852 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 054 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -61.06 144.79 99.48 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.207 1.938 . . . . 0.0 112.814 179.709 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 13.1 p -79.5 125.29 38.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.716 179.26 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.9 t -57.37 120.67 8.6 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.502 -0.479 . . . . 0.0 109.845 -179.795 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 054 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.95 -19.55 48.5 Favored 'Trans proline' 0 N--CA 1.491 1.371 0 C-N-CA 122.209 1.939 . . . . 0.0 111.284 179.37 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 79.8 m -74.79 -43.85 52.59 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 177.764 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . 0.426 ' CE2' ' HD2' ' B' ' 245' ' ' ARG . 88.3 t80 -57.52 -46.54 83.69 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.994 -179.584 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 92.5 mt -64.0 -41.62 97.42 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.259 -179.938 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.8 -39.5 87.77 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.99 -179.901 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . 0.511 ' O ' ' OG ' ' B' ' 247' ' ' SER . 62.8 ttp180 -60.51 -43.97 96.5 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.943 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.628 HH12 ' NH1' ' A' ' 93' ' ' ARG . 79.3 mtp180 -61.77 -40.1 93.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.553 -179.508 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.21 -38.22 85.81 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 120.504 -0.478 . . . . 0.0 109.853 179.127 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' B' B ' 247' ' ' SER . . . . . 0.511 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 80.2 p -68.62 -42.57 77.9 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 178.389 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . 0.47 ' HB2' HH22 ' A' ' 12' ' ' ARG . 82.5 mt-30 -61.89 -35.59 78.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.536 179.568 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 22.5 t -60.64 -46.87 95.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.941 0.401 . . . . 0.0 110.159 179.221 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -62.93 -28.72 70.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.002 179.311 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -85.92 -15.9 40.21 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.896 179.902 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 83.5 mt -101.18 179.86 4.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.488 179.838 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -141.25 175.48 9.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.626 179.693 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -64.7 -10.14 25.02 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.925 -179.188 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -65.7 -16.42 63.74 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.844 0.354 . . . . 0.0 110.36 179.73 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.491 ' O ' ' OD1' ' B' ' 256' ' ' ASP . 48.6 p30 -72.06 51.0 0.22 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.457 179.501 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -56.62 -10.09 0.91 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.69 -178.761 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.66 ' O ' ' N ' ' B' ' 260' ' ' GLU . 96.1 m-20 -94.14 -2.24 52.99 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.947 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.476 ' C ' ' O ' ' B' ' 258' ' ' ASP . 36.2 p30 10.54 48.48 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 114.333 -1.303 . . . . 0.0 113.006 179.136 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.66 ' N ' ' O ' ' B' ' 258' ' ' ASP . 99.5 mt-10 59.44 -0.39 0.18 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 179.092 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . 0.464 ' N ' ' O ' ' B' ' 258' ' ' ASP . 60.0 mt -110.42 137.19 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 120.516 -0.474 . . . . 0.0 109.867 179.722 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 44.7 t -126.89 134.63 65.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.731 179.465 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -94.14 117.25 29.84 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.462 -178.85 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -67.93 -47.99 67.17 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.15 -179.985 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -82.62 157.99 66.36 Favored Pre-proline 0 CA--C 1.516 -0.354 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.681 -179.123 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.82 138.54 49.01 Favored 'Trans proline' 0 C--N 1.301 -1.933 0 C-N-CA 122.5 2.133 . . . . 0.0 112.641 179.586 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 1.4 pt . . . . . 0 C--N 1.325 -0.491 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.259 178.522 . . . . . . . . 0 0 . 1 . 055 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 N--CA 1.489 1.229 0 CA-C-O 120.697 0.207 . . . . 0.0 111.789 . . . . . . . . . 0 0 . 1 . 055 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 78.9 p -137.92 -37.84 0.58 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.933 0.397 . . . . 0.0 110.73 -179.855 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.561 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 96.0 mtt-85 -96.24 117.77 31.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.594 -179.53 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.569 ' HE ' ' CE1' ' A' ' 19' ' ' HIS . 85.6 mtp180 -131.37 139.02 49.4 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.054 0.454 . . . . 0.0 111.601 179.877 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 37.1 tp -114.26 128.88 56.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.486 179.519 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 64.4 t -108.68 131.6 58.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.694 -0.403 . . . . 0.0 110.026 -179.684 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.3 m -82.56 152.23 26.06 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.601 0.715 . . . . 0.0 112.181 -178.714 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.5 mt -120.08 140.2 44.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.101 177.46 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 73.0 mttt -89.05 157.12 18.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.17 0.509 . . . . 0.0 110.501 179.551 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.562 ' NH2' ' O ' ' B' ' 245' ' ' ARG . 79.3 mtp180 -56.35 -31.03 63.39 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.665 -179.758 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.3 m -77.83 -9.33 58.99 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.764 -0.375 . . . . 0.0 110.339 179.589 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.83 38.98 5.35 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 179.878 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.4 t -124.09 133.42 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 120.92 0.39 . . . . 0.0 111.64 -179.692 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -76.71 138.66 40.12 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.078 178.939 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -134.47 -116.43 1.65 Allowed Glycine 0 CA--C 1.538 1.508 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.965 -179.521 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.95 152.09 45.95 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 122.499 2.133 . . . . 0.0 113.096 -179.163 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.569 ' CE1' ' HE ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -116.14 158.77 22.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.935 0.397 . . . . 0.0 110.48 179.904 . . . . . . . . 3 3 . 1 . 055 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -124.15 108.38 29.9 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.589 -179.382 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -75.58 127.95 10.67 Favored 'Trans proline' 0 N--CA 1.488 1.201 0 C-N-CA 121.605 1.537 . . . . 0.0 111.361 -179.196 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 61.6 mt -82.86 49.41 1.5 Allowed 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.137 -178.808 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.6 t -63.1 -32.5 73.9 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 178.75 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.452 ' HG ' HE22 ' B' ' 265' ' ' GLN . 68.5 mt -70.77 142.25 51.4 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.831 179.711 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.5 m -63.87 -22.96 67.16 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.507 -179.289 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.3 m -133.27 133.93 43.27 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.953 -179.761 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.676 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 3.0 t -127.14 114.87 18.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.81 179.664 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.2 tp -111.55 125.69 54.19 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.228 -178.741 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.676 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 18.4 m-85 -100.69 128.51 46.71 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 177.93 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 179.26 -155.86 17.01 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 120.027 -1.082 . . . . 0.0 112.309 -179.588 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.599 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 81.8 mtm-85 -109.98 -25.23 10.37 Favored 'General case' 0 N--CA 1.46 0.067 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.074 179.902 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.48 161.29 21.92 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.194 -0.763 . . . . 0.0 111.194 -179.13 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.455 ' CD1' ' NH1' ' A' ' 38' ' ' ARG . 10.9 tp -67.38 -39.44 82.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.949 0.404 . . . . 0.0 110.418 179.959 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.4 ' H ' HG21 ' A' ' 33' ' ' ILE . 97.7 mt-10 -57.48 -31.58 66.11 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.109 -179.981 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.3 m -50.81 120.64 4.97 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.022 179.803 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -60.71 -33.4 72.83 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.406 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 96.4 mt -124.94 116.92 48.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.395 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.455 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 83.9 mtp180 -103.31 137.26 41.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.507 -177.927 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.507 ' C ' ' H ' ' A' ' 41' ' ' LEU . 92.7 mt -120.22 131.34 72.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.534 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -73.83 25.98 0.07 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.651 -178.234 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.507 ' H ' ' C ' ' A' ' 39' ' ' ILE . 15.1 mt -101.68 122.95 45.84 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.647 179.947 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.9 -8.68 21.57 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 122.295 1.997 . . . . 0.0 112.144 -179.753 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.2 m -92.91 0.74 9.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.656 179.325 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.599 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 93.7 t -98.27 103.47 14.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.858 179.449 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.538 ' O ' ' O ' ' A' ' 44' ' ' VAL . 1.4 t -34.11 162.11 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.451 0.643 . . . . 0.0 112.022 -178.846 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -60.69 -41.85 95.97 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.019 -0.992 . . . . 0.0 112.175 -178.371 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.584 ' O ' ' N ' ' A' ' 49' ' ' CYS . 90.8 mm-40 -107.67 -18.04 13.94 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.556 0.693 . . . . 0.0 109.902 179.589 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.0 t60 37.22 -78.16 0.0 OUTLIER 'General case' 0 C--O 1.239 0.53 0 CA-C-N 114.541 -1.209 . . . . 0.0 113.738 179.901 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.584 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -134.54 139.23 45.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.115 0.483 . . . . 0.0 112.072 -178.455 . . . . . . . . 3 3 . 1 . 055 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -129.15 125.26 36.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.555 179.594 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.5 mt -109.32 133.79 53.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.102 179.863 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.592 ' CD ' ' HE2' ' A' ' 54' ' ' HIS . 74.5 tt0 -113.17 126.37 55.37 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.324 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.8 mm -98.63 118.61 45.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.325 0.583 . . . . 0.0 112.141 -178.201 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.592 ' HE2' ' CD ' ' A' ' 52' ' ' GLU . 96.5 m-70 -119.46 132.22 55.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.375 178.411 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.469 ' C ' ' O ' ' A' ' 54' ' ' HIS . 76.0 tt0 -40.72 -28.37 0.07 Allowed 'General case' 0 CA--C 1.518 -0.25 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.719 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.492 ' N ' ' O ' ' A' ' 54' ' ' HIS . 86.0 mt-30 -66.41 -68.47 0.37 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.329 178.387 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.461 ' CB ' ' HE ' ' A' ' 81' ' ' ARG . 1.4 pt-20 -156.12 -168.81 2.86 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.843 -179.307 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -114.52 128.66 56.45 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.039 179.474 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.2 mt -116.85 127.94 74.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.2 0.524 . . . . 0.0 111.157 -179.748 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.2 tp -95.92 129.18 43.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.507 -179.69 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -115.68 136.32 53.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.984 179.636 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.665 ' ND2' ' H ' ' A' ' 69' ' ' THR . 12.8 t-20 -99.4 110.53 23.01 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.121 179.935 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -99.59 -8.38 24.56 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 120.856 0.36 . . . . 0.0 110.55 179.365 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.0 t -76.17 99.05 4.57 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.063 179.964 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 45.9 t -75.09 -44.59 46.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.663 0.744 . . . . 0.0 109.527 178.463 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.83 -43.36 98.99 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.495 -1.23 . . . . 0.0 111.021 -179.17 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -143.39 97.07 5.65 Favored Pre-proline 0 N--CA 1.468 0.436 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.216 -179.792 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.84 146.3 86.75 Favored 'Trans proline' 0 N--CA 1.499 1.844 0 C-N-CA 122.294 1.996 . . . . 0.0 112.963 179.553 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.665 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 29.1 m -69.34 137.05 52.58 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.068 178.927 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -98.69 140.16 33.32 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.548 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 25.2 t -132.96 137.12 54.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.359 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 54.61 33.59 19.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.136 0.494 . . . . 0.0 109.914 -179.34 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.73 30.24 66.42 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.952 179.473 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.2 m -145.16 140.35 27.9 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 117.464 0.632 . . . . 0.0 112.193 -179.505 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.2 t -70.44 136.23 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.677 179.944 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.562 ' CG2' ' O ' ' A' ' 78' ' ' GLU . 88.6 mt -107.81 117.69 53.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.495 179.943 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -89.16 -29.13 19.55 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.68 178.928 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.562 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.0 OUTLIER -126.03 166.61 20.49 Favored Pre-proline 0 N--CA 1.467 0.401 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.122 -178.947 . . . . . . . . 3 3 . 1 . 055 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.07 148.96 91.36 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 122.469 2.112 . . . . 0.0 112.354 -179.946 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.2 m -141.41 151.55 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 121.354 0.597 . . . . 0.0 112.605 -179.559 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.461 ' HE ' ' CB ' ' A' ' 57' ' ' GLU . 74.6 ttt180 -78.13 128.31 33.6 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.543 179.066 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.9 mt -81.64 134.03 35.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.119 0.485 . . . . 0.0 111.229 -179.625 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -128.39 152.12 48.56 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.117 179.265 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.7 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 5.1 t60 -53.8 117.76 3.42 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.489 -179.535 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.62 -3.41 27.71 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -179.248 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.404 ' C ' ' OD1' ' A' ' 86' ' ' ASP . 45.7 t0 -80.34 121.29 25.49 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.083 -0.339 . . . . 0.0 110.083 179.628 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 74.5 t -108.43 132.68 55.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.042 -178.249 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 84.8 mt -99.11 131.98 45.35 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.682 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.3 m -115.93 125.04 52.05 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.345 0.593 . . . . 0.0 111.061 -179.179 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.484 ' O ' ' N ' ' A' ' 93' ' ' ARG . 92.0 mt -118.85 123.31 71.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.898 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.468 ' C ' ' O ' ' A' ' 90' ' ' ILE . 46.7 mm 35.13 -104.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.972 -179.727 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 92' ' ' ASP . 37.1 p-10 -105.91 11.11 32.13 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -179.555 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.544 HH21 ' CG ' ' B' ' 260' ' ' GLU . 86.0 mtt-85 -127.58 147.31 50.34 Favored 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.193 -179.426 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 29.0 t -137.18 153.22 50.5 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.079 0.466 . . . . 0.0 110.331 179.271 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -126.64 129.14 47.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.426 179.76 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -94.15 135.07 35.92 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.26 -179.003 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.561 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 83.8 t80 -99.91 124.2 44.97 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.357 179.912 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -124.89 127.53 47.25 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.728 179.508 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.7 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 63.5 t-20 -106.86 103.51 12.95 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.171 179.436 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.478 ' O ' ' O ' ' A' ' 99' ' ' ASN . 82.3 tt0 . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.157 -179.521 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 30.5 m . . . . . 0 N--CA 1.452 -0.366 0 CA-C-O 120.877 0.37 . . . . 0.0 110.78 . . . . . . . . . 0 0 . 1 . 055 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -87.87 3.31 48.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.524 -179.509 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . 0.531 ' O ' ' NE2' ' B' ' 231' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.531 ' NE2' ' O ' ' B' ' 230' ' ' SEP . 0.7 OUTLIER 159.17 27.99 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.376 -179.925 . . . . . . . . 3 3 . 1 . 055 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -119.24 -155.79 9.89 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.956 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.45 160.45 41.7 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 122.699 2.266 . . . . 0.0 113.083 -179.459 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 055 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -70.83 168.95 21.48 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 121.736 1.624 . . . . 0.0 111.936 179.453 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 37.0 t -114.08 133.4 60.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.751 179.952 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 2.6 t -73.25 124.17 25.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.668 179.43 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . 0.456 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . 0.456 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 31.6 Cg_exo -59.64 -24.76 76.62 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.511 2.141 . . . . 0.0 112.571 -179.663 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 99.2 m -73.21 -46.02 52.81 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.375 0.607 . . . . 0.0 109.709 178.067 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -57.65 -45.36 85.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.485 -179.433 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 95.8 mt -64.17 -41.4 97.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.548 -179.25 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -63.19 -41.5 99.2 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.225 -179.951 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -62.49 -43.44 98.82 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.976 0.417 . . . . 0.0 110.055 179.533 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.562 ' O ' ' NH2' ' A' ' 12' ' ' ARG . 24.4 mmt180 -61.26 -43.02 99.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.64 -179.473 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.66 -38.99 92.49 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.803 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 11.1 t -64.72 -46.22 83.2 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 177.696 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . 0.556 ' O ' ' N ' ' B' ' 252' ' ' LEU . 83.6 mt-30 -60.39 -37.74 81.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.123 179.709 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 61.9 t -60.92 -45.65 97.91 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 C-N-CA 120.217 -0.593 . . . . 0.0 109.744 179.898 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -60.17 -27.31 67.01 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.908 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -95.1 -14.36 24.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.894 179.671 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.556 ' N ' ' O ' ' B' ' 248' ' ' GLN . 61.1 tp -72.17 138.8 47.88 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.983 0.42 . . . . 0.0 110.901 -179.807 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -94.07 128.79 40.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.704 179.995 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . 0.492 ' C ' ' H ' ' B' ' 256' ' ' ASP . 99.7 m-20 -66.25 -29.32 69.54 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.216 -179.891 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 31.2 p-10 -63.29 2.56 0.37 Allowed 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.973 -179.216 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.601 ' O ' ' N ' ' B' ' 258' ' ' ASP . 92.0 m-20 -87.31 -22.55 25.06 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.124 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 14.1 tttm 41.33 13.01 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.205 179.812 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.601 ' N ' ' O ' ' B' ' 256' ' ' ASP . 96.3 m-20 -131.4 103.41 6.42 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.096 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.589 ' CG ' ' H ' ' B' ' 260' ' ' GLU . 30.5 p-10 -71.14 -102.14 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.847 -178.458 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.589 ' H ' ' CG ' ' B' ' 259' ' ' ASP . 97.6 mt-10 -148.49 18.37 1.05 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.771 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 60.3 mt -111.11 138.07 40.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.867 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 48.6 t -128.55 136.08 60.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.682 0.277 . . . . 0.0 110.296 179.502 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -99.2 122.03 41.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.276 0.56 . . . . 0.0 111.791 -178.465 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -65.71 -44.3 86.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.021 179.233 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . 0.452 HE22 ' HG ' ' A' ' 24' ' ' LEU . 0.3 OUTLIER -103.77 162.14 20.86 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.737 -178.831 . . . . . . . . 3 3 . 1 . 055 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -60.75 152.79 67.02 Favored 'Trans proline' 0 N--CA 1.499 1.836 0 C-N-CA 123.17 2.58 . . . . 0.0 112.702 179.376 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 40.1 pt . . . . . 0 C--N 1.327 -0.39 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.55 -179.844 . . . . . . . . 0 0 . 1 . 056 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo . . . . . 0 N--CA 1.487 1.088 0 N-CA-C 111.125 -0.375 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 056 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 52.9 p -78.44 -31.94 48.28 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.016 -179.265 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.5 mtt85 -100.43 122.06 42.56 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.972 -178.919 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -132.14 142.08 49.35 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.173 179.909 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 40.0 tp -114.68 125.25 53.52 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.493 179.494 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 32.0 m -104.85 132.82 50.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.701 -179.413 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.1 m -79.68 142.83 35.16 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.386 -179.119 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.439 HD13 HG23 ' A' ' 10' ' ' ILE . 86.0 mt -111.49 135.94 49.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 177.492 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -89.2 157.73 18.15 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.627 179.291 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.5 HH21 ' CD2' ' B' ' 252' ' ' LEU . 87.8 mtm180 -57.2 -26.57 60.88 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.151 -179.191 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 44.9 m -80.48 -12.53 59.54 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 179.541 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.23 35.89 5.87 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.955 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.6 t -124.21 133.56 68.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 120.803 0.335 . . . . 0.0 110.793 -179.101 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -72.26 130.33 40.54 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.546 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -119.98 -122.68 3.03 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.282 -178.826 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.58 145.17 51.65 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 121.357 1.372 . . . . 0.0 112.402 -179.458 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 61.6 m170 -103.72 140.34 37.73 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.642 -179.975 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.4 ' CD2' HD12 ' A' ' 37' ' ' ILE . 59.3 t80 -114.39 96.19 42.16 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.073 -179.466 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -59.28 125.88 19.27 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.93 1.754 . . . . 0.0 112.497 -179.01 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 89.0 mt -85.62 44.91 1.14 Allowed 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.533 -179.893 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 66.3 p -60.17 -30.69 69.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.979 0.419 . . . . 0.0 109.943 179.57 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 68.5 mt -72.54 144.98 47.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.22 178.987 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.09 -20.64 65.83 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.568 -178.343 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.499 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 23.0 m -133.05 136.95 46.25 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.655 -179.321 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.621 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 3.7 t -129.43 118.36 22.03 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.794 178.052 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 49.5 tp -114.55 130.61 56.78 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.173 -178.859 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.621 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 9.1 m-85 -109.21 138.28 45.81 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.195 -0.911 . . . . 0.0 108.91 179.174 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.42 -166.72 36.67 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.145 179.105 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.574 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 81.7 mtm-85 -89.81 -29.62 18.52 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 179.8 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.562 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -52.96 148.77 12.28 Favored Glycine 0 CA--C 1.521 0.458 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.314 -179.413 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.498 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 11.1 tp -66.01 -39.83 85.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.874 0.369 . . . . 0.0 110.191 -179.98 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.498 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 78.3 mm-40 -58.78 -21.99 57.13 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.217 -178.373 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.562 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 14.3 m -56.86 121.05 8.96 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.829 -179.804 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.499 ' OD2' ' O ' ' A' ' 26' ' ' THR . 95.3 m-20 -57.93 -26.06 61.72 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.17 179.807 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.432 HG23 HD13 ' A' ' 37' ' ' ILE . 86.3 mt -130.06 122.08 53.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 176.848 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.466 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 83.9 mtp180 -105.6 135.15 47.54 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.358 -178.737 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.407 ' C ' ' H ' ' A' ' 41' ' ' LEU . 96.9 mt -119.97 129.56 75.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.945 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -75.74 24.65 0.12 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -177.771 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.563 ' CD2' ' NH2' ' B' ' 245' ' ' ARG . 34.0 mt -92.49 125.55 55.58 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 119.841 -0.744 . . . . 0.0 110.848 179.667 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -72.62 -8.93 23.31 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.048 1.832 . . . . 0.0 112.558 -179.151 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.6 m -101.55 5.13 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.393 -179.648 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.574 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 40.7 t -99.09 106.65 19.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.152 -179.843 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.551 ' O ' ' O ' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -31.96 162.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.554 -178.762 . . . . . . . . 3 3 . 1 . 056 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -59.22 -47.39 85.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.3 -178.933 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.63 ' O ' ' N ' ' A' ' 49' ' ' CYS . 98.4 mt-30 -107.25 -12.44 15.36 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.491 0.662 . . . . 0.0 110.071 179.592 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.403 ' ND1' HG11 ' A' ' 44' ' ' VAL . 20.0 t60 37.99 -75.51 0.0 OUTLIER 'General case' 0 C--O 1.239 0.539 0 CA-C-N 114.812 -1.085 . . . . 0.0 113.765 179.744 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.63 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -139.1 140.72 38.06 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.584 -178.664 . . . . . . . . 3 3 . 1 . 056 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -128.04 127.61 43.47 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.893 179.51 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 91.4 mt -110.16 135.02 50.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.319 -179.951 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -117.97 128.42 54.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.513 178.149 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 94.2 mt -111.95 117.73 55.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.498 0.666 . . . . 0.0 111.603 -179.225 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.588 ' O ' ' N ' ' A' ' 56' ' ' GLN . 89.3 m-70 -117.59 144.86 44.73 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.94 179.63 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 54' ' ' HIS . 80.0 mm-40 -38.94 -23.91 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.215 -0.594 . . . . 0.0 109.928 -179.825 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.588 ' N ' ' O ' ' A' ' 54' ' ' HIS . 56.3 tt0 -67.76 -68.78 0.36 Allowed 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.267 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -161.66 -158.27 0.54 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.034 179.337 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.81 131.43 55.7 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.059 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.448 HG23 HD12 ' A' ' 59' ' ' ILE . 80.0 mt -120.78 131.03 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 121.061 0.457 . . . . 0.0 112.231 -179.354 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.434 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 28.8 tp -102.29 131.43 48.88 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.635 -179.376 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -112.81 133.44 54.8 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.593 179.132 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.598 HD22 ' CB ' ' A' ' 68' ' ' PRO . 57.4 t-20 -95.0 107.84 19.89 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -178.675 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -98.75 -11.58 21.75 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.401 179.693 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 3.9 t -84.1 100.26 11.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.236 179.593 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.6 p -83.55 -40.7 18.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.528 0.68 . . . . 0.0 109.393 179.298 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.64 -43.15 97.89 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.012 -0.994 . . . . 0.0 109.986 -179.984 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.436 ' O ' ' OG ' ' A' ' 64' ' ' SER . 8.4 m-80 -141.41 97.32 6.8 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.088 178.695 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.598 ' CB ' HD22 ' A' ' 62' ' ' ASN . 52.9 Cg_endo -66.4 152.73 80.28 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 121.932 1.754 . . . . 0.0 113.165 -178.19 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.418 ' CG2' ' N ' ' A' ' 70' ' ' GLN . 18.5 m -73.98 153.99 39.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.572 -179.25 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.47 ' O ' ' N ' ' A' ' 89' ' ' THR . 74.0 mt-30 -113.82 140.09 48.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.527 178.947 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.4 t -128.63 135.42 62.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.344 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 52.07 32.94 11.11 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -178.96 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.02 28.23 68.91 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.783 179.707 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 69.9 m -140.6 140.53 35.11 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.997 179.884 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 52.1 t -65.23 136.87 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.589 179.827 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.47 ' CG1' ' O ' ' A' ' 78' ' ' GLU . 7.5 tt -104.57 89.64 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.779 178.793 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -63.88 -35.19 79.83 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.722 -179.483 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.47 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 1.7 mt-10 -128.02 168.46 15.33 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.803 -179.475 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.84 143.75 80.07 Favored 'Trans proline' 0 N--CA 1.501 1.967 0 C-N-CA 122.282 1.988 . . . . 0.0 112.815 -178.747 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.7 p -139.87 142.95 31.18 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 121.329 0.585 . . . . 0.0 111.782 179.571 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -75.17 133.65 41.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.701 179.782 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 56.9 mt -92.5 134.33 35.07 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.801 -179.098 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.518 ' O ' ' OD2' ' A' ' 86' ' ' ASP . 99.8 mttt -120.14 153.07 36.72 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.904 -179.825 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.715 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 9.3 t60 -51.1 119.13 3.71 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.243 -179.317 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.89 -14.61 34.38 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -179.614 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.518 ' OD2' ' O ' ' A' ' 83' ' ' LYS . 2.1 p30 -69.28 131.1 44.33 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.15 179.422 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 13.5 p -105.31 140.55 22.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.56 -179.198 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 38.6 mm -102.99 128.94 55.45 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 177.851 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.47 ' N ' ' O ' ' A' ' 70' ' ' GLN . 41.1 m -121.91 130.21 53.16 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -177.654 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.532 ' O ' ' N ' ' A' ' 93' ' ' ARG . 97.5 mt -115.9 129.74 71.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 113.881 -1.509 . . . . 0.0 107.398 177.442 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.513 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 23.5 mt -31.74 107.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.022 0.439 . . . . 0.0 111.118 -178.37 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.513 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 2.2 t70 88.89 -25.66 0.08 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 178.691 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 90' ' ' ILE . 55.6 mtt85 -130.09 139.85 50.89 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 121.329 -0.149 . . . . 0.0 110.618 -178.658 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 34.0 p -142.51 158.56 43.55 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.222 0.534 . . . . 0.0 110.474 -179.997 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -132.06 133.65 44.61 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.79 179.414 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 78.3 mtp85 -95.75 136.89 35.57 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 119.767 -0.773 . . . . 0.0 109.988 179.0 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -95.46 125.7 40.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.227 -179.116 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -122.09 122.19 38.69 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.265 179.062 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.715 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 49.4 t-20 -122.94 106.32 10.75 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.708 -179.976 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 121.059 0.457 . . . . 0.0 110.328 179.76 . . . . . . . . 0 0 . 1 . 056 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . 0.431 HG12 ' N ' ' B' ' 229' ' ' ASP . 6.2 t . . . . . 0 N--CA 1.451 -0.416 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 . . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' B' ' 231' ' ' GLN . 55.6 t0 -98.94 100.98 12.22 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.609 179.838 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 056 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.492 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 75.8 mt-30 -121.73 27.01 8.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.575 -179.718 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -111.1 -157.04 14.48 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 179.667 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -77.06 158.83 34.07 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 123.165 2.577 . . . . 0.0 112.456 -179.378 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 056 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.65 167.75 25.79 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.661 2.24 . . . . 0.0 111.702 -179.908 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 25.6 t -110.3 133.2 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-O 120.949 0.404 . . . . 0.0 110.505 -179.509 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 3.5 t -76.36 130.93 38.79 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.157 0.503 . . . . 0.0 110.608 -179.643 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . 0.463 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . 0.463 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 34.6 Cg_exo -57.81 -24.09 62.13 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 122.872 2.382 . . . . 0.0 112.605 -178.827 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 99.9 m -72.73 -43.97 62.28 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.628 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -56.91 -47.68 80.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.264 -179.679 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 92.7 mt -62.61 -41.2 98.85 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.927 -179.173 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -63.63 -40.0 95.76 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.517 -0.473 . . . . 0.0 109.749 179.886 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . 0.55 ' O ' ' OG ' ' B' ' 247' ' ' SER . 72.9 ttt180 -59.84 -43.6 94.53 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.176 179.35 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.563 ' NH2' ' CD2' ' A' ' 41' ' ' LEU . 22.2 mmt180 -62.44 -41.41 98.7 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.675 -179.279 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.71 -39.06 90.16 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.261 0.553 . . . . 0.0 109.769 179.658 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' B' B ' 247' ' ' SER . . . . . 0.55 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 57.6 p -67.15 -42.87 83.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.141 178.306 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . 0.465 ' O ' ' N ' ' B' ' 252' ' ' LEU . 83.8 mt-30 -61.33 -35.84 78.52 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.028 179.789 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 49.8 t -60.84 -45.69 97.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 O-C-N 121.595 -0.691 . . . . 0.0 110.118 178.638 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -58.77 -27.38 64.92 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.383 -179.876 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -100.24 -7.33 24.78 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.024 179.014 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.5 ' CD2' HH21 ' A' ' 12' ' ' ARG . 35.5 tp -77.02 144.89 38.35 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.597 -179.705 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -113.65 148.0 37.09 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.35 179.154 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -66.4 -17.25 64.67 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.075 0.464 . . . . 0.0 110.139 179.347 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -66.58 -14.36 62.26 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.237 -179.528 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.442 ' C ' ' H ' ' B' ' 258' ' ' ASP . 64.2 t0 -95.32 76.91 3.41 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.995 0.426 . . . . 0.0 110.221 179.425 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -76.12 14.62 0.68 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.959 -178.988 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.676 ' O ' ' N ' ' B' ' 260' ' ' GLU . 88.0 m-20 -97.02 -4.73 39.16 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.186 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.48 ' C ' ' O ' ' B' ' 258' ' ' ASP . 53.7 p30 -1.83 59.9 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 113.858 -1.519 . . . . 0.0 113.476 179.766 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.676 ' N ' ' O ' ' B' ' 258' ' ' ASP . 96.6 mt-10 48.85 4.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 178.061 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . 0.47 ' H ' ' C ' ' B' ' 259' ' ' ASP . 82.7 mt -112.06 130.95 64.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.821 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 60.8 t -126.4 134.34 66.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.16 -179.434 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -94.95 119.81 34.11 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.329 0.585 . . . . 0.0 110.975 -179.334 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.99 -43.92 97.45 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.071 179.48 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -100.98 155.31 36.45 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.619 -179.227 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -68.43 143.98 59.77 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 123.099 2.533 . . . . 0.0 113.659 -179.029 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 43.6 pt . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.047 178.35 . . . . . . . . 0 0 . 1 . 057 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo . . . . . 0 N--CA 1.493 1.468 0 CA-C-O 120.856 0.273 . . . . 0.0 112.28 . . . . . . . . . 0 0 . 1 . 057 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.8 p -84.4 -28.2 27.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.104 -179.605 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.641 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 95.7 mtt-85 -97.65 115.51 28.05 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.09 -178.877 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.415 HH12 ' HG3' ' A' ' 100' ' ' GLU . 84.6 mtt85 -129.44 138.54 51.51 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.997 0.427 . . . . 0.0 111.897 -179.874 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 32.5 tp -115.01 136.89 52.62 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.999 179.29 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 53.9 t -112.91 132.22 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.606 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 m -94.91 117.69 30.56 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.821 0.675 . . . . 0.0 112.821 -178.136 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 95.6 mt -82.97 143.71 11.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.85 179.569 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.461 ' NZ ' ' HA ' ' B' ' 257' ' ' LYS . 98.5 mttt -90.6 159.89 16.21 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.042 178.419 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.583 HH12 ' CD ' ' B' ' 260' ' ' GLU . 55.0 mtm-85 -58.51 -28.29 65.28 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.403 -179.397 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.6 p -77.87 -8.6 58.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.876 0.37 . . . . 0.0 110.457 179.907 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.68 34.05 8.08 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.94 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.6 t -118.91 132.8 67.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.866 0.365 . . . . 0.0 111.065 -179.81 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -72.07 136.03 46.48 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.315 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -127.7 -121.77 2.45 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 120.541 -0.837 . . . . 0.0 111.94 -179.135 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -73.12 149.57 46.5 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.313 2.009 . . . . 0.0 112.865 -178.601 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -106.45 152.9 23.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.638 179.868 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -121.36 92.92 48.78 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.017 179.789 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -59.51 125.95 19.33 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.636 1.558 . . . . 0.0 110.713 -179.595 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.2 mt -90.83 45.83 1.28 Allowed 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.558 -178.242 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 94.5 p -60.53 -23.4 64.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.216 0.532 . . . . 0.0 109.635 179.545 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.7 mt -77.1 144.44 38.5 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.323 179.494 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.7 m -67.81 -18.75 64.94 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -178.373 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 59.3 m -134.72 135.16 41.75 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.671 -179.559 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.6 t -127.2 119.47 26.48 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.059 178.871 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.424 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 35.9 tp -113.45 128.12 56.34 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 121.178 -0.209 . . . . 0.0 111.537 -178.609 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.511 ' O ' ' O ' ' A' ' 47' ' ' GLN . 13.5 m-85 -107.69 130.48 54.92 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.532 179.181 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -176.26 -171.3 39.89 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.707 179.883 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.558 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 39.7 ttp-105 -93.9 -9.31 37.6 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.249 -0.476 . . . . 0.0 111.298 -179.422 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.485 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -93.93 158.88 23.44 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.671 -178.651 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.423 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 11.1 tp -66.81 -40.22 85.41 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 115.078 -0.561 . . . . 0.0 110.496 179.82 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.423 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 85.2 tt0 -53.15 -22.43 6.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.035 0.445 . . . . 0.0 110.053 -179.695 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 2.7 m -71.52 139.31 49.46 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.762 179.839 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.424 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 99.6 m-20 -60.8 -31.26 70.64 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.145 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.43 HG23 HD12 ' A' ' 37' ' ' ILE . 84.5 mt -129.27 120.33 50.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.489 177.34 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 77.2 ttt-85 -107.41 135.1 49.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.843 -178.981 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.417 ' C ' ' H ' ' A' ' 41' ' ' LEU . 99.7 mt -117.45 130.72 71.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.902 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -73.65 34.98 0.08 Allowed 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -177.588 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.653 ' CD1' ' HE ' ' A' ' 93' ' ' ARG . 37.6 mt -114.41 132.18 22.94 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.582 179.478 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.47 -12.01 26.87 Favored 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 122.574 2.182 . . . . 0.0 112.997 -179.036 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.2 m -88.11 0.9 6.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.416 179.743 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.645 ' CG2' ' NH2' ' A' ' 93' ' ' ARG . 55.7 t -90.54 131.77 36.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.156 179.331 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 46.4 t -70.75 165.31 23.32 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.345 -179.107 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 70.2 mttt -61.9 -39.97 93.83 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.142 -179.26 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.679 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.9 mt-30 -120.5 -21.54 6.76 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.046 179.772 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 16.6 t60 36.15 -75.05 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 178.991 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.679 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -128.52 132.66 48.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.104 0.478 . . . . 0.0 111.677 -178.891 . . . . . . . . 3 3 . 1 . 057 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -128.51 125.25 37.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.138 179.234 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.0 mt -107.07 133.38 51.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.526 -179.529 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.544 ' CD ' ' HE2' ' A' ' 54' ' ' HIS . 82.4 tt0 -117.24 126.06 52.15 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.562 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.5 119.72 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -177.625 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.553 ' O ' ' N ' ' A' ' 56' ' ' GLN . 97.4 m-70 -114.46 141.28 47.89 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.628 178.813 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 54' ' ' HIS . 58.8 mp0 -40.71 -24.46 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.801 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.553 ' N ' ' O ' ' A' ' 54' ' ' HIS . 99.8 mm-40 -71.86 -69.16 0.41 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.548 178.848 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.452 ' OE2' ' NE ' ' A' ' 81' ' ' ARG . 2.3 pt-20 -152.61 -174.71 5.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.294 0.568 . . . . 0.0 111.602 -178.95 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.47 130.18 55.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.672 179.156 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 86.2 mt -121.08 131.04 74.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.162 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 24.0 tp -100.01 129.16 46.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.318 179.442 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -113.51 135.38 53.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.149 179.573 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.444 ' ND2' ' H ' ' A' ' 69' ' ' THR . 9.1 t-20 -95.09 105.62 17.56 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.866 -0.333 . . . . 0.0 111.338 -179.988 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -98.07 -6.96 30.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.209 178.847 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.403 ' HB2' HD22 ' A' ' 62' ' ' ASN . 1.0 OUTLIER -69.36 102.28 1.72 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.401 179.846 . . . . . . . . 3 3 . 1 . 057 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.6 p -89.51 -6.51 56.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.788 0.328 . . . . 0.0 110.484 179.397 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.28 -42.12 6.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.332 0.587 . . . . 0.0 109.637 179.928 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -141.21 99.87 6.45 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.668 -179.919 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.404 ' HA ' HD22 ' A' ' 62' ' ' ASN . 48.8 Cg_exo -55.53 146.44 63.87 Favored 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 122.595 2.197 . . . . 0.0 112.982 -179.282 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.444 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 48.3 m -72.67 139.17 47.12 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.167 179.278 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -105.88 140.45 38.89 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.754 -179.589 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.441 ' O ' ' OG ' ' A' ' 74' ' ' SER . 54.9 t -132.23 132.9 60.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.041 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 52.91 32.93 13.44 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.049 -0.66 . . . . 0.0 109.332 -179.079 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.75 27.98 69.87 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.892 179.858 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 28.9 p -141.02 140.78 34.34 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 117.206 0.503 . . . . 0.0 111.22 179.895 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 13.4 t -72.4 142.48 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.804 -179.79 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.9 pt -115.67 88.69 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.66 178.967 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -63.67 -25.64 68.3 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.361 179.396 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.52 173.62 4.3 Favored Pre-proline 0 C--O 1.233 0.221 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.959 -179.704 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -61.66 142.37 94.14 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.401 2.067 . . . . 0.0 111.812 179.349 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 79.2 t -135.38 136.7 50.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.615 179.631 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.452 ' NE ' ' OE2' ' A' ' 57' ' ' GLU . 84.0 mtp180 -73.99 131.91 41.87 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.768 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.2 mt -82.45 139.94 33.68 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.954 0.407 . . . . 0.0 110.939 -179.38 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -131.12 151.35 51.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.698 -179.836 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.612 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 4.1 t60 -54.06 114.94 1.79 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.391 179.982 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.81 -6.39 29.42 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 -179.382 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.435 ' C ' ' OD1' ' A' ' 86' ' ' ASP . 26.7 t0 -79.4 125.28 29.33 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.306 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 42.6 t -110.03 130.54 63.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.604 -178.341 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 95.6 mt -92.46 130.62 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.804 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 25.7 m -121.65 126.75 49.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.449 0.643 . . . . 0.0 112.277 -178.124 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.623 ' CG2' HH12 ' A' ' 93' ' ' ARG . 70.8 mt -121.69 127.54 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.442 178.977 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 82.9 mt 38.59 -101.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.629 -179.511 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -115.88 15.72 16.28 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 120.666 -0.413 . . . . 0.0 111.693 -179.183 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.653 ' HE ' ' CD1' ' A' ' 41' ' ' LEU . 4.5 ptt85 -131.64 146.32 52.13 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.839 179.125 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 53.0 m -139.24 155.48 47.74 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.572 -179.388 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -122.22 121.04 35.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.657 179.775 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -83.7 130.95 34.97 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.878 0.371 . . . . 0.0 111.59 -178.872 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.641 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 76.6 t80 -96.37 123.62 40.08 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.23 -179.47 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -123.53 126.29 46.44 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.895 179.801 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.612 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 59.7 t-20 -112.81 121.86 45.96 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.243 179.43 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.415 ' HG3' HH12 ' A' ' 6' ' ' ARG . 79.2 mm-40 . . . . . 0 C--N 1.329 -0.312 0 C-N-CA 120.646 -0.421 . . . . 0.0 110.824 -179.522 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 31.3 m . . . . . 0 N--CA 1.448 -0.57 0 CA-C-O 121.413 0.625 . . . . 0.0 111.489 . . . . . . . . . 0 0 . 1 . 057 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.664 ' O ' ' N ' ' B' ' 231' ' ' GLN . 60.4 t0 -88.67 117.31 27.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.459 -179.716 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . 0.554 ' O ' ' CB ' ' B' ' 231' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.664 ' N ' ' O ' ' B' ' 229' ' ' ASP . 25.0 mt-30 121.81 31.05 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 O-C-N 124.712 1.257 . . . . 0.0 109.964 179.916 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . 0.524 ' N ' HH21 ' A' ' 31' ' ' ARG . . . -98.96 -144.66 17.17 Favored Glycine 0 CA--C 1.534 1.276 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 179.443 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -58.68 150.0 73.04 Favored 'Trans proline' 0 N--CA 1.502 2.001 0 C-N-CA 122.755 2.303 . . . . 0.0 113.126 179.915 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 057 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -61.11 135.75 60.71 Favored 'Trans proline' 0 C--N 1.301 -1.965 0 C-N-CA 122.415 2.077 . . . . 0.0 113.406 -179.24 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 31.2 t -65.29 136.6 26.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.864 179.102 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 5.7 t -60.1 121.63 12.38 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.626 -0.429 . . . . 0.0 110.099 -179.685 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . 0.405 ' O1P' ' OG1' ' B' ' 240' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.64 -24.47 70.62 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.224 1.949 . . . . 0.0 112.609 179.405 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' B' B ' 240' ' ' THR . . . . . 0.405 ' OG1' ' O1P' ' B' ' 238' ' ' TPO . 96.2 m -73.33 -44.9 58.03 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.515 0.674 . . . . 0.0 109.334 178.551 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -56.11 -44.8 79.43 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.826 -179.861 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 92.1 mt -62.81 -40.86 98.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 179.818 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -64.42 -39.94 94.8 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.419 -179.26 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 59.8 ttm-85 -60.01 -44.86 94.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.044 0.45 . . . . 0.0 109.962 179.781 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.448 HH21 ' HG2' ' A' ' 12' ' ' ARG . 58.1 mtp180 -63.32 -41.55 98.93 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.749 -179.823 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -62.85 -40.76 98.46 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.239 -0.585 . . . . 0.0 109.806 179.376 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 38.5 t -64.38 -45.05 89.4 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 122.052 0.929 . . . . 0.0 108.679 178.167 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . 0.446 ' O ' ' N ' ' B' ' 252' ' ' LEU . 51.3 tt0 -59.52 -37.28 77.93 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.41 -179.973 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 21.8 t -59.31 -45.07 93.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.753 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -58.59 -30.5 67.25 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.726 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -90.4 -10.57 43.4 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.817 179.258 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' B' ' 248' ' ' GLN . 1.0 OUTLIER -115.5 -175.3 2.68 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.207 -179.882 . . . . . . . . 3 3 . 1 . 057 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . 0.427 ' H ' ' HG ' ' B' ' 252' ' ' LEU . 0.4 OUTLIER 73.89 18.23 3.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.803 0.335 . . . . 0.0 111.107 179.768 . . . . . . . . 3 3 . 1 . 057 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . 0.419 ' O ' ' CB ' ' B' ' 255' ' ' ASP . 56.0 m-20 -64.86 -38.48 91.11 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.56 178.92 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . 0.486 ' CG ' ' O ' ' B' ' 255' ' ' ASP . 14.2 t0 156.94 54.78 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.151 -0.931 . . . . 0.0 108.964 -179.47 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.504 ' O ' ' C ' ' B' ' 257' ' ' LYS . 51.6 p-10 -120.16 11.93 11.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.273 -179.295 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . 0.504 ' C ' ' O ' ' B' ' 256' ' ' ASP . 98.1 mttt 29.82 -95.12 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 O-C-N 123.603 0.564 . . . . 0.0 110.623 -179.139 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.476 ' C ' ' O ' ' B' ' 257' ' ' LYS . 89.4 m-20 -29.74 138.36 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.549 -179.9 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.609 ' C ' ' H ' ' B' ' 261' ' ' ILE . 53.1 p30 -126.62 -174.26 3.08 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.88 0.848 . . . . 0.0 111.837 -178.758 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.583 ' CD ' HH12 ' A' ' 12' ' ' ARG . 53.5 mp0 -56.16 9.57 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.164 -1.38 . . . . 0.0 112.345 -179.166 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . 0.609 ' H ' ' C ' ' B' ' 259' ' ' ASP . 69.4 mt -108.58 135.53 47.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.738 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 55.0 t -127.45 134.0 66.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.947 0.404 . . . . 0.0 110.896 -178.384 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -97.38 119.75 36.48 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.557 -179.331 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.85 -43.84 94.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.924 179.038 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -95.79 153.78 39.24 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.362 -179.598 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.85 147.05 80.13 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 123.087 2.525 . . . . 0.0 113.288 -179.273 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.4 pt . . . . . 0 C--N 1.331 -0.223 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.678 178.455 . . . . . . . . 0 0 . 1 . 058 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo . . . . . 0 N--CA 1.492 1.391 0 CA-C-O 121.225 0.427 . . . . 0.0 112.769 . . . . . . . . . 0 0 . 1 . 058 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.444 ' HG1' ' N ' ' A' ' 5' ' ' ARG . 50.0 p -102.68 -49.31 3.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.25 179.96 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.444 ' N ' ' HG1' ' A' ' 4' ' ' THR . 84.9 mtt85 -89.39 122.27 32.45 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.493 -179.449 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -124.79 139.44 53.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.24 -179.922 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 29.4 tp -116.39 132.83 56.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.133 -179.4 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.477 ' CG1' ' NH2' ' A' ' 96' ' ' ARG . 67.6 t -108.18 130.19 61.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.36 -179.676 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.581 ' OG1' ' O ' ' A' ' 18' ' ' PRO . 59.2 p -91.28 114.22 26.69 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.455 0.645 . . . . 0.0 112.485 -178.83 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 95.5 mt -79.71 140.9 16.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.396 178.953 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.45 ' NZ ' ' O ' ' B' ' 256' ' ' ASP . 97.8 mttt -87.69 158.19 18.89 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.15 0.5 . . . . 0.0 111.008 179.179 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.592 ' NH1' ' OE2' ' B' ' 260' ' ' GLU . 81.3 mtp180 -58.3 -31.03 67.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.554 -179.305 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 93.2 p -74.82 -12.79 60.47 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.933 179.275 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.34 25.93 10.57 Favored Glycine 0 CA--C 1.531 1.045 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -179.566 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.2 t -119.27 134.98 61.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.695 0.283 . . . . 0.0 110.541 179.981 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.633 ' CG ' HH22 ' A' ' 96' ' ' ARG . 90.6 m-20 -67.6 139.23 56.86 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.426 -179.837 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -127.04 -123.71 2.66 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.068 -179.023 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.581 ' O ' ' OG1' ' A' ' 9' ' ' THR . 61.1 Cg_endo -72.43 146.34 44.51 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 122.321 2.014 . . . . 0.0 113.184 -178.426 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.61 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -111.08 131.01 55.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.094 0.473 . . . . 0.0 111.049 -179.561 . . . . . . . . 3 3 . 1 . 058 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -101.35 107.7 51.93 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.014 -179.602 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -73.64 127.45 11.68 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 121.129 1.219 . . . . 0.0 111.645 -179.748 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.9 mt -87.87 50.58 2.02 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.139 -178.769 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 97.4 p -65.97 -19.07 65.74 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.051 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 68.0 mt -79.03 140.57 37.9 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.283 179.848 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.7 t -62.43 -25.5 68.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.866 179.916 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 66.0 m -129.79 130.96 46.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.193 -179.768 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.61 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 8.6 t -129.3 124.17 33.69 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.605 178.903 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 42.8 tp -119.28 132.05 55.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.928 0.394 . . . . 0.0 111.184 -178.747 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.61 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 10.0 m-85 -108.97 139.98 43.09 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.022 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 167.76 -155.7 26.77 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 119.942 -1.123 . . . . 0.0 112.069 179.846 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.538 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 37.6 ttp-105 -111.2 -21.64 11.8 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.88 -0.16 . . . . 0.0 110.855 -179.459 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.458 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -73.77 163.59 54.69 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.553 -179.161 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.514 ' CD1' ' NH1' ' A' ' 38' ' ' ARG . 46.2 mm -64.52 -45.67 94.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 O-C-N 122.746 -0.267 . . . . 0.0 110.944 -179.876 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -49.78 -21.95 1.27 Allowed 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.503 179.962 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.572 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 4.8 m -67.75 121.87 16.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.11 -179.513 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -59.41 -25.9 64.7 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.757 -179.494 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.452 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 98.1 mt -128.77 124.16 60.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.086 177.64 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.514 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 56.6 mtm180 -110.34 141.43 43.38 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 120.634 -0.427 . . . . 0.0 111.237 -179.704 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.478 HD12 HH21 ' A' ' 93' ' ' ARG . 81.0 mt -121.17 132.65 70.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.034 179.916 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -74.75 29.81 0.09 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.569 -177.762 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.663 ' CD1' ' NH1' ' A' ' 93' ' ' ARG . 51.5 mt -109.34 133.55 20.77 Favored Pre-proline 0 C--N 1.325 -0.494 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.643 -179.559 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.2 -12.92 25.74 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.741 2.294 . . . . 0.0 112.016 179.598 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.4 m -88.61 3.71 5.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.069 179.448 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.538 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 55.1 t -98.99 130.88 47.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 C-N-CA 120.434 -0.507 . . . . 0.0 109.699 178.432 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 75.6 m -70.74 172.62 8.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.632 -179.077 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.572 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 10.5 mttm -63.79 -41.87 97.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.259 179.939 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.658 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.2 mt-30 -117.48 -16.15 10.21 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 123.337 0.398 . . . . 0.0 111.732 -179.315 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.5 t60 33.78 -72.58 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 179.081 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.658 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -135.99 140.32 43.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.067 0.461 . . . . 0.0 112.036 -178.752 . . . . . . . . 3 3 . 1 . 058 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -126.63 135.51 51.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.556 179.918 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 92.3 mt -121.52 134.17 65.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.013 -179.483 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -116.14 127.34 54.75 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.849 179.036 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.423 HG23 HD12 ' A' ' 53' ' ' ILE . 82.1 mt -106.57 113.27 42.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 119.853 -0.739 . . . . 0.0 112.288 -179.606 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.426 ' O ' ' C ' ' A' ' 55' ' ' GLU . 98.0 m-70 -113.25 143.89 43.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.742 179.426 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 54' ' ' HIS . 41.3 tt0 -40.9 -30.68 0.14 Allowed 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.028 -0.669 . . . . 0.0 109.4 -179.407 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.47 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 85.7 mt-30 -60.79 -68.88 0.26 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.37 179.131 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.47 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 4.2 tp10 -157.91 -164.95 1.63 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.809 179.775 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.44 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -111.59 126.77 55.36 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 178.317 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.412 HD12 HG22 ' A' ' 59' ' ' ILE . 94.4 mt -115.36 131.56 67.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.247 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.443 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 22.0 tp -101.05 131.24 47.04 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.835 179.773 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -114.26 134.71 54.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.499 -179.779 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 56.6 t-20 -92.84 105.06 17.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.933 0.397 . . . . 0.0 111.434 -179.309 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -101.82 -9.56 20.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.277 179.417 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.92 98.2 10.21 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.717 -179.581 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.5 m -76.69 -38.41 54.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.359 0.599 . . . . 0.0 109.854 178.996 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.49 -44.66 95.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.832 -178.688 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.421 HD22 ' HA ' ' B' ' 236' ' ' VAL . 85.4 m-20 -139.16 95.86 9.21 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.624 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -54.8 144.29 66.79 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 121.787 1.658 . . . . 0.0 112.542 -179.038 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 97.0 m -73.42 138.38 45.19 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.625 178.76 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -99.96 137.81 37.91 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.272 179.881 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 54.2 t -131.89 133.21 61.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 178.517 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 53.71 32.1 14.06 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.218 -179.121 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.4 27.66 67.38 Favored Glycine 0 CA--C 1.536 1.38 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.225 179.691 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 58.6 m -144.35 140.45 29.11 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 117.319 0.56 . . . . 0.0 111.657 -179.964 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.6 m -74.28 146.8 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.748 179.515 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.8 pt -116.43 98.5 6.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.262 0.553 . . . . 0.0 111.549 179.837 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -67.14 -26.58 66.74 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 178.465 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.31 166.36 17.51 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.602 -179.868 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -64.22 150.5 88.18 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.684 2.256 . . . . 0.0 112.183 179.249 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.4 m -141.63 141.99 29.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.347 -179.482 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -74.91 135.22 41.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.966 179.18 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 98.2 mt -83.82 137.53 33.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.236 0.541 . . . . 0.0 110.838 -179.631 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -129.27 154.85 46.42 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.808 179.974 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -56.99 116.19 3.06 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.843 -178.901 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.06 -12.8 29.06 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -179.743 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.409 ' C ' ' OD1' ' A' ' 86' ' ' ASP . 43.6 t0 -67.78 128.47 36.59 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.963 0.411 . . . . 0.0 110.283 179.651 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.3 p -109.11 134.87 49.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.559 -179.053 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 81.2 mt -106.8 131.17 57.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.275 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.8 m -119.9 123.67 44.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.446 0.641 . . . . 0.0 111.479 -179.033 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 84.8 mt -116.74 124.47 72.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.914 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.462 HG22 HD12 ' A' ' 91' ' ' ILE . 44.8 mm 44.61 -103.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.773 -179.607 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.664 ' OD1' ' NH1' ' A' ' 93' ' ' ARG . 12.3 p-10 -117.49 17.58 14.5 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.995 0.426 . . . . 0.0 110.488 -179.803 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.664 ' NH1' ' OD1' ' A' ' 92' ' ' ASP . 34.2 mtm-85 -127.1 142.68 51.46 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.024 -179.366 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.407 ' HG ' ' N ' ' A' ' 95' ' ' PHE . 41.2 t -135.25 150.26 50.02 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.564 -179.826 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.505 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 19.2 m-85 -124.97 124.02 41.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.581 -179.892 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.633 HH22 ' CG ' ' A' ' 16' ' ' ASP . 89.8 mtm-85 -85.66 128.41 34.77 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.932 -178.915 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -92.12 124.53 36.28 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.193 179.083 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -127.69 118.55 24.03 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.549 -179.547 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 61.4 t-20 -103.37 104.01 14.07 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.009 179.589 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 . . . . . 0 C--N 1.333 -0.144 0 CA-C-O 120.863 0.364 . . . . 0.0 111.0 -179.252 . . . . . . . . 0 0 . 1 . 058 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . 0.471 ' O ' ' C ' ' B' ' 229' ' ' ASP . 27.7 m . . . . . 0 N--CA 1.451 -0.378 0 CA-C-O 120.697 0.284 . . . . 0.0 110.389 . . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.471 ' C ' ' O ' ' B' ' 228' ' ' VAL . 87.5 m-20 34.83 -111.44 0.06 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.076 -179.417 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 058 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.568 ' O ' ' NZ ' ' A' ' 46' ' ' LYS . 82.6 mt-30 -135.82 -5.74 2.18 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.335 -179.859 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . 0.479 ' N ' HH21 ' A' ' 31' ' ' ARG . . . -50.19 -171.99 0.01 OUTLIER Glycine 0 CA--C 1.527 0.825 0 C-N-CA 121.206 -0.521 . . . . 0.0 112.096 -178.852 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -65.7 160.88 41.37 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 123.519 2.813 . . . . 0.0 113.176 -179.617 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 058 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.87 140.28 31.65 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 121.169 1.246 . . . . 0.0 113.019 -178.878 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . 0.421 ' HA ' HD22 ' A' ' 67' ' ' ASN . 17.5 t -57.56 141.09 15.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.485 -179.597 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 16.5 t -58.8 121.08 10.22 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.455 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 058 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.39 -29.21 57.49 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 122.447 2.098 . . . . 0.0 113.057 179.127 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 13.7 p -73.96 -39.2 63.9 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.218 179.044 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -57.42 -46.34 83.65 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.357 -179.872 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 94.9 mt -63.45 -40.76 98.0 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.215 179.95 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -58.18 -41.77 84.64 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.14 179.558 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -64.34 -38.8 92.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.447 179.844 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.494 ' NE ' ' CB ' ' A' ' 92' ' ' ASP . 10.1 ttm180 -57.8 -44.93 86.65 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.56 -179.511 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -61.65 -41.23 97.23 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.758 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 10.2 t -63.8 -45.97 87.25 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.323 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . 0.418 ' HG2' HH12 ' A' ' 12' ' ' ARG . 67.0 tp60 -58.51 -41.15 84.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.688 -1.142 . . . . 0.0 111.406 -179.531 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 55.0 t -59.85 -44.56 94.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 C-N-CA 120.559 -0.457 . . . . 0.0 109.792 179.897 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -60.27 -34.17 73.35 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.573 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -74.93 -14.15 60.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.369 179.295 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 97.7 mt -106.05 166.34 10.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.393 -179.968 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -127.47 160.68 30.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.146 -179.597 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -59.35 -26.98 65.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.949 179.785 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 40.7 p-10 -82.12 1.57 35.46 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.421 -179.119 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.45 ' O ' ' NZ ' ' A' ' 11' ' ' LYS . 37.0 t70 -60.25 146.03 45.23 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.193 0.52 . . . . 0.0 109.724 179.083 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -131.04 155.9 46.08 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.007 -179.562 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.508 ' O ' ' N ' ' B' ' 260' ' ' GLU . 94.3 m-20 61.16 50.83 4.68 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.549 0.69 . . . . 0.0 109.534 -178.705 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . . . . . . . . . 55.6 p-10 -58.02 69.0 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.629 -1.169 . . . . 0.0 112.32 -178.946 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.592 ' OE2' ' NH1' ' A' ' 12' ' ' ARG . 95.7 mt-10 60.01 3.43 0.5 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.982 1.105 . . . . 0.0 113.982 178.172 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 73.9 mt -109.41 134.11 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 118.644 0.656 . . . . 0.0 109.691 179.684 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . 0.421 ' N ' ' O ' ' A' ' 38' ' ' ARG . 56.1 t -123.9 131.94 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.052 -179.532 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -98.77 120.64 39.56 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.21 0.528 . . . . 0.0 111.174 -178.683 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -63.05 -48.3 79.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.332 -179.681 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -88.78 161.86 40.3 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.029 -179.068 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -62.28 143.54 94.13 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.276 1.984 . . . . 0.0 112.279 -179.963 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . 0.428 ' CD1' ' O ' ' A' ' 19' ' ' HIS . 4.2 tt . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.877 -179.647 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo . . . . . 0 N--CA 1.492 1.412 0 CA-C-O 120.831 0.263 . . . . 0.0 112.142 . . . . . . . . . 0 0 . 1 . 059 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.452 ' HG1' ' N ' ' A' ' 5' ' ' ARG . 73.8 p -102.6 -44.19 5.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.99 0.424 . . . . 0.0 110.409 179.641 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.452 ' N ' ' HG1' ' A' ' 4' ' ' THR . 89.9 mtm-85 -91.24 125.75 36.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.151 -179.75 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 86.5 mtm-85 -131.43 137.14 48.52 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.849 179.522 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 40.8 tp -113.32 131.38 55.97 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.983 -179.905 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.6 t -109.07 131.71 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 120.947 0.403 . . . . 0.0 110.984 -179.586 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 m -90.65 112.64 24.45 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.748 -179.341 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.7 mt -79.72 144.67 10.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.405 178.646 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -90.6 158.32 17.03 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.142 0.496 . . . . 0.0 110.588 179.17 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.729 HH12 ' NE2' ' B' ' 248' ' ' GLN . 87.2 mtm180 -58.39 -28.39 65.13 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.727 -178.846 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 93.6 p -80.36 -11.22 59.73 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.473 179.795 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.55 31.34 7.16 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.108 179.212 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.1 t -122.61 133.45 68.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.789 0.328 . . . . 0.0 110.729 179.623 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -73.64 138.64 44.93 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.207 179.479 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.66 -118.34 1.93 Allowed Glycine 0 CA--C 1.534 1.225 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.764 -179.899 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.42 146.14 55.29 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 121.912 1.741 . . . . 0.0 112.332 -179.112 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -110.83 158.54 18.58 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.157 0.503 . . . . 0.0 110.649 -179.337 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -125.74 102.0 29.32 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.617 -179.491 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -69.8 128.56 16.16 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 121.279 1.32 . . . . 0.0 111.468 -178.947 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.8 mt -85.72 49.48 1.78 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.543 -178.183 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 92.2 p -61.55 -24.93 66.97 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.055 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 65.7 mt -78.64 141.27 38.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.076 179.779 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 91.9 p -65.33 -19.99 66.2 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.811 179.962 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.409 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 61.8 m -130.28 131.46 45.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.6 -178.852 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.2 t -125.0 112.71 16.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.429 178.385 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.7 tp -109.36 127.74 54.57 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.923 -178.593 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.453 ' CE2' ' CD1' ' A' ' 37' ' ' ILE . 2.5 m-85 -110.07 143.41 40.16 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.745 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 150.98 -166.82 30.5 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.233 178.468 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.531 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 46.2 mtm105 -82.62 -30.98 29.07 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 179.946 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.544 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -50.84 139.08 24.31 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 120.556 -0.83 . . . . 0.0 111.298 -178.854 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 31.3 mm -63.92 -43.79 97.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 121.064 0.459 . . . . 0.0 110.332 179.396 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -55.72 -14.41 2.25 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.132 179.879 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.544 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 56.6 m -64.43 135.2 55.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.93 179.954 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.409 ' OD2' ' O ' ' A' ' 26' ' ' THR . 58.5 m-20 -61.23 -33.84 74.15 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.646 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.453 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 88.2 mt -127.32 122.58 60.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 177.471 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 77.5 ttt-85 -111.42 138.6 47.71 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.516 -178.187 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 83.8 mt -119.86 131.48 72.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-O 120.88 0.371 . . . . 0.0 110.409 -179.89 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -78.06 33.82 0.19 Allowed 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 -178.49 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.529 ' CD1' ' CZ ' ' A' ' 93' ' ' ARG . 33.4 mt -109.09 131.86 21.56 Favored Pre-proline 0 C--N 1.325 -0.461 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.293 -179.651 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.79 -15.41 29.94 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.392 2.061 . . . . 0.0 112.874 -179.681 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.2 m -90.27 1.01 8.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.281 179.592 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.531 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 45.3 t -93.25 133.74 33.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.061 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.9 m -71.53 164.09 26.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.4 0.619 . . . . 0.0 112.02 -178.609 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -63.73 -43.3 96.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.187 -178.834 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.623 ' O ' ' N ' ' A' ' 49' ' ' CYS . 93.1 mm-40 -111.95 -17.88 12.78 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.966 0.412 . . . . 0.0 110.148 -179.791 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 14.9 t60 30.66 -76.15 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 179.908 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.623 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.52 137.25 47.09 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -178.43 . . . . . . . . 3 3 . 1 . 059 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -128.69 126.69 40.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.876 179.809 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 91.8 mt -108.71 133.71 52.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.129 0.49 . . . . 0.0 110.738 179.868 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.448 ' OE2' ' CE1' ' A' ' 54' ' ' HIS . 81.0 tt0 -118.23 123.83 46.42 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.354 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 92.5 mt -107.5 119.25 56.78 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 CA-C-O 122.013 0.911 . . . . 0.0 112.858 -178.531 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.461 ' O ' ' C ' ' A' ' 55' ' ' GLU . 98.7 m-70 -108.02 134.14 51.34 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 113.871 -1.513 . . . . 0.0 108.865 179.075 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.461 ' C ' ' O ' ' A' ' 54' ' ' HIS . 97.3 mt-10 -42.5 -33.13 0.63 Allowed 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.524 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.408 ' N ' ' C ' ' A' ' 54' ' ' HIS . 78.6 mt-30 -64.53 -68.33 0.36 Allowed 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.071 -0.968 . . . . 0.0 108.835 177.722 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -143.82 179.12 7.36 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.562 0.696 . . . . 0.0 112.404 -178.567 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.9 120.59 41.96 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.095 178.429 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.7 mt -118.34 133.03 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.994 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.427 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 15.7 tp -99.29 129.45 45.51 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.317 179.487 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -110.8 136.89 49.16 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.559 -179.945 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -98.9 106.97 19.29 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.007 0.432 . . . . 0.0 111.905 -179.052 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -100.21 -6.06 26.67 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.779 179.402 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.7 99.18 8.06 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.376 -179.667 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.7 p -88.53 -20.42 25.12 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.738 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.6 m -74.18 -50.91 17.22 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.467 179.189 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.452 HD22 ' HA ' ' B' ' 236' ' ' VAL . 72.2 m-20 -137.43 99.42 9.66 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 114.698 -1.137 . . . . 0.0 108.923 179.766 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -54.0 144.62 56.18 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 121.954 1.769 . . . . 0.0 113.403 -178.762 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 26.8 m -72.12 139.87 48.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.493 178.581 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -105.1 140.53 38.13 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.166 -0.614 . . . . 0.0 110.648 179.932 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.2 p -134.06 134.22 55.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.707 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 51.6 31.89 8.33 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -179.065 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.92 27.39 68.91 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.887 -179.751 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.7 t -139.07 136.73 35.55 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 117.497 0.649 . . . . 0.0 111.804 -179.839 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.5 m -73.75 143.25 13.87 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.151 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.048 179.667 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 9.9 pt -117.07 100.61 10.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.411 0.624 . . . . 0.0 111.028 179.795 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -71.0 -21.97 62.22 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.072 179.46 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.438 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.3 OUTLIER -130.19 177.21 2.31 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.736 179.78 . . . . . . . . 3 3 . 1 . 059 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.438 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 36.7 Cg_exo -59.96 142.32 98.24 Favored 'Trans proline' 0 N--CA 1.5 1.906 0 C-N-CA 122.865 2.377 . . . . 0.0 112.708 -179.335 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 61.4 t -133.03 139.32 49.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.065 179.602 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.527 HH21 ' CE ' ' A' ' 83' ' ' LYS . 62.5 ttp180 -76.61 126.73 31.49 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.955 179.043 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 94.4 mt -82.78 138.45 34.0 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.942 0.401 . . . . 0.0 111.703 -179.285 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.527 ' CE ' HH21 ' A' ' 81' ' ' ARG . 99.3 mttt -128.38 150.95 49.89 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.035 179.712 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.432 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 6.1 t60 -55.43 122.31 10.92 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.068 0.461 . . . . 0.0 111.174 -179.18 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.96 -16.64 42.73 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 -179.894 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -65.82 136.54 56.32 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.62 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 42.0 t -114.5 132.76 62.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.427 -178.364 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 91.6 mt -95.51 131.43 42.33 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.43 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.7 m -123.98 124.96 43.74 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.6 0.714 . . . . 0.0 112.634 -178.319 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.5 ' O ' ' N ' ' A' ' 92' ' ' ASP . 93.7 mt -113.15 125.91 70.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 114.695 -1.139 . . . . 0.0 108.427 178.432 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.425 ' C ' ' O ' ' A' ' 90' ' ' ILE . 73.9 mt 39.5 -94.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 C-N-CA 120.716 -0.393 . . . . 0.0 110.53 -179.458 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.517 ' O ' ' OD1' ' A' ' 92' ' ' ASP . 62.3 t0 -124.94 19.0 8.49 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.071 0.463 . . . . 0.0 110.905 -179.78 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.676 ' NH1' ' NH2' ' B' ' 245' ' ' ARG . 58.0 mtm-85 -127.62 141.98 51.48 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.472 -179.841 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 25.8 p -139.27 154.2 47.91 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 119.59 -0.844 . . . . 0.0 111.426 -179.798 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -123.22 121.79 36.77 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.078 179.702 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 -80.14 127.65 32.57 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.953 -179.148 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -95.1 125.13 39.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.111 -179.825 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -124.87 121.62 35.06 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.636 179.651 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.432 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 53.2 t-20 -116.63 113.79 23.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.012 179.453 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.302 -179.305 . . . . . . . . 0 0 . 1 . 059 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . 0.449 ' CG1' ' O ' ' B' ' 228' ' ' VAL . 44.5 t . . . . . 0 N--CA 1.457 -0.123 0 CA-C-O 120.613 0.244 . . . . 0.0 110.844 . . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -60.71 -47.89 84.24 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.542 -179.984 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 059 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 9.0 mp0 -118.65 46.91 1.73 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.873 -178.733 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -126.82 -177.2 14.77 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.424 -179.974 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -66.79 153.86 76.48 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 123.37 2.714 . . . . 0.0 112.662 -179.814 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 059 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.88 139.1 17.22 Favored 'Trans proline' 0 C--N 1.302 -1.879 0 C-N-CA 121.863 1.709 . . . . 0.0 112.489 -179.74 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . 0.452 ' HA ' HD22 ' A' ' 67' ' ' ASN . 10.9 m -67.39 147.75 12.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.191 -178.919 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 3.0 t -68.45 129.18 39.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.847 179.891 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . 0.432 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . 0.432 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 31.8 Cg_exo -58.97 -27.07 83.81 Favored 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 122.893 2.396 . . . . 0.0 113.585 -178.794 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 97.3 m -73.61 -44.21 57.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.179 0.514 . . . . 0.0 109.844 179.074 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -58.31 -46.11 86.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.652 -179.516 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 94.7 mt -63.54 -40.13 96.2 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.852 0.358 . . . . 0.0 110.284 -179.834 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 51.9 tp10 -60.77 -43.73 97.65 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.496 -179.749 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -60.04 -41.74 92.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.175 0.512 . . . . 0.0 109.841 179.548 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.676 ' NH2' ' NH1' ' A' ' 93' ' ' ARG . 61.3 ttm-85 -60.04 -44.75 94.46 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.718 -179.544 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -61.87 -40.9 96.98 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.056 0.455 . . . . 0.0 110.141 -179.719 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 61.4 m -66.94 -44.01 81.73 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 177.949 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . 0.729 ' NE2' HH12 ' A' ' 12' ' ' ARG . 59.0 tt0 -60.87 -37.8 83.38 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.201 179.867 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 53.6 t -62.21 -45.97 97.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 C-N-CA 119.926 -0.709 . . . . 0.0 110.037 -179.966 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -58.77 -28.86 66.31 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.603 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -89.56 -14.76 34.39 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.52 179.355 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.657 ' CD2' HH21 ' A' ' 12' ' ' ARG . 64.2 tp -76.28 136.58 39.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.484 -179.237 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -104.19 144.04 32.12 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.956 178.988 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -64.62 -19.18 65.53 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.038 -179.722 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -65.58 -11.32 43.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.658 -179.889 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.514 ' C ' ' H ' ' B' ' 258' ' ' ASP . 85.3 m-20 -92.97 71.25 4.66 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.998 0.428 . . . . 0.0 110.48 179.228 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -66.43 13.16 0.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.621 -179.16 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.731 ' O ' ' N ' ' B' ' 260' ' ' GLU . 48.2 p-10 -101.61 1.34 37.67 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.033 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.457 ' C ' ' O ' ' B' ' 258' ' ' ASP . 56.0 p-10 4.7 49.72 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 O-C-N 124.477 1.11 . . . . 0.0 113.806 179.593 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.731 ' N ' ' O ' ' B' ' 258' ' ' ASP . 97.7 mt-10 58.67 4.25 0.36 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 178.764 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 75.2 mt -113.11 134.9 54.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 179.065 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 59.2 t -124.22 133.27 69.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.924 0.392 . . . . 0.0 110.842 -179.564 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -96.48 118.5 33.11 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.141 0.496 . . . . 0.0 110.928 -179.424 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -65.32 -47.95 74.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.857 -179.945 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -95.15 164.84 18.22 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.143 -178.436 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -64.34 149.63 89.78 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 122.91 2.406 . . . . 0.0 112.696 -179.575 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 47.7 pt . . . . . 0 C--N 1.33 -0.243 0 CA-C-O 121.366 0.603 . . . . 0.0 111.436 -179.851 . . . . . . . . 0 0 . 1 . 060 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo . . . . . 0 N--CA 1.494 1.546 0 CA-C-O 120.669 0.196 . . . . 0.0 112.355 . . . . . . . . . 0 0 . 1 . 060 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.2 m -76.04 -48.67 20.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.915 0.388 . . . . 0.0 111.065 179.341 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.1 mtt85 -90.08 136.45 33.04 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.657 -178.559 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -127.59 137.35 52.55 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.787 179.482 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 40.6 tp -115.67 134.0 55.48 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.651 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.0 t -111.76 130.98 64.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -179.799 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.2 m -90.45 111.76 23.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.393 0.616 . . . . 0.0 112.09 -178.644 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 95.2 mt -79.97 142.13 14.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.703 178.64 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -91.42 159.97 15.7 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.021 0.439 . . . . 0.0 111.368 -179.832 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 91.3 mtm180 -57.68 -29.38 64.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.282 -179.68 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.7 t -80.69 -11.01 59.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.339 179.557 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.63 34.82 6.42 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.356 -0.697 . . . . 0.0 111.356 -179.985 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.4 t -121.65 131.33 73.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.604 0.24 . . . . 0.0 110.696 179.531 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -73.27 135.7 44.49 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.146 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -124.82 -117.08 2.21 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.145 -179.288 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -73.62 144.55 35.83 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.153 1.902 . . . . 0.0 113.056 -178.581 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.424 ' O ' ' CG2' ' B' ' 267' ' ' ILE . 6.3 m170 -102.63 149.36 24.51 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.93 179.602 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -127.22 104.37 22.44 Favored Pre-proline 0 CA--C 1.536 0.437 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.538 -178.759 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.51 ' O ' ' NE2' ' B' ' 265' ' ' GLN . 61.5 Cg_endo -75.25 134.91 17.98 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.359 1.373 . . . . 0.0 112.433 -179.399 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 68.2 mt -88.98 54.27 2.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.341 -178.714 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.3 p -61.21 -20.53 62.89 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.984 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 80.8 mt -84.91 141.08 30.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.451 179.165 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.9 p -67.81 -15.9 63.85 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -178.595 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.513 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 85.6 m -132.52 134.72 45.35 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.071 179.905 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.7 t -127.8 115.78 19.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.226 179.409 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.1 tp -114.5 128.68 56.46 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.487 -178.991 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.518 ' O ' ' O ' ' A' ' 47' ' ' GLN . 3.4 m-85 -107.11 136.48 46.88 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.205 179.297 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 163.7 -175.87 39.85 Favored Glycine 0 N--CA 1.467 0.766 0 C-N-CA 120.094 -1.05 . . . . 0.0 112.591 178.88 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.626 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 84.1 mtm-85 -72.34 -30.2 64.52 Favored 'General case' 0 CA--C 1.522 -0.111 0 CA-C-O 121.035 0.445 . . . . 0.0 110.06 179.311 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.511 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -55.77 138.78 43.91 Favored Glycine 0 CA--C 1.523 0.54 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.401 -177.98 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.4 tp -69.09 -41.15 81.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.84 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 -54.04 -18.24 3.41 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 178.767 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.511 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 18.7 m -66.81 139.18 57.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.577 -179.769 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.513 ' OD2' ' O ' ' A' ' 26' ' ' THR . 60.5 m-20 -62.47 -34.73 77.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.613 -179.13 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.438 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 96.8 mt -127.18 120.84 56.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 177.796 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 51.3 ttt180 -108.39 133.94 51.87 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.26 -179.026 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 79.5 mt -117.49 133.93 62.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.439 -179.657 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -79.45 29.91 0.23 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.466 -178.096 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 24.1 mt -98.49 125.82 41.57 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.915 179.39 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.94 -9.07 24.13 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.369 2.046 . . . . 0.0 113.326 -178.749 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.0 m -98.94 7.34 8.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.633 -179.797 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.626 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 53.6 t -96.7 135.75 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.809 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.0 m -70.01 171.33 9.68 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.114 0.483 . . . . 0.0 111.638 -179.234 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -61.67 -41.55 97.69 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.405 -179.044 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.633 ' O ' ' N ' ' A' ' 49' ' ' CYS . 97.1 mt-30 -112.5 -18.88 12.31 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 123.384 0.428 . . . . 0.0 110.757 -179.92 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 16.0 t60 36.93 -76.23 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 179.513 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.633 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.12 136.23 48.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.317 0.58 . . . . 0.0 112.121 -178.856 . . . . . . . . 3 3 . 1 . 060 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -126.27 127.98 46.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.259 179.623 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 95.5 mt -116.29 134.36 59.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.998 -179.916 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.562 ' CD ' ' HE2' ' A' ' 61' ' ' HIS . 14.5 pt-20 -114.71 140.3 48.97 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.331 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 50.1 mm -107.66 120.41 58.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.185 -0.606 . . . . 0.0 111.821 -179.11 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.515 ' HE2' ' CD ' ' A' ' 52' ' ' GLU . 98.5 m-70 -123.68 133.36 53.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.661 178.488 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 54' ' ' HIS . 98.7 mt-10 -39.56 -31.81 0.11 Allowed 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.415 -0.514 . . . . 0.0 109.938 -178.261 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.422 ' N ' ' O ' ' A' ' 54' ' ' HIS . 85.9 mt-30 -63.2 -67.82 0.39 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.476 178.894 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.414 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 7.1 tp10 -152.22 -153.54 0.49 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.529 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.414 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -131.71 134.14 45.59 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.644 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.3 mt -119.14 130.61 73.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -178.262 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.412 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 26.3 tp -95.7 127.46 41.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.754 179.201 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.562 ' HE2' ' CD ' ' A' ' 52' ' ' GLU . 99.0 m-70 -114.4 138.23 50.82 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.596 -179.409 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.428 ' C ' ' OD1' ' A' ' 62' ' ' ASN . 55.6 t-20 -96.08 106.2 18.35 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -178.54 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -101.56 -12.16 18.7 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.947 0.403 . . . . 0.0 110.038 178.425 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.13 104.78 3.72 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.369 179.613 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.5 p -88.29 -19.49 26.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.164 0.506 . . . . 0.0 109.831 179.648 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.66 -44.49 12.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.783 -179.874 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 -140.62 98.3 7.18 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.181 -179.715 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -54.91 143.99 69.51 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.279 1.986 . . . . 0.0 112.673 -179.614 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.1 m -70.28 136.57 49.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.117 179.32 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -101.72 141.1 35.1 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.442 179.937 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 51.6 t -126.15 136.21 61.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.649 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 51.27 33.61 10.06 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -179.821 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.41 28.42 71.27 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.162 -179.968 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.5 t -140.18 138.34 35.08 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.259 -179.727 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 64.1 t -69.3 131.82 33.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.896 -179.34 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.3 100.39 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.765 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -84.33 -16.42 43.02 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.972 -179.013 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.23 160.82 29.82 Favored Pre-proline 0 C--O 1.219 -0.524 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.238 179.866 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -58.24 142.27 97.24 Favored 'Trans proline' 0 N--CA 1.502 1.989 0 C-N-CA 121.932 1.755 . . . . 0.0 112.968 -179.151 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.3 p -142.15 141.08 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 120.996 0.427 . . . . 0.0 111.459 179.575 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -74.52 131.05 40.67 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.41 179.492 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.7 mt -83.46 136.86 34.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.171 0.51 . . . . 0.0 110.96 -179.984 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -128.22 151.2 49.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.152 -179.785 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.717 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 4.6 t60 -53.45 120.21 5.8 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.383 -179.209 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.13 -15.7 27.92 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -179.34 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -73.75 124.9 26.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.007 0.432 . . . . 0.0 110.245 179.753 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.2 t -104.57 133.38 48.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.127 -178.953 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 33.1 mm -90.08 130.91 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.1 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.5 m -121.56 126.28 48.76 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -177.84 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.524 ' O ' ' N ' ' A' ' 92' ' ' ASP . 91.9 mt -115.75 125.3 72.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.843 178.612 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.456 ' C ' ' O ' ' A' ' 90' ' ' ILE . 42.1 mm 35.66 -93.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.974 179.261 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 90' ' ' ILE . 28.1 t70 -122.85 19.29 10.18 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.745 0.307 . . . . 0.0 111.294 -179.711 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.475 ' HG3' HH22 ' B' ' 245' ' ' ARG . 99.1 mtt180 -129.75 145.22 51.56 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.443 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 60.8 p -140.63 157.04 46.04 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 119.634 -0.826 . . . . 0.0 111.35 -179.95 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 46.6 m-85 -125.87 122.13 35.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.894 179.893 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 52.2 ttt85 -82.49 128.5 34.34 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.582 -179.757 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -96.54 127.79 42.86 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.739 179.871 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -134.22 124.52 26.1 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.639 179.888 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.717 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 46.6 p30 -105.45 -146.86 0.39 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.71 -179.863 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.021 -179.307 . . . . . . . . 0 0 . 1 . 060 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . 0.444 ' CG1' ' O ' ' B' ' 228' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.461 0.093 0 CA-C-O 121.095 0.474 . . . . 0.0 109.745 . . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -69.89 139.44 53.0 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.589 -179.713 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 060 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -119.52 32.16 6.22 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.131 179.973 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -111.8 -170.78 18.73 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 -179.91 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -74.93 162.29 37.52 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 123.092 2.528 . . . . 0.0 112.416 179.943 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 060 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.67 170.53 18.06 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.274 1.982 . . . . 0.0 112.562 -179.965 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . 0.456 ' O ' ' CG1' ' B' ' 236' ' ' VAL . 3.0 p -101.55 125.95 55.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.722 -179.814 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 32.1 t -65.07 122.89 18.1 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.533 179.689 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 060 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -54.29 -22.32 26.05 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.203 1.935 . . . . 0.0 111.801 179.407 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 96.7 m -71.95 -43.89 64.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.582 0.706 . . . . 0.0 109.334 178.13 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . 0.411 ' CE2' ' HD2' ' B' ' 245' ' ' ARG . 80.8 t80 -57.85 -46.15 85.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.172 -179.44 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 89.0 mt -63.73 -42.19 97.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.541 -179.634 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -64.85 -40.01 94.48 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.412 -179.254 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -61.71 -44.98 95.89 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.073 -179.458 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.475 HH22 ' HG3' ' A' ' 93' ' ' ARG . 79.9 mtp180 -63.2 -40.42 97.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.36 -179.475 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.95 -39.69 95.4 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.924 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 75.2 m -64.06 -45.03 90.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.35 177.942 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 -61.58 -37.31 83.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.786 -179.761 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 39.1 t -61.85 -43.74 97.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 C-N-CA 119.951 -0.699 . . . . 0.0 109.263 178.644 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -62.67 -28.23 69.79 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.571 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -83.57 -9.21 59.08 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.68 179.151 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 76.7 mt -101.09 -176.93 3.3 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.387 178.276 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -118.05 148.83 41.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.768 0.318 . . . . 0.0 111.376 -179.47 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -63.68 -25.2 68.1 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.241 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -79.2 13.23 1.94 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.531 -179.684 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -84.1 93.26 8.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.153 0.501 . . . . 0.0 109.963 -179.88 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -76.83 -9.28 58.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.859 -179.007 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -80.76 110.34 16.16 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.191 -0.603 . . . . 0.0 109.827 179.86 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.702 ' C ' ' H ' ' B' ' 261' ' ' ILE . 58.5 t0 -103.89 123.46 47.17 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.89 -179.143 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -54.56 11.66 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.814 -1.085 . . . . 0.0 111.9 179.893 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . 0.702 ' H ' ' C ' ' B' ' 259' ' ' ASP . 95.7 mt -103.76 137.42 32.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 177.909 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 69.2 t -125.38 132.44 71.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 120.421 -0.511 . . . . 0.0 110.544 -178.715 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -97.71 122.61 40.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.2 0.524 . . . . 0.0 111.734 -178.365 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -69.26 -42.8 75.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.551 179.899 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . 0.51 ' NE2' ' O ' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -88.06 161.21 44.41 Favored Pre-proline 0 CA--C 1.518 -0.269 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.933 -178.328 . . . . . . . . 3 3 . 1 . 060 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -59.23 145.68 97.0 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 121.973 1.782 . . . . 0.0 109.924 178.633 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . 0.424 ' CG2' ' O ' ' A' ' 19' ' ' HIS . 4.3 mt . . . . . 0 C--N 1.326 -0.443 0 C-N-CA 119.946 -0.702 . . . . 0.0 110.953 -178.081 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo . . . . . 0 N--CA 1.491 1.365 0 CA-C-O 121.087 0.37 . . . . 0.0 112.636 . . . . . . . . . 0 0 . 1 . 061 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 26.0 m -74.27 -45.19 49.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.214 -179.757 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -98.33 136.34 38.64 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.21 -177.667 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.409 HH22 ' HB2' ' A' ' 100' ' ' GLU . 85.1 mtm-85 -138.25 150.19 46.45 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.808 -179.807 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.5 mt -115.0 143.43 45.2 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.744 -179.908 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.4 t -115.97 127.66 73.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.338 179.07 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 m -77.85 134.16 38.02 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.647 0.737 . . . . 0.0 112.156 -178.888 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.515 ' CD1' ' OD1' ' A' ' 16' ' ' ASP . 50.5 mm -104.47 134.23 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 114.653 -1.158 . . . . 0.0 107.943 177.086 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.698 ' HZ2' ' N ' ' B' ' 258' ' ' ASP . 65.3 mttm -96.67 159.81 14.73 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.197 0.522 . . . . 0.0 111.103 -179.246 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 84.7 mtt-85 -57.52 -31.1 65.71 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.111 -178.84 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.2 p -72.97 -15.15 61.55 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.808 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.7 17.04 46.42 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.647 179.948 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.3 m -108.15 139.72 29.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.127 0.489 . . . . 0.0 110.632 -179.845 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.515 ' OD1' ' CD1' ' A' ' 10' ' ' ILE . 99.0 m-20 -76.76 138.5 39.95 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.953 179.849 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -128.48 -117.72 2.04 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 120.193 -1.003 . . . . 0.0 111.653 -179.774 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -74.73 151.58 41.16 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.6 2.2 . . . . 0.0 112.635 -179.126 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -111.17 144.32 40.5 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.265 179.28 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -108.28 94.64 13.76 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.582 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.83 137.3 29.4 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 121.169 1.246 . . . . 0.0 111.855 -178.795 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.9 mt -93.18 107.75 19.5 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.144 0.497 . . . . 0.0 111.419 -178.755 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.477 ' HG ' ' NE2' ' B' ' 265' ' ' GLN . 94.4 p -111.53 -6.34 14.43 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.348 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 70.7 mt -104.32 146.69 28.44 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.764 -179.739 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 83.8 p -66.32 -16.56 64.14 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.75 -178.754 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 29.8 m -132.9 134.16 44.22 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.939 -179.43 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.629 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 9.2 t -127.39 120.77 29.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.881 178.839 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 32.0 tp -118.5 128.46 54.61 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.788 0.328 . . . . 0.0 111.38 -178.428 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.629 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 14.5 m-85 -105.15 140.15 38.75 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.561 179.12 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 153.38 -179.58 29.63 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 119.944 -1.122 . . . . 0.0 112.637 178.537 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.499 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 45.3 mtm180 -70.04 -33.05 71.47 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.03 0.443 . . . . 0.0 110.637 178.516 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.57 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -52.96 141.31 29.44 Favored Glycine 0 CA--C 1.521 0.449 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.95 -178.401 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.434 HG22 HD13 ' A' ' 33' ' ' ILE . 78.7 mt -63.05 -43.05 98.8 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.162 178.974 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.407 ' HA ' ' NZ ' ' B' ' 264' ' ' LYS . 97.2 mt-10 -51.1 -18.85 0.93 Allowed 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.403 -0.519 . . . . 0.0 109.666 179.67 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.57 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 23.0 m -67.26 122.58 18.18 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.163 -179.527 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -57.05 -22.86 42.39 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -179.534 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 84.2 mt -130.98 118.28 40.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.987 177.904 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 57.4 mtt180 -99.74 133.5 44.0 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.29 -179.022 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 97.4 mt -116.81 126.93 74.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 120.417 -0.513 . . . . 0.0 109.999 179.339 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -75.27 42.64 0.2 Allowed 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -177.104 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.626 ' CD1' ' CZ ' ' A' ' 93' ' ' ARG . 85.4 mt -118.43 131.48 24.22 Favored Pre-proline 0 C--N 1.326 -0.451 0 C-N-CA 120.521 -0.472 . . . . 0.0 111.098 179.657 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.41 -10.32 23.81 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 122.235 1.957 . . . . 0.0 111.892 179.786 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.4 m -96.02 2.69 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.056 179.724 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.499 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 37.3 t -99.44 104.02 15.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.916 0.388 . . . . 0.0 111.262 -179.621 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.471 ' O ' ' O ' ' A' ' 44' ' ' VAL . 5.0 m -37.92 161.35 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.301 0.572 . . . . 0.0 111.108 -179.797 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.3 mttp -63.5 -38.71 92.18 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.82 -179.096 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.599 ' O ' ' N ' ' A' ' 49' ' ' CYS . 96.2 mm-40 -108.9 -25.53 10.71 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.264 0.554 . . . . 0.0 110.417 -179.482 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 18.2 t60 38.67 -76.33 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 179.467 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.599 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.57 135.41 46.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.132 0.492 . . . . 0.0 112.018 -178.162 . . . . . . . . 3 3 . 1 . 061 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -130.14 131.0 45.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.808 179.89 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 91.1 mt -115.53 136.03 53.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.222 179.65 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -118.82 128.9 54.9 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.412 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.0 mt -105.67 114.26 44.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.626 -179.508 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.558 ' O ' ' N ' ' A' ' 56' ' ' GLN . 79.7 m-70 -112.22 143.53 43.12 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.336 179.385 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.459 ' C ' ' O ' ' A' ' 54' ' ' HIS . 98.5 mt-10 -40.09 -25.48 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -179.699 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.558 ' N ' ' O ' ' A' ' 54' ' ' HIS . 82.8 mt-30 -67.73 -68.96 0.35 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.407 178.519 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.452 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 4.1 tp10 -160.4 -162.91 1.02 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.724 179.957 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.422 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -111.19 124.41 52.16 Favored 'General case' 0 N--CA 1.461 0.119 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.326 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 79.4 mt -116.58 131.15 70.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.802 -178.36 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.3 tp -96.86 129.83 44.24 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.487 179.836 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -113.13 133.48 55.01 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.235 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -96.26 108.48 20.98 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.496 -179.374 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -99.75 -9.53 22.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.425 179.896 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.9 t -74.17 100.56 3.7 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.508 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.4 m -84.17 -22.7 30.88 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.428 -179.767 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.415 ' O ' ' OD1' ' A' ' 67' ' ' ASN . 0.2 OUTLIER -78.34 -43.72 27.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.147 0.498 . . . . 0.0 110.222 179.993 . . . . . . . . 3 3 . 1 . 061 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.415 ' OD1' ' O ' ' A' ' 66' ' ' THR . 22.8 m-20 -140.88 100.41 6.57 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.749 -179.833 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.48 147.24 79.56 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 121.954 1.77 . . . . 0.0 112.438 -179.656 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.3 m -74.61 151.74 39.33 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.182 179.234 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -111.23 140.67 45.6 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.267 179.932 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.421 ' CG1' ' OD1' ' A' ' 86' ' ' ASP . 55.8 t -129.99 134.39 62.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.962 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 52.08 32.0 9.72 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -179.024 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.89 29.12 67.59 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.528 -179.834 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.7 m -141.82 138.5 32.24 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.583 -179.64 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.5 t -68.22 140.5 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.208 -179.275 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 9.2 pt -113.0 92.18 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 121.272 0.558 . . . . 0.0 110.164 178.306 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -64.83 -29.37 70.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.98 -179.779 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.423 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.8 OUTLIER -125.28 177.78 1.74 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.986 179.383 . . . . . . . . 3 3 . 1 . 061 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.423 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 36.0 Cg_exo -60.43 145.68 98.24 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 122.527 2.152 . . . . 0.0 112.097 179.814 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.8 p -137.73 141.22 39.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-O 121.166 0.507 . . . . 0.0 111.365 -179.778 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 45.3 ttm180 -79.88 131.97 35.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.711 179.68 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 89.3 mt -84.54 138.39 32.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.899 -179.043 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -130.84 152.57 50.03 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.75 179.065 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.435 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 6.9 t60 -55.88 119.09 5.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.84 0.352 . . . . 0.0 110.817 -179.451 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.57 -9.0 35.01 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.824 -0.911 . . . . 0.0 110.824 -179.675 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.421 ' OD1' ' CG1' ' A' ' 71' ' ' VAL . 61.0 t0 -75.61 126.58 31.28 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.727 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 39.9 t -107.35 131.07 58.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.788 -179.032 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.496 ' O ' ' OG ' ' A' ' 94' ' ' SER . 87.4 mt -97.0 131.51 43.62 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.396 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.9 m -122.46 125.38 45.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.566 0.698 . . . . 0.0 112.033 -178.429 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.455 ' O ' ' C ' ' A' ' 91' ' ' ILE . 95.7 mt -113.25 124.35 69.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.471 178.912 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.455 ' C ' ' O ' ' A' ' 90' ' ' ILE . 95.0 mt 35.09 -99.95 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 121.166 -0.213 . . . . 0.0 110.527 -178.612 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -116.41 20.22 14.3 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.025 0.441 . . . . 0.0 110.929 179.745 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.626 ' CZ ' ' CD1' ' A' ' 41' ' ' LEU . 29.9 mtm-85 -130.13 142.34 50.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.473 -179.783 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.496 ' OG ' ' O ' ' A' ' 88' ' ' ILE . 30.2 t -140.48 152.4 45.59 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.637 -179.037 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -123.31 122.0 37.24 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.157 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -83.98 134.13 34.66 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.827 -179.496 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -92.81 120.82 33.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.579 179.807 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -123.2 116.54 23.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.018 179.735 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.435 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 50.9 t-20 -105.48 107.63 18.71 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.329 179.768 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.409 ' HB2' HH22 ' A' ' 6' ' ' ARG . 86.7 tt0 . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.373 -179.334 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 N--CA 1.451 -0.376 0 CA-C-O 120.855 0.36 . . . . 0.0 110.064 . . . . . . . . . 0 0 . 1 . 061 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.512 ' O ' ' CB ' ' B' ' 230' ' ' SEP . 85.4 m-20 53.61 32.69 14.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.4 178.85 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . 0.512 ' CB ' ' O ' ' B' ' 229' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.41 ' NE2' ' O3P' ' B' ' 230' ' ' SEP . 78.1 mm-40 -128.21 62.77 1.43 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.937 -179.002 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -122.39 170.63 15.2 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 -179.861 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -74.35 161.2 40.77 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 123.873 3.048 . . . . 0.0 111.966 179.814 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 061 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -61.69 139.02 78.56 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 121.877 1.718 . . . . 0.0 111.707 179.155 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 42.7 t -61.35 136.36 24.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.628 179.612 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 14.9 t -67.41 123.88 21.61 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.493 -0.483 . . . . 0.0 109.737 -179.787 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . 0.444 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . 0.444 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 51.0 Cg_exo -57.77 -28.35 81.7 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 123.158 2.572 . . . . 0.0 113.25 -179.837 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 20.7 m -72.93 -49.2 30.95 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.299 -0.561 . . . . 0.0 110.091 179.16 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -58.08 -47.49 83.01 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.324 -179.066 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 86.8 mt -64.48 -42.18 96.04 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -179.177 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -65.54 -39.36 91.65 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.201 -0.6 . . . . 0.0 111.099 -179.539 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . 0.42 ' O ' ' OG ' ' B' ' 247' ' ' SER . 81.7 mtp180 -61.84 -42.88 99.57 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.167 -0.613 . . . . 0.0 109.591 179.784 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -63.07 -41.23 99.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.717 -179.846 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -62.1 -42.66 99.45 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.45 0.643 . . . . 0.0 109.89 179.41 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' B' B ' 247' ' ' SER . . . . . 0.42 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 67.3 p -67.83 -43.99 78.27 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.245 -0.888 . . . . 0.0 109.129 178.652 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . 0.417 ' H ' ' HG ' ' B' ' 247' ' ' SER . 52.5 tt0 -61.39 -39.49 90.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.388 179.882 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . 0.41 HG13 ' N ' ' B' ' 250' ' ' ALA . 0.4 OUTLIER -60.79 -42.1 91.04 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.872 179.674 . . . . . . . . 3 3 . 1 . 061 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . 0.41 ' N ' HG13 ' B' ' 249' ' ' VAL . . . -60.31 -33.09 71.88 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.271 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -81.57 -13.25 58.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.257 177.877 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.415 ' O ' ' HB2' ' B' ' 253' ' ' ASN . 1.3 tp -110.94 -172.07 1.95 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.674 179.268 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . 0.415 ' HB2' ' O ' ' B' ' 252' ' ' LEU . 12.7 m120 80.91 32.55 0.14 Allowed 'General case' 0 N--CA 1.464 0.242 0 O-C-N 123.912 0.758 . . . . 0.0 111.138 -179.881 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . 0.44 ' N ' ' OD1' ' B' ' 254' ' ' ASP . 21.9 p-10 -63.03 -33.75 76.09 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.168 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . 0.529 ' O ' ' CB ' ' B' ' 256' ' ' ASP . 82.2 m-20 -115.15 -67.92 0.96 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.055 179.029 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.529 ' CB ' ' O ' ' B' ' 255' ' ' ASP . 4.3 m-20 96.81 39.9 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.429 -179.256 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . 0.439 ' C ' ' HZ2' ' A' ' 11' ' ' LYS . 71.5 mmtt -116.69 -22.14 8.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.627 -179.734 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.698 ' N ' ' HZ2' ' A' ' 11' ' ' LYS . 30.0 p-10 -144.82 126.81 15.49 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.941 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -139.79 84.15 1.96 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 119.682 -0.807 . . . . 0.0 112.975 -179.046 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 59.77 12.09 2.8 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 177.223 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 80.8 mt -119.46 132.33 69.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.35 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 51.1 t -126.79 135.61 63.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.021 0.439 . . . . 0.0 110.874 -179.69 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -94.59 117.44 30.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.186 0.517 . . . . 0.0 110.78 -179.176 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . 0.407 ' NZ ' ' HA ' ' A' ' 34' ' ' GLU . 88.8 tttt -70.53 -44.23 67.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.79 -179.69 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . 0.477 ' NE2' ' HG ' ' A' ' 23' ' ' SER . 0.1 OUTLIER -94.68 162.18 26.39 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.771 -179.032 . . . . . . . . 3 3 . 1 . 061 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -59.94 151.74 69.52 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.9 2.4 . . . . 0.0 111.588 179.364 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 47.8 pt . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 121.44 0.638 . . . . 0.0 111.827 -178.708 . . . . . . . . 0 0 . 1 . 062 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo . . . . . 0 N--CA 1.489 1.255 0 CA-C-O 120.745 0.227 . . . . 0.0 111.668 . . . . . . . . . 0 0 . 1 . 062 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 30.3 p -72.94 -40.76 65.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.629 -179.863 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.436 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 93.7 mtt-85 -91.68 131.2 37.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.819 -179.27 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -135.23 144.62 47.0 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.452 179.312 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 69.3 mt -119.64 146.46 45.54 Favored 'General case' 0 CA--C 1.527 0.083 0 CA-C-O 121.025 0.44 . . . . 0.0 111.451 -179.389 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.2 t -117.87 129.79 73.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.584 178.9 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 m -91.35 114.46 27.0 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.933 0.397 . . . . 0.0 111.067 -179.631 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 92.9 mt -81.11 144.66 10.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.282 179.508 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -84.78 150.76 24.83 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.339 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.606 ' NH1' ' NH1' ' B' ' 245' ' ' ARG . 87.8 mtm180 -58.28 -24.99 61.26 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -179.888 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.1 t -76.73 -13.03 60.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.876 178.738 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.97 35.27 6.82 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 179.946 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.0 t -121.39 135.6 61.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.734 0.302 . . . . 0.0 110.888 -179.861 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -71.29 118.67 14.38 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.886 179.384 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -111.38 -126.43 4.87 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 120.976 -0.631 . . . . 0.0 111.751 -179.017 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.63 148.68 42.38 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.236 1.958 . . . . 0.0 112.196 -179.239 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -105.77 154.57 20.3 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.647 179.801 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.416 ' CD2' HD13 ' A' ' 37' ' ' ILE . 51.5 t80 -122.44 92.37 49.01 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.1 -179.33 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -74.16 139.92 27.3 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 121.331 1.354 . . . . 0.0 111.557 -179.517 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.3 mt -102.54 125.29 49.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.22 0.533 . . . . 0.0 111.798 -178.176 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 61.6 p -121.71 -2.73 9.31 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.381 -0.827 . . . . 0.0 108.806 178.292 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.9 mt -104.82 147.17 28.02 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.154 -179.203 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 90.6 p -68.63 -17.15 64.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.001 -178.912 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 44.2 m -128.53 131.78 48.27 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.365 0.603 . . . . 0.0 111.997 -179.121 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.683 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -128.52 121.6 29.22 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.188 178.896 . . . . . . . . 3 3 . 1 . 062 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.516 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 42.8 tp -120.76 126.43 50.13 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -178.208 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.683 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 66.0 m-85 -103.08 145.14 30.35 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 178.616 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 155.64 -169.87 33.49 Favored Glycine 0 C--N 1.321 -0.27 0 C-N-CA 119.886 -1.15 . . . . 0.0 112.273 178.611 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 33.2 ttp-105 -86.64 -31.11 21.28 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -179.624 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -57.09 152.09 25.24 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-N 116.217 -0.447 . . . . 0.0 112.168 -178.977 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.421 ' CD1' ' CZ ' ' A' ' 38' ' ' ARG . 37.5 mm -63.93 -44.04 97.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-O 120.766 0.317 . . . . 0.0 110.93 179.93 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -55.74 -17.5 6.14 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.095 -179.075 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 83.2 m -64.05 119.65 10.53 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.662 -179.71 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.589 ' OD2' ' SG ' ' A' ' 27' ' ' CYS . 12.0 p-10 -56.54 -24.07 44.26 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.97 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.449 ' N ' ' OD1' ' A' ' 36' ' ' ASP . 45.2 mm -126.17 116.33 45.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.1 -0.955 . . . . 0.0 108.761 176.803 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.421 ' CZ ' ' CD1' ' A' ' 33' ' ' ILE . 84.5 mtp180 -100.97 132.24 46.48 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -179.195 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.417 HG23 HD12 ' A' ' 39' ' ' ILE . 96.6 mt -123.08 131.53 73.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.173 0.511 . . . . 0.0 111.058 -179.341 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -81.75 35.18 0.41 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.642 -178.628 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.58 ' CD2' ' CZ ' ' B' ' 245' ' ' ARG . 40.3 mt -100.17 115.72 65.21 Favored Pre-proline 0 C--N 1.325 -0.494 0 C-N-CA 120.388 -0.525 . . . . 0.0 110.391 179.502 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -56.22 -15.4 14.42 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 121.944 1.763 . . . . 0.0 112.421 178.794 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.9 m -98.24 8.32 7.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.556 -179.583 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.7 t -99.21 132.51 44.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.103 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.2 m -71.96 169.06 16.7 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.585 0.707 . . . . 0.0 111.775 -178.829 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -64.78 -40.69 95.67 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.671 -1.15 . . . . 0.0 111.457 -179.076 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.602 ' O ' ' N ' ' A' ' 49' ' ' CYS . 93.7 mm-40 -106.91 -23.86 12.22 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.259 0.552 . . . . 0.0 110.036 179.821 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.6 t60 38.17 -78.46 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.144 -0.935 . . . . 0.0 112.975 179.487 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.602 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.1 OUTLIER -135.36 137.0 41.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.226 0.536 . . . . 0.0 111.767 -178.428 . . . . . . . . 3 3 . 1 . 062 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -124.74 128.22 48.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.603 179.155 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 82.4 mt -111.07 131.49 62.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.852 179.303 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -114.29 132.49 56.15 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.371 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.448 HG22 HD13 ' A' ' 53' ' ' ILE . 43.4 mm -103.33 114.32 42.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 120.161 -0.616 . . . . 0.0 111.106 -179.278 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.449 ' O ' ' C ' ' A' ' 55' ' ' GLU . 96.9 m-70 -116.71 137.17 52.39 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.633 179.195 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 54' ' ' HIS . 80.2 mm-40 -39.95 -35.73 0.39 Allowed 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.057 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -60.27 -68.63 0.28 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.013 178.804 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.582 ' OE2' ' NH1' ' A' ' 81' ' ' ARG . 9.5 pt-20 -160.37 -158.46 0.62 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.327 178.88 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -120.95 133.96 55.29 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.764 0.316 . . . . 0.0 110.917 -179.648 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 87.6 mt -116.83 131.4 69.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.3 0.571 . . . . 0.0 112.457 -178.837 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.465 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 37.5 tp -95.22 126.91 40.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.695 179.833 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -116.0 134.34 55.07 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.668 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -98.96 105.23 17.35 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.787 -179.369 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -96.83 -7.89 32.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.301 179.134 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.96 99.47 6.85 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.069 0.461 . . . . 0.0 110.627 179.906 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 91.5 p -78.39 -33.09 49.04 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.945 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.2 m -66.9 -46.09 75.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.072 -179.351 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -146.05 97.27 4.51 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.835 -179.118 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.6 146.67 52.58 Favored 'Trans proline' 0 N--CA 1.501 1.958 0 C-N-CA 122.625 2.217 . . . . 0.0 113.585 -179.965 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 93.4 m -72.14 138.74 47.91 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.463 178.669 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -102.35 140.73 36.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.092 -179.918 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.6 t -131.36 139.69 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.118 178.568 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 8.9 m120 52.36 32.4 11.04 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.346 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.09 30.23 65.64 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.51 179.185 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.7 m -146.2 143.76 29.47 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 117.659 0.729 . . . . 0.0 111.798 -179.825 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 74.8 t -69.8 138.35 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.235 -179.376 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.536 ' CG2' ' O ' ' A' ' 78' ' ' GLU . 95.6 mt -105.15 100.31 10.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.569 179.744 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -65.94 -39.56 90.58 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.599 179.57 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.536 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.1 OUTLIER -129.63 177.48 2.16 Favored Pre-proline 0 N--CA 1.466 0.374 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.405 -178.989 . . . . . . . . 3 3 . 1 . 062 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.423 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 33.8 Cg_exo -58.93 145.05 98.53 Favored 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 122.56 2.173 . . . . 0.0 112.54 -179.45 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.4 p -142.68 141.32 27.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.508 -179.778 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.582 ' NH1' ' OE2' ' A' ' 57' ' ' GLU . 93.9 mtt-85 -73.85 133.09 43.12 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.613 -179.507 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 94.3 mt -87.15 139.24 30.77 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.356 0.598 . . . . 0.0 111.76 -179.17 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -130.89 155.36 46.88 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.727 -179.566 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.507 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 5.9 t60 -56.22 118.51 4.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.803 0.335 . . . . 0.0 110.229 -179.748 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.31 -12.52 26.13 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.367 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.405 ' C ' ' OD1' ' A' ' 86' ' ' ASP . 48.1 t0 -68.99 128.19 35.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.851 0.358 . . . . 0.0 110.605 179.762 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 53.6 t -109.81 131.84 59.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.78 -178.81 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.499 ' O ' ' OG ' ' A' ' 94' ' ' SER . 5.4 mm -94.65 127.79 46.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.091 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 53.1 m -118.14 124.93 49.21 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.881 -179.558 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.444 ' O ' ' C ' ' A' ' 91' ' ' ILE . 96.0 mt -122.19 126.18 73.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.26 179.321 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.445 HG21 HD13 ' A' ' 91' ' ' ILE . 31.8 mm 35.87 -109.55 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.01 -179.464 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -103.1 11.59 36.94 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.755 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.555 ' NH2' ' OE1' ' B' ' 260' ' ' GLU . 17.4 ptp180 -130.88 147.25 52.51 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.827 179.822 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.499 ' OG ' ' O ' ' A' ' 88' ' ' ILE . 29.8 t -137.07 152.75 50.4 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.736 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -121.35 121.47 37.72 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.73 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -85.18 129.54 34.78 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.004 -0.679 . . . . 0.0 110.515 -179.112 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.565 ' HH ' ' ND2' ' A' ' 99' ' ' ASN . 24.3 t80 -97.37 122.83 40.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.093 0.473 . . . . 0.0 110.236 179.869 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -121.86 123.26 41.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.062 179.849 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.565 ' ND2' ' HH ' ' A' ' 97' ' ' TYR . 20.6 t-20 -101.24 108.23 19.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.888 -179.51 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 . . . . . 0 C--N 1.329 -0.313 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.295 . . . . . . . . 0 0 . 1 . 062 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 54.7 t . . . . . 0 N--CA 1.455 -0.204 0 CA-C-O 120.87 0.367 . . . . 0.0 110.52 . . . . . . . . . 0 0 . 1 . 062 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.488 ' C ' ' H ' ' B' ' 231' ' ' GLN . 97.1 m-20 -73.29 141.94 47.17 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.515 179.834 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . 0.427 ' N ' ' O3P' ' B' ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.488 ' H ' ' C ' ' B' ' 229' ' ' ASP . 72.9 mt-30 -128.3 35.24 4.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.324 179.937 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -119.02 -164.53 12.82 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.487 -178.647 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.5 150.32 76.43 Favored 'Trans proline' 0 N--CA 1.501 1.95 0 C-N-CA 124.411 3.407 . . . . 0.0 113.618 -179.494 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 062 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.26 140.11 69.2 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.085 1.857 . . . . 0.0 114.041 -179.415 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -75.1 139.38 19.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 113.939 -1.482 . . . . 0.0 111.017 -179.244 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.9 t -75.89 125.05 28.35 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.225 -179.975 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 062 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -58.5 -25.26 73.33 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 122.833 2.355 . . . . 0.0 113.164 -179.233 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 16.7 m -73.14 -47.27 45.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.258 0.551 . . . . 0.0 110.434 179.385 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -57.88 -46.81 84.32 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.633 -178.932 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 96.7 mt -63.55 -42.32 98.37 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.669 -179.241 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -66.1 -39.1 89.71 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.338 -179.668 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . 0.535 ' NH1' ' OE1' ' B' ' 248' ' ' GLN . 78.4 ttt-85 -59.83 -45.72 91.52 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.953 -179.593 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.606 ' NH1' ' NH1' ' A' ' 12' ' ' ARG . 95.6 mtt-85 -65.81 -37.14 85.45 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.483 -179.5 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -60.28 -40.65 91.16 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.817 179.667 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 78.2 p -69.97 -43.02 72.36 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.108 0.48 . . . . 0.0 110.103 178.948 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . 0.535 ' OE1' ' NH1' ' B' ' 244' ' ' ARG . 88.0 mt-30 -64.19 -36.69 84.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.321 -179.768 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 60.4 t -64.1 -45.79 95.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.356 -0.538 . . . . 0.0 109.912 179.444 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -64.22 -24.12 67.55 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 179.252 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -95.31 -4.02 46.3 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.946 -179.936 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 42.8 mt -109.48 129.14 55.57 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.989 0.423 . . . . 0.0 111.255 179.318 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -57.54 148.5 23.75 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.16 -179.623 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . 0.438 ' N ' ' OD1' ' B' ' 254' ' ' ASP . 32.2 p-10 -74.02 -10.13 59.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.2 179.704 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -87.38 2.97 48.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.278 -179.353 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -82.14 94.73 7.3 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.131 -0.627 . . . . 0.0 109.513 178.834 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . 0.442 ' HG2' ' H ' ' B' ' 258' ' ' ASP . 70.4 tttt -68.24 168.52 12.17 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.801 -179.063 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.442 ' H ' ' HG2' ' B' ' 257' ' ' LYS . 87.6 m-20 61.3 71.67 0.55 Allowed 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.39 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -85.59 72.69 10.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.417 -178.944 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.57 ' CD ' HH12 ' B' ' 245' ' ' ARG . 97.0 mt-10 57.45 10.63 0.99 Allowed 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 177.562 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . 0.41 ' CG1' HH11 ' A' ' 93' ' ' ARG . 69.8 mt -118.43 132.37 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 178.079 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 52.3 t -124.89 132.74 70.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.232 179.46 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -93.42 117.11 29.68 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.135 0.493 . . . . 0.0 110.897 -178.259 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -67.4 -45.97 74.61 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.393 -179.87 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 25.6 mm100 -88.6 153.34 50.25 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.887 -178.729 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -61.28 147.19 96.25 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.448 2.099 . . . . 0.0 112.253 179.362 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.4 pt . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.282 -179.329 . . . . . . . . 0 0 . 1 . 063 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo . . . . . 0 N--CA 1.506 2.258 0 N-CA-C 113.058 0.369 . . . . 0.0 113.058 . . . . . . . . . 0 0 . 1 . 063 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 46.0 p -102.44 -58.5 1.86 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.238 0.542 . . . . 0.0 110.368 178.867 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.8 mtt85 -85.92 131.05 34.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.324 -179.592 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -129.09 139.41 52.0 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.348 179.975 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 32.7 tp -116.49 133.31 56.16 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.836 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 70.7 t -112.42 131.06 64.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.068 0.461 . . . . 0.0 110.174 -179.293 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.8 m -80.99 144.5 31.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.769 0.795 . . . . 0.0 112.472 -178.236 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.534 ' CD1' ' OD1' ' A' ' 16' ' ' ASP . 48.5 mm -111.86 135.78 50.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.54 178.389 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -93.48 157.95 15.96 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.318 0.58 . . . . 0.0 110.31 178.433 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.451 ' HD3' HH21 ' B' ' 245' ' ' ARG . 88.5 mtm180 -58.02 -23.49 54.42 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.435 -179.514 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 87.7 p -80.08 -13.13 59.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.329 179.913 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.19 20.06 34.07 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.56 179.228 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.4 m -115.65 138.21 46.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.166 179.301 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.534 ' OD1' ' CD1' ' A' ' 10' ' ' ILE . 83.1 m-20 -70.3 139.97 52.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.11 -179.91 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -126.22 -120.21 2.37 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 121.063 -0.589 . . . . 0.0 111.634 -179.638 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.38 146.1 39.33 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.018 1.812 . . . . 0.0 113.117 -178.621 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -104.82 145.64 30.1 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.09 179.468 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -119.45 103.5 46.67 Favored Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.496 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -73.64 130.06 14.34 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 121.617 1.544 . . . . 0.0 112.588 -178.433 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.2 mt -85.87 57.05 4.25 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.104 -178.666 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.59 -33.07 74.22 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.479 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.7 mt -74.91 142.5 44.01 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.139 179.791 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.59 -14.98 63.37 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.186 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.529 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 54.4 m -132.13 132.13 42.96 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.842 -179.798 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.5 t -124.57 117.16 23.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.804 178.683 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 32.6 tp -115.44 126.23 54.08 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.447 -178.96 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.493 ' O ' ' O ' ' A' ' 47' ' ' GLN . 4.8 m-85 -107.11 138.92 42.39 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.831 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.13 -168.78 37.29 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 120.071 -1.061 . . . . 0.0 112.577 179.424 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.711 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 83.9 mtm-85 -82.54 -26.68 32.24 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.744 0.307 . . . . 0.0 110.585 -179.753 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.474 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -61.69 134.62 47.13 Favored Glycine 0 N--CA 1.466 0.644 0 C-N-CA 121.354 -0.45 . . . . 0.0 112.349 -178.018 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.431 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 10.7 tp -62.79 -41.43 92.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.101 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.431 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 83.8 tt0 -51.87 -16.09 0.64 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.883 179.137 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.474 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 40.8 m -70.54 142.4 51.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.751 179.709 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.529 ' OD2' ' O ' ' A' ' 26' ' ' THR . 59.1 m-20 -60.96 -34.08 74.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.703 -179.736 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.438 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 85.1 mt -129.89 124.31 58.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.031 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 70.6 ttp85 -109.63 138.45 45.98 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.18 -179.407 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 97.7 mt -116.6 131.36 69.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.687 -179.433 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -74.82 30.78 0.09 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -178.083 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.616 ' CD1' ' CZ ' ' A' ' 93' ' ' ARG . 17.3 mt -110.36 129.81 23.55 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 120.132 -0.627 . . . . 0.0 111.954 179.921 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.48 -10.38 26.76 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.567 2.178 . . . . 0.0 112.971 -179.878 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.7 m -95.83 -1.88 10.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 121.056 -0.258 . . . . 0.0 111.407 -179.827 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.711 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 53.4 t -87.24 135.85 24.34 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.54 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.994 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.427 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 0.6 OUTLIER -62.55 162.39 10.49 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.248 0.547 . . . . 0.0 111.551 -179.183 . . . . . . . . 3 3 . 1 . 063 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -62.57 -45.1 94.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.857 -178.861 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.642 ' O ' ' N ' ' A' ' 49' ' ' CYS . 85.8 mt-30 -113.81 -12.69 12.69 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 123.937 0.773 . . . . 0.0 110.243 179.397 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.427 ' H ' ' HB3' ' A' ' 45' ' ' SER . 10.3 t60 31.01 -72.7 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 179.305 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.642 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.5 135.26 46.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.396 0.617 . . . . 0.0 112.196 -178.233 . . . . . . . . 3 3 . 1 . 063 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -126.92 128.85 47.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.054 179.307 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.2 mt -115.18 134.54 57.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.971 -179.808 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -111.98 131.35 55.45 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.039 179.036 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 51.5 mm -101.55 110.4 28.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 120.144 -0.622 . . . . 0.0 111.015 179.617 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.465 ' O ' ' C ' ' A' ' 55' ' ' GLU . 97.7 m-70 -113.54 135.33 54.01 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.267 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.465 ' C ' ' O ' ' A' ' 54' ' ' HIS . 93.2 mt-10 -41.2 -32.0 0.25 Allowed 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -179.998 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.454 ' N ' ' C ' ' A' ' 54' ' ' HIS . 99.8 mm-40 -65.23 -68.26 0.38 Allowed 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.638 178.402 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.478 ' HG3' ' NE ' ' A' ' 81' ' ' ARG . 1.0 OUTLIER -155.13 -171.84 3.96 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.539 0.685 . . . . 0.0 111.499 -179.638 . . . . . . . . 3 3 . 1 . 063 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -115.24 122.53 46.27 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.477 178.781 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.0 mt -114.55 133.58 60.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.258 0.551 . . . . 0.0 111.675 -178.423 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 21.5 tp -97.6 128.3 44.22 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.779 -179.751 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -110.45 133.61 53.12 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.09 179.689 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.411 HD22 ' HA ' ' A' ' 68' ' ' PRO . 60.8 t-20 -90.88 106.98 18.89 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.193 -179.589 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -97.95 -11.08 23.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.376 179.202 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 54.1 p -74.15 100.74 3.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.043 0.449 . . . . 0.0 110.923 179.82 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.1 p -86.2 -14.26 44.47 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.249 179.542 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.72 -42.98 8.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.954 -179.886 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.462 ' O ' ' OG ' ' A' ' 64' ' ' SER . 34.4 m-80 -136.93 99.3 10.18 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.369 179.887 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.411 ' HA ' HD22 ' A' ' 62' ' ' ASN . 49.2 Cg_exo -54.39 143.86 64.13 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.15 1.9 . . . . 0.0 112.985 -179.585 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.3 m -77.16 141.5 40.11 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.824 179.192 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -107.3 138.8 42.82 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.435 0.636 . . . . 0.0 110.821 179.975 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 66.8 t -131.4 135.07 60.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.494 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 53.84 32.35 14.89 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.035 -0.666 . . . . 0.0 110.398 -179.469 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.18 29.63 66.29 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.8 178.296 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 73.3 m -146.51 138.2 24.64 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.496 -0.482 . . . . 0.0 111.05 179.302 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -69.42 144.26 14.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.974 179.739 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.8 pt -119.14 95.09 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.133 179.048 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 78' ' ' GLU . 49.0 p-10 -71.09 -24.01 62.23 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.254 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.491 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 5.5 mt-10 -118.92 163.96 23.49 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.745 179.545 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -62.23 150.1 88.17 Favored 'Trans proline' 0 N--CA 1.501 1.943 0 C-N-CA 122.656 2.237 . . . . 0.0 112.483 179.78 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.0 p -140.54 143.87 28.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-O 121.478 0.656 . . . . 0.0 112.352 -179.003 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.478 ' NE ' ' HG3' ' A' ' 57' ' ' GLU . 68.2 ttt180 -73.33 126.79 30.95 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.558 179.245 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.0 mt -82.13 132.43 35.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.956 0.407 . . . . 0.0 110.955 -179.623 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -123.57 149.22 45.55 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.706 179.284 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.45 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 5.2 t60 -52.44 121.01 6.22 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.962 -179.249 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.01 -13.67 45.02 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.529 -0.629 . . . . 0.0 111.529 179.676 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -71.21 139.22 50.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.954 0.407 . . . . 0.0 111.095 -179.939 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.7 t -117.92 130.18 73.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.468 -178.5 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 92.7 mt -94.0 131.93 39.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.225 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.8 m -115.91 127.6 55.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.307 0.575 . . . . 0.0 112.252 -178.568 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.534 ' O ' ' N ' ' A' ' 93' ' ' ARG . 93.5 mt -125.87 124.8 67.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.176 178.346 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.537 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 72.2 mt -3.61 89.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -179.856 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.537 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 8.9 t0 86.84 -15.44 0.44 Allowed 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 177.158 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.73 ' NH1' HH22 ' B' ' 245' ' ' ARG . 23.3 mtm-85 -131.27 145.82 52.05 Favored 'General case' 0 CA--C 1.512 -0.519 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.698 -179.127 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.8 p -138.0 156.13 48.15 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 121.134 0.493 . . . . 0.0 110.164 179.567 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -130.08 122.12 27.71 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.536 -179.292 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 44.5 ttm180 -84.66 128.62 34.7 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 120.446 -0.502 . . . . 0.0 111.202 -179.616 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 92.9 t80 -91.88 125.33 36.54 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.616 179.947 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -126.5 121.22 31.73 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.807 179.539 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.491 ' O ' ' O ' ' A' ' 100' ' ' GLU . 64.8 t-20 -98.45 107.15 19.53 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.393 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.491 ' O ' ' O ' ' A' ' 99' ' ' ASN . 95.6 mt-10 . . . . . 0 C--N 1.33 -0.265 0 C-N-CA 120.561 -0.455 . . . . 0.0 109.824 -179.239 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 60.2 t . . . . . 0 N--CA 1.456 -0.163 0 CA-C-O 120.776 0.322 . . . . 0.0 110.164 . . . . . . . . . 0 0 . 1 . 063 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -143.12 94.65 2.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.965 179.508 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 063 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -131.43 30.06 4.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.033 0.444 . . . . 0.0 110.026 179.672 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -124.84 -152.48 8.31 Favored Glycine 0 CA--C 1.534 1.219 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.436 -178.822 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.41 148.71 70.15 Favored 'Trans proline' 0 N--CA 1.5 1.872 0 C-N-CA 123.614 2.876 . . . . 0.0 113.173 -179.327 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 063 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -58.03 166.84 5.02 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.829 2.352 . . . . 0.0 111.787 179.102 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 2.4 p -114.03 135.74 52.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.129 179.746 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -68.73 123.14 20.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.18 0.514 . . . . 0.0 110.071 -179.878 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 063 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -50.06 -20.15 4.9 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 121.983 1.789 . . . . 0.0 112.257 179.674 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 27.4 p -77.08 -39.67 48.92 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.24 178.274 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -58.99 -47.04 86.58 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.934 -179.798 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 80.2 mt -67.27 -39.63 86.08 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.127 179.033 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -65.22 -40.88 94.69 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.824 -178.903 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 78.1 ttt-85 -63.01 -43.67 98.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 120.431 -0.507 . . . . 0.0 110.557 -179.553 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.73 HH22 ' NH1' ' A' ' 93' ' ' ARG . 85.6 mtp180 -64.53 -37.32 87.15 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.678 -178.894 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.27 -40.15 96.59 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.095 178.811 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 44.6 t -64.07 -44.18 93.18 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.701 0.763 . . . . 0.0 109.211 178.499 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . 0.502 ' O ' ' N ' ' B' ' 252' ' ' LEU . 93.8 mm-40 -62.41 -36.32 81.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.263 179.727 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 60.0 t -62.34 -46.47 96.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.307 179.708 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -63.42 -27.19 69.12 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.422 0.63 . . . . 0.0 109.568 179.125 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -94.44 -7.84 40.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.74 179.176 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.502 ' N ' ' O ' ' B' ' 248' ' ' GLN . 38.2 tp -108.09 126.85 53.24 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.329 0.585 . . . . 0.0 111.356 -179.233 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -57.94 142.33 46.64 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.924 -179.16 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -73.2 -8.31 55.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.678 179.188 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . 0.41 ' OD1' ' C ' ' B' ' 255' ' ' ASP . 40.3 p-10 -82.07 3.6 26.22 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.349 -179.05 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -80.24 90.54 5.53 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.867 179.702 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . 0.567 ' C ' ' H ' ' B' ' 259' ' ' ASP . 99.7 mttt -83.07 4.71 25.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.42 -178.399 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.544 ' O ' ' C ' ' B' ' 259' ' ' ASP . 87.1 m-20 -76.4 15.78 0.56 Allowed 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.441 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.678 ' C ' ' H ' ' B' ' 261' ' ' ILE . 51.1 p-10 -15.15 123.74 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.916 179.562 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -53.32 8.41 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.805 -179.189 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . 0.678 ' H ' ' C ' ' B' ' 259' ' ' ASP . 64.1 mt -108.46 135.13 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.735 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 78.4 t -127.98 136.45 60.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.913 0.387 . . . . 0.0 109.961 -179.684 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -99.68 121.11 40.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.42 -178.398 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -66.52 -45.51 79.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.932 179.217 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.41 152.2 47.21 Favored Pre-proline 0 CA--C 1.52 -0.199 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.283 -179.448 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -62.5 140.51 82.21 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.754 2.303 . . . . 0.0 112.234 -179.831 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 41.8 pt . . . . . 0 C--N 1.322 -0.599 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.01 179.14 . . . . . . . . 0 0 . 1 . 064 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo . . . . . 0 N--CA 1.497 1.682 0 CA-C-O 120.905 0.294 . . . . 0.0 112.322 . . . . . . . . . 0 0 . 1 . 064 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 60.1 p -115.91 -46.23 2.84 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.642 179.76 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.9 mtt85 -90.65 126.84 36.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.505 -179.676 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -135.95 146.43 47.27 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.384 -0.526 . . . . 0.0 111.688 -179.646 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 73.3 mt -114.41 142.83 45.85 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.021 179.358 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.2 t -118.31 130.34 73.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.195 179.686 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 50.0 m -79.22 135.44 36.79 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.294 0.569 . . . . 0.0 111.956 -178.843 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.6 mt -112.51 138.11 42.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.301 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.521 ' HZ2' ' C ' ' B' ' 257' ' ' LYS . 66.4 mttm -91.71 157.15 17.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.089 0.471 . . . . 0.0 111.507 -179.009 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 85.7 mtm-85 -58.27 -24.42 59.36 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.6 -178.623 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 86.2 p -84.78 -7.92 59.02 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.261 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.44 38.8 6.53 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.82 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.9 t -122.14 134.54 65.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.897 0.38 . . . . 0.0 111.416 -179.709 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -77.09 122.53 25.1 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.705 179.824 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -114.75 -122.85 3.68 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.657 -179.435 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.38 148.99 34.56 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.406 2.071 . . . . 0.0 112.914 -178.985 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -103.97 153.8 20.4 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.919 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -124.23 91.15 49.96 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.245 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.0 139.71 36.5 Favored 'Trans proline' 0 C--N 1.315 -1.191 0 C-N-CA 121.253 1.302 . . . . 0.0 111.785 -179.299 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 83.1 mt -101.23 122.53 43.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.265 0.555 . . . . 0.0 111.187 -178.866 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.6 p -117.76 -6.74 11.05 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.47 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 67.2 mt -102.79 148.31 25.77 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.555 -179.623 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.9 m -72.53 -14.49 61.66 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.438 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.417 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 31.5 m -127.92 129.42 46.81 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.411 -179.799 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.2 t -123.91 119.34 29.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.272 178.268 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.5 tp -116.3 130.23 56.67 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.94 0.4 . . . . 0.0 111.355 -178.084 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.654 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 5.7 m-85 -109.4 138.98 44.94 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.011 -179.897 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 148.08 -171.83 28.48 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.081 178.944 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 47.6 mtm180 -79.1 -32.75 44.74 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 -179.919 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.557 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -45.32 147.63 1.85 Allowed Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 -178.751 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 36.2 mm -63.88 -43.51 97.82 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 CA-C-O 120.921 0.391 . . . . 0.0 110.149 179.958 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -56.87 -21.25 28.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.955 -179.654 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.557 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 59.7 m -52.87 115.16 1.69 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.133 -179.667 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.417 ' OD2' ' O ' ' A' ' 26' ' ' THR . 79.3 m-20 -57.16 -21.6 34.07 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -179.697 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.454 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 98.9 mt -132.25 122.24 47.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.124 -0.943 . . . . 0.0 109.334 177.037 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -104.77 135.94 45.22 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 -179.791 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 95.1 mt -115.26 127.72 72.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.615 -179.99 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -69.94 40.08 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -177.361 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.64 ' CD1' ' NH1' ' A' ' 93' ' ' ARG . 20.5 mt -124.18 132.32 24.29 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.957 -179.934 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.08 -7.2 19.57 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.679 2.252 . . . . 0.0 112.931 -179.509 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.2 m -99.8 2.25 10.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.685 179.53 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 29.4 t -87.94 136.54 22.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.345 179.526 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.2 m -65.9 157.2 31.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.182 0.515 . . . . 0.0 111.179 -179.659 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -62.74 -43.65 98.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.161 -178.888 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.638 ' O ' ' N ' ' A' ' 49' ' ' CYS . 96.7 mt-30 -113.99 -15.0 12.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.957 0.408 . . . . 0.0 110.511 179.677 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 18.3 t60 28.38 -74.86 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 178.875 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.654 ' SG ' ' CD1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -128.23 133.96 48.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.258 0.552 . . . . 0.0 112.436 -178.666 . . . . . . . . 3 3 . 1 . 064 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -127.63 131.05 49.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.122 179.17 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.4 mt -115.39 133.63 61.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.894 -179.56 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -113.84 123.01 48.77 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.345 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.0 mt -105.62 113.8 43.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.448 0.642 . . . . 0.0 111.778 -178.662 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.422 ' O ' ' N ' ' A' ' 56' ' ' GLN . 82.2 m-70 -114.6 144.44 43.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.592 179.783 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 54' ' ' HIS . 78.2 mm-40 -41.07 -29.5 0.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.02 -179.02 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.422 ' N ' ' O ' ' A' ' 54' ' ' HIS . 95.7 mt-30 -64.73 -68.93 0.32 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.031 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.1 -166.1 1.99 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.061 179.86 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.29 127.89 56.29 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.324 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.404 HG21 HD12 ' A' ' 59' ' ' ILE . 95.5 mt -115.52 127.88 72.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.098 0.475 . . . . 0.0 111.795 -179.211 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 24.8 tp -97.42 126.95 42.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.043 179.596 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -111.2 135.33 51.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.858 179.925 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.521 ' ND2' ' H ' ' A' ' 69' ' ' THR . 22.0 t-20 -98.83 106.9 19.22 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.974 -179.705 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -95.09 -6.64 41.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.534 178.994 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.5 t -71.65 99.84 2.18 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.493 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 79.0 p -87.21 -16.52 35.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.275 179.823 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.72 -42.82 10.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.278 -179.806 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 56.8 m-20 -139.25 97.96 8.42 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.983 -179.802 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -56.67 146.0 78.95 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 122.321 2.014 . . . . 0.0 113.156 -179.435 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.521 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 2.9 m -76.68 149.95 36.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.59 179.492 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -110.77 140.03 45.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.154 -179.653 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.42 ' CG1' ' OD1' ' A' ' 86' ' ' ASP . 60.6 t -131.09 135.3 60.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.386 -0.824 . . . . 0.0 108.87 179.624 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 51.59 33.35 10.51 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 119.834 -0.747 . . . . 0.0 109.103 -179.835 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.3 25.96 71.65 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.066 179.531 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 67.6 m -142.18 139.91 32.22 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 117.503 0.651 . . . . 0.0 111.561 179.948 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -68.13 143.91 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.185 179.897 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.4 pt -116.05 94.38 3.08 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-O 121.166 0.507 . . . . 0.0 110.479 179.111 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -67.21 -25.83 66.31 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.739 179.762 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.478 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.1 OUTLIER -129.98 179.73 1.24 Allowed Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.818 -179.876 . . . . . . . . 3 3 . 1 . 064 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.478 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 23.8 Cg_exo -62.06 146.83 96.02 Favored 'Trans proline' 0 N--CA 1.5 1.878 0 C-N-CA 123.087 2.524 . . . . 0.0 112.703 -179.379 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.4 m -142.41 137.97 29.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.813 -179.748 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 85.2 mtt85 -73.33 129.35 37.83 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.258 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.3 mt -83.17 137.6 33.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.942 0.401 . . . . 0.0 110.493 179.987 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -131.49 156.7 45.2 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.614 -179.883 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.585 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 3.6 t-160 -59.07 118.64 6.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.029 0.442 . . . . 0.0 110.115 -179.899 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.12 -8.0 35.61 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 -179.046 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.42 ' OD1' ' CG1' ' A' ' 71' ' ' VAL . 64.4 t0 -77.2 126.99 31.84 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.478 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 13.0 p -107.16 137.47 37.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.471 -178.897 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.49 ' O ' ' OG ' ' A' ' 94' ' ' SER . 83.3 mt -103.9 128.22 57.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.502 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.5 m -123.17 126.56 47.23 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 121.624 0.726 . . . . 0.0 112.82 -178.243 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.474 ' O ' ' C ' ' A' ' 91' ' ' ILE . 97.9 mt -117.51 126.88 74.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.988 178.547 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.474 ' C ' ' O ' ' A' ' 90' ' ' ILE . 96.8 mt 32.79 -98.73 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.669 -179.499 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -112.13 12.1 20.45 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -179.84 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.64 ' NH1' ' CD1' ' A' ' 41' ' ' LEU . 39.6 mtm-85 -126.19 142.55 51.48 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 120.984 -0.287 . . . . 0.0 110.441 -179.499 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.49 ' OG ' ' O ' ' A' ' 88' ' ' ILE . 43.7 t -138.55 149.57 45.46 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.706 179.92 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.406 ' N ' ' HG ' ' A' ' 94' ' ' SER . 96.8 m-85 -121.0 121.2 37.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.038 178.558 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 55.3 ttt85 -84.45 131.03 34.71 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.546 -0.462 . . . . 0.0 109.766 -179.774 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -90.38 122.52 33.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.402 -179.753 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -124.24 120.64 32.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.843 0.354 . . . . 0.0 110.836 179.893 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.585 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 62.8 t-20 -110.69 112.43 24.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.221 179.688 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 . . . . . 0 C--N 1.329 -0.313 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.883 -179.769 . . . . . . . . 0 0 . 1 . 064 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 26.1 t . . . . . 0 CA--C 1.527 0.058 0 CA-C-O 120.542 0.211 . . . . 0.0 110.606 . . . . . . . . . 0 0 . 1 . 064 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.58 ' C ' ' H ' ' B' ' 231' ' ' GLN . 67.0 t0 -137.94 97.61 3.46 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.987 -179.749 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 064 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.58 ' H ' ' C ' ' B' ' 229' ' ' ASP . 2.6 mt-30 -115.31 -27.42 7.24 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.311 -179.429 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . 0.513 ' O ' ' O ' ' B' ' 231' ' ' GLN . . . -34.14 161.34 0.01 OUTLIER Glycine 0 CA--C 1.527 0.813 0 N-CA-C 111.798 -0.521 . . . . 0.0 111.798 -179.265 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.28 162.25 42.58 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 123.597 2.865 . . . . 0.0 112.451 179.993 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 064 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.08 142.01 30.4 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 C-N-CA 121.723 1.615 . . . . 0.0 112.331 179.582 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 49.8 t -65.5 135.68 27.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.714 -179.623 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.7 t -66.69 130.56 43.58 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.723 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . 0.468 ' P ' ' HG1' ' B' ' 240' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -53.63 -33.0 67.19 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 123.183 2.589 . . . . 0.0 113.668 179.677 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' B' B ' 240' ' ' THR . . . . . 0.468 ' HG1' ' P ' ' B' ' 238' ' ' TPO . 39.8 p -73.47 -38.59 65.39 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.977 179.182 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -58.09 -48.14 81.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.845 -179.004 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 98.0 mt -67.71 -42.36 82.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.884 0.373 . . . . 0.0 111.674 -179.687 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -63.25 -45.16 92.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.884 -178.62 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -63.53 -43.82 96.05 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.841 0.353 . . . . 0.0 111.141 -179.527 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . . . . . . . . . 48.5 ttm-85 -65.27 -41.9 93.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.469 -179.334 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -63.4 -39.02 93.36 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.179 179.159 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 20.3 m -65.12 -42.64 93.74 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 177.895 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 63.6 tp60 -59.63 -35.41 74.31 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.53 -1.213 . . . . 0.0 110.179 179.493 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 49.9 t -64.22 -44.72 97.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-O 120.873 0.368 . . . . 0.0 110.227 178.926 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -64.01 -33.43 75.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.985 179.157 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -88.36 -5.45 58.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.438 179.4 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 36.6 tp -71.38 138.67 49.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.113 -179.498 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . 0.639 ' C ' ' H ' ' B' ' 255' ' ' ASP . 95.0 m-20 -38.1 154.3 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.25 -178.756 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' B' ' 254' ' ' ASP . 57.8 t0 -62.66 4.99 0.13 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.95 179.466 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . 0.639 ' H ' ' C ' ' B' ' 253' ' ' ASN . 90.8 m-20 -83.72 -84.21 0.14 Allowed 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.424 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' B' ' 253' ' ' ASN . 12.8 m-20 66.08 13.2 8.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.176 -179.459 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . 0.521 ' C ' ' HZ2' ' A' ' 11' ' ' LYS . 98.0 mttt -65.16 -35.36 80.86 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.889 178.917 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -100.84 137.58 39.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.278 179.159 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.506 ' CG ' ' H ' ' B' ' 260' ' ' GLU . 33.3 p-10 -109.3 -118.43 0.28 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.177 0.513 . . . . 0.0 112.239 -178.604 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.506 ' H ' ' CG ' ' B' ' 259' ' ' ASP . 97.7 mt-10 -146.43 26.58 1.16 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.514 179.92 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 70.6 mt -115.47 134.48 58.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.168 179.94 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 54.6 t -124.16 132.91 70.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.725 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -94.54 119.02 32.57 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.387 0.613 . . . . 0.0 111.612 -177.88 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -66.83 -46.48 74.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.287 179.68 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -72.85 166.44 43.05 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.181 -179.25 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -64.26 141.26 74.65 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 121.569 1.513 . . . . 0.0 111.282 179.878 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 11.9 tt . . . . . 0 C--N 1.324 -0.517 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.34 -178.869 . . . . . . . . 0 0 . 1 . 065 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo . . . . . 0 N--CA 1.494 1.518 0 CA-C-O 121.003 0.335 . . . . 0.0 111.757 . . . . . . . . . 0 0 . 1 . 065 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.408 ' OG1' ' N ' ' A' ' 5' ' ' ARG . 6.6 p -115.56 -52.57 2.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.326 -179.802 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.408 ' N ' ' OG1' ' A' ' 4' ' ' THR . 85.3 mtt85 -94.21 128.24 40.54 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.816 -179.885 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -132.86 144.33 50.12 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.389 -0.525 . . . . 0.0 111.354 -179.345 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 79.9 mt -115.41 145.59 42.4 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.669 179.633 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.7 t -118.48 130.18 73.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.855 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 m -90.66 117.04 29.0 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.308 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.0 mt -86.94 142.36 13.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.305 177.724 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.447 ' HZ3' ' N ' ' B' ' 258' ' ' ASP . 68.1 mttm -95.16 169.73 9.89 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.869 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 88.9 mtm180 -56.96 -29.6 63.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.8 -178.784 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.6 t -81.11 -7.35 59.54 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.757 179.295 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.27 40.19 8.67 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 -178.892 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.8 t -116.64 134.06 61.32 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.076 0 CA-C-O 120.832 0.349 . . . . 0.0 111.602 -178.713 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.468 ' C ' ' OD1' ' A' ' 16' ' ' ASP . 39.4 t0 -77.64 124.36 27.84 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.138 179.448 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -124.09 -115.56 2.16 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 120.655 -0.784 . . . . 0.0 111.408 179.94 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -72.95 144.21 37.94 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.153 1.902 . . . . 0.0 113.621 -178.808 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 50.9 m170 -106.05 142.41 35.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.275 179.781 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -114.2 93.02 29.12 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.221 -179.571 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -69.07 135.15 31.31 Favored 'Trans proline' 0 N--CA 1.488 1.187 0 C-N-CA 121.51 1.474 . . . . 0.0 111.668 -179.537 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 92.4 mt -84.84 80.31 9.32 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.187 -178.699 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 85.6 p -82.33 -10.85 58.93 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.078 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 58.0 mt -103.85 144.66 31.21 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.401 -179.202 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.8 t -67.5 -14.84 63.29 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.968 -179.856 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.548 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 89.2 m -131.38 133.69 45.52 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 120.696 -0.401 . . . . 0.0 111.395 -179.809 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.601 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 13.2 t -125.27 116.14 21.48 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.632 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.4 tp -115.23 131.29 56.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.29 -178.161 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.601 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 23.3 m-85 -109.38 136.91 48.04 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.632 178.943 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 154.22 -177.19 31.76 Favored Glycine 0 C--O 1.221 -0.677 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.778 178.804 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.497 ' NH1' ' O ' ' B' ' 229' ' ' ASP . 46.4 mtm180 -77.47 -31.08 53.48 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.646 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.508 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -51.33 150.55 6.85 Favored Glycine 0 N--CA 1.465 0.582 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.395 -178.327 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.472 ' CD1' ' NH1' ' A' ' 38' ' ' ARG . 11.0 tp -66.44 -41.62 89.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.646 0.26 . . . . 0.0 110.533 179.967 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.47 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 81.0 mm-40 -55.72 -24.23 33.61 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.347 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.508 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 39.0 m -53.3 118.04 3.51 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.823 179.971 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.548 ' OD2' ' O ' ' A' ' 26' ' ' THR . 93.2 m-20 -59.14 -27.99 66.15 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.855 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.409 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 97.9 mt -127.53 119.12 51.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 176.479 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.472 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 82.9 mtp180 -102.2 134.82 44.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.901 0.382 . . . . 0.0 111.901 -178.439 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.0 mt -122.02 130.05 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.114 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.693 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -82.93 34.36 0.45 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.001 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 31.3 mt -95.65 129.03 35.71 Favored Pre-proline 0 C--N 1.325 -0.477 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.33 179.458 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.17 -12.16 27.62 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 C-N-CA 122.218 1.945 . . . . 0.0 112.361 -179.616 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.4 m -98.08 5.73 9.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.872 0.368 . . . . 0.0 110.495 -179.949 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.477 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 37.4 t -98.82 135.11 35.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.414 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.632 ' HG ' ' H ' ' A' ' 46' ' ' LYS . 6.9 t -70.34 174.68 5.37 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.229 0.538 . . . . 0.0 111.233 -179.031 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.632 ' H ' ' HG ' ' A' ' 45' ' ' SER . 50.4 mttp -64.03 -41.01 97.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.1 -179.926 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.628 ' O ' ' N ' ' A' ' 49' ' ' CYS . 85.6 mt-30 -112.85 -20.08 11.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.919 -179.272 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 28.2 t60 39.17 -76.8 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 179.751 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.628 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.2 133.46 46.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.306 -178.548 . . . . . . . . 3 3 . 1 . 065 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -127.35 130.57 49.69 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.541 179.34 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 86.2 mt -115.98 134.86 57.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.812 -179.826 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.568 ' CD ' ' HE2' ' A' ' 54' ' ' HIS . 74.6 tt0 -120.47 125.8 48.81 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.791 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 93.9 mt -106.56 119.08 55.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.567 0.698 . . . . 0.0 112.26 -179.009 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.568 ' HE2' ' CD ' ' A' ' 52' ' ' GLU . 99.6 m-70 -112.36 140.34 47.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.605 -1.179 . . . . 0.0 108.959 178.961 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.9 mm-40 -40.78 -28.02 0.07 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 -179.86 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.462 ' N ' ' O ' ' A' ' 54' ' ' HIS . 82.3 mt-30 -65.88 -68.04 0.4 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.434 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -154.14 -171.51 3.9 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.382 -179.613 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.16 128.99 55.78 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.497 -0.556 . . . . 0.0 109.497 179.021 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 98.0 mt -119.02 130.96 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -178.752 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 32.1 tp -99.33 131.7 45.17 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.003 179.277 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -114.55 136.44 53.02 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.072 179.197 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.407 HD22 ' HA ' ' A' ' 68' ' ' PRO . 57.9 t-20 -97.81 111.09 23.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.187 0.518 . . . . 0.0 111.651 -179.543 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -104.8 -10.37 17.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.484 179.91 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.4 101.46 12.02 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.491 -179.813 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 77.8 p -76.19 -35.57 59.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.257 0.551 . . . . 0.0 109.903 179.244 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.01 -43.02 99.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.285 -178.827 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -147.25 99.77 3.9 Favored Pre-proline 0 C--N 1.317 -0.834 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.484 -179.034 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.407 ' HA ' HD22 ' A' ' 62' ' ' ASN . 33.6 Cg_exo -57.55 146.46 84.02 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 C-N-CA 121.783 1.656 . . . . 0.0 112.681 -178.78 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 18.2 m -70.24 136.17 49.68 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.351 178.316 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -96.94 143.9 27.37 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.171 -0.612 . . . . 0.0 111.229 -179.162 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.48 ' CG2' ' OD1' ' A' ' 86' ' ' ASP . 5.4 p -129.5 133.88 64.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.837 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 49.17 30.12 2.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.157 0.503 . . . . 0.0 109.952 -179.331 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 78.2 27.47 57.85 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.393 179.064 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.6 t -138.0 139.59 39.73 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.997 0.398 . . . . 0.0 110.46 179.739 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -67.78 142.29 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.846 179.907 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.528 ' CG2' ' O ' ' A' ' 78' ' ' GLU . 96.6 mt -101.72 103.72 15.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.936 -179.742 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -67.63 -40.97 84.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.989 179.028 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.528 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.6 OUTLIER -134.68 179.37 1.4 Allowed Pre-proline 0 CA--C 1.53 0.186 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.727 -178.35 . . . . . . . . 3 3 . 1 . 065 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.467 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 31.8 Cg_exo -59.37 144.59 99.36 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 122.804 2.336 . . . . 0.0 112.648 -179.585 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.8 m -143.1 141.24 26.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.995 -179.806 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 91.7 mtm180 -71.68 131.39 43.09 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.526 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.4 mt -80.19 139.99 36.51 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.838 0.351 . . . . 0.0 110.978 -179.538 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -131.44 150.2 52.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.426 -179.903 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.641 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 5.8 t60 -55.92 123.09 13.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.908 0.385 . . . . 0.0 110.982 -179.304 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.12 -14.19 48.42 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 -179.472 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.48 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 64.9 t0 -71.4 129.75 39.6 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.028 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.447 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 95.0 t -109.36 130.55 62.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.265 -178.819 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.4 mt -97.0 131.57 43.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.984 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 63.9 m -127.97 127.63 43.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.713 0.768 . . . . 0.0 113.002 -178.512 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.607 ' O ' ' N ' ' A' ' 92' ' ' ASP . 82.2 mt -107.03 123.06 61.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 177.682 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.437 ' C ' ' O ' ' A' ' 90' ' ' ILE . 70.3 mt 38.87 -88.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 120.511 -0.475 . . . . 0.0 110.646 -179.467 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.607 ' N ' ' O ' ' A' ' 90' ' ' ILE . 32.4 t70 -128.18 16.17 6.69 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -179.746 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.625 ' HE ' HH12 ' B' ' 245' ' ' ARG . 98.3 mtt180 -123.01 139.91 53.59 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.115 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 31.7 p -138.84 151.87 47.37 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 119.23 -0.988 . . . . 0.0 112.011 -179.684 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -122.1 121.61 37.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.554 -1.203 . . . . 0.0 108.364 178.958 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -83.56 133.32 34.87 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.176 -0.609 . . . . 0.0 111.48 -178.52 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -96.83 122.47 39.82 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.234 -179.615 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -123.67 124.58 43.08 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.864 179.947 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.641 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 62.9 t-20 -106.97 107.15 18.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.787 179.478 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 . . . . . 0 C--N 1.33 -0.272 0 C-N-CA 120.204 -0.598 . . . . 0.0 110.229 179.691 . . . . . . . . 0 0 . 1 . 065 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . 0.444 ' CG1' ' O ' ' B' ' 228' ' ' VAL . 29.5 t . . . . . 0 CA--C 1.53 0.182 0 N-CA-C 111.497 0.184 . . . . 0.0 111.497 . . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.497 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 88.6 m-20 -71.14 137.34 48.73 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.233 0.54 . . . . 0.0 111.05 -179.779 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . 0.537 ' C ' ' OE1' ' B' ' 231' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.537 ' OE1' ' C ' ' B' ' 230' ' ' SEP . 1.6 mp0 -124.65 46.14 2.38 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.13 178.677 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -125.4 179.99 15.96 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 -179.398 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.83 161.51 45.83 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 123.24 2.626 . . . . 0.0 113.448 -179.642 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 065 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.87 144.34 43.14 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 121.804 1.669 . . . . 0.0 113.307 -178.656 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 12.2 p -58.35 135.73 22.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.135 -179.642 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 10.0 t -66.77 132.99 49.24 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.742 -179.502 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . 0.436 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . 0.436 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 31.9 Cg_exo -60.7 -27.92 85.64 Favored 'Trans proline' 0 N--CA 1.502 1.999 0 C-N-CA 123.131 2.554 . . . . 0.0 114.085 -178.769 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 97.4 m -67.45 -47.09 71.15 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.379 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . 0.415 ' CE2' ' HD2' ' B' ' 245' ' ' ARG . 91.7 t80 -57.93 -46.21 85.4 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.335 -179.459 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 87.6 mt -65.43 -38.83 91.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.842 0.353 . . . . 0.0 110.64 179.962 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -60.77 -41.11 94.83 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.077 0.465 . . . . 0.0 110.044 -179.98 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 62.0 ttp180 -61.45 -43.17 99.34 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.195 179.877 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.625 HH12 ' HE ' ' A' ' 93' ' ' ARG . 76.0 mtp85 -60.07 -42.09 93.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.866 -179.689 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.29 -41.34 96.81 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.28 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 8.6 t -63.4 -46.13 87.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.738 178.381 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -59.33 -38.45 80.35 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.808 -178.989 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 25.1 t -59.61 -46.06 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.677 178.846 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -64.61 -31.81 73.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.085 0.469 . . . . 0.0 109.909 179.054 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -67.43 -19.91 65.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.641 -179.814 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 97.9 mt -66.2 134.65 53.16 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.109 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -101.63 -39.54 7.43 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.137 0.494 . . . . 0.0 110.441 179.534 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . 0.48 ' C ' ' H ' ' B' ' 256' ' ' ASP . 96.0 m-20 -67.78 -18.0 64.72 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.341 179.53 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 26.8 t0 56.99 12.14 1.14 Allowed 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -178.808 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.48 ' H ' ' C ' ' B' ' 254' ' ' ASP . 68.3 t0 -172.25 90.03 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.555 179.855 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . 0.522 ' O ' ' C ' ' B' ' 258' ' ' ASP . 88.5 tttt -156.97 138.21 13.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.449 -179.862 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.522 ' C ' ' O ' ' B' ' 257' ' ' LYS . 66.4 t0 -21.82 138.19 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 O-C-N 123.926 0.766 . . . . 0.0 110.6 -179.713 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.517 ' N ' ' OD1' ' B' ' 258' ' ' ASP . 20.4 p-10 -119.43 68.0 0.81 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -179.018 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.544 ' OE1' ' NH2' ' A' ' 93' ' ' ARG . 97.8 mt-10 58.68 22.61 10.12 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 177.559 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 76.3 mt -114.51 128.98 71.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.178 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 54.4 t -126.85 133.9 67.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.137 0.494 . . . . 0.0 110.973 -179.203 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -96.38 120.36 36.54 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.99 -179.299 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -64.07 -42.72 96.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.533 0.682 . . . . 0.0 110.045 179.24 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . 0.534 ' N ' HE21 ' B' ' 265' ' ' GLN . 0.0 OUTLIER -103.26 171.52 5.09 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.006 -178.604 . . . . . . . . 3 3 . 1 . 065 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -54.52 149.73 37.79 Favored 'Trans proline' 0 N--CA 1.501 1.953 0 C-N-CA 123.143 2.562 . . . . 0.0 114.154 -179.728 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 33.0 pt . . . . . 0 C--O 1.232 0.178 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.001 179.907 . . . . . . . . 0 0 . 1 . 066 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo . . . . . 0 N--CA 1.495 1.587 0 CA-C-O 120.861 0.275 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 066 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 68.2 p -119.0 -34.77 3.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.543 179.391 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.549 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 95.1 mtt-85 -95.5 122.11 37.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.128 -179.644 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.411 ' NE ' ' OE1' ' A' ' 98' ' ' GLU . 31.1 ptt180 -138.48 145.34 40.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.072 0.463 . . . . 0.0 111.298 -179.86 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 36.9 tp -118.93 136.47 54.05 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.359 179.007 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.0 t -110.35 131.6 60.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.822 -178.548 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.5 m -93.47 114.73 27.19 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.156 0.503 . . . . 0.0 112.12 -179.144 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 45.7 mm -79.63 144.93 10.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.611 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -90.52 158.92 16.77 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.181 178.595 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.55 ' NE ' ' NH2' ' B' ' 245' ' ' ARG . 84.7 mtp180 -54.87 -27.84 45.6 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.801 -178.825 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 85.9 p -79.19 -10.71 59.89 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 120.876 -0.329 . . . . 0.0 111.626 179.982 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.69 33.36 7.96 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 -179.223 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.6 t -120.6 134.61 63.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.87 0.367 . . . . 0.0 110.969 -179.531 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -71.22 129.28 38.49 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.818 179.58 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -125.35 -121.53 2.54 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.527 -179.076 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.21 144.62 42.13 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.16 1.907 . . . . 0.0 113.019 -178.104 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 59.2 m170 -104.22 145.78 29.73 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.647 -179.443 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -116.21 91.37 32.19 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.992 -179.924 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -60.35 125.36 17.26 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 121.779 1.652 . . . . 0.0 111.135 179.52 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.0 mt -84.48 50.51 1.9 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.292 -178.762 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.4 p -61.21 -23.69 65.8 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.962 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.3 mt -83.53 141.84 31.33 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.173 -179.832 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.2 m -67.25 -17.84 64.97 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.834 -178.696 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.74 133.73 40.23 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.252 -0.579 . . . . 0.0 112.029 -178.977 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.5 t -128.19 119.96 26.29 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.25 179.207 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 38.5 tp -111.75 128.54 56.12 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.88 -178.938 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.478 ' O ' ' O ' ' A' ' 47' ' ' GLN . 57.6 m-85 -108.35 134.86 50.57 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.329 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 156.83 -170.7 34.25 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 119.904 -1.141 . . . . 0.0 112.449 179.344 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.603 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 10.4 mtp180 -85.6 -31.45 22.61 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -179.779 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -51.45 155.45 3.77 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 -178.648 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.489 ' CD1' HH12 ' A' ' 38' ' ' ARG . 1.1 tp -66.16 -42.69 91.66 Favored 'Isoleucine or valine' 0 C--N 1.34 0.195 0 CA-C-N 117.149 0.475 . . . . 0.0 111.01 -179.707 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.406 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 73.6 mm-40 -58.06 -16.82 14.27 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.409 -179.64 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 68.6 m -59.8 120.34 9.36 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.838 -179.485 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -60.89 -32.27 71.73 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.73 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.425 HG13 ' CE2' ' A' ' 29' ' ' PHE . 48.9 mm -120.13 113.77 41.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.554 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.489 HH12 ' CD1' ' A' ' 33' ' ' ILE . 77.4 mtt180 -101.06 132.77 46.33 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.028 -0.669 . . . . 0.0 111.287 -177.876 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 95.9 mt -123.73 129.85 74.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.283 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -83.56 43.74 0.92 Allowed 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -176.98 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.578 ' CD1' ' CZ ' ' A' ' 93' ' ' ARG . 39.9 mt -109.4 126.58 28.91 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 120.403 -0.519 . . . . 0.0 111.781 179.885 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -68.86 -13.84 37.63 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.174 1.916 . . . . 0.0 112.779 179.709 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.2 m -90.68 4.43 6.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.891 0.377 . . . . 0.0 110.701 179.996 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.603 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 54.7 t -107.03 136.43 42.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.23 -179.698 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.3 m -70.68 168.31 16.8 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.527 0.68 . . . . 0.0 111.281 -179.386 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.5 mttm -62.07 -38.77 90.06 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.109 -179.293 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.708 ' O ' ' N ' ' A' ' 49' ' ' CYS . 99.0 mt-30 -109.58 -14.98 14.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.532 -179.077 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 23.5 t60 37.13 -72.75 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -179.836 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.708 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -151.69 151.92 32.09 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.997 179.943 . . . . . . . . 3 3 . 1 . 066 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -138.36 143.57 39.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.96 -179.96 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.8 mt -114.39 133.06 61.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.483 179.934 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -114.67 124.58 52.18 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.494 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.4 mt -105.89 118.59 53.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -177.356 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.423 ' O ' ' C ' ' A' ' 55' ' ' GLU . 97.7 m-70 -112.97 138.43 49.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.267 -1.333 . . . . 0.0 108.718 178.055 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 54' ' ' HIS . 94.8 mt-10 -39.47 -35.67 0.31 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.186 0.517 . . . . 0.0 109.807 -178.822 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -60.26 -68.17 0.32 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.649 179.071 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.522 ' CD ' ' NH1' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -151.99 -171.26 3.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.11 0.481 . . . . 0.0 111.063 179.523 . . . . . . . . 3 3 . 1 . 066 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.04 129.15 55.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.398 179.505 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.4 mt -116.84 129.14 73.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.234 0.54 . . . . 0.0 112.39 -178.555 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 25.4 tp -98.38 128.29 44.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.439 179.669 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -112.84 134.61 54.27 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.151 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.648 HD22 ' CB ' ' A' ' 68' ' ' PRO . 61.6 t-20 -98.4 109.59 22.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.925 -178.429 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -98.71 -3.89 34.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.094 179.726 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.1 t -92.8 110.36 21.8 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.085 -179.274 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 56.3 p -93.59 -28.75 15.85 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.577 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.447 ' O ' ' OD1' ' A' ' 67' ' ' ASN . 0.3 OUTLIER -65.52 -43.68 89.29 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.834 179.734 . . . . . . . . 3 3 . 1 . 066 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.447 ' OD1' ' O ' ' A' ' 66' ' ' THR . 33.2 m-20 -149.2 103.91 3.33 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.884 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.648 ' CB ' HD22 ' A' ' 62' ' ' ASN . 68.0 Cg_endo -71.03 158.21 55.83 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 121.657 1.571 . . . . 0.0 113.337 -177.424 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.1 m -73.04 140.03 46.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.296 179.656 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.539 ' O ' ' N ' ' A' ' 89' ' ' THR . 89.3 mt-30 -102.76 142.42 33.94 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.34 -179.507 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.566 ' CG2' ' OD1' ' A' ' 86' ' ' ASP . 8.9 p -132.04 138.63 52.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.766 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 50.39 31.81 5.78 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 -179.616 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.68 30.03 64.63 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.493 179.962 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 65.6 m -140.7 136.35 32.53 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 117.151 0.475 . . . . 0.0 111.847 -179.235 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.8 t -63.8 137.2 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.732 179.758 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.551 ' CG2' ' O ' ' A' ' 78' ' ' GLU . 92.6 mt -101.91 110.87 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 178.631 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.474 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 18.6 p-10 -75.45 -37.15 60.52 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.13 179.546 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.551 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.8 OUTLIER -133.15 -177.95 0.78 Allowed Pre-proline 0 N--CA 1.465 0.316 0 CA-C-O 120.895 0.379 . . . . 0.0 111.823 -178.938 . . . . . . . . 3 3 . 1 . 066 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.516 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 32.5 Cg_exo -59.51 144.78 99.33 Favored 'Trans proline' 0 N--CA 1.499 1.822 0 C-N-CA 122.84 2.36 . . . . 0.0 112.545 -179.653 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 23.5 m -142.22 141.39 28.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.566 -179.627 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.522 ' NH1' ' CD ' ' A' ' 57' ' ' GLU . 96.7 mtt-85 -74.97 136.71 41.31 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.785 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 97.7 mt -92.31 136.43 33.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.461 0.648 . . . . 0.0 111.173 -179.579 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -125.31 155.53 40.08 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.824 179.965 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.455 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 10.4 t60 -57.43 121.88 11.28 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.954 -179.451 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.21 -22.44 20.59 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.962 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.566 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 64.9 t0 -64.32 131.27 46.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.712 0.292 . . . . 0.0 110.835 179.656 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.503 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 39.7 t -108.88 130.86 61.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.906 -179.463 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.5 mt -91.46 128.88 42.93 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.165 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.539 ' N ' ' O ' ' A' ' 70' ' ' GLN . 53.3 m -123.78 125.51 44.85 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.677 0.751 . . . . 0.0 112.002 -178.853 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 95.2 mt -115.97 123.0 70.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.588 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.444 HD11 HH22 ' A' ' 93' ' ' ARG . 96.6 mt 43.53 -102.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.934 -178.768 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.62 ' OD1' ' NH1' ' A' ' 93' ' ' ARG . 46.0 p-10 -118.39 14.67 13.8 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.166 0.508 . . . . 0.0 110.972 179.938 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.62 ' NH1' ' OD1' ' A' ' 92' ' ' ASP . 51.2 mtm-85 -122.57 143.76 49.53 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.533 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 29.0 p -139.63 153.01 47.23 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 119.499 -0.881 . . . . 0.0 111.732 -179.137 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -122.51 120.78 34.87 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 114.786 -1.097 . . . . 0.0 108.686 178.906 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 44.4 ttm180 -82.85 128.7 34.66 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.144 -0.622 . . . . 0.0 111.455 -178.657 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.549 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 83.3 t80 -97.78 127.95 44.08 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.92 179.736 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.411 ' OE1' ' NE ' ' A' ' 6' ' ' ARG . 98.2 mt-10 -130.7 123.78 30.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.048 179.637 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.455 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 63.8 t-20 -113.74 100.08 8.19 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.028 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.428 -178.619 . . . . . . . . 0 0 . 1 . 066 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 1.9 t . . . . . 0 N--CA 1.462 0.147 0 CA-C-O 121.013 0.435 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 066 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.545 ' C ' ' H ' ' B' ' 231' ' ' GLN . 50.9 t0 -91.04 116.24 28.64 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.923 179.922 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 066 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.545 ' H ' ' C ' ' B' ' 229' ' ' ASP . 75.3 mt-30 -124.54 42.19 3.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.217 -179.454 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -131.24 -166.26 11.66 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.294 -179.144 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -59.96 151.93 68.23 Favored 'Trans proline' 0 N--CA 1.5 1.859 0 C-N-CA 124.174 3.25 . . . . 0.0 113.879 -179.304 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 066 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -66.83 139.95 53.83 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 121.083 1.189 . . . . 0.0 113.494 -178.625 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . 0.407 ' HA ' HD22 ' A' ' 67' ' ' ASN . 23.0 t -57.44 140.81 15.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.843 -179.067 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 49.0 t -69.05 127.25 32.47 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.599 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . 0.447 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . 0.447 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 31.5 Cg_exo -58.57 -25.71 75.66 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 123.086 2.524 . . . . 0.0 113.406 -179.039 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 16.9 m -73.13 -47.7 41.83 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 119.953 -0.699 . . . . 0.0 109.394 178.972 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -57.49 -44.84 85.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.192 179.911 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 92.9 mt -65.32 -39.1 92.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.811 179.816 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -62.87 -42.15 99.65 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.296 -179.053 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . 0.48 ' O ' ' OG ' ' B' ' 247' ' ' SER . 95.1 mtm-85 -62.84 -42.23 99.65 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.231 -179.429 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.55 ' NH2' ' NE ' ' A' ' 12' ' ' ARG . 77.2 mtp85 -63.54 -40.57 97.37 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.5 -0.48 . . . . 0.0 112.095 -179.33 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.42 -38.84 88.56 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 120.205 -0.598 . . . . 0.0 109.682 179.658 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' B' B ' 247' ' ' SER . . . . . 0.48 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 70.7 p -67.17 -42.5 84.16 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 177.959 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . 0.58 ' O ' ' N ' ' B' ' 252' ' ' LEU . 75.5 mm-40 -62.7 -33.1 74.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.757 179.641 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 37.5 t -63.23 -46.3 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.978 179.583 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -60.45 -29.13 68.83 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.997 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -92.77 -14.83 27.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.874 179.499 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.58 ' N ' ' O ' ' B' ' 248' ' ' GLN . 42.4 tp -76.32 147.45 38.15 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.991 0.424 . . . . 0.0 111.299 -179.602 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -98.65 131.09 45.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.558 179.464 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -65.66 -25.84 67.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.263 -179.515 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -84.03 5.29 26.38 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.162 -179.308 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -94.54 97.82 10.41 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.003 179.266 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -65.84 174.92 2.15 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -179.822 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 58.95 67.84 0.88 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -178.294 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.591 ' C ' ' H ' ' B' ' 261' ' ' ILE . 68.1 t0 -84.91 86.29 7.38 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.956 -179.14 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 35.3 tp10 60.73 -9.59 0.06 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.552 178.947 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . 0.591 ' H ' ' C ' ' B' ' 259' ' ' ASP . 63.5 mt -111.97 135.85 49.98 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 CA-C-O 120.811 0.339 . . . . 0.0 110.517 -179.719 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 38.2 t -127.63 134.2 66.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.053 179.447 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -96.69 121.02 38.07 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.991 0.424 . . . . 0.0 111.544 -178.597 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -65.15 -48.09 74.76 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.711 179.583 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -95.63 157.87 35.37 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.286 -178.891 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -64.47 154.67 70.48 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 123.209 2.606 . . . . 0.0 112.575 178.987 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 36.0 pt . . . . . 0 C--N 1.332 -0.156 0 CA-C-O 121.594 0.711 . . . . 0.0 112.401 -179.346 . . . . . . . . 0 0 . 1 . 067 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo . . . . . 0 N--CA 1.499 1.811 0 CA-C-O 121.096 0.373 . . . . 0.0 112.831 . . . . . . . . . 0 0 . 1 . 067 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.9 p -61.22 -44.8 96.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.414 -179.207 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.693 ' NE ' ' CZ ' ' A' ' 97' ' ' TYR . 2.6 mmp_? -90.9 118.2 30.11 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.781 -178.805 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.6 mtp180 -129.08 137.1 51.06 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.202 0.525 . . . . 0.0 111.541 179.522 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 22.6 tp -114.49 131.05 56.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.268 179.807 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 76.6 t -108.91 130.89 61.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.072 -179.602 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.6 m -77.71 142.93 38.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.683 -179.341 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.439 ' CD1' ' OD1' ' A' ' 16' ' ' ASP . 50.4 mm -111.11 136.16 48.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.954 178.85 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -89.91 155.64 18.99 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.53 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.494 ' HD3' HH21 ' B' ' 245' ' ' ARG . 89.7 mtm180 -59.78 -24.45 64.1 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.039 -178.951 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.4 p -82.97 -6.97 59.7 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.447 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.77 38.11 7.65 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 179.691 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.6 t -122.84 133.63 68.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.662 0.267 . . . . 0.0 110.565 179.533 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.439 ' OD1' ' CD1' ' A' ' 10' ' ' ILE . 90.9 m-20 -73.7 135.15 43.66 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.271 179.64 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -124.84 -121.57 2.57 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 120.596 -0.811 . . . . 0.0 111.897 -179.633 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.59 145.32 41.69 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.139 1.892 . . . . 0.0 112.888 -178.709 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -104.56 143.76 32.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.711 179.995 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.417 ' CD2' HD13 ' A' ' 37' ' ' ILE . 38.7 t80 -115.36 107.21 49.69 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.19 179.374 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -74.78 127.5 10.89 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 121.373 1.382 . . . . 0.0 111.758 -179.159 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 82.2 mt -84.12 48.81 1.53 Allowed 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.29 -179.383 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 93.6 p -60.72 -25.36 66.37 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.467 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 66.8 mt -76.04 139.02 41.24 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.383 179.986 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.2 m -63.21 -19.25 64.35 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.286 -179.489 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.467 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 22.8 m -136.81 135.0 37.58 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.478 -179.723 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.9 t -126.43 118.49 25.08 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.058 0.456 . . . . 0.0 110.182 178.104 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 53.5 tp -114.17 132.42 56.09 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.121 -179.016 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.515 ' O ' ' O ' ' A' ' 47' ' ' GLN . 34.1 m-85 -112.04 137.34 50.2 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.376 -179.341 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 152.93 -177.96 30.3 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.304 179.17 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 45.4 mtm180 -70.6 -32.03 69.25 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 179.772 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.568 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -51.79 148.04 10.64 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 121.133 -0.556 . . . . 0.0 112.477 -178.084 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.444 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 11.0 tp -66.71 -41.47 88.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 120.886 0.374 . . . . 0.0 110.152 179.315 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.444 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 77.5 tt0 -57.33 -24.08 52.83 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.497 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.568 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 16.5 m -56.6 120.36 7.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.93 179.343 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.467 ' OD2' ' O ' ' A' ' 26' ' ' THR . 95.7 m-20 -61.87 -25.5 67.58 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.537 0.684 . . . . 0.0 109.155 -179.692 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.417 HD13 ' CD2' ' A' ' 20' ' ' PHE . 39.5 mm -126.88 117.11 46.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.888 178.848 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 62.0 mtm180 -104.1 135.24 45.96 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.614 -179.871 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.2 mt -120.13 127.95 75.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.521 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -75.05 34.58 0.1 Allowed 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -177.108 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.414 HD11 ' NH2' ' B' ' 245' ' ' ARG . 96.2 mt -103.37 127.88 28.71 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.986 179.588 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.79 -9.83 24.23 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.491 2.128 . . . . 0.0 112.197 -179.915 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.8 m -96.77 9.96 6.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.613 179.818 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 20.1 t -103.31 135.72 39.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.428 179.71 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.501 ' OG ' ' OG ' ' A' ' 64' ' ' SER . 13.2 m -70.04 170.15 11.98 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.357 0.599 . . . . 0.0 111.048 -179.895 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -64.3 -40.16 95.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.698 -179.685 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.616 ' O ' ' N ' ' A' ' 49' ' ' CYS . 69.5 mm-40 -110.07 -25.07 10.42 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.131 0.491 . . . . 0.0 110.676 -179.158 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.5 t60 40.08 -74.69 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 179.119 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.616 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.48 136.86 45.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.406 0.622 . . . . 0.0 112.396 -177.834 . . . . . . . . 3 3 . 1 . 067 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -127.1 128.05 45.61 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.938 179.011 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.8 mt -116.85 134.59 59.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.84 -179.737 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -115.75 135.8 53.68 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.662 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 49.9 mm -102.08 114.2 40.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 120.169 -0.613 . . . . 0.0 110.62 -179.945 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -115.4 134.39 55.14 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.078 179.01 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -42.13 -32.9 0.51 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.01 -179.487 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -63.04 -66.23 0.57 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.739 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -157.69 -160.33 0.92 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.131 179.671 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -121.29 133.83 55.14 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.561 -179.926 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.9 mt -118.27 128.48 75.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.266 0.555 . . . . 0.0 112.099 -179.265 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.4 tp -95.69 125.01 39.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.623 179.575 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -112.02 136.06 51.85 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.69 0.281 . . . . 0.0 110.444 -179.794 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.752 ' ND2' ' H ' ' A' ' 69' ' ' THR . 21.2 t-20 -97.88 107.7 20.24 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.529 -179.808 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -98.66 -10.65 22.95 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.222 179.37 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.501 ' OG ' ' OG ' ' A' ' 45' ' ' SER . 0.1 OUTLIER -80.73 97.96 7.53 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.233 179.954 . . . . . . . . 3 3 . 1 . 067 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.0 p -71.67 -32.56 68.01 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.78 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.0 m -64.0 -47.07 81.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.504 -178.956 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -141.99 97.41 6.42 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.888 -178.984 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -56.06 146.76 68.09 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.009 1.806 . . . . 0.0 111.63 179.696 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.752 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 6.7 m -73.91 146.16 44.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.291 0.567 . . . . 0.0 111.151 -179.698 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -104.81 140.9 37.43 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.996 179.791 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.499 ' O ' ' OG ' ' A' ' 74' ' ' SER . 43.0 t -129.02 135.53 61.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.214 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 51.94 33.48 11.77 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.209 -0.596 . . . . 0.0 109.533 -179.733 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.33 29.84 71.71 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.431 179.703 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.499 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 16.5 p -141.55 136.14 30.83 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.754 0.311 . . . . 0.0 110.895 179.987 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.1 p -68.42 139.14 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 CA-C-O 121.083 0.468 . . . . 0.0 111.678 -179.753 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.7 109.45 21.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.092 179.492 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -90.46 -17.55 26.93 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.845 -179.201 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -116.01 164.88 16.2 Favored Pre-proline 0 N--CA 1.469 0.505 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.824 179.77 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -56.78 142.97 91.93 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 C-N-CA 121.59 1.526 . . . . 0.0 111.562 179.296 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.0 p -139.9 138.91 38.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.983 0.42 . . . . 0.0 110.989 -178.909 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.2 mtm180 -77.94 133.03 38.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.482 -179.982 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 93.4 mt -86.72 139.84 30.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.143 0.497 . . . . 0.0 111.074 -179.445 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -133.31 155.51 49.3 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.697 -179.501 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.496 ' CE1' ' O ' ' A' ' 99' ' ' ASN . 3.4 t-160 -55.36 113.3 1.36 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.899 -179.458 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.66 -17.54 18.12 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 121.068 -0.587 . . . . 0.0 111.921 179.475 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -70.94 133.3 46.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.998 0.428 . . . . 0.0 110.371 -179.901 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.418 ' CG2' ' OG ' ' A' ' 94' ' ' SER . 14.2 p -107.87 132.76 54.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.008 -179.217 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 91.3 mt -97.68 130.3 46.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.372 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 51.6 m -122.14 126.23 47.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.735 0.779 . . . . 0.0 112.561 -178.417 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.491 ' O ' ' N ' ' A' ' 92' ' ' ASP . 80.7 mt -113.04 120.07 62.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 114.509 -1.223 . . . . 0.0 108.186 178.661 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.41 ' C ' ' O ' ' A' ' 90' ' ' ILE . 57.1 mt 38.09 -92.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.715 -0.221 . . . . 0.0 111.144 -179.533 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 90' ' ' ILE . 10.3 t0 -119.35 14.75 12.95 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.572 -179.254 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.589 ' NH1' ' OD2' ' B' ' 259' ' ' ASP . 79.6 mtt-85 -128.89 146.73 50.86 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.148 179.726 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.418 ' OG ' ' CG2' ' A' ' 87' ' ' VAL . 12.8 t -139.45 153.98 47.67 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.651 0.739 . . . . 0.0 111.701 -179.73 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -126.65 121.88 33.39 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.109 179.061 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -82.42 131.29 35.22 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.226 -178.944 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.693 ' CZ ' ' NE ' ' A' ' 5' ' ' ARG . 67.5 t80 -92.25 121.39 33.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.031 179.95 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.463 ' C ' ' NH2' ' A' ' 5' ' ' ARG . 93.5 mt-10 -126.57 131.37 51.55 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -177.886 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.61 ' CG ' HH12 ' A' ' 5' ' ' ARG . 63.1 t-20 -106.89 107.48 18.52 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.179 178.591 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 . . . . . 0 C--N 1.324 -0.51 0 C-N-CA 120.052 -0.659 . . . . 0.0 109.899 179.404 . . . . . . . . 0 0 . 1 . 067 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . 0.458 ' O ' ' N ' ' B' ' 231' ' ' GLN . 54.9 t . . . . . 0 N--CA 1.462 0.168 0 CA-C-O 120.997 0.427 . . . . 0.0 110.779 . . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.583 ' C ' ' H ' ' B' ' 231' ' ' GLN . 92.3 m-20 39.57 50.26 2.12 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.093 179.577 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 067 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.583 ' H ' ' C ' ' B' ' 229' ' ' ASP . 2.7 mp0 -113.88 60.47 0.66 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.684 0.278 . . . . 0.0 110.695 -179.833 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -134.05 173.42 21.32 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 -179.83 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.22 159.46 53.71 Favored 'Trans proline' 0 C--N 1.3 -2.006 0 C-N-CA 123.309 2.673 . . . . 0.0 112.002 179.794 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 067 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -73.38 138.83 27.95 Favored 'Trans proline' 0 C--N 1.302 -1.898 0 C-N-CA 121.915 1.744 . . . . 0.0 112.621 -179.784 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 31.4 m -59.25 142.74 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.618 -179.72 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 2.4 t -67.0 128.99 38.43 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.789 179.926 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 067 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -54.56 -23.94 34.31 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.289 1.992 . . . . 0.0 113.039 179.852 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 26.2 p -74.16 -40.02 62.85 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 120.421 -0.511 . . . . 0.0 109.696 178.401 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -59.96 -46.67 88.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.109 -179.358 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 90.6 mt -65.25 -41.43 94.32 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -179.561 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -65.47 -40.62 93.37 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.422 -179.374 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . 0.489 ' O ' ' OG ' ' B' ' 247' ' ' SER . 82.3 mtp180 -62.04 -42.71 99.46 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.52 -179.886 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.494 HH21 ' HD3' ' A' ' 12' ' ' ARG . 85.3 mtp180 -65.9 -39.95 91.07 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.579 -179.912 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -62.16 -40.81 97.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.167 0.508 . . . . 0.0 110.106 178.887 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' B' B ' 247' ' ' SER . . . . . 0.489 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 73.5 p -66.19 -41.69 89.85 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.463 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -61.27 -36.19 79.36 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.116 179.431 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 27.8 t -60.84 -45.28 98.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 120.166 -0.614 . . . . 0.0 109.49 178.769 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -60.44 -27.83 67.81 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.687 179.332 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -89.22 -6.75 56.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.978 179.305 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 94.5 mt -116.32 112.94 22.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.919 178.661 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -65.21 178.97 0.79 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.492 -179.032 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 42.1 p-10 -71.69 -7.49 48.3 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.038 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -68.65 -15.23 63.46 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.75 -179.539 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -79.97 76.57 6.68 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.457 -179.203 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -71.19 -8.86 56.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.345 -179.659 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -112.45 80.83 1.38 Allowed 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.434 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.589 ' OD2' ' NH1' ' A' ' 93' ' ' ARG . 30.9 t0 -60.73 -103.43 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.41 -179.123 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.57 ' N ' ' OD1' ' B' ' 259' ' ' ASP . 94.4 mt-10 -151.05 25.95 0.72 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.954 -179.25 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 68.2 mt -115.62 136.99 50.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -179.312 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 55.2 t -124.89 132.56 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 121.102 0.477 . . . . 0.0 110.769 -179.837 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -94.6 118.45 31.71 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.875 -179.101 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -64.23 -46.53 83.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.273 179.974 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -97.2 158.79 32.67 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.417 -179.3 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -65.94 149.2 86.44 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 123.486 2.791 . . . . 0.0 113.664 -179.716 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 42.3 pt . . . . . 0 CA--C 1.529 0.163 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.3 179.014 . . . . . . . . 0 0 . 1 . 068 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo . . . . . 0 N--CA 1.494 1.504 0 CA-C-O 120.833 0.264 . . . . 0.0 111.904 . . . . . . . . . 0 0 . 1 . 068 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.7 m -68.49 -45.37 72.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.039 -179.767 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 86.0 mtt85 -90.57 127.54 36.29 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -177.677 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.5 mtp180 -127.88 136.84 51.94 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.207 179.982 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 43.3 tp -114.79 135.2 54.45 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 179.55 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.8 t -113.85 129.65 69.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.281 -179.404 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.4 m -93.61 112.61 24.53 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -178.209 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.587 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 97.0 mt -78.22 144.4 11.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 177.419 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.468 ' C ' HH12 ' A' ' 93' ' ' ARG . 96.6 mttt -91.83 165.99 12.97 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 119.841 -0.744 . . . . 0.0 109.915 178.584 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.749 HH11 HH11 ' B' ' 245' ' ' ARG . 86.2 mtm180 -57.51 -27.95 63.03 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.635 -178.769 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.7 m -79.21 -10.47 59.83 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.433 -179.522 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.61 25.66 19.99 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.018 179.551 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.5 m -117.58 138.83 46.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.597 179.803 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -64.56 127.36 31.21 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.059 -179.717 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -114.88 -128.55 4.51 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 121.146 -0.55 . . . . 0.0 112.054 -179.062 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -75.67 148.84 33.28 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.416 2.077 . . . . 0.0 112.29 -179.14 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -102.77 165.37 11.1 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.6 -179.933 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -139.57 103.74 7.06 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.325 -179.778 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -72.45 126.7 11.81 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 121.446 1.431 . . . . 0.0 111.566 -178.757 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 69.2 mt -85.27 50.75 2.01 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.722 -178.924 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 99.1 p -60.4 -28.63 68.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.1 179.778 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.1 mt -74.61 143.12 44.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.359 -179.732 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 91.5 p -63.91 -17.39 63.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.907 -178.484 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.405 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 31.9 m -133.55 133.54 42.24 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.135 179.857 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.4 t -124.81 116.72 22.73 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.443 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.401 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 36.0 tp -113.98 126.26 54.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.139 -179.218 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.491 ' O ' ' O ' ' A' ' 47' ' ' GLN . 12.7 m-85 -104.88 137.96 41.86 Favored 'General case' 0 C--N 1.334 -0.091 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.652 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 175.57 -174.21 46.71 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 119.95 -1.119 . . . . 0.0 112.011 179.66 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.471 ' NH1' ' H ' ' B' ' 231' ' ' GLN . 27.9 ttp85 -91.59 -16.12 27.59 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.623 -0.288 . . . . 0.0 111.263 179.843 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -81.7 154.35 34.1 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 121.068 -0.587 . . . . 0.0 111.782 -179.43 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.409 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 10.5 tp -66.46 -41.67 89.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.754 0.311 . . . . 0.0 110.459 179.436 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.409 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 80.7 tt0 -50.3 -18.65 0.65 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.912 0.387 . . . . 0.0 110.106 -179.613 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.425 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 82.3 m -73.83 140.72 45.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.207 179.685 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.405 ' OD2' ' O ' ' A' ' 26' ' ' THR . 94.6 m-20 -60.48 -32.78 71.74 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -179.552 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 84.1 mt -126.95 122.5 60.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 176.559 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 67.8 ttp85 -106.36 133.56 50.86 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.461 -179.476 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.458 ' C ' ' H ' ' A' ' 41' ' ' LEU . 79.7 mt -114.37 131.71 65.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.71 -179.55 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -74.5 25.37 0.08 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.962 -178.281 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.458 ' H ' ' C ' ' A' ' 39' ' ' ILE . 50.5 mt -100.29 128.21 31.08 Favored Pre-proline 0 C--N 1.326 -0.427 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.407 179.144 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -73.1 -9.2 23.18 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.347 2.031 . . . . 0.0 111.858 179.678 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.2 m -92.18 5.46 6.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.656 179.829 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 36.1 t -96.84 131.8 42.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.2 179.574 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.9 t -70.17 173.02 7.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.26 -179.052 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.425 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 64.2 mttp -62.77 -42.21 99.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.814 -179.529 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.65 ' O ' ' N ' ' A' ' 49' ' ' CYS . 99.5 mt-30 -114.33 -18.23 11.61 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.203 -179.399 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.4 t60 35.14 -76.53 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 179.8 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.65 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.42 134.58 47.22 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.157 0.503 . . . . 0.0 111.956 -178.521 . . . . . . . . 3 3 . 1 . 068 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -127.16 134.07 50.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.849 -179.966 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.6 mt -119.68 133.42 66.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.96 -179.749 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -108.77 127.48 54.04 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.591 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.7 mm -101.35 115.44 43.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 119.995 -0.682 . . . . 0.0 111.33 -178.726 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.469 ' O ' ' C ' ' A' ' 55' ' ' GLU . 95.8 m-70 -119.1 134.13 55.38 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.731 179.155 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.469 ' C ' ' O ' ' A' ' 54' ' ' HIS . 84.9 tt0 -40.75 -30.71 0.13 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.91 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.453 ' N ' ' C ' ' A' ' 54' ' ' HIS . 94.1 mm-40 -66.19 -68.63 0.36 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.034 178.705 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.53 ' OE1' ' CZ ' ' A' ' 81' ' ' ARG . 2.0 pt-20 -153.92 -172.99 4.41 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.334 -178.823 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -116.46 128.0 55.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.622 179.313 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.2 mt -115.8 130.48 70.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.296 0.57 . . . . 0.0 112.023 -178.279 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 23.4 tp -97.43 129.03 44.68 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.09 179.876 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -113.19 137.04 52.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.882 -179.644 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 62.0 t-20 -93.56 105.62 17.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.468 -179.132 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -101.96 -10.59 19.65 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.324 179.319 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 60.4 p -72.99 102.41 3.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.603 179.742 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.7 p -82.11 -19.0 41.02 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.677 179.742 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.98 -41.29 14.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.001 -179.077 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.443 ' O ' ' OG ' ' A' ' 64' ' ' SER . 47.3 m-20 -143.32 106.93 5.18 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.36 -179.47 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -56.49 143.4 87.8 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 121.606 1.537 . . . . 0.0 112.142 -179.927 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.8 m -69.85 137.35 51.65 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.726 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -97.82 138.34 35.33 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.997 -179.761 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.9 t -133.93 134.52 55.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.994 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 9.9 m120 52.97 30.03 8.76 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 -178.836 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.34 27.49 69.71 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.134 -179.513 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.4 t -140.48 138.82 34.93 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.906 0.384 . . . . 0.0 111.756 -179.606 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.2 m -73.82 141.69 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.996 -179.97 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 10.3 pt -108.36 96.39 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 121.238 0.542 . . . . 0.0 111.462 179.67 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -64.39 -35.62 81.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.777 179.263 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -121.48 171.77 5.72 Favored Pre-proline 0 CA--C 1.533 0.301 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.989 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -60.08 147.25 93.84 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.165 1.91 . . . . 0.0 111.917 179.854 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.9 p -139.2 141.99 34.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.376 0.608 . . . . 0.0 111.755 -179.512 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.53 ' CZ ' ' OE1' ' A' ' 57' ' ' GLU . 79.5 ttt180 -74.78 128.66 36.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.176 179.224 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.2 mt -79.91 135.35 36.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.026 0.441 . . . . 0.0 110.897 -179.888 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -124.47 147.79 48.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.733 179.203 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.557 ' ND1' ' OD1' ' A' ' 99' ' ' ASN . 10.5 t60 -53.36 122.48 9.71 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.005 -179.074 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.93 -16.91 42.54 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.976 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -66.76 135.25 53.69 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.483 -0.487 . . . . 0.0 109.821 179.77 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 53.2 t -109.84 131.93 59.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.011 -178.305 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.1 mt -98.98 130.93 47.14 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.426 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.1 m -121.29 127.52 51.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.632 0.729 . . . . 0.0 112.226 -178.722 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.646 ' O ' ' N ' ' A' ' 93' ' ' ARG . 97.6 mt -119.93 125.21 74.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 178.001 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.525 ' C ' ' O ' ' A' ' 90' ' ' ILE . 62.2 mt -11.15 97.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -178.129 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 78.17 -9.71 1.47 Allowed 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 177.938 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.72 HH12 ' N ' ' A' ' 12' ' ' ARG . 20.0 mmm180 -130.09 133.07 46.42 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.669 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 89.0 p -138.54 153.5 48.73 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.176 179.299 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -130.03 132.23 46.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.268 -179.324 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 92.0 mtm-85 -88.51 130.39 35.24 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.539 -179.825 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -95.58 126.49 40.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.502 -179.452 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -134.8 118.13 16.69 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.192 179.489 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.557 ' OD1' ' ND1' ' A' ' 84' ' ' HIS . 53.4 p-10 -100.64 5.98 43.97 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.336 -179.489 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 . . . . . 0 C--N 1.327 -0.408 0 CA-C-O 121.196 0.522 . . . . 0.0 111.086 179.721 . . . . . . . . 0 0 . 1 . 068 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 5.5 p . . . . . 0 N--CA 1.457 -0.111 0 CA-C-O 120.827 0.346 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 068 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.448 ' O ' ' OD1' ' B' ' 229' ' ' ASP . 52.2 p-10 -63.72 145.63 55.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.857 0.361 . . . . 0.0 110.372 -179.813 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . 0.407 ' O ' ' CB ' ' B' ' 231' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.476 ' O ' ' O ' ' B' ' 232' ' ' GLY . 2.5 mt-30 162.3 -23.83 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 O-C-N 123.583 0.552 . . . . 0.0 110.439 179.727 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' B' ' 231' ' ' GLN . . . -48.33 -171.6 0.01 OUTLIER Glycine 0 CA--C 1.529 0.957 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.373 -179.063 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -64.34 154.6 70.45 Favored 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 123.674 2.916 . . . . 0.0 113.164 -179.44 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 068 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.58 135.47 60.87 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.396 2.064 . . . . 0.0 114.032 -178.379 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 68.0 t -63.65 135.42 27.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.483 179.097 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 2.0 t -46.08 110.25 0.25 Allowed 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.294 -179.842 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . 0.448 HG22 ' H ' ' B' ' 241' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.94 -22.93 19.66 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 122.04 1.826 . . . . 0.0 112.513 179.182 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 21.6 p -76.37 -45.63 31.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.897 0.379 . . . . 0.0 110.39 179.035 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . 0.448 ' H ' HG22 ' B' ' 238' ' ' TPO . 85.4 t80 -58.9 -48.41 81.53 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.32 -178.742 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 80.1 mt -65.45 -42.11 92.69 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.09 -179.892 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -61.28 -43.64 98.53 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.555 -178.87 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 77.0 ttt-85 -63.41 -43.68 96.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.903 0.382 . . . . 0.0 111.312 -179.14 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.749 HH11 HH11 ' A' ' 12' ' ' ARG . 52.8 ttm-85 -64.08 -40.52 96.43 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.862 -179.262 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -60.13 -36.99 78.74 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.744 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 20.2 m -66.15 -42.8 88.54 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 177.189 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . 0.516 ' CD ' HH12 ' A' ' 12' ' ' ARG . 56.7 tt0 -60.27 -34.36 73.61 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.097 179.662 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 55.7 t -63.58 -46.91 93.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.118 178.974 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -58.69 -25.06 62.46 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 179.102 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -93.26 -10.3 36.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.314 178.732 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.497 ' CD2' HH21 ' A' ' 12' ' ' ARG . 55.8 tp -76.5 145.86 38.87 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.283 -179.58 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -106.58 141.44 37.86 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.981 179.797 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . 0.589 ' C ' ' H ' ' B' ' 256' ' ' ASP . 95.8 m-20 -63.46 -30.99 72.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.767 -179.704 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 44.5 p-10 -58.5 0.95 0.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.877 -179.137 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.589 ' H ' ' C ' ' B' ' 254' ' ' ASP . 94.4 m-20 -88.23 175.35 7.72 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.635 178.823 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . 0.693 ' O ' ' N ' ' B' ' 259' ' ' ASP . 98.4 mttt -147.31 -113.37 0.08 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.415 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.659 ' O ' ' N ' ' B' ' 260' ' ' GLU . 97.6 m-20 -33.72 -22.05 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.734 -178.885 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.693 ' N ' ' O ' ' B' ' 257' ' ' LYS . 28.0 t70 40.86 -72.54 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 113.248 0.832 . . . . 0.0 113.248 177.377 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.659 ' N ' ' O ' ' B' ' 258' ' ' ASP . 95.9 mt-10 -136.79 1.99 2.59 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -178.765 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . 0.643 ' CD1' HH21 ' A' ' 93' ' ' ARG . 42.5 mt -110.17 138.3 38.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.101 -179.811 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 43.0 t -125.61 132.33 71.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.005 0.431 . . . . 0.0 110.221 179.262 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -96.39 120.52 36.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.877 -178.94 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -66.01 -47.32 74.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.387 -179.315 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.8 151.99 44.22 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.445 -179.018 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -64.55 147.71 90.34 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.754 2.303 . . . . 0.0 112.31 179.613 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.1 pt . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.448 179.82 . . . . . . . . 0 0 . 1 . 069 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 N--CA 1.494 1.529 0 N-CA-C 111.331 -0.296 . . . . 0.0 111.331 . . . . . . . . . 0 0 . 1 . 069 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 99.2 m -76.96 -46.69 23.17 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -179.55 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.722 ' NH1' ' HH ' ' A' ' 97' ' ' TYR . 95.5 mtt-85 -88.04 128.85 35.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.671 -178.579 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -129.33 140.37 51.42 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 120.471 -0.492 . . . . 0.0 112.13 -179.242 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 34.0 tp -116.25 134.38 54.97 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.843 178.966 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.3 t -110.78 130.83 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.016 -179.945 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 m -94.14 116.86 29.32 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.678 -178.77 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.458 ' CD1' ' HG ' ' A' ' 94' ' ' SER . 96.8 mt -80.18 143.55 12.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.32 179.061 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -91.22 158.88 16.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.022 0.439 . . . . 0.0 110.268 178.637 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.811 HH12 ' NE2' ' B' ' 248' ' ' GLN . 80.9 mtp180 -58.2 -32.07 67.93 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.539 -179.854 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.2 m -77.23 -9.95 59.11 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.006 -179.947 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.71 33.67 7.33 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.446 -0.662 . . . . 0.0 111.446 179.877 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.0 t -119.57 134.22 63.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.733 0.301 . . . . 0.0 110.79 -179.823 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -63.17 122.41 16.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.26 179.942 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -106.89 -139.58 9.38 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.553 -179.266 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.79 155.49 62.43 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.215 1.944 . . . . 0.0 112.082 -179.164 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -107.29 146.8 31.06 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.975 -179.05 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -115.16 101.68 54.52 Favored Pre-proline 0 CA--C 1.536 0.437 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.898 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.72 131.78 17.7 Favored 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 121.398 1.399 . . . . 0.0 111.475 -179.392 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 83.4 mt -86.48 52.44 2.5 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 119.961 -0.695 . . . . 0.0 111.197 -178.44 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.8 p -61.8 -29.87 70.43 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.797 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 67.5 mt -79.06 142.45 36.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.187 179.757 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 72.6 p -66.39 -20.17 66.0 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.969 -0.293 . . . . 0.0 111.713 -179.494 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.416 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 53.2 m -127.04 128.9 47.03 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.292 0.568 . . . . 0.0 112.011 -179.633 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.545 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 11.8 t -123.57 113.54 18.85 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.774 178.697 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.565 ' O ' ' N ' ' A' ' 36' ' ' ASP . 63.4 tp -110.42 125.33 53.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.185 0.517 . . . . 0.0 110.786 -179.555 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.545 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 4.5 m-85 -107.06 140.02 40.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.282 179.583 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 170.38 -160.22 32.88 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.377 179.388 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 27.4 ptt-85 -107.22 -8.92 16.25 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.411 179.817 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.478 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -85.37 167.24 40.93 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.286 -179.945 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.495 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 10.9 tp -67.29 -42.41 87.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.719 0.295 . . . . 0.0 110.779 -179.814 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.495 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 78.4 mm-40 -53.14 -25.55 13.76 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.144 0.497 . . . . 0.0 110.021 -178.908 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.478 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 3.7 m -62.38 124.21 20.32 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.402 179.521 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.565 ' N ' ' O ' ' A' ' 28' ' ' LEU . 63.7 m-20 -58.54 -29.03 66.02 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -179.055 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.459 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 93.6 mt -126.56 122.32 60.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 176.237 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 72.0 ttp85 -106.57 135.81 47.44 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.116 -178.511 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 98.6 mt -115.68 129.1 72.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.009 -179.573 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -74.09 31.5 0.08 Allowed 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 -177.918 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.49 ' CG ' HH21 ' A' ' 93' ' ' ARG . 86.2 mt -107.49 135.88 19.67 Favored Pre-proline 0 C--N 1.323 -0.559 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.888 179.539 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.56 -10.13 24.89 Favored 'Trans proline' 0 C--N 1.315 -1.216 0 C-N-CA 122.067 1.845 . . . . 0.0 111.428 179.215 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.7 m -97.22 6.62 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.216 -179.936 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.0 t -92.78 128.48 44.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.045 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 41.2 t -66.71 172.76 3.96 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.51 0.671 . . . . 0.0 111.628 -178.59 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -65.83 -43.24 89.12 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.96 -179.631 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.628 ' O ' ' N ' ' A' ' 49' ' ' CYS . 86.8 mt-30 -119.36 -5.34 10.37 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.847 -179.002 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.503 ' C ' ' O ' ' A' ' 47' ' ' GLN . 17.8 t60 14.05 -73.37 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 -178.852 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.628 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -126.08 129.53 49.29 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 119.716 -0.793 . . . . 0.0 112.876 -179.069 . . . . . . . . 3 3 . 1 . 069 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -126.58 128.66 47.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.013 178.508 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.425 HG22 HD11 ' A' ' 51' ' ' ILE . 97.2 mt -116.41 134.3 60.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.685 -179.292 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -112.18 122.12 46.86 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.603 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.442 HG21 HD13 ' A' ' 53' ' ' ILE . 95.7 mt -101.8 116.49 45.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 119.543 -0.863 . . . . 0.0 111.847 -178.638 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.485 ' O ' ' N ' ' A' ' 56' ' ' GLN . 94.1 m-70 -114.19 141.52 47.43 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.922 -179.828 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.475 ' OE1' ' N ' ' A' ' 55' ' ' GLU . 51.7 mp0 -40.15 -29.37 0.07 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 179.852 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.485 ' N ' ' O ' ' A' ' 54' ' ' HIS . 56.1 tt0 -65.34 -68.14 0.39 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.241 -0.89 . . . . 0.0 108.997 178.192 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.488 ' OE1' ' O ' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -159.53 -166.28 1.74 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.257 0.551 . . . . 0.0 111.868 -179.531 . . . . . . . . 3 3 . 1 . 069 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.488 ' O ' ' OE1' ' A' ' 57' ' ' GLU . . . -112.88 125.48 54.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.313 179.633 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 99.0 mt -116.08 129.55 72.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -177.924 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.414 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 50.9 tp -96.3 128.87 43.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.642 179.706 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -111.57 135.31 52.33 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.74 179.722 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -100.57 106.84 18.39 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -178.749 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -99.89 -1.44 37.36 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.994 179.031 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.46 100.04 12.46 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.404 -179.553 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.0 p -81.7 -15.16 55.35 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.214 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.92 -35.57 14.65 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.213 -179.86 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -150.7 89.0 4.47 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.24 -179.815 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -57.12 148.9 66.46 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.68 2.253 . . . . 0.0 112.717 -179.665 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 38.1 m -71.99 138.37 47.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.324 179.327 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -96.63 144.54 26.58 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.101 -179.664 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.404 ' O ' ' N ' ' A' ' 74' ' ' SER . 3.9 p -127.87 135.74 62.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.956 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 8.3 m120 48.71 31.46 3.06 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.287 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.56 27.44 63.29 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.686 179.87 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 71' ' ' VAL . 21.1 t -136.67 134.53 37.36 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.998 0.399 . . . . 0.0 110.907 179.784 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -60.64 143.95 13.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.342 -179.911 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.536 ' CG2' ' O ' ' A' ' 78' ' ' GLU . 97.2 mt -107.97 102.93 14.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.456 179.565 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -64.92 -42.31 94.81 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.716 0.294 . . . . 0.0 111.556 179.365 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.536 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.3 OUTLIER -133.67 -179.41 1.06 Allowed Pre-proline 0 CA--C 1.532 0.28 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.597 -178.581 . . . . . . . . 3 3 . 1 . 069 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.471 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 52.3 Cg_exo -55.18 138.05 78.25 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 122.331 2.021 . . . . 0.0 112.779 -178.687 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 72.7 t -134.48 136.68 52.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.792 -179.576 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -73.84 135.49 43.43 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.608 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 97.4 mt -84.89 137.56 33.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.284 0.564 . . . . 0.0 111.466 -179.225 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -126.74 151.04 48.72 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.219 -179.963 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.472 ' ND1' ' OD1' ' A' ' 99' ' ' ASN . 15.0 t60 -60.46 125.76 24.92 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.041 0.448 . . . . 0.0 110.774 -179.43 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.11 -17.88 47.18 Favored Glycine 0 CA--C 1.519 0.289 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.516 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 87' ' ' VAL . 66.4 t0 -72.52 133.05 44.59 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.041 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.512 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 33.6 t -109.36 133.3 54.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.1 0.476 . . . . 0.0 110.998 -179.119 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.4 mt -93.33 131.46 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 178.841 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.3 m -122.44 124.54 43.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.495 0.664 . . . . 0.0 112.311 -178.321 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.575 ' O ' ' N ' ' A' ' 93' ' ' ARG . 98.0 mt -117.84 133.46 64.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.752 178.725 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.49 ' C ' ' O ' ' A' ' 90' ' ' ILE . 80.8 mt -23.7 97.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -178.614 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.473 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 3.2 m-20 89.73 -20.07 0.16 Allowed 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.801 1.038 . . . . 0.0 113.801 177.792 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.603 ' NH2' ' OE1' ' B' ' 260' ' ' GLU . 54.3 mtt-85 -130.33 140.81 50.62 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.6 -179.114 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.458 ' HG ' ' CD1' ' A' ' 10' ' ' ILE . 11.2 p -137.53 150.71 47.73 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.712 0.291 . . . . 0.0 110.241 -179.931 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.541 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 15.4 m-85 -129.53 123.78 32.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.077 -179.038 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -79.37 127.7 32.42 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.137 0.494 . . . . 0.0 111.337 -179.464 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.722 ' HH ' ' NH1' ' A' ' 5' ' ' ARG . 67.9 t80 -94.26 127.68 40.27 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.997 -179.707 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -141.26 116.96 10.33 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.702 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 100' ' ' GLU . 52.4 p30 -71.85 -22.37 61.54 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.48 179.72 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.524 ' N ' ' OD1' ' A' ' 99' ' ' ASN . 96.7 mt-10 . . . . . 0 CA--C 1.53 0.204 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.736 179.798 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 15.2 m . . . . . 0 N--CA 1.448 -0.566 0 CA-C-O 120.932 0.396 . . . . 0.0 110.653 . . . . . . . . . 0 0 . 1 . 069 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 41.55 -108.38 0.09 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.258 -179.923 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 069 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.495 ' O ' ' O ' ' B' ' 232' ' ' GLY . 99.5 mm-40 -123.56 -22.86 4.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.693 -179.742 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' B' ' 231' ' ' GLN . . . -44.76 179.45 0.01 OUTLIER Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 -179.448 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.08 161.95 43.72 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 123.328 2.685 . . . . 0.0 112.762 179.976 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 069 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -75.03 171.16 18.86 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.019 1.813 . . . . 0.0 112.082 -179.841 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 2.9 p -115.18 133.64 60.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.914 179.864 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 2.3 t -74.97 130.11 38.8 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.635 -179.418 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . 0.43 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . 0.43 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 40.7 Cg_exo -57.59 -28.55 81.71 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.849 2.366 . . . . 0.0 113.175 -179.411 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 14.5 m -69.11 -45.68 69.59 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.582 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -57.3 -45.93 83.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.364 -179.327 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 90.6 mt -64.53 -41.37 96.41 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -179.91 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -64.09 -39.11 93.35 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.967 -178.95 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -61.82 -41.64 98.03 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.544 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . . . . . . . . . 71.3 ttp85 -60.9 -42.51 98.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.981 179.847 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.18 -40.59 90.52 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.097 -179.506 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 68.6 m -68.07 -42.99 79.61 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.481 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . 0.811 ' NE2' HH12 ' A' ' 12' ' ' ARG . 56.0 tt0 -62.37 -38.07 88.13 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.61 -179.18 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 77.8 t -60.4 -45.86 96.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.108 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -59.87 -26.75 66.12 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.636 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -83.88 -11.38 57.03 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.703 178.552 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.559 ' O ' ' CB ' ' B' ' 253' ' ' ASN . 97.0 mt -115.01 -173.92 2.4 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.624 179.554 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . 0.559 ' CB ' ' O ' ' B' ' 252' ' ' LEU . 0.3 OUTLIER 91.42 28.01 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.932 179.905 . . . . . . . . 3 3 . 1 . 069 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . 0.585 ' O ' ' CB ' ' B' ' 255' ' ' ASP . 24.0 p-10 -88.4 -6.01 57.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.355 179.534 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . 0.585 ' CB ' ' O ' ' B' ' 254' ' ' ASP . 51.3 t0 112.96 62.36 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 O-C-N 124.286 0.991 . . . . 0.0 110.904 179.636 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 37.2 p30 -98.41 -175.53 3.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.068 0.461 . . . . 0.0 110.865 179.871 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . 0.582 ' C ' ' H ' ' B' ' 259' ' ' ASP . 98.5 mttt -141.01 159.45 42.2 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.185 179.614 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.544 ' O ' ' N ' ' B' ' 260' ' ' GLU . 87.0 m-20 52.34 5.3 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.382 -179.9 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.582 ' H ' ' C ' ' B' ' 257' ' ' LYS . 1.6 p-10 28.55 -87.1 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.011 0.434 . . . . 0.0 111.789 -179.948 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.603 ' OE1' ' NH2' ' A' ' 93' ' ' ARG . 90.8 mt-10 -146.53 14.12 1.23 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.702 -179.95 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 50.5 mt -107.87 139.42 29.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.762 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 61.1 t -126.73 135.27 64.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.511 -179.741 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -98.97 121.54 41.05 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.302 0.572 . . . . 0.0 111.089 -178.833 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -64.66 -46.72 81.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.952 179.913 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -93.15 150.09 38.57 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.956 -179.269 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.7 148.54 65.7 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.549 2.166 . . . . 0.0 112.678 -179.869 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.3 pt . . . . . 0 C--N 1.327 -0.39 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.535 179.589 . . . . . . . . 0 0 . 1 . 070 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo . . . . . 0 N--CA 1.494 1.515 0 CA-C-O 120.678 0.199 . . . . 0.0 111.683 . . . . . . . . . 0 0 . 1 . 070 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 41.4 p -112.29 -44.46 3.39 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.699 -179.692 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 89.7 mtm-85 -88.66 123.68 33.35 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.751 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -130.79 138.48 49.93 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -178.393 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 68.2 mt -112.98 133.52 54.9 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.088 178.645 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 66.4 t -108.77 128.37 64.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.415 179.672 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.9 m -92.17 114.45 27.0 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.729 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.435 ' CD1' ' HG ' ' A' ' 94' ' ' SER . 96.4 mt -78.39 141.88 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.766 178.605 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.74 155.37 20.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.316 179.827 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -57.57 -31.96 66.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.682 -179.515 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.0 p -78.21 -8.3 58.16 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.146 0.498 . . . . 0.0 110.61 -179.877 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.76 38.2 6.21 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 -179.547 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 52.9 t -121.52 132.74 70.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.716 -0.393 . . . . 0.0 111.153 -179.49 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -68.54 116.61 9.28 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.795 -0.816 . . . . 0.0 108.795 179.53 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -107.53 -131.32 6.58 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.994 -178.975 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.58 149.45 61.7 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 121.945 1.763 . . . . 0.0 112.816 -178.63 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -106.85 145.0 32.68 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.598 179.351 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -115.17 96.45 45.41 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.184 -178.805 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.3 134.03 20.27 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.337 1.358 . . . . 0.0 112.311 -179.048 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.5 mt -84.54 83.02 8.15 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.017 -179.172 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 24.3 p -87.31 -12.03 47.73 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.535 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 58.9 mt -99.47 142.41 30.98 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.178 -179.732 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 77.9 p -66.82 -14.92 63.21 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.283 -178.953 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.0 m -130.73 131.98 45.08 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.973 0.416 . . . . 0.0 111.147 -179.721 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.9 t -125.71 119.44 28.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.453 178.992 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 50.5 tp -116.15 131.11 57.03 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.837 0.351 . . . . 0.0 111.408 -178.27 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.562 ' O ' ' O ' ' A' ' 47' ' ' GLN . 10.8 m-85 -108.8 143.29 38.16 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.63 179.704 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 156.74 -152.98 24.32 Favored Glycine 0 C--O 1.223 -0.536 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.262 179.448 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.609 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 32.9 mtm180 -108.0 -26.48 10.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.806 0.336 . . . . 0.0 110.414 179.251 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.562 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -58.29 155.39 22.95 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 121.205 -0.521 . . . . 0.0 111.917 -178.639 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 35.9 mm -63.4 -42.56 96.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.753 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -55.06 -29.6 57.85 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.147 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.562 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 5.7 m -53.99 113.82 1.37 Allowed 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.085 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -59.08 -23.93 62.49 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -178.558 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.451 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 91.1 mt -128.4 121.95 56.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 177.197 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.432 ' O ' ' N ' ' B' ' 262' ' ' VAL . 43.4 mtm180 -110.64 136.81 49.17 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.359 -179.151 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.446 ' C ' ' H ' ' A' ' 41' ' ' LEU . 93.3 mt -115.66 128.91 72.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.688 179.397 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -71.71 33.72 0.06 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.704 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.618 ' CD1' ' NH1' ' A' ' 93' ' ' ARG . 41.6 mt -115.39 131.57 23.54 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 120.189 -0.604 . . . . 0.0 111.14 179.739 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.26 -15.11 31.69 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.345 2.03 . . . . 0.0 113.321 -179.637 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.2 m -84.25 -0.49 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-O 121.009 0.433 . . . . 0.0 110.534 179.61 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.609 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 66.4 t -94.65 133.07 36.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.6 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 38.4 t -71.85 170.73 13.05 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.465 0.65 . . . . 0.0 111.962 -178.335 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.558 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 51.7 mttp -62.48 -40.43 96.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.424 -179.874 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.695 ' O ' ' N ' ' A' ' 49' ' ' CYS . 86.2 mt-30 -119.55 -15.01 9.06 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 123.239 0.337 . . . . 0.0 111.65 -179.249 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.6 t60 32.41 -71.91 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 179.534 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.695 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -134.44 137.34 43.91 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.952 -178.582 . . . . . . . . 3 3 . 1 . 070 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -127.41 131.04 50.36 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.045 179.416 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.6 mt -116.74 135.32 57.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.441 -179.606 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -117.28 124.76 49.79 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.765 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 80.9 mt -104.72 115.75 47.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.724 0.773 . . . . 0.0 112.096 -178.788 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.588 ' O ' ' N ' ' A' ' 56' ' ' GLN . 96.9 m-70 -112.59 141.59 46.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.547 -1.206 . . . . 0.0 108.844 179.129 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 54' ' ' HIS . 50.6 tp10 -39.36 -24.57 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -179.336 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.588 ' N ' ' O ' ' A' ' 54' ' ' HIS . 49.8 tt0 -64.93 -68.2 0.38 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.123 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.93 -155.15 0.4 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.484 178.476 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -116.86 126.04 52.43 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.711 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 99.2 mt -114.92 131.09 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 121.152 0.501 . . . . 0.0 112.064 -178.628 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.409 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 23.9 tp -101.5 129.29 47.54 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.389 -179.451 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -113.23 136.0 53.21 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.577 -179.896 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.456 HD22 ' HA ' ' A' ' 68' ' ' PRO . 41.0 t30 -95.87 105.34 17.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.559 179.998 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -99.12 -10.11 22.95 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.803 179.56 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.41 98.49 11.04 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.865 179.709 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.8 m -75.55 -30.29 59.67 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.407 178.998 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.4 m -61.01 -45.42 94.88 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.856 -179.296 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.2 m-20 -144.07 102.18 4.84 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.982 -179.659 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.456 ' HA ' HD22 ' A' ' 62' ' ' ASN . 32.4 Cg_exo -56.39 146.01 75.81 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 121.479 1.452 . . . . 0.0 112.343 179.554 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.7 m -73.07 144.39 47.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.144 179.17 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -102.8 138.68 39.37 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.491 179.399 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 52.2 t -132.78 131.63 59.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.185 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 54.3 34.12 19.83 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.131 -0.628 . . . . 0.0 109.978 -179.43 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.52 25.56 72.2 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.647 178.901 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 29.1 t -145.55 142.49 29.21 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 117.524 0.662 . . . . 0.0 111.34 179.751 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -73.2 141.63 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.838 179.749 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 11.4 pt -108.13 98.51 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-O 121.43 0.633 . . . . 0.0 110.888 179.0 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -66.23 -32.06 73.26 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.322 179.406 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -123.61 172.84 5.1 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.454 -179.283 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.63 146.72 94.53 Favored 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 122.468 2.112 . . . . 0.0 112.276 179.927 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.7 p -139.97 140.39 35.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.137 0.494 . . . . 0.0 111.304 -179.86 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -75.39 131.94 40.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.573 179.691 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 93.2 mt -87.27 138.39 31.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.274 0.559 . . . . 0.0 111.449 -179.645 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -130.1 156.43 44.55 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.665 179.368 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.751 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 4.7 t60 -59.86 123.83 18.25 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.604 -179.574 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.84 -13.86 45.64 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.877 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -69.7 136.99 51.72 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.472 -0.491 . . . . 0.0 109.864 179.728 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 50.7 t -113.61 130.64 67.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.837 -178.797 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 98.7 mt -103.84 133.33 48.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.734 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 95.8 m -128.58 129.89 46.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.907 0.861 . . . . 0.0 113.217 -178.379 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.465 ' O ' ' N ' ' A' ' 92' ' ' ASP . 92.8 mt -113.2 124.96 70.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.106 -1.406 . . . . 0.0 107.918 178.135 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.452 ' C ' ' O ' ' A' ' 90' ' ' ILE . 52.6 mt 34.68 -94.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.73 -178.719 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.623 ' OD1' ' NH1' ' A' ' 93' ' ' ARG . 31.5 p-10 -116.79 10.3 14.19 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.927 -179.754 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.623 ' NH1' ' OD1' ' A' ' 92' ' ' ASP . 53.4 mtm-85 -122.39 139.43 53.85 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -179.581 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.435 ' HG ' ' CD1' ' A' ' 10' ' ' ILE . 58.5 p -140.31 155.33 46.86 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.961 -179.78 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -124.67 121.96 36.18 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.501 179.711 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -81.18 132.54 35.36 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 119.651 -0.819 . . . . 0.0 110.249 -179.901 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.626 ' OH ' ' ND2' ' A' ' 99' ' ' ASN . 87.2 t80 -102.02 124.98 48.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.494 -178.873 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -140.49 127.7 21.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.045 179.148 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.751 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 94.3 m-20 -107.83 142.25 38.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.166 178.996 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 . . . . . 0 C--N 1.328 -0.356 0 CA-C-O 121.043 0.449 . . . . 0.0 111.043 -179.851 . . . . . . . . 0 0 . 1 . 070 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . 0.467 ' O ' ' O ' ' B' ' 229' ' ' ASP . 89.8 t . . . . . 0 N--CA 1.463 0.206 0 CA-C-O 120.429 0.157 . . . . 0.0 110.784 . . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.513 ' C ' ' H ' ' B' ' 231' ' ' GLN . 95.6 m-20 55.89 118.8 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.463 179.324 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 070 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.513 ' H ' ' C ' ' B' ' 229' ' ' ASP . 69.7 mt-30 -132.37 49.83 2.29 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.325 -179.187 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -116.16 -171.41 16.18 Favored Glycine 0 CA--C 1.531 1.09 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 -179.468 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.12 161.12 45.58 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 123.336 2.691 . . . . 0.0 113.162 -179.766 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 070 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.49 138.95 88.64 Favored 'Trans proline' 0 C--N 1.302 -1.89 0 C-N-CA 121.983 1.789 . . . . 0.0 112.26 179.735 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 3.6 m -66.76 138.69 22.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 114.552 -1.204 . . . . 0.0 110.263 -178.996 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.5 t -59.05 114.97 2.85 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.392 -0.523 . . . . 0.0 109.7 179.918 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . 0.411 ' O1P' ' OG1' ' B' ' 240' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_exo -55.69 -25.62 51.82 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 122.177 1.918 . . . . 0.0 112.137 179.578 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' B' B ' 240' ' ' THR . . . . . 0.411 ' OG1' ' O1P' ' B' ' 238' ' ' TPO . 71.4 m -68.88 -44.77 72.6 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.004 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . 0.713 ' CD1' ' NH2' ' B' ' 245' ' ' ARG . 62.7 t80 -58.07 -46.1 86.0 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.503 -179.4 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 71.9 mt -62.11 -41.04 97.82 Favored 'General case' 0 N--CA 1.462 0.127 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 179.972 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.83 -39.36 93.45 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.208 -179.471 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -59.47 -44.24 93.06 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.659 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.713 ' NH2' ' CD1' ' B' ' 241' ' ' PHE . 0.6 OUTLIER -62.22 -40.9 97.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.44 179.423 . . . . . . . . 3 3 . 1 . 070 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -61.98 -43.74 98.2 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.477 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 38.9 t -63.13 -44.19 96.25 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.529 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -61.35 -33.66 73.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.355 179.764 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 51.3 t -63.12 -45.95 97.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.013 179.548 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -61.41 -28.56 69.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.689 178.932 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -89.16 -7.91 54.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.986 179.258 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.445 ' HG ' ' N ' ' B' ' 253' ' ' ASN . 33.3 tp -96.09 167.92 10.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.456 -179.766 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . 0.445 ' N ' ' HG ' ' B' ' 252' ' ' LEU . 97.7 m-20 -116.85 145.33 43.63 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.319 178.95 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -62.59 -32.24 73.2 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.328 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . 0.449 ' C ' ' OD1' ' B' ' 255' ' ' ASP . 39.1 p-10 -94.77 8.82 41.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.954 179.235 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.689 ' CG ' ' H ' ' B' ' 257' ' ' LYS . 25.4 p-10 -41.44 -94.39 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.014 -179.293 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . 0.689 ' H ' ' CG ' ' B' ' 256' ' ' ASP . 59.3 pttt 171.65 172.64 0.09 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.442 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.566 ' O ' ' O ' ' B' ' 257' ' ' LYS . 86.3 m-20 -27.28 151.97 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.23 0.538 . . . . 0.0 111.257 -178.854 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.603 ' C ' ' H ' ' B' ' 261' ' ' ILE . 24.9 p30 -101.01 -177.48 3.47 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.786 0.803 . . . . 0.0 111.388 -179.465 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -64.04 23.18 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.462 -1.244 . . . . 0.0 112.069 -178.139 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . 0.603 ' H ' ' C ' ' B' ' 259' ' ' ASP . 73.6 mt -109.57 132.88 56.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.335 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . 0.432 ' N ' ' O ' ' A' ' 38' ' ' ARG . 53.7 t -124.37 133.19 70.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.605 -178.775 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -98.91 121.59 41.07 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.135 0.493 . . . . 0.0 111.936 -178.382 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -65.59 -44.04 87.84 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.621 179.417 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.23 158.51 83.85 Favored Pre-proline 0 CA--C 1.517 -0.312 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.828 -179.102 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -57.79 139.47 90.41 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 C-N-CA 122.2 1.933 . . . . 0.0 111.302 179.444 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 19.1 tt . . . . . 0 N--CA 1.441 -0.876 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.206 -179.313 . . . . . . . . 0 0 . 1 . 071 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo . . . . . 0 N--CA 1.495 1.567 0 CA-C-O 120.873 0.28 . . . . 0.0 112.015 . . . . . . . . . 0 0 . 1 . 071 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 99' ' ' ASN . 2.5 t -134.11 24.37 3.87 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.881 179.471 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.603 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 94.9 mtt-85 -81.64 135.7 35.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.038 179.894 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.4 mtp180 -130.54 140.37 50.47 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 121.504 0.669 . . . . 0.0 112.469 -178.63 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 44.4 tp -117.16 133.56 55.85 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.154 179.391 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.2 t -109.33 130.97 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.264 -178.752 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.7 m -89.96 115.59 27.37 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 121.316 0.579 . . . . 0.0 112.357 -178.842 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 94.1 mt -83.9 143.37 11.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.641 178.725 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -86.95 155.0 20.37 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.4 178.364 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.741 HH11 HH11 ' B' ' 245' ' ' ARG . 91.1 mtm180 -52.92 -26.99 16.73 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.848 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 91.6 p -81.36 -6.26 58.72 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.292 179.309 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.63 36.95 9.91 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.322 -179.267 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 36.1 t -120.62 137.09 55.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.953 0.406 . . . . 0.0 111.453 -178.883 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -76.56 121.26 22.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.149 -179.504 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -117.18 -123.79 3.44 Favored Glycine 0 CA--C 1.542 1.739 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -179.786 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -74.8 148.88 36.89 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 122.48 2.12 . . . . 0.0 113.134 -179.359 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -102.96 165.97 10.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.293 179.03 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.44 ' CD2' HD12 ' A' ' 37' ' ' ILE . 52.8 t80 -134.63 97.44 14.23 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.206 -179.248 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.79 122.66 10.81 Favored 'Trans proline' 0 N--CA 1.501 1.943 0 C-N-CA 122.441 2.094 . . . . 0.0 112.694 -179.896 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.6 mt -83.94 49.53 1.65 Allowed 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 121.126 -0.23 . . . . 0.0 111.375 -179.477 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 91.6 p -65.23 -22.55 66.89 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.051 0.453 . . . . 0.0 109.789 179.396 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 80.5 mt -77.58 139.48 39.54 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.991 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.458 ' H ' ' HG ' ' A' ' 25' ' ' SER . 0.8 OUTLIER -63.81 -17.52 63.19 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.223 -0.444 . . . . 0.0 112.047 -178.28 . . . . . . . . 3 3 . 1 . 071 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 86.2 m -133.26 133.97 43.34 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.444 -179.613 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.7 t -122.98 114.79 20.88 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.107 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.41 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 31.4 tp -111.09 128.43 55.88 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.489 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.52 ' O ' ' O ' ' A' ' 47' ' ' GLN . 55.8 m-85 -108.44 137.05 47.05 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.939 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 165.77 -170.94 40.79 Favored Glycine 0 C--O 1.224 -0.52 0 C-N-CA 119.833 -1.175 . . . . 0.0 112.555 179.786 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 37.4 ttp85 -90.19 -30.04 17.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.078 -0.561 . . . . 0.0 111.489 179.843 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.495 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -57.26 155.25 17.92 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.714 -0.555 . . . . 0.0 111.714 -179.226 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.504 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 10.2 tp -66.71 -42.43 89.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.594 -179.704 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.504 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 16.2 pt-20 -58.95 -13.42 6.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.362 -179.418 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.58 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 6.6 m -68.27 128.54 36.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.979 0.418 . . . . 0.0 110.414 -179.507 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.41 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 61.9 m-20 -60.18 -32.84 71.45 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.469 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.44 HD12 ' CD2' ' A' ' 20' ' ' PHE . 47.1 mm -119.59 111.29 32.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 177.275 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 88.4 mtm-85 -100.47 133.57 44.7 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.722 -178.327 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.7 mt -118.91 129.64 74.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.317 0.58 . . . . 0.0 109.813 178.839 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -72.44 33.82 0.06 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.221 -0.9 . . . . 0.0 112.782 -177.381 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.553 ' CD1' ' CZ ' ' A' ' 93' ' ' ARG . 49.6 mt -110.48 133.23 21.19 Favored Pre-proline 0 N--CA 1.468 0.44 0 C-N-CA 119.81 -0.756 . . . . 0.0 111.834 -179.855 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -71.35 -9.38 25.2 Favored 'Trans proline' 0 N--CA 1.488 1.164 0 C-N-CA 122.363 2.042 . . . . 0.0 113.107 -179.11 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.1 m -102.6 6.11 10.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.018 179.864 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 24.1 t -90.91 133.7 31.86 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.956 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.3 m -68.46 158.07 34.52 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.127 -178.83 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.58 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 9.2 mtmp? -63.39 -39.29 94.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.24 -179.506 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.652 ' O ' ' N ' ' A' ' 49' ' ' CYS . 97.9 mt-30 -114.13 -21.43 10.51 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-O 120.885 0.374 . . . . 0.0 110.318 179.559 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.4 t60 33.06 -74.17 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -179.711 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.652 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -129.82 133.28 46.85 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.121 0.486 . . . . 0.0 111.909 -179.001 . . . . . . . . 3 3 . 1 . 071 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -125.27 126.67 45.51 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.809 179.668 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 94.8 mt -113.4 132.51 62.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.606 -179.766 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -112.3 134.87 53.6 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 178.74 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 49.8 mm -104.43 112.86 39.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.752 -179.471 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.443 ' C ' ' N ' ' A' ' 56' ' ' GLN . 97.5 m-70 -116.07 135.36 54.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.944 179.163 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.489 ' OE1' ' N ' ' A' ' 55' ' ' GLU . 53.8 mp0 -41.2 -29.6 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.546 0.689 . . . . 0.0 109.454 -179.58 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.443 ' N ' ' C ' ' A' ' 54' ' ' HIS . 24.4 mt-30 -67.83 -67.75 0.44 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.394 178.526 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.453 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 4.3 tp10 -155.51 -168.46 2.83 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.742 -179.404 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.453 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -116.09 124.47 50.48 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.388 179.121 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.4 HG21 HD12 ' A' ' 59' ' ' ILE . 92.8 mt -110.52 128.8 66.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 120.867 0.365 . . . . 0.0 111.936 -178.928 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 32.2 tp -94.97 124.56 39.09 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.875 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -110.09 134.24 52.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.958 -179.392 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -93.08 108.41 20.0 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.227 -179.234 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -103.36 -11.62 17.77 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.516 179.331 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.474 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 2.1 t -73.77 99.0 3.05 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.452 -179.676 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.5 t -77.22 -43.01 35.14 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.102 0.477 . . . . 0.0 110.552 178.691 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.1 p -66.8 -39.76 87.85 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.865 -179.001 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.474 ' O ' ' OG ' ' A' ' 64' ' ' SER . 39.6 m-80 -142.84 97.43 5.88 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.672 -179.361 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.2 144.21 60.25 Favored 'Trans proline' 0 N--CA 1.502 2.005 0 C-N-CA 122.636 2.224 . . . . 0.0 113.5 -179.813 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 16.4 m -69.65 134.85 49.19 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.547 178.413 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -102.62 138.49 39.46 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.054 -0.658 . . . . 0.0 109.987 179.71 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 75.9 t -131.44 133.97 61.35 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.473 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.831 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 53.91 33.75 17.96 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -178.767 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.54 29.46 72.92 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.335 -179.666 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 73.4 m -141.11 136.14 31.63 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.007 0.432 . . . . 0.0 111.577 -179.633 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.3 p -68.74 142.51 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.681 179.929 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.7 pt -119.46 88.28 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.139 178.729 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -68.01 -26.23 65.79 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.411 0.624 . . . . 0.0 109.588 178.329 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -113.8 159.07 37.23 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 114.935 -1.029 . . . . 0.0 109.889 179.532 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.32 155.1 71.9 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.147 1.898 . . . . 0.0 111.5 179.916 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.0 m -149.65 146.51 16.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.874 -179.222 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.6 mtm-85 -72.19 131.53 42.89 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.366 179.494 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 99.7 mt -82.63 139.09 33.95 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.423 0.63 . . . . 0.0 110.255 179.75 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -124.34 150.17 45.78 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.221 -179.906 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.756 ' HD1' ' H ' ' A' ' 99' ' ' ASN . 5.9 t60 -63.25 126.04 26.11 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 119.719 -0.793 . . . . 0.0 109.495 -179.764 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.07 -18.94 33.2 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.207 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -69.16 143.26 54.12 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.428 179.586 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.4 p -112.57 134.81 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.781 -178.528 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 85.9 mt -103.06 131.15 52.0 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.526 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 53.6 m -121.18 127.85 51.9 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.616 0.722 . . . . 0.0 112.312 -179.106 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.453 ' O ' ' N ' ' A' ' 92' ' ' ASP . 98.0 mt -121.05 128.32 76.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.211 179.886 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.445 ' C ' ' O ' ' A' ' 90' ' ' ILE . 39.4 mm 39.26 -98.58 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.685 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.534 ' O ' ' OD1' ' A' ' 92' ' ' ASP . 65.5 t0 -125.04 23.07 7.85 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.546 0.688 . . . . 0.0 110.642 179.387 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.553 ' CZ ' ' CD1' ' A' ' 41' ' ' LEU . 38.0 mtm-85 -129.52 142.44 50.77 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.147 -0.933 . . . . 0.0 108.865 179.862 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.8 m -135.21 151.22 50.42 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.031 -179.414 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -126.93 120.42 29.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.594 179.179 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -83.12 129.55 35.03 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.151 -0.619 . . . . 0.0 110.644 179.846 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.603 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 93.8 t80 -94.38 126.85 39.9 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.814 179.748 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -142.82 122.46 13.32 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.015 0.436 . . . . 0.0 111.274 -179.879 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.756 ' H ' ' HD1' ' A' ' 84' ' ' HIS . 86.8 m-20 -61.63 -42.81 99.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.502 179.813 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 . . . . . 0 CA--C 1.531 0.215 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.299 179.355 . . . . . . . . 0 0 . 1 . 071 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 43.6 t . . . . . 0 N--CA 1.453 -0.32 0 CA-C-O 120.939 0.399 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 071 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.599 ' C ' ' H ' ' B' ' 231' ' ' GLN . 67.0 t0 -151.07 52.02 0.85 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.812 179.165 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 071 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.599 ' H ' ' C ' ' B' ' 229' ' ' ASP . 78.5 mm-40 -103.93 -23.77 13.32 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.099 0.476 . . . . 0.0 110.904 -179.491 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -62.38 117.51 11.64 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 111.209 -0.757 . . . . 0.0 111.209 -179.751 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.61 134.72 59.33 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 CA-C-N 119.352 1.576 . . . . 0.0 111.165 178.577 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 071 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -78.52 148.48 23.32 Favored 'Trans proline' 0 N--CA 1.489 1.226 0 C-N-CA 122.706 2.271 . . . . 0.0 112.929 179.004 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 14.7 p -62.28 134.95 27.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.49 -179.869 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 7.4 t -67.45 132.82 48.36 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.541 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 071 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -57.2 -25.51 64.81 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.329 2.019 . . . . 0.0 111.427 178.701 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 95.6 m -68.47 -45.23 72.97 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.352 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -58.59 -48.6 80.42 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.182 179.737 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 86.8 mt -64.69 -42.0 95.62 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.916 0.389 . . . . 0.0 110.971 -179.917 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -66.04 -47.06 75.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.282 -179.287 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -62.55 -41.85 99.16 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.167 -179.743 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.741 HH11 HH11 ' A' ' 12' ' ' ARG . 52.1 ttm-85 -64.17 -39.45 94.03 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.188 -179.727 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -59.28 -38.44 80.16 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.361 0.601 . . . . 0.0 109.468 179.923 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 15.9 m -67.14 -42.21 84.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.778 177.974 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -64.04 -31.14 72.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.46 179.881 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.04 -45.33 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.065 178.513 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -62.29 -23.44 66.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.266 0.555 . . . . 0.0 109.794 179.94 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -97.92 -3.31 38.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.065 179.274 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.421 ' CD1' ' O ' ' B' ' 253' ' ' ASN . 1.7 tm? -87.8 126.54 35.07 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.941 0.4 . . . . 0.0 111.288 -178.353 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . 0.421 ' O ' ' CD1' ' B' ' 252' ' ' LEU . 82.9 m-20 -68.79 136.3 52.56 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.636 -179.556 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . 0.448 ' C ' ' H ' ' B' ' 256' ' ' ASP . 22.8 p-10 -71.01 -26.1 62.97 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.092 179.446 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -65.16 0.23 1.42 Allowed 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.655 -179.812 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.502 ' O ' ' C ' ' B' ' 257' ' ' LYS . 78.9 m-20 -92.27 -3.64 55.18 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 120.219 -0.592 . . . . 0.0 109.659 179.502 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . 0.502 ' C ' ' O ' ' B' ' 256' ' ' ASP . 96.9 mttt 27.93 -101.94 0.01 OUTLIER 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.14 -179.58 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.483 ' C ' ' O ' ' B' ' 257' ' ' LYS . 82.1 m-20 -30.95 136.81 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.145 179.955 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.631 ' C ' ' H ' ' B' ' 261' ' ' ILE . 52.7 p30 -121.26 -172.9 2.5 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 122.086 0.946 . . . . 0.0 111.488 -179.186 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -58.65 12.96 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 113.891 -1.504 . . . . 0.0 112.021 -178.832 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . 0.631 ' H ' ' C ' ' B' ' 259' ' ' ASP . 66.3 mt -107.94 136.41 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 177.845 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 55.2 t -127.59 135.34 63.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.88 -178.618 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -94.74 117.16 29.69 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.907 -178.744 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -64.5 -46.11 84.37 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.264 179.935 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.68 158.24 36.95 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.657 -179.53 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -61.24 147.43 95.63 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 C-N-CA 123.041 2.494 . . . . 0.0 112.609 179.47 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.4 pt . . . . . 0 C--N 1.326 -0.427 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.073 -179.783 . . . . . . . . 0 0 . 1 . 072 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo . . . . . 0 N--CA 1.491 1.375 0 N-CA-C 111.488 -0.235 . . . . 0.0 111.488 . . . . . . . . . 0 0 . 1 . 072 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.4 p -73.46 -34.54 65.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.501 -179.479 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.7 mtm-85 -100.72 115.5 30.41 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 121.031 -0.268 . . . . 0.0 110.761 -179.57 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -131.65 141.23 49.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.277 0.56 . . . . 0.0 111.427 179.769 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 36.4 tp -114.47 127.7 55.95 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.413 179.908 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 75.8 t -103.15 127.86 56.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.521 -0.471 . . . . 0.0 110.268 -179.406 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 m -92.85 114.45 27.01 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 121.113 0.482 . . . . 0.0 111.398 -179.52 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 85.9 mt -80.86 146.78 6.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.419 179.746 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -90.3 154.17 19.91 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 177.811 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.48 ' NH1' ' OD2' ' A' ' 92' ' ' ASP . 38.4 mtp85 -58.04 -28.71 64.75 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.547 -179.245 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 86.0 p -74.81 -14.9 60.74 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.606 -0.437 . . . . 0.0 110.142 178.949 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.54 36.44 4.84 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 -179.518 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.6 t -123.72 133.78 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-O 120.848 0.356 . . . . 0.0 111.68 -179.447 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -66.02 125.87 26.83 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.364 179.512 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -117.28 -126.98 3.83 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.458 -178.951 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -73.76 147.33 39.61 Favored 'Trans proline' 0 N--CA 1.5 1.874 0 C-N-CA 122.604 2.203 . . . . 0.0 112.955 -178.446 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 62.7 m170 -109.23 132.17 54.37 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.913 0.387 . . . . 0.0 110.705 -179.955 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -102.22 105.42 42.76 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.936 -179.893 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -74.93 128.66 11.72 Favored 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 121.464 1.443 . . . . 0.0 111.529 -179.418 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 64.9 mt -89.99 44.17 1.19 Allowed 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.387 -178.472 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 84.8 p -59.23 -21.94 60.31 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.408 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 73.6 mt -76.92 146.05 37.82 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.326 179.836 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.0 m -64.24 -23.18 67.21 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.23 -178.981 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 61.2 m -136.26 136.45 39.84 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.897 -179.039 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.1 t -128.01 120.05 26.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.062 179.063 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.4 tp -114.81 132.34 56.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.641 0.258 . . . . 0.0 111.112 -178.749 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.506 ' O ' ' O ' ' A' ' 47' ' ' GLN . 5.9 m-85 -111.92 139.8 47.11 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.902 179.715 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.44 -167.56 30.84 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 120.564 -0.826 . . . . 0.0 112.164 178.755 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.502 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 45.8 mtm180 -84.5 -32.0 24.19 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.867 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.572 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -49.49 143.69 9.65 Favored Glycine 0 CA--C 1.519 0.323 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 -178.662 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.0 tp -65.99 -41.1 89.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 120.248 -0.581 . . . . 0.0 109.932 179.995 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.407 ' HA ' ' HZ2' ' B' ' 264' ' ' LYS . 82.5 tt0 -54.71 -20.48 8.42 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.228 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.572 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 34.2 m -59.65 126.54 28.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.924 -179.834 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -59.83 -31.98 70.24 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.249 0.547 . . . . 0.0 109.547 -179.623 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.455 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 97.4 mt -123.83 116.56 48.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.148 177.761 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 25.9 mtp85 -100.86 132.39 46.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.434 -178.197 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 92.8 mt -121.7 131.11 73.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.987 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -79.53 34.16 0.26 Allowed 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -177.849 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.563 ' CD1' HH21 ' A' ' 93' ' ' ARG . 23.6 mt -104.76 127.88 27.96 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.895 178.92 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -73.42 -9.49 23.03 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 122.303 2.002 . . . . 0.0 112.277 -179.997 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.0 m -91.73 1.09 8.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.73 0.3 . . . . 0.0 110.677 179.798 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.502 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 42.8 t -98.35 138.02 24.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.989 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 64.0 m -72.38 170.58 13.91 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.101 0.477 . . . . 0.0 111.364 -178.794 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -62.48 -41.41 98.77 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.884 -179.099 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.626 ' O ' ' N ' ' A' ' 49' ' ' CYS . 89.6 mt-30 -111.44 -18.5 12.85 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.631 0.253 . . . . 0.0 111.489 -179.698 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.6 t60 36.61 -77.06 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 179.262 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.626 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.66 136.08 47.41 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.067 0.461 . . . . 0.0 111.559 -178.475 . . . . . . . . 3 3 . 1 . 072 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -129.45 132.17 46.89 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.477 179.774 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.7 mt -115.13 134.31 58.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.855 -179.745 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -116.65 124.22 49.22 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.783 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 98.0 mt -107.25 114.69 46.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.483 -179.668 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.459 ' O ' ' N ' ' A' ' 56' ' ' GLN . 89.5 m-70 -114.22 145.95 41.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.831 179.924 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 54' ' ' HIS . 53.4 tp10 -40.7 -28.63 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.603 -179.819 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.459 ' N ' ' O ' ' A' ' 54' ' ' HIS . 84.1 mt-30 -63.53 -68.79 0.32 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.962 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.468 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 6.1 tp10 -159.9 -163.48 1.15 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.996 179.379 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.468 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -110.3 127.49 55.04 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.659 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.7 mt -117.22 130.2 72.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.371 0.605 . . . . 0.0 112.099 -178.911 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.8 tp -99.17 129.12 45.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.292 -179.74 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -114.53 137.48 51.81 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.618 179.975 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.446 HD22 ' HA ' ' A' ' 68' ' ' PRO . 54.1 t30 -97.61 107.55 20.08 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.374 -179.757 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -98.9 -10.1 23.29 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 179.918 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.2 t -74.98 102.71 4.9 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.548 179.429 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.7 p -82.28 -17.7 44.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.98 0.419 . . . . 0.0 110.382 179.764 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.24 -39.96 11.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.009 -179.102 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.414 HD22 ' HA ' ' B' ' 236' ' ' VAL . 71.2 m-20 -140.65 94.52 8.22 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.555 -179.936 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.446 ' HA ' HD22 ' A' ' 62' ' ' ASN . 32.2 Cg_exo -57.01 146.34 80.91 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.005 1.804 . . . . 0.0 112.028 -179.404 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.1 m -72.93 137.48 45.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.496 179.967 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -100.76 141.27 33.87 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.104 -179.827 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 46.0 t -127.2 136.95 59.24 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.155 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 51.29 32.31 8.13 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.714 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.96 29.92 68.52 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 -179.965 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.3 p -140.25 134.76 31.52 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 120.641 -0.423 . . . . 0.0 111.644 -179.3 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 52.9 t -67.8 132.89 32.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-O 121.248 0.547 . . . . 0.0 110.929 179.708 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.13 111.39 25.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.807 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -96.25 -10.62 27.54 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.734 -0.387 . . . . 0.0 111.772 -178.592 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -117.25 158.12 45.36 Favored Pre-proline 0 C--N 1.329 -0.3 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.627 -179.412 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -56.12 142.49 86.31 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 121.919 1.746 . . . . 0.0 112.216 179.522 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 18.9 m -144.57 139.96 23.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.623 179.306 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 89.3 mtm-85 -72.91 133.07 44.22 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.876 0.37 . . . . 0.0 110.176 179.758 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 93.7 mt -81.45 138.98 35.48 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.169 -179.434 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -126.78 148.91 49.89 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.466 179.429 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.692 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 12.4 t60 -58.48 124.89 21.14 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.886 0.374 . . . . 0.0 111.209 -178.667 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.07 -20.96 34.69 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.444 -0.662 . . . . 0.0 111.444 179.967 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -66.87 138.44 57.32 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 120.491 -0.483 . . . . 0.0 110.023 179.731 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 79.5 t -110.36 132.69 58.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.25 -178.747 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 82.5 mt -100.63 132.6 45.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.324 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 93.7 m -120.82 125.52 47.76 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.032 -0.667 . . . . 0.0 112.172 -178.203 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.422 ' O ' ' C ' ' A' ' 91' ' ' ILE . 96.2 mt -116.25 123.96 71.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.019 -0.991 . . . . 0.0 108.61 178.694 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.422 ' C ' ' O ' ' A' ' 90' ' ' ILE . 48.8 mm 39.72 -106.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.618 -179.318 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.48 ' OD2' ' NH1' ' A' ' 12' ' ' ARG . 32.8 p-10 -110.1 13.09 23.34 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.787 0.327 . . . . 0.0 111.698 -179.346 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.563 HH21 ' CD1' ' A' ' 41' ' ' LEU . 9.5 mtm105 -118.51 140.4 49.94 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.198 179.732 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.0 m -128.88 144.8 51.28 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.006 179.007 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 41.7 m-85 -126.73 123.53 37.69 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.497 -179.782 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -85.95 128.49 34.85 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 119.953 -0.699 . . . . 0.0 109.721 -179.754 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -93.98 127.98 40.07 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 120.897 0.38 . . . . 0.0 110.495 -179.995 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -126.56 128.79 47.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.56 -179.323 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.692 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 43.8 t30 -135.24 104.27 5.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.538 179.485 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.1 tp10 . . . . . 0 C--N 1.328 -0.367 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -179.663 . . . . . . . . 0 0 . 1 . 072 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 34.7 m . . . . . 0 N--CA 1.454 -0.246 0 CA-C-O 121.171 0.51 . . . . 0.0 110.097 . . . . . . . . . 0 0 . 1 . 072 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.616 ' O ' ' N ' ' B' ' 231' ' ' GLN . 97.5 m-20 -60.83 140.25 57.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.741 -179.64 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . 0.46 ' C ' ' O ' ' B' ' 229' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.616 ' N ' ' O ' ' B' ' 229' ' ' ASP . 0.9 OUTLIER -169.6 43.74 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 121.378 0.608 . . . . 0.0 110.247 179.956 . . . . . . . . 3 3 . 1 . 072 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -132.79 163.14 24.2 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 179.987 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.84 156.89 56.18 Favored 'Trans proline' 0 N--CA 1.499 1.822 0 C-N-CA 123.828 3.019 . . . . 0.0 113.123 -179.964 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 072 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.71 138.93 30.0 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 C-N-CA 122.035 1.823 . . . . 0.0 112.763 179.253 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . 0.414 ' HA ' HD22 ' A' ' 67' ' ' ASN . 77.5 t -59.83 134.98 24.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.664 -179.625 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 4.5 t -51.91 126.9 19.55 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.493 -179.117 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . 0.429 ' O2P' ' OG1' ' B' ' 240' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.36 -18.47 64.83 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.462 2.108 . . . . 0.0 111.736 -179.683 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' B' B ' 240' ' ' THR . . . . . 0.429 ' OG1' ' O2P' ' B' ' 238' ' ' TPO . 73.5 m -75.07 -45.36 41.97 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 176.956 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -57.07 -47.52 80.8 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.265 -179.106 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 93.0 mt -66.07 -39.85 90.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.15 -179.611 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -62.4 -42.18 99.23 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.577 -179.257 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -63.39 -42.0 98.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.019 0.438 . . . . 0.0 110.058 179.523 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.497 ' CA ' ' HE ' ' B' ' 245' ' ' ARG . 0.0 OUTLIER -63.19 -43.15 99.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.81 -179.348 . . . . . . . . 3 3 . 1 . 072 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.76 -37.71 87.7 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.66 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 39.0 t -64.71 -42.61 95.13 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 177.29 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -59.26 -36.88 76.31 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.073 179.997 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 46.3 t -62.99 -45.25 99.36 Favored 'Isoleucine or valine' 0 C--O 1.23 0.057 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.129 178.829 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -57.71 -29.13 64.45 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.152 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -90.91 -9.97 44.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.288 179.393 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 53.0 tp -80.97 150.84 28.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.69 179.754 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -109.35 141.19 42.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.162 178.966 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . 0.434 ' C ' ' H ' ' B' ' 256' ' ' ASP . 38.7 t70 -61.73 -29.06 69.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.835 0.35 . . . . 0.0 110.993 -179.65 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -65.09 1.24 1.02 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.255 -179.237 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.531 ' CG ' ' H ' ' B' ' 257' ' ' LYS . 32.6 t70 -89.4 -179.13 5.77 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 179.397 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . 0.607 ' O ' ' C ' ' B' ' 258' ' ' ASP . 97.8 mttt -145.32 -119.63 0.08 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.122 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.607 ' C ' ' O ' ' B' ' 257' ' ' LYS . 96.3 m-20 -7.26 78.17 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 O-C-N 123.741 0.651 . . . . 0.0 111.004 -179.951 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.559 ' C ' ' H ' ' B' ' 261' ' ' ILE . 61.2 t0 -83.3 85.9 7.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.41 0.624 . . . . 0.0 110.624 -179.138 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 56.14 -1.91 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.025 -0.988 . . . . 0.0 111.735 179.443 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . 0.559 ' H ' ' C ' ' B' ' 259' ' ' ASP . 16.8 mt -115.84 135.85 54.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.51 -179.627 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 45.2 t -127.23 133.72 67.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.537 179.272 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -96.37 119.93 35.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.151 0.5 . . . . 0.0 111.711 -178.638 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . 0.407 ' HZ2' ' HA ' ' A' ' 34' ' ' GLU . 88.4 tttt -65.45 -44.51 87.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.335 178.964 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -100.25 157.35 33.97 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.979 -179.171 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.4 157.51 54.22 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.945 2.43 . . . . 0.0 112.0 178.763 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 45.3 pt . . . . . 0 C--N 1.33 -0.258 0 CA-C-O 121.336 0.588 . . . . 0.0 112.306 -178.868 . . . . . . . . 0 0 . 1 . 073 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo . . . . . 0 N--CA 1.496 1.638 0 CA-C-O 120.891 0.288 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 073 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.4 t -122.78 34.44 5.14 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.145 179.749 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -94.07 123.1 37.23 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.918 -179.57 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 -128.23 137.14 51.89 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.214 -179.903 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 39.6 tp -112.87 130.98 55.91 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.845 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 66.7 t -109.53 130.99 61.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.325 -179.439 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 m -90.87 118.56 30.37 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.163 -178.765 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.598 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 96.0 mt -81.63 140.54 16.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.063 179.282 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.577 ' NZ ' ' O ' ' B' ' 257' ' ' LYS . 41.5 mmtt -83.71 158.91 21.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.955 0.407 . . . . 0.0 110.058 178.89 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.563 ' N ' HH12 ' A' ' 93' ' ' ARG . 85.4 mtp180 -57.74 -35.48 70.76 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.12 -178.646 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.4 t -76.08 -8.52 57.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.739 0.304 . . . . 0.0 111.414 -179.787 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.66 35.07 5.76 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 -179.184 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.6 t -121.84 132.9 69.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.785 0.326 . . . . 0.0 111.189 -179.72 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -77.71 137.12 38.31 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.313 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.95 -118.34 2.03 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 120.617 -0.802 . . . . 0.0 111.492 -179.63 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.53 151.96 48.03 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.216 1.944 . . . . 0.0 112.274 -179.25 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.459 ' CD2' ' C ' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -117.1 156.62 27.28 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.309 179.814 . . . . . . . . 3 3 . 1 . 073 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -124.04 107.03 30.83 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.924 -179.13 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.24 135.16 22.2 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 121.546 1.497 . . . . 0.0 111.961 -179.282 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 62.2 mt -96.44 40.95 1.12 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.166 -178.512 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.8 p -63.07 -18.47 63.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.146 0.498 . . . . 0.0 109.957 179.541 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.9 mt -75.53 149.49 38.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.504 179.219 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 26.3 m -62.99 -25.52 68.42 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.494 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.478 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 95.7 m -139.25 139.66 37.48 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 120.1 -0.64 . . . . 0.0 112.541 -179.59 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.0 t -128.09 116.63 20.27 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.852 179.027 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.9 tp -113.81 128.91 56.6 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.84 0.352 . . . . 0.0 110.976 -179.073 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.503 ' O ' ' O ' ' A' ' 47' ' ' GLN . 5.1 m-85 -108.07 137.04 46.75 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.171 -179.511 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 152.54 -172.79 31.67 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.216 -0.992 . . . . 0.0 112.267 178.756 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 48.1 mtm180 -76.98 -32.57 57.35 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 179.851 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.498 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -48.23 144.95 6.2 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 120.674 -0.775 . . . . 0.0 111.263 -178.693 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.469 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 9.9 tp -65.64 -41.16 89.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.824 0.345 . . . . 0.0 110.12 -179.99 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.469 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 80.3 mm-40 -57.06 -19.54 19.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.959 -179.987 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 62.8 m -56.05 122.69 12.23 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.703 -179.751 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.478 ' OD2' ' O ' ' A' ' 26' ' ' THR . 56.0 m-20 -58.88 -30.72 67.97 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -179.947 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.435 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 85.6 mt -127.01 120.51 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.361 177.333 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 84.4 mtp180 -102.46 135.15 44.59 Favored 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.472 -179.354 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.427 ' C ' ' H ' ' A' ' 41' ' ' LEU . 97.1 mt -116.12 126.31 73.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.145 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -75.05 30.62 0.09 Allowed 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -177.87 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.427 ' H ' ' C ' ' A' ' 39' ' ' ILE . 45.9 mt -98.27 126.22 40.57 Favored Pre-proline 0 C--N 1.325 -0.49 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.3 179.259 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -72.4 -8.22 22.27 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 C-N-CA 122.315 2.01 . . . . 0.0 112.853 -179.719 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.5 m -101.73 6.32 10.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.069 0.462 . . . . 0.0 110.422 179.52 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.1 t -91.01 137.41 21.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.431 178.747 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.8 m -68.72 169.24 11.63 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.613 0.72 . . . . 0.0 112.214 -178.332 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -62.78 -43.93 97.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.177 -179.041 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.586 ' O ' ' N ' ' A' ' 49' ' ' CYS . 95.2 mm-40 -113.65 -25.75 8.56 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.95 -179.532 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.1 t60 40.42 -78.74 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.878 -1.056 . . . . 0.0 113.43 179.661 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.586 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -129.05 136.03 49.72 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.025 . . . . . . . . 3 3 . 1 . 073 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -129.53 126.82 39.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.798 -179.931 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.1 mt -112.04 134.72 53.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.341 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -119.77 127.67 53.02 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.624 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 83.6 mt -105.67 121.52 58.02 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 CA-C-O 121.694 0.759 . . . . 0.0 111.609 -178.904 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.548 ' O ' ' N ' ' A' ' 56' ' ' GLN . 92.5 m-70 -117.11 142.81 46.52 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.105 -179.504 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 54' ' ' HIS . 92.4 mt-10 -39.0 -26.75 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -179.295 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.548 ' N ' ' O ' ' A' ' 54' ' ' HIS . 87.7 mt-30 -68.63 -67.39 0.47 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.679 179.045 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.485 ' CD ' HH21 ' A' ' 81' ' ' ARG . 5.3 tp10 -159.66 -156.98 0.54 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.221 179.802 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -120.88 131.17 54.24 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.039 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 93.5 mt -120.77 131.22 73.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.031 0.443 . . . . 0.0 112.027 -178.455 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 34.7 tp -94.48 125.2 38.98 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.042 179.566 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -111.21 138.22 47.93 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.16 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.617 HD22 ' CB ' ' A' ' 68' ' ' PRO . 63.5 t-20 -101.74 107.82 19.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.43 . . . . 0.0 112.013 -178.53 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -99.33 -9.87 23.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.43 -179.991 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.49 99.93 9.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.691 0.281 . . . . 0.0 110.295 -179.634 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.2 p -82.34 -35.9 27.42 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.963 179.811 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.69 -48.19 81.9 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.182 0.515 . . . . 0.0 109.902 -179.517 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -139.63 100.63 7.45 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.683 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.617 ' CB ' HD22 ' A' ' 62' ' ' ASN . 44.7 Cg_endo -66.9 151.22 82.64 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 121.56 1.507 . . . . 0.0 113.662 -177.79 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.41 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 16.6 m -68.38 144.02 54.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.116 -179.835 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -103.73 140.6 37.38 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.85 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.9 p -129.27 135.85 60.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.621 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 49.83 34.34 7.58 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.628 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.04 28.19 70.83 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.529 -179.838 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.0 m -139.64 139.69 36.76 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.796 -179.421 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.3 t -68.56 135.93 27.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 120.909 0.385 . . . . 0.0 111.231 179.661 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.518 ' CG1' ' O ' ' A' ' 78' ' ' GLU . 9.6 tt -105.45 96.56 4.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.332 179.906 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -64.57 -35.59 81.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.67 179.736 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.518 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 0.0 OUTLIER -133.55 177.22 2.36 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 120.596 -0.441 . . . . 0.0 111.722 -179.157 . . . . . . . . 3 3 . 1 . 073 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.433 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 48.8 Cg_exo -56.22 141.72 87.84 Favored 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 122.842 2.362 . . . . 0.0 112.944 -179.661 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 42.1 t -134.58 141.26 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.027 -179.636 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.485 HH21 ' CD ' ' A' ' 57' ' ' GLU . 60.2 ttt180 -74.03 122.83 23.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.022 178.353 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 98.5 mt -75.02 140.44 43.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.174 0.511 . . . . 0.0 111.3 -179.144 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -133.17 147.7 52.06 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.58 179.701 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.516 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 7.8 t60 -52.66 114.4 1.38 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.316 179.38 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 113.85 -14.67 21.82 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.179 -0.769 . . . . 0.0 111.179 179.997 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -69.42 131.32 44.59 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.028 179.684 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 66.8 t -110.55 129.4 65.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.369 -178.95 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 89.7 mt -101.71 133.9 43.78 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.51 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 66.5 m -121.71 121.85 38.23 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.583 0.706 . . . . 0.0 111.529 -179.135 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.632 ' O ' ' N ' ' A' ' 93' ' ' ARG . 86.6 mt -110.32 128.98 66.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.533 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.539 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 61.8 mt -15.42 92.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -178.519 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.539 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 2.7 t70 88.73 -22.33 0.13 Allowed 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 177.595 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.632 ' N ' ' O ' ' A' ' 90' ' ' ILE . 19.6 mmm180 -122.94 138.74 54.59 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.789 -0.365 . . . . 0.0 110.349 -179.603 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 69.4 m -134.88 150.0 50.38 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.707 179.688 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.409 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 55.3 m-85 -127.56 121.35 30.39 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.361 -179.917 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 96' ' ' ARG . 42.1 ttp-105 -84.77 133.51 34.35 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.906 0.384 . . . . 0.0 110.257 -179.834 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -94.3 121.34 35.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.199 -179.327 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -127.56 123.08 34.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.616 179.971 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.516 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 7.8 p-10 -134.55 130.2 36.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.047 179.4 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 . . . . . 0 C--N 1.33 -0.262 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.593 -179.376 . . . . . . . . 0 0 . 1 . 073 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 58.0 t . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 120.794 0.331 . . . . 0.0 110.587 . . . . . . . . . 0 0 . 1 . 073 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -63.6 -161.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.316 179.924 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 073 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -161.96 55.05 0.25 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.45 179.065 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -110.9 -152.62 12.77 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 -179.733 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -61.35 150.98 82.45 Favored 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 123.307 2.671 . . . . 0.0 112.889 -179.902 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 073 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -60.2 146.12 97.03 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.768 2.312 . . . . 0.0 112.7 179.982 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 28.3 t -89.48 131.08 37.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.038 178.89 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 8.0 t -66.35 123.11 19.08 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.984 0.421 . . . . 0.0 110.965 -179.264 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 073 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -60.28 -20.47 62.63 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.251 1.967 . . . . 0.0 111.712 -179.432 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 3.1 m -74.05 -41.8 61.22 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 177.259 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -57.49 -47.24 82.44 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.238 -179.69 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 99.3 mt -65.55 -39.87 92.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.778 -179.787 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -61.28 -42.05 97.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.425 -179.801 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -62.0 -43.41 98.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.64 179.512 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.417 ' NH1' ' OE1' ' B' ' 248' ' ' GLN . 2.6 mpt_? -60.33 -40.74 91.7 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.292 -179.927 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -63.5 -43.01 98.49 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.375 0.607 . . . . 0.0 109.76 179.089 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 72.3 m -62.71 -44.38 96.37 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.646 179.094 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . 0.485 ' O ' ' N ' ' B' ' 252' ' ' LEU . 86.5 mt-30 -61.11 -36.68 80.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.572 -179.887 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 22.9 t -60.03 -44.77 95.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.139 179.301 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -65.18 -30.31 71.21 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.263 178.741 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -90.92 -13.47 33.48 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.221 -179.223 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.485 ' N ' ' O ' ' B' ' 248' ' ' GLN . 33.0 mt -85.6 171.17 11.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.008 0.433 . . . . 0.0 110.049 178.672 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . 0.585 ' C ' ' H ' ' B' ' 255' ' ' ASP . 69.5 m-80 -144.07 178.42 7.88 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.006 -179.559 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -46.09 -10.83 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.212 -179.895 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . 0.585 ' H ' ' C ' ' B' ' 253' ' ' ASN . 96.6 m-20 -70.74 -6.35 36.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.976 0.417 . . . . 0.0 110.085 178.668 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.404 ' C ' ' OD1' ' B' ' 256' ' ' ASP . 39.9 p-10 -97.17 16.81 18.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.797 -179.916 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . 0.577 ' O ' ' NZ ' ' A' ' 11' ' ' LYS . 88.4 tttt -58.3 -22.05 51.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.176 179.156 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.467 ' O ' ' OD1' ' B' ' 259' ' ' ASP . 91.5 m-20 -63.52 -44.43 94.29 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.428 -179.832 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.551 ' C ' ' H ' ' B' ' 261' ' ' ILE . 4.0 p30 57.58 138.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.812 0.815 . . . . 0.0 110.965 -178.192 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.658 ' CD ' ' H ' ' B' ' 260' ' ' GLU . 1.3 pm0 -65.64 25.87 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.318 -1.31 . . . . 0.0 112.421 -178.359 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . 0.551 ' H ' ' C ' ' B' ' 259' ' ' ASP . 60.1 mt -118.67 131.69 70.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.146 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 50.8 t -128.88 134.81 63.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.057 -179.515 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -94.45 119.92 33.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.174 0.511 . . . . 0.0 111.206 -178.582 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.26 -44.72 94.35 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.507 179.56 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -102.19 159.93 27.91 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.408 -179.086 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -65.88 161.45 39.37 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.602 2.201 . . . . 0.0 111.723 179.68 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.4 pt . . . . . 0 C--N 1.33 -0.258 0 CA-C-O 121.435 0.636 . . . . 0.0 111.952 -179.03 . . . . . . . . 0 0 . 1 . 074 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo . . . . . 0 N--CA 1.495 1.572 0 N-CA-C 112.999 0.346 . . . . 0.0 112.999 . . . . . . . . . 0 0 . 1 . 074 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 54.2 m -103.4 -58.61 1.85 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.494 179.306 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.507 ' NH2' ' O ' ' A' ' 22' ' ' LEU . 82.9 mtm-85 -81.72 132.61 35.29 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.41 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 91.0 mtm-85 -127.1 131.42 50.84 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.295 -179.768 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 29.8 tp -117.22 126.24 52.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.409 179.348 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.8 m -101.3 133.65 43.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.903 -179.277 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.7 m -92.2 113.87 26.26 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.072 -178.874 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.3 mt -81.78 144.53 10.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.683 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.582 ' HZ3' ' C ' ' B' ' 257' ' ' LYS . 66.8 mttm -101.02 164.02 12.01 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.618 179.965 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.432 ' HD3' HH12 ' A' ' 93' ' ' ARG . 87.4 mtm180 -59.35 -31.56 69.31 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.569 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.1 t -70.35 -20.59 62.97 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.484 179.239 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.39 17.3 20.24 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.727 179.36 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.5 m -110.23 135.49 49.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.991 0.424 . . . . 0.0 111.198 -179.733 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 17' ' ' GLY . 64.0 t0 -76.55 135.75 39.28 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.029 179.602 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.511 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -126.63 -114.03 1.88 Allowed Glycine 0 CA--C 1.537 1.428 0 C-N-CA 120.361 -0.924 . . . . 0.0 111.961 -179.897 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.91 147.64 50.06 Favored 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 122.434 2.089 . . . . 0.0 113.488 -178.678 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -109.83 142.1 41.58 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.148 179.325 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -113.32 106.14 54.75 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.041 -179.829 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.62 129.46 13.67 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 121.419 1.413 . . . . 0.0 111.831 -179.432 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.507 ' O ' ' NH2' ' A' ' 5' ' ' ARG . 25.8 mt -94.77 39.94 1.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.858 -178.556 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.9 t -63.12 -15.82 57.99 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.405 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.8 mt -73.7 145.36 45.27 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.327 179.891 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 86.6 p -58.44 -26.38 63.26 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.049 -178.42 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 87.3 m -141.41 139.99 33.56 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.487 -179.584 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.665 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 6.6 t -129.29 119.88 24.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.668 178.856 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 50.1 tp -114.7 130.49 56.83 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.373 -178.422 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.665 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 7.0 m-85 -107.68 141.02 39.84 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.807 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 153.39 -171.39 32.27 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 119.95 -1.119 . . . . 0.0 112.538 179.053 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.5 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 45.0 mtm180 -85.8 -32.57 21.72 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 111.497 0.184 . . . . 0.0 111.497 179.564 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -47.36 150.05 2.55 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 -178.977 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.545 ' O ' ' NH2' ' A' ' 38' ' ' ARG . 8.2 tp -64.54 -41.52 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 O-C-N 122.442 -0.446 . . . . 0.0 110.574 -179.579 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.464 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 95.5 mt-10 -59.08 -18.82 38.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.898 -179.315 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 71.4 m -57.11 118.94 5.53 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.119 -179.869 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -56.4 -29.89 62.1 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.328 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.445 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 75.1 mt -124.37 118.81 54.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 177.01 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.545 ' NH2' ' O ' ' A' ' 33' ' ' ILE . 72.0 mtt85 -103.86 134.38 47.25 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.469 -178.427 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.432 ' C ' ' H ' ' A' ' 41' ' ' LEU . 77.6 mt -117.96 129.61 74.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.877 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -76.84 29.99 0.13 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.749 -178.974 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.432 ' H ' ' C ' ' A' ' 39' ' ' ILE . 7.3 mt -99.66 127.14 34.87 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.188 179.902 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.16 -13.27 31.05 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.278 1.986 . . . . 0.0 113.438 -179.202 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.4 p -96.13 5.06 8.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.114 179.73 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.5 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 42.4 t -88.68 133.45 30.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.275 179.431 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.15 162.69 19.21 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.213 0.53 . . . . 0.0 110.576 179.965 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.41 ' CE ' ' O ' ' B' ' 232' ' ' GLY . 96.4 mttt -60.6 -42.14 96.2 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.944 -178.512 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.615 ' O ' ' N ' ' A' ' 49' ' ' CYS . 97.6 mm-40 -109.33 -16.07 14.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.11 179.837 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.6 t60 34.88 -77.82 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.686 -179.316 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.615 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.11 136.64 45.95 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.113 0.483 . . . . 0.0 111.364 -178.931 . . . . . . . . 3 3 . 1 . 074 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -127.86 129.54 47.08 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.867 179.855 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.8 mt -112.18 133.03 59.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.14 179.663 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.527 ' CD ' ' HE2' ' A' ' 54' ' ' HIS . 81.7 tt0 -115.61 124.03 49.92 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.048 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.445 HG23 HD12 ' A' ' 53' ' ' ILE . 48.4 mm -96.33 117.61 40.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.155 0.502 . . . . 0.0 111.886 -178.345 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.527 ' HE2' ' CD ' ' A' ' 52' ' ' GLU . 95.8 m-70 -115.42 132.52 56.59 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.116 179.065 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 54' ' ' HIS . 96.9 mt-10 -42.54 -30.16 0.33 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.375 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.457 ' N ' ' C ' ' A' ' 54' ' ' HIS . 59.3 tt0 -67.09 -68.37 0.38 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.602 178.216 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -151.16 -174.83 4.93 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.475 0.655 . . . . 0.0 111.905 -179.66 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.35 122.16 46.54 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.978 178.372 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 98.5 mt -117.2 132.35 67.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -178.505 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.1 tp -98.76 130.16 45.21 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.173 179.302 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -110.35 135.43 51.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.785 179.585 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 64.2 t-20 -95.31 105.97 17.97 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.915 179.983 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -98.34 -9.81 24.8 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.581 179.52 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.1 m -72.99 100.63 3.02 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 178.988 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.2 p -87.11 -21.55 25.93 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.114 179.95 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.72 -44.86 11.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.215 -179.73 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -132.34 93.14 26.35 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.285 179.75 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -56.25 142.71 87.18 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.45 2.1 . . . . 0.0 112.84 -178.6 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 45.6 m -75.74 152.99 37.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.819 179.607 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -116.08 140.67 49.04 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.835 -179.278 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 55.6 t -129.25 134.5 63.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.336 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 53.29 33.41 15.5 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -179.163 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.9 28.62 70.32 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.696 179.944 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 45.0 t -141.65 140.05 33.16 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 117.04 0.42 . . . . 0.0 111.39 -179.972 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.1 t -66.66 136.38 26.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.685 -179.86 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.7 pt -111.88 79.19 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.617 179.276 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -62.27 -26.94 68.67 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.355 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.08 162.04 26.27 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.837 179.187 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.41 146.43 89.66 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.544 2.163 . . . . 0.0 111.561 179.724 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.7 m -137.77 142.95 34.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.17 0.51 . . . . 0.0 111.555 -179.6 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -72.32 127.52 32.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.585 -179.759 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.0 mt -78.52 139.19 38.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.185 0.517 . . . . 0.0 111.185 -179.596 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -135.72 150.06 49.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.209 -178.68 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.412 ' HD1' ' HB2' ' A' ' 99' ' ' ASN . 3.5 t-160 -53.35 113.21 1.07 Allowed 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.73 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.32 -10.89 26.43 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -179.784 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.42 ' OD1' ' C ' ' A' ' 86' ' ' ASP . 49.0 t0 -74.19 127.24 32.44 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.41 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 13.1 p -108.78 132.64 56.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.639 -178.493 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 94.9 mt -98.66 130.37 47.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.11 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.1 m -117.38 127.25 53.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.725 0.774 . . . . 0.0 112.177 -178.669 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.595 ' O ' ' N ' ' A' ' 93' ' ' ARG . 94.7 mt -116.39 132.86 64.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 114.46 -1.245 . . . . 0.0 108.436 178.536 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.534 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 89.1 mt -25.64 99.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 -179.098 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.534 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 6.9 t0 90.06 -21.88 0.12 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 178.08 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.595 ' N ' ' O ' ' A' ' 90' ' ' ILE . 63.2 mtt85 -131.27 146.09 52.16 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.215 -179.289 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 44.8 p -140.67 154.56 46.44 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.026 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -128.26 128.51 44.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.033 -179.825 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -94.81 135.07 36.74 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 119.461 -0.896 . . . . 0.0 110.66 -179.948 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.461 ' CE2' ' OD1' ' A' ' 99' ' ' ASN . 88.0 t80 -95.04 125.89 40.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.707 -179.705 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.521 ' N ' ' OE1' ' A' ' 98' ' ' GLU . 55.7 mp0 -134.94 126.94 29.64 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.423 -179.652 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.461 ' OD1' ' CE2' ' A' ' 97' ' ' TYR . 98.3 m-20 -89.67 166.04 13.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.867 179.122 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 . . . . . 0 C--N 1.326 -0.451 0 CA-C-O 120.93 0.395 . . . . 0.0 110.834 -179.945 . . . . . . . . 0 0 . 1 . 074 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 67.1 t . . . . . 0 N--CA 1.455 -0.211 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 . . . . . . . . . 0 0 . 1 . 074 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.473 ' O ' ' CB ' ' B' ' 230' ' ' SEP . 96.2 m-20 -73.54 -23.4 59.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.968 -179.542 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . 0.473 ' CB ' ' O ' ' B' ' 229' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.471 ' H ' ' C ' ' B' ' 229' ' ' ASP . 1.2 pt20 -142.54 29.02 1.59 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.666 179.665 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . 0.41 ' O ' ' CE ' ' A' ' 46' ' ' LYS . . . -106.03 -134.52 7.82 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.777 -179.326 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -78.57 161.29 28.11 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.933 2.422 . . . . 0.0 113.213 -178.737 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 074 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.12 169.12 22.99 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 122.384 2.056 . . . . 0.0 112.415 -179.998 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 40.2 t -114.03 136.5 50.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.933 -179.764 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.24 128.48 36.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.008 -179.207 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . 0.407 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 50.9 Cg_exo -56.21 -31.7 84.86 Favored 'Trans proline' 0 N--CA 1.501 1.921 0 C-N-CA 123.227 2.618 . . . . 0.0 114.241 -178.59 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 44.8 p -79.52 -34.62 41.0 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.321 179.423 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . 0.544 ' CE2' ' CZ ' ' B' ' 245' ' ' ARG . 78.9 t80 -57.9 -47.86 81.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.702 -179.572 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . 0.408 HD22 ' NH2' ' B' ' 245' ' ' ARG . 72.0 mt -65.36 -43.16 91.68 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.005 0.431 . . . . 0.0 110.774 179.276 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -65.8 -39.43 90.91 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.463 -179.245 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -61.67 -47.23 86.27 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.962 -179.719 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.544 ' CZ ' ' CE2' ' B' ' 241' ' ' PHE . 78.1 mtm180 -65.95 -37.99 87.44 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.39 -179.275 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -59.57 -42.17 91.84 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.994 0.426 . . . . 0.0 111.006 179.703 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' B' B ' 247' ' ' SER . . . . . 0.606 ' HG ' ' N ' ' B' ' 248' ' ' GLN . 81.2 p -68.95 -42.98 75.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.664 0.745 . . . . 0.0 109.112 178.981 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . 0.606 ' N ' ' HG ' ' B' ' 247' ' ' SER . 94.7 mt-30 -62.97 -37.92 89.03 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.783 179.749 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 55.1 t -60.86 -44.79 98.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.112 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -60.25 -23.52 64.15 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.577 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -93.05 -9.42 39.74 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.065 179.572 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -74.72 154.0 38.6 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.424 0.63 . . . . 0.0 111.263 179.83 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -69.07 171.16 8.64 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.053 179.437 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -76.48 4.83 8.31 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.139 0.495 . . . . 0.0 109.945 -179.876 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -85.42 -88.12 0.12 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.126 178.799 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.569 ' O ' ' NZ ' ' A' ' 11' ' ' LYS . 97.6 m-20 58.42 28.1 16.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.868 -179.272 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . 0.582 ' C ' ' HZ3' ' A' ' 11' ' ' LYS . 85.4 tttt -59.4 -29.76 67.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.461 -0.791 . . . . 0.0 112.487 -178.16 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.547 ' O ' ' C ' ' B' ' 259' ' ' ASP . 48.9 p-10 -115.28 3.76 14.31 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.263 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.547 ' C ' ' O ' ' B' ' 258' ' ' ASP . 35.5 t0 23.85 -94.05 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.18 0 O-C-N 124.403 1.065 . . . . 0.0 109.516 -179.208 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.47 ' N ' ' O ' ' B' ' 258' ' ' ASP . 99.0 mt-10 -149.1 17.13 0.96 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.235 178.878 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 70.5 mt -112.88 134.89 54.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -179.999 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 48.8 t -126.51 134.35 66.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.122 179.47 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -94.79 120.94 35.84 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.155 0.502 . . . . 0.0 110.993 -179.457 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . 0.417 ' HG3' HH22 ' A' ' 38' ' ' ARG . 88.2 tttt -62.93 -45.7 91.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.016 179.414 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 5.7 mm100 -97.68 152.7 38.29 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.336 -179.803 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -69.88 148.98 65.51 Favored 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 122.906 2.404 . . . . 0.0 113.305 -179.279 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 18.7 pt . . . . . 0 N--CA 1.462 0.146 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.313 178.9 . . . . . . . . 0 0 . 1 . 075 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo . . . . . 0 N--CA 1.492 1.398 0 CA-C-O 121.054 0.356 . . . . 0.0 111.798 . . . . . . . . . 0 0 . 1 . 075 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 59.6 p -70.13 -40.56 74.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.451 -179.462 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.726 HH11 ' HH ' ' A' ' 97' ' ' TYR . 91.5 mtt-85 -92.49 129.77 38.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.071 -177.941 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -136.47 141.99 43.54 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.362 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 26.1 mt -116.48 142.12 47.29 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.87 179.207 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.7 t -114.76 129.32 71.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.138 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 m -94.57 118.54 31.84 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -177.725 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 91.0 mt -81.39 143.58 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.804 179.587 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 69.9 mttt -87.51 160.73 18.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.374 178.671 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.522 HH21 ' HG3' ' B' ' 245' ' ' ARG . 81.3 mtp180 -56.18 -33.14 64.99 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.693 -178.76 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 99.8 p -79.82 -8.29 59.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.311 -179.314 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.64 39.75 5.82 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 179.831 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 37.1 t -123.15 133.96 67.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.237 0.542 . . . . 0.0 111.261 -179.454 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -68.9 123.23 20.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.128 179.905 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -115.38 -125.31 3.92 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.507 -179.577 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -74.32 150.08 41.13 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.139 1.893 . . . . 0.0 112.363 -179.342 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -107.21 150.91 26.11 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.9 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -119.24 90.98 43.11 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.286 -178.585 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -63.94 130.82 28.69 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.509 2.14 . . . . 0.0 111.36 178.708 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.1 mt -96.05 122.37 38.81 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.738 -179.671 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.4 p -121.87 -26.38 4.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.126 179.284 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.3 mt -78.3 143.72 36.73 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.054 179.008 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.0 p -69.93 -13.82 62.42 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.307 -179.389 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.443 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 20.3 m -127.75 130.39 48.68 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 120.599 -0.441 . . . . 0.0 110.905 179.452 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.8 t -126.67 119.03 25.98 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.595 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' A' ' 36' ' ' ASP . 52.9 tp -117.57 124.35 48.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.901 0.382 . . . . 0.0 111.667 -178.776 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.442 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 4.7 m-85 -100.39 142.55 31.71 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 178.768 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 155.55 -177.14 32.86 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 119.972 -1.109 . . . . 0.0 112.265 178.709 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.61 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 87.8 mtm-85 -75.34 -32.18 60.81 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.139 0.495 . . . . 0.0 110.007 179.388 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.546 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -53.0 146.5 18.22 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.112 -178.434 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.44 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 10.2 tp -66.88 -41.57 87.83 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.158 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.44 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 78.2 mm-40 -54.07 -19.55 5.06 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.758 179.818 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.546 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 38.6 m -60.67 124.61 20.93 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.072 179.917 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.443 ' OD2' ' O ' ' A' ' 26' ' ' THR . 56.1 m-20 -59.11 -32.41 69.81 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -179.793 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 85.5 mt -124.04 120.82 60.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 175.724 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -108.43 136.0 48.79 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.209 -0.596 . . . . 0.0 111.242 -179.189 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 76.8 mt -115.67 132.0 66.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.99 -179.879 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -80.31 25.62 0.39 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.124 -178.476 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 36.2 mt -99.04 129.14 30.22 Favored Pre-proline 0 C--N 1.328 -0.333 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.266 179.332 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.45 -13.53 33.03 Favored 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 122.184 1.922 . . . . 0.0 112.798 -179.638 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -91.58 1.25 8.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.499 -0.48 . . . . 0.0 111.75 -179.542 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.61 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 66.0 t -93.22 132.32 37.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.352 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.454 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 0.3 OUTLIER -61.69 164.7 5.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.241 0.543 . . . . 0.0 111.551 -178.585 . . . . . . . . 3 3 . 1 . 075 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.473 ' CG ' ' NH2' ' A' ' 31' ' ' ARG . 96.6 mttt -61.99 -45.08 95.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.825 -179.142 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.589 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.2 mt-30 -110.53 -12.34 14.38 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-O 121.519 0.676 . . . . 0.0 109.548 179.315 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.454 ' H ' ' HB3' ' A' ' 45' ' ' SER . 25.1 t60 28.8 -75.45 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.219 -1.355 . . . . 0.0 114.255 179.277 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.589 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.43 135.87 46.37 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -177.688 . . . . . . . . 3 3 . 1 . 075 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -126.78 130.49 50.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.616 179.36 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 98.3 mt -115.22 133.31 61.86 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.135 179.537 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -112.48 122.47 47.81 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.309 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 94.7 mt -104.13 113.57 41.41 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 C-N-CA 119.726 -0.79 . . . . 0.0 111.943 -179.004 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.441 ' C ' ' N ' ' A' ' 56' ' ' GLN . 89.9 m-70 -113.5 141.21 47.4 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.592 179.274 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 54' ' ' HIS . 94.8 mt-10 -40.67 -31.87 0.18 Allowed 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -179.365 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.441 ' N ' ' C ' ' A' ' 54' ' ' HIS . 54.7 mt-30 -63.4 -67.75 0.4 Allowed 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.359 -0.837 . . . . 0.0 108.78 178.623 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -154.99 -174.77 5.12 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.785 0.803 . . . . 0.0 112.611 -179.285 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.65 119.54 39.71 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 114.457 -1.247 . . . . 0.0 108.198 177.689 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.2 mt -110.48 130.12 64.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.842 0.353 . . . . 0.0 111.823 -178.467 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 28.0 tp -97.05 128.24 43.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.464 179.88 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -113.43 138.77 49.61 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.535 179.746 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -96.44 111.09 23.31 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -179.233 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -104.5 -8.49 19.04 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.762 178.698 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.7 t -75.23 104.61 5.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.765 0.316 . . . . 0.0 110.303 179.281 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 94.7 p -87.59 -8.33 56.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.021 0.439 . . . . 0.0 110.331 179.843 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.4 ' HB ' ' ND2' ' A' ' 67' ' ' ASN . 0.2 OUTLIER -101.94 -37.26 8.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.207 -179.213 . . . . . . . . 3 3 . 1 . 075 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.4 ' ND2' ' HB ' ' A' ' 66' ' ' THR . 6.3 m-80 -145.07 98.87 4.68 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.489 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -57.29 145.84 85.3 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 121.8 1.667 . . . . 0.0 112.258 -178.782 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 28.8 m -67.7 137.34 55.44 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.291 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -102.42 140.78 36.24 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.399 179.576 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 55.7 t -130.95 133.22 63.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.675 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 54.59 30.51 13.32 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.671 -178.922 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.98 23.97 73.12 Favored Glycine 0 CA--C 1.534 1.27 0 CA-C-N 115.307 -0.861 . . . . 0.0 112.711 179.001 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 58.5 m -139.09 145.65 39.77 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 117.522 0.661 . . . . 0.0 110.742 179.478 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.9 m -71.03 142.74 15.21 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-O 121.138 0.494 . . . . 0.0 111.87 -179.351 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.478 ' CG1' ' O ' ' A' ' 78' ' ' GLU . 6.7 tt -109.54 92.35 2.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.196 179.155 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -65.89 -34.98 79.37 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.746 -179.685 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.478 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 0.2 OUTLIER -126.04 175.06 3.44 Favored Pre-proline 0 N--CA 1.464 0.259 0 C-N-CA 120.414 -0.515 . . . . 0.0 111.481 -179.578 . . . . . . . . 3 3 . 1 . 075 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.421 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 35.5 Cg_exo -57.68 140.98 95.28 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.509 2.139 . . . . 0.0 112.396 -179.881 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 72.1 t -137.43 137.83 45.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.181 -179.671 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 91.9 mtm-85 -74.29 132.02 41.7 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.713 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 97.8 mt -87.95 139.27 30.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.174 0.512 . . . . 0.0 111.852 -178.72 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -129.63 154.18 47.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.487 -179.43 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.623 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 7.6 t60 -57.0 120.69 8.4 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.84 0.353 . . . . 0.0 111.462 -179.29 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.15 -16.48 27.43 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.651 -0.58 . . . . 0.0 111.651 179.299 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -69.94 136.99 51.15 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.105 0.478 . . . . 0.0 110.276 179.812 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 53.3 t -111.88 132.07 61.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.169 -178.936 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.463 HG21 HD13 ' A' ' 88' ' ' ILE . 96.1 mt -99.1 130.94 47.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.559 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.5 m -122.82 126.41 47.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.293 0.568 . . . . 0.0 111.816 -178.387 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.495 ' O ' ' N ' ' A' ' 93' ' ' ARG . 96.2 mt -113.31 124.18 69.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.291 178.164 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.456 ' C ' ' O ' ' A' ' 90' ' ' ILE . 48.5 mm 35.03 -98.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.796 -179.533 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.578 ' OD2' ' NE ' ' B' ' 245' ' ' ARG . 85.3 m-20 -110.44 5.14 21.16 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -179.517 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.572 ' CZ ' ' O ' ' B' ' 259' ' ' ASP . 84.6 mtt-85 -120.39 145.48 47.13 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.943 -179.129 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.5 p -140.64 152.87 45.74 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.199 0.523 . . . . 0.0 111.196 179.789 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -123.95 123.17 39.81 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.841 179.592 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -80.6 129.19 34.37 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.287 -179.87 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.726 ' HH ' HH11 ' A' ' 5' ' ' ARG . 86.8 t80 -96.15 125.45 40.68 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.792 0.33 . . . . 0.0 111.267 -179.645 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -130.85 123.17 28.44 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 121.064 0.459 . . . . 0.0 111.532 -179.882 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.623 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 58.4 t-20 -111.5 112.69 24.61 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.445 179.845 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 . . . . . 0 C--N 1.331 -0.212 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.743 -179.68 . . . . . . . . 0 0 . 1 . 075 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 3.5 p . . . . . 0 N--CA 1.455 -0.216 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 . . . . . . . . . 0 0 . 1 . 075 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -57.16 139.53 52.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.009 0.433 . . . . 0.0 110.889 -179.166 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 075 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -121.97 38.66 4.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.684 -179.604 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -119.28 -173.84 15.6 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 111.404 -0.679 . . . . 0.0 111.404 -179.715 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.87 155.57 68.17 Favored 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 123.021 2.481 . . . . 0.0 112.611 -179.913 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 075 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.52 172.91 15.21 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 122.748 2.299 . . . . 0.0 112.213 179.079 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 2.7 p -118.99 137.14 53.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.557 -179.729 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 3.0 t -68.87 127.55 33.52 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.514 -179.74 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . 0.494 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . 0.494 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 32.6 Cg_exo -59.72 -24.59 76.2 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.758 2.305 . . . . 0.0 112.446 -179.825 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' B' B ' 240' ' ' THR . . . . . 0.416 ' OG1' ' O3P' ' B' ' 238' ' ' TPO . 97.8 m -73.21 -44.89 58.96 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.271 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -57.88 -45.77 85.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.855 -179.493 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . 0.53 ' CD2' ' OD1' ' A' ' 92' ' ' ASP . 97.2 mt -63.46 -41.08 98.63 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 120.746 -0.381 . . . . 0.0 110.466 -179.634 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -60.28 -42.89 96.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.351 -179.476 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -64.04 -39.9 95.13 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.353 -179.997 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.578 ' NE ' ' OD2' ' A' ' 92' ' ' ASP . 57.9 ttm-85 -59.49 -44.13 93.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.862 -179.978 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -60.8 -42.95 98.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.039 0.447 . . . . 0.0 111.033 -179.472 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 67.8 p -69.68 -44.12 71.1 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.608 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . 0.603 ' O ' ' N ' ' B' ' 252' ' ' LEU . 66.3 tp60 -59.19 -39.2 81.85 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.474 179.758 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 73.4 t -60.98 -46.42 96.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.495 179.682 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -62.57 -31.87 72.76 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.14 0.495 . . . . 0.0 109.899 179.331 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -91.02 -18.84 23.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.115 179.603 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.603 ' N ' ' O ' ' B' ' 248' ' ' GLN . 57.4 tp -70.64 135.89 48.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.014 0.435 . . . . 0.0 110.952 -179.169 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -99.22 136.24 39.46 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.414 -179.822 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -70.21 -22.0 62.96 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.866 -0.607 . . . . 0.0 109.756 178.691 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -66.01 -8.69 24.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.447 -179.419 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.649 ' O ' ' N ' ' B' ' 258' ' ' ASP . 42.5 p-10 -96.38 -7.99 33.62 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.343 179.667 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . 0.431 ' C ' ' O ' ' B' ' 256' ' ' ASP . 62.7 mttp 33.44 24.4 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.299 179.599 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.649 ' N ' ' O ' ' B' ' 256' ' ' ASP . 45.1 t0 -102.68 110.51 22.47 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.557 -179.582 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.572 ' O ' ' CZ ' ' A' ' 93' ' ' ARG . 50.8 p-10 -102.24 18.7 20.27 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.809 -179.079 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 65.54 10.32 6.56 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 179.341 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 65.7 mt -111.74 134.97 52.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.915 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 42.2 t -125.35 132.76 70.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.909 0.385 . . . . 0.0 110.467 179.464 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -98.6 121.02 40.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.938 -178.648 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -69.21 -47.1 65.74 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.276 -179.368 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -67.31 165.69 26.67 Favored Pre-proline 0 N--CA 1.464 0.266 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.904 -179.237 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -62.42 143.58 93.65 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.472 2.115 . . . . 0.0 111.603 179.217 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 19.8 tt . . . . . 0 N--CA 1.446 -0.649 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.056 -179.413 . . . . . . . . 0 0 . 1 . 076 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo . . . . . 0 N--CA 1.499 1.805 0 N-CA-C 111.705 -0.152 . . . . 0.0 111.705 . . . . . . . . . 0 0 . 1 . 076 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 95.9 m -74.31 -45.01 50.19 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.396 -0.521 . . . . 0.0 111.598 -179.597 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.6 mtt85 -93.63 125.69 38.39 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.538 -178.145 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -124.19 140.5 52.9 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.015 -179.4 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 38.0 tp -113.66 131.34 56.19 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.792 179.704 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.2 m -110.55 130.73 63.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 121.13 0.491 . . . . 0.0 111.334 -179.393 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.1 m -78.45 141.97 37.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.297 -179.182 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.5 mm -109.97 136.43 45.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.033 177.296 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -91.42 154.77 18.93 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.435 179.54 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.477 ' CD ' ' OD2' ' A' ' 92' ' ' ASP . 89.1 mtm180 -54.56 -27.23 37.3 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.301 -179.684 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 91.8 p -80.48 -7.37 59.15 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.926 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.19 39.65 7.82 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 179.938 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.9 t -125.15 137.54 57.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -178.835 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.44 ' CG ' ' HE2' ' A' ' 19' ' ' HIS . 67.4 t0 -69.96 127.49 33.04 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.086 179.827 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -113.6 -127.51 4.6 Favored Glycine 0 CA--C 1.54 1.606 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 179.735 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -75.36 154.19 40.63 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 122.345 2.03 . . . . 0.0 112.311 -179.51 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.44 ' HE2' ' CG ' ' A' ' 16' ' ' ASP . 64.3 m170 -109.37 140.65 42.8 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.234 0.54 . . . . 0.0 111.888 -178.267 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -112.66 106.14 55.64 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.918 179.771 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -74.59 126.23 10.08 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 121.635 1.557 . . . . 0.0 111.563 -179.538 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.452 ' CD2' ' SG ' ' A' ' 27' ' ' CYS . 87.7 mt -82.8 52.66 2.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.899 0.38 . . . . 0.0 110.905 -179.263 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.6 t -64.66 -27.61 69.04 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.929 179.607 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.6 mt -79.11 142.96 35.97 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.705 179.568 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 44.0 t -63.67 -18.47 64.01 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 121.17 -0.212 . . . . 0.0 111.422 -179.341 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 40.7 m -131.13 131.6 44.23 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.867 -179.321 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.452 ' SG ' ' CD2' ' A' ' 22' ' ' LEU . 4.0 t -124.15 115.24 20.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.197 178.908 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.431 ' O ' ' N ' ' A' ' 36' ' ' ASP . 53.1 tp -112.26 122.79 48.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.162 0.506 . . . . 0.0 111.825 -178.849 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.525 ' O ' ' O ' ' A' ' 47' ' ' GLN . 5.4 m-85 -102.28 139.42 37.91 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.403 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 167.09 -171.56 41.9 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 118.699 -1.715 . . . . 0.0 113.513 179.304 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.563 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 36.7 ttp-105 -89.57 -31.54 17.54 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 114.549 -0.826 . . . . 0.0 109.377 179.585 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.46 151.62 39.48 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.767 -0.533 . . . . 0.0 111.767 -179.465 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.564 ' CD1' ' CZ ' ' A' ' 38' ' ' ARG . 39.5 mm -63.31 -44.41 99.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 121.106 0.479 . . . . 0.0 110.314 -179.965 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -52.95 -18.98 2.25 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.628 -179.208 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.55 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 78.6 m -62.78 128.19 34.77 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.247 -179.882 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 28' ' ' LEU . 62.2 m-20 -59.41 -31.3 69.14 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -179.56 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.441 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 93.3 mt -124.81 116.02 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.59 177.683 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.564 ' CZ ' ' CD1' ' A' ' 33' ' ' ILE . 83.7 mtp180 -99.25 137.63 37.5 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.928 -178.48 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.501 ' C ' ' H ' ' A' ' 41' ' ' LEU . 96.6 mt -119.82 129.02 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 121.335 0.588 . . . . 0.0 110.166 179.044 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -68.92 23.64 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.402 -178.156 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.65 ' CD1' ' NH1' ' A' ' 93' ' ' ARG . 36.6 mt -106.0 129.68 24.2 Favored Pre-proline 0 C--N 1.324 -0.527 0 C-N-CA 120.015 -0.674 . . . . 0.0 111.247 -179.451 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.69 -10.4 25.04 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 C-N-CA 122.085 1.857 . . . . 0.0 112.589 179.714 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.2 m -91.55 1.42 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.213 179.183 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.563 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 51.4 t -90.83 136.01 25.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.03 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.3 m -71.78 168.34 18.03 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.492 0.663 . . . . 0.0 111.461 -178.783 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.55 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 97.9 mttt -60.15 -42.03 94.04 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.832 -1.077 . . . . 0.0 111.454 -179.257 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.665 ' O ' ' N ' ' A' ' 49' ' ' CYS . 87.2 mt-30 -116.29 -17.68 10.7 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 123.246 0.341 . . . . 0.0 110.976 179.789 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 31.6 t60 34.58 -74.81 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -179.691 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.665 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.29 137.44 46.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.326 0.584 . . . . 0.0 112.455 -178.831 . . . . . . . . 3 3 . 1 . 076 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -128.96 133.14 47.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.011 -179.749 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 88.2 mt -116.62 134.44 60.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.384 179.89 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -115.54 123.48 48.61 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 177.719 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 76.4 mt -103.75 114.11 42.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.287 -178.954 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.595 ' O ' ' N ' ' A' ' 56' ' ' GLN . 92.6 m-70 -111.8 141.75 45.02 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.007 179.233 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.48 ' OE1' ' N ' ' A' ' 55' ' ' GLU . 56.0 mp0 -39.47 -24.12 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.495 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.595 ' N ' ' O ' ' A' ' 54' ' ' HIS . 58.1 tt0 -67.95 -69.25 0.33 Allowed 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.177 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.69 ' CB ' ' HE ' ' A' ' 81' ' ' ARG . 2.8 tp10 -158.02 -163.11 1.25 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.334 179.914 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -115.98 125.42 52.48 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.012 -0.995 . . . . 0.0 108.531 178.347 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.4 mt -113.76 129.91 68.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.848 -178.413 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 50.5 tp -94.11 126.62 39.45 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.483 179.761 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -112.67 136.61 52.04 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.246 179.798 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -98.63 108.75 21.51 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.134 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -100.11 -11.24 20.67 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.432 179.473 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.1 t -69.64 103.35 2.09 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.596 179.106 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.0 p -84.51 -12.47 54.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.288 0.566 . . . . 0.0 109.548 178.856 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.19 -37.27 9.76 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.756 179.956 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -144.18 90.27 6.79 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.847 179.741 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -56.23 146.33 72.3 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.21 1.94 . . . . 0.0 112.264 -179.862 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 56.8 m -73.32 144.02 46.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.159 179.913 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -102.97 141.04 36.44 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.694 179.639 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.8 t -130.34 134.67 62.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.553 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 53.71 34.73 19.58 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.27 -179.431 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.29 29.4 70.27 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.499 179.217 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.9 t -143.64 136.75 27.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 117.355 0.577 . . . . 0.0 110.783 179.314 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.8 p -70.72 139.96 19.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.692 -179.401 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.568 ' CD1' ' O ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -132.76 125.56 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.931 179.31 . . . . . . . . 3 3 . 1 . 076 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -97.73 -9.27 26.95 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.755 -179.382 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.568 ' O ' ' CD1' ' A' ' 76' ' ' ILE . 0.4 OUTLIER -125.19 170.33 9.42 Favored Pre-proline 0 N--CA 1.469 0.482 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.162 -179.431 . . . . . . . . 3 3 . 1 . 076 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -61.41 143.29 97.52 Favored 'Trans proline' 0 N--CA 1.501 1.915 0 C-N-CA 122.442 2.095 . . . . 0.0 113.271 -179.601 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 42.7 t -136.21 136.9 48.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.329 178.403 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.69 ' HE ' ' CB ' ' A' ' 57' ' ' GLU . 72.1 ttt180 -75.63 131.95 40.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.872 179.98 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.6 mt -84.89 136.73 33.51 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.369 0.604 . . . . 0.0 112.417 -178.369 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.528 ' HZ3' ' CZ ' ' A' ' 81' ' ' ARG . 74.0 mmtt -125.73 149.21 48.71 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.494 179.495 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.463 ' CE1' ' O ' ' A' ' 99' ' ' ASN . 5.3 t-160 -54.48 113.81 1.43 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.837 0.351 . . . . 0.0 110.989 -179.934 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.3 -15.67 25.06 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.018 178.938 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -68.3 137.22 54.5 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.099 -0.64 . . . . 0.0 109.403 179.534 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 23.3 t -110.04 134.26 52.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.868 -178.728 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 86.2 mt -103.76 129.42 55.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.1 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.9 m -116.36 129.35 56.2 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.515 -178.958 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.58 ' O ' ' N ' ' A' ' 93' ' ' ARG . 94.3 mt -119.65 128.85 75.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.53 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.509 ' O ' ' NH1' ' A' ' 93' ' ' ARG . 94.5 mt -20.41 95.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -178.984 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.477 ' OD2' ' CD ' ' A' ' 12' ' ' ARG . 5.2 t0 90.07 -22.12 0.11 Allowed 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 177.985 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.65 ' NH1' ' CD1' ' A' ' 41' ' ' LEU . 14.7 mtm-85 -130.58 145.84 51.97 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.235 -179.69 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.8 p -138.01 155.79 48.49 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.038 0.447 . . . . 0.0 110.781 -179.361 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -131.65 129.44 40.81 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.643 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 44.4 ttm180 -96.83 136.34 37.51 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 119.836 -0.745 . . . . 0.0 110.229 179.83 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -89.68 125.48 35.28 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.682 -179.724 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -125.65 127.3 46.07 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.5 -179.366 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.463 ' O ' ' CE1' ' A' ' 84' ' ' HIS . 55.5 t-20 -102.35 109.89 21.69 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.199 179.601 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 . . . . . 0 C--N 1.326 -0.419 0 CA-C-O 120.884 0.373 . . . . 0.0 110.433 179.989 . . . . . . . . 0 0 . 1 . 076 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 27.0 m . . . . . 0 N--CA 1.461 0.092 0 CA-C-O 120.943 0.401 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 076 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -82.31 -1.64 50.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.033 -179.117 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 076 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -141.34 18.94 2.23 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.868 179.832 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -131.27 -176.05 14.26 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 111.419 -0.672 . . . . 0.0 111.419 -179.666 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -71.94 164.56 35.28 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 123.432 2.755 . . . . 0.0 112.252 179.834 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 076 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -70.08 169.89 18.24 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.055 1.837 . . . . 0.0 111.923 179.509 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 6.6 p -115.19 137.28 49.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.762 -179.893 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 5.7 t -80.24 126.93 31.75 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 120.876 0.37 . . . . 0.0 110.958 -178.52 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . 0.476 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . 0.476 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 37.6 Cg_exo -58.44 -26.04 76.15 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.95 2.433 . . . . 0.0 112.292 -179.473 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' B' B ' 240' ' ' THR . . . . . 0.442 ' OG1' ' O2P' ' B' ' 238' ' ' TPO . 94.6 m -75.51 -42.75 51.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.043 0.449 . . . . 0.0 110.352 178.813 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -57.54 -47.34 82.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.761 -179.832 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 90.1 mt -63.72 -41.19 98.1 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.086 0.47 . . . . 0.0 109.781 179.439 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -60.93 -41.31 95.95 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.873 179.789 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 73.6 ttt-85 -63.05 -43.23 99.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.668 -179.78 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.482 ' NH2' ' CD2' ' A' ' 41' ' ' LEU . 24.0 mmt180 -59.9 -43.27 94.91 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.55 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.48 -41.93 98.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.818 179.215 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 11.8 t -65.73 -44.05 87.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.725 0.774 . . . . 0.0 108.957 179.512 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -60.89 -37.5 82.42 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.938 -179.447 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . 0.463 ' O ' ' O ' ' B' ' 252' ' ' LEU . 62.7 t -63.77 -46.1 95.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.614 179.647 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -61.38 -27.14 68.31 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.828 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -89.86 -10.84 43.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.574 179.24 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.463 ' O ' ' O ' ' B' ' 249' ' ' VAL . 40.3 tp -116.77 115.11 24.97 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.717 178.579 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . 0.548 ' C ' ' H ' ' B' ' 255' ' ' ASP . 5.4 m-80 -78.39 -159.74 0.18 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.414 0.626 . . . . 0.0 111.711 -179.228 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -49.69 -6.8 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.561 -178.887 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . 0.548 ' H ' ' C ' ' B' ' 253' ' ' ASN . 96.0 m-20 -63.41 -11.85 26.3 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.686 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.651 ' O ' ' N ' ' B' ' 258' ' ' ASP . 22.3 t70 -47.05 -28.89 1.86 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.348 179.474 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . 0.505 ' C ' ' O ' ' B' ' 256' ' ' ASP . 98.5 mttt -26.17 -35.16 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 O-C-N 123.353 0.408 . . . . 0.0 111.03 -179.137 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.651 ' N ' ' O ' ' B' ' 256' ' ' ASP . 44.1 p-10 -104.2 59.83 0.72 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 177.371 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.571 ' N ' ' O ' ' B' ' 256' ' ' ASP . 47.5 p30 -47.09 -115.71 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.592 -177.904 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.55 ' H ' ' CG ' ' B' ' 259' ' ' ASP . 99.7 mt-10 -147.55 23.52 1.13 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.546 -179.648 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 65.9 mt -113.9 133.8 58.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.852 -179.856 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 43.5 t -126.91 134.23 66.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.508 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -97.38 123.65 41.28 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.137 0.494 . . . . 0.0 111.495 -178.255 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -64.07 -41.49 97.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.572 179.697 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -105.53 173.14 3.43 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.547 -178.956 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -57.26 150.78 55.97 Favored 'Trans proline' 0 N--CA 1.502 1.973 0 C-N-CA 122.824 2.349 . . . . 0.0 114.219 -179.614 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 41.4 pt . . . . . 0 C--O 1.232 0.16 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.501 179.823 . . . . . . . . 0 0 . 1 . 077 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 N--CA 1.492 1.428 0 CA-C-O 120.903 0.293 . . . . 0.0 112.381 . . . . . . . . . 0 0 . 1 . 077 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.9 m -73.34 -44.72 58.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.663 -179.872 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.505 ' NH1' ' CG2' ' A' ' 53' ' ' ILE . 85.0 mtt85 -89.57 134.21 34.23 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.355 -178.549 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -134.82 144.3 47.53 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.292 179.982 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 85.1 mt -114.94 135.65 53.98 Favored 'General case' 0 C--N 1.334 -0.097 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.635 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 76.7 t -111.83 130.36 65.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.562 -0.455 . . . . 0.0 109.994 -179.363 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.1 m -80.3 140.24 36.25 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -178.132 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.412 HG22 HD13 ' A' ' 10' ' ' ILE . 96.6 mt -106.13 132.47 53.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 176.673 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.644 ' C ' HH22 ' A' ' 93' ' ' ARG . 97.3 mttt -86.25 154.2 21.45 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.189 0.518 . . . . 0.0 109.729 179.134 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.637 ' N ' HH22 ' A' ' 93' ' ' ARG . 84.9 mtp180 -56.15 -28.8 59.39 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.186 -179.263 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 86.1 p -80.7 -8.83 59.77 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.641 179.747 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.55 33.17 8.72 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.721 -0.551 . . . . 0.0 111.721 179.367 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 54.3 t -119.82 135.33 60.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.784 0.326 . . . . 0.0 110.414 179.818 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -65.03 125.99 26.65 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.776 179.81 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -111.19 -133.33 6.26 Favored Glycine 0 CA--C 1.539 1.575 0 C-N-CA 120.722 -0.752 . . . . 0.0 111.942 -179.184 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.85 151.88 40.86 Favored 'Trans proline' 0 N--CA 1.499 1.827 0 C-N-CA 122.571 2.181 . . . . 0.0 113.037 -178.624 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.501 ' H ' ' CD2' ' A' ' 19' ' ' HIS . 0.1 OUTLIER -106.02 147.87 28.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.363 179.508 . . . . . . . . 3 3 . 1 . 077 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -117.26 95.24 46.96 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.353 -179.571 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -64.15 127.32 19.01 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 122.613 2.209 . . . . 0.0 111.96 -179.468 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 93.3 mt -85.61 83.33 7.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.086 0.469 . . . . 0.0 111.357 -179.485 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 92.2 p -88.17 -14.17 39.3 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.488 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 66.9 mt -95.52 138.39 33.26 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.091 -179.688 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 27.5 t -64.37 -17.67 63.94 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.058 -179.742 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 46.8 m -128.67 129.53 45.94 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.563 179.582 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.9 t -121.38 115.63 23.29 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.128 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.404 ' O ' ' N ' ' A' ' 36' ' ' ASP . 53.9 tp -113.38 122.02 46.11 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.466 -178.857 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.434 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 18.3 m-85 -100.07 141.34 33.03 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.455 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 169.35 -161.08 34.56 Favored Glycine 0 C--O 1.226 -0.392 0 C-N-CA 119.541 -1.314 . . . . 0.0 112.467 179.238 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 29.5 ttp85 -108.0 -9.84 15.59 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -178.372 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -89.21 170.62 37.66 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.798 -178.714 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.409 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 10.7 tp -66.88 -41.45 87.66 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 O-C-N 122.759 -0.259 . . . . 0.0 110.562 179.861 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.409 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 72.3 mm-40 -54.27 -26.66 30.3 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.055 0.455 . . . . 0.0 110.721 -179.19 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.548 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 79.2 m -64.2 121.31 13.92 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.485 -179.982 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 28' ' ' LEU . 87.4 m-20 -59.7 -28.2 67.09 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.342 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.418 HG22 HD11 ' A' ' 37' ' ' ILE . 89.4 mt -127.08 123.04 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.175 177.726 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 -104.24 136.05 44.57 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.242 -179.595 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.486 ' C ' ' H ' ' A' ' 41' ' ' LEU . 97.4 mt -117.5 128.93 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.912 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -72.39 34.0 0.06 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.244 -178.199 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.531 ' CD2' ' CZ ' ' B' ' 245' ' ' ARG . 32.2 mt -102.87 126.5 32.43 Favored Pre-proline 0 C--N 1.322 -0.624 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.428 179.339 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -73.03 -7.12 20.17 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.147 1.898 . . . . 0.0 112.655 -179.418 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.7 m -102.99 13.23 7.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.499 179.394 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 29.1 t -99.76 133.26 43.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.172 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 33.2 t -72.49 175.05 6.61 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.439 0.638 . . . . 0.0 112.538 -178.329 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.548 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 61.0 mttp -65.18 -40.64 94.54 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.797 -179.455 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.659 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.1 mt-30 -112.86 -18.06 12.36 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.211 -179.853 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 23.9 t60 32.73 -74.48 0.0 OUTLIER 'General case' 0 C--O 1.236 0.357 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 179.882 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.659 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.48 134.0 46.73 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.998 0.428 . . . . 0.0 111.594 -179.578 . . . . . . . . 3 3 . 1 . 077 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -125.77 130.36 51.29 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.465 179.183 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.6 mt -117.43 134.01 62.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.226 179.611 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -114.52 131.03 56.79 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.396 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.505 ' CG2' ' NH1' ' A' ' 5' ' ' ARG . 48.3 mm -99.45 120.29 48.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.46 -178.449 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.462 ' O ' ' C ' ' A' ' 55' ' ' GLU . 94.0 m-70 -119.73 132.36 55.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.262 179.103 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.462 ' C ' ' O ' ' A' ' 54' ' ' HIS . 98.4 mt-10 -40.31 -37.17 0.62 Allowed 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.728 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.456 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 84.3 mt-30 -62.76 -67.25 0.44 Allowed 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.379 179.028 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.456 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 6.1 tp10 -151.03 -166.62 2.58 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.2 -179.039 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.453 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -125.48 135.71 52.59 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 -179.957 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.9 mt -119.04 131.49 71.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -178.311 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.431 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 32.7 tp -97.94 125.93 43.09 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 114.827 -1.079 . . . . 0.0 108.846 178.471 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -112.71 136.79 51.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.743 -179.058 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 26.0 t30 -96.31 105.61 17.7 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.788 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.422 ' CD2' ' OE1' ' A' ' 47' ' ' GLN . 27.0 m-85 -96.48 -9.21 30.21 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.066 178.613 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.515 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 42.2 t -73.83 100.22 3.41 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.477 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.9 m -83.18 -16.61 45.94 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.383 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.42 -38.95 15.68 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.252 -179.782 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.515 ' O ' ' OG ' ' A' ' 64' ' ' SER . 77.4 m-20 -146.62 98.73 4.17 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.343 -179.86 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.38 147.78 55.09 Favored 'Trans proline' 0 N--CA 1.501 1.961 0 C-N-CA 122.392 2.062 . . . . 0.0 113.688 -179.423 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 89.1 m -71.41 136.09 47.55 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.695 179.1 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -98.88 140.89 32.38 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.642 -179.722 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.455 ' CG1' ' OD1' ' A' ' 86' ' ' ASP . 71.5 t -129.43 134.71 63.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.07 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 51.28 34.78 12.17 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.604 -0.838 . . . . 0.0 109.655 -179.773 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.23 30.11 69.78 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.933 179.64 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.6 p -142.22 133.7 26.59 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.469 -179.693 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -67.6 142.37 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.309 -179.964 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.465 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 2.9 pt -119.02 121.27 66.39 Favored 'Isoleucine or valine' 0 C--N 1.343 0.285 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.109 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -87.2 -24.09 24.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.401 -179.894 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -127.04 172.98 5.81 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.907 -179.585 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.51 144.1 99.5 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 122.434 2.09 . . . . 0.0 112.58 179.514 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.7 t -132.16 138.57 52.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.737 178.922 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -73.31 131.17 41.6 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.442 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 97.3 mt -84.26 135.49 34.31 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.079 0.466 . . . . 0.0 111.536 -179.912 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -127.12 149.58 49.88 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.811 179.796 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.723 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 6.7 t60 -55.6 116.63 3.01 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.423 179.819 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.1 -18.77 23.45 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 -179.416 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.455 ' OD1' ' CG1' ' A' ' 71' ' ' VAL . 36.4 t70 -66.81 132.28 47.71 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.535 0.207 . . . . 0.0 110.449 179.151 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 53.4 t -106.86 132.19 54.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.194 -178.927 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.457 ' O ' ' OG ' ' A' ' 94' ' ' SER . 80.0 mt -101.33 129.79 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 177.914 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.3 m -120.42 126.09 49.58 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.531 0.681 . . . . 0.0 112.353 -178.875 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.599 ' O ' ' N ' ' A' ' 93' ' ' ARG . 91.7 mt -113.18 133.26 59.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 177.746 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.526 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 68.0 mt -30.9 102.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 O-C-N 123.112 0.257 . . . . 0.0 111.66 -178.759 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 4.8 t70 87.67 -22.18 0.15 Allowed 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 178.743 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.644 HH22 ' C ' ' A' ' 11' ' ' LYS . 2.0 mmp_? -127.73 139.62 52.57 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.564 -179.337 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 88' ' ' ILE . 34.7 t -141.1 148.66 40.48 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.929 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -129.19 130.47 46.38 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.397 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -89.03 134.36 34.02 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.325 -179.488 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.506 ' CZ ' ' OD1' ' A' ' 99' ' ' ASN . 91.1 t80 -94.45 124.52 38.53 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.142 -179.991 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -139.2 123.96 18.58 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.513 -179.173 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.723 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 79.5 m-20 -87.96 134.33 33.75 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.621 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 . . . . . 0 N--CA 1.463 0.189 0 CA-C-O 120.749 0.309 . . . . 0.0 110.505 -179.701 . . . . . . . . 0 0 . 1 . 077 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 CA--C 1.534 0.339 0 CA-C-O 120.663 0.268 . . . . 0.0 111.224 . . . . . . . . . 0 0 . 1 . 077 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.571 ' C ' ' H ' ' B' ' 231' ' ' GLN . 93.0 m-20 -72.67 142.14 48.26 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.766 0.317 . . . . 0.0 111.65 -179.428 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 077 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.571 ' H ' ' C ' ' B' ' 229' ' ' ASP . 72.4 mt-30 -130.73 50.89 2.17 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.34 -178.969 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -120.7 -171.75 14.46 Favored Glycine 0 CA--C 1.537 1.451 0 N-CA-C 111.843 -0.503 . . . . 0.0 111.843 -179.341 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.74 162.74 41.13 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 123.613 2.876 . . . . 0.0 113.25 -179.793 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 077 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -77.79 146.5 23.68 Favored 'Trans proline' 0 C--N 1.315 -1.205 0 C-N-CA 121.736 1.624 . . . . 0.0 112.909 -178.792 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 25.0 t -60.05 138.64 20.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.766 -179.808 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 4.1 t -71.63 129.3 38.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.562 -179.659 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . 0.411 ' P ' ' HD2' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . 0.411 ' HD2' ' P ' ' B' ' 238' ' ' TPO . 41.0 Cg_exo -54.18 -24.14 32.4 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 122.415 2.076 . . . . 0.0 113.576 179.909 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 17.2 p -73.54 -41.25 63.25 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 119.836 -0.746 . . . . 0.0 109.268 177.981 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . 0.505 ' CZ ' ' NE ' ' B' ' 245' ' ' ARG . 75.7 t80 -56.86 -47.37 80.56 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.752 -179.415 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 90.7 mt -67.08 -40.14 86.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.515 179.172 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -63.4 -43.06 98.6 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.399 -178.653 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -61.72 -42.57 99.12 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.093 0.473 . . . . 0.0 110.637 179.69 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.531 ' CZ ' ' CD2' ' A' ' 41' ' ' LEU . 95.6 mtt-85 -64.0 -39.05 93.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.12 -179.637 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.02 -39.01 93.46 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.061 179.495 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 32.8 t -67.55 -42.18 83.08 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.22 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . 0.531 ' O ' ' N ' ' B' ' 252' ' ' LEU . 61.7 tt0 -58.24 -36.77 73.71 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.903 179.205 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' B' ' 252' ' ' LEU . 41.3 t -64.31 -45.26 96.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.501 179.259 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -58.65 -27.98 65.26 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.024 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -100.58 -9.41 22.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.741 178.999 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.531 ' N ' ' O ' ' B' ' 248' ' ' GLN . 42.7 tp -124.0 125.38 44.47 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.63 179.896 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . 0.665 ' O ' ' N ' ' B' ' 255' ' ' ASP . 0.2 OUTLIER -159.4 -80.47 0.05 Allowed 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.286 . . . . . . . . 3 3 . 1 . 077 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . 0.476 ' O ' ' C ' ' B' ' 255' ' ' ASP . 91.8 m-20 -31.81 -25.94 0.0 OUTLIER 'General case' 0 C--O 1.231 0.114 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.051 -178.521 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . 0.665 ' N ' ' O ' ' B' ' 253' ' ' ASN . 34.8 t70 -32.5 -38.96 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 110.425 -0.213 . . . . 0.0 110.425 -179.795 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.586 ' CB ' ' O ' ' B' ' 255' ' ' ASP . 26.7 t0 98.2 -133.55 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 O-C-N 124.105 0.878 . . . . 0.0 111.115 178.976 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . 0.441 ' H ' ' CG ' ' B' ' 256' ' ' ASP . 98.9 mttt -88.46 -165.34 1.3 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.745 -179.46 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 61.58 51.43 4.04 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -178.529 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -83.08 73.19 10.08 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.757 -178.915 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 60.23 13.1 3.69 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 178.117 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 64.6 mt -119.26 132.35 69.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.398 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 56.1 t -126.9 135.9 62.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.366 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -99.32 120.22 39.21 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.901 -177.885 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -65.48 -43.48 90.09 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.571 0.701 . . . . 0.0 109.916 179.451 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -100.78 172.6 4.36 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.255 -178.951 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.0 150.05 66.85 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 121.985 1.79 . . . . 0.0 112.599 179.742 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 42.5 pt . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.741 178.996 . . . . . . . . 0 0 . 1 . 078 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo . . . . . 0 N--CA 1.489 1.232 0 N-CA-C 110.952 -0.441 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 078 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 46.1 m -101.76 -47.28 4.66 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.78 -179.043 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.466 HH11 HD11 ' A' ' 53' ' ' ILE . 99.1 mtt180 -99.79 127.03 45.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.517 -179.016 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.792 ' HE ' ' CE1' ' A' ' 19' ' ' HIS . 83.2 mtp180 -129.3 148.67 51.25 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.877 -179.075 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 99.6 mt -112.87 142.23 45.77 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.557 178.872 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.459 HG12 HH21 ' A' ' 96' ' ' ARG . 72.8 t -116.24 128.38 73.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.59 -0.444 . . . . 0.0 109.996 179.855 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 m -81.57 141.09 34.06 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.456 0.646 . . . . 0.0 112.674 -178.293 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 83.1 mt -113.93 135.93 52.02 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.056 178.133 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.6 mttp -86.91 158.29 19.34 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.101 178.792 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.608 ' CD ' HH21 ' B' ' 245' ' ' ARG . 89.3 mtm180 -58.75 -27.46 64.98 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.193 -179.86 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 99.0 p -83.56 -8.87 59.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.825 179.771 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.43 37.73 6.49 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.863 179.819 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.1 t -118.76 131.3 71.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-O 120.835 0.35 . . . . 0.0 111.11 179.811 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -75.72 124.34 27.1 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.671 179.83 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -113.41 -122.52 3.88 Favored Glycine 0 CA--C 1.543 1.806 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.721 -179.84 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -76.4 155.54 36.58 Favored 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 123.043 2.495 . . . . 0.0 112.267 -178.702 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.792 ' CE1' ' HE ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -117.67 149.28 40.98 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.829 . . . . . . . . 3 3 . 1 . 078 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -115.5 100.49 53.64 Favored Pre-proline 0 N--CA 1.468 0.438 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.748 -177.658 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.407 ' HG3' ' NE2' ' A' ' 19' ' ' HIS . 3.0 Cg_exo -65.04 129.96 24.47 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 121.367 1.378 . . . . 0.0 111.557 179.48 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 90.6 mt -83.85 71.32 10.47 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.834 -179.896 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 80.6 p -78.66 -15.27 58.69 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.754 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 80.3 mt -93.64 140.78 29.23 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.211 -179.866 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 80.4 p -66.64 -17.51 64.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.959 -179.72 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.484 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 94.9 m -130.7 132.77 45.57 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.907 179.69 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.8 t -125.26 116.65 22.31 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.015 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 44.1 tp -114.16 129.02 56.63 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 121.169 -0.213 . . . . 0.0 111.181 -178.506 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.417 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 13.9 m-85 -109.25 140.8 42.43 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.285 179.649 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 156.78 -178.35 33.26 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 119.932 -1.128 . . . . 0.0 112.069 178.603 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.6 ' NH2' ' O ' ' B' ' 233' ' ' PRO . 43.7 mtm180 -74.72 -27.12 60.24 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.457 178.773 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.465 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -57.58 148.38 34.61 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.406 -177.771 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.432 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 11.1 tp -66.9 -41.47 87.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.097 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.432 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 92.8 mt-10 -52.49 -21.82 4.16 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.744 178.767 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.465 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 13.8 m -64.85 120.73 13.07 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.597 -179.492 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.484 ' OD2' ' O ' ' A' ' 26' ' ' THR . 99.4 m-20 -54.89 -25.21 27.43 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.316 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.414 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 96.8 mt -130.73 124.78 57.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.229 176.837 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 40.4 ttp180 -115.73 139.24 50.34 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.973 -179.386 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.432 ' C ' ' H ' ' A' ' 41' ' ' LEU . 89.2 mt -117.88 133.47 64.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.704 -178.927 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -73.49 20.38 0.09 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.106 -178.527 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.432 ' H ' ' C ' ' A' ' 39' ' ' ILE . 30.3 mt -91.2 128.41 47.47 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.924 179.488 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.14 -6.55 19.12 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 122.757 2.305 . . . . 0.0 113.143 -179.118 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.2 m -105.23 4.9 10.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.91 179.615 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.518 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 19.8 t -85.91 133.16 30.29 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.931 178.853 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.3 m -64.27 157.96 24.6 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.199 -179.496 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.405 ' HG2' ' H ' ' A' ' 47' ' ' GLN . 10.4 ptmt -60.71 -46.34 90.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.476 -178.815 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.695 ' O ' ' N ' ' A' ' 49' ' ' CYS . 78.6 mt-30 -113.39 -12.31 13.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.553 179.578 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 24.1 t60 28.36 -70.27 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 179.712 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.695 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -146.67 149.57 33.72 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.699 0.762 . . . . 0.0 112.522 -179.064 . . . . . . . . 3 3 . 1 . 078 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -139.07 131.12 27.94 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.517 -1.22 . . . . 0.0 111.237 179.945 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.6 mt -106.41 135.25 45.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.796 179.875 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -112.76 135.72 53.18 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.062 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.466 HD11 HH11 ' A' ' 5' ' ' ARG . 38.8 mm -101.08 124.8 54.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 119.744 -0.782 . . . . 0.0 110.877 -179.646 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.437 ' O ' ' N ' ' A' ' 56' ' ' GLN . 95.6 m-70 -128.45 133.42 48.52 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.41 178.902 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 54' ' ' HIS . 97.8 mt-10 -39.97 -29.98 0.08 Allowed 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 120.492 -0.483 . . . . 0.0 109.761 -179.154 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.437 ' N ' ' O ' ' A' ' 54' ' ' HIS . 69.8 tp60 -64.91 -67.37 0.44 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.041 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.432 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 9.6 tp10 -155.3 -152.05 0.38 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.92 -179.572 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.432 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -127.74 134.72 49.53 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.576 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.1 mt -120.99 132.71 69.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.027 -0.669 . . . . 0.0 112.306 -178.274 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 21.1 tp -101.57 128.05 48.01 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.897 -179.558 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -110.95 136.85 49.35 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.733 -179.973 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -97.09 107.69 20.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.206 0.527 . . . . 0.0 111.745 -179.813 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -98.9 -10.29 23.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.2 179.676 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.09 101.66 7.09 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.28 -179.179 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.7 m -83.15 -43.41 16.22 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.187 0.518 . . . . 0.0 110.363 178.958 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.49 -46.83 88.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.858 -179.042 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -133.52 93.81 20.77 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.617 -179.724 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.442 ' O ' ' NE2' ' A' ' 70' ' ' GLN . 53.1 Cg_exo -52.11 140.3 50.8 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.222 1.948 . . . . 0.0 112.819 -179.325 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.1 m -69.79 146.25 51.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.622 179.281 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.446 ' OE1' ' CG2' ' A' ' 75' ' ' VAL . 81.5 mm-40 -109.7 141.5 42.2 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.121 -179.765 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.451 ' O ' ' N ' ' A' ' 74' ' ' SER . 3.6 p -129.94 135.55 60.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.901 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 49.13 31.5 3.53 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -179.043 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.04 29.12 65.26 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.638 -179.429 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.451 ' N ' ' O ' ' A' ' 71' ' ' VAL . 22.3 m -139.61 139.46 36.75 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 120.454 -0.498 . . . . 0.0 112.046 179.99 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.446 ' CG2' ' OE1' ' A' ' 70' ' ' GLN . 58.7 t -61.14 137.37 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.018 -179.706 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.4 pt -117.34 72.53 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 120.661 -0.415 . . . . 0.0 109.927 178.498 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.486 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 21.3 p-10 -61.59 -27.6 68.76 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.689 179.974 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -112.89 159.48 34.37 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.431 178.979 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.84 144.42 88.49 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.014 1.809 . . . . 0.0 112.329 179.776 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 51.4 t -131.84 138.89 51.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.88 -179.57 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -73.82 130.87 40.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.296 179.447 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.8 mt -80.85 135.48 35.94 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.592 0.711 . . . . 0.0 111.569 -178.97 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -128.11 151.15 49.54 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.955 179.028 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.792 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 7.0 t60 -55.03 117.25 3.29 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.938 -178.847 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 113.32 -15.18 22.83 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.089 179.4 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -70.0 133.31 47.1 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 117.139 0.47 . . . . 0.0 110.7 -179.921 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.5 p -108.91 137.31 41.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.674 -179.469 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 88.2 mt -104.96 129.81 57.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 177.908 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.509 ' OG1' ' OG ' ' A' ' 94' ' ' SER . 2.5 m -121.42 129.34 52.94 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -177.45 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.414 ' N ' ' O ' ' A' ' 93' ' ' ARG . 89.2 mt -116.63 122.95 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 114.306 -1.315 . . . . 0.0 109.151 178.335 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 38.8 mm 40.05 -98.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.064 -179.562 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -117.68 17.0 14.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.213 0.53 . . . . 0.0 109.978 -179.787 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.414 ' O ' ' N ' ' A' ' 90' ' ' ILE . 39.3 ttm180 -130.26 144.05 51.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.176 -179.671 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.509 ' OG ' ' OG1' ' A' ' 89' ' ' THR . 36.7 m -140.62 158.9 43.3 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.793 0.806 . . . . 0.0 111.855 -179.494 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -128.35 123.24 33.42 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.304 179.434 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.459 HH21 HG12 ' A' ' 8' ' ' VAL . 95.2 mtm-85 -86.24 135.59 33.5 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.957 -179.407 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -93.33 122.8 36.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.826 178.745 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -125.72 126.29 44.38 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.252 -178.907 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.792 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 28.9 t-20 -109.02 107.35 17.67 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.725 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 . . . . . 0 C--N 1.323 -0.552 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.671 -179.044 . . . . . . . . 0 0 . 1 . 078 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 54.4 t . . . . . 0 N--CA 1.465 0.32 0 CA-C-O 120.958 0.409 . . . . 0.0 110.763 . . . . . . . . . 0 0 . 1 . 078 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.496 ' O ' ' CB ' ' B' ' 230' ' ' SEP . 47.5 p30 -98.8 176.16 5.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.557 -179.091 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . 0.496 ' CB ' ' O ' ' B' ' 229' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 62.0 56.47 2.3 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 121.096 0.474 . . . . 0.0 110.218 -179.33 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -98.53 -173.16 32.26 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 179.929 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . 0.6 ' O ' ' NH2' ' A' ' 31' ' ' ARG . 57.6 Cg_endo -67.83 154.6 72.6 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.559 2.172 . . . . 0.0 112.468 -179.394 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 078 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.44 142.65 54.93 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 121.948 1.765 . . . . 0.0 111.937 179.646 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 52.5 t -77.95 131.86 33.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.215 -178.545 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 2.5 t -75.66 127.43 33.05 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.99 179.224 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . 0.435 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . 0.435 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 32.1 Cg_exo -59.41 -25.46 78.61 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.503 2.136 . . . . 0.0 112.471 -179.566 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' B' B ' 240' ' ' THR . . . . . 0.423 ' OG1' ' O3P' ' B' ' 238' ' ' TPO . 27.5 m -72.74 -46.02 55.64 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.296 178.545 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . 0.415 ' CE2' ' HD2' ' B' ' 245' ' ' ARG . 71.6 t80 -58.21 -45.7 87.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.743 -179.243 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 88.9 mt -64.35 -42.53 96.18 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 120.829 0.347 . . . . 0.0 111.003 179.345 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -62.9 -43.23 99.35 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.289 -178.68 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 87.8 mtm180 -63.29 -42.03 99.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.986 0.422 . . . . 0.0 110.631 -179.005 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.608 HH21 ' CD ' ' A' ' 12' ' ' ARG . 75.9 mtp180 -61.52 -42.07 98.27 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.255 179.955 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -64.56 -40.2 95.13 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.379 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 15.3 t -65.56 -44.96 85.16 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.558 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' B' ' 252' ' ' LEU . 5.7 tp-100 -60.21 -37.89 81.67 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.025 -179.945 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 37.4 t -62.87 -43.67 99.06 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-O 120.811 0.338 . . . . 0.0 110.52 178.93 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -62.07 -34.48 76.36 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.147 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -91.37 -9.2 45.69 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.754 179.046 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' B' ' 248' ' ' GLN . 48.8 tp -72.78 131.06 41.83 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.985 0.421 . . . . 0.0 110.946 -179.518 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . 0.512 ' C ' ' H ' ' B' ' 255' ' ' ASP . 71.6 m-20 -95.67 154.96 16.95 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.466 179.255 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -56.39 -7.38 0.38 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.133 0.492 . . . . 0.0 109.976 179.389 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . 0.512 ' H ' ' C ' ' B' ' 253' ' ' ASN . 99.3 m-20 -63.91 -19.33 65.01 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.213 -179.863 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -102.94 32.29 3.77 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.082 179.886 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -65.68 -6.63 12.01 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.467 179.022 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.566 ' O ' ' CG ' ' B' ' 259' ' ' ASP . 50.8 m-20 -63.29 -41.84 99.02 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.861 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.624 ' CG ' ' H ' ' B' ' 261' ' ' ILE . 11.0 p-10 106.03 -158.02 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.622 0 C-N-CA 124.242 1.017 . . . . 0.0 110.145 179.112 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.552 ' OE2' ' CZ ' ' A' ' 12' ' ' ARG . 98.3 mt-10 -138.15 10.65 2.8 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 114.034 -1.439 . . . . 0.0 107.661 178.842 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . 0.624 ' H ' ' CG ' ' B' ' 259' ' ' ASP . 2.8 mt -116.0 140.84 36.02 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.537 -179.795 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 62.3 t -127.81 136.21 60.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.376 179.354 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . 0.446 ' CG ' ' CG2' ' B' ' 267' ' ' ILE . 68.3 m-85 -99.59 124.64 44.98 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.395 0.616 . . . . 0.0 111.615 -178.271 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -62.09 -40.79 97.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.744 179.572 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -107.05 173.6 3.02 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 114.838 -1.073 . . . . 0.0 110.232 -179.336 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.77 150.45 62.38 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 122.63 2.22 . . . . 0.0 113.535 -179.63 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . 0.446 ' CG2' ' CG ' ' B' ' 263' ' ' PHE . 41.1 pt . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.813 179.576 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo . . . . . 0 N--CA 1.495 1.569 0 CA-C-O 120.647 0.186 . . . . 0.0 112.138 . . . . . . . . . 0 0 . 1 . 079 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.2 t -142.39 36.55 1.5 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.186 0.517 . . . . 0.0 110.397 179.305 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.421 HH12 HG22 ' A' ' 53' ' ' ILE . 99.9 mtt180 -88.7 139.08 30.83 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.506 -179.822 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.7 mtm180 -130.97 136.21 48.34 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.429 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 83.3 mt -112.47 138.9 48.56 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-O 120.778 0.323 . . . . 0.0 110.624 179.515 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 43.5 t -112.34 128.36 69.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.25 178.988 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.593 ' OG1' ' O ' ' A' ' 18' ' ' PRO . 74.8 p -83.14 138.94 33.46 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.49 0.662 . . . . 0.0 112.023 -178.815 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.415 HG23 HD12 ' A' ' 10' ' ' ILE . 47.0 mm -105.66 134.07 48.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.656 179.38 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.4 mttt -86.79 153.86 21.36 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.054 178.266 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 91.8 mtm180 -57.22 -25.87 59.77 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.446 -0.502 . . . . 0.0 109.968 -179.556 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.1 m -79.48 -10.48 59.81 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.771 179.158 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.64 40.09 7.9 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.066 -1.213 . . . . 0.0 110.066 -178.946 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.8 t -120.48 131.08 73.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 114.996 -0.602 . . . . 0.0 109.894 -179.992 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -71.38 125.24 26.49 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.18 179.679 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -120.64 -120.85 2.8 Favored Glycine 0 CA--C 1.54 1.643 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.214 -179.23 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.593 ' O ' ' OG1' ' A' ' 9' ' ' THR . 74.1 Cg_endo -72.87 145.26 40.18 Favored 'Trans proline' 0 N--CA 1.503 2.087 0 C-N-CA 122.848 2.365 . . . . 0.0 114.307 -177.769 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -110.65 129.17 55.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.011 -179.784 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -100.1 102.38 17.71 Favored Pre-proline 0 N--CA 1.465 0.323 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.817 -179.995 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -78.21 139.09 16.57 Favored 'Trans proline' 0 C--N 1.314 -1.242 0 C-N-CA 121.608 1.538 . . . . 0.0 111.957 -179.45 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 87.8 mt -101.39 130.26 47.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.255 0.55 . . . . 0.0 111.498 -179.109 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 45.1 p -139.54 4.03 2.14 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.875 177.725 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.1 mt -107.35 151.25 25.75 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.332 -179.654 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.457 ' H ' ' HG ' ' A' ' 25' ' ' SER . 1.2 m -62.93 -24.29 67.79 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.369 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 87.1 m -133.97 135.42 43.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.428 0.632 . . . . 0.0 111.948 -179.483 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.599 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 3.1 t -126.19 117.19 22.58 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 177.769 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 49.2 tp -115.41 131.31 56.97 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.807 -176.842 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.599 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 11.2 m-85 -107.44 128.48 54.52 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.719 -179.913 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 165.01 -176.18 40.8 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 119.918 -1.134 . . . . 0.0 113.549 178.14 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 48.6 mtm180 -74.67 -31.91 62.07 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.746 0.308 . . . . 0.0 110.63 179.129 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.526 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -51.14 145.45 11.68 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.033 -178.568 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 32.4 mm -65.78 -43.87 93.26 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.102 0 CA-C-O 120.81 0.338 . . . . 0.0 110.913 179.305 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -55.64 -23.51 28.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.028 0.442 . . . . 0.0 109.831 -179.682 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.526 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 35.2 m -54.46 126.61 24.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.287 -179.369 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -61.35 -33.22 73.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.872 -179.459 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 77.9 mt -126.54 122.87 61.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 177.38 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.424 ' O ' ' N ' ' B' ' 262' ' ' VAL . 39.6 mtm180 -106.23 137.63 43.83 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -179.602 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.515 ' C ' ' H ' ' A' ' 41' ' ' LEU . 80.3 mt -117.42 125.9 74.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.918 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -71.34 29.33 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.894 -178.604 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.515 ' H ' ' C ' ' A' ' 39' ' ' ILE . 13.0 mt -100.73 127.61 32.02 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.955 -179.942 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.07 -9.17 24.15 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.096 1.864 . . . . 0.0 112.722 -179.385 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 18.1 m -99.07 7.86 8.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.089 -0.644 . . . . 0.0 111.301 -179.723 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 42.8 t -91.86 135.88 25.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.799 178.677 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.7 m -68.94 166.97 16.76 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.207 -179.476 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -61.21 -42.57 98.83 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.208 -0.906 . . . . 0.0 111.045 -179.055 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.627 ' O ' ' N ' ' A' ' 49' ' ' CYS . 12.5 mm100 -115.57 -26.84 7.33 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 123.853 0.721 . . . . 0.0 109.825 -179.518 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.44 ' O ' ' OG ' ' A' ' 64' ' ' SER . 21.3 t60 44.95 -74.86 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.493 179.556 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.627 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -134.81 139.59 45.21 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.703 -179.195 . . . . . . . . 3 3 . 1 . 079 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 21.7 ttpt -130.61 129.52 42.83 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.0 179.007 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 91.5 mt -107.56 130.47 59.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.34 179.615 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -114.52 123.15 48.65 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 177.598 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.421 HG22 HH12 ' A' ' 5' ' ' ARG . 95.3 mt -103.04 115.91 45.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 119.816 -0.753 . . . . 0.0 111.626 -179.195 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.52 ' O ' ' N ' ' A' ' 56' ' ' GLN . 84.7 m-70 -113.24 141.19 47.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.162 179.551 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.1 tt0 -39.97 -26.13 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.446 0.641 . . . . 0.0 109.528 -178.827 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.52 ' N ' ' O ' ' A' ' 54' ' ' HIS . 63.2 tt0 -68.13 -67.98 0.42 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.816 -1.083 . . . . 0.0 109.628 179.104 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -157.58 -168.48 2.58 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.607 -179.426 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -107.5 127.09 53.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.615 179.24 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.1 mt -120.28 129.67 75.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.213 0.53 . . . . 0.0 111.979 -179.618 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.481 ' CD1' ' HG ' ' A' ' 49' ' ' CYS . 23.5 tp -101.42 128.51 47.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.152 -179.907 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -113.8 138.57 50.09 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.882 -179.296 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.518 HD22 ' CA ' ' A' ' 68' ' ' PRO . 55.3 t-20 -100.39 108.34 20.33 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.825 0.345 . . . . 0.0 111.649 -179.934 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -98.03 -9.45 25.99 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.538 -179.89 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -78.82 117.11 19.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.971 0.415 . . . . 0.0 111.107 -179.818 . . . . . . . . 3 3 . 1 . 079 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.7 p -101.2 -14.6 17.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.64 179.351 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.73 -44.44 10.55 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.346 0.593 . . . . 0.0 109.421 -179.596 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -138.85 95.47 9.69 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.137 -0.938 . . . . 0.0 108.584 178.286 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.518 ' CA ' HD22 ' A' ' 62' ' ' ASN . 37.5 Cg_endo -66.4 150.11 84.52 Favored 'Trans proline' 0 C--N 1.316 -1.156 0 C-N-CA 121.18 1.253 . . . . 0.0 113.029 -177.918 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.447 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 5.3 m -72.13 140.26 48.76 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.949 -179.401 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -103.33 140.9 36.81 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.514 178.547 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.495 ' CG2' ' OD1' ' A' ' 86' ' ' ASP . 5.6 p -128.48 135.5 62.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.043 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 48.37 31.03 2.54 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 119.415 -0.914 . . . . 0.0 108.629 -178.628 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.08 24.73 73.01 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.683 -179.583 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.459 ' N ' ' O ' ' A' ' 71' ' ' VAL . 35.9 t -136.24 139.55 42.81 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.94 0.37 . . . . 0.0 111.11 -179.711 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 79.3 t -68.02 140.7 18.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.169 179.807 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.9 pt -111.77 70.97 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 120.927 0.394 . . . . 0.0 110.437 179.021 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -54.95 -32.72 61.67 Favored 'General case' 0 N--CA 1.461 0.096 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.313 179.578 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -118.88 163.05 28.11 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.96 179.399 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -59.46 144.57 99.37 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.886 1.724 . . . . 0.0 112.829 -179.158 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.0 m -138.14 138.39 43.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.176 -179.68 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -73.12 129.08 37.27 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 120.646 -0.422 . . . . 0.0 109.919 179.47 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 94.6 mt -80.51 141.27 35.32 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.994 0.426 . . . . 0.0 110.631 179.717 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.42 ' HG2' ' N ' ' A' ' 84' ' ' HIS . 88.3 tttt -136.03 157.78 46.01 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.952 -179.56 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.74 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 6.2 t60 -57.3 118.41 5.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.924 0.392 . . . . 0.0 110.834 -179.36 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.68 -7.67 29.89 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -179.989 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.495 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 50.5 t0 -74.76 124.88 27.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.023 0.439 . . . . 0.0 110.115 179.316 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.409 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 75.0 t -108.02 131.36 58.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.658 -178.685 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 80.3 mt -99.47 130.67 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.341 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.652 ' HG1' ' HG ' ' A' ' 94' ' ' SER . 2.2 m -118.46 124.78 48.45 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.409 0.623 . . . . 0.0 112.494 -179.121 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.461 ' O ' ' C ' ' A' ' 91' ' ' ILE . 96.9 mt -114.0 124.68 70.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 177.902 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.472 HD11 HG22 ' A' ' 91' ' ' ILE . 34.5 mm 36.09 -99.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 -178.764 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.509 ' CG ' ' NH2' ' B' ' 245' ' ' ARG . 37.7 p-10 -116.08 14.01 15.93 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.247 179.425 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.531 ' CZ ' ' O ' ' B' ' 259' ' ' ASP . 84.7 mtt-85 -121.96 145.52 48.04 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.282 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.652 ' HG ' ' HG1' ' A' ' 89' ' ' THR . 73.7 m -136.72 154.96 50.45 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.009 179.766 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -126.59 120.65 30.11 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.333 179.378 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -85.42 136.58 33.39 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.39 -178.936 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -98.18 122.81 41.8 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.302 -179.521 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -134.76 129.33 34.47 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.275 0.56 . . . . 0.0 112.004 -179.601 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.74 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 13.3 p30 -132.78 169.67 16.38 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.762 179.399 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 . . . . . 0 C--N 1.324 -0.517 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.354 -179.769 . . . . . . . . 0 0 . 1 . 079 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 12.0 t . . . . . 0 N--CA 1.453 -0.285 0 CA-C-O 120.819 0.343 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 079 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.622 ' O ' ' C ' ' B' ' 230' ' ' SEP . 52.6 t0 -95.02 110.61 22.51 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.047 179.187 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . 0.622 ' C ' ' O ' ' B' ' 229' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.579 ' N ' ' O ' ' B' ' 229' ' ' ASP . 10.2 mt-30 82.42 52.52 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.815 -179.522 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . 0.601 ' N ' ' O ' ' B' ' 229' ' ' ASP . . . -97.32 -149.28 25.19 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.899 -0.881 . . . . 0.0 110.899 -179.565 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -58.98 148.34 85.53 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 123.046 2.498 . . . . 0.0 111.787 179.3 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 079 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -70.23 147.71 60.47 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 121.814 1.676 . . . . 0.0 112.372 179.95 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 11.4 t -85.4 129.26 38.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.127 -179.568 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -73.58 127.11 31.84 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.59 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . 0.425 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . 0.425 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 32.1 Cg_exo -58.28 -27.48 81.06 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.532 2.155 . . . . 0.0 113.222 -178.367 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 23.4 m -74.17 -44.6 52.88 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.273 179.008 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . 0.43 ' CE2' ' NE ' ' B' ' 245' ' ' ARG . 89.1 t80 -56.35 -46.92 79.77 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.634 -179.436 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . 0.483 HD21 HH21 ' B' ' 245' ' ' ARG . 93.3 mt -63.02 -42.27 99.75 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.846 0.355 . . . . 0.0 110.634 179.869 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -67.6 -40.24 84.75 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -179.425 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -60.97 -45.0 96.53 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.328 -178.832 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.509 ' NH2' ' CG ' ' A' ' 92' ' ' ASP . 60.5 mtm180 -65.36 -38.55 90.42 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.626 -0.429 . . . . 0.0 111.513 -179.662 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -61.49 -41.15 96.84 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.41 -179.845 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 62.9 m -64.91 -41.07 95.89 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.052 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . 0.433 ' O ' ' N ' ' B' ' 252' ' ' LEU . 58.3 tt0 -62.13 -37.48 85.3 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.797 179.882 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 27.3 t -63.83 -45.68 96.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.255 179.359 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -59.81 -28.31 67.35 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.211 -0.596 . . . . 0.0 109.521 179.282 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -95.14 -8.73 35.59 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.322 179.558 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' B' ' 248' ' ' GLN . 40.6 tp -77.46 136.86 38.4 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.595 -178.656 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -88.17 135.37 33.47 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.349 179.762 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . 0.577 ' OD1' ' N ' ' B' ' 255' ' ' ASP . 23.3 p-10 -65.91 -24.71 66.89 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.773 0.32 . . . . 0.0 111.255 -179.176 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . 0.577 ' N ' ' OD1' ' B' ' 254' ' ' ASP . 45.7 p-10 -65.44 -1.65 2.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.71 -178.701 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.637 ' O ' ' N ' ' B' ' 258' ' ' ASP . 89.1 m-20 -87.55 -19.81 27.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.143 0.497 . . . . 0.0 110.062 179.454 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 3.2 tttm 37.16 20.53 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.652 179.605 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.637 ' N ' ' O ' ' B' ' 256' ' ' ASP . 51.9 t0 -92.43 108.05 19.67 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.686 -179.878 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.531 ' O ' ' CZ ' ' A' ' 93' ' ' ARG . 35.3 p-10 -85.12 1.71 46.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.584 -178.344 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 70.76 7.52 6.24 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.352 0.596 . . . . 0.0 110.275 179.195 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 81.3 mt -114.42 136.8 49.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.324 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . 0.424 ' N ' ' O ' ' A' ' 38' ' ' ARG . 88.1 t -124.51 132.0 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 120.816 -0.353 . . . . 0.0 110.424 -179.202 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -96.93 118.55 33.59 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.192 0.52 . . . . 0.0 112.193 -178.18 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -67.2 -46.01 75.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.553 179.057 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 62.6 mm-40 -91.77 160.78 35.51 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.622 -178.168 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -62.51 154.3 65.51 Favored 'Trans proline' 0 N--CA 1.501 1.942 0 C-N-CA 122.664 2.243 . . . . 0.0 111.082 179.11 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.1 pt . . . . . 0 CA--C 1.519 -0.238 0 CA-C-O 121.497 0.665 . . . . 0.0 112.139 -178.771 . . . . . . . . 0 0 . 1 . 080 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo . . . . . 0 N--CA 1.494 1.531 0 CA-C-O 121.217 0.424 . . . . 0.0 112.672 . . . . . . . . . 0 0 . 1 . 080 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 74.1 m -64.17 -44.6 91.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.195 -179.406 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.695 ' NH1' ' HH ' ' A' ' 97' ' ' TYR . 95.5 mtt-85 -93.62 118.12 30.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.718 0.294 . . . . 0.0 111.205 -178.671 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.8 mtp180 -133.51 138.16 45.98 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.397 -0.521 . . . . 0.0 111.509 179.468 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 35.8 tp -113.85 133.62 55.31 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.331 179.876 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.4 t -109.69 130.96 61.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.865 0.364 . . . . 0.0 110.106 -179.966 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.483 HG23 HH21 ' A' ' 93' ' ' ARG . 1.5 m -88.33 115.65 25.98 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.092 -0.503 . . . . 0.0 112.046 -178.698 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.652 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 95.4 mt -84.04 141.5 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.245 178.712 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -94.78 157.17 16.06 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.332 0.586 . . . . 0.0 111.812 179.526 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.584 ' NH2' ' CD1' ' B' ' 252' ' ' LEU . 89.9 mtm180 -57.85 -27.67 63.44 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.459 -178.92 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.0 t -75.72 -16.36 60.16 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.449 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.22 26.88 11.52 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -179.441 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 49.7 t -117.26 133.59 63.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.75 0.31 . . . . 0.0 110.632 179.865 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -75.47 138.56 41.68 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 178.835 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.5 -113.94 1.69 Allowed Glycine 0 CA--C 1.534 1.237 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.316 -179.292 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -72.1 143.01 39.29 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.18 1.92 . . . . 0.0 113.015 -178.415 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 55.0 m170 -102.76 143.35 32.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.028 179.863 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -117.08 92.43 39.36 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.297 -179.49 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -60.8 127.49 22.65 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.162 1.908 . . . . 0.0 111.755 179.965 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.6 mt -90.01 51.01 1.96 Allowed 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.739 -0.384 . . . . 0.0 111.126 -179.156 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.6 p -63.33 -20.14 65.24 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.21 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.3 mt -81.45 141.89 33.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.501 179.266 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.9 m -66.51 -20.44 66.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.665 -178.742 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 83.9 m -129.32 131.01 46.84 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.048 0.451 . . . . 0.0 111.332 179.551 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.8 t -127.08 123.34 36.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.804 178.898 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 40.8 tp -120.32 127.46 52.37 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.36 -178.782 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 11.2 m-85 -104.36 130.77 52.21 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.773 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 178.37 -159.24 24.48 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 111.424 -0.671 . . . . 0.0 111.424 -179.771 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 29.3 ptt-85 -108.48 -15.88 14.34 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.955 -179.87 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -77.0 165.59 53.58 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.017 -178.852 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 30.9 mm -64.5 -43.07 96.86 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.843 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.9 mp0 -52.27 -29.14 21.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.168 -179.887 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 58.6 m -60.88 121.08 11.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.846 179.831 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -55.36 -29.35 58.23 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.958 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.423 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 99.3 mt -129.49 124.43 59.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.247 -0.888 . . . . 0.0 108.868 177.505 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 45.7 mtm180 -101.8 134.25 45.27 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.703 -179.905 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.556 ' C ' ' H ' ' A' ' 41' ' ' LEU . 92.1 mt -119.37 129.04 75.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.813 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -70.24 35.19 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.921 -178.88 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.556 ' H ' ' C ' ' A' ' 39' ' ' ILE . 23.6 mt -103.65 115.93 62.74 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.267 -179.75 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -74.64 -7.78 19.78 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.145 1.896 . . . . 0.0 111.771 -179.847 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.9 m -100.36 8.2 8.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.59 179.843 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.5 p -96.72 140.86 16.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.455 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.0 m -70.98 166.63 20.89 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.336 0.589 . . . . 0.0 111.612 -178.728 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -63.38 -40.84 98.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.01 -179.696 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.582 ' O ' ' N ' ' A' ' 49' ' ' CYS . 87.7 mt-30 -116.93 -6.65 11.45 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.405 -179.89 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.478 ' C ' ' O ' ' A' ' 47' ' ' GLN . 13.1 t60 15.21 -74.88 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -179.568 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.582 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -125.48 130.15 51.22 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.885 -0.726 . . . . 0.0 112.061 -178.435 . . . . . . . . 3 3 . 1 . 080 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -127.67 126.42 41.92 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.102 179.979 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 83.5 mt -110.23 133.56 55.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.912 -179.309 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -115.18 126.54 54.71 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.497 178.931 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.3 mm -97.84 113.3 32.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 119.675 -0.81 . . . . 0.0 111.085 -179.694 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.437 ' O ' ' C ' ' A' ' 55' ' ' GLU . 97.4 m-70 -114.85 136.3 53.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.432 179.114 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 54' ' ' HIS . 98.4 mt-10 -40.31 -38.68 0.83 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.42 -0.512 . . . . 0.0 109.741 -179.428 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.495 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 50.8 tt0 -62.34 -66.43 0.54 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.035 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.495 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 4.0 tp10 -155.58 -169.42 3.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.334 -179.377 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.415 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -114.52 129.42 56.66 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.61 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 93.9 mt -115.4 131.83 66.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.408 0.623 . . . . 0.0 111.913 -178.796 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.487 ' CD1' ' HG ' ' A' ' 49' ' ' CYS . 28.2 tp -100.61 130.8 46.72 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.196 179.994 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -111.3 131.52 55.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.819 -179.343 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 62.6 t-20 -94.74 106.16 18.13 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.819 0.343 . . . . 0.0 111.429 -179.673 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -97.52 -7.74 30.71 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.178 -179.683 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.8 p -84.06 108.21 16.86 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 119.997 -0.681 . . . . 0.0 111.3 -179.334 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 89.6 p -91.27 -16.25 27.87 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.783 178.874 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.23 -42.53 13.72 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.128 179.95 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -139.82 97.64 8.02 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.085 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -56.08 143.22 84.54 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 121.974 1.782 . . . . 0.0 112.781 -178.501 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.5 m -69.83 138.25 52.45 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.349 178.588 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -102.73 140.29 37.2 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.272 0.558 . . . . 0.0 111.091 -179.561 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.401 ' O ' ' N ' ' A' ' 74' ' ' SER . 4.0 p -133.14 135.66 56.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.92 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 50.09 31.79 5.26 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.361 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.13 26.51 68.38 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.769 179.91 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.401 ' N ' ' O ' ' A' ' 71' ' ' VAL . 7.6 t -140.6 138.23 34.27 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 117.266 0.533 . . . . 0.0 111.929 -179.546 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.6 m -72.39 141.94 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.789 179.374 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.9 pt -113.68 94.16 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.203 0.525 . . . . 0.0 111.148 179.461 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -65.35 -29.05 69.74 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.752 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -122.12 165.02 22.18 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.219 179.909 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.14 152.28 81.6 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.647 2.231 . . . . 0.0 112.6 -179.819 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.3 m -143.33 143.46 24.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.466 -179.424 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -72.01 133.33 45.25 Favored 'General case' 0 C--O 1.231 0.098 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.036 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 98.1 mt -82.34 141.57 32.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.026 0.441 . . . . 0.0 111.564 -179.487 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -131.38 151.9 51.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.425 179.682 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.491 ' HD1' ' C ' ' A' ' 99' ' ' ASN . 7.4 t60 -54.37 117.7 3.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.712 0.291 . . . . 0.0 110.813 -179.785 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.5 -15.43 27.15 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.196 -0.526 . . . . 0.0 111.821 179.515 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -67.4 134.46 51.48 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.345 -0.542 . . . . 0.0 110.545 -179.741 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 74.3 t -109.74 135.91 47.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.244 -178.225 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.474 ' O ' ' OG ' ' A' ' 94' ' ' SER . 6.5 mm -99.26 128.74 50.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.761 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.4 m -119.98 121.22 38.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.686 0.755 . . . . 0.0 111.976 -178.989 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.613 ' O ' ' N ' ' A' ' 93' ' ' ARG . 96.2 mt -115.87 127.75 73.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.002 178.667 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.537 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 72.5 mt -18.64 99.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -178.763 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.537 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 2.6 t70 88.68 -21.96 0.14 Allowed 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 178.031 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.652 ' NH2' ' O ' ' A' ' 10' ' ' ILE . 8.0 mmm180 -130.06 146.02 51.7 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.0 -179.609 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.474 ' OG ' ' O ' ' A' ' 88' ' ' ILE . 32.6 t -139.45 148.83 43.28 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.991 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -126.92 122.14 33.75 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 -179.992 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 79.0 mtp85 -82.07 130.31 35.05 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.89 0.376 . . . . 0.0 111.249 -179.184 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.695 ' HH ' ' NH1' ' A' ' 5' ' ' ARG . 82.8 t80 -96.23 124.92 40.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.554 179.498 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -122.39 127.04 49.22 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.6 179.852 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.491 ' C ' ' HD1' ' A' ' 84' ' ' HIS . 61.6 t-20 -127.01 108.61 11.09 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.217 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 . . . . . 0 C--N 1.332 -0.16 0 CA-C-O 120.967 0.413 . . . . 0.0 111.075 -178.866 . . . . . . . . 0 0 . 1 . 080 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . 0.434 ' CG1' ' N ' ' B' ' 229' ' ' ASP . 11.0 p . . . . . 0 CA--C 1.528 0.126 0 CA-C-O 120.676 0.274 . . . . 0.0 111.217 . . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.565 ' CG ' ' H ' ' B' ' 230' ' ' SEP . 66.5 t0 56.58 -125.06 1.91 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.215 -179.093 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . 0.565 ' H ' ' CG ' ' B' ' 229' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.476 ' O ' ' O ' ' B' ' 232' ' ' GLY . 75.1 mt-30 -141.33 -5.22 1.1 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.027 -179.075 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' B' ' 231' ' ' GLN . . . -52.68 -158.68 0.01 OUTLIER Glycine 0 CA--C 1.532 1.122 0 CA-C-N 116.413 -0.358 . . . . 0.0 112.407 -179.144 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -64.88 157.5 56.3 Favored 'Trans proline' 0 N--CA 1.5 1.86 0 C-N-CA 123.559 2.839 . . . . 0.0 112.789 -179.73 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 080 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -73.71 170.93 18.85 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 122.386 2.057 . . . . 0.0 113.015 -179.559 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 25.6 t -110.28 133.37 55.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.998 -179.396 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.6 t -77.42 130.71 37.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.867 -179.902 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . 0.415 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . 0.415 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 31.8 Cg_exo -57.72 -24.5 63.59 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 122.569 2.179 . . . . 0.0 111.926 -179.546 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 16.8 m -73.74 -44.92 54.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.203 0.525 . . . . 0.0 110.29 178.357 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -58.17 -45.54 87.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.873 -178.724 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 94.0 mt -63.64 -39.76 95.16 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.328 -0.549 . . . . 0.0 109.575 179.568 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -62.04 -42.75 99.51 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.258 179.988 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -64.89 -40.64 95.42 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.126 -179.713 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.434 ' NE ' ' OD2' ' A' ' 92' ' ' ASP . 13.6 mmm180 -61.05 -38.92 87.88 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.298 -178.778 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -65.06 -38.82 92.05 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.38 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 30.4 m -62.39 -45.8 91.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.497 178.475 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -61.08 -35.35 76.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.457 -179.739 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 24.2 t -60.42 -45.0 97.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.39 -0.524 . . . . 0.0 109.697 179.423 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -59.75 -30.23 68.7 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.52 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -82.9 -12.4 57.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.413 179.495 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.584 ' CD1' ' NH2' ' A' ' 12' ' ' ARG . 93.6 mt -110.03 -176.8 3.09 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.708 179.778 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 30.3 p30 -141.95 173.01 11.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.068 -179.745 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -69.77 -18.3 63.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.57 179.537 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -67.95 -9.2 43.38 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.4 -179.472 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -82.14 81.06 8.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.089 0.471 . . . . 0.0 110.501 -179.855 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -66.56 -7.36 19.63 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.908 -178.818 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.695 ' O ' ' N ' ' B' ' 260' ' ' GLU . 89.0 m-20 -102.35 -0.87 32.02 Favored 'General case' 0 C--O 1.224 -0.264 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.541 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.551 ' O ' ' NH1' ' A' ' 93' ' ' ARG . 64.9 t0 -12.99 67.45 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 114.84 -1.073 . . . . 0.0 113.529 -178.867 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.695 ' N ' ' O ' ' B' ' 258' ' ' ASP . 50.4 mm-40 60.83 1.98 0.49 Allowed 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 177.365 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . 0.4 HG13 ' NH2' ' A' ' 93' ' ' ARG . 4.6 mm -110.46 130.78 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-N 119.113 0.87 . . . . 0.0 109.945 179.537 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 53.5 t -124.48 131.77 72.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.032 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -99.73 122.51 42.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.064 0.459 . . . . 0.0 111.613 -178.257 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -63.85 -46.78 83.46 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.358 0.599 . . . . 0.0 110.135 179.927 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.55 157.34 34.92 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.654 -179.367 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -60.3 145.23 99.02 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.893 2.395 . . . . 0.0 113.059 -179.647 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 14.5 pt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.178 179.483 . . . . . . . . 0 0 . 1 . 081 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo . . . . . 0 N--CA 1.491 1.347 0 CA-C-O 120.992 0.33 . . . . 0.0 112.356 . . . . . . . . . 0 0 . 1 . 081 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.6 p -108.53 -34.75 6.66 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.5 179.033 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.511 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 96.1 mtt-85 -91.99 118.7 31.02 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.274 -179.882 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.581 HH21 ' ND1' ' A' ' 19' ' ' HIS . 76.7 ttt180 -128.29 129.78 46.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.926 0.394 . . . . 0.0 111.56 -179.476 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 33.9 tp -112.91 130.06 56.25 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.581 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.8 t -109.06 134.29 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-O 120.835 0.35 . . . . 0.0 110.795 -179.39 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.7 m -91.96 120.93 33.07 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.502 -178.521 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.495 ' CD1' ' OD1' ' A' ' 16' ' ' ASP . 49.4 mm -82.15 138.68 19.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.539 179.651 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -91.6 159.65 15.79 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 121.331 0.586 . . . . 0.0 111.561 179.115 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.57 ' NH2' ' OE1' ' B' ' 248' ' ' GLN . 77.3 mtp180 -54.72 -33.07 60.53 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.32 -179.109 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.8 p -78.4 -12.78 60.03 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.76 -179.594 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.59 13.56 40.65 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.973 178.899 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.3 m -109.71 141.49 24.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.317 179.947 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.495 ' OD1' ' CD1' ' A' ' 10' ' ' ILE . 86.4 m-20 -73.6 139.26 45.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.56 -179.327 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.43 -117.33 1.96 Allowed Glycine 0 CA--C 1.535 1.295 0 C-N-CA 120.383 -0.913 . . . . 0.0 111.638 179.94 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.17 143.28 43.74 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 122.096 1.864 . . . . 0.0 113.319 -178.73 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.581 ' ND1' HH21 ' A' ' 6' ' ' ARG . 1.0 OUTLIER -106.85 157.6 17.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.402 -179.861 . . . . . . . . 3 3 . 1 . 081 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.439 ' CZ ' ' OE1' ' B' ' 265' ' ' GLN . 48.3 t80 -131.52 102.19 15.44 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.773 179.918 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.08 132.73 17.09 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 121.728 1.619 . . . . 0.0 112.061 -179.037 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.9 mt -83.36 55.4 3.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.901 0.381 . . . . 0.0 111.46 -178.535 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 52.4 p -68.04 -25.39 65.34 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.558 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.0 mt -80.65 139.65 36.09 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.539 -0.755 . . . . 0.0 108.966 179.083 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 80.3 p -65.5 -19.38 65.91 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.408 -179.224 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.52 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 44.6 m -131.95 131.49 42.67 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.175 -179.446 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.1 t -125.15 117.18 23.32 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.711 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.429 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 52.0 tp -113.93 126.06 54.73 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.915 -179.6 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.494 ' O ' ' O ' ' A' ' 47' ' ' GLN . 7.8 m-85 -104.7 141.09 37.08 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.944 179.465 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 153.34 -174.24 32.03 Favored Glycine 0 N--CA 1.469 0.864 0 C-N-CA 120.288 -0.958 . . . . 0.0 112.328 178.481 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.628 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 80.7 mtm-85 -77.39 -32.51 54.89 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-O 120.93 0.395 . . . . 0.0 110.842 -179.982 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.485 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -46.04 144.63 3.65 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 -179.057 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.449 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 10.0 tp -65.96 -41.41 89.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-O 120.883 0.373 . . . . 0.0 110.056 179.667 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.449 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 79.4 mm-40 -57.63 -15.65 8.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.861 -179.845 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 80.2 m -56.87 124.4 18.42 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.587 -179.628 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.52 ' OD2' ' O ' ' A' ' 26' ' ' THR . 57.0 m-20 -60.2 -33.15 71.83 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 179.443 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.41 HD12 ' CZ ' ' A' ' 29' ' ' PHE . 87.1 mt -127.57 120.33 54.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 176.346 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 76.8 ttt-85 -105.85 135.53 47.11 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.352 -177.923 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 94.5 mt -117.32 130.09 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 121.045 0.45 . . . . 0.0 110.888 -179.537 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.456 ' NE2' ' OD2' ' B' ' 258' ' ' ASP . 49.8 mt-30 -81.09 30.62 0.33 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.496 -179.216 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 20.8 mt -91.32 112.8 55.94 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.758 179.262 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -57.38 -14.24 15.43 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.347 2.032 . . . . 0.0 113.343 179.636 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.4 m -103.78 11.15 8.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.748 -178.988 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.628 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 6.0 p -98.56 138.39 23.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.018 179.629 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.0 m -68.91 167.87 14.8 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.616 0.722 . . . . 0.0 111.983 -179.138 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -63.02 -43.79 97.75 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 114.768 -1.106 . . . . 0.0 111.997 -178.394 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.649 ' O ' ' N ' ' A' ' 49' ' ' CYS . 21.6 mp0 -110.74 -14.55 14.0 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.935 0.398 . . . . 0.0 110.035 179.966 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 25.7 t60 32.45 -75.31 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.083 -0.962 . . . . 0.0 113.551 179.633 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.649 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.82 137.82 45.3 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -178.594 . . . . . . . . 3 3 . 1 . 081 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -125.02 131.83 53.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.016 179.599 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 88.3 mt -114.12 130.54 68.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.337 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -117.98 121.35 40.42 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.422 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 86.3 mt -103.82 116.04 46.86 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-O 121.572 0.701 . . . . 0.0 111.649 -178.854 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.454 ' O ' ' N ' ' A' ' 56' ' ' GLN . 53.0 m-70 -111.84 146.08 38.31 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.864 -179.837 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 54' ' ' HIS . 95.5 mt-10 -39.83 -30.45 0.08 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.128 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.465 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 89.6 mt-30 -63.97 -68.74 0.32 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.991 179.213 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.465 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 4.6 tp10 -159.13 -161.82 0.99 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.668 179.401 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.432 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -116.63 122.31 44.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.578 179.158 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 91.4 mt -113.59 130.48 67.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.266 0.555 . . . . 0.0 112.132 -178.926 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.3 tp -92.37 125.39 37.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.15 179.47 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -111.36 136.28 50.71 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.635 0.255 . . . . 0.0 110.921 179.73 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.682 ' ND2' ' H ' ' A' ' 69' ' ' THR . 8.1 t-20 -97.76 104.48 16.51 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.133 179.114 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -95.99 -8.87 32.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.026 179.447 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.25 101.01 2.73 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.941 179.423 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.9 p -84.58 -10.17 57.64 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.438 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.39 -44.3 6.92 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.881 179.519 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.404 HD22 ' HA ' ' B' ' 236' ' ' VAL . 74.8 m-20 -137.45 91.62 14.05 Favored Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.57 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.68 144.29 54.02 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.422 2.081 . . . . 0.0 112.46 -179.055 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.682 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 20.4 m -72.17 138.29 47.53 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.786 179.164 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -100.98 141.22 34.19 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.36 -179.867 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 54.5 t -130.3 134.27 62.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.101 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 52.13 32.48 10.56 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.13 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.93 29.72 66.7 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.781 179.68 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.7 m -139.02 130.65 27.35 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.521 -0.472 . . . . 0.0 111.425 -179.599 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -69.56 138.26 22.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.619 179.844 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.544 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 1.2 pt -118.54 112.39 37.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-O 121.37 0.605 . . . . 0.0 111.501 -179.763 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -80.32 -20.52 44.09 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.583 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -121.55 160.2 47.25 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.394 179.741 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -61.99 148.49 93.05 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.901 1.734 . . . . 0.0 112.444 179.69 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 76.9 t -130.35 138.13 54.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.021 -179.469 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.462 ' HE ' ' HG2' ' A' ' 57' ' ' GLU . 72.5 ttt180 -70.77 129.48 39.21 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.713 178.948 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.4 mt -80.68 135.29 36.0 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.309 0.576 . . . . 0.0 111.276 -179.921 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -133.06 151.75 52.01 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.51 -179.912 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.552 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 4.6 t60 -52.04 116.44 2.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.168 -179.16 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.16 -14.79 36.73 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 121.234 -0.508 . . . . 0.0 111.953 179.551 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -68.89 134.94 50.28 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.953 -179.512 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.9 t -114.13 132.68 62.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.647 -178.207 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.5 mt -100.54 131.81 47.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.317 -0.856 . . . . 0.0 108.79 178.888 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.9 m -120.91 124.2 44.35 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.343 0.592 . . . . 0.0 112.064 -178.431 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.578 ' O ' ' N ' ' A' ' 92' ' ' ASP . 82.2 mt -111.15 122.59 65.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 178.099 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.475 ' C ' ' O ' ' A' ' 90' ' ' ILE . 43.8 mm 36.89 -92.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.02 -179.471 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.578 ' N ' ' O ' ' A' ' 90' ' ' ILE . 59.2 t0 -121.48 7.46 10.09 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.881 0.372 . . . . 0.0 111.296 179.649 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.73 HH12 HH22 ' B' ' 245' ' ' ARG . 48.5 mmt-85 -111.59 135.01 52.76 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.101 178.9 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.6 m -133.5 148.18 51.67 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.96 179.466 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -124.81 124.66 42.59 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.429 -179.684 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 77.1 mtp85 -86.99 131.75 33.99 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 119.687 -0.805 . . . . 0.0 110.976 -179.109 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.511 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 71.2 t80 -96.62 125.55 41.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.492 179.674 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -126.26 123.16 37.5 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.382 179.835 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.552 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 63.7 t-20 -107.66 109.78 21.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.078 179.371 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 . . . . . 0 C--N 1.329 -0.3 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.758 . . . . . . . . 0 0 . 1 . 081 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . 0.431 ' CG2' ' NE ' ' A' ' 31' ' ' ARG . 7.9 p . . . . . 0 C--O 1.233 0.189 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 . . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' B' ' 230' ' ' SEP . 83.9 m-20 -92.5 0.61 57.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.9 -179.752 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . 0.578 ' O ' ' NE2' ' B' ' 231' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.578 ' NE2' ' O ' ' B' ' 230' ' ' SEP . 93.8 mm-40 -127.87 31.87 5.04 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.463 178.849 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -110.62 -158.58 16.15 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.69 -179.269 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.93 151.11 59.46 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 123.309 2.673 . . . . 0.0 112.895 179.681 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 081 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -79.91 130.52 8.56 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.377 2.051 . . . . 0.0 113.621 -178.846 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . 0.404 ' HA ' HD22 ' A' ' 67' ' ' ASN . 1.2 m -68.86 147.84 12.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.079 -178.876 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 4.3 t -79.15 128.28 33.09 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.897 -179.966 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . 0.444 ' O1P' ' OG1' ' B' ' 240' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -55.76 -28.68 68.04 Favored 'Trans proline' 0 N--CA 1.5 1.893 0 C-N-CA 123.249 2.633 . . . . 0.0 112.772 -179.149 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' B' B ' 240' ' ' THR . . . . . 0.444 ' OG1' ' O1P' ' B' ' 238' ' ' TPO . 51.6 m -70.91 -45.72 63.79 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.864 179.239 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -58.4 -46.5 86.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.523 -178.928 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 82.8 mt -63.11 -41.79 99.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.277 -179.061 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -67.0 -38.67 86.44 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.113 -179.652 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -61.61 -43.91 97.98 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.313 179.539 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.73 HH22 HH12 ' A' ' 93' ' ' ARG . 37.9 mtp85 -61.38 -40.98 96.31 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.018 -179.881 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -60.89 -41.19 95.54 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 178.122 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 48.0 t -62.87 -44.27 96.57 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 177.916 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . 0.57 ' OE1' ' NH2' ' A' ' 12' ' ' ARG . 87.5 mt-30 -60.02 -37.15 78.9 Favored 'General case' 0 CA--C 1.523 -0.074 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.051 179.598 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 55.8 t -61.62 -43.82 97.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.663 179.689 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -65.51 -35.7 81.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.25 179.097 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -82.45 -13.54 56.57 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.903 179.9 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.457 ' CD1' ' NH1' ' A' ' 12' ' ' ARG . 61.4 mt -101.42 -174.49 2.61 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.293 0.568 . . . . 0.0 111.199 179.874 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . 0.428 ' C ' ' H ' ' B' ' 255' ' ' ASP . 88.5 m-20 -142.98 176.69 8.89 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.947 178.987 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . 0.428 ' N ' ' OD1' ' B' ' 254' ' ' ASP . 35.5 p-10 -69.79 -1.5 9.44 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.33 0.586 . . . . 0.0 109.44 179.871 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . 0.428 ' H ' ' C ' ' B' ' 253' ' ' ASN . 35.7 t70 -66.66 -25.85 66.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.934 178.928 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.432 ' O ' ' OD1' ' B' ' 259' ' ' ASP . 66.8 t0 -69.01 59.0 0.1 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.0 0.429 . . . . 0.0 110.316 -179.074 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . 0.428 ' N ' ' O ' ' B' ' 255' ' ' ASP . 88.7 tttt -55.63 -17.12 4.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.641 -179.62 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.456 ' OD2' ' NE2' ' A' ' 40' ' ' GLN . 39.2 t70 -61.81 -51.94 66.23 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 119.997 -0.681 . . . . 0.0 109.677 179.724 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.525 ' C ' HH21 ' A' ' 93' ' ' ARG . 2.5 m-20 65.3 10.23 6.31 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.619 -179.594 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 60.88 18.42 8.75 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 121.078 -0.249 . . . . 0.0 110.915 179.788 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 66.8 mt -123.13 132.91 70.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.891 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 55.6 t -125.84 134.08 67.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.888 0.375 . . . . 0.0 110.631 -179.932 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -96.17 117.67 31.2 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.155 0.503 . . . . 0.0 110.968 -179.25 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -66.88 -45.48 77.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.89 179.555 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . 0.439 ' OE1' ' CZ ' ' A' ' 20' ' ' PHE . 0.3 OUTLIER -93.85 157.82 37.43 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.309 -179.61 . . . . . . . . 3 3 . 1 . 081 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -64.49 150.42 88.27 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 C-N-CA 123.006 2.471 . . . . 0.0 112.436 -179.892 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 30.3 pt . . . . . 0 C--N 1.328 -0.369 0 CA-C-O 121.247 0.546 . . . . 0.0 111.048 179.762 . . . . . . . . 0 0 . 1 . 082 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo . . . . . 0 N--CA 1.493 1.48 0 CA-C-O 120.88 0.283 . . . . 0.0 112.156 . . . . . . . . . 0 0 . 1 . 082 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.1 m -112.28 -66.32 1.09 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.073 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 86.0 mtt85 -89.6 129.68 36.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.041 179.318 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -128.4 141.77 51.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.071 0.462 . . . . 0.0 111.545 -179.93 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 28.1 tp -114.44 130.46 56.72 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.354 179.696 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 52.3 t -106.04 129.26 59.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.554 -0.459 . . . . 0.0 110.474 -179.429 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.573 ' OG1' ' O ' ' A' ' 18' ' ' PRO . 77.6 p -81.89 140.79 33.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.458 -178.243 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.453 HG22 HD13 ' A' ' 10' ' ' ILE . 96.6 mt -110.88 136.41 47.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.098 178.653 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.1 mttm -87.96 160.08 18.05 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.36 179.224 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.474 ' HD3' HH21 ' B' ' 245' ' ' ARG . 89.7 mtm180 -58.44 -29.41 66.11 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.962 -179.259 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 87.1 p -81.24 -7.28 59.54 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.005 179.936 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.0 35.72 6.64 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 179.696 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.6 t -119.03 132.44 68.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.693 0.282 . . . . 0.0 111.076 -179.978 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -77.45 135.56 38.28 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.637 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -128.11 -114.04 1.78 Allowed Glycine 0 CA--C 1.535 1.31 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.052 -179.098 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.573 ' O ' ' OG1' ' A' ' 9' ' ' THR . 61.4 Cg_endo -72.24 145.71 44.27 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 122.445 2.097 . . . . 0.0 113.378 -178.657 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -108.79 129.52 55.38 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.384 179.776 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -98.63 99.85 8.34 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.604 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.76 134.4 20.02 Favored 'Trans proline' 0 C--N 1.315 -1.229 0 C-N-CA 121.12 1.214 . . . . 0.0 111.099 -179.347 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.9 mt -94.15 118.42 31.53 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.547 -178.982 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.4 p -125.03 -4.36 7.49 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.509 179.328 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 49.8 mt -104.47 148.77 26.09 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.545 -179.032 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.36 -22.43 66.26 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.11 -178.906 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 88.0 m -128.34 130.06 47.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.282 0.563 . . . . 0.0 111.76 -179.433 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.628 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -127.96 121.75 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.878 178.565 . . . . . . . . 3 3 . 1 . 082 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.527 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 53.7 tp -123.87 124.16 42.03 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -177.649 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.628 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 46.5 m-85 -97.4 141.28 30.67 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.091 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 168.69 -164.44 38.05 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.109 -1.044 . . . . 0.0 112.423 179.582 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.509 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 33.9 ttp-105 -96.99 -28.91 13.95 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.684 -0.758 . . . . 0.0 110.186 -179.611 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.9 162.08 53.99 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.777 -178.439 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.0 tp -64.47 -39.45 85.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.056 -0.572 . . . . 0.0 110.153 179.342 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -53.31 -28.08 26.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.435 -179.643 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.3 m -64.37 116.71 6.34 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.434 -179.969 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.527 ' OD1' ' O ' ' A' ' 28' ' ' LEU . 12.5 p-10 -58.02 -26.24 62.18 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.539 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 34.6 mm -122.33 113.96 40.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.361 177.636 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -105.36 136.67 44.47 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.784 179.479 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.52 ' C ' ' H ' ' A' ' 41' ' ' LEU . 91.3 mt -119.61 132.13 70.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.36 -0.836 . . . . 0.0 108.976 179.603 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -71.29 29.4 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.669 -178.808 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.52 ' H ' ' C ' ' A' ' 39' ' ' ILE . 31.4 mt -91.1 122.73 66.1 Favored Pre-proline 0 C--N 1.323 -0.549 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.037 179.805 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.44 -7.47 20.95 Favored 'Trans proline' 0 N--CA 1.49 1.298 0 C-N-CA 122.12 1.88 . . . . 0.0 111.64 -179.161 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.2 m -107.54 9.97 9.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.844 -179.164 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.509 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 9.6 p -92.16 141.85 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.061 179.835 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.0 m -71.26 159.43 34.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.714 0.769 . . . . 0.0 112.215 -178.659 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -61.89 -39.72 92.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.814 -1.084 . . . . 0.0 110.797 -179.602 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.595 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.3 mt-30 -117.14 -8.76 11.13 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.678 0.275 . . . . 0.0 111.047 179.445 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.471 ' CG ' ' HG ' ' A' ' 64' ' ' SER . 24.3 t60 16.19 -73.88 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 114.633 1.345 . . . . 0.0 114.633 -178.527 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.595 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.8 134.64 47.03 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 119.966 -0.693 . . . . 0.0 112.72 -177.724 . . . . . . . . 3 3 . 1 . 082 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -126.02 131.16 52.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.638 179.742 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.9 mt -116.0 133.38 62.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.166 0.508 . . . . 0.0 110.728 179.649 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -118.67 122.58 42.87 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.371 -0.832 . . . . 0.0 108.774 179.051 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 92.1 mt -105.2 116.09 48.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.561 0.696 . . . . 0.0 111.653 -178.974 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.439 ' O ' ' C ' ' A' ' 55' ' ' GLU . 87.6 m-70 -114.42 144.78 42.75 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.604 -179.848 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 54' ' ' HIS . 92.1 mt-10 -39.77 -33.11 0.17 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.318 -0.553 . . . . 0.0 109.911 -179.037 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.449 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 82.7 mt-30 -61.73 -68.38 0.32 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.788 179.227 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.449 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 4.5 tp10 -158.2 -166.35 1.92 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.393 -179.492 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.433 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -110.1 130.13 55.59 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.921 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.5 mt -119.4 129.07 75.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.226 0.536 . . . . 0.0 112.24 -178.549 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.449 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 17.4 tp -99.27 126.25 45.06 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.216 179.535 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -113.22 137.1 51.97 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.928 -179.886 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.506 ' ND2' ' O ' ' A' ' 76' ' ' ILE . 22.3 p-10 -100.66 111.19 23.39 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.992 0.425 . . . . 0.0 111.929 -179.246 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -102.61 -6.84 22.33 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.352 179.73 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.471 ' HG ' ' CG ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -78.44 100.12 6.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.81 0.338 . . . . 0.0 111.579 -179.476 . . . . . . . . 3 3 . 1 . 082 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.9 p -75.6 -32.17 60.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.207 178.288 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.4 m -65.25 -49.24 70.39 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.108 -179.069 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -145.4 103.95 4.32 Favored Pre-proline 0 N--CA 1.466 0.348 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.831 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -54.68 145.14 61.44 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 121.446 1.43 . . . . 0.0 112.004 -179.096 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.9 m -68.8 138.73 55.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.867 178.872 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -99.32 139.98 34.17 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.991 -179.764 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 55.0 t -134.38 134.47 54.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.735 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.573 ' ND2' ' OD1' ' A' ' 86' ' ' ASP . 74.1 m-20 53.8 32.12 14.34 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.611 -179.5 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.65 28.34 63.4 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.736 179.251 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.5 m -147.98 144.85 28.26 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 117.74 0.77 . . . . 0.0 111.734 179.902 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.4 m -75.88 139.54 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.435 179.247 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.506 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 4.5 pt -104.99 101.61 12.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.411 0.624 . . . . 0.0 111.319 -179.912 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -65.01 -34.86 79.45 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.808 179.431 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.457 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.7 OUTLIER -126.15 178.52 1.48 Allowed Pre-proline 0 CA--C 1.53 0.176 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.52 179.803 . . . . . . . . 3 3 . 1 . 082 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.457 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 21.7 Cg_exo -63.26 146.89 94.13 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 C-N-CA 122.826 2.351 . . . . 0.0 112.174 -179.899 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.5 p -141.64 140.96 30.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.067 179.668 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -72.6 129.86 39.25 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.121 179.41 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 93.0 mt -86.63 135.84 33.26 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.344 -179.926 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -126.83 155.0 43.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.811 -179.554 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.612 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 6.1 t60 -53.96 116.64 2.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.441 -179.597 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.55 -14.48 27.41 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -179.509 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.573 ' OD1' ' ND2' ' A' ' 72' ' ' ASN . 26.2 t70 -69.12 129.7 40.62 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 179.551 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.0 t -109.24 135.64 47.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.312 -178.761 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 89.3 mt -103.43 132.29 50.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.25 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.843 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.0 m -122.15 127.59 50.26 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.762 0.791 . . . . 0.0 112.799 -178.342 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.611 ' O ' ' N ' ' A' ' 93' ' ' ARG . 97.4 mt -121.26 122.94 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 114.369 -1.287 . . . . 0.0 108.492 177.953 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.508 ' C ' ' O ' ' A' ' 90' ' ' ILE . 56.6 mt -3.74 95.62 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -179.77 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.589 ' CG ' ' HE ' ' B' ' 245' ' ' ARG . 1.4 t70 78.73 -13.42 0.97 Allowed 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 177.69 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.611 ' N ' ' O ' ' A' ' 90' ' ' ILE . 1.6 tpp180 -130.78 139.41 50.22 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.628 -179.192 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.9 p -140.15 157.08 46.18 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.283 0.563 . . . . 0.0 111.436 -179.204 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -130.04 125.97 36.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.207 -179.584 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -88.78 132.19 34.73 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.945 -179.231 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -96.94 125.43 41.36 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.498 -179.811 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -127.2 119.73 27.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.082 179.114 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.612 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 58.9 t-20 -105.04 114.31 28.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.504 179.583 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 . . . . . 0 C--N 1.328 -0.365 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.184 179.588 . . . . . . . . 0 0 . 1 . 082 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 17.5 m . . . . . 0 N--CA 1.455 -0.207 0 CA-C-O 120.745 0.307 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 082 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -68.32 154.98 40.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.565 -179.425 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . 0.407 ' HA ' ' HE ' ' A' ' 31' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -119.95 27.78 8.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.872 179.752 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -114.39 -152.68 10.58 Favored Glycine 0 CA--C 1.536 1.388 0 N-CA-C 111.832 -0.507 . . . . 0.0 111.832 -179.363 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -75.49 162.18 36.26 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 123.127 2.551 . . . . 0.0 113.211 -179.097 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 082 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -57.89 150.07 65.82 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 C-N-CA 122.674 2.249 . . . . 0.0 113.282 179.584 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 6.0 p -97.1 132.8 40.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.11 179.641 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . 0.403 ' HG ' ' CG2' ' A' ' 91' ' ' ILE . 10.7 t -55.84 111.96 1.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.201 -179.221 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . 0.448 HG23 ' H ' ' B' ' 241' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -50.83 -26.97 19.11 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 121.993 1.795 . . . . 0.0 112.592 -179.826 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 42.5 p -74.37 -36.62 63.56 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.577 -0.449 . . . . 0.0 109.793 178.762 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . 0.611 ' CZ ' ' NH1' ' B' ' 245' ' ' ARG . 85.9 t80 -59.39 -48.04 83.15 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.261 -179.153 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 94.3 mt -64.64 -42.28 95.56 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.445 -179.892 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -69.37 -42.13 75.6 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.867 -179.439 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 62.2 ttp180 -61.87 -46.66 88.43 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.703 -178.799 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.611 ' NH1' ' CZ ' ' B' ' 241' ' ' PHE . 10.7 ptm85 -71.47 -38.89 71.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.292 -179.476 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -61.54 -39.99 93.05 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.504 179.737 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 23.0 t -69.35 -42.77 74.83 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.289 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 64.1 tp60 -58.21 -40.14 80.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.838 179.758 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 89.0 t -67.43 -43.78 87.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.698 179.826 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -57.51 -28.72 63.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.563 -179.879 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -105.95 10.61 32.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.625 179.297 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 46.0 tp -91.44 137.63 32.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.227 -179.76 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . 0.569 ' C ' ' H ' ' B' ' 255' ' ' ASP . 19.4 t-20 -88.42 158.58 18.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.04 0.448 . . . . 0.0 111.078 -179.983 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -61.38 4.12 0.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.637 179.528 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . 0.569 ' H ' ' C ' ' B' ' 253' ' ' ASN . 99.2 m-20 -60.08 -20.9 60.4 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.813 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.425 ' C ' ' H ' ' B' ' 258' ' ' ASP . 92.9 m-20 -95.91 35.21 1.43 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.356 179.186 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -60.07 -9.57 3.34 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.453 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.425 ' H ' ' C ' ' B' ' 256' ' ' ASP . 91.6 m-20 -62.8 -42.71 99.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.321 179.718 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.649 ' C ' ' H ' ' B' ' 261' ' ' ILE . 35.5 t0 80.87 118.57 0.05 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.422 0.63 . . . . 0.0 111.58 179.957 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -54.24 10.91 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.645 -179.636 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . 0.649 ' H ' ' C ' ' B' ' 259' ' ' ASP . 54.9 mt -103.84 134.65 44.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.75 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 77.7 t -123.18 132.37 71.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.43 -179.163 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -95.03 111.92 23.67 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.88 -177.677 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -61.93 -45.52 93.32 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.33 179.19 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -98.99 156.77 35.12 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.308 -179.472 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.28 152.94 71.77 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 123.158 2.572 . . . . 0.0 113.427 -178.866 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 26.3 pt . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.196 179.112 . . . . . . . . 0 0 . 1 . 083 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo . . . . . 0 N--CA 1.489 1.233 0 CA-C-O 120.869 0.279 . . . . 0.0 111.777 . . . . . . . . . 0 0 . 1 . 083 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 67.3 p -109.51 -35.49 6.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.701 -179.705 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.835 HH11 ' HH ' ' A' ' 97' ' ' TYR . 94.0 mtt-85 -93.11 119.99 32.92 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.228 -179.286 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -131.14 139.25 49.76 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.436 179.937 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 46.9 tp -115.25 131.88 56.79 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.979 179.749 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 73.8 t -110.65 133.07 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.597 -178.759 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 m -84.42 143.23 29.56 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.717 0.77 . . . . 0.0 112.475 -179.094 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 50.6 mm -109.39 137.08 43.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 114.238 -1.346 . . . . 0.0 108.807 177.794 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -91.58 160.84 15.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.302 0.573 . . . . 0.0 111.127 179.877 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.44 HH22 ' CB ' ' B' ' 248' ' ' GLN . 82.0 mtp180 -54.1 -32.29 54.53 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.015 -178.949 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 97.7 p -81.64 -6.27 58.85 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.281 -179.958 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.03 38.2 6.92 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -179.869 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.5 t -123.74 133.73 68.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.02 0.438 . . . . 0.0 110.519 179.964 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.481 ' O ' ' OD1' ' A' ' 16' ' ' ASP . 50.8 p-10 -80.19 136.9 36.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.292 179.695 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -131.76 -110.63 1.3 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 120.3 -0.953 . . . . 0.0 112.169 -179.613 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.17 144.08 41.24 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.288 1.992 . . . . 0.0 113.25 -178.608 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -109.06 148.79 30.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.372 179.909 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -118.48 94.69 47.72 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.633 -179.262 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -60.69 126.57 20.15 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 121.926 1.751 . . . . 0.0 111.638 179.653 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 63.5 mt -91.18 47.81 1.44 Allowed 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -178.576 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.9 m -66.28 -16.77 64.3 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.701 179.629 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.2 mt -78.43 141.3 38.4 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.163 179.496 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 94.3 p -61.17 -21.98 64.29 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.756 -0.657 . . . . 0.0 112.054 -178.488 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 44.5 m -137.42 136.45 37.83 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 120.397 -0.521 . . . . 0.0 112.081 -179.435 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.2 t -129.43 122.6 29.72 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.035 178.315 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 47.6 tp -117.08 130.63 56.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.197 -179.23 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.45 ' CE2' ' CD1' ' A' ' 37' ' ' ILE . 7.9 m-85 -107.41 125.67 51.51 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.562 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 172.72 178.64 42.94 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 120.297 -0.954 . . . . 0.0 112.303 179.831 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.652 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 81.2 mtm-85 -77.6 -31.48 53.0 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.016 179.362 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -52.49 150.2 9.29 Favored Glycine 0 N--CA 1.464 0.553 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 -178.872 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.479 ' CD1' ' NH1' ' A' ' 38' ' ' ARG . 8.8 tp -66.76 -42.77 89.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.815 -179.514 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.436 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 83.8 tt0 -53.44 -18.28 2.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.386 179.406 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.9 m -62.38 127.05 29.5 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.537 -179.742 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -61.09 -31.64 71.31 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -179.459 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.45 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 98.5 mt -126.14 120.98 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 176.539 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.479 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 83.7 mtp180 -100.41 128.55 46.44 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.739 -178.951 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 89.5 mt -112.94 128.08 69.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.205 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -80.93 26.74 0.41 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.976 -0.557 . . . . 0.0 112.382 -177.432 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.616 ' CD1' ' HE ' ' A' ' 93' ' ' ARG . 68.4 mt -94.98 131.73 29.64 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.185 179.263 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.93 -12.1 31.91 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.098 1.865 . . . . 0.0 112.897 -179.676 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.5 m -98.27 12.67 5.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.278 -179.796 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.652 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 14.3 t -100.89 130.86 49.59 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 C-N-CA 120.577 -0.449 . . . . 0.0 109.893 178.695 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.715 ' HG ' ' H ' ' A' ' 46' ' ' LYS . 29.6 t -71.38 173.42 7.87 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.448 0.642 . . . . 0.0 112.125 -178.559 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.715 ' H ' ' HG ' ' A' ' 45' ' ' SER . 46.6 mttp -64.51 -41.39 96.46 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.89 179.919 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.588 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.2 mt-30 -116.45 -7.32 11.69 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 121.111 -0.235 . . . . 0.0 111.338 -179.566 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.474 ' C ' ' O ' ' A' ' 47' ' ' GLN . 14.9 t60 15.91 -74.88 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -178.695 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.588 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -129.24 133.27 47.44 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.088 -0.645 . . . . 0.0 112.341 -178.335 . . . . . . . . 3 3 . 1 . 083 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -128.47 131.15 48.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.293 179.763 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.4 mt -117.35 133.67 63.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.008 -179.697 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.518 ' CD ' ' HE2' ' A' ' 54' ' ' HIS . 81.7 tt0 -112.41 133.26 54.6 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.51 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.4 mm -101.96 124.28 55.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.448 0.642 . . . . 0.0 111.661 -178.637 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.57 ' O ' ' N ' ' A' ' 56' ' ' GLN . 96.9 m-70 -124.92 132.35 53.31 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.488 178.747 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.47 ' C ' ' O ' ' A' ' 54' ' ' HIS . 77.9 tt0 -39.79 -25.34 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.894 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.57 ' N ' ' O ' ' A' ' 54' ' ' HIS . 91.3 mt-30 -66.59 -68.34 0.38 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.018 178.018 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.46 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 5.3 tp10 -158.71 -160.75 0.9 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.209 179.942 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.46 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -118.69 127.89 54.0 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.224 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.7 mt -115.65 129.56 71.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.476 0.655 . . . . 0.0 111.523 -178.927 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.8 tp -96.62 128.86 43.96 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.383 -179.62 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -110.63 132.89 53.8 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.764 179.82 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -94.47 103.95 15.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.299 -179.391 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -97.07 -7.9 31.62 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.741 -0.383 . . . . 0.0 111.015 179.209 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.49 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 12.9 t -72.17 100.92 2.67 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-O 120.779 0.323 . . . . 0.0 110.169 179.256 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.7 p -82.99 -13.85 55.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.874 179.641 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.27 -38.3 10.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.181 -179.534 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.49 ' O ' ' OG ' ' A' ' 64' ' ' SER . 76.1 m-20 -143.11 101.23 5.28 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.772 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.01 146.39 87.55 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 121.509 1.473 . . . . 0.0 112.436 179.951 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.7 m -73.61 143.53 46.31 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.906 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -104.37 140.94 37.19 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.041 -179.355 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 43.9 t -132.26 135.54 57.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.372 -0.831 . . . . 0.0 108.82 179.562 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 14.0 m120 52.8 26.95 4.91 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -179.235 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.28 29.1 62.72 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.651 -179.634 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.3 m -142.46 140.47 31.92 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.865 0.365 . . . . 0.0 110.827 179.875 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -73.22 142.75 14.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.013 -179.21 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.5 pt -109.88 92.62 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-O 121.224 0.535 . . . . 0.0 110.911 179.115 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -63.95 -30.95 71.99 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.715 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -121.31 169.49 8.99 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.362 179.865 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -59.06 144.89 99.18 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 121.918 1.745 . . . . 0.0 111.751 179.429 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.2 p -135.21 140.94 44.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.108 0.48 . . . . 0.0 111.445 -179.627 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.437 HH21 ' CE ' ' A' ' 83' ' ' LYS . 62.7 ttp180 -78.2 132.64 37.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.881 179.085 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.8 mt -87.67 137.12 32.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.933 -178.541 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.437 ' CE ' HH21 ' A' ' 81' ' ' ARG . 99.2 mttt -124.86 151.23 45.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.432 179.532 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.495 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 6.8 t60 -54.62 121.3 8.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.771 -179.377 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.28 -18.99 35.2 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.034 -0.827 . . . . 0.0 111.034 -179.942 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -69.05 136.69 52.74 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.551 -0.46 . . . . 0.0 109.86 179.735 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.0 t -113.24 133.53 58.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.543 -178.305 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 89.2 mt -98.32 133.72 39.54 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.684 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 97.4 m -123.2 127.67 48.96 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 119.605 -0.838 . . . . 0.0 112.36 -179.195 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.612 ' O ' ' N ' ' A' ' 93' ' ' ARG . 96.8 mt -116.45 129.64 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 114.123 -1.399 . . . . 0.0 108.41 178.418 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.517 ' C ' ' O ' ' A' ' 90' ' ' ILE . 79.4 mt -18.98 101.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 O-C-N 123.744 0.652 . . . . 0.0 112.279 -179.246 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.496 ' OD1' ' NE ' ' B' ' 245' ' ' ARG . 73.8 m-20 80.37 -18.27 0.51 Allowed 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 178.919 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.616 ' HE ' ' CD1' ' A' ' 41' ' ' LEU . 59.4 mtt-85 -129.51 141.59 50.96 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.61 179.93 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 30.7 p -138.27 152.83 48.92 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.169 0.509 . . . . 0.0 110.027 179.901 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -128.79 121.93 29.41 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.623 -179.563 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -80.52 128.78 33.99 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.711 -0.395 . . . . 0.0 111.2 -179.705 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.835 ' HH ' HH11 ' A' ' 5' ' ' ARG . 89.4 t80 -94.62 124.97 38.97 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.597 179.632 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -127.66 122.84 34.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.937 0.399 . . . . 0.0 111.32 -179.89 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.495 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 61.6 t-20 -106.89 107.49 18.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.085 179.095 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 . . . . . 0 C--N 1.331 -0.208 0 CA-C-O 120.861 0.363 . . . . 0.0 110.888 -179.604 . . . . . . . . 0 0 . 1 . 083 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.669 0.271 . . . . 0.0 111.321 . . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.634 ' O ' ' N ' ' B' ' 231' ' ' GLN . 51.9 t0 -98.32 105.75 17.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.781 -179.62 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 083 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.634 ' N ' ' O ' ' B' ' 229' ' ' ASP . 6.0 mt-30 -57.34 -51.52 69.04 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.96 -178.995 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . 0.504 ' O ' ' NH2' ' A' ' 31' ' ' ARG . . . -38.13 161.7 0.01 OUTLIER Glycine 0 CA--C 1.528 0.901 0 N-CA-C 111.743 -0.543 . . . . 0.0 111.743 -179.709 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -74.0 161.24 41.56 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 123.683 2.922 . . . . 0.0 112.99 179.648 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 083 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -79.46 140.69 15.33 Favored 'Trans proline' 0 C--N 1.3 -1.998 0 C-N-CA 121.757 1.638 . . . . 0.0 112.71 -179.011 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . 0.452 ' HA ' HD22 ' A' ' 67' ' ' ASN . 53.1 t -57.46 141.99 13.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.456 179.687 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 17.4 t -63.49 128.58 36.48 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.782 -179.263 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . 0.417 ' O1P' ' OG1' ' B' ' 240' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -58.28 -22.76 59.18 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.176 1.917 . . . . 0.0 112.851 -179.835 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' B' B ' 240' ' ' THR . . . . . 0.417 ' OG1' ' O1P' ' B' ' 238' ' ' TPO . 54.6 m -74.05 -44.22 55.03 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 121.029 0.443 . . . . 0.0 109.849 178.198 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -56.84 -47.12 81.08 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.894 -178.989 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . 0.405 ' CD2' ' OD1' ' A' ' 92' ' ' ASP . 97.1 mt -66.99 -40.82 87.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.734 179.541 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -60.73 -43.19 98.18 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.854 -179.812 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -60.43 -42.86 96.95 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.505 179.739 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.496 ' NE ' ' OD1' ' A' ' 92' ' ' ASP . 71.7 ttp85 -61.64 -40.61 95.52 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.604 -0.439 . . . . 0.0 111.253 -179.524 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -60.54 -40.16 90.53 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.46 -179.718 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 80.8 p -69.85 -42.22 73.85 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.058 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . 0.442 ' O ' ' N ' ' B' ' 252' ' ' LEU . 87.4 mt-30 -63.55 -32.41 73.86 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.209 179.778 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 54.9 t -64.39 -45.45 95.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 120.113 -0.635 . . . . 0.0 109.64 178.477 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -58.72 -31.03 67.91 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.811 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -92.11 -9.74 41.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.843 179.162 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' B' ' 248' ' ' GLN . 35.9 tp -78.63 148.66 33.13 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.274 0.559 . . . . 0.0 111.278 -179.327 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -96.88 123.86 40.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.713 179.362 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -53.32 -27.99 26.1 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.594 -179.431 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -71.67 3.25 4.2 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.674 179.676 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -61.36 146.75 47.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.248 0.547 . . . . 0.0 110.906 -179.861 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -135.1 157.65 46.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.947 179.573 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.615 ' O ' ' N ' ' B' ' 260' ' ' GLU . 1.1 t0 62.47 48.01 4.79 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -178.794 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.477 ' C ' ' OE1' ' B' ' 260' ' ' GLU . 43.6 p-10 -55.75 65.96 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.176 -178.314 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.615 ' N ' ' O ' ' B' ' 258' ' ' ASP . 52.8 mp0 59.07 6.97 0.75 Allowed 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 179.044 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 67.0 mt -113.98 132.17 63.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.202 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 53.2 t -127.12 131.43 70.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.786 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -93.07 120.66 33.61 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.222 0.534 . . . . 0.0 110.335 -178.49 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -64.82 -44.94 88.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.989 -179.416 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.74 158.56 31.9 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.786 -179.221 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -65.16 153.82 76.47 Favored 'Trans proline' 0 N--CA 1.503 2.039 0 C-N-CA 123.278 2.652 . . . . 0.0 111.846 -179.979 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 47.0 pt . . . . . 0 C--O 1.232 0.153 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -178.514 . . . . . . . . 0 0 . 1 . 084 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo . . . . . 0 N--CA 1.489 1.254 0 N-CA-C 111.24 -0.331 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 084 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.5 m -91.08 -42.38 10.53 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.223 0.535 . . . . 0.0 110.351 179.815 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.3 mtt85 -91.8 129.35 37.78 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.433 -178.728 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.5 mtt85 -130.83 138.0 49.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.276 -179.973 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 39.4 tp -115.11 128.35 56.16 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.619 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.3 m -109.49 132.49 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 121.155 0.502 . . . . 0.0 111.413 -179.078 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 m -80.36 138.56 36.7 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.246 -179.437 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.5 mt -107.83 138.23 35.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.695 177.715 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -89.14 155.97 19.1 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.014 0.435 . . . . 0.0 109.849 178.434 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.557 HH11 ' CZ ' ' A' ' 93' ' ' ARG . 72.7 mtp85 -58.05 -24.17 57.37 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.429 -179.04 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.2 p -82.47 -8.63 59.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.037 0.446 . . . . 0.0 110.16 178.982 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.76 36.16 6.94 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -179.834 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.6 t -121.88 133.5 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.801 0.334 . . . . 0.0 111.069 -179.993 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 17' ' ' GLY . 61.6 t0 -78.43 132.58 37.38 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.236 179.397 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.461 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -125.72 -113.56 1.92 Allowed Glycine 0 CA--C 1.537 1.458 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.954 -179.736 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -71.68 143.9 43.0 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 122.324 2.016 . . . . 0.0 113.298 -178.568 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.541 ' O ' ' CD1' ' B' ' 267' ' ' ILE . 0.3 OUTLIER -111.29 135.81 51.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.135 0.493 . . . . 0.0 111.119 -179.89 . . . . . . . . 3 3 . 1 . 084 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -105.81 105.76 54.25 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.405 179.976 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -74.31 129.49 13.04 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 121.33 1.353 . . . . 0.0 111.911 -178.899 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 74.5 mt -83.97 47.04 1.25 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.859 -178.777 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.0 p -64.08 -21.57 66.58 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.969 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.3 mt -83.31 143.71 30.19 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.007 179.796 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.7 t -64.14 -21.73 66.66 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.947 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.415 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 56.2 m -135.63 135.54 40.28 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.181 -0.608 . . . . 0.0 112.369 -179.012 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.551 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 16.9 t -127.9 119.83 26.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.324 178.4 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 49.1 tp -118.07 130.89 56.41 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.229 -178.546 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.551 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 5.5 m-85 -108.53 140.78 41.38 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.2 179.852 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 152.21 -176.28 30.55 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.249 178.393 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.695 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 76.8 mtm-85 -75.89 -32.23 59.57 Favored 'General case' 0 C--N 1.338 0.068 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.197 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.582 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -48.08 143.37 7.04 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 -178.471 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.512 ' CD1' ' CZ ' ' A' ' 38' ' ' ARG . 32.2 mm -65.79 -43.91 93.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.647 179.803 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -54.28 -17.74 3.25 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.789 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.582 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 39.4 m -60.16 121.47 11.99 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.218 179.851 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.415 ' OD2' ' O ' ' A' ' 26' ' ' THR . 99.0 m-20 -60.69 -28.64 68.77 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.238 -179.264 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.446 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 96.7 mt -126.13 120.54 57.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 176.798 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.512 ' CZ ' ' CD1' ' A' ' 33' ' ' ILE . 84.0 mtp180 -103.99 132.53 50.15 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.938 -178.199 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 84.8 mt -121.49 130.79 74.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 121.03 0.443 . . . . 0.0 109.961 179.491 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -78.44 41.5 0.4 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.232 -178.495 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 77.8 mt -105.88 104.99 51.71 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.44 179.41 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -57.61 -15.39 20.22 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.117 1.878 . . . . 0.0 112.148 179.532 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.0 m -91.11 4.89 6.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.237 -179.632 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.695 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 24.9 t -104.18 140.32 22.62 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.354 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.128 180.0 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.4 m -71.05 168.09 17.84 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.284 0.564 . . . . 0.0 112.276 -179.236 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -61.8 -39.29 91.2 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.271 -179.678 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.643 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.6 mt-30 -111.17 -19.43 12.7 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.904 179.813 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.3 t60 35.85 -75.86 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 179.015 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.643 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.83 134.45 46.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.266 0.555 . . . . 0.0 112.106 -177.871 . . . . . . . . 3 3 . 1 . 084 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -127.43 131.71 50.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.458 179.668 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 98.0 mt -118.03 133.88 63.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.175 179.933 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -117.69 134.37 54.96 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.102 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 48.3 mm -98.56 119.71 46.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.831 179.819 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.483 ' O ' ' N ' ' A' ' 56' ' ' GLN . 98.4 m-70 -123.85 135.53 53.8 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.137 -179.989 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 54' ' ' HIS . 92.8 mt-10 -41.28 -25.97 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -179.396 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.483 ' N ' ' O ' ' A' ' 54' ' ' HIS . 47.9 tt0 -67.3 -68.87 0.35 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.75 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -156.95 -163.44 1.41 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.399 179.094 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -108.92 126.09 52.71 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 177.47 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.9 mt -114.9 129.52 70.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.243 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.1 tp -100.14 129.2 46.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.135 179.634 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -113.24 135.56 53.7 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.877 -179.713 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.4 HD22 ' HA ' ' A' ' 68' ' ' PRO . 47.6 t30 -94.35 104.7 16.67 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.403 179.708 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -96.75 -10.78 26.06 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.194 179.397 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.4 t -68.18 101.47 1.18 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.046 179.653 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.5 p -84.35 -7.22 59.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.066 0.46 . . . . 0.0 110.024 179.895 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.44 -43.85 5.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.836 -179.131 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -140.23 99.39 7.25 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.646 -179.769 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.4 ' HA ' HD22 ' A' ' 62' ' ' ASN . 52.9 Cg_exo -55.19 145.95 62.7 Favored 'Trans proline' 0 N--CA 1.5 1.904 0 C-N-CA 122.359 2.039 . . . . 0.0 113.236 -179.348 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.2 m -73.11 137.96 45.52 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.869 178.796 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -99.24 140.77 32.91 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.517 179.82 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 55.9 t -128.82 135.34 62.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.685 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 52.04 31.44 8.76 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.124 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.8 28.18 69.42 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.489 179.921 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.1 p -140.69 139.22 34.71 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 120.774 -0.371 . . . . 0.0 111.48 -179.735 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 38.8 t -70.37 138.32 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.16 -179.6 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.7 pt -112.73 96.68 4.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.1 178.321 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -66.65 -26.14 66.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.189 -179.76 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.437 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.3 OUTLIER -130.93 178.55 1.68 Allowed Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.312 -179.086 . . . . . . . . 3 3 . 1 . 084 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.437 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 36.1 Cg_exo -59.99 146.27 96.38 Favored 'Trans proline' 0 N--CA 1.505 2.155 0 C-N-CA 123.09 2.527 . . . . 0.0 112.802 -179.775 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.6 p -144.37 141.65 24.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.634 179.984 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -78.89 133.95 36.93 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.52 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 89.0 mt -91.18 140.44 29.8 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.991 0.424 . . . . 0.0 111.522 -179.074 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -128.2 157.5 40.68 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.981 179.165 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.532 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 5.8 t60 -53.99 115.71 2.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.523 -178.553 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.3 -10.65 26.52 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.142 179.16 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -67.67 135.34 52.65 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.018 -179.836 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.41 HG22 ' NH1' ' A' ' 96' ' ' ARG . 48.9 t -109.44 126.57 66.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.43 -179.665 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 84.8 mt -100.42 131.25 48.31 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 178.514 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 75.3 m -122.84 129.1 51.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.715 0.769 . . . . 0.0 112.584 -178.189 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.462 ' O ' ' C ' ' A' ' 91' ' ' ILE . 95.0 mt -116.53 128.07 73.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 114.493 -1.23 . . . . 0.0 108.621 178.537 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.462 ' C ' ' O ' ' A' ' 90' ' ' ILE . 42.4 mm 34.02 -99.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.166 -179.428 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.504 ' O ' ' OD1' ' A' ' 92' ' ' ASP . 61.7 t0 -115.55 16.49 16.55 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 120.94 0.4 . . . . 0.0 110.847 -179.576 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.571 HH21 ' CD ' ' B' ' 260' ' ' GLU . 73.1 mtt-85 -127.93 144.5 51.1 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.67 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.6 p -140.92 156.81 46.01 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.391 0.615 . . . . 0.0 111.637 -179.551 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -132.54 133.58 43.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.412 179.617 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.41 ' NH1' HG22 ' A' ' 87' ' ' VAL . 70.4 mtp85 -98.48 137.78 36.66 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 119.881 -0.727 . . . . 0.0 110.361 179.906 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 93.9 t80 -93.24 122.99 36.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.689 -179.881 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -123.93 119.48 29.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.166 179.397 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.532 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 47.5 t-20 -104.22 113.81 27.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.64 180.0 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.182 179.813 . . . . . . . . 0 0 . 1 . 084 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 86.2 t . . . . . 0 N--CA 1.456 -0.173 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 . . . . . . . . . 0 0 . 1 . 084 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 57.56 32.12 21.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.218 178.971 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . 0.456 ' O ' ' NE2' ' B' ' 231' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.456 ' NE2' ' O ' ' B' ' 230' ' ' SEP . 96.4 mm-40 -136.87 30.83 2.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.577 179.759 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -142.76 177.99 21.44 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.671 -0.571 . . . . 0.0 111.671 -179.366 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.76 163.19 37.82 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 123.933 3.088 . . . . 0.0 112.47 -179.921 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 084 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -78.13 141.59 18.68 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 C-N-CA 121.87 1.713 . . . . 0.0 112.288 -179.758 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 54.7 t -60.58 140.53 18.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.383 -179.541 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 6.5 t -67.29 131.64 46.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.235 -179.747 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 084 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -50.77 -22.55 9.96 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 122.171 1.914 . . . . 0.0 112.962 179.826 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 40.9 p -75.95 -40.27 54.35 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.289 -0.564 . . . . 0.0 109.909 178.441 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . 0.561 ' CZ ' ' NE ' ' B' ' 245' ' ' ARG . 81.6 t80 -57.3 -48.04 79.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.415 -179.626 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 89.4 mt -65.91 -42.09 90.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.018 179.964 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -67.94 -39.87 83.39 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.798 -179.463 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -60.88 -46.63 89.88 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.444 -179.154 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.561 ' NE ' ' CZ ' ' B' ' 241' ' ' PHE . 94.0 mtt-85 -67.78 -38.53 83.51 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.615 179.806 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -60.78 -40.28 91.99 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.101 -179.45 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 9.7 t -65.53 -45.62 82.73 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.656 0.741 . . . . 0.0 109.56 177.911 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -64.91 -31.44 72.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.539 -179.914 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 93.8 t -68.54 -46.81 79.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.966 0.412 . . . . 0.0 110.538 179.363 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -59.89 -25.11 64.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.587 179.765 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -96.98 5.34 50.63 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.408 178.844 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.462 ' CD1' ' OD2' ' B' ' 256' ' ' ASP . 37.3 tp -106.77 130.29 54.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.055 0.455 . . . . 0.0 111.113 -178.966 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -60.56 146.42 45.18 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.814 -179.22 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -70.62 -16.93 62.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.154 179.921 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -78.54 -1.48 34.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.454 -179.352 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.462 ' OD2' ' CD1' ' B' ' 252' ' ' LEU . 84.7 m-20 -85.41 89.4 7.67 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.716 -179.903 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -72.38 179.73 3.31 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.796 -0.361 . . . . 0.0 110.454 -179.896 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 58.24 67.93 0.89 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -179.097 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.521 ' CG ' HH12 ' A' ' 93' ' ' ARG . 34.2 t0 -80.61 62.84 4.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.095 -179.667 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.571 ' CD ' HH21 ' A' ' 93' ' ' ARG . 94.8 mt-10 65.1 13.41 8.68 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.898 179.149 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 68.2 mt -113.77 131.05 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.34 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 40.4 t -128.46 135.86 61.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.829 0.347 . . . . 0.0 111.308 -179.076 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -97.24 119.01 34.97 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.221 0.534 . . . . 0.0 111.651 -179.31 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -62.98 -46.45 87.62 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.986 178.984 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -90.15 156.39 46.38 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.191 -179.554 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -60.17 142.59 98.63 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 C-N-CA 122.226 1.951 . . . . 0.0 112.183 -179.845 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . 0.541 ' CD1' ' O ' ' A' ' 19' ' ' HIS . 3.9 tt . . . . . 0 C--N 1.325 -0.494 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.946 -179.72 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo . . . . . 0 N--CA 1.495 1.591 0 CA-C-O 120.554 0.147 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 085 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.1 m -73.75 -46.62 44.69 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -179.493 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.457 ' CD ' ' OH ' ' A' ' 97' ' ' TYR . 82.0 mtt85 -102.04 134.34 45.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.832 0.349 . . . . 0.0 111.218 -178.782 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.453 HH21 ' CD ' ' A' ' 98' ' ' GLU . 36.8 ptt180 -142.48 157.42 44.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.866 179.722 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 74.0 mt -120.83 147.19 45.71 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.033 -179.811 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.7 t -116.21 126.77 73.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.377 178.658 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.3 m -78.66 138.48 38.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.487 0.661 . . . . 0.0 111.801 -178.692 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.6 mm -103.37 132.61 49.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.63 178.208 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -86.75 155.86 20.17 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.12 179.5 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.641 HH21 ' CD2' ' B' ' 252' ' ' LEU . 87.4 mtm180 -58.39 -30.28 66.69 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.052 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.6 t -74.62 -15.06 60.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.805 179.246 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.0 30.75 7.7 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 -179.431 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.1 t -119.09 133.99 64.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.94 0.4 . . . . 0.0 111.121 -179.964 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -74.75 136.98 41.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.838 178.981 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.51 -120.31 2.24 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 120.558 -0.829 . . . . 0.0 111.782 -179.905 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -73.54 152.84 49.09 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.173 1.915 . . . . 0.0 112.428 -179.111 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -114.1 156.07 24.84 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.015 179.471 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -119.97 104.04 44.63 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.451 -179.946 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.3 130.43 16.29 Favored 'Trans proline' 0 N--CA 1.488 1.19 0 C-N-CA 121.356 1.371 . . . . 0.0 112.59 -178.913 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.1 mt -83.88 45.7 1.11 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.749 -179.431 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.8 m -59.29 -28.73 67.02 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.666 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.3 mt -77.84 143.12 38.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.622 179.976 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 95.7 p -64.44 -21.08 66.54 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.219 -179.567 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 90.9 m -135.48 136.04 40.96 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.053 0.454 . . . . 0.0 112.153 -179.593 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.643 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 3.4 t -131.72 124.05 28.98 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.515 178.361 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.409 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 31.4 tp -116.36 130.49 56.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.934 -178.982 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.643 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 14.4 m-85 -107.34 141.07 39.28 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.436 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 160.21 -164.34 34.33 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 119.566 -1.302 . . . . 0.0 112.979 179.198 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.8 ttp85 -98.85 -32.11 11.51 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 114.977 -0.612 . . . . 0.0 111.88 -179.268 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -57.56 156.25 17.11 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.509 -1.037 . . . . 0.0 110.509 -179.795 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.584 ' O ' ' NE ' ' A' ' 38' ' ' ARG . 8.7 tp -63.97 -42.37 95.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 117.327 0.563 . . . . 0.0 112.235 -178.616 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.541 ' OE1' ' N ' ' A' ' 34' ' ' GLU . 57.9 mp0 -56.89 -17.41 9.38 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.267 -178.699 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.585 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 89.5 m -59.86 122.74 14.99 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.244 -0.583 . . . . 0.0 110.087 179.522 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.448 ' O ' ' CB ' ' B' ' 264' ' ' LYS . 71.5 m-20 -59.9 -31.18 69.57 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.273 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.45 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 94.6 mt -122.03 115.52 46.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 176.384 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.584 ' NE ' ' O ' ' A' ' 33' ' ' ILE . 74.5 mtt85 -104.43 138.22 41.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.006 -177.267 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 80.1 mt -119.5 130.49 73.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.839 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -73.7 38.79 0.1 Allowed 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -177.867 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.579 ' CD1' HH21 ' A' ' 93' ' ' ARG . 39.7 mt -125.04 129.64 24.47 Favored Pre-proline 0 C--N 1.325 -0.487 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.938 179.771 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.06 -11.83 27.58 Favored 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 122.404 2.069 . . . . 0.0 113.392 -178.973 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.411 ' CG2' ' CZ ' ' B' ' 241' ' ' PHE . 27.5 m -83.94 -4.32 8.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.411 179.549 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 40.8 t -87.38 133.13 30.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.209 179.578 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.5 t -65.25 161.16 19.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.779 -179.198 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.585 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 93.7 mttt -62.02 -44.35 96.9 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.485 -178.951 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.643 ' O ' ' N ' ' A' ' 49' ' ' CYS . 89.5 mt-30 -116.9 -18.23 10.22 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.921 0.391 . . . . 0.0 111.014 179.682 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.434 ' CE1' ' HG ' ' A' ' 64' ' ' SER . 16.7 t60 33.66 -72.21 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 179.415 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.643 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.11 137.18 46.22 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -177.726 . . . . . . . . 3 3 . 1 . 085 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -125.32 126.78 45.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.686 179.176 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 88.0 mt -110.36 131.73 60.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.995 -179.933 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -115.38 131.29 56.98 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.925 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.1 mm -100.39 122.24 52.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.841 -179.312 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.454 ' O ' ' C ' ' A' ' 55' ' ' GLU . 97.1 m-70 -122.42 132.15 54.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.199 179.25 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 54' ' ' HIS . 76.6 mt-10 -40.68 -36.71 0.64 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -178.457 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.487 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 88.7 mt-30 -62.85 -66.7 0.5 Allowed 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.401 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.487 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 3.8 tp10 -153.74 -168.3 2.93 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.678 -179.658 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.41 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -118.4 132.87 56.24 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.099 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.1 mt -118.59 129.89 74.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.392 0.615 . . . . 0.0 111.956 -178.666 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 40.1 tp -95.13 129.07 42.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.046 179.997 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -113.76 136.12 53.21 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 179.956 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.584 ' ND2' ' H ' ' A' ' 69' ' ' THR . 17.1 t-20 -97.41 107.64 20.19 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.988 0.423 . . . . 0.0 111.787 -179.582 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -98.65 -10.77 22.8 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.622 179.162 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.434 ' HG ' ' CE1' ' A' ' 48' ' ' HIS . 1.3 t -69.78 101.03 1.61 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.443 179.914 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 90.3 p -84.34 -14.27 50.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.972 0.415 . . . . 0.0 110.039 179.614 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.45 -40.8 8.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.161 -179.004 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -137.09 93.79 13.0 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.053 -179.687 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -56.75 144.03 88.33 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.256 1.97 . . . . 0.0 112.226 -179.822 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.584 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 95.1 m -71.29 137.13 48.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.056 179.707 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -98.32 141.29 31.4 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.614 178.982 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 55.5 t -130.15 136.55 58.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.251 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 53.37 32.33 13.6 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.252 -179.691 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.11 27.5 72.86 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.48 -179.99 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.1 m -138.37 137.51 37.38 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.383 -179.634 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.9 p -71.05 135.51 27.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.017 0.437 . . . . 0.0 111.897 -179.67 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.543 ' CD1' ' O ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -136.18 121.95 29.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.727 178.545 . . . . . . . . 3 3 . 1 . 085 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.7 p-10 -103.22 -5.02 23.56 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 120.801 -0.359 . . . . 0.0 111.475 -179.273 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.543 ' O ' ' CD1' ' A' ' 76' ' ' ILE . 21.4 mt-10 -116.13 151.49 46.71 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.747 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -60.35 146.23 97.03 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.016 1.811 . . . . 0.0 112.422 -179.12 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.6 m -141.32 147.26 22.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.325 -179.644 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -73.87 131.12 41.16 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 178.858 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.7 mt -78.46 134.76 37.3 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.257 179.965 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -124.9 148.83 48.12 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 178.848 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.523 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 6.1 t60 -55.1 121.42 8.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.393 -178.944 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.32 -19.13 34.86 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 179.975 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -67.61 134.79 51.82 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.385 179.919 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.5 t -110.04 132.48 58.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.811 -179.257 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.516 ' O ' ' OG ' ' A' ' 94' ' ' SER . 86.6 mt -101.33 132.16 47.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 178.697 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.458 ' HG1' ' HG ' ' A' ' 94' ' ' SER . 55.7 m -124.89 124.1 41.34 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 119.953 -0.699 . . . . 0.0 112.054 -178.543 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.461 ' O ' ' C ' ' A' ' 91' ' ' ILE . 86.6 mt -109.74 127.84 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.058 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.493 ' CG2' ' N ' ' A' ' 92' ' ' ASP . 95.3 mt 37.32 -100.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.583 -179.149 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.493 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 1.6 t70 -118.36 15.93 13.9 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.816 0.341 . . . . 0.0 110.963 -179.827 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.579 HH21 ' CD1' ' A' ' 41' ' ' LEU . 3.4 mtm105 -124.04 138.69 54.41 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.916 -179.588 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.516 ' OG ' ' O ' ' A' ' 88' ' ' ILE . 47.0 t -137.7 151.85 48.65 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.917 -179.405 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -127.21 123.33 36.35 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.582 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -82.85 135.98 34.77 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.048 -178.304 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.457 ' OH ' ' CD ' ' A' ' 5' ' ' ARG . 88.4 t80 -93.97 122.83 36.87 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.337 -179.854 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.453 ' CD ' HH21 ' A' ' 6' ' ' ARG . 76.1 tt0 -126.93 122.25 34.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.779 179.911 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.523 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 62.0 t-20 -109.26 113.27 25.96 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.588 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 . . . . . 0 C--N 1.33 -0.28 0 CA-C-O 120.974 0.416 . . . . 0.0 110.938 -179.189 . . . . . . . . 0 0 . 1 . 085 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . 0.523 ' O ' ' O ' ' B' ' 229' ' ' ASP . 15.4 m . . . . . 0 CA--C 1.522 -0.107 0 CA-C-O 120.532 0.206 . . . . 0.0 111.029 . . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.618 ' C ' ' H ' ' B' ' 231' ' ' GLN . 97.4 m-20 57.11 129.89 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.247 -179.403 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 085 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.618 ' H ' ' C ' ' B' ' 229' ' ' ASP . 82.7 mt-30 -122.62 -17.37 6.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.513 0.673 . . . . 0.0 109.32 179.599 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' B' ' 231' ' ' GLN . . . -47.03 -173.39 0.01 OUTLIER Glycine 0 CA--C 1.525 0.702 0 CA-C-N 114.975 -1.011 . . . . 0.0 112.675 -178.974 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.31 161.61 43.92 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 123.489 2.793 . . . . 0.0 113.584 -179.25 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 085 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -60.54 131.83 40.11 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.077 1.851 . . . . 0.0 112.872 -179.753 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 40.4 t -66.78 135.35 28.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.225 -0.898 . . . . 0.0 108.72 178.662 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 35.9 t -54.62 120.54 6.85 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.085 -179.027 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . 0.412 ' O2P' ' OG1' ' B' ' 240' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -57.46 -25.25 65.45 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.361 2.041 . . . . 0.0 112.199 179.018 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' B' B ' 240' ' ' THR . . . . . 0.412 ' OG1' ' O2P' ' B' ' 238' ' ' TPO . 24.7 m -73.34 -44.81 58.15 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.238 0.542 . . . . 0.0 109.552 178.286 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . 0.411 ' CZ ' ' CG2' ' A' ' 43' ' ' VAL . 83.4 t80 -56.67 -45.71 81.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.79 -179.963 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 88.8 mt -64.08 -41.65 97.24 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.559 179.871 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -60.69 -40.78 93.46 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.429 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -64.29 -42.32 96.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.423 179.094 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.59 HH11 ' CD ' ' A' ' 12' ' ' ARG . 58.1 ttm-85 -58.06 -42.9 86.48 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.168 -179.895 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -60.71 -39.94 90.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.167 -179.977 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 59.2 m -65.14 -44.49 88.46 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.025 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . 0.417 ' O ' ' N ' ' B' ' 252' ' ' LEU . 81.9 mt-30 -60.41 -37.45 80.9 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.802 -179.895 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 38.7 t -61.04 -46.44 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 C-N-CA 119.864 -0.734 . . . . 0.0 109.805 178.908 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -58.2 -30.29 66.35 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.528 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -90.56 -10.89 41.78 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.964 178.847 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.641 ' CD2' HH21 ' A' ' 12' ' ' ARG . 38.5 tp -79.14 138.99 38.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.779 -179.903 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -109.48 143.54 38.95 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.136 179.043 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -62.48 -21.77 65.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.104 0.478 . . . . 0.0 109.919 -179.378 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -67.99 -7.65 30.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.68 -179.455 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.458 ' C ' ' H ' ' B' ' 258' ' ' ASP . 68.3 t0 -98.51 81.59 2.74 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.281 179.086 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -73.23 19.12 0.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.889 -178.554 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.668 ' O ' ' N ' ' B' ' 260' ' ' GLU . 43.1 t0 -99.07 0.82 44.47 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 177.869 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.541 ' C ' ' H ' ' B' ' 261' ' ' ILE . 32.9 t70 6.09 51.58 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 114.272 -1.331 . . . . 0.0 113.4 179.487 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.668 ' N ' ' O ' ' B' ' 258' ' ' ASP . 51.7 mp0 54.12 1.25 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 179.398 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . 0.541 ' H ' ' C ' ' B' ' 259' ' ' ASP . 75.4 mt -114.21 136.46 50.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.086 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . 0.459 ' N ' ' O ' ' A' ' 38' ' ' ARG . 50.2 t -128.18 137.92 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.86 0.362 . . . . 0.0 110.939 -179.565 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -100.86 122.64 43.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.117 0.484 . . . . 0.0 111.386 -179.117 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . 0.448 ' CB ' ' O ' ' A' ' 36' ' ' ASP . 89.2 tttt -64.35 -45.88 85.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.309 179.238 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 5.0 mp0 -99.82 163.63 18.07 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.976 -179.008 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.59 156.47 65.46 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.836 2.357 . . . . 0.0 111.459 178.916 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 37.6 pt . . . . . 0 C--N 1.325 -0.461 0 CA-C-O 121.267 0.556 . . . . 0.0 112.085 -178.832 . . . . . . . . 0 0 . 1 . 086 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo . . . . . 0 N--CA 1.491 1.327 0 CA-C-O 120.968 0.32 . . . . 0.0 112.034 . . . . . . . . . 0 0 . 1 . 086 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.404 ' O ' ' OG1' ' A' ' 4' ' ' THR . 1.8 t -123.56 29.07 6.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.854 -179.253 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.405 ' HG2' ' HH ' ' A' ' 97' ' ' TYR . 83.9 mtt85 -85.63 122.11 29.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.341 -179.589 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -126.73 137.46 53.25 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.537 179.847 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 30.6 tp -114.67 127.54 55.82 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.617 179.98 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.48 ' CG1' ' OD1' ' A' ' 16' ' ' ASP . 64.2 t -104.53 134.19 46.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.105 179.684 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 m -94.42 118.93 32.38 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.247 0.546 . . . . 0.0 112.141 -178.516 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.612 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 95.3 mt -83.02 141.8 14.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.999 179.541 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.431 ' HA ' HH22 ' A' ' 93' ' ' ARG . 98.0 mttt -88.44 159.26 18.07 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 178.856 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.583 HH12 ' CD ' ' B' ' 248' ' ' GLN . 84.5 mtp180 -57.22 -29.63 63.92 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 121.059 -0.257 . . . . 0.0 111.139 -178.764 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.4 m -81.18 -6.21 58.59 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.605 179.393 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.97 36.85 7.5 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 -179.557 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.3 t -119.1 132.64 68.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.836 0.351 . . . . 0.0 110.633 -179.535 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.48 ' OD1' ' CG1' ' A' ' 8' ' ' VAL . 68.4 t0 -76.21 130.81 38.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.65 -179.549 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.17 -116.08 1.87 Allowed Glycine 0 CA--C 1.539 1.579 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.737 -179.438 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.5 145.91 38.53 Favored 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 122.797 2.331 . . . . 0.0 113.867 -178.301 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -109.23 150.12 28.41 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.12 0.486 . . . . 0.0 110.807 179.544 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -120.42 106.06 40.79 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.02 179.577 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -73.21 125.91 10.66 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 C-N-CA 121.459 1.439 . . . . 0.0 112.137 -178.583 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.0 mt -88.27 43.5 1.13 Allowed 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.108 -178.796 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 80.0 p -66.24 -19.55 65.86 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.564 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 90.0 mt -73.46 142.71 46.83 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.678 179.575 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 71.5 p -59.41 -24.95 63.9 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.474 -179.135 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 39.1 m -136.93 134.05 36.35 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.918 -179.6 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.5 t -126.03 122.24 35.31 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.335 178.169 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 41.7 tp -118.09 129.79 55.76 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.478 -178.441 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 4.7 m-85 -108.29 139.57 42.8 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 123.425 0.453 . . . . 0.0 110.06 179.395 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 178.22 -170.34 42.44 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 178.861 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.527 ' NH2' ' O ' ' B' ' 233' ' ' PRO . 27.9 ptt-85 -100.11 -3.23 32.27 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.543 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -81.87 166.29 46.66 Favored Glycine 0 CA--C 1.52 0.371 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -179.326 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 19.3 tt -96.16 5.73 8.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.216 0.532 . . . . 0.0 110.308 179.969 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -95.64 -7.96 36.13 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.989 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.2 m -91.44 151.1 20.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.137 -179.94 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -60.77 -32.36 71.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.186 -179.641 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 98.4 mt -128.12 127.29 67.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.463 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -113.42 136.85 52.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.894 -178.775 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.422 ' C ' ' H ' ' A' ' 41' ' ' LEU . 85.6 mt -118.34 130.64 72.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.685 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -73.02 35.43 0.08 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.29 -178.035 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.422 ' H ' ' C ' ' A' ' 39' ' ' ILE . 59.7 mt -109.97 129.07 24.34 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.017 -179.83 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.5 -6.86 19.85 Favored 'Trans proline' 0 N--CA 1.49 1.292 0 C-N-CA 122.314 2.009 . . . . 0.0 112.623 -179.798 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.1 m -102.41 7.21 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.035 179.368 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 37.1 t -93.3 134.11 32.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.817 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.9 m -68.14 160.37 29.16 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.639 0.733 . . . . 0.0 112.481 -178.782 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -63.56 -41.3 98.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.088 -179.445 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.641 ' O ' ' N ' ' A' ' 49' ' ' CYS . 98.3 mm-40 -113.84 -19.22 11.58 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.005 -179.971 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.505 ' CG ' ' HG ' ' A' ' 64' ' ' SER . 21.7 t60 26.83 -74.65 0.0 OUTLIER 'General case' 0 C--O 1.235 0.335 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 179.969 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.641 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.19 134.48 46.53 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.6 0.714 . . . . 0.0 112.727 -178.206 . . . . . . . . 3 3 . 1 . 086 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -127.36 129.63 47.95 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.313 179.865 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 98.1 mt -113.92 132.25 63.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.438 179.859 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -111.19 126.38 54.8 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 178.088 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.445 HG22 HD11 ' A' ' 53' ' ' ILE . 82.2 mt -104.22 115.18 45.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.819 0.819 . . . . 0.0 111.952 -179.002 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.428 ' O ' ' C ' ' A' ' 55' ' ' GLU . 98.3 m-70 -117.55 142.57 47.03 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.265 -1.334 . . . . 0.0 110.165 179.844 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 54' ' ' HIS . 87.3 tt0 -40.5 -33.16 0.24 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.673 179.539 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.502 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 64.6 tp60 -61.72 -68.03 0.36 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.55 179.417 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.502 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 6.5 tp10 -156.41 -168.71 2.8 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.463 -178.641 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.449 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -110.46 126.81 54.73 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.412 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.8 mt -115.09 131.15 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -177.689 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 21.6 tp -101.59 127.78 48.15 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.769 179.862 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -110.92 135.58 51.24 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.737 179.876 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.466 ' ND2' ' O ' ' A' ' 76' ' ' ILE . 48.6 t-20 -94.92 104.5 16.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.296 -179.196 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -99.53 -9.65 23.04 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.307 179.729 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.505 ' HG ' ' CG ' ' A' ' 48' ' ' HIS . 0.8 OUTLIER -69.05 102.75 1.69 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.478 . . . . . . . . 3 3 . 1 . 086 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 81.6 p -88.91 -15.94 33.12 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.225 179.911 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.97 -42.78 10.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.261 -179.805 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 46.4 m-20 -141.2 103.45 6.1 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.483 -179.729 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -56.25 144.85 80.13 Favored 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 121.9 1.733 . . . . 0.0 113.188 -179.097 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.5 m -73.3 140.05 46.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.593 178.459 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -101.26 139.61 36.7 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.15 0.5 . . . . 0.0 111.532 -179.874 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 45.1 t -136.4 133.79 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.956 178.63 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 8.0 m120 54.49 32.31 16.52 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.075 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.67 29.16 63.9 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-N 115.14 -0.936 . . . . 0.0 112.212 179.388 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 64.1 m -149.87 147.47 27.99 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 117.401 0.601 . . . . 0.0 111.674 -179.742 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.8 m -75.82 149.48 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.103 0.477 . . . . 0.0 111.733 -179.695 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.466 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 4.0 pt -120.97 97.94 5.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.663 179.312 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -69.25 -23.34 63.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.719 179.724 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -129.85 177.25 2.28 Favored Pre-proline 0 N--CA 1.469 0.506 0 C-N-CA 121.191 -0.203 . . . . 0.0 111.324 -179.84 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -61.02 146.7 97.41 Favored 'Trans proline' 0 N--CA 1.503 2.071 0 C-N-CA 123.042 2.495 . . . . 0.0 112.744 179.649 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.4 p -143.67 138.99 25.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.696 179.884 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 88.9 mtm180 -74.84 133.05 41.94 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.176 179.475 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 93.3 mt -89.23 129.09 35.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.963 0.411 . . . . 0.0 110.696 179.77 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -117.22 156.15 28.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.243 179.594 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.407 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 6.4 t60 -56.01 118.41 4.62 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.178 179.978 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.35 -17.42 18.99 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -179.775 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.45 ' OD1' ' N ' ' A' ' 87' ' ' VAL . 54.3 t0 -65.63 127.57 32.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.256 0.55 . . . . 0.0 110.851 179.725 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.45 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 56.0 t -109.14 132.99 55.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.43 -179.226 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 77.2 mt -101.05 130.54 50.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.843 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 51.5 m -122.54 122.88 39.95 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.608 0.718 . . . . 0.0 112.221 -178.629 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.519 ' O ' ' N ' ' A' ' 93' ' ' ARG . 96.7 mt -113.9 124.66 70.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 114.642 -1.163 . . . . 0.0 108.592 178.24 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.437 ' C ' ' O ' ' A' ' 90' ' ' ILE . 46.3 mm 39.17 -96.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.323 -179.27 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.531 ' CB ' ' HE ' ' B' ' 245' ' ' ARG . 54.7 t0 -119.95 5.07 10.9 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.978 0.418 . . . . 0.0 110.742 -179.826 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.617 HH21 ' CD1' ' B' ' 261' ' ' ILE . 17.9 mmm180 -106.89 134.97 49.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.699 179.925 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 47.1 t -132.12 144.07 50.45 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.838 -179.872 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -123.19 120.26 32.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.1 179.766 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 44.2 ttm180 -84.47 127.35 33.98 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.142 -179.8 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.724 ' HH ' ' ND2' ' A' ' 99' ' ' ASN . 88.9 t80 -95.73 129.05 43.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.462 179.854 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -142.66 128.63 19.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.973 0.416 . . . . 0.0 111.938 -179.445 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.724 ' ND2' ' HH ' ' A' ' 97' ' ' TYR . 89.1 m-20 -109.75 105.33 14.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.987 179.228 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 . . . . . 0 C--O 1.233 0.203 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.225 -179.635 . . . . . . . . 0 0 . 1 . 086 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 45.8 t . . . . . 0 N--CA 1.453 -0.303 0 CA-C-O 120.731 0.3 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 086 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -68.24 145.54 54.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.034 0.445 . . . . 0.0 111.277 -179.989 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 086 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -119.4 38.74 3.78 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.921 -179.152 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . 0.461 ' O ' ' NH2' ' A' ' 31' ' ' ARG . . . -117.14 -177.74 17.72 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.804 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . 0.527 ' O ' ' NH2' ' A' ' 31' ' ' ARG . 72.5 Cg_endo -72.5 161.69 43.46 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 123.674 2.916 . . . . 0.0 113.378 -179.502 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 086 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -77.18 136.95 16.65 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.403 2.068 . . . . 0.0 113.095 -179.299 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 55.6 t -67.75 136.02 27.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 114.612 -1.176 . . . . 0.0 111.803 -179.357 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.9 t -81.44 128.36 33.79 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.644 178.774 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . 0.431 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . 0.431 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 51.7 Cg_exo -57.97 -28.56 83.52 Favored 'Trans proline' 0 N--CA 1.504 2.091 0 C-N-CA 123.456 2.77 . . . . 0.0 113.609 -179.674 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' B' B ' 240' ' ' THR . . . . . 0.404 ' OG1' ' O2P' ' B' ' 238' ' ' TPO . 37.2 m -72.28 -45.52 59.74 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.201 0.524 . . . . 0.0 110.341 179.135 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -56.61 -45.41 81.49 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.659 -179.733 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 98.6 mt -64.31 -41.31 96.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.31 179.82 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -64.99 -37.42 87.61 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.642 179.903 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -60.36 -43.41 96.57 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.616 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.531 ' HE ' ' CB ' ' A' ' 92' ' ' ASP . 75.1 mtp85 -62.34 -37.48 85.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.75 -179.966 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -62.04 -41.37 98.05 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.238 179.809 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 10.2 t -65.63 -44.07 87.58 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.757 0.789 . . . . 0.0 108.932 177.812 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . 0.583 ' CD ' HH12 ' A' ' 12' ' ' ARG . 64.5 tt0 -62.11 -32.2 72.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.454 179.455 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 55.6 t -61.99 -45.89 97.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 179.109 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -60.95 -31.19 70.75 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.609 179.032 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -91.63 -11.06 38.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.447 178.82 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' B' ' 248' ' ' GLN . 51.8 tp -75.86 141.22 42.46 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.123 0.487 . . . . 0.0 111.546 -179.302 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -100.42 142.96 31.18 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.286 179.753 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -64.47 -19.19 65.41 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.29 179.446 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -63.46 -10.45 17.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.379 -178.688 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.41 ' O ' ' N ' ' B' ' 259' ' ' ASP . 49.2 p-10 -81.84 64.24 6.45 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.346 -0.542 . . . . 0.0 109.934 179.645 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -56.83 -9.72 0.87 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.042 -179.026 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.475 ' O ' ' C ' ' B' ' 259' ' ' ASP . 83.5 m-20 -106.91 -0.36 23.27 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 177.45 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.475 ' C ' ' O ' ' B' ' 258' ' ' ASP . 0.6 OUTLIER 28.57 -102.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.043 -179.227 . . . . . . . . 3 3 . 1 . 086 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -140.66 17.89 2.35 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.156 179.703 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . 0.617 ' CD1' HH21 ' A' ' 93' ' ' ARG . 39.7 mt -118.09 138.34 49.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -179.734 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 52.9 t -126.56 135.28 64.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.431 -179.847 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -98.23 118.62 35.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.135 0.493 . . . . 0.0 111.242 -178.903 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.86 -47.35 78.22 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.446 179.273 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -92.48 150.6 40.21 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.253 -179.22 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -66.44 147.76 83.04 Favored 'Trans proline' 0 N--CA 1.499 1.828 0 C-N-CA 123.169 2.579 . . . . 0.0 113.34 -179.488 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 19.7 pt . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.128 178.722 . . . . . . . . 0 0 . 1 . 087 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo . . . . . 0 N--CA 1.489 1.238 0 CA-C-O 120.856 0.273 . . . . 0.0 112.299 . . . . . . . . . 0 0 . 1 . 087 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.6 p -108.7 -36.72 6.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.931 179.72 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.45 119.95 33.95 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.247 0.546 . . . . 0.0 110.719 -179.894 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 83.9 mtp180 -133.48 143.57 48.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.309 179.107 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -112.32 127.48 56.0 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.416 179.067 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.9 t -98.77 125.67 52.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.058 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 m -76.84 138.08 39.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.473 0.654 . . . . 0.0 112.2 -178.923 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.611 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 48.1 mm -105.19 132.45 51.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.625 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -87.73 156.8 19.27 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.09 -0.644 . . . . 0.0 110.994 179.918 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.63 ' NH2' HE21 ' B' ' 248' ' ' GLN . 73.2 mtp180 -54.02 -33.56 57.54 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.612 -179.286 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.7 m -78.73 -5.41 53.13 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.42 179.008 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.42 35.02 9.78 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -179.343 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.3 t -119.15 134.6 62.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.66 0.267 . . . . 0.0 110.284 -179.84 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.403 ' OD1' ' CD1' ' A' ' 10' ' ' ILE . 86.7 m-20 -76.15 137.97 40.42 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.862 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.25 -118.15 2.05 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.514 -179.176 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.43 147.9 47.47 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.215 1.943 . . . . 0.0 113.002 -178.217 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 64.7 m170 -105.45 132.76 51.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.236 179.577 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -104.61 97.52 12.58 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.115 179.784 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -71.37 129.11 15.42 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 121.326 1.351 . . . . 0.0 111.675 -179.859 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 49.6 mt -96.92 54.12 1.25 Allowed 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.421 -179.131 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 92.0 p -61.78 -17.94 57.97 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.855 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 76.7 mt -77.15 142.21 39.8 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.293 178.88 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.7 t -63.61 -20.83 65.99 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -178.866 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 72.1 m -132.92 133.43 43.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.137 0.494 . . . . 0.0 111.739 -179.652 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.567 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 9.6 t -126.34 119.09 26.43 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.493 179.291 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.461 ' O ' ' N ' ' A' ' 36' ' ' ASP . 34.0 tp -115.55 126.57 54.41 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.566 -0.453 . . . . 0.0 111.854 -178.084 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.567 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 10.5 m-85 -104.12 139.86 38.6 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.994 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 171.82 -171.83 44.33 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 119.812 -1.185 . . . . 0.0 112.063 179.738 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 31.2 ttp85 -100.26 -8.73 23.16 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.114 -0.543 . . . . 0.0 111.778 -179.444 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.451 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -88.78 167.31 34.83 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 120.688 -0.767 . . . . 0.0 111.284 -179.996 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.433 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 9.9 tp -64.71 -42.06 93.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 O-C-N 122.551 -0.382 . . . . 0.0 110.975 -179.732 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.433 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 93.0 mt-10 -53.7 -22.23 8.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.766 0.317 . . . . 0.0 111.047 -179.334 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 4.0 m -65.96 124.83 23.59 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.438 -179.873 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 28' ' ' LEU . 53.1 m-20 -60.31 -30.65 69.63 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.349 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 79.7 mt -123.93 121.41 62.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 176.825 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.439 HH12 ' HA ' ' B' ' 264' ' ' LYS . 89.2 mtm-85 -103.84 133.93 48.0 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.006 -178.228 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.451 ' C ' ' H ' ' A' ' 41' ' ' LEU . 97.9 mt -116.9 128.95 74.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.289 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -73.23 26.46 0.06 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.014 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.451 ' H ' ' C ' ' A' ' 39' ' ' ILE . 51.5 mt -95.64 127.44 41.6 Favored Pre-proline 0 C--N 1.324 -0.543 0 C-N-CA 120.478 -0.489 . . . . 0.0 109.921 179.022 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.91 -7.96 22.08 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 122.186 1.924 . . . . 0.0 111.964 -179.628 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.8 m -97.92 10.97 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.299 179.982 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 33.5 t -99.0 133.52 41.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-O 120.675 0.274 . . . . 0.0 110.846 179.467 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.0 m -74.45 170.69 15.17 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.255 0.55 . . . . 0.0 111.927 -178.934 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -64.53 -41.45 96.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.202 -179.301 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.617 ' O ' ' N ' ' A' ' 49' ' ' CYS . 97.8 mm-40 -109.58 -27.41 9.41 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.164 0.507 . . . . 0.0 110.025 -179.578 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.441 ' O ' ' OG ' ' A' ' 64' ' ' SER . 18.8 t60 38.94 -77.52 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.666 -1.152 . . . . 0.0 112.661 179.623 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.617 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.45 133.68 46.5 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.259 0.552 . . . . 0.0 111.114 -179.066 . . . . . . . . 3 3 . 1 . 087 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -128.76 131.45 47.84 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.494 -179.819 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 94.7 mt -116.88 133.21 64.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.183 0.516 . . . . 0.0 110.744 179.633 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -115.81 125.92 53.33 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.704 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 95.5 mt -105.02 113.67 42.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.482 0.658 . . . . 0.0 111.77 -178.938 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.475 ' O ' ' N ' ' A' ' 56' ' ' GLN . 90.7 m-70 -112.11 142.94 43.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.316 -179.883 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 54' ' ' HIS . 78.4 tt0 -40.9 -27.48 0.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.298 0.57 . . . . 0.0 109.897 -179.317 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.475 ' N ' ' O ' ' A' ' 54' ' ' HIS . 70.0 tp60 -65.86 -67.88 0.41 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.727 179.715 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.464 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 5.8 tp10 -158.12 -168.17 2.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.042 -0.527 . . . . 0.0 109.676 -179.257 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.464 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -108.87 122.63 47.6 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.909 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.0 mt -114.56 131.43 66.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -177.763 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.406 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 24.5 tp -103.07 127.22 50.41 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.216 -179.417 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -111.05 136.78 49.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.141 179.335 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.468 HD22 ' HA ' ' A' ' 68' ' ' PRO . 58.9 t-20 -97.92 106.95 19.33 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.693 -178.954 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -101.43 -7.3 23.01 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.471 179.606 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 48' ' ' HIS . 0.7 OUTLIER -74.36 99.48 3.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.484 -178.794 . . . . . . . . 3 3 . 1 . 087 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 76.7 p -81.08 -32.41 33.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.059 0.457 . . . . 0.0 109.863 179.337 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.8 m -62.92 -49.97 72.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.683 -179.935 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 -144.15 106.33 4.83 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.933 -179.854 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.468 ' HA ' HD22 ' A' ' 62' ' ' ASN . 45.4 Cg_exo -54.08 146.89 46.2 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 121.923 1.748 . . . . 0.0 112.949 -179.231 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.4 m -74.98 138.95 42.6 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.924 178.885 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -101.78 140.67 35.75 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.95 179.841 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.455 ' O ' ' OG ' ' A' ' 74' ' ' SER . 64.8 t -131.8 133.17 61.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.052 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 53.74 32.39 14.69 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.007 -178.611 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.12 29.09 67.18 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.417 -179.73 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 4.9 p -145.42 140.4 27.6 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.953 -179.682 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.1 t -65.82 139.85 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.456 179.741 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.3 pt -110.2 78.13 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.089 0 CA-C-O 121.021 0.439 . . . . 0.0 110.214 178.587 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -57.59 -31.69 66.43 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.004 179.993 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -118.81 168.85 8.91 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.55 179.762 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.3 141.99 98.51 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.019 1.813 . . . . 0.0 111.941 179.607 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 61.2 t -135.78 136.57 50.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.188 -179.913 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -72.64 131.55 42.57 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.614 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 93.3 mt -83.25 138.59 33.53 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.761 -179.836 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -130.71 154.46 47.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.024 -179.661 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.414 ' CD2' ' C ' ' A' ' 84' ' ' HIS . 7.7 t60 -54.35 116.42 2.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.372 179.88 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.72 -19.15 31.23 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -179.846 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.434 ' C ' ' OD1' ' A' ' 86' ' ' ASP . 45.5 t0 -65.54 126.95 29.93 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.144 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 52.8 t -109.94 134.55 51.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.432 -0.507 . . . . 0.0 111.312 -178.386 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 79.5 mt -100.96 130.17 50.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.172 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 68.3 m -122.44 123.05 40.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.514 0.673 . . . . 0.0 111.545 -178.762 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.632 ' O ' ' N ' ' A' ' 93' ' ' ARG . 79.6 mt -107.08 121.02 59.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 178.382 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.49 ' C ' ' O ' ' A' ' 90' ' ' ILE . 96.7 mt 33.99 -91.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.818 -179.707 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.576 ' N ' ' O ' ' A' ' 90' ' ' ILE . 46.6 p-10 -118.49 2.7 11.82 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.899 0.381 . . . . 0.0 111.118 179.654 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.738 ' NH2' ' H ' ' A' ' 94' ' ' SER . 0.5 OUTLIER -111.87 132.49 54.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.31 -179.98 . . . . . . . . 3 3 . 1 . 087 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.738 ' H ' ' NH2' ' A' ' 93' ' ' ARG . 16.7 m -135.7 152.28 51.02 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.612 0.72 . . . . 0.0 112.019 -179.455 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.449 ' CZ ' ' NH1' ' A' ' 93' ' ' ARG . 84.4 m-85 -129.67 126.29 37.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.901 179.06 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 96' ' ' ARG . 37.9 ttp-105 -88.11 133.33 34.02 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.612 179.662 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -93.42 125.77 38.2 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.926 -179.73 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -124.47 131.02 53.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.612 179.93 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 59.8 t-20 -120.5 83.62 2.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.042 -179.741 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.186 179.352 . . . . . . . . 0 0 . 1 . 087 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 58.3 t . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.851 0.358 . . . . 0.0 110.699 . . . . . . . . . 0 0 . 1 . 087 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.648 ' O ' ' N ' ' B' ' 231' ' ' GLN . 96.5 m-20 -87.76 151.56 22.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.596 -179.301 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . 0.468 ' O1P' ' NE2' ' B' ' 231' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.648 ' N ' ' O ' ' B' ' 229' ' ' ASP . 39.2 mm-40 -65.7 -47.52 75.11 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.806 -179.849 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' B' ' 231' ' ' GLN . . . -33.71 153.36 0.01 OUTLIER Glycine 0 CA--C 1.534 1.257 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.235 -179.271 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.76 160.99 46.49 Favored 'Trans proline' 0 N--CA 1.499 1.84 0 C-N-CA 123.58 2.853 . . . . 0.0 112.497 179.403 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 087 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -60.65 138.1 77.65 Favored 'Trans proline' 0 C--N 1.301 -1.94 0 C-N-CA 121.961 1.774 . . . . 0.0 112.167 179.817 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.58 137.61 22.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.074 179.817 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 3.7 t -68.57 121.24 15.99 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.223 -178.701 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 087 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.27 -23.53 62.98 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 122.332 2.022 . . . . 0.0 111.888 179.778 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 98.3 m -72.91 -44.65 60.98 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.314 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -57.99 -45.06 87.42 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.865 -179.415 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 97.1 mt -64.81 -40.9 95.97 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -179.426 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -61.22 -42.89 99.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.786 179.964 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -63.21 -39.43 94.6 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.44 -0.504 . . . . 0.0 109.682 179.946 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.616 HH11 ' CZ ' ' A' ' 12' ' ' ARG . 14.5 tpp180 -59.04 -42.42 90.22 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 179.604 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -60.4 -43.03 97.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.403 179.131 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 16.5 t -65.1 -44.88 87.39 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.948 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . 0.63 HE21 ' NH2' ' A' ' 12' ' ' ARG . 27.4 mt-30 -60.84 -32.84 72.23 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.465 -179.825 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 54.1 t -62.96 -46.2 96.93 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.046 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -59.86 -28.34 67.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.794 178.949 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -95.86 -11.89 26.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.872 179.764 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.491 ' N ' ' O ' ' B' ' 248' ' ' GLN . 47.7 tp -73.68 145.02 45.57 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.986 -179.714 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -102.96 135.01 45.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.006 0.431 . . . . 0.0 110.61 179.726 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -63.12 -27.26 69.26 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.042 -179.867 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 -65.71 1.17 1.37 Allowed 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -178.674 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -99.15 85.78 3.3 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.494 -0.482 . . . . 0.0 111.266 -179.929 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -78.92 7.55 7.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.761 0.315 . . . . 0.0 111.42 -179.015 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.503 ' O ' ' C ' ' B' ' 259' ' ' ASP . 95.2 m-20 -106.27 -6.54 18.35 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 177.532 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.503 ' C ' ' O ' ' B' ' 258' ' ' ASP . 34.9 t0 22.01 -102.38 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 113.669 -1.605 . . . . 0.0 110.53 -179.676 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.568 ' OE2' ' NH1' ' A' ' 12' ' ' ARG . 92.7 mt-10 -136.57 15.38 3.16 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.292 179.213 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 59.1 mt -116.53 134.12 60.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.958 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 52.9 t -126.5 134.03 67.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.946 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -93.95 117.86 30.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.479 0.657 . . . . 0.0 111.97 -178.412 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . 0.439 ' HA ' HH12 ' A' ' 38' ' ' ARG . 87.5 tttt -63.34 -43.86 96.51 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.981 179.128 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 9.3 mp0 -100.65 157.43 33.74 Favored Pre-proline 0 N--CA 1.449 -0.492 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.548 -179.686 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -70.2 143.57 49.13 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 C-N-CA 122.847 2.364 . . . . 0.0 113.312 -179.157 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 29.5 pt . . . . . 0 N--CA 1.451 -0.378 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.072 178.564 . . . . . . . . 0 0 . 1 . 088 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo . . . . . 0 N--CA 1.493 1.471 0 CA-C-O 120.732 0.222 . . . . 0.0 111.931 . . . . . . . . . 0 0 . 1 . 088 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.598 ' HG1' ' H ' ' A' ' 5' ' ' ARG . 37.2 p -115.17 -54.64 2.54 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.3 -179.715 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.598 ' H ' ' HG1' ' A' ' 4' ' ' THR . 82.6 mtm-85 -99.71 134.93 41.89 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.902 -179.366 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -138.82 144.9 39.51 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 120.222 -0.591 . . . . 0.0 111.626 -179.859 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.4 mt -108.73 140.62 41.88 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.003 178.58 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.4 t -112.54 129.21 68.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.616 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 m -93.45 117.77 30.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.272 0.558 . . . . 0.0 112.299 -178.049 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.5 mt -83.07 143.04 12.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.785 179.582 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -95.94 164.31 12.77 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.967 179.498 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.435 ' HG3' ' NH1' ' A' ' 93' ' ' ARG . 82.7 mtp180 -58.36 -30.09 66.49 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.281 -179.366 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 88.0 p -73.25 -15.08 61.43 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.229 179.561 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.93 11.09 44.3 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -179.869 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.4 m -112.02 138.73 39.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.956 0.408 . . . . 0.0 110.484 179.931 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.419 ' O ' ' OD1' ' A' ' 16' ' ' ASP . 54.2 p-10 -80.19 146.85 31.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.006 179.446 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.21 -106.09 1.01 Allowed Glycine 0 CA--C 1.537 1.447 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 179.822 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.1 146.92 37.39 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 122.963 2.442 . . . . 0.0 112.248 -179.994 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -112.97 153.18 28.43 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.194 179.901 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.422 ' CD2' HD11 ' A' ' 37' ' ' ILE . 62.5 t80 -117.53 89.21 31.59 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.665 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -61.3 132.62 42.12 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.556 2.171 . . . . 0.0 111.089 179.914 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.7 mt -87.97 82.23 7.29 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.653 -178.847 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 86.0 p -86.59 -11.14 52.32 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 178.379 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 63.4 mt -101.92 144.06 31.03 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.526 -179.186 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.1 m -67.86 -21.2 65.19 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.779 0.323 . . . . 0.0 111.199 -179.724 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 63.1 m -127.52 133.31 49.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.708 179.619 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.657 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 9.8 t -129.78 122.13 28.2 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.463 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 49.8 tp -118.08 132.5 56.35 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.149 -178.246 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.657 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 38.0 m-85 -110.49 142.46 42.22 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.8 0.334 . . . . 0.0 110.197 179.837 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 150.13 -176.16 28.89 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 179.406 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 46.6 mtm180 -77.76 -31.68 52.19 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.64 179.605 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.578 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -47.8 149.37 3.27 Favored Glycine 0 N--CA 1.466 0.688 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 -179.012 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.0 tp -68.58 -41.04 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.583 -179.918 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -55.07 -21.98 14.51 Favored 'General case' 0 C--O 1.231 0.096 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -179.995 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.578 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 19.0 m -57.34 113.01 1.57 Allowed 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.771 178.812 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -58.36 -26.72 63.47 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 -179.99 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.422 HD11 ' CD2' ' A' ' 20' ' ' PHE . 50.5 mm -122.4 113.48 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.476 177.289 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 42.2 mtm180 -98.02 131.63 44.27 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.829 -179.662 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.401 ' C ' ' H ' ' A' ' 41' ' ' LEU . 99.2 mt -118.17 131.25 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 121.465 0.65 . . . . 0.0 111.31 179.79 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -79.79 32.39 0.25 Allowed 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.159 -178.631 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.401 ' H ' ' C ' ' A' ' 39' ' ' ILE . 31.9 mt -98.22 121.56 56.73 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.484 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -72.33 -13.0 27.92 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 121.552 1.501 . . . . 0.0 111.499 -179.823 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.2 m -96.2 7.73 7.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.505 -179.451 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.457 HG23 ' ND1' ' A' ' 48' ' ' HIS . 5.0 p -101.86 142.5 16.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.533 179.958 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.8 m -71.95 170.35 13.95 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.363 0.602 . . . . 0.0 111.129 -179.391 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -63.81 -41.2 97.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.986 -179.764 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.637 ' O ' ' N ' ' A' ' 49' ' ' CYS . 87.7 mt-30 -108.96 -9.92 15.08 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 121.086 -0.246 . . . . 0.0 110.994 -179.958 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.457 ' ND1' HG23 ' A' ' 44' ' ' VAL . 30.0 t60 31.41 -76.32 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 179.635 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.637 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.51 137.37 45.58 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.132 0.491 . . . . 0.0 111.685 -178.472 . . . . . . . . 3 3 . 1 . 088 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -123.75 131.56 53.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.899 178.733 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.5 mt -116.05 133.46 62.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.197 -179.109 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -117.85 125.63 50.89 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.02 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.456 HD13 ' HE ' ' A' ' 5' ' ' ARG . 67.7 mt -103.29 116.6 47.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 C-N-CA 119.853 -0.739 . . . . 0.0 111.207 -179.488 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.503 ' O ' ' N ' ' A' ' 56' ' ' GLN . 6.3 m-70 -111.72 135.8 51.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.182 179.637 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.0 mm-40 -41.51 -26.58 0.07 Allowed 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.477 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.503 ' N ' ' O ' ' A' ' 54' ' ' HIS . 82.4 mt-30 -68.39 -68.55 0.38 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.215 178.679 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.468 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 5.2 tp10 -151.0 -178.3 6.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.557 -179.357 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.468 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -102.41 128.7 48.89 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.554 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.464 HG21 HD12 ' A' ' 59' ' ' ILE . 40.9 mm -111.89 126.57 69.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.886 -178.117 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.428 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 23.0 tp -101.37 124.24 46.75 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.923 178.878 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -114.81 137.04 52.42 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.419 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.636 ' ND2' ' H ' ' A' ' 69' ' ' THR . 21.5 t-20 -102.21 108.28 19.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.03 0.443 . . . . 0.0 111.288 179.49 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -94.43 -3.03 50.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.805 179.298 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.8 t -82.31 100.98 10.26 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.446 -0.501 . . . . 0.0 110.081 179.521 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.9 m -82.76 -17.2 45.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.62 179.954 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.52 -36.09 17.8 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.376 -179.338 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -146.05 100.58 4.22 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.873 -179.54 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -57.81 144.09 94.25 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 121.736 1.624 . . . . 0.0 112.708 -179.336 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.636 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 37.2 m -70.21 134.55 48.17 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.171 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -96.08 141.1 29.87 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.635 -178.909 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.5 t -134.32 134.07 55.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.321 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 53.49 31.89 13.09 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 119.84 -0.744 . . . . 0.0 109.023 -179.104 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.04 25.68 72.98 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.26 179.852 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 37.8 t -141.72 143.57 33.6 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 117.297 0.549 . . . . 0.0 111.528 -179.993 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.8 m -76.69 139.13 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.884 179.984 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.414 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 1.1 pt -104.08 104.05 16.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.622 179.106 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.428 ' C ' ' OE1' ' A' ' 78' ' ' GLU . 57.9 m-20 -63.24 -35.88 81.8 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-O 121.191 0.519 . . . . 0.0 109.911 179.964 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.428 ' OE1' ' C ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -125.79 177.95 1.7 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.345 -179.128 . . . . . . . . 3 3 . 1 . 088 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.418 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 34.6 Cg_exo -60.48 142.64 98.5 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 122.302 2.001 . . . . 0.0 111.914 179.966 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 42.9 t -132.7 138.19 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 120.946 0.403 . . . . 0.0 111.665 179.722 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -75.32 132.83 41.25 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.679 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 86.1 mt -87.41 137.2 32.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.326 0.584 . . . . 0.0 111.318 -179.121 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -126.02 151.85 46.54 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.321 -179.704 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.724 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 9.1 t60 -55.12 122.98 12.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.227 0.537 . . . . 0.0 111.246 -178.973 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 103.35 -13.22 54.89 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.143 -179.657 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -70.72 139.06 51.04 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 117.079 0.44 . . . . 0.0 110.696 179.687 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 8.7 p -111.69 135.81 49.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.411 -0.515 . . . . 0.0 111.841 -178.996 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 81.2 mt -102.4 128.99 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 177.606 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 95.3 m -123.93 125.07 43.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.702 0.763 . . . . 0.0 111.759 -178.438 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.63 ' O ' ' N ' ' A' ' 93' ' ' ARG . 96.1 mt -113.99 121.65 66.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 114.547 -1.206 . . . . 0.0 108.062 178.324 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.555 ' C ' ' O ' ' A' ' 90' ' ' ILE . 66.5 mt -3.44 95.31 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -179.833 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.427 ' CB ' ' NH1' ' B' ' 245' ' ' ARG . 2.0 t0 77.83 -20.3 0.39 Allowed 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 178.18 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.709 ' HE ' ' CD1' ' B' ' 261' ' ' ILE . 6.8 tpt180 -120.31 130.08 54.29 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 110.465 -0.198 . . . . 0.0 110.465 -178.372 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 64.3 m -134.62 151.11 50.83 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -178.486 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -122.63 120.74 34.62 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.308 178.551 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 37.7 ttp-105 -87.86 134.95 33.59 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 119.914 -0.715 . . . . 0.0 110.727 -179.652 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -96.93 123.86 40.75 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.124 -178.14 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -125.12 120.26 30.9 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.234 179.415 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.724 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 15.9 t-20 -103.11 109.48 21.06 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.507 -179.225 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.461 ' C ' ' O ' ' A' ' 99' ' ' ASN . 76.9 tt0 . . . . . 0 CA--C 1.517 -0.312 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.73 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 2.4 t . . . . . 0 CA--C 1.528 0.129 0 CA-C-O 120.572 0.225 . . . . 0.0 110.794 . . . . . . . . . 0 0 . 1 . 088 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.632 ' C ' ' H ' ' B' ' 231' ' ' GLN . 75.7 m-20 -67.36 138.73 56.96 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.214 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 088 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.632 ' H ' ' C ' ' B' ' 229' ' ' ASP . 99.3 mm-40 -105.72 -24.66 12.47 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.162 0.506 . . . . 0.0 110.368 179.681 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' B' ' 229' ' ' ASP . . . -33.35 158.82 0.01 OUTLIER Glycine 0 CA--C 1.531 1.037 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.459 -179.142 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -71.49 161.4 45.57 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 123.581 2.854 . . . . 0.0 111.591 179.565 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 088 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -75.0 141.86 27.16 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 121.946 1.764 . . . . 0.0 113.388 -179.844 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 60.5 t -60.82 137.61 22.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.48 179.667 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 2.7 t -64.61 134.42 54.29 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.038 -179.559 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . 0.407 ' O3P' ' OG1' ' B' ' 240' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -55.42 -22.54 34.51 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.534 2.156 . . . . 0.0 112.241 -179.959 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' B' B ' 240' ' ' THR . . . . . 0.407 ' OG1' ' O3P' ' B' ' 238' ' ' TPO . 86.2 m -72.24 -44.05 63.46 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.439 0.638 . . . . 0.0 109.417 178.485 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -58.47 -51.01 71.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.324 -178.624 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 97.2 mt -63.51 -42.04 98.49 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.183 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -64.29 -42.24 96.49 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -178.734 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -62.2 -41.8 98.7 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.344 -179.591 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.427 ' NH1' ' CB ' ' A' ' 92' ' ' ASP . 83.5 mtp180 -63.21 -39.32 94.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.636 -178.495 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -62.01 -38.46 88.73 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.016 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 21.0 m -65.49 -42.61 91.97 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.499 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . 0.471 ' O ' ' N ' ' B' ' 252' ' ' LEU . 87.2 mt-30 -62.33 -32.92 73.75 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.156 179.705 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 53.1 t -61.18 -45.93 97.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 120.121 -0.632 . . . . 0.0 109.419 178.74 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -59.24 -29.3 67.43 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.229 179.343 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -96.48 -9.35 29.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.083 179.228 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.471 ' N ' ' O ' ' B' ' 248' ' ' GLN . 35.3 tp -75.59 142.82 42.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.669 -178.601 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -100.44 141.02 33.87 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.256 179.354 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -65.04 -20.38 66.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.463 0.649 . . . . 0.0 110.522 -179.134 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -63.06 -9.59 11.0 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.247 -179.957 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 46.2 p-10 -65.01 149.1 50.44 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.069 0.462 . . . . 0.0 110.707 179.984 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . 0.571 ' C ' ' H ' ' B' ' 259' ' ' ASP . 99.0 mttt -134.86 153.7 51.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.74 179.983 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.53 ' O ' ' C ' ' B' ' 259' ' ' ASP . 87.0 m-20 45.49 15.83 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -179.409 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.571 ' H ' ' C ' ' B' ' 257' ' ' LYS . 29.2 t70 -2.36 -77.21 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.041 -0.982 . . . . 0.0 112.137 -178.948 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -133.7 9.21 3.92 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.838 -179.4 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . 0.709 ' CD1' ' HE ' ' A' ' 93' ' ' ARG . 64.9 mt -117.6 134.36 61.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -179.883 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 47.8 t -123.4 130.65 74.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.162 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -93.47 117.07 29.63 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.272 0.558 . . . . 0.0 111.106 -177.924 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -64.48 -46.6 82.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.687 -179.781 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -92.49 165.78 18.59 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.069 -178.465 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -69.07 148.01 68.6 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 122.122 1.882 . . . . 0.0 112.739 -178.93 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 32.1 pt . . . . . 0 C--N 1.321 -0.646 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.15 -179.876 . . . . . . . . 0 0 . 1 . 089 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo . . . . . 0 N--CA 1.495 1.575 0 CA-C-O 121.116 0.382 . . . . 0.0 112.774 . . . . . . . . . 0 0 . 1 . 089 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.0 p -89.17 -39.48 13.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.294 179.509 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.55 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 80.5 mtp85 -87.69 126.73 35.14 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.064 -179.465 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -129.62 133.53 47.19 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.013 -179.863 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 35.1 tp -117.1 128.38 55.08 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.748 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.6 m -106.16 136.09 41.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.419 -179.768 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 m -95.29 117.84 30.99 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.142 -0.936 . . . . 0.0 112.589 -178.589 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.7 mt -84.65 145.59 7.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.386 179.02 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -96.4 162.3 13.55 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.95 0.405 . . . . 0.0 110.773 179.315 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.593 ' NH1' ' OE2' ' B' ' 260' ' ' GLU . 87.6 mtm180 -58.45 -27.38 64.32 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.558 -178.636 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 89.3 p -81.82 -9.77 59.52 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.093 -0.643 . . . . 0.0 109.697 179.646 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.3 36.75 6.47 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.61 179.8 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.3 t -118.38 132.37 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-O 120.787 0.327 . . . . 0.0 111.42 179.993 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -69.64 124.48 24.06 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.862 179.274 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -116.08 -128.89 4.34 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.271 -178.937 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -70.61 148.07 58.76 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.031 1.821 . . . . 0.0 112.816 -178.623 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -106.51 144.87 32.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.814 -179.572 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.408 ' CD2' HD13 ' A' ' 37' ' ' ILE . 34.6 t80 -112.25 100.98 51.19 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.321 179.862 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.414 ' CD ' ' O ' ' B' ' 267' ' ' ILE . 57.8 Cg_endo -75.79 128.82 11.15 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 121.47 1.446 . . . . 0.0 111.42 -179.632 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 88.0 mt -83.8 81.17 8.88 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.855 -178.871 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 87.8 p -86.01 -13.7 46.72 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.987 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 73.8 mt -100.03 145.36 28.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.422 -179.967 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 54.2 p -68.56 -15.77 63.64 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.506 -178.804 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 85.6 m -128.61 131.48 48.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.237 0.541 . . . . 0.0 111.778 -179.691 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.9 t -128.11 122.15 31.34 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.304 178.543 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.8 tp -115.27 130.58 56.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.956 0.408 . . . . 0.0 111.002 -179.074 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.55 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 44.8 m-85 -111.36 140.47 45.92 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.796 179.718 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 152.64 -168.4 31.63 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 120.886 -0.673 . . . . 0.0 111.504 179.394 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.578 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 49.5 ptt85 -118.29 17.27 13.92 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 122.76 -0.259 . . . . 0.0 111.034 179.901 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.629 ' O ' ' N ' ' A' ' 34' ' ' GLU . . . -88.05 32.96 4.16 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.814 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.68 ' C ' ' H ' ' A' ' 35' ' ' CYS . 2.0 tt 52.03 -62.09 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 123.28 0.632 . . . . 0.0 112.587 -179.609 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.629 ' N ' ' O ' ' A' ' 32' ' ' GLY . 72.0 tt0 -52.26 2.21 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 O-C-N 121.974 -0.454 . . . . 0.0 110.899 -178.934 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.68 ' H ' ' C ' ' A' ' 33' ' ' ILE . 3.9 m -82.77 133.81 35.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.891 0.377 . . . . 0.0 111.027 179.82 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -61.88 -26.81 68.37 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.88 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.419 HG22 HD12 ' A' ' 37' ' ' ILE . 49.0 mm -123.41 117.09 50.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 177.267 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 82.1 mtt180 -100.33 132.92 45.43 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.85 -179.133 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 80.9 mt -120.31 130.98 73.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.469 -0.493 . . . . 0.0 110.446 -179.727 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -79.11 33.97 0.23 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.507 -179.046 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 17.9 mt -102.06 108.74 57.85 Favored Pre-proline 0 C--N 1.326 -0.427 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.78 -179.974 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -57.56 -13.81 14.91 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.21 1.94 . . . . 0.0 112.406 179.159 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.6 m -97.31 9.7 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.858 -179.893 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.578 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 15.7 t -102.17 135.88 37.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.092 0.473 . . . . 0.0 110.957 -179.744 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.53 162.23 21.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.204 -179.12 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -62.89 -42.42 99.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.702 -179.392 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.595 ' O ' ' N ' ' A' ' 49' ' ' CYS . 87.6 mt-30 -112.34 -2.58 14.76 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.916 0.389 . . . . 0.0 110.579 178.882 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.456 ' C ' ' O ' ' A' ' 47' ' ' GLN . 14.8 t60 15.88 -73.51 0.0 OUTLIER 'General case' 0 C--O 1.235 0.29 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -179.287 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.595 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.91 134.69 44.9 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.331 -0.548 . . . . 0.0 112.094 -178.127 . . . . . . . . 3 3 . 1 . 089 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -127.41 132.36 50.13 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.399 179.793 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.2 mt -115.93 133.24 62.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.977 0.417 . . . . 0.0 111.432 -179.491 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -117.41 127.93 54.52 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.428 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 93.0 mt -105.53 118.36 52.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 119.941 -0.703 . . . . 0.0 112.231 -179.089 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.454 ' O ' ' N ' ' A' ' 56' ' ' GLN . 92.9 m-70 -116.39 144.01 44.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.692 -179.522 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 54' ' ' HIS . 95.3 mt-10 -40.28 -29.69 0.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.857 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.483 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 53.4 tt0 -63.87 -68.31 0.36 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.411 178.733 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.483 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 5.5 tp10 -160.09 -159.44 0.71 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.047 179.371 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.448 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -116.04 124.97 51.79 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.213 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.417 HG22 HD11 ' A' ' 59' ' ' ILE . 96.5 mt -116.69 132.43 66.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.243 0.545 . . . . 0.0 112.22 -178.329 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.1 tp -100.54 129.03 46.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.319 -179.971 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -110.22 135.65 50.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.704 -179.66 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.438 HD22 ' HA ' ' A' ' 68' ' ' PRO . 47.2 t-20 -95.95 105.22 17.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.729 -179.247 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -98.0 -5.74 33.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.815 179.086 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.23 101.39 3.98 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.702 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.6 p -87.37 -11.13 50.2 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.699 -179.877 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.1 -36.08 9.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.169 -179.272 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 60.2 m-80 -142.78 97.72 5.87 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.664 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.438 ' HA ' HD22 ' A' ' 62' ' ' ASN . 32.6 Cg_exo -55.92 146.08 70.21 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 122.299 2.0 . . . . 0.0 113.633 -178.358 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.3 m -69.23 133.19 47.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.023 178.641 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -97.78 141.78 30.37 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.224 -0.59 . . . . 0.0 111.347 -179.287 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.3 p -133.46 133.58 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.801 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 50.64 32.96 7.43 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 119.921 -0.712 . . . . 0.0 109.219 -179.321 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.21 29.27 62.62 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.943 179.788 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.5 m -142.33 135.31 28.55 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.233 -0.587 . . . . 0.0 111.962 -179.727 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -72.84 139.23 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.471 179.277 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.547 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 1.1 pt -107.07 111.81 37.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-O 121.719 0.771 . . . . 0.0 111.023 179.721 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -67.3 -31.98 72.64 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.993 179.303 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.615 ' N ' ' OE1' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -133.13 -179.19 1.0 Allowed Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.847 -179.322 . . . . . . . . 3 3 . 1 . 089 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.496 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 31.3 Cg_exo -60.77 146.72 96.92 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 122.973 2.449 . . . . 0.0 113.08 179.828 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.9 m -137.4 140.53 41.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.857 179.018 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 52.3 ttp180 -73.15 129.96 39.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.317 179.3 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.0 mt -81.92 140.82 33.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.374 0.607 . . . . 0.0 111.694 -179.227 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.66 152.23 51.62 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.94 179.599 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.626 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 5.6 t60 -56.85 121.11 9.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.991 0.424 . . . . 0.0 110.916 -179.477 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.61 -18.75 37.46 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 179.924 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -67.48 135.57 53.27 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.963 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.4 t -113.71 132.73 61.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.329 -177.671 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.431 ' O ' ' OG ' ' A' ' 94' ' ' SER . 97.9 mt -96.52 129.3 46.78 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 177.801 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 43.1 m -121.71 124.96 45.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.622 0.725 . . . . 0.0 112.133 -178.0 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.572 ' O ' ' N ' ' A' ' 93' ' ' ARG . 95.4 mt -113.07 128.84 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 114.708 -1.133 . . . . 0.0 107.987 178.404 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.527 ' C ' ' O ' ' A' ' 90' ' ' ILE . 61.3 mt -20.88 102.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -178.673 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.461 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 5.1 m-20 87.17 -23.72 0.13 Allowed 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 177.881 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.572 ' N ' ' O ' ' A' ' 90' ' ' ILE . 17.3 mmm-85 -129.24 144.6 51.28 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.413 179.926 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 88' ' ' ILE . 41.5 t -140.24 152.87 46.29 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.249 0.547 . . . . 0.0 110.814 179.979 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.4 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 51.7 m-85 -123.2 122.06 37.47 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.985 -179.768 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -88.49 130.98 35.08 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 119.655 -0.818 . . . . 0.0 109.959 179.591 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.55 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 41.0 t80 -93.83 127.71 39.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.168 -179.941 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -123.94 122.29 37.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.689 179.56 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.626 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 27.5 t-20 -97.25 116.11 28.85 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.32 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.103 -179.07 . . . . . . . . 0 0 . 1 . 089 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 9.2 p . . . . . 0 C--O 1.232 0.144 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 089 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.601 ' C ' ' H ' ' B' ' 231' ' ' GLN . 52.0 t0 -88.23 116.15 26.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.101 -179.162 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . 0.419 ' C ' ' O ' ' B' ' 229' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.601 ' H ' ' C ' ' B' ' 229' ' ' ASP . 90.5 mm-40 -113.89 -21.57 10.56 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.373 179.387 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' B' ' 229' ' ' ASP . . . -40.86 170.79 0.01 OUTLIER Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 -179.916 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.41 161.63 44.95 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 123.464 2.776 . . . . 0.0 112.961 -179.421 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 089 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -76.42 139.4 20.69 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.141 1.894 . . . . 0.0 114.27 -179.078 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 55.4 t -65.38 142.07 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.301 179.529 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 3.5 t -71.1 136.1 48.04 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.378 179.892 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . 0.414 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . 0.414 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 41.8 Cg_exo -57.6 -28.41 81.13 Favored 'Trans proline' 0 N--CA 1.499 1.817 0 C-N-CA 123.193 2.596 . . . . 0.0 113.07 -179.305 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' B' B ' 240' ' ' THR . . . . . 0.401 ' OG1' ' O2P' ' B' ' 238' ' ' TPO . 30.4 m -68.62 -46.69 68.59 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.077 0.465 . . . . 0.0 110.031 178.73 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -59.52 -46.31 89.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.483 -178.607 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 84.7 mt -63.72 -42.65 97.88 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -178.907 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -65.56 -40.02 92.34 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.406 -0.517 . . . . 0.0 111.093 -178.931 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 63.7 ttm-85 -63.62 -44.12 94.86 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.441 -0.503 . . . . 0.0 109.849 179.649 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . . . . . . . . . 70.6 ttp85 -61.28 -42.53 98.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.757 -179.928 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -59.17 -37.95 78.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.019 -179.675 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 49.0 m -68.92 -41.66 77.84 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 177.454 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . 0.447 ' O ' ' N ' ' B' ' 252' ' ' LEU . 70.2 tp60 -61.16 -38.38 86.26 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.515 179.954 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 38.6 t -62.15 -46.02 97.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.119 179.232 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -60.84 -25.77 66.88 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.149 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -95.52 -10.52 29.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.927 179.112 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.494 ' CD2' HH21 ' A' ' 12' ' ' ARG . 56.2 tp -76.7 140.18 40.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.817 -179.26 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -100.48 139.54 36.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.019 178.708 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -67.56 -22.62 65.39 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.911 -179.882 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -69.38 -5.86 26.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.419 -179.773 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -84.1 76.09 10.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.251 179.677 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -66.81 0.78 2.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.312 -179.398 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.535 ' O ' ' C ' ' B' ' 259' ' ' ASP . 97.4 m-20 -98.17 1.28 47.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.61 0.243 . . . . 0.0 110.39 178.538 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.573 ' CG ' ' H ' ' B' ' 260' ' ' GLU . 31.9 p-10 11.93 -118.89 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 O-C-N 124.082 0.864 . . . . 0.0 111.989 179.951 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.593 ' OE2' ' NH1' ' A' ' 12' ' ' ARG . 98.1 mt-10 -130.32 5.19 4.8 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.186 -179.871 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 81.1 mt -116.41 138.06 48.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.86 0.362 . . . . 0.0 110.18 179.972 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 43.9 t -127.07 136.44 60.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.363 179.739 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -97.72 118.02 33.33 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.249 0.547 . . . . 0.0 110.979 -178.748 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -64.7 -46.53 81.94 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.599 179.509 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . 0.413 ' CB ' ' CD ' ' B' ' 266' ' ' PRO . 1.1 mm-40 -98.73 177.74 1.5 Allowed Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.467 -179.111 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . 0.413 ' CD ' ' CB ' ' B' ' 265' ' ' GLN . 38.8 Cg_exo -60.75 143.36 99.38 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.544 2.162 . . . . 0.0 113.193 -178.895 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . 0.414 ' O ' ' CD ' ' A' ' 21' ' ' PRO . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.314 179.296 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo . . . . . 0 N--CA 1.497 1.679 0 CA-C-O 120.746 0.227 . . . . 0.0 112.326 . . . . . . . . . 0 0 . 1 . 090 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.4 p -78.55 -30.54 46.98 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.503 179.465 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.587 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 93.6 mtt-85 -100.21 117.12 33.78 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.89 -179.092 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.426 HH12 ' HB2' ' A' ' 100' ' ' GLU . 32.3 ptt-85 -132.96 141.78 48.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.25 179.871 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 33.2 tp -118.24 136.18 53.82 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.899 -179.805 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.0 t -112.56 131.2 64.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 -179.784 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.8 m -91.08 113.62 25.93 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.548 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 84.6 mt -81.63 145.01 9.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.666 178.477 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.433 ' HZ2' ' HA ' ' B' ' 257' ' ' LYS . 87.2 mttt -89.9 157.89 17.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.083 0.468 . . . . 0.0 111.066 178.949 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.628 ' NH1' HH11 ' B' ' 245' ' ' ARG . 90.4 mtm180 -58.61 -32.07 68.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.93 -179.454 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.5 m -75.64 -13.49 60.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.917 0.389 . . . . 0.0 110.381 179.675 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.06 35.54 5.51 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.363 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.4 t -121.66 133.17 68.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.849 0.357 . . . . 0.0 111.551 -179.12 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -72.43 122.62 21.54 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.767 179.415 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -114.63 -129.26 4.69 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.529 -179.354 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.49 156.18 54.42 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.301 2.001 . . . . 0.0 112.859 -178.969 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.482 ' CD2' ' C ' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -112.91 156.0 23.75 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.128 0.49 . . . . 0.0 110.762 -179.336 . . . . . . . . 3 3 . 1 . 090 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -126.19 104.39 25.72 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.517 -179.436 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -74.01 132.8 17.29 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 C-N-CA 121.07 1.18 . . . . 0.0 111.472 -179.363 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 73.9 mt -89.98 49.97 1.8 Allowed 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.196 -178.351 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 93.9 p -63.13 -19.65 64.65 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.893 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 87.0 mt -77.48 140.2 39.76 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.069 179.592 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 77.9 p -61.57 -21.38 64.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.593 -178.973 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.488 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 20.8 m -136.27 135.7 39.21 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.786 -0.365 . . . . 0.0 111.304 -179.752 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.0 t -124.84 116.65 22.59 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.46 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.1 tp -113.73 127.8 56.17 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.906 0.384 . . . . 0.0 110.87 -179.052 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.641 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 9.6 m-85 -106.33 132.5 52.3 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.666 179.773 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 163.24 -173.53 39.41 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 119.724 -1.227 . . . . 0.0 112.879 179.144 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.635 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 87.3 mtm-85 -77.44 -31.02 53.65 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-O 120.907 0.384 . . . . 0.0 110.167 179.51 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.498 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -52.81 148.1 13.53 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.365 -178.075 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.461 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 8.2 tp -67.36 -40.6 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.417 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.461 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 79.5 mm-40 -54.45 -24.93 22.21 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.221 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 61.6 m -51.85 120.65 5.52 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.122 -179.786 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.488 ' OD2' ' O ' ' A' ' 26' ' ' THR . 68.0 m-20 -57.56 -27.3 62.54 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 179.932 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.42 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 84.4 mt -129.35 121.26 53.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.92 177.367 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 66.7 ttp85 -112.13 138.23 49.08 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.857 -179.177 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.46 ' CD1' ' NH1' ' A' ' 93' ' ' ARG . 78.0 mt -117.66 132.53 67.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.975 0.417 . . . . 0.0 110.312 -179.54 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -72.45 32.49 0.06 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.478 -178.168 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.542 ' CD1' HH21 ' A' ' 93' ' ' ARG . 78.7 mt -118.64 128.1 26.16 Favored Pre-proline 0 CA--C 1.535 0.392 0 C-N-CA 120.249 -0.58 . . . . 0.0 111.95 -179.722 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.85 -11.35 25.67 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 122.46 2.107 . . . . 0.0 113.222 -179.85 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 m -87.63 -5.58 10.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.344 179.403 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.635 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 55.3 t -84.51 133.17 29.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 177.541 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.34 161.37 9.26 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.127 0.489 . . . . 0.0 111.265 -179.086 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -61.99 -44.66 96.26 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.704 -178.988 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.604 ' O ' ' N ' ' A' ' 49' ' ' CYS . 95.1 mt-30 -113.94 -15.03 12.4 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.17 179.904 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 24.1 t60 31.35 -76.51 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 179.394 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.641 ' SG ' ' CD1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -130.26 135.87 48.57 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.28 0.562 . . . . 0.0 112.193 -178.194 . . . . . . . . 3 3 . 1 . 090 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -128.16 126.84 41.85 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.246 179.534 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.4 mt -113.19 136.3 49.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.753 -179.659 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -115.62 132.84 56.51 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.917 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 51.5 mm -102.51 119.67 51.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.171 -0.612 . . . . 0.0 111.445 -178.948 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.451 ' O ' ' N ' ' A' ' 56' ' ' GLN . 96.5 m-70 -121.44 134.07 55.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.14 179.398 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 54' ' ' HIS . 81.0 tt0 -40.3 -29.82 0.09 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -179.765 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.451 ' N ' ' O ' ' A' ' 54' ' ' HIS . 60.0 tt0 -67.58 -67.29 0.47 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.544 179.083 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.433 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 5.3 tp10 -154.72 -161.56 1.23 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.125 -179.185 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.433 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -124.96 132.17 53.32 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.143 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.5 mt -116.99 129.21 73.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.175 0.512 . . . . 0.0 112.339 -179.097 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 34.7 tp -96.92 128.53 43.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.184 179.121 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -111.82 136.04 51.63 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.497 -179.58 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -94.63 106.86 18.85 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.441 -179.671 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -99.87 -10.72 21.42 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.342 179.292 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.7 t -71.65 100.78 2.38 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.297 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.7 m -87.66 -19.27 27.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.083 0.468 . . . . 0.0 110.405 -179.858 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.85 -43.0 10.92 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.105 179.809 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -133.23 91.94 26.29 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.497 179.994 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -54.8 143.5 70.48 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.15 1.9 . . . . 0.0 112.702 -178.986 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.4 m -74.84 141.47 44.24 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.812 -1.086 . . . . 0.0 111.005 -179.781 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -104.32 142.05 35.24 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.396 179.527 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.493 ' CG2' ' OD1' ' A' ' 86' ' ' ASP . 4.9 p -128.55 134.13 65.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.207 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 46.65 34.7 2.6 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 -179.426 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.05 26.53 68.51 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.916 179.802 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.454 ' N ' ' O ' ' A' ' 71' ' ' VAL . 14.5 m -138.43 135.41 35.21 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 117.164 0.482 . . . . 0.0 111.499 179.928 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 43.3 t -64.72 136.36 26.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.422 179.965 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 pt -116.64 83.87 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.588 179.036 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -66.28 -22.26 66.3 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.88 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.401 ' H ' ' CD ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -118.45 163.43 25.46 Favored Pre-proline 0 C--N 1.333 -0.146 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.841 178.994 . . . . . . . . 3 3 . 1 . 090 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -67.93 152.0 77.46 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.65 2.234 . . . . 0.0 112.685 -179.685 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.6 m -144.3 146.22 20.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.597 -179.719 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 91.5 mtm180 -73.48 131.3 41.63 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.78 179.179 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.4 mt -84.06 133.72 34.64 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.016 0.436 . . . . 0.0 110.939 -179.696 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -130.68 157.03 43.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.763 179.879 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -58.13 117.51 4.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.903 0.382 . . . . 0.0 110.526 -179.72 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.77 -11.46 20.88 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -179.449 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.493 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 61.7 t0 -79.18 120.11 23.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.984 0.421 . . . . 0.0 110.185 179.586 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.8 t -108.21 130.79 60.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.92 -178.985 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.2 mt -94.73 132.18 39.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.108 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.9 m -116.61 127.16 54.21 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 121.53 0.681 . . . . 0.0 111.477 -179.831 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.47 ' O ' ' C ' ' A' ' 91' ' ' ILE . 96.6 mt -122.86 125.15 71.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.001 179.044 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.47 ' C ' ' O ' ' A' ' 90' ' ' ILE . 87.4 mt 33.09 -101.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.155 -179.455 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.498 ' O ' ' OD1' ' A' ' 92' ' ' ASP . 56.9 t0 -109.69 14.98 23.11 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 121.067 -0.253 . . . . 0.0 111.615 -179.123 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.604 HH22 ' CG2' ' A' ' 44' ' ' VAL . 8.9 mtm105 -127.87 143.02 51.12 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.806 -179.449 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.3 m -134.8 148.48 50.2 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.945 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -126.94 126.97 44.12 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.884 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -89.77 131.04 35.93 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.812 179.857 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.587 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 88.9 t80 -97.99 129.2 44.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.938 0.399 . . . . 0.0 110.127 179.569 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -133.14 123.91 26.54 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.222 -179.514 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -117.32 105.62 12.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.818 -179.682 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.426 ' HB2' HH12 ' A' ' 6' ' ' ARG . 49.0 tt0 . . . . . 0 C--N 1.326 -0.451 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.716 179.86 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 54.4 t . . . . . 0 C--O 1.233 0.195 0 CA-C-O 120.676 0.274 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 090 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' A' ' 31' ' ' ARG . 91.0 m-20 -61.79 -42.75 99.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.964 -179.472 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 090 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -111.83 26.2 10.86 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.724 -178.198 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -119.16 -173.41 15.53 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -179.798 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -73.5 158.44 47.79 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 123.183 2.588 . . . . 0.0 112.428 179.988 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 090 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.91 172.74 13.98 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 122.285 1.99 . . . . 0.0 110.958 178.757 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 4.1 p -118.14 136.48 55.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 120.976 0.417 . . . . 0.0 111.026 -179.277 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 11.9 t -70.92 128.1 34.84 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.377 -179.939 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . 0.41 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . 0.41 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 46.9 Cg_exo -57.19 -25.42 64.28 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 123.02 2.48 . . . . 0.0 112.881 -179.461 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 36.2 m -73.58 -44.76 56.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.229 0.538 . . . . 0.0 109.837 178.224 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -57.28 -46.31 83.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.448 -179.413 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 97.9 mt -63.61 -41.2 98.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.919 0.39 . . . . 0.0 110.06 -179.871 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -62.75 -45.05 94.51 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.099 179.736 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . 0.518 ' O ' ' OG ' ' B' ' 247' ' ' SER . 73.6 ttt180 -65.03 -41.85 94.9 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.045 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.628 HH11 ' NH1' ' A' ' 12' ' ' ARG . 9.0 tpp180 -58.91 -43.95 91.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.543 -179.122 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -64.93 -42.05 95.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.122 0.487 . . . . 0.0 109.874 178.796 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' B' B ' 247' ' ' SER . . . . . 0.521 ' HG ' ' N ' ' B' ' 248' ' ' GLN . 78.3 p -62.05 -46.32 89.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.037 179.774 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . 0.521 ' N ' ' HG ' ' B' ' 247' ' ' SER . 84.4 mt-30 -62.61 -39.02 92.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.278 -179.575 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 42.6 t -59.76 -45.41 94.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.303 -179.946 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -65.16 -32.81 74.68 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.435 0.636 . . . . 0.0 109.374 178.612 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -71.09 -19.51 62.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.753 -179.44 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 79.6 mt -66.9 122.65 18.18 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.903 -179.866 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . 0.595 ' ND2' ' OD1' ' B' ' 254' ' ' ASP . 2.1 p-10 -66.92 -42.98 84.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.064 -179.999 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . 0.595 ' OD1' ' ND2' ' B' ' 253' ' ' ASN . 99.3 m-20 -65.9 -11.12 44.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.084 -179.52 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . 0.448 ' CB ' ' O ' ' B' ' 254' ' ' ASP . 1.6 t0 80.07 26.89 0.32 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.402 -179.791 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.409 ' CB ' ' O ' ' B' ' 255' ' ' ASP . 4.5 t0 75.51 39.63 0.34 Allowed 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.253 179.339 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . 0.433 ' HA ' ' HZ2' ' A' ' 11' ' ' LYS . 88.5 tttt -64.64 -41.3 96.25 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.764 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.49 ' O ' ' O ' ' B' ' 259' ' ' ASP . 32.7 p-10 -115.75 96.6 5.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.491 178.586 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.49 ' O ' ' O ' ' B' ' 258' ' ' ASP . 63.4 t0 -53.46 -111.14 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.794 -178.92 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.587 ' OE2' ' NH1' ' B' ' 245' ' ' ARG . 95.7 mt-10 -152.17 27.43 0.6 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.555 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 55.0 mt -111.12 139.91 32.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.554 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 58.9 t -128.25 135.71 61.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.129 179.765 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -97.41 120.8 38.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.252 0.549 . . . . 0.0 111.9 -178.178 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -63.88 -46.63 84.08 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.231 179.267 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -94.01 161.78 28.77 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.903 -179.674 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.93 146.36 58.88 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 122.854 2.369 . . . . 0.0 112.768 -179.64 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 45.3 pt . . . . . 0 C--N 1.328 -0.342 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.679 . . . . . . . . 0 0 . 1 . 091 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo . . . . . 0 N--CA 1.494 1.524 0 CA-C-O 120.884 0.285 . . . . 0.0 111.626 . . . . . . . . . 0 0 . 1 . 091 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 68.2 p -99.37 -46.71 5.41 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.469 -179.587 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.8 mtt85 -93.08 129.19 39.13 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.37 -0.532 . . . . 0.0 109.589 -179.743 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -133.99 145.44 49.5 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 120.641 -0.423 . . . . 0.0 111.363 -179.476 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 66.0 mt -115.34 136.31 53.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.316 179.635 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.489 ' CG1' ' NH2' ' A' ' 96' ' ' ARG . 27.4 t -109.71 127.06 66.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.715 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.0 m -77.26 142.04 39.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.356 -178.493 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.5 mt -110.43 134.15 53.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.871 177.261 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -88.51 158.77 18.22 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.06 0.457 . . . . 0.0 110.815 179.99 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.422 ' NH2' ' HB3' ' B' ' 248' ' ' GLN . 82.1 mtp180 -57.25 -32.82 66.95 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.901 -178.824 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 65.2 m -77.31 -6.78 54.5 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.201 178.767 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.07 31.63 10.7 Favored Glycine 0 CA--C 1.519 0.302 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 -179.595 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.1 t -113.5 133.04 60.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.987 0.423 . . . . 0.0 111.451 -178.924 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.631 ' CG ' HH22 ' A' ' 96' ' ' ARG . 97.5 m-20 -74.03 137.03 43.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.874 179.651 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.47 -122.91 2.49 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 120.459 -0.877 . . . . 0.0 113.029 -178.633 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -71.78 149.93 55.12 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.463 2.109 . . . . 0.0 113.235 -177.965 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -111.29 127.39 55.61 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.688 179.962 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.411 ' CD2' HD11 ' A' ' 37' ' ' ILE . 55.9 t80 -99.29 105.55 33.49 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.854 179.903 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -75.82 135.29 17.45 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 121.112 1.208 . . . . 0.0 111.255 -179.516 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.5 mt -85.94 58.94 5.33 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.484 -178.528 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 90.8 p -64.17 -34.5 78.21 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.003 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 66.2 mt -75.77 144.94 41.13 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.53 179.423 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.8 m -68.63 -17.09 64.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.873 -178.624 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.483 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 58.1 m -133.22 134.22 43.73 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.666 -0.413 . . . . 0.0 112.024 -179.198 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.5 t -126.23 116.2 20.91 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.64 179.14 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 63.2 tp -113.2 128.9 56.62 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 121.006 -0.277 . . . . 0.0 111.087 -179.486 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.429 ' CE2' HG13 ' A' ' 37' ' ' ILE . 19.3 m-85 -107.1 129.04 54.88 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.783 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 172.46 -175.44 45.6 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.455 179.96 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.623 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 83.8 mtm-85 -80.28 -26.55 38.88 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.98 0.419 . . . . 0.0 110.33 179.363 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -55.44 144.45 33.29 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.132 -178.041 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.464 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 11.1 tp -64.91 -41.77 93.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.17 0.509 . . . . 0.0 109.634 179.334 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.464 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 17.3 pt-20 -57.19 -16.74 8.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.331 -179.874 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 45.8 m -66.21 134.01 51.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.204 0.526 . . . . 0.0 111.096 -178.84 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.483 ' OD2' ' O ' ' A' ' 26' ' ' THR . 60.9 m-20 -63.17 -36.34 83.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.316 -179.461 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.463 HG23 HD13 ' A' ' 37' ' ' ILE . 49.1 mm -121.14 117.4 52.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.483 177.693 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.43 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 81.4 mtp180 -107.2 134.7 49.91 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 120.374 -0.531 . . . . 0.0 111.018 -179.259 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 85.3 mt -120.92 131.34 73.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 120.126 -0.63 . . . . 0.0 109.711 178.916 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -77.84 24.93 0.21 Allowed 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -177.492 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 32.8 mt -94.23 132.61 28.84 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.973 179.433 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.57 -12.26 29.04 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.121 1.881 . . . . 0.0 113.584 -179.239 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.0 m -97.41 9.53 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 120.034 -0.666 . . . . 0.0 110.787 179.309 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.623 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 33.8 t -94.84 131.79 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 177.918 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.9 m -76.1 173.49 11.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.579 0.704 . . . . 0.0 111.865 -178.755 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.564 ' NZ ' ' O ' ' B' ' 232' ' ' GLY . 62.7 mttp -64.75 -38.62 91.6 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.477 -179.862 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.649 ' O ' ' N ' ' A' ' 49' ' ' CYS . 93.8 mm-40 -113.34 -23.52 9.84 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.993 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.7 t60 34.26 -77.42 0.0 OUTLIER 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.63 179.978 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.649 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.72 135.74 47.08 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.981 0.42 . . . . 0.0 111.62 -179.385 . . . . . . . . 3 3 . 1 . 091 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -128.82 127.32 41.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.506 179.911 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 85.7 mt -111.6 132.85 59.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.599 -179.451 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -115.59 125.66 53.22 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.434 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.412 HG23 HD11 ' A' ' 53' ' ' ILE . 97.7 mt -107.3 115.13 47.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.029 -179.497 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.466 ' C ' ' N ' ' A' ' 56' ' ' GLN . 94.1 m-70 -112.45 144.75 41.37 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.771 -179.711 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 54' ' ' HIS . 94.9 mt-10 -41.62 -27.52 0.1 Allowed 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.152 -179.908 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.466 ' N ' ' C ' ' A' ' 54' ' ' HIS . 88.1 mt-30 -65.0 -68.89 0.33 Allowed 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.157 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -159.34 -164.9 1.46 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.954 179.489 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -108.97 130.75 55.47 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.608 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.4 mt -121.15 130.53 74.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -177.961 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.405 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 22.7 tp -101.15 126.93 47.9 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.66 179.514 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -109.77 135.71 50.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.697 178.726 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.599 HD22 ' CA ' ' A' ' 68' ' ' PRO . 56.2 t-20 -98.14 103.71 15.68 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.76 -179.159 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -98.86 -7.24 27.59 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -179.693 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 26.2 t -76.6 99.58 5.05 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.998 179.954 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.7 p -74.95 -38.46 61.72 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.993 0.425 . . . . 0.0 109.902 178.999 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.0 p -67.18 -39.35 86.39 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.538 179.859 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.454 ' O ' ' OG ' ' A' ' 64' ' ' SER . 46.3 m-20 -147.47 97.51 4.04 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.44 -179.277 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.599 ' CA ' HD22 ' A' ' 62' ' ' ASN . 37.3 Cg_exo -56.55 148.11 65.66 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 121.988 1.792 . . . . 0.0 112.574 179.544 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.556 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 8.3 m -74.36 137.43 42.78 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.36 179.718 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -99.03 140.12 33.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.427 179.827 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 25.2 t -130.49 134.69 61.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.65 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 53.12 35.94 21.06 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 120.127 -0.629 . . . . 0.0 109.399 -179.716 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 66.56 30.15 75.96 Favored Glycine 0 CA--C 1.523 0.557 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.204 179.484 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 83.4 p -138.44 125.86 21.84 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.625 -179.141 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.3 p -63.01 140.78 19.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.104 0.478 . . . . 0.0 111.57 -179.657 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.549 ' CG2' ' O ' ' A' ' 78' ' ' GLU . 97.1 mt -116.17 124.27 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.085 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.044 -179.883 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.454 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 30.6 p-10 -96.76 -24.58 15.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.974 179.198 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.549 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 2.5 mt-10 -129.54 169.91 12.12 Favored Pre-proline 0 N--CA 1.468 0.451 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.092 -179.055 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -56.8 143.25 91.3 Favored 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 121.994 1.796 . . . . 0.0 112.581 -179.95 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 78.0 t -136.4 138.22 47.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.756 179.975 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 85.4 mtt85 -74.17 134.68 42.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.629 179.199 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.1 mt -86.02 136.61 33.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.388 0.613 . . . . 0.0 111.393 -179.754 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -126.95 151.46 48.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.967 179.764 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.718 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 7.8 t60 -56.58 120.14 7.27 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.963 0.411 . . . . 0.0 111.296 -179.447 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.7 -17.73 30.17 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 179.465 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -71.06 134.54 47.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.943 0.401 . . . . 0.0 110.47 -179.85 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.8 p -106.59 135.93 43.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.825 -178.859 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.9 mt -105.95 131.44 55.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 179.0 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 99.9 m -122.51 127.75 49.93 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -178.314 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.519 ' N ' ' O ' ' A' ' 93' ' ' ARG . 96.9 mt -112.67 132.27 61.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 177.428 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.579 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 2.5 mp -37.74 101.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.777 -178.766 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.579 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 37.5 t0 101.49 -30.94 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.732 0 O-C-N 124.225 0.953 . . . . 0.0 112.496 179.01 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 90' ' ' ILE . 36.0 mmt180 -128.99 143.18 50.79 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.951 -178.647 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.1 p -138.26 151.25 47.45 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.474 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -130.76 125.05 32.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.736 -179.351 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.631 HH22 ' CG ' ' A' ' 16' ' ' ASP . 92.8 mtm-85 -84.35 138.39 32.91 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.113 178.869 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -96.2 116.59 29.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.488 -179.392 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -120.64 122.59 40.83 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.777 0.322 . . . . 0.0 110.362 179.743 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.718 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 21.5 t-20 -101.1 111.8 24.1 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.372 179.897 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 . . . . . 0 N--CA 1.466 0.369 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.102 -179.372 . . . . . . . . 0 0 . 1 . 091 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 17.3 t . . . . . 0 CA--C 1.53 0.204 0 CA-C-O 120.756 0.312 . . . . 0.0 111.349 . . . . . . . . . 0 0 . 1 . 091 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.543 ' O ' ' CB ' ' B' ' 230' ' ' SEP . 79.7 m-20 -90.58 -5.36 56.0 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.593 178.986 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . 0.543 ' CB ' ' O ' ' B' ' 229' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.446 ' NE2' ' P ' ' B' ' 230' ' ' SEP . 13.7 mt-30 -125.4 42.81 3.2 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.302 179.857 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . 0.564 ' O ' ' NZ ' ' A' ' 46' ' ' LYS . . . -118.35 -175.7 16.65 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -179.435 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.6 164.06 35.86 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 123.814 3.009 . . . . 0.0 113.33 -179.822 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 091 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -77.3 152.3 30.52 Favored 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 122.408 2.072 . . . . 0.0 112.803 179.531 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 8.9 p -80.44 124.64 38.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.277 179.969 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -61.64 122.1 14.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.608 -179.354 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 091 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.04 -19.66 33.81 Favored 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 121.855 1.703 . . . . 0.0 111.395 178.986 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 73.8 m -71.35 -45.53 62.71 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.194 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -57.89 -46.72 84.49 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.336 179.588 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 90.0 mt -64.58 -40.07 94.88 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.667 179.026 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -61.41 -40.81 95.77 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 120.778 0.323 . . . . 0.0 110.686 -179.979 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -60.04 -42.07 93.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.569 179.466 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . . . . . . . . . 67.9 ttp85 -59.92 -42.97 95.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.538 179.878 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -62.83 -41.66 99.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.211 -179.225 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 59.5 p -69.53 -41.55 75.83 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.879 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . 0.447 ' O ' ' N ' ' B' ' 252' ' ' LEU . 67.2 tp60 -60.95 -38.22 85.12 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.424 -179.937 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . 0.457 ' O ' ' O ' ' B' ' 252' ' ' LEU . 39.3 t -60.73 -47.19 94.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.547 179.543 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -62.17 -26.75 68.52 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.129 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -89.45 -15.31 33.44 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.307 -179.932 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' B' ' 249' ' ' VAL . 57.3 tp -122.83 115.84 22.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.374 179.178 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 174.38 30.35 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.707 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . 0.59 ' O ' ' CB ' ' B' ' 255' ' ' ASP . 75.9 m-20 -87.81 -4.61 58.86 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.093 -179.971 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . 0.59 ' CB ' ' O ' ' B' ' 254' ' ' ASP . 52.5 t0 111.11 64.73 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 O-C-N 124.459 1.1 . . . . 0.0 110.575 -179.703 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.532 ' O ' ' C ' ' B' ' 257' ' ' LYS . 50.9 p-10 -94.2 14.85 18.88 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.289 -179.559 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . 0.532 ' C ' ' O ' ' B' ' 256' ' ' ASP . 98.6 mttt 25.13 -120.16 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 O-C-N 123.553 0.533 . . . . 0.0 110.366 -179.991 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.476 ' C ' ' O ' ' B' ' 257' ' ' LYS . 86.4 m-20 -33.48 148.11 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.813 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.599 ' C ' ' H ' ' B' ' 261' ' ' ILE . 49.4 p30 -125.43 -169.41 1.99 Allowed 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.242 0.544 . . . . 0.0 110.953 -179.267 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.449 ' HB2' HH21 ' A' ' 93' ' ' ARG . 77.2 mt-10 -62.12 17.91 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.991 -178.734 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . 0.599 ' H ' ' C ' ' B' ' 259' ' ' ASP . 83.2 mt -107.59 132.07 56.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.949 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 54.9 t -124.78 132.37 71.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.082 -179.947 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -94.3 118.35 31.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.052 -178.636 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -67.13 -44.8 78.93 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.606 179.276 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . 0.508 ' OE1' ' O ' ' B' ' 266' ' ' PRO . 0.0 OUTLIER -87.42 162.12 43.64 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.999 -179.621 . . . . . . . . 3 3 . 1 . 091 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . 0.508 ' O ' ' OE1' ' B' ' 265' ' ' GLN . 36.6 Cg_endo -62.15 144.07 95.32 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 121.974 1.783 . . . . 0.0 111.91 -179.85 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 11.8 tt . . . . . 0 C--N 1.322 -0.589 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.623 -178.925 . . . . . . . . 0 0 . 1 . 092 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo . . . . . 0 N--CA 1.499 1.817 0 N-CA-C 111.825 -0.106 . . . . 0.0 111.825 . . . . . . . . . 0 0 . 1 . 092 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.6 m -96.65 -37.79 10.2 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.426 -179.881 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.612 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 95.3 mtt-85 -90.97 122.98 34.1 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.457 -179.665 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -133.08 140.21 47.55 Favored 'General case' 0 CA--C 1.522 -0.105 0 CA-C-O 121.246 0.546 . . . . 0.0 112.134 -179.65 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 37.3 tp -114.57 135.81 53.72 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.347 -179.883 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.8 t -111.66 130.1 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 120.683 0.278 . . . . 0.0 110.487 -179.735 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 m -88.93 118.47 28.67 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -177.837 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.437 ' CD1' ' HG ' ' A' ' 94' ' ' SER . 97.0 mt -83.32 139.07 18.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.37 178.935 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -88.97 160.46 17.12 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.981 179.275 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.504 ' NE ' ' NH2' ' B' ' 245' ' ' ARG . 84.4 mtp180 -56.3 -30.97 63.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.269 -179.27 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.415 ' HB3' HD22 ' B' ' 253' ' ' ASN . 84.3 p -79.22 -7.27 58.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.424 -179.803 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.61 28.08 22.81 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 -179.817 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.7 t -112.01 133.03 59.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.829 0.347 . . . . 0.0 110.629 -179.625 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -77.02 141.24 40.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.732 179.317 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -133.3 -114.91 1.56 Allowed Glycine 0 CA--C 1.536 1.396 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.64 -179.319 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -74.45 149.56 39.68 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.406 2.071 . . . . 0.0 113.324 -179.171 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -112.52 148.88 33.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.986 179.941 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -114.58 105.4 53.62 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.714 179.983 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.17 122.41 8.37 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 C-N-CA 121.123 1.215 . . . . 0.0 110.895 -179.678 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 74.2 mt -78.51 46.11 0.62 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.256 -0.578 . . . . 0.0 110.442 -179.2 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.9 p -59.53 -30.25 68.46 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.333 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 73.3 mt -72.86 142.91 47.96 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.996 179.532 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.5 m -62.94 -22.97 67.15 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.255 -179.382 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 86.3 m -135.43 137.89 42.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.504 -179.606 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.687 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 3.5 t -132.57 123.83 27.23 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.825 0.345 . . . . 0.0 110.266 178.227 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.409 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 41.0 tp -112.72 130.3 56.11 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.957 -179.228 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.687 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 6.9 m-85 -108.88 140.03 42.91 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.768 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 167.63 -169.05 40.98 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 118.84 -1.647 . . . . 0.0 113.436 179.203 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.451 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 36.9 ttp-105 -90.77 -28.47 18.23 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 114.53 -0.835 . . . . 0.0 110.537 -179.966 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.08 152.35 49.03 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.517 -179.344 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.635 ' O ' ' NE ' ' A' ' 38' ' ' ARG . 7.0 tp -66.42 -42.28 90.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.449 0.642 . . . . 0.0 110.273 179.506 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.486 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 79.9 tt0 -54.62 -13.87 1.13 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.874 -178.925 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 83.4 m -67.58 133.32 49.21 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.497 179.801 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.431 ' O ' ' CB ' ' B' ' 264' ' ' LYS . 51.3 m-20 -58.69 -32.34 69.05 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.473 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.466 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 92.4 mt -125.33 120.61 58.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 177.228 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.635 ' NE ' ' O ' ' A' ' 33' ' ' ILE . 71.0 mtt85 -107.01 135.84 47.88 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.064 -177.34 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.438 ' C ' ' H ' ' A' ' 41' ' ' LEU . 89.4 mt -118.12 133.55 64.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.069 0.461 . . . . 0.0 110.593 179.019 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -75.16 23.42 0.1 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.966 -178.864 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.508 HD13 ' HE ' ' A' ' 93' ' ' ARG . 21.0 mt -92.23 123.77 61.58 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.248 178.831 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -71.99 -8.27 22.61 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 121.821 1.681 . . . . 0.0 112.713 -179.503 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.8 m -101.14 7.83 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.58 -179.736 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.451 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 21.0 t -91.12 137.19 22.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 120.394 -0.522 . . . . 0.0 109.838 179.674 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.606 ' HG ' ' N ' ' A' ' 46' ' ' LYS . 0.4 OUTLIER -65.66 164.78 13.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.167 0.508 . . . . 0.0 111.192 -179.451 . . . . . . . . 3 3 . 1 . 092 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.606 ' N ' ' HG ' ' A' ' 45' ' ' SER . 97.2 mttt -62.54 -44.53 96.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.221 -178.822 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.644 ' O ' ' N ' ' A' ' 49' ' ' CYS . 83.4 mt-30 -113.8 -20.59 11.06 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 123.526 0.516 . . . . 0.0 110.376 179.092 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.513 ' O ' ' OG ' ' A' ' 64' ' ' SER . 24.5 t60 35.52 -73.27 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 179.846 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.644 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -129.91 134.18 47.32 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -178.381 . . . . . . . . 3 3 . 1 . 092 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -125.74 129.95 50.51 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.41 178.67 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.2 mt -113.9 134.66 56.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.015 -179.421 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -119.08 124.93 48.1 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.917 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 94.2 mt -104.27 114.13 43.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.483 0.659 . . . . 0.0 111.447 -179.326 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.44 ' O ' ' C ' ' A' ' 55' ' ' GLU . 94.8 m-70 -114.26 142.23 46.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.638 -1.165 . . . . 0.0 109.93 -179.681 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 54' ' ' HIS . 97.5 mt-10 -40.11 -31.14 0.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -179.703 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.433 ' N ' ' O ' ' A' ' 54' ' ' HIS . 89.1 mt-30 -62.35 -67.98 0.37 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.491 178.604 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.435 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 4.8 tp10 -159.21 -162.98 1.13 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.902 179.742 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.435 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -114.19 127.24 55.8 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.009 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.6 mt -116.44 130.9 70.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.21 0.529 . . . . 0.0 112.369 -177.952 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 25.6 tp -98.62 130.29 45.15 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.464 179.442 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -116.58 137.52 52.12 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.548 -179.437 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.667 ' ND2' ' H ' ' A' ' 69' ' ' THR . 16.1 t-20 -98.88 106.7 19.0 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.935 179.496 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -98.14 -7.24 29.88 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.001 178.453 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.513 ' OG ' ' O ' ' A' ' 48' ' ' HIS . 0.7 OUTLIER -70.29 100.93 1.8 Allowed 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.698 179.456 . . . . . . . . 3 3 . 1 . 092 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.3 m -86.05 -8.7 57.73 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.031 0.443 . . . . 0.0 110.268 179.917 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.67 -39.52 8.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.226 179.817 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 67.3 m-20 -142.63 93.79 6.82 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.111 179.569 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.403 ' HA ' HD22 ' A' ' 62' ' ' ASN . 42.4 Cg_exo -55.07 148.59 47.7 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 122.384 2.056 . . . . 0.0 112.13 -179.782 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.667 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 33.5 m -73.4 149.64 42.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.301 -179.761 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -114.11 140.56 48.4 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.405 -179.911 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.445 ' O ' ' N ' ' A' ' 74' ' ' SER . 4.2 p -128.78 134.8 63.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.671 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 48.8 30.49 2.68 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.086 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.09 27.9 67.55 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.569 -179.984 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.445 ' N ' ' O ' ' A' ' 71' ' ' VAL . 71.5 m -134.81 134.91 41.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.674 0.273 . . . . 0.0 110.434 179.935 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.5 p -68.51 145.19 13.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -178.748 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.1 pt -122.36 86.08 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.839 179.801 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 46.4 p-10 -67.21 -21.89 65.74 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.846 0.355 . . . . 0.0 110.406 179.68 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -122.5 170.28 8.24 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.446 179.918 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -62.96 144.53 93.29 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 122.298 1.999 . . . . 0.0 112.21 -179.888 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.9 p -139.28 139.68 39.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.858 -179.831 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -74.71 132.88 42.01 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.791 -0.363 . . . . 0.0 110.449 179.452 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 97.7 mt -83.0 138.48 33.74 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.643 179.925 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -128.47 149.42 50.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.36 179.697 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.753 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 6.2 t60 -54.15 119.71 5.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.057 0.456 . . . . 0.0 111.105 -179.426 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.97 -15.73 36.73 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 179.208 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -70.15 137.56 51.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.836 0.35 . . . . 0.0 110.616 179.821 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.0 t -111.08 132.73 58.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.14 -178.728 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.457 HG21 HD13 ' A' ' 88' ' ' ILE . 97.3 mt -100.52 132.22 46.58 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.829 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.2 m -120.7 121.71 38.86 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 119.862 -0.735 . . . . 0.0 112.027 -179.136 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.535 ' N ' ' O ' ' A' ' 93' ' ' ARG . 97.4 mt -108.12 119.63 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 177.74 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.429 ' C ' ' O ' ' A' ' 90' ' ' ILE . 91.7 mt 35.16 -96.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.486 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.633 ' OD2' ' NE ' ' B' ' 245' ' ' ARG . 31.5 p-10 -110.1 10.82 23.95 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -178.323 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.535 ' O ' ' N ' ' A' ' 90' ' ' ILE . 80.1 mtt-85 -130.04 145.56 51.67 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.624 -179.785 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.437 ' HG ' ' CD1' ' A' ' 10' ' ' ILE . 54.3 p -139.72 151.94 46.26 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.389 0.614 . . . . 0.0 110.133 179.392 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.4 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 54.8 m-85 -125.38 126.2 44.63 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.953 -179.924 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -85.57 131.94 34.27 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.971 -179.351 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.681 ' HH ' HD22 ' A' ' 99' ' ' ASN . 88.4 t80 -100.53 125.54 46.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.916 -179.659 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -145.1 132.79 20.99 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.066 0.46 . . . . 0.0 111.912 -179.961 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.753 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 98.7 m-20 -96.84 140.67 31.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.714 179.57 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 . . . . . 0 C--N 1.324 -0.505 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.65 -178.718 . . . . . . . . 0 0 . 1 . 092 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 19.0 t . . . . . 0 C--O 1.234 0.238 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 . . . . . . . . . 0 0 . 1 . 092 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.523 ' O ' ' CB ' ' B' ' 230' ' ' SEP . 99.3 m-20 -76.98 -18.71 58.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.069 179.314 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . 0.523 ' CB ' ' O ' ' B' ' 229' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 169.68 36.64 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.784 179.886 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -126.23 -167.69 12.49 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.554 -179.525 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -61.85 156.84 46.32 Favored 'Trans proline' 0 C--N 1.299 -2.061 0 C-N-CA 123.929 3.086 . . . . 0.0 112.634 179.407 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 092 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.38 154.89 32.82 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.719 2.28 . . . . 0.0 112.357 179.653 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 12.0 m -101.78 130.21 51.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.836 179.615 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.7 t -61.92 115.47 4.07 Favored 'General case' 0 CA--C 1.52 -0.19 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.198 -179.705 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 092 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -55.73 -25.48 51.51 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 122.196 1.931 . . . . 0.0 112.243 179.081 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 19.8 m -70.33 -43.14 70.87 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.096 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -57.94 -49.06 78.08 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.801 179.825 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 97.1 mt -63.66 -41.76 98.17 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.569 -179.193 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -65.12 -40.91 95.15 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -178.829 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -61.59 -43.77 98.24 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.183 -179.59 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.633 ' NE ' ' OD2' ' A' ' 92' ' ' ASP . 76.3 mtp85 -65.14 -40.49 94.49 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.765 -179.6 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -61.6 -39.55 91.65 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.008 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 14.4 t -65.14 -43.86 90.53 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.416 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . 0.444 ' O ' ' N ' ' B' ' 252' ' ' LEU . 55.9 tt0 -61.07 -37.83 84.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.254 179.689 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . 0.529 ' O ' ' O ' ' B' ' 252' ' ' LEU . 70.5 t -63.22 -44.14 99.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 120.526 -0.47 . . . . 0.0 109.833 178.768 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -58.28 -29.14 65.59 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.379 0.609 . . . . 0.0 109.374 179.143 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -96.96 -9.45 28.28 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.782 179.504 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.529 ' O ' ' O ' ' B' ' 249' ' ' VAL . 31.5 tp -124.47 121.53 35.12 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.801 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . 0.438 ' CB ' ' O ' ' B' ' 252' ' ' LEU . 0.3 OUTLIER 167.49 24.91 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.421 -179.827 . . . . . . . . 3 3 . 1 . 092 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . 0.459 ' O ' ' CB ' ' B' ' 255' ' ' ASP . 92.7 m-20 -61.47 -41.28 97.0 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.594 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . 0.459 ' CB ' ' O ' ' B' ' 254' ' ' ASP . 4.6 t0 154.31 73.28 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.187 -1.369 . . . . 0.0 108.238 179.756 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' B' ' 258' ' ' ASP . 63.8 t0 -97.08 92.47 6.07 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.688 -179.074 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -67.19 -8.06 28.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.35 -179.855 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.401 ' O ' ' OD1' ' B' ' 256' ' ' ASP . 97.6 m-20 -110.98 135.71 51.08 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.322 179.018 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.595 ' C ' ' H ' ' B' ' 261' ' ' ILE . 47.5 p30 -124.9 165.87 17.3 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.469 0.652 . . . . 0.0 110.208 179.83 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.427 ' HB2' ' NH2' ' A' ' 93' ' ' ARG . 98.3 mt-10 -61.61 17.48 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.034 -0.985 . . . . 0.0 112.467 -178.755 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . 0.595 ' H ' ' C ' ' B' ' 259' ' ' ASP . 69.2 mt -108.91 134.69 50.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.848 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 59.1 t -128.88 134.79 63.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.918 0.39 . . . . 0.0 110.621 -179.684 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -97.21 122.08 39.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.661 -178.898 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . 0.459 ' HG3' HH22 ' A' ' 38' ' ' ARG . 86.9 tttt -66.81 -44.51 81.01 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.293 179.424 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 9.7 mp0 -100.87 160.31 27.1 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.482 -177.935 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -62.3 151.38 82.81 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 123.423 2.748 . . . . 0.0 112.803 -179.336 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 40.8 pt . . . . . 0 C--N 1.33 -0.261 0 CA-C-O 121.844 0.83 . . . . 0.0 112.431 -178.722 . . . . . . . . 0 0 . 1 . 093 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo . . . . . 0 N--CA 1.496 1.639 0 N-CA-C 113.58 0.569 . . . . 0.0 113.58 . . . . . . . . . 0 0 . 1 . 093 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.7 m -65.24 -45.02 86.32 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.127 -179.715 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.603 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 96.3 mtt-85 -88.12 118.01 27.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.916 0.388 . . . . 0.0 110.743 -178.844 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.645 HH21 ' ND1' ' A' ' 19' ' ' HIS . 75.6 ttt180 -125.99 126.42 44.28 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.288 -179.499 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 22.5 tp -109.13 130.98 55.49 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.467 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 76.5 t -106.82 127.46 62.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.355 179.97 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.5 m -80.23 144.75 32.66 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.375 0.607 . . . . 0.0 111.674 -179.047 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.409 HD13 HG22 ' A' ' 10' ' ' ILE . 98.1 mt -116.1 138.41 46.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.235 178.451 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -91.26 156.36 17.87 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.361 179.013 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.437 ' NH2' ' OE2' ' B' ' 260' ' ' GLU . 89.9 mtm180 -60.02 -28.75 67.99 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.615 -179.852 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 84.0 p -74.3 -14.47 60.9 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.524 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.34 35.42 5.73 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 -179.699 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 49.6 t -120.55 130.95 73.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.747 0.308 . . . . 0.0 111.049 -179.797 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -77.08 138.28 39.44 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.632 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.17 -118.24 2.06 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.936 -179.301 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -69.85 148.07 63.71 Favored 'Trans proline' 0 N--CA 1.501 1.938 0 C-N-CA 122.317 2.011 . . . . 0.0 113.685 -178.468 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.645 ' ND1' HH21 ' A' ' 6' ' ' ARG . 0.9 OUTLIER -111.95 130.27 55.9 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.376 -179.863 . . . . . . . . 3 3 . 1 . 093 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -107.02 105.43 55.53 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.15 -179.108 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.05 135.17 22.59 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 120.717 0.944 . . . . 0.0 111.306 -179.9 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 74.9 mt -87.13 48.14 1.61 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.754 -178.899 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.9 m -60.46 -29.91 69.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.91 178.829 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 73.1 mt -71.12 143.42 50.6 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.372 -179.939 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.3 m -58.94 -25.99 64.0 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.918 -179.143 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 78.0 m -138.77 141.17 38.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.182 0.515 . . . . 0.0 111.431 -179.862 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.8 t -130.42 121.85 26.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.694 178.683 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 41.2 tp -117.12 126.61 53.09 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.63 -179.652 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.442 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 4.3 m-85 -101.92 125.78 48.68 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.441 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 172.12 178.39 42.33 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 119.75 -1.214 . . . . 0.0 113.016 179.624 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.422 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 45.8 mtm180 -73.33 -32.77 64.75 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.771 0.32 . . . . 0.0 111.308 179.01 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -48.9 147.02 5.75 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 -178.967 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.439 ' HA ' HH11 ' A' ' 38' ' ' ARG . 11.0 tp -67.02 -40.66 86.01 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 CA-C-O 121.249 0.547 . . . . 0.0 109.929 179.714 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -57.68 -19.83 29.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.387 -179.951 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 76.8 m -59.72 129.95 44.42 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.821 -179.399 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.41 ' O ' ' CB ' ' B' ' 264' ' ' LYS . 66.0 m-20 -61.82 -35.03 77.02 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 -179.589 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.417 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 93.6 mt -123.5 118.32 54.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 177.395 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.439 HH11 ' HA ' ' A' ' 33' ' ' ILE . 21.8 mtp85 -104.57 136.22 44.53 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.447 -178.375 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.467 ' C ' ' H ' ' A' ' 41' ' ' LEU . 94.0 mt -117.54 129.85 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 121.036 0.446 . . . . 0.0 110.595 -179.955 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.633 ' NE2' ' OD2' ' B' ' 258' ' ' ASP . 73.4 mt-30 -73.36 28.54 0.07 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.808 -178.42 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.568 ' CD1' ' HE ' ' A' ' 93' ' ' ARG . 49.0 mt -103.14 127.89 28.82 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 120.296 -0.561 . . . . 0.0 110.803 -179.985 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.9 -7.47 20.77 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.129 1.886 . . . . 0.0 112.673 -179.369 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.8 m -98.7 4.73 9.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 120.776 -0.369 . . . . 0.0 111.06 179.941 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.422 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 16.1 t -88.4 134.8 27.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.158 178.434 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.2 m -70.54 168.58 15.99 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.447 0.641 . . . . 0.0 111.93 -179.264 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -62.9 -43.67 98.17 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.285 -178.98 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.623 ' O ' ' N ' ' A' ' 49' ' ' CYS . 97.2 mt-30 -114.24 -25.03 8.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.575 179.472 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.6 t60 37.0 -77.21 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.076 -0.966 . . . . 0.0 113.023 179.064 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.623 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -127.39 132.86 50.07 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.228 0.537 . . . . 0.0 111.775 -178.279 . . . . . . . . 3 3 . 1 . 093 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -128.86 132.47 47.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.07 -179.578 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.1 mt -117.12 132.31 67.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.488 179.488 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -114.73 127.85 55.98 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.79 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.5 mm -100.27 111.81 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-O 121.105 0.479 . . . . 0.0 110.736 -179.22 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.448 ' O ' ' C ' ' A' ' 55' ' ' GLU . 88.6 m-70 -110.64 132.91 53.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.17 179.434 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 54' ' ' HIS . 76.9 tt0 -40.82 -32.17 0.21 Allowed 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.394 -179.945 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.409 ' N ' ' O ' ' A' ' 54' ' ' HIS . 98.4 mm-40 -69.16 -68.48 0.4 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.599 179.171 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -146.13 -178.59 6.21 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.706 0.765 . . . . 0.0 111.939 -178.354 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -116.16 122.0 43.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.788 178.206 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 94.0 mt -118.85 133.92 64.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.161 0.505 . . . . 0.0 111.825 -178.638 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 22.9 tp -98.25 131.53 44.51 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.718 -179.896 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -114.22 139.49 49.34 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 121.053 0.454 . . . . 0.0 111.448 -178.955 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 59.1 t-20 -98.31 106.12 18.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.822 -179.485 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -98.63 -12.23 21.3 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.728 179.379 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.0 t -70.69 103.43 2.55 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.533 179.892 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.4 p -88.97 -18.73 26.83 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.432 179.695 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.68 -44.27 11.96 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.285 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -137.13 97.9 10.6 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.803 179.425 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -57.09 145.31 86.82 Favored 'Trans proline' 0 N--CA 1.499 1.82 0 C-N-CA 122.173 1.916 . . . . 0.0 113.014 -179.426 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.3 m -73.78 141.69 46.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.64 179.365 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -102.16 147.77 26.22 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.146 -179.637 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.546 ' CG2' ' OD1' ' A' ' 86' ' ' ASP . 4.3 p -128.04 136.04 61.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.88 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 47.75 31.59 2.26 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.226 -0.59 . . . . 0.0 109.653 -179.352 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.66 28.37 61.34 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.669 179.887 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 71' ' ' VAL . 58.3 m -140.35 141.57 35.64 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.192 -179.729 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 71.0 t -68.18 132.37 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.125 0 CA-C-O 121.358 0.599 . . . . 0.0 112.0 -179.131 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.58 100.3 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.72 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -87.07 -13.91 42.94 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.98 -178.717 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -117.02 164.96 16.7 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.967 -179.177 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -60.22 143.58 99.51 Favored 'Trans proline' 0 N--CA 1.501 1.956 0 C-N-CA 121.827 1.684 . . . . 0.0 111.613 -179.775 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.3 p -139.62 139.46 38.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.066 0.46 . . . . 0.0 110.782 -178.856 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -72.08 125.65 27.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.006 179.931 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.3 mt -77.95 137.25 38.22 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.269 0.557 . . . . 0.0 110.889 -179.894 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -134.96 152.8 52.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.993 -179.696 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.724 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 5.1 t60 -57.28 113.3 1.69 Allowed 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.347 -179.745 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.85 1.67 22.59 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 -179.843 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.546 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 67.7 t0 -86.16 122.96 30.9 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.596 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 28.0 t -105.7 134.27 47.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.791 -179.286 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.7 mt -105.26 132.61 51.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 178.453 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 37.4 m -121.02 125.45 47.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.484 0.659 . . . . 0.0 111.866 -178.901 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.401 ' O ' ' C ' ' A' ' 91' ' ' ILE . 84.8 mt -117.01 125.22 73.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.49 179.096 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.401 ' C ' ' O ' ' A' ' 90' ' ' ILE . 44.5 mm 40.47 -105.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.586 -179.443 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.459 ' O ' ' OD1' ' A' ' 92' ' ' ASP . 56.5 t0 -114.86 19.55 15.79 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.921 0.391 . . . . 0.0 110.633 -179.679 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.568 ' HE ' ' CD1' ' A' ' 41' ' ' LEU . 73.7 mtt-85 -129.32 145.49 51.37 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 -179.856 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.4 p -140.94 157.4 45.41 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.241 -179.834 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -131.09 124.96 31.92 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.055 -179.772 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -90.82 136.31 33.16 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.531 -179.707 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.603 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 72.2 t80 -100.16 124.55 45.71 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.833 -179.574 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -141.13 132.08 26.06 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 121.256 0.55 . . . . 0.0 111.829 -179.908 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.724 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 97.9 m-20 -101.16 142.05 33.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.393 178.413 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 120.913 0.387 . . . . 0.0 111.068 -179.984 . . . . . . . . 0 0 . 1 . 093 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 18.1 m . . . . . 0 N--CA 1.455 -0.185 0 CA-C-O 120.808 0.337 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 093 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -47.48 166.37 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.559 -179.838 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . 0.624 ' O ' ' NE2' ' B' ' 231' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.624 ' NE2' ' O ' ' B' ' 230' ' ' SEP . 99.6 mm-40 -139.41 38.95 2.07 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.708 0.289 . . . . 0.0 110.263 179.12 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -111.55 -154.52 12.91 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.106 -178.799 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -74.83 156.46 43.76 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 122.69 2.26 . . . . 0.0 112.788 -179.332 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 093 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -72.88 171.14 18.05 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 121.858 1.705 . . . . 0.0 111.722 179.773 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 25.6 t -113.36 134.1 57.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.787 -178.958 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 44.6 t -73.24 128.03 34.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.634 -179.905 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . 0.43 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . 0.43 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 31.5 Cg_exo -59.41 -27.02 83.91 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 123.005 2.47 . . . . 0.0 112.711 -179.188 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' B' B ' 240' ' ' THR . . . . . 0.411 ' OG1' ' O1P' ' B' ' 238' ' ' TPO . 71.6 m -73.67 -42.91 60.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.239 0.543 . . . . 0.0 109.757 178.008 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -57.0 -47.02 81.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.981 -179.186 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 89.2 mt -63.42 -40.06 96.16 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.66 -179.998 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.7 -40.5 96.95 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.742 -179.948 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -63.44 -42.53 98.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.227 0.537 . . . . 0.0 110.374 179.309 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.403 ' HD3' ' NH1' ' A' ' 12' ' ' ARG . 21.9 mmt180 -59.36 -41.53 89.46 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.404 -179.125 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -65.35 -40.54 93.74 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.112 -0.635 . . . . 0.0 109.997 178.038 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 48.7 m -61.36 -46.82 88.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.261 178.703 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -62.56 -36.01 81.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.117 -179.724 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 33.2 t -59.48 -46.17 93.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.92 -179.928 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -65.75 -36.47 83.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.47 0.652 . . . . 0.0 109.802 178.891 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -68.3 -21.5 64.78 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.496 -179.661 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.446 ' CD1' ' OD1' ' B' ' 256' ' ' ASP . 70.7 mt -72.1 120.61 17.94 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.738 -179.398 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . 0.543 ' C ' HD21 ' B' ' 253' ' ' ASN . 0.4 OUTLIER -68.14 -44.41 76.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.487 179.956 . . . . . . . . 3 3 . 1 . 093 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . 0.488 ' O ' ' CB ' ' B' ' 255' ' ' ASP . 96.6 m-20 -65.46 -18.4 65.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.732 179.676 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . 0.488 ' CB ' ' O ' ' B' ' 254' ' ' ASP . 2.0 m-20 86.89 13.75 0.12 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.776 -179.323 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.487 ' CB ' ' O ' ' B' ' 255' ' ' ASP . 3.7 t0 82.03 48.01 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.285 -179.746 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -65.92 -37.9 87.28 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.509 179.053 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.633 ' OD2' ' NE2' ' A' ' 40' ' ' GLN . 28.7 t70 -55.98 -50.54 70.55 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.49 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.464 ' CB ' ' O ' ' B' ' 258' ' ' ASP . 12.5 t0 83.69 0.86 1.02 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.952 178.876 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.458 ' OE1' ' C ' ' B' ' 259' ' ' ASP . 53.3 mp0 59.66 4.2 0.52 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.11 0.414 . . . . 0.0 111.739 179.528 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . 0.438 ' H ' ' C ' ' B' ' 259' ' ' ASP . 84.3 mt -110.18 133.26 56.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.927 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 55.3 t -127.31 131.13 70.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.444 0.64 . . . . 0.0 110.914 -179.347 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -93.61 122.73 36.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.219 -0.901 . . . . 0.0 112.165 -178.804 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . 0.41 ' CB ' ' O ' ' A' ' 36' ' ' ASP . 88.1 tttt -65.78 -46.74 77.59 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.306 179.929 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.98 160.99 45.3 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.285 -179.365 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -59.8 140.58 93.94 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.363 2.042 . . . . 0.0 111.905 179.278 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 3.4 tt . . . . . 0 C--N 1.321 -0.639 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.881 179.908 . . . . . . . . 0 0 . 1 . 094 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.482 ' O ' ' CB ' ' A' ' 4' ' ' THR . 95.3 Cg_endo . . . . . 0 N--CA 1.49 1.283 0 N-CA-C 112.685 0.225 . . . . 0.0 112.685 . . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.498 ' O ' ' O ' ' A' ' 99' ' ' ASN . 1.8 t 148.94 -27.8 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 O-C-N 124.283 0.99 . . . . 0.0 110.281 179.021 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 80.4 mtt85 -86.22 124.58 32.77 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.76 -179.526 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -133.6 141.31 47.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.244 0.545 . . . . 0.0 111.773 -179.228 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 42.8 tp -117.34 130.71 56.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.053 179.014 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 63.8 t -108.96 132.7 56.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.754 -179.226 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.0 m -92.35 111.59 23.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.795 -178.874 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 86.7 mt -78.69 147.89 6.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.373 179.142 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -92.12 158.34 16.24 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.329 178.101 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.428 ' NH1' HH11 ' B' ' 245' ' ' ARG . 87.9 mtm180 -57.85 -26.43 62.05 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.266 -178.492 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 97.9 p -80.61 -11.76 59.6 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 120.324 -0.551 . . . . 0.0 111.049 -179.876 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.98 24.22 13.43 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.409 178.777 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.4 m -116.89 136.56 53.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.281 179.037 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -65.91 126.41 28.43 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.423 -179.984 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -113.0 -128.64 4.95 Favored Glycine 0 CA--C 1.535 1.336 0 N-CA-C 111.381 -0.687 . . . . 0.0 111.381 -179.255 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -74.13 150.63 43.03 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 121.979 1.786 . . . . 0.0 111.951 -179.445 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -108.18 162.68 13.85 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.156 0.503 . . . . 0.0 110.604 -179.654 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -129.51 88.93 48.64 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.403 -179.051 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -61.44 131.08 34.38 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.464 2.109 . . . . 0.0 110.993 179.106 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 87.7 mt -98.68 121.44 40.63 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 119.819 -0.752 . . . . 0.0 111.355 -178.559 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 82.8 p -114.84 -28.34 7.1 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.562 178.66 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.7 mt -78.59 145.74 34.58 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.856 -1.066 . . . . 0.0 109.952 179.799 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 57.1 m -71.65 -8.27 53.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 0.0 112.216 -178.558 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.5 m -135.59 135.84 40.59 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.331 -179.687 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.5 t -126.4 117.1 22.24 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.227 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.0 tp -113.65 131.97 55.94 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.249 -178.362 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.507 ' O ' ' O ' ' A' ' 47' ' ' GLN . 4.9 m-85 -110.89 134.02 52.89 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.95 -179.655 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.29 -172.12 38.32 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 119.963 -1.113 . . . . 0.0 112.468 178.687 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.663 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 82.2 mtm-85 -83.28 -32.53 26.33 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.644 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -49.8 149.91 5.2 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -178.86 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.559 ' O ' ' NH2' ' A' ' 38' ' ' ARG . 36.5 mm -64.03 -43.28 97.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.33 -179.823 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -53.68 -21.61 7.35 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.943 -179.234 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 71.5 m -56.6 118.52 4.93 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.717 -179.695 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -57.13 -31.05 64.95 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.864 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 96.3 mt -123.56 117.08 50.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 176.734 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.559 ' NH2' ' O ' ' A' ' 33' ' ' ILE . 72.0 mtt85 -102.91 134.33 46.52 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.571 -177.928 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 78.7 mt -118.74 131.22 72.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.2 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -80.71 24.66 0.47 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.084 -178.652 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 27.8 mt -89.61 126.51 57.78 Favored Pre-proline 0 C--N 1.323 -0.579 0 C-N-CA 120.377 -0.529 . . . . 0.0 109.595 179.953 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -68.77 -13.0 36.05 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.258 1.972 . . . . 0.0 113.668 -179.158 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.41 ' CG2' ' CZ ' ' B' ' 241' ' ' PHE . 2.9 m -99.83 6.47 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.925 179.969 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.663 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 24.1 t -90.52 132.1 36.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.988 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.518 ' OG ' ' N ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -64.79 169.38 5.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.219 0.533 . . . . 0.0 111.375 -178.674 . . . . . . . . 3 3 . 1 . 094 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -62.64 -44.88 95.16 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.292 -179.366 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.651 ' O ' ' N ' ' A' ' 49' ' ' CYS . 96.2 mt-30 -113.21 -13.05 13.02 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.424 178.983 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.518 ' N ' ' OG ' ' A' ' 45' ' ' SER . 14.7 t60 34.2 -75.97 0.0 OUTLIER 'General case' 0 C--O 1.235 0.29 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 179.066 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.651 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.81 136.74 47.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.173 0.511 . . . . 0.0 112.003 -178.773 . . . . . . . . 3 3 . 1 . 094 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -126.38 127.08 44.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.205 179.655 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 92.3 mt -110.85 134.07 54.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.313 -179.113 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -116.5 121.46 41.88 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.718 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.5 mt -107.15 112.57 40.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.139 -0.624 . . . . 0.0 111.653 -179.571 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.44 ' O ' ' C ' ' A' ' 55' ' ' GLU . 96.2 m-70 -111.52 144.66 40.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.847 179.936 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.2 tt0 -40.85 -32.26 0.21 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.308 -0.626 . . . . 0.0 109.308 -179.944 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.425 ' N ' ' C ' ' A' ' 54' ' ' HIS . 98.1 mt-30 -63.8 -68.15 0.37 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.452 178.805 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.438 ' CD ' ' CD ' ' A' ' 81' ' ' ARG . 14.7 pt-20 -157.4 -171.82 3.75 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.484 -178.626 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.26 123.33 49.09 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.679 179.51 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.417 HG22 HD11 ' A' ' 59' ' ' ILE . 84.2 mt -114.73 128.08 71.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 120.345 -0.542 . . . . 0.0 112.343 -178.93 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 47.3 tp -93.85 127.49 39.62 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.352 179.517 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -115.04 135.41 54.25 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 178.795 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.642 ' ND2' ' H ' ' A' ' 69' ' ' THR . 16.0 t-20 -101.65 112.13 24.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.182 0.515 . . . . 0.0 111.576 -179.369 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -102.44 -7.08 22.25 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.749 179.784 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.36 100.7 3.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.368 179.899 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.2 m -84.98 -9.2 58.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.941 0.4 . . . . 0.0 109.928 179.678 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.92 -39.02 9.59 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.26 179.895 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -149.19 98.32 3.52 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.344 179.987 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -56.04 147.36 64.53 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 122.36 2.04 . . . . 0.0 112.713 179.968 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.642 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 38.1 m -69.64 138.78 53.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.088 178.872 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 89' ' ' THR . 83.7 mt-30 -101.02 139.67 36.39 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.161 179.795 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.2 t -131.36 135.97 58.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.356 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 53.86 34.59 19.67 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.949 -179.733 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.23 30.38 71.72 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.031 179.251 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 41.0 m -143.63 134.88 25.83 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 117.105 0.453 . . . . 0.0 111.054 -179.907 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -68.99 137.77 23.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.505 179.897 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.573 ' CG2' ' O ' ' A' ' 78' ' ' GLU . 97.2 mt -102.65 105.16 17.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.888 -179.634 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -67.55 -40.87 84.95 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.849 178.751 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.573 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 1.9 mt-10 -127.64 170.91 9.21 Favored Pre-proline 0 N--CA 1.469 0.482 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.147 -178.514 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -59.54 148.71 86.06 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.181 1.921 . . . . 0.0 112.133 179.983 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.7 m -147.39 148.84 16.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.179 0.514 . . . . 0.0 111.869 179.708 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.438 ' CD ' ' CD ' ' A' ' 57' ' ' GLU . 61.4 ttp180 -72.81 128.86 36.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.518 179.779 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 94.9 mt -85.32 135.94 33.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.142 0.496 . . . . 0.0 110.94 179.712 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -119.94 148.93 42.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.79 179.561 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.437 ' C ' ' CD2' ' A' ' 84' ' ' HIS . 5.8 t60 -51.41 123.16 9.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.673 -179.396 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.69 -14.95 49.64 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 179.878 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -67.12 139.09 57.5 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.4 -0.52 . . . . 0.0 109.639 179.507 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 72.6 t -109.99 134.22 52.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.394 -178.195 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 30.5 mm -90.71 127.28 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 177.492 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.509 ' N ' ' O ' ' A' ' 70' ' ' GLN . 31.6 m -119.74 123.36 43.55 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.467 0.651 . . . . 0.0 111.148 -178.652 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 92' ' ' ASP . 89.2 mt -118.08 126.03 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.314 179.5 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.427 ' C ' ' O ' ' A' ' 90' ' ' ILE . 87.9 mt 37.1 -95.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.056 -179.956 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 90' ' ' ILE . 54.2 t0 -119.62 14.38 12.66 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.917 0.389 . . . . 0.0 111.453 -179.356 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.418 HH22 ' HB2' ' B' ' 260' ' ' GLU . 2.2 tpp180 -128.48 142.25 51.14 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.286 -179.555 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.0 m -133.45 150.08 51.76 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.428 0.632 . . . . 0.0 111.362 -179.847 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -121.58 123.24 41.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.422 -0.808 . . . . 0.0 108.907 178.895 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -81.33 126.68 31.88 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.52 -179.725 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.572 ' CE2' ' OD1' ' A' ' 99' ' ' ASN . 76.8 t80 -95.6 123.48 39.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.11 -179.193 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -126.24 115.88 20.41 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.118 179.061 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.572 ' OD1' ' CE2' ' A' ' 97' ' ' TYR . 86.1 m-20 -66.22 -43.35 86.94 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.94 -179.643 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 . . . . . 0 C--N 1.328 -0.358 0 CA-C-O 120.968 0.413 . . . . 0.0 111.097 179.991 . . . . . . . . 0 0 . 1 . 094 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 27.2 m . . . . . 0 N--CA 1.453 -0.317 0 CA-C-O 120.633 0.254 . . . . 0.0 110.543 . . . . . . . . . 0 0 . 1 . 094 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.55 ' C ' ' H ' ' B' ' 231' ' ' GLN . 90.6 m-20 -72.29 144.11 48.48 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.511 179.686 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . 0.461 ' N ' ' O2P' ' B' ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.55 ' H ' ' C ' ' B' ' 229' ' ' ASP . 74.9 mt-30 -130.36 39.59 3.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.609 179.637 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -115.01 -164.12 14.36 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 111.684 -0.567 . . . . 0.0 111.684 -178.726 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -72.88 160.6 45.68 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.823 2.349 . . . . 0.0 112.241 -179.658 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 094 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -73.19 170.53 19.62 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 121.718 1.612 . . . . 0.0 111.715 178.977 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 3.1 p -112.29 133.42 58.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.861 -179.498 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 5.6 t -67.19 123.09 19.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.892 179.834 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . 0.44 ' P ' ' OG1' ' B' ' 240' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -55.64 -23.87 42.63 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 121.963 1.775 . . . . 0.0 111.989 179.004 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' B' B ' 240' ' ' THR . . . . . 0.44 ' OG1' ' P ' ' B' ' 238' ' ' TPO . 4.6 p -75.93 -38.9 57.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 177.908 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . 0.41 ' CZ ' ' CG2' ' A' ' 43' ' ' VAL . 74.8 t80 -57.71 -46.61 84.14 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.837 -179.466 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 92.5 mt -64.67 -40.85 96.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.163 179.711 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -61.87 -43.48 98.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.379 179.565 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . 0.413 ' O ' ' OG ' ' B' ' 247' ' ' SER . 63.4 ttm-85 -63.71 -42.96 97.89 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.366 179.431 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.428 HH11 ' NH1' ' A' ' 12' ' ' ARG . 12.4 tpp180 -61.99 -44.6 96.4 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.117 -179.617 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -64.63 -38.97 92.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.453 178.712 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' B' B ' 247' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 69.7 p -68.22 -43.76 77.27 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.253 0.549 . . . . 0.0 109.795 179.057 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -58.76 -37.88 77.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.325 179.824 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 77.0 t -64.43 -45.07 96.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.909 179.934 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -63.5 -26.97 68.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.39 179.662 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -95.6 -8.85 33.78 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.38 -179.728 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.423 ' CD2' ' NH2' ' A' ' 12' ' ' ARG . 31.4 tp -106.63 120.53 42.21 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.929 -179.934 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -54.29 149.09 10.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.285 0.564 . . . . 0.0 111.299 -179.122 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -68.01 -15.38 63.58 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.177 178.429 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -71.47 -1.2 12.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.27 179.88 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 42.3 p-10 -70.37 78.27 0.55 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.575 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -69.28 -10.85 59.75 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.916 -179.204 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -86.31 112.52 21.49 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.774 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.693 ' C ' ' H ' ' B' ' 261' ' ' ILE . 39.6 p-10 -101.58 127.83 48.12 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.393 0.616 . . . . 0.0 110.613 -179.492 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.418 ' HB2' HH22 ' A' ' 93' ' ' ARG . 90.6 mt-10 -55.19 9.66 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.026 -179.628 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . 0.693 ' H ' ' C ' ' B' ' 259' ' ' ASP . 60.9 mt -106.62 137.24 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.877 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 69.8 t -127.54 134.48 65.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.031 -179.548 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -94.94 119.16 33.01 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.986 -177.367 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . 0.471 ' HG3' HH22 ' A' ' 38' ' ' ARG . 88.5 tttt -68.48 -44.63 74.35 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.252 179.612 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.69 156.98 49.9 Favored Pre-proline 0 C--O 1.236 0.353 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.374 -179.43 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -62.26 144.6 95.64 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.935 2.423 . . . . 0.0 112.713 -179.563 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 47.2 pt . . . . . 0 N--CA 1.455 -0.204 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.572 178.673 . . . . . . . . 0 0 . 1 . 095 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo . . . . . 0 N--CA 1.495 1.565 0 CA-C-O 120.852 0.272 . . . . 0.0 112.097 . . . . . . . . . 0 0 . 1 . 095 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.5 p -95.58 -43.74 7.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.17 -179.504 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 76.5 mtm-85 -88.58 125.05 34.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.315 -178.95 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -130.91 144.43 51.46 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.216 179.35 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 69.7 mt -117.24 141.12 48.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.442 179.761 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.5 t -113.37 127.61 70.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.784 179.652 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.9 m -82.76 135.14 35.07 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.233 -178.29 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.421 HD13 HG21 ' A' ' 10' ' ' ILE . 98.9 mt -105.65 137.04 37.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.348 178.368 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.551 ' HZ2' ' CB ' ' B' ' 259' ' ' ASP . 27.6 mttm -89.69 161.03 16.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.042 0.449 . . . . 0.0 110.348 179.389 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.695 ' HE ' ' NZ ' ' B' ' 257' ' ' LYS . 87.7 mtm180 -54.55 -27.13 36.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.198 -179.018 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.4 m -82.71 -5.1 58.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.197 179.443 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.39 35.3 14.66 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 179.519 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.1 t -115.51 135.36 55.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.773 0.321 . . . . 0.0 110.474 -179.995 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -78.45 132.6 37.36 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.203 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -126.55 -114.95 1.94 Allowed Glycine 0 CA--C 1.537 1.416 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.967 -179.139 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -71.9 144.49 43.34 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 122.338 2.025 . . . . 0.0 112.631 -178.97 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -106.54 132.66 52.28 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.984 0.421 . . . . 0.0 110.701 -179.746 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.406 ' CD2' HD13 ' A' ' 37' ' ' ILE . 56.0 t80 -101.18 102.35 20.31 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.44 -179.41 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -76.22 129.92 11.66 Favored 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 121.67 1.58 . . . . 0.0 111.789 -179.75 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 89.8 mt -87.41 80.28 8.18 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.165 -179.07 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.587 ' HG ' ' NE2' ' B' ' 265' ' ' GLN . 35.6 p -84.73 -9.92 57.75 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.437 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 66.6 mt -100.16 143.23 30.61 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.96 -179.676 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 93.1 p -65.56 -15.91 63.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.131 -178.642 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.488 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 33.4 m -130.13 130.74 45.17 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.864 -179.407 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.618 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 2.2 t -124.9 118.85 27.21 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.979 178.921 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.8 tp -120.01 131.86 55.28 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.509 -178.142 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.618 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 54.8 m-85 -108.45 143.13 37.81 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.289 179.689 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 156.29 -151.04 22.51 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 179.156 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.666 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 84.2 mtm-85 -108.89 -23.45 11.72 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.634 179.326 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.469 ' N ' ' SG ' ' A' ' 35' ' ' CYS . . . -55.49 156.86 8.79 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 121.281 -0.485 . . . . 0.0 112.206 -178.584 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.448 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 11.0 tp -65.69 -41.93 91.55 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 CA-C-O 120.986 0.422 . . . . 0.0 110.061 179.606 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.448 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 96.4 mt-10 -60.11 -28.46 67.88 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.803 179.873 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.543 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 9.3 m -53.13 115.46 1.89 Allowed 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.071 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.488 ' OD2' ' O ' ' A' ' 26' ' ' THR . 99.5 m-20 -60.74 -26.71 67.39 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -179.245 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.406 HD13 ' CD2' ' A' ' 20' ' ' PHE . 47.5 mm -123.24 112.37 33.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.67 177.516 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -105.0 137.65 42.42 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.773 -179.832 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 98.2 mt -121.76 132.85 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.138 179.058 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -79.33 34.26 0.25 Allowed 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -177.588 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.545 ' CD1' ' HE ' ' A' ' 93' ' ' ARG . 9.7 mt -113.59 137.61 22.25 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.553 178.9 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.09 -10.79 29.1 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.836 2.358 . . . . 0.0 113.93 -178.138 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.4 m -95.51 3.34 9.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.223 -0.591 . . . . 0.0 111.206 -179.993 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.666 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 37.3 t -94.5 130.19 43.69 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.717 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.9 m -70.97 163.47 27.46 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -177.796 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.543 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 54.8 mttp -62.75 -41.62 99.29 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.486 -179.048 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.633 ' O ' ' N ' ' A' ' 49' ' ' CYS . 10.8 mm100 -113.98 -24.63 8.95 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.239 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 24.5 t60 35.26 -74.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 178.944 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.633 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.79 138.64 45.83 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -177.993 . . . . . . . . 3 3 . 1 . 095 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -128.6 127.83 43.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.789 179.817 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.8 mt -115.42 134.22 59.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.516 179.244 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -114.17 137.84 51.23 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.449 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.429 HG21 HD12 ' A' ' 53' ' ' ILE . 39.5 mm -98.15 120.01 46.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.307 0.575 . . . . 0.0 110.679 -179.367 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.454 ' O ' ' C ' ' A' ' 55' ' ' GLU . 38.0 m-70 -120.78 131.35 54.43 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.303 179.452 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 54' ' ' HIS . 99.5 mt-10 -40.07 -34.46 0.3 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -179.774 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -62.75 -66.85 0.48 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.845 -1.071 . . . . 0.0 108.953 178.358 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -160.05 -159.14 0.69 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.426 178.854 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.62 131.03 56.28 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.814 -0.355 . . . . 0.0 110.362 -179.938 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.453 HG22 HD11 ' A' ' 59' ' ' ILE . 37.6 mm -108.64 123.5 64.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.004 -179.25 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 38.9 tp -95.77 124.01 39.6 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.149 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -113.01 134.17 54.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.259 -179.547 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -95.33 104.65 16.55 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.951 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -99.26 -7.51 26.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.957 178.838 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.9 t -78.08 98.94 5.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.133 -179.175 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.8 m -77.64 -37.49 49.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.127 0.489 . . . . 0.0 109.955 178.599 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.56 -40.45 80.61 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.458 -179.705 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -146.68 96.98 4.33 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.963 -179.286 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -56.36 148.28 62.75 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.455 2.104 . . . . 0.0 112.467 179.505 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.4 m -74.68 143.06 44.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.313 -179.764 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.416 ' O ' ' N ' ' A' ' 89' ' ' THR . 87.5 mt-30 -104.12 140.39 37.86 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.225 179.385 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.9 t -130.08 135.77 60.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.024 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 52.98 37.14 23.83 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.38 -179.898 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.29 29.53 74.4 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.095 179.204 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.3 t -144.94 136.05 24.94 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.481 -179.983 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.1 p -72.2 138.59 21.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.16 -179.256 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.526 ' CD1' ' O ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -133.6 126.76 52.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.96 179.289 . . . . . . . . 3 3 . 1 . 095 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -99.4 -9.76 23.07 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.658 -179.308 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.526 ' O ' ' CD1' ' A' ' 76' ' ' ILE . 1.2 pm0 -118.47 161.05 37.37 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 120.776 -0.37 . . . . 0.0 111.035 -179.18 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -57.54 143.77 93.8 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 121.613 1.542 . . . . 0.0 111.859 179.696 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.8 p -139.63 141.61 34.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.353 -179.462 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -78.39 134.12 37.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.394 -179.867 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.1 mt -93.46 139.36 30.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.241 0.543 . . . . 0.0 111.622 -179.269 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -126.06 155.93 40.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.997 179.765 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.751 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 8.4 t60 -55.83 118.55 4.68 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.9 0.381 . . . . 0.0 110.235 -179.523 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.82 -17.1 27.9 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 -179.704 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -68.14 137.47 54.92 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.224 179.968 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.55 ' CG2' ' OG ' ' A' ' 94' ' ' SER . 7.7 p -111.55 134.18 54.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.061 0.457 . . . . 0.0 112.031 -178.557 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 47.5 mm -93.81 128.02 45.46 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.093 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 178.069 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.416 ' N ' ' O ' ' A' ' 70' ' ' GLN . 47.9 m -126.57 126.68 44.05 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -178.001 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.459 ' O ' ' C ' ' A' ' 91' ' ' ILE . 86.4 mt -116.07 126.63 73.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 114.225 -1.352 . . . . 0.0 108.259 178.57 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.459 ' C ' ' O ' ' A' ' 90' ' ' ILE . 94.6 mt 35.71 -96.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 121.024 -0.271 . . . . 0.0 110.922 -179.593 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 90' ' ' ILE . 26.5 m-20 -120.11 17.28 12.43 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.86 0.362 . . . . 0.0 111.432 179.802 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.774 HH21 ' NH2' ' B' ' 245' ' ' ARG . 0.6 OUTLIER -124.71 138.22 54.3 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.845 . . . . . . . . 3 3 . 1 . 095 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.55 ' OG ' ' CG2' ' A' ' 87' ' ' VAL . 8.1 t -139.97 151.1 45.25 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 119.826 -0.75 . . . . 0.0 111.751 -179.055 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -122.69 122.51 38.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.561 178.734 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -87.2 134.12 33.57 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.315 -178.865 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.518 ' OH ' ' OD1' ' A' ' 99' ' ' ASN . 75.0 t80 -97.59 125.8 42.53 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.518 179.79 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -143.72 130.07 19.91 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.779 -179.908 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.751 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 84.7 m-20 -89.61 112.64 23.92 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.411 179.112 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.616 -179.991 . . . . . . . . 0 0 . 1 . 095 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . 0.597 ' O ' ' N ' ' B' ' 230' ' ' SEP . 3.5 p . . . . . 0 N--CA 1.455 -0.187 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 . . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' B' ' 228' ' ' VAL . 62.6 t0 33.61 -86.27 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.235 179.763 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . 0.597 ' N ' ' O ' ' B' ' 228' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -122.01 51.75 1.32 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.922 -179.2 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -128.33 -177.57 14.93 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 -179.418 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -74.19 160.77 41.95 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 123.863 3.042 . . . . 0.0 113.5 -179.398 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 095 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -57.42 132.69 52.27 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 121.935 1.757 . . . . 0.0 111.969 -179.434 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 24.8 t -59.6 137.53 21.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.006 179.441 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.9 t -52.67 112.58 0.86 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.169 -179.324 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 095 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -57.96 -24.73 66.64 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 121.741 1.627 . . . . 0.0 111.519 178.95 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 97.0 m -71.03 -45.35 64.05 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.967 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -58.38 -46.8 85.64 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.754 -179.601 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 92.6 mt -64.04 -42.1 97.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.878 -179.577 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -63.3 -43.21 98.51 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 120.871 -0.331 . . . . 0.0 111.076 -179.402 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -63.0 -40.11 96.79 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.699 179.8 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.774 ' NH2' HH21 ' A' ' 93' ' ' ARG . 61.2 ttm-85 -61.76 -44.54 96.69 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.084 179.574 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -62.52 -41.53 98.92 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.469 -179.618 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 57.9 m -66.97 -46.03 75.89 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.291 0.567 . . . . 0.0 110.521 179.122 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . 0.401 ' O ' ' HG ' ' B' ' 252' ' ' LEU . 86.2 mt-30 -62.92 -33.56 75.59 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.447 -179.46 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 61.4 t -66.12 -45.2 90.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 121.19 0.519 . . . . 0.0 111.55 179.867 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -69.95 -20.82 63.31 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.984 -178.948 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -90.99 4.67 51.43 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.324 -178.983 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' B' ' 248' ' ' GLN . 36.4 mt -77.93 159.94 28.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.392 0.615 . . . . 0.0 112.349 -178.981 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . 0.547 ' OD1' ' N ' ' B' ' 254' ' ' ASP . 25.5 t-20 -75.7 176.45 7.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.594 178.864 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . 0.547 ' N ' ' OD1' ' B' ' 253' ' ' ASN . 88.6 m-20 -98.1 0.88 46.92 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -178.757 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . 0.507 ' O ' ' OD1' ' B' ' 256' ' ' ASP . 74.2 m-20 -148.66 43.73 1.0 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -178.437 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.507 ' OD1' ' O ' ' B' ' 255' ' ' ASP . 93.8 m-20 -138.75 -141.31 0.15 Allowed 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 119.715 -0.794 . . . . 0.0 111.865 178.909 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . 0.695 ' NZ ' ' HE ' ' A' ' 12' ' ' ARG . 82.2 tttt 62.7 110.05 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.174 0 O-C-N 121.896 -0.502 . . . . 0.0 112.048 179.986 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.505 ' O ' ' OD2' ' B' ' 259' ' ' ASP . 36.8 p-10 -85.78 -4.57 59.2 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.22 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.627 ' C ' ' H ' ' B' ' 261' ' ' ILE . 0.0 OUTLIER 80.87 111.88 0.07 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.624 -179.653 . . . . . . . . 3 3 . 1 . 095 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.501 ' OE1' ' N ' ' B' ' 260' ' ' GLU . 57.4 mp0 -57.64 11.92 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.012 -0.994 . . . . 0.0 112.261 -178.524 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . 0.627 ' H ' ' C ' ' B' ' 259' ' ' ASP . 66.4 mt -106.01 134.35 47.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 178.123 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 72.0 t -123.71 132.27 71.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.26 0.552 . . . . 0.0 110.238 -178.812 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -95.18 117.4 30.18 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.543 -177.869 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . 0.418 ' NZ ' ' HA ' ' A' ' 34' ' ' GLU . 88.5 tttt -65.17 -45.77 83.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.572 179.745 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . 0.587 ' NE2' ' HG ' ' A' ' 23' ' ' SER . 0.0 OUTLIER -80.26 158.9 71.34 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.144 -179.819 . . . . . . . . 3 3 . 1 . 095 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -60.1 140.59 93.2 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 C-N-CA 122.237 1.958 . . . . 0.0 111.733 179.499 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 13.8 tt . . . . . 0 C--N 1.326 -0.414 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.156 -179.541 . . . . . . . . 0 0 . 1 . 096 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo . . . . . 0 N--CA 1.498 1.745 0 N-CA-C 112.973 0.336 . . . . 0.0 112.973 . . . . . . . . . 0 0 . 1 . 096 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.6 m -135.75 -59.37 0.76 Allowed 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.707 -179.313 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 88.1 mtm-85 -94.87 131.57 40.62 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.936 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -142.86 151.54 41.18 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 119.958 -0.697 . . . . 0.0 112.305 179.933 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 80.3 mt -115.25 131.52 56.9 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.14 178.653 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 73.0 t -103.65 128.21 57.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.942 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 m -87.82 120.9 29.6 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -177.377 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 91.1 mt -82.18 134.92 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.659 178.462 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -88.37 160.73 17.46 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.4 0.619 . . . . 0.0 111.394 179.365 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.638 ' CG ' HH12 ' A' ' 93' ' ' ARG . 76.7 mtp180 -53.9 -40.98 67.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.921 -178.759 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.5 t -72.2 -11.11 60.58 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.024 179.892 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.25 35.31 5.3 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 -179.513 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.7 t -123.66 135.96 61.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.103 0.478 . . . . 0.0 111.914 -179.474 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -70.07 136.43 50.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.809 179.504 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -122.0 -125.34 3.11 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.919 -179.332 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.65 150.26 56.45 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 122.051 1.834 . . . . 0.0 113.222 -178.469 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 53.3 m170 -110.28 132.91 53.76 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.52 -179.251 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -102.12 100.73 15.99 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.301 -179.506 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -73.37 127.69 12.11 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 C-N-CA 121.421 1.414 . . . . 0.0 110.855 179.979 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 99.3 mt -79.99 55.58 2.16 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.816 -0.353 . . . . 0.0 111.886 -178.345 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 87.1 p -67.13 -22.21 65.8 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.508 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 69.9 mt -83.52 139.8 32.67 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.563 179.573 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.9 m -67.42 -18.6 65.17 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.429 -178.965 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 36.4 m -129.23 130.91 46.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.238 0.542 . . . . 0.0 111.918 -179.717 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.671 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.7 OUTLIER -125.62 118.33 25.45 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.65 178.735 . . . . . . . . 3 3 . 1 . 096 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.519 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 56.0 tp -119.79 125.69 49.21 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.522 -178.424 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.671 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 48.2 m-85 -101.76 128.07 48.26 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.492 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 177.5 -176.84 48.23 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.282 -0.961 . . . . 0.0 111.762 179.101 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.655 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 84.6 mtm-85 -82.39 -28.07 31.68 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.12 0.486 . . . . 0.0 110.242 179.75 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.61 155.02 41.63 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.282 -178.368 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.1 tp -65.98 -39.38 84.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.489 -0.355 . . . . 0.0 110.56 179.23 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -55.17 -21.61 14.2 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.659 -179.795 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.8 m -64.03 119.86 10.93 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.088 -179.982 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.585 ' OD2' ' SG ' ' A' ' 27' ' ' CYS . 28.2 p-10 -54.26 -26.12 27.19 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.385 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.51 ' N ' ' OD1' ' A' ' 36' ' ' ASP . 94.9 mt -130.59 123.61 55.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.29 -0.868 . . . . 0.0 108.879 178.043 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 20.9 mtm180 -109.3 137.63 46.88 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.761 -179.099 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 92.8 mt -118.65 131.62 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.936 179.293 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -77.89 31.64 0.17 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -177.877 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 34.7 mt -102.88 130.64 23.37 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.742 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.53 -6.09 18.17 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 121.909 1.739 . . . . 0.0 112.534 -179.459 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.419 HG22 ' CE2' ' B' ' 241' ' ' PHE . 4.9 m -101.39 3.74 10.59 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.501 -179.686 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.655 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 34.3 t -90.57 133.48 32.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.632 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -69.74 170.22 11.39 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.779 0.799 . . . . 0.0 112.753 -177.5 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -64.04 -43.83 94.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.512 -179.324 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.636 ' O ' ' N ' ' A' ' 49' ' ' CYS . 90.5 mm-40 -111.69 -17.39 13.01 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.299 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.4 t60 32.56 -78.11 0.0 OUTLIER 'General case' 0 C--O 1.238 0.492 0 CA-C-N 114.686 -1.143 . . . . 0.0 112.985 179.765 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.636 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.66 135.97 46.16 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.482 -179.003 . . . . . . . . 3 3 . 1 . 096 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -125.89 131.4 52.36 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.702 179.003 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.1 mt -117.64 135.17 58.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.574 -179.967 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -114.18 135.57 53.89 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.669 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.0 mm -103.01 125.19 57.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.941 -179.398 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.473 ' O ' ' N ' ' A' ' 56' ' ' GLN . 33.3 m-70 -127.04 129.31 47.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.596 179.349 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' A' ' 54' ' ' HIS . 96.0 mt-10 -40.2 -29.74 0.08 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.216 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.473 ' N ' ' O ' ' A' ' 54' ' ' HIS . 88.3 mt-30 -67.08 -67.28 0.46 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.41 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -154.92 -168.1 2.78 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.707 -179.807 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.11 131.09 55.65 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.407 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.3 mm -108.66 125.2 65.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.869 -179.433 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 34.1 tp -99.44 126.3 45.33 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.258 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -115.76 137.61 51.92 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.579 -179.187 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -102.57 105.18 15.65 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.368 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -95.89 -4.28 43.84 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.513 178.997 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.52 104.45 15.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.553 -179.187 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.3 p -87.31 -35.89 18.17 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.698 179.124 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.6 -45.71 92.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.793 -179.714 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -145.58 104.43 4.27 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.07 179.248 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -67.04 151.43 81.88 Favored 'Trans proline' 0 N--CA 1.491 1.332 0 C-N-CA 121.74 1.627 . . . . 0.0 113.287 -177.87 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 33.9 m -70.79 146.93 49.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.598 179.95 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -110.87 139.92 45.77 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.758 -179.404 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 54.2 t -129.66 134.99 62.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.05 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 53.6 34.41 18.57 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.221 179.829 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.31 28.71 69.43 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.91 179.468 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.6 t -144.93 142.62 30.01 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 117.182 0.491 . . . . 0.0 110.986 179.758 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.4 m -68.97 143.71 14.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.496 -179.497 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.477 ' CG1' ' O ' ' A' ' 78' ' ' GLU . 10.0 tt -111.67 90.92 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.92 -179.801 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -65.55 -35.25 80.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.115 179.52 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.477 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 5.0 mt-10 -124.67 164.74 28.99 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.387 -178.402 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.74 138.87 77.12 Favored 'Trans proline' 0 N--CA 1.501 1.954 0 C-N-CA 122.102 1.868 . . . . 0.0 112.874 -179.879 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 73.2 t -132.37 137.39 54.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.781 179.956 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 84.6 mtt85 -71.38 129.32 38.52 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.487 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.6 mt -82.75 137.36 34.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.164 0.507 . . . . 0.0 111.072 -179.876 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -128.09 152.35 48.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.593 -179.621 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.516 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 7.7 t60 -55.86 117.77 3.99 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.431 179.948 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.85 -20.43 19.93 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 179.851 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -67.03 136.63 55.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.979 0.418 . . . . 0.0 110.216 179.948 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.1 t -109.43 133.87 53.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.684 -178.758 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 88.6 mt -102.86 129.93 53.75 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.514 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 178.275 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 61.5 m -123.41 128.43 49.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.799 0.809 . . . . 0.0 112.249 -178.014 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.678 ' O ' ' N ' ' A' ' 93' ' ' ARG . 93.9 mt -116.53 132.86 64.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.077 178.7 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.517 ' C ' ' O ' ' A' ' 90' ' ' ILE . 51.0 mt -22.5 98.82 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.067 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.535 ' CG ' ' HE ' ' B' ' 245' ' ' ARG . 0.7 OUTLIER 80.08 -17.57 0.57 Allowed 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 178.354 . . . . . . . . 3 3 . 1 . 096 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.678 ' N ' ' O ' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -122.52 132.64 54.42 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 119.64 -0.219 . . . . 0.0 110.868 -179.747 . . . . . . . . 3 3 . 1 . 096 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.1 t -136.28 146.88 47.16 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 118.488 0.586 . . . . 0.0 111.129 -179.781 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -125.74 122.06 35.19 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.647 179.593 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -84.43 134.85 34.45 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.399 -179.249 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -97.82 126.43 43.18 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.492 -179.598 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -143.12 128.38 18.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.644 179.827 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.539 ' O ' ' OD1' ' A' ' 99' ' ' ASN . 29.0 p30 -118.06 136.76 53.36 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 121.483 0.658 . . . . 0.0 111.343 -179.898 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 C--N 1.325 -0.492 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.211 -179.75 . . . . . . . . 0 0 . 1 . 096 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . 0.424 ' O ' ' C ' ' B' ' 229' ' ' ASP . 53.6 t . . . . . 0 C--O 1.234 0.258 0 CA-C-O 120.728 0.299 . . . . 0.0 111.016 . . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' B' ' 228' ' ' VAL . 83.5 m-20 39.21 -106.75 0.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.741 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . 0.415 ' O1P' ' O ' ' B' ' 229' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -139.18 29.05 2.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.017 -179.112 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -106.39 -158.01 21.79 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -179.611 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -58.43 151.97 57.7 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 C-N-CA 123.168 2.579 . . . . 0.0 113.041 -179.951 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 096 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -77.4 172.7 15.47 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.343 2.028 . . . . 0.0 111.927 -179.939 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 3.8 p -113.7 132.65 62.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.095 -179.719 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -66.27 121.41 15.17 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 120.248 -0.581 . . . . 0.0 109.493 179.943 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . 0.541 ' P ' ' OG1' ' B' ' 240' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -54.61 -24.27 36.09 Favored 'Trans proline' 0 N--CA 1.49 1.284 0 C-N-CA 121.941 1.761 . . . . 0.0 111.349 -179.792 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' B' B ' 240' ' ' THR . . . . . 0.541 ' OG1' ' P ' ' B' ' 238' ' ' TPO . 2.5 p -74.35 -39.75 62.58 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 177.784 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . 0.419 ' CE2' HG22 ' A' ' 43' ' ' VAL . 71.0 t80 -58.04 -47.46 83.03 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.047 -179.264 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 98.0 mt -64.66 -40.18 94.97 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.043 0.449 . . . . 0.0 110.07 -179.823 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -63.61 -44.0 95.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.795 179.567 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . 0.411 ' HA ' ' HG ' ' B' ' 247' ' ' SER . 99.4 mtt180 -61.54 -41.24 97.07 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.109 -179.855 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.535 ' HE ' ' CG ' ' A' ' 92' ' ' ASP . 22.1 mmm180 -61.61 -40.37 94.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.348 -179.859 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -63.77 -42.43 97.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.801 0.334 . . . . 0.0 110.794 179.313 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' B' B ' 247' ' ' SER . . . . . 0.411 ' HG ' ' HA ' ' B' ' 244' ' ' ARG . 72.2 p -64.95 -43.19 93.51 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.729 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -62.36 -37.33 85.25 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.682 179.668 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . 0.533 ' O ' ' O ' ' B' ' 252' ' ' LEU . 79.3 t -65.75 -45.41 91.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.2 179.019 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -63.08 -30.67 71.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.861 179.876 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -90.75 -10.87 41.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.983 179.619 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.533 ' O ' ' O ' ' B' ' 249' ' ' VAL . 64.0 tp -121.75 118.51 29.25 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.594 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -177.8 39.54 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.08 -179.674 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . 0.586 ' O ' ' CB ' ' B' ' 255' ' ' ASP . 33.1 p-10 -95.14 1.81 54.92 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 178.927 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . 0.586 ' CB ' ' O ' ' B' ' 254' ' ' ASP . 64.6 t0 116.12 58.64 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 O-C-N 124.796 1.31 . . . . 0.0 109.994 -179.623 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.506 ' O ' ' OD1' ' B' ' 256' ' ' ASP . 55.8 p-10 -56.71 76.88 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.941 0.4 . . . . 0.0 110.206 -179.937 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . 0.586 ' N ' ' O ' ' B' ' 255' ' ' ASP . 98.2 mttt -63.65 -35.87 81.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.951 179.573 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -61.23 -68.13 0.34 Allowed 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.026 -179.223 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.598 ' OD1' ' N ' ' B' ' 261' ' ' ILE . 0.0 OUTLIER 69.57 129.68 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.495 0.664 . . . . 0.0 110.591 -179.224 . . . . . . . . 3 3 . 1 . 096 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -56.3 11.57 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.559 -1.201 . . . . 0.0 113.987 -177.808 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . 0.598 ' N ' ' OD1' ' B' ' 259' ' ' ASP . 41.0 mt -109.66 133.11 55.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 119.881 -0.728 . . . . 0.0 109.111 178.824 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 44.1 t -127.8 135.5 62.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.541 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -100.22 123.64 44.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.249 0.547 . . . . 0.0 112.415 -177.6 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -63.98 -47.35 80.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.111 178.59 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -96.84 163.76 19.48 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.477 179.972 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -60.76 156.74 41.35 Favored 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 122.941 2.427 . . . . 0.0 111.982 178.72 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 10.6 pt . . . . . 0 N--CA 1.466 0.35 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.893 -178.224 . . . . . . . . 0 0 . 1 . 097 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo . . . . . 0 N--CA 1.499 1.801 0 N-CA-C 111.593 -0.195 . . . . 0.0 111.593 . . . . . . . . . 0 0 . 1 . 097 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.5 p -100.99 -46.56 5.05 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.858 0.361 . . . . 0.0 110.354 -179.765 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.449 ' NH1' ' CG2' ' A' ' 53' ' ' ILE . 99.9 mtt180 -94.11 132.28 38.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.747 179.213 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 91.6 mtm180 -134.07 141.93 47.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.015 -179.911 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 42.3 tp -111.94 131.27 55.49 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.122 179.416 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.7 t -107.07 130.27 59.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.382 179.832 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 m -92.84 115.06 27.77 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.437 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 88.6 mt -80.93 142.74 13.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.667 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.423 ' HZ2' ' N ' ' B' ' 257' ' ' LYS . 97.6 mttt -84.81 156.04 21.52 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.562 178.823 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.429 ' HG3' ' NH2' ' B' ' 245' ' ' ARG . 58.0 ttp180 -58.16 -35.85 72.16 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.069 -179.795 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.1 t -68.21 -21.59 64.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.988 0.423 . . . . 0.0 110.13 178.638 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.57 29.02 4.6 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 111.156 -0.777 . . . . 0.0 111.156 179.993 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.8 t -117.78 132.9 66.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.869 0.366 . . . . 0.0 111.152 -179.804 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 17' ' ' GLY . 63.5 t0 -79.29 130.83 35.85 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.67 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.462 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -129.93 -108.71 1.31 Allowed Glycine 0 CA--C 1.532 1.133 0 C-N-CA 119.707 -1.235 . . . . 0.0 112.221 -179.66 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.1 145.19 48.88 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.496 2.131 . . . . 0.0 113.81 -178.333 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.451 ' O ' ' CD1' ' B' ' 267' ' ' ILE . 0.2 OUTLIER -110.56 145.62 37.49 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.475 178.871 . . . . . . . . 3 3 . 1 . 097 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -113.99 92.21 25.14 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.856 -179.084 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.83 130.02 34.86 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 122.037 1.825 . . . . 0.0 111.189 -179.602 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.5 mt -87.73 84.71 7.03 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.314 -179.483 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 51.4 p -89.85 -10.44 45.33 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.164 179.486 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.412 ' CD1' ' CD ' ' B' ' 265' ' ' GLN . 59.4 mt -102.24 146.6 27.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.289 -179.723 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 52.4 p -68.84 -17.36 63.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.564 -179.614 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.48 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 30.5 m -128.87 130.73 47.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.873 0.368 . . . . 0.0 110.992 -179.437 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.8 t -126.03 119.28 27.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.718 178.844 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.433 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 42.8 tp -116.77 130.17 56.55 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.155 -178.098 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.504 ' O ' ' O ' ' A' ' 47' ' ' GLN . 10.1 m-85 -109.01 140.41 42.57 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.41 179.921 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 153.88 -177.24 31.47 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.316 -0.945 . . . . 0.0 112.431 177.969 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -71.13 -32.51 69.07 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 111.725 0.268 . . . . 0.0 111.725 179.336 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.453 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -50.38 140.27 19.46 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.812 -178.0 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.464 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 11.0 tp -67.1 -41.87 87.6 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 C-N-CA 120.381 -0.527 . . . . 0.0 109.597 179.569 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.464 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 77.3 tt0 -55.6 -16.98 4.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.226 179.457 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 24.1 m -66.63 136.26 55.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.119 -179.79 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.48 ' OD2' ' O ' ' A' ' 26' ' ' THR . 68.8 m-20 -61.53 -33.72 74.3 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -178.999 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 98.3 mt -125.05 119.67 56.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 177.188 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -104.64 133.11 50.04 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.774 -177.999 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 98.9 mt -119.36 129.13 75.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.587 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -76.39 29.63 0.12 Allowed 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -178.082 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 30.4 mt -94.12 129.03 38.7 Favored Pre-proline 0 C--N 1.322 -0.613 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.91 -179.806 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -72.86 -10.34 24.72 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 122.58 2.187 . . . . 0.0 113.046 -178.996 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.447 HG23 ' CE2' ' B' ' 241' ' ' PHE . 29.4 m -109.66 4.19 9.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.589 179.804 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.449 ' O ' ' O ' ' A' ' 45' ' ' SER . 4.5 t -91.8 108.17 19.72 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 CA-C-O 121.454 0.645 . . . . 0.0 110.642 179.623 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.449 ' O ' ' O ' ' A' ' 44' ' ' VAL . 1.1 m -32.09 153.05 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.999 -1.0 . . . . 0.0 112.167 -179.523 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -62.0 -42.36 99.06 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 114.406 -1.27 . . . . 0.0 111.192 -179.104 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.698 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.7 mt-30 -113.1 -18.09 12.24 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.097 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.521 ' CG ' ' HG ' ' A' ' 64' ' ' SER . 35.5 t60 31.83 -71.42 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 114.902 -1.045 . . . . 0.0 113.23 179.879 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.698 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.66 135.41 47.82 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.282 . . . . . . . . 3 3 . 1 . 097 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -127.82 131.72 49.52 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.507 179.098 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.7 mt -116.28 136.2 54.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.536 -179.576 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -120.55 125.25 47.32 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.619 178.877 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.449 ' CG2' ' NH1' ' A' ' 5' ' ' ARG . 96.4 mt -105.24 114.27 44.34 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 CA-C-O 121.363 0.602 . . . . 0.0 111.569 -179.839 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.572 ' O ' ' N ' ' A' ' 56' ' ' GLN . 93.8 m-70 -112.22 144.46 41.59 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.671 179.641 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.474 ' C ' ' O ' ' A' ' 54' ' ' HIS . 81.8 tt0 -38.83 -26.42 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.81 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.572 ' N ' ' O ' ' A' ' 54' ' ' HIS . 68.9 tp60 -69.62 -68.11 0.43 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.676 178.32 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -160.82 -165.21 1.33 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.551 -179.695 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.41 124.93 52.65 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.013 179.468 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 98.5 mt -113.57 129.22 69.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.245 0.545 . . . . 0.0 112.445 -179.042 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 51.1 tp -95.17 126.73 40.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.355 179.227 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -113.94 135.93 53.45 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.402 -179.305 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -95.74 106.67 18.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.952 0.406 . . . . 0.0 111.897 -179.678 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -99.17 -9.52 23.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.602 179.095 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.521 ' HG ' ' CG ' ' A' ' 48' ' ' HIS . 0.7 OUTLIER -72.45 102.93 3.32 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.489 179.785 . . . . . . . . 3 3 . 1 . 097 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 99.1 p -87.45 -1.58 58.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.083 0.468 . . . . 0.0 109.92 179.445 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -112.11 -35.81 5.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.378 -179.916 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 31.4 m-20 -144.27 90.42 6.69 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.607 179.675 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.38 147.1 48.24 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 123.108 2.539 . . . . 0.0 113.445 -178.298 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 58.8 m -71.85 130.41 40.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.32 179.609 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -98.91 143.57 29.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.771 179.637 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.0 t -131.67 133.22 61.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 179.161 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 54.04 33.62 18.03 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 119.491 -0.884 . . . . 0.0 109.286 179.489 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.34 28.73 69.34 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.235 179.627 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.1 m -139.27 133.0 30.65 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 117.439 0.619 . . . . 0.0 112.227 -179.854 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -72.28 137.91 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.213 179.75 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.543 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 1.7 pt -119.07 115.85 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 121.194 0.521 . . . . 0.0 110.057 178.737 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -82.37 -18.5 41.83 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.165 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.558 ' CD ' ' H ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -124.89 164.71 29.67 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.875 -179.975 . . . . . . . . 3 3 . 1 . 097 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -63.54 153.4 75.09 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 C-N-CA 122.789 2.326 . . . . 0.0 112.473 179.816 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.3 p -142.76 147.59 20.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.719 -179.259 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -78.65 129.95 35.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.746 179.294 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.0 mt -85.44 137.92 32.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.15 0.5 . . . . 0.0 111.257 -179.085 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -128.45 150.87 49.95 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.106 179.578 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.622 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 8.5 t60 -53.13 120.65 6.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.979 0.418 . . . . 0.0 111.156 -179.505 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.14 -20.82 23.28 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 179.746 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -67.56 136.03 53.88 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.053 0.454 . . . . 0.0 110.812 -179.814 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.1 t -116.53 132.18 66.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.058 -178.796 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 93.3 mt -92.6 131.77 38.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.291 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 54.5 m -123.47 124.71 43.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.8 0.809 . . . . 0.0 112.817 -178.41 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.492 ' O ' ' C ' ' A' ' 91' ' ' ILE . 96.5 mt -110.68 124.07 67.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.35 177.874 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.492 ' C ' ' O ' ' A' ' 90' ' ' ILE . 73.1 mt 33.98 -95.5 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.724 179.575 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' A' ' 90' ' ' ILE . 97.9 m-20 -113.72 9.52 17.75 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.557 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.715 ' HE ' HH22 ' B' ' 245' ' ' ARG . 97.5 mtt180 -125.08 144.25 50.51 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.513 -179.114 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.5 m -139.89 152.47 46.46 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.522 0.677 . . . . 0.0 111.388 -179.125 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -125.62 121.98 35.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.572 179.81 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -80.3 128.2 33.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.072 0.463 . . . . 0.0 111.639 -178.957 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -97.35 123.86 41.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.315 179.478 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -126.44 125.66 42.51 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.796 179.984 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.622 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 61.5 t-20 -114.26 113.79 25.08 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.255 179.443 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 . . . . . 0 N--CA 1.466 0.343 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.98 -179.632 . . . . . . . . 0 0 . 1 . 097 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 12.8 m . . . . . 0 N--CA 1.452 -0.365 0 CA-C-O 120.763 0.316 . . . . 0.0 110.703 . . . . . . . . . 0 0 . 1 . 097 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 49.6 p-10 -114.05 43.3 1.87 Allowed 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.445 -179.187 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . 0.67 ' O ' ' NE2' ' B' ' 231' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.67 ' NE2' ' O ' ' B' ' 230' ' ' SEP . 0.0 OUTLIER -141.09 -48.23 0.41 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.93 179.778 . . . . . . . . 3 3 . 1 . 097 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -84.09 159.3 35.6 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.052 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -66.92 140.89 56.52 Favored 'Trans proline' 0 C--N 1.297 -2.177 0 C-N-CA 122.739 2.293 . . . . 0.0 112.653 -179.37 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . 0.649 ' P ' ' H ' ' B' ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -75.83 148.17 31.81 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 C-N-CA 121.697 1.598 . . . . 0.0 112.453 179.133 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 53.7 t -63.35 136.4 26.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.088 179.942 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 4.2 t -70.53 134.64 47.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.446 -179.743 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . 0.437 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . 0.437 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 36.7 Cg_exo -57.26 -29.15 82.79 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 123.03 2.487 . . . . 0.0 112.472 -178.986 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 16.1 m -66.78 -45.12 79.46 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.35 0.595 . . . . 0.0 109.529 178.644 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . 0.447 ' CE2' HG23 ' A' ' 43' ' ' VAL . 79.6 t80 -59.18 -46.13 89.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.034 -178.827 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 99.7 mt -64.58 -40.06 94.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.736 0.303 . . . . 0.0 111.332 -178.978 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 -62.95 -39.62 95.21 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.735 -179.289 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 87.7 mtm180 -64.03 -42.19 97.17 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.334 179.942 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.715 HH22 ' HE ' ' A' ' 93' ' ' ARG . 75.9 mtp85 -61.12 -41.33 96.52 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.781 -179.196 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -62.75 -41.36 99.17 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.479 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 8.7 t -63.59 -45.67 89.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.364 177.979 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -60.14 -39.11 85.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.128 -179.378 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 74.3 t -62.31 -43.88 98.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.256 -0.578 . . . . 0.0 110.274 179.643 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -63.61 -34.91 78.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.302 0.572 . . . . 0.0 109.78 179.116 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -80.12 -11.35 59.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.357 179.691 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 75.4 mt -110.52 -175.06 2.63 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.861 179.298 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . 0.555 ' CG ' ' H ' ' B' ' 254' ' ' ASP . 44.5 p-10 -125.62 -123.23 0.25 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.763 -179.869 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . 0.576 ' C ' ' H ' ' B' ' 256' ' ' ASP . 82.9 m-20 -79.1 4.03 15.8 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 178.634 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . 0.518 ' O ' ' O ' ' B' ' 256' ' ' ASP . 80.6 m-20 60.01 3.03 0.45 Allowed 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.291 -178.498 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.576 ' H ' ' C ' ' B' ' 254' ' ' ASP . 63.7 t0 47.13 109.74 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.694 -179.324 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . 0.552 ' C ' ' O ' ' B' ' 256' ' ' ASP . 98.9 mttt 13.29 -101.42 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 O-C-N 123.738 0.649 . . . . 0.0 111.559 179.983 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' B' ' 257' ' ' LYS . 89.0 m-20 -35.05 119.92 0.5 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.122 -179.729 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.605 ' CG ' ' H ' ' B' ' 260' ' ' GLU . 28.8 t70 -127.11 -174.22 3.1 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.055 0.455 . . . . 0.0 110.076 179.197 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.616 ' OE1' ' NH2' ' A' ' 93' ' ' ARG . 93.8 mt-10 -59.01 9.36 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.371 -178.762 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . 0.592 ' H ' ' C ' ' B' ' 259' ' ' ASP . 59.5 mt -108.87 133.28 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.95 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 44.7 t -127.69 134.91 64.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.975 0.416 . . . . 0.0 111.109 -178.959 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -95.57 119.45 34.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.627 -178.767 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -64.79 -48.47 74.34 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.472 -179.517 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . 0.412 ' CD ' ' CD1' ' A' ' 24' ' ' LEU . 2.3 mt-30 -82.42 167.96 26.68 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.291 -179.236 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.85 144.98 89.92 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 121.701 1.601 . . . . 0.0 111.904 -179.554 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . 0.451 ' CD1' ' O ' ' A' ' 19' ' ' HIS . 7.8 tt . . . . . 0 C--N 1.321 -0.635 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.302 -179.275 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo . . . . . 0 N--CA 1.498 1.774 0 CA-C-O 121.388 0.495 . . . . 0.0 113.235 . . . . . . . . . 0 0 . 1 . 098 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.9 p -108.92 -46.91 3.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.384 -179.966 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 89.6 mtm-85 -92.53 131.91 37.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.786 -179.398 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -133.01 141.93 48.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.011 0.434 . . . . 0.0 111.693 -179.927 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 26.4 tp -114.92 130.0 56.82 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.787 179.729 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 56.1 t -106.58 128.95 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.288 -179.012 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 m -80.27 140.46 36.2 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.263 0.554 . . . . 0.0 111.365 -179.833 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.493 ' CD1' ' OD1' ' A' ' 16' ' ' ASP . 50.6 mm -113.19 137.95 44.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.549 179.609 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -90.66 156.71 17.91 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.716 179.367 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -59.36 -24.0 63.02 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.172 179.676 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 81.8 p -81.61 -10.92 59.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.069 0.461 . . . . 0.0 109.856 179.301 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.02 34.34 8.94 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 -179.975 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.2 t -118.06 131.75 69.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.742 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.493 ' OD1' ' CD1' ' A' ' 10' ' ' ILE . 89.4 m-20 -72.4 134.05 45.21 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.229 -0.589 . . . . 0.0 109.628 179.264 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -118.53 -125.37 3.46 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.48 -179.1 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.59 152.71 38.41 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.372 2.048 . . . . 0.0 112.537 -178.689 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 10.6 m80 -102.71 154.61 18.99 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.907 0.384 . . . . 0.0 110.627 179.549 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -124.71 91.21 49.81 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.829 179.557 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -60.6 129.66 30.32 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.206 1.937 . . . . 0.0 111.719 179.872 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 90.6 mt -88.81 84.25 6.67 Favored 'General case' 0 N--CA 1.461 0.119 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.974 -179.302 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.2 p -86.21 -10.53 54.51 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.653 179.411 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.445 ' CD1' ' CD ' ' B' ' 265' ' ' GLN . 66.4 mt -102.14 145.77 28.89 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.094 -179.405 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 81.9 p -68.33 -15.9 63.74 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.045 0.45 . . . . 0.0 110.833 -179.257 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 46.3 m -128.47 132.43 48.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.674 -179.201 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.9 t -126.23 114.17 17.95 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.765 178.611 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.414 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 57.6 tp -111.31 122.51 48.05 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.906 0.384 . . . . 0.0 111.413 -178.459 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.537 ' O ' ' O ' ' A' ' 47' ' ' GLN . 11.1 m-85 -101.95 142.56 33.06 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.404 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 156.04 -169.63 33.67 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 120.136 -1.031 . . . . 0.0 112.453 179.17 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 31.9 ttp85 -89.28 -32.5 17.35 Favored 'General case' 0 N--CA 1.461 0.096 0 CA-C-O 120.817 0.342 . . . . 0.0 110.824 -179.899 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.432 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -50.36 145.41 9.7 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 -179.879 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 35.7 mm -63.69 -43.93 98.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.555 -179.614 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -54.8 -18.14 4.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.473 179.778 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.432 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 51.2 m -62.1 128.55 36.68 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.162 179.944 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.414 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 61.7 m-20 -58.97 -30.7 68.13 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -178.9 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.437 ' CD1' ' CE2' ' A' ' 29' ' ' PHE . 79.4 mt -126.5 121.74 59.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 177.126 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 47.6 mtt180 -101.12 136.06 41.59 Favored 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.266 -178.724 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.446 ' C ' ' H ' ' A' ' 41' ' ' LEU . 91.7 mt -117.12 125.33 73.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.995 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -70.92 39.07 0.05 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.308 -177.686 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.446 ' H ' ' C ' ' A' ' 39' ' ' ILE . 43.3 mt -112.69 125.17 30.37 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 120.556 -0.458 . . . . 0.0 109.796 179.16 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.56 -2.75 12.61 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.224 1.949 . . . . 0.0 112.61 -179.143 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.41 HG22 ' CE2' ' B' ' 241' ' ' PHE . 33.3 m -109.1 2.97 9.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.767 179.088 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.463 ' O ' ' O ' ' A' ' 45' ' ' SER . 2.7 t -89.72 109.7 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 120.703 0.287 . . . . 0.0 110.592 -179.865 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.58 ' OG ' ' N ' ' A' ' 48' ' ' HIS . 1.1 t -31.79 152.08 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.384 0.611 . . . . 0.0 111.775 -178.771 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.567 ' N ' ' HG ' ' A' ' 45' ' ' SER . 95.4 mttt -63.26 -43.0 99.21 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.04 -179.194 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.605 ' O ' ' N ' ' A' ' 49' ' ' CYS . 13.3 mm100 -108.9 -26.43 10.24 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.635 0.731 . . . . 0.0 109.113 179.205 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.58 ' N ' ' OG ' ' A' ' 45' ' ' SER . 36.5 t60 39.68 -74.46 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.257 -1.338 . . . . 0.0 113.681 179.471 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.605 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.54 136.44 46.62 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -177.985 . . . . . . . . 3 3 . 1 . 098 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -128.07 127.67 43.53 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.803 179.317 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.3 mt -108.85 133.78 52.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.297 179.838 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.581 ' CD ' ' HE2' ' A' ' 54' ' ' HIS . 82.1 tt0 -118.73 123.81 45.78 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.006 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.0 mt -106.85 116.0 49.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -178.565 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.581 ' HE2' ' CD ' ' A' ' 52' ' ' GLU . 96.9 m-70 -111.32 143.51 42.0 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.123 178.366 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.9 mm-40 -39.35 -26.85 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.278 0.561 . . . . 0.0 109.761 -179.841 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.53 ' N ' ' O ' ' A' ' 54' ' ' HIS . 47.2 tp60 -67.89 -68.3 0.4 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.262 178.918 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -158.92 -165.79 1.71 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.25 179.734 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.88 131.52 54.99 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.013 179.843 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 93.5 mt -121.41 132.31 70.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.233 0.54 . . . . 0.0 112.003 -179.09 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 37.0 tp -101.53 125.69 48.22 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.758 -179.175 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -110.81 135.97 50.57 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.636 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -97.94 105.34 17.47 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -178.123 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -98.28 -8.6 26.9 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.624 179.13 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.4 ' OG ' ' ND1' ' A' ' 48' ' ' HIS . 0.2 OUTLIER -78.2 98.23 5.78 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.985 0.422 . . . . 0.0 110.557 -179.716 . . . . . . . . 3 3 . 1 . 098 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.7 m -84.55 -33.94 23.34 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.886 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.4 m -64.41 -50.64 66.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.843 179.64 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -136.28 96.74 12.34 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.831 -179.752 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -55.29 143.43 75.95 Favored 'Trans proline' 0 N--CA 1.499 1.822 0 C-N-CA 122.151 1.901 . . . . 0.0 112.856 -178.822 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 18.2 m -72.06 140.34 48.92 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.406 179.93 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -104.01 140.35 37.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.438 -179.96 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 49.3 t -130.1 137.09 57.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.907 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 7.9 m120 54.05 32.55 15.83 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.267 -0.573 . . . . 0.0 109.791 -179.643 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.22 29.18 72.13 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.05 179.623 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 49.8 m -141.28 135.65 30.84 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.163 -179.996 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.4 p -70.86 136.32 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 121.181 0.515 . . . . 0.0 111.681 -179.303 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.597 ' CD1' ' O ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -132.68 125.25 52.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.837 179.77 . . . . . . . . 3 3 . 1 . 098 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -99.32 -9.02 24.08 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.121 -179.713 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.597 ' O ' ' CD1' ' A' ' 76' ' ' ILE . 16.3 mt-10 -119.6 156.72 53.3 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.299 -179.082 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -62.52 148.15 93.76 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.48 2.12 . . . . 0.0 112.702 -179.951 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.5 m -143.76 145.4 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.427 -179.608 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 87.3 mtm-85 -73.35 130.2 39.66 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.529 179.349 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.0 mt -85.35 140.69 30.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.278 0.561 . . . . 0.0 111.274 -179.682 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -133.62 157.51 45.57 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.256 -179.661 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.562 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 5.5 t60 -58.81 117.19 4.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.242 -179.664 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.65 -1.29 29.06 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 -179.365 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.415 ' C ' ' OD1' ' A' ' 86' ' ' ASP . 60.7 t0 -86.17 125.36 33.46 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.027 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.409 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 9.5 p -103.38 135.37 41.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 C-N-CA 120.461 -0.495 . . . . 0.0 111.543 -178.875 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 33.2 mm -96.14 128.28 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 177.789 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 36.3 m -122.79 121.55 36.56 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 119.688 -0.805 . . . . 0.0 113.08 -178.27 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.467 ' O ' ' C ' ' A' ' 91' ' ' ILE . 93.3 mt -110.36 124.79 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 114.624 -1.171 . . . . 0.0 108.623 177.672 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.467 ' C ' ' O ' ' A' ' 90' ' ' ILE . 61.1 mt 33.54 -99.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 121.034 -0.267 . . . . 0.0 111.195 179.7 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.506 ' O ' ' OD1' ' A' ' 92' ' ' ASP . 59.3 t0 -112.98 15.61 19.61 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.489 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.511 HH21 ' CD ' ' B' ' 260' ' ' GLU . 87.3 mtt-85 -129.32 140.61 51.34 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.128 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 75.2 m -137.17 154.73 50.16 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 119.958 -0.697 . . . . 0.0 111.585 -179.491 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -125.17 121.43 34.16 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.209 179.689 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 79.1 mtp85 -85.82 134.05 33.94 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.617 -179.685 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -93.53 123.76 37.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.736 -179.825 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -125.09 119.24 28.05 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.778 -179.769 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.562 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 59.7 t-20 -99.74 110.03 22.44 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.266 -179.754 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.466 0.337 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.359 179.725 . . . . . . . . 0 0 . 1 . 098 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 33.0 m . . . . . 0 CA--C 1.531 0.214 0 CA-C-O 121.006 0.431 . . . . 0.0 110.396 . . . . . . . . . 0 0 . 1 . 098 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.509 ' O ' ' CB ' ' B' ' 230' ' ' SEP . 55.8 m-20 -63.9 -34.47 78.04 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.422 179.858 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . 0.509 ' CB ' ' O ' ' B' ' 229' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 75.0 mm-40 -113.89 59.17 0.67 Allowed 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 179.192 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -154.57 127.9 2.21 Favored Glycine 0 CA--C 1.535 1.292 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 -179.812 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -50.63 132.74 36.88 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 121.883 1.722 . . . . 0.0 112.55 -179.45 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . 0.737 ' P ' ' H ' ' B' ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -75.35 151.6 38.17 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 122.554 2.169 . . . . 0.0 112.69 179.494 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 3.3 p -69.22 138.11 22.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.558 -0.747 . . . . 0.0 111.275 -178.841 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.5 t -81.66 134.03 35.43 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.168 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . 0.472 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . 0.472 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 47.7 Cg_exo -57.97 -30.2 89.11 Favored 'Trans proline' 0 N--CA 1.502 2.001 0 C-N-CA 123.771 2.98 . . . . 0.0 113.189 -179.641 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 89.4 m -72.21 -44.75 62.5 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.396 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . 0.5 ' CE2' ' NE ' ' B' ' 245' ' ' ARG . 80.8 t80 -57.33 -46.5 83.18 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.072 -179.777 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 91.2 mt -64.19 -43.09 96.15 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 -179.936 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -65.52 -39.93 92.39 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.061 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 53.8 ttt85 -62.97 -46.22 88.73 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.354 -179.563 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.5 ' NE ' ' CE2' ' B' ' 241' ' ' PHE . 45.4 mtm180 -66.97 -37.9 85.1 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.903 -179.801 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -60.43 -45.94 91.82 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.207 -179.423 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 11.6 t -64.78 -44.66 89.29 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.677 178.681 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -63.52 -32.22 73.61 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.868 179.884 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 71.9 t -67.85 -43.07 86.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.286 -0.566 . . . . 0.0 109.644 179.46 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -62.5 -30.14 71.06 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.151 179.477 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -92.13 2.24 56.71 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.627 179.321 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.544 ' CD1' ' OD1' ' B' ' 256' ' ' ASP . 49.1 tp -110.66 125.14 53.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.466 -179.61 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . 0.513 ' ND2' ' CG ' ' B' ' 255' ' ' ASP . 12.5 p-10 -74.61 173.38 10.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.44 0.638 . . . . 0.0 111.872 -178.526 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -70.15 -5.0 24.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.224 -179.455 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . 0.552 ' OD1' ' N ' ' B' ' 256' ' ' ASP . 48.5 p-10 -58.06 -18.65 26.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.788 0.327 . . . . 0.0 110.192 -179.829 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.552 ' N ' ' OD1' ' B' ' 255' ' ' ASP . 1.6 m-20 -79.95 48.46 0.97 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.124 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -63.03 -14.44 48.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.126 179.801 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -62.85 -43.5 98.63 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.182 179.763 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.665 ' C ' ' H ' ' B' ' 261' ' ' ILE . 66.6 t0 65.59 125.47 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.111 0.482 . . . . 0.0 110.532 -178.853 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.511 ' CD ' HH21 ' A' ' 93' ' ' ARG . 95.4 mt-10 -57.2 16.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.18 -179.102 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . 0.665 ' H ' ' C ' ' B' ' 259' ' ' ASP . 74.0 mt -111.96 134.69 53.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.269 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 73.9 t -127.1 133.72 67.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.955 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -94.97 121.23 36.36 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.132 0.491 . . . . 0.0 111.483 -177.303 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -64.51 -43.99 92.34 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.956 179.606 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . 0.445 ' CD ' ' CD1' ' A' ' 24' ' ' LEU . 2.1 mt-30 -89.05 167.14 18.82 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.191 -178.068 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.77 149.27 60.21 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.744 2.296 . . . . 0.0 112.115 -179.885 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . 0.418 ' CD1' ' N ' ' B' ' 267' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.394 0 CA-C-O 121.594 0.712 . . . . 0.0 109.448 179.568 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo . . . . . 0 N--CA 1.499 1.796 0 CA-C-O 121.139 0.391 . . . . 0.0 113.001 . . . . . . . . . 0 0 . 1 . 099 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 36.1 p -70.62 -39.26 73.86 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.218 -179.292 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.58 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 94.6 mtt-85 -90.48 123.76 34.44 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.659 -0.417 . . . . 0.0 111.709 -178.034 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.7 mtm-85 -127.7 130.53 49.01 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 121.113 0.482 . . . . 0.0 110.497 179.155 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 51.7 tp -113.01 125.14 54.08 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.885 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.7 m -104.7 133.44 48.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.42 -178.94 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.9 m -83.03 143.81 30.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.771 -179.268 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.411 HG22 HD13 ' A' ' 10' ' ' ILE . 97.2 mt -116.88 140.98 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.464 177.687 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -92.32 156.54 17.18 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.587 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.04 -15.87 37.24 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.779 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.6 p -77.16 -19.53 56.7 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.103 178.131 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.57 14.02 42.32 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.48 178.984 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.4 m -113.15 144.48 20.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.023 0.44 . . . . 0.0 111.101 -179.891 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 17' ' ' GLY . 61.9 t0 -80.1 130.47 35.27 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.999 -179.363 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.462 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -116.84 -122.55 3.35 Favored Glycine 0 CA--C 1.535 1.334 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 -179.803 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -71.97 151.77 56.67 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 121.737 1.625 . . . . 0.0 112.653 -178.913 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -108.28 151.65 25.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.989 0.423 . . . . 0.0 110.344 -179.508 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -120.09 96.91 49.4 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.478 -179.066 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.57 137.26 20.28 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 121.024 1.15 . . . . 0.0 111.686 -179.252 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.1 mt -99.21 120.76 40.05 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 119.884 -0.726 . . . . 0.0 111.848 -178.717 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.7 p -122.4 -0.46 9.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.64 178.366 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 63.6 mt -105.85 149.34 26.6 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.994 -179.054 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.3 p -69.39 -21.0 63.81 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.984 -179.397 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 42.8 m -128.8 131.96 47.82 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.056 -179.829 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.486 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -132.85 126.38 32.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.274 178.205 . . . . . . . . 3 3 . 1 . 099 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 33.3 tp -122.23 133.23 54.71 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.973 -178.056 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.505 ' O ' ' O ' ' A' ' 47' ' ' GLN . 51.0 m-85 -106.06 138.19 42.68 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.323 -0.853 . . . . 0.0 108.925 178.808 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 155.04 -172.85 33.38 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 120.381 -0.914 . . . . 0.0 111.731 179.181 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.42 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 46.7 mtm105 -81.32 -31.27 33.61 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -179.467 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.506 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -48.06 148.36 4.05 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.706 -179.004 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.437 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 9.9 tp -65.79 -43.45 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 120.695 0.283 . . . . 0.0 111.037 179.733 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.437 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 81.8 tt0 -59.39 -18.38 38.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.416 -179.736 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 33.4 m -57.84 126.81 29.02 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.739 -179.327 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.524 ' CG ' HE22 ' B' ' 265' ' ' GLN . 50.1 m-20 -62.59 -33.9 75.9 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.523 -179.606 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 40.6 mm -119.87 111.33 32.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 177.312 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.419 ' NH2' ' O3P' ' B' ' 230' ' ' SEP . 85.2 mtp180 -99.23 132.45 44.54 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 120.681 -0.407 . . . . 0.0 110.225 -179.403 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 80.7 mt -122.71 131.76 72.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.803 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -82.31 32.95 0.4 Allowed 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -177.859 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 70.3 mt -96.1 131.11 29.49 Favored Pre-proline 0 N--CA 1.469 0.483 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.121 178.992 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -73.4 -14.46 25.23 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.169 1.913 . . . . 0.0 112.156 179.672 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.3 m -93.07 7.14 5.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.602 179.931 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.42 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 24.3 t -101.37 134.46 41.57 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.482 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.5 m -71.84 168.14 18.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.282 0.563 . . . . 0.0 111.14 -179.131 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -60.91 -39.15 88.26 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.114 -178.98 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.602 ' O ' ' N ' ' A' ' 49' ' ' CYS . 13.4 mm100 -112.47 -18.07 12.52 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.619 0.247 . . . . 0.0 110.725 -179.828 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 23.3 t60 36.66 -75.9 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 179.634 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.602 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.1 OUTLIER -136.68 139.19 41.8 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.796 -178.581 . . . . . . . . 3 3 . 1 . 099 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -124.65 139.11 54.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.848 179.572 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 17.3 tt -128.95 138.29 54.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.143 179.959 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -117.22 137.84 52.1 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.015 179.144 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.7 mm -103.36 124.26 57.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.514 0.673 . . . . 0.0 111.159 -179.318 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.474 ' O ' ' N ' ' A' ' 56' ' ' GLN . 50.3 m-70 -125.41 132.15 52.81 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.17 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.473 ' C ' ' O ' ' A' ' 54' ' ' HIS . 97.7 mt-10 -39.59 -30.56 0.07 Allowed 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.125 -178.8 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.474 ' N ' ' O ' ' A' ' 54' ' ' HIS . 98.6 mt-30 -65.37 -69.9 0.27 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.264 179.33 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -154.88 -159.47 0.95 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.691 -179.777 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -119.71 137.9 53.63 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.864 0.364 . . . . 0.0 110.601 -179.84 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.3 mm -111.61 120.6 62.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.11 179.936 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.7 tp -98.22 126.04 43.53 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.248 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -113.34 136.14 53.09 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.817 -179.412 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.429 HD22 ' HA ' ' A' ' 68' ' ' PRO . 61.2 t-20 -96.21 109.8 22.21 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.98 0.419 . . . . 0.0 111.683 179.915 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -102.38 -9.41 20.33 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.343 179.4 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.22 98.8 9.58 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.821 0.343 . . . . 0.0 111.185 -179.296 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.3 p -78.77 -38.5 38.44 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.967 0.413 . . . . 0.0 109.959 178.729 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.41 -44.57 90.83 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.647 -179.488 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.411 ' CG ' ' H ' ' B' ' 237' ' ' CYS . 89.9 m-20 -139.41 89.56 12.03 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.188 179.897 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.429 ' HA ' HD22 ' A' ' 62' ' ' ASN . 46.4 Cg_exo -54.14 145.59 53.17 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.427 2.085 . . . . 0.0 112.449 -179.675 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.5 m -75.91 143.81 41.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.907 -179.175 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -103.88 142.84 33.7 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.658 179.994 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.48 ' CG2' ' OD1' ' A' ' 86' ' ' ASP . 4.5 p -131.33 135.47 59.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.198 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 51.92 28.95 5.57 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -179.576 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.86 27.45 64.71 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.319 179.995 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.415 ' N ' ' O ' ' A' ' 71' ' ' VAL . 25.5 m -139.9 140.5 36.46 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.86 -179.498 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 51.1 t -68.42 136.96 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -179.309 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.3 pt -110.74 79.68 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.226 0 CA-C-O 121.118 0.485 . . . . 0.0 111.491 179.188 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -61.13 -31.76 71.46 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.918 179.326 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.585 ' N ' ' OE1' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -114.84 159.6 36.79 Favored Pre-proline 0 CA--C 1.517 -0.305 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.766 . . . . . . . . 3 3 . 1 . 099 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -62.49 144.51 94.78 Favored 'Trans proline' 0 C--N 1.294 -2.341 0 C-N-CA 122.462 2.108 . . . . 0.0 111.72 -179.343 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 44.1 t -135.09 138.21 49.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.94 -179.151 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -74.63 137.65 42.39 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.831 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 93.3 mt -91.46 141.0 29.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.177 0.513 . . . . 0.0 112.349 -178.782 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -129.91 154.42 47.34 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.076 179.293 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.626 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 5.8 t60 -53.03 117.21 2.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.71 -179.565 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.38 -22.03 12.42 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 179.56 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 87' ' ' VAL . 59.4 t0 -62.76 130.27 44.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.259 0.552 . . . . 0.0 111.292 -179.873 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.526 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 61.7 t -105.65 133.05 51.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.231 -179.247 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 86.4 mt -103.12 128.74 55.82 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.639 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.8 m -119.06 129.01 54.86 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -178.422 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.674 ' O ' ' N ' ' A' ' 93' ' ' ARG . 98.6 mt -115.84 133.96 60.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 113.974 -1.466 . . . . 0.0 107.826 177.121 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.514 ' C ' ' O ' ' A' ' 90' ' ' ILE . 77.5 mt -19.12 94.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.028 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.42 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 0.4 OUTLIER 80.34 -13.22 0.96 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 177.771 . . . . . . . . 3 3 . 1 . 099 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.674 ' N ' ' O ' ' A' ' 90' ' ' ILE . 88.2 mtt180 -128.4 137.92 52.1 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.564 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 62.6 p -139.27 156.7 46.88 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.396 0.617 . . . . 0.0 110.697 -179.549 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -130.63 127.33 38.73 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.496 -0.775 . . . . 0.0 108.995 179.596 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -94.91 138.15 33.05 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.832 -179.514 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.58 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 83.1 t80 -96.71 126.1 41.64 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.876 -179.087 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -124.81 119.73 29.72 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.828 179.521 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.626 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 59.7 t-20 -102.67 107.77 18.8 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.124 -179.462 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 99' ' ' ASN . 81.4 tt0 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.274 179.282 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 32.6 m . . . . . 0 N--CA 1.454 -0.262 0 CA-C-O 120.618 0.247 . . . . 0.0 110.799 . . . . . . . . . 0 0 . 1 . 099 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.419 ' O ' ' CB ' ' B' ' 230' ' ' SEP . 95.9 m-20 -89.28 1.53 55.61 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.424 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . 0.419 ' CB ' ' O ' ' B' ' 229' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 174.87 39.12 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.731 179.9 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -121.88 -176.53 15.2 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.604 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.11 155.88 66.73 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 123.09 2.527 . . . . 0.0 112.632 -179.706 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 099 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -57.59 132.12 48.49 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 123.044 2.496 . . . . 0.0 113.654 179.338 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 38.8 t -61.77 137.47 23.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.461 179.213 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . 0.411 ' H ' ' CG ' ' A' ' 67' ' ' ASN . 0.7 OUTLIER -53.5 112.16 0.85 Allowed 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.263 -178.902 . . . . . . . . 3 3 . 1 . 099 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 099 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -56.38 -24.27 51.08 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 121.833 1.688 . . . . 0.0 111.601 179.678 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 94.7 m -72.89 -46.05 54.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.952 179.095 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -59.33 -45.63 90.83 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.579 -178.528 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 77.4 mt -65.32 -44.31 88.22 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.992 -179.178 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -62.48 -41.01 98.49 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.558 -179.098 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -63.84 -46.33 85.55 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.311 -179.251 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . . . . . . . . . 57.1 ttm-85 -64.82 -42.95 94.57 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.133 -179.246 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -63.27 -39.11 93.68 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.37 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 38.7 t -63.53 -44.98 92.64 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.674 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -58.61 -37.23 75.42 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.815 -179.687 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . 0.401 HG11 ' N ' ' B' ' 250' ' ' ALA . 0.3 OUTLIER -69.2 -40.18 80.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.896 179.839 . . . . . . . . 3 3 . 1 . 099 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . 0.401 ' N ' HG11 ' B' ' 249' ' ' VAL . . . -60.63 -35.07 75.29 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.803 0.335 . . . . 0.0 111.031 -179.687 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -98.69 10.4 41.2 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.686 -178.973 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 61.4 tp -116.55 129.12 56.0 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.992 0.425 . . . . 0.0 110.254 179.66 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . 0.641 ' C ' ' H ' ' B' ' 255' ' ' ASP . 24.5 m-80 -74.2 173.72 9.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.229 0.537 . . . . 0.0 111.686 -178.896 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 52.6 p-10 -54.76 4.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.393 -179.55 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . 0.641 ' H ' ' C ' ' B' ' 253' ' ' ASN . 44.8 p-10 -65.85 -20.92 66.41 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 120.854 0.359 . . . . 0.0 110.826 -179.659 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.714 ' O ' ' N ' ' B' ' 258' ' ' ASP . 45.0 p-10 -51.68 -21.02 2.35 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.182 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' B' ' 256' ' ' ASP . 86.7 tttt -20.88 -35.1 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.089 -0.96 . . . . 0.0 112.526 -179.239 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.714 ' N ' ' O ' ' B' ' 256' ' ' ASP . 88.4 m-20 -56.11 -48.73 75.64 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 119.646 -0.822 . . . . 0.0 108.833 179.465 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.621 ' C ' ' H ' ' B' ' 261' ' ' ILE . 43.8 t0 72.37 116.36 0.05 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.544 178.816 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.538 ' OE1' ' N ' ' B' ' 260' ' ' GLU . 56.8 mp0 -62.6 15.61 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.551 -179.462 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . 0.621 ' H ' ' C ' ' B' ' 259' ' ' ASP . 72.1 mt -109.81 137.98 39.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.705 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 55.2 t -127.42 134.45 65.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 C-N-CA 120.202 -0.599 . . . . 0.0 111.239 -178.506 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -93.7 118.01 30.83 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.379 -178.861 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -67.02 -46.94 72.94 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.61 179.751 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . 0.524 HE22 ' CG ' ' A' ' 36' ' ' ASP . 2.1 mp0 -81.6 162.64 57.43 Favored Pre-proline 0 CA--C 1.514 -0.422 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.934 -178.785 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.9 144.49 58.84 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 121.617 1.545 . . . . 0.0 111.643 179.088 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 43.3 pt . . . . . 0 C--N 1.32 -0.717 0 CA-C-O 121.386 0.613 . . . . 0.0 109.43 178.553 . . . . . . . . 0 0 . 1 . 100 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo . . . . . 0 N--CA 1.494 1.548 0 CA-C-O 120.709 0.212 . . . . 0.0 111.667 . . . . . . . . . 0 0 . 1 . 100 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.459 ' H ' ' HG1' ' A' ' 4' ' ' THR . 11.0 p -86.74 -38.22 17.14 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.943 179.407 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.742 ' NH1' ' HH ' ' A' ' 97' ' ' TYR . 92.2 mtt-85 -92.47 124.08 36.25 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.268 -179.177 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -130.15 139.57 50.86 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.551 -179.877 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 33.5 tp -115.95 130.91 57.03 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.274 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.3 m -111.25 134.32 53.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 C-N-CA 120.744 -0.383 . . . . 0.0 110.77 -179.779 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.5 m -95.02 117.87 30.89 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -177.817 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.6 mt -80.94 144.27 10.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.13 178.443 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -92.64 163.8 13.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.755 178.8 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.625 ' CZ ' HH11 ' B' ' 245' ' ' ARG . 83.1 mtp180 -55.47 -30.54 60.77 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.885 -179.191 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 95.8 p -79.95 -7.58 58.86 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 120.666 -0.413 . . . . 0.0 111.521 -179.983 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.39 35.11 8.16 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.853 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.6 t -121.46 133.62 67.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.86 0.362 . . . . 0.0 110.626 -179.671 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -73.95 135.48 43.23 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 178.788 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.5 -116.95 1.93 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 120.412 -0.899 . . . . 0.0 111.699 -179.603 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -68.37 142.13 53.65 Favored 'Trans proline' 0 N--CA 1.49 1.276 0 C-N-CA 121.593 1.528 . . . . 0.0 112.545 -178.665 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 49.4 m170 -106.15 142.68 35.43 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.269 -179.377 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -113.32 93.32 26.01 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.272 -179.673 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -62.45 126.82 19.28 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 121.713 1.608 . . . . 0.0 110.387 179.7 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.6 mt -86.75 51.75 2.32 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.406 -178.719 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 88.9 p -61.67 -23.64 66.22 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.198 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 92.6 mt -77.61 139.03 39.45 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.264 179.36 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 99.3 p -66.4 -16.86 64.41 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.837 -178.461 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 61.8 m -138.83 138.44 37.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.565 0.222 . . . . 0.0 110.669 179.998 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.682 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -138.2 133.53 33.36 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.987 0.423 . . . . 0.0 110.69 179.205 . . . . . . . . 3 3 . 1 . 100 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 34.7 tp -123.04 131.45 53.71 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.745 -178.056 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.682 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 8.2 m-85 -107.2 141.95 37.69 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.115 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 158.5 -175.66 35.56 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.92 179.169 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.601 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 86.8 mtm-85 -74.94 -27.34 60.16 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 122.659 -0.318 . . . . 0.0 110.928 -179.935 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.566 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -59.14 138.05 49.83 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.154 -177.925 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.437 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 10.0 tp -66.51 -41.56 88.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.721 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.437 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 84.4 tt0 -51.93 -19.0 1.55 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.376 178.854 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.566 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 13.8 m -67.91 137.77 55.48 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.568 179.209 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -60.74 -33.77 73.42 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -179.251 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 96.8 mt -127.26 124.72 64.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.247 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.406 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 78.4 ttt-85 -109.34 134.23 52.07 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.115 -178.579 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 82.0 mt -116.45 130.59 71.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.929 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -78.82 26.04 0.25 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.792 -178.056 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.439 ' CD2' ' OE1' ' B' ' 260' ' ' GLU . 31.5 mt -95.37 125.96 47.86 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.977 179.947 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.69 -14.33 33.06 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.555 2.17 . . . . 0.0 113.056 -179.786 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.3 m -93.83 6.05 6.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.92 0.39 . . . . 0.0 110.7 -179.698 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.601 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 57.5 t -100.71 134.57 40.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.429 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.45 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 0.2 OUTLIER -66.07 167.71 9.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.165 0.507 . . . . 0.0 112.023 -178.658 . . . . . . . . 3 3 . 1 . 100 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -60.21 -42.67 95.62 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.664 -179.676 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.728 ' O ' ' N ' ' A' ' 49' ' ' CYS . 85.0 mt-30 -111.64 -12.15 13.93 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.463 179.675 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.45 ' H ' ' HB3' ' A' ' 45' ' ' SER . 27.7 t60 32.94 -68.17 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -179.852 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.728 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -142.87 143.87 32.25 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.202 -0.599 . . . . 0.0 112.152 -179.464 . . . . . . . . 3 3 . 1 . 100 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -125.18 137.62 54.14 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.832 179.436 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.8 tt -125.09 138.08 55.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.072 0.463 . . . . 0.0 110.128 -179.724 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -122.8 135.07 54.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.284 -179.463 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.7 mt -109.88 117.04 53.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.61 0.719 . . . . 0.0 111.949 -179.602 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.555 ' O ' ' N ' ' A' ' 56' ' ' GLN . 94.9 m-70 -116.37 142.52 46.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.475 -1.239 . . . . 0.0 110.351 -179.981 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 54' ' ' HIS . 80.8 mm-40 -39.88 -24.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.993 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.555 ' N ' ' O ' ' A' ' 54' ' ' HIS . 59.5 tt0 -69.47 -67.57 0.47 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.272 178.613 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.494 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 6.0 tp10 -161.12 -158.87 0.61 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.23 179.237 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.429 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -114.39 125.06 53.42 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.816 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.2 mt -114.12 130.91 67.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.129 0.49 . . . . 0.0 111.883 -178.447 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 56.5 tp -99.85 129.05 45.9 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.717 -179.391 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -113.59 136.72 52.5 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.542 179.65 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.413 ' ND2' ' HB3' ' A' ' 68' ' ' PRO . 29.9 t30 -95.28 108.79 20.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.04 0.447 . . . . 0.0 111.777 -179.962 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -98.78 -8.51 25.83 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.739 179.182 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.7 t -81.2 105.84 12.72 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.263 179.721 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.7 p -87.36 -20.36 26.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.244 0.545 . . . . 0.0 109.668 179.567 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -86.32 -33.58 20.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.196 -179.642 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 -150.84 93.95 3.64 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.17 179.926 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.413 ' HB3' ' ND2' ' A' ' 62' ' ' ASN . 32.2 Cg_exo -56.73 149.29 60.38 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.165 1.91 . . . . 0.0 112.009 -179.801 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 51.9 m -73.57 137.41 44.31 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.04 178.846 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -98.0 141.16 31.3 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.59 -179.768 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 51.8 t -126.45 134.11 67.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.21 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 51.65 33.18 10.35 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.974 -0.69 . . . . 0.0 109.416 -179.099 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.66 29.97 69.06 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.659 179.81 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.4 m -140.6 135.37 31.69 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 117.001 0.401 . . . . 0.0 111.142 -179.912 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.7 t -69.1 136.74 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.725 -179.606 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.55 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 1.1 pt -104.96 100.4 10.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-O 121.361 0.6 . . . . 0.0 110.677 178.959 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -65.45 -35.47 81.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.311 179.166 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -123.66 175.99 2.48 Favored Pre-proline 0 CA--C 1.536 0.404 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.548 -179.008 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.01 145.34 96.74 Favored 'Trans proline' 0 N--CA 1.501 1.926 0 C-N-CA 122.575 2.183 . . . . 0.0 111.954 -179.443 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.5 m -136.01 138.93 46.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.995 0.426 . . . . 0.0 112.14 -179.235 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -76.36 133.14 40.03 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 178.819 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 89.9 mt -89.43 136.01 33.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.413 0.625 . . . . 0.0 112.009 -178.589 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -121.26 148.61 44.06 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.742 179.014 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.714 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 9.2 t60 -54.49 123.04 11.84 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.931 0.396 . . . . 0.0 110.279 -179.577 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.13 -20.28 31.07 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.67 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -66.11 137.62 57.17 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.728 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.2 t -112.6 133.16 59.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.521 -178.368 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 92.2 mt -99.22 130.68 47.82 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 178.7 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 65.9 m -122.45 124.91 44.71 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.067 -0.653 . . . . 0.0 112.067 -178.735 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.514 ' N ' ' O ' ' A' ' 93' ' ' ARG . 77.0 mt -109.53 121.5 62.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.255 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.432 ' C ' ' O ' ' A' ' 90' ' ' ILE . 77.4 mt 35.24 -97.76 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.493 -179.867 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.562 ' OD2' ' NE ' ' B' ' 245' ' ' ARG . 42.0 p-10 -110.73 7.68 22.24 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.666 0.269 . . . . 0.0 111.633 -179.219 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.539 ' CZ ' ' O ' ' B' ' 259' ' ' ASP . 85.6 mtt-85 -124.01 144.4 49.85 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.667 179.916 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.7 p -137.9 151.02 47.59 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.49 0.662 . . . . 0.0 111.056 179.553 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.406 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 35.1 m-85 -124.01 122.11 37.04 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.324 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 74.7 mtp85 -87.85 135.22 33.49 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.851 -178.658 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.742 ' HH ' ' NH1' ' A' ' 5' ' ' ARG . 89.7 t80 -99.25 125.16 44.81 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.629 -179.669 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -143.77 125.46 15.03 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.475 179.472 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.714 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 95.4 m-20 -99.67 138.65 36.46 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.567 179.705 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 . . . . . 0 C--N 1.328 -0.327 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.803 . . . . . . . . 0 0 . 1 . 100 nuclear orig full ' B' B ' 228' ' ' VAL . . . . . 0.41 HG11 ' H ' ' B' ' 232' ' ' GLY . 61.6 t . . . . . 0 N--CA 1.448 -0.551 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 . . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.43 ' C ' ' H ' ' B' ' 231' ' ' GLN . 64.4 t0 -84.29 59.2 5.24 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.596 -179.458 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 100 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.43 ' H ' ' C ' ' B' ' 229' ' ' ASP . 0.0 OUTLIER -144.62 77.29 1.53 Allowed 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.091 179.651 . . . . . . . . 3 3 . 1 . 100 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . 0.41 ' H ' HG11 ' B' ' 228' ' ' VAL . . . -128.16 -173.3 13.42 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 121.026 -0.607 . . . . 0.0 111.795 -179.583 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -65.45 154.69 72.54 Favored 'Trans proline' 0 N--CA 1.499 1.85 0 C-N-CA 123.628 2.885 . . . . 0.0 112.638 -179.864 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 100 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -55.74 129.24 33.95 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.501 2.134 . . . . 0.0 113.342 -179.761 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 71.4 t -58.25 131.09 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.013 -179.806 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 4.5 t -51.81 113.35 0.97 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.644 -179.539 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 100 nuclear orig full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.04 -20.34 44.99 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.039 1.826 . . . . 0.0 111.945 179.536 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 29.3 m -72.72 -45.76 57.12 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.079 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -58.69 -45.97 88.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.729 -179.872 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 82.1 mt -64.41 -39.04 93.08 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.012 0.434 . . . . 0.0 110.28 -179.899 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -64.08 -39.94 95.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.16 -179.239 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -62.47 -41.42 98.75 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.987 0.422 . . . . 0.0 110.212 179.831 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' B' B ' 245' ' ' ARG . . . . . 0.625 HH11 ' CZ ' ' A' ' 12' ' ' ARG . 14.9 tpp180 -60.86 -42.38 97.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.081 -179.735 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.39 -42.87 98.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.727 179.738 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' B' B ' 247' ' ' SER . . . . . 0.458 ' HG ' ' H ' ' B' ' 248' ' ' GLN . 43.8 p -65.37 -44.01 88.94 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.834 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' B' B ' 248' ' ' GLN . . . . . 0.619 ' O ' ' N ' ' B' ' 252' ' ' LEU . 84.5 mt-30 -64.42 -34.48 78.27 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.919 179.737 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 79.7 t -60.99 -45.65 98.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 C-N-CA 120.271 -0.572 . . . . 0.0 109.919 179.788 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -65.62 -27.77 68.63 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.121 179.109 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -95.42 -13.88 24.26 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.014 -179.863 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' B' B ' 252' ' ' LEU . . . . . 0.619 ' N ' ' O ' ' B' ' 248' ' ' GLN . 46.4 tp -91.81 127.42 37.26 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.52 0.676 . . . . 0.0 111.576 -178.874 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -73.41 -147.78 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.512 -178.947 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -93.3 3.15 56.1 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.697 179.133 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' B' B ' 255' ' ' ASP . . . . . 0.604 ' C ' ' H ' ' B' ' 257' ' ' LYS . 98.0 m-20 -64.06 -12.29 37.52 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.208 -178.907 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 30.0 p-10 -65.49 37.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.878 0.371 . . . . 0.0 111.26 -179.854 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' B' B ' 257' ' ' LYS . . . . . 0.604 ' H ' ' C ' ' B' ' 255' ' ' ASP . 88.6 tttt -61.73 -40.64 95.81 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.457 -179.824 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.689 ' O ' ' N ' ' B' ' 260' ' ' GLU . 29.5 p-10 -94.7 9.26 39.57 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.87 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.539 ' O ' ' CZ ' ' A' ' 93' ' ' ARG . 55.2 p-10 8.1 48.32 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 113.917 -1.492 . . . . 0.0 113.507 179.622 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' B' B ' 260' ' ' GLU . . . . . 0.689 ' N ' ' O ' ' B' ' 258' ' ' ASP . 96.8 mt-10 60.05 9.07 1.66 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 178.782 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . 0.463 ' N ' ' O ' ' B' ' 258' ' ' ASP . 75.7 mt -117.14 134.27 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 C-N-CA 120.544 -0.462 . . . . 0.0 109.911 179.587 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 45.8 t -127.06 133.61 67.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.066 179.549 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -98.76 122.15 41.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.088 0.471 . . . . 0.0 111.857 -178.499 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -66.17 -43.11 87.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.134 178.356 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -102.2 174.16 3.06 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.344 -179.699 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -56.56 150.62 50.92 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 122.825 2.35 . . . . 0.0 113.765 179.76 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 34.2 pt . . . . . 0 C--N 1.332 -0.165 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.164 179.153 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 65.7 p . . . . . 0 N--CA 1.462 0.149 0 CA-C-O 120.848 0.356 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.8 mtt85 -89.0 126.91 35.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.647 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -127.48 138.52 52.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.795 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.575 HD11 ' HB3' ' A' ' 95' ' ' PHE . 24.3 tp -117.21 131.63 56.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.023 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.2 t -108.98 131.9 58.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.681 0.276 . . . . 0.0 110.708 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.6 m -82.15 133.18 35.25 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.395 0.617 . . . . 0.0 112.206 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.526 HD12 ' HB2' ' A' ' 94' ' ' SER . 92.8 mt -103.78 137.61 31.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.619 177.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.426 ' HD3' HG23 ' A' ' 15' ' ' VAL . 50.0 mtpt -97.83 160.03 14.56 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.99 -178.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -58.14 -25.57 61.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.299 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.801 ' OG ' HG22 ' A' ' 15' ' ' VAL . 60.1 p -79.64 -13.69 59.32 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.582 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.81 19.73 33.44 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.002 -0.618 . . . . 0.0 111.772 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.801 HG22 ' OG ' ' A' ' 13' ' ' SER . 27.5 m -115.94 135.67 55.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -76.1 141.06 42.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.828 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -123.25 -118.17 2.41 Favored Glycine 0 CA--C 1.542 1.728 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.795 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -72.04 147.96 49.88 Favored 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 122.415 2.077 . . . . 0.0 112.8 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -108.06 150.07 27.64 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.172 0.51 . . . . 0.0 110.768 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.469 ' CD2' HD11 ' A' ' 37' ' ' ILE . 28.8 t80 -119.56 111.64 36.13 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.898 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.12 123.64 6.27 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.555 1.503 . . . . 0.0 111.259 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 82.1 mt -77.65 52.49 1.0 Allowed 'General case' 0 C--O 1.233 0.196 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.665 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.6 t -62.06 -42.16 98.9 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.101 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.6 mt -69.1 146.51 52.5 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 58.4 p -67.45 -16.57 64.3 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.496 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 90.2 m -131.23 133.89 45.91 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.414 -0.514 . . . . 0.0 111.542 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.8 t -124.33 116.05 21.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.446 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.46 HD21 ' HG2' ' A' ' 47' ' ' GLN . 56.9 tp -114.66 124.86 52.89 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.85 0.357 . . . . 0.0 111.422 -178.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.725 ' CE2' HD12 ' A' ' 37' ' ' ILE . 22.7 m-85 -104.5 141.31 36.61 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.518 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 156.59 -173.08 34.36 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.25 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.545 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 27.2 mtm180 -80.0 -27.74 39.55 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.055 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.532 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -56.18 137.78 46.58 Favored Glycine 0 CA--C 1.521 0.453 0 C-N-CA 120.186 -1.007 . . . . 0.0 110.695 -178.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.427 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.6 tp -65.18 -40.12 87.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.671 -0.412 . . . . 0.0 109.99 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.427 ' N ' HG23 ' A' ' 33' ' ' ILE . 74.0 tt0 -53.99 -13.54 0.81 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.256 179.086 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.532 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 37.8 m -71.24 138.25 49.3 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.513 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.496 ' OD2' ' O ' ' A' ' 26' ' ' THR . 56.0 m-20 -61.55 -34.28 75.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.443 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.725 HD12 ' CE2' ' A' ' 29' ' ' PHE . 94.2 mt -127.59 122.56 59.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 38' ' ' ARG . 13.2 ttp180 -111.86 137.25 50.07 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.418 -178.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 94.6 mt -120.63 130.31 74.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.402 HE21 ' HA ' ' B' ' 260' ' ' GLU . 26.9 pt20 -81.74 38.4 0.51 Allowed 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.607 ' CD1' ' CZ ' ' A' ' 93' ' ' ARG . 39.9 mt -103.08 132.72 20.86 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.91 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.89 -11.37 30.54 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.459 2.106 . . . . 0.0 113.214 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.456 HG21 ' CE2' ' B' ' 241' ' ' PHE . 28.1 m -96.32 4.56 9.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.898 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.545 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 44.1 t -96.23 133.97 35.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.975 0.417 . . . . 0.0 110.562 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.2 m -70.93 165.51 23.19 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.825 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.0 mttm -63.23 -39.18 93.87 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.661 -178.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.695 ' O ' ' N ' ' A' ' 49' ' ' CYS . 86.4 mt-30 -113.92 -16.08 12.25 Favored 'General case' 0 C--O 1.227 -0.128 0 O-C-N 123.31 0.381 . . . . 0.0 111.247 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 28.7 t60 34.26 -74.13 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.695 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.52 138.96 46.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.129 0.49 . . . . 0.0 111.962 -179.025 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -127.56 130.93 49.96 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.877 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.9 mt -114.62 132.81 62.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.602 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -118.65 123.27 44.54 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.8 mt -106.44 117.06 51.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.019 -0.672 . . . . 0.0 112.345 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.431 ' O ' ' C ' ' A' ' 55' ' ' GLU . 81.0 m-70 -114.15 145.17 42.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.233 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 54' ' ' HIS . 96.3 mt-10 -40.5 -31.8 0.17 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.339 0.59 . . . . 0.0 109.471 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.516 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 58.6 tt0 -63.9 -68.6 0.33 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.162 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.516 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 5.1 tp10 -157.38 -170.24 3.17 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.287 -178.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.445 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -109.45 125.97 53.0 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.048 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.6 mt -116.63 130.21 71.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.235 0.54 . . . . 0.0 111.857 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 19.4 tp -101.39 126.25 48.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.841 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -110.14 136.64 49.06 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.966 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.444 HD21 ' HA ' ' A' ' 68' ' ' PRO . 64.7 t-20 -96.48 105.48 17.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.684 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -97.63 -7.47 31.01 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.56 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 t -77.01 99.64 5.37 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.012 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.4 m -86.83 -18.18 31.6 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.468 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -88.88 -43.35 11.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.52 -179.898 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -135.31 91.64 18.73 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.803 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.444 ' HA ' HD21 ' A' ' 62' ' ' ASN . 47.3 Cg_exo -56.24 145.51 76.78 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.193 1.929 . . . . 0.0 113.408 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 18.9 m -79.39 137.17 37.19 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.84 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -102.0 141.37 34.95 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.017 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 93.1 t -132.21 134.33 59.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 29.9 m120 50.92 32.87 7.89 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.219 0.533 . . . . 0.0 109.593 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.93 29.56 60.69 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.135 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 31.0 t -148.97 143.83 26.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 117.439 0.619 . . . . 0.0 111.335 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 62.1 t -69.38 143.16 15.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.465 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.1 pt -113.89 68.46 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.223 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -52.12 -27.69 15.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.662 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -120.74 169.57 8.6 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.549 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -60.28 143.14 99.51 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 122.354 2.036 . . . . 0.0 112.23 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.9 m -139.57 139.31 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-O 120.83 0.348 . . . . 0.0 111.223 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -75.51 131.82 40.34 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.445 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 92.3 mt -79.51 139.79 37.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.089 0.471 . . . . 0.0 111.086 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -127.87 144.9 51.09 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.748 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.481 ' CE1' ' H ' ' A' ' 99' ' ' ASN . 3.4 t-160 -54.54 117.67 3.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.924 0.392 . . . . 0.0 110.088 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.67 -14.75 27.06 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.074 -0.811 . . . . 0.0 111.074 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -74.84 133.47 41.88 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.049 0.452 . . . . 0.0 110.316 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.557 HG22 ' HA ' ' A' ' 96' ' ' ARG . 49.4 t -112.38 133.68 57.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.676 -178.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 89.6 mt -93.09 129.99 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 177.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.461 HG23 ' OG ' ' A' ' 94' ' ' SER . 51.6 m -118.17 125.37 50.07 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.717 0.77 . . . . 0.0 112.43 -178.277 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.539 ' N ' ' O ' ' A' ' 93' ' ' ARG . 87.0 mt -116.62 123.08 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 114.505 -1.225 . . . . 0.0 108.505 178.231 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.656 HG22 ' N ' ' A' ' 92' ' ' ASP . 94.6 mt 33.24 -101.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.463 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.656 ' N ' HG22 ' A' ' 91' ' ' ILE . 82.6 m-20 -105.86 7.02 32.06 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.64 0.257 . . . . 0.0 111.599 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.607 ' CZ ' ' CD1' ' A' ' 41' ' ' LEU . 40.7 mtm-85 -125.07 142.21 51.63 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.716 -178.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.526 ' HB2' HD12 ' A' ' 10' ' ' ILE . 51.0 m -139.51 157.32 46.04 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.499 -0.481 . . . . 0.0 110.617 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.575 ' HB3' HD11 ' A' ' 7' ' ' LEU . 94.9 m-85 -125.96 120.47 30.45 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.655 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.557 ' HA ' HG22 ' A' ' 87' ' ' VAL . 44.4 ttm180 -80.35 127.08 31.96 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.251 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -92.56 125.7 37.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.805 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -121.6 127.41 50.85 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.263 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.481 ' H ' ' CE1' ' A' ' 84' ' ' HIS . 49.4 t-20 . . . . . 0 C--N 1.324 -0.54 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.654 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo . . . . . 0 N--CA 1.485 1.028 0 CA-C-O 121.651 0.605 . . . . 0.0 112.809 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.468 ' CG2' HG22 ' A' ' 66' ' ' THR . 53.5 t -57.79 142.83 12.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.659 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 5.1 t . . . . . 0 C--N 1.327 -0.396 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.29 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo . . . . . 0 N--CA 1.5 1.881 0 N-CA-C 112.838 0.284 . . . . 0.0 112.838 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 70.2 m -69.37 -47.17 65.09 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.526 -0.47 . . . . 0.0 109.787 178.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.456 ' CE2' HG21 ' A' ' 43' ' ' VAL . 71.2 t80 -59.97 -46.67 88.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.624 -179.123 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.407 ' HA ' HD23 ' B' ' 242' ' ' LEU . 94.5 mt -63.27 -41.29 99.01 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.821 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -65.18 -39.66 93.19 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.009 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -61.97 -41.8 98.41 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.074 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.528 ' NH2' ' CD2' ' A' ' 41' ' ' LEU . 24.9 mmt180 -63.3 -43.15 98.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.676 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -62.68 -41.98 99.39 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.482 -0.487 . . . . 0.0 109.863 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 5.3 t -65.15 -44.86 87.21 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 69.4 tp60 -57.43 -41.16 79.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.778 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--N 1.326 -0.415 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.91 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.471 ' OE1' HD21 ' A' ' 41' ' ' LEU . 98.2 mt-10 . . . . . 0 C--O 1.236 0.348 0 CA-C-O 120.697 0.284 . . . . 0.0 110.255 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 56.5 mt -112.74 134.5 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 53.4 t -122.86 133.32 69.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -96.84 119.54 35.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.243 0.544 . . . . 0.0 111.018 -178.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -67.34 -45.67 75.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.249 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.68 158.18 34.82 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.437 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -60.58 150.32 82.37 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 122.873 2.382 . . . . 0.0 112.478 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 42.9 pt . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 121.581 0.705 . . . . 0.0 111.587 -179.319 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.0 p . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.834 0.349 . . . . 0.0 110.707 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.747 ' NE ' HD13 ' A' ' 53' ' ' ILE . 89.2 mtm-85 -87.18 121.77 30.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.346 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -126.26 134.75 51.09 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.679 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.513 HD12 ' O ' ' A' ' 96' ' ' ARG . 36.4 tp -115.81 130.94 57.04 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.848 HG22 ' CD2' ' A' ' 19' ' ' HIS . 44.3 t -108.9 131.77 58.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.474 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 m -92.21 114.01 26.43 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 121.13 0.49 . . . . 0.0 111.819 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.427 HD12 ' HB3' ' A' ' 94' ' ' SER . 96.8 mt -81.32 146.09 7.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.151 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -92.71 157.7 16.31 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.443 HH11 ' HG3' ' B' ' 245' ' ' ARG . 87.8 mtm180 -59.91 -21.97 61.79 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.741 -0.383 . . . . 0.0 110.469 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.1 m -80.76 -12.01 59.52 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.1 35.51 8.11 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.9 t -120.72 134.31 64.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.667 0.27 . . . . 0.0 110.869 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -66.41 118.77 10.53 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.409 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -108.29 -130.84 6.31 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.196 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.03 148.34 39.88 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 122.546 2.164 . . . . 0.0 113.321 -178.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.848 ' CD2' HG22 ' A' ' 8' ' ' VAL . 65.0 m170 -104.03 140.0 38.36 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.115 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -111.7 97.87 38.89 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.505 -0.771 . . . . 0.0 108.958 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.432 ' HD2' HG22 ' B' ' 267' ' ' ILE . 57.1 Cg_endo -72.46 127.04 12.11 Favored 'Trans proline' 0 C--N 1.314 -1.24 0 C-N-CA 121.194 1.263 . . . . 0.0 110.922 -178.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.414 ' HA ' HD23 ' A' ' 22' ' ' LEU . 92.8 mt -84.51 81.33 8.89 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.625 0.726 . . . . 0.0 110.563 -178.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 91.1 p -86.72 -9.29 56.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.467 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.0 mt -102.6 145.35 29.77 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.008 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.6 t -65.09 -16.2 63.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.333 -178.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.07 132.63 42.0 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.972 0.415 . . . . 0.0 111.803 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.8 t -123.35 117.58 25.55 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.658 178.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.622 HD21 ' OE1' ' A' ' 47' ' ' GLN . 39.3 tp -115.55 127.4 55.24 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 120.702 0.287 . . . . 0.0 111.35 -178.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.71 ' CE2' HD12 ' A' ' 37' ' ' ILE . 8.4 m-85 -107.62 142.69 37.17 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.504 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 153.97 -170.36 32.58 Favored Glycine 0 N--CA 1.467 0.75 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.966 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.631 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 81.4 mtm-85 -84.0 -31.34 25.53 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.952 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.562 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -53.48 148.65 15.28 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.142 -178.277 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.532 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.1 tp -68.38 -42.82 84.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.801 0.334 . . . . 0.0 110.454 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.532 ' N ' HG23 ' A' ' 33' ' ' ILE . 51.6 tp10 -53.09 -19.89 3.23 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.562 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 5.3 m -66.8 124.95 24.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.821 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -59.5 -27.41 66.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.312 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.71 HD12 ' CE2' ' A' ' 29' ' ' PHE . 97.7 mt -128.45 121.14 54.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.831 178.236 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 74.1 mtm180 -100.4 135.45 41.82 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.492 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.79 HG21 ' CZ ' ' A' ' 93' ' ' ARG . 99.4 mt -119.99 131.8 71.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.458 0.647 . . . . 0.0 110.57 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -78.78 28.22 0.21 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.999 -1.0 . . . . 0.0 112.987 -178.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.657 ' O ' HG12 ' A' ' 44' ' ' VAL . 7.3 mt -105.97 104.69 50.48 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 120.539 -0.465 . . . . 0.0 109.804 178.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -53.84 -8.74 0.96 Allowed 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 122.417 2.078 . . . . 0.0 113.254 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.62 HG21 ' CE2' ' B' ' 241' ' ' PHE . 26.9 m -95.62 3.69 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.637 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.657 HG12 ' O ' ' A' ' 41' ' ' LEU . 5.9 p -95.45 138.23 21.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.079 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.46 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 0.5 OUTLIER -65.88 162.54 18.8 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.487 0.66 . . . . 0.0 111.527 -179.101 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt -62.94 -40.55 97.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.433 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.676 ' O ' ' N ' ' A' ' 49' ' ' CYS . 15.1 mm100 -109.47 -13.28 14.6 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.381 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.46 ' H ' ' HB3' ' A' ' 45' ' ' SER . 25.8 t60 35.88 -73.31 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.288 -0.869 . . . . 0.0 113.163 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.676 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -149.35 149.76 31.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.19 0.519 . . . . 0.0 111.661 -179.564 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -135.85 134.9 39.32 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.675 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 89.4 mt -105.81 133.39 50.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.024 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -111.71 120.37 41.79 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.747 HD13 ' NE ' ' A' ' 5' ' ' ARG . 91.3 mt -104.46 110.02 29.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.581 0.705 . . . . 0.0 111.613 -178.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.468 ' O ' ' N ' ' A' ' 56' ' ' GLN . 95.0 m-70 -112.19 144.37 41.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.644 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 54' ' ' HIS . 83.7 tt0 -41.18 -28.35 0.09 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.468 ' N ' ' O ' ' A' ' 54' ' ' HIS . 99.7 mm-40 -66.53 -68.82 0.34 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.151 178.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -158.75 -169.69 2.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.479 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -108.43 124.61 50.67 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.509 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 98.9 mt -115.58 129.32 72.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.084 0.468 . . . . 0.0 112.059 -178.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.451 HD11 ' SG ' ' A' ' 49' ' ' CYS . 43.9 tp -94.51 124.18 38.38 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.973 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -108.82 132.1 54.33 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.865 0.364 . . . . 0.0 110.019 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 33.5 t-20 -94.32 105.04 17.02 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.813 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -96.31 -6.56 37.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.033 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.2 t -85.58 97.58 10.16 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.199 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 77.5 p -78.09 -33.59 50.61 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 177.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.7 m -63.68 -46.25 86.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.817 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -142.48 95.98 6.41 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.777 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.49 144.45 62.47 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 121.877 1.718 . . . . 0.0 112.122 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 33.0 m -72.09 138.07 47.52 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.128 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -100.98 139.28 36.88 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.642 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 70.8 t -129.97 135.42 61.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 52.43 32.87 11.98 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 119.774 -0.77 . . . . 0.0 109.063 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.23 27.85 69.25 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.611 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 34.4 t -142.23 137.32 30.65 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 117.671 0.736 . . . . 0.0 111.91 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -69.18 143.6 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.511 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.562 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 1.2 pt -113.47 108.1 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 121.564 0.697 . . . . 0.0 110.553 178.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -70.8 -31.62 68.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.282 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.485 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -129.38 -179.35 0.98 Allowed Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.752 -179.588 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 24.7 Cg_exo -62.6 146.94 95.41 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 122.779 2.32 . . . . 0.0 112.061 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.8 p -140.12 141.69 33.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.019 0.438 . . . . 0.0 111.164 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -76.56 133.44 39.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.724 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 82' ' ' LEU . 98.3 mt -88.93 139.14 30.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.206 0.527 . . . . 0.0 111.501 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.405 ' N ' ' OD2' ' A' ' 86' ' ' ASP . 99.4 mttt -123.2 149.76 44.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.803 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.512 ' ND1' ' N ' ' A' ' 99' ' ' ASN . 8.1 t60 -54.39 121.92 9.33 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.125 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.8 -13.24 38.41 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.405 ' OD2' ' N ' ' A' ' 83' ' ' LYS . 84.3 m-20 -68.88 136.58 52.85 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.056 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.401 ' CG1' ' OG ' ' A' ' 94' ' ' SER . 70.3 t -109.14 131.56 59.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.422 -178.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 25.7 mm -93.37 129.58 43.62 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 178.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.0 m -120.42 123.88 44.1 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.104 -0.639 . . . . 0.0 112.205 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.669 ' CG2' HH12 ' A' ' 93' ' ' ARG . 94.9 mt -122.61 126.75 74.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.367 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.476 HG22 ' N ' ' A' ' 92' ' ' ASP . 47.9 mm 35.34 -105.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 121.041 -0.264 . . . . 0.0 111.246 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.477 ' OD1' ' CD2' ' B' ' 242' ' ' LEU . 87.8 m-20 -109.12 16.4 22.55 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.747 0.308 . . . . 0.0 111.064 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.79 ' CZ ' HG21 ' A' ' 39' ' ' ILE . 1.8 mtm105 -126.39 144.57 50.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.073 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.427 ' HB3' HD12 ' A' ' 10' ' ' ILE . 47.4 t -138.7 148.73 44.31 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 178.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.48 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 27.3 m-85 -125.6 125.11 42.63 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.659 -179.152 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.513 ' O ' HD12 ' A' ' 7' ' ' LEU . 78.4 mtp85 -85.91 128.02 34.74 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.433 -179.047 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.559 ' CZ ' ' OD1' ' A' ' 99' ' ' ASN . 92.0 t80 -95.41 127.17 41.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.945 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -138.67 124.6 19.96 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.222 -0.591 . . . . 0.0 111.969 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.559 ' OD1' ' CZ ' ' A' ' 97' ' ' TYR . 96.9 m-20 . . . . . 0 N--CA 1.463 0.217 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.107 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo . . . . . 0 N--CA 1.483 0.882 0 CA-C-O 121.826 0.678 . . . . 0.0 113.115 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -67.37 139.89 20.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.327 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 6.3 t . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.016 -179.941 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo . . . . . 0 N--CA 1.504 2.093 0 N-CA-C 113.842 0.67 . . . . 0.0 113.842 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 35.4 m -74.61 -43.21 56.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.314 0.578 . . . . 0.0 109.851 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.62 ' CE2' HG21 ' A' ' 43' ' ' VAL . 68.7 t80 -59.18 -45.96 89.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.926 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.477 ' CD2' ' OD1' ' A' ' 92' ' ' ASP . 81.6 mt -62.47 -41.73 98.99 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.777 -0.192 . . . . 0.0 111.382 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -65.86 -36.9 84.72 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.676 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 244' ' ' ARG . . . . . 0.453 ' HE ' HE21 ' B' ' 248' ' ' GLN . 80.0 ttt180 -59.63 -42.85 93.63 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.606 ' NE ' ' CZ ' ' B' ' 241' ' ' PHE . 2.4 mpt_? -60.64 -41.77 95.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.193 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -60.83 -40.45 92.82 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 16.5 m -64.26 -46.55 83.22 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.622 178.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 248' ' ' GLN . . . . . 0.53 ' OE1' ' NH1' ' B' ' 245' ' ' ARG . 86.9 mt-30 -61.62 -36.48 80.87 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.12 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 249' ' ' VAL . . . . . 0.401 HG23 ' O ' ' B' ' 245' ' ' ARG . 42.1 t . . . . . 0 C--N 1.329 -0.29 0 C-N-CA 120.347 -0.541 . . . . 0.0 110.099 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 57.8 mp0 . . . . . 0 CA--C 1.529 0.162 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 70.8 mt -117.36 134.28 61.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 54.2 t -127.74 135.06 64.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.295 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -95.28 117.69 30.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.217 0.532 . . . . 0.0 111.151 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -65.13 -44.18 89.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.08 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -91.55 150.43 41.1 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.658 -178.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -67.03 146.07 75.85 Favored 'Trans proline' 0 N--CA 1.497 1.678 0 C-N-CA 122.644 2.229 . . . . 0.0 112.697 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 267' ' ' ILE . . . . . 0.432 HG22 ' HD2' ' A' ' 21' ' ' PRO . 25.1 pt . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.114 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.9 p . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.511 0.196 . . . . 0.0 111.487 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 87.8 mtm-85 -104.38 125.79 50.91 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.076 0.465 . . . . 0.0 111.638 -178.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -134.04 138.67 45.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.922 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.585 HD12 ' O ' ' A' ' 96' ' ' ARG . 31.4 tp -113.29 129.62 56.48 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.6 m -107.58 133.52 52.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-O 121.085 0.469 . . . . 0.0 110.681 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.2 m -90.68 115.39 27.74 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.457 -0.792 . . . . 0.0 113.136 -177.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.4 mt -79.02 142.1 14.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 178.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -88.74 157.64 18.44 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.552 HH12 ' CD ' ' B' ' 248' ' ' GLN . 84.2 mtp180 -59.04 -33.07 70.33 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.021 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.7 t -69.91 -18.6 63.39 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.267 0.556 . . . . 0.0 109.849 178.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.82 34.75 4.24 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.6 t -124.95 134.16 67.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.13 0.49 . . . . 0.0 111.517 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -70.11 131.31 44.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.253 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -113.13 -128.04 4.8 Favored Glycine 0 CA--C 1.539 1.545 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.586 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -73.74 154.76 49.2 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.35 2.033 . . . . 0.0 112.625 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.498 ' O ' ' CG2' ' B' ' 267' ' ' ILE . 11.8 m-70 -110.01 139.98 44.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.269 0.557 . . . . 0.0 111.177 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.433 ' CD2' HD11 ' A' ' 37' ' ' ILE . 27.9 t80 -108.6 99.38 33.27 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.014 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.87 128.14 15.51 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 121.19 1.26 . . . . 0.0 111.334 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 72.5 mt -79.06 47.86 0.81 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.301 -178.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 99.5 p -59.1 -24.87 63.32 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.672 HD11 ' HG2' ' B' ' 265' ' ' GLN . 71.0 mt -78.35 139.52 38.8 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.417 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.8 t -66.15 -18.45 65.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.354 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.479 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 85.1 m -133.02 135.17 45.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.813 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.8 t -127.06 115.34 19.03 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.417 HD12 ' O ' ' A' ' 49' ' ' CYS . 51.2 tp -114.93 129.88 56.8 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.195 0.522 . . . . 0.0 110.915 -178.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.849 ' CE2' HD12 ' A' ' 37' ' ' ILE . 14.3 m-85 -110.96 135.16 51.89 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.146 -0.933 . . . . 0.0 109.576 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 160.21 -172.06 36.59 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.704 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -81.2 -31.6 33.86 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.705 0.288 . . . . 0.0 110.998 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.529 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -54.9 150.31 18.75 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 111.714 -0.554 . . . . 0.0 111.714 -178.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.47 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.9 tp -66.44 -40.05 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-O 120.791 0.329 . . . . 0.0 110.158 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.47 ' N ' HG23 ' A' ' 33' ' ' ILE . 96.9 mt-10 -51.72 -27.87 13.27 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.338 -0.545 . . . . 0.0 109.542 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.529 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 14.2 m -57.16 110.99 0.93 Allowed 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.934 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.479 ' OD2' ' O ' ' A' ' 26' ' ' THR . 97.5 m-20 -51.18 -18.75 0.96 Allowed 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.849 HD12 ' CE2' ' A' ' 29' ' ' PHE . 76.2 mt -134.06 125.77 48.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.94 177.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 71.5 mtm180 -103.46 135.06 45.76 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.612 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 99.2 mt -117.17 129.1 74.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -77.25 25.48 0.17 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -177.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.526 HD21 ' NH1' ' B' ' 245' ' ' ARG . 67.2 mt -96.81 128.06 37.08 Favored Pre-proline 0 N--CA 1.466 0.35 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.554 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -73.22 -9.75 23.58 Favored 'Trans proline' 0 N--CA 1.487 1.132 0 C-N-CA 122.052 1.835 . . . . 0.0 112.848 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.439 HG23 HG13 ' A' ' 91' ' ' ILE . 28.9 m -96.71 4.2 9.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 120.758 0.313 . . . . 0.0 110.582 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 38.1 t -93.08 135.71 27.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.871 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.9 m -70.67 173.01 7.69 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.473 0.654 . . . . 0.0 111.584 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 40.7 mtmt -63.73 -41.66 98.02 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.527 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.614 ' O ' ' N ' ' A' ' 49' ' ' CYS . 86.1 mt-30 -114.52 -20.95 10.55 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.919 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 27.5 t60 37.75 -76.13 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 113.971 1.101 . . . . 0.0 113.971 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.614 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -128.78 133.27 48.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.926 0.393 . . . . 0.0 111.516 -178.621 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -125.66 127.95 47.07 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.31 178.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 94.5 mt -110.25 132.41 58.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -114.5 120.3 39.78 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.3 mt -102.93 114.94 43.95 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 C-N-CA 119.714 -0.794 . . . . 0.0 111.968 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.55 ' O ' ' N ' ' A' ' 56' ' ' GLN . 97.0 m-70 -112.57 141.16 46.66 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.221 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.469 ' C ' ' O ' ' A' ' 54' ' ' HIS . 95.1 mt-10 -39.73 -26.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 -178.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.55 ' N ' ' O ' ' A' ' 54' ' ' HIS . 84.6 mt-30 -66.05 -67.98 0.4 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.948 177.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -161.84 -158.27 0.53 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.479 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -116.71 129.76 56.32 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.575 0.226 . . . . 0.0 110.66 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 98.2 mt -119.55 131.59 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 121.046 0.451 . . . . 0.0 111.762 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.474 ' HB2' HD11 ' A' ' 82' ' ' LEU . 28.7 tp -99.27 129.34 45.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.977 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -116.48 138.22 51.55 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.825 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 38.2 p-10 -101.89 107.33 18.47 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.629 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -94.27 -11.61 29.82 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.896 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.3 p -77.19 100.75 5.9 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.286 178.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.7 p -73.43 -34.27 65.35 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.447 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.3 OUTLIER -71.11 -40.29 71.55 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.699 -179.987 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -144.07 90.95 6.63 Favored Pre-proline 0 N--CA 1.467 0.412 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -64.81 149.45 89.61 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 C-N-CA 120.988 1.126 . . . . 0.0 112.089 -179.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.8 m -71.11 151.51 44.4 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.386 0.612 . . . . 0.0 111.776 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -106.7 147.06 30.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.833 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.501 ' CG2' ' OD1' ' A' ' 86' ' ' ASP . 4.8 p -132.88 134.86 57.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 51.75 32.11 9.02 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.185 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.88 27.64 70.26 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.878 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 68.6 m -139.26 142.35 37.78 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.2 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.7 t -75.45 133.3 31.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.381 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.3 pt -101.84 102.12 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.516 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -64.1 -34.42 78.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.492 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.402 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 1.3 mt-10 -129.74 178.49 1.68 Allowed Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.79 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.402 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 31.3 Cg_exo -60.09 143.63 99.53 Favored 'Trans proline' 0 N--CA 1.504 2.09 0 C-N-CA 122.742 2.295 . . . . 0.0 112.469 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.5 p -135.91 138.46 47.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.371 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 83.3 mtm-85 -73.17 129.88 39.02 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.5 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.474 HD11 ' HB2' ' A' ' 60' ' ' LEU . 97.0 mt -83.77 137.41 33.74 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.161 -178.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -129.17 152.98 48.16 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.363 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.533 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 7.5 t60 -53.36 119.18 4.48 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.264 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.64 -14.46 29.73 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 87' ' ' VAL . 59.4 t0 -66.25 130.41 43.14 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.229 0.538 . . . . 0.0 110.623 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.599 HG22 ' HG2' ' A' ' 96' ' ' ARG . 71.1 t -109.27 130.85 61.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.001 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 87.6 mt -105.78 134.1 48.27 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.6 m -118.21 124.33 47.65 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 121.191 0.519 . . . . 0.0 111.64 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.576 ' N ' ' O ' ' A' ' 93' ' ' ARG . 97.4 mt -114.82 126.08 72.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.37 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.448 HG22 ' N ' ' A' ' 92' ' ' ASP . 36.2 mm 38.28 -109.3 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.697 -179.035 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.537 ' OD1' ' CD2' ' B' ' 242' ' ' LEU . 98.1 m-20 -107.77 14.61 25.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.501 0.667 . . . . 0.0 110.011 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.576 ' O ' ' N ' ' A' ' 90' ' ' ILE . 18.8 mtp85 -126.86 146.95 50.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.298 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 66.4 m -137.69 150.65 47.5 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 121.235 0.54 . . . . 0.0 110.778 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.541 ' CE1' HD12 ' A' ' 90' ' ' ILE . 89.0 m-85 -124.39 122.28 37.23 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.69 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.599 ' HG2' HG22 ' A' ' 87' ' ' VAL . 99.8 mtt180 -89.79 135.84 33.39 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 119.378 -0.929 . . . . 0.0 110.685 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -96.75 124.72 40.81 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.431 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -124.79 122.08 36.41 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.533 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 46.3 t30 . . . . . 0 C--N 1.333 -0.136 0 C-N-CA 120.671 -0.411 . . . . 0.0 111.257 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo . . . . . 0 N--CA 1.494 1.545 0 CA-C-O 121.835 0.681 . . . . 0.0 113.767 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.447 ' CG2' HG22 ' A' ' 66' ' ' THR . 24.0 t -67.99 135.08 29.16 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.921 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 16.0 t . . . . . 0 C--N 1.325 -0.482 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.391 179.839 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo . . . . . 0 N--CA 1.506 2.236 0 N-CA-C 113.905 0.694 . . . . 0.0 113.905 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 21.2 m -71.64 -45.93 60.55 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.202 0.525 . . . . 0.0 109.933 178.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.435 ' HZ ' HD22 ' A' ' 41' ' ' LEU . 45.9 t80 -58.09 -44.89 87.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.068 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.537 ' CD2' ' OD1' ' A' ' 92' ' ' ASP . 93.7 mt -62.21 -40.81 97.35 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.566 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -61.62 -45.17 95.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.362 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 -62.4 -43.07 99.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.733 0.301 . . . . 0.0 110.995 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.526 ' NH1' HD21 ' A' ' 41' ' ' LEU . 16.1 mmm180 -58.67 -44.88 90.34 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.76 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -63.27 -39.24 94.05 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.874 0.369 . . . . 0.0 110.175 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 38.8 t -65.48 -44.77 86.09 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 122.0 0.905 . . . . 0.0 109.137 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 248' ' ' GLN . . . . . 0.552 ' CD ' HH12 ' A' ' 12' ' ' ARG . 7.3 tt0 -59.62 -39.76 85.34 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.74 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 26.0 t . . . . . 0 CA--C 1.519 -0.25 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.659 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.472 ' OE1' ' NH1' ' B' ' 245' ' ' ARG . 98.5 mt-10 . . . . . 0 N--CA 1.465 0.299 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.449 HD11 ' NE ' ' A' ' 93' ' ' ARG . 78.7 mt -112.38 132.01 62.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.068 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 46.0 t -127.5 134.18 66.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.193 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -99.09 123.58 43.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.341 0.591 . . . . 0.0 110.897 -178.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -64.28 -40.6 96.3 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.414 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 265' ' ' GLN . . . . . 0.672 ' HG2' HD11 ' A' ' 24' ' ' LEU . 5.1 mp0 -95.81 164.67 18.21 Favored Pre-proline 0 N--CA 1.463 0.224 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.254 -178.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -61.27 145.13 98.81 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 122.283 1.989 . . . . 0.0 110.916 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 267' ' ' ILE . . . . . 0.498 ' CG2' ' O ' ' A' ' 19' ' ' HIS . 2.6 mt . . . . . 0 C--N 1.321 -0.657 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.425 -178.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.4 p . . . . . 0 CA--C 1.531 0.243 0 CA-C-O 120.79 0.329 . . . . 0.0 111.471 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.5 mtt85 -88.28 129.81 35.27 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.249 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -126.09 136.18 52.61 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.27 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.61 HD12 ' O ' ' A' ' 96' ' ' ARG . 30.6 tp -115.82 132.58 56.6 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.9 t -110.2 132.37 58.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.063 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 m -88.72 114.2 25.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.024 -0.534 . . . . 0.0 112.118 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.437 HD12 ' HB2' ' A' ' 94' ' ' SER . 95.5 mt -85.13 144.02 10.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -96.09 160.33 14.5 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.514 HH12 ' CD ' ' B' ' 260' ' ' GLU . 94.7 mtm-85 -62.38 -20.2 64.18 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.901 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.0 p -78.58 -16.25 57.63 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 120.592 -0.443 . . . . 0.0 109.909 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.41 17.72 30.56 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.369 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.0 m -115.14 135.63 54.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 117.191 0.496 . . . . 0.0 110.169 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -72.52 142.86 48.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.341 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -126.72 -117.72 2.14 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.499 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.63 146.77 44.26 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.161 1.907 . . . . 0.0 112.129 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.595 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -108.03 138.98 43.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.06 0.457 . . . . 0.0 110.909 -179.69 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.631 ' CE2' HD11 ' A' ' 37' ' ' ILE . 50.2 t80 -110.1 104.85 56.45 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.955 -178.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.83 130.19 14.29 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.211 1.274 . . . . 0.0 112.016 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.4 mt -83.74 60.27 5.65 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.603 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.3 t -62.83 -40.67 98.15 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 69.9 mt -71.6 144.1 49.59 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.149 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 92.3 p -69.41 -14.06 62.7 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.055 -0.521 . . . . 0.0 112.101 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.407 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 62.6 m -130.42 133.65 46.51 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.38 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.5 t -124.95 115.94 21.39 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 58.5 tp -113.56 130.26 56.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.911 0.386 . . . . 0.0 110.928 -178.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.522 ' O ' ' O ' ' A' ' 47' ' ' GLN . 59.2 m-85 -110.17 136.33 49.56 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.219 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 160.83 -174.26 37.45 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.284 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.581 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 82.3 mtm-85 -79.93 -30.48 39.98 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.552 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -53.4 149.18 13.67 Favored Glycine 0 N--CA 1.467 0.718 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.496 -177.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.539 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.5 tp -67.65 -43.24 86.93 Favored 'Isoleucine or valine' 0 C--N 1.341 0.2 0 CA-C-O 120.868 0.366 . . . . 0.0 111.008 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.539 ' N ' HG23 ' A' ' 33' ' ' ILE . 81.3 tt0 -56.09 -19.39 12.9 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.825 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.552 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 9.6 m -63.02 126.44 27.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.607 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.407 ' OD2' ' O ' ' A' ' 26' ' ' THR . 89.8 m-20 -61.41 -32.6 72.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.337 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.631 HD11 ' CE2' ' A' ' 20' ' ' PHE . 50.5 mm -123.38 114.58 42.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.195 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 38' ' ' ARG . 47.0 mtm180 -99.72 137.14 38.62 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 121.169 -0.212 . . . . 0.0 110.667 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 82.2 mt -120.06 131.27 72.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 120.184 -0.606 . . . . 0.0 111.093 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -73.22 28.31 0.06 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.332 -0.849 . . . . 0.0 113.001 -177.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.722 HD12 ' CZ ' ' A' ' 93' ' ' ARG . 65.9 mt -113.06 130.92 23.1 Favored Pre-proline 0 C--N 1.323 -0.564 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.692 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.84 -9.67 23.98 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 122.262 1.974 . . . . 0.0 112.184 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.488 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 13.1 m -90.86 2.6 7.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.026 0.441 . . . . 0.0 110.017 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.581 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 55.2 t -94.51 132.3 38.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.7 m -71.22 169.2 15.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.562 0.696 . . . . 0.0 111.932 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -62.46 -41.78 99.0 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.442 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.639 ' O ' ' N ' ' A' ' 49' ' ' CYS . 96.3 mt-30 -116.34 -15.26 10.99 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.281 0.363 . . . . 0.0 110.834 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.0 t60 31.08 -74.25 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.639 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.5 138.34 47.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.212 0.529 . . . . 0.0 112.126 -178.67 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -127.99 133.35 49.16 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.443 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.6 mt -118.25 133.94 63.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.026 0.441 . . . . 0.0 110.705 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.438 ' CD ' ' NE2' ' A' ' 54' ' ' HIS . 85.1 tt0 -121.03 124.07 43.93 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.0 mt -106.54 117.26 51.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.661 0.743 . . . . 0.0 112.914 -178.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.438 ' NE2' ' CD ' ' A' ' 52' ' ' GLU . 94.3 m-70 -110.66 143.3 41.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.098 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 54' ' ' HIS . 83.2 tt0 -40.39 -30.32 0.1 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.278 -0.569 . . . . 0.0 109.807 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.434 ' N ' ' O ' ' A' ' 54' ' ' HIS . 59.9 tt0 -64.11 -67.62 0.42 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -157.21 -169.44 2.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.071 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.458 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -110.75 125.95 54.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.767 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.6 mt -115.48 128.52 72.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.31 0.576 . . . . 0.0 111.933 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 24.9 tp -99.07 132.1 44.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.968 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -115.4 135.83 53.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.528 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -97.17 108.58 21.34 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.929 0.395 . . . . 0.0 111.185 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -100.88 -8.57 22.43 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.263 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.7 t -74.64 98.84 3.5 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.092 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.2 m -74.51 -40.38 61.81 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.25 0.547 . . . . 0.0 110.236 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.537 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.3 OUTLIER -64.54 -43.38 94.16 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.264 -178.904 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -144.34 97.36 5.17 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.011 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -57.25 149.4 64.54 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.977 1.785 . . . . 0.0 111.858 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.46 HG22 ' N ' ' A' ' 70' ' ' GLN . 85.4 m -76.41 156.34 33.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.324 0.583 . . . . 0.0 110.933 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.46 ' N ' HG22 ' A' ' 69' ' ' THR . 88.0 mt-30 -114.84 139.36 49.82 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.61 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 55.3 t -128.42 136.23 60.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.54 ' ND2' ' OD1' ' A' ' 86' ' ' ASP . 82.2 m-20 53.25 33.36 15.29 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 119.777 -0.769 . . . . 0.0 109.1 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.04 27.38 73.93 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 115.106 -0.952 . . . . 0.0 112.032 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 74.3 m -141.56 136.37 31.02 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 117.29 0.545 . . . . 0.0 111.31 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.7 p -63.46 144.01 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.803 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.497 HG21 HG21 ' A' ' 80' ' ' VAL . 7.3 pt -118.78 90.96 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.091 0 CA-C-O 121.065 0.459 . . . . 0.0 110.538 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -67.46 -26.94 66.64 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.443 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -122.58 169.34 9.9 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.063 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.79 144.23 99.48 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.075 1.85 . . . . 0.0 111.773 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.497 HG21 HG21 ' A' ' 76' ' ' ILE . 3.3 m -136.47 138.43 46.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.22 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -73.88 134.48 43.25 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.498 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.458 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 95.7 mt -86.09 135.81 33.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.03 0.443 . . . . 0.0 111.324 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -127.79 148.33 50.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.502 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.479 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 5.3 t60 -48.86 116.16 1.54 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.081 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.01 -13.87 40.85 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.161 -0.775 . . . . 0.0 111.161 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.54 ' OD1' ' ND2' ' A' ' 72' ' ' ASN . 34.4 t70 -66.23 133.7 51.16 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 70.8 t -114.19 133.29 60.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.354 -0.538 . . . . 0.0 111.517 -178.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 71.1 mt -100.02 131.77 46.83 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.588 HG23 ' OG ' ' A' ' 94' ' ' SER . 89.4 m -123.97 125.9 45.39 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.83 -178.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.504 ' O ' ' N ' ' A' ' 92' ' ' ASP . 94.2 mt -112.5 123.65 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.591 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.47 HG22 ' N ' ' A' ' 92' ' ' ASP . 94.5 mt 38.61 -94.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.028 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 90' ' ' ILE . 52.1 t0 -121.71 16.35 11.08 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 120.941 -0.303 . . . . 0.0 111.564 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.722 ' CZ ' HD12 ' A' ' 41' ' ' LEU . 44.3 mtm-85 -128.43 139.05 52.56 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.588 ' OG ' HG23 ' A' ' 89' ' ' THR . 58.0 m -133.69 152.14 51.81 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 119.979 -0.689 . . . . 0.0 111.169 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.522 ' HB3' HD11 ' A' ' 7' ' ' LEU . 80.8 m-85 -123.85 121.74 36.16 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.088 178.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.61 ' O ' HD12 ' A' ' 7' ' ' LEU . 79.8 mtp85 -85.21 131.75 34.38 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.113 0.483 . . . . 0.0 111.304 -178.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -95.63 124.73 39.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.003 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -125.6 122.31 36.09 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.967 0.413 . . . . 0.0 110.702 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.479 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 55.3 t-20 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.957 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo . . . . . 0 N--CA 1.486 1.057 0 CA-C-O 121.474 0.531 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.537 ' CG2' HG22 ' A' ' 66' ' ' THR . 24.1 t -111.08 132.55 59.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.273 -179.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 40.1 t . . . . . 0 C--N 1.332 -0.188 0 CA-C-O 120.97 0.414 . . . . 0.0 110.046 179.639 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo . . . . . 0 N--CA 1.496 1.66 0 CA-C-O 120.795 0.248 . . . . 0.0 112.043 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 18.8 m -74.16 -44.35 53.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.316 0.579 . . . . 0.0 109.806 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.488 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 82.1 t80 -58.14 -46.55 85.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.0 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' B' ' 242' ' ' LEU . 95.0 mt -64.5 -39.62 94.12 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.154 0.502 . . . . 0.0 109.993 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -61.33 -41.7 97.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.577 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -60.9 -42.24 97.66 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.326 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.485 ' NH2' ' CE1' ' B' ' 241' ' ' PHE . 47.8 mmt-85 -61.17 -40.49 94.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.93 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -61.34 -39.27 89.96 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 24.0 m -65.76 -43.73 88.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -60.48 -37.65 81.73 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 114.511 -1.222 . . . . 0.0 110.426 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 46.8 t . . . . . 0 CA--C 1.531 0.229 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.051 179.003 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.524 ' OE1' HD21 ' A' ' 41' ' ' LEU . 97.5 mt-10 . . . . . 0 N--CA 1.462 0.143 0 CA-C-O 120.426 0.155 . . . . 0.0 111.053 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 61.5 mt -112.34 135.06 52.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 43.6 t -123.86 133.3 69.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.202 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -94.79 117.46 30.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.988 0.423 . . . . 0.0 110.976 -178.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 264' ' ' LYS . . . . . 0.422 ' HZ1' ' HA ' ' A' ' 34' ' ' GLU . 88.5 tttt -65.39 -47.01 77.81 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.275 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.34 160.89 61.31 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.201 -0.908 . . . . 0.0 110.257 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -60.37 141.65 96.18 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.162 1.908 . . . . 0.0 111.753 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 267' ' ' ILE . . . . . 0.552 HG23 ' O ' ' B' ' 267' ' ' ILE . 13.8 tt . . . . . 0 C--N 1.324 -0.532 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.919 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 35.3 p . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.734 0.302 . . . . 0.0 111.267 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.665 HH22 ' CB ' ' A' ' 99' ' ' ASN . 7.0 mmp_? -90.52 118.0 29.64 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -178.137 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.664 ' NH2' ' ND1' ' A' ' 19' ' ' HIS . 77.8 ttt-85 -127.36 127.23 43.9 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.696 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.929 HD11 HD11 ' A' ' 22' ' ' LEU . 77.6 mt -113.67 144.71 42.47 Favored 'General case' 0 C--N 1.339 0.139 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 51.2 t -121.12 130.94 74.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.47 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.1 m -81.37 142.17 33.28 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.579 0.704 . . . . 0.0 112.432 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.402 ' CD1' ' OD1' ' A' ' 16' ' ' ASP . 47.0 mm -108.59 134.35 50.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.62 177.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -90.15 156.58 18.24 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.998 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.679 ' NH1' ' NH2' ' B' ' 245' ' ' ARG . 88.8 mtm180 -58.85 -25.91 63.7 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.247 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.9 p -78.26 -10.11 59.52 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.78 37.85 9.14 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.7 t -122.1 134.3 65.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.674 0.273 . . . . 0.0 110.658 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.402 ' OD1' ' CD1' ' A' ' 10' ' ' ILE . 96.8 m-20 -71.4 133.39 45.9 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.34 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -122.41 -118.02 2.46 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 120.806 -0.711 . . . . 0.0 111.887 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -74.65 145.04 32.38 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.265 1.976 . . . . 0.0 112.812 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.664 ' ND1' ' NH2' ' A' ' 6' ' ' ARG . 17.9 m170 -101.73 140.69 35.67 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.66 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.493 ' CD2' HD11 ' A' ' 37' ' ' ILE . 40.1 t80 -114.42 97.03 45.1 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.441 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -79.67 139.22 14.01 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 121.836 1.691 . . . . 0.0 110.66 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.929 HD11 HD11 ' A' ' 7' ' ' LEU . 92.8 mt -101.43 124.08 46.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.747 0.784 . . . . 0.0 110.529 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.6 p -124.18 -1.31 8.22 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.261 -1.336 . . . . 0.0 108.683 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 42.2 mt -104.67 147.99 27.06 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 114.508 -1.224 . . . . 0.0 109.732 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 96.1 p -65.98 -17.26 64.56 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.345 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 85.2 m -132.37 133.77 44.36 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.246 0.546 . . . . 0.0 112.122 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.573 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 2.9 t -126.4 121.51 32.68 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.239 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.619 HD21 ' OE1' ' A' ' 47' ' ' GLN . 55.4 tp -120.9 132.22 54.84 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.824 0.345 . . . . 0.0 111.922 -177.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.692 ' CE2' HD12 ' A' ' 37' ' ' ILE . 8.9 m-85 -109.22 140.79 42.38 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 151.44 -177.78 29.17 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.447 178.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.492 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 46.0 mtm180 -74.19 -33.52 63.45 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.501 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -48.12 148.44 4.07 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.808 -0.71 . . . . 0.0 111.587 -178.052 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.515 HG23 ' N ' ' A' ' 34' ' ' GLU . 9.9 tp -66.53 -41.96 89.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-O 120.9 0.381 . . . . 0.0 110.438 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.515 ' N ' HG23 ' A' ' 33' ' ' ILE . 79.2 tt0 -58.55 -25.83 62.92 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 17.9 m -52.73 115.45 1.82 Allowed 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.448 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 63.5 m-20 -53.05 -25.0 11.1 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.538 -178.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.692 HD12 ' CE2' ' A' ' 29' ' ' PHE . 96.2 mt -129.71 122.06 54.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.251 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.503 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 83.8 mtp180 -106.06 135.53 47.35 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.015 0.435 . . . . 0.0 110.853 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 95.5 mt -118.09 129.55 74.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.059 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -73.73 34.24 0.08 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -177.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.76 HD11 ' NH1' ' A' ' 93' ' ' ARG . 55.9 mt -111.24 129.04 24.44 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.684 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.76 -10.25 24.76 Favored 'Trans proline' 0 N--CA 1.489 1.237 0 C-N-CA 122.445 2.096 . . . . 0.0 113.101 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.52 HG21 ' CE2' ' B' ' 241' ' ' PHE . 35.9 m -94.15 1.12 9.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.562 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.492 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 42.6 t -89.75 136.05 24.65 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.24 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.072 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.6 m -69.8 164.79 22.84 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.424 0.63 . . . . 0.0 111.297 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -62.65 -43.26 99.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.287 -179.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.619 ' OE1' HD21 ' A' ' 28' ' ' LEU . 92.7 mm-40 -111.34 -24.15 10.38 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.318 0.58 . . . . 0.0 110.002 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.0 t60 39.22 -78.05 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.251 -0.886 . . . . 0.0 113.382 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.594 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -129.53 133.73 47.39 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.385 0.612 . . . . 0.0 112.225 -178.663 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -126.83 132.44 50.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.307 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 93.7 mt -117.54 135.41 58.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.568 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.485 ' CD ' ' NE2' ' A' ' 54' ' ' HIS . 79.7 tt0 -120.48 124.62 45.87 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 84.9 mt -102.04 117.83 47.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.324 0.583 . . . . 0.0 111.57 -178.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.485 ' NE2' ' CD ' ' A' ' 52' ' ' GLU . 97.5 m-70 -112.94 141.01 47.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.258 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 54' ' ' HIS . 94.1 mt-10 -39.75 -28.85 0.05 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -178.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.49 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 58.1 tt0 -63.55 -67.67 0.41 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.301 178.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.49 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 3.7 tp10 -158.16 -164.43 1.5 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.336 -178.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -111.49 129.96 55.88 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.9 mt -118.87 128.09 75.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.386 0.612 . . . . 0.0 112.157 -178.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 28.1 tp -97.29 127.87 43.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.934 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -113.23 136.47 52.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.127 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.41 HD21 ' HA ' ' A' ' 68' ' ' PRO . 58.5 t-20 -97.12 104.61 16.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.188 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -96.51 -9.7 29.03 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 120.757 0.313 . . . . 0.0 110.747 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.15 101.44 1.85 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.101 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 79.0 p -87.73 -10.13 52.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.206 0.527 . . . . 0.0 109.591 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.653 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -100.92 -43.22 6.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.249 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.405 HD21 ' HA ' ' B' ' 236' ' ' VAL . 78.9 m-20 -135.85 94.86 14.31 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.025 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.486 ' HB2' HG23 ' A' ' 75' ' ' VAL . 50.4 Cg_exo -57.17 142.9 94.51 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 121.966 1.777 . . . . 0.0 113.014 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 95.9 m -74.49 144.1 44.3 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.401 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -104.88 139.47 39.57 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.056 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 68.8 t -131.02 133.11 63.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 53.65 32.11 13.92 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.149 -0.621 . . . . 0.0 110.065 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.45 26.88 68.9 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-N 115.606 -0.724 . . . . 0.0 112.129 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 43.4 t -142.68 139.93 31.37 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 117.36 0.58 . . . . 0.0 111.08 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.486 HG23 ' HB2' ' A' ' 68' ' ' PRO . 1.2 p -70.25 140.85 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.486 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.8 pt -113.96 90.72 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.82 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -68.43 -28.94 67.51 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.478 ' N ' ' CD ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -116.49 162.18 28.0 Favored Pre-proline 0 C--O 1.232 0.168 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.582 179.129 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -66.56 150.54 83.94 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.571 2.181 . . . . 0.0 112.466 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.4 m -141.78 141.76 29.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.142 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -70.52 129.92 40.49 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.077 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 82' ' ' LEU . 91.3 mt -79.64 140.17 37.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.175 0.512 . . . . 0.0 111.13 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -131.84 151.23 51.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.729 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.42 ' CE1' ' H ' ' A' ' 99' ' ' ASN . 6.1 t60 -53.78 120.14 5.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.052 0.453 . . . . 0.0 111.162 -179.157 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.81 -17.67 32.54 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -67.51 135.06 52.44 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 120.184 -0.607 . . . . 0.0 110.258 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.519 HG22 ' HG2' ' A' ' 96' ' ' ARG . 58.5 t -113.67 132.51 62.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.115 -178.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 84.5 mt -103.78 132.78 49.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 90.1 m -122.63 128.97 51.35 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.48 0.657 . . . . 0.0 112.646 -178.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.492 ' O ' ' N ' ' A' ' 93' ' ' ARG . 81.2 mt -113.91 126.02 71.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.499 178.156 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.458 ' C ' ' O ' ' A' ' 90' ' ' ILE . 41.2 mm 35.99 -98.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.746 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 90' ' ' ILE . 41.3 p-10 -116.13 12.11 15.44 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.04 0.448 . . . . 0.0 110.918 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.76 ' NH1' HD11 ' A' ' 41' ' ' LEU . 53.9 mtt85 -123.07 140.44 53.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.334 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 29.4 t -137.27 151.15 48.38 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 120.319 -0.553 . . . . 0.0 110.722 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.488 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 98.0 m-85 -123.6 122.21 37.57 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.519 ' HG2' HG22 ' A' ' 87' ' ' VAL . 99.5 mtt180 -84.65 136.35 33.79 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.167 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.61 ' CZ ' ' CZ ' ' A' ' 5' ' ' ARG . 60.0 t80 -94.48 118.02 31.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.742 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.412 ' HG3' ' CE1' ' A' ' 84' ' ' HIS . 79.8 tt0 -125.47 125.71 43.75 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 111.971 0.359 . . . . 0.0 111.971 -178.476 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.665 ' CB ' HH22 ' A' ' 5' ' ' ARG . 12.1 t-20 . . . . . 0 C--N 1.333 -0.142 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo . . . . . 0 N--CA 1.487 1.138 0 CA-C-O 121.499 0.541 . . . . 0.0 112.922 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.653 ' CG2' HG22 ' A' ' 66' ' ' THR . 54.9 t -64.71 139.82 20.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.716 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 7.3 t . . . . . 0 C--N 1.329 -0.312 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 179.188 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo . . . . . 0 N--CA 1.496 1.666 0 N-CA-C 112.83 0.281 . . . . 0.0 112.83 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 90.9 m -73.61 -45.19 54.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.546 0.689 . . . . 0.0 109.668 178.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.52 ' CE2' HG21 ' A' ' 43' ' ' VAL . 68.9 t80 -58.33 -46.22 86.61 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.622 -178.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 94.9 mt -62.67 -41.64 99.2 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 120.981 0.419 . . . . 0.0 110.481 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -59.29 -37.06 76.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.415 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -62.92 -43.4 98.91 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.012 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.752 ' NH2' HH22 ' A' ' 93' ' ' ARG . 26.5 mmm180 -58.59 -41.65 86.24 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -64.21 -43.22 95.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.349 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 27.9 t -64.08 -44.98 90.7 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -57.38 -40.31 77.93 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.29 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 54.3 t . . . . . 0 C--N 1.328 -0.358 0 C-N-CA 120.658 -0.417 . . . . 0.0 109.916 178.957 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.57 ' OE1' ' NH2' ' B' ' 245' ' ' ARG . 96.4 mt-10 . . . . . 0 N--CA 1.467 0.421 0 CA-C-O 120.793 0.33 . . . . 0.0 111.163 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.488 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 89.6 mt -109.78 133.08 56.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.234 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 41.5 t -124.32 133.71 68.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.945 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 263' ' ' PHE . . . . . 0.534 ' CD2' HG21 ' B' ' 267' ' ' ILE . 70.6 m-85 -98.77 121.29 40.53 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.299 0.571 . . . . 0.0 110.818 -178.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 264' ' ' LYS . . . . . 0.402 ' HD3' ' NE2' ' B' ' 265' ' ' GLN . 88.5 tttt -65.92 -39.2 90.32 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.905 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 265' ' ' GLN . . . . . 0.414 ' CB ' ' CD ' ' B' ' 266' ' ' PRO . 7.2 mm-40 -103.2 179.47 0.96 Allowed Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.099 -178.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 266' ' ' PRO . . . . . 0.414 ' CD ' ' CB ' ' B' ' 265' ' ' GLN . 24.4 Cg_exo -62.25 149.81 89.27 Favored 'Trans proline' 0 N--CA 1.498 1.742 0 C-N-CA 122.822 2.348 . . . . 0.0 113.536 -178.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 267' ' ' ILE . . . . . 0.534 HG21 ' CD2' ' B' ' 263' ' ' PHE . 15.8 pt . . . . . 0 N--CA 1.465 0.308 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.051 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.0 p . . . . . 0 CA--C 1.524 -0.027 0 CA-C-O 120.864 0.364 . . . . 0.0 110.373 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.728 HH12 ' HB2' ' A' ' 58' ' ' ALA . 94.3 mtt-85 -97.25 115.01 26.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.957 -178.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.61 HH21 ' CE1' ' A' ' 19' ' ' HIS . 73.5 ttt180 -128.24 130.8 48.49 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.667 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.563 HD11 ' HB3' ' A' ' 95' ' ' PHE . 34.2 tp -113.17 133.25 55.14 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.197 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.0 t -109.87 131.57 60.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.851 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.414 HG23 ' CD1' ' B' ' 261' ' ' ILE . 2.1 m -92.17 113.86 26.25 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.942 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.8 mt -79.15 143.69 12.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.901 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -87.99 159.37 18.33 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.153 0.502 . . . . 0.0 110.64 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.441 ' NH2' ' HB2' ' B' ' 248' ' ' GLN . 82.1 mtp180 -53.27 -32.42 48.46 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.066 -178.574 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 91.1 p -79.37 -7.39 58.33 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.954 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.15 31.96 11.25 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.7 t -117.86 132.71 66.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -75.11 138.91 42.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.556 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -131.94 -114.89 1.63 Allowed Glycine 0 CA--C 1.538 1.479 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.321 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -74.07 148.31 39.65 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.46 2.107 . . . . 0.0 112.56 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.61 ' CE1' HH21 ' A' ' 6' ' ' ARG . 0.0 OUTLIER -111.37 160.82 16.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.479 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.406 ' CD2' HD11 ' A' ' 37' ' ' ILE . 39.4 t80 -131.21 103.51 15.29 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.706 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.98 135.83 17.77 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 121.346 1.364 . . . . 0.0 111.627 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 64.7 mt -85.22 51.83 2.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.228 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.2 p -64.25 -24.85 67.81 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.7 mt -80.33 141.82 35.07 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.678 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.8 t -63.14 -20.73 65.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.563 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 94.4 m -134.88 135.64 41.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.106 0.479 . . . . 0.0 111.577 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.2 t -127.99 120.7 28.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.591 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.528 HD12 ' O ' ' A' ' 49' ' ' CYS . 56.3 tp -118.51 131.65 56.23 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.262 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.635 ' CE2' HD12 ' A' ' 37' ' ' ILE . 3.8 m-85 -108.83 141.78 40.38 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.291 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 158.15 -170.92 35.01 Favored Glycine 0 N--CA 1.469 0.894 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.219 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.578 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 81.9 mtm-85 -84.42 -27.91 27.24 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 122.447 -0.443 . . . . 0.0 110.821 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -54.66 146.07 27.19 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.051 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.406 HD13 ' HA ' ' A' ' 33' ' ' ILE . 31.2 mm -64.54 -43.57 96.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.014 0.435 . . . . 0.0 110.291 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -57.17 -19.86 23.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.048 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 81.7 m -62.77 131.97 50.65 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.491 -0.483 . . . . 0.0 110.171 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.456 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 64.8 m-20 -61.48 -34.79 76.06 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.222 -178.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.635 HD12 ' CE2' ' A' ' 29' ' ' PHE . 99.4 mt -125.16 125.88 70.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.413 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 44.4 mtm-85 -119.39 145.14 46.48 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.879 -177.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 80.9 mt -123.2 133.16 69.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.422 -178.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -75.88 25.64 0.12 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.973 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.744 HD11 ' CZ ' ' A' ' 93' ' ' ARG . 30.4 mt -96.81 129.41 32.78 Favored Pre-proline 0 C--N 1.324 -0.528 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.087 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.428 ' O ' ' HD2' ' B' ' 235' ' ' PRO . 42.8 Cg_endo -71.09 -13.09 31.1 Favored 'Trans proline' 0 N--CA 1.489 1.225 0 C-N-CA 122.029 1.819 . . . . 0.0 112.618 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.612 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 26.9 m -98.06 3.22 10.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.619 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.578 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 35.4 t -89.88 135.69 25.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.48 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 0.6 OUTLIER -65.15 160.62 20.86 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.373 0.606 . . . . 0.0 111.782 -178.864 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -62.46 -42.31 99.38 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.071 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.614 ' O ' ' N ' ' A' ' 49' ' ' CYS . 86.7 mt-30 -114.97 -14.4 11.87 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 123.609 0.568 . . . . 0.0 110.069 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.48 ' H ' ' HB3' ' A' ' 45' ' ' SER . 19.7 t60 31.1 -73.75 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.614 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.85 137.19 44.87 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -177.631 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -125.16 132.33 53.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.909 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.9 mt -118.57 133.03 66.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.832 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -119.99 127.38 52.57 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 177.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.402 HD13 ' CD ' ' A' ' 5' ' ' ARG . 86.7 mt -108.36 124.15 64.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -177.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.517 ' CD2' ' N ' ' A' ' 54' ' ' HIS . 2.7 m-70 -117.5 141.02 48.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.538 -1.21 . . . . 0.0 109.479 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 54' ' ' HIS . 96.3 mt-10 -39.91 -29.5 0.07 Allowed 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.993 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.458 ' N ' ' O ' ' A' ' 54' ' ' HIS . 69.0 tp60 -64.38 -65.93 0.61 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -158.5 -155.44 0.49 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.099 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.728 ' HB2' HH12 ' A' ' 5' ' ' ARG . . . -120.5 131.41 54.71 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.208 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.7 mm -112.58 123.62 68.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.668 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.474 ' HB2' HD11 ' A' ' 82' ' ' LEU . 30.9 tp -97.67 127.21 43.45 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -115.01 136.18 53.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.956 0.408 . . . . 0.0 110.847 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -97.29 106.22 18.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.48 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -98.74 -8.18 26.47 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.086 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.2 m -69.74 101.33 1.66 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 95.4 p -83.57 -13.23 54.88 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.123 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -91.35 -46.81 7.82 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.199 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -139.67 101.51 7.26 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.916 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.594 ' HB2' HG13 ' A' ' 75' ' ' VAL . 36.6 Cg_exo -57.07 147.66 73.82 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 121.986 1.791 . . . . 0.0 112.884 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.7 m -74.66 145.83 42.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.543 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -107.54 140.34 40.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.256 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.1 t -129.66 133.91 64.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 53.59 32.93 15.29 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 119.899 -0.72 . . . . 0.0 109.284 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.45 27.57 71.14 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.702 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 21.3 t -141.99 138.79 32.14 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 117.133 0.466 . . . . 0.0 112.003 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.594 HG13 ' HB2' ' A' ' 68' ' ' PRO . 48.3 t -68.76 140.3 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.143 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.483 HG21 HG11 ' A' ' 80' ' ' VAL . 4.9 pt -113.36 93.86 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-O 120.983 0.42 . . . . 0.0 110.808 178.613 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -65.04 -28.98 69.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.63 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.462 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.2 OUTLIER -126.34 178.96 1.3 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.178 -179.313 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.462 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 36.5 Cg_exo -59.36 143.05 99.85 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 122.68 2.253 . . . . 0.0 111.45 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.483 HG11 HG21 ' A' ' 76' ' ' ILE . 5.2 p -137.69 140.78 40.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.464 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.454 HH11 ' HD3' ' A' ' 81' ' ' ARG . 34.0 mmt-85 -79.29 129.4 34.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.221 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.474 HD11 ' HB2' ' A' ' 60' ' ' LEU . 98.4 mt -85.21 136.58 33.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.985 0.421 . . . . 0.0 111.381 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -125.85 152.2 45.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.459 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.407 ' CD2' ' C ' ' A' ' 84' ' ' HIS . 6.9 t60 -53.37 115.78 2.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.79 0.329 . . . . 0.0 110.422 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.7 -16.7 25.99 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -69.01 135.2 50.52 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.215 -0.594 . . . . 0.0 109.958 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.1 t -112.39 131.29 64.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.138 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 91.6 mt -94.62 131.37 41.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 25.6 m -122.79 128.18 50.11 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -177.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.474 ' O ' ' C ' ' A' ' 91' ' ' ILE . 79.5 mt -113.79 125.14 71.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.01 178.082 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.516 HG22 ' N ' ' A' ' 92' ' ' ASP . 97.9 mt 33.64 -96.36 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.074 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.593 ' OD1' ' NH1' ' A' ' 93' ' ' ARG . 47.9 p-10 -114.74 12.24 17.02 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.744 ' CZ ' HD11 ' A' ' 41' ' ' LEU . 70.6 mtt85 -124.62 140.05 53.3 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.683 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 56.6 m -136.09 151.1 49.46 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.45 0.643 . . . . 0.0 111.137 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.563 ' HB3' HD11 ' A' ' 7' ' ' LEU . 63.0 m-85 -121.95 120.74 35.3 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.851 179.126 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.526 ' O ' HD12 ' A' ' 7' ' ' LEU . 39.6 ttm180 -81.65 129.21 34.62 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.616 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.586 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 87.1 t80 -94.9 124.31 38.88 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.722 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -123.3 122.01 37.27 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.617 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.415 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 47.7 t30 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.373 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 235' ' ' PRO . . . . . 0.428 ' HD2' ' O ' ' A' ' 42' ' ' PRO . 26.8 Cg_exo . . . . . 0 N--CA 1.491 1.382 0 CA-C-O 121.532 0.555 . . . . 0.0 112.779 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -78.76 133.17 30.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.87 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 237' ' ' CYS . . . . . 0.451 ' SG ' HG23 ' A' ' 91' ' ' ILE . 34.7 t . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.963 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo . . . . . 0 N--CA 1.494 1.537 0 CA-C-O 120.551 0.146 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 79.8 m -74.38 -43.0 58.35 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.29 0.567 . . . . 0.0 109.62 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.612 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 73.6 t80 -55.54 -46.65 77.06 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.693 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 98.4 mt -64.75 -39.49 93.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.108 0.48 . . . . 0.0 110.331 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 51.2 tp10 -61.12 -42.52 98.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.761 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -63.72 -39.43 94.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.307 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.488 ' NH2' ' CE1' ' B' ' 241' ' ' PHE . 40.3 mmt-85 -61.74 -40.74 96.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.706 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -62.18 -41.38 98.28 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.412 -0.515 . . . . 0.0 109.95 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 37.3 t -65.04 -45.38 85.66 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 248' ' ' GLN . . . . . 0.441 ' HB2' ' NH2' ' A' ' 12' ' ' ARG . 74.8 mt-30 -61.2 -35.41 77.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.554 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 249' ' ' VAL . . . . . 0.47 HG23 ' O ' ' B' ' 245' ' ' ARG . 39.4 t . . . . . 0 C--N 1.33 -0.247 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.452 ' OE1' ' NH2' ' A' ' 93' ' ' ARG . 95.2 mt-10 . . . . . 0 CA--C 1.529 0.159 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.414 ' CD1' HG23 ' A' ' 9' ' ' THR . 76.5 mt -111.61 134.0 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.391 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 54.8 t -125.58 132.85 70.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.738 0.304 . . . . 0.0 111.098 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -98.33 120.36 38.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.312 0.577 . . . . 0.0 111.626 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -66.85 -44.61 80.58 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.203 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.42 159.2 30.13 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.033 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.02 154.4 67.39 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 123.051 2.501 . . . . 0.0 111.864 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 47.0 pt . . . . . 0 C--N 1.327 -0.393 0 CA-C-O 121.309 0.576 . . . . 0.0 111.819 -178.931 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.5 p . . . . . 0 CA--C 1.529 0.152 0 CA-C-O 120.901 0.381 . . . . 0.0 110.716 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.4 mtt85 -94.87 124.93 39.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.908 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -133.53 140.25 47.09 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.343 -0.543 . . . . 0.0 111.521 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.879 HD11 HD11 ' A' ' 22' ' ' LEU . 79.2 mt -113.0 138.45 49.86 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.502 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 54.7 t -112.78 131.34 64.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.3 m -85.38 136.32 33.51 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.595 0.712 . . . . 0.0 112.32 -178.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 95.0 mt -108.89 138.03 38.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.185 178.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -91.4 158.36 16.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.191 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.476 ' CD ' HH21 ' B' ' 245' ' ' ARG . 87.5 mtm180 -59.26 -23.51 62.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.044 0.45 . . . . 0.0 110.271 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.2 t -79.05 -16.83 56.26 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.358 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.05 36.62 5.93 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.6 t -119.46 134.18 63.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 121.191 0.519 . . . . 0.0 112.052 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.401 ' C ' ' OD1' ' A' ' 16' ' ' ASP . 60.5 t0 -76.96 120.1 21.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.38 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -115.48 -124.75 3.82 Favored Glycine 0 CA--C 1.539 1.583 0 C-N-CA 120.919 -0.657 . . . . 0.0 111.665 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.24 153.25 40.52 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.551 2.167 . . . . 0.0 113.192 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -111.61 156.58 21.58 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.029 0.442 . . . . 0.0 110.563 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.417 ' CD2' HD11 ' A' ' 37' ' ' ILE . 38.7 t80 -123.58 100.91 37.54 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.066 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.53 134.44 20.49 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 C-N-CA 121.344 1.363 . . . . 0.0 111.928 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.879 HD11 HD11 ' A' ' 7' ' ' LEU . 95.3 mt -88.55 71.74 8.86 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.844 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 89.2 p -79.9 -8.22 59.18 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.652 HD11 ' HG2' ' B' ' 265' ' ' GLN . 51.8 mt -97.4 142.5 29.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.801 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.9 p -66.2 -21.69 66.32 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.099 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 86.0 m -133.68 136.23 44.58 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.006 0.431 . . . . 0.0 110.775 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.559 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -134.81 129.53 34.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.486 178.632 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.51 HD12 ' O ' ' A' ' 49' ' ' CYS . 48.1 tp -119.71 131.22 55.34 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.745 -178.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.757 ' CE2' HD12 ' A' ' 37' ' ' ILE . 38.1 m-85 -104.98 140.78 37.68 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.702 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 149.3 -166.4 29.53 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 120.299 -0.953 . . . . 0.0 112.574 178.021 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 44.5 mtm180 -86.0 -32.01 21.72 Favored 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.415 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -49.33 151.16 3.84 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 -178.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.462 HG23 ' N ' ' A' ' 34' ' ' GLU . 11.3 tp -66.41 -40.5 86.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.462 ' N ' HG23 ' A' ' 33' ' ' ILE . 85.1 tt0 -54.8 -23.96 20.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.022 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.415 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 59.5 m -56.79 115.02 2.32 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.827 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -57.82 -21.41 42.09 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.757 HD12 ' CE2' ' A' ' 29' ' ' PHE . 97.6 mt -129.99 120.98 50.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.278 -0.874 . . . . 0.0 108.912 177.207 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 84.7 mtp180 -105.54 133.66 49.93 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.514 -179.017 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.0 mt -118.49 128.07 75.47 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -80.25 43.59 0.64 Allowed 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -177.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.971 HD11 ' NH1' ' A' ' 93' ' ' ARG . 59.0 mt -111.14 134.06 21.16 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.379 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.81 -9.76 21.2 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 122.223 1.948 . . . . 0.0 111.965 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.626 HG21 ' CE2' ' B' ' 241' ' ' PHE . 27.0 m -101.11 2.28 10.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.772 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 25.1 t -93.34 135.84 26.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.278 0.561 . . . . 0.0 109.945 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.4 m -68.25 159.94 30.24 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.377 -178.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -61.47 -42.46 98.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.928 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.675 ' O ' ' N ' ' A' ' 49' ' ' CYS . 82.9 mt-30 -114.58 -16.37 11.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.459 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.2 t60 32.81 -73.82 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.675 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -134.8 138.13 43.98 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -178.221 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -125.5 136.76 53.69 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.42 -0.809 . . . . 0.0 108.909 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.532 HG22 ' O ' ' A' ' 27' ' ' CYS . 14.9 tt -126.5 140.72 48.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.074 0.464 . . . . 0.0 110.89 -178.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -122.59 135.56 54.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.393 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.8 mt -110.6 114.62 47.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.283 0.564 . . . . 0.0 111.355 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.47 ' O ' ' N ' ' A' ' 56' ' ' GLN . 92.3 m-70 -115.76 143.89 44.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.571 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 54' ' ' HIS . 96.1 mt-10 -40.06 -29.36 0.07 Allowed 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.308 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.47 ' N ' ' O ' ' A' ' 54' ' ' HIS . 87.9 mt-30 -63.48 -69.66 0.26 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -160.57 -164.1 1.18 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.555 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -108.42 131.91 54.3 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.163 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 89.2 mt -122.0 132.27 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -178.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.553 HD11 ' SG ' ' A' ' 49' ' ' CYS . 57.9 tp -99.35 128.83 45.51 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.825 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -115.53 134.95 54.58 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -95.74 103.53 15.42 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -95.25 -8.25 36.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.427 178.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.44 98.42 8.88 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.989 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.9 p -79.57 -31.82 41.97 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.448 HG22 HG12 ' B' ' 236' ' ' VAL . 3.5 m -65.32 -49.08 70.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.917 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.479 HD21 ' HA ' ' B' ' 236' ' ' VAL . 73.8 m-20 -138.96 95.9 9.39 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.742 -179.204 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -54.04 144.32 58.0 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 121.901 1.734 . . . . 0.0 112.74 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.3 m -71.11 132.29 44.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.783 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -97.56 140.64 31.67 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.071 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.5 p -133.25 137.68 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 49.85 32.38 5.38 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.3 29.35 70.3 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.901 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 58.3 m -135.13 124.77 25.17 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 117.364 0.582 . . . . 0.0 112.086 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.7 m -69.27 137.0 25.12 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.526 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 1.6 pt -116.26 120.17 64.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 C-N-CA 120.659 -0.417 . . . . 0.0 110.726 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -85.29 -18.93 32.42 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.02 167.07 17.96 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.2 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.88 151.46 73.91 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.697 2.265 . . . . 0.0 112.807 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.5 m -141.2 148.81 20.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.193 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -79.09 133.7 36.76 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.331 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 97.0 mt -85.57 144.34 27.95 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.238 0.542 . . . . 0.0 111.304 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -128.47 151.1 49.79 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.913 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.5 ' ND1' ' N ' ' A' ' 99' ' ' ASN . 7.0 t60 -53.72 118.34 3.85 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.059 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.28 -17.33 31.61 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.994 -0.843 . . . . 0.0 110.994 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -67.16 135.38 53.43 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.227 0.537 . . . . 0.0 110.214 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.525 ' O ' HG13 ' A' ' 87' ' ' VAL . 12.5 p -113.54 133.47 59.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.877 -178.395 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.1 mt -99.67 131.7 46.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 177.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 98.6 m -122.91 125.67 45.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.642 0.735 . . . . 0.0 112.527 -178.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.591 ' O ' ' N ' ' A' ' 92' ' ' ASP . 96.6 mt -111.03 125.26 68.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 114.519 -1.218 . . . . 0.0 108.198 178.194 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.552 HD12 ' HB2' ' B' ' 237' ' ' CYS . 23.4 mm 35.17 -90.23 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -178.387 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.591 ' N ' ' O ' ' A' ' 90' ' ' ILE . 1.0 OUTLIER -125.44 5.81 7.65 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.14 0.495 . . . . 0.0 110.735 178.793 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.971 ' NH1' HD11 ' A' ' 41' ' ' LEU . 71.4 mtt85 -108.4 137.01 47.09 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.186 178.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 31.0 t -139.21 151.27 46.42 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.167 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.532 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 78.9 m-85 -124.81 126.02 44.94 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -87.06 135.99 33.08 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.99 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -97.82 123.0 41.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.358 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -139.62 130.69 26.42 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.158 -0.617 . . . . 0.0 112.069 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.5 ' N ' ' ND1' ' A' ' 84' ' ' HIS . 77.8 m-20 . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.626 178.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo . . . . . 0 N--CA 1.484 0.96 0 CA-C-O 121.038 0.349 . . . . 0.0 111.949 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.479 ' HA ' HD21 ' A' ' 67' ' ' ASN . 3.5 m -65.75 147.55 12.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 237' ' ' CYS . . . . . 0.552 ' HB2' HD12 ' A' ' 91' ' ' ILE . 8.5 t . . . . . 0 C--N 1.328 -0.354 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.246 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo . . . . . 0 N--CA 1.503 2.068 0 N-CA-C 113.254 0.444 . . . . 0.0 113.254 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 42.9 m -72.11 -43.39 64.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.051 0.453 . . . . 0.0 110.214 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.626 ' CE2' HG21 ' A' ' 43' ' ' VAL . 63.6 t80 -58.11 -46.76 85.0 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.097 -178.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 82.7 mt -63.79 -41.66 97.88 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.85 -39.67 90.99 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.565 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -61.74 -40.72 96.09 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.237 -0.585 . . . . 0.0 109.617 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.857 ' O ' HG23 ' B' ' 249' ' ' VAL . 77.9 mtp180 -63.35 -42.53 98.92 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.289 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -62.99 -41.06 99.46 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.382 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 33.5 p -67.62 -44.27 78.4 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.285 0.564 . . . . 0.0 109.905 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -63.49 -32.85 74.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.42 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 249' ' ' VAL . . . . . 0.857 HG23 ' O ' ' B' ' 245' ' ' ARG . 75.8 t . . . . . 0 C--N 1.328 -0.361 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 . . . . . 0 CA--C 1.529 0.14 0 CA-C-O 120.741 0.305 . . . . 0.0 111.371 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.532 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 75.6 mt -110.84 134.1 54.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 178.055 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 79.1 t -126.22 135.04 65.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.766 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -95.25 120.41 35.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.145 -178.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 40.5 tttp -65.33 -45.52 83.93 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.034 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 265' ' ' GLN . . . . . 0.652 ' HG2' HD11 ' A' ' 24' ' ' LEU . 2.9 mp0 -91.54 160.92 35.67 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.714 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.46 148.54 67.22 Favored 'Trans proline' 0 C--N 1.301 -1.923 0 C-N-CA 122.698 2.265 . . . . 0.0 112.829 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 42.7 pt . . . . . 0 C--N 1.332 -0.165 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.759 179.384 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.3 p . . . . . 0 CA--C 1.523 -0.066 0 CA-C-O 120.665 0.269 . . . . 0.0 110.834 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.582 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 93.5 mtt-85 -93.84 120.74 34.49 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.546 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -130.09 137.08 49.99 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.057 0.456 . . . . 0.0 111.782 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.621 HD11 ' HB3' ' A' ' 95' ' ' PHE . 43.8 tp -110.49 130.57 55.53 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.7 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 43.3 t -107.37 130.23 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 120.744 0.307 . . . . 0.0 110.72 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 m -90.91 116.4 28.69 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -177.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.625 HD12 ' OG ' ' A' ' 94' ' ' SER . 96.6 mt -83.72 142.89 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.21 178.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -93.32 157.85 16.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.265 0.555 . . . . 0.0 111.147 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.602 HH22 ' CG ' ' B' ' 248' ' ' GLN . 59.1 mtp180 -57.97 -31.9 67.34 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.232 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.4 p -71.59 -15.62 62.27 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.064 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.03 37.18 5.76 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 46.3 t -124.81 133.6 69.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.181 -0.509 . . . . 0.0 111.328 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -77.22 136.9 38.57 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.87 -120.25 2.22 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.486 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -71.53 151.52 58.98 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.273 1.982 . . . . 0.0 113.147 -178.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -108.01 158.59 17.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.178 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.55 ' CD2' HD11 ' A' ' 37' ' ' ILE . 53.0 t80 -129.22 94.98 31.99 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.22 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -57.93 124.9 17.05 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.038 1.825 . . . . 0.0 111.862 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 89.3 mt -87.39 46.94 1.43 Allowed 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.676 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.5 t -59.81 -20.21 55.42 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.692 HD11 ' HG2' ' B' ' 265' ' ' GLN . 71.7 mt -77.78 139.44 39.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.02 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.1 p -64.62 -20.98 66.59 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.906 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.5 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 28.2 m -132.45 132.98 43.3 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.716 -0.393 . . . . 0.0 110.769 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.2 t -124.98 117.92 25.09 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.3 tp -115.99 129.05 56.2 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.278 -178.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.68 ' CE2' HD12 ' A' ' 37' ' ' ILE . 4.9 m-85 -108.56 139.96 42.59 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.056 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.76 -178.11 29.24 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.479 178.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 31' ' ' ARG . 46.5 mtm180 -70.96 -33.3 70.33 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.685 0.278 . . . . 0.0 111.264 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.452 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -47.15 143.62 5.47 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.475 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.3 tp -67.1 -41.11 86.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.475 ' N ' HG23 ' A' ' 33' ' ' ILE . 79.7 mm-40 -55.79 -19.25 10.73 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.899 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.452 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 86.0 m -55.96 122.13 10.88 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.232 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.5 ' OD2' ' O ' ' A' ' 26' ' ' THR . 63.8 m-20 -58.15 -29.2 65.39 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.68 HD12 ' CE2' ' A' ' 29' ' ' PHE . 79.4 mt -128.38 119.09 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 176.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 68.8 ttp85 -106.47 135.85 47.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.319 -178.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.426 HG22 ' H ' ' A' ' 41' ' ' LEU . 95.1 mt -116.17 129.93 71.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-O 121.168 0.508 . . . . 0.0 110.853 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -75.92 25.46 0.12 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.415 -178.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.483 HD23 ' HA ' ' A' ' 41' ' ' LEU . 29.7 mt -92.22 128.85 43.47 Favored Pre-proline 0 C--N 1.326 -0.43 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.403 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.19 -8.21 21.7 Favored 'Trans proline' 0 C--N 1.316 -1.18 0 C-N-CA 122.083 1.856 . . . . 0.0 111.905 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.593 HG21 ' CE2' ' B' ' 241' ' ' PHE . 35.2 m -104.58 5.33 10.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.496 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.7 t -90.64 137.81 20.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.8 m -66.68 168.06 10.07 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.295 0.569 . . . . 0.0 112.035 -178.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -63.15 -45.71 90.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.237 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.651 ' O ' ' N ' ' A' ' 49' ' ' CYS . 86.9 mt-30 -115.02 -16.82 11.6 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.193 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.578 ' NE2' HG23 ' A' ' 90' ' ' ILE . 19.7 t60 35.97 -74.81 0.0 OUTLIER 'General case' 0 C--O 1.236 0.373 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 179.215 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.651 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.4 134.35 47.07 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -177.971 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -127.46 126.8 42.99 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.852 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.7 mt -111.52 134.26 54.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.332 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.493 ' CD ' ' NE2' ' A' ' 54' ' ' HIS . 82.7 tt0 -116.66 122.63 45.11 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 178.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 74.3 mt -103.46 118.7 50.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.008 -0.677 . . . . 0.0 112.276 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.56 ' O ' ' N ' ' A' ' 56' ' ' GLN . 99.3 m-70 -114.25 139.91 49.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.14 178.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.459 ' C ' ' O ' ' A' ' 54' ' ' HIS . 97.3 mt-10 -39.79 -25.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.465 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.56 ' N ' ' O ' ' A' ' 54' ' ' HIS . 60.4 tt0 -64.99 -67.55 0.43 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.369 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.712 ' CB ' ' HE ' ' A' ' 81' ' ' ARG . 4.7 tp10 -158.37 -159.14 0.77 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.104 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.406 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -118.25 128.36 54.61 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.116 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 87.7 mt -118.68 129.68 74.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.895 -178.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.629 ' HB2' HD11 ' A' ' 82' ' ' LEU . 26.7 tp -99.59 129.65 45.76 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.857 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -110.97 135.93 50.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.147 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.507 HD21 ' HB3' ' A' ' 68' ' ' PRO . 36.7 t-20 -97.26 109.45 22.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.835 0.35 . . . . 0.0 111.748 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -99.83 -9.66 22.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.692 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.9 t -78.74 119.81 22.5 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.106 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 95.2 p -101.04 -29.92 11.9 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.404 ' O ' ' OD1' ' A' ' 67' ' ' ASN . 0.6 OUTLIER -66.57 -42.06 87.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.608 178.67 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.404 ' OD1' ' O ' ' A' ' 66' ' ' THR . 1.4 m-20 -147.97 101.13 3.65 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.162 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.507 ' HB3' HD21 ' A' ' 62' ' ' ASN . 39.1 Cg_endo -66.2 154.22 75.0 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 121.624 1.549 . . . . 0.0 112.753 -178.243 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.1 m -75.24 149.9 38.75 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.612 -178.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -112.84 140.18 47.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.663 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 41.1 t -129.08 135.66 61.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.483 ' H ' HG13 ' A' ' 87' ' ' VAL . 89.6 m-20 52.22 31.81 9.76 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.42 25.81 71.76 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.893 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 63.4 m -136.78 135.94 38.47 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 120.324 -0.55 . . . . 0.0 112.031 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 43.5 t -66.63 135.84 27.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.233 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.0 pt -106.62 98.82 7.4 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.088 0 CA-C-O 121.322 0.582 . . . . 0.0 111.001 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -63.13 -33.26 75.07 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.39 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.498 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.2 OUTLIER -129.58 -178.71 0.85 Allowed Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.262 -179.531 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.498 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 31.5 Cg_exo -60.5 146.53 96.71 Favored 'Trans proline' 0 N--CA 1.504 2.1 0 C-N-CA 123.297 2.665 . . . . 0.0 112.459 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.4 p -140.01 139.65 36.69 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 CA-C-O 120.93 0.395 . . . . 0.0 111.626 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.712 ' HE ' ' CB ' ' A' ' 57' ' ' GLU . 70.5 ttt180 -75.34 127.65 33.63 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.687 178.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.629 HD11 ' HB2' ' A' ' 60' ' ' LEU . 92.4 mt -84.12 141.26 31.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.167 0.508 . . . . 0.0 111.206 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -130.73 149.36 52.41 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.882 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.471 ' ND1' ' N ' ' A' ' 99' ' ' ASN . 7.8 t60 -52.39 117.99 3.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.64 -179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.36 -16.97 34.61 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -66.37 139.72 58.04 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 121.213 0.53 . . . . 0.0 110.308 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.483 HG13 ' H ' ' A' ' 72' ' ' ASN . 7.4 p -111.09 133.01 58.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.869 -178.27 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.7 mt -101.14 129.65 51.81 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 76.8 m -124.48 122.29 37.22 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.642 0.734 . . . . 0.0 112.445 -178.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.578 HG23 ' NE2' ' A' ' 48' ' ' HIS . 76.5 mt -108.34 125.24 65.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.003 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.511 ' C ' ' O ' ' A' ' 90' ' ' ILE . 94.5 mt 34.73 -97.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.063 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.569 ' OD2' ' CZ ' ' B' ' 245' ' ' ARG . 54.4 p-10 -117.41 6.8 12.66 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.919 0.39 . . . . 0.0 111.196 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.57 ' N ' ' O ' ' A' ' 90' ' ' ILE . 23.1 mmt180 -110.53 134.27 52.53 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.625 ' OG ' HD12 ' A' ' 10' ' ' ILE . 71.6 p -137.55 150.95 47.89 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 119.661 -0.815 . . . . 0.0 110.429 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.621 ' HB3' HD11 ' A' ' 7' ' ' LEU . 82.9 m-85 -125.43 124.6 41.79 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.408 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.471 ' O ' HD12 ' A' ' 7' ' ' LEU . 69.4 mtp85 -87.12 134.11 33.55 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.316 -0.554 . . . . 0.0 110.951 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.601 ' OH ' ' ND2' ' A' ' 99' ' ' ASN . 92.6 t80 -99.25 126.67 45.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.15 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -143.5 125.98 15.8 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.967 0.413 . . . . 0.0 111.668 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.601 ' ND2' ' OH ' ' A' ' 97' ' ' TYR . 97.5 m-20 . . . . . 0 N--CA 1.464 0.266 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.308 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo . . . . . 0 N--CA 1.492 1.416 0 CA-C-O 121.391 0.496 . . . . 0.0 112.411 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.467 HG13 ' O ' ' B' ' 236' ' ' VAL . 14.6 p -87.2 127.81 40.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.22 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.6 t . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.662 -179.531 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo . . . . . 0 N--CA 1.494 1.526 0 CA-C-O 120.637 0.182 . . . . 0.0 111.819 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 20.4 m -68.14 -44.97 74.84 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 177.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.593 ' CE2' HG21 ' A' ' 43' ' ' VAL . 80.9 t80 -58.67 -45.62 89.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.144 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 84.0 mt -63.35 -41.66 98.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.917 0.389 . . . . 0.0 111.49 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -63.3 -42.07 99.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.151 -178.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 77.8 ttt-85 -61.44 -43.46 98.83 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.934 0.397 . . . . 0.0 110.572 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.569 ' CZ ' ' OD2' ' A' ' 92' ' ' ASP . 8.4 tpp85 -59.82 -42.4 93.45 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.849 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.98 -39.86 96.0 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 58.2 m -64.98 -44.28 89.82 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 177.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 248' ' ' GLN . . . . . 0.602 ' CG ' HH22 ' A' ' 12' ' ' ARG . 60.9 tt0 -58.67 -38.36 78.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.437 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 42.1 t . . . . . 0 C--N 1.329 -0.283 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.95 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.484 ' HB2' HH21 ' A' ' 93' ' ' ARG . 50.7 mp0 . . . . . 0 N--CA 1.467 0.383 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 53.2 mt -116.02 135.6 55.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 61.7 t -129.08 135.54 61.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.865 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -95.19 119.46 33.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.435 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -64.63 -47.15 79.59 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.838 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 265' ' ' GLN . . . . . 0.692 ' HG2' HD11 ' A' ' 24' ' ' LEU . 4.6 mp0 -93.67 159.15 35.39 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.038 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -69.44 148.1 66.41 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.818 2.345 . . . . 0.0 112.754 -179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 44.8 pt . . . . . 0 C--N 1.326 -0.451 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.54 179.007 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.48 ' O ' ' O ' ' A' ' 99' ' ' ASN . 80.5 m . . . . . 0 CA--C 1.529 0.149 0 CA-C-O 120.731 0.3 . . . . 0.0 111.214 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.3 mtt85 -86.58 137.23 32.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.136 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -129.33 131.52 46.93 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.372 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.577 HD11 ' HB3' ' A' ' 95' ' ' PHE . 32.7 tp -109.64 131.66 54.85 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.4 t -113.27 131.17 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 121.172 0.511 . . . . 0.0 111.002 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.401 HG23 ' CD1' ' B' ' 261' ' ' ILE . 17.2 m -80.18 145.51 32.25 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.429 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.537 ' CD1' ' OD1' ' A' ' 16' ' ' ASP . 46.2 mm -112.83 136.24 49.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.579 177.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -88.3 151.74 22.42 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.771 HH11 ' NH2' ' A' ' 93' ' ' ARG . 79.0 mtm-85 -58.17 -21.8 48.77 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.175 -178.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 93.9 p -78.12 -10.9 59.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.767 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.98 31.8 11.67 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.184 -1.167 . . . . 0.0 110.184 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 51.2 t -118.34 132.64 67.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.796 0.332 . . . . 0.0 110.325 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.537 ' OD1' ' CD1' ' A' ' 10' ' ' ILE . 79.8 m-20 -75.85 137.51 40.51 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -130.89 -116.59 1.83 Allowed Glycine 0 CA--C 1.537 1.433 0 C-N-CA 120.364 -0.922 . . . . 0.0 112.597 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.63 146.84 44.39 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.337 2.025 . . . . 0.0 112.755 -178.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -109.21 155.15 21.43 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.012 0.435 . . . . 0.0 110.004 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.46 ' CD2' HD11 ' A' ' 37' ' ' ILE . 48.8 t80 -127.94 104.38 20.78 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.993 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.58 134.78 19.03 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 C-N-CA 121.371 1.381 . . . . 0.0 111.388 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 90.7 mt -87.23 59.61 5.66 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.374 -178.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 88.2 p -65.39 -33.08 75.12 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.8 mt -76.43 142.44 41.04 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.705 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 77.4 p -65.17 -17.6 64.61 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.417 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 92.0 m -135.31 136.96 41.99 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.725 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.0 t -128.12 119.73 25.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.056 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.666 HD21 ' HG2' ' A' ' 47' ' ' GLN . 38.6 tp -117.27 128.1 54.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.856 -178.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.668 ' CE2' HD12 ' A' ' 37' ' ' ILE . 4.7 m-85 -106.13 138.56 42.1 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 123.594 0.559 . . . . 0.0 109.834 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 160.8 -164.62 34.78 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.147 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.62 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 83.3 mtm-85 -86.82 -26.63 23.96 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.483 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.569 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -55.82 149.66 24.74 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-N 116.249 -0.432 . . . . 0.0 112.912 -178.087 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.513 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.5 tp -70.35 -42.77 78.67 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 CA-C-O 121.118 0.485 . . . . 0.0 109.823 178.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.513 ' N ' HG23 ' A' ' 33' ' ' ILE . 21.6 pt-20 -54.78 -20.15 7.91 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.498 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.569 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 13.3 m -61.63 128.15 34.9 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.205 -179.357 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.417 ' OD2' ' O ' ' A' ' 26' ' ' THR . 55.0 m-20 -61.88 -32.76 73.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.447 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.668 HD12 ' CE2' ' A' ' 29' ' ' PHE . 98.6 mt -128.62 125.51 63.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.692 178.176 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 70.8 mtm180 -106.57 138.17 43.25 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.931 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.687 HG21 HD12 ' A' ' 41' ' ' LEU . 94.2 mt -117.81 127.66 75.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -72.83 32.83 0.07 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.696 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.687 HD12 HG21 ' A' ' 39' ' ' ILE . 25.9 mt -98.44 120.99 58.08 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.667 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.1 -9.27 23.26 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.309 2.006 . . . . 0.0 112.45 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.645 HG23 HD13 ' A' ' 91' ' ' ILE . 12.1 m -103.5 10.71 8.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.664 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.62 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 11.0 t -100.8 138.1 26.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.5 m -69.91 172.17 8.19 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.577 0.703 . . . . 0.0 112.11 -178.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -63.98 -40.91 97.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.393 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.666 ' HG2' HD21 ' A' ' 28' ' ' LEU . 86.8 mt-30 -112.73 -20.03 11.8 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 123.172 0.295 . . . . 0.0 110.766 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 26.0 t60 37.12 -73.57 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.663 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.46 136.83 48.26 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.017 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -126.85 129.59 48.56 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.357 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.8 mt -115.01 133.75 60.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.584 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -115.2 128.68 56.32 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 52.0 mm -98.28 115.83 39.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.214 0.531 . . . . 0.0 110.959 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.486 ' O ' ' N ' ' A' ' 56' ' ' GLN . 97.2 m-70 -119.4 135.0 54.94 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.159 179.145 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 54' ' ' HIS . 51.6 tp10 -40.26 -28.69 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.041 -0.663 . . . . 0.0 109.375 -179.092 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.486 ' N ' ' O ' ' A' ' 54' ' ' HIS . 50.7 tt0 -65.39 -67.87 0.41 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.113 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.431 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 5.8 tp10 -158.8 -159.72 0.8 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.049 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.466 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -120.73 130.46 54.06 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.5 mt -116.92 128.8 74.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.191 0.519 . . . . 0.0 111.514 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.578 HD21 HG21 ' A' ' 69' ' ' THR . 22.6 tp -96.96 127.05 42.54 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.403 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -110.88 136.44 49.92 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.22 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -95.63 106.97 19.12 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.291 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -99.97 -12.03 20.11 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.31 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.44 100.44 10.72 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.779 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.8 m -73.31 -34.7 65.84 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.999 0.428 . . . . 0.0 110.491 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.71 -37.09 81.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.096 -179.127 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -145.05 92.37 5.73 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.171 -178.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.455 ' HB2' HG23 ' A' ' 75' ' ' VAL . 33.5 Cg_exo -56.65 146.42 76.53 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.205 1.937 . . . . 0.0 112.735 -178.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.578 HG21 HD21 ' A' ' 60' ' ' LEU . 3.3 m -72.84 136.96 45.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.61 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -102.43 140.15 37.09 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.668 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 51.7 t -131.78 133.25 61.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.581 ' ND2' ' OD1' ' A' ' 86' ' ' ASP . 83.8 m-20 53.01 32.16 12.34 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.488 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.99 28.29 64.9 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.905 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 66.1 m -142.71 138.95 30.91 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 117.048 0.424 . . . . 0.0 111.214 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.455 HG23 ' HB2' ' A' ' 68' ' ' PRO . 0.4 OUTLIER -71.39 141.47 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.399 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.1 pt -112.41 90.09 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.848 178.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -65.37 -26.97 68.25 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -121.63 168.09 12.07 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.544 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -56.51 142.46 89.69 Favored 'Trans proline' 0 N--CA 1.501 1.935 0 C-N-CA 122.312 2.008 . . . . 0.0 112.272 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.7 p -134.3 138.87 49.2 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 CA-C-O 121.072 0.463 . . . . 0.0 111.255 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -78.3 131.29 36.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.507 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.466 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 89.9 mt -83.14 131.22 35.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.261 0.553 . . . . 0.0 111.06 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -119.91 143.59 47.87 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.048 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -48.81 118.04 2.37 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.384 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.66 -12.84 42.58 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.581 ' OD1' ' ND2' ' A' ' 72' ' ' ASN . 26.3 t70 -69.71 132.2 45.76 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.3 t -108.27 133.53 52.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.19 -178.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 87.8 mt -102.21 131.79 49.55 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 54.1 m -120.89 127.4 51.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.535 0.683 . . . . 0.0 112.749 -178.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.486 ' O ' ' N ' ' A' ' 93' ' ' ARG . 88.9 mt -112.35 121.96 65.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.588 178.073 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.645 HD13 HG23 ' A' ' 43' ' ' VAL . 75.3 mt 31.71 -95.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.522 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 92' ' ' ASP . 38.7 p-10 -107.87 6.71 27.62 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -178.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.771 ' NH2' HH11 ' A' ' 12' ' ' ARG . 91.0 mtt-85 -129.98 147.95 51.78 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.458 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.3 t -136.77 154.18 50.63 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.626 0.727 . . . . 0.0 111.241 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.577 ' HB3' HD11 ' A' ' 7' ' ' LEU . 93.7 m-85 -125.46 120.93 32.33 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.893 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.474 ' O ' HD12 ' A' ' 7' ' ' LEU . 79.7 mtp85 -83.5 132.53 34.94 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.106 -0.638 . . . . 0.0 110.551 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -94.04 123.55 37.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.302 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -125.46 117.08 22.89 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.48 ' O ' ' O ' ' A' ' 4' ' ' THR . 7.2 t-20 . . . . . 0 C--N 1.326 -0.43 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.543 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo . . . . . 0 N--CA 1.485 1.009 0 CA-C-O 121.676 0.615 . . . . 0.0 113.032 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.484 HG13 ' O ' ' B' ' 236' ' ' VAL . 9.7 p -77.47 128.31 38.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.403 -178.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.425 179.926 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo . . . . . 0 N--CA 1.498 1.751 0 N-CA-C 113.057 0.368 . . . . 0.0 113.057 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 240' ' ' THR . . . . . 0.405 HG22 ' NE ' ' B' ' 244' ' ' ARG . 18.6 m -72.88 -43.81 62.08 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.274 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.51 ' CE2' HG21 ' A' ' 43' ' ' VAL . 85.5 t80 -58.14 -46.72 85.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.577 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.467 HD21 ' CG2' ' A' ' 91' ' ' ILE . 87.4 mt -65.16 -41.91 94.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.973 0.416 . . . . 0.0 110.988 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 50.3 tp10 -65.22 -44.82 87.03 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.065 -179.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 244' ' ' ARG . . . . . 0.405 ' NE ' HG22 ' B' ' 240' ' ' THR . 88.6 mtm180 -64.34 -44.1 92.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.049 0.452 . . . . 0.0 111.046 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.593 ' NH1' ' OE2' ' B' ' 260' ' ' GLU . 54.5 ttm-85 -65.53 -41.06 93.52 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.709 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -60.86 -36.78 80.04 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 40.2 t -66.11 -43.24 87.76 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 177.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 67.4 tp60 -61.04 -36.46 79.61 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.286 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 249' ' ' VAL . . . . . 0.478 ' CG2' ' HE ' ' A' ' 12' ' ' ARG . 47.5 t . . . . . 0 CA--C 1.519 -0.225 0 CA-C-O 120.959 0.409 . . . . 0.0 109.988 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.593 ' OE2' ' NH1' ' B' ' 245' ' ' ARG . 97.7 mt-10 . . . . . 0 CA--C 1.523 -0.073 0 CA-C-O 120.973 0.416 . . . . 0.0 110.361 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.527 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 85.0 mt -115.25 135.15 56.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.569 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 45.5 t -125.83 133.7 68.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.082 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -98.95 120.71 39.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.555 0.693 . . . . 0.0 112.421 -177.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -67.29 -41.59 85.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.623 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.12 159.39 29.53 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.576 -178.165 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -61.01 153.76 61.74 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 123.128 2.552 . . . . 0.0 112.598 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 45.4 pt . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.872 -179.347 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.553 ' O ' ' O ' ' A' ' 99' ' ' ASN . 25.0 m . . . . . 0 C--O 1.227 -0.116 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.7 mtt85 -92.94 138.54 31.39 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.632 -178.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -133.42 141.83 48.04 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.729 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.715 HD11 HD11 ' A' ' 22' ' ' LEU . 65.7 mt -116.57 139.04 50.93 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.6 t -110.81 132.61 58.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 C-N-CA 120.349 -0.541 . . . . 0.0 110.158 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 m -91.58 116.79 29.16 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -177.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.6 mt -84.11 142.51 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.057 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -94.85 155.82 16.62 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.272 0.558 . . . . 0.0 111.266 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.523 ' CD ' ' NH2' ' B' ' 245' ' ' ARG . 83.4 mtm180 -59.05 -32.15 69.5 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.159 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 93.9 p -70.49 -22.51 62.64 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.49 30.05 5.73 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.329 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.3 t -118.04 131.03 71.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.107 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -78.26 138.64 38.72 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.89 -113.83 1.48 Allowed Glycine 0 CA--C 1.53 0.988 0 C-N-CA 120.041 -1.076 . . . . 0.0 112.426 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.6 149.42 55.31 Favored 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 121.953 1.769 . . . . 0.0 112.006 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -114.51 144.65 43.01 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.094 0.473 . . . . 0.0 110.304 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.53 ' CD2' HD11 ' A' ' 37' ' ' ILE . 33.8 t80 -105.87 102.74 40.67 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.344 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -77.74 132.6 12.1 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 121.95 1.766 . . . . 0.0 111.415 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.715 HD11 HD11 ' A' ' 7' ' ' LEU . 95.9 mt -84.56 76.63 10.16 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -177.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 61.5 p -79.9 -12.17 59.76 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 177.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.638 HD11 ' HG2' ' B' ' 265' ' ' GLN . 44.5 mt -102.61 146.81 27.62 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.521 -178.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -68.89 -15.31 63.46 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.832 0.348 . . . . 0.0 111.397 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.454 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 92.1 m -132.48 134.96 45.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.017 0.437 . . . . 0.0 111.295 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.448 ' HB2' HD22 ' A' ' 22' ' ' LEU . 5.1 t -127.3 118.91 25.12 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.05 178.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.503 HD21 ' HG2' ' A' ' 47' ' ' GLN . 33.6 tp -118.2 125.51 50.32 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.814 -178.284 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.756 ' CE2' HD12 ' A' ' 37' ' ' ILE . 5.1 m-85 -102.61 135.94 43.34 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 123.669 0.606 . . . . 0.0 109.679 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 154.91 -179.9 30.61 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 120.353 -0.927 . . . . 0.0 112.568 179.032 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 47.1 mtm180 -70.9 -33.48 70.59 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 122.653 -0.322 . . . . 0.0 111.552 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.551 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -43.94 140.18 3.52 Favored Glycine 0 N--CA 1.464 0.553 0 N-CA-C 111.306 -0.717 . . . . 0.0 111.306 -178.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.553 HG23 ' N ' ' A' ' 34' ' ' GLU . 9.7 tp -65.51 -41.99 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.553 ' N ' HG23 ' A' ' 33' ' ' ILE . 50.6 tp10 -56.92 -18.82 14.77 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.805 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.551 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 20.2 m -62.54 128.06 34.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.29 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.454 ' OD2' ' O ' ' A' ' 26' ' ' THR . 95.5 m-20 -60.4 -28.97 68.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.621 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.756 HD12 ' CE2' ' A' ' 29' ' ' PHE . 92.1 mt -128.32 118.56 48.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 177.385 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.513 ' CZ ' HD12 ' A' ' 33' ' ' ILE . 80.6 mtp180 -104.97 138.12 41.67 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.463 -178.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 88.6 mt -120.32 129.35 75.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 120.536 -0.465 . . . . 0.0 110.318 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -73.79 34.63 0.09 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.143 -178.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.572 ' CD1' ' NH2' ' A' ' 93' ' ' ARG . 32.3 mt -109.25 129.54 23.79 Favored Pre-proline 0 C--N 1.326 -0.435 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.06 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.12 -9.11 21.77 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 C-N-CA 121.975 1.784 . . . . 0.0 112.634 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.572 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 27.6 m -96.74 -0.67 10.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.627 0.251 . . . . 0.0 110.866 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 37.2 t -87.95 136.93 22.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.0 m -69.7 167.54 16.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.294 0.568 . . . . 0.0 111.553 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -64.46 -42.17 96.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.446 -178.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.656 ' O ' ' N ' ' A' ' 49' ' ' CYS . 86.5 mt-30 -115.13 -19.51 10.82 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.384 178.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 24.6 t60 37.3 -76.5 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.656 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -129.1 133.24 47.58 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.27 0.557 . . . . 0.0 111.722 -178.649 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -125.12 126.2 44.94 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.231 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 98.3 mt -112.86 134.55 55.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.578 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.454 ' CD ' ' NE2' ' A' ' 54' ' ' HIS . 84.6 tt0 -122.29 127.06 49.4 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.43 122.95 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 CA-C-O 121.754 0.788 . . . . 0.0 112.754 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.55 ' O ' ' N ' ' A' ' 56' ' ' GLN . 98.0 m-70 -114.02 139.42 49.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.388 -1.278 . . . . 0.0 109.308 179.116 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.473 ' C ' ' O ' ' A' ' 54' ' ' HIS . 83.3 tt0 -38.96 -26.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.55 ' N ' ' O ' ' A' ' 54' ' ' HIS . 91.2 mt-30 -67.36 -67.64 0.44 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.871 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.452 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 3.3 tp10 -155.2 -165.18 1.95 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.826 -179.052 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.41 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -114.33 133.38 55.72 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.527 178.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.2 mt -121.72 127.54 75.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.005 0.431 . . . . 0.0 111.561 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.571 ' HB2' HD11 ' A' ' 82' ' ' LEU . 28.9 tp -100.26 127.43 46.55 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.223 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.401 ' CE1' ' HB3' ' A' ' 79' ' ' PRO . 98.8 m-70 -113.53 138.71 49.75 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.041 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.528 HD22 ' HA ' ' A' ' 68' ' ' PRO . 49.5 t30 -100.65 108.78 20.75 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.389 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -100.88 -9.82 21.25 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.335 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -75.98 99.15 4.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.098 0.475 . . . . 0.0 110.307 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.8 t -73.04 -36.52 66.96 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.519 0.676 . . . . 0.0 109.354 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.5 m -65.31 -48.14 74.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.81 -1.086 . . . . 0.0 111.789 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.454 ' OD1' HG23 ' B' ' 236' ' ' VAL . 3.0 m-20 -142.81 95.11 6.37 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.546 -178.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.591 ' HB2' HG13 ' A' ' 75' ' ' VAL . 43.3 Cg_exo -55.17 146.78 57.93 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 122.18 1.92 . . . . 0.0 112.287 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 59.0 m -74.57 140.45 44.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.284 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -99.18 142.51 30.57 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.647 179.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 54.5 t -131.12 134.73 61.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 25.9 m120 51.07 30.25 5.32 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 119.321 -0.951 . . . . 0.0 108.601 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.07 26.13 69.5 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.221 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.4 p -137.85 137.34 38.02 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.98 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.591 HG13 ' HB2' ' A' ' 68' ' ' PRO . 25.7 t -70.99 136.07 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.312 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.4 pt -109.4 93.99 2.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.729 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -67.81 -29.43 68.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.087 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -125.46 174.65 3.73 Favored Pre-proline 0 CA--C 1.536 0.419 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.172 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.401 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 27.4 Cg_exo -61.36 144.58 98.48 Favored 'Trans proline' 0 N--CA 1.501 1.936 0 C-N-CA 122.871 2.38 . . . . 0.0 112.745 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.7 m -144.03 143.06 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.352 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 92.4 mtt-85 -75.36 129.88 38.1 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.61 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.571 HD11 ' HB2' ' A' ' 60' ' ' LEU . 88.1 mt -83.77 139.24 32.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.705 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -126.9 151.16 48.8 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.489 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.495 ' C ' ' CD2' ' A' ' 84' ' ' HIS . 6.1 t60 -58.06 122.39 12.93 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.91 0.385 . . . . 0.0 110.388 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.49 -13.67 32.97 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.574 -0.61 . . . . 0.0 111.574 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -75.0 136.82 41.24 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.728 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.3 t -108.28 131.98 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.068 -178.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.7 mt -97.09 132.07 42.44 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.448 HG23 ' OG ' ' A' ' 94' ' ' SER . 84.5 m -124.68 126.7 46.13 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -177.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.426 ' O ' ' C ' ' A' ' 91' ' ' ILE . 93.2 mt -114.79 122.03 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.593 HG22 ' N ' ' A' ' 92' ' ' ASP . 89.7 mt 36.29 -103.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.593 ' N ' HG22 ' A' ' 91' ' ' ILE . 88.3 m-20 -103.77 9.02 37.22 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -178.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.626 HH21 ' CZ ' ' B' ' 245' ' ' ARG . 2.5 ptp85 -132.46 148.16 52.39 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.509 -0.477 . . . . 0.0 111.194 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.448 ' OG ' HG23 ' A' ' 89' ' ' THR . 65.2 m -135.15 152.33 51.5 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.349 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -119.32 121.56 39.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.25 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -81.56 131.05 35.26 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 119.821 -0.751 . . . . 0.0 111.391 -179.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -93.24 120.28 33.34 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.247 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -136.4 122.29 20.02 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.727 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.553 ' O ' ' O ' ' A' ' 4' ' ' THR . 90.6 m-20 . . . . . 0 N--CA 1.455 -0.176 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 178.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo . . . . . 0 N--CA 1.491 1.335 0 CA-C-O 121.68 0.616 . . . . 0.0 112.83 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.454 HG23 ' OD1' ' A' ' 67' ' ' ASN . 0.5 OUTLIER -73.12 137.65 22.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 114.559 -1.2 . . . . 0.0 109.713 179.412 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.33 -0.276 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.444 -179.245 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo . . . . . 0 N--CA 1.495 1.606 0 N-CA-C 112.986 0.341 . . . . 0.0 112.986 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 40.1 p -73.99 -39.46 63.65 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.572 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 81.7 t80 -57.45 -45.7 84.44 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.427 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.49 HD23 ' OD2' ' A' ' 92' ' ' ASP . 90.9 mt -62.89 -40.16 96.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.991 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.77 -43.02 97.64 Favored 'General case' 0 CA--C 1.522 -0.105 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.794 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -61.4 -42.82 99.34 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.839 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.626 ' CZ ' HH21 ' A' ' 93' ' ' ARG . 70.6 mtp85 -61.3 -43.89 98.12 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.484 0.549 . . . . 0.0 112.484 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -62.87 -39.61 94.96 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.099 -0.64 . . . . 0.0 109.298 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 39.7 t -67.23 -46.56 73.43 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.025 178.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -59.27 -37.21 77.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.36 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 249' ' ' VAL . . . . . 0.451 HG23 ' O ' ' B' ' 245' ' ' ARG . 40.7 t . . . . . 0 C--N 1.33 -0.268 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.798 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.436 ' OE2' ' NH1' ' A' ' 12' ' ' ARG . 97.3 mt-10 . . . . . 0 CA--C 1.54 0.569 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 82.6 mt -117.61 132.88 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 43.2 t -126.97 135.35 63.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.495 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -96.91 120.58 37.52 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.194 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -65.48 -46.11 81.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.539 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 265' ' ' GLN . . . . . 0.638 ' HG2' HD11 ' A' ' 24' ' ' LEU . 3.3 mp0 -96.9 164.95 16.85 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.277 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -64.32 152.58 80.83 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.351 2.034 . . . . 0.0 111.91 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 42.6 pt . . . . . 0 C--N 1.328 -0.328 0 CA-C-O 121.307 0.575 . . . . 0.0 112.103 -178.553 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.7 p . . . . . 0 CA--C 1.529 0.159 0 CA-C-O 120.823 0.344 . . . . 0.0 111.258 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.494 ' NH2' HG21 ' A' ' 53' ' ' ILE . 88.0 mtm-85 -86.09 127.49 34.7 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -128.48 144.28 51.12 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.83 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 1.061 HD11 HD11 ' A' ' 22' ' ' LEU . 82.0 mt -113.89 142.62 45.89 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.188 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.5 t -114.14 126.76 71.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.0 m -77.4 140.68 39.95 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.505 0.669 . . . . 0.0 111.52 -178.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.446 ' HB ' ' H ' ' A' ' 94' ' ' SER . 49.2 mm -109.95 135.31 49.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.088 178.422 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -94.6 158.29 15.6 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.339 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -57.9 -20.97 41.06 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.89 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.7 p -81.23 -11.65 59.33 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.969 179.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.23 16.55 57.29 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-N 116.086 -0.506 . . . . 0.0 113.094 178.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.5 m -109.05 147.31 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 117.434 0.617 . . . . 0.0 111.533 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.431 ' C ' ' OD1' ' A' ' 16' ' ' ASP . 58.9 t0 -69.74 126.42 29.67 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.18 -178.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.402 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -115.86 -132.35 5.06 Favored Glycine 0 CA--C 1.542 1.751 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -74.18 153.36 46.06 Favored 'Trans proline' 0 N--CA 1.5 1.868 0 C-N-CA 122.509 2.139 . . . . 0.0 112.952 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -109.7 162.51 14.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.006 0.431 . . . . 0.0 110.615 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.427 ' CD2' HD11 ' A' ' 37' ' ' ILE . 38.0 t80 -132.43 106.76 13.24 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.047 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -73.58 127.37 11.66 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 121.903 1.736 . . . . 0.0 112.603 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 1.061 HD11 HD11 ' A' ' 7' ' ' LEU . 95.5 mt -92.05 48.26 1.41 Allowed 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.523 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.8 p -64.82 -13.05 54.45 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 119.559 -0.856 . . . . 0.0 109.222 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.616 HD11 ' OE1' ' B' ' 265' ' ' GLN . 75.4 mt -81.29 141.6 33.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.222 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 87.8 p -62.19 -21.65 65.27 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.971 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 57.6 m -139.54 138.84 36.63 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 119.827 -0.749 . . . . 0.0 112.164 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.509 ' HB2' HD22 ' A' ' 22' ' ' LEU . 5.7 t -128.6 123.92 34.57 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.849 178.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.6 tp -117.43 128.18 54.76 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.979 -178.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.791 ' CE2' HD12 ' A' ' 37' ' ' ILE . 4.4 m-85 -107.35 139.61 41.56 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.703 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 155.8 -173.37 33.84 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.196 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.629 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 83.9 mtm-85 -79.79 -31.03 40.76 Favored 'General case' 0 CA--C 1.527 0.079 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.561 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -52.38 146.08 16.52 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 121.003 -0.618 . . . . 0.0 111.695 -178.53 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.43 HD13 ' CZ ' ' A' ' 38' ' ' ARG . 33.2 mm -63.8 -43.61 97.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.877 0.37 . . . . 0.0 110.078 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -53.0 -18.11 1.82 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.989 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.561 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 59.6 m -61.18 123.39 17.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.982 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -60.18 -31.73 70.4 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.791 HD12 ' CE2' ' A' ' 29' ' ' PHE . 81.0 mt -124.65 119.33 55.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 176.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.43 ' CZ ' HD13 ' A' ' 33' ' ' ILE . 84.3 mtp180 -102.41 137.31 40.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.723 -178.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.471 HG22 ' H ' ' A' ' 41' ' ' LEU . 98.2 mt -122.99 131.62 72.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.521 179.295 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -80.3 26.0 0.38 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.529 -178.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.471 ' H ' HG22 ' A' ' 39' ' ' ILE . 34.8 mt -90.11 132.62 35.48 Favored Pre-proline 0 C--N 1.325 -0.477 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.377 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -71.4 -12.65 29.88 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 121.904 1.736 . . . . 0.0 111.53 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.532 HG21 ' CE2' ' B' ' 241' ' ' PHE . 3.6 m -102.14 7.59 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.629 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 11.4 t -93.51 129.95 43.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.28 168.04 6.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.272 0.558 . . . . 0.0 110.894 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -63.25 -43.32 98.32 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.1 -178.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.626 ' O ' ' N ' ' A' ' 49' ' ' CYS . 86.3 mt-30 -111.18 -11.83 14.19 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.55 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 18.6 t60 30.23 -76.68 0.0 OUTLIER 'General case' 0 C--O 1.237 0.402 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.626 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.95 136.04 47.04 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.266 0.555 . . . . 0.0 112.061 -178.549 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -127.38 127.09 43.62 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.064 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 95.8 mt -111.6 133.13 58.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.208 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -114.4 131.69 56.49 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.494 HG21 ' NH2' ' A' ' 5' ' ' ARG . 45.5 mm -103.51 115.37 45.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.296 0.57 . . . . 0.0 111.269 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.426 ' O ' ' C ' ' A' ' 55' ' ' GLU . 93.2 m-70 -117.04 137.57 52.16 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.959 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 54' ' ' HIS . 80.1 mm-40 -40.18 -35.39 0.39 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.256 0.551 . . . . 0.0 109.777 -179.399 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.478 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 98.5 mm-40 -64.13 -67.11 0.46 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.983 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.478 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 6.1 tp10 -155.64 -166.08 2.14 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.534 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.455 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -119.88 127.93 53.17 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 91.3 mt -116.02 130.54 70.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.11 0.481 . . . . 0.0 111.496 -178.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.562 ' HB2' HD11 ' A' ' 82' ' ' LEU . 19.6 tp -96.88 127.36 42.78 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.145 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -110.58 136.19 50.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.803 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -97.15 111.66 23.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.856 0.36 . . . . 0.0 111.575 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.444 ' CD2' ' OE1' ' A' ' 47' ' ' GLN . 32.8 m-85 -99.8 -8.22 24.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.667 178.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.8 t -70.59 99.26 1.62 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 88.3 p -85.08 -6.12 59.32 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.324 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.534 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -102.04 -38.04 7.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.286 179.782 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -144.68 97.49 5.0 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.032 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.4 147.71 55.62 Favored 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 122.504 2.136 . . . . 0.0 113.376 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.1 m -72.08 138.06 47.55 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.56 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -101.54 139.04 37.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.533 179.146 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.477 ' HB ' HD11 ' A' ' 76' ' ' ILE . 25.5 t -130.5 134.17 62.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.069 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 54.94 32.46 18.01 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.288 0.566 . . . . 0.0 109.696 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.13 27.35 70.36 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.895 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.8 m -138.06 131.66 30.95 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.785 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -67.47 142.42 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 121.101 0.476 . . . . 0.0 111.123 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.525 ' CG2' ' O ' ' A' ' 78' ' ' GLU . 75.1 mt -114.51 123.79 70.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.845 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -96.14 -24.09 16.45 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.981 179.094 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.525 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 3.7 mm-40 -129.27 172.42 7.16 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.785 -178.57 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -60.6 146.49 96.98 Favored 'Trans proline' 0 N--CA 1.501 1.943 0 C-N-CA 122.285 1.99 . . . . 0.0 112.652 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.491 HG11 HD13 ' A' ' 76' ' ' ILE . 4.1 p -140.15 144.97 26.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.209 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -77.85 129.66 35.68 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.157 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.562 HD11 ' HB2' ' A' ' 60' ' ' LEU . 96.9 mt -86.56 135.94 33.25 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.249 0.547 . . . . 0.0 111.107 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -131.1 154.25 48.49 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.629 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.433 ' ND1' ' N ' ' A' ' 99' ' ' ASN . 8.2 t60 -53.44 117.37 3.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.626 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 113.87 -25.38 10.9 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.1 -0.572 . . . . 0.0 112.157 178.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -66.8 137.0 56.3 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.871 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 68.4 t -113.38 132.68 61.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.7 -178.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.0 mt -93.4 130.79 41.9 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 N-CA-C 107.994 -1.114 . . . . 0.0 107.994 178.213 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 51.4 m -118.52 128.26 54.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.639 0.733 . . . . 0.0 112.575 -178.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.458 ' O ' ' C ' ' A' ' 91' ' ' ILE . 95.3 mt -118.03 124.63 73.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.682 178.373 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.504 HD12 ' CB ' ' B' ' 237' ' ' CYS . 42.6 mm 34.14 -95.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.944 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 90' ' ' ILE . 47.9 t0 -117.65 15.36 14.53 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.727 0.298 . . . . 0.0 111.336 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.571 ' NH2' ' OE1' ' B' ' 260' ' ' GLU . 55.6 mtt85 -127.13 143.44 51.27 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.09 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.446 ' H ' ' HB ' ' A' ' 10' ' ' ILE . 38.2 m -135.69 154.53 51.25 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.531 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.594 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 91.8 m-85 -127.56 121.58 30.98 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -88.58 133.62 34.12 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.984 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -93.07 122.98 36.0 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.166 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -124.51 118.81 27.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.838 0.351 . . . . 0.0 110.294 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.433 ' N ' ' ND1' ' A' ' 84' ' ' HIS . 58.5 t-20 . . . . . 0 C--N 1.33 -0.265 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo . . . . . 0 N--CA 1.484 0.954 0 CA-C-O 121.038 0.349 . . . . 0.0 111.712 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.534 ' CG2' HG22 ' A' ' 66' ' ' THR . 27.9 t -112.84 133.6 58.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.375 -179.472 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 237' ' ' CYS . . . . . 0.504 ' CB ' HD12 ' A' ' 91' ' ' ILE . 2.3 t . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.438 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo . . . . . 0 N--CA 1.499 1.796 0 N-CA-C 113.795 0.652 . . . . 0.0 113.795 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 240' ' ' THR . . . . . 0.407 ' HB ' ' NH1' ' B' ' 244' ' ' ARG . 18.1 p -76.04 -42.57 47.33 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.735 178.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.532 ' CE2' HG21 ' A' ' 43' ' ' VAL . 83.8 t80 -58.08 -45.0 87.87 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.837 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' B' ' 242' ' ' LEU . 95.6 mt -64.54 -41.87 96.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.781 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -63.95 -36.92 85.53 Favored 'General case' 0 C--N 1.334 -0.093 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.38 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 244' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' B' ' 244' ' ' ARG . 78.2 mtt85 -61.74 -43.25 99.21 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.628 -0.429 . . . . 0.0 109.981 179.217 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.575 ' O ' HG23 ' B' ' 249' ' ' VAL . 24.8 mmt180 -63.2 -41.88 99.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.427 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -63.53 -39.36 94.23 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 11.2 t -64.28 -46.59 83.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.129 178.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -61.42 -35.87 78.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.611 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 249' ' ' VAL . . . . . 0.575 HG23 ' O ' ' B' ' 245' ' ' ARG . 77.3 t . . . . . 0 C--N 1.328 -0.328 0 CA-C-O 120.903 0.382 . . . . 0.0 110.188 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.571 ' OE1' ' NH2' ' A' ' 93' ' ' ARG . 96.0 mt-10 . . . . . 0 CA--C 1.53 0.179 0 CA-C-O 120.611 0.244 . . . . 0.0 111.461 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.594 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 68.5 mt -107.77 134.5 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 178.095 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 77.3 t -128.07 136.76 59.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.369 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -95.49 118.18 31.74 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.296 0.57 . . . . 0.0 111.499 -178.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -65.05 -44.02 90.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.289 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 265' ' ' GLN . . . . . 0.616 ' OE1' HD11 ' A' ' 24' ' ' LEU . 10.4 mm-40 -96.73 154.01 38.53 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.57 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -61.65 146.24 96.94 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.326 2.017 . . . . 0.0 112.355 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 45.6 pt . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.872 -179.637 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 96.4 m . . . . . 0 CA--C 1.521 -0.172 0 CA-C-O 120.769 0.318 . . . . 0.0 111.382 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.6 mtt85 -87.51 129.74 34.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.436 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -133.93 139.55 46.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.611 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.734 HD12 ' O ' ' A' ' 96' ' ' ARG . 34.5 tp -114.59 129.2 56.65 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.764 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.7 t -108.19 131.11 59.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.29 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.8 m -81.76 148.23 29.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.287 0.565 . . . . 0.0 111.711 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.427 HD12 ' HB3' ' A' ' 94' ' ' SER . 92.6 mt -117.93 138.06 49.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 114.979 -1.01 . . . . 0.0 108.74 178.203 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -91.14 160.73 15.41 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.045 0.45 . . . . 0.0 111.408 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.54 HH12 ' CD ' ' B' ' 248' ' ' GLN . 89.9 mtm180 -58.63 -28.82 66.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.781 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.5 p -78.41 -7.61 57.56 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.636 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.67 33.17 9.38 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -178.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.5 t -123.78 135.27 64.02 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 CA-C-O 121.385 0.612 . . . . 0.0 111.55 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -76.27 138.11 40.34 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.547 179.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -126.29 -121.62 2.5 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 111.404 -0.678 . . . . 0.0 111.404 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.24 152.92 45.47 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.281 1.988 . . . . 0.0 112.829 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -110.34 153.81 24.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.16 0.505 . . . . 0.0 110.658 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.8 ' CD2' HD11 ' A' ' 37' ' ' ILE . 43.8 t80 -122.58 94.9 47.26 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.335 -179.151 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -59.36 127.03 22.47 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 121.349 1.366 . . . . 0.0 111.254 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.4 mt -84.77 50.17 1.86 Allowed 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.448 -178.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 72.4 m -60.86 -33.83 73.67 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.2 0.524 . . . . 0.0 109.845 179.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.702 HD11 ' HG2' ' B' ' 265' ' ' GLN . 66.7 mt -69.97 139.96 52.91 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.369 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.0 t -65.69 -18.83 65.61 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.405 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.9 m -134.51 133.53 40.45 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.246 -0.582 . . . . 0.0 111.444 -178.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.2 t -129.54 120.37 25.24 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.313 0.578 . . . . 0.0 110.249 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.525 HD12 ' O ' ' A' ' 49' ' ' CYS . 48.4 tp -117.37 131.74 56.72 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.994 -178.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.462 ' O ' ' O ' ' A' ' 47' ' ' GLN . 37.3 m-85 -109.7 140.5 43.5 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.848 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 153.86 -175.49 32.14 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 120.783 -0.723 . . . . 0.0 111.686 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 45.0 mtm180 -75.15 -32.29 61.27 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.609 0.242 . . . . 0.0 111.428 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.589 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -45.04 140.04 4.76 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.468 HG23 ' N ' ' A' ' 34' ' ' GLU . 7.1 tp -66.91 -41.07 87.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.374 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.468 ' N ' HG23 ' A' ' 33' ' ' ILE . 51.6 tp10 -61.41 -15.73 39.66 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.205 0.526 . . . . 0.0 110.149 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.589 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 8.8 m -61.17 131.62 51.05 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.289 -0.564 . . . . 0.0 109.752 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -60.67 -33.43 72.82 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.8 HD11 ' CD2' ' A' ' 20' ' ' PHE . 44.1 mm -121.4 115.12 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.061 177.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.474 ' NH2' HG11 ' B' ' 262' ' ' VAL . 88.3 mtm-85 -100.72 133.08 45.71 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.828 HG23 ' NH1' ' A' ' 93' ' ' ARG . 96.2 mt -119.24 129.8 74.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.689 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -74.92 24.14 0.09 Allowed 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -177.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.753 HD21 ' NH2' ' A' ' 93' ' ' ARG . 95.6 mt -97.87 126.71 39.64 Favored Pre-proline 0 C--N 1.324 -0.512 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.384 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -70.97 -9.67 26.13 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.682 2.254 . . . . 0.0 113.232 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.554 HG21 ' CE2' ' B' ' 241' ' ' PHE . 27.1 m -97.71 5.33 9.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.393 -179.456 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.4 t -94.96 136.79 25.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.692 0.282 . . . . 0.0 110.38 179.06 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.492 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 1.2 t -67.52 165.62 16.44 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.164 0.507 . . . . 0.0 110.857 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 41.1 mtmt -62.51 -41.99 99.21 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.36 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.605 ' O ' ' N ' ' A' ' 49' ' ' CYS . 84.2 mt-30 -111.46 -17.72 13.02 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.954 0.407 . . . . 0.0 111.111 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.492 ' H ' ' HB3' ' A' ' 45' ' ' SER . 26.8 t60 34.06 -75.92 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.605 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.81 136.94 49.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.321 0.581 . . . . 0.0 112.559 -177.785 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -127.09 129.0 47.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.979 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 93.5 mt -114.83 133.31 61.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.43 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -117.1 126.98 53.67 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 77.5 mt -108.81 113.78 45.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.705 0.765 . . . . 0.0 111.714 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.582 ' O ' ' N ' ' A' ' 56' ' ' GLN . 86.4 m-70 -114.27 146.79 40.0 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.806 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 54' ' ' HIS . 57.7 mp0 -40.58 -22.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.653 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.582 ' N ' ' O ' ' A' ' 54' ' ' HIS . 14.8 mm100 -72.57 -69.38 0.41 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -160.58 -164.89 1.3 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.191 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.493 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -109.8 124.26 50.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.663 179.036 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.6 mt -113.5 130.02 68.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.026 0.441 . . . . 0.0 111.751 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.719 HD22 ' CD1' ' A' ' 88' ' ' ILE . 25.6 tp -99.76 128.3 45.87 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.011 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -113.15 136.04 53.15 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.147 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -93.48 107.97 19.73 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.642 0.258 . . . . 0.0 111.67 -178.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -101.19 -11.51 19.48 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.714 179.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.6 t -72.45 98.43 2.27 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.9 t -82.69 -17.33 44.84 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.806 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.481 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -93.32 -43.21 8.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.287 -178.766 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -133.31 97.35 16.35 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -57.62 144.33 92.88 Favored 'Trans proline' 0 N--CA 1.5 1.894 0 C-N-CA 122.183 1.922 . . . . 0.0 113.224 -178.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.6 m -72.51 150.01 43.6 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.372 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -114.42 141.25 47.9 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.482 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.687 HG13 ' OD1' ' A' ' 86' ' ' ASP . 44.6 t -127.72 134.1 66.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 54.84 32.02 16.85 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.139 -0.625 . . . . 0.0 110.12 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.12 23.28 77.99 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.124 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.7 t -138.33 143.95 40.16 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 117.011 0.405 . . . . 0.0 110.99 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 44.2 t -67.08 132.33 32.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.502 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.426 HG12 ' O ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -118.56 79.29 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.426 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -65.96 -21.35 66.41 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.117 -178.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.426 ' O ' HG12 ' A' ' 76' ' ' ILE . 0.6 OUTLIER -110.35 159.95 30.2 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -179.562 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.41 145.87 92.83 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 C-N-CA 121.148 1.232 . . . . 0.0 111.196 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.42 145.73 21.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 89.9 mtm180 -75.29 132.05 40.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.795 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.493 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 92.0 mt -80.77 141.27 34.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.066 0.46 . . . . 0.0 110.927 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -129.02 149.84 50.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.779 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.471 ' C ' ' CD2' ' A' ' 84' ' ' HIS . 7.7 t60 -54.67 119.91 5.99 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.376 -0.529 . . . . 0.0 110.57 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.07 -8.32 41.94 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.687 ' OD1' HG13 ' A' ' 71' ' ' VAL . 45.6 t0 -71.62 127.54 32.9 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.078 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.516 HG22 ' HG2' ' A' ' 96' ' ' ARG . 76.6 t -105.56 134.62 46.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.401 -178.16 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.719 ' CD1' HD22 ' A' ' 60' ' ' LEU . 11.6 mm -98.16 128.55 49.49 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.661 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.7 m -122.48 129.06 51.61 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.841 0.829 . . . . 0.0 112.875 -178.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.476 ' O ' ' C ' ' A' ' 91' ' ' ILE . 74.1 mt -121.01 127.03 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 114.445 -1.252 . . . . 0.0 108.429 178.661 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.476 ' C ' ' O ' ' A' ' 90' ' ' ILE . 37.5 mm 35.91 -99.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 C-N-CA 120.576 -0.449 . . . . 0.0 110.252 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.504 ' O ' ' OD1' ' A' ' 92' ' ' ASP . 39.0 t0 -118.07 17.6 14.03 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.989 0.424 . . . . 0.0 110.91 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.828 ' NH1' HG23 ' A' ' 39' ' ' ILE . 97.7 mtt180 -125.67 142.17 51.65 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.759 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.45 ' OG ' ' CG1' ' A' ' 87' ' ' VAL . 16.6 t -140.12 152.85 46.44 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 120.184 -0.607 . . . . 0.0 110.781 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.518 ' HB3' HD11 ' A' ' 7' ' ' LEU . 76.4 m-85 -126.07 125.12 42.07 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.617 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.734 ' O ' HD12 ' A' ' 7' ' ' LEU . 99.6 mtt180 -88.03 134.09 33.82 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 120.351 -0.539 . . . . 0.0 111.605 -178.176 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -97.64 125.92 42.66 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.858 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -131.03 124.28 30.56 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.216 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 45.5 p-10 . . . . . 0 N--CA 1.466 0.339 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.841 -179.844 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo . . . . . 0 N--CA 1.485 1.005 0 CA-C-O 121.201 0.417 . . . . 0.0 112.765 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.481 ' CG2' HG22 ' A' ' 66' ' ' THR . 39.8 t -67.78 136.56 26.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.72 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 10.4 t . . . . . 0 CA--C 1.52 -0.206 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.594 -179.795 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo . . . . . 0 N--CA 1.494 1.533 0 CA-C-O 120.596 0.165 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 24.7 m -71.41 -42.95 67.68 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.139 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.554 ' CE2' HG21 ' A' ' 43' ' ' VAL . 87.8 t80 -58.33 -46.61 85.88 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.221 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 88.0 mt -62.97 -41.17 99.46 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.491 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -61.34 -38.76 88.08 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.408 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -63.79 -42.77 97.67 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.419 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 245' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -60.88 -40.27 92.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.259 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -64.17 -38.45 91.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.863 0.364 . . . . 0.0 110.763 179.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 80.8 p -68.61 -40.56 80.37 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 248' ' ' GLN . . . . . 0.54 ' CD ' HH12 ' A' ' 12' ' ' ARG . 59.8 tt0 -60.53 -38.27 83.9 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.442 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 24.4 t . . . . . 0 N--CA 1.452 -0.335 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.986 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.535 ' OE1' ' NH2' ' A' ' 93' ' ' ARG . 91.1 mt-10 . . . . . 0 N--CA 1.464 0.242 0 CA-C-O 120.485 0.183 . . . . 0.0 111.347 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 64.6 mt -108.59 141.45 23.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 262' ' ' VAL . . . . . 0.474 HG11 ' NH2' ' A' ' 38' ' ' ARG . 54.3 t -127.27 135.62 62.93 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 CA-C-O 121.065 0.459 . . . . 0.0 110.957 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -98.81 124.06 43.44 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.519 -178.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -64.69 -47.1 79.61 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.705 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 265' ' ' GLN . . . . . 0.702 ' HG2' HD11 ' A' ' 24' ' ' LEU . 2.6 mp0 -96.74 159.1 32.42 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.547 -179.344 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -68.05 143.51 60.19 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 122.998 2.465 . . . . 0.0 113.395 -179.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 47.9 pt . . . . . 0 C--N 1.326 -0.438 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.535 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.8 m . . . . . 0 CA--C 1.522 -0.116 0 CA-C-O 121.399 0.619 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.591 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 93.9 mtt-85 -92.39 130.81 37.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.309 -178.37 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.593 ' HE ' ' CE1' ' A' ' 19' ' ' HIS . 85.6 mtp180 -128.7 141.4 51.34 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.106 0.479 . . . . 0.0 111.343 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.491 HD12 ' O ' ' A' ' 96' ' ' ARG . 41.7 tp -117.8 136.46 53.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.065 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.7 t -114.26 130.01 69.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 CA-C-O 120.775 0.321 . . . . 0.0 111.353 -178.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 m -94.87 116.16 28.37 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.553 -178.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 66.9 mt -84.93 150.93 3.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.99 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -92.93 161.15 14.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.714 0.292 . . . . 0.0 110.358 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.776 HH11 HH11 ' B' ' 245' ' ' ARG . 91.0 mtm180 -57.22 -29.3 63.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.917 -179.094 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 75.4 p -77.28 -11.09 59.79 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.831 -0.347 . . . . 0.0 110.818 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.88 29.28 11.95 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.1 t -114.49 133.69 59.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.735 0.303 . . . . 0.0 110.668 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' A' ' 17' ' ' GLY . 64.8 t0 -69.34 127.64 33.77 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.809 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.409 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -119.31 -123.67 3.19 Favored Glycine 0 CA--C 1.537 1.42 0 C-N-CA 121.083 -0.579 . . . . 0.0 112.166 -179.348 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -74.34 149.08 39.45 Favored 'Trans proline' 0 N--CA 1.497 1.709 0 C-N-CA 122.492 2.128 . . . . 0.0 113.338 -178.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.593 ' CE1' ' HE ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -109.28 151.72 26.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.902 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.488 ' CD2' HD11 ' A' ' 37' ' ' ILE . 65.1 t80 -121.29 104.5 40.57 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.906 -178.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -77.48 127.37 8.9 Favored 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 121.767 1.645 . . . . 0.0 111.722 -179.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.433 HD13 HD11 ' A' ' 53' ' ' ILE . 79.3 mt -77.23 80.36 3.75 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.369 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 66.4 p -82.91 -10.99 58.54 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.8 mt -108.07 148.93 29.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.574 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 94.7 p -72.19 -13.4 61.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.845 -178.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 29.0 m -129.57 131.34 46.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.185 0.517 . . . . 0.0 110.777 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.684 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -128.0 119.64 25.88 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.579 179.191 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.507 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 49.2 tp -120.02 125.29 47.99 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.737 -178.525 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.684 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 19.5 m-85 -98.96 124.36 43.86 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.255 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -176.98 -156.77 16.53 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 119.894 -1.146 . . . . 0.0 112.503 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.622 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 84.7 mtm-85 -107.9 -24.31 11.69 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 120.354 -0.539 . . . . 0.0 110.599 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.28 165.06 36.06 Favored Glycine 0 CA--C 1.524 0.644 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.135 -178.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.455 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.5 tp -67.14 -40.01 84.34 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 CA-C-N 115.529 -0.336 . . . . 0.0 110.713 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.455 ' N ' HG23 ' A' ' 33' ' ' ILE . 93.1 mt-10 -57.62 -32.64 67.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.533 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 68.9 m -49.52 116.18 1.64 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.936 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.572 ' OD1' ' N ' ' A' ' 37' ' ' ILE . 6.6 p-10 -58.16 -29.65 65.76 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.595 HD12 ' CE2' ' A' ' 29' ' ' PHE . 80.2 mt -129.23 117.11 42.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 177.56 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -101.28 138.74 37.9 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.871 0.367 . . . . 0.0 111.459 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.471 HG22 ' H ' ' A' ' 41' ' ' LEU . 91.6 mt -119.71 130.6 73.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.473 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.431 ' OE1' ' OE1' ' B' ' 260' ' ' GLU . 73.8 mt-30 -73.53 21.9 0.08 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.396 -178.464 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.941 HD11 ' NH1' ' A' ' 93' ' ' ARG . 20.1 mt -90.65 123.52 64.94 Favored Pre-proline 0 C--N 1.326 -0.426 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.165 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.31 -8.52 22.02 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 121.671 1.581 . . . . 0.0 112.128 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.4 m -101.42 4.77 10.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 C-N-CA 120.43 -0.508 . . . . 0.0 111.451 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.622 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 38.0 t -96.72 106.77 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.297 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.533 ' O ' ' O ' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -33.84 162.91 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.963 0.887 . . . . 0.0 112.385 -179.143 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -61.66 -41.06 97.0 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.354 -1.294 . . . . 0.0 111.461 -178.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.616 ' O ' ' N ' ' A' ' 49' ' ' CYS . 89.7 mm-40 -109.57 -17.45 13.73 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 123.728 0.642 . . . . 0.0 110.303 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.466 ' O ' ' OG ' ' A' ' 64' ' ' SER . 19.1 t60 36.87 -78.51 0.0 OUTLIER 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.072 -0.967 . . . . 0.0 113.02 -179.476 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.616 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -135.93 139.75 43.5 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.616 -178.588 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -126.41 131.68 51.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.843 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 87.9 mt -115.38 131.91 66.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.176 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -118.07 129.36 55.51 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.433 HD11 HD13 ' A' ' 22' ' ' LEU . 96.9 mt -110.49 121.85 64.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.548 0.689 . . . . 0.0 112.852 -178.007 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.464 ' O ' ' C ' ' A' ' 55' ' ' GLU . 97.3 m-70 -116.49 140.33 49.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.406 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 54' ' ' HIS . 92.1 mt-10 -39.92 -30.32 0.08 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.462 ' N ' ' O ' ' A' ' 54' ' ' HIS . 88.4 mt-30 -64.57 -68.79 0.33 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.798 178.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -152.21 -171.45 3.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.404 0.621 . . . . 0.0 110.748 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -111.91 124.63 52.78 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.507 178.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 91.0 mt -114.21 131.22 66.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.179 0.514 . . . . 0.0 112.128 -178.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.456 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 16.2 tp -104.1 129.6 51.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.191 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -115.2 138.09 51.31 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.167 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -102.02 110.6 22.6 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.965 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -98.4 -5.35 32.8 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.157 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.466 ' OG ' ' O ' ' A' ' 48' ' ' HIS . 1.4 m -71.64 100.64 2.34 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.277 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.7 m -84.11 -20.48 32.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.119 0.485 . . . . 0.0 109.963 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.718 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -90.76 -40.85 11.58 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.619 -179.457 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -138.94 95.16 9.7 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.872 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.41 ' HB2' HG13 ' A' ' 75' ' ' VAL . 35.8 Cg_exo -57.77 143.65 95.0 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 122.287 1.991 . . . . 0.0 112.552 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.402 ' CG2' ' N ' ' A' ' 70' ' ' GLN . 4.5 m -77.08 154.79 32.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.58 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.402 ' N ' ' CG2' ' A' ' 69' ' ' THR . 75.3 mt-30 -114.87 140.45 48.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.921 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 50.6 t -128.43 135.72 61.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 50.27 33.56 7.55 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.38 28.41 67.9 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.775 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.4 t -142.47 139.45 31.56 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.173 -0.611 . . . . 0.0 112.197 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.41 HG13 ' HB2' ' A' ' 68' ' ' PRO . 40.7 t -67.51 137.54 24.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.282 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 10.9 pt -108.6 81.33 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.154 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -60.85 -33.54 73.22 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.542 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.471 ' N ' ' CD ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -117.05 165.4 15.54 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.873 179.754 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.54 142.39 98.82 Favored 'Trans proline' 0 N--CA 1.502 1.979 0 C-N-CA 122.346 2.031 . . . . 0.0 112.162 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.5 m -135.6 138.17 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-O 120.961 0.41 . . . . 0.0 111.904 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.7 mtm180 -72.39 131.18 42.27 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.1 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.7 mt -80.02 136.61 36.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.266 0.555 . . . . 0.0 111.436 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -126.41 146.79 49.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.935 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.696 ' CE1' ' H ' ' A' ' 99' ' ' ASN . 3.5 t-160 -54.41 121.88 9.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.146 0.498 . . . . 0.0 110.909 -178.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.73 -10.84 38.37 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -71.86 136.71 47.06 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.49 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.468 ' O ' HG13 ' A' ' 87' ' ' VAL . 9.7 p -114.12 132.21 63.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.182 -178.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 69.1 mt -101.65 132.9 46.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 53.0 m -118.65 128.72 54.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.686 0.755 . . . . 0.0 112.121 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.567 HD12 ' HE1' ' A' ' 95' ' ' PHE . 98.1 mt -118.81 131.26 72.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 177.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.51 HG23 HD21 ' B' ' 242' ' ' LEU . 88.9 mt -24.43 98.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.547 ' OD1' ' CD2' ' B' ' 242' ' ' LEU . 2.7 m-20 89.01 -15.78 0.31 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 177.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.941 ' NH1' HD11 ' A' ' 41' ' ' LEU . 69.6 mtt85 -132.5 141.89 48.97 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.159 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.6 t -135.98 149.98 49.07 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.567 ' HE1' HD12 ' A' ' 90' ' ' ILE . 36.7 m-85 -126.57 123.63 38.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.785 -179.192 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.491 ' O ' HD12 ' A' ' 7' ' ' LEU . 42.7 ttm180 -84.42 129.09 34.9 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.599 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.591 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 87.8 t80 -91.78 124.67 36.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.137 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -123.76 132.42 53.8 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.737 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.696 ' H ' ' CE1' ' A' ' 84' ' ' HIS . 41.5 t-20 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.137 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo . . . . . 0 N--CA 1.488 1.173 0 CA-C-O 121.151 0.396 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.718 ' CG2' HG22 ' A' ' 66' ' ' THR . 44.1 t -112.61 132.5 61.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.644 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 237' ' ' CYS . . . . . 0.448 ' CB ' HD13 ' A' ' 91' ' ' ILE . 2.5 t . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.159 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo . . . . . 0 N--CA 1.501 1.945 0 N-CA-C 113.611 0.581 . . . . 0.0 113.611 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 19.0 p -82.76 -38.9 22.58 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.347 -0.541 . . . . 0.0 109.886 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -57.9 -46.48 84.87 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.726 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.547 ' CD2' ' OD1' ' A' ' 92' ' ' ASP . 97.3 mt -66.23 -42.43 88.64 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.386 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -63.39 -43.27 98.04 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.996 -178.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -63.43 -43.32 97.8 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.858 0.361 . . . . 0.0 111.04 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.776 HH11 HH11 ' A' ' 12' ' ' ARG . 58.0 ttm-85 -61.4 -42.28 98.47 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.797 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -63.17 -37.85 88.85 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.205 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 67.3 m -67.46 -43.8 80.15 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 177.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 63.5 tp60 -59.58 -39.85 85.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.979 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 249' ' ' VAL . . . . . 0.544 HG23 ' O ' ' B' ' 245' ' ' ARG . 77.6 t . . . . . 0 C--N 1.331 -0.231 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.582 ' CG ' HH21 ' A' ' 93' ' ' ARG . 49.9 mm-40 . . . . . 0 CA--C 1.531 0.215 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 89.4 mt -110.1 135.09 50.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 69.2 t -127.5 132.06 69.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.927 0.394 . . . . 0.0 110.204 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 263' ' ' PHE . . . . . 0.478 ' HB2' HD11 ' B' ' 267' ' ' ILE . 72.7 m-85 -96.35 120.7 37.13 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.241 0.543 . . . . 0.0 111.493 -178.352 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -67.96 -41.35 82.59 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.417 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.59 161.41 30.54 Favored Pre-proline 0 N--CA 1.463 0.202 0 CA-C-N 116.62 -0.263 . . . . 0.0 111.419 -177.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -59.31 143.55 99.7 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.227 1.951 . . . . 0.0 111.181 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 267' ' ' ILE . . . . . 0.55 ' CG2' ' O ' ' A' ' 19' ' ' HIS . 2.1 mt . . . . . 0 N--CA 1.449 -0.477 0 C-N-CA 120.304 -0.559 . . . . 0.0 110.55 -178.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.1 m . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.977 0.417 . . . . 0.0 110.665 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.652 ' NH1' HG23 ' A' ' 53' ' ' ILE . 99.8 mtt180 -98.56 135.38 40.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.037 -179.012 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -137.89 150.4 47.06 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.498 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 86.2 mt -116.5 139.22 50.71 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.455 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.413 HG11 ' OD2' ' A' ' 16' ' ' ASP . 65.5 t -110.92 127.98 67.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.457 ' CG2' HD12 ' B' ' 261' ' ' ILE . 54.8 m -79.04 142.06 36.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.387 0.613 . . . . 0.0 112.386 -178.547 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.418 HD12 ' HB3' ' A' ' 94' ' ' SER . 96.9 mt -114.17 135.88 52.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.467 176.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -86.91 160.01 18.85 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 90.9 mtm180 -57.84 -29.31 64.86 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.578 -178.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 42.8 m -80.81 -9.49 59.81 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.712 0.291 . . . . 0.0 110.928 179.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.68 40.67 5.58 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.6 t -121.09 133.02 69.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.919 0.39 . . . . 0.0 110.74 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.413 ' OD2' HG11 ' A' ' 8' ' ' VAL . 65.7 t0 -75.19 125.45 28.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.154 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -120.54 -121.01 2.82 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.062 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -74.89 150.78 39.25 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.464 2.109 . . . . 0.0 112.777 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.97 155.85 22.1 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.548 ' CD2' HD11 ' A' ' 37' ' ' ILE . 64.0 t80 -122.29 93.24 48.65 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.2 -179.296 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.467 ' O ' ' NE2' ' B' ' 265' ' ' GLN . 27.3 Cg_exo -61.66 130.47 31.62 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.159 1.906 . . . . 0.0 111.74 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 22' ' ' LEU . 96.7 mt -85.79 82.22 8.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.426 0.631 . . . . 0.0 110.396 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.7 p -86.78 -8.14 57.62 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.002 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 42.7 mt -108.08 147.99 30.42 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.964 -178.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.9 t -65.39 -18.25 65.17 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -178.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 21.6 m -136.65 136.96 39.56 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.463 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.7 t -129.73 123.4 30.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.514 178.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 52.5 tp -116.69 129.69 56.28 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.037 0.446 . . . . 0.0 111.642 -178.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.763 ' CE2' HD12 ' A' ' 37' ' ' ILE . 3.2 m-85 -109.16 144.47 37.18 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.99 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 146.97 -170.12 27.94 Favored Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.764 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 31' ' ' ARG . 47.9 mtm180 -78.53 -32.3 47.91 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.491 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -50.83 146.77 9.15 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.63 -178.483 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.488 HG23 ' N ' ' A' ' 34' ' ' GLU . 7.6 tp -67.17 -41.78 87.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.488 ' N ' HG23 ' A' ' 33' ' ' ILE . 70.3 mm-40 -53.33 -17.65 1.98 Allowed 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.813 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 59.8 m -62.27 121.42 13.11 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.749 -179.056 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -57.83 -29.71 65.15 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.763 HD12 ' CE2' ' A' ' 29' ' ' PHE . 92.5 mt -128.23 121.93 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.107 176.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.431 ' CZ ' HD12 ' A' ' 33' ' ' ILE . 81.9 mtp180 -106.97 137.94 44.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.092 -178.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.613 ' CG2' HD12 ' A' ' 41' ' ' LEU . 95.5 mt -120.53 129.32 75.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.117 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -78.2 26.99 0.2 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.613 HD12 ' CG2' ' A' ' 39' ' ' ILE . 9.4 mt -92.73 126.84 50.33 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.808 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.79 -12.41 30.89 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.499 2.133 . . . . 0.0 113.632 -179.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.656 HG21 ' CE2' ' B' ' 241' ' ' PHE . 35.2 m -99.92 5.83 9.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.791 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.7 t -89.32 136.61 23.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.986 179.485 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.2 m -67.84 161.33 26.48 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.52 0.676 . . . . 0.0 111.548 -178.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -61.65 -42.99 99.67 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.112 -178.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.603 ' O ' ' N ' ' A' ' 49' ' ' CYS . 95.5 mt-30 -115.72 -6.26 12.13 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 123.652 0.595 . . . . 0.0 111.064 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.463 ' C ' ' O ' ' A' ' 47' ' ' GLN . 15.2 t60 15.9 -73.43 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 -178.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.603 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -128.48 132.67 48.38 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.483 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -126.85 126.57 43.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.179 179.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 85.6 mt -106.71 130.32 58.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.048 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -116.81 119.83 36.62 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.652 HG23 ' NH1' ' A' ' 5' ' ' ARG . 97.5 mt -103.62 116.55 47.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.02 -0.672 . . . . 0.0 112.285 -178.243 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.551 ' O ' ' N ' ' A' ' 56' ' ' GLN . 87.0 m-70 -114.88 142.91 45.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.303 179.175 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.4 mm-40 -39.52 -26.35 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -178.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.551 ' N ' ' O ' ' A' ' 54' ' ' HIS . 77.7 mt-30 -69.47 -68.73 0.39 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.891 178.6 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.409 ' CD ' ' N ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -157.68 -166.13 1.93 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.321 -179.174 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.59 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -112.9 130.2 56.2 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.2 mt -119.8 130.78 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 29.0 tp -100.14 125.83 46.32 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.291 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -107.53 137.57 45.32 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.575 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -99.92 106.95 18.82 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -99.35 -5.35 29.8 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.662 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.521 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 23.1 t -86.77 99.88 12.11 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 120.401 -0.52 . . . . 0.0 112.014 -178.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.5 m -73.68 -37.6 65.17 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 177.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.7 p -65.66 -36.24 83.09 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.636 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.521 ' O ' ' OG ' ' A' ' 64' ' ' SER . 36.3 m-80 -153.05 97.92 2.8 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.547 -179.077 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -59.28 147.01 92.87 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.063 1.842 . . . . 0.0 112.758 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 60.4 m -65.62 133.58 51.46 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 177.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -96.82 141.55 29.88 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.223 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.741 ' HB ' HD11 ' A' ' 76' ' ' ILE . 5.2 p -129.66 134.67 62.93 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 50.96 32.97 8.08 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 119.694 -0.802 . . . . 0.0 109.15 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.05 28.53 66.38 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.443 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.2 t -140.24 139.43 35.58 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 117.308 0.554 . . . . 0.0 110.743 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -68.05 144.1 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 120.903 0.382 . . . . 0.0 111.48 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.741 HD11 ' HB ' ' A' ' 71' ' ' VAL . 85.9 mt -106.28 108.73 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.693 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -76.18 -39.17 55.48 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.1 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.511 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 1.5 mt-10 -128.64 172.99 6.11 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.737 -178.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -57.54 143.57 94.29 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 122.16 1.907 . . . . 0.0 112.57 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.1 t -133.0 138.03 52.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.425 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -74.32 131.35 41.07 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 178.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.527 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 96.4 mt -82.84 136.73 34.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.982 0.42 . . . . 0.0 111.491 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -132.61 154.95 49.55 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.301 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.405 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 5.2 t60 -54.94 117.28 3.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.894 0.378 . . . . 0.0 111.596 -179.147 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.39 -14.03 30.51 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.525 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 52.5 t0 -69.44 127.8 34.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.089 0.471 . . . . 0.0 110.445 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.461 HG22 ' HG2' ' A' ' 96' ' ' ARG . 72.5 t -108.79 132.64 56.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.359 -178.429 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.1 mt -102.48 131.13 51.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 89.7 m -119.49 129.49 54.74 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.643 0.735 . . . . 0.0 112.119 -178.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.623 ' O ' ' N ' ' A' ' 93' ' ' ARG . 92.0 mt -118.35 133.08 66.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 114.615 -1.175 . . . . 0.0 108.769 178.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.543 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 70.3 mt -20.77 91.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.656 ' CG ' ' HE ' ' B' ' 245' ' ' ARG . 21.3 t0 93.36 -21.73 0.07 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 177.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.623 ' N ' ' O ' ' A' ' 90' ' ' ILE . 87.8 mtt-85 -130.4 146.01 51.9 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.103 -0.639 . . . . 0.0 111.029 -179.361 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.418 ' HB3' HD12 ' A' ' 10' ' ' ILE . 32.7 t -138.9 151.77 47.21 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.149 0.5 . . . . 0.0 110.317 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.638 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 91.6 m-85 -125.65 127.27 46.02 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.461 ' HG2' HG22 ' A' ' 87' ' ' VAL . 99.8 mtt180 -89.06 138.02 31.79 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.745 -179.19 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -94.91 119.37 33.34 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.512 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -123.18 120.96 34.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.852 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.405 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 64.1 t-20 . . . . . 0 C--N 1.325 -0.476 0 C-N-CA 120.679 -0.409 . . . . 0.0 110.141 179.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo . . . . . 0 N--CA 1.495 1.608 0 CA-C-O 121.333 0.472 . . . . 0.0 112.982 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.441 HG13 ' O ' ' B' ' 236' ' ' VAL . 10.7 p -78.39 128.87 38.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.254 178.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 237' ' ' CYS . . . . . 0.517 ' HB2' HD13 ' A' ' 91' ' ' ILE . 1.8 t . . . . . 0 C--N 1.328 -0.339 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.184 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo . . . . . 0 N--CA 1.491 1.377 0 CA-C-O 120.711 0.213 . . . . 0.0 111.981 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 20.0 m -68.72 -46.89 67.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.442 0.639 . . . . 0.0 109.774 178.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.744 ' CD2' ' NH1' ' B' ' 245' ' ' ARG . 77.2 t80 -58.65 -44.0 89.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.767 -179.105 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 1.046 HD23 HH22 ' B' ' 245' ' ' ARG . 60.6 mt -61.34 -43.87 98.14 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.214 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -64.69 -37.7 88.49 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -62.68 -47.2 84.69 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.632 -178.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 1.046 HH22 HD23 ' B' ' 242' ' ' LEU . 27.8 mtm-85 -63.93 -37.55 87.84 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.773 -179.178 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -62.49 -41.2 98.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.809 0.338 . . . . 0.0 110.443 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 76.7 p -66.16 -41.12 90.82 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -62.08 -38.98 90.88 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.111 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 249' ' ' VAL . . . . . 0.457 HG23 ' O ' ' B' ' 245' ' ' ARG . 52.5 t . . . . . 0 N--CA 1.451 -0.4 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 . . . . . 0 C--O 1.231 0.124 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.638 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 66.7 mt -107.32 133.6 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.02 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 56.5 t -125.86 132.94 70.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.109 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -96.23 118.78 33.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.401 0.62 . . . . 0.0 111.969 -177.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -66.23 -44.65 83.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.767 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 265' ' ' GLN . . . . . 0.467 ' NE2' ' O ' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -95.83 156.15 37.6 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.09 -179.462 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -64.93 144.21 82.03 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 C-N-CA 122.674 2.249 . . . . 0.0 112.926 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 47.3 pt . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.912 179.463 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.0 p . . . . . 0 CA--C 1.528 0.129 0 CA-C-O 120.912 0.387 . . . . 0.0 110.851 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.763 ' NH1' ' HB2' ' A' ' 58' ' ' ALA . 96.8 mtt-85 -90.24 122.39 33.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.87 -178.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -130.69 138.08 49.85 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.918 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 1.032 HD11 HD11 ' A' ' 22' ' ' LEU . 83.3 mt -115.26 139.42 49.97 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.57 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.6 t -112.1 127.65 69.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.452 HG23 ' CD1' ' B' ' 261' ' ' ILE . 4.3 m -87.62 111.83 21.67 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.234 0.54 . . . . 0.0 111.43 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 90.9 mt -82.82 145.52 8.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.717 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -92.0 158.19 16.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.783 0.325 . . . . 0.0 110.754 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -58.01 -24.75 59.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.529 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.2 m -80.94 -10.05 59.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.033 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.07 39.81 6.81 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.1 t -123.31 134.62 65.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.849 0.356 . . . . 0.0 111.328 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' A' ' 17' ' ' GLY . 62.6 t0 -73.93 127.24 32.36 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.931 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.428 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -123.8 -122.73 2.73 Favored Glycine 0 CA--C 1.542 1.746 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.217 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.95 148.63 45.75 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 122.671 2.247 . . . . 0.0 113.626 -178.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -107.39 154.83 20.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.166 0.508 . . . . 0.0 110.832 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -130.76 103.2 16.03 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.582 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -78.05 138.62 16.49 Favored 'Trans proline' 0 N--CA 1.488 1.191 0 C-N-CA 121.911 1.74 . . . . 0.0 112.635 -179.087 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 1.032 HD11 HD11 ' A' ' 7' ' ' LEU . 94.0 mt -92.65 54.42 2.24 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.225 -0.443 . . . . 0.0 112.188 -178.341 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.6 p -59.67 -29.03 67.78 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 63.1 mt -75.43 142.11 43.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.609 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.32 -16.65 64.22 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -178.354 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 30.3 m -140.5 140.29 35.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.021 0.438 . . . . 0.0 111.16 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.617 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -136.28 134.2 37.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.382 178.545 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 47.5 tp -121.73 127.38 50.63 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.214 -178.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.82 ' CE2' HD12 ' A' ' 37' ' ' ILE . 21.0 m-85 -101.86 131.99 47.89 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.663 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.62 -177.79 38.61 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 120.274 -0.965 . . . . 0.0 112.285 179.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.671 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 73.0 mtm-85 -77.9 -31.95 51.47 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.764 0.316 . . . . 0.0 110.554 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.435 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -52.45 149.21 10.34 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -178.551 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.514 HG23 ' N ' ' A' ' 34' ' ' GLU . 8.1 tp -66.44 -42.04 89.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 C-N-CA 120.759 -0.377 . . . . 0.0 110.272 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.514 ' N ' HG23 ' A' ' 33' ' ' ILE . 80.0 mm-40 -53.16 -18.87 2.5 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.435 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 57.1 m -63.25 121.88 14.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.533 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -57.94 -29.41 65.14 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.82 HD12 ' CE2' ' A' ' 29' ' ' PHE . 93.4 mt -122.64 119.78 59.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 176.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.457 ' HD3' HD12 ' A' ' 33' ' ' ILE . 87.9 mtm-85 -104.0 133.67 48.56 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.355 -178.427 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.45 HG22 ' H ' ' A' ' 41' ' ' LEU . 98.9 mt -117.53 129.36 74.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.148 0.499 . . . . 0.0 110.24 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -77.92 24.1 0.24 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.857 -177.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.769 HD12 ' CZ ' ' A' ' 93' ' ' ARG . 38.3 mt -105.02 128.24 27.1 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.912 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.47 -12.93 30.02 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.434 2.089 . . . . 0.0 113.309 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.589 HG21 ' CE2' ' B' ' 241' ' ' PHE . 25.5 m -88.45 -2.21 8.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.871 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.671 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 55.8 t -92.86 134.55 30.39 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.255 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 178.338 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.451 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 0.6 OUTLIER -65.1 162.04 17.74 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.291 0.567 . . . . 0.0 111.793 -178.766 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -59.86 -43.6 94.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.19 -178.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.67 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.5 mt-30 -111.5 -18.08 12.93 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.191 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.451 ' H ' ' HB3' ' A' ' 45' ' ' SER . 19.5 t60 32.59 -71.93 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.467 -1.242 . . . . 0.0 114.108 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.67 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.19 136.21 45.53 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.296 0.57 . . . . 0.0 112.263 -177.847 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -125.68 135.76 52.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.333 178.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.578 HD11 HD12 ' A' ' 82' ' ' LEU . 18.0 tt -124.29 136.39 60.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.03 0.443 . . . . 0.0 110.14 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -122.46 132.57 54.41 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.981 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.55 HD13 ' HD2' ' A' ' 5' ' ' ARG . 95.6 mt -106.99 112.25 39.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.823 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.501 ' O ' ' N ' ' A' ' 56' ' ' GLN . 81.4 m-70 -112.92 145.96 39.83 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.156 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' A' ' 54' ' ' HIS . 99.1 mt-10 -40.2 -27.02 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.894 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.501 ' N ' ' O ' ' A' ' 54' ' ' HIS . 85.7 mt-30 -67.04 -68.92 0.34 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.608 178.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -158.68 -168.22 2.35 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.209 0.528 . . . . 0.0 110.945 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.763 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -104.04 120.74 41.72 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 177.344 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.6 mt -110.99 128.89 67.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.588 HD11 ' SG ' ' A' ' 49' ' ' CYS . 56.5 tp -97.82 129.78 44.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.682 179.252 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -114.86 136.95 52.54 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.731 0.3 . . . . 0.0 111.147 -179.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -94.35 106.55 18.53 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -102.75 -10.18 19.37 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.311 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.5 t -74.27 101.59 4.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.381 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 92.2 p -82.61 -12.69 57.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.01 0.434 . . . . 0.0 110.035 179.212 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.15 -35.64 9.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.434 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -145.33 92.75 5.54 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.39 -179.312 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.548 ' HB2' HG13 ' A' ' 75' ' ' VAL . 45.1 Cg_exo -55.57 146.19 65.67 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 122.648 2.232 . . . . 0.0 112.721 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 61.8 m -77.03 138.65 39.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.585 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -102.68 141.15 35.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.088 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.4 t -129.79 135.18 61.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 52.42 32.13 10.77 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.2 24.72 70.48 Favored Glycine 0 CA--C 1.535 1.281 0 CA-C-N 115.131 -0.941 . . . . 0.0 112.885 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 47.6 t -141.66 140.85 33.33 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 118.053 0.927 . . . . 0.0 112.057 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.548 HG13 ' HB2' ' A' ' 68' ' ' PRO . 43.0 t -68.03 139.43 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.343 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.2 pt -114.59 89.36 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.25 178.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -63.72 -24.0 67.6 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -123.62 166.74 17.36 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.128 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -65.55 150.64 86.43 Favored 'Trans proline' 0 N--CA 1.5 1.86 0 C-N-CA 122.845 2.364 . . . . 0.0 113.441 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 29.7 m -143.1 143.92 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.59 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -75.27 138.56 41.95 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 178.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.578 HD12 HD11 ' A' ' 51' ' ' ILE . 92.0 mt -96.67 134.83 39.42 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.249 0.547 . . . . 0.0 111.571 -178.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -121.45 157.3 30.88 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.769 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -55.46 120.71 7.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.354 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.38 -19.3 26.93 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -68.14 135.94 52.91 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.307 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 42.2 t -114.6 133.54 60.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.524 -178.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.404 ' O ' ' OG ' ' A' ' 94' ' ' SER . 80.9 mt -100.61 132.49 46.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.248 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.6 m -125.56 130.09 51.02 Favored 'General case' 0 C--N 1.334 -0.097 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -179.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.49 HG22 HG12 ' A' ' 91' ' ' ILE . 84.0 mt -119.32 127.59 75.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.28 178.391 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.808 HG22 ' NH2' ' B' ' 245' ' ' ARG . 36.0 mm 42.26 -97.82 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -178.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.515 ' CB ' HH22 ' B' ' 245' ' ' ARG . 48.0 t0 -126.85 23.92 6.57 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.283 0.564 . . . . 0.0 110.02 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.769 ' CZ ' HD12 ' A' ' 41' ' ' LEU . 54.5 mtm-85 -126.45 139.75 53.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.001 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.404 ' OG ' ' O ' ' A' ' 88' ' ' ILE . 15.9 t -139.75 150.57 44.94 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.223 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -118.83 119.38 34.21 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.194 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 96' ' ' ARG . 39.2 ttp-105 -82.23 130.58 35.13 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.33 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.517 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 61.6 t80 -97.74 124.85 42.25 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.059 0.456 . . . . 0.0 111.271 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -128.52 123.65 34.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.523 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 . . . . . 0 C--N 1.329 -0.317 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.361 179.891 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo . . . . . 0 N--CA 1.491 1.328 0 CA-C-O 121.959 0.733 . . . . 0.0 112.95 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 4.0 p -65.25 136.55 26.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 114.572 -1.195 . . . . 0.0 110.446 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 20.2 t . . . . . 0 C--N 1.327 -0.412 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.214 -179.764 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo . . . . . 0 N--CA 1.5 1.86 0 N-CA-C 112.595 0.19 . . . . 0.0 112.595 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 19.5 m -70.28 -45.29 66.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.657 0.742 . . . . 0.0 109.038 178.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.589 ' CE2' HG21 ' A' ' 43' ' ' VAL . 87.7 t80 -58.15 -43.94 87.62 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.585 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 1.041 HD23 HH21 ' B' ' 245' ' ' ARG . 75.8 mt -61.76 -41.96 98.37 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.767 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.44 -39.28 91.88 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.49 -179.148 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -60.02 -45.71 91.9 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.566 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 1.041 HH21 HD23 ' B' ' 242' ' ' LEU . 64.3 mtm180 -63.3 -38.22 90.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.468 -179.111 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.3 -39.08 91.79 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 120.101 -0.64 . . . . 0.0 109.652 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 18.0 m -63.98 -44.15 93.56 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -60.23 -35.84 76.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.517 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 38.0 t . . . . . 0 N--CA 1.453 -0.286 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.572 179.717 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.61 ' OE1' HD11 ' A' ' 41' ' ' LEU . 97.8 mt-10 . . . . . 0 CA--C 1.534 0.358 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.452 ' CD1' HG23 ' A' ' 9' ' ' THR . 66.1 mt -114.57 134.8 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 41.2 t -127.57 136.2 61.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -95.5 117.24 30.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.171 0.51 . . . . 0.0 110.865 -178.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -63.65 -47.11 82.64 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.448 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -96.63 154.42 38.47 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.853 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.29 147.65 59.93 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 123.015 2.477 . . . . 0.0 113.639 -178.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 29.9 pt . . . . . 0 C--N 1.33 -0.244 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.203 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 69.6 p . . . . . 0 N--CA 1.463 0.19 0 CA-C-O 120.719 0.295 . . . . 0.0 111.507 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.1 mtt85 -87.74 120.24 28.86 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.264 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -124.22 135.86 53.75 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.134 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.555 HD12 ' O ' ' A' ' 96' ' ' ARG . 33.2 tp -116.05 131.91 56.81 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.605 -0.438 . . . . 0.0 109.853 179.52 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 53.8 t -109.04 132.55 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.328 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 m -88.68 112.57 23.28 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.958 0.409 . . . . 0.0 112.043 -178.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.738 HD12 ' OG ' ' A' ' 94' ' ' SER . 79.4 mt -80.75 141.85 14.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -97.42 160.87 14.07 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.021 0.439 . . . . 0.0 109.852 178.43 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -59.69 -19.86 52.52 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.983 -179.07 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.5 t -78.71 -16.48 57.2 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.282 178.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.85 24.49 22.88 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.5 m -119.77 135.83 58.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -70.89 139.46 50.77 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.238 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -125.1 -121.99 2.59 Favored Glycine 0 CA--C 1.534 1.246 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.4 148.14 54.03 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 121.869 1.712 . . . . 0.0 112.888 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -108.34 143.85 36.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.29 0.567 . . . . 0.0 111.139 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.452 ' CD2' HD11 ' A' ' 37' ' ' ILE . 39.6 t80 -114.68 98.82 50.55 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.358 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.55 132.01 18.29 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 121.101 1.2 . . . . 0.0 111.359 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.418 HD22 ' HB2' ' A' ' 27' ' ' CYS . 80.2 mt -84.5 56.12 3.68 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.07 -178.309 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 79.8 p -64.48 -22.39 66.95 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 92.1 mt -84.96 141.91 30.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.545 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 45.3 t -61.8 -18.1 58.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.524 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.514 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 33.5 m -133.93 132.93 40.82 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.593 -0.443 . . . . 0.0 112.008 -179.171 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.418 ' HB2' HD22 ' A' ' 22' ' ' LEU . 4.5 t -122.09 114.59 21.11 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.021 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.47 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 53.8 tp -113.95 131.37 56.34 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.523 -178.291 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.684 ' CE2' HD12 ' A' ' 37' ' ' ILE . 12.5 m-85 -109.76 127.18 54.46 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.051 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 173.63 -173.6 45.86 Favored Glycine 0 N--CA 1.474 1.199 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.492 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.649 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 85.9 mtm-85 -86.29 -26.72 24.79 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.463 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.547 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -58.31 154.52 25.01 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.99 -178.192 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.514 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.5 tp -66.57 -41.81 88.97 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-O 120.746 0.308 . . . . 0.0 111.002 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.514 ' N ' HG23 ' A' ' 33' ' ' ILE . 83.1 tt0 -57.63 -20.27 32.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.776 -179.301 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.547 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 7.5 m -60.69 129.41 41.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.234 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.514 ' OD2' ' O ' ' A' ' 26' ' ' THR . 54.3 m-20 -61.93 -34.35 75.93 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.684 HD12 ' CE2' ' A' ' 29' ' ' PHE . 87.9 mt -126.3 121.39 58.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 178.023 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.437 ' NH1' HD12 ' A' ' 33' ' ' ILE . 83.5 mtp180 -103.53 134.28 47.15 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.631 -178.159 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 89.9 mt -117.34 129.72 73.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.074 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -78.47 39.35 0.33 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -177.132 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.547 HD12 ' NH2' ' A' ' 93' ' ' ARG . 75.9 mt -119.94 137.72 26.12 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.844 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -72.78 -11.93 26.15 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 122.608 2.206 . . . . 0.0 112.455 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.8 m -92.04 4.15 7.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.517 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.649 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 48.0 t -98.69 130.35 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.3 m -73.05 172.32 11.24 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.747 0.784 . . . . 0.0 112.642 -178.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -64.63 -40.32 95.26 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.091 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.649 ' O ' ' N ' ' A' ' 49' ' ' CYS . 84.0 mm-40 -114.12 -19.25 11.43 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.921 0.391 . . . . 0.0 110.345 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.7 t60 31.37 -77.41 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.649 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -128.05 133.25 49.06 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.605 -178.931 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -129.2 128.84 44.15 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.401 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 85.9 mt -114.04 133.15 60.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.416 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -113.53 125.07 53.79 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.344 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.9 mm -93.99 123.98 46.29 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 121.602 0.715 . . . . 0.0 112.088 -178.082 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.425 ' O ' ' C ' ' A' ' 55' ' ' GLU . 96.5 m-70 -124.75 131.03 53.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.386 178.648 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 54' ' ' HIS . 47.9 tp10 -42.73 -32.2 0.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -64.12 -67.57 0.42 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.213 -0.903 . . . . 0.0 108.914 178.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.545 ' OE2' ' CD ' ' A' ' 81' ' ' ARG . 0.2 OUTLIER -152.3 -175.36 5.23 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.639 179.808 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.55 129.04 56.63 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.704 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.4 mt -116.77 131.55 69.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -178.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.506 ' HB2' HD21 ' A' ' 82' ' ' LEU . 50.1 tp -94.38 125.69 39.18 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.322 178.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -110.33 132.52 54.1 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.11 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.427 ' ND2' ' O ' ' A' ' 76' ' ' ILE . 41.5 t30 -94.05 106.23 18.21 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.25 0.548 . . . . 0.0 111.705 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -100.57 -9.45 21.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.397 179.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.0 t -76.75 98.18 4.71 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 120.036 -0.666 . . . . 0.0 109.831 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.4 p -74.99 -32.82 61.75 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.377 178.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.28 -43.24 57.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.461 -179.085 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.496 ' OD1' HG13 ' B' ' 236' ' ' VAL . 71.9 m-20 -140.57 97.77 7.34 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -55.51 145.01 71.39 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.295 1.997 . . . . 0.0 112.532 -178.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 13.2 m -71.79 137.15 47.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.157 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -101.02 140.73 34.91 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.666 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.7 p -135.17 136.08 51.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 50.11 30.93 4.52 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.96 28.86 65.88 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.972 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.4 m -135.3 124.55 24.6 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.826 -179.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.6 m -71.87 140.75 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.024 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.427 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 46.2 pt -121.0 141.88 39.56 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-O 121.203 0.525 . . . . 0.0 111.281 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 21.5 p-10 -104.29 -14.32 15.84 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 178.064 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -128.66 166.77 22.36 Favored Pre-proline 0 CA--C 1.528 0.098 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.148 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -64.12 146.88 91.35 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 122.673 2.249 . . . . 0.0 112.772 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.7 t -133.95 140.47 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.837 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.545 ' CD ' ' OE2' ' A' ' 57' ' ' GLU . 88.6 mtm180 -71.95 128.99 37.49 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.659 -0.417 . . . . 0.0 110.952 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.506 HD21 ' HB2' ' A' ' 60' ' ' LEU . 92.8 mt -84.37 131.23 34.72 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.341 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -124.53 153.2 42.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.702 178.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.401 ' ND1' ' N ' ' A' ' 99' ' ' ASN . 12.4 t60 -56.94 122.52 12.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.956 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.22 -19.96 33.74 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.05 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -66.27 139.26 58.06 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.501 HG22 ' HG2' ' A' ' 96' ' ' ARG . 77.1 t -112.03 129.99 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.326 -178.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.2 mt -95.66 131.21 43.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 42.3 m -120.69 124.53 45.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.494 0.664 . . . . 0.0 111.82 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.447 HG22 HG12 ' A' ' 91' ' ' ILE . 86.0 mt -119.57 121.06 65.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.173 179.091 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.484 HG22 ' N ' ' A' ' 92' ' ' ASP . 36.0 mm 52.45 -112.51 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -178.534 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.484 ' N ' HG22 ' A' ' 91' ' ' ILE . 56.6 t0 -116.25 24.25 11.53 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.337 0.589 . . . . 0.0 110.371 179.281 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.547 ' NH2' HD12 ' A' ' 41' ' ' LEU . 47.5 mtm-85 -131.26 146.72 52.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.224 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.738 ' OG ' HD12 ' A' ' 10' ' ' ILE . 23.3 p -140.65 158.58 43.78 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.318 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.544 ' HB3' HD11 ' A' ' 7' ' ' LEU . 73.0 m-85 -126.37 124.24 39.78 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.238 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.555 ' O ' HD12 ' A' ' 7' ' ' LEU . 79.8 mtp85 -85.14 127.68 34.35 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 121.075 0.464 . . . . 0.0 111.053 -179.09 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -96.09 125.64 40.77 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.885 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -130.5 122.38 27.53 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.428 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.401 ' N ' ' ND1' ' A' ' 84' ' ' HIS . 49.2 t-20 . . . . . 0 C--N 1.331 -0.215 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.967 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo . . . . . 0 N--CA 1.485 1.015 0 CA-C-O 121.417 0.507 . . . . 0.0 112.263 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.496 HG13 ' OD1' ' A' ' 67' ' ' ASN . 76.3 t -59.09 139.85 18.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.215 -179.14 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 237' ' ' CYS . . . . . 0.603 ' SG ' ' CD1' ' B' ' 241' ' ' PHE . 4.9 t . . . . . 0 C--N 1.331 -0.211 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.062 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo . . . . . 0 N--CA 1.5 1.863 0 N-CA-C 113.222 0.431 . . . . 0.0 113.222 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 98.7 m -73.27 -45.72 54.05 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.631 0.729 . . . . 0.0 109.541 178.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.603 ' CD1' ' SG ' ' B' ' 237' ' ' CYS . 54.4 t80 -57.31 -45.63 84.02 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.102 -178.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' B' ' 242' ' ' LEU . 89.0 mt -65.24 -42.23 93.53 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -61.67 -38.75 88.93 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.404 -0.519 . . . . 0.0 110.357 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 244' ' ' ARG . . . . . 0.534 ' O ' ' OG ' ' B' ' 247' ' ' SER . 82.7 mtp180 -64.12 -40.72 96.79 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.544 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.449 ' NH2' ' CD2' ' A' ' 41' ' ' LEU . 22.0 mmt180 -64.73 -41.4 95.98 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.382 -179.247 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.46 -38.05 88.27 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 247' ' ' SER . . . . . 0.534 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 77.8 p -67.46 -42.78 82.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.441 179.258 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -61.56 -36.2 79.95 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.838 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 34.9 t . . . . . 0 C--N 1.326 -0.447 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.358 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.503 ' N ' ' OE1' ' B' ' 260' ' ' GLU . 44.5 mp0 . . . . . 0 C--O 1.223 -0.335 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 74.5 mt -118.62 133.67 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 75.5 t -129.25 137.19 57.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.987 0.423 . . . . 0.0 110.884 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -97.31 119.56 36.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.595 -178.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -67.87 -45.89 73.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.364 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.57 156.17 41.47 Favored Pre-proline 0 C--N 1.332 -0.16 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.049 -179.006 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -63.65 148.28 92.32 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.995 2.464 . . . . 0.0 112.17 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 33.9 pt . . . . . 0 C--N 1.326 -0.439 0 CA-C-O 121.416 0.627 . . . . 0.0 111.185 -179.535 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 63.3 p . . . . . 0 C--O 1.232 0.147 0 CA-C-O 121.027 0.442 . . . . 0.0 110.308 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 86.0 mtt85 -97.43 132.42 43.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.219 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -134.37 145.31 48.85 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.844 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.479 HD11 HD11 ' A' ' 22' ' ' LEU . 87.5 mt -114.07 142.95 45.55 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.049 179.01 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.584 HG22 ' CD2' ' A' ' 19' ' ' HIS . 42.9 t -115.82 129.9 71.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 m -90.74 119.32 30.87 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.485 0.66 . . . . 0.0 112.776 -177.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.1 mm -81.33 135.48 24.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.496 178.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.425 ' HB2' ' H ' ' A' ' 15' ' ' VAL . 95.7 mttt -85.86 156.3 20.6 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.792 179.1 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.427 ' NE ' ' HD2' ' B' ' 245' ' ' ARG . 83.7 mtp180 -58.36 -34.61 70.85 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.3 p -70.25 -18.88 63.15 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.202 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.65 34.38 5.78 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.425 ' H ' ' HB2' ' A' ' 11' ' ' LYS . 43.0 t -121.15 133.09 68.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 114.992 -0.604 . . . . 0.0 110.922 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -73.26 136.38 44.59 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -135.52 -114.56 1.4 Allowed Glycine 0 CA--C 1.534 1.276 0 C-N-CA 119.752 -1.213 . . . . 0.0 112.827 -179.023 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.67 144.09 43.5 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.33 2.02 . . . . 0.0 113.653 -177.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.584 ' CD2' HG22 ' A' ' 8' ' ' VAL . 63.8 m170 -107.9 137.94 45.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.678 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.494 ' CD2' HD11 ' A' ' 37' ' ' ILE . 26.1 t80 -106.12 96.51 13.32 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.131 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.6 134.59 22.51 Favored 'Trans proline' 0 C--N 1.315 -1.231 0 C-N-CA 121.283 1.322 . . . . 0.0 110.745 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.479 HD11 HD11 ' A' ' 7' ' ' LEU . 95.9 mt -86.06 74.16 10.14 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.663 -178.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.1 p -79.6 -10.24 59.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.41 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.1 mt -105.86 148.0 28.06 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.108 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.2 t -68.22 -16.16 63.86 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.5 m -134.41 136.97 43.69 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.419 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.664 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 4.1 t -131.69 124.47 29.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.923 178.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.479 HD21 ' OE1' ' A' ' 47' ' ' GLN . 47.7 tp -118.38 129.61 55.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.532 -178.355 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.744 ' CE2' HD12 ' A' ' 37' ' ' ILE . 6.8 m-85 -106.06 134.72 48.74 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.422 179.283 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 156.5 -177.91 33.24 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 120.451 -0.88 . . . . 0.0 112.322 179.03 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 45.5 mtm105 -75.1 -32.44 61.42 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.48 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -50.34 150.85 5.25 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.778 -178.304 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.534 HG23 ' N ' ' A' ' 34' ' ' GLU . 9.8 tp -66.11 -41.66 89.9 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-O 121.021 0.439 . . . . 0.0 110.1 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.534 ' N ' HG23 ' A' ' 33' ' ' ILE . 97.7 mt-10 -56.07 -24.3 39.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.806 -179.641 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.48 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 32.0 m -55.8 117.2 3.44 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.685 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -57.37 -29.15 63.8 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.744 HD12 ' CE2' ' A' ' 29' ' ' PHE . 98.7 mt -125.64 118.66 52.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.417 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 84.1 mtp180 -104.06 136.73 43.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.689 -178.533 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.522 HD13 ' NH1' ' A' ' 93' ' ' ARG . 97.6 mt -118.08 129.82 73.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 121.29 0.567 . . . . 0.0 110.771 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -74.96 35.19 0.1 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 114.975 -1.011 . . . . 0.0 113.092 -177.658 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.685 ' CD1' ' HE ' ' A' ' 93' ' ' ARG . 28.3 mt -118.94 130.93 24.56 Favored Pre-proline 0 C--N 1.323 -0.561 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.457 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.476 ' O ' ' HD2' ' B' ' 235' ' ' PRO . 44.2 Cg_endo -67.84 -18.97 47.23 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.379 2.052 . . . . 0.0 113.454 -179.025 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 241' ' ' PHE . 34.2 m -83.87 -0.08 5.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.836 -0.345 . . . . 0.0 110.896 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 56.8 t -88.08 133.0 31.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.926 0.393 . . . . 0.0 110.124 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.9 m -67.89 162.49 24.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.426 0.631 . . . . 0.0 111.325 -179.484 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -60.88 -41.53 96.19 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.591 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.629 ' O ' ' N ' ' A' ' 49' ' ' CYS . 97.9 mm-40 -115.33 -25.32 8.04 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.436 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.8 t60 36.54 -76.07 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.629 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.53 134.04 46.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.37 0.605 . . . . 0.0 112.177 -178.091 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -126.8 131.62 51.22 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.196 179.387 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 91.6 mt -115.41 133.32 62.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.507 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -119.34 126.55 51.7 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 89.1 mt -106.38 118.18 53.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.555 0.693 . . . . 0.0 111.83 -179.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.453 ' O ' ' N ' ' A' ' 56' ' ' GLN . 86.5 m-70 -113.86 142.66 45.82 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.331 179.366 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 54' ' ' HIS . 80.0 mm-40 -40.21 -29.46 0.08 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.453 ' N ' ' O ' ' A' ' 54' ' ' HIS . 88.5 mt-30 -63.7 -66.98 0.47 Allowed 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.065 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.439 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 5.5 tp10 -158.36 -163.32 1.26 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.138 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.454 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -112.8 129.16 56.53 Favored 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.1 mt -119.29 128.88 75.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.385 0.612 . . . . 0.0 112.145 -178.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.4 tp -97.79 126.58 43.22 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.054 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -110.97 136.36 50.09 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.843 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -97.33 104.44 16.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.575 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -99.07 -10.06 23.07 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.891 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.52 99.03 3.48 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.248 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.7 m -73.55 -39.82 64.44 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.377 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.825 HG22 HG22 ' B' ' 236' ' ' VAL . 0.2 OUTLIER -63.66 -47.46 81.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.818 -178.707 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.505 ' OD1' HG13 ' B' ' 236' ' ' VAL . 2.2 m-20 -142.9 99.03 5.6 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.653 ' HB2' HG13 ' A' ' 75' ' ' VAL . 51.7 Cg_exo -53.38 148.35 33.66 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.361 2.04 . . . . 0.0 113.26 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.5 m -69.32 139.54 54.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.862 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -100.33 141.93 32.5 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.431 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.495 ' CG2' ' OD1' ' A' ' 86' ' ' ASP . 8.5 p -130.79 135.17 60.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 44.99 33.71 1.09 Allowed 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.082 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.05 29.28 62.93 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.837 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.485 ' N ' ' O ' ' A' ' 71' ' ' VAL . 15.8 m -140.65 139.43 34.82 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 120.576 -0.449 . . . . 0.0 111.239 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.653 HG13 ' HB2' ' A' ' 68' ' ' PRO . 29.2 t -72.59 137.93 22.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.243 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.0 pt -109.38 91.99 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.707 178.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -65.41 -30.29 71.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.56 179.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -122.86 168.7 11.37 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.458 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -60.71 148.87 90.3 Favored 'Trans proline' 0 N--CA 1.501 1.917 0 C-N-CA 122.41 2.073 . . . . 0.0 112.26 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.6 p -142.72 142.89 26.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.42 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.7 mtm180 -75.58 131.43 39.99 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.454 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 93.0 mt -78.42 140.33 38.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.128 0.49 . . . . 0.0 111.471 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -128.4 148.13 50.69 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.534 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -55.36 117.21 3.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.213 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.07 -8.71 31.38 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.495 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 60.6 t0 -73.7 128.18 34.81 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.73 0.3 . . . . 0.0 110.441 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.457 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 48.3 t -109.9 132.64 57.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.463 -178.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.8 mt -105.37 134.01 48.06 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 97.6 m -121.53 126.65 49.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.33 0.586 . . . . 0.0 111.898 -178.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.412 ' CG2' HH12 ' A' ' 93' ' ' ARG . 97.8 mt -115.71 124.81 72.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 177.5 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.4 mm 40.81 -101.66 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 -178.078 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -118.39 23.56 11.47 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.096 0.475 . . . . 0.0 110.615 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.685 ' HE ' ' CD1' ' A' ' 41' ' ' LEU . 7.9 mtm105 -128.2 146.5 50.71 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.095 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.1 t -137.06 147.16 45.96 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.469 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -120.13 121.0 37.83 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -84.87 135.07 34.24 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.344 -178.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -95.16 120.36 35.25 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.524 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -122.26 123.8 42.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.319 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 62.5 t-20 . . . . . 0 C--N 1.33 -0.282 0 CA-C-O 120.832 0.348 . . . . 0.0 110.576 179.818 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 235' ' ' PRO . . . . . 0.476 ' HD2' ' O ' ' A' ' 42' ' ' PRO . 31.3 Cg_exo . . . . . 0 N--CA 1.488 1.199 0 CA-C-O 121.756 0.648 . . . . 0.0 112.726 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.825 HG22 HG22 ' A' ' 66' ' ' THR . 25.5 t -68.56 133.66 31.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 114.572 -1.195 . . . . 0.0 109.406 179.433 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.403 0 C-N-CA 120.218 -0.593 . . . . 0.0 110.199 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo . . . . . 0 N--CA 1.493 1.447 0 CA-C-O 120.948 0.312 . . . . 0.0 111.76 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 21.4 m -74.21 -46.2 43.35 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.79 177.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.442 ' CE2' HG21 ' A' ' 43' ' ' VAL . 70.9 t80 -57.84 -44.87 86.77 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.276 -179.311 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 79.2 mt -63.76 -39.76 95.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.406 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -60.34 -42.42 95.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.317 -0.401 . . . . 0.0 109.96 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -65.67 -39.47 91.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.203 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.427 ' HD2' ' NE ' ' A' ' 12' ' ' ARG . 3.1 tpp85 -57.5 -43.69 84.38 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -64.4 -41.52 96.6 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 68.1 m -60.93 -45.51 94.39 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 248' ' ' GLN . . . . . 0.423 ' OE1' ' NH2' ' A' ' 12' ' ' ARG . 86.3 mt-30 -62.53 -34.21 76.45 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.339 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 19.0 t . . . . . 0 CA--C 1.519 -0.234 0 C-N-CA 120.409 -0.516 . . . . 0.0 109.92 179.544 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 . . . . . 0 CA--C 1.53 0.19 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 59.3 mt -116.35 132.19 66.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 42.9 t -125.3 134.42 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.094 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -95.54 118.01 31.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.296 0.569 . . . . 0.0 111.038 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -65.02 -44.24 89.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.463 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -100.84 157.83 32.96 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.039 -178.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.23 153.47 69.7 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.777 2.318 . . . . 0.0 111.883 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 41.9 pt . . . . . 0 C--N 1.328 -0.355 0 CA-C-O 121.65 0.738 . . . . 0.0 111.995 -178.877 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.543 HG22 ' OD1' ' A' ' 99' ' ' ASN . 19.2 m . . . . . 0 N--CA 1.467 0.393 0 CA-C-O 120.666 0.27 . . . . 0.0 111.14 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.595 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 95.2 mtt-85 -97.76 112.31 24.26 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.556 -179.019 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 60.7 ttp180 -124.73 131.5 53.45 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.862 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.659 HD11 ' HB3' ' A' ' 95' ' ' PHE . 43.8 tp -109.32 132.63 53.94 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 37.1 t -109.81 131.41 60.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.809 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.473 ' CG2' HD12 ' B' ' 261' ' ' ILE . 18.6 m -91.45 113.49 25.77 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -177.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.63 HD12 ' OG ' ' A' ' 94' ' ' SER . 97.0 mt -81.91 143.59 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.648 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -89.79 158.42 17.51 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.039 0.447 . . . . 0.0 110.97 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -57.28 -32.21 66.39 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.994 -178.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.4 p -79.76 -7.9 58.92 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.419 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.82 40.29 4.99 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.2 t -122.59 131.16 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 O-C-N 122.753 -0.263 . . . . 0.0 111.446 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -73.59 134.29 43.7 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -126.97 -123.52 2.65 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.036 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -74.37 153.16 44.94 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 122.362 2.042 . . . . 0.0 112.167 -178.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.571 ' O ' ' CG2' ' B' ' 267' ' ' ILE . 0.2 OUTLIER -108.16 159.88 16.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.971 0.415 . . . . 0.0 110.842 -179.516 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.602 ' CD2' HD11 ' A' ' 37' ' ' ILE . 43.8 t80 -128.38 92.3 41.55 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.64 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.23 125.55 18.84 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.026 1.817 . . . . 0.0 111.292 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.484 HD22 ' SG ' ' A' ' 27' ' ' CYS . 93.1 mt -87.92 42.25 1.04 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.896 0.379 . . . . 0.0 111.404 -178.409 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.7 t -59.37 -23.35 62.49 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.678 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.0 mt -76.62 143.9 39.87 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 82.2 p -66.66 -20.31 65.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.676 -178.406 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.512 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 93.8 m -128.74 128.96 45.06 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.379 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.484 ' SG ' HD22 ' A' ' 22' ' ' LEU . 6.5 t -121.94 112.57 18.46 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.02 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.666 HD21 ' OE1' ' A' ' 47' ' ' GLN . 52.6 tp -113.47 126.07 54.92 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.233 -177.757 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.712 ' CE2' HD12 ' A' ' 37' ' ' ILE . 6.6 m-85 -106.44 136.66 45.8 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.454 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 160.37 -173.11 36.91 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.284 -0.96 . . . . 0.0 112.421 178.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.571 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 39.3 mtm180 -79.38 -29.21 41.99 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.575 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -61.89 151.03 45.09 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.523 -177.614 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 78.2 mt -64.87 -42.92 96.15 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.337 0 CA-C-N 115.564 -0.318 . . . . 0.0 110.916 179.056 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -52.64 -26.03 12.49 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 119.657 -0.817 . . . . 0.0 108.893 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.575 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 11.4 m -57.81 118.74 5.63 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.295 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.512 ' OD2' ' O ' ' A' ' 26' ' ' THR . 98.5 m-20 -56.09 -24.07 37.9 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.222 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.712 HD12 ' CE2' ' A' ' 29' ' ' PHE . 96.9 mt -131.66 122.75 50.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.838 178.377 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.4 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 32.2 mtm180 -107.71 140.47 40.71 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.016 0.436 . . . . 0.0 111.5 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 78.0 mt -121.04 128.79 76.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.096 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -70.57 32.3 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -177.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.568 ' CD1' ' CZ ' ' A' ' 93' ' ' ARG . 64.7 mt -110.79 133.68 21.15 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.956 -179.401 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.7 -8.92 24.07 Favored 'Trans proline' 0 N--CA 1.501 1.959 0 C-N-CA 123.478 2.785 . . . . 0.0 113.863 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.6 m -101.13 2.65 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.032 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.571 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 18.4 t -89.54 100.98 11.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.649 -179.147 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.521 ' O ' ' O ' ' A' ' 44' ' ' VAL . 3.6 t -34.99 164.29 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.936 -179.1 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -63.59 -43.55 96.61 Favored 'General case' 0 C--O 1.238 0.447 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.776 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.666 ' OE1' HD21 ' A' ' 28' ' ' LEU . 94.5 mm-40 -111.21 -23.51 10.81 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.007 0.432 . . . . 0.0 110.421 -179.285 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.457 ' NE2' HG23 ' A' ' 90' ' ' ILE . 16.5 t60 41.29 -78.3 0.0 OUTLIER 'General case' 0 C--O 1.24 0.576 0 CA-C-N 115.421 -0.808 . . . . 0.0 112.679 179.316 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.609 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.45 136.93 48.37 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.914 -178.861 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -129.81 129.51 44.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.181 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 89.0 mt -114.61 138.41 44.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.313 -179.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -118.0 122.51 43.4 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 89.3 mt -103.47 114.09 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 C-N-CA 120.104 -0.639 . . . . 0.0 111.285 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.5 ' O ' ' N ' ' A' ' 56' ' ' GLN . 96.6 m-70 -111.41 139.9 46.44 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.828 179.271 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 54' ' ' HIS . 81.2 tt0 -39.56 -28.43 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.5 ' N ' ' O ' ' A' ' 54' ' ' HIS . 99.6 mm-40 -64.19 -68.14 0.38 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.164 178.377 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -157.98 -168.02 2.39 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.865 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.561 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -112.54 128.4 56.34 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.24 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 87.6 mt -118.64 129.89 74.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 121.175 0.512 . . . . 0.0 111.963 -178.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 25.1 tp -96.31 128.38 43.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.671 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -113.13 138.57 49.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.295 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.603 HD21 ' CB ' ' A' ' 68' ' ' PRO . 61.1 t-20 -99.8 107.01 18.95 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.648 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -98.68 -8.03 26.86 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.803 0.335 . . . . 0.0 110.444 179.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.05 100.68 12.33 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.781 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.6 p -88.31 -30.34 19.67 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.215 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.594 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -63.7 -46.37 85.78 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.317 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -142.49 101.89 5.55 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 115.174 -0.921 . . . . 0.0 108.693 178.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.603 ' CB ' HD21 ' A' ' 62' ' ' ASN . 60.0 Cg_endo -69.44 152.25 70.97 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.097 1.865 . . . . 0.0 114.032 -177.594 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.961 ' O ' HG22 ' A' ' 76' ' ' ILE . 11.4 m -70.94 145.57 50.03 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.286 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -106.82 143.61 34.66 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.7 179.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.505 ' CG2' ' OD1' ' A' ' 86' ' ' ASP . 6.3 p -131.67 136.26 57.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 48.5 32.27 3.29 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.85 27.52 68.77 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.341 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 71' ' ' VAL . 31.3 m -137.67 133.2 33.98 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.322 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 54.7 t -60.97 136.52 24.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.858 0.361 . . . . 0.0 110.57 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.961 HG22 ' O ' ' A' ' 69' ' ' THR . 14.0 tt -103.1 89.73 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.892 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -63.43 -35.84 81.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.746 179.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.505 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 0.8 OUTLIER -128.69 167.52 19.05 Favored Pre-proline 0 N--CA 1.464 0.233 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.372 -179.214 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -56.74 141.78 91.93 Favored 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 122.27 1.98 . . . . 0.0 112.674 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 73.0 t -131.72 137.8 54.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.617 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 83.1 mtt85 -70.24 129.16 38.61 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 97.0 mt -82.53 137.12 34.7 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.456 -0.497 . . . . 0.0 111.394 -178.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -129.29 152.73 48.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.107 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.53 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 7.2 t60 -54.19 118.34 3.99 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.734 0.302 . . . . 0.0 110.428 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.73 -13.15 24.95 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.505 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 59.8 t0 -71.43 128.41 35.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.845 0.355 . . . . 0.0 110.464 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.405 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 69.3 t -110.83 129.05 66.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.674 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 93.8 mt -97.28 132.58 41.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 94.0 m -122.8 127.74 49.51 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 120.026 -0.67 . . . . 0.0 112.553 -178.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.525 HG22 HG12 ' A' ' 91' ' ' ILE . 82.2 mt -120.31 125.37 74.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 114.944 -1.026 . . . . 0.0 108.26 178.245 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.525 HG12 HG22 ' A' ' 90' ' ' ILE . 25.1 mm 43.22 -116.33 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -178.511 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.419 ' HB2' ' HE ' ' B' ' 245' ' ' ARG . 94.3 m-20 -102.74 14.47 31.87 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.854 0.359 . . . . 0.0 110.849 178.643 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.819 HH11 ' NH2' ' B' ' 245' ' ' ARG . 37.2 mtm-85 -123.37 145.13 49.0 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.427 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.63 ' OG ' HD12 ' A' ' 10' ' ' ILE . 38.3 p -140.99 151.86 44.46 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 120.687 -0.405 . . . . 0.0 109.927 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.659 ' HB3' HD11 ' A' ' 7' ' ' LEU . 82.7 m-85 -120.07 121.65 39.34 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.249 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.51 ' O ' HD12 ' A' ' 7' ' ' LEU . 79.6 mtp85 -81.56 130.3 35.0 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.471 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.595 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 86.7 t80 -96.62 123.05 40.17 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.198 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -127.41 131.62 50.26 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.007 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.543 ' OD1' HG22 ' A' ' 4' ' ' THR . 64.9 t-20 . . . . . 0 CA--C 1.52 -0.206 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.412 -179.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo . . . . . 0 N--CA 1.486 1.076 0 CA-C-O 121.21 0.421 . . . . 0.0 112.17 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.594 ' CG2' HG22 ' A' ' 66' ' ' THR . 41.1 t -70.13 133.02 32.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.441 -178.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 4.8 t . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.751 179.059 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo . . . . . 0 N--CA 1.497 1.713 0 N-CA-C 113.419 0.507 . . . . 0.0 113.419 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 96.6 m -74.03 -44.65 53.65 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.307 -0.557 . . . . 0.0 109.579 178.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.414 ' HZ ' HD22 ' A' ' 41' ' ' LEU . 82.4 t80 -59.71 -46.54 88.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.263 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.425 ' HA ' HD23 ' B' ' 242' ' ' LEU . 88.3 mt -63.87 -42.36 97.54 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.092 0.472 . . . . 0.0 110.569 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -61.81 -38.89 89.81 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.255 -179.447 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -62.36 -44.75 95.74 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.4 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.819 ' NH2' HH11 ' A' ' 93' ' ' ARG . 72.6 mtp85 -61.18 -39.7 91.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.894 -179.392 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -63.67 -41.74 98.14 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 120.375 -0.53 . . . . 0.0 109.683 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 62.6 m -66.17 -45.36 81.17 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -58.03 -39.3 78.04 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.879 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 249' ' ' VAL . . . . . 0.436 HG23 ' O ' ' B' ' 245' ' ' ARG . 54.7 t . . . . . 0 C--N 1.33 -0.282 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.633 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 . . . . . 0 C--O 1.231 0.116 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.473 HD12 ' CG2' ' A' ' 9' ' ' THR . 74.6 mt -103.22 136.64 34.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.061 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 72.0 t -125.96 135.76 62.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.45 0.643 . . . . 0.0 111.359 -178.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -97.46 116.55 29.88 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.781 -178.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -67.58 -39.6 84.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.505 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.56 159.46 32.57 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.344 -178.556 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 266' ' ' PRO . . . . . 0.414 ' C ' HD13 ' B' ' 267' ' ' ILE . 37.9 Cg_endo -61.2 147.61 95.15 Favored 'Trans proline' 0 C--N 1.302 -1.891 0 C-N-CA 122.27 1.98 . . . . 0.0 111.925 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 267' ' ' ILE . . . . . 0.571 ' CG2' ' O ' ' A' ' 19' ' ' HIS . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.904 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.627 HG22 ' OD1' ' A' ' 99' ' ' ASN . 16.6 m . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.59 0.233 . . . . 0.0 111.1 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.65 ' NE ' HD13 ' A' ' 53' ' ' ILE . 91.5 mtm-85 -95.91 117.46 30.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.012 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -128.31 134.92 49.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.864 0.364 . . . . 0.0 110.251 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.633 HD12 ' O ' ' A' ' 96' ' ' ARG . 24.2 tp -113.87 132.85 55.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.989 -179.048 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.652 HG22 ' CD2' ' A' ' 19' ' ' HIS . 51.5 t -108.49 130.86 60.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.424 HG23 ' CD1' ' B' ' 261' ' ' ILE . 2.7 m -90.79 121.34 32.58 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.356 0.598 . . . . 0.0 112.124 -178.658 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 98.2 mt -89.18 141.06 14.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.23 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -91.03 162.87 14.52 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.564 HH12 ' CD ' ' B' ' 248' ' ' GLN . 87.4 mtm180 -55.83 -27.56 52.04 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.075 -178.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 92.6 p -84.87 -6.26 59.34 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.791 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.51 42.17 7.49 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.436 -1.065 . . . . 0.0 110.436 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.2 t -118.57 132.99 66.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.797 0.332 . . . . 0.0 110.996 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.545 ' CG ' ' HE2' ' A' ' 19' ' ' HIS . 63.9 t0 -74.17 120.24 19.47 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.872 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -117.37 -120.76 3.12 Favored Glycine 0 CA--C 1.539 1.582 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.748 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -74.34 147.45 37.07 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 122.413 2.075 . . . . 0.0 112.703 -179.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.652 ' CD2' HG22 ' A' ' 8' ' ' VAL . 65.2 m170 -109.66 143.87 38.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.083 0.468 . . . . 0.0 110.818 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.731 ' CD2' HD11 ' A' ' 37' ' ' ILE . 30.1 t80 -112.28 104.14 55.81 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.71 -178.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -74.02 128.18 12.06 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 121.34 1.36 . . . . 0.0 111.106 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.3 mt -85.07 47.32 1.39 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.811 -177.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 97.2 p -59.07 -28.44 66.47 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.3 mt -74.29 141.78 45.26 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.8 m -70.95 -16.29 62.64 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.972 -0.291 . . . . 0.0 111.724 -178.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.9 m -134.07 135.88 43.58 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.97 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.676 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 2.4 t -131.05 123.05 27.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.945 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.3 tp -117.51 130.24 56.31 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.686 0.279 . . . . 0.0 110.92 -178.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.676 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 59.3 m-85 -108.02 143.63 36.45 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.823 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 147.84 -177.61 25.99 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.035 178.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 46.6 mtm180 -70.83 -32.67 69.79 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.924 0.392 . . . . 0.0 111.042 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.535 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -48.67 143.92 7.56 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 -178.539 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.538 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.8 tp -66.22 -41.59 89.49 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.151 0 CA-C-O 121.046 0.45 . . . . 0.0 110.078 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.538 ' N ' HG23 ' A' ' 33' ' ' ILE . 97.9 mt-10 -54.88 -22.1 13.67 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.519 179.455 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.535 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 50.0 m -56.73 118.39 4.85 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.348 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -59.54 -26.89 65.74 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.731 HD11 ' CD2' ' A' ' 20' ' ' PHE . 47.5 mm -123.54 108.54 21.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 176.491 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -102.28 132.95 47.92 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.843 -177.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 84.0 mt -123.42 131.51 73.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.554 ' NE2' ' O ' ' A' ' 40' ' ' GLN . 0.0 OUTLIER -88.56 43.71 1.15 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 119.626 -0.83 . . . . 0.0 112.558 -178.112 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.983 HD11 ' NH1' ' A' ' 93' ' ' ARG . 36.6 mt -95.36 128.87 36.83 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.27 178.617 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -70.78 -13.34 32.04 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 122.095 1.863 . . . . 0.0 113.534 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 18.6 m -100.61 5.67 10.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.028 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 34.5 t -95.7 139.07 19.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.123 0.487 . . . . 0.0 111.086 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.87 166.04 11.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.548 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -63.87 -44.12 94.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.003 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.625 ' O ' ' N ' ' A' ' 49' ' ' CYS . 98.2 mt-30 -113.4 -12.08 13.04 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.885 0.374 . . . . 0.0 111.049 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 26.1 t60 34.48 -74.77 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 178.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.625 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -135.53 139.54 44.04 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.405 0.622 . . . . 0.0 112.095 -177.938 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -127.66 131.09 49.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.78 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.8 mt -113.24 132.95 60.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.107 179.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.464 ' CD ' ' NE2' ' A' ' 54' ' ' HIS . 83.4 tt0 -117.89 123.32 45.57 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.093 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.65 HD13 ' NE ' ' A' ' 5' ' ' ARG . 85.1 mt -107.22 117.11 52.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 119.968 -0.693 . . . . 0.0 112.559 -178.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.464 ' NE2' ' CD ' ' A' ' 52' ' ' GLU . 97.7 m-70 -110.93 139.67 46.06 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.968 178.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.5 tt0 -40.77 -32.55 0.23 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.5 -0.48 . . . . 0.0 109.802 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -66.3 -65.97 0.61 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.99 -173.23 4.43 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.098 0.475 . . . . 0.0 111.797 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.84 129.22 56.61 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.698 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 91.3 mt -118.14 130.87 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 121.609 0.719 . . . . 0.0 112.76 -178.3 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.543 HD22 ' CD1' ' A' ' 88' ' ' ILE . 43.1 tp -98.69 128.06 44.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.456 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -115.06 136.03 53.56 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.948 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.615 ' C ' HD21 ' A' ' 62' ' ' ASN . 0.3 OUTLIER -97.32 104.72 16.77 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.25 -179.648 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.439 ' N ' HD21 ' A' ' 62' ' ' ASN . 25.2 m-85 -96.44 -11.66 25.31 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.865 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.503 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 85.1 p -74.71 98.4 3.44 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.098 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.8 m -78.67 -32.85 47.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.345 179.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.489 HG22 HG22 ' B' ' 236' ' ' VAL . 0.2 OUTLIER -75.19 -42.72 55.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.595 -179.225 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.503 ' O ' ' OG ' ' A' ' 64' ' ' SER . 79.5 m-20 -135.88 95.06 14.07 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.919 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.437 ' HB2' HG13 ' A' ' 75' ' ' VAL . 40.1 Cg_exo -54.92 143.33 72.77 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.383 2.055 . . . . 0.0 113.242 -178.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.464 ' HB ' HD11 ' A' ' 76' ' ' ILE . 12.2 m -70.94 152.87 43.18 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.309 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -115.54 141.24 48.33 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.535 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.547 ' CG2' ' OD1' ' A' ' 86' ' ' ASP . 4.4 p -130.9 137.51 55.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 49.26 32.16 4.17 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.05 28.79 69.8 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.959 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.464 ' N ' ' O ' ' A' ' 71' ' ' VAL . 9.0 t -140.24 137.3 34.16 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.914 0.388 . . . . 0.0 111.363 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.437 HG13 ' HB2' ' A' ' 68' ' ' PRO . 40.7 t -64.9 135.97 27.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.673 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.464 HD11 ' HB ' ' A' ' 69' ' ' THR . 11.9 pt -110.49 77.93 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.12 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.318 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -59.93 -33.02 71.33 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -112.9 159.35 34.84 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.785 178.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.55 154.27 71.97 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.413 2.075 . . . . 0.0 111.67 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.0 m -148.15 149.02 15.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.873 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -73.1 132.15 42.95 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-O 120.983 0.42 . . . . 0.0 110.449 179.102 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.408 HD21 ' HB2' ' A' ' 60' ' ' LEU . 97.6 mt -80.95 140.97 34.95 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.198 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -133.63 154.6 50.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.767 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -55.15 116.46 2.81 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.259 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.17 -18.39 18.58 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.547 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 56.9 t0 -66.08 123.36 19.67 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.271 0.557 . . . . 0.0 109.508 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.502 ' CG2' ' OG ' ' A' ' 94' ' ' SER . 7.4 p -104.37 132.94 49.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.078 -178.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.543 ' CD1' HD22 ' A' ' 60' ' ' LEU . 29.4 mm -92.48 130.47 41.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 178.184 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.6 m -121.96 126.44 48.6 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 119.364 -0.934 . . . . 0.0 112.9 -178.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.517 ' O ' ' C ' ' A' ' 91' ' ' ILE . 98.0 mt -120.39 127.69 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 113.988 -1.46 . . . . 0.0 107.996 177.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.553 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 44.0 mt -21.21 101.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 O-C-N 123.612 0.57 . . . . 0.0 112.243 -179.348 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.553 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 11.3 t0 89.87 -19.81 0.16 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 177.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.983 ' NH1' HD11 ' A' ' 41' ' ' LEU . 71.7 mtt85 -131.44 139.85 49.48 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.806 -178.466 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.502 ' OG ' ' CG2' ' A' ' 87' ' ' VAL . 15.8 t -135.04 146.91 49.43 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 120.894 0.378 . . . . 0.0 110.09 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.592 ' HB3' HD11 ' A' ' 7' ' ' LEU . 72.7 m-85 -123.78 124.52 42.87 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.752 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.633 ' O ' HD12 ' A' ' 7' ' ' LEU . 99.8 mtt180 -88.29 133.47 34.05 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 119.568 -0.853 . . . . 0.0 110.932 -179.633 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -95.28 124.34 39.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.875 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -123.12 127.62 48.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.421 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.627 ' OD1' HG22 ' A' ' 4' ' ' THR . 62.6 t-20 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.385 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo . . . . . 0 N--CA 1.492 1.386 0 CA-C-O 121.306 0.461 . . . . 0.0 112.635 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.489 HG22 HG22 ' A' ' 66' ' ' THR . 72.8 t -66.2 133.26 31.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.818 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 2.0 t . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.113 179.651 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo . . . . . 0 N--CA 1.495 1.598 0 CA-C-O 120.64 0.184 . . . . 0.0 112.263 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 98.9 m -67.25 -48.0 69.08 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.453 ' HZ ' HD22 ' A' ' 41' ' ' LEU . 88.9 t80 -59.31 -47.57 84.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.13 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.486 HD21 HG23 ' A' ' 91' ' ' ILE . 85.9 mt -65.36 -40.13 93.18 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.14 -179.468 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -62.16 -42.4 99.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.896 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 79.2 ttt-85 -61.19 -42.48 98.65 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.078 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.619 ' NH1' HE22 ' B' ' 248' ' ' GLN . 22.5 mmt180 -62.72 -42.33 99.6 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.749 -179.669 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -62.11 -43.12 99.53 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 54.3 m -65.35 -44.05 88.93 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 248' ' ' GLN . . . . . 0.619 HE22 ' NH1' ' B' ' 245' ' ' ARG . 7.3 tt0 -57.26 -41.29 79.4 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.521 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 249' ' ' VAL . . . . . 0.417 HG23 ' O ' ' B' ' 245' ' ' ARG . 55.1 t . . . . . 0 C--N 1.331 -0.232 0 CA-C-O 120.75 0.309 . . . . 0.0 110.649 179.323 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.605 ' CB ' HH21 ' A' ' 93' ' ' ARG . 51.1 mp0 . . . . . 0 C--O 1.237 0.437 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.424 ' CD1' HG23 ' A' ' 9' ' ' THR . 78.1 mt -110.81 136.21 47.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 76.7 t -122.91 131.19 73.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.999 0.428 . . . . 0.0 110.254 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -94.23 117.48 30.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.202 0.525 . . . . 0.0 110.958 -178.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.32 -44.81 90.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.543 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.75 160.36 28.07 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.801 -179.158 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -57.07 152.87 41.8 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.987 2.458 . . . . 0.0 111.716 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 39.8 pt . . . . . 0 C--N 1.327 -0.383 0 CA-C-O 121.622 0.725 . . . . 0.0 111.978 -178.921 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.503 ' O ' ' O ' ' A' ' 99' ' ' ASN . 2.9 m . . . . . 0 CA--C 1.529 0.16 0 CA-C-O 120.795 0.331 . . . . 0.0 111.318 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.746 ' HE ' HD13 ' A' ' 53' ' ' ILE . 82.5 mtm-85 -89.98 130.68 36.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.958 -179.135 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -131.06 148.04 52.69 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.155 0.502 . . . . 0.0 111.921 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.762 HD11 HD11 ' A' ' 22' ' ' LEU . 94.1 mt -115.4 141.7 47.68 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.257 179.11 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.9 t -113.14 128.22 70.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.7 m -91.69 113.73 26.08 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.321 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.681 HD12 ' OG ' ' A' ' 94' ' ' SER . 96.8 mt -77.58 138.77 19.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.291 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -86.32 157.04 19.99 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.425 179.014 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -58.01 -30.84 66.41 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.782 -179.202 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 87.0 p -78.55 -9.74 59.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.871 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.56 34.78 6.81 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.756 -0.937 . . . . 0.0 110.756 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 52.3 t -121.51 133.84 66.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.574 0.226 . . . . 0.0 110.813 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.403 ' C ' ' OD1' ' A' ' 16' ' ' ASP . 62.3 t0 -66.24 120.15 12.75 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.934 0.397 . . . . 0.0 110.383 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -104.43 -136.12 8.7 Favored Glycine 0 CA--C 1.535 1.337 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.374 -178.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.97 151.54 45.15 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.581 2.187 . . . . 0.0 112.693 -178.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -107.85 128.93 55.04 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.965 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.835 ' CD2' HD11 ' A' ' 37' ' ' ILE . 59.8 t80 -97.67 106.36 32.83 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.053 -178.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.85 128.13 9.87 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 121.703 1.602 . . . . 0.0 111.405 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.762 HD11 HD11 ' A' ' 7' ' ' LEU . 97.5 mt -83.39 84.0 7.67 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.381 -0.528 . . . . 0.0 111.552 -178.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 57.2 p -83.44 -13.66 54.27 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.516 HD11 ' CD ' ' B' ' 265' ' ' GLN . 58.6 mt -99.55 142.57 30.85 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.963 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 27.1 m -69.48 -10.44 58.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.646 -178.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 29.2 m -132.16 132.56 43.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.757 0.313 . . . . 0.0 110.57 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.6 t -128.1 123.68 35.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.508 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.456 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 54.7 tp -117.45 131.67 56.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.017 -179.058 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.423 ' CE2' HG13 ' A' ' 37' ' ' ILE . 32.1 m-85 -110.33 135.91 50.32 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 155.81 -164.38 32.18 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 120.367 -0.921 . . . . 0.0 112.328 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.62 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 47.6 ptt85 -119.18 19.54 12.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.651 -0.275 . . . . 0.0 110.352 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.63 ' O ' ' N ' ' A' ' 34' ' ' GLU . . . -88.32 29.74 5.53 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.588 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 1.7 tp 55.63 -61.85 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 O-C-N 123.849 0.382 . . . . 0.0 111.163 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.63 ' N ' ' O ' ' A' ' 32' ' ' GLY . 49.8 tp10 -50.46 -9.64 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.415 0.626 . . . . 0.0 109.514 179.575 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.551 ' H ' ' C ' ' A' ' 33' ' ' ILE . 35.1 m -65.42 124.74 23.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.39 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.456 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 60.5 m-20 -60.34 -31.66 70.51 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.835 HD11 ' CD2' ' A' ' 20' ' ' PHE . 42.6 mm -118.95 114.08 43.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 177.456 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.758 HH22 ' NZ ' ' B' ' 264' ' ' LYS . 77.3 mtt85 -103.64 136.09 43.99 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.448 -177.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.668 HD13 ' HE ' ' A' ' 93' ' ' ARG . 97.8 mt -122.58 132.23 71.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 121.006 0.432 . . . . 0.0 110.439 179.559 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -77.27 33.0 0.15 Allowed 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -176.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.71 HD12 ' CZ ' ' A' ' 93' ' ' ARG . 47.4 mt -109.81 134.75 20.54 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 120.091 -0.643 . . . . 0.0 111.546 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.55 -8.23 21.36 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.456 2.104 . . . . 0.0 113.517 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.562 HG21 ' CE2' ' B' ' 241' ' ' PHE . 27.6 m -100.56 3.23 10.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.468 179.36 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.62 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 37.2 t -88.96 132.74 32.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.482 -0.487 . . . . 0.0 109.713 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.8 t -66.02 155.86 35.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.498 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.516 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 40.3 mtmt -63.04 -40.76 98.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.027 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.646 ' O ' ' N ' ' A' ' 49' ' ' CYS . 87.5 mt-30 -115.94 -7.57 11.96 Favored 'General case' 0 N--CA 1.464 0.23 0 O-C-N 123.319 0.387 . . . . 0.0 111.334 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.469 ' C ' ' O ' ' A' ' 47' ' ' GLN . 17.0 t60 15.7 -71.4 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -178.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.646 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.46 133.42 45.15 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -178.49 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -125.36 129.02 49.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.784 178.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 90.5 mt -115.1 134.86 56.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.042 0.449 . . . . 0.0 111.732 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.443 ' CD ' ' NE2' ' A' ' 54' ' ' HIS . 81.5 tt0 -117.59 126.15 52.05 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.338 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.746 HD13 ' HE ' ' A' ' 5' ' ' ARG . 94.9 mt -108.14 118.87 56.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 113.086 0.772 . . . . 0.0 113.086 -178.211 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.443 ' NE2' ' CD ' ' A' ' 52' ' ' GLU . 98.4 m-70 -111.23 138.28 47.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.015 178.81 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 54' ' ' HIS . 78.6 tt0 -40.72 -33.87 0.33 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -179.171 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -63.79 -67.14 0.45 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.696 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.51 ' OE2' ' CD ' ' A' ' 81' ' ' ARG . 0.1 OUTLIER -148.56 -178.97 6.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.203 0.525 . . . . 0.0 111.519 -179.373 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -106.51 126.47 52.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.189 178.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 86.6 mt -116.9 128.6 74.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.429 0.633 . . . . 0.0 112.351 -178.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.623 ' HB2' HD11 ' A' ' 82' ' ' LEU . 24.8 tp -99.85 130.57 46.06 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.499 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -112.61 132.9 54.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.098 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 63.9 t-20 -92.16 106.77 18.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.353 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -98.25 -7.57 28.91 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.44 102.06 4.33 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.039 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.5 m -89.42 -6.52 56.48 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.553 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -102.2 -40.14 6.92 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.126 -179.894 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 56.9 m-20 -142.69 99.04 5.72 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.107 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.531 ' HB2' HG13 ' A' ' 75' ' ' VAL . 51.9 Cg_exo -55.36 146.2 63.25 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.286 1.991 . . . . 0.0 113.546 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.9 m -76.01 144.95 40.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.837 178.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -105.63 139.16 40.64 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.795 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 54.9 t -130.1 134.44 62.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 52.67 33.78 14.54 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.6 27.91 71.8 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.233 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 68.2 m -142.77 138.26 30.32 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 117.626 0.713 . . . . 0.0 111.853 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.531 HG13 ' HB2' ' A' ' 68' ' ' PRO . 3.4 t -68.12 140.8 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.853 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.5 pt -114.16 105.99 19.79 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.063 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.67 178.183 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 20.5 p-10 -74.37 -26.54 60.18 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.131 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.442 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.3 OUTLIER -130.4 178.52 1.69 Allowed Pre-proline 0 C--N 1.33 -0.258 0 C-N-CA 120.866 -0.333 . . . . 0.0 110.62 -179.794 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 31.2 Cg_exo -59.91 141.87 97.42 Favored 'Trans proline' 0 N--CA 1.502 1.985 0 C-N-CA 122.687 2.258 . . . . 0.0 113.158 -179.173 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 47.1 t -133.77 135.92 54.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.725 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.51 ' CD ' ' OE2' ' A' ' 57' ' ' GLU . 88.9 mtm180 -71.91 132.98 45.11 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.057 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.623 HD11 ' HB2' ' A' ' 60' ' ' LEU . 96.1 mt -86.86 136.82 32.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.257 0.551 . . . . 0.0 111.615 -178.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -121.31 148.79 43.85 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.613 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.439 ' CD2' ' C ' ' A' ' 84' ' ' HIS . 7.9 t60 -58.55 125.76 24.73 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.029 0.442 . . . . 0.0 110.291 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.57 -17.44 42.91 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.809 -0.917 . . . . 0.0 110.809 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -67.74 140.39 56.72 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.101 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.537 ' O ' HG13 ' A' ' 87' ' ' VAL . 12.1 p -112.33 127.96 69.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.476 -178.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 88.0 mt -92.81 130.59 41.67 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 177.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.1 m -125.85 128.9 48.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.975 0.893 . . . . 0.0 113.111 -178.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.546 ' O ' ' C ' ' A' ' 91' ' ' ILE . 95.9 mt -114.44 137.81 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 114.004 -1.453 . . . . 0.0 108.217 178.738 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.546 ' C ' ' O ' ' A' ' 90' ' ' ILE . 87.4 mt 17.02 -85.74 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 O-C-N 123.645 0.591 . . . . 0.0 111.771 -178.425 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.499 ' N ' ' O ' ' A' ' 90' ' ' ILE . 53.9 t0 -121.63 14.33 10.97 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 120.315 -0.554 . . . . 0.0 112.023 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.71 ' CZ ' HD12 ' A' ' 41' ' ' LEU . 45.1 mtm-85 -129.31 140.75 51.3 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.642 -0.423 . . . . 0.0 109.974 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.681 ' OG ' HD12 ' A' ' 10' ' ' ILE . 55.0 p -139.14 153.96 48.04 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.124 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -127.13 126.84 43.6 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.746 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -84.34 129.36 34.88 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.85 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.557 ' CE2' ' OD1' ' A' ' 99' ' ' ASN . 88.8 t80 -89.63 123.86 34.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.951 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -134.12 113.24 11.85 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.076 0.465 . . . . 0.0 111.146 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.557 ' OD1' ' CE2' ' A' ' 97' ' ' TYR . 99.1 m-20 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.152 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 N--CA 1.487 1.14 0 CA-C-O 121.588 0.578 . . . . 0.0 113.098 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.553 ' CG2' HG22 ' A' ' 66' ' ' THR . 55.0 t -65.22 137.14 25.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 114.585 -1.189 . . . . 0.0 111.156 -179.245 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 237' ' ' CYS . . . . . 0.497 ' SG ' HG23 ' A' ' 91' ' ' ILE . 5.9 t . . . . . 0 C--N 1.331 -0.214 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo . . . . . 0 N--CA 1.492 1.425 0 CA-C-O 120.443 0.101 . . . . 0.0 112.266 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 21.9 p -74.18 -41.19 61.85 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 121.188 0.518 . . . . 0.0 109.835 178.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.562 ' CE2' HG21 ' A' ' 43' ' ' VAL . 84.5 t80 -58.22 -45.56 87.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.964 -179.302 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 89.1 mt -64.18 -40.46 96.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.658 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -61.81 -40.55 95.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.027 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 80.4 mtt85 -62.16 -42.52 99.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.168 0.509 . . . . 0.0 109.994 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.923 ' O ' HG23 ' B' ' 249' ' ' VAL . 78.0 mtp85 -61.98 -41.95 98.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.657 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -61.92 -43.32 99.09 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.274 -0.57 . . . . 0.0 110.398 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 46.9 t -65.97 -45.22 82.48 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.18 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -63.43 -34.49 77.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.012 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 249' ' ' VAL . . . . . 0.923 HG23 ' O ' ' B' ' 245' ' ' ARG . 59.8 t . . . . . 0 C--N 1.33 -0.278 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.127 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.585 ' OE1' HD21 ' A' ' 41' ' ' LEU . 97.1 mt-10 . . . . . 0 N--CA 1.457 -0.077 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 61.6 mt -109.33 132.41 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 75.2 t -127.87 137.08 58.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.282 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 263' ' ' PHE . . . . . 0.578 ' CD2' HD13 ' B' ' 267' ' ' ILE . 67.1 m-85 -98.61 120.48 39.11 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.052 -177.733 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 264' ' ' LYS . . . . . 0.758 ' NZ ' HH22 ' A' ' 38' ' ' ARG . 64.6 tttp -65.18 -48.07 74.73 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.924 178.741 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 265' ' ' GLN . . . . . 0.516 ' CD ' HD11 ' A' ' 24' ' ' LEU . 0.4 OUTLIER -85.5 172.04 9.48 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.281 -178.809 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -58.08 143.98 95.62 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.343 2.029 . . . . 0.0 112.943 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 267' ' ' ILE . . . . . 0.578 HD13 ' CD2' ' B' ' 263' ' ' PHE . 18.5 tt . . . . . 0 N--CA 1.448 -0.569 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.361 179.216 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.9 p . . . . . 0 N--CA 1.456 -0.136 0 CA-C-O 120.874 0.369 . . . . 0.0 111.014 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.688 ' NH2' HG21 ' A' ' 53' ' ' ILE . 91.4 mtm-85 -99.76 124.43 45.02 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.02 -178.641 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -133.74 144.81 49.32 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.261 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.562 HD11 HD11 ' A' ' 22' ' ' LEU . 69.4 mt -111.73 138.96 47.61 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.855 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.8 t -112.29 125.88 69.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.982 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.3 m -74.93 138.65 42.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.916 -178.693 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.614 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 98.5 mt -109.89 132.86 56.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.547 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -90.38 157.25 17.71 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.479 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.53 ' NH1' ' CD ' ' B' ' 260' ' ' GLU . 93.2 mtm-85 -61.31 -23.49 65.75 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.048 -179.28 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.5 m -76.08 -16.6 59.89 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.552 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.06 33.26 7.03 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.596 -1.001 . . . . 0.0 110.596 -179.331 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 37.0 t -117.64 131.82 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-O 120.573 0.225 . . . . 0.0 111.499 -179.521 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -74.02 136.65 43.14 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 178.376 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -130.46 -119.95 2.17 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.308 -179.169 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -72.95 150.16 48.46 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 122.464 2.109 . . . . 0.0 112.646 -178.748 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -112.38 156.96 21.63 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.306 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.625 ' CD2' HD11 ' A' ' 37' ' ' ILE . 46.9 t80 -123.13 103.99 35.67 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.143 -179.261 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -71.49 127.24 13.01 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 121.622 1.548 . . . . 0.0 111.929 -179.414 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.562 HD11 HD11 ' A' ' 7' ' ' LEU . 98.3 mt -84.31 48.83 1.55 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -178.295 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 94.3 p -61.35 -24.33 66.38 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.728 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.625 HD11 ' CD ' ' B' ' 265' ' ' GLN . 73.3 mt -77.36 139.76 39.81 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.667 179.485 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 91.8 p -66.18 -18.96 65.67 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.165 -179.302 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.428 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 40.4 m -132.8 132.83 42.63 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.024 -179.777 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.46 ' HB2' HD22 ' A' ' 22' ' ' LEU . 3.7 t -125.27 118.33 25.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.847 178.96 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.423 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 39.7 tp -116.82 128.55 55.38 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.055 -178.646 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.713 ' CE2' HD12 ' A' ' 37' ' ' ILE . 4.5 m-85 -107.58 141.06 39.62 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.158 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 158.13 -168.76 34.65 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 120.033 -1.079 . . . . 0.0 112.615 179.016 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.6 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 86.5 mtm-85 -81.23 -31.1 33.99 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-O 121.005 0.431 . . . . 0.0 110.185 179.687 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.485 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -50.56 142.07 16.37 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 115.745 -0.662 . . . . 0.0 112.39 -177.979 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.477 HD13 ' CZ ' ' A' ' 38' ' ' ARG . 38.8 mm -65.67 -43.65 93.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.276 0.56 . . . . 0.0 109.492 179.087 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.3 tp10 -57.8 -19.38 28.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.973 -179.637 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 34.9 m -59.69 130.9 49.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.42 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.428 ' OD2' ' O ' ' A' ' 26' ' ' THR . 54.6 m-20 -60.78 -33.83 73.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.838 -179.351 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.713 HD12 ' CE2' ' A' ' 29' ' ' PHE . 89.7 mt -127.84 120.66 54.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 177.48 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.477 ' CZ ' HD13 ' A' ' 33' ' ' ILE . 81.4 mtp180 -103.12 137.02 41.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.824 -178.722 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 98.4 mt -118.26 127.55 75.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.805 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -73.16 31.92 0.07 Allowed 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -177.405 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.872 HD21 ' OE1' ' B' ' 260' ' ' GLU . 88.2 mt -108.45 132.09 21.34 Favored Pre-proline 0 C--N 1.325 -0.482 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.012 179.657 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.37 -9.79 23.38 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.459 2.106 . . . . 0.0 112.797 179.742 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.2 m -95.03 2.62 9.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.512 -0.475 . . . . 0.0 109.801 179.51 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.6 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 21.0 t -88.57 131.6 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.602 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.632 ' OG ' ' N ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -66.42 167.48 10.57 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.325 0.583 . . . . 0.0 111.798 -177.897 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -61.37 -45.84 92.68 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.423 -178.746 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.622 ' O ' ' N ' ' A' ' 49' ' ' CYS . 86.1 mt-30 -113.62 -15.71 12.47 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.557 178.825 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.632 ' N ' ' OG ' ' A' ' 45' ' ' SER . 16.8 t60 34.93 -76.61 0.0 OUTLIER 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.067 -0.969 . . . . 0.0 113.604 179.765 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.622 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -129.56 134.41 47.72 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.367 0.603 . . . . 0.0 112.294 -178.433 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -125.67 132.23 52.46 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.845 178.67 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.2 mt -116.46 134.26 60.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.927 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -117.83 122.97 44.78 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.562 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.688 HG21 ' NH2' ' A' ' 5' ' ' ARG . 72.7 mt -105.27 115.8 47.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.419 0.628 . . . . 0.0 111.476 -178.861 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.46 ' O ' ' N ' ' A' ' 56' ' ' GLN . 87.2 m-70 -114.79 144.86 42.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.816 -1.083 . . . . 0.0 109.868 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.8 mm-40 -40.84 -27.15 0.05 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.07 0.462 . . . . 0.0 110.156 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.46 ' N ' ' O ' ' A' ' 54' ' ' HIS . 86.9 mm-40 -68.96 -67.61 0.46 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.151 179.094 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -158.99 -166.37 1.83 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.37 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.34 129.35 55.77 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.195 -179.853 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 90.0 mt -120.48 130.18 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 121.166 0.508 . . . . 0.0 112.338 -178.85 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.412 ' HB2' HD11 ' A' ' 82' ' ' LEU . 36.0 tp -97.71 129.25 44.77 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.156 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -114.61 136.41 53.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.206 179.677 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -97.42 104.87 16.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.97 0.414 . . . . 0.0 111.614 -179.613 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -94.2 -10.5 32.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.68 178.971 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.8 t -76.95 102.94 6.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.225 179.237 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 88.8 p -86.76 -8.7 57.13 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.574 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.82 HG22 HG22 ' B' ' 236' ' ' VAL . 0.2 OUTLIER -95.84 -37.91 10.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.117 0.484 . . . . 0.0 110.019 179.966 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -146.2 95.57 4.71 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.961 179.879 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.0 148.57 76.03 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 122.363 2.042 . . . . 0.0 112.526 -179.652 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 57.1 m -70.29 141.23 52.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.469 179.197 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -98.53 146.71 25.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.562 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.754 ' HB ' HD11 ' A' ' 76' ' ' ILE . 6.1 p -130.55 135.99 59.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.2 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 48.3 32.37 3.14 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 -179.694 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.12 29.57 62.34 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 111.414 -0.674 . . . . 0.0 111.414 -179.836 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.415 ' N ' ' O ' ' A' ' 71' ' ' VAL . 15.0 m -138.87 136.32 35.43 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.817 0.308 . . . . 0.0 111.052 -179.62 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.8 p -64.38 143.81 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 120.931 0.396 . . . . 0.0 111.835 -179.194 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.754 HD11 ' HB ' ' A' ' 71' ' ' VAL . 95.5 mt -107.64 103.51 15.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.036 179.672 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -64.58 -41.84 96.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.519 179.082 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.527 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.4 OUTLIER -137.38 -177.46 0.71 Allowed Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.456 -178.362 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.506 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 35.7 Cg_exo -58.69 145.71 94.71 Favored 'Trans proline' 0 N--CA 1.5 1.885 0 C-N-CA 122.838 2.359 . . . . 0.0 112.779 -179.598 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.3 m -144.48 147.25 19.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.556 179.808 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -77.53 131.82 38.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.807 178.99 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.412 HD11 ' HB2' ' A' ' 60' ' ' LEU . 96.0 mt -84.76 140.52 31.19 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.08 0.467 . . . . 0.0 111.482 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -129.32 151.36 50.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.646 179.58 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.426 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 5.2 t60 -54.42 120.87 7.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.482 -179.656 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.82 -13.8 41.66 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 -179.269 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.513 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 55.1 t0 -70.05 126.38 29.53 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.363 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 71.4 t -103.88 135.02 43.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.625 -178.998 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 84.7 mt -103.91 129.52 55.92 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.769 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 87.5 m -124.53 124.69 42.81 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 119.861 -0.736 . . . . 0.0 112.675 -178.269 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.582 ' O ' ' N ' ' A' ' 93' ' ' ARG . 98.4 mt -111.93 131.54 63.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 114.697 -1.138 . . . . 0.0 107.944 177.942 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.671 HD13 ' HB2' ' B' ' 237' ' ' CYS . 66.0 mt -21.9 97.61 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.585 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.502 ' CG ' ' NE ' ' B' ' 245' ' ' ARG . 3.3 m-20 89.2 -24.9 0.08 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 178.098 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.614 ' NH2' ' O ' ' A' ' 10' ' ' ILE . 6.2 mmm180 -124.15 140.05 53.34 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.532 -179.288 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.498 ' HB3' HD12 ' A' ' 10' ' ' ILE . 46.0 t -141.22 151.59 43.89 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.768 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -128.24 123.14 33.44 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.267 179.323 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -80.08 134.09 36.16 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.289 179.22 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -94.83 123.69 38.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.669 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.404 ' HG3' ' CE1' ' A' ' 84' ' ' HIS . 79.5 tt0 -124.63 122.19 36.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.785 -179.874 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.426 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 59.9 t-20 . . . . . 0 C--N 1.33 -0.244 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.038 179.61 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo . . . . . 0 N--CA 1.493 1.478 0 N-CA-C 113.759 0.638 . . . . 0.0 113.759 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.82 HG22 HG22 ' A' ' 66' ' ' THR . 19.0 t -78.21 131.5 34.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.019 179.968 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 237' ' ' CYS . . . . . 0.671 ' HB2' HD13 ' A' ' 91' ' ' ILE . 3.3 t . . . . . 0 C--N 1.33 -0.25 0 CA-C-O 120.807 0.337 . . . . 0.0 111.268 -179.353 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo . . . . . 0 N--CA 1.494 1.552 0 N-CA-C 113.306 0.464 . . . . 0.0 113.306 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 6.7 p -77.29 -38.25 51.15 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 120.187 -0.605 . . . . 0.0 109.528 177.94 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -58.63 -45.47 89.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.327 179.78 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.588 HD23 ' HE ' ' B' ' 245' ' ' ARG . 95.3 mt -62.6 -41.54 99.03 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 121.161 0.505 . . . . 0.0 110.537 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -67.9 -38.4 82.92 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.571 -179.645 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -61.12 -48.02 83.57 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.502 -178.593 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.588 ' HE ' HD23 ' B' ' 242' ' ' LEU . 52.0 ptt85 -64.64 -37.37 87.36 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.613 -179.303 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -61.21 -39.72 91.28 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.294 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 14.0 t -66.75 -42.3 86.42 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.364 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -58.07 -39.88 79.6 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.853 179.674 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 42.9 t . . . . . 0 CA--C 1.52 -0.21 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.918 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.872 ' OE1' HD21 ' A' ' 41' ' ' LEU . 97.6 mt-10 . . . . . 0 N--CA 1.462 0.163 0 CA-C-O 120.519 0.2 . . . . 0.0 110.84 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 47.6 mt -115.37 137.92 47.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -179.555 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 55.3 t -127.23 133.93 67.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.897 179.223 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -97.31 122.6 40.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.051 0.453 . . . . 0.0 111.348 -178.411 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -66.18 -44.08 85.04 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.359 179.568 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 265' ' ' GLN . . . . . 0.625 ' CD ' HD11 ' A' ' 24' ' ' LEU . 1.5 mt-30 -99.87 170.0 7.32 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.554 -178.723 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.77 154.56 67.56 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.414 2.076 . . . . 0.0 112.017 -179.83 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 45.0 pt . . . . . 0 C--N 1.328 -0.362 0 CA-C-O 121.484 0.659 . . . . 0.0 111.936 -179.147 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 37.1 m . . . . . 0 CA--C 1.52 -0.2 0 CA-C-O 121.017 0.437 . . . . 0.0 110.667 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.58 ' NH1' ' HB2' ' A' ' 58' ' ' ALA . 95.9 mtt-85 -90.76 125.4 35.69 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.749 -178.425 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -134.73 143.93 47.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.871 -179.243 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.717 HD11 HD11 ' A' ' 22' ' ' LEU . 73.1 mt -116.75 142.06 47.41 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.775 179.667 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.7 t -117.19 128.31 74.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.968 0.413 . . . . 0.0 110.279 179.536 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.2 m -74.68 140.8 44.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.354 0.597 . . . . 0.0 112.325 -179.187 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.631 HD12 ' OG ' ' A' ' 94' ' ' SER . 90.0 mt -112.47 134.06 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.838 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -91.6 158.08 16.63 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.193 0.52 . . . . 0.0 111.77 -179.311 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.76 HH11 HH11 ' B' ' 245' ' ' ARG . 86.4 mtm180 -58.21 -30.99 66.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.505 -178.952 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.5 p -78.15 -10.2 59.52 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.601 178.96 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.81 36.17 7.42 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 179.951 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.5 t -118.07 132.74 67.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.01 0.433 . . . . 0.0 111.579 -179.615 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -73.22 128.86 36.68 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.003 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -125.45 -120.68 2.46 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 120.139 -1.029 . . . . 0.0 112.709 -178.797 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -72.01 146.67 47.53 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 122.242 1.962 . . . . 0.0 112.517 -178.202 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -108.71 147.33 32.11 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.94 179.372 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.526 ' CD2' HD11 ' A' ' 37' ' ' ILE . 29.3 t80 -116.87 102.8 52.87 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.578 -179.375 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.61 133.84 17.75 Favored 'Trans proline' 0 N--CA 1.486 1.049 0 C-N-CA 121.122 1.215 . . . . 0.0 110.504 -179.357 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.717 HD11 HD11 ' A' ' 7' ' ' LEU . 92.3 mt -87.64 62.87 7.27 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.723 -177.822 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 80.6 p -70.71 -21.0 62.61 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 177.79 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.698 HD11 ' HG2' ' B' ' 265' ' ' GLN . 71.0 mt -85.03 138.34 32.5 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.339 -179.61 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -62.4 -20.9 64.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.612 -179.12 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.1 m -134.17 135.49 43.11 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.821 -179.827 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.661 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -129.88 122.92 29.57 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.187 178.883 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.531 HD21 ' OE1' ' A' ' 47' ' ' GLN . 35.0 tp -120.98 126.8 50.87 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.7 -178.688 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.661 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 36.3 m-85 -99.74 127.16 45.88 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.134 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -176.39 -156.16 14.77 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.499 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -115.46 -17.67 11.17 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 117.174 0.487 . . . . 0.0 110.415 179.13 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.23 161.88 47.35 Favored Glycine 0 CA--C 1.519 0.337 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -179.656 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.526 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.8 tp -66.04 -41.63 90.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.408 179.585 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.526 ' N ' HG23 ' A' ' 33' ' ' ILE . 15.0 pt-20 -56.86 -22.77 39.41 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.801 -179.727 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.7 m -63.23 126.3 26.96 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.874 0.369 . . . . 0.0 110.706 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.611 ' OD1' ' N ' ' A' ' 37' ' ' ILE . 11.0 p-10 -61.97 -28.89 69.87 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.096 -179.316 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.611 ' N ' ' OD1' ' A' ' 36' ' ' ASP . 97.5 mt -130.55 122.42 52.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 177.724 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 75.0 mtm180 -103.82 136.24 43.88 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.198 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.572 HG21 HD12 ' A' ' 41' ' ' LEU . 97.2 mt -117.66 129.23 74.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.857 179.748 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -70.52 32.4 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.814 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.58 HD23 ' NH2' ' B' ' 245' ' ' ARG . 43.4 mt -110.33 121.77 40.52 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 120.446 -0.502 . . . . 0.0 109.668 179.043 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.02 -1.47 10.92 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.244 1.963 . . . . 0.0 112.351 -178.809 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.433 HG23 HG13 ' A' ' 91' ' ' ILE . 18.3 m -99.2 6.73 9.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.323 179.813 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.499 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 29.6 t -89.96 133.94 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.25 178.797 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.479 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 0.6 OUTLIER -67.04 159.56 28.43 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.02 0.438 . . . . 0.0 110.551 179.514 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -61.77 -39.16 90.67 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.273 -178.817 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.606 ' O ' ' N ' ' A' ' 49' ' ' CYS . 96.3 mm-40 -111.53 -18.22 12.88 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.46 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.479 ' H ' ' HB3' ' A' ' 45' ' ' SER . 19.4 t60 29.96 -78.85 0.0 OUTLIER 'General case' 0 C--O 1.236 0.377 0 CA-C-N 114.716 -1.129 . . . . 0.0 113.124 -179.683 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.606 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -129.47 134.21 47.69 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.914 -179.342 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -125.66 128.49 47.91 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.223 179.364 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 93.0 mt -114.54 133.31 61.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.787 -179.849 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -113.27 133.68 54.98 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.807 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.562 HD12 ' CD ' ' A' ' 5' ' ' ARG . 47.9 mm -103.14 114.5 42.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.558 -179.462 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.44 ' O ' ' C ' ' A' ' 55' ' ' GLU . 95.0 m-70 -115.47 132.8 56.51 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.473 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 54' ' ' HIS . 95.4 mt-10 -40.47 -34.13 0.32 Allowed 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 121.195 0.522 . . . . 0.0 109.92 -178.673 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -62.75 -67.32 0.43 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.233 179.418 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -152.43 -164.38 1.94 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.333 -179.63 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.58 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -127.28 131.18 50.56 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.011 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 91.7 mt -112.32 129.9 67.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.255 0.55 . . . . 0.0 112.205 -178.237 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.548 ' HB2' HD21 ' A' ' 82' ' ' LEU . 44.3 tp -94.46 120.22 34.37 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.224 179.028 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -107.85 135.05 49.9 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.962 0.41 . . . . 0.0 111.336 -178.823 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -96.14 104.91 16.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.246 179.627 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -99.31 -10.84 21.82 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.614 179.549 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.4 t -69.61 100.87 1.52 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.538 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.9 p -85.01 -15.96 42.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.038 0.447 . . . . 0.0 109.924 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.586 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -90.24 -46.13 8.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.752 -179.852 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.459 HD21 ' HA ' ' B' ' 236' ' ' VAL . 65.5 m-20 -135.08 97.71 13.38 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.283 -0.872 . . . . 0.0 109.456 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.502 ' HB2' HG13 ' A' ' 75' ' ' VAL . 41.2 Cg_exo -56.74 144.64 86.22 Favored 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 122.501 2.134 . . . . 0.0 113.612 -178.838 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.0 m -75.36 140.39 43.0 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.264 178.756 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -104.3 141.42 36.34 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.321 179.938 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.641 HG13 ' OD1' ' A' ' 86' ' ' ASP . 53.0 t -131.92 135.29 58.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.739 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 51.92 31.96 9.26 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -178.399 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.31 27.48 69.79 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.095 -179.924 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.5 p -140.39 140.83 35.57 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 117.608 0.704 . . . . 0.0 111.696 179.776 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.502 HG13 ' HB2' ' A' ' 68' ' ' PRO . 41.5 t -68.87 135.83 27.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.041 179.451 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.478 HG21 HG21 ' A' ' 80' ' ' VAL . 7.4 pt -113.34 82.22 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.974 0.416 . . . . 0.0 110.696 178.588 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -61.62 -24.69 66.87 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.441 179.885 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -118.79 167.36 11.88 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.997 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -62.46 145.54 95.6 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 122.386 2.058 . . . . 0.0 112.568 179.63 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.478 HG21 HG21 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -139.34 140.01 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 120.822 0.344 . . . . 0.0 110.996 179.291 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -74.77 133.18 42.01 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.456 179.519 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.548 HD21 ' HB2' ' A' ' 60' ' ' LEU . 95.6 mt -79.23 134.9 36.66 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.196 0.522 . . . . 0.0 110.92 -179.596 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -129.52 150.18 50.98 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.385 179.479 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -52.32 113.63 1.1 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.501 -179.852 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.29 -11.16 19.69 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.641 ' OD1' HG13 ' A' ' 71' ' ' VAL . 52.4 t0 -68.96 123.6 21.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.205 0.526 . . . . 0.0 110.998 -179.713 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.6 t -108.94 130.89 61.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.71 -179.572 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 83.9 mt -104.46 133.2 49.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.726 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 82.8 m -120.61 129.45 53.74 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.6 0.714 . . . . 0.0 112.491 -178.53 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.464 ' O ' ' N ' ' A' ' 93' ' ' ARG . 89.5 mt -121.13 122.59 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 114.501 -1.227 . . . . 0.0 108.1 178.235 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.433 HG13 HG23 ' A' ' 43' ' ' VAL . 36.8 mm 40.73 -112.45 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.016 -178.831 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.42 ' OD1' HD22 ' B' ' 242' ' ' LEU . 97.6 m-20 -103.16 10.88 37.62 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.544 0.211 . . . . 0.0 111.05 179.079 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.673 ' CZ ' HD11 ' B' ' 261' ' ' ILE . 6.5 mmm180 -120.76 143.97 48.53 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.674 -179.123 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.631 ' OG ' HD12 ' A' ' 10' ' ' ILE . 39.1 p -142.26 155.76 45.25 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.904 0.383 . . . . 0.0 110.838 -179.96 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -128.0 124.99 38.56 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.273 179.35 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -86.95 133.67 33.57 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.505 0.193 . . . . 0.0 110.827 -179.737 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.54 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 69.6 t80 -93.96 123.79 37.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.893 179.886 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -123.85 128.83 50.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.42 -179.923 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 . . . . . 0 C--N 1.326 -0.447 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.147 178.992 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo . . . . . 0 N--CA 1.49 1.28 0 CA-C-O 121.485 0.535 . . . . 0.0 112.784 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.586 ' CG2' HG22 ' A' ' 66' ' ' THR . 27.8 t -72.08 137.29 23.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.782 -179.771 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 8.0 t . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.175 -179.628 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo . . . . . 0 N--CA 1.499 1.829 0 CA-C-O 120.881 0.284 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 99.8 m -73.04 -45.16 59.13 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.714 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -55.17 -45.31 75.74 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.875 -179.575 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.42 HD22 ' OD1' ' A' ' 92' ' ' ASP . 89.6 mt -63.11 -42.6 99.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.791 -179.185 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -65.3 -42.18 93.32 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.368 -179.024 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -61.98 -44.88 95.8 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.167 0.508 . . . . 0.0 110.509 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.76 HH11 HH11 ' A' ' 12' ' ' ARG . 49.5 ttm-85 -64.78 -41.49 95.81 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.682 -179.345 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -60.74 -38.17 84.26 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.708 0.29 . . . . 0.0 110.532 179.398 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 88.3 p -69.29 -40.56 77.65 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.528 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -58.64 -37.53 76.13 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.66 178.78 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 54.1 t . . . . . 0 CA--C 1.528 0.105 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.262 178.824 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.455 ' C ' HD13 ' B' ' 261' ' ' ILE . 47.4 mm-40 . . . . . 0 CA--C 1.544 0.727 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.673 HD11 ' CZ ' ' A' ' 93' ' ' ARG . 2.7 mm -114.05 133.28 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-N 119.334 0.97 . . . . 0.0 110.223 178.854 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 52.6 t -126.5 133.23 69.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.159 178.894 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -100.41 122.02 42.47 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.191 0.52 . . . . 0.0 111.266 -178.637 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -63.3 -47.62 81.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.222 179.432 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 265' ' ' GLN . . . . . 0.698 ' HG2' HD11 ' A' ' 24' ' ' LEU . 4.1 mp0 -96.47 161.57 26.38 Favored Pre-proline 0 N--CA 1.453 -0.314 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.474 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.98 150.18 37.87 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 123.035 2.49 . . . . 0.0 112.585 -178.877 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 28.5 pt . . . . . 0 C--N 1.325 -0.497 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.248 178.926 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.8 p . . . . . 0 C--O 1.231 0.105 0 CA-C-O 121.013 0.435 . . . . 0.0 110.108 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.803 ' NH1' ' HB2' ' A' ' 58' ' ' ALA . 94.6 mtt-85 -98.02 113.53 25.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.136 -179.585 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -127.62 138.18 52.77 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.92 0.39 . . . . 0.0 111.331 -179.711 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.527 HD12 ' O ' ' A' ' 96' ' ' ARG . 42.3 tp -117.41 129.94 56.17 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.586 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.1 t -106.15 130.8 57.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.911 -179.536 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 m -92.2 114.81 27.45 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.253 -179.635 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.2 mt -80.96 145.66 8.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.516 179.359 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -88.13 161.69 17.16 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.076 0.465 . . . . 0.0 111.169 -179.866 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.708 HH11 ' NH2' ' A' ' 93' ' ' ARG . 58.0 mtp85 -55.21 -32.59 62.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.458 -179.445 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 42.9 t -80.74 -6.67 58.77 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.859 179.502 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.57 33.86 12.72 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -179.527 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.8 t -114.16 132.75 62.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.724 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 63.0 t0 -65.31 120.69 13.23 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.865 -179.448 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -107.88 -133.56 7.12 Favored Glycine 0 CA--C 1.536 1.366 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 -179.279 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.73 149.88 49.26 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 122.106 1.87 . . . . 0.0 112.341 -179.21 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -105.78 139.23 40.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.891 0.377 . . . . 0.0 109.991 179.493 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.775 ' CD2' HD11 ' A' ' 37' ' ' ILE . 24.6 t80 -111.45 103.5 55.1 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.684 -179.614 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.69 132.16 16.91 Favored 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 121.437 1.425 . . . . 0.0 111.972 -179.216 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 75.5 mt -87.5 45.98 1.33 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.887 -178.728 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 79.2 p -65.22 -17.82 64.81 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.276 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.5 mt -81.38 143.0 32.48 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.27 178.518 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.0 t -64.8 -23.65 67.3 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -178.872 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 66.3 m -135.03 136.87 42.44 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.56 -179.505 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.8 t -130.02 121.78 27.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.066 178.924 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.443 HD21 ' NE2' ' A' ' 47' ' ' GLN . 59.6 tp -116.78 127.65 54.54 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.579 -179.269 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.671 ' CE2' HD12 ' A' ' 37' ' ' ILE . 7.6 m-85 -104.86 141.3 36.77 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.291 178.915 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 156.33 -174.24 34.15 Favored Glycine 0 N--CA 1.469 0.867 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.415 178.922 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.636 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 83.2 mtm-85 -78.62 -29.3 45.86 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.168 179.56 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.553 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -54.47 148.98 19.94 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.643 -178.759 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.509 HG23 ' N ' ' A' ' 34' ' ' GLU . 11.1 tp -67.78 -40.81 84.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.084 0.469 . . . . 0.0 110.023 179.512 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.509 ' N ' HG23 ' A' ' 33' ' ' ILE . 80.1 mm-40 -54.4 -21.8 10.69 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.773 179.546 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.553 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 58.8 m -55.64 118.62 4.68 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.93 179.553 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -55.89 -29.69 60.38 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 179.936 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.775 HD11 ' CD2' ' A' ' 20' ' ' PHE . 73.0 mt -128.48 120.55 53.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.36 176.226 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 78.2 ttt-85 -108.35 137.26 46.61 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.602 -177.898 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.786 HG21 HD12 ' A' ' 41' ' ' LEU . 96.2 mt -121.45 132.09 71.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.4 -179.54 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -80.94 32.21 0.32 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -177.962 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.786 HD12 HG21 ' A' ' 39' ' ' ILE . 16.4 mt -97.2 133.54 23.87 Favored Pre-proline 0 C--N 1.32 -0.691 0 C-N-CA 120.049 -0.661 . . . . 0.0 110.711 -179.938 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.12 -10.41 25.88 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 122.364 2.043 . . . . 0.0 112.221 -179.746 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.556 HG21 ' CE2' ' B' ' 241' ' ' PHE . 32.2 m -105.47 4.05 10.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.269 -179.384 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.636 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 17.4 t -88.77 131.15 36.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 177.714 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.77 163.16 19.87 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.082 0.467 . . . . 0.0 110.812 -178.858 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -61.38 -40.9 96.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.013 -178.8 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.608 ' O ' ' N ' ' A' ' 49' ' ' CYS . 12.3 mm100 -110.31 -17.0 13.6 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 123.573 0.546 . . . . 0.0 110.299 -179.852 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 21.7 t60 33.09 -75.73 0.0 OUTLIER 'General case' 0 C--O 1.239 0.525 0 CA-C-N 114.943 -1.026 . . . . 0.0 113.634 -179.601 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.608 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -135.48 139.77 44.3 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -178.299 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -127.57 133.52 49.76 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.633 179.707 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.0 mt -119.04 134.14 63.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.082 -179.855 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -116.63 127.75 54.75 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.065 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.3 mt -109.46 111.52 36.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.473 0.654 . . . . 0.0 111.218 -179.756 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.548 ' O ' ' N ' ' A' ' 56' ' ' GLN . 94.8 m-70 -110.51 143.18 41.25 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.801 -1.09 . . . . 0.0 108.984 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.557 ' OE1' ' N ' ' A' ' 55' ' ' GLU . 55.1 mp0 -40.65 -24.44 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.853 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.548 ' N ' ' O ' ' A' ' 54' ' ' HIS . 88.8 mm-40 -68.16 -69.26 0.33 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.07 179.044 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.445 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 5.5 tp10 -158.91 -168.31 2.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.987 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.803 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -109.73 126.09 53.36 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.099 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.29 130.25 70.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.467 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.497 ' HB2' HD21 ' A' ' 82' ' ' LEU . 26.6 tp -98.66 130.21 45.16 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.429 179.724 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -117.47 137.65 52.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.857 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.58 HD21 ' CB ' ' A' ' 68' ' ' PRO . 64.1 t-20 -98.08 104.68 16.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.08 179.805 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -96.27 -7.28 35.88 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.864 179.342 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.38 100.81 10.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.984 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.1 m -87.08 -37.69 17.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.677 179.75 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.583 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -61.08 -44.11 97.86 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.418 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -141.23 101.23 6.24 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.119 179.415 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.58 ' CB ' HD21 ' A' ' 62' ' ' ASN . 44.5 Cg_endo -67.76 152.32 77.76 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 121.676 1.584 . . . . 0.0 113.602 -178.242 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.5 m -77.38 149.11 35.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.775 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -111.99 140.53 46.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.345 179.404 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.5 t -128.5 136.32 60.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.598 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 53.65 32.97 15.52 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.225 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.98 25.93 74.88 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.437 -179.759 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 66.7 m -141.14 141.78 34.12 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 117.114 0.457 . . . . 0.0 111.856 -179.564 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 75.2 t -67.91 139.14 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.687 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 9.2 pt -111.2 82.63 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-O 121.126 0.488 . . . . 0.0 111.049 178.55 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -62.56 -32.79 73.82 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.98 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -113.95 156.95 43.21 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.834 178.676 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.6 152.39 80.55 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.18 1.92 . . . . 0.0 111.582 178.928 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.1 m -146.89 149.0 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 121.28 0.562 . . . . 0.0 112.03 179.89 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -72.4 133.68 45.02 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.871 179.678 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.497 HD21 ' HB2' ' A' ' 60' ' ' LEU . 96.4 mt -77.26 137.94 39.11 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.098 0.475 . . . . 0.0 110.767 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -128.56 147.12 50.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.514 179.535 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.523 ' HD1' ' C ' ' A' ' 99' ' ' ASN . 6.8 t60 -56.06 118.99 5.17 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.579 -179.525 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.27 -20.04 23.9 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -179.801 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -66.44 131.18 45.49 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.595 179.305 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.6 t -114.86 131.35 67.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.159 -178.501 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 84.6 mt -95.05 133.75 34.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.725 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.0 m -120.7 128.38 52.9 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.62 0.724 . . . . 0.0 112.574 -178.833 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.543 ' O ' ' N ' ' A' ' 92' ' ' ASP . 97.5 mt -115.06 123.4 70.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 114.559 -1.2 . . . . 0.0 108.664 178.54 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.457 ' CG2' ' CZ ' ' B' ' 245' ' ' ARG . 32.2 mm 38.71 -93.25 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.35 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.78 ' H ' ' NH1' ' B' ' 245' ' ' ARG . 16.9 t0 -125.97 20.16 7.68 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.011 0.434 . . . . 0.0 110.86 179.139 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.754 ' CZ ' HD11 ' A' ' 41' ' ' LEU . 75.5 mtt85 -124.85 142.57 51.35 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.351 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 30.2 p -139.61 154.73 47.64 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.96 179.763 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.505 ' HE1' HD12 ' A' ' 90' ' ' ILE . 17.1 m-85 -125.16 121.96 35.72 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.035 179.54 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.527 ' O ' HD12 ' A' ' 7' ' ' LEU . 39.1 ttp-105 -85.08 130.67 34.57 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.125 -0.63 . . . . 0.0 110.713 -179.256 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.63 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 87.7 t80 -94.66 123.67 38.24 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.962 -179.556 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -121.41 122.88 40.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.962 179.647 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.523 ' C ' ' HD1' ' A' ' 84' ' ' HIS . 54.7 t-20 . . . . . 0 C--N 1.328 -0.37 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.976 179.001 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 N--CA 1.491 1.38 0 N-CA-C 113.997 0.73 . . . . 0.0 113.997 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.583 ' CG2' HG22 ' A' ' 66' ' ' THR . 39.4 t -76.0 133.62 30.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 114.781 -1.1 . . . . 0.0 110.998 -179.454 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 7.6 t . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.675 179.367 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo . . . . . 0 N--CA 1.496 1.63 0 N-CA-C 112.671 0.219 . . . . 0.0 112.671 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 97.2 m -74.08 -42.52 60.04 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.857 0.361 . . . . 0.0 110.161 178.664 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.556 ' CE2' HG21 ' A' ' 43' ' ' VAL . 64.1 t80 -58.02 -45.75 86.41 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -179.54 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 87.2 mt -62.61 -40.86 98.3 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.177 179.964 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -61.52 -39.72 92.04 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.713 179.609 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 244' ' ' ARG . . . . . 0.45 ' HE ' ' HA ' ' B' ' 241' ' ' PHE . 88.7 mtm180 -62.08 -40.38 95.62 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.77 179.69 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.78 ' NH1' ' H ' ' A' ' 92' ' ' ASP . 89.4 mtt180 -60.1 -42.48 94.79 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.224 179.084 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -64.23 -42.79 96.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.016 0.436 . . . . 0.0 110.488 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 35.8 p -63.86 -44.86 91.85 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.73 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -58.58 -40.29 82.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.965 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 249' ' ' VAL . . . . . 0.489 HG23 ' O ' ' B' ' 245' ' ' ARG . 55.3 t . . . . . 0 C--N 1.327 -0.372 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.267 -179.885 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.514 ' OE1' ' NH2' ' A' ' 93' ' ' ARG . 94.6 mt-10 . . . . . 0 CA--C 1.531 0.236 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 68.6 mt -108.24 132.16 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.757 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 53.4 t -128.25 134.39 65.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.805 -178.609 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -99.54 121.92 41.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.51 0.671 . . . . 0.0 111.176 -178.955 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -67.06 -44.88 79.0 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.902 178.874 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -92.76 150.63 39.91 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.706 -178.235 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.84 143.98 47.1 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 122.86 2.373 . . . . 0.0 112.581 179.999 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 33.3 pt . . . . . 0 C--N 1.33 -0.265 0 CA-C-O 121.04 0.448 . . . . 0.0 110.7 179.209 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.2 p . . . . . 0 C--O 1.231 0.122 0 CA-C-O 121.165 0.507 . . . . 0.0 110.064 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.624 ' NH1' ' HB2' ' A' ' 58' ' ' ALA . 96.3 mtt-85 -89.47 124.5 34.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.922 -179.858 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -134.43 139.39 45.52 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.287 -0.565 . . . . 0.0 112.322 -179.342 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.445 HD11 HD11 ' A' ' 22' ' ' LEU . 75.7 mt -113.55 143.56 44.33 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.072 178.718 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.536 HG22 ' CD2' ' A' ' 19' ' ' HIS . 70.3 t -117.03 128.93 74.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.224 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.4 ' O ' HG22 ' A' ' 9' ' ' THR . 1.5 m -92.87 113.87 26.26 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.132 0.492 . . . . 0.0 112.076 -178.436 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 86.8 mt -79.19 143.86 11.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.784 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -89.54 161.6 16.12 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.223 0.535 . . . . 0.0 110.9 179.64 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.437 HH22 ' NE2' ' B' ' 248' ' ' GLN . 80.9 mtp180 -58.19 -33.41 69.23 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.802 -179.326 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.7 t -76.02 -13.11 60.23 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.706 179.218 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.39 35.05 5.83 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 -178.878 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.0 t -119.04 132.42 68.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.092 0.472 . . . . 0.0 110.966 -179.9 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.48 ' OD1' ' CG1' ' A' ' 8' ' ' VAL . 43.6 t0 -68.5 124.98 25.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.749 179.581 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -117.58 -126.41 3.72 Favored Glycine 0 CA--C 1.541 1.673 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.225 -178.916 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.29 147.88 42.76 Favored 'Trans proline' 0 N--CA 1.504 2.107 0 C-N-CA 122.741 2.294 . . . . 0.0 114.523 -177.808 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.536 ' CD2' HG22 ' A' ' 8' ' ' VAL . 60.1 m170 -104.77 144.73 31.34 Favored 'General case' 0 C--N 1.335 -0.059 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.08 179.37 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.473 ' CD2' HD11 ' A' ' 37' ' ' ILE . 72.1 t80 -121.82 105.44 37.99 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.996 -179.579 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -75.63 132.84 15.02 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 C-N-CA 121.682 1.588 . . . . 0.0 112.292 -179.14 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.445 HD11 HD11 ' A' ' 7' ' ' LEU . 89.6 mt -81.3 54.73 2.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.834 0.349 . . . . 0.0 110.935 -179.253 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.7 t -59.8 -37.58 79.53 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.877 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 66.0 mt -74.02 141.6 45.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.666 179.519 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 m -66.76 -15.23 63.41 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.075 -0.512 . . . . 0.0 112.271 -178.029 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.49 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 40.4 m -136.24 137.87 41.24 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.017 0.437 . . . . 0.0 110.724 179.504 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.668 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 4.3 t -131.58 122.87 26.81 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.908 179.65 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.501 HD21 ' HG2' ' A' ' 47' ' ' GLN . 42.4 tp -119.77 128.16 53.47 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.896 -178.98 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.668 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 14.1 m-85 -104.23 140.33 38.0 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.179 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.95 -171.79 38.81 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 119.647 -1.263 . . . . 0.0 112.764 179.1 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.623 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 85.4 mtm-85 -80.37 -28.08 38.07 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.418 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.55 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -60.68 141.22 48.06 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.3 -0.476 . . . . 0.0 112.287 -178.168 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.492 HG23 ' N ' ' A' ' 34' ' ' GLU . 11.0 tp -66.06 -41.43 89.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.095 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.492 ' N ' HG23 ' A' ' 33' ' ' ILE . 82.5 tt0 -54.52 -16.41 2.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.125 179.839 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.55 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 33.5 m -66.01 135.93 55.35 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.265 179.862 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.49 ' OD2' ' O ' ' A' ' 26' ' ' THR . 56.0 m-20 -61.42 -33.32 73.51 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.38 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.651 HD12 ' CE2' ' A' ' 29' ' ' PHE . 93.4 mt -127.66 122.46 59.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 177.17 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 76.8 ttt-85 -111.26 137.99 48.29 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.607 -178.317 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.452 HG22 ' H ' ' A' ' 41' ' ' LEU . 92.9 mt -119.11 131.87 70.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.846 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -75.13 20.69 0.13 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.686 -178.693 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.538 HD11 ' CZ ' ' A' ' 93' ' ' ARG . 22.7 mt -93.52 124.44 57.21 Favored Pre-proline 0 C--N 1.321 -0.66 0 C-N-CA 120.261 -0.575 . . . . 0.0 111.105 -179.449 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.47 -14.25 27.79 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 C-N-CA 121.901 1.734 . . . . 0.0 112.375 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 18.0 m -88.67 0.62 7.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.135 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.623 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 72.6 t -95.33 136.11 27.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.186 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.4 m -69.39 171.16 9.09 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.322 0.582 . . . . 0.0 111.699 -178.749 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -61.84 -42.11 98.63 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.671 -178.13 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.679 ' O ' ' N ' ' A' ' 49' ' ' CYS . 87.8 mt-30 -113.75 -14.99 12.51 Favored 'General case' 0 CA--C 1.521 -0.155 0 O-C-N 123.365 0.416 . . . . 0.0 110.337 179.873 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 30.1 t60 33.44 -73.11 0.0 OUTLIER 'General case' 0 C--O 1.236 0.393 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 179.654 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.679 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.68 135.35 45.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.06 0.457 . . . . 0.0 111.921 -178.649 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -123.85 128.66 49.82 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.389 179.3 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.4 mt -115.16 134.46 58.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.351 -179.686 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.453 ' CD ' ' NE2' ' A' ' 54' ' ' HIS . 83.9 tt0 -120.01 128.29 53.4 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.782 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.437 HD13 ' HD2' ' A' ' 5' ' ' ARG . 97.0 mt -108.18 118.8 56.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.471 0.653 . . . . 0.0 112.611 -178.549 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.545 ' O ' ' N ' ' A' ' 56' ' ' GLN . 99.0 m-70 -115.3 141.23 48.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.326 178.859 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.6 mm-40 -40.12 -25.94 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.906 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.545 ' N ' ' O ' ' A' ' 54' ' ' HIS . 85.9 mt-30 -65.71 -68.3 0.38 Allowed 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.2 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -159.94 -162.77 1.04 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.905 179.614 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.624 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -114.29 126.44 55.03 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.398 179.147 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.7 mt -112.68 127.9 69.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.441 0.638 . . . . 0.0 111.95 -178.923 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 40.1 tp -95.44 128.85 42.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.955 -179.74 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -115.33 135.8 53.77 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.549 -179.748 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.4 ' OD1' ' C ' ' A' ' 62' ' ' ASN . 51.1 t-20 -95.12 106.22 18.21 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.897 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -100.86 -10.05 21.05 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 179.279 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.3 t -78.85 100.61 7.26 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.269 -179.619 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.4 p -76.95 -33.84 57.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.042 0.448 . . . . 0.0 110.636 178.918 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.82 -40.65 65.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.485 -178.86 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -141.29 93.52 7.96 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.163 -179.726 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.06 145.67 51.94 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.344 2.029 . . . . 0.0 113.053 -179.488 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.2 m -72.65 139.54 47.39 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.338 179.533 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -102.89 139.77 38.03 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.662 179.641 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.648 HG13 ' OD1' ' A' ' 86' ' ' ASP . 75.3 t -133.46 134.43 56.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.097 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 54.79 26.92 8.18 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -178.397 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.53 24.13 66.05 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-N 115.039 -0.982 . . . . 0.0 112.048 179.585 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.2 t -138.48 140.4 39.2 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 117.371 0.585 . . . . 0.0 111.28 179.695 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.47 ' H ' HG12 ' A' ' 75' ' ' VAL . 0.2 OUTLIER -70.99 140.38 18.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.183 179.918 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.2 pt -115.42 91.95 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.122 179.941 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -66.87 -25.72 66.54 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.653 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.19 162.19 27.41 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.505 179.484 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.13 154.16 66.53 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.62 2.213 . . . . 0.0 112.247 179.899 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.9 m -145.65 148.62 17.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.833 -179.781 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.2 mtm-85 -75.65 134.83 40.5 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.158 179.531 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 90.0 mt -89.7 134.02 34.37 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.138 0.495 . . . . 0.0 111.161 -179.677 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -125.1 156.62 37.99 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.052 179.143 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.414 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 4.2 t60 -54.1 120.02 5.87 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.546 -0.461 . . . . 0.0 111.089 -178.701 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.07 -15.65 28.11 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 179.797 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.648 ' OD1' HG13 ' A' ' 71' ' ' VAL . 59.1 t0 -65.41 128.21 34.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.882 0.372 . . . . 0.0 110.422 179.988 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.53 HG22 ' HG2' ' A' ' 96' ' ' ARG . 53.6 t -112.13 130.93 64.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.291 -179.382 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.7 mt -101.64 134.02 43.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.383 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 76.9 m -124.33 129.22 50.34 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -178.53 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.585 ' O ' ' N ' ' A' ' 92' ' ' ASP . 95.0 mt -112.18 126.67 69.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 114.516 -1.22 . . . . 0.0 108.159 177.57 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.527 HG23 ' SG ' ' B' ' 237' ' ' CYS . 45.4 mm 40.19 -92.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 C-N-CA 120.269 -0.572 . . . . 0.0 109.716 -179.257 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.585 ' N ' ' O ' ' A' ' 90' ' ' ILE . 0.7 OUTLIER -129.43 20.48 5.69 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.928 0.395 . . . . 0.0 110.87 179.732 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.717 ' HE ' HH12 ' B' ' 245' ' ' ARG . 98.5 mtt180 -124.31 142.09 51.54 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.326 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 75.6 m -137.55 151.36 48.31 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.203 -179.725 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.455 ' HE1' HD12 ' A' ' 90' ' ' ILE . 62.6 m-85 -121.95 122.33 39.13 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.534 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.53 ' HG2' HG22 ' A' ' 87' ' ' VAL . 98.2 mtt180 -84.95 133.96 34.26 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 119.638 -0.825 . . . . 0.0 111.375 -178.581 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -95.8 120.08 35.43 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.158 179.532 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -122.31 119.67 31.8 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.263 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.414 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 64.8 t-20 . . . . . 0 C--N 1.326 -0.453 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.333 179.7 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo . . . . . 0 N--CA 1.486 1.05 0 CA-C-O 120.933 0.306 . . . . 0.0 111.607 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 4.9 p -116.85 132.75 65.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.328 -179.664 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 237' ' ' CYS . . . . . 0.527 ' SG ' HG23 ' A' ' 91' ' ' ILE . 45.9 t . . . . . 0 N--CA 1.465 0.294 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.532 -179.256 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo . . . . . 0 N--CA 1.498 1.736 0 N-CA-C 113.53 0.55 . . . . 0.0 113.53 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 5.2 p -73.29 -41.6 63.39 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.026 -0.669 . . . . 0.0 109.305 178.28 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.445 ' HZ ' HD22 ' A' ' 41' ' ' LEU . 57.9 t80 -58.24 -46.65 85.56 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.12 -179.524 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.424 ' HA ' HD23 ' B' ' 242' ' ' LEU . 94.4 mt -62.79 -40.45 97.35 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.605 -179.674 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -63.9 -37.37 87.14 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.271 179.545 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -62.4 -41.75 98.91 Favored 'General case' 0 C--N 1.334 -0.1 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.488 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.841 ' O ' HG23 ' B' ' 249' ' ' VAL . 60.9 ttm-85 -58.07 -44.19 87.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.006 -179.495 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -63.33 -40.4 97.22 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.029 0.442 . . . . 0.0 110.759 -179.475 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 41.8 m -69.0 -46.13 68.81 Favored 'General case' 0 C--N 1.334 -0.104 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.65 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 248' ' ' GLN . . . . . 0.437 ' NE2' HH22 ' A' ' 12' ' ' ARG . 7.0 tt0 -61.78 -36.94 82.52 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.818 -179.55 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 249' ' ' VAL . . . . . 0.841 HG23 ' O ' ' B' ' 245' ' ' ARG . 75.4 t . . . . . 0 N--CA 1.453 -0.288 0 C-N-CA 120.257 -0.577 . . . . 0.0 109.513 179.42 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.637 ' OE1' ' NH2' ' A' ' 93' ' ' ARG . 95.1 mt-10 . . . . . 0 N--CA 1.462 0.137 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 79.4 mt -106.78 132.31 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 177.589 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 47.6 t -126.4 133.09 69.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 120.904 0.383 . . . . 0.0 111.014 -179.15 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -97.88 124.13 42.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.12 -179.297 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -69.36 -45.42 69.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.261 179.457 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.22 155.79 40.73 Favored Pre-proline 0 CA--C 1.521 -0.16 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.201 -179.428 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.85 144.26 70.18 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 122.584 2.189 . . . . 0.0 113.052 -179.664 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 45.0 pt . . . . . 0 C--N 1.331 -0.206 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.87 178.835 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.0 p . . . . . 0 CA--C 1.521 -0.156 0 CA-C-O 120.976 0.417 . . . . 0.0 110.505 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.3 mtt85 -100.12 123.42 44.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.171 -179.616 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -130.01 144.35 51.29 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.685 -179.84 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 83.9 mt -113.18 135.45 53.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.392 179.045 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.6 m -110.79 132.06 60.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-O 120.95 0.405 . . . . 0.0 110.019 179.254 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.7 m -79.97 142.53 34.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.495 -0.775 . . . . 0.0 113.044 -178.193 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.478 HD12 ' HB3' ' A' ' 94' ' ' SER . 96.5 mt -112.15 136.67 47.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.024 176.611 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -90.32 158.94 16.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.842 0.353 . . . . 0.0 110.432 179.754 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -58.45 -30.92 67.3 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.088 -178.875 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.3 p -76.44 -11.58 59.91 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.199 179.594 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.08 35.57 6.02 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -179.635 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 54.0 t -120.14 132.04 70.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.935 0.398 . . . . 0.0 110.816 -179.81 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -81.21 138.41 35.81 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.805 179.624 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -133.42 -116.15 1.68 Allowed Glycine 0 CA--C 1.538 1.517 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.124 -179.718 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.36 153.1 61.35 Favored 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 122.473 2.116 . . . . 0.0 112.849 -178.83 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -116.04 161.68 18.52 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.604 -179.832 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.509 ' CD2' HD11 ' A' ' 37' ' ' ILE . 34.2 t80 -122.88 91.84 49.5 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.417 -179.563 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -59.96 127.63 23.96 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 121.957 1.772 . . . . 0.0 110.564 179.346 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.6 mt -82.02 57.56 3.56 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.566 -0.454 . . . . 0.0 111.233 -179.002 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 89.8 p -67.84 -22.97 65.12 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.576 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 80.2 mt -83.63 138.9 33.13 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.233 179.79 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 92.9 p -64.22 -18.09 64.19 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.03 -179.48 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.495 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 88.0 m -134.37 134.82 42.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.985 179.91 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.666 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 1.4 t -128.21 118.11 22.75 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.235 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.5 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 40.8 tp -117.47 128.73 55.27 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.22 -177.699 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.783 ' CE2' HD12 ' A' ' 37' ' ' ILE . 19.8 m-85 -104.89 135.8 45.57 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.657 179.045 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 164.22 178.62 37.86 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 120.283 -0.961 . . . . 0.0 112.778 179.034 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.424 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 42.3 mtm180 -75.44 -31.1 60.2 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.903 0.382 . . . . 0.0 110.503 178.654 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -50.48 144.86 10.58 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.19 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.455 HG23 ' N ' ' A' ' 34' ' ' GLU . 8.6 tp -66.92 -41.05 87.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.908 -179.585 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.455 ' N ' HG23 ' A' ' 33' ' ' ILE . 84.8 tt0 -58.03 -20.83 41.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.869 0.366 . . . . 0.0 110.813 -179.92 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 62.4 m -57.63 131.52 50.48 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.878 -179.512 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.5 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 56.0 m-20 -60.25 -33.56 72.47 Favored 'General case' 0 C--N 1.334 -0.097 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -178.781 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.783 HD12 ' CE2' ' A' ' 29' ' ' PHE . 84.8 mt -126.12 123.8 64.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 176.65 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.493 HH21 HG11 ' B' ' 262' ' ' VAL . 84.2 mtm-85 -105.45 135.04 47.58 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.439 -0.505 . . . . 0.0 110.609 -178.246 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 95.8 mt -118.78 131.02 72.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 120.304 -0.559 . . . . 0.0 111.36 -179.82 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -75.45 32.26 0.11 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.52 -0.763 . . . . 0.0 112.318 -178.794 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.72 HD21 ' OE1' ' B' ' 260' ' ' GLU . 61.0 mt -106.18 127.07 29.02 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.65 179.378 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.33 -8.49 22.79 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 122.406 2.071 . . . . 0.0 113.117 -179.42 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.5 m -95.38 6.77 7.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.39 179.737 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.424 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 36.1 t -96.86 135.36 31.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.331 179.475 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.493 ' HB2' ' H ' ' A' ' 48' ' ' HIS . 4.1 m -73.02 173.68 8.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.205 -178.883 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -63.02 -40.35 97.49 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.819 179.476 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.64 ' O ' ' N ' ' A' ' 49' ' ' CYS . 9.8 mm100 -113.24 -23.3 10.02 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.974 -0.291 . . . . 0.0 110.519 -179.712 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.493 ' H ' ' HB2' ' A' ' 45' ' ' SER . 20.4 t60 43.58 -77.69 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.894 -179.735 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.64 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -134.03 136.97 44.41 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.991 -179.517 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -125.77 133.13 52.16 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.485 179.75 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 98.6 mt -115.98 131.43 68.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.058 179.945 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.587 ' OE2' ' NE2' ' A' ' 54' ' ' HIS . 79.4 tt0 -118.11 125.73 50.85 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.765 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 86.2 mt -108.06 123.17 63.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.896 0.855 . . . . 0.0 112.992 -177.826 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.587 ' NE2' ' OE2' ' A' ' 52' ' ' GLU . 98.5 m-70 -117.57 136.92 52.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 113.989 -1.459 . . . . 0.0 109.056 178.902 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 54' ' ' HIS . 96.2 mt-10 -41.18 -32.23 0.26 Allowed 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.156 -0.617 . . . . 0.0 109.89 -179.571 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -64.22 -67.93 0.39 Allowed 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.291 -0.564 . . . . 0.0 109.893 179.224 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.569 ' CG ' ' H ' ' A' ' 58' ' ' ALA . 52.9 tt0 -150.56 -179.35 7.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.863 -178.593 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.569 ' H ' ' CG ' ' A' ' 57' ' ' GLU . . . -108.83 131.86 54.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.052 -179.697 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.8 mt -119.85 129.5 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -178.33 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.487 HD11 ' SG ' ' A' ' 49' ' ' CYS . 38.6 tp -97.39 129.03 44.67 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.041 -0.982 . . . . 0.0 110.051 179.47 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -115.92 136.32 53.15 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 179.595 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.628 HD21 ' CB ' ' A' ' 68' ' ' PRO . 62.7 t-20 -100.32 105.24 16.74 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 120.965 0.412 . . . . 0.0 111.134 -179.477 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -97.52 -9.57 26.85 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.229 179.855 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.87 98.55 7.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.021 0.438 . . . . 0.0 110.271 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.4 t -76.27 -42.65 44.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.844 179.396 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.405 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.3 OUTLIER -61.28 -45.43 94.52 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.293 -178.68 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.41 HD21 ' HA ' ' B' ' 236' ' ' VAL . 37.2 m-80 -139.36 94.84 9.4 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 115.503 -0.771 . . . . 0.0 108.958 -179.503 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.628 ' CB ' HD21 ' A' ' 62' ' ' ASN . 35.6 Cg_endo -64.86 150.52 88.01 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 121.528 1.485 . . . . 0.0 112.507 -178.173 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.8 m -73.01 142.11 47.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.7 -178.883 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -99.51 148.04 24.68 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.788 179.84 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.407 ' O ' HG13 ' A' ' 71' ' ' VAL . 5.6 p -132.61 135.47 57.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.239 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 50.85 33.02 7.91 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.455 -179.861 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.69 27.69 70.5 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -179.442 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 10.4 t -138.12 139.42 39.43 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.462 -179.501 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 77.8 t -69.22 134.0 30.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.031 0.443 . . . . 0.0 111.636 -179.715 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.16 95.58 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.482 179.266 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -81.92 -16.62 49.95 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.666 -179.209 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -110.01 156.91 39.21 Favored Pre-proline 0 C--O 1.222 -0.372 0 C-N-CA 121.099 -0.241 . . . . 0.0 110.481 -179.733 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -64.57 145.98 88.26 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.369 2.046 . . . . 0.0 112.669 -179.807 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.9 m -147.61 148.08 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.106 -179.463 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 91.2 mtm180 -73.97 132.36 42.33 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.403 179.391 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 82' ' ' LEU . 77.8 mt -79.39 141.2 37.09 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.996 0.427 . . . . 0.0 111.417 179.693 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -132.75 151.29 52.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.775 179.55 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.536 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 5.5 t60 -56.23 116.82 3.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.024 -179.801 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.92 -14.32 26.55 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.061 179.235 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -74.48 134.97 42.26 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.229 179.867 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.47 HG22 ' HG2' ' A' ' 96' ' ' ARG . 59.0 t -108.07 132.13 56.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.749 -178.891 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 88.8 mt -104.99 131.87 53.12 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.769 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 65.2 m -120.78 130.01 53.83 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 119.745 -0.782 . . . . 0.0 112.778 -177.96 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.597 ' O ' ' N ' ' A' ' 93' ' ' ARG . 96.6 mt -114.58 131.19 67.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 114.29 -1.323 . . . . 0.0 108.611 178.335 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.677 HG22 HH22 ' B' ' 245' ' ' ARG . 95.6 mt -20.38 95.26 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -179.565 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.554 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 10.5 t0 90.42 -23.55 0.09 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 178.084 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.597 ' N ' ' O ' ' A' ' 90' ' ' ILE . 88.2 mtt-85 -130.0 147.02 51.71 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.03 -179.621 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.478 ' HB3' HD12 ' A' ' 10' ' ' ILE . 38.7 t -139.1 152.27 47.37 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.384 0.611 . . . . 0.0 110.598 -179.911 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.568 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 91.2 m-85 -125.07 121.36 34.08 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.649 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.47 ' HG2' HG22 ' A' ' 87' ' ' VAL . 99.9 mtt180 -87.51 140.27 29.69 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 119.453 -0.899 . . . . 0.0 109.976 -179.561 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -96.65 123.17 40.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.031 -178.292 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -126.03 120.77 31.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.781 179.711 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.536 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 64.4 t-20 . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.259 179.817 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo . . . . . 0 N--CA 1.489 1.244 0 N-CA-C 113.722 0.624 . . . . 0.0 113.722 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.41 ' HA ' HD21 ' A' ' 67' ' ' ASN . 50.1 t -64.42 132.46 30.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.036 179.231 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.324 -0.511 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.063 -179.693 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo . . . . . 0 N--CA 1.499 1.835 0 N-CA-C 113.009 0.35 . . . . 0.0 113.009 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 86.0 m -74.84 -45.99 39.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.949 0.404 . . . . 0.0 110.881 179.234 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.641 ' CE2' ' CZ ' ' B' ' 245' ' ' ARG . 57.2 t80 -58.37 -48.31 81.0 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.033 -178.31 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.451 HD23 ' NH2' ' B' ' 245' ' ' ARG . 44.7 mt -64.73 -42.62 95.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.252 0.548 . . . . 0.0 110.757 179.681 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -62.99 -43.09 99.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.016 -178.72 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -61.55 -45.56 93.65 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.692 -179.041 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.677 HH22 HG22 ' A' ' 91' ' ' ILE . 89.7 mtm180 -63.86 -37.05 85.96 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.904 -178.771 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.7 -39.7 92.42 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.305 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 70.2 m -63.49 -44.09 95.38 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.606 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 93.9 mm-40 -61.11 -37.11 81.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.281 -179.779 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 47.1 t . . . . . 0 C--N 1.327 -0.39 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.914 179.792 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.72 ' OE1' HD21 ' A' ' 41' ' ' LEU . 95.5 mt-10 . . . . . 0 CA--C 1.523 -0.085 0 CA-C-O 121.446 0.641 . . . . 0.0 109.694 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.568 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 82.6 mt -115.91 133.55 61.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.79 179.951 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 262' ' ' VAL . . . . . 0.493 HG11 HH21 ' A' ' 38' ' ' ARG . 55.0 t -126.6 133.13 69.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.979 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -96.12 121.95 38.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.204 0.526 . . . . 0.0 111.219 -178.53 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 264' ' ' LYS . . . . . 0.443 ' CB ' ' O ' ' A' ' 36' ' ' ASP . 87.6 tttt -63.78 -43.45 96.34 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.477 179.551 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.24 160.14 31.37 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.327 -179.398 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -61.17 145.42 98.74 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.686 2.257 . . . . 0.0 111.031 178.464 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 267' ' ' ILE . . . . . 0.868 ' O ' HD13 ' B' ' 267' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.49 0 C-N-CA 120.151 -0.62 . . . . 0.0 111.28 -179.415 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.55 ' O ' ' O ' ' A' ' 99' ' ' ASN . 2.4 t . . . . . 0 N--CA 1.474 0.743 0 CA-C-O 120.6 0.238 . . . . 0.0 110.592 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.499 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 92.9 mtt-85 -86.08 130.54 34.5 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.635 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -135.0 142.38 46.43 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.536 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.8 mt -111.7 132.74 54.41 Favored 'General case' 0 CA--C 1.523 -0.076 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.29 179.405 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.6 t -109.01 125.89 66.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.988 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.1 m -77.17 140.94 40.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.679 -178.779 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.554 HD12 ' HB2' ' A' ' 94' ' ' SER . 97.3 mt -110.27 135.19 50.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.125 178.578 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.404 ' HA ' HH12 ' A' ' 93' ' ' ARG . 81.7 mttt -90.68 159.51 16.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.202 0.525 . . . . 0.0 110.947 -179.809 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.607 HH11 ' NH1' ' B' ' 245' ' ' ARG . 91.1 mtm180 -56.95 -29.35 63.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.601 -178.546 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.3 p -81.44 -8.49 59.74 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.279 -179.734 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.29 33.27 7.74 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 179.676 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.7 t -120.38 134.7 63.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.572 0.225 . . . . 0.0 111.518 -179.59 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -72.4 136.4 46.07 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.105 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -124.84 -119.41 2.39 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.679 -179.893 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.62 148.3 36.93 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 122.52 2.147 . . . . 0.0 113.318 -178.989 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -109.55 138.31 46.1 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.515 179.853 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.721 ' CD2' HD11 ' A' ' 37' ' ' ILE . 29.9 t80 -111.54 104.04 55.69 Favored Pre-proline 0 N--CA 1.469 0.477 0 N-CA-C 110.056 -0.349 . . . . 0.0 110.056 -179.746 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -76.15 138.43 20.34 Favored 'Trans proline' 0 N--CA 1.489 1.235 0 C-N-CA 121.949 1.766 . . . . 0.0 112.217 -179.133 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.431 HD22 ' HB2' ' A' ' 27' ' ' CYS . 93.4 mt -88.83 92.06 9.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.143 0.497 . . . . 0.0 111.106 -178.878 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 88.6 p -93.55 -8.07 42.36 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.728 179.017 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 67.3 mt -109.58 150.07 28.74 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.859 -179.424 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.9 m -68.97 -16.39 63.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.734 0.302 . . . . 0.0 111.311 -179.148 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 78.4 m -128.59 132.01 48.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.058 0.456 . . . . 0.0 111.464 -179.766 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.631 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 5.2 t -128.1 119.19 24.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.451 178.816 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.573 HD12 ' O ' ' A' ' 49' ' ' CYS . 31.6 tp -117.68 130.34 56.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.41 -178.496 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.751 ' CE2' HD12 ' A' ' 37' ' ' ILE . 17.5 m-85 -107.72 137.23 46.1 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.666 179.441 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 156.91 -177.48 33.79 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 120.384 -0.912 . . . . 0.0 112.425 178.899 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.405 ' HD2' HH11 ' A' ' 31' ' ' ARG . 46.3 mtm180 -74.91 -32.55 61.84 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.581 0.229 . . . . 0.0 111.48 179.202 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.489 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -53.04 145.68 20.58 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.264 -178.514 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.51 HG23 ' N ' ' A' ' 34' ' ' GLU . 11.1 tp -66.36 -41.93 89.71 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-O 120.856 0.36 . . . . 0.0 110.204 179.873 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.51 ' N ' HG23 ' A' ' 33' ' ' ILE . 49.9 tp10 -52.3 -22.1 4.16 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.605 179.511 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.489 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 9.9 m -65.46 126.03 26.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.064 -179.791 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -57.67 -27.5 62.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.023 -179.551 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.751 HD12 ' CE2' ' A' ' 29' ' ' PHE . 78.7 mt -130.26 123.71 56.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.484 178.295 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 75.2 mtm180 -101.61 135.33 43.31 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.317 179.979 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.589 HG21 HD12 ' A' ' 41' ' ' LEU . 97.3 mt -117.56 129.58 73.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.131 0.491 . . . . 0.0 109.97 179.068 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -74.24 29.1 0.08 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.205 -178.952 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.589 HD12 HG21 ' A' ' 39' ' ' ILE . 26.9 mt -93.72 121.36 64.75 Favored Pre-proline 0 CA--C 1.533 0.303 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.204 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.4 -8.45 20.73 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 121.779 1.653 . . . . 0.0 111.676 -179.642 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 m -102.53 9.88 8.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.906 -179.981 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.415 HG12 ' O ' ' A' ' 45' ' ' SER . 10.9 t -96.59 141.36 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 121.077 0.465 . . . . 0.0 110.595 179.324 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.415 ' O ' HG12 ' A' ' 44' ' ' VAL . 12.8 m -71.64 165.59 23.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.517 -179.24 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -62.17 -40.83 97.34 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.665 -179.426 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.634 ' O ' ' N ' ' A' ' 49' ' ' CYS . 85.7 mt-30 -113.59 -25.0 8.93 Favored 'General case' 0 C--O 1.226 -0.133 0 CA-C-O 121.102 0.477 . . . . 0.0 110.27 -179.907 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.8 t60 37.08 -76.01 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 179.405 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.634 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -127.34 133.54 50.07 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.243 0.544 . . . . 0.0 112.187 -178.128 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -130.88 129.18 41.95 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.051 179.993 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 94.4 mt -113.07 133.8 57.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.561 179.842 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -118.94 126.96 52.98 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.641 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.2 mt -104.67 113.72 42.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.049 -0.66 . . . . 0.0 111.215 -179.398 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.559 ' O ' ' N ' ' A' ' 56' ' ' GLN . 95.3 m-70 -113.4 145.4 41.19 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.569 179.789 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 54' ' ' HIS . 77.3 tt0 -39.85 -24.59 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -179.694 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.559 ' N ' ' O ' ' A' ' 54' ' ' HIS . 87.0 mt-30 -71.14 -68.69 0.42 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.222 178.9 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.496 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 2.5 tp10 -158.62 -169.17 2.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.234 0.54 . . . . 0.0 111.025 -178.962 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -105.71 121.89 44.94 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 177.961 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.7 mt -114.66 129.42 70.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.223 0.535 . . . . 0.0 112.093 -178.443 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 29.5 tp -96.64 127.48 42.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.47 179.706 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -112.01 135.32 52.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.857 0.36 . . . . 0.0 110.404 -179.821 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -93.46 106.5 18.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.635 -179.847 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -98.38 -12.57 21.29 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.72 179.056 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 t -73.98 100.51 3.58 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.204 179.749 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.2 p -86.09 -20.76 28.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.897 0.38 . . . . 0.0 110.761 179.768 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.607 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -85.62 -44.65 12.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.213 -179.612 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.404 ' OD1' HG13 ' B' ' 236' ' ' VAL . 22.5 m-80 -135.1 94.17 16.3 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.175 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -55.38 145.11 69.31 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.393 2.062 . . . . 0.0 113.57 -178.435 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 53.1 m -74.03 142.59 45.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.332 179.176 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -104.6 140.97 37.24 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.663 179.765 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.711 HG13 ' OD1' ' A' ' 86' ' ' ASP . 53.0 t -128.52 131.46 68.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.83 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 51.09 32.03 7.26 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.149 -0.621 . . . . 0.0 109.489 -179.06 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.56 26.33 67.9 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.861 179.749 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.9 p -136.78 133.93 36.5 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 122.451 -0.44 . . . . 0.0 111.061 -179.989 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -68.03 138.12 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.494 179.821 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.9 pt -116.28 92.34 2.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.659 179.729 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -68.2 -20.89 64.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.075 0.464 . . . . 0.0 109.841 178.933 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.86 168.2 11.96 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.726 -179.533 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.65 152.43 69.9 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.778 2.319 . . . . 0.0 112.255 179.601 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.4 p -143.09 145.11 23.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.866 -179.742 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.8 mtm-85 -73.24 128.16 34.7 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.483 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 82' ' ' LEU . 95.7 mt -80.4 137.37 36.52 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.203 -179.345 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -130.6 153.42 48.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.429 179.767 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -58.17 118.87 5.93 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.011 0.434 . . . . 0.0 110.505 -179.542 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.59 -7.24 26.22 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.746 -0.941 . . . . 0.0 110.746 -179.472 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.711 ' OD1' HG13 ' A' ' 71' ' ' VAL . 52.2 t0 -81.12 123.85 28.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.092 0.472 . . . . 0.0 110.365 179.792 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 42.9 t -104.05 134.17 46.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.648 -179.162 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.1 mt -103.32 129.94 54.39 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 178.104 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.434 HG23 ' OG ' ' A' ' 94' ' ' SER . 29.4 m -119.08 128.09 53.99 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.531 0.682 . . . . 0.0 111.832 -178.616 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.459 HD12 ' HE1' ' A' ' 95' ' ' PHE . 94.6 mt -118.1 125.29 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.954 179.295 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.411 ' C ' ' O ' ' A' ' 90' ' ' ILE . 38.2 mm 38.36 -105.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.991 -179.117 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.54 ' CG ' ' NE ' ' B' ' 245' ' ' ARG . 1.1 p30 -108.24 12.07 26.84 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -178.808 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.625 ' HE ' HD11 ' B' ' 261' ' ' ILE . 53.4 mtp85 -132.91 147.9 52.29 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.068 179.616 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.554 ' HB2' HD12 ' A' ' 10' ' ' ILE . 38.1 m -138.8 158.27 44.53 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.233 -179.064 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.463 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 78.9 m-85 -125.89 122.95 37.53 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.354 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 79.4 mtp85 -81.35 135.53 35.69 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.491 179.471 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.499 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 80.6 t80 -95.15 122.07 37.44 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.997 179.952 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -134.64 119.96 18.97 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.999 -179.257 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.55 ' O ' ' O ' ' A' ' 4' ' ' THR . 91.9 m-20 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.758 179.381 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo . . . . . 0 N--CA 1.49 1.295 0 CA-C-O 121.467 0.528 . . . . 0.0 112.944 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.607 ' CG2' HG22 ' A' ' 66' ' ' THR . 74.3 t -76.22 132.72 32.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.898 -179.381 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 37.5 t . . . . . 0 C--N 1.331 -0.22 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.776 -179.728 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo . . . . . 0 N--CA 1.499 1.795 0 N-CA-C 113.189 0.419 . . . . 0.0 113.189 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 21.8 m -73.18 -45.58 55.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.261 0.553 . . . . 0.0 109.89 178.829 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -58.59 -47.23 85.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.362 -179.381 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' B' ' 242' ' ' LEU . 98.8 mt -66.53 -39.79 88.78 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.832 0.348 . . . . 0.0 111.251 -179.805 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 51.5 tp10 -62.87 -45.09 94.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.171 -179.372 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -62.09 -40.8 97.08 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.258 0.552 . . . . 0.0 109.915 179.807 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.607 ' NH1' HH11 ' A' ' 12' ' ' ARG . 56.2 ttm-85 -60.13 -42.98 95.99 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.423 -179.229 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -62.23 -38.46 89.3 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.563 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 47.8 t -64.8 -44.21 90.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.433 177.849 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -60.94 -36.32 79.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.344 179.933 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 22.3 t . . . . . 0 N--CA 1.454 -0.228 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.932 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 . . . . . 0 N--CA 1.463 0.224 0 CA-C-O 121.223 0.535 . . . . 0.0 110.065 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.625 HD11 ' HE ' ' A' ' 93' ' ' ARG . 58.6 mt -115.3 147.22 18.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.73 179.52 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 78.7 t -128.91 136.38 59.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.39 179.468 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -98.18 120.92 39.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.259 0.552 . . . . 0.0 111.567 -178.74 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -68.55 -46.2 70.11 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.783 -179.684 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -96.37 176.65 2.05 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.055 -178.715 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -59.54 146.13 96.02 Favored 'Trans proline' 0 N--CA 1.5 1.879 0 C-N-CA 122.644 2.229 . . . . 0.0 113.252 -178.938 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 1.1 tt . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.451 -179.829 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.4 p . . . . . 0 N--CA 1.462 0.164 0 CA-C-O 120.609 0.242 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.2 mtt85 -97.2 127.23 42.98 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.783 -178.679 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 94.5 mtm-85 -129.6 135.44 48.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.993 179.816 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.595 HD11 ' HB3' ' A' ' 95' ' ' PHE . 39.9 tp -108.79 134.11 51.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.301 -179.47 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 54.9 t -114.98 130.7 69.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.128 -179.704 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.1 m -79.51 142.29 35.93 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.81 -179.605 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.622 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 90.0 mt -109.32 135.51 48.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.39 -0.823 . . . . 0.0 108.857 177.769 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.68 ' CA ' HH22 ' A' ' 93' ' ' ARG . 97.4 mttt -87.25 153.68 21.3 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.766 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.581 ' NH1' ' OE2' ' B' ' 260' ' ' GLU . 88.8 mtm180 -58.11 -23.81 56.33 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.414 -0.515 . . . . 0.0 110.474 -179.357 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.0 m -80.38 -10.72 59.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.385 179.524 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.67 30.28 9.19 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 179.644 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.9 t -121.21 132.12 71.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.795 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -73.55 140.01 46.01 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.362 179.418 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -122.42 -121.46 2.72 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 121.031 -0.604 . . . . 0.0 111.916 -179.041 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.05 149.74 53.16 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 122.094 1.863 . . . . 0.0 112.489 -179.059 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.423 ' CE1' ' HD3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -109.95 140.44 43.94 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.925 -179.092 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.565 ' CD2' HD11 ' A' ' 37' ' ' ILE . 33.9 t80 -112.86 104.71 55.97 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.614 -178.807 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.423 ' HD3' ' CE1' ' A' ' 19' ' ' HIS . 55.9 Cg_endo -72.63 131.36 17.2 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.103 1.202 . . . . 0.0 111.579 -178.488 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 92.2 mt -86.21 48.68 1.65 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.926 -178.189 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.6 p -65.33 -22.31 66.8 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.918 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.8 mt -80.28 141.47 35.49 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.018 179.965 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.7 m -62.48 -21.6 65.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.985 -179.206 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 74.7 m -138.15 135.77 36.04 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.693 -179.404 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.0 t -126.73 122.09 33.87 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 177.888 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.65 HD21 ' HG2' ' A' ' 47' ' ' GLN . 44.1 tp -118.01 127.35 53.72 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.104 0.478 . . . . 0.0 111.163 -178.386 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.763 ' CE2' HD12 ' A' ' 37' ' ' ILE . 9.3 m-85 -105.36 132.45 51.53 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.904 179.83 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.79 -175.93 39.13 Favored Glycine 0 N--CA 1.467 0.749 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.158 179.425 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.601 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 78.9 mtm-85 -77.73 -30.12 51.51 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.873 0.368 . . . . 0.0 110.338 179.262 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -50.62 149.2 6.78 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.923 -0.471 . . . . 0.0 111.923 -178.208 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.472 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.9 tp -67.05 -40.57 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.458 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.472 ' N ' HG23 ' A' ' 33' ' ' ILE . 96.5 mt-10 -57.2 -25.4 58.98 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.885 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.439 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 47.7 m -53.59 118.41 3.88 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.995 179.824 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.468 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 55.3 m-20 -58.56 -28.26 65.35 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.155 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.763 HD12 ' CE2' ' A' ' 29' ' ' PHE . 90.4 mt -129.0 124.62 61.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 176.494 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -107.72 136.6 47.19 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.636 -178.61 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.407 HG23 ' O ' ' B' ' 260' ' ' GLU . 92.5 mt -118.0 130.31 73.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 179.501 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -73.44 30.54 0.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.441 -177.747 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.42 ' HA ' HD23 ' A' ' 41' ' ' LEU . 82.3 mt -100.85 127.85 31.23 Favored Pre-proline 0 C--N 1.326 -0.417 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.521 179.865 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.24 -8.09 20.49 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 122.267 1.978 . . . . 0.0 111.77 179.636 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.558 HG23 HD13 ' A' ' 91' ' ' ILE . 16.4 m -100.21 6.37 9.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.008 -179.776 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.601 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 9.4 t -97.25 138.0 23.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 179.151 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.7 m -68.75 165.16 20.15 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.502 0.668 . . . . 0.0 111.496 -178.882 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.439 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 9.6 mtmt -61.94 -40.06 94.21 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.825 -179.459 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.65 ' HG2' HD21 ' A' ' 28' ' ' LEU . 85.8 mt-30 -118.06 -20.28 8.75 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.91 0.386 . . . . 0.0 111.322 179.742 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 33.7 t60 32.57 -73.97 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 178.887 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.639 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -124.83 131.52 53.43 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.157 0.503 . . . . 0.0 112.213 -178.305 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -126.82 127.89 45.7 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.229 179.914 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.1 mt -113.48 131.13 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.532 179.883 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.569 ' OE2' ' NE2' ' A' ' 54' ' ' HIS . 81.2 tt0 -118.34 128.06 54.29 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.742 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 88.6 mt -106.87 117.14 52.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 121.597 0.713 . . . . 0.0 112.19 -178.017 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.569 ' NE2' ' OE2' ' A' ' 52' ' ' GLU . 96.6 m-70 -112.24 141.11 46.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.628 179.759 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 54' ' ' HIS . 96.9 mt-10 -40.44 -29.92 0.1 Allowed 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.381 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' ' 54' ' ' HIS . 89.0 mt-30 -67.33 -67.1 0.48 Allowed 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.461 178.654 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.531 ' OE1' ' N ' ' A' ' 58' ' ' ALA . 1.3 mm-40 -155.49 -177.28 6.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.486 0.66 . . . . 0.0 112.212 -178.263 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.531 ' N ' ' OE1' ' A' ' 57' ' ' GLU . . . -106.38 118.85 37.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.456 178.585 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 94.2 mt -110.63 131.57 61.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.541 0.686 . . . . 0.0 111.804 -178.775 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 23.8 tp -98.99 128.69 45.19 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.59 179.519 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -115.27 135.84 53.73 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.021 -179.773 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -97.76 108.49 21.22 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.423 179.859 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -96.82 -8.06 32.02 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.649 179.413 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 6.7 t -71.19 97.83 1.6 Allowed 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.343 179.808 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.0 m -74.15 -43.29 57.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.292 0.568 . . . . 0.0 110.068 178.819 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.531 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.3 OUTLIER -65.04 -43.23 93.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.808 -178.82 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.427 ' O ' ' OG ' ' A' ' 64' ' ' SER . 36.7 m-20 -140.16 99.95 7.2 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.189 -179.386 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.507 ' HB2' HG13 ' A' ' 75' ' ' VAL . 44.0 Cg_exo -56.77 146.29 78.55 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 122.281 1.987 . . . . 0.0 112.871 -179.593 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.3 m -75.28 142.6 43.28 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.419 179.391 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -104.65 138.44 40.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.64 179.694 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 72.2 t -128.74 134.14 65.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.464 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 52.4 34.86 16.0 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.346 -179.425 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.86 26.47 69.07 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.541 179.212 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 41.8 m -146.46 141.29 26.95 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 117.563 0.681 . . . . 0.0 112.031 179.93 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.507 HG13 ' HB2' ' A' ' 68' ' ' PRO . 6.9 t -68.56 138.11 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.454 179.764 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.5 pt -113.48 89.09 1.23 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-O 121.158 0.504 . . . . 0.0 111.147 178.739 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -65.51 -27.2 68.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.567 179.114 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -120.01 166.08 16.08 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.067 -179.723 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.76 144.32 99.47 Favored 'Trans proline' 0 N--CA 1.501 1.936 0 C-N-CA 122.581 2.187 . . . . 0.0 112.197 -179.72 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.5 m -136.92 138.25 46.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.999 179.767 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.9 mtm180 -73.25 132.74 43.5 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.259 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.1 mt -81.5 133.79 35.44 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.113 -179.051 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -125.88 149.57 48.59 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.834 179.96 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -52.6 112.51 0.84 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.156 0.503 . . . . 0.0 111.062 -179.268 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.6 -11.43 25.69 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.799 179.233 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -70.36 132.48 45.71 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 117.289 0.545 . . . . 0.0 110.679 -179.823 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.0 t -108.16 132.69 55.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.929 -178.877 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.7 mt -104.32 130.92 54.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.759 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 87.0 m -122.8 123.59 41.39 Favored 'General case' 0 CA--C 1.523 -0.086 0 CA-C-O 121.628 0.728 . . . . 0.0 112.003 -178.83 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.549 ' O ' ' N ' ' A' ' 93' ' ' ARG . 78.9 mt -110.91 123.93 67.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.658 178.852 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.558 HD13 HG23 ' A' ' 43' ' ' VAL . 96.8 mt 31.78 -95.63 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.896 179.044 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 92' ' ' ASP . 24.1 p-10 -114.29 7.51 16.47 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.517 -179.763 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.68 HH22 ' CA ' ' A' ' 11' ' ' LYS . 1.7 mmp_? -119.41 137.22 53.9 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.651 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 44.9 t -138.26 150.17 46.42 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.234 179.951 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.595 ' HB3' HD11 ' A' ' 7' ' ' LEU . 83.4 m-85 -129.22 134.14 47.85 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.839 179.581 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.416 ' O ' HD12 ' A' ' 7' ' ' LEU . 39.5 ttm180 -95.05 134.05 38.16 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.353 -179.406 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -93.51 121.54 35.03 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.914 -179.541 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -134.41 127.39 31.48 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 120.453 -0.499 . . . . 0.0 112.071 -179.915 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 . . . . . 0 C--N 1.333 -0.118 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.875 179.395 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo . . . . . 0 N--CA 1.486 1.076 0 CA-C-O 121.782 0.659 . . . . 0.0 112.662 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.531 ' CG2' HG22 ' A' ' 66' ' ' THR . 30.5 t -64.86 131.42 30.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 114.429 -1.26 . . . . 0.0 109.856 -179.76 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 2.0 t . . . . . 0 C--N 1.327 -0.379 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.88 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo . . . . . 0 N--CA 1.5 1.867 0 CA-C-O 120.695 0.206 . . . . 0.0 112.208 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 23.6 m -73.29 -44.11 59.75 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.818 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.703 ' CD1' ' NH2' ' B' ' 245' ' ' ARG . 77.2 t80 -57.57 -46.41 84.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.839 -179.63 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 91.6 mt -63.09 -40.65 98.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.424 0.63 . . . . 0.0 110.143 -179.945 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -62.4 -41.41 98.64 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.158 -179.663 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 244' ' ' ARG . . . . . 0.43 ' O ' ' OG ' ' B' ' 247' ' ' SER . 94.4 mtt-85 -61.44 -43.16 99.36 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.882 0.372 . . . . 0.0 111.039 -179.465 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.703 ' NH2' ' CD1' ' B' ' 241' ' ' PHE . 0.3 OUTLIER -61.24 -38.27 86.04 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.834 -179.921 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.11 -39.13 91.46 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.492 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 247' ' ' SER . . . . . 0.43 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 64.5 p -68.81 -41.41 78.7 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.293 178.164 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -58.86 -38.57 79.07 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.899 179.014 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 48.5 t . . . . . 0 N--CA 1.451 -0.411 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.003 179.297 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.581 ' OE2' ' NH1' ' A' ' 12' ' ' ARG . 98.7 mt-10 . . . . . 0 CA--C 1.537 0.475 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.495 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 80.1 mt -115.58 134.71 57.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.422 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 40.3 t -127.69 132.87 68.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.529 179.014 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -97.11 120.14 36.92 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.213 -179.46 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -63.98 -46.27 85.35 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.508 179.148 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -97.99 151.96 37.81 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.565 -179.42 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -66.99 146.84 78.81 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.929 2.42 . . . . 0.0 113.055 -178.932 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 27.5 pt . . . . . 0 C--N 1.327 -0.387 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.514 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 69.5 p . . . . . 0 C--O 1.233 0.198 0 CA-C-O 121.029 0.443 . . . . 0.0 110.583 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.823 HH12 ' HB2' ' A' ' 58' ' ' ALA . 94.5 mtt-85 -91.89 113.4 25.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.458 -179.321 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -126.31 133.72 51.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.379 -179.747 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.563 HD11 ' HB3' ' A' ' 95' ' ' PHE . 31.8 tp -113.62 133.85 55.05 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.781 -179.816 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.9 t -110.21 129.22 65.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.868 0.366 . . . . 0.0 111.116 -179.425 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.466 HG23 ' CD1' ' B' ' 261' ' ' ILE . 3.8 m -83.43 137.44 33.91 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.084 -178.864 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.561 HD12 ' HB2' ' A' ' 94' ' ' SER . 96.6 mt -104.64 135.65 41.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.583 177.623 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -88.97 158.9 17.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.569 179.916 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.624 ' CD ' HH22 ' A' ' 93' ' ' ARG . 77.5 mtp180 -56.5 -29.27 61.61 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.076 179.881 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.9 m -79.25 -7.79 58.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.847 179.599 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.96 28.97 24.43 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -179.21 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.3 t -113.7 132.67 62.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.505 -0.347 . . . . 0.0 110.467 -179.695 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -77.61 138.71 39.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.407 179.944 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -133.87 -119.66 2.01 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 120.348 -0.93 . . . . 0.0 112.748 -179.141 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -66.44 143.12 68.3 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.144 1.896 . . . . 0.0 113.499 -177.828 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.435 ' O ' ' CD1' ' B' ' 267' ' ' ILE . 0.6 OUTLIER -108.04 130.56 55.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.576 -179.728 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.524 ' CD2' HD11 ' A' ' 37' ' ' ILE . 41.7 t80 -101.26 107.65 51.46 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.304 -179.181 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -74.64 128.9 12.16 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 121.753 1.636 . . . . 0.0 111.679 -179.562 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 86.6 mt -86.43 51.24 2.17 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -178.063 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.7 p -62.41 -22.37 66.11 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.456 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.74 HD11 ' HG2' ' B' ' 265' ' ' GLN . 64.6 mt -79.15 137.95 37.68 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.209 179.043 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 81.0 p -66.57 -17.46 64.83 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.925 -179.424 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.433 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 86.4 m -129.98 131.03 45.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.066 0.46 . . . . 0.0 111.046 179.616 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.6 t -123.54 115.25 21.21 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.292 178.155 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.797 HD21 ' OE1' ' A' ' 47' ' ' GLN . 43.8 tp -112.01 124.55 52.64 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.928 -179.219 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.756 ' CE2' HD12 ' A' ' 37' ' ' ILE . 3.9 m-85 -106.42 143.51 34.44 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.763 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 157.49 -170.55 34.59 Favored Glycine 0 C--O 1.225 -0.408 0 C-N-CA 120.005 -1.093 . . . . 0.0 111.715 178.852 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.0 ttp85 -87.49 -27.41 22.67 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.84 -0.18 . . . . 0.0 111.212 -179.903 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.564 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -59.19 151.13 35.71 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 179.99 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.482 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.5 tp -66.24 -40.41 86.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.218 -0.593 . . . . 0.0 110.298 179.854 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.482 ' N ' HG23 ' A' ' 33' ' ' ILE . 79.4 mm-40 -53.98 -15.68 1.52 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.353 -179.884 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.564 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 34.1 m -64.48 123.63 19.72 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 120.162 -0.615 . . . . 0.0 109.394 179.631 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.433 ' OD2' ' O ' ' A' ' 26' ' ' THR . 98.6 m-20 -56.95 -25.0 57.06 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -179.501 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.756 HD12 ' CE2' ' A' ' 29' ' ' PHE . 99.0 mt -129.82 120.83 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.367 176.761 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.538 ' NH2' HG21 ' B' ' 262' ' ' VAL . 68.9 ttp85 -108.22 133.94 51.76 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.791 -178.648 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 97.6 mt -116.31 130.08 71.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.875 -179.825 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -75.24 34.59 0.11 Allowed 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -178.205 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.432 HD22 ' HZ ' ' B' ' 241' ' ' PHE . 57.8 mt -110.84 127.55 26.75 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.753 179.651 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.81 -8.45 22.39 Favored 'Trans proline' 0 N--CA 1.498 1.742 0 C-N-CA 122.684 2.256 . . . . 0.0 114.063 -179.024 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.2 m -100.61 1.8 10.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.317 179.711 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.487 ' O ' ' O ' ' A' ' 45' ' ' SER . 91.2 t -97.26 103.35 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.034 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.487 ' O ' ' O ' ' A' ' 44' ' ' VAL . 12.5 t -32.71 157.54 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.785 0.803 . . . . 0.0 111.961 -178.688 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -64.25 -38.38 90.83 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.963 -179.695 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.797 ' OE1' HD21 ' A' ' 28' ' ' LEU . 95.6 mm-40 -113.22 -6.67 13.6 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 123.474 0.484 . . . . 0.0 111.055 -179.015 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.605 ' CD2' ' HG1' ' A' ' 69' ' ' THR . 20.8 t60 14.28 -71.66 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 -178.982 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.577 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.3 136.06 45.22 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -177.352 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -125.99 125.56 42.87 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.69 178.827 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.6 mt -110.72 132.79 58.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.978 179.894 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.418 ' CD ' ' CE1' ' A' ' 54' ' ' HIS . 75.6 tt0 -115.64 124.78 51.78 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.487 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.6 mt -103.16 120.68 53.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 119.913 -0.715 . . . . 0.0 112.422 -178.309 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.592 ' O ' ' N ' ' A' ' 56' ' ' GLN . 2.4 m-70 -114.91 138.4 50.86 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.084 178.723 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.462 ' C ' ' O ' ' A' ' 54' ' ' HIS . 96.5 mt-10 -39.86 -23.88 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 -179.655 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.592 ' N ' ' O ' ' A' ' 54' ' ' HIS . 66.2 tp60 -68.49 -67.93 0.43 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.142 178.257 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -159.2 -163.38 1.2 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.74 -179.529 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.823 ' HB2' HH12 ' A' ' 5' ' ' ARG . . . -109.42 131.7 54.82 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.401 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 41.2 mm -112.23 125.08 69.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.068 -178.801 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.433 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 28.9 tp -100.43 125.63 46.73 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.805 0.336 . . . . 0.0 110.097 -179.849 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -115.68 136.96 52.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.157 179.456 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.558 HD22 ' HA ' ' A' ' 68' ' ' PRO . 50.6 t30 -100.54 106.73 18.28 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.4 -179.856 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -97.58 -6.93 32.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.587 179.462 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.48 100.6 0.87 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.886 179.563 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.2 m -83.25 -14.95 52.11 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.276 -0.569 . . . . 0.0 109.677 179.374 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.5 -43.5 9.65 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.594 179.964 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.652 ' HB3' HD11 ' A' ' 91' ' ' ILE . 44.0 m-20 -146.97 101.66 3.88 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.452 -179.485 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.558 ' HA ' HD22 ' A' ' 62' ' ' ASN . 32.5 Cg_exo -56.04 150.53 46.97 Favored 'Trans proline' 0 N--CA 1.499 1.824 0 C-N-CA 122.664 2.243 . . . . 0.0 113.998 -178.795 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.605 ' HG1' ' CD2' ' A' ' 48' ' ' HIS . 11.3 m -71.57 136.99 47.68 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.794 178.987 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.556 ' O ' ' N ' ' A' ' 89' ' ' THR . 70.2 mt-30 -99.64 146.04 26.92 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.597 179.947 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.721 ' HB ' HD11 ' A' ' 76' ' ' ILE . 4.1 p -133.75 139.73 48.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.499 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 48.24 33.13 3.5 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -179.63 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.23 29.79 65.96 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.299 -179.549 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.442 ' N ' ' O ' ' A' ' 71' ' ' VAL . 18.2 t -140.67 137.32 33.46 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.975 -179.199 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.44 HG13 ' HB2' ' A' ' 68' ' ' PRO . 38.9 t -66.76 139.09 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.375 -179.321 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.721 HD11 ' HB ' ' A' ' 71' ' ' VAL . 89.8 mt -107.64 116.21 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.528 179.055 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 24.5 p-10 -87.75 -33.54 18.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.661 0.267 . . . . 0.0 111.064 179.274 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.455 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 5.0 pt-20 -128.88 174.05 4.95 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.949 -179.292 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -58.8 144.48 98.35 Favored 'Trans proline' 0 N--CA 1.501 1.929 0 C-N-CA 122.305 2.003 . . . . 0.0 112.513 -179.4 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.6 p -141.6 144.26 26.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.308 0.575 . . . . 0.0 111.689 179.747 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -77.6 132.98 38.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.095 179.611 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.543 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 91.2 mt -88.02 140.26 29.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.922 0.392 . . . . 0.0 111.146 -179.451 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -129.69 154.45 47.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.576 -179.87 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -54.46 117.81 3.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.038 0.447 . . . . 0.0 110.654 -179.502 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.81 -16.73 30.72 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 -179.396 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.544 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 45.3 t0 -69.94 126.52 29.94 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.185 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 49.7 t -102.5 135.58 38.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.006 -178.981 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 28.3 mm -92.59 129.03 43.77 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.605 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 177.485 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.654 HG23 ' OG ' ' A' ' 94' ' ' SER . 98.8 m -121.23 125.15 46.4 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 122.031 0.919 . . . . 0.0 112.597 -178.245 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.591 ' O ' ' N ' ' A' ' 93' ' ' ARG . 97.0 mt -117.38 132.47 67.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 113.993 -1.458 . . . . 0.0 107.924 177.919 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.652 HD11 ' HB3' ' A' ' 67' ' ' ASN . 69.7 mt -26.78 104.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 O-C-N 123.448 0.467 . . . . 0.0 111.257 -179.225 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.509 ' CG ' ' NE ' ' B' ' 245' ' ' ARG . 90.9 m-20 79.37 -16.51 0.66 Allowed 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 179.147 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.624 HH22 ' CD ' ' A' ' 12' ' ' ARG . 23.5 mtt85 -130.62 137.36 49.59 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.661 -0.415 . . . . 0.0 110.84 179.028 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.654 ' OG ' HG23 ' A' ' 89' ' ' THR . 48.2 m -138.82 152.42 47.85 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.156 0.503 . . . . 0.0 109.888 -179.989 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.563 ' HB3' HD11 ' A' ' 7' ' ' LEU . 79.1 m-85 -126.16 122.95 37.13 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.094 -179.61 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.531 ' O ' HD12 ' A' ' 7' ' ' LEU . 99.6 mtt180 -83.69 132.05 34.9 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.82 -179.59 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.611 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 72.5 t80 -96.87 127.16 42.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.691 -179.525 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -124.94 120.95 33.07 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.271 179.533 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 59.4 t-20 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.044 179.988 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo . . . . . 0 N--CA 1.488 1.201 0 CA-C-O 121.582 0.576 . . . . 0.0 112.358 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 36.8 t -63.06 141.67 17.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.226 179.511 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.464 0.249 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.193 -179.72 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo . . . . . 0 N--CA 1.498 1.769 0 N-CA-C 112.834 0.282 . . . . 0.0 112.834 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 18.8 m -72.15 -44.96 62.3 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.212 0.529 . . . . 0.0 109.897 178.618 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.432 ' HZ ' HD22 ' A' ' 41' ' ' LEU . 87.5 t80 -55.92 -47.13 78.08 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.6 -179.439 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.437 ' CD2' ' OD1' ' A' ' 92' ' ' ASP . 93.3 mt -65.39 -41.49 93.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.776 -179.653 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -60.59 -40.68 92.64 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.738 -179.242 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -61.76 -42.44 98.99 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.785 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.716 ' O ' HG23 ' B' ' 249' ' ' VAL . 70.4 ttp85 -60.77 -43.56 97.88 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.559 -179.739 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.98 -42.11 97.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.986 0.422 . . . . 0.0 109.957 -179.548 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 73.9 m -66.64 -45.09 80.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.542 0.687 . . . . 0.0 109.292 178.303 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 248' ' ' GLN . . . . . 0.448 ' HG2' HH22 ' A' ' 12' ' ' ARG . 68.8 tp60 -59.84 -35.44 74.75 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.325 -179.992 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 249' ' ' VAL . . . . . 0.716 HG23 ' O ' ' B' ' 245' ' ' ARG . 71.4 t . . . . . 0 C--N 1.33 -0.273 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.063 179.887 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 . . . . . 0 CA--C 1.533 0.291 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.466 ' CD1' HG23 ' A' ' 9' ' ' THR . 73.1 mt -109.87 132.86 56.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.183 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 262' ' ' VAL . . . . . 0.538 HG21 ' NH2' ' A' ' 38' ' ' ARG . 54.9 t -123.18 131.57 72.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.187 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -94.46 119.93 33.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.038 0.447 . . . . 0.0 111.723 -178.576 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -63.29 -48.45 78.08 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.899 179.74 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 265' ' ' GLN . . . . . 0.74 ' HG2' HD11 ' A' ' 24' ' ' LEU . 8.0 mp0 -89.34 160.3 42.71 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.609 -179.067 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -60.04 140.64 93.61 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.194 1.93 . . . . 0.0 111.727 179.867 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 267' ' ' ILE . . . . . 0.435 ' CD1' ' O ' ' A' ' 19' ' ' HIS . 3.2 tt . . . . . 0 C--N 1.324 -0.508 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.169 -179.249 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.6 m . . . . . 0 C--O 1.234 0.257 0 CA-C-O 120.945 0.402 . . . . 0.0 110.464 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.547 ' NH2' HG21 ' A' ' 53' ' ' ILE . 87.0 mtm-85 -100.51 131.51 46.38 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.026 -179.209 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -130.87 154.37 48.14 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.202 0.525 . . . . 0.0 111.995 -179.364 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.722 HD11 HD11 ' A' ' 22' ' ' LEU . 87.1 mt -119.96 141.93 49.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.625 179.387 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 45.9 t -115.53 129.83 71.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.787 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.0 m -88.46 111.98 22.42 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.426 0.631 . . . . 0.0 112.079 -178.14 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 35.5 mm -79.57 142.86 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.215 178.539 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -95.28 160.47 14.52 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.414 0.626 . . . . 0.0 111.189 -179.547 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.466 HH22 ' HB2' ' B' ' 248' ' ' GLN . 82.7 mtp180 -58.84 -27.53 65.21 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.94 179.41 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 93.8 p -74.11 -18.48 60.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.0 178.833 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.67 21.2 12.85 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-N 116.213 -0.449 . . . . 0.0 112.134 179.266 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.0 p -125.57 139.72 50.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.977 0.417 . . . . 0.0 110.189 179.897 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.447 ' OD1' ' N ' ' A' ' 16' ' ' ASP . 33.4 p-10 -84.72 149.14 25.99 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.463 -179.696 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -138.54 -97.85 0.42 Allowed Glycine 0 CA--C 1.53 1.021 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.768 -179.817 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.84 141.39 27.08 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.198 1.932 . . . . 0.0 112.395 -179.087 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -106.95 146.67 30.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.985 0.421 . . . . 0.0 110.375 -179.482 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -114.74 98.63 50.18 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.334 -179.931 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.32 133.52 14.75 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.872 1.715 . . . . 0.0 112.069 -178.411 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.722 HD11 HD11 ' A' ' 7' ' ' LEU . 92.2 mt -87.71 86.27 7.16 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.062 -178.806 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 89.5 p -83.65 -11.34 57.38 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.566 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.1 mt -109.15 154.86 21.74 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.378 -179.697 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 59.9 m -79.56 -8.53 59.23 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -178.648 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.477 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 24.2 m -126.43 129.14 48.14 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.827 -179.637 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.1 t -123.78 114.52 20.01 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.991 178.505 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.581 HD21 ' HG2' ' A' ' 47' ' ' GLN . 45.4 tp -112.25 128.49 56.27 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.451 -178.39 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.732 ' CE2' HD12 ' A' ' 37' ' ' ILE . 7.0 m-85 -110.36 130.9 55.46 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.482 -179.953 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 165.2 -176.65 40.84 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.411 178.692 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.639 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 81.5 mtm-85 -75.51 -30.96 59.98 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 122.483 -0.422 . . . . 0.0 112.032 -179.346 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -54.6 143.66 31.41 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 121.387 -0.435 . . . . 0.0 112.181 -178.131 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.48 HG23 ' N ' ' A' ' 34' ' ' GLU . 11.1 tp -64.43 -41.09 91.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.252 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.48 ' N ' HG23 ' A' ' 33' ' ' ILE . 80.8 tt0 -54.44 -15.95 2.0 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.357 179.5 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.7 m -69.16 133.13 47.59 Favored 'General case' 0 N--CA 1.461 0.1 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.989 -179.319 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.477 ' OD2' ' O ' ' A' ' 26' ' ' THR . 91.2 m-20 -59.95 -31.2 69.65 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.922 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.732 HD12 ' CE2' ' A' ' 29' ' ' PHE . 98.8 mt -126.68 124.59 65.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 177.008 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.429 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 70.1 ttt180 -110.64 133.49 53.27 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.54 -178.566 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 94.6 mt -118.17 131.4 71.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 121.073 0.463 . . . . 0.0 110.736 -179.148 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -75.89 32.79 0.12 Allowed 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -178.168 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.745 HD12 ' CZ ' ' A' ' 93' ' ' ARG . 52.9 mt -113.45 128.19 25.97 Favored Pre-proline 0 N--CA 1.471 0.581 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.306 179.571 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.84 -15.03 29.86 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.239 1.959 . . . . 0.0 113.269 -179.034 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.665 HG23 ' O ' ' B' ' 235' ' ' PRO . 2.9 p -86.05 -1.41 7.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.103 179.729 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.741 HG12 ' O ' ' A' ' 41' ' ' LEU . 5.3 p -95.1 139.28 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.958 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.463 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 0.5 OUTLIER -68.79 171.91 7.18 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.563 0.697 . . . . 0.0 112.456 -178.09 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 44.7 mttm -64.26 -45.36 88.45 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.592 -179.369 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.662 ' O ' ' N ' ' A' ' 49' ' ' CYS . 84.6 mt-30 -113.05 -12.75 13.16 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.781 -179.607 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.463 ' H ' ' HB3' ' A' ' 45' ' ' SER . 21.3 t60 33.86 -75.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.238 -0.892 . . . . 0.0 113.385 179.52 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.662 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.2 134.77 46.8 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.759 -178.466 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -127.67 127.55 43.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.422 179.769 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 92.8 mt -109.73 133.06 56.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.868 -179.635 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -115.72 117.47 30.35 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.012 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.547 HG21 ' NH2' ' A' ' 5' ' ' ARG . 90.1 mt -101.1 112.72 34.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 119.972 -0.691 . . . . 0.0 111.328 -178.691 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.427 ' O ' ' C ' ' A' ' 55' ' ' GLU . 92.7 m-70 -110.05 141.06 43.41 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.483 -1.235 . . . . 0.0 109.561 -179.685 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 54' ' ' HIS . 99.2 mt-10 -41.23 -36.05 0.71 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.234 0.54 . . . . 0.0 109.693 -179.895 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -60.38 -66.23 0.56 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.371 179.637 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -154.0 -174.01 4.8 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.13 -179.369 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.56 123.18 48.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.292 179.152 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.9 mt -117.42 131.42 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -178.679 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 24.2 tp -100.76 127.87 47.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.209 179.267 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -109.22 135.48 50.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.054 179.817 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.403 HD21 ' CA ' ' A' ' 68' ' ' PRO . 61.1 t-20 -96.71 108.34 20.96 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.999 0.428 . . . . 0.0 111.261 -179.263 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -101.25 -7.29 23.19 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.668 179.855 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.7 t -76.71 97.79 4.57 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.883 -179.877 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.1 p -78.39 -33.01 49.11 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.092 179.113 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.39 -44.47 51.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.044 -179.213 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.439 HD21 ' HA ' ' B' ' 236' ' ' VAL . 79.0 m-20 -139.54 94.78 9.24 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.082 -179.693 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.568 ' HB2' HG13 ' A' ' 75' ' ' VAL . 54.2 Cg_exo -54.48 147.23 48.59 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.522 2.148 . . . . 0.0 113.465 -179.725 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 59.3 m -77.05 149.06 35.83 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.115 179.095 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -110.08 141.06 43.46 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.711 -179.61 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.688 HG13 ' OD1' ' A' ' 86' ' ' ASP . 55.0 t -132.37 135.48 57.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.316 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 33.0 m120 52.99 33.34 14.51 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -178.711 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.6 28.98 70.17 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.153 179.495 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.2 t -143.74 142.83 31.12 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 117.037 0.419 . . . . 0.0 111.138 179.51 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.568 HG13 ' HB2' ' A' ' 68' ' ' PRO . 52.9 t -68.0 138.64 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.066 -0.516 . . . . 0.0 112.062 -179.193 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.409 HG21 HG11 ' A' ' 80' ' ' VAL . 2.6 pt -112.46 92.75 2.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-O 121.274 0.559 . . . . 0.0 109.899 178.369 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -63.98 -28.45 69.82 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.628 -179.743 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.439 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.8 OUTLIER -130.81 179.46 1.34 Allowed Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.801 -179.67 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.439 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 31.9 Cg_exo -60.58 146.19 97.48 Favored 'Trans proline' 0 N--CA 1.501 1.951 0 C-N-CA 123.137 2.558 . . . . 0.0 113.244 179.898 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.409 HG11 HG21 ' A' ' 76' ' ' ILE . 2.7 p -140.4 137.95 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.381 179.484 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 68.2 ttp85 -73.12 129.07 37.25 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.904 -0.319 . . . . 0.0 110.77 179.925 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 97.4 mt -81.2 139.58 35.44 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.355 0.598 . . . . 0.0 110.946 179.936 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -136.71 152.19 50.09 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.352 -179.748 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -52.15 114.82 1.45 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.927 0.394 . . . . 0.0 110.366 -179.797 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.81 -18.34 22.13 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.034 -0.827 . . . . 0.0 111.034 -179.718 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.688 ' OD1' HG13 ' A' ' 71' ' ' VAL . 53.3 t0 -66.21 129.49 40.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.276 0.56 . . . . 0.0 110.021 179.153 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.501 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 9.3 p -109.16 133.91 52.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.687 -179.051 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.1 mt -99.88 129.47 50.47 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.204 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.6 m -123.58 127.74 48.72 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.699 0.761 . . . . 0.0 112.761 -178.456 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.483 ' O ' ' N ' ' A' ' 93' ' ' ARG . 96.5 mt -117.37 125.82 74.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 114.44 -1.255 . . . . 0.0 108.551 177.626 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.555 HG22 ' N ' ' A' ' 92' ' ' ASP . 82.4 mt 36.55 -103.3 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.929 179.949 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.555 ' N ' HG22 ' A' ' 91' ' ' ILE . 89.8 m-20 -109.32 7.82 25.32 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.571 179.715 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.745 ' CZ ' HD12 ' A' ' 41' ' ' LEU . 40.9 mtm-85 -121.94 140.85 51.94 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -179.208 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.5 t -138.03 152.26 48.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.297 0.57 . . . . 0.0 111.091 -179.698 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -121.99 120.96 35.92 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.417 179.081 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 53.6 ttt85 -84.87 129.98 34.73 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.871 -179.197 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -93.74 122.84 36.61 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.208 -179.242 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -123.0 124.19 42.58 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.88 179.967 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 63.2 t-20 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.055 -179.711 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' B' B ' 235' ' ' PRO . . . . . 0.665 ' O ' HG23 ' A' ' 43' ' ' VAL . 56.9 Cg_endo . . . . . 0 N--CA 1.493 1.451 0 CA-C-O 121.138 0.391 . . . . 0.0 112.667 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.439 ' HA ' HD21 ' A' ' 67' ' ' ASN . 24.4 t -57.74 137.33 20.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.798 -179.61 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 7.0 t . . . . . 0 C--N 1.327 -0.376 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.257 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo . . . . . 0 N--CA 1.49 1.317 0 CA-C-O 120.338 0.057 . . . . 0.0 112.159 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 91.3 m -73.57 -47.52 40.0 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-O 121.132 0.492 . . . . 0.0 109.732 178.894 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.48 ' CZ ' HG11 ' A' ' 43' ' ' VAL . 69.0 t80 -59.83 -45.66 91.69 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.71 -179.29 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 91.9 mt -64.5 -40.56 95.87 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.86 0.362 . . . . 0.0 110.887 -179.728 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -60.14 -42.11 94.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.351 -179.2 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 244' ' ' ARG . . . . . 0.511 ' O ' ' OG ' ' B' ' 247' ' ' SER . 89.4 mtm180 -65.3 -39.29 92.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.594 179.276 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.505 ' NH2' HH11 ' A' ' 93' ' ' ARG . 16.8 mmm180 -60.72 -43.66 97.57 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.863 -178.471 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -63.92 -40.19 95.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.208 0.528 . . . . 0.0 109.819 179.353 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 247' ' ' SER . . . . . 0.511 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 67.9 p -64.03 -44.72 91.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.625 179.182 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 248' ' ' GLN . . . . . 0.466 ' HB2' HH22 ' A' ' 12' ' ' ARG . 87.3 mt-30 -61.1 -33.79 73.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.68 179.665 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 55.4 t . . . . . 0 C--N 1.332 -0.185 0 C-N-CA 120.259 -0.577 . . . . 0.0 109.754 179.139 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.471 ' OE1' HD21 ' A' ' 41' ' ' LEU . 97.4 mt-10 . . . . . 0 CA--C 1.522 -0.102 0 CA-C-O 120.472 0.177 . . . . 0.0 110.916 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 66.8 mt -115.96 135.35 56.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.765 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 72.7 t -127.39 135.39 63.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.113 179.543 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -96.84 118.18 32.71 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.396 0.617 . . . . 0.0 110.769 -179.163 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -66.85 -46.72 74.18 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.066 -179.917 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -75.31 168.5 27.09 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.588 -179.083 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -64.64 144.17 83.45 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 121.356 1.371 . . . . 0.0 111.024 179.275 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 10.6 tt . . . . . 0 C--N 1.322 -0.613 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.534 -178.936 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.4 m . . . . . 0 N--CA 1.463 0.185 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.96 ' NE ' HD13 ' A' ' 53' ' ' ILE . 86.2 mtm-85 -90.83 130.68 36.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.068 0.461 . . . . 0.0 111.328 -178.407 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.661 ' C ' HD12 ' A' ' 7' ' ' LEU . 99.8 mtt180 -135.41 143.0 45.74 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.966 179.677 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.661 HD12 ' C ' ' A' ' 6' ' ' ARG . 10.9 mp -120.08 139.33 52.71 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.93 0.395 . . . . 0.0 110.937 179.773 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.598 HG22 ' CD2' ' A' ' 19' ' ' HIS . 46.5 t -111.88 132.02 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.102 -179.729 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.411 HG23 HD12 ' B' ' 261' ' ' ILE . 9.0 m -84.21 139.37 32.43 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -178.286 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.2 mm -108.31 135.11 48.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.821 177.324 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -90.8 159.93 16.03 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 177.802 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.534 HH11 ' HB2' ' B' ' 245' ' ' ARG . 90.9 mtm180 -56.2 -20.98 20.41 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.149 -179.42 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.9 m -83.62 -13.16 54.92 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.12 179.876 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.25 31.49 11.75 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.102 179.634 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.1 m -118.78 142.54 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 120.982 0.42 . . . . 0.0 111.77 -179.793 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -73.21 119.12 17.01 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.237 -179.151 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -110.96 -128.21 5.3 Favored Glycine 0 CA--C 1.54 1.654 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 -179.752 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -74.8 149.53 37.83 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 122.538 2.159 . . . . 0.0 113.209 -178.854 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.598 ' CD2' HG22 ' A' ' 8' ' ' VAL . 47.8 m170 -101.72 143.55 31.52 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.126 -179.665 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.764 ' CD2' HD11 ' A' ' 37' ' ' ILE . 39.0 t80 -113.42 92.52 23.48 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.192 179.53 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.463 ' HD2' HG22 ' B' ' 267' ' ' ILE . 94.4 Cg_endo -77.67 138.19 16.87 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 121.878 1.719 . . . . 0.0 111.767 -179.415 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 82.9 mt -101.65 125.54 48.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.454 0.645 . . . . 0.0 111.465 -179.007 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 82.9 p -120.34 -1.03 10.28 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.329 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.589 HD12 ' CD ' ' B' ' 265' ' ' GLN . 45.4 mt -111.37 152.83 26.86 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 114.402 -1.272 . . . . 0.0 109.398 -178.921 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.9 m -77.27 -11.76 59.87 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -177.818 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 20.7 m -127.31 130.92 50.4 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 120.131 -0.628 . . . . 0.0 112.03 -179.617 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.5 t -126.15 117.97 24.24 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.851 178.841 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.538 HD21 ' OE1' ' A' ' 47' ' ' GLN . 31.9 tp -113.57 134.97 54.4 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 120.838 0.351 . . . . 0.0 111.215 -178.851 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.511 ' O ' ' O ' ' A' ' 47' ' ' GLN . 79.0 m-85 -112.44 135.82 52.68 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.682 179.244 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 165.39 -164.94 37.56 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 120.617 -0.801 . . . . 0.0 111.422 179.784 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 31.1 ptt-85 -103.41 -26.19 12.99 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.544 -0.462 . . . . 0.0 111.24 179.996 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -50.29 158.55 1.71 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 179.859 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.564 ' O ' ' NH2' ' A' ' 38' ' ' ARG . 7.9 tp -66.94 -41.87 88.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 117.644 0.722 . . . . 0.0 110.588 -179.22 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.448 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 80.4 tt0 -60.13 -19.68 54.72 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 -178.914 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.408 ' HA ' HD23 ' A' ' 28' ' ' LEU . 55.8 m -59.84 130.98 49.42 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.276 -0.57 . . . . 0.0 111.002 -179.238 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.565 ' CG ' ' NE2' ' B' ' 265' ' ' GLN . 74.2 m-20 -61.5 -32.65 72.69 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.907 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.764 HD11 ' CD2' ' A' ' 20' ' ' PHE . 46.6 mm -119.83 112.84 38.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.102 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.564 ' NH2' ' O ' ' A' ' 33' ' ' ILE . 74.0 mtt85 -98.95 131.16 45.22 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.579 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.642 HD13 ' HD2' ' A' ' 93' ' ' ARG . 91.8 mt -121.76 132.13 71.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.882 0.373 . . . . 0.0 110.711 -178.265 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -75.46 33.02 0.11 Allowed 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -177.664 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.683 HD12 ' CZ ' ' A' ' 93' ' ' ARG . 88.5 mt -115.19 123.76 31.21 Favored Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 120.261 -0.575 . . . . 0.0 110.159 179.138 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.95 -7.21 19.68 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.291 1.994 . . . . 0.0 113.427 -178.986 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.9 m -87.26 1.24 6.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 119.791 -0.763 . . . . 0.0 109.129 178.69 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.63 HG12 ' O ' ' A' ' 41' ' ' LEU . 2.4 p -96.29 138.39 21.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.262 178.533 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.449 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 3.7 t -75.22 173.36 10.93 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.592 0.71 . . . . 0.0 111.86 -178.348 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 43.6 mttp -64.13 -41.77 97.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.043 179.954 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.647 ' O ' ' N ' ' A' ' 49' ' ' CYS . 10.7 mm100 -109.72 -20.69 12.72 Favored 'General case' 0 C--N 1.334 -0.068 0 CA-C-O 120.766 0.317 . . . . 0.0 110.952 -179.691 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.449 ' H ' ' HB3' ' A' ' 45' ' ' SER . 15.1 t60 37.54 -77.81 0.0 OUTLIER 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.647 -179.862 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.647 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.65 135.31 45.76 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.331 0.586 . . . . 0.0 111.581 -179.337 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -126.02 131.83 52.12 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.157 179.844 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 99.2 mt -118.27 133.45 65.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.267 179.912 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.491 ' OE2' ' NE2' ' A' ' 61' ' ' HIS . 21.8 pt-20 -116.62 128.43 55.38 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.48 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.96 HD13 ' NE ' ' A' ' 5' ' ' ARG . 83.4 mt -107.53 114.92 47.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.506 -178.074 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.522 ' O ' ' N ' ' A' ' 56' ' ' GLN . 99.5 m-70 -113.28 144.7 42.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.983 179.894 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 54' ' ' HIS . 84.6 tt0 -39.62 -27.58 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -179.717 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.522 ' N ' ' O ' ' A' ' 54' ' ' HIS . 89.1 mt-30 -65.66 -68.99 0.32 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.534 178.798 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -161.25 -161.83 0.85 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.92 0.39 . . . . 0.0 111.073 179.23 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.431 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -111.35 125.15 53.55 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.781 179.42 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.7 mt -113.91 128.34 70.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.997 0.427 . . . . 0.0 111.39 -179.076 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.454 ' HB2' HD11 ' A' ' 82' ' ' LEU . 27.1 tp -98.19 128.35 44.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.928 -179.798 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.491 ' NE2' ' OE2' ' A' ' 52' ' ' GLU . 99.6 m-70 -116.3 138.11 51.59 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.711 -179.268 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -103.13 105.36 15.65 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 179.944 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -96.94 -4.41 40.01 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.93 178.988 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.65 100.83 11.1 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.044 179.355 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.2 m -87.64 -14.47 39.93 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.089 179.852 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.471 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -85.71 -41.19 15.35 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.499 -179.849 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -144.2 95.05 5.64 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.486 179.702 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -64.65 150.86 87.51 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 121.28 1.32 . . . . 0.0 112.988 -178.483 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.6 m -72.73 137.45 45.93 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.829 -179.705 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -97.2 140.19 32.05 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.506 -0.478 . . . . 0.0 109.842 178.997 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.457 ' O ' ' N ' ' A' ' 74' ' ' SER . 7.3 p -129.43 135.95 60.47 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.504 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.131 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 48.86 29.83 2.46 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -178.78 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 76.11 25.07 67.29 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-N 115.045 -0.98 . . . . 0.0 112.18 179.94 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 71' ' ' VAL . 12.9 t -137.37 139.16 40.59 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 117.383 0.591 . . . . 0.0 111.733 -179.874 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.4 m -73.57 138.32 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.055 179.985 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.569 HG21 HG21 ' A' ' 80' ' ' VAL . 7.6 pt -105.15 94.25 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 121.184 0.516 . . . . 0.0 111.274 179.611 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -65.33 -33.62 76.4 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.226 179.285 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -121.16 167.35 13.42 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.404 -179.129 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -60.32 142.81 99.03 Favored 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 121.842 1.695 . . . . 0.0 112.104 -179.304 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.569 HG21 HG21 ' A' ' 76' ' ' ILE . 24.2 m -137.04 137.57 46.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.094 0.473 . . . . 0.0 110.834 179.237 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -71.56 133.09 45.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.947 179.705 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.454 HD11 ' HB2' ' A' ' 60' ' ' LEU . 92.8 mt -85.74 139.59 31.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.219 0.533 . . . . 0.0 110.604 179.872 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -123.97 151.23 43.89 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.319 179.824 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.439 ' ND1' ' N ' ' A' ' 99' ' ' ASN . 5.6 t60 -57.56 122.64 13.19 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.653 -179.67 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.47 -15.84 35.05 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 179.616 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -69.27 137.74 53.32 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.415 -179.766 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 40.6 t -110.17 130.56 63.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.964 0.411 . . . . 0.0 110.829 -179.239 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 88.0 mt -98.71 130.64 47.26 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 178.373 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 94.5 m -123.14 124.54 43.3 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 119.816 -0.754 . . . . 0.0 112.187 -178.866 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.496 ' O ' ' C ' ' A' ' 91' ' ' ILE . 92.1 mt -115.46 130.89 69.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.129 178.284 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.579 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 84.7 mt -15.68 98.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -178.059 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.453 ' OD1' ' NE ' ' B' ' 245' ' ' ARG . 23.7 m-20 85.23 -22.11 0.21 Allowed 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 177.617 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.683 ' CZ ' HD12 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -130.59 144.1 51.19 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.985 -179.676 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 66.8 p -137.96 153.97 49.41 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.177 0.513 . . . . 0.0 110.072 -179.859 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.667 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 81.8 m-85 -125.15 122.73 37.92 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.481 179.792 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -84.69 132.16 34.49 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.619 -179.627 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.619 ' CZ ' ' OD1' ' A' ' 99' ' ' ASN . 88.0 t80 -97.12 123.93 41.01 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.775 -179.525 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -134.49 127.52 31.58 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.673 179.954 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.619 ' OD1' ' CZ ' ' A' ' 97' ' ' TYR . 70.1 m-20 . . . . . 0 N--CA 1.467 0.378 0 CA-C-O 120.916 0.389 . . . . 0.0 110.854 179.296 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo . . . . . 0 N--CA 1.491 1.331 0 CA-C-O 121.159 0.399 . . . . 0.0 112.899 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.471 ' CG2' HG22 ' A' ' 66' ' ' THR . 78.6 t -61.48 139.4 20.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.184 -179.591 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 237' ' ' CYS . . . . . 0.466 ' HB2' HD13 ' A' ' 91' ' ' ILE . 3.8 t . . . . . 0 C--N 1.33 -0.242 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.279 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo . . . . . 0 N--CA 1.498 1.745 0 CA-C-O 120.744 0.227 . . . . 0.0 112.455 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 28.4 m -69.07 -48.83 61.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.234 0.54 . . . . 0.0 110.194 178.557 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -60.15 -46.64 88.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.788 -178.62 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.421 ' CD2' ' OD1' ' A' ' 92' ' ' ASP . 97.3 mt -63.92 -41.19 97.72 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.761 -0.375 . . . . 0.0 111.964 -178.59 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -66.32 -39.96 89.62 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.167 -179.635 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -62.18 -48.96 77.74 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.162 -0.615 . . . . 0.0 112.274 -178.754 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.534 ' HB2' HH11 ' A' ' 12' ' ' ARG . 3.9 ppt_? -65.72 -37.61 86.89 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.074 -178.515 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 246' ' ' LYS . . . . . 0.439 ' N ' ' HG3' ' B' ' 245' ' ' ARG . 36.7 ttmt -62.73 -40.44 97.22 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.519 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 50.5 m -65.73 -41.79 91.81 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.945 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -56.79 -39.47 74.16 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.934 179.486 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 58.1 t . . . . . 0 N--CA 1.452 -0.343 0 CA-C-O 121.079 0.466 . . . . 0.0 110.201 179.206 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.566 ' OE1' HD21 ' A' ' 41' ' ' LEU . 97.6 mt-10 . . . . . 0 CA--C 1.523 -0.086 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.667 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 58.2 mt -114.77 137.51 47.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.947 -179.865 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 48.8 t -124.43 133.95 68.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.883 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -93.01 117.3 29.91 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.768 -178.262 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -67.33 -44.88 78.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.623 179.411 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 265' ' ' GLN . . . . . 0.589 ' CD ' HD12 ' A' ' 24' ' ' LEU . 33.6 mt-30 -88.84 152.41 48.69 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.039 -178.957 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -62.22 141.36 87.75 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.44 2.093 . . . . 0.0 113.259 179.878 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 267' ' ' ILE . . . . . 0.463 HG22 ' HD2' ' A' ' 21' ' ' PRO . 20.5 pt . . . . . 0 N--CA 1.463 0.209 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.827 179.026 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.7 p . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.852 0.358 . . . . 0.0 110.675 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.5 mtt85 -99.46 131.49 45.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.014 -179.731 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -135.66 144.71 46.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.343 179.27 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 83.2 mt -112.13 141.19 46.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.125 179.007 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 31.1 t -114.84 129.13 71.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.576 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.473 ' CG2' HD12 ' B' ' 261' ' ' ILE . 5.1 m -92.07 114.99 27.68 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -177.943 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.478 HD12 ' OG ' ' A' ' 94' ' ' SER . 96.7 mt -81.68 144.73 9.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.543 178.205 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.9 mttt -94.48 162.27 13.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.892 0.377 . . . . 0.0 110.436 179.221 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -57.89 -30.04 65.53 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.531 -178.969 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.562 ' OG ' HG22 ' A' ' 15' ' ' VAL . 78.2 p -76.28 -20.56 57.22 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.649 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.7 32.62 4.4 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.903 179.649 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.562 HG22 ' OG ' ' A' ' 13' ' ' SER . 6.7 m -128.07 134.47 65.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.881 0.372 . . . . 0.0 110.85 179.399 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -71.45 139.01 49.48 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.321 179.276 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -127.08 -118.1 2.15 Favored Glycine 0 CA--C 1.536 1.345 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -179.89 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.02 147.7 43.7 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 121.951 1.768 . . . . 0.0 112.619 -179.331 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -111.52 153.54 26.06 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.779 179.801 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -122.45 94.01 48.06 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.199 -178.598 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.52 127.99 25.67 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.145 1.897 . . . . 0.0 111.601 179.426 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.415 ' HA ' HD23 ' A' ' 22' ' ' LEU . 95.9 mt -82.77 56.42 3.39 Favored 'General case' 0 CA--C 1.522 -0.134 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.949 -179.733 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 91.9 p -62.74 -16.16 56.41 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.028 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.664 HD11 ' HG2' ' B' ' 265' ' ' GLN . 56.4 mt -91.92 143.15 26.79 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 114.761 -1.108 . . . . 0.0 110.676 -179.794 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.9 m -69.1 -17.02 63.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.697 -179.303 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.2 m -134.61 137.52 43.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.048 -179.874 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.615 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.6 OUTLIER -130.82 124.23 30.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.012 178.554 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.572 HD21 ' HG2' ' A' ' 47' ' ' GLN . 52.4 tp -118.36 128.72 54.91 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.966 0.412 . . . . 0.0 112.03 -177.758 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.615 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 60.5 m-85 -103.49 124.25 48.4 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.951 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 176.35 -178.23 47.74 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 119.822 -1.18 . . . . 0.0 112.965 179.449 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 46.2 mtm180 -80.05 -28.53 39.22 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.807 0.337 . . . . 0.0 110.6 179.034 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -54.66 143.35 32.22 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 -178.985 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.3 mm -64.92 -43.17 96.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.177 0.513 . . . . 0.0 109.816 179.166 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -55.91 -20.3 15.36 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.086 -179.851 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 38.5 m -63.95 131.05 46.49 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.509 -179.918 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 37' ' ' ILE . 6.6 p-10 -59.47 -30.39 68.5 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.838 -178.956 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.535 ' N ' ' OD1' ' A' ' 36' ' ' ASP . 96.5 mt -126.14 121.43 59.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.528 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 77.1 ttt-85 -110.51 136.89 48.95 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.061 -178.377 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.723 HG21 HD12 ' A' ' 41' ' ' LEU . 82.9 mt -119.61 131.35 72.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.922 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -75.56 24.0 0.12 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.246 -179.1 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.723 HD12 HG21 ' A' ' 39' ' ' ILE . 24.6 mt -89.31 122.96 68.09 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.365 179.808 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.73 -14.86 30.17 Favored 'Trans proline' 0 N--CA 1.488 1.177 0 C-N-CA 121.783 1.655 . . . . 0.0 112.594 -179.72 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.624 HG21 ' CE2' ' B' ' 241' ' ' PHE . 1.1 m -93.65 3.41 8.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.087 179.913 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.451 HG12 ' O ' ' A' ' 45' ' ' SER . 25.0 t -89.44 137.02 22.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 120.441 -0.504 . . . . 0.0 109.945 179.069 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.451 ' O ' HG12 ' A' ' 44' ' ' VAL . 2.3 m -68.61 171.98 6.87 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.568 0.699 . . . . 0.0 111.504 -179.596 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -63.4 -43.58 97.15 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.659 -179.802 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.623 ' O ' ' N ' ' A' ' 49' ' ' CYS . 89.9 mt-30 -116.94 -20.53 9.36 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.805 179.904 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.3 t60 36.21 -78.58 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 179.491 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.623 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -125.89 133.82 51.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.217 0.532 . . . . 0.0 112.194 -178.847 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -126.51 129.91 49.56 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.688 179.827 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.6 mt -113.71 132.91 61.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.984 0.421 . . . . 0.0 110.419 179.01 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.461 ' OE2' ' CE1' ' A' ' 54' ' ' HIS . 83.4 tt0 -118.08 125.35 50.14 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 178.62 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 93.4 mt -108.63 123.04 64.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.808 0.813 . . . . 0.0 112.855 -178.155 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.554 ' O ' ' N ' ' A' ' 56' ' ' GLN . 98.0 m-70 -115.85 139.05 50.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.258 -1.337 . . . . 0.0 109.285 179.143 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.482 ' C ' ' O ' ' A' ' 54' ' ' HIS . 83.5 tt0 -39.99 -26.25 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -179.666 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.554 ' N ' ' O ' ' A' ' 54' ' ' HIS . 91.5 mt-30 -64.46 -68.97 0.31 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.027 177.812 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -159.7 -161.89 0.96 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.578 179.81 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -118.41 131.79 56.27 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.517 179.99 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.0 mt -117.57 129.21 74.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-O 121.387 0.613 . . . . 0.0 111.727 -179.301 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.546 ' HB2' HD11 ' A' ' 82' ' ' LEU . 28.2 tp -98.68 127.31 44.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.338 -179.782 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -111.79 135.48 52.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.21 179.858 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.41 HD21 ' CA ' ' A' ' 68' ' ' PRO . 62.7 t-20 -94.77 106.99 19.01 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.42 179.995 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -99.38 -10.38 22.33 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 179.53 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.446 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 7.4 t -76.22 98.62 4.49 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.727 -179.565 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.9 p -80.71 -35.16 33.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.143 0.497 . . . . 0.0 109.768 178.671 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.5 m -65.16 -49.65 69.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.692 179.859 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.446 ' O ' ' OG ' ' A' ' 64' ' ' SER . 0.6 OUTLIER -136.57 96.35 12.17 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.461 179.535 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.48 ' HB2' HG13 ' A' ' 75' ' ' VAL . 32.5 Cg_exo -55.38 144.73 71.15 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.105 1.87 . . . . 0.0 112.082 -179.204 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.7 m -73.76 146.81 44.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.332 179.831 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -110.29 141.25 43.54 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.782 179.955 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 42.0 t -127.92 134.27 65.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.426 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 52.54 30.53 8.6 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -179.447 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.65 25.47 69.85 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.74 179.792 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 58.3 m -136.52 138.48 41.38 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.452 -179.642 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.48 HG13 ' HB2' ' A' ' 68' ' ' PRO . 44.4 t -68.94 138.28 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.433 179.982 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.9 pt -116.19 85.88 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.202 179.502 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.524 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 15.4 p-10 -66.47 -26.57 67.25 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.538 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -114.04 159.54 35.83 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.333 179.7 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -66.75 149.45 83.61 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.772 2.315 . . . . 0.0 111.822 179.278 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.2 m -141.45 144.42 26.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.692 -179.427 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -71.68 130.72 41.85 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.281 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.546 HD11 ' HB2' ' A' ' 60' ' ' LEU . 96.9 mt -81.89 138.82 34.95 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.096 0.474 . . . . 0.0 111.93 -178.738 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -130.91 151.65 51.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.715 179.585 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -57.0 121.1 9.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.893 0.378 . . . . 0.0 111.145 -179.228 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.13 -17.28 19.68 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 179.48 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -71.4 134.68 46.83 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.269 0.557 . . . . 0.0 111.082 -179.784 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 68.1 t -111.02 133.86 55.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.713 -179.361 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 79.1 mt -103.58 133.4 47.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.366 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 84.8 m -121.59 131.24 54.01 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.789 0.804 . . . . 0.0 112.589 -178.53 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 76.5 mt -123.47 126.46 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 114.29 -1.323 . . . . 0.0 108.783 179.247 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.469 HG22 ' N ' ' A' ' 92' ' ' ASP . 44.9 mm 43.42 -107.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.002 -179.253 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.562 ' HB3' ' HE ' ' B' ' 245' ' ' ARG . 45.7 t0 -114.89 16.59 17.22 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.943 0.402 . . . . 0.0 111.048 -179.795 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 17.4 mtp180 -130.78 148.22 52.54 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.067 179.4 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.478 ' OG ' HD12 ' A' ' 10' ' ' ILE . 19.4 p -138.64 157.35 46.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.966 0.412 . . . . 0.0 110.839 -179.23 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.574 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 66.7 m-85 -124.0 121.62 35.73 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.563 179.086 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -80.2 131.67 35.74 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.306 -179.78 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -96.62 121.28 38.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.955 -179.865 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -121.49 122.87 40.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.118 -179.89 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 60.4 t-20 . . . . . 0 CA--C 1.521 -0.152 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.324 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo . . . . . 0 N--CA 1.494 1.532 0 CA-C-O 121.026 0.344 . . . . 0.0 112.38 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.411 ' O ' HG13 ' B' ' 236' ' ' VAL . 4.4 p -101.72 129.5 52.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.945 179.381 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 53.2 t . . . . . 0 C--N 1.325 -0.462 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.143 -179.341 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo . . . . . 0 N--CA 1.498 1.753 0 CA-C-O 120.732 0.222 . . . . 0.0 112.589 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 96.3 m -73.5 -46.75 46.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.48 179.3 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.624 ' CE2' HG21 ' A' ' 43' ' ' VAL . 72.2 t80 -59.91 -45.35 92.84 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.588 -179.123 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' B' ' 242' ' ' LEU . 93.9 mt -64.71 -39.25 93.33 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.018 0.437 . . . . 0.0 110.218 179.397 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -61.75 -42.83 99.48 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.339 -179.368 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -62.37 -40.67 97.21 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.231 179.903 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.63 ' NH1' HD21 ' A' ' 41' ' ' LEU . 77.6 mtp85 -60.84 -41.97 96.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.166 -179.943 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.22 -40.8 98.49 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 179.247 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 10.9 t -65.26 -46.71 79.44 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.855 178.448 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -60.12 -39.11 85.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.247 -179.549 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 249' ' ' VAL . . . . . 0.443 HG23 ' O ' ' B' ' 245' ' ' ARG . 45.3 t . . . . . 0 C--N 1.327 -0.398 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.291 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 . . . . . 0 N--CA 1.461 0.086 0 CA-C-O 120.706 0.289 . . . . 0.0 110.7 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.574 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 78.5 mt -101.89 137.58 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 178.312 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 64.6 t -126.64 134.3 66.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.79 -178.95 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -96.73 119.54 35.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.111 0.481 . . . . 0.0 111.231 -178.672 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -64.66 -40.66 95.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.454 179.532 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 265' ' ' GLN . . . . . 0.664 ' HG2' HD11 ' A' ' 24' ' ' LEU . 2.4 mp0 -101.96 160.82 25.3 Favored Pre-proline 0 N--CA 1.464 0.247 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.431 -179.242 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -70.94 145.76 51.13 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 122.595 2.197 . . . . 0.0 113.221 -179.105 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.4 pt . . . . . 0 C--N 1.326 -0.434 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.197 178.86 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.7 p . . . . . 0 N--CA 1.452 -0.359 0 CA-C-O 121.282 0.563 . . . . 0.0 109.636 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.596 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 92.4 mtt-85 -88.17 131.49 34.71 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.951 -179.526 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.5 mtp180 -133.27 141.03 47.8 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 120.312 -0.555 . . . . 0.0 112.389 -179.274 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.609 HD11 ' HB3' ' A' ' 95' ' ' PHE . 40.0 tp -117.42 132.97 56.47 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.243 179.488 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.511 HG13 ' CE1' ' A' ' 19' ' ' HIS . 53.0 t -108.37 131.07 59.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.897 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.407 ' CG2' HD12 ' B' ' 261' ' ' ILE . 1.7 m -93.71 117.45 30.1 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.346 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.489 ' CD1' ' OD1' ' A' ' 16' ' ' ASP . 48.3 mm -82.27 143.28 12.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.645 179.649 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -90.97 160.48 15.62 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 177.701 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.409 ' CG ' ' NH1' ' A' ' 93' ' ' ARG . 83.4 mtm180 -57.0 -24.48 53.93 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.962 -178.442 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 68.6 p -83.9 -8.26 59.23 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.922 179.754 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.21 35.12 9.03 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 179.887 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 32.2 t -117.3 132.49 66.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 -179.997 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.489 ' OD1' ' CD1' ' A' ' 10' ' ' ILE . 92.4 m-20 -70.04 133.46 47.23 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.656 -0.418 . . . . 0.0 109.952 179.762 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -126.03 -122.26 2.57 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.593 -179.547 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -72.91 145.92 41.18 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.002 1.801 . . . . 0.0 112.575 -179.036 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.511 ' CE1' HG13 ' A' ' 8' ' ' VAL . 4.8 m-70 -107.83 143.44 36.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.132 0.491 . . . . 0.0 111.126 -179.331 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.533 ' CD2' HD11 ' A' ' 37' ' ' ILE . 25.8 t80 -115.04 93.96 36.8 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.069 -179.207 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -56.79 124.4 16.15 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 121.896 1.731 . . . . 0.0 111.681 179.136 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.7 mt -87.79 41.73 1.01 Allowed 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.384 -179.781 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.8 p -64.7 -20.44 66.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.788 179.594 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.8 mt -74.04 142.09 45.73 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.568 179.778 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 73.8 p -61.42 -25.15 67.02 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.362 -179.21 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 45.3 m -134.69 134.33 40.97 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.221 -0.592 . . . . 0.0 111.534 179.917 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.692 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -128.37 120.2 26.51 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.069 178.345 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.522 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 43.4 tp -120.03 124.96 47.18 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.999 -177.02 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.692 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 38.8 m-85 -101.37 140.83 35.12 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.23 179.282 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 158.67 -173.58 35.67 Favored Glycine 0 N--CA 1.464 0.536 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.156 178.269 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.63 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 72.2 mtm-85 -83.29 -30.74 27.33 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.876 0.37 . . . . 0.0 110.21 179.895 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.561 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -56.29 152.08 21.15 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 121.126 -0.559 . . . . 0.0 111.728 -178.26 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.578 HD12 ' HD3' ' A' ' 38' ' ' ARG . 7.1 tp -66.7 -40.51 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.677 179.958 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.418 ' N ' HG23 ' A' ' 33' ' ' ILE . 96.9 mt-10 -53.69 -21.39 6.92 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.293 179.972 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.561 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 4.2 m -63.88 115.78 5.17 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.118 -179.974 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.594 ' OD1' ' N ' ' A' ' 37' ' ' ILE . 39.2 p-10 -50.97 -24.59 3.79 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.758 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.673 HD12 ' CE2' ' A' ' 29' ' ' PHE . 94.2 mt -130.67 123.49 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.223 178.062 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.578 ' HD3' HD12 ' A' ' 33' ' ' ILE . 88.2 mtm-85 -103.97 134.66 46.88 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.4 -0.52 . . . . 0.0 109.801 -179.434 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.717 HG21 HD12 ' A' ' 41' ' ' LEU . 98.1 mt -117.91 130.54 72.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.064 0.459 . . . . 0.0 109.796 -179.809 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -79.23 30.37 0.22 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.201 -179.043 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.717 HD12 HG21 ' A' ' 39' ' ' ILE . 33.9 mt -94.8 123.24 58.44 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.476 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.99 -10.76 26.59 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 121.856 1.704 . . . . 0.0 112.047 -179.386 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.6 m -100.51 8.31 8.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.771 -179.211 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.63 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 42.2 t -100.63 136.75 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.459 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.448 ' HB2' ' H ' ' A' ' 48' ' ' HIS . 2.7 m -67.66 169.47 9.4 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.317 0.579 . . . . 0.0 111.478 -179.179 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -62.26 -40.35 95.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.455 -179.474 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.697 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.1 mt-30 -114.59 -11.19 12.42 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 123.348 0.405 . . . . 0.0 111.357 -179.933 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.448 ' H ' ' HB2' ' A' ' 45' ' ' SER . 22.8 t60 31.86 -73.45 0.0 OUTLIER 'General case' 0 C--O 1.237 0.423 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 179.649 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.697 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -134.95 139.5 44.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.284 0.564 . . . . 0.0 112.324 -178.621 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -125.42 128.68 48.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.049 179.323 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 94.6 mt -115.45 133.3 62.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.016 -179.552 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -115.5 127.25 55.17 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.859 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.563 HD13 ' HD2' ' A' ' 5' ' ' ARG . 75.9 mt -108.36 111.99 38.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.95 -179.386 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.538 ' O ' ' N ' ' A' ' 56' ' ' GLN . 82.3 m-70 -110.8 143.94 40.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.541 -179.598 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 54' ' ' HIS . 96.9 mt-10 -41.06 -24.84 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.532 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.538 ' N ' ' O ' ' A' ' 54' ' ' HIS . 94.2 mm-40 -68.8 -68.8 0.37 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.463 178.712 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.595 ' CB ' ' HE ' ' A' ' 81' ' ' ARG . 5.1 tp10 -159.17 -167.76 2.16 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.328 179.895 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.539 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -110.67 125.33 53.34 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.937 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.14 129.54 71.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.353 0.596 . . . . 0.0 112.391 -177.757 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.5 HD11 ' SG ' ' A' ' 49' ' ' CYS . 49.3 tp -94.72 123.45 38.17 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.38 -179.431 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -111.68 136.47 50.87 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.362 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -97.94 105.41 17.55 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.734 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -96.08 -7.32 36.44 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.682 178.976 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 10.1 t -79.46 100.8 7.85 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.279 178.798 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.0 m -84.74 -17.77 37.26 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.084 0.469 . . . . 0.0 110.025 179.577 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.05 -36.61 15.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.602 -179.845 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.437 ' O ' ' OG ' ' A' ' 64' ' ' SER . 79.5 m-20 -144.12 95.24 5.64 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.398 179.765 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.96 146.78 85.49 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.128 1.885 . . . . 0.0 112.658 -179.098 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.5 m -70.71 134.89 47.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.278 178.792 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -99.71 139.77 34.89 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.57 179.989 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 31.4 t -130.49 135.93 59.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 178.706 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 53.42 31.72 12.63 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -178.613 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.37 29.5 70.04 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.152 -179.866 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 81.1 p -137.63 130.5 30.16 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 120.446 -0.502 . . . . 0.0 111.999 -179.283 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.4 t -63.7 141.43 18.16 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.935 179.581 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.584 ' CG2' ' O ' ' A' ' 78' ' ' GLU . 96.3 mt -112.14 111.15 34.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.352 179.511 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -76.31 -34.34 59.04 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.801 179.579 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.584 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.1 OUTLIER -131.51 178.13 1.9 Allowed Pre-proline 0 N--CA 1.468 0.445 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.874 -179.734 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 35.5 Cg_exo -57.13 141.5 94.31 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 122.522 2.148 . . . . 0.0 112.739 -179.079 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.4 t -133.19 138.07 52.17 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.132 179.75 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.595 ' HE ' ' CB ' ' A' ' 57' ' ' GLU . 73.3 ttt180 -74.62 131.46 40.94 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.633 179.28 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.425 HD21 ' HB2' ' A' ' 60' ' ' LEU . 91.2 mt -87.25 140.97 29.01 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.16 0.505 . . . . 0.0 112.272 -178.645 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -134.4 156.12 49.09 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.406 179.59 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.573 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 6.3 t60 -56.77 120.17 7.41 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.868 0.366 . . . . 0.0 111.44 -179.359 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.33 -21.23 22.25 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.52 179.316 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -65.84 135.54 54.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.254 0.55 . . . . 0.0 110.341 -179.788 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.2 t -113.37 133.79 58.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.233 -178.213 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.7 mt -98.35 130.17 47.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.678 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 55.1 m -120.02 124.64 46.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.531 0.682 . . . . 0.0 112.26 -178.818 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.482 HG22 HG12 ' A' ' 91' ' ' ILE . 93.3 mt -115.54 124.0 71.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.091 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.548 HG23 ' SG ' ' B' ' 237' ' ' CYS . 27.5 mm 43.89 -106.49 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -178.812 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.608 ' OD1' ' NH2' ' B' ' 245' ' ' ARG . 40.6 p-10 -114.93 12.73 16.9 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.076 0.465 . . . . 0.0 110.473 179.273 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.515 ' CD ' HD11 ' B' ' 261' ' ' ILE . 6.1 ttp180 -120.39 143.62 48.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.577 179.732 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 38.2 t -137.7 152.83 49.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.353 0.596 . . . . 0.0 111.371 -178.76 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.609 ' HB3' HD11 ' A' ' 7' ' ' LEU . 46.5 m-85 -120.42 120.73 36.8 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.803 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.483 ' O ' HD12 ' A' ' 7' ' ' LEU . 99.7 mtt180 -84.04 131.69 34.79 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.363 -178.562 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.596 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 84.0 t80 -94.26 124.2 38.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.65 179.813 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -129.92 123.26 30.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.009 0.433 . . . . 0.0 111.638 -179.702 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.573 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 65.0 t-20 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.841 179.121 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 N--CA 1.487 1.097 0 CA-C-O 121.283 0.451 . . . . 0.0 112.889 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.435 ' HA ' HD21 ' A' ' 67' ' ' ASN . 31.3 t -59.63 134.78 24.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.794 -179.672 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 237' ' ' CYS . . . . . 0.548 ' SG ' HG23 ' A' ' 91' ' ' ILE . 8.6 t . . . . . 0 C--N 1.328 -0.359 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -179.861 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo . . . . . 0 N--CA 1.492 1.428 0 CA-C-O 120.444 0.102 . . . . 0.0 112.165 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 76.0 m -72.88 -44.46 61.28 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 178.337 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.464 ' CE2' ' HD2' ' B' ' 245' ' ' ARG . 63.3 t80 -58.75 -47.64 83.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.29 -179.465 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' B' ' 242' ' ' LEU . 89.2 mt -64.59 -42.49 95.55 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -179.386 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -65.52 -38.72 90.49 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.521 -0.472 . . . . 0.0 111.136 -179.08 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -61.77 -44.08 97.59 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.855 179.78 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.608 ' NH2' ' OD1' ' A' ' 92' ' ' ASP . 82.2 mtp180 -63.16 -37.66 88.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.089 -179.028 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.82 -39.4 91.65 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.359 -0.537 . . . . 0.0 109.99 179.225 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 61.9 m -67.49 -43.79 80.1 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.571 0.701 . . . . 0.0 109.516 178.274 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -60.82 -37.35 81.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.699 -179.863 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 249' ' ' VAL . . . . . 0.456 HG23 ' O ' ' B' ' 245' ' ' ARG . 50.0 t . . . . . 0 N--CA 1.447 -0.587 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.185 179.61 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.418 ' HB2' ' NH2' ' A' ' 93' ' ' ARG . 96.5 mt-10 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 121.0 0.429 . . . . 0.0 110.408 . . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.515 HD11 ' CD ' ' A' ' 93' ' ' ARG . 74.0 mt -112.93 137.64 45.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.684 179.978 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 262' ' ' VAL . . . . . 0.496 HG11 ' NH2' ' A' ' 38' ' ' ARG . 41.3 t -126.86 134.15 66.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.906 0.384 . . . . 0.0 110.579 179.891 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 263' ' ' PHE . . . . . 0.44 ' CD2' HG21 ' B' ' 267' ' ' ILE . 84.0 m-85 -97.55 122.26 40.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.979 0.418 . . . . 0.0 111.961 -178.528 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 264' ' ' LYS . . . . . 0.451 ' HA ' HH12 ' A' ' 38' ' ' ARG . 87.4 tttt -62.56 -44.9 95.2 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.663 179.578 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -99.52 164.97 15.59 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.01 179.977 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.72 153.13 51.63 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.392 2.062 . . . . 0.0 112.099 179.567 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 267' ' ' ILE . . . . . 0.485 HG22 ' HD1' ' A' ' 20' ' ' PHE . 36.4 pt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.089 -178.576 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 51.0 p . . . . . 0 CA--C 1.522 -0.127 0 CA-C-O 120.902 0.382 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.933 ' NH1' HG23 ' A' ' 53' ' ' ILE . 99.2 mtt180 -99.52 129.73 45.71 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.556 -178.78 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -129.23 143.08 50.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.495 -179.726 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.524 HD11 HD11 ' A' ' 22' ' ' LEU . 90.9 mt -113.29 136.37 52.82 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.697 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 50.0 t -112.94 131.92 63.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.839 -0.345 . . . . 0.0 110.303 -179.384 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.428 ' CG2' HD12 ' B' ' 261' ' ' ILE . 5.2 m -90.07 115.88 27.67 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 -177.722 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.47 HD12 ' HB2' ' A' ' 94' ' ' SER . 96.8 mt -85.09 142.22 13.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.292 178.153 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -91.42 159.98 15.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.97 0.414 . . . . 0.0 110.515 179.36 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 88.9 mtm180 -58.05 -29.53 65.45 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.792 -179.229 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.1 p -76.75 -17.3 59.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.86 0.362 . . . . 0.0 110.544 179.471 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.93 32.75 5.5 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -179.679 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.4 t -121.35 132.46 70.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.054 0.454 . . . . 0.0 111.106 -179.994 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -78.23 138.44 38.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.667 178.883 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.7 -115.72 1.67 Allowed Glycine 0 CA--C 1.533 1.162 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.467 179.936 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.11 148.56 56.63 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 121.841 1.694 . . . . 0.0 112.433 -179.392 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.515 ' CE1' ' HD3' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -113.13 158.05 20.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.016 0.436 . . . . 0.0 109.921 179.701 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.747 ' CD2' HD11 ' A' ' 37' ' ' ILE . 48.1 t80 -120.53 101.31 46.32 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.164 -179.044 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.515 ' HD3' ' CE1' ' A' ' 19' ' ' HIS . 59.7 Cg_endo -75.2 131.41 14.04 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.016 1.811 . . . . 0.0 111.891 -179.617 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.524 HD11 HD11 ' A' ' 7' ' ' LEU . 83.8 mt -86.71 85.32 7.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.158 0.504 . . . . 0.0 112.043 -178.486 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 92.6 p -89.01 -9.68 50.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.194 178.058 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 47.2 mt -104.45 148.12 26.81 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.071 -179.816 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.5 m -70.83 -16.23 62.7 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.498 -179.463 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.421 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 55.8 m -131.31 134.11 46.03 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.752 -179.916 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.6 t -129.63 120.54 25.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.955 178.179 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.464 HD11 ' HB3' ' A' ' 47' ' ' GLN . 35.3 tp -116.4 129.82 56.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.887 -179.078 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.528 ' O ' ' O ' ' A' ' 47' ' ' GLN . 9.8 m-85 -108.95 139.11 44.26 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.697 179.904 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 151.94 -178.71 29.05 Favored Glycine 0 N--CA 1.47 0.925 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.161 178.316 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.412 ' HD2' HH11 ' A' ' 31' ' ' ARG . 46.9 mtm180 -67.14 -33.29 75.12 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 179.381 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.54 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -46.78 131.8 12.29 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 -178.812 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.521 HG23 ' N ' ' A' ' 34' ' ' GLU . 9.3 tp -64.79 -42.03 93.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 O-C-N 122.434 -0.451 . . . . 0.0 110.024 179.387 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.521 ' N ' HG23 ' A' ' 33' ' ' ILE . 7.9 pt-20 -56.4 -13.01 1.93 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.228 179.292 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.54 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 31.3 m -70.16 139.15 52.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.595 -179.301 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.461 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 57.2 m-20 -63.77 -34.74 78.58 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.329 -179.505 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.747 HD11 ' CD2' ' A' ' 20' ' ' PHE . 40.6 mm -122.22 112.82 36.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 177.978 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.415 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 15.9 ttp180 -101.83 130.88 48.38 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.596 -178.636 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.675 HG21 HD12 ' A' ' 41' ' ' LEU . 93.2 mt -118.68 131.85 70.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.157 -179.395 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -76.03 32.45 0.12 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.606 -179.528 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.942 HD11 HH21 ' A' ' 93' ' ' ARG . 20.3 mt -95.55 118.46 66.14 Favored Pre-proline 0 CA--C 1.534 0.355 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.507 179.499 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -73.36 -11.4 24.7 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 121.908 1.739 . . . . 0.0 111.985 -179.922 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.1 m -95.39 5.26 8.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.207 179.431 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.446 HG12 ' O ' ' A' ' 45' ' ' SER . 5.0 t -98.69 139.84 19.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.577 -179.464 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.446 ' O ' HG12 ' A' ' 44' ' ' VAL . 75.3 m -68.73 175.18 3.71 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.682 0.753 . . . . 0.0 111.315 -179.589 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -65.12 -43.17 92.82 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.958 -179.699 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.616 ' O ' ' N ' ' A' ' 49' ' ' CYS . 81.9 mt-30 -113.77 -12.72 12.72 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.542 -179.682 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.9 t60 38.7 -76.89 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 178.873 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.616 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -135.58 140.32 44.56 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.252 0.548 . . . . 0.0 111.812 -178.657 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -125.51 132.65 52.58 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.788 179.891 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.5 mt -116.42 134.1 60.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.918 179.49 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.438 ' CG ' ' NE2' ' A' ' 54' ' ' HIS . 47.2 tp10 -119.96 128.6 53.73 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.369 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.933 HG23 ' NH1' ' A' ' 5' ' ' ARG . 96.8 mt -105.57 123.54 60.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.591 0.71 . . . . 0.0 112.159 -178.678 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.569 ' O ' ' N ' ' A' ' 56' ' ' GLN . 3.3 m-70 -120.54 139.9 52.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.452 -179.752 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.467 ' C ' ' O ' ' A' ' 54' ' ' HIS . 83.9 tt0 -39.3 -25.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.73 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' A' ' 54' ' ' HIS . 67.9 tp60 -69.11 -68.2 0.42 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.096 178.301 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.479 ' HA ' HH22 ' A' ' 5' ' ' ARG . 8.8 pt-20 -160.03 -157.52 0.56 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.708 179.64 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.406 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -113.73 132.3 55.87 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.505 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.448 ' CG2' ' NE2' ' A' ' 61' ' ' HIS . 45.5 mm -111.08 127.54 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 121.051 -0.26 . . . . 0.0 111.636 -178.65 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.435 ' HB3' HG13 ' A' ' 80' ' ' VAL . 28.8 tp -103.51 125.3 49.99 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.955 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.448 ' NE2' ' CG2' ' A' ' 59' ' ' ILE . 97.9 m-70 -118.37 139.49 51.3 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.486 -179.211 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.454 HD22 ' HA ' ' A' ' 68' ' ' PRO . 47.2 t30 -102.7 107.86 18.91 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.596 179.741 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -94.83 -7.8 39.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.66 179.142 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.09 99.7 11.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.856 0.36 . . . . 0.0 110.878 -179.861 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.6 p -77.39 -32.91 55.15 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.885 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.7 m -63.55 -49.35 73.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.221 -179.405 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -136.55 91.92 15.6 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.957 -179.626 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.56 ' HB2' HG13 ' A' ' 75' ' ' VAL . 52.4 Cg_exo -54.77 143.55 69.99 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.157 1.904 . . . . 0.0 112.568 -179.599 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.8 m -74.71 138.07 42.51 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.839 179.246 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -100.12 140.48 34.28 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.271 179.636 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.453 ' O ' ' N ' ' A' ' 74' ' ' SER . 5.1 p -131.59 136.42 57.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 178.939 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 48.35 31.98 3.0 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -178.675 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.84 29.48 63.05 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.437 -179.831 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.453 ' N ' ' O ' ' A' ' 71' ' ' VAL . 19.5 m -140.34 133.5 29.56 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 120.58 -0.448 . . . . 0.0 112.112 -179.479 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.56 HG13 ' HB2' ' A' ' 68' ' ' PRO . 7.0 t -70.43 139.06 20.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.475 179.152 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.429 HG21 HG11 ' A' ' 80' ' ' VAL . 3.7 pt -112.26 94.37 3.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.117 0.484 . . . . 0.0 111.266 179.814 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -65.22 -29.08 69.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.974 178.956 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.0 176.1 2.85 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.392 -179.979 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -59.93 144.08 99.51 Favored 'Trans proline' 0 N--CA 1.5 1.899 0 C-N-CA 122.515 2.143 . . . . 0.0 112.591 -179.776 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.435 HG13 ' HB3' ' A' ' 60' ' ' LEU . 7.1 p -136.7 141.26 41.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.521 179.679 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -81.02 130.21 34.91 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.473 179.377 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.5 mt -83.61 141.3 31.64 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.039 0.447 . . . . 0.0 111.642 -179.791 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -130.75 151.16 51.49 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.909 179.171 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.405 ' CE1' ' H ' ' A' ' 99' ' ' ASN . 4.3 t60 -52.12 118.66 3.65 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.001 0.429 . . . . 0.0 111.587 -178.637 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.03 -13.57 37.53 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 179.455 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -67.99 135.37 52.23 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.19 179.831 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.4 t -112.44 133.29 58.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.81 -178.205 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 92.8 mt -104.53 132.35 51.36 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.643 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 58.8 m -119.39 128.0 53.66 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.325 -0.55 . . . . 0.0 112.112 -178.766 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 98.2 mt -122.08 124.83 72.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.846 178.588 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.402 HG22 ' N ' ' A' ' 92' ' ' ASP . 26.0 mm 41.45 -114.99 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 121.068 -0.253 . . . . 0.0 110.629 -178.837 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.402 ' N ' HG22 ' A' ' 91' ' ' ILE . 93.4 m-20 -101.56 12.94 36.38 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.767 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.942 HH21 HD11 ' A' ' 41' ' ' LEU . 11.4 mtm180 -131.46 149.07 52.67 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.382 -179.497 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.47 ' HB2' HD12 ' A' ' 10' ' ' ILE . 71.7 m -135.49 154.15 51.51 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.008 0.432 . . . . 0.0 111.337 -179.631 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.452 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 85.1 m-85 -120.49 120.52 36.12 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.539 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 78.1 mtp85 -85.22 136.79 33.37 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 120.308 -0.557 . . . . 0.0 111.059 -179.238 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 92.2 t80 -96.5 118.81 33.79 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.402 -179.625 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -122.7 122.95 40.0 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.755 0.312 . . . . 0.0 111.0 179.549 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.405 ' H ' ' CE1' ' A' ' 84' ' ' HIS . 52.7 t-20 . . . . . 0 C--O 1.231 0.097 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.717 179.733 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 N--CA 1.49 1.294 0 N-CA-C 113.652 0.597 . . . . 0.0 113.652 . . . . . . . . . 0 0 . 1 . 033 nuclear build core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -68.48 140.27 19.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.648 -179.74 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 19.4 t . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.734 -179.858 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo . . . . . 0 N--CA 1.498 1.775 0 N-CA-C 113.431 0.512 . . . . 0.0 113.431 . . . . . . . . . 0 0 . 1 . 033 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 59.5 m -73.9 -43.51 58.24 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.18 0.514 . . . . 0.0 109.698 178.358 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -58.93 -45.81 89.49 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.558 -179.243 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' B' ' 242' ' ' LEU . 91.1 mt -64.77 -40.87 95.99 Favored 'General case' 0 CA--C 1.521 -0.161 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.192 -179.429 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -59.96 -40.72 89.99 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.05 -179.638 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 62.0 ttp180 -62.39 -43.32 99.11 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.792 0.33 . . . . 0.0 110.794 179.786 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.594 ' NH1' ' OE1' ' B' ' 248' ' ' GLN . 1.9 mpt_? -59.32 -43.73 92.64 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.111 -179.307 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.7 -40.96 98.77 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.838 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 65.6 m -64.38 -45.21 88.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.411 0.624 . . . . 0.0 109.327 178.194 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 248' ' ' GLN . . . . . 0.594 ' OE1' ' NH1' ' B' ' 245' ' ' ARG . 80.4 mt-30 -60.36 -37.38 80.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.116 -179.81 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 249' ' ' VAL . . . . . 0.47 HG23 ' O ' ' B' ' 245' ' ' ARG . 48.7 t . . . . . 0 C--N 1.328 -0.364 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.325 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.498 ' OE1' ' NH2' ' A' ' 93' ' ' ARG . 93.6 mt-10 . . . . . 0 N--CA 1.463 0.186 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 . . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.452 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 81.0 mt -109.77 131.97 59.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.194 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 40.4 t -124.06 132.67 70.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.348 -179.807 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -94.42 117.23 29.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.104 0.478 . . . . 0.0 111.108 -178.509 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -67.87 -46.59 71.28 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.513 179.949 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.17 163.43 23.44 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.223 -178.96 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -60.33 149.59 85.0 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.177 1.918 . . . . 0.0 112.031 179.857 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.3 pt . . . . . 0 C--N 1.328 -0.344 0 CA-C-O 121.485 0.66 . . . . 0.0 111.886 -178.396 . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 CA--C 1.517 -0.29 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 87.2 mtm-85 -93.5 111.3 22.94 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.098 0.475 . . . . 0.0 110.392 -179.372 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.481 ' NH2' ' ND1' ' A' ' 19' ' ' HIS . 79.5 ttt180 -127.44 131.22 50.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.184 -179.776 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.545 HD11 HD21 ' A' ' 22' ' ' LEU . 80.0 mt -110.12 135.64 50.6 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.832 179.952 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.82 HG21 ' NH2' ' A' ' 96' ' ' ARG . 89.0 t -106.74 120.38 57.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.479 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.601 HG21 ' HZ ' ' B' ' 263' ' ' PHE . 70.0 p -77.45 140.81 39.91 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.576 0.703 . . . . 0.0 110.99 -179.05 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 51.0 mm -103.76 130.18 54.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.619 -179.791 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.462 ' HA ' HH12 ' A' ' 93' ' ' ARG . 95.9 mttt -83.98 154.99 23.01 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.889 178.001 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.543 HH22 ' CB ' ' B' ' 248' ' ' GLN . 75.8 mtp180 -56.61 -34.3 67.09 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.532 -179.214 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 67.4 m -76.76 -6.13 50.98 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.428 179.093 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.32 32.09 10.92 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.529 179.482 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.0 t -113.53 132.25 62.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.794 0.331 . . . . 0.0 110.639 -179.998 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -73.13 136.28 44.81 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.503 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -130.75 -115.98 1.78 Allowed Glycine 0 CA--C 1.534 1.279 0 C-N-CA 120.18 -1.009 . . . . 0.0 112.886 -178.855 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.81 143.18 45.1 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 122.24 1.96 . . . . 0.0 112.937 -177.952 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.596 ' NE2' HG13 ' A' ' 8' ' ' VAL . 57.4 m170 -110.29 123.08 49.15 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.446 179.591 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.566 ' CD2' HD11 ' A' ' 37' ' ' ILE . 43.1 t80 -98.04 109.07 50.1 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.907 -179.513 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -79.03 139.09 14.95 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 121.344 1.363 . . . . 0.0 111.707 179.373 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.545 HD21 HD11 ' A' ' 7' ' ' LEU . 74.3 mt -91.66 50.13 1.67 Allowed 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.205 -178.967 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.8 t -63.82 -17.44 63.12 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 119.45 -0.9 . . . . 0.0 108.692 178.968 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.76 HD11 ' HG2' ' B' ' 265' ' ' GLN . 46.2 mt -78.65 138.45 38.32 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.875 179.951 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.15 -23.05 65.27 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.608 -179.274 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 94.5 m -133.78 134.91 43.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.561 179.147 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.447 ' SG ' HD22 ' A' ' 22' ' ' LEU . 6.1 t -124.37 118.43 26.71 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.536 179.008 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.483 HD21 ' HG2' ' A' ' 47' ' ' GLN . 44.4 tp -115.49 131.63 56.87 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.224 0.535 . . . . 0.0 111.78 -178.421 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.706 ' CE2' HD12 ' A' ' 37' ' ' ILE . 2.3 m-85 -111.2 138.96 46.99 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.572 179.865 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 150.85 179.21 26.4 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.539 178.68 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 45.7 mtm180 -70.22 -33.04 71.19 Favored 'General case' 0 C--O 1.227 -0.123 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 179.795 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.616 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -51.32 148.05 9.21 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.193 -179.065 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.413 HG23 ' N ' ' A' ' 34' ' ' GLU . 11.0 tp -67.5 -39.72 83.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.217 -0.593 . . . . 0.0 109.508 179.54 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.413 ' N ' HG23 ' A' ' 33' ' ' ILE . 98.4 mt-10 -53.06 -21.55 4.79 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.261 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.616 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 48.3 m -55.84 118.51 4.66 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.706 -179.597 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -59.72 -32.79 70.86 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -179.924 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.706 HD12 ' CE2' ' A' ' 29' ' ' PHE . 91.1 mt -123.5 120.96 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 176.256 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -109.04 135.33 50.38 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.949 -177.326 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.456 HG21 HD12 ' A' ' 41' ' ' LEU . 95.1 mt -119.87 130.27 74.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.618 -179.652 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -75.17 25.67 0.1 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.473 -179.099 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.456 HD12 HG21 ' A' ' 39' ' ' ILE . 24.3 mt -88.9 123.26 67.97 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.184 -179.915 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -73.28 -10.15 23.87 Favored 'Trans proline' 0 N--CA 1.49 1.285 0 C-N-CA 121.877 1.718 . . . . 0.0 112.548 179.714 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.51 HG21 ' CE2' ' B' ' 241' ' ' PHE . 30.0 m -97.97 8.26 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.114 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.555 179.442 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 25.5 t -101.26 139.56 22.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.449 179.068 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.1 m -74.11 171.85 12.8 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.061 0.458 . . . . 0.0 111.444 -178.974 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.6 mttp -61.37 -42.46 98.75 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.245 -178.778 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.62 ' O ' ' N ' ' A' ' 49' ' ' CYS . 95.5 mt-30 -112.81 -15.96 12.83 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.575 0.226 . . . . 0.0 111.162 -179.163 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 18.5 t60 37.25 -75.64 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 179.071 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.62 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.76 137.82 48.34 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.266 0.555 . . . . 0.0 111.366 -177.661 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -129.71 134.05 47.41 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.156 -179.983 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.4 mt -118.34 135.57 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.682 -179.688 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -112.78 127.84 56.26 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.638 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.4 mm -100.55 125.76 54.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 119.674 -0.81 . . . . 0.0 110.712 -179.668 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.456 ' O ' ' N ' ' A' ' 56' ' ' GLN . 94.7 m-70 -130.35 136.22 48.87 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.307 179.806 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 54' ' ' HIS . 42.7 tt0 -40.74 -28.85 0.08 Allowed 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.217 -0.593 . . . . 0.0 109.845 -179.272 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.456 ' N ' ' O ' ' A' ' 54' ' ' HIS . 55.0 tt0 -65.99 -68.28 0.38 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.301 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -158.37 -164.55 1.5 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.801 179.737 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -118.3 135.13 54.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.983 0.42 . . . . 0.0 110.394 179.775 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.05 130.27 74.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.564 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.599 ' HB2' HD21 ' A' ' 82' ' ' LEU . 50.1 tp -93.17 126.69 38.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.546 178.923 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -113.91 134.32 54.89 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.236 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 31.5 t30 -97.59 104.27 16.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.955 -179.481 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -96.44 -9.69 29.22 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.677 178.86 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.2 m -72.19 98.17 2.1 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.693 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.5 p -77.34 -36.1 54.15 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.705 0.765 . . . . 0.0 109.231 178.644 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.8 m -65.23 -48.57 72.83 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.387 -1.279 . . . . 0.0 110.78 -179.147 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -142.04 100.76 5.87 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.201 -179.128 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.18 145.75 85.11 Favored 'Trans proline' 0 N--CA 1.5 1.872 0 C-N-CA 122.022 1.815 . . . . 0.0 111.858 -179.564 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.3 m -72.49 141.87 48.56 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.199 0.523 . . . . 0.0 110.548 -179.642 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -101.0 141.61 33.64 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.805 -179.606 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.532 ' HB ' HD11 ' A' ' 76' ' ' ILE . 23.5 t -131.27 136.52 57.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 177.25 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 54.04 31.41 13.6 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -178.795 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.85 24.01 76.83 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.004 179.65 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 44.1 t -134.99 137.26 42.85 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.325 0.583 . . . . 0.0 111.527 -179.737 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.3 t -68.04 139.87 20.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.076 -179.544 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.585 ' CG2' ' O ' ' A' ' 78' ' ' GLU . 95.9 mt -113.88 116.77 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.986 179.407 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -90.74 -24.15 20.47 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.712 179.054 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.585 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.2 OUTLIER -128.9 168.18 16.91 Favored Pre-proline 0 C--O 1.222 -0.388 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.879 -178.669 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -66.28 148.02 84.09 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 122.463 2.109 . . . . 0.0 112.7 -179.941 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.1 m -141.18 151.93 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.164 179.976 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -78.53 129.23 34.6 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.485 179.345 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.599 HD21 ' HB2' ' A' ' 60' ' ' LEU . 95.9 mt -82.42 140.56 33.37 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.931 0.396 . . . . 0.0 110.736 -179.114 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -129.92 151.94 49.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.552 179.745 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.447 ' C ' ' CD2' ' A' ' 84' ' ' HIS . 7.5 t60 -56.5 119.98 6.96 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.165 -178.89 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.17 -18.13 23.79 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 121.155 -0.545 . . . . 0.0 111.767 179.128 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -69.51 133.23 47.44 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.331 179.912 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.0 t -107.76 136.9 41.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.45 -178.6 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 95.3 mt -103.07 129.1 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 178.167 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 96.2 m -120.33 127.32 52.23 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 119.913 -0.715 . . . . 0.0 112.025 -178.532 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.526 ' O ' ' N ' ' A' ' 93' ' ' ARG . 90.7 mt -116.5 134.86 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 CA-C-N 115.023 -0.989 . . . . 0.0 108.961 178.229 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.507 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 47.1 mt -29.13 97.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.415 -178.807 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.507 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 1.4 m-20 92.05 -22.4 0.08 Allowed 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 112.872 0.694 . . . . 0.0 112.872 178.047 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.745 HH21 ' CD1' ' B' ' 261' ' ' ILE . 25.2 mmm180 -131.04 143.73 50.92 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.17 -179.734 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 43.2 t -138.38 152.25 48.24 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.975 0.417 . . . . 0.0 110.421 -179.901 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -127.26 123.36 36.29 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.353 179.659 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.82 ' NH2' HG21 ' A' ' 8' ' ' VAL . 38.3 ttp-105 -90.31 135.58 33.59 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.487 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 81.4 t80 -98.93 127.89 44.96 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -178.489 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -134.0 120.68 20.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.28 179.552 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.44 ' OD1' ' ND1' ' A' ' 84' ' ' HIS . 43.1 p-10 . . . . . 0 C--N 1.332 -0.168 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.338 -179.949 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo . . . . . 0 N--CA 1.489 1.213 0 N-CA-C 113.936 0.706 . . . . 0.0 113.936 . . . . . . . . . 0 0 . 1 . 034 nuclear build core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.19 139.62 20.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.7 179.854 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' B' B ' 237' ' ' CYS . . . . . 0.421 ' HB2' HD13 ' A' ' 91' ' ' ILE . 4.0 t . . . . . 0 C--N 1.323 -0.582 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.569 -178.575 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo . . . . . 0 N--CA 1.496 1.646 0 N-CA-C 112.735 0.244 . . . . 0.0 112.735 . . . . . . . . . 0 0 . 1 . 034 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 2.8 m -74.78 -43.65 53.66 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 177.898 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.57 ' CZ ' ' NH2' ' B' ' 245' ' ' ARG . 79.0 t80 -58.36 -46.91 85.39 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.499 -179.374 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 95.9 mt -67.78 -39.3 84.07 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.058 179.384 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 73.3 tt0 -61.07 -41.56 96.86 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.539 179.906 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 244' ' ' ARG . . . . . 0.625 ' NH1' ' NE2' ' B' ' 248' ' ' GLN . 78.4 ttt-85 -64.12 -40.98 97.36 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.245 0.545 . . . . 0.0 109.653 179.538 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.645 ' O ' HG23 ' B' ' 249' ' ' VAL . 10.1 tpp180 -57.33 -42.7 82.42 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.054 -179.525 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.48 -41.45 98.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.445 179.824 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 47.1 t -63.27 -45.07 93.2 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.468 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 248' ' ' GLN . . . . . 0.625 ' NE2' ' NH1' ' B' ' 244' ' ' ARG . 84.6 mt-30 -60.67 -32.53 71.73 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.473 179.655 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' B' B ' 249' ' ' VAL . . . . . 0.645 HG23 ' O ' ' B' ' 245' ' ' ARG . 72.5 t . . . . . 0 N--CA 1.451 -0.381 0 C-N-CA 119.977 -0.689 . . . . 0.0 109.477 179.52 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 . . . . . 0 N--CA 1.467 0.389 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 . . . . . . . . . 0 0 . 1 . 034 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.745 ' CD1' HH21 ' A' ' 93' ' ' ARG . 66.0 mt -112.97 133.93 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.254 179.888 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 45.9 t -124.18 132.63 71.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.743 178.918 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 263' ' ' PHE . . . . . 0.601 ' HZ ' HG21 ' A' ' 9' ' ' THR . 49.2 m-85 -97.13 118.66 34.04 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.377 0.608 . . . . 0.0 111.909 -178.131 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -62.41 -44.19 97.02 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.767 178.813 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 265' ' ' GLN . . . . . 0.76 ' HG2' HD11 ' A' ' 24' ' ' LEU . 6.5 mp0 -84.55 162.31 51.13 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.366 -179.809 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -65.59 144.96 80.69 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.095 1.863 . . . . 0.0 112.44 179.9 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.536 0.435 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.551 -179.896 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 72.3 p . . . . . 0 C--O 1.234 0.265 0 CA-C-O 120.914 0.388 . . . . 0.0 110.446 . . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.8 mtt85 -88.57 132.0 34.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.554 179.718 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 19.5 ptp180 -139.02 148.67 43.72 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 120.029 -0.668 . . . . 0.0 111.717 179.877 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.594 HD11 HD11 ' A' ' 22' ' ' LEU . 67.1 mt -115.26 144.8 43.18 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.766 179.676 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.463 HG22 ' CD2' ' A' ' 19' ' ' HIS . 48.6 t -117.37 124.83 73.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.475 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.1 m -73.73 138.12 44.44 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.927 0.394 . . . . 0.0 111.846 -179.079 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.693 HD12 ' OG ' ' A' ' 94' ' ' SER . 78.8 mt -111.31 137.11 45.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.377 178.079 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -92.76 155.11 17.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.663 179.868 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.855 HH11 HH11 ' B' ' 245' ' ' ARG . 90.6 mtm180 -58.1 -23.73 55.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.505 -179.126 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.8 p -81.97 -10.15 59.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.1 0.476 . . . . 0.0 109.736 179.031 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.55 34.58 7.83 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 -179.819 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.6 t -122.45 133.31 69.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.706 0.288 . . . . 0.0 110.903 -179.959 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -74.99 141.06 44.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.861 179.844 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.04 -118.96 2.13 Favored Glycine 0 CA--C 1.542 1.727 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.369 -179.309 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.11 145.53 44.55 Favored 'Trans proline' 0 N--CA 1.501 1.918 0 C-N-CA 122.517 2.145 . . . . 0.0 114.065 -177.932 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.463 ' CD2' HG22 ' A' ' 8' ' ' VAL . 57.8 m170 -105.56 139.08 40.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.248 179.842 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.503 ' CD2' HD11 ' A' ' 37' ' ' ILE . 31.2 t80 -112.15 104.6 56.12 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 108.957 -0.756 . . . . 0.0 108.957 179.505 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -75.47 133.42 15.88 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 C-N-CA 121.404 1.403 . . . . 0.0 110.772 -178.983 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.594 HD11 HD11 ' A' ' 7' ' ' LEU . 97.2 mt -87.81 59.18 5.25 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 119.879 -0.728 . . . . 0.0 111.784 -178.187 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.2 p -67.61 -21.13 65.41 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.473 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 70.2 mt -84.01 140.69 31.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.628 -179.686 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 77.7 p -62.56 -21.31 65.49 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.78 -179.507 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.505 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 65.5 m -131.94 132.82 43.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.848 0.356 . . . . 0.0 111.748 -179.234 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.551 ' HB2' HD22 ' A' ' 22' ' ' LEU . 7.1 t -124.86 118.51 26.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.302 178.242 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 45.5 tp -115.95 128.45 55.76 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.439 -178.908 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.744 ' CE2' HD12 ' A' ' 37' ' ' ILE . 6.3 m-85 -106.51 136.0 47.04 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.335 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 159.02 -169.64 35.29 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 119.727 -1.225 . . . . 0.0 112.402 178.854 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.422 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 42.1 mtm180 -87.34 -31.1 20.34 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.418 179.376 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.416 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -50.82 148.18 7.89 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -179.735 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 36.9 mm -63.98 -43.73 97.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 O-C-N 122.611 -0.346 . . . . 0.0 111.046 -179.409 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -53.69 -18.12 2.8 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.82 -179.511 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.416 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 70.3 m -59.68 123.47 17.04 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 121.13 0.49 . . . . 0.0 111.189 -179.449 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.505 ' OD2' ' O ' ' A' ' 26' ' ' THR . 71.1 m-20 -60.77 -29.95 69.73 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.804 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.744 HD12 ' CE2' ' A' ' 29' ' ' PHE . 95.6 mt -127.17 123.95 63.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.241 -0.89 . . . . 0.0 108.822 177.492 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' A' ' 38' ' ' ARG . 26.8 mtm180 -107.18 138.11 43.99 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.283 -179.107 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 95.9 mt -119.26 128.63 75.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.445 -179.911 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -73.16 30.72 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.123 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.584 HD21 ' OE1' ' B' ' 260' ' ' GLU . 94.0 mt -108.19 128.31 25.95 Favored Pre-proline 0 N--CA 1.464 0.257 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.649 179.137 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.75 -8.87 21.99 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.488 2.125 . . . . 0.0 112.107 179.953 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.7 m -93.13 4.22 7.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 121.209 0.528 . . . . 0.0 110.274 179.293 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.422 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 20.4 t -95.13 133.7 35.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.512 -0.767 . . . . 0.0 108.941 178.332 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.2 t -70.41 170.52 11.78 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.287 0.565 . . . . 0.0 111.506 -178.266 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 52.2 mttp -62.97 -42.57 99.87 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.132 -179.444 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.607 ' O ' ' N ' ' A' ' 49' ' ' CYS . 87.1 mt-30 -114.49 -22.9 9.59 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 123.436 0.46 . . . . 0.0 110.709 -179.808 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.3 t60 37.13 -75.83 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 179.502 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.607 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -128.36 134.04 48.77 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.101 0.477 . . . . 0.0 111.955 -177.817 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -128.87 136.94 51.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.608 -179.932 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.7 mt -121.93 135.94 60.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.978 -179.932 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -113.85 127.1 55.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.634 178.973 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 48.8 mm -96.1 114.3 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-O 121.174 0.512 . . . . 0.0 111.555 -179.522 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.463 ' O ' ' N ' ' A' ' 56' ' ' GLN . 94.6 m-70 -117.54 134.61 54.68 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.622 178.684 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.478 ' H ' ' CD ' ' A' ' 55' ' ' GLU . 57.6 mp0 -39.72 -29.72 0.06 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -179.718 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.463 ' N ' ' O ' ' A' ' 54' ' ' HIS . 87.7 mt-30 -66.55 -67.87 0.42 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.545 178.735 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.11 -165.18 1.77 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.698 -179.275 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -120.28 129.46 54.04 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.569 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.4 mt -114.05 130.66 67.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -178.493 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.424 ' HB2' HD11 ' A' ' 82' ' ' LEU . 51.2 tp -94.59 124.54 38.69 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.884 179.585 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -112.84 137.6 50.94 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.099 -179.232 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.558 ' ND2' ' O ' ' A' ' 76' ' ' ILE . 50.7 p-10 -98.33 104.57 16.61 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.866 -179.841 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -93.88 -7.28 43.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.162 0.506 . . . . 0.0 109.825 178.328 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.4 t -75.21 100.9 4.45 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.013 179.531 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.9 m -87.46 -9.31 54.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.234 -179.962 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.573 HG22 HG22 ' B' ' 236' ' ' VAL . 0.2 OUTLIER -96.16 -41.92 8.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.09 0.472 . . . . 0.0 109.829 -179.85 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 40.9 m-20 -140.59 101.29 6.65 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.746 179.586 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -56.02 143.32 83.54 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 121.996 1.797 . . . . 0.0 112.24 -179.466 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 92.4 m -70.78 138.33 50.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.27 178.763 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -98.3 139.63 33.79 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.058 -179.999 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.407 HG21 HD23 ' A' ' 60' ' ' LEU . 55.5 t -133.5 132.38 57.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.288 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 53.22 34.31 17.31 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.612 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.5 29.02 66.51 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 114.958 -1.019 . . . . 0.0 112.53 179.928 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 47.3 t -145.72 142.42 28.94 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.924 179.763 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.0 m -74.75 140.24 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.515 179.278 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.587 HG22 HG21 ' A' ' 80' ' ' VAL . 4.6 pt -105.34 98.91 7.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.618 0.723 . . . . 0.0 109.901 178.781 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -63.86 -34.66 78.44 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.573 -179.705 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.458 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 1.2 mt-10 -128.9 -178.78 0.85 Allowed Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.748 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.458 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 25.0 Cg_exo -61.42 142.43 95.49 Favored 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 122.192 1.928 . . . . 0.0 113.03 -178.813 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.587 HG21 HG22 ' A' ' 76' ' ' ILE . 78.0 t -132.72 137.53 53.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.159 179.736 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -75.99 128.51 35.2 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.576 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.424 HD11 ' HB2' ' A' ' 60' ' ' LEU . 96.6 mt -84.01 136.43 34.05 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.99 -179.702 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -120.53 149.94 41.63 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.767 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.539 ' ND1' ' N ' ' A' ' 99' ' ' ASN . 6.1 t60 -55.31 123.88 15.25 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.995 -178.603 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.05 -13.55 52.46 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.513 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -71.24 136.91 48.22 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.49 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.4 p -105.5 140.42 23.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.776 -0.37 . . . . 0.0 111.38 -178.815 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 72.1 mt -108.25 130.81 60.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.092 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 53.5 m -126.39 128.8 47.6 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -177.355 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 91.4 mt -112.66 121.67 65.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 114.228 -1.351 . . . . 0.0 107.354 177.197 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.622 HG22 ' N ' ' A' ' 92' ' ' ASP . 97.0 mt 35.57 -99.01 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.751 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.622 ' N ' HG22 ' A' ' 91' ' ' ILE . 94.5 m-20 -110.38 8.62 23.37 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -178.982 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.505 HH21 HG13 ' B' ' 261' ' ' ILE . 50.3 mtp85 -127.12 144.26 51.07 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -179.846 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.693 ' OG ' HD12 ' A' ' 10' ' ' ILE . 19.4 p -141.28 159.28 42.54 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.37 0.605 . . . . 0.0 112.217 -178.458 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.661 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 87.9 m-85 -129.24 125.01 35.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.084 178.231 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -82.12 135.16 35.34 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 119.769 -0.773 . . . . 0.0 110.49 179.967 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -97.2 122.92 40.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.323 0.582 . . . . 0.0 111.091 -179.271 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -124.31 117.16 23.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.533 179.455 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.539 ' N ' ' ND1' ' A' ' 84' ' ' HIS . 64.7 t-20 . . . . . 0 C--N 1.322 -0.619 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.704 -179.747 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo . . . . . 0 N--CA 1.488 1.17 0 CA-C-O 121.42 0.508 . . . . 0.0 112.067 . . . . . . . . . 0 0 . 1 . 035 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.573 HG22 HG22 ' A' ' 66' ' ' THR . 53.3 t -62.61 135.42 27.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.559 179.666 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 14.9 t . . . . . 0 CA--C 1.518 -0.259 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.413 -179.511 . . . . . . . . 0 0 . 1 . 035 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo . . . . . 0 N--CA 1.495 1.597 0 N-CA-C 112.476 0.145 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 035 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 17.4 p -73.65 -40.74 63.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.017 0.436 . . . . 0.0 110.006 178.371 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -56.6 -46.53 80.8 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.871 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.442 HD23 ' OD2' ' A' ' 92' ' ' ASP . 93.6 mt -62.57 -43.52 98.6 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.941 -179.335 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -64.73 -40.01 94.61 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.07 -178.861 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 244' ' ' ARG . . . . . 0.47 ' O ' ' OG ' ' B' ' 247' ' ' SER . 95.0 mtt-85 -64.51 -42.01 96.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.218 0.532 . . . . 0.0 110.071 179.649 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.855 HH11 HH11 ' A' ' 12' ' ' ARG . 25.0 ttm-85 -61.79 -42.19 98.68 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.765 -179.339 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -61.56 -36.4 80.51 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.809 0.337 . . . . 0.0 110.285 179.113 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 247' ' ' SER . . . . . 0.47 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 78.6 p -69.94 -40.39 75.52 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 177.958 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -57.61 -40.18 78.55 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.024 179.324 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 56.9 t . . . . . 0 C--N 1.327 -0.376 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 178.627 . . . . . . . . 0 0 . 1 . 035 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.584 ' OE1' HD21 ' A' ' 41' ' ' LEU . 96.9 mt-10 . . . . . 0 N--CA 1.466 0.327 0 CA-C-O 120.759 0.314 . . . . 0.0 111.187 . . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.661 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 71.6 mt -116.93 135.2 58.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.609 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 50.0 t -123.78 132.32 71.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.541 179.309 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -95.57 119.52 34.21 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.264 0.554 . . . . 0.0 111.781 -178.234 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -64.9 -45.3 86.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.354 179.769 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -100.78 163.96 17.07 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.284 -179.831 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -61.41 156.86 43.93 Favored 'Trans proline' 0 N--CA 1.503 2.051 0 C-N-CA 122.992 2.462 . . . . 0.0 113.062 -179.604 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 25.9 pt . . . . . 0 N--CA 1.465 0.285 0 CA-C-O 121.312 0.577 . . . . 0.0 111.775 -178.986 . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.7 m . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.897 0.379 . . . . 0.0 111.477 . . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.608 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 85.1 mtt-85 -100.25 148.75 24.31 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.492 -177.995 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -134.55 141.68 46.76 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.516 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 98.5 mt -113.8 139.74 48.88 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 178.73 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 67.9 t -113.89 129.46 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.407 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 m -93.22 116.62 29.19 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.402 0.62 . . . . 0.0 112.516 -178.258 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 81.7 mt -85.67 147.66 5.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.111 179.149 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.464 ' HD2' HG23 ' A' ' 15' ' ' VAL . 94.8 mttt -93.61 157.87 15.97 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.479 179.092 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.595 ' NH2' ' OE2' ' B' ' 260' ' ' GLU . 91.1 mtm180 -60.98 -27.56 68.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.304 -0.407 . . . . 0.0 109.997 179.859 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.558 ' OG ' HG22 ' A' ' 15' ' ' VAL . 91.1 p -70.6 -22.69 62.52 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.755 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.73 6.94 37.27 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-N 115.72 -0.673 . . . . 0.0 113.699 178.576 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.558 HG22 ' OG ' ' A' ' 13' ' ' SER . 17.8 m -104.82 142.92 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 117.995 0.898 . . . . 0.0 111.568 -179.693 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 17' ' ' GLY . 61.8 t0 -69.15 127.85 34.55 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.063 -179.397 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.437 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -115.72 -127.94 4.26 Favored Glycine 0 CA--C 1.535 1.325 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 -179.814 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.93 155.88 38.78 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.483 2.122 . . . . 0.0 112.788 -178.872 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -112.78 158.78 19.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.985 0.421 . . . . 0.0 111.191 -178.591 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.554 ' CD2' HD11 ' A' ' 37' ' ' ILE . 39.0 t80 -128.35 98.61 25.69 Favored Pre-proline 0 N--CA 1.467 0.403 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.578 -179.727 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.441 ' HD2' HG22 ' B' ' 267' ' ' ILE . 73.6 Cg_endo -74.28 139.57 26.48 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 121.587 1.525 . . . . 0.0 112.508 -178.905 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.441 HD13 HD11 ' A' ' 53' ' ' ILE . 80.2 mt -88.33 86.01 6.99 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.203 -179.331 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 59.7 p -86.39 -7.95 58.04 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.515 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.0 mt -108.69 148.82 29.86 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.041 -179.184 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.3 m -68.73 -15.06 63.4 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.127 -179.117 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 57.0 m -130.02 134.63 47.54 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.452 -0.499 . . . . 0.0 112.143 -179.975 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.7 t -127.96 118.76 24.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.914 178.573 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.525 HD12 ' O ' ' A' ' 49' ' ' CYS . 57.3 tp -118.46 130.8 56.15 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 120.954 0.406 . . . . 0.0 111.031 -179.056 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.816 ' CE2' HD12 ' A' ' 37' ' ' ILE . 18.3 m-85 -110.25 141.6 42.99 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.988 -179.893 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 153.67 -174.88 32.19 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.883 178.795 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 45.1 mtm180 -74.82 -32.53 61.98 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 122.704 -0.291 . . . . 0.0 111.722 179.348 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.594 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -58.14 149.57 34.59 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.579 -177.714 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.431 ' C ' ' N ' ' A' ' 35' ' ' CYS . 82.4 mt -66.37 -43.06 91.49 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 178.247 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -49.9 -25.28 3.07 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.222 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.594 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 3.6 m -65.69 115.01 5.4 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.723 179.47 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -52.76 -21.09 3.71 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.166 -178.135 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.816 HD12 ' CE2' ' A' ' 29' ' ' PHE . 85.4 mt -131.4 123.92 53.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.657 177.809 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 47.3 mtm180 -107.3 138.5 43.38 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.836 -179.865 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 1.028 HG21 ' NH1' ' A' ' 93' ' ' ARG . 63.9 mt -120.56 132.44 70.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.419 -0.512 . . . . 0.0 110.48 179.762 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -75.41 24.08 0.11 Allowed 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -178.068 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.747 HD12 ' CZ ' ' A' ' 93' ' ' ARG . 25.7 mt -105.48 128.67 26.09 Favored Pre-proline 0 C--N 1.323 -0.56 0 C-N-CA 119.591 -0.844 . . . . 0.0 109.855 179.341 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.07 -10.27 25.75 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.523 2.149 . . . . 0.0 112.566 -178.773 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.8 m -87.11 -0.21 7.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.622 179.927 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.459 HG21 HH12 ' A' ' 93' ' ' ARG . 48.0 t -91.38 131.64 37.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.131 0.491 . . . . 0.0 111.006 -179.223 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.05 160.64 20.54 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.987 179.77 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 28.2 mtmt -59.93 -42.54 94.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.702 -178.839 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.629 ' O ' ' N ' ' A' ' 49' ' ' CYS . 12.4 mm100 -111.49 -16.52 13.28 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 123.481 0.488 . . . . 0.0 110.048 -179.549 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.2 t60 35.62 -76.37 0.0 OUTLIER 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.076 -0.966 . . . . 0.0 113.348 -179.763 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.629 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -137.09 140.18 41.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.941 0.401 . . . . 0.0 111.799 -178.622 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -127.01 131.91 50.89 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.511 179.728 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.9 mt -114.87 135.93 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-O 121.098 0.475 . . . . 0.0 110.738 179.54 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -113.75 125.55 54.23 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.067 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.441 HD11 HD13 ' A' ' 22' ' ' LEU . 93.9 mt -108.2 113.62 44.36 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.461 -179.856 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.582 ' O ' ' N ' ' A' ' 56' ' ' GLN . 91.5 m-70 -115.42 141.36 48.15 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.125 179.974 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.467 ' C ' ' O ' ' A' ' 54' ' ' HIS . 84.1 tt0 -38.92 -25.18 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 120.293 -0.563 . . . . 0.0 109.527 -179.109 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.582 ' N ' ' O ' ' A' ' 54' ' ' HIS . 57.3 tt0 -67.51 -67.31 0.47 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.386 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -160.65 -163.66 1.11 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.193 -179.586 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.79 127.16 55.9 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.577 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 89.2 mt -113.89 128.76 70.67 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 CA-C-O 121.297 0.57 . . . . 0.0 111.688 -179.228 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 43.4 tp -97.39 126.91 42.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.883 -179.975 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -114.7 138.01 51.22 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.962 179.105 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -101.12 109.62 21.53 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.067 0.461 . . . . 0.0 111.602 -179.564 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -94.89 -4.59 46.65 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.254 179.108 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.0 t -90.42 101.06 13.79 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.728 -179.712 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.4 p -87.59 -24.21 24.06 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.388 -0.525 . . . . 0.0 109.996 178.087 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.58 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.3 OUTLIER -69.74 -43.29 72.61 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.6 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.432 HD21 ' HA ' ' B' ' 236' ' ' VAL . 31.4 m-80 -142.97 100.9 5.36 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.69 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -66.28 150.85 84.52 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.264 1.309 . . . . 0.0 113.532 -177.831 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 33.7 m -69.93 137.95 51.96 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.912 179.555 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -101.38 142.43 32.79 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.662 179.906 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.716 ' HB ' HD11 ' A' ' 76' ' ' ILE . 5.0 p -129.5 137.2 57.47 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.14 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 49.57 32.8 5.18 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.583 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.51 27.85 64.65 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.057 -179.903 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 62.8 m -141.06 138.8 33.86 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 117.549 0.675 . . . . 0.0 112.098 -179.473 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.4 m -65.62 137.45 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.527 179.734 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.716 HD11 ' HB ' ' A' ' 71' ' ' VAL . 96.2 mt -99.57 96.39 4.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.594 179.856 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -65.15 -41.49 94.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.853 0.359 . . . . 0.0 110.867 179.645 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.497 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.1 OUTLIER -126.72 166.05 24.65 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.492 -179.343 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -57.24 143.32 93.87 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.174 1.916 . . . . 0.0 112.565 -179.052 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.6 t -133.32 137.49 53.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.654 -179.894 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 87.7 mtm-85 -68.98 134.43 49.48 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.535 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.441 HD23 ' HA ' ' A' ' 82' ' ' LEU . 80.3 mt -81.08 137.28 36.0 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.472 0.653 . . . . 0.0 111.589 -179.22 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -125.64 147.08 49.44 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.656 179.724 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.482 ' ND1' ' N ' ' A' ' 99' ' ' ASN . 4.8 t60 -57.19 124.97 20.67 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.578 -179.318 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.73 -24.22 26.03 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -179.151 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.544 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 41.4 t0 -64.57 134.48 54.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.991 0.424 . . . . 0.0 110.198 179.347 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.544 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 9.9 p -110.9 132.9 58.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.509 -178.157 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 79.0 mt -99.09 130.18 48.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.857 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 17.7 m -116.85 123.73 47.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.514 0.673 . . . . 0.0 111.405 179.895 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.634 ' O ' ' N ' ' A' ' 93' ' ' ARG . 96.8 mt -117.36 129.04 74.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.062 178.306 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.494 ' C ' ' O ' ' A' ' 90' ' ' ILE . 85.5 mt -14.97 96.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -178.876 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 79.06 -11.23 1.24 Allowed 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 177.963 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 1.028 ' NH1' HG21 ' A' ' 39' ' ' ILE . 17.7 mtm180 -130.95 134.28 46.59 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.349 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.2 m -133.81 147.95 51.28 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.6 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.407 ' HE1' HD12 ' A' ' 90' ' ' ILE . 54.7 m-85 -122.81 120.13 32.62 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.549 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.429 ' NE ' ' OE2' ' A' ' 98' ' ' GLU . 37.8 ttp-105 -79.97 130.92 35.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.061 0.458 . . . . 0.0 110.989 -179.362 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.608 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 46.0 t80 -98.5 122.97 42.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.413 -179.704 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.429 ' OE2' ' NE ' ' A' ' 96' ' ' ARG . 96.3 mt-10 -139.07 129.31 25.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.188 0.518 . . . . 0.0 111.333 179.832 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.509 ' OD1' ' OH ' ' A' ' 97' ' ' TYR . 91.4 m-20 . . . . . 0 C--N 1.324 -0.543 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.356 179.734 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo . . . . . 0 N--CA 1.487 1.139 0 CA-C-O 121.226 0.427 . . . . 0.0 111.843 . . . . . . . . . 0 0 . 1 . 036 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.58 ' CG2' HG22 ' A' ' 66' ' ' THR . 37.7 t -112.73 134.07 56.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.83 179.871 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' B' B ' 237' ' ' CYS . . . . . 0.413 ' HB2' HD13 ' A' ' 91' ' ' ILE . 3.7 t . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.553 -179.539 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo . . . . . 0 N--CA 1.489 1.255 0 N-CA-C 111.622 -0.184 . . . . 0.0 111.622 . . . . . . . . . 0 0 . 1 . 036 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 18.5 m -71.92 -46.78 56.39 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 120.606 -0.437 . . . . 0.0 110.421 179.092 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.5 ' CZ ' ' NH1' ' B' ' 245' ' ' ARG . 80.5 t80 -58.7 -45.73 88.86 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.616 -178.846 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 93.9 mt -64.16 -40.16 95.55 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.04 -179.178 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -60.98 -45.16 95.92 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.489 -179.689 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -66.91 -38.67 86.65 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.598 179.744 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.603 ' CA ' ' HE ' ' B' ' 245' ' ' ARG . 0.0 OUTLIER -60.11 -44.62 94.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.97 -179.029 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.59 -40.77 97.8 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.353 0.597 . . . . 0.0 109.473 179.117 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 26.8 m -60.44 -45.74 92.57 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.44 179.226 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -58.23 -37.93 75.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.416 179.793 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 54.6 t . . . . . 0 C--N 1.329 -0.287 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.013 179.35 . . . . . . . . 0 0 . 1 . 036 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.595 ' OE2' ' NH2' ' A' ' 12' ' ' ARG . 56.6 mp0 . . . . . 0 C--O 1.225 -0.231 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 . . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 66.3 mt -112.77 135.45 52.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.671 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 55.1 t -130.16 134.88 62.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.124 0.488 . . . . 0.0 111.048 -178.657 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -95.06 118.81 32.5 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.551 0.691 . . . . 0.0 111.277 -178.503 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -66.01 -47.52 74.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.159 179.424 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -89.06 151.45 46.92 Favored Pre-proline 0 N--CA 1.449 -0.494 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.185 -178.981 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.9 149.46 72.32 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.919 2.412 . . . . 0.0 112.838 179.747 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 267' ' ' ILE . . . . . 0.441 HG22 ' HD2' ' A' ' 21' ' ' PRO . 44.1 pt . . . . . 0 C--N 1.33 -0.262 0 CA-C-O 121.313 0.578 . . . . 0.0 110.09 179.042 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.0 p . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.883 0.373 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.547 ' NE ' HD13 ' A' ' 53' ' ' ILE . 88.6 mtm-85 -90.26 126.4 35.83 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.28 179.913 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -129.79 135.37 48.35 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.095 0.474 . . . . 0.0 111.032 179.826 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.698 HD12 ' O ' ' A' ' 96' ' ' ARG . 29.5 tp -115.3 133.82 55.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.136 -179.38 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 45.0 t -109.15 131.98 58.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.407 -179.95 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 m -90.99 118.39 30.34 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.34 0.59 . . . . 0.0 112.541 -178.408 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.469 HD12 ' HB2' ' A' ' 94' ' ' SER . 97.0 mt -85.85 142.14 13.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.536 179.248 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -89.31 160.68 16.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.027 0.441 . . . . 0.0 110.919 179.262 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.593 HH11 HH11 ' B' ' 245' ' ' ARG . 90.5 mtm180 -55.94 -33.07 64.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.662 -178.902 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.6 t -77.75 -8.54 58.12 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.234 179.837 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.92 31.14 9.49 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -179.924 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.0 t -116.8 132.69 65.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.857 0.36 . . . . 0.0 110.081 179.681 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 45.4 p-10 -84.19 142.8 30.06 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.978 179.612 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -133.89 -108.05 1.02 Allowed Glycine 0 CA--C 1.532 1.098 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.733 -179.531 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -73.29 148.57 43.91 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 122.347 2.032 . . . . 0.0 112.028 -179.454 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -111.94 147.58 35.57 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.149 -179.844 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -115.05 104.72 53.73 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.981 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.42 133.14 15.63 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.164 1.242 . . . . 0.0 110.992 -178.81 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 82.9 mt -87.61 51.76 2.31 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -177.51 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.5 m -59.28 -34.1 71.87 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.879 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.538 HD11 ' HG2' ' B' ' 265' ' ' GLN . 60.9 mt -71.62 144.75 49.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.45 -179.845 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.6 m -68.18 -16.38 63.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.415 -179.355 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.448 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 95.5 m -133.77 134.42 42.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.834 0.35 . . . . 0.0 111.664 -179.806 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.9 t -125.78 116.66 21.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.902 178.424 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 58.2 tp -113.71 127.83 56.18 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.794 -178.924 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.609 ' CE2' HD12 ' A' ' 37' ' ' ILE . 9.4 m-85 -106.93 139.23 41.67 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.851 179.65 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 146.5 -175.93 25.67 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 120.982 -0.628 . . . . 0.0 111.622 178.972 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 31' ' ' ARG . 47.6 mtm180 -75.46 -33.72 60.88 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -179.851 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.505 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -44.45 142.95 2.75 Favored Glycine 0 C--O 1.223 -0.535 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 -178.465 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.416 HD13 ' CZ ' ' A' ' 38' ' ' ARG . 32.5 mm -62.6 -43.13 98.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 117.194 0.497 . . . . 0.0 110.033 179.957 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -54.81 -20.73 9.24 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.51 -0.476 . . . . 0.0 109.865 179.551 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.505 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 60.0 m -56.63 119.61 6.4 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-O 120.968 0.413 . . . . 0.0 111.141 -179.47 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.448 ' OD2' ' O ' ' A' ' 26' ' ' THR . 80.0 m-20 -58.09 -26.63 62.81 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -179.817 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.609 HD12 ' CE2' ' A' ' 29' ' ' PHE . 95.1 mt -129.18 118.97 47.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.235 177.381 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.416 ' CZ ' HD13 ' A' ' 33' ' ' ILE . 84.7 mtp180 -103.34 133.5 48.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.634 -179.106 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.423 HG21 HD12 ' A' ' 41' ' ' LEU . 83.6 mt -118.13 129.94 73.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 120.511 -0.475 . . . . 0.0 110.021 179.744 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -75.24 36.71 0.12 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.85 -178.057 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.723 ' O ' HG12 ' A' ' 44' ' ' VAL . 70.0 mt -111.74 119.32 44.98 Favored Pre-proline 0 C--N 1.325 -0.457 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.061 -179.678 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -71.29 -12.77 30.27 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 121.835 1.69 . . . . 0.0 112.824 -179.987 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.706 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 31.1 m -86.76 -3.51 8.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.949 -0.301 . . . . 0.0 110.716 179.657 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.723 HG12 ' O ' ' A' ' 41' ' ' LEU . 3.3 p -96.62 146.76 6.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.103 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.9 m -74.65 166.14 24.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.469 0.652 . . . . 0.0 112.519 -178.478 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 45.6 mttp -63.23 -40.05 96.34 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.03 -0.987 . . . . 0.0 111.737 179.975 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.669 ' O ' ' N ' ' A' ' 49' ' ' CYS . 89.7 mt-30 -113.36 -19.83 11.58 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.385 179.858 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.0 t60 34.83 -75.93 0.0 OUTLIER 'General case' 0 C--O 1.234 0.274 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 179.048 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.669 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.1 134.45 47.36 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.248 0.547 . . . . 0.0 112.253 -178.948 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -127.01 128.65 46.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.257 179.021 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.3 mt -111.56 133.74 56.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.189 179.845 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -116.79 126.55 53.26 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.463 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.547 HD13 ' NE ' ' A' ' 5' ' ' ARG . 84.8 mt -106.15 112.91 41.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.404 -179.067 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.504 ' O ' ' N ' ' A' ' 56' ' ' GLN . 95.0 m-70 -112.78 144.03 43.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.399 179.54 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 54' ' ' HIS . 84.1 tt0 -39.9 -27.21 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.358 -0.537 . . . . 0.0 109.992 -178.839 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.504 ' N ' ' O ' ' A' ' 54' ' ' HIS . 75.8 mt-30 -69.08 -66.99 0.51 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.949 179.132 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -157.92 -169.2 2.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.347 -179.11 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -111.85 125.32 53.89 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.741 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.5 mt -114.73 132.05 65.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -178.203 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.494 ' HB2' HD21 ' A' ' 82' ' ' LEU . 44.0 tp -94.8 122.54 37.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.8 179.266 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -109.08 136.35 48.73 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.159 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.475 HD21 ' HA ' ' A' ' 68' ' ' PRO . 63.5 t-20 -97.54 109.54 22.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.068 0.461 . . . . 0.0 112.241 -178.422 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.405 ' CD2' ' OE1' ' A' ' 47' ' ' GLN . 28.3 m-85 -100.91 -9.87 21.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.121 179.326 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.7 t -76.22 98.62 4.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.805 0.336 . . . . 0.0 110.844 -179.389 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 34.2 t -79.09 -40.79 30.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.323 0.582 . . . . 0.0 109.744 178.683 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.613 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -64.75 -47.02 79.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.02 -179.112 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 42.3 m-20 -136.97 97.91 10.77 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.452 179.894 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.475 ' HA ' HD21 ' A' ' 62' ' ' ASN . 36.2 Cg_exo -56.45 145.05 81.55 Favored 'Trans proline' 0 N--CA 1.494 1.5 0 C-N-CA 121.799 1.666 . . . . 0.0 112.612 -179.121 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.3 m -73.83 140.01 45.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.393 -179.992 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -104.59 141.79 35.79 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.749 -179.188 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.509 ' CG1' ' OD1' ' A' ' 86' ' ' ASP . 55.3 t -130.96 136.23 58.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.491 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 52.26 33.3 12.33 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -179.394 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.58 29.48 72.88 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.284 179.726 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.7 p -141.66 136.65 31.11 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.714 -0.395 . . . . 0.0 110.867 -179.974 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.414 HG13 ' HB2' ' A' ' 68' ' ' PRO . 78.6 t -66.01 135.82 27.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.087 -179.907 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.08 96.65 3.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.409 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -84.56 -16.69 41.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.536 -0.757 . . . . 0.0 112.014 -178.583 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -111.47 162.6 20.3 Favored Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.557 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -58.96 142.24 99.1 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 121.45 1.433 . . . . 0.0 111.693 179.684 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.5 p -140.48 139.1 35.89 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 CA-C-O 120.957 0.408 . . . . 0.0 110.758 179.814 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.635 HH21 ' CE ' ' A' ' 83' ' ' LYS . 61.9 ttp180 -73.39 127.71 33.44 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.461 179.616 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.494 HD21 ' HB2' ' A' ' 60' ' ' LEU . 98.2 mt -78.78 138.16 38.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.79 -180.0 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.635 ' CE ' HH21 ' A' ' 81' ' ' ARG . 97.7 mttt -130.29 151.93 50.26 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.342 179.237 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.643 ' HD1' ' CG ' ' A' ' 99' ' ' ASN . 3.7 t-160 -55.59 120.95 8.02 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.287 -179.334 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.08 -15.06 36.89 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -179.58 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.509 ' OD1' ' CG1' ' A' ' 71' ' ' VAL . 35.2 t70 -68.79 126.54 30.07 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.312 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.9 t -109.51 127.09 66.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.578 -178.922 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 90.7 mt -93.27 133.54 34.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.896 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 53.7 m -124.19 123.08 39.5 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.592 0.71 . . . . 0.0 112.387 -178.555 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.451 ' N ' ' O ' ' A' ' 93' ' ' ARG . 93.1 mt -107.91 124.27 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 177.498 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.707 HD12 HH22 ' A' ' 93' ' ' ARG . 93.9 mt 39.47 -98.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.171 -178.445 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.613 ' OD1' ' NH1' ' A' ' 93' ' ' ARG . 28.9 p-10 -119.71 16.54 12.76 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.015 0.436 . . . . 0.0 110.837 179.365 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.707 HH22 HD12 ' A' ' 91' ' ' ILE . 45.0 mtm-85 -120.0 138.12 53.68 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.765 179.877 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.469 ' HB2' HD12 ' A' ' 10' ' ' ILE . 66.9 m -137.44 152.41 49.55 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 119.886 -0.726 . . . . 0.0 111.283 -179.871 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.533 ' HB3' HD11 ' A' ' 7' ' ' LEU . 74.6 m-85 -123.79 121.45 35.45 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.098 179.413 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.698 ' O ' HD12 ' A' ' 7' ' ' LEU . 99.8 mtt180 -81.95 129.08 34.67 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.75 -179.045 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -99.0 126.99 44.82 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.832 179.876 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -137.22 127.88 26.98 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.653 179.996 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.643 ' CG ' ' HD1' ' A' ' 84' ' ' HIS . 41.2 p30 . . . . . 0 N--CA 1.463 0.223 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.532 -179.965 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo . . . . . 0 N--CA 1.49 1.314 0 CA-C-O 121.212 0.422 . . . . 0.0 112.657 . . . . . . . . . 0 0 . 1 . 037 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.613 ' CG2' HG22 ' A' ' 66' ' ' THR . 31.4 t -64.09 135.5 27.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.391 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-O 121.093 0.473 . . . . 0.0 110.805 -178.741 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo . . . . . 0 N--CA 1.492 1.389 0 CA-C-O 120.495 0.123 . . . . 0.0 111.806 . . . . . . . . . 0 0 . 1 . 037 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 52.0 m -73.03 -46.19 53.38 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.05 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.706 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 71.3 t80 -56.6 -48.15 78.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.757 -179.793 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 85.8 mt -66.18 -43.6 86.4 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -179.887 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -65.48 -45.14 84.8 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.447 -178.228 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -62.68 -44.53 96.02 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.435 179.626 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.593 HH11 HH11 ' A' ' 12' ' ' ARG . 52.2 ttm-85 -63.56 -44.09 95.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.98 -179.627 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -63.97 -36.89 85.45 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.554 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 32.7 m -64.08 -43.78 94.38 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.47 178.022 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -61.64 -34.59 75.96 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.877 -179.962 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 43.4 t . . . . . 0 C--N 1.332 -0.192 0 C-N-CA 120.774 -0.371 . . . . 0.0 110.232 179.098 . . . . . . . . 0 0 . 1 . 037 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.481 ' OE1' HD21 ' A' ' 41' ' ' LEU . 99.1 mt-10 . . . . . 0 CA--C 1.527 0.069 0 CA-C-O 120.66 0.267 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 66.9 mt -109.69 134.56 51.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 178.945 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 61.9 t -125.23 133.88 68.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.746 -179.311 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -94.43 118.95 32.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.043 -178.986 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -68.2 -41.16 81.79 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.281 179.392 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 265' ' ' GLN . . . . . 0.538 ' HG2' HD11 ' A' ' 24' ' ' LEU . 4.6 mp0 -103.56 163.69 16.92 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.814 -178.878 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -62.27 153.27 71.26 Favored 'Trans proline' 0 N--CA 1.5 1.856 0 C-N-CA 123.202 2.601 . . . . 0.0 113.08 -179.429 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 42.5 pt . . . . . 0 C--N 1.33 -0.253 0 CA-C-O 121.693 0.759 . . . . 0.0 112.328 -179.02 . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.7 m . . . . . 0 CA--C 1.531 0.234 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 . . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.524 ' NE ' ' HB2' ' A' ' 58' ' ' ALA . 85.7 mtt85 -97.76 137.22 36.97 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.918 0.389 . . . . 0.0 111.997 -177.494 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.529 ' C ' HD22 ' A' ' 7' ' ' LEU . 89.4 mtm180 -137.62 145.98 43.41 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.518 179.576 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.717 HD21 HD11 ' A' ' 22' ' ' LEU . 3.0 mm? -112.96 141.54 46.68 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.94 178.395 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.0 t -114.09 127.02 71.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.852 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.531 ' CG2' HD12 ' B' ' 261' ' ' ILE . 50.0 m -78.64 139.68 38.51 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -177.998 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.485 HD12 ' CB ' ' A' ' 94' ' ' SER . 99.6 mt -109.22 136.47 45.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.185 177.494 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -88.8 158.46 18.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.006 0.431 . . . . 0.0 110.926 179.942 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.504 ' CD ' HH11 ' B' ' 245' ' ' ARG . 86.3 mtm180 -57.16 -30.59 64.59 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.801 -178.611 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 88.6 p -80.93 -7.07 59.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.192 179.988 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.88 34.44 6.85 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.692 179.527 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.2 t -119.64 132.73 68.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.748 0.308 . . . . 0.0 111.111 -179.988 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -74.84 138.23 42.39 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.73 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -131.65 -118.89 2.02 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 120.533 -0.842 . . . . 0.0 112.616 -178.939 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -73.79 149.12 42.32 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.414 2.076 . . . . 0.0 113.066 -178.427 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -110.58 157.46 19.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.697 -179.962 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.971 ' CD2' HD11 ' A' ' 37' ' ' ILE . 35.2 t80 -124.64 99.83 35.36 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.924 -179.553 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -74.81 135.52 19.58 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 121.374 1.383 . . . . 0.0 112.48 -179.499 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.717 HD11 HD21 ' A' ' 7' ' ' LEU . 80.5 mt -87.65 81.98 7.54 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 120.872 0.367 . . . . 0.0 111.093 -179.24 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.9 p -86.33 -8.68 57.51 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.164 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.5 mt -103.82 146.22 28.96 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.611 179.917 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.6 m -67.81 -14.82 63.27 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -179.219 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 39.7 m -131.03 132.6 45.06 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.694 -179.948 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.435 ' HB2' HD22 ' A' ' 22' ' ' LEU . 5.1 t -126.96 120.21 28.55 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.653 178.835 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.446 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 35.1 tp -117.22 130.86 56.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.779 0.323 . . . . 0.0 111.42 -178.561 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.446 ' O ' ' O ' ' A' ' 47' ' ' GLN . 54.1 m-85 -107.43 133.44 51.94 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.615 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 179.42 -173.46 45.39 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.186 -1.007 . . . . 0.0 112.718 -179.967 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.2 ttp-105 -93.75 -23.4 18.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.234 -0.483 . . . . 0.0 110.349 179.746 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.467 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -72.2 163.96 54.49 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.932 -179.095 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.59 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.4 tp -68.17 -43.25 85.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.948 0.404 . . . . 0.0 111.582 -179.846 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.59 ' N ' HG23 ' A' ' 33' ' ' ILE . 52.1 tp10 -54.19 -19.81 5.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.862 -178.594 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.467 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 3.5 m -67.77 129.01 38.59 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.275 -179.777 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.446 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 66.0 m-20 -61.58 -33.84 74.58 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.961 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.971 HD11 ' CD2' ' A' ' 20' ' ' PHE . 36.9 mm -120.11 116.6 50.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.097 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.56 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 83.2 mtp180 -105.63 134.85 48.07 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.681 -178.404 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 78.6 mt -121.13 129.13 75.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.35 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -77.22 27.72 0.15 Allowed 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -177.921 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.741 HD21 ' OE1' ' B' ' 260' ' ' GLU . 78.9 mt -99.09 139.18 20.81 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.121 179.55 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.45 -14.73 20.1 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.492 2.128 . . . . 0.0 112.277 -179.395 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.1 m -91.19 7.87 4.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.534 179.868 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 55.6 t -100.36 132.11 46.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.359 179.09 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.4 m -74.11 170.32 15.73 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.768 0.794 . . . . 0.0 111.655 -179.52 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -64.83 -38.54 91.32 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.093 179.799 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.642 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.0 mt-30 -114.74 -19.2 11.15 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.167 179.875 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 14.8 t60 32.61 -76.58 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 179.805 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.642 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.82 134.16 46.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.3 0.571 . . . . 0.0 112.066 -178.662 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -125.34 132.55 52.82 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.189 179.08 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.8 mt -116.46 133.78 61.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.986 -179.563 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -113.87 123.76 50.58 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.513 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.407 HD11 HD13 ' A' ' 22' ' ' LEU . 96.6 mt -105.87 111.6 35.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.659 -179.484 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.458 ' O ' ' N ' ' A' ' 56' ' ' GLN . 81.4 m-70 -113.77 142.85 45.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.313 179.834 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 54' ' ' HIS . 99.2 mt-10 -40.67 -28.46 0.07 Allowed 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.266 -0.574 . . . . 0.0 109.826 -179.771 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.488 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 95.1 mt-30 -63.78 -68.55 0.34 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.546 178.866 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.488 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 3.4 tp10 -157.24 -168.32 2.58 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.585 -179.671 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.524 ' HB2' ' NE ' ' A' ' 5' ' ' ARG . . . -110.12 124.71 52.02 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 178.473 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 98.0 mt -115.83 130.28 70.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.283 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 47.1 tp -97.98 127.98 44.26 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.249 179.258 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -114.94 138.24 51.06 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.467 -179.995 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.47 HD21 ' CA ' ' A' ' 68' ' ' PRO . 57.8 t-20 -98.69 106.83 19.15 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.903 0.383 . . . . 0.0 111.961 -179.692 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -102.33 -9.5 20.29 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.032 179.406 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.38 100.14 4.35 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.173 -179.932 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 85.0 p -84.24 -32.11 24.65 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.341 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.501 HG22 HG12 ' B' ' 236' ' ' VAL . 1.7 m -64.43 -51.46 63.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.699 -179.745 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.552 ' HB3' HD11 ' A' ' 91' ' ' ILE . 55.5 m-80 -138.79 95.96 9.58 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.673 179.825 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.47 ' CA ' HD21 ' A' ' 62' ' ' ASN . 52.0 Cg_exo -55.0 146.7 56.46 Favored 'Trans proline' 0 N--CA 1.499 1.809 0 C-N-CA 122.286 1.99 . . . . 0.0 113.328 -178.957 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 44.3 m -75.06 145.16 42.58 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.289 -179.984 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -108.11 143.37 36.95 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.808 -179.733 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.435 ' O ' ' N ' ' A' ' 74' ' ' SER . 5.4 p -131.99 135.97 57.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.77 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 49.16 33.17 4.69 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.238 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.69 29.09 69.92 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.317 -179.577 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 71' ' ' VAL . 66.8 m -138.65 136.06 35.51 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.906 0.353 . . . . 0.0 111.161 -179.616 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -66.32 141.75 17.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.176 -179.806 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.2 pt -118.71 78.99 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.677 179.107 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -63.34 -24.02 67.67 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.768 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -116.84 158.71 43.14 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.838 179.559 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -64.97 148.62 89.81 Favored 'Trans proline' 0 N--CA 1.5 1.884 0 C-N-CA 122.859 2.373 . . . . 0.0 113.044 -179.6 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 65.9 t -138.41 138.99 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.088 179.815 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -69.33 132.11 45.89 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 178.817 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 90.0 mt -78.85 138.38 38.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.304 0.574 . . . . 0.0 111.113 -179.985 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -132.36 150.14 52.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.075 179.949 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.453 ' ND1' ' N ' ' A' ' 99' ' ' ASN . 4.9 t60 -58.17 119.12 6.29 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.874 0.369 . . . . 0.0 110.401 -179.674 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.51 -23.04 16.19 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 -179.66 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 87' ' ' VAL . 57.7 t0 -67.93 132.11 46.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.029 0.442 . . . . 0.0 110.939 179.736 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.526 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 50.0 t -110.63 132.15 59.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.512 -179.038 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 87.3 mt -95.75 131.26 43.01 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 177.957 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 44.6 m -121.99 128.97 52.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.989 0.899 . . . . 0.0 113.314 -177.244 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.626 ' O ' ' N ' ' A' ' 93' ' ' ARG . 97.9 mt -116.42 129.94 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-N 113.926 -1.488 . . . . 0.0 108.379 178.453 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.552 HD11 ' HB3' ' A' ' 67' ' ' ASN . 70.4 mt -21.49 98.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.415 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.566 ' OD2' ' NH1' ' B' ' 245' ' ' ARG . 0.8 OUTLIER 88.46 -23.8 0.11 Allowed 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 178.171 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.626 ' N ' ' O ' ' A' ' 90' ' ' ILE . 83.4 mtt-85 -128.35 145.02 51.2 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.273 -179.53 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.485 ' CB ' HD12 ' A' ' 10' ' ' ILE . 11.3 t -140.7 153.76 46.08 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.325 0.583 . . . . 0.0 110.576 -179.9 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.647 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 95.8 m-85 -124.96 121.49 34.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.464 179.363 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -81.6 131.68 35.28 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.342 -179.937 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.584 ' CZ ' ' OD1' ' A' ' 99' ' ' ASN . 85.8 t80 -94.66 126.22 39.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.691 -179.647 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -136.4 128.59 29.84 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 120.572 -0.451 . . . . 0.0 112.001 -179.531 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.584 ' OD1' ' CZ ' ' A' ' 97' ' ' TYR . 93.7 m-20 . . . . . 0 CA--C 1.531 0.219 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.827 179.083 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo . . . . . 0 N--CA 1.494 1.505 0 N-CA-C 114.474 0.913 . . . . 0.0 114.474 . . . . . . . . . 0 0 . 1 . 038 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.501 HG12 HG22 ' A' ' 66' ' ' THR . 26.8 m -72.43 143.35 14.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 114.279 -1.328 . . . . 0.0 109.174 179.34 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 10.3 t . . . . . 0 C--N 1.322 -0.599 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.705 -179.028 . . . . . . . . 0 0 . 1 . 038 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo . . . . . 0 N--CA 1.494 1.518 0 CA-C-O 120.607 0.169 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 038 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 99.3 m -73.22 -45.09 58.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.905 0.384 . . . . 0.0 111.023 179.376 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -57.08 -47.84 80.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.251 -179.29 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 87.1 mt -63.5 -42.56 98.5 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.412 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -63.67 -41.88 98.12 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.892 -179.547 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 62.9 ttm-85 -64.31 -44.21 92.29 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.009 0.433 . . . . 0.0 110.422 179.938 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.603 ' NH2' HD13 ' A' ' 41' ' ' LEU . 4.0 tpp85 -61.43 -42.9 99.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.773 -179.61 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -59.48 -40.09 85.81 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.825 0.345 . . . . 0.0 110.271 -179.734 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 78.0 p -70.31 -39.88 74.55 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.816 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 63.7 tp60 -59.25 -38.53 80.3 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.699 179.823 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 38.3 t . . . . . 0 C--N 1.332 -0.18 0 CA-C-O 120.734 0.302 . . . . 0.0 110.35 179.029 . . . . . . . . 0 0 . 1 . 038 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.741 ' OE1' HD21 ' A' ' 41' ' ' LEU . 98.2 mt-10 . . . . . 0 N--CA 1.465 0.312 0 CA-C-O 120.767 0.318 . . . . 0.0 110.173 . . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.647 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 67.6 mt -114.11 134.19 57.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.655 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 44.4 t -124.99 134.53 66.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.168 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -96.17 117.72 31.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.275 0.559 . . . . 0.0 111.578 -178.222 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -65.96 -46.29 78.66 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.163 179.611 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.0 155.51 38.2 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.336 -179.192 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -64.31 148.86 90.99 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 123.212 2.608 . . . . 0.0 113.42 -179.222 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 47.1 pt . . . . . 0 C--N 1.332 -0.157 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.761 178.693 . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.8 p . . . . . 0 N--CA 1.456 -0.164 0 CA-C-O 121.096 0.474 . . . . 0.0 110.549 . . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.716 ' NH1' ' HB2' ' A' ' 58' ' ' ALA . 99.9 mtt180 -98.84 135.34 40.44 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.212 -179.736 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.497 ' NE ' ' OE1' ' A' ' 98' ' ' GLU . 33.4 ptt180 -140.85 155.44 46.34 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.27 -0.572 . . . . 0.0 112.034 -179.569 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 78.5 mt -118.91 145.19 45.94 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.747 179.703 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.6 t -114.43 129.88 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 178.177 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.413 ' CG2' HD12 ' B' ' 261' ' ' ILE . 22.4 m -91.64 118.27 30.49 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -177.553 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.43 HD12 ' HB2' ' A' ' 94' ' ' SER . 98.1 mt -84.67 142.87 12.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.436 178.284 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -94.99 167.89 11.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.845 0.355 . . . . 0.0 110.942 179.566 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.457 ' HG2' HH11 ' B' ' 245' ' ' ARG . 83.5 mtm180 -56.49 -32.44 65.02 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.465 -178.407 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.486 ' OG ' HG13 ' B' ' 249' ' ' VAL . 3.5 m -80.25 -7.61 59.09 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.47 179.893 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.71 39.83 6.98 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 -179.545 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.3 t -119.58 130.85 73.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.959 0.409 . . . . 0.0 110.869 -179.403 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -77.16 136.68 38.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.558 179.305 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -137.59 -114.86 1.32 Allowed Glycine 0 CA--C 1.535 1.297 0 C-N-CA 120.2 -1.0 . . . . 0.0 111.746 -179.9 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -71.92 149.0 52.62 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.088 1.859 . . . . 0.0 112.502 -178.994 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -113.45 157.6 21.75 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.793 179.932 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.599 ' CD2' HD11 ' A' ' 37' ' ' ILE . 34.1 t80 -118.13 97.71 50.94 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.487 179.864 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -74.17 131.76 15.74 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 121.39 1.393 . . . . 0.0 111.342 -179.328 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 82.0 mt -83.51 80.63 9.04 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.632 -178.791 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 87.9 p -84.55 -11.15 56.6 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.867 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 67.5 mt -107.16 149.18 27.96 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.191 -179.885 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 28.5 t -67.88 -15.79 63.78 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.811 -179.408 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.531 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 58.8 m -127.16 130.04 49.01 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.594 -0.442 . . . . 0.0 112.181 -179.192 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.7 t -123.76 113.46 18.61 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 177.799 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.456 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 41.0 tp -115.68 131.09 57.04 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.619 -178.232 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.745 ' CE2' HD12 ' A' ' 37' ' ' ILE . 6.9 m-85 -108.51 131.1 55.16 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.706 179.796 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 166.59 -175.25 41.99 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 119.934 -1.127 . . . . 0.0 112.862 179.386 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.503 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 76.4 mtm-85 -80.1 -32.11 39.17 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-O 120.876 0.369 . . . . 0.0 110.594 179.95 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.563 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -51.3 146.23 11.4 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.512 -178.147 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.549 HD13 ' CZ ' ' A' ' 38' ' ' ARG . 36.9 mm -64.44 -43.46 96.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.74 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -54.91 -21.24 10.93 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.633 -179.769 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.563 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 17.2 m -59.08 129.07 40.37 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.155 0.503 . . . . 0.0 110.521 -179.672 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.531 ' OD2' ' O ' ' A' ' 26' ' ' THR . 59.0 m-20 -60.9 -33.35 72.99 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.457 -179.109 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.745 HD12 ' CE2' ' A' ' 29' ' ' PHE . 89.4 mt -125.97 119.78 55.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 177.998 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.549 ' CZ ' HD13 ' A' ' 33' ' ' ILE . 83.3 mtp180 -103.75 137.84 41.22 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.889 -178.497 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 90.3 mt -121.08 131.76 72.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.267 179.551 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -75.24 26.35 0.1 Allowed 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -178.319 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.587 ' CD1' ' CZ ' ' A' ' 93' ' ' ARG . 81.9 mt -102.2 131.74 22.27 Favored Pre-proline 0 C--N 1.326 -0.42 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.301 179.947 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.69 -13.18 27.05 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 122.292 1.995 . . . . 0.0 112.47 -179.535 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.525 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 3.8 m -92.81 2.04 8.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.159 -179.621 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.503 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 38.0 t -91.7 133.8 32.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 177.875 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.0 m -72.64 175.0 6.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.501 0.667 . . . . 0.0 111.586 -178.285 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -63.35 -42.58 98.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.736 -179.787 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.629 ' O ' ' N ' ' A' ' 49' ' ' CYS . 89.0 mt-30 -116.98 -17.01 10.48 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.426 0.454 . . . . 0.0 111.335 -179.948 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.1 t60 34.05 -76.52 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 179.665 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.629 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -127.8 135.1 49.63 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.225 0.536 . . . . 0.0 112.222 -178.766 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -126.74 133.08 50.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.896 179.476 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.3 mt -119.37 132.04 70.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.63 179.107 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.41 ' HB3' ' HE1' ' A' ' 54' ' ' HIS . 79.6 tt0 -115.21 126.09 54.14 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.944 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.48 HD12 HH11 ' A' ' 5' ' ' ARG . 47.4 mm -93.68 122.66 45.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.326 0.584 . . . . 0.0 111.356 -178.029 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.463 ' O ' ' C ' ' A' ' 55' ' ' GLU . 8.7 m80 -117.76 127.42 53.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.168 179.104 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' A' ' 54' ' ' HIS . 97.5 mt-10 -40.96 -31.33 0.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.967 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.428 ' N ' ' C ' ' A' ' 54' ' ' HIS . 85.7 mt-30 -67.0 -67.61 0.44 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.664 178.046 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -149.77 -172.79 4.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.157 -179.63 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.716 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -115.01 132.19 56.68 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.951 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 47.6 mm -113.21 128.11 70.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 120.493 -0.483 . . . . 0.0 112.022 -178.286 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.42 ' HB2' HD11 ' A' ' 82' ' ' LEU . 22.9 tp -98.65 126.61 44.3 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.545 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -117.92 139.09 51.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.739 0.304 . . . . 0.0 110.595 -179.724 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.536 HD22 ' HA ' ' A' ' 68' ' ' PRO . 51.2 t30 -101.58 113.93 27.51 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.85 0.357 . . . . 0.0 111.493 -179.728 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -102.45 -7.92 21.54 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.653 179.878 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.42 99.16 11.01 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.423 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.9 m -76.25 -32.31 58.79 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.246 0.546 . . . . 0.0 109.938 179.064 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.0 m -63.48 -45.97 88.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.598 -179.309 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -142.93 93.15 6.73 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.597 179.208 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.536 ' HA ' HD22 ' A' ' 62' ' ' ASN . 32.6 Cg_exo -56.93 148.89 64.8 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.056 1.837 . . . . 0.0 111.859 -179.721 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.967 ' O ' HG22 ' A' ' 76' ' ' ILE . 41.7 m -70.66 156.43 39.48 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.106 -179.589 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.413 ' N ' HG22 ' A' ' 69' ' ' THR . 86.7 mt-30 -114.6 140.98 48.36 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.915 179.683 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.642 HG13 ' OD1' ' A' ' 86' ' ' ASP . 55.6 t -130.21 135.68 60.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.762 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 52.81 32.38 12.19 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 119.857 -0.737 . . . . 0.0 109.359 -179.142 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.25 29.17 68.84 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.511 179.99 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 11.3 p -142.03 140.15 32.55 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.286 179.965 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.2 p -63.0 143.27 15.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.698 -179.433 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.967 HG22 ' O ' ' A' ' 69' ' ' THR . 10.5 tt -113.88 87.28 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.577 -179.849 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 20.5 p-10 -66.4 -33.03 74.79 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.952 179.891 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.418 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 2.7 mt-10 -124.65 167.41 15.96 Favored Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.27 -179.053 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -60.3 144.87 99.5 Favored 'Trans proline' 0 N--CA 1.502 2.001 0 C-N-CA 122.582 2.188 . . . . 0.0 112.891 179.647 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.1 m -138.77 152.81 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 CA-C-O 121.618 0.723 . . . . 0.0 111.962 178.665 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -79.45 127.31 31.95 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.835 179.548 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.42 HD11 ' HB2' ' A' ' 60' ' ' LEU . 98.1 mt -83.41 129.49 34.99 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.28 0.562 . . . . 0.0 110.434 -179.623 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -121.91 150.45 41.96 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.283 -179.881 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.428 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 6.1 t60 -49.63 118.35 2.75 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.955 -179.397 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.15 -20.35 28.55 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 179.685 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.642 ' OD1' HG13 ' A' ' 71' ' ' VAL . 56.7 t0 -61.54 132.49 53.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.17 0.509 . . . . 0.0 110.437 179.864 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.503 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 56.7 t -109.48 129.75 63.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.278 -179.03 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.8 mt -98.09 131.56 44.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.613 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.455 HG23 ' OG ' ' A' ' 94' ' ' SER . 74.7 m -126.05 127.92 46.6 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.624 0.726 . . . . 0.0 112.405 -178.42 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.569 ' O ' ' N ' ' A' ' 92' ' ' ASP . 97.8 mt -110.13 125.4 67.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.009 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.894 HD12 HH22 ' A' ' 93' ' ' ARG . 88.6 mt 40.0 -91.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 120.584 -0.447 . . . . 0.0 110.315 -178.7 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.569 ' N ' ' O ' ' A' ' 90' ' ' ILE . 33.9 t70 -128.06 20.05 6.43 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.04 0.448 . . . . 0.0 111.238 -179.776 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.894 HH22 HD12 ' A' ' 91' ' ' ILE . 45.8 mtm-85 -126.65 140.41 52.43 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.541 -179.798 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.455 ' OG ' HG23 ' A' ' 89' ' ' THR . 57.4 m -138.89 153.31 48.27 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 119.602 -0.839 . . . . 0.0 112.2 -179.154 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -121.92 122.44 39.4 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.705 178.864 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -81.55 130.11 34.93 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 119.884 -0.726 . . . . 0.0 110.449 -179.108 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -94.27 124.24 38.17 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.272 -179.283 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.497 ' OE1' ' NE ' ' A' ' 6' ' ' ARG . 80.3 tt0 -124.5 123.44 40.13 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.97 179.868 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.428 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 64.0 t-20 . . . . . 0 N--CA 1.463 0.193 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.668 -179.959 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo . . . . . 0 N--CA 1.484 0.925 0 CA-C-O 120.947 0.311 . . . . 0.0 111.59 . . . . . . . . . 0 0 . 1 . 039 nuclear build core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 5.9 p -113.91 133.2 60.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.799 179.704 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 237' ' ' CYS . . . . . 0.461 ' HG ' ' HD2' ' B' ' 241' ' ' PHE . 4.6 t . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.48 -178.923 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo . . . . . 0 N--CA 1.495 1.584 0 CA-C-O 120.621 0.176 . . . . 0.0 112.003 . . . . . . . . . 0 0 . 1 . 039 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 94.4 m -71.88 -45.84 59.91 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.147 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.525 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 83.3 t80 -58.79 -47.05 86.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.101 -179.376 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.407 ' HA ' HD23 ' B' ' 242' ' ' LEU . 95.3 mt -63.56 -41.1 98.42 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -179.046 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -63.12 -38.87 92.91 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.967 -179.792 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -63.49 -41.85 98.56 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.126 0.489 . . . . 0.0 110.002 179.613 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.633 ' NH2' ' NH1' ' A' ' 93' ' ' ARG . 62.4 ttm-85 -60.05 -44.72 94.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.008 -179.168 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -64.77 -40.05 94.62 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.752 179.467 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 66.6 m -63.77 -45.42 89.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.499 179.509 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -60.7 -39.47 88.65 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.259 -179.461 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 249' ' ' VAL . . . . . 0.486 HG13 ' OG ' ' A' ' 13' ' ' SER . 21.0 t . . . . . 0 N--CA 1.452 -0.351 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.445 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 . . . . . 0 CA--C 1.531 0.247 0 CA-C-O 120.481 0.181 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 039 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.413 HD12 ' CG2' ' A' ' 9' ' ' THR . 73.5 mt -106.39 138.73 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.783 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 54.1 t -129.05 136.66 59.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.274 -178.765 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -97.4 117.12 30.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.318 0.58 . . . . 0.0 111.126 -179.397 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 43.3 tttp -67.05 -43.41 82.8 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.502 178.99 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 53.8 mm-40 -94.0 155.2 40.43 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.721 -179.014 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -61.31 154.1 60.82 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.103 1.869 . . . . 0.0 111.036 178.561 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 40.3 pt . . . . . 0 C--N 1.324 -0.539 0 CA-C-O 121.702 0.763 . . . . 0.0 112.372 -178.328 . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 68.5 p . . . . . 0 CA--C 1.521 -0.152 0 CA-C-O 120.787 0.327 . . . . 0.0 110.58 . . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.871 ' NH1' HG23 ' A' ' 53' ' ' ILE . 99.9 mtt180 -94.72 130.73 41.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.941 179.924 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -128.27 137.85 52.16 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.424 179.514 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.56 HD11 ' HB3' ' A' ' 95' ' ' PHE . 45.0 tp -106.88 130.88 54.49 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.47 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.6 t -110.04 129.31 65.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.475 -178.991 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.412 ' O ' HG22 ' A' ' 9' ' ' THR . 1.8 m -90.9 111.9 23.52 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.461 -178.971 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.7 mt -83.13 148.03 5.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.599 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -94.15 168.6 10.83 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.383 0.611 . . . . 0.0 111.434 179.705 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.446 ' HD3' HH12 ' A' ' 93' ' ' ARG . 87.9 mtm180 -58.06 -29.74 65.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.886 -179.038 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.8 p -80.54 -6.24 57.93 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.687 179.796 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.04 23.6 37.6 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.163 179.159 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.1 m -109.54 140.86 26.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.535 179.742 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.41 ' C ' ' OD1' ' A' ' 16' ' ' ASP . 57.3 t0 -69.32 122.75 19.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.682 -179.6 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -108.74 -131.91 6.49 Favored Glycine 0 CA--C 1.538 1.506 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 -179.344 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -74.71 153.95 43.64 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.342 2.028 . . . . 0.0 112.031 -179.258 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -109.15 155.92 20.45 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.148 -179.536 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.439 ' CD2' HD11 ' A' ' 37' ' ' ILE . 57.2 t80 -126.12 92.28 46.13 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.477 179.927 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.94 126.72 22.53 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 121.865 1.71 . . . . 0.0 111.551 -179.789 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.2 mt -80.02 54.3 1.88 Allowed 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 120.808 0.337 . . . . 0.0 110.708 -179.351 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.6 t -62.46 -40.62 97.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.802 179.587 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 46.8 mt -70.54 144.49 51.29 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.178 -179.77 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.6 t -66.01 -17.84 64.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.444 -178.84 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.549 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 50.2 m -132.53 134.13 44.61 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.996 -179.777 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.647 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 2.7 t -127.66 116.81 20.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.111 0.481 . . . . 0.0 109.798 178.585 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.617 HD21 ' OE1' ' A' ' 47' ' ' GLN . 44.7 tp -114.82 130.14 56.82 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.631 -178.291 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.778 ' CE2' HD12 ' A' ' 37' ' ' ILE . 27.1 m-85 -108.7 139.18 43.86 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.171 -179.894 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.87 -175.38 30.65 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.405 178.574 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.6 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 81.5 mtm-85 -74.04 -32.96 63.54 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.911 0.386 . . . . 0.0 110.868 -179.961 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.428 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -46.86 139.8 7.46 Favored Glycine 0 N--CA 1.465 0.584 0 N-CA-C 111.554 -0.619 . . . . 0.0 111.554 -178.582 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.547 ' CD1' ' CZ ' ' A' ' 38' ' ' ARG . 36.3 mm -64.99 -44.71 96.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.805 0.336 . . . . 0.0 110.975 -179.951 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -57.98 -13.91 5.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.45 -179.173 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.428 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 60.0 m -63.02 131.23 47.91 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.524 -179.877 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.549 ' OD2' ' O ' ' A' ' 26' ' ' THR . 58.9 m-20 -61.24 -30.79 70.66 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.288 -179.326 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.778 HD12 ' CE2' ' A' ' 29' ' ' PHE . 77.9 mt -128.44 119.34 50.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.019 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.547 ' CZ ' ' CD1' ' A' ' 33' ' ' ILE . 83.8 mtp180 -100.04 135.54 41.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.518 -179.052 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.561 HG21 HD12 ' A' ' 41' ' ' LEU . 95.2 mt -121.28 128.96 76.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.55 -0.46 . . . . 0.0 109.907 179.98 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -79.36 31.26 0.22 Allowed 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -178.318 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.561 HD12 HG21 ' A' ' 39' ' ' ILE . 13.2 mt -97.85 128.48 33.92 Favored Pre-proline 0 CA--C 1.535 0.366 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.763 179.544 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -72.51 -12.69 27.27 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.487 2.125 . . . . 0.0 113.272 -179.276 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.439 HG21 ' CE2' ' B' ' 241' ' ' PHE . 27.1 m -100.29 6.99 9.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.316 -0.554 . . . . 0.0 110.432 179.525 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.6 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 32.0 t -95.43 134.99 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.934 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.67 164.47 19.2 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.502 0.668 . . . . 0.0 111.94 -178.691 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -63.56 -42.31 98.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.056 -179.375 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.638 ' O ' ' N ' ' A' ' 49' ' ' CYS . 95.3 mm-40 -109.2 -23.04 11.81 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.591 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.473 ' O ' ' OG ' ' A' ' 64' ' ' SER . 17.1 t60 38.18 -76.04 0.0 OUTLIER 'General case' 0 C--O 1.235 0.336 0 CA-C-N 114.621 -1.172 . . . . 0.0 113.086 179.135 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.638 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.59 136.79 45.13 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.347 -0.541 . . . . 0.0 112.04 -178.218 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -128.17 130.39 47.98 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.394 179.431 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 95.8 mt -112.36 133.36 58.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.043 -179.934 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 73.3 tt0 -116.92 125.32 51.29 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.864 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.871 HG23 ' NH1' ' A' ' 5' ' ' ARG . 91.8 mt -104.33 123.81 58.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.666 0.746 . . . . 0.0 112.913 -177.796 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.494 ' O ' ' N ' ' A' ' 56' ' ' GLN . 2.0 m-70 -118.21 137.19 53.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.506 -1.225 . . . . 0.0 109.437 179.06 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.466 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.9 mm-40 -39.38 -29.57 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -179.508 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.494 ' N ' ' O ' ' A' ' 54' ' ' HIS . 98.6 mm-40 -65.22 -66.52 0.53 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.955 178.656 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -157.49 -166.03 1.93 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.198 -179.65 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.499 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -108.95 130.79 55.46 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.699 179.129 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 37.1 mm -112.43 125.84 69.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.902 -179.473 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.1 tp -99.72 123.41 43.95 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.723 0.297 . . . . 0.0 110.53 -179.888 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -111.23 134.6 52.69 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.152 179.853 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.408 ' ND2' ' O ' ' A' ' 76' ' ' ILE . 46.6 p-10 -99.89 108.3 20.51 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 121.0 0.429 . . . . 0.0 111.537 -179.845 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -97.52 -9.65 26.72 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.7 -179.937 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.473 ' OG ' ' O ' ' A' ' 48' ' ' HIS . 0.3 OUTLIER -77.25 99.88 5.64 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 120.95 0.405 . . . . 0.0 110.764 -179.689 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 86.5 p -79.08 -31.44 44.37 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.875 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.588 HG22 HG12 ' B' ' 236' ' ' VAL . 3.6 m -64.41 -47.99 77.08 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.764 -179.796 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -147.61 99.17 3.85 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.25 -179.699 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -56.27 149.66 53.93 Favored 'Trans proline' 0 N--CA 1.499 1.794 0 C-N-CA 122.117 1.878 . . . . 0.0 113.215 -178.489 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 50.3 m -68.06 138.7 56.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.174 178.849 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -100.45 144.54 29.33 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.731 -179.745 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.697 ' HB ' HD11 ' A' ' 76' ' ' ILE . 5.1 p -131.21 136.28 58.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.167 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 51.12 30.93 6.01 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -178.967 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.41 26.2 70.76 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.936 -179.86 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 71' ' ' VAL . 12.0 t -135.65 137.8 42.21 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.194 0.521 . . . . 0.0 111.534 -179.511 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.5 t -66.68 136.43 26.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.813 -179.784 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.697 HD11 ' HB ' ' A' ' 71' ' ' VAL . 97.0 mt -101.27 100.86 11.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.561 179.383 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -64.44 -41.15 96.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.875 179.872 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.515 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.9 OUTLIER -132.54 -178.07 0.79 Allowed Pre-proline 0 N--CA 1.464 0.227 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.346 -178.656 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 31.3 Cg_exo -59.38 143.8 99.6 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.49 2.127 . . . . 0.0 111.642 -179.815 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.2 p -141.01 147.65 22.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-O 121.186 0.517 . . . . 0.0 112.078 -179.041 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -79.7 128.16 33.08 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.283 179.27 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.499 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 96.0 mt -83.33 139.15 33.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.22 -179.84 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.484 ' N ' ' OD2' ' A' ' 86' ' ' ASP . 99.2 mttt -128.81 153.67 47.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.795 179.166 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.538 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 3.6 t-160 -55.54 119.4 5.6 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.892 0.377 . . . . 0.0 110.383 -179.661 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.0 -13.66 31.65 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.687 179.606 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.523 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 2.4 p30 -72.06 133.2 45.11 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.406 -0.517 . . . . 0.0 109.894 179.564 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 45.7 t -109.21 130.12 62.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.583 -178.309 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 89.4 mt -98.21 131.29 45.56 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 178.401 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.6 m -119.27 127.91 53.67 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.951 0.882 . . . . 0.0 112.628 -178.066 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.587 ' O ' ' N ' ' A' ' 93' ' ' ARG . 98.4 mt -115.28 134.11 59.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.471 178.496 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.617 HD13 ' HB2' ' B' ' 237' ' ' CYS . 53.9 mt -31.73 100.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 O-C-N 123.028 0.205 . . . . 0.0 111.295 -179.857 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.488 ' HB2' ' O ' ' A' ' 91' ' ' ILE . 83.8 m-20 86.67 -16.11 0.42 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.132 0.973 . . . . 0.0 113.259 179.169 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.587 ' N ' ' O ' ' A' ' 90' ' ' ILE . 81.1 mmt-85 -130.43 141.53 50.53 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.902 179.517 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.5 m -139.02 148.58 43.6 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.611 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.56 ' HB3' HD11 ' A' ' 7' ' ' LEU . 18.8 m-85 -126.8 125.37 41.59 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.544 -179.804 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 96' ' ' ARG . 49.0 ttt85 -84.5 131.18 34.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.885 0.374 . . . . 0.0 110.893 -179.647 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -94.73 122.2 37.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.917 -179.781 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -124.1 120.73 33.22 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.637 -179.679 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.538 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 43.9 t-20 . . . . . 0 C--N 1.332 -0.17 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.199 179.364 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo . . . . . 0 N--CA 1.49 1.319 0 CA-C-O 121.631 0.596 . . . . 0.0 113.289 . . . . . . . . . 0 0 . 1 . 040 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.588 HG12 HG22 ' A' ' 66' ' ' THR . 35.1 m -76.44 135.42 26.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 114.66 -1.154 . . . . 0.0 109.989 179.799 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' B' B ' 237' ' ' CYS . . . . . 0.617 ' HB2' HD13 ' A' ' 91' ' ' ILE . 5.1 t . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.403 -178.732 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo . . . . . 0 N--CA 1.492 1.387 0 CA-C-O 120.922 0.301 . . . . 0.0 111.579 . . . . . . . . . 0 0 . 1 . 040 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 60.4 m -75.27 -43.01 53.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.599 177.445 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.439 ' CE2' HG21 ' A' ' 43' ' ' VAL . 90.1 t80 -59.18 -45.11 91.9 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.031 -179.949 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.518 HD21 HG23 ' A' ' 91' ' ' ILE . 98.2 mt -63.8 -39.32 93.95 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.091 0.472 . . . . 0.0 110.124 179.899 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -62.25 -41.71 98.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.768 179.985 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -62.36 -37.2 84.77 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.178 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.593 ' NH2' ' OE1' ' B' ' 248' ' ' GLN . 0.0 OUTLIER -58.5 -43.14 88.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.875 179.684 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -61.16 -38.48 86.6 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.587 -0.524 . . . . 0.0 109.587 178.95 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 38.0 t -64.1 -43.08 96.43 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 177.601 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 248' ' ' GLN . . . . . 0.593 ' OE1' ' NH2' ' B' ' 245' ' ' ARG . 36.7 mt-30 -58.49 -37.9 76.53 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.419 179.881 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 38.5 t . . . . . 0 N--CA 1.454 -0.238 0 C-N-CA 120.546 -0.461 . . . . 0.0 110.345 179.859 . . . . . . . . 0 0 . 1 . 040 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.411 ' HB2' ' NH2' ' A' ' 93' ' ' ARG . 95.5 mt-10 . . . . . 0 N--CA 1.462 0.161 0 N-CA-C 111.366 0.136 . . . . 0.0 111.366 . . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.503 HD11 ' HD2' ' A' ' 93' ' ' ARG . 82.8 mt -111.47 132.28 60.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.838 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 54.9 t -127.98 136.03 61.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.149 -179.873 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -96.99 121.97 39.46 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.41 0.624 . . . . 0.0 111.258 -179.029 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -66.25 -46.16 78.07 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.037 179.473 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 265' ' ' GLN . . . . . 0.661 ' NE2' ' O ' ' B' ' 266' ' ' PRO . 0.0 OUTLIER -94.8 157.22 37.18 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.036 -179.418 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' B' B ' 266' ' ' PRO . . . . . 0.661 ' O ' ' NE2' ' B' ' 265' ' ' GLN . 57.2 Cg_endo -65.72 145.26 80.73 Favored 'Trans proline' 0 N--CA 1.5 1.882 0 C-N-CA 123.15 2.566 . . . . 0.0 113.118 -178.852 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 43.9 pt . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.224 178.95 . . . . . . . . 0 0 . 1 . 041 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 34.2 p . . . . . 0 N--CA 1.456 -0.148 0 CA-C-O 120.975 0.417 . . . . 0.0 110.528 . . . . . . . . . 0 0 . 1 . 041 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.619 ' NE ' ' OH ' ' A' ' 97' ' ' TYR . 83.5 mtp180 -85.17 129.89 34.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.155 -179.418 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.602 ' NH2' ' ND1' ' A' ' 19' ' ' HIS . 79.5 ttt180 -124.42 131.38 53.5 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -178.783 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.429 HD11 ' HB3' ' A' ' 95' ' ' PHE . 40.3 tp -109.81 132.36 54.22 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.208 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.7 t -109.79 128.45 65.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.467 -178.952 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.442 HG23 ' CD1' ' B' ' 261' ' ' ILE . 1.6 m -89.93 115.04 26.93 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.565 -179.429 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.666 HD12 ' OG ' ' A' ' 94' ' ' SER . 97.4 mt -79.87 140.14 17.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.151 179.393 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -89.93 160.41 16.43 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.182 0.515 . . . . 0.0 111.046 179.071 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.597 ' NH2' ' N ' ' B' ' 249' ' ' VAL . 73.5 mtp180 -57.52 -31.96 66.57 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.779 -179.757 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 99.7 p -77.38 -11.59 59.86 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.634 -179.634 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.93 31.68 9.72 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 -179.682 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.7 t -115.86 133.37 62.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.432 -0.384 . . . . 0.0 110.427 -179.68 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.436 ' C ' ' OD1' ' A' ' 16' ' ' ASP . 49.0 t0 -62.02 120.33 10.61 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.6 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -103.31 -134.81 8.42 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 120.892 -0.67 . . . . 0.0 111.808 -178.7 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -75.14 150.7 37.94 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.526 2.151 . . . . 0.0 112.534 -178.945 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.602 ' ND1' ' NH2' ' A' ' 6' ' ' ARG . 0.6 OUTLIER -108.51 131.08 55.18 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.64 -179.541 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.558 ' CD2' HD11 ' A' ' 37' ' ' ILE . 37.8 t80 -100.84 100.38 12.59 Favored Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.347 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.28 134.74 21.45 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 121.095 1.197 . . . . 0.0 111.581 -178.303 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 68.2 mt -99.38 124.17 44.28 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.627 0.727 . . . . 0.0 111.574 -178.118 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.6 p -137.09 -19.7 1.27 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.404 -1.271 . . . . 0.0 109.284 178.714 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.652 HD11 ' CD ' ' B' ' 265' ' ' GLN . 58.7 mt -79.15 144.92 34.02 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.355 179.41 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 90.9 p -61.82 -21.3 64.5 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -178.248 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.441 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 53.9 m -135.08 134.79 40.69 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.213 -0.595 . . . . 0.0 112.561 -178.618 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.9 t -124.81 116.23 21.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.602 178.119 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.666 HD12 ' O ' ' A' ' 49' ' ' CYS . 49.6 tp -116.73 132.86 56.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.957 0.408 . . . . 0.0 112.042 -178.337 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.714 ' CE2' HD12 ' A' ' 37' ' ' ILE . 10.8 m-85 -110.49 140.6 44.6 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.233 178.973 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 154.13 -176.29 32.06 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.044 178.735 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.646 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 80.2 mtm-85 -75.48 -30.72 59.99 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 120.956 0.407 . . . . 0.0 110.111 179.562 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.556 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -51.06 145.07 11.69 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.848 -178.608 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.488 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.7 tp -68.12 -41.0 83.86 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 120.872 0.368 . . . . 0.0 110.095 179.271 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.488 ' N ' HG23 ' A' ' 33' ' ' ILE . 80.6 tt0 -55.67 -22.09 21.36 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.47 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.556 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 19.0 m -58.82 121.41 11.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.837 179.369 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.441 ' OD2' ' O ' ' A' ' 26' ' ' THR . 96.2 m-20 -58.65 -25.05 62.36 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -178.767 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.714 HD12 ' CE2' ' A' ' 29' ' ' PHE . 82.1 mt -131.21 122.74 51.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.565 177.27 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.441 ' HD3' HD12 ' A' ' 33' ' ' ILE . 60.6 mtm180 -101.08 134.22 44.41 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.491 179.658 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.4 mt -116.47 127.87 73.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.484 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -74.66 28.21 0.09 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.23 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.595 HD21 ' OE1' ' B' ' 260' ' ' GLU . 40.7 mt -98.31 129.54 30.34 Favored Pre-proline 0 CA--C 1.538 0.508 0 C-N-CA 119.924 -0.711 . . . . 0.0 110.737 179.922 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.59 -7.53 20.35 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.607 2.205 . . . . 0.0 112.072 -179.523 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.4 m -102.06 6.79 9.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.112 -179.355 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.646 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 17.4 t -95.08 136.43 26.17 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.268 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.864 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.5 m -69.43 167.48 16.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.054 0.454 . . . . 0.0 111.147 -179.384 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 47.3 mttp -63.5 -38.6 91.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.966 -179.53 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.676 ' O ' ' N ' ' A' ' 49' ' ' CYS . 91.7 mm-40 -113.66 -17.99 12.0 Favored 'General case' 0 C--O 1.223 -0.338 0 O-C-N 123.474 0.484 . . . . 0.0 111.371 -179.159 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 23.2 t60 29.63 -74.97 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.52 0.934 . . . . 0.0 113.52 -179.608 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.676 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.11 133.83 46.0 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.427 0.632 . . . . 0.0 112.402 -178.287 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -128.55 128.37 44.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.2 179.537 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 85.2 mt -109.47 132.37 57.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.422 179.667 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -114.63 124.24 51.33 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.11 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.567 HD13 ' NH1' ' A' ' 5' ' ' ARG . 64.5 mt -107.46 116.59 51.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 120.02 -0.672 . . . . 0.0 112.727 -177.661 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.455 ' O ' ' C ' ' A' ' 55' ' ' GLU . 97.4 m-70 -111.49 139.26 47.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.905 178.654 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 54' ' ' HIS . 84.0 tt0 -41.21 -30.05 0.15 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 119.926 -0.709 . . . . 0.0 109.306 -179.943 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.431 ' N ' ' O ' ' A' ' 54' ' ' HIS . 84.8 mt-30 -61.08 -68.09 0.34 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.622 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -156.19 -174.04 4.77 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.1 -179.772 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.597 ' HB1' HH22 ' A' ' 5' ' ' ARG . . . -108.32 125.3 51.54 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.022 179.732 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.1 mt -119.23 130.77 73.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.369 0.604 . . . . 0.0 112.471 -178.55 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.587 ' HB2' HD11 ' A' ' 82' ' ' LEU . 18.4 tp -97.86 127.94 44.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.367 179.503 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -109.0 134.81 51.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.891 179.621 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.447 HD21 ' CA ' ' A' ' 68' ' ' PRO . 64.5 t-20 -94.49 105.49 17.46 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.39 -178.866 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -98.75 -8.28 26.28 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.689 179.497 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.6 m -71.52 101.93 2.58 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.304 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 89.7 p -87.84 -24.13 23.8 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.107 179.821 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.508 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -78.27 -42.1 32.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.312 0.577 . . . . 0.0 109.769 179.323 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 36.7 m-20 -143.13 99.31 5.46 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.875 -179.498 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.447 ' CA ' HD21 ' A' ' 62' ' ' ASN . 52.7 Cg_exo -54.77 148.17 46.95 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.197 1.931 . . . . 0.0 113.41 -179.578 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.1 m -75.04 142.07 43.81 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.293 179.457 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -108.2 139.9 42.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.928 179.688 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.681 HG13 ' OD1' ' A' ' 86' ' ' ASP . 54.8 t -131.75 135.33 59.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.579 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 51.81 31.72 8.63 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.28 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.51 25.06 68.79 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-N 114.957 -1.02 . . . . 0.0 112.132 179.743 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 66.1 m -142.93 142.52 31.71 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 117.725 0.762 . . . . 0.0 112.57 -179.576 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.8 t -69.85 142.08 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.312 179.424 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.3 pt -110.98 77.08 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.478 179.221 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -52.55 -29.56 26.14 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.4 179.943 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.56 171.25 6.34 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.145 179.366 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -60.63 148.44 91.4 Favored 'Trans proline' 0 N--CA 1.499 1.84 0 C-N-CA 122.276 1.984 . . . . 0.0 111.832 179.631 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.8 p -138.15 140.83 39.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.995 0.426 . . . . 0.0 111.625 -179.391 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.9 mtm180 -75.12 128.53 35.73 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.025 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.587 HD11 ' HB2' ' A' ' 60' ' ' LEU . 91.5 mt -84.4 138.96 32.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.958 0.409 . . . . 0.0 111.054 -179.449 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -131.83 155.63 47.46 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.583 179.987 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.598 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 5.7 t60 -56.92 115.13 2.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.446 179.944 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.3 -12.49 26.15 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 -179.462 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.681 ' OD1' HG13 ' A' ' 71' ' ' VAL . 58.7 t0 -70.01 129.79 40.41 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 179.615 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.464 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 60.9 t -110.96 131.82 61.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.228 -179.237 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 94.4 mt -97.63 129.79 47.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.379 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 77.7 m -120.46 125.71 48.59 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.69 0.757 . . . . 0.0 112.777 -178.231 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.464 ' O ' ' C ' ' A' ' 91' ' ' ILE . 95.7 mt -112.2 123.47 67.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.347 178.079 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.608 HG22 ' N ' ' A' ' 92' ' ' ASP . 96.0 mt 34.33 -98.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 121.201 -0.2 . . . . 0.0 110.972 -178.883 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.608 ' N ' HG22 ' A' ' 91' ' ' ILE . 50.1 p-10 -114.43 15.03 17.97 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.913 0.387 . . . . 0.0 111.544 -179.99 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.442 HH21 ' CD ' ' B' ' 260' ' ' GLU . 84.6 mtt-85 -124.89 142.48 51.43 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.765 179.058 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.666 ' OG ' HD12 ' A' ' 10' ' ' ILE . 53.8 p -141.0 154.43 46.02 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.715 179.549 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.429 ' HB3' HD11 ' A' ' 7' ' ' LEU . 47.9 m-85 -124.32 125.46 44.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.555 179.757 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.425 ' O ' HD12 ' A' ' 7' ' ' LEU . 79.4 mtp85 -88.48 132.4 34.5 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.83 -179.494 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.619 ' OH ' ' NE ' ' A' ' 5' ' ' ARG . 88.3 t80 -95.21 127.87 41.6 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.197 -179.609 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -131.24 116.43 17.64 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.303 -179.613 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.598 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 61.9 t-20 . . . . . 0 N--CA 1.464 0.243 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.963 -179.806 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo . . . . . 0 N--CA 1.486 1.043 0 CA-C-O 121.624 0.594 . . . . 0.0 113.44 . . . . . . . . . 0 0 . 1 . 041 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.508 ' CG2' HG22 ' A' ' 66' ' ' THR . 53.7 t -63.91 136.32 26.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.542 -179.355 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 14.8 t . . . . . 0 C--N 1.332 -0.187 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.764 . . . . . . . . 0 0 . 1 . 041 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo . . . . . 0 N--CA 1.493 1.473 0 CA-C-O 120.656 0.19 . . . . 0.0 111.986 . . . . . . . . . 0 0 . 1 . 041 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 19.9 m -68.3 -44.42 75.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.321 0.581 . . . . 0.0 109.67 178.001 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.419 ' HZ ' HD22 ' A' ' 41' ' ' LEU . 89.0 t80 -58.47 -47.26 84.62 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.411 -179.296 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 93.8 mt -63.32 -40.68 97.99 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.146 -179.501 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -64.42 -41.25 96.71 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.115 -179.42 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -62.0 -41.86 98.52 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.016 -179.653 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.587 ' CZ ' ' OD2' ' A' ' 92' ' ' ASP . 8.2 tpp85 -61.28 -42.02 97.94 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.277 179.595 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' B' B ' 246' ' ' LYS . . . . . 0.47 ' O ' HG12 ' B' ' 249' ' ' VAL . 98.4 mttt -61.39 -41.38 97.04 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.412 179.891 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 58.5 m -68.75 -41.91 78.27 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.305 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' B' B ' 248' ' ' GLN . . . . . 0.448 ' HB3' HH22 ' A' ' 12' ' ' ARG . 62.1 tt0 -61.1 -39.67 90.84 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.119 -179.422 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' B' B ' 249' ' ' VAL . . . . . 0.597 ' N ' ' NH2' ' A' ' 12' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.465 0.297 0 C-N-CA 119.932 -0.707 . . . . 0.0 109.25 179.165 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.595 ' OE1' HD21 ' A' ' 41' ' ' LEU . 97.0 mt-10 . . . . . 0 CA--C 1.535 0.402 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 . . . . . . . . . 1 1 . 1 . 041 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.442 ' CD1' HG23 ' A' ' 9' ' ' THR . 65.0 mt -118.4 133.44 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 120.604 -0.438 . . . . 0.0 109.839 179.703 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 49.6 t -128.46 135.91 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 120.786 0.327 . . . . 0.0 110.836 -179.693 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -97.42 119.64 36.32 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.298 0.57 . . . . 0.0 112.156 -178.641 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -64.93 -45.37 86.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.292 178.552 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' B' B ' 265' ' ' GLN . . . . . 0.652 ' CD ' HD11 ' A' ' 24' ' ' LEU . 2.0 mm-40 -89.9 157.84 45.48 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.393 -179.002 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -60.71 144.15 99.5 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 C-N-CA 122.055 1.837 . . . . 0.0 111.139 179.173 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' B' B ' 267' ' ' ILE . . . . . 0.498 ' CD1' ' O ' ' A' ' 19' ' ' HIS . 2.5 tt . . . . . 0 C--N 1.324 -0.514 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.549 -178.555 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.7 p . . . . . 0 C--O 1.232 0.164 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 . . . . . . . . . 0 0 . 1 . 042 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.4 mtm-85 -93.4 121.61 34.97 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.282 -178.725 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.695 HH21 ' CG ' ' A' ' 19' ' ' HIS . 80.5 ttt180 -130.23 132.01 45.78 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.757 -179.566 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.569 HD12 ' O ' ' A' ' 96' ' ' ARG . 26.0 tp -112.84 133.33 54.88 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -179.928 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.6 t -110.49 131.98 60.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 121.071 -0.251 . . . . 0.0 110.903 -179.492 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 m -93.24 114.38 26.84 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.317 0.58 . . . . 0.0 112.026 -178.713 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 98.2 mt -83.73 146.63 6.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.712 178.538 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -90.49 158.77 16.86 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.903 0.382 . . . . 0.0 110.028 179.063 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.47 HH11 ' HD2' ' B' ' 245' ' ' ARG . 89.7 mtm180 -57.55 -25.54 60.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.03 -179.608 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 90.3 p -79.94 -10.67 59.8 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.838 179.56 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.59 34.69 7.74 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 -179.738 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.3 t -121.03 135.28 61.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.988 0.423 . . . . 0.0 111.381 -179.681 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -74.06 123.49 24.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.278 179.39 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -118.36 -119.97 2.95 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 120.894 -0.67 . . . . 0.0 111.724 -179.327 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -76.21 149.81 32.37 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.137 1.891 . . . . 0.0 111.549 -179.321 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.695 ' CG ' HH21 ' A' ' 6' ' ' ARG . 0.3 OUTLIER -111.79 156.66 21.61 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.787 179.93 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.608 ' CD2' HD11 ' A' ' 37' ' ' ILE . 58.1 t80 -121.76 101.97 42.06 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.03 -179.025 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -73.72 129.59 13.72 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 121.515 1.476 . . . . 0.0 111.359 -179.907 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 93.7 mt -82.12 52.64 2.04 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 120.779 0.324 . . . . 0.0 111.745 -178.567 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.401 ' OG ' ' OE1' ' B' ' 265' ' ' GLN . 91.5 p -62.69 -17.67 61.04 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.415 0.626 . . . . 0.0 109.947 179.22 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.0 mt -90.38 142.17 28.0 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.605 -179.545 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.1 m -66.08 -20.04 66.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.256 -179.847 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.5 m -130.41 131.96 45.51 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.516 -179.816 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.6 t -124.77 116.44 22.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.368 178.655 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 36' ' ' ASP . 50.9 tp -114.41 125.35 53.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.85 -178.753 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.52 ' O ' ' O ' ' A' ' 47' ' ' GLN . 6.9 m-85 -108.11 142.1 38.81 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.789 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 163.86 -165.98 37.24 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.197 -1.002 . . . . 0.0 112.336 178.71 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 28.8 ttp-105 -91.48 -31.0 16.14 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.8 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.576 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -60.75 156.63 31.68 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -179.659 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.617 HD12 ' CD ' ' A' ' 38' ' ' ARG . 5.7 tp -69.06 -39.27 79.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.872 -179.988 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.416 ' N ' HG23 ' A' ' 33' ' ' ILE . 95.8 mt-10 -52.41 -23.46 6.07 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.969 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.576 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 6.1 m -61.25 118.84 7.39 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.118 -179.586 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.549 ' N ' ' O ' ' A' ' 28' ' ' LEU . 99.0 m-20 -58.53 -25.02 61.99 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.448 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.608 HD11 ' CD2' ' A' ' 20' ' ' PHE . 47.5 mm -123.63 108.57 21.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 177.021 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.617 ' CD ' HD12 ' A' ' 33' ' ' ILE . 45.0 mtm180 -100.36 135.08 42.34 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -177.969 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.756 HG21 ' CZ ' ' A' ' 93' ' ' ARG . 96.8 mt -122.03 132.46 70.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.401 0.62 . . . . 0.0 111.477 -178.851 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -68.84 13.37 0.1 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 114.929 -1.032 . . . . 0.0 112.974 -178.579 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.985 HD12 HH21 ' A' ' 93' ' ' ARG . 17.5 mt -94.18 124.87 54.57 Favored Pre-proline 0 C--N 1.32 -0.712 0 C-N-CA 118.973 -1.091 . . . . 0.0 110.166 179.87 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -73.91 -8.97 21.92 Favored 'Trans proline' 0 C--N 1.315 -1.207 0 C-N-CA 122.165 1.91 . . . . 0.0 111.715 179.939 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.0 m -90.29 -0.1 8.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.193 179.302 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.712 HG12 ' O ' ' A' ' 41' ' ' LEU . 4.0 p -91.03 139.32 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-O 121.123 0.487 . . . . 0.0 110.205 -179.986 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.8 t -68.88 161.86 27.77 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.226 0.536 . . . . 0.0 111.354 -178.768 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.468 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 79.9 mttt -61.22 -42.37 98.49 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.614 -178.383 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.672 ' O ' ' N ' ' A' ' 49' ' ' CYS . 90.1 mt-30 -115.44 -12.45 11.7 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 121.061 -0.256 . . . . 0.0 111.246 179.512 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.55 ' CD2' ' HG1' ' A' ' 69' ' ' THR . 20.1 t60 30.76 -73.37 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 179.49 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.672 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -135.56 140.51 44.72 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 119.91 -0.716 . . . . 0.0 112.324 -178.6 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -129.24 130.7 46.59 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.769 179.876 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.7 mt -111.83 131.96 61.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.989 179.717 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -113.34 124.56 52.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.863 179.032 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 48.3 mm -99.45 108.17 22.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.533 -179.895 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.458 ' O ' ' C ' ' A' ' 55' ' ' GLU . 94.7 m-70 -106.48 133.21 51.51 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.681 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 54' ' ' HIS . 95.7 mt-10 -42.32 -31.17 0.37 Allowed 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 119.585 -0.846 . . . . 0.0 108.974 -179.599 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.416 ' N ' ' C ' ' A' ' 54' ' ' HIS . 88.2 mt-30 -67.99 -68.83 0.36 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.759 178.831 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -146.86 176.16 10.1 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.13 0.491 . . . . 0.0 111.603 -179.128 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -111.33 123.2 49.73 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.678 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 93.1 mt -117.06 135.25 58.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -177.631 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.554 ' HB2' HD11 ' A' ' 82' ' ' LEU . 24.9 tp -100.59 125.64 46.98 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.876 -179.932 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -111.34 137.4 49.14 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.197 -179.539 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.422 HD21 ' HA ' ' A' ' 68' ' ' PRO . 64.0 t-20 -98.66 106.22 18.47 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.243 179.478 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -97.26 -10.68 25.29 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 179.865 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.98 106.86 3.36 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 179.955 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 85.7 p -91.88 -15.04 28.69 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.166 -0.613 . . . . 0.0 110.03 179.229 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.495 HG22 HG23 ' B' ' 236' ' ' VAL . 0.2 OUTLIER -93.2 -46.12 7.55 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.567 -179.83 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -132.48 92.93 26.33 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.729 179.724 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.441 ' HB2' HG13 ' A' ' 75' ' ' VAL . 52.4 Cg_exo -56.15 140.89 87.87 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.226 1.95 . . . . 0.0 112.821 -179.378 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.55 ' HG1' ' CD2' ' A' ' 48' ' ' HIS . 86.9 m -72.5 140.32 48.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.388 179.143 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -101.71 140.65 35.72 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.943 178.896 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.445 ' CG1' ' OD1' ' A' ' 86' ' ' ASP . 75.1 t -134.04 133.11 56.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.436 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.59 ' ND2' ' OD1' ' A' ' 86' ' ' ASP . 89.1 m-20 53.8 33.08 16.15 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 119.909 -0.716 . . . . 0.0 109.128 -179.264 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.63 28.68 68.86 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.077 179.587 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 43.3 t -145.61 143.94 30.16 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 117.242 0.521 . . . . 0.0 111.615 179.942 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.441 HG13 ' HB2' ' A' ' 68' ' ' PRO . 50.9 t -70.28 135.19 28.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.024 179.744 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 9.1 pt -108.36 70.47 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.16 179.048 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -56.17 -30.65 62.52 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.949 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.32 157.75 37.22 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.487 178.605 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -64.05 149.59 90.13 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.314 2.009 . . . . 0.0 112.202 -179.841 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.7 m -139.03 142.93 32.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.202 -179.645 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 60.2 ttp180 -72.69 125.32 27.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.394 179.25 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.554 HD11 ' HB2' ' A' ' 60' ' ' LEU . 98.0 mt -77.33 138.7 39.5 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.362 0.601 . . . . 0.0 110.779 179.299 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -136.35 155.15 50.46 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.93 -179.411 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -55.83 113.16 1.38 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.358 -179.647 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.79 -6.76 22.16 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 121.169 -0.539 . . . . 0.0 111.767 179.977 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.59 ' OD1' ' ND2' ' A' ' 72' ' ' ASN . 37.9 t0 -76.73 124.34 27.53 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.249 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 45.8 t -108.12 129.5 62.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.328 -178.476 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 81.9 mt -97.13 132.2 42.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.842 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.9 m -116.41 126.23 53.15 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.072 0.463 . . . . 0.0 111.605 -179.448 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.416 ' CG2' HH12 ' A' ' 93' ' ' ARG . 87.8 mt -122.2 123.14 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.465 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.418 HG22 ' N ' ' A' ' 92' ' ' ASP . 45.0 mm 40.31 -106.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 121.065 -0.254 . . . . 0.0 110.506 -179.609 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.562 ' O ' ' OD1' ' A' ' 92' ' ' ASP . 66.3 t0 -110.48 18.93 19.28 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.06 0.457 . . . . 0.0 110.677 -179.863 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.985 HH21 HD12 ' A' ' 41' ' ' LEU . 8.5 mtm105 -125.44 142.95 51.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.369 -179.985 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 75.2 m -134.43 147.36 50.42 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 120.355 -0.538 . . . . 0.0 109.713 178.296 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.481 ' HB3' HD11 ' A' ' 7' ' ' LEU . 61.2 m-85 -125.28 124.29 41.31 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.931 -179.566 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.569 ' O ' HD12 ' A' ' 7' ' ' LEU . 99.9 mtt180 -90.58 131.76 36.11 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.292 -179.116 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -93.4 123.76 36.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.372 179.269 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -120.04 126.48 50.9 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.213 -179.855 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 . . . . . 0 C--N 1.331 -0.212 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.612 179.732 . . . . . . . . 0 0 . 1 . 042 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo . . . . . 0 N--CA 1.491 1.346 0 CA-C-O 121.334 0.473 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 042 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.495 HG23 HG22 ' A' ' 66' ' ' THR . 39.4 t -61.81 138.59 22.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.271 -179.757 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 10.4 t . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.433 -179.428 . . . . . . . . 0 0 . 1 . 042 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo . . . . . 0 N--CA 1.495 1.607 0 N-CA-C 112.945 0.325 . . . . 0.0 112.945 . . . . . . . . . 0 0 . 1 . 042 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 2.9 p -73.65 -40.67 63.55 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.908 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -57.25 -46.9 82.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.115 179.976 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' B' ' 242' ' ' LEU . 95.7 mt -64.12 -41.4 97.25 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.884 -179.758 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -62.1 -39.72 93.43 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.757 -179.457 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -63.0 -41.3 99.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.889 0.376 . . . . 0.0 110.688 179.407 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.47 ' HD2' HH11 ' A' ' 12' ' ' ARG . 22.7 mmt180 -62.61 -39.01 92.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.026 -179.605 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.32 -39.58 93.5 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.007 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 46.1 t -64.75 -45.01 88.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.488 177.629 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -60.4 -38.15 83.07 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.793 -179.348 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 40.3 t . . . . . 0 N--CA 1.448 -0.533 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.514 -179.791 . . . . . . . . 0 0 . 1 . 042 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.57 ' N ' ' OE1' ' B' ' 260' ' ' GLU . 44.1 mp0 . . . . . 0 C--O 1.226 -0.146 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 . . . . . . . . . 1 1 . 1 . 042 nuclear build core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 44.6 mt -114.48 134.58 56.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.609 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' B' B ' 262' ' ' VAL . . . . . 0.403 HG11 ' NH2' ' A' ' 38' ' ' ARG . 74.0 t -126.4 130.77 71.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.114 0.483 . . . . 0.0 110.18 179.6 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -90.62 116.38 28.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.467 -178.403 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -64.91 -44.41 89.67 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.18 179.688 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' B' B ' 265' ' ' GLN . . . . . 0.401 ' OE1' ' OG ' ' A' ' 23' ' ' SER . 0.0 OUTLIER -92.97 156.34 40.56 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.421 -179.144 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -61.74 145.66 97.18 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.843 2.362 . . . . 0.0 112.146 -179.944 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 27.2 pt . . . . . 0 C--N 1.321 -0.65 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.99 -179.695 . . . . . . . . 0 0 . 1 . 043 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.0 p . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.948 0.404 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 043 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.488 ' NH2' HG21 ' A' ' 53' ' ' ILE . 90.9 mtm-85 -98.7 124.98 43.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.489 -179.624 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 88.6 mtm-85 -129.0 137.85 51.59 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.903 -179.995 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.573 HD12 ' O ' ' A' ' 96' ' ' ARG . 33.9 tp -109.96 129.52 55.65 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.986 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 52.8 t -109.76 131.15 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 120.942 0.401 . . . . 0.0 110.662 -179.463 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.432 HG23 ' CD1' ' B' ' 261' ' ' ILE . 2.8 m -79.78 140.33 36.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.449 -179.097 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.436 ' CD1' ' OD1' ' A' ' 16' ' ' ASP . 50.6 mm -108.69 135.52 47.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.509 177.505 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.7 mttm -86.86 156.4 19.87 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.258 179.185 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.496 ' CD ' ' OD2' ' A' ' 92' ' ' ASP . 89.3 mtm180 -57.1 -29.57 63.63 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.64 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.4 t -78.11 -14.54 59.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.674 179.303 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.75 35.57 5.83 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.208 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.1 t -119.98 130.45 74.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.963 0.411 . . . . 0.0 110.958 -179.623 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.436 ' OD1' ' CD1' ' A' ' 10' ' ' ILE . 97.7 m-20 -72.25 136.36 46.3 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.193 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -127.85 -122.74 2.54 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 120.533 -0.841 . . . . 0.0 111.971 -178.887 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -74.12 151.03 43.69 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.33 2.02 . . . . 0.0 112.779 -178.616 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -110.76 149.79 30.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.621 -179.712 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.426 ' CD2' HD11 ' A' ' 37' ' ' ILE . 69.3 t80 -122.19 102.7 39.91 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.475 -179.395 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.43 134.41 22.54 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.551 1.501 . . . . 0.0 112.105 -178.485 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 91.1 mt -81.62 56.53 3.02 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.129 -179.285 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.0 p -68.09 -23.09 64.89 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.142 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.5 mt -86.21 142.26 28.73 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.599 178.737 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 70.3 p -67.8 -16.17 63.98 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.484 -179.108 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.504 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 66.8 m -133.17 135.29 45.03 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.489 179.973 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.676 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 2.1 t -127.85 114.94 17.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.068 178.675 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.503 HD21 ' HG2' ' A' ' 47' ' ' GLN . 46.1 tp -110.96 128.16 55.74 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.588 -178.873 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.676 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 35.1 m-85 -104.75 137.57 42.35 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.788 178.933 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 158.55 -171.29 35.29 Favored Glycine 0 N--CA 1.471 1.022 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.809 179.091 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.591 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 83.2 mtm-85 -86.82 -29.61 22.13 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.442 -179.67 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -54.3 157.96 5.93 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 -178.355 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.432 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.9 tp -68.89 -40.26 80.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 O-C-N 122.639 -0.33 . . . . 0.0 110.539 179.65 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.432 ' N ' HG23 ' A' ' 33' ' ' ILE . 94.6 mt-10 -57.05 -25.68 59.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.284 -179.825 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.418 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 75.9 m -50.84 115.07 1.34 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.349 179.709 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.504 ' OD2' ' O ' ' A' ' 26' ' ' THR . 94.2 m-20 -58.57 -31.86 68.39 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -179.594 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.655 HD12 ' CE2' ' A' ' 29' ' ' PHE . 95.2 mt -126.13 122.22 61.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 176.381 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 50.3 mtm180 -105.6 138.85 41.12 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.168 -0.613 . . . . 0.0 112.484 -178.721 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 90.5 mt -122.94 129.28 75.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.937 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -77.33 29.47 0.15 Allowed 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -177.894 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.434 ' HA ' HD23 ' A' ' 41' ' ' LEU . 78.5 mt -90.96 122.11 67.12 Favored Pre-proline 0 C--N 1.323 -0.581 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.671 179.455 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.7 -7.91 22.09 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 122.032 1.821 . . . . 0.0 112.061 -179.252 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.6 m -101.56 5.98 10.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.024 179.673 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.591 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 54.3 t -107.0 114.19 45.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.63 179.682 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.8 t -42.75 170.88 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 122.208 1.004 . . . . 0.0 113.303 -178.208 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.418 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 50.3 mttp -63.21 -40.32 97.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.475 -1.238 . . . . 0.0 112.003 -179.763 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.637 ' O ' ' N ' ' A' ' 49' ' ' CYS . 89.0 mt-30 -112.61 -13.34 13.31 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.217 -179.604 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.475 ' ND1' HG13 ' A' ' 44' ' ' VAL . 34.6 t60 36.73 -74.88 0.0 OUTLIER 'General case' 0 C--O 1.237 0.407 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 179.132 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.637 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -134.84 139.63 45.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.141 -178.336 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -128.94 132.77 47.66 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.603 179.927 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 95.5 mt -117.07 134.48 60.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.38 179.892 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -121.54 127.62 51.16 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.467 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.488 HG21 ' NH2' ' A' ' 5' ' ' ARG . 95.8 mt -102.22 118.32 48.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.368 0.604 . . . . 0.0 112.283 -178.473 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.536 ' O ' ' N ' ' A' ' 56' ' ' GLN . 1.9 m-70 -112.89 139.86 48.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.264 178.992 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.9 mm-40 -39.91 -26.48 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -179.586 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.536 ' N ' ' O ' ' A' ' 54' ' ' HIS . 88.5 mt-30 -65.08 -67.32 0.45 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.086 -0.961 . . . . 0.0 108.662 178.028 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -160.9 -162.7 0.95 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.806 0.336 . . . . 0.0 111.377 179.733 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.486 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -106.45 127.46 53.31 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.617 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 44.4 mm -110.51 125.96 67.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.432 -178.781 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 35.7 tp -99.82 126.84 45.99 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.615 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -117.12 136.71 52.8 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.614 0.245 . . . . 0.0 111.377 -179.328 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -98.33 106.41 18.69 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.384 179.573 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -98.59 -8.58 26.18 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 179.664 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.2 t -81.07 98.85 8.18 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.274 -179.799 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.4 t -77.87 -39.61 42.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.243 0.544 . . . . 0.0 109.651 178.238 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.498 HG22 HG23 ' B' ' 236' ' ' VAL . 0.3 OUTLIER -63.09 -46.33 87.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.745 -179.49 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.462 ' HB3' HD11 ' A' ' 91' ' ' ILE . 89.2 m-20 -137.23 93.86 12.76 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.26 -179.809 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -64.57 148.76 90.56 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.4 1.4 . . . . 0.0 112.733 -177.76 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.432 HG22 ' N ' ' A' ' 70' ' ' GLN . 89.2 m -75.42 153.62 37.57 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.6 -179.29 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.432 ' N ' HG22 ' A' ' 69' ' ' THR . 88.8 mt-30 -115.47 140.59 49.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.852 -179.572 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 50.4 t -129.46 136.15 59.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.679 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 52.32 32.55 11.19 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.522 0.677 . . . . 0.0 109.484 -179.784 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.06 25.04 74.61 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 114.909 -1.041 . . . . 0.0 112.523 178.973 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.8 t -139.31 141.38 37.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 117.444 0.622 . . . . 0.0 110.631 179.131 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 68.7 t -66.4 136.32 26.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.628 -179.559 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.1 pt -108.32 80.06 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.102 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.474 178.963 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -63.93 -31.63 72.88 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.361 0.601 . . . . 0.0 109.744 179.396 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -111.35 155.83 42.16 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.362 179.024 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -63.52 147.43 93.11 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 122.309 2.006 . . . . 0.0 112.209 -179.707 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.3 m -140.25 145.24 26.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.267 0.556 . . . . 0.0 111.534 -179.884 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -74.4 135.64 42.41 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.171 179.79 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.486 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 96.2 mt -81.02 134.19 35.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.921 0.391 . . . . 0.0 111.134 -179.552 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -128.49 149.29 50.65 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.778 179.119 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -52.01 118.3 3.36 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.873 0.368 . . . . 0.0 111.164 -178.669 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.42 -15.27 30.02 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.184 -0.767 . . . . 0.0 111.184 -179.844 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -69.6 131.93 45.42 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.681 179.975 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.43 HG22 ' HG2' ' A' ' 96' ' ' ARG . 71.4 t -113.78 133.85 58.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.94 -178.531 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.8 mt -102.91 132.87 48.16 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.985 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 96.7 m -120.35 126.91 51.68 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 120.027 -0.669 . . . . 0.0 111.669 -179.497 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.583 ' O ' ' N ' ' A' ' 93' ' ' ARG . 89.4 mt -116.07 130.37 70.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.329 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.556 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 84.5 mt -20.93 94.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -178.202 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.556 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 12.9 t0 94.44 -24.78 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 177.847 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.951 ' HE ' HD11 ' B' ' 261' ' ' ILE . 18.2 mtp85 -131.22 146.67 52.41 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.819 -179.949 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 93.9 p -140.04 156.28 46.68 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.95 0.405 . . . . 0.0 110.251 179.739 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.541 ' HB3' HD11 ' A' ' 7' ' ' LEU . 73.9 m-85 -130.64 128.21 40.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.234 -179.631 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.573 ' O ' HD12 ' A' ' 7' ' ' LEU . 73.7 mtp85 -89.43 134.69 33.98 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.503 -179.606 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -95.37 124.55 39.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.515 179.698 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -125.23 127.8 47.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.488 -179.9 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 59.8 t-20 . . . . . 0 C--N 1.331 -0.203 0 CA-C-O 120.82 0.343 . . . . 0.0 110.686 179.999 . . . . . . . . 0 0 . 1 . 043 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo . . . . . 0 N--CA 1.491 1.376 0 CA-C-O 121.469 0.529 . . . . 0.0 112.998 . . . . . . . . . 0 0 . 1 . 043 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.498 HG23 HG22 ' A' ' 66' ' ' THR . 55.3 t -60.56 138.31 21.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.279 -179.958 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 2.0 t . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.066 179.821 . . . . . . . . 0 0 . 1 . 043 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo . . . . . 0 N--CA 1.491 1.356 0 N-CA-C 112.379 0.107 . . . . 0.0 112.379 . . . . . . . . . 0 0 . 1 . 043 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 99.2 m -73.33 -46.07 51.5 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.042 178.513 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -58.3 -47.3 84.12 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.907 -178.47 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' B' ' 242' ' ' LEU . 95.7 mt -63.8 -42.6 97.68 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.719 -0.393 . . . . 0.0 111.8 -179.392 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -65.48 -44.06 88.28 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.183 -179.197 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' B' B ' 244' ' ' ARG . . . . . 0.533 ' NH1' ' OE1' ' B' ' 248' ' ' GLN . 71.0 ttp85 -65.06 -43.49 92.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.999 0.428 . . . . 0.0 110.3 179.16 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.541 ' O ' HG23 ' B' ' 249' ' ' VAL . 14.5 tpp180 -61.68 -43.81 98.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.542 -179.604 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -65.49 -38.17 88.98 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.046 178.845 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 47.1 t -63.62 -45.15 91.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.464 179.257 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' B' B ' 248' ' ' GLN . . . . . 0.533 ' OE1' ' NH1' ' B' ' 244' ' ' ARG . 26.1 mt-30 -61.75 -36.13 80.12 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.758 -179.431 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' B' B ' 249' ' ' VAL . . . . . 0.541 HG23 ' O ' ' B' ' 245' ' ' ARG . 77.5 t . . . . . 0 C--N 1.327 -0.391 0 CA-C-O 121.025 0.44 . . . . 0.0 110.458 179.197 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 . . . . . 0 N--CA 1.454 -0.255 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 . . . . . . . . . 0 0 . 1 . 043 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.951 HD11 ' HE ' ' A' ' 93' ' ' ARG . 60.9 mt -107.2 134.01 50.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.691 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 62.3 t -126.56 131.69 71.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.454 -179.545 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -95.06 120.52 35.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.693 -178.361 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -65.46 -45.24 84.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.659 179.137 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.5 152.77 47.73 Favored Pre-proline 0 C--O 1.231 0.117 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.606 -179.107 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -64.04 141.86 78.71 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.494 2.129 . . . . 0.0 112.116 -179.876 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.1 pt . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.818 179.052 . . . . . . . . 0 0 . 1 . 044 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.469 ' O ' ' O ' ' A' ' 99' ' ' ASN . 26.8 m . . . . . 0 N--CA 1.46 0.071 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 . . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.6 mtt85 -92.49 137.26 32.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.229 -178.208 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.7 mtt85 -130.5 139.62 50.51 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.187 -0.46 . . . . 0.0 112.032 -179.655 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.642 HD12 ' O ' ' A' ' 96' ' ' ARG . 27.3 tp -113.42 130.84 56.21 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.479 179.862 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.5 ' CG1' ' OD1' ' A' ' 16' ' ' ASP . 41.0 t -109.43 129.61 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.215 -178.867 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.9 m -80.2 145.31 32.33 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.797 -178.798 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.7 mt -116.19 137.64 49.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 114.66 -1.155 . . . . 0.0 109.42 178.244 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.1 mttt -88.43 160.21 17.64 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.402 179.854 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.625 ' HG3' HH11 ' A' ' 93' ' ' ARG . 90.0 mtm180 -57.82 -32.33 67.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.428 -179.329 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.1 t -79.82 -5.87 56.24 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.356 179.358 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.45 38.17 7.25 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.933 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.5 t -115.0 132.57 63.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.298 0.57 . . . . 0.0 111.324 -179.799 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.5 ' OD1' ' CG1' ' A' ' 8' ' ' VAL . 67.1 t0 -77.15 122.84 25.57 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.106 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -118.3 -120.1 2.97 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.173 -178.509 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -74.46 152.56 43.81 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.317 2.011 . . . . 0.0 112.395 -178.893 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -111.17 147.74 34.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.057 0.456 . . . . 0.0 110.18 179.913 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.463 ' CD2' HD11 ' A' ' 37' ' ' ILE . 70.3 t80 -117.54 101.68 52.35 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.075 -179.255 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -73.08 136.54 24.87 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.279 1.32 . . . . 0.0 111.696 -179.592 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.0 mt -86.57 65.78 9.18 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.527 -178.307 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.0 p -68.8 -22.43 64.26 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.693 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 76.2 mt -87.53 142.19 28.05 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.378 179.977 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 61.4 p -66.21 -15.6 63.3 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.658 -179.322 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.507 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 35.6 m -133.02 134.04 43.89 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.988 0.423 . . . . 0.0 110.902 -179.558 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.8 t -126.56 118.13 24.24 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.275 179.911 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.449 HD21 ' HG2' ' A' ' 47' ' ' GLN . 44.6 tp -116.87 128.96 55.76 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.05 -179.071 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.71 ' CE2' HD12 ' A' ' 37' ' ' ILE . 5.8 m-85 -105.94 131.02 53.75 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.868 179.717 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.8 179.9 37.65 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 120.253 -0.975 . . . . 0.0 112.368 179.267 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.471 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 45.3 mtm105 -73.39 -32.53 64.51 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 179.573 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.567 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -48.44 149.28 3.97 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -178.548 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.534 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.4 tp -68.06 -41.99 84.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.339 0.59 . . . . 0.0 110.109 179.676 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.534 ' N ' HG23 ' A' ' 33' ' ' ILE . 80.8 tt0 -56.74 -20.71 23.46 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.386 -179.823 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.567 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 14.8 m -58.12 128.41 37.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.129 -179.819 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.507 ' OD2' ' O ' ' A' ' 26' ' ' THR . 54.0 m-20 -62.4 -33.47 74.82 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.127 -179.712 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.71 HD12 ' CE2' ' A' ' 29' ' ' PHE . 93.2 mt -125.55 118.57 52.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 177.45 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.533 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 82.9 mtp180 -103.36 139.65 38.49 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.137 -178.762 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.418 ' C ' ' H ' ' A' ' 41' ' ' LEU . 80.5 mt -121.54 129.28 75.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.37 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -74.58 34.93 0.1 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.737 -178.367 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.452 ' HA ' HD23 ' A' ' 41' ' ' LEU . 38.2 mt -102.35 122.66 45.78 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.63 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.1 -6.11 18.45 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 122.415 2.077 . . . . 0.0 112.729 -178.802 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.522 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 2.9 m -107.3 6.26 9.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.328 -179.749 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.48 ' O ' ' O ' ' A' ' 45' ' ' SER . 11.8 t -98.27 110.42 25.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.296 0.569 . . . . 0.0 110.693 -179.673 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.48 ' O ' ' O ' ' A' ' 44' ' ' VAL . 1.2 t -33.85 160.25 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.112 -0.949 . . . . 0.0 112.266 -178.94 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -62.04 -42.01 98.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.107 -179.416 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.653 ' O ' ' N ' ' A' ' 49' ' ' CYS . 90.0 mt-30 -114.75 -17.7 11.54 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.696 179.659 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 29.5 t60 35.98 -72.59 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 179.293 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.653 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.71 137.86 47.05 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.067 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -126.84 128.62 46.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.557 179.401 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.3 mt -116.67 135.19 57.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.73 0.3 . . . . 0.0 110.231 179.202 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -113.23 136.79 52.35 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.232 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.8 mm -104.19 124.24 58.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.078 -179.245 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.444 ' O ' ' C ' ' A' ' 55' ' ' GLU . 97.4 m-70 -128.63 135.76 49.75 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.967 179.348 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 54' ' ' HIS . 51.7 tp10 -40.26 -30.37 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.022 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.463 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 92.2 mt-30 -66.34 -67.89 0.41 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.255 178.266 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.52 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 8.3 tp10 -157.93 -158.07 0.7 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.726 -179.352 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.52 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -124.2 130.93 53.38 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.738 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.2 mt -119.55 130.67 73.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.188 0.518 . . . . 0.0 111.48 -179.109 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.493 ' HB2' HD11 ' A' ' 82' ' ' LEU . 25.1 tp -95.71 132.23 41.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.845 -179.753 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -117.02 137.38 52.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.075 179.519 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 62.5 t-20 -95.45 106.44 18.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.046 -178.508 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -97.15 -13.54 22.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.972 179.201 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.12 101.21 4.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.46 179.869 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.6 m -87.2 -16.53 35.06 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.118 179.628 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.472 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -87.8 -45.64 10.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.16 179.453 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -135.96 95.67 13.54 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.373 -179.988 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.539 ' HB2' HG23 ' A' ' 75' ' ' VAL . 50.0 Cg_exo -55.16 142.8 77.15 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.227 1.951 . . . . 0.0 113.124 -179.934 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.96 ' O ' HG22 ' A' ' 76' ' ' ILE . 5.3 m -70.41 140.85 52.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.008 179.181 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -102.1 140.72 36.01 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.507 -0.477 . . . . 0.0 109.953 179.57 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 51.8 t -129.78 134.64 62.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.52 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 50.28 32.84 6.61 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -179.585 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.37 25.7 67.6 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.628 179.532 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 29.6 t -140.74 141.23 34.89 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 117.606 0.703 . . . . 0.0 111.207 179.573 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.539 HG23 ' HB2' ' A' ' 68' ' ' PRO . 0.5 OUTLIER -68.19 140.46 19.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.191 -179.878 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.96 HG22 ' O ' ' A' ' 69' ' ' THR . 9.4 tt -106.74 94.03 2.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.43 179.59 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.5 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 16.2 p-10 -68.24 -34.33 76.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.43 179.844 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.462 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 0.1 OUTLIER -130.65 174.88 4.15 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.115 -178.838 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -61.0 142.89 98.86 Favored 'Trans proline' 0 N--CA 1.501 1.954 0 C-N-CA 122.678 2.252 . . . . 0.0 112.775 -179.615 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.2 m -140.33 143.67 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.402 179.857 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -75.05 126.65 31.47 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.812 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.493 HD11 ' HB2' ' A' ' 60' ' ' LEU . 96.6 mt -79.42 139.26 37.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.917 -179.677 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -126.36 150.12 48.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.445 179.956 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -58.03 121.34 10.37 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.13 -179.561 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.84 -13.82 26.91 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -179.711 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -68.58 134.69 50.36 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.421 179.841 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.543 HG22 ' HG2' ' A' ' 96' ' ' ARG . 74.2 t -108.65 131.84 58.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.68 -178.794 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 83.0 mt -105.6 132.09 53.41 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.1 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.926 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 94.5 m -121.0 125.64 47.88 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 120.305 -0.558 . . . . 0.0 112.044 -178.261 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.454 ' O ' ' C ' ' A' ' 91' ' ' ILE . 92.4 mt -119.05 124.88 73.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 178.716 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.454 ' C ' ' O ' ' A' ' 90' ' ' ILE . 45.0 mm 35.17 -107.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.729 -178.761 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.454 ' N ' HG22 ' A' ' 91' ' ' ILE . 31.3 p-10 -106.04 12.07 30.82 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.385 -179.825 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.625 HH11 ' HG3' ' A' ' 12' ' ' ARG . 19.6 mmm180 -125.85 144.12 50.79 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.593 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 26.4 t -137.59 155.52 49.11 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.896 -179.858 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.516 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 87.2 m-85 -130.13 130.96 45.45 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.559 -0.292 . . . . 0.0 110.739 179.889 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.642 ' O ' HD12 ' A' ' 7' ' ' LEU . 97.8 mtt180 -94.65 134.1 37.59 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.157 179.441 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -97.63 126.51 42.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.853 179.727 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -134.88 125.69 27.27 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.177 179.849 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.469 ' O ' ' O ' ' A' ' 4' ' ' THR . 91.1 m-20 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.512 178.849 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo . . . . . 0 N--CA 1.49 1.29 0 CA-C-O 121.348 0.478 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 044 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.472 ' CG2' HG22 ' A' ' 66' ' ' THR . 47.6 t -76.05 131.42 34.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.107 -0.951 . . . . 0.0 112.009 -178.334 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 4.0 t . . . . . 0 CA--C 1.518 -0.283 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 178.165 . . . . . . . . 0 0 . 1 . 044 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo . . . . . 0 N--CA 1.497 1.707 0 N-CA-C 112.694 0.229 . . . . 0.0 112.694 . . . . . . . . . 0 0 . 1 . 044 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 86.3 m -73.56 -44.09 58.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.224 0.535 . . . . 0.0 109.61 178.259 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.717 ' CE1' ' NE ' ' B' ' 245' ' ' ARG . 53.4 t80 -56.85 -46.93 81.42 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.705 -178.911 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 95.7 mt -64.01 -40.57 96.63 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 121.076 0.465 . . . . 0.0 110.517 -179.856 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -64.1 -39.9 95.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.649 -179.303 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 44.2 ttm180 -60.84 -44.77 96.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.876 0.369 . . . . 0.0 110.209 -179.69 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.717 ' NE ' ' CE1' ' B' ' 241' ' ' PHE . 2.2 mtm-85 -63.26 -40.67 98.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.011 179.858 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.36 -41.42 98.83 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.268 179.117 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 31.3 t -65.93 -45.88 80.25 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.464 0.65 . . . . 0.0 109.674 178.959 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -63.43 -34.53 77.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.261 -179.792 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' B' B ' 249' ' ' VAL . . . . . 0.696 HG23 ' O ' ' B' ' 245' ' ' ARG . 51.7 t . . . . . 0 C--N 1.327 -0.405 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.687 179.743 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 CA--C 1.529 0.17 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 . . . . . . . . . 0 0 . 1 . 044 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.53 HD11 ' HE ' ' A' ' 93' ' ' ARG . 73.3 mt -109.78 140.44 28.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.913 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 78.7 t -128.34 136.38 60.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.865 -178.904 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -97.93 121.01 39.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.362 0.601 . . . . 0.0 111.71 -179.027 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -66.26 -42.79 88.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.194 179.479 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.44 161.64 23.9 Favored Pre-proline 0 N--CA 1.465 0.322 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.274 -178.73 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -60.95 149.69 87.56 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.531 2.154 . . . . 0.0 112.14 178.875 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 44.5 pt . . . . . 0 C--N 1.331 -0.201 0 CA-C-O 121.534 0.683 . . . . 0.0 112.295 -179.091 . . . . . . . . 0 0 . 1 . 045 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.1 p . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.746 0.308 . . . . 0.0 110.663 . . . . . . . . . 0 0 . 1 . 045 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.819 ' NE ' HD13 ' A' ' 53' ' ' ILE . 87.7 mtm-85 -98.06 121.6 40.18 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.595 -179.711 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.442 ' C ' HD22 ' A' ' 7' ' ' LEU . 99.7 mtt180 -129.98 137.9 50.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.072 179.839 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.455 ' CD2' ' N ' ' A' ' 7' ' ' LEU . 1.1 mm? -111.12 135.37 51.74 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.512 179.416 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.673 HG22 ' CD2' ' A' ' 19' ' ' HIS . 55.0 t -111.09 126.41 68.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.642 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 m -82.86 112.83 20.03 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.124 -178.337 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 98.1 mt -81.83 139.78 17.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.914 179.242 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -90.44 153.37 20.45 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.286 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.569 ' NH1' ' OD2' ' A' ' 92' ' ' ASP . 30.2 mtp85 -59.75 -26.46 65.69 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.709 179.82 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.3 p -72.53 -19.0 61.59 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.993 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.74 31.3 6.09 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 -179.646 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 51.9 t -121.06 132.37 70.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.928 0.394 . . . . 0.0 111.02 -179.814 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -76.85 139.87 40.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.062 179.262 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -130.9 -115.11 1.7 Allowed Glycine 0 CA--C 1.538 1.524 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.165 -179.378 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -70.21 144.89 52.95 Favored 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 122.2 1.933 . . . . 0.0 113.054 -178.538 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.673 ' CD2' HG22 ' A' ' 8' ' ' VAL . 59.0 m170 -109.14 135.15 50.74 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.586 -179.543 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.921 ' CD2' HD11 ' A' ' 37' ' ' ILE . 65.0 t80 -106.92 102.57 43.31 Favored Pre-proline 0 N--CA 1.467 0.385 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.043 -179.149 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.47 132.49 16.23 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 121.422 1.414 . . . . 0.0 111.971 -179.986 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 22' ' ' LEU . 73.3 mt -85.8 58.48 5.07 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -178.745 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 86.5 p -66.76 -17.31 64.8 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 178.842 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.511 HD11 ' HG2' ' B' ' 265' ' ' GLN . 62.1 mt -86.68 139.67 30.54 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.475 -179.76 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.4 t -63.6 -18.61 64.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.717 -179.905 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.15 140.93 36.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.626 -179.19 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.666 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -137.37 132.57 33.73 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.093 178.875 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.526 HD12 ' O ' ' A' ' 49' ' ' CYS . 56.3 tp -125.45 123.16 38.64 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.805 -179.067 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.666 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 46.5 m-85 -95.82 141.33 29.4 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.811 179.683 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 147.44 -176.8 26.11 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.066 178.685 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 31' ' ' ARG . 45.5 mtm180 -70.8 -33.11 70.38 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 179.285 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.577 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -42.62 140.31 2.24 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -179.35 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 33' ' ' ILE . 11.0 tp -67.0 -39.29 83.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.936 -179.694 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -58.81 -20.58 51.58 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.189 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.577 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 66.8 m -50.24 119.9 4.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.971 179.632 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -61.75 -31.77 71.98 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 179.736 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.921 HD11 ' CD2' ' A' ' 20' ' ' PHE . 27.1 mm -120.85 105.0 16.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 177.044 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.443 HH12 ' HG2' ' A' ' 40' ' ' GLN . 68.2 ttp85 -98.21 135.98 39.08 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.559 -178.457 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.712 HG23 ' NH1' ' A' ' 93' ' ' ARG . 94.5 mt -121.58 131.59 72.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.902 -179.683 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.443 ' HG2' HH12 ' A' ' 38' ' ' ARG . 74.5 mt-30 -78.26 31.78 0.18 Allowed 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -177.693 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.771 ' O ' HG12 ' A' ' 44' ' ' VAL . 87.1 mt -96.34 122.93 56.4 Favored Pre-proline 0 C--N 1.326 -0.454 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.727 179.586 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.08 -8.29 21.92 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 122.261 1.974 . . . . 0.0 112.601 -179.361 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.445 HG12 ' HG2' ' B' ' 235' ' ' PRO . 35.5 m -102.17 4.76 10.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.191 179.997 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.771 HG12 ' O ' ' A' ' 41' ' ' LEU . 6.0 p -97.32 150.3 4.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.348 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.2 163.43 27.85 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.805 0.812 . . . . 0.0 112.186 -178.869 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.9 mtmt -63.76 -38.1 89.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.131 -179.558 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.621 ' O ' ' N ' ' A' ' 49' ' ' CYS . 10.4 mm100 -110.58 -20.33 12.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.024 0.44 . . . . 0.0 109.967 179.897 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.534 ' NE2' HG23 ' A' ' 90' ' ' ILE . 22.8 t60 38.3 -77.32 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 179.021 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.763 ' SG ' HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -134.73 137.73 43.73 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.42 -0.512 . . . . 0.0 112.085 -178.038 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -123.65 131.57 53.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.886 179.225 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.439 HD11 HD12 ' A' ' 82' ' ' LEU . 16.2 tt -120.13 134.62 63.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.716 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -120.75 128.42 52.9 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.35 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.819 HD13 ' NE ' ' A' ' 5' ' ' ARG . 78.4 mt -106.43 122.37 60.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 119.774 -0.77 . . . . 0.0 112.262 -178.754 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.51 ' CD2' ' N ' ' A' ' 54' ' ' HIS . 2.4 m-70 -114.42 137.95 51.18 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.785 179.666 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.466 ' C ' ' O ' ' A' ' 54' ' ' HIS . 97.7 mt-10 -40.93 -29.77 0.11 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.75 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.452 ' N ' ' C ' ' A' ' 54' ' ' HIS . 59.4 tt0 -64.31 -68.21 0.37 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.798 178.294 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -156.82 -168.31 2.63 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.202 -179.853 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -105.52 133.23 50.61 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.532 -179.747 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 41.4 mm -118.86 125.55 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 120.511 -0.475 . . . . 0.0 111.502 -179.491 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.763 HD11 ' SG ' ' A' ' 49' ' ' CYS . 57.3 tp -104.65 130.48 52.66 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.836 -179.954 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.9 m-70 -121.55 140.41 52.26 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.741 179.923 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.401 HD22 ' HA ' ' A' ' 68' ' ' PRO . 31.3 t30 -104.62 110.77 23.21 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.892 0.377 . . . . 0.0 111.957 179.743 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -96.66 -4.33 41.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.417 179.18 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.44 100.65 9.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.518 179.97 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 86.5 p -84.87 -29.11 25.53 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.285 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.42 ' O ' ' OD1' ' A' ' 67' ' ' ASN . 2.1 m -64.3 -49.27 72.43 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.078 179.388 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.625 ' OD1' HG23 ' B' ' 236' ' ' VAL . 2.7 m-20 -145.75 100.37 4.33 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.563 179.623 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.401 ' HA ' HD22 ' A' ' 62' ' ' ASN . 36.7 Cg_endo -64.79 153.23 78.88 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 121.308 1.338 . . . . 0.0 112.038 -178.933 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 28.3 m -75.14 150.41 38.76 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.642 -179.5 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -108.48 141.18 40.74 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.933 179.307 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.719 HG13 ' OD1' ' A' ' 86' ' ' ASP . 48.8 t -128.2 134.4 65.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.309 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 53.66 31.4 12.63 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -178.622 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.76 29.16 67.82 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.051 179.522 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 67.0 m -139.67 138.52 36.12 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 117.076 0.438 . . . . 0.0 111.213 -179.967 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.7 t -69.94 133.98 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.707 179.527 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.3 pt -101.38 94.14 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 CA-C-O 121.241 0.543 . . . . 0.0 110.506 179.338 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -63.95 -34.47 78.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.123 179.714 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -124.44 172.64 5.6 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.922 179.978 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.61 143.21 99.72 Favored 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 122.151 1.901 . . . . 0.0 112.549 -179.709 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 48.1 t -131.36 138.97 51.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.075 179.905 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 95.8 mtm-85 -76.38 128.82 35.59 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.777 179.174 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.609 HD11 ' HB2' ' A' ' 60' ' ' LEU . 93.7 mt -86.04 134.04 33.87 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.245 0.545 . . . . 0.0 111.277 -179.333 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -124.45 154.41 40.51 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.244 178.954 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.579 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 4.5 t60 -53.63 118.9 4.27 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.32 -179.504 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.44 -11.66 28.31 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.823 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.719 ' OD1' HG13 ' A' ' 71' ' ' VAL . 50.2 t0 -71.73 126.09 28.82 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.407 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 43.7 t -107.86 129.08 62.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.493 -179.203 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 94.3 mt -94.29 132.52 38.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.315 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.8 m -123.47 123.26 40.24 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.49 0.662 . . . . 0.0 112.572 -178.775 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.534 HG23 ' NE2' ' A' ' 48' ' ' HIS . 90.0 mt -109.51 123.82 65.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.197 177.845 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.487 ' C ' ' O ' ' A' ' 90' ' ' ILE . 86.8 mt 35.2 -96.82 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.509 -0.477 . . . . 0.0 110.613 179.746 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.569 ' OD2' ' NH1' ' A' ' 12' ' ' ARG . 20.8 p-10 -115.03 12.19 16.65 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.736 179.999 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.712 ' NH1' HG23 ' A' ' 39' ' ' ILE . 98.9 mtt180 -124.02 142.13 51.44 Favored 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.444 179.938 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 38.9 t -138.5 147.62 43.38 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.583 179.834 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.449 ' HE1' HD12 ' A' ' 90' ' ' ILE . 85.7 m-85 -121.78 120.64 35.21 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.095 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -79.7 131.79 36.04 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.343 -178.656 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -95.41 122.18 37.86 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.606 179.855 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -124.56 124.57 42.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.706 -179.708 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.579 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 59.0 t-20 . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.213 -179.929 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' B' B ' 235' ' ' PRO . . . . . 0.445 ' HG2' HG12 ' A' ' 43' ' ' VAL . 61.7 Cg_endo . . . . . 0 N--CA 1.486 1.051 0 CA-C-O 121.714 0.631 . . . . 0.0 112.799 . . . . . . . . . 1 1 . 1 . 045 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.625 HG23 ' OD1' ' A' ' 67' ' ' ASN . 1.0 OUTLIER -64.44 136.9 25.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.01 -179.473 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' B' B ' 237' ' ' CYS . . . . . 0.43 ' SG ' HG23 ' A' ' 91' ' ' ILE . 7.7 t . . . . . 0 C--N 1.332 -0.186 0 CA-C-O 120.843 0.354 . . . . 0.0 110.488 -179.079 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo . . . . . 0 N--CA 1.495 1.578 0 N-CA-C 112.866 0.295 . . . . 0.0 112.866 . . . . . . . . . 0 0 . 1 . 045 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 35.8 p -75.47 -40.69 57.07 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.316 -0.553 . . . . 0.0 109.704 178.603 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.466 ' HZ ' HD22 ' A' ' 41' ' ' LEU . 83.3 t80 -57.17 -47.36 81.42 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.677 -179.592 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.42 ' HA ' HD23 ' B' ' 242' ' ' LEU . 91.6 mt -62.65 -41.11 98.87 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.635 179.93 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -65.26 -41.49 94.2 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.76 -179.29 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 80.9 mtt85 -62.18 -43.04 99.72 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.093 179.495 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.708 ' NH2' HH21 ' A' ' 93' ' ' ARG . 24.1 mmm180 -61.19 -39.76 91.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.082 -178.622 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.43 -38.71 90.8 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 179.057 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 71.1 m -62.9 -43.66 98.19 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 177.413 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -59.15 -36.6 75.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.194 179.761 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' B' B ' 249' ' ' VAL . . . . . 0.428 HG23 HH21 ' A' ' 12' ' ' ARG . 63.3 t . . . . . 0 N--CA 1.453 -0.297 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.393 179.646 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.627 ' OE1' ' NH2' ' A' ' 93' ' ' ARG . 98.3 mt-10 . . . . . 0 CA--C 1.531 0.214 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 . . . . . . . . . 1 1 . 1 . 045 nuclear build core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 77.9 mt -118.31 133.84 63.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 177.225 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 68.3 t -126.24 133.04 69.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.381 -178.494 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' B' B ' 263' ' ' PHE . . . . . 0.558 ' CD2' HG21 ' B' ' 267' ' ' ILE . 62.1 m-85 -93.42 116.64 29.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.802 -179.307 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -64.49 -42.33 95.94 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.207 179.212 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' B' B ' 265' ' ' GLN . . . . . 0.511 ' HG2' HD11 ' A' ' 24' ' ' LEU . 1.1 mp0 -101.84 169.77 7.26 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.875 -179.398 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -62.29 149.68 89.81 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 121.752 1.635 . . . . 0.0 113.495 -179.281 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' B' B ' 267' ' ' ILE . . . . . 0.558 HG21 ' CD2' ' B' ' 263' ' ' PHE . 19.8 pt . . . . . 0 N--CA 1.462 0.151 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.912 -179.175 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.6 p . . . . . 0 CA--C 1.521 -0.137 0 CA-C-O 120.619 0.247 . . . . 0.0 111.311 . . . . . . . . . 0 0 . 1 . 046 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.89 ' NH1' HG23 ' A' ' 53' ' ' ILE . 99.6 mtt180 -96.52 122.08 39.04 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.094 -179.417 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -128.35 142.61 51.07 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.184 0.516 . . . . 0.0 111.339 -179.14 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.61 HD11 ' HB3' ' A' ' 95' ' ' PHE . 45.2 tp -113.38 133.09 55.34 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.304 -179.362 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.0 t -109.01 131.11 60.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.32 -179.617 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.469 HG23 ' CD1' ' B' ' 261' ' ' ILE . 1.5 m -92.3 115.55 28.18 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.514 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.414 HD12 ' HB3' ' A' ' 94' ' ' SER . 98.4 mt -83.13 145.43 8.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.242 179.014 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -91.44 162.08 14.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.163 0.506 . . . . 0.0 110.863 178.928 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.572 ' NH1' ' OE2' ' B' ' 260' ' ' GLU . 88.6 mtm180 -57.95 -30.07 65.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.792 -179.638 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.2 m -78.35 -8.61 58.63 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.813 0.339 . . . . 0.0 110.591 179.759 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.3 29.38 12.51 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -179.89 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.8 t -120.02 133.72 65.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.841 0.353 . . . . 0.0 110.075 179.95 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.488 ' O ' ' OD1' ' A' ' 16' ' ' ASP . 43.3 p30 -79.7 141.59 36.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.553 -179.978 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -128.42 -112.29 1.65 Allowed Glycine 0 CA--C 1.535 1.327 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 -179.923 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -75.02 150.05 37.51 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 122.627 2.218 . . . . 0.0 112.978 -179.329 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -111.24 148.97 31.69 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.415 179.694 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.471 ' CD2' HD11 ' A' ' 37' ' ' ILE . 34.7 t80 -117.44 104.58 49.67 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.66 -179.817 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.83 131.43 15.76 Favored 'Trans proline' 0 N--CA 1.489 1.229 0 C-N-CA 121.371 1.381 . . . . 0.0 111.942 -178.905 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 83.4 mt -88.97 46.03 1.35 Allowed 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.082 -178.67 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -55.99 -32.01 63.55 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.668 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.622 HD11 ' HG2' ' B' ' 265' ' ' GLN . 69.4 mt -69.75 142.78 53.2 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.654 179.436 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 97.8 p -63.5 -16.86 61.91 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.327 -178.917 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.5 m -145.15 145.42 31.36 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.694 -0.403 . . . . 0.0 110.845 179.61 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.677 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -136.54 127.82 28.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.662 179.327 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.519 HD13 ' HD3' ' A' ' 50' ' ' LYS . 40.0 tp -114.39 123.92 50.68 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -178.156 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.677 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 54.3 m-85 -97.39 133.59 41.78 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.987 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 177.09 -177.7 48.25 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 119.533 -1.318 . . . . 0.0 112.871 179.609 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 23.6 ttp85 -89.25 -23.79 22.25 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.946 -0.627 . . . . 0.0 110.994 179.944 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.71 152.16 45.59 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 -179.823 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.541 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.6 tp -64.12 -41.26 91.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.104 0.478 . . . . 0.0 110.195 179.45 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.541 ' N ' HG23 ' A' ' 33' ' ' ILE . 83.1 tt0 -51.37 -17.49 0.77 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.972 -179.764 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 24.0 m -75.08 139.08 42.55 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.493 179.986 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.502 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 57.1 m-20 -61.13 -32.81 72.5 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 -179.445 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.673 HD12 ' CE2' ' A' ' 29' ' ' PHE . 94.2 mt -123.03 116.98 50.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 177.44 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.1 ttp180 -103.95 131.95 50.68 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.397 -178.425 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.8 HD13 ' CZ ' ' A' ' 93' ' ' ARG . 80.0 mt -117.34 132.26 67.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.086 0.47 . . . . 0.0 110.012 -179.41 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -76.71 30.93 0.13 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.77 -177.857 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.677 HD22 HH22 ' B' ' 245' ' ' ARG . 33.3 mt -103.2 131.84 21.72 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.727 179.247 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.96 -10.01 24.22 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.531 2.154 . . . . 0.0 112.642 -179.519 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.434 HG21 ' CE2' ' B' ' 241' ' ' PHE . 22.1 m -97.62 7.22 8.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.872 -179.989 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.499 ' CG2' ' NH2' ' A' ' 93' ' ' ARG . 28.6 t -95.09 134.61 31.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.202 179.236 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.3 t -73.44 171.16 13.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.409 0.623 . . . . 0.0 111.54 -179.152 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -63.5 -42.88 98.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.8 -179.053 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.652 ' O ' ' N ' ' A' ' 49' ' ' CYS . 98.3 mt-30 -113.89 -21.19 10.76 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.384 -179.612 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.0 t60 41.04 -74.94 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.957 179.621 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.828 ' SG ' HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -140.29 141.75 35.75 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.537 -179.201 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.519 ' HD3' HD13 ' A' ' 28' ' ' LEU . 29.1 ttpt -128.02 133.03 49.08 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.639 178.795 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.411 HD11 HD12 ' A' ' 82' ' ' LEU . 18.5 tt -112.06 134.46 54.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -179.872 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -118.15 132.81 56.31 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 -179.875 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.89 HG23 ' NH1' ' A' ' 5' ' ' ARG . 98.3 mt -112.21 117.89 56.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.664 0.745 . . . . 0.0 112.613 -179.135 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.452 ' O ' ' N ' ' A' ' 56' ' ' GLN . 91.4 m-70 -116.65 139.63 50.31 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.211 178.808 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 54' ' ' HIS . 82.6 tt0 -40.13 -30.0 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.252 0.548 . . . . 0.0 109.634 -179.295 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.477 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 60.1 tt0 -65.34 -68.21 0.38 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.053 179.118 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.477 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 3.4 tp10 -154.15 -172.95 4.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.833 -178.976 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.554 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -107.24 130.02 54.8 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.827 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.6 mt -120.05 129.65 75.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.437 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.828 HD11 ' SG ' ' A' ' 49' ' ' CYS . 45.2 tp -100.17 127.88 46.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.209 179.532 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -114.97 137.79 51.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.502 -179.877 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -100.27 108.24 20.26 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.755 0.312 . . . . 0.0 111.825 179.802 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -99.21 -7.39 26.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.995 179.454 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.36 102.22 13.81 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.733 0.301 . . . . 0.0 111.112 -179.742 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.1 m -83.99 -27.69 28.25 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.643 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.3 m -64.24 -48.66 74.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.604 179.769 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.499 ' OD1' HG22 ' B' ' 236' ' ' VAL . 56.8 m-80 -140.13 95.31 8.47 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.02 -179.899 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.498 ' HB2' HG13 ' A' ' 75' ' ' VAL . 46.4 Cg_exo -56.78 144.6 86.73 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.173 1.915 . . . . 0.0 112.534 -179.765 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 18.3 m -75.79 141.79 42.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.473 179.248 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -103.57 140.98 36.8 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.523 -179.73 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 55.7 t -129.57 132.44 66.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.966 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 51.38 31.72 7.58 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.184 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.9 28.13 63.29 Favored Glycine 0 CA--C 1.534 1.25 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.088 179.636 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 35.0 t -142.35 141.65 32.36 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 117.274 0.537 . . . . 0.0 111.451 179.945 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.498 HG13 ' HB2' ' A' ' 68' ' ' PRO . 54.1 t -69.79 141.5 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.109 179.946 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.48 HD13 HD23 ' A' ' 60' ' ' LEU . 5.1 pt -116.22 75.83 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.557 179.233 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -65.67 -26.22 67.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.84 0.352 . . . . 0.0 110.26 179.832 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -112.18 160.98 28.08 Favored Pre-proline 0 CA--C 1.532 0.26 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.376 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.8 140.24 94.24 Favored 'Trans proline' 0 N--CA 1.499 1.827 0 C-N-CA 121.46 1.44 . . . . 0.0 111.994 179.852 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.3 t -133.61 136.32 54.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.999 179.944 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -74.9 130.44 39.41 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 178.764 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.451 HD11 ' HB2' ' A' ' 60' ' ' LEU . 95.0 mt -84.1 140.64 31.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.161 0.505 . . . . 0.0 111.611 -179.607 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -129.33 151.24 50.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.371 179.69 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -54.69 119.0 4.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.704 -179.225 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.66 -13.33 35.47 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 179.873 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -68.85 134.22 49.36 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.337 -0.545 . . . . 0.0 109.762 179.631 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.449 HG22 ' HG2' ' A' ' 96' ' ' ARG . 54.3 t -109.38 132.23 58.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.139 -178.425 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 81.6 mt -103.82 131.06 53.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.844 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.5 m -118.72 125.73 50.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.468 0.651 . . . . 0.0 111.823 -179.607 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.522 ' O ' ' N ' ' A' ' 93' ' ' ARG . 89.3 mt -118.1 123.7 72.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.535 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.473 HG22 ' N ' ' A' ' 92' ' ' ASP . 46.7 mm 40.78 -108.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.205 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.473 ' N ' HG22 ' A' ' 91' ' ' ILE . 45.5 t0 -111.28 12.68 21.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.253 0.549 . . . . 0.0 110.132 178.829 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.8 ' CZ ' HD13 ' A' ' 39' ' ' ILE . 18.8 mtm105 -112.28 139.6 47.7 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.862 179.715 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.414 ' HB3' HD12 ' A' ' 10' ' ' ILE . 37.4 t -135.54 145.54 47.13 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.775 178.976 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.61 ' HB3' HD11 ' A' ' 7' ' ' LEU . 46.1 m-85 -124.15 122.6 38.26 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.87 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.476 ' O ' HD12 ' A' ' 7' ' ' LEU . 99.7 mtt180 -86.35 132.74 33.89 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.2 -0.6 . . . . 0.0 111.387 -179.324 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.516 ' CZ ' ' OD1' ' A' ' 99' ' ' ASN . 93.8 t80 -95.5 124.16 39.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.969 179.485 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -139.81 127.18 21.38 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.257 -0.577 . . . . 0.0 111.51 -179.161 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.516 ' OD1' ' CZ ' ' A' ' 97' ' ' TYR . 92.3 m-20 . . . . . 0 CA--C 1.529 0.144 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.977 -179.754 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo . . . . . 0 N--CA 1.494 1.528 0 N-CA-C 114.41 0.888 . . . . 0.0 114.41 . . . . . . . . . 0 0 . 1 . 046 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.499 HG22 ' OD1' ' A' ' 67' ' ' ASN . 0.5 OUTLIER -69.28 137.73 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 114.38 -1.282 . . . . 0.0 110.445 179.991 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 6.8 t . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.384 -179.687 . . . . . . . . 0 0 . 1 . 046 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo . . . . . 0 N--CA 1.503 2.043 0 N-CA-C 114.31 0.85 . . . . 0.0 114.31 . . . . . . . . . 0 0 . 1 . 046 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 7.7 p -74.76 -38.89 62.08 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.154 -0.619 . . . . 0.0 110.02 179.071 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.485 ' CZ ' ' NH2' ' B' ' 245' ' ' ARG . 66.6 t80 -58.71 -45.3 89.85 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.696 -179.294 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 95.6 mt -64.91 -40.66 95.42 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.838 0.351 . . . . 0.0 111.209 179.681 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -64.33 -44.06 92.71 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.088 -179.025 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 62.8 ttm-85 -60.49 -42.53 96.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.264 0.554 . . . . 0.0 109.886 179.556 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.677 HH22 HD22 ' A' ' 41' ' ' LEU . 48.5 ttm-85 -60.62 -43.18 97.78 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.127 -178.965 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.02 -38.64 89.44 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.35 -179.516 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 15.6 t -65.91 -42.99 89.46 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 177.536 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 69.2 tp60 -59.4 -38.02 79.5 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.61 179.845 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 43.3 t . . . . . 0 C--N 1.331 -0.213 0 C-N-CA 120.614 -0.435 . . . . 0.0 109.873 179.315 . . . . . . . . 0 0 . 1 . 046 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.672 ' O ' HG23 ' A' ' 39' ' ' ILE . 97.0 mt-10 . . . . . 0 CA--C 1.529 0.138 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 . . . . . . . . . 1 1 . 1 . 046 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.469 ' CD1' HG23 ' A' ' 9' ' ' THR . 64.5 mt -118.4 134.01 63.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.078 -179.743 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 40.7 t -128.24 134.85 64.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.996 -179.705 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -96.03 119.0 33.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.554 -178.904 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -65.22 -44.46 88.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.924 178.871 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' B' B ' 265' ' ' GLN . . . . . 0.622 ' HG2' HD11 ' A' ' 24' ' ' LEU . 4.4 mp0 -97.35 158.38 33.28 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.382 -179.728 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -69.53 145.74 59.42 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 123.022 2.481 . . . . 0.0 113.398 -179.264 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 48.6 pt . . . . . 0 C--N 1.332 -0.155 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.434 179.061 . . . . . . . . 0 0 . 1 . 047 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 77.0 p . . . . . 0 C--O 1.232 0.177 0 CA-C-O 121.032 0.444 . . . . 0.0 110.439 . . . . . . . . . 0 0 . 1 . 047 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.4 mtt85 -96.46 119.59 35.22 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.784 179.875 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.9 mtm180 -132.85 141.42 48.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.936 0.398 . . . . 0.0 111.323 -179.292 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.846 HD11 HD11 ' A' ' 22' ' ' LEU . 64.0 mt -114.35 142.37 46.41 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.669 -179.375 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 76.6 t -117.05 130.55 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.651 178.833 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.8 m -87.28 113.58 23.13 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -178.163 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.489 HD12 ' HB2' ' A' ' 94' ' ' SER . 95.1 mt -80.9 140.05 17.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.404 177.781 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -88.21 155.42 19.77 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 178.36 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.693 HH12 ' NH1' ' B' ' 245' ' ' ARG . 75.1 mtp85 -59.29 -26.5 65.01 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.235 -178.899 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.0 m -76.9 -18.75 58.1 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.034 0.445 . . . . 0.0 110.667 179.328 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.08 33.99 4.73 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.196 -1.161 . . . . 0.0 110.196 -179.718 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.2 t -124.13 129.91 73.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.478 0.18 . . . . 0.0 110.533 179.991 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -73.3 138.02 45.19 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.439 179.265 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -125.96 -117.03 2.13 Favored Glycine 0 CA--C 1.541 1.688 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.323 -179.298 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -75.95 147.67 30.77 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 122.765 2.31 . . . . 0.0 112.384 -178.505 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -108.36 148.66 29.78 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.414 179.913 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.487 ' CD2' HD11 ' A' ' 37' ' ' ILE . 31.7 t80 -118.69 101.28 50.72 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.284 -179.876 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.31 135.04 23.92 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.012 1.808 . . . . 0.0 111.629 -179.266 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.846 HD11 HD11 ' A' ' 7' ' ' LEU . 95.6 mt -91.03 49.49 1.65 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.069 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 34.4 t -61.71 -19.1 62.02 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.508 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.734 HD11 ' HG2' ' B' ' 265' ' ' GLN . 80.7 mt -80.14 138.0 36.83 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.057 -179.895 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.1 m -64.76 -19.79 66.0 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.994 -179.486 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.505 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 39.0 m -135.45 135.2 40.34 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.618 -179.405 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.683 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 5.4 t -130.38 120.75 24.76 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.163 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.513 HD21 ' OE1' ' A' ' 47' ' ' GLN . 62.8 tp -118.99 128.77 54.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.308 -178.723 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.743 ' CE2' HD12 ' A' ' 37' ' ' ILE . 3.9 m-85 -105.05 142.59 34.56 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -179.875 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 146.83 -174.36 26.69 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.887 178.587 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 31' ' ' ARG . 46.3 mtm180 -74.03 -33.03 63.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 179.42 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.504 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -41.85 144.81 0.8 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 -179.05 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.556 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.3 tp -67.42 -41.86 86.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 O-C-N 122.219 -0.577 . . . . 0.0 109.824 179.483 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.556 ' N ' HG23 ' A' ' 33' ' ' ILE . 76.4 mm-40 -58.15 -23.3 54.78 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.178 179.374 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.504 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 57.4 m -50.9 118.24 3.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.077 179.969 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.505 ' OD2' ' O ' ' A' ' 26' ' ' THR . 57.6 m-20 -57.52 -30.6 65.29 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.817 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.743 HD12 ' CE2' ' A' ' 29' ' ' PHE . 87.8 mt -125.15 118.86 54.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.239 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -104.74 134.74 47.39 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.913 -178.962 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 95.7 mt -114.57 127.23 72.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 121.2 0.524 . . . . 0.0 110.788 179.294 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -70.74 39.37 0.05 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.289 -0.869 . . . . 0.0 113.115 -178.322 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.808 HD11 ' NH2' ' A' ' 93' ' ' ARG . 79.3 mt -117.02 130.99 24.21 Favored Pre-proline 0 C--N 1.326 -0.449 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.369 179.738 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -72.7 -9.19 23.58 Favored 'Trans proline' 0 N--CA 1.489 1.235 0 C-N-CA 122.122 1.881 . . . . 0.0 112.162 179.522 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.458 HG21 ' CE2' ' B' ' 241' ' ' PHE . 28.0 m -99.11 1.98 10.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.894 179.808 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.3 t -86.92 134.93 26.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.268 0.556 . . . . 0.0 110.315 179.412 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.8 m -65.06 160.02 21.95 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.742 -178.987 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -63.72 -43.63 95.98 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.276 -179.085 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.636 ' O ' ' N ' ' A' ' 49' ' ' CYS . 12.1 mm100 -112.75 -23.43 10.17 Favored 'General case' 0 C--O 1.227 -0.123 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.424 179.929 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.3 t60 37.14 -76.75 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.078 -0.964 . . . . 0.0 112.932 179.855 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.636 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.0 136.1 47.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.337 0.589 . . . . 0.0 112.28 -178.539 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -125.39 129.09 49.2 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.781 179.683 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 93.8 mt -114.11 133.71 59.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.181 178.781 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -115.25 128.89 56.43 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.532 179.013 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 51.8 mm -99.0 118.66 45.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.989 -179.807 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.435 ' O ' ' C ' ' A' ' 55' ' ' GLU . 99.5 m-70 -120.31 135.09 55.13 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.33 179.646 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 54' ' ' HIS . 82.6 tt0 -40.46 -32.03 0.18 Allowed 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -179.675 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.434 ' N ' ' C ' ' A' ' 54' ' ' HIS . 88.7 mt-30 -67.53 -68.48 0.38 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.041 179.236 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.479 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 5.1 tp10 -153.84 -167.05 2.55 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.369 -179.067 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.479 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -119.44 130.4 55.25 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.435 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 99.5 mt -117.97 131.16 71.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.634 0.731 . . . . 0.0 111.981 -178.433 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.7 tp -99.78 127.53 45.93 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.213 179.624 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -110.16 133.64 53.01 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.208 -178.881 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 61.4 t-20 -93.25 104.57 16.74 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.948 179.889 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -100.93 -11.93 19.35 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 120.995 -0.282 . . . . 0.0 111.594 179.812 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 m -68.29 99.78 0.96 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.421 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 87.9 p -85.38 -10.11 56.7 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.525 -179.774 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.548 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -100.19 -43.12 6.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.117 179.88 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -133.84 95.61 17.17 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.991 -179.709 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.0 141.2 86.72 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.395 2.063 . . . . 0.0 112.882 -179.735 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.2 m -74.07 136.63 43.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.283 179.174 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -100.6 139.31 36.47 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.212 179.362 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.7 t -131.62 133.37 61.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 178.76 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 54.52 32.68 17.34 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -178.844 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.3 27.22 72.02 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.115 179.487 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 28.5 t -141.29 136.96 32.11 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 117.377 0.589 . . . . 0.0 111.501 -179.966 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -70.06 138.58 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.862 179.652 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.3 pt -114.08 91.57 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 121.208 0.528 . . . . 0.0 111.401 179.664 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -66.49 -26.86 67.38 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.823 178.494 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.495 ' N ' ' OE1' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -119.21 162.07 33.66 Favored Pre-proline 0 N--CA 1.465 0.295 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.81 179.71 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.29 151.09 86.84 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.694 2.263 . . . . 0.0 112.388 -179.388 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 36.0 m -142.05 148.69 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.107 0 CA-C-O 121.273 0.559 . . . . 0.0 112.107 -179.483 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -75.86 127.54 33.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.018 178.865 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 82' ' ' LEU . 92.9 mt -75.55 140.06 42.5 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.488 179.609 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -130.51 146.08 51.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.2 179.515 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.592 ' HD1' ' C ' ' A' ' 99' ' ' ASN . 7.2 t60 -51.4 119.62 4.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.133 -179.178 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.81 -12.19 49.8 Favored Glycine 0 CA--C 1.522 0.51 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.938 179.463 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -69.66 137.22 51.99 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.316 -0.553 . . . . 0.0 110.204 179.705 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.492 ' O ' HG13 ' A' ' 87' ' ' VAL . 8.7 p -106.89 134.86 47.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.876 -178.667 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 93.4 mt -103.27 129.48 55.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 177.696 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 47.5 m -123.98 124.81 43.4 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.577 0.704 . . . . 0.0 112.783 -178.171 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.425 ' O ' ' N ' ' A' ' 92' ' ' ASP . 94.0 mt -111.6 124.2 68.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.005 178.102 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.621 HG22 ' NH2' ' B' ' 245' ' ' ARG . 64.4 mt 39.36 -96.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.987 -179.201 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.49 ' CB ' ' NH2' ' B' ' 245' ' ' ARG . 52.8 t0 -120.51 18.15 12.08 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.792 0.33 . . . . 0.0 111.888 -178.791 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.832 HH22 ' NH1' ' B' ' 245' ' ' ARG . 1.1 ptp85 -131.25 144.29 51.19 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.067 178.679 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.489 ' HB2' HD12 ' A' ' 10' ' ' ILE . 38.1 m -136.14 152.83 51.23 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.298 0.571 . . . . 0.0 111.232 -179.913 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.419 ' HE1' HD12 ' A' ' 90' ' ' ILE . 65.1 m-85 -122.95 122.09 37.71 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.629 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 45.2 ttm180 -78.95 131.77 36.47 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.216 -178.726 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -95.93 119.62 34.75 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.76 179.924 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.41 ' HG3' ' CE1' ' A' ' 84' ' ' HIS . 79.7 tt0 -122.5 122.21 38.39 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.262 -179.969 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.592 ' C ' ' HD1' ' A' ' 84' ' ' HIS . 59.4 t-20 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.615 -179.651 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' B' B ' 235' ' ' PRO . . . . . 0.446 ' HG2' HG12 ' A' ' 43' ' ' VAL . 76.5 Cg_endo . . . . . 0 N--CA 1.489 1.21 0 CA-C-O 121.316 0.465 . . . . 0.0 113.156 . . . . . . . . . 1 1 . 1 . 047 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.548 ' CG2' HG22 ' A' ' 66' ' ' THR . 67.9 t -66.93 133.27 31.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.771 179.836 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.332 -0.188 0 CA-C-O 121.036 0.445 . . . . 0.0 110.555 -179.468 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo . . . . . 0 N--CA 1.491 1.35 0 CA-C-O 120.488 0.12 . . . . 0.0 112.018 . . . . . . . . . 0 0 . 1 . 047 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 2.8 m -75.96 -42.39 48.64 Favored 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.532 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.458 ' CE2' HG21 ' A' ' 43' ' ' VAL . 79.9 t80 -58.16 -46.11 86.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.143 -179.788 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.704 HD23 HH21 ' B' ' 245' ' ' ARG . 92.9 mt -63.82 -41.95 97.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.171 0.51 . . . . 0.0 110.851 179.874 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -63.04 -43.0 99.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.979 -179.092 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -61.51 -43.89 98.04 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.271 179.935 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.832 ' NH1' HH22 ' A' ' 93' ' ' ARG . 75.6 mtm180 -63.54 -40.04 95.99 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.881 -178.926 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -61.31 -39.01 88.91 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.263 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 13.5 t -65.91 -45.37 82.18 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.711 0.767 . . . . 0.0 109.496 178.051 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -62.17 -33.63 74.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.558 179.872 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' B' B ' 249' ' ' VAL . . . . . 0.512 HG23 ' O ' ' B' ' 245' ' ' ARG . 54.0 t . . . . . 0 N--CA 1.452 -0.338 0 C-N-CA 119.986 -0.686 . . . . 0.0 109.335 178.761 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 53.5 mp0 . . . . . 0 N--CA 1.463 0.188 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 . . . . . . . . . 0 0 . 1 . 047 nuclear build core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 56.6 mt -119.29 130.2 74.26 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 177.89 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 54.1 t -122.69 133.83 67.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.427 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -95.27 122.14 37.66 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.263 0.554 . . . . 0.0 110.685 -178.7 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -62.53 -46.06 90.11 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.564 -179.889 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' B' B ' 265' ' ' GLN . . . . . 0.734 ' HG2' HD11 ' A' ' 24' ' ' LEU . 3.2 mp0 -94.85 160.71 30.58 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.82 -179.403 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.41 147.49 58.83 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.478 2.119 . . . . 0.0 112.94 -179.695 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 47.9 pt . . . . . 0 N--CA 1.466 0.346 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.666 179.13 . . . . . . . . 0 0 . 1 . 048 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 121.008 0.433 . . . . 0.0 110.481 . . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.571 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 94.9 mtt-85 -98.6 122.09 41.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.128 -179.381 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.578 ' NH2' ' OE2' ' A' ' 98' ' ' GLU . 33.6 ptt-85 -146.01 158.38 43.87 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.103 -0.639 . . . . 0.0 112.009 179.937 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.3 mt -118.86 144.85 46.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.261 179.604 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.826 HG13 ' NE2' ' A' ' 19' ' ' HIS . 67.0 t -114.31 125.46 71.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.568 -0.453 . . . . 0.0 109.903 179.446 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.2 m -74.21 134.16 42.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.019 0.438 . . . . 0.0 111.313 -179.689 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.662 HD12 ' OG ' ' A' ' 94' ' ' SER . 97.0 mt -104.0 133.98 46.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.759 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -86.71 154.25 21.11 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.279 -0.568 . . . . 0.0 109.881 179.307 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 89.9 mtm180 -54.99 -27.74 46.44 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.581 -178.983 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.4 m -81.1 -5.67 57.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.759 0.314 . . . . 0.0 110.589 179.809 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.82 34.09 9.35 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 -179.959 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.8 t -121.08 135.59 60.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.86 0.362 . . . . 0.0 110.91 -179.852 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.463 ' O ' ' OD1' ' A' ' 16' ' ' ASP . 48.7 p-10 -75.97 133.36 40.47 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.459 179.727 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -121.39 -121.15 2.76 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.794 -179.327 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.48 147.24 40.78 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.131 1.888 . . . . 0.0 112.8 -178.871 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.826 ' NE2' HG13 ' A' ' 8' ' ' VAL . 62.0 m170 -109.76 143.37 39.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.635 -179.664 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.588 ' CE2' HD11 ' A' ' 37' ' ' ILE . 37.3 t80 -112.52 99.83 48.4 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.849 -179.717 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -70.6 131.51 20.18 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 C-N-CA 120.912 1.075 . . . . 0.0 110.787 -179.638 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 75.8 mt -85.39 77.36 9.95 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 120.261 -0.575 . . . . 0.0 110.784 -178.749 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 97.3 p -85.56 -10.61 55.68 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.077 178.744 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 52.2 mt -102.57 146.19 28.51 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.312 -179.047 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 94.9 p -65.91 -20.02 66.07 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -178.488 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 27.6 m -133.25 133.06 42.18 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.481 -0.487 . . . . 0.0 111.359 -179.777 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.0 t -122.71 116.84 24.44 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.589 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 56.8 tp -113.61 129.37 56.57 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -177.673 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.499 ' O ' ' O ' ' A' ' 47' ' ' GLN . 72.6 m-85 -109.77 131.51 55.0 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.449 179.804 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 160.46 -173.41 37.02 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.882 179.072 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.627 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 75.9 mtm-85 -80.89 -28.52 35.9 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.243 179.364 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.553 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -46.35 146.41 3.16 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -178.645 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.49 HG23 ' N ' ' A' ' 34' ' ' GLU . 9.9 tp -67.72 -41.91 85.78 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 CA-C-O 120.843 0.354 . . . . 0.0 110.285 179.823 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.49 ' N ' HG23 ' A' ' 33' ' ' ILE . 81.7 tt0 -59.03 -21.34 58.92 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.462 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.553 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 22.4 m -55.84 123.46 14.32 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.401 -179.96 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -62.08 -30.96 71.36 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.397 -179.71 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.588 HD11 ' CE2' ' A' ' 20' ' ' PHE . 47.1 mm -124.61 121.13 60.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.17 178.649 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.417 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 60.0 mtm180 -108.81 137.25 47.05 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 120.279 -0.569 . . . . 0.0 111.386 -179.977 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 89.6 mt -121.19 129.31 75.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.047 179.349 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -74.89 32.34 0.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -177.941 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.484 HD23 ' HA ' ' A' ' 41' ' ' LEU . 25.8 mt -98.27 129.07 31.47 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.317 179.272 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -73.14 -5.32 16.97 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 122.317 2.012 . . . . 0.0 112.368 -179.941 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.628 HG23 HD13 ' A' ' 91' ' ' ILE . 27.9 m -107.63 8.71 9.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.356 179.81 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.627 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 13.7 t -95.15 137.6 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.601 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.7 m -69.05 167.28 16.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.479 0.657 . . . . 0.0 112.381 -178.095 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.3 mttp -63.99 -41.65 97.45 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.033 -179.577 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.639 ' O ' ' N ' ' A' ' 49' ' ' CYS . 96.2 mt-30 -115.62 -25.24 7.93 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.098 0.475 . . . . 0.0 110.245 179.864 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.825 ' NE2' HG23 ' A' ' 90' ' ' ILE . 32.1 t60 38.39 -72.44 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 178.912 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.639 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -134.83 139.26 44.93 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -177.967 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.9 ttpp -132.95 133.95 43.88 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.539 178.827 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 92.3 mt -113.27 135.7 51.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.883 179.683 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.408 ' CD ' ' NE2' ' A' ' 54' ' ' HIS . 79.8 tt0 -117.32 132.12 56.67 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.255 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.1 mm -103.6 118.55 50.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.403 -0.519 . . . . 0.0 112.295 -177.924 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.434 ' O ' ' C ' ' A' ' 55' ' ' GLU . 97.9 m-70 -117.66 134.22 55.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.11 178.052 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 54' ' ' HIS . 84.6 tt0 -40.15 -35.47 0.4 Allowed 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.038 -179.085 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -64.27 -66.7 0.51 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.945 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -150.43 -167.96 2.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.286 -179.718 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -119.2 134.61 55.11 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.536 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 98.0 mt -120.2 130.77 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 121.385 0.612 . . . . 0.0 112.615 -178.729 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 21.7 tp -98.72 128.44 44.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.084 179.624 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -109.84 134.62 51.85 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.051 -179.346 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.527 HD21 ' CA ' ' A' ' 68' ' ' PRO . 62.7 t-20 -95.65 104.62 16.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.802 -178.848 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -97.19 -10.46 25.82 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.373 179.535 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 10.3 t -78.01 98.93 5.88 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.666 -179.477 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.2 m -76.09 -40.26 53.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.249 0.547 . . . . 0.0 110.055 178.509 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.37 -41.35 85.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.451 -179.671 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.628 ' OD1' HG23 ' B' ' 236' ' ' VAL . 59.8 m-20 -140.51 93.29 8.81 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.718 -179.895 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.551 ' HB2' HG13 ' A' ' 75' ' ' VAL . 40.6 Cg_exo -56.56 147.55 69.15 Favored 'Trans proline' 0 N--CA 1.498 1.784 0 C-N-CA 122.551 2.167 . . . . 0.0 113.029 -179.064 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.406 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 3.9 m -72.25 136.83 46.44 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.472 179.227 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -100.43 141.56 33.11 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.578 179.49 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.571 HG13 ' OD1' ' A' ' 86' ' ' ASP . 56.1 t -128.54 135.97 61.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.236 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 50.97 31.87 6.79 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.464 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.94 29.27 63.18 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.028 179.569 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 12.1 p -141.34 141.0 33.87 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 117.139 0.469 . . . . 0.0 111.412 179.878 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.551 HG13 ' HB2' ' A' ' 68' ' ' PRO . 53.5 t -74.76 136.5 25.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-O 121.115 0.483 . . . . 0.0 111.74 -179.854 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.958 HD13 ' O ' ' A' ' 76' ' ' ILE . 0.0 OUTLIER -137.15 119.45 19.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.824 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.401 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 38.3 p-10 -101.17 -0.42 36.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.922 -178.038 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.91 ' O ' HD11 ' A' ' 76' ' ' ILE . 5.2 pt-20 -119.93 165.09 18.87 Favored Pre-proline 0 C--N 1.331 -0.225 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.256 179.965 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.98 141.86 96.36 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 121.747 1.632 . . . . 0.0 111.866 179.772 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.7 p -140.21 140.31 35.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.725 -179.879 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -78.96 130.3 35.41 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.961 179.542 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 82' ' ' LEU . 96.8 mt -78.87 140.19 38.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.01 0.433 . . . . 0.0 110.728 179.96 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -129.7 149.38 51.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.329 179.978 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -55.62 116.6 2.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.012 0.434 . . . . 0.0 110.885 -179.168 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.44 -16.41 37.88 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -179.751 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.571 ' OD1' HG13 ' A' ' 71' ' ' VAL . 53.7 t0 -67.68 131.07 44.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.717 0.294 . . . . 0.0 110.231 179.314 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.542 HG22 ' HG2' ' A' ' 96' ' ' ARG . 76.7 t -104.92 135.54 42.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.937 0.399 . . . . 0.0 111.298 -178.8 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 88.4 mt -104.13 130.28 55.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.443 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.8 m -122.53 123.58 41.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.828 0.823 . . . . 0.0 112.836 -178.884 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.825 HG23 ' NE2' ' A' ' 48' ' ' HIS . 86.9 mt -109.38 125.95 66.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 114.236 -1.347 . . . . 0.0 108.281 178.274 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.68 HG22 ' N ' ' A' ' 92' ' ' ASP . 97.8 mt 29.42 -101.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.932 0.396 . . . . 0.0 111.578 -179.165 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.68 ' N ' HG22 ' A' ' 91' ' ' ILE . 35.6 p-10 -105.54 11.42 32.45 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.137 -179.035 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.877 ' NE ' HD11 ' B' ' 261' ' ' ILE . 8.7 mtp85 -130.2 145.2 51.71 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.045 -179.55 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.662 ' OG ' HD12 ' A' ' 10' ' ' ILE . 21.1 p -140.64 153.24 45.95 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.178 0.513 . . . . 0.0 110.699 179.747 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -129.77 127.41 40.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.953 179.814 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.542 ' HG2' HG22 ' A' ' 87' ' ' VAL . 99.9 mtt180 -82.9 133.64 35.11 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.376 -0.529 . . . . 0.0 110.182 179.979 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.571 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 85.0 t80 -94.61 126.21 39.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.485 -179.24 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.578 ' OE2' ' NH2' ' A' ' 6' ' ' ARG . 82.5 tt0 -135.5 118.88 16.77 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.823 179.546 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.42 ' C ' ' OD1' ' A' ' 99' ' ' ASN . 55.5 p30 . . . . . 0 C--N 1.333 -0.136 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.67 -179.998 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo . . . . . 0 N--CA 1.486 1.047 0 CA-C-O 121.509 0.545 . . . . 0.0 111.971 . . . . . . . . . 0 0 . 1 . 048 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.628 HG23 ' OD1' ' A' ' 67' ' ' ASN . 4.8 p -64.73 141.51 18.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.548 -179.606 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' B' B ' 237' ' ' CYS . . . . . 0.465 ' SG ' ' CD2' ' B' ' 241' ' ' PHE . 2.8 t . . . . . 0 C--N 1.333 -0.113 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.217 -179.594 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo . . . . . 0 N--CA 1.495 1.607 0 CA-C-O 120.825 0.26 . . . . 0.0 112.062 . . . . . . . . . 0 0 . 1 . 048 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 87.8 m -64.34 -46.42 83.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.433 0.635 . . . . 0.0 109.317 178.771 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.474 ' HZ ' HD22 ' A' ' 41' ' ' LEU . 85.4 t80 -58.02 -47.5 82.87 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.546 -179.378 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.4 ' HA ' HD23 ' B' ' 242' ' ' LEU . 96.9 mt -62.8 -41.92 99.49 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.89 -178.584 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -65.09 -39.02 92.58 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.224 -179.271 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' B' B ' 244' ' ' ARG . . . . . 0.431 ' O ' ' OG ' ' B' ' 247' ' ' SER . 99.5 mtt180 -63.41 -40.24 96.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.085 0.469 . . . . 0.0 109.835 179.884 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' B' B ' 245' ' ' ARG . . . . . . . . . . . . . 71.2 ttp85 -61.21 -43.16 99.32 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.845 -179.505 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.37 -40.62 97.05 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.321 -179.652 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' B' B ' 247' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 79.4 p -64.51 -42.84 95.55 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.726 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -61.66 -39.12 90.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.193 -179.991 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 54.3 t . . . . . 0 N--CA 1.456 -0.157 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.303 179.059 . . . . . . . . 0 0 . 1 . 048 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.475 ' OE1' HD21 ' A' ' 41' ' ' LEU . 99.2 mt-10 . . . . . 0 CA--C 1.534 0.363 0 N-CA-C 115.316 1.598 . . . . 0.0 115.316 . . . . . . . . . 1 1 . 1 . 048 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.877 HD11 ' NE ' ' A' ' 93' ' ' ARG . 74.2 mt -118.21 132.89 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 119.434 1.016 . . . . 0.0 109.274 178.388 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 55.9 t -125.11 135.21 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-O 120.932 0.396 . . . . 0.0 111.191 -179.625 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -98.79 119.12 37.01 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.278 0.561 . . . . 0.0 110.581 -179.761 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -66.24 -43.89 85.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.045 179.934 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -103.13 157.98 32.68 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.355 -179.1 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -63.89 155.54 63.45 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 122.949 2.432 . . . . 0.0 112.703 -179.833 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.0 pt . . . . . 0 C--N 1.331 -0.217 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.117 -178.745 . . . . . . . . 0 0 . 1 . 049 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.1 p . . . . . 0 C--O 1.233 0.201 0 CA-C-O 120.591 0.234 . . . . 0.0 111.035 . . . . . . . . . 0 0 . 1 . 049 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.607 ' HG2' ' HH ' ' A' ' 97' ' ' TYR . 85.6 mtt85 -83.71 123.12 29.52 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.26 -179.865 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -127.45 136.52 51.92 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.23 -179.404 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.524 HD11 ' HB3' ' A' ' 95' ' ' PHE . 25.3 tp -112.67 130.6 55.99 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.836 -179.755 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.561 HG22 ' CE1' ' A' ' 19' ' ' HIS . 47.0 t -108.07 129.15 62.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.914 -179.479 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.0 m -81.05 143.83 32.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.471 0.653 . . . . 0.0 111.921 -179.606 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.8 mm -111.81 135.15 51.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.613 178.729 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -89.9 157.27 17.95 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.01 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.49 HH11 ' CD ' ' B' ' 245' ' ' ARG . 84.5 mtm180 -58.6 -22.57 56.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.059 -179.466 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.615 ' OG ' HG13 ' B' ' 249' ' ' VAL . 5.2 m -85.08 -9.45 57.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.991 -179.63 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.49 40.24 6.47 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.189 -0.765 . . . . 0.0 111.189 179.716 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 54.6 t -125.89 135.36 64.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.726 0.298 . . . . 0.0 111.627 -179.265 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.441 ' CG ' ' HE2' ' A' ' 19' ' ' HIS . 62.8 t0 -67.68 124.55 23.59 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.163 179.115 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -115.62 -124.8 3.81 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 120.959 -0.639 . . . . 0.0 111.863 -179.18 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -75.82 146.61 30.0 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.31 2.006 . . . . 0.0 113.334 -178.688 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.561 ' CE1' HG22 ' A' ' 8' ' ' VAL . 59.4 m170 -106.1 142.17 36.23 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.563 -179.935 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.414 ' CD2' HD11 ' A' ' 37' ' ' ILE . 44.0 t80 -117.74 106.85 45.35 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.096 179.977 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.29 127.49 12.71 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 121.541 1.494 . . . . 0.0 112.03 -178.382 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 56.3 mt -89.01 43.92 1.18 Allowed 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.35 -178.361 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 65.3 p -67.54 -19.85 65.34 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.554 -0.458 . . . . 0.0 109.849 179.381 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.9 mt -74.39 144.06 44.54 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.61 179.954 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 92.8 p -58.07 -26.08 62.08 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.035 -178.39 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 97.8 m -141.22 138.63 33.44 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.206 -0.598 . . . . 0.0 111.839 -179.113 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.655 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 2.5 t -128.77 121.7 28.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.053 178.393 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.555 HD12 ' O ' ' A' ' 49' ' ' CYS . 52.1 tp -119.74 129.33 54.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.377 -178.167 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.731 ' CE2' HD12 ' A' ' 37' ' ' ILE . 3.0 m-85 -104.68 137.17 42.9 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.473 179.495 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 163.55 -167.46 37.74 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.419 178.883 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.636 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 86.3 mtm-85 -88.05 -27.99 21.64 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.767 0.318 . . . . 0.0 110.263 179.97 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.408 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -55.64 149.87 23.36 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 121.133 -0.556 . . . . 0.0 111.837 -178.168 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.543 ' CD1' ' NH1' ' A' ' 38' ' ' ARG . 10.5 tp -68.09 -41.6 84.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 CA-C-O 120.864 0.364 . . . . 0.0 110.518 179.92 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.467 ' N ' HG23 ' A' ' 33' ' ' ILE . 83.0 tt0 -57.4 -23.34 48.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.226 0.536 . . . . 0.0 110.099 179.77 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.408 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 33.3 m -56.0 126.12 24.47 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.185 179.683 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.436 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 55.0 m-20 -61.04 -33.14 72.82 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.602 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.731 HD12 ' CE2' ' A' ' 29' ' ' PHE . 94.8 mt -123.98 121.9 63.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 177.314 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.543 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 83.1 mtp180 -109.84 139.1 45.29 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.405 -178.544 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 97.4 mt -120.36 130.58 74.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.987 179.004 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -79.75 35.67 0.31 Allowed 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -177.768 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.781 HD12 ' CZ ' ' A' ' 93' ' ' ARG . 60.5 mt -112.95 135.17 21.67 Favored Pre-proline 0 C--N 1.328 -0.328 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.112 178.191 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.67 -9.78 26.49 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.629 2.22 . . . . 0.0 113.22 -178.717 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.694 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 1.8 m -96.52 2.0 10.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.444 -179.828 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.636 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 53.2 t -88.3 131.96 34.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.614 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.403 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 1.6 m -63.99 158.39 22.57 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.159 0.504 . . . . 0.0 111.328 -179.106 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -61.42 -42.08 98.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.663 -179.086 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.612 ' O ' ' N ' ' A' ' 49' ' ' CYS . 10.8 mm100 -115.43 -20.23 10.35 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.919 179.677 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.403 ' H ' ' HB3' ' A' ' 45' ' ' SER . 20.5 t60 33.21 -74.54 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 179.082 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.612 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -129.54 133.94 47.49 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -177.608 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -123.93 133.07 53.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.663 179.284 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 98.1 mt -119.49 134.38 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.679 -179.218 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -115.92 127.99 55.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.402 179.154 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.3 mm -100.49 109.86 26.15 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 CA-C-O 121.251 0.548 . . . . 0.0 110.861 -179.481 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.445 ' O ' ' C ' ' A' ' 55' ' ' GLU . 97.8 m-70 -111.36 135.22 52.22 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.512 179.247 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 54' ' ' HIS . 93.1 mt-10 -41.8 -34.32 0.63 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -179.396 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 73.5 tp60 -63.72 -67.2 0.45 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.373 178.572 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -155.68 -169.52 3.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.691 -179.829 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -117.47 129.94 56.14 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.592 -179.729 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 87.9 mt -117.51 130.51 72.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 121.324 0.583 . . . . 0.0 112.416 -178.902 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.5 ' HB2' HD21 ' A' ' 82' ' ' LEU . 50.5 tp -95.27 129.19 42.49 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.931 179.81 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -115.19 133.44 56.03 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.799 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -96.57 108.3 20.87 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.266 -179.684 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -97.51 -7.02 32.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.256 179.532 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.543 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 78.7 p -76.25 97.93 4.31 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.306 179.579 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.3 m -80.39 -32.95 37.49 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.2 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.1 m -65.55 -48.07 73.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.293 179.597 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.583 ' OD1' HG23 ' B' ' 236' ' ' VAL . 1.5 m-20 -137.72 102.02 8.68 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.032 -179.663 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.414 ' HB2' HG23 ' A' ' 75' ' ' VAL . 32.4 Cg_exo -55.14 146.05 61.62 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 121.752 1.635 . . . . 0.0 112.326 -179.85 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.2 m -74.68 140.64 44.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.595 179.075 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -104.61 139.02 40.07 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.14 179.673 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 56.4 t -132.02 132.96 61.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.879 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 54.38 33.48 18.66 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.025 -0.67 . . . . 0.0 109.622 -179.391 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.7 29.29 65.7 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.77 178.921 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.1 t -148.08 140.39 24.3 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 117.492 0.646 . . . . 0.0 111.342 179.342 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.428 ' H ' HG12 ' A' ' 75' ' ' VAL . 0.2 OUTLIER -68.65 144.0 14.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.379 -179.485 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.1 pt -118.19 94.35 3.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 121.034 0.445 . . . . 0.0 110.585 179.068 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.58 ' OD1' ' N ' ' A' ' 78' ' ' GLU . 37.0 p-10 -69.4 -23.96 63.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.281 179.727 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.58 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 2.6 mt-10 -124.28 170.04 9.53 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.459 179.656 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -60.73 147.27 95.51 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 122.485 2.123 . . . . 0.0 112.601 179.283 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 29.3 m -138.32 138.71 42.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.473 179.626 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.575 HH21 ' CE ' ' A' ' 83' ' ' LYS . 61.7 ttp180 -72.8 130.44 40.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.632 179.281 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.5 HD21 ' HB2' ' A' ' 60' ' ' LEU . 97.0 mt -81.58 136.02 35.57 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.015 0.436 . . . . 0.0 111.7 -179.386 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.575 ' CE ' HH21 ' A' ' 81' ' ' ARG . 99.1 mttt -129.05 149.0 51.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.409 179.426 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.444 ' CD2' ' C ' ' A' ' 84' ' ' HIS . 7.2 t60 -54.58 116.81 2.88 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.162 179.897 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 113.09 -15.35 23.28 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.572 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -67.96 135.67 52.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.29 0.567 . . . . 0.0 110.672 -179.569 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.513 HG22 ' HG2' ' A' ' 96' ' ' ARG . 77.0 t -112.48 131.57 63.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.752 -178.652 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 81.0 mt -104.29 131.14 53.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.081 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 38.8 m -123.26 128.24 49.7 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -177.807 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.427 ' O ' ' C ' ' A' ' 91' ' ' ILE . 91.4 mt -115.76 124.17 71.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.051 178.679 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.624 HG23 ' SG ' ' B' ' 237' ' ' CYS . 76.6 mt 39.72 -100.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.445 179.989 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.601 ' OD1' ' NH1' ' A' ' 93' ' ' ARG . 24.2 p-10 -116.21 13.4 15.68 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.779 0.323 . . . . 0.0 111.482 -179.919 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.781 ' CZ ' HD12 ' A' ' 41' ' ' LEU . 57.0 mtm-85 -125.07 143.45 50.91 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.878 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.2 t -138.75 156.18 47.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.628 0.728 . . . . 0.0 111.887 -179.413 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.524 ' HB3' HD11 ' A' ' 7' ' ' LEU . 86.5 m-85 -128.32 124.62 36.93 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.454 179.294 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.513 ' HG2' HG22 ' A' ' 87' ' ' VAL . 99.6 mtt180 -89.6 134.54 34.08 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.951 -0.7 . . . . 0.0 110.959 -179.316 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.607 ' HH ' ' HG2' ' A' ' 5' ' ' ARG . 85.7 t80 -98.0 123.27 41.93 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.046 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -141.11 126.91 19.14 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.093 -179.617 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.471 ' OD1' ' CZ ' ' A' ' 97' ' ' TYR . 95.0 m-20 . . . . . 0 N--CA 1.462 0.153 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.434 179.214 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo . . . . . 0 N--CA 1.49 1.276 0 CA-C-O 121.506 0.544 . . . . 0.0 112.015 . . . . . . . . . 0 0 . 1 . 049 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.583 HG23 ' OD1' ' A' ' 67' ' ' ASN . 8.2 p -109.9 135.07 50.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.248 -179.767 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' B' B ' 237' ' ' CYS . . . . . 0.624 ' SG ' HG23 ' A' ' 91' ' ' ILE . 19.9 t . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.289 -179.426 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo . . . . . 0 N--CA 1.494 1.543 0 CA-C-O 120.854 0.272 . . . . 0.0 111.884 . . . . . . . . . 0 0 . 1 . 049 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 77.6 m -73.3 -46.69 48.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.566 178.834 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.694 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 57.5 t80 -58.19 -45.84 86.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.693 -178.999 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.446 ' HA ' HD23 ' B' ' 242' ' ' LEU . 78.4 mt -64.27 -40.46 96.02 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.478 179.85 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -61.67 -40.63 95.63 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.951 0.405 . . . . 0.0 110.206 179.922 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -61.8 -43.1 99.52 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.628 179.601 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.605 ' NH2' HD22 ' A' ' 41' ' ' LEU . 40.0 mmt-85 -62.19 -39.79 93.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.605 -179.514 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.08 -40.2 96.96 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.238 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 11.2 t -62.84 -44.06 97.15 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 177.693 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -60.0 -38.11 81.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.785 -179.917 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' B' B ' 249' ' ' VAL . . . . . 0.615 HG13 ' OG ' ' A' ' 13' ' ' SER . 25.0 t . . . . . 0 C--N 1.327 -0.374 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.797 179.724 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.569 ' OE1' HD11 ' A' ' 41' ' ' LEU . 98.5 mt-10 . . . . . 0 CA--C 1.52 -0.174 0 CA-C-O 121.029 0.443 . . . . 0.0 110.037 . . . . . . . . . 1 1 . 1 . 049 nuclear build core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 66.7 mt -113.3 141.12 30.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.303 -178.799 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 56.0 t -127.63 134.04 66.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.329 -179.812 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -99.43 122.92 43.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.441 0.639 . . . . 0.0 111.238 -179.208 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' B' B ' 264' ' ' LYS . . . . . 0.408 ' NZ ' ' HA ' ' A' ' 34' ' ' GLU . 88.2 tttt -64.78 -44.88 88.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.42 179.772 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -98.5 155.29 36.98 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.796 -178.901 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.74 149.71 83.6 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.776 2.318 . . . . 0.0 111.791 179.202 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 25.1 pt . . . . . 0 C--N 1.325 -0.481 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.271 -179.425 . . . . . . . . 0 0 . 1 . 050 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 74.8 p . . . . . 0 N--CA 1.461 0.098 0 CA-C-O 120.929 0.395 . . . . 0.0 111.218 . . . . . . . . . 0 0 . 1 . 050 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.664 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 93.7 mtt-85 -92.72 126.22 37.7 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.305 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 89.6 mtm-85 -134.5 151.45 51.14 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.247 0.546 . . . . 0.0 112.255 -179.075 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.42 ' CD1' HD21 ' A' ' 22' ' ' LEU . 85.5 mt -119.16 146.97 44.71 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.875 -179.55 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.0 t -118.55 129.79 74.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.816 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.535 HG22 HH21 ' A' ' 93' ' ' ARG . 53.5 m -89.07 112.74 23.76 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -178.126 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.49 HD12 ' OG ' ' A' ' 94' ' ' SER . 95.8 mt -83.64 143.13 12.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 177.748 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.1 tttm -92.33 167.64 11.86 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.108 -0.637 . . . . 0.0 111.063 -179.735 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.601 ' NH1' ' OE2' ' B' ' 260' ' ' GLU . 90.5 mtm180 -58.25 -31.54 67.52 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.517 -179.165 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 90.5 p -83.35 -6.13 59.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.962 0.41 . . . . 0.0 110.024 179.136 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.2 39.78 7.23 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.89 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.1 t -117.26 134.19 61.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.029 0.442 . . . . 0.0 111.617 -179.198 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -73.09 116.68 13.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.702 -179.839 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -110.95 -124.24 4.57 Favored Glycine 0 CA--C 1.54 1.596 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 179.416 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.93 147.58 39.19 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 122.41 2.073 . . . . 0.0 113.518 -179.219 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.551 ' O ' ' CD1' ' B' ' 267' ' ' ILE . 0.4 OUTLIER -110.59 131.01 55.42 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.234 179.333 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.584 ' CD2' HD11 ' A' ' 37' ' ' ILE . 24.7 t80 -99.58 101.01 12.04 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.533 -179.098 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.97 135.63 23.55 Favored 'Trans proline' 0 C--N 1.315 -1.204 0 C-N-CA 121.332 1.355 . . . . 0.0 111.36 -179.69 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.575 HD13 HD11 ' A' ' 53' ' ' ILE . 79.8 mt -85.95 76.58 9.82 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.965 -178.542 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 95.5 p -82.67 -10.34 58.97 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.757 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.701 HD11 ' HG2' ' B' ' 265' ' ' GLN . 59.2 mt -102.16 146.02 28.55 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.611 -179.682 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.8 m -66.19 -14.8 62.46 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.929 -0.308 . . . . 0.0 111.514 -179.255 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.426 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 75.0 m -135.49 136.48 41.29 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.912 0.387 . . . . 0.0 111.875 -179.539 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.411 ' HB2' HD22 ' A' ' 22' ' ' LEU . 12.2 t -126.2 117.18 22.57 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.911 178.626 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.563 HD21 ' OE1' ' A' ' 47' ' ' GLN . 58.4 tp -113.57 127.88 56.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.602 0.239 . . . . 0.0 110.861 -179.171 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.823 ' CE2' HD12 ' A' ' 37' ' ' ILE . 6.0 m-85 -107.4 141.81 38.21 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.741 179.473 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 149.64 -178.5 27.1 Favored Glycine 0 N--CA 1.467 0.751 0 C-N-CA 120.175 -1.012 . . . . 0.0 112.418 178.676 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.479 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 45.8 mtm180 -73.56 -32.92 64.43 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 179.787 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.535 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -50.13 141.68 15.36 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 120.474 -0.87 . . . . 0.0 111.317 -178.579 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.571 ' CD1' ' CZ ' ' A' ' 38' ' ' ARG . 34.4 mm -63.17 -43.62 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-O 120.874 0.369 . . . . 0.0 110.029 179.529 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -53.81 -19.25 4.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.962 179.806 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.535 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 39.6 m -61.6 129.27 40.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.396 -179.923 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.426 ' OD2' ' O ' ' A' ' 26' ' ' THR . 91.4 m-20 -60.73 -30.38 69.94 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.645 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.823 HD12 ' CE2' ' A' ' 29' ' ' PHE . 82.7 mt -126.93 119.96 54.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.482 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.571 ' CZ ' ' CD1' ' A' ' 33' ' ' ILE . 82.0 mtp180 -99.95 133.75 43.87 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.029 -178.822 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.744 HG21 HD12 ' A' ' 41' ' ' LEU . 96.8 mt -118.44 128.81 75.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-O 121.131 0.491 . . . . 0.0 110.339 179.991 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -76.67 26.87 0.13 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.253 -178.683 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.744 HD12 HG21 ' A' ' 39' ' ' ILE . 26.3 mt -94.84 124.76 53.56 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.554 179.731 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.88 -10.84 26.88 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 122.371 2.047 . . . . 0.0 112.542 -179.443 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.54 HG21 ' CE2' ' B' ' 241' ' ' PHE . 4.1 m -100.86 8.88 8.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.941 0.4 . . . . 0.0 111.27 179.996 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.479 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 21.9 t -97.44 136.31 28.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.329 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.3 m -70.45 170.45 11.97 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.635 0.731 . . . . 0.0 111.921 -178.467 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -62.28 -41.41 98.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.039 -179.144 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.607 ' O ' ' N ' ' A' ' 49' ' ' CYS . 13.9 mm100 -110.91 -20.95 12.26 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.265 0.555 . . . . 0.0 110.403 -179.849 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.408 ' NE2' HG23 ' A' ' 90' ' ' ILE . 11.0 t60 39.74 -78.34 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.006 -0.997 . . . . 0.0 113.209 179.087 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.607 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.16 137.69 46.32 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.216 0.531 . . . . 0.0 111.791 -178.886 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -129.15 135.36 48.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.217 179.661 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.6 mt -121.27 136.95 56.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.142 -179.11 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -117.01 123.89 47.99 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.755 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.575 HD11 HD13 ' A' ' 22' ' ' LEU . 96.4 mt -102.37 116.05 45.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.528 0.68 . . . . 0.0 111.521 -178.714 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.492 ' O ' ' N ' ' A' ' 56' ' ' GLN . 90.8 m-70 -117.67 144.57 45.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.143 179.932 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 54' ' ' HIS . 80.7 tt0 -39.2 -29.16 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -179.626 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.492 ' N ' ' O ' ' A' ' 54' ' ' HIS . 86.5 mt-30 -66.59 -68.59 0.36 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.733 178.944 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.44 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 6.1 tp10 -157.65 -158.99 0.79 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.562 -179.67 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.44 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -118.42 128.77 54.94 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.064 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.9 mt -118.38 129.3 74.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.304 0.573 . . . . 0.0 112.248 -178.477 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 49.2 tp -95.31 129.19 42.53 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.584 -179.954 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -114.23 134.71 54.73 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.154 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.681 HD21 ' CB ' ' A' ' 68' ' ' PRO . 63.7 t-20 -97.84 105.8 18.0 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -178.078 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -98.24 -8.55 27.12 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.911 179.568 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.3 t -81.06 99.23 8.37 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.694 0.283 . . . . 0.0 110.983 179.684 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.4 t -83.99 -32.74 24.81 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.804 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.6 m -61.29 -47.46 85.85 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.918 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -144.17 108.62 4.96 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.714 178.587 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.681 ' CB ' HD21 ' A' ' 62' ' ' ASN . 40.1 Cg_endo -68.6 152.64 74.56 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 121.535 1.49 . . . . 0.0 113.019 -178.473 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.9 m -70.66 138.97 51.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.22 -179.636 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -101.76 140.28 36.26 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.833 -179.682 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.567 ' CG2' HD11 ' A' ' 76' ' ' ILE . 12.9 t -134.89 136.29 52.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 178.13 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 28.7 m120 56.91 33.51 23.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.993 0.425 . . . . 0.0 110.064 -179.581 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.97 30.64 67.66 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.173 179.219 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 36.0 m -148.18 146.39 28.7 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 117.359 0.58 . . . . 0.0 111.348 -179.661 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.4 m -72.78 147.36 10.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-O 121.015 0.436 . . . . 0.0 111.002 -179.703 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.567 HD11 ' CG2' ' A' ' 71' ' ' VAL . 98.3 mt -107.2 107.21 22.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.406 -179.474 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -66.09 -42.25 89.58 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.64 179.233 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.545 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.4 OUTLIER -136.71 -177.55 0.72 Allowed Pre-proline 0 N--CA 1.466 0.346 0 CA-C-O 120.666 0.269 . . . . 0.0 111.298 -178.737 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.509 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 45.2 Cg_exo -58.69 145.22 96.57 Favored 'Trans proline' 0 N--CA 1.5 1.895 0 C-N-CA 122.842 2.361 . . . . 0.0 113.199 -179.753 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.8 m -143.76 143.07 24.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.985 179.634 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.46 ' HE ' ' HE2' ' A' ' 83' ' ' LYS . 59.6 ttp180 -76.25 133.59 40.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.107 179.449 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 82' ' ' LEU . 98.4 mt -82.35 143.87 30.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.151 0.501 . . . . 0.0 111.675 -179.153 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.46 ' HE2' ' HE ' ' A' ' 81' ' ' ARG . 73.3 mmtt -132.72 151.68 51.92 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.489 179.556 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.418 ' CE1' ' H ' ' A' ' 99' ' ' ASN . 5.4 t60 -56.26 117.8 4.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.421 -178.847 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.67 -18.58 24.58 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 111.189 -0.765 . . . . 0.0 111.189 179.527 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -69.61 135.08 49.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.163 0.506 . . . . 0.0 110.554 -179.899 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 49.7 t -110.16 132.78 57.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.91 -179.178 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.439 ' HA ' HG22 ' A' ' 71' ' ' VAL . 97.1 mt -101.12 130.22 50.89 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 177.676 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 49.6 m -120.1 126.42 50.71 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 119.876 -0.73 . . . . 0.0 112.209 -178.663 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.591 ' O ' ' N ' ' A' ' 93' ' ' ARG . 99.1 mt -114.78 129.91 70.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 114.798 -1.092 . . . . 0.0 108.25 177.993 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.504 HG23 HD21 ' B' ' 242' ' ' LEU . 75.6 mt -23.04 95.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -178.612 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.501 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 3.8 m-20 92.88 -27.19 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 178.551 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.666 ' NE ' HD11 ' B' ' 261' ' ' ILE . 7.9 mmm180 -125.93 143.21 51.18 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.418 -179.3 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.49 ' OG ' HD12 ' A' ' 10' ' ' ILE . 87.0 p -138.81 154.36 48.46 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.6 -0.44 . . . . 0.0 109.995 179.345 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -129.12 126.79 40.1 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.32 -179.539 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 96' ' ' ARG . 41.7 ttp-105 -90.91 135.69 33.57 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.661 -0.415 . . . . 0.0 110.429 -179.605 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.664 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 89.1 t80 -92.39 121.34 33.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.905 -179.759 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -121.63 123.43 41.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.831 -179.568 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.418 ' H ' ' CE1' ' A' ' 84' ' ' HIS . 60.3 t-20 . . . . . 0 C--N 1.333 -0.118 0 CA-C-O 120.921 0.391 . . . . 0.0 110.285 179.923 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo . . . . . 0 N--CA 1.485 1.023 0 CA-C-O 121.413 0.506 . . . . 0.0 112.708 . . . . . . . . . 0 0 . 1 . 050 nuclear build core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 2.1 p -107.72 132.4 55.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.058 179.071 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 3.2 t . . . . . 0 C--N 1.329 -0.305 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.03 -179.282 . . . . . . . . 0 0 . 1 . 050 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo . . . . . 0 N--CA 1.502 2.003 0 N-CA-C 113.078 0.376 . . . . 0.0 113.078 . . . . . . . . . 0 0 . 1 . 050 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 98.9 m -74.47 -46.39 39.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.064 0.459 . . . . 0.0 110.357 178.894 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.54 ' CE2' HG21 ' A' ' 43' ' ' VAL . 88.1 t80 -59.63 -45.34 92.26 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.82 -178.8 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.504 HD21 HG23 ' A' ' 91' ' ' ILE . 89.9 mt -65.79 -39.96 91.47 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 119.86 -0.736 . . . . 0.0 110.563 179.398 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -60.67 -41.84 95.86 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.854 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -65.81 -37.58 86.64 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.314 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.475 HH11 ' NH1' ' A' ' 12' ' ' ARG . 10.7 tpp180 -62.62 -44.52 96.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.334 -179.68 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -63.08 -36.62 84.19 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.978 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 10.2 t -63.53 -44.65 93.6 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.629 177.974 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 66.6 mm-40 -57.83 -37.63 74.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.919 -179.952 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 C--N 1.326 -0.426 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.576 178.934 . . . . . . . . 0 0 . 1 . 050 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.601 ' OE2' ' NH1' ' A' ' 12' ' ' ARG . 92.4 mt-10 . . . . . 0 N--CA 1.448 -0.528 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 . . . . . . . . . 1 1 . 1 . 050 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.666 HD11 ' NE ' ' A' ' 93' ' ' ARG . 3.0 mm -112.72 131.36 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 114.31 -1.314 . . . . 0.0 109.407 -179.109 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 39.2 t -124.95 132.31 71.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.629 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -98.56 122.05 41.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.2 0.524 . . . . 0.0 111.889 -178.302 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -65.06 -45.9 83.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.694 179.326 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' B' B ' 265' ' ' GLN . . . . . 0.701 ' HG2' HD11 ' A' ' 24' ' ' LEU . 2.9 mp0 -92.47 163.9 24.75 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.436 -179.882 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.86 146.92 92.23 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.21 1.94 . . . . 0.0 112.56 -179.89 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' B' B ' 267' ' ' ILE . . . . . 0.551 ' CD1' ' O ' ' A' ' 19' ' ' HIS . 4.9 tt . . . . . 0 C--N 1.323 -0.582 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.246 -179.607 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.1 m . . . . . 0 C--O 1.237 0.411 0 CA-C-O 120.813 0.34 . . . . 0.0 111.745 . . . . . . . . . 0 0 . 1 . 051 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.658 ' NH1' HG23 ' A' ' 53' ' ' ILE . 90.0 mtt180 -91.4 138.66 31.4 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.949 -178.011 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -139.0 147.23 41.87 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 179.761 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.551 HD12 ' O ' ' A' ' 96' ' ' ARG . 42.4 tp -117.82 133.61 55.76 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.258 179.241 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 53.7 t -110.8 132.02 60.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.265 -178.668 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.444 HG23 ' CD1' ' B' ' 261' ' ' ILE . 4.7 m -96.6 115.84 28.1 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.874 -179.249 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 87.2 mt -83.41 150.96 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.578 179.888 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.403 ' HB2' ' H ' ' A' ' 15' ' ' VAL . 72.8 mmtt -86.17 154.09 21.58 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 178.527 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.533 ' NH2' ' OE2' ' B' ' 260' ' ' GLU . 87.7 mtm180 -58.22 -25.47 61.7 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.373 179.776 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.2 m -79.49 -8.25 59.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.843 179.84 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.01 31.84 8.89 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -179.893 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.403 ' H ' ' HB2' ' A' ' 11' ' ' LYS . 23.8 t -118.65 133.64 64.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.611 0.243 . . . . 0.0 110.898 -179.949 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -72.89 133.02 44.22 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.524 -0.546 . . . . 0.0 109.524 179.141 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -127.54 -118.63 2.17 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 120.403 -0.903 . . . . 0.0 111.931 -179.54 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -76.17 149.06 31.62 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.56 2.173 . . . . 0.0 112.593 -179.028 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -110.81 151.08 28.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.339 0.59 . . . . 0.0 111.246 -179.432 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.402 ' HB2' ' CE1' ' B' ' 263' ' ' PHE . 40.4 t80 -112.54 91.75 17.87 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.304 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.518 ' HD2' HG22 ' B' ' 267' ' ' ILE . 59.8 Cg_endo -71.47 133.53 22.64 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 121.226 1.284 . . . . 0.0 111.269 -178.329 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.594 ' O ' ' CB ' ' A' ' 23' ' ' SER . 72.0 mt -73.45 -149.56 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.976 -178.429 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.594 ' CB ' ' O ' ' A' ' 22' ' ' LEU . 6.9 p 135.98 -40.16 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -179.181 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.3 mt -77.52 142.84 38.86 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.55 -1.204 . . . . 0.0 109.769 179.746 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 m -65.26 -17.13 64.25 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -178.766 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.1 m -133.86 133.56 41.69 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.619 0.599 . . . . 0.0 112.619 -179.2 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.662 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.4 OUTLIER -126.15 119.44 27.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.185 178.146 . . . . . . . . 3 3 . 1 . 051 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.512 HD21 ' OE1' ' A' ' 47' ' ' GLN . 36.7 tp -119.7 128.07 53.45 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.826 -178.391 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.705 ' CE2' HD12 ' A' ' 37' ' ' ILE . 25.1 m-85 -100.73 128.18 46.88 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.262 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -173.35 -165.04 29.61 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 120.057 -1.068 . . . . 0.0 112.876 -179.79 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.499 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 38.0 ttp-105 -105.75 -8.5 17.78 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.169 -0.515 . . . . 0.0 111.694 -179.138 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -91.52 170.05 33.49 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.66 -178.865 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.52 HG23 ' N ' ' A' ' 34' ' ' GLU . 11.0 tp -68.45 -41.7 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 115.638 -0.281 . . . . 0.0 111.301 -179.884 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.52 ' N ' HG23 ' A' ' 33' ' ' ILE . 48.8 tt0 -56.76 -29.46 62.62 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.458 -179.429 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.9 m -63.5 129.94 42.28 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.479 -179.975 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.426 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 57.0 m-20 -60.51 -31.3 70.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.383 -178.768 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.705 HD12 ' CE2' ' A' ' 29' ' ' PHE . 97.6 mt -127.25 118.65 50.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 178.258 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.492 ' CZ ' HD12 ' A' ' 33' ' ' ILE . 59.9 mtm180 -102.29 137.2 40.86 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.57 179.9 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.819 HD13 ' NH1' ' A' ' 93' ' ' ARG . 75.8 mt -119.38 131.94 70.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.617 -179.583 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -67.2 18.82 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -177.934 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.702 HD12 HH21 ' A' ' 93' ' ' ARG . 15.5 mt -104.64 127.73 28.34 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.87 179.96 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.67 -5.89 17.8 Favored 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 122.368 2.046 . . . . 0.0 112.326 -179.737 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.543 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 11.0 m -91.8 5.51 6.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.065 179.462 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.499 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 54.7 t -96.51 135.52 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.882 178.885 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.2 m -74.27 167.99 20.51 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.747 0.784 . . . . 0.0 112.951 -178.377 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.7 mtmt -64.13 -37.97 89.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.689 179.588 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.612 ' O ' ' N ' ' A' ' 49' ' ' CYS . 92.1 mm-40 -115.16 -32.26 5.75 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.135 0.493 . . . . 0.0 110.103 -179.984 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 18.7 t60 41.74 -77.2 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.764 179.636 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.612 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.37 134.74 47.38 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.793 -178.916 . . . . . . . . 3 3 . 1 . 051 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -126.05 129.25 48.79 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.359 -179.972 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 95.5 mt -114.89 131.98 65.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.208 -179.736 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -116.93 125.8 52.0 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.552 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.658 HG23 ' NH1' ' A' ' 5' ' ' ARG . 98.0 mt -106.73 114.5 46.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 119.975 -0.69 . . . . 0.0 112.022 -178.585 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.426 ' O ' ' C ' ' A' ' 55' ' ' GLU . 86.2 m-70 -113.27 146.32 39.55 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.719 179.804 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 54' ' ' HIS . 52.8 tp10 -40.66 -33.39 0.28 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.527 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -61.39 -68.94 0.27 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.744 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -161.35 -160.58 0.73 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.145 178.723 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.11 128.15 56.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.365 -179.926 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 91.2 mt -116.59 129.88 72.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.036 0.446 . . . . 0.0 111.892 -179.013 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.575 ' HB2' HD11 ' A' ' 82' ' ' LEU . 28.5 tp -100.0 130.39 46.16 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.896 -179.14 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -115.92 136.17 53.29 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.718 179.849 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -97.09 106.54 18.89 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -178.994 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -100.58 -7.47 24.01 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.213 178.73 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.99 100.97 7.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.187 179.789 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.3 m -88.47 -10.92 47.42 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.999 179.606 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.593 HG22 HG23 ' B' ' 236' ' ' VAL . 0.2 OUTLIER -91.98 -43.6 9.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.284 -179.724 . . . . . . . . 3 3 . 1 . 051 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.446 ' OD1' HG22 ' B' ' 236' ' ' VAL . 80.1 m-20 -140.05 101.26 7.03 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.08 -179.877 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -56.7 143.11 90.83 Favored 'Trans proline' 0 N--CA 1.501 1.929 0 C-N-CA 122.297 1.998 . . . . 0.0 113.355 -179.312 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.939 ' O ' HG22 ' A' ' 76' ' ' ILE . 2.9 m -72.27 140.35 48.57 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.096 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 89' ' ' THR . 72.8 mt-30 -104.57 140.35 38.12 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.327 -0.549 . . . . 0.0 111.39 -179.005 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.465 HG22 HD13 ' A' ' 88' ' ' ILE . 55.8 t -131.61 133.43 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.982 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 29.0 m120 54.21 33.06 17.25 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.976 179.947 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.5 24.29 70.89 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.993 178.932 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.7 t -142.79 143.52 32.21 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 117.585 0.692 . . . . 0.0 111.058 179.844 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.401 HG22 ' H ' ' A' ' 75' ' ' VAL . 2.5 m -69.22 144.11 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.311 179.945 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.939 HG22 ' O ' ' A' ' 69' ' ' THR . 8.2 tt -106.42 91.39 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.259 179.191 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -64.11 -37.27 86.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.966 179.925 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.486 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 3.5 mt-10 -126.89 168.7 13.85 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.254 -179.044 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -59.74 145.38 98.31 Favored 'Trans proline' 0 N--CA 1.501 1.912 0 C-N-CA 122.042 1.828 . . . . 0.0 112.705 -179.56 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.2 m -145.48 151.58 14.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.801 178.922 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -78.83 132.94 37.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.762 179.552 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.575 HD11 ' HB2' ' A' ' 60' ' ' LEU . 96.1 mt -89.39 140.92 29.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.16 0.505 . . . . 0.0 111.281 -179.681 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -123.13 151.94 41.61 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.852 179.351 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.405 ' CE1' ' HG3' ' A' ' 98' ' ' GLU . 6.5 t60 -53.82 121.69 8.45 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.403 -179.861 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.15 -13.99 37.01 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -179.888 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -68.71 135.59 51.55 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.575 -0.45 . . . . 0.0 109.937 179.671 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.495 ' CG1' ' OG ' ' A' ' 94' ' ' SER . 91.4 t -107.06 132.28 54.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.213 -179.024 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.465 HD13 HG22 ' A' ' 71' ' ' VAL . 45.2 mm -91.05 128.28 42.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.768 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.526 ' N ' ' O ' ' A' ' 70' ' ' GLN . 63.5 m -124.26 123.35 40.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.505 0.669 . . . . 0.0 112.531 -178.02 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.443 ' O ' ' C ' ' A' ' 91' ' ' ILE . 85.1 mt -121.55 129.06 75.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.432 179.295 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.553 HG22 ' N ' ' A' ' 92' ' ' ASP . 95.8 mt 34.2 -99.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.454 -179.797 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.553 ' N ' HG22 ' A' ' 91' ' ' ILE . 36.7 t0 -114.05 16.87 18.1 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.703 0.287 . . . . 0.0 111.33 -179.216 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.819 ' NH1' HD13 ' A' ' 39' ' ' ILE . 4.8 mtm105 -124.71 139.18 54.09 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.812 -179.298 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.495 ' OG ' ' CG1' ' A' ' 87' ' ' VAL . 41.7 t -132.72 141.81 48.74 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.103 0.478 . . . . 0.0 110.128 179.606 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.494 ' HB3' HD11 ' A' ' 7' ' ' LEU . 27.2 m-85 -125.06 123.26 39.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.886 -179.993 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.551 ' O ' HD12 ' A' ' 7' ' ' LEU . 99.6 mtt180 -82.53 126.42 32.25 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.508 -179.855 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.585 ' CE2' ' OD1' ' A' ' 99' ' ' ASN . 74.7 t80 -90.59 124.27 34.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.658 179.607 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.405 ' HG3' ' CE1' ' A' ' 84' ' ' HIS . 82.0 tt0 -128.52 113.5 15.56 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.801 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.585 ' OD1' ' CE2' ' A' ' 97' ' ' TYR . 87.2 m-20 . . . . . 0 C--N 1.327 -0.41 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.544 179.961 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo . . . . . 0 N--CA 1.491 1.331 0 CA-C-O 121.531 0.555 . . . . 0.0 113.159 . . . . . . . . . 0 0 . 1 . 051 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.593 HG23 HG22 ' A' ' 66' ' ' THR . 1.8 t -61.03 138.9 21.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.306 -179.882 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.243 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.288 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo . . . . . 0 N--CA 1.497 1.733 0 N-CA-C 112.7 0.231 . . . . 0.0 112.7 . . . . . . . . . 0 0 . 1 . 051 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 25.9 m -74.52 -42.6 58.61 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.073 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.543 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 73.1 t80 -57.17 -47.41 81.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.585 -179.219 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 91.0 mt -65.31 -39.47 92.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.039 0.447 . . . . 0.0 110.206 179.634 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -62.35 -41.25 98.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.757 -179.615 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -64.33 -40.78 96.58 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.65 179.85 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.435 HH11 ' HD3' ' B' ' 245' ' ' ARG . 25.9 mmt180 -61.37 -42.69 99.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.33 -179.354 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.4 -39.76 95.36 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.304 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 11.0 t -66.04 -45.89 79.77 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.849 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -55.11 -40.87 70.96 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.693 179.996 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 44.3 t . . . . . 0 C--N 1.332 -0.175 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.857 . . . . . . . . 0 0 . 1 . 051 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.533 ' OE2' ' NH2' ' A' ' 12' ' ' ARG . 53.5 mp0 . . . . . 0 C--O 1.226 -0.174 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 . . . . . . . . . 1 1 . 1 . 051 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.444 ' CD1' HG23 ' A' ' 9' ' ' THR . 64.5 mt -111.7 134.28 54.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.48 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 77.1 t -128.02 135.27 63.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.761 -179.225 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' B' B ' 263' ' ' PHE . . . . . 0.402 ' CE1' ' HB2' ' A' ' 20' ' ' PHE . 42.3 m-85 -96.53 119.25 34.67 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.072 -178.224 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -66.42 -46.82 75.23 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.156 178.976 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.37 156.2 51.17 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.859 -178.543 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -62.23 149.19 91.54 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 C-N-CA 122.46 2.107 . . . . 0.0 111.071 179.261 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' B' B ' 267' ' ' ILE . . . . . 0.518 HG22 ' HD2' ' A' ' 21' ' ' PRO . 30.1 pt . . . . . 0 C--N 1.325 -0.489 0 CA-C-O 121.47 0.652 . . . . 0.0 111.964 -178.42 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 69.1 p . . . . . 0 N--CA 1.455 -0.214 0 CA-C-O 120.919 0.39 . . . . 0.0 110.556 . . . . . . . . . 0 0 . 1 . 052 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.5 mtt85 -94.2 132.76 38.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.248 -179.808 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.502 HH21 ' CD ' ' A' ' 98' ' ' GLU . 39.5 ptt180 -143.57 153.43 42.55 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 120.311 -0.556 . . . . 0.0 111.784 -179.943 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 68.5 mt -117.98 138.71 52.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.817 -179.757 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.703 HG11 ' NH2' ' A' ' 96' ' ' ARG . 26.6 t -112.03 130.3 65.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.524 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.427 ' HG1' ' HE2' ' A' ' 95' ' ' PHE . 3.5 m -79.27 141.24 37.23 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -178.389 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.73 HD11 ' NH1' ' A' ' 96' ' ' ARG . 47.9 mm -106.2 132.4 53.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.096 -0.957 . . . . 0.0 109.035 177.547 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -87.74 154.42 20.58 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.406 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.442 ' HG2' HH12 ' B' ' 245' ' ' ARG . 80.8 mtm180 -57.78 -23.67 53.46 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -178.806 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.4 m -82.89 -9.5 59.28 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.623 179.653 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.27 32.58 10.34 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -179.746 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.1 t -120.53 132.09 71.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.875 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.605 ' CG ' HH22 ' A' ' 96' ' ' ARG . 98.2 m-20 -69.8 137.96 52.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.438 -179.649 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -124.77 -121.23 2.54 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.28 -179.093 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -75.93 146.62 29.66 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.578 2.185 . . . . 0.0 113.192 -178.486 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -106.65 143.69 34.39 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.154 0.502 . . . . 0.0 110.461 179.754 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.529 ' CD2' HD11 ' A' ' 37' ' ' ILE . 33.7 t80 -112.35 96.22 34.63 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.371 -179.707 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -68.89 129.35 18.36 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 121.369 1.379 . . . . 0.0 112.332 -178.422 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 94.4 mt -83.88 78.05 9.79 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.114 0.483 . . . . 0.0 111.052 -178.922 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.7 p -82.29 -13.14 57.45 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.176 178.93 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.2 mt -102.86 148.22 25.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.428 -179.312 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 80.0 p -69.95 -14.78 62.87 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.568 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 58.3 m -129.48 131.48 46.69 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.315 -179.985 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.3 t -124.55 112.7 17.15 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 178.63 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.499 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 40.6 tp -110.01 124.58 51.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.524 -178.749 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.734 ' CE2' HD12 ' A' ' 37' ' ' ILE . 5.5 m-85 -104.76 140.77 37.59 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.175 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -179.97 -176.08 47.12 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.001 -1.095 . . . . 0.0 112.428 179.507 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 31' ' ' ARG . 37.2 ttp180 -91.27 -10.01 43.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.928 0.394 . . . . 0.0 109.959 -179.933 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.434 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -93.86 154.53 21.64 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.763 -179.652 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.468 HG23 ' N ' ' A' ' 34' ' ' GLU . 11.3 tp -66.92 -40.84 86.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 179.435 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.468 ' N ' HG23 ' A' ' 33' ' ' ILE . 80.9 tt0 -46.92 -16.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.478 -179.968 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.435 ' N ' ' C ' ' A' ' 33' ' ' ILE . 2.8 m -83.19 145.14 29.34 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.764 -179.983 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.499 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 54.8 m-20 -58.85 -32.81 69.77 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -179.539 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.734 HD12 ' CE2' ' A' ' 29' ' ' PHE . 85.3 mt -129.04 124.54 60.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.314 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 36.0 ttp180 -108.47 138.71 44.32 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.541 -0.464 . . . . 0.0 111.228 -179.514 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 98.3 mt -121.23 132.54 70.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.125 0.488 . . . . 0.0 110.418 -179.915 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -76.38 29.19 0.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.35 -178.803 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.489 HD22 ' HZ ' ' B' ' 241' ' ' PHE . 38.2 mt -98.72 128.87 31.35 Favored Pre-proline 0 C--N 1.324 -0.523 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.476 179.736 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.89 -9.59 22.44 Favored 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 122.135 1.89 . . . . 0.0 111.345 179.316 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.5 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 31.4 m -97.43 5.5 9.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.804 -179.917 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 24.8 t -96.46 133.12 38.96 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-O 121.134 0.492 . . . . 0.0 110.058 179.272 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 28.7 m -72.21 160.93 31.6 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.944 -179.291 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.27 -39.31 89.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.832 -178.891 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.534 ' O ' ' N ' ' A' ' 49' ' ' CYS . 99.4 mm-40 -111.45 -9.81 14.21 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.903 0.382 . . . . 0.0 110.966 -179.549 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.606 ' CG ' ' HG ' ' A' ' 64' ' ' SER . 15.1 t60 15.36 -76.05 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -178.16 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.534 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.65 135.09 46.64 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 -177.613 . . . . . . . . 3 3 . 1 . 052 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -128.55 128.73 44.83 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.648 179.57 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.9 mt -112.84 133.5 58.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.364 179.796 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -116.81 125.27 51.34 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.34 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 87.5 mt -107.27 113.56 43.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.62 0.724 . . . . 0.0 111.812 -179.117 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.433 ' C ' ' N ' ' A' ' 56' ' ' GLN . 86.7 m-70 -109.68 141.77 41.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.442 -179.941 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 54' ' ' HIS . 94.3 mt-10 -42.72 -28.35 0.23 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.729 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.487 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 86.7 mt-30 -65.0 -69.44 0.29 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.642 178.791 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.487 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 4.4 tp10 -154.79 -174.56 5.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.762 -179.064 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -108.62 127.92 54.39 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.252 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 91.6 mt -119.18 132.17 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -178.512 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.618 HD22 ' CD1' ' A' ' 88' ' ' ILE . 26.1 tp -100.85 129.58 46.74 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.693 178.934 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -114.35 137.72 51.45 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.787 -179.601 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -98.42 104.28 16.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.266 -0.424 . . . . 0.0 112.11 -179.568 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -101.22 -5.31 25.72 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.518 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.606 ' HG ' ' CG ' ' A' ' 48' ' ' HIS . 0.2 OUTLIER -77.03 99.51 5.33 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.917 -179.844 . . . . . . . . 3 3 . 1 . 052 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.0 m -78.74 -31.72 46.43 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.311 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.62 ' O ' HG12 ' B' ' 236' ' ' VAL . 6.5 m -63.45 -49.0 75.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.596 -179.808 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.449 HD21 ' HA ' ' B' ' 236' ' ' VAL . 49.7 m-80 -150.61 100.93 3.1 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.002 -179.487 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -52.34 149.1 23.74 Favored 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 122.468 2.112 . . . . 0.0 112.843 -179.823 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 31.3 m -72.83 137.07 45.5 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.774 179.877 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -100.15 142.02 32.19 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.098 -179.972 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.418 ' O ' ' OG ' ' A' ' 74' ' ' SER . 54.6 t -130.36 134.04 63.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.932 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 51.59 33.01 9.88 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 119.684 -0.806 . . . . 0.0 109.497 179.99 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.68 29.51 67.5 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.344 179.402 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 24.0 p -140.92 133.49 28.6 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 117.486 0.643 . . . . 0.0 111.424 -179.96 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.1 t -69.93 139.18 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.092 179.978 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.55 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 1.2 pt -108.63 107.41 22.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.454 0.645 . . . . 0.0 111.213 179.551 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.432 ' O ' ' OE1' ' A' ' 78' ' ' GLU . 58.3 m-20 -65.64 -33.87 76.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.851 179.051 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.513 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.1 OUTLIER -128.45 -177.72 0.68 Allowed Pre-proline 0 N--CA 1.465 0.282 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.318 179.988 . . . . . . . . 3 3 . 1 . 052 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.513 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 39.7 Cg_exo -61.56 145.08 98.07 Favored 'Trans proline' 0 N--CA 1.499 1.822 0 C-N-CA 122.705 2.27 . . . . 0.0 112.441 179.75 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.2 t -133.21 136.55 54.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.587 179.426 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -73.24 131.19 41.66 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.161 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.441 HD11 ' HB2' ' A' ' 60' ' ' LEU . 90.3 mt -87.46 136.65 32.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.035 0.445 . . . . 0.0 111.279 -179.006 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.537 ' N ' ' OD2' ' A' ' 86' ' ' ASP . 99.2 mttt -125.36 152.26 45.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.953 -179.929 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.498 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 6.1 t60 -52.08 114.73 1.41 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.829 -179.317 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.95 -12.09 29.42 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 179.634 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.537 ' OD2' ' N ' ' A' ' 83' ' ' LYS . 97.5 m-20 -69.98 137.71 51.67 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.086 179.767 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 88.6 t -111.41 134.15 54.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.418 -178.573 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.618 ' CD1' HD22 ' A' ' 60' ' ' LEU . 37.5 mm -93.31 126.53 45.73 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 178.291 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 51.2 m -125.4 127.44 46.57 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.944 0.878 . . . . 0.0 113.08 -178.125 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.531 ' O ' ' C ' ' A' ' 91' ' ' ILE . 89.0 mt -111.76 133.95 55.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 113.933 -1.485 . . . . 0.0 108.043 178.739 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.531 ' C ' ' O ' ' A' ' 90' ' ' ILE . 74.3 mt 16.17 -83.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 O-C-N 123.65 0.594 . . . . 0.0 112.171 -177.333 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' A' ' 90' ' ' ILE . 46.6 t0 -120.7 8.18 10.59 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.593 -179.515 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.757 ' NH1' HH22 ' B' ' 245' ' ' ARG . 2.4 tpp180 -124.65 137.92 54.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.085 -179.784 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 91.0 p -140.79 158.7 43.58 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.577 0.703 . . . . 0.0 112.343 -178.711 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.512 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 87.3 m-85 -130.05 128.8 42.68 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.483 179.573 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.73 ' NH1' HD11 ' A' ' 10' ' ' ILE . 92.4 mtm-85 -87.55 132.97 33.86 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 119.591 -0.844 . . . . 0.0 111.168 -179.812 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -95.48 125.15 39.89 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.46 179.369 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.502 ' CD ' HH21 ' A' ' 6' ' ' ARG . 83.4 tt0 -126.52 121.68 33.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.623 179.931 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.498 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 64.7 t-20 . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.996 179.764 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo . . . . . 0 N--CA 1.482 0.821 0 CA-C-O 121.376 0.49 . . . . 0.0 112.892 . . . . . . . . . 0 0 . 1 . 052 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.62 HG12 ' O ' ' A' ' 66' ' ' THR . 24.8 m -65.67 153.31 8.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.602 -179.263 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 8.6 t . . . . . 0 C--N 1.328 -0.337 0 CA-C-O 121.214 0.531 . . . . 0.0 111.122 -178.629 . . . . . . . . 0 0 . 1 . 052 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo . . . . . 0 N--CA 1.498 1.769 0 N-CA-C 112.826 0.279 . . . . 0.0 112.826 . . . . . . . . . 0 0 . 1 . 052 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 84.2 m -74.21 -40.21 62.6 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.202 0.525 . . . . 0.0 109.595 178.017 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.5 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 92.1 t80 -58.5 -48.06 82.04 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.751 -179.227 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' B' ' 242' ' ' LEU . 86.9 mt -63.5 -42.27 98.53 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 120.858 0.361 . . . . 0.0 111.32 179.86 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -66.17 -36.72 83.83 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.451 -179.471 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -61.24 -44.06 97.86 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.454 -0.499 . . . . 0.0 109.808 179.416 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.757 HH22 ' NH1' ' A' ' 93' ' ' ARG . 2.9 mtt-85 -59.9 -41.13 90.97 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.871 0.367 . . . . 0.0 110.432 179.776 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -61.77 -43.05 99.62 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.354 179.505 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 10.5 t -64.26 -45.41 88.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.284 0.564 . . . . 0.0 109.687 178.958 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 28.7 mm100 -62.01 -35.69 79.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.977 -179.363 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' B' B ' 249' ' ' VAL . . . . . 0.457 HG23 ' O ' ' B' ' 245' ' ' ARG . 44.8 t . . . . . 0 C--N 1.331 -0.22 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.677 179.357 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 . . . . . 0 CA--C 1.531 0.245 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 . . . . . . . . . 0 0 . 1 . 052 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.56 HD11 ' HD2' ' A' ' 93' ' ' ARG . 75.1 mt -118.23 131.37 71.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.061 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 53.6 t -125.23 132.37 71.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.575 179.81 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -96.18 115.75 27.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.2 -178.927 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -65.53 -46.7 78.57 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.747 179.289 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -87.25 150.39 49.27 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.13 -178.957 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.13 142.98 63.26 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.327 2.018 . . . . 0.0 112.254 -179.745 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 44.5 pt . . . . . 0 C--N 1.327 -0.396 0 CA-C-O 121.148 0.499 . . . . 0.0 109.841 179.114 . . . . . . . . 0 0 . 1 . 053 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.0 p . . . . . 0 N--CA 1.456 -0.173 0 CA-C-O 120.953 0.406 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 053 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.968 ' NH2' HD11 ' A' ' 53' ' ' ILE . 15.0 mtm180 -93.69 128.84 40.08 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.564 -179.086 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.7 mtp180 -126.94 139.15 53.27 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.155 0.502 . . . . 0.0 111.456 179.74 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.578 HD11 ' HB3' ' A' ' 95' ' ' PHE . 32.3 tp -112.51 132.83 54.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.057 -179.6 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.0 t -109.45 129.68 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.822 0.344 . . . . 0.0 110.648 179.982 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.475 HG23 ' CD1' ' B' ' 261' ' ' ILE . 3.8 m -86.28 111.93 20.91 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.715 -179.368 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 79.5 mt -80.42 142.76 13.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.15 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -93.56 159.02 15.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.992 0.425 . . . . 0.0 111.587 179.994 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.425 ' HB3' HG21 ' B' ' 249' ' ' VAL . 89.9 mtm180 -59.12 -29.8 67.66 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.417 179.682 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.4 m -75.51 -15.41 60.4 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.43 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.8 31.83 7.18 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -179.86 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.7 t -119.66 131.17 72.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.835 0.35 . . . . 0.0 110.911 -179.496 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -74.96 139.42 42.98 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.436 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.84 -115.57 1.65 Allowed Glycine 0 CA--C 1.534 1.227 0 C-N-CA 120.118 -1.039 . . . . 0.0 112.11 -179.355 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.71 146.68 43.65 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.264 1.976 . . . . 0.0 112.909 -178.717 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -109.77 146.9 34.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.031 -179.622 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.764 ' CD2' HD11 ' A' ' 37' ' ' ILE . 40.3 t80 -117.27 101.29 53.03 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.584 -179.813 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -72.47 127.35 12.44 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 121.714 1.61 . . . . 0.0 111.546 -178.743 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.606 HD13 ' NH2' ' A' ' 5' ' ' ARG . 62.6 mt -78.02 52.29 1.06 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.985 -178.555 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.6 p -61.83 -33.28 73.87 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.398 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 68.6 mt -74.06 141.87 45.69 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.818 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 94.7 p -67.07 -16.61 64.45 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.879 0.371 . . . . 0.0 110.814 -179.35 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 56.4 m -130.83 132.46 45.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.962 -179.992 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.661 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 2.6 t -128.25 120.04 26.38 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.828 179.471 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.667 HD21 ' OE1' ' A' ' 47' ' ' GLN . 27.6 tp -120.15 130.98 54.85 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.541 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.661 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 35.6 m-85 -108.15 144.29 35.75 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.826 179.92 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 149.23 -178.92 26.44 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 120.928 -0.654 . . . . 0.0 112.074 177.929 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.413 ' HD2' HH11 ' A' ' 31' ' ' ARG . 45.6 mtm180 -69.72 -32.88 71.68 Favored 'General case' 0 CA--C 1.522 -0.119 0 CA-C-O 120.936 0.398 . . . . 0.0 111.256 178.76 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.562 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -52.78 135.68 38.26 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -178.813 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.435 ' C ' ' N ' ' A' ' 35' ' ' CYS . 80.1 mt -63.89 -43.45 97.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.48 179.419 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -51.48 -18.9 1.2 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.406 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.562 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 13.9 m -68.79 129.13 39.04 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.718 179.037 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -60.42 -28.63 68.42 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.689 -179.103 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.764 HD11 ' CD2' ' A' ' 20' ' ' PHE . 48.2 mm -122.5 116.0 47.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.9 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -100.79 131.44 46.68 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.678 -179.39 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.629 HG21 HD12 ' A' ' 41' ' ' LEU . 91.8 mt -119.52 130.36 74.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.205 -0.598 . . . . 0.0 109.798 -179.549 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -78.04 27.81 0.18 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.207 -178.594 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.712 ' O ' HG12 ' A' ' 44' ' ' VAL . 16.0 mt -95.3 110.73 52.1 Favored Pre-proline 0 C--N 1.325 -0.483 0 C-N-CA 120.592 -0.443 . . . . 0.0 109.827 179.769 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -56.55 -12.05 7.79 Favored 'Trans proline' 0 N--CA 1.499 1.809 0 C-N-CA 122.115 1.877 . . . . 0.0 113.223 -179.266 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.471 HG23 HG13 ' A' ' 91' ' ' ILE . 6.6 m -102.64 9.14 9.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -178.888 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.712 HG12 ' O ' ' A' ' 41' ' ' LEU . 8.8 p -103.3 106.59 20.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.021 179.894 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.532 ' O ' ' O ' ' A' ' 44' ' ' VAL . 0.4 OUTLIER -34.05 167.08 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 114.911 -1.04 . . . . 0.0 113.122 -178.109 . . . . . . . . 3 3 . 1 . 053 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -62.37 -42.82 99.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.471 -178.723 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.667 ' OE1' HD21 ' A' ' 28' ' ' LEU . 88.0 mm-40 -111.97 -20.03 12.14 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.421 -179.445 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.463 ' NE2' HG23 ' A' ' 90' ' ' ILE . 24.6 t60 36.55 -75.26 0.0 OUTLIER 'General case' 0 C--O 1.236 0.361 0 CA-C-N 114.89 -1.05 . . . . 0.0 113.493 179.685 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.66 ' O ' HD12 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -133.27 135.91 45.21 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.759 -178.118 . . . . . . . . 3 3 . 1 . 053 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -128.56 134.82 48.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.776 179.809 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.0 mt -117.05 132.73 65.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.21 179.701 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -118.56 127.24 53.43 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.647 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.968 HD11 ' NH2' ' A' ' 5' ' ' ARG . 86.7 mt -102.72 116.27 46.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.487 0.66 . . . . 0.0 111.593 -179.562 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.448 ' O ' ' C ' ' A' ' 55' ' ' GLU . 79.6 m-70 -111.83 139.04 47.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.114 -179.921 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 54' ' ' HIS . 97.6 mt-10 -40.55 -34.69 0.38 Allowed 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.654 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -60.73 -67.96 0.35 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.832 178.599 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -155.63 -171.89 3.94 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.286 0.565 . . . . 0.0 111.571 -179.03 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.18 128.17 54.81 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.668 179.18 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.4 mt -125.48 133.53 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -178.77 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.415 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 16.5 tp -97.89 131.68 44.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.138 179.024 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -113.35 136.2 53.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.959 179.992 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -97.97 104.1 16.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.37 -179.921 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -95.99 -8.7 33.0 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.17 179.636 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.09 109.58 7.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.933 0.397 . . . . 0.0 111.364 -179.579 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.7 p -90.44 -18.07 26.05 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.07 179.022 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.8 HG22 HG22 ' B' ' 236' ' ' VAL . 0.2 OUTLIER -87.91 -40.88 13.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.221 -179.901 . . . . . . . . 3 3 . 1 . 053 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -145.67 99.1 4.45 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.47 -179.766 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -57.86 147.49 81.02 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 122.049 1.833 . . . . 0.0 112.779 179.99 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.0 m -68.08 137.17 54.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.884 179.519 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -98.52 143.62 28.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.977 179.353 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.773 ' HB ' HD11 ' A' ' 76' ' ' ILE . 5.1 p -130.82 137.9 54.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.342 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 50.58 31.84 6.11 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.946 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.91 28.68 68.29 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.355 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.414 ' N ' ' O ' ' A' ' 71' ' ' VAL . 14.8 t -137.97 135.29 35.86 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.846 0.355 . . . . 0.0 111.357 -179.726 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.4 p -61.73 143.03 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.914 -179.207 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.773 HD11 ' HB ' ' A' ' 71' ' ' VAL . 96.5 mt -108.3 106.01 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.931 -179.855 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -68.74 -42.04 78.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.428 179.067 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.55 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.7 OUTLIER -135.01 -179.92 1.21 Allowed Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.522 -178.774 . . . . . . . . 3 3 . 1 . 053 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.473 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 32.1 Cg_exo -57.48 146.94 81.25 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.631 2.221 . . . . 0.0 112.699 -179.595 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 18.2 m -139.67 142.81 31.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.48 -179.315 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.538 HH21 ' CE ' ' A' ' 83' ' ' LYS . 61.2 ttp180 -76.07 131.28 39.37 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.579 179.013 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.3 mt -80.61 135.5 36.07 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-O 121.148 0.499 . . . . 0.0 111.69 -179.413 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.538 ' CE ' HH21 ' A' ' 81' ' ' ARG . 99.0 mttt -129.07 150.57 50.41 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.868 178.937 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.481 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 6.3 t60 -55.3 115.72 2.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.831 0.348 . . . . 0.0 111.748 -179.172 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.24 -18.75 18.09 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.936 -0.65 . . . . 0.0 111.595 179.016 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -69.52 136.37 51.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.34 0.591 . . . . 0.0 110.608 179.913 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.8 t -114.5 131.24 67.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.04 -179.014 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 92.8 mt -97.23 132.26 42.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.645 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.8 m -118.55 124.92 48.71 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.338 -178.544 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.474 ' O ' ' N ' ' A' ' 92' ' ' ASP . 78.0 mt -112.38 126.96 69.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.134 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.743 HG22 ' NH2' ' B' ' 245' ' ' ARG . 33.8 mm 38.74 -97.09 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -178.749 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.546 ' CB ' HH22 ' B' ' 245' ' ' ARG . 44.2 t0 -123.09 17.45 10.0 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.097 0.475 . . . . 0.0 110.494 178.883 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.454 ' HG3' HD11 ' A' ' 41' ' ' LEU . 29.7 mmm-85 -122.96 138.78 54.59 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.855 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.3 m -135.04 151.59 50.92 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.87 -179.248 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.578 ' HB3' HD11 ' A' ' 7' ' ' LEU . 88.6 m-85 -122.62 120.83 34.9 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.246 179.271 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.52 ' O ' HD12 ' A' ' 7' ' ' LEU . 38.9 ttp-105 -81.16 130.55 35.07 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.831 -179.671 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -97.69 125.55 42.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.035 -179.917 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -128.15 129.25 46.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.327 -179.956 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.481 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 60.5 t-20 . . . . . 0 N--CA 1.464 0.227 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.778 -179.411 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo . . . . . 0 N--CA 1.485 0.972 0 CA-C-O 121.179 0.408 . . . . 0.0 111.846 . . . . . . . . . 0 0 . 1 . 053 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.8 HG22 HG22 ' A' ' 66' ' ' THR . 15.7 t -98.84 128.38 50.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.206 -179.744 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 5.7 t . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.548 -179.848 . . . . . . . . 0 0 . 1 . 053 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo . . . . . 0 N--CA 1.495 1.577 0 N-CA-C 113.115 0.39 . . . . 0.0 113.115 . . . . . . . . . 0 0 . 1 . 053 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 96.0 m -72.88 -45.66 57.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.288 0.566 . . . . 0.0 109.779 179.123 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.433 ' CE2' ' NE ' ' B' ' 245' ' ' ARG . 80.3 t80 -57.38 -44.42 84.42 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.968 -179.722 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.491 HD23 HH21 ' B' ' 245' ' ' ARG . 97.0 mt -63.51 -41.83 98.5 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.641 -179.796 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -66.31 -37.23 84.91 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.707 0.289 . . . . 0.0 111.108 -179.497 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 78.2 ttt-85 -63.1 -47.62 82.07 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.636 -179.429 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.743 ' NH2' HG22 ' A' ' 91' ' ' ILE . 55.9 mtm180 -65.53 -39.3 91.62 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.621 -179.585 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -59.79 -40.3 87.85 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.325 179.991 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 28.2 m -68.22 -42.83 79.19 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.5 0.667 . . . . 0.0 109.587 178.301 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -62.54 -36.26 82.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.862 179.731 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' B' B ' 249' ' ' VAL . . . . . 0.671 HG23 ' O ' ' B' ' 245' ' ' ARG . 95.0 t . . . . . 0 N--CA 1.451 -0.387 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.961 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 . . . . . 0 CA--C 1.536 0.432 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 . . . . . . . . . 0 0 . 1 . 053 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.475 ' CD1' HG23 ' A' ' 9' ' ' THR . 76.7 mt -112.18 134.6 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 119.101 0.864 . . . . 0.0 109.571 178.814 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 40.4 t -127.74 134.11 66.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.993 -179.74 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -94.33 115.14 27.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.662 -179.016 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -66.3 -46.92 75.31 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.628 179.78 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.09 155.16 43.19 Favored Pre-proline 0 N--CA 1.454 -0.267 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.708 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -63.0 141.77 85.24 Favored 'Trans proline' 0 C--N 1.302 -1.906 0 C-N-CA 122.86 2.373 . . . . 0.0 113.085 179.965 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 37.4 pt . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.607 178.355 . . . . . . . . 0 0 . 1 . 054 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.489 ' O ' ' O ' ' A' ' 99' ' ' ASN . 23.8 m . . . . . 0 N--CA 1.464 0.258 0 N-CA-C 111.787 0.292 . . . . 0.0 111.787 . . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.522 ' CZ ' HG23 ' A' ' 53' ' ' ILE . 86.2 mtt85 -82.31 134.24 35.26 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.906 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -131.14 139.06 49.74 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 120.266 -0.573 . . . . 0.0 111.984 -179.075 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 34.2 mt -115.75 133.65 55.81 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.958 179.948 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.55 HG13 ' CE1' ' A' ' 19' ' ' HIS . 76.3 t -107.25 127.61 62.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.349 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 m -91.01 114.75 27.35 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 112.943 0.719 . . . . 0.0 112.943 -177.31 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.743 HD12 ' OG ' ' A' ' 94' ' ' SER . 92.6 mt -80.99 141.9 14.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.645 179.242 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -90.43 159.54 16.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.063 0.458 . . . . 0.0 110.748 179.157 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.516 HH22 ' HB2' ' B' ' 248' ' ' GLN . 81.3 mtp180 -58.77 -32.75 69.58 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.405 -179.426 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.7 p -74.45 -13.62 60.73 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.584 179.674 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.26 29.91 7.28 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -179.745 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.3 t -117.58 130.17 72.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.721 0.296 . . . . 0.0 111.205 -179.494 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -73.62 139.26 45.37 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 177.773 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.2 -112.8 1.43 Allowed Glycine 0 CA--C 1.53 0.978 0 C-N-CA 120.161 -1.018 . . . . 0.0 112.232 -179.088 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -73.45 144.8 36.91 Favored 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 122.138 1.892 . . . . 0.0 113.009 -178.524 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.55 ' CE1' HG13 ' A' ' 8' ' ' VAL . 3.9 m-70 -104.0 135.58 45.26 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.453 179.662 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.876 ' CD2' HD11 ' A' ' 37' ' ' ILE . 47.4 t80 -106.07 91.97 6.05 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.024 -179.274 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -72.95 139.27 29.83 Favored 'Trans proline' 0 N--CA 1.488 1.193 0 C-N-CA 121.634 1.556 . . . . 0.0 111.352 -179.33 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 86.2 mt -101.31 124.03 46.36 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.423 -178.592 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 65.3 p -117.37 -8.93 10.99 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.602 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 54.9 mt -101.73 149.78 23.81 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.587 -179.083 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 97.3 p -70.18 -12.14 61.39 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.27 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.434 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 41.9 m -132.35 133.98 44.64 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.257 -0.577 . . . . 0.0 111.89 -179.544 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 10.0 t -125.25 116.46 22.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.323 -0.853 . . . . 0.0 108.901 178.384 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.705 HD21 ' OE1' ' A' ' 47' ' ' GLN . 52.1 tp -116.88 132.8 56.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.997 -178.04 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.499 ' O ' ' O ' ' A' ' 47' ' ' GLN . 42.1 m-85 -110.16 136.67 49.02 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.366 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 164.48 -166.79 38.04 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 120.111 -1.042 . . . . 0.0 112.344 179.541 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.645 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 85.4 mtm-85 -89.27 -29.03 19.5 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 115.606 -0.297 . . . . 0.0 110.462 179.581 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.461 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -57.23 153.1 23.49 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 121.273 -0.489 . . . . 0.0 112.715 -177.73 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.525 ' CD1' ' NH1' ' A' ' 38' ' ' ARG . 9.4 tp -66.55 -41.87 89.12 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 N-CA-C 110.356 -0.238 . . . . 0.0 110.356 179.389 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.488 ' N ' HG23 ' A' ' 33' ' ' ILE . 50.9 tp10 -56.49 -27.07 56.16 Favored 'General case' 0 N--CA 1.461 0.124 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.647 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.461 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 19.3 m -54.54 122.75 11.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.693 179.701 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.462 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 55.5 m-20 -60.87 -33.35 72.95 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -179.566 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.876 HD11 ' CD2' ' A' ' 20' ' ' PHE . 44.0 mm -119.1 109.91 28.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 177.792 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.525 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 84.9 mtp180 -98.21 134.83 40.71 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -179.097 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 98.1 mt -120.42 132.34 70.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.028 -179.922 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -76.11 29.11 0.11 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.498 -0.773 . . . . 0.0 112.113 -178.495 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.57 HD12 ' CZ ' ' A' ' 93' ' ' ARG . 44.9 mt -106.12 130.07 23.56 Favored Pre-proline 0 CA--C 1.534 0.348 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.448 178.973 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.25 -12.65 25.49 Favored 'Trans proline' 0 N--CA 1.49 1.268 0 C-N-CA 122.448 2.099 . . . . 0.0 112.736 -179.455 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.479 HG21 ' CE2' ' B' ' 241' ' ' PHE . 30.7 m -92.57 -0.61 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.695 179.851 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.645 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 46.1 t -86.71 132.83 31.36 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.452 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.014 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.6 m -70.15 167.96 16.67 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.331 0.586 . . . . 0.0 111.22 -178.588 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt -62.64 -40.55 97.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.703 -178.872 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.705 ' OE1' HD21 ' A' ' 28' ' ' LEU . 95.4 mm-40 -115.38 -20.9 10.09 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.928 0.394 . . . . 0.0 110.483 -179.568 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.3 t60 34.05 -74.52 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -179.947 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.652 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.99 136.92 46.33 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -177.97 . . . . . . . . 3 3 . 1 . 054 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -128.23 132.2 48.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.861 179.558 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.9 mt -116.59 134.09 61.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.69 179.901 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -111.21 129.01 56.09 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.957 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.522 HG23 ' CZ ' ' A' ' 5' ' ' ARG . 47.9 mm -100.16 118.6 47.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.304 0.573 . . . . 0.0 111.253 -179.138 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.452 ' O ' ' C ' ' A' ' 55' ' ' GLU . 98.0 m-70 -119.86 130.79 55.04 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.915 179.296 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' A' ' 54' ' ' HIS . 81.8 tt0 -40.83 -31.35 0.16 Allowed 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -179.866 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.458 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 98.4 mm-40 -64.82 -67.76 0.41 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.94 178.649 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.459 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 5.5 tp10 -153.49 -170.51 3.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.0 -179.481 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.459 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -118.43 128.41 54.59 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.513 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.0 mt -114.51 130.67 68.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.134 0.492 . . . . 0.0 112.23 -178.732 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.525 ' HB2' HD11 ' A' ' 82' ' ' LEU . 26.7 tp -99.56 128.88 45.68 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.471 179.996 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -112.7 136.7 51.98 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.742 179.649 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.539 HD21 ' CA ' ' A' ' 68' ' ' PRO . 59.5 t-20 -95.96 110.32 22.55 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.403 -178.763 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -103.94 -7.92 20.03 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 179.84 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.559 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 97.9 p -81.37 98.48 8.21 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.18 -179.419 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.3 m -74.64 -38.86 62.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.449 0.642 . . . . 0.0 109.482 178.427 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p -65.46 -39.21 91.74 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.342 -179.629 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.559 ' O ' ' OG ' ' A' ' 64' ' ' SER . 54.2 m-80 -146.18 92.79 5.2 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.424 -179.53 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.539 ' CA ' HD21 ' A' ' 62' ' ' ASN . 46.8 Cg_exo -54.22 145.98 52.14 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.541 2.16 . . . . 0.0 111.873 -179.072 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.442 ' HB ' HD11 ' A' ' 76' ' ' ILE . 17.7 m -70.87 150.6 45.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.956 179.665 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -117.23 140.16 49.88 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.777 -179.768 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 48.9 t -130.92 134.86 61.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.353 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 29.9 m120 51.79 32.32 9.44 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -179.37 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.27 27.06 68.86 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.957 179.688 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.9 t -140.15 138.05 34.9 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 117.359 0.579 . . . . 0.0 111.599 179.864 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.479 HG13 ' HB2' ' A' ' 68' ' ' PRO . 10.9 t -68.67 140.68 18.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.685 179.958 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.442 HD11 ' HB ' ' A' ' 69' ' ' THR . 7.0 pt -112.08 84.33 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.949 179.403 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -61.91 -32.17 72.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.449 179.532 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -118.46 168.21 10.01 Favored Pre-proline 0 CA--C 1.531 0.249 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.534 179.587 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.71 145.09 99.09 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 122.205 1.936 . . . . 0.0 112.52 179.965 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.2 p -138.9 140.0 39.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.986 179.652 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.6 mtm-85 -73.25 131.46 41.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.846 179.243 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.525 HD11 ' HB2' ' A' ' 60' ' ' LEU . 95.8 mt -84.95 137.57 33.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.114 0.483 . . . . 0.0 111.58 -179.136 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -126.95 151.06 49.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.563 179.028 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -56.94 123.28 14.56 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.849 -179.736 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.26 -21.76 28.29 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 179.592 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -69.24 138.47 53.99 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.023 0.44 . . . . 0.0 110.513 179.784 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.2 t -111.75 131.1 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.85 -177.928 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.7 mt -93.01 134.32 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.117 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 94.5 m -126.55 126.5 43.78 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 119.933 -0.707 . . . . 0.0 112.492 -179.026 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.577 ' O ' ' N ' ' A' ' 92' ' ' ASP . 89.6 mt -110.48 125.66 67.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.085 -0.961 . . . . 0.0 108.695 178.367 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.518 HD12 HH22 ' A' ' 93' ' ' ARG . 89.2 mt 38.85 -91.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.113 -179.087 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.577 ' N ' ' O ' ' A' ' 90' ' ' ILE . 42.7 t0 -126.8 21.17 7.0 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.385 179.82 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.632 ' NH1' HH12 ' B' ' 245' ' ' ARG . 50.4 mtm-85 -129.01 143.39 50.85 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.321 -179.607 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.743 ' OG ' HD12 ' A' ' 10' ' ' ILE . 28.9 p -139.61 153.87 47.45 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 119.796 -0.762 . . . . 0.0 111.729 179.634 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -123.38 121.6 36.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.623 178.439 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -74.24 126.57 30.91 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.373 -179.534 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.49 ' CE2' ' OD1' ' A' ' 99' ' ' ASN . 92.0 t80 -94.51 121.42 36.04 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.929 0.395 . . . . 0.0 110.719 -179.972 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -131.63 116.57 17.54 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.725 -179.959 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.49 ' OD1' ' CE2' ' A' ' 97' ' ' TYR . 91.5 m-20 . . . . . 0 C--N 1.33 -0.244 0 CA-C-O 120.974 0.416 . . . . 0.0 111.044 179.905 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo . . . . . 0 N--CA 1.489 1.231 0 CA-C-O 121.706 0.628 . . . . 0.0 112.814 . . . . . . . . . 0 0 . 1 . 054 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.541 HG13 ' O ' ' B' ' 236' ' ' VAL . 13.1 p -79.5 125.29 38.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.716 179.26 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.9 t . . . . . 0 C--N 1.331 -0.226 0 C-N-CA 120.502 -0.479 . . . . 0.0 109.845 -179.795 . . . . . . . . 0 0 . 1 . 054 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo . . . . . 0 N--CA 1.491 1.371 0 N-CA-C 111.284 -0.314 . . . . 0.0 111.284 . . . . . . . . . 0 0 . 1 . 054 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 79.8 m -74.79 -43.85 52.59 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 177.764 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.479 ' CE2' HG21 ' A' ' 43' ' ' VAL . 88.3 t80 -57.52 -46.54 83.69 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.994 -179.584 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 92.5 mt -64.0 -41.62 97.42 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.259 -179.938 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.8 -39.5 87.77 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.99 -179.901 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' B' B ' 244' ' ' ARG . . . . . 0.499 ' O ' ' OG ' ' B' ' 247' ' ' SER . 62.8 ttp180 -60.51 -43.97 96.5 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.943 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.632 HH12 ' NH1' ' A' ' 93' ' ' ARG . 79.3 mtp180 -61.77 -40.1 93.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.553 -179.508 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.21 -38.22 85.81 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 120.504 -0.478 . . . . 0.0 109.853 179.127 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' B' B ' 247' ' ' SER . . . . . 0.499 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 80.2 p -68.62 -42.57 77.9 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 178.389 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' B' B ' 248' ' ' GLN . . . . . 0.516 ' HB2' HH22 ' A' ' 12' ' ' ARG . 82.5 mt-30 -61.89 -35.59 78.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.536 179.568 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 22.5 t . . . . . 0 C--N 1.33 -0.25 0 CA-C-O 120.941 0.401 . . . . 0.0 110.159 179.221 . . . . . . . . 0 0 . 1 . 054 nuclear build core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 . . . . . 0 CA--C 1.537 0.451 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 . . . . . . . . . 0 0 . 1 . 054 nuclear build core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 60.0 mt -110.42 137.19 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 120.516 -0.474 . . . . 0.0 109.867 179.722 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 44.7 t -126.89 134.63 65.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.731 179.465 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -94.14 117.25 29.84 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.462 -178.85 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -67.93 -47.99 67.17 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.15 -179.985 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -82.62 157.99 66.36 Favored Pre-proline 0 CA--C 1.516 -0.354 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.681 -179.123 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.82 138.54 49.01 Favored 'Trans proline' 0 C--N 1.301 -1.933 0 C-N-CA 122.5 2.133 . . . . 0.0 112.641 179.586 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 1.4 pt . . . . . 0 C--N 1.325 -0.491 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.259 178.522 . . . . . . . . 0 0 . 1 . 055 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 78.9 p . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.933 0.397 . . . . 0.0 110.73 . . . . . . . . . 0 0 . 1 . 055 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.787 ' NH1' ' HB2' ' A' ' 58' ' ' ALA . 96.0 mtt-85 -96.24 117.77 31.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.594 -179.53 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.596 ' HE ' ' CE1' ' A' ' 19' ' ' HIS . 85.6 mtp180 -131.37 139.02 49.4 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.054 0.454 . . . . 0.0 111.601 179.877 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.628 HD12 ' O ' ' A' ' 96' ' ' ARG . 37.1 tp -114.26 128.88 56.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.486 179.519 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 64.4 t -108.68 131.6 58.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.694 -0.403 . . . . 0.0 110.026 -179.684 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.403 HG21 HD12 ' B' ' 261' ' ' ILE . 18.3 m -82.56 152.23 26.06 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.601 0.715 . . . . 0.0 112.181 -178.714 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.413 HD12 ' HB3' ' A' ' 94' ' ' SER . 96.5 mt -120.08 140.2 44.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.101 177.46 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 73.0 mttt -89.05 157.12 18.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.17 0.509 . . . . 0.0 110.501 179.551 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.562 ' NH2' ' O ' ' B' ' 245' ' ' ARG . 79.3 mtp180 -56.35 -31.03 63.39 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.665 -179.758 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.3 m -77.83 -9.33 58.99 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.764 -0.375 . . . . 0.0 110.339 179.589 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.83 38.98 5.35 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 179.878 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.4 t -124.09 133.42 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 120.92 0.39 . . . . 0.0 111.64 -179.692 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -76.71 138.66 40.12 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.078 178.939 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -134.47 -116.43 1.65 Allowed Glycine 0 CA--C 1.538 1.508 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.965 -179.521 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.95 152.09 45.95 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 122.499 2.133 . . . . 0.0 113.096 -179.163 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.596 ' CE1' ' HE ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -116.14 158.77 22.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.935 0.397 . . . . 0.0 110.48 179.904 . . . . . . . . 3 3 . 1 . 055 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.663 ' CD2' HD11 ' A' ' 37' ' ' ILE . 36.9 t80 -124.15 108.38 29.9 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.589 -179.382 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -75.58 127.95 10.67 Favored 'Trans proline' 0 N--CA 1.488 1.201 0 C-N-CA 121.605 1.537 . . . . 0.0 111.361 -179.196 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 61.6 mt -82.86 49.41 1.5 Allowed 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.137 -178.808 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.6 t -63.1 -32.5 73.9 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 178.75 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 68.5 mt -70.77 142.25 51.4 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.831 179.711 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.5 m -63.87 -22.96 67.16 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.507 -179.289 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.3 m -133.27 133.93 43.27 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.953 -179.761 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.676 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 3.0 t -127.14 114.87 18.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.81 179.664 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.588 HD21 ' OE1' ' A' ' 47' ' ' GLN . 54.2 tp -111.55 125.69 54.19 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.228 -178.741 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.676 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 18.4 m-85 -100.69 128.51 46.71 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 177.93 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 179.26 -155.86 17.01 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 120.027 -1.082 . . . . 0.0 112.309 -179.588 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.599 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 81.8 mtm-85 -109.98 -25.23 10.37 Favored 'General case' 0 N--CA 1.46 0.067 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.074 179.902 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.48 161.29 21.92 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.194 -0.763 . . . . 0.0 111.194 -179.13 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.508 HD12 ' NH1' ' A' ' 38' ' ' ARG . 10.9 tp -67.38 -39.44 82.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.949 0.404 . . . . 0.0 110.418 179.959 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.427 ' N ' HG23 ' A' ' 33' ' ' ILE . 97.7 mt-10 -57.48 -31.58 66.11 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.109 -179.981 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.3 m -50.81 120.64 4.97 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.022 179.803 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -60.71 -33.4 72.83 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.406 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.663 HD11 ' CD2' ' A' ' 20' ' ' PHE . 96.4 mt -124.94 116.92 48.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.395 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.508 ' NH1' HD12 ' A' ' 33' ' ' ILE . 83.9 mtp180 -103.31 137.26 41.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.507 -177.927 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.644 HG21 HD12 ' A' ' 41' ' ' LEU . 92.7 mt -120.22 131.34 72.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.534 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -73.83 25.98 0.07 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.651 -178.234 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.644 HD12 HG21 ' A' ' 39' ' ' ILE . 15.1 mt -101.68 122.95 45.84 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.647 179.947 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.9 -8.68 21.57 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 122.295 1.997 . . . . 0.0 112.144 -179.753 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.2 m -92.91 0.74 9.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.656 179.325 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.599 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 93.7 t -98.27 103.47 14.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.858 179.449 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.538 ' O ' ' O ' ' A' ' 44' ' ' VAL . 1.4 t -34.11 162.11 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.451 0.643 . . . . 0.0 112.022 -178.846 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -60.69 -41.85 95.97 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.019 -0.992 . . . . 0.0 112.175 -178.371 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.588 ' OE1' HD21 ' A' ' 28' ' ' LEU . 90.8 mm-40 -107.67 -18.04 13.94 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.556 0.693 . . . . 0.0 109.902 179.589 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.0 t60 37.22 -78.16 0.0 OUTLIER 'General case' 0 C--O 1.239 0.53 0 CA-C-N 114.541 -1.209 . . . . 0.0 113.738 179.901 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.584 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -134.54 139.23 45.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.115 0.483 . . . . 0.0 112.072 -178.455 . . . . . . . . 3 3 . 1 . 055 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -129.15 125.26 36.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.555 179.594 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.5 mt -109.32 133.79 53.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.102 179.863 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.458 ' CD ' ' NE2' ' A' ' 54' ' ' HIS . 74.5 tt0 -113.17 126.37 55.37 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.324 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.8 mm -98.63 118.61 45.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.325 0.583 . . . . 0.0 112.141 -178.201 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.492 ' O ' ' N ' ' A' ' 56' ' ' GLN . 96.5 m-70 -119.46 132.22 55.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.375 178.411 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.469 ' C ' ' O ' ' A' ' 54' ' ' HIS . 76.0 tt0 -40.72 -28.37 0.07 Allowed 'General case' 0 CA--C 1.518 -0.25 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.719 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.492 ' N ' ' O ' ' A' ' 54' ' ' HIS . 86.0 mt-30 -66.41 -68.47 0.37 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.329 178.387 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.491 ' CB ' ' HE ' ' A' ' 81' ' ' ARG . 1.4 pt-20 -156.12 -168.81 2.86 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.843 -179.307 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.787 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -114.52 128.66 56.45 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.039 179.474 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.2 mt -116.85 127.94 74.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.2 0.524 . . . . 0.0 111.157 -179.748 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.2 tp -95.92 129.18 43.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.507 -179.69 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -115.68 136.32 53.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.984 179.636 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.592 HD22 ' HA ' ' A' ' 68' ' ' PRO . 52.6 t30 -99.4 110.53 23.01 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.121 179.935 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -99.59 -8.38 24.56 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 120.856 0.36 . . . . 0.0 110.55 179.365 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.0 t -76.17 99.05 4.57 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.063 179.964 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 45.9 t -75.09 -44.59 46.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.663 0.744 . . . . 0.0 109.527 178.463 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.683 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -62.83 -43.36 98.99 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.495 -1.23 . . . . 0.0 111.021 -179.17 . . . . . . . . 3 3 . 1 . 055 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -143.39 97.07 5.65 Favored Pre-proline 0 N--CA 1.468 0.436 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.216 -179.792 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.592 ' HA ' HD22 ' A' ' 62' ' ' ASN . 31.5 Cg_exo -57.84 146.3 86.75 Favored 'Trans proline' 0 N--CA 1.499 1.844 0 C-N-CA 122.294 1.996 . . . . 0.0 112.963 179.553 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.436 ' CG2' HG23 ' A' ' 88' ' ' ILE . 29.1 m -69.34 137.05 52.58 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.068 178.927 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -98.69 140.16 33.32 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.548 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.622 ' HB ' HD11 ' A' ' 76' ' ' ILE . 25.2 t -132.96 137.12 54.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.359 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 54.61 33.59 19.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.136 0.494 . . . . 0.0 109.914 -179.34 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.73 30.24 66.42 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.952 179.473 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.2 m -145.16 140.35 27.9 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 117.464 0.632 . . . . 0.0 112.193 -179.505 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.414 HG13 ' HB2' ' A' ' 68' ' ' PRO . 25.2 t -70.44 136.23 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.677 179.944 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.622 HD11 ' HB ' ' A' ' 71' ' ' VAL . 88.6 mt -107.81 117.69 53.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.495 179.943 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -89.16 -29.13 19.55 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.68 178.928 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.562 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.0 OUTLIER -126.03 166.61 20.49 Favored Pre-proline 0 N--CA 1.467 0.401 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.122 -178.947 . . . . . . . . 3 3 . 1 . 055 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.07 148.96 91.36 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 122.469 2.112 . . . . 0.0 112.354 -179.946 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.2 m -141.41 151.55 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 121.354 0.597 . . . . 0.0 112.605 -179.559 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.491 ' HE ' ' CB ' ' A' ' 57' ' ' GLU . 74.6 ttt180 -78.13 128.31 33.6 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.543 179.066 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.482 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 96.9 mt -81.64 134.03 35.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.119 0.485 . . . . 0.0 111.229 -179.625 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -128.39 152.12 48.56 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.117 179.265 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -53.8 117.76 3.42 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.489 -179.535 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.62 -3.41 27.71 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -179.248 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.499 ' OD1' HG13 ' A' ' 71' ' ' VAL . 45.7 t0 -80.34 121.29 25.49 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.083 -0.339 . . . . 0.0 110.083 179.628 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.497 HG22 ' HG2' ' A' ' 96' ' ' ARG . 74.5 t -108.43 132.68 55.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.042 -178.249 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.436 HG23 ' CG2' ' A' ' 69' ' ' THR . 84.8 mt -99.11 131.98 45.35 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.682 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.3 m -115.93 125.04 52.05 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.345 0.593 . . . . 0.0 111.061 -179.179 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.468 ' O ' ' C ' ' A' ' 91' ' ' ILE . 92.0 mt -118.85 123.31 71.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.898 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.609 HD12 ' CB ' ' B' ' 237' ' ' CYS . 46.7 mm 35.13 -104.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.972 -179.727 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.505 ' N ' HG22 ' A' ' 91' ' ' ILE . 37.1 p-10 -105.91 11.11 32.13 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -179.555 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.558 HH21 ' CG ' ' B' ' 260' ' ' GLU . 86.0 mtt-85 -127.58 147.31 50.34 Favored 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.193 -179.426 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.413 ' HB3' HD12 ' A' ' 10' ' ' ILE . 29.0 t -137.18 153.22 50.5 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.079 0.466 . . . . 0.0 110.331 179.271 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.602 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 93.6 m-85 -126.64 129.14 47.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.426 179.76 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.628 ' O ' HD12 ' A' ' 7' ' ' LEU . 99.9 mtt180 -94.15 135.07 35.92 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.26 -179.003 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.561 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 83.8 t80 -99.91 124.2 44.97 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.357 179.912 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -124.89 127.53 47.25 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.728 179.508 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 63.5 t-20 . . . . . 0 C--N 1.331 -0.222 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.171 179.436 . . . . . . . . 0 0 . 1 . 055 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo . . . . . 0 N--CA 1.484 0.958 0 CA-C-O 121.02 0.342 . . . . 0.0 111.936 . . . . . . . . . 0 0 . 1 . 055 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.683 ' CG2' HG22 ' A' ' 66' ' ' THR . 37.0 t -114.08 133.4 60.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.751 179.952 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' B' B ' 237' ' ' CYS . . . . . 0.609 ' CB ' HD12 ' A' ' 91' ' ' ILE . 2.6 t . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.668 179.43 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo . . . . . 0 N--CA 1.492 1.4 0 N-CA-C 112.571 0.181 . . . . 0.0 112.571 . . . . . . . . . 0 0 . 1 . 055 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 99.2 m -73.21 -46.02 52.81 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.375 0.607 . . . . 0.0 109.709 178.067 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -57.65 -45.36 85.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.485 -179.433 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 95.8 mt -64.17 -41.4 97.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.548 -179.25 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -63.19 -41.5 99.2 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.225 -179.951 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -62.49 -43.44 98.82 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.976 0.417 . . . . 0.0 110.055 179.533 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.562 ' O ' ' NH2' ' A' ' 12' ' ' ARG . 24.4 mmt180 -61.26 -43.02 99.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.64 -179.473 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.66 -38.99 92.49 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.803 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 11.1 t -64.72 -46.22 83.2 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 177.696 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' B' B ' 248' ' ' GLN . . . . . 0.459 ' HB2' HH22 ' A' ' 12' ' ' ARG . 83.6 mt-30 -60.39 -37.74 81.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.123 179.709 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' B' B ' 249' ' ' VAL . . . . . 0.508 HG23 ' O ' ' B' ' 245' ' ' ARG . 61.9 t . . . . . 0 CA--C 1.519 -0.22 0 C-N-CA 120.217 -0.593 . . . . 0.0 109.744 179.898 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.558 ' CG ' HH21 ' A' ' 93' ' ' ARG . 97.6 mt-10 . . . . . 0 C--O 1.231 0.121 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 . . . . . . . . . 1 1 . 1 . 055 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.602 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 60.3 mt -111.11 138.07 40.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.867 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 48.6 t -128.55 136.08 60.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.682 0.277 . . . . 0.0 110.296 179.502 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -99.2 122.03 41.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.276 0.56 . . . . 0.0 111.791 -178.465 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -65.71 -44.3 86.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.021 179.233 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -103.77 162.14 20.86 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.737 -178.831 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -60.75 152.79 67.02 Favored 'Trans proline' 0 N--CA 1.499 1.836 0 C-N-CA 123.17 2.58 . . . . 0.0 112.702 179.376 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 40.1 pt . . . . . 0 C--N 1.327 -0.39 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.55 -179.844 . . . . . . . . 0 0 . 1 . 056 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 52.9 p . . . . . 0 CA--C 1.517 -0.318 0 CA-C-O 121.142 0.496 . . . . 0.0 111.016 . . . . . . . . . 0 0 . 1 . 056 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.5 mtt85 -100.43 122.06 42.56 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.972 -178.919 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -132.14 142.08 49.35 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.173 179.909 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.498 HD12 ' O ' ' A' ' 96' ' ' ARG . 40.0 tp -114.68 125.25 53.52 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.493 179.494 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.4 HG12 ' CD2' ' A' ' 19' ' ' HIS . 32.0 m -104.85 132.82 50.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.701 -179.413 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.446 ' HG1' ' HE2' ' A' ' 95' ' ' PHE . 3.1 m -79.68 142.83 35.16 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.386 -179.119 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.622 HD12 ' OG ' ' A' ' 94' ' ' SER . 86.0 mt -111.49 135.94 49.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 177.492 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -89.2 157.73 18.15 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.627 179.291 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.439 ' HD3' HH22 ' A' ' 93' ' ' ARG . 87.8 mtm180 -57.2 -26.57 60.88 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.151 -179.191 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 44.9 m -80.48 -12.53 59.54 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 179.541 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.23 35.89 5.87 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.955 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.6 t -124.21 133.56 68.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 120.803 0.335 . . . . 0.0 110.793 -179.101 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -72.26 130.33 40.54 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.546 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -119.98 -122.68 3.03 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.282 -178.826 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.58 145.17 51.65 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 121.357 1.372 . . . . 0.0 112.402 -179.458 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.4 ' CD2' HG12 ' A' ' 8' ' ' VAL . 61.6 m170 -103.72 140.34 37.73 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.642 -179.975 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.473 ' CD2' HD11 ' A' ' 37' ' ' ILE . 59.3 t80 -114.39 96.19 42.16 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.073 -179.466 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -59.28 125.88 19.27 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.93 1.754 . . . . 0.0 112.497 -179.01 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 89.0 mt -85.62 44.91 1.14 Allowed 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.533 -179.893 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 66.3 p -60.17 -30.69 69.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.979 0.419 . . . . 0.0 109.943 179.57 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 68.5 mt -72.54 144.98 47.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.22 178.987 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.09 -20.64 65.83 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.568 -178.343 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.499 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 23.0 m -133.05 136.95 46.25 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.655 -179.321 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.595 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 3.7 t -129.43 118.36 22.03 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.794 178.052 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.544 HD12 ' O ' ' A' ' 49' ' ' CYS . 49.5 tp -114.55 130.61 56.78 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.173 -178.859 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.711 ' CE2' HD12 ' A' ' 37' ' ' ILE . 9.1 m-85 -109.21 138.28 45.81 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.195 -0.911 . . . . 0.0 108.91 179.174 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.42 -166.72 36.67 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.145 179.105 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.574 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 81.7 mtm-85 -89.81 -29.62 18.52 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 179.8 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.562 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -52.96 148.77 12.28 Favored Glycine 0 CA--C 1.521 0.458 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.314 -179.413 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.522 HG23 ' N ' ' A' ' 34' ' ' GLU . 11.1 tp -66.01 -39.83 85.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.874 0.369 . . . . 0.0 110.191 -179.98 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.522 ' N ' HG23 ' A' ' 33' ' ' ILE . 78.3 mm-40 -58.78 -21.99 57.13 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.217 -178.373 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.562 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 14.3 m -56.86 121.05 8.96 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.829 -179.804 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.499 ' OD2' ' O ' ' A' ' 26' ' ' THR . 95.3 m-20 -57.93 -26.06 61.72 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.17 179.807 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.711 HD12 ' CE2' ' A' ' 29' ' ' PHE . 86.3 mt -130.06 122.08 53.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 176.848 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.466 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 83.9 mtp180 -105.6 135.15 47.54 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.358 -178.737 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.9 mt -119.97 129.56 75.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.945 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -75.74 24.65 0.12 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -177.771 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.563 ' CD2' ' NH2' ' B' ' 245' ' ' ARG . 34.0 mt -92.49 125.55 55.58 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 119.841 -0.744 . . . . 0.0 110.848 179.667 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -72.62 -8.93 23.31 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.048 1.832 . . . . 0.0 112.558 -179.151 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.6 m -101.55 5.13 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.393 -179.648 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.574 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 40.7 t -99.09 106.65 19.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.152 -179.843 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.551 ' O ' ' O ' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -31.96 162.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.554 -178.762 . . . . . . . . 3 3 . 1 . 056 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -59.22 -47.39 85.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.3 -178.933 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.63 ' O ' ' N ' ' A' ' 49' ' ' CYS . 98.4 mt-30 -107.25 -12.44 15.36 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.491 0.662 . . . . 0.0 110.071 179.592 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.464 ' H ' ' HB3' ' A' ' 45' ' ' SER . 20.0 t60 37.99 -75.51 0.0 OUTLIER 'General case' 0 C--O 1.239 0.539 0 CA-C-N 114.812 -1.085 . . . . 0.0 113.765 179.744 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.63 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -139.1 140.72 38.06 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.584 -178.664 . . . . . . . . 3 3 . 1 . 056 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -128.04 127.61 43.47 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.893 179.51 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 91.4 mt -110.16 135.02 50.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.319 -179.951 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -117.97 128.42 54.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.513 178.149 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 94.2 mt -111.95 117.73 55.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.498 0.666 . . . . 0.0 111.603 -179.225 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.588 ' O ' ' N ' ' A' ' 56' ' ' GLN . 89.3 m-70 -117.59 144.86 44.73 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.94 179.63 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 54' ' ' HIS . 80.0 mm-40 -38.94 -23.91 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.215 -0.594 . . . . 0.0 109.928 -179.825 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.588 ' N ' ' O ' ' A' ' 54' ' ' HIS . 56.3 tt0 -67.76 -68.78 0.36 Allowed 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.267 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -161.66 -158.27 0.54 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.034 179.337 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.504 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -112.81 131.43 55.7 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.059 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 80.0 mt -120.78 131.03 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 121.061 0.457 . . . . 0.0 112.231 -179.354 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.719 HD22 HD12 ' A' ' 88' ' ' ILE . 28.8 tp -102.29 131.43 48.88 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.635 -179.376 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -112.81 133.44 54.8 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.593 179.132 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.631 HD21 ' CB ' ' A' ' 68' ' ' PRO . 57.4 t-20 -95.0 107.84 19.89 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -178.675 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -98.75 -11.58 21.75 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.401 179.693 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.9 t -84.1 100.26 11.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.236 179.593 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.6 p -83.55 -40.7 18.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.528 0.68 . . . . 0.0 109.393 179.298 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.67 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -60.64 -43.15 97.89 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.012 -0.994 . . . . 0.0 109.986 -179.984 . . . . . . . . 3 3 . 1 . 056 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -141.41 97.32 6.8 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.088 178.695 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.631 ' CB ' HD21 ' A' ' 62' ' ' ASN . 52.9 Cg_endo -66.4 152.73 80.28 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 121.932 1.754 . . . . 0.0 113.165 -178.19 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.843 ' O ' HG22 ' A' ' 76' ' ' ILE . 18.5 m -73.98 153.99 39.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.572 -179.25 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.47 ' O ' ' N ' ' A' ' 89' ' ' THR . 74.0 mt-30 -113.82 140.09 48.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.527 178.947 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.4 t -128.63 135.42 62.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.344 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.428 ' H ' HG13 ' A' ' 87' ' ' VAL . 84.9 m-20 52.07 32.94 11.11 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -178.96 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.02 28.23 68.91 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.783 179.707 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 69.9 m -140.6 140.53 35.11 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.997 179.884 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 52.1 t -65.23 136.87 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.589 179.827 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.843 HG22 ' O ' ' A' ' 69' ' ' THR . 7.5 tt -104.57 89.64 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.779 178.793 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -63.88 -35.19 79.83 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.722 -179.483 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.47 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 1.7 mt-10 -128.02 168.46 15.33 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.803 -179.475 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.84 143.75 80.07 Favored 'Trans proline' 0 N--CA 1.501 1.967 0 C-N-CA 122.282 1.988 . . . . 0.0 112.815 -178.747 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.48 HG12 HD12 ' A' ' 76' ' ' ILE . 4.7 p -139.87 142.95 31.18 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 121.329 0.585 . . . . 0.0 111.782 179.571 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -75.17 133.65 41.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.701 179.782 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.522 HD11 ' HB2' ' A' ' 60' ' ' LEU . 56.9 mt -92.5 134.33 35.07 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.801 -179.098 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.518 ' O ' ' OD2' ' A' ' 86' ' ' ASP . 99.8 mttt -120.14 153.07 36.72 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.904 -179.825 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.489 ' HD1' ' C ' ' A' ' 99' ' ' ASN . 9.3 t60 -51.1 119.13 3.71 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.243 -179.317 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.89 -14.61 34.38 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -179.614 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.518 ' OD2' ' O ' ' A' ' 83' ' ' LYS . 2.1 p30 -69.28 131.1 44.33 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.15 179.422 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.428 HG13 ' H ' ' A' ' 72' ' ' ASN . 13.5 p -105.31 140.55 22.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.56 -179.198 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.719 HD12 HD22 ' A' ' 60' ' ' LEU . 38.6 mm -102.99 128.94 55.45 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 177.851 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.47 ' N ' ' O ' ' A' ' 70' ' ' GLN . 41.1 m -121.91 130.21 53.16 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -177.654 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.532 ' O ' ' N ' ' A' ' 93' ' ' ARG . 97.5 mt -115.9 129.74 71.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 113.881 -1.509 . . . . 0.0 107.398 177.442 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.688 HG21 ' SG ' ' B' ' 237' ' ' CYS . 23.5 mt -31.74 107.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.022 0.439 . . . . 0.0 111.118 -178.37 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.513 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 2.2 t70 88.89 -25.66 0.08 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 178.691 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 90' ' ' ILE . 55.6 mtt85 -130.09 139.85 50.89 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 121.329 -0.149 . . . . 0.0 110.618 -178.658 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.622 ' OG ' HD12 ' A' ' 10' ' ' ILE . 34.0 p -142.51 158.56 43.55 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.222 0.534 . . . . 0.0 110.474 -179.997 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.463 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 59.1 m-85 -132.06 133.65 44.61 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.79 179.414 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.507 ' HG3' HD11 ' A' ' 10' ' ' ILE . 78.3 mtp85 -95.75 136.89 35.57 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 119.767 -0.773 . . . . 0.0 109.988 179.0 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -95.46 125.7 40.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.227 -179.116 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -122.09 122.19 38.69 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.265 179.062 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.489 ' C ' ' HD1' ' A' ' 84' ' ' HIS . 49.4 t-20 . . . . . 0 C--N 1.324 -0.507 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.708 -179.976 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo . . . . . 0 N--CA 1.492 1.425 0 N-CA-C 111.702 -0.153 . . . . 0.0 111.702 . . . . . . . . . 0 0 . 1 . 056 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.67 ' CG2' HG22 ' A' ' 66' ' ' THR . 25.6 t -110.3 133.2 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-O 120.949 0.404 . . . . 0.0 110.505 -179.509 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' B' B ' 237' ' ' CYS . . . . . 0.688 ' SG ' HG21 ' A' ' 91' ' ' ILE . 3.5 t . . . . . 0 CA--C 1.515 -0.403 0 CA-C-O 121.157 0.503 . . . . 0.0 110.608 -179.643 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo . . . . . 0 N--CA 1.491 1.379 0 N-CA-C 112.605 0.194 . . . . 0.0 112.605 . . . . . . . . . 0 0 . 1 . 056 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 99.9 m -72.73 -43.97 62.28 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.628 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.453 ' HD2' ' HG ' ' B' ' 237' ' ' CYS . 82.7 t80 -56.91 -47.68 80.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.264 -179.679 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.447 HD21 HG23 ' A' ' 91' ' ' ILE . 92.7 mt -62.61 -41.2 98.85 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.927 -179.173 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -63.63 -40.0 95.76 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.517 -0.473 . . . . 0.0 109.749 179.886 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' B' B ' 244' ' ' ARG . . . . . 0.537 ' O ' ' OG ' ' B' ' 247' ' ' SER . 72.9 ttt180 -59.84 -43.6 94.53 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.176 179.35 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.563 ' NH2' ' CD2' ' A' ' 41' ' ' LEU . 22.2 mmt180 -62.44 -41.41 98.7 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.675 -179.279 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.71 -39.06 90.16 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.261 0.553 . . . . 0.0 109.769 179.658 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' B' B ' 247' ' ' SER . . . . . 0.537 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 57.6 p -67.15 -42.87 83.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.141 178.306 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -61.33 -35.84 78.52 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.028 179.789 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 49.8 t . . . . . 0 C--N 1.328 -0.347 0 O-C-N 121.595 -0.691 . . . . 0.0 110.118 178.638 . . . . . . . . 0 0 . 1 . 056 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.475 ' OE1' ' NH2' ' A' ' 93' ' ' ARG . 96.6 mt-10 . . . . . 0 CA--C 1.531 0.231 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 . . . . . . . . . 1 1 . 1 . 056 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.463 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 82.7 mt -112.06 130.95 64.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.821 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 60.8 t -126.4 134.34 66.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.16 -179.434 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -94.95 119.81 34.11 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.329 0.585 . . . . 0.0 110.975 -179.334 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.99 -43.92 97.45 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.071 179.48 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -100.98 155.31 36.45 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.619 -179.227 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -68.43 143.98 59.77 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 123.099 2.533 . . . . 0.0 113.659 -179.029 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 43.6 pt . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.047 178.35 . . . . . . . . 0 0 . 1 . 057 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.8 p . . . . . 0 CA--C 1.528 0.131 0 CA-C-O 120.756 0.312 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 057 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.78 ' NH1' ' HB2' ' A' ' 58' ' ' ALA . 95.7 mtt-85 -97.65 115.51 28.05 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.09 -178.877 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.6 mtt85 -129.44 138.54 51.51 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.997 0.427 . . . . 0.0 111.897 -179.874 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.603 HD11 ' HB3' ' A' ' 95' ' ' PHE . 32.5 tp -115.01 136.89 52.62 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.999 179.29 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 53.9 t -112.91 132.22 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.606 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 m -94.91 117.69 30.56 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.821 0.675 . . . . 0.0 112.821 -178.136 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 95.6 mt -82.97 143.71 11.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.85 179.569 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -90.6 159.89 16.21 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.042 178.419 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.601 HH12 ' CD ' ' B' ' 260' ' ' GLU . 55.0 mtm-85 -58.51 -28.29 65.28 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.403 -179.397 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.6 p -77.87 -8.6 58.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.876 0.37 . . . . 0.0 110.457 179.907 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.68 34.05 8.08 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.94 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.6 t -118.91 132.8 67.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.866 0.365 . . . . 0.0 111.065 -179.81 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -72.07 136.03 46.48 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.315 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -127.7 -121.77 2.45 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 120.541 -0.837 . . . . 0.0 111.94 -179.135 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -73.12 149.57 46.5 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.313 2.009 . . . . 0.0 112.865 -178.601 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -106.45 152.9 23.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.638 179.868 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.65 ' CD2' HD11 ' A' ' 37' ' ' ILE . 30.1 t80 -121.36 92.92 48.78 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.017 179.789 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -59.51 125.95 19.33 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.636 1.558 . . . . 0.0 110.713 -179.595 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.2 mt -90.83 45.83 1.28 Allowed 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.558 -178.242 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 94.5 p -60.53 -23.4 64.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.216 0.532 . . . . 0.0 109.635 179.545 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.7 mt -77.1 144.44 38.5 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.323 179.494 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.7 m -67.81 -18.75 64.94 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -178.373 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 59.3 m -134.72 135.16 41.75 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.671 -179.559 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.6 t -127.2 119.47 26.48 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.059 178.871 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.481 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 35.9 tp -113.45 128.12 56.34 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 121.178 -0.209 . . . . 0.0 111.537 -178.609 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.731 ' CE2' HD12 ' A' ' 37' ' ' ILE . 13.5 m-85 -107.69 130.48 54.92 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.532 179.181 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -176.26 -171.3 39.89 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.707 179.883 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.558 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 39.7 ttp-105 -93.9 -9.31 37.6 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.249 -0.476 . . . . 0.0 111.298 -179.422 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.485 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -93.93 158.88 23.44 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.671 -178.651 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.448 HG23 ' N ' ' A' ' 34' ' ' GLU . 11.1 tp -66.81 -40.22 85.41 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 115.078 -0.561 . . . . 0.0 110.496 179.82 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.448 ' N ' HG23 ' A' ' 33' ' ' ILE . 85.2 tt0 -53.15 -22.43 6.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.035 0.445 . . . . 0.0 110.053 -179.695 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 2.7 m -71.52 139.31 49.46 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.762 179.839 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.481 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 99.6 m-20 -60.8 -31.26 70.64 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.145 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.731 HD12 ' CE2' ' A' ' 29' ' ' PHE . 84.5 mt -129.27 120.33 50.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.489 177.34 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 77.2 ttt-85 -107.41 135.1 49.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.843 -178.981 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 99.7 mt -117.45 130.72 71.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.902 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -73.65 34.98 0.08 Allowed 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -177.588 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.691 ' CD1' ' HE ' ' A' ' 93' ' ' ARG . 37.6 mt -114.41 132.18 22.94 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.582 179.478 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.47 -12.01 26.87 Favored 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 122.574 2.182 . . . . 0.0 112.997 -179.036 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.438 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 19.2 m -88.11 0.9 6.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.416 179.743 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.648 HG22 HH22 ' A' ' 93' ' ' ARG . 55.7 t -90.54 131.77 36.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.156 179.331 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 46.4 t -70.75 165.31 23.32 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.345 -179.107 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 70.2 mttt -61.9 -39.97 93.83 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.142 -179.26 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.679 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.9 mt-30 -120.5 -21.54 6.76 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.046 179.772 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 16.6 t60 36.15 -75.05 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 178.991 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.679 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -128.52 132.66 48.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.104 0.478 . . . . 0.0 111.677 -178.891 . . . . . . . . 3 3 . 1 . 057 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -128.51 125.25 37.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.138 179.234 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.0 mt -107.07 133.38 51.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.526 -179.529 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.417 ' CD ' ' NE2' ' A' ' 54' ' ' HIS . 82.4 tt0 -117.24 126.06 52.15 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.562 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.5 119.72 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -177.625 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.553 ' O ' ' N ' ' A' ' 56' ' ' GLN . 97.4 m-70 -114.46 141.28 47.89 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.628 178.813 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 54' ' ' HIS . 58.8 mp0 -40.71 -24.46 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.801 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.553 ' N ' ' O ' ' A' ' 54' ' ' HIS . 99.8 mm-40 -71.86 -69.16 0.41 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.548 178.848 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.452 ' OE2' ' NE ' ' A' ' 81' ' ' ARG . 2.3 pt-20 -152.61 -174.71 5.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.294 0.568 . . . . 0.0 111.602 -178.95 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.78 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -110.47 130.18 55.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.672 179.156 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 86.2 mt -121.08 131.04 74.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.162 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 24.0 tp -100.01 129.16 46.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.318 179.442 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -113.51 135.38 53.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.149 179.573 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -95.09 105.62 17.56 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.866 -0.333 . . . . 0.0 111.338 -179.988 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -98.07 -6.96 30.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.209 178.847 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.36 102.28 1.72 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.401 179.846 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.6 p -89.51 -6.51 56.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.788 0.328 . . . . 0.0 110.484 179.397 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.64 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -101.28 -42.12 6.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.332 0.587 . . . . 0.0 109.637 179.928 . . . . . . . . 3 3 . 1 . 057 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.427 HD21 ' HA ' ' B' ' 236' ' ' VAL . 69.8 m-20 -141.21 99.87 6.45 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.668 -179.919 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.401 ' HB2' HG13 ' A' ' 75' ' ' VAL . 48.8 Cg_exo -55.53 146.44 63.87 Favored 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 122.595 2.197 . . . . 0.0 112.982 -179.282 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 48.3 m -72.67 139.17 47.12 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.167 179.278 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -105.88 140.45 38.89 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.754 -179.589 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.652 HG13 ' OD1' ' A' ' 86' ' ' ASP . 54.9 t -132.23 132.9 60.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.041 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 52.91 32.93 13.44 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.049 -0.66 . . . . 0.0 109.332 -179.079 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.75 27.98 69.87 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.892 179.858 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 28.9 p -141.02 140.78 34.34 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 117.206 0.503 . . . . 0.0 111.22 179.895 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.401 HG13 ' HB2' ' A' ' 68' ' ' PRO . 13.4 t -72.4 142.48 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.804 -179.79 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.46 HG22 HG21 ' A' ' 80' ' ' VAL . 3.9 pt -115.67 88.69 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.66 178.967 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -63.67 -25.64 68.3 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.361 179.396 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.52 173.62 4.3 Favored Pre-proline 0 C--O 1.233 0.221 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.959 -179.704 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -61.66 142.37 94.14 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.401 2.067 . . . . 0.0 111.812 179.349 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.46 HG21 HG22 ' A' ' 76' ' ' ILE . 79.2 t -135.38 136.7 50.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.615 179.631 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.452 ' NE ' ' OE2' ' A' ' 57' ' ' GLU . 84.0 mtp180 -73.99 131.91 41.87 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.768 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.2 mt -82.45 139.94 33.68 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.954 0.407 . . . . 0.0 110.939 -179.38 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -131.12 151.35 51.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.698 -179.836 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.612 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 4.1 t60 -54.06 114.94 1.79 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.391 179.982 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.81 -6.39 29.42 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 -179.382 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.652 ' OD1' HG13 ' A' ' 71' ' ' VAL . 26.7 t0 -79.4 125.28 29.33 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.306 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 42.6 t -110.03 130.54 63.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.604 -178.341 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 95.6 mt -92.46 130.62 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.804 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 25.7 m -121.65 126.75 49.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.449 0.643 . . . . 0.0 112.277 -178.124 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.73 HG21 HH12 ' A' ' 93' ' ' ARG . 70.8 mt -121.69 127.54 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.442 178.977 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.489 HG22 ' N ' ' A' ' 92' ' ' ASP . 82.9 mt 38.59 -101.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.629 -179.511 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.489 ' N ' HG22 ' A' ' 91' ' ' ILE . 26.5 t70 -115.88 15.72 16.28 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 120.666 -0.413 . . . . 0.0 111.693 -179.183 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.73 HH12 HG21 ' A' ' 90' ' ' ILE . 4.5 ptt85 -131.64 146.32 52.13 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.839 179.125 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 53.0 m -139.24 155.48 47.74 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.572 -179.388 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.603 ' HB3' HD11 ' A' ' 7' ' ' LEU . 61.4 m-85 -122.22 121.04 35.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.657 179.775 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.518 ' O ' HD12 ' A' ' 7' ' ' LEU . 42.4 ttm180 -83.7 130.95 34.97 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.878 0.371 . . . . 0.0 111.59 -178.872 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.641 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 76.6 t80 -96.37 123.62 40.08 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.23 -179.47 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -123.53 126.29 46.44 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.895 179.801 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.612 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 59.7 t-20 . . . . . 0 N--CA 1.464 0.231 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.243 179.43 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo . . . . . 0 N--CA 1.491 1.361 0 CA-C-O 121.519 0.55 . . . . 0.0 113.406 . . . . . . . . . 0 0 . 1 . 057 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.64 ' CG2' HG22 ' A' ' 66' ' ' THR . 31.2 t -65.29 136.6 26.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.864 179.102 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 5.7 t . . . . . 0 C--N 1.327 -0.41 0 C-N-CA 120.626 -0.429 . . . . 0.0 110.099 -179.685 . . . . . . . . 0 0 . 1 . 057 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo . . . . . 0 N--CA 1.494 1.506 0 N-CA-C 112.609 0.196 . . . . 0.0 112.609 . . . . . . . . . 0 0 . 1 . 057 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 96.2 m -73.33 -44.9 58.03 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.515 0.674 . . . . 0.0 109.334 178.551 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.502 ' HZ ' HD22 ' A' ' 41' ' ' LEU . 80.8 t80 -56.11 -44.8 79.43 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.826 -179.861 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 92.1 mt -62.81 -40.86 98.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 179.818 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -64.42 -39.94 94.8 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.419 -179.26 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 59.8 ttm-85 -60.01 -44.86 94.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.044 0.45 . . . . 0.0 109.962 179.781 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.474 HH21 ' HG2' ' A' ' 12' ' ' ARG . 58.1 mtp180 -63.32 -41.55 98.93 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.749 -179.823 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -62.85 -40.76 98.46 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.239 -0.585 . . . . 0.0 109.806 179.376 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 38.5 t -64.38 -45.05 89.4 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 122.052 0.929 . . . . 0.0 108.679 178.167 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -59.52 -37.28 77.93 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.41 -179.973 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 21.8 t . . . . . 0 C--N 1.33 -0.267 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.753 . . . . . . . . 0 0 . 1 . 057 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.601 ' CD ' HH12 ' A' ' 12' ' ' ARG . 53.5 mp0 . . . . . 0 N--CA 1.461 0.119 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 . . . . . . . . . 1 1 . 1 . 057 nuclear build core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 69.4 mt -108.58 135.53 47.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.738 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 55.0 t -127.45 134.0 66.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.947 0.404 . . . . 0.0 110.896 -178.384 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -97.38 119.75 36.48 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.557 -179.331 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.85 -43.84 94.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.924 179.038 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -95.79 153.78 39.24 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.362 -179.598 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.85 147.05 80.13 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 123.087 2.525 . . . . 0.0 113.288 -179.273 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.4 pt . . . . . 0 C--N 1.331 -0.223 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.678 178.455 . . . . . . . . 0 0 . 1 . 058 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 50.0 p . . . . . 0 N--CA 1.453 -0.277 0 CA-C-O 121.238 0.542 . . . . 0.0 110.25 . . . . . . . . . 0 0 . 1 . 058 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.485 ' HD2' HD13 ' A' ' 53' ' ' ILE . 84.9 mtt85 -89.39 122.27 32.45 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.493 -179.449 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -124.79 139.44 53.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.24 -179.922 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.579 HD12 ' O ' ' A' ' 96' ' ' ARG . 29.4 tp -116.39 132.83 56.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.133 -179.4 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.892 HG11 ' NH2' ' A' ' 96' ' ' ARG . 67.6 t -108.18 130.19 61.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.36 -179.676 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.601 HG21 ' HZ ' ' B' ' 263' ' ' PHE . 59.2 p -91.28 114.22 26.69 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.455 0.645 . . . . 0.0 112.485 -178.83 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.435 HD12 ' HB3' ' A' ' 94' ' ' SER . 95.5 mt -79.71 140.9 16.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.396 178.953 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -87.69 158.19 18.89 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.15 0.5 . . . . 0.0 111.008 179.179 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.592 ' NH1' ' OE2' ' B' ' 260' ' ' GLU . 81.3 mtp180 -58.3 -31.03 67.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.554 -179.305 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 93.2 p -74.82 -12.79 60.47 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.933 179.275 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.34 25.93 10.57 Favored Glycine 0 CA--C 1.531 1.045 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -179.566 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.2 t -119.27 134.98 61.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.695 0.283 . . . . 0.0 110.541 179.981 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.657 ' CG ' HH22 ' A' ' 96' ' ' ARG . 90.6 m-20 -67.6 139.23 56.86 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.426 -179.837 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -127.04 -123.71 2.66 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.068 -179.023 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.43 146.34 44.51 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 122.321 2.014 . . . . 0.0 113.184 -178.426 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.428 ' O ' ' CD1' ' B' ' 267' ' ' ILE . 0.0 OUTLIER -111.08 131.01 55.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.094 0.473 . . . . 0.0 111.049 -179.561 . . . . . . . . 3 3 . 1 . 058 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.545 ' CD2' HD11 ' A' ' 37' ' ' ILE . 25.2 t80 -101.35 107.7 51.93 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.014 -179.602 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -73.64 127.45 11.68 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 121.129 1.219 . . . . 0.0 111.645 -179.748 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.9 mt -87.87 50.58 2.02 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.139 -178.769 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 97.4 p -65.97 -19.07 65.74 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.051 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.605 HD11 ' HG2' ' B' ' 265' ' ' GLN . 68.0 mt -79.03 140.57 37.9 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.283 179.848 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.7 t -62.43 -25.5 68.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.866 179.916 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 66.0 m -129.79 130.96 46.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.193 -179.768 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.61 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 8.6 t -129.3 124.17 33.69 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.605 178.903 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.576 HD21 ' HG2' ' A' ' 47' ' ' GLN . 42.8 tp -119.28 132.05 55.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.928 0.394 . . . . 0.0 111.184 -178.747 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.771 ' CE2' HD12 ' A' ' 37' ' ' ILE . 10.0 m-85 -108.97 139.98 43.09 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.022 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 167.76 -155.7 26.77 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 119.942 -1.123 . . . . 0.0 112.069 179.846 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.538 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 37.6 ttp-105 -111.2 -21.64 11.8 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.88 -0.16 . . . . 0.0 110.855 -179.459 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.458 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -73.77 163.59 54.69 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.553 -179.161 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.514 ' CD1' ' NH1' ' A' ' 38' ' ' ARG . 46.2 mm -64.52 -45.67 94.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 O-C-N 122.746 -0.267 . . . . 0.0 110.944 -179.876 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -49.78 -21.95 1.27 Allowed 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.503 179.962 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.572 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 4.8 m -67.75 121.87 16.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.11 -179.513 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -59.41 -25.9 64.7 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.757 -179.494 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.771 HD12 ' CE2' ' A' ' 29' ' ' PHE . 98.1 mt -128.77 124.16 60.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.086 177.64 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.514 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 56.6 mtm180 -110.34 141.43 43.38 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 120.634 -0.427 . . . . 0.0 111.237 -179.704 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.658 HD13 ' HE ' ' A' ' 93' ' ' ARG . 81.0 mt -121.17 132.65 70.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.034 179.916 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -74.75 29.81 0.09 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.569 -177.762 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.712 HD12 ' CZ ' ' A' ' 93' ' ' ARG . 51.5 mt -109.34 133.55 20.77 Favored Pre-proline 0 C--N 1.325 -0.494 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.643 -179.559 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.2 -12.92 25.74 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.741 2.294 . . . . 0.0 112.016 179.598 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.4 m -88.61 3.71 5.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.069 179.448 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.538 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 55.1 t -98.99 130.88 47.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 C-N-CA 120.434 -0.507 . . . . 0.0 109.699 178.432 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 75.6 m -70.74 172.62 8.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.632 -179.077 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.572 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 10.5 mttm -63.79 -41.87 97.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.259 179.939 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.658 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.2 mt-30 -117.48 -16.15 10.21 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 123.337 0.398 . . . . 0.0 111.732 -179.315 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.42 ' NE2' HG23 ' A' ' 90' ' ' ILE . 17.5 t60 33.78 -72.58 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 179.081 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.658 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -135.99 140.32 43.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.067 0.461 . . . . 0.0 112.036 -178.752 . . . . . . . . 3 3 . 1 . 058 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -126.63 135.51 51.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.556 179.918 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 92.3 mt -121.52 134.17 65.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.013 -179.483 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -116.14 127.34 54.75 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.849 179.036 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.485 HD13 ' HD2' ' A' ' 5' ' ' ARG . 82.1 mt -106.57 113.27 42.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 119.853 -0.739 . . . . 0.0 112.288 -179.606 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.426 ' O ' ' C ' ' A' ' 55' ' ' GLU . 98.0 m-70 -113.25 143.89 43.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.742 179.426 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 54' ' ' HIS . 41.3 tt0 -40.9 -30.68 0.14 Allowed 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.028 -0.669 . . . . 0.0 109.4 -179.407 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.47 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 85.7 mt-30 -60.79 -68.88 0.26 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.37 179.131 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.47 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 4.2 tp10 -157.91 -164.95 1.63 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.809 179.775 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.437 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -111.59 126.77 55.36 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 178.317 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 94.4 mt -115.36 131.56 67.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.247 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.443 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 22.0 tp -101.05 131.24 47.04 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.835 179.773 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -114.26 134.71 54.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.499 -179.779 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 56.6 t-20 -92.84 105.06 17.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.933 0.397 . . . . 0.0 111.434 -179.309 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -101.82 -9.56 20.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.277 179.417 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.92 98.2 10.21 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.717 -179.581 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.5 m -76.69 -38.41 54.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.359 0.599 . . . . 0.0 109.854 178.996 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.418 ' O ' HG22 ' B' ' 236' ' ' VAL . 0.2 OUTLIER -62.49 -44.66 95.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.832 -178.688 . . . . . . . . 3 3 . 1 . 058 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.464 HD21 ' HA ' ' B' ' 236' ' ' VAL . 85.4 m-20 -139.16 95.86 9.21 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.624 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -54.8 144.29 66.79 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 121.787 1.658 . . . . 0.0 112.542 -179.038 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 97.0 m -73.42 138.38 45.19 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.625 178.76 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -99.96 137.81 37.91 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.272 179.881 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.663 HG13 ' OD1' ' A' ' 86' ' ' ASP . 54.2 t -131.89 133.21 61.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 178.517 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 53.71 32.1 14.06 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.218 -179.121 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.4 27.66 67.38 Favored Glycine 0 CA--C 1.536 1.38 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.225 179.691 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 58.6 m -144.35 140.45 29.11 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 117.319 0.56 . . . . 0.0 111.657 -179.964 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.444 ' H ' HG22 ' A' ' 75' ' ' VAL . 4.6 m -74.28 146.8 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.748 179.515 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.8 pt -116.43 98.5 6.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.262 0.553 . . . . 0.0 111.549 179.837 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -67.14 -26.58 66.74 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 178.465 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.31 166.36 17.51 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.602 -179.868 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -64.22 150.5 88.18 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.684 2.256 . . . . 0.0 112.183 179.249 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.4 m -141.63 141.99 29.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.347 -179.482 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -74.91 135.22 41.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.966 179.18 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.437 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 98.2 mt -83.82 137.53 33.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.236 0.541 . . . . 0.0 110.838 -179.631 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -129.27 154.85 46.42 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.808 179.974 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -56.99 116.19 3.06 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.843 -178.901 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.06 -12.8 29.06 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -179.743 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.663 ' OD1' HG13 ' A' ' 71' ' ' VAL . 43.6 t0 -67.78 128.47 36.59 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.963 0.411 . . . . 0.0 110.283 179.651 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.411 ' O ' HG13 ' A' ' 87' ' ' VAL . 9.3 p -109.11 134.87 49.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.559 -179.053 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 81.2 mt -106.8 131.17 57.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.275 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.8 m -119.9 123.67 44.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.446 0.641 . . . . 0.0 111.479 -179.033 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.549 HD12 ' CE1' ' A' ' 95' ' ' PHE . 84.8 mt -116.74 124.47 72.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.914 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.402 HG22 ' N ' ' A' ' 92' ' ' ASP . 44.8 mm 44.61 -103.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.773 -179.607 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.664 ' OD1' ' NH1' ' A' ' 93' ' ' ARG . 12.3 p-10 -117.49 17.58 14.5 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.995 0.426 . . . . 0.0 110.488 -179.803 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.712 ' CZ ' HD12 ' A' ' 41' ' ' LEU . 34.2 mtm-85 -127.1 142.68 51.46 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.024 -179.366 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.435 ' HB3' HD12 ' A' ' 10' ' ' ILE . 41.2 t -135.25 150.26 50.02 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.564 -179.826 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.549 ' CE1' HD12 ' A' ' 90' ' ' ILE . 19.2 m-85 -124.97 124.02 41.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.581 -179.892 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.892 ' NH2' HG11 ' A' ' 8' ' ' VAL . 89.8 mtm-85 -85.66 128.41 34.77 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.932 -178.915 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -92.12 124.53 36.28 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.193 179.083 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -127.69 118.55 24.03 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.549 -179.547 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 61.4 t-20 . . . . . 0 C--N 1.326 -0.431 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.009 179.589 . . . . . . . . 0 0 . 1 . 058 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo . . . . . 0 N--CA 1.483 0.874 0 CA-C-O 121.66 0.608 . . . . 0.0 113.019 . . . . . . . . . 0 0 . 1 . 058 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.464 ' HA ' HD21 ' A' ' 67' ' ' ASN . 17.5 t -57.56 141.09 15.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.485 -179.597 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 16.5 t . . . . . 0 C--N 1.332 -0.154 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.455 . . . . . . . . 0 0 . 1 . 058 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo . . . . . 0 N--CA 1.498 1.758 0 N-CA-C 113.057 0.368 . . . . 0.0 113.057 . . . . . . . . . 0 0 . 1 . 058 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 13.7 p -73.96 -39.2 63.9 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.218 179.044 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.42 ' HZ ' HD22 ' A' ' 41' ' ' LEU . 68.3 t80 -57.42 -46.34 83.65 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.357 -179.872 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.457 HD22 ' NH2' ' B' ' 245' ' ' ARG . 94.9 mt -63.45 -40.76 98.0 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.215 179.95 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -58.18 -41.77 84.64 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.14 179.558 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -64.34 -38.8 92.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.447 179.844 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.494 ' NE ' ' CB ' ' A' ' 92' ' ' ASP . 10.1 ttm180 -57.8 -44.93 86.65 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.56 -179.511 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -61.65 -41.23 97.23 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.758 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 10.2 t -63.8 -45.97 87.25 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.323 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' B' B ' 248' ' ' GLN . . . . . 0.443 ' HG2' HH12 ' A' ' 12' ' ' ARG . 67.0 tp60 -58.51 -41.15 84.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.688 -1.142 . . . . 0.0 111.406 -179.531 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 55.0 t . . . . . 0 C--N 1.332 -0.158 0 C-N-CA 120.559 -0.457 . . . . 0.0 109.792 179.897 . . . . . . . . 0 0 . 1 . 058 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.592 ' OE2' ' NH1' ' A' ' 12' ' ' ARG . 95.7 mt-10 . . . . . 0 N--CA 1.464 0.239 0 N-CA-C 113.982 1.105 . . . . 0.0 113.982 . . . . . . . . . 1 1 . 1 . 058 nuclear build core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 73.9 mt -109.41 134.11 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 118.644 0.656 . . . . 0.0 109.691 179.684 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 56.1 t -123.9 131.94 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.052 -179.532 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' B' B ' 263' ' ' PHE . . . . . 0.601 ' HZ ' HG21 ' A' ' 9' ' ' THR . 51.2 m-85 -98.77 120.64 39.56 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.21 0.528 . . . . 0.0 111.174 -178.683 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -63.05 -48.3 79.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.332 -179.681 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' B' B ' 265' ' ' GLN . . . . . 0.605 ' HG2' HD11 ' A' ' 24' ' ' LEU . 6.0 mp0 -88.78 161.86 40.3 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.029 -179.068 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -62.28 143.54 94.13 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.276 1.984 . . . . 0.0 112.279 -179.963 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' B' B ' 267' ' ' ILE . . . . . 0.428 ' CD1' ' O ' ' A' ' 19' ' ' HIS . 4.2 tt . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.877 -179.647 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 73.8 p . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.99 0.424 . . . . 0.0 110.409 . . . . . . . . . 0 0 . 1 . 059 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.738 ' NE ' HD13 ' A' ' 53' ' ' ILE . 89.9 mtm-85 -91.24 125.75 36.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.151 -179.75 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 86.5 mtm-85 -131.43 137.14 48.52 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.849 179.522 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.551 HD12 ' O ' ' A' ' 96' ' ' ARG . 40.8 tp -113.32 131.38 55.97 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.983 -179.905 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.6 t -109.07 131.71 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 120.947 0.403 . . . . 0.0 110.984 -179.586 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.426 ' O ' HG22 ' A' ' 9' ' ' THR . 1.8 m -90.65 112.64 24.45 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.748 -179.341 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.7 mt -79.72 144.67 10.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.405 178.646 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -90.6 158.32 17.03 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.142 0.496 . . . . 0.0 110.588 179.17 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.611 HH12 ' CD ' ' B' ' 248' ' ' GLN . 87.2 mtm180 -58.39 -28.39 65.13 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.727 -178.846 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 93.6 p -80.36 -11.22 59.73 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.473 179.795 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.55 31.34 7.16 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.108 179.212 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.1 t -122.61 133.45 68.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.789 0.328 . . . . 0.0 110.729 179.623 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -73.64 138.64 44.93 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.207 179.479 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.66 -118.34 1.93 Allowed Glycine 0 CA--C 1.534 1.225 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.764 -179.899 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.42 146.14 55.29 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 121.912 1.741 . . . . 0.0 112.332 -179.112 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -110.83 158.54 18.58 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.157 0.503 . . . . 0.0 110.649 -179.337 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -125.74 102.0 29.32 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.617 -179.491 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -69.8 128.56 16.16 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 121.279 1.32 . . . . 0.0 111.468 -178.947 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.8 mt -85.72 49.48 1.78 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.543 -178.183 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 92.2 p -61.55 -24.93 66.97 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.055 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.619 HD11 ' HG2' ' B' ' 265' ' ' GLN . 65.7 mt -78.64 141.27 38.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.076 179.779 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 91.9 p -65.33 -19.99 66.2 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.811 179.962 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.409 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 61.8 m -130.28 131.46 45.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.6 -178.852 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.2 t -125.0 112.71 16.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.429 178.385 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.685 HD21 ' OE1' ' A' ' 47' ' ' GLN . 54.7 tp -109.36 127.74 54.57 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.923 -178.593 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.82 ' CE2' HD12 ' A' ' 37' ' ' ILE . 2.5 m-85 -110.07 143.41 40.16 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.745 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 150.98 -166.82 30.5 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.233 178.468 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.531 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 46.2 mtm105 -82.62 -30.98 29.07 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 179.946 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.544 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -50.84 139.08 24.31 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 120.556 -0.83 . . . . 0.0 111.298 -178.854 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.451 HD13 ' HD2' ' A' ' 38' ' ' ARG . 31.3 mm -63.92 -43.79 97.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 121.064 0.459 . . . . 0.0 110.332 179.396 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -55.72 -14.41 2.25 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.132 179.879 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.544 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 56.6 m -64.43 135.2 55.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.93 179.954 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.409 ' OD2' ' O ' ' A' ' 26' ' ' THR . 58.5 m-20 -61.23 -33.84 74.15 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.646 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.82 HD12 ' CE2' ' A' ' 29' ' ' PHE . 88.2 mt -127.32 122.58 60.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 177.471 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.451 ' HD2' HD13 ' A' ' 33' ' ' ILE . 77.5 ttt-85 -111.42 138.6 47.71 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.516 -178.187 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 83.8 mt -119.86 131.48 72.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-O 120.88 0.371 . . . . 0.0 110.409 -179.89 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -78.06 33.82 0.19 Allowed 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 -178.49 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.529 ' CD1' ' CZ ' ' A' ' 93' ' ' ARG . 33.4 mt -109.09 131.86 21.56 Favored Pre-proline 0 C--N 1.325 -0.461 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.293 -179.651 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.79 -15.41 29.94 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.392 2.061 . . . . 0.0 112.874 -179.681 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.55 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 19.2 m -90.27 1.01 8.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.281 179.592 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.531 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 45.3 t -93.25 133.74 33.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.061 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.9 m -71.53 164.09 26.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.4 0.619 . . . . 0.0 112.02 -178.609 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -63.73 -43.3 96.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.187 -178.834 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.685 ' OE1' HD21 ' A' ' 28' ' ' LEU . 93.1 mm-40 -111.95 -17.88 12.78 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.966 0.412 . . . . 0.0 110.148 -179.791 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 14.9 t60 30.66 -76.15 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 179.908 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.623 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.52 137.25 47.09 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -178.43 . . . . . . . . 3 3 . 1 . 059 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -128.69 126.69 40.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.876 179.809 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 91.8 mt -108.71 133.71 52.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.129 0.49 . . . . 0.0 110.738 179.868 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.448 ' OE2' ' CE1' ' A' ' 54' ' ' HIS . 81.0 tt0 -118.23 123.83 46.42 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.354 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.738 HD13 ' NE ' ' A' ' 5' ' ' ARG . 92.5 mt -107.5 119.25 56.78 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 CA-C-O 122.013 0.911 . . . . 0.0 112.858 -178.531 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.461 ' O ' ' C ' ' A' ' 55' ' ' GLU . 98.7 m-70 -108.02 134.14 51.34 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 113.871 -1.513 . . . . 0.0 108.865 179.075 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.461 ' C ' ' O ' ' A' ' 54' ' ' HIS . 97.3 mt-10 -42.5 -33.13 0.63 Allowed 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.524 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.408 ' N ' ' C ' ' A' ' 54' ' ' HIS . 78.6 mt-30 -64.53 -68.33 0.36 Allowed 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.071 -0.968 . . . . 0.0 108.835 177.722 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -143.82 179.12 7.36 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.562 0.696 . . . . 0.0 112.404 -178.567 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.9 120.59 41.96 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.095 178.429 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.7 mt -118.34 133.03 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.994 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.523 ' HB2' HD11 ' A' ' 82' ' ' LEU . 15.7 tp -99.29 129.45 45.51 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.317 179.487 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -110.8 136.89 49.16 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.559 -179.945 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -98.9 106.97 19.29 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.007 0.432 . . . . 0.0 111.905 -179.052 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -100.21 -6.06 26.67 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.779 179.402 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.7 99.18 8.06 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.376 -179.667 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.7 p -88.53 -20.42 25.12 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.738 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.451 HG22 HG12 ' B' ' 236' ' ' VAL . 2.6 m -74.18 -50.91 17.22 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.467 179.189 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.49 HD21 ' HA ' ' B' ' 236' ' ' VAL . 72.2 m-20 -137.43 99.42 9.66 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 114.698 -1.137 . . . . 0.0 108.923 179.766 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -54.0 144.62 56.18 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 121.954 1.769 . . . . 0.0 113.403 -178.762 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 26.8 m -72.12 139.87 48.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.493 178.581 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -105.1 140.53 38.13 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.166 -0.614 . . . . 0.0 110.648 179.932 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.2 p -134.06 134.22 55.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.707 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 51.6 31.89 8.33 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -179.065 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.92 27.39 68.91 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.887 -179.751 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.7 t -139.07 136.73 35.55 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 117.497 0.649 . . . . 0.0 111.804 -179.839 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.5 m -73.75 143.25 13.87 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.151 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.048 179.667 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.559 ' CG2' HG21 ' A' ' 80' ' ' VAL . 9.9 pt -117.07 100.61 10.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.411 0.624 . . . . 0.0 111.028 179.795 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -71.0 -21.97 62.22 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.072 179.46 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.438 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.3 OUTLIER -130.19 177.21 2.31 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.736 179.78 . . . . . . . . 3 3 . 1 . 059 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.438 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 36.7 Cg_exo -59.96 142.32 98.24 Favored 'Trans proline' 0 N--CA 1.5 1.906 0 C-N-CA 122.865 2.377 . . . . 0.0 112.708 -179.335 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.559 HG21 ' CG2' ' A' ' 76' ' ' ILE . 61.4 t -133.03 139.32 49.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.065 179.602 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.546 HH21 ' CE ' ' A' ' 83' ' ' LYS . 62.5 ttp180 -76.61 126.73 31.49 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.955 179.043 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.523 HD11 ' HB2' ' A' ' 60' ' ' LEU . 94.4 mt -82.78 138.45 34.0 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.942 0.401 . . . . 0.0 111.703 -179.285 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.546 ' CE ' HH21 ' A' ' 81' ' ' ARG . 99.3 mttt -128.38 150.95 49.89 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.035 179.712 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -55.43 122.31 10.92 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.068 0.461 . . . . 0.0 111.174 -179.18 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.96 -16.64 42.73 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 -179.894 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -65.82 136.54 56.32 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.62 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 42.0 t -114.5 132.76 62.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.427 -178.364 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 91.6 mt -95.51 131.43 42.33 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.43 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.7 m -123.98 124.96 43.74 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.6 0.714 . . . . 0.0 112.634 -178.319 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.5 ' O ' ' N ' ' A' ' 92' ' ' ASP . 93.7 mt -113.15 125.91 70.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 114.695 -1.139 . . . . 0.0 108.427 178.432 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.591 HD12 HH22 ' A' ' 93' ' ' ARG . 73.9 mt 39.5 -94.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 C-N-CA 120.716 -0.393 . . . . 0.0 110.53 -179.458 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.517 ' O ' ' OD1' ' A' ' 92' ' ' ASP . 62.3 t0 -124.94 19.0 8.49 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.071 0.463 . . . . 0.0 110.905 -179.78 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.676 ' NH1' ' NH2' ' B' ' 245' ' ' ARG . 58.0 mtm-85 -127.62 141.98 51.48 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.472 -179.841 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 25.8 p -139.27 154.2 47.91 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 119.59 -0.844 . . . . 0.0 111.426 -179.798 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.535 ' HB3' HD11 ' A' ' 7' ' ' LEU . 63.8 m-85 -123.22 121.79 36.77 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.078 179.702 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.551 ' O ' HD12 ' A' ' 7' ' ' LEU . 44.8 ttm180 -80.14 127.65 32.57 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.953 -179.148 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -95.1 125.13 39.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.111 -179.825 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -124.87 121.62 35.06 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.636 179.651 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.012 179.453 . . . . . . . . 0 0 . 1 . 059 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 N--CA 1.482 0.818 0 CA-C-O 121.501 0.542 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 059 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.49 ' HA ' HD21 ' A' ' 67' ' ' ASN . 10.9 m -67.39 147.75 12.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.191 -178.919 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 3.0 t . . . . . 0 C--N 1.323 -0.546 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.847 179.891 . . . . . . . . 0 0 . 1 . 059 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo . . . . . 0 N--CA 1.498 1.787 0 N-CA-C 113.585 0.571 . . . . 0.0 113.585 . . . . . . . . . 0 0 . 1 . 059 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 97.3 m -73.61 -44.21 57.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.179 0.514 . . . . 0.0 109.844 179.074 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.55 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 90.6 t80 -58.31 -46.11 86.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.652 -179.516 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 94.7 mt -63.54 -40.13 96.2 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.852 0.358 . . . . 0.0 110.284 -179.834 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 51.9 tp10 -60.77 -43.73 97.65 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.496 -179.749 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -60.04 -41.74 92.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.175 0.512 . . . . 0.0 109.841 179.548 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.676 ' NH2' ' NH1' ' A' ' 93' ' ' ARG . 61.3 ttm-85 -60.04 -44.75 94.46 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.718 -179.544 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -61.87 -40.9 96.98 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.056 0.455 . . . . 0.0 110.141 -179.719 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 61.4 m -66.94 -44.01 81.73 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 177.949 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' B' B ' 248' ' ' GLN . . . . . 0.611 ' CD ' HH12 ' A' ' 12' ' ' ARG . 6.8 tt0 -60.87 -37.8 83.38 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.201 179.867 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' B' B ' 249' ' ' VAL . . . . . 0.444 HG23 ' O ' ' B' ' 245' ' ' ARG . 53.6 t . . . . . 0 N--CA 1.455 -0.177 0 C-N-CA 119.926 -0.709 . . . . 0.0 110.037 -179.966 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 . . . . . 0 N--CA 1.465 0.319 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 . . . . . . . . . 0 0 . 1 . 059 nuclear build core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 75.2 mt -113.11 134.9 54.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 179.065 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 59.2 t -124.22 133.27 69.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.924 0.392 . . . . 0.0 110.842 -179.564 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -96.48 118.5 33.11 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.141 0.496 . . . . 0.0 110.928 -179.424 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -65.32 -47.95 74.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.857 -179.945 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' B' B ' 265' ' ' GLN . . . . . 0.619 ' HG2' HD11 ' A' ' 24' ' ' LEU . 1.3 mp0 -95.15 164.84 18.22 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.143 -178.436 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -64.34 149.63 89.78 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 122.91 2.406 . . . . 0.0 112.696 -179.575 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 47.7 pt . . . . . 0 C--N 1.33 -0.243 0 CA-C-O 121.366 0.603 . . . . 0.0 111.436 -179.851 . . . . . . . . 0 0 . 1 . 060 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.2 m . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.915 0.388 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 060 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.1 mtt85 -90.08 136.45 33.04 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.657 -178.559 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -127.59 137.35 52.55 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.787 179.482 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.65 HD11 ' HB3' ' A' ' 95' ' ' PHE . 40.6 tp -115.67 134.0 55.48 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.651 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.0 t -111.76 130.98 64.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -179.799 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.459 ' CG2' HD12 ' B' ' 261' ' ' ILE . 4.2 m -90.45 111.76 23.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.393 0.616 . . . . 0.0 112.09 -178.644 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 95.2 mt -79.97 142.13 14.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.703 178.64 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -91.42 159.97 15.7 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.021 0.439 . . . . 0.0 111.368 -179.832 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 91.3 mtm180 -57.68 -29.38 64.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.282 -179.68 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.7 t -80.69 -11.01 59.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.339 179.557 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.63 34.82 6.42 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.356 -0.697 . . . . 0.0 111.356 -179.985 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.4 t -121.65 131.33 73.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.604 0.24 . . . . 0.0 110.696 179.531 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -73.27 135.7 44.49 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.146 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -124.82 -117.08 2.21 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.145 -179.288 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -73.62 144.55 35.83 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.153 1.902 . . . . 0.0 113.056 -178.581 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.424 ' O ' ' CG2' ' B' ' 267' ' ' ILE . 9.1 m-70 -102.63 149.36 24.51 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.93 179.602 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -127.22 104.37 22.44 Favored Pre-proline 0 CA--C 1.536 0.437 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.538 -178.759 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.51 ' O ' ' NE2' ' B' ' 265' ' ' GLN . 61.5 Cg_endo -75.25 134.91 17.98 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.359 1.373 . . . . 0.0 112.433 -179.399 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 68.2 mt -88.98 54.27 2.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.341 -178.714 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.3 p -61.21 -20.53 62.89 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.984 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 80.8 mt -84.91 141.08 30.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.451 179.165 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.9 p -67.81 -15.9 63.85 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -178.595 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.513 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 85.6 m -132.52 134.72 45.35 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.071 179.905 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.7 t -127.8 115.78 19.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.226 179.409 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.495 HD21 ' HG2' ' A' ' 47' ' ' GLN . 43.1 tp -114.5 128.68 56.46 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.487 -178.991 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.622 ' CE2' HD12 ' A' ' 37' ' ' ILE . 3.4 m-85 -107.11 136.48 46.88 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.205 179.297 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 163.7 -175.87 39.85 Favored Glycine 0 N--CA 1.467 0.766 0 C-N-CA 120.094 -1.05 . . . . 0.0 112.591 178.88 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.626 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 84.1 mtm-85 -72.34 -30.2 64.52 Favored 'General case' 0 CA--C 1.522 -0.111 0 CA-C-O 121.035 0.445 . . . . 0.0 110.06 179.311 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.511 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -55.77 138.78 43.91 Favored Glycine 0 CA--C 1.523 0.54 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.401 -177.98 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.435 HG23 ' N ' ' A' ' 34' ' ' GLU . 9.4 tp -69.09 -41.15 81.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.84 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.435 ' N ' HG23 ' A' ' 33' ' ' ILE . 52.3 tp10 -54.04 -18.24 3.41 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 178.767 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.511 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 18.7 m -66.81 139.18 57.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.577 -179.769 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.513 ' OD2' ' O ' ' A' ' 26' ' ' THR . 60.5 m-20 -62.47 -34.73 77.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.613 -179.13 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.622 HD12 ' CE2' ' A' ' 29' ' ' PHE . 96.8 mt -127.18 120.84 56.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 177.796 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 51.3 ttt180 -108.39 133.94 51.87 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.26 -179.026 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 79.5 mt -117.49 133.93 62.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.439 -179.657 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -79.45 29.91 0.23 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.466 -178.096 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 41' ' ' LEU . 24.1 mt -98.49 125.82 41.57 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.915 179.39 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.94 -9.07 24.13 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.369 2.046 . . . . 0.0 113.326 -178.749 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.578 HG21 ' CE2' ' B' ' 241' ' ' PHE . 22.0 m -98.94 7.34 8.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.633 -179.797 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.626 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 53.6 t -96.7 135.75 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.809 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.0 m -70.01 171.33 9.68 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.114 0.483 . . . . 0.0 111.638 -179.234 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -61.67 -41.55 97.69 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.405 -179.044 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.633 ' O ' ' N ' ' A' ' 49' ' ' CYS . 97.1 mt-30 -112.5 -18.88 12.31 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 123.384 0.428 . . . . 0.0 110.757 -179.92 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 16.0 t60 36.93 -76.23 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 179.513 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.633 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.12 136.23 48.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.317 0.58 . . . . 0.0 112.121 -178.856 . . . . . . . . 3 3 . 1 . 060 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -126.27 127.98 46.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.259 179.623 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 95.5 mt -116.29 134.36 59.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.998 -179.916 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -114.71 140.3 48.97 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.331 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 50.1 mm -107.66 120.41 58.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.185 -0.606 . . . . 0.0 111.821 -179.11 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.422 ' O ' ' N ' ' A' ' 56' ' ' GLN . 98.5 m-70 -123.68 133.36 53.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.661 178.488 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 54' ' ' HIS . 98.7 mt-10 -39.56 -31.81 0.11 Allowed 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.415 -0.514 . . . . 0.0 109.938 -178.261 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.422 ' N ' ' O ' ' A' ' 54' ' ' HIS . 85.9 mt-30 -63.2 -67.82 0.39 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.476 178.894 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.424 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 7.1 tp10 -152.22 -153.54 0.49 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.529 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.432 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -131.71 134.14 45.59 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.644 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.3 mt -119.14 130.61 73.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -178.262 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.684 HD22 ' CD1' ' A' ' 88' ' ' ILE . 26.3 tp -95.7 127.46 41.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.754 179.201 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -114.4 138.23 50.82 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.596 -179.409 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.428 ' C ' ' OD1' ' A' ' 62' ' ' ASN . 55.6 t-20 -96.08 106.2 18.35 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -178.54 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -101.56 -12.16 18.7 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.947 0.403 . . . . 0.0 110.038 178.425 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.13 104.78 3.72 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.369 179.613 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.5 p -88.29 -19.49 26.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.164 0.506 . . . . 0.0 109.831 179.648 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.66 -44.49 12.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.783 -179.874 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 -140.62 98.3 7.18 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.181 -179.715 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -54.91 143.99 69.51 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.279 1.986 . . . . 0.0 112.673 -179.614 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.1 m -70.28 136.57 49.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.117 179.32 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -101.72 141.1 35.1 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.442 179.937 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.686 HG13 ' OD1' ' A' ' 86' ' ' ASP . 51.6 t -126.15 136.21 61.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.649 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 51.27 33.61 10.06 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -179.821 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.41 28.42 71.27 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.162 -179.968 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.5 t -140.18 138.34 35.08 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.259 -179.727 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 64.1 t -69.3 131.82 33.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.896 -179.34 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.3 100.39 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.765 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -84.33 -16.42 43.02 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.972 -179.013 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.23 160.82 29.82 Favored Pre-proline 0 C--O 1.219 -0.524 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.238 179.866 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -58.24 142.27 97.24 Favored 'Trans proline' 0 N--CA 1.502 1.989 0 C-N-CA 121.932 1.755 . . . . 0.0 112.968 -179.151 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.3 p -142.15 141.08 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 120.996 0.427 . . . . 0.0 111.459 179.575 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -74.52 131.05 40.67 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.41 179.492 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.432 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 96.7 mt -83.46 136.86 34.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.171 0.51 . . . . 0.0 110.96 -179.984 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -128.22 151.2 49.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.152 -179.785 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.459 ' ND1' ' OD1' ' A' ' 99' ' ' ASN . 4.6 t60 -53.45 120.21 5.8 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.383 -179.209 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.13 -15.7 27.92 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -179.34 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.686 ' OD1' HG13 ' A' ' 71' ' ' VAL . 65.4 t0 -73.75 124.9 26.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.007 0.432 . . . . 0.0 110.245 179.753 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.448 HG22 ' HA ' ' A' ' 96' ' ' ARG . 26.2 t -104.57 133.38 48.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.127 -178.953 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.684 ' CD1' HD22 ' A' ' 60' ' ' LEU . 33.1 mm -90.08 130.91 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.1 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.5 m -121.56 126.28 48.76 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -177.84 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.524 ' O ' ' N ' ' A' ' 92' ' ' ASP . 91.9 mt -115.75 125.3 72.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.843 178.612 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.518 HG23 ' SG ' ' B' ' 237' ' ' CYS . 42.1 mm 35.66 -93.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.974 179.261 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 90' ' ' ILE . 28.1 t70 -122.85 19.29 10.18 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.745 0.307 . . . . 0.0 111.294 -179.711 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.499 ' HG3' HH22 ' B' ' 245' ' ' ARG . 99.1 mtt180 -129.75 145.22 51.56 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.443 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 60.8 p -140.63 157.04 46.04 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 119.634 -0.826 . . . . 0.0 111.35 -179.95 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.65 ' HB3' HD11 ' A' ' 7' ' ' LEU . 46.6 m-85 -125.87 122.13 35.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.894 179.893 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.509 ' O ' HD12 ' A' ' 7' ' ' LEU . 52.2 ttt85 -82.49 128.5 34.34 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.582 -179.757 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -96.54 127.79 42.86 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.739 179.871 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -134.22 124.52 26.1 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.639 179.888 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.459 ' OD1' ' ND1' ' A' ' 84' ' ' HIS . 46.6 p30 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.71 -179.863 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo . . . . . 0 N--CA 1.485 1.024 0 CA-C-O 121.173 0.406 . . . . 0.0 112.562 . . . . . . . . . 0 0 . 1 . 060 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.487 HG13 ' O ' ' B' ' 236' ' ' VAL . 3.0 p -101.55 125.95 55.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.722 -179.814 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' B' B ' 237' ' ' CYS . . . . . 0.518 ' SG ' HG23 ' A' ' 91' ' ' ILE . 32.1 t . . . . . 0 N--CA 1.453 -0.314 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.533 179.689 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo . . . . . 0 N--CA 1.494 1.533 0 CA-C-O 120.75 0.229 . . . . 0.0 111.801 . . . . . . . . . 0 0 . 1 . 060 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 96.7 m -71.95 -43.89 64.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.582 0.706 . . . . 0.0 109.334 178.13 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.578 ' CE2' HG21 ' A' ' 43' ' ' VAL . 80.8 t80 -57.85 -46.15 85.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.172 -179.44 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 89.0 mt -63.73 -42.19 97.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.541 -179.634 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -64.85 -40.01 94.48 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.412 -179.254 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -61.71 -44.98 95.89 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.073 -179.458 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.499 HH22 ' HG3' ' A' ' 93' ' ' ARG . 79.9 mtp180 -63.2 -40.42 97.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.36 -179.475 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.95 -39.69 95.4 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.924 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 75.2 m -64.06 -45.03 90.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.35 177.942 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 -61.58 -37.31 83.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.786 -179.761 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 39.1 t . . . . . 0 C--N 1.332 -0.17 0 C-N-CA 119.951 -0.699 . . . . 0.0 109.263 178.644 . . . . . . . . 0 0 . 1 . 060 nuclear build core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 . . . . . 0 CA--C 1.53 0.196 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 . . . . . . . . . 0 0 . 1 . 060 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.459 HD12 ' CG2' ' A' ' 9' ' ' THR . 95.7 mt -103.76 137.42 32.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 177.909 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 69.2 t -125.38 132.44 71.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 120.421 -0.511 . . . . 0.0 110.544 -178.715 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -97.71 122.61 40.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.2 0.524 . . . . 0.0 111.734 -178.365 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -69.26 -42.8 75.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.551 179.899 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' B' B ' 265' ' ' GLN . . . . . 0.51 ' NE2' ' O ' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -88.06 161.21 44.41 Favored Pre-proline 0 CA--C 1.518 -0.269 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.933 -178.328 . . . . . . . . 3 3 . 1 . 060 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -59.23 145.68 97.0 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 121.973 1.782 . . . . 0.0 109.924 178.633 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' B' B ' 267' ' ' ILE . . . . . 0.424 ' CG2' ' O ' ' A' ' 19' ' ' HIS . 4.3 mt . . . . . 0 C--N 1.326 -0.443 0 C-N-CA 119.946 -0.702 . . . . 0.0 110.953 -178.081 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 26.0 m . . . . . 0 N--CA 1.463 0.177 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 . . . . . . . . . 0 0 . 1 . 061 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.724 ' NH1' ' HB2' ' A' ' 58' ' ' ALA . 99.8 mtt180 -98.33 136.34 38.64 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.21 -177.667 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.1 mtm-85 -138.25 150.19 46.45 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.808 -179.807 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.633 HD11 HD11 ' A' ' 22' ' ' LEU . 84.5 mt -115.0 143.43 45.2 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.744 -179.908 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.4 t -115.97 127.66 73.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.338 179.07 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 m -77.85 134.16 38.02 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.647 0.737 . . . . 0.0 112.156 -178.888 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.515 ' CD1' ' OD1' ' A' ' 16' ' ' ASP . 50.5 mm -104.47 134.23 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 114.653 -1.158 . . . . 0.0 107.943 177.086 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -96.67 159.81 14.73 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.197 0.522 . . . . 0.0 111.103 -179.246 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.421 ' CB ' HG21 ' B' ' 249' ' ' VAL . 84.7 mtt-85 -57.52 -31.1 65.71 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.111 -178.84 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.421 ' OG ' HG22 ' A' ' 15' ' ' VAL . 80.2 p -72.97 -15.15 61.55 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.808 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.7 17.04 46.42 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.647 179.948 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.421 HG22 ' OG ' ' A' ' 13' ' ' SER . 4.3 m -108.15 139.72 29.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.127 0.489 . . . . 0.0 110.632 -179.845 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.515 ' OD1' ' CD1' ' A' ' 10' ' ' ILE . 99.0 m-20 -76.76 138.5 39.95 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.953 179.849 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -128.48 -117.72 2.04 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 120.193 -1.003 . . . . 0.0 111.653 -179.774 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -74.73 151.58 41.16 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.6 2.2 . . . . 0.0 112.635 -179.126 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -111.17 144.32 40.5 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.265 179.28 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.561 ' CD2' HD11 ' A' ' 37' ' ' ILE . 38.8 t80 -108.28 94.64 13.76 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.582 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.83 137.3 29.4 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 121.169 1.246 . . . . 0.0 111.855 -178.795 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.633 HD11 HD11 ' A' ' 7' ' ' LEU . 97.9 mt -93.18 107.75 19.5 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.144 0.497 . . . . 0.0 111.419 -178.755 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 94.4 p -111.53 -6.34 14.43 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.348 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 70.7 mt -104.32 146.69 28.44 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.764 -179.739 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 83.8 p -66.32 -16.56 64.14 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.75 -178.754 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 29.8 m -132.9 134.16 44.22 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.939 -179.43 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.629 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 9.2 t -127.39 120.77 29.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.881 178.839 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.444 HD21 ' OE1' ' A' ' 47' ' ' GLN . 32.0 tp -118.5 128.46 54.61 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.788 0.328 . . . . 0.0 111.38 -178.428 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.74 ' CE2' HD12 ' A' ' 37' ' ' ILE . 14.5 m-85 -105.15 140.15 38.75 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.561 179.12 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 153.38 -179.58 29.63 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 119.944 -1.122 . . . . 0.0 112.637 178.537 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.499 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 45.3 mtm180 -70.04 -33.05 71.47 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.03 0.443 . . . . 0.0 110.637 178.516 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.57 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -52.96 141.31 29.44 Favored Glycine 0 CA--C 1.521 0.449 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.95 -178.401 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.648 HG23 ' NH2' ' A' ' 38' ' ' ARG . 78.7 mt -63.05 -43.05 98.8 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.162 178.974 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.406 ' HA ' ' NZ ' ' B' ' 264' ' ' LYS . 97.2 mt-10 -51.1 -18.85 0.93 Allowed 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.403 -0.519 . . . . 0.0 109.666 179.67 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.57 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 23.0 m -67.26 122.58 18.18 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.163 -179.527 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -57.05 -22.86 42.39 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -179.534 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.74 HD12 ' CE2' ' A' ' 29' ' ' PHE . 84.2 mt -130.98 118.28 40.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.987 177.904 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.648 ' NH2' HG23 ' A' ' 33' ' ' ILE . 57.4 mtt180 -99.74 133.5 44.0 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.29 -179.022 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 97.4 mt -116.81 126.93 74.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 120.417 -0.513 . . . . 0.0 109.999 179.339 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -75.27 42.64 0.2 Allowed 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -177.104 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.686 HD21 ' OE1' ' B' ' 260' ' ' GLU . 85.4 mt -118.43 131.48 24.22 Favored Pre-proline 0 C--N 1.326 -0.451 0 C-N-CA 120.521 -0.472 . . . . 0.0 111.098 179.657 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.41 -10.32 23.81 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 122.235 1.957 . . . . 0.0 111.892 179.786 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.443 HG21 ' CE2' ' B' ' 241' ' ' PHE . 19.4 m -96.02 2.69 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.056 179.724 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.499 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 37.3 t -99.44 104.02 15.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.916 0.388 . . . . 0.0 111.262 -179.621 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.471 ' O ' ' O ' ' A' ' 44' ' ' VAL . 5.0 m -37.92 161.35 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.301 0.572 . . . . 0.0 111.108 -179.797 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.3 mttp -63.5 -38.71 92.18 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.82 -179.096 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.599 ' O ' ' N ' ' A' ' 49' ' ' CYS . 96.2 mm-40 -108.9 -25.53 10.71 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.264 0.554 . . . . 0.0 110.417 -179.482 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.411 ' NE2' HG23 ' A' ' 90' ' ' ILE . 18.2 t60 38.67 -76.33 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 179.467 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.599 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.57 135.41 46.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.132 0.492 . . . . 0.0 112.018 -178.162 . . . . . . . . 3 3 . 1 . 061 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -130.14 131.0 45.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.808 179.89 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 91.1 mt -115.53 136.03 53.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.222 179.65 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -118.82 128.9 54.9 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.412 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.52 HG23 ' NH1' ' A' ' 5' ' ' ARG . 97.0 mt -105.67 114.26 44.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.626 -179.508 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.558 ' O ' ' N ' ' A' ' 56' ' ' GLN . 79.7 m-70 -112.22 143.53 43.12 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.336 179.385 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.459 ' C ' ' O ' ' A' ' 54' ' ' HIS . 98.5 mt-10 -40.09 -25.48 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -179.699 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.558 ' N ' ' O ' ' A' ' 54' ' ' HIS . 82.8 mt-30 -67.73 -68.96 0.35 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.407 178.519 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.452 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 4.1 tp10 -160.4 -162.91 1.02 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.724 179.957 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.724 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -111.19 124.41 52.16 Favored 'General case' 0 N--CA 1.461 0.119 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.326 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 79.4 mt -116.58 131.15 70.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.802 -178.36 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.3 tp -96.86 129.83 44.24 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.487 179.836 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -113.13 133.48 55.01 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.235 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.443 ' ND2' ' H ' ' A' ' 69' ' ' THR . 9.6 t-20 -96.26 108.48 20.98 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.496 -179.374 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -99.75 -9.53 22.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.425 179.896 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.9 t -74.17 100.56 3.7 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.508 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.4 m -84.17 -22.7 30.88 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.428 -179.767 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.519 HG22 HG22 ' B' ' 236' ' ' VAL . 0.2 OUTLIER -78.34 -43.72 27.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.147 0.498 . . . . 0.0 110.222 179.993 . . . . . . . . 3 3 . 1 . 061 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.415 ' OD1' ' O ' ' A' ' 66' ' ' THR . 22.8 m-20 -140.88 100.41 6.57 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.749 -179.833 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.583 ' HB2' HG13 ' A' ' 75' ' ' VAL . 32.1 Cg_exo -57.48 147.24 79.56 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 121.954 1.77 . . . . 0.0 112.438 -179.656 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.443 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 10.3 m -74.61 151.74 39.33 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.182 179.234 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -111.23 140.67 45.6 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.267 179.932 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.699 HG13 ' OD1' ' A' ' 86' ' ' ASP . 55.8 t -129.99 134.39 62.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.962 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 52.08 32.0 9.72 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -179.024 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.89 29.12 67.59 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.528 -179.834 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.7 m -141.82 138.5 32.24 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.583 -179.64 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.583 HG13 ' HB2' ' A' ' 68' ' ' PRO . 40.5 t -68.22 140.5 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.208 -179.275 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 9.2 pt -113.0 92.18 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 121.272 0.558 . . . . 0.0 110.164 178.306 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -64.83 -29.37 70.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.98 -179.779 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.423 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.8 OUTLIER -125.28 177.78 1.74 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.986 179.383 . . . . . . . . 3 3 . 1 . 061 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.423 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 36.0 Cg_exo -60.43 145.68 98.24 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 122.527 2.152 . . . . 0.0 112.097 179.814 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.8 p -137.73 141.22 39.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-O 121.166 0.507 . . . . 0.0 111.365 -179.778 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 45.3 ttm180 -79.88 131.97 35.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.711 179.68 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 89.3 mt -84.54 138.39 32.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.899 -179.043 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -130.84 152.57 50.03 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.75 179.065 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -55.88 119.09 5.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.84 0.352 . . . . 0.0 110.817 -179.451 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.57 -9.0 35.01 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.824 -0.911 . . . . 0.0 110.824 -179.675 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.699 ' OD1' HG13 ' A' ' 71' ' ' VAL . 61.0 t0 -75.61 126.58 31.28 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.727 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 39.9 t -107.35 131.07 58.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.788 -179.032 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 87.4 mt -97.0 131.51 43.62 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.396 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.9 m -122.46 125.38 45.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.566 0.698 . . . . 0.0 112.033 -178.429 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.455 ' O ' ' C ' ' A' ' 91' ' ' ILE . 95.7 mt -113.25 124.35 69.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.471 178.912 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.668 HG23 ' SG ' ' B' ' 237' ' ' CYS . 95.0 mt 35.09 -99.95 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 121.166 -0.213 . . . . 0.0 110.527 -178.612 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.518 ' N ' HG22 ' A' ' 91' ' ' ILE . 42.8 t0 -116.41 20.22 14.3 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.025 0.441 . . . . 0.0 110.929 179.745 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.626 ' CZ ' ' CD1' ' A' ' 41' ' ' LEU . 29.9 mtm-85 -130.13 142.34 50.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.473 -179.783 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 30.2 t -140.48 152.4 45.59 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.637 -179.037 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -123.31 122.0 37.24 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.157 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -83.98 134.13 34.66 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.827 -179.496 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -92.81 120.82 33.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.579 179.807 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -123.2 116.54 23.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.018 179.735 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 . . . . . 0 C--N 1.329 -0.305 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.329 179.768 . . . . . . . . 0 0 . 1 . 061 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo . . . . . 0 N--CA 1.488 1.182 0 CA-C-O 121.032 0.347 . . . . 0.0 111.707 . . . . . . . . . 0 0 . 1 . 061 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.519 HG22 HG22 ' A' ' 66' ' ' THR . 42.7 t -61.35 136.36 24.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.628 179.612 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' B' B ' 237' ' ' CYS . . . . . 0.668 ' SG ' HG23 ' A' ' 91' ' ' ILE . 14.9 t . . . . . 0 C--N 1.328 -0.343 0 C-N-CA 120.493 -0.483 . . . . 0.0 109.737 -179.787 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo . . . . . 0 N--CA 1.499 1.802 0 N-CA-C 113.25 0.442 . . . . 0.0 113.25 . . . . . . . . . 0 0 . 1 . 061 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 20.7 m -72.93 -49.2 30.95 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.299 -0.561 . . . . 0.0 110.091 179.16 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.443 ' CE2' HG21 ' A' ' 43' ' ' VAL . 82.2 t80 -58.08 -47.49 83.01 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.324 -179.066 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 86.8 mt -64.48 -42.18 96.04 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -179.177 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -65.54 -39.36 91.65 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.201 -0.6 . . . . 0.0 111.099 -179.539 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -61.84 -42.88 99.57 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.167 -0.613 . . . . 0.0 109.591 179.784 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' B' B ' 245' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -63.07 -41.23 99.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.717 -179.846 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -62.1 -42.66 99.45 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.45 0.643 . . . . 0.0 109.89 179.41 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 67.3 p -67.83 -43.99 78.27 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.245 -0.888 . . . . 0.0 109.129 178.652 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -61.39 -39.49 90.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.388 179.882 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' B' B ' 249' ' ' VAL . . . . . 0.421 HG21 ' CB ' ' A' ' 12' ' ' ARG . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.087 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.872 179.674 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.686 ' OE1' HD21 ' A' ' 41' ' ' LEU . 96.7 mt-10 . . . . . 0 CA--C 1.531 0.242 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 . . . . . . . . . 1 1 . 1 . 061 nuclear build core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 80.8 mt -119.46 132.33 69.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.35 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 51.1 t -126.79 135.61 63.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.021 0.439 . . . . 0.0 110.874 -179.69 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -94.59 117.44 30.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.186 0.517 . . . . 0.0 110.78 -179.176 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' B' B ' 264' ' ' LYS . . . . . 0.406 ' NZ ' ' HA ' ' A' ' 34' ' ' GLU . 88.8 tttt -70.53 -44.23 67.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.79 -179.69 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.68 162.18 26.39 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.771 -179.032 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -59.94 151.74 69.52 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.9 2.4 . . . . 0.0 111.588 179.364 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 47.8 pt . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 121.44 0.638 . . . . 0.0 111.827 -178.708 . . . . . . . . 0 0 . 1 . 062 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 30.3 p . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 120.951 0.405 . . . . 0.0 110.629 . . . . . . . . . 0 0 . 1 . 062 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.631 ' NH1' ' HB2' ' A' ' 58' ' ' ALA . 93.7 mtt-85 -91.68 131.2 37.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.819 -179.27 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -135.23 144.62 47.0 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.452 179.312 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.855 HD11 HD11 ' A' ' 22' ' ' LEU . 69.3 mt -119.64 146.46 45.54 Favored 'General case' 0 CA--C 1.527 0.083 0 CA-C-O 121.025 0.44 . . . . 0.0 111.451 -179.389 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.2 t -117.87 129.79 73.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.584 178.9 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.426 HG23 ' CD1' ' B' ' 261' ' ' ILE . 1.9 m -91.35 114.46 27.0 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.933 0.397 . . . . 0.0 111.067 -179.631 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 92.9 mt -81.11 144.66 10.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.282 179.508 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.456 ' HB2' ' H ' ' A' ' 15' ' ' VAL . 71.3 mmtt -84.78 150.76 24.83 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.339 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.613 HH11 HH11 ' B' ' 245' ' ' ARG . 87.8 mtm180 -58.28 -24.99 61.26 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -179.888 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.447 ' HA ' HG11 ' B' ' 249' ' ' VAL . 28.1 t -76.73 -13.03 60.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.876 178.738 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.97 35.27 6.82 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 179.946 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.456 ' H ' ' HB2' ' A' ' 11' ' ' LYS . 48.0 t -121.39 135.6 61.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.734 0.302 . . . . 0.0 110.888 -179.861 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -71.29 118.67 14.38 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.886 179.384 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -111.38 -126.43 4.87 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 120.976 -0.631 . . . . 0.0 111.751 -179.017 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.63 148.68 42.38 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.236 1.958 . . . . 0.0 112.196 -179.239 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -105.77 154.57 20.3 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.647 179.801 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.832 ' CD2' HD11 ' A' ' 37' ' ' ILE . 51.5 t80 -122.44 92.37 49.01 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.1 -179.33 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -74.16 139.92 27.3 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 121.331 1.354 . . . . 0.0 111.557 -179.517 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.855 HD11 HD11 ' A' ' 7' ' ' LEU . 81.3 mt -102.54 125.29 49.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.22 0.533 . . . . 0.0 111.798 -178.176 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 61.6 p -121.71 -2.73 9.31 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.381 -0.827 . . . . 0.0 108.806 178.292 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.9 mt -104.82 147.17 28.02 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.154 -179.203 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 90.6 p -68.63 -17.15 64.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.001 -178.912 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 44.2 m -128.53 131.78 48.27 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.365 0.603 . . . . 0.0 111.997 -179.121 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.683 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -128.52 121.6 29.22 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.188 178.896 . . . . . . . . 3 3 . 1 . 062 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.516 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 42.8 tp -120.76 126.43 50.13 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -178.208 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.683 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 66.0 m-85 -103.08 145.14 30.35 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 178.616 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 155.64 -169.87 33.49 Favored Glycine 0 C--N 1.321 -0.27 0 C-N-CA 119.886 -1.15 . . . . 0.0 112.273 178.611 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 31' ' ' ARG . 33.2 ttp-105 -86.64 -31.11 21.28 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -179.624 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -57.09 152.09 25.24 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-N 116.217 -0.447 . . . . 0.0 112.168 -178.977 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.421 ' CD1' ' CZ ' ' A' ' 38' ' ' ARG . 37.5 mm -63.93 -44.04 97.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-O 120.766 0.317 . . . . 0.0 110.93 179.93 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -55.74 -17.5 6.14 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.095 -179.075 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 83.2 m -64.05 119.65 10.53 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.662 -179.71 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.589 ' OD2' ' SG ' ' A' ' 27' ' ' CYS . 12.0 p-10 -56.54 -24.07 44.26 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.97 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.832 HD11 ' CD2' ' A' ' 20' ' ' PHE . 45.2 mm -126.17 116.33 45.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.1 -0.955 . . . . 0.0 108.761 176.803 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.421 ' CZ ' ' CD1' ' A' ' 33' ' ' ILE . 84.5 mtp180 -100.97 132.24 46.48 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -179.195 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.6 mt -123.08 131.53 73.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.173 0.511 . . . . 0.0 111.058 -179.341 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -81.75 35.18 0.41 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.642 -178.628 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.749 HD11 ' NE ' ' A' ' 93' ' ' ARG . 40.3 mt -100.17 115.72 65.21 Favored Pre-proline 0 C--N 1.325 -0.494 0 C-N-CA 120.388 -0.525 . . . . 0.0 110.391 179.502 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -56.22 -15.4 14.42 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 121.944 1.763 . . . . 0.0 112.421 178.794 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.445 HG23 HG13 ' A' ' 91' ' ' ILE . 25.9 m -98.24 8.32 7.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.556 -179.583 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.7 t -99.21 132.51 44.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.103 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.2 m -71.96 169.06 16.7 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.585 0.707 . . . . 0.0 111.775 -178.829 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -64.78 -40.69 95.67 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.671 -1.15 . . . . 0.0 111.457 -179.076 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.602 ' O ' ' N ' ' A' ' 49' ' ' CYS . 93.7 mm-40 -106.91 -23.86 12.22 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.259 0.552 . . . . 0.0 110.036 179.821 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.6 t60 38.17 -78.46 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.144 -0.935 . . . . 0.0 112.975 179.487 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.602 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.1 OUTLIER -135.36 137.0 41.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.226 0.536 . . . . 0.0 111.767 -178.428 . . . . . . . . 3 3 . 1 . 062 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -124.74 128.22 48.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.603 179.155 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 82.4 mt -111.07 131.49 62.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.852 179.303 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -114.29 132.49 56.15 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.371 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.41 HD12 ' CD ' ' A' ' 5' ' ' ARG . 43.4 mm -103.33 114.32 42.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 120.161 -0.616 . . . . 0.0 111.106 -179.278 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.449 ' O ' ' C ' ' A' ' 55' ' ' GLU . 96.9 m-70 -116.71 137.17 52.39 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.633 179.195 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 54' ' ' HIS . 80.2 mm-40 -39.95 -35.73 0.39 Allowed 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.057 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -60.27 -68.63 0.28 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.013 178.804 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.582 ' OE2' ' NH1' ' A' ' 81' ' ' ARG . 9.5 pt-20 -160.37 -158.46 0.62 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.327 178.88 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.631 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -120.95 133.96 55.29 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.764 0.316 . . . . 0.0 110.917 -179.648 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 87.6 mt -116.83 131.4 69.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.3 0.571 . . . . 0.0 112.457 -178.837 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.495 HD23 HD13 ' A' ' 76' ' ' ILE . 37.5 tp -95.22 126.91 40.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.695 179.833 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -116.0 134.34 55.07 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.668 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -98.96 105.23 17.35 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.787 -179.369 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -96.83 -7.89 32.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.301 179.134 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.96 99.47 6.85 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.069 0.461 . . . . 0.0 110.627 179.906 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 91.5 p -78.39 -33.09 49.04 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.945 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.2 m -66.9 -46.09 75.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.072 -179.351 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.447 HD21 ' HA ' ' B' ' 236' ' ' VAL . 35.2 m-80 -146.05 97.27 4.51 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.835 -179.118 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.536 ' HB2' HG13 ' A' ' 75' ' ' VAL . 51.5 Cg_exo -54.6 146.67 52.58 Favored 'Trans proline' 0 N--CA 1.501 1.958 0 C-N-CA 122.625 2.217 . . . . 0.0 113.585 -179.965 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 93.4 m -72.14 138.74 47.91 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.463 178.669 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -102.35 140.73 36.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.092 -179.918 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.473 ' HB ' HD11 ' A' ' 76' ' ' ILE . 5.6 t -131.36 139.69 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.118 178.568 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 52.36 32.4 11.04 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.346 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.09 30.23 65.64 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.51 179.185 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.7 m -146.2 143.76 29.47 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 117.659 0.729 . . . . 0.0 111.798 -179.825 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.536 HG13 ' HB2' ' A' ' 68' ' ' PRO . 74.8 t -69.8 138.35 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.235 -179.376 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.536 ' CG2' ' O ' ' A' ' 78' ' ' GLU . 95.6 mt -105.15 100.31 10.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.569 179.744 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -65.94 -39.56 90.58 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.599 179.57 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.536 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.1 OUTLIER -129.63 177.48 2.16 Favored Pre-proline 0 N--CA 1.466 0.374 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.405 -178.989 . . . . . . . . 3 3 . 1 . 062 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.423 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 33.8 Cg_exo -58.93 145.05 98.53 Favored 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 122.56 2.173 . . . . 0.0 112.54 -179.45 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.4 p -142.68 141.32 27.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.508 -179.778 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.582 ' NH1' ' OE2' ' A' ' 57' ' ' GLU . 93.9 mtt-85 -73.85 133.09 43.12 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.613 -179.507 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.447 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 94.3 mt -87.15 139.24 30.77 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.356 0.598 . . . . 0.0 111.76 -179.17 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -130.89 155.36 46.88 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.727 -179.566 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -56.22 118.51 4.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.803 0.335 . . . . 0.0 110.229 -179.748 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.31 -12.52 26.13 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.367 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.46 ' OD1' HG13 ' A' ' 71' ' ' VAL . 48.1 t0 -68.99 128.19 35.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.851 0.358 . . . . 0.0 110.605 179.762 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.429 HG22 ' HG2' ' A' ' 96' ' ' ARG . 53.6 t -109.81 131.84 59.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.78 -178.81 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.4 mm -94.65 127.79 46.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.091 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 53.1 m -118.14 124.93 49.21 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.881 -179.558 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.444 ' O ' ' C ' ' A' ' 91' ' ' ILE . 96.0 mt -122.19 126.18 73.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.26 179.321 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.445 HG13 HG23 ' A' ' 43' ' ' VAL . 31.8 mm 35.87 -109.55 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.01 -179.464 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.411 ' N ' HG22 ' A' ' 91' ' ' ILE . 86.6 m-20 -103.1 11.59 36.94 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.755 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.749 ' NE ' HD11 ' A' ' 41' ' ' LEU . 17.4 ptp180 -130.88 147.25 52.51 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.827 179.822 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 29.8 t -137.07 152.75 50.4 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.736 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.407 ' HE1' HD12 ' A' ' 90' ' ' ILE . 80.5 m-85 -121.35 121.47 37.72 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.73 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.429 ' HG2' HG22 ' A' ' 87' ' ' VAL . 99.3 mtt180 -85.18 129.54 34.78 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.004 -0.679 . . . . 0.0 110.515 -179.112 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.494 ' OH ' ' ND2' ' A' ' 99' ' ' ASN . 24.3 t80 -97.37 122.83 40.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.093 0.473 . . . . 0.0 110.236 179.869 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -121.86 123.26 41.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.062 179.849 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.494 ' ND2' ' OH ' ' A' ' 97' ' ' TYR . 20.6 t-20 . . . . . 0 C--N 1.327 -0.401 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.888 -179.51 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo . . . . . 0 N--CA 1.494 1.517 0 CA-C-O 122.292 0.872 . . . . 0.0 114.041 . . . . . . . . . 0 0 . 1 . 062 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.447 ' HA ' HD21 ' A' ' 67' ' ' ASN . 0.3 OUTLIER -75.1 139.38 19.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 113.939 -1.482 . . . . 0.0 111.017 -179.244 . . . . . . . . 3 3 . 1 . 062 nuclear build core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.9 t . . . . . 0 C--O 1.232 0.152 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.225 -179.975 . . . . . . . . 0 0 . 1 . 062 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo . . . . . 0 N--CA 1.496 1.619 0 N-CA-C 113.164 0.409 . . . . 0.0 113.164 . . . . . . . . . 0 0 . 1 . 062 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 16.7 m -73.14 -47.27 45.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.258 0.551 . . . . 0.0 110.434 179.385 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -57.88 -46.81 84.32 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.633 -178.932 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 96.7 mt -63.55 -42.32 98.37 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.669 -179.241 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -66.1 -39.1 89.71 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.338 -179.668 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' B' B ' 244' ' ' ARG . . . . . 0.535 ' NH1' ' OE1' ' B' ' 248' ' ' GLN . 78.4 ttt-85 -59.83 -45.72 91.52 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.953 -179.593 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.613 HH11 HH11 ' A' ' 12' ' ' ARG . 95.6 mtt-85 -65.81 -37.14 85.45 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.483 -179.5 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -60.28 -40.65 91.16 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.817 179.667 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 78.2 p -69.97 -43.02 72.36 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.108 0.48 . . . . 0.0 110.103 178.948 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' B' B ' 248' ' ' GLN . . . . . 0.535 ' OE1' ' NH1' ' B' ' 244' ' ' ARG . 88.0 mt-30 -64.19 -36.69 84.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.321 -179.768 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' B' B ' 249' ' ' VAL . . . . . 0.562 HG23 ' O ' ' B' ' 245' ' ' ARG . 60.4 t . . . . . 0 C--N 1.329 -0.299 0 C-N-CA 120.356 -0.538 . . . . 0.0 109.912 179.444 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.587 ' CD ' HH12 ' B' ' 245' ' ' ARG . 97.0 mt-10 . . . . . 0 CA--C 1.537 0.457 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 . . . . . . . . . 1 1 . 1 . 062 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.426 ' CD1' HG23 ' A' ' 9' ' ' THR . 69.8 mt -118.43 132.37 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 178.079 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 52.3 t -124.89 132.74 70.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.232 179.46 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -93.42 117.11 29.68 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.135 0.493 . . . . 0.0 110.897 -178.259 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -67.4 -45.97 74.61 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.393 -179.87 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 25.6 mm100 -88.6 153.34 50.25 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.887 -178.729 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -61.28 147.19 96.25 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.448 2.099 . . . . 0.0 112.253 179.362 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.4 pt . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.282 -179.329 . . . . . . . . 0 0 . 1 . 063 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 46.0 p . . . . . 0 N--CA 1.471 0.599 0 CA-C-O 121.238 0.542 . . . . 0.0 110.368 . . . . . . . . . 0 0 . 1 . 063 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.8 mtt85 -85.92 131.05 34.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.324 -179.592 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -129.09 139.41 52.0 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.348 179.975 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.581 HD12 ' O ' ' A' ' 96' ' ' ARG . 32.7 tp -116.49 133.31 56.16 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.836 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 70.7 t -112.42 131.06 64.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.068 0.461 . . . . 0.0 110.174 -179.293 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.8 m -80.99 144.5 31.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.769 0.795 . . . . 0.0 112.472 -178.236 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.534 ' CD1' ' OD1' ' A' ' 16' ' ' ASP . 48.5 mm -111.86 135.78 50.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.54 178.389 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -93.48 157.95 15.96 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.318 0.58 . . . . 0.0 110.31 178.433 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.486 ' HD3' HH21 ' B' ' 245' ' ' ARG . 88.5 mtm180 -58.02 -23.49 54.42 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.435 -179.514 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 87.7 p -80.08 -13.13 59.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.329 179.913 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.19 20.06 34.07 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.56 179.228 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.4 m -115.65 138.21 46.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.166 179.301 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.534 ' OD1' ' CD1' ' A' ' 10' ' ' ILE . 83.1 m-20 -70.3 139.97 52.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.11 -179.91 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -126.22 -120.21 2.37 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 121.063 -0.589 . . . . 0.0 111.634 -179.638 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.38 146.1 39.33 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.018 1.812 . . . . 0.0 113.117 -178.621 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -104.82 145.64 30.1 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.09 179.468 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.465 ' CD2' HD11 ' A' ' 37' ' ' ILE . 61.3 t80 -119.45 103.5 46.67 Favored Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.496 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -73.64 130.06 14.34 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 121.617 1.544 . . . . 0.0 112.588 -178.433 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.2 mt -85.87 57.05 4.25 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.104 -178.666 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.59 -33.07 74.22 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.479 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.7 mt -74.91 142.5 44.01 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.139 179.791 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.59 -14.98 63.37 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.186 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.529 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 54.4 m -132.13 132.13 42.96 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.842 -179.798 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.5 t -124.57 117.16 23.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.804 178.683 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.472 HD11 ' HB3' ' A' ' 47' ' ' GLN . 32.6 tp -115.44 126.23 54.08 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.447 -178.96 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.81 ' CE2' HD12 ' A' ' 37' ' ' ILE . 4.8 m-85 -107.11 138.92 42.39 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.831 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.13 -168.78 37.29 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 120.071 -1.061 . . . . 0.0 112.577 179.424 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.711 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 83.9 mtm-85 -82.54 -26.68 32.24 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.744 0.307 . . . . 0.0 110.585 -179.753 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.474 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -61.69 134.62 47.13 Favored Glycine 0 N--CA 1.466 0.644 0 C-N-CA 121.354 -0.45 . . . . 0.0 112.349 -178.018 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.449 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.7 tp -62.79 -41.43 92.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.101 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.449 ' N ' HG23 ' A' ' 33' ' ' ILE . 83.8 tt0 -51.87 -16.09 0.64 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.883 179.137 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.474 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 40.8 m -70.54 142.4 51.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.751 179.709 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.529 ' OD2' ' O ' ' A' ' 26' ' ' THR . 59.1 m-20 -60.96 -34.08 74.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.703 -179.736 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.81 HD12 ' CE2' ' A' ' 29' ' ' PHE . 85.1 mt -129.89 124.31 58.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.031 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 70.6 ttp85 -109.63 138.45 45.98 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.18 -179.407 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.495 ' CG2' HD12 ' A' ' 41' ' ' LEU . 97.7 mt -116.6 131.36 69.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.687 -179.433 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -74.82 30.78 0.09 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -178.083 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.616 ' CD1' ' CZ ' ' A' ' 93' ' ' ARG . 17.3 mt -110.36 129.81 23.55 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 120.132 -0.627 . . . . 0.0 111.954 179.921 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.48 -10.38 26.76 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.567 2.178 . . . . 0.0 112.971 -179.878 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.628 HG21 ' CE2' ' B' ' 241' ' ' PHE . 11.7 m -95.83 -1.88 10.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 121.056 -0.258 . . . . 0.0 111.407 -179.827 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.711 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 53.4 t -87.24 135.85 24.34 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.54 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.994 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.525 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 0.6 OUTLIER -62.55 162.39 10.49 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.248 0.547 . . . . 0.0 111.551 -179.183 . . . . . . . . 3 3 . 1 . 063 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -62.57 -45.1 94.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.857 -178.861 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.642 ' O ' ' N ' ' A' ' 49' ' ' CYS . 85.8 mt-30 -113.81 -12.69 12.69 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 123.937 0.773 . . . . 0.0 110.243 179.397 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.525 ' H ' ' HB3' ' A' ' 45' ' ' SER . 10.3 t60 31.01 -72.7 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 179.305 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.642 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.5 135.26 46.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.396 0.617 . . . . 0.0 112.196 -178.233 . . . . . . . . 3 3 . 1 . 063 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -126.92 128.85 47.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.054 179.307 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.2 mt -115.18 134.54 57.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.971 -179.808 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -111.98 131.35 55.45 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.039 179.036 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 51.5 mm -101.55 110.4 28.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 120.144 -0.622 . . . . 0.0 111.015 179.617 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.465 ' O ' ' C ' ' A' ' 55' ' ' GLU . 97.7 m-70 -113.54 135.33 54.01 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.267 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.465 ' C ' ' O ' ' A' ' 54' ' ' HIS . 93.2 mt-10 -41.2 -32.0 0.25 Allowed 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -179.998 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.454 ' N ' ' C ' ' A' ' 54' ' ' HIS . 99.8 mm-40 -65.23 -68.26 0.38 Allowed 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.638 178.402 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.484 ' HG3' ' NE ' ' A' ' 81' ' ' ARG . 1.0 OUTLIER -155.13 -171.84 3.96 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.539 0.685 . . . . 0.0 111.499 -179.638 . . . . . . . . 3 3 . 1 . 063 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -115.24 122.53 46.27 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.477 178.781 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.0 mt -114.55 133.58 60.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.258 0.551 . . . . 0.0 111.675 -178.423 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 21.5 tp -97.6 128.3 44.22 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.779 -179.751 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -110.45 133.61 53.12 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.09 179.689 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.431 HD21 ' HA ' ' A' ' 68' ' ' PRO . 60.8 t-20 -90.88 106.98 18.89 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.193 -179.589 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -97.95 -11.08 23.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.376 179.202 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 54.1 p -74.15 100.74 3.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.043 0.449 . . . . 0.0 110.923 179.82 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.1 p -86.2 -14.26 44.47 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.249 179.542 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.72 -42.98 8.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.954 -179.886 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.462 ' O ' ' OG ' ' A' ' 64' ' ' SER . 34.4 m-80 -136.93 99.3 10.18 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.369 179.887 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.431 ' HA ' HD21 ' A' ' 62' ' ' ASN . 49.2 Cg_exo -54.39 143.86 64.13 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.15 1.9 . . . . 0.0 112.985 -179.585 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.3 m -77.16 141.5 40.11 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.824 179.192 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -107.3 138.8 42.82 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.435 0.636 . . . . 0.0 110.821 179.975 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 66.8 t -131.4 135.07 60.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.494 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 53.84 32.35 14.89 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.035 -0.666 . . . . 0.0 110.398 -179.469 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.18 29.63 66.29 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.8 178.296 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 73.3 m -146.51 138.2 24.64 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.496 -0.482 . . . . 0.0 111.05 179.302 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -69.42 144.26 14.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.974 179.739 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.8 pt -119.14 95.09 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.133 179.048 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 78' ' ' GLU . 49.0 p-10 -71.09 -24.01 62.23 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.254 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.491 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 5.5 mt-10 -118.92 163.96 23.49 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.745 179.545 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -62.23 150.1 88.17 Favored 'Trans proline' 0 N--CA 1.501 1.943 0 C-N-CA 122.656 2.237 . . . . 0.0 112.483 179.78 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.0 p -140.54 143.87 28.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-O 121.478 0.656 . . . . 0.0 112.352 -179.003 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.484 ' NE ' ' HG3' ' A' ' 57' ' ' GLU . 68.2 ttt180 -73.33 126.79 30.95 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.558 179.245 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.0 mt -82.13 132.43 35.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.956 0.407 . . . . 0.0 110.955 -179.623 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -123.57 149.22 45.55 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.706 179.284 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -52.44 121.01 6.22 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.962 -179.249 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.01 -13.67 45.02 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.529 -0.629 . . . . 0.0 111.529 179.676 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -71.21 139.22 50.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.954 0.407 . . . . 0.0 111.095 -179.939 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.7 t -117.92 130.18 73.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.468 -178.5 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 92.7 mt -94.0 131.93 39.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.225 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.8 m -115.91 127.6 55.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.307 0.575 . . . . 0.0 112.252 -178.568 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.511 ' O ' ' C ' ' A' ' 91' ' ' ILE . 93.5 mt -125.87 124.8 67.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.176 178.346 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.537 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 72.2 mt -3.61 89.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -179.856 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.537 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 8.9 t0 86.84 -15.44 0.44 Allowed 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 177.158 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.751 ' NH1' HH22 ' B' ' 245' ' ' ARG . 23.3 mtm-85 -131.27 145.82 52.05 Favored 'General case' 0 CA--C 1.512 -0.519 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.698 -179.127 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.8 p -138.0 156.13 48.15 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 121.134 0.493 . . . . 0.0 110.164 179.567 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.56 ' HB3' HD11 ' A' ' 7' ' ' LEU . 91.2 m-85 -130.08 122.12 27.71 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.536 -179.292 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.581 ' O ' HD12 ' A' ' 7' ' ' LEU . 44.5 ttm180 -84.66 128.62 34.7 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 120.446 -0.502 . . . . 0.0 111.202 -179.616 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 92.9 t80 -91.88 125.33 36.54 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.616 179.947 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -126.5 121.22 31.73 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.807 179.539 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 . . . . . 0 C--N 1.329 -0.292 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.393 . . . . . . . . 0 0 . 1 . 063 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo . . . . . 0 N--CA 1.492 1.392 0 CA-C-O 121.028 0.345 . . . . 0.0 111.787 . . . . . . . . . 0 0 . 1 . 063 nuclear build core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 2.4 p -114.03 135.74 52.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.129 179.746 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' B' B ' 237' ' ' CYS . . . . . 0.463 ' HB2' HD13 ' A' ' 91' ' ' ILE . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 121.18 0.514 . . . . 0.0 110.071 -179.878 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo . . . . . 0 N--CA 1.49 1.287 0 N-CA-C 112.257 0.06 . . . . 0.0 112.257 . . . . . . . . . 0 0 . 1 . 063 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 27.4 p -77.08 -39.67 48.92 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.24 178.274 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.628 ' CE2' HG21 ' A' ' 43' ' ' VAL . 80.2 t80 -58.99 -47.04 86.58 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.934 -179.798 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 80.2 mt -67.27 -39.63 86.08 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.127 179.033 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -65.22 -40.88 94.69 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.824 -178.903 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 78.1 ttt-85 -63.01 -43.67 98.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 120.431 -0.507 . . . . 0.0 110.557 -179.553 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.751 HH22 ' NH1' ' A' ' 93' ' ' ARG . 85.6 mtp180 -64.53 -37.32 87.15 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.678 -178.894 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.27 -40.15 96.59 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.095 178.811 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 44.6 t -64.07 -44.18 93.18 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.701 0.763 . . . . 0.0 109.211 178.499 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -62.41 -36.32 81.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.263 179.727 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' B' B ' 249' ' ' VAL . . . . . 0.601 HG23 ' O ' ' B' ' 245' ' ' ARG . 60.0 t . . . . . 0 C--N 1.327 -0.382 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.307 179.708 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 . . . . . 0 C--O 1.227 -0.127 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 . . . . . . . . . 0 0 . 1 . 063 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.516 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 64.1 mt -108.46 135.13 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.735 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 78.4 t -127.98 136.45 60.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.913 0.387 . . . . 0.0 109.961 -179.684 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -99.68 121.11 40.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.42 -178.398 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -66.52 -45.51 79.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.932 179.217 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.41 152.2 47.21 Favored Pre-proline 0 CA--C 1.52 -0.199 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.283 -179.448 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -62.5 140.51 82.21 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.754 2.303 . . . . 0.0 112.234 -179.831 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 41.8 pt . . . . . 0 C--N 1.322 -0.599 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.01 179.14 . . . . . . . . 0 0 . 1 . 064 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 60.1 p . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.858 0.361 . . . . 0.0 110.642 . . . . . . . . . 0 0 . 1 . 064 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.9 mtt85 -90.65 126.84 36.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.505 -179.676 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -135.95 146.43 47.27 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.384 -0.526 . . . . 0.0 111.688 -179.646 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.858 HD11 HD11 ' A' ' 22' ' ' LEU . 73.3 mt -114.41 142.83 45.85 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.021 179.358 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.2 t -118.31 130.34 73.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.195 179.686 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 50.0 m -79.22 135.44 36.79 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.294 0.569 . . . . 0.0 111.956 -178.843 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.6 mt -112.51 138.11 42.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.301 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -91.71 157.15 17.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.089 0.471 . . . . 0.0 111.507 -179.009 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 85.7 mtm-85 -58.27 -24.42 59.36 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.6 -178.623 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 86.2 p -84.78 -7.92 59.02 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.261 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.44 38.8 6.53 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.82 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.9 t -122.14 134.54 65.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.897 0.38 . . . . 0.0 111.416 -179.709 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -77.09 122.53 25.1 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.705 179.824 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -114.75 -122.85 3.68 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.657 -179.435 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.38 148.99 34.56 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.406 2.071 . . . . 0.0 112.914 -178.985 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -103.97 153.8 20.4 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.919 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.465 ' CD2' HD11 ' A' ' 37' ' ' ILE . 47.0 t80 -124.23 91.15 49.96 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.245 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.0 139.71 36.5 Favored 'Trans proline' 0 C--N 1.315 -1.191 0 C-N-CA 121.253 1.302 . . . . 0.0 111.785 -179.299 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.858 HD11 HD11 ' A' ' 7' ' ' LEU . 83.1 mt -101.23 122.53 43.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.265 0.555 . . . . 0.0 111.187 -178.866 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.6 p -117.76 -6.74 11.05 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.47 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 67.2 mt -102.79 148.31 25.77 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.555 -179.623 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.9 m -72.53 -14.49 61.66 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.438 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.417 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 31.5 m -127.92 129.42 46.81 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.411 -179.799 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.2 t -123.91 119.34 29.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.272 178.268 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.5 tp -116.3 130.23 56.67 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.94 0.4 . . . . 0.0 111.355 -178.084 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.786 ' CE2' HD12 ' A' ' 37' ' ' ILE . 5.7 m-85 -109.4 138.98 44.94 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.011 -179.897 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 148.08 -171.83 28.48 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.081 178.944 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.412 ' HD2' HH11 ' A' ' 31' ' ' ARG . 47.6 mtm180 -79.1 -32.75 44.74 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 -179.919 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.557 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -45.32 147.63 1.85 Allowed Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 -178.751 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 36.2 mm -63.88 -43.51 97.82 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 CA-C-O 120.921 0.391 . . . . 0.0 110.149 179.958 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -56.87 -21.25 28.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.955 -179.654 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.557 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 59.7 m -52.87 115.16 1.69 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.133 -179.667 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.417 ' OD2' ' O ' ' A' ' 26' ' ' THR . 79.3 m-20 -57.16 -21.6 34.07 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -179.697 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.786 HD12 ' CE2' ' A' ' 29' ' ' PHE . 98.9 mt -132.25 122.24 47.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.124 -0.943 . . . . 0.0 109.334 177.037 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -104.77 135.94 45.22 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 -179.791 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.412 HD13 ' HE ' ' A' ' 93' ' ' ARG . 95.1 mt -115.26 127.72 72.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.615 -179.99 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -69.94 40.08 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -177.361 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.64 ' CD1' ' NH1' ' A' ' 93' ' ' ARG . 20.5 mt -124.18 132.32 24.29 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.957 -179.934 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.08 -7.2 19.57 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.679 2.252 . . . . 0.0 112.931 -179.509 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.492 HG21 ' CE2' ' B' ' 241' ' ' PHE . 17.2 m -99.8 2.25 10.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.685 179.53 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 29.4 t -87.94 136.54 22.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.345 179.526 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.2 m -65.9 157.2 31.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.182 0.515 . . . . 0.0 111.179 -179.659 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -62.74 -43.65 98.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.161 -178.888 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.638 ' O ' ' N ' ' A' ' 49' ' ' CYS . 96.7 mt-30 -113.99 -15.0 12.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.957 0.408 . . . . 0.0 110.511 179.677 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 18.3 t60 28.38 -74.86 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 178.875 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.638 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -128.23 133.96 48.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.258 0.552 . . . . 0.0 112.436 -178.666 . . . . . . . . 3 3 . 1 . 064 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -127.63 131.05 49.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.122 179.17 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.4 mt -115.39 133.63 61.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.894 -179.56 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -113.84 123.01 48.77 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.345 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.0 mt -105.62 113.8 43.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.448 0.642 . . . . 0.0 111.778 -178.662 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.422 ' O ' ' N ' ' A' ' 56' ' ' GLN . 82.2 m-70 -114.6 144.44 43.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.592 179.783 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 54' ' ' HIS . 78.2 mm-40 -41.07 -29.5 0.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.02 -179.02 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.422 ' N ' ' O ' ' A' ' 54' ' ' HIS . 95.7 mt-30 -64.73 -68.93 0.32 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.031 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.1 -166.1 1.99 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.061 179.86 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.42 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -113.29 127.89 56.29 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.324 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.5 mt -115.52 127.88 72.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.098 0.475 . . . . 0.0 111.795 -179.211 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.541 ' HB2' HD11 ' A' ' 82' ' ' LEU . 24.8 tp -97.42 126.95 42.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.043 179.596 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -111.2 135.33 51.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.858 179.925 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -98.83 106.9 19.22 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.974 -179.705 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -95.09 -6.64 41.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.534 178.994 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.5 t -71.65 99.84 2.18 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.493 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 79.0 p -87.21 -16.52 35.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.275 179.823 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.495 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -90.72 -42.82 10.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.278 -179.806 . . . . . . . . 3 3 . 1 . 064 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.405 HD21 ' HA ' ' B' ' 236' ' ' VAL . 56.8 m-20 -139.25 97.96 8.42 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.983 -179.802 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -56.67 146.0 78.95 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 122.321 2.014 . . . . 0.0 113.156 -179.435 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.9 m -76.68 149.95 36.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.59 179.492 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -110.77 140.03 45.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.154 -179.653 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.666 HG13 ' OD1' ' A' ' 86' ' ' ASP . 60.6 t -131.09 135.3 60.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.386 -0.824 . . . . 0.0 108.87 179.624 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 51.59 33.35 10.51 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 119.834 -0.747 . . . . 0.0 109.103 -179.835 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.3 25.96 71.65 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.066 179.531 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 67.6 m -142.18 139.91 32.22 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 117.503 0.651 . . . . 0.0 111.561 179.948 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -68.13 143.91 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.185 179.897 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.475 HG21 HG21 ' A' ' 80' ' ' VAL . 5.4 pt -116.05 94.38 3.08 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-O 121.166 0.507 . . . . 0.0 110.479 179.111 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -67.21 -25.83 66.31 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.739 179.762 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.478 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.1 OUTLIER -129.98 179.73 1.24 Allowed Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.818 -179.876 . . . . . . . . 3 3 . 1 . 064 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.478 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 23.8 Cg_exo -62.06 146.83 96.02 Favored 'Trans proline' 0 N--CA 1.5 1.878 0 C-N-CA 123.087 2.524 . . . . 0.0 112.703 -179.379 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.475 HG21 HG21 ' A' ' 76' ' ' ILE . 2.4 m -142.41 137.97 29.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.813 -179.748 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 85.2 mtt85 -73.33 129.35 37.83 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.258 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.541 HD11 ' HB2' ' A' ' 60' ' ' LEU . 95.3 mt -83.17 137.6 33.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.942 0.401 . . . . 0.0 110.493 179.987 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -131.49 156.7 45.2 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.614 -179.883 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.585 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 3.6 t-160 -59.07 118.64 6.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.029 0.442 . . . . 0.0 110.115 -179.899 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.12 -8.0 35.61 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 -179.046 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.666 ' OD1' HG13 ' A' ' 71' ' ' VAL . 64.4 t0 -77.2 126.99 31.84 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.478 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 13.0 p -107.16 137.47 37.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.471 -178.897 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 83.3 mt -103.9 128.22 57.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.502 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.5 m -123.17 126.56 47.23 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 121.624 0.726 . . . . 0.0 112.82 -178.243 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.474 ' O ' ' C ' ' A' ' 91' ' ' ILE . 97.9 mt -117.51 126.88 74.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.988 178.547 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.542 HG22 ' N ' ' A' ' 92' ' ' ASP . 96.8 mt 32.79 -98.73 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.669 -179.499 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.542 ' N ' HG22 ' A' ' 91' ' ' ILE . 97.6 m-20 -112.13 12.1 20.45 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -179.84 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.64 ' NH1' ' CD1' ' A' ' 41' ' ' LEU . 39.6 mtm-85 -126.19 142.55 51.48 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 120.984 -0.287 . . . . 0.0 110.441 -179.499 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 43.7 t -138.55 149.57 45.46 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.706 179.92 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.624 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 96.8 m-85 -121.0 121.2 37.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.038 178.558 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 55.3 ttt85 -84.45 131.03 34.71 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.546 -0.462 . . . . 0.0 109.766 -179.774 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -90.38 122.52 33.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.402 -179.753 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -124.24 120.64 32.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.843 0.354 . . . . 0.0 110.836 179.893 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.585 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 62.8 t-20 . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.221 179.688 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo . . . . . 0 N--CA 1.486 1.054 0 CA-C-O 121.248 0.436 . . . . 0.0 112.331 . . . . . . . . . 0 0 . 1 . 064 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.495 ' CG2' HG22 ' A' ' 66' ' ' THR . 49.8 t -65.5 135.68 27.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.714 -179.623 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.7 t . . . . . 0 CA--C 1.52 -0.191 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.723 . . . . . . . . 0 0 . 1 . 064 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo . . . . . 0 N--CA 1.5 1.867 0 N-CA-C 113.668 0.603 . . . . 0.0 113.668 . . . . . . . . . 0 0 . 1 . 064 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 39.8 p -73.47 -38.59 65.39 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.977 179.182 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.492 ' CE2' HG21 ' A' ' 43' ' ' VAL . 77.6 t80 -58.09 -48.14 81.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.845 -179.004 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.402 HD22 ' OD1' ' A' ' 92' ' ' ASP . 98.0 mt -67.71 -42.36 82.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.884 0.373 . . . . 0.0 111.674 -179.687 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -63.25 -45.16 92.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.884 -178.62 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -63.53 -43.82 96.05 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.841 0.353 . . . . 0.0 111.141 -179.527 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.445 ' O ' HG23 ' B' ' 249' ' ' VAL . 48.5 ttm-85 -65.27 -41.9 93.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.469 -179.334 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -63.4 -39.02 93.36 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.179 179.159 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 20.3 m -65.12 -42.64 93.74 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 177.895 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 63.6 tp60 -59.63 -35.41 74.31 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.53 -1.213 . . . . 0.0 110.179 179.493 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' B' B ' 249' ' ' VAL . . . . . 0.445 HG23 ' O ' ' B' ' 245' ' ' ARG . 49.9 t . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.873 0.368 . . . . 0.0 110.227 178.926 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 . . . . . 0 N--CA 1.455 -0.181 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 064 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.624 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 70.6 mt -115.47 134.48 58.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.168 179.94 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 54.6 t -124.16 132.91 70.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.725 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -94.54 119.02 32.57 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.387 0.613 . . . . 0.0 111.612 -177.88 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -66.83 -46.48 74.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.287 179.68 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -72.85 166.44 43.05 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.181 -179.25 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -64.26 141.26 74.65 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 121.569 1.513 . . . . 0.0 111.282 179.878 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 11.9 tt . . . . . 0 C--N 1.324 -0.517 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.34 -178.869 . . . . . . . . 0 0 . 1 . 065 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.408 ' OG1' ' N ' ' A' ' 5' ' ' ARG . 6.6 p . . . . . 0 CA--C 1.518 -0.256 0 CA-C-O 121.302 0.572 . . . . 0.0 110.326 . . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.408 ' N ' ' OG1' ' A' ' 4' ' ' THR . 85.3 mtt85 -94.21 128.24 40.54 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.816 -179.885 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -132.86 144.33 50.12 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.389 -0.525 . . . . 0.0 111.354 -179.345 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 79.9 mt -115.41 145.59 42.4 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.669 179.633 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.641 HG22 ' CD2' ' A' ' 19' ' ' HIS . 49.7 t -118.48 130.18 73.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.855 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 m -90.66 117.04 29.0 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.308 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.595 HD12 ' OG ' ' A' ' 94' ' ' SER . 96.0 mt -86.94 142.36 13.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.305 177.724 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -95.16 169.73 9.89 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.869 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.411 ' NH1' ' HB3' ' B' ' 248' ' ' GLN . 88.9 mtm180 -56.96 -29.6 63.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.8 -178.784 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.6 t -81.11 -7.35 59.54 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.757 179.295 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.27 40.19 8.67 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 -178.892 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.8 t -116.64 134.06 61.32 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.076 0 CA-C-O 120.832 0.349 . . . . 0.0 111.602 -178.713 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.468 ' C ' ' OD1' ' A' ' 16' ' ' ASP . 39.4 t0 -77.64 124.36 27.84 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.138 179.448 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -124.09 -115.56 2.16 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 120.655 -0.784 . . . . 0.0 111.408 179.94 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -72.95 144.21 37.94 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.153 1.902 . . . . 0.0 113.621 -178.808 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.641 ' CD2' HG22 ' A' ' 8' ' ' VAL . 50.9 m170 -106.05 142.41 35.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.275 179.781 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.435 ' HD1' HG22 ' B' ' 267' ' ' ILE . 45.5 t80 -114.2 93.02 29.12 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.221 -179.571 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -69.07 135.15 31.31 Favored 'Trans proline' 0 N--CA 1.488 1.187 0 C-N-CA 121.51 1.474 . . . . 0.0 111.668 -179.537 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.474 HD22 ' HB2' ' A' ' 27' ' ' CYS . 92.4 mt -84.84 80.31 9.32 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.187 -178.699 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 85.6 p -82.33 -10.85 58.93 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.078 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 58.0 mt -103.85 144.66 31.21 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.401 -179.202 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.8 t -67.5 -14.84 63.29 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.968 -179.856 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.548 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 89.2 m -131.38 133.69 45.52 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 120.696 -0.401 . . . . 0.0 111.395 -179.809 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.595 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 13.2 t -125.27 116.14 21.48 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.632 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.531 HD12 ' O ' ' A' ' 49' ' ' CYS . 43.4 tp -115.23 131.29 56.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.29 -178.161 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.607 ' CE2' HD12 ' A' ' 37' ' ' ILE . 23.3 m-85 -109.38 136.91 48.04 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.632 178.943 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 154.22 -177.19 31.76 Favored Glycine 0 C--O 1.221 -0.677 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.778 178.804 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.477 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 46.4 mtm180 -77.47 -31.08 53.48 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.646 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.508 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -51.33 150.55 6.85 Favored Glycine 0 N--CA 1.465 0.582 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.395 -178.327 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.551 HG23 ' N ' ' A' ' 34' ' ' GLU . 11.0 tp -66.44 -41.62 89.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.646 0.26 . . . . 0.0 110.533 179.967 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.551 ' N ' HG23 ' A' ' 33' ' ' ILE . 81.0 mm-40 -55.72 -24.23 33.61 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.347 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.508 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 39.0 m -53.3 118.04 3.51 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.823 179.971 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.548 ' OD2' ' O ' ' A' ' 26' ' ' THR . 93.2 m-20 -59.14 -27.99 66.15 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.855 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.607 HD12 ' CE2' ' A' ' 29' ' ' PHE . 97.9 mt -127.53 119.12 51.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 176.479 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.472 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 82.9 mtp180 -102.2 134.82 44.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.901 0.382 . . . . 0.0 111.901 -178.439 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.0 mt -122.02 130.05 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.114 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.693 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -82.93 34.36 0.45 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.001 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.715 HD11 ' CZ ' ' A' ' 93' ' ' ARG . 31.3 mt -95.65 129.03 35.71 Favored Pre-proline 0 C--N 1.325 -0.477 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.33 179.458 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.17 -12.16 27.62 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 C-N-CA 122.218 1.945 . . . . 0.0 112.361 -179.616 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.4 m -98.08 5.73 9.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.872 0.368 . . . . 0.0 110.495 -179.949 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.477 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 37.4 t -98.82 135.11 35.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.414 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.43 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 6.9 t -70.34 174.68 5.37 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.229 0.538 . . . . 0.0 111.233 -179.031 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 50.4 mttp -64.03 -41.01 97.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.1 -179.926 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.628 ' O ' ' N ' ' A' ' 49' ' ' CYS . 85.6 mt-30 -112.85 -20.08 11.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.919 -179.272 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.43 ' H ' ' HB3' ' A' ' 45' ' ' SER . 28.2 t60 39.17 -76.8 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 179.751 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.628 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.2 133.46 46.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.306 -178.548 . . . . . . . . 3 3 . 1 . 065 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -127.35 130.57 49.69 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.541 179.34 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 86.2 mt -115.98 134.86 57.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.812 -179.826 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.516 ' CD ' ' NE2' ' A' ' 54' ' ' HIS . 74.6 tt0 -120.47 125.8 48.81 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.791 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 93.9 mt -106.56 119.08 55.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.567 0.698 . . . . 0.0 112.26 -179.009 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.516 ' NE2' ' CD ' ' A' ' 52' ' ' GLU . 99.6 m-70 -112.36 140.34 47.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.605 -1.179 . . . . 0.0 108.959 178.961 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.9 mm-40 -40.78 -28.02 0.07 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 -179.86 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.462 ' N ' ' O ' ' A' ' 54' ' ' HIS . 82.3 mt-30 -65.88 -68.04 0.4 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.434 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -154.14 -171.51 3.9 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.382 -179.613 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.454 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -110.16 128.99 55.78 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.497 -0.556 . . . . 0.0 109.497 179.021 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 98.0 mt -119.02 130.96 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -178.752 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 32.1 tp -99.33 131.7 45.17 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.003 179.277 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -114.55 136.44 53.02 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.072 179.197 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -97.81 111.09 23.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.187 0.518 . . . . 0.0 111.651 -179.543 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -104.8 -10.37 17.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.484 179.91 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.4 101.46 12.02 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.491 -179.813 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 77.8 p -76.19 -35.57 59.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.257 0.551 . . . . 0.0 109.903 179.244 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.01 -43.02 99.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.285 -178.827 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -147.25 99.77 3.9 Favored Pre-proline 0 C--N 1.317 -0.834 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.484 -179.034 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -57.55 146.46 84.02 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 C-N-CA 121.783 1.656 . . . . 0.0 112.681 -178.78 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 18.2 m -70.24 136.17 49.68 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.351 178.316 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -96.94 143.9 27.37 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.171 -0.612 . . . . 0.0 111.229 -179.162 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.696 ' HB ' HD11 ' A' ' 76' ' ' ILE . 5.4 p -129.5 133.88 64.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.837 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 49.17 30.12 2.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.157 0.503 . . . . 0.0 109.952 -179.331 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 78.2 27.47 57.85 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.393 179.064 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.6 t -138.0 139.59 39.73 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.997 0.398 . . . . 0.0 110.46 179.739 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -67.78 142.29 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.846 179.907 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.696 HD11 ' HB ' ' A' ' 71' ' ' VAL . 96.6 mt -101.72 103.72 15.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.936 -179.742 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -67.63 -40.97 84.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.989 179.028 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.528 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.6 OUTLIER -134.68 179.37 1.4 Allowed Pre-proline 0 CA--C 1.53 0.186 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.727 -178.35 . . . . . . . . 3 3 . 1 . 065 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.467 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 31.8 Cg_exo -59.37 144.59 99.36 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 122.804 2.336 . . . . 0.0 112.648 -179.585 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.8 m -143.1 141.24 26.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.995 -179.806 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 91.7 mtm180 -71.68 131.39 43.09 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.526 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.454 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 96.4 mt -80.19 139.99 36.51 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.838 0.351 . . . . 0.0 110.978 -179.538 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -131.44 150.2 52.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.426 -179.903 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -55.92 123.09 13.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.908 0.385 . . . . 0.0 110.982 -179.304 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.12 -14.19 48.42 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 -179.472 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.48 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 64.9 t0 -71.4 129.75 39.6 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.028 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.447 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 95.0 t -109.36 130.55 62.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.265 -178.819 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.4 mt -97.0 131.57 43.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.984 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 63.9 m -127.97 127.63 43.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.713 0.768 . . . . 0.0 113.002 -178.512 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.607 ' O ' ' N ' ' A' ' 92' ' ' ASP . 82.2 mt -107.03 123.06 61.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 177.682 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.437 ' C ' ' O ' ' A' ' 90' ' ' ILE . 70.3 mt 38.87 -88.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 120.511 -0.475 . . . . 0.0 110.646 -179.467 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.607 ' N ' ' O ' ' A' ' 90' ' ' ILE . 32.4 t70 -128.18 16.17 6.69 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -179.746 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.715 ' CZ ' HD11 ' A' ' 41' ' ' LEU . 98.3 mtt180 -123.01 139.91 53.59 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.115 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.595 ' OG ' HD12 ' A' ' 10' ' ' ILE . 31.7 p -138.84 151.87 47.37 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 119.23 -0.988 . . . . 0.0 112.011 -179.684 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -122.1 121.61 37.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.554 -1.203 . . . . 0.0 108.364 178.958 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -83.56 133.32 34.87 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.176 -0.609 . . . . 0.0 111.48 -178.52 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -96.83 122.47 39.82 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.234 -179.615 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -123.67 124.58 43.08 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.864 179.947 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 62.9 t-20 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.787 179.478 . . . . . . . . 0 0 . 1 . 065 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 N--CA 1.487 1.104 0 CA-C-O 121.785 0.66 . . . . 0.0 113.307 . . . . . . . . . 0 0 . 1 . 065 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.42 HG13 ' O ' ' B' ' 236' ' ' VAL . 12.2 p -58.35 135.73 22.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.135 -179.642 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 10.0 t . . . . . 0 C--N 1.329 -0.311 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.742 -179.502 . . . . . . . . 0 0 . 1 . 065 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo . . . . . 0 N--CA 1.502 1.999 0 N-CA-C 114.085 0.764 . . . . 0.0 114.085 . . . . . . . . . 0 0 . 1 . 065 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 97.4 m -67.45 -47.09 71.15 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.379 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.489 ' HZ ' HD22 ' A' ' 41' ' ' LEU . 91.7 t80 -57.93 -46.21 85.4 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.335 -179.459 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 87.6 mt -65.43 -38.83 91.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.842 0.353 . . . . 0.0 110.64 179.962 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -60.77 -41.11 94.83 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.077 0.465 . . . . 0.0 110.044 -179.98 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 62.0 ttp180 -61.45 -43.17 99.34 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.195 179.877 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.658 HH12 ' HE ' ' A' ' 93' ' ' ARG . 76.0 mtp85 -60.07 -42.09 93.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.866 -179.689 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.29 -41.34 96.81 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.28 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 8.6 t -63.4 -46.13 87.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.738 178.381 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' B' B ' 248' ' ' GLN . . . . . 0.411 ' HB3' ' NH1' ' A' ' 12' ' ' ARG . 83.2 mt-30 -59.33 -38.45 80.35 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.808 -178.989 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 25.1 t . . . . . 0 N--CA 1.455 -0.207 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.677 178.846 . . . . . . . . 0 0 . 1 . 065 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.544 ' OE1' ' NH2' ' A' ' 93' ' ' ARG . 97.8 mt-10 . . . . . 0 N--CA 1.456 -0.155 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 . . . . . . . . . 1 1 . 1 . 065 nuclear build core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 76.3 mt -114.51 128.98 71.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.178 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 54.4 t -126.85 133.9 67.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.137 0.494 . . . . 0.0 110.973 -179.203 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' B' B ' 263' ' ' PHE . . . . . 0.673 ' CD2' HG21 ' B' ' 267' ' ' ILE . 54.9 m-85 -96.38 120.36 36.54 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.99 -179.299 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -64.07 -42.72 96.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.533 0.682 . . . . 0.0 110.045 179.24 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.26 171.52 5.09 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.006 -178.604 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -54.52 149.73 37.79 Favored 'Trans proline' 0 N--CA 1.501 1.953 0 C-N-CA 123.143 2.562 . . . . 0.0 114.154 -179.728 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' B' B ' 267' ' ' ILE . . . . . 0.673 HG21 ' CD2' ' B' ' 263' ' ' PHE . 33.0 pt . . . . . 0 C--O 1.232 0.178 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.001 179.907 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 68.2 p . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.952 0.406 . . . . 0.0 110.543 . . . . . . . . . 0 0 . 1 . 066 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.809 ' NH1' ' HB2' ' A' ' 58' ' ' ALA . 95.1 mtt-85 -95.5 122.11 37.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.128 -179.644 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.411 ' NE ' ' OE1' ' A' ' 98' ' ' GLU . 31.1 ptt180 -138.48 145.34 40.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.072 0.463 . . . . 0.0 111.298 -179.86 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.618 HD12 ' O ' ' A' ' 96' ' ' ARG . 36.9 tp -118.93 136.47 54.05 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.359 179.007 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.81 HG22 ' CD2' ' A' ' 19' ' ' HIS . 41.0 t -110.35 131.6 60.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.822 -178.548 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.5 m -93.47 114.73 27.19 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.156 0.503 . . . . 0.0 112.12 -179.144 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 45.7 mm -79.63 144.93 10.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.611 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -90.52 158.92 16.77 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.181 178.595 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.55 ' NE ' ' NH2' ' B' ' 245' ' ' ARG . 84.7 mtp180 -54.87 -27.84 45.6 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.801 -178.825 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 85.9 p -79.19 -10.71 59.89 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 120.876 -0.329 . . . . 0.0 111.626 179.982 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.69 33.36 7.96 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 -179.223 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.6 t -120.6 134.61 63.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.87 0.367 . . . . 0.0 110.969 -179.531 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -71.22 129.28 38.49 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.818 179.58 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -125.35 -121.53 2.54 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.527 -179.076 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.21 144.62 42.13 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.16 1.907 . . . . 0.0 113.019 -178.104 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.81 ' CD2' HG22 ' A' ' 8' ' ' VAL . 59.2 m170 -104.22 145.78 29.73 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.647 -179.443 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.726 ' CD2' HD11 ' A' ' 37' ' ' ILE . 34.7 t80 -116.21 91.37 32.19 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.992 -179.924 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -60.35 125.36 17.26 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 121.779 1.652 . . . . 0.0 111.135 179.52 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 22' ' ' LEU . 96.0 mt -84.48 50.51 1.9 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.292 -178.762 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.4 p -61.21 -23.69 65.8 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.962 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.602 HD11 ' OE1' ' B' ' 265' ' ' GLN . 64.3 mt -83.53 141.84 31.33 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.173 -179.832 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.2 m -67.25 -17.84 64.97 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.834 -178.696 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.74 133.73 40.23 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.252 -0.579 . . . . 0.0 112.029 -178.977 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.5 t -128.19 119.96 26.29 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.25 179.207 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.459 HD23 ' HA ' ' A' ' 35' ' ' CYS . 38.5 tp -111.75 128.54 56.12 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.88 -178.938 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.478 ' O ' ' O ' ' A' ' 47' ' ' GLN . 57.6 m-85 -108.35 134.86 50.57 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.329 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 156.83 -170.7 34.25 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 119.904 -1.141 . . . . 0.0 112.449 179.344 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.603 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 10.4 mtp180 -85.6 -31.45 22.61 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -179.779 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -51.45 155.45 3.77 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 -178.648 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.649 HD12 ' NH1' ' A' ' 38' ' ' ARG . 1.1 tp -66.16 -42.69 91.66 Favored 'Isoleucine or valine' 0 C--N 1.34 0.195 0 CA-C-N 117.149 0.475 . . . . 0.0 111.01 -179.707 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.474 ' N ' HG23 ' A' ' 33' ' ' ILE . 73.6 mm-40 -58.06 -16.82 14.27 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.409 -179.64 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.459 ' HA ' HD23 ' A' ' 28' ' ' LEU . 68.6 m -59.8 120.34 9.36 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.838 -179.485 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.431 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 56.5 m-20 -60.89 -32.27 71.73 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.73 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.726 HD11 ' CD2' ' A' ' 20' ' ' PHE . 48.9 mm -120.13 113.77 41.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.554 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.649 ' NH1' HD12 ' A' ' 33' ' ' ILE . 77.4 mtt180 -101.06 132.77 46.33 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.028 -0.669 . . . . 0.0 111.287 -177.876 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 95.9 mt -123.73 129.85 74.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.283 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.442 HE21 ' HA ' ' B' ' 260' ' ' GLU . 2.4 pm0 -83.56 43.74 0.92 Allowed 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -176.98 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.578 ' CD1' ' CZ ' ' A' ' 93' ' ' ARG . 39.9 mt -109.4 126.58 28.91 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 120.403 -0.519 . . . . 0.0 111.781 179.885 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -68.86 -13.84 37.63 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.174 1.916 . . . . 0.0 112.779 179.709 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.467 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 25.2 m -90.68 4.43 6.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.891 0.377 . . . . 0.0 110.701 179.996 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.603 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 54.7 t -107.03 136.43 42.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.23 -179.698 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.3 m -70.68 168.31 16.8 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.527 0.68 . . . . 0.0 111.281 -179.386 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.5 mttm -62.07 -38.77 90.06 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.109 -179.293 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.708 ' O ' ' N ' ' A' ' 49' ' ' CYS . 99.0 mt-30 -109.58 -14.98 14.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.532 -179.077 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.543 ' NE2' HG23 ' A' ' 90' ' ' ILE . 23.5 t60 37.13 -72.75 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -179.836 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.708 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -151.69 151.92 32.09 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.997 179.943 . . . . . . . . 3 3 . 1 . 066 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -138.36 143.57 39.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.96 -179.96 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.8 mt -114.39 133.06 61.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.483 179.934 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -114.67 124.58 52.18 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.494 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.4 mt -105.89 118.59 53.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -177.356 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.423 ' O ' ' C ' ' A' ' 55' ' ' GLU . 97.7 m-70 -112.97 138.43 49.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.267 -1.333 . . . . 0.0 108.718 178.055 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 54' ' ' HIS . 94.8 mt-10 -39.47 -35.67 0.31 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.186 0.517 . . . . 0.0 109.807 -178.822 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -60.26 -68.17 0.32 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.649 179.071 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.522 ' CD ' ' NH1' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -151.99 -171.26 3.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.11 0.481 . . . . 0.0 111.063 179.523 . . . . . . . . 3 3 . 1 . 066 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.809 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -110.04 129.15 55.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.398 179.505 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.4 mt -116.84 129.14 73.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.234 0.54 . . . . 0.0 112.39 -178.555 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.459 ' HB2' HD11 ' A' ' 82' ' ' LEU . 25.4 tp -98.38 128.29 44.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.439 179.669 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -112.84 134.61 54.27 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.151 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.681 HD21 ' CB ' ' A' ' 68' ' ' PRO . 61.6 t-20 -98.4 109.59 22.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.925 -178.429 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -98.71 -3.89 34.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.094 179.726 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.1 t -92.8 110.36 21.8 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.085 -179.274 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 56.3 p -93.59 -28.75 15.85 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.577 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.447 ' O ' ' OD1' ' A' ' 67' ' ' ASN . 0.3 OUTLIER -65.52 -43.68 89.29 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.834 179.734 . . . . . . . . 3 3 . 1 . 066 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.456 HD21 ' HA ' ' B' ' 236' ' ' VAL . 33.2 m-20 -149.2 103.91 3.33 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.884 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.681 ' CB ' HD21 ' A' ' 62' ' ' ASN . 68.0 Cg_endo -71.03 158.21 55.83 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 121.657 1.571 . . . . 0.0 113.337 -177.424 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.1 m -73.04 140.03 46.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.296 179.656 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.45 ' O ' ' N ' ' A' ' 89' ' ' THR . 89.3 mt-30 -102.76 142.42 33.94 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.34 -179.507 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.688 ' HB ' HD11 ' A' ' 76' ' ' ILE . 8.9 p -132.04 138.63 52.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.766 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 50.39 31.81 5.78 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 -179.616 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.68 30.03 64.63 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.493 179.962 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 65.6 m -140.7 136.35 32.53 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 117.151 0.475 . . . . 0.0 111.847 -179.235 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.417 HG13 ' HG2' ' A' ' 68' ' ' PRO . 19.8 t -63.8 137.2 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.732 179.758 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.688 HD11 ' HB ' ' A' ' 71' ' ' VAL . 92.6 mt -101.91 110.87 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 178.631 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 18.6 p-10 -75.45 -37.15 60.52 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.13 179.546 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.551 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.8 OUTLIER -133.15 -177.95 0.78 Allowed Pre-proline 0 N--CA 1.465 0.316 0 CA-C-O 120.895 0.379 . . . . 0.0 111.823 -178.938 . . . . . . . . 3 3 . 1 . 066 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.516 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 32.5 Cg_exo -59.51 144.78 99.33 Favored 'Trans proline' 0 N--CA 1.499 1.822 0 C-N-CA 122.84 2.36 . . . . 0.0 112.545 -179.653 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 23.5 m -142.22 141.39 28.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.566 -179.627 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.522 ' NH1' ' CD ' ' A' ' 57' ' ' GLU . 96.7 mtt-85 -74.97 136.71 41.31 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.785 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.459 HD11 ' HB2' ' A' ' 60' ' ' LEU . 97.7 mt -92.31 136.43 33.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.461 0.648 . . . . 0.0 111.173 -179.579 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.407 ' HG2' ' N ' ' A' ' 84' ' ' HIS . 88.5 tttt -125.31 155.53 40.08 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.824 179.965 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.407 ' N ' ' HG2' ' A' ' 83' ' ' LYS . 10.4 t60 -57.43 121.88 11.28 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.954 -179.451 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.21 -22.44 20.59 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.962 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.566 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 64.9 t0 -64.32 131.27 46.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.712 0.292 . . . . 0.0 110.835 179.656 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.503 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 39.7 t -108.88 130.86 61.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.906 -179.463 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.5 mt -91.46 128.88 42.93 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.165 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.45 ' N ' ' O ' ' A' ' 70' ' ' GLN . 53.3 m -123.78 125.51 44.85 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.677 0.751 . . . . 0.0 112.002 -178.853 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.543 HG23 ' NE2' ' A' ' 48' ' ' HIS . 95.2 mt -115.97 123.0 70.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.588 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.703 HD12 HH22 ' A' ' 93' ' ' ARG . 96.6 mt 43.53 -102.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.934 -178.768 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.643 ' N ' HG22 ' A' ' 91' ' ' ILE . 46.0 p-10 -118.39 14.67 13.8 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.166 0.508 . . . . 0.0 110.972 179.938 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.703 HH22 HD12 ' A' ' 91' ' ' ILE . 51.2 mtm-85 -122.57 143.76 49.53 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.533 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 29.0 p -139.63 153.01 47.23 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 119.499 -0.881 . . . . 0.0 111.732 -179.137 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.482 ' HB3' HD11 ' A' ' 7' ' ' LEU . 60.2 m-85 -122.51 120.78 34.87 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 114.786 -1.097 . . . . 0.0 108.686 178.906 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.618 ' O ' HD12 ' A' ' 7' ' ' LEU . 44.4 ttm180 -82.85 128.7 34.66 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.144 -0.622 . . . . 0.0 111.455 -178.657 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.549 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 83.3 t80 -97.78 127.95 44.08 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.92 179.736 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.411 ' OE1' ' NE ' ' A' ' 6' ' ' ARG . 98.2 mt-10 -130.7 123.78 30.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.048 179.637 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 63.8 t-20 . . . . . 0 C--N 1.327 -0.386 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.028 . . . . . . . . 0 0 . 1 . 066 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo . . . . . 0 N--CA 1.49 1.304 0 CA-C-O 121.798 0.666 . . . . 0.0 113.494 . . . . . . . . . 0 0 . 1 . 066 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.456 ' HA ' HD21 ' A' ' 67' ' ' ASN . 23.0 t -57.44 140.81 15.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.843 -179.067 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 49.0 t . . . . . 0 C--N 1.331 -0.211 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.599 . . . . . . . . 0 0 . 1 . 066 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo . . . . . 0 N--CA 1.498 1.767 0 N-CA-C 113.406 0.502 . . . . 0.0 113.406 . . . . . . . . . 0 0 . 1 . 066 nuclear build core ' B' B ' 240' ' ' THR . . . . . 0.737 HG22 ' NH1' ' B' ' 244' ' ' ARG . 16.9 m -73.13 -47.7 41.83 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 119.953 -0.699 . . . . 0.0 109.394 178.972 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.495 ' HZ ' HD22 ' A' ' 41' ' ' LEU . 87.7 t80 -57.49 -44.84 85.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.192 179.911 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 92.9 mt -65.32 -39.1 92.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.811 179.816 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -62.87 -42.15 99.65 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.296 -179.053 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' B' B ' 244' ' ' ARG . . . . . 0.737 ' NH1' HG22 ' B' ' 240' ' ' THR . 95.1 mtm-85 -62.84 -42.23 99.65 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.231 -179.429 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.57 ' NE ' ' OD2' ' A' ' 92' ' ' ASP . 77.2 mtp85 -63.54 -40.57 97.37 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.5 -0.48 . . . . 0.0 112.095 -179.33 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.42 -38.84 88.56 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 120.205 -0.598 . . . . 0.0 109.682 179.658 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' B' B ' 247' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 70.7 p -67.17 -42.5 84.16 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 177.959 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 75.5 mm-40 -62.7 -33.1 74.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.757 179.641 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 37.5 t . . . . . 0 N--CA 1.453 -0.308 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.978 179.583 . . . . . . . . 0 0 . 1 . 066 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.442 ' HA ' HE21 ' A' ' 40' ' ' GLN . 35.3 tp10 . . . . . 0 CA--C 1.534 0.335 0 N-CA-C 111.552 0.205 . . . . 0.0 111.552 . . . . . . . . . 1 1 . 1 . 066 nuclear build core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 63.5 mt -111.97 135.85 49.98 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 CA-C-O 120.811 0.339 . . . . 0.0 110.517 -179.719 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 38.2 t -127.63 134.2 66.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.053 179.447 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -96.69 121.02 38.07 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.991 0.424 . . . . 0.0 111.544 -178.597 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -65.15 -48.09 74.76 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.711 179.583 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' B' B ' 265' ' ' GLN . . . . . 0.602 ' OE1' HD11 ' A' ' 24' ' ' LEU . 3.8 mm-40 -95.63 157.87 35.37 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.286 -178.891 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -64.47 154.67 70.48 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 123.209 2.606 . . . . 0.0 112.575 178.987 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 36.0 pt . . . . . 0 C--N 1.332 -0.156 0 CA-C-O 121.594 0.711 . . . . 0.0 112.401 -179.346 . . . . . . . . 0 0 . 1 . 067 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.9 p . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.739 0.304 . . . . 0.0 111.414 . . . . . . . . . 0 0 . 1 . 067 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.693 ' NE ' ' CZ ' ' A' ' 97' ' ' TYR . 2.6 mmp_? -90.9 118.2 30.11 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.781 -178.805 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.6 mtp180 -129.08 137.1 51.06 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.202 0.525 . . . . 0.0 111.541 179.522 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.644 HD12 ' O ' ' A' ' 96' ' ' ARG . 22.6 tp -114.49 131.05 56.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.268 179.807 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 76.6 t -108.91 130.89 61.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.072 -179.602 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.6 m -77.71 142.93 38.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.683 -179.341 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.439 ' CD1' ' OD1' ' A' ' 16' ' ' ASP . 50.4 mm -111.11 136.16 48.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.954 178.85 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -89.91 155.64 18.99 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.53 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.54 ' HD3' HH21 ' B' ' 245' ' ' ARG . 89.7 mtm180 -59.78 -24.45 64.1 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.039 -178.951 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.4 p -82.97 -6.97 59.7 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.447 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.77 38.11 7.65 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 179.691 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.6 t -122.84 133.63 68.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.662 0.267 . . . . 0.0 110.565 179.533 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.439 ' OD1' ' CD1' ' A' ' 10' ' ' ILE . 90.9 m-20 -73.7 135.15 43.66 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.271 179.64 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -124.84 -121.57 2.57 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 120.596 -0.811 . . . . 0.0 111.897 -179.633 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.59 145.32 41.69 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.139 1.892 . . . . 0.0 112.888 -178.709 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -104.56 143.76 32.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.711 179.995 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.887 ' CD2' HD11 ' A' ' 37' ' ' ILE . 38.7 t80 -115.36 107.21 49.69 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.19 179.374 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -74.78 127.5 10.89 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 121.373 1.382 . . . . 0.0 111.758 -179.159 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 82.2 mt -84.12 48.81 1.53 Allowed 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.29 -179.383 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 93.6 p -60.72 -25.36 66.37 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.467 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.582 HD11 ' HG2' ' B' ' 265' ' ' GLN . 66.8 mt -76.04 139.02 41.24 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.383 179.986 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.2 m -63.21 -19.25 64.35 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.286 -179.489 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.467 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 22.8 m -136.81 135.0 37.58 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.478 -179.723 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.9 t -126.43 118.49 25.08 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.058 0.456 . . . . 0.0 110.182 178.104 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.523 HD12 ' O ' ' A' ' 49' ' ' CYS . 53.5 tp -114.17 132.42 56.09 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.121 -179.016 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.515 ' O ' ' O ' ' A' ' 47' ' ' GLN . 34.1 m-85 -112.04 137.34 50.2 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.376 -179.341 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 152.93 -177.96 30.3 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.304 179.17 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 45.4 mtm180 -70.6 -32.03 69.25 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 179.772 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.568 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -51.79 148.04 10.64 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 121.133 -0.556 . . . . 0.0 112.477 -178.084 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.526 HG23 ' N ' ' A' ' 34' ' ' GLU . 11.0 tp -66.71 -41.47 88.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 120.886 0.374 . . . . 0.0 110.152 179.315 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.526 ' N ' HG23 ' A' ' 33' ' ' ILE . 77.5 tt0 -57.33 -24.08 52.83 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.497 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.568 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 16.5 m -56.6 120.36 7.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.93 179.343 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.467 ' OD2' ' O ' ' A' ' 26' ' ' THR . 95.7 m-20 -61.87 -25.5 67.58 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.537 0.684 . . . . 0.0 109.155 -179.692 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.887 HD11 ' CD2' ' A' ' 20' ' ' PHE . 39.5 mm -126.88 117.11 46.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.888 178.848 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.419 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 62.0 mtm180 -104.1 135.24 45.96 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.614 -179.871 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.2 mt -120.13 127.95 75.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.521 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -75.05 34.58 0.1 Allowed 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -177.108 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.616 HD11 ' HE ' ' A' ' 93' ' ' ARG . 96.2 mt -103.37 127.88 28.71 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.986 179.588 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.79 -9.83 24.23 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.491 2.128 . . . . 0.0 112.197 -179.915 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.573 HG21 ' CE2' ' B' ' 241' ' ' PHE . 15.8 m -96.77 9.96 6.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.613 179.818 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.438 HG12 ' O ' ' A' ' 45' ' ' SER . 20.1 t -103.31 135.72 39.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.428 179.71 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.438 ' O ' HG12 ' A' ' 44' ' ' VAL . 13.2 m -70.04 170.15 11.98 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.357 0.599 . . . . 0.0 111.048 -179.895 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -64.3 -40.16 95.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.698 -179.685 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.616 ' O ' ' N ' ' A' ' 49' ' ' CYS . 69.5 mm-40 -110.07 -25.07 10.42 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.131 0.491 . . . . 0.0 110.676 -179.158 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.512 ' NE2' HG23 ' A' ' 90' ' ' ILE . 20.5 t60 40.08 -74.69 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 179.119 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.616 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.48 136.86 45.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.406 0.622 . . . . 0.0 112.396 -177.834 . . . . . . . . 3 3 . 1 . 067 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -127.1 128.05 45.61 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.938 179.011 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.8 mt -116.85 134.59 59.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.84 -179.737 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -115.75 135.8 53.68 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.662 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 49.9 mm -102.08 114.2 40.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 120.169 -0.613 . . . . 0.0 110.62 -179.945 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -115.4 134.39 55.14 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.078 179.01 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -42.13 -32.9 0.51 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.01 -179.487 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -63.04 -66.23 0.57 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.739 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -157.69 -160.33 0.92 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.131 179.671 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.511 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -121.29 133.83 55.14 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.561 -179.926 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.9 mt -118.27 128.48 75.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.266 0.555 . . . . 0.0 112.099 -179.265 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.4 tp -95.69 125.01 39.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.623 179.575 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -112.02 136.06 51.85 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.69 0.281 . . . . 0.0 110.444 -179.794 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -97.88 107.7 20.24 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.529 -179.808 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -98.66 -10.65 22.95 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.222 179.37 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.73 97.96 7.53 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.233 179.954 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.0 p -71.67 -32.56 68.01 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.78 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.0 m -64.0 -47.07 81.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.504 -178.956 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -141.99 97.41 6.42 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.888 -178.984 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -56.06 146.76 68.09 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.009 1.806 . . . . 0.0 111.63 179.696 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.7 m -73.91 146.16 44.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.291 0.567 . . . . 0.0 111.151 -179.698 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -104.81 140.9 37.43 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.996 179.791 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.485 ' O ' ' OG ' ' A' ' 74' ' ' SER . 43.0 t -129.02 135.53 61.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.214 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 51.94 33.48 11.77 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.209 -0.596 . . . . 0.0 109.533 -179.733 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.33 29.84 71.71 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.431 179.703 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.485 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 16.5 p -141.55 136.14 30.83 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.754 0.311 . . . . 0.0 110.895 179.987 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.1 p -68.42 139.14 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 CA-C-O 121.083 0.468 . . . . 0.0 111.678 -179.753 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.7 109.45 21.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.092 179.492 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -90.46 -17.55 26.93 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.845 -179.201 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -116.01 164.88 16.2 Favored Pre-proline 0 N--CA 1.469 0.505 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.824 179.77 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -56.78 142.97 91.93 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 C-N-CA 121.59 1.526 . . . . 0.0 111.562 179.296 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.0 p -139.9 138.91 38.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.983 0.42 . . . . 0.0 110.989 -178.909 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.2 mtm180 -77.94 133.03 38.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.482 -179.982 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.511 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 93.4 mt -86.72 139.84 30.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.143 0.497 . . . . 0.0 111.074 -179.445 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -133.31 155.51 49.3 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.697 -179.501 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.496 ' CE1' ' O ' ' A' ' 99' ' ' ASN . 3.4 t-160 -55.36 113.3 1.36 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.899 -179.458 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.66 -17.54 18.12 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 121.068 -0.587 . . . . 0.0 111.921 179.475 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -70.94 133.3 46.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.998 0.428 . . . . 0.0 110.371 -179.901 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.47 ' O ' HG13 ' A' ' 87' ' ' VAL . 14.2 p -107.87 132.76 54.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.008 -179.217 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 91.3 mt -97.68 130.3 46.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.372 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 51.6 m -122.14 126.23 47.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.735 0.779 . . . . 0.0 112.561 -178.417 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.512 HG23 ' NE2' ' A' ' 48' ' ' HIS . 80.7 mt -113.04 120.07 62.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 114.509 -1.223 . . . . 0.0 108.186 178.661 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.57 ' CD1' HG23 ' A' ' 43' ' ' VAL . 57.1 mt 38.09 -92.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.715 -0.221 . . . . 0.0 111.144 -179.533 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 90' ' ' ILE . 10.3 t0 -119.35 14.75 12.95 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.572 -179.254 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.616 ' HE ' HD11 ' A' ' 41' ' ' LEU . 79.6 mtt-85 -128.89 146.73 50.86 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.148 179.726 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.418 ' OG ' ' CG2' ' A' ' 87' ' ' VAL . 12.8 t -139.45 153.98 47.67 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.651 0.739 . . . . 0.0 111.701 -179.73 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.533 ' HB3' HD11 ' A' ' 7' ' ' LEU . 96.7 m-85 -126.65 121.88 33.39 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.109 179.061 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.644 ' O ' HD12 ' A' ' 7' ' ' LEU . 99.6 mtt180 -82.42 131.29 35.22 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.226 -178.944 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.693 ' CZ ' ' NE ' ' A' ' 5' ' ' ARG . 67.5 t80 -92.25 121.39 33.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.031 179.95 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.463 ' C ' ' NH2' ' A' ' 5' ' ' ARG . 93.5 mt-10 -126.57 131.37 51.55 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -177.886 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.632 ' CG ' HH12 ' A' ' 5' ' ' ARG . 63.1 t-20 . . . . . 0 C--N 1.333 -0.119 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.179 178.591 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo . . . . . 0 N--CA 1.483 0.909 0 CA-C-O 121.222 0.426 . . . . 0.0 112.621 . . . . . . . . . 0 0 . 1 . 067 nuclear build core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 31.4 m -59.25 142.74 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.618 -179.72 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 2.4 t . . . . . 0 C--N 1.322 -0.604 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.789 179.926 . . . . . . . . 0 0 . 1 . 067 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo . . . . . 0 N--CA 1.494 1.548 0 N-CA-C 113.039 0.361 . . . . 0.0 113.039 . . . . . . . . . 0 0 . 1 . 067 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 26.2 p -74.16 -40.02 62.85 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 120.421 -0.511 . . . . 0.0 109.696 178.401 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.573 ' CE2' HG21 ' A' ' 43' ' ' VAL . 70.0 t80 -59.96 -46.67 88.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.109 -179.358 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' B' ' 242' ' ' LEU . 90.6 mt -65.25 -41.43 94.32 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -179.561 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -65.47 -40.62 93.37 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.422 -179.374 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' B' B ' 244' ' ' ARG . . . . . 0.431 ' O ' ' OG ' ' B' ' 247' ' ' SER . 82.3 mtp180 -62.04 -42.71 99.46 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.52 -179.886 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.54 HH21 ' HD3' ' A' ' 12' ' ' ARG . 85.3 mtp180 -65.9 -39.95 91.07 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.579 -179.912 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -62.16 -40.81 97.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.167 0.508 . . . . 0.0 110.106 178.887 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' B' B ' 247' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 73.5 p -66.19 -41.69 89.85 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.463 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -61.27 -36.19 79.36 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.116 179.431 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 27.8 t . . . . . 0 C--N 1.326 -0.449 0 C-N-CA 120.166 -0.614 . . . . 0.0 109.49 178.769 . . . . . . . . 0 0 . 1 . 067 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.4 ' HB2' ' NH2' ' A' ' 93' ' ' ARG . 94.4 mt-10 . . . . . 0 N--CA 1.462 0.152 0 CA-C-O 120.558 0.218 . . . . 0.0 110.954 . . . . . . . . . 1 1 . 1 . 067 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.49 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 68.2 mt -115.62 136.99 50.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -179.312 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 55.2 t -124.89 132.56 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 121.102 0.477 . . . . 0.0 110.769 -179.837 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -94.6 118.45 31.71 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.875 -179.101 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -64.23 -46.53 83.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.273 179.974 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' B' B ' 265' ' ' GLN . . . . . 0.582 ' HG2' HD11 ' A' ' 24' ' ' LEU . 6.7 mp0 -97.2 158.79 32.67 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.417 -179.3 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -65.94 149.2 86.44 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 123.486 2.791 . . . . 0.0 113.664 -179.716 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 42.3 pt . . . . . 0 CA--C 1.529 0.163 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.3 179.014 . . . . . . . . 0 0 . 1 . 068 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.7 m . . . . . 0 N--CA 1.457 -0.079 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 . . . . . . . . . 0 0 . 1 . 068 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 86.0 mtt85 -90.57 127.54 36.29 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -177.677 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.5 mtp180 -127.88 136.84 51.94 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.207 179.982 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.616 HD11 ' HB3' ' A' ' 95' ' ' PHE . 43.3 tp -114.79 135.2 54.45 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 179.55 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.768 HG11 ' NH2' ' A' ' 96' ' ' ARG . 29.8 t -113.85 129.65 69.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.281 -179.404 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.4 m -93.61 112.61 24.53 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -178.209 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.587 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 97.0 mt -78.22 144.4 11.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 177.419 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.488 ' HA ' HH22 ' A' ' 93' ' ' ARG . 96.6 mttt -91.83 165.99 12.97 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 119.841 -0.744 . . . . 0.0 109.915 178.584 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.775 HH11 HH11 ' B' ' 245' ' ' ARG . 86.2 mtm180 -57.51 -27.95 63.03 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.635 -178.769 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.7 m -79.21 -10.47 59.83 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.433 -179.522 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.61 25.66 19.99 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.018 179.551 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.5 m -117.58 138.83 46.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.597 179.803 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.43 ' OD1' HG13 ' A' ' 8' ' ' VAL . 67.1 t0 -64.56 127.36 31.21 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.059 -179.717 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -114.88 -128.55 4.51 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 121.146 -0.55 . . . . 0.0 112.054 -179.062 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -75.67 148.84 33.28 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.416 2.077 . . . . 0.0 112.29 -179.14 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -102.77 165.37 11.1 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.6 -179.933 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.565 ' CD2' HD11 ' A' ' 37' ' ' ILE . 42.3 t80 -139.57 103.74 7.06 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.325 -179.778 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -72.45 126.7 11.81 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 121.446 1.431 . . . . 0.0 111.566 -178.757 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.6 HD22 ' SG ' ' A' ' 27' ' ' CYS . 69.2 mt -85.27 50.75 2.01 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.722 -178.924 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 99.1 p -60.4 -28.63 68.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.1 179.778 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.1 mt -74.61 143.12 44.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.359 -179.732 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 91.5 p -63.91 -17.39 63.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.907 -178.484 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.405 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 31.9 m -133.55 133.54 42.24 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.135 179.857 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.6 ' SG ' HD22 ' A' ' 22' ' ' LEU . 5.4 t -124.81 116.72 22.73 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.443 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.434 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 36.0 tp -113.98 126.26 54.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.139 -179.218 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.764 ' CE2' HD12 ' A' ' 37' ' ' ILE . 12.7 m-85 -104.88 137.96 41.86 Favored 'General case' 0 C--N 1.334 -0.091 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.652 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 175.57 -174.21 46.71 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 119.95 -1.119 . . . . 0.0 112.011 179.66 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 27.9 ttp85 -91.59 -16.12 27.59 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.623 -0.288 . . . . 0.0 111.263 179.843 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -81.7 154.35 34.1 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 121.068 -0.587 . . . . 0.0 111.782 -179.43 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.498 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.5 tp -66.46 -41.67 89.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.754 0.311 . . . . 0.0 110.459 179.436 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.498 ' N ' HG23 ' A' ' 33' ' ' ILE . 80.7 tt0 -50.3 -18.65 0.65 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.912 0.387 . . . . 0.0 110.106 -179.613 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.425 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 82.3 m -73.83 140.72 45.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.207 179.685 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.434 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 94.6 m-20 -60.48 -32.78 71.74 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -179.552 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.764 HD12 ' CE2' ' A' ' 29' ' ' PHE . 84.1 mt -126.95 122.5 60.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 176.559 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 67.8 ttp85 -106.36 133.56 50.86 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.461 -179.476 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.415 HG22 ' HG ' ' A' ' 41' ' ' LEU . 79.7 mt -114.37 131.71 65.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.71 -179.55 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -74.5 25.37 0.08 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.962 -178.281 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.634 HD21 ' OE1' ' B' ' 260' ' ' GLU . 50.5 mt -100.29 128.21 31.08 Favored Pre-proline 0 C--N 1.326 -0.427 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.407 179.144 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -73.1 -9.2 23.18 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.347 2.031 . . . . 0.0 111.858 179.678 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.2 m -92.18 5.46 6.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.656 179.829 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 36.1 t -96.84 131.8 42.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.2 179.574 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.409 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 7.9 t -70.17 173.02 7.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.26 -179.052 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.425 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 64.2 mttp -62.77 -42.21 99.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.814 -179.529 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.65 ' O ' ' N ' ' A' ' 49' ' ' CYS . 99.5 mt-30 -114.33 -18.23 11.61 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.203 -179.399 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.409 ' H ' ' HB3' ' A' ' 45' ' ' SER . 20.4 t60 35.14 -76.53 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 179.8 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.65 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.42 134.58 47.22 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.157 0.503 . . . . 0.0 111.956 -178.521 . . . . . . . . 3 3 . 1 . 068 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -127.16 134.07 50.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.849 -179.966 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.6 mt -119.68 133.42 66.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.96 -179.749 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -108.77 127.48 54.04 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.591 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.7 mm -101.35 115.44 43.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 119.995 -0.682 . . . . 0.0 111.33 -178.726 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.469 ' O ' ' C ' ' A' ' 55' ' ' GLU . 95.8 m-70 -119.1 134.13 55.38 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.731 179.155 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.469 ' C ' ' O ' ' A' ' 54' ' ' HIS . 84.9 tt0 -40.75 -30.71 0.13 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.91 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.453 ' N ' ' C ' ' A' ' 54' ' ' HIS . 94.1 mm-40 -66.19 -68.63 0.36 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.034 178.705 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.53 ' OE1' ' CZ ' ' A' ' 81' ' ' ARG . 2.0 pt-20 -153.92 -172.99 4.41 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.334 -178.823 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -116.46 128.0 55.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.622 179.313 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.2 mt -115.8 130.48 70.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.296 0.57 . . . . 0.0 112.023 -178.279 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 23.4 tp -97.43 129.03 44.68 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.09 179.876 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -113.19 137.04 52.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.882 -179.644 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 62.0 t-20 -93.56 105.62 17.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.468 -179.132 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -101.96 -10.59 19.65 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.324 179.319 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.479 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 60.4 p -72.99 102.41 3.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.603 179.742 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.7 p -82.11 -19.0 41.02 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.677 179.742 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.575 HG22 HG22 ' B' ' 236' ' ' VAL . 0.2 OUTLIER -86.98 -41.29 14.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.001 -179.077 . . . . . . . . 3 3 . 1 . 068 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.479 ' O ' ' OG ' ' A' ' 64' ' ' SER . 47.3 m-20 -143.32 106.93 5.18 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.36 -179.47 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -56.49 143.4 87.8 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 121.606 1.537 . . . . 0.0 112.142 -179.927 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.8 m -69.85 137.35 51.65 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.726 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -97.82 138.34 35.33 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.997 -179.761 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.9 t -133.93 134.52 55.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.994 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 52.97 30.03 8.76 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 -178.836 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.34 27.49 69.71 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.134 -179.513 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.4 t -140.48 138.82 34.93 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.906 0.384 . . . . 0.0 111.756 -179.606 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.458 ' H ' HG22 ' A' ' 75' ' ' VAL . 6.2 m -73.82 141.69 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.996 -179.97 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 10.3 pt -108.36 96.39 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 121.238 0.542 . . . . 0.0 111.462 179.67 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -64.39 -35.62 81.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.777 179.263 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -121.48 171.77 5.72 Favored Pre-proline 0 CA--C 1.533 0.301 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.989 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -60.08 147.25 93.84 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.165 1.91 . . . . 0.0 111.917 179.854 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.9 p -139.2 141.99 34.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.376 0.608 . . . . 0.0 111.755 -179.512 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.53 ' CZ ' ' OE1' ' A' ' 57' ' ' GLU . 79.5 ttt180 -74.78 128.66 36.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.176 179.224 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.434 HD23 ' HA ' ' A' ' 82' ' ' LEU . 95.2 mt -79.91 135.35 36.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.026 0.441 . . . . 0.0 110.897 -179.888 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -124.47 147.79 48.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.733 179.203 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.557 ' ND1' ' OD1' ' A' ' 99' ' ' ASN . 10.5 t60 -53.36 122.48 9.71 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.005 -179.074 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.93 -16.91 42.54 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.976 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -66.76 135.25 53.69 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.483 -0.487 . . . . 0.0 109.821 179.77 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 53.2 t -109.84 131.93 59.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.011 -178.305 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.1 mt -98.98 130.93 47.14 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.426 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.1 m -121.29 127.52 51.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.632 0.729 . . . . 0.0 112.226 -178.722 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.646 ' O ' ' N ' ' A' ' 93' ' ' ARG . 97.6 mt -119.93 125.21 74.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 178.001 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.525 ' C ' ' O ' ' A' ' 90' ' ' ILE . 62.2 mt -11.15 97.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -178.129 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 78.17 -9.71 1.47 Allowed 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 177.938 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.734 HH12 ' N ' ' A' ' 12' ' ' ARG . 20.0 mmm180 -130.09 133.07 46.42 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.669 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.486 ' OG ' HD12 ' A' ' 10' ' ' ILE . 89.0 p -138.54 153.5 48.73 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.176 179.299 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.616 ' HB3' HD11 ' A' ' 7' ' ' LEU . 55.6 m-85 -130.03 132.23 46.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.268 -179.324 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.768 ' NH2' HG11 ' A' ' 8' ' ' VAL . 92.0 mtm-85 -88.51 130.39 35.24 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.539 -179.825 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -95.58 126.49 40.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.502 -179.452 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -134.8 118.13 16.69 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.192 179.489 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.557 ' OD1' ' ND1' ' A' ' 84' ' ' HIS . 53.4 p-10 . . . . . 0 C--N 1.332 -0.175 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.336 -179.489 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo . . . . . 0 N--CA 1.494 1.535 0 N-CA-C 114.032 0.743 . . . . 0.0 114.032 . . . . . . . . . 0 0 . 1 . 068 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.575 HG22 HG22 ' A' ' 66' ' ' THR . 68.0 t -63.65 135.42 27.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.483 179.097 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' B' B ' 237' ' ' CYS . . . . . 0.424 ' SG ' HD11 ' B' ' 242' ' ' LEU . 2.0 t . . . . . 0 C--N 1.328 -0.367 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.294 -179.842 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo . . . . . 0 N--CA 1.496 1.619 0 CA-C-O 120.63 0.179 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 068 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 21.6 p -76.37 -45.63 31.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.897 0.379 . . . . 0.0 110.39 179.035 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -58.9 -48.41 81.53 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.32 -178.742 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.424 HD11 ' SG ' ' B' ' 237' ' ' CYS . 80.1 mt -65.45 -42.11 92.69 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.09 -179.892 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -61.28 -43.64 98.53 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.555 -178.87 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 77.0 ttt-85 -63.41 -43.68 96.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.903 0.382 . . . . 0.0 111.312 -179.14 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.775 HH11 HH11 ' A' ' 12' ' ' ARG . 52.8 ttm-85 -64.08 -40.52 96.43 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.862 -179.262 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -60.13 -36.99 78.74 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.744 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 20.2 m -66.15 -42.8 88.54 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 177.189 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' B' B ' 248' ' ' GLN . . . . . 0.536 ' CD ' HH12 ' A' ' 12' ' ' ARG . 56.7 tt0 -60.27 -34.36 73.61 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.097 179.662 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 55.7 t . . . . . 0 N--CA 1.454 -0.234 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.118 178.974 . . . . . . . . 0 0 . 1 . 068 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.634 ' OE1' HD21 ' A' ' 41' ' ' LEU . 95.9 mt-10 . . . . . 0 CA--C 1.531 0.242 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 . . . . . . . . . 1 1 . 1 . 068 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.665 ' CD1' HH21 ' A' ' 93' ' ' ARG . 42.5 mt -110.17 138.3 38.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.101 -179.811 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 43.0 t -125.61 132.33 71.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.005 0.431 . . . . 0.0 110.221 179.262 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -96.39 120.52 36.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.877 -178.94 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -66.01 -47.32 74.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.387 -179.315 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.8 151.99 44.22 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.445 -179.018 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -64.55 147.71 90.34 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.754 2.303 . . . . 0.0 112.31 179.613 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.1 pt . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.448 179.82 . . . . . . . . 0 0 . 1 . 069 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 99.2 m . . . . . 0 N--CA 1.461 0.112 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 . . . . . . . . . 0 0 . 1 . 069 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.504 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 95.5 mtt-85 -88.04 128.85 35.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.671 -178.579 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -129.33 140.37 51.42 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 120.471 -0.492 . . . . 0.0 112.13 -179.242 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.505 HD11 ' CB ' ' A' ' 95' ' ' PHE . 34.0 tp -116.25 134.38 54.97 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.843 178.966 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.3 t -110.78 130.83 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.016 -179.945 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.421 HG23 ' CD1' ' B' ' 261' ' ' ILE . 1.4 m -94.14 116.86 29.32 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.678 -178.77 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.649 HD12 ' OG ' ' A' ' 94' ' ' SER . 96.8 mt -80.18 143.55 12.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.32 179.061 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -91.22 158.88 16.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.022 0.439 . . . . 0.0 110.268 178.637 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.519 ' NH1' ' OE2' ' B' ' 260' ' ' GLU . 80.9 mtp180 -58.2 -32.07 67.93 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.539 -179.854 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.2 m -77.23 -9.95 59.11 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.006 -179.947 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.71 33.67 7.33 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.446 -0.662 . . . . 0.0 111.446 179.877 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.0 t -119.57 134.22 63.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.733 0.301 . . . . 0.0 110.79 -179.823 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -63.17 122.41 16.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.26 179.942 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -106.89 -139.58 9.38 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.553 -179.266 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.79 155.49 62.43 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.215 1.944 . . . . 0.0 112.082 -179.164 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -107.29 146.8 31.06 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.975 -179.05 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.692 ' CD2' HD11 ' A' ' 37' ' ' ILE . 23.6 t80 -115.16 101.68 54.52 Favored Pre-proline 0 CA--C 1.536 0.437 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.898 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.72 131.78 17.7 Favored 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 121.398 1.399 . . . . 0.0 111.475 -179.392 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 83.4 mt -86.48 52.44 2.5 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 119.961 -0.695 . . . . 0.0 111.197 -178.44 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.8 p -61.8 -29.87 70.43 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.797 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.431 HD11 ' CD ' ' B' ' 265' ' ' GLN . 67.5 mt -79.06 142.45 36.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.187 179.757 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 72.6 p -66.39 -20.17 66.0 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.969 -0.293 . . . . 0.0 111.713 -179.494 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.416 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 53.2 m -127.04 128.9 47.03 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.292 0.568 . . . . 0.0 112.011 -179.633 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.454 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 11.8 t -123.57 113.54 18.85 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.774 178.697 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.565 ' O ' ' N ' ' A' ' 36' ' ' ASP . 63.4 tp -110.42 125.33 53.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.185 0.517 . . . . 0.0 110.786 -179.555 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.862 ' CE2' HD12 ' A' ' 37' ' ' ILE . 4.5 m-85 -107.06 140.02 40.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.282 179.583 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 170.38 -160.22 32.88 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.377 179.388 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 27.4 ptt-85 -107.22 -8.92 16.25 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.411 179.817 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.478 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -85.37 167.24 40.93 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.286 -179.945 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.569 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.9 tp -67.29 -42.41 87.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.719 0.295 . . . . 0.0 110.779 -179.814 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.569 ' N ' HG23 ' A' ' 33' ' ' ILE . 78.4 mm-40 -53.14 -25.55 13.76 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.144 0.497 . . . . 0.0 110.021 -178.908 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.478 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 3.7 m -62.38 124.21 20.32 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.402 179.521 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.565 ' N ' ' O ' ' A' ' 28' ' ' LEU . 63.7 m-20 -58.54 -29.03 66.02 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -179.055 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.862 HD12 ' CE2' ' A' ' 29' ' ' PHE . 93.6 mt -126.56 122.32 60.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 176.237 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 72.0 ttp85 -106.57 135.81 47.44 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.116 -178.511 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 98.6 mt -115.68 129.1 72.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.009 -179.573 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -74.09 31.5 0.08 Allowed 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 -177.918 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.507 ' CG ' HH21 ' A' ' 93' ' ' ARG . 86.2 mt -107.49 135.88 19.67 Favored Pre-proline 0 C--N 1.323 -0.559 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.888 179.539 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.56 -10.13 24.89 Favored 'Trans proline' 0 C--N 1.315 -1.216 0 C-N-CA 122.067 1.845 . . . . 0.0 111.428 179.215 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.526 HG21 ' CE2' ' B' ' 241' ' ' PHE . 9.7 m -97.22 6.62 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.216 -179.936 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.0 t -92.78 128.48 44.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.045 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 41.2 t -66.71 172.76 3.96 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.51 0.671 . . . . 0.0 111.628 -178.59 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -65.83 -43.24 89.12 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.96 -179.631 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.628 ' O ' ' N ' ' A' ' 49' ' ' CYS . 86.8 mt-30 -119.36 -5.34 10.37 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.847 -179.002 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.503 ' C ' ' O ' ' A' ' 47' ' ' GLN . 17.8 t60 14.05 -73.37 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 -178.852 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.628 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -126.08 129.53 49.29 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 119.716 -0.793 . . . . 0.0 112.876 -179.069 . . . . . . . . 3 3 . 1 . 069 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -126.58 128.66 47.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.013 178.508 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.2 mt -116.41 134.3 60.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.685 -179.292 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -112.18 122.12 46.86 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.603 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 95.7 mt -101.8 116.49 45.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 119.543 -0.863 . . . . 0.0 111.847 -178.638 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.485 ' O ' ' N ' ' A' ' 56' ' ' GLN . 94.1 m-70 -114.19 141.52 47.43 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.922 -179.828 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 54' ' ' HIS . 51.7 mp0 -40.15 -29.37 0.07 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 179.852 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.485 ' N ' ' O ' ' A' ' 54' ' ' HIS . 56.1 tt0 -65.34 -68.14 0.39 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.241 -0.89 . . . . 0.0 108.997 178.192 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.488 ' OE1' ' O ' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -159.53 -166.28 1.74 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.257 0.551 . . . . 0.0 111.868 -179.531 . . . . . . . . 3 3 . 1 . 069 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.488 ' O ' ' OE1' ' A' ' 57' ' ' GLU . . . -112.88 125.48 54.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.313 179.633 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 99.0 mt -116.08 129.55 72.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -177.924 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.45 ' HB2' HD11 ' A' ' 82' ' ' LEU . 50.9 tp -96.3 128.87 43.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.642 179.706 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -111.57 135.31 52.33 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.74 179.722 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -100.57 106.84 18.39 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -178.749 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -99.89 -1.44 37.36 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.994 179.031 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.46 100.04 12.46 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.404 -179.553 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.0 p -81.7 -15.16 55.35 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.214 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.92 -35.57 14.65 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.213 -179.86 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.491 ' HB3' HD11 ' A' ' 91' ' ' ILE . 11.1 m-80 -150.7 89.0 4.47 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.24 -179.815 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -57.12 148.9 66.46 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.68 2.253 . . . . 0.0 112.717 -179.665 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 38.1 m -71.99 138.37 47.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.324 179.327 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -96.63 144.54 26.58 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.101 -179.664 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.711 ' HB ' HD11 ' A' ' 76' ' ' ILE . 3.9 p -127.87 135.74 62.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.956 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 48.71 31.46 3.06 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.287 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.56 27.44 63.29 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.686 179.87 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 71' ' ' VAL . 21.1 t -136.67 134.53 37.36 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.998 0.399 . . . . 0.0 110.907 179.784 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.4 ' H ' HG12 ' A' ' 75' ' ' VAL . 0.2 OUTLIER -60.64 143.95 13.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.342 -179.911 . . . . . . . . 3 3 . 1 . 069 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.711 HD11 ' HB ' ' A' ' 71' ' ' VAL . 97.2 mt -107.97 102.93 14.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.456 179.565 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -64.92 -42.31 94.81 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.716 0.294 . . . . 0.0 111.556 179.365 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.536 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.3 OUTLIER -133.67 -179.41 1.06 Allowed Pre-proline 0 CA--C 1.532 0.28 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.597 -178.581 . . . . . . . . 3 3 . 1 . 069 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.471 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 52.3 Cg_exo -55.18 138.05 78.25 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 122.331 2.021 . . . . 0.0 112.779 -178.687 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 72.7 t -134.48 136.68 52.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.792 -179.576 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -73.84 135.49 43.43 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.608 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.45 HD11 ' HB2' ' A' ' 60' ' ' LEU . 97.4 mt -84.89 137.56 33.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.284 0.564 . . . . 0.0 111.466 -179.225 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -126.74 151.04 48.72 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.219 -179.963 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.475 ' HD1' ' H ' ' A' ' 99' ' ' ASN . 15.0 t60 -60.46 125.76 24.92 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.041 0.448 . . . . 0.0 110.774 -179.43 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.11 -17.88 47.18 Favored Glycine 0 CA--C 1.519 0.289 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.516 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 87' ' ' VAL . 66.4 t0 -72.52 133.05 44.59 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.041 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.512 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 33.6 t -109.36 133.3 54.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.1 0.476 . . . . 0.0 110.998 -179.119 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.4 mt -93.33 131.46 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 178.841 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.3 m -122.44 124.54 43.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.495 0.664 . . . . 0.0 112.311 -178.321 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.575 ' O ' ' N ' ' A' ' 93' ' ' ARG . 98.0 mt -117.84 133.46 64.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.752 178.725 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.491 HD11 ' HB3' ' A' ' 67' ' ' ASN . 80.8 mt -23.7 97.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -178.614 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.473 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 3.2 m-20 89.73 -20.07 0.16 Allowed 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.801 1.038 . . . . 0.0 113.801 177.792 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.603 ' NH2' ' OE1' ' B' ' 260' ' ' GLU . 54.3 mtt-85 -130.33 140.81 50.62 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.6 -179.114 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.649 ' OG ' HD12 ' A' ' 10' ' ' ILE . 11.2 p -137.53 150.71 47.73 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.712 0.291 . . . . 0.0 110.241 -179.931 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.541 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 15.4 m-85 -129.53 123.78 32.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.077 -179.038 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.447 ' HA ' HG22 ' A' ' 87' ' ' VAL . 42.9 ttm180 -79.37 127.7 32.42 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.137 0.494 . . . . 0.0 111.337 -179.464 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.504 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 67.9 t80 -94.26 127.68 40.27 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.997 -179.707 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -141.26 116.96 10.33 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.702 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.475 ' H ' ' HD1' ' A' ' 84' ' ' HIS . 52.4 p30 . . . . . 0 C--N 1.331 -0.234 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.48 179.72 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo . . . . . 0 N--CA 1.481 0.754 0 CA-C-O 121.241 0.434 . . . . 0.0 112.082 . . . . . . . . . 0 0 . 1 . 069 nuclear build core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 2.9 p -115.18 133.64 60.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.914 179.864 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' B' B ' 237' ' ' CYS . . . . . 0.465 ' CB ' HD13 ' A' ' 91' ' ' ILE . 2.3 t . . . . . 0 C--N 1.326 -0.448 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.635 -179.418 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo . . . . . 0 N--CA 1.496 1.645 0 N-CA-C 113.175 0.413 . . . . 0.0 113.175 . . . . . . . . . 0 0 . 1 . 069 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 14.5 m -69.11 -45.68 69.59 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.582 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.526 ' CE2' HG21 ' A' ' 43' ' ' VAL . 64.8 t80 -57.3 -45.93 83.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.364 -179.327 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 90.6 mt -64.53 -41.37 96.41 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -179.91 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -64.09 -39.11 93.35 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.967 -178.95 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -61.82 -41.64 98.03 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.544 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.603 ' O ' HG23 ' B' ' 249' ' ' VAL . 71.3 ttp85 -60.9 -42.51 98.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.981 179.847 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.18 -40.59 90.52 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.097 -179.506 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 68.6 m -68.07 -42.99 79.61 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.481 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' B' B ' 248' ' ' GLN . . . . . 0.499 ' CD ' HH22 ' A' ' 12' ' ' ARG . 7.3 tt0 -62.37 -38.07 88.13 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.61 -179.18 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' B' B ' 249' ' ' VAL . . . . . 0.603 HG23 ' O ' ' B' ' 245' ' ' ARG . 77.8 t . . . . . 0 N--CA 1.454 -0.267 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.108 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.603 ' OE1' ' NH2' ' A' ' 93' ' ' ARG . 90.8 mt-10 . . . . . 0 N--CA 1.456 -0.163 0 CA-C-O 121.237 0.541 . . . . 0.0 110.702 . . . . . . . . . 1 1 . 1 . 069 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.421 ' CD1' HG23 ' A' ' 9' ' ' THR . 50.5 mt -107.87 139.42 29.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.762 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 61.1 t -126.73 135.27 64.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.511 -179.741 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -98.97 121.54 41.05 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.302 0.572 . . . . 0.0 111.089 -178.833 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -64.66 -46.72 81.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.952 179.913 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' B' B ' 265' ' ' GLN . . . . . 0.431 ' CD ' HD11 ' A' ' 24' ' ' LEU . 21.7 mm-40 -93.15 150.09 38.57 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.956 -179.269 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.7 148.54 65.7 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.549 2.166 . . . . 0.0 112.678 -179.869 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.3 pt . . . . . 0 C--N 1.327 -0.39 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.535 179.589 . . . . . . . . 0 0 . 1 . 070 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 41.4 p . . . . . 0 CA--C 1.523 -0.076 0 CA-C-O 120.78 0.324 . . . . 0.0 110.699 . . . . . . . . . 0 0 . 1 . 070 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.816 ' NE ' HD13 ' A' ' 53' ' ' ILE . 89.7 mtm-85 -88.66 123.68 33.35 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.751 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -130.79 138.48 49.93 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -178.393 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.565 HD11 HD11 ' A' ' 22' ' ' LEU . 68.2 mt -112.98 133.52 54.9 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.088 178.645 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 66.4 t -108.77 128.37 64.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.415 179.672 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.465 ' CG2' HD12 ' B' ' 261' ' ' ILE . 11.9 m -92.17 114.45 27.0 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.729 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.563 HD12 ' OG ' ' A' ' 94' ' ' SER . 96.4 mt -78.39 141.88 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.766 178.605 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.74 155.37 20.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.316 179.827 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -57.57 -31.96 66.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.682 -179.515 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.0 p -78.21 -8.3 58.16 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.146 0.498 . . . . 0.0 110.61 -179.877 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.76 38.2 6.21 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 -179.547 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 52.9 t -121.52 132.74 70.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.716 -0.393 . . . . 0.0 111.153 -179.49 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -68.54 116.61 9.28 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.795 -0.816 . . . . 0.0 108.795 179.53 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -107.53 -131.32 6.58 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.994 -178.975 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.58 149.45 61.7 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 121.945 1.763 . . . . 0.0 112.816 -178.63 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -106.85 145.0 32.68 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.598 179.351 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -115.17 96.45 45.41 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.184 -178.805 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.3 134.03 20.27 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.337 1.358 . . . . 0.0 112.311 -179.048 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.565 HD11 HD11 ' A' ' 7' ' ' LEU . 95.5 mt -84.54 83.02 8.15 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.017 -179.172 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 24.3 p -87.31 -12.03 47.73 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.535 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 58.9 mt -99.47 142.41 30.98 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.178 -179.732 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 77.9 p -66.82 -14.92 63.21 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.283 -178.953 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.0 m -130.73 131.98 45.08 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.973 0.416 . . . . 0.0 111.147 -179.721 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.498 ' HB2' HD22 ' A' ' 22' ' ' LEU . 9.9 t -125.71 119.44 28.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.453 178.992 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.439 HD21 ' HG2' ' A' ' 47' ' ' GLN . 50.5 tp -116.15 131.11 57.03 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.837 0.351 . . . . 0.0 111.408 -178.27 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.697 ' CE2' HD12 ' A' ' 37' ' ' ILE . 10.8 m-85 -108.8 143.29 38.16 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.63 179.704 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 156.74 -152.98 24.32 Favored Glycine 0 C--O 1.223 -0.536 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.262 179.448 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.539 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 32.9 mtm180 -108.0 -26.48 10.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.806 0.336 . . . . 0.0 110.414 179.251 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.562 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -58.29 155.39 22.95 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 121.205 -0.521 . . . . 0.0 111.917 -178.639 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.432 HD13 ' HA ' ' A' ' 33' ' ' ILE . 35.9 mm -63.4 -42.56 96.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.753 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -55.06 -29.6 57.85 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.147 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.562 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 5.7 m -53.99 113.82 1.37 Allowed 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.085 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -59.08 -23.93 62.49 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -178.558 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.697 HD12 ' CE2' ' A' ' 29' ' ' PHE . 91.1 mt -128.4 121.95 56.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 177.197 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.432 ' O ' ' N ' ' B' ' 262' ' ' VAL . 43.4 mtm180 -110.64 136.81 49.17 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.359 -179.151 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.63 HD13 ' HE ' ' A' ' 93' ' ' ARG . 93.3 mt -115.66 128.91 72.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.688 179.397 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -71.71 33.72 0.06 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.704 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.713 HD12 ' CZ ' ' A' ' 93' ' ' ARG . 41.6 mt -115.39 131.57 23.54 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 120.189 -0.604 . . . . 0.0 111.14 179.739 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.4 ' O ' ' HD2' ' B' ' 235' ' ' PRO . 57.0 Cg_endo -71.26 -15.11 31.69 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.345 2.03 . . . . 0.0 113.321 -179.637 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.553 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 26.2 m -84.25 -0.49 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-O 121.009 0.433 . . . . 0.0 110.534 179.61 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.539 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 66.4 t -94.65 133.07 36.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.6 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 38.4 t -71.85 170.73 13.05 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.465 0.65 . . . . 0.0 111.962 -178.335 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.558 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 51.7 mttp -62.48 -40.43 96.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.424 -179.874 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.695 ' O ' ' N ' ' A' ' 49' ' ' CYS . 86.2 mt-30 -119.55 -15.01 9.06 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 123.239 0.337 . . . . 0.0 111.65 -179.249 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.6 t60 32.41 -71.91 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 179.534 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.695 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -134.44 137.34 43.91 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.952 -178.582 . . . . . . . . 3 3 . 1 . 070 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -127.41 131.04 50.36 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.045 179.416 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.6 mt -116.74 135.32 57.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.441 -179.606 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -117.28 124.76 49.79 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.765 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.816 HD13 ' NE ' ' A' ' 5' ' ' ARG . 80.9 mt -104.72 115.75 47.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.724 0.773 . . . . 0.0 112.096 -178.788 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.588 ' O ' ' N ' ' A' ' 56' ' ' GLN . 96.9 m-70 -112.59 141.59 46.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.547 -1.206 . . . . 0.0 108.844 179.129 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 54' ' ' HIS . 50.6 tp10 -39.36 -24.57 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -179.336 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.588 ' N ' ' O ' ' A' ' 54' ' ' HIS . 49.8 tt0 -64.93 -68.2 0.38 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.123 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.93 -155.15 0.4 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.484 178.476 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.431 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -116.86 126.04 52.43 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.711 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 99.2 mt -114.92 131.09 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 121.152 0.501 . . . . 0.0 112.064 -178.628 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.52 ' HB2' HD11 ' A' ' 82' ' ' LEU . 23.9 tp -101.5 129.29 47.54 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.389 -179.451 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -113.23 136.0 53.21 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.577 -179.896 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.449 HD21 ' HA ' ' A' ' 68' ' ' PRO . 41.0 t30 -95.87 105.34 17.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.559 179.998 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -99.12 -10.11 22.95 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.803 179.56 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.41 98.49 11.04 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.865 179.709 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.8 m -75.55 -30.29 59.67 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.407 178.998 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.598 ' CG2' HG12 ' B' ' 236' ' ' VAL . 5.4 m -61.01 -45.42 94.88 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.856 -179.296 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.2 m-20 -144.07 102.18 4.84 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.982 -179.659 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.449 ' HA ' HD21 ' A' ' 62' ' ' ASN . 32.4 Cg_exo -56.39 146.01 75.81 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 121.479 1.452 . . . . 0.0 112.343 179.554 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.7 m -73.07 144.39 47.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.144 179.17 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -102.8 138.68 39.37 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.491 179.399 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.433 HG22 HG12 ' A' ' 88' ' ' ILE . 52.2 t -132.78 131.63 59.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.185 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 54.3 34.12 19.83 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.131 -0.628 . . . . 0.0 109.978 -179.43 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.52 25.56 72.2 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.647 178.901 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 29.1 t -145.55 142.49 29.21 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 117.524 0.662 . . . . 0.0 111.34 179.751 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.404 HG12 ' H ' ' A' ' 75' ' ' VAL . 0.2 OUTLIER -73.2 141.63 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.838 179.749 . . . . . . . . 3 3 . 1 . 070 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 11.4 pt -108.13 98.51 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-O 121.43 0.633 . . . . 0.0 110.888 179.0 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -66.23 -32.06 73.26 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.322 179.406 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -123.61 172.84 5.1 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.454 -179.283 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.63 146.72 94.53 Favored 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 122.468 2.112 . . . . 0.0 112.276 179.927 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.7 p -139.97 140.39 35.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.137 0.494 . . . . 0.0 111.304 -179.86 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -75.39 131.94 40.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.573 179.691 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.52 HD11 ' HB2' ' A' ' 60' ' ' LEU . 93.2 mt -87.27 138.39 31.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.274 0.559 . . . . 0.0 111.449 -179.645 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -130.1 156.43 44.55 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.665 179.368 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.552 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 4.7 t60 -59.86 123.83 18.25 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.604 -179.574 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.84 -13.86 45.64 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.877 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -69.7 136.99 51.72 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.472 -0.491 . . . . 0.0 109.864 179.728 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 50.7 t -113.61 130.64 67.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.837 -178.797 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.433 HG12 HG22 ' A' ' 71' ' ' VAL . 98.7 mt -103.84 133.33 48.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.734 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 95.8 m -128.58 129.89 46.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.907 0.861 . . . . 0.0 113.217 -178.379 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.465 ' O ' ' N ' ' A' ' 92' ' ' ASP . 92.8 mt -113.2 124.96 70.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.106 -1.406 . . . . 0.0 107.918 178.135 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.452 ' C ' ' O ' ' A' ' 90' ' ' ILE . 52.6 mt 34.68 -94.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.73 -178.719 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.623 ' OD1' ' NH1' ' A' ' 93' ' ' ARG . 31.5 p-10 -116.79 10.3 14.19 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.927 -179.754 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.713 ' CZ ' HD12 ' A' ' 41' ' ' LEU . 53.4 mtm-85 -122.39 139.43 53.85 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -179.581 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.563 ' OG ' HD12 ' A' ' 10' ' ' ILE . 58.5 p -140.31 155.33 46.86 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.961 -179.78 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -124.67 121.96 36.18 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.501 179.711 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -81.18 132.54 35.36 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 119.651 -0.819 . . . . 0.0 110.249 -179.901 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.668 ' CZ ' ' ND2' ' A' ' 99' ' ' ASN . 87.2 t80 -102.02 124.98 48.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.494 -178.873 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -140.49 127.7 21.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.045 179.148 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.668 ' ND2' ' CZ ' ' A' ' 97' ' ' TYR . 7.7 m120 . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.166 178.996 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' B' B ' 235' ' ' PRO . . . . . 0.4 ' HD2' ' O ' ' A' ' 42' ' ' PRO . 31.6 Cg_exo . . . . . 0 N--CA 1.487 1.109 0 CA-C-O 121.914 0.714 . . . . 0.0 112.26 . . . . . . . . . 1 1 . 1 . 070 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.598 HG12 ' CG2' ' A' ' 66' ' ' THR . 3.6 m -66.76 138.69 22.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 114.552 -1.204 . . . . 0.0 110.263 -178.996 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.5 t . . . . . 0 C--N 1.323 -0.556 0 C-N-CA 120.392 -0.523 . . . . 0.0 109.7 179.918 . . . . . . . . 0 0 . 1 . 070 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_exo . . . . . 0 N--CA 1.498 1.779 0 CA-C-O 120.69 0.204 . . . . 0.0 112.137 . . . . . . . . . 0 0 . 1 . 070 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 71.4 m -68.88 -44.77 72.6 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.004 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.713 ' CD1' ' NH2' ' B' ' 245' ' ' ARG . 62.7 t80 -58.07 -46.1 86.0 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.503 -179.4 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.417 ' HA ' HD23 ' B' ' 242' ' ' LEU . 71.9 mt -62.11 -41.04 97.82 Favored 'General case' 0 N--CA 1.462 0.127 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 179.972 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.83 -39.36 93.45 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.208 -179.471 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -59.47 -44.24 93.06 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.659 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.713 ' NH2' ' CD1' ' B' ' 241' ' ' PHE . 0.6 OUTLIER -62.22 -40.9 97.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.44 179.423 . . . . . . . . 3 3 . 1 . 070 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -61.98 -43.74 98.2 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.477 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 38.9 t -63.13 -44.19 96.25 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.529 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -61.35 -33.66 73.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.355 179.764 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' B' B ' 249' ' ' VAL . . . . . 0.521 HG23 ' O ' ' B' ' 245' ' ' ARG . 51.3 t . . . . . 0 C--N 1.333 -0.132 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.013 179.548 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 . . . . . 0 N--CA 1.455 -0.176 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 . . . . . . . . . 0 0 . 1 . 070 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.465 HD12 ' CG2' ' A' ' 9' ' ' THR . 73.6 mt -109.57 132.88 56.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.335 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' B' B ' 262' ' ' VAL . . . . . 0.432 ' N ' ' O ' ' A' ' 38' ' ' ARG . 53.7 t -124.37 133.19 70.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.605 -178.775 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -98.91 121.59 41.07 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.135 0.493 . . . . 0.0 111.936 -178.382 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -65.59 -44.04 87.84 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.621 179.417 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.23 158.51 83.85 Favored Pre-proline 0 CA--C 1.517 -0.312 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.828 -179.102 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -57.79 139.47 90.41 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 C-N-CA 122.2 1.933 . . . . 0.0 111.302 179.444 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 19.1 tt . . . . . 0 N--CA 1.441 -0.876 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.206 -179.313 . . . . . . . . 0 0 . 1 . 071 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 99' ' ' ASN . 2.5 t . . . . . 0 N--CA 1.454 -0.237 0 CA-C-O 120.986 0.422 . . . . 0.0 109.881 . . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.66 HH11 ' HH ' ' A' ' 97' ' ' TYR . 94.9 mtt-85 -81.64 135.7 35.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.038 179.894 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.4 mtp180 -130.54 140.37 50.47 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 121.504 0.669 . . . . 0.0 112.469 -178.63 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.613 HD12 ' O ' ' A' ' 96' ' ' ARG . 44.4 tp -117.16 133.56 55.85 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.154 179.391 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.2 t -109.33 130.97 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.264 -178.752 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.44 HG23 ' CD1' ' B' ' 261' ' ' ILE . 9.7 m -89.96 115.59 27.37 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 121.316 0.579 . . . . 0.0 112.357 -178.842 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.424 HD12 ' HB2' ' A' ' 94' ' ' SER . 94.1 mt -83.9 143.37 11.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.641 178.725 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -86.95 155.0 20.37 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.4 178.364 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.759 HH11 HH11 ' B' ' 245' ' ' ARG . 91.1 mtm180 -52.92 -26.99 16.73 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.848 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 91.6 p -81.36 -6.26 58.72 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.292 179.309 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.63 36.95 9.91 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.322 -179.267 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 36.1 t -120.62 137.09 55.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.953 0.406 . . . . 0.0 111.453 -178.883 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -76.56 121.26 22.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.149 -179.504 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -117.18 -123.79 3.44 Favored Glycine 0 CA--C 1.542 1.739 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -179.786 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -74.8 148.88 36.89 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 122.48 2.12 . . . . 0.0 113.134 -179.359 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -102.96 165.97 10.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.293 179.03 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.678 ' CD2' HD11 ' A' ' 37' ' ' ILE . 52.8 t80 -134.63 97.44 14.23 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.206 -179.248 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.79 122.66 10.81 Favored 'Trans proline' 0 N--CA 1.501 1.943 0 C-N-CA 122.441 2.094 . . . . 0.0 112.694 -179.896 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.6 mt -83.94 49.53 1.65 Allowed 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 121.126 -0.23 . . . . 0.0 111.375 -179.477 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 91.6 p -65.23 -22.55 66.89 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.051 0.453 . . . . 0.0 109.789 179.396 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 80.5 mt -77.58 139.48 39.54 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.991 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.81 -17.52 63.19 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.223 -0.444 . . . . 0.0 112.047 -178.28 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 86.2 m -133.26 133.97 43.34 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.444 -179.613 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.7 t -122.98 114.79 20.88 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.107 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.518 HD21 ' HG2' ' A' ' 47' ' ' GLN . 31.4 tp -111.09 128.43 55.88 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.489 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.52 ' O ' ' O ' ' A' ' 47' ' ' GLN . 55.8 m-85 -108.44 137.05 47.05 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.939 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 165.77 -170.94 40.79 Favored Glycine 0 C--O 1.224 -0.52 0 C-N-CA 119.833 -1.175 . . . . 0.0 112.555 179.786 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 37.4 ttp85 -90.19 -30.04 17.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.078 -0.561 . . . . 0.0 111.489 179.843 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.495 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -57.26 155.25 17.92 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.714 -0.555 . . . . 0.0 111.714 -179.226 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.527 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.2 tp -66.71 -42.43 89.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.594 -179.704 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.527 ' N ' HG23 ' A' ' 33' ' ' ILE . 16.2 pt-20 -58.95 -13.42 6.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.362 -179.418 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.577 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 6.6 m -68.27 128.54 36.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.979 0.418 . . . . 0.0 110.414 -179.507 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.445 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 61.9 m-20 -60.18 -32.84 71.45 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.469 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.678 HD11 ' CD2' ' A' ' 20' ' ' PHE . 47.1 mm -119.59 111.29 32.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 177.275 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 88.4 mtm-85 -100.47 133.57 44.7 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.722 -178.327 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.426 HD13 ' HE ' ' A' ' 93' ' ' ARG . 96.7 mt -118.91 129.64 74.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.317 0.58 . . . . 0.0 109.813 178.839 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -72.44 33.82 0.06 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.221 -0.9 . . . . 0.0 112.782 -177.381 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.553 ' CD1' ' CZ ' ' A' ' 93' ' ' ARG . 49.6 mt -110.48 133.23 21.19 Favored Pre-proline 0 N--CA 1.468 0.44 0 C-N-CA 119.81 -0.756 . . . . 0.0 111.834 -179.855 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -71.35 -9.38 25.2 Favored 'Trans proline' 0 N--CA 1.488 1.164 0 C-N-CA 122.363 2.042 . . . . 0.0 113.107 -179.11 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.1 m -102.6 6.11 10.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.018 179.864 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 24.1 t -90.91 133.7 31.86 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.956 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.3 m -68.46 158.07 34.52 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.127 -178.83 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.577 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 9.2 mtmp? -63.39 -39.29 94.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.24 -179.506 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.652 ' O ' ' N ' ' A' ' 49' ' ' CYS . 97.9 mt-30 -114.13 -21.43 10.51 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-O 120.885 0.374 . . . . 0.0 110.318 179.559 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.4 t60 33.06 -74.17 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -179.711 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.652 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -129.82 133.28 46.85 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.121 0.486 . . . . 0.0 111.909 -179.001 . . . . . . . . 3 3 . 1 . 071 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -125.27 126.67 45.51 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.809 179.668 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 94.8 mt -113.4 132.51 62.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.606 -179.766 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -112.3 134.87 53.6 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 178.74 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 49.8 mm -104.43 112.86 39.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.752 -179.471 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.443 ' C ' ' N ' ' A' ' 56' ' ' GLN . 97.5 m-70 -116.07 135.36 54.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.944 179.163 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.533 ' H ' ' CD ' ' A' ' 55' ' ' GLU . 53.8 mp0 -41.2 -29.6 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.546 0.689 . . . . 0.0 109.454 -179.58 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.443 ' N ' ' C ' ' A' ' 54' ' ' HIS . 96.9 mt-30 -67.83 -67.75 0.44 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.394 178.526 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.462 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 4.3 tp10 -155.51 -168.46 2.83 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.742 -179.404 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.462 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -116.09 124.47 50.48 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.388 179.121 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.8 mt -110.52 128.8 66.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 120.867 0.365 . . . . 0.0 111.936 -178.928 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.53 ' HB2' HD11 ' A' ' 82' ' ' LEU . 32.2 tp -94.97 124.56 39.09 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.875 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -110.09 134.24 52.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.958 -179.392 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -93.08 108.41 20.0 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.227 -179.234 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -103.36 -11.62 17.77 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.516 179.331 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.474 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 2.1 t -73.77 99.0 3.05 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.452 -179.676 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.5 t -77.22 -43.01 35.14 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.102 0.477 . . . . 0.0 110.552 178.691 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.1 p -66.8 -39.76 87.85 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.865 -179.001 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.474 ' O ' ' OG ' ' A' ' 64' ' ' SER . 39.6 m-80 -142.84 97.43 5.88 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.672 -179.361 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.547 ' HB2' HG23 ' A' ' 75' ' ' VAL . 51.6 Cg_exo -54.2 144.21 60.25 Favored 'Trans proline' 0 N--CA 1.502 2.005 0 C-N-CA 122.636 2.224 . . . . 0.0 113.5 -179.813 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 16.4 m -69.65 134.85 49.19 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.547 178.413 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -102.62 138.49 39.46 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.054 -0.658 . . . . 0.0 109.987 179.71 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 75.9 t -131.44 133.97 61.35 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.473 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.831 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 53.91 33.75 17.96 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -178.767 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.54 29.46 72.92 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.335 -179.666 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 73.4 m -141.11 136.14 31.63 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.007 0.432 . . . . 0.0 111.577 -179.633 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.547 HG23 ' HB2' ' A' ' 68' ' ' PRO . 1.3 p -68.74 142.51 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.681 179.929 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.7 pt -119.46 88.28 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.139 178.729 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -68.01 -26.23 65.79 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.411 0.624 . . . . 0.0 109.588 178.329 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -113.8 159.07 37.23 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 114.935 -1.029 . . . . 0.0 109.889 179.532 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.32 155.1 71.9 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.147 1.898 . . . . 0.0 111.5 179.916 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.0 m -149.65 146.51 16.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.874 -179.222 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.6 mtm-85 -72.19 131.53 42.89 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.366 179.494 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.53 HD11 ' HB2' ' A' ' 60' ' ' LEU . 99.7 mt -82.63 139.09 33.95 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.423 0.63 . . . . 0.0 110.255 179.75 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -124.34 150.17 45.78 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.221 -179.906 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.516 ' C ' ' CD2' ' A' ' 84' ' ' HIS . 5.9 t60 -63.25 126.04 26.11 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 119.719 -0.793 . . . . 0.0 109.495 -179.764 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.07 -18.94 33.2 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.207 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -69.16 143.26 54.12 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.428 179.586 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.4 p -112.57 134.81 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.781 -178.528 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 85.9 mt -103.06 131.15 52.0 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.526 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 53.6 m -121.18 127.85 51.9 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.616 0.722 . . . . 0.0 112.312 -179.106 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.453 ' O ' ' N ' ' A' ' 92' ' ' ASP . 98.0 mt -121.05 128.32 76.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.211 179.886 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.445 ' C ' ' O ' ' A' ' 90' ' ' ILE . 39.4 mm 39.26 -98.58 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.685 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.534 ' O ' ' OD1' ' A' ' 92' ' ' ASP . 65.5 t0 -125.04 23.07 7.85 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.546 0.688 . . . . 0.0 110.642 179.387 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.553 ' CZ ' ' CD1' ' A' ' 41' ' ' LEU . 38.0 mtm-85 -129.52 142.44 50.77 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.147 -0.933 . . . . 0.0 108.865 179.862 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.424 ' HB2' HD12 ' A' ' 10' ' ' ILE . 58.8 m -135.21 151.22 50.42 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.031 -179.414 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.596 ' HB3' HD11 ' A' ' 7' ' ' LEU . 58.4 m-85 -126.93 120.42 29.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.594 179.179 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.613 ' O ' HD12 ' A' ' 7' ' ' LEU . 99.5 mtt180 -83.12 129.55 35.03 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.151 -0.619 . . . . 0.0 110.644 179.846 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.66 ' HH ' HH11 ' A' ' 5' ' ' ARG . 93.8 t80 -94.38 126.85 39.9 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.814 179.748 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -142.82 122.46 13.32 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.015 0.436 . . . . 0.0 111.274 -179.879 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.472 ' O ' ' O ' ' A' ' 4' ' ' THR . 86.8 m-20 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.502 179.813 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo . . . . . 0 N--CA 1.489 1.226 0 CA-C-O 121.448 0.52 . . . . 0.0 112.929 . . . . . . . . . 0 0 . 1 . 071 nuclear build core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 14.7 p -62.28 134.95 27.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.49 -179.869 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 7.4 t . . . . . 0 C--N 1.329 -0.298 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.541 . . . . . . . . 0 0 . 1 . 071 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo . . . . . 0 N--CA 1.493 1.443 0 CA-C-O 120.947 0.311 . . . . 0.0 111.427 . . . . . . . . . 0 0 . 1 . 071 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 95.6 m -68.47 -45.23 72.97 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.352 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.538 ' HZ ' HD22 ' A' ' 41' ' ' LEU . 82.3 t80 -58.59 -48.6 80.42 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.182 179.737 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 86.8 mt -64.69 -42.0 95.62 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.916 0.389 . . . . 0.0 110.971 -179.917 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -66.04 -47.06 75.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.282 -179.287 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -62.55 -41.85 99.16 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.167 -179.743 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.759 HH11 HH11 ' A' ' 12' ' ' ARG . 52.1 ttm-85 -64.17 -39.45 94.03 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.188 -179.727 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -59.28 -38.44 80.16 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.361 0.601 . . . . 0.0 109.468 179.923 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 15.9 m -67.14 -42.21 84.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.778 177.974 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -64.04 -31.14 72.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.46 179.881 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 55.6 t . . . . . 0 N--CA 1.456 -0.138 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.065 178.513 . . . . . . . . 0 0 . 1 . 071 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.526 ' OE1' HD21 ' A' ' 41' ' ' LEU . 99.2 mt-10 . . . . . 0 N--CA 1.452 -0.354 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 . . . . . . . . . 1 1 . 1 . 071 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.44 ' CD1' HG23 ' A' ' 9' ' ' THR . 66.3 mt -107.94 136.41 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 177.845 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 55.2 t -127.59 135.34 63.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.88 -178.618 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -94.74 117.16 29.69 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.907 -178.744 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -64.5 -46.11 84.37 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.264 179.935 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.68 158.24 36.95 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.657 -179.53 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -61.24 147.43 95.63 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 C-N-CA 123.041 2.494 . . . . 0.0 112.609 179.47 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.4 pt . . . . . 0 C--N 1.326 -0.427 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.073 -179.783 . . . . . . . . 0 0 . 1 . 072 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.4 p . . . . . 0 CA--C 1.531 0.224 0 CA-C-O 120.598 0.237 . . . . 0.0 111.501 . . . . . . . . . 0 0 . 1 . 072 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.728 ' NE ' HD13 ' A' ' 53' ' ' ILE . 91.7 mtm-85 -100.72 115.5 30.41 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 121.031 -0.268 . . . . 0.0 110.761 -179.57 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -131.65 141.23 49.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.277 0.56 . . . . 0.0 111.427 179.769 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.564 HD11 ' HB3' ' A' ' 95' ' ' PHE . 36.4 tp -114.47 127.7 55.95 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.413 179.908 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.575 HG13 ' CD2' ' A' ' 19' ' ' HIS . 75.8 t -103.15 127.86 56.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.521 -0.471 . . . . 0.0 110.268 -179.406 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 m -92.85 114.45 27.01 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 121.113 0.482 . . . . 0.0 111.398 -179.52 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.442 HD12 ' HB2' ' A' ' 94' ' ' SER . 85.9 mt -80.86 146.78 6.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.419 179.746 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -90.3 154.17 19.91 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 177.811 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.48 ' NH1' ' OD2' ' A' ' 92' ' ' ASP . 38.4 mtp85 -58.04 -28.71 64.75 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.547 -179.245 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 86.0 p -74.81 -14.9 60.74 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.606 -0.437 . . . . 0.0 110.142 178.949 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.54 36.44 4.84 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 -179.518 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.6 t -123.72 133.78 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-O 120.848 0.356 . . . . 0.0 111.68 -179.447 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -66.02 125.87 26.83 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.364 179.512 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -117.28 -126.98 3.83 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.458 -178.951 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -73.76 147.33 39.61 Favored 'Trans proline' 0 N--CA 1.5 1.874 0 C-N-CA 122.604 2.203 . . . . 0.0 112.955 -178.446 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.575 ' CD2' HG13 ' A' ' 8' ' ' VAL . 62.7 m170 -109.23 132.17 54.37 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.913 0.387 . . . . 0.0 110.705 -179.955 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.462 ' CD2' HD11 ' A' ' 37' ' ' ILE . 32.1 t80 -102.22 105.42 42.76 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.936 -179.893 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -74.93 128.66 11.72 Favored 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 121.464 1.443 . . . . 0.0 111.529 -179.418 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 64.9 mt -89.99 44.17 1.19 Allowed 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.387 -178.472 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 84.8 p -59.23 -21.94 60.31 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.408 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 73.6 mt -76.92 146.05 37.82 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.326 179.836 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.0 m -64.24 -23.18 67.21 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.23 -178.981 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 61.2 m -136.26 136.45 39.84 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.897 -179.039 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.1 t -128.01 120.05 26.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.062 179.063 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.404 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 57.4 tp -114.81 132.34 56.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.641 0.258 . . . . 0.0 111.112 -178.749 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.754 ' CE2' HD12 ' A' ' 37' ' ' ILE . 5.9 m-85 -111.92 139.8 47.11 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.902 179.715 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.44 -167.56 30.84 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 120.564 -0.826 . . . . 0.0 112.164 178.755 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.542 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 45.8 mtm180 -84.5 -32.0 24.19 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.867 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.572 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -49.49 143.69 9.65 Favored Glycine 0 CA--C 1.519 0.323 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 -178.662 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.49 HD12 ' HD2' ' A' ' 38' ' ' ARG . 7.0 tp -65.99 -41.1 89.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 120.248 -0.581 . . . . 0.0 109.932 179.995 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.443 ' N ' HG23 ' A' ' 33' ' ' ILE . 82.5 tt0 -54.71 -20.48 8.42 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.228 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.572 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 34.2 m -59.65 126.54 28.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.924 -179.834 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.404 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 56.1 m-20 -59.83 -31.98 70.24 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.249 0.547 . . . . 0.0 109.547 -179.623 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.754 HD12 ' CE2' ' A' ' 29' ' ' PHE . 97.4 mt -123.83 116.56 48.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.148 177.761 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.49 ' HD2' HD12 ' A' ' 33' ' ' ILE . 25.9 mtp85 -100.86 132.39 46.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.434 -178.197 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.796 HG21 ' NH2' ' A' ' 93' ' ' ARG . 92.8 mt -121.7 131.11 73.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.987 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.413 ' H ' ' HG2' ' A' ' 40' ' ' GLN . 13.5 pt20 -79.53 34.16 0.26 Allowed 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -177.849 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.959 HD12 HH21 ' A' ' 93' ' ' ARG . 23.6 mt -104.76 127.88 27.96 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.895 178.92 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -73.42 -9.49 23.03 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 122.303 2.002 . . . . 0.0 112.277 -179.997 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.0 m -91.73 1.09 8.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.73 0.3 . . . . 0.0 110.677 179.798 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.542 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 42.8 t -98.35 138.02 24.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.989 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 64.0 m -72.38 170.58 13.91 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.101 0.477 . . . . 0.0 111.364 -178.794 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -62.48 -41.41 98.77 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.884 -179.099 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.626 ' O ' ' N ' ' A' ' 49' ' ' CYS . 89.6 mt-30 -111.44 -18.5 12.85 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.631 0.253 . . . . 0.0 111.489 -179.698 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.49 ' NE2' HG23 ' A' ' 90' ' ' ILE . 12.6 t60 36.61 -77.06 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 179.262 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.626 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.66 136.08 47.41 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.067 0.461 . . . . 0.0 111.559 -178.475 . . . . . . . . 3 3 . 1 . 072 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -129.45 132.17 46.89 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.477 179.774 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.7 mt -115.13 134.31 58.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.855 -179.745 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -116.65 124.22 49.22 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.783 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.728 HD13 ' NE ' ' A' ' 5' ' ' ARG . 98.0 mt -107.25 114.69 46.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.483 -179.668 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.459 ' O ' ' N ' ' A' ' 56' ' ' GLN . 89.5 m-70 -114.22 145.95 41.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.831 179.924 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 54' ' ' HIS . 53.4 tp10 -40.7 -28.63 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.603 -179.819 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.459 ' N ' ' O ' ' A' ' 54' ' ' HIS . 84.1 mt-30 -63.53 -68.79 0.32 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.962 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.467 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 6.1 tp10 -159.9 -163.48 1.15 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.996 179.379 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.467 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -110.3 127.49 55.04 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.659 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.7 mt -117.22 130.2 72.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.371 0.605 . . . . 0.0 112.099 -178.911 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.8 tp -99.17 129.12 45.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.292 -179.74 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -114.53 137.48 51.81 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.618 179.975 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.438 HD21 ' HA ' ' A' ' 68' ' ' PRO . 54.1 t30 -97.61 107.55 20.08 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.374 -179.757 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -98.9 -10.1 23.29 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 179.918 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.2 t -74.98 102.71 4.9 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.548 179.429 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.7 p -82.28 -17.7 44.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.98 0.419 . . . . 0.0 110.382 179.764 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.513 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -91.24 -39.96 11.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.009 -179.102 . . . . . . . . 3 3 . 1 . 072 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.469 ' OD1' HG13 ' B' ' 236' ' ' VAL . 71.2 m-20 -140.65 94.52 8.22 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.555 -179.936 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.504 ' HB2' HG13 ' A' ' 75' ' ' VAL . 32.2 Cg_exo -57.01 146.34 80.91 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.005 1.804 . . . . 0.0 112.028 -179.404 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.1 m -72.93 137.48 45.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.496 179.967 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -100.76 141.27 33.87 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.104 -179.827 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 46.0 t -127.2 136.95 59.24 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.155 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 51.29 32.31 8.13 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.714 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.96 29.92 68.52 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 -179.965 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.3 p -140.25 134.76 31.52 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 120.641 -0.423 . . . . 0.0 111.644 -179.3 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.504 HG13 ' HB2' ' A' ' 68' ' ' PRO . 52.9 t -67.8 132.89 32.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-O 121.248 0.547 . . . . 0.0 110.929 179.708 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.13 111.39 25.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.807 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -96.25 -10.62 27.54 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.734 -0.387 . . . . 0.0 111.772 -178.592 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -117.25 158.12 45.36 Favored Pre-proline 0 C--N 1.329 -0.3 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.627 -179.412 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -56.12 142.49 86.31 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 121.919 1.746 . . . . 0.0 112.216 179.522 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 18.9 m -144.57 139.96 23.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.623 179.306 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 89.3 mtm-85 -72.91 133.07 44.22 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.876 0.37 . . . . 0.0 110.176 179.758 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.441 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 93.7 mt -81.45 138.98 35.48 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.169 -179.434 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -126.78 148.91 49.89 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.466 179.429 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.423 ' ND1' ' N ' ' A' ' 99' ' ' ASN . 12.4 t60 -58.48 124.89 21.14 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.886 0.374 . . . . 0.0 111.209 -178.667 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.07 -20.96 34.69 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.444 -0.662 . . . . 0.0 111.444 179.967 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -66.87 138.44 57.32 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 120.491 -0.483 . . . . 0.0 110.023 179.731 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.507 HG22 ' HG2' ' A' ' 96' ' ' ARG . 79.5 t -110.36 132.69 58.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.25 -178.747 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 82.5 mt -100.63 132.6 45.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.324 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 93.7 m -120.82 125.52 47.76 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.032 -0.667 . . . . 0.0 112.172 -178.203 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.49 HG23 ' NE2' ' A' ' 48' ' ' HIS . 96.2 mt -116.25 123.96 71.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.019 -0.991 . . . . 0.0 108.61 178.694 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.541 HG22 ' N ' ' A' ' 92' ' ' ASP . 48.8 mm 39.72 -106.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.618 -179.318 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.541 ' N ' HG22 ' A' ' 91' ' ' ILE . 32.8 p-10 -110.1 13.09 23.34 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.787 0.327 . . . . 0.0 111.698 -179.346 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.959 HH21 HD12 ' A' ' 41' ' ' LEU . 9.5 mtm105 -118.51 140.4 49.94 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.198 179.732 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.442 ' HB2' HD12 ' A' ' 10' ' ' ILE . 17.0 m -128.88 144.8 51.28 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.006 179.007 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.564 ' HB3' HD11 ' A' ' 7' ' ' LEU . 41.7 m-85 -126.73 123.53 37.69 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.497 -179.782 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.507 ' HG2' HG22 ' A' ' 87' ' ' VAL . 99.7 mtt180 -85.95 128.49 34.85 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 119.953 -0.699 . . . . 0.0 109.721 -179.754 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -93.98 127.98 40.07 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 120.897 0.38 . . . . 0.0 110.495 -179.995 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -126.56 128.79 47.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.56 -179.323 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.423 ' N ' ' ND1' ' A' ' 84' ' ' HIS . 43.8 t30 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.538 179.485 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 N--CA 1.488 1.184 0 CA-C-O 121.071 0.363 . . . . 0.0 112.763 . . . . . . . . . 0 0 . 1 . 072 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.513 ' CG2' HG22 ' A' ' 66' ' ' THR . 77.5 t -59.83 134.98 24.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.664 -179.625 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 4.5 t . . . . . 0 C--N 1.327 -0.412 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.493 -179.117 . . . . . . . . 0 0 . 1 . 072 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo . . . . . 0 N--CA 1.489 1.207 0 N-CA-C 111.736 -0.14 . . . . 0.0 111.736 . . . . . . . . . 0 0 . 1 . 072 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 73.5 m -75.07 -45.36 41.97 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 176.956 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -57.07 -47.52 80.8 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.265 -179.106 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' B' ' 242' ' ' LEU . 93.0 mt -66.07 -39.85 90.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.15 -179.611 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -62.4 -42.18 99.23 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.577 -179.257 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -63.39 -42.0 98.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.019 0.438 . . . . 0.0 110.058 179.523 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.533 ' CA ' ' HE ' ' B' ' 245' ' ' ARG . 0.0 OUTLIER -63.19 -43.15 99.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.81 -179.348 . . . . . . . . 3 3 . 1 . 072 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.76 -37.71 87.7 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.66 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 39.0 t -64.71 -42.61 95.13 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 177.29 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -59.26 -36.88 76.31 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.073 179.997 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' B' B ' 249' ' ' VAL . . . . . 0.459 HG23 HH21 ' A' ' 12' ' ' ARG . 46.3 t . . . . . 0 C--O 1.23 0.057 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.129 178.829 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.599 ' O ' HG23 ' A' ' 39' ' ' ILE . 93.5 mt-10 . . . . . 0 N--CA 1.453 -0.32 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 . . . . . . . . . 1 1 . 1 . 072 nuclear build core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 16.8 mt -115.84 135.85 54.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.51 -179.627 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 45.2 t -127.23 133.72 67.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.537 179.272 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -96.37 119.93 35.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.151 0.5 . . . . 0.0 111.711 -178.638 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -65.45 -44.51 87.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.335 178.964 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -100.25 157.35 33.97 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.979 -179.171 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.4 157.51 54.22 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.945 2.43 . . . . 0.0 112.0 178.763 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 45.3 pt . . . . . 0 C--N 1.33 -0.258 0 CA-C-O 121.336 0.588 . . . . 0.0 112.306 -178.868 . . . . . . . . 0 0 . 1 . 073 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.4 t . . . . . 0 C--O 1.235 0.291 0 CA-C-O 120.843 0.354 . . . . 0.0 110.145 . . . . . . . . . 0 0 . 1 . 073 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -94.07 123.1 37.23 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.918 -179.57 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 -128.23 137.14 51.89 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.214 -179.903 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.6 HD11 ' HB3' ' A' ' 95' ' ' PHE . 39.6 tp -112.87 130.98 55.91 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.845 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 66.7 t -109.53 130.99 61.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.325 -179.439 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 m -90.87 118.56 30.37 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.163 -178.765 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.598 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 96.0 mt -81.63 140.54 16.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.063 179.282 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.483 ' HA ' HH22 ' A' ' 93' ' ' ARG . 41.5 mmtt -83.71 158.91 21.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.955 0.407 . . . . 0.0 110.058 178.89 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.58 ' N ' HH12 ' A' ' 93' ' ' ARG . 85.4 mtp180 -57.74 -35.48 70.76 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.12 -178.646 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.4 t -76.08 -8.52 57.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.739 0.304 . . . . 0.0 111.414 -179.787 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.66 35.07 5.76 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 -179.184 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.6 t -121.84 132.9 69.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.785 0.326 . . . . 0.0 111.189 -179.72 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -77.71 137.12 38.31 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.313 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.95 -118.34 2.03 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 120.617 -0.802 . . . . 0.0 111.492 -179.63 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.53 151.96 48.03 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.216 1.944 . . . . 0.0 112.274 -179.25 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.459 ' CD2' ' C ' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -117.1 156.62 27.28 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.309 179.814 . . . . . . . . 3 3 . 1 . 073 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.457 ' CD2' HD11 ' A' ' 37' ' ' ILE . 49.1 t80 -124.04 107.03 30.83 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.924 -179.13 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.24 135.16 22.2 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 121.546 1.497 . . . . 0.0 111.961 -179.282 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.461 HD22 ' SG ' ' A' ' 27' ' ' CYS . 62.2 mt -96.44 40.95 1.12 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.166 -178.512 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.8 p -63.07 -18.47 63.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.146 0.498 . . . . 0.0 109.957 179.541 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.9 mt -75.53 149.49 38.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.504 179.219 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 26.3 m -62.99 -25.52 68.42 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.494 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.478 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 95.7 m -139.25 139.66 37.48 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 120.1 -0.64 . . . . 0.0 112.541 -179.59 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.461 ' SG ' HD22 ' A' ' 22' ' ' LEU . 4.0 t -128.09 116.63 20.27 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.852 179.027 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.571 HD21 ' OE1' ' A' ' 47' ' ' GLN . 54.9 tp -113.81 128.91 56.6 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.84 0.352 . . . . 0.0 110.976 -179.073 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.791 ' CE2' HD12 ' A' ' 37' ' ' ILE . 5.1 m-85 -108.07 137.04 46.75 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.171 -179.511 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 152.54 -172.79 31.67 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.216 -0.992 . . . . 0.0 112.267 178.756 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 48.1 mtm180 -76.98 -32.57 57.35 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 179.851 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.498 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -48.23 144.95 6.2 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 120.674 -0.775 . . . . 0.0 111.263 -178.693 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.491 HG23 ' N ' ' A' ' 34' ' ' GLU . 9.9 tp -65.64 -41.16 89.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.824 0.345 . . . . 0.0 110.12 -179.99 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.491 ' N ' HG23 ' A' ' 33' ' ' ILE . 80.3 mm-40 -57.06 -19.54 19.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.959 -179.987 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 62.8 m -56.05 122.69 12.23 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.703 -179.751 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.478 ' OD2' ' O ' ' A' ' 26' ' ' THR . 56.0 m-20 -58.88 -30.72 67.97 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -179.947 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.791 HD12 ' CE2' ' A' ' 29' ' ' PHE . 85.6 mt -127.01 120.51 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.361 177.333 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 84.4 mtp180 -102.46 135.15 44.59 Favored 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.472 -179.354 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 97.1 mt -116.12 126.31 73.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.145 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -75.05 30.62 0.09 Allowed 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -177.87 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.418 ' HA ' HD23 ' A' ' 41' ' ' LEU . 45.9 mt -98.27 126.22 40.57 Favored Pre-proline 0 C--N 1.325 -0.49 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.3 179.259 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -72.4 -8.22 22.27 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 C-N-CA 122.315 2.01 . . . . 0.0 112.853 -179.719 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.575 HG21 ' CE2' ' B' ' 241' ' ' PHE . 27.5 m -101.73 6.32 10.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.069 0.462 . . . . 0.0 110.422 179.52 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.1 t -91.01 137.41 21.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.431 178.747 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.8 m -68.72 169.24 11.63 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.613 0.72 . . . . 0.0 112.214 -178.332 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -62.78 -43.93 97.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.177 -179.041 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.586 ' O ' ' N ' ' A' ' 49' ' ' CYS . 95.2 mm-40 -113.65 -25.75 8.56 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.95 -179.532 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.1 t60 40.42 -78.74 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.878 -1.056 . . . . 0.0 113.43 179.661 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.586 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -129.05 136.03 49.72 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.025 . . . . . . . . 3 3 . 1 . 073 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -129.53 126.82 39.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.798 -179.931 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.1 mt -112.04 134.72 53.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.341 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -119.77 127.67 53.02 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.624 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 83.6 mt -105.67 121.52 58.02 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 CA-C-O 121.694 0.759 . . . . 0.0 111.609 -178.904 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.548 ' O ' ' N ' ' A' ' 56' ' ' GLN . 92.5 m-70 -117.11 142.81 46.52 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.105 -179.504 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 54' ' ' HIS . 92.4 mt-10 -39.0 -26.75 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -179.295 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.548 ' N ' ' O ' ' A' ' 54' ' ' HIS . 87.7 mt-30 -68.63 -67.39 0.47 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.679 179.045 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.493 ' CD ' HH21 ' A' ' 81' ' ' ARG . 5.3 tp10 -159.66 -156.98 0.54 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.221 179.802 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -120.88 131.17 54.24 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.039 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 93.5 mt -120.77 131.22 73.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.031 0.443 . . . . 0.0 112.027 -178.455 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 34.7 tp -94.48 125.2 38.98 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.042 179.566 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -111.21 138.22 47.93 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.16 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.653 HD21 ' CB ' ' A' ' 68' ' ' PRO . 63.5 t-20 -101.74 107.82 19.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.43 . . . . 0.0 112.013 -178.53 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -99.33 -9.87 23.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.43 -179.991 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.49 99.93 9.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.691 0.281 . . . . 0.0 110.295 -179.634 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.2 p -82.34 -35.9 27.42 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.963 179.811 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.543 HG22 HG22 ' B' ' 236' ' ' VAL . 0.3 OUTLIER -61.69 -48.19 81.9 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.182 0.515 . . . . 0.0 109.902 -179.517 . . . . . . . . 3 3 . 1 . 073 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -139.63 100.63 7.45 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.683 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.653 ' CB ' HD21 ' A' ' 62' ' ' ASN . 44.7 Cg_endo -66.9 151.22 82.64 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 121.56 1.507 . . . . 0.0 113.662 -177.79 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.928 ' O ' HG22 ' A' ' 76' ' ' ILE . 16.6 m -68.38 144.02 54.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.116 -179.835 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -103.73 140.6 37.38 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.85 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.9 p -129.27 135.85 60.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.621 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 49.83 34.34 7.58 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.628 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.04 28.19 70.83 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.529 -179.838 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.0 m -139.64 139.69 36.76 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.796 -179.421 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.3 t -68.56 135.93 27.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 120.909 0.385 . . . . 0.0 111.231 179.661 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.928 HG22 ' O ' ' A' ' 69' ' ' THR . 9.6 tt -105.45 96.56 4.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.332 179.906 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -64.57 -35.59 81.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.67 179.736 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.518 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 0.0 OUTLIER -133.55 177.22 2.36 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 120.596 -0.441 . . . . 0.0 111.722 -179.157 . . . . . . . . 3 3 . 1 . 073 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.433 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 48.8 Cg_exo -56.22 141.72 87.84 Favored 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 122.842 2.362 . . . . 0.0 112.944 -179.661 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 42.1 t -134.58 141.26 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.027 -179.636 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.493 HH21 ' CD ' ' A' ' 57' ' ' GLU . 60.2 ttt180 -74.03 122.83 23.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.022 178.353 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 82' ' ' LEU . 98.5 mt -75.02 140.44 43.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.174 0.511 . . . . 0.0 111.3 -179.144 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -133.17 147.7 52.06 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.58 179.701 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.516 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 7.8 t60 -52.66 114.4 1.38 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.316 179.38 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 113.85 -14.67 21.82 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.179 -0.769 . . . . 0.0 111.179 179.997 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -69.42 131.32 44.59 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.028 179.684 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.405 HG22 ' HG3' ' A' ' 96' ' ' ARG . 66.8 t -110.55 129.4 65.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.369 -178.95 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 89.7 mt -101.71 133.9 43.78 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.51 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.556 HG23 ' OG ' ' A' ' 94' ' ' SER . 66.5 m -121.71 121.85 38.23 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.583 0.706 . . . . 0.0 111.529 -179.135 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.632 ' O ' ' N ' ' A' ' 93' ' ' ARG . 86.6 mt -110.32 128.98 66.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.533 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.647 HD13 ' HB2' ' B' ' 237' ' ' CYS . 61.8 mt -15.42 92.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -178.519 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.539 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 2.7 t70 88.73 -22.33 0.13 Allowed 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 177.595 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.632 ' N ' ' O ' ' A' ' 90' ' ' ILE . 19.6 mmm180 -122.94 138.74 54.59 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.789 -0.365 . . . . 0.0 110.349 -179.603 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.556 ' OG ' HG23 ' A' ' 89' ' ' THR . 69.4 m -134.88 150.0 50.38 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.707 179.688 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.6 ' HB3' HD11 ' A' ' 7' ' ' LEU . 55.3 m-85 -127.56 121.35 30.39 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.361 -179.917 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.575 ' O ' HD12 ' A' ' 7' ' ' LEU . 42.1 ttp-105 -84.77 133.51 34.35 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.906 0.384 . . . . 0.0 110.257 -179.834 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -94.3 121.34 35.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.199 -179.327 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -127.56 123.08 34.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.616 179.971 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.516 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 7.8 p-10 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.047 179.4 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo . . . . . 0 N--CA 1.497 1.691 0 CA-C-O 120.967 0.319 . . . . 0.0 112.7 . . . . . . . . . 0 0 . 1 . 073 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.543 HG22 HG22 ' A' ' 66' ' ' THR . 28.3 t -89.48 131.08 37.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.038 178.89 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' B' B ' 237' ' ' CYS . . . . . 0.647 ' HB2' HD13 ' A' ' 91' ' ' ILE . 8.0 t . . . . . 0 C--N 1.325 -0.474 0 CA-C-O 120.984 0.421 . . . . 0.0 110.965 -179.264 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo . . . . . 0 N--CA 1.493 1.46 0 CA-C-O 120.687 0.203 . . . . 0.0 111.712 . . . . . . . . . 0 0 . 1 . 073 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 3.1 m -74.05 -41.8 61.22 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 177.259 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.575 ' CE2' HG21 ' A' ' 43' ' ' VAL . 87.7 t80 -57.49 -47.24 82.44 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.238 -179.69 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 99.3 mt -65.55 -39.87 92.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.778 -179.787 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -61.28 -42.05 97.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.425 -179.801 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -62.0 -43.41 98.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.64 179.512 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.417 ' NH1' ' OE1' ' B' ' 248' ' ' GLN . 2.6 mpt_? -60.33 -40.74 91.7 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.292 -179.927 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -63.5 -43.01 98.49 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.375 0.607 . . . . 0.0 109.76 179.089 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 72.3 m -62.71 -44.38 96.37 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.646 179.094 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' B' B ' 248' ' ' GLN . . . . . 0.417 ' OE1' ' NH1' ' B' ' 245' ' ' ARG . 86.5 mt-30 -61.11 -36.68 80.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.572 -179.887 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 22.9 t . . . . . 0 C--N 1.33 -0.273 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.139 179.301 . . . . . . . . 0 0 . 1 . 073 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.412 ' N ' ' CD ' ' B' ' 260' ' ' GLU . 1.3 pm0 . . . . . 0 C--O 1.226 -0.162 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 . . . . . . . . . 1 1 . 1 . 073 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.565 HD11 ' HE ' ' A' ' 93' ' ' ARG . 60.1 mt -118.67 131.69 70.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.146 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 50.8 t -128.88 134.81 63.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.057 -179.515 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -94.45 119.92 33.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.174 0.511 . . . . 0.0 111.206 -178.582 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.26 -44.72 94.35 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.507 179.56 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -102.19 159.93 27.91 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.408 -179.086 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -65.88 161.45 39.37 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.602 2.201 . . . . 0.0 111.723 179.68 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.4 pt . . . . . 0 C--N 1.33 -0.258 0 CA-C-O 121.435 0.636 . . . . 0.0 111.952 -179.03 . . . . . . . . 0 0 . 1 . 074 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 54.2 m . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.836 0.351 . . . . 0.0 110.494 . . . . . . . . . 0 0 . 1 . 074 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.507 ' NH2' ' O ' ' A' ' 22' ' ' LEU . 82.9 mtm-85 -81.72 132.61 35.29 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.41 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 91.0 mtm-85 -127.1 131.42 50.84 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.295 -179.768 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.7 HD12 ' O ' ' A' ' 96' ' ' ARG . 29.8 tp -117.22 126.24 52.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.409 179.348 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.476 HG12 ' ND1' ' A' ' 19' ' ' HIS . 35.8 m -101.3 133.65 43.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.903 -179.277 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.444 ' CG2' HD12 ' B' ' 261' ' ' ILE . 9.7 m -92.2 113.87 26.26 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.072 -178.874 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.463 HD12 ' OG ' ' A' ' 94' ' ' SER . 96.3 mt -81.78 144.53 10.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.683 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -101.02 164.02 12.01 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.618 179.965 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.487 ' HB3' HG21 ' B' ' 249' ' ' VAL . 87.4 mtm180 -59.35 -31.56 69.31 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.569 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.1 t -70.35 -20.59 62.97 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.484 179.239 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.39 17.3 20.24 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.727 179.36 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.5 m -110.23 135.49 49.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.991 0.424 . . . . 0.0 111.198 -179.733 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 17' ' ' GLY . 64.0 t0 -76.55 135.75 39.28 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.029 179.602 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.511 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -126.63 -114.03 1.88 Allowed Glycine 0 CA--C 1.537 1.428 0 C-N-CA 120.361 -0.924 . . . . 0.0 111.961 -179.897 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.91 147.64 50.06 Favored 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 122.434 2.089 . . . . 0.0 113.488 -178.678 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.476 ' ND1' HG12 ' A' ' 8' ' ' VAL . 22.2 m-70 -109.83 142.1 41.58 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.148 179.325 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.424 ' CD2' HD11 ' A' ' 37' ' ' ILE . 27.4 t80 -113.32 106.14 54.75 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.041 -179.829 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.62 129.46 13.67 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 121.419 1.413 . . . . 0.0 111.831 -179.432 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.507 ' O ' ' NH2' ' A' ' 5' ' ' ARG . 25.8 mt -94.77 39.94 1.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.858 -178.556 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.9 t -63.12 -15.82 57.99 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.405 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.8 mt -73.7 145.36 45.27 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.327 179.891 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 86.6 p -58.44 -26.38 63.26 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.049 -178.42 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 87.3 m -141.41 139.99 33.56 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.487 -179.584 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.665 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 6.6 t -129.29 119.88 24.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.668 178.856 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.619 HD21 ' OE1' ' A' ' 47' ' ' GLN . 50.1 tp -114.7 130.49 56.83 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.373 -178.422 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.837 ' CE2' HD12 ' A' ' 37' ' ' ILE . 7.0 m-85 -107.68 141.02 39.84 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.807 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 153.39 -171.39 32.27 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 119.95 -1.119 . . . . 0.0 112.538 179.053 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.5 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 45.0 mtm180 -85.8 -32.57 21.72 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 111.497 0.184 . . . . 0.0 111.497 179.564 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -47.36 150.05 2.55 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 -178.977 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.545 ' O ' ' NH2' ' A' ' 38' ' ' ARG . 8.2 tp -64.54 -41.52 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 O-C-N 122.442 -0.446 . . . . 0.0 110.574 -179.579 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.543 ' N ' HG23 ' A' ' 33' ' ' ILE . 95.5 mt-10 -59.08 -18.82 38.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.898 -179.315 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 71.4 m -57.11 118.94 5.53 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.119 -179.869 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -56.4 -29.89 62.1 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.328 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.837 HD12 ' CE2' ' A' ' 29' ' ' PHE . 75.1 mt -124.37 118.81 54.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 177.01 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.545 ' NH2' ' O ' ' A' ' 33' ' ' ILE . 72.0 mtt85 -103.86 134.38 47.25 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.469 -178.427 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.728 ' CG2' HD12 ' A' ' 41' ' ' LEU . 77.6 mt -117.96 129.61 74.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.877 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -76.84 29.99 0.13 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.749 -178.974 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.728 HD12 ' CG2' ' A' ' 39' ' ' ILE . 7.3 mt -99.66 127.14 34.87 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.188 179.902 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.16 -13.27 31.05 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.278 1.986 . . . . 0.0 113.438 -179.202 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.463 HG21 ' N ' ' B' ' 237' ' ' CYS . 1.4 p -96.13 5.06 8.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.114 179.73 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.5 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 42.4 t -88.68 133.45 30.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.275 179.431 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.438 ' O ' HG12 ' A' ' 44' ' ' VAL . 0.6 OUTLIER -66.15 162.69 19.21 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.213 0.53 . . . . 0.0 110.576 179.965 . . . . . . . . 3 3 . 1 . 074 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -60.6 -42.14 96.2 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.944 -178.512 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.619 ' OE1' HD21 ' A' ' 28' ' ' LEU . 97.6 mm-40 -109.33 -16.07 14.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.11 179.837 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.6 t60 34.88 -77.82 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.686 -179.316 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.615 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.11 136.64 45.95 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.113 0.483 . . . . 0.0 111.364 -178.931 . . . . . . . . 3 3 . 1 . 074 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -127.86 129.54 47.08 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.867 179.855 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.8 mt -112.18 133.03 59.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.14 179.663 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.505 ' OE2' ' CE1' ' A' ' 54' ' ' HIS . 81.7 tt0 -115.61 124.03 49.92 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.048 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 48.4 mm -96.33 117.61 40.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.155 0.502 . . . . 0.0 111.886 -178.345 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.505 ' CE1' ' OE2' ' A' ' 52' ' ' GLU . 95.8 m-70 -115.42 132.52 56.59 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.116 179.065 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 54' ' ' HIS . 96.9 mt-10 -42.54 -30.16 0.33 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.375 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.457 ' N ' ' C ' ' A' ' 54' ' ' HIS . 59.3 tt0 -67.09 -68.37 0.38 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.602 178.216 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -151.16 -174.83 4.93 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.475 0.655 . . . . 0.0 111.905 -179.66 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.35 122.16 46.54 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.978 178.372 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 98.5 mt -117.2 132.35 67.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -178.505 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.1 tp -98.76 130.16 45.21 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.173 179.302 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -110.35 135.43 51.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.785 179.585 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 64.2 t-20 -95.31 105.97 17.97 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.915 179.983 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -98.34 -9.81 24.8 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.581 179.52 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.1 m -72.99 100.63 3.02 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 178.988 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.2 p -87.11 -21.55 25.93 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.114 179.95 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.661 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -86.72 -44.86 11.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.215 -179.73 . . . . . . . . 3 3 . 1 . 074 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -132.34 93.14 26.35 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.285 179.75 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -56.25 142.71 87.18 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.45 2.1 . . . . 0.0 112.84 -178.6 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 45.6 m -75.74 152.99 37.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.819 179.607 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -116.08 140.67 49.04 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.835 -179.278 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.736 HG13 ' OD1' ' A' ' 86' ' ' ASP . 55.6 t -129.25 134.5 63.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.336 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 53.29 33.41 15.5 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -179.163 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.9 28.62 70.32 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.696 179.944 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 45.0 t -141.65 140.05 33.16 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 117.04 0.42 . . . . 0.0 111.39 -179.972 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.1 t -66.66 136.38 26.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.685 -179.86 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.7 pt -111.88 79.19 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.617 179.276 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -62.27 -26.94 68.67 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.355 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.08 162.04 26.27 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.837 179.187 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.41 146.43 89.66 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.544 2.163 . . . . 0.0 111.561 179.724 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.7 m -137.77 142.95 34.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.17 0.51 . . . . 0.0 111.555 -179.6 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -72.32 127.52 32.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.585 -179.759 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 82' ' ' LEU . 96.0 mt -78.52 139.19 38.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.185 0.517 . . . . 0.0 111.185 -179.596 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -135.72 150.06 49.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.209 -178.68 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -53.35 113.21 1.07 Allowed 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.73 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.32 -10.89 26.43 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -179.784 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.736 ' OD1' HG13 ' A' ' 71' ' ' VAL . 49.0 t0 -74.19 127.24 32.44 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.41 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.47 ' O ' HG13 ' A' ' 87' ' ' VAL . 13.1 p -108.78 132.64 56.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.639 -178.493 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 94.9 mt -98.66 130.37 47.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.11 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.1 m -117.38 127.25 53.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.725 0.774 . . . . 0.0 112.177 -178.669 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.595 ' O ' ' N ' ' A' ' 93' ' ' ARG . 94.7 mt -116.39 132.86 64.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 114.46 -1.245 . . . . 0.0 108.436 178.536 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.93 HG22 HH22 ' B' ' 245' ' ' ARG . 89.1 mt -25.64 99.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 -179.098 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.534 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 6.9 t0 90.06 -21.88 0.12 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 178.08 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.595 ' N ' ' O ' ' A' ' 90' ' ' ILE . 63.2 mtt85 -131.27 146.09 52.16 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.215 -179.289 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.463 ' OG ' HD12 ' A' ' 10' ' ' ILE . 44.8 p -140.67 154.56 46.44 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.026 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.502 ' HE1' HD12 ' A' ' 90' ' ' ILE . 56.5 m-85 -128.26 128.51 44.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.033 -179.825 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.7 ' O ' HD12 ' A' ' 7' ' ' LEU . 99.4 mtt180 -94.81 135.07 36.74 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 119.461 -0.896 . . . . 0.0 110.66 -179.948 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.461 ' CE2' ' OD1' ' A' ' 99' ' ' ASN . 88.0 t80 -95.04 125.89 40.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.707 -179.705 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.521 ' N ' ' OE1' ' A' ' 98' ' ' GLU . 55.7 mp0 -134.94 126.94 29.64 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.423 -179.652 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.461 ' OD1' ' CE2' ' A' ' 97' ' ' TYR . 98.3 m-20 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.867 179.122 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo . . . . . 0 N--CA 1.492 1.39 0 CA-C-O 120.966 0.319 . . . . 0.0 112.415 . . . . . . . . . 0 0 . 1 . 074 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.661 ' CG2' HG22 ' A' ' 66' ' ' THR . 40.2 t -114.03 136.5 50.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.933 -179.764 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' B' B ' 237' ' ' CYS . . . . . 0.463 ' N ' HG21 ' A' ' 43' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.008 -179.207 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo . . . . . 0 N--CA 1.501 1.921 0 N-CA-C 114.241 0.824 . . . . 0.0 114.241 . . . . . . . . . 0 0 . 1 . 074 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 44.8 p -79.52 -34.62 41.0 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.321 179.423 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.544 ' CE2' ' CZ ' ' B' ' 245' ' ' ARG . 78.9 t80 -57.9 -47.86 81.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.702 -179.572 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.427 HD23 HH21 ' B' ' 245' ' ' ARG . 72.0 mt -65.36 -43.16 91.68 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.005 0.431 . . . . 0.0 110.774 179.276 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -65.8 -39.43 90.91 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.463 -179.245 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -61.67 -47.23 86.27 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.962 -179.719 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.93 HH22 HG22 ' A' ' 91' ' ' ILE . 78.1 mtm180 -65.95 -37.99 87.44 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.39 -179.275 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -59.57 -42.17 91.84 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.994 0.426 . . . . 0.0 111.006 179.703 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 81.2 p -68.95 -42.98 75.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.664 0.745 . . . . 0.0 109.112 178.981 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -62.97 -37.92 89.03 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.783 179.749 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' B' B ' 249' ' ' VAL . . . . . 0.513 HG23 ' O ' ' B' ' 245' ' ' ARG . 55.1 t . . . . . 0 N--CA 1.454 -0.261 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.112 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.446 ' OE1' ' NH2' ' A' ' 93' ' ' ARG . 99.0 mt-10 . . . . . 0 N--CA 1.455 -0.2 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 . . . . . . . . . 1 1 . 1 . 074 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.444 HD12 ' CG2' ' A' ' 9' ' ' THR . 70.5 mt -112.88 134.89 54.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -179.999 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 48.8 t -126.51 134.35 66.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.122 179.47 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -94.79 120.94 35.84 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.155 0.502 . . . . 0.0 110.993 -179.457 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' B' B ' 264' ' ' LYS . . . . . 0.441 ' HG3' HH22 ' A' ' 38' ' ' ARG . 88.2 tttt -62.93 -45.7 91.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.016 179.414 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 5.7 mm100 -97.68 152.7 38.29 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.336 -179.803 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -69.88 148.98 65.51 Favored 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 122.906 2.404 . . . . 0.0 113.305 -179.279 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 18.7 pt . . . . . 0 N--CA 1.462 0.146 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.313 178.9 . . . . . . . . 0 0 . 1 . 075 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 59.6 p . . . . . 0 N--CA 1.463 0.219 0 CA-C-O 120.904 0.383 . . . . 0.0 111.451 . . . . . . . . . 0 0 . 1 . 075 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.603 ' HD2' HD13 ' A' ' 53' ' ' ILE . 91.5 mtt-85 -92.49 129.77 38.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.071 -177.941 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -136.47 141.99 43.54 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.362 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.643 ' CD1' HD11 ' A' ' 22' ' ' LEU . 26.1 mt -116.48 142.12 47.29 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.87 179.207 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.7 t -114.76 129.32 71.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.138 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 m -94.57 118.54 31.84 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -177.725 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.734 HD12 ' OG ' ' A' ' 94' ' ' SER . 91.0 mt -81.39 143.58 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.804 179.587 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 69.9 mttt -87.51 160.73 18.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.374 178.671 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.57 HH21 ' HG3' ' B' ' 245' ' ' ARG . 81.3 mtp180 -56.18 -33.14 64.99 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.693 -178.76 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 99.8 p -79.82 -8.29 59.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.311 -179.314 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.64 39.75 5.82 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 179.831 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 37.1 t -123.15 133.96 67.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.237 0.542 . . . . 0.0 111.261 -179.454 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -68.9 123.23 20.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.128 179.905 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -115.38 -125.31 3.92 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.507 -179.577 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -74.32 150.08 41.13 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.139 1.893 . . . . 0.0 112.363 -179.342 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -107.21 150.91 26.11 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.9 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.437 ' CD2' HD11 ' A' ' 37' ' ' ILE . 54.8 t80 -119.24 90.98 43.11 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.286 -178.585 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -63.94 130.82 28.69 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.509 2.14 . . . . 0.0 111.36 178.708 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.643 HD11 ' CD1' ' A' ' 7' ' ' LEU . 95.1 mt -96.05 122.37 38.81 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.738 -179.671 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.401 ' H ' HE22 ' B' ' 265' ' ' GLN . 11.4 p -121.87 -26.38 4.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.126 179.284 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.3 mt -78.3 143.72 36.73 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.054 179.008 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.0 p -69.93 -13.82 62.42 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.307 -179.389 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.443 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 20.3 m -127.75 130.39 48.68 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 120.599 -0.441 . . . . 0.0 110.905 179.452 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.8 t -126.67 119.03 25.98 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.595 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' A' ' 36' ' ' ASP . 52.9 tp -117.57 124.35 48.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.901 0.382 . . . . 0.0 111.667 -178.776 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.822 ' CE2' HD12 ' A' ' 37' ' ' ILE . 4.7 m-85 -100.39 142.55 31.71 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 178.768 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 155.55 -177.14 32.86 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 119.972 -1.109 . . . . 0.0 112.265 178.709 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.61 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 87.8 mtm-85 -75.34 -32.18 60.81 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.139 0.495 . . . . 0.0 110.007 179.388 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.546 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -53.0 146.5 18.22 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.112 -178.434 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.499 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.2 tp -66.88 -41.57 87.83 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.158 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.499 ' N ' HG23 ' A' ' 33' ' ' ILE . 78.2 mm-40 -54.07 -19.55 5.06 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.758 179.818 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.546 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 38.6 m -60.67 124.61 20.93 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.072 179.917 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.443 ' OD2' ' O ' ' A' ' 26' ' ' THR . 56.1 m-20 -59.11 -32.41 69.81 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -179.793 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.822 HD12 ' CE2' ' A' ' 29' ' ' PHE . 85.5 mt -124.04 120.82 60.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 175.724 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -108.43 136.0 48.79 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.209 -0.596 . . . . 0.0 111.242 -179.189 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.432 HG22 ' H ' ' A' ' 41' ' ' LEU . 76.8 mt -115.67 132.0 66.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.99 -179.879 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -80.31 25.62 0.39 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.124 -178.476 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.482 HD21 ' OE1' ' B' ' 260' ' ' GLU . 36.2 mt -99.04 129.14 30.22 Favored Pre-proline 0 C--N 1.328 -0.333 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.266 179.332 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.45 -13.53 33.03 Favored 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 122.184 1.922 . . . . 0.0 112.798 -179.638 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.424 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 0.7 OUTLIER -91.58 1.25 8.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.499 -0.48 . . . . 0.0 111.75 -179.542 . . . . . . . . 3 3 . 1 . 075 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.61 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 66.0 t -93.22 132.32 37.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.352 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.551 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 0.3 OUTLIER -61.69 164.7 5.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.241 0.543 . . . . 0.0 111.551 -178.585 . . . . . . . . 3 3 . 1 . 075 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.473 ' CG ' ' NH2' ' A' ' 31' ' ' ARG . 96.6 mttt -61.99 -45.08 95.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.825 -179.142 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.589 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.2 mt-30 -110.53 -12.34 14.38 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-O 121.519 0.676 . . . . 0.0 109.548 179.315 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.551 ' H ' ' HB3' ' A' ' 45' ' ' SER . 25.1 t60 28.8 -75.45 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.219 -1.355 . . . . 0.0 114.255 179.277 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.589 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.43 135.87 46.37 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -177.688 . . . . . . . . 3 3 . 1 . 075 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -126.78 130.49 50.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.616 179.36 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 98.3 mt -115.22 133.31 61.86 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.135 179.537 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -112.48 122.47 47.81 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.309 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.603 HD13 ' HD2' ' A' ' 5' ' ' ARG . 94.7 mt -104.13 113.57 41.41 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 C-N-CA 119.726 -0.79 . . . . 0.0 111.943 -179.004 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.441 ' C ' ' N ' ' A' ' 56' ' ' GLN . 89.9 m-70 -113.5 141.21 47.4 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.592 179.274 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 54' ' ' HIS . 94.8 mt-10 -40.67 -31.87 0.18 Allowed 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -179.365 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.441 ' N ' ' C ' ' A' ' 54' ' ' HIS . 54.7 mt-30 -63.4 -67.75 0.4 Allowed 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.359 -0.837 . . . . 0.0 108.78 178.623 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.464 ' OE1' ' N ' ' A' ' 58' ' ' ALA . 1.4 mm-40 -154.99 -174.77 5.12 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.785 0.803 . . . . 0.0 112.611 -179.285 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.464 ' N ' ' OE1' ' A' ' 57' ' ' GLU . . . -109.65 119.54 39.71 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 114.457 -1.247 . . . . 0.0 108.198 177.689 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.2 mt -110.48 130.12 64.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.842 0.353 . . . . 0.0 111.823 -178.467 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.562 ' HB2' HD11 ' A' ' 82' ' ' LEU . 28.0 tp -97.05 128.24 43.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.464 179.88 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -113.43 138.77 49.61 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.535 179.746 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -96.44 111.09 23.31 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -179.233 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -104.5 -8.49 19.04 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.762 178.698 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.7 t -75.23 104.61 5.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.765 0.316 . . . . 0.0 110.303 179.281 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 94.7 p -87.59 -8.33 56.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.021 0.439 . . . . 0.0 110.331 179.843 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.408 ' HB ' ' ND2' ' A' ' 67' ' ' ASN . 0.2 OUTLIER -101.94 -37.26 8.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.207 -179.213 . . . . . . . . 3 3 . 1 . 075 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.413 ' OD1' HG23 ' B' ' 236' ' ' VAL . 6.3 m-80 -145.07 98.87 4.68 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.489 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -57.29 145.84 85.3 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 121.8 1.667 . . . . 0.0 112.258 -178.782 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.912 ' O ' HG22 ' A' ' 76' ' ' ILE . 28.8 m -67.7 137.34 55.44 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.291 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -102.42 140.78 36.24 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.399 179.576 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 55.7 t -130.95 133.22 63.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.675 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 54.59 30.51 13.32 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.671 -178.922 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.98 23.97 73.12 Favored Glycine 0 CA--C 1.534 1.27 0 CA-C-N 115.307 -0.861 . . . . 0.0 112.711 179.001 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 58.5 m -139.09 145.65 39.77 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 117.522 0.661 . . . . 0.0 110.742 179.478 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.421 ' H ' HG22 ' A' ' 75' ' ' VAL . 7.9 m -71.03 142.74 15.21 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-O 121.138 0.494 . . . . 0.0 111.87 -179.351 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.912 HG22 ' O ' ' A' ' 69' ' ' THR . 6.7 tt -109.54 92.35 2.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.196 179.155 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -65.89 -34.98 79.37 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.746 -179.685 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.478 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 0.2 OUTLIER -126.04 175.06 3.44 Favored Pre-proline 0 N--CA 1.464 0.259 0 C-N-CA 120.414 -0.515 . . . . 0.0 111.481 -179.578 . . . . . . . . 3 3 . 1 . 075 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.421 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 35.5 Cg_exo -57.68 140.98 95.28 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.509 2.139 . . . . 0.0 112.396 -179.881 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 72.1 t -137.43 137.83 45.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.181 -179.671 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 91.9 mtm-85 -74.29 132.02 41.7 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.713 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.562 HD11 ' HB2' ' A' ' 60' ' ' LEU . 97.8 mt -87.95 139.27 30.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.174 0.512 . . . . 0.0 111.852 -178.72 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -129.63 154.18 47.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.487 -179.43 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -57.0 120.69 8.4 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.84 0.353 . . . . 0.0 111.462 -179.29 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.15 -16.48 27.43 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.651 -0.58 . . . . 0.0 111.651 179.299 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -69.94 136.99 51.15 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.105 0.478 . . . . 0.0 110.276 179.812 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 53.3 t -111.88 132.07 61.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.169 -178.936 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.1 mt -99.1 130.94 47.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.559 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.5 m -122.82 126.41 47.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.293 0.568 . . . . 0.0 111.816 -178.387 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.488 ' O ' ' N ' ' A' ' 93' ' ' ARG . 96.2 mt -113.31 124.18 69.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.291 178.164 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.456 ' C ' ' O ' ' A' ' 90' ' ' ILE . 48.5 mm 35.03 -98.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.796 -179.533 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.578 ' OD2' ' NE ' ' B' ' 245' ' ' ARG . 85.3 m-20 -110.44 5.14 21.16 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -179.517 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.498 ' NH2' ' HD2' ' A' ' 12' ' ' ARG . 84.6 mtt-85 -120.39 145.48 47.13 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.943 -179.129 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.734 ' OG ' HD12 ' A' ' 10' ' ' ILE . 33.5 p -140.64 152.87 45.74 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.199 0.523 . . . . 0.0 111.196 179.789 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -123.95 123.17 39.81 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.841 179.592 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -80.6 129.19 34.37 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.287 -179.87 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.599 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 86.8 t80 -96.15 125.45 40.68 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.792 0.33 . . . . 0.0 111.267 -179.645 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -130.85 123.17 28.44 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 121.064 0.459 . . . . 0.0 111.532 -179.882 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 . . . . . 0 C--N 1.327 -0.386 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.445 179.845 . . . . . . . . 0 0 . 1 . 075 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo . . . . . 0 N--CA 1.49 1.312 0 CA-C-O 121.028 0.345 . . . . 0.0 112.213 . . . . . . . . . 0 0 . 1 . 075 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.413 HG23 ' OD1' ' A' ' 67' ' ' ASN . 2.7 p -118.99 137.14 53.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.557 -179.729 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 3.0 t . . . . . 0 C--N 1.332 -0.171 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.514 -179.74 . . . . . . . . 0 0 . 1 . 075 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo . . . . . 0 N--CA 1.494 1.541 0 CA-C-O 120.547 0.144 . . . . 0.0 112.446 . . . . . . . . . 0 0 . 1 . 075 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 97.8 m -73.21 -44.89 58.96 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.271 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.424 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 86.5 t80 -57.88 -45.77 85.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.855 -179.493 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.53 ' CD2' ' OD1' ' A' ' 92' ' ' ASP . 97.2 mt -63.46 -41.08 98.63 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 120.746 -0.381 . . . . 0.0 110.466 -179.634 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -60.28 -42.89 96.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.351 -179.476 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -64.04 -39.9 95.13 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.353 -179.997 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.714 ' O ' HG23 ' B' ' 249' ' ' VAL . 57.9 ttm-85 -59.49 -44.13 93.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.862 -179.978 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -60.8 -42.95 98.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.039 0.447 . . . . 0.0 111.033 -179.472 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 67.8 p -69.68 -44.12 71.1 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.608 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' B' B ' 248' ' ' GLN . . . . . 0.462 ' HG2' HH22 ' A' ' 12' ' ' ARG . 66.3 tp60 -59.19 -39.2 81.85 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.474 179.758 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' B' B ' 249' ' ' VAL . . . . . 0.714 HG23 ' O ' ' B' ' 245' ' ' ARG . 73.4 t . . . . . 0 C--N 1.332 -0.161 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.495 179.682 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.482 ' OE1' HD21 ' A' ' 41' ' ' LEU . 99.4 mt-10 . . . . . 0 N--CA 1.463 0.197 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 . . . . . . . . . 1 1 . 1 . 075 nuclear build core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 65.7 mt -111.74 134.97 52.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.915 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 42.2 t -125.35 132.76 70.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.909 0.385 . . . . 0.0 110.467 179.464 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -98.6 121.02 40.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.938 -178.648 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -69.21 -47.1 65.74 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.276 -179.368 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' B' B ' 265' ' ' GLN . . . . . 0.401 HE22 ' H ' ' A' ' 23' ' ' SER . 0.4 OUTLIER -67.31 165.69 26.67 Favored Pre-proline 0 N--CA 1.464 0.266 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.904 -179.237 . . . . . . . . 3 3 . 1 . 075 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -62.42 143.58 93.65 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.472 2.115 . . . . 0.0 111.603 179.217 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 19.8 tt . . . . . 0 N--CA 1.446 -0.649 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.056 -179.413 . . . . . . . . 0 0 . 1 . 076 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 95.9 m . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.692 0.282 . . . . 0.0 111.598 . . . . . . . . . 0 0 . 1 . 076 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.6 mtt85 -93.63 125.69 38.39 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.538 -178.145 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -124.19 140.5 52.9 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.015 -179.4 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.643 HD11 ' HB3' ' A' ' 95' ' ' PHE . 38.0 tp -113.66 131.34 56.19 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.792 179.704 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.401 ' O ' HG23 ' A' ' 8' ' ' VAL . 19.2 m -110.55 130.73 63.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 121.13 0.491 . . . . 0.0 111.334 -179.393 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.1 m -78.45 141.97 37.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.297 -179.182 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.5 mm -109.97 136.43 45.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.033 177.296 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -91.42 154.77 18.93 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.435 179.54 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.477 ' CD ' ' OD2' ' A' ' 92' ' ' ASP . 89.1 mtm180 -54.56 -27.23 37.3 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.301 -179.684 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 91.8 p -80.48 -7.37 59.15 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.926 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.19 39.65 7.82 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 179.938 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.9 t -125.15 137.54 57.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -178.835 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -69.96 127.49 33.04 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.086 179.827 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -113.6 -127.51 4.6 Favored Glycine 0 CA--C 1.54 1.606 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 179.735 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -75.36 154.19 40.63 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 122.345 2.03 . . . . 0.0 112.311 -179.51 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 64.3 m170 -109.37 140.65 42.8 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.234 0.54 . . . . 0.0 111.888 -178.267 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.589 ' CD2' HD11 ' A' ' 37' ' ' ILE . 25.7 t80 -112.66 106.14 55.64 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.918 179.771 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -74.59 126.23 10.08 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 121.635 1.557 . . . . 0.0 111.563 -179.538 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.452 ' CD2' ' SG ' ' A' ' 27' ' ' CYS . 87.7 mt -82.8 52.66 2.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.899 0.38 . . . . 0.0 110.905 -179.263 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.6 t -64.66 -27.61 69.04 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.929 179.607 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.526 HD11 ' HG2' ' B' ' 265' ' ' GLN . 94.6 mt -79.11 142.96 35.97 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.705 179.568 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 44.0 t -63.67 -18.47 64.01 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 121.17 -0.212 . . . . 0.0 111.422 -179.341 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 40.7 m -131.13 131.6 44.23 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.867 -179.321 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.452 ' SG ' ' CD2' ' A' ' 22' ' ' LEU . 4.0 t -124.15 115.24 20.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.197 178.908 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.431 ' O ' ' N ' ' A' ' 36' ' ' ASP . 53.1 tp -112.26 122.79 48.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.162 0.506 . . . . 0.0 111.825 -178.849 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.765 ' CE2' HD12 ' A' ' 37' ' ' ILE . 5.4 m-85 -102.28 139.42 37.91 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.403 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 167.09 -171.56 41.9 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 118.699 -1.715 . . . . 0.0 113.513 179.304 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.563 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 36.7 ttp-105 -89.57 -31.54 17.54 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 114.549 -0.826 . . . . 0.0 109.377 179.585 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.46 151.62 39.48 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.767 -0.533 . . . . 0.0 111.767 -179.465 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.564 ' CD1' ' CZ ' ' A' ' 38' ' ' ARG . 39.5 mm -63.31 -44.41 99.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 121.106 0.479 . . . . 0.0 110.314 -179.965 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -52.95 -18.98 2.25 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.628 -179.208 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.55 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 78.6 m -62.78 128.19 34.77 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.247 -179.882 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 28' ' ' LEU . 62.2 m-20 -59.41 -31.3 69.14 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -179.56 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.765 HD12 ' CE2' ' A' ' 29' ' ' PHE . 93.3 mt -124.81 116.02 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.59 177.683 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.564 ' CZ ' ' CD1' ' A' ' 33' ' ' ILE . 83.7 mtp180 -99.25 137.63 37.5 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.928 -178.48 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.609 HD13 ' HE ' ' A' ' 93' ' ' ARG . 96.6 mt -119.82 129.02 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 121.335 0.588 . . . . 0.0 110.166 179.044 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -68.92 23.64 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.402 -178.156 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.787 HD12 ' CZ ' ' A' ' 93' ' ' ARG . 36.6 mt -106.0 129.68 24.2 Favored Pre-proline 0 C--N 1.324 -0.527 0 C-N-CA 120.015 -0.674 . . . . 0.0 111.247 -179.451 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.69 -10.4 25.04 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 C-N-CA 122.085 1.857 . . . . 0.0 112.589 179.714 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.495 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 5.2 m -91.55 1.42 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.213 179.183 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.563 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 51.4 t -90.83 136.01 25.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.03 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.3 m -71.78 168.34 18.03 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.492 0.663 . . . . 0.0 111.461 -178.783 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.55 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 97.9 mttt -60.15 -42.03 94.04 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.832 -1.077 . . . . 0.0 111.454 -179.257 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.665 ' O ' ' N ' ' A' ' 49' ' ' CYS . 87.2 mt-30 -116.29 -17.68 10.7 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 123.246 0.341 . . . . 0.0 110.976 179.789 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 31.6 t60 34.58 -74.81 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -179.691 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.665 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.29 137.44 46.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.326 0.584 . . . . 0.0 112.455 -178.831 . . . . . . . . 3 3 . 1 . 076 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -128.96 133.14 47.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.011 -179.749 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 88.2 mt -116.62 134.44 60.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.384 179.89 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -115.54 123.48 48.61 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 177.719 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 76.4 mt -103.75 114.11 42.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.287 -178.954 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.595 ' O ' ' N ' ' A' ' 56' ' ' GLN . 92.6 m-70 -111.8 141.75 45.02 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.007 179.233 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.48 ' OE1' ' N ' ' A' ' 55' ' ' GLU . 56.0 mp0 -39.47 -24.12 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.495 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.595 ' N ' ' O ' ' A' ' 54' ' ' HIS . 58.1 tt0 -67.95 -69.25 0.33 Allowed 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.177 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.732 ' CB ' ' HE ' ' A' ' 81' ' ' ARG . 2.8 tp10 -158.02 -163.11 1.25 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.334 179.914 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -115.98 125.42 52.48 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.012 -0.995 . . . . 0.0 108.531 178.347 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.4 mt -113.76 129.91 68.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.848 -178.413 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.43 HD11 ' SG ' ' A' ' 49' ' ' CYS . 50.5 tp -94.11 126.62 39.45 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.483 179.761 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -112.67 136.61 52.04 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.246 179.798 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -98.63 108.75 21.51 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.134 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -100.11 -11.24 20.67 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.432 179.473 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.1 t -69.64 103.35 2.09 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.596 179.106 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.0 p -84.51 -12.47 54.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.288 0.566 . . . . 0.0 109.548 178.856 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.19 -37.27 9.76 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.756 179.956 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.473 ' HB3' HD11 ' A' ' 91' ' ' ILE . 23.3 m-80 -144.18 90.27 6.79 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.847 179.741 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -56.23 146.33 72.3 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.21 1.94 . . . . 0.0 112.264 -179.862 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 56.8 m -73.32 144.02 46.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.159 179.913 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -102.97 141.04 36.44 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.694 179.639 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.8 t -130.34 134.67 62.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.553 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 53.71 34.73 19.58 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.27 -179.431 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.29 29.4 70.27 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.499 179.217 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.9 t -143.64 136.75 27.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 117.355 0.577 . . . . 0.0 110.783 179.314 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.8 p -70.72 139.96 19.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.692 -179.401 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.914 HD13 ' O ' ' A' ' 76' ' ' ILE . 0.0 OUTLIER -132.76 125.56 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.931 179.31 . . . . . . . . 3 3 . 1 . 076 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -97.73 -9.27 26.95 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.755 -179.382 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.84 ' O ' HD11 ' A' ' 76' ' ' ILE . 0.4 OUTLIER -125.19 170.33 9.42 Favored Pre-proline 0 N--CA 1.469 0.482 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.162 -179.431 . . . . . . . . 3 3 . 1 . 076 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -61.41 143.29 97.52 Favored 'Trans proline' 0 N--CA 1.501 1.915 0 C-N-CA 122.442 2.095 . . . . 0.0 113.271 -179.601 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 42.7 t -136.21 136.9 48.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.329 178.403 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.732 ' HE ' ' CB ' ' A' ' 57' ' ' GLU . 72.1 ttt180 -75.63 131.95 40.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.872 179.98 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 82' ' ' LEU . 96.6 mt -84.89 136.73 33.51 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.369 0.604 . . . . 0.0 112.417 -178.369 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -125.73 149.21 48.71 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.494 179.495 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.469 ' CG ' ' H ' ' A' ' 99' ' ' ASN . 5.3 t-160 -54.48 113.81 1.43 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.837 0.351 . . . . 0.0 110.989 -179.934 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.3 -15.67 25.06 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.018 178.938 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -68.3 137.22 54.5 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.099 -0.64 . . . . 0.0 109.403 179.534 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 23.3 t -110.04 134.26 52.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.868 -178.728 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 86.2 mt -103.76 129.42 55.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.1 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.9 m -116.36 129.35 56.2 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.515 -178.958 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.58 ' O ' ' N ' ' A' ' 93' ' ' ARG . 94.3 mt -119.65 128.85 75.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.53 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.531 HD13 ' HB3' ' B' ' 237' ' ' CYS . 94.5 mt -20.41 95.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -178.984 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.477 ' OD2' ' CD ' ' A' ' 12' ' ' ARG . 5.2 t0 90.07 -22.12 0.11 Allowed 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 177.985 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.787 ' CZ ' HD12 ' A' ' 41' ' ' LEU . 14.7 mtm-85 -130.58 145.84 51.97 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.235 -179.69 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.8 p -138.01 155.79 48.49 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.038 0.447 . . . . 0.0 110.781 -179.361 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.643 ' HB3' HD11 ' A' ' 7' ' ' LEU . 81.6 m-85 -131.65 129.44 40.81 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.643 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.49 ' O ' HD12 ' A' ' 7' ' ' LEU . 44.4 ttm180 -96.83 136.34 37.51 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 119.836 -0.745 . . . . 0.0 110.229 179.83 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -89.68 125.48 35.28 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.682 -179.724 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -125.65 127.3 46.07 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.5 -179.366 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.469 ' H ' ' CG ' ' A' ' 84' ' ' HIS . 55.5 t-20 . . . . . 0 N--CA 1.463 0.225 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.199 179.601 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo . . . . . 0 N--CA 1.486 1.069 0 CA-C-O 121.187 0.411 . . . . 0.0 111.923 . . . . . . . . . 0 0 . 1 . 076 nuclear build core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 6.6 p -115.19 137.28 49.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.762 -179.893 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' B' B ' 237' ' ' CYS . . . . . 0.531 ' HB3' HD13 ' A' ' 91' ' ' ILE . 5.7 t . . . . . 0 CA--C 1.52 -0.189 0 CA-C-O 120.876 0.37 . . . . 0.0 110.958 -178.52 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo . . . . . 0 N--CA 1.494 1.506 0 CA-C-O 120.518 0.132 . . . . 0.0 112.292 . . . . . . . . . 0 0 . 1 . 076 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 94.6 m -75.51 -42.75 51.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.043 0.449 . . . . 0.0 110.352 178.813 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.576 ' HZ ' HD22 ' A' ' 41' ' ' LEU . 60.2 t80 -57.54 -47.34 82.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.761 -179.832 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.437 HD21 HG23 ' A' ' 91' ' ' ILE . 90.1 mt -63.72 -41.19 98.1 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.086 0.47 . . . . 0.0 109.781 179.439 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -60.93 -41.31 95.95 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.873 179.789 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 73.6 ttt-85 -63.05 -43.23 99.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.668 -179.78 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.598 ' O ' HG23 ' B' ' 249' ' ' VAL . 24.0 mmt180 -59.9 -43.27 94.91 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.55 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.48 -41.93 98.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.818 179.215 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 11.8 t -65.73 -44.05 87.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.725 0.774 . . . . 0.0 108.957 179.512 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -60.89 -37.5 82.42 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.938 -179.447 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' B' B ' 249' ' ' VAL . . . . . 0.598 HG23 ' O ' ' B' ' 245' ' ' ARG . 62.7 t . . . . . 0 C--N 1.33 -0.272 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.614 179.647 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.535 ' OE1' HD21 ' A' ' 41' ' ' LEU . 99.7 mt-10 . . . . . 0 N--CA 1.462 0.151 0 CA-C-O 120.891 0.377 . . . . 0.0 110.546 . . . . . . . . . 1 1 . 1 . 076 nuclear build core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 65.9 mt -113.9 133.8 58.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.852 -179.856 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 43.5 t -126.91 134.23 66.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.508 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' B' B ' 263' ' ' PHE . . . . . 0.643 ' CD2' HG21 ' B' ' 267' ' ' ILE . 78.9 m-85 -97.38 123.65 41.28 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.137 0.494 . . . . 0.0 111.495 -178.255 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -64.07 -41.49 97.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.572 179.697 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' B' B ' 265' ' ' GLN . . . . . 0.526 ' HG2' HD11 ' A' ' 24' ' ' LEU . 2.8 mp0 -105.53 173.14 3.43 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.547 -178.956 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -57.26 150.78 55.97 Favored 'Trans proline' 0 N--CA 1.502 1.973 0 C-N-CA 122.824 2.349 . . . . 0.0 114.219 -179.614 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' B' B ' 267' ' ' ILE . . . . . 0.643 HG21 ' CD2' ' B' ' 263' ' ' PHE . 41.4 pt . . . . . 0 C--O 1.232 0.16 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.501 179.823 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.9 m . . . . . 0 N--CA 1.465 0.289 0 CA-C-O 121.076 0.465 . . . . 0.0 111.663 . . . . . . . . . 0 0 . 1 . 077 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.505 ' NH1' ' CG2' ' A' ' 53' ' ' ILE . 85.0 mtt85 -89.57 134.21 34.23 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.355 -178.549 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -134.82 144.3 47.53 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.292 179.982 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.69 HD11 HD11 ' A' ' 22' ' ' LEU . 85.1 mt -114.94 135.65 53.98 Favored 'General case' 0 C--N 1.334 -0.097 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.635 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 76.7 t -111.83 130.36 65.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.562 -0.455 . . . . 0.0 109.994 -179.363 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.1 m -80.3 140.24 36.25 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -178.132 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.519 HD12 ' HB3' ' A' ' 94' ' ' SER . 96.6 mt -106.13 132.47 53.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 176.673 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.661 ' C ' HH22 ' A' ' 93' ' ' ARG . 97.3 mttt -86.25 154.2 21.45 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.189 0.518 . . . . 0.0 109.729 179.134 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.648 ' N ' HH22 ' A' ' 93' ' ' ARG . 84.9 mtp180 -56.15 -28.8 59.39 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.186 -179.263 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 86.1 p -80.7 -8.83 59.77 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.641 179.747 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.55 33.17 8.72 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.721 -0.551 . . . . 0.0 111.721 179.367 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 54.3 t -119.82 135.33 60.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.784 0.326 . . . . 0.0 110.414 179.818 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -65.03 125.99 26.65 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.776 179.81 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -111.19 -133.33 6.26 Favored Glycine 0 CA--C 1.539 1.575 0 C-N-CA 120.722 -0.752 . . . . 0.0 111.942 -179.184 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.85 151.88 40.86 Favored 'Trans proline' 0 N--CA 1.499 1.827 0 C-N-CA 122.571 2.181 . . . . 0.0 113.037 -178.624 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -106.02 147.87 28.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.363 179.508 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.632 ' CD2' HD11 ' A' ' 37' ' ' ILE . 35.2 t80 -117.26 95.24 46.96 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.353 -179.571 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -64.15 127.32 19.01 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 122.613 2.209 . . . . 0.0 111.96 -179.468 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.69 HD11 HD11 ' A' ' 7' ' ' LEU . 93.3 mt -85.61 83.33 7.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.086 0.469 . . . . 0.0 111.357 -179.485 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 92.2 p -88.17 -14.17 39.3 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.488 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.651 HD11 ' HG2' ' B' ' 265' ' ' GLN . 66.9 mt -95.52 138.39 33.26 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.091 -179.688 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 27.5 t -64.37 -17.67 63.94 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.058 -179.742 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 46.8 m -128.67 129.53 45.94 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.563 179.582 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.9 t -121.38 115.63 23.29 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.128 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.404 ' O ' ' N ' ' A' ' 36' ' ' ASP . 53.9 tp -113.38 122.02 46.11 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.466 -178.857 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.816 ' CE2' HD12 ' A' ' 37' ' ' ILE . 18.3 m-85 -100.07 141.34 33.03 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.455 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 169.35 -161.08 34.56 Favored Glycine 0 C--O 1.226 -0.392 0 C-N-CA 119.541 -1.314 . . . . 0.0 112.467 179.238 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 29.5 ttp85 -108.0 -9.84 15.59 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -178.372 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -89.21 170.62 37.66 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.798 -178.714 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.469 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.7 tp -66.88 -41.45 87.66 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 O-C-N 122.759 -0.259 . . . . 0.0 110.562 179.861 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.469 ' N ' HG23 ' A' ' 33' ' ' ILE . 72.3 mm-40 -54.27 -26.66 30.3 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.055 0.455 . . . . 0.0 110.721 -179.19 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.548 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 79.2 m -64.2 121.31 13.92 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.485 -179.982 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 28' ' ' LEU . 87.4 m-20 -59.7 -28.2 67.09 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.342 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.816 HD12 ' CE2' ' A' ' 29' ' ' PHE . 89.4 mt -127.08 123.04 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.175 177.726 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 -104.24 136.05 44.57 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.242 -179.595 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.443 ' C ' ' H ' ' A' ' 41' ' ' LEU . 97.4 mt -117.5 128.93 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.912 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -72.39 34.0 0.06 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.244 -178.199 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.531 ' CD2' ' CZ ' ' B' ' 245' ' ' ARG . 32.2 mt -102.87 126.5 32.43 Favored Pre-proline 0 C--N 1.322 -0.624 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.428 179.339 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -73.03 -7.12 20.17 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.147 1.898 . . . . 0.0 112.655 -179.418 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.7 m -102.99 13.23 7.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.499 179.394 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 29.1 t -99.76 133.26 43.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.172 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 33.2 t -72.49 175.05 6.61 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.439 0.638 . . . . 0.0 112.538 -178.329 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.548 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 61.0 mttp -65.18 -40.64 94.54 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.797 -179.455 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.659 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.1 mt-30 -112.86 -18.06 12.36 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.211 -179.853 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 23.9 t60 32.73 -74.48 0.0 OUTLIER 'General case' 0 C--O 1.236 0.357 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 179.882 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.659 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.48 134.0 46.73 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.998 0.428 . . . . 0.0 111.594 -179.578 . . . . . . . . 3 3 . 1 . 077 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -125.77 130.36 51.29 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.465 179.183 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.6 mt -117.43 134.01 62.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.226 179.611 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -114.52 131.03 56.79 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.396 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.505 ' CG2' ' NH1' ' A' ' 5' ' ' ARG . 48.3 mm -99.45 120.29 48.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.46 -178.449 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.462 ' O ' ' C ' ' A' ' 55' ' ' GLU . 94.0 m-70 -119.73 132.36 55.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.262 179.103 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.462 ' C ' ' O ' ' A' ' 54' ' ' HIS . 98.4 mt-10 -40.31 -37.17 0.62 Allowed 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.728 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.456 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 84.3 mt-30 -62.76 -67.25 0.44 Allowed 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.379 179.028 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.457 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 6.1 tp10 -151.03 -166.62 2.58 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.2 -179.039 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.457 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -125.48 135.71 52.59 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 -179.957 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.9 mt -119.04 131.49 71.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -178.311 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.431 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 32.7 tp -97.94 125.93 43.09 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 114.827 -1.079 . . . . 0.0 108.846 178.471 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -112.71 136.79 51.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.743 -179.058 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 26.0 t30 -96.31 105.61 17.7 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.788 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.422 ' CD2' ' OE1' ' A' ' 47' ' ' GLN . 27.0 m-85 -96.48 -9.21 30.21 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.066 178.613 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.515 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 42.2 t -73.83 100.22 3.41 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.477 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.9 m -83.18 -16.61 45.94 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.383 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.42 -38.95 15.68 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.252 -179.782 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.515 ' O ' ' OG ' ' A' ' 64' ' ' SER . 77.4 m-20 -146.62 98.73 4.17 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.343 -179.86 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.38 147.78 55.09 Favored 'Trans proline' 0 N--CA 1.501 1.961 0 C-N-CA 122.392 2.062 . . . . 0.0 113.688 -179.423 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 89.1 m -71.41 136.09 47.55 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.695 179.1 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -98.88 140.89 32.38 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.642 -179.722 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.455 ' CG1' ' OD1' ' A' ' 86' ' ' ASP . 71.5 t -129.43 134.71 63.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.07 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 51.28 34.78 12.17 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.604 -0.838 . . . . 0.0 109.655 -179.773 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.23 30.11 69.78 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.933 179.64 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.6 p -142.22 133.7 26.59 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.469 -179.693 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -67.6 142.37 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.309 -179.964 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.465 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 2.9 pt -119.02 121.27 66.39 Favored 'Isoleucine or valine' 0 C--N 1.343 0.285 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.109 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -87.2 -24.09 24.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.401 -179.894 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -127.04 172.98 5.81 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.907 -179.585 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.51 144.1 99.5 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 122.434 2.09 . . . . 0.0 112.58 179.514 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.7 t -132.16 138.57 52.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.737 178.922 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -73.31 131.17 41.6 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.442 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 97.3 mt -84.26 135.49 34.31 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.079 0.466 . . . . 0.0 111.536 -179.912 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -127.12 149.58 49.88 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.811 179.796 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.438 ' ND1' ' N ' ' A' ' 99' ' ' ASN . 6.7 t60 -55.6 116.63 3.01 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.423 179.819 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.1 -18.77 23.45 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 -179.416 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.455 ' OD1' ' CG1' ' A' ' 71' ' ' VAL . 36.4 t70 -66.81 132.28 47.71 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.535 0.207 . . . . 0.0 110.449 179.151 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.611 HG22 ' HG2' ' A' ' 96' ' ' ARG . 53.4 t -106.86 132.19 54.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.194 -178.927 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 80.0 mt -101.33 129.79 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 177.914 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.3 m -120.42 126.09 49.58 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.531 0.681 . . . . 0.0 112.353 -178.875 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.599 ' O ' ' N ' ' A' ' 93' ' ' ARG . 91.7 mt -113.18 133.26 59.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 177.746 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.526 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 68.0 mt -30.9 102.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 O-C-N 123.112 0.257 . . . . 0.0 111.66 -178.759 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 4.8 t70 87.67 -22.18 0.15 Allowed 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 178.743 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.661 HH22 ' C ' ' A' ' 11' ' ' LYS . 2.0 mmp_? -127.73 139.62 52.57 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.564 -179.337 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.519 ' HB3' HD12 ' A' ' 10' ' ' ILE . 34.7 t -141.1 148.66 40.48 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.929 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.421 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 82.4 m-85 -129.19 130.47 46.38 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.397 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.611 ' HG2' HG22 ' A' ' 87' ' ' VAL . 99.9 mtt180 -89.03 134.36 34.02 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.325 -179.488 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.506 ' CZ ' ' OD1' ' A' ' 99' ' ' ASN . 91.1 t80 -94.45 124.52 38.53 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.142 -179.991 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -139.2 123.96 18.58 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.513 -179.173 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.506 ' OD1' ' CZ ' ' A' ' 97' ' ' TYR . 79.5 m-20 . . . . . 0 C--N 1.328 -0.339 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.621 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo . . . . . 0 N--CA 1.487 1.112 0 CA-C-O 121.77 0.654 . . . . 0.0 112.909 . . . . . . . . . 0 0 . 1 . 077 nuclear build core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 25.0 t -60.05 138.64 20.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.766 -179.808 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' B' B ' 237' ' ' CYS . . . . . 0.506 ' HB2' HD13 ' A' ' 91' ' ' ILE . 4.1 t . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.562 -179.659 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo . . . . . 0 N--CA 1.497 1.731 0 N-CA-C 113.576 0.568 . . . . 0.0 113.576 . . . . . . . . . 0 0 . 1 . 077 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 17.2 p -73.54 -41.25 63.25 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 119.836 -0.746 . . . . 0.0 109.268 177.981 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.505 ' CZ ' ' NE ' ' B' ' 245' ' ' ARG . 75.7 t80 -56.86 -47.37 80.56 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.752 -179.415 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.42 ' HA ' HD23 ' B' ' 242' ' ' LEU . 90.7 mt -67.08 -40.14 86.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.515 179.172 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -63.4 -43.06 98.6 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.399 -178.653 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -61.72 -42.57 99.12 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.093 0.473 . . . . 0.0 110.637 179.69 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.531 ' CZ ' ' CD2' ' A' ' 41' ' ' LEU . 95.6 mtt-85 -64.0 -39.05 93.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.12 -179.637 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.02 -39.01 93.46 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.061 179.495 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 32.8 t -67.55 -42.18 83.08 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.22 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -58.24 -36.77 73.71 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.903 179.205 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 41.3 t . . . . . 0 N--CA 1.453 -0.321 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.501 179.259 . . . . . . . . 0 0 . 1 . 077 nuclear build core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 . . . . . 0 N--CA 1.464 0.235 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 . . . . . . . . . 0 0 . 1 . 077 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.421 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 64.6 mt -119.26 132.35 69.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.398 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 56.1 t -126.9 135.9 62.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.366 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' B' B ' 263' ' ' PHE . . . . . 0.695 ' CD2' HG21 ' B' ' 267' ' ' ILE . 69.4 m-85 -99.32 120.22 39.21 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.901 -177.885 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -65.48 -43.48 90.09 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.571 0.701 . . . . 0.0 109.916 179.451 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' B' B ' 265' ' ' GLN . . . . . 0.651 ' HG2' HD11 ' A' ' 24' ' ' LEU . 2.5 mp0 -100.78 172.6 4.36 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.255 -178.951 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.0 150.05 66.85 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 121.985 1.79 . . . . 0.0 112.599 179.742 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' B' B ' 267' ' ' ILE . . . . . 0.695 HG21 ' CD2' ' B' ' 263' ' ' PHE . 42.5 pt . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.741 178.996 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 46.1 m . . . . . 0 N--CA 1.455 -0.211 0 CA-C-O 121.129 0.49 . . . . 0.0 110.78 . . . . . . . . . 0 0 . 1 . 078 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.574 ' NH1' HG23 ' A' ' 53' ' ' ILE . 99.1 mtt180 -99.79 127.03 45.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.517 -179.016 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.595 HH21 ' CE1' ' A' ' 19' ' ' HIS . 83.2 mtp180 -129.3 148.67 51.25 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.877 -179.075 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.432 HD11 HD11 ' A' ' 22' ' ' LEU . 99.6 mt -112.87 142.23 45.77 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.557 178.872 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.543 HG11 HH21 ' A' ' 96' ' ' ARG . 72.8 t -116.24 128.38 73.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.59 -0.444 . . . . 0.0 109.996 179.855 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 m -81.57 141.09 34.06 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.456 0.646 . . . . 0.0 112.674 -178.293 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.465 HD12 ' HB2' ' A' ' 94' ' ' SER . 83.1 mt -113.93 135.93 52.02 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.056 178.133 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.6 mttp -86.91 158.29 19.34 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.101 178.792 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.629 ' CD ' HH21 ' B' ' 245' ' ' ARG . 89.3 mtm180 -58.75 -27.46 64.98 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.193 -179.86 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 99.0 p -83.56 -8.87 59.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.825 179.771 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.43 37.73 6.49 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.863 179.819 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.1 t -118.76 131.3 71.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-O 120.835 0.35 . . . . 0.0 111.11 179.811 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -75.72 124.34 27.1 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.671 179.83 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -113.41 -122.52 3.88 Favored Glycine 0 CA--C 1.543 1.806 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.721 -179.84 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -76.4 155.54 36.58 Favored 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 123.043 2.495 . . . . 0.0 112.267 -178.702 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.614 ' CE1' ' HG3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -117.67 149.28 40.98 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.829 . . . . . . . . 3 3 . 1 . 078 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.47 ' CD2' HD11 ' A' ' 37' ' ' ILE . 37.7 t80 -115.5 100.49 53.64 Favored Pre-proline 0 N--CA 1.468 0.438 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.748 -177.658 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.614 ' HG3' ' CE1' ' A' ' 19' ' ' HIS . 3.0 Cg_exo -65.04 129.96 24.47 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 121.367 1.378 . . . . 0.0 111.557 179.48 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.432 HD11 HD11 ' A' ' 7' ' ' LEU . 90.6 mt -83.85 71.32 10.47 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.834 -179.896 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 80.6 p -78.66 -15.27 58.69 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.754 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.574 HD11 ' HG2' ' B' ' 265' ' ' GLN . 80.3 mt -93.64 140.78 29.23 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.211 -179.866 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 80.4 p -66.64 -17.51 64.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.959 -179.72 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.484 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 94.9 m -130.7 132.77 45.57 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.907 179.69 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.8 t -125.26 116.65 22.31 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.015 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 44.1 tp -114.16 129.02 56.63 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 121.169 -0.213 . . . . 0.0 111.181 -178.506 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.675 ' CE2' HD12 ' A' ' 37' ' ' ILE . 13.9 m-85 -109.25 140.8 42.43 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.285 179.649 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 156.78 -178.35 33.26 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 119.932 -1.128 . . . . 0.0 112.069 178.603 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.518 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 43.7 mtm180 -74.72 -27.12 60.24 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.457 178.773 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.465 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -57.58 148.38 34.61 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.406 -177.771 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.466 HG23 ' N ' ' A' ' 34' ' ' GLU . 11.1 tp -66.9 -41.47 87.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.097 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.466 ' N ' HG23 ' A' ' 33' ' ' ILE . 92.8 mt-10 -52.49 -21.82 4.16 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.744 178.767 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.465 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 13.8 m -64.85 120.73 13.07 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.597 -179.492 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.484 ' OD2' ' O ' ' A' ' 26' ' ' THR . 99.4 m-20 -54.89 -25.21 27.43 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.316 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.675 HD12 ' CE2' ' A' ' 29' ' ' PHE . 96.8 mt -130.73 124.78 57.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.229 176.837 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 40.4 ttp180 -115.73 139.24 50.34 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.973 -179.386 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.453 HG12 HG23 ' B' ' 261' ' ' ILE . 89.2 mt -117.88 133.47 64.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.704 -178.927 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -73.49 20.38 0.09 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.106 -178.527 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' A' ' 41' ' ' LEU . 30.3 mt -91.2 128.41 47.47 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.924 179.488 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.14 -6.55 19.12 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 122.757 2.305 . . . . 0.0 113.143 -179.118 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.599 HG21 ' CE2' ' B' ' 241' ' ' PHE . 27.2 m -105.23 4.9 10.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.91 179.615 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.518 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 19.8 t -85.91 133.16 30.29 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.931 178.853 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.3 m -64.27 157.96 24.6 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.199 -179.496 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.411 ' HG2' ' H ' ' A' ' 47' ' ' GLN . 10.4 ptmt -60.71 -46.34 90.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.476 -178.815 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.695 ' O ' ' N ' ' A' ' 49' ' ' CYS . 78.6 mt-30 -113.39 -12.31 13.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.553 179.578 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.403 ' CE1' ' HG ' ' A' ' 64' ' ' SER . 24.1 t60 28.36 -70.27 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 179.712 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.695 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -146.67 149.57 33.72 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.699 0.762 . . . . 0.0 112.522 -179.064 . . . . . . . . 3 3 . 1 . 078 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -139.07 131.12 27.94 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.517 -1.22 . . . . 0.0 111.237 179.945 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.6 mt -106.41 135.25 45.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.796 179.875 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -112.76 135.72 53.18 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.062 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.574 HG23 ' NH1' ' A' ' 5' ' ' ARG . 38.8 mm -101.08 124.8 54.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 119.744 -0.782 . . . . 0.0 110.877 -179.646 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.437 ' O ' ' N ' ' A' ' 56' ' ' GLN . 95.6 m-70 -128.45 133.42 48.52 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.41 178.902 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 54' ' ' HIS . 97.8 mt-10 -39.97 -29.98 0.08 Allowed 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 120.492 -0.483 . . . . 0.0 109.761 -179.154 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.437 ' N ' ' O ' ' A' ' 54' ' ' HIS . 69.8 tp60 -64.91 -67.37 0.44 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.041 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.442 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 9.6 tp10 -155.3 -152.05 0.38 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.92 -179.572 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.458 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -127.74 134.72 49.53 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.576 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.1 mt -120.99 132.71 69.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.027 -0.669 . . . . 0.0 112.306 -178.274 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.404 ' HB2' HD21 ' A' ' 82' ' ' LEU . 21.1 tp -101.57 128.05 48.01 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.897 -179.558 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -110.95 136.85 49.35 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.733 -179.973 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -97.09 107.69 20.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.206 0.527 . . . . 0.0 111.745 -179.813 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -98.9 -10.29 23.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.2 179.676 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.403 ' HG ' ' CE1' ' A' ' 48' ' ' HIS . 0.3 OUTLIER -78.09 101.66 7.09 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.28 -179.179 . . . . . . . . 3 3 . 1 . 078 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.7 m -83.15 -43.41 16.22 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.187 0.518 . . . . 0.0 110.363 178.958 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.59 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -61.49 -46.83 88.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.858 -179.042 . . . . . . . . 3 3 . 1 . 078 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.435 HD21 ' HA ' ' B' ' 236' ' ' VAL . 64.7 m-80 -133.52 93.81 20.77 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.617 -179.724 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.559 ' HB2' HG13 ' A' ' 75' ' ' VAL . 53.1 Cg_exo -52.11 140.3 50.8 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.222 1.948 . . . . 0.0 112.819 -179.325 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.499 ' HB ' HD11 ' A' ' 76' ' ' ILE . 8.1 m -69.79 146.25 51.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.622 179.281 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.504 ' OE1' HG22 ' A' ' 75' ' ' VAL . 81.5 mm-40 -109.7 141.5 42.2 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.121 -179.765 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.451 ' O ' ' N ' ' A' ' 74' ' ' SER . 3.6 p -129.94 135.55 60.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.901 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 49.13 31.5 3.53 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -179.043 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.04 29.12 65.26 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.638 -179.429 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.451 ' N ' ' O ' ' A' ' 71' ' ' VAL . 22.3 m -139.61 139.46 36.75 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 120.454 -0.498 . . . . 0.0 112.046 179.99 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.559 HG13 ' HB2' ' A' ' 68' ' ' PRO . 58.7 t -61.14 137.37 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.018 -179.706 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.499 HD11 ' HB ' ' A' ' 69' ' ' THR . 1.4 pt -117.34 72.53 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 120.661 -0.415 . . . . 0.0 109.927 178.498 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.486 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 21.3 p-10 -61.59 -27.6 68.76 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.689 179.974 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -112.89 159.48 34.37 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.431 178.979 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.84 144.42 88.49 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.014 1.809 . . . . 0.0 112.329 179.776 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 51.4 t -131.84 138.89 51.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.88 -179.57 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -73.82 130.87 40.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.296 179.447 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.404 HD21 ' HB2' ' A' ' 60' ' ' LEU . 96.8 mt -80.85 135.48 35.94 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.592 0.711 . . . . 0.0 111.569 -178.97 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -128.11 151.15 49.54 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.955 179.028 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.607 ' CE1' ' H ' ' A' ' 99' ' ' ASN . 7.0 t60 -55.03 117.25 3.29 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.938 -178.847 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 113.32 -15.18 22.83 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.089 179.4 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -70.0 133.31 47.1 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 117.139 0.47 . . . . 0.0 110.7 -179.921 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.5 p -108.91 137.31 41.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.674 -179.469 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 88.2 mt -104.96 129.81 57.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 177.908 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.5 m -121.42 129.34 52.94 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -177.45 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.414 ' N ' ' O ' ' A' ' 93' ' ' ARG . 89.2 mt -116.63 122.95 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 114.306 -1.315 . . . . 0.0 109.151 178.335 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.49 HD12 ' CB ' ' B' ' 237' ' ' CYS . 38.8 mm 40.05 -98.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.064 -179.562 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -117.68 17.0 14.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.213 0.53 . . . . 0.0 109.978 -179.787 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.414 ' O ' ' N ' ' A' ' 90' ' ' ILE . 39.3 ttm180 -130.26 144.05 51.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.176 -179.671 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.465 ' HB2' HD12 ' A' ' 10' ' ' ILE . 36.7 m -140.62 158.9 43.3 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.793 0.806 . . . . 0.0 111.855 -179.494 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -128.35 123.24 33.42 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.304 179.434 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.543 HH21 HG11 ' A' ' 8' ' ' VAL . 95.2 mtm-85 -86.24 135.59 33.5 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.957 -179.407 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -93.33 122.8 36.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.826 178.745 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.4 ' HG3' ' CE1' ' A' ' 84' ' ' HIS . 80.4 tt0 -125.72 126.29 44.38 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.252 -178.907 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.607 ' H ' ' CE1' ' A' ' 84' ' ' HIS . 28.9 t-20 . . . . . 0 C--N 1.332 -0.195 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.725 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo . . . . . 0 N--CA 1.49 1.303 0 CA-C-O 121.11 0.379 . . . . 0.0 111.937 . . . . . . . . . 0 0 . 1 . 078 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.59 ' CG2' HG22 ' A' ' 66' ' ' THR . 52.5 t -77.95 131.86 33.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.215 -178.545 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' B' B ' 237' ' ' CYS . . . . . 0.49 ' CB ' HD12 ' A' ' 91' ' ' ILE . 2.5 t . . . . . 0 N--CA 1.463 0.211 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.99 179.224 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo . . . . . 0 N--CA 1.491 1.344 0 N-CA-C 112.471 0.143 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 078 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 27.5 m -72.74 -46.02 55.64 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.296 178.545 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.599 ' CE2' HG21 ' A' ' 43' ' ' VAL . 71.6 t80 -58.21 -45.7 87.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.743 -179.243 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 88.9 mt -64.35 -42.53 96.18 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 120.829 0.347 . . . . 0.0 111.003 179.345 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -62.9 -43.23 99.35 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.289 -178.68 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 87.8 mtm180 -63.29 -42.03 99.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.986 0.422 . . . . 0.0 110.631 -179.005 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.629 HH21 ' CD ' ' A' ' 12' ' ' ARG . 75.9 mtp180 -61.52 -42.07 98.27 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.255 179.955 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -64.56 -40.2 95.13 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.379 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 15.3 t -65.56 -44.96 85.16 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.558 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -60.21 -37.89 81.67 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.025 -179.945 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' B' B ' 249' ' ' VAL . . . . . 0.438 HG23 ' O ' ' B' ' 245' ' ' ARG . 37.4 t . . . . . 0 N--CA 1.462 0.169 0 CA-C-O 120.811 0.338 . . . . 0.0 110.52 178.93 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.552 ' OE2' ' CZ ' ' A' ' 12' ' ' ARG . 98.3 mt-10 . . . . . 0 N--CA 1.444 -0.725 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 . . . . . . . . . 1 1 . 1 . 078 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.453 HG23 HG12 ' A' ' 39' ' ' ILE . 2.8 mt -116.0 140.84 36.02 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.537 -179.795 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 62.3 t -127.81 136.21 60.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.376 179.354 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' B' B ' 263' ' ' PHE . . . . . 0.691 ' CD2' HG21 ' B' ' 267' ' ' ILE . 68.3 m-85 -99.59 124.64 44.98 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.395 0.616 . . . . 0.0 111.615 -178.271 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -62.09 -40.79 97.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.744 179.572 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' B' B ' 265' ' ' GLN . . . . . 0.574 ' HG2' HD11 ' A' ' 24' ' ' LEU . 0.8 OUTLIER -107.05 173.6 3.02 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 114.838 -1.073 . . . . 0.0 110.232 -179.336 . . . . . . . . 3 3 . 1 . 078 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.77 150.45 62.38 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 122.63 2.22 . . . . 0.0 113.535 -179.63 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' B' B ' 267' ' ' ILE . . . . . 0.691 HG21 ' CD2' ' B' ' 263' ' ' PHE . 41.1 pt . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.813 179.576 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.2 t . . . . . 0 N--CA 1.462 0.146 0 CA-C-O 121.186 0.517 . . . . 0.0 110.397 . . . . . . . . . 0 0 . 1 . 079 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.702 HH12 HG23 ' A' ' 53' ' ' ILE . 99.9 mtt180 -88.7 139.08 30.83 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.506 -179.822 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.7 mtm180 -130.97 136.21 48.34 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.429 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.921 HD11 HD11 ' A' ' 22' ' ' LEU . 83.3 mt -112.47 138.9 48.56 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-O 120.778 0.323 . . . . 0.0 110.624 179.515 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 43.5 t -112.34 128.36 69.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.25 178.988 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.576 HG21 ' HZ ' ' B' ' 263' ' ' PHE . 74.8 p -83.14 138.94 33.46 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.49 0.662 . . . . 0.0 112.023 -178.815 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.0 mm -105.66 134.07 48.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.656 179.38 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.4 mttt -86.79 153.86 21.36 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.054 178.266 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 91.8 mtm180 -57.22 -25.87 59.77 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.446 -0.502 . . . . 0.0 109.968 -179.556 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.1 m -79.48 -10.48 59.81 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.771 179.158 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.64 40.09 7.9 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.066 -1.213 . . . . 0.0 110.066 -178.946 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.8 t -120.48 131.08 73.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 114.996 -0.602 . . . . 0.0 109.894 -179.992 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -71.38 125.24 26.49 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.18 179.679 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -120.64 -120.85 2.8 Favored Glycine 0 CA--C 1.54 1.643 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.214 -179.23 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.87 145.26 40.18 Favored 'Trans proline' 0 N--CA 1.503 2.087 0 C-N-CA 122.848 2.365 . . . . 0.0 114.307 -177.769 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -110.65 129.17 55.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.011 -179.784 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.645 ' CD2' HD11 ' A' ' 37' ' ' ILE . 47.8 t80 -100.1 102.38 17.71 Favored Pre-proline 0 N--CA 1.465 0.323 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.817 -179.995 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -78.21 139.09 16.57 Favored 'Trans proline' 0 C--N 1.314 -1.242 0 C-N-CA 121.608 1.538 . . . . 0.0 111.957 -179.45 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.921 HD11 HD11 ' A' ' 7' ' ' LEU . 87.8 mt -101.39 130.26 47.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.255 0.55 . . . . 0.0 111.498 -179.109 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 45.1 p -139.54 4.03 2.14 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.875 177.725 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.1 mt -107.35 151.25 25.75 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.332 -179.654 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 m -62.93 -24.29 67.79 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.369 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 87.1 m -133.97 135.42 43.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.428 0.632 . . . . 0.0 111.948 -179.483 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.595 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 3.1 t -126.19 117.19 22.58 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 177.769 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.736 HD13 ' HD3' ' A' ' 50' ' ' LYS . 49.2 tp -115.41 131.31 56.97 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.807 -176.842 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.765 ' CE2' HD12 ' A' ' 37' ' ' ILE . 11.2 m-85 -107.44 128.48 54.52 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.719 -179.913 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 165.01 -176.18 40.8 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 119.918 -1.134 . . . . 0.0 113.549 178.14 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 48.6 mtm180 -74.67 -31.91 62.07 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.746 0.308 . . . . 0.0 110.63 179.129 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.526 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -51.14 145.45 11.68 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.033 -178.568 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.417 HD13 ' HA ' ' A' ' 33' ' ' ILE . 32.4 mm -65.78 -43.87 93.26 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.102 0 CA-C-O 120.81 0.338 . . . . 0.0 110.913 179.305 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -55.64 -23.51 28.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.028 0.442 . . . . 0.0 109.831 -179.682 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.526 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 35.2 m -54.46 126.61 24.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.287 -179.369 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.408 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 54.8 m-20 -61.35 -33.22 73.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.872 -179.459 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.765 HD12 ' CE2' ' A' ' 29' ' ' PHE . 77.9 mt -126.54 122.87 61.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 177.38 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 39.6 mtm180 -106.23 137.63 43.83 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -179.602 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.718 ' CG2' HD12 ' A' ' 41' ' ' LEU . 80.3 mt -117.42 125.9 74.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.918 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -71.34 29.33 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.894 -178.604 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.718 HD12 ' CG2' ' A' ' 39' ' ' ILE . 13.0 mt -100.73 127.61 32.02 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.955 -179.942 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.07 -9.17 24.15 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.096 1.864 . . . . 0.0 112.722 -179.385 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.551 HG21 ' CE2' ' B' ' 241' ' ' PHE . 18.1 m -99.07 7.86 8.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.089 -0.644 . . . . 0.0 111.301 -179.723 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 42.8 t -91.86 135.88 25.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.799 178.677 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.7 m -68.94 166.97 16.76 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.207 -179.476 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -61.21 -42.57 98.83 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.208 -0.906 . . . . 0.0 111.045 -179.055 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.627 ' O ' ' N ' ' A' ' 49' ' ' CYS . 12.5 mm100 -115.57 -26.84 7.33 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 123.853 0.721 . . . . 0.0 109.825 -179.518 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.44 ' O ' ' OG ' ' A' ' 64' ' ' SER . 21.3 t60 44.95 -74.86 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.493 179.556 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.627 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -134.81 139.59 45.21 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.703 -179.195 . . . . . . . . 3 3 . 1 . 079 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.736 ' HD3' HD13 ' A' ' 28' ' ' LEU . 21.7 ttpt -130.61 129.52 42.83 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.0 179.007 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 91.5 mt -107.56 130.47 59.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.34 179.615 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -114.52 123.15 48.65 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 177.598 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.702 HG23 HH12 ' A' ' 5' ' ' ARG . 95.3 mt -103.04 115.91 45.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 119.816 -0.753 . . . . 0.0 111.626 -179.195 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.52 ' O ' ' N ' ' A' ' 56' ' ' GLN . 84.7 m-70 -113.24 141.19 47.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.162 179.551 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.1 tt0 -39.97 -26.13 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.446 0.641 . . . . 0.0 109.528 -178.827 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.52 ' N ' ' O ' ' A' ' 54' ' ' HIS . 63.2 tt0 -68.13 -67.98 0.42 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.816 -1.083 . . . . 0.0 109.628 179.104 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -157.58 -168.48 2.58 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.607 -179.426 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -107.5 127.09 53.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.615 179.24 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.1 mt -120.28 129.67 75.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.213 0.53 . . . . 0.0 111.979 -179.618 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.543 ' HB2' HD11 ' A' ' 82' ' ' LEU . 23.5 tp -101.42 128.51 47.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.152 -179.907 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -113.8 138.57 50.09 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.882 -179.296 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.56 HD21 ' CA ' ' A' ' 68' ' ' PRO . 55.3 t-20 -100.39 108.34 20.33 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.825 0.345 . . . . 0.0 111.649 -179.934 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -98.03 -9.45 25.99 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.538 -179.89 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -78.82 117.11 19.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.971 0.415 . . . . 0.0 111.107 -179.818 . . . . . . . . 3 3 . 1 . 079 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.7 p -101.2 -14.6 17.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.64 179.351 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.912 HG22 HG22 ' B' ' 236' ' ' VAL . 0.2 OUTLIER -88.73 -44.44 10.55 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.346 0.593 . . . . 0.0 109.421 -179.596 . . . . . . . . 3 3 . 1 . 079 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -138.85 95.47 9.69 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.137 -0.938 . . . . 0.0 108.584 178.286 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.56 ' CA ' HD21 ' A' ' 62' ' ' ASN . 37.5 Cg_endo -66.4 150.11 84.52 Favored 'Trans proline' 0 C--N 1.316 -1.156 0 C-N-CA 121.18 1.253 . . . . 0.0 113.029 -177.918 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.439 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 5.3 m -72.13 140.26 48.76 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.949 -179.401 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -103.33 140.9 36.81 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.514 178.547 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.495 ' CG2' ' OD1' ' A' ' 86' ' ' ASP . 5.6 p -128.48 135.5 62.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.043 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 48.37 31.03 2.54 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 119.415 -0.914 . . . . 0.0 108.629 -178.628 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.08 24.73 73.01 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.683 -179.583 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.459 ' N ' ' O ' ' A' ' 71' ' ' VAL . 35.9 t -136.24 139.55 42.81 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.94 0.37 . . . . 0.0 111.11 -179.711 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 79.3 t -68.02 140.7 18.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.169 179.807 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.9 pt -111.77 70.97 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 120.927 0.394 . . . . 0.0 110.437 179.021 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -54.95 -32.72 61.67 Favored 'General case' 0 N--CA 1.461 0.096 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.313 179.578 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -118.88 163.05 28.11 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.96 179.399 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -59.46 144.57 99.37 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.886 1.724 . . . . 0.0 112.829 -179.158 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.0 m -138.14 138.39 43.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.176 -179.68 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -73.12 129.08 37.27 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 120.646 -0.422 . . . . 0.0 109.919 179.47 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.543 HD11 ' HB2' ' A' ' 60' ' ' LEU . 94.6 mt -80.51 141.27 35.32 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.994 0.426 . . . . 0.0 110.631 179.717 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.438 ' HG2' ' N ' ' A' ' 84' ' ' HIS . 88.3 tttt -136.03 157.78 46.01 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.952 -179.56 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.612 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 6.2 t60 -57.3 118.41 5.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.924 0.392 . . . . 0.0 110.834 -179.36 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.68 -7.67 29.89 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -179.989 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.495 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 50.5 t0 -74.76 124.88 27.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.023 0.439 . . . . 0.0 110.115 179.316 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.547 HG22 ' HG2' ' A' ' 96' ' ' ARG . 75.0 t -108.02 131.36 58.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.658 -178.685 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 80.3 mt -99.47 130.67 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.341 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.2 m -118.46 124.78 48.45 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.409 0.623 . . . . 0.0 112.494 -179.121 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.491 HD12 ' HE1' ' A' ' 95' ' ' PHE . 96.9 mt -114.0 124.68 70.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 177.902 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.524 HG22 ' NH2' ' B' ' 245' ' ' ARG . 34.5 mm 36.09 -99.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 -178.764 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.509 ' CG ' ' NH2' ' B' ' 245' ' ' ARG . 37.7 p-10 -116.08 14.01 15.93 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.247 179.425 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.432 ' O ' ' N ' ' A' ' 90' ' ' ILE . 84.7 mtt-85 -121.96 145.52 48.04 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.282 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 73.7 m -136.72 154.96 50.45 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.009 179.766 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.491 ' HE1' HD12 ' A' ' 90' ' ' ILE . 79.7 m-85 -126.59 120.65 30.11 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.333 179.378 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.547 ' HG2' HG22 ' A' ' 87' ' ' VAL . 99.6 mtt180 -85.42 136.58 33.39 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.39 -178.936 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -98.18 122.81 41.8 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.302 -179.521 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -134.76 129.33 34.47 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.275 0.56 . . . . 0.0 112.004 -179.601 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.612 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 13.3 p30 . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.762 179.399 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo . . . . . 0 N--CA 1.488 1.205 0 CA-C-O 121.291 0.454 . . . . 0.0 112.372 . . . . . . . . . 0 0 . 1 . 079 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.912 HG22 HG22 ' A' ' 66' ' ' THR . 11.4 t -85.4 129.26 38.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.127 -179.568 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.243 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.59 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo . . . . . 0 N--CA 1.493 1.446 0 N-CA-C 113.222 0.432 . . . . 0.0 113.222 . . . . . . . . . 0 0 . 1 . 079 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 23.4 m -74.17 -44.6 52.88 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.273 179.008 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.551 ' CE2' HG21 ' A' ' 43' ' ' VAL . 89.1 t80 -56.35 -46.92 79.77 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.634 -179.436 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.75 HD23 HH21 ' B' ' 245' ' ' ARG . 93.3 mt -63.02 -42.27 99.75 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.846 0.355 . . . . 0.0 110.634 179.869 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -67.6 -40.24 84.75 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -179.425 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -60.97 -45.0 96.53 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.328 -178.832 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.75 HH21 HD23 ' B' ' 242' ' ' LEU . 60.5 mtm180 -65.36 -38.55 90.42 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.626 -0.429 . . . . 0.0 111.513 -179.662 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -61.49 -41.15 96.84 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.41 -179.845 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 62.9 m -64.91 -41.07 95.89 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.052 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -62.13 -37.48 85.3 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.797 179.882 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 27.3 t . . . . . 0 N--CA 1.456 -0.156 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.255 179.359 . . . . . . . . 0 0 . 1 . 079 nuclear build core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 . . . . . 0 C--O 1.233 0.225 0 CA-C-O 121.352 0.596 . . . . 0.0 110.275 . . . . . . . . . 0 0 . 1 . 079 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.452 HD13 ' CE2' ' A' ' 95' ' ' PHE . 81.3 mt -114.42 136.8 49.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.324 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 88.1 t -124.51 132.0 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 120.816 -0.353 . . . . 0.0 110.424 -179.202 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' B' B ' 263' ' ' PHE . . . . . 0.576 ' HZ ' HG21 ' A' ' 9' ' ' THR . 48.2 m-85 -96.93 118.55 33.59 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.192 0.52 . . . . 0.0 112.193 -178.18 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -67.2 -46.01 75.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.553 179.057 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 62.6 mm-40 -91.77 160.78 35.51 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.622 -178.168 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -62.51 154.3 65.51 Favored 'Trans proline' 0 N--CA 1.501 1.942 0 C-N-CA 122.664 2.243 . . . . 0.0 111.082 179.11 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.1 pt . . . . . 0 CA--C 1.519 -0.238 0 CA-C-O 121.497 0.665 . . . . 0.0 112.139 -178.771 . . . . . . . . 0 0 . 1 . 080 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 74.1 m . . . . . 0 N--CA 1.457 -0.12 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 . . . . . . . . . 0 0 . 1 . 080 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.661 ' NH1' ' HB2' ' A' ' 58' ' ' ALA . 95.5 mtt-85 -93.62 118.12 30.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.718 0.294 . . . . 0.0 111.205 -178.671 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.8 mtp180 -133.51 138.16 45.98 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.397 -0.521 . . . . 0.0 111.509 179.468 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.738 HD12 ' O ' ' A' ' 96' ' ' ARG . 35.8 tp -113.85 133.62 55.31 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.331 179.876 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.621 HG22 ' ND1' ' A' ' 19' ' ' HIS . 47.4 t -109.69 130.96 61.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.865 0.364 . . . . 0.0 110.106 -179.966 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.452 HG23 HH21 ' A' ' 93' ' ' ARG . 1.5 m -88.33 115.65 25.98 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.092 -0.503 . . . . 0.0 112.046 -178.698 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.652 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 95.4 mt -84.04 141.5 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.245 178.712 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -94.78 157.17 16.06 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.332 0.586 . . . . 0.0 111.812 179.526 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.473 ' CD ' ' OD2' ' A' ' 92' ' ' ASP . 89.9 mtm180 -57.85 -27.67 63.44 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.459 -178.92 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.0 t -75.72 -16.36 60.16 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.449 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.22 26.88 11.52 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -179.441 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 49.7 t -117.26 133.59 63.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.75 0.31 . . . . 0.0 110.632 179.865 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -75.47 138.56 41.68 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 178.835 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.5 -113.94 1.69 Allowed Glycine 0 CA--C 1.534 1.237 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.316 -179.292 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -72.1 143.01 39.29 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.18 1.92 . . . . 0.0 113.015 -178.415 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.621 ' ND1' HG22 ' A' ' 8' ' ' VAL . 6.2 m-70 -102.76 143.35 32.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.028 179.863 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.627 ' CD2' HD11 ' A' ' 37' ' ' ILE . 45.5 t80 -117.08 92.43 39.36 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.297 -179.49 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -60.8 127.49 22.65 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.162 1.908 . . . . 0.0 111.755 179.965 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.6 mt -90.01 51.01 1.96 Allowed 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.739 -0.384 . . . . 0.0 111.126 -179.156 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.6 p -63.33 -20.14 65.24 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.21 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.568 HD11 ' OE1' ' B' ' 265' ' ' GLN . 79.3 mt -81.45 141.89 33.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.501 179.266 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.9 m -66.51 -20.44 66.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.665 -178.742 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 83.9 m -129.32 131.01 46.84 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.048 0.451 . . . . 0.0 111.332 179.551 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.8 t -127.08 123.34 36.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.804 178.898 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 40.8 tp -120.32 127.46 52.37 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.36 -178.782 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.744 ' CE2' HD12 ' A' ' 37' ' ' ILE . 11.2 m-85 -104.36 130.77 52.21 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.773 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 178.37 -159.24 24.48 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 111.424 -0.671 . . . . 0.0 111.424 -179.771 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 29.3 ptt-85 -108.48 -15.88 14.34 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.955 -179.87 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -77.0 165.59 53.58 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.017 -178.852 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.418 HD13 ' HA ' ' A' ' 33' ' ' ILE . 30.9 mm -64.5 -43.07 96.86 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.843 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.9 mp0 -52.27 -29.14 21.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.168 -179.887 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 58.6 m -60.88 121.08 11.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.846 179.831 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -55.36 -29.35 58.23 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.958 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.744 HD12 ' CE2' ' A' ' 29' ' ' PHE . 99.3 mt -129.49 124.43 59.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.247 -0.888 . . . . 0.0 108.868 177.505 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 45.7 mtm180 -101.8 134.25 45.27 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.703 -179.905 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.739 HG21 HD12 ' A' ' 41' ' ' LEU . 92.1 mt -119.37 129.04 75.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.813 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -70.24 35.19 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.921 -178.88 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.875 ' O ' HG12 ' A' ' 44' ' ' VAL . 23.6 mt -103.65 115.93 62.74 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.267 -179.75 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -74.64 -7.78 19.78 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.145 1.896 . . . . 0.0 111.771 -179.847 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.9 m -100.36 8.2 8.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.59 179.843 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.875 HG12 ' O ' ' A' ' 41' ' ' LEU . 8.5 p -96.72 140.86 16.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.455 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.0 m -70.98 166.63 20.89 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.336 0.589 . . . . 0.0 111.612 -178.728 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -63.38 -40.84 98.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.01 -179.696 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.582 ' O ' ' N ' ' A' ' 49' ' ' CYS . 87.7 mt-30 -116.93 -6.65 11.45 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.405 -179.89 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.478 ' C ' ' O ' ' A' ' 47' ' ' GLN . 13.1 t60 15.21 -74.88 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -179.568 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.582 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -125.48 130.15 51.22 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.885 -0.726 . . . . 0.0 112.061 -178.435 . . . . . . . . 3 3 . 1 . 080 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -127.67 126.42 41.92 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.102 179.979 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 83.5 mt -110.23 133.56 55.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.912 -179.309 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -115.18 126.54 54.71 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.497 178.931 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.3 mm -97.84 113.3 32.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 119.675 -0.81 . . . . 0.0 111.085 -179.694 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.437 ' O ' ' C ' ' A' ' 55' ' ' GLU . 97.4 m-70 -114.85 136.3 53.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.432 179.114 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 54' ' ' HIS . 98.4 mt-10 -40.31 -38.68 0.83 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.42 -0.512 . . . . 0.0 109.741 -179.428 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.495 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 50.8 tt0 -62.34 -66.43 0.54 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.035 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.495 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 4.0 tp10 -155.58 -169.42 3.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.334 -179.377 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.661 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -114.52 129.42 56.66 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.61 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 93.9 mt -115.4 131.83 66.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.408 0.623 . . . . 0.0 111.913 -178.796 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.496 HD22 ' CD1' ' A' ' 88' ' ' ILE . 28.2 tp -100.61 130.8 46.72 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.196 179.994 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -111.3 131.52 55.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.819 -179.343 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 62.6 t-20 -94.74 106.16 18.13 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.819 0.343 . . . . 0.0 111.429 -179.673 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -97.52 -7.74 30.71 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.178 -179.683 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.8 p -84.06 108.21 16.86 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 119.997 -0.681 . . . . 0.0 111.3 -179.334 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 89.6 p -91.27 -16.25 27.87 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.783 178.874 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.583 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -86.23 -42.53 13.72 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.128 179.95 . . . . . . . . 3 3 . 1 . 080 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -139.82 97.64 8.02 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.085 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -56.08 143.22 84.54 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 121.974 1.782 . . . . 0.0 112.781 -178.501 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.5 m -69.83 138.25 52.45 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.349 178.588 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -102.73 140.29 37.2 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.272 0.558 . . . . 0.0 111.091 -179.561 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.0 p -133.14 135.66 56.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.92 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 50.09 31.79 5.26 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.361 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.13 26.51 68.38 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.769 179.91 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.6 t -140.6 138.23 34.27 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 117.266 0.533 . . . . 0.0 111.929 -179.546 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.417 ' H ' HG22 ' A' ' 75' ' ' VAL . 2.6 m -72.39 141.94 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.789 179.374 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.9 pt -113.68 94.16 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.203 0.525 . . . . 0.0 111.148 179.461 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -65.35 -29.05 69.74 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.752 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -122.12 165.02 22.18 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.219 179.909 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.14 152.28 81.6 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.647 2.231 . . . . 0.0 112.6 -179.819 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.3 m -143.33 143.46 24.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.466 -179.424 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -72.01 133.33 45.25 Favored 'General case' 0 C--O 1.231 0.098 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.036 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.468 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 98.1 mt -82.34 141.57 32.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.026 0.441 . . . . 0.0 111.564 -179.487 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -131.38 151.9 51.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.425 179.682 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.531 ' HD1' ' C ' ' A' ' 99' ' ' ASN . 7.4 t60 -54.37 117.7 3.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.712 0.291 . . . . 0.0 110.813 -179.785 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.5 -15.43 27.15 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.196 -0.526 . . . . 0.0 111.821 179.515 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -67.4 134.46 51.48 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.345 -0.542 . . . . 0.0 110.545 -179.741 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.468 HG22 ' HG2' ' A' ' 96' ' ' ARG . 74.3 t -109.74 135.91 47.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.244 -178.225 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.496 ' CD1' HD22 ' A' ' 60' ' ' LEU . 6.5 mm -99.26 128.74 50.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.761 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.4 m -119.98 121.22 38.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.686 0.755 . . . . 0.0 111.976 -178.989 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.567 ' O ' ' N ' ' A' ' 93' ' ' ARG . 96.2 mt -115.87 127.75 73.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.002 178.667 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.537 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 72.5 mt -18.64 99.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -178.763 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.537 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 2.6 t70 88.68 -21.96 0.14 Allowed 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 178.031 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.652 ' NH2' ' O ' ' A' ' 10' ' ' ILE . 8.0 mmm180 -130.06 146.02 51.7 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.0 -179.609 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.6 t -139.45 148.83 43.28 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.991 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.553 ' HB3' HD11 ' A' ' 7' ' ' LEU . 58.3 m-85 -126.92 122.14 33.75 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 -179.992 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.738 ' O ' HD12 ' A' ' 7' ' ' LEU . 79.0 mtp85 -82.07 130.31 35.05 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.89 0.376 . . . . 0.0 111.249 -179.184 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.63 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 82.8 t80 -96.23 124.92 40.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.554 179.498 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -122.39 127.04 49.22 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.6 179.852 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.531 ' C ' ' HD1' ' A' ' 84' ' ' HIS . 61.6 t-20 . . . . . 0 C--N 1.328 -0.342 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.217 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo . . . . . 0 N--CA 1.489 1.235 0 CA-C-O 121.357 0.482 . . . . 0.0 113.015 . . . . . . . . . 0 0 . 1 . 080 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.583 ' CG2' HG22 ' A' ' 66' ' ' THR . 25.6 t -110.28 133.37 55.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.998 -179.396 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.6 t . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.867 -179.902 . . . . . . . . 0 0 . 1 . 080 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo . . . . . 0 N--CA 1.493 1.495 0 CA-C-O 120.769 0.237 . . . . 0.0 111.926 . . . . . . . . . 0 0 . 1 . 080 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 16.8 m -73.74 -44.92 54.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.203 0.525 . . . . 0.0 110.29 178.357 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -58.17 -45.54 87.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.873 -178.724 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.411 ' HA ' HD23 ' B' ' 242' ' ' LEU . 94.0 mt -63.64 -39.76 95.16 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.328 -0.549 . . . . 0.0 109.575 179.568 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -62.04 -42.75 99.51 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.258 179.988 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -64.89 -40.64 95.42 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.126 -179.713 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.783 ' CZ ' HD21 ' A' ' 41' ' ' LEU . 13.6 mmm180 -61.05 -38.92 87.88 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.298 -178.778 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -65.06 -38.82 92.05 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.38 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 30.4 m -62.39 -45.8 91.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.497 178.475 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -61.08 -35.35 76.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.457 -179.739 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 24.2 t . . . . . 0 C--N 1.328 -0.342 0 C-N-CA 120.39 -0.524 . . . . 0.0 109.697 179.423 . . . . . . . . 0 0 . 1 . 080 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.443 ' C ' HD13 ' B' ' 261' ' ' ILE . 50.4 mm-40 . . . . . 0 CA--C 1.54 0.584 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 . . . . . . . . . 1 1 . 1 . 080 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.543 HD11 ' CZ ' ' A' ' 93' ' ' ARG . 4.6 mm -110.46 130.78 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-N 119.113 0.87 . . . . 0.0 109.945 179.537 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 53.5 t -124.48 131.77 72.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.032 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -99.73 122.51 42.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.064 0.459 . . . . 0.0 111.613 -178.257 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -63.85 -46.78 83.46 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.358 0.599 . . . . 0.0 110.135 179.927 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' B' B ' 265' ' ' GLN . . . . . 0.568 ' OE1' HD11 ' A' ' 24' ' ' LEU . 1.5 mm-40 -97.55 157.34 34.92 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.654 -179.367 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -60.3 145.23 99.02 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.893 2.395 . . . . 0.0 113.059 -179.647 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 14.5 pt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.178 179.483 . . . . . . . . 0 0 . 1 . 081 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.6 p . . . . . 0 N--CA 1.45 -0.461 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 081 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.566 ' NH1' ' HB2' ' A' ' 58' ' ' ALA . 96.1 mtt-85 -91.99 118.7 31.02 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.274 -179.882 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -128.29 129.78 46.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.926 0.394 . . . . 0.0 111.56 -179.476 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.537 HD11 ' HB3' ' A' ' 95' ' ' PHE . 33.9 tp -112.91 130.06 56.25 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.581 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.8 t -109.06 134.29 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-O 120.835 0.35 . . . . 0.0 110.795 -179.39 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.409 HG23 ' CD1' ' B' ' 261' ' ' ILE . 3.7 m -91.96 120.93 33.07 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.502 -178.521 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.495 ' CD1' ' OD1' ' A' ' 16' ' ' ASP . 49.4 mm -82.15 138.68 19.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.539 179.651 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -91.6 159.65 15.79 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 121.331 0.586 . . . . 0.0 111.561 179.115 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.57 ' NH2' ' OE1' ' B' ' 248' ' ' GLN . 77.3 mtp180 -54.72 -33.07 60.53 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.32 -179.109 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.8 p -78.4 -12.78 60.03 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.76 -179.594 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.59 13.56 40.65 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.973 178.899 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.3 m -109.71 141.49 24.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.317 179.947 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.495 ' OD1' ' CD1' ' A' ' 10' ' ' ILE . 86.4 m-20 -73.6 139.26 45.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.56 -179.327 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.43 -117.33 1.96 Allowed Glycine 0 CA--C 1.535 1.295 0 C-N-CA 120.383 -0.913 . . . . 0.0 111.638 179.94 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.17 143.28 43.74 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 122.096 1.864 . . . . 0.0 113.319 -178.73 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -106.85 157.6 17.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.402 -179.861 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.465 ' CD2' HD11 ' A' ' 37' ' ' ILE . 48.3 t80 -131.52 102.19 15.44 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.773 179.918 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.08 132.73 17.09 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 121.728 1.619 . . . . 0.0 112.061 -179.037 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.9 mt -83.36 55.4 3.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.901 0.381 . . . . 0.0 111.46 -178.535 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 52.4 p -68.04 -25.39 65.34 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.558 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.0 mt -80.65 139.65 36.09 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.539 -0.755 . . . . 0.0 108.966 179.083 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 80.3 p -65.5 -19.38 65.91 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.408 -179.224 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.52 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 44.6 m -131.95 131.49 42.67 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.175 -179.446 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.1 t -125.15 117.18 23.32 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.711 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.549 HD21 ' HG3' ' A' ' 47' ' ' GLN . 52.0 tp -113.93 126.06 54.73 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.915 -179.6 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.676 ' CE2' HD12 ' A' ' 37' ' ' ILE . 7.8 m-85 -104.7 141.09 37.08 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.944 179.465 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 153.34 -174.24 32.03 Favored Glycine 0 N--CA 1.469 0.864 0 C-N-CA 120.288 -0.958 . . . . 0.0 112.328 178.481 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.628 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 80.7 mtm-85 -77.39 -32.51 54.89 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-O 120.93 0.395 . . . . 0.0 110.842 -179.982 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.485 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -46.04 144.63 3.65 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 -179.057 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.513 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.0 tp -65.96 -41.41 89.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-O 120.883 0.373 . . . . 0.0 110.056 179.667 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.513 ' N ' HG23 ' A' ' 33' ' ' ILE . 79.4 mm-40 -57.63 -15.65 8.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.861 -179.845 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 80.2 m -56.87 124.4 18.42 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.587 -179.628 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.52 ' OD2' ' O ' ' A' ' 26' ' ' THR . 57.0 m-20 -60.2 -33.15 71.83 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 179.443 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.676 HD12 ' CE2' ' A' ' 29' ' ' PHE . 87.1 mt -127.57 120.33 54.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 176.346 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 76.8 ttt-85 -105.85 135.53 47.11 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.352 -177.923 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.628 HG21 HD12 ' A' ' 41' ' ' LEU . 94.5 mt -117.32 130.09 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 121.045 0.45 . . . . 0.0 110.888 -179.537 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -81.09 30.62 0.33 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.496 -179.216 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.708 ' O ' HG12 ' A' ' 44' ' ' VAL . 20.8 mt -91.32 112.8 55.94 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.758 179.262 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -57.38 -14.24 15.43 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.347 2.032 . . . . 0.0 113.343 179.636 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.48 HG21 ' CE2' ' B' ' 241' ' ' PHE . 2.4 m -103.78 11.15 8.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.748 -178.988 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.708 HG12 ' O ' ' A' ' 41' ' ' LEU . 6.0 p -98.56 138.39 23.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.018 179.629 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.0 m -68.91 167.87 14.8 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.616 0.722 . . . . 0.0 111.983 -179.138 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -63.02 -43.79 97.75 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 114.768 -1.106 . . . . 0.0 111.997 -178.394 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.649 ' O ' ' N ' ' A' ' 49' ' ' CYS . 21.6 mp0 -110.74 -14.55 14.0 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.935 0.398 . . . . 0.0 110.035 179.966 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 25.7 t60 32.45 -75.31 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.083 -0.962 . . . . 0.0 113.551 179.633 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.649 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.82 137.82 45.3 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -178.594 . . . . . . . . 3 3 . 1 . 081 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -125.02 131.83 53.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.016 179.599 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 88.3 mt -114.12 130.54 68.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.337 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -117.98 121.35 40.42 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.422 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 86.3 mt -103.82 116.04 46.86 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-O 121.572 0.701 . . . . 0.0 111.649 -178.854 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.454 ' O ' ' N ' ' A' ' 56' ' ' GLN . 53.0 m-70 -111.84 146.08 38.31 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.864 -179.837 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 54' ' ' HIS . 95.5 mt-10 -39.83 -30.45 0.08 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.128 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.465 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 89.6 mt-30 -63.97 -68.74 0.32 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.991 179.213 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.507 ' HG2' ' HE ' ' A' ' 81' ' ' ARG . 4.6 tp10 -159.13 -161.82 0.99 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.668 179.401 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.566 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -116.63 122.31 44.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.578 179.158 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 91.4 mt -113.59 130.48 67.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.266 0.555 . . . . 0.0 112.132 -178.926 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.599 ' HB2' HD21 ' A' ' 82' ' ' LEU . 48.3 tp -92.37 125.39 37.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.15 179.47 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.416 ' ND1' ' HB3' ' A' ' 79' ' ' PRO . 97.6 m-70 -111.36 136.28 50.71 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.635 0.255 . . . . 0.0 110.921 179.73 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.607 HD22 ' HA ' ' A' ' 68' ' ' PRO . 50.0 t30 -97.76 104.48 16.51 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.133 179.114 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -95.99 -8.87 32.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.026 179.447 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.25 101.01 2.73 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.941 179.423 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.9 p -84.58 -10.17 57.64 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.438 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.733 HG22 HG12 ' B' ' 236' ' ' VAL . 0.2 OUTLIER -97.39 -44.3 6.92 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.881 179.519 . . . . . . . . 3 3 . 1 . 081 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.448 HD21 ' HA ' ' B' ' 236' ' ' VAL . 74.8 m-20 -137.45 91.62 14.05 Favored Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.57 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.607 ' HA ' HD22 ' A' ' 62' ' ' ASN . 51.1 Cg_exo -53.68 144.29 54.02 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.422 2.081 . . . . 0.0 112.46 -179.055 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.4 m -72.17 138.29 47.53 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.786 179.164 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -100.98 141.22 34.19 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.36 -179.867 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 54.5 t -130.3 134.27 62.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.101 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 52.13 32.48 10.56 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.13 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.93 29.72 66.7 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.781 179.68 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.7 m -139.02 130.65 27.35 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.521 -0.472 . . . . 0.0 111.425 -179.599 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.42 ' H ' HG12 ' A' ' 75' ' ' VAL . 0.1 OUTLIER -69.56 138.26 22.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.619 179.844 . . . . . . . . 3 3 . 1 . 081 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.544 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 1.2 pt -118.54 112.39 37.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-O 121.37 0.605 . . . . 0.0 111.501 -179.763 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -80.32 -20.52 44.09 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.583 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -121.55 160.2 47.25 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.394 179.741 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.416 ' HB3' ' ND1' ' A' ' 61' ' ' HIS . 30.6 Cg_endo -61.99 148.49 93.05 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.901 1.734 . . . . 0.0 112.444 179.69 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 76.9 t -130.35 138.13 54.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.021 -179.469 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.507 ' HE ' ' HG2' ' A' ' 57' ' ' GLU . 72.5 ttt180 -70.77 129.48 39.21 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.713 178.948 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.599 HD21 ' HB2' ' A' ' 60' ' ' LEU . 95.4 mt -80.68 135.29 36.0 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.309 0.576 . . . . 0.0 111.276 -179.921 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -133.06 151.75 52.01 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.51 -179.912 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.552 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 4.6 t60 -52.04 116.44 2.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.168 -179.16 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.16 -14.79 36.73 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 121.234 -0.508 . . . . 0.0 111.953 179.551 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -68.89 134.94 50.28 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.953 -179.512 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.9 t -114.13 132.68 62.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.647 -178.207 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.5 mt -100.54 131.81 47.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.317 -0.856 . . . . 0.0 108.79 178.888 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.9 m -120.91 124.2 44.35 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.343 0.592 . . . . 0.0 112.064 -178.431 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.578 ' O ' ' N ' ' A' ' 92' ' ' ASP . 82.2 mt -111.15 122.59 65.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 178.099 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.612 HD12 ' CB ' ' B' ' 237' ' ' CYS . 43.8 mm 36.89 -92.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.02 -179.471 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.588 ' CB ' ' HE ' ' B' ' 245' ' ' ARG . 59.2 t0 -121.48 7.46 10.09 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.881 0.372 . . . . 0.0 111.296 179.649 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.735 ' NH1' HH22 ' B' ' 245' ' ' ARG . 48.5 mmt-85 -111.59 135.01 52.76 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.101 178.9 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.6 m -133.5 148.18 51.67 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.96 179.466 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.537 ' HB3' HD11 ' A' ' 7' ' ' LEU . 67.2 m-85 -124.81 124.66 42.59 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.429 -179.684 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.535 ' O ' HD12 ' A' ' 7' ' ' LEU . 77.1 mtp85 -86.99 131.75 33.99 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 119.687 -0.805 . . . . 0.0 110.976 -179.109 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.511 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 71.2 t80 -96.62 125.55 41.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.492 179.674 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -126.26 123.16 37.5 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.382 179.835 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.552 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 63.7 t-20 . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.078 179.371 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo . . . . . 0 N--CA 1.487 1.146 0 CA-C-O 121.71 0.629 . . . . 0.0 113.621 . . . . . . . . . 0 0 . 1 . 081 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.733 HG12 HG22 ' A' ' 66' ' ' THR . 1.2 m -68.86 147.84 12.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.079 -178.876 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' B' B ' 237' ' ' CYS . . . . . 0.612 ' CB ' HD12 ' A' ' 91' ' ' ILE . 4.3 t . . . . . 0 N--CA 1.466 0.359 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.897 -179.966 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo . . . . . 0 N--CA 1.5 1.893 0 N-CA-C 112.772 0.258 . . . . 0.0 112.772 . . . . . . . . . 0 0 . 1 . 081 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 51.6 m -70.91 -45.72 63.79 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.864 179.239 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.48 ' CE2' HG21 ' A' ' 43' ' ' VAL . 68.5 t80 -58.4 -46.5 86.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.523 -178.928 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' B' ' 242' ' ' LEU . 82.8 mt -63.11 -41.79 99.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.277 -179.061 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -67.0 -38.67 86.44 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.113 -179.652 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -61.61 -43.91 97.98 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.313 179.539 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.735 HH22 ' NH1' ' A' ' 93' ' ' ARG . 37.9 mtp85 -61.38 -40.98 96.31 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.018 -179.881 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -60.89 -41.19 95.54 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 178.122 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 48.0 t -62.87 -44.27 96.57 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 177.916 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' B' B ' 248' ' ' GLN . . . . . 0.57 ' OE1' ' NH2' ' A' ' 12' ' ' ARG . 87.5 mt-30 -60.02 -37.15 78.9 Favored 'General case' 0 CA--C 1.523 -0.074 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.051 179.598 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' B' B ' 249' ' ' VAL . . . . . 0.443 HG22 ' HB3' ' A' ' 12' ' ' ARG . 55.8 t . . . . . 0 C--N 1.33 -0.252 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.663 179.689 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 . . . . . 0 N--CA 1.462 0.155 0 CA-C-O 120.574 0.226 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 081 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.409 ' CD1' HG23 ' A' ' 9' ' ' THR . 66.8 mt -123.13 132.91 70.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.891 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 55.6 t -125.84 134.08 67.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.888 0.375 . . . . 0.0 110.631 -179.932 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -96.17 117.67 31.2 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.155 0.503 . . . . 0.0 110.968 -179.25 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -66.88 -45.48 77.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.89 179.555 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.85 157.82 37.43 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.309 -179.61 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -64.49 150.42 88.27 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 C-N-CA 123.006 2.471 . . . . 0.0 112.436 -179.892 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 30.3 pt . . . . . 0 C--N 1.328 -0.369 0 CA-C-O 121.247 0.546 . . . . 0.0 111.048 179.762 . . . . . . . . 0 0 . 1 . 082 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.1 m . . . . . 0 C--O 1.233 0.191 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 . . . . . . . . . 0 0 . 1 . 082 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 86.0 mtt85 -89.6 129.68 36.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.041 179.318 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -128.4 141.77 51.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.071 0.462 . . . . 0.0 111.545 -179.93 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.75 HD12 ' O ' ' A' ' 96' ' ' ARG . 28.1 tp -114.44 130.46 56.72 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.354 179.696 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 52.3 t -106.04 129.26 59.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.554 -0.459 . . . . 0.0 110.474 -179.429 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.577 HG21 ' HZ ' ' B' ' 263' ' ' PHE . 77.6 p -81.89 140.79 33.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.458 -178.243 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.57 HD12 ' OG ' ' A' ' 94' ' ' SER . 96.6 mt -110.88 136.41 47.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.098 178.653 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.1 mttm -87.96 160.08 18.05 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.36 179.224 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.517 ' HD3' HH21 ' B' ' 245' ' ' ARG . 89.7 mtm180 -58.44 -29.41 66.11 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.962 -179.259 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 87.1 p -81.24 -7.28 59.54 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.005 179.936 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.0 35.72 6.64 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 179.696 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.6 t -119.03 132.44 68.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.693 0.282 . . . . 0.0 111.076 -179.978 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -77.45 135.56 38.28 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.637 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -128.11 -114.04 1.78 Allowed Glycine 0 CA--C 1.535 1.31 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.052 -179.098 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.517 ' O ' ' OG1' ' A' ' 9' ' ' THR . 61.4 Cg_endo -72.24 145.71 44.27 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 122.445 2.097 . . . . 0.0 113.378 -178.657 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -108.79 129.52 55.38 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.384 179.776 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.827 ' CD2' HD11 ' A' ' 37' ' ' ILE . 51.8 t80 -98.63 99.85 8.34 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.604 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.514 ' HD2' HG22 ' B' ' 267' ' ' ILE . 73.9 Cg_endo -73.76 134.4 20.02 Favored 'Trans proline' 0 C--N 1.315 -1.229 0 C-N-CA 121.12 1.214 . . . . 0.0 111.099 -179.347 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.9 mt -94.15 118.42 31.53 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.547 -178.982 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.4 p -125.03 -4.36 7.49 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.509 179.328 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.552 HD11 ' OE1' ' B' ' 265' ' ' GLN . 49.8 mt -104.47 148.77 26.09 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.545 -179.032 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.36 -22.43 66.26 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.11 -178.906 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 88.0 m -128.34 130.06 47.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.282 0.563 . . . . 0.0 111.76 -179.433 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.628 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -127.96 121.75 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.878 178.565 . . . . . . . . 3 3 . 1 . 082 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.671 HD12 ' O ' ' A' ' 49' ' ' CYS . 53.7 tp -123.87 124.16 42.03 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -177.649 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.628 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 46.5 m-85 -97.4 141.28 30.67 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.091 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 168.69 -164.44 38.05 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.109 -1.044 . . . . 0.0 112.423 179.582 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.509 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 33.9 ttp-105 -96.99 -28.91 13.95 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.684 -0.758 . . . . 0.0 110.186 -179.611 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.9 162.08 53.99 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.777 -178.439 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.464 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.0 tp -64.47 -39.45 85.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.056 -0.572 . . . . 0.0 110.153 179.342 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.464 ' N ' HG23 ' A' ' 33' ' ' ILE . 80.1 mm-40 -53.31 -28.08 26.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.435 -179.643 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.3 m -64.37 116.71 6.34 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.434 -179.969 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.527 ' OD1' ' O ' ' A' ' 28' ' ' LEU . 12.5 p-10 -58.02 -26.24 62.18 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.539 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.827 HD11 ' CD2' ' A' ' 20' ' ' PHE . 34.6 mm -122.33 113.96 40.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.361 177.636 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -105.36 136.67 44.47 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.784 179.479 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.485 ' C ' ' H ' ' A' ' 41' ' ' LEU . 91.3 mt -119.61 132.13 70.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.36 -0.836 . . . . 0.0 108.976 179.603 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -71.29 29.4 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.669 -178.808 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.713 HD21 HH22 ' B' ' 245' ' ' ARG . 31.4 mt -91.1 122.73 66.1 Favored Pre-proline 0 C--N 1.323 -0.549 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.037 179.805 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.44 -7.47 20.95 Favored 'Trans proline' 0 N--CA 1.49 1.298 0 C-N-CA 122.12 1.88 . . . . 0.0 111.64 -179.161 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.2 m -107.54 9.97 9.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.844 -179.164 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.628 HG12 ' O ' ' A' ' 41' ' ' LEU . 9.6 p -92.16 141.85 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.061 179.835 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.0 m -71.26 159.43 34.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.714 0.769 . . . . 0.0 112.215 -178.659 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -61.89 -39.72 92.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.814 -1.084 . . . . 0.0 110.797 -179.602 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.595 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.3 mt-30 -117.14 -8.76 11.13 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.678 0.275 . . . . 0.0 111.047 179.445 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.466 ' C ' ' O ' ' A' ' 47' ' ' GLN . 24.3 t60 16.19 -73.88 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 114.633 1.345 . . . . 0.0 114.633 -178.527 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.671 ' O ' HD12 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -130.8 134.64 47.03 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 119.966 -0.693 . . . . 0.0 112.72 -177.724 . . . . . . . . 3 3 . 1 . 082 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -126.02 131.16 52.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.638 179.742 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.9 mt -116.0 133.38 62.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.166 0.508 . . . . 0.0 110.728 179.649 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -118.67 122.58 42.87 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.371 -0.832 . . . . 0.0 108.774 179.051 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 92.1 mt -105.2 116.09 48.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.561 0.696 . . . . 0.0 111.653 -178.974 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.439 ' O ' ' C ' ' A' ' 55' ' ' GLU . 87.6 m-70 -114.42 144.78 42.75 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.604 -179.848 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 54' ' ' HIS . 92.1 mt-10 -39.77 -33.11 0.17 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.318 -0.553 . . . . 0.0 109.911 -179.037 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.449 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 82.7 mt-30 -61.73 -68.38 0.32 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.788 179.227 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.449 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 4.5 tp10 -158.2 -166.35 1.92 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.393 -179.492 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.424 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -110.1 130.13 55.59 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.921 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.5 mt -119.4 129.07 75.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.226 0.536 . . . . 0.0 112.24 -178.549 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.652 ' HB2' HD11 ' A' ' 82' ' ' LEU . 17.4 tp -99.27 126.25 45.06 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.216 179.535 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -113.22 137.1 51.97 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.928 -179.886 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.506 ' ND2' ' O ' ' A' ' 76' ' ' ILE . 22.3 p-10 -100.66 111.19 23.39 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.992 0.425 . . . . 0.0 111.929 -179.246 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -102.61 -6.84 22.33 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.352 179.73 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.44 100.12 6.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.81 0.338 . . . . 0.0 111.579 -179.476 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.9 p -75.6 -32.17 60.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.207 178.288 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.4 m -65.25 -49.24 70.39 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.108 -179.069 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -145.4 103.95 4.32 Favored Pre-proline 0 N--CA 1.466 0.348 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.831 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -54.68 145.14 61.44 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 121.446 1.43 . . . . 0.0 112.004 -179.096 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.9 m -68.8 138.73 55.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.867 178.872 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -99.32 139.98 34.17 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.991 -179.764 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 55.0 t -134.38 134.47 54.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.735 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.573 ' ND2' ' OD1' ' A' ' 86' ' ' ASP . 74.1 m-20 53.8 32.12 14.34 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.611 -179.5 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.65 28.34 63.4 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.736 179.251 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.5 m -147.98 144.85 28.26 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 117.74 0.77 . . . . 0.0 111.734 179.902 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.404 ' H ' HG22 ' A' ' 75' ' ' VAL . 2.4 m -75.88 139.54 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.435 179.247 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.506 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 4.5 pt -104.99 101.61 12.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.411 0.624 . . . . 0.0 111.319 -179.912 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -65.01 -34.86 79.45 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.808 179.431 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.457 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.7 OUTLIER -126.15 178.52 1.48 Allowed Pre-proline 0 CA--C 1.53 0.176 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.52 179.803 . . . . . . . . 3 3 . 1 . 082 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.457 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 21.7 Cg_exo -63.26 146.89 94.13 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 C-N-CA 122.826 2.351 . . . . 0.0 112.174 -179.899 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.5 p -141.64 140.96 30.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.067 179.668 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -72.6 129.86 39.25 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.121 179.41 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.652 HD11 ' HB2' ' A' ' 60' ' ' LEU . 93.0 mt -86.63 135.84 33.26 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.344 -179.926 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -126.83 155.0 43.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.811 -179.554 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.498 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 6.1 t60 -53.96 116.64 2.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.441 -179.597 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.55 -14.48 27.41 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -179.509 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.573 ' OD1' ' ND2' ' A' ' 72' ' ' ASN . 26.2 t70 -69.12 129.7 40.62 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 179.551 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.0 t -109.24 135.64 47.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.312 -178.761 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 89.3 mt -103.43 132.29 50.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.25 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.843 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.0 m -122.15 127.59 50.26 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.762 0.791 . . . . 0.0 112.799 -178.342 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.55 ' O ' ' N ' ' A' ' 93' ' ' ARG . 97.4 mt -121.26 122.94 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 114.369 -1.287 . . . . 0.0 108.492 177.953 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.56 HG23 HD21 ' B' ' 242' ' ' LEU . 56.6 mt -3.74 95.62 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -179.77 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.629 ' CG ' ' HE ' ' B' ' 245' ' ' ARG . 1.4 t70 78.73 -13.42 0.97 Allowed 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 177.69 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.564 ' HD2' HD11 ' B' ' 261' ' ' ILE . 1.6 tpp180 -130.78 139.41 50.22 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.628 -179.192 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.57 ' OG ' HD12 ' A' ' 10' ' ' ILE . 14.9 p -140.15 157.08 46.18 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.283 0.563 . . . . 0.0 111.436 -179.204 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.519 ' HB3' HD11 ' A' ' 7' ' ' LEU . 65.2 m-85 -130.04 125.97 36.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.207 -179.584 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.75 ' O ' HD12 ' A' ' 7' ' ' LEU . 99.9 mtt180 -88.78 132.19 34.73 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.945 -179.231 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -96.94 125.43 41.36 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.498 -179.811 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -127.2 119.73 27.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.082 179.114 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.498 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 58.9 t-20 . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.504 179.583 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo . . . . . 0 N--CA 1.494 1.543 0 CA-C-O 121.573 0.572 . . . . 0.0 113.282 . . . . . . . . . 0 0 . 1 . 082 nuclear build core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 6.0 p -97.1 132.8 40.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.11 179.641 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 10.7 t . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.201 -179.221 . . . . . . . . 0 0 . 1 . 082 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo . . . . . 0 N--CA 1.494 1.542 0 N-CA-C 112.592 0.189 . . . . 0.0 112.592 . . . . . . . . . 0 0 . 1 . 082 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 42.5 p -74.37 -36.62 63.56 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.577 -0.449 . . . . 0.0 109.793 178.762 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.611 ' CZ ' ' NH1' ' B' ' 245' ' ' ARG . 85.9 t80 -59.39 -48.04 83.15 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.261 -179.153 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.56 HD21 HG23 ' A' ' 91' ' ' ILE . 94.3 mt -64.64 -42.28 95.56 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.445 -179.892 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -69.37 -42.13 75.6 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.867 -179.439 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 62.2 ttp180 -61.87 -46.66 88.43 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.703 -178.799 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.713 HH22 HD21 ' A' ' 41' ' ' LEU . 10.7 ptm85 -71.47 -38.89 71.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.292 -179.476 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -61.54 -39.99 93.05 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.504 179.737 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 23.0 t -69.35 -42.77 74.83 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.289 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 64.1 tp60 -58.21 -40.14 80.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.838 179.758 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' B' B ' 249' ' ' VAL . . . . . 0.664 HG23 ' O ' ' B' ' 245' ' ' ARG . 89.0 t . . . . . 0 N--CA 1.452 -0.348 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.698 179.826 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 . . . . . 0 N--CA 1.461 0.119 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 . . . . . . . . . 0 0 . 1 . 082 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.564 HD11 ' HD2' ' A' ' 93' ' ' ARG . 54.9 mt -103.84 134.65 44.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.75 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 77.7 t -123.18 132.37 71.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.43 -179.163 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' B' B ' 263' ' ' PHE . . . . . 0.577 ' HZ ' HG21 ' A' ' 9' ' ' THR . 45.7 m-85 -95.03 111.92 23.67 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.88 -177.677 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -61.93 -45.52 93.32 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.33 179.19 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' B' B ' 265' ' ' GLN . . . . . 0.552 ' OE1' HD11 ' A' ' 24' ' ' LEU . 1.8 mm-40 -98.99 156.77 35.12 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.308 -179.472 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.28 152.94 71.77 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 123.158 2.572 . . . . 0.0 113.427 -178.866 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' B' B ' 267' ' ' ILE . . . . . 0.514 HG22 ' HD2' ' A' ' 21' ' ' PRO . 26.3 pt . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.196 179.112 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 67.3 p . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.917 0.389 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 083 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.894 ' NH1' ' HB2' ' A' ' 58' ' ' ALA . 94.0 mtt-85 -93.11 119.99 32.92 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.228 -179.286 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -131.14 139.25 49.76 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.436 179.937 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.62 HD11 ' HB3' ' A' ' 95' ' ' PHE . 46.9 tp -115.25 131.88 56.79 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.979 179.749 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 73.8 t -110.65 133.07 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.597 -178.759 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 m -84.42 143.23 29.56 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.717 0.77 . . . . 0.0 112.475 -179.094 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 50.6 mm -109.39 137.08 43.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 114.238 -1.346 . . . . 0.0 108.807 177.794 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -91.58 160.84 15.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.302 0.573 . . . . 0.0 111.127 179.877 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.457 HH21 ' HG3' ' B' ' 245' ' ' ARG . 82.0 mtp180 -54.1 -32.29 54.53 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.015 -178.949 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 97.7 p -81.64 -6.27 58.85 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.281 -179.958 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.03 38.2 6.92 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -179.869 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.5 t -123.74 133.73 68.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.02 0.438 . . . . 0.0 110.519 179.964 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.481 ' O ' ' OD1' ' A' ' 16' ' ' ASP . 50.8 p-10 -80.19 136.9 36.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.292 179.695 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -131.76 -110.63 1.3 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 120.3 -0.953 . . . . 0.0 112.169 -179.613 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.17 144.08 41.24 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.288 1.992 . . . . 0.0 113.25 -178.608 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -109.06 148.79 30.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.372 179.909 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.521 ' CD2' HD11 ' A' ' 37' ' ' ILE . 35.5 t80 -118.48 94.69 47.72 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.633 -179.262 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -60.69 126.57 20.15 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 121.926 1.751 . . . . 0.0 111.638 179.653 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 63.5 mt -91.18 47.81 1.44 Allowed 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -178.576 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.9 m -66.28 -16.77 64.3 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.701 179.629 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.602 HD11 ' OE1' ' B' ' 265' ' ' GLN . 94.2 mt -78.43 141.3 38.4 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.163 179.496 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 94.3 p -61.17 -21.98 64.29 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.756 -0.657 . . . . 0.0 112.054 -178.488 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 44.5 m -137.42 136.45 37.83 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 120.397 -0.521 . . . . 0.0 112.081 -179.435 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.2 t -129.43 122.6 29.72 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.035 178.315 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.431 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 47.6 tp -117.08 130.63 56.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.197 -179.23 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.739 ' CE2' HD12 ' A' ' 37' ' ' ILE . 7.9 m-85 -107.41 125.67 51.51 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.562 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 172.72 178.64 42.94 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 120.297 -0.954 . . . . 0.0 112.303 179.831 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.652 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 81.2 mtm-85 -77.6 -31.48 53.0 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.016 179.362 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -52.49 150.2 9.29 Favored Glycine 0 N--CA 1.464 0.553 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 -178.872 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.484 HG23 ' N ' ' A' ' 34' ' ' GLU . 8.8 tp -66.76 -42.77 89.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.815 -179.514 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.484 ' N ' HG23 ' A' ' 33' ' ' ILE . 83.8 tt0 -53.44 -18.28 2.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.386 179.406 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.9 m -62.38 127.05 29.5 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.537 -179.742 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.431 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 55.9 m-20 -61.09 -31.64 71.31 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -179.459 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.739 HD12 ' CE2' ' A' ' 29' ' ' PHE . 98.5 mt -126.14 120.98 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 176.539 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.479 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 83.7 mtp180 -100.41 128.55 46.44 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.739 -178.951 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.405 HG22 ' H ' ' A' ' 41' ' ' LEU . 89.5 mt -112.94 128.08 69.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.205 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -80.93 26.74 0.41 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.976 -0.557 . . . . 0.0 112.382 -177.432 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.774 HD11 ' NE ' ' A' ' 93' ' ' ARG . 68.4 mt -94.98 131.73 29.64 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.185 179.263 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.93 -12.1 31.91 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.098 1.865 . . . . 0.0 112.897 -179.676 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.5 m -98.27 12.67 5.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.278 -179.796 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.652 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 14.3 t -100.89 130.86 49.59 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 C-N-CA 120.577 -0.449 . . . . 0.0 109.893 178.695 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.6 t -71.38 173.42 7.87 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.448 0.642 . . . . 0.0 112.125 -178.559 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.6 mttp -64.51 -41.39 96.46 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.89 179.919 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.588 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.2 mt-30 -116.45 -7.32 11.69 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 121.111 -0.235 . . . . 0.0 111.338 -179.566 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.474 ' C ' ' O ' ' A' ' 47' ' ' GLN . 14.9 t60 15.91 -74.88 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -178.695 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.588 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -129.24 133.27 47.44 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.088 -0.645 . . . . 0.0 112.341 -178.335 . . . . . . . . 3 3 . 1 . 083 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -128.47 131.15 48.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.293 179.763 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.4 mt -117.35 133.67 63.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.008 -179.697 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.453 ' OE2' ' CE1' ' A' ' 54' ' ' HIS . 81.7 tt0 -112.41 133.26 54.6 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.51 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.545 HD12 ' HD3' ' A' ' 5' ' ' ARG . 46.4 mm -101.96 124.28 55.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.448 0.642 . . . . 0.0 111.661 -178.637 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.57 ' O ' ' N ' ' A' ' 56' ' ' GLN . 96.9 m-70 -124.92 132.35 53.31 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.488 178.747 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.47 ' C ' ' O ' ' A' ' 54' ' ' HIS . 77.9 tt0 -39.79 -25.34 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.894 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.57 ' N ' ' O ' ' A' ' 54' ' ' HIS . 91.3 mt-30 -66.59 -68.34 0.38 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.018 178.018 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.464 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 5.3 tp10 -158.71 -160.75 0.9 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.209 179.942 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.894 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -118.69 127.89 54.0 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.224 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.7 mt -115.65 129.56 71.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.476 0.655 . . . . 0.0 111.523 -178.927 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.8 tp -96.62 128.86 43.96 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.383 -179.62 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -110.63 132.89 53.8 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.764 179.82 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -94.47 103.95 15.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.299 -179.391 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -97.07 -7.9 31.62 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.741 -0.383 . . . . 0.0 111.015 179.209 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.487 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 12.9 t -72.17 100.92 2.67 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-O 120.779 0.323 . . . . 0.0 110.169 179.256 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.7 p -82.99 -13.85 55.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.874 179.641 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.415 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -96.27 -38.3 10.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.181 -179.534 . . . . . . . . 3 3 . 1 . 083 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.488 HD21 ' HA ' ' B' ' 236' ' ' VAL . 76.1 m-20 -143.11 101.23 5.28 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.772 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.429 ' HB2' HG23 ' A' ' 75' ' ' VAL . 31.5 Cg_exo -58.01 146.39 87.55 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 121.509 1.473 . . . . 0.0 112.436 179.951 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.7 m -73.61 143.53 46.31 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.906 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -104.37 140.94 37.19 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.041 -179.355 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 43.9 t -132.26 135.54 57.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.372 -0.831 . . . . 0.0 108.82 179.562 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 52.8 26.95 4.91 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -179.235 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.28 29.1 62.72 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.651 -179.634 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.3 m -142.46 140.47 31.92 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.865 0.365 . . . . 0.0 110.827 179.875 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.446 ' H ' HG12 ' A' ' 75' ' ' VAL . 0.2 OUTLIER -73.22 142.75 14.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.013 -179.21 . . . . . . . . 3 3 . 1 . 083 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.467 HG21 HG11 ' A' ' 80' ' ' VAL . 7.5 pt -109.88 92.62 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-O 121.224 0.535 . . . . 0.0 110.911 179.115 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -63.95 -30.95 71.99 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.715 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -121.31 169.49 8.99 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.362 179.865 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -59.06 144.89 99.18 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 121.918 1.745 . . . . 0.0 111.751 179.429 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.467 HG11 HG21 ' A' ' 76' ' ' ILE . 8.2 p -135.21 140.94 44.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.108 0.48 . . . . 0.0 111.445 -179.627 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.455 HH21 ' CE ' ' A' ' 83' ' ' LYS . 62.7 ttp180 -78.2 132.64 37.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.881 179.085 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.429 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 91.8 mt -87.67 137.12 32.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.933 -178.541 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.455 ' CE ' HH21 ' A' ' 81' ' ' ARG . 99.2 mttt -124.86 151.23 45.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.432 179.532 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.495 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 6.8 t60 -54.62 121.3 8.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.771 -179.377 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.28 -18.99 35.2 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.034 -0.827 . . . . 0.0 111.034 -179.942 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -69.05 136.69 52.74 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.551 -0.46 . . . . 0.0 109.86 179.735 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.0 t -113.24 133.53 58.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.543 -178.305 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 89.2 mt -98.32 133.72 39.54 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.684 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 97.4 m -123.2 127.67 48.96 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 119.605 -0.838 . . . . 0.0 112.36 -179.195 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.612 ' O ' ' N ' ' A' ' 93' ' ' ARG . 96.8 mt -116.45 129.64 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 114.123 -1.399 . . . . 0.0 108.41 178.418 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.527 HD13 ' HB2' ' B' ' 237' ' ' CYS . 79.4 mt -18.98 101.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 O-C-N 123.744 0.652 . . . . 0.0 112.279 -179.246 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.496 ' OD1' ' NE ' ' B' ' 245' ' ' ARG . 73.8 m-20 80.37 -18.27 0.51 Allowed 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 178.919 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.774 ' NE ' HD11 ' A' ' 41' ' ' LEU . 59.4 mtt-85 -129.51 141.59 50.96 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.61 179.93 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 30.7 p -138.27 152.83 48.92 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.169 0.509 . . . . 0.0 110.027 179.901 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.62 ' HB3' HD11 ' A' ' 7' ' ' LEU . 65.9 m-85 -128.79 121.93 29.41 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.623 -179.563 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.537 ' O ' HD12 ' A' ' 7' ' ' LEU . 43.8 ttm180 -80.52 128.78 33.99 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.711 -0.395 . . . . 0.0 111.2 -179.705 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.592 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 89.4 t80 -94.62 124.97 38.97 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.597 179.632 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -127.66 122.84 34.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.937 0.399 . . . . 0.0 111.32 -179.89 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.495 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 61.6 t-20 . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.085 179.095 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo . . . . . 0 N--CA 1.487 1.105 0 CA-C-O 121.266 0.444 . . . . 0.0 112.71 . . . . . . . . . 0 0 . 1 . 083 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.488 ' HA ' HD21 ' A' ' 67' ' ' ASN . 53.1 t -57.46 141.99 13.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.456 179.687 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' B' B ' 237' ' ' CYS . . . . . 0.527 ' HB2' HD13 ' A' ' 91' ' ' ILE . 17.4 t . . . . . 0 C--N 1.328 -0.345 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.782 -179.263 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo . . . . . 0 N--CA 1.496 1.641 0 N-CA-C 112.851 0.289 . . . . 0.0 112.851 . . . . . . . . . 0 0 . 1 . 083 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 54.6 m -74.05 -44.22 55.03 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 121.029 0.443 . . . . 0.0 109.849 178.198 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -56.84 -47.12 81.08 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.894 -178.989 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.434 HD23 ' OD1' ' A' ' 92' ' ' ASP . 97.1 mt -66.99 -40.82 87.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.734 179.541 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -60.73 -43.19 98.18 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.854 -179.812 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -60.43 -42.86 96.95 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.505 179.739 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.605 ' O ' HG23 ' B' ' 249' ' ' VAL . 71.7 ttp85 -61.64 -40.61 95.52 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.604 -0.439 . . . . 0.0 111.253 -179.524 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -60.54 -40.16 90.53 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.46 -179.718 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 80.8 p -69.85 -42.22 73.85 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.058 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' B' B ' 248' ' ' GLN . . . . . 0.455 ' CB ' HH22 ' A' ' 12' ' ' ARG . 87.4 mt-30 -63.55 -32.41 73.86 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.209 179.778 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' B' B ' 249' ' ' VAL . . . . . 0.605 HG23 ' O ' ' B' ' 245' ' ' ARG . 54.9 t . . . . . 0 C--O 1.233 0.232 0 C-N-CA 120.113 -0.635 . . . . 0.0 109.64 178.477 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 52.8 mp0 . . . . . 0 CA--C 1.518 -0.279 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 . . . . . . . . . 0 0 . 1 . 083 nuclear build core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 67.0 mt -113.98 132.17 63.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.202 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 53.2 t -127.12 131.43 70.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.786 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -93.07 120.66 33.61 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.222 0.534 . . . . 0.0 110.335 -178.49 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -64.82 -44.94 88.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.989 -179.416 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' B' B ' 265' ' ' GLN . . . . . 0.602 ' OE1' HD11 ' A' ' 24' ' ' LEU . 1.4 mm-40 -99.74 158.56 31.9 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.786 -179.221 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -65.16 153.82 76.47 Favored 'Trans proline' 0 N--CA 1.503 2.039 0 C-N-CA 123.278 2.652 . . . . 0.0 111.846 -179.979 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 47.0 pt . . . . . 0 C--O 1.232 0.153 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -178.514 . . . . . . . . 0 0 . 1 . 084 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.5 m . . . . . 0 N--CA 1.454 -0.23 0 CA-C-O 121.223 0.535 . . . . 0.0 110.351 . . . . . . . . . 0 0 . 1 . 084 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.3 mtt85 -91.8 129.35 37.78 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.433 -178.728 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.5 mtt85 -130.83 138.0 49.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.276 -179.973 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.545 HD11 ' HB3' ' A' ' 95' ' ' PHE . 39.4 tp -115.11 128.35 56.16 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.619 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.3 m -109.49 132.49 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 121.155 0.502 . . . . 0.0 111.413 -179.078 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.409 ' HG1' ' HE2' ' A' ' 95' ' ' PHE . 2.7 m -80.36 138.56 36.7 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.246 -179.437 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.612 HD12 ' OG ' ' A' ' 94' ' ' SER . 96.5 mt -107.83 138.23 35.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.695 177.715 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -89.14 155.97 19.1 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.014 0.435 . . . . 0.0 109.849 178.434 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.575 HH11 ' CZ ' ' A' ' 93' ' ' ARG . 72.7 mtp85 -58.05 -24.17 57.37 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.429 -179.04 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.2 p -82.47 -8.63 59.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.037 0.446 . . . . 0.0 110.16 178.982 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.76 36.16 6.94 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -179.834 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.6 t -121.88 133.5 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.801 0.334 . . . . 0.0 111.069 -179.993 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 17' ' ' GLY . 61.6 t0 -78.43 132.58 37.38 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.236 179.397 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.461 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -125.72 -113.56 1.92 Allowed Glycine 0 CA--C 1.537 1.458 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.954 -179.736 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -71.68 143.9 43.0 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 122.324 2.016 . . . . 0.0 113.298 -178.568 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.541 ' O ' ' CD1' ' B' ' 267' ' ' ILE . 0.3 OUTLIER -111.29 135.81 51.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.135 0.493 . . . . 0.0 111.119 -179.89 . . . . . . . . 3 3 . 1 . 084 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -105.81 105.76 54.25 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.405 179.976 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -74.31 129.49 13.04 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 121.33 1.353 . . . . 0.0 111.911 -178.899 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 74.5 mt -83.97 47.04 1.25 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.859 -178.777 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.0 p -64.08 -21.57 66.58 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.969 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.478 HD11 ' OE1' ' B' ' 265' ' ' GLN . 79.3 mt -83.31 143.71 30.19 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.007 179.796 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.7 t -64.14 -21.73 66.66 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.947 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.415 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 56.2 m -135.63 135.54 40.28 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.181 -0.608 . . . . 0.0 112.369 -179.012 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.574 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 16.9 t -127.9 119.83 26.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.324 178.4 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.441 HD12 ' O ' ' A' ' 49' ' ' CYS . 49.1 tp -118.07 130.89 56.41 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.229 -178.546 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.621 ' CE2' HD12 ' A' ' 37' ' ' ILE . 5.5 m-85 -108.53 140.78 41.38 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.2 179.852 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 152.21 -176.28 30.55 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.249 178.393 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.695 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 76.8 mtm-85 -75.89 -32.23 59.57 Favored 'General case' 0 C--N 1.338 0.068 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.197 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.582 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -48.08 143.37 7.04 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 -178.471 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.512 ' CD1' ' CZ ' ' A' ' 38' ' ' ARG . 32.2 mm -65.79 -43.91 93.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.647 179.803 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -54.28 -17.74 3.25 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.789 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.582 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 39.4 m -60.16 121.47 11.99 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.218 179.851 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.415 ' OD2' ' O ' ' A' ' 26' ' ' THR . 99.0 m-20 -60.69 -28.64 68.77 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.238 -179.264 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.621 HD12 ' CE2' ' A' ' 29' ' ' PHE . 96.7 mt -126.13 120.54 57.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 176.798 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.512 ' CZ ' ' CD1' ' A' ' 33' ' ' ILE . 84.0 mtp180 -103.99 132.53 50.15 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.938 -178.199 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.581 HG21 HD12 ' A' ' 41' ' ' LEU . 84.8 mt -121.49 130.79 74.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 121.03 0.443 . . . . 0.0 109.961 179.491 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -78.44 41.5 0.4 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.232 -178.495 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.581 HD12 HG21 ' A' ' 39' ' ' ILE . 77.8 mt -105.88 104.99 51.71 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.44 179.41 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -57.61 -15.39 20.22 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.117 1.878 . . . . 0.0 112.148 179.532 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.461 HG21 ' CE2' ' B' ' 241' ' ' PHE . 35.0 m -91.11 4.89 6.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.237 -179.632 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.695 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 24.9 t -104.18 140.32 22.62 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.354 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.128 180.0 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.4 m -71.05 168.09 17.84 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.284 0.564 . . . . 0.0 112.276 -179.236 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -61.8 -39.29 91.2 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.271 -179.678 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.643 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.6 mt-30 -111.17 -19.43 12.7 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.904 179.813 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.3 t60 35.85 -75.86 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 179.015 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.643 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.83 134.45 46.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.266 0.555 . . . . 0.0 112.106 -177.871 . . . . . . . . 3 3 . 1 . 084 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -127.43 131.71 50.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.458 179.668 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 98.0 mt -118.03 133.88 63.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.175 179.933 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -117.69 134.37 54.96 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.102 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 48.3 mm -98.56 119.71 46.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.831 179.819 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.483 ' O ' ' N ' ' A' ' 56' ' ' GLN . 98.4 m-70 -123.85 135.53 53.8 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.137 -179.989 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 54' ' ' HIS . 92.8 mt-10 -41.28 -25.97 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -179.396 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.483 ' N ' ' O ' ' A' ' 54' ' ' HIS . 47.9 tt0 -67.3 -68.87 0.35 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.75 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -156.95 -163.44 1.41 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.399 179.094 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.412 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -108.92 126.09 52.71 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 177.47 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.9 mt -114.9 129.52 70.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.243 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.621 ' HB2' HD11 ' A' ' 82' ' ' LEU . 26.1 tp -100.14 129.2 46.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.135 179.634 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -113.24 135.56 53.7 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.877 -179.713 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -94.35 104.7 16.67 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.403 179.708 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -96.75 -10.78 26.06 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.194 179.397 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.4 t -68.18 101.47 1.18 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.046 179.653 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.5 p -84.35 -7.22 59.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.066 0.46 . . . . 0.0 110.024 179.895 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.433 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -103.44 -43.85 5.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.836 -179.131 . . . . . . . . 3 3 . 1 . 084 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.424 ' OD1' HG13 ' B' ' 236' ' ' VAL . 64.2 m-20 -140.23 99.39 7.25 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.646 -179.769 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.591 ' HB2' HG13 ' A' ' 75' ' ' VAL . 52.9 Cg_exo -55.19 145.95 62.7 Favored 'Trans proline' 0 N--CA 1.5 1.904 0 C-N-CA 122.359 2.039 . . . . 0.0 113.236 -179.348 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.2 m -73.11 137.96 45.52 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.869 178.796 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -99.24 140.77 32.91 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.517 179.82 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 55.9 t -128.82 135.34 62.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.685 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 52.04 31.44 8.76 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.124 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.8 28.18 69.42 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.489 179.921 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.1 p -140.69 139.22 34.71 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 120.774 -0.371 . . . . 0.0 111.48 -179.735 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.591 HG13 ' HB2' ' A' ' 68' ' ' PRO . 38.8 t -70.37 138.32 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.16 -179.6 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.7 pt -112.73 96.68 4.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.1 178.321 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -66.65 -26.14 66.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.189 -179.76 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.437 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.3 OUTLIER -130.93 178.55 1.68 Allowed Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.312 -179.086 . . . . . . . . 3 3 . 1 . 084 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.437 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 36.1 Cg_exo -59.99 146.27 96.38 Favored 'Trans proline' 0 N--CA 1.505 2.155 0 C-N-CA 123.09 2.527 . . . . 0.0 112.802 -179.775 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.6 p -144.37 141.65 24.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.634 179.984 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -78.89 133.95 36.93 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.52 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.621 HD11 ' HB2' ' A' ' 60' ' ' LEU . 89.0 mt -91.18 140.44 29.8 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.991 0.424 . . . . 0.0 111.522 -179.074 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -128.2 157.5 40.68 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.981 179.165 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.452 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 5.8 t60 -53.99 115.71 2.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.523 -178.553 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.3 -10.65 26.52 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.142 179.16 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -67.67 135.34 52.65 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.018 -179.836 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.58 HG22 ' HG2' ' A' ' 96' ' ' ARG . 48.9 t -109.44 126.57 66.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.43 -179.665 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 84.8 mt -100.42 131.25 48.31 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 178.514 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 75.3 m -122.84 129.1 51.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.715 0.769 . . . . 0.0 112.584 -178.189 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.462 ' O ' ' C ' ' A' ' 91' ' ' ILE . 95.0 mt -116.53 128.07 73.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 114.493 -1.23 . . . . 0.0 108.621 178.537 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.462 ' C ' ' O ' ' A' ' 90' ' ' ILE . 42.4 mm 34.02 -99.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.166 -179.428 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.504 ' O ' ' OD1' ' A' ' 92' ' ' ASP . 61.7 t0 -115.55 16.49 16.55 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 120.94 0.4 . . . . 0.0 110.847 -179.576 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.58 HH21 ' CD ' ' B' ' 260' ' ' GLU . 73.1 mtt-85 -127.93 144.5 51.1 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.67 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.612 ' OG ' HD12 ' A' ' 10' ' ' ILE . 12.6 p -140.92 156.81 46.01 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.391 0.615 . . . . 0.0 111.637 -179.551 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.545 ' HB3' HD11 ' A' ' 7' ' ' LEU . 61.1 m-85 -132.54 133.58 43.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.412 179.617 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.58 ' HG2' HG22 ' A' ' 87' ' ' VAL . 70.4 mtp85 -98.48 137.78 36.66 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 119.881 -0.727 . . . . 0.0 110.361 179.906 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 93.9 t80 -93.24 122.99 36.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.689 -179.881 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.408 ' HG3' ' CE1' ' A' ' 84' ' ' HIS . 84.4 tt0 -123.93 119.48 29.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.166 179.397 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.452 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 47.5 t-20 . . . . . 0 C--N 1.327 -0.412 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.64 180.0 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo . . . . . 0 N--CA 1.483 0.87 0 CA-C-O 121.324 0.468 . . . . 0.0 112.288 . . . . . . . . . 0 0 . 1 . 084 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.433 ' CG2' HG22 ' A' ' 66' ' ' THR . 54.7 t -60.58 140.53 18.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.383 -179.541 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 6.5 t . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.235 -179.747 . . . . . . . . 0 0 . 1 . 084 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo . . . . . 0 N--CA 1.494 1.542 0 N-CA-C 112.962 0.331 . . . . 0.0 112.962 . . . . . . . . . 0 0 . 1 . 084 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 40.9 p -75.95 -40.27 54.35 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.289 -0.564 . . . . 0.0 109.909 178.441 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.561 ' CZ ' ' NE ' ' B' ' 245' ' ' ARG . 81.6 t80 -57.3 -48.04 79.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.415 -179.626 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.424 ' HA ' HD23 ' B' ' 242' ' ' LEU . 89.4 mt -65.91 -42.09 90.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.018 179.964 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -67.94 -39.87 83.39 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.798 -179.463 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -60.88 -46.63 89.88 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.444 -179.154 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.859 ' O ' HG23 ' B' ' 249' ' ' VAL . 94.0 mtt-85 -67.78 -38.53 83.51 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.615 179.806 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -60.78 -40.28 91.99 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.101 -179.45 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 9.7 t -65.53 -45.62 82.73 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.656 0.741 . . . . 0.0 109.56 177.911 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -64.91 -31.44 72.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.539 -179.914 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' B' B ' 249' ' ' VAL . . . . . 0.859 HG23 ' O ' ' B' ' 245' ' ' ARG . 93.8 t . . . . . 0 C--N 1.331 -0.212 0 CA-C-O 120.966 0.412 . . . . 0.0 110.538 179.363 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.58 ' CD ' HH21 ' A' ' 93' ' ' ARG . 94.8 mt-10 . . . . . 0 N--CA 1.463 0.224 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 . . . . . . . . . 1 1 . 1 . 084 nuclear build core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 68.2 mt -113.77 131.05 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.34 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 40.4 t -128.46 135.86 61.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.829 0.347 . . . . 0.0 111.308 -179.076 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -97.24 119.01 34.97 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.221 0.534 . . . . 0.0 111.651 -179.31 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -62.98 -46.45 87.62 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.986 178.984 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' B' B ' 265' ' ' GLN . . . . . 0.478 ' OE1' HD11 ' A' ' 24' ' ' LEU . 3.6 mm-40 -90.15 156.39 46.38 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.191 -179.554 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -60.17 142.59 98.63 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 C-N-CA 122.226 1.951 . . . . 0.0 112.183 -179.845 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' B' B ' 267' ' ' ILE . . . . . 0.541 ' CD1' ' O ' ' A' ' 19' ' ' HIS . 3.9 tt . . . . . 0 C--N 1.325 -0.494 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.946 -179.72 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.454 HG22 ' OD1' ' A' ' 99' ' ' ASN . 22.1 m . . . . . 0 N--CA 1.463 0.176 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 . . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.457 ' CD ' ' OH ' ' A' ' 97' ' ' TYR . 82.0 mtt85 -102.04 134.34 45.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.832 0.349 . . . . 0.0 111.218 -178.782 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.471 HH21 ' CD ' ' A' ' 98' ' ' GLU . 36.8 ptt180 -142.48 157.42 44.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.866 179.722 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 74.0 mt -120.83 147.19 45.71 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.033 -179.811 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.7 t -116.21 126.77 73.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.377 178.658 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.3 m -78.66 138.48 38.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.487 0.661 . . . . 0.0 111.801 -178.692 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.6 mm -103.37 132.61 49.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.63 178.208 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -86.75 155.86 20.17 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.12 179.5 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.604 ' CD ' HH11 ' B' ' 245' ' ' ARG . 87.4 mtm180 -58.39 -30.28 66.69 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.052 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.6 t -74.62 -15.06 60.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.805 179.246 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.0 30.75 7.7 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 -179.431 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.1 t -119.09 133.99 64.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.94 0.4 . . . . 0.0 111.121 -179.964 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -74.75 136.98 41.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.838 178.981 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.51 -120.31 2.24 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 120.558 -0.829 . . . . 0.0 111.782 -179.905 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -73.54 152.84 49.09 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.173 1.915 . . . . 0.0 112.428 -179.111 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -114.1 156.07 24.84 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.015 179.471 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.558 ' CD2' HD11 ' A' ' 37' ' ' ILE . 37.3 t80 -119.97 104.04 44.63 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.451 -179.946 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.3 130.43 16.29 Favored 'Trans proline' 0 N--CA 1.488 1.19 0 C-N-CA 121.356 1.371 . . . . 0.0 112.59 -178.913 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.1 mt -83.88 45.7 1.11 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.749 -179.431 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.8 m -59.29 -28.73 67.02 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.666 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.691 HD11 ' HG2' ' B' ' 265' ' ' GLN . 78.3 mt -77.84 143.12 38.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.622 179.976 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 95.7 p -64.44 -21.08 66.54 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.219 -179.567 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 90.9 m -135.48 136.04 40.96 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.053 0.454 . . . . 0.0 112.153 -179.593 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.643 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 3.4 t -131.72 124.05 28.98 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.515 178.361 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.529 HD21 ' HG2' ' A' ' 47' ' ' GLN . 31.4 tp -116.36 130.49 56.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.934 -178.982 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.759 ' CE2' HD12 ' A' ' 37' ' ' ILE . 14.4 m-85 -107.34 141.07 39.28 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.436 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 160.21 -164.34 34.33 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 119.566 -1.302 . . . . 0.0 112.979 179.198 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.8 ttp85 -98.85 -32.11 11.51 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 114.977 -0.612 . . . . 0.0 111.88 -179.268 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -57.56 156.25 17.11 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.509 -1.037 . . . . 0.0 110.509 -179.795 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.584 ' O ' ' NE ' ' A' ' 38' ' ' ARG . 8.7 tp -63.97 -42.37 95.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 117.327 0.563 . . . . 0.0 112.235 -178.616 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.481 ' OE1' ' N ' ' A' ' 34' ' ' GLU . 57.9 mp0 -56.89 -17.41 9.38 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.267 -178.699 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.585 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 89.5 m -59.86 122.74 14.99 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.244 -0.583 . . . . 0.0 110.087 179.522 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.448 ' O ' ' CB ' ' B' ' 264' ' ' LYS . 71.5 m-20 -59.9 -31.18 69.57 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.273 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.759 HD12 ' CE2' ' A' ' 29' ' ' PHE . 94.6 mt -122.03 115.52 46.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 176.384 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.584 ' NE ' ' O ' ' A' ' 33' ' ' ILE . 74.5 mtt85 -104.43 138.22 41.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.006 -177.267 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.597 HG23 ' O ' ' B' ' 260' ' ' GLU . 80.1 mt -119.5 130.49 73.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.839 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -73.7 38.79 0.1 Allowed 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -177.867 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.723 HD13 HH21 ' A' ' 93' ' ' ARG . 39.7 mt -125.04 129.64 24.47 Favored Pre-proline 0 C--N 1.325 -0.487 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.938 179.771 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.06 -11.83 27.58 Favored 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 122.404 2.069 . . . . 0.0 113.392 -178.973 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.652 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 27.5 m -83.94 -4.32 8.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.411 179.549 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 40.8 t -87.38 133.13 30.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.209 179.578 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.5 t -65.25 161.16 19.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.779 -179.198 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.585 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 93.7 mttt -62.02 -44.35 96.9 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.485 -178.951 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.643 ' O ' ' N ' ' A' ' 49' ' ' CYS . 89.5 mt-30 -116.9 -18.23 10.22 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.921 0.391 . . . . 0.0 111.014 179.682 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 16.7 t60 33.66 -72.21 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 179.415 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.643 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.11 137.18 46.22 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -177.726 . . . . . . . . 3 3 . 1 . 085 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -125.32 126.78 45.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.686 179.176 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 88.0 mt -110.36 131.73 60.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.995 -179.933 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -115.38 131.29 56.98 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.925 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.1 mm -100.39 122.24 52.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.841 -179.312 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.454 ' O ' ' C ' ' A' ' 55' ' ' GLU . 97.1 m-70 -122.42 132.15 54.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.199 179.25 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 54' ' ' HIS . 76.6 mt-10 -40.68 -36.71 0.64 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -178.457 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.487 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 88.7 mt-30 -62.85 -66.7 0.5 Allowed 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.401 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.487 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 3.8 tp10 -153.74 -168.3 2.93 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.678 -179.658 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.448 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -118.4 132.87 56.24 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.099 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.1 mt -118.59 129.89 74.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.392 0.615 . . . . 0.0 111.956 -178.666 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.453 ' HB2' HD21 ' A' ' 82' ' ' LEU . 40.1 tp -95.13 129.07 42.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.046 179.997 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -113.76 136.12 53.21 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 179.956 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -97.41 107.64 20.19 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.988 0.423 . . . . 0.0 111.787 -179.582 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -98.65 -10.77 22.8 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.622 179.162 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.3 t -69.78 101.03 1.61 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.443 179.914 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 90.3 p -84.34 -14.27 50.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.972 0.415 . . . . 0.0 110.039 179.614 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.578 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -98.45 -40.8 8.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.161 -179.004 . . . . . . . . 3 3 . 1 . 085 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -137.09 93.79 13.0 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.053 -179.687 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -56.75 144.03 88.33 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.256 1.97 . . . . 0.0 112.226 -179.822 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 95.1 m -71.29 137.13 48.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.056 179.707 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -98.32 141.29 31.4 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.614 178.982 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 55.5 t -130.15 136.55 58.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.251 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 53.37 32.33 13.6 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.252 -179.691 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.11 27.5 72.86 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.48 -179.99 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.1 m -138.37 137.51 37.38 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.383 -179.634 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.403 ' O ' HG13 ' A' ' 75' ' ' VAL . 5.9 p -71.05 135.51 27.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.017 0.437 . . . . 0.0 111.897 -179.67 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.877 HD11 ' O ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -136.18 121.95 29.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.727 178.545 . . . . . . . . 3 3 . 1 . 085 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.7 p-10 -103.22 -5.02 23.56 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 120.801 -0.359 . . . . 0.0 111.475 -179.273 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.877 ' O ' HD11 ' A' ' 76' ' ' ILE . 21.4 mt-10 -116.13 151.49 46.71 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.747 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -60.35 146.23 97.03 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.016 1.811 . . . . 0.0 112.422 -179.12 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.6 m -141.32 147.26 22.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.325 -179.644 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -73.87 131.12 41.16 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 178.858 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.453 HD21 ' HB2' ' A' ' 60' ' ' LEU . 95.7 mt -78.46 134.76 37.3 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.257 179.965 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -124.9 148.83 48.12 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 178.848 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.415 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 6.1 t60 -55.1 121.42 8.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.393 -178.944 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.32 -19.13 34.86 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 179.975 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -67.61 134.79 51.82 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.385 179.919 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.544 HG22 ' HG2' ' A' ' 96' ' ' ARG . 47.5 t -110.04 132.48 58.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.811 -179.257 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 86.6 mt -101.33 132.16 47.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 178.697 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 55.7 m -124.89 124.1 41.34 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 119.953 -0.699 . . . . 0.0 112.054 -178.543 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.461 ' O ' ' C ' ' A' ' 91' ' ' ILE . 86.6 mt -109.74 127.84 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.058 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.734 HG22 ' N ' ' A' ' 92' ' ' ASP . 95.3 mt 37.32 -100.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.583 -179.149 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.734 ' N ' HG22 ' A' ' 91' ' ' ILE . 1.6 t70 -118.36 15.93 13.9 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.816 0.341 . . . . 0.0 110.963 -179.827 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.723 HH21 HD13 ' A' ' 41' ' ' LEU . 3.4 mtm105 -124.04 138.69 54.41 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.916 -179.588 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 47.0 t -137.7 151.85 48.65 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.917 -179.405 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.475 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 82.4 m-85 -127.21 123.33 36.35 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.582 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.544 ' HG2' HG22 ' A' ' 87' ' ' VAL . 99.6 mtt180 -82.85 135.98 34.77 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.048 -178.304 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.457 ' OH ' ' CD ' ' A' ' 5' ' ' ARG . 88.4 t80 -93.97 122.83 36.87 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.337 -179.854 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.471 ' CD ' HH21 ' A' ' 6' ' ' ARG . 76.1 tt0 -126.93 122.25 34.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.779 179.911 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.454 ' OD1' HG22 ' A' ' 4' ' ' THR . 62.0 t-20 . . . . . 0 C--N 1.327 -0.377 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.588 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo . . . . . 0 N--CA 1.49 1.293 0 CA-C-O 121.287 0.453 . . . . 0.0 112.872 . . . . . . . . . 0 0 . 1 . 085 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.578 ' CG2' HG22 ' A' ' 66' ' ' THR . 40.4 t -66.78 135.35 28.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.225 -0.898 . . . . 0.0 108.72 178.662 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 35.9 t . . . . . 0 C--N 1.323 -0.545 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.085 -179.027 . . . . . . . . 0 0 . 1 . 085 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo . . . . . 0 N--CA 1.496 1.665 0 CA-C-O 120.39 0.079 . . . . 0.0 112.199 . . . . . . . . . 0 0 . 1 . 085 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 24.7 m -73.34 -44.81 58.15 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.238 0.542 . . . . 0.0 109.552 178.286 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.652 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 83.4 t80 -56.67 -45.71 81.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.79 -179.963 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' B' ' 242' ' ' LEU . 88.8 mt -64.08 -41.65 97.24 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.559 179.871 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -60.69 -40.78 93.46 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.429 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -64.29 -42.32 96.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.423 179.094 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.604 HH11 ' CD ' ' A' ' 12' ' ' ARG . 58.1 ttm-85 -58.06 -42.9 86.48 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.168 -179.895 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -60.71 -39.94 90.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.167 -179.977 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 59.2 m -65.14 -44.49 88.46 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.025 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -60.41 -37.45 80.9 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.802 -179.895 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 38.7 t . . . . . 0 N--CA 1.452 -0.357 0 C-N-CA 119.864 -0.734 . . . . 0.0 109.805 178.908 . . . . . . . . 0 0 . 1 . 085 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.597 ' O ' HG23 ' A' ' 39' ' ' ILE . 51.7 mp0 . . . . . 0 CA--C 1.534 0.358 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 . . . . . . . . . 1 1 . 1 . 085 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.475 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 75.4 mt -114.21 136.46 50.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.086 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' B' B ' 262' ' ' VAL . . . . . 0.405 ' N ' ' O ' ' A' ' 38' ' ' ARG . 50.2 t -128.18 137.92 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.86 0.362 . . . . 0.0 110.939 -179.565 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -100.86 122.64 43.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.117 0.484 . . . . 0.0 111.386 -179.117 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' B' B ' 264' ' ' LYS . . . . . 0.46 ' HG3' HH22 ' A' ' 38' ' ' ARG . 89.2 tttt -64.35 -45.88 85.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.309 179.238 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' B' B ' 265' ' ' GLN . . . . . 0.691 ' HG2' HD11 ' A' ' 24' ' ' LEU . 5.0 mp0 -99.82 163.63 18.07 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.976 -179.008 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.59 156.47 65.46 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.836 2.357 . . . . 0.0 111.459 178.916 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 37.6 pt . . . . . 0 C--N 1.325 -0.461 0 CA-C-O 121.267 0.556 . . . . 0.0 112.085 -178.832 . . . . . . . . 0 0 . 1 . 086 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 C--O 1.233 0.229 0 CA-C-O 120.807 0.336 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 086 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.401 ' HD2' HD13 ' A' ' 53' ' ' ILE . 83.9 mtt85 -85.63 122.11 29.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.341 -179.589 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -126.73 137.46 53.25 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.537 179.847 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.537 HD11 ' HB3' ' A' ' 95' ' ' PHE . 30.6 tp -114.67 127.54 55.82 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.617 179.98 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.553 HG11 ' OD2' ' A' ' 16' ' ' ASP . 64.2 t -104.53 134.19 46.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.105 179.684 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.417 HG23 ' CD1' ' B' ' 261' ' ' ILE . 2.8 m -94.42 118.93 32.38 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.247 0.546 . . . . 0.0 112.141 -178.516 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.612 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 95.3 mt -83.02 141.8 14.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.999 179.541 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.461 ' HA ' HH22 ' A' ' 93' ' ' ARG . 98.0 mttt -88.44 159.26 18.07 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 178.856 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.602 HH12 ' CD ' ' B' ' 248' ' ' GLN . 84.5 mtp180 -57.22 -29.63 63.92 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 121.059 -0.257 . . . . 0.0 111.139 -178.764 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.4 m -81.18 -6.21 58.59 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.605 179.393 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.97 36.85 7.5 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 -179.557 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.3 t -119.1 132.64 68.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.836 0.351 . . . . 0.0 110.633 -179.535 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.553 ' OD2' HG11 ' A' ' 8' ' ' VAL . 68.4 t0 -76.21 130.81 38.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.65 -179.549 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.17 -116.08 1.87 Allowed Glycine 0 CA--C 1.539 1.579 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.737 -179.438 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.5 145.91 38.53 Favored 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 122.797 2.331 . . . . 0.0 113.867 -178.301 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -109.23 150.12 28.41 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.12 0.486 . . . . 0.0 110.807 179.544 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.518 ' CD2' HD11 ' A' ' 37' ' ' ILE . 30.8 t80 -120.42 106.06 40.79 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.02 179.577 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -73.21 125.91 10.66 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 C-N-CA 121.459 1.439 . . . . 0.0 112.137 -178.583 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.419 HD22 ' SG ' ' A' ' 27' ' ' CYS . 57.0 mt -88.27 43.5 1.13 Allowed 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.108 -178.796 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 80.0 p -66.24 -19.55 65.86 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.564 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 90.0 mt -73.46 142.71 46.83 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.678 179.575 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 71.5 p -59.41 -24.95 63.9 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.474 -179.135 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 39.1 m -136.93 134.05 36.35 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.918 -179.6 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.419 ' SG ' HD22 ' A' ' 22' ' ' LEU . 5.5 t -126.03 122.24 35.31 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.335 178.169 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.609 HD21 ' OE1' ' A' ' 47' ' ' GLN . 41.7 tp -118.09 129.79 55.76 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.478 -178.441 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.649 ' CE2' HD12 ' A' ' 37' ' ' ILE . 4.7 m-85 -108.29 139.57 42.8 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 123.425 0.453 . . . . 0.0 110.06 179.395 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 178.22 -170.34 42.44 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 178.861 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 27.9 ptt-85 -100.11 -3.23 32.27 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.543 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -81.87 166.29 46.66 Favored Glycine 0 CA--C 1.52 0.371 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -179.326 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 19.3 tt -96.16 5.73 8.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.216 0.532 . . . . 0.0 110.308 179.969 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -95.64 -7.96 36.13 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.989 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.2 m -91.44 151.1 20.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.137 -179.94 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.419 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 55.1 m-20 -60.77 -32.36 71.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.186 -179.641 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.649 HD12 ' CE2' ' A' ' 29' ' ' PHE . 98.4 mt -128.12 127.29 67.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.463 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -113.42 136.85 52.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.894 -178.775 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 85.6 mt -118.34 130.64 72.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.685 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -73.02 35.43 0.08 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.29 -178.035 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.481 HD21 ' NH1' ' B' ' 245' ' ' ARG . 59.7 mt -109.97 129.07 24.34 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.017 -179.83 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.413 ' O ' ' HD2' ' B' ' 235' ' ' PRO . 60.9 Cg_endo -72.5 -6.86 19.85 Favored 'Trans proline' 0 N--CA 1.49 1.292 0 C-N-CA 122.314 2.009 . . . . 0.0 112.623 -179.798 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.447 HG21 ' CE2' ' B' ' 241' ' ' PHE . 6.1 m -102.41 7.21 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.035 179.368 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 37.1 t -93.3 134.11 32.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.817 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.9 m -68.14 160.37 29.16 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.639 0.733 . . . . 0.0 112.481 -178.782 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -63.56 -41.3 98.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.088 -179.445 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.641 ' O ' ' N ' ' A' ' 49' ' ' CYS . 98.3 mm-40 -113.84 -19.22 11.58 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.005 -179.971 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 21.7 t60 26.83 -74.65 0.0 OUTLIER 'General case' 0 C--O 1.235 0.335 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 179.969 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.641 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.19 134.48 46.53 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.6 0.714 . . . . 0.0 112.727 -178.206 . . . . . . . . 3 3 . 1 . 086 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -127.36 129.63 47.95 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.313 179.865 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 98.1 mt -113.92 132.25 63.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.438 179.859 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -111.19 126.38 54.8 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 178.088 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.401 HD13 ' HD2' ' A' ' 5' ' ' ARG . 82.2 mt -104.22 115.18 45.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.819 0.819 . . . . 0.0 111.952 -179.002 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.428 ' O ' ' C ' ' A' ' 55' ' ' GLU . 98.3 m-70 -117.55 142.57 47.03 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.265 -1.334 . . . . 0.0 110.165 179.844 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 54' ' ' HIS . 87.3 tt0 -40.5 -33.16 0.24 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.673 179.539 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.502 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 64.6 tp60 -61.72 -68.03 0.36 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.55 179.417 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.502 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 6.5 tp10 -156.41 -168.71 2.8 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.463 -178.641 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.442 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -110.46 126.81 54.73 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.412 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.8 mt -115.09 131.15 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -177.689 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.556 ' HB2' HD11 ' A' ' 82' ' ' LEU . 21.6 tp -101.59 127.78 48.15 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.769 179.862 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -110.92 135.58 51.24 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.737 179.876 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.466 ' ND2' ' O ' ' A' ' 76' ' ' ILE . 48.6 t-20 -94.92 104.5 16.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.296 -179.196 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -99.53 -9.65 23.04 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.307 179.729 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.05 102.75 1.69 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.478 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 81.6 p -88.91 -15.94 33.12 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.225 179.911 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.618 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -90.97 -42.78 10.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.261 -179.805 . . . . . . . . 3 3 . 1 . 086 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.445 HD21 ' HA ' ' B' ' 236' ' ' VAL . 46.4 m-20 -141.2 103.45 6.1 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.483 -179.729 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -56.25 144.85 80.13 Favored 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 121.9 1.733 . . . . 0.0 113.188 -179.097 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.5 m -73.3 140.05 46.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.593 178.459 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -101.26 139.61 36.7 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.15 0.5 . . . . 0.0 111.532 -179.874 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.68 HG13 ' OD1' ' A' ' 86' ' ' ASP . 45.1 t -136.4 133.79 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.956 178.63 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 54.49 32.31 16.52 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.075 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.67 29.16 63.9 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-N 115.14 -0.936 . . . . 0.0 112.212 179.388 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 64.1 m -149.87 147.47 27.99 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 117.401 0.601 . . . . 0.0 111.674 -179.742 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.8 m -75.82 149.48 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.103 0.477 . . . . 0.0 111.733 -179.695 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.466 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 4.0 pt -120.97 97.94 5.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.663 179.312 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -69.25 -23.34 63.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.719 179.724 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -129.85 177.25 2.28 Favored Pre-proline 0 N--CA 1.469 0.506 0 C-N-CA 121.191 -0.203 . . . . 0.0 111.324 -179.84 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -61.02 146.7 97.41 Favored 'Trans proline' 0 N--CA 1.503 2.071 0 C-N-CA 123.042 2.495 . . . . 0.0 112.744 179.649 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.4 p -143.67 138.99 25.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.696 179.884 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 88.9 mtm180 -74.84 133.05 41.94 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.176 179.475 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.556 HD11 ' HB2' ' A' ' 60' ' ' LEU . 93.3 mt -89.23 129.09 35.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.963 0.411 . . . . 0.0 110.696 179.77 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -117.22 156.15 28.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.243 179.594 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -56.01 118.41 4.62 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.178 179.978 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.35 -17.42 18.99 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -179.775 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.68 ' OD1' HG13 ' A' ' 71' ' ' VAL . 54.3 t0 -65.63 127.57 32.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.256 0.55 . . . . 0.0 110.851 179.725 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.45 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 56.0 t -109.14 132.99 55.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.43 -179.226 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 77.2 mt -101.05 130.54 50.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.843 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 51.5 m -122.54 122.88 39.95 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.608 0.718 . . . . 0.0 112.221 -178.629 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.557 ' O ' ' N ' ' A' ' 93' ' ' ARG . 96.7 mt -113.9 124.66 70.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 114.642 -1.163 . . . . 0.0 108.592 178.24 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.5 HD12 ' CB ' ' B' ' 237' ' ' CYS . 46.3 mm 39.17 -96.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.323 -179.27 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.575 ' CB ' ' HE ' ' B' ' 245' ' ' ARG . 54.7 t0 -119.95 5.07 10.9 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.978 0.418 . . . . 0.0 110.742 -179.826 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.641 HH21 ' CD1' ' B' ' 261' ' ' ILE . 17.9 mmm180 -106.89 134.97 49.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.699 179.925 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 47.1 t -132.12 144.07 50.45 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.838 -179.872 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.537 ' HB3' HD11 ' A' ' 7' ' ' LEU . 79.7 m-85 -123.19 120.26 32.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.1 179.766 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.497 ' O ' HD12 ' A' ' 7' ' ' LEU . 44.2 ttm180 -84.47 127.35 33.98 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.142 -179.8 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.535 ' CZ ' ' OD1' ' A' ' 99' ' ' ASN . 88.9 t80 -95.73 129.05 43.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.462 179.854 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -142.66 128.63 19.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.973 0.416 . . . . 0.0 111.938 -179.445 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.535 ' OD1' ' CZ ' ' A' ' 97' ' ' TYR . 89.1 m-20 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.987 179.228 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' B' B ' 235' ' ' PRO . . . . . 0.413 ' HD2' ' O ' ' A' ' 42' ' ' PRO . 81.5 Cg_endo . . . . . 0 N--CA 1.488 1.175 0 CA-C-O 121.568 0.57 . . . . 0.0 113.095 . . . . . . . . . 1 1 . 1 . 086 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.618 ' CG2' HG22 ' A' ' 66' ' ' THR . 55.6 t -67.75 136.02 27.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 114.612 -1.176 . . . . 0.0 111.803 -179.357 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' B' B ' 237' ' ' CYS . . . . . 0.5 ' CB ' HD12 ' A' ' 91' ' ' ILE . 1.9 t . . . . . 0 C--N 1.331 -0.22 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.644 178.774 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo . . . . . 0 N--CA 1.504 2.091 0 N-CA-C 113.609 0.58 . . . . 0.0 113.609 . . . . . . . . . 0 0 . 1 . 086 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 37.2 m -72.28 -45.52 59.74 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.201 0.524 . . . . 0.0 110.341 179.135 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.447 ' CE2' HG21 ' A' ' 43' ' ' VAL . 81.0 t80 -56.61 -45.41 81.49 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.659 -179.733 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 98.6 mt -64.31 -41.31 96.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.31 179.82 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -64.99 -37.42 87.61 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.642 179.903 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -60.36 -43.41 96.57 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.616 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.671 ' O ' HG23 ' B' ' 249' ' ' VAL . 75.1 mtp85 -62.34 -37.48 85.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.75 -179.966 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -62.04 -41.37 98.05 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.238 179.809 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 10.2 t -65.63 -44.07 87.58 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.757 0.789 . . . . 0.0 108.932 177.812 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' B' B ' 248' ' ' GLN . . . . . 0.602 ' CD ' HH12 ' A' ' 12' ' ' ARG . 64.5 tt0 -62.11 -32.2 72.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.454 179.455 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' B' B ' 249' ' ' VAL . . . . . 0.671 HG23 ' O ' ' B' ' 245' ' ' ARG . 55.6 t . . . . . 0 N--CA 1.456 -0.173 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 179.109 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 . . . . . 0 N--CA 1.462 0.168 0 CA-C-O 120.7 0.286 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 086 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.641 ' CD1' HH21 ' A' ' 93' ' ' ARG . 39.7 mt -118.09 138.34 49.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -179.734 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 52.9 t -126.56 135.28 64.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.431 -179.847 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -98.23 118.62 35.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.135 0.493 . . . . 0.0 111.242 -178.903 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.86 -47.35 78.22 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.446 179.273 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -92.48 150.6 40.21 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.253 -179.22 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -66.44 147.76 83.04 Favored 'Trans proline' 0 N--CA 1.499 1.828 0 C-N-CA 123.169 2.579 . . . . 0.0 113.34 -179.488 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 19.7 pt . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.128 178.722 . . . . . . . . 0 0 . 1 . 087 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.6 p . . . . . 0 C--O 1.236 0.361 0 CA-C-O 120.726 0.298 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 087 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.45 119.95 33.95 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.247 0.546 . . . . 0.0 110.719 -179.894 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.514 ' C ' HD22 ' A' ' 7' ' ' LEU . 83.9 mtp180 -133.48 143.57 48.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.309 179.107 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.581 HD12 ' HB3' ' A' ' 95' ' ' PHE . 3.1 mm? -112.32 127.48 56.0 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.416 179.067 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.616 HG13 ' NE2' ' A' ' 19' ' ' HIS . 86.9 t -98.77 125.67 52.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.058 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 m -76.84 138.08 39.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.473 0.654 . . . . 0.0 112.2 -178.923 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.611 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 48.1 mm -105.19 132.45 51.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.625 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -87.73 156.8 19.27 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.09 -0.644 . . . . 0.0 110.994 179.918 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.635 ' CZ ' HH11 ' B' ' 245' ' ' ARG . 73.2 mtp180 -54.02 -33.56 57.54 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.612 -179.286 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.7 m -78.73 -5.41 53.13 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.42 179.008 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.42 35.02 9.78 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -179.343 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.3 t -119.15 134.6 62.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.66 0.267 . . . . 0.0 110.284 -179.84 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.404 ' OD1' HD13 ' A' ' 10' ' ' ILE . 86.7 m-20 -76.15 137.97 40.42 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.862 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.25 -118.15 2.05 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.514 -179.176 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.43 147.9 47.47 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.215 1.943 . . . . 0.0 113.002 -178.217 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.616 ' NE2' HG13 ' A' ' 8' ' ' VAL . 64.7 m170 -105.45 132.76 51.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.236 179.577 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.629 ' CD2' HD11 ' A' ' 37' ' ' ILE . 35.5 t80 -104.61 97.52 12.58 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.115 179.784 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -71.37 129.11 15.42 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 121.326 1.351 . . . . 0.0 111.675 -179.859 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.451 HD22 ' HB2' ' A' ' 27' ' ' CYS . 49.6 mt -96.92 54.12 1.25 Allowed 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.421 -179.131 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 92.0 p -61.78 -17.94 57.97 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.855 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.458 HD11 ' HG2' ' B' ' 265' ' ' GLN . 76.7 mt -77.15 142.21 39.8 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.293 178.88 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.7 t -63.61 -20.83 65.99 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -178.866 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 72.1 m -132.92 133.43 43.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.137 0.494 . . . . 0.0 111.739 -179.652 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.567 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 9.6 t -126.34 119.09 26.43 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.493 179.291 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.618 HD21 ' OE1' ' A' ' 47' ' ' GLN . 34.0 tp -115.55 126.57 54.41 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.566 -0.453 . . . . 0.0 111.854 -178.084 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.833 ' CE2' HD12 ' A' ' 37' ' ' ILE . 10.5 m-85 -104.12 139.86 38.6 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.994 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 171.82 -171.83 44.33 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 119.812 -1.185 . . . . 0.0 112.063 179.738 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 31.2 ttp85 -100.26 -8.73 23.16 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.114 -0.543 . . . . 0.0 111.778 -179.444 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.451 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -88.78 167.31 34.83 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 120.688 -0.767 . . . . 0.0 111.284 -179.996 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.519 HG23 ' N ' ' A' ' 34' ' ' GLU . 9.9 tp -64.71 -42.06 93.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 O-C-N 122.551 -0.382 . . . . 0.0 110.975 -179.732 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.519 ' N ' HG23 ' A' ' 33' ' ' ILE . 93.0 mt-10 -53.7 -22.23 8.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.766 0.317 . . . . 0.0 111.047 -179.334 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 4.0 m -65.96 124.83 23.59 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.438 -179.873 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 28' ' ' LEU . 53.1 m-20 -60.31 -30.65 69.63 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.349 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.833 HD12 ' CE2' ' A' ' 29' ' ' PHE . 79.7 mt -123.93 121.41 62.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 176.825 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.468 HH12 ' HA ' ' B' ' 264' ' ' LYS . 89.2 mtm-85 -103.84 133.93 48.0 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.006 -178.228 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.419 ' C ' ' H ' ' A' ' 41' ' ' LEU . 97.9 mt -116.9 128.95 74.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.289 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -73.23 26.46 0.06 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.014 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.472 HD21 ' OE1' ' B' ' 260' ' ' GLU . 51.5 mt -95.64 127.44 41.6 Favored Pre-proline 0 C--N 1.324 -0.543 0 C-N-CA 120.478 -0.489 . . . . 0.0 109.921 179.022 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.91 -7.96 22.08 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 122.186 1.924 . . . . 0.0 111.964 -179.628 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.8 m -97.92 10.97 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.299 179.982 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 33.5 t -99.0 133.52 41.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-O 120.675 0.274 . . . . 0.0 110.846 179.467 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.0 m -74.45 170.69 15.17 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.255 0.55 . . . . 0.0 111.927 -178.934 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -64.53 -41.45 96.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.202 -179.301 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.618 ' OE1' HD21 ' A' ' 28' ' ' LEU . 97.8 mm-40 -109.58 -27.41 9.41 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.164 0.507 . . . . 0.0 110.025 -179.578 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.794 ' NE2' HG23 ' A' ' 90' ' ' ILE . 18.8 t60 38.94 -77.52 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.666 -1.152 . . . . 0.0 112.661 179.623 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.617 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.45 133.68 46.5 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.259 0.552 . . . . 0.0 111.114 -179.066 . . . . . . . . 3 3 . 1 . 087 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -128.76 131.45 47.84 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.494 -179.819 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 94.7 mt -116.88 133.21 64.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.183 0.516 . . . . 0.0 110.744 179.633 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -115.81 125.92 53.33 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.704 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 95.5 mt -105.02 113.67 42.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.482 0.658 . . . . 0.0 111.77 -178.938 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.475 ' O ' ' N ' ' A' ' 56' ' ' GLN . 90.7 m-70 -112.11 142.94 43.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.316 -179.883 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 54' ' ' HIS . 78.4 tt0 -40.9 -27.48 0.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.298 0.57 . . . . 0.0 109.897 -179.317 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.475 ' N ' ' O ' ' A' ' 54' ' ' HIS . 70.0 tp60 -65.86 -67.88 0.41 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.727 179.715 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.469 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 5.8 tp10 -158.12 -168.17 2.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.042 -0.527 . . . . 0.0 109.676 -179.257 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.469 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -108.87 122.63 47.6 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.909 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.0 mt -114.56 131.43 66.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -177.763 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.413 ' HB2' HD11 ' A' ' 82' ' ' LEU . 24.5 tp -103.07 127.22 50.41 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.216 -179.417 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -111.05 136.78 49.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.141 179.335 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.488 HD21 ' HA ' ' A' ' 68' ' ' PRO . 58.9 t-20 -97.92 106.95 19.33 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.693 -178.954 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -101.43 -7.3 23.01 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.471 179.606 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.472 ' OG ' ' O ' ' A' ' 48' ' ' HIS . 0.7 OUTLIER -74.36 99.48 3.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.484 -178.794 . . . . . . . . 3 3 . 1 . 087 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 76.7 p -81.08 -32.41 33.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.059 0.457 . . . . 0.0 109.863 179.337 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.8 m -62.92 -49.97 72.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.683 -179.935 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.467 ' OD1' HG22 ' B' ' 236' ' ' VAL . 13.6 m-20 -144.15 106.33 4.83 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.933 -179.854 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.488 ' HA ' HD21 ' A' ' 62' ' ' ASN . 45.4 Cg_exo -54.08 146.89 46.2 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 121.923 1.748 . . . . 0.0 112.949 -179.231 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.4 m -74.98 138.95 42.6 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.924 178.885 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -101.78 140.67 35.75 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.95 179.841 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.665 HG13 ' OD1' ' A' ' 86' ' ' ASP . 64.8 t -131.8 133.17 61.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.052 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 53.74 32.39 14.69 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.007 -178.611 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.12 29.09 67.18 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.417 -179.73 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 4.9 p -145.42 140.4 27.6 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.953 -179.682 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.401 HG13 ' HB2' ' A' ' 68' ' ' PRO . 15.1 t -65.82 139.85 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.456 179.741 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.3 pt -110.2 78.13 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.089 0 CA-C-O 121.021 0.439 . . . . 0.0 110.214 178.587 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -57.59 -31.69 66.43 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.004 179.993 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -118.81 168.85 8.91 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.55 179.762 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.3 141.99 98.51 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.019 1.813 . . . . 0.0 111.941 179.607 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 61.2 t -135.78 136.57 50.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.188 -179.913 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -72.64 131.55 42.57 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.614 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.413 HD11 ' HB2' ' A' ' 60' ' ' LEU . 93.3 mt -83.25 138.59 33.53 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.761 -179.836 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -130.71 154.46 47.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.024 -179.661 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.414 ' CD2' ' C ' ' A' ' 84' ' ' HIS . 7.7 t60 -54.35 116.42 2.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.372 179.88 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.72 -19.15 31.23 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -179.846 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.665 ' OD1' HG13 ' A' ' 71' ' ' VAL . 45.5 t0 -65.54 126.95 29.93 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.144 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 52.8 t -109.94 134.55 51.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.432 -0.507 . . . . 0.0 111.312 -178.386 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 79.5 mt -100.96 130.17 50.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.172 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.514 HG23 ' OG ' ' A' ' 94' ' ' SER . 68.3 m -122.44 123.05 40.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.514 0.673 . . . . 0.0 111.545 -178.762 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.794 HG23 ' NE2' ' A' ' 48' ' ' HIS . 79.6 mt -107.08 121.02 59.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 178.382 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.49 ' C ' ' O ' ' A' ' 90' ' ' ILE . 96.7 mt 33.99 -91.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.818 -179.707 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.576 ' N ' ' O ' ' A' ' 90' ' ' ILE . 46.6 p-10 -118.49 2.7 11.82 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.899 0.381 . . . . 0.0 111.118 179.654 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.782 ' NH2' ' H ' ' A' ' 94' ' ' SER . 0.5 OUTLIER -111.87 132.49 54.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.31 -179.98 . . . . . . . . 3 3 . 1 . 087 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.782 ' H ' ' NH2' ' A' ' 93' ' ' ARG . 16.7 m -135.7 152.28 51.02 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.612 0.72 . . . . 0.0 112.019 -179.455 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.581 ' HB3' HD12 ' A' ' 7' ' ' LEU . 84.4 m-85 -129.67 126.29 37.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.901 179.06 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.504 ' O ' HD13 ' A' ' 7' ' ' LEU . 37.9 ttp-105 -88.11 133.33 34.02 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.612 179.662 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -93.42 125.77 38.2 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.926 -179.73 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -124.47 131.02 53.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.612 179.93 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 59.8 t-20 . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.042 -179.741 . . . . . . . . 0 0 . 1 . 087 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo . . . . . 0 N--CA 1.487 1.091 0 CA-C-O 121.37 0.487 . . . . 0.0 112.167 . . . . . . . . . 0 0 . 1 . 087 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.467 HG22 ' OD1' ' A' ' 67' ' ' ASN . 0.4 OUTLIER -60.58 137.61 22.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.074 179.817 . . . . . . . . 3 3 . 1 . 087 nuclear build core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 3.7 t . . . . . 0 C--N 1.331 -0.223 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.223 -178.701 . . . . . . . . 0 0 . 1 . 087 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo . . . . . 0 N--CA 1.498 1.768 0 CA-C-O 120.929 0.304 . . . . 0.0 111.888 . . . . . . . . . 0 0 . 1 . 087 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 98.3 m -72.91 -44.65 60.98 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.314 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.46 ' HZ ' HD22 ' A' ' 41' ' ' LEU . 81.1 t80 -57.99 -45.06 87.42 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.865 -179.415 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.401 ' HA ' HD23 ' B' ' 242' ' ' LEU . 97.1 mt -64.81 -40.9 95.97 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -179.426 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -61.22 -42.89 99.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.786 179.964 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -63.21 -39.43 94.6 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.44 -0.504 . . . . 0.0 109.682 179.946 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.65 ' O ' HG23 ' B' ' 249' ' ' VAL . 14.5 tpp180 -59.04 -42.42 90.22 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 179.604 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -60.4 -43.03 97.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.403 179.131 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 16.5 t -65.1 -44.88 87.39 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.948 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' B' B ' 248' ' ' GLN . . . . . 0.492 ' HB3' HH22 ' A' ' 12' ' ' ARG . 87.6 mt-30 -60.84 -32.84 72.23 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.465 -179.825 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' B' B ' 249' ' ' VAL . . . . . 0.65 HG23 ' O ' ' B' ' 245' ' ' ARG . 54.1 t . . . . . 0 CA--C 1.52 -0.183 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.046 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.568 ' OE2' ' NH1' ' A' ' 12' ' ' ARG . 92.7 mt-10 . . . . . 0 C--O 1.226 -0.145 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 . . . . . . . . . 1 1 . 1 . 087 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.589 HD11 ' CZ ' ' A' ' 93' ' ' ARG . 59.1 mt -116.53 134.12 60.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.958 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' B' B ' 262' ' ' VAL . . . . . 0.433 HG11 ' NH2' ' A' ' 38' ' ' ARG . 52.9 t -126.5 134.03 67.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.946 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -93.95 117.86 30.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.479 0.657 . . . . 0.0 111.97 -178.412 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' B' B ' 264' ' ' LYS . . . . . 0.468 ' HA ' HH12 ' A' ' 38' ' ' ARG . 87.5 tttt -63.34 -43.86 96.51 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.981 179.128 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' B' B ' 265' ' ' GLN . . . . . 0.458 ' HG2' HD11 ' A' ' 24' ' ' LEU . 9.3 mp0 -100.65 157.43 33.74 Favored Pre-proline 0 N--CA 1.449 -0.492 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.548 -179.686 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -70.2 143.57 49.13 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 C-N-CA 122.847 2.364 . . . . 0.0 113.312 -179.157 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 29.5 pt . . . . . 0 N--CA 1.451 -0.378 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.072 178.564 . . . . . . . . 0 0 . 1 . 088 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 37.2 p . . . . . 0 N--CA 1.462 0.137 0 CA-C-O 120.772 0.32 . . . . 0.0 111.3 . . . . . . . . . 0 0 . 1 . 088 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.703 ' NH2' HG21 ' A' ' 53' ' ' ILE . 82.6 mtm-85 -99.71 134.93 41.89 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.902 -179.366 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -138.82 144.9 39.51 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 120.222 -0.591 . . . . 0.0 111.626 -179.859 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.4 mt -108.73 140.62 41.88 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.003 178.58 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.4 t -112.54 129.21 68.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.616 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.471 HG23 HD12 ' B' ' 261' ' ' ILE . 1.8 m -93.45 117.77 30.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.272 0.558 . . . . 0.0 112.299 -178.049 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.5 mt -83.07 143.04 12.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.785 179.582 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -95.94 164.31 12.77 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.967 179.498 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.458 ' HG3' ' NH1' ' A' ' 93' ' ' ARG . 82.7 mtp180 -58.36 -30.09 66.49 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.281 -179.366 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.541 ' OG ' HG22 ' A' ' 15' ' ' VAL . 88.0 p -73.25 -15.08 61.43 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.229 179.561 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.93 11.09 44.3 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -179.869 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.541 HG22 ' OG ' ' A' ' 13' ' ' SER . 11.4 m -112.02 138.73 39.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.956 0.408 . . . . 0.0 110.484 179.931 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.419 ' O ' ' OD1' ' A' ' 16' ' ' ASP . 54.2 p-10 -80.19 146.85 31.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.006 179.446 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.21 -106.09 1.01 Allowed Glycine 0 CA--C 1.537 1.447 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 179.822 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.1 146.92 37.39 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 122.963 2.442 . . . . 0.0 112.248 -179.994 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -112.97 153.18 28.43 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.194 179.901 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.641 ' CD2' HD11 ' A' ' 37' ' ' ILE . 62.5 t80 -117.53 89.21 31.59 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.665 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -61.3 132.62 42.12 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.556 2.171 . . . . 0.0 111.089 179.914 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.7 mt -87.97 82.23 7.29 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.653 -178.847 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 86.0 p -86.59 -11.14 52.32 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 178.379 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.67 HD11 ' HG2' ' B' ' 265' ' ' GLN . 63.4 mt -101.92 144.06 31.03 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.526 -179.186 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.1 m -67.86 -21.2 65.19 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.779 0.323 . . . . 0.0 111.199 -179.724 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 63.1 m -127.52 133.31 49.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.708 179.619 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.653 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 9.8 t -129.78 122.13 28.2 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.463 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 49.8 tp -118.08 132.5 56.35 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.149 -178.246 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.653 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 38.0 m-85 -110.49 142.46 42.22 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.8 0.334 . . . . 0.0 110.197 179.837 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 150.13 -176.16 28.89 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 179.406 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 46.6 mtm180 -77.76 -31.68 52.19 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.64 179.605 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.578 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -47.8 149.37 3.27 Favored Glycine 0 N--CA 1.466 0.688 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 -179.012 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.448 HD12 ' HD3' ' A' ' 38' ' ' ARG . 11.0 tp -68.58 -41.04 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.583 -179.918 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.442 ' N ' HG23 ' A' ' 33' ' ' ILE . 78.2 mm-40 -55.07 -21.98 14.51 Favored 'General case' 0 C--O 1.231 0.096 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -179.995 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.578 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 19.0 m -57.34 113.01 1.57 Allowed 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.771 178.812 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -58.36 -26.72 63.47 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 -179.99 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.641 HD11 ' CD2' ' A' ' 20' ' ' PHE . 50.5 mm -122.4 113.48 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.476 177.289 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.448 ' HD3' HD12 ' A' ' 33' ' ' ILE . 42.2 mtm180 -98.02 131.63 44.27 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.829 -179.662 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.504 HG21 HD12 ' A' ' 41' ' ' LEU . 99.2 mt -118.17 131.25 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 121.465 0.65 . . . . 0.0 111.31 179.79 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -79.79 32.39 0.25 Allowed 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.159 -178.631 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.71 ' O ' HG12 ' A' ' 44' ' ' VAL . 31.9 mt -98.22 121.56 56.73 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.484 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -72.33 -13.0 27.92 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 121.552 1.501 . . . . 0.0 111.499 -179.823 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.2 m -96.2 7.73 7.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.505 -179.451 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.71 HG12 ' O ' ' A' ' 41' ' ' LEU . 5.0 p -101.86 142.5 16.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.533 179.958 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.8 m -71.95 170.35 13.95 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.363 0.602 . . . . 0.0 111.129 -179.391 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -63.81 -41.2 97.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.986 -179.764 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.637 ' O ' ' N ' ' A' ' 49' ' ' CYS . 87.7 mt-30 -108.96 -9.92 15.08 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 121.086 -0.246 . . . . 0.0 110.994 -179.958 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.594 ' ND1' HG23 ' A' ' 44' ' ' VAL . 30.0 t60 31.41 -76.32 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 179.635 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.637 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.51 137.37 45.58 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.132 0.491 . . . . 0.0 111.685 -178.472 . . . . . . . . 3 3 . 1 . 088 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -123.75 131.56 53.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.899 178.733 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.5 mt -116.05 133.46 62.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.197 -179.109 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -117.85 125.63 50.89 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.02 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.703 HG21 ' NH2' ' A' ' 5' ' ' ARG . 67.7 mt -103.29 116.6 47.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 C-N-CA 119.853 -0.739 . . . . 0.0 111.207 -179.488 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.503 ' O ' ' N ' ' A' ' 56' ' ' GLN . 6.3 m-70 -111.72 135.8 51.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.182 179.637 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.0 mm-40 -41.51 -26.58 0.07 Allowed 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.477 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.503 ' N ' ' O ' ' A' ' 54' ' ' HIS . 82.4 mt-30 -68.39 -68.55 0.38 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.215 178.679 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.447 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 5.2 tp10 -151.0 -178.3 6.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.557 -179.357 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.447 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -102.41 128.7 48.89 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.554 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 40.9 mm -111.89 126.57 69.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.886 -178.117 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.627 ' HB2' HD11 ' A' ' 82' ' ' LEU . 23.0 tp -101.37 124.24 46.75 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.923 178.878 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -114.81 137.04 52.42 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.419 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -102.21 108.28 19.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.03 0.443 . . . . 0.0 111.288 179.49 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -94.43 -3.03 50.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.805 179.298 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.8 t -82.31 100.98 10.26 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.446 -0.501 . . . . 0.0 110.081 179.521 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.9 m -82.76 -17.2 45.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.62 179.954 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.467 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -87.52 -36.09 17.8 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.376 -179.338 . . . . . . . . 3 3 . 1 . 088 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -146.05 100.58 4.22 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.873 -179.54 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -57.81 144.09 94.25 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 121.736 1.624 . . . . 0.0 112.708 -179.336 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 37.2 m -70.21 134.55 48.17 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.171 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -96.08 141.1 29.87 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.635 -178.909 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.5 t -134.32 134.07 55.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.321 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 53.49 31.89 13.09 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 119.84 -0.744 . . . . 0.0 109.023 -179.104 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.04 25.68 72.98 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.26 179.852 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 37.8 t -141.72 143.57 33.6 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 117.297 0.549 . . . . 0.0 111.528 -179.993 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.8 m -76.69 139.13 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.884 179.984 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.414 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 1.1 pt -104.08 104.05 16.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.622 179.106 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.428 ' C ' ' OE1' ' A' ' 78' ' ' GLU . 57.9 m-20 -63.24 -35.88 81.8 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-O 121.191 0.519 . . . . 0.0 109.911 179.964 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.428 ' OE1' ' C ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -125.79 177.95 1.7 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.345 -179.128 . . . . . . . . 3 3 . 1 . 088 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.418 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 34.6 Cg_exo -60.48 142.64 98.5 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 122.302 2.001 . . . . 0.0 111.914 179.966 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 42.9 t -132.7 138.19 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 120.946 0.403 . . . . 0.0 111.665 179.722 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -75.32 132.83 41.25 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.679 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.627 HD11 ' HB2' ' A' ' 60' ' ' LEU . 86.1 mt -87.41 137.2 32.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.326 0.584 . . . . 0.0 111.318 -179.121 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -126.02 151.85 46.54 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.321 -179.704 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.455 ' ND1' ' N ' ' A' ' 99' ' ' ASN . 9.1 t60 -55.12 122.98 12.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.227 0.537 . . . . 0.0 111.246 -178.973 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 103.35 -13.22 54.89 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.143 -179.657 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -70.72 139.06 51.04 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 117.079 0.44 . . . . 0.0 110.696 179.687 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.427 ' O ' HG13 ' A' ' 87' ' ' VAL . 8.7 p -111.69 135.81 49.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.411 -0.515 . . . . 0.0 111.841 -178.996 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 81.2 mt -102.4 128.99 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 177.606 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.783 HG23 ' OG ' ' A' ' 94' ' ' SER . 95.3 m -123.93 125.07 43.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.702 0.763 . . . . 0.0 111.759 -178.438 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.63 ' O ' ' N ' ' A' ' 93' ' ' ARG . 96.1 mt -113.99 121.65 66.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 114.547 -1.206 . . . . 0.0 108.062 178.324 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.555 ' C ' ' O ' ' A' ' 90' ' ' ILE . 66.5 mt -3.44 95.31 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -179.833 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.427 ' CB ' ' NH1' ' B' ' 245' ' ' ARG . 2.0 t0 77.83 -20.3 0.39 Allowed 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 178.18 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.754 ' HE ' ' CD1' ' B' ' 261' ' ' ILE . 6.8 tpt180 -120.31 130.08 54.29 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 110.465 -0.198 . . . . 0.0 110.465 -178.372 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.783 ' OG ' HG23 ' A' ' 89' ' ' THR . 64.3 m -134.62 151.11 50.83 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -178.486 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.481 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 82.9 m-85 -122.63 120.74 34.62 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.308 178.551 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 37.7 ttp-105 -87.86 134.95 33.59 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 119.914 -0.715 . . . . 0.0 110.727 -179.652 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -96.93 123.86 40.75 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.124 -178.14 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -125.12 120.26 30.9 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.234 179.415 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.455 ' N ' ' ND1' ' A' ' 84' ' ' HIS . 15.9 t-20 . . . . . 0 N--CA 1.472 0.657 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.507 -179.225 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo . . . . . 0 N--CA 1.49 1.275 0 N-CA-C 113.388 0.495 . . . . 0.0 113.388 . . . . . . . . . 0 0 . 1 . 088 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.467 ' CG2' HG22 ' A' ' 66' ' ' THR . 60.5 t -60.82 137.61 22.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.48 179.667 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' B' B ' 237' ' ' CYS . . . . . 0.535 ' HB2' HD13 ' A' ' 91' ' ' ILE . 2.7 t . . . . . 0 C--N 1.321 -0.651 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.038 -179.559 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo . . . . . 0 N--CA 1.496 1.655 0 CA-C-O 120.775 0.24 . . . . 0.0 112.241 . . . . . . . . . 0 0 . 1 . 088 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 86.2 m -72.24 -44.05 63.46 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.439 0.638 . . . . 0.0 109.417 178.485 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.406 ' CZ ' ' HD2' ' B' ' 245' ' ' ARG . 72.2 t80 -58.47 -51.01 71.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.324 -178.624 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.475 HD21 HG23 ' A' ' 91' ' ' ILE . 97.2 mt -63.51 -42.04 98.49 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.183 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -64.29 -42.24 96.49 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -178.734 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -62.2 -41.8 98.7 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.344 -179.591 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.438 ' O ' HG23 ' B' ' 249' ' ' VAL . 83.5 mtp180 -63.21 -39.32 94.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.636 -178.495 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -62.01 -38.46 88.73 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.016 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 21.0 m -65.49 -42.61 91.97 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.499 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -62.33 -32.92 73.75 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.156 179.705 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' B' B ' 249' ' ' VAL . . . . . 0.438 HG23 ' O ' ' B' ' 245' ' ' ARG . 53.1 t . . . . . 0 N--CA 1.45 -0.439 0 C-N-CA 120.121 -0.632 . . . . 0.0 109.419 178.74 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 . . . . . 0 C--O 1.23 0.075 0 N-CA-C 111.838 0.311 . . . . 0.0 111.838 . . . . . . . . . 0 0 . 1 . 088 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.754 ' CD1' ' HE ' ' A' ' 93' ' ' ARG . 64.9 mt -117.6 134.36 61.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -179.883 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 47.8 t -123.4 130.65 74.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.162 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -93.47 117.07 29.63 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.272 0.558 . . . . 0.0 111.106 -177.924 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -64.48 -46.6 82.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.687 -179.781 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' B' B ' 265' ' ' GLN . . . . . 0.67 ' HG2' HD11 ' A' ' 24' ' ' LEU . 0.8 OUTLIER -92.49 165.78 18.59 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.069 -178.465 . . . . . . . . 3 3 . 1 . 088 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -69.07 148.01 68.6 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 122.122 1.882 . . . . 0.0 112.739 -178.93 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 32.1 pt . . . . . 0 C--N 1.321 -0.646 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.15 -179.876 . . . . . . . . 0 0 . 1 . 089 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.0 p . . . . . 0 N--CA 1.455 -0.183 0 CA-C-O 121.133 0.492 . . . . 0.0 110.294 . . . . . . . . . 0 0 . 1 . 089 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.55 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 80.5 mtp85 -87.69 126.73 35.14 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.064 -179.465 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -129.62 133.53 47.19 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.013 -179.863 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.514 HD11 ' HB3' ' A' ' 95' ' ' PHE . 35.1 tp -117.1 128.38 55.08 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.748 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.6 m -106.16 136.09 41.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.419 -179.768 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.516 HG23 HD12 ' B' ' 261' ' ' ILE . 1.8 m -95.29 117.84 30.99 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.142 -0.936 . . . . 0.0 112.589 -178.589 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.7 mt -84.65 145.59 7.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.386 179.02 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -96.4 162.3 13.55 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.95 0.405 . . . . 0.0 110.773 179.315 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.593 ' NH1' ' OE2' ' B' ' 260' ' ' GLU . 87.6 mtm180 -58.45 -27.38 64.32 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.558 -178.636 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 89.3 p -81.82 -9.77 59.52 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.093 -0.643 . . . . 0.0 109.697 179.646 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.3 36.75 6.47 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.61 179.8 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.3 t -118.38 132.37 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-O 120.787 0.327 . . . . 0.0 111.42 179.993 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -69.64 124.48 24.06 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.862 179.274 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -116.08 -128.89 4.34 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.271 -178.937 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -70.61 148.07 58.76 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.031 1.821 . . . . 0.0 112.816 -178.623 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -106.51 144.87 32.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.814 -179.572 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.757 ' CD2' HD11 ' A' ' 37' ' ' ILE . 34.6 t80 -112.25 100.98 51.19 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.321 179.862 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.414 ' CD ' ' O ' ' B' ' 267' ' ' ILE . 57.8 Cg_endo -75.79 128.82 11.15 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 121.47 1.446 . . . . 0.0 111.42 -179.632 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 88.0 mt -83.8 81.17 8.88 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.855 -178.871 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 87.8 p -86.01 -13.7 46.72 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.987 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 73.8 mt -100.03 145.36 28.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.422 -179.967 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 54.2 p -68.56 -15.77 63.64 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.506 -178.804 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.517 HG23 ' OE2' ' A' ' 52' ' ' GLU . 85.6 m -128.61 131.48 48.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.237 0.541 . . . . 0.0 111.778 -179.691 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.9 t -128.11 122.15 31.34 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.304 178.543 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.8 tp -115.27 130.58 56.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.956 0.408 . . . . 0.0 111.002 -179.074 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.522 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 44.8 m-85 -111.36 140.47 45.92 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.796 179.718 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 152.64 -168.4 31.63 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 120.886 -0.673 . . . . 0.0 111.504 179.394 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.578 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 49.5 ptt85 -118.29 17.27 13.92 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 122.76 -0.259 . . . . 0.0 111.034 179.901 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.629 ' O ' ' N ' ' A' ' 34' ' ' GLU . . . -88.05 32.96 4.16 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.814 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.65 ' C ' ' H ' ' A' ' 35' ' ' CYS . 2.0 tt 52.03 -62.09 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 123.28 0.632 . . . . 0.0 112.587 -179.609 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.629 ' N ' ' O ' ' A' ' 32' ' ' GLY . 72.0 tt0 -52.26 2.21 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 O-C-N 121.974 -0.454 . . . . 0.0 110.899 -178.934 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.65 ' H ' ' C ' ' A' ' 33' ' ' ILE . 3.9 m -82.77 133.81 35.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.891 0.377 . . . . 0.0 111.027 179.82 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -61.88 -26.81 68.37 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.88 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.757 HD11 ' CD2' ' A' ' 20' ' ' PHE . 49.0 mm -123.41 117.09 50.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 177.267 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.411 ' NH1' HG13 ' A' ' 33' ' ' ILE . 82.1 mtt180 -100.33 132.92 45.43 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.85 -179.133 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.721 HG21 HD12 ' A' ' 41' ' ' LEU . 80.9 mt -120.31 130.98 73.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.469 -0.493 . . . . 0.0 110.446 -179.727 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -79.11 33.97 0.23 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.507 -179.046 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.721 HD12 HG21 ' A' ' 39' ' ' ILE . 17.9 mt -102.06 108.74 57.85 Favored Pre-proline 0 C--N 1.326 -0.427 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.78 -179.974 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -57.56 -13.81 14.91 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.21 1.94 . . . . 0.0 112.406 179.159 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.6 m -97.31 9.7 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.858 -179.893 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.578 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 15.7 t -102.17 135.88 37.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.092 0.473 . . . . 0.0 110.957 -179.744 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.53 162.23 21.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.204 -179.12 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -62.89 -42.42 99.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.702 -179.392 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.595 ' O ' ' N ' ' A' ' 49' ' ' CYS . 87.6 mt-30 -112.34 -2.58 14.76 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.916 0.389 . . . . 0.0 110.579 178.882 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.456 ' C ' ' O ' ' A' ' 47' ' ' GLN . 14.8 t60 15.88 -73.51 0.0 OUTLIER 'General case' 0 C--O 1.235 0.29 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -179.287 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.595 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.91 134.69 44.9 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.331 -0.548 . . . . 0.0 112.094 -178.127 . . . . . . . . 3 3 . 1 . 089 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -127.41 132.36 50.13 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.399 179.793 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.2 mt -115.93 133.24 62.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.977 0.417 . . . . 0.0 111.432 -179.491 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.517 ' OE2' HG23 ' A' ' 26' ' ' THR . 70.8 mm-40 -117.41 127.93 54.52 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.428 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 93.0 mt -105.53 118.36 52.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 119.941 -0.703 . . . . 0.0 112.231 -179.089 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.454 ' O ' ' N ' ' A' ' 56' ' ' GLN . 92.9 m-70 -116.39 144.01 44.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.692 -179.522 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 54' ' ' HIS . 95.3 mt-10 -40.28 -29.69 0.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.857 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.483 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 53.4 tt0 -63.87 -68.31 0.36 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.411 178.733 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.483 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 5.5 tp10 -160.09 -159.44 0.71 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.047 179.371 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.442 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -116.04 124.97 51.79 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.213 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.5 mt -116.69 132.43 66.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.243 0.545 . . . . 0.0 112.22 -178.329 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.1 tp -100.54 129.03 46.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.319 -179.971 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -110.22 135.65 50.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.704 -179.66 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.414 HD21 ' HA ' ' A' ' 68' ' ' PRO . 47.2 t-20 -95.95 105.22 17.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.729 -179.247 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -98.0 -5.74 33.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.815 179.086 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.23 101.39 3.98 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.702 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.6 p -87.37 -11.13 50.2 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.699 -179.877 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.49 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -101.1 -36.08 9.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.169 -179.272 . . . . . . . . 3 3 . 1 . 089 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 60.2 m-80 -142.78 97.72 5.87 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.664 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.414 ' HA ' HD21 ' A' ' 62' ' ' ASN . 32.6 Cg_exo -55.92 146.08 70.21 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 122.299 2.0 . . . . 0.0 113.633 -178.358 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.3 m -69.23 133.19 47.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.023 178.641 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -97.78 141.78 30.37 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.224 -0.59 . . . . 0.0 111.347 -179.287 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.3 p -133.46 133.58 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.801 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 50.64 32.96 7.43 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 119.921 -0.712 . . . . 0.0 109.219 -179.321 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.21 29.27 62.62 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.943 179.788 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.5 m -142.33 135.31 28.55 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.233 -0.587 . . . . 0.0 111.962 -179.727 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.431 ' H ' HG22 ' A' ' 75' ' ' VAL . 0.5 OUTLIER -72.84 139.23 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.471 179.277 . . . . . . . . 3 3 . 1 . 089 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.547 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 1.1 pt -107.07 111.81 37.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-O 121.719 0.771 . . . . 0.0 111.023 179.721 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -67.3 -31.98 72.64 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.993 179.303 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.615 ' N ' ' OE1' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -133.13 -179.19 1.0 Allowed Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.847 -179.322 . . . . . . . . 3 3 . 1 . 089 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.496 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 31.3 Cg_exo -60.77 146.72 96.92 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 122.973 2.449 . . . . 0.0 113.08 179.828 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.9 m -137.4 140.53 41.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.857 179.018 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 52.3 ttp180 -73.15 129.96 39.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.317 179.3 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.0 mt -81.92 140.82 33.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.374 0.607 . . . . 0.0 111.694 -179.227 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.66 152.23 51.62 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.94 179.599 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -56.85 121.11 9.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.991 0.424 . . . . 0.0 110.916 -179.477 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.61 -18.75 37.46 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 179.924 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -67.48 135.57 53.27 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.963 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.4 t -113.71 132.73 61.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.329 -177.671 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.9 mt -96.52 129.3 46.78 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 177.801 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 43.1 m -121.71 124.96 45.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.622 0.725 . . . . 0.0 112.133 -178.0 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.527 ' O ' ' C ' ' A' ' 91' ' ' ILE . 95.4 mt -113.07 128.84 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 114.708 -1.133 . . . . 0.0 107.987 178.404 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.527 ' C ' ' O ' ' A' ' 90' ' ' ILE . 61.3 mt -20.88 102.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -178.673 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.461 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 5.1 m-20 87.17 -23.72 0.13 Allowed 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 177.881 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 90' ' ' ILE . 17.3 mmm-85 -129.24 144.6 51.28 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.413 179.926 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.5 t -140.24 152.87 46.29 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.249 0.547 . . . . 0.0 110.814 179.979 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.573 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 51.7 m-85 -123.2 122.06 37.47 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.985 -179.768 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.439 ' O ' HD12 ' A' ' 7' ' ' LEU . 42.7 ttm180 -88.49 130.98 35.08 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 119.655 -0.818 . . . . 0.0 109.959 179.591 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.55 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 41.0 t80 -93.83 127.71 39.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.168 -179.941 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -123.94 122.29 37.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.689 179.56 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 . . . . . 0 C--N 1.328 -0.368 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.32 . . . . . . . . 0 0 . 1 . 089 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo . . . . . 0 N--CA 1.492 1.409 0 N-CA-C 114.27 0.834 . . . . 0.0 114.27 . . . . . . . . . 0 0 . 1 . 089 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.49 ' CG2' HG22 ' A' ' 66' ' ' THR . 55.4 t -65.38 142.07 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.301 179.529 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 3.5 t . . . . . 0 N--CA 1.464 0.227 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.378 179.892 . . . . . . . . 0 0 . 1 . 089 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo . . . . . 0 N--CA 1.499 1.817 0 N-CA-C 113.07 0.373 . . . . 0.0 113.07 . . . . . . . . . 0 0 . 1 . 089 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 30.4 m -68.62 -46.69 68.59 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.077 0.465 . . . . 0.0 110.031 178.73 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -59.52 -46.31 89.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.483 -178.607 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 84.7 mt -63.72 -42.65 97.88 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -178.907 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -65.56 -40.02 92.34 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.406 -0.517 . . . . 0.0 111.093 -178.931 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 63.7 ttm-85 -63.62 -44.12 94.86 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.441 -0.503 . . . . 0.0 109.849 179.649 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' B' B ' 245' ' ' ARG . . . . . . . . . . . . . 70.6 ttp85 -61.28 -42.53 98.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.757 -179.928 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -59.17 -37.95 78.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.019 -179.675 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 49.0 m -68.92 -41.66 77.84 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 177.454 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 70.2 tp60 -61.16 -38.38 86.26 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.515 179.954 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 38.6 t . . . . . 0 C--N 1.331 -0.227 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.119 179.232 . . . . . . . . 0 0 . 1 . 089 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.593 ' OE2' ' NH1' ' A' ' 12' ' ' ARG . 98.1 mt-10 . . . . . 0 N--CA 1.461 0.108 0 CA-C-O 120.487 0.184 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 089 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.573 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 81.1 mt -116.41 138.06 48.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.86 0.362 . . . . 0.0 110.18 179.972 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 43.9 t -127.07 136.44 60.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.363 179.739 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -97.72 118.02 33.33 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.249 0.547 . . . . 0.0 110.979 -178.748 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -64.7 -46.53 81.94 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.599 179.509 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' B' B ' 265' ' ' GLN . . . . . 0.413 ' CB ' ' CD ' ' B' ' 266' ' ' PRO . 1.1 mm-40 -98.73 177.74 1.5 Allowed Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.467 -179.111 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' B' B ' 266' ' ' PRO . . . . . 0.413 ' CD ' ' CB ' ' B' ' 265' ' ' GLN . 38.8 Cg_exo -60.75 143.36 99.38 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.544 2.162 . . . . 0.0 113.193 -178.895 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' B' B ' 267' ' ' ILE . . . . . 0.414 ' O ' ' CD ' ' A' ' 21' ' ' PRO . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.314 179.296 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.4 p . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.786 0.327 . . . . 0.0 110.503 . . . . . . . . . 0 0 . 1 . 090 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.668 ' NH1' ' HB2' ' A' ' 58' ' ' ALA . 93.6 mtt-85 -100.21 117.12 33.78 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.89 -179.092 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 32.3 ptt-85 -132.96 141.78 48.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.25 179.871 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.587 HD11 ' HB3' ' A' ' 95' ' ' PHE . 33.2 tp -118.24 136.18 53.82 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.899 -179.805 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.0 t -112.56 131.2 64.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 -179.784 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.469 ' CG2' HD12 ' B' ' 261' ' ' ILE . 12.8 m -91.08 113.62 25.93 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.548 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 84.6 mt -81.63 145.01 9.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.666 178.477 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -89.9 157.89 17.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.083 0.468 . . . . 0.0 111.066 178.949 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.648 ' NH1' HH11 ' B' ' 245' ' ' ARG . 90.4 mtm180 -58.61 -32.07 68.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.93 -179.454 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.5 m -75.64 -13.49 60.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.917 0.389 . . . . 0.0 110.381 179.675 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.06 35.54 5.51 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.363 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.4 t -121.66 133.17 68.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.849 0.357 . . . . 0.0 111.551 -179.12 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -72.43 122.62 21.54 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.767 179.415 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -114.63 -129.26 4.69 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.529 -179.354 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.49 156.18 54.42 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.301 2.001 . . . . 0.0 112.859 -178.969 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.539 ' CE1' ' HD3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -112.91 156.0 23.75 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.128 0.49 . . . . 0.0 110.762 -179.336 . . . . . . . . 3 3 . 1 . 090 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.443 ' CD2' HD11 ' A' ' 37' ' ' ILE . 39.0 t80 -126.19 104.39 25.72 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.517 -179.436 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.539 ' HD3' ' CE1' ' A' ' 19' ' ' HIS . 61.6 Cg_endo -74.01 132.8 17.29 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 C-N-CA 121.07 1.18 . . . . 0.0 111.472 -179.363 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.443 HD22 ' SG ' ' A' ' 27' ' ' CYS . 73.9 mt -89.98 49.97 1.8 Allowed 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.196 -178.351 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 93.9 p -63.13 -19.65 64.65 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.893 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.717 HD11 ' CD ' ' B' ' 265' ' ' GLN . 87.0 mt -77.48 140.2 39.76 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.069 179.592 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 77.9 p -61.57 -21.38 64.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.593 -178.973 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.488 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 20.8 m -136.27 135.7 39.21 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.786 -0.365 . . . . 0.0 111.304 -179.752 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.443 ' SG ' HD22 ' A' ' 22' ' ' LEU . 5.0 t -124.84 116.65 22.59 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.46 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.1 tp -113.73 127.8 56.17 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.906 0.384 . . . . 0.0 110.87 -179.052 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.785 ' CE2' HD12 ' A' ' 37' ' ' ILE . 9.6 m-85 -106.33 132.5 52.3 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.666 179.773 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 163.24 -173.53 39.41 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 119.724 -1.227 . . . . 0.0 112.879 179.144 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.635 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 87.3 mtm-85 -77.44 -31.02 53.65 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-O 120.907 0.384 . . . . 0.0 110.167 179.51 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.498 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -52.81 148.1 13.53 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.365 -178.075 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.461 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 8.2 tp -67.36 -40.6 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.417 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.461 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 79.5 mm-40 -54.45 -24.93 22.21 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.221 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 61.6 m -51.85 120.65 5.52 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.122 -179.786 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.488 ' OD2' ' O ' ' A' ' 26' ' ' THR . 68.0 m-20 -57.56 -27.3 62.54 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 179.932 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.785 HD12 ' CE2' ' A' ' 29' ' ' PHE . 84.4 mt -129.35 121.26 53.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.92 177.367 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 66.7 ttp85 -112.13 138.23 49.08 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.857 -179.177 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.833 HD13 ' NH1' ' A' ' 93' ' ' ARG . 78.0 mt -117.66 132.53 67.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.975 0.417 . . . . 0.0 110.312 -179.54 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -72.45 32.49 0.06 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.478 -178.168 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.933 HD12 HH21 ' A' ' 93' ' ' ARG . 78.7 mt -118.64 128.1 26.16 Favored Pre-proline 0 CA--C 1.535 0.392 0 C-N-CA 120.249 -0.58 . . . . 0.0 111.95 -179.722 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.85 -11.35 25.67 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 122.46 2.107 . . . . 0.0 113.222 -179.85 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.576 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 2.5 m -87.63 -5.58 10.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.344 179.403 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.635 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 55.3 t -84.51 133.17 29.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 177.541 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.455 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 0.4 OUTLIER -61.34 161.37 9.26 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.127 0.489 . . . . 0.0 111.265 -179.086 . . . . . . . . 3 3 . 1 . 090 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -61.99 -44.66 96.26 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.704 -178.988 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.604 ' O ' ' N ' ' A' ' 49' ' ' CYS . 95.1 mt-30 -113.94 -15.03 12.4 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.17 179.904 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.455 ' H ' ' HB3' ' A' ' 45' ' ' SER . 24.1 t60 31.35 -76.51 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 179.394 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.604 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.26 135.87 48.57 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.28 0.562 . . . . 0.0 112.193 -178.194 . . . . . . . . 3 3 . 1 . 090 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -128.16 126.84 41.85 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.246 179.534 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.4 mt -113.19 136.3 49.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.753 -179.659 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -115.62 132.84 56.51 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.917 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 51.5 mm -102.51 119.67 51.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.171 -0.612 . . . . 0.0 111.445 -178.948 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.451 ' O ' ' N ' ' A' ' 56' ' ' GLN . 96.5 m-70 -121.44 134.07 55.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.14 179.398 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 54' ' ' HIS . 81.0 tt0 -40.3 -29.82 0.09 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -179.765 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.451 ' N ' ' O ' ' A' ' 54' ' ' HIS . 60.0 tt0 -67.58 -67.29 0.47 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.544 179.083 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.427 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 5.3 tp10 -154.72 -161.56 1.23 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.125 -179.185 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.668 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -124.96 132.17 53.32 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.143 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.5 mt -116.99 129.21 73.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.175 0.512 . . . . 0.0 112.339 -179.097 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.526 ' HB2' HD11 ' A' ' 82' ' ' LEU . 34.7 tp -96.92 128.53 43.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.184 179.121 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -111.82 136.04 51.63 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.497 -179.58 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.416 HD21 ' HA ' ' A' ' 68' ' ' PRO . 58.2 t-20 -94.63 106.86 18.85 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.441 -179.671 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -99.87 -10.72 21.42 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.342 179.292 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.448 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 2.7 t -71.65 100.78 2.38 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.297 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.7 m -87.66 -19.27 27.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.083 0.468 . . . . 0.0 110.405 -179.858 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.85 -43.0 10.92 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.105 179.809 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.637 ' OD1' HG23 ' B' ' 236' ' ' VAL . 27.0 m-80 -133.23 91.94 26.29 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.497 179.994 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.44 ' HB2' HG13 ' A' ' 75' ' ' VAL . 41.5 Cg_exo -54.8 143.5 70.48 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.15 1.9 . . . . 0.0 112.702 -178.986 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.4 m -74.84 141.47 44.24 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.812 -1.086 . . . . 0.0 111.005 -179.781 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -104.32 142.05 35.24 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.396 179.527 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.493 ' CG2' ' OD1' ' A' ' 86' ' ' ASP . 4.9 p -128.55 134.13 65.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.207 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 46.65 34.7 2.6 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 -179.426 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.05 26.53 68.51 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.916 179.802 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.454 ' N ' ' O ' ' A' ' 71' ' ' VAL . 14.5 m -138.43 135.41 35.21 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 117.164 0.482 . . . . 0.0 111.499 179.928 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.44 HG13 ' HB2' ' A' ' 68' ' ' PRO . 43.3 t -64.72 136.36 26.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.422 179.965 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 pt -116.64 83.87 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.588 179.036 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -66.28 -22.26 66.3 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.88 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.486 ' CD ' ' H ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -118.45 163.43 25.46 Favored Pre-proline 0 C--N 1.333 -0.146 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.841 178.994 . . . . . . . . 3 3 . 1 . 090 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -67.93 152.0 77.46 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.65 2.234 . . . . 0.0 112.685 -179.685 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.6 m -144.3 146.22 20.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.597 -179.719 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 91.5 mtm180 -73.48 131.3 41.63 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.78 179.179 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.526 HD11 ' HB2' ' A' ' 60' ' ' LEU . 95.4 mt -84.06 133.72 34.64 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.016 0.436 . . . . 0.0 110.939 -179.696 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -130.68 157.03 43.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.763 179.879 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -58.13 117.51 4.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.903 0.382 . . . . 0.0 110.526 -179.72 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.77 -11.46 20.88 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -179.449 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.493 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 61.7 t0 -79.18 120.11 23.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.984 0.421 . . . . 0.0 110.185 179.586 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.8 t -108.21 130.79 60.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.92 -178.985 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.2 mt -94.73 132.18 39.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.108 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.9 m -116.61 127.16 54.21 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 121.53 0.681 . . . . 0.0 111.477 -179.831 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.47 ' O ' ' C ' ' A' ' 91' ' ' ILE . 96.6 mt -122.86 125.15 71.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.001 179.044 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.577 HG22 ' N ' ' A' ' 92' ' ' ASP . 87.4 mt 33.09 -101.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.155 -179.455 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.577 ' N ' HG22 ' A' ' 91' ' ' ILE . 56.9 t0 -109.69 14.98 23.11 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 121.067 -0.253 . . . . 0.0 111.615 -179.123 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.933 HH21 HD12 ' A' ' 41' ' ' LEU . 8.9 mtm105 -127.87 143.02 51.12 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.806 -179.449 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.3 m -134.8 148.48 50.2 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.945 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.587 ' HB3' HD11 ' A' ' 7' ' ' LEU . 75.9 m-85 -126.94 126.97 44.12 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.884 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.481 ' O ' HD12 ' A' ' 7' ' ' LEU . 99.8 mtt180 -89.77 131.04 35.93 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.812 179.857 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.587 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 88.9 t80 -97.99 129.2 44.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.938 0.399 . . . . 0.0 110.127 179.569 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -133.14 123.91 26.54 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.222 -179.514 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 54.3 t30 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.818 -179.682 . . . . . . . . 0 0 . 1 . 090 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo . . . . . 0 N--CA 1.486 1.072 0 N-CA-C 110.958 -0.439 . . . . 0.0 110.958 . . . . . . . . . 0 0 . 1 . 090 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.637 HG23 ' OD1' ' A' ' 67' ' ' ASN . 4.1 p -118.14 136.48 55.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 120.976 0.417 . . . . 0.0 111.026 -179.277 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 11.9 t . . . . . 0 CA--C 1.52 -0.197 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.377 -179.939 . . . . . . . . 0 0 . 1 . 090 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo . . . . . 0 N--CA 1.499 1.812 0 N-CA-C 112.881 0.3 . . . . 0.0 112.881 . . . . . . . . . 0 0 . 1 . 090 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 36.2 m -73.58 -44.76 56.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.229 0.538 . . . . 0.0 109.837 178.224 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.576 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 47.7 t80 -57.28 -46.31 83.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.448 -179.413 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 97.9 mt -63.61 -41.2 98.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.919 0.39 . . . . 0.0 110.06 -179.871 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -62.75 -45.05 94.51 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.099 179.736 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' B' B ' 244' ' ' ARG . . . . . 0.502 ' O ' ' OG ' ' B' ' 247' ' ' SER . 73.6 ttt180 -65.03 -41.85 94.9 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.045 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.648 HH11 ' NH1' ' A' ' 12' ' ' ARG . 9.0 tpp180 -58.91 -43.95 91.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.543 -179.122 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -64.93 -42.05 95.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.122 0.487 . . . . 0.0 109.874 178.796 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' B' B ' 247' ' ' SER . . . . . 0.502 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 78.3 p -62.05 -46.32 89.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.037 179.774 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -62.61 -39.02 92.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.278 -179.575 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' B' B ' 249' ' ' VAL . . . . . 0.452 HG23 ' O ' ' B' ' 245' ' ' ARG . 42.6 t . . . . . 0 C--N 1.329 -0.32 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.303 -179.946 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.674 ' OE1' HD21 ' A' ' 41' ' ' LEU . 95.7 mt-10 . . . . . 0 C--O 1.228 -0.042 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 . . . . . . . . . 1 1 . 1 . 090 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.469 HD12 ' CG2' ' A' ' 9' ' ' THR . 55.0 mt -111.12 139.91 32.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.554 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 58.9 t -128.25 135.71 61.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.129 179.765 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -97.41 120.8 38.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.252 0.549 . . . . 0.0 111.9 -178.178 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -63.88 -46.63 84.08 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.231 179.267 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' B' B ' 265' ' ' GLN . . . . . 0.717 ' CD ' HD11 ' A' ' 24' ' ' LEU . 2.7 mt-30 -94.01 161.78 28.77 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.903 -179.674 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.93 146.36 58.88 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 122.854 2.369 . . . . 0.0 112.768 -179.64 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 45.3 pt . . . . . 0 C--N 1.328 -0.342 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.679 . . . . . . . . 0 0 . 1 . 091 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 68.2 p . . . . . 0 CA--C 1.516 -0.34 0 CA-C-O 121.017 0.437 . . . . 0.0 110.469 . . . . . . . . . 0 0 . 1 . 091 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.8 mtt85 -93.08 129.19 39.13 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.37 -0.532 . . . . 0.0 109.589 -179.743 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -133.99 145.44 49.5 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 120.641 -0.423 . . . . 0.0 111.363 -179.476 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.402 HD11 HD11 ' A' ' 22' ' ' LEU . 66.0 mt -115.34 136.31 53.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.316 179.635 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.818 HG11 ' NH2' ' A' ' 96' ' ' ARG . 27.4 t -109.71 127.06 66.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.715 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.0 m -77.26 142.04 39.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.356 -178.493 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.631 HD12 ' OG ' ' A' ' 94' ' ' SER . 97.5 mt -110.43 134.15 53.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.871 177.261 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -88.51 158.77 18.22 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.06 0.457 . . . . 0.0 110.815 179.99 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.433 ' NH2' ' HB3' ' B' ' 248' ' ' GLN . 82.1 mtp180 -57.25 -32.82 66.95 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.901 -178.824 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 65.2 m -77.31 -6.78 54.5 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.201 178.767 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.07 31.63 10.7 Favored Glycine 0 CA--C 1.519 0.302 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 -179.595 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.1 t -113.5 133.04 60.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.987 0.423 . . . . 0.0 111.451 -178.924 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.658 ' CG ' HH22 ' A' ' 96' ' ' ARG . 97.5 m-20 -74.03 137.03 43.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.874 179.651 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.47 -122.91 2.49 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 120.459 -0.877 . . . . 0.0 113.029 -178.633 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -71.78 149.93 55.12 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.463 2.109 . . . . 0.0 113.235 -177.965 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -111.29 127.39 55.61 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.688 179.962 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.743 ' CD2' HD11 ' A' ' 37' ' ' ILE . 55.9 t80 -99.29 105.55 33.49 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.854 179.903 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -75.82 135.29 17.45 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 121.112 1.208 . . . . 0.0 111.255 -179.516 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.402 HD11 HD11 ' A' ' 7' ' ' LEU . 96.5 mt -85.94 58.94 5.33 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.484 -178.528 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 90.8 p -64.17 -34.5 78.21 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.003 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 66.2 mt -75.77 144.94 41.13 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.53 179.423 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.8 m -68.63 -17.09 64.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.873 -178.624 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.483 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 58.1 m -133.22 134.22 43.73 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.666 -0.413 . . . . 0.0 112.024 -179.198 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.5 t -126.23 116.2 20.91 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.64 179.14 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.492 HD21 ' OE1' ' A' ' 47' ' ' GLN . 63.2 tp -113.2 128.9 56.62 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 121.006 -0.277 . . . . 0.0 111.087 -179.486 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.445 ' CE2' HG13 ' A' ' 37' ' ' ILE . 19.3 m-85 -107.1 129.04 54.88 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.783 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 172.46 -175.44 45.6 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.455 179.96 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.623 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 83.8 mtm-85 -80.28 -26.55 38.88 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.98 0.419 . . . . 0.0 110.33 179.363 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -55.44 144.45 33.29 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.132 -178.041 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.498 HG23 ' N ' ' A' ' 34' ' ' GLU . 11.1 tp -64.91 -41.77 93.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.17 0.509 . . . . 0.0 109.634 179.334 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.498 ' N ' HG23 ' A' ' 33' ' ' ILE . 17.3 pt-20 -57.19 -16.74 8.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.331 -179.874 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 45.8 m -66.21 134.01 51.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.204 0.526 . . . . 0.0 111.096 -178.84 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.483 ' OD2' ' O ' ' A' ' 26' ' ' THR . 60.9 m-20 -63.17 -36.34 83.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.316 -179.461 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.743 HD11 ' CD2' ' A' ' 20' ' ' PHE . 49.1 mm -121.14 117.4 52.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.483 177.693 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.43 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 81.4 mtp180 -107.2 134.7 49.91 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 120.374 -0.531 . . . . 0.0 111.018 -179.259 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 85.3 mt -120.92 131.34 73.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 120.126 -0.63 . . . . 0.0 109.711 178.916 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -77.84 24.93 0.21 Allowed 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -177.492 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 32.8 mt -94.23 132.61 28.84 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.973 179.433 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.57 -12.26 29.04 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.121 1.881 . . . . 0.0 113.584 -179.239 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.0 m -97.41 9.53 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 120.034 -0.666 . . . . 0.0 110.787 179.309 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.623 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 33.8 t -94.84 131.79 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 177.918 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.436 ' HB2' ' H ' ' A' ' 48' ' ' HIS . 5.9 m -76.1 173.49 11.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.579 0.704 . . . . 0.0 111.865 -178.755 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -64.75 -38.62 91.6 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.477 -179.862 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.649 ' O ' ' N ' ' A' ' 49' ' ' CYS . 93.8 mm-40 -113.34 -23.52 9.84 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.993 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.436 ' H ' ' HB2' ' A' ' 45' ' ' SER . 12.7 t60 34.26 -77.42 0.0 OUTLIER 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.63 179.978 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.649 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.72 135.74 47.08 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.981 0.42 . . . . 0.0 111.62 -179.385 . . . . . . . . 3 3 . 1 . 091 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -128.82 127.32 41.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.506 179.911 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 85.7 mt -111.6 132.85 59.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.599 -179.451 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -115.59 125.66 53.22 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.434 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.7 mt -107.3 115.13 47.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.029 -179.497 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.466 ' C ' ' N ' ' A' ' 56' ' ' GLN . 94.1 m-70 -112.45 144.75 41.37 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.771 -179.711 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 54' ' ' HIS . 94.9 mt-10 -41.62 -27.52 0.1 Allowed 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.152 -179.908 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.466 ' N ' ' C ' ' A' ' 54' ' ' HIS . 88.1 mt-30 -65.0 -68.89 0.33 Allowed 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.157 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -159.34 -164.9 1.46 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.954 179.489 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -108.97 130.75 55.47 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.608 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.4 mt -121.15 130.53 74.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -177.961 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.405 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 22.7 tp -101.15 126.93 47.9 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.66 179.514 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -109.77 135.71 50.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.697 178.726 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.625 ' C ' HD21 ' A' ' 62' ' ' ASN . 0.2 OUTLIER -98.14 103.71 15.68 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.76 -179.159 . . . . . . . . 3 3 . 1 . 091 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -98.86 -7.24 27.59 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -179.693 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 26.2 t -76.6 99.58 5.05 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.998 179.954 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.7 p -74.95 -38.46 61.72 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.993 0.425 . . . . 0.0 109.902 178.999 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.0 p -67.18 -39.35 86.39 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.538 179.859 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.454 ' O ' ' OG ' ' A' ' 64' ' ' SER . 46.3 m-20 -147.47 97.51 4.04 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.44 -179.277 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.45 ' HA ' HD22 ' A' ' 62' ' ' ASN . 37.3 Cg_exo -56.55 148.11 65.66 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 121.988 1.792 . . . . 0.0 112.574 179.544 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.3 m -74.36 137.43 42.78 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.36 179.718 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -99.03 140.12 33.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.427 179.827 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.517 ' HB ' HD11 ' A' ' 76' ' ' ILE . 25.2 t -130.49 134.69 61.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.65 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 53.12 35.94 21.06 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 120.127 -0.629 . . . . 0.0 109.399 -179.716 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 66.56 30.15 75.96 Favored Glycine 0 CA--C 1.523 0.557 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.204 179.484 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 83.4 p -138.44 125.86 21.84 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.625 -179.141 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.3 p -63.01 140.78 19.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.104 0.478 . . . . 0.0 111.57 -179.657 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.549 ' CG2' ' O ' ' A' ' 78' ' ' GLU . 97.1 mt -116.17 124.27 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.085 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.044 -179.883 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 30.6 p-10 -96.76 -24.58 15.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.974 179.198 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.549 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 2.5 mt-10 -129.54 169.91 12.12 Favored Pre-proline 0 N--CA 1.468 0.451 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.092 -179.055 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -56.8 143.25 91.3 Favored 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 121.994 1.796 . . . . 0.0 112.581 -179.95 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 78.0 t -136.4 138.22 47.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.756 179.975 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 85.4 mtt85 -74.17 134.68 42.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.629 179.199 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.1 mt -86.02 136.61 33.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.388 0.613 . . . . 0.0 111.393 -179.754 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -126.95 151.46 48.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.967 179.764 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.429 ' ND1' ' N ' ' A' ' 99' ' ' ASN . 7.8 t60 -56.58 120.14 7.27 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.963 0.411 . . . . 0.0 111.296 -179.447 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.7 -17.73 30.17 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 179.465 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -71.06 134.54 47.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.943 0.401 . . . . 0.0 110.47 -179.85 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.8 p -106.59 135.93 43.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.825 -178.859 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.9 mt -105.95 131.44 55.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 179.0 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 99.9 m -122.51 127.75 49.93 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -178.314 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.519 ' N ' ' O ' ' A' ' 93' ' ' ARG . 96.9 mt -112.67 132.27 61.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 177.428 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.579 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 2.5 mp -37.74 101.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.777 -178.766 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.579 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 37.5 t0 101.49 -30.94 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.732 0 O-C-N 124.225 0.953 . . . . 0.0 112.496 179.01 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 90' ' ' ILE . 36.0 mmt180 -128.99 143.18 50.79 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.951 -178.647 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.631 ' OG ' HD12 ' A' ' 10' ' ' ILE . 17.1 p -138.26 151.25 47.45 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.474 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -130.76 125.05 32.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.736 -179.351 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.818 ' NH2' HG11 ' A' ' 8' ' ' VAL . 92.8 mtm-85 -84.35 138.39 32.91 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.113 178.869 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -96.2 116.59 29.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.488 -179.392 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -120.64 122.59 40.83 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.777 0.322 . . . . 0.0 110.362 179.743 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.429 ' N ' ' ND1' ' A' ' 84' ' ' HIS . 21.5 t-20 . . . . . 0 C--N 1.327 -0.38 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.372 179.897 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo . . . . . 0 N--CA 1.491 1.334 0 CA-C-O 121.113 0.38 . . . . 0.0 112.803 . . . . . . . . . 0 0 . 1 . 091 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.423 HG13 ' O ' ' B' ' 236' ' ' VAL . 8.9 p -80.44 124.64 38.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.277 179.969 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.608 -179.354 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo . . . . . 0 N--CA 1.489 1.26 0 N-CA-C 111.395 -0.271 . . . . 0.0 111.395 . . . . . . . . . 0 0 . 1 . 091 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 73.8 m -71.35 -45.53 62.71 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.194 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -57.89 -46.72 84.49 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.336 179.588 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.429 HD21 HG23 ' A' ' 91' ' ' ILE . 90.0 mt -64.58 -40.07 94.88 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.667 179.026 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -61.41 -40.81 95.77 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 120.778 0.323 . . . . 0.0 110.686 -179.979 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -60.04 -42.07 93.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.569 179.466 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.538 ' O ' HG23 ' B' ' 249' ' ' VAL . 67.9 ttp85 -59.92 -42.97 95.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.538 179.878 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -62.83 -41.66 99.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.211 -179.225 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 59.5 p -69.53 -41.55 75.83 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.879 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' B' B ' 248' ' ' GLN . . . . . 0.433 ' HB3' ' NH2' ' A' ' 12' ' ' ARG . 67.2 tp60 -60.95 -38.22 85.12 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.424 -179.937 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' B' B ' 249' ' ' VAL . . . . . 0.538 HG23 ' O ' ' B' ' 245' ' ' ARG . 39.3 t . . . . . 0 C--N 1.331 -0.207 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.547 179.543 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.456 ' HB2' HH21 ' A' ' 93' ' ' ARG . 77.2 mt-10 . . . . . 0 C--O 1.226 -0.141 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 . . . . . . . . . 1 1 . 1 . 091 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.479 HD11 ' HD2' ' A' ' 93' ' ' ARG . 83.2 mt -107.59 132.07 56.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.949 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 54.9 t -124.78 132.37 71.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.082 -179.947 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -94.3 118.35 31.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.052 -178.636 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -67.13 -44.8 78.93 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.606 179.276 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' B' B ' 265' ' ' GLN . . . . . 0.658 ' NE2' ' O ' ' B' ' 266' ' ' PRO . 0.0 OUTLIER -87.42 162.12 43.64 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.999 -179.621 . . . . . . . . 3 3 . 1 . 091 nuclear build core ' B' B ' 266' ' ' PRO . . . . . 0.658 ' O ' ' NE2' ' B' ' 265' ' ' GLN . 36.6 Cg_endo -62.15 144.07 95.32 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 121.974 1.783 . . . . 0.0 111.91 -179.85 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' B' B ' 267' ' ' ILE . . . . . 0.488 HG23 ' O ' ' B' ' 267' ' ' ILE . 11.8 tt . . . . . 0 C--N 1.322 -0.589 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.623 -178.925 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.6 m . . . . . 0 N--CA 1.463 0.204 0 N-CA-C 111.426 0.158 . . . . 0.0 111.426 . . . . . . . . . 0 0 . 1 . 092 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.612 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 95.3 mtt-85 -90.97 122.98 34.1 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.457 -179.665 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -133.08 140.21 47.55 Favored 'General case' 0 CA--C 1.522 -0.105 0 CA-C-O 121.246 0.546 . . . . 0.0 112.134 -179.65 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.567 HD11 ' HB3' ' A' ' 95' ' ' PHE . 37.3 tp -114.57 135.81 53.72 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.347 -179.883 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.8 t -111.66 130.1 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 120.683 0.278 . . . . 0.0 110.487 -179.735 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.446 HG23 ' CD1' ' B' ' 261' ' ' ILE . 1.8 m -88.93 118.47 28.67 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -177.837 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.562 HD12 ' OG ' ' A' ' 94' ' ' SER . 97.0 mt -83.32 139.07 18.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.37 178.935 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -88.97 160.46 17.12 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.981 179.275 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.504 ' NE ' ' NH2' ' B' ' 245' ' ' ARG . 84.4 mtp180 -56.3 -30.97 63.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.269 -179.27 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 84.3 p -79.22 -7.27 58.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.424 -179.803 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.61 28.08 22.81 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 -179.817 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.7 t -112.01 133.03 59.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.829 0.347 . . . . 0.0 110.629 -179.625 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -77.02 141.24 40.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.732 179.317 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -133.3 -114.91 1.56 Allowed Glycine 0 CA--C 1.536 1.396 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.64 -179.319 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -74.45 149.56 39.68 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.406 2.071 . . . . 0.0 113.324 -179.171 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -112.52 148.88 33.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.986 179.941 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.575 ' CD2' HD11 ' A' ' 37' ' ' ILE . 22.0 t80 -114.58 105.4 53.62 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.714 179.983 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.17 122.41 8.37 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 C-N-CA 121.123 1.215 . . . . 0.0 110.895 -179.678 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 74.2 mt -78.51 46.11 0.62 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.256 -0.578 . . . . 0.0 110.442 -179.2 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.9 p -59.53 -30.25 68.46 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.333 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.645 HD11 ' HG2' ' B' ' 265' ' ' GLN . 73.3 mt -72.86 142.91 47.96 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.996 179.532 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.5 m -62.94 -22.97 67.15 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.255 -179.382 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 86.3 m -135.43 137.89 42.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.504 -179.606 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.67 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 3.5 t -132.57 123.83 27.23 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.825 0.345 . . . . 0.0 110.266 178.227 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.442 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 41.0 tp -112.72 130.3 56.11 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.957 -179.228 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.724 ' CE2' HD12 ' A' ' 37' ' ' ILE . 6.9 m-85 -108.88 140.03 42.91 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.768 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 167.63 -169.05 40.98 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 118.84 -1.647 . . . . 0.0 113.436 179.203 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.451 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 36.9 ttp-105 -90.77 -28.47 18.23 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 114.53 -0.835 . . . . 0.0 110.537 -179.966 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.08 152.35 49.03 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.517 -179.344 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.635 ' O ' ' NE ' ' A' ' 38' ' ' ARG . 7.0 tp -66.42 -42.28 90.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.449 0.642 . . . . 0.0 110.273 179.506 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.542 ' N ' HG23 ' A' ' 33' ' ' ILE . 79.9 tt0 -54.62 -13.87 1.13 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.874 -178.925 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 83.4 m -67.58 133.32 49.21 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.497 179.801 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.442 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 51.3 m-20 -58.69 -32.34 69.05 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.473 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.724 HD12 ' CE2' ' A' ' 29' ' ' PHE . 92.4 mt -125.33 120.61 58.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 177.228 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.635 ' NE ' ' O ' ' A' ' 33' ' ' ILE . 71.0 mtt85 -107.01 135.84 47.88 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.064 -177.34 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.433 HG22 ' H ' ' A' ' 41' ' ' LEU . 89.4 mt -118.12 133.55 64.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.069 0.461 . . . . 0.0 110.593 179.019 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -75.16 23.42 0.1 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.966 -178.864 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.62 HD21 ' NH1' ' B' ' 245' ' ' ARG . 21.0 mt -92.23 123.77 61.58 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.248 178.831 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -71.99 -8.27 22.61 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 121.821 1.681 . . . . 0.0 112.713 -179.503 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.604 HG12 ' HB2' ' B' ' 235' ' ' PRO . 23.8 m -101.14 7.83 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.58 -179.736 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.451 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 21.0 t -91.12 137.19 22.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 120.394 -0.522 . . . . 0.0 109.838 179.674 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.43 ' O ' HG12 ' A' ' 44' ' ' VAL . 0.4 OUTLIER -65.66 164.78 13.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.167 0.508 . . . . 0.0 111.192 -179.451 . . . . . . . . 3 3 . 1 . 092 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -62.54 -44.53 96.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.221 -178.822 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.644 ' O ' ' N ' ' A' ' 49' ' ' CYS . 83.4 mt-30 -113.8 -20.59 11.06 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 123.526 0.516 . . . . 0.0 110.376 179.092 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.513 ' O ' ' OG ' ' A' ' 64' ' ' SER . 24.5 t60 35.52 -73.27 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 179.846 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.644 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -129.91 134.18 47.32 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -178.381 . . . . . . . . 3 3 . 1 . 092 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -125.74 129.95 50.51 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.41 178.67 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.2 mt -113.9 134.66 56.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.015 -179.421 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -119.08 124.93 48.1 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.917 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 94.2 mt -104.27 114.13 43.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.483 0.659 . . . . 0.0 111.447 -179.326 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.44 ' O ' ' C ' ' A' ' 55' ' ' GLU . 94.8 m-70 -114.26 142.23 46.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.638 -1.165 . . . . 0.0 109.93 -179.681 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 54' ' ' HIS . 97.5 mt-10 -40.11 -31.14 0.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -179.703 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.433 ' N ' ' O ' ' A' ' 54' ' ' HIS . 89.1 mt-30 -62.35 -67.98 0.37 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.491 178.604 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.423 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 4.8 tp10 -159.21 -162.98 1.13 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.902 179.742 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.543 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -114.19 127.24 55.8 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.009 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.6 mt -116.44 130.9 70.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.21 0.529 . . . . 0.0 112.369 -177.952 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 25.6 tp -98.62 130.29 45.15 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.464 179.442 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -116.58 137.52 52.12 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.548 -179.437 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.42 HD22 ' HA ' ' A' ' 68' ' ' PRO . 47.5 t30 -98.88 106.7 19.0 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.935 179.496 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -98.14 -7.24 29.88 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.001 178.453 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.513 ' OG ' ' O ' ' A' ' 48' ' ' HIS . 0.7 OUTLIER -70.29 100.93 1.8 Allowed 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.698 179.456 . . . . . . . . 3 3 . 1 . 092 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.3 m -86.05 -8.7 57.73 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.031 0.443 . . . . 0.0 110.268 179.917 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.764 HG22 HG12 ' B' ' 236' ' ' VAL . 0.2 OUTLIER -99.67 -39.52 8.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.226 179.817 . . . . . . . . 3 3 . 1 . 092 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 67.3 m-20 -142.63 93.79 6.82 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.111 179.569 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.42 ' HA ' HD22 ' A' ' 62' ' ' ASN . 42.4 Cg_exo -55.07 148.59 47.7 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 122.384 2.056 . . . . 0.0 112.13 -179.782 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.65 ' HB ' HD11 ' A' ' 76' ' ' ILE . 33.5 m -73.4 149.64 42.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.301 -179.761 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -114.11 140.56 48.4 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.405 -179.911 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.414 ' O ' ' N ' ' A' ' 74' ' ' SER . 4.2 p -128.78 134.8 63.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.671 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 48.8 30.49 2.68 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.086 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.09 27.9 67.55 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.569 -179.984 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.414 ' N ' ' O ' ' A' ' 71' ' ' VAL . 71.5 m -134.81 134.91 41.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.674 0.273 . . . . 0.0 110.434 179.935 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.5 p -68.51 145.19 13.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -178.748 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.65 HD11 ' HB ' ' A' ' 69' ' ' THR . 3.1 pt -122.36 86.08 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.839 179.801 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 46.4 p-10 -67.21 -21.89 65.74 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.846 0.355 . . . . 0.0 110.406 179.68 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -122.5 170.28 8.24 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.446 179.918 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -62.96 144.53 93.29 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 122.298 1.999 . . . . 0.0 112.21 -179.888 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.9 p -139.28 139.68 39.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.858 -179.831 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -74.71 132.88 42.01 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.791 -0.363 . . . . 0.0 110.449 179.452 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 97.7 mt -83.0 138.48 33.74 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.643 179.925 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -128.47 149.42 50.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.36 179.697 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -54.15 119.71 5.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.057 0.456 . . . . 0.0 111.105 -179.426 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.97 -15.73 36.73 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 179.208 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -70.15 137.56 51.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.836 0.35 . . . . 0.0 110.616 179.821 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.465 HG22 ' HG2' ' A' ' 96' ' ' ARG . 59.0 t -111.08 132.73 58.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.14 -178.728 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.3 mt -100.52 132.22 46.58 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.829 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.2 m -120.7 121.71 38.86 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 119.862 -0.735 . . . . 0.0 112.027 -179.136 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.535 ' N ' ' O ' ' A' ' 93' ' ' ARG . 97.4 mt -108.12 119.63 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 177.74 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.517 HG22 ' N ' ' A' ' 92' ' ' ASP . 91.7 mt 35.16 -96.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.486 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.633 ' OD2' ' NE ' ' B' ' 245' ' ' ARG . 31.5 p-10 -110.1 10.82 23.95 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -178.323 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.535 ' O ' ' N ' ' A' ' 90' ' ' ILE . 80.1 mtt-85 -130.04 145.56 51.67 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.624 -179.785 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.562 ' OG ' HD12 ' A' ' 10' ' ' ILE . 54.3 p -139.72 151.94 46.26 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.389 0.614 . . . . 0.0 110.133 179.392 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.567 ' HB3' HD11 ' A' ' 7' ' ' LEU . 54.8 m-85 -125.38 126.2 44.63 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.953 -179.924 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.465 ' HG2' HG22 ' A' ' 87' ' ' VAL . 99.7 mtt180 -85.57 131.94 34.27 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.971 -179.351 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.612 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 88.4 t80 -100.53 125.54 46.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.916 -179.659 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -145.1 132.79 20.99 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.066 0.46 . . . . 0.0 111.912 -179.961 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.714 179.57 . . . . . . . . 0 0 . 1 . 092 nuclear build core ' B' B ' 235' ' ' PRO . . . . . 0.604 ' HB2' HG12 ' A' ' 43' ' ' VAL . 31.5 Cg_exo . . . . . 0 N--CA 1.497 1.703 0 CA-C-O 120.837 0.265 . . . . 0.0 112.357 . . . . . . . . . 1 1 . 1 . 092 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.764 HG12 HG22 ' A' ' 66' ' ' THR . 12.0 m -101.78 130.21 51.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.836 179.615 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.7 t . . . . . 0 CA--C 1.52 -0.19 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.198 -179.705 . . . . . . . . 0 0 . 1 . 092 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo . . . . . 0 N--CA 1.495 1.575 0 CA-C-O 120.565 0.152 . . . . 0.0 112.243 . . . . . . . . . 0 0 . 1 . 092 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 19.8 m -70.33 -43.14 70.87 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.096 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.496 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 76.8 t80 -57.94 -49.06 78.08 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.801 179.825 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 97.1 mt -63.66 -41.76 98.17 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.569 -179.193 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -65.12 -40.91 95.15 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -178.829 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -61.59 -43.77 98.24 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.183 -179.59 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.633 ' NE ' ' OD2' ' A' ' 92' ' ' ASP . 76.3 mtp85 -65.14 -40.49 94.49 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.765 -179.6 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -61.6 -39.55 91.65 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.008 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 14.4 t -65.14 -43.86 90.53 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.416 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' B' B ' 248' ' ' GLN . . . . . 0.4 ' OE1' ' NH2' ' A' ' 12' ' ' ARG . 55.9 tt0 -61.07 -37.83 84.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.254 179.689 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' B' B ' 249' ' ' VAL . . . . . 0.572 HG23 ' O ' ' B' ' 245' ' ' ARG . 70.5 t . . . . . 0 N--CA 1.453 -0.287 0 C-N-CA 120.526 -0.47 . . . . 0.0 109.833 178.768 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.429 ' HB2' ' NH2' ' A' ' 93' ' ' ARG . 98.3 mt-10 . . . . . 0 CA--C 1.529 0.147 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 . . . . . . . . . 1 1 . 1 . 092 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.446 ' CD1' HG23 ' A' ' 9' ' ' THR . 69.2 mt -108.91 134.69 50.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.848 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 59.1 t -128.88 134.79 63.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.918 0.39 . . . . 0.0 110.621 -179.684 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -97.21 122.08 39.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.661 -178.898 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' B' B ' 264' ' ' LYS . . . . . 0.481 ' HG3' HH22 ' A' ' 38' ' ' ARG . 86.9 tttt -66.81 -44.51 81.01 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.293 179.424 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' B' B ' 265' ' ' GLN . . . . . 0.645 ' HG2' HD11 ' A' ' 24' ' ' LEU . 9.7 mp0 -100.87 160.31 27.1 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.482 -177.935 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -62.3 151.38 82.81 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 123.423 2.748 . . . . 0.0 112.803 -179.336 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 40.8 pt . . . . . 0 C--N 1.33 -0.261 0 CA-C-O 121.844 0.83 . . . . 0.0 112.431 -178.722 . . . . . . . . 0 0 . 1 . 093 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.7 m . . . . . 0 N--CA 1.463 0.192 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 . . . . . . . . . 0 0 . 1 . 093 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.603 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 96.3 mtt-85 -88.12 118.01 27.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.916 0.388 . . . . 0.0 110.743 -178.844 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.413 HH21 ' CE1' ' A' ' 19' ' ' HIS . 75.6 ttt180 -125.99 126.42 44.28 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.288 -179.499 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.627 HD12 ' O ' ' A' ' 96' ' ' ARG . 22.5 tp -109.13 130.98 55.49 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.467 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 76.5 t -106.82 127.46 62.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.355 179.97 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.5 m -80.23 144.75 32.66 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.375 0.607 . . . . 0.0 111.674 -179.047 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.64 HD12 ' OG ' ' A' ' 94' ' ' SER . 98.1 mt -116.1 138.41 46.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.235 178.451 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -91.26 156.36 17.87 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.361 179.013 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.437 ' NH2' ' OE2' ' B' ' 260' ' ' GLU . 89.9 mtm180 -60.02 -28.75 67.99 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.615 -179.852 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 84.0 p -74.3 -14.47 60.9 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.524 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.34 35.42 5.73 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 -179.699 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 49.6 t -120.55 130.95 73.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.747 0.308 . . . . 0.0 111.049 -179.797 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -77.08 138.28 39.44 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.632 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.17 -118.24 2.06 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.936 -179.301 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -69.85 148.07 63.71 Favored 'Trans proline' 0 N--CA 1.501 1.938 0 C-N-CA 122.317 2.011 . . . . 0.0 113.685 -178.468 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.413 ' CE1' HH21 ' A' ' 6' ' ' ARG . 0.9 OUTLIER -111.95 130.27 55.9 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.376 -179.863 . . . . . . . . 3 3 . 1 . 093 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.403 ' CD2' HD11 ' A' ' 37' ' ' ILE . 64.9 t80 -107.02 105.43 55.53 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.15 -179.108 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.05 135.17 22.59 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 120.717 0.944 . . . . 0.0 111.306 -179.9 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 74.9 mt -87.13 48.14 1.61 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.754 -178.899 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.9 m -60.46 -29.91 69.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.91 178.829 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 73.1 mt -71.12 143.42 50.6 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.372 -179.939 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.3 m -58.94 -25.99 64.0 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.918 -179.143 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 78.0 m -138.77 141.17 38.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.182 0.515 . . . . 0.0 111.431 -179.862 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.8 t -130.42 121.85 26.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.694 178.683 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 41.2 tp -117.12 126.61 53.09 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.63 -179.652 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.65 ' CE2' HD12 ' A' ' 37' ' ' ILE . 4.3 m-85 -101.92 125.78 48.68 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.441 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 172.12 178.39 42.33 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 119.75 -1.214 . . . . 0.0 113.016 179.624 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 45.8 mtm180 -73.33 -32.77 64.75 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.771 0.32 . . . . 0.0 111.308 179.01 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -48.9 147.02 5.75 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 -178.967 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.456 ' HA ' HH11 ' A' ' 38' ' ' ARG . 11.0 tp -67.02 -40.66 86.01 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 CA-C-O 121.249 0.547 . . . . 0.0 109.929 179.714 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.446 ' N ' HG23 ' A' ' 33' ' ' ILE . 50.1 tp10 -57.68 -19.83 29.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.387 -179.951 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 76.8 m -59.72 129.95 44.42 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.821 -179.399 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.41 ' O ' ' CB ' ' B' ' 264' ' ' LYS . 66.0 m-20 -61.82 -35.03 77.02 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 -179.589 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.65 HD12 ' CE2' ' A' ' 29' ' ' PHE . 93.6 mt -123.5 118.32 54.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 177.395 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.456 HH11 ' HA ' ' A' ' 33' ' ' ILE . 21.8 mtp85 -104.57 136.22 44.53 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.447 -178.375 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.425 ' C ' ' H ' ' A' ' 41' ' ' LEU . 94.0 mt -117.54 129.85 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 121.036 0.446 . . . . 0.0 110.595 -179.955 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -73.36 28.54 0.07 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.808 -178.42 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.627 ' CD1' ' HE ' ' A' ' 93' ' ' ARG . 49.0 mt -103.14 127.89 28.82 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 120.296 -0.561 . . . . 0.0 110.803 -179.985 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.9 -7.47 20.77 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.129 1.886 . . . . 0.0 112.673 -179.369 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.8 m -98.7 4.73 9.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 120.776 -0.369 . . . . 0.0 111.06 179.941 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.1 t -88.4 134.8 27.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.158 178.434 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.2 m -70.54 168.58 15.99 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.447 0.641 . . . . 0.0 111.93 -179.264 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -62.9 -43.67 98.17 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.285 -178.98 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.623 ' O ' ' N ' ' A' ' 49' ' ' CYS . 97.2 mt-30 -114.24 -25.03 8.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.575 179.472 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.6 t60 37.0 -77.21 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.076 -0.966 . . . . 0.0 113.023 179.064 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.623 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -127.39 132.86 50.07 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.228 0.537 . . . . 0.0 111.775 -178.279 . . . . . . . . 3 3 . 1 . 093 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -128.86 132.47 47.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.07 -179.578 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.1 mt -117.12 132.31 67.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.488 179.488 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -114.73 127.85 55.98 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.79 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.5 mm -100.27 111.81 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-O 121.105 0.479 . . . . 0.0 110.736 -179.22 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.448 ' O ' ' C ' ' A' ' 55' ' ' GLU . 88.6 m-70 -110.64 132.91 53.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.17 179.434 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 54' ' ' HIS . 76.9 tt0 -40.82 -32.17 0.21 Allowed 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.394 -179.945 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.409 ' N ' ' O ' ' A' ' 54' ' ' HIS . 98.4 mm-40 -69.16 -68.48 0.4 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.599 179.171 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -146.13 -178.59 6.21 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.706 0.765 . . . . 0.0 111.939 -178.354 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.55 ' HB2' ' NH2' ' A' ' 5' ' ' ARG . . . -116.16 122.0 43.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.788 178.206 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 94.0 mt -118.85 133.92 64.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.161 0.505 . . . . 0.0 111.825 -178.638 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 22.9 tp -98.25 131.53 44.51 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.718 -179.896 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -114.22 139.49 49.34 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 121.053 0.454 . . . . 0.0 111.448 -178.955 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 59.1 t-20 -98.31 106.12 18.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.822 -179.485 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -98.63 -12.23 21.3 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.728 179.379 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.0 t -70.69 103.43 2.55 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.533 179.892 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.4 p -88.97 -18.73 26.83 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.432 179.695 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.596 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -86.68 -44.27 11.96 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.285 . . . . . . . . 3 3 . 1 . 093 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -137.13 97.9 10.6 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.803 179.425 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -57.09 145.31 86.82 Favored 'Trans proline' 0 N--CA 1.499 1.82 0 C-N-CA 122.173 1.916 . . . . 0.0 113.014 -179.426 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.3 m -73.78 141.69 46.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.64 179.365 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -102.16 147.77 26.22 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.146 -179.637 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.546 ' CG2' ' OD1' ' A' ' 86' ' ' ASP . 4.3 p -128.04 136.04 61.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.88 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 47.75 31.59 2.26 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.226 -0.59 . . . . 0.0 109.653 -179.352 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.66 28.37 61.34 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.669 179.887 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 71' ' ' VAL . 58.3 m -140.35 141.57 35.64 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.192 -179.729 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 71.0 t -68.18 132.37 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.125 0 CA-C-O 121.358 0.599 . . . . 0.0 112.0 -179.131 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.58 100.3 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.72 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -87.07 -13.91 42.94 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.98 -178.717 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -117.02 164.96 16.7 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.967 -179.177 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -60.22 143.58 99.51 Favored 'Trans proline' 0 N--CA 1.501 1.956 0 C-N-CA 121.827 1.684 . . . . 0.0 111.613 -179.775 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.3 p -139.62 139.46 38.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.066 0.46 . . . . 0.0 110.782 -178.856 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -72.08 125.65 27.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.006 179.931 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.3 mt -77.95 137.25 38.22 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.269 0.557 . . . . 0.0 110.889 -179.894 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -134.96 152.8 52.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.993 -179.696 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -57.28 113.3 1.69 Allowed 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.347 -179.745 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.85 1.67 22.59 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 -179.843 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.546 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 67.7 t0 -86.16 122.96 30.9 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.596 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.412 HG22 ' HG2' ' A' ' 96' ' ' ARG . 28.0 t -105.7 134.27 47.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.791 -179.286 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.7 mt -105.26 132.61 51.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 178.453 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 37.4 m -121.02 125.45 47.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.484 0.659 . . . . 0.0 111.866 -178.901 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.401 ' O ' ' C ' ' A' ' 91' ' ' ILE . 84.8 mt -117.01 125.22 73.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.49 179.096 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.452 HG22 ' N ' ' A' ' 92' ' ' ASP . 44.5 mm 40.47 -105.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.586 -179.443 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.459 ' O ' ' OD1' ' A' ' 92' ' ' ASP . 56.5 t0 -114.86 19.55 15.79 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.921 0.391 . . . . 0.0 110.633 -179.679 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.627 ' HE ' ' CD1' ' A' ' 41' ' ' LEU . 73.7 mtt-85 -129.32 145.49 51.37 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 -179.856 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.64 ' OG ' HD12 ' A' ' 10' ' ' ILE . 11.4 p -140.94 157.4 45.41 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.241 -179.834 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.592 ' HB3' HD11 ' A' ' 7' ' ' LEU . 92.3 m-85 -131.09 124.96 31.92 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.055 -179.772 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.627 ' O ' HD12 ' A' ' 7' ' ' LEU . 99.8 mtt180 -90.82 136.31 33.16 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.531 -179.707 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.603 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 72.2 t80 -100.16 124.55 45.71 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.833 -179.574 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -141.13 132.08 26.06 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 121.256 0.55 . . . . 0.0 111.829 -179.908 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.435 ' ND2' ' OH ' ' A' ' 97' ' ' TYR . 97.9 m-20 . . . . . 0 C--N 1.327 -0.409 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.393 178.413 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo . . . . . 0 N--CA 1.484 0.917 0 CA-C-O 121.033 0.347 . . . . 0.0 111.722 . . . . . . . . . 0 0 . 1 . 093 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.596 ' CG2' HG22 ' A' ' 66' ' ' THR . 25.6 t -113.36 134.1 57.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.787 -178.958 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 44.6 t . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.634 -179.905 . . . . . . . . 0 0 . 1 . 093 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo . . . . . 0 N--CA 1.496 1.643 0 N-CA-C 112.711 0.235 . . . . 0.0 112.711 . . . . . . . . . 0 0 . 1 . 093 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 71.6 m -73.67 -42.91 60.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.239 0.543 . . . . 0.0 109.757 178.008 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -57.0 -47.02 81.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.981 -179.186 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 89.2 mt -63.42 -40.06 96.16 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.66 -179.998 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.7 -40.5 96.95 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.742 -179.948 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -63.44 -42.53 98.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.227 0.537 . . . . 0.0 110.374 179.309 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.527 ' O ' HG23 ' B' ' 249' ' ' VAL . 21.9 mmt180 -59.36 -41.53 89.46 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.404 -179.125 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -65.35 -40.54 93.74 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.112 -0.635 . . . . 0.0 109.997 178.038 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 48.7 m -61.36 -46.82 88.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.261 178.703 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -62.56 -36.01 81.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.117 -179.724 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' B' B ' 249' ' ' VAL . . . . . 0.527 HG23 ' O ' ' B' ' 245' ' ' ARG . 33.2 t . . . . . 0 C--N 1.329 -0.301 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.92 -179.928 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.457 ' HB2' ' CZ ' ' A' ' 93' ' ' ARG . 53.3 mp0 . . . . . 0 N--CA 1.47 0.542 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 . . . . . . . . . 1 1 . 1 . 093 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.585 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 84.3 mt -110.18 133.26 56.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.927 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 55.3 t -127.31 131.13 70.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.444 0.64 . . . . 0.0 110.914 -179.347 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -93.61 122.73 36.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.219 -0.901 . . . . 0.0 112.165 -178.804 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' B' B ' 264' ' ' LYS . . . . . 0.41 ' CB ' ' O ' ' A' ' 36' ' ' ASP . 88.1 tttt -65.78 -46.74 77.59 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.306 179.929 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.98 160.99 45.3 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.285 -179.365 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -59.8 140.58 93.94 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.363 2.042 . . . . 0.0 111.905 179.278 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 3.4 tt . . . . . 0 C--N 1.321 -0.639 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.881 179.908 . . . . . . . . 0 0 . 1 . 094 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.498 ' O ' ' O ' ' A' ' 99' ' ' ASN . 1.8 t . . . . . 0 N--CA 1.471 0.594 0 CA-C-O 121.027 0.442 . . . . 0.0 110.281 . . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.484 ' HG3' HG23 ' A' ' 4' ' ' THR . 80.4 mtt85 -86.22 124.58 32.77 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.76 -179.526 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -133.6 141.31 47.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.244 0.545 . . . . 0.0 111.773 -179.228 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.57 HD11 ' HB3' ' A' ' 95' ' ' PHE . 42.8 tp -117.34 130.71 56.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.053 179.014 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 63.8 t -108.96 132.7 56.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.754 -179.226 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.519 ' CG2' HD12 ' B' ' 261' ' ' ILE . 23.0 m -92.35 111.59 23.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.795 -178.874 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.419 HD11 ' HG3' ' A' ' 96' ' ' ARG . 86.7 mt -78.69 147.89 6.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.373 179.142 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -92.12 158.34 16.24 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.329 178.101 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.447 ' NH1' HH11 ' B' ' 245' ' ' ARG . 87.9 mtm180 -57.85 -26.43 62.05 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.266 -178.492 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 97.9 p -80.61 -11.76 59.6 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 120.324 -0.551 . . . . 0.0 111.049 -179.876 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.98 24.22 13.43 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.409 178.777 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.4 m -116.89 136.56 53.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.281 179.037 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -65.91 126.41 28.43 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.423 -179.984 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -113.0 -128.64 4.95 Favored Glycine 0 CA--C 1.535 1.336 0 N-CA-C 111.381 -0.687 . . . . 0.0 111.381 -179.255 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -74.13 150.63 43.03 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 121.979 1.786 . . . . 0.0 111.951 -179.445 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -108.18 162.68 13.85 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.156 0.503 . . . . 0.0 110.604 -179.654 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -129.51 88.93 48.64 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.403 -179.051 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -61.44 131.08 34.38 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.464 2.109 . . . . 0.0 110.993 179.106 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 22' ' ' LEU . 87.7 mt -98.68 121.44 40.63 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 119.819 -0.752 . . . . 0.0 111.355 -178.559 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 82.8 p -114.84 -28.34 7.1 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.562 178.66 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.7 mt -78.59 145.74 34.58 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.856 -1.066 . . . . 0.0 109.952 179.799 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 57.1 m -71.65 -8.27 53.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 0.0 112.216 -178.558 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.5 m -135.59 135.84 40.59 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.331 -179.687 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.5 t -126.4 117.1 22.24 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.227 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.405 HD12 ' O ' ' A' ' 49' ' ' CYS . 55.0 tp -113.65 131.97 55.94 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.249 -178.362 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.676 ' CE2' HD12 ' A' ' 37' ' ' ILE . 4.9 m-85 -110.89 134.02 52.89 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.95 -179.655 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.29 -172.12 38.32 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 119.963 -1.113 . . . . 0.0 112.468 178.687 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.663 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 82.2 mtm-85 -83.28 -32.53 26.33 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.644 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -49.8 149.91 5.2 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -178.86 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.559 ' O ' ' NH2' ' A' ' 38' ' ' ARG . 36.5 mm -64.03 -43.28 97.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.33 -179.823 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -53.68 -21.61 7.35 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.943 -179.234 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 71.5 m -56.6 118.52 4.93 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.717 -179.695 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -57.13 -31.05 64.95 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.864 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.676 HD12 ' CE2' ' A' ' 29' ' ' PHE . 96.3 mt -123.56 117.08 50.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 176.734 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.559 ' NH2' ' O ' ' A' ' 33' ' ' ILE . 72.0 mtt85 -102.91 134.33 46.52 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.571 -177.928 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.664 HG21 HD12 ' A' ' 41' ' ' LEU . 78.7 mt -118.74 131.22 72.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.2 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -80.71 24.66 0.47 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.084 -178.652 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.664 HD12 HG21 ' A' ' 39' ' ' ILE . 27.8 mt -89.61 126.51 57.78 Favored Pre-proline 0 C--N 1.323 -0.579 0 C-N-CA 120.377 -0.529 . . . . 0.0 109.595 179.953 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -68.77 -13.0 36.05 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.258 1.972 . . . . 0.0 113.668 -179.158 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.462 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 2.9 m -99.83 6.47 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.925 179.969 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.663 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 24.1 t -90.52 132.1 36.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.988 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.506 ' OG ' ' N ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -64.79 169.38 5.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.219 0.533 . . . . 0.0 111.375 -178.674 . . . . . . . . 3 3 . 1 . 094 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -62.64 -44.88 95.16 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.292 -179.366 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.651 ' O ' ' N ' ' A' ' 49' ' ' CYS . 96.2 mt-30 -113.21 -13.05 13.02 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.424 178.983 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.506 ' N ' ' OG ' ' A' ' 45' ' ' SER . 14.7 t60 34.2 -75.97 0.0 OUTLIER 'General case' 0 C--O 1.235 0.29 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 179.066 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.651 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.81 136.74 47.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.173 0.511 . . . . 0.0 112.003 -178.773 . . . . . . . . 3 3 . 1 . 094 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -126.38 127.08 44.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.205 179.655 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 92.3 mt -110.85 134.07 54.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.313 -179.113 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -116.5 121.46 41.88 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.718 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.431 HD13 ' HD3' ' A' ' 5' ' ' ARG . 96.5 mt -107.15 112.57 40.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.139 -0.624 . . . . 0.0 111.653 -179.571 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.44 ' O ' ' C ' ' A' ' 55' ' ' GLU . 96.2 m-70 -111.52 144.66 40.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.847 179.936 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.2 tt0 -40.85 -32.26 0.21 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.308 -0.626 . . . . 0.0 109.308 -179.944 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.425 ' N ' ' C ' ' A' ' 54' ' ' HIS . 98.1 mt-30 -63.8 -68.15 0.37 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.452 178.805 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.438 ' CD ' ' CD ' ' A' ' 81' ' ' ARG . 14.7 pt-20 -157.4 -171.82 3.75 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.484 -178.626 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.26 123.33 49.09 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.679 179.51 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 84.2 mt -114.73 128.08 71.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 120.345 -0.542 . . . . 0.0 112.343 -178.93 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.556 ' HB2' HD11 ' A' ' 82' ' ' LEU . 47.3 tp -93.85 127.49 39.62 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.352 179.517 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -115.04 135.41 54.25 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 178.795 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -101.65 112.13 24.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.182 0.515 . . . . 0.0 111.576 -179.369 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -102.44 -7.08 22.25 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.749 179.784 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.36 100.7 3.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.368 179.899 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.2 m -84.98 -9.2 58.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.941 0.4 . . . . 0.0 109.928 179.678 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.92 -39.02 9.59 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.26 179.895 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -149.19 98.32 3.52 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.344 179.987 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -56.04 147.36 64.53 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 122.36 2.04 . . . . 0.0 112.713 179.968 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 38.1 m -69.64 138.78 53.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.088 178.872 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 89' ' ' THR . 83.7 mt-30 -101.02 139.67 36.39 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.161 179.795 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.437 HG22 HD13 ' A' ' 88' ' ' ILE . 18.2 t -131.36 135.97 58.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.356 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 28.4 m120 53.86 34.59 19.67 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.949 -179.733 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.23 30.38 71.72 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.031 179.251 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 41.0 m -143.63 134.88 25.83 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 117.105 0.453 . . . . 0.0 111.054 -179.907 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.4 ' H ' HG12 ' A' ' 75' ' ' VAL . 0.1 OUTLIER -68.99 137.77 23.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.505 179.897 . . . . . . . . 3 3 . 1 . 094 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.573 ' CG2' ' O ' ' A' ' 78' ' ' GLU . 97.2 mt -102.65 105.16 17.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.888 -179.634 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -67.55 -40.87 84.95 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.849 178.751 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.573 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 1.9 mt-10 -127.64 170.91 9.21 Favored Pre-proline 0 N--CA 1.469 0.482 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.147 -178.514 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -59.54 148.71 86.06 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.181 1.921 . . . . 0.0 112.133 179.983 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.7 m -147.39 148.84 16.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.179 0.514 . . . . 0.0 111.869 179.708 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.438 ' CD ' ' CD ' ' A' ' 57' ' ' GLU . 61.4 ttp180 -72.81 128.86 36.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.518 179.779 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.556 HD11 ' HB2' ' A' ' 60' ' ' LEU . 94.9 mt -85.32 135.94 33.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.142 0.496 . . . . 0.0 110.94 179.712 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -119.94 148.93 42.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.79 179.561 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 9.1 t-80 -51.41 123.16 9.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.673 -179.396 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.69 -14.95 49.64 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 179.878 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -67.12 139.09 57.5 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.4 -0.52 . . . . 0.0 109.639 179.507 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.427 HG22 ' HG2' ' A' ' 96' ' ' ARG . 72.6 t -109.99 134.22 52.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.394 -178.195 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.437 HD13 HG22 ' A' ' 71' ' ' VAL . 30.5 mm -90.71 127.28 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 177.492 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.509 ' N ' ' O ' ' A' ' 70' ' ' GLN . 31.6 m -119.74 123.36 43.55 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.467 0.651 . . . . 0.0 111.148 -178.652 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 92' ' ' ASP . 89.2 mt -118.08 126.03 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.314 179.5 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.501 HG22 ' N ' ' A' ' 92' ' ' ASP . 87.9 mt 37.1 -95.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.056 -179.956 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.501 ' N ' HG22 ' A' ' 91' ' ' ILE . 54.2 t0 -119.62 14.38 12.66 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.917 0.389 . . . . 0.0 111.453 -179.356 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.526 ' NE ' HD11 ' B' ' 261' ' ' ILE . 2.2 tpp180 -128.48 142.25 51.14 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.286 -179.555 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.0 m -133.45 150.08 51.76 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.428 0.632 . . . . 0.0 111.362 -179.847 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.57 ' HB3' HD11 ' A' ' 7' ' ' LEU . 89.1 m-85 -121.58 123.24 41.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.422 -0.808 . . . . 0.0 108.907 178.895 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.528 ' O ' HD12 ' A' ' 7' ' ' LEU . 99.7 mtt180 -81.33 126.68 31.88 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.52 -179.725 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.572 ' CE2' ' OD1' ' A' ' 99' ' ' ASN . 76.8 t80 -95.6 123.48 39.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.11 -179.193 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -126.24 115.88 20.41 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.118 179.061 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.572 ' OD1' ' CE2' ' A' ' 97' ' ' TYR . 86.1 m-20 . . . . . 0 C--N 1.327 -0.401 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.94 -179.643 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo . . . . . 0 N--CA 1.482 0.836 0 CA-C-O 121.02 0.342 . . . . 0.0 111.715 . . . . . . . . . 0 0 . 1 . 094 nuclear build core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 3.1 p -112.29 133.42 58.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.861 -179.498 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 5.6 t . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.892 179.834 . . . . . . . . 0 0 . 1 . 094 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo . . . . . 0 N--CA 1.492 1.409 0 CA-C-O 120.529 0.137 . . . . 0.0 111.989 . . . . . . . . . 0 0 . 1 . 094 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 4.6 p -75.93 -38.9 57.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 177.908 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.462 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 74.8 t80 -57.71 -46.61 84.14 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.837 -179.466 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' B' ' 242' ' ' LEU . 92.5 mt -64.67 -40.85 96.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.163 179.711 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -61.87 -43.48 98.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.379 179.565 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 63.4 ttm-85 -63.71 -42.96 97.89 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.366 179.431 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.618 ' O ' HG23 ' B' ' 249' ' ' VAL . 12.4 tpp180 -61.99 -44.6 96.4 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.117 -179.617 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -64.63 -38.97 92.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.453 178.712 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 69.7 p -68.22 -43.76 77.27 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.253 0.549 . . . . 0.0 109.795 179.057 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -58.76 -37.88 77.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.325 179.824 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' B' B ' 249' ' ' VAL . . . . . 0.618 HG23 ' O ' ' B' ' 245' ' ' ARG . 77.0 t . . . . . 0 C--N 1.327 -0.406 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.909 179.934 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.441 ' HB2' HH22 ' A' ' 93' ' ' ARG . 90.6 mt-10 . . . . . 0 CA--C 1.529 0.15 0 CA-C-O 120.606 0.241 . . . . 0.0 111.026 . . . . . . . . . 1 1 . 1 . 094 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.526 HD11 ' NE ' ' A' ' 93' ' ' ARG . 60.9 mt -106.62 137.24 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.877 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 69.8 t -127.54 134.48 65.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.031 -179.548 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -94.94 119.16 33.01 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.986 -177.367 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' B' B ' 264' ' ' LYS . . . . . 0.494 ' HG3' HH22 ' A' ' 38' ' ' ARG . 88.5 tttt -68.48 -44.63 74.35 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.252 179.612 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.69 156.98 49.9 Favored Pre-proline 0 C--O 1.236 0.353 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.374 -179.43 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -62.26 144.6 95.64 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.935 2.423 . . . . 0.0 112.713 -179.563 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 47.2 pt . . . . . 0 N--CA 1.455 -0.204 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.572 178.673 . . . . . . . . 0 0 . 1 . 095 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.5 p . . . . . 0 C--O 1.231 0.095 0 CA-C-O 121.02 0.438 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 095 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.505 ' NH2' HG21 ' A' ' 53' ' ' ILE . 76.5 mtm-85 -88.58 125.05 34.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.315 -178.95 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -130.91 144.43 51.46 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.216 179.35 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.965 HD11 HD11 ' A' ' 22' ' ' LEU . 69.7 mt -117.24 141.12 48.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.442 179.761 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.5 t -113.37 127.61 70.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.784 179.652 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.421 ' CG2' HD12 ' B' ' 261' ' ' ILE . 4.9 m -82.76 135.14 35.07 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.233 -178.29 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.515 HD12 ' HB3' ' A' ' 94' ' ' SER . 98.9 mt -105.65 137.04 37.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.348 178.368 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.6 mttm -89.69 161.03 16.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.042 0.449 . . . . 0.0 110.348 179.389 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.507 ' CD ' HH11 ' B' ' 245' ' ' ARG . 87.7 mtm180 -54.55 -27.13 36.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.198 -179.018 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.4 m -82.71 -5.1 58.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.197 179.443 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.39 35.3 14.66 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 179.519 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.1 t -115.51 135.36 55.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.773 0.321 . . . . 0.0 110.474 -179.995 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -78.45 132.6 37.36 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.203 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -126.55 -114.95 1.94 Allowed Glycine 0 CA--C 1.537 1.416 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.967 -179.139 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -71.9 144.49 43.34 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 122.338 2.025 . . . . 0.0 112.631 -178.97 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.43 ' O ' HD11 ' B' ' 267' ' ' ILE . 0.2 OUTLIER -106.54 132.66 52.28 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.984 0.421 . . . . 0.0 110.701 -179.746 . . . . . . . . 3 3 . 1 . 095 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.685 ' CD2' HD11 ' A' ' 37' ' ' ILE . 56.0 t80 -101.18 102.35 20.31 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.44 -179.41 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -76.22 129.92 11.66 Favored 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 121.67 1.58 . . . . 0.0 111.789 -179.75 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.965 HD11 HD11 ' A' ' 7' ' ' LEU . 89.8 mt -87.41 80.28 8.18 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.165 -179.07 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.6 p -84.73 -9.92 57.75 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.437 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 66.6 mt -100.16 143.23 30.61 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.96 -179.676 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 93.1 p -65.56 -15.91 63.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.131 -178.642 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.488 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 33.4 m -130.13 130.74 45.17 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.864 -179.407 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.618 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 2.2 t -124.9 118.85 27.21 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.979 178.921 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.483 HD12 ' O ' ' A' ' 49' ' ' CYS . 54.8 tp -120.01 131.86 55.28 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.509 -178.142 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.618 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 54.8 m-85 -108.45 143.13 37.81 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.289 179.689 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 156.29 -151.04 22.51 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 179.156 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.666 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 84.2 mtm-85 -108.89 -23.45 11.72 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.634 179.326 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.469 ' N ' ' SG ' ' A' ' 35' ' ' CYS . . . -55.49 156.86 8.79 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 121.281 -0.485 . . . . 0.0 112.206 -178.584 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.506 HG23 ' N ' ' A' ' 34' ' ' GLU . 11.0 tp -65.69 -41.93 91.55 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 CA-C-O 120.986 0.422 . . . . 0.0 110.061 179.606 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.506 ' N ' HG23 ' A' ' 33' ' ' ILE . 96.4 mt-10 -60.11 -28.46 67.88 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.803 179.873 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.534 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 9.3 m -53.13 115.46 1.89 Allowed 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.071 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.488 ' OD2' ' O ' ' A' ' 26' ' ' THR . 99.5 m-20 -60.74 -26.71 67.39 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -179.245 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.685 HD11 ' CD2' ' A' ' 20' ' ' PHE . 47.5 mm -123.24 112.37 33.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.67 177.516 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -105.0 137.65 42.42 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.773 -179.832 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.489 ' CG2' HD12 ' A' ' 41' ' ' LEU . 98.2 mt -121.76 132.85 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.138 179.058 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -79.33 34.26 0.25 Allowed 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -177.588 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.582 ' CD1' ' HE ' ' A' ' 93' ' ' ARG . 9.7 mt -113.59 137.61 22.25 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.553 178.9 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.09 -10.79 29.1 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.836 2.358 . . . . 0.0 113.93 -178.138 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.435 HG21 ' CE2' ' B' ' 241' ' ' PHE . 27.4 m -95.51 3.34 9.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.223 -0.591 . . . . 0.0 111.206 -179.993 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.666 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 37.3 t -94.5 130.19 43.69 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.717 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.9 m -70.97 163.47 27.46 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -177.796 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.534 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 54.8 mttp -62.75 -41.62 99.29 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.486 -179.048 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.633 ' O ' ' N ' ' A' ' 49' ' ' CYS . 10.8 mm100 -113.98 -24.63 8.95 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.239 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 24.5 t60 35.26 -74.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 178.944 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.633 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.79 138.64 45.83 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -177.993 . . . . . . . . 3 3 . 1 . 095 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -128.6 127.83 43.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.789 179.817 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.8 mt -115.42 134.22 59.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.516 179.244 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -114.17 137.84 51.23 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.449 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.505 HG21 ' NH2' ' A' ' 5' ' ' ARG . 39.5 mm -98.15 120.01 46.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.307 0.575 . . . . 0.0 110.679 -179.367 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.454 ' O ' ' C ' ' A' ' 55' ' ' GLU . 38.0 m-70 -120.78 131.35 54.43 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.303 179.452 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 54' ' ' HIS . 99.5 mt-10 -40.07 -34.46 0.3 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -179.774 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -62.75 -66.85 0.48 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.845 -1.071 . . . . 0.0 108.953 178.358 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -160.05 -159.14 0.69 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.426 178.854 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.669 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -113.62 131.03 56.28 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.814 -0.355 . . . . 0.0 110.362 -179.938 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 37.6 mm -108.64 123.5 64.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.004 -179.25 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.413 HD22 ' CD1' ' A' ' 88' ' ' ILE . 38.9 tp -95.77 124.01 39.6 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.149 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -113.01 134.17 54.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.259 -179.547 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -95.33 104.65 16.55 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.951 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -99.26 -7.51 26.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.957 178.838 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.9 t -78.08 98.94 5.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.133 -179.175 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.8 m -77.64 -37.49 49.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.127 0.489 . . . . 0.0 109.955 178.599 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.56 -40.45 80.61 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.458 -179.705 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -146.68 96.98 4.33 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.963 -179.286 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -56.36 148.28 62.75 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.455 2.104 . . . . 0.0 112.467 179.505 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.4 m -74.68 143.06 44.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.313 -179.764 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -104.12 140.39 37.86 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.225 179.385 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.9 t -130.08 135.77 60.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.024 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 52.98 37.14 23.83 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.38 -179.898 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.29 29.53 74.4 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.095 179.204 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.3 t -144.94 136.05 24.94 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.481 -179.983 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.1 p -72.2 138.59 21.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.16 -179.256 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.894 HD13 ' O ' ' A' ' 76' ' ' ILE . 0.0 OUTLIER -133.6 126.76 52.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.96 179.289 . . . . . . . . 3 3 . 1 . 095 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -99.4 -9.76 23.07 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.658 -179.308 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.788 ' O ' HD11 ' A' ' 76' ' ' ILE . 1.2 pm0 -118.47 161.05 37.37 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 120.776 -0.37 . . . . 0.0 111.035 -179.18 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -57.54 143.77 93.8 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 121.613 1.542 . . . . 0.0 111.859 179.696 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.409 HG13 ' HB3' ' A' ' 60' ' ' LEU . 2.8 p -139.63 141.61 34.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.353 -179.462 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -78.39 134.12 37.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.394 -179.867 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.669 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 91.1 mt -93.46 139.36 30.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.241 0.543 . . . . 0.0 111.622 -179.269 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -126.06 155.93 40.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.997 179.765 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.423 ' ND1' ' N ' ' A' ' 99' ' ' ASN . 8.4 t60 -55.83 118.55 4.68 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.9 0.381 . . . . 0.0 110.235 -179.523 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.82 -17.1 27.9 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 -179.704 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -68.14 137.47 54.92 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.224 179.968 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.55 ' CG2' ' OG ' ' A' ' 94' ' ' SER . 7.7 p -111.55 134.18 54.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.061 0.457 . . . . 0.0 112.031 -178.557 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.413 ' CD1' HD22 ' A' ' 60' ' ' LEU . 47.5 mm -93.81 128.02 45.46 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.093 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 178.069 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 47.9 m -126.57 126.68 44.05 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -178.001 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.459 ' O ' ' C ' ' A' ' 91' ' ' ILE . 86.4 mt -116.07 126.63 73.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 114.225 -1.352 . . . . 0.0 108.259 178.57 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.476 HG22 ' N ' ' A' ' 92' ' ' ASP . 94.6 mt 35.71 -96.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 121.024 -0.271 . . . . 0.0 110.922 -179.593 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.476 ' N ' HG22 ' A' ' 91' ' ' ILE . 26.5 m-20 -120.11 17.28 12.43 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.86 0.362 . . . . 0.0 111.432 179.802 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.79 HH21 ' NH2' ' B' ' 245' ' ' ARG . 0.6 OUTLIER -124.71 138.22 54.3 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.845 . . . . . . . . 3 3 . 1 . 095 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.55 ' OG ' ' CG2' ' A' ' 87' ' ' VAL . 8.1 t -139.97 151.1 45.25 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 119.826 -0.75 . . . . 0.0 111.751 -179.055 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -122.69 122.51 38.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.561 178.734 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -87.2 134.12 33.57 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.315 -178.865 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -97.59 125.8 42.53 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.518 179.79 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -143.72 130.07 19.91 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.779 -179.908 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.423 ' N ' ' ND1' ' A' ' 84' ' ' HIS . 84.7 m-20 . . . . . 0 C--N 1.332 -0.18 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.411 179.112 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo . . . . . 0 N--CA 1.488 1.155 0 CA-C-O 121.082 0.367 . . . . 0.0 111.969 . . . . . . . . . 0 0 . 1 . 095 nuclear build core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 24.8 t -59.6 137.53 21.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.006 179.441 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.9 t . . . . . 0 C--N 1.325 -0.465 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.169 -179.324 . . . . . . . . 0 0 . 1 . 095 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo . . . . . 0 N--CA 1.492 1.433 0 N-CA-C 111.519 -0.224 . . . . 0.0 111.519 . . . . . . . . . 0 0 . 1 . 095 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 97.0 m -71.03 -45.35 64.05 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.967 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.435 ' CE2' HG21 ' A' ' 43' ' ' VAL . 89.6 t80 -58.38 -46.8 85.64 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.754 -179.601 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 92.6 mt -64.04 -42.1 97.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.878 -179.577 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -63.3 -43.21 98.51 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 120.871 -0.331 . . . . 0.0 111.076 -179.402 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -63.0 -40.11 96.79 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.699 179.8 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.79 ' NH2' HH21 ' A' ' 93' ' ' ARG . 61.2 ttm-85 -61.76 -44.54 96.69 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.084 179.574 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -62.52 -41.53 98.92 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.469 -179.618 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 57.9 m -66.97 -46.03 75.89 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.291 0.567 . . . . 0.0 110.521 179.122 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -62.92 -33.56 75.59 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.447 -179.46 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' B' B ' 249' ' ' VAL . . . . . 0.729 HG23 ' O ' ' B' ' 245' ' ' ARG . 61.4 t . . . . . 0 CA--C 1.532 0.259 0 CA-C-O 121.19 0.519 . . . . 0.0 111.55 179.867 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.55 ' N ' ' OE1' ' B' ' 260' ' ' GLU . 57.4 mp0 . . . . . 0 N--CA 1.461 0.109 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 . . . . . . . . . 1 1 . 1 . 095 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.421 HD12 ' CG2' ' A' ' 9' ' ' THR . 66.4 mt -106.01 134.35 47.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 178.123 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 72.0 t -123.71 132.27 71.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.26 0.552 . . . . 0.0 110.238 -178.812 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -95.18 117.4 30.18 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.543 -177.869 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' B' B ' 264' ' ' LYS . . . . . 0.427 ' NZ ' ' HA ' ' A' ' 34' ' ' GLU . 88.5 tttt -65.17 -45.77 83.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.572 179.745 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.26 158.9 71.34 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.144 -179.819 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -60.1 140.59 93.2 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 C-N-CA 122.237 1.958 . . . . 0.0 111.733 179.499 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' B' B ' 267' ' ' ILE . . . . . 0.469 HG23 ' O ' ' B' ' 267' ' ' ILE . 13.8 tt . . . . . 0 C--N 1.326 -0.414 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.156 -179.541 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.6 m . . . . . 0 C--O 1.231 0.107 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 . . . . . . . . . 0 0 . 1 . 096 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.546 ' NH2' HG21 ' A' ' 53' ' ' ILE . 88.1 mtm-85 -94.87 131.57 40.62 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.936 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -142.86 151.54 41.18 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 119.958 -0.697 . . . . 0.0 112.305 179.933 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 80.3 mt -115.25 131.52 56.9 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.14 178.653 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 73.0 t -103.65 128.21 57.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.942 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.553 HG23 ' CD1' ' B' ' 261' ' ' ILE . 2.7 m -87.82 120.9 29.6 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -177.377 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 91.1 mt -82.18 134.92 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.659 178.462 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -88.37 160.73 17.46 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.4 0.619 . . . . 0.0 111.394 179.365 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.67 ' CG ' HH12 ' A' ' 93' ' ' ARG . 76.7 mtp180 -53.9 -40.98 67.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.921 -178.759 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.5 t -72.2 -11.11 60.58 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.024 179.892 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.25 35.31 5.3 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 -179.513 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.7 t -123.66 135.96 61.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.103 0.478 . . . . 0.0 111.914 -179.474 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -70.07 136.43 50.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.809 179.504 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -122.0 -125.34 3.11 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.919 -179.332 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.65 150.26 56.45 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 122.051 1.834 . . . . 0.0 113.222 -178.469 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 53.3 m170 -110.28 132.91 53.76 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.52 -179.251 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.444 ' CD2' HD11 ' A' ' 37' ' ' ILE . 25.1 t80 -102.12 100.73 15.99 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.301 -179.506 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -73.37 127.69 12.11 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 C-N-CA 121.421 1.414 . . . . 0.0 110.855 179.979 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 99.3 mt -79.99 55.58 2.16 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.816 -0.353 . . . . 0.0 111.886 -178.345 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 87.1 p -67.13 -22.21 65.8 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.508 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.649 HD11 ' HG2' ' B' ' 265' ' ' GLN . 69.9 mt -83.52 139.8 32.67 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.563 179.573 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.9 m -67.42 -18.6 65.17 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.429 -178.965 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 36.4 m -129.23 130.91 46.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.238 0.542 . . . . 0.0 111.918 -179.717 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.671 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.7 OUTLIER -125.62 118.33 25.45 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.65 178.735 . . . . . . . . 3 3 . 1 . 096 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.519 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 56.0 tp -119.79 125.69 49.21 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.522 -178.424 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.671 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 48.2 m-85 -101.76 128.07 48.26 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.492 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 177.5 -176.84 48.23 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.282 -0.961 . . . . 0.0 111.762 179.101 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.662 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 84.6 mtm-85 -82.39 -28.07 31.68 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.12 0.486 . . . . 0.0 110.242 179.75 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.61 155.02 41.63 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.282 -178.368 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.443 HD12 ' HD3' ' A' ' 38' ' ' ARG . 9.1 tp -65.98 -39.38 84.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.489 -0.355 . . . . 0.0 110.56 179.23 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.413 ' N ' HG23 ' A' ' 33' ' ' ILE . 71.0 mm-40 -55.17 -21.61 14.2 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.659 -179.795 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.8 m -64.03 119.86 10.93 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.088 -179.982 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.585 ' OD2' ' SG ' ' A' ' 27' ' ' CYS . 28.2 p-10 -54.26 -26.12 27.19 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.385 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.603 HD12 ' CE2' ' A' ' 29' ' ' PHE . 94.9 mt -130.59 123.61 55.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.29 -0.868 . . . . 0.0 108.879 178.043 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.443 ' HD3' HD12 ' A' ' 33' ' ' ILE . 20.9 mtm180 -109.3 137.63 46.88 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.761 -179.099 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 92.8 mt -118.65 131.62 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.936 179.293 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -77.89 31.64 0.17 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -177.877 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.568 HD21 ' OE1' ' B' ' 260' ' ' GLU . 34.7 mt -102.88 130.64 23.37 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.742 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.53 -6.09 18.17 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 121.909 1.739 . . . . 0.0 112.534 -179.459 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.458 HG21 ' CE2' ' B' ' 241' ' ' PHE . 4.9 m -101.39 3.74 10.59 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.501 -179.686 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.662 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 34.3 t -90.57 133.48 32.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.632 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.453 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 0.6 OUTLIER -69.74 170.22 11.39 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.779 0.799 . . . . 0.0 112.753 -177.5 . . . . . . . . 3 3 . 1 . 096 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -64.04 -43.83 94.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.512 -179.324 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.636 ' O ' ' N ' ' A' ' 49' ' ' CYS . 90.5 mm-40 -111.69 -17.39 13.01 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.299 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.453 ' H ' ' HB3' ' A' ' 45' ' ' SER . 13.4 t60 32.56 -78.11 0.0 OUTLIER 'General case' 0 C--O 1.238 0.492 0 CA-C-N 114.686 -1.143 . . . . 0.0 112.985 179.765 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.636 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.66 135.97 46.16 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.482 -179.003 . . . . . . . . 3 3 . 1 . 096 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -125.89 131.4 52.36 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.702 179.003 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.1 mt -117.64 135.17 58.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.574 -179.967 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -114.18 135.57 53.89 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.669 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.546 HG21 ' NH2' ' A' ' 5' ' ' ARG . 46.0 mm -103.01 125.19 57.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.941 -179.398 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.473 ' O ' ' N ' ' A' ' 56' ' ' GLN . 33.3 m-70 -127.04 129.31 47.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.596 179.349 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' A' ' 54' ' ' HIS . 96.0 mt-10 -40.2 -29.74 0.08 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.216 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.473 ' N ' ' O ' ' A' ' 54' ' ' HIS . 88.3 mt-30 -67.08 -67.28 0.46 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.41 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -154.92 -168.1 2.78 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.707 -179.807 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.566 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -112.11 131.09 55.65 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.407 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.3 mm -108.66 125.2 65.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.869 -179.433 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 34.1 tp -99.44 126.3 45.33 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.258 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -115.76 137.61 51.92 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.579 -179.187 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -102.57 105.18 15.65 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.368 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -95.89 -4.28 43.84 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.513 178.997 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.52 104.45 15.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.553 -179.187 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.3 p -87.31 -35.89 18.17 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.698 179.124 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.6 -45.71 92.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.793 -179.714 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.41 ' OD1' HG23 ' B' ' 236' ' ' VAL . 2.9 m-80 -145.58 104.43 4.27 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.07 179.248 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -67.04 151.43 81.88 Favored 'Trans proline' 0 N--CA 1.491 1.332 0 C-N-CA 121.74 1.627 . . . . 0.0 113.287 -177.87 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.928 ' O ' HG22 ' A' ' 76' ' ' ILE . 33.9 m -70.79 146.93 49.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.598 179.95 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -110.87 139.92 45.77 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.758 -179.404 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 54.2 t -129.66 134.99 62.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.05 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 53.6 34.41 18.57 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.221 179.829 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.31 28.71 69.43 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.91 179.468 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.6 t -144.93 142.62 30.01 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 117.182 0.491 . . . . 0.0 110.986 179.758 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.4 m -68.97 143.71 14.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.496 -179.497 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.928 HG22 ' O ' ' A' ' 69' ' ' THR . 10.0 tt -111.67 90.92 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.92 -179.801 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -65.55 -35.25 80.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.115 179.52 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.477 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 5.0 mt-10 -124.67 164.74 28.99 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.387 -178.402 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.74 138.87 77.12 Favored 'Trans proline' 0 N--CA 1.501 1.954 0 C-N-CA 122.102 1.868 . . . . 0.0 112.874 -179.879 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 73.2 t -132.37 137.39 54.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.781 179.956 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 84.6 mtt85 -71.38 129.32 38.52 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.487 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.566 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 95.6 mt -82.75 137.36 34.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.164 0.507 . . . . 0.0 111.072 -179.876 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -128.09 152.35 48.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.593 -179.621 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.415 ' HD1' ' H ' ' A' ' 99' ' ' ASN . 7.7 t60 -55.86 117.77 3.99 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.431 179.948 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.85 -20.43 19.93 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 179.851 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -67.03 136.63 55.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.979 0.418 . . . . 0.0 110.216 179.948 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.1 t -109.43 133.87 53.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.684 -178.758 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 88.6 mt -102.86 129.93 53.75 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.514 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 178.275 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 61.5 m -123.41 128.43 49.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.799 0.809 . . . . 0.0 112.249 -178.014 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.678 ' O ' ' N ' ' A' ' 93' ' ' ARG . 93.9 mt -116.53 132.86 64.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.077 178.7 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.517 ' C ' ' O ' ' A' ' 90' ' ' ILE . 51.0 mt -22.5 98.82 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.067 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.573 ' CG ' ' HE ' ' B' ' 245' ' ' ARG . 0.7 OUTLIER 80.08 -17.57 0.57 Allowed 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 178.354 . . . . . . . . 3 3 . 1 . 096 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.678 ' N ' ' O ' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -122.52 132.64 54.42 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 119.64 -0.219 . . . . 0.0 110.868 -179.747 . . . . . . . . 3 3 . 1 . 096 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.1 t -136.28 146.88 47.16 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 118.488 0.586 . . . . 0.0 111.129 -179.781 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -125.74 122.06 35.19 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.647 179.593 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -84.43 134.85 34.45 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.399 -179.249 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -97.82 126.43 43.18 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.492 -179.598 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -143.12 128.38 18.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.644 179.827 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.539 ' O ' ' OD1' ' A' ' 99' ' ' ASN . 29.0 p30 . . . . . 0 C--N 1.333 -0.113 0 CA-C-O 121.483 0.658 . . . . 0.0 111.343 -179.898 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo . . . . . 0 N--CA 1.483 0.902 0 CA-C-O 121.084 0.369 . . . . 0.0 111.927 . . . . . . . . . 0 0 . 1 . 096 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.41 HG23 ' OD1' ' A' ' 67' ' ' ASN . 3.8 p -113.7 132.65 62.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.095 -179.719 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' B' B ' 237' ' ' CYS . . . . . 0.427 ' HB2' HD13 ' A' ' 91' ' ' ILE . 1.0 OUTLIER . . . . . 0 CA--C 1.515 -0.378 0 C-N-CA 120.248 -0.581 . . . . 0.0 109.493 179.943 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo . . . . . 0 N--CA 1.49 1.284 0 N-CA-C 111.349 -0.289 . . . . 0.0 111.349 . . . . . . . . . 0 0 . 1 . 096 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 2.5 p -74.35 -39.75 62.58 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 177.784 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.458 ' CE2' HG21 ' A' ' 43' ' ' VAL . 71.0 t80 -58.04 -47.46 83.03 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.047 -179.264 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.465 HD21 HG23 ' A' ' 91' ' ' ILE . 98.0 mt -64.66 -40.18 94.97 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.043 0.449 . . . . 0.0 110.07 -179.823 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -63.61 -44.0 95.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.795 179.567 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -61.54 -41.24 97.07 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.109 -179.855 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.715 ' O ' HG23 ' B' ' 249' ' ' VAL . 22.1 mmm180 -61.61 -40.37 94.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.348 -179.859 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -63.77 -42.43 97.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.801 0.334 . . . . 0.0 110.794 179.313 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 72.2 p -64.95 -43.19 93.51 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.729 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -62.36 -37.33 85.25 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.682 179.668 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' B' B ' 249' ' ' VAL . . . . . 0.715 HG23 ' O ' ' B' ' 245' ' ' ARG . 79.3 t . . . . . 0 N--CA 1.453 -0.29 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.2 179.019 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.568 ' OE1' HD21 ' A' ' 41' ' ' LEU . 99.6 mt-10 . . . . . 0 C--O 1.227 -0.11 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 . . . . . . . . . 1 1 . 1 . 096 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.553 ' CD1' HG23 ' A' ' 9' ' ' THR . 41.0 mt -109.66 133.11 55.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 119.881 -0.728 . . . . 0.0 109.111 178.824 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 44.1 t -127.8 135.5 62.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.541 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -100.22 123.64 44.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.249 0.547 . . . . 0.0 112.415 -177.6 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -63.98 -47.35 80.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.111 178.59 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' B' B ' 265' ' ' GLN . . . . . 0.649 ' HG2' HD11 ' A' ' 24' ' ' LEU . 6.0 mp0 -96.84 163.76 19.48 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.477 179.972 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -60.76 156.74 41.35 Favored 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 122.941 2.427 . . . . 0.0 111.982 178.72 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 10.6 pt . . . . . 0 N--CA 1.466 0.35 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.893 -178.224 . . . . . . . . 0 0 . 1 . 097 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.5 p . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.858 0.361 . . . . 0.0 110.354 . . . . . . . . . 0 0 . 1 . 097 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.776 HH12 HG23 ' A' ' 53' ' ' ILE . 99.9 mtt180 -94.11 132.28 38.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.747 179.213 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 91.6 mtm180 -134.07 141.93 47.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.015 -179.911 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.559 HD11 ' HB3' ' A' ' 95' ' ' PHE . 42.3 tp -111.94 131.27 55.49 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.122 179.416 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.666 HG11 ' OD2' ' A' ' 16' ' ' ASP . 61.7 t -107.07 130.27 59.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.382 179.832 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 m -92.84 115.06 27.77 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.437 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 88.6 mt -80.93 142.74 13.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.667 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -84.81 156.04 21.52 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.562 178.823 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.424 ' HG3' ' NH2' ' B' ' 245' ' ' ARG . 58.0 ttp180 -58.16 -35.85 72.16 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.069 -179.795 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.1 t -68.21 -21.59 64.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.988 0.423 . . . . 0.0 110.13 178.638 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.57 29.02 4.6 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 111.156 -0.777 . . . . 0.0 111.156 179.993 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.8 t -117.78 132.9 66.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.869 0.366 . . . . 0.0 111.152 -179.804 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.666 ' OD2' HG11 ' A' ' 8' ' ' VAL . 63.5 t0 -79.29 130.83 35.85 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.67 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.462 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -129.93 -108.71 1.31 Allowed Glycine 0 CA--C 1.532 1.133 0 C-N-CA 119.707 -1.235 . . . . 0.0 112.221 -179.66 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.1 145.19 48.88 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.496 2.131 . . . . 0.0 113.81 -178.333 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.451 ' O ' ' CD1' ' B' ' 267' ' ' ILE . 0.2 OUTLIER -110.56 145.62 37.49 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.475 178.871 . . . . . . . . 3 3 . 1 . 097 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.421 ' CD2' HD11 ' A' ' 37' ' ' ILE . 54.0 t80 -113.99 92.21 25.14 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.856 -179.084 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.83 130.02 34.86 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 122.037 1.825 . . . . 0.0 111.189 -179.602 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.5 mt -87.73 84.71 7.03 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.314 -179.483 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 51.4 p -89.85 -10.44 45.33 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.164 179.486 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.77 HD11 ' CD ' ' B' ' 265' ' ' GLN . 59.4 mt -102.24 146.6 27.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.289 -179.723 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 52.4 p -68.84 -17.36 63.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.564 -179.614 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.48 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 30.5 m -128.87 130.73 47.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.873 0.368 . . . . 0.0 110.992 -179.437 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.8 t -126.03 119.28 27.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.718 178.844 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.478 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 42.8 tp -116.77 130.17 56.55 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.155 -178.098 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.721 ' CE2' HD12 ' A' ' 37' ' ' ILE . 10.1 m-85 -109.01 140.41 42.57 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.41 179.921 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 153.88 -177.24 31.47 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.316 -0.945 . . . . 0.0 112.431 177.969 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -71.13 -32.51 69.07 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 111.725 0.268 . . . . 0.0 111.725 179.336 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.453 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -50.38 140.27 19.46 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.812 -178.0 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.48 HG23 ' N ' ' A' ' 34' ' ' GLU . 11.0 tp -67.1 -41.87 87.6 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 C-N-CA 120.381 -0.527 . . . . 0.0 109.597 179.569 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.48 ' N ' HG23 ' A' ' 33' ' ' ILE . 77.3 tt0 -55.6 -16.98 4.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.226 179.457 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 24.1 m -66.63 136.26 55.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.119 -179.79 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.48 ' OD2' ' O ' ' A' ' 26' ' ' THR . 68.8 m-20 -61.53 -33.72 74.3 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -178.999 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.721 HD12 ' CE2' ' A' ' 29' ' ' PHE . 98.3 mt -125.05 119.67 56.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 177.188 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -104.64 133.11 50.04 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.774 -177.999 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 98.9 mt -119.36 129.13 75.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.587 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -76.39 29.63 0.12 Allowed 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -178.082 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 41' ' ' LEU . 30.4 mt -94.12 129.03 38.7 Favored Pre-proline 0 C--N 1.322 -0.613 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.91 -179.806 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -72.86 -10.34 24.72 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 122.58 2.187 . . . . 0.0 113.046 -178.996 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.521 HG21 ' CE2' ' B' ' 241' ' ' PHE . 29.4 m -109.66 4.19 9.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.589 179.804 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.449 ' O ' ' O ' ' A' ' 45' ' ' SER . 4.5 t -91.8 108.17 19.72 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 CA-C-O 121.454 0.645 . . . . 0.0 110.642 179.623 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.507 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 1.1 m -32.09 153.05 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.999 -1.0 . . . . 0.0 112.167 -179.523 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -62.0 -42.36 99.06 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 114.406 -1.27 . . . . 0.0 111.192 -179.104 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.698 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.7 mt-30 -113.1 -18.09 12.24 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.097 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.507 ' H ' ' HB3' ' A' ' 45' ' ' SER . 35.5 t60 31.83 -71.42 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 114.902 -1.045 . . . . 0.0 113.23 179.879 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.698 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.66 135.41 47.82 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.282 . . . . . . . . 3 3 . 1 . 097 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -127.82 131.72 49.52 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.507 179.098 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.7 mt -116.28 136.2 54.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.536 -179.576 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -120.55 125.25 47.32 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.619 178.877 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.776 HG23 HH12 ' A' ' 5' ' ' ARG . 96.4 mt -105.24 114.27 44.34 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 CA-C-O 121.363 0.602 . . . . 0.0 111.569 -179.839 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.572 ' O ' ' N ' ' A' ' 56' ' ' GLN . 93.8 m-70 -112.22 144.46 41.59 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.671 179.641 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.474 ' C ' ' O ' ' A' ' 54' ' ' HIS . 81.8 tt0 -38.83 -26.42 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.81 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.572 ' N ' ' O ' ' A' ' 54' ' ' HIS . 68.9 tp60 -69.62 -68.11 0.43 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.676 178.32 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -160.82 -165.21 1.33 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.551 -179.695 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.41 124.93 52.65 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.013 179.468 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 98.5 mt -113.57 129.22 69.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.245 0.545 . . . . 0.0 112.445 -179.042 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.478 ' HB2' HD21 ' A' ' 82' ' ' LEU . 51.1 tp -95.17 126.73 40.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.355 179.227 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.409 ' ND1' ' HB3' ' A' ' 79' ' ' PRO . 96.0 m-70 -113.94 135.93 53.45 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.402 -179.305 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -95.74 106.67 18.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.952 0.406 . . . . 0.0 111.897 -179.678 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -99.17 -9.52 23.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.602 179.095 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.45 102.93 3.32 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.489 179.785 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 99.1 p -87.45 -1.58 58.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.083 0.468 . . . . 0.0 109.92 179.445 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -112.11 -35.81 5.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.378 -179.916 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 31.4 m-20 -144.27 90.42 6.69 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.607 179.675 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.38 147.1 48.24 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 123.108 2.539 . . . . 0.0 113.445 -178.298 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 58.8 m -71.85 130.41 40.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.32 179.609 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -98.91 143.57 29.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.771 179.637 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.0 t -131.67 133.22 61.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 179.161 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 54.04 33.62 18.03 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 119.491 -0.884 . . . . 0.0 109.286 179.489 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.34 28.73 69.34 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.235 179.627 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.1 m -139.27 133.0 30.65 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 117.439 0.619 . . . . 0.0 112.227 -179.854 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.453 ' H ' HG12 ' A' ' 75' ' ' VAL . 0.1 OUTLIER -72.28 137.91 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.213 179.75 . . . . . . . . 3 3 . 1 . 097 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.543 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 1.7 pt -119.07 115.85 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 121.194 0.521 . . . . 0.0 110.057 178.737 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -82.37 -18.5 41.83 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.165 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.622 ' CD ' ' H ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -124.89 164.71 29.67 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.875 -179.975 . . . . . . . . 3 3 . 1 . 097 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.409 ' HB3' ' ND1' ' A' ' 61' ' ' HIS . 33.6 Cg_endo -63.54 153.4 75.09 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 C-N-CA 122.789 2.326 . . . . 0.0 112.473 179.816 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.3 p -142.76 147.59 20.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.719 -179.259 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -78.65 129.95 35.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.746 179.294 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.478 HD21 ' HB2' ' A' ' 60' ' ' LEU . 91.0 mt -85.44 137.92 32.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.15 0.5 . . . . 0.0 111.257 -179.085 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -128.45 150.87 49.95 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.106 179.578 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.478 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 8.5 t60 -53.13 120.65 6.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.979 0.418 . . . . 0.0 111.156 -179.505 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.14 -20.82 23.28 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 179.746 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -67.56 136.03 53.88 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.053 0.454 . . . . 0.0 110.812 -179.814 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.1 t -116.53 132.18 66.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.058 -178.796 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 93.3 mt -92.6 131.77 38.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.291 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 54.5 m -123.47 124.71 43.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.8 0.809 . . . . 0.0 112.817 -178.41 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.492 ' O ' ' C ' ' A' ' 91' ' ' ILE . 96.5 mt -110.68 124.07 67.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.35 177.874 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.492 ' C ' ' O ' ' A' ' 90' ' ' ILE . 73.1 mt 33.98 -95.5 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.724 179.575 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' A' ' 90' ' ' ILE . 97.9 m-20 -113.72 9.52 17.75 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.557 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.759 ' HE ' HH22 ' B' ' 245' ' ' ARG . 97.5 mtt180 -125.08 144.25 50.51 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.513 -179.114 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.5 m -139.89 152.47 46.46 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.522 0.677 . . . . 0.0 111.388 -179.125 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.559 ' HB3' HD11 ' A' ' 7' ' ' LEU . 51.2 m-85 -125.62 121.98 35.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.572 179.81 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.51 ' O ' HD12 ' A' ' 7' ' ' LEU . 43.1 ttm180 -80.3 128.2 33.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.072 0.463 . . . . 0.0 111.639 -178.957 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -97.35 123.86 41.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.315 179.478 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -126.44 125.66 42.51 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.796 179.984 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.478 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 61.5 t-20 . . . . . 0 CA--C 1.53 0.193 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.255 179.443 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo . . . . . 0 N--CA 1.488 1.197 0 CA-C-O 121.32 0.467 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 097 nuclear build core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 53.7 t -63.35 136.4 26.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.088 179.942 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 4.2 t . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.446 -179.743 . . . . . . . . 0 0 . 1 . 097 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo . . . . . 0 N--CA 1.495 1.582 0 CA-C-O 120.63 0.179 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 097 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 16.1 m -66.78 -45.12 79.46 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.35 0.595 . . . . 0.0 109.529 178.644 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.521 ' CE2' HG21 ' A' ' 43' ' ' VAL . 79.6 t80 -59.18 -46.13 89.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.034 -178.827 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 99.7 mt -64.58 -40.06 94.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.736 0.303 . . . . 0.0 111.332 -178.978 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 -62.95 -39.62 95.21 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.735 -179.289 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' B' B ' 244' ' ' ARG . . . . . 0.4 ' HE ' ' HA ' ' B' ' 241' ' ' PHE . 87.7 mtm180 -64.03 -42.19 97.17 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.334 179.942 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.759 HH22 ' HE ' ' A' ' 93' ' ' ARG . 75.9 mtp85 -61.12 -41.33 96.52 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.781 -179.196 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -62.75 -41.36 99.17 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.479 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 8.7 t -63.59 -45.67 89.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.364 177.979 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -60.14 -39.11 85.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.128 -179.378 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' B' B ' 249' ' ' VAL . . . . . 0.495 HG23 ' O ' ' B' ' 245' ' ' ARG . 74.3 t . . . . . 0 C--N 1.329 -0.301 0 C-N-CA 120.256 -0.578 . . . . 0.0 110.274 179.643 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.616 ' OE1' ' NH2' ' A' ' 93' ' ' ARG . 93.8 mt-10 . . . . . 0 N--CA 1.464 0.265 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 . . . . . . . . . 1 1 . 1 . 097 nuclear build core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 59.5 mt -108.87 133.28 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.95 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 44.7 t -127.69 134.91 64.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.975 0.416 . . . . 0.0 111.109 -178.959 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -95.57 119.45 34.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.627 -178.767 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -64.79 -48.47 74.34 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.472 -179.517 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' B' B ' 265' ' ' GLN . . . . . 0.77 ' CD ' HD11 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -82.42 167.96 26.68 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.291 -179.236 . . . . . . . . 3 3 . 1 . 097 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.85 144.98 89.92 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 121.701 1.601 . . . . 0.0 111.904 -179.554 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' B' B ' 267' ' ' ILE . . . . . 0.451 ' CD1' ' O ' ' A' ' 19' ' ' HIS . 7.8 tt . . . . . 0 C--N 1.321 -0.635 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.302 -179.275 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.9 p . . . . . 0 N--CA 1.462 0.158 0 CA-C-O 121.03 0.443 . . . . 0.0 110.384 . . . . . . . . . 0 0 . 1 . 098 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.728 ' NE ' HD13 ' A' ' 53' ' ' ILE . 89.6 mtm-85 -92.53 131.91 37.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.786 -179.398 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -133.01 141.93 48.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.011 0.434 . . . . 0.0 111.693 -179.927 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.486 HD12 ' O ' ' A' ' 96' ' ' ARG . 26.4 tp -114.92 130.0 56.82 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.787 179.729 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 56.1 t -106.58 128.95 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.288 -179.012 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.416 HG23 HD12 ' B' ' 261' ' ' ILE . 2.8 m -80.27 140.46 36.2 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.263 0.554 . . . . 0.0 111.365 -179.833 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.493 ' CD1' ' OD1' ' A' ' 16' ' ' ASP . 50.6 mm -113.19 137.95 44.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.549 179.609 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -90.66 156.71 17.91 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.716 179.367 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.409 ' HD3' ' NH1' ' B' ' 245' ' ' ARG . 90.0 mtm180 -59.36 -24.0 63.02 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.172 179.676 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 81.8 p -81.61 -10.92 59.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.069 0.461 . . . . 0.0 109.856 179.301 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.02 34.34 8.94 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 -179.975 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.2 t -118.06 131.75 69.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.742 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.493 ' OD1' ' CD1' ' A' ' 10' ' ' ILE . 89.4 m-20 -72.4 134.05 45.21 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.229 -0.589 . . . . 0.0 109.628 179.264 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -118.53 -125.37 3.46 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.48 -179.1 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.59 152.71 38.41 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.372 2.048 . . . . 0.0 112.537 -178.689 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 27.1 m-70 -102.71 154.61 18.99 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.907 0.384 . . . . 0.0 110.627 179.549 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.462 ' CD2' HD11 ' A' ' 37' ' ' ILE . 53.2 t80 -124.71 91.21 49.81 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.829 179.557 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -60.6 129.66 30.32 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.206 1.937 . . . . 0.0 111.719 179.872 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 90.6 mt -88.81 84.25 6.67 Favored 'General case' 0 N--CA 1.461 0.119 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.974 -179.302 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.2 p -86.21 -10.53 54.51 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.653 179.411 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.676 HD11 ' CD ' ' B' ' 265' ' ' GLN . 66.4 mt -102.14 145.77 28.89 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.094 -179.405 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 81.9 p -68.33 -15.9 63.74 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.045 0.45 . . . . 0.0 110.833 -179.257 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 46.3 m -128.47 132.43 48.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.674 -179.201 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.9 t -126.23 114.17 17.95 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.765 178.611 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.506 HD12 ' O ' ' A' ' 49' ' ' CYS . 57.6 tp -111.31 122.51 48.05 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.906 0.384 . . . . 0.0 111.413 -178.459 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.831 ' CE2' HD12 ' A' ' 37' ' ' ILE . 11.1 m-85 -101.95 142.56 33.06 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.404 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 156.04 -169.63 33.67 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 120.136 -1.031 . . . . 0.0 112.453 179.17 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 31.9 ttp85 -89.28 -32.5 17.35 Favored 'General case' 0 N--CA 1.461 0.096 0 CA-C-O 120.817 0.342 . . . . 0.0 110.824 -179.899 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.432 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -50.36 145.41 9.7 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 -179.879 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.416 HD13 ' HA ' ' A' ' 33' ' ' ILE . 35.7 mm -63.69 -43.93 98.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.555 -179.614 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -54.8 -18.14 4.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.473 179.778 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.432 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 51.2 m -62.1 128.55 36.68 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.162 179.944 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.452 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 61.7 m-20 -58.97 -30.7 68.13 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -178.9 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.831 HD12 ' CE2' ' A' ' 29' ' ' PHE . 79.4 mt -126.5 121.74 59.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 177.126 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 47.6 mtt180 -101.12 136.06 41.59 Favored 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.266 -178.724 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.407 ' C ' ' H ' ' A' ' 41' ' ' LEU . 91.7 mt -117.12 125.33 73.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.995 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -70.92 39.07 0.05 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.308 -177.686 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 41' ' ' LEU . 43.3 mt -112.69 125.17 30.37 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 120.556 -0.458 . . . . 0.0 109.796 179.16 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.56 -2.75 12.61 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.224 1.949 . . . . 0.0 112.61 -179.143 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.529 HG21 ' CE2' ' B' ' 241' ' ' PHE . 33.3 m -109.1 2.97 9.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.767 179.088 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.463 ' O ' ' O ' ' A' ' 45' ' ' SER . 2.7 t -89.72 109.7 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 120.703 0.287 . . . . 0.0 110.592 -179.865 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.58 ' OG ' ' N ' ' A' ' 48' ' ' HIS . 1.1 t -31.79 152.08 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.384 0.611 . . . . 0.0 111.775 -178.771 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -63.26 -43.0 99.21 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.04 -179.194 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.605 ' O ' ' N ' ' A' ' 49' ' ' CYS . 13.3 mm100 -108.9 -26.43 10.24 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.635 0.731 . . . . 0.0 109.113 179.205 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.58 ' N ' ' OG ' ' A' ' 45' ' ' SER . 36.5 t60 39.68 -74.46 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.257 -1.338 . . . . 0.0 113.681 179.471 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.605 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.54 136.44 46.62 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -177.985 . . . . . . . . 3 3 . 1 . 098 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -128.07 127.67 43.53 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.803 179.317 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.3 mt -108.85 133.78 52.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.297 179.838 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.455 ' CD ' ' NE2' ' A' ' 54' ' ' HIS . 82.1 tt0 -118.73 123.81 45.78 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.006 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.728 HD13 ' NE ' ' A' ' 5' ' ' ARG . 97.0 mt -106.85 116.0 49.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -178.565 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.53 ' O ' ' N ' ' A' ' 56' ' ' GLN . 96.9 m-70 -111.32 143.51 42.0 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.123 178.366 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.9 mm-40 -39.35 -26.85 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.278 0.561 . . . . 0.0 109.761 -179.841 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.53 ' N ' ' O ' ' A' ' 54' ' ' HIS . 47.2 tp60 -67.89 -68.3 0.4 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.262 178.918 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -158.92 -165.79 1.71 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.25 179.734 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.406 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -109.88 131.52 54.99 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.013 179.843 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 93.5 mt -121.41 132.31 70.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.233 0.54 . . . . 0.0 112.003 -179.09 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.546 HD22 HD12 ' A' ' 88' ' ' ILE . 37.0 tp -101.53 125.69 48.22 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.758 -179.175 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -110.81 135.97 50.57 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.636 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -97.94 105.34 17.47 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -178.123 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -98.28 -8.6 26.9 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.624 179.13 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -78.2 98.23 5.78 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.985 0.422 . . . . 0.0 110.557 -179.716 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.7 m -84.55 -33.94 23.34 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.886 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.447 HG22 ' HA ' ' B' ' 236' ' ' VAL . 1.4 m -64.41 -50.64 66.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.843 179.64 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -136.28 96.74 12.34 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.831 -179.752 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.499 ' HB2' HG23 ' A' ' 75' ' ' VAL . 43.0 Cg_exo -55.29 143.43 75.95 Favored 'Trans proline' 0 N--CA 1.499 1.822 0 C-N-CA 122.151 1.901 . . . . 0.0 112.856 -178.822 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 18.2 m -72.06 140.34 48.92 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.406 179.93 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -104.01 140.35 37.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.438 -179.96 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.689 HG13 ' OD1' ' A' ' 86' ' ' ASP . 49.3 t -130.1 137.09 57.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.907 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 54.05 32.55 15.83 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.267 -0.573 . . . . 0.0 109.791 -179.643 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.22 29.18 72.13 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.05 179.623 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 49.8 m -141.28 135.65 30.84 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.163 -179.996 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.499 HG23 ' HB2' ' A' ' 68' ' ' PRO . 2.4 p -70.86 136.32 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 121.181 0.515 . . . . 0.0 111.681 -179.303 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.878 HD13 ' O ' ' A' ' 76' ' ' ILE . 0.0 OUTLIER -132.68 125.25 52.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.837 179.77 . . . . . . . . 3 3 . 1 . 098 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -99.32 -9.02 24.08 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.121 -179.713 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.847 ' O ' HD11 ' A' ' 76' ' ' ILE . 16.3 mt-10 -119.6 156.72 53.3 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.299 -179.082 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -62.52 148.15 93.76 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.48 2.12 . . . . 0.0 112.702 -179.951 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.5 m -143.76 145.4 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.427 -179.608 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 87.3 mtm-85 -73.35 130.2 39.66 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.529 179.349 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.497 HD11 ' HB2' ' A' ' 60' ' ' LEU . 96.0 mt -85.35 140.69 30.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.278 0.561 . . . . 0.0 111.274 -179.682 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -133.62 157.51 45.57 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.256 -179.661 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -58.81 117.19 4.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.242 -179.664 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.65 -1.29 29.06 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 -179.365 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.689 ' OD1' HG13 ' A' ' 71' ' ' VAL . 60.7 t0 -86.17 125.36 33.46 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.027 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.409 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 9.5 p -103.38 135.37 41.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 C-N-CA 120.461 -0.495 . . . . 0.0 111.543 -178.875 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.546 HD12 HD22 ' A' ' 60' ' ' LEU . 33.2 mm -96.14 128.28 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 177.789 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 36.3 m -122.79 121.55 36.56 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 119.688 -0.805 . . . . 0.0 113.08 -178.27 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.481 HD12 ' HE1' ' A' ' 95' ' ' PHE . 93.3 mt -110.36 124.79 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 114.624 -1.171 . . . . 0.0 108.623 177.672 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.593 HG22 ' NH2' ' B' ' 245' ' ' ARG . 61.1 mt 33.54 -99.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 121.034 -0.267 . . . . 0.0 111.195 179.7 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.506 ' O ' ' OD1' ' A' ' 92' ' ' ASP . 59.3 t0 -112.98 15.61 19.61 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.489 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.526 HH21 ' CD ' ' B' ' 260' ' ' GLU . 87.3 mtt-85 -129.32 140.61 51.34 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.128 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 75.2 m -137.17 154.73 50.16 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 119.958 -0.697 . . . . 0.0 111.585 -179.491 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.481 ' HE1' HD12 ' A' ' 90' ' ' ILE . 78.4 m-85 -125.17 121.43 34.16 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.209 179.689 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.486 ' O ' HD12 ' A' ' 7' ' ' LEU . 79.1 mtp85 -85.82 134.05 33.94 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.617 -179.685 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -93.53 123.76 37.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.736 -179.825 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -125.09 119.24 28.05 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.778 -179.769 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 . . . . . 0 N--CA 1.469 0.482 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.266 -179.754 . . . . . . . . 0 0 . 1 . 098 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo . . . . . 0 N--CA 1.492 1.433 0 CA-C-O 121.462 0.526 . . . . 0.0 112.69 . . . . . . . . . 0 0 . 1 . 098 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.447 ' HA ' HG22 ' A' ' 66' ' ' THR . 3.3 p -69.22 138.11 22.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.558 -0.747 . . . . 0.0 111.275 -178.841 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.5 t . . . . . 0 CA--C 1.516 -0.33 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.168 . . . . . . . . 0 0 . 1 . 098 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo . . . . . 0 N--CA 1.502 2.001 0 N-CA-C 113.189 0.419 . . . . 0.0 113.189 . . . . . . . . . 0 0 . 1 . 098 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 89.4 m -72.21 -44.75 62.5 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.396 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.529 ' CE2' HG21 ' A' ' 43' ' ' VAL . 80.8 t80 -57.33 -46.5 83.18 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.072 -179.777 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.432 HD21 HG23 ' A' ' 91' ' ' ILE . 91.2 mt -64.19 -43.09 96.15 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 -179.936 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -65.52 -39.93 92.39 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.061 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 53.8 ttt85 -62.97 -46.22 88.73 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.354 -179.563 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.801 ' O ' HG23 ' B' ' 249' ' ' VAL . 45.4 mtm180 -66.97 -37.9 85.1 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.903 -179.801 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -60.43 -45.94 91.82 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.207 -179.423 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 11.6 t -64.78 -44.66 89.29 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.677 178.681 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -63.52 -32.22 73.61 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.868 179.884 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' B' B ' 249' ' ' VAL . . . . . 0.801 HG23 ' O ' ' B' ' 245' ' ' ARG . 71.9 t . . . . . 0 C--N 1.326 -0.443 0 C-N-CA 120.286 -0.566 . . . . 0.0 109.644 179.46 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.526 ' CD ' HH21 ' A' ' 93' ' ' ARG . 95.4 mt-10 . . . . . 0 CA--C 1.527 0.087 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 . . . . . . . . . 1 1 . 1 . 098 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.416 HD12 HG23 ' A' ' 9' ' ' THR . 74.0 mt -111.96 134.69 53.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.269 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 73.9 t -127.1 133.72 67.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.955 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -94.97 121.23 36.36 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.132 0.491 . . . . 0.0 111.483 -177.303 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -64.51 -43.99 92.34 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.956 179.606 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' B' B ' 265' ' ' GLN . . . . . 0.676 ' CD ' HD11 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -89.05 167.14 18.82 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.191 -178.068 . . . . . . . . 3 3 . 1 . 098 nuclear build core ' B' B ' 266' ' ' PRO . . . . . 0.443 ' C ' HD13 ' B' ' 267' ' ' ILE . 60.6 Cg_endo -70.77 149.27 60.21 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.744 2.296 . . . . 0.0 112.115 -179.885 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' B' B ' 267' ' ' ILE . . . . . 0.566 ' N ' HD13 ' B' ' 267' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.394 0 CA-C-O 121.594 0.712 . . . . 0.0 109.448 179.568 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 36.1 p . . . . . 0 N--CA 1.465 0.314 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 . . . . . . . . . 0 0 . 1 . 099 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.633 ' NH1' ' HB2' ' A' ' 58' ' ' ALA . 94.6 mtt-85 -90.48 123.76 34.44 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.659 -0.417 . . . . 0.0 111.709 -178.034 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.7 mtm-85 -127.7 130.53 49.01 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 121.113 0.482 . . . . 0.0 110.497 179.155 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.627 HD11 ' HB3' ' A' ' 95' ' ' PHE . 51.7 tp -113.01 125.14 54.08 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.885 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.7 m -104.7 133.44 48.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.42 -178.94 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.9 m -83.03 143.81 30.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.771 -179.268 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.627 HD12 ' OG ' ' A' ' 94' ' ' SER . 97.2 mt -116.88 140.98 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.464 177.687 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -92.32 156.54 17.18 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.587 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.04 -15.87 37.24 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.779 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.6 p -77.16 -19.53 56.7 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.103 178.131 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.57 14.02 42.32 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.48 178.984 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.4 m -113.15 144.48 20.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.023 0.44 . . . . 0.0 111.101 -179.891 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 17' ' ' GLY . 61.9 t0 -80.1 130.47 35.27 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.999 -179.363 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.462 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -116.84 -122.55 3.35 Favored Glycine 0 CA--C 1.535 1.334 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 -179.803 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -71.97 151.77 56.67 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 121.737 1.625 . . . . 0.0 112.653 -178.913 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -108.28 151.65 25.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.989 0.423 . . . . 0.0 110.344 -179.508 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.854 ' CD2' HD11 ' A' ' 37' ' ' ILE . 49.2 t80 -120.09 96.91 49.4 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.478 -179.066 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.451 ' HD2' HG22 ' B' ' 267' ' ' ILE . 87.6 Cg_endo -75.57 137.26 20.28 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 121.024 1.15 . . . . 0.0 111.686 -179.252 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 22' ' ' LEU . 84.1 mt -99.21 120.76 40.05 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 119.884 -0.726 . . . . 0.0 111.848 -178.717 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.7 p -122.4 -0.46 9.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.64 178.366 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.424 HD11 ' CG ' ' B' ' 265' ' ' GLN . 63.6 mt -105.85 149.34 26.6 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.994 -179.054 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.3 p -69.39 -21.0 63.81 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.984 -179.397 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 42.8 m -128.8 131.96 47.82 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.056 -179.829 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.486 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -132.85 126.38 32.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.274 178.205 . . . . . . . . 3 3 . 1 . 099 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.755 HD21 ' OE1' ' A' ' 47' ' ' GLN . 33.3 tp -122.23 133.23 54.71 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.973 -178.056 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.505 ' O ' ' O ' ' A' ' 47' ' ' GLN . 51.0 m-85 -106.06 138.19 42.68 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.323 -0.853 . . . . 0.0 108.925 178.808 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 155.04 -172.85 33.38 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 120.381 -0.914 . . . . 0.0 111.731 179.181 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.42 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 46.7 mtm105 -81.32 -31.27 33.61 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -179.467 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.506 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -48.06 148.36 4.05 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.706 -179.004 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.555 HG23 ' N ' ' A' ' 34' ' ' GLU . 9.9 tp -65.79 -43.45 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 120.695 0.283 . . . . 0.0 111.037 179.733 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.555 ' N ' HG23 ' A' ' 33' ' ' ILE . 81.8 tt0 -59.39 -18.38 38.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.416 -179.736 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 33.4 m -57.84 126.81 29.02 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.739 -179.327 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -62.59 -33.9 75.9 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.523 -179.606 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.854 HD11 ' CD2' ' A' ' 20' ' ' PHE . 40.6 mm -119.87 111.33 32.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 177.312 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.407 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 85.2 mtp180 -99.23 132.45 44.54 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 120.681 -0.407 . . . . 0.0 110.225 -179.403 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.578 HG23 ' NH1' ' A' ' 93' ' ' ARG . 80.7 mt -122.71 131.76 72.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.803 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -82.31 32.95 0.4 Allowed 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -177.859 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.665 HD21 ' NH2' ' A' ' 93' ' ' ARG . 70.3 mt -96.1 131.11 29.49 Favored Pre-proline 0 N--CA 1.469 0.483 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.121 178.992 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -73.4 -14.46 25.23 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.169 1.913 . . . . 0.0 112.156 179.672 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.583 HG21 ' CE2' ' B' ' 241' ' ' PHE . 21.3 m -93.07 7.14 5.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.602 179.931 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.42 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 24.3 t -101.37 134.46 41.57 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.482 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.5 m -71.84 168.14 18.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.282 0.563 . . . . 0.0 111.14 -179.131 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -60.91 -39.15 88.26 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.114 -178.98 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.755 ' OE1' HD21 ' A' ' 28' ' ' LEU . 13.4 mm100 -112.47 -18.07 12.52 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.619 0.247 . . . . 0.0 110.725 -179.828 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 23.3 t60 36.66 -75.9 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 179.634 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.772 ' SG ' HD11 ' A' ' 60' ' ' LEU . 0.1 OUTLIER -136.68 139.19 41.8 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.796 -178.581 . . . . . . . . 3 3 . 1 . 099 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -124.65 139.11 54.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.848 179.572 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.617 HD11 HD12 ' A' ' 82' ' ' LEU . 17.3 tt -128.95 138.29 54.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.143 179.959 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -117.22 137.84 52.1 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.015 179.144 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.7 mm -103.36 124.26 57.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.514 0.673 . . . . 0.0 111.159 -179.318 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.474 ' O ' ' N ' ' A' ' 56' ' ' GLN . 50.3 m-70 -125.41 132.15 52.81 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.17 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.473 ' C ' ' O ' ' A' ' 54' ' ' HIS . 97.7 mt-10 -39.59 -30.56 0.07 Allowed 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.125 -178.8 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.474 ' N ' ' O ' ' A' ' 54' ' ' HIS . 98.6 mt-30 -65.37 -69.9 0.27 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.264 179.33 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -154.88 -159.47 0.95 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.691 -179.777 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.633 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -119.71 137.9 53.63 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.864 0.364 . . . . 0.0 110.601 -179.84 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.3 mm -111.61 120.6 62.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.11 179.936 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.772 HD11 ' SG ' ' A' ' 49' ' ' CYS . 48.7 tp -98.22 126.04 43.53 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.248 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -113.34 136.14 53.09 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.817 -179.412 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.477 HD21 ' HA ' ' A' ' 68' ' ' PRO . 61.2 t-20 -96.21 109.8 22.21 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.98 0.419 . . . . 0.0 111.683 179.915 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -102.38 -9.41 20.33 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.343 179.4 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.22 98.8 9.58 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.821 0.343 . . . . 0.0 111.185 -179.296 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.3 p -78.77 -38.5 38.44 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.967 0.413 . . . . 0.0 109.959 178.729 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.41 -44.57 90.83 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.647 -179.488 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.431 ' CG ' ' H ' ' B' ' 237' ' ' CYS . 89.9 m-20 -139.41 89.56 12.03 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.188 179.897 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.529 ' HB2' HG13 ' A' ' 75' ' ' VAL . 46.4 Cg_exo -54.14 145.59 53.17 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.427 2.085 . . . . 0.0 112.449 -179.675 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.5 m -75.91 143.81 41.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.907 -179.175 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -103.88 142.84 33.7 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.658 179.994 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.48 ' CG2' ' OD1' ' A' ' 86' ' ' ASP . 4.5 p -131.33 135.47 59.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.198 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 51.92 28.95 5.57 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -179.576 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.86 27.45 64.71 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.319 179.995 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.415 ' N ' ' O ' ' A' ' 71' ' ' VAL . 25.5 m -139.9 140.5 36.46 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.86 -179.498 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.529 HG13 ' HB2' ' A' ' 68' ' ' PRO . 51.1 t -68.42 136.96 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -179.309 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.3 pt -110.74 79.68 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.226 0 CA-C-O 121.118 0.485 . . . . 0.0 111.491 179.188 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -61.13 -31.76 71.46 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.918 179.326 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.581 ' OE1' ' N ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -114.84 159.6 36.79 Favored Pre-proline 0 CA--C 1.517 -0.305 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.766 . . . . . . . . 3 3 . 1 . 099 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -62.49 144.51 94.78 Favored 'Trans proline' 0 C--N 1.294 -2.341 0 C-N-CA 122.462 2.108 . . . . 0.0 111.72 -179.343 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 44.1 t -135.09 138.21 49.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.94 -179.151 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -74.63 137.65 42.39 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.831 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.617 HD12 HD11 ' A' ' 51' ' ' ILE . 93.3 mt -91.46 141.0 29.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.177 0.513 . . . . 0.0 112.349 -178.782 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -129.91 154.42 47.34 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.076 179.293 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -53.03 117.21 2.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.71 -179.565 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.38 -22.03 12.42 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 179.56 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 87' ' ' VAL . 59.4 t0 -62.76 130.27 44.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.259 0.552 . . . . 0.0 111.292 -179.873 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.588 HG22 ' HG2' ' A' ' 96' ' ' ARG . 61.7 t -105.65 133.05 51.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.231 -179.247 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 86.4 mt -103.12 128.74 55.82 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.639 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.8 m -119.06 129.01 54.86 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -178.422 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.674 ' O ' ' N ' ' A' ' 93' ' ' ARG . 98.6 mt -115.84 133.96 60.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 113.974 -1.466 . . . . 0.0 107.826 177.121 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.615 HG23 HD21 ' B' ' 242' ' ' LEU . 77.5 mt -19.12 94.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.028 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.42 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 0.4 OUTLIER 80.34 -13.22 0.96 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 177.771 . . . . . . . . 3 3 . 1 . 099 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.674 ' N ' ' O ' ' A' ' 90' ' ' ILE . 88.2 mtt180 -128.4 137.92 52.1 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.564 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.627 ' OG ' HD12 ' A' ' 10' ' ' ILE . 62.6 p -139.27 156.7 46.88 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.396 0.617 . . . . 0.0 110.697 -179.549 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.627 ' HB3' HD11 ' A' ' 7' ' ' LEU . 78.0 m-85 -130.63 127.33 38.73 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.496 -0.775 . . . . 0.0 108.995 179.596 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.588 ' HG2' HG22 ' A' ' 87' ' ' VAL . 99.5 mtt180 -94.91 138.15 33.05 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.832 -179.514 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.58 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 83.1 t80 -96.71 126.1 41.64 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.876 -179.087 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -124.81 119.73 29.72 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.828 179.521 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 . . . . . 0 N--CA 1.464 0.242 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.124 -179.462 . . . . . . . . 0 0 . 1 . 099 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo . . . . . 0 N--CA 1.495 1.615 0 N-CA-C 113.654 0.598 . . . . 0.0 113.654 . . . . . . . . . 0 0 . 1 . 099 nuclear build core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 38.8 t -61.77 137.47 23.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.461 179.213 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' B' B ' 237' ' ' CYS . . . . . 0.431 ' H ' ' CG ' ' A' ' 67' ' ' ASN . 0.7 OUTLIER . . . . . 0 C--N 1.326 -0.452 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.263 -178.902 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo . . . . . 0 N--CA 1.49 1.305 0 N-CA-C 111.601 -0.192 . . . . 0.0 111.601 . . . . . . . . . 0 0 . 1 . 099 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 94.7 m -72.89 -46.05 54.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.952 179.095 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.583 ' CE2' HG21 ' A' ' 43' ' ' VAL . 76.1 t80 -59.33 -45.63 90.83 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.579 -178.528 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.615 HD21 HG23 ' A' ' 91' ' ' ILE . 77.4 mt -65.32 -44.31 88.22 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.992 -179.178 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -62.48 -41.01 98.49 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.558 -179.098 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -63.84 -46.33 85.55 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.311 -179.251 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' B' B ' 245' ' ' ARG . . . . . . . . . . . . . 57.1 ttm-85 -64.82 -42.95 94.57 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.133 -179.246 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' B' B ' 246' ' ' LYS . . . . . 0.401 ' O ' HG12 ' B' ' 249' ' ' VAL . 98.3 mttt -63.27 -39.11 93.68 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.37 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 38.7 t -63.53 -44.98 92.64 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.674 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -58.61 -37.23 75.42 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.815 -179.687 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' B' B ' 249' ' ' VAL . . . . . 0.401 HG12 ' O ' ' B' ' 246' ' ' LYS . 0.3 OUTLIER . . . . . 0 CA--C 1.533 0.291 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.896 179.839 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.61 ' N ' ' OE1' ' B' ' 260' ' ' GLU . 56.8 mp0 . . . . . 0 C--O 1.233 0.195 0 CA-C-O 121.146 0.498 . . . . 0.0 111.551 . . . . . . . . . 1 1 . 1 . 099 nuclear build core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 72.1 mt -109.81 137.98 39.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.705 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 55.2 t -127.42 134.45 65.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 C-N-CA 120.202 -0.599 . . . . 0.0 111.239 -178.506 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -93.7 118.01 30.83 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.379 -178.861 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -67.02 -46.94 72.94 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.61 179.751 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' B' B ' 265' ' ' GLN . . . . . 0.424 ' CG ' HD11 ' A' ' 24' ' ' LEU . 5.0 mp0 -81.6 162.64 57.43 Favored Pre-proline 0 CA--C 1.514 -0.422 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.934 -178.785 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.9 144.49 58.84 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 121.617 1.545 . . . . 0.0 111.643 179.088 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' B' B ' 267' ' ' ILE . . . . . 0.451 HG22 ' HD2' ' A' ' 21' ' ' PRO . 43.3 pt . . . . . 0 C--N 1.32 -0.717 0 CA-C-O 121.386 0.613 . . . . 0.0 109.43 178.553 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.0 p . . . . . 0 CA--C 1.528 0.107 0 CA-C-O 121.023 0.439 . . . . 0.0 109.943 . . . . . . . . . 0 0 . 1 . 100 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.733 ' NH1' ' HB2' ' A' ' 58' ' ' ALA . 92.2 mtt-85 -92.47 124.08 36.25 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.268 -179.177 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -130.15 139.57 50.86 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.551 -179.877 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.511 HD11 ' HB3' ' A' ' 95' ' ' PHE . 33.5 tp -115.95 130.91 57.03 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.274 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.674 HG12 ' CD2' ' A' ' 19' ' ' HIS . 33.3 m -111.25 134.32 53.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 C-N-CA 120.744 -0.383 . . . . 0.0 110.77 -179.779 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.5 m -95.02 117.87 30.89 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -177.817 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.664 HD12 ' OG ' ' A' ' 94' ' ' SER . 97.6 mt -80.94 144.27 10.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.13 178.443 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -92.64 163.8 13.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.755 178.8 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.644 ' CZ ' HH11 ' B' ' 245' ' ' ARG . 83.1 mtp180 -55.47 -30.54 60.77 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.885 -179.191 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 95.8 p -79.95 -7.58 58.86 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 120.666 -0.413 . . . . 0.0 111.521 -179.983 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.39 35.11 8.16 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.853 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.6 t -121.46 133.62 67.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.86 0.362 . . . . 0.0 110.626 -179.671 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -73.95 135.48 43.23 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 178.788 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.5 -116.95 1.93 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 120.412 -0.899 . . . . 0.0 111.699 -179.603 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -68.37 142.13 53.65 Favored 'Trans proline' 0 N--CA 1.49 1.276 0 C-N-CA 121.593 1.528 . . . . 0.0 112.545 -178.665 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.674 ' CD2' HG12 ' A' ' 8' ' ' VAL . 49.4 m170 -106.15 142.68 35.43 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.269 -179.377 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.544 ' CD2' HD11 ' A' ' 37' ' ' ILE . 37.6 t80 -113.32 93.32 26.01 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.272 -179.673 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -62.45 126.82 19.28 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 121.713 1.608 . . . . 0.0 110.387 179.7 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.6 mt -86.75 51.75 2.32 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.406 -178.719 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 88.9 p -61.67 -23.64 66.22 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.198 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.506 HD11 ' CD ' ' B' ' 265' ' ' GLN . 92.6 mt -77.61 139.03 39.45 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.264 179.36 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 99.3 p -66.4 -16.86 64.41 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.837 -178.461 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 61.8 m -138.83 138.44 37.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.565 0.222 . . . . 0.0 110.669 179.998 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.682 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -138.2 133.53 33.36 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.987 0.423 . . . . 0.0 110.69 179.205 . . . . . . . . 3 3 . 1 . 100 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.56 HD21 ' HG2' ' A' ' 47' ' ' GLN . 34.7 tp -123.04 131.45 53.71 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.745 -178.056 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.728 ' CE2' HD12 ' A' ' 37' ' ' ILE . 8.2 m-85 -107.2 141.95 37.69 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.115 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 158.5 -175.66 35.56 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.92 179.169 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.599 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 86.8 mtm-85 -74.94 -27.34 60.16 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 122.659 -0.318 . . . . 0.0 110.928 -179.935 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.566 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -59.14 138.05 49.83 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.154 -177.925 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.449 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.0 tp -66.51 -41.56 88.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.721 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.449 ' N ' HG23 ' A' ' 33' ' ' ILE . 84.4 tt0 -51.93 -19.0 1.55 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.376 178.854 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.566 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 13.8 m -67.91 137.77 55.48 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.568 179.209 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -60.74 -33.77 73.42 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -179.251 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.728 HD12 ' CE2' ' A' ' 29' ' ' PHE . 96.8 mt -127.26 124.72 64.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.247 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.431 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 78.4 ttt-85 -109.34 134.23 52.07 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.115 -178.579 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 82.0 mt -116.45 130.59 71.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.929 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -78.82 26.04 0.25 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.792 -178.056 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.739 HD21 ' OE1' ' B' ' 260' ' ' GLU . 31.5 mt -95.37 125.96 47.86 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.977 179.947 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.69 -14.33 33.06 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.555 2.17 . . . . 0.0 113.056 -179.786 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.598 HG23 HD13 ' A' ' 91' ' ' ILE . 15.3 m -93.83 6.05 6.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.92 0.39 . . . . 0.0 110.7 -179.698 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.599 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 57.5 t -100.71 134.57 40.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.429 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.529 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 0.2 OUTLIER -66.07 167.71 9.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.165 0.507 . . . . 0.0 112.023 -178.658 . . . . . . . . 3 3 . 1 . 100 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -60.21 -42.67 95.62 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.664 -179.676 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.728 ' O ' ' N ' ' A' ' 49' ' ' CYS . 85.0 mt-30 -111.64 -12.15 13.93 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.463 179.675 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.529 ' H ' ' HB3' ' A' ' 45' ' ' SER . 27.7 t60 32.94 -68.17 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -179.852 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.728 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -142.87 143.87 32.25 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.202 -0.599 . . . . 0.0 112.152 -179.464 . . . . . . . . 3 3 . 1 . 100 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -125.18 137.62 54.14 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.832 179.436 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.51 HD11 HD12 ' A' ' 82' ' ' LEU . 19.8 tt -125.09 138.08 55.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.072 0.463 . . . . 0.0 110.128 -179.724 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -122.8 135.07 54.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.284 -179.463 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.521 HD13 ' HD2' ' A' ' 5' ' ' ARG . 96.7 mt -109.88 117.04 53.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.61 0.719 . . . . 0.0 111.949 -179.602 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.555 ' O ' ' N ' ' A' ' 56' ' ' GLN . 94.9 m-70 -116.37 142.52 46.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.475 -1.239 . . . . 0.0 110.351 -179.981 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 54' ' ' HIS . 80.8 mm-40 -39.88 -24.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.993 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.555 ' N ' ' O ' ' A' ' 54' ' ' HIS . 59.5 tt0 -69.47 -67.57 0.47 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.272 178.613 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.494 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 6.0 tp10 -161.12 -158.87 0.61 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.23 179.237 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.733 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -114.39 125.06 53.42 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.816 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.2 mt -114.12 130.91 67.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.129 0.49 . . . . 0.0 111.883 -178.447 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.507 HD11 ' SG ' ' A' ' 49' ' ' CYS . 56.5 tp -99.85 129.05 45.9 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.717 -179.391 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -113.59 136.72 52.5 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.542 179.65 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.407 ' ND2' ' HB3' ' A' ' 68' ' ' PRO . 29.9 t30 -95.28 108.79 20.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.04 0.447 . . . . 0.0 111.777 -179.962 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -98.78 -8.51 25.83 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.739 179.182 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.7 t -81.2 105.84 12.72 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.263 179.721 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.7 p -87.36 -20.36 26.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.244 0.545 . . . . 0.0 109.668 179.567 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.461 HG22 HG22 ' B' ' 236' ' ' VAL . 0.3 OUTLIER -86.32 -33.58 20.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.196 -179.642 . . . . . . . . 3 3 . 1 . 100 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.4 HD21 ' HA ' ' B' ' 236' ' ' VAL . 74.7 m-80 -150.84 93.95 3.64 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.17 179.926 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.726 ' HB2' HG13 ' A' ' 75' ' ' VAL . 32.2 Cg_exo -56.73 149.29 60.38 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.165 1.91 . . . . 0.0 112.009 -179.801 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 51.9 m -73.57 137.41 44.31 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.04 178.846 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -98.0 141.16 31.3 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.59 -179.768 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 51.8 t -126.45 134.11 67.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.21 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 51.65 33.18 10.35 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.974 -0.69 . . . . 0.0 109.416 -179.099 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.66 29.97 69.06 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.659 179.81 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.4 m -140.6 135.37 31.69 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 117.001 0.401 . . . . 0.0 111.142 -179.912 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.726 HG13 ' HB2' ' A' ' 68' ' ' PRO . 55.7 t -69.1 136.74 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.725 -179.606 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.55 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 1.1 pt -104.96 100.4 10.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-O 121.361 0.6 . . . . 0.0 110.677 178.959 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -65.45 -35.47 81.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.311 179.166 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -123.66 175.99 2.48 Favored Pre-proline 0 CA--C 1.536 0.404 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.548 -179.008 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.01 145.34 96.74 Favored 'Trans proline' 0 N--CA 1.501 1.926 0 C-N-CA 122.575 2.183 . . . . 0.0 111.954 -179.443 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.5 m -136.01 138.93 46.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.995 0.426 . . . . 0.0 112.14 -179.235 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -76.36 133.14 40.03 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 178.819 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.51 HD12 HD11 ' A' ' 51' ' ' ILE . 89.9 mt -89.43 136.01 33.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.413 0.625 . . . . 0.0 112.009 -178.589 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -121.26 148.61 44.06 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.742 179.014 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -54.49 123.04 11.84 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.931 0.396 . . . . 0.0 110.279 -179.577 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.13 -20.28 31.07 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.67 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -66.11 137.62 57.17 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.728 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.449 HG22 ' HG2' ' A' ' 96' ' ' ARG . 55.2 t -112.6 133.16 59.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.521 -178.368 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 92.2 mt -99.22 130.68 47.82 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 178.7 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 65.9 m -122.45 124.91 44.71 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.067 -0.653 . . . . 0.0 112.067 -178.735 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.549 HD12 ' HE1' ' A' ' 95' ' ' PHE . 77.0 mt -109.53 121.5 62.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.255 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.598 HD13 HG23 ' A' ' 43' ' ' VAL . 77.4 mt 35.24 -97.76 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.493 -179.867 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.562 ' OD2' ' NE ' ' B' ' 245' ' ' ARG . 42.0 p-10 -110.73 7.68 22.24 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.666 0.269 . . . . 0.0 111.633 -179.219 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 90' ' ' ILE . 85.6 mtt-85 -124.01 144.4 49.85 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.667 179.916 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.664 ' OG ' HD12 ' A' ' 10' ' ' ILE . 32.7 p -137.9 151.02 47.59 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.49 0.662 . . . . 0.0 111.056 179.553 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.549 ' HE1' HD12 ' A' ' 90' ' ' ILE . 35.1 m-85 -124.01 122.11 37.04 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.324 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.449 ' HG2' HG22 ' A' ' 87' ' ' VAL . 74.7 mtp85 -87.85 135.22 33.49 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.851 -178.658 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.571 ' HH ' ' HG2' ' A' ' 5' ' ' ARG . 89.7 t80 -99.25 125.16 44.81 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.629 -179.669 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -143.77 125.46 15.03 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.475 179.472 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.538 ' OD1' ' CZ ' ' A' ' 97' ' ' TYR . 95.4 m-20 . . . . . 0 C--N 1.331 -0.225 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.567 179.705 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo . . . . . 0 N--CA 1.495 1.614 0 N-CA-C 113.342 0.478 . . . . 0.0 113.342 . . . . . . . . . 0 0 . 1 . 100 nuclear build core ' B' B ' 236' ' ' VAL . . . . . 0.461 HG22 HG22 ' A' ' 66' ' ' THR . 71.4 t -58.25 131.09 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.013 -179.806 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 4.5 t . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.644 -179.539 . . . . . . . . 0 0 . 1 . 100 nuclear build core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo . . . . . 0 N--CA 1.494 1.558 0 CA-C-O 120.745 0.227 . . . . 0.0 111.945 . . . . . . . . . 0 0 . 1 . 100 nuclear build core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 29.3 m -72.72 -45.76 57.12 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.079 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' B' B ' 241' ' ' PHE . . . . . 0.481 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 79.4 t80 -58.69 -45.97 88.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.729 -179.872 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.403 ' HA ' HD23 ' B' ' 242' ' ' LEU . 82.1 mt -64.41 -39.04 93.08 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.012 0.434 . . . . 0.0 110.28 -179.899 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -64.08 -39.94 95.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.16 -179.239 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -62.47 -41.42 98.75 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.987 0.422 . . . . 0.0 110.212 179.831 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' B' B ' 245' ' ' ARG . . . . . 0.811 ' O ' HG23 ' B' ' 249' ' ' VAL . 14.9 tpp180 -60.86 -42.38 97.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.081 -179.735 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.39 -42.87 98.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.727 179.738 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 43.8 p -65.37 -44.01 88.94 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.834 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' B' B ' 248' ' ' GLN . . . . . 0.537 ' HB3' HH22 ' A' ' 12' ' ' ARG . 84.5 mt-30 -64.42 -34.48 78.27 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.919 179.737 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' B' B ' 249' ' ' VAL . . . . . 0.811 HG23 ' O ' ' B' ' 245' ' ' ARG . 79.7 t . . . . . 0 N--CA 1.455 -0.219 0 C-N-CA 120.271 -0.572 . . . . 0.0 109.919 179.788 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' B' B ' 260' ' ' GLU . . . . . 0.739 ' OE1' HD21 ' A' ' 41' ' ' LEU . 96.8 mt-10 . . . . . 0 CA--C 1.532 0.257 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 . . . . . . . . . 1 1 . 1 . 100 nuclear build core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 75.7 mt -117.14 134.27 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 C-N-CA 120.544 -0.462 . . . . 0.0 109.911 179.587 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 45.8 t -127.06 133.61 67.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.066 179.549 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' B' B ' 263' ' ' PHE . . . . . 0.651 ' CD2' HG21 ' B' ' 267' ' ' ILE . 85.4 m-85 -98.76 122.15 41.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.088 0.471 . . . . 0.0 111.857 -178.499 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -66.17 -43.11 87.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.134 178.356 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' B' B ' 265' ' ' GLN . . . . . 0.506 ' CD ' HD11 ' A' ' 24' ' ' LEU . 0.9 OUTLIER -102.2 174.16 3.06 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.344 -179.699 . . . . . . . . 3 3 . 1 . 100 nuclear build core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -56.56 150.62 50.92 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 122.825 2.35 . . . . 0.0 113.765 179.76 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' B' B ' 267' ' ' ILE . . . . . 0.651 HG21 ' CD2' ' B' ' 263' ' ' PHE . 34.2 pt . . . . . 0 C--N 1.332 -0.165 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.164 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo . . . . . 0 N--CA 1.493 1.476 0 CA-C-O 120.956 0.315 . . . . 0.0 112.25 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 65.7 p -88.87 -42.86 11.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.839 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.8 mtt85 -89.0 126.91 35.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.647 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -127.48 138.52 52.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.795 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.575 HD11 ' HB3' ' A' ' 95' ' ' PHE . 24.3 tp -117.21 131.63 56.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.023 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.2 t -108.98 131.9 58.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.681 0.276 . . . . 0.0 110.708 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.6 m -82.15 133.18 35.25 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.395 0.617 . . . . 0.0 112.206 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.526 HD12 ' HB2' ' A' ' 94' ' ' SER . 92.8 mt -103.78 137.61 31.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.619 177.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.426 ' HD3' HG23 ' A' ' 15' ' ' VAL . 50.0 mtpt -97.83 160.03 14.56 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.99 -178.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -58.14 -25.57 61.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.299 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.801 ' OG ' HG22 ' A' ' 15' ' ' VAL . 60.1 p -79.64 -13.69 59.32 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.582 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.81 19.73 33.44 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.002 -0.618 . . . . 0.0 111.772 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.801 HG22 ' OG ' ' A' ' 13' ' ' SER . 27.5 m -115.94 135.67 55.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -76.1 141.06 42.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.828 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -123.25 -118.17 2.41 Favored Glycine 0 CA--C 1.542 1.728 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.795 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -72.04 147.96 49.88 Favored 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 122.415 2.077 . . . . 0.0 112.8 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -108.06 150.07 27.64 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.172 0.51 . . . . 0.0 110.768 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.469 ' CD2' HD11 ' A' ' 37' ' ' ILE . 28.8 t80 -119.56 111.64 36.13 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.898 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.12 123.64 6.27 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.555 1.503 . . . . 0.0 111.259 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 82.1 mt -77.65 52.49 1.0 Allowed 'General case' 0 C--O 1.233 0.196 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.665 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.6 t -62.06 -42.16 98.9 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.101 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.6 mt -69.1 146.51 52.5 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 58.4 p -67.45 -16.57 64.3 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.496 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 90.2 m -131.23 133.89 45.91 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.414 -0.514 . . . . 0.0 111.542 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.8 t -124.33 116.05 21.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.446 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.46 HD21 ' HG2' ' A' ' 47' ' ' GLN . 56.9 tp -114.66 124.86 52.89 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.85 0.357 . . . . 0.0 111.422 -178.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.725 ' CE2' HD12 ' A' ' 37' ' ' ILE . 22.7 m-85 -104.5 141.31 36.61 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.518 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 156.59 -173.08 34.36 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.25 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.545 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 27.2 mtm180 -80.0 -27.74 39.55 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.055 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.532 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -56.18 137.78 46.58 Favored Glycine 0 CA--C 1.521 0.453 0 C-N-CA 120.186 -1.007 . . . . 0.0 110.695 -178.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.427 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.6 tp -65.18 -40.12 87.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.671 -0.412 . . . . 0.0 109.99 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.427 ' N ' HG23 ' A' ' 33' ' ' ILE . 74.0 tt0 -53.99 -13.54 0.81 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.256 179.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.532 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 37.8 m -71.24 138.25 49.3 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.513 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.496 ' OD2' ' O ' ' A' ' 26' ' ' THR . 56.0 m-20 -61.55 -34.28 75.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.443 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.725 HD12 ' CE2' ' A' ' 29' ' ' PHE . 94.2 mt -127.59 122.56 59.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 38' ' ' ARG . 13.2 ttp180 -111.86 137.25 50.07 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.418 -178.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 94.6 mt -120.63 130.31 74.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.402 HE21 ' HA ' ' B' ' 260' ' ' GLU . 26.9 pt20 -81.74 38.4 0.51 Allowed 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.607 ' CD1' ' CZ ' ' A' ' 93' ' ' ARG . 39.9 mt -103.08 132.72 20.86 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.91 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.89 -11.37 30.54 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.459 2.106 . . . . 0.0 113.214 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.456 HG21 ' CE2' ' B' ' 241' ' ' PHE . 28.1 m -96.32 4.56 9.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.898 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.545 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 44.1 t -96.23 133.97 35.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.975 0.417 . . . . 0.0 110.562 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.2 m -70.93 165.51 23.19 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.825 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.0 mttm -63.23 -39.18 93.87 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.661 -178.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.695 ' O ' ' N ' ' A' ' 49' ' ' CYS . 86.4 mt-30 -113.92 -16.08 12.25 Favored 'General case' 0 C--O 1.227 -0.128 0 O-C-N 123.31 0.381 . . . . 0.0 111.247 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 28.7 t60 34.26 -74.13 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.695 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.52 138.96 46.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.129 0.49 . . . . 0.0 111.962 -179.025 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -127.56 130.93 49.96 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.877 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.9 mt -114.62 132.81 62.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.602 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -118.65 123.27 44.54 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.8 mt -106.44 117.06 51.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.019 -0.672 . . . . 0.0 112.345 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.431 ' O ' ' C ' ' A' ' 55' ' ' GLU . 81.0 m-70 -114.15 145.17 42.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.233 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 54' ' ' HIS . 96.3 mt-10 -40.5 -31.8 0.17 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.339 0.59 . . . . 0.0 109.471 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.516 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 58.6 tt0 -63.9 -68.6 0.33 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.162 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.516 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 5.1 tp10 -157.38 -170.24 3.17 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.287 -178.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.445 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -109.45 125.97 53.0 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.6 mt -116.63 130.21 71.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.235 0.54 . . . . 0.0 111.857 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 19.4 tp -101.39 126.25 48.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.841 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -110.14 136.64 49.06 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.966 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.444 HD21 ' HA ' ' A' ' 68' ' ' PRO . 64.7 t-20 -96.48 105.48 17.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.684 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -97.63 -7.47 31.01 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.56 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 t -77.01 99.64 5.37 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.012 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.4 m -86.83 -18.18 31.6 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.874 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.2 OUTLIER -88.88 -43.35 11.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.52 -179.898 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -135.31 91.64 18.73 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.803 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.444 ' HA ' HD21 ' A' ' 62' ' ' ASN . 47.3 Cg_exo -56.24 145.51 76.78 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.193 1.929 . . . . 0.0 113.408 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 18.9 m -79.39 137.17 37.19 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.84 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -102.0 141.37 34.95 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.017 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 93.1 t -132.21 134.33 59.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 29.9 m120 50.92 32.87 7.89 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.219 0.533 . . . . 0.0 109.593 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.93 29.56 60.69 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.135 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 31.0 t -148.97 143.83 26.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 117.439 0.619 . . . . 0.0 111.335 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 62.1 t -69.38 143.16 15.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.465 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.1 pt -113.89 68.46 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.223 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -52.12 -27.69 15.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.662 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -120.74 169.57 8.6 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.549 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -60.28 143.14 99.51 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 122.354 2.036 . . . . 0.0 112.23 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.9 m -139.57 139.31 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-O 120.83 0.348 . . . . 0.0 111.223 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -75.51 131.82 40.34 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.445 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 92.3 mt -79.51 139.79 37.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.089 0.471 . . . . 0.0 111.086 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -127.87 144.9 51.09 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.748 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.481 ' CE1' ' H ' ' A' ' 99' ' ' ASN . 3.4 t-160 -54.54 117.67 3.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.924 0.392 . . . . 0.0 110.088 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.67 -14.75 27.06 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.074 -0.811 . . . . 0.0 111.074 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -74.84 133.47 41.88 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.049 0.452 . . . . 0.0 110.316 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.557 HG22 ' HA ' ' A' ' 96' ' ' ARG . 49.4 t -112.38 133.68 57.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.676 -178.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 89.6 mt -93.09 129.99 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 177.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.461 HG23 ' OG ' ' A' ' 94' ' ' SER . 51.6 m -118.17 125.37 50.07 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.717 0.77 . . . . 0.0 112.43 -178.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.539 ' N ' ' O ' ' A' ' 93' ' ' ARG . 87.0 mt -116.62 123.08 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 114.505 -1.225 . . . . 0.0 108.505 178.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.656 HG22 ' N ' ' A' ' 92' ' ' ASP . 94.6 mt 33.24 -101.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.463 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.656 ' N ' HG22 ' A' ' 91' ' ' ILE . 82.6 m-20 -105.86 7.02 32.06 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.64 0.257 . . . . 0.0 111.599 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.607 ' CZ ' ' CD1' ' A' ' 41' ' ' LEU . 40.7 mtm-85 -125.07 142.21 51.63 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.716 -178.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.526 ' HB2' HD12 ' A' ' 10' ' ' ILE . 51.0 m -139.51 157.32 46.04 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.499 -0.481 . . . . 0.0 110.617 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.575 ' HB3' HD11 ' A' ' 7' ' ' LEU . 94.9 m-85 -125.96 120.47 30.45 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.655 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.557 ' HA ' HG22 ' A' ' 87' ' ' VAL . 44.4 ttm180 -80.35 127.08 31.96 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.251 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -92.56 125.7 37.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.805 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -121.6 127.41 50.85 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.263 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.481 ' H ' ' CE1' ' A' ' 84' ' ' HIS . 49.4 t-20 -101.96 111.72 24.09 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.654 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 . . . . . 0 C--N 1.322 -0.591 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.749 179.84 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 44.1 t . . . . . 0 N--CA 1.465 0.306 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.533 ' C ' ' H ' ' B' ' 231' ' ' GLN . 81.0 m-20 -65.78 142.18 58.06 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.237 0.541 . . . . 0.0 111.743 -178.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.533 ' H ' ' C ' ' B' ' 229' ' ' ASP . 78.0 mt-30 -128.53 30.04 5.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.615 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -111.06 -152.5 12.57 Favored Glycine 0 CA--C 1.533 1.211 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -76.9 161.28 33.32 Favored 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 123.067 2.512 . . . . 0.0 113.342 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.874 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -70.56 134.09 25.54 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 121.418 1.412 . . . . 0.0 112.809 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.468 ' CG2' HG22 ' A' ' 66' ' ' THR . 53.5 t -57.79 142.83 12.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.659 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 5.1 t -71.82 129.89 39.74 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 238' ' ' TPO . . . . . 0.405 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 239' ' ' PRO . . . . . 0.405 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 52.5 Cg_exo -56.19 -29.22 74.63 Favored 'Trans proline' 0 N--CA 1.5 1.881 0 C-N-CA 123.011 2.474 . . . . 0.0 112.838 -178.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 70.2 m -69.37 -47.17 65.09 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.526 -0.47 . . . . 0.0 109.787 178.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.456 ' CE2' HG21 ' A' ' 43' ' ' VAL . 71.2 t80 -59.97 -46.67 88.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.624 -179.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.407 ' HA ' HD23 ' B' ' 242' ' ' LEU . 94.5 mt -63.27 -41.29 99.01 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.821 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -65.18 -39.66 93.19 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.009 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -61.97 -41.8 98.41 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.074 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.528 ' NH2' ' CD2' ' A' ' 41' ' ' LEU . 24.9 mmt180 -63.3 -43.15 98.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.676 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -62.68 -41.98 99.39 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.482 -0.487 . . . . 0.0 109.863 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 5.3 t -65.15 -44.86 87.21 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 69.4 tp60 -57.43 -41.16 79.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.778 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 21.5 t -61.52 -42.89 95.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -63.18 -34.76 78.32 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.669 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -79.24 -10.71 59.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.459 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 82.4 mt -102.87 -177.55 3.41 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.568 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 253' ' ' ASN . . . . . 0.55 ' O ' ' N ' ' B' ' 255' ' ' ASP . 67.7 m-80 -154.89 -164.54 1.82 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.831 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -45.44 -14.58 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.264 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 255' ' ' ASP . . . . . 0.55 ' N ' ' O ' ' B' ' 253' ' ' ASN . 97.5 m-20 -65.09 -12.17 47.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.948 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.659 ' O ' ' N ' ' B' ' 258' ' ' ASP . 94.7 m-20 -48.76 -34.44 12.22 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.924 179.179 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 257' ' ' LYS . . . . . 0.498 ' C ' ' O ' ' B' ' 256' ' ' ASP . 88.5 tttt -20.19 -41.38 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 O-C-N 123.928 0.767 . . . . 0.0 111.486 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.659 ' N ' ' O ' ' B' ' 256' ' ' ASP . 93.0 m-20 -100.12 62.19 1.11 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 177.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.539 ' N ' ' O ' ' B' ' 256' ' ' ASP . 41.7 m-20 -50.61 -113.67 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.845 -177.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.471 ' OE1' HD21 ' A' ' 41' ' ' LEU . 98.2 mt-10 -151.72 22.54 0.69 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.255 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 56.5 mt -112.74 134.5 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 53.4 t -122.86 133.32 69.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -96.84 119.54 35.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.243 0.544 . . . . 0.0 111.018 -178.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -67.34 -45.67 75.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.249 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.68 158.18 34.82 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.437 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -60.58 150.32 82.37 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 122.873 2.382 . . . . 0.0 112.478 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 42.9 pt . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 121.581 0.705 . . . . 0.0 111.587 -179.319 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo . . . . . 0 N--CA 1.496 1.647 0 CA-C-O 120.734 0.222 . . . . 0.0 111.808 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.0 p -106.8 -42.23 5.0 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.707 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.747 ' NE ' HD13 ' A' ' 53' ' ' ILE . 89.2 mtm-85 -87.18 121.77 30.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.346 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -126.26 134.75 51.09 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.679 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.513 HD12 ' O ' ' A' ' 96' ' ' ARG . 36.4 tp -115.81 130.94 57.04 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.848 HG22 ' CD2' ' A' ' 19' ' ' HIS . 44.3 t -108.9 131.77 58.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.474 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 m -92.21 114.01 26.43 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 121.13 0.49 . . . . 0.0 111.819 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.427 HD12 ' HB3' ' A' ' 94' ' ' SER . 96.8 mt -81.32 146.09 7.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.151 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -92.71 157.7 16.31 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 1.005 HH21 HD22 ' B' ' 252' ' ' LEU . 87.8 mtm180 -59.91 -21.97 61.79 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.741 -0.383 . . . . 0.0 110.469 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.1 m -80.76 -12.01 59.52 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.1 35.51 8.11 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.9 t -120.72 134.31 64.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.667 0.27 . . . . 0.0 110.869 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -66.41 118.77 10.53 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.409 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -108.29 -130.84 6.31 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.196 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.03 148.34 39.88 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 122.546 2.164 . . . . 0.0 113.321 -178.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.848 ' CD2' HG22 ' A' ' 8' ' ' VAL . 65.0 m170 -104.03 140.0 38.36 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.115 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -111.7 97.87 38.89 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.505 -0.771 . . . . 0.0 108.958 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.432 ' HD2' HG22 ' B' ' 267' ' ' ILE . 57.1 Cg_endo -72.46 127.04 12.11 Favored 'Trans proline' 0 C--N 1.314 -1.24 0 C-N-CA 121.194 1.263 . . . . 0.0 110.922 -178.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.414 ' HA ' HD23 ' A' ' 22' ' ' LEU . 92.8 mt -84.51 81.33 8.89 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.625 0.726 . . . . 0.0 110.563 -178.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 91.1 p -86.72 -9.29 56.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.467 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.0 mt -102.6 145.35 29.77 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.008 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.6 t -65.09 -16.2 63.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.333 -178.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.07 132.63 42.0 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.972 0.415 . . . . 0.0 111.803 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.8 t -123.35 117.58 25.55 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.658 178.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.622 HD21 ' OE1' ' A' ' 47' ' ' GLN . 39.3 tp -115.55 127.4 55.24 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 120.702 0.287 . . . . 0.0 111.35 -178.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.71 ' CE2' HD12 ' A' ' 37' ' ' ILE . 8.4 m-85 -107.62 142.69 37.17 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.504 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 153.97 -170.36 32.58 Favored Glycine 0 N--CA 1.467 0.75 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.966 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.631 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 81.4 mtm-85 -84.0 -31.34 25.53 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.952 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.562 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -53.48 148.65 15.28 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.142 -178.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.532 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.1 tp -68.38 -42.82 84.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.801 0.334 . . . . 0.0 110.454 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.532 ' N ' HG23 ' A' ' 33' ' ' ILE . 51.6 tp10 -53.09 -19.89 3.23 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.562 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 5.3 m -66.8 124.95 24.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.821 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -59.5 -27.41 66.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.312 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.71 HD12 ' CE2' ' A' ' 29' ' ' PHE . 97.7 mt -128.45 121.14 54.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.831 178.236 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 74.1 mtm180 -100.4 135.45 41.82 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.492 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.79 HG21 ' CZ ' ' A' ' 93' ' ' ARG . 99.4 mt -119.99 131.8 71.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.458 0.647 . . . . 0.0 110.57 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -78.78 28.22 0.21 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.999 -1.0 . . . . 0.0 112.987 -178.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.657 ' O ' HG12 ' A' ' 44' ' ' VAL . 7.3 mt -105.97 104.69 50.48 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 120.539 -0.465 . . . . 0.0 109.804 178.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -53.84 -8.74 0.96 Allowed 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 122.417 2.078 . . . . 0.0 113.254 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.62 HG21 ' CE2' ' B' ' 241' ' ' PHE . 26.9 m -95.62 3.69 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.637 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.657 HG12 ' O ' ' A' ' 41' ' ' LEU . 5.9 p -95.45 138.23 21.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.079 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.46 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 0.5 OUTLIER -65.88 162.54 18.8 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.487 0.66 . . . . 0.0 111.527 -179.101 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt -62.94 -40.55 97.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.433 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.676 ' O ' ' N ' ' A' ' 49' ' ' CYS . 15.1 mm100 -109.47 -13.28 14.6 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.381 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.46 ' H ' ' HB3' ' A' ' 45' ' ' SER . 25.8 t60 35.88 -73.31 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.288 -0.869 . . . . 0.0 113.163 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.676 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -149.35 149.76 31.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.19 0.519 . . . . 0.0 111.661 -179.564 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -135.85 134.9 39.32 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.675 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 89.4 mt -105.81 133.39 50.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.024 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -111.71 120.37 41.79 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.747 HD13 ' NE ' ' A' ' 5' ' ' ARG . 91.3 mt -104.46 110.02 29.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.581 0.705 . . . . 0.0 111.613 -178.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.468 ' O ' ' N ' ' A' ' 56' ' ' GLN . 95.0 m-70 -112.19 144.37 41.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.644 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 54' ' ' HIS . 83.7 tt0 -41.18 -28.35 0.09 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.468 ' N ' ' O ' ' A' ' 54' ' ' HIS . 99.7 mm-40 -66.53 -68.82 0.34 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.151 178.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -158.75 -169.69 2.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.479 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -108.43 124.61 50.67 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.509 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 98.9 mt -115.58 129.32 72.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.084 0.468 . . . . 0.0 112.059 -178.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.451 HD11 ' SG ' ' A' ' 49' ' ' CYS . 43.9 tp -94.51 124.18 38.38 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.973 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -108.82 132.1 54.33 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.865 0.364 . . . . 0.0 110.019 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 33.5 t-20 -94.32 105.04 17.02 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.813 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -96.31 -6.56 37.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.033 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.2 t -85.58 97.58 10.16 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.199 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 77.5 p -78.09 -33.59 50.61 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 177.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.694 HG21 ' O ' ' B' ' 234' ' ' TPO . 2.7 m -63.68 -46.25 86.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.817 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -142.48 95.98 6.41 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.777 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.49 144.45 62.47 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 121.877 1.718 . . . . 0.0 112.122 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 33.0 m -72.09 138.07 47.52 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.128 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -100.98 139.28 36.88 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.642 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 70.8 t -129.97 135.42 61.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 52.43 32.87 11.98 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 119.774 -0.77 . . . . 0.0 109.063 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.23 27.85 69.25 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.611 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 34.4 t -142.23 137.32 30.65 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 117.671 0.736 . . . . 0.0 111.91 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -69.18 143.6 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.511 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.562 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 1.2 pt -113.47 108.1 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 121.564 0.697 . . . . 0.0 110.553 178.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -70.8 -31.62 68.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.282 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.485 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -129.38 -179.35 0.98 Allowed Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.752 -179.588 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 24.7 Cg_exo -62.6 146.94 95.41 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 122.779 2.32 . . . . 0.0 112.061 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.8 p -140.12 141.69 33.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.019 0.438 . . . . 0.0 111.164 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -76.56 133.44 39.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.724 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 82' ' ' LEU . 98.3 mt -88.93 139.14 30.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.206 0.527 . . . . 0.0 111.501 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.405 ' N ' ' OD2' ' A' ' 86' ' ' ASP . 99.4 mttt -123.2 149.76 44.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.803 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.512 ' ND1' ' N ' ' A' ' 99' ' ' ASN . 8.1 t60 -54.39 121.92 9.33 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.125 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.8 -13.24 38.41 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.405 ' OD2' ' N ' ' A' ' 83' ' ' LYS . 84.3 m-20 -68.88 136.58 52.85 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.056 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.401 ' CG1' ' OG ' ' A' ' 94' ' ' SER . 70.3 t -109.14 131.56 59.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.422 -178.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 25.7 mm -93.37 129.58 43.62 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 178.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.0 m -120.42 123.88 44.1 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.104 -0.639 . . . . 0.0 112.205 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.669 ' CG2' HH12 ' A' ' 93' ' ' ARG . 94.9 mt -122.61 126.75 74.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.367 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.476 HG22 ' N ' ' A' ' 92' ' ' ASP . 47.9 mm 35.34 -105.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 121.041 -0.264 . . . . 0.0 111.246 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.477 ' OD1' ' CD2' ' B' ' 242' ' ' LEU . 87.8 m-20 -109.12 16.4 22.55 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.747 0.308 . . . . 0.0 111.064 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.79 ' CZ ' HG21 ' A' ' 39' ' ' ILE . 1.8 mtm105 -126.39 144.57 50.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.073 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.427 ' HB3' HD12 ' A' ' 10' ' ' ILE . 47.4 t -138.7 148.73 44.31 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 178.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.48 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 27.3 m-85 -125.6 125.11 42.63 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.659 -179.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.513 ' O ' HD12 ' A' ' 7' ' ' LEU . 78.4 mtp85 -85.91 128.02 34.74 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.433 -179.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.559 ' CZ ' ' OD1' ' A' ' 99' ' ' ASN . 92.0 t80 -95.41 127.17 41.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.945 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -138.67 124.6 19.96 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.222 -0.591 . . . . 0.0 111.969 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.559 ' OD1' ' CZ ' ' A' ' 97' ' ' TYR . 96.9 m-20 -100.83 107.21 18.69 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.107 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.492 ' O ' ' O ' ' A' ' 99' ' ' ASN . 46.3 tt0 . . . . . 0 C--N 1.327 -0.371 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.531 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 14.4 p . . . . . 0 CA--C 1.53 0.185 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.443 ' OD1' ' N ' ' B' ' 230' ' ' SEP . 67.1 t0 -45.64 128.37 8.37 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.982 0.42 . . . . 0.0 111.44 -179.104 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 230' ' ' SEP . . . . . 0.443 ' N ' ' OD1' ' B' ' 229' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.49 ' O ' ' O ' ' B' ' 232' ' ' GLY . 71.0 mt-30 -114.2 -27.38 7.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.155 0.502 . . . . 0.0 109.808 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 232' ' ' GLY . . . . . 0.49 ' O ' ' O ' ' B' ' 231' ' ' GLN . . . -45.44 -177.19 0.01 OUTLIER Glycine 0 CA--C 1.53 1.004 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.19 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -70.6 162.07 43.8 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 123.891 3.061 . . . . 0.0 113.136 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.694 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.22 138.22 24.75 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 121.679 1.586 . . . . 0.0 113.115 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -67.37 139.89 20.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.327 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 6.3 t -73.8 133.19 43.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.016 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 238' ' ' TPO . . . . . 0.441 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 239' ' ' PRO . . . . . 0.441 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 31.7 Cg_exo -60.1 -25.99 81.28 Favored 'Trans proline' 0 N--CA 1.504 2.093 0 C-N-CA 123.224 2.616 . . . . 0.0 113.842 -178.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 35.4 m -74.61 -43.21 56.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.314 0.578 . . . . 0.0 109.851 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.62 ' CE2' HG21 ' A' ' 43' ' ' VAL . 68.7 t80 -59.18 -45.96 89.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.926 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.477 ' CD2' ' OD1' ' A' ' 92' ' ' ASP . 81.6 mt -62.47 -41.73 98.99 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.777 -0.192 . . . . 0.0 111.382 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -65.86 -36.9 84.72 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.676 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 244' ' ' ARG . . . . . 0.453 ' HE ' HE21 ' B' ' 248' ' ' GLN . 80.0 ttt180 -59.63 -42.85 93.63 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.606 ' NE ' ' CZ ' ' B' ' 241' ' ' PHE . 2.4 mpt_? -60.64 -41.77 95.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.193 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -60.83 -40.45 92.82 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 16.5 m -64.26 -46.55 83.22 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.622 178.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 248' ' ' GLN . . . . . 0.53 ' OE1' ' NH1' ' B' ' 245' ' ' ARG . 86.9 mt-30 -61.62 -36.48 80.87 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.12 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.401 HG23 ' O ' ' B' ' 245' ' ' ARG . 42.1 t -61.11 -46.27 96.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.347 -0.541 . . . . 0.0 110.099 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -60.34 -28.98 68.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.962 0.41 . . . . 0.0 110.143 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -95.42 -13.68 24.43 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.794 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 1.005 HD22 HH21 ' A' ' 12' ' ' ARG . 46.9 tp -74.52 142.12 44.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.098 0.475 . . . . 0.0 111.865 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -101.06 140.04 35.91 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.523 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -64.35 -19.06 65.22 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.315 0.579 . . . . 0.0 109.527 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -65.58 -10.44 35.34 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.926 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.419 ' C ' ' H ' ' B' ' 258' ' ' ASP . 67.7 t0 -93.7 75.3 4.32 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.34 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -67.82 11.53 0.14 Allowed 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -178.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.661 ' O ' ' N ' ' B' ' 260' ' ' GLU . 91.9 m-20 -96.83 1.26 50.47 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.476 ' C ' ' O ' ' B' ' 258' ' ' ASP . 39.0 t70 4.92 54.25 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 114.393 -1.276 . . . . 0.0 113.284 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.661 ' N ' ' O ' ' B' ' 258' ' ' ASP . 57.8 mp0 55.46 4.37 0.1 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.513 ' N ' ' O ' ' B' ' 258' ' ' ASP . 70.8 mt -117.36 134.28 61.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 54.2 t -127.74 135.06 64.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.295 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -95.28 117.69 30.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.217 0.532 . . . . 0.0 111.151 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -65.13 -44.18 89.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.08 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -91.55 150.43 41.1 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.658 -178.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -67.03 146.07 75.85 Favored 'Trans proline' 0 N--CA 1.497 1.678 0 C-N-CA 122.644 2.229 . . . . 0.0 112.697 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 267' ' ' ILE . . . . . 0.432 HG22 ' HD2' ' A' ' 21' ' ' PRO . 25.1 pt . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.114 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo . . . . . 0 N--CA 1.497 1.728 0 CA-C-O 121.072 0.363 . . . . 0.0 113.005 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.9 p -110.34 -34.29 6.39 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 120.714 -0.395 . . . . 0.0 111.487 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 87.8 mtm-85 -104.38 125.79 50.91 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.076 0.465 . . . . 0.0 111.638 -178.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -134.04 138.67 45.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.922 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.585 HD12 ' O ' ' A' ' 96' ' ' ARG . 31.4 tp -113.29 129.62 56.48 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.6 m -107.58 133.52 52.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-O 121.085 0.469 . . . . 0.0 110.681 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.2 m -90.68 115.39 27.74 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.457 -0.792 . . . . 0.0 113.136 -177.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.4 mt -79.02 142.1 14.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 178.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -88.74 157.64 18.44 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.552 HH12 ' CD ' ' B' ' 248' ' ' GLN . 84.2 mtp180 -59.04 -33.07 70.33 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.021 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.7 t -69.91 -18.6 63.39 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.267 0.556 . . . . 0.0 109.849 178.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.82 34.75 4.24 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.6 t -124.95 134.16 67.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.13 0.49 . . . . 0.0 111.517 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -70.11 131.31 44.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.253 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -113.13 -128.04 4.8 Favored Glycine 0 CA--C 1.539 1.545 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.586 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -73.74 154.76 49.2 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.35 2.033 . . . . 0.0 112.625 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.498 ' O ' ' CG2' ' B' ' 267' ' ' ILE . 11.8 m-70 -110.01 139.98 44.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.269 0.557 . . . . 0.0 111.177 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.433 ' CD2' HD11 ' A' ' 37' ' ' ILE . 27.9 t80 -108.6 99.38 33.27 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.014 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.87 128.14 15.51 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 121.19 1.26 . . . . 0.0 111.334 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 72.5 mt -79.06 47.86 0.81 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.301 -178.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 99.5 p -59.1 -24.87 63.32 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.672 HD11 ' HG2' ' B' ' 265' ' ' GLN . 71.0 mt -78.35 139.52 38.8 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.417 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.8 t -66.15 -18.45 65.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.354 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.479 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 85.1 m -133.02 135.17 45.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.813 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.8 t -127.06 115.34 19.03 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.417 HD12 ' O ' ' A' ' 49' ' ' CYS . 51.2 tp -114.93 129.88 56.8 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.195 0.522 . . . . 0.0 110.915 -178.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.849 ' CE2' HD12 ' A' ' 37' ' ' ILE . 14.3 m-85 -110.96 135.16 51.89 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.146 -0.933 . . . . 0.0 109.576 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 160.21 -172.06 36.59 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.704 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -81.2 -31.6 33.86 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.705 0.288 . . . . 0.0 110.998 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.529 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -54.9 150.31 18.75 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 111.714 -0.554 . . . . 0.0 111.714 -178.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.47 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.9 tp -66.44 -40.05 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-O 120.791 0.329 . . . . 0.0 110.158 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.47 ' N ' HG23 ' A' ' 33' ' ' ILE . 96.9 mt-10 -51.72 -27.87 13.27 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.338 -0.545 . . . . 0.0 109.542 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.529 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 14.2 m -57.16 110.99 0.93 Allowed 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.934 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.479 ' OD2' ' O ' ' A' ' 26' ' ' THR . 97.5 m-20 -51.18 -18.75 0.96 Allowed 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.849 HD12 ' CE2' ' A' ' 29' ' ' PHE . 76.2 mt -134.06 125.77 48.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.94 177.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 71.5 mtm180 -103.46 135.06 45.76 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.612 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 99.2 mt -117.17 129.1 74.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -77.25 25.48 0.17 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -177.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.526 HD21 ' NH1' ' B' ' 245' ' ' ARG . 67.2 mt -96.81 128.06 37.08 Favored Pre-proline 0 N--CA 1.466 0.35 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.554 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -73.22 -9.75 23.58 Favored 'Trans proline' 0 N--CA 1.487 1.132 0 C-N-CA 122.052 1.835 . . . . 0.0 112.848 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.439 HG23 HG13 ' A' ' 91' ' ' ILE . 28.9 m -96.71 4.2 9.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 120.758 0.313 . . . . 0.0 110.582 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 38.1 t -93.08 135.71 27.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.871 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.9 m -70.67 173.01 7.69 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.473 0.654 . . . . 0.0 111.584 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 40.7 mtmt -63.73 -41.66 98.02 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.527 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.614 ' O ' ' N ' ' A' ' 49' ' ' CYS . 86.1 mt-30 -114.52 -20.95 10.55 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.919 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 27.5 t60 37.75 -76.13 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 113.971 1.101 . . . . 0.0 113.971 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.614 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -128.78 133.27 48.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.926 0.393 . . . . 0.0 111.516 -178.621 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -125.66 127.95 47.07 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.31 178.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 94.5 mt -110.25 132.41 58.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -114.5 120.3 39.78 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.3 mt -102.93 114.94 43.95 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 C-N-CA 119.714 -0.794 . . . . 0.0 111.968 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.55 ' O ' ' N ' ' A' ' 56' ' ' GLN . 97.0 m-70 -112.57 141.16 46.66 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.221 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.469 ' C ' ' O ' ' A' ' 54' ' ' HIS . 95.1 mt-10 -39.73 -26.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 -178.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.55 ' N ' ' O ' ' A' ' 54' ' ' HIS . 84.6 mt-30 -66.05 -67.98 0.4 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.948 177.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -161.84 -158.27 0.53 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.479 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -116.71 129.76 56.32 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.575 0.226 . . . . 0.0 110.66 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 98.2 mt -119.55 131.59 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 121.046 0.451 . . . . 0.0 111.762 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.474 ' HB2' HD11 ' A' ' 82' ' ' LEU . 28.7 tp -99.27 129.34 45.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.977 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -116.48 138.22 51.55 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.825 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 38.2 p-10 -101.89 107.33 18.47 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.629 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -94.27 -11.61 29.82 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.896 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.3 p -77.19 100.75 5.9 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.286 178.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.7 p -73.43 -34.27 65.35 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.447 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.3 OUTLIER -71.11 -40.29 71.55 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.699 -179.987 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -144.07 90.95 6.63 Favored Pre-proline 0 N--CA 1.467 0.412 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -64.81 149.45 89.61 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 C-N-CA 120.988 1.126 . . . . 0.0 112.089 -179.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.8 m -71.11 151.51 44.4 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.386 0.612 . . . . 0.0 111.776 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -106.7 147.06 30.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.833 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.501 ' CG2' ' OD1' ' A' ' 86' ' ' ASP . 4.8 p -132.88 134.86 57.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 51.75 32.11 9.02 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.185 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.88 27.64 70.26 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.878 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 68.6 m -139.26 142.35 37.78 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.2 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.7 t -75.45 133.3 31.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.381 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.3 pt -101.84 102.12 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.516 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -64.1 -34.42 78.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.492 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.402 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 1.3 mt-10 -129.74 178.49 1.68 Allowed Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.79 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.402 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 31.3 Cg_exo -60.09 143.63 99.53 Favored 'Trans proline' 0 N--CA 1.504 2.09 0 C-N-CA 122.742 2.295 . . . . 0.0 112.469 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.5 p -135.91 138.46 47.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.371 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 83.3 mtm-85 -73.17 129.88 39.02 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.5 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.474 HD11 ' HB2' ' A' ' 60' ' ' LEU . 97.0 mt -83.77 137.41 33.74 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.161 -178.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -129.17 152.98 48.16 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.363 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.533 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 7.5 t60 -53.36 119.18 4.48 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.264 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.64 -14.46 29.73 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 87' ' ' VAL . 59.4 t0 -66.25 130.41 43.14 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.229 0.538 . . . . 0.0 110.623 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.599 HG22 ' HG2' ' A' ' 96' ' ' ARG . 71.1 t -109.27 130.85 61.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.001 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 87.6 mt -105.78 134.1 48.27 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.6 m -118.21 124.33 47.65 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 121.191 0.519 . . . . 0.0 111.64 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.576 ' N ' ' O ' ' A' ' 93' ' ' ARG . 97.4 mt -114.82 126.08 72.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.448 HG22 ' N ' ' A' ' 92' ' ' ASP . 36.2 mm 38.28 -109.3 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.697 -179.035 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.537 ' OD1' ' CD2' ' B' ' 242' ' ' LEU . 98.1 m-20 -107.77 14.61 25.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.501 0.667 . . . . 0.0 110.011 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.644 ' NH2' ' OD2' ' B' ' 259' ' ' ASP . 18.8 mtp85 -126.86 146.95 50.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.298 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 66.4 m -137.69 150.65 47.5 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 121.235 0.54 . . . . 0.0 110.778 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.541 ' CE1' HD12 ' A' ' 90' ' ' ILE . 89.0 m-85 -124.39 122.28 37.23 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.69 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.599 ' HG2' HG22 ' A' ' 87' ' ' VAL . 99.8 mtt180 -89.79 135.84 33.39 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 119.378 -0.929 . . . . 0.0 110.685 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -96.75 124.72 40.81 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.431 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -124.79 122.08 36.41 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.533 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 46.3 t30 -118.49 103.87 10.16 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.671 -0.411 . . . . 0.0 111.257 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 . . . . . 0 C--N 1.326 -0.44 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.806 179.415 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 228' ' ' VAL . . . . . 0.811 HG23 ' O ' ' B' ' 228' ' ' VAL . 30.4 m . . . . . 0 CA--C 1.521 -0.142 0 CA-C-O 120.988 0.423 . . . . 0.0 110.876 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.545 ' O ' ' CB ' ' B' ' 230' ' ' SEP . 42.0 p-10 -102.58 3.02 36.9 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.367 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 230' ' ' SEP . . . . . 0.545 ' CB ' ' O ' ' B' ' 229' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.429 ' OE1' ' O ' ' B' ' 230' ' ' SEP . 26.7 mm100 -124.98 62.56 1.16 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.251 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -135.35 175.32 20.77 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.684 -178.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.22 160.48 49.7 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 123.396 2.731 . . . . 0.0 112.847 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.29 137.91 45.06 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.258 1.972 . . . . 0.0 113.767 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.447 ' CG2' HG22 ' A' ' 66' ' ' THR . 24.0 t -67.99 135.08 29.16 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.921 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 16.0 t -68.87 128.58 37.17 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.391 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 238' ' ' TPO . . . . . 0.426 ' O2P' ' OG1' ' B' ' 240' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 239' ' ' PRO . . . . . 0.42 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 51.0 Cg_exo -57.49 -26.86 73.72 Favored 'Trans proline' 0 N--CA 1.506 2.236 0 C-N-CA 123.517 2.811 . . . . 0.0 113.905 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 240' ' ' THR . . . . . 0.426 ' OG1' ' O2P' ' B' ' 238' ' ' TPO . 21.2 m -71.64 -45.93 60.55 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.202 0.525 . . . . 0.0 109.933 178.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.435 ' HZ ' HD22 ' A' ' 41' ' ' LEU . 45.9 t80 -58.09 -44.89 87.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.068 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.537 ' CD2' ' OD1' ' A' ' 92' ' ' ASP . 93.7 mt -62.21 -40.81 97.35 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.566 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -61.62 -45.17 95.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.362 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 -62.4 -43.07 99.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.733 0.301 . . . . 0.0 110.995 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.526 ' NH1' HD21 ' A' ' 41' ' ' LEU . 16.1 mmm180 -58.67 -44.88 90.34 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.76 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -63.27 -39.24 94.05 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.874 0.369 . . . . 0.0 110.175 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 38.8 t -65.48 -44.77 86.09 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 122.0 0.905 . . . . 0.0 109.137 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 248' ' ' GLN . . . . . 0.552 ' CD ' HH12 ' A' ' 12' ' ' ARG . 7.3 tt0 -59.62 -39.76 85.34 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.74 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.444 ' HA ' HD12 ' B' ' 252' ' ' LEU . 26.0 t -59.93 -45.59 94.98 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -59.29 -27.74 66.12 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -86.2 -12.57 49.39 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.666 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.444 HD12 ' HA ' ' B' ' 249' ' ' VAL . 66.7 mt -77.51 148.72 35.15 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.401 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -77.41 163.96 25.91 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.353 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 51.7 p-10 -78.98 -7.88 58.44 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -108.13 20.1 19.12 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.737 -1.119 . . . . 0.0 110.31 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -60.11 136.48 58.03 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.391 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 257' ' ' LYS . . . . . 0.689 ' O ' ' N ' ' B' ' 259' ' ' ASP . 99.0 mttt -125.29 -137.68 0.27 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.318 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.61 ' C ' ' O ' ' B' ' 257' ' ' LYS . 99.1 m-20 -9.58 74.37 0.0 OUTLIER 'General case' 0 C--N 1.351 0.668 0 O-C-N 124.096 0.872 . . . . 0.0 109.944 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.689 ' N ' ' O ' ' B' ' 257' ' ' LYS . 51.2 p-10 -78.82 80.96 5.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.922 -176.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.472 ' OE1' ' NH1' ' B' ' 245' ' ' ARG . 98.5 mt-10 46.48 2.75 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.561 ' N ' ' O ' ' B' ' 259' ' ' ASP . 78.7 mt -112.38 132.01 62.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.068 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 46.0 t -127.5 134.18 66.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.193 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -99.09 123.58 43.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.341 0.591 . . . . 0.0 110.897 -178.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -64.28 -40.6 96.3 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.414 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 265' ' ' GLN . . . . . 0.672 ' HG2' HD11 ' A' ' 24' ' ' LEU . 5.1 mp0 -95.81 164.67 18.21 Favored Pre-proline 0 N--CA 1.463 0.224 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.254 -178.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -61.27 145.13 98.81 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 122.283 1.989 . . . . 0.0 110.916 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 267' ' ' ILE . . . . . 0.498 ' CG2' ' O ' ' A' ' 19' ' ' HIS . 2.6 mt . . . . . 0 C--N 1.321 -0.657 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.425 -178.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo . . . . . 0 N--CA 1.492 1.426 0 CA-C-O 120.932 0.305 . . . . 0.0 112.698 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.4 p -89.91 -45.24 9.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.471 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.5 mtt85 -88.28 129.81 35.27 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.249 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -126.09 136.18 52.61 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.27 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.61 HD12 ' O ' ' A' ' 96' ' ' ARG . 30.6 tp -115.82 132.58 56.6 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.9 t -110.2 132.37 58.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.063 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 m -88.72 114.2 25.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.024 -0.534 . . . . 0.0 112.118 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.437 HD12 ' HB2' ' A' ' 94' ' ' SER . 95.5 mt -85.13 144.02 10.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -96.09 160.33 14.5 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.514 HH12 ' CD ' ' B' ' 260' ' ' GLU . 94.7 mtm-85 -62.38 -20.2 64.18 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.901 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.0 p -78.58 -16.25 57.63 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 120.592 -0.443 . . . . 0.0 109.909 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.41 17.72 30.56 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.369 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.0 m -115.14 135.63 54.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 117.191 0.496 . . . . 0.0 110.169 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -72.52 142.86 48.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.341 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -126.72 -117.72 2.14 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.499 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.63 146.77 44.26 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.161 1.907 . . . . 0.0 112.129 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.595 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -108.03 138.98 43.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.06 0.457 . . . . 0.0 110.909 -179.69 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.631 ' CE2' HD11 ' A' ' 37' ' ' ILE . 50.2 t80 -110.1 104.85 56.45 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.955 -178.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.83 130.19 14.29 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.211 1.274 . . . . 0.0 112.016 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.4 mt -83.74 60.27 5.65 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.603 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.3 t -62.83 -40.67 98.15 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 69.9 mt -71.6 144.1 49.59 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.149 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 92.3 p -69.41 -14.06 62.7 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.055 -0.521 . . . . 0.0 112.101 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.407 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 62.6 m -130.42 133.65 46.51 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.38 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.5 t -124.95 115.94 21.39 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 58.5 tp -113.56 130.26 56.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.911 0.386 . . . . 0.0 110.928 -178.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.522 ' O ' ' O ' ' A' ' 47' ' ' GLN . 59.2 m-85 -110.17 136.33 49.56 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.219 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 160.83 -174.26 37.45 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.284 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.581 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 82.3 mtm-85 -79.93 -30.48 39.98 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.552 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -53.4 149.18 13.67 Favored Glycine 0 N--CA 1.467 0.718 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.496 -177.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.539 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.5 tp -67.65 -43.24 86.93 Favored 'Isoleucine or valine' 0 C--N 1.341 0.2 0 CA-C-O 120.868 0.366 . . . . 0.0 111.008 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.539 ' N ' HG23 ' A' ' 33' ' ' ILE . 81.3 tt0 -56.09 -19.39 12.9 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.825 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.552 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 9.6 m -63.02 126.44 27.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.607 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.407 ' OD2' ' O ' ' A' ' 26' ' ' THR . 89.8 m-20 -61.41 -32.6 72.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.337 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.631 HD11 ' CE2' ' A' ' 20' ' ' PHE . 50.5 mm -123.38 114.58 42.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.195 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 38' ' ' ARG . 47.0 mtm180 -99.72 137.14 38.62 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 121.169 -0.212 . . . . 0.0 110.667 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 82.2 mt -120.06 131.27 72.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 120.184 -0.606 . . . . 0.0 111.093 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -73.22 28.31 0.06 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.332 -0.849 . . . . 0.0 113.001 -177.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.722 HD12 ' CZ ' ' A' ' 93' ' ' ARG . 65.9 mt -113.06 130.92 23.1 Favored Pre-proline 0 C--N 1.323 -0.564 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.692 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.84 -9.67 23.98 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 122.262 1.974 . . . . 0.0 112.184 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.488 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 13.1 m -90.86 2.6 7.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.026 0.441 . . . . 0.0 110.017 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.581 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 55.2 t -94.51 132.3 38.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.7 m -71.22 169.2 15.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.562 0.696 . . . . 0.0 111.932 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -62.46 -41.78 99.0 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.442 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.639 ' O ' ' N ' ' A' ' 49' ' ' CYS . 96.3 mt-30 -116.34 -15.26 10.99 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.281 0.363 . . . . 0.0 110.834 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.0 t60 31.08 -74.25 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.639 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.5 138.34 47.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.212 0.529 . . . . 0.0 112.126 -178.67 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -127.99 133.35 49.16 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.443 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.6 mt -118.25 133.94 63.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.026 0.441 . . . . 0.0 110.705 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.438 ' CD ' ' NE2' ' A' ' 54' ' ' HIS . 85.1 tt0 -121.03 124.07 43.93 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.0 mt -106.54 117.26 51.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.661 0.743 . . . . 0.0 112.914 -178.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.438 ' NE2' ' CD ' ' A' ' 52' ' ' GLU . 94.3 m-70 -110.66 143.3 41.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.098 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 54' ' ' HIS . 83.2 tt0 -40.39 -30.32 0.1 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.278 -0.569 . . . . 0.0 109.807 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.434 ' N ' ' O ' ' A' ' 54' ' ' HIS . 59.9 tt0 -64.11 -67.62 0.42 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -157.21 -169.44 2.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.071 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.458 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -110.75 125.95 54.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.767 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.6 mt -115.48 128.52 72.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.31 0.576 . . . . 0.0 111.933 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 24.9 tp -99.07 132.1 44.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.968 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -115.4 135.83 53.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.528 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -97.17 108.58 21.34 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.929 0.395 . . . . 0.0 111.185 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -100.88 -8.57 22.43 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.263 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.7 t -74.64 98.84 3.5 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.092 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.2 m -74.51 -40.38 61.81 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.25 0.547 . . . . 0.0 110.236 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.537 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.3 OUTLIER -64.54 -43.38 94.16 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.264 -178.904 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -144.34 97.36 5.17 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.011 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -57.25 149.4 64.54 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.977 1.785 . . . . 0.0 111.858 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.46 HG22 ' N ' ' A' ' 70' ' ' GLN . 85.4 m -76.41 156.34 33.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.324 0.583 . . . . 0.0 110.933 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.46 ' N ' HG22 ' A' ' 69' ' ' THR . 88.0 mt-30 -114.84 139.36 49.82 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.61 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 55.3 t -128.42 136.23 60.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.54 ' ND2' ' OD1' ' A' ' 86' ' ' ASP . 82.2 m-20 53.25 33.36 15.29 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 119.777 -0.769 . . . . 0.0 109.1 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.04 27.38 73.93 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 115.106 -0.952 . . . . 0.0 112.032 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 74.3 m -141.56 136.37 31.02 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 117.29 0.545 . . . . 0.0 111.31 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.7 p -63.46 144.01 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.803 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.497 HG21 HG21 ' A' ' 80' ' ' VAL . 7.3 pt -118.78 90.96 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.091 0 CA-C-O 121.065 0.459 . . . . 0.0 110.538 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -67.46 -26.94 66.64 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.443 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -122.58 169.34 9.9 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.063 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.79 144.23 99.48 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.075 1.85 . . . . 0.0 111.773 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.497 HG21 HG21 ' A' ' 76' ' ' ILE . 3.3 m -136.47 138.43 46.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.22 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -73.88 134.48 43.25 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.498 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.458 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 95.7 mt -86.09 135.81 33.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.03 0.443 . . . . 0.0 111.324 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -127.79 148.33 50.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.502 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.479 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 5.3 t60 -48.86 116.16 1.54 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.081 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.01 -13.87 40.85 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.161 -0.775 . . . . 0.0 111.161 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.54 ' OD1' ' ND2' ' A' ' 72' ' ' ASN . 34.4 t70 -66.23 133.7 51.16 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 70.8 t -114.19 133.29 60.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.354 -0.538 . . . . 0.0 111.517 -178.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 71.1 mt -100.02 131.77 46.83 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.588 HG23 ' OG ' ' A' ' 94' ' ' SER . 89.4 m -123.97 125.9 45.39 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.83 -178.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.504 ' O ' ' N ' ' A' ' 92' ' ' ASP . 94.2 mt -112.5 123.65 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.591 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.47 HG22 ' N ' ' A' ' 92' ' ' ASP . 94.5 mt 38.61 -94.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.028 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 90' ' ' ILE . 52.1 t0 -121.71 16.35 11.08 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 120.941 -0.303 . . . . 0.0 111.564 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.722 ' CZ ' HD12 ' A' ' 41' ' ' LEU . 44.3 mtm-85 -128.43 139.05 52.56 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.588 ' OG ' HG23 ' A' ' 89' ' ' THR . 58.0 m -133.69 152.14 51.81 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 119.979 -0.689 . . . . 0.0 111.169 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.522 ' HB3' HD11 ' A' ' 7' ' ' LEU . 80.8 m-85 -123.85 121.74 36.16 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.088 178.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.61 ' O ' HD12 ' A' ' 7' ' ' LEU . 79.8 mtp85 -85.21 131.75 34.38 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.113 0.483 . . . . 0.0 111.304 -178.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -95.63 124.73 39.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.003 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -125.6 122.31 36.09 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.967 0.413 . . . . 0.0 110.702 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.479 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 55.3 t-20 -104.38 105.56 15.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.957 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.854 179.585 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 228' ' ' VAL . . . . . 0.569 ' O ' ' CB ' ' B' ' 229' ' ' ASP . 34.0 m . . . . . 0 N--CA 1.455 -0.187 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.569 ' CB ' ' O ' ' B' ' 228' ' ' VAL . 22.1 t0 95.55 158.04 0.02 OUTLIER 'General case' 0 C--O 1.237 0.42 0 O-C-N 123.768 0.668 . . . . 0.0 111.282 179.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 170.41 23.88 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.614 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -115.89 -167.89 15.12 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 111.518 -0.633 . . . . 0.0 111.518 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.52 159.5 53.35 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.694 2.263 . . . . 0.0 112.48 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.509 ' O2P' HG21 ' B' ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -74.29 172.47 15.99 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 122.417 2.078 . . . . 0.0 112.478 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.537 ' CG2' HG22 ' A' ' 66' ' ' THR . 24.1 t -111.08 132.55 59.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.273 -179.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 40.1 t -61.73 120.65 11.06 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.97 0.414 . . . . 0.0 110.046 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -56.67 -22.37 43.72 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 121.757 1.638 . . . . 0.0 112.043 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 18.8 m -74.16 -44.35 53.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.316 0.579 . . . . 0.0 109.806 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.488 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 82.1 t80 -58.14 -46.55 85.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.0 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' B' ' 242' ' ' LEU . 95.0 mt -64.5 -39.62 94.12 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.154 0.502 . . . . 0.0 109.993 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -61.33 -41.7 97.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.577 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -60.9 -42.24 97.66 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.326 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.485 ' NH2' ' CE1' ' B' ' 241' ' ' PHE . 47.8 mmt-85 -61.17 -40.49 94.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.93 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -61.34 -39.27 89.96 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 24.0 m -65.76 -43.73 88.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -60.48 -37.65 81.73 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 114.511 -1.222 . . . . 0.0 110.426 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 46.8 t -61.73 -46.39 96.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.051 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -60.46 -27.52 67.61 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 121.272 0.558 . . . . 0.0 109.793 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -86.16 -11.82 51.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.917 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.567 ' O ' ' CB ' ' B' ' 253' ' ' ASN . 90.7 mt -114.7 -174.5 2.5 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.823 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 253' ' ' ASN . . . . . 0.567 ' CB ' ' O ' ' B' ' 252' ' ' LEU . 17.3 t-20 91.39 27.4 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.116 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 254' ' ' ASP . . . . . 0.582 ' O ' ' CB ' ' B' ' 255' ' ' ASP . 96.6 m-20 -92.91 -6.87 47.63 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.798 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 255' ' ' ASP . . . . . 0.582 ' CB ' ' O ' ' B' ' 254' ' ' ASP . 32.1 t0 106.28 58.05 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 O-C-N 124.04 0.837 . . . . 0.0 108.839 -178.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.579 ' O ' ' C ' ' B' ' 257' ' ' LYS . 54.6 p-10 -120.23 19.07 12.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.124 -178.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 257' ' ' LYS . . . . . 0.6 ' O ' ' N ' ' B' ' 259' ' ' ASP . 99.2 mttt 20.52 -89.24 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.41 0.444 . . . . 0.0 110.729 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' B' ' 256' ' ' ASP . 94.6 m-20 -27.11 87.76 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 O-C-N 123.647 0.592 . . . . 0.0 110.105 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.6 ' N ' ' O ' ' B' ' 257' ' ' LYS . 87.7 m-20 -87.06 -93.09 0.1 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.235 -179.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.524 ' OE1' HD21 ' A' ' 41' ' ' LEU . 97.5 mt-10 -141.46 9.47 2.03 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.053 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 61.5 mt -112.34 135.06 52.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 43.6 t -123.86 133.3 69.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.202 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -94.79 117.46 30.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.988 0.423 . . . . 0.0 110.976 -178.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 264' ' ' LYS . . . . . 0.422 ' HZ1' ' HA ' ' A' ' 34' ' ' GLU . 88.5 tttt -65.39 -47.01 77.81 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.275 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.34 160.89 61.31 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.201 -0.908 . . . . 0.0 110.257 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -60.37 141.65 96.18 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.162 1.908 . . . . 0.0 111.753 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 267' ' ' ILE . . . . . 0.552 HG23 ' O ' ' B' ' 267' ' ' ILE . 13.8 tt . . . . . 0 C--N 1.324 -0.532 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.919 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo . . . . . 0 N--CA 1.489 1.238 0 CA-C-O 120.875 0.281 . . . . 0.0 111.829 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 35.3 p -66.73 -35.38 79.98 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.267 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.665 HH22 ' CB ' ' A' ' 99' ' ' ASN . 7.0 mmp_? -90.52 118.0 29.64 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -178.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.664 ' NH2' ' ND1' ' A' ' 19' ' ' HIS . 77.8 ttt-85 -127.36 127.23 43.9 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.696 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.929 HD11 HD11 ' A' ' 22' ' ' LEU . 77.6 mt -113.67 144.71 42.47 Favored 'General case' 0 C--N 1.339 0.139 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 51.2 t -121.12 130.94 74.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.47 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.407 HG21 ' OD2' ' B' ' 259' ' ' ASP . 16.1 m -81.37 142.17 33.28 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.579 0.704 . . . . 0.0 112.432 -178.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.402 ' CD1' ' OD1' ' A' ' 16' ' ' ASP . 47.0 mm -108.59 134.35 50.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.62 177.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -90.15 156.58 18.24 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.998 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.679 ' NH1' ' NH2' ' B' ' 245' ' ' ARG . 88.8 mtm180 -58.85 -25.91 63.7 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.247 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.9 p -78.26 -10.11 59.52 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.78 37.85 9.14 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.7 t -122.1 134.3 65.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.674 0.273 . . . . 0.0 110.658 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.402 ' OD1' ' CD1' ' A' ' 10' ' ' ILE . 96.8 m-20 -71.4 133.39 45.9 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.34 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -122.41 -118.02 2.46 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 120.806 -0.711 . . . . 0.0 111.887 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -74.65 145.04 32.38 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.265 1.976 . . . . 0.0 112.812 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.664 ' ND1' ' NH2' ' A' ' 6' ' ' ARG . 17.9 m170 -101.73 140.69 35.67 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.66 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.493 ' CD2' HD11 ' A' ' 37' ' ' ILE . 40.1 t80 -114.42 97.03 45.1 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.441 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -79.67 139.22 14.01 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 121.836 1.691 . . . . 0.0 110.66 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.929 HD11 HD11 ' A' ' 7' ' ' LEU . 92.8 mt -101.43 124.08 46.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.747 0.784 . . . . 0.0 110.529 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.6 p -124.18 -1.31 8.22 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.261 -1.336 . . . . 0.0 108.683 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 42.2 mt -104.67 147.99 27.06 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 114.508 -1.224 . . . . 0.0 109.732 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 96.1 p -65.98 -17.26 64.56 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.345 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 85.2 m -132.37 133.77 44.36 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.246 0.546 . . . . 0.0 112.122 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.573 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 2.9 t -126.4 121.51 32.68 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.619 HD21 ' OE1' ' A' ' 47' ' ' GLN . 55.4 tp -120.9 132.22 54.84 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.824 0.345 . . . . 0.0 111.922 -177.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.692 ' CE2' HD12 ' A' ' 37' ' ' ILE . 8.9 m-85 -109.22 140.79 42.38 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 151.44 -177.78 29.17 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.447 178.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.492 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 46.0 mtm180 -74.19 -33.52 63.45 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.501 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -48.12 148.44 4.07 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.808 -0.71 . . . . 0.0 111.587 -178.052 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.515 HG23 ' N ' ' A' ' 34' ' ' GLU . 9.9 tp -66.53 -41.96 89.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-O 120.9 0.381 . . . . 0.0 110.438 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.515 ' N ' HG23 ' A' ' 33' ' ' ILE . 79.2 tt0 -58.55 -25.83 62.92 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 17.9 m -52.73 115.45 1.82 Allowed 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.448 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 63.5 m-20 -53.05 -25.0 11.1 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.538 -178.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.692 HD12 ' CE2' ' A' ' 29' ' ' PHE . 96.2 mt -129.71 122.06 54.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.503 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 83.8 mtp180 -106.06 135.53 47.35 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.015 0.435 . . . . 0.0 110.853 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 95.5 mt -118.09 129.55 74.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.059 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -73.73 34.24 0.08 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -177.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.76 HD11 ' NH1' ' A' ' 93' ' ' ARG . 55.9 mt -111.24 129.04 24.44 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.684 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.76 -10.25 24.76 Favored 'Trans proline' 0 N--CA 1.489 1.237 0 C-N-CA 122.445 2.096 . . . . 0.0 113.101 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.52 HG21 ' CE2' ' B' ' 241' ' ' PHE . 35.9 m -94.15 1.12 9.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.562 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.492 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 42.6 t -89.75 136.05 24.65 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.24 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.072 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.6 m -69.8 164.79 22.84 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.424 0.63 . . . . 0.0 111.297 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -62.65 -43.26 99.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.287 -179.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.619 ' OE1' HD21 ' A' ' 28' ' ' LEU . 92.7 mm-40 -111.34 -24.15 10.38 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.318 0.58 . . . . 0.0 110.002 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.0 t60 39.22 -78.05 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.251 -0.886 . . . . 0.0 113.382 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.594 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -129.53 133.73 47.39 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.385 0.612 . . . . 0.0 112.225 -178.663 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -126.83 132.44 50.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.307 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 93.7 mt -117.54 135.41 58.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.568 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.485 ' CD ' ' NE2' ' A' ' 54' ' ' HIS . 79.7 tt0 -120.48 124.62 45.87 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 84.9 mt -102.04 117.83 47.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.324 0.583 . . . . 0.0 111.57 -178.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.485 ' NE2' ' CD ' ' A' ' 52' ' ' GLU . 97.5 m-70 -112.94 141.01 47.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.258 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 54' ' ' HIS . 94.1 mt-10 -39.75 -28.85 0.05 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -178.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.49 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 58.1 tt0 -63.55 -67.67 0.41 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.301 178.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.49 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 3.7 tp10 -158.16 -164.43 1.5 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.336 -178.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -111.49 129.96 55.88 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.9 mt -118.87 128.09 75.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.386 0.612 . . . . 0.0 112.157 -178.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 28.1 tp -97.29 127.87 43.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.934 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -113.23 136.47 52.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.127 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.41 HD21 ' HA ' ' A' ' 68' ' ' PRO . 58.5 t-20 -97.12 104.61 16.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.188 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -96.51 -9.7 29.03 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 120.757 0.313 . . . . 0.0 110.747 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.15 101.44 1.85 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.101 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 79.0 p -87.73 -10.13 52.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.206 0.527 . . . . 0.0 109.591 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.828 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.2 OUTLIER -100.92 -43.22 6.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.249 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.405 HD21 ' HA ' ' B' ' 236' ' ' VAL . 78.9 m-20 -135.85 94.86 14.31 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.025 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.486 ' HB2' HG23 ' A' ' 75' ' ' VAL . 50.4 Cg_exo -57.17 142.9 94.51 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 121.966 1.777 . . . . 0.0 113.014 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 95.9 m -74.49 144.1 44.3 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.401 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -104.88 139.47 39.57 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.056 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 68.8 t -131.02 133.11 63.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 53.65 32.11 13.92 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.149 -0.621 . . . . 0.0 110.065 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.45 26.88 68.9 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-N 115.606 -0.724 . . . . 0.0 112.129 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 43.4 t -142.68 139.93 31.37 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 117.36 0.58 . . . . 0.0 111.08 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.486 HG23 ' HB2' ' A' ' 68' ' ' PRO . 1.2 p -70.25 140.85 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.486 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.8 pt -113.96 90.72 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.82 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -68.43 -28.94 67.51 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.478 ' N ' ' CD ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -116.49 162.18 28.0 Favored Pre-proline 0 C--O 1.232 0.168 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.582 179.129 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -66.56 150.54 83.94 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.571 2.181 . . . . 0.0 112.466 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.4 m -141.78 141.76 29.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.142 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -70.52 129.92 40.49 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.077 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 82' ' ' LEU . 91.3 mt -79.64 140.17 37.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.175 0.512 . . . . 0.0 111.13 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -131.84 151.23 51.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.729 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.42 ' CE1' ' H ' ' A' ' 99' ' ' ASN . 6.1 t60 -53.78 120.14 5.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.052 0.453 . . . . 0.0 111.162 -179.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.81 -17.67 32.54 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -67.51 135.06 52.44 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 120.184 -0.607 . . . . 0.0 110.258 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.519 HG22 ' HG2' ' A' ' 96' ' ' ARG . 58.5 t -113.67 132.51 62.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.115 -178.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 84.5 mt -103.78 132.78 49.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 90.1 m -122.63 128.97 51.35 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.48 0.657 . . . . 0.0 112.646 -178.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.492 ' O ' ' N ' ' A' ' 93' ' ' ARG . 81.2 mt -113.91 126.02 71.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.499 178.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.458 ' C ' ' O ' ' A' ' 90' ' ' ILE . 41.2 mm 35.99 -98.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.746 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 90' ' ' ILE . 41.3 p-10 -116.13 12.11 15.44 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.04 0.448 . . . . 0.0 110.918 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.76 ' NH1' HD11 ' A' ' 41' ' ' LEU . 53.9 mtt85 -123.07 140.44 53.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.334 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 29.4 t -137.27 151.15 48.38 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 120.319 -0.553 . . . . 0.0 110.722 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.488 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 98.0 m-85 -123.6 122.21 37.57 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.519 ' HG2' HG22 ' A' ' 87' ' ' VAL . 99.5 mtt180 -84.65 136.35 33.79 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.167 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.61 ' CZ ' ' CZ ' ' A' ' 5' ' ' ARG . 60.0 t80 -94.48 118.02 31.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.742 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.412 ' HG3' ' CE1' ' A' ' 84' ' ' HIS . 79.8 tt0 -125.47 125.71 43.75 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 111.971 0.359 . . . . 0.0 111.971 -178.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.665 ' CB ' HH22 ' A' ' 5' ' ' ARG . 12.1 t-20 -96.46 131.5 42.98 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 . . . . . 0 C--N 1.323 -0.587 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.956 -178.996 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 228' ' ' VAL . . . . . 0.616 ' O ' ' N ' ' B' ' 230' ' ' SEP . 14.4 t . . . . . 0 CA--C 1.513 -0.457 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.528 ' C ' ' O ' ' B' ' 228' ' ' VAL . 61.9 t0 15.1 -78.7 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.129 0 O-C-N 124.66 1.225 . . . . 0.0 111.23 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 230' ' ' SEP . . . . . 0.616 ' N ' ' O ' ' B' ' 228' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.525 ' O ' ' O ' ' B' ' 232' ' ' GLY . 4.3 tp60 -116.48 -26.83 6.95 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.887 -179.007 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 232' ' ' GLY . . . . . 0.525 ' O ' ' O ' ' B' ' 231' ' ' GLN . . . -40.22 173.63 0.01 OUTLIER Glycine 0 CA--C 1.528 0.86 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.098 -178.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.42 161.94 43.89 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 123.91 3.074 . . . . 0.0 112.741 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.828 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.65 133.82 19.33 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 121.891 1.727 . . . . 0.0 112.922 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.653 ' CG2' HG22 ' A' ' 66' ' ' THR . 54.9 t -64.71 139.82 20.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.716 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 7.3 t -73.62 132.18 42.5 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 238' ' ' TPO . . . . . 0.44 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 239' ' ' PRO . . . . . 0.44 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 35.5 Cg_exo -57.97 -27.45 79.15 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 122.877 2.385 . . . . 0.0 112.83 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 90.9 m -73.61 -45.19 54.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.546 0.689 . . . . 0.0 109.668 178.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.52 ' CE2' HG21 ' A' ' 43' ' ' VAL . 68.9 t80 -58.33 -46.22 86.61 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.622 -178.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 94.9 mt -62.67 -41.64 99.2 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 120.981 0.419 . . . . 0.0 110.481 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -59.29 -37.06 76.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.415 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -62.92 -43.4 98.91 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.012 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.752 ' NH2' HH22 ' A' ' 93' ' ' ARG . 26.5 mmm180 -58.59 -41.65 86.24 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -64.21 -43.22 95.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.349 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 27.9 t -64.08 -44.98 90.7 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 248' ' ' GLN . . . . . 0.587 ' O ' ' N ' ' B' ' 252' ' ' LEU . 87.2 mt-30 -57.38 -40.31 77.93 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.29 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.457 ' O ' ' O ' ' B' ' 252' ' ' LEU . 54.3 t -62.82 -42.91 98.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 120.658 -0.417 . . . . 0.0 109.916 178.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -61.37 -36.42 80.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.2 0.524 . . . . 0.0 109.625 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -90.81 -11.3 39.8 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.063 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.587 ' N ' ' O ' ' B' ' 248' ' ' GLN . 37.3 tp -124.22 109.87 13.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.067 179.08 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 253' ' ' ASN . . . . . 0.609 ' ND2' ' O ' ' B' ' 253' ' ' ASN . 0.2 OUTLIER -177.47 12.79 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 178.781 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 254' ' ' ASP . . . . . 0.417 ' O ' ' CB ' ' B' ' 255' ' ' ASP . 34.7 t70 -62.92 -44.34 96.33 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 119.519 -0.873 . . . . 0.0 109.513 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 255' ' ' ASP . . . . . 0.464 ' CG ' ' O ' ' B' ' 255' ' ' ASP . 4.3 t0 156.27 66.3 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.495 -1.229 . . . . 0.0 107.74 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.46 ' C ' ' H ' ' B' ' 258' ' ' ASP . 46.5 t0 -105.76 98.47 8.16 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.873 -178.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -66.2 8.29 0.23 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.352 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.46 ' H ' ' C ' ' B' ' 256' ' ' ASP . 59.6 t0 -91.22 106.19 18.33 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.407 ' OD2' HG21 ' A' ' 9' ' ' THR . 53.6 p-10 -102.46 17.51 23.41 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -177.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.57 ' OE1' ' NH2' ' B' ' 245' ' ' ARG . 96.4 mt-10 62.87 7.64 2.71 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.25 0.477 . . . . 0.0 111.163 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.488 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 89.6 mt -109.78 133.08 56.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.234 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 41.5 t -124.32 133.71 68.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.945 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 263' ' ' PHE . . . . . 0.534 ' CD2' HG21 ' B' ' 267' ' ' ILE . 70.6 m-85 -98.77 121.29 40.53 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.299 0.571 . . . . 0.0 110.818 -178.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 264' ' ' LYS . . . . . 0.402 ' HD3' ' NE2' ' B' ' 265' ' ' GLN . 88.5 tttt -65.92 -39.2 90.32 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.905 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 265' ' ' GLN . . . . . 0.414 ' CB ' ' CD ' ' B' ' 266' ' ' PRO . 7.2 mm-40 -103.2 179.47 0.96 Allowed Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.099 -178.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 266' ' ' PRO . . . . . 0.414 ' CD ' ' CB ' ' B' ' 265' ' ' GLN . 24.4 Cg_exo -62.25 149.81 89.27 Favored 'Trans proline' 0 N--CA 1.498 1.742 0 C-N-CA 122.822 2.348 . . . . 0.0 113.536 -178.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 267' ' ' ILE . . . . . 0.534 HG21 ' CD2' ' B' ' 263' ' ' PHE . 15.8 pt . . . . . 0 N--CA 1.465 0.308 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.051 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo . . . . . 0 N--CA 1.495 1.606 0 CA-C-O 121.17 0.404 . . . . 0.0 113.063 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.0 p -100.86 -23.16 14.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.373 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.728 HH12 ' HB2' ' A' ' 58' ' ' ALA . 94.3 mtt-85 -97.25 115.01 26.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.957 -178.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.61 HH21 ' CE1' ' A' ' 19' ' ' HIS . 73.5 ttt180 -128.24 130.8 48.49 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.667 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.563 HD11 ' HB3' ' A' ' 95' ' ' PHE . 34.2 tp -113.17 133.25 55.14 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.197 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.0 t -109.87 131.57 60.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.851 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.414 HG23 ' CD1' ' B' ' 261' ' ' ILE . 2.1 m -92.17 113.86 26.25 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.942 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.8 mt -79.15 143.69 12.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.901 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -87.99 159.37 18.33 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.153 0.502 . . . . 0.0 110.64 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.441 ' NH2' ' HB2' ' B' ' 248' ' ' GLN . 82.1 mtp180 -53.27 -32.42 48.46 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.066 -178.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 91.1 p -79.37 -7.39 58.33 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.954 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.15 31.96 11.25 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.7 t -117.86 132.71 66.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -75.11 138.91 42.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.556 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -131.94 -114.89 1.63 Allowed Glycine 0 CA--C 1.538 1.479 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.321 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -74.07 148.31 39.65 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.46 2.107 . . . . 0.0 112.56 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.61 ' CE1' HH21 ' A' ' 6' ' ' ARG . 0.0 OUTLIER -111.37 160.82 16.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.479 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.406 ' CD2' HD11 ' A' ' 37' ' ' ILE . 39.4 t80 -131.21 103.51 15.29 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.706 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.98 135.83 17.77 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 121.346 1.364 . . . . 0.0 111.627 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 64.7 mt -85.22 51.83 2.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.228 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.2 p -64.25 -24.85 67.81 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.7 mt -80.33 141.82 35.07 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.678 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.8 t -63.14 -20.73 65.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.563 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 94.4 m -134.88 135.64 41.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.106 0.479 . . . . 0.0 111.577 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.2 t -127.99 120.7 28.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.591 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.528 HD12 ' O ' ' A' ' 49' ' ' CYS . 56.3 tp -118.51 131.65 56.23 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.262 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.635 ' CE2' HD12 ' A' ' 37' ' ' ILE . 3.8 m-85 -108.83 141.78 40.38 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.291 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 158.15 -170.92 35.01 Favored Glycine 0 N--CA 1.469 0.894 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.219 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.578 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 81.9 mtm-85 -84.42 -27.91 27.24 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 122.447 -0.443 . . . . 0.0 110.821 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -54.66 146.07 27.19 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.051 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.406 HD13 ' HA ' ' A' ' 33' ' ' ILE . 31.2 mm -64.54 -43.57 96.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.014 0.435 . . . . 0.0 110.291 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -57.17 -19.86 23.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.048 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 81.7 m -62.77 131.97 50.65 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.491 -0.483 . . . . 0.0 110.171 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.456 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 64.8 m-20 -61.48 -34.79 76.06 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.222 -178.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.635 HD12 ' CE2' ' A' ' 29' ' ' PHE . 99.4 mt -125.16 125.88 70.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.413 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 44.4 mtm-85 -119.39 145.14 46.48 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.879 -177.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 80.9 mt -123.2 133.16 69.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.422 -178.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -75.88 25.64 0.12 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.973 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.744 HD11 ' CZ ' ' A' ' 93' ' ' ARG . 30.4 mt -96.81 129.41 32.78 Favored Pre-proline 0 C--N 1.324 -0.528 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.087 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.545 ' HB3' HG11 ' B' ' 228' ' ' VAL . 42.8 Cg_endo -71.09 -13.09 31.1 Favored 'Trans proline' 0 N--CA 1.489 1.225 0 C-N-CA 122.029 1.819 . . . . 0.0 112.618 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.612 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 26.9 m -98.06 3.22 10.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.619 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.578 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 35.4 t -89.88 135.69 25.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.48 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 0.6 OUTLIER -65.15 160.62 20.86 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.373 0.606 . . . . 0.0 111.782 -178.864 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -62.46 -42.31 99.38 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.071 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.614 ' O ' ' N ' ' A' ' 49' ' ' CYS . 86.7 mt-30 -114.97 -14.4 11.87 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 123.609 0.568 . . . . 0.0 110.069 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.48 ' H ' ' HB3' ' A' ' 45' ' ' SER . 19.7 t60 31.1 -73.75 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.614 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.85 137.19 44.87 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -177.631 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -125.16 132.33 53.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.909 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.9 mt -118.57 133.03 66.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.832 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -119.99 127.38 52.57 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 177.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.402 HD13 ' CD ' ' A' ' 5' ' ' ARG . 86.7 mt -108.36 124.15 64.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -177.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.517 ' CD2' ' N ' ' A' ' 54' ' ' HIS . 2.7 m-70 -117.5 141.02 48.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.538 -1.21 . . . . 0.0 109.479 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 54' ' ' HIS . 96.3 mt-10 -39.91 -29.5 0.07 Allowed 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.993 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.458 ' N ' ' O ' ' A' ' 54' ' ' HIS . 69.0 tp60 -64.38 -65.93 0.61 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -158.5 -155.44 0.49 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.099 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.728 ' HB2' HH12 ' A' ' 5' ' ' ARG . . . -120.5 131.41 54.71 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.208 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.7 mm -112.58 123.62 68.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.668 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.474 ' HB2' HD11 ' A' ' 82' ' ' LEU . 30.9 tp -97.67 127.21 43.45 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -115.01 136.18 53.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.956 0.408 . . . . 0.0 110.847 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -97.29 106.22 18.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.48 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -98.74 -8.18 26.47 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.086 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.2 m -69.74 101.33 1.66 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 95.4 p -83.57 -13.23 54.88 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.123 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.623 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.3 OUTLIER -91.35 -46.81 7.82 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.199 -179.95 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -139.67 101.51 7.26 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.916 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.594 ' HB2' HG13 ' A' ' 75' ' ' VAL . 36.6 Cg_exo -57.07 147.66 73.82 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 121.986 1.791 . . . . 0.0 112.884 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.7 m -74.66 145.83 42.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.543 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -107.54 140.34 40.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.256 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.1 t -129.66 133.91 64.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 53.59 32.93 15.29 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 119.899 -0.72 . . . . 0.0 109.284 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.45 27.57 71.14 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.702 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 21.3 t -141.99 138.79 32.14 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 117.133 0.466 . . . . 0.0 112.003 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.594 HG13 ' HB2' ' A' ' 68' ' ' PRO . 48.3 t -68.76 140.3 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.143 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.483 HG21 HG11 ' A' ' 80' ' ' VAL . 4.9 pt -113.36 93.86 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-O 120.983 0.42 . . . . 0.0 110.808 178.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -65.04 -28.98 69.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.63 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.462 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.2 OUTLIER -126.34 178.96 1.3 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.178 -179.313 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.462 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 36.5 Cg_exo -59.36 143.05 99.85 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 122.68 2.253 . . . . 0.0 111.45 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.483 HG11 HG21 ' A' ' 76' ' ' ILE . 5.2 p -137.69 140.78 40.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.464 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.454 HH11 ' HD3' ' A' ' 81' ' ' ARG . 34.0 mmt-85 -79.29 129.4 34.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.221 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.474 HD11 ' HB2' ' A' ' 60' ' ' LEU . 98.4 mt -85.21 136.58 33.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.985 0.421 . . . . 0.0 111.381 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -125.85 152.2 45.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.459 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.407 ' CD2' ' C ' ' A' ' 84' ' ' HIS . 6.9 t60 -53.37 115.78 2.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.79 0.329 . . . . 0.0 110.422 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.7 -16.7 25.99 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -69.01 135.2 50.52 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.215 -0.594 . . . . 0.0 109.958 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.1 t -112.39 131.29 64.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.138 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 91.6 mt -94.62 131.37 41.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 25.6 m -122.79 128.18 50.11 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -177.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.474 ' O ' ' C ' ' A' ' 91' ' ' ILE . 79.5 mt -113.79 125.14 71.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.01 178.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.516 HG22 ' N ' ' A' ' 92' ' ' ASP . 97.9 mt 33.64 -96.36 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.074 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.593 ' OD1' ' NH1' ' A' ' 93' ' ' ARG . 47.9 p-10 -114.74 12.24 17.02 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.744 ' CZ ' HD11 ' A' ' 41' ' ' LEU . 70.6 mtt85 -124.62 140.05 53.3 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.683 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 56.6 m -136.09 151.1 49.46 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.45 0.643 . . . . 0.0 111.137 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.563 ' HB3' HD11 ' A' ' 7' ' ' LEU . 63.0 m-85 -121.95 120.74 35.3 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.851 179.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.526 ' O ' HD12 ' A' ' 7' ' ' LEU . 39.6 ttm180 -81.65 129.21 34.62 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.616 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.586 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 87.1 t80 -94.9 124.31 38.88 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.722 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -123.3 122.01 37.27 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.617 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.415 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 47.7 t30 -125.53 115.83 20.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.373 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 . . . . . 0 C--N 1.329 -0.313 0 CA-C-O 120.771 0.32 . . . . 0.0 110.541 -179.875 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 228' ' ' VAL . . . . . 0.545 HG11 ' HB3' ' A' ' 42' ' ' PRO . 3.7 t . . . . . 0 CA--C 1.517 -0.294 0 CA-C-O 121.204 0.526 . . . . 0.0 111.541 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.609 ' C ' ' H ' ' B' ' 231' ' ' GLN . 98.0 m-20 58.76 88.23 0.07 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.682 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 230' ' ' SEP . . . . . 0.437 ' O ' ' OE1' ' B' ' 231' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.609 ' H ' ' C ' ' B' ' 229' ' ' ASP . 28.4 mm100 -137.32 51.0 1.96 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.18 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -116.25 -173.98 17.32 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.251 -0.74 . . . . 0.0 111.251 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.09 158.82 56.34 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.8 2.333 . . . . 0.0 112.517 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.623 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 235' ' ' PRO . . . . . 0.428 ' HD2' ' O ' ' A' ' 42' ' ' PRO . 26.8 Cg_exo -60.03 141.49 96.44 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.911 2.407 . . . . 0.0 112.779 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -78.76 133.17 30.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.87 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 237' ' ' CYS . . . . . 0.451 ' SG ' HG23 ' A' ' 91' ' ' ILE . 34.7 t -68.18 126.39 29.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.963 -179.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -59.38 -23.54 70.67 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.63 2.22 . . . . 0.0 112.458 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 79.8 m -74.38 -43.0 58.35 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.29 0.567 . . . . 0.0 109.62 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.612 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 73.6 t80 -55.54 -46.65 77.06 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.693 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 98.4 mt -64.75 -39.49 93.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.108 0.48 . . . . 0.0 110.331 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 51.2 tp10 -61.12 -42.52 98.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.761 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -63.72 -39.43 94.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.307 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.488 ' NH2' ' CE1' ' B' ' 241' ' ' PHE . 40.3 mmt-85 -61.74 -40.74 96.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.706 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -62.18 -41.38 98.28 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.412 -0.515 . . . . 0.0 109.95 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 37.3 t -65.04 -45.38 85.66 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 248' ' ' GLN . . . . . 0.441 ' HB2' ' NH2' ' A' ' 12' ' ' ARG . 74.8 mt-30 -61.2 -35.41 77.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.554 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.47 HG23 ' O ' ' B' ' 245' ' ' ARG . 39.4 t -60.34 -45.75 96.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -59.07 -27.38 65.48 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -86.47 -10.11 54.86 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.097 178.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.413 ' O ' ' CB ' ' B' ' 253' ' ' ASN . 96.2 mt -117.52 -176.19 2.97 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.61 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 253' ' ' ASN . . . . . 0.587 ' ND2' ' O ' ' B' ' 253' ' ' ASN . 0.2 OUTLIER 79.62 14.49 0.98 Allowed 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.11 179.509 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 254' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' B' ' 255' ' ' ASP . 96.8 m-20 -65.57 -31.0 71.81 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 255' ' ' ASP . . . . . 0.478 ' O ' ' CB ' ' B' ' 256' ' ' ASP . 91.3 m-20 -137.61 -80.94 0.36 Allowed 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.668 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.478 ' CB ' ' O ' ' B' ' 255' ' ' ASP . 1.9 p30 154.24 116.97 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -178.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 257' ' ' LYS . . . . . 0.559 ' O ' ' C ' ' B' ' 258' ' ' ASP . 62.2 pttt -174.32 151.87 1.68 Allowed 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.514 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.559 ' C ' ' O ' ' B' ' 257' ' ' LYS . 66.7 t0 -6.31 119.48 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 O-C-N 124.344 1.027 . . . . 0.0 111.449 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 259' ' ' ASP . . . . . . . . . . . . . 46.3 p-10 -105.55 61.19 0.67 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.26 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.452 ' OE1' ' NH2' ' A' ' 93' ' ' ARG . 95.2 mt-10 62.74 9.46 3.6 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.414 ' CD1' HG23 ' A' ' 9' ' ' THR . 76.5 mt -111.61 134.0 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 54.8 t -125.58 132.85 70.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.738 0.304 . . . . 0.0 111.098 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -98.33 120.36 38.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.312 0.577 . . . . 0.0 111.626 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -66.85 -44.61 80.58 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.203 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.42 159.2 30.13 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.033 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.02 154.4 67.39 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 123.051 2.501 . . . . 0.0 111.864 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 47.0 pt . . . . . 0 C--N 1.327 -0.393 0 CA-C-O 121.309 0.576 . . . . 0.0 111.819 -178.931 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo . . . . . 0 N--CA 1.493 1.472 0 CA-C-O 120.961 0.317 . . . . 0.0 112.401 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.5 p -87.04 -36.01 18.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.716 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.4 mtt85 -94.87 124.93 39.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.908 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -133.53 140.25 47.09 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.343 -0.543 . . . . 0.0 111.521 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.879 HD11 HD11 ' A' ' 22' ' ' LEU . 79.2 mt -113.0 138.45 49.86 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.502 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 54.7 t -112.78 131.34 64.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.3 m -85.38 136.32 33.51 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.595 0.712 . . . . 0.0 112.32 -178.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 95.0 mt -108.89 138.03 38.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.185 178.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -91.4 158.36 16.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.191 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.774 ' HE ' ' HZ2' ' B' ' 257' ' ' LYS . 87.5 mtm180 -59.26 -23.51 62.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.044 0.45 . . . . 0.0 110.271 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.2 t -79.05 -16.83 56.26 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.358 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.05 36.62 5.93 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.6 t -119.46 134.18 63.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 121.191 0.519 . . . . 0.0 112.052 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.401 ' C ' ' OD1' ' A' ' 16' ' ' ASP . 60.5 t0 -76.96 120.1 21.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.38 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -115.48 -124.75 3.82 Favored Glycine 0 CA--C 1.539 1.583 0 C-N-CA 120.919 -0.657 . . . . 0.0 111.665 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.24 153.25 40.52 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.551 2.167 . . . . 0.0 113.192 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -111.61 156.58 21.58 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.029 0.442 . . . . 0.0 110.563 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.417 ' CD2' HD11 ' A' ' 37' ' ' ILE . 38.7 t80 -123.58 100.91 37.54 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.066 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.53 134.44 20.49 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 C-N-CA 121.344 1.363 . . . . 0.0 111.928 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.879 HD11 HD11 ' A' ' 7' ' ' LEU . 95.3 mt -88.55 71.74 8.86 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.844 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 89.2 p -79.9 -8.22 59.18 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.652 HD11 ' HG2' ' B' ' 265' ' ' GLN . 51.8 mt -97.4 142.5 29.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.801 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.9 p -66.2 -21.69 66.32 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.099 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 86.0 m -133.68 136.23 44.58 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.006 0.431 . . . . 0.0 110.775 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.559 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -134.81 129.53 34.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.486 178.632 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.51 HD12 ' O ' ' A' ' 49' ' ' CYS . 48.1 tp -119.71 131.22 55.34 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.745 -178.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.757 ' CE2' HD12 ' A' ' 37' ' ' ILE . 38.1 m-85 -104.98 140.78 37.68 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.702 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 149.3 -166.4 29.53 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 120.299 -0.953 . . . . 0.0 112.574 178.021 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 44.5 mtm180 -86.0 -32.01 21.72 Favored 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.415 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -49.33 151.16 3.84 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 -178.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.462 HG23 ' N ' ' A' ' 34' ' ' GLU . 11.3 tp -66.41 -40.5 86.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.462 ' N ' HG23 ' A' ' 33' ' ' ILE . 85.1 tt0 -54.8 -23.96 20.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.022 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.415 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 59.5 m -56.79 115.02 2.32 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.827 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -57.82 -21.41 42.09 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.757 HD12 ' CE2' ' A' ' 29' ' ' PHE . 97.6 mt -129.99 120.98 50.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.278 -0.874 . . . . 0.0 108.912 177.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 84.7 mtp180 -105.54 133.66 49.93 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.514 -179.017 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.0 mt -118.49 128.07 75.47 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -80.25 43.59 0.64 Allowed 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -177.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.971 HD11 ' NH1' ' A' ' 93' ' ' ARG . 59.0 mt -111.14 134.06 21.16 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.379 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.81 -9.76 21.2 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 122.223 1.948 . . . . 0.0 111.965 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.626 HG21 ' CE2' ' B' ' 241' ' ' PHE . 27.0 m -101.11 2.28 10.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.772 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 25.1 t -93.34 135.84 26.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.278 0.561 . . . . 0.0 109.945 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.4 m -68.25 159.94 30.24 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.377 -178.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -61.47 -42.46 98.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.928 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.675 ' O ' ' N ' ' A' ' 49' ' ' CYS . 82.9 mt-30 -114.58 -16.37 11.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.459 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.2 t60 32.81 -73.82 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.675 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -134.8 138.13 43.98 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -178.221 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -125.5 136.76 53.69 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.42 -0.809 . . . . 0.0 108.909 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.532 HG22 ' O ' ' A' ' 27' ' ' CYS . 14.9 tt -126.5 140.72 48.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.074 0.464 . . . . 0.0 110.89 -178.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -122.59 135.56 54.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.393 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.8 mt -110.6 114.62 47.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.283 0.564 . . . . 0.0 111.355 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.47 ' O ' ' N ' ' A' ' 56' ' ' GLN . 92.3 m-70 -115.76 143.89 44.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.571 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 54' ' ' HIS . 96.1 mt-10 -40.06 -29.36 0.07 Allowed 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.308 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.47 ' N ' ' O ' ' A' ' 54' ' ' HIS . 87.9 mt-30 -63.48 -69.66 0.26 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -160.57 -164.1 1.18 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.555 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -108.42 131.91 54.3 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.163 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 89.2 mt -122.0 132.27 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -178.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.553 HD11 ' SG ' ' A' ' 49' ' ' CYS . 57.9 tp -99.35 128.83 45.51 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.825 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -115.53 134.95 54.58 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -95.74 103.53 15.42 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -95.25 -8.25 36.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.427 178.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.44 98.42 8.88 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.989 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.9 p -79.57 -31.82 41.97 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.747 HG21 ' O ' ' B' ' 234' ' ' TPO . 3.5 m -65.32 -49.08 70.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.917 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.479 HD21 ' HA ' ' B' ' 236' ' ' VAL . 73.8 m-20 -138.96 95.9 9.39 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.742 -179.204 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -54.04 144.32 58.0 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 121.901 1.734 . . . . 0.0 112.74 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.3 m -71.11 132.29 44.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.783 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -97.56 140.64 31.67 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.071 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.5 p -133.25 137.68 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 49.85 32.38 5.38 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.3 29.35 70.3 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.901 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 58.3 m -135.13 124.77 25.17 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 117.364 0.582 . . . . 0.0 112.086 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.7 m -69.27 137.0 25.12 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.526 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 1.6 pt -116.26 120.17 64.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 C-N-CA 120.659 -0.417 . . . . 0.0 110.726 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -85.29 -18.93 32.42 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.02 167.07 17.96 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.2 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.88 151.46 73.91 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.697 2.265 . . . . 0.0 112.807 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.5 m -141.2 148.81 20.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.193 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -79.09 133.7 36.76 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.331 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 97.0 mt -85.57 144.34 27.95 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.238 0.542 . . . . 0.0 111.304 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -128.47 151.1 49.79 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.913 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.5 ' ND1' ' N ' ' A' ' 99' ' ' ASN . 7.0 t60 -53.72 118.34 3.85 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.059 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.28 -17.33 31.61 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.994 -0.843 . . . . 0.0 110.994 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -67.16 135.38 53.43 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.227 0.537 . . . . 0.0 110.214 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.525 ' O ' HG13 ' A' ' 87' ' ' VAL . 12.5 p -113.54 133.47 59.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.877 -178.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.1 mt -99.67 131.7 46.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 177.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 98.6 m -122.91 125.67 45.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.642 0.735 . . . . 0.0 112.527 -178.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.591 ' O ' ' N ' ' A' ' 92' ' ' ASP . 96.6 mt -111.03 125.26 68.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 114.519 -1.218 . . . . 0.0 108.198 178.194 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.552 HD12 ' HB2' ' B' ' 237' ' ' CYS . 23.4 mm 35.17 -90.23 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -178.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.591 ' N ' ' O ' ' A' ' 90' ' ' ILE . 1.0 OUTLIER -125.44 5.81 7.65 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.14 0.495 . . . . 0.0 110.735 178.793 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.971 ' NH1' HD11 ' A' ' 41' ' ' LEU . 71.4 mtt85 -108.4 137.01 47.09 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.186 178.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 31.0 t -139.21 151.27 46.42 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.167 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.532 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 78.9 m-85 -124.81 126.02 44.94 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -87.06 135.99 33.08 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.99 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -97.82 123.0 41.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.358 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -139.62 130.69 26.42 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.158 -0.617 . . . . 0.0 112.069 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.5 ' N ' ' ND1' ' A' ' 84' ' ' HIS . 77.8 m-20 -97.79 127.21 43.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.626 178.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 . . . . . 0 C--N 1.324 -0.519 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.922 -179.975 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 228' ' ' VAL . . . . . 0.449 ' O ' ' C ' ' B' ' 229' ' ' ASP . 33.3 m . . . . . 0 N--CA 1.455 -0.206 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.449 ' C ' ' O ' ' B' ' 228' ' ' VAL . 67.1 t0 -34.33 -83.6 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.501 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -134.65 54.12 1.96 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.084 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -117.23 -169.22 14.92 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.559 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -65.83 153.41 78.26 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 123.598 2.865 . . . . 0.0 112.7 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.747 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -77.63 141.19 19.47 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 C-N-CA 121.815 1.677 . . . . 0.0 111.949 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.479 ' HA ' HD21 ' A' ' 67' ' ' ASN . 3.5 m -65.75 147.55 12.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 237' ' ' CYS . . . . . 0.552 ' HB2' HD12 ' A' ' 91' ' ' ILE . 8.5 t -67.7 133.26 48.99 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.246 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.1 -29.94 85.05 Favored 'Trans proline' 0 N--CA 1.503 2.068 0 C-N-CA 123.019 2.479 . . . . 0.0 113.254 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 42.9 m -72.11 -43.39 64.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.051 0.453 . . . . 0.0 110.214 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.626 ' CE2' HG21 ' A' ' 43' ' ' VAL . 63.6 t80 -58.11 -46.76 85.0 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.097 -178.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 82.7 mt -63.79 -41.66 97.88 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.85 -39.67 90.99 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.565 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -61.74 -40.72 96.09 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.237 -0.585 . . . . 0.0 109.617 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.857 ' O ' HG23 ' B' ' 249' ' ' VAL . 77.9 mtp180 -63.35 -42.53 98.92 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.289 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -62.99 -41.06 99.46 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.382 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 33.5 p -67.62 -44.27 78.4 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.285 0.564 . . . . 0.0 109.905 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -63.49 -32.85 74.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.42 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.857 HG23 ' O ' ' B' ' 245' ' ' ARG . 75.8 t -62.34 -45.75 98.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -61.45 -28.09 69.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.45 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -85.39 -10.45 56.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.81 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.492 ' O ' ' O ' ' B' ' 249' ' ' VAL . 96.2 mt -120.63 108.91 14.6 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.467 177.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 253' ' ' ASN . . . . . 0.589 ' ND2' ' O ' ' B' ' 253' ' ' ASN . 0.3 OUTLIER 178.88 18.7 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 121.116 -0.233 . . . . 0.0 111.018 179.475 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -63.32 -42.69 99.02 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.057 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 255' ' ' ASP . . . . . 0.57 ' O ' ' CB ' ' B' ' 256' ' ' ASP . 36.4 t0 170.21 63.29 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.758 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.57 ' CB ' ' O ' ' B' ' 255' ' ' ASP . 63.1 m-20 109.28 129.24 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 O-C-N 124.446 1.091 . . . . 0.0 110.72 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 257' ' ' LYS . . . . . 0.774 ' HZ2' ' HE ' ' A' ' 12' ' ' ARG . 11.7 ptmt -106.13 28.3 7.8 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.36 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.449 ' C ' ' O ' ' B' ' 257' ' ' LYS . 87.3 m-20 41.59 64.63 1.0 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -178.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.637 ' C ' ' H ' ' B' ' 261' ' ' ILE . 50.6 p-10 -32.67 114.42 0.16 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.676 -178.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -61.9 19.33 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.711 -1.131 . . . . 0.0 111.371 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.637 ' H ' ' C ' ' B' ' 259' ' ' ASP . 75.6 mt -110.84 134.1 54.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 178.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 79.1 t -126.22 135.04 65.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.766 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -95.25 120.41 35.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.145 -178.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 40.5 tttp -65.33 -45.52 83.93 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.034 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 265' ' ' GLN . . . . . 0.652 ' HG2' HD11 ' A' ' 24' ' ' LEU . 2.9 mp0 -91.54 160.92 35.67 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.714 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.46 148.54 67.22 Favored 'Trans proline' 0 C--N 1.301 -1.923 0 C-N-CA 122.698 2.265 . . . . 0.0 112.829 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 42.7 pt . . . . . 0 C--N 1.332 -0.165 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.759 179.384 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.42 ' HG2' HH21 ' A' ' 6' ' ' ARG . 91.7 Cg_endo . . . . . 0 N--CA 1.492 1.431 0 N-CA-C 112.899 0.307 . . . . 0.0 112.899 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.3 p -122.22 -40.06 2.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.834 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.582 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 93.5 mtt-85 -93.84 120.74 34.49 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.546 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.557 ' NH1' ' OE2' ' A' ' 100' ' ' GLU . 99.5 mtt180 -130.09 137.08 49.99 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.057 0.456 . . . . 0.0 111.782 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.621 HD11 ' HB3' ' A' ' 95' ' ' PHE . 43.8 tp -110.49 130.57 55.53 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.7 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 43.3 t -107.37 130.23 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 120.744 0.307 . . . . 0.0 110.72 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 m -90.91 116.4 28.69 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -177.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.625 HD12 ' OG ' ' A' ' 94' ' ' SER . 96.6 mt -83.72 142.89 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.21 178.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -93.32 157.85 16.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.265 0.555 . . . . 0.0 111.147 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.602 HH22 ' CG ' ' B' ' 248' ' ' GLN . 59.1 mtp180 -57.97 -31.9 67.34 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.232 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.4 p -71.59 -15.62 62.27 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.064 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.03 37.18 5.76 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 46.3 t -124.81 133.6 69.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.181 -0.509 . . . . 0.0 111.328 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -77.22 136.9 38.57 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.87 -120.25 2.22 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.486 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -71.53 151.52 58.98 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.273 1.982 . . . . 0.0 113.147 -178.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -108.01 158.59 17.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.178 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.55 ' CD2' HD11 ' A' ' 37' ' ' ILE . 53.0 t80 -129.22 94.98 31.99 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.22 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -57.93 124.9 17.05 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.038 1.825 . . . . 0.0 111.862 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 89.3 mt -87.39 46.94 1.43 Allowed 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.676 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.5 t -59.81 -20.21 55.42 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.692 HD11 ' HG2' ' B' ' 265' ' ' GLN . 71.7 mt -77.78 139.44 39.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.02 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.1 p -64.62 -20.98 66.59 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.906 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.5 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 28.2 m -132.45 132.98 43.3 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.716 -0.393 . . . . 0.0 110.769 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.2 t -124.98 117.92 25.09 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.3 tp -115.99 129.05 56.2 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.278 -178.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.68 ' CE2' HD12 ' A' ' 37' ' ' ILE . 4.9 m-85 -108.56 139.96 42.59 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.056 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.76 -178.11 29.24 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.479 178.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 31' ' ' ARG . 46.5 mtm180 -70.96 -33.3 70.33 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.685 0.278 . . . . 0.0 111.264 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.452 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -47.15 143.62 5.47 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.475 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.3 tp -67.1 -41.11 86.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.475 ' N ' HG23 ' A' ' 33' ' ' ILE . 79.7 mm-40 -55.79 -19.25 10.73 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.899 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.452 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 86.0 m -55.96 122.13 10.88 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.232 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.5 ' OD2' ' O ' ' A' ' 26' ' ' THR . 63.8 m-20 -58.15 -29.2 65.39 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.68 HD12 ' CE2' ' A' ' 29' ' ' PHE . 79.4 mt -128.38 119.09 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 176.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 68.8 ttp85 -106.47 135.85 47.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.319 -178.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.426 HG22 ' H ' ' A' ' 41' ' ' LEU . 95.1 mt -116.17 129.93 71.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-O 121.168 0.508 . . . . 0.0 110.853 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -75.92 25.46 0.12 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.415 -178.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.483 HD23 ' HA ' ' A' ' 41' ' ' LEU . 29.7 mt -92.22 128.85 43.47 Favored Pre-proline 0 C--N 1.326 -0.43 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.403 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.19 -8.21 21.7 Favored 'Trans proline' 0 C--N 1.316 -1.18 0 C-N-CA 122.083 1.856 . . . . 0.0 111.905 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.593 HG21 ' CE2' ' B' ' 241' ' ' PHE . 35.2 m -104.58 5.33 10.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.496 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.7 t -90.64 137.81 20.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.8 m -66.68 168.06 10.07 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.295 0.569 . . . . 0.0 112.035 -178.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -63.15 -45.71 90.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.237 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.651 ' O ' ' N ' ' A' ' 49' ' ' CYS . 86.9 mt-30 -115.02 -16.82 11.6 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.193 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.578 ' NE2' HG23 ' A' ' 90' ' ' ILE . 19.7 t60 35.97 -74.81 0.0 OUTLIER 'General case' 0 C--O 1.236 0.373 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 179.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.651 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.4 134.35 47.07 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -177.971 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -127.46 126.8 42.99 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.852 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.7 mt -111.52 134.26 54.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.332 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.493 ' CD ' ' NE2' ' A' ' 54' ' ' HIS . 82.7 tt0 -116.66 122.63 45.11 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 178.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 74.3 mt -103.46 118.7 50.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.008 -0.677 . . . . 0.0 112.276 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.56 ' O ' ' N ' ' A' ' 56' ' ' GLN . 99.3 m-70 -114.25 139.91 49.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.14 178.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.459 ' C ' ' O ' ' A' ' 54' ' ' HIS . 97.3 mt-10 -39.79 -25.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.465 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.56 ' N ' ' O ' ' A' ' 54' ' ' HIS . 60.4 tt0 -64.99 -67.55 0.43 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.712 ' CB ' ' HE ' ' A' ' 81' ' ' ARG . 4.7 tp10 -158.37 -159.14 0.77 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.104 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.406 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -118.25 128.36 54.61 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.116 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 87.7 mt -118.68 129.68 74.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.895 -178.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.629 ' HB2' HD11 ' A' ' 82' ' ' LEU . 26.7 tp -99.59 129.65 45.76 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.857 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -110.97 135.93 50.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.147 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.507 HD21 ' HB3' ' A' ' 68' ' ' PRO . 36.7 t-20 -97.26 109.45 22.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.835 0.35 . . . . 0.0 111.748 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -99.83 -9.66 22.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.692 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.9 t -78.74 119.81 22.5 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.106 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 95.2 p -101.04 -29.92 11.9 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.404 ' O ' ' OD1' ' A' ' 67' ' ' ASN . 0.6 OUTLIER -66.57 -42.06 87.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.608 178.67 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.404 ' OD1' ' O ' ' A' ' 66' ' ' THR . 1.4 m-20 -147.97 101.13 3.65 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.162 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.507 ' HB3' HD21 ' A' ' 62' ' ' ASN . 39.1 Cg_endo -66.2 154.22 75.0 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 121.624 1.549 . . . . 0.0 112.753 -178.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.1 m -75.24 149.9 38.75 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.612 -178.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -112.84 140.18 47.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.663 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 41.1 t -129.08 135.66 61.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.483 ' H ' HG13 ' A' ' 87' ' ' VAL . 89.6 m-20 52.22 31.81 9.76 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.42 25.81 71.76 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.893 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 63.4 m -136.78 135.94 38.47 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 120.324 -0.55 . . . . 0.0 112.031 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 43.5 t -66.63 135.84 27.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.233 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.0 pt -106.62 98.82 7.4 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.088 0 CA-C-O 121.322 0.582 . . . . 0.0 111.001 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -63.13 -33.26 75.07 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.39 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.498 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.2 OUTLIER -129.58 -178.71 0.85 Allowed Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.262 -179.531 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.498 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 31.5 Cg_exo -60.5 146.53 96.71 Favored 'Trans proline' 0 N--CA 1.504 2.1 0 C-N-CA 123.297 2.665 . . . . 0.0 112.459 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.4 p -140.01 139.65 36.69 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 CA-C-O 120.93 0.395 . . . . 0.0 111.626 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.712 ' HE ' ' CB ' ' A' ' 57' ' ' GLU . 70.5 ttt180 -75.34 127.65 33.63 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.687 178.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.629 HD11 ' HB2' ' A' ' 60' ' ' LEU . 92.4 mt -84.12 141.26 31.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.167 0.508 . . . . 0.0 111.206 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -130.73 149.36 52.41 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.882 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.471 ' ND1' ' N ' ' A' ' 99' ' ' ASN . 7.8 t60 -52.39 117.99 3.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.64 -179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.36 -16.97 34.61 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -66.37 139.72 58.04 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 121.213 0.53 . . . . 0.0 110.308 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.483 HG13 ' H ' ' A' ' 72' ' ' ASN . 7.4 p -111.09 133.01 58.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.869 -178.27 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.7 mt -101.14 129.65 51.81 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 76.8 m -124.48 122.29 37.22 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.642 0.734 . . . . 0.0 112.445 -178.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.578 HG23 ' NE2' ' A' ' 48' ' ' HIS . 76.5 mt -108.34 125.24 65.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.003 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.511 ' C ' ' O ' ' A' ' 90' ' ' ILE . 94.5 mt 34.73 -97.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.063 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.569 ' OD2' ' CZ ' ' B' ' 245' ' ' ARG . 54.4 p-10 -117.41 6.8 12.66 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.919 0.39 . . . . 0.0 111.196 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.595 ' NH2' ' O ' ' B' ' 259' ' ' ASP . 23.1 mmt180 -110.53 134.27 52.53 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.625 ' OG ' HD12 ' A' ' 10' ' ' ILE . 71.6 p -137.55 150.95 47.89 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 119.661 -0.815 . . . . 0.0 110.429 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.621 ' HB3' HD11 ' A' ' 7' ' ' LEU . 82.9 m-85 -125.43 124.6 41.79 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.408 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.471 ' O ' HD12 ' A' ' 7' ' ' LEU . 69.4 mtp85 -87.12 134.11 33.55 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.316 -0.554 . . . . 0.0 110.951 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.601 ' OH ' ' ND2' ' A' ' 99' ' ' ASN . 92.6 t80 -99.25 126.67 45.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.15 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -143.5 125.98 15.8 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.967 0.413 . . . . 0.0 111.668 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.601 ' ND2' ' OH ' ' A' ' 97' ' ' TYR . 97.5 m-20 -104.61 127.73 52.43 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.308 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.557 ' OE2' ' NH1' ' A' ' 6' ' ' ARG . 96.8 mt-10 . . . . . 0 C--N 1.33 -0.269 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 43.1 t . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.943 0.402 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.597 ' O ' ' C ' ' B' ' 230' ' ' SEP . 59.6 t0 -89.85 110.84 21.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.953 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 230' ' ' SEP . . . . . 0.597 ' C ' ' O ' ' B' ' 229' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.484 ' N ' ' O ' ' B' ' 229' ' ' ASP . 33.7 mm-40 77.49 52.45 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.858 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 232' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' B' ' 229' ' ' ASP . . . -99.72 -124.69 5.29 Favored Glycine 0 CA--C 1.534 1.243 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -77.56 157.04 32.33 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 122.551 2.167 . . . . 0.0 112.867 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -58.68 145.71 94.69 Favored 'Trans proline' 0 C--N 1.301 -1.956 0 C-N-CA 122.443 2.095 . . . . 0.0 112.411 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.467 HG13 ' O ' ' B' ' 236' ' ' VAL . 14.6 p -87.2 127.81 40.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.22 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.6 t -59.98 118.86 6.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.662 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -55.84 -22.97 39.89 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.845 1.697 . . . . 0.0 111.819 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 20.4 m -68.14 -44.97 74.84 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 177.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.593 ' CE2' HG21 ' A' ' 43' ' ' VAL . 80.9 t80 -58.67 -45.62 89.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.144 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 84.0 mt -63.35 -41.66 98.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.917 0.389 . . . . 0.0 111.49 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -63.3 -42.07 99.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.151 -178.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 77.8 ttt-85 -61.44 -43.46 98.83 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.934 0.397 . . . . 0.0 110.572 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.569 ' CZ ' ' OD2' ' A' ' 92' ' ' ASP . 8.4 tpp85 -59.82 -42.4 93.45 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.849 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.98 -39.86 96.0 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 58.2 m -64.98 -44.28 89.82 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 177.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 248' ' ' GLN . . . . . 0.602 ' CG ' HH22 ' A' ' 12' ' ' ARG . 60.9 tt0 -58.67 -38.36 78.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.437 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 42.1 t -61.79 -44.11 98.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -58.33 -29.79 66.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.645 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -97.88 -11.47 23.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.962 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.896 HD11 ' OD2' ' B' ' 256' ' ' ASP . 38.6 tp -120.89 110.92 16.89 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.44 -179.058 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 51.7 t30 176.99 40.69 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 254' ' ' ASP . . . . . 0.595 ' O ' ' CB ' ' B' ' 255' ' ' ASP . 81.3 m-20 -93.72 -4.21 50.87 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.202 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 255' ' ' ASP . . . . . 0.595 ' CB ' ' O ' ' B' ' 254' ' ' ASP . 61.1 t0 111.57 60.62 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 O-C-N 124.478 1.111 . . . . 0.0 110.45 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.896 ' OD2' HD11 ' B' ' 252' ' ' LEU . 95.4 m-20 -72.73 -66.3 0.68 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.504 0.668 . . . . 0.0 109.628 178.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 257' ' ' LYS . . . . . 0.434 ' CB ' ' O ' ' B' ' 256' ' ' ASP . 34.4 tttt 80.87 -5.04 1.72 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.323 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.709 ' O ' ' N ' ' B' ' 260' ' ' GLU . 50.6 p-10 -98.42 6.02 47.61 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 177.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.595 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 7.3 p30 -0.36 53.39 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 113.437 -1.71 . . . . 0.0 113.993 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.709 ' N ' ' O ' ' B' ' 258' ' ' ASP . 50.7 mp0 50.39 7.56 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.422 ' H ' ' C ' ' B' ' 259' ' ' ASP . 53.2 mt -116.02 135.6 55.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 61.7 t -129.08 135.54 61.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.865 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -95.19 119.46 33.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.435 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -64.63 -47.15 79.59 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.838 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 265' ' ' GLN . . . . . 0.692 ' HG2' HD11 ' A' ' 24' ' ' LEU . 4.6 mp0 -93.67 159.15 35.39 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.038 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -69.44 148.1 66.41 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.818 2.345 . . . . 0.0 112.754 -179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 44.8 pt . . . . . 0 C--N 1.326 -0.451 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.54 179.007 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo . . . . . 0 N--CA 1.497 1.711 0 CA-C-O 120.882 0.284 . . . . 0.0 112.241 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.48 ' O ' ' O ' ' A' ' 99' ' ' ASN . 80.5 m -100.52 -56.33 2.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.214 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.3 mtt85 -86.58 137.23 32.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.136 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -129.33 131.52 46.93 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.372 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.577 HD11 ' HB3' ' A' ' 95' ' ' PHE . 32.7 tp -109.64 131.66 54.85 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.4 t -113.27 131.17 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 121.172 0.511 . . . . 0.0 111.002 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.401 HG23 ' CD1' ' B' ' 261' ' ' ILE . 17.2 m -80.18 145.51 32.25 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.429 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.537 ' CD1' ' OD1' ' A' ' 16' ' ' ASP . 46.2 mm -112.83 136.24 49.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.579 177.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -88.3 151.74 22.42 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.771 HH11 ' NH2' ' A' ' 93' ' ' ARG . 79.0 mtm-85 -58.17 -21.8 48.77 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.175 -178.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 93.9 p -78.12 -10.9 59.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.767 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.98 31.8 11.67 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.184 -1.167 . . . . 0.0 110.184 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 51.2 t -118.34 132.64 67.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.796 0.332 . . . . 0.0 110.325 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.537 ' OD1' ' CD1' ' A' ' 10' ' ' ILE . 79.8 m-20 -75.85 137.51 40.51 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -130.89 -116.59 1.83 Allowed Glycine 0 CA--C 1.537 1.433 0 C-N-CA 120.364 -0.922 . . . . 0.0 112.597 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.63 146.84 44.39 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.337 2.025 . . . . 0.0 112.755 -178.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -109.21 155.15 21.43 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.012 0.435 . . . . 0.0 110.004 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.46 ' CD2' HD11 ' A' ' 37' ' ' ILE . 48.8 t80 -127.94 104.38 20.78 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.993 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.58 134.78 19.03 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 C-N-CA 121.371 1.381 . . . . 0.0 111.388 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 90.7 mt -87.23 59.61 5.66 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.374 -178.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 88.2 p -65.39 -33.08 75.12 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.8 mt -76.43 142.44 41.04 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.705 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 77.4 p -65.17 -17.6 64.61 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.417 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 92.0 m -135.31 136.96 41.99 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.725 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.0 t -128.12 119.73 25.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.056 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.666 HD21 ' HG2' ' A' ' 47' ' ' GLN . 38.6 tp -117.27 128.1 54.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.856 -178.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.668 ' CE2' HD12 ' A' ' 37' ' ' ILE . 4.7 m-85 -106.13 138.56 42.1 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 123.594 0.559 . . . . 0.0 109.834 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 160.8 -164.62 34.78 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.147 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.62 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 83.3 mtm-85 -86.82 -26.63 23.96 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.483 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.569 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -55.82 149.66 24.74 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-N 116.249 -0.432 . . . . 0.0 112.912 -178.087 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.513 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.5 tp -70.35 -42.77 78.67 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 CA-C-O 121.118 0.485 . . . . 0.0 109.823 178.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.513 ' N ' HG23 ' A' ' 33' ' ' ILE . 21.6 pt-20 -54.78 -20.15 7.91 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.498 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.569 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 13.3 m -61.63 128.15 34.9 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.205 -179.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.417 ' OD2' ' O ' ' A' ' 26' ' ' THR . 55.0 m-20 -61.88 -32.76 73.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.447 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.668 HD12 ' CE2' ' A' ' 29' ' ' PHE . 98.6 mt -128.62 125.51 63.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.692 178.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 70.8 mtm180 -106.57 138.17 43.25 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.931 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.687 HG21 HD12 ' A' ' 41' ' ' LEU . 94.2 mt -117.81 127.66 75.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -72.83 32.83 0.07 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.696 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.687 HD12 HG21 ' A' ' 39' ' ' ILE . 25.9 mt -98.44 120.99 58.08 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.667 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.1 -9.27 23.26 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.309 2.006 . . . . 0.0 112.45 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.645 HG23 HD13 ' A' ' 91' ' ' ILE . 12.1 m -103.5 10.71 8.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.664 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.62 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 11.0 t -100.8 138.1 26.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.5 m -69.91 172.17 8.19 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.577 0.703 . . . . 0.0 112.11 -178.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -63.98 -40.91 97.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.393 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.666 ' HG2' HD21 ' A' ' 28' ' ' LEU . 86.8 mt-30 -112.73 -20.03 11.8 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 123.172 0.295 . . . . 0.0 110.766 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 26.0 t60 37.12 -73.57 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.663 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.46 136.83 48.26 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.017 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -126.85 129.59 48.56 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.357 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.8 mt -115.01 133.75 60.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.584 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -115.2 128.68 56.32 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 52.0 mm -98.28 115.83 39.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.214 0.531 . . . . 0.0 110.959 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.486 ' O ' ' N ' ' A' ' 56' ' ' GLN . 97.2 m-70 -119.4 135.0 54.94 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.159 179.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 54' ' ' HIS . 51.6 tp10 -40.26 -28.69 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.041 -0.663 . . . . 0.0 109.375 -179.092 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.486 ' N ' ' O ' ' A' ' 54' ' ' HIS . 50.7 tt0 -65.39 -67.87 0.41 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.113 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.431 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 5.8 tp10 -158.8 -159.72 0.8 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.049 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.466 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -120.73 130.46 54.06 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.5 mt -116.92 128.8 74.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.191 0.519 . . . . 0.0 111.514 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.578 HD21 HG21 ' A' ' 69' ' ' THR . 22.6 tp -96.96 127.05 42.54 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.403 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -110.88 136.44 49.92 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.22 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -95.63 106.97 19.12 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.291 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -99.97 -12.03 20.11 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.31 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.44 100.44 10.72 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.779 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.8 m -73.31 -34.7 65.84 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.999 0.428 . . . . 0.0 110.491 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.71 -37.09 81.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.096 -179.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -145.05 92.37 5.73 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.171 -178.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.455 ' HB2' HG23 ' A' ' 75' ' ' VAL . 33.5 Cg_exo -56.65 146.42 76.53 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.205 1.937 . . . . 0.0 112.735 -178.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.578 HG21 HD21 ' A' ' 60' ' ' LEU . 3.3 m -72.84 136.96 45.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.61 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -102.43 140.15 37.09 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.668 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 51.7 t -131.78 133.25 61.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.581 ' ND2' ' OD1' ' A' ' 86' ' ' ASP . 83.8 m-20 53.01 32.16 12.34 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.488 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.99 28.29 64.9 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.905 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 66.1 m -142.71 138.95 30.91 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 117.048 0.424 . . . . 0.0 111.214 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.455 HG23 ' HB2' ' A' ' 68' ' ' PRO . 0.4 OUTLIER -71.39 141.47 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.399 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.1 pt -112.41 90.09 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.848 178.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -65.37 -26.97 68.25 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -121.63 168.09 12.07 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.544 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -56.51 142.46 89.69 Favored 'Trans proline' 0 N--CA 1.501 1.935 0 C-N-CA 122.312 2.008 . . . . 0.0 112.272 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.7 p -134.3 138.87 49.2 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 CA-C-O 121.072 0.463 . . . . 0.0 111.255 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -78.3 131.29 36.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.507 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.466 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 89.9 mt -83.14 131.22 35.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.261 0.553 . . . . 0.0 111.06 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -119.91 143.59 47.87 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.048 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -48.81 118.04 2.37 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.384 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.66 -12.84 42.58 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.581 ' OD1' ' ND2' ' A' ' 72' ' ' ASN . 26.3 t70 -69.71 132.2 45.76 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.3 t -108.27 133.53 52.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.19 -178.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 87.8 mt -102.21 131.79 49.55 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 54.1 m -120.89 127.4 51.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.535 0.683 . . . . 0.0 112.749 -178.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.486 ' O ' ' N ' ' A' ' 93' ' ' ARG . 88.9 mt -112.35 121.96 65.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.588 178.073 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.645 HD13 HG23 ' A' ' 43' ' ' VAL . 75.3 mt 31.71 -95.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.522 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 92' ' ' ASP . 38.7 p-10 -107.87 6.71 27.62 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -178.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.771 ' NH2' HH11 ' A' ' 12' ' ' ARG . 91.0 mtt-85 -129.98 147.95 51.78 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.458 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.3 t -136.77 154.18 50.63 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.626 0.727 . . . . 0.0 111.241 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.577 ' HB3' HD11 ' A' ' 7' ' ' LEU . 93.7 m-85 -125.46 120.93 32.33 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.893 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.474 ' O ' HD12 ' A' ' 7' ' ' LEU . 79.7 mtp85 -83.5 132.53 34.94 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.106 -0.638 . . . . 0.0 110.551 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -94.04 123.55 37.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.302 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -125.46 117.08 22.89 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.48 ' O ' ' O ' ' A' ' 4' ' ' THR . 7.2 t-20 -64.27 -41.87 96.72 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.543 -178.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 . . . . . 0 C--N 1.332 -0.19 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.375 -179.758 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.455 -0.193 0 CA-C-O 120.747 0.308 . . . . 0.0 110.767 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -68.58 141.36 55.49 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.056 0.455 . . . . 0.0 111.292 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -125.94 36.47 4.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.732 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -110.14 -175.75 20.84 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.21 160.42 49.65 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 122.895 2.397 . . . . 0.0 111.889 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.12 147.21 47.99 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 121.672 1.582 . . . . 0.0 113.032 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.484 HG13 ' O ' ' B' ' 236' ' ' VAL . 9.7 p -77.47 128.31 38.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.403 -178.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.8 t -72.78 124.12 24.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.425 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.81 -22.36 67.76 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.646 2.231 . . . . 0.0 113.057 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 240' ' ' THR . . . . . 0.405 HG22 ' NE ' ' B' ' 244' ' ' ARG . 18.6 m -72.88 -43.81 62.08 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.274 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.51 ' CE2' HG21 ' A' ' 43' ' ' VAL . 85.5 t80 -58.14 -46.72 85.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.577 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.467 HD21 ' CG2' ' A' ' 91' ' ' ILE . 87.4 mt -65.16 -41.91 94.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.973 0.416 . . . . 0.0 110.988 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 50.3 tp10 -65.22 -44.82 87.03 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.065 -179.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 244' ' ' ARG . . . . . 0.405 ' NE ' HG22 ' B' ' 240' ' ' THR . 88.6 mtm180 -64.34 -44.1 92.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.049 0.452 . . . . 0.0 111.046 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.593 ' NH1' ' OE2' ' B' ' 260' ' ' GLU . 54.5 ttm-85 -65.53 -41.06 93.52 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.709 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -60.86 -36.78 80.04 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 40.2 t -66.11 -43.24 87.76 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 177.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 248' ' ' GLN . . . . . 0.554 ' O ' ' N ' ' B' ' 252' ' ' LEU . 67.4 tp60 -61.04 -36.46 79.61 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.286 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.478 ' CG2' ' HE ' ' A' ' 12' ' ' ARG . 47.5 t -62.78 -45.74 98.1 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 CA-C-O 120.959 0.409 . . . . 0.0 109.988 179.066 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -62.92 -23.67 67.48 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.505 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -101.6 -8.7 21.61 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.189 178.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.554 ' N ' ' O ' ' B' ' 248' ' ' GLN . 37.9 tp -76.58 154.61 34.29 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.533 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -55.9 160.28 2.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.691 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 254' ' ' ASP . . . . . 0.409 ' N ' ' OD1' ' B' ' 254' ' ' ASP . 36.9 p-10 -80.91 5.97 14.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.441 0.639 . . . . 0.0 109.497 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -83.08 -88.62 0.09 Allowed 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.525 ' OD1' ' CD2' ' B' ' 252' ' ' LEU . 71.4 m-20 60.51 31.05 20.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.12 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.28 -36.61 84.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.971 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.494 ' O ' ' C ' ' B' ' 259' ' ' ASP . 92.4 m-20 -103.25 -2.06 27.84 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.588 ' CG ' ' H ' ' B' ' 260' ' ' GLU . 8.3 p-10 27.39 -101.95 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 113.928 -1.487 . . . . 0.0 109.728 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.593 ' OE2' ' NH1' ' B' ' 245' ' ' ARG . 97.7 mt-10 -144.13 19.39 1.76 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.361 179.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.527 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 85.0 mt -115.25 135.15 56.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.569 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 45.5 t -125.83 133.7 68.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.082 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -98.95 120.71 39.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.555 0.693 . . . . 0.0 112.421 -177.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -67.29 -41.59 85.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.623 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.12 159.39 29.53 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.576 -178.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -61.01 153.76 61.74 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 123.128 2.552 . . . . 0.0 112.598 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 45.4 pt . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.872 -179.347 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo . . . . . 0 N--CA 1.496 1.667 0 N-CA-C 110.854 -0.479 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.553 ' O ' ' O ' ' A' ' 99' ' ' ASN . 25.0 m -73.71 -46.0 48.78 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -178.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.7 mtt85 -92.94 138.54 31.39 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.632 -178.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -133.42 141.83 48.04 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.729 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.715 HD11 HD11 ' A' ' 22' ' ' LEU . 65.7 mt -116.57 139.04 50.93 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.6 t -110.81 132.61 58.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 C-N-CA 120.349 -0.541 . . . . 0.0 110.158 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 m -91.58 116.79 29.16 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -177.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.6 mt -84.11 142.51 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.057 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -94.85 155.82 16.62 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.272 0.558 . . . . 0.0 111.266 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.799 ' NH2' HD23 ' B' ' 252' ' ' LEU . 83.4 mtm180 -59.05 -32.15 69.5 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.159 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 93.9 p -70.49 -22.51 62.64 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.49 30.05 5.73 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.329 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.3 t -118.04 131.03 71.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.107 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -78.26 138.64 38.72 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.89 -113.83 1.48 Allowed Glycine 0 CA--C 1.53 0.988 0 C-N-CA 120.041 -1.076 . . . . 0.0 112.426 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.6 149.42 55.31 Favored 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 121.953 1.769 . . . . 0.0 112.006 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -114.51 144.65 43.01 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.094 0.473 . . . . 0.0 110.304 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.53 ' CD2' HD11 ' A' ' 37' ' ' ILE . 33.8 t80 -105.87 102.74 40.67 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.344 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -77.74 132.6 12.1 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 121.95 1.766 . . . . 0.0 111.415 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.715 HD11 HD11 ' A' ' 7' ' ' LEU . 95.9 mt -84.56 76.63 10.16 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -177.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 61.5 p -79.9 -12.17 59.76 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 177.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.638 HD11 ' HG2' ' B' ' 265' ' ' GLN . 44.5 mt -102.61 146.81 27.62 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.521 -178.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -68.89 -15.31 63.46 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.832 0.348 . . . . 0.0 111.397 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.454 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 92.1 m -132.48 134.96 45.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.017 0.437 . . . . 0.0 111.295 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.448 ' HB2' HD22 ' A' ' 22' ' ' LEU . 5.1 t -127.3 118.91 25.12 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.05 178.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.503 HD21 ' HG2' ' A' ' 47' ' ' GLN . 33.6 tp -118.2 125.51 50.32 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.814 -178.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.756 ' CE2' HD12 ' A' ' 37' ' ' ILE . 5.1 m-85 -102.61 135.94 43.34 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 123.669 0.606 . . . . 0.0 109.679 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 154.91 -179.9 30.61 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 120.353 -0.927 . . . . 0.0 112.568 179.032 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.465 ' NH1' ' O ' ' B' ' 229' ' ' ASP . 47.1 mtm180 -70.9 -33.48 70.59 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 122.653 -0.322 . . . . 0.0 111.552 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.551 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -43.94 140.18 3.52 Favored Glycine 0 N--CA 1.464 0.553 0 N-CA-C 111.306 -0.717 . . . . 0.0 111.306 -178.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.553 HG23 ' N ' ' A' ' 34' ' ' GLU . 9.7 tp -65.51 -41.99 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.553 ' N ' HG23 ' A' ' 33' ' ' ILE . 50.6 tp10 -56.92 -18.82 14.77 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.805 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.551 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 20.2 m -62.54 128.06 34.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.29 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.454 ' OD2' ' O ' ' A' ' 26' ' ' THR . 95.5 m-20 -60.4 -28.97 68.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.621 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.756 HD12 ' CE2' ' A' ' 29' ' ' PHE . 92.1 mt -128.32 118.56 48.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 177.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.513 ' CZ ' HD12 ' A' ' 33' ' ' ILE . 80.6 mtp180 -104.97 138.12 41.67 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.463 -178.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 88.6 mt -120.32 129.35 75.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 120.536 -0.465 . . . . 0.0 110.318 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -73.79 34.63 0.09 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.143 -178.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.572 ' CD1' ' NH2' ' A' ' 93' ' ' ARG . 32.3 mt -109.25 129.54 23.79 Favored Pre-proline 0 C--N 1.326 -0.435 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.06 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.12 -9.11 21.77 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 C-N-CA 121.975 1.784 . . . . 0.0 112.634 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.572 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 27.6 m -96.74 -0.67 10.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.627 0.251 . . . . 0.0 110.866 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 37.2 t -87.95 136.93 22.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.0 m -69.7 167.54 16.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.294 0.568 . . . . 0.0 111.553 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -64.46 -42.17 96.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.446 -178.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.656 ' O ' ' N ' ' A' ' 49' ' ' CYS . 86.5 mt-30 -115.13 -19.51 10.82 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.384 178.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 24.6 t60 37.3 -76.5 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.656 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -129.1 133.24 47.58 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.27 0.557 . . . . 0.0 111.722 -178.649 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -125.12 126.2 44.94 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.231 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 98.3 mt -112.86 134.55 55.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.578 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.454 ' CD ' ' NE2' ' A' ' 54' ' ' HIS . 84.6 tt0 -122.29 127.06 49.4 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.43 122.95 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 CA-C-O 121.754 0.788 . . . . 0.0 112.754 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.55 ' O ' ' N ' ' A' ' 56' ' ' GLN . 98.0 m-70 -114.02 139.42 49.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.388 -1.278 . . . . 0.0 109.308 179.116 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.473 ' C ' ' O ' ' A' ' 54' ' ' HIS . 83.3 tt0 -38.96 -26.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.55 ' N ' ' O ' ' A' ' 54' ' ' HIS . 91.2 mt-30 -67.36 -67.64 0.44 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.871 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.452 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 3.3 tp10 -155.2 -165.18 1.95 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.826 -179.052 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.41 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -114.33 133.38 55.72 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.527 178.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.2 mt -121.72 127.54 75.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.005 0.431 . . . . 0.0 111.561 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.571 ' HB2' HD11 ' A' ' 82' ' ' LEU . 28.9 tp -100.26 127.43 46.55 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.223 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.401 ' CE1' ' HB3' ' A' ' 79' ' ' PRO . 98.8 m-70 -113.53 138.71 49.75 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.041 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.528 HD22 ' HA ' ' A' ' 68' ' ' PRO . 49.5 t30 -100.65 108.78 20.75 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.389 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -100.88 -9.82 21.25 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.335 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -75.98 99.15 4.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.098 0.475 . . . . 0.0 110.307 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.8 t -73.04 -36.52 66.96 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.519 0.676 . . . . 0.0 109.354 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.704 HG21 ' O ' ' B' ' 234' ' ' TPO . 1.5 m -65.31 -48.14 74.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.81 -1.086 . . . . 0.0 111.789 -178.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.454 ' OD1' HG23 ' B' ' 236' ' ' VAL . 3.0 m-20 -142.81 95.11 6.37 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.546 -178.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.591 ' HB2' HG13 ' A' ' 75' ' ' VAL . 43.3 Cg_exo -55.17 146.78 57.93 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 122.18 1.92 . . . . 0.0 112.287 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 59.0 m -74.57 140.45 44.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.284 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -99.18 142.51 30.57 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.647 179.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 54.5 t -131.12 134.73 61.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 25.9 m120 51.07 30.25 5.32 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 119.321 -0.951 . . . . 0.0 108.601 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.07 26.13 69.5 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.221 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.4 p -137.85 137.34 38.02 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.98 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.591 HG13 ' HB2' ' A' ' 68' ' ' PRO . 25.7 t -70.99 136.07 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.312 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.4 pt -109.4 93.99 2.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.729 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -67.81 -29.43 68.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.087 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -125.46 174.65 3.73 Favored Pre-proline 0 CA--C 1.536 0.419 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.172 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.401 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 27.4 Cg_exo -61.36 144.58 98.48 Favored 'Trans proline' 0 N--CA 1.501 1.936 0 C-N-CA 122.871 2.38 . . . . 0.0 112.745 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.7 m -144.03 143.06 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.352 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 92.4 mtt-85 -75.36 129.88 38.1 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.61 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.571 HD11 ' HB2' ' A' ' 60' ' ' LEU . 88.1 mt -83.77 139.24 32.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.705 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -126.9 151.16 48.8 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.489 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.495 ' C ' ' CD2' ' A' ' 84' ' ' HIS . 6.1 t60 -58.06 122.39 12.93 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.91 0.385 . . . . 0.0 110.388 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.49 -13.67 32.97 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.574 -0.61 . . . . 0.0 111.574 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -75.0 136.82 41.24 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.728 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.3 t -108.28 131.98 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.068 -178.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.7 mt -97.09 132.07 42.44 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.448 HG23 ' OG ' ' A' ' 94' ' ' SER . 84.5 m -124.68 126.7 46.13 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -177.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.426 ' O ' ' C ' ' A' ' 91' ' ' ILE . 93.2 mt -114.79 122.03 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.593 HG22 ' N ' ' A' ' 92' ' ' ASP . 89.7 mt 36.29 -103.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.593 ' N ' HG22 ' A' ' 91' ' ' ILE . 88.3 m-20 -103.77 9.02 37.22 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -178.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.626 HH21 ' CZ ' ' B' ' 245' ' ' ARG . 2.5 ptp85 -132.46 148.16 52.39 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.509 -0.477 . . . . 0.0 111.194 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.448 ' OG ' HG23 ' A' ' 89' ' ' THR . 65.2 m -135.15 152.33 51.5 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.349 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -119.32 121.56 39.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.25 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -81.56 131.05 35.26 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 119.821 -0.751 . . . . 0.0 111.391 -179.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -93.24 120.28 33.34 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.247 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -136.4 122.29 20.02 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.727 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.553 ' O ' ' O ' ' A' ' 4' ' ' THR . 90.6 m-20 -63.59 -40.77 97.79 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 178.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.606 179.243 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 34.1 m . . . . . 0 N--CA 1.453 -0.299 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.465 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 75.4 m-20 -71.24 130.71 42.13 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.209 0.528 . . . . 0.0 110.868 -178.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 230' ' ' SEP . . . . . 0.569 ' P ' ' H ' ' B' ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.437 ' H ' ' C ' ' B' ' 229' ' ' ASP . 75.0 mt-30 -123.9 35.19 4.89 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.988 -1.006 . . . . 0.0 109.449 178.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -114.36 -177.87 19.05 Favored Glycine 0 CA--C 1.533 1.17 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.45 161.11 44.78 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 123.399 2.733 . . . . 0.0 113.04 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.704 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -61.5 138.7 77.62 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.637 2.225 . . . . 0.0 112.83 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.454 HG23 ' OD1' ' A' ' 67' ' ' ASN . 0.5 OUTLIER -73.12 137.65 22.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 114.559 -1.2 . . . . 0.0 109.713 179.412 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.8 t -52.39 116.18 2.13 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.444 -179.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -50.7 -26.48 17.43 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.543 2.162 . . . . 0.0 112.986 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 40.1 p -73.99 -39.46 63.65 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.572 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 81.7 t80 -57.45 -45.7 84.44 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.427 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.49 HD23 ' OD2' ' A' ' 92' ' ' ASP . 90.9 mt -62.89 -40.16 96.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.991 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.77 -43.02 97.64 Favored 'General case' 0 CA--C 1.522 -0.105 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.794 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -61.4 -42.82 99.34 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.839 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.626 ' CZ ' HH21 ' A' ' 93' ' ' ARG . 70.6 mtp85 -61.3 -43.89 98.12 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.484 0.549 . . . . 0.0 112.484 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -62.87 -39.61 94.96 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.099 -0.64 . . . . 0.0 109.298 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 39.7 t -67.23 -46.56 73.43 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.025 178.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 248' ' ' GLN . . . . . 0.633 ' O ' ' N ' ' B' ' 252' ' ' LEU . 73.4 mt-30 -59.27 -37.21 77.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.36 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.451 HG23 ' O ' ' B' ' 245' ' ' ARG . 40.7 t -62.79 -46.19 96.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.798 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -58.15 -29.75 65.82 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -96.64 -16.1 21.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.499 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.799 HD23 ' NH2' ' A' ' 12' ' ' ARG . 63.4 tp -123.13 111.36 16.42 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 178.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 253' ' ' ASN . . . . . 0.444 ' O ' ' OD1' ' B' ' 253' ' ' ASN . 54.7 t-20 179.49 24.3 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.669 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -99.45 -3.92 32.59 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 255' ' ' ASP . . . . . 0.406 ' C ' ' H ' ' B' ' 257' ' ' LYS . 67.7 t0 -177.54 55.06 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.586 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.574 ' N ' ' OD1' ' B' ' 256' ' ' ASP . 6.1 p-10 -78.26 31.6 0.18 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.892 0.377 . . . . 0.0 111.035 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 257' ' ' LYS . . . . . 0.406 ' H ' ' C ' ' B' ' 255' ' ' ASP . 98.5 mttt -60.74 -29.54 69.45 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.744 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.685 ' O ' ' N ' ' B' ' 260' ' ' GLU . 23.3 p-10 -99.82 3.0 44.5 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.977 0.418 . . . . 0.0 110.351 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.451 ' C ' ' O ' ' B' ' 258' ' ' ASP . 48.9 p30 1.12 54.13 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 114.52 -1.218 . . . . 0.0 114.128 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.685 ' N ' ' O ' ' B' ' 258' ' ' ASP . 97.3 mt-10 55.22 9.91 0.39 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 178.087 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 82.6 mt -117.61 132.88 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 43.2 t -126.97 135.35 63.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.495 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -96.91 120.58 37.52 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.194 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -65.48 -46.11 81.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.539 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 265' ' ' GLN . . . . . 0.638 ' HG2' HD11 ' A' ' 24' ' ' LEU . 3.3 mp0 -96.9 164.95 16.85 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.277 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -64.32 152.58 80.83 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.351 2.034 . . . . 0.0 111.91 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 42.6 pt . . . . . 0 C--N 1.328 -0.328 0 CA-C-O 121.307 0.575 . . . . 0.0 112.103 -178.553 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo . . . . . 0 N--CA 1.494 1.504 0 N-CA-C 111.459 -0.247 . . . . 0.0 111.459 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.7 p -127.79 26.36 5.88 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.814 -0.354 . . . . 0.0 111.258 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.494 ' NH2' HG21 ' A' ' 53' ' ' ILE . 88.0 mtm-85 -86.09 127.49 34.7 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -128.48 144.28 51.12 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.83 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 1.061 HD11 HD11 ' A' ' 22' ' ' LEU . 82.0 mt -113.89 142.62 45.89 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.188 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.5 t -114.14 126.76 71.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.0 m -77.4 140.68 39.95 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.505 0.669 . . . . 0.0 111.52 -178.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.446 ' HB ' ' H ' ' A' ' 94' ' ' SER . 49.2 mm -109.95 135.31 49.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.088 178.422 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -94.6 158.29 15.6 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.339 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -57.9 -20.97 41.06 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.89 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.7 p -81.23 -11.65 59.33 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.969 179.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.23 16.55 57.29 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-N 116.086 -0.506 . . . . 0.0 113.094 178.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.5 m -109.05 147.31 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 117.434 0.617 . . . . 0.0 111.533 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.431 ' C ' ' OD1' ' A' ' 16' ' ' ASP . 58.9 t0 -69.74 126.42 29.67 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.18 -178.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.402 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -115.86 -132.35 5.06 Favored Glycine 0 CA--C 1.542 1.751 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -74.18 153.36 46.06 Favored 'Trans proline' 0 N--CA 1.5 1.868 0 C-N-CA 122.509 2.139 . . . . 0.0 112.952 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -109.7 162.51 14.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.006 0.431 . . . . 0.0 110.615 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.427 ' CD2' HD11 ' A' ' 37' ' ' ILE . 38.0 t80 -132.43 106.76 13.24 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.047 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -73.58 127.37 11.66 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 121.903 1.736 . . . . 0.0 112.603 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 1.061 HD11 HD11 ' A' ' 7' ' ' LEU . 95.5 mt -92.05 48.26 1.41 Allowed 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.523 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.8 p -64.82 -13.05 54.45 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 119.559 -0.856 . . . . 0.0 109.222 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.616 HD11 ' OE1' ' B' ' 265' ' ' GLN . 75.4 mt -81.29 141.6 33.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.222 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 87.8 p -62.19 -21.65 65.27 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.971 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 57.6 m -139.54 138.84 36.63 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 119.827 -0.749 . . . . 0.0 112.164 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.509 ' HB2' HD22 ' A' ' 22' ' ' LEU . 5.7 t -128.6 123.92 34.57 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.849 178.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.6 tp -117.43 128.18 54.76 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.979 -178.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.791 ' CE2' HD12 ' A' ' 37' ' ' ILE . 4.4 m-85 -107.35 139.61 41.56 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.703 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 155.8 -173.37 33.84 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.196 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.629 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 83.9 mtm-85 -79.79 -31.03 40.76 Favored 'General case' 0 CA--C 1.527 0.079 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.561 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -52.38 146.08 16.52 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 121.003 -0.618 . . . . 0.0 111.695 -178.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.43 HD13 ' CZ ' ' A' ' 38' ' ' ARG . 33.2 mm -63.8 -43.61 97.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.877 0.37 . . . . 0.0 110.078 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -53.0 -18.11 1.82 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.989 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.561 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 59.6 m -61.18 123.39 17.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.982 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -60.18 -31.73 70.4 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.791 HD12 ' CE2' ' A' ' 29' ' ' PHE . 81.0 mt -124.65 119.33 55.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 176.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.43 ' CZ ' HD13 ' A' ' 33' ' ' ILE . 84.3 mtp180 -102.41 137.31 40.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.723 -178.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.471 HG22 ' H ' ' A' ' 41' ' ' LEU . 98.2 mt -122.99 131.62 72.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.521 179.295 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -80.3 26.0 0.38 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.529 -178.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.471 ' H ' HG22 ' A' ' 39' ' ' ILE . 34.8 mt -90.11 132.62 35.48 Favored Pre-proline 0 C--N 1.325 -0.477 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.377 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -71.4 -12.65 29.88 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 121.904 1.736 . . . . 0.0 111.53 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.532 HG21 ' CE2' ' B' ' 241' ' ' PHE . 3.6 m -102.14 7.59 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.629 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 11.4 t -93.51 129.95 43.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.28 168.04 6.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.272 0.558 . . . . 0.0 110.894 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -63.25 -43.32 98.32 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.1 -178.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.626 ' O ' ' N ' ' A' ' 49' ' ' CYS . 86.3 mt-30 -111.18 -11.83 14.19 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.55 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 18.6 t60 30.23 -76.68 0.0 OUTLIER 'General case' 0 C--O 1.237 0.402 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.626 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.95 136.04 47.04 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.266 0.555 . . . . 0.0 112.061 -178.549 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -127.38 127.09 43.62 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.064 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 95.8 mt -111.6 133.13 58.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.208 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -114.4 131.69 56.49 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.494 HG21 ' NH2' ' A' ' 5' ' ' ARG . 45.5 mm -103.51 115.37 45.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.296 0.57 . . . . 0.0 111.269 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.426 ' O ' ' C ' ' A' ' 55' ' ' GLU . 93.2 m-70 -117.04 137.57 52.16 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.959 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 54' ' ' HIS . 80.1 mm-40 -40.18 -35.39 0.39 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.256 0.551 . . . . 0.0 109.777 -179.399 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.478 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 98.5 mm-40 -64.13 -67.11 0.46 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.983 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.478 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 6.1 tp10 -155.64 -166.08 2.14 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.534 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.455 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -119.88 127.93 53.17 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 91.3 mt -116.02 130.54 70.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.11 0.481 . . . . 0.0 111.496 -178.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.562 ' HB2' HD11 ' A' ' 82' ' ' LEU . 19.6 tp -96.88 127.36 42.78 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.145 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -110.58 136.19 50.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.803 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -97.15 111.66 23.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.856 0.36 . . . . 0.0 111.575 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.444 ' CD2' ' OE1' ' A' ' 47' ' ' GLN . 32.8 m-85 -99.8 -8.22 24.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.667 178.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.8 t -70.59 99.26 1.62 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 88.3 p -85.08 -6.12 59.32 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.324 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.534 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -102.04 -38.04 7.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.286 179.782 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -144.68 97.49 5.0 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.032 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.4 147.71 55.62 Favored 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 122.504 2.136 . . . . 0.0 113.376 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.1 m -72.08 138.06 47.55 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.56 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -101.54 139.04 37.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.533 179.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.477 ' HB ' HD11 ' A' ' 76' ' ' ILE . 25.5 t -130.5 134.17 62.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.069 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 54.94 32.46 18.01 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.288 0.566 . . . . 0.0 109.696 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.13 27.35 70.36 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.895 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.8 m -138.06 131.66 30.95 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.785 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -67.47 142.42 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 121.101 0.476 . . . . 0.0 111.123 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.525 ' CG2' ' O ' ' A' ' 78' ' ' GLU . 75.1 mt -114.51 123.79 70.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.845 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -96.14 -24.09 16.45 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.981 179.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.525 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 3.7 mm-40 -129.27 172.42 7.16 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.785 -178.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -60.6 146.49 96.98 Favored 'Trans proline' 0 N--CA 1.501 1.943 0 C-N-CA 122.285 1.99 . . . . 0.0 112.652 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.491 HG11 HD13 ' A' ' 76' ' ' ILE . 4.1 p -140.15 144.97 26.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.209 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -77.85 129.66 35.68 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.157 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.562 HD11 ' HB2' ' A' ' 60' ' ' LEU . 96.9 mt -86.56 135.94 33.25 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.249 0.547 . . . . 0.0 111.107 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -131.1 154.25 48.49 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.629 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.433 ' ND1' ' N ' ' A' ' 99' ' ' ASN . 8.2 t60 -53.44 117.37 3.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.626 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 113.87 -25.38 10.9 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.1 -0.572 . . . . 0.0 112.157 178.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -66.8 137.0 56.3 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.871 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 68.4 t -113.38 132.68 61.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.7 -178.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.0 mt -93.4 130.79 41.9 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 N-CA-C 107.994 -1.114 . . . . 0.0 107.994 178.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 51.4 m -118.52 128.26 54.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.639 0.733 . . . . 0.0 112.575 -178.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.458 ' O ' ' C ' ' A' ' 91' ' ' ILE . 95.3 mt -118.03 124.63 73.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.682 178.373 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.504 HD12 ' CB ' ' B' ' 237' ' ' CYS . 42.6 mm 34.14 -95.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.944 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 90' ' ' ILE . 47.9 t0 -117.65 15.36 14.53 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.727 0.298 . . . . 0.0 111.336 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.571 ' NH2' ' OE1' ' B' ' 260' ' ' GLU . 55.6 mtt85 -127.13 143.44 51.27 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.09 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.446 ' H ' ' HB ' ' A' ' 10' ' ' ILE . 38.2 m -135.69 154.53 51.25 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.531 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.594 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 91.8 m-85 -127.56 121.58 30.98 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -88.58 133.62 34.12 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.984 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -93.07 122.98 36.0 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.166 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -124.51 118.81 27.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.838 0.351 . . . . 0.0 110.294 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.433 ' N ' ' ND1' ' A' ' 84' ' ' HIS . 58.5 t-20 -100.19 102.65 14.0 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.641 -178.557 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 47.5 t . . . . . 0 N--CA 1.45 -0.465 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.474 ' C ' ' H ' ' B' ' 231' ' ' GLN . 87.3 m-20 -68.97 143.84 54.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.513 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 230' ' ' SEP . . . . . 0.466 ' N ' ' O3P' ' B' ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.474 ' H ' ' C ' ' B' ' 229' ' ' ASP . 75.0 mt-30 -130.16 33.34 4.37 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.5 -179.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -109.15 -157.7 18.09 Favored Glycine 0 CA--C 1.531 1.072 0 N-CA-C 111.582 -0.607 . . . . 0.0 111.582 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -77.86 160.2 30.81 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 123.002 2.468 . . . . 0.0 112.831 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -77.57 172.93 14.98 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.602 2.201 . . . . 0.0 111.712 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.534 ' CG2' HG22 ' A' ' 66' ' ' THR . 27.9 t -112.84 133.6 58.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.375 -179.472 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 237' ' ' CYS . . . . . 0.504 ' CB ' HD12 ' A' ' 91' ' ' ILE . 2.3 t -78.17 121.46 24.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.438 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 238' ' ' TPO . . . . . 0.552 ' P ' ' HG1' ' B' ' 240' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 239' ' ' PRO . . . . . 0.441 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 42.3 Cg_exo -57.77 -24.98 66.46 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 122.995 2.463 . . . . 0.0 113.795 -179.02 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 240' ' ' THR . . . . . 0.552 ' HG1' ' P ' ' B' ' 238' ' ' TPO . 18.1 p -76.04 -42.57 47.33 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.735 178.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.532 ' CE2' HG21 ' A' ' 43' ' ' VAL . 83.8 t80 -58.08 -45.0 87.87 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.837 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' B' ' 242' ' ' LEU . 95.6 mt -64.54 -41.87 96.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.781 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -63.95 -36.92 85.53 Favored 'General case' 0 C--N 1.334 -0.093 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.38 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 244' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' B' ' 244' ' ' ARG . 78.2 mtt85 -61.74 -43.25 99.21 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.628 -0.429 . . . . 0.0 109.981 179.217 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.575 ' O ' HG23 ' B' ' 249' ' ' VAL . 24.8 mmt180 -63.2 -41.88 99.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.427 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -63.53 -39.36 94.23 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 11.2 t -64.28 -46.59 83.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.129 178.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -61.42 -35.87 78.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.611 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.575 HG23 ' O ' ' B' ' 245' ' ' ARG . 77.3 t -64.92 -44.23 96.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.903 0.382 . . . . 0.0 110.188 179.035 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -60.22 -33.88 72.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.564 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -95.61 -5.51 42.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.305 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.469 ' O ' ' O ' ' B' ' 249' ' ' VAL . 54.5 tp -119.79 120.19 35.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.502 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -70.92 -179.86 2.43 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.916 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 254' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' B' ' 254' ' ' ASP . 36.3 p-10 -91.37 2.34 56.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.707 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -70.44 -9.45 56.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.979 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.47 ' OD1' ' OD1' ' B' ' 258' ' ' ASP . 25.9 t0 -84.33 90.17 7.51 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.134 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -81.56 7.23 12.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.546 -178.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.524 ' O ' ' C ' ' B' ' 259' ' ' ASP . 12.7 p-10 -82.8 23.07 0.84 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.683 ' C ' ' H ' ' B' ' 261' ' ' ILE . 38.0 p30 -19.68 124.91 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 123.99 0.806 . . . . 0.0 111.603 -179.36 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.571 ' OE1' ' NH2' ' A' ' 93' ' ' ARG . 96.0 mt-10 -52.71 7.78 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.461 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.683 ' H ' ' C ' ' B' ' 259' ' ' ASP . 68.5 mt -107.77 134.5 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 178.095 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 77.3 t -128.07 136.76 59.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.369 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -95.49 118.18 31.74 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.296 0.57 . . . . 0.0 111.499 -178.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -65.05 -44.02 90.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.289 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 265' ' ' GLN . . . . . 0.616 ' OE1' HD11 ' A' ' 24' ' ' LEU . 10.4 mm-40 -96.73 154.01 38.53 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.57 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -61.65 146.24 96.94 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.326 2.017 . . . . 0.0 112.355 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 45.6 pt . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.872 -179.637 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo . . . . . 0 N--CA 1.494 1.556 0 CA-C-O 120.645 0.185 . . . . 0.0 112.171 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 96.4 m -96.61 -45.05 6.87 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.382 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.6 mtt85 -87.51 129.74 34.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.436 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -133.93 139.55 46.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.611 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.734 HD12 ' O ' ' A' ' 96' ' ' ARG . 34.5 tp -114.59 129.2 56.65 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.764 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.7 t -108.19 131.11 59.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.29 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.8 m -81.76 148.23 29.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.287 0.565 . . . . 0.0 111.711 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.427 HD12 ' HB3' ' A' ' 94' ' ' SER . 92.6 mt -117.93 138.06 49.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 114.979 -1.01 . . . . 0.0 108.74 178.203 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -91.14 160.73 15.41 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.045 0.45 . . . . 0.0 111.408 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.54 HH12 ' CD ' ' B' ' 248' ' ' GLN . 89.9 mtm180 -58.63 -28.82 66.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.781 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.5 p -78.41 -7.61 57.56 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.636 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.67 33.17 9.38 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -178.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.5 t -123.78 135.27 64.02 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 CA-C-O 121.385 0.612 . . . . 0.0 111.55 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -76.27 138.11 40.34 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.547 179.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -126.29 -121.62 2.5 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 111.404 -0.678 . . . . 0.0 111.404 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.24 152.92 45.47 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.281 1.988 . . . . 0.0 112.829 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -110.34 153.81 24.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.16 0.505 . . . . 0.0 110.658 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.8 ' CD2' HD11 ' A' ' 37' ' ' ILE . 43.8 t80 -122.58 94.9 47.26 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.335 -179.151 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -59.36 127.03 22.47 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 121.349 1.366 . . . . 0.0 111.254 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.4 mt -84.77 50.17 1.86 Allowed 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.448 -178.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 72.4 m -60.86 -33.83 73.67 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.2 0.524 . . . . 0.0 109.845 179.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.702 HD11 ' HG2' ' B' ' 265' ' ' GLN . 66.7 mt -69.97 139.96 52.91 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.369 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.0 t -65.69 -18.83 65.61 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.405 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.9 m -134.51 133.53 40.45 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.246 -0.582 . . . . 0.0 111.444 -178.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.2 t -129.54 120.37 25.24 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.313 0.578 . . . . 0.0 110.249 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.525 HD12 ' O ' ' A' ' 49' ' ' CYS . 48.4 tp -117.37 131.74 56.72 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.994 -178.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.462 ' O ' ' O ' ' A' ' 47' ' ' GLN . 37.3 m-85 -109.7 140.5 43.5 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.848 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 153.86 -175.49 32.14 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 120.783 -0.723 . . . . 0.0 111.686 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 45.0 mtm180 -75.15 -32.29 61.27 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.609 0.242 . . . . 0.0 111.428 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.589 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -45.04 140.04 4.76 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.468 HG23 ' N ' ' A' ' 34' ' ' GLU . 7.1 tp -66.91 -41.07 87.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.374 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.468 ' N ' HG23 ' A' ' 33' ' ' ILE . 51.6 tp10 -61.41 -15.73 39.66 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.205 0.526 . . . . 0.0 110.149 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.589 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 8.8 m -61.17 131.62 51.05 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.289 -0.564 . . . . 0.0 109.752 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -60.67 -33.43 72.82 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.8 HD11 ' CD2' ' A' ' 20' ' ' PHE . 44.1 mm -121.4 115.12 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.061 177.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.474 ' NH2' HG11 ' B' ' 262' ' ' VAL . 88.3 mtm-85 -100.72 133.08 45.71 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.828 HG23 ' NH1' ' A' ' 93' ' ' ARG . 96.2 mt -119.24 129.8 74.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.689 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -74.92 24.14 0.09 Allowed 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -177.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.753 HD21 ' NH2' ' A' ' 93' ' ' ARG . 95.6 mt -97.87 126.71 39.64 Favored Pre-proline 0 C--N 1.324 -0.512 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.384 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -70.97 -9.67 26.13 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.682 2.254 . . . . 0.0 113.232 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.554 HG21 ' CE2' ' B' ' 241' ' ' PHE . 27.1 m -97.71 5.33 9.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.393 -179.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.4 t -94.96 136.79 25.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.692 0.282 . . . . 0.0 110.38 179.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.492 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 1.2 t -67.52 165.62 16.44 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.164 0.507 . . . . 0.0 110.857 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 41.1 mtmt -62.51 -41.99 99.21 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.36 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.605 ' O ' ' N ' ' A' ' 49' ' ' CYS . 84.2 mt-30 -111.46 -17.72 13.02 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.954 0.407 . . . . 0.0 111.111 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.492 ' H ' ' HB3' ' A' ' 45' ' ' SER . 26.8 t60 34.06 -75.92 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.605 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.81 136.94 49.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.321 0.581 . . . . 0.0 112.559 -177.785 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -127.09 129.0 47.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.979 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 93.5 mt -114.83 133.31 61.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.43 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -117.1 126.98 53.67 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 77.5 mt -108.81 113.78 45.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.705 0.765 . . . . 0.0 111.714 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.582 ' O ' ' N ' ' A' ' 56' ' ' GLN . 86.4 m-70 -114.27 146.79 40.0 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.806 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 54' ' ' HIS . 57.7 mp0 -40.58 -22.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.653 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.582 ' N ' ' O ' ' A' ' 54' ' ' HIS . 14.8 mm100 -72.57 -69.38 0.41 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -160.58 -164.89 1.3 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.191 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.493 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -109.8 124.26 50.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.663 179.036 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.6 mt -113.5 130.02 68.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.026 0.441 . . . . 0.0 111.751 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.719 HD22 ' CD1' ' A' ' 88' ' ' ILE . 25.6 tp -99.76 128.3 45.87 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.011 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -113.15 136.04 53.15 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.147 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -93.48 107.97 19.73 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.642 0.258 . . . . 0.0 111.67 -178.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -101.19 -11.51 19.48 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.714 179.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.6 t -72.45 98.43 2.27 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.9 t -82.69 -17.33 44.84 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.806 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.481 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -93.32 -43.21 8.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.287 -178.766 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -133.31 97.35 16.35 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -57.62 144.33 92.88 Favored 'Trans proline' 0 N--CA 1.5 1.894 0 C-N-CA 122.183 1.922 . . . . 0.0 113.224 -178.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.6 m -72.51 150.01 43.6 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.372 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -114.42 141.25 47.9 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.482 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.687 HG13 ' OD1' ' A' ' 86' ' ' ASP . 44.6 t -127.72 134.1 66.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 54.84 32.02 16.85 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.139 -0.625 . . . . 0.0 110.12 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.12 23.28 77.99 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.124 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.7 t -138.33 143.95 40.16 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 117.011 0.405 . . . . 0.0 110.99 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 44.2 t -67.08 132.33 32.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.502 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.426 HG12 ' O ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -118.56 79.29 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.426 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -65.96 -21.35 66.41 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.117 -178.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.426 ' O ' HG12 ' A' ' 76' ' ' ILE . 0.6 OUTLIER -110.35 159.95 30.2 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -179.562 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.41 145.87 92.83 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 C-N-CA 121.148 1.232 . . . . 0.0 111.196 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.42 145.73 21.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 89.9 mtm180 -75.29 132.05 40.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.795 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.493 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 92.0 mt -80.77 141.27 34.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.066 0.46 . . . . 0.0 110.927 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -129.02 149.84 50.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.779 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.471 ' C ' ' CD2' ' A' ' 84' ' ' HIS . 7.7 t60 -54.67 119.91 5.99 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.376 -0.529 . . . . 0.0 110.57 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.07 -8.32 41.94 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.687 ' OD1' HG13 ' A' ' 71' ' ' VAL . 45.6 t0 -71.62 127.54 32.9 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.078 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.516 HG22 ' HG2' ' A' ' 96' ' ' ARG . 76.6 t -105.56 134.62 46.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.401 -178.16 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.719 ' CD1' HD22 ' A' ' 60' ' ' LEU . 11.6 mm -98.16 128.55 49.49 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.7 m -122.48 129.06 51.61 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.841 0.829 . . . . 0.0 112.875 -178.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.476 ' O ' ' C ' ' A' ' 91' ' ' ILE . 74.1 mt -121.01 127.03 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 114.445 -1.252 . . . . 0.0 108.429 178.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.476 ' C ' ' O ' ' A' ' 90' ' ' ILE . 37.5 mm 35.91 -99.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 C-N-CA 120.576 -0.449 . . . . 0.0 110.252 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.504 ' O ' ' OD1' ' A' ' 92' ' ' ASP . 39.0 t0 -118.07 17.6 14.03 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.989 0.424 . . . . 0.0 110.91 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.828 ' NH1' HG23 ' A' ' 39' ' ' ILE . 97.7 mtt180 -125.67 142.17 51.65 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.759 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.45 ' OG ' ' CG1' ' A' ' 87' ' ' VAL . 16.6 t -140.12 152.85 46.44 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 120.184 -0.607 . . . . 0.0 110.781 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.518 ' HB3' HD11 ' A' ' 7' ' ' LEU . 76.4 m-85 -126.07 125.12 42.07 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.617 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.734 ' O ' HD12 ' A' ' 7' ' ' LEU . 99.6 mtt180 -88.03 134.09 33.82 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 120.351 -0.539 . . . . 0.0 111.605 -178.176 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -97.64 125.92 42.66 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.858 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -131.03 124.28 30.56 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.216 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 45.5 p-10 -102.52 9.94 39.19 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.841 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 . . . . . 0 C--N 1.323 -0.544 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.905 179.649 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 78.3 t . . . . . 0 CA--C 1.529 0.141 0 CA-C-O 120.577 0.227 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.439 ' C ' ' H ' ' B' ' 231' ' ' GLN . 86.6 m-20 -98.6 -4.1 34.74 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.81 0.338 . . . . 0.0 110.434 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 230' ' ' SEP . . . . . 0.49 ' O ' ' OE1' ' B' ' 231' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.49 ' OE1' ' O ' ' B' ' 230' ' ' SEP . 27.4 mm100 -135.63 39.83 2.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.363 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -110.38 -162.51 18.61 Favored Glycine 0 CA--C 1.521 0.441 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.736 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -70.94 156.08 60.91 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 123.465 2.777 . . . . 0.0 112.176 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -78.12 140.22 17.62 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 121.768 1.645 . . . . 0.0 112.765 -179.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.481 ' CG2' HG22 ' A' ' 66' ' ' THR . 39.8 t -67.78 136.56 26.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.72 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 10.4 t -62.55 126.81 28.62 Favored 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.594 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -57.77 -23.15 56.89 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 121.921 1.747 . . . . 0.0 112.5 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 24.7 m -71.41 -42.95 67.68 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.554 ' CE2' HG21 ' A' ' 43' ' ' VAL . 87.8 t80 -58.33 -46.61 85.88 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.221 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 88.0 mt -62.97 -41.17 99.46 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.491 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -61.34 -38.76 88.08 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.408 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -63.79 -42.77 97.67 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.419 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 245' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -60.88 -40.27 92.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.259 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -64.17 -38.45 91.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.863 0.364 . . . . 0.0 110.763 179.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 80.8 p -68.61 -40.56 80.37 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 248' ' ' GLN . . . . . 0.54 ' CD ' HH12 ' A' ' 12' ' ' ARG . 59.8 tt0 -60.53 -38.27 83.9 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.442 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 24.4 t -63.04 -44.96 99.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -59.96 -27.62 66.97 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.72 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -96.59 -12.44 23.97 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.748 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.443 ' N ' ' O ' ' B' ' 248' ' ' GLN . 54.3 tp -124.39 115.66 21.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.305 178.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 171.63 23.0 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.042 178.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 254' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' B' ' 255' ' ' ASP . 29.2 p-10 -65.89 -46.4 78.5 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 255' ' ' ASP . . . . . 0.538 ' N ' ' OD1' ' B' ' 254' ' ' ASP . 24.6 p-10 170.38 64.41 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.551 179.281 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -120.33 99.48 6.6 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 120.551 -0.459 . . . . 0.0 111.725 -178.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 257' ' ' LYS . . . . . 0.597 ' O ' ' N ' ' B' ' 259' ' ' ASP . 98.8 mttt -65.76 -84.14 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.98 0.419 . . . . 0.0 110.161 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.583 ' O ' ' N ' ' B' ' 260' ' ' GLU . 97.4 m-20 -33.97 -28.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.476 -178.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.597 ' N ' ' O ' ' B' ' 257' ' ' LYS . 61.3 t0 45.86 -79.3 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.448 178.319 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.583 ' N ' ' O ' ' B' ' 258' ' ' ASP . 91.1 mt-10 -148.22 10.42 0.88 Allowed 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.347 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 64.6 mt -108.59 141.45 23.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 262' ' ' VAL . . . . . 0.474 HG11 ' NH2' ' A' ' 38' ' ' ARG . 54.3 t -127.27 135.62 62.93 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 CA-C-O 121.065 0.459 . . . . 0.0 110.957 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -98.81 124.06 43.44 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.519 -178.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -64.69 -47.1 79.61 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.705 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 265' ' ' GLN . . . . . 0.702 ' HG2' HD11 ' A' ' 24' ' ' LEU . 2.6 mp0 -96.74 159.1 32.42 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.547 -179.344 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -68.05 143.51 60.19 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 122.998 2.465 . . . . 0.0 113.395 -179.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 47.9 pt . . . . . 0 C--N 1.326 -0.438 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.535 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo . . . . . 0 N--CA 1.496 1.654 0 CA-C-O 120.588 0.162 . . . . 0.0 111.874 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.8 m -100.84 -55.47 2.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.399 0.619 . . . . 0.0 110.137 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.591 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 93.9 mtt-85 -92.39 130.81 37.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.309 -178.37 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.593 ' HE ' ' CE1' ' A' ' 19' ' ' HIS . 85.6 mtp180 -128.7 141.4 51.34 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.106 0.479 . . . . 0.0 111.343 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.491 HD12 ' O ' ' A' ' 96' ' ' ARG . 41.7 tp -117.8 136.46 53.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.065 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.7 t -114.26 130.01 69.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 CA-C-O 120.775 0.321 . . . . 0.0 111.353 -178.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 m -94.87 116.16 28.37 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.553 -178.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 66.9 mt -84.93 150.93 3.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.99 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -92.93 161.15 14.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.714 0.292 . . . . 0.0 110.358 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.776 HH11 HH11 ' B' ' 245' ' ' ARG . 91.0 mtm180 -57.22 -29.3 63.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.917 -179.094 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 75.4 p -77.28 -11.09 59.79 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.831 -0.347 . . . . 0.0 110.818 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.88 29.28 11.95 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.1 t -114.49 133.69 59.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.735 0.303 . . . . 0.0 110.668 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' A' ' 17' ' ' GLY . 64.8 t0 -69.34 127.64 33.77 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.809 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.409 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -119.31 -123.67 3.19 Favored Glycine 0 CA--C 1.537 1.42 0 C-N-CA 121.083 -0.579 . . . . 0.0 112.166 -179.348 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -74.34 149.08 39.45 Favored 'Trans proline' 0 N--CA 1.497 1.709 0 C-N-CA 122.492 2.128 . . . . 0.0 113.338 -178.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.593 ' CE1' ' HE ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -109.28 151.72 26.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.902 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.488 ' CD2' HD11 ' A' ' 37' ' ' ILE . 65.1 t80 -121.29 104.5 40.57 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.906 -178.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -77.48 127.37 8.9 Favored 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 121.767 1.645 . . . . 0.0 111.722 -179.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.433 HD13 HD11 ' A' ' 53' ' ' ILE . 79.3 mt -77.23 80.36 3.75 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.369 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 66.4 p -82.91 -10.99 58.54 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.8 mt -108.07 148.93 29.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.574 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 94.7 p -72.19 -13.4 61.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.845 -178.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 29.0 m -129.57 131.34 46.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.185 0.517 . . . . 0.0 110.777 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.684 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -128.0 119.64 25.88 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.579 179.191 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.507 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 49.2 tp -120.02 125.29 47.99 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.737 -178.525 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.684 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 19.5 m-85 -98.96 124.36 43.86 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.255 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -176.98 -156.77 16.53 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 119.894 -1.146 . . . . 0.0 112.503 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.622 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 84.7 mtm-85 -107.9 -24.31 11.69 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 120.354 -0.539 . . . . 0.0 110.599 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.28 165.06 36.06 Favored Glycine 0 CA--C 1.524 0.644 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.135 -178.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.455 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.5 tp -67.14 -40.01 84.34 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 CA-C-N 115.529 -0.336 . . . . 0.0 110.713 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.455 ' N ' HG23 ' A' ' 33' ' ' ILE . 93.1 mt-10 -57.62 -32.64 67.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.533 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 68.9 m -49.52 116.18 1.64 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.936 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.572 ' OD1' ' N ' ' A' ' 37' ' ' ILE . 6.6 p-10 -58.16 -29.65 65.76 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.595 HD12 ' CE2' ' A' ' 29' ' ' PHE . 80.2 mt -129.23 117.11 42.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 177.56 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -101.28 138.74 37.9 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.871 0.367 . . . . 0.0 111.459 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.471 HG22 ' H ' ' A' ' 41' ' ' LEU . 91.6 mt -119.71 130.6 73.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.473 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.431 ' OE1' ' OE1' ' B' ' 260' ' ' GLU . 73.8 mt-30 -73.53 21.9 0.08 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.396 -178.464 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.941 HD11 ' NH1' ' A' ' 93' ' ' ARG . 20.1 mt -90.65 123.52 64.94 Favored Pre-proline 0 C--N 1.326 -0.426 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.165 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.31 -8.52 22.02 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 121.671 1.581 . . . . 0.0 112.128 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.4 m -101.42 4.77 10.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 C-N-CA 120.43 -0.508 . . . . 0.0 111.451 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.622 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 38.0 t -96.72 106.77 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.297 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.533 ' O ' ' O ' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -33.84 162.91 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.963 0.887 . . . . 0.0 112.385 -179.143 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.45 ' CE ' ' O ' ' B' ' 232' ' ' GLY . 96.3 mttt -61.66 -41.06 97.0 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.354 -1.294 . . . . 0.0 111.461 -178.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.616 ' O ' ' N ' ' A' ' 49' ' ' CYS . 89.7 mm-40 -109.57 -17.45 13.73 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 123.728 0.642 . . . . 0.0 110.303 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.466 ' O ' ' OG ' ' A' ' 64' ' ' SER . 19.1 t60 36.87 -78.51 0.0 OUTLIER 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.072 -0.967 . . . . 0.0 113.02 -179.476 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.616 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -135.93 139.75 43.5 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.616 -178.588 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -126.41 131.68 51.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.843 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 87.9 mt -115.38 131.91 66.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.176 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -118.07 129.36 55.51 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.433 HD11 HD13 ' A' ' 22' ' ' LEU . 96.9 mt -110.49 121.85 64.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.548 0.689 . . . . 0.0 112.852 -178.007 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.464 ' O ' ' C ' ' A' ' 55' ' ' GLU . 97.3 m-70 -116.49 140.33 49.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.406 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 54' ' ' HIS . 92.1 mt-10 -39.92 -30.32 0.08 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.462 ' N ' ' O ' ' A' ' 54' ' ' HIS . 88.4 mt-30 -64.57 -68.79 0.33 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.798 178.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -152.21 -171.45 3.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.404 0.621 . . . . 0.0 110.748 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -111.91 124.63 52.78 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.507 178.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 91.0 mt -114.21 131.22 66.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.179 0.514 . . . . 0.0 112.128 -178.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.456 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 16.2 tp -104.1 129.6 51.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.191 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -115.2 138.09 51.31 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.167 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -102.02 110.6 22.6 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.965 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -98.4 -5.35 32.8 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.157 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.466 ' OG ' ' O ' ' A' ' 48' ' ' HIS . 1.4 m -71.64 100.64 2.34 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.277 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.7 m -84.11 -20.48 32.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.119 0.485 . . . . 0.0 109.963 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.718 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -90.76 -40.85 11.58 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.619 -179.457 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -138.94 95.16 9.7 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.872 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.41 ' HB2' HG13 ' A' ' 75' ' ' VAL . 35.8 Cg_exo -57.77 143.65 95.0 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 122.287 1.991 . . . . 0.0 112.552 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.402 ' CG2' ' N ' ' A' ' 70' ' ' GLN . 4.5 m -77.08 154.79 32.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.58 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.402 ' N ' ' CG2' ' A' ' 69' ' ' THR . 75.3 mt-30 -114.87 140.45 48.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.921 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 50.6 t -128.43 135.72 61.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 50.27 33.56 7.55 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.38 28.41 67.9 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.775 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.4 t -142.47 139.45 31.56 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.173 -0.611 . . . . 0.0 112.197 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.41 HG13 ' HB2' ' A' ' 68' ' ' PRO . 40.7 t -67.51 137.54 24.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.282 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 10.9 pt -108.6 81.33 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.154 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -60.85 -33.54 73.22 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.542 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.471 ' N ' ' CD ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -117.05 165.4 15.54 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.873 179.754 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.54 142.39 98.82 Favored 'Trans proline' 0 N--CA 1.502 1.979 0 C-N-CA 122.346 2.031 . . . . 0.0 112.162 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.5 m -135.6 138.17 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-O 120.961 0.41 . . . . 0.0 111.904 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.7 mtm180 -72.39 131.18 42.27 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.7 mt -80.02 136.61 36.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.266 0.555 . . . . 0.0 111.436 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -126.41 146.79 49.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.935 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.696 ' CE1' ' H ' ' A' ' 99' ' ' ASN . 3.5 t-160 -54.41 121.88 9.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.146 0.498 . . . . 0.0 110.909 -178.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.73 -10.84 38.37 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -71.86 136.71 47.06 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.49 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.468 ' O ' HG13 ' A' ' 87' ' ' VAL . 9.7 p -114.12 132.21 63.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.182 -178.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 69.1 mt -101.65 132.9 46.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 53.0 m -118.65 128.72 54.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.686 0.755 . . . . 0.0 112.121 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.567 HD12 ' HE1' ' A' ' 95' ' ' PHE . 98.1 mt -118.81 131.26 72.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 177.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.51 HG23 HD21 ' B' ' 242' ' ' LEU . 88.9 mt -24.43 98.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.547 ' OD1' ' CD2' ' B' ' 242' ' ' LEU . 2.7 m-20 89.01 -15.78 0.31 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 177.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.941 ' NH1' HD11 ' A' ' 41' ' ' LEU . 69.6 mtt85 -132.5 141.89 48.97 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.159 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.6 t -135.98 149.98 49.07 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.567 ' HE1' HD12 ' A' ' 90' ' ' ILE . 36.7 m-85 -126.57 123.63 38.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.785 -179.192 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.491 ' O ' HD12 ' A' ' 7' ' ' LEU . 42.7 ttm180 -84.42 129.09 34.9 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.599 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.591 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 87.8 t80 -91.78 124.67 36.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.137 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -123.76 132.42 53.8 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.737 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.696 ' H ' ' CE1' ' A' ' 84' ' ' HIS . 41.5 t-20 -115.09 115.06 26.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.137 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 121.11 0.481 . . . . 0.0 110.281 179.926 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 121.134 0.492 . . . . 0.0 110.613 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.553 ' O ' ' CB ' ' B' ' 230' ' ' SEP . 98.0 m-20 -97.39 -12.07 23.19 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.503 179.252 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 230' ' ' SEP . . . . . 0.553 ' CB ' ' O ' ' B' ' 229' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -167.85 62.06 0.07 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.382 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 232' ' ' GLY . . . . . 0.45 ' O ' ' CE ' ' A' ' 46' ' ' LYS . . . -98.17 -140.77 11.61 Favored Glycine 0 CA--C 1.535 1.311 0 N-CA-C 110.926 -0.869 . . . . 0.0 110.926 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -76.09 160.13 36.8 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.29 1.993 . . . . 0.0 112.8 -179.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.416 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -69.8 167.78 23.5 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.144 1.896 . . . . 0.0 112.45 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.718 ' CG2' HG22 ' A' ' 66' ' ' THR . 44.1 t -112.61 132.5 61.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.644 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 237' ' ' CYS . . . . . 0.448 ' CB ' HD13 ' A' ' 91' ' ' ILE . 2.5 t -72.03 133.47 45.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.159 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 238' ' ' TPO . . . . . 0.566 ' P ' ' OG1' ' B' ' 240' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 239' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 31.4 Cg_exo -59.28 -23.43 69.78 Favored 'Trans proline' 0 N--CA 1.501 1.945 0 C-N-CA 123.289 2.659 . . . . 0.0 113.611 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 240' ' ' THR . . . . . 0.566 ' OG1' ' P ' ' B' ' 238' ' ' TPO . 19.0 p -82.76 -38.9 22.58 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.347 -0.541 . . . . 0.0 109.886 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -57.9 -46.48 84.87 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.726 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.547 ' CD2' ' OD1' ' A' ' 92' ' ' ASP . 97.3 mt -66.23 -42.43 88.64 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.386 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -63.39 -43.27 98.04 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.996 -178.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -63.43 -43.32 97.8 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.858 0.361 . . . . 0.0 111.04 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.776 HH11 HH11 ' A' ' 12' ' ' ARG . 58.0 ttm-85 -61.4 -42.28 98.47 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.797 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -63.17 -37.85 88.85 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.205 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 67.3 m -67.46 -43.8 80.15 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 177.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 63.5 tp60 -59.58 -39.85 85.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.979 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.544 HG23 ' O ' ' B' ' 245' ' ' ARG . 77.6 t -62.51 -44.18 99.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -61.18 -25.04 66.75 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -82.19 -8.6 59.65 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.41 178.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.546 ' CD1' ' NH2' ' A' ' 12' ' ' ARG . 85.7 mt -100.49 -179.75 4.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.82 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 253' ' ' ASN . . . . . 0.493 ' N ' ' OD1' ' B' ' 253' ' ' ASN . 7.1 p-10 -153.2 -170.96 3.77 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.836 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -49.63 -11.55 0.06 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.224 -178.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 255' ' ' ASP . . . . . 0.489 ' OD1' ' OD1' ' B' ' 253' ' ' ASN . 44.4 p-10 -84.11 7.83 17.53 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.007 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.408 ' N ' ' O ' ' B' ' 253' ' ' ASN . 53.8 p-10 -72.29 39.94 0.08 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.251 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 257' ' ' LYS . . . . . 0.482 ' H ' ' C ' ' B' ' 255' ' ' ASP . 98.8 mttt -69.91 153.12 43.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.87 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' B' ' 260' ' ' GLU . 99.7 m-20 59.58 55.99 3.84 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -178.069 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.423 ' O ' ' OD1' ' B' ' 259' ' ' ASP . 43.5 p30 -58.45 58.13 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.043 -0.981 . . . . 0.0 112.907 -177.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.582 ' CG ' HH21 ' A' ' 93' ' ' ARG . 49.9 mm-40 63.64 5.51 2.23 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 177.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 89.4 mt -110.1 135.09 50.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 69.2 t -127.5 132.06 69.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.927 0.394 . . . . 0.0 110.204 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 263' ' ' PHE . . . . . 0.478 ' HB2' HD11 ' B' ' 267' ' ' ILE . 72.7 m-85 -96.35 120.7 37.13 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.241 0.543 . . . . 0.0 111.493 -178.352 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -67.96 -41.35 82.59 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.417 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.59 161.41 30.54 Favored Pre-proline 0 N--CA 1.463 0.202 0 CA-C-N 116.62 -0.263 . . . . 0.0 111.419 -177.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -59.31 143.55 99.7 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.227 1.951 . . . . 0.0 111.181 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 267' ' ' ILE . . . . . 0.55 ' CG2' ' O ' ' A' ' 19' ' ' HIS . 2.1 mt . . . . . 0 N--CA 1.449 -0.477 0 C-N-CA 120.304 -0.559 . . . . 0.0 110.55 -178.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo . . . . . 0 N--CA 1.491 1.378 0 CA-C-O 120.946 0.311 . . . . 0.0 112.294 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.1 m -126.74 -63.05 1.1 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.665 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.652 ' NH1' HG23 ' A' ' 53' ' ' ILE . 99.8 mtt180 -98.56 135.38 40.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.037 -179.012 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -137.89 150.4 47.06 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.498 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 86.2 mt -116.5 139.22 50.71 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.455 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.413 HG11 ' OD2' ' A' ' 16' ' ' ASP . 65.5 t -110.92 127.98 67.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.457 ' CG2' HD12 ' B' ' 261' ' ' ILE . 54.8 m -79.04 142.06 36.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.387 0.613 . . . . 0.0 112.386 -178.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.418 HD12 ' HB3' ' A' ' 94' ' ' SER . 96.9 mt -114.17 135.88 52.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.467 176.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -86.91 160.01 18.85 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.546 ' NH2' HD22 ' B' ' 252' ' ' LEU . 90.9 mtm180 -57.84 -29.31 64.86 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.578 -178.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 42.8 m -80.81 -9.49 59.81 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.712 0.291 . . . . 0.0 110.928 179.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.68 40.67 5.58 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.6 t -121.09 133.02 69.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.919 0.39 . . . . 0.0 110.74 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.413 ' OD2' HG11 ' A' ' 8' ' ' VAL . 65.7 t0 -75.19 125.45 28.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.154 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -120.54 -121.01 2.82 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.062 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -74.89 150.78 39.25 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.464 2.109 . . . . 0.0 112.777 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.97 155.85 22.1 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.548 ' CD2' HD11 ' A' ' 37' ' ' ILE . 64.0 t80 -122.29 93.24 48.65 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.2 -179.296 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.467 ' O ' ' NE2' ' B' ' 265' ' ' GLN . 27.3 Cg_exo -61.66 130.47 31.62 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.159 1.906 . . . . 0.0 111.74 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 22' ' ' LEU . 96.7 mt -85.79 82.22 8.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.426 0.631 . . . . 0.0 110.396 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.7 p -86.78 -8.14 57.62 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.002 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 42.7 mt -108.08 147.99 30.42 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.964 -178.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.9 t -65.39 -18.25 65.17 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -178.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 21.6 m -136.65 136.96 39.56 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.463 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.7 t -129.73 123.4 30.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.514 178.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 52.5 tp -116.69 129.69 56.28 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.037 0.446 . . . . 0.0 111.642 -178.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.763 ' CE2' HD12 ' A' ' 37' ' ' ILE . 3.2 m-85 -109.16 144.47 37.18 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.99 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 146.97 -170.12 27.94 Favored Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.764 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 31' ' ' ARG . 47.9 mtm180 -78.53 -32.3 47.91 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.491 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -50.83 146.77 9.15 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.63 -178.483 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.488 HG23 ' N ' ' A' ' 34' ' ' GLU . 7.6 tp -67.17 -41.78 87.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.488 ' N ' HG23 ' A' ' 33' ' ' ILE . 70.3 mm-40 -53.33 -17.65 1.98 Allowed 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.813 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 59.8 m -62.27 121.42 13.11 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.749 -179.056 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -57.83 -29.71 65.15 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.763 HD12 ' CE2' ' A' ' 29' ' ' PHE . 92.5 mt -128.23 121.93 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.107 176.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.431 ' CZ ' HD12 ' A' ' 33' ' ' ILE . 81.9 mtp180 -106.97 137.94 44.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.092 -178.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.613 ' CG2' HD12 ' A' ' 41' ' ' LEU . 95.5 mt -120.53 129.32 75.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.117 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -78.2 26.99 0.2 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.613 HD12 ' CG2' ' A' ' 39' ' ' ILE . 9.4 mt -92.73 126.84 50.33 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.808 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.79 -12.41 30.89 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.499 2.133 . . . . 0.0 113.632 -179.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.656 HG21 ' CE2' ' B' ' 241' ' ' PHE . 35.2 m -99.92 5.83 9.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.791 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.7 t -89.32 136.61 23.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.986 179.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.2 m -67.84 161.33 26.48 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.52 0.676 . . . . 0.0 111.548 -178.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -61.65 -42.99 99.67 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.112 -178.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.603 ' O ' ' N ' ' A' ' 49' ' ' CYS . 95.5 mt-30 -115.72 -6.26 12.13 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 123.652 0.595 . . . . 0.0 111.064 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.463 ' C ' ' O ' ' A' ' 47' ' ' GLN . 15.2 t60 15.9 -73.43 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 -178.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.603 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -128.48 132.67 48.38 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.483 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -126.85 126.57 43.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.179 179.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 85.6 mt -106.71 130.32 58.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.048 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -116.81 119.83 36.62 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.652 HG23 ' NH1' ' A' ' 5' ' ' ARG . 97.5 mt -103.62 116.55 47.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.02 -0.672 . . . . 0.0 112.285 -178.243 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.551 ' O ' ' N ' ' A' ' 56' ' ' GLN . 87.0 m-70 -114.88 142.91 45.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.303 179.175 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.4 mm-40 -39.52 -26.35 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -178.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.551 ' N ' ' O ' ' A' ' 54' ' ' HIS . 77.7 mt-30 -69.47 -68.73 0.39 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.891 178.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.409 ' CD ' ' N ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -157.68 -166.13 1.93 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.321 -179.174 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.59 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -112.9 130.2 56.2 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.2 mt -119.8 130.78 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 29.0 tp -100.14 125.83 46.32 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.291 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -107.53 137.57 45.32 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.575 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -99.92 106.95 18.82 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -99.35 -5.35 29.8 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.662 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.521 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 23.1 t -86.77 99.88 12.11 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 120.401 -0.52 . . . . 0.0 112.014 -178.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.5 m -73.68 -37.6 65.17 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 177.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.7 p -65.66 -36.24 83.09 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.636 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.521 ' O ' ' OG ' ' A' ' 64' ' ' SER . 36.3 m-80 -153.05 97.92 2.8 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.547 -179.077 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -59.28 147.01 92.87 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.063 1.842 . . . . 0.0 112.758 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 60.4 m -65.62 133.58 51.46 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 177.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -96.82 141.55 29.88 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.223 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.741 ' HB ' HD11 ' A' ' 76' ' ' ILE . 5.2 p -129.66 134.67 62.93 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 50.96 32.97 8.08 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 119.694 -0.802 . . . . 0.0 109.15 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.05 28.53 66.38 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.443 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.2 t -140.24 139.43 35.58 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 117.308 0.554 . . . . 0.0 110.743 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -68.05 144.1 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 120.903 0.382 . . . . 0.0 111.48 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.741 HD11 ' HB ' ' A' ' 71' ' ' VAL . 85.9 mt -106.28 108.73 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.693 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -76.18 -39.17 55.48 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.1 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.511 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 1.5 mt-10 -128.64 172.99 6.11 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.737 -178.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -57.54 143.57 94.29 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 122.16 1.907 . . . . 0.0 112.57 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.1 t -133.0 138.03 52.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.425 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -74.32 131.35 41.07 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 178.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.527 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 96.4 mt -82.84 136.73 34.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.982 0.42 . . . . 0.0 111.491 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -132.61 154.95 49.55 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.301 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.405 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 5.2 t60 -54.94 117.28 3.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.894 0.378 . . . . 0.0 111.596 -179.147 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.39 -14.03 30.51 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.525 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 52.5 t0 -69.44 127.8 34.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.089 0.471 . . . . 0.0 110.445 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.461 HG22 ' HG2' ' A' ' 96' ' ' ARG . 72.5 t -108.79 132.64 56.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.359 -178.429 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.1 mt -102.48 131.13 51.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 89.7 m -119.49 129.49 54.74 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.643 0.735 . . . . 0.0 112.119 -178.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.623 ' O ' ' N ' ' A' ' 93' ' ' ARG . 92.0 mt -118.35 133.08 66.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 114.615 -1.175 . . . . 0.0 108.769 178.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.543 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 70.3 mt -20.77 91.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.656 ' CG ' ' HE ' ' B' ' 245' ' ' ARG . 21.3 t0 93.36 -21.73 0.07 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 177.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.623 ' N ' ' O ' ' A' ' 90' ' ' ILE . 87.8 mtt-85 -130.4 146.01 51.9 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.103 -0.639 . . . . 0.0 111.029 -179.361 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.418 ' HB3' HD12 ' A' ' 10' ' ' ILE . 32.7 t -138.9 151.77 47.21 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.149 0.5 . . . . 0.0 110.317 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.638 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 91.6 m-85 -125.65 127.27 46.02 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.461 ' HG2' HG22 ' A' ' 87' ' ' VAL . 99.8 mtt180 -89.06 138.02 31.79 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.745 -179.19 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -94.91 119.37 33.34 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.512 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -123.18 120.96 34.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.852 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.405 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 64.1 t-20 -104.65 112.99 26.29 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.679 -0.409 . . . . 0.0 110.141 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 . . . . . 0 C--N 1.328 -0.361 0 CA-C-O 120.943 0.402 . . . . 0.0 110.012 179.861 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 228' ' ' VAL . . . . . 0.513 ' O ' ' O ' ' B' ' 229' ' ' ASP . 52.2 t . . . . . 0 N--CA 1.453 -0.289 0 CA-C-O 120.72 0.295 . . . . 0.0 110.638 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.513 ' O ' ' O ' ' B' ' 228' ' ' VAL . 83.1 m-20 39.68 -166.65 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.212 0.53 . . . . 0.0 110.529 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 230' ' ' SEP . . . . . 0.451 ' O1P' ' N ' ' B' ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -167.79 73.73 0.12 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.917 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -104.47 -156.85 23.62 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -63.73 155.08 65.57 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 123.156 2.57 . . . . 0.0 112.244 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.53 141.99 97.79 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.688 2.259 . . . . 0.0 112.982 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.441 HG13 ' O ' ' B' ' 236' ' ' VAL . 10.7 p -78.39 128.87 38.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.254 178.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 237' ' ' CYS . . . . . 0.517 ' HB2' HD13 ' A' ' 91' ' ' ILE . 1.8 t -60.76 119.82 8.91 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.184 -179.316 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -56.3 -24.92 53.87 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 122.219 1.946 . . . . 0.0 111.981 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 20.0 m -68.72 -46.89 67.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.442 0.639 . . . . 0.0 109.774 178.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.744 ' CD2' ' NH1' ' B' ' 245' ' ' ARG . 77.2 t80 -58.65 -44.0 89.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.767 -179.105 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 1.046 HD23 HH22 ' B' ' 245' ' ' ARG . 60.6 mt -61.34 -43.87 98.14 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.214 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -64.69 -37.7 88.49 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -62.68 -47.2 84.69 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.632 -178.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 1.046 HH22 HD23 ' B' ' 242' ' ' LEU . 27.8 mtm-85 -63.93 -37.55 87.84 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.773 -179.178 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -62.49 -41.2 98.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.809 0.338 . . . . 0.0 110.443 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 76.7 p -66.16 -41.12 90.82 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -62.08 -38.98 90.88 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.111 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.457 HG23 ' O ' ' B' ' 245' ' ' ARG . 52.5 t -62.0 -43.87 98.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -61.23 -28.09 68.91 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -87.51 -8.32 56.53 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.684 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.546 HD22 ' NH2' ' A' ' 12' ' ' ARG . 2.6 tp -102.81 -178.71 3.75 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.116 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 23.0 p30 -143.05 169.87 16.77 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.339 0.59 . . . . 0.0 112.142 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -71.43 -20.9 62.05 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.417 179.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -70.11 -10.32 58.37 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.768 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.443 ' OD2' HD21 ' B' ' 252' ' ' LEU . 62.8 t0 -85.93 83.33 7.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.42 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -82.79 6.51 17.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.543 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.466 ' O ' ' C ' ' B' ' 259' ' ' ASP . 98.3 m-20 -87.09 30.94 0.73 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.031 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.588 ' C ' ' H ' ' B' ' 261' ' ' ILE . 50.9 p-10 -31.4 141.05 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.869 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -59.45 12.89 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.075 -178.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.638 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 66.7 mt -107.32 133.6 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.02 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 56.5 t -125.86 132.94 70.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.109 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -96.23 118.78 33.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.401 0.62 . . . . 0.0 111.969 -177.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -66.23 -44.65 83.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.767 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 265' ' ' GLN . . . . . 0.467 ' NE2' ' O ' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -95.83 156.15 37.6 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.09 -179.462 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -64.93 144.21 82.03 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 C-N-CA 122.674 2.249 . . . . 0.0 112.926 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 47.3 pt . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.912 179.463 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo . . . . . 0 N--CA 1.494 1.52 0 CA-C-O 120.984 0.326 . . . . 0.0 112.746 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.0 p -93.22 -37.9 11.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.851 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.763 ' NH1' ' HB2' ' A' ' 58' ' ' ALA . 96.8 mtt-85 -90.24 122.39 33.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.87 -178.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -130.69 138.08 49.85 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.918 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 1.032 HD11 HD11 ' A' ' 22' ' ' LEU . 83.3 mt -115.26 139.42 49.97 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.57 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.6 t -112.1 127.65 69.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.452 HG23 ' CD1' ' B' ' 261' ' ' ILE . 4.3 m -87.62 111.83 21.67 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.234 0.54 . . . . 0.0 111.43 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 90.9 mt -82.82 145.52 8.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.717 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -92.0 158.19 16.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.783 0.325 . . . . 0.0 110.754 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.447 HH21 HD22 ' B' ' 252' ' ' LEU . 90.1 mtm180 -58.01 -24.75 59.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.529 -179.236 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.2 m -80.94 -10.05 59.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.033 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.07 39.81 6.81 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.1 t -123.31 134.62 65.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.849 0.356 . . . . 0.0 111.328 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' A' ' 17' ' ' GLY . 62.6 t0 -73.93 127.24 32.36 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.931 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.428 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -123.8 -122.73 2.73 Favored Glycine 0 CA--C 1.542 1.746 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.217 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.95 148.63 45.75 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 122.671 2.247 . . . . 0.0 113.626 -178.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -107.39 154.83 20.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.166 0.508 . . . . 0.0 110.832 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -130.76 103.2 16.03 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.582 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -78.05 138.62 16.49 Favored 'Trans proline' 0 N--CA 1.488 1.191 0 C-N-CA 121.911 1.74 . . . . 0.0 112.635 -179.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 1.032 HD11 HD11 ' A' ' 7' ' ' LEU . 94.0 mt -92.65 54.42 2.24 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.225 -0.443 . . . . 0.0 112.188 -178.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.6 p -59.67 -29.03 67.78 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 63.1 mt -75.43 142.11 43.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.609 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.32 -16.65 64.22 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -178.354 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 30.3 m -140.5 140.29 35.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.021 0.438 . . . . 0.0 111.16 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.617 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -136.28 134.2 37.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.382 178.545 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 47.5 tp -121.73 127.38 50.63 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.214 -178.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.82 ' CE2' HD12 ' A' ' 37' ' ' ILE . 21.0 m-85 -101.86 131.99 47.89 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.663 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.62 -177.79 38.61 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 120.274 -0.965 . . . . 0.0 112.285 179.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.671 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 73.0 mtm-85 -77.9 -31.95 51.47 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.764 0.316 . . . . 0.0 110.554 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.435 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -52.45 149.21 10.34 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -178.551 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.514 HG23 ' N ' ' A' ' 34' ' ' GLU . 8.1 tp -66.44 -42.04 89.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 C-N-CA 120.759 -0.377 . . . . 0.0 110.272 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.514 ' N ' HG23 ' A' ' 33' ' ' ILE . 80.0 mm-40 -53.16 -18.87 2.5 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.435 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 57.1 m -63.25 121.88 14.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.533 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -57.94 -29.41 65.14 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.82 HD12 ' CE2' ' A' ' 29' ' ' PHE . 93.4 mt -122.64 119.78 59.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 176.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.457 ' HD3' HD12 ' A' ' 33' ' ' ILE . 87.9 mtm-85 -104.0 133.67 48.56 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.355 -178.427 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.45 HG22 ' H ' ' A' ' 41' ' ' LEU . 98.9 mt -117.53 129.36 74.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.148 0.499 . . . . 0.0 110.24 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -77.92 24.1 0.24 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.857 -177.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.769 HD12 ' CZ ' ' A' ' 93' ' ' ARG . 38.3 mt -105.02 128.24 27.1 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.912 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.47 -12.93 30.02 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.434 2.089 . . . . 0.0 113.309 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.589 HG21 ' CE2' ' B' ' 241' ' ' PHE . 25.5 m -88.45 -2.21 8.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.871 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.671 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 55.8 t -92.86 134.55 30.39 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.255 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 178.338 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.451 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 0.6 OUTLIER -65.1 162.04 17.74 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.291 0.567 . . . . 0.0 111.793 -178.766 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -59.86 -43.6 94.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.19 -178.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.67 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.5 mt-30 -111.5 -18.08 12.93 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.191 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.451 ' H ' ' HB3' ' A' ' 45' ' ' SER . 19.5 t60 32.59 -71.93 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.467 -1.242 . . . . 0.0 114.108 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.67 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.19 136.21 45.53 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.296 0.57 . . . . 0.0 112.263 -177.847 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -125.68 135.76 52.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.333 178.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.578 HD11 HD12 ' A' ' 82' ' ' LEU . 18.0 tt -124.29 136.39 60.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.03 0.443 . . . . 0.0 110.14 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -122.46 132.57 54.41 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.981 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.55 HD13 ' HD2' ' A' ' 5' ' ' ARG . 95.6 mt -106.99 112.25 39.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.823 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.501 ' O ' ' N ' ' A' ' 56' ' ' GLN . 81.4 m-70 -112.92 145.96 39.83 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.156 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' A' ' 54' ' ' HIS . 99.1 mt-10 -40.2 -27.02 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.894 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.501 ' N ' ' O ' ' A' ' 54' ' ' HIS . 85.7 mt-30 -67.04 -68.92 0.34 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.608 178.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -158.68 -168.22 2.35 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.209 0.528 . . . . 0.0 110.945 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.763 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -104.04 120.74 41.72 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 177.344 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.6 mt -110.99 128.89 67.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.588 HD11 ' SG ' ' A' ' 49' ' ' CYS . 56.5 tp -97.82 129.78 44.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.682 179.252 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -114.86 136.95 52.54 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.731 0.3 . . . . 0.0 111.147 -179.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -94.35 106.55 18.53 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -102.75 -10.18 19.37 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.311 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.5 t -74.27 101.59 4.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.381 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 92.2 p -82.61 -12.69 57.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.01 0.434 . . . . 0.0 110.035 179.212 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.503 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.0 OUTLIER -101.15 -35.64 9.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.434 -179.625 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -145.33 92.75 5.54 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.39 -179.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.548 ' HB2' HG13 ' A' ' 75' ' ' VAL . 45.1 Cg_exo -55.57 146.19 65.67 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 122.648 2.232 . . . . 0.0 112.721 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 61.8 m -77.03 138.65 39.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.585 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -102.68 141.15 35.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.088 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.4 t -129.79 135.18 61.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 52.42 32.13 10.77 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.2 24.72 70.48 Favored Glycine 0 CA--C 1.535 1.281 0 CA-C-N 115.131 -0.941 . . . . 0.0 112.885 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 47.6 t -141.66 140.85 33.33 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 118.053 0.927 . . . . 0.0 112.057 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.548 HG13 ' HB2' ' A' ' 68' ' ' PRO . 43.0 t -68.03 139.43 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.343 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.2 pt -114.59 89.36 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.25 178.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -63.72 -24.0 67.6 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -123.62 166.74 17.36 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.128 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -65.55 150.64 86.43 Favored 'Trans proline' 0 N--CA 1.5 1.86 0 C-N-CA 122.845 2.364 . . . . 0.0 113.441 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 29.7 m -143.1 143.92 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.59 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -75.27 138.56 41.95 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 178.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.578 HD12 HD11 ' A' ' 51' ' ' ILE . 92.0 mt -96.67 134.83 39.42 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.249 0.547 . . . . 0.0 111.571 -178.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -121.45 157.3 30.88 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.769 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -55.46 120.71 7.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.354 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.38 -19.3 26.93 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -68.14 135.94 52.91 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.307 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 42.2 t -114.6 133.54 60.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.524 -178.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.404 ' O ' ' OG ' ' A' ' 94' ' ' SER . 80.9 mt -100.61 132.49 46.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.248 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.6 m -125.56 130.09 51.02 Favored 'General case' 0 C--N 1.334 -0.097 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -179.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.49 HG22 HG12 ' A' ' 91' ' ' ILE . 84.0 mt -119.32 127.59 75.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.28 178.391 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.808 HG22 ' NH2' ' B' ' 245' ' ' ARG . 36.0 mm 42.26 -97.82 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -178.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.515 ' CB ' HH22 ' B' ' 245' ' ' ARG . 48.0 t0 -126.85 23.92 6.57 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.283 0.564 . . . . 0.0 110.02 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.769 ' CZ ' HD12 ' A' ' 41' ' ' LEU . 54.5 mtm-85 -126.45 139.75 53.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.001 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.404 ' OG ' ' O ' ' A' ' 88' ' ' ILE . 15.9 t -139.75 150.57 44.94 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.223 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -118.83 119.38 34.21 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 96' ' ' ARG . 39.2 ttp-105 -82.23 130.58 35.13 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.33 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.517 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 61.6 t80 -97.74 124.85 42.25 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.059 0.456 . . . . 0.0 111.271 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -128.52 123.65 34.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.523 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 -100.15 109.52 21.79 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.361 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.857 -179.932 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 228' ' ' VAL . . . . . 0.511 ' O ' HG12 ' B' ' 228' ' ' VAL . 98.6 t . . . . . 0 N--CA 1.457 -0.108 0 CA-C-O 120.697 0.284 . . . . 0.0 111.145 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.553 ' OD1' ' N ' ' B' ' 232' ' ' GLY . 51.9 p-10 -156.56 176.17 13.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.768 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -124.03 40.38 3.74 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 232' ' ' GLY . . . . . 0.553 ' N ' ' OD1' ' B' ' 229' ' ' ASP . . . -114.54 -173.13 17.91 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.956 -178.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -61.81 156.84 46.09 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 123.506 2.804 . . . . 0.0 112.675 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.503 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -63.95 135.68 49.0 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 121.335 1.357 . . . . 0.0 112.95 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 4.0 p -65.25 136.55 26.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 114.572 -1.195 . . . . 0.0 110.446 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 20.2 t -64.2 123.1 18.22 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.214 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 238' ' ' TPO . . . . . 0.402 ' O3P' ' OG1' ' B' ' 240' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -55.55 -23.51 40.11 Favored 'Trans proline' 0 N--CA 1.5 1.86 0 C-N-CA 122.283 1.989 . . . . 0.0 112.595 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 240' ' ' THR . . . . . 0.402 ' OG1' ' O3P' ' B' ' 238' ' ' TPO . 19.5 m -70.28 -45.29 66.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.657 0.742 . . . . 0.0 109.038 178.322 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.589 ' CE2' HG21 ' A' ' 43' ' ' VAL . 87.7 t80 -58.15 -43.94 87.62 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.585 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 1.041 HD23 HH21 ' B' ' 245' ' ' ARG . 75.8 mt -61.76 -41.96 98.37 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.767 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.44 -39.28 91.88 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.49 -179.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -60.02 -45.71 91.9 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.566 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 1.041 HH21 HD23 ' B' ' 242' ' ' LEU . 64.3 mtm180 -63.3 -38.22 90.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.468 -179.111 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.3 -39.08 91.79 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 120.101 -0.64 . . . . 0.0 109.652 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 18.0 m -63.98 -44.15 93.56 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 248' ' ' GLN . . . . . 0.446 ' O ' ' N ' ' B' ' 252' ' ' LEU . 84.6 mt-30 -60.23 -35.84 76.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.517 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 38.0 t -62.07 -46.44 96.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.572 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -60.19 -30.08 69.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.21 0.528 . . . . 0.0 109.594 179.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -91.76 -10.4 40.12 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.515 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.447 HD22 HH21 ' A' ' 12' ' ' ARG . 63.9 tp -75.54 144.11 42.09 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.06 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -98.06 130.12 44.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.377 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 254' ' ' ASP . . . . . 0.546 ' C ' ' H ' ' B' ' 256' ' ' ASP . 38.7 t70 -62.59 -32.59 73.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.892 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -58.6 3.01 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.733 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.546 ' H ' ' C ' ' B' ' 254' ' ' ASP . 62.2 t0 -121.59 104.21 9.47 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.754 0.311 . . . . 0.0 110.846 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 257' ' ' LYS . . . . . 0.591 ' O ' ' N ' ' B' ' 259' ' ' ASP . 99.8 mttt -66.64 -85.77 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.38 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.528 ' C ' ' O ' ' B' ' 257' ' ' LYS . 65.0 t0 -14.02 79.06 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 O-C-N 124.077 0.861 . . . . 0.0 111.494 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.591 ' N ' ' O ' ' B' ' 257' ' ' LYS . 42.8 t0 -91.03 79.43 5.82 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.567 -179.136 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.61 ' OE1' HD11 ' A' ' 41' ' ' LEU . 97.8 mt-10 56.05 2.44 0.08 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 178.319 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.452 ' CD1' HG23 ' A' ' 9' ' ' THR . 66.1 mt -114.57 134.8 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 41.2 t -127.57 136.2 61.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -95.5 117.24 30.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.171 0.51 . . . . 0.0 110.865 -178.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -63.65 -47.11 82.64 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.448 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -96.63 154.42 38.47 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.853 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.29 147.65 59.93 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 123.015 2.477 . . . . 0.0 113.639 -178.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 29.9 pt . . . . . 0 C--N 1.33 -0.244 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.203 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo . . . . . 0 N--CA 1.497 1.683 0 N-CA-C 112.847 0.287 . . . . 0.0 112.847 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 69.6 p -125.89 -47.43 1.66 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.507 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.1 mtt85 -87.74 120.24 28.86 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.264 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -124.22 135.86 53.75 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.134 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.555 HD12 ' O ' ' A' ' 96' ' ' ARG . 33.2 tp -116.05 131.91 56.81 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.605 -0.438 . . . . 0.0 109.853 179.52 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 53.8 t -109.04 132.55 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.328 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 m -88.68 112.57 23.28 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.958 0.409 . . . . 0.0 112.043 -178.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.738 HD12 ' OG ' ' A' ' 94' ' ' SER . 79.4 mt -80.75 141.85 14.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -97.42 160.87 14.07 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.021 0.439 . . . . 0.0 109.852 178.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -59.69 -19.86 52.52 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.983 -179.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.5 t -78.71 -16.48 57.2 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.282 178.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.85 24.49 22.88 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.5 m -119.77 135.83 58.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -70.89 139.46 50.77 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.238 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -125.1 -121.99 2.59 Favored Glycine 0 CA--C 1.534 1.246 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.4 148.14 54.03 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 121.869 1.712 . . . . 0.0 112.888 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -108.34 143.85 36.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.29 0.567 . . . . 0.0 111.139 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.452 ' CD2' HD11 ' A' ' 37' ' ' ILE . 39.6 t80 -114.68 98.82 50.55 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.358 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.55 132.01 18.29 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 121.101 1.2 . . . . 0.0 111.359 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.418 HD22 ' HB2' ' A' ' 27' ' ' CYS . 80.2 mt -84.5 56.12 3.68 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.07 -178.309 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 79.8 p -64.48 -22.39 66.95 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 92.1 mt -84.96 141.91 30.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.545 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 45.3 t -61.8 -18.1 58.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.524 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.514 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 33.5 m -133.93 132.93 40.82 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.593 -0.443 . . . . 0.0 112.008 -179.171 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.418 ' HB2' HD22 ' A' ' 22' ' ' LEU . 4.5 t -122.09 114.59 21.11 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.021 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.47 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 53.8 tp -113.95 131.37 56.34 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.523 -178.291 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.684 ' CE2' HD12 ' A' ' 37' ' ' ILE . 12.5 m-85 -109.76 127.18 54.46 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.051 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 173.63 -173.6 45.86 Favored Glycine 0 N--CA 1.474 1.199 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.492 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.649 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 85.9 mtm-85 -86.29 -26.72 24.79 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.463 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.547 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -58.31 154.52 25.01 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.99 -178.192 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.514 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.5 tp -66.57 -41.81 88.97 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-O 120.746 0.308 . . . . 0.0 111.002 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.514 ' N ' HG23 ' A' ' 33' ' ' ILE . 83.1 tt0 -57.63 -20.27 32.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.776 -179.301 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.547 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 7.5 m -60.69 129.41 41.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.234 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.514 ' OD2' ' O ' ' A' ' 26' ' ' THR . 54.3 m-20 -61.93 -34.35 75.93 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.684 HD12 ' CE2' ' A' ' 29' ' ' PHE . 87.9 mt -126.3 121.39 58.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 178.023 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.437 ' NH1' HD12 ' A' ' 33' ' ' ILE . 83.5 mtp180 -103.53 134.28 47.15 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.631 -178.159 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 89.9 mt -117.34 129.72 73.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.074 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -78.47 39.35 0.33 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -177.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.547 HD12 ' NH2' ' A' ' 93' ' ' ARG . 75.9 mt -119.94 137.72 26.12 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.844 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -72.78 -11.93 26.15 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 122.608 2.206 . . . . 0.0 112.455 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.8 m -92.04 4.15 7.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.517 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.649 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 48.0 t -98.69 130.35 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.3 m -73.05 172.32 11.24 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.747 0.784 . . . . 0.0 112.642 -178.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -64.63 -40.32 95.26 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.091 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.649 ' O ' ' N ' ' A' ' 49' ' ' CYS . 84.0 mm-40 -114.12 -19.25 11.43 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.921 0.391 . . . . 0.0 110.345 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.7 t60 31.37 -77.41 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.649 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -128.05 133.25 49.06 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.605 -178.931 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -129.2 128.84 44.15 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.401 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 85.9 mt -114.04 133.15 60.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.416 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -113.53 125.07 53.79 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.9 mm -93.99 123.98 46.29 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 121.602 0.715 . . . . 0.0 112.088 -178.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.425 ' O ' ' C ' ' A' ' 55' ' ' GLU . 96.5 m-70 -124.75 131.03 53.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.386 178.648 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 54' ' ' HIS . 47.9 tp10 -42.73 -32.2 0.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -64.12 -67.57 0.42 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.213 -0.903 . . . . 0.0 108.914 178.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.545 ' OE2' ' CD ' ' A' ' 81' ' ' ARG . 0.2 OUTLIER -152.3 -175.36 5.23 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.639 179.808 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.55 129.04 56.63 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.704 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.4 mt -116.77 131.55 69.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -178.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.506 ' HB2' HD21 ' A' ' 82' ' ' LEU . 50.1 tp -94.38 125.69 39.18 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.322 178.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -110.33 132.52 54.1 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.11 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.427 ' ND2' ' O ' ' A' ' 76' ' ' ILE . 41.5 t30 -94.05 106.23 18.21 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.25 0.548 . . . . 0.0 111.705 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -100.57 -9.45 21.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.397 179.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.0 t -76.75 98.18 4.71 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 120.036 -0.666 . . . . 0.0 109.831 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.4 p -74.99 -32.82 61.75 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.377 178.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.924 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.2 OUTLIER -74.28 -43.24 57.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.461 -179.085 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.496 ' OD1' HG13 ' B' ' 236' ' ' VAL . 71.9 m-20 -140.57 97.77 7.34 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -55.51 145.01 71.39 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.295 1.997 . . . . 0.0 112.532 -178.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 13.2 m -71.79 137.15 47.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.157 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -101.02 140.73 34.91 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.666 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.7 p -135.17 136.08 51.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 50.11 30.93 4.52 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.96 28.86 65.88 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.972 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.4 m -135.3 124.55 24.6 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.826 -179.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.6 m -71.87 140.75 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.024 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.427 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 46.2 pt -121.0 141.88 39.56 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-O 121.203 0.525 . . . . 0.0 111.281 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 21.5 p-10 -104.29 -14.32 15.84 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 178.064 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -128.66 166.77 22.36 Favored Pre-proline 0 CA--C 1.528 0.098 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.148 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -64.12 146.88 91.35 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 122.673 2.249 . . . . 0.0 112.772 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.7 t -133.95 140.47 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.837 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.545 ' CD ' ' OE2' ' A' ' 57' ' ' GLU . 88.6 mtm180 -71.95 128.99 37.49 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.659 -0.417 . . . . 0.0 110.952 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.506 HD21 ' HB2' ' A' ' 60' ' ' LEU . 92.8 mt -84.37 131.23 34.72 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.341 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -124.53 153.2 42.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.702 178.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.401 ' ND1' ' N ' ' A' ' 99' ' ' ASN . 12.4 t60 -56.94 122.52 12.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.956 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.22 -19.96 33.74 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.05 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -66.27 139.26 58.06 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.501 HG22 ' HG2' ' A' ' 96' ' ' ARG . 77.1 t -112.03 129.99 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.326 -178.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.2 mt -95.66 131.21 43.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 42.3 m -120.69 124.53 45.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.494 0.664 . . . . 0.0 111.82 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.447 HG22 HG12 ' A' ' 91' ' ' ILE . 86.0 mt -119.57 121.06 65.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.173 179.091 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.484 HG22 ' N ' ' A' ' 92' ' ' ASP . 36.0 mm 52.45 -112.51 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -178.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.484 ' N ' HG22 ' A' ' 91' ' ' ILE . 56.6 t0 -116.25 24.25 11.53 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.337 0.589 . . . . 0.0 110.371 179.281 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.547 ' NH2' HD12 ' A' ' 41' ' ' LEU . 47.5 mtm-85 -131.26 146.72 52.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.224 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.738 ' OG ' HD12 ' A' ' 10' ' ' ILE . 23.3 p -140.65 158.58 43.78 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.318 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.544 ' HB3' HD11 ' A' ' 7' ' ' LEU . 73.0 m-85 -126.37 124.24 39.78 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.238 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.555 ' O ' HD12 ' A' ' 7' ' ' LEU . 79.8 mtp85 -85.14 127.68 34.35 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 121.075 0.464 . . . . 0.0 111.053 -179.09 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -96.09 125.64 40.77 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.885 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -130.5 122.38 27.53 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.428 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.401 ' N ' ' ND1' ' A' ' 84' ' ' HIS . 49.2 t-20 -111.05 90.62 3.38 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.967 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.401 ' OE2' ' CE1' ' A' ' 84' ' ' HIS . 96.0 mt-10 . . . . . 0 C--N 1.331 -0.213 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.777 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 228' ' ' VAL . . . . . 0.435 ' O ' ' N ' ' B' ' 230' ' ' SEP . 33.5 m . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' B' ' 228' ' ' VAL . 93.7 m-20 36.66 -96.85 0.02 OUTLIER 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.583 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 230' ' ' SEP . . . . . 0.435 ' N ' ' O ' ' B' ' 228' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -136.05 66.14 1.51 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.754 -178.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -132.51 -177.88 15.19 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.108 -0.567 . . . . 0.0 112.136 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.77 160.86 48.06 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 123.62 2.88 . . . . 0.0 112.982 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.924 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.39 142.93 37.95 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 121.284 1.323 . . . . 0.0 112.263 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.496 HG13 ' OD1' ' A' ' 67' ' ' ASN . 76.3 t -59.09 139.85 18.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.215 -179.14 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 237' ' ' CYS . . . . . 0.603 ' SG ' ' CD1' ' B' ' 241' ' ' PHE . 4.9 t -72.36 133.32 44.88 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.062 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 238' ' ' TPO . . . . . 0.472 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 239' ' ' PRO . . . . . 0.472 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 32.7 Cg_exo -60.67 -25.0 80.03 Favored 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 123.119 2.546 . . . . 0.0 113.222 -179.134 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 98.7 m -73.27 -45.72 54.05 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.631 0.729 . . . . 0.0 109.541 178.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.603 ' CD1' ' SG ' ' B' ' 237' ' ' CYS . 54.4 t80 -57.31 -45.63 84.02 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.102 -178.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' B' ' 242' ' ' LEU . 89.0 mt -65.24 -42.23 93.53 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -61.67 -38.75 88.93 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.404 -0.519 . . . . 0.0 110.357 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 244' ' ' ARG . . . . . 0.534 ' O ' ' OG ' ' B' ' 247' ' ' SER . 82.7 mtp180 -64.12 -40.72 96.79 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.544 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.449 ' NH2' ' CD2' ' A' ' 41' ' ' LEU . 22.0 mmt180 -64.73 -41.4 95.98 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.382 -179.247 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.46 -38.05 88.27 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 247' ' ' SER . . . . . 0.534 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 77.8 p -67.46 -42.78 82.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.441 179.258 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 248' ' ' GLN . . . . . 0.482 ' O ' ' N ' ' B' ' 252' ' ' LEU . 86.7 mt-30 -61.56 -36.2 79.95 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.838 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 34.9 t -65.76 -43.72 93.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -58.61 -29.85 66.8 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.155 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -105.8 -5.11 20.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.543 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' B' ' 248' ' ' GLN . 51.5 tp -111.03 115.65 29.82 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.047 0.451 . . . . 0.0 110.142 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -52.54 155.53 2.14 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.495 -178.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -74.55 -8.66 57.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.396 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 255' ' ' ASP . . . . . 0.409 ' OD1' ' C ' ' B' ' 255' ' ' ASP . 47.1 p-10 -86.66 1.54 51.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.328 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.481 ' CG ' ' O ' ' B' ' 256' ' ' ASP . 18.7 p-10 -69.78 91.81 0.65 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.375 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -70.85 162.54 29.06 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 58.79 71.72 0.57 Allowed 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -178.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.466 ' OD1' ' OE1' ' B' ' 260' ' ' GLU . 37.1 t0 -87.86 77.09 8.6 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.43 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.503 ' N ' ' OE1' ' B' ' 260' ' ' GLU . 44.5 mp0 57.52 6.03 0.37 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 178.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 74.5 mt -118.62 133.67 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 75.5 t -129.25 137.19 57.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.987 0.423 . . . . 0.0 110.884 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -97.31 119.56 36.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.595 -178.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -67.87 -45.89 73.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.364 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.57 156.17 41.47 Favored Pre-proline 0 C--N 1.332 -0.16 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.049 -179.006 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -63.65 148.28 92.32 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.995 2.464 . . . . 0.0 112.17 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 33.9 pt . . . . . 0 C--N 1.326 -0.439 0 CA-C-O 121.416 0.627 . . . . 0.0 111.185 -179.535 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo . . . . . 0 N--CA 1.497 1.7 0 CA-C-O 121.179 0.408 . . . . 0.0 112.986 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 63.3 p -104.19 -48.43 3.87 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.308 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 86.0 mtt85 -97.43 132.42 43.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.219 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -134.37 145.31 48.85 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.844 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.479 HD11 HD11 ' A' ' 22' ' ' LEU . 87.5 mt -114.07 142.95 45.55 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.049 179.01 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.584 HG22 ' CD2' ' A' ' 19' ' ' HIS . 42.9 t -115.82 129.9 71.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 m -90.74 119.32 30.87 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.485 0.66 . . . . 0.0 112.776 -177.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.1 mm -81.33 135.48 24.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.496 178.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.425 ' HB2' ' H ' ' A' ' 15' ' ' VAL . 95.7 mttt -85.86 156.3 20.6 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.792 179.1 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.427 ' NE ' ' HD2' ' B' ' 245' ' ' ARG . 83.7 mtp180 -58.36 -34.61 70.85 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.3 p -70.25 -18.88 63.15 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.202 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.65 34.38 5.78 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.425 ' H ' ' HB2' ' A' ' 11' ' ' LYS . 43.0 t -121.15 133.09 68.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 114.992 -0.604 . . . . 0.0 110.922 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -73.26 136.38 44.59 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -135.52 -114.56 1.4 Allowed Glycine 0 CA--C 1.534 1.276 0 C-N-CA 119.752 -1.213 . . . . 0.0 112.827 -179.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.67 144.09 43.5 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.33 2.02 . . . . 0.0 113.653 -177.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.584 ' CD2' HG22 ' A' ' 8' ' ' VAL . 63.8 m170 -107.9 137.94 45.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.678 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.494 ' CD2' HD11 ' A' ' 37' ' ' ILE . 26.1 t80 -106.12 96.51 13.32 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.131 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.6 134.59 22.51 Favored 'Trans proline' 0 C--N 1.315 -1.231 0 C-N-CA 121.283 1.322 . . . . 0.0 110.745 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.479 HD11 HD11 ' A' ' 7' ' ' LEU . 95.9 mt -86.06 74.16 10.14 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.663 -178.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.1 p -79.6 -10.24 59.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.41 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.1 mt -105.86 148.0 28.06 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.108 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.2 t -68.22 -16.16 63.86 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.5 m -134.41 136.97 43.69 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.419 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.664 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 4.1 t -131.69 124.47 29.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.923 178.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.479 HD21 ' OE1' ' A' ' 47' ' ' GLN . 47.7 tp -118.38 129.61 55.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.532 -178.355 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.744 ' CE2' HD12 ' A' ' 37' ' ' ILE . 6.8 m-85 -106.06 134.72 48.74 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.422 179.283 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 156.5 -177.91 33.24 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 120.451 -0.88 . . . . 0.0 112.322 179.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 45.5 mtm105 -75.1 -32.44 61.42 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.48 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -50.34 150.85 5.25 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.778 -178.304 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.534 HG23 ' N ' ' A' ' 34' ' ' GLU . 9.8 tp -66.11 -41.66 89.9 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-O 121.021 0.439 . . . . 0.0 110.1 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.534 ' N ' HG23 ' A' ' 33' ' ' ILE . 97.7 mt-10 -56.07 -24.3 39.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.806 -179.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.48 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 32.0 m -55.8 117.2 3.44 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.685 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -57.37 -29.15 63.8 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.744 HD12 ' CE2' ' A' ' 29' ' ' PHE . 98.7 mt -125.64 118.66 52.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.417 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 84.1 mtp180 -104.06 136.73 43.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.689 -178.533 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.522 HD13 ' NH1' ' A' ' 93' ' ' ARG . 97.6 mt -118.08 129.82 73.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 121.29 0.567 . . . . 0.0 110.771 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -74.96 35.19 0.1 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 114.975 -1.011 . . . . 0.0 113.092 -177.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.685 ' CD1' ' HE ' ' A' ' 93' ' ' ARG . 28.3 mt -118.94 130.93 24.56 Favored Pre-proline 0 C--N 1.323 -0.561 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.457 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.476 ' O ' ' HD2' ' B' ' 235' ' ' PRO . 44.2 Cg_endo -67.84 -18.97 47.23 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.379 2.052 . . . . 0.0 113.454 -179.025 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 241' ' ' PHE . 34.2 m -83.87 -0.08 5.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.836 -0.345 . . . . 0.0 110.896 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 56.8 t -88.08 133.0 31.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.926 0.393 . . . . 0.0 110.124 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.9 m -67.89 162.49 24.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.426 0.631 . . . . 0.0 111.325 -179.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -60.88 -41.53 96.19 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.591 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.629 ' O ' ' N ' ' A' ' 49' ' ' CYS . 97.9 mm-40 -115.33 -25.32 8.04 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.436 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.8 t60 36.54 -76.07 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.629 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.53 134.04 46.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.37 0.605 . . . . 0.0 112.177 -178.091 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -126.8 131.62 51.22 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.196 179.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 91.6 mt -115.41 133.32 62.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.507 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -119.34 126.55 51.7 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 89.1 mt -106.38 118.18 53.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.555 0.693 . . . . 0.0 111.83 -179.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.453 ' O ' ' N ' ' A' ' 56' ' ' GLN . 86.5 m-70 -113.86 142.66 45.82 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.331 179.366 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 54' ' ' HIS . 80.0 mm-40 -40.21 -29.46 0.08 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.453 ' N ' ' O ' ' A' ' 54' ' ' HIS . 88.5 mt-30 -63.7 -66.98 0.47 Allowed 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.065 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.439 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 5.5 tp10 -158.36 -163.32 1.26 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.138 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.454 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -112.8 129.16 56.53 Favored 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.1 mt -119.29 128.88 75.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.385 0.612 . . . . 0.0 112.145 -178.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.4 tp -97.79 126.58 43.22 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.054 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -110.97 136.36 50.09 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.843 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -97.33 104.44 16.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.575 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -99.07 -10.06 23.07 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.891 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.52 99.03 3.48 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.248 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.7 m -73.55 -39.82 64.44 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.377 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.825 HG22 HG22 ' B' ' 236' ' ' VAL . 0.2 OUTLIER -63.66 -47.46 81.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.818 -178.707 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.505 ' OD1' HG13 ' B' ' 236' ' ' VAL . 2.2 m-20 -142.9 99.03 5.6 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.653 ' HB2' HG13 ' A' ' 75' ' ' VAL . 51.7 Cg_exo -53.38 148.35 33.66 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.361 2.04 . . . . 0.0 113.26 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.5 m -69.32 139.54 54.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.862 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -100.33 141.93 32.5 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.431 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.495 ' CG2' ' OD1' ' A' ' 86' ' ' ASP . 8.5 p -130.79 135.17 60.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 44.99 33.71 1.09 Allowed 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.082 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.05 29.28 62.93 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.837 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.485 ' N ' ' O ' ' A' ' 71' ' ' VAL . 15.8 m -140.65 139.43 34.82 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 120.576 -0.449 . . . . 0.0 111.239 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.653 HG13 ' HB2' ' A' ' 68' ' ' PRO . 29.2 t -72.59 137.93 22.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.243 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.0 pt -109.38 91.99 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.707 178.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -65.41 -30.29 71.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.56 179.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -122.86 168.7 11.37 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.458 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -60.71 148.87 90.3 Favored 'Trans proline' 0 N--CA 1.501 1.917 0 C-N-CA 122.41 2.073 . . . . 0.0 112.26 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.6 p -142.72 142.89 26.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.42 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.7 mtm180 -75.58 131.43 39.99 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.454 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 93.0 mt -78.42 140.33 38.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.128 0.49 . . . . 0.0 111.471 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -128.4 148.13 50.69 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.534 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -55.36 117.21 3.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.213 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.07 -8.71 31.38 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.495 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 60.6 t0 -73.7 128.18 34.81 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.73 0.3 . . . . 0.0 110.441 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.457 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 48.3 t -109.9 132.64 57.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.463 -178.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.8 mt -105.37 134.01 48.06 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 97.6 m -121.53 126.65 49.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.33 0.586 . . . . 0.0 111.898 -178.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.412 ' CG2' HH12 ' A' ' 93' ' ' ARG . 97.8 mt -115.71 124.81 72.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 177.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.4 mm 40.81 -101.66 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 -178.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -118.39 23.56 11.47 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.096 0.475 . . . . 0.0 110.615 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.685 ' HE ' ' CD1' ' A' ' 41' ' ' LEU . 7.9 mtm105 -128.2 146.5 50.71 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.095 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.1 t -137.06 147.16 45.96 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.469 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -120.13 121.0 37.83 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -84.87 135.07 34.24 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.344 -178.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -95.16 120.36 35.25 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.524 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -122.26 123.8 42.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.319 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 62.5 t-20 -105.88 115.71 30.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.832 0.348 . . . . 0.0 110.576 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.029 -179.621 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 53.6 t . . . . . 0 C--O 1.231 0.093 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.458 ' O ' ' CB ' ' B' ' 230' ' ' SEP . 53.0 p30 -108.47 176.48 5.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.234 179.29 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 230' ' ' SEP . . . . . 0.525 ' OG ' ' N ' ' B' ' 231' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.525 ' N ' ' OG ' ' B' ' 230' ' ' SEP . 30.4 mm100 -149.64 68.76 1.02 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 121.114 -0.234 . . . . 0.0 110.914 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -118.14 177.88 16.66 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.517 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -66.04 151.87 82.77 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 123.228 2.618 . . . . 0.0 112.194 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.45 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 235' ' ' PRO . . . . . 0.476 ' HD2' ' O ' ' A' ' 42' ' ' PRO . 31.3 Cg_exo -57.96 137.05 78.94 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 121.84 1.694 . . . . 0.0 112.726 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.825 HG22 HG22 ' A' ' 66' ' ' THR . 25.5 t -68.56 133.66 31.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 114.572 -1.195 . . . . 0.0 109.406 179.433 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -59.71 118.79 6.55 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.218 -0.593 . . . . 0.0 110.199 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 238' ' ' TPO . . . . . 0.404 HG23 ' O ' ' B' ' 236' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -59.49 -20.38 56.55 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.543 2.162 . . . . 0.0 111.76 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 21.4 m -74.21 -46.2 43.35 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.79 177.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.442 ' CE2' HG21 ' A' ' 43' ' ' VAL . 70.9 t80 -57.84 -44.87 86.77 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.276 -179.311 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 79.2 mt -63.76 -39.76 95.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.406 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -60.34 -42.42 95.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.317 -0.401 . . . . 0.0 109.96 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -65.67 -39.47 91.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.203 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.427 ' HD2' ' NE ' ' A' ' 12' ' ' ARG . 3.1 tpp85 -57.5 -43.69 84.38 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -64.4 -41.52 96.6 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 68.1 m -60.93 -45.51 94.39 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 248' ' ' GLN . . . . . 0.423 ' OE1' ' NH2' ' A' ' 12' ' ' ARG . 86.3 mt-30 -62.53 -34.21 76.45 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.339 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 19.0 t -60.25 -45.74 95.77 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 C-N-CA 120.409 -0.516 . . . . 0.0 109.92 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -62.31 -35.0 77.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.284 0.564 . . . . 0.0 109.899 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -79.56 -16.27 56.22 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.725 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 87.1 mt -122.29 111.58 17.09 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.547 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 253' ' ' ASN . . . . . 0.421 ' O ' ' CG ' ' B' ' 253' ' ' ASN . 13.9 t-20 -175.57 29.26 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 120.499 -0.48 . . . . 0.0 111.684 179.213 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 254' ' ' ASP . . . . . 0.543 ' O ' ' CB ' ' B' ' 255' ' ' ASP . 80.6 m-20 -97.0 -2.65 43.04 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.044 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 255' ' ' ASP . . . . . 0.543 ' CB ' ' O ' ' B' ' 254' ' ' ASP . 4.8 p-10 105.08 59.35 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 O-C-N 124.271 0.982 . . . . 0.0 109.88 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.567 ' O ' ' CB ' ' B' ' 257' ' ' LYS . 96.3 m-20 -73.6 -70.99 0.34 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.8 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 257' ' ' LYS . . . . . 0.567 ' CB ' ' O ' ' B' ' 256' ' ' ASP . 70.9 tttt 96.72 167.22 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.334 -178.659 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.608 ' O ' ' N ' ' B' ' 260' ' ' GLU . 74.0 m-20 56.61 38.12 29.34 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -177.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 259' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -49.96 77.22 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.536 -1.211 . . . . 0.0 111.43 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.608 ' N ' ' O ' ' B' ' 258' ' ' ASP . 56.0 mm-40 54.92 5.23 0.09 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.085 -0.961 . . . . 0.0 112.788 178.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 59.3 mt -116.35 132.19 66.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 42.9 t -125.3 134.42 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.094 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -95.54 118.01 31.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.296 0.569 . . . . 0.0 111.038 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -65.02 -44.24 89.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.463 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -100.84 157.83 32.96 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.039 -178.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.23 153.47 69.7 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.777 2.318 . . . . 0.0 111.883 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 41.9 pt . . . . . 0 C--N 1.328 -0.355 0 CA-C-O 121.65 0.738 . . . . 0.0 111.995 -178.877 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo . . . . . 0 N--CA 1.493 1.456 0 N-CA-C 110.884 -0.468 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.789 HG23 ' O ' ' A' ' 100' ' ' GLU . 19.2 m -62.04 -43.39 98.93 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.14 -178.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.595 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 95.2 mtt-85 -97.76 112.31 24.26 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.556 -179.019 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 60.7 ttp180 -124.73 131.5 53.45 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.862 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.659 HD11 ' HB3' ' A' ' 95' ' ' PHE . 43.8 tp -109.32 132.63 53.94 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 37.1 t -109.81 131.41 60.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.809 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.473 ' CG2' HD12 ' B' ' 261' ' ' ILE . 18.6 m -91.45 113.49 25.77 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -177.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.63 HD12 ' OG ' ' A' ' 94' ' ' SER . 97.0 mt -81.91 143.59 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.648 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -89.79 158.42 17.51 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.039 0.447 . . . . 0.0 110.97 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.519 ' NH2' ' CD2' ' B' ' 252' ' ' LEU . 89.0 mtm180 -57.28 -32.21 66.39 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.994 -178.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.4 p -79.76 -7.9 58.92 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.419 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.82 40.29 4.99 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.2 t -122.59 131.16 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 O-C-N 122.753 -0.263 . . . . 0.0 111.446 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -73.59 134.29 43.7 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -126.97 -123.52 2.65 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.036 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -74.37 153.16 44.94 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 122.362 2.042 . . . . 0.0 112.167 -178.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.571 ' O ' ' CG2' ' B' ' 267' ' ' ILE . 0.2 OUTLIER -108.16 159.88 16.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.971 0.415 . . . . 0.0 110.842 -179.516 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.602 ' CD2' HD11 ' A' ' 37' ' ' ILE . 43.8 t80 -128.38 92.3 41.55 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.64 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.23 125.55 18.84 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.026 1.817 . . . . 0.0 111.292 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.484 HD22 ' SG ' ' A' ' 27' ' ' CYS . 93.1 mt -87.92 42.25 1.04 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.896 0.379 . . . . 0.0 111.404 -178.409 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.7 t -59.37 -23.35 62.49 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.678 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.0 mt -76.62 143.9 39.87 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 82.2 p -66.66 -20.31 65.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.676 -178.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.512 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 93.8 m -128.74 128.96 45.06 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.379 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.484 ' SG ' HD22 ' A' ' 22' ' ' LEU . 6.5 t -121.94 112.57 18.46 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.02 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.666 HD21 ' OE1' ' A' ' 47' ' ' GLN . 52.6 tp -113.47 126.07 54.92 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.233 -177.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.712 ' CE2' HD12 ' A' ' 37' ' ' ILE . 6.6 m-85 -106.44 136.66 45.8 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.454 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 160.37 -173.11 36.91 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.284 -0.96 . . . . 0.0 112.421 178.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.571 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 39.3 mtm180 -79.38 -29.21 41.99 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.575 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -61.89 151.03 45.09 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.523 -177.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 78.2 mt -64.87 -42.92 96.15 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.337 0 CA-C-N 115.564 -0.318 . . . . 0.0 110.916 179.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -52.64 -26.03 12.49 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 119.657 -0.817 . . . . 0.0 108.893 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.575 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 11.4 m -57.81 118.74 5.63 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.295 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.512 ' OD2' ' O ' ' A' ' 26' ' ' THR . 98.5 m-20 -56.09 -24.07 37.9 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.222 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.712 HD12 ' CE2' ' A' ' 29' ' ' PHE . 96.9 mt -131.66 122.75 50.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.838 178.377 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.4 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 32.2 mtm180 -107.71 140.47 40.71 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.016 0.436 . . . . 0.0 111.5 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 78.0 mt -121.04 128.79 76.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -70.57 32.3 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -177.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.568 ' CD1' ' CZ ' ' A' ' 93' ' ' ARG . 64.7 mt -110.79 133.68 21.15 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.956 -179.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.7 -8.92 24.07 Favored 'Trans proline' 0 N--CA 1.501 1.959 0 C-N-CA 123.478 2.785 . . . . 0.0 113.863 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.6 m -101.13 2.65 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.032 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.571 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 18.4 t -89.54 100.98 11.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.649 -179.147 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.521 ' O ' ' O ' ' A' ' 44' ' ' VAL . 3.6 t -34.99 164.29 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.936 -179.1 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -63.59 -43.55 96.61 Favored 'General case' 0 C--O 1.238 0.447 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.776 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.666 ' OE1' HD21 ' A' ' 28' ' ' LEU . 94.5 mm-40 -111.21 -23.51 10.81 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.007 0.432 . . . . 0.0 110.421 -179.285 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.457 ' NE2' HG23 ' A' ' 90' ' ' ILE . 16.5 t60 41.29 -78.3 0.0 OUTLIER 'General case' 0 C--O 1.24 0.576 0 CA-C-N 115.421 -0.808 . . . . 0.0 112.679 179.316 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.609 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.45 136.93 48.37 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.914 -178.861 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -129.81 129.51 44.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.181 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 89.0 mt -114.61 138.41 44.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.313 -179.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -118.0 122.51 43.4 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 89.3 mt -103.47 114.09 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 C-N-CA 120.104 -0.639 . . . . 0.0 111.285 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.5 ' O ' ' N ' ' A' ' 56' ' ' GLN . 96.6 m-70 -111.41 139.9 46.44 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.828 179.271 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 54' ' ' HIS . 81.2 tt0 -39.56 -28.43 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.5 ' N ' ' O ' ' A' ' 54' ' ' HIS . 99.6 mm-40 -64.19 -68.14 0.38 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.164 178.377 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -157.98 -168.02 2.39 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.865 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.561 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -112.54 128.4 56.34 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.24 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 87.6 mt -118.64 129.89 74.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 121.175 0.512 . . . . 0.0 111.963 -178.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 25.1 tp -96.31 128.38 43.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.671 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -113.13 138.57 49.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.295 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.603 HD21 ' CB ' ' A' ' 68' ' ' PRO . 61.1 t-20 -99.8 107.01 18.95 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.648 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -98.68 -8.03 26.86 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.803 0.335 . . . . 0.0 110.444 179.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.05 100.68 12.33 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.781 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.6 p -88.31 -30.34 19.67 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.215 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.636 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.2 OUTLIER -63.7 -46.37 85.78 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.317 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -142.49 101.89 5.55 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 115.174 -0.921 . . . . 0.0 108.693 178.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.603 ' CB ' HD21 ' A' ' 62' ' ' ASN . 60.0 Cg_endo -69.44 152.25 70.97 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.097 1.865 . . . . 0.0 114.032 -177.594 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.961 ' O ' HG22 ' A' ' 76' ' ' ILE . 11.4 m -70.94 145.57 50.03 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.286 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -106.82 143.61 34.66 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.7 179.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.505 ' CG2' ' OD1' ' A' ' 86' ' ' ASP . 6.3 p -131.67 136.26 57.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 48.5 32.27 3.29 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.85 27.52 68.77 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.341 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 71' ' ' VAL . 31.3 m -137.67 133.2 33.98 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.322 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 54.7 t -60.97 136.52 24.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.858 0.361 . . . . 0.0 110.57 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.961 HG22 ' O ' ' A' ' 69' ' ' THR . 14.0 tt -103.1 89.73 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.892 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -63.43 -35.84 81.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.746 179.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.505 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 0.8 OUTLIER -128.69 167.52 19.05 Favored Pre-proline 0 N--CA 1.464 0.233 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.372 -179.214 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -56.74 141.78 91.93 Favored 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 122.27 1.98 . . . . 0.0 112.674 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 73.0 t -131.72 137.8 54.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.617 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 83.1 mtt85 -70.24 129.16 38.61 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 97.0 mt -82.53 137.12 34.7 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.456 -0.497 . . . . 0.0 111.394 -178.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -129.29 152.73 48.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.107 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.53 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 7.2 t60 -54.19 118.34 3.99 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.734 0.302 . . . . 0.0 110.428 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.73 -13.15 24.95 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.505 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 59.8 t0 -71.43 128.41 35.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.845 0.355 . . . . 0.0 110.464 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.405 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 69.3 t -110.83 129.05 66.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.674 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 93.8 mt -97.28 132.58 41.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 94.0 m -122.8 127.74 49.51 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 120.026 -0.67 . . . . 0.0 112.553 -178.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.525 HG22 HG12 ' A' ' 91' ' ' ILE . 82.2 mt -120.31 125.37 74.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 114.944 -1.026 . . . . 0.0 108.26 178.245 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.525 HG12 HG22 ' A' ' 90' ' ' ILE . 25.1 mm 43.22 -116.33 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -178.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.419 ' HB2' ' HE ' ' B' ' 245' ' ' ARG . 94.3 m-20 -102.74 14.47 31.87 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.854 0.359 . . . . 0.0 110.849 178.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.819 HH11 ' NH2' ' B' ' 245' ' ' ARG . 37.2 mtm-85 -123.37 145.13 49.0 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.427 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.63 ' OG ' HD12 ' A' ' 10' ' ' ILE . 38.3 p -140.99 151.86 44.46 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 120.687 -0.405 . . . . 0.0 109.927 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.659 ' HB3' HD11 ' A' ' 7' ' ' LEU . 82.7 m-85 -120.07 121.65 39.34 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.249 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.51 ' O ' HD12 ' A' ' 7' ' ' LEU . 79.6 mtp85 -81.56 130.3 35.0 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.471 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.595 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 86.7 t80 -96.62 123.05 40.17 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.198 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -127.41 131.62 50.26 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.007 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.543 ' OD1' HG22 ' A' ' 4' ' ' THR . 64.9 t-20 -126.46 121.21 31.75 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.412 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.789 ' O ' HG23 ' A' ' 4' ' ' THR . 86.5 mt-10 . . . . . 0 C--N 1.323 -0.568 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.655 178.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 228' ' ' VAL . . . . . 0.464 HG23 ' N ' ' B' ' 229' ' ' ASP . 26.1 m . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.643 0.258 . . . . 0.0 110.801 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.464 ' N ' HG23 ' B' ' 228' ' ' VAL . 52.2 p-10 -85.56 171.18 11.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.698 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 230' ' ' SEP . . . . . 0.551 ' OG ' ' N ' ' B' ' 231' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.551 ' N ' ' OG ' ' B' ' 230' ' ' SEP . 25.4 mp0 -148.65 65.49 1.06 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.884 0.373 . . . . 0.0 110.864 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 232' ' ' GLY . . . . . 0.468 ' C ' HH12 ' A' ' 31' ' ' ARG . . . -111.21 177.3 19.04 Favored Glycine 0 CA--C 1.532 1.1 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 -179.601 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.06 160.41 50.03 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 123.163 2.576 . . . . 0.0 112.705 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.636 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.9 141.72 30.55 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 122.211 1.941 . . . . 0.0 112.17 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.594 ' CG2' HG22 ' A' ' 66' ' ' THR . 41.1 t -70.13 133.02 32.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.441 -178.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 4.8 t -72.19 134.79 45.87 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.751 179.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -58.67 -25.59 75.93 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 123.143 2.562 . . . . 0.0 113.419 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 96.6 m -74.03 -44.65 53.65 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.307 -0.557 . . . . 0.0 109.579 178.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.414 ' HZ ' HD22 ' A' ' 41' ' ' LEU . 82.4 t80 -59.71 -46.54 88.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.263 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.425 ' HA ' HD23 ' B' ' 242' ' ' LEU . 88.3 mt -63.87 -42.36 97.54 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.092 0.472 . . . . 0.0 110.569 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -61.81 -38.89 89.81 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.255 -179.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -62.36 -44.75 95.74 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.4 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.819 ' NH2' HH11 ' A' ' 93' ' ' ARG . 72.6 mtp85 -61.18 -39.7 91.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.894 -179.392 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -63.67 -41.74 98.14 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 120.375 -0.53 . . . . 0.0 109.683 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 62.6 m -66.17 -45.36 81.17 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 248' ' ' GLN . . . . . 0.674 ' O ' HD13 ' B' ' 252' ' ' LEU . 25.9 mt-30 -58.03 -39.3 78.04 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.879 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.436 HG23 ' O ' ' B' ' 245' ' ' ARG . 54.7 t -64.05 -45.32 96.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.633 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -65.73 -28.9 69.39 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.795 0.331 . . . . 0.0 110.772 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -89.29 -11.06 44.58 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.132 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.715 HD23 ' CB ' ' B' ' 256' ' ' ASP . 3.0 mp -88.11 173.26 8.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.983 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 253' ' ' ASN . . . . . 0.554 ' O ' ' N ' ' B' ' 255' ' ' ASP . 39.7 m-80 -153.35 -174.13 4.83 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.14 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -44.01 -14.29 0.02 OUTLIER 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.929 0.395 . . . . 0.0 111.164 -178.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 255' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' B' ' 253' ' ' ASN . 25.5 p-10 -76.29 -5.76 48.46 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.747 179.283 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.715 ' CB ' HD23 ' B' ' 252' ' ' LEU . 42.0 p-10 -103.75 13.09 33.78 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 120.739 0.304 . . . . 0.0 110.185 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -66.45 -11.67 53.21 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.112 178.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.494 ' O ' ' OD2' ' B' ' 259' ' ' ASP . 34.6 t70 -58.51 -44.85 89.62 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' B' ' 261' ' ' ILE . 0.0 OUTLIER 80.73 116.58 0.06 Allowed 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.99 179.501 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -63.44 10.71 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.107 -178.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.538 ' N ' ' OD1' ' B' ' 259' ' ' ASP . 74.6 mt -103.22 136.64 34.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.061 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 72.0 t -125.96 135.76 62.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.45 0.643 . . . . 0.0 111.359 -178.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -97.46 116.55 29.88 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.781 -178.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -67.58 -39.6 84.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.505 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.56 159.46 32.57 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.344 -178.556 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 266' ' ' PRO . . . . . 0.414 ' C ' HD13 ' B' ' 267' ' ' ILE . 37.9 Cg_endo -61.2 147.61 95.15 Favored 'Trans proline' 0 C--N 1.302 -1.891 0 C-N-CA 122.27 1.98 . . . . 0.0 111.925 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 267' ' ' ILE . . . . . 0.571 ' CG2' ' O ' ' A' ' 19' ' ' HIS . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.904 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo . . . . . 0 N--CA 1.493 1.48 0 CA-C-O 120.82 0.258 . . . . 0.0 112.375 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.627 HG22 ' OD1' ' A' ' 99' ' ' ASN . 16.6 m -62.16 -44.87 95.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.1 -179.449 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.65 ' NE ' HD13 ' A' ' 53' ' ' ILE . 91.5 mtm-85 -95.91 117.46 30.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.012 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -128.31 134.92 49.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.864 0.364 . . . . 0.0 110.251 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.633 HD12 ' O ' ' A' ' 96' ' ' ARG . 24.2 tp -113.87 132.85 55.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.989 -179.048 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.652 HG22 ' CD2' ' A' ' 19' ' ' HIS . 51.5 t -108.49 130.86 60.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.424 HG23 ' CD1' ' B' ' 261' ' ' ILE . 2.7 m -90.79 121.34 32.58 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.356 0.598 . . . . 0.0 112.124 -178.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 98.2 mt -89.18 141.06 14.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.23 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -91.03 162.87 14.52 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.564 HH12 ' CD ' ' B' ' 248' ' ' GLN . 87.4 mtm180 -55.83 -27.56 52.04 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.075 -178.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 92.6 p -84.87 -6.26 59.34 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.791 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.51 42.17 7.49 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.436 -1.065 . . . . 0.0 110.436 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.2 t -118.57 132.99 66.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.797 0.332 . . . . 0.0 110.996 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.545 ' CG ' ' HE2' ' A' ' 19' ' ' HIS . 63.9 t0 -74.17 120.24 19.47 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.872 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -117.37 -120.76 3.12 Favored Glycine 0 CA--C 1.539 1.582 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.748 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -74.34 147.45 37.07 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 122.413 2.075 . . . . 0.0 112.703 -179.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.652 ' CD2' HG22 ' A' ' 8' ' ' VAL . 65.2 m170 -109.66 143.87 38.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.083 0.468 . . . . 0.0 110.818 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.731 ' CD2' HD11 ' A' ' 37' ' ' ILE . 30.1 t80 -112.28 104.14 55.81 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.71 -178.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -74.02 128.18 12.06 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 121.34 1.36 . . . . 0.0 111.106 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.3 mt -85.07 47.32 1.39 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.811 -177.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 97.2 p -59.07 -28.44 66.47 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.3 mt -74.29 141.78 45.26 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.8 m -70.95 -16.29 62.64 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.972 -0.291 . . . . 0.0 111.724 -178.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.9 m -134.07 135.88 43.58 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.97 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.676 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 2.4 t -131.05 123.05 27.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.945 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.3 tp -117.51 130.24 56.31 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.686 0.279 . . . . 0.0 110.92 -178.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.676 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 59.3 m-85 -108.02 143.63 36.45 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.823 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 147.84 -177.61 25.99 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.035 178.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 46.6 mtm180 -70.83 -32.67 69.79 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.924 0.392 . . . . 0.0 111.042 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.535 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -48.67 143.92 7.56 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 -178.539 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.538 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.8 tp -66.22 -41.59 89.49 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.151 0 CA-C-O 121.046 0.45 . . . . 0.0 110.078 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.538 ' N ' HG23 ' A' ' 33' ' ' ILE . 97.9 mt-10 -54.88 -22.1 13.67 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.519 179.455 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.535 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 50.0 m -56.73 118.39 4.85 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.348 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -59.54 -26.89 65.74 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.731 HD11 ' CD2' ' A' ' 20' ' ' PHE . 47.5 mm -123.54 108.54 21.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 176.491 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -102.28 132.95 47.92 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.843 -177.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 84.0 mt -123.42 131.51 73.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.554 ' NE2' ' O ' ' A' ' 40' ' ' GLN . 0.0 OUTLIER -88.56 43.71 1.15 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 119.626 -0.83 . . . . 0.0 112.558 -178.112 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.983 HD11 ' NH1' ' A' ' 93' ' ' ARG . 36.6 mt -95.36 128.87 36.83 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.27 178.617 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -70.78 -13.34 32.04 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 122.095 1.863 . . . . 0.0 113.534 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 18.6 m -100.61 5.67 10.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.028 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 34.5 t -95.7 139.07 19.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.123 0.487 . . . . 0.0 111.086 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.87 166.04 11.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.548 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -63.87 -44.12 94.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.003 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.625 ' O ' ' N ' ' A' ' 49' ' ' CYS . 98.2 mt-30 -113.4 -12.08 13.04 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.885 0.374 . . . . 0.0 111.049 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 26.1 t60 34.48 -74.77 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 178.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.625 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -135.53 139.54 44.04 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.405 0.622 . . . . 0.0 112.095 -177.938 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -127.66 131.09 49.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.78 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.8 mt -113.24 132.95 60.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.107 179.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.464 ' CD ' ' NE2' ' A' ' 54' ' ' HIS . 83.4 tt0 -117.89 123.32 45.57 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.093 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.65 HD13 ' NE ' ' A' ' 5' ' ' ARG . 85.1 mt -107.22 117.11 52.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 119.968 -0.693 . . . . 0.0 112.559 -178.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.464 ' NE2' ' CD ' ' A' ' 52' ' ' GLU . 97.7 m-70 -110.93 139.67 46.06 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.968 178.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.5 tt0 -40.77 -32.55 0.23 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.5 -0.48 . . . . 0.0 109.802 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -66.3 -65.97 0.61 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.99 -173.23 4.43 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.098 0.475 . . . . 0.0 111.797 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.84 129.22 56.61 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.698 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 91.3 mt -118.14 130.87 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 121.609 0.719 . . . . 0.0 112.76 -178.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.543 HD22 ' CD1' ' A' ' 88' ' ' ILE . 43.1 tp -98.69 128.06 44.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.456 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -115.06 136.03 53.56 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.948 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.615 ' C ' HD21 ' A' ' 62' ' ' ASN . 0.3 OUTLIER -97.32 104.72 16.77 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.25 -179.648 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.439 ' N ' HD21 ' A' ' 62' ' ' ASN . 25.2 m-85 -96.44 -11.66 25.31 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.865 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.503 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 85.1 p -74.71 98.4 3.44 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.098 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.8 m -78.67 -32.85 47.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.345 179.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.589 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.2 OUTLIER -75.19 -42.72 55.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.595 -179.225 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.503 ' O ' ' OG ' ' A' ' 64' ' ' SER . 79.5 m-20 -135.88 95.06 14.07 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.919 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.437 ' HB2' HG13 ' A' ' 75' ' ' VAL . 40.1 Cg_exo -54.92 143.33 72.77 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.383 2.055 . . . . 0.0 113.242 -178.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.464 ' HB ' HD11 ' A' ' 76' ' ' ILE . 12.2 m -70.94 152.87 43.18 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.309 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -115.54 141.24 48.33 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.535 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.547 ' CG2' ' OD1' ' A' ' 86' ' ' ASP . 4.4 p -130.9 137.51 55.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 49.26 32.16 4.17 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.05 28.79 69.8 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.959 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.464 ' N ' ' O ' ' A' ' 71' ' ' VAL . 9.0 t -140.24 137.3 34.16 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.914 0.388 . . . . 0.0 111.363 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.437 HG13 ' HB2' ' A' ' 68' ' ' PRO . 40.7 t -64.9 135.97 27.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.673 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.464 HD11 ' HB ' ' A' ' 69' ' ' THR . 11.9 pt -110.49 77.93 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.12 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.318 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -59.93 -33.02 71.33 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -112.9 159.35 34.84 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.785 178.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.55 154.27 71.97 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.413 2.075 . . . . 0.0 111.67 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.0 m -148.15 149.02 15.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.873 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -73.1 132.15 42.95 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-O 120.983 0.42 . . . . 0.0 110.449 179.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.408 HD21 ' HB2' ' A' ' 60' ' ' LEU . 97.6 mt -80.95 140.97 34.95 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.198 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -133.63 154.6 50.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.767 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -55.15 116.46 2.81 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.259 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.17 -18.39 18.58 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.547 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 56.9 t0 -66.08 123.36 19.67 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.271 0.557 . . . . 0.0 109.508 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.502 ' CG2' ' OG ' ' A' ' 94' ' ' SER . 7.4 p -104.37 132.94 49.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.078 -178.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.543 ' CD1' HD22 ' A' ' 60' ' ' LEU . 29.4 mm -92.48 130.47 41.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 178.184 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.6 m -121.96 126.44 48.6 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 119.364 -0.934 . . . . 0.0 112.9 -178.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.517 ' O ' ' C ' ' A' ' 91' ' ' ILE . 98.0 mt -120.39 127.69 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 113.988 -1.46 . . . . 0.0 107.996 177.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.553 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 44.0 mt -21.21 101.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 O-C-N 123.612 0.57 . . . . 0.0 112.243 -179.348 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.553 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 11.3 t0 89.87 -19.81 0.16 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 177.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.983 ' NH1' HD11 ' A' ' 41' ' ' LEU . 71.7 mtt85 -131.44 139.85 49.48 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.806 -178.466 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.502 ' OG ' ' CG2' ' A' ' 87' ' ' VAL . 15.8 t -135.04 146.91 49.43 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 120.894 0.378 . . . . 0.0 110.09 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.592 ' HB3' HD11 ' A' ' 7' ' ' LEU . 72.7 m-85 -123.78 124.52 42.87 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.752 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.633 ' O ' HD12 ' A' ' 7' ' ' LEU . 99.8 mtt180 -88.29 133.47 34.05 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 119.568 -0.853 . . . . 0.0 110.932 -179.633 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -95.28 124.34 39.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.875 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -123.12 127.62 48.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.421 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.627 ' OD1' HG22 ' A' ' 4' ' ' THR . 62.6 t-20 -130.22 112.36 13.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.385 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.4 ' O ' ' O ' ' A' ' 99' ' ' ASN . 82.6 tt0 . . . . . 0 C--N 1.33 -0.246 0 CA-C-O 120.897 0.379 . . . . 0.0 110.05 -179.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 CA--C 1.528 0.114 0 CA-C-O 120.827 0.346 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.508 ' O ' ' N ' ' B' ' 231' ' ' GLN . 75.9 m-20 -70.57 140.29 51.68 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.508 ' N ' ' O ' ' B' ' 229' ' ' ASP . 4.3 mt-30 -46.26 -47.27 18.17 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.136 -179.068 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 232' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' B' ' 231' ' ' GLN . . . -36.71 165.64 0.01 OUTLIER Glycine 0 CA--C 1.529 0.958 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.463 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.04 162.97 40.21 Favored 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 124.384 3.39 . . . . 0.0 112.813 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.589 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.44 141.63 42.93 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 121.902 1.735 . . . . 0.0 112.635 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.489 HG22 HG22 ' A' ' 66' ' ' THR . 72.8 t -66.2 133.26 31.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.818 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 2.0 t -74.88 135.6 41.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.113 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 238' ' ' TPO . . . . . 0.466 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 239' ' ' PRO . . . . . 0.466 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 33.1 Cg_exo -59.17 -24.01 71.91 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.728 2.285 . . . . 0.0 112.263 -179.11 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 98.9 m -67.25 -48.0 69.08 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.453 ' HZ ' HD22 ' A' ' 41' ' ' LEU . 88.9 t80 -59.31 -47.57 84.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.13 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.486 HD21 HG23 ' A' ' 91' ' ' ILE . 85.9 mt -65.36 -40.13 93.18 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.14 -179.468 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -62.16 -42.4 99.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.896 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 79.2 ttt-85 -61.19 -42.48 98.65 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.078 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.619 ' NH1' HE22 ' B' ' 248' ' ' GLN . 22.5 mmt180 -62.72 -42.33 99.6 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.749 -179.669 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -62.11 -43.12 99.53 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 54.3 m -65.35 -44.05 88.93 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 248' ' ' GLN . . . . . 0.619 HE22 ' NH1' ' B' ' 245' ' ' ARG . 7.3 tt0 -57.26 -41.29 79.4 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.521 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.417 HG23 ' O ' ' B' ' 245' ' ' ARG . 55.1 t -65.51 -43.83 94.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.75 0.309 . . . . 0.0 110.649 179.323 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -55.33 -29.8 59.01 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -87.3 -3.78 59.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.856 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.4 ' HA ' HD23 ' B' ' 252' ' ' LEU . 94.9 mt -123.62 116.2 22.72 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.968 178.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -61.5 -174.96 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.019 0.438 . . . . 0.0 111.345 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -62.47 -13.33 29.04 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.18 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -70.98 -14.92 62.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.853 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.406 ' CG ' ' N ' ' B' ' 257' ' ' LYS . 38.9 t70 38.09 -114.99 0.14 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.71 179.296 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 257' ' ' LYS . . . . . 0.491 ' O ' ' OD1' ' B' ' 259' ' ' ASP . 55.8 pttt 178.22 -130.94 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.39 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.584 ' OD1' ' N ' ' B' ' 259' ' ' ASP . 43.7 p-10 -65.23 -26.73 68.24 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.361 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.584 ' N ' ' OD1' ' B' ' 258' ' ' ASP . 1.1 m-20 89.98 12.58 0.06 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.582 179.462 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.605 ' CB ' HH21 ' A' ' 93' ' ' ARG . 51.1 mp0 56.28 -3.0 0.03 OUTLIER 'General case' 0 C--O 1.237 0.437 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 178.378 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.53 ' H ' ' C ' ' B' ' 259' ' ' ASP . 78.1 mt -110.81 136.21 47.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 76.7 t -122.91 131.19 73.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.999 0.428 . . . . 0.0 110.254 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -94.23 117.48 30.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.202 0.525 . . . . 0.0 110.958 -178.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.32 -44.81 90.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.543 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.75 160.36 28.07 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.801 -179.158 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -57.07 152.87 41.8 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.987 2.458 . . . . 0.0 111.716 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 39.8 pt . . . . . 0 C--N 1.327 -0.383 0 CA-C-O 121.622 0.725 . . . . 0.0 111.978 -178.921 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo . . . . . 0 N--CA 1.501 1.929 0 CA-C-O 121.105 0.377 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.503 ' O ' ' O ' ' A' ' 99' ' ' ASN . 2.9 m -93.18 -53.83 3.96 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.318 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.746 ' HE ' HD13 ' A' ' 53' ' ' ILE . 82.5 mtm-85 -89.98 130.68 36.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.958 -179.135 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -131.06 148.04 52.69 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.155 0.502 . . . . 0.0 111.921 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.762 HD11 HD11 ' A' ' 22' ' ' LEU . 94.1 mt -115.4 141.7 47.68 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.257 179.11 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.9 t -113.14 128.22 70.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.7 m -91.69 113.73 26.08 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.681 HD12 ' OG ' ' A' ' 94' ' ' SER . 96.8 mt -77.58 138.77 19.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.291 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -86.32 157.04 19.99 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.425 179.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -58.01 -30.84 66.41 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.782 -179.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 87.0 p -78.55 -9.74 59.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.871 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.56 34.78 6.81 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.756 -0.937 . . . . 0.0 110.756 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 52.3 t -121.51 133.84 66.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.574 0.226 . . . . 0.0 110.813 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.403 ' C ' ' OD1' ' A' ' 16' ' ' ASP . 62.3 t0 -66.24 120.15 12.75 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.934 0.397 . . . . 0.0 110.383 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -104.43 -136.12 8.7 Favored Glycine 0 CA--C 1.535 1.337 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.374 -178.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.97 151.54 45.15 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.581 2.187 . . . . 0.0 112.693 -178.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -107.85 128.93 55.04 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.965 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.835 ' CD2' HD11 ' A' ' 37' ' ' ILE . 59.8 t80 -97.67 106.36 32.83 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.053 -178.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.85 128.13 9.87 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 121.703 1.602 . . . . 0.0 111.405 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.762 HD11 HD11 ' A' ' 7' ' ' LEU . 97.5 mt -83.39 84.0 7.67 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.381 -0.528 . . . . 0.0 111.552 -178.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 57.2 p -83.44 -13.66 54.27 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.516 HD11 ' CD ' ' B' ' 265' ' ' GLN . 58.6 mt -99.55 142.57 30.85 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.963 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 27.1 m -69.48 -10.44 58.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.646 -178.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 29.2 m -132.16 132.56 43.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.757 0.313 . . . . 0.0 110.57 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.6 t -128.1 123.68 35.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.508 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.456 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 54.7 tp -117.45 131.67 56.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.017 -179.058 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.423 ' CE2' HG13 ' A' ' 37' ' ' ILE . 32.1 m-85 -110.33 135.91 50.32 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 155.81 -164.38 32.18 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 120.367 -0.921 . . . . 0.0 112.328 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.62 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 47.6 ptt85 -119.18 19.54 12.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.651 -0.275 . . . . 0.0 110.352 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.63 ' O ' ' N ' ' A' ' 34' ' ' GLU . . . -88.32 29.74 5.53 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.588 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 1.7 tp 55.63 -61.85 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 O-C-N 123.849 0.382 . . . . 0.0 111.163 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.63 ' N ' ' O ' ' A' ' 32' ' ' GLY . 49.8 tp10 -50.46 -9.64 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.415 0.626 . . . . 0.0 109.514 179.575 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.551 ' H ' ' C ' ' A' ' 33' ' ' ILE . 35.1 m -65.42 124.74 23.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.39 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.456 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 60.5 m-20 -60.34 -31.66 70.51 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.835 HD11 ' CD2' ' A' ' 20' ' ' PHE . 42.6 mm -118.95 114.08 43.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 177.456 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.758 HH22 ' NZ ' ' B' ' 264' ' ' LYS . 77.3 mtt85 -103.64 136.09 43.99 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.448 -177.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.668 HD13 ' HE ' ' A' ' 93' ' ' ARG . 97.8 mt -122.58 132.23 71.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 121.006 0.432 . . . . 0.0 110.439 179.559 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -77.27 33.0 0.15 Allowed 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -176.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.71 HD12 ' CZ ' ' A' ' 93' ' ' ARG . 47.4 mt -109.81 134.75 20.54 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 120.091 -0.643 . . . . 0.0 111.546 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.55 -8.23 21.36 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.456 2.104 . . . . 0.0 113.517 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.562 HG21 ' CE2' ' B' ' 241' ' ' PHE . 27.6 m -100.56 3.23 10.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.468 179.36 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.62 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 37.2 t -88.96 132.74 32.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.482 -0.487 . . . . 0.0 109.713 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.8 t -66.02 155.86 35.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.498 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.516 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 40.3 mtmt -63.04 -40.76 98.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.027 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.646 ' O ' ' N ' ' A' ' 49' ' ' CYS . 87.5 mt-30 -115.94 -7.57 11.96 Favored 'General case' 0 N--CA 1.464 0.23 0 O-C-N 123.319 0.387 . . . . 0.0 111.334 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.469 ' C ' ' O ' ' A' ' 47' ' ' GLN . 17.0 t60 15.7 -71.4 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -178.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.646 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.46 133.42 45.15 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -178.49 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -125.36 129.02 49.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.784 178.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 90.5 mt -115.1 134.86 56.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.042 0.449 . . . . 0.0 111.732 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.443 ' CD ' ' NE2' ' A' ' 54' ' ' HIS . 81.5 tt0 -117.59 126.15 52.05 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.338 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.746 HD13 ' HE ' ' A' ' 5' ' ' ARG . 94.9 mt -108.14 118.87 56.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 113.086 0.772 . . . . 0.0 113.086 -178.211 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.443 ' NE2' ' CD ' ' A' ' 52' ' ' GLU . 98.4 m-70 -111.23 138.28 47.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.015 178.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 54' ' ' HIS . 78.6 tt0 -40.72 -33.87 0.33 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -179.171 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -63.79 -67.14 0.45 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.696 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.51 ' OE2' ' CD ' ' A' ' 81' ' ' ARG . 0.1 OUTLIER -148.56 -178.97 6.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.203 0.525 . . . . 0.0 111.519 -179.373 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -106.51 126.47 52.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.189 178.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 86.6 mt -116.9 128.6 74.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.429 0.633 . . . . 0.0 112.351 -178.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.623 ' HB2' HD11 ' A' ' 82' ' ' LEU . 24.8 tp -99.85 130.57 46.06 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.499 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -112.61 132.9 54.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.098 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 63.9 t-20 -92.16 106.77 18.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.353 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -98.25 -7.57 28.91 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.44 102.06 4.33 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.039 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.5 m -89.42 -6.52 56.48 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.831 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.2 OUTLIER -102.2 -40.14 6.92 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.126 -179.894 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 56.9 m-20 -142.69 99.04 5.72 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.107 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.531 ' HB2' HG13 ' A' ' 75' ' ' VAL . 51.9 Cg_exo -55.36 146.2 63.25 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.286 1.991 . . . . 0.0 113.546 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.9 m -76.01 144.95 40.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.837 178.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -105.63 139.16 40.64 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.795 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 54.9 t -130.1 134.44 62.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 52.67 33.78 14.54 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.6 27.91 71.8 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.233 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 68.2 m -142.77 138.26 30.32 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 117.626 0.713 . . . . 0.0 111.853 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.531 HG13 ' HB2' ' A' ' 68' ' ' PRO . 3.4 t -68.12 140.8 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.853 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.5 pt -114.16 105.99 19.79 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.063 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.67 178.183 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 20.5 p-10 -74.37 -26.54 60.18 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.131 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.442 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.3 OUTLIER -130.4 178.52 1.69 Allowed Pre-proline 0 C--N 1.33 -0.258 0 C-N-CA 120.866 -0.333 . . . . 0.0 110.62 -179.794 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 31.2 Cg_exo -59.91 141.87 97.42 Favored 'Trans proline' 0 N--CA 1.502 1.985 0 C-N-CA 122.687 2.258 . . . . 0.0 113.158 -179.173 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 47.1 t -133.77 135.92 54.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.725 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.51 ' CD ' ' OE2' ' A' ' 57' ' ' GLU . 88.9 mtm180 -71.91 132.98 45.11 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.057 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.623 HD11 ' HB2' ' A' ' 60' ' ' LEU . 96.1 mt -86.86 136.82 32.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.257 0.551 . . . . 0.0 111.615 -178.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -121.31 148.79 43.85 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.613 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.439 ' CD2' ' C ' ' A' ' 84' ' ' HIS . 7.9 t60 -58.55 125.76 24.73 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.029 0.442 . . . . 0.0 110.291 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.57 -17.44 42.91 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.809 -0.917 . . . . 0.0 110.809 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -67.74 140.39 56.72 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.101 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.537 ' O ' HG13 ' A' ' 87' ' ' VAL . 12.1 p -112.33 127.96 69.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.476 -178.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 88.0 mt -92.81 130.59 41.67 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 177.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.1 m -125.85 128.9 48.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.975 0.893 . . . . 0.0 113.111 -178.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.546 ' O ' ' C ' ' A' ' 91' ' ' ILE . 95.9 mt -114.44 137.81 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 114.004 -1.453 . . . . 0.0 108.217 178.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.546 ' C ' ' O ' ' A' ' 90' ' ' ILE . 87.4 mt 17.02 -85.74 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 O-C-N 123.645 0.591 . . . . 0.0 111.771 -178.425 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.499 ' N ' ' O ' ' A' ' 90' ' ' ILE . 53.9 t0 -121.63 14.33 10.97 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 120.315 -0.554 . . . . 0.0 112.023 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.71 ' CZ ' HD12 ' A' ' 41' ' ' LEU . 45.1 mtm-85 -129.31 140.75 51.3 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.642 -0.423 . . . . 0.0 109.974 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.681 ' OG ' HD12 ' A' ' 10' ' ' ILE . 55.0 p -139.14 153.96 48.04 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.124 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -127.13 126.84 43.6 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.746 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -84.34 129.36 34.88 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.85 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.557 ' CE2' ' OD1' ' A' ' 99' ' ' ASN . 88.8 t80 -89.63 123.86 34.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.951 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -134.12 113.24 11.85 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.076 0.465 . . . . 0.0 111.146 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.557 ' OD1' ' CE2' ' A' ' 97' ' ' TYR . 99.1 m-20 -68.17 -40.42 82.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.152 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.91 -179.542 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 39.0 t . . . . . 0 N--CA 1.456 -0.127 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 45.1 t0 61.98 -173.5 0.14 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.074 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 230' ' ' SEP . . . . . 0.598 ' O ' ' NE2' ' B' ' 231' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.598 ' NE2' ' O ' ' B' ' 230' ' ' SEP . 99.0 mm-40 -145.41 75.64 1.44 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.03 179.231 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -123.26 -174.08 14.18 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 120.986 -0.626 . . . . 0.0 111.754 -178.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 233' ' ' PRO . . . . . 0.606 ' O ' ' NH2' ' A' ' 31' ' ' ARG . 87.9 Cg_endo -73.66 155.22 49.65 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 123.415 2.743 . . . . 0.0 112.85 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.831 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.46 136.47 33.87 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 121.735 1.624 . . . . 0.0 113.098 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.553 ' CG2' HG22 ' A' ' 66' ' ' THR . 55.0 t -65.22 137.14 25.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 114.585 -1.189 . . . . 0.0 111.156 -179.245 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 237' ' ' CYS . . . . . 0.497 ' SG ' HG23 ' A' ' 91' ' ' ILE . 5.9 t -63.68 125.05 23.03 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -52.6 -23.02 18.41 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.934 1.756 . . . . 0.0 112.266 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 21.9 p -74.18 -41.19 61.85 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 121.188 0.518 . . . . 0.0 109.835 178.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.562 ' CE2' HG21 ' A' ' 43' ' ' VAL . 84.5 t80 -58.22 -45.56 87.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.964 -179.302 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 89.1 mt -64.18 -40.46 96.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.658 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -61.81 -40.55 95.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.027 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 80.4 mtt85 -62.16 -42.52 99.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.168 0.509 . . . . 0.0 109.994 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.923 ' O ' HG23 ' B' ' 249' ' ' VAL . 78.0 mtp85 -61.98 -41.95 98.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.657 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -61.92 -43.32 99.09 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.274 -0.57 . . . . 0.0 110.398 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 46.9 t -65.97 -45.22 82.48 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -63.43 -34.49 77.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.012 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.923 HG23 ' O ' ' B' ' 245' ' ' ARG . 59.8 t -61.06 -47.03 95.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.127 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -65.52 -29.71 70.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.788 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -78.12 -13.95 59.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.471 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 99.0 mt -114.44 115.08 26.71 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.971 0.415 . . . . 0.0 110.528 178.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 253' ' ' ASN . . . . . 0.567 ' O ' ' N ' ' B' ' 255' ' ' ASP . 1.6 m-80 -83.47 -157.35 0.24 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.534 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -47.31 -5.74 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.565 -179.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 255' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' B' ' 253' ' ' ASN . 44.7 p-10 -70.95 -1.89 13.44 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.272 0.558 . . . . 0.0 109.9 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.657 ' O ' ' N ' ' B' ' 258' ' ' ASP . 93.8 m-20 -58.61 -33.09 69.62 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 257' ' ' LYS . . . . . 0.501 ' C ' ' O ' ' B' ' 256' ' ' ASP . 87.8 tttt -25.06 -36.33 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 O-C-N 124.211 0.945 . . . . 0.0 110.951 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.657 ' N ' ' O ' ' B' ' 256' ' ' ASP . 96.6 m-20 -86.99 44.86 1.21 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.072 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.591 ' N ' ' O ' ' B' ' 256' ' ' ASP . 48.3 p30 -48.15 144.54 3.72 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.526 0.679 . . . . 0.0 111.952 -178.469 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.585 ' OE1' HD21 ' A' ' 41' ' ' LEU . 97.1 mt-10 -61.93 20.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.588 -1.187 . . . . 0.0 112.495 -178.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.553 ' H ' ' C ' ' B' ' 259' ' ' ASP . 61.6 mt -109.33 132.41 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.264 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 75.2 t -127.87 137.08 58.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.282 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 263' ' ' PHE . . . . . 0.578 ' CD2' HD13 ' B' ' 267' ' ' ILE . 67.1 m-85 -98.61 120.48 39.11 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.052 -177.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 264' ' ' LYS . . . . . 0.758 ' NZ ' HH22 ' A' ' 38' ' ' ARG . 64.6 tttp -65.18 -48.07 74.73 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.924 178.741 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 265' ' ' GLN . . . . . 0.516 ' CD ' HD11 ' A' ' 24' ' ' LEU . 0.4 OUTLIER -85.5 172.04 9.48 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.281 -178.809 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -58.08 143.98 95.62 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.343 2.029 . . . . 0.0 112.943 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 267' ' ' ILE . . . . . 0.578 HD13 ' CD2' ' B' ' 263' ' ' PHE . 18.5 tt . . . . . 0 N--CA 1.448 -0.569 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.361 179.216 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo . . . . . 0 N--CA 1.49 1.294 0 CA-C-O 120.743 0.226 . . . . 0.0 111.616 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.9 p -78.07 -36.48 48.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.014 179.641 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.688 ' NH2' HG21 ' A' ' 53' ' ' ILE . 91.4 mtm-85 -99.76 124.43 45.02 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.02 -178.641 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -133.74 144.81 49.32 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.261 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.562 HD11 HD11 ' A' ' 22' ' ' LEU . 69.4 mt -111.73 138.96 47.61 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.855 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.8 t -112.29 125.88 69.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.982 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.3 m -74.93 138.65 42.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.916 -178.693 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.614 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 98.5 mt -109.89 132.86 56.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.547 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -90.38 157.25 17.71 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.479 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.53 ' NH1' ' CD ' ' B' ' 260' ' ' GLU . 93.2 mtm-85 -61.31 -23.49 65.75 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.048 -179.28 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.5 m -76.08 -16.6 59.89 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.552 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.06 33.26 7.03 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.596 -1.001 . . . . 0.0 110.596 -179.331 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 37.0 t -117.64 131.82 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-O 120.573 0.225 . . . . 0.0 111.499 -179.521 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -74.02 136.65 43.14 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 178.376 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -130.46 -119.95 2.17 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.308 -179.169 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -72.95 150.16 48.46 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 122.464 2.109 . . . . 0.0 112.646 -178.748 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -112.38 156.96 21.63 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.306 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.625 ' CD2' HD11 ' A' ' 37' ' ' ILE . 46.9 t80 -123.13 103.99 35.67 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.143 -179.261 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -71.49 127.24 13.01 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 121.622 1.548 . . . . 0.0 111.929 -179.414 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.562 HD11 HD11 ' A' ' 7' ' ' LEU . 98.3 mt -84.31 48.83 1.55 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -178.295 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 94.3 p -61.35 -24.33 66.38 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.728 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.625 HD11 ' CD ' ' B' ' 265' ' ' GLN . 73.3 mt -77.36 139.76 39.81 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.667 179.485 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 91.8 p -66.18 -18.96 65.67 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.165 -179.302 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.428 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 40.4 m -132.8 132.83 42.63 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.024 -179.777 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.46 ' HB2' HD22 ' A' ' 22' ' ' LEU . 3.7 t -125.27 118.33 25.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.847 178.96 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.423 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 39.7 tp -116.82 128.55 55.38 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.055 -178.646 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.713 ' CE2' HD12 ' A' ' 37' ' ' ILE . 4.5 m-85 -107.58 141.06 39.62 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.158 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 158.13 -168.76 34.65 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 120.033 -1.079 . . . . 0.0 112.615 179.016 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.6 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 86.5 mtm-85 -81.23 -31.1 33.99 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-O 121.005 0.431 . . . . 0.0 110.185 179.687 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.485 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -50.56 142.07 16.37 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 115.745 -0.662 . . . . 0.0 112.39 -177.979 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.477 HD13 ' CZ ' ' A' ' 38' ' ' ARG . 38.8 mm -65.67 -43.65 93.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.276 0.56 . . . . 0.0 109.492 179.087 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.3 tp10 -57.8 -19.38 28.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.973 -179.637 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 34.9 m -59.69 130.9 49.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.42 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.428 ' OD2' ' O ' ' A' ' 26' ' ' THR . 54.6 m-20 -60.78 -33.83 73.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.838 -179.351 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.713 HD12 ' CE2' ' A' ' 29' ' ' PHE . 89.7 mt -127.84 120.66 54.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 177.48 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.477 ' CZ ' HD13 ' A' ' 33' ' ' ILE . 81.4 mtp180 -103.12 137.02 41.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.824 -178.722 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 98.4 mt -118.26 127.55 75.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.805 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -73.16 31.92 0.07 Allowed 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -177.405 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.872 HD21 ' OE1' ' B' ' 260' ' ' GLU . 88.2 mt -108.45 132.09 21.34 Favored Pre-proline 0 C--N 1.325 -0.482 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.012 179.657 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.37 -9.79 23.38 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.459 2.106 . . . . 0.0 112.797 179.742 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.2 m -95.03 2.62 9.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.512 -0.475 . . . . 0.0 109.801 179.51 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.6 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 21.0 t -88.57 131.6 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.602 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.632 ' OG ' ' N ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -66.42 167.48 10.57 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.325 0.583 . . . . 0.0 111.798 -177.897 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -61.37 -45.84 92.68 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.423 -178.746 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.622 ' O ' ' N ' ' A' ' 49' ' ' CYS . 86.1 mt-30 -113.62 -15.71 12.47 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.557 178.825 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.632 ' N ' ' OG ' ' A' ' 45' ' ' SER . 16.8 t60 34.93 -76.61 0.0 OUTLIER 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.067 -0.969 . . . . 0.0 113.604 179.765 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.622 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -129.56 134.41 47.72 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.367 0.603 . . . . 0.0 112.294 -178.433 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -125.67 132.23 52.46 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.845 178.67 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.2 mt -116.46 134.26 60.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.927 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -117.83 122.97 44.78 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.562 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.688 HG21 ' NH2' ' A' ' 5' ' ' ARG . 72.7 mt -105.27 115.8 47.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.419 0.628 . . . . 0.0 111.476 -178.861 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.46 ' O ' ' N ' ' A' ' 56' ' ' GLN . 87.2 m-70 -114.79 144.86 42.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.816 -1.083 . . . . 0.0 109.868 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.8 mm-40 -40.84 -27.15 0.05 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.07 0.462 . . . . 0.0 110.156 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.46 ' N ' ' O ' ' A' ' 54' ' ' HIS . 86.9 mm-40 -68.96 -67.61 0.46 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.151 179.094 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -158.99 -166.37 1.83 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.37 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.34 129.35 55.77 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.195 -179.853 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 90.0 mt -120.48 130.18 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 121.166 0.508 . . . . 0.0 112.338 -178.85 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.412 ' HB2' HD11 ' A' ' 82' ' ' LEU . 36.0 tp -97.71 129.25 44.77 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.156 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -114.61 136.41 53.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.206 179.677 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -97.42 104.87 16.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.97 0.414 . . . . 0.0 111.614 -179.613 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -94.2 -10.5 32.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.68 178.971 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.8 t -76.95 102.94 6.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.225 179.237 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 88.8 p -86.76 -8.7 57.13 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.574 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.82 HG22 HG22 ' B' ' 236' ' ' VAL . 0.2 OUTLIER -95.84 -37.91 10.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.117 0.484 . . . . 0.0 110.019 179.966 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -146.2 95.57 4.71 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.961 179.879 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.0 148.57 76.03 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 122.363 2.042 . . . . 0.0 112.526 -179.652 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 57.1 m -70.29 141.23 52.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.469 179.197 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -98.53 146.71 25.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.562 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.754 ' HB ' HD11 ' A' ' 76' ' ' ILE . 6.1 p -130.55 135.99 59.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.2 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 48.3 32.37 3.14 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 -179.694 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.12 29.57 62.34 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 111.414 -0.674 . . . . 0.0 111.414 -179.836 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.415 ' N ' ' O ' ' A' ' 71' ' ' VAL . 15.0 m -138.87 136.32 35.43 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.817 0.308 . . . . 0.0 111.052 -179.62 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.8 p -64.38 143.81 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 120.931 0.396 . . . . 0.0 111.835 -179.194 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.754 HD11 ' HB ' ' A' ' 71' ' ' VAL . 95.5 mt -107.64 103.51 15.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.036 179.672 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -64.58 -41.84 96.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.519 179.082 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.527 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.4 OUTLIER -137.38 -177.46 0.71 Allowed Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.456 -178.362 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.506 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 35.7 Cg_exo -58.69 145.71 94.71 Favored 'Trans proline' 0 N--CA 1.5 1.885 0 C-N-CA 122.838 2.359 . . . . 0.0 112.779 -179.598 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.3 m -144.48 147.25 19.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.556 179.808 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -77.53 131.82 38.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.807 178.99 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.412 HD11 ' HB2' ' A' ' 60' ' ' LEU . 96.0 mt -84.76 140.52 31.19 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.08 0.467 . . . . 0.0 111.482 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -129.32 151.36 50.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.646 179.58 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.426 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 5.2 t60 -54.42 120.87 7.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.482 -179.656 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.82 -13.8 41.66 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 -179.269 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.513 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 55.1 t0 -70.05 126.38 29.53 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.363 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 71.4 t -103.88 135.02 43.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.625 -178.998 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 84.7 mt -103.91 129.52 55.92 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.769 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 87.5 m -124.53 124.69 42.81 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 119.861 -0.736 . . . . 0.0 112.675 -178.269 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.582 ' O ' ' N ' ' A' ' 93' ' ' ARG . 98.4 mt -111.93 131.54 63.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 114.697 -1.138 . . . . 0.0 107.944 177.942 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.671 HD13 ' HB2' ' B' ' 237' ' ' CYS . 66.0 mt -21.9 97.61 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.585 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.502 ' CG ' ' NE ' ' B' ' 245' ' ' ARG . 3.3 m-20 89.2 -24.9 0.08 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 178.098 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.614 ' NH2' ' O ' ' A' ' 10' ' ' ILE . 6.2 mmm180 -124.15 140.05 53.34 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.532 -179.288 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.498 ' HB3' HD12 ' A' ' 10' ' ' ILE . 46.0 t -141.22 151.59 43.89 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.768 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -128.24 123.14 33.44 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.267 179.323 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -80.08 134.09 36.16 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.289 179.22 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -94.83 123.69 38.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.669 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.404 ' HG3' ' CE1' ' A' ' 84' ' ' HIS . 79.5 tt0 -124.63 122.19 36.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.785 -179.874 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.426 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 59.9 t-20 -106.52 104.18 13.81 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.038 179.61 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 . . . . . 0 C--N 1.328 -0.341 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.035 179.795 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.766 0.317 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -86.48 120.2 27.55 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.64 -179.765 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -126.19 45.78 2.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.401 -179.496 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -116.94 -174.57 17.21 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 121.061 -0.59 . . . . 0.0 111.736 -179.458 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.11 162.04 41.75 Favored 'Trans proline' 0 N--CA 1.497 1.678 0 C-N-CA 123.712 2.941 . . . . 0.0 113.002 -179.739 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.471 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.78 147.71 56.89 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.081 1.854 . . . . 0.0 113.759 -179.404 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.82 HG22 HG22 ' A' ' 66' ' ' THR . 19.0 t -78.21 131.5 34.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.019 179.968 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 237' ' ' CYS . . . . . 0.671 ' HB2' HD13 ' A' ' 91' ' ' ILE . 3.3 t -60.35 126.41 27.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.807 0.337 . . . . 0.0 111.268 -179.353 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 238' ' ' TPO . . . . . 0.531 ' P ' ' OG1' ' B' ' 240' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -60.75 -23.53 76.58 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.813 2.342 . . . . 0.0 113.306 -179.171 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 240' ' ' THR . . . . . 0.531 ' OG1' ' P ' ' B' ' 238' ' ' TPO . 6.7 p -77.29 -38.25 51.15 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 120.187 -0.605 . . . . 0.0 109.528 177.94 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -58.63 -45.47 89.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.327 179.78 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.588 HD23 ' HE ' ' B' ' 245' ' ' ARG . 95.3 mt -62.6 -41.54 99.03 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 121.161 0.505 . . . . 0.0 110.537 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -67.9 -38.4 82.92 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.571 -179.645 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -61.12 -48.02 83.57 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.502 -178.593 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.588 ' HE ' HD23 ' B' ' 242' ' ' LEU . 52.0 ptt85 -64.64 -37.37 87.36 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.613 -179.303 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -61.21 -39.72 91.28 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.294 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 14.0 t -66.75 -42.3 86.42 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.364 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -58.07 -39.88 79.6 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.853 179.674 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.447 ' HA ' HD12 ' B' ' 252' ' ' LEU . 42.9 t -59.64 -45.42 94.29 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.21 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.918 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -63.35 -23.64 67.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.056 178.941 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -87.66 -12.74 44.56 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.821 -179.624 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.447 HD12 ' HA ' ' B' ' 249' ' ' VAL . 78.1 mt -71.16 148.34 47.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.129 0.49 . . . . 0.0 110.645 179.364 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -173.02 39.25 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.687 179.751 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 254' ' ' ASP . . . . . 0.549 ' O ' ' CB ' ' B' ' 255' ' ' ASP . 46.5 p-10 -99.03 -3.03 35.76 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.067 179.109 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 255' ' ' ASP . . . . . 0.579 ' O ' ' CB ' ' B' ' 256' ' ' ASP . 48.2 p-10 129.51 -25.67 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.792 0 O-C-N 124.668 1.23 . . . . 0.0 109.936 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.579 ' CB ' ' O ' ' B' ' 255' ' ' ASP . 28.2 t0 105.01 13.34 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 O-C-N 124.157 0.91 . . . . 0.0 110.726 -179.815 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -108.71 161.0 15.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.117 179.784 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 64.04 55.44 1.54 Allowed 'General case' 0 C--O 1.231 0.126 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.553 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.579 ' CG ' ' H ' ' B' ' 260' ' ' GLU . 17.1 p-10 -65.76 -99.4 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.639 -179.0 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.872 ' OE1' HD21 ' A' ' 41' ' ' LEU . 97.6 mt-10 -145.05 16.88 1.57 Allowed 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 121.079 -0.248 . . . . 0.0 110.84 -179.66 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 47.6 mt -115.37 137.92 47.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -179.555 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 55.3 t -127.23 133.93 67.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.897 179.223 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -97.31 122.6 40.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.051 0.453 . . . . 0.0 111.348 -178.411 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -66.18 -44.08 85.04 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.359 179.568 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 265' ' ' GLN . . . . . 0.625 ' CD ' HD11 ' A' ' 24' ' ' LEU . 1.5 mt-30 -99.87 170.0 7.32 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.554 -178.723 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.77 154.56 67.56 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.414 2.076 . . . . 0.0 112.017 -179.83 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 45.0 pt . . . . . 0 C--N 1.328 -0.362 0 CA-C-O 121.484 0.659 . . . . 0.0 111.936 -179.147 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo . . . . . 0 N--CA 1.494 1.516 0 CA-C-O 120.678 0.199 . . . . 0.0 111.996 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.417 HG23 ' O ' ' A' ' 100' ' ' GLU . 37.1 m -99.42 -43.16 6.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.017 0.437 . . . . 0.0 110.667 179.227 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.58 ' NH1' ' HB2' ' A' ' 58' ' ' ALA . 95.9 mtt-85 -90.76 125.4 35.69 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.749 -178.425 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -134.73 143.93 47.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.871 -179.243 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.717 HD11 HD11 ' A' ' 22' ' ' LEU . 73.1 mt -116.75 142.06 47.41 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.775 179.667 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.7 t -117.19 128.31 74.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.968 0.413 . . . . 0.0 110.279 179.536 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.2 m -74.68 140.8 44.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.354 0.597 . . . . 0.0 112.325 -179.187 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.631 HD12 ' OG ' ' A' ' 94' ' ' SER . 90.0 mt -112.47 134.06 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.838 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.415 ' NZ ' ' HA ' ' B' ' 257' ' ' LYS . 97.3 mttt -91.6 158.08 16.63 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.193 0.52 . . . . 0.0 111.77 -179.311 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.855 ' NH2' HD23 ' B' ' 252' ' ' LEU . 86.4 mtm180 -58.21 -30.99 66.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.505 -178.952 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.5 p -78.15 -10.2 59.52 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.601 178.96 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.81 36.17 7.42 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 179.951 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.5 t -118.07 132.74 67.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.01 0.433 . . . . 0.0 111.579 -179.615 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -73.22 128.86 36.68 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.003 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -125.45 -120.68 2.46 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 120.139 -1.029 . . . . 0.0 112.709 -178.797 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -72.01 146.67 47.53 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 122.242 1.962 . . . . 0.0 112.517 -178.202 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -108.71 147.33 32.11 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.94 179.372 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.526 ' CD2' HD11 ' A' ' 37' ' ' ILE . 29.3 t80 -116.87 102.8 52.87 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.578 -179.375 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.61 133.84 17.75 Favored 'Trans proline' 0 N--CA 1.486 1.049 0 C-N-CA 121.122 1.215 . . . . 0.0 110.504 -179.357 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.717 HD11 HD11 ' A' ' 7' ' ' LEU . 92.3 mt -87.64 62.87 7.27 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.723 -177.822 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 80.6 p -70.71 -21.0 62.61 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 177.79 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.698 HD11 ' HG2' ' B' ' 265' ' ' GLN . 71.0 mt -85.03 138.34 32.5 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.339 -179.61 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -62.4 -20.9 64.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.612 -179.12 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.1 m -134.17 135.49 43.11 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.821 -179.827 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.661 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -129.88 122.92 29.57 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.187 178.883 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.531 HD21 ' OE1' ' A' ' 47' ' ' GLN . 35.0 tp -120.98 126.8 50.87 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.7 -178.688 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.661 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 36.3 m-85 -99.74 127.16 45.88 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.134 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -176.39 -156.16 14.77 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.499 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -115.46 -17.67 11.17 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 117.174 0.487 . . . . 0.0 110.415 179.13 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.23 161.88 47.35 Favored Glycine 0 CA--C 1.519 0.337 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -179.656 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.526 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.8 tp -66.04 -41.63 90.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.408 179.585 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.526 ' N ' HG23 ' A' ' 33' ' ' ILE . 15.0 pt-20 -56.86 -22.77 39.41 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.801 -179.727 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.7 m -63.23 126.3 26.96 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.874 0.369 . . . . 0.0 110.706 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.611 ' OD1' ' N ' ' A' ' 37' ' ' ILE . 11.0 p-10 -61.97 -28.89 69.87 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.096 -179.316 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.611 ' N ' ' OD1' ' A' ' 36' ' ' ASP . 97.5 mt -130.55 122.42 52.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 177.724 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 75.0 mtm180 -103.82 136.24 43.88 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.198 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.572 HG21 HD12 ' A' ' 41' ' ' LEU . 97.2 mt -117.66 129.23 74.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.857 179.748 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -70.52 32.4 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.814 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.58 HD23 ' NH2' ' B' ' 245' ' ' ARG . 43.4 mt -110.33 121.77 40.52 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 120.446 -0.502 . . . . 0.0 109.668 179.043 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.02 -1.47 10.92 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.244 1.963 . . . . 0.0 112.351 -178.809 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.433 HG23 HG13 ' A' ' 91' ' ' ILE . 18.3 m -99.2 6.73 9.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.323 179.813 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.499 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 29.6 t -89.96 133.94 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.25 178.797 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.479 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 0.6 OUTLIER -67.04 159.56 28.43 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.02 0.438 . . . . 0.0 110.551 179.514 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -61.77 -39.16 90.67 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.273 -178.817 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.606 ' O ' ' N ' ' A' ' 49' ' ' CYS . 96.3 mm-40 -111.53 -18.22 12.88 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.46 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.479 ' H ' ' HB3' ' A' ' 45' ' ' SER . 19.4 t60 29.96 -78.85 0.0 OUTLIER 'General case' 0 C--O 1.236 0.377 0 CA-C-N 114.716 -1.129 . . . . 0.0 113.124 -179.683 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.606 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -129.47 134.21 47.69 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.914 -179.342 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -125.66 128.49 47.91 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.223 179.364 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 93.0 mt -114.54 133.31 61.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.787 -179.849 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -113.27 133.68 54.98 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.807 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.562 HD12 ' CD ' ' A' ' 5' ' ' ARG . 47.9 mm -103.14 114.5 42.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.558 -179.462 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.44 ' O ' ' C ' ' A' ' 55' ' ' GLU . 95.0 m-70 -115.47 132.8 56.51 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.473 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 54' ' ' HIS . 95.4 mt-10 -40.47 -34.13 0.32 Allowed 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 121.195 0.522 . . . . 0.0 109.92 -178.673 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -62.75 -67.32 0.43 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.233 179.418 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -152.43 -164.38 1.94 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.333 -179.63 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.58 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -127.28 131.18 50.56 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.011 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 91.7 mt -112.32 129.9 67.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.255 0.55 . . . . 0.0 112.205 -178.237 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.548 ' HB2' HD21 ' A' ' 82' ' ' LEU . 44.3 tp -94.46 120.22 34.37 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.224 179.028 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -107.85 135.05 49.9 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.962 0.41 . . . . 0.0 111.336 -178.823 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -96.14 104.91 16.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.246 179.627 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -99.31 -10.84 21.82 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.614 179.549 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.4 t -69.61 100.87 1.52 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.538 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.9 p -85.01 -15.96 42.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.038 0.447 . . . . 0.0 109.924 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.586 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -90.24 -46.13 8.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.752 -179.852 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.459 HD21 ' HA ' ' B' ' 236' ' ' VAL . 65.5 m-20 -135.08 97.71 13.38 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.283 -0.872 . . . . 0.0 109.456 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.502 ' HB2' HG13 ' A' ' 75' ' ' VAL . 41.2 Cg_exo -56.74 144.64 86.22 Favored 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 122.501 2.134 . . . . 0.0 113.612 -178.838 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.0 m -75.36 140.39 43.0 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.264 178.756 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -104.3 141.42 36.34 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.321 179.938 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.641 HG13 ' OD1' ' A' ' 86' ' ' ASP . 53.0 t -131.92 135.29 58.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.739 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 51.92 31.96 9.26 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -178.399 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.31 27.48 69.79 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.095 -179.924 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.5 p -140.39 140.83 35.57 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 117.608 0.704 . . . . 0.0 111.696 179.776 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.502 HG13 ' HB2' ' A' ' 68' ' ' PRO . 41.5 t -68.87 135.83 27.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.041 179.451 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.478 HG21 HG21 ' A' ' 80' ' ' VAL . 7.4 pt -113.34 82.22 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.974 0.416 . . . . 0.0 110.696 178.588 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -61.62 -24.69 66.87 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.441 179.885 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -118.79 167.36 11.88 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.997 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -62.46 145.54 95.6 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 122.386 2.058 . . . . 0.0 112.568 179.63 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.478 HG21 HG21 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -139.34 140.01 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 120.822 0.344 . . . . 0.0 110.996 179.291 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -74.77 133.18 42.01 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.456 179.519 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.548 HD21 ' HB2' ' A' ' 60' ' ' LEU . 95.6 mt -79.23 134.9 36.66 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.196 0.522 . . . . 0.0 110.92 -179.596 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -129.52 150.18 50.98 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.385 179.479 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -52.32 113.63 1.1 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.501 -179.852 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.29 -11.16 19.69 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.641 ' OD1' HG13 ' A' ' 71' ' ' VAL . 52.4 t0 -68.96 123.6 21.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.205 0.526 . . . . 0.0 110.998 -179.713 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.6 t -108.94 130.89 61.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.71 -179.572 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 83.9 mt -104.46 133.2 49.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.726 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 82.8 m -120.61 129.45 53.74 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.6 0.714 . . . . 0.0 112.491 -178.53 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.464 ' O ' ' N ' ' A' ' 93' ' ' ARG . 89.5 mt -121.13 122.59 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 114.501 -1.227 . . . . 0.0 108.1 178.235 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.433 HG13 HG23 ' A' ' 43' ' ' VAL . 36.8 mm 40.73 -112.45 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.016 -178.831 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.42 ' OD1' HD22 ' B' ' 242' ' ' LEU . 97.6 m-20 -103.16 10.88 37.62 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.544 0.211 . . . . 0.0 111.05 179.079 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.673 ' CZ ' HD11 ' B' ' 261' ' ' ILE . 6.5 mmm180 -120.76 143.97 48.53 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.674 -179.123 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.631 ' OG ' HD12 ' A' ' 10' ' ' ILE . 39.1 p -142.26 155.76 45.25 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.904 0.383 . . . . 0.0 110.838 -179.96 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -128.0 124.99 38.56 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.273 179.35 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -86.95 133.67 33.57 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.505 0.193 . . . . 0.0 110.827 -179.737 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.54 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 69.6 t80 -93.96 123.79 37.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.893 179.886 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -123.85 128.83 50.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.42 -179.923 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -103.53 106.62 17.18 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.147 178.992 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.417 ' O ' HG23 ' A' ' 4' ' ' THR . 81.6 tt0 . . . . . 0 C--N 1.331 -0.231 0 CA-C-O 120.819 0.342 . . . . 0.0 110.877 -179.934 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 228' ' ' VAL . . . . . 0.79 ' C ' ' H2 ' ' B' ' 230' ' ' SEP . 55.3 t . . . . . 0 CA--C 1.533 0.297 0 CA-C-O 120.743 0.306 . . . . 0.0 111.445 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.434 ' C ' ' H ' ' B' ' 231' ' ' GLN . 93.8 m-20 41.8 13.11 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 179.542 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 230' ' ' SEP . . . . . 0.79 ' H2 ' ' C ' ' B' ' 228' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.515 ' O ' ' O ' ' B' ' 232' ' ' GLY . 7.6 mt-30 -120.46 -10.9 9.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.183 0.516 . . . . 0.0 110.648 -179.866 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 232' ' ' GLY . . . . . 0.515 ' O ' ' O ' ' B' ' 231' ' ' GLN . . . -39.91 -179.34 0.01 OUTLIER Glycine 0 CA--C 1.533 1.18 0 CA-C-N 115.097 -0.956 . . . . 0.0 113.901 -178.419 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.66 162.02 42.4 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 124.344 3.363 . . . . 0.0 112.62 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.416 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -65.99 135.57 41.36 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 121.66 1.574 . . . . 0.0 112.784 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.586 ' CG2' HG22 ' A' ' 66' ' ' THR . 27.8 t -72.08 137.29 23.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.782 -179.771 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 8.0 t -69.06 127.38 32.9 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.175 -179.628 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -56.67 -25.53 60.4 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 122.378 2.052 . . . . 0.0 112.51 179.626 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 99.8 m -73.04 -45.16 59.13 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.714 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -55.17 -45.31 75.74 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.875 -179.575 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.42 HD22 ' OD1' ' A' ' 92' ' ' ASP . 89.6 mt -63.11 -42.6 99.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.791 -179.185 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -65.3 -42.18 93.32 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.368 -179.024 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -61.98 -44.88 95.8 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.167 0.508 . . . . 0.0 110.509 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.76 HH11 HH11 ' A' ' 12' ' ' ARG . 49.5 ttm-85 -64.78 -41.49 95.81 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.682 -179.345 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -60.74 -38.17 84.26 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.708 0.29 . . . . 0.0 110.532 179.398 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 88.3 p -69.29 -40.56 77.65 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.528 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -58.64 -37.53 76.13 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.66 178.78 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.517 ' O ' ' O ' ' B' ' 252' ' ' LEU . 54.1 t -63.96 -45.79 95.85 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.262 178.824 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -56.08 -24.14 38.17 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.055 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -98.65 -8.81 25.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.075 179.493 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.855 HD23 ' NH2' ' A' ' 12' ' ' ARG . 61.8 tp -125.54 116.53 21.91 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.448 177.886 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -179.66 15.08 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 119.66 -0.816 . . . . 0.0 112.879 179.474 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 254' ' ' ASP . . . . . 0.401 ' O ' ' CB ' ' B' ' 255' ' ' ASP . 38.8 t70 -61.19 -44.67 96.91 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 178.827 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 255' ' ' ASP . . . . . 0.471 ' O ' ' CG ' ' B' ' 255' ' ' ASP . 1.3 t70 164.56 69.8 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.589 -1.187 . . . . 0.0 108.632 179.921 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.645 ' OD2' HD21 ' B' ' 252' ' ' LEU . 51.5 t0 -86.19 81.45 8.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.697 -179.515 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 257' ' ' LYS . . . . . 0.415 ' HA ' ' NZ ' ' A' ' 11' ' ' LYS . 99.0 mttt -65.11 -9.42 22.5 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.059 -178.292 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.658 ' O ' ' N ' ' B' ' 260' ' ' GLU . 17.8 p-10 -114.66 16.26 17.53 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.363 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.587 ' O ' ' NH1' ' A' ' 93' ' ' ARG . 39.4 t0 -24.58 76.23 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 114.404 -1.271 . . . . 0.0 113.045 -179.106 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.658 ' N ' ' O ' ' B' ' 258' ' ' ASP . 47.4 mm-40 59.46 6.44 0.79 Allowed 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 177.606 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.673 HD11 ' CZ ' ' A' ' 93' ' ' ARG . 2.7 mm -114.05 133.28 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-N 119.334 0.97 . . . . 0.0 110.223 178.854 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 52.6 t -126.5 133.23 69.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.159 178.894 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -100.41 122.02 42.47 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.191 0.52 . . . . 0.0 111.266 -178.637 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -63.3 -47.62 81.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.222 179.432 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 265' ' ' GLN . . . . . 0.698 ' HG2' HD11 ' A' ' 24' ' ' LEU . 4.1 mp0 -96.47 161.57 26.38 Favored Pre-proline 0 N--CA 1.453 -0.314 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.474 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.98 150.18 37.87 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 123.035 2.49 . . . . 0.0 112.585 -178.877 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 28.5 pt . . . . . 0 C--N 1.325 -0.497 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.248 178.926 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo . . . . . 0 N--CA 1.5 1.865 0 CA-C-O 120.86 0.275 . . . . 0.0 112.709 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.8 p -113.49 -30.63 6.79 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.108 179.14 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.803 ' NH1' ' HB2' ' A' ' 58' ' ' ALA . 94.6 mtt-85 -98.02 113.53 25.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.136 -179.585 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -127.62 138.18 52.77 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.92 0.39 . . . . 0.0 111.331 -179.711 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.527 HD12 ' O ' ' A' ' 96' ' ' ARG . 42.3 tp -117.41 129.94 56.17 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.586 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.1 t -106.15 130.8 57.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.911 -179.536 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 m -92.2 114.81 27.45 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.253 -179.635 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.2 mt -80.96 145.66 8.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.516 179.359 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -88.13 161.69 17.16 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.076 0.465 . . . . 0.0 111.169 -179.866 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.708 HH11 ' NH2' ' A' ' 93' ' ' ARG . 58.0 mtp85 -55.21 -32.59 62.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.458 -179.445 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 42.9 t -80.74 -6.67 58.77 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.859 179.502 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.57 33.86 12.72 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -179.527 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.8 t -114.16 132.75 62.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.724 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 63.0 t0 -65.31 120.69 13.23 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.865 -179.448 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -107.88 -133.56 7.12 Favored Glycine 0 CA--C 1.536 1.366 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 -179.279 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.73 149.88 49.26 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 122.106 1.87 . . . . 0.0 112.341 -179.21 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -105.78 139.23 40.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.891 0.377 . . . . 0.0 109.991 179.493 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.775 ' CD2' HD11 ' A' ' 37' ' ' ILE . 24.6 t80 -111.45 103.5 55.1 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.684 -179.614 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.69 132.16 16.91 Favored 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 121.437 1.425 . . . . 0.0 111.972 -179.216 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 75.5 mt -87.5 45.98 1.33 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.887 -178.728 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 79.2 p -65.22 -17.82 64.81 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.276 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.5 mt -81.38 143.0 32.48 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.27 178.518 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.0 t -64.8 -23.65 67.3 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -178.872 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 66.3 m -135.03 136.87 42.44 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.56 -179.505 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.8 t -130.02 121.78 27.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.066 178.924 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.443 HD21 ' NE2' ' A' ' 47' ' ' GLN . 59.6 tp -116.78 127.65 54.54 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.579 -179.269 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.671 ' CE2' HD12 ' A' ' 37' ' ' ILE . 7.6 m-85 -104.86 141.3 36.77 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.291 178.915 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 156.33 -174.24 34.15 Favored Glycine 0 N--CA 1.469 0.867 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.415 178.922 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.636 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 83.2 mtm-85 -78.62 -29.3 45.86 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.168 179.56 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.553 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -54.47 148.98 19.94 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.643 -178.759 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.509 HG23 ' N ' ' A' ' 34' ' ' GLU . 11.1 tp -67.78 -40.81 84.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.084 0.469 . . . . 0.0 110.023 179.512 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.509 ' N ' HG23 ' A' ' 33' ' ' ILE . 80.1 mm-40 -54.4 -21.8 10.69 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.773 179.546 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.553 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 58.8 m -55.64 118.62 4.68 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.93 179.553 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -55.89 -29.69 60.38 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 179.936 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.775 HD11 ' CD2' ' A' ' 20' ' ' PHE . 73.0 mt -128.48 120.55 53.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.36 176.226 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 78.2 ttt-85 -108.35 137.26 46.61 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.602 -177.898 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.786 HG21 HD12 ' A' ' 41' ' ' LEU . 96.2 mt -121.45 132.09 71.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.4 -179.54 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -80.94 32.21 0.32 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -177.962 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.786 HD12 HG21 ' A' ' 39' ' ' ILE . 16.4 mt -97.2 133.54 23.87 Favored Pre-proline 0 C--N 1.32 -0.691 0 C-N-CA 120.049 -0.661 . . . . 0.0 110.711 -179.938 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.12 -10.41 25.88 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 122.364 2.043 . . . . 0.0 112.221 -179.746 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.556 HG21 ' CE2' ' B' ' 241' ' ' PHE . 32.2 m -105.47 4.05 10.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.269 -179.384 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.636 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 17.4 t -88.77 131.15 36.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 177.714 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.77 163.16 19.87 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.082 0.467 . . . . 0.0 110.812 -178.858 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -61.38 -40.9 96.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.013 -178.8 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.608 ' O ' ' N ' ' A' ' 49' ' ' CYS . 12.3 mm100 -110.31 -17.0 13.6 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 123.573 0.546 . . . . 0.0 110.299 -179.852 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 21.7 t60 33.09 -75.73 0.0 OUTLIER 'General case' 0 C--O 1.239 0.525 0 CA-C-N 114.943 -1.026 . . . . 0.0 113.634 -179.601 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.608 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -135.48 139.77 44.3 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -178.299 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -127.57 133.52 49.76 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.633 179.707 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.0 mt -119.04 134.14 63.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.082 -179.855 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -116.63 127.75 54.75 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.065 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.3 mt -109.46 111.52 36.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.473 0.654 . . . . 0.0 111.218 -179.756 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.548 ' O ' ' N ' ' A' ' 56' ' ' GLN . 94.8 m-70 -110.51 143.18 41.25 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.801 -1.09 . . . . 0.0 108.984 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.557 ' OE1' ' N ' ' A' ' 55' ' ' GLU . 55.1 mp0 -40.65 -24.44 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.853 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.548 ' N ' ' O ' ' A' ' 54' ' ' HIS . 88.8 mm-40 -68.16 -69.26 0.33 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.07 179.044 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.445 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 5.5 tp10 -158.91 -168.31 2.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.987 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.803 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -109.73 126.09 53.36 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.099 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.29 130.25 70.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.467 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.497 ' HB2' HD21 ' A' ' 82' ' ' LEU . 26.6 tp -98.66 130.21 45.16 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.429 179.724 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -117.47 137.65 52.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.857 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.58 HD21 ' CB ' ' A' ' 68' ' ' PRO . 64.1 t-20 -98.08 104.68 16.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.08 179.805 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -96.27 -7.28 35.88 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.864 179.342 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.38 100.81 10.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.984 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.1 m -87.08 -37.69 17.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.677 179.75 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.583 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -61.08 -44.11 97.86 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.418 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -141.23 101.23 6.24 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.119 179.415 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.58 ' CB ' HD21 ' A' ' 62' ' ' ASN . 44.5 Cg_endo -67.76 152.32 77.76 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 121.676 1.584 . . . . 0.0 113.602 -178.242 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.5 m -77.38 149.11 35.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.775 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -111.99 140.53 46.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.345 179.404 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.5 t -128.5 136.32 60.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.598 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 53.65 32.97 15.52 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.225 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.98 25.93 74.88 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.437 -179.759 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 66.7 m -141.14 141.78 34.12 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 117.114 0.457 . . . . 0.0 111.856 -179.564 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 75.2 t -67.91 139.14 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.687 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 9.2 pt -111.2 82.63 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-O 121.126 0.488 . . . . 0.0 111.049 178.55 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -62.56 -32.79 73.82 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.98 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -113.95 156.95 43.21 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.834 178.676 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.6 152.39 80.55 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.18 1.92 . . . . 0.0 111.582 178.928 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.1 m -146.89 149.0 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 121.28 0.562 . . . . 0.0 112.03 179.89 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -72.4 133.68 45.02 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.871 179.678 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.497 HD21 ' HB2' ' A' ' 60' ' ' LEU . 96.4 mt -77.26 137.94 39.11 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.098 0.475 . . . . 0.0 110.767 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -128.56 147.12 50.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.514 179.535 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.523 ' HD1' ' C ' ' A' ' 99' ' ' ASN . 6.8 t60 -56.06 118.99 5.17 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.579 -179.525 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.27 -20.04 23.9 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -179.801 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -66.44 131.18 45.49 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.595 179.305 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.6 t -114.86 131.35 67.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.159 -178.501 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 84.6 mt -95.05 133.75 34.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.725 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.0 m -120.7 128.38 52.9 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.62 0.724 . . . . 0.0 112.574 -178.833 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.543 ' O ' ' N ' ' A' ' 92' ' ' ASP . 97.5 mt -115.06 123.4 70.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 114.559 -1.2 . . . . 0.0 108.664 178.54 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.457 ' CG2' ' CZ ' ' B' ' 245' ' ' ARG . 32.2 mm 38.71 -93.25 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.35 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.78 ' H ' ' NH1' ' B' ' 245' ' ' ARG . 16.9 t0 -125.97 20.16 7.68 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.011 0.434 . . . . 0.0 110.86 179.139 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.754 ' CZ ' HD11 ' A' ' 41' ' ' LEU . 75.5 mtt85 -124.85 142.57 51.35 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.351 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 30.2 p -139.61 154.73 47.64 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.96 179.763 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.505 ' HE1' HD12 ' A' ' 90' ' ' ILE . 17.1 m-85 -125.16 121.96 35.72 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.035 179.54 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.527 ' O ' HD12 ' A' ' 7' ' ' LEU . 39.1 ttp-105 -85.08 130.67 34.57 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.125 -0.63 . . . . 0.0 110.713 -179.256 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.63 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 87.7 t80 -94.66 123.67 38.24 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.962 -179.556 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -121.41 122.88 40.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.962 179.647 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.523 ' C ' ' HD1' ' A' ' 84' ' ' HIS . 54.7 t-20 -117.72 110.8 18.29 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.976 179.001 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 . . . . . 0 C--N 1.328 -0.368 0 CA-C-O 121.008 0.432 . . . . 0.0 110.763 -179.241 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 29.0 m . . . . . 0 N--CA 1.455 -0.223 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.468 ' C ' ' H ' ' B' ' 231' ' ' GLN . 88.6 m-20 -68.11 142.24 55.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.112 -179.545 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.468 ' H ' ' C ' ' B' ' 229' ' ' ASP . 75.8 mt-30 -127.81 26.49 5.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.255 -179.631 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -114.32 -157.12 11.85 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 120.711 -0.756 . . . . 0.0 111.818 -178.882 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.78 151.27 71.93 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 123.755 2.97 . . . . 0.0 113.555 -179.294 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.495 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.91 141.84 49.96 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.14 1.893 . . . . 0.0 113.997 -178.183 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.583 ' CG2' HG22 ' A' ' 66' ' ' THR . 39.4 t -76.0 133.62 30.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 114.781 -1.1 . . . . 0.0 110.998 -179.454 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 7.6 t -75.31 129.58 37.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.675 179.367 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -56.13 -27.6 66.09 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 122.889 2.393 . . . . 0.0 112.671 -179.643 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 97.2 m -74.08 -42.52 60.04 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.857 0.361 . . . . 0.0 110.161 178.664 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.556 ' CE2' HG21 ' A' ' 43' ' ' VAL . 64.1 t80 -58.02 -45.75 86.41 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -179.54 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 87.2 mt -62.61 -40.86 98.3 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.177 179.964 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -61.52 -39.72 92.04 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.713 179.609 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 244' ' ' ARG . . . . . 0.45 ' HE ' ' HA ' ' B' ' 241' ' ' PHE . 88.7 mtm180 -62.08 -40.38 95.62 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.77 179.69 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.78 ' NH1' ' H ' ' A' ' 92' ' ' ASP . 89.4 mtt180 -60.1 -42.48 94.79 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.224 179.084 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -64.23 -42.79 96.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.016 0.436 . . . . 0.0 110.488 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 35.8 p -63.86 -44.86 91.85 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.73 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -58.58 -40.29 82.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.965 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.489 HG23 ' O ' ' B' ' 245' ' ' ARG . 55.3 t -62.09 -44.0 98.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.267 -179.885 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -64.34 -33.77 76.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.677 178.837 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -76.26 -13.13 60.17 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.839 179.191 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 67.5 mt -104.23 -178.39 3.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.128 178.988 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -118.95 151.21 38.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.795 179.699 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -65.18 -20.0 66.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.887 -179.641 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 42.0 p-10 -82.64 18.94 1.39 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.762 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -70.53 93.78 0.93 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.403 0.62 . . . . 0.0 111.066 -179.289 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -66.18 -31.28 72.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.01 -0.995 . . . . 0.0 112.564 179.962 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -103.57 129.66 50.84 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.995 0.426 . . . . 0.0 110.908 -179.766 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.65 ' OD1' ' N ' ' B' ' 260' ' ' GLU . 35.7 t0 -125.3 158.97 32.85 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.555 0.693 . . . . 0.0 109.928 179.621 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.65 ' N ' ' OD1' ' B' ' 259' ' ' ASP . 94.6 mt-10 -56.84 13.02 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.684 -1.144 . . . . 0.0 112.11 -179.354 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.597 ' H ' ' C ' ' B' ' 259' ' ' ASP . 68.6 mt -108.24 132.16 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.757 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 53.4 t -128.25 134.39 65.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.805 -178.609 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -99.54 121.92 41.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.51 0.671 . . . . 0.0 111.176 -178.955 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -67.06 -44.88 79.0 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.902 178.874 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -92.76 150.63 39.91 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.706 -178.235 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.84 143.98 47.1 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 122.86 2.373 . . . . 0.0 112.581 179.999 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 33.3 pt . . . . . 0 C--N 1.33 -0.265 0 CA-C-O 121.04 0.448 . . . . 0.0 110.7 179.209 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo . . . . . 0 N--CA 1.496 1.628 0 CA-C-O 120.783 0.243 . . . . 0.0 112.564 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.2 p -122.67 -52.27 1.91 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.064 179.013 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.624 ' NH1' ' HB2' ' A' ' 58' ' ' ALA . 96.3 mtt-85 -89.47 124.5 34.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.922 -179.858 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -134.43 139.39 45.52 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.287 -0.565 . . . . 0.0 112.322 -179.342 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.445 HD11 HD11 ' A' ' 22' ' ' LEU . 75.7 mt -113.55 143.56 44.33 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.072 178.718 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.536 HG22 ' CD2' ' A' ' 19' ' ' HIS . 70.3 t -117.03 128.93 74.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.224 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.4 ' O ' HG22 ' A' ' 9' ' ' THR . 1.5 m -92.87 113.87 26.26 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.132 0.492 . . . . 0.0 112.076 -178.436 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 86.8 mt -79.19 143.86 11.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.784 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -89.54 161.6 16.12 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.223 0.535 . . . . 0.0 110.9 179.64 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.437 HH22 ' NE2' ' B' ' 248' ' ' GLN . 80.9 mtp180 -58.19 -33.41 69.23 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.802 -179.326 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.7 t -76.02 -13.11 60.23 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.706 179.218 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.39 35.05 5.83 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 -178.878 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.0 t -119.04 132.42 68.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.092 0.472 . . . . 0.0 110.966 -179.9 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.48 ' OD1' ' CG1' ' A' ' 8' ' ' VAL . 43.6 t0 -68.5 124.98 25.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.749 179.581 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -117.58 -126.41 3.72 Favored Glycine 0 CA--C 1.541 1.673 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.225 -178.916 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.29 147.88 42.76 Favored 'Trans proline' 0 N--CA 1.504 2.107 0 C-N-CA 122.741 2.294 . . . . 0.0 114.523 -177.808 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.536 ' CD2' HG22 ' A' ' 8' ' ' VAL . 60.1 m170 -104.77 144.73 31.34 Favored 'General case' 0 C--N 1.335 -0.059 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.08 179.37 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.473 ' CD2' HD11 ' A' ' 37' ' ' ILE . 72.1 t80 -121.82 105.44 37.99 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.996 -179.579 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -75.63 132.84 15.02 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 C-N-CA 121.682 1.588 . . . . 0.0 112.292 -179.14 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.445 HD11 HD11 ' A' ' 7' ' ' LEU . 89.6 mt -81.3 54.73 2.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.834 0.349 . . . . 0.0 110.935 -179.253 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.7 t -59.8 -37.58 79.53 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.877 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 66.0 mt -74.02 141.6 45.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.666 179.519 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 m -66.76 -15.23 63.41 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.075 -0.512 . . . . 0.0 112.271 -178.029 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.49 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 40.4 m -136.24 137.87 41.24 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.017 0.437 . . . . 0.0 110.724 179.504 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.668 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 4.3 t -131.58 122.87 26.81 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.908 179.65 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.501 HD21 ' HG2' ' A' ' 47' ' ' GLN . 42.4 tp -119.77 128.16 53.47 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.896 -178.98 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.668 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 14.1 m-85 -104.23 140.33 38.0 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.179 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.95 -171.79 38.81 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 119.647 -1.263 . . . . 0.0 112.764 179.1 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.623 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 85.4 mtm-85 -80.37 -28.08 38.07 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.418 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.55 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -60.68 141.22 48.06 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.3 -0.476 . . . . 0.0 112.287 -178.168 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.492 HG23 ' N ' ' A' ' 34' ' ' GLU . 11.0 tp -66.06 -41.43 89.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.095 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.492 ' N ' HG23 ' A' ' 33' ' ' ILE . 82.5 tt0 -54.52 -16.41 2.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.125 179.839 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.55 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 33.5 m -66.01 135.93 55.35 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.265 179.862 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.49 ' OD2' ' O ' ' A' ' 26' ' ' THR . 56.0 m-20 -61.42 -33.32 73.51 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.38 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.651 HD12 ' CE2' ' A' ' 29' ' ' PHE . 93.4 mt -127.66 122.46 59.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 177.17 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 76.8 ttt-85 -111.26 137.99 48.29 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.607 -178.317 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.452 HG22 ' H ' ' A' ' 41' ' ' LEU . 92.9 mt -119.11 131.87 70.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.846 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -75.13 20.69 0.13 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.686 -178.693 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.538 HD11 ' CZ ' ' A' ' 93' ' ' ARG . 22.7 mt -93.52 124.44 57.21 Favored Pre-proline 0 C--N 1.321 -0.66 0 C-N-CA 120.261 -0.575 . . . . 0.0 111.105 -179.449 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.47 -14.25 27.79 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 C-N-CA 121.901 1.734 . . . . 0.0 112.375 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 18.0 m -88.67 0.62 7.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.135 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.623 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 72.6 t -95.33 136.11 27.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.186 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.4 m -69.39 171.16 9.09 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.322 0.582 . . . . 0.0 111.699 -178.749 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -61.84 -42.11 98.63 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.671 -178.13 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.679 ' O ' ' N ' ' A' ' 49' ' ' CYS . 87.8 mt-30 -113.75 -14.99 12.51 Favored 'General case' 0 CA--C 1.521 -0.155 0 O-C-N 123.365 0.416 . . . . 0.0 110.337 179.873 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 30.1 t60 33.44 -73.11 0.0 OUTLIER 'General case' 0 C--O 1.236 0.393 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 179.654 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.679 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.68 135.35 45.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.06 0.457 . . . . 0.0 111.921 -178.649 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -123.85 128.66 49.82 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.389 179.3 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.4 mt -115.16 134.46 58.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.351 -179.686 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.453 ' CD ' ' NE2' ' A' ' 54' ' ' HIS . 83.9 tt0 -120.01 128.29 53.4 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.782 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.437 HD13 ' HD2' ' A' ' 5' ' ' ARG . 97.0 mt -108.18 118.8 56.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.471 0.653 . . . . 0.0 112.611 -178.549 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.545 ' O ' ' N ' ' A' ' 56' ' ' GLN . 99.0 m-70 -115.3 141.23 48.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.326 178.859 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.6 mm-40 -40.12 -25.94 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.906 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.545 ' N ' ' O ' ' A' ' 54' ' ' HIS . 85.9 mt-30 -65.71 -68.3 0.38 Allowed 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.2 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -159.94 -162.77 1.04 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.905 179.614 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.624 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -114.29 126.44 55.03 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.398 179.147 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.7 mt -112.68 127.9 69.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.441 0.638 . . . . 0.0 111.95 -178.923 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 40.1 tp -95.44 128.85 42.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.955 -179.74 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -115.33 135.8 53.77 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.549 -179.748 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.4 ' OD1' ' C ' ' A' ' 62' ' ' ASN . 51.1 t-20 -95.12 106.22 18.21 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.897 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -100.86 -10.05 21.05 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 179.279 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.3 t -78.85 100.61 7.26 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.269 -179.619 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.4 p -76.95 -33.84 57.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.042 0.448 . . . . 0.0 110.636 178.918 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.82 -40.65 65.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.485 -178.86 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -141.29 93.52 7.96 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.163 -179.726 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.06 145.67 51.94 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.344 2.029 . . . . 0.0 113.053 -179.488 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.2 m -72.65 139.54 47.39 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.338 179.533 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -102.89 139.77 38.03 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.662 179.641 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.648 HG13 ' OD1' ' A' ' 86' ' ' ASP . 75.3 t -133.46 134.43 56.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.097 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 54.79 26.92 8.18 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -178.397 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.53 24.13 66.05 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-N 115.039 -0.982 . . . . 0.0 112.048 179.585 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.2 t -138.48 140.4 39.2 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 117.371 0.585 . . . . 0.0 111.28 179.695 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.47 ' H ' HG12 ' A' ' 75' ' ' VAL . 0.2 OUTLIER -70.99 140.38 18.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.183 179.918 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.2 pt -115.42 91.95 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.122 179.941 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -66.87 -25.72 66.54 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.653 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.19 162.19 27.41 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.505 179.484 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.13 154.16 66.53 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.62 2.213 . . . . 0.0 112.247 179.899 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.9 m -145.65 148.62 17.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.833 -179.781 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.2 mtm-85 -75.65 134.83 40.5 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.158 179.531 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 90.0 mt -89.7 134.02 34.37 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.138 0.495 . . . . 0.0 111.161 -179.677 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -125.1 156.62 37.99 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.052 179.143 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.414 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 4.2 t60 -54.1 120.02 5.87 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.546 -0.461 . . . . 0.0 111.089 -178.701 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.07 -15.65 28.11 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 179.797 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.648 ' OD1' HG13 ' A' ' 71' ' ' VAL . 59.1 t0 -65.41 128.21 34.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.882 0.372 . . . . 0.0 110.422 179.988 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.53 HG22 ' HG2' ' A' ' 96' ' ' ARG . 53.6 t -112.13 130.93 64.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.291 -179.382 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.7 mt -101.64 134.02 43.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.383 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 76.9 m -124.33 129.22 50.34 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -178.53 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.585 ' O ' ' N ' ' A' ' 92' ' ' ASP . 95.0 mt -112.18 126.67 69.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 114.516 -1.22 . . . . 0.0 108.159 177.57 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.527 HG23 ' SG ' ' B' ' 237' ' ' CYS . 45.4 mm 40.19 -92.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 C-N-CA 120.269 -0.572 . . . . 0.0 109.716 -179.257 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.585 ' N ' ' O ' ' A' ' 90' ' ' ILE . 0.7 OUTLIER -129.43 20.48 5.69 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.928 0.395 . . . . 0.0 110.87 179.732 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.717 ' HE ' HH12 ' B' ' 245' ' ' ARG . 98.5 mtt180 -124.31 142.09 51.54 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.326 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 75.6 m -137.55 151.36 48.31 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.203 -179.725 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.455 ' HE1' HD12 ' A' ' 90' ' ' ILE . 62.6 m-85 -121.95 122.33 39.13 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.534 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.53 ' HG2' HG22 ' A' ' 87' ' ' VAL . 98.2 mtt180 -84.95 133.96 34.26 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 119.638 -0.825 . . . . 0.0 111.375 -178.581 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -95.8 120.08 35.43 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.158 179.532 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -122.31 119.67 31.8 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.263 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.414 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 64.8 t-20 -102.11 114.12 27.98 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.333 179.7 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 . . . . . 0 C--N 1.326 -0.425 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.834 179.469 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 28.3 m . . . . . 0 N--CA 1.453 -0.306 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.513 ' C ' ' H ' ' B' ' 231' ' ' GLN . 77.6 m-20 -72.56 141.03 48.43 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.699 179.785 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 230' ' ' SEP . . . . . 0.44 ' C ' ' CD ' ' B' ' 231' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.513 ' H ' ' C ' ' B' ' 229' ' ' ASP . 16.5 mp0 -136.86 31.28 2.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.599 179.608 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -115.02 -161.62 13.35 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -179.547 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -60.84 150.93 80.69 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 123.456 2.771 . . . . 0.0 112.685 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.661 ' O2P' HG21 ' B' ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -74.62 172.04 16.99 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 122.262 1.975 . . . . 0.0 111.607 178.704 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 4.9 p -116.85 132.75 65.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.328 -179.664 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 237' ' ' CYS . . . . . 0.527 ' SG ' HG23 ' A' ' 91' ' ' ILE . 45.9 t -69.9 126.24 29.11 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.532 -179.256 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 238' ' ' TPO . . . . . 0.538 ' P ' ' HG1' ' B' ' 240' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 239' ' ' PRO . . . . . 0.477 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 35.8 Cg_exo -58.22 -25.9 74.07 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 C-N-CA 122.876 2.384 . . . . 0.0 113.53 -178.993 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 240' ' ' THR . . . . . 0.538 ' HG1' ' P ' ' B' ' 238' ' ' TPO . 5.2 p -73.29 -41.6 63.39 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.026 -0.669 . . . . 0.0 109.305 178.28 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.445 ' HZ ' HD22 ' A' ' 41' ' ' LEU . 57.9 t80 -58.24 -46.65 85.56 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.12 -179.524 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.424 ' HA ' HD23 ' B' ' 242' ' ' LEU . 94.4 mt -62.79 -40.45 97.35 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.605 -179.674 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -63.9 -37.37 87.14 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.271 179.545 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -62.4 -41.75 98.91 Favored 'General case' 0 C--N 1.334 -0.1 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.488 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.841 ' O ' HG23 ' B' ' 249' ' ' VAL . 60.9 ttm-85 -58.07 -44.19 87.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.006 -179.495 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -63.33 -40.4 97.22 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.029 0.442 . . . . 0.0 110.759 -179.475 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 41.8 m -69.0 -46.13 68.81 Favored 'General case' 0 C--N 1.334 -0.104 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.65 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 248' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' B' ' 252' ' ' LEU . 7.0 tt0 -61.78 -36.94 82.52 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.818 -179.55 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.841 HG23 ' O ' ' B' ' 245' ' ' ARG . 75.4 t -61.12 -45.47 98.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 120.257 -0.577 . . . . 0.0 109.513 179.42 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -59.53 -29.69 68.07 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.806 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -91.96 -15.21 28.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.609 178.886 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.53 ' N ' ' O ' ' B' ' 248' ' ' GLN . 40.7 tp -75.07 139.56 42.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.442 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -103.07 136.74 42.31 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.39 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -67.04 -23.72 65.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.823 -179.616 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 49.6 p-10 -75.98 -0.27 20.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.099 -179.2 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.455 ' O ' ' C ' ' B' ' 257' ' ' LYS . 90.3 m-20 -93.32 -2.96 54.31 Favored 'General case' 0 C--N 1.334 -0.099 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.403 179.175 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 257' ' ' LYS . . . . . 0.564 ' O ' ' C ' ' B' ' 258' ' ' ASP . 88.1 tttt 32.82 -103.19 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.441 -179.699 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.564 ' C ' ' O ' ' B' ' 257' ' ' LYS . 99.3 m-20 -17.66 87.15 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.587 0.708 . . . . 0.0 110.652 -179.308 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' B' ' 257' ' ' LYS . 23.3 p-10 -86.78 59.41 5.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.576 -1.193 . . . . 0.0 112.078 -178.481 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.637 ' OE1' ' NH2' ' A' ' 93' ' ' ARG . 95.1 mt-10 62.54 4.72 1.43 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.317 -0.401 . . . . 0.0 112.035 179.15 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 79.4 mt -106.78 132.31 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 177.589 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 47.6 t -126.4 133.09 69.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 120.904 0.383 . . . . 0.0 111.014 -179.15 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -97.88 124.13 42.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.12 -179.297 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -69.36 -45.42 69.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.261 179.457 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.22 155.79 40.73 Favored Pre-proline 0 CA--C 1.521 -0.16 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.201 -179.428 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.85 144.26 70.18 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 122.584 2.189 . . . . 0.0 113.052 -179.664 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 45.0 pt . . . . . 0 C--N 1.331 -0.206 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.87 178.835 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo . . . . . 0 N--CA 1.494 1.552 0 CA-C-O 120.825 0.261 . . . . 0.0 112.064 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.0 p -107.72 -46.59 3.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.976 0.417 . . . . 0.0 110.505 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.3 mtt85 -100.12 123.42 44.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.171 -179.616 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -130.01 144.35 51.29 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.685 -179.84 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 83.9 mt -113.18 135.45 53.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.392 179.045 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.6 m -110.79 132.06 60.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-O 120.95 0.405 . . . . 0.0 110.019 179.254 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.7 m -79.97 142.53 34.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.495 -0.775 . . . . 0.0 113.044 -178.193 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.478 HD12 ' HB3' ' A' ' 94' ' ' SER . 96.5 mt -112.15 136.67 47.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.024 176.611 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -90.32 158.94 16.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.842 0.353 . . . . 0.0 110.432 179.754 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -58.45 -30.92 67.3 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.088 -178.875 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.3 p -76.44 -11.58 59.91 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.199 179.594 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.08 35.57 6.02 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -179.635 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 54.0 t -120.14 132.04 70.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.935 0.398 . . . . 0.0 110.816 -179.81 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -81.21 138.41 35.81 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.805 179.624 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -133.42 -116.15 1.68 Allowed Glycine 0 CA--C 1.538 1.517 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.124 -179.718 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.36 153.1 61.35 Favored 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 122.473 2.116 . . . . 0.0 112.849 -178.83 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -116.04 161.68 18.52 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.604 -179.832 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.509 ' CD2' HD11 ' A' ' 37' ' ' ILE . 34.2 t80 -122.88 91.84 49.5 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.417 -179.563 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -59.96 127.63 23.96 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 121.957 1.772 . . . . 0.0 110.564 179.346 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.6 mt -82.02 57.56 3.56 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.566 -0.454 . . . . 0.0 111.233 -179.002 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 89.8 p -67.84 -22.97 65.12 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.576 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 80.2 mt -83.63 138.9 33.13 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.233 179.79 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 92.9 p -64.22 -18.09 64.19 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.03 -179.48 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.495 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 88.0 m -134.37 134.82 42.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.985 179.91 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.666 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 1.4 t -128.21 118.11 22.75 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.235 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.5 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 40.8 tp -117.47 128.73 55.27 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.22 -177.699 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.783 ' CE2' HD12 ' A' ' 37' ' ' ILE . 19.8 m-85 -104.89 135.8 45.57 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.657 179.045 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 164.22 178.62 37.86 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 120.283 -0.961 . . . . 0.0 112.778 179.034 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.424 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 42.3 mtm180 -75.44 -31.1 60.2 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.903 0.382 . . . . 0.0 110.503 178.654 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -50.48 144.86 10.58 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.19 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.455 HG23 ' N ' ' A' ' 34' ' ' GLU . 8.6 tp -66.92 -41.05 87.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.908 -179.585 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.455 ' N ' HG23 ' A' ' 33' ' ' ILE . 84.8 tt0 -58.03 -20.83 41.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.869 0.366 . . . . 0.0 110.813 -179.92 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 62.4 m -57.63 131.52 50.48 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.878 -179.512 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.5 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 56.0 m-20 -60.25 -33.56 72.47 Favored 'General case' 0 C--N 1.334 -0.097 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -178.781 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.783 HD12 ' CE2' ' A' ' 29' ' ' PHE . 84.8 mt -126.12 123.8 64.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 176.65 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.493 HH21 HG11 ' B' ' 262' ' ' VAL . 84.2 mtm-85 -105.45 135.04 47.58 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.439 -0.505 . . . . 0.0 110.609 -178.246 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 95.8 mt -118.78 131.02 72.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 120.304 -0.559 . . . . 0.0 111.36 -179.82 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -75.45 32.26 0.11 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.52 -0.763 . . . . 0.0 112.318 -178.794 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.72 HD21 ' OE1' ' B' ' 260' ' ' GLU . 61.0 mt -106.18 127.07 29.02 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.65 179.378 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.33 -8.49 22.79 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 122.406 2.071 . . . . 0.0 113.117 -179.42 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.5 m -95.38 6.77 7.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.39 179.737 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.424 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 36.1 t -96.86 135.36 31.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.331 179.475 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.493 ' HB2' ' H ' ' A' ' 48' ' ' HIS . 4.1 m -73.02 173.68 8.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.205 -178.883 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -63.02 -40.35 97.49 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.819 179.476 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.64 ' O ' ' N ' ' A' ' 49' ' ' CYS . 9.8 mm100 -113.24 -23.3 10.02 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.974 -0.291 . . . . 0.0 110.519 -179.712 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.493 ' H ' ' HB2' ' A' ' 45' ' ' SER . 20.4 t60 43.58 -77.69 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.894 -179.735 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.64 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -134.03 136.97 44.41 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.991 -179.517 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -125.77 133.13 52.16 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.485 179.75 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 98.6 mt -115.98 131.43 68.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.058 179.945 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.587 ' OE2' ' NE2' ' A' ' 54' ' ' HIS . 79.4 tt0 -118.11 125.73 50.85 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.765 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 86.2 mt -108.06 123.17 63.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.896 0.855 . . . . 0.0 112.992 -177.826 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.587 ' NE2' ' OE2' ' A' ' 52' ' ' GLU . 98.5 m-70 -117.57 136.92 52.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 113.989 -1.459 . . . . 0.0 109.056 178.902 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 54' ' ' HIS . 96.2 mt-10 -41.18 -32.23 0.26 Allowed 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.156 -0.617 . . . . 0.0 109.89 -179.571 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -64.22 -67.93 0.39 Allowed 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.291 -0.564 . . . . 0.0 109.893 179.224 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.569 ' CG ' ' H ' ' A' ' 58' ' ' ALA . 52.9 tt0 -150.56 -179.35 7.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.863 -178.593 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.569 ' H ' ' CG ' ' A' ' 57' ' ' GLU . . . -108.83 131.86 54.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.052 -179.697 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.8 mt -119.85 129.5 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -178.33 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.487 HD11 ' SG ' ' A' ' 49' ' ' CYS . 38.6 tp -97.39 129.03 44.67 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.041 -0.982 . . . . 0.0 110.051 179.47 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -115.92 136.32 53.15 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 179.595 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.628 HD21 ' CB ' ' A' ' 68' ' ' PRO . 62.7 t-20 -100.32 105.24 16.74 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 120.965 0.412 . . . . 0.0 111.134 -179.477 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -97.52 -9.57 26.85 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.229 179.855 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.87 98.55 7.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.021 0.438 . . . . 0.0 110.271 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.4 t -76.27 -42.65 44.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.844 179.396 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.405 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.3 OUTLIER -61.28 -45.43 94.52 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.293 -178.68 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.41 HD21 ' HA ' ' B' ' 236' ' ' VAL . 37.2 m-80 -139.36 94.84 9.4 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 115.503 -0.771 . . . . 0.0 108.958 -179.503 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.628 ' CB ' HD21 ' A' ' 62' ' ' ASN . 35.6 Cg_endo -64.86 150.52 88.01 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 121.528 1.485 . . . . 0.0 112.507 -178.173 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.8 m -73.01 142.11 47.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.7 -178.883 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -99.51 148.04 24.68 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.788 179.84 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.407 ' O ' HG13 ' A' ' 71' ' ' VAL . 5.6 p -132.61 135.47 57.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.239 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 50.85 33.02 7.91 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.455 -179.861 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.69 27.69 70.5 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -179.442 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 10.4 t -138.12 139.42 39.43 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.462 -179.501 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 77.8 t -69.22 134.0 30.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.031 0.443 . . . . 0.0 111.636 -179.715 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.16 95.58 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.482 179.266 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -81.92 -16.62 49.95 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.666 -179.209 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -110.01 156.91 39.21 Favored Pre-proline 0 C--O 1.222 -0.372 0 C-N-CA 121.099 -0.241 . . . . 0.0 110.481 -179.733 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -64.57 145.98 88.26 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.369 2.046 . . . . 0.0 112.669 -179.807 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.9 m -147.61 148.08 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.106 -179.463 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 91.2 mtm180 -73.97 132.36 42.33 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.403 179.391 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 82' ' ' LEU . 77.8 mt -79.39 141.2 37.09 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.996 0.427 . . . . 0.0 111.417 179.693 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -132.75 151.29 52.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.775 179.55 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.536 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 5.5 t60 -56.23 116.82 3.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.024 -179.801 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.92 -14.32 26.55 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.061 179.235 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -74.48 134.97 42.26 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.229 179.867 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.47 HG22 ' HG2' ' A' ' 96' ' ' ARG . 59.0 t -108.07 132.13 56.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.749 -178.891 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 88.8 mt -104.99 131.87 53.12 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.769 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 65.2 m -120.78 130.01 53.83 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 119.745 -0.782 . . . . 0.0 112.778 -177.96 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.597 ' O ' ' N ' ' A' ' 93' ' ' ARG . 96.6 mt -114.58 131.19 67.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 114.29 -1.323 . . . . 0.0 108.611 178.335 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.677 HG22 HH22 ' B' ' 245' ' ' ARG . 95.6 mt -20.38 95.26 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -179.565 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.554 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 10.5 t0 90.42 -23.55 0.09 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 178.084 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.597 ' N ' ' O ' ' A' ' 90' ' ' ILE . 88.2 mtt-85 -130.0 147.02 51.71 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.03 -179.621 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.478 ' HB3' HD12 ' A' ' 10' ' ' ILE . 38.7 t -139.1 152.27 47.37 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.384 0.611 . . . . 0.0 110.598 -179.911 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.568 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 91.2 m-85 -125.07 121.36 34.08 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.649 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.47 ' HG2' HG22 ' A' ' 87' ' ' VAL . 99.9 mtt180 -87.51 140.27 29.69 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 119.453 -0.899 . . . . 0.0 109.976 -179.561 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -96.65 123.17 40.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.031 -178.292 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -126.03 120.77 31.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.781 179.711 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.536 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 64.4 t-20 -108.36 113.92 27.37 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.259 179.817 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.0 tp10 . . . . . 0 C--N 1.327 -0.405 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.58 -179.571 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 54.6 t . . . . . 0 N--CA 1.449 -0.482 0 CA-C-O 120.924 0.393 . . . . 0.0 109.946 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.434 ' C ' ' OD1' ' B' ' 229' ' ' ASP . 49.8 p30 -100.55 173.99 6.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.675 -179.813 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 230' ' ' SEP . . . . . 0.596 ' O ' ' NE2' ' B' ' 231' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.596 ' NE2' ' O ' ' B' ' 230' ' ' SEP . 97.0 mm-40 -140.82 62.08 1.49 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.405 -179.724 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -119.95 179.53 16.54 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -179.677 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.69 159.89 49.66 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 123.582 2.855 . . . . 0.0 113.127 -179.838 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.44 145.33 47.49 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 121.996 1.797 . . . . 0.0 113.722 -179.176 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.41 ' HA ' HD21 ' A' ' 67' ' ' ASN . 50.1 t -64.42 132.46 30.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.036 179.231 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -67.62 137.55 55.72 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.063 -179.693 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -57.71 -25.81 70.04 Favored 'Trans proline' 0 N--CA 1.499 1.835 0 C-N-CA 123.023 2.482 . . . . 0.0 113.009 -179.665 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 86.0 m -74.84 -45.99 39.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.949 0.404 . . . . 0.0 110.881 179.234 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.641 ' CE2' ' CZ ' ' B' ' 245' ' ' ARG . 57.2 t80 -58.37 -48.31 81.0 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.033 -178.31 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.451 HD23 ' NH2' ' B' ' 245' ' ' ARG . 44.7 mt -64.73 -42.62 95.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.252 0.548 . . . . 0.0 110.757 179.681 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -62.99 -43.09 99.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.016 -178.72 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -61.55 -45.56 93.65 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.692 -179.041 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.677 HH22 HG22 ' A' ' 91' ' ' ILE . 89.7 mtm180 -63.86 -37.05 85.96 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.904 -178.771 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.7 -39.7 92.42 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.305 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 70.2 m -63.49 -44.09 95.38 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.606 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 93.9 mm-40 -61.11 -37.11 81.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.281 -179.779 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 47.1 t -62.22 -44.61 99.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.914 179.792 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -61.37 -27.14 68.31 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.564 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 -82.85 -14.62 53.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.828 179.254 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 94.3 mt -101.21 -179.83 4.15 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.307 178.543 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 253' ' ' ASN . . . . . 0.589 ' O ' ' N ' ' B' ' 255' ' ' ASP . 18.3 m-80 -150.8 -173.07 4.37 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.838 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 254' ' ' ASP . . . . . 0.53 ' C ' ' H ' ' B' ' 256' ' ' ASP . 14.9 t70 -43.57 -15.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.237 -179.719 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 255' ' ' ASP . . . . . 0.589 ' N ' ' O ' ' B' ' 253' ' ' ASN . 87.8 m-20 -73.52 16.39 0.2 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.308 0.575 . . . . 0.0 109.707 179.371 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.751 ' O ' ' O ' ' B' ' 257' ' ' LYS . 94.3 m-20 -60.52 -36.4 78.3 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.544 -179.772 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 257' ' ' LYS . . . . . 0.751 ' O ' ' O ' ' B' ' 256' ' ' ASP . 99.0 mttt -2.1 138.8 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.113 0 O-C-N 124.604 1.19 . . . . 0.0 112.221 -179.425 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.533 ' O ' ' C ' ' B' ' 259' ' ' ASP . 98.8 m-20 59.1 -3.14 0.09 Allowed 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.634 ' H ' ' C ' ' B' ' 257' ' ' LYS . 0.1 OUTLIER 15.55 -90.37 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.021 179.902 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.72 ' OE1' HD21 ' A' ' 41' ' ' LEU . 95.5 mt-10 -146.7 18.66 1.3 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.446 0.641 . . . . 0.0 109.694 179.07 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.568 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 82.6 mt -115.91 133.55 61.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.79 179.951 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 262' ' ' VAL . . . . . 0.493 HG11 HH21 ' A' ' 38' ' ' ARG . 55.0 t -126.6 133.13 69.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.979 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -96.12 121.95 38.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.204 0.526 . . . . 0.0 111.219 -178.53 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 264' ' ' LYS . . . . . 0.443 ' CB ' ' O ' ' A' ' 36' ' ' ASP . 87.6 tttt -63.78 -43.45 96.34 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.477 179.551 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.24 160.14 31.37 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.327 -179.398 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -61.17 145.42 98.74 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.686 2.257 . . . . 0.0 111.031 178.464 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 267' ' ' ILE . . . . . 0.868 ' O ' HD13 ' B' ' 267' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.49 0 C-N-CA 120.151 -0.62 . . . . 0.0 111.28 -179.415 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.554 ' C ' HG22 ' A' ' 4' ' ' THR . 52.9 Cg_endo . . . . . 0 N--CA 1.491 1.348 0 N-CA-C 111.969 -0.051 . . . . 0.0 111.969 . . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.554 HG22 ' C ' ' A' ' 3' ' ' PRO . 2.4 t 143.42 -7.86 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 O-C-N 124.269 0.981 . . . . 0.0 110.592 179.421 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.499 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 92.9 mtt-85 -86.08 130.54 34.5 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.635 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -135.0 142.38 46.43 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.536 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.8 mt -111.7 132.74 54.41 Favored 'General case' 0 CA--C 1.523 -0.076 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.29 179.405 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.6 t -109.01 125.89 66.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.988 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.1 m -77.17 140.94 40.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.679 -178.779 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.554 HD12 ' HB2' ' A' ' 94' ' ' SER . 97.3 mt -110.27 135.19 50.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.125 178.578 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.404 ' HA ' HH12 ' A' ' 93' ' ' ARG . 81.7 mttt -90.68 159.51 16.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.202 0.525 . . . . 0.0 110.947 -179.809 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.607 HH11 ' NH1' ' B' ' 245' ' ' ARG . 91.1 mtm180 -56.95 -29.35 63.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.601 -178.546 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.3 p -81.44 -8.49 59.74 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.279 -179.734 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.29 33.27 7.74 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 179.676 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.7 t -120.38 134.7 63.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.572 0.225 . . . . 0.0 111.518 -179.59 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -72.4 136.4 46.07 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.105 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -124.84 -119.41 2.39 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.679 -179.893 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.62 148.3 36.93 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 122.52 2.147 . . . . 0.0 113.318 -178.989 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -109.55 138.31 46.1 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.515 179.853 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.721 ' CD2' HD11 ' A' ' 37' ' ' ILE . 29.9 t80 -111.54 104.04 55.69 Favored Pre-proline 0 N--CA 1.469 0.477 0 N-CA-C 110.056 -0.349 . . . . 0.0 110.056 -179.746 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -76.15 138.43 20.34 Favored 'Trans proline' 0 N--CA 1.489 1.235 0 C-N-CA 121.949 1.766 . . . . 0.0 112.217 -179.133 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.431 HD22 ' HB2' ' A' ' 27' ' ' CYS . 93.4 mt -88.83 92.06 9.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.143 0.497 . . . . 0.0 111.106 -178.878 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 88.6 p -93.55 -8.07 42.36 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.728 179.017 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 67.3 mt -109.58 150.07 28.74 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.859 -179.424 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.9 m -68.97 -16.39 63.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.734 0.302 . . . . 0.0 111.311 -179.148 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 78.4 m -128.59 132.01 48.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.058 0.456 . . . . 0.0 111.464 -179.766 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.631 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 5.2 t -128.1 119.19 24.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.451 178.816 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.573 HD12 ' O ' ' A' ' 49' ' ' CYS . 31.6 tp -117.68 130.34 56.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.41 -178.496 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.751 ' CE2' HD12 ' A' ' 37' ' ' ILE . 17.5 m-85 -107.72 137.23 46.1 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.666 179.441 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 156.91 -177.48 33.79 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 120.384 -0.912 . . . . 0.0 112.425 178.899 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.405 ' HD2' HH11 ' A' ' 31' ' ' ARG . 46.3 mtm180 -74.91 -32.55 61.84 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.581 0.229 . . . . 0.0 111.48 179.202 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.489 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -53.04 145.68 20.58 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.264 -178.514 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.51 HG23 ' N ' ' A' ' 34' ' ' GLU . 11.1 tp -66.36 -41.93 89.71 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-O 120.856 0.36 . . . . 0.0 110.204 179.873 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.51 ' N ' HG23 ' A' ' 33' ' ' ILE . 49.9 tp10 -52.3 -22.1 4.16 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.605 179.511 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.489 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 9.9 m -65.46 126.03 26.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.064 -179.791 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -57.67 -27.5 62.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.023 -179.551 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.751 HD12 ' CE2' ' A' ' 29' ' ' PHE . 78.7 mt -130.26 123.71 56.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.484 178.295 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 75.2 mtm180 -101.61 135.33 43.31 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.317 179.979 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.589 HG21 HD12 ' A' ' 41' ' ' LEU . 97.3 mt -117.56 129.58 73.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.131 0.491 . . . . 0.0 109.97 179.068 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -74.24 29.1 0.08 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.205 -178.952 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.589 HD12 HG21 ' A' ' 39' ' ' ILE . 26.9 mt -93.72 121.36 64.75 Favored Pre-proline 0 CA--C 1.533 0.303 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.204 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.4 -8.45 20.73 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 121.779 1.653 . . . . 0.0 111.676 -179.642 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 m -102.53 9.88 8.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.906 -179.981 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.415 HG12 ' O ' ' A' ' 45' ' ' SER . 10.9 t -96.59 141.36 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 121.077 0.465 . . . . 0.0 110.595 179.324 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.415 ' O ' HG12 ' A' ' 44' ' ' VAL . 12.8 m -71.64 165.59 23.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.517 -179.24 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -62.17 -40.83 97.34 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.665 -179.426 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.634 ' O ' ' N ' ' A' ' 49' ' ' CYS . 85.7 mt-30 -113.59 -25.0 8.93 Favored 'General case' 0 C--O 1.226 -0.133 0 CA-C-O 121.102 0.477 . . . . 0.0 110.27 -179.907 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.8 t60 37.08 -76.01 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 179.405 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.634 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -127.34 133.54 50.07 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.243 0.544 . . . . 0.0 112.187 -178.128 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -130.88 129.18 41.95 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.051 179.993 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 94.4 mt -113.07 133.8 57.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.561 179.842 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -118.94 126.96 52.98 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.641 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.2 mt -104.67 113.72 42.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.049 -0.66 . . . . 0.0 111.215 -179.398 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.559 ' O ' ' N ' ' A' ' 56' ' ' GLN . 95.3 m-70 -113.4 145.4 41.19 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.569 179.789 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 54' ' ' HIS . 77.3 tt0 -39.85 -24.59 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -179.694 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.559 ' N ' ' O ' ' A' ' 54' ' ' HIS . 87.0 mt-30 -71.14 -68.69 0.42 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.222 178.9 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.496 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 2.5 tp10 -158.62 -169.17 2.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.234 0.54 . . . . 0.0 111.025 -178.962 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -105.71 121.89 44.94 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 177.961 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.7 mt -114.66 129.42 70.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.223 0.535 . . . . 0.0 112.093 -178.443 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 29.5 tp -96.64 127.48 42.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.47 179.706 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -112.01 135.32 52.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.857 0.36 . . . . 0.0 110.404 -179.821 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -93.46 106.5 18.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.635 -179.847 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -98.38 -12.57 21.29 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.72 179.056 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 t -73.98 100.51 3.58 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.204 179.749 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.2 p -86.09 -20.76 28.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.897 0.38 . . . . 0.0 110.761 179.768 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.607 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -85.62 -44.65 12.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.213 -179.612 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.404 ' OD1' HG13 ' B' ' 236' ' ' VAL . 22.5 m-80 -135.1 94.17 16.3 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.175 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -55.38 145.11 69.31 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.393 2.062 . . . . 0.0 113.57 -178.435 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 53.1 m -74.03 142.59 45.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.332 179.176 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -104.6 140.97 37.24 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.663 179.765 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.711 HG13 ' OD1' ' A' ' 86' ' ' ASP . 53.0 t -128.52 131.46 68.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.83 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 51.09 32.03 7.26 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.149 -0.621 . . . . 0.0 109.489 -179.06 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.56 26.33 67.9 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.861 179.749 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.9 p -136.78 133.93 36.5 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 122.451 -0.44 . . . . 0.0 111.061 -179.989 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -68.03 138.12 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.494 179.821 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.9 pt -116.28 92.34 2.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.659 179.729 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -68.2 -20.89 64.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.075 0.464 . . . . 0.0 109.841 178.933 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.86 168.2 11.96 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.726 -179.533 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.65 152.43 69.9 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.778 2.319 . . . . 0.0 112.255 179.601 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.4 p -143.09 145.11 23.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.866 -179.742 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.8 mtm-85 -73.24 128.16 34.7 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.483 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 82' ' ' LEU . 95.7 mt -80.4 137.37 36.52 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.203 -179.345 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -130.6 153.42 48.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.429 179.767 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -58.17 118.87 5.93 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.011 0.434 . . . . 0.0 110.505 -179.542 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.59 -7.24 26.22 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.746 -0.941 . . . . 0.0 110.746 -179.472 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.711 ' OD1' HG13 ' A' ' 71' ' ' VAL . 52.2 t0 -81.12 123.85 28.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.092 0.472 . . . . 0.0 110.365 179.792 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 42.9 t -104.05 134.17 46.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.648 -179.162 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.1 mt -103.32 129.94 54.39 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 178.104 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.434 HG23 ' OG ' ' A' ' 94' ' ' SER . 29.4 m -119.08 128.09 53.99 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.531 0.682 . . . . 0.0 111.832 -178.616 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.459 HD12 ' HE1' ' A' ' 95' ' ' PHE . 94.6 mt -118.1 125.29 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.954 179.295 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.411 ' C ' ' O ' ' A' ' 90' ' ' ILE . 38.2 mm 38.36 -105.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.991 -179.117 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.54 ' CG ' ' NE ' ' B' ' 245' ' ' ARG . 1.1 p30 -108.24 12.07 26.84 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -178.808 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.625 ' HE ' HD11 ' B' ' 261' ' ' ILE . 53.4 mtp85 -132.91 147.9 52.29 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.068 179.616 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.554 ' HB2' HD12 ' A' ' 10' ' ' ILE . 38.1 m -138.8 158.27 44.53 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.233 -179.064 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.463 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 78.9 m-85 -125.89 122.95 37.53 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.354 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 79.4 mtp85 -81.35 135.53 35.69 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.491 179.471 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.499 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 80.6 t80 -95.15 122.07 37.44 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.997 179.952 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -134.64 119.96 18.97 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.999 -179.257 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.55 ' O ' ' O ' ' A' ' 4' ' ' THR . 91.9 m-20 -65.92 -40.33 91.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.758 179.381 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 . . . . . 0 C--N 1.326 -0.417 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.475 -179.274 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' B' B ' 228' ' ' VAL . . . . . 0.736 ' O ' HG12 ' B' ' 228' ' ' VAL . 48.6 t . . . . . 0 CA--C 1.533 0.306 0 CA-C-O 120.62 0.248 . . . . 0.0 110.937 . . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.506 ' C ' ' H ' ' B' ' 231' ' ' GLN . 90.0 m-20 -67.03 143.11 56.95 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.725 0.298 . . . . 0.0 111.726 -179.333 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.506 ' H ' ' C ' ' B' ' 229' ' ' ASP . 11.8 mp0 -111.96 -26.69 8.76 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.231 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 232' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' B' ' 231' ' ' GLN . . . -36.55 164.84 0.01 OUTLIER Glycine 0 CA--C 1.526 0.754 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.899 -179.499 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.3 162.4 41.68 Favored 'Trans proline' 0 C--N 1.301 -1.957 0 C-N-CA 123.777 2.984 . . . . 0.0 112.925 179.758 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -70.91 143.53 45.53 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 121.726 1.617 . . . . 0.0 112.944 -179.067 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.607 ' CG2' HG22 ' A' ' 66' ' ' THR . 74.3 t -76.22 132.72 32.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.898 -179.381 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 37.5 t -72.52 132.87 44.39 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.776 -179.728 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -58.24 -23.87 64.49 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 122.951 2.434 . . . . 0.0 113.189 179.915 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 21.8 m -73.18 -45.58 55.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.261 0.553 . . . . 0.0 109.89 178.829 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -58.59 -47.23 85.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.362 -179.381 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' B' ' 242' ' ' LEU . 98.8 mt -66.53 -39.79 88.78 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.832 0.348 . . . . 0.0 111.251 -179.805 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 51.5 tp10 -62.87 -45.09 94.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.171 -179.372 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -62.09 -40.8 97.08 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.258 0.552 . . . . 0.0 109.915 179.807 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.607 ' NH1' HH11 ' A' ' 12' ' ' ARG . 56.2 ttm-85 -60.13 -42.98 95.99 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.423 -179.229 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -62.23 -38.46 89.3 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.563 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 47.8 t -64.8 -44.21 90.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.433 177.849 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -60.94 -36.32 79.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.344 179.933 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 22.3 t -61.89 -45.1 99.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.932 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -61.63 -28.83 69.65 Favored 'General case' 0 C--O 1.231 0.092 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.83 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -85.13 -9.08 58.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.533 178.924 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.557 ' O ' ' CB ' ' B' ' 253' ' ' ASN . 2.0 mp -108.2 -175.76 2.87 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.888 179.385 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 253' ' ' ASN . . . . . 0.557 ' CB ' ' O ' ' B' ' 252' ' ' LEU . 15.9 t-20 89.75 26.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.033 179.659 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 254' ' ' ASP . . . . . 0.541 ' O ' ' CB ' ' B' ' 255' ' ' ASP . 31.5 t70 -66.5 -39.26 88.6 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.671 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 255' ' ' ASP . . . . . 0.541 ' CB ' ' O ' ' B' ' 254' ' ' ASP . 46.0 m-20 138.01 73.6 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 O-C-N 124.605 1.19 . . . . 0.0 109.486 179.821 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' B' ' 257' ' ' LYS . 40.8 t0 -161.26 141.52 10.9 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.414 179.969 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 257' ' ' LYS . . . . . 0.462 ' N ' ' OD1' ' B' ' 256' ' ' ASP . 88.4 tttt -61.11 -103.82 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.499 -0.48 . . . . 0.0 109.906 179.708 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 19.7 t0 43.02 75.09 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.074 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.582 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 40.9 p-10 -81.79 14.22 2.8 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.686 -177.507 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 69.29 -3.12 1.64 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.223 0.535 . . . . 0.0 110.065 179.643 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.625 HD11 ' HE ' ' A' ' 93' ' ' ARG . 58.6 mt -115.3 147.22 18.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.73 179.52 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 78.7 t -128.91 136.38 59.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.39 179.468 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -98.18 120.92 39.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.259 0.552 . . . . 0.0 111.567 -178.74 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -68.55 -46.2 70.11 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.783 -179.684 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -96.37 176.65 2.05 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.055 -178.715 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -59.54 146.13 96.02 Favored 'Trans proline' 0 N--CA 1.5 1.879 0 C-N-CA 122.644 2.229 . . . . 0.0 113.252 -178.938 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 1.1 tt . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.451 -179.829 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo . . . . . 0 N--CA 1.498 1.742 0 CA-C-O 120.515 0.131 . . . . 0.0 111.848 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.4 p -91.55 -36.83 13.48 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.873 179.721 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.2 mtt85 -97.2 127.23 42.98 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.783 -178.679 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 94.5 mtm-85 -129.6 135.44 48.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.993 179.816 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.595 HD11 ' HB3' ' A' ' 95' ' ' PHE . 39.9 tp -108.79 134.11 51.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.301 -179.47 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 54.9 t -114.98 130.7 69.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.128 -179.704 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.1 m -79.51 142.29 35.93 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.81 -179.605 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.622 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 90.0 mt -109.32 135.51 48.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.39 -0.823 . . . . 0.0 108.857 177.769 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.68 ' CA ' HH22 ' A' ' 93' ' ' ARG . 97.4 mttt -87.25 153.68 21.3 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.766 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.581 ' NH1' ' OE2' ' B' ' 260' ' ' GLU . 88.8 mtm180 -58.11 -23.81 56.33 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.414 -0.515 . . . . 0.0 110.474 -179.357 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.0 m -80.38 -10.72 59.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.385 179.524 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.67 30.28 9.19 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 179.644 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.9 t -121.21 132.12 71.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.795 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -73.55 140.01 46.01 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.362 179.418 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -122.42 -121.46 2.72 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 121.031 -0.604 . . . . 0.0 111.916 -179.041 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.05 149.74 53.16 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 122.094 1.863 . . . . 0.0 112.489 -179.059 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.423 ' CE1' ' HD3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -109.95 140.44 43.94 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.925 -179.092 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.565 ' CD2' HD11 ' A' ' 37' ' ' ILE . 33.9 t80 -112.86 104.71 55.97 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.614 -178.807 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.423 ' HD3' ' CE1' ' A' ' 19' ' ' HIS . 55.9 Cg_endo -72.63 131.36 17.2 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.103 1.202 . . . . 0.0 111.579 -178.488 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 92.2 mt -86.21 48.68 1.65 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.926 -178.189 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.6 p -65.33 -22.31 66.8 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.918 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.8 mt -80.28 141.47 35.49 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.018 179.965 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.7 m -62.48 -21.6 65.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.985 -179.206 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 74.7 m -138.15 135.77 36.04 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.693 -179.404 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.0 t -126.73 122.09 33.87 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 177.888 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.65 HD21 ' HG2' ' A' ' 47' ' ' GLN . 44.1 tp -118.01 127.35 53.72 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.104 0.478 . . . . 0.0 111.163 -178.386 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.763 ' CE2' HD12 ' A' ' 37' ' ' ILE . 9.3 m-85 -105.36 132.45 51.53 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.904 179.83 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.79 -175.93 39.13 Favored Glycine 0 N--CA 1.467 0.749 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.158 179.425 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.601 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 78.9 mtm-85 -77.73 -30.12 51.51 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.873 0.368 . . . . 0.0 110.338 179.262 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -50.62 149.2 6.78 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.923 -0.471 . . . . 0.0 111.923 -178.208 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.472 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.9 tp -67.05 -40.57 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.458 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.472 ' N ' HG23 ' A' ' 33' ' ' ILE . 96.5 mt-10 -57.2 -25.4 58.98 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.885 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.439 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 47.7 m -53.59 118.41 3.88 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.995 179.824 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.468 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 55.3 m-20 -58.56 -28.26 65.35 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.155 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.763 HD12 ' CE2' ' A' ' 29' ' ' PHE . 90.4 mt -129.0 124.62 61.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 176.494 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -107.72 136.6 47.19 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.636 -178.61 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.407 HG23 ' O ' ' B' ' 260' ' ' GLU . 92.5 mt -118.0 130.31 73.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 179.501 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -73.44 30.54 0.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.441 -177.747 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.42 ' HA ' HD23 ' A' ' 41' ' ' LEU . 82.3 mt -100.85 127.85 31.23 Favored Pre-proline 0 C--N 1.326 -0.417 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.521 179.865 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.24 -8.09 20.49 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 122.267 1.978 . . . . 0.0 111.77 179.636 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.558 HG23 HD13 ' A' ' 91' ' ' ILE . 16.4 m -100.21 6.37 9.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.008 -179.776 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.601 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 9.4 t -97.25 138.0 23.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 179.151 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.7 m -68.75 165.16 20.15 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.502 0.668 . . . . 0.0 111.496 -178.882 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.439 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 9.6 mtmt -61.94 -40.06 94.21 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.825 -179.459 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.65 ' HG2' HD21 ' A' ' 28' ' ' LEU . 85.8 mt-30 -118.06 -20.28 8.75 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.91 0.386 . . . . 0.0 111.322 179.742 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 33.7 t60 32.57 -73.97 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 178.887 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.639 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -124.83 131.52 53.43 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.157 0.503 . . . . 0.0 112.213 -178.305 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -126.82 127.89 45.7 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.229 179.914 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.1 mt -113.48 131.13 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.532 179.883 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.569 ' OE2' ' NE2' ' A' ' 54' ' ' HIS . 81.2 tt0 -118.34 128.06 54.29 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.742 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 88.6 mt -106.87 117.14 52.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 121.597 0.713 . . . . 0.0 112.19 -178.017 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.569 ' NE2' ' OE2' ' A' ' 52' ' ' GLU . 96.6 m-70 -112.24 141.11 46.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.628 179.759 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 54' ' ' HIS . 96.9 mt-10 -40.44 -29.92 0.1 Allowed 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.381 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' ' 54' ' ' HIS . 89.0 mt-30 -67.33 -67.1 0.48 Allowed 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.461 178.654 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.531 ' OE1' ' N ' ' A' ' 58' ' ' ALA . 1.3 mm-40 -155.49 -177.28 6.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.486 0.66 . . . . 0.0 112.212 -178.263 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.531 ' N ' ' OE1' ' A' ' 57' ' ' GLU . . . -106.38 118.85 37.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.456 178.585 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 94.2 mt -110.63 131.57 61.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.541 0.686 . . . . 0.0 111.804 -178.775 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 23.8 tp -98.99 128.69 45.19 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.59 179.519 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -115.27 135.84 53.73 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.021 -179.773 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -97.76 108.49 21.22 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.423 179.859 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -96.82 -8.06 32.02 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.649 179.413 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 6.7 t -71.19 97.83 1.6 Allowed 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.343 179.808 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.0 m -74.15 -43.29 57.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.292 0.568 . . . . 0.0 110.068 178.819 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.531 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.3 OUTLIER -65.04 -43.23 93.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.808 -178.82 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.427 ' O ' ' OG ' ' A' ' 64' ' ' SER . 36.7 m-20 -140.16 99.95 7.2 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.189 -179.386 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.507 ' HB2' HG13 ' A' ' 75' ' ' VAL . 44.0 Cg_exo -56.77 146.29 78.55 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 122.281 1.987 . . . . 0.0 112.871 -179.593 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.3 m -75.28 142.6 43.28 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.419 179.391 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -104.65 138.44 40.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.64 179.694 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 72.2 t -128.74 134.14 65.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.464 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 52.4 34.86 16.0 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.346 -179.425 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.86 26.47 69.07 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.541 179.212 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 41.8 m -146.46 141.29 26.95 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 117.563 0.681 . . . . 0.0 112.031 179.93 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.507 HG13 ' HB2' ' A' ' 68' ' ' PRO . 6.9 t -68.56 138.11 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.454 179.764 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.5 pt -113.48 89.09 1.23 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-O 121.158 0.504 . . . . 0.0 111.147 178.739 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -65.51 -27.2 68.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.567 179.114 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -120.01 166.08 16.08 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.067 -179.723 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.76 144.32 99.47 Favored 'Trans proline' 0 N--CA 1.501 1.936 0 C-N-CA 122.581 2.187 . . . . 0.0 112.197 -179.72 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.5 m -136.92 138.25 46.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.999 179.767 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.9 mtm180 -73.25 132.74 43.5 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.259 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.1 mt -81.5 133.79 35.44 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.113 -179.051 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -125.88 149.57 48.59 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.834 179.96 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -52.6 112.51 0.84 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.156 0.503 . . . . 0.0 111.062 -179.268 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.6 -11.43 25.69 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.799 179.233 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -70.36 132.48 45.71 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 117.289 0.545 . . . . 0.0 110.679 -179.823 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.0 t -108.16 132.69 55.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.929 -178.877 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.7 mt -104.32 130.92 54.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.759 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 87.0 m -122.8 123.59 41.39 Favored 'General case' 0 CA--C 1.523 -0.086 0 CA-C-O 121.628 0.728 . . . . 0.0 112.003 -178.83 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.549 ' O ' ' N ' ' A' ' 93' ' ' ARG . 78.9 mt -110.91 123.93 67.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.658 178.852 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.558 HD13 HG23 ' A' ' 43' ' ' VAL . 96.8 mt 31.78 -95.63 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.896 179.044 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 92' ' ' ASP . 24.1 p-10 -114.29 7.51 16.47 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.517 -179.763 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.68 HH22 ' CA ' ' A' ' 11' ' ' LYS . 1.7 mmp_? -119.41 137.22 53.9 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.651 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 44.9 t -138.26 150.17 46.42 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.234 179.951 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.595 ' HB3' HD11 ' A' ' 7' ' ' LEU . 83.4 m-85 -129.22 134.14 47.85 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.839 179.581 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.416 ' O ' HD12 ' A' ' 7' ' ' LEU . 39.5 ttm180 -95.05 134.05 38.16 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.353 -179.406 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -93.51 121.54 35.03 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.914 -179.541 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -134.41 127.39 31.48 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 120.453 -0.499 . . . . 0.0 112.071 -179.915 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -94.24 170.33 9.59 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.875 179.395 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 . . . . . 0 C--N 1.329 -0.324 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.365 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 67.3 t . . . . . 0 N--CA 1.451 -0.386 0 CA-C-O 120.727 0.299 . . . . 0.0 111.312 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.461 ' O ' ' CD ' ' B' ' 231' ' ' GLN . 97.6 m-20 -45.3 98.62 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.018 0.437 . . . . 0.0 112.167 -179.396 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 230' ' ' SEP . . . . . 0.447 ' C ' ' O ' ' B' ' 229' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.461 ' CD ' ' O ' ' B' ' 229' ' ' ASP . 1.0 OUTLIER -148.62 -57.83 0.22 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.961 0.41 . . . . 0.0 109.961 179.163 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' B' B ' 232' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' B' ' 231' ' ' GLN . . . -42.79 170.44 0.01 OUTLIER Glycine 0 CA--C 1.525 0.658 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.891 -179.472 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -68.95 164.7 32.69 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 C-N-CA 124.341 3.361 . . . . 0.0 112.242 179.631 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.48 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.69 137.36 72.7 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 122.106 1.871 . . . . 0.0 112.662 -179.534 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.531 ' CG2' HG22 ' A' ' 66' ' ' THR . 30.5 t -64.86 131.42 30.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 114.429 -1.26 . . . . 0.0 109.856 -179.76 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 2.0 t -62.54 122.15 15.06 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.88 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -56.57 -22.02 41.25 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 122.081 1.854 . . . . 0.0 112.208 -179.045 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 23.6 m -73.29 -44.11 59.75 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.818 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.703 ' CD1' ' NH2' ' B' ' 245' ' ' ARG . 77.2 t80 -57.57 -46.41 84.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.839 -179.63 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 91.6 mt -63.09 -40.65 98.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.424 0.63 . . . . 0.0 110.143 -179.945 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -62.4 -41.41 98.64 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.158 -179.663 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 244' ' ' ARG . . . . . 0.43 ' O ' ' OG ' ' B' ' 247' ' ' SER . 94.4 mtt-85 -61.44 -43.16 99.36 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.882 0.372 . . . . 0.0 111.039 -179.465 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.703 ' NH2' ' CD1' ' B' ' 241' ' ' PHE . 0.3 OUTLIER -61.24 -38.27 86.04 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.834 -179.921 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.11 -39.13 91.46 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.492 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 247' ' ' SER . . . . . 0.43 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 64.5 p -68.81 -41.41 78.7 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.293 178.164 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -58.86 -38.57 79.07 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.899 179.014 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 48.5 t -61.78 -44.68 99.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.003 179.297 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -58.29 -28.05 64.62 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.08 179.331 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -93.37 -8.04 43.0 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.752 178.985 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.461 ' HG ' ' H ' ' B' ' 253' ' ' ASN . 5.0 tp -100.33 179.59 4.41 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.205 0.526 . . . . 0.0 110.953 -179.475 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 253' ' ' ASN . . . . . 0.489 ' ND2' ' OD2' ' B' ' 255' ' ' ASP . 16.1 p30 -140.66 172.38 12.79 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.099 179.861 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 254' ' ' ASP . . . . . 0.482 ' N ' ' OD1' ' B' ' 254' ' ' ASP . 27.7 p-10 -67.89 -4.2 12.12 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.764 0.316 . . . . 0.0 110.845 -179.593 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 255' ' ' ASP . . . . . 0.489 ' OD2' ' ND2' ' B' ' 253' ' ' ASN . 95.4 m-20 -66.95 -16.7 64.51 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.097 179.859 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 50.2 p-10 -73.08 57.71 0.47 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.358 -178.87 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.73 -11.52 18.06 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 121.104 -0.238 . . . . 0.0 111.313 -179.729 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.687 ' O ' ' N ' ' B' ' 260' ' ' GLU . 88.3 m-20 -97.15 -0.01 47.67 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 177.54 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.476 ' C ' ' O ' ' B' ' 258' ' ' ASP . 50.1 p-10 0.83 57.04 0.0 OUTLIER 'General case' 0 C--O 1.221 -0.409 0 O-C-N 124.932 1.395 . . . . 0.0 113.073 -179.921 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.687 ' N ' ' O ' ' B' ' 258' ' ' ASP . 98.7 mt-10 58.19 6.99 0.59 Allowed 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 178.509 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.495 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 80.1 mt -115.58 134.71 57.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.422 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 40.3 t -127.69 132.87 68.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.529 179.014 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -97.11 120.14 36.92 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.213 -179.46 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -63.98 -46.27 85.35 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.508 179.148 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -97.99 151.96 37.81 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.565 -179.42 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -66.99 146.84 78.81 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.929 2.42 . . . . 0.0 113.055 -178.932 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 27.5 pt . . . . . 0 C--N 1.327 -0.387 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.514 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo . . . . . 0 N--CA 1.486 1.062 0 N-CA-C 111.343 -0.291 . . . . 0.0 111.343 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 69.5 p -70.13 -35.72 74.29 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.583 -179.905 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.823 HH12 ' HB2' ' A' ' 58' ' ' ALA . 94.5 mtt-85 -91.89 113.4 25.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.458 -179.321 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -126.31 133.72 51.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.379 -179.747 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.563 HD11 ' HB3' ' A' ' 95' ' ' PHE . 31.8 tp -113.62 133.85 55.05 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.781 -179.816 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.9 t -110.21 129.22 65.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.868 0.366 . . . . 0.0 111.116 -179.425 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.466 HG23 ' CD1' ' B' ' 261' ' ' ILE . 3.8 m -83.43 137.44 33.91 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.084 -178.864 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.561 HD12 ' HB2' ' A' ' 94' ' ' SER . 96.6 mt -104.64 135.65 41.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.583 177.623 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -88.97 158.9 17.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.569 179.916 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.624 ' CD ' HH22 ' A' ' 93' ' ' ARG . 77.5 mtp180 -56.5 -29.27 61.61 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.076 179.881 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.9 m -79.25 -7.79 58.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.847 179.599 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.96 28.97 24.43 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -179.21 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.3 t -113.7 132.67 62.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.505 -0.347 . . . . 0.0 110.467 -179.695 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -77.61 138.71 39.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.407 179.944 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -133.87 -119.66 2.01 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 120.348 -0.93 . . . . 0.0 112.748 -179.141 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -66.44 143.12 68.3 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.144 1.896 . . . . 0.0 113.499 -177.828 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.435 ' O ' ' CD1' ' B' ' 267' ' ' ILE . 0.6 OUTLIER -108.04 130.56 55.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.576 -179.728 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.524 ' CD2' HD11 ' A' ' 37' ' ' ILE . 41.7 t80 -101.26 107.65 51.46 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.304 -179.181 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -74.64 128.9 12.16 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 121.753 1.636 . . . . 0.0 111.679 -179.562 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 86.6 mt -86.43 51.24 2.17 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -178.063 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.7 p -62.41 -22.37 66.11 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.456 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.74 HD11 ' HG2' ' B' ' 265' ' ' GLN . 64.6 mt -79.15 137.95 37.68 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.209 179.043 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 81.0 p -66.57 -17.46 64.83 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.925 -179.424 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.433 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 86.4 m -129.98 131.03 45.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.066 0.46 . . . . 0.0 111.046 179.616 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.6 t -123.54 115.25 21.21 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.292 178.155 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.797 HD21 ' OE1' ' A' ' 47' ' ' GLN . 43.8 tp -112.01 124.55 52.64 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.928 -179.219 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.756 ' CE2' HD12 ' A' ' 37' ' ' ILE . 3.9 m-85 -106.42 143.51 34.44 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.763 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 157.49 -170.55 34.59 Favored Glycine 0 C--O 1.225 -0.408 0 C-N-CA 120.005 -1.093 . . . . 0.0 111.715 178.852 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.0 ttp85 -87.49 -27.41 22.67 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.84 -0.18 . . . . 0.0 111.212 -179.903 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.564 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -59.19 151.13 35.71 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 179.99 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.482 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.5 tp -66.24 -40.41 86.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.218 -0.593 . . . . 0.0 110.298 179.854 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.482 ' N ' HG23 ' A' ' 33' ' ' ILE . 79.4 mm-40 -53.98 -15.68 1.52 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.353 -179.884 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.564 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 34.1 m -64.48 123.63 19.72 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 120.162 -0.615 . . . . 0.0 109.394 179.631 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.433 ' OD2' ' O ' ' A' ' 26' ' ' THR . 98.6 m-20 -56.95 -25.0 57.06 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -179.501 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.756 HD12 ' CE2' ' A' ' 29' ' ' PHE . 99.0 mt -129.82 120.83 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.367 176.761 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.538 ' NH2' HG21 ' B' ' 262' ' ' VAL . 68.9 ttp85 -108.22 133.94 51.76 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.791 -178.648 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 97.6 mt -116.31 130.08 71.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.875 -179.825 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -75.24 34.59 0.11 Allowed 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -178.205 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.432 HD22 ' HZ ' ' B' ' 241' ' ' PHE . 57.8 mt -110.84 127.55 26.75 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.753 179.651 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.81 -8.45 22.39 Favored 'Trans proline' 0 N--CA 1.498 1.742 0 C-N-CA 122.684 2.256 . . . . 0.0 114.063 -179.024 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.2 m -100.61 1.8 10.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.317 179.711 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.487 ' O ' ' O ' ' A' ' 45' ' ' SER . 91.2 t -97.26 103.35 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.034 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.561 ' HA ' HG21 ' B' ' 234' ' ' TPO . 12.5 t -32.71 157.54 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.785 0.803 . . . . 0.0 111.961 -178.688 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -64.25 -38.38 90.83 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.963 -179.695 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.797 ' OE1' HD21 ' A' ' 28' ' ' LEU . 95.6 mm-40 -113.22 -6.67 13.6 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 123.474 0.484 . . . . 0.0 111.055 -179.015 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.605 ' CD2' ' HG1' ' A' ' 69' ' ' THR . 20.8 t60 14.28 -71.66 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 -178.982 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.577 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.3 136.06 45.22 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -177.352 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -125.99 125.56 42.87 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.69 178.827 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.6 mt -110.72 132.79 58.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.978 179.894 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.418 ' CD ' ' CE1' ' A' ' 54' ' ' HIS . 75.6 tt0 -115.64 124.78 51.78 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.487 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.6 mt -103.16 120.68 53.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 119.913 -0.715 . . . . 0.0 112.422 -178.309 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.592 ' O ' ' N ' ' A' ' 56' ' ' GLN . 2.4 m-70 -114.91 138.4 50.86 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.084 178.723 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.462 ' C ' ' O ' ' A' ' 54' ' ' HIS . 96.5 mt-10 -39.86 -23.88 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 -179.655 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.592 ' N ' ' O ' ' A' ' 54' ' ' HIS . 66.2 tp60 -68.49 -67.93 0.43 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.142 178.257 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -159.2 -163.38 1.2 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.74 -179.529 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.823 ' HB2' HH12 ' A' ' 5' ' ' ARG . . . -109.42 131.7 54.82 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.401 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 41.2 mm -112.23 125.08 69.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.068 -178.801 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.433 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 28.9 tp -100.43 125.63 46.73 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.805 0.336 . . . . 0.0 110.097 -179.849 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -115.68 136.96 52.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.157 179.456 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.558 HD22 ' HA ' ' A' ' 68' ' ' PRO . 50.6 t30 -100.54 106.73 18.28 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.4 -179.856 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -97.58 -6.93 32.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.587 179.462 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.48 100.6 0.87 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.886 179.563 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.2 m -83.25 -14.95 52.11 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.276 -0.569 . . . . 0.0 109.677 179.374 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.85 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.2 OUTLIER -91.5 -43.5 9.65 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.594 179.964 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.652 ' HB3' HD11 ' A' ' 91' ' ' ILE . 44.0 m-20 -146.97 101.66 3.88 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.452 -179.485 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.558 ' HA ' HD22 ' A' ' 62' ' ' ASN . 32.5 Cg_exo -56.04 150.53 46.97 Favored 'Trans proline' 0 N--CA 1.499 1.824 0 C-N-CA 122.664 2.243 . . . . 0.0 113.998 -178.795 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.605 ' HG1' ' CD2' ' A' ' 48' ' ' HIS . 11.3 m -71.57 136.99 47.68 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.794 178.987 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.556 ' O ' ' N ' ' A' ' 89' ' ' THR . 70.2 mt-30 -99.64 146.04 26.92 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.597 179.947 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.721 ' HB ' HD11 ' A' ' 76' ' ' ILE . 4.1 p -133.75 139.73 48.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.499 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 48.24 33.13 3.5 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -179.63 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.23 29.79 65.96 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.299 -179.549 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.442 ' N ' ' O ' ' A' ' 71' ' ' VAL . 18.2 t -140.67 137.32 33.46 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.975 -179.199 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.44 HG13 ' HB2' ' A' ' 68' ' ' PRO . 38.9 t -66.76 139.09 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.375 -179.321 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.721 HD11 ' HB ' ' A' ' 71' ' ' VAL . 89.8 mt -107.64 116.21 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.528 179.055 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 24.5 p-10 -87.75 -33.54 18.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.661 0.267 . . . . 0.0 111.064 179.274 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.455 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 5.0 pt-20 -128.88 174.05 4.95 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.949 -179.292 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -58.8 144.48 98.35 Favored 'Trans proline' 0 N--CA 1.501 1.929 0 C-N-CA 122.305 2.003 . . . . 0.0 112.513 -179.4 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.6 p -141.6 144.26 26.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.308 0.575 . . . . 0.0 111.689 179.747 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -77.6 132.98 38.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.095 179.611 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.543 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 91.2 mt -88.02 140.26 29.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.922 0.392 . . . . 0.0 111.146 -179.451 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -129.69 154.45 47.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.576 -179.87 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -54.46 117.81 3.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.038 0.447 . . . . 0.0 110.654 -179.502 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.81 -16.73 30.72 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 -179.396 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.544 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 45.3 t0 -69.94 126.52 29.94 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.185 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 49.7 t -102.5 135.58 38.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.006 -178.981 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 28.3 mm -92.59 129.03 43.77 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.605 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 177.485 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.654 HG23 ' OG ' ' A' ' 94' ' ' SER . 98.8 m -121.23 125.15 46.4 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 122.031 0.919 . . . . 0.0 112.597 -178.245 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.591 ' O ' ' N ' ' A' ' 93' ' ' ARG . 97.0 mt -117.38 132.47 67.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 113.993 -1.458 . . . . 0.0 107.924 177.919 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.652 HD11 ' HB3' ' A' ' 67' ' ' ASN . 69.7 mt -26.78 104.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 O-C-N 123.448 0.467 . . . . 0.0 111.257 -179.225 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.509 ' CG ' ' NE ' ' B' ' 245' ' ' ARG . 90.9 m-20 79.37 -16.51 0.66 Allowed 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 179.147 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.624 HH22 ' CD ' ' A' ' 12' ' ' ARG . 23.5 mtt85 -130.62 137.36 49.59 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.661 -0.415 . . . . 0.0 110.84 179.028 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.654 ' OG ' HG23 ' A' ' 89' ' ' THR . 48.2 m -138.82 152.42 47.85 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.156 0.503 . . . . 0.0 109.888 -179.989 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.563 ' HB3' HD11 ' A' ' 7' ' ' LEU . 79.1 m-85 -126.16 122.95 37.13 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.094 -179.61 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.531 ' O ' HD12 ' A' ' 7' ' ' LEU . 99.6 mtt180 -83.69 132.05 34.9 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.82 -179.59 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.611 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 72.5 t80 -96.87 127.16 42.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.691 -179.525 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -124.94 120.95 33.07 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.271 179.533 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 59.4 t-20 -116.82 110.11 17.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.044 179.988 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 . . . . . 0 C--N 1.331 -0.225 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.004 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 47.6 t . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.776 0.322 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.535 ' C ' ' H ' ' B' ' 231' ' ' GLN . 98.9 m-20 -74.13 145.64 44.14 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.875 0.369 . . . . 0.0 111.152 179.675 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.535 ' H ' ' C ' ' B' ' 229' ' ' ASP . 0.7 OUTLIER -115.84 -25.55 7.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.075 0.464 . . . . 0.0 110.625 179.898 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' B' B ' 232' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' B' ' 231' ' ' GLN . . . -41.01 172.14 0.01 OUTLIER Glycine 0 CA--C 1.527 0.814 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.416 -179.089 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.24 163.84 35.57 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 124.248 3.299 . . . . 0.0 112.731 179.73 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.85 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -79.52 142.97 16.74 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 121.645 1.563 . . . . 0.0 112.358 179.537 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 36.8 t -63.06 141.67 17.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.226 179.511 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 2.2 t -71.99 132.67 44.61 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.193 -179.72 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 238' ' ' TPO . . . . . 0.401 ' O3P' ' OG1' ' B' ' 240' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -57.5 -25.36 66.24 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 122.874 2.383 . . . . 0.0 112.834 -179.814 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 240' ' ' THR . . . . . 0.401 ' OG1' ' O3P' ' B' ' 238' ' ' TPO . 18.8 m -72.15 -44.96 62.3 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.212 0.529 . . . . 0.0 109.897 178.618 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.432 ' HZ ' HD22 ' A' ' 41' ' ' LEU . 87.5 t80 -55.92 -47.13 78.08 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.6 -179.439 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.437 ' CD2' ' OD1' ' A' ' 92' ' ' ASP . 93.3 mt -65.39 -41.49 93.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.776 -179.653 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -60.59 -40.68 92.64 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.738 -179.242 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -61.76 -42.44 98.99 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.785 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.716 ' O ' HG23 ' B' ' 249' ' ' VAL . 70.4 ttp85 -60.77 -43.56 97.88 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.559 -179.739 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.98 -42.11 97.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.986 0.422 . . . . 0.0 109.957 -179.548 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 73.9 m -66.64 -45.09 80.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.542 0.687 . . . . 0.0 109.292 178.303 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 248' ' ' GLN . . . . . 0.451 ' O ' ' N ' ' B' ' 252' ' ' LEU . 68.8 tp60 -59.84 -35.44 74.75 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.325 -179.992 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.716 HG23 ' O ' ' B' ' 245' ' ' ARG . 71.4 t -63.05 -47.58 91.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.063 179.887 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -60.85 -28.81 69.11 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 121.445 0.641 . . . . 0.0 109.404 179.685 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -90.7 -11.91 38.26 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.982 178.986 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.451 ' N ' ' O ' ' B' ' 248' ' ' GLN . 46.0 tp -76.51 145.55 39.05 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.581 -179.499 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -100.79 130.97 46.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.81 179.368 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 254' ' ' ASP . . . . . 0.476 ' C ' ' H ' ' B' ' 256' ' ' ASP . 37.8 t70 -63.44 -33.5 75.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.734 179.783 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -61.86 3.91 0.14 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.929 -179.726 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.476 ' H ' ' C ' ' B' ' 254' ' ' ASP . 27.9 t0 -93.71 86.39 5.13 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 120.24 -0.584 . . . . 0.0 110.781 -179.515 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -71.18 7.12 1.36 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.165 179.701 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.433 ' H ' ' C ' ' B' ' 256' ' ' ASP . 22.0 t0 -128.77 97.57 4.71 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.113 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.541 ' CG ' ' NH2' ' A' ' 93' ' ' ARG . 46.0 t0 -88.95 -90.69 0.13 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.339 -0.545 . . . . 0.0 111.23 -178.793 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -149.09 16.92 0.95 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.807 -179.186 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.466 ' CD1' HG23 ' A' ' 9' ' ' THR . 73.1 mt -109.87 132.86 56.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.183 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 262' ' ' VAL . . . . . 0.538 HG21 ' NH2' ' A' ' 38' ' ' ARG . 54.9 t -123.18 131.57 72.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.187 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -94.46 119.93 33.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.038 0.447 . . . . 0.0 111.723 -178.576 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -63.29 -48.45 78.08 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.899 179.74 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 265' ' ' GLN . . . . . 0.74 ' HG2' HD11 ' A' ' 24' ' ' LEU . 8.0 mp0 -89.34 160.3 42.71 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.609 -179.067 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -60.04 140.64 93.61 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.194 1.93 . . . . 0.0 111.727 179.867 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 267' ' ' ILE . . . . . 0.435 ' CD1' ' O ' ' A' ' 19' ' ' HIS . 3.2 tt . . . . . 0 C--N 1.324 -0.508 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.169 -179.249 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo . . . . . 0 N--CA 1.496 1.62 0 CA-C-O 120.574 0.156 . . . . 0.0 111.805 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.6 m -104.6 -55.92 2.27 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.945 0.402 . . . . 0.0 110.464 179.459 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.547 ' NH2' HG21 ' A' ' 53' ' ' ILE . 87.0 mtm-85 -100.51 131.51 46.38 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.026 -179.209 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -130.87 154.37 48.14 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.202 0.525 . . . . 0.0 111.995 -179.364 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.722 HD11 HD11 ' A' ' 22' ' ' LEU . 87.1 mt -119.96 141.93 49.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.625 179.387 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 45.9 t -115.53 129.83 71.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.787 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.0 m -88.46 111.98 22.42 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.426 0.631 . . . . 0.0 112.079 -178.14 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 35.5 mm -79.57 142.86 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.215 178.539 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -95.28 160.47 14.52 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.414 0.626 . . . . 0.0 111.189 -179.547 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.466 HH22 ' HB2' ' B' ' 248' ' ' GLN . 82.7 mtp180 -58.84 -27.53 65.21 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.94 179.41 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 93.8 p -74.11 -18.48 60.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.0 178.833 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.67 21.2 12.85 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-N 116.213 -0.449 . . . . 0.0 112.134 179.266 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.0 p -125.57 139.72 50.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.977 0.417 . . . . 0.0 110.189 179.897 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.447 ' OD1' ' N ' ' A' ' 16' ' ' ASP . 33.4 p-10 -84.72 149.14 25.99 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.463 -179.696 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -138.54 -97.85 0.42 Allowed Glycine 0 CA--C 1.53 1.021 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.768 -179.817 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.84 141.39 27.08 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.198 1.932 . . . . 0.0 112.395 -179.087 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -106.95 146.67 30.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.985 0.421 . . . . 0.0 110.375 -179.482 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -114.74 98.63 50.18 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.334 -179.931 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.32 133.52 14.75 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.872 1.715 . . . . 0.0 112.069 -178.411 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.722 HD11 HD11 ' A' ' 7' ' ' LEU . 92.2 mt -87.71 86.27 7.16 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.062 -178.806 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 89.5 p -83.65 -11.34 57.38 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.566 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.1 mt -109.15 154.86 21.74 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.378 -179.697 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 59.9 m -79.56 -8.53 59.23 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -178.648 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.477 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 24.2 m -126.43 129.14 48.14 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.827 -179.637 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.1 t -123.78 114.52 20.01 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.991 178.505 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.581 HD21 ' HG2' ' A' ' 47' ' ' GLN . 45.4 tp -112.25 128.49 56.27 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.451 -178.39 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.732 ' CE2' HD12 ' A' ' 37' ' ' ILE . 7.0 m-85 -110.36 130.9 55.46 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.482 -179.953 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 165.2 -176.65 40.84 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.411 178.692 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.639 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 81.5 mtm-85 -75.51 -30.96 59.98 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 122.483 -0.422 . . . . 0.0 112.032 -179.346 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -54.6 143.66 31.41 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 121.387 -0.435 . . . . 0.0 112.181 -178.131 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.48 HG23 ' N ' ' A' ' 34' ' ' GLU . 11.1 tp -64.43 -41.09 91.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.252 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.48 ' N ' HG23 ' A' ' 33' ' ' ILE . 80.8 tt0 -54.44 -15.95 2.0 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.357 179.5 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.7 m -69.16 133.13 47.59 Favored 'General case' 0 N--CA 1.461 0.1 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.989 -179.319 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.477 ' OD2' ' O ' ' A' ' 26' ' ' THR . 91.2 m-20 -59.95 -31.2 69.65 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.922 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.732 HD12 ' CE2' ' A' ' 29' ' ' PHE . 98.8 mt -126.68 124.59 65.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 177.008 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.429 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 70.1 ttt180 -110.64 133.49 53.27 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.54 -178.566 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 94.6 mt -118.17 131.4 71.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 121.073 0.463 . . . . 0.0 110.736 -179.148 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -75.89 32.79 0.12 Allowed 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -178.168 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.745 HD12 ' CZ ' ' A' ' 93' ' ' ARG . 52.9 mt -113.45 128.19 25.97 Favored Pre-proline 0 N--CA 1.471 0.581 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.306 179.571 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.84 -15.03 29.86 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.239 1.959 . . . . 0.0 113.269 -179.034 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.665 HG23 ' O ' ' B' ' 235' ' ' PRO . 2.9 p -86.05 -1.41 7.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.103 179.729 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.741 HG12 ' O ' ' A' ' 41' ' ' LEU . 5.3 p -95.1 139.28 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.958 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.463 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 0.5 OUTLIER -68.79 171.91 7.18 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.563 0.697 . . . . 0.0 112.456 -178.09 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.561 ' NZ ' ' O ' ' B' ' 231' ' ' GLN . 44.7 mttm -64.26 -45.36 88.45 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.592 -179.369 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.662 ' O ' ' N ' ' A' ' 49' ' ' CYS . 84.6 mt-30 -113.05 -12.75 13.16 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.781 -179.607 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.463 ' H ' ' HB3' ' A' ' 45' ' ' SER . 21.3 t60 33.86 -75.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.238 -0.892 . . . . 0.0 113.385 179.52 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.662 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.2 134.77 46.8 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.759 -178.466 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -127.67 127.55 43.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.422 179.769 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 92.8 mt -109.73 133.06 56.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.868 -179.635 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -115.72 117.47 30.35 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.012 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.547 HG21 ' NH2' ' A' ' 5' ' ' ARG . 90.1 mt -101.1 112.72 34.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 119.972 -0.691 . . . . 0.0 111.328 -178.691 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.427 ' O ' ' C ' ' A' ' 55' ' ' GLU . 92.7 m-70 -110.05 141.06 43.41 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.483 -1.235 . . . . 0.0 109.561 -179.685 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 54' ' ' HIS . 99.2 mt-10 -41.23 -36.05 0.71 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.234 0.54 . . . . 0.0 109.693 -179.895 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -60.38 -66.23 0.56 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.371 179.637 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -154.0 -174.01 4.8 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.13 -179.369 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.56 123.18 48.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.292 179.152 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.9 mt -117.42 131.42 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -178.679 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 24.2 tp -100.76 127.87 47.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.209 179.267 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -109.22 135.48 50.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.054 179.817 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.403 HD21 ' CA ' ' A' ' 68' ' ' PRO . 61.1 t-20 -96.71 108.34 20.96 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.999 0.428 . . . . 0.0 111.261 -179.263 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -101.25 -7.29 23.19 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.668 179.855 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.7 t -76.71 97.79 4.57 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.883 -179.877 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.1 p -78.39 -33.01 49.11 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.092 179.113 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.39 -44.47 51.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.044 -179.213 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.439 HD21 ' HA ' ' B' ' 236' ' ' VAL . 79.0 m-20 -139.54 94.78 9.24 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.082 -179.693 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.568 ' HB2' HG13 ' A' ' 75' ' ' VAL . 54.2 Cg_exo -54.48 147.23 48.59 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.522 2.148 . . . . 0.0 113.465 -179.725 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 59.3 m -77.05 149.06 35.83 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.115 179.095 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -110.08 141.06 43.46 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.711 -179.61 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.688 HG13 ' OD1' ' A' ' 86' ' ' ASP . 55.0 t -132.37 135.48 57.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.316 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 33.0 m120 52.99 33.34 14.51 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -178.711 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.6 28.98 70.17 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.153 179.495 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.2 t -143.74 142.83 31.12 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 117.037 0.419 . . . . 0.0 111.138 179.51 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.568 HG13 ' HB2' ' A' ' 68' ' ' PRO . 52.9 t -68.0 138.64 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.066 -0.516 . . . . 0.0 112.062 -179.193 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.409 HG21 HG11 ' A' ' 80' ' ' VAL . 2.6 pt -112.46 92.75 2.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-O 121.274 0.559 . . . . 0.0 109.899 178.369 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -63.98 -28.45 69.82 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.628 -179.743 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.439 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.8 OUTLIER -130.81 179.46 1.34 Allowed Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.801 -179.67 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.439 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 31.9 Cg_exo -60.58 146.19 97.48 Favored 'Trans proline' 0 N--CA 1.501 1.951 0 C-N-CA 123.137 2.558 . . . . 0.0 113.244 179.898 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.409 HG11 HG21 ' A' ' 76' ' ' ILE . 2.7 p -140.4 137.95 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.381 179.484 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 68.2 ttp85 -73.12 129.07 37.25 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.904 -0.319 . . . . 0.0 110.77 179.925 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 97.4 mt -81.2 139.58 35.44 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.355 0.598 . . . . 0.0 110.946 179.936 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -136.71 152.19 50.09 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.352 -179.748 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -52.15 114.82 1.45 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.927 0.394 . . . . 0.0 110.366 -179.797 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.81 -18.34 22.13 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.034 -0.827 . . . . 0.0 111.034 -179.718 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.688 ' OD1' HG13 ' A' ' 71' ' ' VAL . 53.3 t0 -66.21 129.49 40.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.276 0.56 . . . . 0.0 110.021 179.153 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.501 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 9.3 p -109.16 133.91 52.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.687 -179.051 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.1 mt -99.88 129.47 50.47 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.204 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.6 m -123.58 127.74 48.72 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.699 0.761 . . . . 0.0 112.761 -178.456 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.483 ' O ' ' N ' ' A' ' 93' ' ' ARG . 96.5 mt -117.37 125.82 74.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 114.44 -1.255 . . . . 0.0 108.551 177.626 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.555 HG22 ' N ' ' A' ' 92' ' ' ASP . 82.4 mt 36.55 -103.3 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.929 179.949 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.555 ' N ' HG22 ' A' ' 91' ' ' ILE . 89.8 m-20 -109.32 7.82 25.32 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.571 179.715 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.745 ' CZ ' HD12 ' A' ' 41' ' ' LEU . 40.9 mtm-85 -121.94 140.85 51.94 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -179.208 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.5 t -138.03 152.26 48.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.297 0.57 . . . . 0.0 111.091 -179.698 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -121.99 120.96 35.92 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.417 179.081 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 53.6 ttt85 -84.87 129.98 34.73 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.871 -179.197 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -93.74 122.84 36.61 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.208 -179.242 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -123.0 124.19 42.58 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.88 179.967 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 63.2 t-20 -105.42 102.78 12.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.055 -179.711 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 . . . . . 0 C--N 1.328 -0.357 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.785 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 88.8 t . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.77 0.319 . . . . 0.0 110.615 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.589 ' O ' ' CB ' ' B' ' 230' ' ' SEP . 85.4 m-20 -88.34 -2.02 58.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.799 179.64 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 230' ' ' SEP . . . . . 0.589 ' CB ' ' O ' ' B' ' 229' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.561 ' O ' ' NZ ' ' A' ' 46' ' ' LYS . 1.7 pt20 -150.28 7.59 0.6 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.005 -179.873 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 232' ' ' GLY . . . . . 0.511 ' O ' ' O ' ' B' ' 231' ' ' GLN . . . -48.27 -166.58 0.01 OUTLIER Glycine 0 CA--C 1.531 1.041 0 CA-C-N 116.527 -0.306 . . . . 0.0 112.748 -179.029 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -60.37 152.96 63.5 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 123.806 3.004 . . . . 0.0 112.998 -179.186 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' B' B ' 235' ' ' PRO . . . . . 0.665 ' O ' HG23 ' A' ' 43' ' ' VAL . 56.9 Cg_endo -74.44 130.88 14.35 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.446 1.431 . . . . 0.0 112.667 179.574 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.439 ' HA ' HD21 ' A' ' 67' ' ' ASN . 24.4 t -57.74 137.33 20.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.798 -179.61 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 7.0 t -65.8 122.57 17.61 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.257 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 238' ' ' TPO . . . . . 0.477 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 239' ' ' PRO . . . . . 0.477 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 34.0 Cg_exo -59.3 -24.51 74.59 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.558 2.172 . . . . 0.0 112.159 -179.612 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 91.3 m -73.57 -47.52 40.0 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-O 121.132 0.492 . . . . 0.0 109.732 178.894 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.48 ' CZ ' HG11 ' A' ' 43' ' ' VAL . 69.0 t80 -59.83 -45.66 91.69 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.71 -179.29 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 91.9 mt -64.5 -40.56 95.87 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.86 0.362 . . . . 0.0 110.887 -179.728 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -60.14 -42.11 94.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.351 -179.2 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 244' ' ' ARG . . . . . 0.511 ' O ' ' OG ' ' B' ' 247' ' ' SER . 89.4 mtm180 -65.3 -39.29 92.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.594 179.276 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.505 ' NH2' HH11 ' A' ' 93' ' ' ARG . 16.8 mmm180 -60.72 -43.66 97.57 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.863 -178.471 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -63.92 -40.19 95.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.208 0.528 . . . . 0.0 109.819 179.353 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 247' ' ' SER . . . . . 0.511 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 67.9 p -64.03 -44.72 91.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.625 179.182 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 248' ' ' GLN . . . . . 0.466 ' HB2' HH22 ' A' ' 12' ' ' ARG . 87.3 mt-30 -61.1 -33.79 73.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.68 179.665 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 55.4 t -63.38 -44.86 99.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 120.259 -0.577 . . . . 0.0 109.754 179.139 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -64.4 -28.64 69.82 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.129 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -84.76 -13.53 50.94 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.792 179.959 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 86.4 mt -103.35 -179.42 3.95 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.3 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -118.83 149.22 41.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.888 0.375 . . . . 0.0 110.877 179.981 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -65.99 -19.15 65.76 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.556 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -81.7 10.33 6.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.786 179.797 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -79.01 92.42 4.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.258 0.551 . . . . 0.0 109.771 179.665 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -67.61 -12.9 61.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.135 -0.938 . . . . 0.0 112.052 -178.632 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -126.14 101.96 7.0 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.211 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.587 ' CG ' ' H ' ' B' ' 260' ' ' GLU . 19.7 p-10 -89.57 -92.22 0.13 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.143 -179.563 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.587 ' H ' ' CG ' ' B' ' 259' ' ' ASP . 97.4 mt-10 -147.35 20.76 1.2 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.916 -179.994 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 66.8 mt -115.96 135.35 56.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.765 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 72.7 t -127.39 135.39 63.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.113 179.543 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -96.84 118.18 32.71 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.396 0.617 . . . . 0.0 110.769 -179.163 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -66.85 -46.72 74.18 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.066 -179.917 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -75.31 168.5 27.09 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.588 -179.083 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -64.64 144.17 83.45 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 121.356 1.371 . . . . 0.0 111.024 179.275 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 10.6 tt . . . . . 0 C--N 1.322 -0.613 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.534 -178.936 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo . . . . . 0 N--CA 1.499 1.814 0 CA-C-O 120.805 0.252 . . . . 0.0 112.325 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.4 m -71.82 -44.52 63.76 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.136 -179.65 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.96 ' NE ' HD13 ' A' ' 53' ' ' ILE . 86.2 mtm-85 -90.83 130.68 36.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.068 0.461 . . . . 0.0 111.328 -178.407 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.661 ' C ' HD12 ' A' ' 7' ' ' LEU . 99.8 mtt180 -135.41 143.0 45.74 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.966 179.677 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.661 HD12 ' C ' ' A' ' 6' ' ' ARG . 10.9 mp -120.08 139.33 52.71 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.93 0.395 . . . . 0.0 110.937 179.773 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.598 HG22 ' CD2' ' A' ' 19' ' ' HIS . 46.5 t -111.88 132.02 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.102 -179.729 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.411 HG23 HD12 ' B' ' 261' ' ' ILE . 9.0 m -84.21 139.37 32.43 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -178.286 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.2 mm -108.31 135.11 48.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.821 177.324 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.607 ' HZ3' ' HB3' ' B' ' 256' ' ' ASP . 96.4 mttt -90.8 159.93 16.03 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 177.802 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.534 HH11 ' HB2' ' B' ' 245' ' ' ARG . 90.9 mtm180 -56.2 -20.98 20.41 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.149 -179.42 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.9 m -83.62 -13.16 54.92 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.12 179.876 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.25 31.49 11.75 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.102 179.634 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.1 m -118.78 142.54 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 120.982 0.42 . . . . 0.0 111.77 -179.793 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -73.21 119.12 17.01 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.237 -179.151 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -110.96 -128.21 5.3 Favored Glycine 0 CA--C 1.54 1.654 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 -179.752 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -74.8 149.53 37.83 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 122.538 2.159 . . . . 0.0 113.209 -178.854 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.598 ' CD2' HG22 ' A' ' 8' ' ' VAL . 47.8 m170 -101.72 143.55 31.52 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.126 -179.665 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.764 ' CD2' HD11 ' A' ' 37' ' ' ILE . 39.0 t80 -113.42 92.52 23.48 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.192 179.53 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.463 ' HD2' HG22 ' B' ' 267' ' ' ILE . 94.4 Cg_endo -77.67 138.19 16.87 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 121.878 1.719 . . . . 0.0 111.767 -179.415 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 82.9 mt -101.65 125.54 48.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.454 0.645 . . . . 0.0 111.465 -179.007 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 82.9 p -120.34 -1.03 10.28 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.329 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.589 HD12 ' CD ' ' B' ' 265' ' ' GLN . 45.4 mt -111.37 152.83 26.86 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 114.402 -1.272 . . . . 0.0 109.398 -178.921 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.9 m -77.27 -11.76 59.87 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -177.818 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 20.7 m -127.31 130.92 50.4 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 120.131 -0.628 . . . . 0.0 112.03 -179.617 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.5 t -126.15 117.97 24.24 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.851 178.841 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.538 HD21 ' OE1' ' A' ' 47' ' ' GLN . 31.9 tp -113.57 134.97 54.4 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 120.838 0.351 . . . . 0.0 111.215 -178.851 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.511 ' O ' ' O ' ' A' ' 47' ' ' GLN . 79.0 m-85 -112.44 135.82 52.68 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.682 179.244 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 165.39 -164.94 37.56 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 120.617 -0.801 . . . . 0.0 111.422 179.784 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.614 ' NH2' ' O ' ' B' ' 232' ' ' GLY . 31.1 ptt-85 -103.41 -26.19 12.99 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.544 -0.462 . . . . 0.0 111.24 179.996 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -50.29 158.55 1.71 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 179.859 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.564 ' O ' ' NH2' ' A' ' 38' ' ' ARG . 7.9 tp -66.94 -41.87 88.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 117.644 0.722 . . . . 0.0 110.588 -179.22 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.448 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 80.4 tt0 -60.13 -19.68 54.72 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 -178.914 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.408 ' HA ' HD23 ' A' ' 28' ' ' LEU . 55.8 m -59.84 130.98 49.42 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.276 -0.57 . . . . 0.0 111.002 -179.238 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.565 ' CG ' ' NE2' ' B' ' 265' ' ' GLN . 74.2 m-20 -61.5 -32.65 72.69 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.907 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.764 HD11 ' CD2' ' A' ' 20' ' ' PHE . 46.6 mm -119.83 112.84 38.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.102 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.564 ' NH2' ' O ' ' A' ' 33' ' ' ILE . 74.0 mtt85 -98.95 131.16 45.22 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.579 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.642 HD13 ' HD2' ' A' ' 93' ' ' ARG . 91.8 mt -121.76 132.13 71.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.882 0.373 . . . . 0.0 110.711 -178.265 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -75.46 33.02 0.11 Allowed 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -177.664 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.683 HD12 ' CZ ' ' A' ' 93' ' ' ARG . 88.5 mt -115.19 123.76 31.21 Favored Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 120.261 -0.575 . . . . 0.0 110.159 179.138 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.95 -7.21 19.68 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.291 1.994 . . . . 0.0 113.427 -178.986 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.9 m -87.26 1.24 6.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 119.791 -0.763 . . . . 0.0 109.129 178.69 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.63 HG12 ' O ' ' A' ' 41' ' ' LEU . 2.4 p -96.29 138.39 21.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.262 178.533 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.449 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 3.7 t -75.22 173.36 10.93 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.592 0.71 . . . . 0.0 111.86 -178.348 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 43.6 mttp -64.13 -41.77 97.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.043 179.954 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.647 ' O ' ' N ' ' A' ' 49' ' ' CYS . 10.7 mm100 -109.72 -20.69 12.72 Favored 'General case' 0 C--N 1.334 -0.068 0 CA-C-O 120.766 0.317 . . . . 0.0 110.952 -179.691 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.449 ' H ' ' HB3' ' A' ' 45' ' ' SER . 15.1 t60 37.54 -77.81 0.0 OUTLIER 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.647 -179.862 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.647 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.65 135.31 45.76 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.331 0.586 . . . . 0.0 111.581 -179.337 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -126.02 131.83 52.12 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.157 179.844 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 99.2 mt -118.27 133.45 65.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.267 179.912 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.491 ' OE2' ' NE2' ' A' ' 61' ' ' HIS . 21.8 pt-20 -116.62 128.43 55.38 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.48 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.96 HD13 ' NE ' ' A' ' 5' ' ' ARG . 83.4 mt -107.53 114.92 47.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.506 -178.074 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.522 ' O ' ' N ' ' A' ' 56' ' ' GLN . 99.5 m-70 -113.28 144.7 42.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.983 179.894 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 54' ' ' HIS . 84.6 tt0 -39.62 -27.58 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -179.717 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.522 ' N ' ' O ' ' A' ' 54' ' ' HIS . 89.1 mt-30 -65.66 -68.99 0.32 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.534 178.798 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -161.25 -161.83 0.85 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.92 0.39 . . . . 0.0 111.073 179.23 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.431 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -111.35 125.15 53.55 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.781 179.42 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.7 mt -113.91 128.34 70.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.997 0.427 . . . . 0.0 111.39 -179.076 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.454 ' HB2' HD11 ' A' ' 82' ' ' LEU . 27.1 tp -98.19 128.35 44.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.928 -179.798 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.491 ' NE2' ' OE2' ' A' ' 52' ' ' GLU . 99.6 m-70 -116.3 138.11 51.59 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.711 -179.268 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -103.13 105.36 15.65 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 179.944 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -96.94 -4.41 40.01 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.93 178.988 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.65 100.83 11.1 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.044 179.355 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.2 m -87.64 -14.47 39.93 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.089 179.852 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.895 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.2 OUTLIER -85.71 -41.19 15.35 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.499 -179.849 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -144.2 95.05 5.64 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.486 179.702 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -64.65 150.86 87.51 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 121.28 1.32 . . . . 0.0 112.988 -178.483 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.6 m -72.73 137.45 45.93 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.829 -179.705 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -97.2 140.19 32.05 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.506 -0.478 . . . . 0.0 109.842 178.997 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.457 ' O ' ' N ' ' A' ' 74' ' ' SER . 7.3 p -129.43 135.95 60.47 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.504 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.131 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 48.86 29.83 2.46 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -178.78 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 76.11 25.07 67.29 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-N 115.045 -0.98 . . . . 0.0 112.18 179.94 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 71' ' ' VAL . 12.9 t -137.37 139.16 40.59 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 117.383 0.591 . . . . 0.0 111.733 -179.874 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.4 m -73.57 138.32 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.055 179.985 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.569 HG21 HG21 ' A' ' 80' ' ' VAL . 7.6 pt -105.15 94.25 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 121.184 0.516 . . . . 0.0 111.274 179.611 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -65.33 -33.62 76.4 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.226 179.285 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -121.16 167.35 13.42 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.404 -179.129 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -60.32 142.81 99.03 Favored 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 121.842 1.695 . . . . 0.0 112.104 -179.304 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.569 HG21 HG21 ' A' ' 76' ' ' ILE . 24.2 m -137.04 137.57 46.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.094 0.473 . . . . 0.0 110.834 179.237 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -71.56 133.09 45.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.947 179.705 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.454 HD11 ' HB2' ' A' ' 60' ' ' LEU . 92.8 mt -85.74 139.59 31.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.219 0.533 . . . . 0.0 110.604 179.872 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -123.97 151.23 43.89 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.319 179.824 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.439 ' ND1' ' N ' ' A' ' 99' ' ' ASN . 5.6 t60 -57.56 122.64 13.19 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.653 -179.67 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.47 -15.84 35.05 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 179.616 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -69.27 137.74 53.32 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.415 -179.766 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 40.6 t -110.17 130.56 63.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.964 0.411 . . . . 0.0 110.829 -179.239 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 88.0 mt -98.71 130.64 47.26 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 178.373 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 94.5 m -123.14 124.54 43.3 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 119.816 -0.754 . . . . 0.0 112.187 -178.866 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.496 ' O ' ' C ' ' A' ' 91' ' ' ILE . 92.1 mt -115.46 130.89 69.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.129 178.284 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.579 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 84.7 mt -15.68 98.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -178.059 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.453 ' OD1' ' NE ' ' B' ' 245' ' ' ARG . 23.7 m-20 85.23 -22.11 0.21 Allowed 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 177.617 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.683 ' CZ ' HD12 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -130.59 144.1 51.19 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.985 -179.676 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 66.8 p -137.96 153.97 49.41 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.177 0.513 . . . . 0.0 110.072 -179.859 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.667 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 81.8 m-85 -125.15 122.73 37.92 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.481 179.792 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -84.69 132.16 34.49 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.619 -179.627 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.619 ' CZ ' ' OD1' ' A' ' 99' ' ' ASN . 88.0 t80 -97.12 123.93 41.01 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.775 -179.525 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -134.49 127.52 31.58 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.673 179.954 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.619 ' OD1' ' CZ ' ' A' ' 97' ' ' TYR . 70.1 m-20 -103.32 128.09 50.48 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.916 0.389 . . . . 0.0 110.854 179.296 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.403 ' OE2' ' CZ ' ' A' ' 6' ' ' ARG . 95.9 mt-10 . . . . . 0 N--CA 1.464 0.24 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.126 -179.935 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 59.8 t . . . . . 0 N--CA 1.455 -0.199 0 CA-C-O 120.727 0.299 . . . . 0.0 111.538 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.547 ' O ' ' NE2' ' B' ' 231' ' ' GLN . 75.6 m-20 -60.85 151.21 30.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.151 0.5 . . . . 0.0 110.944 -179.773 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 230' ' ' SEP . . . . . 0.46 ' CB ' ' NE2' ' B' ' 231' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.547 ' NE2' ' O ' ' B' ' 229' ' ' ASP . 0.0 OUTLIER 179.16 61.9 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.443 179.529 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' B' B ' 232' ' ' GLY . . . . . 0.614 ' O ' ' NH2' ' A' ' 31' ' ' ARG . . . -132.68 161.44 24.02 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.905 -179.877 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -76.27 157.64 37.42 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 123.539 2.826 . . . . 0.0 112.49 179.031 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.895 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.53 136.05 16.99 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.438 2.092 . . . . 0.0 112.899 179.293 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.471 ' CG2' HG22 ' A' ' 66' ' ' THR . 78.6 t -61.48 139.4 20.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.184 -179.591 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 237' ' ' CYS . . . . . 0.466 ' HB2' HD13 ' A' ' 91' ' ' ILE . 3.8 t -67.86 136.06 53.49 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.279 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 238' ' ' TPO . . . . . 0.422 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 239' ' ' PRO . . . . . 0.422 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 45.2 Cg_exo -57.42 -27.46 76.08 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.979 2.452 . . . . 0.0 112.455 -179.918 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 240' ' ' THR . . . . . 0.416 ' OG1' ' O2P' ' B' ' 238' ' ' TPO . 28.4 m -69.07 -48.83 61.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.234 0.54 . . . . 0.0 110.194 178.557 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -60.15 -46.64 88.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.788 -178.62 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.421 ' CD2' ' OD1' ' A' ' 92' ' ' ASP . 97.3 mt -63.92 -41.19 97.72 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.761 -0.375 . . . . 0.0 111.964 -178.59 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -66.32 -39.96 89.62 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.167 -179.635 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -62.18 -48.96 77.74 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.162 -0.615 . . . . 0.0 112.274 -178.754 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.534 ' HB2' HH11 ' A' ' 12' ' ' ARG . 3.9 ppt_? -65.72 -37.61 86.89 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.074 -178.515 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 246' ' ' LYS . . . . . 0.439 ' N ' ' HG3' ' B' ' 245' ' ' ARG . 36.7 ttmt -62.73 -40.44 97.22 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.519 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 50.5 m -65.73 -41.79 91.81 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.945 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -56.79 -39.47 74.16 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.934 179.486 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 58.1 t -63.18 -45.51 98.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-O 121.079 0.466 . . . . 0.0 110.201 179.206 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -64.96 -36.12 83.35 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.853 179.08 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -80.87 -6.96 59.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.987 179.585 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.492 HD11 ' HD3' ' B' ' 257' ' ' LYS . 31.7 tp -63.45 135.72 57.11 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.268 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 253' ' ' ASN . . . . . 0.402 ' OD1' ' C ' ' B' ' 253' ' ' ASN . 12.3 t-20 -73.73 -46.06 48.27 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -176.967 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -96.32 3.32 53.06 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.479 -0.488 . . . . 0.0 109.936 -179.569 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 255' ' ' ASP . . . . . 0.522 ' O ' ' CG ' ' B' ' 256' ' ' ASP . 84.4 m-20 54.23 23.21 4.1 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.769 179.371 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.607 ' HB3' ' HZ3' ' A' ' 11' ' ' LYS . 7.8 m-20 178.03 -66.77 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 179.776 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 257' ' ' LYS . . . . . 0.492 ' HD3' HD11 ' B' ' 252' ' ' LEU . 13.3 ptmt 28.36 -110.41 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.715 -178.823 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -94.54 146.72 23.91 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.101 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.543 ' CG ' ' H ' ' B' ' 260' ' ' GLU . 33.1 t0 -91.37 -141.14 0.17 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.204 0.526 . . . . 0.0 110.763 -179.839 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.566 ' OE1' HD21 ' A' ' 41' ' ' LEU . 97.6 mt-10 -139.34 13.76 2.58 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.755 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.667 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 58.2 mt -114.77 137.51 47.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.947 -179.865 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 48.8 t -124.43 133.95 68.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.883 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -93.01 117.3 29.91 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.768 -178.262 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -67.33 -44.88 78.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.623 179.411 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 265' ' ' GLN . . . . . 0.589 ' CD ' HD12 ' A' ' 24' ' ' LEU . 33.6 mt-30 -88.84 152.41 48.69 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.039 -178.957 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -62.22 141.36 87.75 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.44 2.093 . . . . 0.0 113.259 179.878 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 267' ' ' ILE . . . . . 0.463 HG22 ' HD2' ' A' ' 21' ' ' PRO . 20.5 pt . . . . . 0 N--CA 1.463 0.209 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.827 179.026 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.474 ' HG2' ' HE ' ' A' ' 6' ' ' ARG . 43.1 Cg_endo . . . . . 0 N--CA 1.494 1.558 0 CA-C-O 120.918 0.299 . . . . 0.0 112.498 . . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.7 p -100.01 -44.11 6.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.675 -179.754 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.5 mtt85 -99.46 131.49 45.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.014 -179.731 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.474 ' HE ' ' HG2' ' A' ' 3' ' ' PRO . 99.5 mtt180 -135.66 144.71 46.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.343 179.27 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 83.2 mt -112.13 141.19 46.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.125 179.007 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 31.1 t -114.84 129.13 71.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.576 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.473 ' CG2' HD12 ' B' ' 261' ' ' ILE . 5.1 m -92.07 114.99 27.68 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -177.943 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.478 HD12 ' OG ' ' A' ' 94' ' ' SER . 96.7 mt -81.68 144.73 9.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.543 178.205 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.9 mttt -94.48 162.27 13.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.892 0.377 . . . . 0.0 110.436 179.221 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.554 ' NH2' ' CD1' ' B' ' 252' ' ' LEU . 86.8 mtm180 -57.89 -30.04 65.53 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.531 -178.969 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.562 ' OG ' HG22 ' A' ' 15' ' ' VAL . 78.2 p -76.28 -20.56 57.22 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.649 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.7 32.62 4.4 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.903 179.649 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.562 HG22 ' OG ' ' A' ' 13' ' ' SER . 6.7 m -128.07 134.47 65.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.881 0.372 . . . . 0.0 110.85 179.399 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -71.45 139.01 49.48 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.321 179.276 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -127.08 -118.1 2.15 Favored Glycine 0 CA--C 1.536 1.345 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -179.89 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.02 147.7 43.7 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 121.951 1.768 . . . . 0.0 112.619 -179.331 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -111.52 153.54 26.06 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.779 179.801 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -122.45 94.01 48.06 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.199 -178.598 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.52 127.99 25.67 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.145 1.897 . . . . 0.0 111.601 179.426 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.415 ' HA ' HD23 ' A' ' 22' ' ' LEU . 95.9 mt -82.77 56.42 3.39 Favored 'General case' 0 CA--C 1.522 -0.134 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.949 -179.733 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 91.9 p -62.74 -16.16 56.41 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.028 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.664 HD11 ' HG2' ' B' ' 265' ' ' GLN . 56.4 mt -91.92 143.15 26.79 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 114.761 -1.108 . . . . 0.0 110.676 -179.794 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.9 m -69.1 -17.02 63.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.697 -179.303 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.2 m -134.61 137.52 43.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.048 -179.874 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.615 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.6 OUTLIER -130.82 124.23 30.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.012 178.554 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.572 HD21 ' HG2' ' A' ' 47' ' ' GLN . 52.4 tp -118.36 128.72 54.91 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.966 0.412 . . . . 0.0 112.03 -177.758 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.615 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 60.5 m-85 -103.49 124.25 48.4 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.951 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 176.35 -178.23 47.74 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 119.822 -1.18 . . . . 0.0 112.965 179.449 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 46.2 mtm180 -80.05 -28.53 39.22 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.807 0.337 . . . . 0.0 110.6 179.034 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -54.66 143.35 32.22 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 -178.985 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.3 mm -64.92 -43.17 96.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.177 0.513 . . . . 0.0 109.816 179.166 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -55.91 -20.3 15.36 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.086 -179.851 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 38.5 m -63.95 131.05 46.49 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.509 -179.918 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 37' ' ' ILE . 6.6 p-10 -59.47 -30.39 68.5 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.838 -178.956 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.535 ' N ' ' OD1' ' A' ' 36' ' ' ASP . 96.5 mt -126.14 121.43 59.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.528 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 77.1 ttt-85 -110.51 136.89 48.95 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.061 -178.377 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.723 HG21 HD12 ' A' ' 41' ' ' LEU . 82.9 mt -119.61 131.35 72.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.922 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -75.56 24.0 0.12 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.246 -179.1 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.723 HD12 HG21 ' A' ' 39' ' ' ILE . 24.6 mt -89.31 122.96 68.09 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.365 179.808 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.73 -14.86 30.17 Favored 'Trans proline' 0 N--CA 1.488 1.177 0 C-N-CA 121.783 1.655 . . . . 0.0 112.594 -179.72 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.624 HG21 ' CE2' ' B' ' 241' ' ' PHE . 1.1 m -93.65 3.41 8.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.087 179.913 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.451 HG12 ' O ' ' A' ' 45' ' ' SER . 25.0 t -89.44 137.02 22.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 120.441 -0.504 . . . . 0.0 109.945 179.069 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.451 ' O ' HG12 ' A' ' 44' ' ' VAL . 2.3 m -68.61 171.98 6.87 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.568 0.699 . . . . 0.0 111.504 -179.596 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -63.4 -43.58 97.15 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.659 -179.802 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.623 ' O ' ' N ' ' A' ' 49' ' ' CYS . 89.9 mt-30 -116.94 -20.53 9.36 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.805 179.904 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.3 t60 36.21 -78.58 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 179.491 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.623 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -125.89 133.82 51.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.217 0.532 . . . . 0.0 112.194 -178.847 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -126.51 129.91 49.56 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.688 179.827 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.6 mt -113.71 132.91 61.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.984 0.421 . . . . 0.0 110.419 179.01 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.461 ' OE2' ' CE1' ' A' ' 54' ' ' HIS . 83.4 tt0 -118.08 125.35 50.14 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 178.62 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 93.4 mt -108.63 123.04 64.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.808 0.813 . . . . 0.0 112.855 -178.155 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.554 ' O ' ' N ' ' A' ' 56' ' ' GLN . 98.0 m-70 -115.85 139.05 50.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.258 -1.337 . . . . 0.0 109.285 179.143 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.482 ' C ' ' O ' ' A' ' 54' ' ' HIS . 83.5 tt0 -39.99 -26.25 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -179.666 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.554 ' N ' ' O ' ' A' ' 54' ' ' HIS . 91.5 mt-30 -64.46 -68.97 0.31 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.027 177.812 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -159.7 -161.89 0.96 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.578 179.81 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -118.41 131.79 56.27 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.517 179.99 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.0 mt -117.57 129.21 74.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-O 121.387 0.613 . . . . 0.0 111.727 -179.301 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.546 ' HB2' HD11 ' A' ' 82' ' ' LEU . 28.2 tp -98.68 127.31 44.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.338 -179.782 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -111.79 135.48 52.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.21 179.858 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.41 HD21 ' CA ' ' A' ' 68' ' ' PRO . 62.7 t-20 -94.77 106.99 19.01 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.42 179.995 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -99.38 -10.38 22.33 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 179.53 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.446 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 7.4 t -76.22 98.62 4.49 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.727 -179.565 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.9 p -80.71 -35.16 33.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.143 0.497 . . . . 0.0 109.768 178.671 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.5 m -65.16 -49.65 69.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.692 179.859 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.446 ' O ' ' OG ' ' A' ' 64' ' ' SER . 0.6 OUTLIER -136.57 96.35 12.17 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.461 179.535 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.48 ' HB2' HG13 ' A' ' 75' ' ' VAL . 32.5 Cg_exo -55.38 144.73 71.15 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.105 1.87 . . . . 0.0 112.082 -179.204 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.7 m -73.76 146.81 44.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.332 179.831 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -110.29 141.25 43.54 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.782 179.955 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 42.0 t -127.92 134.27 65.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.426 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 52.54 30.53 8.6 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -179.447 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.65 25.47 69.85 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.74 179.792 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 58.3 m -136.52 138.48 41.38 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.452 -179.642 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.48 HG13 ' HB2' ' A' ' 68' ' ' PRO . 44.4 t -68.94 138.28 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.433 179.982 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.9 pt -116.19 85.88 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.202 179.502 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.524 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 15.4 p-10 -66.47 -26.57 67.25 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.538 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -114.04 159.54 35.83 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.333 179.7 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -66.75 149.45 83.61 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.772 2.315 . . . . 0.0 111.822 179.278 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.2 m -141.45 144.42 26.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.692 -179.427 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -71.68 130.72 41.85 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.281 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.546 HD11 ' HB2' ' A' ' 60' ' ' LEU . 96.9 mt -81.89 138.82 34.95 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.096 0.474 . . . . 0.0 111.93 -178.738 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -130.91 151.65 51.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.715 179.585 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -57.0 121.1 9.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.893 0.378 . . . . 0.0 111.145 -179.228 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.13 -17.28 19.68 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 179.48 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -71.4 134.68 46.83 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.269 0.557 . . . . 0.0 111.082 -179.784 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 68.1 t -111.02 133.86 55.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.713 -179.361 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 79.1 mt -103.58 133.4 47.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.366 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 84.8 m -121.59 131.24 54.01 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.789 0.804 . . . . 0.0 112.589 -178.53 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 76.5 mt -123.47 126.46 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 114.29 -1.323 . . . . 0.0 108.783 179.247 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.469 HG22 ' N ' ' A' ' 92' ' ' ASP . 44.9 mm 43.42 -107.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.002 -179.253 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.562 ' HB3' ' HE ' ' B' ' 245' ' ' ARG . 45.7 t0 -114.89 16.59 17.22 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.943 0.402 . . . . 0.0 111.048 -179.795 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.422 HH22 ' HB2' ' B' ' 259' ' ' ASP . 17.4 mtp180 -130.78 148.22 52.54 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.067 179.4 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.478 ' OG ' HD12 ' A' ' 10' ' ' ILE . 19.4 p -138.64 157.35 46.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.966 0.412 . . . . 0.0 110.839 -179.23 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.574 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 66.7 m-85 -124.0 121.62 35.73 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.563 179.086 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -80.2 131.67 35.74 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.306 -179.78 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -96.62 121.28 38.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.955 -179.865 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -121.49 122.87 40.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.118 -179.89 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 60.4 t-20 -112.27 104.36 12.54 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.324 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 . . . . . 0 C--N 1.326 -0.43 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.583 -179.893 . . . . . . . . 0 0 . 1 . 031 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.462 0.158 0 CA-C-O 120.944 0.402 . . . . 0.0 111.102 . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.542 ' C ' ' H ' ' B' ' 231' ' ' GLN . 99.0 m-20 -70.56 142.39 51.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.186 179.536 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 230' ' ' SEP . . . . . 0.642 ' P ' ' H ' ' B' ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.542 ' H ' ' C ' ' B' ' 229' ' ' ASP . 77.2 mt-30 -135.43 26.57 3.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.12 179.664 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -111.3 -140.9 8.4 Favored Glycine 0 CA--C 1.539 1.54 0 N-CA-C 111.636 -0.586 . . . . 0.0 111.636 -179.618 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -77.32 161.61 31.73 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.742 2.295 . . . . 0.0 113.209 -178.943 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -60.6 152.07 71.23 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 122.95 2.433 . . . . 0.0 112.38 179.714 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.411 ' O ' HG13 ' B' ' 236' ' ' VAL . 4.4 p -101.72 129.5 52.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.945 179.381 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 53.2 t -73.65 130.79 40.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.143 -179.341 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -57.48 -24.18 59.91 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 122.824 2.349 . . . . 0.0 112.589 179.77 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 96.3 m -73.5 -46.75 46.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.48 179.3 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.624 ' CE2' HG21 ' A' ' 43' ' ' VAL . 72.2 t80 -59.91 -45.35 92.84 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.588 -179.123 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' B' ' 242' ' ' LEU . 93.9 mt -64.71 -39.25 93.33 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.018 0.437 . . . . 0.0 110.218 179.397 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -61.75 -42.83 99.48 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.339 -179.368 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -62.37 -40.67 97.21 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.231 179.903 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.63 ' NH1' HD21 ' A' ' 41' ' ' LEU . 77.6 mtp85 -60.84 -41.97 96.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.166 -179.943 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.22 -40.8 98.49 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 179.247 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 10.9 t -65.26 -46.71 79.44 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.855 178.448 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -60.12 -39.11 85.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.247 -179.549 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.443 HG23 ' O ' ' B' ' 245' ' ' ARG . 45.3 t -60.81 -44.21 97.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.291 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -64.83 -30.83 71.85 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.479 179.252 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -83.24 -11.92 57.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.586 -179.775 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.554 ' CD1' ' NH2' ' A' ' 12' ' ' ARG . 77.2 mt -96.04 178.55 5.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.07 0.462 . . . . 0.0 110.091 179.05 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 253' ' ' ASN . . . . . 0.567 ' O ' ' N ' ' B' ' 255' ' ' ASP . 8.7 p-10 -155.56 -170.49 3.45 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.108 179.668 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 254' ' ' ASP . . . . . 0.407 ' C ' ' O ' ' B' ' 253' ' ' ASN . 28.7 t70 -39.39 -22.32 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.234 0.54 . . . . 0.0 110.515 -179.706 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 255' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' B' ' 253' ' ' ASN . 95.7 m-20 -63.42 -11.07 20.27 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.045 179.666 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' B' ' 253' ' ' ASN . 18.6 p-10 -80.25 20.84 0.64 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.351 -179.957 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -58.9 -28.88 66.6 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.003 179.957 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -80.15 130.44 35.23 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 177.938 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.658 ' C ' ' H ' ' B' ' 261' ' ' ILE . 49.2 p-10 -103.39 128.9 50.4 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.37 0.605 . . . . 0.0 111.314 -178.858 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -54.93 5.41 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.7 179.026 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.658 ' H ' ' C ' ' B' ' 259' ' ' ASP . 78.5 mt -101.89 137.58 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 178.312 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 64.6 t -126.64 134.3 66.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.79 -178.95 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -96.73 119.54 35.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.111 0.481 . . . . 0.0 111.231 -178.672 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -64.66 -40.66 95.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.454 179.532 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 265' ' ' GLN . . . . . 0.664 ' HG2' HD11 ' A' ' 24' ' ' LEU . 2.4 mp0 -101.96 160.82 25.3 Favored Pre-proline 0 N--CA 1.464 0.247 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.431 -179.242 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -70.94 145.76 51.13 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 122.595 2.197 . . . . 0.0 113.221 -179.105 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.4 pt . . . . . 0 C--N 1.326 -0.434 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.197 178.86 . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo . . . . . 0 N--CA 1.494 1.507 0 CA-C-O 121.191 0.413 . . . . 0.0 112.998 . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.7 p -125.7 28.85 6.1 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.636 179.373 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.596 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 92.4 mtt-85 -88.17 131.49 34.71 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.951 -179.526 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.5 mtp180 -133.27 141.03 47.8 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 120.312 -0.555 . . . . 0.0 112.389 -179.274 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.609 HD11 ' HB3' ' A' ' 95' ' ' PHE . 40.0 tp -117.42 132.97 56.47 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.243 179.488 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.511 HG13 ' CE1' ' A' ' 19' ' ' HIS . 53.0 t -108.37 131.07 59.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.897 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.407 ' CG2' HD12 ' B' ' 261' ' ' ILE . 1.7 m -93.71 117.45 30.1 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.346 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.489 ' CD1' ' OD1' ' A' ' 16' ' ' ASP . 48.3 mm -82.27 143.28 12.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.645 179.649 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -90.97 160.48 15.62 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 177.701 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.409 ' CG ' ' NH1' ' A' ' 93' ' ' ARG . 83.4 mtm180 -57.0 -24.48 53.93 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.962 -178.442 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 68.6 p -83.9 -8.26 59.23 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.922 179.754 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.21 35.12 9.03 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 179.887 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 32.2 t -117.3 132.49 66.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 -179.997 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.489 ' OD1' ' CD1' ' A' ' 10' ' ' ILE . 92.4 m-20 -70.04 133.46 47.23 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.656 -0.418 . . . . 0.0 109.952 179.762 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -126.03 -122.26 2.57 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.593 -179.547 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -72.91 145.92 41.18 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.002 1.801 . . . . 0.0 112.575 -179.036 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.511 ' CE1' HG13 ' A' ' 8' ' ' VAL . 4.8 m-70 -107.83 143.44 36.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.132 0.491 . . . . 0.0 111.126 -179.331 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.533 ' CD2' HD11 ' A' ' 37' ' ' ILE . 25.8 t80 -115.04 93.96 36.8 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.069 -179.207 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -56.79 124.4 16.15 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 121.896 1.731 . . . . 0.0 111.681 179.136 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.7 mt -87.79 41.73 1.01 Allowed 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.384 -179.781 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.8 p -64.7 -20.44 66.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.788 179.594 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.8 mt -74.04 142.09 45.73 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.568 179.778 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 73.8 p -61.42 -25.15 67.02 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.362 -179.21 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 45.3 m -134.69 134.33 40.97 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.221 -0.592 . . . . 0.0 111.534 179.917 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.692 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -128.37 120.2 26.51 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.069 178.345 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.522 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 43.4 tp -120.03 124.96 47.18 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.999 -177.02 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.692 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 38.8 m-85 -101.37 140.83 35.12 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.23 179.282 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 158.67 -173.58 35.67 Favored Glycine 0 N--CA 1.464 0.536 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.156 178.269 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.63 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 72.2 mtm-85 -83.29 -30.74 27.33 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.876 0.37 . . . . 0.0 110.21 179.895 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.561 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -56.29 152.08 21.15 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 121.126 -0.559 . . . . 0.0 111.728 -178.26 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.578 HD12 ' HD3' ' A' ' 38' ' ' ARG . 7.1 tp -66.7 -40.51 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.677 179.958 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.418 ' N ' HG23 ' A' ' 33' ' ' ILE . 96.9 mt-10 -53.69 -21.39 6.92 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.293 179.972 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.561 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 4.2 m -63.88 115.78 5.17 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.118 -179.974 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.594 ' OD1' ' N ' ' A' ' 37' ' ' ILE . 39.2 p-10 -50.97 -24.59 3.79 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.758 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.673 HD12 ' CE2' ' A' ' 29' ' ' PHE . 94.2 mt -130.67 123.49 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.223 178.062 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.578 ' HD3' HD12 ' A' ' 33' ' ' ILE . 88.2 mtm-85 -103.97 134.66 46.88 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.4 -0.52 . . . . 0.0 109.801 -179.434 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.717 HG21 HD12 ' A' ' 41' ' ' LEU . 98.1 mt -117.91 130.54 72.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.064 0.459 . . . . 0.0 109.796 -179.809 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -79.23 30.37 0.22 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.201 -179.043 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.717 HD12 HG21 ' A' ' 39' ' ' ILE . 33.9 mt -94.8 123.24 58.44 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.476 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.99 -10.76 26.59 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 121.856 1.704 . . . . 0.0 112.047 -179.386 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.6 m -100.51 8.31 8.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.771 -179.211 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.63 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 42.2 t -100.63 136.75 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.459 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.448 ' HB2' ' H ' ' A' ' 48' ' ' HIS . 2.7 m -67.66 169.47 9.4 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.317 0.579 . . . . 0.0 111.478 -179.179 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -62.26 -40.35 95.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.455 -179.474 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.697 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.1 mt-30 -114.59 -11.19 12.42 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 123.348 0.405 . . . . 0.0 111.357 -179.933 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.448 ' H ' ' HB2' ' A' ' 45' ' ' SER . 22.8 t60 31.86 -73.45 0.0 OUTLIER 'General case' 0 C--O 1.237 0.423 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 179.649 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.697 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -134.95 139.5 44.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.284 0.564 . . . . 0.0 112.324 -178.621 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -125.42 128.68 48.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.049 179.323 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 94.6 mt -115.45 133.3 62.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.016 -179.552 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -115.5 127.25 55.17 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.859 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.563 HD13 ' HD2' ' A' ' 5' ' ' ARG . 75.9 mt -108.36 111.99 38.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.95 -179.386 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.538 ' O ' ' N ' ' A' ' 56' ' ' GLN . 82.3 m-70 -110.8 143.94 40.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.541 -179.598 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 54' ' ' HIS . 96.9 mt-10 -41.06 -24.84 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.532 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.538 ' N ' ' O ' ' A' ' 54' ' ' HIS . 94.2 mm-40 -68.8 -68.8 0.37 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.463 178.712 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.595 ' CB ' ' HE ' ' A' ' 81' ' ' ARG . 5.1 tp10 -159.17 -167.76 2.16 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.328 179.895 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.539 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -110.67 125.33 53.34 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.937 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.14 129.54 71.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.353 0.596 . . . . 0.0 112.391 -177.757 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.5 HD11 ' SG ' ' A' ' 49' ' ' CYS . 49.3 tp -94.72 123.45 38.17 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.38 -179.431 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -111.68 136.47 50.87 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.362 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -97.94 105.41 17.55 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.734 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -96.08 -7.32 36.44 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.682 178.976 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 10.1 t -79.46 100.8 7.85 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.279 178.798 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.0 m -84.74 -17.77 37.26 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.084 0.469 . . . . 0.0 110.025 179.577 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.461 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.3 OUTLIER -89.05 -36.61 15.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.602 -179.845 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.437 ' O ' ' OG ' ' A' ' 64' ' ' SER . 79.5 m-20 -144.12 95.24 5.64 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.398 179.765 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.96 146.78 85.49 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.128 1.885 . . . . 0.0 112.658 -179.098 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.5 m -70.71 134.89 47.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.278 178.792 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -99.71 139.77 34.89 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.57 179.989 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 31.4 t -130.49 135.93 59.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 178.706 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 53.42 31.72 12.63 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -178.613 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.37 29.5 70.04 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.152 -179.866 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 81.1 p -137.63 130.5 30.16 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 120.446 -0.502 . . . . 0.0 111.999 -179.283 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.4 t -63.7 141.43 18.16 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.935 179.581 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.584 ' CG2' ' O ' ' A' ' 78' ' ' GLU . 96.3 mt -112.14 111.15 34.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.352 179.511 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -76.31 -34.34 59.04 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.801 179.579 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.584 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.1 OUTLIER -131.51 178.13 1.9 Allowed Pre-proline 0 N--CA 1.468 0.445 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.874 -179.734 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 35.5 Cg_exo -57.13 141.5 94.31 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 122.522 2.148 . . . . 0.0 112.739 -179.079 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.4 t -133.19 138.07 52.17 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.132 179.75 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.595 ' HE ' ' CB ' ' A' ' 57' ' ' GLU . 73.3 ttt180 -74.62 131.46 40.94 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.633 179.28 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.425 HD21 ' HB2' ' A' ' 60' ' ' LEU . 91.2 mt -87.25 140.97 29.01 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.16 0.505 . . . . 0.0 112.272 -178.645 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -134.4 156.12 49.09 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.406 179.59 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.573 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 6.3 t60 -56.77 120.17 7.41 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.868 0.366 . . . . 0.0 111.44 -179.359 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.33 -21.23 22.25 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.52 179.316 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -65.84 135.54 54.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.254 0.55 . . . . 0.0 110.341 -179.788 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.2 t -113.37 133.79 58.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.233 -178.213 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.7 mt -98.35 130.17 47.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.678 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 55.1 m -120.02 124.64 46.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.531 0.682 . . . . 0.0 112.26 -178.818 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.482 HG22 HG12 ' A' ' 91' ' ' ILE . 93.3 mt -115.54 124.0 71.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.091 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.548 HG23 ' SG ' ' B' ' 237' ' ' CYS . 27.5 mm 43.89 -106.49 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -178.812 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.608 ' OD1' ' NH2' ' B' ' 245' ' ' ARG . 40.6 p-10 -114.93 12.73 16.9 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.076 0.465 . . . . 0.0 110.473 179.273 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.515 ' CD ' HD11 ' B' ' 261' ' ' ILE . 6.1 ttp180 -120.39 143.62 48.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.577 179.732 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 38.2 t -137.7 152.83 49.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.353 0.596 . . . . 0.0 111.371 -178.76 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.609 ' HB3' HD11 ' A' ' 7' ' ' LEU . 46.5 m-85 -120.42 120.73 36.8 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.803 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.483 ' O ' HD12 ' A' ' 7' ' ' LEU . 99.7 mtt180 -84.04 131.69 34.79 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.363 -178.562 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.596 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 84.0 t80 -94.26 124.2 38.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.65 179.813 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -129.92 123.26 30.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.009 0.433 . . . . 0.0 111.638 -179.702 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.573 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 65.0 t-20 -112.56 110.95 21.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.841 179.121 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 99' ' ' ASN . 79.3 mm-40 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.819 0.342 . . . . 0.0 110.48 -179.357 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 228' ' ' VAL . . . . . 0.413 ' O ' HG22 ' B' ' 228' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.453 -0.3 0 CA-C-O 121.25 0.548 . . . . 0.0 110.925 . . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.626 ' C ' ' H ' ' B' ' 231' ' ' GLN . 68.4 t0 -161.08 78.73 0.59 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.544 179.454 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 230' ' ' SEP . . . . . 0.473 ' O ' ' OE1' ' B' ' 231' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.626 ' H ' ' C ' ' B' ' 229' ' ' ASP . 25.7 mm100 -131.57 76.77 1.73 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.392 -179.931 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 232' ' ' GLY . . . . . 0.527 ' O ' ' NH2' ' A' ' 31' ' ' ARG . . . -136.48 172.38 22.5 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.029 -179.476 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.48 159.84 48.15 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 123.983 3.122 . . . . 0.0 113.112 -179.832 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.461 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.15 140.37 27.92 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 121.903 1.735 . . . . 0.0 112.889 -178.933 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.435 ' HA ' HD21 ' A' ' 67' ' ' ASN . 31.3 t -59.63 134.78 24.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.794 -179.672 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 237' ' ' CYS . . . . . 0.548 ' SG ' HG23 ' A' ' 91' ' ' ILE . 8.6 t -62.03 129.78 42.47 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -179.861 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -60.38 -20.77 64.79 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 121.912 1.742 . . . . 0.0 112.165 179.801 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 76.0 m -72.88 -44.46 61.28 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 178.337 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.464 ' CE2' ' HD2' ' B' ' 245' ' ' ARG . 63.3 t80 -58.75 -47.64 83.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.29 -179.465 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' B' ' 242' ' ' LEU . 89.2 mt -64.59 -42.49 95.55 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -179.386 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -65.52 -38.72 90.49 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.521 -0.472 . . . . 0.0 111.136 -179.08 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -61.77 -44.08 97.59 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.855 179.78 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.608 ' NH2' ' OD1' ' A' ' 92' ' ' ASP . 82.2 mtp180 -63.16 -37.66 88.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.089 -179.028 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.82 -39.4 91.65 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.359 -0.537 . . . . 0.0 109.99 179.225 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 61.9 m -67.49 -43.79 80.1 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.571 0.701 . . . . 0.0 109.516 178.274 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -60.82 -37.35 81.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.699 -179.863 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.456 HG23 ' O ' ' B' ' 245' ' ' ARG . 50.0 t -63.91 -44.7 98.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.185 179.61 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -59.29 -26.35 64.89 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.341 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -95.24 -7.1 39.94 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.153 178.666 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 58.0 tp -78.54 149.44 33.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.503 -179.44 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -103.7 142.14 34.86 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.083 179.221 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 254' ' ' ASP . . . . . 0.405 ' C ' ' H ' ' B' ' 256' ' ' ASP . 99.8 m-20 -64.82 -21.72 66.84 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.821 0.343 . . . . 0.0 111.082 -179.229 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -63.4 -5.48 3.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.21 0.529 . . . . 0.0 109.81 179.557 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.572 ' OD1' ' N ' ' B' ' 257' ' ' LYS . 55.5 t0 -66.64 147.95 52.57 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.636 -179.844 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 257' ' ' LYS . . . . . 0.572 ' N ' ' OD1' ' B' ' 256' ' ' ASP . 99.0 mttt -139.5 159.33 42.41 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.395 179.47 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.527 ' O ' ' C ' ' B' ' 259' ' ' ASP . 13.4 m-20 46.2 16.24 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.058 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.544 ' N ' ' C ' ' B' ' 257' ' ' LYS . 36.2 t0 5.52 -80.96 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 114.477 -1.238 . . . . 0.0 112.037 -179.468 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.418 ' HB2' ' NH2' ' A' ' 93' ' ' ARG . 96.5 mt-10 -141.67 13.14 2.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.0 0.429 . . . . 0.0 110.408 179.518 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.515 HD11 ' CD ' ' A' ' 93' ' ' ARG . 74.0 mt -112.93 137.64 45.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.684 179.978 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 262' ' ' VAL . . . . . 0.496 HG11 ' NH2' ' A' ' 38' ' ' ARG . 41.3 t -126.86 134.15 66.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.906 0.384 . . . . 0.0 110.579 179.891 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 263' ' ' PHE . . . . . 0.44 ' CD2' HG21 ' B' ' 267' ' ' ILE . 84.0 m-85 -97.55 122.26 40.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.979 0.418 . . . . 0.0 111.961 -178.528 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 264' ' ' LYS . . . . . 0.451 ' HA ' HH12 ' A' ' 38' ' ' ARG . 87.4 tttt -62.56 -44.9 95.2 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.663 179.578 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -99.52 164.97 15.59 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.01 179.977 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.72 153.13 51.63 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.392 2.062 . . . . 0.0 112.099 179.567 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 267' ' ' ILE . . . . . 0.485 HG22 ' HD1' ' A' ' 20' ' ' PHE . 36.4 pt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.089 -178.576 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.495 ' HG2' HH21 ' A' ' 6' ' ' ARG . 73.2 Cg_endo . . . . . 0 N--CA 1.495 1.566 0 CA-C-O 120.71 0.213 . . . . 0.0 112.468 . . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 51.0 p -116.87 -52.05 2.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.858 179.89 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.933 ' NH1' HG23 ' A' ' 53' ' ' ILE . 99.2 mtt180 -99.52 129.73 45.71 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.556 -178.78 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.495 HH21 ' HG2' ' A' ' 3' ' ' PRO . 99.8 mtt180 -129.23 143.08 50.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.495 -179.726 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.524 HD11 HD11 ' A' ' 22' ' ' LEU . 90.9 mt -113.29 136.37 52.82 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.697 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 50.0 t -112.94 131.92 63.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.839 -0.345 . . . . 0.0 110.303 -179.384 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.428 ' CG2' HD12 ' B' ' 261' ' ' ILE . 5.2 m -90.07 115.88 27.67 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 -177.722 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.47 HD12 ' HB2' ' A' ' 94' ' ' SER . 96.8 mt -85.09 142.22 13.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.292 178.153 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -91.42 159.98 15.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.97 0.414 . . . . 0.0 110.515 179.36 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 88.9 mtm180 -58.05 -29.53 65.45 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.792 -179.229 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.1 p -76.75 -17.3 59.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.86 0.362 . . . . 0.0 110.544 179.471 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.93 32.75 5.5 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -179.679 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.4 t -121.35 132.46 70.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.054 0.454 . . . . 0.0 111.106 -179.994 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -78.23 138.44 38.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.667 178.883 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.7 -115.72 1.67 Allowed Glycine 0 CA--C 1.533 1.162 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.467 179.936 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.11 148.56 56.63 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 121.841 1.694 . . . . 0.0 112.433 -179.392 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.515 ' CE1' ' HD3' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -113.13 158.05 20.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.016 0.436 . . . . 0.0 109.921 179.701 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.747 ' CD2' HD11 ' A' ' 37' ' ' ILE . 48.1 t80 -120.53 101.31 46.32 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.164 -179.044 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.515 ' HD3' ' CE1' ' A' ' 19' ' ' HIS . 59.7 Cg_endo -75.2 131.41 14.04 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.016 1.811 . . . . 0.0 111.891 -179.617 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.524 HD11 HD11 ' A' ' 7' ' ' LEU . 83.8 mt -86.71 85.32 7.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.158 0.504 . . . . 0.0 112.043 -178.486 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 92.6 p -89.01 -9.68 50.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.194 178.058 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 47.2 mt -104.45 148.12 26.81 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.071 -179.816 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.5 m -70.83 -16.23 62.7 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.498 -179.463 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.421 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 55.8 m -131.31 134.11 46.03 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.752 -179.916 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.6 t -129.63 120.54 25.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.955 178.179 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.464 HD11 ' HB3' ' A' ' 47' ' ' GLN . 35.3 tp -116.4 129.82 56.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.887 -179.078 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.528 ' O ' ' O ' ' A' ' 47' ' ' GLN . 9.8 m-85 -108.95 139.11 44.26 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.697 179.904 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 151.94 -178.71 29.05 Favored Glycine 0 N--CA 1.47 0.925 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.161 178.316 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.412 ' HD2' HH11 ' A' ' 31' ' ' ARG . 46.9 mtm180 -67.14 -33.29 75.12 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 179.381 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.54 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -46.78 131.8 12.29 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 -178.812 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.521 HG23 ' N ' ' A' ' 34' ' ' GLU . 9.3 tp -64.79 -42.03 93.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 O-C-N 122.434 -0.451 . . . . 0.0 110.024 179.387 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.521 ' N ' HG23 ' A' ' 33' ' ' ILE . 7.9 pt-20 -56.4 -13.01 1.93 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.228 179.292 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.54 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 31.3 m -70.16 139.15 52.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.595 -179.301 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.461 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 57.2 m-20 -63.77 -34.74 78.58 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.329 -179.505 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.747 HD11 ' CD2' ' A' ' 20' ' ' PHE . 40.6 mm -122.22 112.82 36.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 177.978 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.415 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 15.9 ttp180 -101.83 130.88 48.38 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.596 -178.636 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.675 HG21 HD12 ' A' ' 41' ' ' LEU . 93.2 mt -118.68 131.85 70.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.157 -179.395 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -76.03 32.45 0.12 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.606 -179.528 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.942 HD11 HH21 ' A' ' 93' ' ' ARG . 20.3 mt -95.55 118.46 66.14 Favored Pre-proline 0 CA--C 1.534 0.355 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.507 179.499 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -73.36 -11.4 24.7 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 121.908 1.739 . . . . 0.0 111.985 -179.922 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.1 m -95.39 5.26 8.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.207 179.431 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.446 HG12 ' O ' ' A' ' 45' ' ' SER . 5.0 t -98.69 139.84 19.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.577 -179.464 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.446 ' O ' HG12 ' A' ' 44' ' ' VAL . 75.3 m -68.73 175.18 3.71 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.682 0.753 . . . . 0.0 111.315 -179.589 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -65.12 -43.17 92.82 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.958 -179.699 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.616 ' O ' ' N ' ' A' ' 49' ' ' CYS . 81.9 mt-30 -113.77 -12.72 12.72 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.542 -179.682 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.9 t60 38.7 -76.89 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 178.873 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.616 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -135.58 140.32 44.56 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.252 0.548 . . . . 0.0 111.812 -178.657 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -125.51 132.65 52.58 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.788 179.891 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.5 mt -116.42 134.1 60.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.918 179.49 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.438 ' CG ' ' NE2' ' A' ' 54' ' ' HIS . 47.2 tp10 -119.96 128.6 53.73 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.369 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.933 HG23 ' NH1' ' A' ' 5' ' ' ARG . 96.8 mt -105.57 123.54 60.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.591 0.71 . . . . 0.0 112.159 -178.678 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.569 ' O ' ' N ' ' A' ' 56' ' ' GLN . 3.3 m-70 -120.54 139.9 52.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.452 -179.752 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.467 ' C ' ' O ' ' A' ' 54' ' ' HIS . 83.9 tt0 -39.3 -25.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.73 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' A' ' 54' ' ' HIS . 67.9 tp60 -69.11 -68.2 0.42 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.096 178.301 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.479 ' HA ' HH22 ' A' ' 5' ' ' ARG . 8.8 pt-20 -160.03 -157.52 0.56 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.708 179.64 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.406 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -113.73 132.3 55.87 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.505 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.448 ' CG2' ' NE2' ' A' ' 61' ' ' HIS . 45.5 mm -111.08 127.54 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 121.051 -0.26 . . . . 0.0 111.636 -178.65 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.435 ' HB3' HG13 ' A' ' 80' ' ' VAL . 28.8 tp -103.51 125.3 49.99 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.955 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.448 ' NE2' ' CG2' ' A' ' 59' ' ' ILE . 97.9 m-70 -118.37 139.49 51.3 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.486 -179.211 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.454 HD22 ' HA ' ' A' ' 68' ' ' PRO . 47.2 t30 -102.7 107.86 18.91 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.596 179.741 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -94.83 -7.8 39.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.66 179.142 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.09 99.7 11.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.856 0.36 . . . . 0.0 110.878 -179.861 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.6 p -77.39 -32.91 55.15 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.885 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.783 HG21 ' O ' ' B' ' 234' ' ' TPO . 4.7 m -63.55 -49.35 73.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.221 -179.405 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -136.55 91.92 15.6 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.957 -179.626 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.56 ' HB2' HG13 ' A' ' 75' ' ' VAL . 52.4 Cg_exo -54.77 143.55 69.99 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.157 1.904 . . . . 0.0 112.568 -179.599 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.8 m -74.71 138.07 42.51 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.839 179.246 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -100.12 140.48 34.28 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.271 179.636 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.453 ' O ' ' N ' ' A' ' 74' ' ' SER . 5.1 p -131.59 136.42 57.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 178.939 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 48.35 31.98 3.0 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -178.675 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.84 29.48 63.05 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.437 -179.831 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.453 ' N ' ' O ' ' A' ' 71' ' ' VAL . 19.5 m -140.34 133.5 29.56 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 120.58 -0.448 . . . . 0.0 112.112 -179.479 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.56 HG13 ' HB2' ' A' ' 68' ' ' PRO . 7.0 t -70.43 139.06 20.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.475 179.152 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.429 HG21 HG11 ' A' ' 80' ' ' VAL . 3.7 pt -112.26 94.37 3.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.117 0.484 . . . . 0.0 111.266 179.814 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -65.22 -29.08 69.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.974 178.956 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.0 176.1 2.85 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.392 -179.979 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -59.93 144.08 99.51 Favored 'Trans proline' 0 N--CA 1.5 1.899 0 C-N-CA 122.515 2.143 . . . . 0.0 112.591 -179.776 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.435 HG13 ' HB3' ' A' ' 60' ' ' LEU . 7.1 p -136.7 141.26 41.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.521 179.679 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -81.02 130.21 34.91 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.473 179.377 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.5 mt -83.61 141.3 31.64 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.039 0.447 . . . . 0.0 111.642 -179.791 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -130.75 151.16 51.49 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.909 179.171 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.405 ' CE1' ' H ' ' A' ' 99' ' ' ASN . 4.3 t60 -52.12 118.66 3.65 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.001 0.429 . . . . 0.0 111.587 -178.637 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.03 -13.57 37.53 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 179.455 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -67.99 135.37 52.23 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.19 179.831 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.4 t -112.44 133.29 58.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.81 -178.205 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 92.8 mt -104.53 132.35 51.36 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.643 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 58.8 m -119.39 128.0 53.66 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.325 -0.55 . . . . 0.0 112.112 -178.766 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 98.2 mt -122.08 124.83 72.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.846 178.588 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.402 HG22 ' N ' ' A' ' 92' ' ' ASP . 26.0 mm 41.45 -114.99 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 121.068 -0.253 . . . . 0.0 110.629 -178.837 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.402 ' N ' HG22 ' A' ' 91' ' ' ILE . 93.4 m-20 -101.56 12.94 36.38 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.767 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.942 HH21 HD11 ' A' ' 41' ' ' LEU . 11.4 mtm180 -131.46 149.07 52.67 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.382 -179.497 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.47 ' HB2' HD12 ' A' ' 10' ' ' ILE . 71.7 m -135.49 154.15 51.51 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.008 0.432 . . . . 0.0 111.337 -179.631 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.452 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 85.1 m-85 -120.49 120.52 36.12 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.539 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 78.1 mtp85 -85.22 136.79 33.37 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 120.308 -0.557 . . . . 0.0 111.059 -179.238 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 92.2 t80 -96.5 118.81 33.79 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.402 -179.625 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -122.7 122.95 40.0 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.755 0.312 . . . . 0.0 111.0 179.549 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.405 ' H ' ' CE1' ' A' ' 84' ' ' HIS . 52.7 t-20 -101.54 101.9 12.55 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.717 179.733 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.042 179.413 . . . . . . . . 0 0 . 1 . 033 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.152 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 . . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.501 ' O ' ' CB ' ' B' ' 230' ' ' SEP . 52.2 m-20 -64.61 -35.72 81.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.289 -179.825 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 230' ' ' SEP . . . . . 0.501 ' CB ' ' O ' ' B' ' 229' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.555 ' O ' ' O ' ' B' ' 232' ' ' GLY . 2.4 pt20 -140.04 0.14 1.72 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.99 179.997 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 232' ' ' GLY . . . . . 0.555 ' O ' ' O ' ' B' ' 231' ' ' GLN . . . -51.21 -153.07 0.01 OUTLIER Glycine 0 CA--C 1.532 1.111 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.088 -179.347 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -75.02 162.07 37.67 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 122.884 2.389 . . . . 0.0 113.053 -178.929 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.783 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.64 139.0 22.2 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.238 1.959 . . . . 0.0 113.652 -178.782 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -68.48 140.27 19.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.648 -179.74 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 19.4 t -69.51 135.98 50.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.734 -179.858 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 238' ' ' TPO . . . . . 0.453 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 239' ' ' PRO . . . . . 0.453 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 50.0 Cg_exo -58.48 -28.86 86.83 Favored 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 123.322 2.681 . . . . 0.0 113.431 -179.294 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 59.5 m -73.9 -43.51 58.24 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.18 0.514 . . . . 0.0 109.698 178.358 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -58.93 -45.81 89.49 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.558 -179.243 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' B' ' 242' ' ' LEU . 91.1 mt -64.77 -40.87 95.99 Favored 'General case' 0 CA--C 1.521 -0.161 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.192 -179.429 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -59.96 -40.72 89.99 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.05 -179.638 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 62.0 ttp180 -62.39 -43.32 99.11 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.792 0.33 . . . . 0.0 110.794 179.786 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.594 ' NH1' ' OE1' ' B' ' 248' ' ' GLN . 1.9 mpt_? -59.32 -43.73 92.64 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.111 -179.307 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.7 -40.96 98.77 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.838 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 65.6 m -64.38 -45.21 88.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.411 0.624 . . . . 0.0 109.327 178.194 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 248' ' ' GLN . . . . . 0.594 ' OE1' ' NH1' ' B' ' 245' ' ' ARG . 80.4 mt-30 -60.36 -37.38 80.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.116 -179.81 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.47 HG23 ' O ' ' B' ' 245' ' ' ARG . 48.7 t -60.34 -45.21 96.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.325 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -60.68 -27.27 67.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.535 178.595 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -85.18 -11.57 54.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.573 179.933 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.726 HD22 ' OD2' ' B' ' 256' ' ' ASP . 96.3 mt -111.22 -179.37 3.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.344 179.398 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 253' ' ' ASN . . . . . 0.543 ' OD1' ' N ' ' B' ' 256' ' ' ASP . 46.2 p30 -138.33 171.48 14.32 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.219 0.533 . . . . 0.0 111.42 -179.753 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -68.37 -21.76 64.69 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.788 179.837 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -81.84 -6.76 59.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.089 179.921 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.726 ' OD2' HD22 ' B' ' 252' ' ' LEU . 66.2 t0 -88.23 94.68 9.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.923 0.392 . . . . 0.0 110.39 179.951 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -76.73 -176.65 3.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.906 -178.69 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' B' ' 260' ' ' GLU . 90.3 m-20 62.09 50.42 4.03 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.879 -179.138 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 259' ' ' ASP . . . . . . . . . . . . . 46.4 p30 -63.21 63.69 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.699 -179.574 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.553 ' N ' ' O ' ' B' ' 258' ' ' ASP . 93.6 mt-10 59.35 5.6 0.63 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.215 179.574 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.452 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 81.0 mt -109.77 131.97 59.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.194 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 40.4 t -124.06 132.67 70.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.348 -179.807 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -94.42 117.23 29.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.104 0.478 . . . . 0.0 111.108 -178.509 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -67.87 -46.59 71.28 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.513 179.949 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.17 163.43 23.44 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.223 -178.96 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -60.33 149.59 85.0 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.177 1.918 . . . . 0.0 112.031 179.857 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.3 pt . . . . . 0 C--N 1.328 -0.344 0 CA-C-O 121.485 0.66 . . . . 0.0 111.886 -178.396 . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo . . . . . 0 N--CA 1.49 1.296 0 CA-C-O 120.956 0.315 . . . . 0.0 111.455 . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.1 p -115.32 -27.31 7.27 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.209 179.305 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 87.2 mtm-85 -93.5 111.3 22.94 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.098 0.475 . . . . 0.0 110.392 -179.372 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.481 ' NH2' ' ND1' ' A' ' 19' ' ' HIS . 79.5 ttt180 -127.44 131.22 50.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.184 -179.776 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.545 HD11 HD21 ' A' ' 22' ' ' LEU . 80.0 mt -110.12 135.64 50.6 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.832 179.952 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.82 HG21 ' NH2' ' A' ' 96' ' ' ARG . 89.0 t -106.74 120.38 57.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.479 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.601 HG21 ' HZ ' ' B' ' 263' ' ' PHE . 70.0 p -77.45 140.81 39.91 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.576 0.703 . . . . 0.0 110.99 -179.05 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 51.0 mm -103.76 130.18 54.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.619 -179.791 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.462 ' HA ' HH12 ' A' ' 93' ' ' ARG . 95.9 mttt -83.98 154.99 23.01 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.889 178.001 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.543 HH22 ' CB ' ' B' ' 248' ' ' GLN . 75.8 mtp180 -56.61 -34.3 67.09 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.532 -179.214 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 67.4 m -76.76 -6.13 50.98 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.428 179.093 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.32 32.09 10.92 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.529 179.482 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.0 t -113.53 132.25 62.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.794 0.331 . . . . 0.0 110.639 -179.998 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -73.13 136.28 44.81 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.503 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -130.75 -115.98 1.78 Allowed Glycine 0 CA--C 1.534 1.279 0 C-N-CA 120.18 -1.009 . . . . 0.0 112.886 -178.855 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.81 143.18 45.1 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 122.24 1.96 . . . . 0.0 112.937 -177.952 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.596 ' NE2' HG13 ' A' ' 8' ' ' VAL . 57.4 m170 -110.29 123.08 49.15 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.446 179.591 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.566 ' CD2' HD11 ' A' ' 37' ' ' ILE . 43.1 t80 -98.04 109.07 50.1 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.907 -179.513 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -79.03 139.09 14.95 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 121.344 1.363 . . . . 0.0 111.707 179.373 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.545 HD21 HD11 ' A' ' 7' ' ' LEU . 74.3 mt -91.66 50.13 1.67 Allowed 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.205 -178.967 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.8 t -63.82 -17.44 63.12 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 119.45 -0.9 . . . . 0.0 108.692 178.968 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.76 HD11 ' HG2' ' B' ' 265' ' ' GLN . 46.2 mt -78.65 138.45 38.32 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.875 179.951 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.15 -23.05 65.27 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.608 -179.274 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 94.5 m -133.78 134.91 43.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.561 179.147 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.447 ' SG ' HD22 ' A' ' 22' ' ' LEU . 6.1 t -124.37 118.43 26.71 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.536 179.008 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.483 HD21 ' HG2' ' A' ' 47' ' ' GLN . 44.4 tp -115.49 131.63 56.87 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.224 0.535 . . . . 0.0 111.78 -178.421 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.706 ' CE2' HD12 ' A' ' 37' ' ' ILE . 2.3 m-85 -111.2 138.96 46.99 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.572 179.865 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 150.85 179.21 26.4 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.539 178.68 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 45.7 mtm180 -70.22 -33.04 71.19 Favored 'General case' 0 C--O 1.227 -0.123 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 179.795 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.616 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -51.32 148.05 9.21 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.193 -179.065 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.413 HG23 ' N ' ' A' ' 34' ' ' GLU . 11.0 tp -67.5 -39.72 83.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.217 -0.593 . . . . 0.0 109.508 179.54 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.413 ' N ' HG23 ' A' ' 33' ' ' ILE . 98.4 mt-10 -53.06 -21.55 4.79 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.261 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.616 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 48.3 m -55.84 118.51 4.66 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.706 -179.597 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -59.72 -32.79 70.86 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -179.924 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.706 HD12 ' CE2' ' A' ' 29' ' ' PHE . 91.1 mt -123.5 120.96 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 176.256 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -109.04 135.33 50.38 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.949 -177.326 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.456 HG21 HD12 ' A' ' 41' ' ' LEU . 95.1 mt -119.87 130.27 74.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.618 -179.652 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -75.17 25.67 0.1 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.473 -179.099 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.456 HD12 HG21 ' A' ' 39' ' ' ILE . 24.3 mt -88.9 123.26 67.97 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.184 -179.915 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -73.28 -10.15 23.87 Favored 'Trans proline' 0 N--CA 1.49 1.285 0 C-N-CA 121.877 1.718 . . . . 0.0 112.548 179.714 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.51 HG21 ' CE2' ' B' ' 241' ' ' PHE . 30.0 m -97.97 8.26 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.114 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.555 179.442 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 25.5 t -101.26 139.56 22.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.449 179.068 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.1 m -74.11 171.85 12.8 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.061 0.458 . . . . 0.0 111.444 -178.974 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.6 mttp -61.37 -42.46 98.75 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.245 -178.778 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.62 ' O ' ' N ' ' A' ' 49' ' ' CYS . 95.5 mt-30 -112.81 -15.96 12.83 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.575 0.226 . . . . 0.0 111.162 -179.163 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 18.5 t60 37.25 -75.64 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 179.071 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.62 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.76 137.82 48.34 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.266 0.555 . . . . 0.0 111.366 -177.661 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -129.71 134.05 47.41 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.156 -179.983 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.4 mt -118.34 135.57 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.682 -179.688 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -112.78 127.84 56.26 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.638 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.4 mm -100.55 125.76 54.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 119.674 -0.81 . . . . 0.0 110.712 -179.668 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.456 ' O ' ' N ' ' A' ' 56' ' ' GLN . 94.7 m-70 -130.35 136.22 48.87 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.307 179.806 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 54' ' ' HIS . 42.7 tt0 -40.74 -28.85 0.08 Allowed 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.217 -0.593 . . . . 0.0 109.845 -179.272 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.456 ' N ' ' O ' ' A' ' 54' ' ' HIS . 55.0 tt0 -65.99 -68.28 0.38 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.301 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -158.37 -164.55 1.5 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.801 179.737 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -118.3 135.13 54.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.983 0.42 . . . . 0.0 110.394 179.775 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.05 130.27 74.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.564 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.599 ' HB2' HD21 ' A' ' 82' ' ' LEU . 50.1 tp -93.17 126.69 38.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.546 178.923 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -113.91 134.32 54.89 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.236 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 31.5 t30 -97.59 104.27 16.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.955 -179.481 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -96.44 -9.69 29.22 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.677 178.86 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.2 m -72.19 98.17 2.1 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.693 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.5 p -77.34 -36.1 54.15 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.705 0.765 . . . . 0.0 109.231 178.644 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.653 HG21 ' O ' ' B' ' 234' ' ' TPO . 1.8 m -65.23 -48.57 72.83 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.387 -1.279 . . . . 0.0 110.78 -179.147 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -142.04 100.76 5.87 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.201 -179.128 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.18 145.75 85.11 Favored 'Trans proline' 0 N--CA 1.5 1.872 0 C-N-CA 122.022 1.815 . . . . 0.0 111.858 -179.564 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.3 m -72.49 141.87 48.56 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.199 0.523 . . . . 0.0 110.548 -179.642 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -101.0 141.61 33.64 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.805 -179.606 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.532 ' HB ' HD11 ' A' ' 76' ' ' ILE . 23.5 t -131.27 136.52 57.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 177.25 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 54.04 31.41 13.6 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -178.795 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.85 24.01 76.83 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.004 179.65 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 44.1 t -134.99 137.26 42.85 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.325 0.583 . . . . 0.0 111.527 -179.737 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.3 t -68.04 139.87 20.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.076 -179.544 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.585 ' CG2' ' O ' ' A' ' 78' ' ' GLU . 95.9 mt -113.88 116.77 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.986 179.407 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -90.74 -24.15 20.47 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.712 179.054 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.585 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.2 OUTLIER -128.9 168.18 16.91 Favored Pre-proline 0 C--O 1.222 -0.388 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.879 -178.669 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -66.28 148.02 84.09 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 122.463 2.109 . . . . 0.0 112.7 -179.941 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.1 m -141.18 151.93 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.164 179.976 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -78.53 129.23 34.6 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.485 179.345 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.599 HD21 ' HB2' ' A' ' 60' ' ' LEU . 95.9 mt -82.42 140.56 33.37 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.931 0.396 . . . . 0.0 110.736 -179.114 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -129.92 151.94 49.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.552 179.745 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.447 ' C ' ' CD2' ' A' ' 84' ' ' HIS . 7.5 t60 -56.5 119.98 6.96 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.165 -178.89 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.17 -18.13 23.79 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 121.155 -0.545 . . . . 0.0 111.767 179.128 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -69.51 133.23 47.44 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.331 179.912 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.0 t -107.76 136.9 41.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.45 -178.6 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 95.3 mt -103.07 129.1 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 178.167 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 96.2 m -120.33 127.32 52.23 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 119.913 -0.715 . . . . 0.0 112.025 -178.532 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.526 ' O ' ' N ' ' A' ' 93' ' ' ARG . 90.7 mt -116.5 134.86 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 CA-C-N 115.023 -0.989 . . . . 0.0 108.961 178.229 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.507 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 47.1 mt -29.13 97.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.415 -178.807 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.507 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 1.4 m-20 92.05 -22.4 0.08 Allowed 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 112.872 0.694 . . . . 0.0 112.872 178.047 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.745 HH21 ' CD1' ' B' ' 261' ' ' ILE . 25.2 mmm180 -131.04 143.73 50.92 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.17 -179.734 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 43.2 t -138.38 152.25 48.24 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.975 0.417 . . . . 0.0 110.421 -179.901 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -127.26 123.36 36.29 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.353 179.659 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.82 ' NH2' HG21 ' A' ' 8' ' ' VAL . 38.3 ttp-105 -90.31 135.58 33.59 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.487 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 81.4 t80 -98.93 127.89 44.96 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -178.489 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -134.0 120.68 20.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.28 179.552 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.44 ' OD1' ' ND1' ' A' ' 84' ' ' HIS . 43.1 p-10 -96.22 3.3 53.23 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.338 -179.949 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.092 179.661 . . . . . . . . 0 0 . 1 . 034 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 34.8 m . . . . . 0 CA--C 1.521 -0.165 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.424 ' C ' ' H ' ' B' ' 231' ' ' GLN . 67.9 t0 -87.26 117.08 25.78 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.581 -0.447 . . . . 0.0 110.125 -179.968 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.424 ' H ' ' C ' ' B' ' 229' ' ' ASP . 20.6 mp0 -126.33 41.86 3.43 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.204 179.539 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -117.14 -177.02 17.71 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.101 -0.571 . . . . 0.0 111.749 -179.604 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -66.67 156.55 65.23 Favored 'Trans proline' 0 N--CA 1.5 1.896 0 C-N-CA 123.312 2.675 . . . . 0.0 112.817 179.499 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.653 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.08 140.22 34.1 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 121.467 1.445 . . . . 0.0 113.936 -178.79 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.19 139.62 20.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.7 179.854 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' B' B ' 237' ' ' CYS . . . . . 0.421 ' HB2' HD13 ' A' ' 91' ' ' ILE . 4.0 t -62.61 125.25 23.31 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.569 -178.575 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -62.81 -21.08 72.77 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.489 2.126 . . . . 0.0 112.735 -178.61 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 2.8 m -74.78 -43.65 53.66 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 177.898 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.57 ' CZ ' ' NH2' ' B' ' 245' ' ' ARG . 79.0 t80 -58.36 -46.91 85.39 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.499 -179.374 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 95.9 mt -67.78 -39.3 84.07 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.058 179.384 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 73.3 tt0 -61.07 -41.56 96.86 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.539 179.906 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 244' ' ' ARG . . . . . 0.625 ' NH1' ' NE2' ' B' ' 248' ' ' GLN . 78.4 ttt-85 -64.12 -40.98 97.36 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.245 0.545 . . . . 0.0 109.653 179.538 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.645 ' O ' HG23 ' B' ' 249' ' ' VAL . 10.1 tpp180 -57.33 -42.7 82.42 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.054 -179.525 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.48 -41.45 98.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.445 179.824 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 47.1 t -63.27 -45.07 93.2 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.468 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 248' ' ' GLN . . . . . 0.625 ' NE2' ' NH1' ' B' ' 244' ' ' ARG . 84.6 mt-30 -60.67 -32.53 71.73 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.473 179.655 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.645 HG23 ' O ' ' B' ' 245' ' ' ARG . 72.5 t -62.29 -45.98 97.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 119.977 -0.689 . . . . 0.0 109.477 179.52 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -58.69 -29.71 66.84 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.441 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -91.43 -12.14 35.62 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.494 179.043 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.491 ' N ' ' O ' ' B' ' 248' ' ' GLN . 55.1 tp -73.83 136.32 43.5 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.915 0.388 . . . . 0.0 111.12 -179.123 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -99.27 124.28 44.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.211 -179.543 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -63.33 -33.43 75.51 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.331 0.586 . . . . 0.0 109.912 178.558 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -61.34 2.55 0.15 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.638 -179.223 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.669 ' O ' ' N ' ' B' ' 258' ' ' ASP . 88.4 m-20 -96.78 -8.04 32.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.192 0.52 . . . . 0.0 109.738 179.16 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt 37.46 15.52 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.101 179.572 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.669 ' N ' ' O ' ' B' ' 256' ' ' ASP . 49.2 t0 -138.1 108.12 6.37 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.613 -179.509 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.449 ' CB ' ' NH1' ' A' ' 93' ' ' ARG . 80.8 m-20 -87.37 -90.11 0.12 Allowed 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.241 -0.584 . . . . 0.0 111.384 179.631 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -146.49 20.58 1.34 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 119.794 -0.762 . . . . 0.0 112.357 -179.243 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.745 ' CD1' HH21 ' A' ' 93' ' ' ARG . 66.0 mt -112.97 133.93 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.254 179.888 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 45.9 t -124.18 132.63 71.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.743 178.918 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 263' ' ' PHE . . . . . 0.601 ' HZ ' HG21 ' A' ' 9' ' ' THR . 49.2 m-85 -97.13 118.66 34.04 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.377 0.608 . . . . 0.0 111.909 -178.131 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -62.41 -44.19 97.02 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.767 178.813 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 265' ' ' GLN . . . . . 0.76 ' HG2' HD11 ' A' ' 24' ' ' LEU . 6.5 mp0 -84.55 162.31 51.13 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.366 -179.809 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -65.59 144.96 80.69 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.095 1.863 . . . . 0.0 112.44 179.9 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.536 0.435 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.551 -179.896 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo . . . . . 0 N--CA 1.495 1.595 0 CA-C-O 120.822 0.259 . . . . 0.0 112.236 . . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 72.3 p -108.07 -52.81 2.71 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.446 -179.7 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.8 mtt85 -88.57 132.0 34.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.554 179.718 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 19.5 ptp180 -139.02 148.67 43.72 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 120.029 -0.668 . . . . 0.0 111.717 179.877 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.594 HD11 HD11 ' A' ' 22' ' ' LEU . 67.1 mt -115.26 144.8 43.18 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.766 179.676 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.463 HG22 ' CD2' ' A' ' 19' ' ' HIS . 48.6 t -117.37 124.83 73.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.475 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.1 m -73.73 138.12 44.44 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.927 0.394 . . . . 0.0 111.846 -179.079 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.693 HD12 ' OG ' ' A' ' 94' ' ' SER . 78.8 mt -111.31 137.11 45.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.377 178.079 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -92.76 155.11 17.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.663 179.868 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.855 HH11 HH11 ' B' ' 245' ' ' ARG . 90.6 mtm180 -58.1 -23.73 55.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.505 -179.126 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.8 p -81.97 -10.15 59.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.1 0.476 . . . . 0.0 109.736 179.031 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.55 34.58 7.83 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 -179.819 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.6 t -122.45 133.31 69.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.706 0.288 . . . . 0.0 110.903 -179.959 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -74.99 141.06 44.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.861 179.844 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.04 -118.96 2.13 Favored Glycine 0 CA--C 1.542 1.727 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.369 -179.309 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.11 145.53 44.55 Favored 'Trans proline' 0 N--CA 1.501 1.918 0 C-N-CA 122.517 2.145 . . . . 0.0 114.065 -177.932 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.463 ' CD2' HG22 ' A' ' 8' ' ' VAL . 57.8 m170 -105.56 139.08 40.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.248 179.842 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.503 ' CD2' HD11 ' A' ' 37' ' ' ILE . 31.2 t80 -112.15 104.6 56.12 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 108.957 -0.756 . . . . 0.0 108.957 179.505 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -75.47 133.42 15.88 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 C-N-CA 121.404 1.403 . . . . 0.0 110.772 -178.983 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.594 HD11 HD11 ' A' ' 7' ' ' LEU . 97.2 mt -87.81 59.18 5.25 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 119.879 -0.728 . . . . 0.0 111.784 -178.187 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.2 p -67.61 -21.13 65.41 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.473 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 70.2 mt -84.01 140.69 31.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.628 -179.686 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 77.7 p -62.56 -21.31 65.49 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.78 -179.507 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.505 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 65.5 m -131.94 132.82 43.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.848 0.356 . . . . 0.0 111.748 -179.234 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.551 ' HB2' HD22 ' A' ' 22' ' ' LEU . 7.1 t -124.86 118.51 26.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.302 178.242 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 45.5 tp -115.95 128.45 55.76 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.439 -178.908 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.744 ' CE2' HD12 ' A' ' 37' ' ' ILE . 6.3 m-85 -106.51 136.0 47.04 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.335 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 159.02 -169.64 35.29 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 119.727 -1.225 . . . . 0.0 112.402 178.854 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.529 HH12 ' CA ' ' B' ' 232' ' ' GLY . 42.1 mtm180 -87.34 -31.1 20.34 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.418 179.376 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.416 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -50.82 148.18 7.89 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -179.735 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.566 HD11 ' P ' ' B' ' 230' ' ' SEP . 36.9 mm -63.98 -43.73 97.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 O-C-N 122.611 -0.346 . . . . 0.0 111.046 -179.409 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -53.69 -18.12 2.8 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.82 -179.511 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.416 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 70.3 m -59.68 123.47 17.04 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 121.13 0.49 . . . . 0.0 111.189 -179.449 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.505 ' OD2' ' O ' ' A' ' 26' ' ' THR . 71.1 m-20 -60.77 -29.95 69.73 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.804 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.744 HD12 ' CE2' ' A' ' 29' ' ' PHE . 95.6 mt -127.17 123.95 63.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.241 -0.89 . . . . 0.0 108.822 177.492 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' A' ' 38' ' ' ARG . 26.8 mtm180 -107.18 138.11 43.99 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.283 -179.107 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 95.9 mt -119.26 128.63 75.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.445 -179.911 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -73.16 30.72 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.123 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.584 HD21 ' OE1' ' B' ' 260' ' ' GLU . 94.0 mt -108.19 128.31 25.95 Favored Pre-proline 0 N--CA 1.464 0.257 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.649 179.137 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.75 -8.87 21.99 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.488 2.125 . . . . 0.0 112.107 179.953 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.7 m -93.13 4.22 7.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 121.209 0.528 . . . . 0.0 110.274 179.293 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.422 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 20.4 t -95.13 133.7 35.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.512 -0.767 . . . . 0.0 108.941 178.332 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.2 t -70.41 170.52 11.78 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.287 0.565 . . . . 0.0 111.506 -178.266 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 52.2 mttp -62.97 -42.57 99.87 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.132 -179.444 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.607 ' O ' ' N ' ' A' ' 49' ' ' CYS . 87.1 mt-30 -114.49 -22.9 9.59 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 123.436 0.46 . . . . 0.0 110.709 -179.808 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.3 t60 37.13 -75.83 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 179.502 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.607 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -128.36 134.04 48.77 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.101 0.477 . . . . 0.0 111.955 -177.817 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -128.87 136.94 51.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.608 -179.932 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.7 mt -121.93 135.94 60.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.978 -179.932 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -113.85 127.1 55.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.634 178.973 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 48.8 mm -96.1 114.3 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-O 121.174 0.512 . . . . 0.0 111.555 -179.522 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.463 ' O ' ' N ' ' A' ' 56' ' ' GLN . 94.6 m-70 -117.54 134.61 54.68 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.622 178.684 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.478 ' H ' ' CD ' ' A' ' 55' ' ' GLU . 57.6 mp0 -39.72 -29.72 0.06 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -179.718 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.463 ' N ' ' O ' ' A' ' 54' ' ' HIS . 87.7 mt-30 -66.55 -67.87 0.42 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.545 178.735 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.11 -165.18 1.77 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.698 -179.275 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -120.28 129.46 54.04 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.569 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.4 mt -114.05 130.66 67.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -178.493 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.424 ' HB2' HD11 ' A' ' 82' ' ' LEU . 51.2 tp -94.59 124.54 38.69 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.884 179.585 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -112.84 137.6 50.94 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.099 -179.232 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.558 ' ND2' ' O ' ' A' ' 76' ' ' ILE . 50.7 p-10 -98.33 104.57 16.61 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.866 -179.841 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -93.88 -7.28 43.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.162 0.506 . . . . 0.0 109.825 178.328 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.4 t -75.21 100.9 4.45 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.013 179.531 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.9 m -87.46 -9.31 54.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.234 -179.962 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.573 HG22 HG22 ' B' ' 236' ' ' VAL . 0.2 OUTLIER -96.16 -41.92 8.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.09 0.472 . . . . 0.0 109.829 -179.85 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 40.9 m-20 -140.59 101.29 6.65 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.746 179.586 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -56.02 143.32 83.54 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 121.996 1.797 . . . . 0.0 112.24 -179.466 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 92.4 m -70.78 138.33 50.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.27 178.763 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -98.3 139.63 33.79 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.058 -179.999 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.407 HG21 HD23 ' A' ' 60' ' ' LEU . 55.5 t -133.5 132.38 57.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.288 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 53.22 34.31 17.31 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.612 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.5 29.02 66.51 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 114.958 -1.019 . . . . 0.0 112.53 179.928 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 47.3 t -145.72 142.42 28.94 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.924 179.763 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.0 m -74.75 140.24 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.515 179.278 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.587 HG22 HG21 ' A' ' 80' ' ' VAL . 4.6 pt -105.34 98.91 7.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.618 0.723 . . . . 0.0 109.901 178.781 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -63.86 -34.66 78.44 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.573 -179.705 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.458 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 1.2 mt-10 -128.9 -178.78 0.85 Allowed Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.748 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.458 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 25.0 Cg_exo -61.42 142.43 95.49 Favored 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 122.192 1.928 . . . . 0.0 113.03 -178.813 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.587 HG21 HG22 ' A' ' 76' ' ' ILE . 78.0 t -132.72 137.53 53.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.159 179.736 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -75.99 128.51 35.2 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.576 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.424 HD11 ' HB2' ' A' ' 60' ' ' LEU . 96.6 mt -84.01 136.43 34.05 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.99 -179.702 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -120.53 149.94 41.63 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.767 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.539 ' ND1' ' N ' ' A' ' 99' ' ' ASN . 6.1 t60 -55.31 123.88 15.25 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.995 -178.603 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.05 -13.55 52.46 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.513 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -71.24 136.91 48.22 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.49 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.4 p -105.5 140.42 23.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.776 -0.37 . . . . 0.0 111.38 -178.815 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 72.1 mt -108.25 130.81 60.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.092 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 53.5 m -126.39 128.8 47.6 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -177.355 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 91.4 mt -112.66 121.67 65.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 114.228 -1.351 . . . . 0.0 107.354 177.197 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.622 HG22 ' N ' ' A' ' 92' ' ' ASP . 97.0 mt 35.57 -99.01 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.751 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.622 ' N ' HG22 ' A' ' 91' ' ' ILE . 94.5 m-20 -110.38 8.62 23.37 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -178.982 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.505 HH21 HG13 ' B' ' 261' ' ' ILE . 50.3 mtp85 -127.12 144.26 51.07 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -179.846 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.693 ' OG ' HD12 ' A' ' 10' ' ' ILE . 19.4 p -141.28 159.28 42.54 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.37 0.605 . . . . 0.0 112.217 -178.458 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.661 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 87.9 m-85 -129.24 125.01 35.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.084 178.231 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -82.12 135.16 35.34 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 119.769 -0.773 . . . . 0.0 110.49 179.967 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -97.2 122.92 40.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.323 0.582 . . . . 0.0 111.091 -179.271 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -124.31 117.16 23.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.533 179.455 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.539 ' N ' ' ND1' ' A' ' 84' ' ' HIS . 64.7 t-20 -93.81 120.18 33.74 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.704 -179.747 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 70.6 tt0 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.032 179.792 . . . . . . . . 0 0 . 1 . 035 nuclear build full ' B' B ' 228' ' ' VAL . . . . . 0.432 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 3.3 m . . . . . 0 C--O 1.237 0.404 0 CA-C-O 120.607 0.242 . . . . 0.0 110.938 . . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.552 ' O ' ' CB ' ' B' ' 230' ' ' SEP . 28.8 t0 -74.96 89.2 2.38 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.898 -178.27 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' B' B ' 230' ' ' SEP . . . . . 0.566 ' P ' HD11 ' A' ' 33' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 4.0 tp60 -138.58 50.83 1.85 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.192 -179.948 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 232' ' ' GLY . . . . . 0.529 ' CA ' HH12 ' A' ' 31' ' ' ARG . . . -108.03 -173.25 21.88 Favored Glycine 0 CA--C 1.533 1.201 0 N-CA-C 111.689 -0.564 . . . . 0.0 111.689 179.429 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' B' B ' 233' ' ' PRO . . . . . 0.482 ' O ' ' NH2' ' A' ' 31' ' ' ARG . 85.0 Cg_endo -77.54 162.76 30.19 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 123.815 3.01 . . . . 0.0 112.485 179.843 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 035 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -57.43 137.97 83.97 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 121.946 1.764 . . . . 0.0 112.067 179.059 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.573 HG22 HG22 ' A' ' 66' ' ' THR . 53.3 t -62.61 135.42 27.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.559 179.666 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 14.9 t -56.58 118.22 4.63 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.413 -179.511 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 238' ' ' TPO . . . . . 0.485 ' O3P' HG23 ' B' ' 240' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.71 -26.64 47.94 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.553 2.169 . . . . 0.0 112.476 179.91 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 240' ' ' THR . . . . . 0.485 HG23 ' O3P' ' B' ' 238' ' ' TPO . 17.4 p -73.65 -40.74 63.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.017 0.436 . . . . 0.0 110.006 178.371 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -56.6 -46.53 80.8 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.871 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.442 HD23 ' OD2' ' A' ' 92' ' ' ASP . 93.6 mt -62.57 -43.52 98.6 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.941 -179.335 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -64.73 -40.01 94.61 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.07 -178.861 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 244' ' ' ARG . . . . . 0.47 ' O ' ' OG ' ' B' ' 247' ' ' SER . 95.0 mtt-85 -64.51 -42.01 96.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.218 0.532 . . . . 0.0 110.071 179.649 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.855 HH11 HH11 ' A' ' 12' ' ' ARG . 25.0 ttm-85 -61.79 -42.19 98.68 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.765 -179.339 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -61.56 -36.4 80.51 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.809 0.337 . . . . 0.0 110.285 179.113 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 247' ' ' SER . . . . . 0.47 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 78.6 p -69.94 -40.39 75.52 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 177.958 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -57.61 -40.18 78.55 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.024 179.324 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 56.9 t -61.8 -44.94 99.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 178.627 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -59.23 -27.56 65.87 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.212 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -84.26 -11.6 56.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.928 179.449 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.494 HD22 ' NH2' ' A' ' 12' ' ' ARG . 3.5 mp -108.88 171.49 7.4 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.427 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' B' B ' 253' ' ' ASN . . . . . 0.658 ' C ' ' H ' ' B' ' 255' ' ' ASP . 38.2 t-20 -176.21 -142.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.932 179.661 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' B' B ' 254' ' ' ASP . . . . . 0.551 ' H ' ' CG ' ' B' ' 253' ' ' ASN . 52.8 p30 -50.53 5.71 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.026 -178.716 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' B' B ' 255' ' ' ASP . . . . . 0.658 ' H ' ' C ' ' B' ' 253' ' ' ASN . 99.6 m-20 -38.02 -30.26 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.299 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.577 ' CB ' ' O ' ' B' ' 255' ' ' ASP . 39.4 t0 105.98 -128.62 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 O-C-N 124.192 0.932 . . . . 0.0 111.722 178.509 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -94.35 -158.72 0.65 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.005 -178.868 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 63.89 37.39 9.61 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.731 -179.66 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.486 ' OD2' ' NH1' ' A' ' 93' ' ' ARG . 67.1 t0 -57.83 -96.59 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.738 179.007 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.584 ' OE1' HD21 ' A' ' 41' ' ' LEU . 96.9 mt-10 -139.02 15.91 2.64 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.187 178.969 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.661 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 71.6 mt -116.93 135.2 58.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.609 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 50.0 t -123.78 132.32 71.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.541 179.309 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -95.57 119.52 34.21 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.264 0.554 . . . . 0.0 111.781 -178.234 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -64.9 -45.3 86.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.354 179.769 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -100.78 163.96 17.07 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.284 -179.831 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -61.41 156.86 43.93 Favored 'Trans proline' 0 N--CA 1.503 2.051 0 C-N-CA 122.992 2.462 . . . . 0.0 113.062 -179.604 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 25.9 pt . . . . . 0 N--CA 1.465 0.285 0 CA-C-O 121.312 0.577 . . . . 0.0 111.775 -178.986 . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo . . . . . 0 N--CA 1.499 1.825 0 CA-C-O 120.697 0.207 . . . . 0.0 112.071 . . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.405 HG23 ' OE2' ' A' ' 100' ' ' GLU . 10.7 m -74.91 -50.97 15.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.897 0.379 . . . . 0.0 111.477 -179.932 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.608 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 85.1 mtt-85 -100.25 148.75 24.31 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.492 -177.995 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -134.55 141.68 46.76 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.516 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 98.5 mt -113.8 139.74 48.88 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 178.73 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 67.9 t -113.89 129.46 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.407 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 m -93.22 116.62 29.19 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.402 0.62 . . . . 0.0 112.516 -178.258 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 81.7 mt -85.67 147.66 5.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.111 179.149 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.464 ' HD2' HG23 ' A' ' 15' ' ' VAL . 94.8 mttt -93.61 157.87 15.97 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.479 179.092 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.595 ' NH2' ' OE2' ' B' ' 260' ' ' GLU . 91.1 mtm180 -60.98 -27.56 68.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.304 -0.407 . . . . 0.0 109.997 179.859 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.558 ' OG ' HG22 ' A' ' 15' ' ' VAL . 91.1 p -70.6 -22.69 62.52 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.755 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.73 6.94 37.27 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-N 115.72 -0.673 . . . . 0.0 113.699 178.576 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.558 HG22 ' OG ' ' A' ' 13' ' ' SER . 17.8 m -104.82 142.92 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 117.995 0.898 . . . . 0.0 111.568 -179.693 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 17' ' ' GLY . 61.8 t0 -69.15 127.85 34.55 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.063 -179.397 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.437 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -115.72 -127.94 4.26 Favored Glycine 0 CA--C 1.535 1.325 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 -179.814 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.93 155.88 38.78 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.483 2.122 . . . . 0.0 112.788 -178.872 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -112.78 158.78 19.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.985 0.421 . . . . 0.0 111.191 -178.591 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.554 ' CD2' HD11 ' A' ' 37' ' ' ILE . 39.0 t80 -128.35 98.61 25.69 Favored Pre-proline 0 N--CA 1.467 0.403 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.578 -179.727 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.441 ' HD2' HG22 ' B' ' 267' ' ' ILE . 73.6 Cg_endo -74.28 139.57 26.48 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 121.587 1.525 . . . . 0.0 112.508 -178.905 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.441 HD13 HD11 ' A' ' 53' ' ' ILE . 80.2 mt -88.33 86.01 6.99 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.203 -179.331 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 59.7 p -86.39 -7.95 58.04 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.515 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.0 mt -108.69 148.82 29.86 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.041 -179.184 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.3 m -68.73 -15.06 63.4 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.127 -179.117 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 57.0 m -130.02 134.63 47.54 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.452 -0.499 . . . . 0.0 112.143 -179.975 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.7 t -127.96 118.76 24.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.914 178.573 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.525 HD12 ' O ' ' A' ' 49' ' ' CYS . 57.3 tp -118.46 130.8 56.15 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 120.954 0.406 . . . . 0.0 111.031 -179.056 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.816 ' CE2' HD12 ' A' ' 37' ' ' ILE . 18.3 m-85 -110.25 141.6 42.99 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.988 -179.893 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 153.67 -174.88 32.19 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.883 178.795 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 45.1 mtm180 -74.82 -32.53 61.98 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 122.704 -0.291 . . . . 0.0 111.722 179.348 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.594 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -58.14 149.57 34.59 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.579 -177.714 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.431 ' C ' ' N ' ' A' ' 35' ' ' CYS . 82.4 mt -66.37 -43.06 91.49 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 178.247 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -49.9 -25.28 3.07 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.222 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.594 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 3.6 m -65.69 115.01 5.4 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.723 179.47 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -52.76 -21.09 3.71 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.166 -178.135 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.816 HD12 ' CE2' ' A' ' 29' ' ' PHE . 85.4 mt -131.4 123.92 53.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.657 177.809 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 47.3 mtm180 -107.3 138.5 43.38 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.836 -179.865 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 1.028 HG21 ' NH1' ' A' ' 93' ' ' ARG . 63.9 mt -120.56 132.44 70.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.419 -0.512 . . . . 0.0 110.48 179.762 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -75.41 24.08 0.11 Allowed 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -178.068 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.747 HD12 ' CZ ' ' A' ' 93' ' ' ARG . 25.7 mt -105.48 128.67 26.09 Favored Pre-proline 0 C--N 1.323 -0.56 0 C-N-CA 119.591 -0.844 . . . . 0.0 109.855 179.341 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.07 -10.27 25.75 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.523 2.149 . . . . 0.0 112.566 -178.773 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.8 m -87.11 -0.21 7.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.622 179.927 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.459 HG21 HH12 ' A' ' 93' ' ' ARG . 48.0 t -91.38 131.64 37.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.131 0.491 . . . . 0.0 111.006 -179.223 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.05 160.64 20.54 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.987 179.77 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 28.2 mtmt -59.93 -42.54 94.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.702 -178.839 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.629 ' O ' ' N ' ' A' ' 49' ' ' CYS . 12.4 mm100 -111.49 -16.52 13.28 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 123.481 0.488 . . . . 0.0 110.048 -179.549 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.2 t60 35.62 -76.37 0.0 OUTLIER 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.076 -0.966 . . . . 0.0 113.348 -179.763 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.629 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -137.09 140.18 41.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.941 0.401 . . . . 0.0 111.799 -178.622 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -127.01 131.91 50.89 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.511 179.728 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.9 mt -114.87 135.93 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-O 121.098 0.475 . . . . 0.0 110.738 179.54 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -113.75 125.55 54.23 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.067 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.441 HD11 HD13 ' A' ' 22' ' ' LEU . 93.9 mt -108.2 113.62 44.36 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.461 -179.856 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.582 ' O ' ' N ' ' A' ' 56' ' ' GLN . 91.5 m-70 -115.42 141.36 48.15 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.125 179.974 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.467 ' C ' ' O ' ' A' ' 54' ' ' HIS . 84.1 tt0 -38.92 -25.18 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 120.293 -0.563 . . . . 0.0 109.527 -179.109 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.582 ' N ' ' O ' ' A' ' 54' ' ' HIS . 57.3 tt0 -67.51 -67.31 0.47 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.386 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -160.65 -163.66 1.11 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.193 -179.586 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.79 127.16 55.9 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.577 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 89.2 mt -113.89 128.76 70.67 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 CA-C-O 121.297 0.57 . . . . 0.0 111.688 -179.228 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 43.4 tp -97.39 126.91 42.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.883 -179.975 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -114.7 138.01 51.22 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.962 179.105 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -101.12 109.62 21.53 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.067 0.461 . . . . 0.0 111.602 -179.564 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -94.89 -4.59 46.65 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.254 179.108 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.0 t -90.42 101.06 13.79 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.728 -179.712 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.4 p -87.59 -24.21 24.06 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.388 -0.525 . . . . 0.0 109.996 178.087 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.58 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.3 OUTLIER -69.74 -43.29 72.61 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.6 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.432 HD21 ' HA ' ' B' ' 236' ' ' VAL . 31.4 m-80 -142.97 100.9 5.36 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.69 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -66.28 150.85 84.52 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.264 1.309 . . . . 0.0 113.532 -177.831 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 33.7 m -69.93 137.95 51.96 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.912 179.555 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -101.38 142.43 32.79 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.662 179.906 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.716 ' HB ' HD11 ' A' ' 76' ' ' ILE . 5.0 p -129.5 137.2 57.47 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.14 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 49.57 32.8 5.18 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.583 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.51 27.85 64.65 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.057 -179.903 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 62.8 m -141.06 138.8 33.86 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 117.549 0.675 . . . . 0.0 112.098 -179.473 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.4 m -65.62 137.45 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.527 179.734 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.716 HD11 ' HB ' ' A' ' 71' ' ' VAL . 96.2 mt -99.57 96.39 4.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.594 179.856 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -65.15 -41.49 94.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.853 0.359 . . . . 0.0 110.867 179.645 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.497 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.1 OUTLIER -126.72 166.05 24.65 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.492 -179.343 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -57.24 143.32 93.87 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.174 1.916 . . . . 0.0 112.565 -179.052 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.6 t -133.32 137.49 53.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.654 -179.894 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 87.7 mtm-85 -68.98 134.43 49.48 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.535 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.441 HD23 ' HA ' ' A' ' 82' ' ' LEU . 80.3 mt -81.08 137.28 36.0 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.472 0.653 . . . . 0.0 111.589 -179.22 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -125.64 147.08 49.44 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.656 179.724 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.482 ' ND1' ' N ' ' A' ' 99' ' ' ASN . 4.8 t60 -57.19 124.97 20.67 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.578 -179.318 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.73 -24.22 26.03 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -179.151 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.544 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 41.4 t0 -64.57 134.48 54.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.991 0.424 . . . . 0.0 110.198 179.347 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.544 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 9.9 p -110.9 132.9 58.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.509 -178.157 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 79.0 mt -99.09 130.18 48.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.857 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 17.7 m -116.85 123.73 47.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.514 0.673 . . . . 0.0 111.405 179.895 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.634 ' O ' ' N ' ' A' ' 93' ' ' ARG . 96.8 mt -117.36 129.04 74.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.062 178.306 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.494 ' C ' ' O ' ' A' ' 90' ' ' ILE . 85.5 mt -14.97 96.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -178.876 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 79.06 -11.23 1.24 Allowed 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 177.963 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 1.028 ' NH1' HG21 ' A' ' 39' ' ' ILE . 17.7 mtm180 -130.95 134.28 46.59 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.349 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.2 m -133.81 147.95 51.28 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.6 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.407 ' HE1' HD12 ' A' ' 90' ' ' ILE . 54.7 m-85 -122.81 120.13 32.62 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.549 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.429 ' NE ' ' OE2' ' A' ' 98' ' ' GLU . 37.8 ttp-105 -79.97 130.92 35.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.061 0.458 . . . . 0.0 110.989 -179.362 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.608 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 46.0 t80 -98.5 122.97 42.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.413 -179.704 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.429 ' OE2' ' NE ' ' A' ' 96' ' ' ARG . 96.3 mt-10 -139.07 129.31 25.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.188 0.518 . . . . 0.0 111.333 179.832 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.509 ' OD1' ' OH ' ' A' ' 97' ' ' TYR . 91.4 m-20 -91.32 141.04 29.2 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.356 179.734 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.405 ' OE2' HG23 ' A' ' 4' ' ' THR . 80.2 mm-40 . . . . . 0 C--N 1.325 -0.467 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.656 179.5 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 228' ' ' VAL . . . . . 0.499 ' O ' ' OD1' ' B' ' 229' ' ' ASP . 70.5 t . . . . . 0 N--CA 1.453 -0.309 0 CA-C-O 121.0 0.429 . . . . 0.0 110.139 . . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.499 ' OD1' ' O ' ' B' ' 228' ' ' VAL . 68.5 m-20 -164.93 174.69 10.26 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.934 -179.919 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 036 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -144.04 46.97 1.43 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.377 -179.724 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -112.64 -159.44 14.23 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.474 -0.651 . . . . 0.0 111.474 -178.826 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.84 158.2 53.48 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 122.554 2.169 . . . . 0.0 113.163 -179.381 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.528 HG21 ' O1P' ' B' ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -64.71 169.24 11.81 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.711 2.274 . . . . 0.0 111.843 178.703 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.58 ' CG2' HG22 ' A' ' 66' ' ' THR . 37.7 t -112.73 134.07 56.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.83 179.871 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' B' B ' 237' ' ' CYS . . . . . 0.413 ' HB2' HD13 ' A' ' 91' ' ' ILE . 3.7 t -52.32 112.98 0.9 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.553 -179.539 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' B' B ' 238' ' ' TPO . . . . . 0.404 ' O3P' ' OG1' ' B' ' 240' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -58.71 -22.27 60.26 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 C-N-CA 121.162 1.241 . . . . 0.0 111.622 178.855 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 240' ' ' THR . . . . . 0.404 ' OG1' ' O3P' ' B' ' 238' ' ' TPO . 18.5 m -71.92 -46.78 56.39 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 120.606 -0.437 . . . . 0.0 110.421 179.092 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.5 ' CZ ' ' NH1' ' B' ' 245' ' ' ARG . 80.5 t80 -58.7 -45.73 88.86 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.616 -178.846 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 93.9 mt -64.16 -40.16 95.55 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.04 -179.178 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -60.98 -45.16 95.92 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.489 -179.689 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -66.91 -38.67 86.65 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.598 179.744 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.603 ' CA ' ' HE ' ' B' ' 245' ' ' ARG . 0.0 OUTLIER -60.11 -44.62 94.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.97 -179.029 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.59 -40.77 97.8 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.353 0.597 . . . . 0.0 109.473 179.117 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 26.8 m -60.44 -45.74 92.57 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.44 179.226 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -58.23 -37.93 75.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.416 179.793 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.778 HG22 ' NZ ' ' B' ' 257' ' ' LYS . 54.6 t -61.41 -46.57 96.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.013 179.35 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -57.96 -27.97 63.91 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.84 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -86.45 -12.56 48.68 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.107 179.871 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.542 ' O ' ' CB ' ' B' ' 253' ' ' ASN . 92.5 mt -109.76 -176.67 3.07 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.085 178.58 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' B' B ' 253' ' ' ASN . . . . . 0.542 ' CB ' ' O ' ' B' ' 252' ' ' LEU . 6.4 t-20 84.42 20.9 0.13 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.884 -179.414 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -66.35 -41.96 88.79 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.116 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 255' ' ' ASP . . . . . 0.482 ' O ' ' OD1' ' B' ' 256' ' ' ASP . 52.2 m-20 -111.86 -80.97 0.59 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.219 179.287 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.482 ' OD1' ' O ' ' B' ' 255' ' ' ASP . 98.1 m-20 -142.3 3.35 1.53 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.198 -179.742 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' B' B ' 257' ' ' LYS . . . . . 0.778 ' NZ ' HG22 ' B' ' 249' ' ' VAL . 74.6 tttt 60.55 116.27 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 120.216 -0.593 . . . . 0.0 109.428 -179.151 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.419 ' O ' ' CB ' ' B' ' 259' ' ' ASP . 96.5 m-20 -61.61 -36.64 81.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.712 -178.456 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.612 ' C ' ' H ' ' B' ' 261' ' ' ILE . 27.4 t0 81.36 112.03 0.06 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.187 -178.924 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.595 ' OE2' ' NH2' ' A' ' 12' ' ' ARG . 56.6 mp0 -58.88 19.85 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.279 -179.56 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.612 ' H ' ' C ' ' B' ' 259' ' ' ASP . 66.3 mt -112.77 135.45 52.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.671 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 55.1 t -130.16 134.88 62.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.124 0.488 . . . . 0.0 111.048 -178.657 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -95.06 118.81 32.5 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.551 0.691 . . . . 0.0 111.277 -178.503 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -66.01 -47.52 74.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.159 179.424 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -89.06 151.45 46.92 Favored Pre-proline 0 N--CA 1.449 -0.494 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.185 -178.981 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.9 149.46 72.32 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.919 2.412 . . . . 0.0 112.838 179.747 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 267' ' ' ILE . . . . . 0.441 HG22 ' HD2' ' A' ' 21' ' ' PRO . 44.1 pt . . . . . 0 C--N 1.33 -0.262 0 CA-C-O 121.313 0.578 . . . . 0.0 110.09 179.042 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 N--CA 1.489 1.227 0 CA-C-O 120.691 0.205 . . . . 0.0 111.883 . . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.0 p -103.13 -43.14 5.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.41 -179.892 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.547 ' NE ' HD13 ' A' ' 53' ' ' ILE . 88.6 mtm-85 -90.26 126.4 35.83 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.28 179.913 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -129.79 135.37 48.35 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.095 0.474 . . . . 0.0 111.032 179.826 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.698 HD12 ' O ' ' A' ' 96' ' ' ARG . 29.5 tp -115.3 133.82 55.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.136 -179.38 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 45.0 t -109.15 131.98 58.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.407 -179.95 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 m -90.99 118.39 30.34 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.34 0.59 . . . . 0.0 112.541 -178.408 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.469 HD12 ' HB2' ' A' ' 94' ' ' SER . 97.0 mt -85.85 142.14 13.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.536 179.248 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.555 ' NZ ' ' O ' ' B' ' 256' ' ' ASP . 97.8 mttt -89.31 160.68 16.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.027 0.441 . . . . 0.0 110.919 179.262 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.593 HH11 HH11 ' B' ' 245' ' ' ARG . 90.5 mtm180 -55.94 -33.07 64.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.662 -178.902 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.6 t -77.75 -8.54 58.12 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.234 179.837 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.92 31.14 9.49 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -179.924 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.0 t -116.8 132.69 65.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.857 0.36 . . . . 0.0 110.081 179.681 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 45.4 p-10 -84.19 142.8 30.06 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.978 179.612 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -133.89 -108.05 1.02 Allowed Glycine 0 CA--C 1.532 1.098 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.733 -179.531 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -73.29 148.57 43.91 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 122.347 2.032 . . . . 0.0 112.028 -179.454 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -111.94 147.58 35.57 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.149 -179.844 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -115.05 104.72 53.73 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.981 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.42 133.14 15.63 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.164 1.242 . . . . 0.0 110.992 -178.81 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 82.9 mt -87.61 51.76 2.31 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -177.51 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.5 m -59.28 -34.1 71.87 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.879 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.538 HD11 ' HG2' ' B' ' 265' ' ' GLN . 60.9 mt -71.62 144.75 49.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.45 -179.845 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.6 m -68.18 -16.38 63.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.415 -179.355 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.448 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 95.5 m -133.77 134.42 42.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.834 0.35 . . . . 0.0 111.664 -179.806 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.9 t -125.78 116.66 21.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.902 178.424 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 58.2 tp -113.71 127.83 56.18 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.794 -178.924 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.609 ' CE2' HD12 ' A' ' 37' ' ' ILE . 9.4 m-85 -106.93 139.23 41.67 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.851 179.65 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 146.5 -175.93 25.67 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 120.982 -0.628 . . . . 0.0 111.622 178.972 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 31' ' ' ARG . 47.6 mtm180 -75.46 -33.72 60.88 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -179.851 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.505 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -44.45 142.95 2.75 Favored Glycine 0 C--O 1.223 -0.535 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 -178.465 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.416 HD13 ' CZ ' ' A' ' 38' ' ' ARG . 32.5 mm -62.6 -43.13 98.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 117.194 0.497 . . . . 0.0 110.033 179.957 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -54.81 -20.73 9.24 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.51 -0.476 . . . . 0.0 109.865 179.551 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.505 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 60.0 m -56.63 119.61 6.4 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-O 120.968 0.413 . . . . 0.0 111.141 -179.47 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.448 ' OD2' ' O ' ' A' ' 26' ' ' THR . 80.0 m-20 -58.09 -26.63 62.81 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -179.817 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.609 HD12 ' CE2' ' A' ' 29' ' ' PHE . 95.1 mt -129.18 118.97 47.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.235 177.381 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.416 ' CZ ' HD13 ' A' ' 33' ' ' ILE . 84.7 mtp180 -103.34 133.5 48.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.634 -179.106 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.423 HG21 HD12 ' A' ' 41' ' ' LEU . 83.6 mt -118.13 129.94 73.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 120.511 -0.475 . . . . 0.0 110.021 179.744 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -75.24 36.71 0.12 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.85 -178.057 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.723 ' O ' HG12 ' A' ' 44' ' ' VAL . 70.0 mt -111.74 119.32 44.98 Favored Pre-proline 0 C--N 1.325 -0.457 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.061 -179.678 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -71.29 -12.77 30.27 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 121.835 1.69 . . . . 0.0 112.824 -179.987 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.706 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 31.1 m -86.76 -3.51 8.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.949 -0.301 . . . . 0.0 110.716 179.657 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.723 HG12 ' O ' ' A' ' 41' ' ' LEU . 3.3 p -96.62 146.76 6.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.103 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.9 m -74.65 166.14 24.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.469 0.652 . . . . 0.0 112.519 -178.478 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 45.6 mttp -63.23 -40.05 96.34 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.03 -0.987 . . . . 0.0 111.737 179.975 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.669 ' O ' ' N ' ' A' ' 49' ' ' CYS . 89.7 mt-30 -113.36 -19.83 11.58 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.385 179.858 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.0 t60 34.83 -75.93 0.0 OUTLIER 'General case' 0 C--O 1.234 0.274 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 179.048 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.669 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.1 134.45 47.36 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.248 0.547 . . . . 0.0 112.253 -178.948 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -127.01 128.65 46.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.257 179.021 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.3 mt -111.56 133.74 56.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.189 179.845 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -116.79 126.55 53.26 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.463 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.547 HD13 ' NE ' ' A' ' 5' ' ' ARG . 84.8 mt -106.15 112.91 41.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.404 -179.067 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.504 ' O ' ' N ' ' A' ' 56' ' ' GLN . 95.0 m-70 -112.78 144.03 43.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.399 179.54 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 54' ' ' HIS . 84.1 tt0 -39.9 -27.21 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.358 -0.537 . . . . 0.0 109.992 -178.839 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.504 ' N ' ' O ' ' A' ' 54' ' ' HIS . 75.8 mt-30 -69.08 -66.99 0.51 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.949 179.132 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -157.92 -169.2 2.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.347 -179.11 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -111.85 125.32 53.89 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.741 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.5 mt -114.73 132.05 65.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -178.203 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.494 ' HB2' HD21 ' A' ' 82' ' ' LEU . 44.0 tp -94.8 122.54 37.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.8 179.266 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -109.08 136.35 48.73 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.159 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.475 HD21 ' HA ' ' A' ' 68' ' ' PRO . 63.5 t-20 -97.54 109.54 22.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.068 0.461 . . . . 0.0 112.241 -178.422 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.405 ' CD2' ' OE1' ' A' ' 47' ' ' GLN . 28.3 m-85 -100.91 -9.87 21.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.121 179.326 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.7 t -76.22 98.62 4.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.805 0.336 . . . . 0.0 110.844 -179.389 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 34.2 t -79.09 -40.79 30.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.323 0.582 . . . . 0.0 109.744 178.683 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.784 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.2 OUTLIER -64.75 -47.02 79.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.02 -179.112 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 42.3 m-20 -136.97 97.91 10.77 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.452 179.894 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.475 ' HA ' HD21 ' A' ' 62' ' ' ASN . 36.2 Cg_exo -56.45 145.05 81.55 Favored 'Trans proline' 0 N--CA 1.494 1.5 0 C-N-CA 121.799 1.666 . . . . 0.0 112.612 -179.121 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.3 m -73.83 140.01 45.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.393 -179.992 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -104.59 141.79 35.79 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.749 -179.188 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.509 ' CG1' ' OD1' ' A' ' 86' ' ' ASP . 55.3 t -130.96 136.23 58.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.491 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 52.26 33.3 12.33 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -179.394 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.58 29.48 72.88 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.284 179.726 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.7 p -141.66 136.65 31.11 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.714 -0.395 . . . . 0.0 110.867 -179.974 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.414 HG13 ' HB2' ' A' ' 68' ' ' PRO . 78.6 t -66.01 135.82 27.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.087 -179.907 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.08 96.65 3.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.409 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -84.56 -16.69 41.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.536 -0.757 . . . . 0.0 112.014 -178.583 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -111.47 162.6 20.3 Favored Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.557 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -58.96 142.24 99.1 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 121.45 1.433 . . . . 0.0 111.693 179.684 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.5 p -140.48 139.1 35.89 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 CA-C-O 120.957 0.408 . . . . 0.0 110.758 179.814 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.635 HH21 ' CE ' ' A' ' 83' ' ' LYS . 61.9 ttp180 -73.39 127.71 33.44 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.461 179.616 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.494 HD21 ' HB2' ' A' ' 60' ' ' LEU . 98.2 mt -78.78 138.16 38.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.79 -180.0 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.635 ' CE ' HH21 ' A' ' 81' ' ' ARG . 97.7 mttt -130.29 151.93 50.26 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.342 179.237 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.643 ' HD1' ' CG ' ' A' ' 99' ' ' ASN . 3.7 t-160 -55.59 120.95 8.02 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.287 -179.334 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.08 -15.06 36.89 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -179.58 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.509 ' OD1' ' CG1' ' A' ' 71' ' ' VAL . 35.2 t70 -68.79 126.54 30.07 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.312 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.9 t -109.51 127.09 66.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.578 -178.922 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 90.7 mt -93.27 133.54 34.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.896 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 53.7 m -124.19 123.08 39.5 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.592 0.71 . . . . 0.0 112.387 -178.555 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.451 ' N ' ' O ' ' A' ' 93' ' ' ARG . 93.1 mt -107.91 124.27 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 177.498 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.707 HD12 HH22 ' A' ' 93' ' ' ARG . 93.9 mt 39.47 -98.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.171 -178.445 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.613 ' OD1' ' NH1' ' A' ' 93' ' ' ARG . 28.9 p-10 -119.71 16.54 12.76 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.015 0.436 . . . . 0.0 110.837 179.365 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.707 HH22 HD12 ' A' ' 91' ' ' ILE . 45.0 mtm-85 -120.0 138.12 53.68 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.765 179.877 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.469 ' HB2' HD12 ' A' ' 10' ' ' ILE . 66.9 m -137.44 152.41 49.55 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 119.886 -0.726 . . . . 0.0 111.283 -179.871 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.533 ' HB3' HD11 ' A' ' 7' ' ' LEU . 74.6 m-85 -123.79 121.45 35.45 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.098 179.413 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.698 ' O ' HD12 ' A' ' 7' ' ' LEU . 99.8 mtt180 -81.95 129.08 34.67 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.75 -179.045 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -99.0 126.99 44.82 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.832 179.876 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -137.22 127.88 26.98 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.653 179.996 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.643 ' CG ' ' HD1' ' A' ' 84' ' ' HIS . 41.2 p30 -82.54 -145.58 0.07 Allowed 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.532 -179.965 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.415 ' N ' ' OD1' ' A' ' 99' ' ' ASN . 22.5 pt-20 . . . . . 0 C--N 1.331 -0.233 0 CA-C-O 121.05 0.452 . . . . 0.0 111.11 -179.189 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 4.7 p . . . . . 0 CA--C 1.53 0.203 0 N-CA-C 111.475 0.176 . . . . 0.0 111.475 . . . . . . . . . 0 0 . 1 . 037 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.479 ' C ' ' H ' ' B' ' 231' ' ' GLN . 79.7 m-20 -61.1 139.24 58.13 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.347 -179.786 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 037 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.479 ' H ' ' C ' ' B' ' 229' ' ' ASP . 88.3 mm-40 -132.2 48.84 2.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.906 179.986 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -118.22 -170.74 15.04 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -179.468 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -76.72 161.65 33.47 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 123.655 2.903 . . . . 0.0 113.279 -179.355 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.784 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -58.31 132.7 50.41 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.32 2.013 . . . . 0.0 112.657 179.511 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.613 ' CG2' HG22 ' A' ' 66' ' ' THR . 31.4 t -64.09 135.5 27.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.391 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -57.19 122.51 12.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.093 0.473 . . . . 0.0 110.805 -178.741 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 037 nuclear build full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -59.22 -21.45 60.0 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 121.844 1.696 . . . . 0.0 111.806 178.776 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 52.0 m -73.03 -46.19 53.38 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.05 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.706 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 71.3 t80 -56.6 -48.15 78.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.757 -179.793 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 85.8 mt -66.18 -43.6 86.4 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -179.887 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -65.48 -45.14 84.8 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.447 -178.228 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -62.68 -44.53 96.02 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.435 179.626 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.593 HH11 HH11 ' A' ' 12' ' ' ARG . 52.2 ttm-85 -63.56 -44.09 95.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.98 -179.627 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -63.97 -36.89 85.45 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.554 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 32.7 m -64.08 -43.78 94.38 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.47 178.022 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -61.64 -34.59 75.96 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.877 -179.962 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 43.4 t -63.94 -45.46 96.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 120.774 -0.371 . . . . 0.0 110.232 179.098 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -64.54 -29.77 70.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.273 0.559 . . . . 0.0 109.649 179.208 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -89.78 -7.32 54.67 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.303 -179.701 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 49.6 tp -67.88 144.61 55.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.917 -179.52 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 253' ' ' ASN . . . . . 0.408 ' O ' ' CG ' ' B' ' 253' ' ' ASN . 37.9 t30 -153.77 29.03 0.47 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.07 -179.794 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' B' B ' 254' ' ' ASP . . . . . 0.561 ' O ' ' CB ' ' B' ' 255' ' ' ASP . 80.8 m-20 -96.26 3.83 52.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.453 -0.794 . . . . 0.0 108.994 178.851 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' B' B ' 255' ' ' ASP . . . . . 0.561 ' CB ' ' O ' ' B' ' 254' ' ' ASP . 4.8 t70 93.26 -23.66 0.06 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.564 -178.743 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.555 ' O ' ' NZ ' ' A' ' 11' ' ' LYS . 8.0 t0 77.34 13.53 1.96 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.281 -179.965 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' B' B ' 257' ' ' LYS . . . . . 0.424 ' HA ' ' HZ3' ' A' ' 11' ' ' LYS . 97.2 mttt -67.64 -37.63 82.72 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.098 0.475 . . . . 0.0 111.068 178.345 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -88.81 122.28 32.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.763 179.744 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.668 ' C ' ' H ' ' B' ' 261' ' ' ILE . 43.8 p30 -114.25 143.49 44.76 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.579 0.704 . . . . 0.0 110.694 -179.704 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.481 ' OE1' HD21 ' A' ' 41' ' ' LEU . 99.1 mt-10 -59.93 15.99 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.626 -1.17 . . . . 0.0 111.186 -179.804 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.668 ' H ' ' C ' ' B' ' 259' ' ' ASP . 66.9 mt -109.69 134.56 51.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 178.945 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 61.9 t -125.23 133.88 68.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.746 -179.311 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -94.43 118.95 32.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.043 -178.986 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -68.2 -41.16 81.79 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.281 179.392 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 265' ' ' GLN . . . . . 0.538 ' HG2' HD11 ' A' ' 24' ' ' LEU . 4.6 mp0 -103.56 163.69 16.92 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.814 -178.878 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -62.27 153.27 71.26 Favored 'Trans proline' 0 N--CA 1.5 1.856 0 C-N-CA 123.202 2.601 . . . . 0.0 113.08 -179.429 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 42.5 pt . . . . . 0 C--N 1.33 -0.253 0 CA-C-O 121.693 0.759 . . . . 0.0 112.328 -179.02 . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo . . . . . 0 N--CA 1.496 1.62 0 CA-C-O 120.762 0.234 . . . . 0.0 112.395 . . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.7 m -74.78 -47.98 27.92 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.965 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.524 ' NE ' ' HB2' ' A' ' 58' ' ' ALA . 85.7 mtt85 -97.76 137.22 36.97 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.918 0.389 . . . . 0.0 111.997 -177.494 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.569 ' NE ' ' OE2' ' A' ' 100' ' ' GLU . 89.4 mtm180 -137.62 145.98 43.41 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.518 179.576 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.717 HD21 HD11 ' A' ' 22' ' ' LEU . 3.0 mm? -112.96 141.54 46.68 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.94 178.395 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.0 t -114.09 127.02 71.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.852 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.531 ' CG2' HD12 ' B' ' 261' ' ' ILE . 50.0 m -78.64 139.68 38.51 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -177.998 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.485 HD12 ' CB ' ' A' ' 94' ' ' SER . 99.6 mt -109.22 136.47 45.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.185 177.494 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -88.8 158.46 18.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.006 0.431 . . . . 0.0 110.926 179.942 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.945 HH21 HD22 ' B' ' 252' ' ' LEU . 86.3 mtm180 -57.16 -30.59 64.59 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.801 -178.611 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 88.6 p -80.93 -7.07 59.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.192 179.988 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.88 34.44 6.85 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.692 179.527 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.2 t -119.64 132.73 68.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.748 0.308 . . . . 0.0 111.111 -179.988 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -74.84 138.23 42.39 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.73 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -131.65 -118.89 2.02 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 120.533 -0.842 . . . . 0.0 112.616 -178.939 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -73.79 149.12 42.32 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.414 2.076 . . . . 0.0 113.066 -178.427 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -110.58 157.46 19.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.697 -179.962 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.971 ' CD2' HD11 ' A' ' 37' ' ' ILE . 35.2 t80 -124.64 99.83 35.36 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.924 -179.553 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -74.81 135.52 19.58 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 121.374 1.383 . . . . 0.0 112.48 -179.499 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.717 HD11 HD21 ' A' ' 7' ' ' LEU . 80.5 mt -87.65 81.98 7.54 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 120.872 0.367 . . . . 0.0 111.093 -179.24 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.9 p -86.33 -8.68 57.51 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.164 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.5 mt -103.82 146.22 28.96 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.611 179.917 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.6 m -67.81 -14.82 63.27 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -179.219 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 39.7 m -131.03 132.6 45.06 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.694 -179.948 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.435 ' HB2' HD22 ' A' ' 22' ' ' LEU . 5.1 t -126.96 120.21 28.55 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.653 178.835 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.446 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 35.1 tp -117.22 130.86 56.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.779 0.323 . . . . 0.0 111.42 -178.561 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.446 ' O ' ' O ' ' A' ' 47' ' ' GLN . 54.1 m-85 -107.43 133.44 51.94 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.615 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 179.42 -173.46 45.39 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.186 -1.007 . . . . 0.0 112.718 -179.967 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.2 ttp-105 -93.75 -23.4 18.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.234 -0.483 . . . . 0.0 110.349 179.746 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.467 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -72.2 163.96 54.49 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.932 -179.095 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.59 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.4 tp -68.17 -43.25 85.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.948 0.404 . . . . 0.0 111.582 -179.846 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.59 ' N ' HG23 ' A' ' 33' ' ' ILE . 52.1 tp10 -54.19 -19.81 5.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.862 -178.594 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.467 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 3.5 m -67.77 129.01 38.59 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.275 -179.777 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.446 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 66.0 m-20 -61.58 -33.84 74.58 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.961 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.971 HD11 ' CD2' ' A' ' 20' ' ' PHE . 36.9 mm -120.11 116.6 50.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.097 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.56 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 83.2 mtp180 -105.63 134.85 48.07 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.681 -178.404 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 78.6 mt -121.13 129.13 75.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.35 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -77.22 27.72 0.15 Allowed 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -177.921 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.741 HD21 ' OE1' ' B' ' 260' ' ' GLU . 78.9 mt -99.09 139.18 20.81 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.121 179.55 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.45 -14.73 20.1 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.492 2.128 . . . . 0.0 112.277 -179.395 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.1 m -91.19 7.87 4.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.534 179.868 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 55.6 t -100.36 132.11 46.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.359 179.09 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.4 m -74.11 170.32 15.73 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.768 0.794 . . . . 0.0 111.655 -179.52 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -64.83 -38.54 91.32 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.093 179.799 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.642 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.0 mt-30 -114.74 -19.2 11.15 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.167 179.875 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 14.8 t60 32.61 -76.58 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 179.805 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.642 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.82 134.16 46.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.3 0.571 . . . . 0.0 112.066 -178.662 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -125.34 132.55 52.82 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.189 179.08 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.8 mt -116.46 133.78 61.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.986 -179.563 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -113.87 123.76 50.58 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.513 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.407 HD11 HD13 ' A' ' 22' ' ' LEU . 96.6 mt -105.87 111.6 35.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.659 -179.484 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.458 ' O ' ' N ' ' A' ' 56' ' ' GLN . 81.4 m-70 -113.77 142.85 45.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.313 179.834 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 54' ' ' HIS . 99.2 mt-10 -40.67 -28.46 0.07 Allowed 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.266 -0.574 . . . . 0.0 109.826 -179.771 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.488 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 95.1 mt-30 -63.78 -68.55 0.34 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.546 178.866 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.488 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 3.4 tp10 -157.24 -168.32 2.58 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.585 -179.671 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.524 ' HB2' ' NE ' ' A' ' 5' ' ' ARG . . . -110.12 124.71 52.02 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 178.473 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 98.0 mt -115.83 130.28 70.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.283 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 47.1 tp -97.98 127.98 44.26 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.249 179.258 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -114.94 138.24 51.06 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.467 -179.995 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.47 HD21 ' CA ' ' A' ' 68' ' ' PRO . 57.8 t-20 -98.69 106.83 19.15 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.903 0.383 . . . . 0.0 111.961 -179.692 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -102.33 -9.5 20.29 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.032 179.406 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.38 100.14 4.35 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.173 -179.932 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 85.0 p -84.24 -32.11 24.65 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.341 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.755 HG21 ' O ' ' B' ' 234' ' ' TPO . 1.7 m -64.43 -51.46 63.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.699 -179.745 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.552 ' HB3' HD11 ' A' ' 91' ' ' ILE . 55.5 m-80 -138.79 95.96 9.58 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.673 179.825 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.47 ' CA ' HD21 ' A' ' 62' ' ' ASN . 52.0 Cg_exo -55.0 146.7 56.46 Favored 'Trans proline' 0 N--CA 1.499 1.809 0 C-N-CA 122.286 1.99 . . . . 0.0 113.328 -178.957 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 44.3 m -75.06 145.16 42.58 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.289 -179.984 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -108.11 143.37 36.95 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.808 -179.733 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.435 ' O ' ' N ' ' A' ' 74' ' ' SER . 5.4 p -131.99 135.97 57.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.77 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 49.16 33.17 4.69 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.238 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.69 29.09 69.92 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.317 -179.577 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 71' ' ' VAL . 66.8 m -138.65 136.06 35.51 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.906 0.353 . . . . 0.0 111.161 -179.616 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -66.32 141.75 17.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.176 -179.806 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.2 pt -118.71 78.99 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.677 179.107 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -63.34 -24.02 67.67 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.768 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -116.84 158.71 43.14 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.838 179.559 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -64.97 148.62 89.81 Favored 'Trans proline' 0 N--CA 1.5 1.884 0 C-N-CA 122.859 2.373 . . . . 0.0 113.044 -179.6 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 65.9 t -138.41 138.99 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.088 179.815 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -69.33 132.11 45.89 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 178.817 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 90.0 mt -78.85 138.38 38.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.304 0.574 . . . . 0.0 111.113 -179.985 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -132.36 150.14 52.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.075 179.949 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.453 ' ND1' ' N ' ' A' ' 99' ' ' ASN . 4.9 t60 -58.17 119.12 6.29 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.874 0.369 . . . . 0.0 110.401 -179.674 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.51 -23.04 16.19 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 -179.66 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 87' ' ' VAL . 57.7 t0 -67.93 132.11 46.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.029 0.442 . . . . 0.0 110.939 179.736 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.526 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 50.0 t -110.63 132.15 59.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.512 -179.038 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 87.3 mt -95.75 131.26 43.01 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 177.957 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 44.6 m -121.99 128.97 52.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.989 0.899 . . . . 0.0 113.314 -177.244 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.626 ' O ' ' N ' ' A' ' 93' ' ' ARG . 97.9 mt -116.42 129.94 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-N 113.926 -1.488 . . . . 0.0 108.379 178.453 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.552 HD11 ' HB3' ' A' ' 67' ' ' ASN . 70.4 mt -21.49 98.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.415 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.566 ' OD2' ' NH1' ' B' ' 245' ' ' ARG . 0.8 OUTLIER 88.46 -23.8 0.11 Allowed 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 178.171 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.649 HH22 ' CG ' ' B' ' 259' ' ' ASP . 83.4 mtt-85 -128.35 145.02 51.2 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.273 -179.53 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.485 ' CB ' HD12 ' A' ' 10' ' ' ILE . 11.3 t -140.7 153.76 46.08 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.325 0.583 . . . . 0.0 110.576 -179.9 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.647 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 95.8 m-85 -124.96 121.49 34.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.464 179.363 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -81.6 131.68 35.28 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.342 -179.937 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.584 ' CZ ' ' OD1' ' A' ' 99' ' ' ASN . 85.8 t80 -94.66 126.22 39.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.691 -179.647 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -136.4 128.59 29.84 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 120.572 -0.451 . . . . 0.0 112.001 -179.531 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.584 ' OD1' ' CZ ' ' A' ' 97' ' ' TYR . 93.7 m-20 -96.04 136.0 37.06 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.827 179.083 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.569 ' OE2' ' NE ' ' A' ' 6' ' ' ARG . 96.9 mt-10 . . . . . 0 N--CA 1.464 0.229 0 CA-C-O 120.889 0.376 . . . . 0.0 111.369 -179.482 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 28.4 m . . . . . 0 N--CA 1.45 -0.429 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 . . . . . . . . . 0 0 . 1 . 038 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.438 ' C ' ' H ' ' B' ' 231' ' ' GLN . 99.2 m-20 -68.36 148.21 51.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.033 0.444 . . . . 0.0 111.365 -179.232 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 038 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.438 ' H ' ' C ' ' B' ' 229' ' ' ASP . 74.9 mt-30 -128.18 36.24 4.32 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.678 -179.638 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -116.85 -161.87 12.5 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.602 -178.514 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -60.88 153.18 65.11 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 123.858 3.039 . . . . 0.0 112.401 -179.835 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.755 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -65.68 138.56 54.45 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.739 1.626 . . . . 0.0 114.474 -178.954 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.501 HG12 HG22 ' A' ' 66' ' ' THR . 26.8 m -72.43 143.35 14.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 114.279 -1.328 . . . . 0.0 109.174 179.34 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 10.3 t -72.24 129.31 38.13 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.705 -179.028 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 238' ' ' TPO . . . . . 0.431 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 239' ' ' PRO . . . . . 0.431 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 39.0 Cg_exo -57.26 -26.92 72.61 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.755 2.303 . . . . 0.0 112.493 -179.252 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 99.3 m -73.22 -45.09 58.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.905 0.384 . . . . 0.0 111.023 179.376 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -57.08 -47.84 80.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.251 -179.29 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 87.1 mt -63.5 -42.56 98.5 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.412 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -63.67 -41.88 98.12 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.892 -179.547 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 62.9 ttm-85 -64.31 -44.21 92.29 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.009 0.433 . . . . 0.0 110.422 179.938 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.603 ' NH2' HD13 ' A' ' 41' ' ' LEU . 4.0 tpp85 -61.43 -42.9 99.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.773 -179.61 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -59.48 -40.09 85.81 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.825 0.345 . . . . 0.0 110.271 -179.734 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 78.0 p -70.31 -39.88 74.55 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.816 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 248' ' ' GLN . . . . . 0.416 ' O ' ' N ' ' B' ' 252' ' ' LEU . 63.7 tp60 -59.25 -38.53 80.3 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.699 179.823 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 38.3 t -62.34 -46.91 95.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.734 0.302 . . . . 0.0 110.35 179.029 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -58.67 -26.7 64.07 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.254 0.55 . . . . 0.0 109.831 179.708 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -96.69 -12.07 24.3 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.531 179.727 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.945 HD22 HH21 ' A' ' 12' ' ' ARG . 40.7 tp -73.3 140.2 46.62 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.746 -179.289 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -95.54 129.98 42.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.345 178.855 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 254' ' ' ASP . . . . . 0.532 ' N ' ' OD1' ' B' ' 254' ' ' ASP . 12.9 p-10 -61.39 -19.54 62.02 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.849 -179.249 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -64.63 1.14 0.89 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.968 -179.682 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.72 ' OD2' HD11 ' B' ' 252' ' ' LEU . 55.2 p-10 -91.79 69.88 5.61 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.31 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -64.99 1.76 0.87 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.316 -178.963 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.48 ' O ' ' C ' ' B' ' 259' ' ' ASP . 96.2 m-20 -113.23 0.63 14.94 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 177.799 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.649 ' CG ' HH22 ' A' ' 93' ' ' ARG . 66.6 t0 21.86 -96.99 0.0 OUTLIER 'General case' 0 C--O 1.233 0.199 0 CA-C-N 113.869 -1.514 . . . . 0.0 110.976 -179.674 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.741 ' OE1' HD21 ' A' ' 41' ' ' LEU . 98.2 mt-10 -141.09 14.46 2.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.767 0.318 . . . . 0.0 110.173 178.958 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.647 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 67.6 mt -114.11 134.19 57.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.655 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 44.4 t -124.99 134.53 66.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.168 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -96.17 117.72 31.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.275 0.559 . . . . 0.0 111.578 -178.222 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -65.96 -46.29 78.66 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.163 179.611 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.0 155.51 38.2 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.336 -179.192 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -64.31 148.86 90.99 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 123.212 2.608 . . . . 0.0 113.42 -179.222 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 47.1 pt . . . . . 0 C--N 1.332 -0.157 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.761 178.693 . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo . . . . . 0 N--CA 1.491 1.346 0 CA-C-O 120.699 0.208 . . . . 0.0 112.158 . . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.8 p -89.24 -50.67 6.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.096 0.474 . . . . 0.0 110.549 179.927 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.716 ' NH1' ' HB2' ' A' ' 58' ' ' ALA . 99.9 mtt180 -98.84 135.34 40.44 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.212 -179.736 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.497 ' NE ' ' OE1' ' A' ' 98' ' ' GLU . 33.4 ptt180 -140.85 155.44 46.34 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.27 -0.572 . . . . 0.0 112.034 -179.569 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 78.5 mt -118.91 145.19 45.94 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.747 179.703 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.6 t -114.43 129.88 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 178.177 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.413 ' CG2' HD12 ' B' ' 261' ' ' ILE . 22.4 m -91.64 118.27 30.49 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -177.553 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.43 HD12 ' HB2' ' A' ' 94' ' ' SER . 98.1 mt -84.67 142.87 12.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.436 178.284 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.601 ' NZ ' ' CB ' ' B' ' 256' ' ' ASP . 98.3 mttt -94.99 167.89 11.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.845 0.355 . . . . 0.0 110.942 179.566 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.586 ' NH2' ' CD1' ' B' ' 252' ' ' LEU . 83.5 mtm180 -56.49 -32.44 65.02 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.465 -178.407 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.486 ' OG ' HG13 ' B' ' 249' ' ' VAL . 3.5 m -80.25 -7.61 59.09 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.47 179.893 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.71 39.83 6.98 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 -179.545 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.609 HG21 ' OD1' ' B' ' 254' ' ' ASP . 40.3 t -119.58 130.85 73.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.959 0.409 . . . . 0.0 110.869 -179.403 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -77.16 136.68 38.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.558 179.305 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -137.59 -114.86 1.32 Allowed Glycine 0 CA--C 1.535 1.297 0 C-N-CA 120.2 -1.0 . . . . 0.0 111.746 -179.9 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -71.92 149.0 52.62 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.088 1.859 . . . . 0.0 112.502 -178.994 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -113.45 157.6 21.75 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.793 179.932 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.599 ' CD2' HD11 ' A' ' 37' ' ' ILE . 34.1 t80 -118.13 97.71 50.94 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.487 179.864 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -74.17 131.76 15.74 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 121.39 1.393 . . . . 0.0 111.342 -179.328 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 82.0 mt -83.51 80.63 9.04 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.632 -178.791 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 87.9 p -84.55 -11.15 56.6 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.867 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 67.5 mt -107.16 149.18 27.96 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.191 -179.885 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 28.5 t -67.88 -15.79 63.78 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.811 -179.408 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.531 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 58.8 m -127.16 130.04 49.01 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.594 -0.442 . . . . 0.0 112.181 -179.192 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.7 t -123.76 113.46 18.61 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 177.799 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.456 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 41.0 tp -115.68 131.09 57.04 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.619 -178.232 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.745 ' CE2' HD12 ' A' ' 37' ' ' ILE . 6.9 m-85 -108.51 131.1 55.16 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.706 179.796 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 166.59 -175.25 41.99 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 119.934 -1.127 . . . . 0.0 112.862 179.386 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.503 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 76.4 mtm-85 -80.1 -32.11 39.17 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-O 120.876 0.369 . . . . 0.0 110.594 179.95 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.563 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -51.3 146.23 11.4 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.512 -178.147 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.549 HD13 ' CZ ' ' A' ' 38' ' ' ARG . 36.9 mm -64.44 -43.46 96.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.74 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -54.91 -21.24 10.93 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.633 -179.769 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.563 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 17.2 m -59.08 129.07 40.37 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.155 0.503 . . . . 0.0 110.521 -179.672 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.531 ' OD2' ' O ' ' A' ' 26' ' ' THR . 59.0 m-20 -60.9 -33.35 72.99 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.457 -179.109 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.745 HD12 ' CE2' ' A' ' 29' ' ' PHE . 89.4 mt -125.97 119.78 55.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 177.998 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.549 ' CZ ' HD13 ' A' ' 33' ' ' ILE . 83.3 mtp180 -103.75 137.84 41.22 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.889 -178.497 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 90.3 mt -121.08 131.76 72.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.267 179.551 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -75.24 26.35 0.1 Allowed 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -178.319 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.587 ' CD1' ' CZ ' ' A' ' 93' ' ' ARG . 81.9 mt -102.2 131.74 22.27 Favored Pre-proline 0 C--N 1.326 -0.42 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.301 179.947 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.69 -13.18 27.05 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 122.292 1.995 . . . . 0.0 112.47 -179.535 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.525 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 3.8 m -92.81 2.04 8.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.159 -179.621 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.503 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 38.0 t -91.7 133.8 32.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 177.875 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.0 m -72.64 175.0 6.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.501 0.667 . . . . 0.0 111.586 -178.285 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -63.35 -42.58 98.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.736 -179.787 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.629 ' O ' ' N ' ' A' ' 49' ' ' CYS . 89.0 mt-30 -116.98 -17.01 10.48 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.426 0.454 . . . . 0.0 111.335 -179.948 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.1 t60 34.05 -76.52 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 179.665 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.629 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -127.8 135.1 49.63 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.225 0.536 . . . . 0.0 112.222 -178.766 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -126.74 133.08 50.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.896 179.476 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.3 mt -119.37 132.04 70.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.63 179.107 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.41 ' HB3' ' HE1' ' A' ' 54' ' ' HIS . 79.6 tt0 -115.21 126.09 54.14 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.944 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.48 HD12 HH11 ' A' ' 5' ' ' ARG . 47.4 mm -93.68 122.66 45.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.326 0.584 . . . . 0.0 111.356 -178.029 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.463 ' O ' ' C ' ' A' ' 55' ' ' GLU . 8.7 m80 -117.76 127.42 53.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.168 179.104 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' A' ' 54' ' ' HIS . 97.5 mt-10 -40.96 -31.33 0.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.967 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.428 ' N ' ' C ' ' A' ' 54' ' ' HIS . 85.7 mt-30 -67.0 -67.61 0.44 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.664 178.046 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -149.77 -172.79 4.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.157 -179.63 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.716 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -115.01 132.19 56.68 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.951 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 47.6 mm -113.21 128.11 70.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 120.493 -0.483 . . . . 0.0 112.022 -178.286 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.42 ' HB2' HD11 ' A' ' 82' ' ' LEU . 22.9 tp -98.65 126.61 44.3 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.545 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -117.92 139.09 51.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.739 0.304 . . . . 0.0 110.595 -179.724 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.536 HD22 ' HA ' ' A' ' 68' ' ' PRO . 51.2 t30 -101.58 113.93 27.51 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.85 0.357 . . . . 0.0 111.493 -179.728 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -102.45 -7.92 21.54 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.653 179.878 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.42 99.16 11.01 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.423 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.9 m -76.25 -32.31 58.79 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.246 0.546 . . . . 0.0 109.938 179.064 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.0 m -63.48 -45.97 88.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.598 -179.309 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -142.93 93.15 6.73 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.597 179.208 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.536 ' HA ' HD22 ' A' ' 62' ' ' ASN . 32.6 Cg_exo -56.93 148.89 64.8 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.056 1.837 . . . . 0.0 111.859 -179.721 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.967 ' O ' HG22 ' A' ' 76' ' ' ILE . 41.7 m -70.66 156.43 39.48 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.106 -179.589 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.413 ' N ' HG22 ' A' ' 69' ' ' THR . 86.7 mt-30 -114.6 140.98 48.36 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.915 179.683 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.642 HG13 ' OD1' ' A' ' 86' ' ' ASP . 55.6 t -130.21 135.68 60.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.762 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 52.81 32.38 12.19 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 119.857 -0.737 . . . . 0.0 109.359 -179.142 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.25 29.17 68.84 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.511 179.99 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 11.3 p -142.03 140.15 32.55 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.286 179.965 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.2 p -63.0 143.27 15.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.698 -179.433 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.967 HG22 ' O ' ' A' ' 69' ' ' THR . 10.5 tt -113.88 87.28 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.577 -179.849 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 20.5 p-10 -66.4 -33.03 74.79 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.952 179.891 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.418 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 2.7 mt-10 -124.65 167.41 15.96 Favored Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.27 -179.053 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -60.3 144.87 99.5 Favored 'Trans proline' 0 N--CA 1.502 2.001 0 C-N-CA 122.582 2.188 . . . . 0.0 112.891 179.647 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.1 m -138.77 152.81 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 CA-C-O 121.618 0.723 . . . . 0.0 111.962 178.665 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -79.45 127.31 31.95 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.835 179.548 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.42 HD11 ' HB2' ' A' ' 60' ' ' LEU . 98.1 mt -83.41 129.49 34.99 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.28 0.562 . . . . 0.0 110.434 -179.623 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -121.91 150.45 41.96 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.283 -179.881 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.428 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 6.1 t60 -49.63 118.35 2.75 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.955 -179.397 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.15 -20.35 28.55 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 179.685 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.642 ' OD1' HG13 ' A' ' 71' ' ' VAL . 56.7 t0 -61.54 132.49 53.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.17 0.509 . . . . 0.0 110.437 179.864 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.503 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 56.7 t -109.48 129.75 63.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.278 -179.03 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.8 mt -98.09 131.56 44.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.613 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.455 HG23 ' OG ' ' A' ' 94' ' ' SER . 74.7 m -126.05 127.92 46.6 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.624 0.726 . . . . 0.0 112.405 -178.42 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.569 ' O ' ' N ' ' A' ' 92' ' ' ASP . 97.8 mt -110.13 125.4 67.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.009 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.894 HD12 HH22 ' A' ' 93' ' ' ARG . 88.6 mt 40.0 -91.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 120.584 -0.447 . . . . 0.0 110.315 -178.7 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.569 ' N ' ' O ' ' A' ' 90' ' ' ILE . 33.9 t70 -128.06 20.05 6.43 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.04 0.448 . . . . 0.0 111.238 -179.776 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.894 HH22 HD12 ' A' ' 91' ' ' ILE . 45.8 mtm-85 -126.65 140.41 52.43 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.541 -179.798 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.455 ' OG ' HG23 ' A' ' 89' ' ' THR . 57.4 m -138.89 153.31 48.27 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 119.602 -0.839 . . . . 0.0 112.2 -179.154 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -121.92 122.44 39.4 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.705 178.864 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -81.55 130.11 34.93 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 119.884 -0.726 . . . . 0.0 110.449 -179.108 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -94.27 124.24 38.17 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.272 -179.283 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.497 ' OE1' ' NE ' ' A' ' 6' ' ' ARG . 80.3 tt0 -124.5 123.44 40.13 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.97 179.868 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.428 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 64.0 t-20 -107.71 114.07 27.79 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.668 -179.959 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 . . . . . 0 C--O 1.233 0.202 0 CA-C-O 121.035 0.445 . . . . 0.0 110.679 -179.624 . . . . . . . . 0 0 . 1 . 039 nuclear build full ' B' B ' 228' ' ' VAL . . . . . 0.473 HG21 ' NH2' ' A' ' 31' ' ' ARG . 2.1 p . . . . . 0 CA--C 1.517 -0.305 0 CA-C-O 120.957 0.408 . . . . 0.0 110.598 . . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -61.0 -104.72 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.927 179.67 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 039 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -156.28 39.58 0.35 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 120.955 0.407 . . . . 0.0 111.045 -179.531 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -105.37 -139.94 10.0 Favored Glycine 0 CA--C 1.534 1.252 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -179.984 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -75.46 153.47 39.67 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 122.327 2.018 . . . . 0.0 112.22 -179.366 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.574 HG21 ' O1P' ' B' ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -76.5 172.0 17.03 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.312 2.008 . . . . 0.0 111.59 178.918 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 5.9 p -113.91 133.2 60.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.799 179.704 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 237' ' ' CYS . . . . . 0.461 ' HG ' ' HD2' ' B' ' 241' ' ' PHE . 4.6 t -72.35 129.9 39.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.48 -178.923 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' B' B ' 238' ' ' TPO . . . . . 0.454 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 239' ' ' PRO . . . . . 0.454 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 37.2 Cg_exo -58.94 -22.25 62.13 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.862 2.375 . . . . 0.0 112.003 179.863 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 94.4 m -71.88 -45.84 59.91 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.147 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.525 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 83.3 t80 -58.79 -47.05 86.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.101 -179.376 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.407 ' HA ' HD23 ' B' ' 242' ' ' LEU . 95.3 mt -63.56 -41.1 98.42 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -179.046 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -63.12 -38.87 92.91 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.967 -179.792 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -63.49 -41.85 98.56 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.126 0.489 . . . . 0.0 110.002 179.613 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.633 ' NH2' ' NH1' ' A' ' 93' ' ' ARG . 62.4 ttm-85 -60.05 -44.72 94.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.008 -179.168 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -64.77 -40.05 94.62 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.752 179.467 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 66.6 m -63.77 -45.42 89.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.499 179.509 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -60.7 -39.47 88.65 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.259 -179.461 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.486 HG13 ' OG ' ' A' ' 13' ' ' SER . 21.0 t -60.6 -44.1 96.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.445 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -61.84 -34.49 76.06 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.632 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -75.47 -9.67 58.77 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 178.374 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.586 ' CD1' ' NH2' ' A' ' 12' ' ' ARG . 96.3 mt -113.39 -175.15 2.61 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.834 178.925 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' B' B ' 253' ' ' ASN . . . . . 0.416 ' OD1' ' N ' ' B' ' 253' ' ' ASN . 19.6 p-10 -137.83 177.67 7.7 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.139 0.495 . . . . 0.0 110.629 -179.929 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' B' B ' 254' ' ' ASP . . . . . 0.609 ' OD1' HG21 ' A' ' 15' ' ' VAL . 35.9 t70 -63.84 -16.22 60.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.67 -179.722 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' B' B ' 255' ' ' ASP . . . . . 0.502 ' O ' ' O ' ' B' ' 256' ' ' ASP . 99.3 m-20 -60.62 -3.77 0.78 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.174 -179.373 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.601 ' CB ' ' NZ ' ' A' ' 11' ' ' LYS . 4.0 p30 43.19 -176.1 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.878 0.371 . . . . 0.0 111.332 179.159 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' B' B ' 257' ' ' LYS . . . . . 0.543 ' O ' ' C ' ' B' ' 258' ' ' ASP . 16.1 ptmt -176.31 124.78 0.18 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.318 179.849 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.543 ' C ' ' O ' ' B' ' 257' ' ' LYS . 82.1 m-20 14.95 57.75 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.864 -179.506 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.636 ' C ' ' H ' ' B' ' 261' ' ' ILE . 44.2 p-10 -19.96 129.53 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.657 0.741 . . . . 0.0 112.427 -179.327 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -50.95 1.93 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.209 179.537 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.636 ' H ' ' C ' ' B' ' 259' ' ' ASP . 73.5 mt -106.39 138.73 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.783 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 54.1 t -129.05 136.66 59.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.274 -178.765 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -97.4 117.12 30.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.318 0.58 . . . . 0.0 111.126 -179.397 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 43.3 tttp -67.05 -43.41 82.8 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.502 178.99 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 53.8 mm-40 -94.0 155.2 40.43 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.721 -179.014 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -61.31 154.1 60.82 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.103 1.869 . . . . 0.0 111.036 178.561 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 40.3 pt . . . . . 0 C--N 1.324 -0.539 0 CA-C-O 121.702 0.763 . . . . 0.0 112.372 -178.328 . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo . . . . . 0 N--CA 1.496 1.624 0 CA-C-O 120.748 0.228 . . . . 0.0 112.114 . . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 68.5 p -101.14 -48.59 4.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.58 -179.968 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.871 ' NH1' HG23 ' A' ' 53' ' ' ILE . 99.9 mtt180 -94.72 130.73 41.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.941 179.924 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -128.27 137.85 52.16 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.424 179.514 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.56 HD11 ' HB3' ' A' ' 95' ' ' PHE . 45.0 tp -106.88 130.88 54.49 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.47 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.6 t -110.04 129.31 65.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.475 -178.991 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.412 ' O ' HG22 ' A' ' 9' ' ' THR . 1.8 m -90.9 111.9 23.52 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.461 -178.971 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.7 mt -83.13 148.03 5.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.599 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -94.15 168.6 10.83 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.383 0.611 . . . . 0.0 111.434 179.705 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.801 HH21 HD22 ' B' ' 252' ' ' LEU . 87.9 mtm180 -58.06 -29.74 65.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.886 -179.038 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.8 p -80.54 -6.24 57.93 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.687 179.796 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.04 23.6 37.6 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.163 179.159 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.1 m -109.54 140.86 26.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.535 179.742 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.41 ' C ' ' OD1' ' A' ' 16' ' ' ASP . 57.3 t0 -69.32 122.75 19.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.682 -179.6 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -108.74 -131.91 6.49 Favored Glycine 0 CA--C 1.538 1.506 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 -179.344 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -74.71 153.95 43.64 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.342 2.028 . . . . 0.0 112.031 -179.258 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -109.15 155.92 20.45 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.148 -179.536 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.439 ' CD2' HD11 ' A' ' 37' ' ' ILE . 57.2 t80 -126.12 92.28 46.13 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.477 179.927 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.94 126.72 22.53 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 121.865 1.71 . . . . 0.0 111.551 -179.789 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.2 mt -80.02 54.3 1.88 Allowed 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 120.808 0.337 . . . . 0.0 110.708 -179.351 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.6 t -62.46 -40.62 97.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.802 179.587 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 46.8 mt -70.54 144.49 51.29 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.178 -179.77 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.6 t -66.01 -17.84 64.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.444 -178.84 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.549 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 50.2 m -132.53 134.13 44.61 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.996 -179.777 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.647 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 2.7 t -127.66 116.81 20.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.111 0.481 . . . . 0.0 109.798 178.585 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.617 HD21 ' OE1' ' A' ' 47' ' ' GLN . 44.7 tp -114.82 130.14 56.82 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.631 -178.291 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.778 ' CE2' HD12 ' A' ' 37' ' ' ILE . 27.1 m-85 -108.7 139.18 43.86 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.171 -179.894 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.87 -175.38 30.65 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.405 178.574 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.6 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 81.5 mtm-85 -74.04 -32.96 63.54 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.911 0.386 . . . . 0.0 110.868 -179.961 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.428 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -46.86 139.8 7.46 Favored Glycine 0 N--CA 1.465 0.584 0 N-CA-C 111.554 -0.619 . . . . 0.0 111.554 -178.582 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.547 ' CD1' ' CZ ' ' A' ' 38' ' ' ARG . 36.3 mm -64.99 -44.71 96.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.805 0.336 . . . . 0.0 110.975 -179.951 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -57.98 -13.91 5.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.45 -179.173 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.428 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 60.0 m -63.02 131.23 47.91 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.524 -179.877 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.549 ' OD2' ' O ' ' A' ' 26' ' ' THR . 58.9 m-20 -61.24 -30.79 70.66 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.288 -179.326 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.778 HD12 ' CE2' ' A' ' 29' ' ' PHE . 77.9 mt -128.44 119.34 50.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.019 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.547 ' CZ ' ' CD1' ' A' ' 33' ' ' ILE . 83.8 mtp180 -100.04 135.54 41.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.518 -179.052 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.561 HG21 HD12 ' A' ' 41' ' ' LEU . 95.2 mt -121.28 128.96 76.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.55 -0.46 . . . . 0.0 109.907 179.98 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -79.36 31.26 0.22 Allowed 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -178.318 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.561 HD12 HG21 ' A' ' 39' ' ' ILE . 13.2 mt -97.85 128.48 33.92 Favored Pre-proline 0 CA--C 1.535 0.366 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.763 179.544 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -72.51 -12.69 27.27 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.487 2.125 . . . . 0.0 113.272 -179.276 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.439 HG21 ' CE2' ' B' ' 241' ' ' PHE . 27.1 m -100.29 6.99 9.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.316 -0.554 . . . . 0.0 110.432 179.525 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.6 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 32.0 t -95.43 134.99 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.934 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.67 164.47 19.2 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.502 0.668 . . . . 0.0 111.94 -178.691 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -63.56 -42.31 98.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.056 -179.375 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.638 ' O ' ' N ' ' A' ' 49' ' ' CYS . 95.3 mm-40 -109.2 -23.04 11.81 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.591 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.473 ' O ' ' OG ' ' A' ' 64' ' ' SER . 17.1 t60 38.18 -76.04 0.0 OUTLIER 'General case' 0 C--O 1.235 0.336 0 CA-C-N 114.621 -1.172 . . . . 0.0 113.086 179.135 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.638 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.59 136.79 45.13 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.347 -0.541 . . . . 0.0 112.04 -178.218 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -128.17 130.39 47.98 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.394 179.431 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 95.8 mt -112.36 133.36 58.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.043 -179.934 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 73.3 tt0 -116.92 125.32 51.29 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.864 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.871 HG23 ' NH1' ' A' ' 5' ' ' ARG . 91.8 mt -104.33 123.81 58.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.666 0.746 . . . . 0.0 112.913 -177.796 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.494 ' O ' ' N ' ' A' ' 56' ' ' GLN . 2.0 m-70 -118.21 137.19 53.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.506 -1.225 . . . . 0.0 109.437 179.06 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.466 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.9 mm-40 -39.38 -29.57 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -179.508 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.494 ' N ' ' O ' ' A' ' 54' ' ' HIS . 98.6 mm-40 -65.22 -66.52 0.53 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.955 178.656 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -157.49 -166.03 1.93 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.198 -179.65 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.499 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -108.95 130.79 55.46 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.699 179.129 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 37.1 mm -112.43 125.84 69.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.902 -179.473 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.1 tp -99.72 123.41 43.95 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.723 0.297 . . . . 0.0 110.53 -179.888 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -111.23 134.6 52.69 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.152 179.853 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.408 ' ND2' ' O ' ' A' ' 76' ' ' ILE . 46.6 p-10 -99.89 108.3 20.51 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 121.0 0.429 . . . . 0.0 111.537 -179.845 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -97.52 -9.65 26.72 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.7 -179.937 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.473 ' OG ' ' O ' ' A' ' 48' ' ' HIS . 0.3 OUTLIER -77.25 99.88 5.64 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 120.95 0.405 . . . . 0.0 110.764 -179.689 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 86.5 p -79.08 -31.44 44.37 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.875 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.588 HG22 HG12 ' B' ' 236' ' ' VAL . 3.6 m -64.41 -47.99 77.08 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.764 -179.796 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -147.61 99.17 3.85 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.25 -179.699 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -56.27 149.66 53.93 Favored 'Trans proline' 0 N--CA 1.499 1.794 0 C-N-CA 122.117 1.878 . . . . 0.0 113.215 -178.489 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 50.3 m -68.06 138.7 56.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.174 178.849 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -100.45 144.54 29.33 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.731 -179.745 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.697 ' HB ' HD11 ' A' ' 76' ' ' ILE . 5.1 p -131.21 136.28 58.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.167 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 51.12 30.93 6.01 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -178.967 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.41 26.2 70.76 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.936 -179.86 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 71' ' ' VAL . 12.0 t -135.65 137.8 42.21 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.194 0.521 . . . . 0.0 111.534 -179.511 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.5 t -66.68 136.43 26.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.813 -179.784 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.697 HD11 ' HB ' ' A' ' 71' ' ' VAL . 97.0 mt -101.27 100.86 11.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.561 179.383 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -64.44 -41.15 96.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.875 179.872 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.515 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.9 OUTLIER -132.54 -178.07 0.79 Allowed Pre-proline 0 N--CA 1.464 0.227 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.346 -178.656 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 31.3 Cg_exo -59.38 143.8 99.6 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.49 2.127 . . . . 0.0 111.642 -179.815 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.2 p -141.01 147.65 22.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-O 121.186 0.517 . . . . 0.0 112.078 -179.041 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -79.7 128.16 33.08 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.283 179.27 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.499 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 96.0 mt -83.33 139.15 33.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.22 -179.84 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.484 ' N ' ' OD2' ' A' ' 86' ' ' ASP . 99.2 mttt -128.81 153.67 47.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.795 179.166 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.538 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 3.6 t-160 -55.54 119.4 5.6 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.892 0.377 . . . . 0.0 110.383 -179.661 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.0 -13.66 31.65 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.687 179.606 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.523 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 2.4 p30 -72.06 133.2 45.11 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.406 -0.517 . . . . 0.0 109.894 179.564 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 45.7 t -109.21 130.12 62.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.583 -178.309 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 89.4 mt -98.21 131.29 45.56 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 178.401 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.6 m -119.27 127.91 53.67 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.951 0.882 . . . . 0.0 112.628 -178.066 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.587 ' O ' ' N ' ' A' ' 93' ' ' ARG . 98.4 mt -115.28 134.11 59.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.471 178.496 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.617 HD13 ' HB2' ' B' ' 237' ' ' CYS . 53.9 mt -31.73 100.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 O-C-N 123.028 0.205 . . . . 0.0 111.295 -179.857 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.488 ' HB2' ' O ' ' A' ' 91' ' ' ILE . 83.8 m-20 86.67 -16.11 0.42 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.132 0.973 . . . . 0.0 113.259 179.169 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.587 ' N ' ' O ' ' A' ' 90' ' ' ILE . 81.1 mmt-85 -130.43 141.53 50.53 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.902 179.517 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.5 m -139.02 148.58 43.6 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.611 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.56 ' HB3' HD11 ' A' ' 7' ' ' LEU . 18.8 m-85 -126.8 125.37 41.59 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.544 -179.804 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 96' ' ' ARG . 49.0 ttt85 -84.5 131.18 34.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.885 0.374 . . . . 0.0 110.893 -179.647 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -94.73 122.2 37.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.917 -179.781 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -124.1 120.73 33.22 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.637 -179.679 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.538 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 43.9 t-20 -108.54 112.56 24.99 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.199 179.364 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 C--N 1.327 -0.404 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.281 -179.96 . . . . . . . . 0 0 . 1 . 040 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 2.3 p . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 . . . . . . . . . 0 0 . 1 . 040 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.518 ' C ' ' H ' ' B' ' 231' ' ' GLN . 86.8 m-20 -67.58 144.33 55.64 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.742 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' B' B ' 230' ' ' SEP . . . . . 0.408 ' O1P' ' N ' ' B' ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.518 ' H ' ' C ' ' B' ' 229' ' ' ASP . 74.9 mt-30 -128.68 29.49 5.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.484 -179.571 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -110.78 -156.59 14.72 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.89 -179.414 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -75.36 161.56 37.51 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 123.369 2.712 . . . . 0.0 113.505 -178.972 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 040 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -76.32 143.66 25.28 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 122.375 2.05 . . . . 0.0 113.289 -179.37 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.588 HG12 HG22 ' A' ' 66' ' ' THR . 35.1 m -76.44 135.42 26.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 114.66 -1.154 . . . . 0.0 109.989 179.799 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' B' B ' 237' ' ' CYS . . . . . 0.617 ' HB2' HD13 ' A' ' 91' ' ' ILE . 5.1 t -67.81 128.01 34.9 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.403 -178.732 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' B' B ' 238' ' ' TPO . . . . . 0.411 HG23 ' H ' ' B' ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.82 -19.07 52.54 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.379 2.053 . . . . 0.0 111.579 -179.706 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 60.4 m -75.27 -43.01 53.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.599 177.445 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.439 ' CE2' HG21 ' A' ' 43' ' ' VAL . 90.1 t80 -59.18 -45.11 91.9 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.031 -179.949 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.518 HD21 HG23 ' A' ' 91' ' ' ILE . 98.2 mt -63.8 -39.32 93.95 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.091 0.472 . . . . 0.0 110.124 179.899 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -62.25 -41.71 98.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.768 179.985 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -62.36 -37.2 84.77 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.178 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.593 ' NH2' ' OE1' ' B' ' 248' ' ' GLN . 0.0 OUTLIER -58.5 -43.14 88.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.875 179.684 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -61.16 -38.48 86.6 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.587 -0.524 . . . . 0.0 109.587 178.95 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 38.0 t -64.1 -43.08 96.43 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 177.601 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 248' ' ' GLN . . . . . 0.593 ' OE1' ' NH2' ' B' ' 245' ' ' ARG . 36.7 mt-30 -58.49 -37.9 76.53 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.419 179.881 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 38.5 t -61.11 -46.72 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 120.546 -0.461 . . . . 0.0 110.345 179.859 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -58.89 -29.22 66.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.027 0.441 . . . . 0.0 109.837 179.503 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -91.87 -8.64 45.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.489 179.429 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.801 HD22 HH21 ' A' ' 12' ' ' ARG . 63.2 tp -77.33 139.42 39.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.64 -179.2 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -101.67 124.76 47.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.129 -0.942 . . . . 0.0 110.398 179.453 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 254' ' ' ASP . . . . . 0.47 ' C ' ' H ' ' B' ' 256' ' ' ASP . 95.6 m-20 -61.22 -35.48 77.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.443 -179.645 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -64.92 -0.4 1.52 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.556 179.699 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.47 ' H ' ' C ' ' B' ' 254' ' ' ASP . 42.0 t0 -107.03 96.51 6.48 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.564 179.255 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' B' B ' 257' ' ' LYS . . . . . 0.484 ' O ' ' C ' ' B' ' 258' ' ' ASP . 98.7 mttt -69.96 -81.65 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.582 -179.667 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.484 ' C ' ' O ' ' B' ' 257' ' ' LYS . 84.5 m-20 -28.31 112.78 0.07 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.693 -178.942 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.598 ' C ' ' H ' ' B' ' 261' ' ' ILE . 30.3 t0 -116.94 -177.12 3.12 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.309 0.575 . . . . 0.0 110.299 -179.502 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.429 ' H ' ' CG ' ' B' ' 259' ' ' ASP . 95.5 mt-10 -56.24 5.78 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.366 -179.501 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.598 ' H ' ' C ' ' B' ' 259' ' ' ASP . 82.8 mt -111.47 132.28 60.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.838 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 54.9 t -127.98 136.03 61.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.149 -179.873 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -96.99 121.97 39.46 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.41 0.624 . . . . 0.0 111.258 -179.029 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -66.25 -46.16 78.07 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.037 179.473 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 265' ' ' GLN . . . . . 0.661 ' NE2' ' O ' ' B' ' 266' ' ' PRO . 0.0 OUTLIER -94.8 157.22 37.18 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.036 -179.418 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' B' B ' 266' ' ' PRO . . . . . 0.661 ' O ' ' NE2' ' B' ' 265' ' ' GLN . 57.2 Cg_endo -65.72 145.26 80.73 Favored 'Trans proline' 0 N--CA 1.5 1.882 0 C-N-CA 123.15 2.566 . . . . 0.0 113.118 -178.852 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 43.9 pt . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.224 178.95 . . . . . . . . 0 0 . 1 . 041 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo . . . . . 0 N--CA 1.494 1.525 0 CA-C-O 120.931 0.305 . . . . 0.0 111.85 . . . . . . . . . 0 0 . 1 . 041 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 34.2 p -128.43 26.82 5.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.528 -179.855 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.619 ' NE ' ' OH ' ' A' ' 97' ' ' TYR . 83.5 mtp180 -85.17 129.89 34.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.155 -179.418 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.602 ' NH2' ' ND1' ' A' ' 19' ' ' HIS . 79.5 ttt180 -124.42 131.38 53.5 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -178.783 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.429 HD11 ' HB3' ' A' ' 95' ' ' PHE . 40.3 tp -109.81 132.36 54.22 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.208 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.7 t -109.79 128.45 65.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.467 -178.952 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.442 HG23 ' CD1' ' B' ' 261' ' ' ILE . 1.6 m -89.93 115.04 26.93 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.565 -179.429 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.666 HD12 ' OG ' ' A' ' 94' ' ' SER . 97.4 mt -79.87 140.14 17.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.151 179.393 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -89.93 160.41 16.43 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.182 0.515 . . . . 0.0 111.046 179.071 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.597 ' NH2' ' N ' ' B' ' 249' ' ' VAL . 73.5 mtp180 -57.52 -31.96 66.57 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.779 -179.757 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 99.7 p -77.38 -11.59 59.86 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.634 -179.634 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.93 31.68 9.72 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 -179.682 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.7 t -115.86 133.37 62.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.432 -0.384 . . . . 0.0 110.427 -179.68 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.436 ' C ' ' OD1' ' A' ' 16' ' ' ASP . 49.0 t0 -62.02 120.33 10.61 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.6 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -103.31 -134.81 8.42 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 120.892 -0.67 . . . . 0.0 111.808 -178.7 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -75.14 150.7 37.94 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.526 2.151 . . . . 0.0 112.534 -178.945 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.602 ' ND1' ' NH2' ' A' ' 6' ' ' ARG . 0.6 OUTLIER -108.51 131.08 55.18 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.64 -179.541 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.558 ' CD2' HD11 ' A' ' 37' ' ' ILE . 37.8 t80 -100.84 100.38 12.59 Favored Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.347 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.28 134.74 21.45 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 121.095 1.197 . . . . 0.0 111.581 -178.303 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 68.2 mt -99.38 124.17 44.28 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.627 0.727 . . . . 0.0 111.574 -178.118 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.6 p -137.09 -19.7 1.27 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.404 -1.271 . . . . 0.0 109.284 178.714 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.652 HD11 ' CD ' ' B' ' 265' ' ' GLN . 58.7 mt -79.15 144.92 34.02 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.355 179.41 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 90.9 p -61.82 -21.3 64.5 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -178.248 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.441 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 53.9 m -135.08 134.79 40.69 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.213 -0.595 . . . . 0.0 112.561 -178.618 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.9 t -124.81 116.23 21.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.602 178.119 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.666 HD12 ' O ' ' A' ' 49' ' ' CYS . 49.6 tp -116.73 132.86 56.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.957 0.408 . . . . 0.0 112.042 -178.337 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.714 ' CE2' HD12 ' A' ' 37' ' ' ILE . 10.8 m-85 -110.49 140.6 44.6 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.233 178.973 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 154.13 -176.29 32.06 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.044 178.735 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.646 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 80.2 mtm-85 -75.48 -30.72 59.99 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 120.956 0.407 . . . . 0.0 110.111 179.562 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.556 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -51.06 145.07 11.69 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.848 -178.608 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.488 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.7 tp -68.12 -41.0 83.86 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 120.872 0.368 . . . . 0.0 110.095 179.271 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.488 ' N ' HG23 ' A' ' 33' ' ' ILE . 80.6 tt0 -55.67 -22.09 21.36 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.47 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.556 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 19.0 m -58.82 121.41 11.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.837 179.369 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.441 ' OD2' ' O ' ' A' ' 26' ' ' THR . 96.2 m-20 -58.65 -25.05 62.36 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -178.767 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.714 HD12 ' CE2' ' A' ' 29' ' ' PHE . 82.1 mt -131.21 122.74 51.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.565 177.27 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.441 ' HD3' HD12 ' A' ' 33' ' ' ILE . 60.6 mtm180 -101.08 134.22 44.41 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.491 179.658 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.4 mt -116.47 127.87 73.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.484 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -74.66 28.21 0.09 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.23 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.595 HD21 ' OE1' ' B' ' 260' ' ' GLU . 40.7 mt -98.31 129.54 30.34 Favored Pre-proline 0 CA--C 1.538 0.508 0 C-N-CA 119.924 -0.711 . . . . 0.0 110.737 179.922 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.59 -7.53 20.35 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.607 2.205 . . . . 0.0 112.072 -179.523 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.4 m -102.06 6.79 9.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.112 -179.355 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.646 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 17.4 t -95.08 136.43 26.17 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.268 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.864 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.5 m -69.43 167.48 16.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.054 0.454 . . . . 0.0 111.147 -179.384 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 47.3 mttp -63.5 -38.6 91.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.966 -179.53 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.676 ' O ' ' N ' ' A' ' 49' ' ' CYS . 91.7 mm-40 -113.66 -17.99 12.0 Favored 'General case' 0 C--O 1.223 -0.338 0 O-C-N 123.474 0.484 . . . . 0.0 111.371 -179.159 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 23.2 t60 29.63 -74.97 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.52 0.934 . . . . 0.0 113.52 -179.608 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.676 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.11 133.83 46.0 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.427 0.632 . . . . 0.0 112.402 -178.287 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -128.55 128.37 44.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.2 179.537 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 85.2 mt -109.47 132.37 57.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.422 179.667 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -114.63 124.24 51.33 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.11 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.567 HD13 ' NH1' ' A' ' 5' ' ' ARG . 64.5 mt -107.46 116.59 51.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 120.02 -0.672 . . . . 0.0 112.727 -177.661 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.455 ' O ' ' C ' ' A' ' 55' ' ' GLU . 97.4 m-70 -111.49 139.26 47.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.905 178.654 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 54' ' ' HIS . 84.0 tt0 -41.21 -30.05 0.15 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 119.926 -0.709 . . . . 0.0 109.306 -179.943 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.431 ' N ' ' O ' ' A' ' 54' ' ' HIS . 84.8 mt-30 -61.08 -68.09 0.34 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.622 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -156.19 -174.04 4.77 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.1 -179.772 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.597 ' HB1' HH22 ' A' ' 5' ' ' ARG . . . -108.32 125.3 51.54 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.022 179.732 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.1 mt -119.23 130.77 73.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.369 0.604 . . . . 0.0 112.471 -178.55 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.587 ' HB2' HD11 ' A' ' 82' ' ' LEU . 18.4 tp -97.86 127.94 44.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.367 179.503 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -109.0 134.81 51.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.891 179.621 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.447 HD21 ' CA ' ' A' ' 68' ' ' PRO . 64.5 t-20 -94.49 105.49 17.46 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.39 -178.866 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -98.75 -8.28 26.28 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.689 179.497 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.6 m -71.52 101.93 2.58 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.304 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 89.7 p -87.84 -24.13 23.8 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.107 179.821 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.856 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.2 OUTLIER -78.27 -42.1 32.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.312 0.577 . . . . 0.0 109.769 179.323 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 36.7 m-20 -143.13 99.31 5.46 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.875 -179.498 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.447 ' CA ' HD21 ' A' ' 62' ' ' ASN . 52.7 Cg_exo -54.77 148.17 46.95 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.197 1.931 . . . . 0.0 113.41 -179.578 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.1 m -75.04 142.07 43.81 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.293 179.457 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -108.2 139.9 42.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.928 179.688 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.681 HG13 ' OD1' ' A' ' 86' ' ' ASP . 54.8 t -131.75 135.33 59.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.579 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 51.81 31.72 8.63 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.28 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.51 25.06 68.79 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-N 114.957 -1.02 . . . . 0.0 112.132 179.743 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 66.1 m -142.93 142.52 31.71 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 117.725 0.762 . . . . 0.0 112.57 -179.576 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.8 t -69.85 142.08 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.312 179.424 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.3 pt -110.98 77.08 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.478 179.221 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -52.55 -29.56 26.14 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.4 179.943 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.56 171.25 6.34 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.145 179.366 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -60.63 148.44 91.4 Favored 'Trans proline' 0 N--CA 1.499 1.84 0 C-N-CA 122.276 1.984 . . . . 0.0 111.832 179.631 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.8 p -138.15 140.83 39.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.995 0.426 . . . . 0.0 111.625 -179.391 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.9 mtm180 -75.12 128.53 35.73 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.025 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.587 HD11 ' HB2' ' A' ' 60' ' ' LEU . 91.5 mt -84.4 138.96 32.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.958 0.409 . . . . 0.0 111.054 -179.449 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -131.83 155.63 47.46 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.583 179.987 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.598 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 5.7 t60 -56.92 115.13 2.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.446 179.944 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.3 -12.49 26.15 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 -179.462 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.681 ' OD1' HG13 ' A' ' 71' ' ' VAL . 58.7 t0 -70.01 129.79 40.41 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 179.615 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.464 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 60.9 t -110.96 131.82 61.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.228 -179.237 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 94.4 mt -97.63 129.79 47.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.379 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 77.7 m -120.46 125.71 48.59 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.69 0.757 . . . . 0.0 112.777 -178.231 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.464 ' O ' ' C ' ' A' ' 91' ' ' ILE . 95.7 mt -112.2 123.47 67.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.347 178.079 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.608 HG22 ' N ' ' A' ' 92' ' ' ASP . 96.0 mt 34.33 -98.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 121.201 -0.2 . . . . 0.0 110.972 -178.883 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.608 ' N ' HG22 ' A' ' 91' ' ' ILE . 50.1 p-10 -114.43 15.03 17.97 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.913 0.387 . . . . 0.0 111.544 -179.99 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.442 HH21 ' CD ' ' B' ' 260' ' ' GLU . 84.6 mtt-85 -124.89 142.48 51.43 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.765 179.058 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.666 ' OG ' HD12 ' A' ' 10' ' ' ILE . 53.8 p -141.0 154.43 46.02 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.715 179.549 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.429 ' HB3' HD11 ' A' ' 7' ' ' LEU . 47.9 m-85 -124.32 125.46 44.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.555 179.757 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.425 ' O ' HD12 ' A' ' 7' ' ' LEU . 79.4 mtp85 -88.48 132.4 34.5 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.83 -179.494 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.619 ' OH ' ' NE ' ' A' ' 5' ' ' ARG . 88.3 t80 -95.21 127.87 41.6 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.197 -179.609 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -131.24 116.43 17.64 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.303 -179.613 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.598 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 61.9 t-20 -109.71 111.01 22.21 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.963 -179.806 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 . . . . . 0 C--N 1.331 -0.224 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.656 -179.598 . . . . . . . . 0 0 . 1 . 041 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 37.3 t . . . . . 0 C--O 1.232 0.165 0 N-CA-C 111.542 0.201 . . . . 0.0 111.542 . . . . . . . . . 0 0 . 1 . 041 nuclear build full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -65.12 141.73 58.61 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.404 0.621 . . . . 0.0 111.368 -178.92 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 041 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -121.88 40.14 3.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.301 -179.069 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -122.08 -179.26 15.91 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.679 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.48 161.14 47.08 Favored 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 123.575 2.85 . . . . 0.0 112.697 179.861 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.856 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 041 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -77.19 142.46 21.59 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 121.656 1.57 . . . . 0.0 113.44 -179.331 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.508 ' CG2' HG22 ' A' ' 66' ' ' THR . 53.7 t -63.91 136.32 26.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.542 -179.355 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 14.8 t -57.64 123.51 15.89 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.764 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 041 nuclear build full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.15 -27.22 36.36 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.913 1.742 . . . . 0.0 111.986 179.519 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 19.9 m -68.3 -44.42 75.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.321 0.581 . . . . 0.0 109.67 178.001 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.419 ' HZ ' HD22 ' A' ' 41' ' ' LEU . 89.0 t80 -58.47 -47.26 84.62 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.411 -179.296 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 93.8 mt -63.32 -40.68 97.99 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.146 -179.501 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -64.42 -41.25 96.71 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.115 -179.42 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -62.0 -41.86 98.52 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.016 -179.653 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.587 ' CZ ' ' OD2' ' A' ' 92' ' ' ASP . 8.2 tpp85 -61.28 -42.02 97.94 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.277 179.595 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' B' B ' 246' ' ' LYS . . . . . 0.47 ' O ' HG12 ' B' ' 249' ' ' VAL . 98.4 mttt -61.39 -41.38 97.04 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.412 179.891 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 58.5 m -68.75 -41.91 78.27 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.305 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' B' B ' 248' ' ' GLN . . . . . 0.621 ' O ' ' N ' ' B' ' 252' ' ' LEU . 62.1 tt0 -61.1 -39.67 90.84 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.119 -179.422 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.597 ' N ' ' NH2' ' A' ' 12' ' ' ARG . 0.3 OUTLIER -64.68 -39.02 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 119.932 -0.707 . . . . 0.0 109.25 179.165 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -60.37 -32.0 70.87 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.067 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -100.12 -11.54 20.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.859 178.82 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.629 HD13 ' N ' ' B' ' 253' ' ' ASN . 0.9 OUTLIER -122.3 113.83 19.95 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.127 179.994 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' B' B ' 253' ' ' ASN . . . . . 0.629 ' N ' HD13 ' B' ' 252' ' ' LEU . 9.9 t-20 175.31 42.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.796 179.952 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' B' B ' 254' ' ' ASP . . . . . 0.588 ' O ' ' CB ' ' B' ' 255' ' ' ASP . 38.3 p-10 -93.4 2.18 56.6 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.381 179.941 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' B' B ' 255' ' ' ASP . . . . . 0.588 ' CB ' ' O ' ' B' ' 254' ' ' ASP . 61.5 t0 113.51 57.98 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 O-C-N 124.492 1.12 . . . . 0.0 109.956 -179.775 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -86.88 79.22 8.86 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.802 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -64.28 -4.8 4.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.071 -178.943 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.74 ' O ' ' N ' ' B' ' 260' ' ' GLU . 95.7 m-20 -94.72 -2.36 51.26 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.138 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.463 ' C ' ' O ' ' B' ' 258' ' ' ASP . 48.7 p30 0.1 54.13 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 114.32 -1.309 . . . . 0.0 113.161 -179.807 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.74 ' N ' ' O ' ' B' ' 258' ' ' ASP . 97.0 mt-10 59.09 8.16 0.98 Allowed 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 178.97 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.442 ' CD1' HG23 ' A' ' 9' ' ' THR . 65.0 mt -118.4 133.44 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 120.604 -0.438 . . . . 0.0 109.839 179.703 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 49.6 t -128.46 135.91 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 120.786 0.327 . . . . 0.0 110.836 -179.693 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -97.42 119.64 36.32 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.298 0.57 . . . . 0.0 112.156 -178.641 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -64.93 -45.37 86.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.292 178.552 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' B' B ' 265' ' ' GLN . . . . . 0.652 ' CD ' HD11 ' A' ' 24' ' ' LEU . 2.0 mm-40 -89.9 157.84 45.48 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.393 -179.002 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -60.71 144.15 99.5 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 C-N-CA 122.055 1.837 . . . . 0.0 111.139 179.173 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' B' B ' 267' ' ' ILE . . . . . 0.498 ' CD1' ' O ' ' A' ' 19' ' ' HIS . 2.5 tt . . . . . 0 C--N 1.324 -0.514 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.549 -178.555 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo . . . . . 0 N--CA 1.499 1.848 0 CA-C-O 121.118 0.383 . . . . 0.0 112.608 . . . . . . . . . 0 0 . 1 . 042 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.7 p -117.19 -35.13 4.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.061 -178.592 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.4 mtm-85 -93.4 121.61 34.97 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.282 -178.725 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.695 HH21 ' CG ' ' A' ' 19' ' ' HIS . 80.5 ttt180 -130.23 132.01 45.78 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.757 -179.566 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.569 HD12 ' O ' ' A' ' 96' ' ' ARG . 26.0 tp -112.84 133.33 54.88 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -179.928 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.6 t -110.49 131.98 60.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 121.071 -0.251 . . . . 0.0 110.903 -179.492 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 m -93.24 114.38 26.84 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.317 0.58 . . . . 0.0 112.026 -178.713 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 98.2 mt -83.73 146.63 6.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.712 178.538 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -90.49 158.77 16.86 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.903 0.382 . . . . 0.0 110.028 179.063 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.616 HH21 HD22 ' B' ' 252' ' ' LEU . 89.7 mtm180 -57.55 -25.54 60.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.03 -179.608 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 90.3 p -79.94 -10.67 59.8 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.838 179.56 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.59 34.69 7.74 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 -179.738 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.3 t -121.03 135.28 61.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.988 0.423 . . . . 0.0 111.381 -179.681 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -74.06 123.49 24.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.278 179.39 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -118.36 -119.97 2.95 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 120.894 -0.67 . . . . 0.0 111.724 -179.327 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -76.21 149.81 32.37 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.137 1.891 . . . . 0.0 111.549 -179.321 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.695 ' CG ' HH21 ' A' ' 6' ' ' ARG . 0.3 OUTLIER -111.79 156.66 21.61 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.787 179.93 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.608 ' CD2' HD11 ' A' ' 37' ' ' ILE . 58.1 t80 -121.76 101.97 42.06 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.03 -179.025 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -73.72 129.59 13.72 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 121.515 1.476 . . . . 0.0 111.359 -179.907 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 93.7 mt -82.12 52.64 2.04 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 120.779 0.324 . . . . 0.0 111.745 -178.567 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.401 ' OG ' ' OE1' ' B' ' 265' ' ' GLN . 91.5 p -62.69 -17.67 61.04 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.415 0.626 . . . . 0.0 109.947 179.22 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.0 mt -90.38 142.17 28.0 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.605 -179.545 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.1 m -66.08 -20.04 66.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.256 -179.847 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.5 m -130.41 131.96 45.51 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.516 -179.816 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.6 t -124.77 116.44 22.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.368 178.655 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 36' ' ' ASP . 50.9 tp -114.41 125.35 53.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.85 -178.753 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.52 ' O ' ' O ' ' A' ' 47' ' ' GLN . 6.9 m-85 -108.11 142.1 38.81 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.789 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 163.86 -165.98 37.24 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.197 -1.002 . . . . 0.0 112.336 178.71 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.472 ' NH2' ' O ' ' B' ' 232' ' ' GLY . 28.8 ttp-105 -91.48 -31.0 16.14 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.8 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.576 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -60.75 156.63 31.68 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -179.659 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.617 HD12 ' CD ' ' A' ' 38' ' ' ARG . 5.7 tp -69.06 -39.27 79.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.872 -179.988 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.416 ' N ' HG23 ' A' ' 33' ' ' ILE . 95.8 mt-10 -52.41 -23.46 6.07 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.969 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.576 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 6.1 m -61.25 118.84 7.39 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.118 -179.586 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.549 ' N ' ' O ' ' A' ' 28' ' ' LEU . 99.0 m-20 -58.53 -25.02 61.99 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.448 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.608 HD11 ' CD2' ' A' ' 20' ' ' PHE . 47.5 mm -123.63 108.57 21.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 177.021 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.617 ' CD ' HD12 ' A' ' 33' ' ' ILE . 45.0 mtm180 -100.36 135.08 42.34 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -177.969 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.756 HG21 ' CZ ' ' A' ' 93' ' ' ARG . 96.8 mt -122.03 132.46 70.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.401 0.62 . . . . 0.0 111.477 -178.851 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -68.84 13.37 0.1 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 114.929 -1.032 . . . . 0.0 112.974 -178.579 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.985 HD12 HH21 ' A' ' 93' ' ' ARG . 17.5 mt -94.18 124.87 54.57 Favored Pre-proline 0 C--N 1.32 -0.712 0 C-N-CA 118.973 -1.091 . . . . 0.0 110.166 179.87 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -73.91 -8.97 21.92 Favored 'Trans proline' 0 C--N 1.315 -1.207 0 C-N-CA 122.165 1.91 . . . . 0.0 111.715 179.939 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.0 m -90.29 -0.1 8.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.193 179.302 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.712 HG12 ' O ' ' A' ' 41' ' ' LEU . 4.0 p -91.03 139.32 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-O 121.123 0.487 . . . . 0.0 110.205 -179.986 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.8 t -68.88 161.86 27.77 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.226 0.536 . . . . 0.0 111.354 -178.768 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.468 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 79.9 mttt -61.22 -42.37 98.49 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.614 -178.383 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.672 ' O ' ' N ' ' A' ' 49' ' ' CYS . 90.1 mt-30 -115.44 -12.45 11.7 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 121.061 -0.256 . . . . 0.0 111.246 179.512 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.55 ' CD2' ' HG1' ' A' ' 69' ' ' THR . 20.1 t60 30.76 -73.37 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 179.49 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.672 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -135.56 140.51 44.72 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 119.91 -0.716 . . . . 0.0 112.324 -178.6 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -129.24 130.7 46.59 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.769 179.876 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.7 mt -111.83 131.96 61.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.989 179.717 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -113.34 124.56 52.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.863 179.032 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 48.3 mm -99.45 108.17 22.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.533 -179.895 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.458 ' O ' ' C ' ' A' ' 55' ' ' GLU . 94.7 m-70 -106.48 133.21 51.51 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.681 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 54' ' ' HIS . 95.7 mt-10 -42.32 -31.17 0.37 Allowed 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 119.585 -0.846 . . . . 0.0 108.974 -179.599 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.416 ' N ' ' C ' ' A' ' 54' ' ' HIS . 88.2 mt-30 -67.99 -68.83 0.36 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.759 178.831 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -146.86 176.16 10.1 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.13 0.491 . . . . 0.0 111.603 -179.128 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -111.33 123.2 49.73 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.678 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 93.1 mt -117.06 135.25 58.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -177.631 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.554 ' HB2' HD11 ' A' ' 82' ' ' LEU . 24.9 tp -100.59 125.64 46.98 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.876 -179.932 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -111.34 137.4 49.14 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.197 -179.539 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.422 HD21 ' HA ' ' A' ' 68' ' ' PRO . 64.0 t-20 -98.66 106.22 18.47 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.243 179.478 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -97.26 -10.68 25.29 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 179.865 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.98 106.86 3.36 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 179.955 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 85.7 p -91.88 -15.04 28.69 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.166 -0.613 . . . . 0.0 110.03 179.229 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.707 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.2 OUTLIER -93.2 -46.12 7.55 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.567 -179.83 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -132.48 92.93 26.33 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.729 179.724 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.441 ' HB2' HG13 ' A' ' 75' ' ' VAL . 52.4 Cg_exo -56.15 140.89 87.87 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.226 1.95 . . . . 0.0 112.821 -179.378 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.55 ' HG1' ' CD2' ' A' ' 48' ' ' HIS . 86.9 m -72.5 140.32 48.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.388 179.143 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -101.71 140.65 35.72 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.943 178.896 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.445 ' CG1' ' OD1' ' A' ' 86' ' ' ASP . 75.1 t -134.04 133.11 56.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.436 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.59 ' ND2' ' OD1' ' A' ' 86' ' ' ASP . 89.1 m-20 53.8 33.08 16.15 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 119.909 -0.716 . . . . 0.0 109.128 -179.264 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.63 28.68 68.86 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.077 179.587 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 43.3 t -145.61 143.94 30.16 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 117.242 0.521 . . . . 0.0 111.615 179.942 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.441 HG13 ' HB2' ' A' ' 68' ' ' PRO . 50.9 t -70.28 135.19 28.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.024 179.744 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 9.1 pt -108.36 70.47 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.16 179.048 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -56.17 -30.65 62.52 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.949 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.32 157.75 37.22 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.487 178.605 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -64.05 149.59 90.13 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.314 2.009 . . . . 0.0 112.202 -179.841 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.7 m -139.03 142.93 32.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.202 -179.645 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 60.2 ttp180 -72.69 125.32 27.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.394 179.25 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.554 HD11 ' HB2' ' A' ' 60' ' ' LEU . 98.0 mt -77.33 138.7 39.5 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.362 0.601 . . . . 0.0 110.779 179.299 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -136.35 155.15 50.46 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.93 -179.411 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -55.83 113.16 1.38 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.358 -179.647 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.79 -6.76 22.16 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 121.169 -0.539 . . . . 0.0 111.767 179.977 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.59 ' OD1' ' ND2' ' A' ' 72' ' ' ASN . 37.9 t0 -76.73 124.34 27.53 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.249 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 45.8 t -108.12 129.5 62.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.328 -178.476 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 81.9 mt -97.13 132.2 42.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.842 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.9 m -116.41 126.23 53.15 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.072 0.463 . . . . 0.0 111.605 -179.448 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.416 ' CG2' HH12 ' A' ' 93' ' ' ARG . 87.8 mt -122.2 123.14 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.465 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.418 HG22 ' N ' ' A' ' 92' ' ' ASP . 45.0 mm 40.31 -106.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 121.065 -0.254 . . . . 0.0 110.506 -179.609 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.562 ' O ' ' OD1' ' A' ' 92' ' ' ASP . 66.3 t0 -110.48 18.93 19.28 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.06 0.457 . . . . 0.0 110.677 -179.863 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.985 HH21 HD12 ' A' ' 41' ' ' LEU . 8.5 mtm105 -125.44 142.95 51.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.369 -179.985 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 75.2 m -134.43 147.36 50.42 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 120.355 -0.538 . . . . 0.0 109.713 178.296 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.481 ' HB3' HD11 ' A' ' 7' ' ' LEU . 61.2 m-85 -125.28 124.29 41.31 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.931 -179.566 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.569 ' O ' HD12 ' A' ' 7' ' ' LEU . 99.9 mtt180 -90.58 131.76 36.11 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.292 -179.116 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -93.4 123.76 36.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.372 179.269 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -120.04 126.48 50.9 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.213 -179.855 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -113.77 -163.7 0.88 Allowed 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.612 179.732 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 . . . . . 0 N--CA 1.465 0.307 0 CA-C-O 120.871 0.367 . . . . 0.0 110.342 179.885 . . . . . . . . 0 0 . 1 . 042 nuclear build full ' B' B ' 228' ' ' VAL . . . . . 0.657 ' O ' HG13 ' B' ' 228' ' ' VAL . 10.0 p . . . . . 0 CA--C 1.531 0.222 0 CA-C-O 121.193 0.521 . . . . 0.0 111.213 . . . . . . . . . 1 1 . 1 . 042 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.416 ' O ' ' OD1' ' B' ' 229' ' ' ASP . 56.5 t0 -112.33 22.0 15.16 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.521 179.69 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' B' B ' 230' ' ' SEP . . . . . 0.573 ' O ' ' NE2' ' B' ' 231' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 042 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.573 ' NE2' ' O ' ' B' ' 230' ' ' SEP . 1.0 OUTLIER 158.2 -23.77 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.592 0.557 . . . . 0.0 111.215 179.995 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' B' B ' 232' ' ' GLY . . . . . 0.472 ' O ' ' NH2' ' A' ' 31' ' ' ARG . . . -52.07 -163.46 0.01 OUTLIER Glycine 0 CA--C 1.533 1.203 0 C-N-CA 121.238 -0.506 . . . . 0.0 112.181 -178.63 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -65.06 161.0 38.92 Favored 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 124.149 3.233 . . . . 0.0 112.908 -179.512 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.707 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 042 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -68.94 133.8 28.03 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 121.598 1.532 . . . . 0.0 112.513 -179.206 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.495 HG23 HG22 ' A' ' 66' ' ' THR . 39.4 t -61.81 138.59 22.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.271 -179.757 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 10.4 t -63.9 130.34 43.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.433 -179.428 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' B' B ' 238' ' ' TPO . . . . . 0.643 ' O2P' HG23 ' B' ' 240' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 042 nuclear build full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -59.36 -24.88 76.39 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 122.975 2.45 . . . . 0.0 112.945 -180.0 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' B' B ' 240' ' ' THR . . . . . 0.643 HG23 ' O2P' ' B' ' 238' ' ' TPO . 2.9 p -73.65 -40.67 63.55 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.908 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -57.25 -46.9 82.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.115 179.976 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' B' ' 242' ' ' LEU . 95.7 mt -64.12 -41.4 97.25 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.884 -179.758 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -62.1 -39.72 93.43 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.757 -179.457 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -63.0 -41.3 99.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.889 0.376 . . . . 0.0 110.688 179.407 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.47 ' HD2' HH11 ' A' ' 12' ' ' ARG . 22.7 mmt180 -62.61 -39.01 92.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.026 -179.605 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.32 -39.58 93.5 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.007 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 46.1 t -64.75 -45.01 88.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.488 177.629 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' B' B ' 248' ' ' GLN . . . . . 0.547 ' O ' ' N ' ' B' ' 252' ' ' LEU . 84.8 mt-30 -60.4 -38.15 83.07 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.793 -179.348 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 40.3 t -61.79 -45.67 98.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.514 -179.791 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -60.45 -28.48 68.34 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.566 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -98.6 -8.81 25.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.974 179.172 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.616 HD22 HH21 ' A' ' 12' ' ' ARG . 36.9 tp -76.2 144.36 40.52 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.962 -179.109 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -99.52 136.96 38.69 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.77 179.163 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -67.12 -21.01 65.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.221 -179.559 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 39.2 p-10 -75.45 -0.36 19.81 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.335 -179.135 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.426 ' O ' ' C ' ' B' ' 257' ' ' LYS . 88.5 m-20 -93.07 -7.46 45.57 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.818 0.342 . . . . 0.0 110.104 179.212 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' B' B ' 257' ' ' LYS . . . . . 0.559 ' O ' ' C ' ' B' ' 258' ' ' ASP . 99.4 mttt 35.34 -104.94 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.237 179.947 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.559 ' C ' ' O ' ' B' ' 257' ' ' LYS . 64.7 t0 -8.54 80.1 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 O-C-N 123.912 0.757 . . . . 0.0 111.626 179.523 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' B' ' 257' ' ' LYS . 66.3 t0 -82.69 72.92 9.76 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.829 -178.852 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.57 ' N ' ' OE1' ' B' ' 260' ' ' GLU . 44.1 mp0 56.41 5.84 0.22 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 178.426 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 44.6 mt -114.48 134.58 56.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.609 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' B' B ' 262' ' ' VAL . . . . . 0.403 HG11 ' NH2' ' A' ' 38' ' ' ARG . 74.0 t -126.4 130.77 71.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.114 0.483 . . . . 0.0 110.18 179.6 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -90.62 116.38 28.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.467 -178.403 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -64.91 -44.41 89.67 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.18 179.688 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' B' B ' 265' ' ' GLN . . . . . 0.401 ' OE1' ' OG ' ' A' ' 23' ' ' SER . 0.0 OUTLIER -92.97 156.34 40.56 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.421 -179.144 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -61.74 145.66 97.18 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.843 2.362 . . . . 0.0 112.146 -179.944 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 27.2 pt . . . . . 0 C--N 1.321 -0.65 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.99 -179.695 . . . . . . . . 0 0 . 1 . 043 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo . . . . . 0 N--CA 1.494 1.52 0 CA-C-O 120.907 0.295 . . . . 0.0 111.743 . . . . . . . . . 0 0 . 1 . 043 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.0 p -118.95 -43.07 2.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.815 -179.607 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.488 ' NH2' HG21 ' A' ' 53' ' ' ILE . 90.9 mtm-85 -98.7 124.98 43.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.489 -179.624 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 88.6 mtm-85 -129.0 137.85 51.59 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.903 -179.995 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.573 HD12 ' O ' ' A' ' 96' ' ' ARG . 33.9 tp -109.96 129.52 55.65 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.986 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 52.8 t -109.76 131.15 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 120.942 0.401 . . . . 0.0 110.662 -179.463 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.432 HG23 ' CD1' ' B' ' 261' ' ' ILE . 2.8 m -79.78 140.33 36.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.449 -179.097 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.436 ' CD1' ' OD1' ' A' ' 16' ' ' ASP . 50.6 mm -108.69 135.52 47.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.509 177.505 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.448 ' HZ3' ' HB2' ' B' ' 259' ' ' ASP . 47.7 mttm -86.86 156.4 19.87 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.258 179.185 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.805 ' H ' ' NZ ' ' B' ' 257' ' ' LYS . 89.3 mtm180 -57.1 -29.57 63.63 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.64 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.4 t -78.11 -14.54 59.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.674 179.303 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.75 35.57 5.83 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.208 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.1 t -119.98 130.45 74.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.963 0.411 . . . . 0.0 110.958 -179.623 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.436 ' OD1' ' CD1' ' A' ' 10' ' ' ILE . 97.7 m-20 -72.25 136.36 46.3 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.193 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -127.85 -122.74 2.54 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 120.533 -0.841 . . . . 0.0 111.971 -178.887 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -74.12 151.03 43.69 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.33 2.02 . . . . 0.0 112.779 -178.616 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -110.76 149.79 30.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.621 -179.712 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.426 ' CD2' HD11 ' A' ' 37' ' ' ILE . 69.3 t80 -122.19 102.7 39.91 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.475 -179.395 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.43 134.41 22.54 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.551 1.501 . . . . 0.0 112.105 -178.485 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 91.1 mt -81.62 56.53 3.02 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.129 -179.285 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.0 p -68.09 -23.09 64.89 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.142 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.5 mt -86.21 142.26 28.73 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.599 178.737 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 70.3 p -67.8 -16.17 63.98 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.484 -179.108 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.504 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 66.8 m -133.17 135.29 45.03 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.489 179.973 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.676 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 2.1 t -127.85 114.94 17.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.068 178.675 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.503 HD21 ' HG2' ' A' ' 47' ' ' GLN . 46.1 tp -110.96 128.16 55.74 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.588 -178.873 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.676 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 35.1 m-85 -104.75 137.57 42.35 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.788 178.933 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 158.55 -171.29 35.29 Favored Glycine 0 N--CA 1.471 1.022 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.809 179.091 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.591 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 83.2 mtm-85 -86.82 -29.61 22.13 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.442 -179.67 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -54.3 157.96 5.93 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 -178.355 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.432 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.9 tp -68.89 -40.26 80.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 O-C-N 122.639 -0.33 . . . . 0.0 110.539 179.65 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.432 ' N ' HG23 ' A' ' 33' ' ' ILE . 94.6 mt-10 -57.05 -25.68 59.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.284 -179.825 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.418 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 75.9 m -50.84 115.07 1.34 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.349 179.709 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.504 ' OD2' ' O ' ' A' ' 26' ' ' THR . 94.2 m-20 -58.57 -31.86 68.39 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -179.594 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.655 HD12 ' CE2' ' A' ' 29' ' ' PHE . 95.2 mt -126.13 122.22 61.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 176.381 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 50.3 mtm180 -105.6 138.85 41.12 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.168 -0.613 . . . . 0.0 112.484 -178.721 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 90.5 mt -122.94 129.28 75.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.937 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -77.33 29.47 0.15 Allowed 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -177.894 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.434 ' HA ' HD23 ' A' ' 41' ' ' LEU . 78.5 mt -90.96 122.11 67.12 Favored Pre-proline 0 C--N 1.323 -0.581 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.671 179.455 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.7 -7.91 22.09 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 122.032 1.821 . . . . 0.0 112.061 -179.252 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.6 m -101.56 5.98 10.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.024 179.673 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.591 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 54.3 t -107.0 114.19 45.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.63 179.682 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.8 t -42.75 170.88 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 122.208 1.004 . . . . 0.0 113.303 -178.208 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.418 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 50.3 mttp -63.21 -40.32 97.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.475 -1.238 . . . . 0.0 112.003 -179.763 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.637 ' O ' ' N ' ' A' ' 49' ' ' CYS . 89.0 mt-30 -112.61 -13.34 13.31 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.217 -179.604 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.475 ' ND1' HG13 ' A' ' 44' ' ' VAL . 34.6 t60 36.73 -74.88 0.0 OUTLIER 'General case' 0 C--O 1.237 0.407 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 179.132 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.637 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -134.84 139.63 45.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.141 -178.336 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -128.94 132.77 47.66 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.603 179.927 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 95.5 mt -117.07 134.48 60.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.38 179.892 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -121.54 127.62 51.16 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.467 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.488 HG21 ' NH2' ' A' ' 5' ' ' ARG . 95.8 mt -102.22 118.32 48.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.368 0.604 . . . . 0.0 112.283 -178.473 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.536 ' O ' ' N ' ' A' ' 56' ' ' GLN . 1.9 m-70 -112.89 139.86 48.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.264 178.992 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.9 mm-40 -39.91 -26.48 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -179.586 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.536 ' N ' ' O ' ' A' ' 54' ' ' HIS . 88.5 mt-30 -65.08 -67.32 0.45 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.086 -0.961 . . . . 0.0 108.662 178.028 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -160.9 -162.7 0.95 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.806 0.336 . . . . 0.0 111.377 179.733 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.486 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -106.45 127.46 53.31 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.617 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 44.4 mm -110.51 125.96 67.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.432 -178.781 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 35.7 tp -99.82 126.84 45.99 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.615 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -117.12 136.71 52.8 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.614 0.245 . . . . 0.0 111.377 -179.328 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -98.33 106.41 18.69 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.384 179.573 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -98.59 -8.58 26.18 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 179.664 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.2 t -81.07 98.85 8.18 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.274 -179.799 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.4 t -77.87 -39.61 42.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.243 0.544 . . . . 0.0 109.651 178.238 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.736 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.3 OUTLIER -63.09 -46.33 87.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.745 -179.49 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.462 ' HB3' HD11 ' A' ' 91' ' ' ILE . 89.2 m-20 -137.23 93.86 12.76 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.26 -179.809 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -64.57 148.76 90.56 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.4 1.4 . . . . 0.0 112.733 -177.76 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.432 HG22 ' N ' ' A' ' 70' ' ' GLN . 89.2 m -75.42 153.62 37.57 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.6 -179.29 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.432 ' N ' HG22 ' A' ' 69' ' ' THR . 88.8 mt-30 -115.47 140.59 49.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.852 -179.572 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 50.4 t -129.46 136.15 59.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.679 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 52.32 32.55 11.19 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.522 0.677 . . . . 0.0 109.484 -179.784 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.06 25.04 74.61 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 114.909 -1.041 . . . . 0.0 112.523 178.973 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.8 t -139.31 141.38 37.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 117.444 0.622 . . . . 0.0 110.631 179.131 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 68.7 t -66.4 136.32 26.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.628 -179.559 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.1 pt -108.32 80.06 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.102 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.474 178.963 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -63.93 -31.63 72.88 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.361 0.601 . . . . 0.0 109.744 179.396 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -111.35 155.83 42.16 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.362 179.024 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -63.52 147.43 93.11 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 122.309 2.006 . . . . 0.0 112.209 -179.707 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.3 m -140.25 145.24 26.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.267 0.556 . . . . 0.0 111.534 -179.884 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -74.4 135.64 42.41 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.171 179.79 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.486 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 96.2 mt -81.02 134.19 35.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.921 0.391 . . . . 0.0 111.134 -179.552 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -128.49 149.29 50.65 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.778 179.119 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -52.01 118.3 3.36 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.873 0.368 . . . . 0.0 111.164 -178.669 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.42 -15.27 30.02 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.184 -0.767 . . . . 0.0 111.184 -179.844 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -69.6 131.93 45.42 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.681 179.975 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.43 HG22 ' HG2' ' A' ' 96' ' ' ARG . 71.4 t -113.78 133.85 58.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.94 -178.531 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.8 mt -102.91 132.87 48.16 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.985 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 96.7 m -120.35 126.91 51.68 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 120.027 -0.669 . . . . 0.0 111.669 -179.497 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.583 ' O ' ' N ' ' A' ' 93' ' ' ARG . 89.4 mt -116.07 130.37 70.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.329 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.556 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 84.5 mt -20.93 94.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -178.202 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.556 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 12.9 t0 94.44 -24.78 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 177.847 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.951 ' HE ' HD11 ' B' ' 261' ' ' ILE . 18.2 mtp85 -131.22 146.67 52.41 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.819 -179.949 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 93.9 p -140.04 156.28 46.68 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.95 0.405 . . . . 0.0 110.251 179.739 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.541 ' HB3' HD11 ' A' ' 7' ' ' LEU . 73.9 m-85 -130.64 128.21 40.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.234 -179.631 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.573 ' O ' HD12 ' A' ' 7' ' ' LEU . 73.7 mtp85 -89.43 134.69 33.98 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.503 -179.606 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -95.37 124.55 39.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.515 179.698 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -125.23 127.8 47.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.488 -179.9 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 59.8 t-20 -125.63 114.62 18.94 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.82 0.343 . . . . 0.0 110.686 179.999 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.646 -179.955 . . . . . . . . 0 0 . 1 . 043 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 27.8 m . . . . . 0 N--CA 1.454 -0.27 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 043 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.536 ' O ' ' CB ' ' B' ' 230' ' ' SEP . 46.8 p-10 -102.04 15.89 27.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.351 -179.422 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' B' B ' 230' ' ' SEP . . . . . 0.536 ' CB ' ' O ' ' B' ' 229' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 043 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.401 ' OE1' ' O ' ' B' ' 230' ' ' SEP . 28.2 mm100 -125.03 63.05 1.15 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.697 179.239 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -131.96 -177.96 15.22 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.405 -179.281 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.16 161.56 40.53 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 123.404 2.736 . . . . 0.0 112.64 -179.889 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.736 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 043 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.19 135.77 23.32 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 121.319 1.346 . . . . 0.0 112.998 -179.094 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.498 HG23 HG22 ' A' ' 66' ' ' THR . 55.3 t -60.56 138.31 21.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.279 -179.958 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 2.0 t -70.55 133.41 46.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.066 179.821 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 043 nuclear build full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -58.59 -23.21 64.04 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.482 2.122 . . . . 0.0 112.379 -179.748 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 99.2 m -73.33 -46.07 51.5 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.042 178.513 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -58.3 -47.3 84.12 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.907 -178.47 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' B' ' 242' ' ' LEU . 95.7 mt -63.8 -42.6 97.68 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.719 -0.393 . . . . 0.0 111.8 -179.392 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -65.48 -44.06 88.28 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.183 -179.197 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' B' B ' 244' ' ' ARG . . . . . 0.533 ' NH1' ' OE1' ' B' ' 248' ' ' GLN . 71.0 ttp85 -65.06 -43.49 92.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.999 0.428 . . . . 0.0 110.3 179.16 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.541 ' O ' HG23 ' B' ' 249' ' ' VAL . 14.5 tpp180 -61.68 -43.81 98.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.542 -179.604 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -65.49 -38.17 88.98 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.046 178.845 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 47.1 t -63.62 -45.15 91.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.464 179.257 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' B' B ' 248' ' ' GLN . . . . . 0.533 ' OE1' ' NH1' ' B' ' 244' ' ' ARG . 26.1 mt-30 -61.75 -36.13 80.12 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.758 -179.431 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.541 HG23 ' O ' ' B' ' 245' ' ' ARG . 77.5 t -64.35 -46.31 93.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.025 0.44 . . . . 0.0 110.458 179.197 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -63.68 -32.5 74.01 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.223 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -81.54 -7.57 59.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.482 178.774 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 39.2 tp -105.41 113.8 27.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.936 179.482 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -47.81 145.24 2.94 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.042 -178.367 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -62.62 -30.06 71.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.433 179.64 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' B' B ' 255' ' ' ASP . . . . . 0.417 ' OD1' ' C ' ' B' ' 255' ' ' ASP . 39.0 p-10 -87.07 9.01 21.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.308 179.752 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.504 ' O ' ' HB2' ' B' ' 257' ' ' LYS . 60.2 t0 -132.63 116.49 16.72 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.945 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' B' B ' 257' ' ' LYS . . . . . 0.805 ' NZ ' ' H ' ' A' ' 12' ' ' ARG . 86.0 tttt 165.95 97.97 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.458 0 O-C-N 124.063 0.852 . . . . 0.0 109.641 179.379 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' B' ' 258' ' ' ASP . 19.3 p-10 -69.19 -6.77 30.95 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.699 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.637 ' C ' ' H ' ' B' ' 261' ' ' ILE . 46.0 t0 74.44 106.78 0.07 Allowed 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.422 -179.478 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -57.56 12.51 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.303 -1.317 . . . . 0.0 111.982 -179.088 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.951 HD11 ' HE ' ' A' ' 93' ' ' ARG . 60.9 mt -107.2 134.01 50.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.691 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 62.3 t -126.56 131.69 71.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.454 -179.545 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -95.06 120.52 35.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.693 -178.361 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -65.46 -45.24 84.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.659 179.137 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.5 152.77 47.73 Favored Pre-proline 0 C--O 1.231 0.117 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.606 -179.107 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -64.04 141.86 78.71 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.494 2.129 . . . . 0.0 112.116 -179.876 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.1 pt . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.818 179.052 . . . . . . . . 0 0 . 1 . 044 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo . . . . . 0 N--CA 1.495 1.602 0 CA-C-O 121.083 0.368 . . . . 0.0 111.858 . . . . . . . . . 0 0 . 1 . 044 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.469 ' O ' ' O ' ' A' ' 99' ' ' ASN . 26.8 m -73.24 -46.46 50.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.299 -178.96 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.6 mtt85 -92.49 137.26 32.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.229 -178.208 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.7 mtt85 -130.5 139.62 50.51 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.187 -0.46 . . . . 0.0 112.032 -179.655 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.642 HD12 ' O ' ' A' ' 96' ' ' ARG . 27.3 tp -113.42 130.84 56.21 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.479 179.862 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.5 ' CG1' ' OD1' ' A' ' 16' ' ' ASP . 41.0 t -109.43 129.61 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.215 -178.867 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.9 m -80.2 145.31 32.33 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.797 -178.798 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.7 mt -116.19 137.64 49.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 114.66 -1.155 . . . . 0.0 109.42 178.244 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.429 ' CE ' ' OD1' ' B' ' 259' ' ' ASP . 60.1 mttt -88.43 160.21 17.64 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.402 179.854 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.625 ' HG3' HH11 ' A' ' 93' ' ' ARG . 90.0 mtm180 -57.82 -32.33 67.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.428 -179.329 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.1 t -79.82 -5.87 56.24 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.356 179.358 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.45 38.17 7.25 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.933 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.5 t -115.0 132.57 63.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.298 0.57 . . . . 0.0 111.324 -179.799 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.5 ' OD1' ' CG1' ' A' ' 8' ' ' VAL . 67.1 t0 -77.15 122.84 25.57 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.106 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -118.3 -120.1 2.97 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.173 -178.509 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -74.46 152.56 43.81 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.317 2.011 . . . . 0.0 112.395 -178.893 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -111.17 147.74 34.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.057 0.456 . . . . 0.0 110.18 179.913 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.463 ' CD2' HD11 ' A' ' 37' ' ' ILE . 70.3 t80 -117.54 101.68 52.35 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.075 -179.255 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -73.08 136.54 24.87 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.279 1.32 . . . . 0.0 111.696 -179.592 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.0 mt -86.57 65.78 9.18 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.527 -178.307 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.0 p -68.8 -22.43 64.26 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.693 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 76.2 mt -87.53 142.19 28.05 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.378 179.977 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 61.4 p -66.21 -15.6 63.3 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.658 -179.322 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.507 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 35.6 m -133.02 134.04 43.89 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.988 0.423 . . . . 0.0 110.902 -179.558 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.8 t -126.56 118.13 24.24 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.275 179.911 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.449 HD21 ' HG2' ' A' ' 47' ' ' GLN . 44.6 tp -116.87 128.96 55.76 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.05 -179.071 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.71 ' CE2' HD12 ' A' ' 37' ' ' ILE . 5.8 m-85 -105.94 131.02 53.75 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.868 179.717 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.8 179.9 37.65 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 120.253 -0.975 . . . . 0.0 112.368 179.267 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.471 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 45.3 mtm105 -73.39 -32.53 64.51 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 179.573 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.567 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -48.44 149.28 3.97 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -178.548 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.534 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.4 tp -68.06 -41.99 84.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.339 0.59 . . . . 0.0 110.109 179.676 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.534 ' N ' HG23 ' A' ' 33' ' ' ILE . 80.8 tt0 -56.74 -20.71 23.46 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.386 -179.823 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.567 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 14.8 m -58.12 128.41 37.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.129 -179.819 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.507 ' OD2' ' O ' ' A' ' 26' ' ' THR . 54.0 m-20 -62.4 -33.47 74.82 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.127 -179.712 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.71 HD12 ' CE2' ' A' ' 29' ' ' PHE . 93.2 mt -125.55 118.57 52.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 177.45 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.533 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 82.9 mtp180 -103.36 139.65 38.49 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.137 -178.762 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.418 ' C ' ' H ' ' A' ' 41' ' ' LEU . 80.5 mt -121.54 129.28 75.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.37 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -74.58 34.93 0.1 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.737 -178.367 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.452 ' HA ' HD23 ' A' ' 41' ' ' LEU . 38.2 mt -102.35 122.66 45.78 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.63 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.1 -6.11 18.45 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 122.415 2.077 . . . . 0.0 112.729 -178.802 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.522 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 2.9 m -107.3 6.26 9.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.328 -179.749 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.48 ' O ' ' O ' ' A' ' 45' ' ' SER . 11.8 t -98.27 110.42 25.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.296 0.569 . . . . 0.0 110.693 -179.673 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.48 ' O ' ' O ' ' A' ' 44' ' ' VAL . 1.2 t -33.85 160.25 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.112 -0.949 . . . . 0.0 112.266 -178.94 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -62.04 -42.01 98.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.107 -179.416 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.653 ' O ' ' N ' ' A' ' 49' ' ' CYS . 90.0 mt-30 -114.75 -17.7 11.54 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.696 179.659 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 29.5 t60 35.98 -72.59 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 179.293 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.653 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.71 137.86 47.05 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.067 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -126.84 128.62 46.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.557 179.401 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.3 mt -116.67 135.19 57.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.73 0.3 . . . . 0.0 110.231 179.202 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -113.23 136.79 52.35 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.232 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.8 mm -104.19 124.24 58.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.078 -179.245 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.444 ' O ' ' C ' ' A' ' 55' ' ' GLU . 97.4 m-70 -128.63 135.76 49.75 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.967 179.348 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 54' ' ' HIS . 51.7 tp10 -40.26 -30.37 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.022 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.463 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 92.2 mt-30 -66.34 -67.89 0.41 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.255 178.266 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.52 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 8.3 tp10 -157.93 -158.07 0.7 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.726 -179.352 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.52 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -124.2 130.93 53.38 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.738 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.2 mt -119.55 130.67 73.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.188 0.518 . . . . 0.0 111.48 -179.109 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.493 ' HB2' HD11 ' A' ' 82' ' ' LEU . 25.1 tp -95.71 132.23 41.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.845 -179.753 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -117.02 137.38 52.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.075 179.519 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 62.5 t-20 -95.45 106.44 18.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.046 -178.508 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -97.15 -13.54 22.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.972 179.201 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.12 101.21 4.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.46 179.869 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.6 m -87.2 -16.53 35.06 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.118 179.628 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.472 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -87.8 -45.64 10.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.16 179.453 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -135.96 95.67 13.54 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.373 -179.988 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.539 ' HB2' HG23 ' A' ' 75' ' ' VAL . 50.0 Cg_exo -55.16 142.8 77.15 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.227 1.951 . . . . 0.0 113.124 -179.934 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.96 ' O ' HG22 ' A' ' 76' ' ' ILE . 5.3 m -70.41 140.85 52.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.008 179.181 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -102.1 140.72 36.01 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.507 -0.477 . . . . 0.0 109.953 179.57 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 51.8 t -129.78 134.64 62.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.52 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 50.28 32.84 6.61 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -179.585 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.37 25.7 67.6 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.628 179.532 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 29.6 t -140.74 141.23 34.89 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 117.606 0.703 . . . . 0.0 111.207 179.573 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.539 HG23 ' HB2' ' A' ' 68' ' ' PRO . 0.5 OUTLIER -68.19 140.46 19.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.191 -179.878 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.96 HG22 ' O ' ' A' ' 69' ' ' THR . 9.4 tt -106.74 94.03 2.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.43 179.59 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.5 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 16.2 p-10 -68.24 -34.33 76.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.43 179.844 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.462 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 0.1 OUTLIER -130.65 174.88 4.15 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.115 -178.838 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -61.0 142.89 98.86 Favored 'Trans proline' 0 N--CA 1.501 1.954 0 C-N-CA 122.678 2.252 . . . . 0.0 112.775 -179.615 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.2 m -140.33 143.67 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.402 179.857 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -75.05 126.65 31.47 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.812 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.493 HD11 ' HB2' ' A' ' 60' ' ' LEU . 96.6 mt -79.42 139.26 37.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.917 -179.677 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -126.36 150.12 48.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.445 179.956 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -58.03 121.34 10.37 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.13 -179.561 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.84 -13.82 26.91 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -179.711 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -68.58 134.69 50.36 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.421 179.841 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.543 HG22 ' HG2' ' A' ' 96' ' ' ARG . 74.2 t -108.65 131.84 58.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.68 -178.794 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 83.0 mt -105.6 132.09 53.41 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.1 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.926 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 94.5 m -121.0 125.64 47.88 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 120.305 -0.558 . . . . 0.0 112.044 -178.261 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.454 ' O ' ' C ' ' A' ' 91' ' ' ILE . 92.4 mt -119.05 124.88 73.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 178.716 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.454 ' C ' ' O ' ' A' ' 90' ' ' ILE . 45.0 mm 35.17 -107.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.729 -178.761 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.454 ' N ' HG22 ' A' ' 91' ' ' ILE . 31.3 p-10 -106.04 12.07 30.82 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.385 -179.825 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.625 HH11 ' HG3' ' A' ' 12' ' ' ARG . 19.6 mmm180 -125.85 144.12 50.79 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.593 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 26.4 t -137.59 155.52 49.11 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.896 -179.858 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.516 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 87.2 m-85 -130.13 130.96 45.45 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.559 -0.292 . . . . 0.0 110.739 179.889 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.642 ' O ' HD12 ' A' ' 7' ' ' LEU . 97.8 mtt180 -94.65 134.1 37.59 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.157 179.441 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -97.63 126.51 42.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.853 179.727 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -134.88 125.69 27.27 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.177 179.849 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.469 ' O ' ' O ' ' A' ' 4' ' ' THR . 91.1 m-20 -63.74 -41.37 98.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.512 178.849 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 . . . . . 0 C--N 1.331 -0.204 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.414 -179.719 . . . . . . . . 0 0 . 1 . 044 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.458 -0.061 0 CA-C-O 120.826 0.346 . . . . 0.0 111.107 . . . . . . . . . 0 0 . 1 . 044 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.605 ' O ' ' N ' ' B' ' 231' ' ' GLN . 95.5 m-20 -89.47 147.59 23.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.014 -178.767 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 044 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.605 ' N ' ' O ' ' B' ' 229' ' ' ASP . 0.3 OUTLIER -114.54 57.38 0.71 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.671 -179.019 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -123.04 166.06 15.52 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.082 -0.58 . . . . 0.0 111.687 -179.828 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -73.79 158.33 46.85 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 123.823 3.015 . . . . 0.0 112.472 179.511 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.456 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 044 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -72.01 145.2 44.33 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.243 1.962 . . . . 0.0 112.501 179.879 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.472 ' CG2' HG22 ' A' ' 66' ' ' THR . 47.6 t -76.05 131.42 34.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.107 -0.951 . . . . 0.0 112.009 -178.334 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 4.0 t -76.95 128.02 33.77 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 178.165 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' B' B ' 238' ' ' TPO . . . . . 0.465 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 044 nuclear build full ' B' B ' 239' ' ' PRO . . . . . 0.465 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 34.3 Cg_exo -59.14 -26.46 81.81 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.764 2.31 . . . . 0.0 112.694 -179.857 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 86.3 m -73.56 -44.09 58.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.224 0.535 . . . . 0.0 109.61 178.259 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.717 ' CE1' ' NE ' ' B' ' 245' ' ' ARG . 53.4 t80 -56.85 -46.93 81.42 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.705 -178.911 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 95.7 mt -64.01 -40.57 96.63 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 121.076 0.465 . . . . 0.0 110.517 -179.856 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -64.1 -39.9 95.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.649 -179.303 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 44.2 ttm180 -60.84 -44.77 96.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.876 0.369 . . . . 0.0 110.209 -179.69 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.717 ' NE ' ' CE1' ' B' ' 241' ' ' PHE . 2.2 mtm-85 -63.26 -40.67 98.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.011 179.858 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.36 -41.42 98.83 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.268 179.117 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 31.3 t -65.93 -45.88 80.25 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.464 0.65 . . . . 0.0 109.674 178.959 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -63.43 -34.53 77.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.261 -179.792 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.696 HG23 ' O ' ' B' ' 245' ' ' ARG . 51.7 t -63.66 -45.08 98.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.687 179.743 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -65.51 -26.54 67.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.101 0.476 . . . . 0.0 110.254 179.203 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -96.22 -9.35 30.62 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.983 -179.357 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.912 HD22 ' OD2' ' B' ' 256' ' ' ASP . 13.3 mt -83.09 143.78 30.33 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -179.346 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' B' B ' 253' ' ' ASN . . . . . 0.598 ' O ' ' N ' ' B' ' 255' ' ' ASP . 12.9 t-20 -101.96 161.68 13.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.685 178.926 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' B' B ' 254' ' ' ASP . . . . . 0.431 ' H ' ' ND2' ' B' ' 253' ' ' ASN . 39.1 t70 -42.47 -8.61 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -179.084 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' B' B ' 255' ' ' ASP . . . . . 0.598 ' N ' ' O ' ' B' ' 253' ' ' ASN . 95.8 m-20 -61.58 -12.82 17.27 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.86 -179.334 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.912 ' OD2' HD22 ' B' ' 252' ' ' LEU . 89.5 m-20 -93.42 15.13 16.54 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 120.719 0.295 . . . . 0.0 110.424 179.362 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' B' B ' 257' ' ' LYS . . . . . 0.461 ' O ' ' OD1' ' B' ' 259' ' ' ASP . 88.8 tttt -58.49 -19.77 39.98 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.354 -179.923 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.456 ' O ' ' CB ' ' B' ' 259' ' ' ASP . 90.7 m-20 -60.65 -41.72 95.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.73 179.107 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.639 ' C ' ' H ' ' B' ' 261' ' ' ILE . 0.6 OUTLIER 82.88 114.16 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.473 179.263 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -51.64 6.88 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.9 -179.36 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.639 ' H ' ' C ' ' B' ' 259' ' ' ASP . 73.3 mt -109.78 140.44 28.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.913 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 78.7 t -128.34 136.38 60.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.865 -178.904 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -97.93 121.01 39.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.362 0.601 . . . . 0.0 111.71 -179.027 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -66.26 -42.79 88.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.194 179.479 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.44 161.64 23.9 Favored Pre-proline 0 N--CA 1.465 0.322 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.274 -178.73 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -60.95 149.69 87.56 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.531 2.154 . . . . 0.0 112.14 178.875 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 44.5 pt . . . . . 0 C--N 1.331 -0.201 0 CA-C-O 121.534 0.683 . . . . 0.0 112.295 -179.091 . . . . . . . . 0 0 . 1 . 045 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.422 ' HG2' HH21 ' A' ' 6' ' ' ARG . 59.7 Cg_endo . . . . . 0 N--CA 1.491 1.382 0 CA-C-O 120.778 0.241 . . . . 0.0 111.924 . . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.1 p -115.5 -36.05 4.4 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.663 -179.8 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.819 ' NE ' HD13 ' A' ' 53' ' ' ILE . 87.7 mtm-85 -98.06 121.6 40.18 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.595 -179.711 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.442 ' C ' HD22 ' A' ' 7' ' ' LEU . 99.7 mtt180 -129.98 137.9 50.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.072 179.839 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.455 ' CD2' ' N ' ' A' ' 7' ' ' LEU . 1.1 mm? -111.12 135.37 51.74 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.512 179.416 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.673 HG22 ' CD2' ' A' ' 19' ' ' HIS . 55.0 t -111.09 126.41 68.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.642 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 m -82.86 112.83 20.03 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.124 -178.337 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 98.1 mt -81.83 139.78 17.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.914 179.242 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -90.44 153.37 20.45 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.286 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.569 ' NH1' ' OD2' ' A' ' 92' ' ' ASP . 30.2 mtp85 -59.75 -26.46 65.69 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.709 179.82 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.3 p -72.53 -19.0 61.59 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.993 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.74 31.3 6.09 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 -179.646 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 51.9 t -121.06 132.37 70.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.928 0.394 . . . . 0.0 111.02 -179.814 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -76.85 139.87 40.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.062 179.262 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -130.9 -115.11 1.7 Allowed Glycine 0 CA--C 1.538 1.524 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.165 -179.378 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -70.21 144.89 52.95 Favored 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 122.2 1.933 . . . . 0.0 113.054 -178.538 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.673 ' CD2' HG22 ' A' ' 8' ' ' VAL . 59.0 m170 -109.14 135.15 50.74 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.586 -179.543 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.921 ' CD2' HD11 ' A' ' 37' ' ' ILE . 65.0 t80 -106.92 102.57 43.31 Favored Pre-proline 0 N--CA 1.467 0.385 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.043 -179.149 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.47 132.49 16.23 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 121.422 1.414 . . . . 0.0 111.971 -179.986 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 22' ' ' LEU . 73.3 mt -85.8 58.48 5.07 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -178.745 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 86.5 p -66.76 -17.31 64.8 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 178.842 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.511 HD11 ' HG2' ' B' ' 265' ' ' GLN . 62.1 mt -86.68 139.67 30.54 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.475 -179.76 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.4 t -63.6 -18.61 64.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.717 -179.905 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.15 140.93 36.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.626 -179.19 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.666 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -137.37 132.57 33.73 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.093 178.875 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.526 HD12 ' O ' ' A' ' 49' ' ' CYS . 56.3 tp -125.45 123.16 38.64 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.805 -179.067 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.666 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 46.5 m-85 -95.82 141.33 29.4 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.811 179.683 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 147.44 -176.8 26.11 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.066 178.685 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 31' ' ' ARG . 45.5 mtm180 -70.8 -33.11 70.38 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 179.285 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.577 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -42.62 140.31 2.24 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -179.35 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 33' ' ' ILE . 11.0 tp -67.0 -39.29 83.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.936 -179.694 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -58.81 -20.58 51.58 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.189 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.577 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 66.8 m -50.24 119.9 4.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.971 179.632 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -61.75 -31.77 71.98 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 179.736 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.921 HD11 ' CD2' ' A' ' 20' ' ' PHE . 27.1 mm -120.85 105.0 16.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 177.044 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.443 HH12 ' HG2' ' A' ' 40' ' ' GLN . 68.2 ttp85 -98.21 135.98 39.08 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.559 -178.457 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.712 HG23 ' NH1' ' A' ' 93' ' ' ARG . 94.5 mt -121.58 131.59 72.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.902 -179.683 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.443 ' HG2' HH12 ' A' ' 38' ' ' ARG . 74.5 mt-30 -78.26 31.78 0.18 Allowed 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -177.693 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.771 ' O ' HG12 ' A' ' 44' ' ' VAL . 87.1 mt -96.34 122.93 56.4 Favored Pre-proline 0 C--N 1.326 -0.454 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.727 179.586 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.08 -8.29 21.92 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 122.261 1.974 . . . . 0.0 112.601 -179.361 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.445 HG12 ' HG2' ' B' ' 235' ' ' PRO . 35.5 m -102.17 4.76 10.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.191 179.997 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.771 HG12 ' O ' ' A' ' 41' ' ' LEU . 6.0 p -97.32 150.3 4.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.348 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.2 163.43 27.85 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.805 0.812 . . . . 0.0 112.186 -178.869 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.9 mtmt -63.76 -38.1 89.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.131 -179.558 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.621 ' O ' ' N ' ' A' ' 49' ' ' CYS . 10.4 mm100 -110.58 -20.33 12.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.024 0.44 . . . . 0.0 109.967 179.897 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.534 ' NE2' HG23 ' A' ' 90' ' ' ILE . 22.8 t60 38.3 -77.32 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 179.021 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.763 ' SG ' HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -134.73 137.73 43.73 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.42 -0.512 . . . . 0.0 112.085 -178.038 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -123.65 131.57 53.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.886 179.225 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.439 HD11 HD12 ' A' ' 82' ' ' LEU . 16.2 tt -120.13 134.62 63.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.716 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -120.75 128.42 52.9 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.35 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.819 HD13 ' NE ' ' A' ' 5' ' ' ARG . 78.4 mt -106.43 122.37 60.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 119.774 -0.77 . . . . 0.0 112.262 -178.754 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.51 ' CD2' ' N ' ' A' ' 54' ' ' HIS . 2.4 m-70 -114.42 137.95 51.18 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.785 179.666 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.466 ' C ' ' O ' ' A' ' 54' ' ' HIS . 97.7 mt-10 -40.93 -29.77 0.11 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.75 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.452 ' N ' ' C ' ' A' ' 54' ' ' HIS . 59.4 tt0 -64.31 -68.21 0.37 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.798 178.294 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -156.82 -168.31 2.63 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.202 -179.853 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -105.52 133.23 50.61 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.532 -179.747 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 41.4 mm -118.86 125.55 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 120.511 -0.475 . . . . 0.0 111.502 -179.491 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.763 HD11 ' SG ' ' A' ' 49' ' ' CYS . 57.3 tp -104.65 130.48 52.66 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.836 -179.954 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.9 m-70 -121.55 140.41 52.26 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.741 179.923 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.401 HD22 ' HA ' ' A' ' 68' ' ' PRO . 31.3 t30 -104.62 110.77 23.21 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.892 0.377 . . . . 0.0 111.957 179.743 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -96.66 -4.33 41.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.417 179.18 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.44 100.65 9.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.518 179.97 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 86.5 p -84.87 -29.11 25.53 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.285 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.637 HG21 ' O ' ' B' ' 234' ' ' TPO . 2.1 m -64.3 -49.27 72.43 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.078 179.388 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.625 ' OD1' HG23 ' B' ' 236' ' ' VAL . 2.7 m-20 -145.75 100.37 4.33 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.563 179.623 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.401 ' HA ' HD22 ' A' ' 62' ' ' ASN . 36.7 Cg_endo -64.79 153.23 78.88 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 121.308 1.338 . . . . 0.0 112.038 -178.933 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 28.3 m -75.14 150.41 38.76 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.642 -179.5 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -108.48 141.18 40.74 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.933 179.307 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.719 HG13 ' OD1' ' A' ' 86' ' ' ASP . 48.8 t -128.2 134.4 65.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.309 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 53.66 31.4 12.63 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -178.622 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.76 29.16 67.82 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.051 179.522 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 67.0 m -139.67 138.52 36.12 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 117.076 0.438 . . . . 0.0 111.213 -179.967 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.7 t -69.94 133.98 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.707 179.527 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.3 pt -101.38 94.14 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 CA-C-O 121.241 0.543 . . . . 0.0 110.506 179.338 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -63.95 -34.47 78.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.123 179.714 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -124.44 172.64 5.6 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.922 179.978 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.61 143.21 99.72 Favored 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 122.151 1.901 . . . . 0.0 112.549 -179.709 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 48.1 t -131.36 138.97 51.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.075 179.905 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 95.8 mtm-85 -76.38 128.82 35.59 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.777 179.174 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.609 HD11 ' HB2' ' A' ' 60' ' ' LEU . 93.7 mt -86.04 134.04 33.87 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.245 0.545 . . . . 0.0 111.277 -179.333 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -124.45 154.41 40.51 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.244 178.954 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.579 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 4.5 t60 -53.63 118.9 4.27 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.32 -179.504 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.44 -11.66 28.31 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.823 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.719 ' OD1' HG13 ' A' ' 71' ' ' VAL . 50.2 t0 -71.73 126.09 28.82 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.407 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 43.7 t -107.86 129.08 62.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.493 -179.203 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 94.3 mt -94.29 132.52 38.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.315 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.8 m -123.47 123.26 40.24 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.49 0.662 . . . . 0.0 112.572 -178.775 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.534 HG23 ' NE2' ' A' ' 48' ' ' HIS . 90.0 mt -109.51 123.82 65.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.197 177.845 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.487 ' C ' ' O ' ' A' ' 90' ' ' ILE . 86.8 mt 35.2 -96.82 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.509 -0.477 . . . . 0.0 110.613 179.746 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.569 ' OD2' ' NH1' ' A' ' 12' ' ' ARG . 20.8 p-10 -115.03 12.19 16.65 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.736 179.999 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.712 ' NH1' HG23 ' A' ' 39' ' ' ILE . 98.9 mtt180 -124.02 142.13 51.44 Favored 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.444 179.938 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 38.9 t -138.5 147.62 43.38 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.583 179.834 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.449 ' HE1' HD12 ' A' ' 90' ' ' ILE . 85.7 m-85 -121.78 120.64 35.21 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.095 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -79.7 131.79 36.04 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.343 -178.656 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -95.41 122.18 37.86 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.606 179.855 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -124.56 124.57 42.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.706 -179.708 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.579 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 59.0 t-20 -118.29 116.34 26.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.213 -179.929 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 . . . . . 0 C--N 1.332 -0.157 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.271 -179.549 . . . . . . . . 0 0 . 1 . 045 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 2.3 m . . . . . 0 CA--C 1.529 0.163 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 . . . . . . . . . 0 0 . 1 . 045 nuclear build full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -62.16 -47.55 84.04 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.226 0.536 . . . . 0.0 110.146 -179.896 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' B' B ' 230' ' ' SEP . . . . . 0.506 ' C ' ' H ' ' B' ' 232' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 045 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -75.22 38.99 0.14 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.81 -179.817 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' B' B ' 232' ' ' GLY . . . . . 0.506 ' H ' ' C ' ' B' ' 230' ' ' SEP . . . -127.06 -179.89 16.02 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 179.978 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -72.43 161.13 45.11 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 123.624 2.883 . . . . 0.0 113.732 -179.531 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.637 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 045 nuclear build full ' B' B ' 235' ' ' PRO . . . . . 0.445 ' HG2' HG12 ' A' ' 43' ' ' VAL . 61.7 Cg_endo -72.04 140.58 34.85 Favored 'Trans proline' 0 C--N 1.301 -1.971 0 C-N-CA 121.24 1.293 . . . . 0.0 112.799 -179.352 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.625 HG23 ' OD1' ' A' ' 67' ' ' ASN . 1.0 OUTLIER -64.44 136.9 25.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.01 -179.473 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' B' B ' 237' ' ' CYS . . . . . 0.43 ' SG ' HG23 ' A' ' 91' ' ' ILE . 7.7 t -60.34 126.67 28.34 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.843 0.354 . . . . 0.0 110.488 -179.079 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' B' B ' 238' ' ' TPO . . . . . 0.604 ' O1P' HG23 ' B' ' 240' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 045 nuclear build full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -56.24 -23.04 43.54 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.111 1.874 . . . . 0.0 112.866 179.768 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' B' B ' 240' ' ' THR . . . . . 0.604 HG23 ' O1P' ' B' ' 238' ' ' TPO . 35.8 p -75.47 -40.69 57.07 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.316 -0.553 . . . . 0.0 109.704 178.603 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.466 ' HZ ' HD22 ' A' ' 41' ' ' LEU . 83.3 t80 -57.17 -47.36 81.42 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.677 -179.592 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.42 ' HA ' HD23 ' B' ' 242' ' ' LEU . 91.6 mt -62.65 -41.11 98.87 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.635 179.93 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -65.26 -41.49 94.2 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.76 -179.29 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 80.9 mtt85 -62.18 -43.04 99.72 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.093 179.495 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.708 ' NH2' HH21 ' A' ' 93' ' ' ARG . 24.1 mmm180 -61.19 -39.76 91.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.082 -178.622 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.43 -38.71 90.8 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 179.057 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 71.1 m -62.9 -43.66 98.19 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 177.413 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -59.15 -36.6 75.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.194 179.761 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.428 HG23 HH21 ' A' ' 12' ' ' ARG . 63.3 t -61.59 -45.82 97.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.393 179.646 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -59.39 -30.53 68.5 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.586 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -90.47 -9.79 46.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.883 179.103 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 54.1 tp -78.66 144.23 35.57 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.566 179.641 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -107.3 141.51 38.52 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.891 178.521 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -61.45 -32.14 72.11 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.892 0.377 . . . . 0.0 110.798 -179.61 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -71.49 -1.32 12.88 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.593 -179.222 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.483 ' O ' ' C ' ' B' ' 257' ' ' LYS . 93.2 m-20 -88.59 -5.33 58.24 Favored 'General case' 0 N--CA 1.462 0.133 0 C-N-CA 120.709 -0.397 . . . . 0.0 110.638 179.923 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' B' B ' 257' ' ' LYS . . . . . 0.559 ' O ' ' C ' ' B' ' 258' ' ' ASP . 86.4 tttt 32.41 -106.35 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.331 179.917 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.559 ' C ' ' O ' ' B' ' 257' ' ' LYS . 99.4 m-20 -14.27 99.54 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 O-C-N 123.724 0.64 . . . . 0.0 111.138 -179.975 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' B' B ' 259' ' ' ASP . . . . . . . . . . . . . 49.9 p-10 -99.33 57.54 1.05 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.006 -178.62 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.627 ' OE1' ' NH2' ' A' ' 93' ' ' ARG . 98.3 mt-10 61.83 17.56 8.95 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 178.317 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 77.9 mt -118.31 133.84 63.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 177.225 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 68.3 t -126.24 133.04 69.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.381 -178.494 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' B' B ' 263' ' ' PHE . . . . . 0.558 ' CD2' HG21 ' B' ' 267' ' ' ILE . 62.1 m-85 -93.42 116.64 29.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.802 -179.307 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -64.49 -42.33 95.94 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.207 179.212 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' B' B ' 265' ' ' GLN . . . . . 0.511 ' HG2' HD11 ' A' ' 24' ' ' LEU . 1.1 mp0 -101.84 169.77 7.26 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.875 -179.398 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -62.29 149.68 89.81 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 121.752 1.635 . . . . 0.0 113.495 -179.281 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' B' B ' 267' ' ' ILE . . . . . 0.558 HG21 ' CD2' ' B' ' 263' ' ' PHE . 19.8 pt . . . . . 0 N--CA 1.462 0.151 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.912 -179.175 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo . . . . . 0 N--CA 1.493 1.494 0 N-CA-C 111.73 -0.142 . . . . 0.0 111.73 . . . . . . . . . 0 0 . 1 . 046 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.6 p -99.1 -44.42 6.29 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.311 -179.352 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.89 ' NH1' HG23 ' A' ' 53' ' ' ILE . 99.6 mtt180 -96.52 122.08 39.04 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.094 -179.417 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -128.35 142.61 51.07 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.184 0.516 . . . . 0.0 111.339 -179.14 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.61 HD11 ' HB3' ' A' ' 95' ' ' PHE . 45.2 tp -113.38 133.09 55.34 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.304 -179.362 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.0 t -109.01 131.11 60.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.32 -179.617 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.469 HG23 ' CD1' ' B' ' 261' ' ' ILE . 1.5 m -92.3 115.55 28.18 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.514 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.414 HD12 ' HB3' ' A' ' 94' ' ' SER . 98.4 mt -83.13 145.43 8.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.242 179.014 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -91.44 162.08 14.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.163 0.506 . . . . 0.0 110.863 178.928 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.983 HH21 HD22 ' B' ' 252' ' ' LEU . 88.6 mtm180 -57.95 -30.07 65.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.792 -179.638 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.2 m -78.35 -8.61 58.63 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.813 0.339 . . . . 0.0 110.591 179.759 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.3 29.38 12.51 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -179.89 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.8 t -120.02 133.72 65.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.841 0.353 . . . . 0.0 110.075 179.95 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.488 ' O ' ' OD1' ' A' ' 16' ' ' ASP . 43.3 p30 -79.7 141.59 36.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.553 -179.978 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -128.42 -112.29 1.65 Allowed Glycine 0 CA--C 1.535 1.327 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 -179.923 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -75.02 150.05 37.51 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 122.627 2.218 . . . . 0.0 112.978 -179.329 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -111.24 148.97 31.69 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.415 179.694 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.471 ' CD2' HD11 ' A' ' 37' ' ' ILE . 34.7 t80 -117.44 104.58 49.67 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.66 -179.817 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.83 131.43 15.76 Favored 'Trans proline' 0 N--CA 1.489 1.229 0 C-N-CA 121.371 1.381 . . . . 0.0 111.942 -178.905 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 83.4 mt -88.97 46.03 1.35 Allowed 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.082 -178.67 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -55.99 -32.01 63.55 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.668 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.622 HD11 ' HG2' ' B' ' 265' ' ' GLN . 69.4 mt -69.75 142.78 53.2 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.654 179.436 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 97.8 p -63.5 -16.86 61.91 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.327 -178.917 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.5 m -145.15 145.42 31.36 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.694 -0.403 . . . . 0.0 110.845 179.61 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.677 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -136.54 127.82 28.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.662 179.327 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.519 HD13 ' HD3' ' A' ' 50' ' ' LYS . 40.0 tp -114.39 123.92 50.68 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -178.156 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.677 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 54.3 m-85 -97.39 133.59 41.78 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.987 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 177.09 -177.7 48.25 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 119.533 -1.318 . . . . 0.0 112.871 179.609 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.727 ' NH1' ' H ' ' B' ' 231' ' ' GLN . 23.6 ttp85 -89.25 -23.79 22.25 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.946 -0.627 . . . . 0.0 110.994 179.944 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.71 152.16 45.59 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 -179.823 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.541 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.6 tp -64.12 -41.26 91.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.104 0.478 . . . . 0.0 110.195 179.45 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.541 ' N ' HG23 ' A' ' 33' ' ' ILE . 83.1 tt0 -51.37 -17.49 0.77 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.972 -179.764 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 24.0 m -75.08 139.08 42.55 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.493 179.986 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.502 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 57.1 m-20 -61.13 -32.81 72.5 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 -179.445 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.673 HD12 ' CE2' ' A' ' 29' ' ' PHE . 94.2 mt -123.03 116.98 50.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 177.44 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.1 ttp180 -103.95 131.95 50.68 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.397 -178.425 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.8 HD13 ' CZ ' ' A' ' 93' ' ' ARG . 80.0 mt -117.34 132.26 67.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.086 0.47 . . . . 0.0 110.012 -179.41 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -76.71 30.93 0.13 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.77 -177.857 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.677 HD22 HH22 ' B' ' 245' ' ' ARG . 33.3 mt -103.2 131.84 21.72 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.727 179.247 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.96 -10.01 24.22 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.531 2.154 . . . . 0.0 112.642 -179.519 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.434 HG21 ' CE2' ' B' ' 241' ' ' PHE . 22.1 m -97.62 7.22 8.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.872 -179.989 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.499 ' CG2' ' NH2' ' A' ' 93' ' ' ARG . 28.6 t -95.09 134.61 31.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.202 179.236 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.3 t -73.44 171.16 13.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.409 0.623 . . . . 0.0 111.54 -179.152 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -63.5 -42.88 98.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.8 -179.053 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.652 ' O ' ' N ' ' A' ' 49' ' ' CYS . 98.3 mt-30 -113.89 -21.19 10.76 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.384 -179.612 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.0 t60 41.04 -74.94 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.957 179.621 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.828 ' SG ' HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -140.29 141.75 35.75 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.537 -179.201 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.519 ' HD3' HD13 ' A' ' 28' ' ' LEU . 29.1 ttpt -128.02 133.03 49.08 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.639 178.795 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.411 HD11 HD12 ' A' ' 82' ' ' LEU . 18.5 tt -112.06 134.46 54.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -179.872 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -118.15 132.81 56.31 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 -179.875 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.89 HG23 ' NH1' ' A' ' 5' ' ' ARG . 98.3 mt -112.21 117.89 56.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.664 0.745 . . . . 0.0 112.613 -179.135 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.452 ' O ' ' N ' ' A' ' 56' ' ' GLN . 91.4 m-70 -116.65 139.63 50.31 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.211 178.808 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 54' ' ' HIS . 82.6 tt0 -40.13 -30.0 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.252 0.548 . . . . 0.0 109.634 -179.295 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.477 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 60.1 tt0 -65.34 -68.21 0.38 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.053 179.118 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.477 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 3.4 tp10 -154.15 -172.95 4.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.833 -178.976 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.554 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -107.24 130.02 54.8 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.827 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.6 mt -120.05 129.65 75.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.437 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.828 HD11 ' SG ' ' A' ' 49' ' ' CYS . 45.2 tp -100.17 127.88 46.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.209 179.532 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -114.97 137.79 51.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.502 -179.877 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -100.27 108.24 20.26 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.755 0.312 . . . . 0.0 111.825 179.802 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -99.21 -7.39 26.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.995 179.454 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.36 102.22 13.81 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.733 0.301 . . . . 0.0 111.112 -179.742 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.1 m -83.99 -27.69 28.25 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.643 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.769 HG21 ' O ' ' B' ' 234' ' ' TPO . 3.3 m -64.24 -48.66 74.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.604 179.769 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.499 ' OD1' HG22 ' B' ' 236' ' ' VAL . 56.8 m-80 -140.13 95.31 8.47 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.02 -179.899 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.498 ' HB2' HG13 ' A' ' 75' ' ' VAL . 46.4 Cg_exo -56.78 144.6 86.73 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.173 1.915 . . . . 0.0 112.534 -179.765 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 18.3 m -75.79 141.79 42.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.473 179.248 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -103.57 140.98 36.8 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.523 -179.73 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 55.7 t -129.57 132.44 66.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.966 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 51.38 31.72 7.58 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.184 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.9 28.13 63.29 Favored Glycine 0 CA--C 1.534 1.25 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.088 179.636 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 35.0 t -142.35 141.65 32.36 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 117.274 0.537 . . . . 0.0 111.451 179.945 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.498 HG13 ' HB2' ' A' ' 68' ' ' PRO . 54.1 t -69.79 141.5 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.109 179.946 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.48 HD13 HD23 ' A' ' 60' ' ' LEU . 5.1 pt -116.22 75.83 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.557 179.233 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -65.67 -26.22 67.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.84 0.352 . . . . 0.0 110.26 179.832 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -112.18 160.98 28.08 Favored Pre-proline 0 CA--C 1.532 0.26 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.376 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.8 140.24 94.24 Favored 'Trans proline' 0 N--CA 1.499 1.827 0 C-N-CA 121.46 1.44 . . . . 0.0 111.994 179.852 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.3 t -133.61 136.32 54.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.999 179.944 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -74.9 130.44 39.41 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 178.764 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.451 HD11 ' HB2' ' A' ' 60' ' ' LEU . 95.0 mt -84.1 140.64 31.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.161 0.505 . . . . 0.0 111.611 -179.607 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -129.33 151.24 50.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.371 179.69 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -54.69 119.0 4.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.704 -179.225 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.66 -13.33 35.47 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 179.873 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -68.85 134.22 49.36 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.337 -0.545 . . . . 0.0 109.762 179.631 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.449 HG22 ' HG2' ' A' ' 96' ' ' ARG . 54.3 t -109.38 132.23 58.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.139 -178.425 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 81.6 mt -103.82 131.06 53.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.844 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.5 m -118.72 125.73 50.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.468 0.651 . . . . 0.0 111.823 -179.607 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.522 ' O ' ' N ' ' A' ' 93' ' ' ARG . 89.3 mt -118.1 123.7 72.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.535 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.473 HG22 ' N ' ' A' ' 92' ' ' ASP . 46.7 mm 40.78 -108.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.205 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.473 ' N ' HG22 ' A' ' 91' ' ' ILE . 45.5 t0 -111.28 12.68 21.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.253 0.549 . . . . 0.0 110.132 178.829 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.8 ' CZ ' HD13 ' A' ' 39' ' ' ILE . 18.8 mtm105 -112.28 139.6 47.7 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.862 179.715 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.414 ' HB3' HD12 ' A' ' 10' ' ' ILE . 37.4 t -135.54 145.54 47.13 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.775 178.976 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.61 ' HB3' HD11 ' A' ' 7' ' ' LEU . 46.1 m-85 -124.15 122.6 38.26 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.87 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.476 ' O ' HD12 ' A' ' 7' ' ' LEU . 99.7 mtt180 -86.35 132.74 33.89 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.2 -0.6 . . . . 0.0 111.387 -179.324 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.516 ' CZ ' ' OD1' ' A' ' 99' ' ' ASN . 93.8 t80 -95.5 124.16 39.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.969 179.485 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -139.81 127.18 21.38 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.257 -0.577 . . . . 0.0 111.51 -179.161 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.516 ' OD1' ' CZ ' ' A' ' 97' ' ' TYR . 92.3 m-20 -102.97 139.91 37.92 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.977 -179.754 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.448 179.462 . . . . . . . . 0 0 . 1 . 046 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 18.8 m . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.601 0.238 . . . . 0.0 111.259 . . . . . . . . . 0 0 . 1 . 046 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' B' ' 231' ' ' GLN . 64.2 t0 -62.07 116.94 5.36 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.211 179.925 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' B' B ' 230' ' ' SEP . . . . . 0.497 ' O ' ' CB ' ' B' ' 231' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 046 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.727 ' H ' ' NH1' ' A' ' 31' ' ' ARG . 4.0 mt-30 153.26 -21.34 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 O-C-N 123.723 0.639 . . . . 0.0 110.421 179.122 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' B' B ' 232' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' B' ' 231' ' ' GLN . . . -51.26 -160.58 0.01 OUTLIER Glycine 0 CA--C 1.529 0.928 0 CA-C-N 115.78 -0.646 . . . . 0.0 112.129 -179.283 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -61.29 153.3 66.39 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 123.759 2.972 . . . . 0.0 112.947 -179.769 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.769 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 046 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -71.77 141.24 37.05 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.368 2.045 . . . . 0.0 114.41 -178.752 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.499 HG22 ' OD1' ' A' ' 67' ' ' ASN . 0.5 OUTLIER -69.28 137.73 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 114.38 -1.282 . . . . 0.0 110.445 179.991 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 6.8 t -72.86 134.74 44.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.384 -179.687 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' B' B ' 238' ' ' TPO . . . . . 0.611 ' P ' ' HG1' ' B' ' 240' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 046 nuclear build full ' B' B ' 239' ' ' PRO . . . . . 0.414 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 44.3 Cg_exo -56.83 -29.5 81.47 Favored 'Trans proline' 0 N--CA 1.503 2.043 0 C-N-CA 123.484 2.789 . . . . 0.0 114.31 -178.81 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' B' B ' 240' ' ' THR . . . . . 0.611 ' HG1' ' P ' ' B' ' 238' ' ' TPO . 7.7 p -74.76 -38.89 62.08 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.154 -0.619 . . . . 0.0 110.02 179.071 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.485 ' CZ ' ' NH2' ' B' ' 245' ' ' ARG . 66.6 t80 -58.71 -45.3 89.85 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.696 -179.294 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 95.6 mt -64.91 -40.66 95.42 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.838 0.351 . . . . 0.0 111.209 179.681 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -64.33 -44.06 92.71 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.088 -179.025 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 62.8 ttm-85 -60.49 -42.53 96.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.264 0.554 . . . . 0.0 109.886 179.556 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.677 HH22 HD22 ' A' ' 41' ' ' LEU . 48.5 ttm-85 -60.62 -43.18 97.78 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.127 -178.965 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.02 -38.64 89.44 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.35 -179.516 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 15.6 t -65.91 -42.99 89.46 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 177.536 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' B' B ' 248' ' ' GLN . . . . . 0.461 ' O ' ' N ' ' B' ' 252' ' ' LEU . 69.2 tp60 -59.4 -38.02 79.5 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.61 179.845 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 43.3 t -60.82 -46.01 96.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.614 -0.435 . . . . 0.0 109.873 179.315 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -60.46 -27.12 67.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.187 0.518 . . . . 0.0 109.748 179.376 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -94.95 -12.23 27.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.158 179.167 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.983 HD22 HH21 ' A' ' 12' ' ' ARG . 44.6 tp -73.4 137.57 44.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.695 -178.967 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -95.6 128.6 42.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.008 178.899 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -64.58 -23.28 67.22 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.979 -179.438 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 45.0 p-10 -75.42 0.78 15.83 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.636 -179.676 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.46 ' O ' ' C ' ' B' ' 257' ' ' LYS . 97.3 m-20 -89.87 -3.83 57.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.353 179.504 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' B' B ' 257' ' ' LYS . . . . . 0.608 ' O ' ' N ' ' B' ' 259' ' ' ASP . 86.6 tttt 34.34 -110.04 0.05 OUTLIER 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.015 -179.47 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.568 ' C ' ' O ' ' B' ' 257' ' ' LYS . 98.4 m-20 -12.57 79.26 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 O-C-N 123.885 0.741 . . . . 0.0 110.888 -179.889 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.608 ' N ' ' O ' ' B' ' 257' ' ' LYS . 58.9 t0 -84.62 83.09 8.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.534 -178.635 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.672 ' O ' HG23 ' A' ' 39' ' ' ILE . 97.0 mt-10 55.68 3.68 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.685 178.198 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.469 ' CD1' HG23 ' A' ' 9' ' ' THR . 64.5 mt -118.4 134.01 63.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.078 -179.743 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 40.7 t -128.24 134.85 64.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.996 -179.705 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -96.03 119.0 33.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.554 -178.904 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -65.22 -44.46 88.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.924 178.871 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' B' B ' 265' ' ' GLN . . . . . 0.622 ' HG2' HD11 ' A' ' 24' ' ' LEU . 4.4 mp0 -97.35 158.38 33.28 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.382 -179.728 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -69.53 145.74 59.42 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 123.022 2.481 . . . . 0.0 113.398 -179.264 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 48.6 pt . . . . . 0 C--N 1.332 -0.155 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.434 179.061 . . . . . . . . 0 0 . 1 . 047 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo . . . . . 0 N--CA 1.496 1.64 0 CA-C-O 120.766 0.236 . . . . 0.0 111.963 . . . . . . . . . 0 0 . 1 . 047 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 77.0 p -106.03 -39.44 5.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.439 -179.783 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.4 mtt85 -96.46 119.59 35.22 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.784 179.875 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.448 ' NH2' ' OE2' ' A' ' 100' ' ' GLU . 90.9 mtm180 -132.85 141.42 48.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.936 0.398 . . . . 0.0 111.323 -179.292 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.846 HD11 HD11 ' A' ' 22' ' ' LEU . 64.0 mt -114.35 142.37 46.41 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.669 -179.375 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 76.6 t -117.05 130.55 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.651 178.833 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.8 m -87.28 113.58 23.13 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -178.163 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.489 HD12 ' HB2' ' A' ' 94' ' ' SER . 95.1 mt -80.9 140.05 17.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.404 177.781 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -88.21 155.42 19.77 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 178.36 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.693 HH12 ' NH1' ' B' ' 245' ' ' ARG . 75.1 mtp85 -59.29 -26.5 65.01 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.235 -178.899 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.0 m -76.9 -18.75 58.1 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.034 0.445 . . . . 0.0 110.667 179.328 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.08 33.99 4.73 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.196 -1.161 . . . . 0.0 110.196 -179.718 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.2 t -124.13 129.91 73.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.478 0.18 . . . . 0.0 110.533 179.991 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -73.3 138.02 45.19 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.439 179.265 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -125.96 -117.03 2.13 Favored Glycine 0 CA--C 1.541 1.688 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.323 -179.298 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -75.95 147.67 30.77 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 122.765 2.31 . . . . 0.0 112.384 -178.505 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -108.36 148.66 29.78 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.414 179.913 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.487 ' CD2' HD11 ' A' ' 37' ' ' ILE . 31.7 t80 -118.69 101.28 50.72 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.284 -179.876 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.31 135.04 23.92 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.012 1.808 . . . . 0.0 111.629 -179.266 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.846 HD11 HD11 ' A' ' 7' ' ' LEU . 95.6 mt -91.03 49.49 1.65 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.069 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 34.4 t -61.71 -19.1 62.02 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.508 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.734 HD11 ' HG2' ' B' ' 265' ' ' GLN . 80.7 mt -80.14 138.0 36.83 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.057 -179.895 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.1 m -64.76 -19.79 66.0 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.994 -179.486 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.505 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 39.0 m -135.45 135.2 40.34 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.618 -179.405 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.683 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 5.4 t -130.38 120.75 24.76 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.163 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.513 HD21 ' OE1' ' A' ' 47' ' ' GLN . 62.8 tp -118.99 128.77 54.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.308 -178.723 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.743 ' CE2' HD12 ' A' ' 37' ' ' ILE . 3.9 m-85 -105.05 142.59 34.56 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -179.875 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 146.83 -174.36 26.69 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.887 178.587 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.429 ' NH2' ' O ' ' B' ' 233' ' ' PRO . 46.3 mtm180 -74.03 -33.03 63.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 179.42 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.504 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -41.85 144.81 0.8 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 -179.05 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.556 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.3 tp -67.42 -41.86 86.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 O-C-N 122.219 -0.577 . . . . 0.0 109.824 179.483 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.556 ' N ' HG23 ' A' ' 33' ' ' ILE . 76.4 mm-40 -58.15 -23.3 54.78 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.178 179.374 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.504 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 57.4 m -50.9 118.24 3.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.077 179.969 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.505 ' OD2' ' O ' ' A' ' 26' ' ' THR . 57.6 m-20 -57.52 -30.6 65.29 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.817 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.743 HD12 ' CE2' ' A' ' 29' ' ' PHE . 87.8 mt -125.15 118.86 54.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.239 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -104.74 134.74 47.39 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.913 -178.962 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 95.7 mt -114.57 127.23 72.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 121.2 0.524 . . . . 0.0 110.788 179.294 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -70.74 39.37 0.05 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.289 -0.869 . . . . 0.0 113.115 -178.322 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.808 HD11 ' NH2' ' A' ' 93' ' ' ARG . 79.3 mt -117.02 130.99 24.21 Favored Pre-proline 0 C--N 1.326 -0.449 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.369 179.738 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -72.7 -9.19 23.58 Favored 'Trans proline' 0 N--CA 1.489 1.235 0 C-N-CA 122.122 1.881 . . . . 0.0 112.162 179.522 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.458 HG21 ' CE2' ' B' ' 241' ' ' PHE . 28.0 m -99.11 1.98 10.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.894 179.808 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.3 t -86.92 134.93 26.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.268 0.556 . . . . 0.0 110.315 179.412 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.8 m -65.06 160.02 21.95 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.742 -178.987 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -63.72 -43.63 95.98 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.276 -179.085 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.636 ' O ' ' N ' ' A' ' 49' ' ' CYS . 12.1 mm100 -112.75 -23.43 10.17 Favored 'General case' 0 C--O 1.227 -0.123 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.424 179.929 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.3 t60 37.14 -76.75 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.078 -0.964 . . . . 0.0 112.932 179.855 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.636 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.0 136.1 47.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.337 0.589 . . . . 0.0 112.28 -178.539 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -125.39 129.09 49.2 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.781 179.683 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 93.8 mt -114.11 133.71 59.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.181 178.781 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -115.25 128.89 56.43 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.532 179.013 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 51.8 mm -99.0 118.66 45.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.989 -179.807 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.435 ' O ' ' C ' ' A' ' 55' ' ' GLU . 99.5 m-70 -120.31 135.09 55.13 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.33 179.646 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 54' ' ' HIS . 82.6 tt0 -40.46 -32.03 0.18 Allowed 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -179.675 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.434 ' N ' ' C ' ' A' ' 54' ' ' HIS . 88.7 mt-30 -67.53 -68.48 0.38 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.041 179.236 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.479 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 5.1 tp10 -153.84 -167.05 2.55 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.369 -179.067 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.479 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -119.44 130.4 55.25 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.435 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 99.5 mt -117.97 131.16 71.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.634 0.731 . . . . 0.0 111.981 -178.433 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.7 tp -99.78 127.53 45.93 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.213 179.624 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -110.16 133.64 53.01 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.208 -178.881 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 61.4 t-20 -93.25 104.57 16.74 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.948 179.889 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -100.93 -11.93 19.35 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 120.995 -0.282 . . . . 0.0 111.594 179.812 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 m -68.29 99.78 0.96 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.421 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 87.9 p -85.38 -10.11 56.7 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.525 -179.774 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.625 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.2 OUTLIER -100.19 -43.12 6.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.117 179.88 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -133.84 95.61 17.17 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.991 -179.709 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.0 141.2 86.72 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.395 2.063 . . . . 0.0 112.882 -179.735 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.2 m -74.07 136.63 43.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.283 179.174 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -100.6 139.31 36.47 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.212 179.362 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.7 t -131.62 133.37 61.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 178.76 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 54.52 32.68 17.34 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -178.844 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.3 27.22 72.02 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.115 179.487 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 28.5 t -141.29 136.96 32.11 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 117.377 0.589 . . . . 0.0 111.501 -179.966 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -70.06 138.58 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.862 179.652 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.3 pt -114.08 91.57 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 121.208 0.528 . . . . 0.0 111.401 179.664 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -66.49 -26.86 67.38 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.823 178.494 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.495 ' N ' ' OE1' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -119.21 162.07 33.66 Favored Pre-proline 0 N--CA 1.465 0.295 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.81 179.71 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.29 151.09 86.84 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.694 2.263 . . . . 0.0 112.388 -179.388 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 36.0 m -142.05 148.69 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.107 0 CA-C-O 121.273 0.559 . . . . 0.0 112.107 -179.483 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -75.86 127.54 33.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.018 178.865 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 82' ' ' LEU . 92.9 mt -75.55 140.06 42.5 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.488 179.609 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -130.51 146.08 51.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.2 179.515 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.592 ' HD1' ' C ' ' A' ' 99' ' ' ASN . 7.2 t60 -51.4 119.62 4.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.133 -179.178 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.81 -12.19 49.8 Favored Glycine 0 CA--C 1.522 0.51 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.938 179.463 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -69.66 137.22 51.99 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.316 -0.553 . . . . 0.0 110.204 179.705 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.492 ' O ' HG13 ' A' ' 87' ' ' VAL . 8.7 p -106.89 134.86 47.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.876 -178.667 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 93.4 mt -103.27 129.48 55.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 177.696 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 47.5 m -123.98 124.81 43.4 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.577 0.704 . . . . 0.0 112.783 -178.171 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.425 ' O ' ' N ' ' A' ' 92' ' ' ASP . 94.0 mt -111.6 124.2 68.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.005 178.102 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.621 HG22 ' NH2' ' B' ' 245' ' ' ARG . 64.4 mt 39.36 -96.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.987 -179.201 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.49 ' CB ' ' NH2' ' B' ' 245' ' ' ARG . 52.8 t0 -120.51 18.15 12.08 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.792 0.33 . . . . 0.0 111.888 -178.791 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.832 HH22 ' NH1' ' B' ' 245' ' ' ARG . 1.1 ptp85 -131.25 144.29 51.19 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.067 178.679 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.489 ' HB2' HD12 ' A' ' 10' ' ' ILE . 38.1 m -136.14 152.83 51.23 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.298 0.571 . . . . 0.0 111.232 -179.913 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.419 ' HE1' HD12 ' A' ' 90' ' ' ILE . 65.1 m-85 -122.95 122.09 37.71 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.629 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 45.2 ttm180 -78.95 131.77 36.47 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.216 -178.726 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -95.93 119.62 34.75 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.76 179.924 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.41 ' HG3' ' CE1' ' A' ' 84' ' ' HIS . 79.7 tt0 -122.5 122.21 38.39 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.262 -179.969 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.592 ' C ' ' HD1' ' A' ' 84' ' ' HIS . 59.4 t-20 -121.67 105.32 10.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.615 -179.651 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.448 ' OE2' ' NH2' ' A' ' 6' ' ' ARG . 96.1 mt-10 . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.493 178.625 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' B' B ' 228' ' ' VAL . . . . . 0.515 ' O ' ' CB ' ' B' ' 229' ' ' ASP . 86.7 t . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.759 0.314 . . . . 0.0 111.437 . . . . . . . . . 1 1 . 1 . 047 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' B' ' 230' ' ' SEP . 10.0 t0 83.81 55.38 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.938 179.424 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' B' B ' 230' ' ' SEP . . . . . 0.53 ' CB ' ' O ' ' B' ' 229' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 047 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -145.36 61.31 1.29 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.61 179.446 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' B' B ' 232' ' ' GLY . . . . . 0.423 ' C ' HH12 ' A' ' 31' ' ' ARG . . . -110.91 -177.04 20.57 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.874 -179.132 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' B' B ' 233' ' ' PRO . . . . . 0.429 ' O ' ' NH2' ' A' ' 31' ' ' ARG . 65.4 Cg_endo -71.7 161.14 46.13 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.985 2.457 . . . . 0.0 112.635 -179.643 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.625 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 047 nuclear build full ' B' B ' 235' ' ' PRO . . . . . 0.446 ' HG2' HG12 ' A' ' 43' ' ' VAL . 76.5 Cg_endo -74.08 141.49 29.64 Favored 'Trans proline' 0 C--N 1.299 -2.046 0 C-N-CA 121.845 1.697 . . . . 0.0 113.156 -179.555 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.548 ' CG2' HG22 ' A' ' 66' ' ' THR . 67.9 t -66.93 133.27 31.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.771 179.836 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -64.35 131.63 47.81 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.036 0.445 . . . . 0.0 110.555 -179.468 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 047 nuclear build full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -62.11 -22.37 74.09 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.774 2.316 . . . . 0.0 112.018 179.707 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 2.8 m -75.96 -42.39 48.64 Favored 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.532 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.458 ' CE2' HG21 ' A' ' 43' ' ' VAL . 79.9 t80 -58.16 -46.11 86.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.143 -179.788 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.704 HD23 HH21 ' B' ' 245' ' ' ARG . 92.9 mt -63.82 -41.95 97.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.171 0.51 . . . . 0.0 110.851 179.874 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -63.04 -43.0 99.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.979 -179.092 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -61.51 -43.89 98.04 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.271 179.935 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.832 ' NH1' HH22 ' A' ' 93' ' ' ARG . 75.6 mtm180 -63.54 -40.04 95.99 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.881 -178.926 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -61.31 -39.01 88.91 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.263 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 13.5 t -65.91 -45.37 82.18 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.711 0.767 . . . . 0.0 109.496 178.051 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' B' B ' 248' ' ' GLN . . . . . 0.434 ' O ' ' N ' ' B' ' 252' ' ' LEU . 83.0 mt-30 -62.17 -33.63 74.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.558 179.872 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.512 HG23 ' O ' ' B' ' 245' ' ' ARG . 54.0 t -63.41 -44.43 98.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 119.986 -0.686 . . . . 0.0 109.335 178.761 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -60.91 -27.41 68.17 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.679 179.345 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -95.27 -10.93 28.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.173 179.474 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.434 ' N ' ' O ' ' B' ' 248' ' ' GLN . 44.5 tp -79.81 156.82 27.23 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.581 179.908 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' B' B ' 253' ' ' ASN . . . . . 0.419 ' N ' ' HG ' ' B' ' 252' ' ' LEU . 88.4 m-20 -109.91 139.95 44.42 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.196 179.436 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -66.52 -27.79 68.04 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.769 0.318 . . . . 0.0 111.076 179.984 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -68.71 -2.72 9.89 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.816 0.341 . . . . 0.0 110.847 179.732 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.43 ' O ' ' C ' ' B' ' 257' ' ' LYS . 96.0 m-20 -86.98 -4.81 59.21 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.533 179.929 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' B' B ' 257' ' ' LYS . . . . . 0.579 ' O ' ' C ' ' B' ' 258' ' ' ASP . 87.1 tttt 35.83 -109.66 0.05 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.38 -179.883 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.579 ' C ' ' O ' ' B' ' 257' ' ' LYS . 67.1 t0 -13.08 92.81 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 O-C-N 123.691 0.619 . . . . 0.0 111.088 -179.051 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.45 ' C ' ' OE1' ' B' ' 260' ' ' GLU . 39.8 p-10 -91.55 62.26 4.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.2 -179.168 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.45 ' OE1' ' C ' ' B' ' 259' ' ' ASP . 53.5 mp0 63.78 12.96 7.09 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.029 179.443 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 56.6 mt -119.29 130.2 74.26 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 177.89 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 54.1 t -122.69 133.83 67.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.427 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -95.27 122.14 37.66 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.263 0.554 . . . . 0.0 110.685 -178.7 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -62.53 -46.06 90.11 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.564 -179.889 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' B' B ' 265' ' ' GLN . . . . . 0.734 ' HG2' HD11 ' A' ' 24' ' ' LEU . 3.2 mp0 -94.85 160.71 30.58 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.82 -179.403 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.41 147.49 58.83 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.478 2.119 . . . . 0.0 112.94 -179.695 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 47.9 pt . . . . . 0 N--CA 1.466 0.346 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.666 179.13 . . . . . . . . 0 0 . 1 . 048 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo . . . . . 0 N--CA 1.495 1.597 0 CA-C-O 120.848 0.27 . . . . 0.0 112.701 . . . . . . . . . 0 0 . 1 . 048 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.25 -40.18 0.74 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.481 179.651 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.571 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 94.9 mtt-85 -98.6 122.09 41.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.128 -179.381 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.578 ' NH2' ' OE2' ' A' ' 98' ' ' GLU . 33.6 ptt-85 -146.01 158.38 43.87 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.103 -0.639 . . . . 0.0 112.009 179.937 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.3 mt -118.86 144.85 46.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.261 179.604 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.826 HG13 ' NE2' ' A' ' 19' ' ' HIS . 67.0 t -114.31 125.46 71.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.568 -0.453 . . . . 0.0 109.903 179.446 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.2 m -74.21 134.16 42.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.019 0.438 . . . . 0.0 111.313 -179.689 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.662 HD12 ' OG ' ' A' ' 94' ' ' SER . 97.0 mt -104.0 133.98 46.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.759 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -86.71 154.25 21.11 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.279 -0.568 . . . . 0.0 109.881 179.307 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.472 HH21 HD23 ' B' ' 252' ' ' LEU . 89.9 mtm180 -54.99 -27.74 46.44 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.581 -178.983 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.4 m -81.1 -5.67 57.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.759 0.314 . . . . 0.0 110.589 179.809 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.82 34.09 9.35 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 -179.959 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.8 t -121.08 135.59 60.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.86 0.362 . . . . 0.0 110.91 -179.852 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.463 ' O ' ' OD1' ' A' ' 16' ' ' ASP . 48.7 p-10 -75.97 133.36 40.47 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.459 179.727 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -121.39 -121.15 2.76 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.794 -179.327 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.48 147.24 40.78 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.131 1.888 . . . . 0.0 112.8 -178.871 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.826 ' NE2' HG13 ' A' ' 8' ' ' VAL . 62.0 m170 -109.76 143.37 39.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.635 -179.664 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.588 ' CE2' HD11 ' A' ' 37' ' ' ILE . 37.3 t80 -112.52 99.83 48.4 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.849 -179.717 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -70.6 131.51 20.18 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 C-N-CA 120.912 1.075 . . . . 0.0 110.787 -179.638 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 75.8 mt -85.39 77.36 9.95 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 120.261 -0.575 . . . . 0.0 110.784 -178.749 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 97.3 p -85.56 -10.61 55.68 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.077 178.744 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 52.2 mt -102.57 146.19 28.51 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.312 -179.047 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 94.9 p -65.91 -20.02 66.07 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -178.488 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 27.6 m -133.25 133.06 42.18 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.481 -0.487 . . . . 0.0 111.359 -179.777 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.0 t -122.71 116.84 24.44 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.589 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 56.8 tp -113.61 129.37 56.57 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -177.673 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.499 ' O ' ' O ' ' A' ' 47' ' ' GLN . 72.6 m-85 -109.77 131.51 55.0 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.449 179.804 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 160.46 -173.41 37.02 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.882 179.072 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.627 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 75.9 mtm-85 -80.89 -28.52 35.9 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.243 179.364 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.553 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -46.35 146.41 3.16 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -178.645 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.49 HG23 ' N ' ' A' ' 34' ' ' GLU . 9.9 tp -67.72 -41.91 85.78 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 CA-C-O 120.843 0.354 . . . . 0.0 110.285 179.823 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.49 ' N ' HG23 ' A' ' 33' ' ' ILE . 81.7 tt0 -59.03 -21.34 58.92 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.462 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.553 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 22.4 m -55.84 123.46 14.32 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.401 -179.96 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -62.08 -30.96 71.36 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.397 -179.71 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.588 HD11 ' CE2' ' A' ' 20' ' ' PHE . 47.1 mm -124.61 121.13 60.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.17 178.649 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.417 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 60.0 mtm180 -108.81 137.25 47.05 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 120.279 -0.569 . . . . 0.0 111.386 -179.977 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 89.6 mt -121.19 129.31 75.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.047 179.349 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -74.89 32.34 0.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -177.941 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.484 HD23 ' HA ' ' A' ' 41' ' ' LEU . 25.8 mt -98.27 129.07 31.47 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.317 179.272 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -73.14 -5.32 16.97 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 122.317 2.012 . . . . 0.0 112.368 -179.941 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.628 HG23 HD13 ' A' ' 91' ' ' ILE . 27.9 m -107.63 8.71 9.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.356 179.81 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.627 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 13.7 t -95.15 137.6 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.601 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.7 m -69.05 167.28 16.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.479 0.657 . . . . 0.0 112.381 -178.095 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.3 mttp -63.99 -41.65 97.45 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.033 -179.577 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.639 ' O ' ' N ' ' A' ' 49' ' ' CYS . 96.2 mt-30 -115.62 -25.24 7.93 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.098 0.475 . . . . 0.0 110.245 179.864 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.825 ' NE2' HG23 ' A' ' 90' ' ' ILE . 32.1 t60 38.39 -72.44 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 178.912 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.639 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -134.83 139.26 44.93 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -177.967 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.9 ttpp -132.95 133.95 43.88 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.539 178.827 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 92.3 mt -113.27 135.7 51.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.883 179.683 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.408 ' CD ' ' NE2' ' A' ' 54' ' ' HIS . 79.8 tt0 -117.32 132.12 56.67 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.255 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.1 mm -103.6 118.55 50.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.403 -0.519 . . . . 0.0 112.295 -177.924 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.434 ' O ' ' C ' ' A' ' 55' ' ' GLU . 97.9 m-70 -117.66 134.22 55.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.11 178.052 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 54' ' ' HIS . 84.6 tt0 -40.15 -35.47 0.4 Allowed 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.038 -179.085 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -64.27 -66.7 0.51 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.945 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -150.43 -167.96 2.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.286 -179.718 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -119.2 134.61 55.11 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.536 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 98.0 mt -120.2 130.77 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 121.385 0.612 . . . . 0.0 112.615 -178.729 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 21.7 tp -98.72 128.44 44.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.084 179.624 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -109.84 134.62 51.85 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.051 -179.346 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.527 HD21 ' CA ' ' A' ' 68' ' ' PRO . 62.7 t-20 -95.65 104.62 16.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.802 -178.848 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -97.19 -10.46 25.82 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.373 179.535 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 10.3 t -78.01 98.93 5.88 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.666 -179.477 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.2 m -76.09 -40.26 53.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.249 0.547 . . . . 0.0 110.055 178.509 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.37 -41.35 85.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.451 -179.671 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.628 ' OD1' HG23 ' B' ' 236' ' ' VAL . 59.8 m-20 -140.51 93.29 8.81 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.718 -179.895 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.551 ' HB2' HG13 ' A' ' 75' ' ' VAL . 40.6 Cg_exo -56.56 147.55 69.15 Favored 'Trans proline' 0 N--CA 1.498 1.784 0 C-N-CA 122.551 2.167 . . . . 0.0 113.029 -179.064 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.406 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 3.9 m -72.25 136.83 46.44 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.472 179.227 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -100.43 141.56 33.11 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.578 179.49 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.571 HG13 ' OD1' ' A' ' 86' ' ' ASP . 56.1 t -128.54 135.97 61.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.236 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 50.97 31.87 6.79 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.464 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.94 29.27 63.18 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.028 179.569 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 12.1 p -141.34 141.0 33.87 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 117.139 0.469 . . . . 0.0 111.412 179.878 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.551 HG13 ' HB2' ' A' ' 68' ' ' PRO . 53.5 t -74.76 136.5 25.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-O 121.115 0.483 . . . . 0.0 111.74 -179.854 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.958 HD13 ' O ' ' A' ' 76' ' ' ILE . 0.0 OUTLIER -137.15 119.45 19.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.824 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.401 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 38.3 p-10 -101.17 -0.42 36.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.922 -178.038 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.91 ' O ' HD11 ' A' ' 76' ' ' ILE . 5.2 pt-20 -119.93 165.09 18.87 Favored Pre-proline 0 C--N 1.331 -0.225 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.256 179.965 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.98 141.86 96.36 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 121.747 1.632 . . . . 0.0 111.866 179.772 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.7 p -140.21 140.31 35.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.725 -179.879 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -78.96 130.3 35.41 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.961 179.542 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 82' ' ' LEU . 96.8 mt -78.87 140.19 38.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.01 0.433 . . . . 0.0 110.728 179.96 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -129.7 149.38 51.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.329 179.978 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -55.62 116.6 2.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.012 0.434 . . . . 0.0 110.885 -179.168 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.44 -16.41 37.88 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -179.751 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.571 ' OD1' HG13 ' A' ' 71' ' ' VAL . 53.7 t0 -67.68 131.07 44.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.717 0.294 . . . . 0.0 110.231 179.314 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.542 HG22 ' HG2' ' A' ' 96' ' ' ARG . 76.7 t -104.92 135.54 42.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.937 0.399 . . . . 0.0 111.298 -178.8 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 88.4 mt -104.13 130.28 55.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.443 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.8 m -122.53 123.58 41.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.828 0.823 . . . . 0.0 112.836 -178.884 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.825 HG23 ' NE2' ' A' ' 48' ' ' HIS . 86.9 mt -109.38 125.95 66.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 114.236 -1.347 . . . . 0.0 108.281 178.274 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.68 HG22 ' N ' ' A' ' 92' ' ' ASP . 97.8 mt 29.42 -101.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.932 0.396 . . . . 0.0 111.578 -179.165 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.68 ' N ' HG22 ' A' ' 91' ' ' ILE . 35.6 p-10 -105.54 11.42 32.45 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.137 -179.035 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.877 ' NE ' HD11 ' B' ' 261' ' ' ILE . 8.7 mtp85 -130.2 145.2 51.71 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.045 -179.55 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.662 ' OG ' HD12 ' A' ' 10' ' ' ILE . 21.1 p -140.64 153.24 45.95 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.178 0.513 . . . . 0.0 110.699 179.747 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -129.77 127.41 40.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.953 179.814 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.542 ' HG2' HG22 ' A' ' 87' ' ' VAL . 99.9 mtt180 -82.9 133.64 35.11 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.376 -0.529 . . . . 0.0 110.182 179.979 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.571 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 85.0 t80 -94.61 126.21 39.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.485 -179.24 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.578 ' OE2' ' NH2' ' A' ' 6' ' ' ARG . 82.5 tt0 -135.5 118.88 16.77 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.823 179.546 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.42 ' C ' ' OD1' ' A' ' 99' ' ' ASN . 55.5 p30 -104.31 6.5 35.33 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.67 -179.998 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.507 ' O ' ' OE2' ' A' ' 98' ' ' GLU . 82.2 tt0 . . . . . 0 C--N 1.327 -0.377 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.84 179.633 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 40.6 t . . . . . 0 N--CA 1.454 -0.272 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 . . . . . . . . . 0 0 . 1 . 048 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.439 ' C ' ' H ' ' B' ' 231' ' ' GLN . 97.8 m-20 -50.83 114.16 1.09 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.303 -179.452 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 048 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.439 ' H ' ' C ' ' B' ' 229' ' ' ASP . 99.5 mm-40 -101.48 -25.19 14.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.057 -179.871 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -68.91 153.29 52.87 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -179.161 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.76 132.58 17.36 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.764 2.31 . . . . 0.0 112.343 179.785 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.471 HG21 ' C ' ' A' ' 44' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 048 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -77.23 146.55 25.26 Favored 'Trans proline' 0 C--N 1.317 -1.089 0 C-N-CA 121.719 1.613 . . . . 0.0 111.971 177.303 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.628 HG23 ' OD1' ' A' ' 67' ' ' ASN . 4.8 p -64.73 141.51 18.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.548 -179.606 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' B' B ' 237' ' ' CYS . . . . . 0.465 ' SG ' ' CD2' ' B' ' 241' ' ' PHE . 2.8 t -70.27 130.46 42.06 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.217 -179.594 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 048 nuclear build full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.38 -29.11 56.87 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.53 2.154 . . . . 0.0 112.062 178.961 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 87.8 m -64.34 -46.42 83.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.433 0.635 . . . . 0.0 109.317 178.771 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.474 ' HZ ' HD22 ' A' ' 41' ' ' LEU . 85.4 t80 -58.02 -47.5 82.87 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.546 -179.378 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.4 ' HA ' HD23 ' B' ' 242' ' ' LEU . 96.9 mt -62.8 -41.92 99.49 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.89 -178.584 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -65.09 -39.02 92.58 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.224 -179.271 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' B' B ' 244' ' ' ARG . . . . . 0.431 ' O ' ' OG ' ' B' ' 247' ' ' SER . 99.5 mtt180 -63.41 -40.24 96.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.085 0.469 . . . . 0.0 109.835 179.884 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' B' B ' 245' ' ' ARG . . . . . . . . . . . . . 71.2 ttp85 -61.21 -43.16 99.32 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.845 -179.505 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.37 -40.62 97.05 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.321 -179.652 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' B' B ' 247' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 79.4 p -64.51 -42.84 95.55 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.726 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -61.66 -39.12 90.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.193 -179.991 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 54.3 t -64.32 -44.55 97.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.303 179.059 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -60.75 -34.06 73.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.314 179.975 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -89.95 -4.79 57.29 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.546 179.525 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.472 HD23 HH21 ' A' ' 12' ' ' ARG . 56.1 tp -113.89 112.96 24.19 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.984 0.421 . . . . 0.0 110.926 179.933 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' B' B ' 253' ' ' ASN . . . . . 0.477 ' C ' ' H ' ' B' ' 255' ' ' ASP . 28.3 m-80 -82.42 -162.9 0.62 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.108 -178.837 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 39.3 p-10 -54.22 -5.15 0.07 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.192 -178.907 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' B' B ' 255' ' ' ASP . . . . . 0.477 ' H ' ' C ' ' B' ' 253' ' ' ASN . 99.5 m-20 -63.62 -11.54 25.91 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.011 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.74 ' O ' ' N ' ' B' ' 258' ' ' ASP . 27.7 t70 -51.12 -31.17 18.5 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 114.749 -1.114 . . . . 0.0 112.014 -179.556 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' B' B ' 257' ' ' LYS . . . . . 0.499 ' C ' ' O ' ' B' ' 256' ' ' ASP . 98.6 mttt -7.86 -48.62 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.265 0 O-C-N 123.896 0.747 . . . . 0.0 112.682 -178.635 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.74 ' N ' ' O ' ' B' ' 256' ' ' ASP . 50.6 t0 -104.53 85.38 2.33 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 176.215 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.619 ' O ' ' NH1' ' A' ' 93' ' ' ARG . 26.6 t0 -96.11 72.86 2.93 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -175.825 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.475 ' OE1' HD21 ' A' ' 41' ' ' LEU . 99.2 mt-10 54.15 13.69 0.63 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 115.316 1.598 . . . . 0.0 115.316 176.11 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.877 HD11 ' NE ' ' A' ' 93' ' ' ARG . 74.2 mt -118.21 132.89 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 119.434 1.016 . . . . 0.0 109.274 178.388 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 55.9 t -125.11 135.21 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-O 120.932 0.396 . . . . 0.0 111.191 -179.625 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -98.79 119.12 37.01 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.278 0.561 . . . . 0.0 110.581 -179.761 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -66.24 -43.89 85.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.045 179.934 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -103.13 157.98 32.68 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.355 -179.1 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -63.89 155.54 63.45 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 122.949 2.432 . . . . 0.0 112.703 -179.833 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.0 pt . . . . . 0 C--N 1.331 -0.217 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.117 -178.745 . . . . . . . . 0 0 . 1 . 049 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo . . . . . 0 N--CA 1.494 1.551 0 CA-C-O 120.888 0.287 . . . . 0.0 111.944 . . . . . . . . . 0 0 . 1 . 049 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.1 p -117.41 24.94 10.79 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.035 -179.394 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.607 ' HG2' ' HH ' ' A' ' 97' ' ' TYR . 85.6 mtt85 -83.71 123.12 29.52 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.26 -179.865 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -127.45 136.52 51.92 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.23 -179.404 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.524 HD11 ' HB3' ' A' ' 95' ' ' PHE . 25.3 tp -112.67 130.6 55.99 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.836 -179.755 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.561 HG22 ' CE1' ' A' ' 19' ' ' HIS . 47.0 t -108.07 129.15 62.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.914 -179.479 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.0 m -81.05 143.83 32.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.471 0.653 . . . . 0.0 111.921 -179.606 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.8 mm -111.81 135.15 51.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.613 178.729 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.4 ' NZ ' ' HA ' ' B' ' 257' ' ' LYS . 98.2 mttt -89.9 157.27 17.95 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.01 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.514 ' NH2' ' CD1' ' B' ' 252' ' ' LEU . 84.5 mtm180 -58.6 -22.57 56.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.059 -179.466 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.615 ' OG ' HG13 ' B' ' 249' ' ' VAL . 5.2 m -85.08 -9.45 57.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.991 -179.63 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.49 40.24 6.47 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.189 -0.765 . . . . 0.0 111.189 179.716 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 54.6 t -125.89 135.36 64.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.726 0.298 . . . . 0.0 111.627 -179.265 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.441 ' CG ' ' HE2' ' A' ' 19' ' ' HIS . 62.8 t0 -67.68 124.55 23.59 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.163 179.115 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -115.62 -124.8 3.81 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 120.959 -0.639 . . . . 0.0 111.863 -179.18 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -75.82 146.61 30.0 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.31 2.006 . . . . 0.0 113.334 -178.688 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.561 ' CE1' HG22 ' A' ' 8' ' ' VAL . 59.4 m170 -106.1 142.17 36.23 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.563 -179.935 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.414 ' CD2' HD11 ' A' ' 37' ' ' ILE . 44.0 t80 -117.74 106.85 45.35 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.096 179.977 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.29 127.49 12.71 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 121.541 1.494 . . . . 0.0 112.03 -178.382 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 56.3 mt -89.01 43.92 1.18 Allowed 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.35 -178.361 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 65.3 p -67.54 -19.85 65.34 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.554 -0.458 . . . . 0.0 109.849 179.381 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.9 mt -74.39 144.06 44.54 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.61 179.954 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 92.8 p -58.07 -26.08 62.08 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.035 -178.39 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 97.8 m -141.22 138.63 33.44 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.206 -0.598 . . . . 0.0 111.839 -179.113 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.655 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 2.5 t -128.77 121.7 28.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.053 178.393 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.555 HD12 ' O ' ' A' ' 49' ' ' CYS . 52.1 tp -119.74 129.33 54.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.377 -178.167 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.731 ' CE2' HD12 ' A' ' 37' ' ' ILE . 3.0 m-85 -104.68 137.17 42.9 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.473 179.495 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 163.55 -167.46 37.74 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.419 178.883 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.636 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 86.3 mtm-85 -88.05 -27.99 21.64 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.767 0.318 . . . . 0.0 110.263 179.97 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.408 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -55.64 149.87 23.36 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 121.133 -0.556 . . . . 0.0 111.837 -178.168 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.543 ' CD1' ' NH1' ' A' ' 38' ' ' ARG . 10.5 tp -68.09 -41.6 84.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 CA-C-O 120.864 0.364 . . . . 0.0 110.518 179.92 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.467 ' N ' HG23 ' A' ' 33' ' ' ILE . 83.0 tt0 -57.4 -23.34 48.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.226 0.536 . . . . 0.0 110.099 179.77 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.408 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 33.3 m -56.0 126.12 24.47 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.185 179.683 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.436 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 55.0 m-20 -61.04 -33.14 72.82 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.602 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.731 HD12 ' CE2' ' A' ' 29' ' ' PHE . 94.8 mt -123.98 121.9 63.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 177.314 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.543 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 83.1 mtp180 -109.84 139.1 45.29 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.405 -178.544 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 97.4 mt -120.36 130.58 74.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.987 179.004 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -79.75 35.67 0.31 Allowed 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -177.768 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.781 HD12 ' CZ ' ' A' ' 93' ' ' ARG . 60.5 mt -112.95 135.17 21.67 Favored Pre-proline 0 C--N 1.328 -0.328 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.112 178.191 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.67 -9.78 26.49 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.629 2.22 . . . . 0.0 113.22 -178.717 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.694 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 1.8 m -96.52 2.0 10.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.444 -179.828 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.636 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 53.2 t -88.3 131.96 34.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.614 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.403 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 1.6 m -63.99 158.39 22.57 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.159 0.504 . . . . 0.0 111.328 -179.106 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -61.42 -42.08 98.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.663 -179.086 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.612 ' O ' ' N ' ' A' ' 49' ' ' CYS . 10.8 mm100 -115.43 -20.23 10.35 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.919 179.677 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.403 ' H ' ' HB3' ' A' ' 45' ' ' SER . 20.5 t60 33.21 -74.54 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 179.082 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.612 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -129.54 133.94 47.49 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -177.608 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -123.93 133.07 53.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.663 179.284 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 98.1 mt -119.49 134.38 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.679 -179.218 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -115.92 127.99 55.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.402 179.154 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.3 mm -100.49 109.86 26.15 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 CA-C-O 121.251 0.548 . . . . 0.0 110.861 -179.481 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.445 ' O ' ' C ' ' A' ' 55' ' ' GLU . 97.8 m-70 -111.36 135.22 52.22 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.512 179.247 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 54' ' ' HIS . 93.1 mt-10 -41.8 -34.32 0.63 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -179.396 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 73.5 tp60 -63.72 -67.2 0.45 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.373 178.572 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -155.68 -169.52 3.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.691 -179.829 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -117.47 129.94 56.14 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.592 -179.729 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 87.9 mt -117.51 130.51 72.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 121.324 0.583 . . . . 0.0 112.416 -178.902 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.5 ' HB2' HD21 ' A' ' 82' ' ' LEU . 50.5 tp -95.27 129.19 42.49 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.931 179.81 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -115.19 133.44 56.03 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.799 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -96.57 108.3 20.87 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.266 -179.684 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -97.51 -7.02 32.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.256 179.532 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.543 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 78.7 p -76.25 97.93 4.31 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.306 179.579 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.3 m -80.39 -32.95 37.49 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.2 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.516 HG21 ' O ' ' B' ' 234' ' ' TPO . 2.1 m -65.55 -48.07 73.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.293 179.597 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.583 ' OD1' HG23 ' B' ' 236' ' ' VAL . 1.5 m-20 -137.72 102.02 8.68 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.032 -179.663 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.414 ' HB2' HG23 ' A' ' 75' ' ' VAL . 32.4 Cg_exo -55.14 146.05 61.62 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 121.752 1.635 . . . . 0.0 112.326 -179.85 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.2 m -74.68 140.64 44.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.595 179.075 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -104.61 139.02 40.07 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.14 179.673 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 56.4 t -132.02 132.96 61.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.879 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 54.38 33.48 18.66 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.025 -0.67 . . . . 0.0 109.622 -179.391 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.7 29.29 65.7 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.77 178.921 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.1 t -148.08 140.39 24.3 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 117.492 0.646 . . . . 0.0 111.342 179.342 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.428 ' H ' HG12 ' A' ' 75' ' ' VAL . 0.2 OUTLIER -68.65 144.0 14.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.379 -179.485 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.1 pt -118.19 94.35 3.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 121.034 0.445 . . . . 0.0 110.585 179.068 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.58 ' OD1' ' N ' ' A' ' 78' ' ' GLU . 37.0 p-10 -69.4 -23.96 63.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.281 179.727 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.58 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 2.6 mt-10 -124.28 170.04 9.53 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.459 179.656 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -60.73 147.27 95.51 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 122.485 2.123 . . . . 0.0 112.601 179.283 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 29.3 m -138.32 138.71 42.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.473 179.626 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.575 HH21 ' CE ' ' A' ' 83' ' ' LYS . 61.7 ttp180 -72.8 130.44 40.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.632 179.281 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.5 HD21 ' HB2' ' A' ' 60' ' ' LEU . 97.0 mt -81.58 136.02 35.57 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.015 0.436 . . . . 0.0 111.7 -179.386 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.575 ' CE ' HH21 ' A' ' 81' ' ' ARG . 99.1 mttt -129.05 149.0 51.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.409 179.426 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.444 ' CD2' ' C ' ' A' ' 84' ' ' HIS . 7.2 t60 -54.58 116.81 2.88 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.162 179.897 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 113.09 -15.35 23.28 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.572 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -67.96 135.67 52.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.29 0.567 . . . . 0.0 110.672 -179.569 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.513 HG22 ' HG2' ' A' ' 96' ' ' ARG . 77.0 t -112.48 131.57 63.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.752 -178.652 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 81.0 mt -104.29 131.14 53.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.081 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 38.8 m -123.26 128.24 49.7 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -177.807 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.427 ' O ' ' C ' ' A' ' 91' ' ' ILE . 91.4 mt -115.76 124.17 71.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.051 178.679 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.624 HG23 ' SG ' ' B' ' 237' ' ' CYS . 76.6 mt 39.72 -100.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.445 179.989 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.601 ' OD1' ' NH1' ' A' ' 93' ' ' ARG . 24.2 p-10 -116.21 13.4 15.68 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.779 0.323 . . . . 0.0 111.482 -179.919 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.781 ' CZ ' HD12 ' A' ' 41' ' ' LEU . 57.0 mtm-85 -125.07 143.45 50.91 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.878 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.2 t -138.75 156.18 47.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.628 0.728 . . . . 0.0 111.887 -179.413 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.524 ' HB3' HD11 ' A' ' 7' ' ' LEU . 86.5 m-85 -128.32 124.62 36.93 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.454 179.294 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.513 ' HG2' HG22 ' A' ' 87' ' ' VAL . 99.6 mtt180 -89.6 134.54 34.08 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.951 -0.7 . . . . 0.0 110.959 -179.316 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.607 ' HH ' ' HG2' ' A' ' 5' ' ' ARG . 85.7 t80 -98.0 123.27 41.93 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.046 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -141.11 126.91 19.14 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.093 -179.617 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.471 ' OD1' ' CZ ' ' A' ' 97' ' ' TYR . 95.0 m-20 -101.44 108.16 19.67 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.434 179.214 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 . . . . . 0 C--N 1.328 -0.362 0 C-N-CA 119.868 -0.733 . . . . 0.0 110.271 179.598 . . . . . . . . 0 0 . 1 . 049 nuclear build full ' B' B ' 228' ' ' VAL . . . . . 0.434 HG12 ' H ' ' B' ' 229' ' ' ASP . 3.2 t . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.743 0.306 . . . . 0.0 110.458 . . . . . . . . . 1 1 . 1 . 049 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.519 ' C ' ' H ' ' B' ' 231' ' ' GLN . 30.4 p-10 -113.54 -2.37 13.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.824 179.931 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 049 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.519 ' H ' ' C ' ' B' ' 229' ' ' ASP . 1.5 pt20 -138.4 44.73 2.1 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.054 -179.268 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' B' B ' 232' ' ' GLY . . . . . 0.492 ' N ' ' OD1' ' B' ' 229' ' ' ASP . . . -118.18 -156.55 10.3 Favored Glycine 0 CA--C 1.532 1.116 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 179.909 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.23 160.95 44.14 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.735 2.29 . . . . 0.0 112.679 -179.548 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.516 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 049 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -51.86 156.71 6.6 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.682 2.255 . . . . 0.0 112.015 178.536 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.583 HG23 ' OD1' ' A' ' 67' ' ' ASN . 8.2 p -109.9 135.07 50.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.248 -179.767 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' B' B ' 237' ' ' CYS . . . . . 0.624 ' SG ' HG23 ' A' ' 91' ' ' ILE . 19.9 t -78.85 121.59 25.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.289 -179.426 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' B' B ' 238' ' ' TPO . . . . . 0.431 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 049 nuclear build full ' B' B ' 239' ' ' PRO . . . . . 0.431 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 32.2 Cg_exo -57.72 -24.58 63.93 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.668 2.245 . . . . 0.0 111.884 -179.091 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 77.6 m -73.3 -46.69 48.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.566 178.834 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.694 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 57.5 t80 -58.19 -45.84 86.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.693 -178.999 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.446 ' HA ' HD23 ' B' ' 242' ' ' LEU . 78.4 mt -64.27 -40.46 96.02 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.478 179.85 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -61.67 -40.63 95.63 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.951 0.405 . . . . 0.0 110.206 179.922 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -61.8 -43.1 99.52 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.628 179.601 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.605 ' NH2' HD22 ' A' ' 41' ' ' LEU . 40.0 mmt-85 -62.19 -39.79 93.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.605 -179.514 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.08 -40.2 96.96 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.238 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 11.2 t -62.84 -44.06 97.15 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 177.693 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -60.0 -38.11 81.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.785 -179.917 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.615 HG13 ' OG ' ' A' ' 13' ' ' SER . 25.0 t -61.7 -46.53 96.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.797 179.724 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -61.76 -26.84 68.32 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 179.253 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -88.02 -9.46 53.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.412 179.218 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.514 ' CD1' ' NH2' ' A' ' 12' ' ' ARG . 90.2 mt -114.16 106.83 14.83 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.187 179.919 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' B' B ' 253' ' ' ASN . . . . . 0.553 ' ND2' ' CG ' ' B' ' 255' ' ' ASP . 6.6 p-10 -61.35 179.83 0.2 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.896 0.379 . . . . 0.0 110.361 179.671 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -66.63 -11.42 53.58 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.01 -179.341 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' B' B ' 255' ' ' ASP . . . . . 0.567 ' O ' ' N ' ' B' ' 257' ' ' LYS . 15.7 p-10 -68.96 -8.12 41.61 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.96 -178.996 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -65.57 60.33 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.971 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' B' B ' 257' ' ' LYS . . . . . 0.567 ' N ' ' O ' ' B' ' 255' ' ' ASP . 84.9 tttt -64.71 -24.46 67.58 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.047 179.752 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.422 ' O ' ' O ' ' B' ' 259' ' ' ASP . 94.7 m-20 -108.19 81.62 1.51 Allowed 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 178.591 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.572 ' CG ' ' H ' ' B' ' 260' ' ' GLU . 38.6 p30 -53.77 -109.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.662 -178.862 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.572 ' H ' ' CG ' ' B' ' 259' ' ' ASP . 98.5 mt-10 -145.8 23.18 1.41 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.029 0.443 . . . . 0.0 110.037 179.983 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 66.7 mt -113.3 141.12 30.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.303 -178.799 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 56.0 t -127.63 134.04 66.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.329 -179.812 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -99.43 122.92 43.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.441 0.639 . . . . 0.0 111.238 -179.208 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' B' B ' 264' ' ' LYS . . . . . 0.408 ' NZ ' ' HA ' ' A' ' 34' ' ' GLU . 88.2 tttt -64.78 -44.88 88.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.42 179.772 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -98.5 155.29 36.98 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.796 -178.901 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.74 149.71 83.6 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.776 2.318 . . . . 0.0 111.791 179.202 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 25.1 pt . . . . . 0 C--N 1.325 -0.481 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.271 -179.425 . . . . . . . . 0 0 . 1 . 050 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo . . . . . 0 N--CA 1.493 1.461 0 N-CA-C 113.226 0.433 . . . . 0.0 113.226 . . . . . . . . . 0 0 . 1 . 050 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 74.8 p -105.02 -46.89 4.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.218 -179.398 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.664 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 93.7 mtt-85 -92.72 126.22 37.7 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.305 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 89.6 mtm-85 -134.5 151.45 51.14 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.247 0.546 . . . . 0.0 112.255 -179.075 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.42 ' CD1' HD21 ' A' ' 22' ' ' LEU . 85.5 mt -119.16 146.97 44.71 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.875 -179.55 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.0 t -118.55 129.79 74.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.816 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.535 HG22 HH21 ' A' ' 93' ' ' ARG . 53.5 m -89.07 112.74 23.76 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -178.126 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.49 HD12 ' OG ' ' A' ' 94' ' ' SER . 95.8 mt -83.64 143.13 12.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 177.748 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.1 tttm -92.33 167.64 11.86 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.108 -0.637 . . . . 0.0 111.063 -179.735 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.601 ' NH1' ' OE2' ' B' ' 260' ' ' GLU . 90.5 mtm180 -58.25 -31.54 67.52 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.517 -179.165 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 90.5 p -83.35 -6.13 59.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.962 0.41 . . . . 0.0 110.024 179.136 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.2 39.78 7.23 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.89 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.1 t -117.26 134.19 61.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.029 0.442 . . . . 0.0 111.617 -179.198 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -73.09 116.68 13.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.702 -179.839 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -110.95 -124.24 4.57 Favored Glycine 0 CA--C 1.54 1.596 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 179.416 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.93 147.58 39.19 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 122.41 2.073 . . . . 0.0 113.518 -179.219 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.551 ' O ' ' CD1' ' B' ' 267' ' ' ILE . 0.4 OUTLIER -110.59 131.01 55.42 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.234 179.333 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.584 ' CD2' HD11 ' A' ' 37' ' ' ILE . 24.7 t80 -99.58 101.01 12.04 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.533 -179.098 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.97 135.63 23.55 Favored 'Trans proline' 0 C--N 1.315 -1.204 0 C-N-CA 121.332 1.355 . . . . 0.0 111.36 -179.69 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.575 HD13 HD11 ' A' ' 53' ' ' ILE . 79.8 mt -85.95 76.58 9.82 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.965 -178.542 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 95.5 p -82.67 -10.34 58.97 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.757 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.701 HD11 ' HG2' ' B' ' 265' ' ' GLN . 59.2 mt -102.16 146.02 28.55 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.611 -179.682 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.8 m -66.19 -14.8 62.46 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.929 -0.308 . . . . 0.0 111.514 -179.255 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.426 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 75.0 m -135.49 136.48 41.29 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.912 0.387 . . . . 0.0 111.875 -179.539 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.411 ' HB2' HD22 ' A' ' 22' ' ' LEU . 12.2 t -126.2 117.18 22.57 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.911 178.626 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.563 HD21 ' OE1' ' A' ' 47' ' ' GLN . 58.4 tp -113.57 127.88 56.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.602 0.239 . . . . 0.0 110.861 -179.171 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.823 ' CE2' HD12 ' A' ' 37' ' ' ILE . 6.0 m-85 -107.4 141.81 38.21 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.741 179.473 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 149.64 -178.5 27.1 Favored Glycine 0 N--CA 1.467 0.751 0 C-N-CA 120.175 -1.012 . . . . 0.0 112.418 178.676 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.479 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 45.8 mtm180 -73.56 -32.92 64.43 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 179.787 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.535 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -50.13 141.68 15.36 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 120.474 -0.87 . . . . 0.0 111.317 -178.579 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.571 ' CD1' ' CZ ' ' A' ' 38' ' ' ARG . 34.4 mm -63.17 -43.62 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-O 120.874 0.369 . . . . 0.0 110.029 179.529 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -53.81 -19.25 4.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.962 179.806 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.535 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 39.6 m -61.6 129.27 40.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.396 -179.923 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.426 ' OD2' ' O ' ' A' ' 26' ' ' THR . 91.4 m-20 -60.73 -30.38 69.94 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.645 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.823 HD12 ' CE2' ' A' ' 29' ' ' PHE . 82.7 mt -126.93 119.96 54.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.482 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.571 ' CZ ' ' CD1' ' A' ' 33' ' ' ILE . 82.0 mtp180 -99.95 133.75 43.87 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.029 -178.822 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.744 HG21 HD12 ' A' ' 41' ' ' LEU . 96.8 mt -118.44 128.81 75.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-O 121.131 0.491 . . . . 0.0 110.339 179.991 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -76.67 26.87 0.13 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.253 -178.683 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.744 HD12 HG21 ' A' ' 39' ' ' ILE . 26.3 mt -94.84 124.76 53.56 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.554 179.731 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.88 -10.84 26.88 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 122.371 2.047 . . . . 0.0 112.542 -179.443 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.54 HG21 ' CE2' ' B' ' 241' ' ' PHE . 4.1 m -100.86 8.88 8.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.941 0.4 . . . . 0.0 111.27 179.996 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.479 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 21.9 t -97.44 136.31 28.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.329 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.3 m -70.45 170.45 11.97 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.635 0.731 . . . . 0.0 111.921 -178.467 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -62.28 -41.41 98.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.039 -179.144 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.607 ' O ' ' N ' ' A' ' 49' ' ' CYS . 13.9 mm100 -110.91 -20.95 12.26 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.265 0.555 . . . . 0.0 110.403 -179.849 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.408 ' NE2' HG23 ' A' ' 90' ' ' ILE . 11.0 t60 39.74 -78.34 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.006 -0.997 . . . . 0.0 113.209 179.087 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.607 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.16 137.69 46.32 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.216 0.531 . . . . 0.0 111.791 -178.886 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -129.15 135.36 48.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.217 179.661 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.6 mt -121.27 136.95 56.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.142 -179.11 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -117.01 123.89 47.99 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.755 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.575 HD11 HD13 ' A' ' 22' ' ' LEU . 96.4 mt -102.37 116.05 45.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.528 0.68 . . . . 0.0 111.521 -178.714 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.492 ' O ' ' N ' ' A' ' 56' ' ' GLN . 90.8 m-70 -117.67 144.57 45.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.143 179.932 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 54' ' ' HIS . 80.7 tt0 -39.2 -29.16 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -179.626 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.492 ' N ' ' O ' ' A' ' 54' ' ' HIS . 86.5 mt-30 -66.59 -68.59 0.36 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.733 178.944 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.44 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 6.1 tp10 -157.65 -158.99 0.79 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.562 -179.67 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.44 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -118.42 128.77 54.94 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.064 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.9 mt -118.38 129.3 74.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.304 0.573 . . . . 0.0 112.248 -178.477 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 49.2 tp -95.31 129.19 42.53 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.584 -179.954 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -114.23 134.71 54.73 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.154 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.681 HD21 ' CB ' ' A' ' 68' ' ' PRO . 63.7 t-20 -97.84 105.8 18.0 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -178.078 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -98.24 -8.55 27.12 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.911 179.568 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.3 t -81.06 99.23 8.37 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.694 0.283 . . . . 0.0 110.983 179.684 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.4 t -83.99 -32.74 24.81 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.804 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.6 m -61.29 -47.46 85.85 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.918 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -144.17 108.62 4.96 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.714 178.587 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.681 ' CB ' HD21 ' A' ' 62' ' ' ASN . 40.1 Cg_endo -68.6 152.64 74.56 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 121.535 1.49 . . . . 0.0 113.019 -178.473 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.9 m -70.66 138.97 51.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.22 -179.636 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -101.76 140.28 36.26 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.833 -179.682 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.567 ' CG2' HD11 ' A' ' 76' ' ' ILE . 12.9 t -134.89 136.29 52.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 178.13 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 28.7 m120 56.91 33.51 23.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.993 0.425 . . . . 0.0 110.064 -179.581 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.97 30.64 67.66 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.173 179.219 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 36.0 m -148.18 146.39 28.7 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 117.359 0.58 . . . . 0.0 111.348 -179.661 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.4 m -72.78 147.36 10.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-O 121.015 0.436 . . . . 0.0 111.002 -179.703 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.567 HD11 ' CG2' ' A' ' 71' ' ' VAL . 98.3 mt -107.2 107.21 22.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.406 -179.474 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -66.09 -42.25 89.58 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.64 179.233 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.545 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.4 OUTLIER -136.71 -177.55 0.72 Allowed Pre-proline 0 N--CA 1.466 0.346 0 CA-C-O 120.666 0.269 . . . . 0.0 111.298 -178.737 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.509 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 45.2 Cg_exo -58.69 145.22 96.57 Favored 'Trans proline' 0 N--CA 1.5 1.895 0 C-N-CA 122.842 2.361 . . . . 0.0 113.199 -179.753 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.8 m -143.76 143.07 24.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.985 179.634 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.46 ' HE ' ' HE2' ' A' ' 83' ' ' LYS . 59.6 ttp180 -76.25 133.59 40.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.107 179.449 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 82' ' ' LEU . 98.4 mt -82.35 143.87 30.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.151 0.501 . . . . 0.0 111.675 -179.153 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.46 ' HE2' ' HE ' ' A' ' 81' ' ' ARG . 73.3 mmtt -132.72 151.68 51.92 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.489 179.556 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.418 ' CE1' ' H ' ' A' ' 99' ' ' ASN . 5.4 t60 -56.26 117.8 4.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.421 -178.847 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.67 -18.58 24.58 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 111.189 -0.765 . . . . 0.0 111.189 179.527 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -69.61 135.08 49.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.163 0.506 . . . . 0.0 110.554 -179.899 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 49.7 t -110.16 132.78 57.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.91 -179.178 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.439 ' HA ' HG22 ' A' ' 71' ' ' VAL . 97.1 mt -101.12 130.22 50.89 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 177.676 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 49.6 m -120.1 126.42 50.71 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 119.876 -0.73 . . . . 0.0 112.209 -178.663 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.591 ' O ' ' N ' ' A' ' 93' ' ' ARG . 99.1 mt -114.78 129.91 70.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 114.798 -1.092 . . . . 0.0 108.25 177.993 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.504 HG23 HD21 ' B' ' 242' ' ' LEU . 75.6 mt -23.04 95.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -178.612 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.501 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 3.8 m-20 92.88 -27.19 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 178.551 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.666 ' NE ' HD11 ' B' ' 261' ' ' ILE . 7.9 mmm180 -125.93 143.21 51.18 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.418 -179.3 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.49 ' OG ' HD12 ' A' ' 10' ' ' ILE . 87.0 p -138.81 154.36 48.46 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.6 -0.44 . . . . 0.0 109.995 179.345 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -129.12 126.79 40.1 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.32 -179.539 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 96' ' ' ARG . 41.7 ttp-105 -90.91 135.69 33.57 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.661 -0.415 . . . . 0.0 110.429 -179.605 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.664 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 89.1 t80 -92.39 121.34 33.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.905 -179.759 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -121.63 123.43 41.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.831 -179.568 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.418 ' H ' ' CE1' ' A' ' 84' ' ' HIS . 60.3 t-20 -105.28 118.31 36.22 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.921 0.391 . . . . 0.0 110.285 179.923 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 . . . . . 0 C--N 1.326 -0.42 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.492 -179.49 . . . . . . . . 0 0 . 1 . 050 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 47.1 t . . . . . 0 C--O 1.231 0.131 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 . . . . . . . . . 0 0 . 1 . 050 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' B' ' 231' ' ' GLN . 48.5 t0 -81.81 115.77 21.18 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.022 0.439 . . . . 0.0 110.556 -179.849 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 050 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.503 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 75.3 mt-30 -123.25 -26.13 4.35 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.25 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' B' B ' 232' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' B' ' 231' ' ' GLN . . . -52.1 -160.22 0.01 OUTLIER Glycine 0 CA--C 1.531 1.085 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.978 -179.679 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -72.89 160.89 45.05 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.944 2.43 . . . . 0.0 114.369 -178.551 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 050 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -74.78 168.8 24.02 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 121.931 1.754 . . . . 0.0 112.708 -179.783 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 2.1 p -107.72 132.4 55.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.058 179.071 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 3.2 t -79.19 133.44 36.71 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.03 -179.282 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' B' B ' 238' ' ' TPO . . . . . 0.419 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 050 nuclear build full ' B' B ' 239' ' ' PRO . . . . . 0.419 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 31.6 Cg_exo -59.0 -23.29 67.82 Favored 'Trans proline' 0 N--CA 1.502 2.003 0 C-N-CA 122.992 2.461 . . . . 0.0 113.078 -179.777 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 98.9 m -74.47 -46.39 39.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.064 0.459 . . . . 0.0 110.357 178.894 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.54 ' CE2' HG21 ' A' ' 43' ' ' VAL . 88.1 t80 -59.63 -45.34 92.26 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.82 -178.8 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.504 HD21 HG23 ' A' ' 91' ' ' ILE . 89.9 mt -65.79 -39.96 91.47 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 119.86 -0.736 . . . . 0.0 110.563 179.398 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -60.67 -41.84 95.86 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.854 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -65.81 -37.58 86.64 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.314 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.475 HH11 ' NH1' ' A' ' 12' ' ' ARG . 10.7 tpp180 -62.62 -44.52 96.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.334 -179.68 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -63.08 -36.62 84.19 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.978 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 10.2 t -63.53 -44.65 93.6 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.629 177.974 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 66.6 mm-40 -57.83 -37.63 74.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.919 -179.952 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 21.9 t -63.93 -45.21 97.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.576 178.934 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -59.61 -29.9 68.32 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.078 0.465 . . . . 0.0 110.262 -179.663 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -92.81 -7.17 47.15 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.116 179.613 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.494 HD22 HH21 ' A' ' 12' ' ' ARG . 38.5 tp -75.12 147.19 40.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.863 -179.558 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -105.07 132.24 51.56 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.213 -179.756 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' B' B ' 254' ' ' ASP . . . . . 0.475 ' N ' ' OD1' ' B' ' 254' ' ' ASP . 28.2 p-10 -65.13 -33.66 76.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.516 179.052 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' B' B ' 255' ' ' ASP . . . . . 0.475 ' N ' ' OD1' ' B' ' 254' ' ' ASP . 96.9 m-20 -69.51 -6.28 29.65 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.361 179.897 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.572 ' O ' ' N ' ' B' ' 258' ' ' ASP . 34.9 t70 -98.95 -44.19 6.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.379 0.609 . . . . 0.0 109.844 179.316 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' B' B ' 257' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' B' ' 259' ' ' ASP . 99.1 mttt 58.65 -72.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.244 -179.263 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.573 ' O ' ' CB ' ' B' ' 259' ' ' ASP . 90.3 m-20 38.71 -95.44 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -179.115 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.573 ' CB ' ' O ' ' B' ' 258' ' ' ASP . 30.2 p-10 116.95 -162.94 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.453 0 O-C-N 124.868 1.355 . . . . 0.0 108.564 179.263 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.601 ' OE2' ' NH1' ' A' ' 12' ' ' ARG . 92.4 mt-10 -137.74 16.21 2.89 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 177.486 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.666 HD11 ' NE ' ' A' ' 93' ' ' ARG . 3.0 mm -112.72 131.36 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 114.31 -1.314 . . . . 0.0 109.407 -179.109 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 39.2 t -124.95 132.31 71.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.629 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -98.56 122.05 41.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.2 0.524 . . . . 0.0 111.889 -178.302 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -65.06 -45.9 83.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.694 179.326 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' B' B ' 265' ' ' GLN . . . . . 0.701 ' HG2' HD11 ' A' ' 24' ' ' LEU . 2.9 mp0 -92.47 163.9 24.75 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.436 -179.882 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.86 146.92 92.23 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.21 1.94 . . . . 0.0 112.56 -179.89 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' B' B ' 267' ' ' ILE . . . . . 0.551 ' CD1' ' O ' ' A' ' 19' ' ' HIS . 4.9 tt . . . . . 0 C--N 1.323 -0.582 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.246 -179.607 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo . . . . . 0 N--CA 1.489 1.214 0 CA-C-O 121.094 0.372 . . . . 0.0 112.096 . . . . . . . . . 0 0 . 1 . 051 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.1 m -72.35 -44.02 63.21 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.745 -179.744 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.658 ' NH1' HG23 ' A' ' 53' ' ' ILE . 90.0 mtt180 -91.4 138.66 31.4 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.949 -178.011 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -139.0 147.23 41.87 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 179.761 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.551 HD12 ' O ' ' A' ' 96' ' ' ARG . 42.4 tp -117.82 133.61 55.76 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.258 179.241 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 53.7 t -110.8 132.02 60.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.265 -178.668 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.444 HG23 ' CD1' ' B' ' 261' ' ' ILE . 4.7 m -96.6 115.84 28.1 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.874 -179.249 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 87.2 mt -83.41 150.96 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.578 179.888 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.673 ' HZ3' ' HB2' ' B' ' 259' ' ' ASP . 72.8 mmtt -86.17 154.09 21.58 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 178.527 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.881 HH21 HD11 ' B' ' 252' ' ' LEU . 87.7 mtm180 -58.22 -25.47 61.7 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.373 179.776 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.2 m -79.49 -8.25 59.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.843 179.84 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.01 31.84 8.89 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -179.893 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.403 ' H ' ' HB2' ' A' ' 11' ' ' LYS . 23.8 t -118.65 133.64 64.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.611 0.243 . . . . 0.0 110.898 -179.949 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -72.89 133.02 44.22 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.524 -0.546 . . . . 0.0 109.524 179.141 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -127.54 -118.63 2.17 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 120.403 -0.903 . . . . 0.0 111.931 -179.54 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -76.17 149.06 31.62 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.56 2.173 . . . . 0.0 112.593 -179.028 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -110.81 151.08 28.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.339 0.59 . . . . 0.0 111.246 -179.432 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.402 ' HB2' ' CE1' ' B' ' 263' ' ' PHE . 40.4 t80 -112.54 91.75 17.87 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.304 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.518 ' HD2' HG22 ' B' ' 267' ' ' ILE . 59.8 Cg_endo -71.47 133.53 22.64 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 121.226 1.284 . . . . 0.0 111.269 -178.329 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.594 ' O ' ' CB ' ' A' ' 23' ' ' SER . 72.0 mt -73.45 -149.56 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.976 -178.429 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.594 ' CB ' ' O ' ' A' ' 22' ' ' LEU . 6.9 p 135.98 -40.16 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -179.181 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.3 mt -77.52 142.84 38.86 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.55 -1.204 . . . . 0.0 109.769 179.746 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 m -65.26 -17.13 64.25 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -178.766 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.1 m -133.86 133.56 41.69 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.619 0.599 . . . . 0.0 112.619 -179.2 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.662 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.4 OUTLIER -126.15 119.44 27.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.185 178.146 . . . . . . . . 3 3 . 1 . 051 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.512 HD21 ' OE1' ' A' ' 47' ' ' GLN . 36.7 tp -119.7 128.07 53.45 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.826 -178.391 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.705 ' CE2' HD12 ' A' ' 37' ' ' ILE . 25.1 m-85 -100.73 128.18 46.88 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.262 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -173.35 -165.04 29.61 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 120.057 -1.068 . . . . 0.0 112.876 -179.79 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.499 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 38.0 ttp-105 -105.75 -8.5 17.78 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.169 -0.515 . . . . 0.0 111.694 -179.138 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -91.52 170.05 33.49 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.66 -178.865 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.52 HG23 ' N ' ' A' ' 34' ' ' GLU . 11.0 tp -68.45 -41.7 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 115.638 -0.281 . . . . 0.0 111.301 -179.884 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.52 ' N ' HG23 ' A' ' 33' ' ' ILE . 48.8 tt0 -56.76 -29.46 62.62 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.458 -179.429 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.9 m -63.5 129.94 42.28 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.479 -179.975 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.426 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 57.0 m-20 -60.51 -31.3 70.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.383 -178.768 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.705 HD12 ' CE2' ' A' ' 29' ' ' PHE . 97.6 mt -127.25 118.65 50.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 178.258 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.492 ' CZ ' HD12 ' A' ' 33' ' ' ILE . 59.9 mtm180 -102.29 137.2 40.86 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.57 179.9 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.819 HD13 ' NH1' ' A' ' 93' ' ' ARG . 75.8 mt -119.38 131.94 70.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.617 -179.583 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -67.2 18.82 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -177.934 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.702 HD12 HH21 ' A' ' 93' ' ' ARG . 15.5 mt -104.64 127.73 28.34 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.87 179.96 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.67 -5.89 17.8 Favored 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 122.368 2.046 . . . . 0.0 112.326 -179.737 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.543 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 11.0 m -91.8 5.51 6.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.065 179.462 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.499 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 54.7 t -96.51 135.52 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.882 178.885 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.2 m -74.27 167.99 20.51 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.747 0.784 . . . . 0.0 112.951 -178.377 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.7 mtmt -64.13 -37.97 89.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.689 179.588 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.612 ' O ' ' N ' ' A' ' 49' ' ' CYS . 92.1 mm-40 -115.16 -32.26 5.75 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.135 0.493 . . . . 0.0 110.103 -179.984 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 18.7 t60 41.74 -77.2 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.764 179.636 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.612 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.37 134.74 47.38 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.793 -178.916 . . . . . . . . 3 3 . 1 . 051 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -126.05 129.25 48.79 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.359 -179.972 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 95.5 mt -114.89 131.98 65.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.208 -179.736 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -116.93 125.8 52.0 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.552 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.658 HG23 ' NH1' ' A' ' 5' ' ' ARG . 98.0 mt -106.73 114.5 46.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 119.975 -0.69 . . . . 0.0 112.022 -178.585 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.426 ' O ' ' C ' ' A' ' 55' ' ' GLU . 86.2 m-70 -113.27 146.32 39.55 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.719 179.804 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 54' ' ' HIS . 52.8 tp10 -40.66 -33.39 0.28 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.527 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -61.39 -68.94 0.27 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.744 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -161.35 -160.58 0.73 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.145 178.723 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.11 128.15 56.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.365 -179.926 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 91.2 mt -116.59 129.88 72.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.036 0.446 . . . . 0.0 111.892 -179.013 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.575 ' HB2' HD11 ' A' ' 82' ' ' LEU . 28.5 tp -100.0 130.39 46.16 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.896 -179.14 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -115.92 136.17 53.29 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.718 179.849 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -97.09 106.54 18.89 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -178.994 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -100.58 -7.47 24.01 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.213 178.73 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.99 100.97 7.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.187 179.789 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.3 m -88.47 -10.92 47.42 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.999 179.606 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.796 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.2 OUTLIER -91.98 -43.6 9.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.284 -179.724 . . . . . . . . 3 3 . 1 . 051 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.446 ' OD1' HG22 ' B' ' 236' ' ' VAL . 80.1 m-20 -140.05 101.26 7.03 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.08 -179.877 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -56.7 143.11 90.83 Favored 'Trans proline' 0 N--CA 1.501 1.929 0 C-N-CA 122.297 1.998 . . . . 0.0 113.355 -179.312 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.939 ' O ' HG22 ' A' ' 76' ' ' ILE . 2.9 m -72.27 140.35 48.57 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.096 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 89' ' ' THR . 72.8 mt-30 -104.57 140.35 38.12 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.327 -0.549 . . . . 0.0 111.39 -179.005 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.465 HG22 HD13 ' A' ' 88' ' ' ILE . 55.8 t -131.61 133.43 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.982 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 29.0 m120 54.21 33.06 17.25 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.976 179.947 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.5 24.29 70.89 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.993 178.932 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.7 t -142.79 143.52 32.21 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 117.585 0.692 . . . . 0.0 111.058 179.844 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.401 HG22 ' H ' ' A' ' 75' ' ' VAL . 2.5 m -69.22 144.11 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.311 179.945 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.939 HG22 ' O ' ' A' ' 69' ' ' THR . 8.2 tt -106.42 91.39 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.259 179.191 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -64.11 -37.27 86.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.966 179.925 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.486 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 3.5 mt-10 -126.89 168.7 13.85 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.254 -179.044 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -59.74 145.38 98.31 Favored 'Trans proline' 0 N--CA 1.501 1.912 0 C-N-CA 122.042 1.828 . . . . 0.0 112.705 -179.56 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.2 m -145.48 151.58 14.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.801 178.922 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -78.83 132.94 37.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.762 179.552 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.575 HD11 ' HB2' ' A' ' 60' ' ' LEU . 96.1 mt -89.39 140.92 29.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.16 0.505 . . . . 0.0 111.281 -179.681 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -123.13 151.94 41.61 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.852 179.351 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.405 ' CE1' ' HG3' ' A' ' 98' ' ' GLU . 6.5 t60 -53.82 121.69 8.45 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.403 -179.861 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.15 -13.99 37.01 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -179.888 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -68.71 135.59 51.55 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.575 -0.45 . . . . 0.0 109.937 179.671 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.495 ' CG1' ' OG ' ' A' ' 94' ' ' SER . 91.4 t -107.06 132.28 54.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.213 -179.024 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.465 HD13 HG22 ' A' ' 71' ' ' VAL . 45.2 mm -91.05 128.28 42.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.768 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.526 ' N ' ' O ' ' A' ' 70' ' ' GLN . 63.5 m -124.26 123.35 40.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.505 0.669 . . . . 0.0 112.531 -178.02 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.443 ' O ' ' C ' ' A' ' 91' ' ' ILE . 85.1 mt -121.55 129.06 75.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.432 179.295 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.553 HG22 ' N ' ' A' ' 92' ' ' ASP . 95.8 mt 34.2 -99.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.454 -179.797 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.553 ' N ' HG22 ' A' ' 91' ' ' ILE . 36.7 t0 -114.05 16.87 18.1 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.703 0.287 . . . . 0.0 111.33 -179.216 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.819 ' NH1' HD13 ' A' ' 39' ' ' ILE . 4.8 mtm105 -124.71 139.18 54.09 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.812 -179.298 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.495 ' OG ' ' CG1' ' A' ' 87' ' ' VAL . 41.7 t -132.72 141.81 48.74 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.103 0.478 . . . . 0.0 110.128 179.606 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.494 ' HB3' HD11 ' A' ' 7' ' ' LEU . 27.2 m-85 -125.06 123.26 39.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.886 -179.993 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.551 ' O ' HD12 ' A' ' 7' ' ' LEU . 99.6 mtt180 -82.53 126.42 32.25 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.508 -179.855 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.585 ' CE2' ' OD1' ' A' ' 99' ' ' ASN . 74.7 t80 -90.59 124.27 34.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.658 179.607 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.405 ' HG3' ' CE1' ' A' ' 84' ' ' HIS . 82.0 tt0 -128.52 113.5 15.56 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.801 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.585 ' OD1' ' CE2' ' A' ' 97' ' ' TYR . 87.2 m-20 -66.42 -41.13 89.71 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.544 179.961 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.092 -179.244 . . . . . . . . 0 0 . 1 . 051 nuclear build full ' B' B ' 228' ' ' VAL . . . . . 0.638 ' O ' HG13 ' B' ' 228' ' ' VAL . 4.7 p . . . . . 0 CA--C 1.527 0.068 0 CA-C-O 121.215 0.531 . . . . 0.0 109.809 . . . . . . . . . 1 1 . 1 . 051 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.643 ' O ' ' N ' ' B' ' 231' ' ' GLN . 62.6 t0 -88.05 124.15 33.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.04 179.831 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' B' B ' 230' ' ' SEP . . . . . 0.407 ' O ' ' HB3' ' B' ' 231' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 051 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.643 ' N ' ' O ' ' B' ' 229' ' ' ASP . 5.7 pt20 156.8 -21.72 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.106 179.923 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' B' B ' 232' ' ' GLY . . . . . 0.509 ' O ' ' O ' ' B' ' 231' ' ' GLN . . . -48.89 -164.73 0.01 OUTLIER Glycine 0 CA--C 1.537 1.437 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.264 -179.417 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.51 158.72 55.14 Favored 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 122.863 2.375 . . . . 0.0 113.334 -178.989 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.796 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 051 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.3 140.92 38.03 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 121.655 1.57 . . . . 0.0 113.159 -178.943 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.593 HG23 HG22 ' A' ' 66' ' ' THR . 1.8 t -61.03 138.9 21.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.306 -179.882 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -66.08 128.95 38.12 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.288 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 051 nuclear build full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.77 -29.44 71.75 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 122.995 2.463 . . . . 0.0 112.7 179.974 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 25.9 m -74.52 -42.6 58.61 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.073 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.543 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 73.1 t80 -57.17 -47.41 81.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.585 -179.219 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 91.0 mt -65.31 -39.47 92.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.039 0.447 . . . . 0.0 110.206 179.634 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -62.35 -41.25 98.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.757 -179.615 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -64.33 -40.78 96.58 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.65 179.85 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.435 HH11 ' HD3' ' B' ' 245' ' ' ARG . 25.9 mmt180 -61.37 -42.69 99.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.33 -179.354 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.4 -39.76 95.36 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.304 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 11.0 t -66.04 -45.89 79.77 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.849 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -55.11 -40.87 70.96 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.693 179.996 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.506 ' HA ' HD12 ' B' ' 252' ' ' LEU . 44.3 t -60.96 -43.88 96.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.857 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -60.85 -26.59 67.47 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.539 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -86.62 -13.4 45.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.954 -179.557 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.881 HD11 HH21 ' A' ' 12' ' ' ARG . 69.0 mt -72.39 147.89 45.77 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.161 0.505 . . . . 0.0 110.454 179.472 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' B' B ' 253' ' ' ASN . . . . . 0.444 ' C ' ' H ' ' B' ' 255' ' ' ASP . 80.8 m-20 -73.48 174.86 7.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.012 179.583 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -65.84 0.84 1.57 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.843 179.563 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' B' B ' 255' ' ' ASP . . . . . 0.444 ' H ' ' C ' ' B' ' 253' ' ' ASN . 65.4 m-20 -89.34 -86.34 0.19 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.314 178.69 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.416 ' O ' ' NZ ' ' A' ' 11' ' ' LYS . 34.2 t0 64.13 26.74 13.97 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.907 -179.203 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' B' B ' 257' ' ' LYS . . . . . 0.423 ' C ' ' HZ1' ' A' ' 11' ' ' LYS . 99.6 mttt -80.47 -9.76 59.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.411 -179.546 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -70.99 -71.97 0.23 Allowed 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 120.531 -0.467 . . . . 0.0 109.885 179.093 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.673 ' HB2' ' HZ3' ' A' ' 11' ' ' LYS . 47.0 t0 72.72 124.88 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.311 0.577 . . . . 0.0 111.412 -179.867 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.533 ' OE2' ' NH2' ' A' ' 12' ' ' ARG . 53.5 mp0 -56.42 17.94 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.357 -179.433 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.639 ' H ' ' C ' ' B' ' 259' ' ' ASP . 64.5 mt -111.7 134.28 54.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.48 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 77.1 t -128.02 135.27 63.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.761 -179.225 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' B' B ' 263' ' ' PHE . . . . . 0.402 ' CE1' ' HB2' ' A' ' 20' ' ' PHE . 42.3 m-85 -96.53 119.25 34.67 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.072 -178.224 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -66.42 -46.82 75.23 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.156 178.976 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.37 156.2 51.17 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.859 -178.543 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -62.23 149.19 91.54 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 C-N-CA 122.46 2.107 . . . . 0.0 111.071 179.261 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' B' B ' 267' ' ' ILE . . . . . 0.518 HG22 ' HD2' ' A' ' 21' ' ' PRO . 30.1 pt . . . . . 0 C--N 1.325 -0.489 0 CA-C-O 121.47 0.652 . . . . 0.0 111.964 -178.42 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo . . . . . 0 N--CA 1.495 1.594 0 CA-C-O 120.823 0.259 . . . . 0.0 112.015 . . . . . . . . . 0 0 . 1 . 052 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 69.1 p -102.67 -47.84 4.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.556 179.904 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.5 mtt85 -94.2 132.76 38.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.248 -179.808 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.502 HH21 ' CD ' ' A' ' 98' ' ' GLU . 39.5 ptt180 -143.57 153.43 42.55 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 120.311 -0.556 . . . . 0.0 111.784 -179.943 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 68.5 mt -117.98 138.71 52.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.817 -179.757 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.703 HG11 ' NH2' ' A' ' 96' ' ' ARG . 26.6 t -112.03 130.3 65.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.524 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.427 ' HG1' ' HE2' ' A' ' 95' ' ' PHE . 3.5 m -79.27 141.24 37.23 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -178.389 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.73 HD11 ' NH1' ' A' ' 96' ' ' ARG . 47.9 mm -106.2 132.4 53.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.096 -0.957 . . . . 0.0 109.035 177.547 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -87.74 154.42 20.58 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.406 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.442 ' HG2' HH12 ' B' ' 245' ' ' ARG . 80.8 mtm180 -57.78 -23.67 53.46 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -178.806 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.4 m -82.89 -9.5 59.28 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.623 179.653 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.27 32.58 10.34 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -179.746 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.1 t -120.53 132.09 71.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.875 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.605 ' CG ' HH22 ' A' ' 96' ' ' ARG . 98.2 m-20 -69.8 137.96 52.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.438 -179.649 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -124.77 -121.23 2.54 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.28 -179.093 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -75.93 146.62 29.66 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.578 2.185 . . . . 0.0 113.192 -178.486 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -106.65 143.69 34.39 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.154 0.502 . . . . 0.0 110.461 179.754 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.529 ' CD2' HD11 ' A' ' 37' ' ' ILE . 33.7 t80 -112.35 96.22 34.63 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.371 -179.707 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -68.89 129.35 18.36 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 121.369 1.379 . . . . 0.0 112.332 -178.422 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 94.4 mt -83.88 78.05 9.79 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.114 0.483 . . . . 0.0 111.052 -178.922 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.7 p -82.29 -13.14 57.45 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.176 178.93 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.2 mt -102.86 148.22 25.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.428 -179.312 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 80.0 p -69.95 -14.78 62.87 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.568 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 58.3 m -129.48 131.48 46.69 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.315 -179.985 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.3 t -124.55 112.7 17.15 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 178.63 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.499 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 40.6 tp -110.01 124.58 51.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.524 -178.749 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.734 ' CE2' HD12 ' A' ' 37' ' ' ILE . 5.5 m-85 -104.76 140.77 37.59 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.175 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -179.97 -176.08 47.12 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.001 -1.095 . . . . 0.0 112.428 179.507 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 31' ' ' ARG . 37.2 ttp180 -91.27 -10.01 43.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.928 0.394 . . . . 0.0 109.959 -179.933 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.434 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -93.86 154.53 21.64 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.763 -179.652 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.468 HG23 ' N ' ' A' ' 34' ' ' GLU . 11.3 tp -66.92 -40.84 86.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 179.435 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.468 ' N ' HG23 ' A' ' 33' ' ' ILE . 80.9 tt0 -46.92 -16.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.478 -179.968 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.435 ' N ' ' C ' ' A' ' 33' ' ' ILE . 2.8 m -83.19 145.14 29.34 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.764 -179.983 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.499 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 54.8 m-20 -58.85 -32.81 69.77 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -179.539 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.734 HD12 ' CE2' ' A' ' 29' ' ' PHE . 85.3 mt -129.04 124.54 60.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.314 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 36.0 ttp180 -108.47 138.71 44.32 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.541 -0.464 . . . . 0.0 111.228 -179.514 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 98.3 mt -121.23 132.54 70.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.125 0.488 . . . . 0.0 110.418 -179.915 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -76.38 29.19 0.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.35 -178.803 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.489 HD22 ' HZ ' ' B' ' 241' ' ' PHE . 38.2 mt -98.72 128.87 31.35 Favored Pre-proline 0 C--N 1.324 -0.523 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.476 179.736 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.89 -9.59 22.44 Favored 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 122.135 1.89 . . . . 0.0 111.345 179.316 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.5 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 31.4 m -97.43 5.5 9.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.804 -179.917 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 24.8 t -96.46 133.12 38.96 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-O 121.134 0.492 . . . . 0.0 110.058 179.272 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.561 ' HA ' HG21 ' B' ' 234' ' ' TPO . 28.7 m -72.21 160.93 31.6 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.944 -179.291 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.27 -39.31 89.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.832 -178.891 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.534 ' O ' ' N ' ' A' ' 49' ' ' CYS . 99.4 mm-40 -111.45 -9.81 14.21 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.903 0.382 . . . . 0.0 110.966 -179.549 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.606 ' CG ' ' HG ' ' A' ' 64' ' ' SER . 15.1 t60 15.36 -76.05 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -178.16 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.534 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.65 135.09 46.64 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 -177.613 . . . . . . . . 3 3 . 1 . 052 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -128.55 128.73 44.83 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.648 179.57 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.9 mt -112.84 133.5 58.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.364 179.796 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -116.81 125.27 51.34 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.34 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 87.5 mt -107.27 113.56 43.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.62 0.724 . . . . 0.0 111.812 -179.117 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.433 ' C ' ' N ' ' A' ' 56' ' ' GLN . 86.7 m-70 -109.68 141.77 41.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.442 -179.941 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 54' ' ' HIS . 94.3 mt-10 -42.72 -28.35 0.23 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.729 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.487 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 86.7 mt-30 -65.0 -69.44 0.29 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.642 178.791 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.487 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 4.4 tp10 -154.79 -174.56 5.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.762 -179.064 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -108.62 127.92 54.39 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.252 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 91.6 mt -119.18 132.17 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -178.512 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.618 HD22 ' CD1' ' A' ' 88' ' ' ILE . 26.1 tp -100.85 129.58 46.74 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.693 178.934 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -114.35 137.72 51.45 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.787 -179.601 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -98.42 104.28 16.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.266 -0.424 . . . . 0.0 112.11 -179.568 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -101.22 -5.31 25.72 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.518 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.606 ' HG ' ' CG ' ' A' ' 48' ' ' HIS . 0.2 OUTLIER -77.03 99.51 5.33 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.917 -179.844 . . . . . . . . 3 3 . 1 . 052 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.0 m -78.74 -31.72 46.43 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.311 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.62 ' O ' HG12 ' B' ' 236' ' ' VAL . 6.5 m -63.45 -49.0 75.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.596 -179.808 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.449 HD21 ' HA ' ' B' ' 236' ' ' VAL . 49.7 m-80 -150.61 100.93 3.1 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.002 -179.487 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -52.34 149.1 23.74 Favored 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 122.468 2.112 . . . . 0.0 112.843 -179.823 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 31.3 m -72.83 137.07 45.5 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.774 179.877 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -100.15 142.02 32.19 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.098 -179.972 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.418 ' O ' ' OG ' ' A' ' 74' ' ' SER . 54.6 t -130.36 134.04 63.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.932 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 51.59 33.01 9.88 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 119.684 -0.806 . . . . 0.0 109.497 179.99 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.68 29.51 67.5 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.344 179.402 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 24.0 p -140.92 133.49 28.6 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 117.486 0.643 . . . . 0.0 111.424 -179.96 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.1 t -69.93 139.18 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.092 179.978 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.55 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 1.2 pt -108.63 107.41 22.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.454 0.645 . . . . 0.0 111.213 179.551 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.432 ' O ' ' OE1' ' A' ' 78' ' ' GLU . 58.3 m-20 -65.64 -33.87 76.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.851 179.051 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.513 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.1 OUTLIER -128.45 -177.72 0.68 Allowed Pre-proline 0 N--CA 1.465 0.282 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.318 179.988 . . . . . . . . 3 3 . 1 . 052 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.513 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 39.7 Cg_exo -61.56 145.08 98.07 Favored 'Trans proline' 0 N--CA 1.499 1.822 0 C-N-CA 122.705 2.27 . . . . 0.0 112.441 179.75 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.2 t -133.21 136.55 54.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.587 179.426 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -73.24 131.19 41.66 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.161 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.441 HD11 ' HB2' ' A' ' 60' ' ' LEU . 90.3 mt -87.46 136.65 32.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.035 0.445 . . . . 0.0 111.279 -179.006 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.537 ' N ' ' OD2' ' A' ' 86' ' ' ASP . 99.2 mttt -125.36 152.26 45.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.953 -179.929 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.498 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 6.1 t60 -52.08 114.73 1.41 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.829 -179.317 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.95 -12.09 29.42 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 179.634 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.537 ' OD2' ' N ' ' A' ' 83' ' ' LYS . 97.5 m-20 -69.98 137.71 51.67 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.086 179.767 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 88.6 t -111.41 134.15 54.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.418 -178.573 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.618 ' CD1' HD22 ' A' ' 60' ' ' LEU . 37.5 mm -93.31 126.53 45.73 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 178.291 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 51.2 m -125.4 127.44 46.57 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.944 0.878 . . . . 0.0 113.08 -178.125 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.531 ' O ' ' C ' ' A' ' 91' ' ' ILE . 89.0 mt -111.76 133.95 55.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 113.933 -1.485 . . . . 0.0 108.043 178.739 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.531 ' C ' ' O ' ' A' ' 90' ' ' ILE . 74.3 mt 16.17 -83.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 O-C-N 123.65 0.594 . . . . 0.0 112.171 -177.333 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' A' ' 90' ' ' ILE . 46.6 t0 -120.7 8.18 10.59 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.593 -179.515 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.757 ' NH1' HH22 ' B' ' 245' ' ' ARG . 2.4 tpp180 -124.65 137.92 54.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.085 -179.784 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 91.0 p -140.79 158.7 43.58 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.577 0.703 . . . . 0.0 112.343 -178.711 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.512 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 87.3 m-85 -130.05 128.8 42.68 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.483 179.573 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.73 ' NH1' HD11 ' A' ' 10' ' ' ILE . 92.4 mtm-85 -87.55 132.97 33.86 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 119.591 -0.844 . . . . 0.0 111.168 -179.812 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -95.48 125.15 39.89 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.46 179.369 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.502 ' CD ' HH21 ' A' ' 6' ' ' ARG . 83.4 tt0 -126.52 121.68 33.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.623 179.931 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.498 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 64.7 t-20 -100.54 107.13 18.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.996 179.764 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 . . . . . 0 C--N 1.326 -0.418 0 CA-C-O 120.908 0.385 . . . . 0.0 110.721 -179.687 . . . . . . . . 0 0 . 1 . 052 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 21.3 m . . . . . 0 N--CA 1.452 -0.354 0 CA-C-O 120.863 0.363 . . . . 0.0 110.453 . . . . . . . . . 0 0 . 1 . 052 nuclear build full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -66.48 131.19 45.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.98 -179.701 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 052 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -126.4 41.39 3.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.066 0.46 . . . . 0.0 110.187 179.743 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -118.82 -168.27 14.09 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.835 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -61.3 152.1 74.72 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 123.387 2.725 . . . . 0.0 112.643 179.856 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.561 HG21 ' HA ' ' A' ' 45' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 052 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -81.22 143.8 14.27 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.24 1.96 . . . . 0.0 112.892 -179.478 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.62 HG12 ' O ' ' A' ' 66' ' ' THR . 24.8 m -65.67 153.31 8.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.602 -179.263 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 8.6 t -60.03 120.99 10.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.214 0.531 . . . . 0.0 111.122 -178.629 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 052 nuclear build full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -60.64 -27.71 85.3 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 122.941 2.427 . . . . 0.0 112.826 -178.766 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 84.2 m -74.21 -40.21 62.6 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.202 0.525 . . . . 0.0 109.595 178.017 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.5 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 92.1 t80 -58.5 -48.06 82.04 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.751 -179.227 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' B' ' 242' ' ' LEU . 86.9 mt -63.5 -42.27 98.53 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 120.858 0.361 . . . . 0.0 111.32 179.86 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -66.17 -36.72 83.83 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.451 -179.471 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -61.24 -44.06 97.86 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.454 -0.499 . . . . 0.0 109.808 179.416 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.757 HH22 ' NH1' ' A' ' 93' ' ' ARG . 2.9 mtt-85 -59.9 -41.13 90.97 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.871 0.367 . . . . 0.0 110.432 179.776 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -61.77 -43.05 99.62 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.354 179.505 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 10.5 t -64.26 -45.41 88.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.284 0.564 . . . . 0.0 109.687 178.958 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 28.7 mm100 -62.01 -35.69 79.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.977 -179.363 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.457 HG23 ' O ' ' B' ' 245' ' ' ARG . 44.8 t -64.87 -46.06 93.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.677 179.357 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -62.13 -25.99 68.05 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.399 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -88.68 -11.22 45.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.811 179.697 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.532 HD11 ' CG ' ' B' ' 256' ' ' ASP . 48.8 tp -118.27 114.43 22.98 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.919 0.39 . . . . 0.0 111.777 -179.432 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -53.4 160.67 1.13 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.345 0.593 . . . . 0.0 111.685 -179.298 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -76.41 -21.74 55.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.017 178.748 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -92.44 7.25 43.87 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.389 -179.56 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.532 ' CG ' HD11 ' B' ' 252' ' ' LEU . 39.4 t0 -98.86 115.97 30.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.567 -179.728 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' B' B ' 257' ' ' LYS . . . . . 0.563 ' O ' ' CB ' ' B' ' 258' ' ' ASP . 97.8 mttt -73.3 160.58 31.64 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.675 179.416 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.563 ' CB ' ' O ' ' B' ' 257' ' ' LYS . 25.4 p-10 119.72 72.1 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 O-C-N 124.965 1.415 . . . . 0.0 108.336 -179.337 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' B' B ' 259' ' ' ASP . . . . . . . . . . . . . 38.3 p-10 -89.59 8.48 31.1 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.773 -178.22 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 62.61 20.39 11.97 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 179.931 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.56 HD11 ' HD2' ' A' ' 93' ' ' ARG . 75.1 mt -118.23 131.37 71.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.061 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 53.6 t -125.23 132.37 71.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.575 179.81 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -96.18 115.75 27.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.2 -178.927 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -65.53 -46.7 78.57 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.747 179.289 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -87.25 150.39 49.27 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.13 -178.957 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.13 142.98 63.26 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.327 2.018 . . . . 0.0 112.254 -179.745 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 44.5 pt . . . . . 0 C--N 1.327 -0.396 0 CA-C-O 121.148 0.499 . . . . 0.0 109.841 179.114 . . . . . . . . 0 0 . 1 . 053 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 N--CA 1.489 1.258 0 CA-C-O 120.891 0.288 . . . . 0.0 111.96 . . . . . . . . . 0 0 . 1 . 053 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.0 p -101.68 -50.32 3.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.038 -179.79 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.968 ' NH2' HD11 ' A' ' 53' ' ' ILE . 15.0 mtm180 -93.69 128.84 40.08 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.564 -179.086 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.7 mtp180 -126.94 139.15 53.27 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.155 0.502 . . . . 0.0 111.456 179.74 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.578 HD11 ' HB3' ' A' ' 95' ' ' PHE . 32.3 tp -112.51 132.83 54.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.057 -179.6 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.0 t -109.45 129.68 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.822 0.344 . . . . 0.0 110.648 179.982 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.475 HG23 ' CD1' ' B' ' 261' ' ' ILE . 3.8 m -86.28 111.93 20.91 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.715 -179.368 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 79.5 mt -80.42 142.76 13.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.15 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -93.56 159.02 15.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.992 0.425 . . . . 0.0 111.587 179.994 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.425 ' HB3' HG21 ' B' ' 249' ' ' VAL . 89.9 mtm180 -59.12 -29.8 67.66 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.417 179.682 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.4 m -75.51 -15.41 60.4 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.43 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.8 31.83 7.18 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -179.86 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.7 t -119.66 131.17 72.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.835 0.35 . . . . 0.0 110.911 -179.496 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -74.96 139.42 42.98 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.436 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.84 -115.57 1.65 Allowed Glycine 0 CA--C 1.534 1.227 0 C-N-CA 120.118 -1.039 . . . . 0.0 112.11 -179.355 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.71 146.68 43.65 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.264 1.976 . . . . 0.0 112.909 -178.717 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -109.77 146.9 34.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.031 -179.622 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.764 ' CD2' HD11 ' A' ' 37' ' ' ILE . 40.3 t80 -117.27 101.29 53.03 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.584 -179.813 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -72.47 127.35 12.44 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 121.714 1.61 . . . . 0.0 111.546 -178.743 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.606 HD13 ' NH2' ' A' ' 5' ' ' ARG . 62.6 mt -78.02 52.29 1.06 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.985 -178.555 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.6 p -61.83 -33.28 73.87 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.398 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 68.6 mt -74.06 141.87 45.69 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.818 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 94.7 p -67.07 -16.61 64.45 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.879 0.371 . . . . 0.0 110.814 -179.35 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 56.4 m -130.83 132.46 45.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.962 -179.992 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.661 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 2.6 t -128.25 120.04 26.38 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.828 179.471 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.667 HD21 ' OE1' ' A' ' 47' ' ' GLN . 27.6 tp -120.15 130.98 54.85 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.541 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.661 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 35.6 m-85 -108.15 144.29 35.75 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.826 179.92 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 149.23 -178.92 26.44 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 120.928 -0.654 . . . . 0.0 112.074 177.929 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.413 ' HD2' HH11 ' A' ' 31' ' ' ARG . 45.6 mtm180 -69.72 -32.88 71.68 Favored 'General case' 0 CA--C 1.522 -0.119 0 CA-C-O 120.936 0.398 . . . . 0.0 111.256 178.76 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.562 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -52.78 135.68 38.26 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -178.813 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.435 ' C ' ' N ' ' A' ' 35' ' ' CYS . 80.1 mt -63.89 -43.45 97.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.48 179.419 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -51.48 -18.9 1.2 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.406 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.562 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 13.9 m -68.79 129.13 39.04 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.718 179.037 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -60.42 -28.63 68.42 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.689 -179.103 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.764 HD11 ' CD2' ' A' ' 20' ' ' PHE . 48.2 mm -122.5 116.0 47.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.9 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -100.79 131.44 46.68 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.678 -179.39 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.629 HG21 HD12 ' A' ' 41' ' ' LEU . 91.8 mt -119.52 130.36 74.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.205 -0.598 . . . . 0.0 109.798 -179.549 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -78.04 27.81 0.18 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.207 -178.594 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.712 ' O ' HG12 ' A' ' 44' ' ' VAL . 16.0 mt -95.3 110.73 52.1 Favored Pre-proline 0 C--N 1.325 -0.483 0 C-N-CA 120.592 -0.443 . . . . 0.0 109.827 179.769 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.524 ' HB3' HG11 ' B' ' 228' ' ' VAL . 37.8 Cg_exo -56.55 -12.05 7.79 Favored 'Trans proline' 0 N--CA 1.499 1.809 0 C-N-CA 122.115 1.877 . . . . 0.0 113.223 -179.266 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.471 HG23 HG13 ' A' ' 91' ' ' ILE . 6.6 m -102.64 9.14 9.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -178.888 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.712 HG12 ' O ' ' A' ' 41' ' ' LEU . 8.8 p -103.3 106.59 20.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.021 179.894 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.532 ' O ' ' O ' ' A' ' 44' ' ' VAL . 0.4 OUTLIER -34.05 167.08 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 114.911 -1.04 . . . . 0.0 113.122 -178.109 . . . . . . . . 3 3 . 1 . 053 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -62.37 -42.82 99.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.471 -178.723 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.667 ' OE1' HD21 ' A' ' 28' ' ' LEU . 88.0 mm-40 -111.97 -20.03 12.14 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.421 -179.445 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.463 ' NE2' HG23 ' A' ' 90' ' ' ILE . 24.6 t60 36.55 -75.26 0.0 OUTLIER 'General case' 0 C--O 1.236 0.361 0 CA-C-N 114.89 -1.05 . . . . 0.0 113.493 179.685 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.66 ' O ' HD12 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -133.27 135.91 45.21 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.759 -178.118 . . . . . . . . 3 3 . 1 . 053 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -128.56 134.82 48.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.776 179.809 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.0 mt -117.05 132.73 65.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.21 179.701 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -118.56 127.24 53.43 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.647 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.968 HD11 ' NH2' ' A' ' 5' ' ' ARG . 86.7 mt -102.72 116.27 46.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.487 0.66 . . . . 0.0 111.593 -179.562 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.448 ' O ' ' C ' ' A' ' 55' ' ' GLU . 79.6 m-70 -111.83 139.04 47.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.114 -179.921 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 54' ' ' HIS . 97.6 mt-10 -40.55 -34.69 0.38 Allowed 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.654 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -60.73 -67.96 0.35 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.832 178.599 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -155.63 -171.89 3.94 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.286 0.565 . . . . 0.0 111.571 -179.03 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.18 128.17 54.81 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.668 179.18 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.4 mt -125.48 133.53 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -178.77 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.415 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 16.5 tp -97.89 131.68 44.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.138 179.024 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -113.35 136.2 53.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.959 179.992 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -97.97 104.1 16.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.37 -179.921 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -95.99 -8.7 33.0 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.17 179.636 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.09 109.58 7.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.933 0.397 . . . . 0.0 111.364 -179.579 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.7 p -90.44 -18.07 26.05 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.07 179.022 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.8 HG22 HG22 ' B' ' 236' ' ' VAL . 0.2 OUTLIER -87.91 -40.88 13.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.221 -179.901 . . . . . . . . 3 3 . 1 . 053 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -145.67 99.1 4.45 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.47 -179.766 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -57.86 147.49 81.02 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 122.049 1.833 . . . . 0.0 112.779 179.99 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.0 m -68.08 137.17 54.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.884 179.519 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -98.52 143.62 28.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.977 179.353 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.773 ' HB ' HD11 ' A' ' 76' ' ' ILE . 5.1 p -130.82 137.9 54.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.342 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 50.58 31.84 6.11 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.946 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.91 28.68 68.29 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.355 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.414 ' N ' ' O ' ' A' ' 71' ' ' VAL . 14.8 t -137.97 135.29 35.86 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.846 0.355 . . . . 0.0 111.357 -179.726 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.4 p -61.73 143.03 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.914 -179.207 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.773 HD11 ' HB ' ' A' ' 71' ' ' VAL . 96.5 mt -108.3 106.01 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.931 -179.855 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -68.74 -42.04 78.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.428 179.067 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.55 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.7 OUTLIER -135.01 -179.92 1.21 Allowed Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.522 -178.774 . . . . . . . . 3 3 . 1 . 053 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.473 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 32.1 Cg_exo -57.48 146.94 81.25 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.631 2.221 . . . . 0.0 112.699 -179.595 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 18.2 m -139.67 142.81 31.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.48 -179.315 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.538 HH21 ' CE ' ' A' ' 83' ' ' LYS . 61.2 ttp180 -76.07 131.28 39.37 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.579 179.013 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.3 mt -80.61 135.5 36.07 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-O 121.148 0.499 . . . . 0.0 111.69 -179.413 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.538 ' CE ' HH21 ' A' ' 81' ' ' ARG . 99.0 mttt -129.07 150.57 50.41 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.868 178.937 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.481 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 6.3 t60 -55.3 115.72 2.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.831 0.348 . . . . 0.0 111.748 -179.172 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.24 -18.75 18.09 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.936 -0.65 . . . . 0.0 111.595 179.016 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -69.52 136.37 51.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.34 0.591 . . . . 0.0 110.608 179.913 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.8 t -114.5 131.24 67.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.04 -179.014 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 92.8 mt -97.23 132.26 42.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.645 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.8 m -118.55 124.92 48.71 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.338 -178.544 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.474 ' O ' ' N ' ' A' ' 92' ' ' ASP . 78.0 mt -112.38 126.96 69.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.134 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.743 HG22 ' NH2' ' B' ' 245' ' ' ARG . 33.8 mm 38.74 -97.09 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -178.749 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.546 ' CB ' HH22 ' B' ' 245' ' ' ARG . 44.2 t0 -123.09 17.45 10.0 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.097 0.475 . . . . 0.0 110.494 178.883 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.527 ' NH1' ' O ' ' B' ' 259' ' ' ASP . 29.7 mmm-85 -122.96 138.78 54.59 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.855 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.3 m -135.04 151.59 50.92 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.87 -179.248 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.578 ' HB3' HD11 ' A' ' 7' ' ' LEU . 88.6 m-85 -122.62 120.83 34.9 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.246 179.271 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.52 ' O ' HD12 ' A' ' 7' ' ' LEU . 38.9 ttp-105 -81.16 130.55 35.07 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.831 -179.671 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -97.69 125.55 42.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.035 -179.917 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -128.15 129.25 46.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.327 -179.956 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.481 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 60.5 t-20 -118.03 112.95 20.92 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.778 -179.411 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 121.062 0.458 . . . . 0.0 110.586 179.559 . . . . . . . . 0 0 . 1 . 053 nuclear build full ' B' B ' 228' ' ' VAL . . . . . 0.524 HG11 ' HB3' ' A' ' 42' ' ' PRO . 15.3 m . . . . . 0 N--CA 1.446 -0.66 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 . . . . . . . . . 1 1 . 1 . 053 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.54 ' C ' ' H ' ' B' ' 231' ' ' GLN . 50.7 t0 -80.95 124.05 28.82 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.607 -179.577 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' B' B ' 230' ' ' SEP . . . . . 0.412 ' N ' ' O1P' ' B' ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 053 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.54 ' H ' ' C ' ' B' ' 229' ' ' ASP . 3.9 pt20 -140.63 31.54 1.86 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.256 0.55 . . . . 0.0 110.048 178.888 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -110.42 -159.07 16.77 Favored Glycine 0 CA--C 1.531 1.078 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 179.986 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -58.1 152.63 50.64 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 C-N-CA 123.573 2.848 . . . . 0.0 113.089 179.593 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.453 HG21 ' OG1' ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 053 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.25 160.03 42.9 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.61 1.54 . . . . 0.0 111.846 -179.787 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.8 HG22 HG22 ' A' ' 66' ' ' THR . 15.7 t -98.84 128.38 50.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.206 -179.744 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 5.7 t -69.96 126.96 31.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.548 -179.848 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 053 nuclear build full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -58.45 -25.37 73.36 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.963 2.442 . . . . 0.0 113.115 -178.769 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 96.0 m -72.88 -45.66 57.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.288 0.566 . . . . 0.0 109.779 179.123 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.433 ' CE2' ' NE ' ' B' ' 245' ' ' ARG . 80.3 t80 -57.38 -44.42 84.42 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.968 -179.722 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.491 HD23 HH21 ' B' ' 245' ' ' ARG . 97.0 mt -63.51 -41.83 98.5 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.641 -179.796 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -66.31 -37.23 84.91 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.707 0.289 . . . . 0.0 111.108 -179.497 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 78.2 ttt-85 -63.1 -47.62 82.07 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.636 -179.429 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.743 ' NH2' HG22 ' A' ' 91' ' ' ILE . 55.9 mtm180 -65.53 -39.3 91.62 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.621 -179.585 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -59.79 -40.3 87.85 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.325 179.991 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 28.2 m -68.22 -42.83 79.19 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.5 0.667 . . . . 0.0 109.587 178.301 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -62.54 -36.26 82.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.862 179.731 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.671 HG23 ' O ' ' B' ' 245' ' ' ARG . 95.0 t -65.63 -43.49 93.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.961 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -55.19 -26.19 37.58 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.025 179.502 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -86.22 2.28 47.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.714 177.937 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.468 ' N ' ' O ' ' B' ' 249' ' ' VAL . 97.8 mt -113.21 -175.49 2.68 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.332 -179.585 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 38.7 p30 -134.1 169.86 16.52 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.789 179.733 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -68.59 -18.25 64.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.583 179.287 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -74.91 0.46 15.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.089 -178.998 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -77.0 86.01 3.52 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.386 179.564 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -66.6 -8.15 25.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.698 -178.503 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -127.0 104.61 8.09 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.184 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.527 ' O ' ' NH1' ' A' ' 93' ' ' ARG . 63.4 t0 -121.93 86.9 2.66 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.116 -0.634 . . . . 0.0 112.53 -178.746 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 51.08 2.63 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 177.992 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.475 ' CD1' HG23 ' A' ' 9' ' ' THR . 76.7 mt -112.18 134.6 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 119.101 0.864 . . . . 0.0 109.571 178.814 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 40.4 t -127.74 134.11 66.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.993 -179.74 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -94.33 115.14 27.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.662 -179.016 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -66.3 -46.92 75.31 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.628 179.78 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.09 155.16 43.19 Favored Pre-proline 0 N--CA 1.454 -0.267 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.708 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -63.0 141.77 85.24 Favored 'Trans proline' 0 C--N 1.302 -1.906 0 C-N-CA 122.86 2.373 . . . . 0.0 113.085 179.965 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 37.4 pt . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.607 178.355 . . . . . . . . 0 0 . 1 . 054 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo . . . . . 0 N--CA 1.494 1.504 0 CA-C-O 120.888 0.287 . . . . 0.0 112.133 . . . . . . . . . 0 0 . 1 . 054 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.489 ' O ' ' O ' ' A' ' 99' ' ' ASN . 23.8 m -140.73 -84.22 0.21 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.787 -179.526 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.522 ' CZ ' HG23 ' A' ' 53' ' ' ILE . 86.2 mtt85 -82.31 134.24 35.26 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.906 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -131.14 139.06 49.74 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 120.266 -0.573 . . . . 0.0 111.984 -179.075 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 34.2 mt -115.75 133.65 55.81 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.958 179.948 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.55 HG13 ' CE1' ' A' ' 19' ' ' HIS . 76.3 t -107.25 127.61 62.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.349 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 m -91.01 114.75 27.35 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 112.943 0.719 . . . . 0.0 112.943 -177.31 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.743 HD12 ' OG ' ' A' ' 94' ' ' SER . 92.6 mt -80.99 141.9 14.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.645 179.242 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -90.43 159.54 16.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.063 0.458 . . . . 0.0 110.748 179.157 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.516 HH22 ' HB2' ' B' ' 248' ' ' GLN . 81.3 mtp180 -58.77 -32.75 69.58 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.405 -179.426 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.7 p -74.45 -13.62 60.73 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.584 179.674 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.26 29.91 7.28 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -179.745 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.3 t -117.58 130.17 72.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.721 0.296 . . . . 0.0 111.205 -179.494 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -73.62 139.26 45.37 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 177.773 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.2 -112.8 1.43 Allowed Glycine 0 CA--C 1.53 0.978 0 C-N-CA 120.161 -1.018 . . . . 0.0 112.232 -179.088 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -73.45 144.8 36.91 Favored 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 122.138 1.892 . . . . 0.0 113.009 -178.524 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.55 ' CE1' HG13 ' A' ' 8' ' ' VAL . 3.9 m-70 -104.0 135.58 45.26 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.453 179.662 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.876 ' CD2' HD11 ' A' ' 37' ' ' ILE . 47.4 t80 -106.07 91.97 6.05 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.024 -179.274 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -72.95 139.27 29.83 Favored 'Trans proline' 0 N--CA 1.488 1.193 0 C-N-CA 121.634 1.556 . . . . 0.0 111.352 -179.33 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 86.2 mt -101.31 124.03 46.36 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.423 -178.592 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 65.3 p -117.37 -8.93 10.99 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.602 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 54.9 mt -101.73 149.78 23.81 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.587 -179.083 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 97.3 p -70.18 -12.14 61.39 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.27 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.434 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 41.9 m -132.35 133.98 44.64 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.257 -0.577 . . . . 0.0 111.89 -179.544 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 10.0 t -125.25 116.46 22.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.323 -0.853 . . . . 0.0 108.901 178.384 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.705 HD21 ' OE1' ' A' ' 47' ' ' GLN . 52.1 tp -116.88 132.8 56.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.997 -178.04 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.499 ' O ' ' O ' ' A' ' 47' ' ' GLN . 42.1 m-85 -110.16 136.67 49.02 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.366 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 164.48 -166.79 38.04 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 120.111 -1.042 . . . . 0.0 112.344 179.541 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.645 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 85.4 mtm-85 -89.27 -29.03 19.5 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 115.606 -0.297 . . . . 0.0 110.462 179.581 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.461 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -57.23 153.1 23.49 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 121.273 -0.489 . . . . 0.0 112.715 -177.73 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.525 ' CD1' ' NH1' ' A' ' 38' ' ' ARG . 9.4 tp -66.55 -41.87 89.12 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 N-CA-C 110.356 -0.238 . . . . 0.0 110.356 179.389 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.488 ' N ' HG23 ' A' ' 33' ' ' ILE . 50.9 tp10 -56.49 -27.07 56.16 Favored 'General case' 0 N--CA 1.461 0.124 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.647 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.461 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 19.3 m -54.54 122.75 11.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.693 179.701 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.462 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 55.5 m-20 -60.87 -33.35 72.95 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -179.566 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.876 HD11 ' CD2' ' A' ' 20' ' ' PHE . 44.0 mm -119.1 109.91 28.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 177.792 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.525 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 84.9 mtp180 -98.21 134.83 40.71 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -179.097 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 98.1 mt -120.42 132.34 70.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.028 -179.922 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -76.11 29.11 0.11 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.498 -0.773 . . . . 0.0 112.113 -178.495 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.57 HD12 ' CZ ' ' A' ' 93' ' ' ARG . 44.9 mt -106.12 130.07 23.56 Favored Pre-proline 0 CA--C 1.534 0.348 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.448 178.973 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.25 -12.65 25.49 Favored 'Trans proline' 0 N--CA 1.49 1.268 0 C-N-CA 122.448 2.099 . . . . 0.0 112.736 -179.455 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.479 HG21 ' CE2' ' B' ' 241' ' ' PHE . 30.7 m -92.57 -0.61 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.695 179.851 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.645 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 46.1 t -86.71 132.83 31.36 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.452 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.014 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.6 m -70.15 167.96 16.67 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.331 0.586 . . . . 0.0 111.22 -178.588 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt -62.64 -40.55 97.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.703 -178.872 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.705 ' OE1' HD21 ' A' ' 28' ' ' LEU . 95.4 mm-40 -115.38 -20.9 10.09 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.928 0.394 . . . . 0.0 110.483 -179.568 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.3 t60 34.05 -74.52 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -179.947 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.652 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.99 136.92 46.33 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -177.97 . . . . . . . . 3 3 . 1 . 054 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -128.23 132.2 48.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.861 179.558 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.9 mt -116.59 134.09 61.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.69 179.901 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -111.21 129.01 56.09 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.957 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.522 HG23 ' CZ ' ' A' ' 5' ' ' ARG . 47.9 mm -100.16 118.6 47.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.304 0.573 . . . . 0.0 111.253 -179.138 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.452 ' O ' ' C ' ' A' ' 55' ' ' GLU . 98.0 m-70 -119.86 130.79 55.04 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.915 179.296 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' A' ' 54' ' ' HIS . 81.8 tt0 -40.83 -31.35 0.16 Allowed 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -179.866 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.458 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 98.4 mm-40 -64.82 -67.76 0.41 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.94 178.649 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.459 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 5.5 tp10 -153.49 -170.51 3.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.0 -179.481 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.459 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -118.43 128.41 54.59 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.513 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.0 mt -114.51 130.67 68.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.134 0.492 . . . . 0.0 112.23 -178.732 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.525 ' HB2' HD11 ' A' ' 82' ' ' LEU . 26.7 tp -99.56 128.88 45.68 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.471 179.996 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -112.7 136.7 51.98 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.742 179.649 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.539 HD21 ' CA ' ' A' ' 68' ' ' PRO . 59.5 t-20 -95.96 110.32 22.55 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.403 -178.763 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -103.94 -7.92 20.03 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 179.84 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.559 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 97.9 p -81.37 98.48 8.21 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.18 -179.419 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.3 m -74.64 -38.86 62.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.449 0.642 . . . . 0.0 109.482 178.427 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p -65.46 -39.21 91.74 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.342 -179.629 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.559 ' O ' ' OG ' ' A' ' 64' ' ' SER . 54.2 m-80 -146.18 92.79 5.2 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.424 -179.53 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.539 ' CA ' HD21 ' A' ' 62' ' ' ASN . 46.8 Cg_exo -54.22 145.98 52.14 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.541 2.16 . . . . 0.0 111.873 -179.072 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.442 ' HB ' HD11 ' A' ' 76' ' ' ILE . 17.7 m -70.87 150.6 45.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.956 179.665 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -117.23 140.16 49.88 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.777 -179.768 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 48.9 t -130.92 134.86 61.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.353 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 29.9 m120 51.79 32.32 9.44 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -179.37 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.27 27.06 68.86 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.957 179.688 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.9 t -140.15 138.05 34.9 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 117.359 0.579 . . . . 0.0 111.599 179.864 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.479 HG13 ' HB2' ' A' ' 68' ' ' PRO . 10.9 t -68.67 140.68 18.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.685 179.958 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.442 HD11 ' HB ' ' A' ' 69' ' ' THR . 7.0 pt -112.08 84.33 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.949 179.403 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -61.91 -32.17 72.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.449 179.532 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -118.46 168.21 10.01 Favored Pre-proline 0 CA--C 1.531 0.249 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.534 179.587 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.71 145.09 99.09 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 122.205 1.936 . . . . 0.0 112.52 179.965 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.2 p -138.9 140.0 39.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.986 179.652 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.6 mtm-85 -73.25 131.46 41.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.846 179.243 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.525 HD11 ' HB2' ' A' ' 60' ' ' LEU . 95.8 mt -84.95 137.57 33.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.114 0.483 . . . . 0.0 111.58 -179.136 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -126.95 151.06 49.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.563 179.028 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -56.94 123.28 14.56 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.849 -179.736 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.26 -21.76 28.29 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 179.592 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -69.24 138.47 53.99 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.023 0.44 . . . . 0.0 110.513 179.784 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.2 t -111.75 131.1 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.85 -177.928 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.7 mt -93.01 134.32 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.117 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 94.5 m -126.55 126.5 43.78 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 119.933 -0.707 . . . . 0.0 112.492 -179.026 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.577 ' O ' ' N ' ' A' ' 92' ' ' ASP . 89.6 mt -110.48 125.66 67.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.085 -0.961 . . . . 0.0 108.695 178.367 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.518 HD12 HH22 ' A' ' 93' ' ' ARG . 89.2 mt 38.85 -91.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.113 -179.087 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.577 ' N ' ' O ' ' A' ' 90' ' ' ILE . 42.7 t0 -126.8 21.17 7.0 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.385 179.82 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.632 ' NH1' HH12 ' B' ' 245' ' ' ARG . 50.4 mtm-85 -129.01 143.39 50.85 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.321 -179.607 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.743 ' OG ' HD12 ' A' ' 10' ' ' ILE . 28.9 p -139.61 153.87 47.45 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 119.796 -0.762 . . . . 0.0 111.729 179.634 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -123.38 121.6 36.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.623 178.439 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -74.24 126.57 30.91 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.373 -179.534 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.49 ' CE2' ' OD1' ' A' ' 99' ' ' ASN . 92.0 t80 -94.51 121.42 36.04 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.929 0.395 . . . . 0.0 110.719 -179.972 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -131.63 116.57 17.54 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.725 -179.959 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.49 ' OD1' ' CE2' ' A' ' 97' ' ' TYR . 91.5 m-20 -65.17 -42.44 93.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.974 0.416 . . . . 0.0 111.044 179.905 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.168 179.822 . . . . . . . . 0 0 . 1 . 054 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 56.0 t . . . . . 0 N--CA 1.454 -0.232 0 CA-C-O 120.75 0.31 . . . . 0.0 110.84 . . . . . . . . . 0 0 . 1 . 054 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.496 ' O ' ' OD1' ' B' ' 229' ' ' ASP . 66.6 t0 -170.22 -26.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.945 179.621 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' B' B ' 230' ' ' SEP . . . . . 0.552 ' O ' ' NE2' ' B' ' 231' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 054 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.552 ' NE2' ' O ' ' B' ' 230' ' ' SEP . 1.0 OUTLIER 160.57 40.76 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.201 -179.485 . . . . . . . . 3 3 . 1 . 054 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -121.95 -168.99 13.45 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 -179.611 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.35 157.15 57.48 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.822 2.348 . . . . 0.0 112.637 -179.852 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 054 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -61.06 144.79 99.48 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.207 1.938 . . . . 0.0 112.814 179.709 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.541 HG13 ' O ' ' B' ' 236' ' ' VAL . 13.1 p -79.5 125.29 38.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.716 179.26 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.9 t -57.37 120.67 8.6 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.502 -0.479 . . . . 0.0 109.845 -179.795 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 054 nuclear build full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.95 -19.55 48.5 Favored 'Trans proline' 0 N--CA 1.491 1.371 0 C-N-CA 122.209 1.939 . . . . 0.0 111.284 179.37 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 79.8 m -74.79 -43.85 52.59 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 177.764 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.479 ' CE2' HG21 ' A' ' 43' ' ' VAL . 88.3 t80 -57.52 -46.54 83.69 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.994 -179.584 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 92.5 mt -64.0 -41.62 97.42 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.259 -179.938 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.8 -39.5 87.77 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.99 -179.901 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' B' B ' 244' ' ' ARG . . . . . 0.499 ' O ' ' OG ' ' B' ' 247' ' ' SER . 62.8 ttp180 -60.51 -43.97 96.5 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.943 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.632 HH12 ' NH1' ' A' ' 93' ' ' ARG . 79.3 mtp180 -61.77 -40.1 93.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.553 -179.508 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.21 -38.22 85.81 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 120.504 -0.478 . . . . 0.0 109.853 179.127 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' B' B ' 247' ' ' SER . . . . . 0.499 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 80.2 p -68.62 -42.57 77.9 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 178.389 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' B' B ' 248' ' ' GLN . . . . . 0.516 ' HB2' HH22 ' A' ' 12' ' ' ARG . 82.5 mt-30 -61.89 -35.59 78.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.536 179.568 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 22.5 t -60.64 -46.87 95.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.941 0.401 . . . . 0.0 110.159 179.221 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -62.93 -28.72 70.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.002 179.311 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -85.92 -15.9 40.21 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.896 179.902 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 83.5 mt -101.18 179.86 4.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.488 179.838 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -141.25 175.48 9.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.626 179.693 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -64.7 -10.14 25.02 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.925 -179.188 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -65.7 -16.42 63.74 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.844 0.354 . . . . 0.0 110.36 179.73 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.491 ' O ' ' OD1' ' B' ' 256' ' ' ASP . 48.6 p30 -72.06 51.0 0.22 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.457 179.501 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -56.62 -10.09 0.91 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.69 -178.761 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.66 ' O ' ' N ' ' B' ' 260' ' ' GLU . 96.1 m-20 -94.14 -2.24 52.99 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.947 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.476 ' C ' ' O ' ' B' ' 258' ' ' ASP . 36.2 p30 10.54 48.48 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 114.333 -1.303 . . . . 0.0 113.006 179.136 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.66 ' N ' ' O ' ' B' ' 258' ' ' ASP . 99.5 mt-10 59.44 -0.39 0.18 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 179.092 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.464 ' N ' ' O ' ' B' ' 258' ' ' ASP . 60.0 mt -110.42 137.19 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 120.516 -0.474 . . . . 0.0 109.867 179.722 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 44.7 t -126.89 134.63 65.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.731 179.465 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -94.14 117.25 29.84 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.462 -178.85 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -67.93 -47.99 67.17 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.15 -179.985 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -82.62 157.99 66.36 Favored Pre-proline 0 CA--C 1.516 -0.354 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.681 -179.123 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.82 138.54 49.01 Favored 'Trans proline' 0 C--N 1.301 -1.933 0 C-N-CA 122.5 2.133 . . . . 0.0 112.641 179.586 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 1.4 pt . . . . . 0 C--N 1.325 -0.491 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.259 178.522 . . . . . . . . 0 0 . 1 . 055 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 N--CA 1.489 1.229 0 CA-C-O 120.697 0.207 . . . . 0.0 111.789 . . . . . . . . . 0 0 . 1 . 055 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 78.9 p -137.92 -37.84 0.58 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.933 0.397 . . . . 0.0 110.73 -179.855 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.787 ' NH1' ' HB2' ' A' ' 58' ' ' ALA . 96.0 mtt-85 -96.24 117.77 31.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.594 -179.53 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.596 ' HE ' ' CE1' ' A' ' 19' ' ' HIS . 85.6 mtp180 -131.37 139.02 49.4 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.054 0.454 . . . . 0.0 111.601 179.877 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.628 HD12 ' O ' ' A' ' 96' ' ' ARG . 37.1 tp -114.26 128.88 56.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.486 179.519 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 64.4 t -108.68 131.6 58.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.694 -0.403 . . . . 0.0 110.026 -179.684 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.403 HG21 HD12 ' B' ' 261' ' ' ILE . 18.3 m -82.56 152.23 26.06 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.601 0.715 . . . . 0.0 112.181 -178.714 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.413 HD12 ' HB3' ' A' ' 94' ' ' SER . 96.5 mt -120.08 140.2 44.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.101 177.46 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 73.0 mttt -89.05 157.12 18.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.17 0.509 . . . . 0.0 110.501 179.551 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.562 ' NH2' ' O ' ' B' ' 245' ' ' ARG . 79.3 mtp180 -56.35 -31.03 63.39 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.665 -179.758 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.3 m -77.83 -9.33 58.99 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.764 -0.375 . . . . 0.0 110.339 179.589 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.83 38.98 5.35 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 179.878 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.4 t -124.09 133.42 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 120.92 0.39 . . . . 0.0 111.64 -179.692 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -76.71 138.66 40.12 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.078 178.939 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -134.47 -116.43 1.65 Allowed Glycine 0 CA--C 1.538 1.508 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.965 -179.521 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.95 152.09 45.95 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 122.499 2.133 . . . . 0.0 113.096 -179.163 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.596 ' CE1' ' HE ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -116.14 158.77 22.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.935 0.397 . . . . 0.0 110.48 179.904 . . . . . . . . 3 3 . 1 . 055 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.663 ' CD2' HD11 ' A' ' 37' ' ' ILE . 36.9 t80 -124.15 108.38 29.9 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.589 -179.382 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -75.58 127.95 10.67 Favored 'Trans proline' 0 N--CA 1.488 1.201 0 C-N-CA 121.605 1.537 . . . . 0.0 111.361 -179.196 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 61.6 mt -82.86 49.41 1.5 Allowed 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.137 -178.808 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.6 t -63.1 -32.5 73.9 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 178.75 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 68.5 mt -70.77 142.25 51.4 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.831 179.711 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.5 m -63.87 -22.96 67.16 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.507 -179.289 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.3 m -133.27 133.93 43.27 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.953 -179.761 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.676 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 3.0 t -127.14 114.87 18.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.81 179.664 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.588 HD21 ' OE1' ' A' ' 47' ' ' GLN . 54.2 tp -111.55 125.69 54.19 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.228 -178.741 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.676 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 18.4 m-85 -100.69 128.51 46.71 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 177.93 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 179.26 -155.86 17.01 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 120.027 -1.082 . . . . 0.0 112.309 -179.588 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.599 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 81.8 mtm-85 -109.98 -25.23 10.37 Favored 'General case' 0 N--CA 1.46 0.067 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.074 179.902 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.48 161.29 21.92 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.194 -0.763 . . . . 0.0 111.194 -179.13 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.508 HD12 ' NH1' ' A' ' 38' ' ' ARG . 10.9 tp -67.38 -39.44 82.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.949 0.404 . . . . 0.0 110.418 179.959 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.427 ' N ' HG23 ' A' ' 33' ' ' ILE . 97.7 mt-10 -57.48 -31.58 66.11 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.109 -179.981 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.3 m -50.81 120.64 4.97 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.022 179.803 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -60.71 -33.4 72.83 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.406 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.663 HD11 ' CD2' ' A' ' 20' ' ' PHE . 96.4 mt -124.94 116.92 48.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.395 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.508 ' NH1' HD12 ' A' ' 33' ' ' ILE . 83.9 mtp180 -103.31 137.26 41.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.507 -177.927 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.644 HG21 HD12 ' A' ' 41' ' ' LEU . 92.7 mt -120.22 131.34 72.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.534 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -73.83 25.98 0.07 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.651 -178.234 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.644 HD12 HG21 ' A' ' 39' ' ' ILE . 15.1 mt -101.68 122.95 45.84 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.647 179.947 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.9 -8.68 21.57 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 122.295 1.997 . . . . 0.0 112.144 -179.753 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.2 m -92.91 0.74 9.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.656 179.325 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.599 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 93.7 t -98.27 103.47 14.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.858 179.449 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.538 ' O ' ' O ' ' A' ' 44' ' ' VAL . 1.4 t -34.11 162.11 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.451 0.643 . . . . 0.0 112.022 -178.846 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -60.69 -41.85 95.97 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.019 -0.992 . . . . 0.0 112.175 -178.371 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.588 ' OE1' HD21 ' A' ' 28' ' ' LEU . 90.8 mm-40 -107.67 -18.04 13.94 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.556 0.693 . . . . 0.0 109.902 179.589 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.0 t60 37.22 -78.16 0.0 OUTLIER 'General case' 0 C--O 1.239 0.53 0 CA-C-N 114.541 -1.209 . . . . 0.0 113.738 179.901 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.584 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -134.54 139.23 45.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.115 0.483 . . . . 0.0 112.072 -178.455 . . . . . . . . 3 3 . 1 . 055 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -129.15 125.26 36.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.555 179.594 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.5 mt -109.32 133.79 53.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.102 179.863 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.458 ' CD ' ' NE2' ' A' ' 54' ' ' HIS . 74.5 tt0 -113.17 126.37 55.37 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.324 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.8 mm -98.63 118.61 45.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.325 0.583 . . . . 0.0 112.141 -178.201 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.492 ' O ' ' N ' ' A' ' 56' ' ' GLN . 96.5 m-70 -119.46 132.22 55.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.375 178.411 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.469 ' C ' ' O ' ' A' ' 54' ' ' HIS . 76.0 tt0 -40.72 -28.37 0.07 Allowed 'General case' 0 CA--C 1.518 -0.25 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.719 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.492 ' N ' ' O ' ' A' ' 54' ' ' HIS . 86.0 mt-30 -66.41 -68.47 0.37 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.329 178.387 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.491 ' CB ' ' HE ' ' A' ' 81' ' ' ARG . 1.4 pt-20 -156.12 -168.81 2.86 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.843 -179.307 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.787 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -114.52 128.66 56.45 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.039 179.474 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.2 mt -116.85 127.94 74.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.2 0.524 . . . . 0.0 111.157 -179.748 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.2 tp -95.92 129.18 43.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.507 -179.69 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -115.68 136.32 53.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.984 179.636 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.592 HD22 ' HA ' ' A' ' 68' ' ' PRO . 52.6 t30 -99.4 110.53 23.01 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.121 179.935 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -99.59 -8.38 24.56 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 120.856 0.36 . . . . 0.0 110.55 179.365 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.0 t -76.17 99.05 4.57 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.063 179.964 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 45.9 t -75.09 -44.59 46.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.663 0.744 . . . . 0.0 109.527 178.463 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.683 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -62.83 -43.36 98.99 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.495 -1.23 . . . . 0.0 111.021 -179.17 . . . . . . . . 3 3 . 1 . 055 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -143.39 97.07 5.65 Favored Pre-proline 0 N--CA 1.468 0.436 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.216 -179.792 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.592 ' HA ' HD22 ' A' ' 62' ' ' ASN . 31.5 Cg_exo -57.84 146.3 86.75 Favored 'Trans proline' 0 N--CA 1.499 1.844 0 C-N-CA 122.294 1.996 . . . . 0.0 112.963 179.553 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.436 ' CG2' HG23 ' A' ' 88' ' ' ILE . 29.1 m -69.34 137.05 52.58 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.068 178.927 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -98.69 140.16 33.32 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.548 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.622 ' HB ' HD11 ' A' ' 76' ' ' ILE . 25.2 t -132.96 137.12 54.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.359 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 54.61 33.59 19.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.136 0.494 . . . . 0.0 109.914 -179.34 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.73 30.24 66.42 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.952 179.473 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.2 m -145.16 140.35 27.9 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 117.464 0.632 . . . . 0.0 112.193 -179.505 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.414 HG13 ' HB2' ' A' ' 68' ' ' PRO . 25.2 t -70.44 136.23 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.677 179.944 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.622 HD11 ' HB ' ' A' ' 71' ' ' VAL . 88.6 mt -107.81 117.69 53.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.495 179.943 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -89.16 -29.13 19.55 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.68 178.928 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.562 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.0 OUTLIER -126.03 166.61 20.49 Favored Pre-proline 0 N--CA 1.467 0.401 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.122 -178.947 . . . . . . . . 3 3 . 1 . 055 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.07 148.96 91.36 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 122.469 2.112 . . . . 0.0 112.354 -179.946 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.2 m -141.41 151.55 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 121.354 0.597 . . . . 0.0 112.605 -179.559 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.491 ' HE ' ' CB ' ' A' ' 57' ' ' GLU . 74.6 ttt180 -78.13 128.31 33.6 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.543 179.066 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.482 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 96.9 mt -81.64 134.03 35.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.119 0.485 . . . . 0.0 111.229 -179.625 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -128.39 152.12 48.56 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.117 179.265 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -53.8 117.76 3.42 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.489 -179.535 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.62 -3.41 27.71 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -179.248 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.499 ' OD1' HG13 ' A' ' 71' ' ' VAL . 45.7 t0 -80.34 121.29 25.49 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.083 -0.339 . . . . 0.0 110.083 179.628 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.497 HG22 ' HG2' ' A' ' 96' ' ' ARG . 74.5 t -108.43 132.68 55.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.042 -178.249 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.436 HG23 ' CG2' ' A' ' 69' ' ' THR . 84.8 mt -99.11 131.98 45.35 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.682 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.3 m -115.93 125.04 52.05 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.345 0.593 . . . . 0.0 111.061 -179.179 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.468 ' O ' ' C ' ' A' ' 91' ' ' ILE . 92.0 mt -118.85 123.31 71.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.898 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.609 HD12 ' CB ' ' B' ' 237' ' ' CYS . 46.7 mm 35.13 -104.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.972 -179.727 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.505 ' N ' HG22 ' A' ' 91' ' ' ILE . 37.1 p-10 -105.91 11.11 32.13 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -179.555 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.558 HH21 ' CG ' ' B' ' 260' ' ' GLU . 86.0 mtt-85 -127.58 147.31 50.34 Favored 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.193 -179.426 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.413 ' HB3' HD12 ' A' ' 10' ' ' ILE . 29.0 t -137.18 153.22 50.5 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.079 0.466 . . . . 0.0 110.331 179.271 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.602 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 93.6 m-85 -126.64 129.14 47.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.426 179.76 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.628 ' O ' HD12 ' A' ' 7' ' ' LEU . 99.9 mtt180 -94.15 135.07 35.92 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.26 -179.003 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.561 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 83.8 t80 -99.91 124.2 44.97 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.357 179.912 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -124.89 127.53 47.25 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.728 179.508 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.478 ' O ' ' O ' ' A' ' 100' ' ' GLU . 63.5 t-20 -106.86 103.51 12.95 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.171 179.436 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.478 ' O ' ' O ' ' A' ' 99' ' ' ASN . 82.3 tt0 . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.157 -179.521 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' B' B ' 228' ' ' VAL . . . . . 0.453 HG21 ' HE ' ' A' ' 31' ' ' ARG . 30.5 m . . . . . 0 N--CA 1.452 -0.366 0 CA-C-O 120.877 0.37 . . . . 0.0 110.78 . . . . . . . . . 1 1 . 1 . 055 nuclear build full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -87.87 3.31 48.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.524 -179.509 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' B' B ' 230' ' ' SEP . . . . . 0.531 ' O ' ' NE2' ' B' ' 231' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 055 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.531 ' NE2' ' O ' ' B' ' 230' ' ' SEP . 0.7 OUTLIER 159.17 27.99 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.376 -179.925 . . . . . . . . 3 3 . 1 . 055 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -119.24 -155.79 9.89 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.956 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.45 160.45 41.7 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 122.699 2.266 . . . . 0.0 113.083 -179.459 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 055 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -70.83 168.95 21.48 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 121.736 1.624 . . . . 0.0 111.936 179.453 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.683 ' CG2' HG22 ' A' ' 66' ' ' THR . 37.0 t -114.08 133.4 60.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.751 179.952 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' B' B ' 237' ' ' CYS . . . . . 0.609 ' CB ' HD12 ' A' ' 91' ' ' ILE . 2.6 t -73.25 124.17 25.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.668 179.43 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' B' B ' 238' ' ' TPO . . . . . 0.456 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 055 nuclear build full ' B' B ' 239' ' ' PRO . . . . . 0.456 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 31.6 Cg_exo -59.64 -24.76 76.62 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.511 2.141 . . . . 0.0 112.571 -179.663 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 99.2 m -73.21 -46.02 52.81 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.375 0.607 . . . . 0.0 109.709 178.067 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -57.65 -45.36 85.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.485 -179.433 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 95.8 mt -64.17 -41.4 97.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.548 -179.25 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -63.19 -41.5 99.2 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.225 -179.951 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -62.49 -43.44 98.82 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.976 0.417 . . . . 0.0 110.055 179.533 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.562 ' O ' ' NH2' ' A' ' 12' ' ' ARG . 24.4 mmt180 -61.26 -43.02 99.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.64 -179.473 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.66 -38.99 92.49 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.803 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 11.1 t -64.72 -46.22 83.2 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 177.696 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' B' B ' 248' ' ' GLN . . . . . 0.556 ' O ' ' N ' ' B' ' 252' ' ' LEU . 83.6 mt-30 -60.39 -37.74 81.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.123 179.709 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.508 HG23 ' O ' ' B' ' 245' ' ' ARG . 61.9 t -60.92 -45.65 97.91 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 C-N-CA 120.217 -0.593 . . . . 0.0 109.744 179.898 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -60.17 -27.31 67.01 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.908 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -95.1 -14.36 24.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.894 179.671 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.556 ' N ' ' O ' ' B' ' 248' ' ' GLN . 61.1 tp -72.17 138.8 47.88 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.983 0.42 . . . . 0.0 110.901 -179.807 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -94.07 128.79 40.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.704 179.995 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' B' B ' 254' ' ' ASP . . . . . 0.435 ' C ' ' H ' ' B' ' 256' ' ' ASP . 99.7 m-20 -66.25 -29.32 69.54 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.216 -179.891 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 31.2 p-10 -63.29 2.56 0.37 Allowed 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.973 -179.216 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.601 ' O ' ' N ' ' B' ' 258' ' ' ASP . 92.0 m-20 -87.31 -22.55 25.06 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.124 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 14.1 tttm 41.33 13.01 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.205 179.812 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.601 ' N ' ' O ' ' B' ' 256' ' ' ASP . 96.3 m-20 -131.4 103.41 6.42 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.096 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.557 ' CG ' ' H ' ' B' ' 260' ' ' GLU . 30.5 p-10 -71.14 -102.14 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.847 -178.458 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.558 ' CG ' HH21 ' A' ' 93' ' ' ARG . 97.6 mt-10 -148.49 18.37 1.05 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.771 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.602 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 60.3 mt -111.11 138.07 40.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.867 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 48.6 t -128.55 136.08 60.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.682 0.277 . . . . 0.0 110.296 179.502 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -99.2 122.03 41.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.276 0.56 . . . . 0.0 111.791 -178.465 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -65.71 -44.3 86.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.021 179.233 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -103.77 162.14 20.86 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.737 -178.831 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -60.75 152.79 67.02 Favored 'Trans proline' 0 N--CA 1.499 1.836 0 C-N-CA 123.17 2.58 . . . . 0.0 112.702 179.376 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 40.1 pt . . . . . 0 C--N 1.327 -0.39 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.55 -179.844 . . . . . . . . 0 0 . 1 . 056 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo . . . . . 0 N--CA 1.487 1.088 0 N-CA-C 111.125 -0.375 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 056 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 52.9 p -78.44 -31.94 48.28 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.016 -179.265 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.5 mtt85 -100.43 122.06 42.56 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.972 -178.919 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -132.14 142.08 49.35 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.173 179.909 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.498 HD12 ' O ' ' A' ' 96' ' ' ARG . 40.0 tp -114.68 125.25 53.52 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.493 179.494 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.4 HG12 ' CD2' ' A' ' 19' ' ' HIS . 32.0 m -104.85 132.82 50.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.701 -179.413 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.446 ' HG1' ' HE2' ' A' ' 95' ' ' PHE . 3.1 m -79.68 142.83 35.16 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.386 -179.119 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.622 HD12 ' OG ' ' A' ' 94' ' ' SER . 86.0 mt -111.49 135.94 49.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 177.492 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -89.2 157.73 18.15 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.627 179.291 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.923 HH21 HD22 ' B' ' 252' ' ' LEU . 87.8 mtm180 -57.2 -26.57 60.88 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.151 -179.191 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 44.9 m -80.48 -12.53 59.54 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 179.541 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.23 35.89 5.87 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.955 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.6 t -124.21 133.56 68.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 120.803 0.335 . . . . 0.0 110.793 -179.101 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -72.26 130.33 40.54 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.546 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -119.98 -122.68 3.03 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.282 -178.826 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.58 145.17 51.65 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 121.357 1.372 . . . . 0.0 112.402 -179.458 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.4 ' CD2' HG12 ' A' ' 8' ' ' VAL . 61.6 m170 -103.72 140.34 37.73 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.642 -179.975 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.473 ' CD2' HD11 ' A' ' 37' ' ' ILE . 59.3 t80 -114.39 96.19 42.16 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.073 -179.466 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -59.28 125.88 19.27 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.93 1.754 . . . . 0.0 112.497 -179.01 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 89.0 mt -85.62 44.91 1.14 Allowed 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.533 -179.893 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 66.3 p -60.17 -30.69 69.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.979 0.419 . . . . 0.0 109.943 179.57 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 68.5 mt -72.54 144.98 47.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.22 178.987 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.09 -20.64 65.83 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.568 -178.343 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.499 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 23.0 m -133.05 136.95 46.25 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.655 -179.321 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.595 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 3.7 t -129.43 118.36 22.03 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.794 178.052 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.544 HD12 ' O ' ' A' ' 49' ' ' CYS . 49.5 tp -114.55 130.61 56.78 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.173 -178.859 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.711 ' CE2' HD12 ' A' ' 37' ' ' ILE . 9.1 m-85 -109.21 138.28 45.81 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.195 -0.911 . . . . 0.0 108.91 179.174 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.42 -166.72 36.67 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.145 179.105 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.574 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 81.7 mtm-85 -89.81 -29.62 18.52 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 179.8 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.562 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -52.96 148.77 12.28 Favored Glycine 0 CA--C 1.521 0.458 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.314 -179.413 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.522 HG23 ' N ' ' A' ' 34' ' ' GLU . 11.1 tp -66.01 -39.83 85.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.874 0.369 . . . . 0.0 110.191 -179.98 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.522 ' N ' HG23 ' A' ' 33' ' ' ILE . 78.3 mm-40 -58.78 -21.99 57.13 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.217 -178.373 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.562 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 14.3 m -56.86 121.05 8.96 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.829 -179.804 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.499 ' OD2' ' O ' ' A' ' 26' ' ' THR . 95.3 m-20 -57.93 -26.06 61.72 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.17 179.807 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.711 HD12 ' CE2' ' A' ' 29' ' ' PHE . 86.3 mt -130.06 122.08 53.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 176.848 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.466 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 83.9 mtp180 -105.6 135.15 47.54 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.358 -178.737 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.9 mt -119.97 129.56 75.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.945 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -75.74 24.65 0.12 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -177.771 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.563 ' CD2' ' NH2' ' B' ' 245' ' ' ARG . 34.0 mt -92.49 125.55 55.58 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 119.841 -0.744 . . . . 0.0 110.848 179.667 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -72.62 -8.93 23.31 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.048 1.832 . . . . 0.0 112.558 -179.151 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.6 m -101.55 5.13 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.393 -179.648 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.574 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 40.7 t -99.09 106.65 19.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.152 -179.843 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.551 ' O ' ' O ' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -31.96 162.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.554 -178.762 . . . . . . . . 3 3 . 1 . 056 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -59.22 -47.39 85.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.3 -178.933 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.63 ' O ' ' N ' ' A' ' 49' ' ' CYS . 98.4 mt-30 -107.25 -12.44 15.36 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.491 0.662 . . . . 0.0 110.071 179.592 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.464 ' H ' ' HB3' ' A' ' 45' ' ' SER . 20.0 t60 37.99 -75.51 0.0 OUTLIER 'General case' 0 C--O 1.239 0.539 0 CA-C-N 114.812 -1.085 . . . . 0.0 113.765 179.744 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.63 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -139.1 140.72 38.06 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.584 -178.664 . . . . . . . . 3 3 . 1 . 056 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -128.04 127.61 43.47 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.893 179.51 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 91.4 mt -110.16 135.02 50.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.319 -179.951 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -117.97 128.42 54.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.513 178.149 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 94.2 mt -111.95 117.73 55.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.498 0.666 . . . . 0.0 111.603 -179.225 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.588 ' O ' ' N ' ' A' ' 56' ' ' GLN . 89.3 m-70 -117.59 144.86 44.73 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.94 179.63 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 54' ' ' HIS . 80.0 mm-40 -38.94 -23.91 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.215 -0.594 . . . . 0.0 109.928 -179.825 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.588 ' N ' ' O ' ' A' ' 54' ' ' HIS . 56.3 tt0 -67.76 -68.78 0.36 Allowed 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.267 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -161.66 -158.27 0.54 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.034 179.337 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.504 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -112.81 131.43 55.7 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.059 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 80.0 mt -120.78 131.03 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 121.061 0.457 . . . . 0.0 112.231 -179.354 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.719 HD22 HD12 ' A' ' 88' ' ' ILE . 28.8 tp -102.29 131.43 48.88 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.635 -179.376 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -112.81 133.44 54.8 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.593 179.132 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.631 HD21 ' CB ' ' A' ' 68' ' ' PRO . 57.4 t-20 -95.0 107.84 19.89 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -178.675 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -98.75 -11.58 21.75 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.401 179.693 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.9 t -84.1 100.26 11.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.236 179.593 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.6 p -83.55 -40.7 18.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.528 0.68 . . . . 0.0 109.393 179.298 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.67 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -60.64 -43.15 97.89 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.012 -0.994 . . . . 0.0 109.986 -179.984 . . . . . . . . 3 3 . 1 . 056 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -141.41 97.32 6.8 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.088 178.695 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.631 ' CB ' HD21 ' A' ' 62' ' ' ASN . 52.9 Cg_endo -66.4 152.73 80.28 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 121.932 1.754 . . . . 0.0 113.165 -178.19 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.843 ' O ' HG22 ' A' ' 76' ' ' ILE . 18.5 m -73.98 153.99 39.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.572 -179.25 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.47 ' O ' ' N ' ' A' ' 89' ' ' THR . 74.0 mt-30 -113.82 140.09 48.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.527 178.947 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.4 t -128.63 135.42 62.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.344 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.428 ' H ' HG13 ' A' ' 87' ' ' VAL . 84.9 m-20 52.07 32.94 11.11 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -178.96 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.02 28.23 68.91 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.783 179.707 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 69.9 m -140.6 140.53 35.11 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.997 179.884 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 52.1 t -65.23 136.87 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.589 179.827 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.843 HG22 ' O ' ' A' ' 69' ' ' THR . 7.5 tt -104.57 89.64 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.779 178.793 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -63.88 -35.19 79.83 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.722 -179.483 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.47 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 1.7 mt-10 -128.02 168.46 15.33 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.803 -179.475 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.84 143.75 80.07 Favored 'Trans proline' 0 N--CA 1.501 1.967 0 C-N-CA 122.282 1.988 . . . . 0.0 112.815 -178.747 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.48 HG12 HD12 ' A' ' 76' ' ' ILE . 4.7 p -139.87 142.95 31.18 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 121.329 0.585 . . . . 0.0 111.782 179.571 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -75.17 133.65 41.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.701 179.782 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.522 HD11 ' HB2' ' A' ' 60' ' ' LEU . 56.9 mt -92.5 134.33 35.07 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.801 -179.098 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.518 ' O ' ' OD2' ' A' ' 86' ' ' ASP . 99.8 mttt -120.14 153.07 36.72 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.904 -179.825 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.489 ' HD1' ' C ' ' A' ' 99' ' ' ASN . 9.3 t60 -51.1 119.13 3.71 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.243 -179.317 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.89 -14.61 34.38 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -179.614 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.518 ' OD2' ' O ' ' A' ' 83' ' ' LYS . 2.1 p30 -69.28 131.1 44.33 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.15 179.422 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.428 HG13 ' H ' ' A' ' 72' ' ' ASN . 13.5 p -105.31 140.55 22.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.56 -179.198 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.719 HD12 HD22 ' A' ' 60' ' ' LEU . 38.6 mm -102.99 128.94 55.45 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 177.851 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.47 ' N ' ' O ' ' A' ' 70' ' ' GLN . 41.1 m -121.91 130.21 53.16 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -177.654 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.532 ' O ' ' N ' ' A' ' 93' ' ' ARG . 97.5 mt -115.9 129.74 71.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 113.881 -1.509 . . . . 0.0 107.398 177.442 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.688 HG21 ' SG ' ' B' ' 237' ' ' CYS . 23.5 mt -31.74 107.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.022 0.439 . . . . 0.0 111.118 -178.37 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.513 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 2.2 t70 88.89 -25.66 0.08 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 178.691 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 90' ' ' ILE . 55.6 mtt85 -130.09 139.85 50.89 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 121.329 -0.149 . . . . 0.0 110.618 -178.658 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.622 ' OG ' HD12 ' A' ' 10' ' ' ILE . 34.0 p -142.51 158.56 43.55 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.222 0.534 . . . . 0.0 110.474 -179.997 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.463 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 59.1 m-85 -132.06 133.65 44.61 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.79 179.414 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.507 ' HG3' HD11 ' A' ' 10' ' ' ILE . 78.3 mtp85 -95.75 136.89 35.57 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 119.767 -0.773 . . . . 0.0 109.988 179.0 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -95.46 125.7 40.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.227 -179.116 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -122.09 122.19 38.69 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.265 179.062 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.489 ' C ' ' HD1' ' A' ' 84' ' ' HIS . 49.4 t-20 -122.94 106.32 10.75 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.708 -179.976 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 121.059 0.457 . . . . 0.0 110.328 179.76 . . . . . . . . 0 0 . 1 . 056 nuclear build full ' B' B ' 228' ' ' VAL . . . . . 0.449 HG12 ' N ' ' B' ' 229' ' ' ASP . 6.2 t . . . . . 0 N--CA 1.451 -0.416 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 . . . . . . . . . 1 1 . 1 . 056 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' B' ' 231' ' ' GLN . 55.6 t0 -98.94 100.98 12.22 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.609 179.838 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 056 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.492 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 75.8 mt-30 -121.73 27.01 8.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.575 -179.718 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -111.1 -157.04 14.48 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 179.667 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -77.06 158.83 34.07 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 123.165 2.577 . . . . 0.0 112.456 -179.378 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 056 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.65 167.75 25.79 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.661 2.24 . . . . 0.0 111.702 -179.908 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.67 ' CG2' HG22 ' A' ' 66' ' ' THR . 25.6 t -110.3 133.2 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-O 120.949 0.404 . . . . 0.0 110.505 -179.509 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' B' B ' 237' ' ' CYS . . . . . 0.688 ' SG ' HG21 ' A' ' 91' ' ' ILE . 3.5 t -76.36 130.93 38.79 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.157 0.503 . . . . 0.0 110.608 -179.643 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' B' B ' 238' ' ' TPO . . . . . 0.463 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 056 nuclear build full ' B' B ' 239' ' ' PRO . . . . . 0.463 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 34.6 Cg_exo -57.81 -24.09 62.13 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 122.872 2.382 . . . . 0.0 112.605 -178.827 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 99.9 m -72.73 -43.97 62.28 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.628 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.453 ' HD2' ' HG ' ' B' ' 237' ' ' CYS . 82.7 t80 -56.91 -47.68 80.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.264 -179.679 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.447 HD21 HG23 ' A' ' 91' ' ' ILE . 92.7 mt -62.61 -41.2 98.85 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.927 -179.173 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -63.63 -40.0 95.76 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.517 -0.473 . . . . 0.0 109.749 179.886 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' B' B ' 244' ' ' ARG . . . . . 0.537 ' O ' ' OG ' ' B' ' 247' ' ' SER . 72.9 ttt180 -59.84 -43.6 94.53 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.176 179.35 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.563 ' NH2' ' CD2' ' A' ' 41' ' ' LEU . 22.2 mmt180 -62.44 -41.41 98.7 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.675 -179.279 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.71 -39.06 90.16 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.261 0.553 . . . . 0.0 109.769 179.658 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' B' B ' 247' ' ' SER . . . . . 0.537 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 57.6 p -67.15 -42.87 83.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.141 178.306 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' B' B ' 248' ' ' GLN . . . . . 0.465 ' O ' ' N ' ' B' ' 252' ' ' LEU . 83.8 mt-30 -61.33 -35.84 78.52 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.028 179.789 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 49.8 t -60.84 -45.69 97.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 O-C-N 121.595 -0.691 . . . . 0.0 110.118 178.638 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -58.77 -27.38 64.92 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.383 -179.876 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -100.24 -7.33 24.78 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.024 179.014 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.923 HD22 HH21 ' A' ' 12' ' ' ARG . 35.5 tp -77.02 144.89 38.35 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.597 -179.705 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -113.65 148.0 37.09 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.35 179.154 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -66.4 -17.25 64.67 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.075 0.464 . . . . 0.0 110.139 179.347 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -66.58 -14.36 62.26 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.237 -179.528 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.401 ' C ' ' H ' ' B' ' 258' ' ' ASP . 64.2 t0 -95.32 76.91 3.41 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.995 0.426 . . . . 0.0 110.221 179.425 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -76.12 14.62 0.68 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.959 -178.988 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.676 ' O ' ' N ' ' B' ' 260' ' ' GLU . 88.0 m-20 -97.02 -4.73 39.16 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.186 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.48 ' C ' ' O ' ' B' ' 258' ' ' ASP . 53.7 p30 -1.83 59.9 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 113.858 -1.519 . . . . 0.0 113.476 179.766 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.676 ' N ' ' O ' ' B' ' 258' ' ' ASP . 96.6 mt-10 48.85 4.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 178.061 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.463 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 82.7 mt -112.06 130.95 64.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.821 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 60.8 t -126.4 134.34 66.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.16 -179.434 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -94.95 119.81 34.11 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.329 0.585 . . . . 0.0 110.975 -179.334 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.99 -43.92 97.45 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.071 179.48 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -100.98 155.31 36.45 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.619 -179.227 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -68.43 143.98 59.77 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 123.099 2.533 . . . . 0.0 113.659 -179.029 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 43.6 pt . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.047 178.35 . . . . . . . . 0 0 . 1 . 057 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo . . . . . 0 N--CA 1.493 1.468 0 CA-C-O 120.856 0.273 . . . . 0.0 112.28 . . . . . . . . . 0 0 . 1 . 057 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.8 p -84.4 -28.2 27.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.104 -179.605 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.78 ' NH1' ' HB2' ' A' ' 58' ' ' ALA . 95.7 mtt-85 -97.65 115.51 28.05 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.09 -178.877 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.456 HH12 ' HG3' ' A' ' 100' ' ' GLU . 84.6 mtt85 -129.44 138.54 51.51 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.997 0.427 . . . . 0.0 111.897 -179.874 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.603 HD11 ' HB3' ' A' ' 95' ' ' PHE . 32.5 tp -115.01 136.89 52.62 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.999 179.29 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 53.9 t -112.91 132.22 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.606 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 m -94.91 117.69 30.56 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.821 0.675 . . . . 0.0 112.821 -178.136 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 95.6 mt -82.97 143.71 11.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.85 179.569 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.477 ' NZ ' ' HA ' ' B' ' 257' ' ' LYS . 98.5 mttt -90.6 159.89 16.21 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.042 178.419 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.601 HH12 ' CD ' ' B' ' 260' ' ' GLU . 55.0 mtm-85 -58.51 -28.29 65.28 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.403 -179.397 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.6 p -77.87 -8.6 58.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.876 0.37 . . . . 0.0 110.457 179.907 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.68 34.05 8.08 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.94 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.6 t -118.91 132.8 67.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.866 0.365 . . . . 0.0 111.065 -179.81 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -72.07 136.03 46.48 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.315 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -127.7 -121.77 2.45 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 120.541 -0.837 . . . . 0.0 111.94 -179.135 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -73.12 149.57 46.5 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.313 2.009 . . . . 0.0 112.865 -178.601 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -106.45 152.9 23.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.638 179.868 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.65 ' CD2' HD11 ' A' ' 37' ' ' ILE . 30.1 t80 -121.36 92.92 48.78 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.017 179.789 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -59.51 125.95 19.33 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.636 1.558 . . . . 0.0 110.713 -179.595 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.2 mt -90.83 45.83 1.28 Allowed 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.558 -178.242 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 94.5 p -60.53 -23.4 64.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.216 0.532 . . . . 0.0 109.635 179.545 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.7 mt -77.1 144.44 38.5 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.323 179.494 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.7 m -67.81 -18.75 64.94 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -178.373 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 59.3 m -134.72 135.16 41.75 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.671 -179.559 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.6 t -127.2 119.47 26.48 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.059 178.871 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.481 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 35.9 tp -113.45 128.12 56.34 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 121.178 -0.209 . . . . 0.0 111.537 -178.609 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.731 ' CE2' HD12 ' A' ' 37' ' ' ILE . 13.5 m-85 -107.69 130.48 54.92 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.532 179.181 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -176.26 -171.3 39.89 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.707 179.883 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.558 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 39.7 ttp-105 -93.9 -9.31 37.6 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.249 -0.476 . . . . 0.0 111.298 -179.422 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.485 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -93.93 158.88 23.44 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.671 -178.651 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.448 HG23 ' N ' ' A' ' 34' ' ' GLU . 11.1 tp -66.81 -40.22 85.41 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 115.078 -0.561 . . . . 0.0 110.496 179.82 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.448 ' N ' HG23 ' A' ' 33' ' ' ILE . 85.2 tt0 -53.15 -22.43 6.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.035 0.445 . . . . 0.0 110.053 -179.695 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 2.7 m -71.52 139.31 49.46 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.762 179.839 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.481 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 99.6 m-20 -60.8 -31.26 70.64 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.145 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.731 HD12 ' CE2' ' A' ' 29' ' ' PHE . 84.5 mt -129.27 120.33 50.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.489 177.34 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 77.2 ttt-85 -107.41 135.1 49.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.843 -178.981 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 99.7 mt -117.45 130.72 71.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.902 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -73.65 34.98 0.08 Allowed 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -177.588 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.691 ' CD1' ' HE ' ' A' ' 93' ' ' ARG . 37.6 mt -114.41 132.18 22.94 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.582 179.478 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.47 -12.01 26.87 Favored 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 122.574 2.182 . . . . 0.0 112.997 -179.036 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.438 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 19.2 m -88.11 0.9 6.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.416 179.743 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.648 HG22 HH22 ' A' ' 93' ' ' ARG . 55.7 t -90.54 131.77 36.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.156 179.331 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 46.4 t -70.75 165.31 23.32 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.345 -179.107 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 70.2 mttt -61.9 -39.97 93.83 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.142 -179.26 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.679 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.9 mt-30 -120.5 -21.54 6.76 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.046 179.772 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 16.6 t60 36.15 -75.05 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 178.991 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.679 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -128.52 132.66 48.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.104 0.478 . . . . 0.0 111.677 -178.891 . . . . . . . . 3 3 . 1 . 057 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -128.51 125.25 37.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.138 179.234 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.0 mt -107.07 133.38 51.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.526 -179.529 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.417 ' CD ' ' NE2' ' A' ' 54' ' ' HIS . 82.4 tt0 -117.24 126.06 52.15 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.562 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.5 119.72 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -177.625 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.553 ' O ' ' N ' ' A' ' 56' ' ' GLN . 97.4 m-70 -114.46 141.28 47.89 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.628 178.813 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 54' ' ' HIS . 58.8 mp0 -40.71 -24.46 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.801 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.553 ' N ' ' O ' ' A' ' 54' ' ' HIS . 99.8 mm-40 -71.86 -69.16 0.41 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.548 178.848 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.452 ' OE2' ' NE ' ' A' ' 81' ' ' ARG . 2.3 pt-20 -152.61 -174.71 5.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.294 0.568 . . . . 0.0 111.602 -178.95 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.78 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -110.47 130.18 55.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.672 179.156 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 86.2 mt -121.08 131.04 74.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.162 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 24.0 tp -100.01 129.16 46.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.318 179.442 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -113.51 135.38 53.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.149 179.573 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -95.09 105.62 17.56 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.866 -0.333 . . . . 0.0 111.338 -179.988 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -98.07 -6.96 30.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.209 178.847 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.36 102.28 1.72 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.401 179.846 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.6 p -89.51 -6.51 56.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.788 0.328 . . . . 0.0 110.484 179.397 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.839 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.2 OUTLIER -101.28 -42.12 6.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.332 0.587 . . . . 0.0 109.637 179.928 . . . . . . . . 3 3 . 1 . 057 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.427 HD21 ' HA ' ' B' ' 236' ' ' VAL . 69.8 m-20 -141.21 99.87 6.45 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.668 -179.919 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.401 ' HB2' HG13 ' A' ' 75' ' ' VAL . 48.8 Cg_exo -55.53 146.44 63.87 Favored 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 122.595 2.197 . . . . 0.0 112.982 -179.282 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 48.3 m -72.67 139.17 47.12 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.167 179.278 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -105.88 140.45 38.89 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.754 -179.589 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.652 HG13 ' OD1' ' A' ' 86' ' ' ASP . 54.9 t -132.23 132.9 60.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.041 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 52.91 32.93 13.44 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.049 -0.66 . . . . 0.0 109.332 -179.079 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.75 27.98 69.87 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.892 179.858 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 28.9 p -141.02 140.78 34.34 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 117.206 0.503 . . . . 0.0 111.22 179.895 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.401 HG13 ' HB2' ' A' ' 68' ' ' PRO . 13.4 t -72.4 142.48 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.804 -179.79 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.46 HG22 HG21 ' A' ' 80' ' ' VAL . 3.9 pt -115.67 88.69 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.66 178.967 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -63.67 -25.64 68.3 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.361 179.396 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.52 173.62 4.3 Favored Pre-proline 0 C--O 1.233 0.221 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.959 -179.704 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -61.66 142.37 94.14 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.401 2.067 . . . . 0.0 111.812 179.349 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.46 HG21 HG22 ' A' ' 76' ' ' ILE . 79.2 t -135.38 136.7 50.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.615 179.631 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.452 ' NE ' ' OE2' ' A' ' 57' ' ' GLU . 84.0 mtp180 -73.99 131.91 41.87 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.768 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.2 mt -82.45 139.94 33.68 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.954 0.407 . . . . 0.0 110.939 -179.38 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -131.12 151.35 51.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.698 -179.836 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.612 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 4.1 t60 -54.06 114.94 1.79 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.391 179.982 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.81 -6.39 29.42 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 -179.382 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.652 ' OD1' HG13 ' A' ' 71' ' ' VAL . 26.7 t0 -79.4 125.28 29.33 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.306 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 42.6 t -110.03 130.54 63.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.604 -178.341 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 95.6 mt -92.46 130.62 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.804 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 25.7 m -121.65 126.75 49.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.449 0.643 . . . . 0.0 112.277 -178.124 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.73 HG21 HH12 ' A' ' 93' ' ' ARG . 70.8 mt -121.69 127.54 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.442 178.977 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.489 HG22 ' N ' ' A' ' 92' ' ' ASP . 82.9 mt 38.59 -101.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.629 -179.511 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.489 ' N ' HG22 ' A' ' 91' ' ' ILE . 26.5 t70 -115.88 15.72 16.28 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 120.666 -0.413 . . . . 0.0 111.693 -179.183 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.73 HH12 HG21 ' A' ' 90' ' ' ILE . 4.5 ptt85 -131.64 146.32 52.13 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.839 179.125 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 53.0 m -139.24 155.48 47.74 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.572 -179.388 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.603 ' HB3' HD11 ' A' ' 7' ' ' LEU . 61.4 m-85 -122.22 121.04 35.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.657 179.775 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.518 ' O ' HD12 ' A' ' 7' ' ' LEU . 42.4 ttm180 -83.7 130.95 34.97 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.878 0.371 . . . . 0.0 111.59 -178.872 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.641 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 76.6 t80 -96.37 123.62 40.08 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.23 -179.47 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -123.53 126.29 46.44 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.895 179.801 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.612 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 59.7 t-20 -112.81 121.86 45.96 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.243 179.43 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.456 ' HG3' HH12 ' A' ' 6' ' ' ARG . 79.2 mm-40 . . . . . 0 C--N 1.329 -0.312 0 C-N-CA 120.646 -0.421 . . . . 0.0 110.824 -179.522 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 31.3 m . . . . . 0 N--CA 1.448 -0.57 0 CA-C-O 121.413 0.625 . . . . 0.0 111.489 . . . . . . . . . 0 0 . 1 . 057 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.664 ' O ' ' N ' ' B' ' 231' ' ' GLN . 60.4 t0 -88.67 117.31 27.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.459 -179.716 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' B' B ' 230' ' ' SEP . . . . . 0.554 ' O ' ' CB ' ' B' ' 231' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 057 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.664 ' N ' ' O ' ' B' ' 229' ' ' ASP . 25.0 mt-30 121.81 31.05 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 O-C-N 124.712 1.257 . . . . 0.0 109.964 179.916 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' B' B ' 232' ' ' GLY . . . . . 0.545 ' N ' HH21 ' A' ' 31' ' ' ARG . . . -98.96 -144.66 17.17 Favored Glycine 0 CA--C 1.534 1.276 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 179.443 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -58.68 150.0 73.04 Favored 'Trans proline' 0 N--CA 1.502 2.001 0 C-N-CA 122.755 2.303 . . . . 0.0 113.126 179.915 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.839 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 057 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -61.11 135.75 60.71 Favored 'Trans proline' 0 C--N 1.301 -1.965 0 C-N-CA 122.415 2.077 . . . . 0.0 113.406 -179.24 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.64 ' CG2' HG22 ' A' ' 66' ' ' THR . 31.2 t -65.29 136.6 26.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.864 179.102 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 5.7 t -60.1 121.63 12.38 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.626 -0.429 . . . . 0.0 110.099 -179.685 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 057 nuclear build full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.64 -24.47 70.62 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.224 1.949 . . . . 0.0 112.609 179.405 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 96.2 m -73.33 -44.9 58.03 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.515 0.674 . . . . 0.0 109.334 178.551 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.502 ' HZ ' HD22 ' A' ' 41' ' ' LEU . 80.8 t80 -56.11 -44.8 79.43 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.826 -179.861 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 92.1 mt -62.81 -40.86 98.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 179.818 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -64.42 -39.94 94.8 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.419 -179.26 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 59.8 ttm-85 -60.01 -44.86 94.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.044 0.45 . . . . 0.0 109.962 179.781 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.474 HH21 ' HG2' ' A' ' 12' ' ' ARG . 58.1 mtp180 -63.32 -41.55 98.93 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.749 -179.823 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -62.85 -40.76 98.46 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.239 -0.585 . . . . 0.0 109.806 179.376 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 38.5 t -64.38 -45.05 89.4 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 122.052 0.929 . . . . 0.0 108.679 178.167 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' B' B ' 248' ' ' GLN . . . . . 0.446 ' O ' ' N ' ' B' ' 252' ' ' LEU . 51.3 tt0 -59.52 -37.28 77.93 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.41 -179.973 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 21.8 t -59.31 -45.07 93.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.753 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -58.59 -30.5 67.25 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.726 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -90.4 -10.57 43.4 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.817 179.258 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.467 HD22 ' NH2' ' A' ' 12' ' ' ARG . 1.0 OUTLIER -115.5 -175.3 2.68 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.207 -179.882 . . . . . . . . 3 3 . 1 . 057 nuclear build full ' B' B ' 253' ' ' ASN . . . . . 0.416 ' H ' ' HG ' ' B' ' 252' ' ' LEU . 20.7 t-20 73.89 18.23 3.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.803 0.335 . . . . 0.0 111.107 179.768 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' B' B ' 254' ' ' ASP . . . . . 0.434 ' O ' ' HB2' ' B' ' 255' ' ' ASP . 56.0 m-20 -64.86 -38.48 91.11 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.56 178.92 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' B' B ' 255' ' ' ASP . . . . . 0.486 ' CG ' ' O ' ' B' ' 255' ' ' ASP . 14.2 t0 156.94 54.78 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.151 -0.931 . . . . 0.0 108.964 -179.47 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.504 ' O ' ' C ' ' B' ' 257' ' ' LYS . 51.6 p-10 -120.16 11.93 11.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.273 -179.295 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' B' B ' 257' ' ' LYS . . . . . 0.504 ' C ' ' O ' ' B' ' 256' ' ' ASP . 98.1 mttt 29.82 -95.12 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 O-C-N 123.603 0.564 . . . . 0.0 110.623 -179.139 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.476 ' C ' ' O ' ' B' ' 257' ' ' LYS . 89.4 m-20 -29.74 138.36 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.549 -179.9 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.584 ' C ' ' H ' ' B' ' 261' ' ' ILE . 53.1 p30 -126.62 -174.26 3.08 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.88 0.848 . . . . 0.0 111.837 -178.758 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.601 ' CD ' HH12 ' A' ' 12' ' ' ARG . 53.5 mp0 -56.16 9.57 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.164 -1.38 . . . . 0.0 112.345 -179.166 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.584 ' H ' ' C ' ' B' ' 259' ' ' ASP . 69.4 mt -108.58 135.53 47.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.738 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 55.0 t -127.45 134.0 66.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.947 0.404 . . . . 0.0 110.896 -178.384 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -97.38 119.75 36.48 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.557 -179.331 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.85 -43.84 94.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.924 179.038 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -95.79 153.78 39.24 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.362 -179.598 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.85 147.05 80.13 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 123.087 2.525 . . . . 0.0 113.288 -179.273 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.4 pt . . . . . 0 C--N 1.331 -0.223 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.678 178.455 . . . . . . . . 0 0 . 1 . 058 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo . . . . . 0 N--CA 1.492 1.391 0 CA-C-O 121.225 0.427 . . . . 0.0 112.769 . . . . . . . . . 0 0 . 1 . 058 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 50.0 p -102.68 -49.31 3.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.25 179.96 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.485 ' HD2' HD13 ' A' ' 53' ' ' ILE . 84.9 mtt85 -89.39 122.27 32.45 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.493 -179.449 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -124.79 139.44 53.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.24 -179.922 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.579 HD12 ' O ' ' A' ' 96' ' ' ARG . 29.4 tp -116.39 132.83 56.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.133 -179.4 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.892 HG11 ' NH2' ' A' ' 96' ' ' ARG . 67.6 t -108.18 130.19 61.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.36 -179.676 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.601 HG21 ' HZ ' ' B' ' 263' ' ' PHE . 59.2 p -91.28 114.22 26.69 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.455 0.645 . . . . 0.0 112.485 -178.83 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.435 HD12 ' HB3' ' A' ' 94' ' ' SER . 95.5 mt -79.71 140.9 16.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.396 178.953 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -87.69 158.19 18.89 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.15 0.5 . . . . 0.0 111.008 179.179 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.592 ' NH1' ' OE2' ' B' ' 260' ' ' GLU . 81.3 mtp180 -58.3 -31.03 67.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.554 -179.305 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 93.2 p -74.82 -12.79 60.47 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.933 179.275 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.34 25.93 10.57 Favored Glycine 0 CA--C 1.531 1.045 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -179.566 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.2 t -119.27 134.98 61.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.695 0.283 . . . . 0.0 110.541 179.981 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.657 ' CG ' HH22 ' A' ' 96' ' ' ARG . 90.6 m-20 -67.6 139.23 56.86 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.426 -179.837 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -127.04 -123.71 2.66 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.068 -179.023 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.43 146.34 44.51 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 122.321 2.014 . . . . 0.0 113.184 -178.426 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.428 ' O ' ' CD1' ' B' ' 267' ' ' ILE . 0.0 OUTLIER -111.08 131.01 55.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.094 0.473 . . . . 0.0 111.049 -179.561 . . . . . . . . 3 3 . 1 . 058 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.545 ' CD2' HD11 ' A' ' 37' ' ' ILE . 25.2 t80 -101.35 107.7 51.93 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.014 -179.602 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -73.64 127.45 11.68 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 121.129 1.219 . . . . 0.0 111.645 -179.748 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.9 mt -87.87 50.58 2.02 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.139 -178.769 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 97.4 p -65.97 -19.07 65.74 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.051 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.605 HD11 ' HG2' ' B' ' 265' ' ' GLN . 68.0 mt -79.03 140.57 37.9 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.283 179.848 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.7 t -62.43 -25.5 68.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.866 179.916 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 66.0 m -129.79 130.96 46.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.193 -179.768 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.61 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 8.6 t -129.3 124.17 33.69 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.605 178.903 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.576 HD21 ' HG2' ' A' ' 47' ' ' GLN . 42.8 tp -119.28 132.05 55.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.928 0.394 . . . . 0.0 111.184 -178.747 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.771 ' CE2' HD12 ' A' ' 37' ' ' ILE . 10.0 m-85 -108.97 139.98 43.09 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.022 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 167.76 -155.7 26.77 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 119.942 -1.123 . . . . 0.0 112.069 179.846 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.538 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 37.6 ttp-105 -111.2 -21.64 11.8 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.88 -0.16 . . . . 0.0 110.855 -179.459 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.458 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -73.77 163.59 54.69 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.553 -179.161 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.514 ' CD1' ' NH1' ' A' ' 38' ' ' ARG . 46.2 mm -64.52 -45.67 94.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 O-C-N 122.746 -0.267 . . . . 0.0 110.944 -179.876 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -49.78 -21.95 1.27 Allowed 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.503 179.962 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.572 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 4.8 m -67.75 121.87 16.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.11 -179.513 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -59.41 -25.9 64.7 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.757 -179.494 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.771 HD12 ' CE2' ' A' ' 29' ' ' PHE . 98.1 mt -128.77 124.16 60.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.086 177.64 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.514 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 56.6 mtm180 -110.34 141.43 43.38 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 120.634 -0.427 . . . . 0.0 111.237 -179.704 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.658 HD13 ' HE ' ' A' ' 93' ' ' ARG . 81.0 mt -121.17 132.65 70.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.034 179.916 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -74.75 29.81 0.09 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.569 -177.762 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.712 HD12 ' CZ ' ' A' ' 93' ' ' ARG . 51.5 mt -109.34 133.55 20.77 Favored Pre-proline 0 C--N 1.325 -0.494 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.643 -179.559 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.2 -12.92 25.74 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.741 2.294 . . . . 0.0 112.016 179.598 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.4 m -88.61 3.71 5.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.069 179.448 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.538 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 55.1 t -98.99 130.88 47.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 C-N-CA 120.434 -0.507 . . . . 0.0 109.699 178.432 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 75.6 m -70.74 172.62 8.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.632 -179.077 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.572 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 10.5 mttm -63.79 -41.87 97.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.259 179.939 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.658 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.2 mt-30 -117.48 -16.15 10.21 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 123.337 0.398 . . . . 0.0 111.732 -179.315 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.42 ' NE2' HG23 ' A' ' 90' ' ' ILE . 17.5 t60 33.78 -72.58 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 179.081 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.658 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -135.99 140.32 43.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.067 0.461 . . . . 0.0 112.036 -178.752 . . . . . . . . 3 3 . 1 . 058 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -126.63 135.51 51.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.556 179.918 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 92.3 mt -121.52 134.17 65.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.013 -179.483 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -116.14 127.34 54.75 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.849 179.036 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.485 HD13 ' HD2' ' A' ' 5' ' ' ARG . 82.1 mt -106.57 113.27 42.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 119.853 -0.739 . . . . 0.0 112.288 -179.606 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.426 ' O ' ' C ' ' A' ' 55' ' ' GLU . 98.0 m-70 -113.25 143.89 43.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.742 179.426 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 54' ' ' HIS . 41.3 tt0 -40.9 -30.68 0.14 Allowed 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.028 -0.669 . . . . 0.0 109.4 -179.407 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.47 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 85.7 mt-30 -60.79 -68.88 0.26 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.37 179.131 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.47 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 4.2 tp10 -157.91 -164.95 1.63 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.809 179.775 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.437 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -111.59 126.77 55.36 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 178.317 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 94.4 mt -115.36 131.56 67.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.247 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.443 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 22.0 tp -101.05 131.24 47.04 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.835 179.773 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -114.26 134.71 54.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.499 -179.779 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 56.6 t-20 -92.84 105.06 17.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.933 0.397 . . . . 0.0 111.434 -179.309 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -101.82 -9.56 20.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.277 179.417 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.92 98.2 10.21 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.717 -179.581 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.5 m -76.69 -38.41 54.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.359 0.599 . . . . 0.0 109.854 178.996 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.459 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.2 OUTLIER -62.49 -44.66 95.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.832 -178.688 . . . . . . . . 3 3 . 1 . 058 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.464 HD21 ' HA ' ' B' ' 236' ' ' VAL . 85.4 m-20 -139.16 95.86 9.21 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.624 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -54.8 144.29 66.79 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 121.787 1.658 . . . . 0.0 112.542 -179.038 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 97.0 m -73.42 138.38 45.19 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.625 178.76 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -99.96 137.81 37.91 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.272 179.881 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.663 HG13 ' OD1' ' A' ' 86' ' ' ASP . 54.2 t -131.89 133.21 61.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 178.517 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 53.71 32.1 14.06 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.218 -179.121 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.4 27.66 67.38 Favored Glycine 0 CA--C 1.536 1.38 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.225 179.691 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 58.6 m -144.35 140.45 29.11 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 117.319 0.56 . . . . 0.0 111.657 -179.964 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.444 ' H ' HG22 ' A' ' 75' ' ' VAL . 4.6 m -74.28 146.8 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.748 179.515 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.8 pt -116.43 98.5 6.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.262 0.553 . . . . 0.0 111.549 179.837 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -67.14 -26.58 66.74 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 178.465 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.31 166.36 17.51 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.602 -179.868 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -64.22 150.5 88.18 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.684 2.256 . . . . 0.0 112.183 179.249 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.4 m -141.63 141.99 29.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.347 -179.482 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -74.91 135.22 41.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.966 179.18 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.437 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 98.2 mt -83.82 137.53 33.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.236 0.541 . . . . 0.0 110.838 -179.631 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -129.27 154.85 46.42 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.808 179.974 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -56.99 116.19 3.06 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.843 -178.901 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.06 -12.8 29.06 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -179.743 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.663 ' OD1' HG13 ' A' ' 71' ' ' VAL . 43.6 t0 -67.78 128.47 36.59 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.963 0.411 . . . . 0.0 110.283 179.651 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.411 ' O ' HG13 ' A' ' 87' ' ' VAL . 9.3 p -109.11 134.87 49.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.559 -179.053 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 81.2 mt -106.8 131.17 57.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.275 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.8 m -119.9 123.67 44.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.446 0.641 . . . . 0.0 111.479 -179.033 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.549 HD12 ' CE1' ' A' ' 95' ' ' PHE . 84.8 mt -116.74 124.47 72.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.914 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.402 HG22 ' N ' ' A' ' 92' ' ' ASP . 44.8 mm 44.61 -103.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.773 -179.607 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.664 ' OD1' ' NH1' ' A' ' 93' ' ' ARG . 12.3 p-10 -117.49 17.58 14.5 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.995 0.426 . . . . 0.0 110.488 -179.803 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.712 ' CZ ' HD12 ' A' ' 41' ' ' LEU . 34.2 mtm-85 -127.1 142.68 51.46 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.024 -179.366 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.435 ' HB3' HD12 ' A' ' 10' ' ' ILE . 41.2 t -135.25 150.26 50.02 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.564 -179.826 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.549 ' CE1' HD12 ' A' ' 90' ' ' ILE . 19.2 m-85 -124.97 124.02 41.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.581 -179.892 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.892 ' NH2' HG11 ' A' ' 8' ' ' VAL . 89.8 mtm-85 -85.66 128.41 34.77 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.932 -178.915 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -92.12 124.53 36.28 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.193 179.083 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -127.69 118.55 24.03 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.549 -179.547 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 61.4 t-20 -103.37 104.01 14.07 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.009 179.589 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 . . . . . 0 C--N 1.333 -0.144 0 CA-C-O 120.863 0.364 . . . . 0.0 111.0 -179.252 . . . . . . . . 0 0 . 1 . 058 nuclear build full ' B' B ' 228' ' ' VAL . . . . . 0.471 ' O ' ' C ' ' B' ' 229' ' ' ASP . 27.7 m . . . . . 0 N--CA 1.451 -0.378 0 CA-C-O 120.697 0.284 . . . . 0.0 110.389 . . . . . . . . . 1 1 . 1 . 058 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.471 ' C ' ' O ' ' B' ' 228' ' ' VAL . 87.5 m-20 34.83 -111.44 0.06 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.076 -179.417 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 058 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.568 ' O ' ' NZ ' ' A' ' 46' ' ' LYS . 82.6 mt-30 -135.82 -5.74 2.18 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.335 -179.859 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' B' B ' 232' ' ' GLY . . . . . 0.493 ' N ' HH21 ' A' ' 31' ' ' ARG . . . -50.19 -171.99 0.01 OUTLIER Glycine 0 CA--C 1.527 0.825 0 C-N-CA 121.206 -0.521 . . . . 0.0 112.096 -178.852 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -65.7 160.88 41.37 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 123.519 2.813 . . . . 0.0 113.176 -179.617 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.459 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 058 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.87 140.28 31.65 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 121.169 1.246 . . . . 0.0 113.019 -178.878 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.464 ' HA ' HD21 ' A' ' 67' ' ' ASN . 17.5 t -57.56 141.09 15.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.485 -179.597 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 16.5 t -58.8 121.08 10.22 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.455 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' B' B ' 238' ' ' TPO . . . . . 0.592 ' O2P' HG23 ' B' ' 240' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 058 nuclear build full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.39 -29.21 57.49 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 122.447 2.098 . . . . 0.0 113.057 179.127 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' B' B ' 240' ' ' THR . . . . . 0.592 HG23 ' O2P' ' B' ' 238' ' ' TPO . 13.7 p -73.96 -39.2 63.9 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.218 179.044 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.42 ' HZ ' HD22 ' A' ' 41' ' ' LEU . 68.3 t80 -57.42 -46.34 83.65 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.357 -179.872 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.457 HD22 ' NH2' ' B' ' 245' ' ' ARG . 94.9 mt -63.45 -40.76 98.0 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.215 179.95 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -58.18 -41.77 84.64 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.14 179.558 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -64.34 -38.8 92.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.447 179.844 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.494 ' NE ' ' CB ' ' A' ' 92' ' ' ASP . 10.1 ttm180 -57.8 -44.93 86.65 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.56 -179.511 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -61.65 -41.23 97.23 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.758 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 10.2 t -63.8 -45.97 87.25 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.323 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' B' B ' 248' ' ' GLN . . . . . 0.443 ' HG2' HH12 ' A' ' 12' ' ' ARG . 67.0 tp60 -58.51 -41.15 84.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.688 -1.142 . . . . 0.0 111.406 -179.531 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 55.0 t -59.85 -44.56 94.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 C-N-CA 120.559 -0.457 . . . . 0.0 109.792 179.897 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -60.27 -34.17 73.35 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.573 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -74.93 -14.15 60.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.369 179.295 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' B' ' 252' ' ' LEU . 97.7 mt -106.05 166.34 10.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.393 -179.968 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -127.47 160.68 30.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.146 -179.597 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -59.35 -26.98 65.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.949 179.785 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 40.7 p-10 -82.12 1.57 35.46 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.421 -179.119 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -60.25 146.03 45.23 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.193 0.52 . . . . 0.0 109.724 179.083 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -131.04 155.9 46.08 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.007 -179.562 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.508 ' O ' ' N ' ' B' ' 260' ' ' GLU . 94.3 m-20 61.16 50.83 4.68 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.549 0.69 . . . . 0.0 109.534 -178.705 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' B' B ' 259' ' ' ASP . . . . . . . . . . . . . 55.6 p-10 -58.02 69.0 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.629 -1.169 . . . . 0.0 112.32 -178.946 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.592 ' OE2' ' NH1' ' A' ' 12' ' ' ARG . 95.7 mt-10 60.01 3.43 0.5 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.982 1.105 . . . . 0.0 113.982 178.172 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 73.9 mt -109.41 134.11 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 118.644 0.656 . . . . 0.0 109.691 179.684 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 56.1 t -123.9 131.94 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.052 -179.532 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' B' B ' 263' ' ' PHE . . . . . 0.601 ' HZ ' HG21 ' A' ' 9' ' ' THR . 51.2 m-85 -98.77 120.64 39.56 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.21 0.528 . . . . 0.0 111.174 -178.683 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -63.05 -48.3 79.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.332 -179.681 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' B' B ' 265' ' ' GLN . . . . . 0.605 ' HG2' HD11 ' A' ' 24' ' ' LEU . 6.0 mp0 -88.78 161.86 40.3 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.029 -179.068 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -62.28 143.54 94.13 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.276 1.984 . . . . 0.0 112.279 -179.963 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' B' B ' 267' ' ' ILE . . . . . 0.428 ' CD1' ' O ' ' A' ' 19' ' ' HIS . 4.2 tt . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.877 -179.647 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo . . . . . 0 N--CA 1.492 1.412 0 CA-C-O 120.831 0.263 . . . . 0.0 112.142 . . . . . . . . . 0 0 . 1 . 059 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 73.8 p -102.6 -44.19 5.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.99 0.424 . . . . 0.0 110.409 179.641 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.738 ' NE ' HD13 ' A' ' 53' ' ' ILE . 89.9 mtm-85 -91.24 125.75 36.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.151 -179.75 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 86.5 mtm-85 -131.43 137.14 48.52 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.849 179.522 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.551 HD12 ' O ' ' A' ' 96' ' ' ARG . 40.8 tp -113.32 131.38 55.97 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.983 -179.905 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.6 t -109.07 131.71 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 120.947 0.403 . . . . 0.0 110.984 -179.586 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.426 ' O ' HG22 ' A' ' 9' ' ' THR . 1.8 m -90.65 112.64 24.45 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.748 -179.341 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.7 mt -79.72 144.67 10.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.405 178.646 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -90.6 158.32 17.03 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.142 0.496 . . . . 0.0 110.588 179.17 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 1.091 HH21 HD22 ' B' ' 252' ' ' LEU . 87.2 mtm180 -58.39 -28.39 65.13 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.727 -178.846 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 93.6 p -80.36 -11.22 59.73 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.473 179.795 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.55 31.34 7.16 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.108 179.212 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.1 t -122.61 133.45 68.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.789 0.328 . . . . 0.0 110.729 179.623 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -73.64 138.64 44.93 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.207 179.479 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.66 -118.34 1.93 Allowed Glycine 0 CA--C 1.534 1.225 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.764 -179.899 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.42 146.14 55.29 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 121.912 1.741 . . . . 0.0 112.332 -179.112 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -110.83 158.54 18.58 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.157 0.503 . . . . 0.0 110.649 -179.337 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -125.74 102.0 29.32 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.617 -179.491 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -69.8 128.56 16.16 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 121.279 1.32 . . . . 0.0 111.468 -178.947 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.8 mt -85.72 49.48 1.78 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.543 -178.183 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 92.2 p -61.55 -24.93 66.97 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.055 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.619 HD11 ' HG2' ' B' ' 265' ' ' GLN . 65.7 mt -78.64 141.27 38.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.076 179.779 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 91.9 p -65.33 -19.99 66.2 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.811 179.962 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.409 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 61.8 m -130.28 131.46 45.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.6 -178.852 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.2 t -125.0 112.71 16.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.429 178.385 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.685 HD21 ' OE1' ' A' ' 47' ' ' GLN . 54.7 tp -109.36 127.74 54.57 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.923 -178.593 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.82 ' CE2' HD12 ' A' ' 37' ' ' ILE . 2.5 m-85 -110.07 143.41 40.16 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.745 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 150.98 -166.82 30.5 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.233 178.468 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.531 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 46.2 mtm105 -82.62 -30.98 29.07 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 179.946 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.544 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -50.84 139.08 24.31 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 120.556 -0.83 . . . . 0.0 111.298 -178.854 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.451 HD13 ' HD2' ' A' ' 38' ' ' ARG . 31.3 mm -63.92 -43.79 97.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 121.064 0.459 . . . . 0.0 110.332 179.396 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -55.72 -14.41 2.25 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.132 179.879 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.544 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 56.6 m -64.43 135.2 55.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.93 179.954 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.409 ' OD2' ' O ' ' A' ' 26' ' ' THR . 58.5 m-20 -61.23 -33.84 74.15 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.646 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.82 HD12 ' CE2' ' A' ' 29' ' ' PHE . 88.2 mt -127.32 122.58 60.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 177.471 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.451 ' HD2' HD13 ' A' ' 33' ' ' ILE . 77.5 ttt-85 -111.42 138.6 47.71 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.516 -178.187 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 83.8 mt -119.86 131.48 72.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-O 120.88 0.371 . . . . 0.0 110.409 -179.89 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -78.06 33.82 0.19 Allowed 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 -178.49 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.529 ' CD1' ' CZ ' ' A' ' 93' ' ' ARG . 33.4 mt -109.09 131.86 21.56 Favored Pre-proline 0 C--N 1.325 -0.461 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.293 -179.651 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.79 -15.41 29.94 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.392 2.061 . . . . 0.0 112.874 -179.681 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.55 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 19.2 m -90.27 1.01 8.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.281 179.592 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.531 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 45.3 t -93.25 133.74 33.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.061 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.9 m -71.53 164.09 26.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.4 0.619 . . . . 0.0 112.02 -178.609 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -63.73 -43.3 96.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.187 -178.834 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.685 ' OE1' HD21 ' A' ' 28' ' ' LEU . 93.1 mm-40 -111.95 -17.88 12.78 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.966 0.412 . . . . 0.0 110.148 -179.791 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 14.9 t60 30.66 -76.15 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 179.908 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.623 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.52 137.25 47.09 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -178.43 . . . . . . . . 3 3 . 1 . 059 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -128.69 126.69 40.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.876 179.809 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 91.8 mt -108.71 133.71 52.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.129 0.49 . . . . 0.0 110.738 179.868 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.448 ' OE2' ' CE1' ' A' ' 54' ' ' HIS . 81.0 tt0 -118.23 123.83 46.42 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.354 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.738 HD13 ' NE ' ' A' ' 5' ' ' ARG . 92.5 mt -107.5 119.25 56.78 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 CA-C-O 122.013 0.911 . . . . 0.0 112.858 -178.531 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.461 ' O ' ' C ' ' A' ' 55' ' ' GLU . 98.7 m-70 -108.02 134.14 51.34 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 113.871 -1.513 . . . . 0.0 108.865 179.075 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.461 ' C ' ' O ' ' A' ' 54' ' ' HIS . 97.3 mt-10 -42.5 -33.13 0.63 Allowed 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.524 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.408 ' N ' ' C ' ' A' ' 54' ' ' HIS . 78.6 mt-30 -64.53 -68.33 0.36 Allowed 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.071 -0.968 . . . . 0.0 108.835 177.722 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -143.82 179.12 7.36 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.562 0.696 . . . . 0.0 112.404 -178.567 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.9 120.59 41.96 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.095 178.429 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.7 mt -118.34 133.03 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.994 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.523 ' HB2' HD11 ' A' ' 82' ' ' LEU . 15.7 tp -99.29 129.45 45.51 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.317 179.487 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -110.8 136.89 49.16 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.559 -179.945 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -98.9 106.97 19.29 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.007 0.432 . . . . 0.0 111.905 -179.052 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -100.21 -6.06 26.67 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.779 179.402 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.7 99.18 8.06 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.376 -179.667 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.7 p -88.53 -20.42 25.12 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.738 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.712 HG21 ' O ' ' B' ' 234' ' ' TPO . 2.6 m -74.18 -50.91 17.22 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.467 179.189 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.49 HD21 ' HA ' ' B' ' 236' ' ' VAL . 72.2 m-20 -137.43 99.42 9.66 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 114.698 -1.137 . . . . 0.0 108.923 179.766 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -54.0 144.62 56.18 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 121.954 1.769 . . . . 0.0 113.403 -178.762 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 26.8 m -72.12 139.87 48.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.493 178.581 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -105.1 140.53 38.13 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.166 -0.614 . . . . 0.0 110.648 179.932 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.2 p -134.06 134.22 55.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.707 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 51.6 31.89 8.33 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -179.065 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.92 27.39 68.91 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.887 -179.751 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.7 t -139.07 136.73 35.55 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 117.497 0.649 . . . . 0.0 111.804 -179.839 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.5 m -73.75 143.25 13.87 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.151 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.048 179.667 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.559 ' CG2' HG21 ' A' ' 80' ' ' VAL . 9.9 pt -117.07 100.61 10.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.411 0.624 . . . . 0.0 111.028 179.795 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -71.0 -21.97 62.22 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.072 179.46 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.438 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.3 OUTLIER -130.19 177.21 2.31 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.736 179.78 . . . . . . . . 3 3 . 1 . 059 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.438 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 36.7 Cg_exo -59.96 142.32 98.24 Favored 'Trans proline' 0 N--CA 1.5 1.906 0 C-N-CA 122.865 2.377 . . . . 0.0 112.708 -179.335 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.559 HG21 ' CG2' ' A' ' 76' ' ' ILE . 61.4 t -133.03 139.32 49.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.065 179.602 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.546 HH21 ' CE ' ' A' ' 83' ' ' LYS . 62.5 ttp180 -76.61 126.73 31.49 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.955 179.043 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.523 HD11 ' HB2' ' A' ' 60' ' ' LEU . 94.4 mt -82.78 138.45 34.0 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.942 0.401 . . . . 0.0 111.703 -179.285 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.546 ' CE ' HH21 ' A' ' 81' ' ' ARG . 99.3 mttt -128.38 150.95 49.89 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.035 179.712 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -55.43 122.31 10.92 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.068 0.461 . . . . 0.0 111.174 -179.18 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.96 -16.64 42.73 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 -179.894 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -65.82 136.54 56.32 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.62 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 42.0 t -114.5 132.76 62.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.427 -178.364 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 91.6 mt -95.51 131.43 42.33 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.43 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.7 m -123.98 124.96 43.74 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.6 0.714 . . . . 0.0 112.634 -178.319 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.5 ' O ' ' N ' ' A' ' 92' ' ' ASP . 93.7 mt -113.15 125.91 70.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 114.695 -1.139 . . . . 0.0 108.427 178.432 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.591 HD12 HH22 ' A' ' 93' ' ' ARG . 73.9 mt 39.5 -94.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 C-N-CA 120.716 -0.393 . . . . 0.0 110.53 -179.458 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.517 ' O ' ' OD1' ' A' ' 92' ' ' ASP . 62.3 t0 -124.94 19.0 8.49 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.071 0.463 . . . . 0.0 110.905 -179.78 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.676 ' NH1' ' NH2' ' B' ' 245' ' ' ARG . 58.0 mtm-85 -127.62 141.98 51.48 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.472 -179.841 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 25.8 p -139.27 154.2 47.91 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 119.59 -0.844 . . . . 0.0 111.426 -179.798 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.535 ' HB3' HD11 ' A' ' 7' ' ' LEU . 63.8 m-85 -123.22 121.79 36.77 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.078 179.702 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.551 ' O ' HD12 ' A' ' 7' ' ' LEU . 44.8 ttm180 -80.14 127.65 32.57 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.953 -179.148 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -95.1 125.13 39.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.111 -179.825 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -124.87 121.62 35.06 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.636 179.651 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -116.63 113.79 23.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.012 179.453 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.302 -179.305 . . . . . . . . 0 0 . 1 . 059 nuclear build full ' B' B ' 228' ' ' VAL . . . . . 0.717 ' O ' HG12 ' B' ' 228' ' ' VAL . 44.5 t . . . . . 0 N--CA 1.457 -0.123 0 CA-C-O 120.613 0.244 . . . . 0.0 110.844 . . . . . . . . . 1 1 . 1 . 059 nuclear build full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -60.71 -47.89 84.24 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.542 -179.984 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 059 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 9.0 mp0 -118.65 46.91 1.73 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.873 -178.733 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -126.82 -177.2 14.77 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.424 -179.974 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -66.79 153.86 76.48 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 123.37 2.714 . . . . 0.0 112.662 -179.814 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.712 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 059 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.88 139.1 17.22 Favored 'Trans proline' 0 C--N 1.302 -1.879 0 C-N-CA 121.863 1.709 . . . . 0.0 112.489 -179.74 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.49 ' HA ' HD21 ' A' ' 67' ' ' ASN . 10.9 m -67.39 147.75 12.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.191 -178.919 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 3.0 t -68.45 129.18 39.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.847 179.891 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' B' B ' 238' ' ' TPO . . . . . 0.432 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 059 nuclear build full ' B' B ' 239' ' ' PRO . . . . . 0.432 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 31.8 Cg_exo -58.97 -27.07 83.81 Favored 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 122.893 2.396 . . . . 0.0 113.585 -178.794 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 97.3 m -73.61 -44.21 57.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.179 0.514 . . . . 0.0 109.844 179.074 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.55 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 90.6 t80 -58.31 -46.11 86.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.652 -179.516 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 94.7 mt -63.54 -40.13 96.2 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.852 0.358 . . . . 0.0 110.284 -179.834 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 51.9 tp10 -60.77 -43.73 97.65 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.496 -179.749 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -60.04 -41.74 92.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.175 0.512 . . . . 0.0 109.841 179.548 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.676 ' NH2' ' NH1' ' A' ' 93' ' ' ARG . 61.3 ttm-85 -60.04 -44.75 94.46 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.718 -179.544 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -61.87 -40.9 96.98 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.056 0.455 . . . . 0.0 110.141 -179.719 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 61.4 m -66.94 -44.01 81.73 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 177.949 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' B' B ' 248' ' ' GLN . . . . . 0.611 ' CD ' HH12 ' A' ' 12' ' ' ARG . 6.8 tt0 -60.87 -37.8 83.38 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.201 179.867 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.444 HG23 ' O ' ' B' ' 245' ' ' ARG . 53.6 t -62.21 -45.97 97.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 C-N-CA 119.926 -0.709 . . . . 0.0 110.037 -179.966 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -58.77 -28.86 66.31 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.603 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -89.56 -14.76 34.39 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.52 179.355 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 1.091 HD22 HH21 ' A' ' 12' ' ' ARG . 64.2 tp -76.28 136.58 39.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.484 -179.237 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -104.19 144.04 32.12 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.956 178.988 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -64.62 -19.18 65.53 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.038 -179.722 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -65.58 -11.32 43.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.658 -179.889 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.497 ' C ' ' H ' ' B' ' 258' ' ' ASP . 85.3 m-20 -92.97 71.25 4.66 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.998 0.428 . . . . 0.0 110.48 179.228 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -66.43 13.16 0.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.621 -179.16 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.731 ' O ' ' N ' ' B' ' 260' ' ' GLU . 48.2 p-10 -101.61 1.34 37.67 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.033 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.457 ' C ' ' O ' ' B' ' 258' ' ' ASP . 56.0 p-10 4.7 49.72 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 O-C-N 124.477 1.11 . . . . 0.0 113.806 179.593 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.731 ' N ' ' O ' ' B' ' 258' ' ' ASP . 97.7 mt-10 58.67 4.25 0.36 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 178.764 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 75.2 mt -113.11 134.9 54.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 179.065 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 59.2 t -124.22 133.27 69.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.924 0.392 . . . . 0.0 110.842 -179.564 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -96.48 118.5 33.11 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.141 0.496 . . . . 0.0 110.928 -179.424 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -65.32 -47.95 74.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.857 -179.945 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' B' B ' 265' ' ' GLN . . . . . 0.619 ' HG2' HD11 ' A' ' 24' ' ' LEU . 1.3 mp0 -95.15 164.84 18.22 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.143 -178.436 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -64.34 149.63 89.78 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 122.91 2.406 . . . . 0.0 112.696 -179.575 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 47.7 pt . . . . . 0 C--N 1.33 -0.243 0 CA-C-O 121.366 0.603 . . . . 0.0 111.436 -179.851 . . . . . . . . 0 0 . 1 . 060 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo . . . . . 0 N--CA 1.494 1.546 0 CA-C-O 120.669 0.196 . . . . 0.0 112.355 . . . . . . . . . 0 0 . 1 . 060 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.2 m -76.04 -48.67 20.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.915 0.388 . . . . 0.0 111.065 179.341 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.1 mtt85 -90.08 136.45 33.04 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.657 -178.559 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -127.59 137.35 52.55 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.787 179.482 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.65 HD11 ' HB3' ' A' ' 95' ' ' PHE . 40.6 tp -115.67 134.0 55.48 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.651 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.0 t -111.76 130.98 64.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -179.799 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.459 ' CG2' HD12 ' B' ' 261' ' ' ILE . 4.2 m -90.45 111.76 23.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.393 0.616 . . . . 0.0 112.09 -178.644 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 95.2 mt -79.97 142.13 14.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.703 178.64 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -91.42 159.97 15.7 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.021 0.439 . . . . 0.0 111.368 -179.832 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 91.3 mtm180 -57.68 -29.38 64.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.282 -179.68 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.7 t -80.69 -11.01 59.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.339 179.557 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.63 34.82 6.42 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.356 -0.697 . . . . 0.0 111.356 -179.985 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.4 t -121.65 131.33 73.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.604 0.24 . . . . 0.0 110.696 179.531 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -73.27 135.7 44.49 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.146 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -124.82 -117.08 2.21 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.145 -179.288 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -73.62 144.55 35.83 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.153 1.902 . . . . 0.0 113.056 -178.581 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.424 ' O ' ' CG2' ' B' ' 267' ' ' ILE . 9.1 m-70 -102.63 149.36 24.51 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.93 179.602 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -127.22 104.37 22.44 Favored Pre-proline 0 CA--C 1.536 0.437 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.538 -178.759 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.51 ' O ' ' NE2' ' B' ' 265' ' ' GLN . 61.5 Cg_endo -75.25 134.91 17.98 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.359 1.373 . . . . 0.0 112.433 -179.399 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 68.2 mt -88.98 54.27 2.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.341 -178.714 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.3 p -61.21 -20.53 62.89 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.984 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 80.8 mt -84.91 141.08 30.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.451 179.165 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.9 p -67.81 -15.9 63.85 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -178.595 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.513 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 85.6 m -132.52 134.72 45.35 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.071 179.905 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.7 t -127.8 115.78 19.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.226 179.409 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.495 HD21 ' HG2' ' A' ' 47' ' ' GLN . 43.1 tp -114.5 128.68 56.46 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.487 -178.991 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.622 ' CE2' HD12 ' A' ' 37' ' ' ILE . 3.4 m-85 -107.11 136.48 46.88 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.205 179.297 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 163.7 -175.87 39.85 Favored Glycine 0 N--CA 1.467 0.766 0 C-N-CA 120.094 -1.05 . . . . 0.0 112.591 178.88 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.626 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 84.1 mtm-85 -72.34 -30.2 64.52 Favored 'General case' 0 CA--C 1.522 -0.111 0 CA-C-O 121.035 0.445 . . . . 0.0 110.06 179.311 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.511 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -55.77 138.78 43.91 Favored Glycine 0 CA--C 1.523 0.54 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.401 -177.98 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.435 HG23 ' N ' ' A' ' 34' ' ' GLU . 9.4 tp -69.09 -41.15 81.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.84 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.435 ' N ' HG23 ' A' ' 33' ' ' ILE . 52.3 tp10 -54.04 -18.24 3.41 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 178.767 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.511 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 18.7 m -66.81 139.18 57.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.577 -179.769 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.513 ' OD2' ' O ' ' A' ' 26' ' ' THR . 60.5 m-20 -62.47 -34.73 77.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.613 -179.13 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.622 HD12 ' CE2' ' A' ' 29' ' ' PHE . 96.8 mt -127.18 120.84 56.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 177.796 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 51.3 ttt180 -108.39 133.94 51.87 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.26 -179.026 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 79.5 mt -117.49 133.93 62.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.439 -179.657 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -79.45 29.91 0.23 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.466 -178.096 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 41' ' ' LEU . 24.1 mt -98.49 125.82 41.57 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.915 179.39 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.94 -9.07 24.13 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.369 2.046 . . . . 0.0 113.326 -178.749 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.578 HG21 ' CE2' ' B' ' 241' ' ' PHE . 22.0 m -98.94 7.34 8.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.633 -179.797 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.626 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 53.6 t -96.7 135.75 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.809 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.0 m -70.01 171.33 9.68 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.114 0.483 . . . . 0.0 111.638 -179.234 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -61.67 -41.55 97.69 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.405 -179.044 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.633 ' O ' ' N ' ' A' ' 49' ' ' CYS . 97.1 mt-30 -112.5 -18.88 12.31 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 123.384 0.428 . . . . 0.0 110.757 -179.92 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 16.0 t60 36.93 -76.23 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 179.513 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.633 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.12 136.23 48.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.317 0.58 . . . . 0.0 112.121 -178.856 . . . . . . . . 3 3 . 1 . 060 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -126.27 127.98 46.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.259 179.623 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 95.5 mt -116.29 134.36 59.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.998 -179.916 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -114.71 140.3 48.97 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.331 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 50.1 mm -107.66 120.41 58.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.185 -0.606 . . . . 0.0 111.821 -179.11 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.422 ' O ' ' N ' ' A' ' 56' ' ' GLN . 98.5 m-70 -123.68 133.36 53.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.661 178.488 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 54' ' ' HIS . 98.7 mt-10 -39.56 -31.81 0.11 Allowed 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.415 -0.514 . . . . 0.0 109.938 -178.261 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.422 ' N ' ' O ' ' A' ' 54' ' ' HIS . 85.9 mt-30 -63.2 -67.82 0.39 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.476 178.894 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.424 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 7.1 tp10 -152.22 -153.54 0.49 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.529 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.432 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -131.71 134.14 45.59 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.644 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.3 mt -119.14 130.61 73.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -178.262 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.684 HD22 ' CD1' ' A' ' 88' ' ' ILE . 26.3 tp -95.7 127.46 41.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.754 179.201 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -114.4 138.23 50.82 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.596 -179.409 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.428 ' C ' ' OD1' ' A' ' 62' ' ' ASN . 55.6 t-20 -96.08 106.2 18.35 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -178.54 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -101.56 -12.16 18.7 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.947 0.403 . . . . 0.0 110.038 178.425 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.13 104.78 3.72 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.369 179.613 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.5 p -88.29 -19.49 26.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.164 0.506 . . . . 0.0 109.831 179.648 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.66 -44.49 12.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.783 -179.874 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 -140.62 98.3 7.18 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.181 -179.715 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -54.91 143.99 69.51 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.279 1.986 . . . . 0.0 112.673 -179.614 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.1 m -70.28 136.57 49.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.117 179.32 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -101.72 141.1 35.1 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.442 179.937 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.686 HG13 ' OD1' ' A' ' 86' ' ' ASP . 51.6 t -126.15 136.21 61.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.649 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 51.27 33.61 10.06 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -179.821 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.41 28.42 71.27 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.162 -179.968 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.5 t -140.18 138.34 35.08 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.259 -179.727 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 64.1 t -69.3 131.82 33.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.896 -179.34 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.3 100.39 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.765 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -84.33 -16.42 43.02 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.972 -179.013 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.23 160.82 29.82 Favored Pre-proline 0 C--O 1.219 -0.524 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.238 179.866 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -58.24 142.27 97.24 Favored 'Trans proline' 0 N--CA 1.502 1.989 0 C-N-CA 121.932 1.755 . . . . 0.0 112.968 -179.151 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.3 p -142.15 141.08 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 120.996 0.427 . . . . 0.0 111.459 179.575 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -74.52 131.05 40.67 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.41 179.492 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.432 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 96.7 mt -83.46 136.86 34.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.171 0.51 . . . . 0.0 110.96 -179.984 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -128.22 151.2 49.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.152 -179.785 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.459 ' ND1' ' OD1' ' A' ' 99' ' ' ASN . 4.6 t60 -53.45 120.21 5.8 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.383 -179.209 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.13 -15.7 27.92 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -179.34 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.686 ' OD1' HG13 ' A' ' 71' ' ' VAL . 65.4 t0 -73.75 124.9 26.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.007 0.432 . . . . 0.0 110.245 179.753 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.448 HG22 ' HA ' ' A' ' 96' ' ' ARG . 26.2 t -104.57 133.38 48.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.127 -178.953 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.684 ' CD1' HD22 ' A' ' 60' ' ' LEU . 33.1 mm -90.08 130.91 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.1 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.5 m -121.56 126.28 48.76 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -177.84 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.524 ' O ' ' N ' ' A' ' 92' ' ' ASP . 91.9 mt -115.75 125.3 72.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.843 178.612 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.518 HG23 ' SG ' ' B' ' 237' ' ' CYS . 42.1 mm 35.66 -93.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.974 179.261 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 90' ' ' ILE . 28.1 t70 -122.85 19.29 10.18 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.745 0.307 . . . . 0.0 111.294 -179.711 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.499 ' HG3' HH22 ' B' ' 245' ' ' ARG . 99.1 mtt180 -129.75 145.22 51.56 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.443 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 60.8 p -140.63 157.04 46.04 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 119.634 -0.826 . . . . 0.0 111.35 -179.95 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.65 ' HB3' HD11 ' A' ' 7' ' ' LEU . 46.6 m-85 -125.87 122.13 35.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.894 179.893 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.509 ' O ' HD12 ' A' ' 7' ' ' LEU . 52.2 ttt85 -82.49 128.5 34.34 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.582 -179.757 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -96.54 127.79 42.86 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.739 179.871 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -134.22 124.52 26.1 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.639 179.888 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.459 ' OD1' ' ND1' ' A' ' 84' ' ' HIS . 46.6 p30 -105.45 -146.86 0.39 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.71 -179.863 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.021 -179.307 . . . . . . . . 0 0 . 1 . 060 nuclear build full ' B' B ' 228' ' ' VAL . . . . . 0.681 ' O ' HG13 ' B' ' 228' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.461 0.093 0 CA-C-O 121.095 0.474 . . . . 0.0 109.745 . . . . . . . . . 2 2 . 1 . 060 nuclear build full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -69.89 139.44 53.0 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.589 -179.713 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 060 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -119.52 32.16 6.22 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.131 179.973 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -111.8 -170.78 18.73 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 -179.91 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -74.93 162.29 37.52 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 123.092 2.528 . . . . 0.0 112.416 179.943 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 060 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.67 170.53 18.06 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.274 1.982 . . . . 0.0 112.562 -179.965 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.487 HG13 ' O ' ' B' ' 236' ' ' VAL . 3.0 p -101.55 125.95 55.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.722 -179.814 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' B' B ' 237' ' ' CYS . . . . . 0.518 ' SG ' HG23 ' A' ' 91' ' ' ILE . 32.1 t -65.07 122.89 18.1 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.533 179.689 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 060 nuclear build full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -54.29 -22.32 26.05 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.203 1.935 . . . . 0.0 111.801 179.407 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 96.7 m -71.95 -43.89 64.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.582 0.706 . . . . 0.0 109.334 178.13 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.578 ' CE2' HG21 ' A' ' 43' ' ' VAL . 80.8 t80 -57.85 -46.15 85.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.172 -179.44 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 89.0 mt -63.73 -42.19 97.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.541 -179.634 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -64.85 -40.01 94.48 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.412 -179.254 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -61.71 -44.98 95.89 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.073 -179.458 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.499 HH22 ' HG3' ' A' ' 93' ' ' ARG . 79.9 mtp180 -63.2 -40.42 97.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.36 -179.475 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.95 -39.69 95.4 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.924 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 75.2 m -64.06 -45.03 90.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.35 177.942 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 -61.58 -37.31 83.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.786 -179.761 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 39.1 t -61.85 -43.74 97.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 C-N-CA 119.951 -0.699 . . . . 0.0 109.263 178.644 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -62.67 -28.23 69.79 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.571 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -83.57 -9.21 59.08 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.68 179.151 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 76.7 mt -101.09 -176.93 3.3 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.387 178.276 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -118.05 148.83 41.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.768 0.318 . . . . 0.0 111.376 -179.47 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -63.68 -25.2 68.1 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.241 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -79.2 13.23 1.94 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.531 -179.684 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -84.1 93.26 8.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.153 0.501 . . . . 0.0 109.963 -179.88 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -76.83 -9.28 58.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.859 -179.007 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -80.76 110.34 16.16 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.191 -0.603 . . . . 0.0 109.827 179.86 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.676 ' C ' ' H ' ' B' ' 261' ' ' ILE . 58.5 t0 -103.89 123.46 47.17 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.89 -179.143 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -54.56 11.66 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.814 -1.085 . . . . 0.0 111.9 179.893 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.676 ' H ' ' C ' ' B' ' 259' ' ' ASP . 95.7 mt -103.76 137.42 32.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 177.909 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 69.2 t -125.38 132.44 71.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 120.421 -0.511 . . . . 0.0 110.544 -178.715 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -97.71 122.61 40.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.2 0.524 . . . . 0.0 111.734 -178.365 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -69.26 -42.8 75.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.551 179.899 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' B' B ' 265' ' ' GLN . . . . . 0.51 ' NE2' ' O ' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -88.06 161.21 44.41 Favored Pre-proline 0 CA--C 1.518 -0.269 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.933 -178.328 . . . . . . . . 3 3 . 1 . 060 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -59.23 145.68 97.0 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 121.973 1.782 . . . . 0.0 109.924 178.633 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' B' B ' 267' ' ' ILE . . . . . 0.424 ' CG2' ' O ' ' A' ' 19' ' ' HIS . 4.3 mt . . . . . 0 C--N 1.326 -0.443 0 C-N-CA 119.946 -0.702 . . . . 0.0 110.953 -178.081 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo . . . . . 0 N--CA 1.491 1.365 0 CA-C-O 121.087 0.37 . . . . 0.0 112.636 . . . . . . . . . 0 0 . 1 . 061 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.595 HG23 ' O ' ' A' ' 100' ' ' GLU . 26.0 m -74.27 -45.19 49.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.214 -179.757 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.724 ' NH1' ' HB2' ' A' ' 58' ' ' ALA . 99.8 mtt180 -98.33 136.34 38.64 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.21 -177.667 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.434 HH22 ' HB2' ' A' ' 100' ' ' GLU . 85.1 mtm-85 -138.25 150.19 46.45 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.808 -179.807 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.633 HD11 HD11 ' A' ' 22' ' ' LEU . 84.5 mt -115.0 143.43 45.2 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.744 -179.908 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.4 t -115.97 127.66 73.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.338 179.07 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 m -77.85 134.16 38.02 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.647 0.737 . . . . 0.0 112.156 -178.888 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.515 ' CD1' ' OD1' ' A' ' 16' ' ' ASP . 50.5 mm -104.47 134.23 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 114.653 -1.158 . . . . 0.0 107.943 177.086 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.448 ' HZ1' ' C ' ' B' ' 257' ' ' LYS . 65.3 mttm -96.67 159.81 14.73 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.197 0.522 . . . . 0.0 111.103 -179.246 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.421 ' CB ' HG21 ' B' ' 249' ' ' VAL . 84.7 mtt-85 -57.52 -31.1 65.71 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.111 -178.84 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.421 ' OG ' HG22 ' A' ' 15' ' ' VAL . 80.2 p -72.97 -15.15 61.55 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.808 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.7 17.04 46.42 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.647 179.948 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.421 HG22 ' OG ' ' A' ' 13' ' ' SER . 4.3 m -108.15 139.72 29.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.127 0.489 . . . . 0.0 110.632 -179.845 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.515 ' OD1' ' CD1' ' A' ' 10' ' ' ILE . 99.0 m-20 -76.76 138.5 39.95 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.953 179.849 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -128.48 -117.72 2.04 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 120.193 -1.003 . . . . 0.0 111.653 -179.774 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -74.73 151.58 41.16 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.6 2.2 . . . . 0.0 112.635 -179.126 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -111.17 144.32 40.5 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.265 179.28 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.561 ' CD2' HD11 ' A' ' 37' ' ' ILE . 38.8 t80 -108.28 94.64 13.76 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.582 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.83 137.3 29.4 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 121.169 1.246 . . . . 0.0 111.855 -178.795 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.633 HD11 HD11 ' A' ' 7' ' ' LEU . 97.9 mt -93.18 107.75 19.5 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.144 0.497 . . . . 0.0 111.419 -178.755 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 94.4 p -111.53 -6.34 14.43 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.348 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 70.7 mt -104.32 146.69 28.44 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.764 -179.739 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 83.8 p -66.32 -16.56 64.14 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.75 -178.754 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 29.8 m -132.9 134.16 44.22 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.939 -179.43 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.629 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 9.2 t -127.39 120.77 29.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.881 178.839 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.444 HD21 ' OE1' ' A' ' 47' ' ' GLN . 32.0 tp -118.5 128.46 54.61 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.788 0.328 . . . . 0.0 111.38 -178.428 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.74 ' CE2' HD12 ' A' ' 37' ' ' ILE . 14.5 m-85 -105.15 140.15 38.75 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.561 179.12 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 153.38 -179.58 29.63 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 119.944 -1.122 . . . . 0.0 112.637 178.537 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.499 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 45.3 mtm180 -70.04 -33.05 71.47 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.03 0.443 . . . . 0.0 110.637 178.516 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.57 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -52.96 141.31 29.44 Favored Glycine 0 CA--C 1.521 0.449 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.95 -178.401 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.648 HG23 ' NH2' ' A' ' 38' ' ' ARG . 78.7 mt -63.05 -43.05 98.8 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.162 178.974 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.406 ' HA ' ' NZ ' ' B' ' 264' ' ' LYS . 97.2 mt-10 -51.1 -18.85 0.93 Allowed 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.403 -0.519 . . . . 0.0 109.666 179.67 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.57 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 23.0 m -67.26 122.58 18.18 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.163 -179.527 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -57.05 -22.86 42.39 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -179.534 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.74 HD12 ' CE2' ' A' ' 29' ' ' PHE . 84.2 mt -130.98 118.28 40.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.987 177.904 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.648 ' NH2' HG23 ' A' ' 33' ' ' ILE . 57.4 mtt180 -99.74 133.5 44.0 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.29 -179.022 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 97.4 mt -116.81 126.93 74.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 120.417 -0.513 . . . . 0.0 109.999 179.339 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -75.27 42.64 0.2 Allowed 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -177.104 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.686 HD21 ' OE1' ' B' ' 260' ' ' GLU . 85.4 mt -118.43 131.48 24.22 Favored Pre-proline 0 C--N 1.326 -0.451 0 C-N-CA 120.521 -0.472 . . . . 0.0 111.098 179.657 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.41 -10.32 23.81 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 122.235 1.957 . . . . 0.0 111.892 179.786 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.443 HG21 ' CE2' ' B' ' 241' ' ' PHE . 19.4 m -96.02 2.69 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.056 179.724 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.499 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 37.3 t -99.44 104.02 15.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.916 0.388 . . . . 0.0 111.262 -179.621 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.471 ' O ' ' O ' ' A' ' 44' ' ' VAL . 5.0 m -37.92 161.35 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.301 0.572 . . . . 0.0 111.108 -179.797 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.3 mttp -63.5 -38.71 92.18 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.82 -179.096 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.599 ' O ' ' N ' ' A' ' 49' ' ' CYS . 96.2 mm-40 -108.9 -25.53 10.71 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.264 0.554 . . . . 0.0 110.417 -179.482 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.411 ' NE2' HG23 ' A' ' 90' ' ' ILE . 18.2 t60 38.67 -76.33 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 179.467 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.599 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.57 135.41 46.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.132 0.492 . . . . 0.0 112.018 -178.162 . . . . . . . . 3 3 . 1 . 061 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -130.14 131.0 45.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.808 179.89 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 91.1 mt -115.53 136.03 53.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.222 179.65 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -118.82 128.9 54.9 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.412 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.52 HG23 ' NH1' ' A' ' 5' ' ' ARG . 97.0 mt -105.67 114.26 44.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.626 -179.508 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.558 ' O ' ' N ' ' A' ' 56' ' ' GLN . 79.7 m-70 -112.22 143.53 43.12 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.336 179.385 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.459 ' C ' ' O ' ' A' ' 54' ' ' HIS . 98.5 mt-10 -40.09 -25.48 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -179.699 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.558 ' N ' ' O ' ' A' ' 54' ' ' HIS . 82.8 mt-30 -67.73 -68.96 0.35 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.407 178.519 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.452 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 4.1 tp10 -160.4 -162.91 1.02 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.724 179.957 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.724 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -111.19 124.41 52.16 Favored 'General case' 0 N--CA 1.461 0.119 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.326 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 79.4 mt -116.58 131.15 70.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.802 -178.36 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.3 tp -96.86 129.83 44.24 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.487 179.836 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -113.13 133.48 55.01 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.235 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.443 ' ND2' ' H ' ' A' ' 69' ' ' THR . 9.6 t-20 -96.26 108.48 20.98 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.496 -179.374 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -99.75 -9.53 22.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.425 179.896 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.9 t -74.17 100.56 3.7 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.508 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.4 m -84.17 -22.7 30.88 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.428 -179.767 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.519 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.2 OUTLIER -78.34 -43.72 27.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.147 0.498 . . . . 0.0 110.222 179.993 . . . . . . . . 3 3 . 1 . 061 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.415 ' OD1' ' O ' ' A' ' 66' ' ' THR . 22.8 m-20 -140.88 100.41 6.57 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.749 -179.833 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.583 ' HB2' HG13 ' A' ' 75' ' ' VAL . 32.1 Cg_exo -57.48 147.24 79.56 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 121.954 1.77 . . . . 0.0 112.438 -179.656 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.443 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 10.3 m -74.61 151.74 39.33 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.182 179.234 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -111.23 140.67 45.6 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.267 179.932 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.699 HG13 ' OD1' ' A' ' 86' ' ' ASP . 55.8 t -129.99 134.39 62.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.962 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 52.08 32.0 9.72 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -179.024 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.89 29.12 67.59 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.528 -179.834 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.7 m -141.82 138.5 32.24 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.583 -179.64 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.583 HG13 ' HB2' ' A' ' 68' ' ' PRO . 40.5 t -68.22 140.5 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.208 -179.275 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 9.2 pt -113.0 92.18 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 121.272 0.558 . . . . 0.0 110.164 178.306 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -64.83 -29.37 70.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.98 -179.779 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.423 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.8 OUTLIER -125.28 177.78 1.74 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.986 179.383 . . . . . . . . 3 3 . 1 . 061 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.423 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 36.0 Cg_exo -60.43 145.68 98.24 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 122.527 2.152 . . . . 0.0 112.097 179.814 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.8 p -137.73 141.22 39.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-O 121.166 0.507 . . . . 0.0 111.365 -179.778 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 45.3 ttm180 -79.88 131.97 35.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.711 179.68 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 89.3 mt -84.54 138.39 32.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.899 -179.043 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -130.84 152.57 50.03 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.75 179.065 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -55.88 119.09 5.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.84 0.352 . . . . 0.0 110.817 -179.451 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.57 -9.0 35.01 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.824 -0.911 . . . . 0.0 110.824 -179.675 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.699 ' OD1' HG13 ' A' ' 71' ' ' VAL . 61.0 t0 -75.61 126.58 31.28 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.727 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 39.9 t -107.35 131.07 58.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.788 -179.032 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 87.4 mt -97.0 131.51 43.62 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.396 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.9 m -122.46 125.38 45.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.566 0.698 . . . . 0.0 112.033 -178.429 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.455 ' O ' ' C ' ' A' ' 91' ' ' ILE . 95.7 mt -113.25 124.35 69.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.471 178.912 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.668 HG23 ' SG ' ' B' ' 237' ' ' CYS . 95.0 mt 35.09 -99.95 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 121.166 -0.213 . . . . 0.0 110.527 -178.612 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.518 ' N ' HG22 ' A' ' 91' ' ' ILE . 42.8 t0 -116.41 20.22 14.3 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.025 0.441 . . . . 0.0 110.929 179.745 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.626 ' CZ ' ' CD1' ' A' ' 41' ' ' LEU . 29.9 mtm-85 -130.13 142.34 50.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.473 -179.783 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 30.2 t -140.48 152.4 45.59 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.637 -179.037 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -123.31 122.0 37.24 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.157 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -83.98 134.13 34.66 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.827 -179.496 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -92.81 120.82 33.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.579 179.807 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -123.2 116.54 23.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.018 179.735 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -105.48 107.63 18.71 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.329 179.768 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.595 ' O ' HG23 ' A' ' 4' ' ' THR . 86.7 tt0 . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.373 -179.334 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' B' B ' 228' ' ' VAL . . . . . 0.404 HG23 ' N ' ' B' ' 229' ' ' ASP . 27.6 m . . . . . 0 N--CA 1.451 -0.376 0 CA-C-O 120.855 0.36 . . . . 0.0 110.064 . . . . . . . . . 1 1 . 1 . 061 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.512 ' O ' ' CB ' ' B' ' 230' ' ' SEP . 85.4 m-20 53.61 32.69 14.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.4 178.85 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' B' B ' 230' ' ' SEP . . . . . 0.512 ' CB ' ' O ' ' B' ' 229' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 061 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 20.8 mm100 -128.21 62.77 1.43 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.937 -179.002 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -122.39 170.63 15.2 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 -179.861 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -74.35 161.2 40.77 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 123.873 3.048 . . . . 0.0 111.966 179.814 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.519 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 061 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -61.69 139.02 78.56 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 121.877 1.718 . . . . 0.0 111.707 179.155 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.519 HG22 HG22 ' A' ' 66' ' ' THR . 42.7 t -61.35 136.36 24.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.628 179.612 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' B' B ' 237' ' ' CYS . . . . . 0.668 ' SG ' HG23 ' A' ' 91' ' ' ILE . 14.9 t -67.41 123.88 21.61 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.493 -0.483 . . . . 0.0 109.737 -179.787 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' B' B ' 238' ' ' TPO . . . . . 0.444 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 061 nuclear build full ' B' B ' 239' ' ' PRO . . . . . 0.444 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 51.0 Cg_exo -57.77 -28.35 81.7 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 123.158 2.572 . . . . 0.0 113.25 -179.837 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 20.7 m -72.93 -49.2 30.95 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.299 -0.561 . . . . 0.0 110.091 179.16 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.443 ' CE2' HG21 ' A' ' 43' ' ' VAL . 82.2 t80 -58.08 -47.49 83.01 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.324 -179.066 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 86.8 mt -64.48 -42.18 96.04 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -179.177 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -65.54 -39.36 91.65 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.201 -0.6 . . . . 0.0 111.099 -179.539 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -61.84 -42.88 99.57 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.167 -0.613 . . . . 0.0 109.591 179.784 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' B' B ' 245' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -63.07 -41.23 99.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.717 -179.846 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -62.1 -42.66 99.45 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.45 0.643 . . . . 0.0 109.89 179.41 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 67.3 p -67.83 -43.99 78.27 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.245 -0.888 . . . . 0.0 109.129 178.652 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -61.39 -39.49 90.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.388 179.882 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.444 ' C ' ' H ' ' B' ' 252' ' ' LEU . 0.4 OUTLIER -60.79 -42.1 91.04 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.872 179.674 . . . . . . . . 3 3 . 1 . 061 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -60.31 -33.09 71.88 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.271 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -81.57 -13.25 58.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.257 177.877 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.444 ' H ' ' C ' ' B' ' 249' ' ' VAL . 1.3 tp -110.94 -172.07 1.95 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.674 179.268 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' B' B ' 253' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' B' ' 252' ' ' LEU . 12.7 m120 80.91 32.55 0.14 Allowed 'General case' 0 N--CA 1.464 0.242 0 O-C-N 123.912 0.758 . . . . 0.0 111.138 -179.881 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' B' B ' 254' ' ' ASP . . . . . 0.44 ' N ' ' OD1' ' B' ' 254' ' ' ASP . 21.9 p-10 -63.03 -33.75 76.09 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.168 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' B' B ' 255' ' ' ASP . . . . . 0.529 ' O ' ' CB ' ' B' ' 256' ' ' ASP . 82.2 m-20 -115.15 -67.92 0.96 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.055 179.029 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.529 ' CB ' ' O ' ' B' ' 255' ' ' ASP . 4.3 m-20 96.81 39.9 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.429 -179.256 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' B' B ' 257' ' ' LYS . . . . . 0.448 ' C ' ' HZ1' ' A' ' 11' ' ' LYS . 71.5 mmtt -116.69 -22.14 8.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.627 -179.734 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.433 ' OD1' ' N ' ' B' ' 258' ' ' ASP . 30.0 p-10 -144.82 126.81 15.49 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.941 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' B' B ' 259' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -139.79 84.15 1.96 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 119.682 -0.807 . . . . 0.0 112.975 -179.046 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.686 ' OE1' HD21 ' A' ' 41' ' ' LEU . 96.7 mt-10 59.77 12.09 2.8 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 177.223 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 80.8 mt -119.46 132.33 69.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.35 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 51.1 t -126.79 135.61 63.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.021 0.439 . . . . 0.0 110.874 -179.69 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -94.59 117.44 30.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.186 0.517 . . . . 0.0 110.78 -179.176 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' B' B ' 264' ' ' LYS . . . . . 0.406 ' NZ ' ' HA ' ' A' ' 34' ' ' GLU . 88.8 tttt -70.53 -44.23 67.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.79 -179.69 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.68 162.18 26.39 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.771 -179.032 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -59.94 151.74 69.52 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.9 2.4 . . . . 0.0 111.588 179.364 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 47.8 pt . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 121.44 0.638 . . . . 0.0 111.827 -178.708 . . . . . . . . 0 0 . 1 . 062 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo . . . . . 0 N--CA 1.489 1.255 0 CA-C-O 120.745 0.227 . . . . 0.0 111.668 . . . . . . . . . 0 0 . 1 . 062 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 30.3 p -72.94 -40.76 65.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.629 -179.863 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.631 ' NH1' ' HB2' ' A' ' 58' ' ' ALA . 93.7 mtt-85 -91.68 131.2 37.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.819 -179.27 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -135.23 144.62 47.0 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.452 179.312 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.855 HD11 HD11 ' A' ' 22' ' ' LEU . 69.3 mt -119.64 146.46 45.54 Favored 'General case' 0 CA--C 1.527 0.083 0 CA-C-O 121.025 0.44 . . . . 0.0 111.451 -179.389 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.2 t -117.87 129.79 73.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.584 178.9 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.426 HG23 ' CD1' ' B' ' 261' ' ' ILE . 1.9 m -91.35 114.46 27.0 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.933 0.397 . . . . 0.0 111.067 -179.631 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 92.9 mt -81.11 144.66 10.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.282 179.508 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.456 ' HB2' ' H ' ' A' ' 15' ' ' VAL . 71.3 mmtt -84.78 150.76 24.83 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.339 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.613 HH11 HH11 ' B' ' 245' ' ' ARG . 87.8 mtm180 -58.28 -24.99 61.26 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -179.888 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.447 ' HA ' HG11 ' B' ' 249' ' ' VAL . 28.1 t -76.73 -13.03 60.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.876 178.738 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.97 35.27 6.82 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 179.946 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.456 ' H ' ' HB2' ' A' ' 11' ' ' LYS . 48.0 t -121.39 135.6 61.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.734 0.302 . . . . 0.0 110.888 -179.861 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -71.29 118.67 14.38 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.886 179.384 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -111.38 -126.43 4.87 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 120.976 -0.631 . . . . 0.0 111.751 -179.017 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.63 148.68 42.38 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.236 1.958 . . . . 0.0 112.196 -179.239 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -105.77 154.57 20.3 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.647 179.801 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.832 ' CD2' HD11 ' A' ' 37' ' ' ILE . 51.5 t80 -122.44 92.37 49.01 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.1 -179.33 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -74.16 139.92 27.3 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 121.331 1.354 . . . . 0.0 111.557 -179.517 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.855 HD11 HD11 ' A' ' 7' ' ' LEU . 81.3 mt -102.54 125.29 49.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.22 0.533 . . . . 0.0 111.798 -178.176 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 61.6 p -121.71 -2.73 9.31 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.381 -0.827 . . . . 0.0 108.806 178.292 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.9 mt -104.82 147.17 28.02 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.154 -179.203 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 90.6 p -68.63 -17.15 64.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.001 -178.912 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 44.2 m -128.53 131.78 48.27 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.365 0.603 . . . . 0.0 111.997 -179.121 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.683 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -128.52 121.6 29.22 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.188 178.896 . . . . . . . . 3 3 . 1 . 062 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.516 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 42.8 tp -120.76 126.43 50.13 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -178.208 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.683 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 66.0 m-85 -103.08 145.14 30.35 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 178.616 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 155.64 -169.87 33.49 Favored Glycine 0 C--N 1.321 -0.27 0 C-N-CA 119.886 -1.15 . . . . 0.0 112.273 178.611 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 31' ' ' ARG . 33.2 ttp-105 -86.64 -31.11 21.28 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -179.624 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -57.09 152.09 25.24 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-N 116.217 -0.447 . . . . 0.0 112.168 -178.977 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.421 ' CD1' ' CZ ' ' A' ' 38' ' ' ARG . 37.5 mm -63.93 -44.04 97.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-O 120.766 0.317 . . . . 0.0 110.93 179.93 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -55.74 -17.5 6.14 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.095 -179.075 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 83.2 m -64.05 119.65 10.53 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.662 -179.71 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.589 ' OD2' ' SG ' ' A' ' 27' ' ' CYS . 12.0 p-10 -56.54 -24.07 44.26 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.97 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.832 HD11 ' CD2' ' A' ' 20' ' ' PHE . 45.2 mm -126.17 116.33 45.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.1 -0.955 . . . . 0.0 108.761 176.803 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.421 ' CZ ' ' CD1' ' A' ' 33' ' ' ILE . 84.5 mtp180 -100.97 132.24 46.48 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -179.195 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.6 mt -123.08 131.53 73.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.173 0.511 . . . . 0.0 111.058 -179.341 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -81.75 35.18 0.41 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.642 -178.628 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.749 HD11 ' NE ' ' A' ' 93' ' ' ARG . 40.3 mt -100.17 115.72 65.21 Favored Pre-proline 0 C--N 1.325 -0.494 0 C-N-CA 120.388 -0.525 . . . . 0.0 110.391 179.502 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -56.22 -15.4 14.42 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 121.944 1.763 . . . . 0.0 112.421 178.794 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.445 HG23 HG13 ' A' ' 91' ' ' ILE . 25.9 m -98.24 8.32 7.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.556 -179.583 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.7 t -99.21 132.51 44.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.103 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.2 m -71.96 169.06 16.7 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.585 0.707 . . . . 0.0 111.775 -178.829 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -64.78 -40.69 95.67 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.671 -1.15 . . . . 0.0 111.457 -179.076 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.602 ' O ' ' N ' ' A' ' 49' ' ' CYS . 93.7 mm-40 -106.91 -23.86 12.22 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.259 0.552 . . . . 0.0 110.036 179.821 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.6 t60 38.17 -78.46 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.144 -0.935 . . . . 0.0 112.975 179.487 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.602 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.1 OUTLIER -135.36 137.0 41.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.226 0.536 . . . . 0.0 111.767 -178.428 . . . . . . . . 3 3 . 1 . 062 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -124.74 128.22 48.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.603 179.155 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 82.4 mt -111.07 131.49 62.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.852 179.303 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -114.29 132.49 56.15 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.371 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.41 HD12 ' CD ' ' A' ' 5' ' ' ARG . 43.4 mm -103.33 114.32 42.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 120.161 -0.616 . . . . 0.0 111.106 -179.278 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.449 ' O ' ' C ' ' A' ' 55' ' ' GLU . 96.9 m-70 -116.71 137.17 52.39 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.633 179.195 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 54' ' ' HIS . 80.2 mm-40 -39.95 -35.73 0.39 Allowed 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.057 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -60.27 -68.63 0.28 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.013 178.804 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.582 ' OE2' ' NH1' ' A' ' 81' ' ' ARG . 9.5 pt-20 -160.37 -158.46 0.62 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.327 178.88 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.631 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -120.95 133.96 55.29 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.764 0.316 . . . . 0.0 110.917 -179.648 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 87.6 mt -116.83 131.4 69.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.3 0.571 . . . . 0.0 112.457 -178.837 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.495 HD23 HD13 ' A' ' 76' ' ' ILE . 37.5 tp -95.22 126.91 40.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.695 179.833 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -116.0 134.34 55.07 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.668 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -98.96 105.23 17.35 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.787 -179.369 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -96.83 -7.89 32.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.301 179.134 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.96 99.47 6.85 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.069 0.461 . . . . 0.0 110.627 179.906 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 91.5 p -78.39 -33.09 49.04 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.945 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.597 HG21 ' O ' ' B' ' 234' ' ' TPO . 2.2 m -66.9 -46.09 75.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.072 -179.351 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.447 HD21 ' HA ' ' B' ' 236' ' ' VAL . 35.2 m-80 -146.05 97.27 4.51 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.835 -179.118 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.536 ' HB2' HG13 ' A' ' 75' ' ' VAL . 51.5 Cg_exo -54.6 146.67 52.58 Favored 'Trans proline' 0 N--CA 1.501 1.958 0 C-N-CA 122.625 2.217 . . . . 0.0 113.585 -179.965 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 93.4 m -72.14 138.74 47.91 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.463 178.669 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -102.35 140.73 36.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.092 -179.918 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.473 ' HB ' HD11 ' A' ' 76' ' ' ILE . 5.6 t -131.36 139.69 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.118 178.568 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 52.36 32.4 11.04 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.346 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.09 30.23 65.64 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.51 179.185 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.7 m -146.2 143.76 29.47 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 117.659 0.729 . . . . 0.0 111.798 -179.825 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.536 HG13 ' HB2' ' A' ' 68' ' ' PRO . 74.8 t -69.8 138.35 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.235 -179.376 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.536 ' CG2' ' O ' ' A' ' 78' ' ' GLU . 95.6 mt -105.15 100.31 10.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.569 179.744 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -65.94 -39.56 90.58 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.599 179.57 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.536 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.1 OUTLIER -129.63 177.48 2.16 Favored Pre-proline 0 N--CA 1.466 0.374 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.405 -178.989 . . . . . . . . 3 3 . 1 . 062 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.423 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 33.8 Cg_exo -58.93 145.05 98.53 Favored 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 122.56 2.173 . . . . 0.0 112.54 -179.45 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.4 p -142.68 141.32 27.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.508 -179.778 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.582 ' NH1' ' OE2' ' A' ' 57' ' ' GLU . 93.9 mtt-85 -73.85 133.09 43.12 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.613 -179.507 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.447 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 94.3 mt -87.15 139.24 30.77 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.356 0.598 . . . . 0.0 111.76 -179.17 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -130.89 155.36 46.88 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.727 -179.566 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -56.22 118.51 4.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.803 0.335 . . . . 0.0 110.229 -179.748 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.31 -12.52 26.13 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.367 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.46 ' OD1' HG13 ' A' ' 71' ' ' VAL . 48.1 t0 -68.99 128.19 35.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.851 0.358 . . . . 0.0 110.605 179.762 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.429 HG22 ' HG2' ' A' ' 96' ' ' ARG . 53.6 t -109.81 131.84 59.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.78 -178.81 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.4 mm -94.65 127.79 46.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.091 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 53.1 m -118.14 124.93 49.21 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.881 -179.558 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.444 ' O ' ' C ' ' A' ' 91' ' ' ILE . 96.0 mt -122.19 126.18 73.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.26 179.321 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.445 HG13 HG23 ' A' ' 43' ' ' VAL . 31.8 mm 35.87 -109.55 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.01 -179.464 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.411 ' N ' HG22 ' A' ' 91' ' ' ILE . 86.6 m-20 -103.1 11.59 36.94 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.755 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.749 ' NE ' HD11 ' A' ' 41' ' ' LEU . 17.4 ptp180 -130.88 147.25 52.51 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.827 179.822 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 29.8 t -137.07 152.75 50.4 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.736 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.407 ' HE1' HD12 ' A' ' 90' ' ' ILE . 80.5 m-85 -121.35 121.47 37.72 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.73 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.429 ' HG2' HG22 ' A' ' 87' ' ' VAL . 99.3 mtt180 -85.18 129.54 34.78 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.004 -0.679 . . . . 0.0 110.515 -179.112 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.494 ' OH ' ' ND2' ' A' ' 99' ' ' ASN . 24.3 t80 -97.37 122.83 40.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.093 0.473 . . . . 0.0 110.236 179.869 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -121.86 123.26 41.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.062 179.849 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.494 ' ND2' ' OH ' ' A' ' 97' ' ' TYR . 20.6 t-20 -101.24 108.23 19.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.888 -179.51 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 . . . . . 0 C--N 1.329 -0.313 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.295 . . . . . . . . 0 0 . 1 . 062 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 54.7 t . . . . . 0 N--CA 1.455 -0.204 0 CA-C-O 120.87 0.367 . . . . 0.0 110.52 . . . . . . . . . 0 0 . 1 . 062 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.43 ' C ' ' H ' ' B' ' 231' ' ' GLN . 97.1 m-20 -73.29 141.94 47.17 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.515 179.834 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' B' B ' 230' ' ' SEP . . . . . 0.427 ' N ' ' O3P' ' B' ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 062 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.43 ' H ' ' C ' ' B' ' 229' ' ' ASP . 72.9 mt-30 -128.3 35.24 4.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.324 179.937 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -119.02 -164.53 12.82 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.487 -178.647 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.5 150.32 76.43 Favored 'Trans proline' 0 N--CA 1.501 1.95 0 C-N-CA 124.411 3.407 . . . . 0.0 113.618 -179.494 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.597 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 062 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.26 140.11 69.2 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.085 1.857 . . . . 0.0 114.041 -179.415 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.447 ' HA ' HD21 ' A' ' 67' ' ' ASN . 0.3 OUTLIER -75.1 139.38 19.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 113.939 -1.482 . . . . 0.0 111.017 -179.244 . . . . . . . . 3 3 . 1 . 062 nuclear build full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.9 t -75.89 125.05 28.35 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.225 -179.975 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 062 nuclear build full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -58.5 -25.26 73.33 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 122.833 2.355 . . . . 0.0 113.164 -179.233 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 16.7 m -73.14 -47.27 45.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.258 0.551 . . . . 0.0 110.434 179.385 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -57.88 -46.81 84.32 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.633 -178.932 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 96.7 mt -63.55 -42.32 98.37 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.669 -179.241 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -66.1 -39.1 89.71 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.338 -179.668 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' B' B ' 244' ' ' ARG . . . . . 0.535 ' NH1' ' OE1' ' B' ' 248' ' ' GLN . 78.4 ttt-85 -59.83 -45.72 91.52 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.953 -179.593 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.613 HH11 HH11 ' A' ' 12' ' ' ARG . 95.6 mtt-85 -65.81 -37.14 85.45 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.483 -179.5 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -60.28 -40.65 91.16 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.817 179.667 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 78.2 p -69.97 -43.02 72.36 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.108 0.48 . . . . 0.0 110.103 178.948 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' B' B ' 248' ' ' GLN . . . . . 0.535 ' OE1' ' NH1' ' B' ' 244' ' ' ARG . 88.0 mt-30 -64.19 -36.69 84.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.321 -179.768 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.562 HG23 ' O ' ' B' ' 245' ' ' ARG . 60.4 t -64.1 -45.79 95.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.356 -0.538 . . . . 0.0 109.912 179.444 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -64.22 -24.12 67.55 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 179.252 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -95.31 -4.02 46.3 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.946 -179.936 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 42.8 mt -109.48 129.14 55.57 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.989 0.423 . . . . 0.0 111.255 179.318 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -57.54 148.5 23.75 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.16 -179.623 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' B' B ' 254' ' ' ASP . . . . . 0.438 ' N ' ' OD1' ' B' ' 254' ' ' ASP . 32.2 p-10 -74.02 -10.13 59.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.2 179.704 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -87.38 2.97 48.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.278 -179.353 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -82.14 94.73 7.3 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.131 -0.627 . . . . 0.0 109.513 178.834 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' B' B ' 257' ' ' LYS . . . . . 0.455 ' HG2' ' H ' ' B' ' 258' ' ' ASP . 70.4 tttt -68.24 168.52 12.17 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.801 -179.063 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.455 ' H ' ' HG2' ' B' ' 257' ' ' LYS . 87.6 m-20 61.3 71.67 0.55 Allowed 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.39 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' B' B ' 259' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -85.59 72.69 10.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.417 -178.944 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.587 ' CD ' HH12 ' B' ' 245' ' ' ARG . 97.0 mt-10 57.45 10.63 0.99 Allowed 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 177.562 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.426 ' CD1' HG23 ' A' ' 9' ' ' THR . 69.8 mt -118.43 132.37 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 178.079 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 52.3 t -124.89 132.74 70.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.232 179.46 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -93.42 117.11 29.68 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.135 0.493 . . . . 0.0 110.897 -178.259 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -67.4 -45.97 74.61 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.393 -179.87 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 25.6 mm100 -88.6 153.34 50.25 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.887 -178.729 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -61.28 147.19 96.25 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.448 2.099 . . . . 0.0 112.253 179.362 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.4 pt . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.282 -179.329 . . . . . . . . 0 0 . 1 . 063 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo . . . . . 0 N--CA 1.506 2.258 0 N-CA-C 113.058 0.369 . . . . 0.0 113.058 . . . . . . . . . 0 0 . 1 . 063 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 46.0 p -102.44 -58.5 1.86 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.238 0.542 . . . . 0.0 110.368 178.867 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.8 mtt85 -85.92 131.05 34.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.324 -179.592 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -129.09 139.41 52.0 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.348 179.975 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.581 HD12 ' O ' ' A' ' 96' ' ' ARG . 32.7 tp -116.49 133.31 56.16 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.836 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 70.7 t -112.42 131.06 64.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.068 0.461 . . . . 0.0 110.174 -179.293 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.8 m -80.99 144.5 31.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.769 0.795 . . . . 0.0 112.472 -178.236 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.534 ' CD1' ' OD1' ' A' ' 16' ' ' ASP . 48.5 mm -111.86 135.78 50.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.54 178.389 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -93.48 157.95 15.96 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.318 0.58 . . . . 0.0 110.31 178.433 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.486 ' HD3' HH21 ' B' ' 245' ' ' ARG . 88.5 mtm180 -58.02 -23.49 54.42 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.435 -179.514 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 87.7 p -80.08 -13.13 59.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.329 179.913 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.19 20.06 34.07 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.56 179.228 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.4 m -115.65 138.21 46.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.166 179.301 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.534 ' OD1' ' CD1' ' A' ' 10' ' ' ILE . 83.1 m-20 -70.3 139.97 52.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.11 -179.91 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -126.22 -120.21 2.37 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 121.063 -0.589 . . . . 0.0 111.634 -179.638 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.38 146.1 39.33 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.018 1.812 . . . . 0.0 113.117 -178.621 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -104.82 145.64 30.1 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.09 179.468 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.465 ' CD2' HD11 ' A' ' 37' ' ' ILE . 61.3 t80 -119.45 103.5 46.67 Favored Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.496 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -73.64 130.06 14.34 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 121.617 1.544 . . . . 0.0 112.588 -178.433 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.2 mt -85.87 57.05 4.25 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.104 -178.666 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.59 -33.07 74.22 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.479 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.7 mt -74.91 142.5 44.01 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.139 179.791 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.59 -14.98 63.37 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.186 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.529 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 54.4 m -132.13 132.13 42.96 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.842 -179.798 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.5 t -124.57 117.16 23.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.804 178.683 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.472 HD11 ' HB3' ' A' ' 47' ' ' GLN . 32.6 tp -115.44 126.23 54.08 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.447 -178.96 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.81 ' CE2' HD12 ' A' ' 37' ' ' ILE . 4.8 m-85 -107.11 138.92 42.39 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.831 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.13 -168.78 37.29 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 120.071 -1.061 . . . . 0.0 112.577 179.424 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.711 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 83.9 mtm-85 -82.54 -26.68 32.24 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.744 0.307 . . . . 0.0 110.585 -179.753 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.474 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -61.69 134.62 47.13 Favored Glycine 0 N--CA 1.466 0.644 0 C-N-CA 121.354 -0.45 . . . . 0.0 112.349 -178.018 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.449 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.7 tp -62.79 -41.43 92.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.101 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.449 ' N ' HG23 ' A' ' 33' ' ' ILE . 83.8 tt0 -51.87 -16.09 0.64 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.883 179.137 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.474 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 40.8 m -70.54 142.4 51.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.751 179.709 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.529 ' OD2' ' O ' ' A' ' 26' ' ' THR . 59.1 m-20 -60.96 -34.08 74.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.703 -179.736 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.81 HD12 ' CE2' ' A' ' 29' ' ' PHE . 85.1 mt -129.89 124.31 58.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.031 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 70.6 ttp85 -109.63 138.45 45.98 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.18 -179.407 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.495 ' CG2' HD12 ' A' ' 41' ' ' LEU . 97.7 mt -116.6 131.36 69.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.687 -179.433 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -74.82 30.78 0.09 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -178.083 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.616 ' CD1' ' CZ ' ' A' ' 93' ' ' ARG . 17.3 mt -110.36 129.81 23.55 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 120.132 -0.627 . . . . 0.0 111.954 179.921 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.48 -10.38 26.76 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.567 2.178 . . . . 0.0 112.971 -179.878 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.628 HG21 ' CE2' ' B' ' 241' ' ' PHE . 11.7 m -95.83 -1.88 10.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 121.056 -0.258 . . . . 0.0 111.407 -179.827 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.711 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 53.4 t -87.24 135.85 24.34 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.54 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.994 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.525 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 0.6 OUTLIER -62.55 162.39 10.49 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.248 0.547 . . . . 0.0 111.551 -179.183 . . . . . . . . 3 3 . 1 . 063 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -62.57 -45.1 94.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.857 -178.861 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.642 ' O ' ' N ' ' A' ' 49' ' ' CYS . 85.8 mt-30 -113.81 -12.69 12.69 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 123.937 0.773 . . . . 0.0 110.243 179.397 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.525 ' H ' ' HB3' ' A' ' 45' ' ' SER . 10.3 t60 31.01 -72.7 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 179.305 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.642 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.5 135.26 46.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.396 0.617 . . . . 0.0 112.196 -178.233 . . . . . . . . 3 3 . 1 . 063 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -126.92 128.85 47.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.054 179.307 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.2 mt -115.18 134.54 57.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.971 -179.808 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -111.98 131.35 55.45 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.039 179.036 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 51.5 mm -101.55 110.4 28.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 120.144 -0.622 . . . . 0.0 111.015 179.617 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.465 ' O ' ' C ' ' A' ' 55' ' ' GLU . 97.7 m-70 -113.54 135.33 54.01 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.267 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.465 ' C ' ' O ' ' A' ' 54' ' ' HIS . 93.2 mt-10 -41.2 -32.0 0.25 Allowed 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -179.998 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.454 ' N ' ' C ' ' A' ' 54' ' ' HIS . 99.8 mm-40 -65.23 -68.26 0.38 Allowed 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.638 178.402 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.484 ' HG3' ' NE ' ' A' ' 81' ' ' ARG . 1.0 OUTLIER -155.13 -171.84 3.96 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.539 0.685 . . . . 0.0 111.499 -179.638 . . . . . . . . 3 3 . 1 . 063 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -115.24 122.53 46.27 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.477 178.781 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.0 mt -114.55 133.58 60.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.258 0.551 . . . . 0.0 111.675 -178.423 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 21.5 tp -97.6 128.3 44.22 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.779 -179.751 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -110.45 133.61 53.12 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.09 179.689 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.431 HD21 ' HA ' ' A' ' 68' ' ' PRO . 60.8 t-20 -90.88 106.98 18.89 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.193 -179.589 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -97.95 -11.08 23.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.376 179.202 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 54.1 p -74.15 100.74 3.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.043 0.449 . . . . 0.0 110.923 179.82 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.1 p -86.2 -14.26 44.47 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.249 179.542 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.585 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.2 OUTLIER -93.72 -42.98 8.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.954 -179.886 . . . . . . . . 3 3 . 1 . 063 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.462 ' O ' ' OG ' ' A' ' 64' ' ' SER . 34.4 m-80 -136.93 99.3 10.18 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.369 179.887 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.431 ' HA ' HD21 ' A' ' 62' ' ' ASN . 49.2 Cg_exo -54.39 143.86 64.13 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.15 1.9 . . . . 0.0 112.985 -179.585 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.3 m -77.16 141.5 40.11 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.824 179.192 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -107.3 138.8 42.82 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.435 0.636 . . . . 0.0 110.821 179.975 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 66.8 t -131.4 135.07 60.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.494 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 53.84 32.35 14.89 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.035 -0.666 . . . . 0.0 110.398 -179.469 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.18 29.63 66.29 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.8 178.296 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 73.3 m -146.51 138.2 24.64 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.496 -0.482 . . . . 0.0 111.05 179.302 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -69.42 144.26 14.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.974 179.739 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.8 pt -119.14 95.09 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.133 179.048 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 78' ' ' GLU . 49.0 p-10 -71.09 -24.01 62.23 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.254 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.491 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 5.5 mt-10 -118.92 163.96 23.49 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.745 179.545 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -62.23 150.1 88.17 Favored 'Trans proline' 0 N--CA 1.501 1.943 0 C-N-CA 122.656 2.237 . . . . 0.0 112.483 179.78 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.0 p -140.54 143.87 28.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-O 121.478 0.656 . . . . 0.0 112.352 -179.003 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.484 ' NE ' ' HG3' ' A' ' 57' ' ' GLU . 68.2 ttt180 -73.33 126.79 30.95 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.558 179.245 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.0 mt -82.13 132.43 35.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.956 0.407 . . . . 0.0 110.955 -179.623 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -123.57 149.22 45.55 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.706 179.284 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -52.44 121.01 6.22 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.962 -179.249 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.01 -13.67 45.02 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.529 -0.629 . . . . 0.0 111.529 179.676 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -71.21 139.22 50.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.954 0.407 . . . . 0.0 111.095 -179.939 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.7 t -117.92 130.18 73.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.468 -178.5 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 92.7 mt -94.0 131.93 39.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.225 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.8 m -115.91 127.6 55.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.307 0.575 . . . . 0.0 112.252 -178.568 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.511 ' O ' ' C ' ' A' ' 91' ' ' ILE . 93.5 mt -125.87 124.8 67.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.176 178.346 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.537 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 72.2 mt -3.61 89.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -179.856 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.537 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 8.9 t0 86.84 -15.44 0.44 Allowed 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 177.158 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.751 ' NH1' HH22 ' B' ' 245' ' ' ARG . 23.3 mtm-85 -131.27 145.82 52.05 Favored 'General case' 0 CA--C 1.512 -0.519 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.698 -179.127 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.8 p -138.0 156.13 48.15 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 121.134 0.493 . . . . 0.0 110.164 179.567 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.56 ' HB3' HD11 ' A' ' 7' ' ' LEU . 91.2 m-85 -130.08 122.12 27.71 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.536 -179.292 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.581 ' O ' HD12 ' A' ' 7' ' ' LEU . 44.5 ttm180 -84.66 128.62 34.7 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 120.446 -0.502 . . . . 0.0 111.202 -179.616 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 92.9 t80 -91.88 125.33 36.54 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.616 179.947 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -126.5 121.22 31.73 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.807 179.539 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.491 ' O ' ' O ' ' A' ' 100' ' ' GLU . 64.8 t-20 -98.45 107.15 19.53 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.393 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.491 ' O ' ' O ' ' A' ' 99' ' ' ASN . 95.6 mt-10 . . . . . 0 C--N 1.33 -0.265 0 C-N-CA 120.561 -0.455 . . . . 0.0 109.824 -179.239 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 60.2 t . . . . . 0 N--CA 1.456 -0.163 0 CA-C-O 120.776 0.322 . . . . 0.0 110.164 . . . . . . . . . 0 0 . 1 . 063 nuclear build full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -143.12 94.65 2.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.965 179.508 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 063 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 30.2 mm100 -131.43 30.06 4.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.033 0.444 . . . . 0.0 110.026 179.672 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -124.84 -152.48 8.31 Favored Glycine 0 CA--C 1.534 1.219 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.436 -178.822 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.41 148.71 70.15 Favored 'Trans proline' 0 N--CA 1.5 1.872 0 C-N-CA 123.614 2.876 . . . . 0.0 113.173 -179.327 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.585 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 063 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -58.03 166.84 5.02 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.829 2.352 . . . . 0.0 111.787 179.102 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 2.4 p -114.03 135.74 52.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.129 179.746 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' B' B ' 237' ' ' CYS . . . . . 0.463 ' HB2' HD13 ' A' ' 91' ' ' ILE . 0.5 OUTLIER -68.73 123.14 20.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.18 0.514 . . . . 0.0 110.071 -179.878 . . . . . . . . 3 3 . 1 . 063 nuclear build full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 063 nuclear build full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -50.06 -20.15 4.9 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 121.983 1.789 . . . . 0.0 112.257 179.674 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 27.4 p -77.08 -39.67 48.92 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.24 178.274 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.628 ' CE2' HG21 ' A' ' 43' ' ' VAL . 80.2 t80 -58.99 -47.04 86.58 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.934 -179.798 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 80.2 mt -67.27 -39.63 86.08 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.127 179.033 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -65.22 -40.88 94.69 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.824 -178.903 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 78.1 ttt-85 -63.01 -43.67 98.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 120.431 -0.507 . . . . 0.0 110.557 -179.553 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.751 HH22 ' NH1' ' A' ' 93' ' ' ARG . 85.6 mtp180 -64.53 -37.32 87.15 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.678 -178.894 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.27 -40.15 96.59 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.095 178.811 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 44.6 t -64.07 -44.18 93.18 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.701 0.763 . . . . 0.0 109.211 178.499 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' B' B ' 248' ' ' GLN . . . . . 0.502 ' O ' ' N ' ' B' ' 252' ' ' LEU . 93.8 mm-40 -62.41 -36.32 81.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.263 179.727 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.601 HG23 ' O ' ' B' ' 245' ' ' ARG . 60.0 t -62.34 -46.47 96.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.307 179.708 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -63.42 -27.19 69.12 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.422 0.63 . . . . 0.0 109.568 179.125 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -94.44 -7.84 40.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.74 179.176 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.502 ' N ' ' O ' ' B' ' 248' ' ' GLN . 38.2 tp -108.09 126.85 53.24 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.329 0.585 . . . . 0.0 111.356 -179.233 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -57.94 142.33 46.64 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.924 -179.16 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -73.2 -8.31 55.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.678 179.188 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' B' B ' 255' ' ' ASP . . . . . 0.41 ' OD1' ' C ' ' B' ' 255' ' ' ASP . 40.3 p-10 -82.07 3.6 26.22 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.349 -179.05 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -80.24 90.54 5.53 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.867 179.702 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' B' B ' 257' ' ' LYS . . . . . 0.551 ' C ' ' H ' ' B' ' 259' ' ' ASP . 99.7 mttt -83.07 4.71 25.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.42 -178.399 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.544 ' O ' ' C ' ' B' ' 259' ' ' ASP . 87.1 m-20 -76.4 15.78 0.56 Allowed 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.441 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.667 ' C ' ' H ' ' B' ' 261' ' ' ILE . 51.1 p-10 -15.15 123.74 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.916 179.562 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -53.32 8.41 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.805 -179.189 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.667 ' H ' ' C ' ' B' ' 259' ' ' ASP . 64.1 mt -108.46 135.13 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.735 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 78.4 t -127.98 136.45 60.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.913 0.387 . . . . 0.0 109.961 -179.684 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -99.68 121.11 40.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.42 -178.398 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -66.52 -45.51 79.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.932 179.217 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.41 152.2 47.21 Favored Pre-proline 0 CA--C 1.52 -0.199 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.283 -179.448 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -62.5 140.51 82.21 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.754 2.303 . . . . 0.0 112.234 -179.831 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 41.8 pt . . . . . 0 C--N 1.322 -0.599 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.01 179.14 . . . . . . . . 0 0 . 1 . 064 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo . . . . . 0 N--CA 1.497 1.682 0 CA-C-O 120.905 0.294 . . . . 0.0 112.322 . . . . . . . . . 0 0 . 1 . 064 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 60.1 p -115.91 -46.23 2.84 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.642 179.76 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.9 mtt85 -90.65 126.84 36.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.505 -179.676 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -135.95 146.43 47.27 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.384 -0.526 . . . . 0.0 111.688 -179.646 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.858 HD11 HD11 ' A' ' 22' ' ' LEU . 73.3 mt -114.41 142.83 45.85 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.021 179.358 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.2 t -118.31 130.34 73.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.195 179.686 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 50.0 m -79.22 135.44 36.79 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.294 0.569 . . . . 0.0 111.956 -178.843 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.6 mt -112.51 138.11 42.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.301 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -91.71 157.15 17.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.089 0.471 . . . . 0.0 111.507 -179.009 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 85.7 mtm-85 -58.27 -24.42 59.36 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.6 -178.623 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 86.2 p -84.78 -7.92 59.02 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.261 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.44 38.8 6.53 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.82 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.9 t -122.14 134.54 65.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.897 0.38 . . . . 0.0 111.416 -179.709 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -77.09 122.53 25.1 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.705 179.824 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -114.75 -122.85 3.68 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.657 -179.435 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.38 148.99 34.56 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.406 2.071 . . . . 0.0 112.914 -178.985 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -103.97 153.8 20.4 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.919 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.465 ' CD2' HD11 ' A' ' 37' ' ' ILE . 47.0 t80 -124.23 91.15 49.96 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.245 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.0 139.71 36.5 Favored 'Trans proline' 0 C--N 1.315 -1.191 0 C-N-CA 121.253 1.302 . . . . 0.0 111.785 -179.299 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.858 HD11 HD11 ' A' ' 7' ' ' LEU . 83.1 mt -101.23 122.53 43.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.265 0.555 . . . . 0.0 111.187 -178.866 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.6 p -117.76 -6.74 11.05 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.47 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 67.2 mt -102.79 148.31 25.77 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.555 -179.623 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.9 m -72.53 -14.49 61.66 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.438 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.417 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 31.5 m -127.92 129.42 46.81 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.411 -179.799 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.2 t -123.91 119.34 29.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.272 178.268 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.5 tp -116.3 130.23 56.67 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.94 0.4 . . . . 0.0 111.355 -178.084 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.786 ' CE2' HD12 ' A' ' 37' ' ' ILE . 5.7 m-85 -109.4 138.98 44.94 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.011 -179.897 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 148.08 -171.83 28.48 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.081 178.944 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.412 ' HD2' HH11 ' A' ' 31' ' ' ARG . 47.6 mtm180 -79.1 -32.75 44.74 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 -179.919 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.557 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -45.32 147.63 1.85 Allowed Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 -178.751 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 36.2 mm -63.88 -43.51 97.82 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 CA-C-O 120.921 0.391 . . . . 0.0 110.149 179.958 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -56.87 -21.25 28.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.955 -179.654 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.557 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 59.7 m -52.87 115.16 1.69 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.133 -179.667 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.417 ' OD2' ' O ' ' A' ' 26' ' ' THR . 79.3 m-20 -57.16 -21.6 34.07 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -179.697 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.786 HD12 ' CE2' ' A' ' 29' ' ' PHE . 98.9 mt -132.25 122.24 47.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.124 -0.943 . . . . 0.0 109.334 177.037 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -104.77 135.94 45.22 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 -179.791 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.412 HD13 ' HE ' ' A' ' 93' ' ' ARG . 95.1 mt -115.26 127.72 72.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.615 -179.99 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -69.94 40.08 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -177.361 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.64 ' CD1' ' NH1' ' A' ' 93' ' ' ARG . 20.5 mt -124.18 132.32 24.29 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.957 -179.934 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.08 -7.2 19.57 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.679 2.252 . . . . 0.0 112.931 -179.509 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.492 HG21 ' CE2' ' B' ' 241' ' ' PHE . 17.2 m -99.8 2.25 10.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.685 179.53 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 29.4 t -87.94 136.54 22.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.345 179.526 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.2 m -65.9 157.2 31.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.182 0.515 . . . . 0.0 111.179 -179.659 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -62.74 -43.65 98.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.161 -178.888 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.638 ' O ' ' N ' ' A' ' 49' ' ' CYS . 96.7 mt-30 -113.99 -15.0 12.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.957 0.408 . . . . 0.0 110.511 179.677 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 18.3 t60 28.38 -74.86 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 178.875 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.638 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -128.23 133.96 48.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.258 0.552 . . . . 0.0 112.436 -178.666 . . . . . . . . 3 3 . 1 . 064 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -127.63 131.05 49.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.122 179.17 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.4 mt -115.39 133.63 61.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.894 -179.56 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -113.84 123.01 48.77 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.345 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.0 mt -105.62 113.8 43.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.448 0.642 . . . . 0.0 111.778 -178.662 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.422 ' O ' ' N ' ' A' ' 56' ' ' GLN . 82.2 m-70 -114.6 144.44 43.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.592 179.783 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 54' ' ' HIS . 78.2 mm-40 -41.07 -29.5 0.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.02 -179.02 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.422 ' N ' ' O ' ' A' ' 54' ' ' HIS . 95.7 mt-30 -64.73 -68.93 0.32 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.031 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.1 -166.1 1.99 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.061 179.86 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.42 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -113.29 127.89 56.29 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.324 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.5 mt -115.52 127.88 72.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.098 0.475 . . . . 0.0 111.795 -179.211 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.541 ' HB2' HD11 ' A' ' 82' ' ' LEU . 24.8 tp -97.42 126.95 42.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.043 179.596 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -111.2 135.33 51.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.858 179.925 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -98.83 106.9 19.22 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.974 -179.705 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -95.09 -6.64 41.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.534 178.994 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.5 t -71.65 99.84 2.18 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.493 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 79.0 p -87.21 -16.52 35.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.275 179.823 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.789 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.2 OUTLIER -90.72 -42.82 10.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.278 -179.806 . . . . . . . . 3 3 . 1 . 064 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.405 HD21 ' HA ' ' B' ' 236' ' ' VAL . 56.8 m-20 -139.25 97.96 8.42 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.983 -179.802 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -56.67 146.0 78.95 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 122.321 2.014 . . . . 0.0 113.156 -179.435 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.9 m -76.68 149.95 36.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.59 179.492 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -110.77 140.03 45.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.154 -179.653 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.666 HG13 ' OD1' ' A' ' 86' ' ' ASP . 60.6 t -131.09 135.3 60.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.386 -0.824 . . . . 0.0 108.87 179.624 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 51.59 33.35 10.51 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 119.834 -0.747 . . . . 0.0 109.103 -179.835 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.3 25.96 71.65 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.066 179.531 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 67.6 m -142.18 139.91 32.22 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 117.503 0.651 . . . . 0.0 111.561 179.948 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -68.13 143.91 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.185 179.897 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.475 HG21 HG21 ' A' ' 80' ' ' VAL . 5.4 pt -116.05 94.38 3.08 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-O 121.166 0.507 . . . . 0.0 110.479 179.111 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -67.21 -25.83 66.31 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.739 179.762 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.478 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.1 OUTLIER -129.98 179.73 1.24 Allowed Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.818 -179.876 . . . . . . . . 3 3 . 1 . 064 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.478 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 23.8 Cg_exo -62.06 146.83 96.02 Favored 'Trans proline' 0 N--CA 1.5 1.878 0 C-N-CA 123.087 2.524 . . . . 0.0 112.703 -179.379 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.475 HG21 HG21 ' A' ' 76' ' ' ILE . 2.4 m -142.41 137.97 29.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.813 -179.748 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 85.2 mtt85 -73.33 129.35 37.83 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.258 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.541 HD11 ' HB2' ' A' ' 60' ' ' LEU . 95.3 mt -83.17 137.6 33.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.942 0.401 . . . . 0.0 110.493 179.987 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -131.49 156.7 45.2 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.614 -179.883 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.585 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 3.6 t-160 -59.07 118.64 6.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.029 0.442 . . . . 0.0 110.115 -179.899 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.12 -8.0 35.61 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 -179.046 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.666 ' OD1' HG13 ' A' ' 71' ' ' VAL . 64.4 t0 -77.2 126.99 31.84 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.478 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 13.0 p -107.16 137.47 37.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.471 -178.897 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 83.3 mt -103.9 128.22 57.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.502 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.5 m -123.17 126.56 47.23 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 121.624 0.726 . . . . 0.0 112.82 -178.243 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.474 ' O ' ' C ' ' A' ' 91' ' ' ILE . 97.9 mt -117.51 126.88 74.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.988 178.547 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.542 HG22 ' N ' ' A' ' 92' ' ' ASP . 96.8 mt 32.79 -98.73 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.669 -179.499 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.542 ' N ' HG22 ' A' ' 91' ' ' ILE . 97.6 m-20 -112.13 12.1 20.45 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -179.84 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.64 ' NH1' ' CD1' ' A' ' 41' ' ' LEU . 39.6 mtm-85 -126.19 142.55 51.48 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 120.984 -0.287 . . . . 0.0 110.441 -179.499 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 43.7 t -138.55 149.57 45.46 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.706 179.92 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.624 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 96.8 m-85 -121.0 121.2 37.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.038 178.558 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 55.3 ttt85 -84.45 131.03 34.71 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.546 -0.462 . . . . 0.0 109.766 -179.774 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -90.38 122.52 33.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.402 -179.753 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -124.24 120.64 32.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.843 0.354 . . . . 0.0 110.836 179.893 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.585 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 62.8 t-20 -110.69 112.43 24.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.221 179.688 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 . . . . . 0 C--N 1.329 -0.313 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.883 -179.769 . . . . . . . . 0 0 . 1 . 064 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 26.1 t . . . . . 0 CA--C 1.527 0.058 0 CA-C-O 120.542 0.211 . . . . 0.0 110.606 . . . . . . . . . 0 0 . 1 . 064 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.539 ' C ' ' H ' ' B' ' 231' ' ' GLN . 67.0 t0 -137.94 97.61 3.46 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.987 -179.749 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 064 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.539 ' H ' ' C ' ' B' ' 229' ' ' ASP . 2.6 mt-30 -115.31 -27.42 7.24 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.311 -179.429 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' B' B ' 232' ' ' GLY . . . . . 0.513 ' O ' ' O ' ' B' ' 231' ' ' GLN . . . -34.14 161.34 0.01 OUTLIER Glycine 0 CA--C 1.527 0.813 0 N-CA-C 111.798 -0.521 . . . . 0.0 111.798 -179.265 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.28 162.25 42.58 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 123.597 2.865 . . . . 0.0 112.451 179.993 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.789 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 064 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.08 142.01 30.4 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 C-N-CA 121.723 1.615 . . . . 0.0 112.331 179.582 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.495 ' CG2' HG22 ' A' ' 66' ' ' THR . 49.8 t -65.5 135.68 27.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.714 -179.623 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.7 t -66.69 130.56 43.58 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.723 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' B' B ' 238' ' ' TPO . . . . . 0.589 ' O2P' HG23 ' B' ' 240' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 064 nuclear build full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -53.63 -33.0 67.19 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 123.183 2.589 . . . . 0.0 113.668 179.677 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' B' B ' 240' ' ' THR . . . . . 0.589 HG23 ' O2P' ' B' ' 238' ' ' TPO . 39.8 p -73.47 -38.59 65.39 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.977 179.182 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.492 ' CE2' HG21 ' A' ' 43' ' ' VAL . 77.6 t80 -58.09 -48.14 81.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.845 -179.004 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.402 HD22 ' OD1' ' A' ' 92' ' ' ASP . 98.0 mt -67.71 -42.36 82.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.884 0.373 . . . . 0.0 111.674 -179.687 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -63.25 -45.16 92.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.884 -178.62 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -63.53 -43.82 96.05 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.841 0.353 . . . . 0.0 111.141 -179.527 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.445 ' O ' HG23 ' B' ' 249' ' ' VAL . 48.5 ttm-85 -65.27 -41.9 93.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.469 -179.334 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -63.4 -39.02 93.36 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.179 179.159 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 20.3 m -65.12 -42.64 93.74 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 177.895 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 63.6 tp60 -59.63 -35.41 74.31 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.53 -1.213 . . . . 0.0 110.179 179.493 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.445 HG23 ' O ' ' B' ' 245' ' ' ARG . 49.9 t -64.22 -44.72 97.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-O 120.873 0.368 . . . . 0.0 110.227 178.926 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -64.01 -33.43 75.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.985 179.157 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -88.36 -5.45 58.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.438 179.4 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 36.6 tp -71.38 138.67 49.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.113 -179.498 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' B' B ' 253' ' ' ASN . . . . . 0.56 ' C ' ' H ' ' B' ' 255' ' ' ASP . 95.0 m-20 -38.1 154.3 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.25 -178.756 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' B' B ' 254' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' B' ' 254' ' ' ASP . 57.8 t0 -62.66 4.99 0.13 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.95 179.466 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' B' B ' 255' ' ' ASP . . . . . 0.56 ' H ' ' C ' ' B' ' 253' ' ' ASN . 90.8 m-20 -83.72 -84.21 0.14 Allowed 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.424 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' B' ' 253' ' ' ASN . 12.8 m-20 66.08 13.2 8.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.176 -179.459 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -65.16 -35.36 80.86 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.889 178.917 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -100.84 137.58 39.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.278 179.159 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.458 ' CG ' ' H ' ' B' ' 260' ' ' GLU . 33.3 p-10 -109.3 -118.43 0.28 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.177 0.513 . . . . 0.0 112.239 -178.604 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.458 ' H ' ' CG ' ' B' ' 259' ' ' ASP . 97.7 mt-10 -146.43 26.58 1.16 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.514 179.92 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.624 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 70.6 mt -115.47 134.48 58.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.168 179.94 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 54.6 t -124.16 132.91 70.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.725 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -94.54 119.02 32.57 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.387 0.613 . . . . 0.0 111.612 -177.88 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -66.83 -46.48 74.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.287 179.68 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -72.85 166.44 43.05 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.181 -179.25 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -64.26 141.26 74.65 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 121.569 1.513 . . . . 0.0 111.282 179.878 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 11.9 tt . . . . . 0 C--N 1.324 -0.517 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.34 -178.869 . . . . . . . . 0 0 . 1 . 065 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.41 ' HB2' ' HE ' ' A' ' 6' ' ' ARG . 35.1 Cg_exo . . . . . 0 N--CA 1.494 1.518 0 CA-C-O 121.003 0.335 . . . . 0.0 111.757 . . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.408 ' OG1' ' N ' ' A' ' 5' ' ' ARG . 6.6 p -115.56 -52.57 2.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.326 -179.802 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.408 ' N ' ' OG1' ' A' ' 4' ' ' THR . 85.3 mtt85 -94.21 128.24 40.54 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.816 -179.885 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.41 ' HE ' ' HB2' ' A' ' 3' ' ' PRO . 99.8 mtt180 -132.86 144.33 50.12 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.389 -0.525 . . . . 0.0 111.354 -179.345 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 79.9 mt -115.41 145.59 42.4 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.669 179.633 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.641 HG22 ' CD2' ' A' ' 19' ' ' HIS . 49.7 t -118.48 130.18 73.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.855 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 m -90.66 117.04 29.0 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.308 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.595 HD12 ' OG ' ' A' ' 94' ' ' SER . 96.0 mt -86.94 142.36 13.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.305 177.724 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.41 ' NZ ' ' HA ' ' B' ' 258' ' ' ASP . 68.1 mttm -95.16 169.73 9.89 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.869 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.411 ' NH1' ' HB3' ' B' ' 248' ' ' GLN . 88.9 mtm180 -56.96 -29.6 63.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.8 -178.784 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.6 t -81.11 -7.35 59.54 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.757 179.295 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.27 40.19 8.67 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 -178.892 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.8 t -116.64 134.06 61.32 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.076 0 CA-C-O 120.832 0.349 . . . . 0.0 111.602 -178.713 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.468 ' C ' ' OD1' ' A' ' 16' ' ' ASP . 39.4 t0 -77.64 124.36 27.84 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.138 179.448 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -124.09 -115.56 2.16 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 120.655 -0.784 . . . . 0.0 111.408 179.94 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -72.95 144.21 37.94 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.153 1.902 . . . . 0.0 113.621 -178.808 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.641 ' CD2' HG22 ' A' ' 8' ' ' VAL . 50.9 m170 -106.05 142.41 35.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.275 179.781 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.435 ' HD1' HG22 ' B' ' 267' ' ' ILE . 45.5 t80 -114.2 93.02 29.12 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.221 -179.571 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -69.07 135.15 31.31 Favored 'Trans proline' 0 N--CA 1.488 1.187 0 C-N-CA 121.51 1.474 . . . . 0.0 111.668 -179.537 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.474 HD22 ' HB2' ' A' ' 27' ' ' CYS . 92.4 mt -84.84 80.31 9.32 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.187 -178.699 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 85.6 p -82.33 -10.85 58.93 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.078 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 58.0 mt -103.85 144.66 31.21 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.401 -179.202 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.8 t -67.5 -14.84 63.29 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.968 -179.856 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.548 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 89.2 m -131.38 133.69 45.52 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 120.696 -0.401 . . . . 0.0 111.395 -179.809 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.595 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 13.2 t -125.27 116.14 21.48 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.632 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.531 HD12 ' O ' ' A' ' 49' ' ' CYS . 43.4 tp -115.23 131.29 56.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.29 -178.161 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.607 ' CE2' HD12 ' A' ' 37' ' ' ILE . 23.3 m-85 -109.38 136.91 48.04 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.632 178.943 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 154.22 -177.19 31.76 Favored Glycine 0 C--O 1.221 -0.677 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.778 178.804 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.497 ' NH1' ' O ' ' B' ' 229' ' ' ASP . 46.4 mtm180 -77.47 -31.08 53.48 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.646 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.508 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -51.33 150.55 6.85 Favored Glycine 0 N--CA 1.465 0.582 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.395 -178.327 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.551 HG23 ' N ' ' A' ' 34' ' ' GLU . 11.0 tp -66.44 -41.62 89.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.646 0.26 . . . . 0.0 110.533 179.967 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.551 ' N ' HG23 ' A' ' 33' ' ' ILE . 81.0 mm-40 -55.72 -24.23 33.61 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.347 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.508 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 39.0 m -53.3 118.04 3.51 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.823 179.971 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.548 ' OD2' ' O ' ' A' ' 26' ' ' THR . 93.2 m-20 -59.14 -27.99 66.15 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.855 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.607 HD12 ' CE2' ' A' ' 29' ' ' PHE . 97.9 mt -127.53 119.12 51.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 176.479 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.472 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 82.9 mtp180 -102.2 134.82 44.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.901 0.382 . . . . 0.0 111.901 -178.439 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.0 mt -122.02 130.05 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.114 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.693 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -82.93 34.36 0.45 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.001 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.715 HD11 ' CZ ' ' A' ' 93' ' ' ARG . 31.3 mt -95.65 129.03 35.71 Favored Pre-proline 0 C--N 1.325 -0.477 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.33 179.458 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.17 -12.16 27.62 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 C-N-CA 122.218 1.945 . . . . 0.0 112.361 -179.616 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.4 m -98.08 5.73 9.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.872 0.368 . . . . 0.0 110.495 -179.949 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.477 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 37.4 t -98.82 135.11 35.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.414 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.43 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 6.9 t -70.34 174.68 5.37 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.229 0.538 . . . . 0.0 111.233 -179.031 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 50.4 mttp -64.03 -41.01 97.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.1 -179.926 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.628 ' O ' ' N ' ' A' ' 49' ' ' CYS . 85.6 mt-30 -112.85 -20.08 11.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.919 -179.272 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.43 ' H ' ' HB3' ' A' ' 45' ' ' SER . 28.2 t60 39.17 -76.8 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 179.751 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.628 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.2 133.46 46.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.306 -178.548 . . . . . . . . 3 3 . 1 . 065 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -127.35 130.57 49.69 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.541 179.34 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 86.2 mt -115.98 134.86 57.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.812 -179.826 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.516 ' CD ' ' NE2' ' A' ' 54' ' ' HIS . 74.6 tt0 -120.47 125.8 48.81 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.791 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 93.9 mt -106.56 119.08 55.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.567 0.698 . . . . 0.0 112.26 -179.009 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.516 ' NE2' ' CD ' ' A' ' 52' ' ' GLU . 99.6 m-70 -112.36 140.34 47.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.605 -1.179 . . . . 0.0 108.959 178.961 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.9 mm-40 -40.78 -28.02 0.07 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 -179.86 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.462 ' N ' ' O ' ' A' ' 54' ' ' HIS . 82.3 mt-30 -65.88 -68.04 0.4 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.434 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -154.14 -171.51 3.9 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.382 -179.613 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.454 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -110.16 128.99 55.78 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.497 -0.556 . . . . 0.0 109.497 179.021 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 98.0 mt -119.02 130.96 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -178.752 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 32.1 tp -99.33 131.7 45.17 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.003 179.277 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -114.55 136.44 53.02 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.072 179.197 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -97.81 111.09 23.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.187 0.518 . . . . 0.0 111.651 -179.543 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -104.8 -10.37 17.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.484 179.91 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.4 101.46 12.02 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.491 -179.813 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 77.8 p -76.19 -35.57 59.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.257 0.551 . . . . 0.0 109.903 179.244 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.622 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.8 OUTLIER -63.01 -43.02 99.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.285 -178.827 . . . . . . . . 3 3 . 1 . 065 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -147.25 99.77 3.9 Favored Pre-proline 0 C--N 1.317 -0.834 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.484 -179.034 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -57.55 146.46 84.02 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 C-N-CA 121.783 1.656 . . . . 0.0 112.681 -178.78 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 18.2 m -70.24 136.17 49.68 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.351 178.316 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -96.94 143.9 27.37 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.171 -0.612 . . . . 0.0 111.229 -179.162 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.696 ' HB ' HD11 ' A' ' 76' ' ' ILE . 5.4 p -129.5 133.88 64.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.837 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 49.17 30.12 2.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.157 0.503 . . . . 0.0 109.952 -179.331 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 78.2 27.47 57.85 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.393 179.064 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.6 t -138.0 139.59 39.73 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.997 0.398 . . . . 0.0 110.46 179.739 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -67.78 142.29 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.846 179.907 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.696 HD11 ' HB ' ' A' ' 71' ' ' VAL . 96.6 mt -101.72 103.72 15.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.936 -179.742 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -67.63 -40.97 84.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.989 179.028 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.528 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.6 OUTLIER -134.68 179.37 1.4 Allowed Pre-proline 0 CA--C 1.53 0.186 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.727 -178.35 . . . . . . . . 3 3 . 1 . 065 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.467 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 31.8 Cg_exo -59.37 144.59 99.36 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 122.804 2.336 . . . . 0.0 112.648 -179.585 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.8 m -143.1 141.24 26.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.995 -179.806 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 91.7 mtm180 -71.68 131.39 43.09 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.526 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.454 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 96.4 mt -80.19 139.99 36.51 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.838 0.351 . . . . 0.0 110.978 -179.538 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -131.44 150.2 52.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.426 -179.903 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -55.92 123.09 13.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.908 0.385 . . . . 0.0 110.982 -179.304 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.12 -14.19 48.42 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 -179.472 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.48 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 64.9 t0 -71.4 129.75 39.6 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.028 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.447 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 95.0 t -109.36 130.55 62.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.265 -178.819 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.4 mt -97.0 131.57 43.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.984 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 63.9 m -127.97 127.63 43.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.713 0.768 . . . . 0.0 113.002 -178.512 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.607 ' O ' ' N ' ' A' ' 92' ' ' ASP . 82.2 mt -107.03 123.06 61.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 177.682 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.437 ' C ' ' O ' ' A' ' 90' ' ' ILE . 70.3 mt 38.87 -88.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 120.511 -0.475 . . . . 0.0 110.646 -179.467 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.607 ' N ' ' O ' ' A' ' 90' ' ' ILE . 32.4 t70 -128.18 16.17 6.69 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -179.746 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.715 ' CZ ' HD11 ' A' ' 41' ' ' LEU . 98.3 mtt180 -123.01 139.91 53.59 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.115 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.595 ' OG ' HD12 ' A' ' 10' ' ' ILE . 31.7 p -138.84 151.87 47.37 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 119.23 -0.988 . . . . 0.0 112.011 -179.684 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -122.1 121.61 37.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.554 -1.203 . . . . 0.0 108.364 178.958 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -83.56 133.32 34.87 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.176 -0.609 . . . . 0.0 111.48 -178.52 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -96.83 122.47 39.82 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.234 -179.615 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -123.67 124.58 43.08 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.864 179.947 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 62.9 t-20 -106.97 107.15 18.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.787 179.478 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 . . . . . 0 C--N 1.33 -0.272 0 C-N-CA 120.204 -0.598 . . . . 0.0 110.229 179.691 . . . . . . . . 0 0 . 1 . 065 nuclear build full ' B' B ' 228' ' ' VAL . . . . . 0.705 ' O ' HG12 ' B' ' 228' ' ' VAL . 29.5 t . . . . . 0 CA--C 1.53 0.182 0 N-CA-C 111.497 0.184 . . . . 0.0 111.497 . . . . . . . . . 1 1 . 1 . 065 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.497 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 88.6 m-20 -71.14 137.34 48.73 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.233 0.54 . . . . 0.0 111.05 -179.779 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' B' B ' 230' ' ' SEP . . . . . 0.537 ' C ' ' OE1' ' B' ' 231' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 065 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.537 ' OE1' ' C ' ' B' ' 230' ' ' SEP . 1.6 mp0 -124.65 46.14 2.38 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.13 178.677 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -125.4 179.99 15.96 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 -179.398 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.83 161.51 45.83 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 123.24 2.626 . . . . 0.0 113.448 -179.642 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.622 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 065 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.87 144.34 43.14 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 121.804 1.669 . . . . 0.0 113.307 -178.656 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.42 HG13 ' O ' ' B' ' 236' ' ' VAL . 12.2 p -58.35 135.73 22.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.135 -179.642 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 10.0 t -66.77 132.99 49.24 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.742 -179.502 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' B' B ' 238' ' ' TPO . . . . . 0.436 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 065 nuclear build full ' B' B ' 239' ' ' PRO . . . . . 0.436 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 31.9 Cg_exo -60.7 -27.92 85.64 Favored 'Trans proline' 0 N--CA 1.502 1.999 0 C-N-CA 123.131 2.554 . . . . 0.0 114.085 -178.769 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 97.4 m -67.45 -47.09 71.15 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.379 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.489 ' HZ ' HD22 ' A' ' 41' ' ' LEU . 91.7 t80 -57.93 -46.21 85.4 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.335 -179.459 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 87.6 mt -65.43 -38.83 91.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.842 0.353 . . . . 0.0 110.64 179.962 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -60.77 -41.11 94.83 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.077 0.465 . . . . 0.0 110.044 -179.98 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 62.0 ttp180 -61.45 -43.17 99.34 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.195 179.877 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.658 HH12 ' HE ' ' A' ' 93' ' ' ARG . 76.0 mtp85 -60.07 -42.09 93.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.866 -179.689 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.29 -41.34 96.81 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.28 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 8.6 t -63.4 -46.13 87.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.738 178.381 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' B' B ' 248' ' ' GLN . . . . . 0.411 ' HB3' ' NH1' ' A' ' 12' ' ' ARG . 83.2 mt-30 -59.33 -38.45 80.35 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.808 -178.989 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 25.1 t -59.61 -46.06 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.677 178.846 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -64.61 -31.81 73.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.085 0.469 . . . . 0.0 109.909 179.054 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -67.43 -19.91 65.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.641 -179.814 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 97.9 mt -66.2 134.65 53.16 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.109 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -101.63 -39.54 7.43 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.137 0.494 . . . . 0.0 110.441 179.534 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' B' B ' 254' ' ' ASP . . . . . 0.455 ' C ' ' N ' ' B' ' 256' ' ' ASP . 96.0 m-20 -67.78 -18.0 64.72 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.341 179.53 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 26.8 t0 56.99 12.14 1.14 Allowed 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -178.808 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.455 ' N ' ' C ' ' B' ' 254' ' ' ASP . 68.3 t0 -172.25 90.03 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.555 179.855 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' B' B ' 257' ' ' LYS . . . . . 0.522 ' O ' ' C ' ' B' ' 258' ' ' ASP . 88.5 tttt -156.97 138.21 13.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.449 -179.862 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.522 ' C ' ' O ' ' B' ' 257' ' ' LYS . 66.4 t0 -21.82 138.19 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 O-C-N 123.926 0.766 . . . . 0.0 110.6 -179.713 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.517 ' N ' ' OD1' ' B' ' 258' ' ' ASP . 20.4 p-10 -119.43 68.0 0.81 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -179.018 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.544 ' OE1' ' NH2' ' A' ' 93' ' ' ARG . 97.8 mt-10 58.68 22.61 10.12 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 177.559 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 76.3 mt -114.51 128.98 71.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.178 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 54.4 t -126.85 133.9 67.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.137 0.494 . . . . 0.0 110.973 -179.203 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' B' B ' 263' ' ' PHE . . . . . 0.673 ' CD2' HG21 ' B' ' 267' ' ' ILE . 54.9 m-85 -96.38 120.36 36.54 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.99 -179.299 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -64.07 -42.72 96.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.533 0.682 . . . . 0.0 110.045 179.24 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.26 171.52 5.09 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.006 -178.604 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -54.52 149.73 37.79 Favored 'Trans proline' 0 N--CA 1.501 1.953 0 C-N-CA 123.143 2.562 . . . . 0.0 114.154 -179.728 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' B' B ' 267' ' ' ILE . . . . . 0.673 HG21 ' CD2' ' B' ' 263' ' ' PHE . 33.0 pt . . . . . 0 C--O 1.232 0.178 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.001 179.907 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo . . . . . 0 N--CA 1.495 1.587 0 CA-C-O 120.861 0.275 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 066 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 68.2 p -119.0 -34.77 3.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.543 179.391 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.809 ' NH1' ' HB2' ' A' ' 58' ' ' ALA . 95.1 mtt-85 -95.5 122.11 37.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.128 -179.644 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.411 ' NE ' ' OE1' ' A' ' 98' ' ' GLU . 31.1 ptt180 -138.48 145.34 40.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.072 0.463 . . . . 0.0 111.298 -179.86 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.618 HD12 ' O ' ' A' ' 96' ' ' ARG . 36.9 tp -118.93 136.47 54.05 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.359 179.007 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.81 HG22 ' CD2' ' A' ' 19' ' ' HIS . 41.0 t -110.35 131.6 60.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.822 -178.548 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.5 m -93.47 114.73 27.19 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.156 0.503 . . . . 0.0 112.12 -179.144 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 45.7 mm -79.63 144.93 10.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.611 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -90.52 158.92 16.77 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.181 178.595 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.55 ' NE ' ' NH2' ' B' ' 245' ' ' ARG . 84.7 mtp180 -54.87 -27.84 45.6 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.801 -178.825 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 85.9 p -79.19 -10.71 59.89 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 120.876 -0.329 . . . . 0.0 111.626 179.982 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.69 33.36 7.96 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 -179.223 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.6 t -120.6 134.61 63.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.87 0.367 . . . . 0.0 110.969 -179.531 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -71.22 129.28 38.49 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.818 179.58 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -125.35 -121.53 2.54 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.527 -179.076 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.21 144.62 42.13 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.16 1.907 . . . . 0.0 113.019 -178.104 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.81 ' CD2' HG22 ' A' ' 8' ' ' VAL . 59.2 m170 -104.22 145.78 29.73 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.647 -179.443 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.726 ' CD2' HD11 ' A' ' 37' ' ' ILE . 34.7 t80 -116.21 91.37 32.19 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.992 -179.924 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -60.35 125.36 17.26 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 121.779 1.652 . . . . 0.0 111.135 179.52 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 22' ' ' LEU . 96.0 mt -84.48 50.51 1.9 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.292 -178.762 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.4 p -61.21 -23.69 65.8 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.962 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.602 HD11 ' OE1' ' B' ' 265' ' ' GLN . 64.3 mt -83.53 141.84 31.33 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.173 -179.832 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.2 m -67.25 -17.84 64.97 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.834 -178.696 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.74 133.73 40.23 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.252 -0.579 . . . . 0.0 112.029 -178.977 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.5 t -128.19 119.96 26.29 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.25 179.207 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.459 HD23 ' HA ' ' A' ' 35' ' ' CYS . 38.5 tp -111.75 128.54 56.12 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.88 -178.938 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.478 ' O ' ' O ' ' A' ' 47' ' ' GLN . 57.6 m-85 -108.35 134.86 50.57 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.329 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 156.83 -170.7 34.25 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 119.904 -1.141 . . . . 0.0 112.449 179.344 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.603 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 10.4 mtp180 -85.6 -31.45 22.61 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -179.779 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -51.45 155.45 3.77 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 -178.648 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.649 HD12 ' NH1' ' A' ' 38' ' ' ARG . 1.1 tp -66.16 -42.69 91.66 Favored 'Isoleucine or valine' 0 C--N 1.34 0.195 0 CA-C-N 117.149 0.475 . . . . 0.0 111.01 -179.707 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.474 ' N ' HG23 ' A' ' 33' ' ' ILE . 73.6 mm-40 -58.06 -16.82 14.27 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.409 -179.64 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.459 ' HA ' HD23 ' A' ' 28' ' ' LEU . 68.6 m -59.8 120.34 9.36 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.838 -179.485 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.431 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 56.5 m-20 -60.89 -32.27 71.73 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.73 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.726 HD11 ' CD2' ' A' ' 20' ' ' PHE . 48.9 mm -120.13 113.77 41.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.554 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.649 ' NH1' HD12 ' A' ' 33' ' ' ILE . 77.4 mtt180 -101.06 132.77 46.33 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.028 -0.669 . . . . 0.0 111.287 -177.876 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 95.9 mt -123.73 129.85 74.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.283 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.442 HE21 ' HA ' ' B' ' 260' ' ' GLU . 2.4 pm0 -83.56 43.74 0.92 Allowed 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -176.98 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.578 ' CD1' ' CZ ' ' A' ' 93' ' ' ARG . 39.9 mt -109.4 126.58 28.91 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 120.403 -0.519 . . . . 0.0 111.781 179.885 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -68.86 -13.84 37.63 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.174 1.916 . . . . 0.0 112.779 179.709 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.467 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 25.2 m -90.68 4.43 6.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.891 0.377 . . . . 0.0 110.701 179.996 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.603 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 54.7 t -107.03 136.43 42.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.23 -179.698 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.3 m -70.68 168.31 16.8 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.527 0.68 . . . . 0.0 111.281 -179.386 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.5 mttm -62.07 -38.77 90.06 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.109 -179.293 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.708 ' O ' ' N ' ' A' ' 49' ' ' CYS . 99.0 mt-30 -109.58 -14.98 14.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.532 -179.077 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.543 ' NE2' HG23 ' A' ' 90' ' ' ILE . 23.5 t60 37.13 -72.75 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -179.836 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.708 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -151.69 151.92 32.09 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.997 179.943 . . . . . . . . 3 3 . 1 . 066 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -138.36 143.57 39.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.96 -179.96 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.8 mt -114.39 133.06 61.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.483 179.934 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -114.67 124.58 52.18 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.494 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.4 mt -105.89 118.59 53.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -177.356 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.423 ' O ' ' C ' ' A' ' 55' ' ' GLU . 97.7 m-70 -112.97 138.43 49.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.267 -1.333 . . . . 0.0 108.718 178.055 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 54' ' ' HIS . 94.8 mt-10 -39.47 -35.67 0.31 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.186 0.517 . . . . 0.0 109.807 -178.822 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -60.26 -68.17 0.32 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.649 179.071 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.522 ' CD ' ' NH1' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -151.99 -171.26 3.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.11 0.481 . . . . 0.0 111.063 179.523 . . . . . . . . 3 3 . 1 . 066 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.809 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -110.04 129.15 55.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.398 179.505 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.4 mt -116.84 129.14 73.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.234 0.54 . . . . 0.0 112.39 -178.555 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.459 ' HB2' HD11 ' A' ' 82' ' ' LEU . 25.4 tp -98.38 128.29 44.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.439 179.669 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -112.84 134.61 54.27 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.151 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.681 HD21 ' CB ' ' A' ' 68' ' ' PRO . 61.6 t-20 -98.4 109.59 22.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.925 -178.429 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -98.71 -3.89 34.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.094 179.726 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.1 t -92.8 110.36 21.8 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.085 -179.274 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 56.3 p -93.59 -28.75 15.85 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.577 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.522 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.3 OUTLIER -65.52 -43.68 89.29 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.834 179.734 . . . . . . . . 3 3 . 1 . 066 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.456 HD21 ' HA ' ' B' ' 236' ' ' VAL . 33.2 m-20 -149.2 103.91 3.33 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.884 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.681 ' CB ' HD21 ' A' ' 62' ' ' ASN . 68.0 Cg_endo -71.03 158.21 55.83 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 121.657 1.571 . . . . 0.0 113.337 -177.424 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.1 m -73.04 140.03 46.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.296 179.656 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.45 ' O ' ' N ' ' A' ' 89' ' ' THR . 89.3 mt-30 -102.76 142.42 33.94 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.34 -179.507 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.688 ' HB ' HD11 ' A' ' 76' ' ' ILE . 8.9 p -132.04 138.63 52.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.766 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 50.39 31.81 5.78 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 -179.616 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.68 30.03 64.63 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.493 179.962 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 65.6 m -140.7 136.35 32.53 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 117.151 0.475 . . . . 0.0 111.847 -179.235 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.417 HG13 ' HG2' ' A' ' 68' ' ' PRO . 19.8 t -63.8 137.2 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.732 179.758 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.688 HD11 ' HB ' ' A' ' 71' ' ' VAL . 92.6 mt -101.91 110.87 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 178.631 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 18.6 p-10 -75.45 -37.15 60.52 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.13 179.546 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.551 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.8 OUTLIER -133.15 -177.95 0.78 Allowed Pre-proline 0 N--CA 1.465 0.316 0 CA-C-O 120.895 0.379 . . . . 0.0 111.823 -178.938 . . . . . . . . 3 3 . 1 . 066 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.516 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 32.5 Cg_exo -59.51 144.78 99.33 Favored 'Trans proline' 0 N--CA 1.499 1.822 0 C-N-CA 122.84 2.36 . . . . 0.0 112.545 -179.653 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 23.5 m -142.22 141.39 28.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.566 -179.627 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.522 ' NH1' ' CD ' ' A' ' 57' ' ' GLU . 96.7 mtt-85 -74.97 136.71 41.31 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.785 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.459 HD11 ' HB2' ' A' ' 60' ' ' LEU . 97.7 mt -92.31 136.43 33.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.461 0.648 . . . . 0.0 111.173 -179.579 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.407 ' HG2' ' N ' ' A' ' 84' ' ' HIS . 88.5 tttt -125.31 155.53 40.08 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.824 179.965 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.407 ' N ' ' HG2' ' A' ' 83' ' ' LYS . 10.4 t60 -57.43 121.88 11.28 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.954 -179.451 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.21 -22.44 20.59 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.962 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.566 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 64.9 t0 -64.32 131.27 46.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.712 0.292 . . . . 0.0 110.835 179.656 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.503 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 39.7 t -108.88 130.86 61.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.906 -179.463 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.5 mt -91.46 128.88 42.93 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.165 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.45 ' N ' ' O ' ' A' ' 70' ' ' GLN . 53.3 m -123.78 125.51 44.85 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.677 0.751 . . . . 0.0 112.002 -178.853 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.543 HG23 ' NE2' ' A' ' 48' ' ' HIS . 95.2 mt -115.97 123.0 70.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.588 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.703 HD12 HH22 ' A' ' 93' ' ' ARG . 96.6 mt 43.53 -102.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.934 -178.768 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.643 ' N ' HG22 ' A' ' 91' ' ' ILE . 46.0 p-10 -118.39 14.67 13.8 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.166 0.508 . . . . 0.0 110.972 179.938 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.703 HH22 HD12 ' A' ' 91' ' ' ILE . 51.2 mtm-85 -122.57 143.76 49.53 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.533 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 29.0 p -139.63 153.01 47.23 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 119.499 -0.881 . . . . 0.0 111.732 -179.137 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.482 ' HB3' HD11 ' A' ' 7' ' ' LEU . 60.2 m-85 -122.51 120.78 34.87 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 114.786 -1.097 . . . . 0.0 108.686 178.906 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.618 ' O ' HD12 ' A' ' 7' ' ' LEU . 44.4 ttm180 -82.85 128.7 34.66 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.144 -0.622 . . . . 0.0 111.455 -178.657 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.549 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 83.3 t80 -97.78 127.95 44.08 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.92 179.736 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.411 ' OE1' ' NE ' ' A' ' 6' ' ' ARG . 98.2 mt-10 -130.7 123.78 30.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.048 179.637 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 63.8 t-20 -113.74 100.08 8.19 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.028 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.428 -178.619 . . . . . . . . 0 0 . 1 . 066 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 1.9 t . . . . . 0 N--CA 1.462 0.147 0 CA-C-O 121.013 0.435 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 066 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.497 ' C ' ' H ' ' B' ' 231' ' ' GLN . 50.9 t0 -91.04 116.24 28.64 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.923 179.922 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' B' B ' 230' ' ' SEP . . . . . 0.442 ' HA ' ' HE ' ' A' ' 31' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 066 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.497 ' H ' ' C ' ' B' ' 229' ' ' ASP . 75.3 mt-30 -124.54 42.19 3.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.217 -179.454 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -131.24 -166.26 11.66 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.294 -179.144 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -59.96 151.93 68.23 Favored 'Trans proline' 0 N--CA 1.5 1.859 0 C-N-CA 124.174 3.25 . . . . 0.0 113.879 -179.304 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.522 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 066 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -66.83 139.95 53.83 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 121.083 1.189 . . . . 0.0 113.494 -178.625 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.456 ' HA ' HD21 ' A' ' 67' ' ' ASN . 23.0 t -57.44 140.81 15.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.843 -179.067 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 49.0 t -69.05 127.25 32.47 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.599 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' B' B ' 238' ' ' TPO . . . . . 0.447 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 066 nuclear build full ' B' B ' 239' ' ' PRO . . . . . 0.447 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 31.5 Cg_exo -58.57 -25.71 75.66 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 123.086 2.524 . . . . 0.0 113.406 -179.039 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' B' B ' 240' ' ' THR . . . . . 0.737 HG22 ' NH1' ' B' ' 244' ' ' ARG . 16.9 m -73.13 -47.7 41.83 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 119.953 -0.699 . . . . 0.0 109.394 178.972 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.495 ' HZ ' HD22 ' A' ' 41' ' ' LEU . 87.7 t80 -57.49 -44.84 85.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.192 179.911 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 92.9 mt -65.32 -39.1 92.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.811 179.816 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -62.87 -42.15 99.65 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.296 -179.053 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' B' B ' 244' ' ' ARG . . . . . 0.737 ' NH1' HG22 ' B' ' 240' ' ' THR . 95.1 mtm-85 -62.84 -42.23 99.65 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.231 -179.429 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.57 ' NE ' ' OD2' ' A' ' 92' ' ' ASP . 77.2 mtp85 -63.54 -40.57 97.37 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.5 -0.48 . . . . 0.0 112.095 -179.33 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.42 -38.84 88.56 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 120.205 -0.598 . . . . 0.0 109.682 179.658 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' B' B ' 247' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 70.7 p -67.17 -42.5 84.16 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 177.959 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' B' B ' 248' ' ' GLN . . . . . 0.58 ' O ' ' N ' ' B' ' 252' ' ' LEU . 75.5 mm-40 -62.7 -33.1 74.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.757 179.641 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 37.5 t -63.23 -46.3 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.978 179.583 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -60.45 -29.13 68.83 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.997 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -92.77 -14.83 27.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.874 179.499 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.58 ' N ' ' O ' ' B' ' 248' ' ' GLN . 42.4 tp -76.32 147.45 38.15 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.991 0.424 . . . . 0.0 111.299 -179.602 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -98.65 131.09 45.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.558 179.464 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -65.66 -25.84 67.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.263 -179.515 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -84.03 5.29 26.38 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.162 -179.308 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -94.54 97.82 10.41 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.003 179.266 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -65.84 174.92 2.15 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -179.822 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 58.95 67.84 0.88 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -178.294 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.561 ' C ' ' H ' ' B' ' 261' ' ' ILE . 68.1 t0 -84.91 86.29 7.38 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.956 -179.14 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.442 ' HA ' HE21 ' A' ' 40' ' ' GLN . 35.3 tp10 60.73 -9.59 0.06 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.552 178.947 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.561 ' H ' ' C ' ' B' ' 259' ' ' ASP . 63.5 mt -111.97 135.85 49.98 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 CA-C-O 120.811 0.339 . . . . 0.0 110.517 -179.719 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 38.2 t -127.63 134.2 66.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.053 179.447 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -96.69 121.02 38.07 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.991 0.424 . . . . 0.0 111.544 -178.597 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -65.15 -48.09 74.76 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.711 179.583 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' B' B ' 265' ' ' GLN . . . . . 0.602 ' OE1' HD11 ' A' ' 24' ' ' LEU . 3.8 mm-40 -95.63 157.87 35.37 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.286 -178.891 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -64.47 154.67 70.48 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 123.209 2.606 . . . . 0.0 112.575 178.987 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 36.0 pt . . . . . 0 C--N 1.332 -0.156 0 CA-C-O 121.594 0.711 . . . . 0.0 112.401 -179.346 . . . . . . . . 0 0 . 1 . 067 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo . . . . . 0 N--CA 1.499 1.811 0 CA-C-O 121.096 0.373 . . . . 0.0 112.831 . . . . . . . . . 0 0 . 1 . 067 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.9 p -61.22 -44.8 96.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.414 -179.207 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.693 ' NE ' ' CZ ' ' A' ' 97' ' ' TYR . 2.6 mmp_? -90.9 118.2 30.11 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.781 -178.805 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.6 mtp180 -129.08 137.1 51.06 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.202 0.525 . . . . 0.0 111.541 179.522 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.644 HD12 ' O ' ' A' ' 96' ' ' ARG . 22.6 tp -114.49 131.05 56.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.268 179.807 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 76.6 t -108.91 130.89 61.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.072 -179.602 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.6 m -77.71 142.93 38.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.683 -179.341 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.439 ' CD1' ' OD1' ' A' ' 16' ' ' ASP . 50.4 mm -111.11 136.16 48.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.954 178.85 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -89.91 155.64 18.99 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.53 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.54 ' HD3' HH21 ' B' ' 245' ' ' ARG . 89.7 mtm180 -59.78 -24.45 64.1 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.039 -178.951 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.4 p -82.97 -6.97 59.7 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.447 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.77 38.11 7.65 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 179.691 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.6 t -122.84 133.63 68.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.662 0.267 . . . . 0.0 110.565 179.533 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.439 ' OD1' ' CD1' ' A' ' 10' ' ' ILE . 90.9 m-20 -73.7 135.15 43.66 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.271 179.64 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -124.84 -121.57 2.57 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 120.596 -0.811 . . . . 0.0 111.897 -179.633 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.59 145.32 41.69 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.139 1.892 . . . . 0.0 112.888 -178.709 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -104.56 143.76 32.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.711 179.995 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.887 ' CD2' HD11 ' A' ' 37' ' ' ILE . 38.7 t80 -115.36 107.21 49.69 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.19 179.374 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -74.78 127.5 10.89 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 121.373 1.382 . . . . 0.0 111.758 -179.159 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 82.2 mt -84.12 48.81 1.53 Allowed 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.29 -179.383 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 93.6 p -60.72 -25.36 66.37 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.467 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.582 HD11 ' HG2' ' B' ' 265' ' ' GLN . 66.8 mt -76.04 139.02 41.24 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.383 179.986 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.2 m -63.21 -19.25 64.35 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.286 -179.489 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.467 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 22.8 m -136.81 135.0 37.58 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.478 -179.723 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.9 t -126.43 118.49 25.08 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.058 0.456 . . . . 0.0 110.182 178.104 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.523 HD12 ' O ' ' A' ' 49' ' ' CYS . 53.5 tp -114.17 132.42 56.09 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.121 -179.016 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.515 ' O ' ' O ' ' A' ' 47' ' ' GLN . 34.1 m-85 -112.04 137.34 50.2 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.376 -179.341 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 152.93 -177.96 30.3 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.304 179.17 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 45.4 mtm180 -70.6 -32.03 69.25 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 179.772 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.568 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -51.79 148.04 10.64 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 121.133 -0.556 . . . . 0.0 112.477 -178.084 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.526 HG23 ' N ' ' A' ' 34' ' ' GLU . 11.0 tp -66.71 -41.47 88.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 120.886 0.374 . . . . 0.0 110.152 179.315 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.526 ' N ' HG23 ' A' ' 33' ' ' ILE . 77.5 tt0 -57.33 -24.08 52.83 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.497 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.568 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 16.5 m -56.6 120.36 7.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.93 179.343 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.467 ' OD2' ' O ' ' A' ' 26' ' ' THR . 95.7 m-20 -61.87 -25.5 67.58 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.537 0.684 . . . . 0.0 109.155 -179.692 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.887 HD11 ' CD2' ' A' ' 20' ' ' PHE . 39.5 mm -126.88 117.11 46.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.888 178.848 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.419 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 62.0 mtm180 -104.1 135.24 45.96 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.614 -179.871 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.2 mt -120.13 127.95 75.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.521 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -75.05 34.58 0.1 Allowed 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -177.108 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.616 HD11 ' HE ' ' A' ' 93' ' ' ARG . 96.2 mt -103.37 127.88 28.71 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.986 179.588 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.79 -9.83 24.23 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.491 2.128 . . . . 0.0 112.197 -179.915 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.573 HG21 ' CE2' ' B' ' 241' ' ' PHE . 15.8 m -96.77 9.96 6.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.613 179.818 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.438 HG12 ' O ' ' A' ' 45' ' ' SER . 20.1 t -103.31 135.72 39.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.428 179.71 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.438 ' O ' HG12 ' A' ' 44' ' ' VAL . 13.2 m -70.04 170.15 11.98 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.357 0.599 . . . . 0.0 111.048 -179.895 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -64.3 -40.16 95.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.698 -179.685 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.616 ' O ' ' N ' ' A' ' 49' ' ' CYS . 69.5 mm-40 -110.07 -25.07 10.42 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.131 0.491 . . . . 0.0 110.676 -179.158 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.512 ' NE2' HG23 ' A' ' 90' ' ' ILE . 20.5 t60 40.08 -74.69 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 179.119 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.616 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.48 136.86 45.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.406 0.622 . . . . 0.0 112.396 -177.834 . . . . . . . . 3 3 . 1 . 067 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -127.1 128.05 45.61 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.938 179.011 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.8 mt -116.85 134.59 59.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.84 -179.737 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -115.75 135.8 53.68 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.662 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 49.9 mm -102.08 114.2 40.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 120.169 -0.613 . . . . 0.0 110.62 -179.945 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -115.4 134.39 55.14 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.078 179.01 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -42.13 -32.9 0.51 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.01 -179.487 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -63.04 -66.23 0.57 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.739 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -157.69 -160.33 0.92 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.131 179.671 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.511 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -121.29 133.83 55.14 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.561 -179.926 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.9 mt -118.27 128.48 75.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.266 0.555 . . . . 0.0 112.099 -179.265 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.4 tp -95.69 125.01 39.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.623 179.575 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -112.02 136.06 51.85 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.69 0.281 . . . . 0.0 110.444 -179.794 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -97.88 107.7 20.24 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.529 -179.808 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -98.66 -10.65 22.95 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.222 179.37 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.73 97.96 7.53 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.233 179.954 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.0 p -71.67 -32.56 68.01 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.78 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.836 HG21 ' O ' ' B' ' 234' ' ' TPO . 2.0 m -64.0 -47.07 81.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.504 -178.956 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -141.99 97.41 6.42 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.888 -178.984 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -56.06 146.76 68.09 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.009 1.806 . . . . 0.0 111.63 179.696 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.7 m -73.91 146.16 44.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.291 0.567 . . . . 0.0 111.151 -179.698 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -104.81 140.9 37.43 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.996 179.791 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.485 ' O ' ' OG ' ' A' ' 74' ' ' SER . 43.0 t -129.02 135.53 61.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.214 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 51.94 33.48 11.77 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.209 -0.596 . . . . 0.0 109.533 -179.733 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.33 29.84 71.71 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.431 179.703 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.485 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 16.5 p -141.55 136.14 30.83 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.754 0.311 . . . . 0.0 110.895 179.987 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.1 p -68.42 139.14 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 CA-C-O 121.083 0.468 . . . . 0.0 111.678 -179.753 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.7 109.45 21.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.092 179.492 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -90.46 -17.55 26.93 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.845 -179.201 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -116.01 164.88 16.2 Favored Pre-proline 0 N--CA 1.469 0.505 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.824 179.77 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -56.78 142.97 91.93 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 C-N-CA 121.59 1.526 . . . . 0.0 111.562 179.296 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.0 p -139.9 138.91 38.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.983 0.42 . . . . 0.0 110.989 -178.909 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.2 mtm180 -77.94 133.03 38.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.482 -179.982 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.511 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 93.4 mt -86.72 139.84 30.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.143 0.497 . . . . 0.0 111.074 -179.445 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -133.31 155.51 49.3 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.697 -179.501 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.496 ' CE1' ' O ' ' A' ' 99' ' ' ASN . 3.4 t-160 -55.36 113.3 1.36 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.899 -179.458 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.66 -17.54 18.12 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 121.068 -0.587 . . . . 0.0 111.921 179.475 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -70.94 133.3 46.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.998 0.428 . . . . 0.0 110.371 -179.901 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.47 ' O ' HG13 ' A' ' 87' ' ' VAL . 14.2 p -107.87 132.76 54.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.008 -179.217 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 91.3 mt -97.68 130.3 46.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.372 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 51.6 m -122.14 126.23 47.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.735 0.779 . . . . 0.0 112.561 -178.417 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.512 HG23 ' NE2' ' A' ' 48' ' ' HIS . 80.7 mt -113.04 120.07 62.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 114.509 -1.223 . . . . 0.0 108.186 178.661 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.57 ' CD1' HG23 ' A' ' 43' ' ' VAL . 57.1 mt 38.09 -92.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.715 -0.221 . . . . 0.0 111.144 -179.533 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 90' ' ' ILE . 10.3 t0 -119.35 14.75 12.95 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.572 -179.254 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.616 ' HE ' HD11 ' A' ' 41' ' ' LEU . 79.6 mtt-85 -128.89 146.73 50.86 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.148 179.726 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.418 ' OG ' ' CG2' ' A' ' 87' ' ' VAL . 12.8 t -139.45 153.98 47.67 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.651 0.739 . . . . 0.0 111.701 -179.73 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.533 ' HB3' HD11 ' A' ' 7' ' ' LEU . 96.7 m-85 -126.65 121.88 33.39 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.109 179.061 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.644 ' O ' HD12 ' A' ' 7' ' ' LEU . 99.6 mtt180 -82.42 131.29 35.22 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.226 -178.944 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.693 ' CZ ' ' NE ' ' A' ' 5' ' ' ARG . 67.5 t80 -92.25 121.39 33.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.031 179.95 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.463 ' C ' ' NH2' ' A' ' 5' ' ' ARG . 93.5 mt-10 -126.57 131.37 51.55 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -177.886 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.632 ' CG ' HH12 ' A' ' 5' ' ' ARG . 63.1 t-20 -106.89 107.48 18.52 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.179 178.591 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 . . . . . 0 C--N 1.324 -0.51 0 C-N-CA 120.052 -0.659 . . . . 0.0 109.899 179.404 . . . . . . . . 0 0 . 1 . 067 nuclear build full ' B' B ' 228' ' ' VAL . . . . . 0.458 ' O ' ' N ' ' B' ' 231' ' ' GLN . 54.9 t . . . . . 0 N--CA 1.462 0.168 0 CA-C-O 120.997 0.427 . . . . 0.0 110.779 . . . . . . . . . 1 1 . 1 . 067 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.549 ' C ' ' H ' ' B' ' 231' ' ' GLN . 92.3 m-20 39.57 50.26 2.12 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.093 179.577 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 067 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.549 ' H ' ' C ' ' B' ' 229' ' ' ASP . 2.7 mp0 -113.88 60.47 0.66 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.684 0.278 . . . . 0.0 110.695 -179.833 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -134.05 173.42 21.32 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 -179.83 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.22 159.46 53.71 Favored 'Trans proline' 0 C--N 1.3 -2.006 0 C-N-CA 123.309 2.673 . . . . 0.0 112.002 179.794 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.836 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 067 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -73.38 138.83 27.95 Favored 'Trans proline' 0 C--N 1.302 -1.898 0 C-N-CA 121.915 1.744 . . . . 0.0 112.621 -179.784 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 31.4 m -59.25 142.74 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.618 -179.72 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 2.4 t -67.0 128.99 38.43 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.789 179.926 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' B' B ' 238' ' ' TPO . . . . . 0.628 ' O2P' HG23 ' B' ' 240' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 067 nuclear build full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -54.56 -23.94 34.31 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.289 1.992 . . . . 0.0 113.039 179.852 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' B' B ' 240' ' ' THR . . . . . 0.628 HG23 ' O2P' ' B' ' 238' ' ' TPO . 26.2 p -74.16 -40.02 62.85 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 120.421 -0.511 . . . . 0.0 109.696 178.401 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.573 ' CE2' HG21 ' A' ' 43' ' ' VAL . 70.0 t80 -59.96 -46.67 88.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.109 -179.358 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' B' ' 242' ' ' LEU . 90.6 mt -65.25 -41.43 94.32 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -179.561 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -65.47 -40.62 93.37 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.422 -179.374 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' B' B ' 244' ' ' ARG . . . . . 0.431 ' O ' ' OG ' ' B' ' 247' ' ' SER . 82.3 mtp180 -62.04 -42.71 99.46 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.52 -179.886 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.54 HH21 ' HD3' ' A' ' 12' ' ' ARG . 85.3 mtp180 -65.9 -39.95 91.07 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.579 -179.912 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -62.16 -40.81 97.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.167 0.508 . . . . 0.0 110.106 178.887 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' B' B ' 247' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 73.5 p -66.19 -41.69 89.85 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.463 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -61.27 -36.19 79.36 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.116 179.431 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 27.8 t -60.84 -45.28 98.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 120.166 -0.614 . . . . 0.0 109.49 178.769 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -60.44 -27.83 67.81 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.687 179.332 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -89.22 -6.75 56.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.978 179.305 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 94.5 mt -116.32 112.94 22.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.919 178.661 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -65.21 178.97 0.79 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.492 -179.032 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 42.1 p-10 -71.69 -7.49 48.3 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.038 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -68.65 -15.23 63.46 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.75 -179.539 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -79.97 76.57 6.68 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.457 -179.203 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -71.19 -8.86 56.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.345 -179.659 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -112.45 80.83 1.38 Allowed 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.434 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.589 ' OD2' ' NH1' ' A' ' 93' ' ' ARG . 30.9 t0 -60.73 -103.43 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.41 -179.123 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.57 ' N ' ' OD1' ' B' ' 259' ' ' ASP . 94.4 mt-10 -151.05 25.95 0.72 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.954 -179.25 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.49 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 68.2 mt -115.62 136.99 50.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -179.312 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 55.2 t -124.89 132.56 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 121.102 0.477 . . . . 0.0 110.769 -179.837 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -94.6 118.45 31.71 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.875 -179.101 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -64.23 -46.53 83.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.273 179.974 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' B' B ' 265' ' ' GLN . . . . . 0.582 ' HG2' HD11 ' A' ' 24' ' ' LEU . 6.7 mp0 -97.2 158.79 32.67 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.417 -179.3 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -65.94 149.2 86.44 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 123.486 2.791 . . . . 0.0 113.664 -179.716 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 42.3 pt . . . . . 0 CA--C 1.529 0.163 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.3 179.014 . . . . . . . . 0 0 . 1 . 068 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo . . . . . 0 N--CA 1.494 1.504 0 CA-C-O 120.833 0.264 . . . . 0.0 111.904 . . . . . . . . . 0 0 . 1 . 068 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.7 m -68.49 -45.37 72.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.039 -179.767 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 86.0 mtt85 -90.57 127.54 36.29 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -177.677 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.5 mtp180 -127.88 136.84 51.94 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.207 179.982 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.616 HD11 ' HB3' ' A' ' 95' ' ' PHE . 43.3 tp -114.79 135.2 54.45 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 179.55 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.768 HG11 ' NH2' ' A' ' 96' ' ' ARG . 29.8 t -113.85 129.65 69.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.281 -179.404 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.4 m -93.61 112.61 24.53 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -178.209 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.587 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 97.0 mt -78.22 144.4 11.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 177.419 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.488 ' HA ' HH22 ' A' ' 93' ' ' ARG . 96.6 mttt -91.83 165.99 12.97 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 119.841 -0.744 . . . . 0.0 109.915 178.584 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.87 HH21 HD22 ' B' ' 252' ' ' LEU . 86.2 mtm180 -57.51 -27.95 63.03 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.635 -178.769 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.7 m -79.21 -10.47 59.83 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.433 -179.522 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.61 25.66 19.99 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.018 179.551 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.5 m -117.58 138.83 46.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.597 179.803 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.43 ' OD1' HG13 ' A' ' 8' ' ' VAL . 67.1 t0 -64.56 127.36 31.21 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.059 -179.717 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -114.88 -128.55 4.51 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 121.146 -0.55 . . . . 0.0 112.054 -179.062 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -75.67 148.84 33.28 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.416 2.077 . . . . 0.0 112.29 -179.14 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -102.77 165.37 11.1 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.6 -179.933 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.565 ' CD2' HD11 ' A' ' 37' ' ' ILE . 42.3 t80 -139.57 103.74 7.06 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.325 -179.778 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -72.45 126.7 11.81 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 121.446 1.431 . . . . 0.0 111.566 -178.757 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.6 HD22 ' SG ' ' A' ' 27' ' ' CYS . 69.2 mt -85.27 50.75 2.01 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.722 -178.924 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 99.1 p -60.4 -28.63 68.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.1 179.778 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.1 mt -74.61 143.12 44.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.359 -179.732 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 91.5 p -63.91 -17.39 63.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.907 -178.484 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.405 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 31.9 m -133.55 133.54 42.24 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.135 179.857 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.6 ' SG ' HD22 ' A' ' 22' ' ' LEU . 5.4 t -124.81 116.72 22.73 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.443 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.434 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 36.0 tp -113.98 126.26 54.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.139 -179.218 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.764 ' CE2' HD12 ' A' ' 37' ' ' ILE . 12.7 m-85 -104.88 137.96 41.86 Favored 'General case' 0 C--N 1.334 -0.091 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.652 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 175.57 -174.21 46.71 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 119.95 -1.119 . . . . 0.0 112.011 179.66 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.553 HH12 ' H ' ' B' ' 231' ' ' GLN . 27.9 ttp85 -91.59 -16.12 27.59 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.623 -0.288 . . . . 0.0 111.263 179.843 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -81.7 154.35 34.1 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 121.068 -0.587 . . . . 0.0 111.782 -179.43 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.498 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.5 tp -66.46 -41.67 89.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.754 0.311 . . . . 0.0 110.459 179.436 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.498 ' N ' HG23 ' A' ' 33' ' ' ILE . 80.7 tt0 -50.3 -18.65 0.65 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.912 0.387 . . . . 0.0 110.106 -179.613 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.425 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 82.3 m -73.83 140.72 45.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.207 179.685 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.434 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 94.6 m-20 -60.48 -32.78 71.74 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -179.552 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.764 HD12 ' CE2' ' A' ' 29' ' ' PHE . 84.1 mt -126.95 122.5 60.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 176.559 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 67.8 ttp85 -106.36 133.56 50.86 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.461 -179.476 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.415 HG22 ' HG ' ' A' ' 41' ' ' LEU . 79.7 mt -114.37 131.71 65.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.71 -179.55 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -74.5 25.37 0.08 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.962 -178.281 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.634 HD21 ' OE1' ' B' ' 260' ' ' GLU . 50.5 mt -100.29 128.21 31.08 Favored Pre-proline 0 C--N 1.326 -0.427 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.407 179.144 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -73.1 -9.2 23.18 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.347 2.031 . . . . 0.0 111.858 179.678 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.2 m -92.18 5.46 6.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.656 179.829 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 36.1 t -96.84 131.8 42.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.2 179.574 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.409 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 7.9 t -70.17 173.02 7.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.26 -179.052 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.425 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 64.2 mttp -62.77 -42.21 99.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.814 -179.529 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.65 ' O ' ' N ' ' A' ' 49' ' ' CYS . 99.5 mt-30 -114.33 -18.23 11.61 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.203 -179.399 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.409 ' H ' ' HB3' ' A' ' 45' ' ' SER . 20.4 t60 35.14 -76.53 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 179.8 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.65 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.42 134.58 47.22 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.157 0.503 . . . . 0.0 111.956 -178.521 . . . . . . . . 3 3 . 1 . 068 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -127.16 134.07 50.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.849 -179.966 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.6 mt -119.68 133.42 66.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.96 -179.749 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -108.77 127.48 54.04 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.591 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.7 mm -101.35 115.44 43.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 119.995 -0.682 . . . . 0.0 111.33 -178.726 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.469 ' O ' ' C ' ' A' ' 55' ' ' GLU . 95.8 m-70 -119.1 134.13 55.38 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.731 179.155 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.469 ' C ' ' O ' ' A' ' 54' ' ' HIS . 84.9 tt0 -40.75 -30.71 0.13 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.91 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.453 ' N ' ' C ' ' A' ' 54' ' ' HIS . 94.1 mm-40 -66.19 -68.63 0.36 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.034 178.705 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.53 ' OE1' ' CZ ' ' A' ' 81' ' ' ARG . 2.0 pt-20 -153.92 -172.99 4.41 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.334 -178.823 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -116.46 128.0 55.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.622 179.313 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.2 mt -115.8 130.48 70.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.296 0.57 . . . . 0.0 112.023 -178.279 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 23.4 tp -97.43 129.03 44.68 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.09 179.876 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -113.19 137.04 52.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.882 -179.644 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 62.0 t-20 -93.56 105.62 17.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.468 -179.132 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -101.96 -10.59 19.65 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.324 179.319 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.479 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 60.4 p -72.99 102.41 3.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.603 179.742 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.7 p -82.11 -19.0 41.02 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.677 179.742 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.711 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.2 OUTLIER -86.98 -41.29 14.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.001 -179.077 . . . . . . . . 3 3 . 1 . 068 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.479 ' O ' ' OG ' ' A' ' 64' ' ' SER . 47.3 m-20 -143.32 106.93 5.18 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.36 -179.47 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -56.49 143.4 87.8 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 121.606 1.537 . . . . 0.0 112.142 -179.927 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.8 m -69.85 137.35 51.65 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.726 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -97.82 138.34 35.33 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.997 -179.761 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.9 t -133.93 134.52 55.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.994 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 52.97 30.03 8.76 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 -178.836 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.34 27.49 69.71 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.134 -179.513 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.4 t -140.48 138.82 34.93 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.906 0.384 . . . . 0.0 111.756 -179.606 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.458 ' H ' HG22 ' A' ' 75' ' ' VAL . 6.2 m -73.82 141.69 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.996 -179.97 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 10.3 pt -108.36 96.39 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 121.238 0.542 . . . . 0.0 111.462 179.67 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -64.39 -35.62 81.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.777 179.263 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -121.48 171.77 5.72 Favored Pre-proline 0 CA--C 1.533 0.301 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.989 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -60.08 147.25 93.84 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.165 1.91 . . . . 0.0 111.917 179.854 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.9 p -139.2 141.99 34.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.376 0.608 . . . . 0.0 111.755 -179.512 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.53 ' CZ ' ' OE1' ' A' ' 57' ' ' GLU . 79.5 ttt180 -74.78 128.66 36.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.176 179.224 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.434 HD23 ' HA ' ' A' ' 82' ' ' LEU . 95.2 mt -79.91 135.35 36.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.026 0.441 . . . . 0.0 110.897 -179.888 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -124.47 147.79 48.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.733 179.203 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.557 ' ND1' ' OD1' ' A' ' 99' ' ' ASN . 10.5 t60 -53.36 122.48 9.71 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.005 -179.074 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.93 -16.91 42.54 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.976 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -66.76 135.25 53.69 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.483 -0.487 . . . . 0.0 109.821 179.77 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 53.2 t -109.84 131.93 59.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.011 -178.305 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.1 mt -98.98 130.93 47.14 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.426 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.1 m -121.29 127.52 51.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.632 0.729 . . . . 0.0 112.226 -178.722 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.646 ' O ' ' N ' ' A' ' 93' ' ' ARG . 97.6 mt -119.93 125.21 74.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 178.001 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.525 ' C ' ' O ' ' A' ' 90' ' ' ILE . 62.2 mt -11.15 97.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -178.129 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 78.17 -9.71 1.47 Allowed 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 177.938 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.734 HH12 ' N ' ' A' ' 12' ' ' ARG . 20.0 mmm180 -130.09 133.07 46.42 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.669 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.486 ' OG ' HD12 ' A' ' 10' ' ' ILE . 89.0 p -138.54 153.5 48.73 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.176 179.299 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.616 ' HB3' HD11 ' A' ' 7' ' ' LEU . 55.6 m-85 -130.03 132.23 46.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.268 -179.324 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.768 ' NH2' HG11 ' A' ' 8' ' ' VAL . 92.0 mtm-85 -88.51 130.39 35.24 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.539 -179.825 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -95.58 126.49 40.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.502 -179.452 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -134.8 118.13 16.69 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.192 179.489 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.557 ' OD1' ' ND1' ' A' ' 84' ' ' HIS . 53.4 p-10 -100.64 5.98 43.97 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.336 -179.489 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 . . . . . 0 C--N 1.327 -0.408 0 CA-C-O 121.196 0.522 . . . . 0.0 111.086 179.721 . . . . . . . . 0 0 . 1 . 068 nuclear build full ' B' B ' 228' ' ' VAL . . . . . 0.419 HG22 ' O ' ' B' ' 228' ' ' VAL . 5.5 p . . . . . 0 N--CA 1.457 -0.111 0 CA-C-O 120.827 0.346 . . . . 0.0 110.867 . . . . . . . . . 1 1 . 1 . 068 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.448 ' O ' ' OD1' ' B' ' 229' ' ' ASP . 52.2 p-10 -63.72 145.63 55.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.857 0.361 . . . . 0.0 110.372 -179.813 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' B' B ' 230' ' ' SEP . . . . . 0.407 ' O ' ' CB ' ' B' ' 231' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 068 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.553 ' H ' HH12 ' A' ' 31' ' ' ARG . 2.5 mt-30 162.3 -23.83 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 O-C-N 123.583 0.552 . . . . 0.0 110.439 179.727 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' B' B ' 232' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' B' ' 231' ' ' GLN . . . -48.33 -171.6 0.01 OUTLIER Glycine 0 CA--C 1.529 0.957 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.373 -179.063 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -64.34 154.6 70.45 Favored 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 123.674 2.916 . . . . 0.0 113.164 -179.44 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.711 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 068 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.58 135.47 60.87 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.396 2.064 . . . . 0.0 114.032 -178.379 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.575 HG22 HG22 ' A' ' 66' ' ' THR . 68.0 t -63.65 135.42 27.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.483 179.097 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' B' B ' 237' ' ' CYS . . . . . 0.424 ' SG ' HD11 ' B' ' 242' ' ' LEU . 2.0 t -46.08 110.25 0.25 Allowed 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.294 -179.842 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' B' B ' 238' ' ' TPO . . . . . 0.542 HG22 ' H ' ' B' ' 241' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 068 nuclear build full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.94 -22.93 19.66 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 122.04 1.826 . . . . 0.0 112.513 179.182 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 21.6 p -76.37 -45.63 31.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.897 0.379 . . . . 0.0 110.39 179.035 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.542 ' H ' HG22 ' B' ' 238' ' ' TPO . 85.4 t80 -58.9 -48.41 81.53 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.32 -178.742 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.424 HD11 ' SG ' ' B' ' 237' ' ' CYS . 80.1 mt -65.45 -42.11 92.69 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.09 -179.892 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -61.28 -43.64 98.53 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.555 -178.87 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 77.0 ttt-85 -63.41 -43.68 96.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.903 0.382 . . . . 0.0 111.312 -179.14 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.775 HH11 HH11 ' A' ' 12' ' ' ARG . 52.8 ttm-85 -64.08 -40.52 96.43 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.862 -179.262 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -60.13 -36.99 78.74 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.744 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 20.2 m -66.15 -42.8 88.54 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 177.189 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' B' B ' 248' ' ' GLN . . . . . 0.536 ' CD ' HH12 ' A' ' 12' ' ' ARG . 56.7 tt0 -60.27 -34.36 73.61 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.097 179.662 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 55.7 t -63.58 -46.91 93.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.118 178.974 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -58.69 -25.06 62.46 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 179.102 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -93.26 -10.3 36.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.314 178.732 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.87 HD22 HH21 ' A' ' 12' ' ' ARG . 55.8 tp -76.5 145.86 38.87 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.283 -179.58 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -106.58 141.44 37.86 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.981 179.797 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' B' B ' 254' ' ' ASP . . . . . 0.539 ' C ' ' H ' ' B' ' 256' ' ' ASP . 95.8 m-20 -63.46 -30.99 72.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.767 -179.704 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 44.5 p-10 -58.5 0.95 0.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.877 -179.137 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.539 ' H ' ' C ' ' B' ' 254' ' ' ASP . 94.4 m-20 -88.23 175.35 7.72 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.635 178.823 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' B' B ' 257' ' ' LYS . . . . . 0.693 ' O ' ' N ' ' B' ' 259' ' ' ASP . 98.4 mttt -147.31 -113.37 0.08 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.415 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.659 ' O ' ' N ' ' B' ' 260' ' ' GLU . 97.6 m-20 -33.72 -22.05 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.734 -178.885 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.693 ' N ' ' O ' ' B' ' 257' ' ' LYS . 28.0 t70 40.86 -72.54 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 113.248 0.832 . . . . 0.0 113.248 177.377 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.659 ' N ' ' O ' ' B' ' 258' ' ' ASP . 95.9 mt-10 -136.79 1.99 2.59 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -178.765 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.665 ' CD1' HH21 ' A' ' 93' ' ' ARG . 42.5 mt -110.17 138.3 38.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.101 -179.811 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 43.0 t -125.61 132.33 71.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.005 0.431 . . . . 0.0 110.221 179.262 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -96.39 120.52 36.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.877 -178.94 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -66.01 -47.32 74.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.387 -179.315 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.8 151.99 44.22 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.445 -179.018 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -64.55 147.71 90.34 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.754 2.303 . . . . 0.0 112.31 179.613 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.1 pt . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.448 179.82 . . . . . . . . 0 0 . 1 . 069 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 N--CA 1.494 1.529 0 N-CA-C 111.331 -0.296 . . . . 0.0 111.331 . . . . . . . . . 0 0 . 1 . 069 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 99.2 m -76.96 -46.69 23.17 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -179.55 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.504 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 95.5 mtt-85 -88.04 128.85 35.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.671 -178.579 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -129.33 140.37 51.42 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 120.471 -0.492 . . . . 0.0 112.13 -179.242 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.505 HD11 ' CB ' ' A' ' 95' ' ' PHE . 34.0 tp -116.25 134.38 54.97 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.843 178.966 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.3 t -110.78 130.83 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.016 -179.945 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.421 HG23 ' CD1' ' B' ' 261' ' ' ILE . 1.4 m -94.14 116.86 29.32 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.678 -178.77 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.649 HD12 ' OG ' ' A' ' 94' ' ' SER . 96.8 mt -80.18 143.55 12.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.32 179.061 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -91.22 158.88 16.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.022 0.439 . . . . 0.0 110.268 178.637 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.519 ' NH1' ' OE2' ' B' ' 260' ' ' GLU . 80.9 mtp180 -58.2 -32.07 67.93 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.539 -179.854 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.2 m -77.23 -9.95 59.11 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.006 -179.947 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.71 33.67 7.33 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.446 -0.662 . . . . 0.0 111.446 179.877 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.0 t -119.57 134.22 63.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.733 0.301 . . . . 0.0 110.79 -179.823 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -63.17 122.41 16.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.26 179.942 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -106.89 -139.58 9.38 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.553 -179.266 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.79 155.49 62.43 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.215 1.944 . . . . 0.0 112.082 -179.164 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -107.29 146.8 31.06 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.975 -179.05 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.692 ' CD2' HD11 ' A' ' 37' ' ' ILE . 23.6 t80 -115.16 101.68 54.52 Favored Pre-proline 0 CA--C 1.536 0.437 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.898 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.72 131.78 17.7 Favored 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 121.398 1.399 . . . . 0.0 111.475 -179.392 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 83.4 mt -86.48 52.44 2.5 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 119.961 -0.695 . . . . 0.0 111.197 -178.44 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.8 p -61.8 -29.87 70.43 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.797 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.431 HD11 ' CD ' ' B' ' 265' ' ' GLN . 67.5 mt -79.06 142.45 36.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.187 179.757 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 72.6 p -66.39 -20.17 66.0 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.969 -0.293 . . . . 0.0 111.713 -179.494 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.416 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 53.2 m -127.04 128.9 47.03 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.292 0.568 . . . . 0.0 112.011 -179.633 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.454 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 11.8 t -123.57 113.54 18.85 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.774 178.697 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.565 ' O ' ' N ' ' A' ' 36' ' ' ASP . 63.4 tp -110.42 125.33 53.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.185 0.517 . . . . 0.0 110.786 -179.555 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.862 ' CE2' HD12 ' A' ' 37' ' ' ILE . 4.5 m-85 -107.06 140.02 40.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.282 179.583 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 170.38 -160.22 32.88 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.377 179.388 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 27.4 ptt-85 -107.22 -8.92 16.25 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.411 179.817 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.478 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -85.37 167.24 40.93 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.286 -179.945 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.569 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.9 tp -67.29 -42.41 87.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.719 0.295 . . . . 0.0 110.779 -179.814 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.569 ' N ' HG23 ' A' ' 33' ' ' ILE . 78.4 mm-40 -53.14 -25.55 13.76 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.144 0.497 . . . . 0.0 110.021 -178.908 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.478 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 3.7 m -62.38 124.21 20.32 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.402 179.521 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.565 ' N ' ' O ' ' A' ' 28' ' ' LEU . 63.7 m-20 -58.54 -29.03 66.02 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -179.055 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.862 HD12 ' CE2' ' A' ' 29' ' ' PHE . 93.6 mt -126.56 122.32 60.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 176.237 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 72.0 ttp85 -106.57 135.81 47.44 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.116 -178.511 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 98.6 mt -115.68 129.1 72.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.009 -179.573 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -74.09 31.5 0.08 Allowed 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 -177.918 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.507 ' CG ' HH21 ' A' ' 93' ' ' ARG . 86.2 mt -107.49 135.88 19.67 Favored Pre-proline 0 C--N 1.323 -0.559 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.888 179.539 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.56 -10.13 24.89 Favored 'Trans proline' 0 C--N 1.315 -1.216 0 C-N-CA 122.067 1.845 . . . . 0.0 111.428 179.215 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.526 HG21 ' CE2' ' B' ' 241' ' ' PHE . 9.7 m -97.22 6.62 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.216 -179.936 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.0 t -92.78 128.48 44.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.045 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 41.2 t -66.71 172.76 3.96 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.51 0.671 . . . . 0.0 111.628 -178.59 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -65.83 -43.24 89.12 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.96 -179.631 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.628 ' O ' ' N ' ' A' ' 49' ' ' CYS . 86.8 mt-30 -119.36 -5.34 10.37 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.847 -179.002 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.503 ' C ' ' O ' ' A' ' 47' ' ' GLN . 17.8 t60 14.05 -73.37 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 -178.852 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.628 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -126.08 129.53 49.29 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 119.716 -0.793 . . . . 0.0 112.876 -179.069 . . . . . . . . 3 3 . 1 . 069 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -126.58 128.66 47.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.013 178.508 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.2 mt -116.41 134.3 60.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.685 -179.292 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -112.18 122.12 46.86 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.603 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 95.7 mt -101.8 116.49 45.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 119.543 -0.863 . . . . 0.0 111.847 -178.638 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.485 ' O ' ' N ' ' A' ' 56' ' ' GLN . 94.1 m-70 -114.19 141.52 47.43 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.922 -179.828 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 54' ' ' HIS . 51.7 mp0 -40.15 -29.37 0.07 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 179.852 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.485 ' N ' ' O ' ' A' ' 54' ' ' HIS . 56.1 tt0 -65.34 -68.14 0.39 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.241 -0.89 . . . . 0.0 108.997 178.192 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.488 ' OE1' ' O ' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -159.53 -166.28 1.74 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.257 0.551 . . . . 0.0 111.868 -179.531 . . . . . . . . 3 3 . 1 . 069 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.488 ' O ' ' OE1' ' A' ' 57' ' ' GLU . . . -112.88 125.48 54.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.313 179.633 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 99.0 mt -116.08 129.55 72.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -177.924 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.45 ' HB2' HD11 ' A' ' 82' ' ' LEU . 50.9 tp -96.3 128.87 43.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.642 179.706 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -111.57 135.31 52.33 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.74 179.722 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -100.57 106.84 18.39 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -178.749 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -99.89 -1.44 37.36 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.994 179.031 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.46 100.04 12.46 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.404 -179.553 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.0 p -81.7 -15.16 55.35 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.214 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.92 -35.57 14.65 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.213 -179.86 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.491 ' HB3' HD11 ' A' ' 91' ' ' ILE . 11.1 m-80 -150.7 89.0 4.47 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.24 -179.815 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -57.12 148.9 66.46 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.68 2.253 . . . . 0.0 112.717 -179.665 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 38.1 m -71.99 138.37 47.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.324 179.327 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -96.63 144.54 26.58 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.101 -179.664 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.711 ' HB ' HD11 ' A' ' 76' ' ' ILE . 3.9 p -127.87 135.74 62.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.956 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 48.71 31.46 3.06 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.287 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.56 27.44 63.29 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.686 179.87 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 71' ' ' VAL . 21.1 t -136.67 134.53 37.36 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.998 0.399 . . . . 0.0 110.907 179.784 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.4 ' H ' HG12 ' A' ' 75' ' ' VAL . 0.2 OUTLIER -60.64 143.95 13.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.342 -179.911 . . . . . . . . 3 3 . 1 . 069 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.711 HD11 ' HB ' ' A' ' 71' ' ' VAL . 97.2 mt -107.97 102.93 14.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.456 179.565 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -64.92 -42.31 94.81 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.716 0.294 . . . . 0.0 111.556 179.365 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.536 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.3 OUTLIER -133.67 -179.41 1.06 Allowed Pre-proline 0 CA--C 1.532 0.28 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.597 -178.581 . . . . . . . . 3 3 . 1 . 069 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.471 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 52.3 Cg_exo -55.18 138.05 78.25 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 122.331 2.021 . . . . 0.0 112.779 -178.687 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 72.7 t -134.48 136.68 52.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.792 -179.576 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -73.84 135.49 43.43 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.608 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.45 HD11 ' HB2' ' A' ' 60' ' ' LEU . 97.4 mt -84.89 137.56 33.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.284 0.564 . . . . 0.0 111.466 -179.225 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -126.74 151.04 48.72 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.219 -179.963 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.475 ' HD1' ' H ' ' A' ' 99' ' ' ASN . 15.0 t60 -60.46 125.76 24.92 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.041 0.448 . . . . 0.0 110.774 -179.43 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.11 -17.88 47.18 Favored Glycine 0 CA--C 1.519 0.289 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.516 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 87' ' ' VAL . 66.4 t0 -72.52 133.05 44.59 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.041 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.512 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 33.6 t -109.36 133.3 54.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.1 0.476 . . . . 0.0 110.998 -179.119 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.4 mt -93.33 131.46 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 178.841 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.3 m -122.44 124.54 43.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.495 0.664 . . . . 0.0 112.311 -178.321 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.575 ' O ' ' N ' ' A' ' 93' ' ' ARG . 98.0 mt -117.84 133.46 64.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.752 178.725 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.491 HD11 ' HB3' ' A' ' 67' ' ' ASN . 80.8 mt -23.7 97.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -178.614 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.473 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 3.2 m-20 89.73 -20.07 0.16 Allowed 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.801 1.038 . . . . 0.0 113.801 177.792 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.603 ' NH2' ' OE1' ' B' ' 260' ' ' GLU . 54.3 mtt-85 -130.33 140.81 50.62 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.6 -179.114 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.649 ' OG ' HD12 ' A' ' 10' ' ' ILE . 11.2 p -137.53 150.71 47.73 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.712 0.291 . . . . 0.0 110.241 -179.931 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.541 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 15.4 m-85 -129.53 123.78 32.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.077 -179.038 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.447 ' HA ' HG22 ' A' ' 87' ' ' VAL . 42.9 ttm180 -79.37 127.7 32.42 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.137 0.494 . . . . 0.0 111.337 -179.464 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.504 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 67.9 t80 -94.26 127.68 40.27 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.997 -179.707 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -141.26 116.96 10.33 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.702 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 100' ' ' GLU . 52.4 p30 -71.85 -22.37 61.54 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.48 179.72 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.524 ' N ' ' OD1' ' A' ' 99' ' ' ASN . 96.7 mt-10 . . . . . 0 CA--C 1.53 0.204 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.736 179.798 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 15.2 m . . . . . 0 N--CA 1.448 -0.566 0 CA-C-O 120.932 0.396 . . . . 0.0 110.653 . . . . . . . . . 0 0 . 1 . 069 nuclear build full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 41.55 -108.38 0.09 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.258 -179.923 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 069 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.495 ' O ' ' O ' ' B' ' 232' ' ' GLY . 99.5 mm-40 -123.56 -22.86 4.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.693 -179.742 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' B' B ' 232' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' B' ' 231' ' ' GLN . . . -44.76 179.45 0.01 OUTLIER Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 -179.448 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.08 161.95 43.72 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 123.328 2.685 . . . . 0.0 112.762 179.976 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 069 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -75.03 171.16 18.86 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.019 1.813 . . . . 0.0 112.082 -179.841 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 2.9 p -115.18 133.64 60.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.914 179.864 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' B' B ' 237' ' ' CYS . . . . . 0.465 ' CB ' HD13 ' A' ' 91' ' ' ILE . 2.3 t -74.97 130.11 38.8 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.635 -179.418 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' B' B ' 238' ' ' TPO . . . . . 0.43 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 069 nuclear build full ' B' B ' 239' ' ' PRO . . . . . 0.43 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 40.7 Cg_exo -57.59 -28.55 81.71 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.849 2.366 . . . . 0.0 113.175 -179.411 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 14.5 m -69.11 -45.68 69.59 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.582 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.526 ' CE2' HG21 ' A' ' 43' ' ' VAL . 64.8 t80 -57.3 -45.93 83.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.364 -179.327 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 90.6 mt -64.53 -41.37 96.41 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -179.91 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -64.09 -39.11 93.35 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.967 -178.95 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -61.82 -41.64 98.03 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.544 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.603 ' O ' HG23 ' B' ' 249' ' ' VAL . 71.3 ttp85 -60.9 -42.51 98.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.981 179.847 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.18 -40.59 90.52 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.097 -179.506 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 68.6 m -68.07 -42.99 79.61 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.481 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' B' B ' 248' ' ' GLN . . . . . 0.499 ' CD ' HH22 ' A' ' 12' ' ' ARG . 7.3 tt0 -62.37 -38.07 88.13 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.61 -179.18 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.603 HG23 ' O ' ' B' ' 245' ' ' ARG . 77.8 t -60.4 -45.86 96.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.108 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -59.87 -26.75 66.12 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.636 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -83.88 -11.38 57.03 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.703 178.552 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.559 ' O ' ' CB ' ' B' ' 253' ' ' ASN . 97.0 mt -115.01 -173.92 2.4 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.624 179.554 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' B' B ' 253' ' ' ASN . . . . . 0.559 ' CB ' ' O ' ' B' ' 252' ' ' LEU . 16.2 t-20 91.42 28.01 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.932 179.905 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' B' B ' 254' ' ' ASP . . . . . 0.585 ' O ' ' CB ' ' B' ' 255' ' ' ASP . 24.0 p-10 -88.4 -6.01 57.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.355 179.534 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' B' B ' 255' ' ' ASP . . . . . 0.585 ' CB ' ' O ' ' B' ' 254' ' ' ASP . 51.3 t0 112.96 62.36 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 O-C-N 124.286 0.991 . . . . 0.0 110.904 179.636 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 37.2 p30 -98.41 -175.53 3.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.068 0.461 . . . . 0.0 110.865 179.871 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' B' B ' 257' ' ' LYS . . . . . 0.553 ' C ' ' H ' ' B' ' 259' ' ' ASP . 98.5 mttt -141.01 159.45 42.2 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.185 179.614 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.544 ' O ' ' N ' ' B' ' 260' ' ' GLU . 87.0 m-20 52.34 5.3 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.382 -179.9 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.553 ' H ' ' C ' ' B' ' 257' ' ' LYS . 1.6 p-10 28.55 -87.1 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.011 0.434 . . . . 0.0 111.789 -179.948 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.603 ' OE1' ' NH2' ' A' ' 93' ' ' ARG . 90.8 mt-10 -146.53 14.12 1.23 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.702 -179.95 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.421 ' CD1' HG23 ' A' ' 9' ' ' THR . 50.5 mt -107.87 139.42 29.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.762 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 61.1 t -126.73 135.27 64.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.511 -179.741 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -98.97 121.54 41.05 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.302 0.572 . . . . 0.0 111.089 -178.833 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -64.66 -46.72 81.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.952 179.913 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' B' B ' 265' ' ' GLN . . . . . 0.431 ' CD ' HD11 ' A' ' 24' ' ' LEU . 21.7 mm-40 -93.15 150.09 38.57 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.956 -179.269 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.7 148.54 65.7 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.549 2.166 . . . . 0.0 112.678 -179.869 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.3 pt . . . . . 0 C--N 1.327 -0.39 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.535 179.589 . . . . . . . . 0 0 . 1 . 070 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo . . . . . 0 N--CA 1.494 1.515 0 CA-C-O 120.678 0.199 . . . . 0.0 111.683 . . . . . . . . . 0 0 . 1 . 070 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 41.4 p -112.29 -44.46 3.39 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.699 -179.692 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.816 ' NE ' HD13 ' A' ' 53' ' ' ILE . 89.7 mtm-85 -88.66 123.68 33.35 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.751 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -130.79 138.48 49.93 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -178.393 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.565 HD11 HD11 ' A' ' 22' ' ' LEU . 68.2 mt -112.98 133.52 54.9 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.088 178.645 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 66.4 t -108.77 128.37 64.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.415 179.672 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.465 ' CG2' HD12 ' B' ' 261' ' ' ILE . 11.9 m -92.17 114.45 27.0 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.729 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.563 HD12 ' OG ' ' A' ' 94' ' ' SER . 96.4 mt -78.39 141.88 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.766 178.605 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.74 155.37 20.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.316 179.827 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -57.57 -31.96 66.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.682 -179.515 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.0 p -78.21 -8.3 58.16 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.146 0.498 . . . . 0.0 110.61 -179.877 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.76 38.2 6.21 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 -179.547 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 52.9 t -121.52 132.74 70.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.716 -0.393 . . . . 0.0 111.153 -179.49 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -68.54 116.61 9.28 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.795 -0.816 . . . . 0.0 108.795 179.53 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -107.53 -131.32 6.58 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.994 -178.975 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.58 149.45 61.7 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 121.945 1.763 . . . . 0.0 112.816 -178.63 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -106.85 145.0 32.68 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.598 179.351 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -115.17 96.45 45.41 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.184 -178.805 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.3 134.03 20.27 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.337 1.358 . . . . 0.0 112.311 -179.048 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.565 HD11 HD11 ' A' ' 7' ' ' LEU . 95.5 mt -84.54 83.02 8.15 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.017 -179.172 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 24.3 p -87.31 -12.03 47.73 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.535 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 58.9 mt -99.47 142.41 30.98 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.178 -179.732 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 77.9 p -66.82 -14.92 63.21 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.283 -178.953 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.0 m -130.73 131.98 45.08 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.973 0.416 . . . . 0.0 111.147 -179.721 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.498 ' HB2' HD22 ' A' ' 22' ' ' LEU . 9.9 t -125.71 119.44 28.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.453 178.992 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.439 HD21 ' HG2' ' A' ' 47' ' ' GLN . 50.5 tp -116.15 131.11 57.03 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.837 0.351 . . . . 0.0 111.408 -178.27 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.697 ' CE2' HD12 ' A' ' 37' ' ' ILE . 10.8 m-85 -108.8 143.29 38.16 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.63 179.704 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 156.74 -152.98 24.32 Favored Glycine 0 C--O 1.223 -0.536 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.262 179.448 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.539 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 32.9 mtm180 -108.0 -26.48 10.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.806 0.336 . . . . 0.0 110.414 179.251 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.562 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -58.29 155.39 22.95 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 121.205 -0.521 . . . . 0.0 111.917 -178.639 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.432 HD13 ' HA ' ' A' ' 33' ' ' ILE . 35.9 mm -63.4 -42.56 96.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.753 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -55.06 -29.6 57.85 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.147 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.562 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 5.7 m -53.99 113.82 1.37 Allowed 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.085 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -59.08 -23.93 62.49 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -178.558 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.697 HD12 ' CE2' ' A' ' 29' ' ' PHE . 91.1 mt -128.4 121.95 56.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 177.197 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.432 ' O ' ' N ' ' B' ' 262' ' ' VAL . 43.4 mtm180 -110.64 136.81 49.17 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.359 -179.151 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.63 HD13 ' HE ' ' A' ' 93' ' ' ARG . 93.3 mt -115.66 128.91 72.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.688 179.397 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -71.71 33.72 0.06 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.704 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.713 HD12 ' CZ ' ' A' ' 93' ' ' ARG . 41.6 mt -115.39 131.57 23.54 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 120.189 -0.604 . . . . 0.0 111.14 179.739 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.4 ' O ' ' HD2' ' B' ' 235' ' ' PRO . 57.0 Cg_endo -71.26 -15.11 31.69 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.345 2.03 . . . . 0.0 113.321 -179.637 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.553 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 26.2 m -84.25 -0.49 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-O 121.009 0.433 . . . . 0.0 110.534 179.61 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.539 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 66.4 t -94.65 133.07 36.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.6 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 38.4 t -71.85 170.73 13.05 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.465 0.65 . . . . 0.0 111.962 -178.335 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.558 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 51.7 mttp -62.48 -40.43 96.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.424 -179.874 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.695 ' O ' ' N ' ' A' ' 49' ' ' CYS . 86.2 mt-30 -119.55 -15.01 9.06 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 123.239 0.337 . . . . 0.0 111.65 -179.249 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.6 t60 32.41 -71.91 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 179.534 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.695 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -134.44 137.34 43.91 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.952 -178.582 . . . . . . . . 3 3 . 1 . 070 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -127.41 131.04 50.36 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.045 179.416 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.6 mt -116.74 135.32 57.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.441 -179.606 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -117.28 124.76 49.79 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.765 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.816 HD13 ' NE ' ' A' ' 5' ' ' ARG . 80.9 mt -104.72 115.75 47.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.724 0.773 . . . . 0.0 112.096 -178.788 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.588 ' O ' ' N ' ' A' ' 56' ' ' GLN . 96.9 m-70 -112.59 141.59 46.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.547 -1.206 . . . . 0.0 108.844 179.129 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 54' ' ' HIS . 50.6 tp10 -39.36 -24.57 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -179.336 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.588 ' N ' ' O ' ' A' ' 54' ' ' HIS . 49.8 tt0 -64.93 -68.2 0.38 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.123 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.93 -155.15 0.4 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.484 178.476 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.431 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -116.86 126.04 52.43 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.711 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 99.2 mt -114.92 131.09 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 121.152 0.501 . . . . 0.0 112.064 -178.628 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.52 ' HB2' HD11 ' A' ' 82' ' ' LEU . 23.9 tp -101.5 129.29 47.54 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.389 -179.451 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -113.23 136.0 53.21 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.577 -179.896 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.449 HD21 ' HA ' ' A' ' 68' ' ' PRO . 41.0 t30 -95.87 105.34 17.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.559 179.998 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -99.12 -10.11 22.95 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.803 179.56 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.41 98.49 11.04 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.865 179.709 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.8 m -75.55 -30.29 59.67 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.407 178.998 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.598 ' CG2' HG12 ' B' ' 236' ' ' VAL . 5.4 m -61.01 -45.42 94.88 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.856 -179.296 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.2 m-20 -144.07 102.18 4.84 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.982 -179.659 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.449 ' HA ' HD21 ' A' ' 62' ' ' ASN . 32.4 Cg_exo -56.39 146.01 75.81 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 121.479 1.452 . . . . 0.0 112.343 179.554 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.7 m -73.07 144.39 47.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.144 179.17 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -102.8 138.68 39.37 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.491 179.399 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.433 HG22 HG12 ' A' ' 88' ' ' ILE . 52.2 t -132.78 131.63 59.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.185 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 54.3 34.12 19.83 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.131 -0.628 . . . . 0.0 109.978 -179.43 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.52 25.56 72.2 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.647 178.901 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 29.1 t -145.55 142.49 29.21 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 117.524 0.662 . . . . 0.0 111.34 179.751 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.404 HG12 ' H ' ' A' ' 75' ' ' VAL . 0.2 OUTLIER -73.2 141.63 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.838 179.749 . . . . . . . . 3 3 . 1 . 070 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 11.4 pt -108.13 98.51 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-O 121.43 0.633 . . . . 0.0 110.888 179.0 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -66.23 -32.06 73.26 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.322 179.406 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -123.61 172.84 5.1 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.454 -179.283 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.63 146.72 94.53 Favored 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 122.468 2.112 . . . . 0.0 112.276 179.927 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.7 p -139.97 140.39 35.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.137 0.494 . . . . 0.0 111.304 -179.86 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -75.39 131.94 40.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.573 179.691 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.52 HD11 ' HB2' ' A' ' 60' ' ' LEU . 93.2 mt -87.27 138.39 31.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.274 0.559 . . . . 0.0 111.449 -179.645 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -130.1 156.43 44.55 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.665 179.368 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.552 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 4.7 t60 -59.86 123.83 18.25 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.604 -179.574 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.84 -13.86 45.64 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.877 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -69.7 136.99 51.72 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.472 -0.491 . . . . 0.0 109.864 179.728 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 50.7 t -113.61 130.64 67.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.837 -178.797 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.433 HG12 HG22 ' A' ' 71' ' ' VAL . 98.7 mt -103.84 133.33 48.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.734 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 95.8 m -128.58 129.89 46.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.907 0.861 . . . . 0.0 113.217 -178.379 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.465 ' O ' ' N ' ' A' ' 92' ' ' ASP . 92.8 mt -113.2 124.96 70.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.106 -1.406 . . . . 0.0 107.918 178.135 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.452 ' C ' ' O ' ' A' ' 90' ' ' ILE . 52.6 mt 34.68 -94.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.73 -178.719 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.623 ' OD1' ' NH1' ' A' ' 93' ' ' ARG . 31.5 p-10 -116.79 10.3 14.19 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.927 -179.754 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.713 ' CZ ' HD12 ' A' ' 41' ' ' LEU . 53.4 mtm-85 -122.39 139.43 53.85 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -179.581 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.563 ' OG ' HD12 ' A' ' 10' ' ' ILE . 58.5 p -140.31 155.33 46.86 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.961 -179.78 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -124.67 121.96 36.18 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.501 179.711 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -81.18 132.54 35.36 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 119.651 -0.819 . . . . 0.0 110.249 -179.901 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.668 ' CZ ' ' ND2' ' A' ' 99' ' ' ASN . 87.2 t80 -102.02 124.98 48.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.494 -178.873 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -140.49 127.7 21.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.045 179.148 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.668 ' ND2' ' CZ ' ' A' ' 97' ' ' TYR . 7.7 m120 -107.83 142.25 38.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.166 178.996 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 . . . . . 0 C--N 1.328 -0.356 0 CA-C-O 121.043 0.449 . . . . 0.0 111.043 -179.851 . . . . . . . . 0 0 . 1 . 070 nuclear build full ' B' B ' 228' ' ' VAL . . . . . 0.467 ' O ' ' O ' ' B' ' 229' ' ' ASP . 89.8 t . . . . . 0 N--CA 1.463 0.206 0 CA-C-O 120.429 0.157 . . . . 0.0 110.784 . . . . . . . . . 1 1 . 1 . 070 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.477 ' C ' ' H ' ' B' ' 231' ' ' GLN . 95.6 m-20 55.89 118.8 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.463 179.324 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 070 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.477 ' H ' ' C ' ' B' ' 229' ' ' ASP . 69.7 mt-30 -132.37 49.83 2.29 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.325 -179.187 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -116.16 -171.41 16.18 Favored Glycine 0 CA--C 1.531 1.09 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 -179.468 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.12 161.12 45.58 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 123.336 2.691 . . . . 0.0 113.162 -179.766 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.565 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 070 nuclear build full ' B' B ' 235' ' ' PRO . . . . . 0.4 ' HD2' ' O ' ' A' ' 42' ' ' PRO . 31.6 Cg_exo -58.49 138.95 88.64 Favored 'Trans proline' 0 C--N 1.302 -1.89 0 C-N-CA 121.983 1.789 . . . . 0.0 112.26 179.735 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.598 HG12 ' CG2' ' A' ' 66' ' ' THR . 3.6 m -66.76 138.69 22.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 114.552 -1.204 . . . . 0.0 110.263 -178.996 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.5 t -59.05 114.97 2.85 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.392 -0.523 . . . . 0.0 109.7 179.918 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 070 nuclear build full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_exo -55.69 -25.62 51.82 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 122.177 1.918 . . . . 0.0 112.137 179.578 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 71.4 m -68.88 -44.77 72.6 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.004 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.713 ' CD1' ' NH2' ' B' ' 245' ' ' ARG . 62.7 t80 -58.07 -46.1 86.0 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.503 -179.4 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.417 ' HA ' HD23 ' B' ' 242' ' ' LEU . 71.9 mt -62.11 -41.04 97.82 Favored 'General case' 0 N--CA 1.462 0.127 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 179.972 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.83 -39.36 93.45 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.208 -179.471 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -59.47 -44.24 93.06 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.659 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.713 ' NH2' ' CD1' ' B' ' 241' ' ' PHE . 0.6 OUTLIER -62.22 -40.9 97.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.44 179.423 . . . . . . . . 3 3 . 1 . 070 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -61.98 -43.74 98.2 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.477 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 38.9 t -63.13 -44.19 96.25 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.529 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -61.35 -33.66 73.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.355 179.764 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.521 HG23 ' O ' ' B' ' 245' ' ' ARG . 51.3 t -63.12 -45.95 97.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.013 179.548 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -61.41 -28.56 69.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.689 178.932 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -89.16 -7.91 54.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.986 179.258 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.466 ' HG ' ' N ' ' B' ' 253' ' ' ASN . 33.3 tp -96.09 167.92 10.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.456 -179.766 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' B' B ' 253' ' ' ASN . . . . . 0.466 ' N ' ' HG ' ' B' ' 252' ' ' LEU . 97.7 m-20 -116.85 145.33 43.63 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.319 178.95 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -62.59 -32.24 73.2 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.328 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' B' B ' 255' ' ' ASP . . . . . 0.449 ' C ' ' OD1' ' B' ' 255' ' ' ASP . 39.1 p-10 -94.77 8.82 41.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.954 179.235 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.668 ' CG ' ' H ' ' B' ' 257' ' ' LYS . 25.4 p-10 -41.44 -94.39 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.014 -179.293 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' B' B ' 257' ' ' LYS . . . . . 0.668 ' H ' ' CG ' ' B' ' 256' ' ' ASP . 59.3 pttt 171.65 172.64 0.09 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.442 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.566 ' O ' ' O ' ' B' ' 257' ' ' LYS . 86.3 m-20 -27.28 151.97 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.23 0.538 . . . . 0.0 111.257 -178.854 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.572 ' C ' ' H ' ' B' ' 261' ' ' ILE . 24.9 p30 -101.01 -177.48 3.47 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.786 0.803 . . . . 0.0 111.388 -179.465 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -64.04 23.18 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.462 -1.244 . . . . 0.0 112.069 -178.139 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.572 ' H ' ' C ' ' B' ' 259' ' ' ASP . 73.6 mt -109.57 132.88 56.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.335 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' B' B ' 262' ' ' VAL . . . . . 0.432 ' N ' ' O ' ' A' ' 38' ' ' ARG . 53.7 t -124.37 133.19 70.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.605 -178.775 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -98.91 121.59 41.07 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.135 0.493 . . . . 0.0 111.936 -178.382 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -65.59 -44.04 87.84 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.621 179.417 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.23 158.51 83.85 Favored Pre-proline 0 CA--C 1.517 -0.312 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.828 -179.102 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -57.79 139.47 90.41 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 C-N-CA 122.2 1.933 . . . . 0.0 111.302 179.444 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 19.1 tt . . . . . 0 N--CA 1.441 -0.876 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.206 -179.313 . . . . . . . . 0 0 . 1 . 071 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo . . . . . 0 N--CA 1.495 1.567 0 CA-C-O 120.873 0.28 . . . . 0.0 112.015 . . . . . . . . . 0 0 . 1 . 071 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 99' ' ' ASN . 2.5 t -134.11 24.37 3.87 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.881 179.471 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.66 HH11 ' HH ' ' A' ' 97' ' ' TYR . 94.9 mtt-85 -81.64 135.7 35.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.038 179.894 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.4 mtp180 -130.54 140.37 50.47 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 121.504 0.669 . . . . 0.0 112.469 -178.63 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.613 HD12 ' O ' ' A' ' 96' ' ' ARG . 44.4 tp -117.16 133.56 55.85 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.154 179.391 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.2 t -109.33 130.97 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.264 -178.752 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.44 HG23 ' CD1' ' B' ' 261' ' ' ILE . 9.7 m -89.96 115.59 27.37 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 121.316 0.579 . . . . 0.0 112.357 -178.842 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.424 HD12 ' HB2' ' A' ' 94' ' ' SER . 94.1 mt -83.9 143.37 11.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.641 178.725 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -86.95 155.0 20.37 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.4 178.364 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.759 HH11 HH11 ' B' ' 245' ' ' ARG . 91.1 mtm180 -52.92 -26.99 16.73 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.848 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 91.6 p -81.36 -6.26 58.72 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.292 179.309 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.63 36.95 9.91 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.322 -179.267 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 36.1 t -120.62 137.09 55.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.953 0.406 . . . . 0.0 111.453 -178.883 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -76.56 121.26 22.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.149 -179.504 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -117.18 -123.79 3.44 Favored Glycine 0 CA--C 1.542 1.739 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -179.786 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -74.8 148.88 36.89 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 122.48 2.12 . . . . 0.0 113.134 -179.359 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -102.96 165.97 10.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.293 179.03 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.678 ' CD2' HD11 ' A' ' 37' ' ' ILE . 52.8 t80 -134.63 97.44 14.23 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.206 -179.248 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.79 122.66 10.81 Favored 'Trans proline' 0 N--CA 1.501 1.943 0 C-N-CA 122.441 2.094 . . . . 0.0 112.694 -179.896 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.6 mt -83.94 49.53 1.65 Allowed 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 121.126 -0.23 . . . . 0.0 111.375 -179.477 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 91.6 p -65.23 -22.55 66.89 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.051 0.453 . . . . 0.0 109.789 179.396 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 80.5 mt -77.58 139.48 39.54 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.991 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.81 -17.52 63.19 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.223 -0.444 . . . . 0.0 112.047 -178.28 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 86.2 m -133.26 133.97 43.34 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.444 -179.613 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.7 t -122.98 114.79 20.88 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.107 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.518 HD21 ' HG2' ' A' ' 47' ' ' GLN . 31.4 tp -111.09 128.43 55.88 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.489 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.52 ' O ' ' O ' ' A' ' 47' ' ' GLN . 55.8 m-85 -108.44 137.05 47.05 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.939 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 165.77 -170.94 40.79 Favored Glycine 0 C--O 1.224 -0.52 0 C-N-CA 119.833 -1.175 . . . . 0.0 112.555 179.786 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 37.4 ttp85 -90.19 -30.04 17.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.078 -0.561 . . . . 0.0 111.489 179.843 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.495 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -57.26 155.25 17.92 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.714 -0.555 . . . . 0.0 111.714 -179.226 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.527 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.2 tp -66.71 -42.43 89.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.594 -179.704 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.527 ' N ' HG23 ' A' ' 33' ' ' ILE . 16.2 pt-20 -58.95 -13.42 6.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.362 -179.418 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.577 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 6.6 m -68.27 128.54 36.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.979 0.418 . . . . 0.0 110.414 -179.507 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.445 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 61.9 m-20 -60.18 -32.84 71.45 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.469 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.678 HD11 ' CD2' ' A' ' 20' ' ' PHE . 47.1 mm -119.59 111.29 32.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 177.275 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 88.4 mtm-85 -100.47 133.57 44.7 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.722 -178.327 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.426 HD13 ' HE ' ' A' ' 93' ' ' ARG . 96.7 mt -118.91 129.64 74.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.317 0.58 . . . . 0.0 109.813 178.839 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -72.44 33.82 0.06 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.221 -0.9 . . . . 0.0 112.782 -177.381 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.553 ' CD1' ' CZ ' ' A' ' 93' ' ' ARG . 49.6 mt -110.48 133.23 21.19 Favored Pre-proline 0 N--CA 1.468 0.44 0 C-N-CA 119.81 -0.756 . . . . 0.0 111.834 -179.855 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -71.35 -9.38 25.2 Favored 'Trans proline' 0 N--CA 1.488 1.164 0 C-N-CA 122.363 2.042 . . . . 0.0 113.107 -179.11 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.1 m -102.6 6.11 10.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.018 179.864 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.542 ' O ' HG21 ' B' ' 234' ' ' TPO . 24.1 t -90.91 133.7 31.86 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.956 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.3 m -68.46 158.07 34.52 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.127 -178.83 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.577 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 9.2 mtmp? -63.39 -39.29 94.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.24 -179.506 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.652 ' O ' ' N ' ' A' ' 49' ' ' CYS . 97.9 mt-30 -114.13 -21.43 10.51 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-O 120.885 0.374 . . . . 0.0 110.318 179.559 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.4 t60 33.06 -74.17 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -179.711 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.652 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -129.82 133.28 46.85 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.121 0.486 . . . . 0.0 111.909 -179.001 . . . . . . . . 3 3 . 1 . 071 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -125.27 126.67 45.51 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.809 179.668 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 94.8 mt -113.4 132.51 62.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.606 -179.766 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -112.3 134.87 53.6 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 178.74 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 49.8 mm -104.43 112.86 39.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.752 -179.471 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.443 ' C ' ' N ' ' A' ' 56' ' ' GLN . 97.5 m-70 -116.07 135.36 54.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.944 179.163 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.533 ' H ' ' CD ' ' A' ' 55' ' ' GLU . 53.8 mp0 -41.2 -29.6 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.546 0.689 . . . . 0.0 109.454 -179.58 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.443 ' N ' ' C ' ' A' ' 54' ' ' HIS . 96.9 mt-30 -67.83 -67.75 0.44 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.394 178.526 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.462 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 4.3 tp10 -155.51 -168.46 2.83 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.742 -179.404 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.462 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -116.09 124.47 50.48 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.388 179.121 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.8 mt -110.52 128.8 66.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 120.867 0.365 . . . . 0.0 111.936 -178.928 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.53 ' HB2' HD11 ' A' ' 82' ' ' LEU . 32.2 tp -94.97 124.56 39.09 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.875 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -110.09 134.24 52.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.958 -179.392 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -93.08 108.41 20.0 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.227 -179.234 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -103.36 -11.62 17.77 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.516 179.331 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.474 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 2.1 t -73.77 99.0 3.05 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.452 -179.676 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.5 t -77.22 -43.01 35.14 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.102 0.477 . . . . 0.0 110.552 178.691 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.748 HG21 ' O ' ' B' ' 234' ' ' TPO . 17.1 p -66.8 -39.76 87.85 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.865 -179.001 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.474 ' O ' ' OG ' ' A' ' 64' ' ' SER . 39.6 m-80 -142.84 97.43 5.88 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.672 -179.361 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.547 ' HB2' HG23 ' A' ' 75' ' ' VAL . 51.6 Cg_exo -54.2 144.21 60.25 Favored 'Trans proline' 0 N--CA 1.502 2.005 0 C-N-CA 122.636 2.224 . . . . 0.0 113.5 -179.813 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 16.4 m -69.65 134.85 49.19 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.547 178.413 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -102.62 138.49 39.46 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.054 -0.658 . . . . 0.0 109.987 179.71 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 75.9 t -131.44 133.97 61.35 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.473 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.831 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 53.91 33.75 17.96 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -178.767 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.54 29.46 72.92 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.335 -179.666 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 73.4 m -141.11 136.14 31.63 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.007 0.432 . . . . 0.0 111.577 -179.633 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.547 HG23 ' HB2' ' A' ' 68' ' ' PRO . 1.3 p -68.74 142.51 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.681 179.929 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.7 pt -119.46 88.28 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.139 178.729 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -68.01 -26.23 65.79 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.411 0.624 . . . . 0.0 109.588 178.329 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -113.8 159.07 37.23 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 114.935 -1.029 . . . . 0.0 109.889 179.532 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.32 155.1 71.9 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.147 1.898 . . . . 0.0 111.5 179.916 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.0 m -149.65 146.51 16.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.874 -179.222 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.6 mtm-85 -72.19 131.53 42.89 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.366 179.494 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.53 HD11 ' HB2' ' A' ' 60' ' ' LEU . 99.7 mt -82.63 139.09 33.95 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.423 0.63 . . . . 0.0 110.255 179.75 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -124.34 150.17 45.78 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.221 -179.906 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.516 ' C ' ' CD2' ' A' ' 84' ' ' HIS . 5.9 t60 -63.25 126.04 26.11 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 119.719 -0.793 . . . . 0.0 109.495 -179.764 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.07 -18.94 33.2 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.207 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -69.16 143.26 54.12 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.428 179.586 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.4 p -112.57 134.81 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.781 -178.528 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 85.9 mt -103.06 131.15 52.0 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.526 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 53.6 m -121.18 127.85 51.9 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.616 0.722 . . . . 0.0 112.312 -179.106 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.453 ' O ' ' N ' ' A' ' 92' ' ' ASP . 98.0 mt -121.05 128.32 76.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.211 179.886 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.445 ' C ' ' O ' ' A' ' 90' ' ' ILE . 39.4 mm 39.26 -98.58 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.685 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.534 ' O ' ' OD1' ' A' ' 92' ' ' ASP . 65.5 t0 -125.04 23.07 7.85 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.546 0.688 . . . . 0.0 110.642 179.387 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.553 ' CZ ' ' CD1' ' A' ' 41' ' ' LEU . 38.0 mtm-85 -129.52 142.44 50.77 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.147 -0.933 . . . . 0.0 108.865 179.862 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.424 ' HB2' HD12 ' A' ' 10' ' ' ILE . 58.8 m -135.21 151.22 50.42 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.031 -179.414 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.596 ' HB3' HD11 ' A' ' 7' ' ' LEU . 58.4 m-85 -126.93 120.42 29.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.594 179.179 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.613 ' O ' HD12 ' A' ' 7' ' ' LEU . 99.5 mtt180 -83.12 129.55 35.03 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.151 -0.619 . . . . 0.0 110.644 179.846 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.66 ' HH ' HH11 ' A' ' 5' ' ' ARG . 93.8 t80 -94.38 126.85 39.9 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.814 179.748 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -142.82 122.46 13.32 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.015 0.436 . . . . 0.0 111.274 -179.879 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.472 ' O ' ' O ' ' A' ' 4' ' ' THR . 86.8 m-20 -61.63 -42.81 99.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.502 179.813 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 . . . . . 0 CA--C 1.531 0.215 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.299 179.355 . . . . . . . . 0 0 . 1 . 071 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 43.6 t . . . . . 0 N--CA 1.453 -0.32 0 CA-C-O 120.939 0.399 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 071 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.578 ' C ' ' H ' ' B' ' 231' ' ' GLN . 67.0 t0 -151.07 52.02 0.85 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.812 179.165 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 071 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.578 ' H ' ' C ' ' B' ' 229' ' ' ASP . 78.5 mm-40 -103.93 -23.77 13.32 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.099 0.476 . . . . 0.0 110.904 -179.491 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -62.38 117.51 11.64 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 111.209 -0.757 . . . . 0.0 111.209 -179.751 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.61 134.72 59.33 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 CA-C-N 119.352 1.576 . . . . 0.0 111.165 178.577 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.748 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 071 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -78.52 148.48 23.32 Favored 'Trans proline' 0 N--CA 1.489 1.226 0 C-N-CA 122.706 2.271 . . . . 0.0 112.929 179.004 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 14.7 p -62.28 134.95 27.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.49 -179.869 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 7.4 t -67.45 132.82 48.36 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.541 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' B' B ' 238' ' ' TPO . . . . . 0.426 HG23 ' H ' ' B' ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 071 nuclear build full ' B' B ' 239' ' ' PRO . . . . . 0.412 ' HD2' ' P ' ' B' ' 238' ' ' TPO . 44.5 Cg_exo -57.2 -25.51 64.81 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.329 2.019 . . . . 0.0 111.427 178.701 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 95.6 m -68.47 -45.23 72.97 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.352 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.538 ' HZ ' HD22 ' A' ' 41' ' ' LEU . 82.3 t80 -58.59 -48.6 80.42 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.182 179.737 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 86.8 mt -64.69 -42.0 95.62 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.916 0.389 . . . . 0.0 110.971 -179.917 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -66.04 -47.06 75.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.282 -179.287 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -62.55 -41.85 99.16 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.167 -179.743 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.759 HH11 HH11 ' A' ' 12' ' ' ARG . 52.1 ttm-85 -64.17 -39.45 94.03 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.188 -179.727 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -59.28 -38.44 80.16 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.361 0.601 . . . . 0.0 109.468 179.923 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 15.9 m -67.14 -42.21 84.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.778 177.974 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -64.04 -31.14 72.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.46 179.881 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.04 -45.33 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.065 178.513 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -62.29 -23.44 66.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.266 0.555 . . . . 0.0 109.794 179.94 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -97.92 -3.31 38.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.065 179.274 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.768 HD13 ' N ' ' B' ' 253' ' ' ASN . 1.7 tm? -87.8 126.54 35.07 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.941 0.4 . . . . 0.0 111.288 -178.353 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' B' B ' 253' ' ' ASN . . . . . 0.768 ' N ' HD13 ' B' ' 252' ' ' LEU . 82.9 m-20 -68.79 136.3 52.56 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.636 -179.556 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' B' B ' 254' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' B' ' 254' ' ' ASP . 22.8 p-10 -71.01 -26.1 62.97 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.092 179.446 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -65.16 0.23 1.42 Allowed 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.655 -179.812 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.502 ' O ' ' C ' ' B' ' 257' ' ' LYS . 78.9 m-20 -92.27 -3.64 55.18 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 120.219 -0.592 . . . . 0.0 109.659 179.502 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' B' B ' 257' ' ' LYS . . . . . 0.502 ' C ' ' O ' ' B' ' 256' ' ' ASP . 96.9 mttt 27.93 -101.94 0.01 OUTLIER 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.14 -179.58 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.483 ' C ' ' O ' ' B' ' 257' ' ' LYS . 82.1 m-20 -30.95 136.81 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.145 179.955 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.592 ' C ' ' H ' ' B' ' 261' ' ' ILE . 52.7 p30 -121.26 -172.9 2.5 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 122.086 0.946 . . . . 0.0 111.488 -179.186 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.526 ' OE1' HD21 ' A' ' 41' ' ' LEU . 99.2 mt-10 -58.65 12.96 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 113.891 -1.504 . . . . 0.0 112.021 -178.832 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.592 ' H ' ' C ' ' B' ' 259' ' ' ASP . 66.3 mt -107.94 136.41 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 177.845 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 55.2 t -127.59 135.34 63.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.88 -178.618 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -94.74 117.16 29.69 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.907 -178.744 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -64.5 -46.11 84.37 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.264 179.935 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.68 158.24 36.95 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.657 -179.53 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -61.24 147.43 95.63 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 C-N-CA 123.041 2.494 . . . . 0.0 112.609 179.47 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.4 pt . . . . . 0 C--N 1.326 -0.427 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.073 -179.783 . . . . . . . . 0 0 . 1 . 072 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo . . . . . 0 N--CA 1.491 1.375 0 N-CA-C 111.488 -0.235 . . . . 0.0 111.488 . . . . . . . . . 0 0 . 1 . 072 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.4 p -73.46 -34.54 65.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.501 -179.479 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.728 ' NE ' HD13 ' A' ' 53' ' ' ILE . 91.7 mtm-85 -100.72 115.5 30.41 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 121.031 -0.268 . . . . 0.0 110.761 -179.57 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -131.65 141.23 49.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.277 0.56 . . . . 0.0 111.427 179.769 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.564 HD11 ' HB3' ' A' ' 95' ' ' PHE . 36.4 tp -114.47 127.7 55.95 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.413 179.908 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.575 HG13 ' CD2' ' A' ' 19' ' ' HIS . 75.8 t -103.15 127.86 56.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.521 -0.471 . . . . 0.0 110.268 -179.406 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 m -92.85 114.45 27.01 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 121.113 0.482 . . . . 0.0 111.398 -179.52 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.442 HD12 ' HB2' ' A' ' 94' ' ' SER . 85.9 mt -80.86 146.78 6.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.419 179.746 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -90.3 154.17 19.91 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 177.811 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.48 ' NH1' ' OD2' ' A' ' 92' ' ' ASP . 38.4 mtp85 -58.04 -28.71 64.75 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.547 -179.245 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 86.0 p -74.81 -14.9 60.74 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.606 -0.437 . . . . 0.0 110.142 178.949 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.54 36.44 4.84 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 -179.518 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.6 t -123.72 133.78 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-O 120.848 0.356 . . . . 0.0 111.68 -179.447 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -66.02 125.87 26.83 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.364 179.512 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -117.28 -126.98 3.83 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.458 -178.951 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -73.76 147.33 39.61 Favored 'Trans proline' 0 N--CA 1.5 1.874 0 C-N-CA 122.604 2.203 . . . . 0.0 112.955 -178.446 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.575 ' CD2' HG13 ' A' ' 8' ' ' VAL . 62.7 m170 -109.23 132.17 54.37 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.913 0.387 . . . . 0.0 110.705 -179.955 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.462 ' CD2' HD11 ' A' ' 37' ' ' ILE . 32.1 t80 -102.22 105.42 42.76 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.936 -179.893 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -74.93 128.66 11.72 Favored 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 121.464 1.443 . . . . 0.0 111.529 -179.418 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 64.9 mt -89.99 44.17 1.19 Allowed 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.387 -178.472 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 84.8 p -59.23 -21.94 60.31 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.408 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 73.6 mt -76.92 146.05 37.82 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.326 179.836 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.0 m -64.24 -23.18 67.21 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.23 -178.981 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 61.2 m -136.26 136.45 39.84 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.897 -179.039 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.1 t -128.01 120.05 26.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.062 179.063 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.404 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 57.4 tp -114.81 132.34 56.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.641 0.258 . . . . 0.0 111.112 -178.749 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.754 ' CE2' HD12 ' A' ' 37' ' ' ILE . 5.9 m-85 -111.92 139.8 47.11 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.902 179.715 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.44 -167.56 30.84 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 120.564 -0.826 . . . . 0.0 112.164 178.755 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.542 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 45.8 mtm180 -84.5 -32.0 24.19 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.867 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.572 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -49.49 143.69 9.65 Favored Glycine 0 CA--C 1.519 0.323 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 -178.662 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.49 HD12 ' HD2' ' A' ' 38' ' ' ARG . 7.0 tp -65.99 -41.1 89.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 120.248 -0.581 . . . . 0.0 109.932 179.995 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.443 ' N ' HG23 ' A' ' 33' ' ' ILE . 82.5 tt0 -54.71 -20.48 8.42 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.228 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.572 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 34.2 m -59.65 126.54 28.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.924 -179.834 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.404 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 56.1 m-20 -59.83 -31.98 70.24 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.249 0.547 . . . . 0.0 109.547 -179.623 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.754 HD12 ' CE2' ' A' ' 29' ' ' PHE . 97.4 mt -123.83 116.56 48.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.148 177.761 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.49 ' HD2' HD12 ' A' ' 33' ' ' ILE . 25.9 mtp85 -100.86 132.39 46.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.434 -178.197 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.796 HG21 ' NH2' ' A' ' 93' ' ' ARG . 92.8 mt -121.7 131.11 73.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.987 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.413 ' H ' ' HG2' ' A' ' 40' ' ' GLN . 13.5 pt20 -79.53 34.16 0.26 Allowed 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -177.849 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.959 HD12 HH21 ' A' ' 93' ' ' ARG . 23.6 mt -104.76 127.88 27.96 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.895 178.92 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -73.42 -9.49 23.03 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 122.303 2.002 . . . . 0.0 112.277 -179.997 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.0 m -91.73 1.09 8.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.73 0.3 . . . . 0.0 110.677 179.798 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.542 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 42.8 t -98.35 138.02 24.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.989 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.508 ' OG ' HG21 ' B' ' 234' ' ' TPO . 64.0 m -72.38 170.58 13.91 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.101 0.477 . . . . 0.0 111.364 -178.794 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -62.48 -41.41 98.77 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.884 -179.099 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.626 ' O ' ' N ' ' A' ' 49' ' ' CYS . 89.6 mt-30 -111.44 -18.5 12.85 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.631 0.253 . . . . 0.0 111.489 -179.698 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.49 ' NE2' HG23 ' A' ' 90' ' ' ILE . 12.6 t60 36.61 -77.06 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 179.262 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.626 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.66 136.08 47.41 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.067 0.461 . . . . 0.0 111.559 -178.475 . . . . . . . . 3 3 . 1 . 072 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -129.45 132.17 46.89 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.477 179.774 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.7 mt -115.13 134.31 58.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.855 -179.745 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -116.65 124.22 49.22 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.783 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.728 HD13 ' NE ' ' A' ' 5' ' ' ARG . 98.0 mt -107.25 114.69 46.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.483 -179.668 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.459 ' O ' ' N ' ' A' ' 56' ' ' GLN . 89.5 m-70 -114.22 145.95 41.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.831 179.924 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 54' ' ' HIS . 53.4 tp10 -40.7 -28.63 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.603 -179.819 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.459 ' N ' ' O ' ' A' ' 54' ' ' HIS . 84.1 mt-30 -63.53 -68.79 0.32 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.962 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.467 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 6.1 tp10 -159.9 -163.48 1.15 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.996 179.379 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.467 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -110.3 127.49 55.04 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.659 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.7 mt -117.22 130.2 72.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.371 0.605 . . . . 0.0 112.099 -178.911 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.8 tp -99.17 129.12 45.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.292 -179.74 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -114.53 137.48 51.81 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.618 179.975 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.438 HD21 ' HA ' ' A' ' 68' ' ' PRO . 54.1 t30 -97.61 107.55 20.08 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.374 -179.757 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -98.9 -10.1 23.29 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 179.918 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.2 t -74.98 102.71 4.9 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.548 179.429 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.7 p -82.28 -17.7 44.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.98 0.419 . . . . 0.0 110.382 179.764 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.887 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.2 OUTLIER -91.24 -39.96 11.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.009 -179.102 . . . . . . . . 3 3 . 1 . 072 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.469 ' OD1' HG13 ' B' ' 236' ' ' VAL . 71.2 m-20 -140.65 94.52 8.22 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.555 -179.936 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.504 ' HB2' HG13 ' A' ' 75' ' ' VAL . 32.2 Cg_exo -57.01 146.34 80.91 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.005 1.804 . . . . 0.0 112.028 -179.404 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.1 m -72.93 137.48 45.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.496 179.967 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -100.76 141.27 33.87 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.104 -179.827 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 46.0 t -127.2 136.95 59.24 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.155 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 51.29 32.31 8.13 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.714 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.96 29.92 68.52 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 -179.965 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.3 p -140.25 134.76 31.52 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 120.641 -0.423 . . . . 0.0 111.644 -179.3 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.504 HG13 ' HB2' ' A' ' 68' ' ' PRO . 52.9 t -67.8 132.89 32.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-O 121.248 0.547 . . . . 0.0 110.929 179.708 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.13 111.39 25.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.807 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -96.25 -10.62 27.54 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.734 -0.387 . . . . 0.0 111.772 -178.592 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -117.25 158.12 45.36 Favored Pre-proline 0 C--N 1.329 -0.3 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.627 -179.412 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -56.12 142.49 86.31 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 121.919 1.746 . . . . 0.0 112.216 179.522 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 18.9 m -144.57 139.96 23.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.623 179.306 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 89.3 mtm-85 -72.91 133.07 44.22 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.876 0.37 . . . . 0.0 110.176 179.758 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.441 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 93.7 mt -81.45 138.98 35.48 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.169 -179.434 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -126.78 148.91 49.89 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.466 179.429 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.423 ' ND1' ' N ' ' A' ' 99' ' ' ASN . 12.4 t60 -58.48 124.89 21.14 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.886 0.374 . . . . 0.0 111.209 -178.667 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.07 -20.96 34.69 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.444 -0.662 . . . . 0.0 111.444 179.967 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -66.87 138.44 57.32 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 120.491 -0.483 . . . . 0.0 110.023 179.731 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.507 HG22 ' HG2' ' A' ' 96' ' ' ARG . 79.5 t -110.36 132.69 58.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.25 -178.747 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 82.5 mt -100.63 132.6 45.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.324 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 93.7 m -120.82 125.52 47.76 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.032 -0.667 . . . . 0.0 112.172 -178.203 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.49 HG23 ' NE2' ' A' ' 48' ' ' HIS . 96.2 mt -116.25 123.96 71.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.019 -0.991 . . . . 0.0 108.61 178.694 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.541 HG22 ' N ' ' A' ' 92' ' ' ASP . 48.8 mm 39.72 -106.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.618 -179.318 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.541 ' N ' HG22 ' A' ' 91' ' ' ILE . 32.8 p-10 -110.1 13.09 23.34 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.787 0.327 . . . . 0.0 111.698 -179.346 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.959 HH21 HD12 ' A' ' 41' ' ' LEU . 9.5 mtm105 -118.51 140.4 49.94 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.198 179.732 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.442 ' HB2' HD12 ' A' ' 10' ' ' ILE . 17.0 m -128.88 144.8 51.28 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.006 179.007 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.564 ' HB3' HD11 ' A' ' 7' ' ' LEU . 41.7 m-85 -126.73 123.53 37.69 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.497 -179.782 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.507 ' HG2' HG22 ' A' ' 87' ' ' VAL . 99.7 mtt180 -85.95 128.49 34.85 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 119.953 -0.699 . . . . 0.0 109.721 -179.754 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -93.98 127.98 40.07 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 120.897 0.38 . . . . 0.0 110.495 -179.995 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -126.56 128.79 47.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.56 -179.323 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.423 ' N ' ' ND1' ' A' ' 84' ' ' HIS . 43.8 t30 -135.24 104.27 5.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.538 179.485 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.1 tp10 . . . . . 0 C--N 1.328 -0.367 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -179.663 . . . . . . . . 0 0 . 1 . 072 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 34.7 m . . . . . 0 N--CA 1.454 -0.246 0 CA-C-O 121.171 0.51 . . . . 0.0 110.097 . . . . . . . . . 0 0 . 1 . 072 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.616 ' O ' ' N ' ' B' ' 231' ' ' GLN . 97.5 m-20 -60.83 140.25 57.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.741 -179.64 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' B' B ' 230' ' ' SEP . . . . . 0.46 ' C ' ' O ' ' B' ' 229' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 072 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.616 ' N ' ' O ' ' B' ' 229' ' ' ASP . 0.9 OUTLIER -169.6 43.74 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 121.378 0.608 . . . . 0.0 110.247 179.956 . . . . . . . . 3 3 . 1 . 072 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -132.79 163.14 24.2 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 179.987 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.84 156.89 56.18 Favored 'Trans proline' 0 N--CA 1.499 1.822 0 C-N-CA 123.828 3.019 . . . . 0.0 113.123 -179.964 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.887 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 072 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.71 138.93 30.0 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 C-N-CA 122.035 1.823 . . . . 0.0 112.763 179.253 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.513 ' CG2' HG22 ' A' ' 66' ' ' THR . 77.5 t -59.83 134.98 24.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.664 -179.625 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 4.5 t -51.91 126.9 19.55 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.493 -179.117 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 072 nuclear build full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.36 -18.47 64.83 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.462 2.108 . . . . 0.0 111.736 -179.683 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 73.5 m -75.07 -45.36 41.97 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 176.956 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -57.07 -47.52 80.8 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.265 -179.106 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' B' ' 242' ' ' LEU . 93.0 mt -66.07 -39.85 90.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.15 -179.611 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -62.4 -42.18 99.23 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.577 -179.257 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -63.39 -42.0 98.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.019 0.438 . . . . 0.0 110.058 179.523 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.533 ' CA ' ' HE ' ' B' ' 245' ' ' ARG . 0.0 OUTLIER -63.19 -43.15 99.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.81 -179.348 . . . . . . . . 3 3 . 1 . 072 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.76 -37.71 87.7 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.66 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 39.0 t -64.71 -42.61 95.13 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 177.29 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -59.26 -36.88 76.31 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.073 179.997 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.459 HG23 HH21 ' A' ' 12' ' ' ARG . 46.3 t -62.99 -45.25 99.36 Favored 'Isoleucine or valine' 0 C--O 1.23 0.057 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.129 178.829 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -57.71 -29.13 64.45 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.152 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -90.91 -9.97 44.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.288 179.393 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 53.0 tp -80.97 150.84 28.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.69 179.754 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -109.35 141.19 42.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.162 178.966 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -61.73 -29.06 69.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.835 0.35 . . . . 0.0 110.993 -179.65 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -65.09 1.24 1.02 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.255 -179.237 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.483 ' CG ' ' H ' ' B' ' 257' ' ' LYS . 32.6 t70 -89.4 -179.13 5.77 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 179.397 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' B' B ' 257' ' ' LYS . . . . . 0.607 ' O ' ' C ' ' B' ' 258' ' ' ASP . 97.8 mttt -145.32 -119.63 0.08 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.122 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.607 ' C ' ' O ' ' B' ' 257' ' ' LYS . 96.3 m-20 -7.26 78.17 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 O-C-N 123.741 0.651 . . . . 0.0 111.004 -179.951 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' B' ' 257' ' ' LYS . 61.2 t0 -83.3 85.9 7.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.41 0.624 . . . . 0.0 110.624 -179.138 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.599 ' O ' HG23 ' A' ' 39' ' ' ILE . 93.5 mt-10 56.14 -1.91 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.025 -0.988 . . . . 0.0 111.735 179.443 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.517 ' H ' ' C ' ' B' ' 259' ' ' ASP . 16.8 mt -115.84 135.85 54.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.51 -179.627 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 45.2 t -127.23 133.72 67.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.537 179.272 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -96.37 119.93 35.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.151 0.5 . . . . 0.0 111.711 -178.638 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -65.45 -44.51 87.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.335 178.964 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -100.25 157.35 33.97 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.979 -179.171 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.4 157.51 54.22 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.945 2.43 . . . . 0.0 112.0 178.763 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 45.3 pt . . . . . 0 C--N 1.33 -0.258 0 CA-C-O 121.336 0.588 . . . . 0.0 112.306 -178.868 . . . . . . . . 0 0 . 1 . 073 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo . . . . . 0 N--CA 1.496 1.638 0 CA-C-O 120.891 0.288 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 073 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.4 t -122.78 34.44 5.14 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.145 179.749 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -94.07 123.1 37.23 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.918 -179.57 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 -128.23 137.14 51.89 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.214 -179.903 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.6 HD11 ' HB3' ' A' ' 95' ' ' PHE . 39.6 tp -112.87 130.98 55.91 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.845 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 66.7 t -109.53 130.99 61.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.325 -179.439 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 m -90.87 118.56 30.37 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.163 -178.765 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.598 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 96.0 mt -81.63 140.54 16.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.063 179.282 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.577 ' NZ ' ' O ' ' B' ' 257' ' ' LYS . 41.5 mmtt -83.71 158.91 21.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.955 0.407 . . . . 0.0 110.058 178.89 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.58 ' N ' HH12 ' A' ' 93' ' ' ARG . 85.4 mtp180 -57.74 -35.48 70.76 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.12 -178.646 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.4 t -76.08 -8.52 57.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.739 0.304 . . . . 0.0 111.414 -179.787 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.66 35.07 5.76 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 -179.184 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.6 t -121.84 132.9 69.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.785 0.326 . . . . 0.0 111.189 -179.72 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -77.71 137.12 38.31 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.313 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.95 -118.34 2.03 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 120.617 -0.802 . . . . 0.0 111.492 -179.63 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.53 151.96 48.03 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.216 1.944 . . . . 0.0 112.274 -179.25 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.459 ' CD2' ' C ' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -117.1 156.62 27.28 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.309 179.814 . . . . . . . . 3 3 . 1 . 073 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.457 ' CD2' HD11 ' A' ' 37' ' ' ILE . 49.1 t80 -124.04 107.03 30.83 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.924 -179.13 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.24 135.16 22.2 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 121.546 1.497 . . . . 0.0 111.961 -179.282 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.461 HD22 ' SG ' ' A' ' 27' ' ' CYS . 62.2 mt -96.44 40.95 1.12 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.166 -178.512 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.8 p -63.07 -18.47 63.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.146 0.498 . . . . 0.0 109.957 179.541 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.9 mt -75.53 149.49 38.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.504 179.219 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 26.3 m -62.99 -25.52 68.42 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.494 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.478 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 95.7 m -139.25 139.66 37.48 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 120.1 -0.64 . . . . 0.0 112.541 -179.59 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.461 ' SG ' HD22 ' A' ' 22' ' ' LEU . 4.0 t -128.09 116.63 20.27 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.852 179.027 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.571 HD21 ' OE1' ' A' ' 47' ' ' GLN . 54.9 tp -113.81 128.91 56.6 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.84 0.352 . . . . 0.0 110.976 -179.073 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.791 ' CE2' HD12 ' A' ' 37' ' ' ILE . 5.1 m-85 -108.07 137.04 46.75 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.171 -179.511 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 152.54 -172.79 31.67 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.216 -0.992 . . . . 0.0 112.267 178.756 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 48.1 mtm180 -76.98 -32.57 57.35 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 179.851 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.498 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -48.23 144.95 6.2 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 120.674 -0.775 . . . . 0.0 111.263 -178.693 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.491 HG23 ' N ' ' A' ' 34' ' ' GLU . 9.9 tp -65.64 -41.16 89.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.824 0.345 . . . . 0.0 110.12 -179.99 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.491 ' N ' HG23 ' A' ' 33' ' ' ILE . 80.3 mm-40 -57.06 -19.54 19.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.959 -179.987 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 62.8 m -56.05 122.69 12.23 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.703 -179.751 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.478 ' OD2' ' O ' ' A' ' 26' ' ' THR . 56.0 m-20 -58.88 -30.72 67.97 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -179.947 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.791 HD12 ' CE2' ' A' ' 29' ' ' PHE . 85.6 mt -127.01 120.51 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.361 177.333 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 84.4 mtp180 -102.46 135.15 44.59 Favored 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.472 -179.354 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 97.1 mt -116.12 126.31 73.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.145 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -75.05 30.62 0.09 Allowed 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -177.87 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.418 ' HA ' HD23 ' A' ' 41' ' ' LEU . 45.9 mt -98.27 126.22 40.57 Favored Pre-proline 0 C--N 1.325 -0.49 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.3 179.259 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -72.4 -8.22 22.27 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 C-N-CA 122.315 2.01 . . . . 0.0 112.853 -179.719 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.575 HG21 ' CE2' ' B' ' 241' ' ' PHE . 27.5 m -101.73 6.32 10.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.069 0.462 . . . . 0.0 110.422 179.52 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.1 t -91.01 137.41 21.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.431 178.747 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.8 m -68.72 169.24 11.63 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.613 0.72 . . . . 0.0 112.214 -178.332 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -62.78 -43.93 97.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.177 -179.041 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.586 ' O ' ' N ' ' A' ' 49' ' ' CYS . 95.2 mm-40 -113.65 -25.75 8.56 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.95 -179.532 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.1 t60 40.42 -78.74 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.878 -1.056 . . . . 0.0 113.43 179.661 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.586 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -129.05 136.03 49.72 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.025 . . . . . . . . 3 3 . 1 . 073 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -129.53 126.82 39.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.798 -179.931 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.1 mt -112.04 134.72 53.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.341 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -119.77 127.67 53.02 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.624 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 83.6 mt -105.67 121.52 58.02 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 CA-C-O 121.694 0.759 . . . . 0.0 111.609 -178.904 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.548 ' O ' ' N ' ' A' ' 56' ' ' GLN . 92.5 m-70 -117.11 142.81 46.52 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.105 -179.504 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 54' ' ' HIS . 92.4 mt-10 -39.0 -26.75 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -179.295 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.548 ' N ' ' O ' ' A' ' 54' ' ' HIS . 87.7 mt-30 -68.63 -67.39 0.47 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.679 179.045 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.493 ' CD ' HH21 ' A' ' 81' ' ' ARG . 5.3 tp10 -159.66 -156.98 0.54 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.221 179.802 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -120.88 131.17 54.24 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.039 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 93.5 mt -120.77 131.22 73.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.031 0.443 . . . . 0.0 112.027 -178.455 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 34.7 tp -94.48 125.2 38.98 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.042 179.566 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -111.21 138.22 47.93 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.16 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.653 HD21 ' CB ' ' A' ' 68' ' ' PRO . 63.5 t-20 -101.74 107.82 19.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.43 . . . . 0.0 112.013 -178.53 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -99.33 -9.87 23.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.43 -179.991 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.49 99.93 9.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.691 0.281 . . . . 0.0 110.295 -179.634 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.2 p -82.34 -35.9 27.42 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.963 179.811 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.543 HG22 HG22 ' B' ' 236' ' ' VAL . 0.3 OUTLIER -61.69 -48.19 81.9 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.182 0.515 . . . . 0.0 109.902 -179.517 . . . . . . . . 3 3 . 1 . 073 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -139.63 100.63 7.45 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.683 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.653 ' CB ' HD21 ' A' ' 62' ' ' ASN . 44.7 Cg_endo -66.9 151.22 82.64 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 121.56 1.507 . . . . 0.0 113.662 -177.79 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.928 ' O ' HG22 ' A' ' 76' ' ' ILE . 16.6 m -68.38 144.02 54.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.116 -179.835 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -103.73 140.6 37.38 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.85 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.9 p -129.27 135.85 60.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.621 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 49.83 34.34 7.58 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.628 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.04 28.19 70.83 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.529 -179.838 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.0 m -139.64 139.69 36.76 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.796 -179.421 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.3 t -68.56 135.93 27.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 120.909 0.385 . . . . 0.0 111.231 179.661 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.928 HG22 ' O ' ' A' ' 69' ' ' THR . 9.6 tt -105.45 96.56 4.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.332 179.906 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -64.57 -35.59 81.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.67 179.736 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.518 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 0.0 OUTLIER -133.55 177.22 2.36 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 120.596 -0.441 . . . . 0.0 111.722 -179.157 . . . . . . . . 3 3 . 1 . 073 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.433 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 48.8 Cg_exo -56.22 141.72 87.84 Favored 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 122.842 2.362 . . . . 0.0 112.944 -179.661 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 42.1 t -134.58 141.26 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.027 -179.636 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.493 HH21 ' CD ' ' A' ' 57' ' ' GLU . 60.2 ttt180 -74.03 122.83 23.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.022 178.353 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 82' ' ' LEU . 98.5 mt -75.02 140.44 43.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.174 0.511 . . . . 0.0 111.3 -179.144 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -133.17 147.7 52.06 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.58 179.701 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.516 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 7.8 t60 -52.66 114.4 1.38 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.316 179.38 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 113.85 -14.67 21.82 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.179 -0.769 . . . . 0.0 111.179 179.997 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -69.42 131.32 44.59 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.028 179.684 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.405 HG22 ' HG3' ' A' ' 96' ' ' ARG . 66.8 t -110.55 129.4 65.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.369 -178.95 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 89.7 mt -101.71 133.9 43.78 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.51 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.556 HG23 ' OG ' ' A' ' 94' ' ' SER . 66.5 m -121.71 121.85 38.23 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.583 0.706 . . . . 0.0 111.529 -179.135 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.632 ' O ' ' N ' ' A' ' 93' ' ' ARG . 86.6 mt -110.32 128.98 66.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.533 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.647 HD13 ' HB2' ' B' ' 237' ' ' CYS . 61.8 mt -15.42 92.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -178.519 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.539 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 2.7 t70 88.73 -22.33 0.13 Allowed 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 177.595 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.632 ' N ' ' O ' ' A' ' 90' ' ' ILE . 19.6 mmm180 -122.94 138.74 54.59 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.789 -0.365 . . . . 0.0 110.349 -179.603 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.556 ' OG ' HG23 ' A' ' 89' ' ' THR . 69.4 m -134.88 150.0 50.38 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.707 179.688 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.6 ' HB3' HD11 ' A' ' 7' ' ' LEU . 55.3 m-85 -127.56 121.35 30.39 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.361 -179.917 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.575 ' O ' HD12 ' A' ' 7' ' ' LEU . 42.1 ttp-105 -84.77 133.51 34.35 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.906 0.384 . . . . 0.0 110.257 -179.834 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -94.3 121.34 35.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.199 -179.327 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -127.56 123.08 34.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.616 179.971 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.516 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 7.8 p-10 -134.55 130.2 36.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.047 179.4 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 . . . . . 0 C--N 1.33 -0.262 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.593 -179.376 . . . . . . . . 0 0 . 1 . 073 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 58.0 t . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 120.794 0.331 . . . . 0.0 110.587 . . . . . . . . . 0 0 . 1 . 073 nuclear build full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -63.6 -161.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.316 179.924 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 073 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.96 55.05 0.25 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.45 179.065 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -110.9 -152.62 12.77 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 -179.733 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -61.35 150.98 82.45 Favored 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 123.307 2.671 . . . . 0.0 112.889 -179.902 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.448 HG21 ' O1P' ' B' ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 073 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -60.2 146.12 97.03 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.768 2.312 . . . . 0.0 112.7 179.982 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.543 HG22 HG22 ' A' ' 66' ' ' THR . 28.3 t -89.48 131.08 37.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.038 178.89 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' B' B ' 237' ' ' CYS . . . . . 0.647 ' HB2' HD13 ' A' ' 91' ' ' ILE . 8.0 t -66.35 123.11 19.08 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.984 0.421 . . . . 0.0 110.965 -179.264 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 073 nuclear build full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -60.28 -20.47 62.63 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.251 1.967 . . . . 0.0 111.712 -179.432 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 3.1 m -74.05 -41.8 61.22 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 177.259 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.575 ' CE2' HG21 ' A' ' 43' ' ' VAL . 87.7 t80 -57.49 -47.24 82.44 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.238 -179.69 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 99.3 mt -65.55 -39.87 92.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.778 -179.787 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -61.28 -42.05 97.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.425 -179.801 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -62.0 -43.41 98.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.64 179.512 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.417 ' NH1' ' OE1' ' B' ' 248' ' ' GLN . 2.6 mpt_? -60.33 -40.74 91.7 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.292 -179.927 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -63.5 -43.01 98.49 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.375 0.607 . . . . 0.0 109.76 179.089 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 72.3 m -62.71 -44.38 96.37 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.646 179.094 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' B' B ' 248' ' ' GLN . . . . . 0.485 ' O ' ' N ' ' B' ' 252' ' ' LEU . 86.5 mt-30 -61.11 -36.68 80.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.572 -179.887 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 22.9 t -60.03 -44.77 95.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.139 179.301 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -65.18 -30.31 71.21 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.263 178.741 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -90.92 -13.47 33.48 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.221 -179.223 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.485 ' N ' ' O ' ' B' ' 248' ' ' GLN . 33.0 mt -85.6 171.17 11.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.008 0.433 . . . . 0.0 110.049 178.672 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' B' B ' 253' ' ' ASN . . . . . 0.583 ' O ' ' N ' ' B' ' 255' ' ' ASP . 69.5 m-80 -144.07 178.42 7.88 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.006 -179.559 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -46.09 -10.83 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.212 -179.895 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' B' B ' 255' ' ' ASP . . . . . 0.583 ' N ' ' O ' ' B' ' 253' ' ' ASN . 96.6 m-20 -70.74 -6.35 36.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.976 0.417 . . . . 0.0 110.085 178.668 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.404 ' C ' ' OD1' ' B' ' 256' ' ' ASP . 39.9 p-10 -97.17 16.81 18.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.797 -179.916 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' B' B ' 257' ' ' LYS . . . . . 0.577 ' O ' ' NZ ' ' A' ' 11' ' ' LYS . 88.4 tttt -58.3 -22.05 51.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.176 179.156 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.467 ' O ' ' OD1' ' B' ' 259' ' ' ASP . 91.5 m-20 -63.52 -44.43 94.29 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.428 -179.832 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.524 ' OD2' ' NZ ' ' A' ' 11' ' ' LYS . 4.0 p30 57.58 138.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.812 0.815 . . . . 0.0 110.965 -178.192 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.751 ' CD ' ' H ' ' B' ' 260' ' ' GLU . 1.3 pm0 -65.64 25.87 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.318 -1.31 . . . . 0.0 112.421 -178.359 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.565 HD11 ' HE ' ' A' ' 93' ' ' ARG . 60.1 mt -118.67 131.69 70.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.146 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 50.8 t -128.88 134.81 63.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.057 -179.515 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -94.45 119.92 33.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.174 0.511 . . . . 0.0 111.206 -178.582 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.26 -44.72 94.35 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.507 179.56 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -102.19 159.93 27.91 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.408 -179.086 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -65.88 161.45 39.37 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.602 2.201 . . . . 0.0 111.723 179.68 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.4 pt . . . . . 0 C--N 1.33 -0.258 0 CA-C-O 121.435 0.636 . . . . 0.0 111.952 -179.03 . . . . . . . . 0 0 . 1 . 074 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo . . . . . 0 N--CA 1.495 1.572 0 N-CA-C 112.999 0.346 . . . . 0.0 112.999 . . . . . . . . . 0 0 . 1 . 074 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 54.2 m -103.4 -58.61 1.85 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.494 179.306 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.507 ' NH2' ' O ' ' A' ' 22' ' ' LEU . 82.9 mtm-85 -81.72 132.61 35.29 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.41 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.412 HH22 ' HA ' ' A' ' 100' ' ' GLU . 91.0 mtm-85 -127.1 131.42 50.84 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.295 -179.768 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.7 HD12 ' O ' ' A' ' 96' ' ' ARG . 29.8 tp -117.22 126.24 52.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.409 179.348 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.476 HG12 ' ND1' ' A' ' 19' ' ' HIS . 35.8 m -101.3 133.65 43.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.903 -179.277 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.444 ' CG2' HD12 ' B' ' 261' ' ' ILE . 9.7 m -92.2 113.87 26.26 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.072 -178.874 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.463 HD12 ' OG ' ' A' ' 94' ' ' SER . 96.3 mt -81.78 144.53 10.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.683 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.5 ' NZ ' ' O ' ' B' ' 256' ' ' ASP . 66.8 mttm -101.02 164.02 12.01 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.618 179.965 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.487 ' HB3' HG21 ' B' ' 249' ' ' VAL . 87.4 mtm180 -59.35 -31.56 69.31 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.569 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.1 t -70.35 -20.59 62.97 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.484 179.239 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.39 17.3 20.24 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.727 179.36 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.5 m -110.23 135.49 49.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.991 0.424 . . . . 0.0 111.198 -179.733 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 17' ' ' GLY . 64.0 t0 -76.55 135.75 39.28 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.029 179.602 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.511 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -126.63 -114.03 1.88 Allowed Glycine 0 CA--C 1.537 1.428 0 C-N-CA 120.361 -0.924 . . . . 0.0 111.961 -179.897 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.91 147.64 50.06 Favored 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 122.434 2.089 . . . . 0.0 113.488 -178.678 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.476 ' ND1' HG12 ' A' ' 8' ' ' VAL . 22.2 m-70 -109.83 142.1 41.58 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.148 179.325 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.424 ' CD2' HD11 ' A' ' 37' ' ' ILE . 27.4 t80 -113.32 106.14 54.75 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.041 -179.829 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.62 129.46 13.67 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 121.419 1.413 . . . . 0.0 111.831 -179.432 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.507 ' O ' ' NH2' ' A' ' 5' ' ' ARG . 25.8 mt -94.77 39.94 1.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.858 -178.556 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.9 t -63.12 -15.82 57.99 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.405 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.8 mt -73.7 145.36 45.27 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.327 179.891 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 86.6 p -58.44 -26.38 63.26 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.049 -178.42 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 87.3 m -141.41 139.99 33.56 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.487 -179.584 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.665 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 6.6 t -129.29 119.88 24.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.668 178.856 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.619 HD21 ' OE1' ' A' ' 47' ' ' GLN . 50.1 tp -114.7 130.49 56.83 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.373 -178.422 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.837 ' CE2' HD12 ' A' ' 37' ' ' ILE . 7.0 m-85 -107.68 141.02 39.84 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.807 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 153.39 -171.39 32.27 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 119.95 -1.119 . . . . 0.0 112.538 179.053 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.5 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 45.0 mtm180 -85.8 -32.57 21.72 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 111.497 0.184 . . . . 0.0 111.497 179.564 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -47.36 150.05 2.55 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 -178.977 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.545 ' O ' ' NH2' ' A' ' 38' ' ' ARG . 8.2 tp -64.54 -41.52 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 O-C-N 122.442 -0.446 . . . . 0.0 110.574 -179.579 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.543 ' N ' HG23 ' A' ' 33' ' ' ILE . 95.5 mt-10 -59.08 -18.82 38.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.898 -179.315 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 71.4 m -57.11 118.94 5.53 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.119 -179.869 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -56.4 -29.89 62.1 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.328 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.837 HD12 ' CE2' ' A' ' 29' ' ' PHE . 75.1 mt -124.37 118.81 54.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 177.01 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.545 ' NH2' ' O ' ' A' ' 33' ' ' ILE . 72.0 mtt85 -103.86 134.38 47.25 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.469 -178.427 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.728 ' CG2' HD12 ' A' ' 41' ' ' LEU . 77.6 mt -117.96 129.61 74.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.877 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -76.84 29.99 0.13 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.749 -178.974 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.728 HD12 ' CG2' ' A' ' 39' ' ' ILE . 7.3 mt -99.66 127.14 34.87 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.188 179.902 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.16 -13.27 31.05 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.278 1.986 . . . . 0.0 113.438 -179.202 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.463 HG21 ' N ' ' B' ' 237' ' ' CYS . 1.4 p -96.13 5.06 8.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.114 179.73 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.5 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 42.4 t -88.68 133.45 30.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.275 179.431 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.438 ' O ' HG12 ' A' ' 44' ' ' VAL . 0.6 OUTLIER -66.15 162.69 19.21 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.213 0.53 . . . . 0.0 110.576 179.965 . . . . . . . . 3 3 . 1 . 074 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.41 ' CE ' ' O ' ' B' ' 232' ' ' GLY . 96.4 mttt -60.6 -42.14 96.2 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.944 -178.512 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.619 ' OE1' HD21 ' A' ' 28' ' ' LEU . 97.6 mm-40 -109.33 -16.07 14.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.11 179.837 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.6 t60 34.88 -77.82 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.686 -179.316 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.615 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.11 136.64 45.95 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.113 0.483 . . . . 0.0 111.364 -178.931 . . . . . . . . 3 3 . 1 . 074 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -127.86 129.54 47.08 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.867 179.855 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.8 mt -112.18 133.03 59.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.14 179.663 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.505 ' OE2' ' CE1' ' A' ' 54' ' ' HIS . 81.7 tt0 -115.61 124.03 49.92 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.048 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 48.4 mm -96.33 117.61 40.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.155 0.502 . . . . 0.0 111.886 -178.345 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.505 ' CE1' ' OE2' ' A' ' 52' ' ' GLU . 95.8 m-70 -115.42 132.52 56.59 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.116 179.065 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 54' ' ' HIS . 96.9 mt-10 -42.54 -30.16 0.33 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.375 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.457 ' N ' ' C ' ' A' ' 54' ' ' HIS . 59.3 tt0 -67.09 -68.37 0.38 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.602 178.216 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -151.16 -174.83 4.93 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.475 0.655 . . . . 0.0 111.905 -179.66 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.35 122.16 46.54 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.978 178.372 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 98.5 mt -117.2 132.35 67.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -178.505 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.1 tp -98.76 130.16 45.21 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.173 179.302 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -110.35 135.43 51.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.785 179.585 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 64.2 t-20 -95.31 105.97 17.97 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.915 179.983 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -98.34 -9.81 24.8 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.581 179.52 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.1 m -72.99 100.63 3.02 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 178.988 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.2 p -87.11 -21.55 25.93 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.114 179.95 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.661 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -86.72 -44.86 11.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.215 -179.73 . . . . . . . . 3 3 . 1 . 074 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -132.34 93.14 26.35 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.285 179.75 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -56.25 142.71 87.18 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.45 2.1 . . . . 0.0 112.84 -178.6 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 45.6 m -75.74 152.99 37.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.819 179.607 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -116.08 140.67 49.04 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.835 -179.278 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.736 HG13 ' OD1' ' A' ' 86' ' ' ASP . 55.6 t -129.25 134.5 63.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.336 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 53.29 33.41 15.5 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -179.163 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.9 28.62 70.32 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.696 179.944 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 45.0 t -141.65 140.05 33.16 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 117.04 0.42 . . . . 0.0 111.39 -179.972 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.1 t -66.66 136.38 26.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.685 -179.86 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.7 pt -111.88 79.19 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.617 179.276 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -62.27 -26.94 68.67 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.355 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.08 162.04 26.27 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.837 179.187 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.41 146.43 89.66 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.544 2.163 . . . . 0.0 111.561 179.724 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.7 m -137.77 142.95 34.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.17 0.51 . . . . 0.0 111.555 -179.6 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -72.32 127.52 32.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.585 -179.759 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 82' ' ' LEU . 96.0 mt -78.52 139.19 38.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.185 0.517 . . . . 0.0 111.185 -179.596 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -135.72 150.06 49.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.209 -178.68 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -53.35 113.21 1.07 Allowed 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.73 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.32 -10.89 26.43 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -179.784 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.736 ' OD1' HG13 ' A' ' 71' ' ' VAL . 49.0 t0 -74.19 127.24 32.44 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.41 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.47 ' O ' HG13 ' A' ' 87' ' ' VAL . 13.1 p -108.78 132.64 56.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.639 -178.493 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 94.9 mt -98.66 130.37 47.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.11 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.1 m -117.38 127.25 53.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.725 0.774 . . . . 0.0 112.177 -178.669 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.595 ' O ' ' N ' ' A' ' 93' ' ' ARG . 94.7 mt -116.39 132.86 64.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 114.46 -1.245 . . . . 0.0 108.436 178.536 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.93 HG22 HH22 ' B' ' 245' ' ' ARG . 89.1 mt -25.64 99.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 -179.098 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.534 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 6.9 t0 90.06 -21.88 0.12 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 178.08 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.595 ' N ' ' O ' ' A' ' 90' ' ' ILE . 63.2 mtt85 -131.27 146.09 52.16 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.215 -179.289 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.463 ' OG ' HD12 ' A' ' 10' ' ' ILE . 44.8 p -140.67 154.56 46.44 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.026 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.502 ' HE1' HD12 ' A' ' 90' ' ' ILE . 56.5 m-85 -128.26 128.51 44.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.033 -179.825 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.7 ' O ' HD12 ' A' ' 7' ' ' LEU . 99.4 mtt180 -94.81 135.07 36.74 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 119.461 -0.896 . . . . 0.0 110.66 -179.948 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.461 ' CE2' ' OD1' ' A' ' 99' ' ' ASN . 88.0 t80 -95.04 125.89 40.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.707 -179.705 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.521 ' N ' ' OE1' ' A' ' 98' ' ' GLU . 55.7 mp0 -134.94 126.94 29.64 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.423 -179.652 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.461 ' OD1' ' CE2' ' A' ' 97' ' ' TYR . 98.3 m-20 -89.67 166.04 13.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.867 179.122 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.412 ' HA ' HH22 ' A' ' 6' ' ' ARG . 42.1 tt0 . . . . . 0 C--N 1.326 -0.451 0 CA-C-O 120.93 0.395 . . . . 0.0 110.834 -179.945 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' B' B ' 228' ' ' VAL . . . . . 0.444 HG13 ' HD2' ' A' ' 31' ' ' ARG . 67.1 t . . . . . 0 N--CA 1.455 -0.211 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 . . . . . . . . . 1 1 . 1 . 074 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.473 ' O ' ' CB ' ' B' ' 230' ' ' SEP . 96.2 m-20 -73.54 -23.4 59.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.968 -179.542 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' B' B ' 230' ' ' SEP . . . . . 0.473 ' CB ' ' O ' ' B' ' 229' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 074 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.445 ' H ' ' C ' ' B' ' 229' ' ' ASP . 1.2 pt20 -142.54 29.02 1.59 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.666 179.665 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' B' B ' 232' ' ' GLY . . . . . 0.41 ' O ' ' CE ' ' A' ' 46' ' ' LYS . . . -106.03 -134.52 7.82 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.777 -179.326 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -78.57 161.29 28.11 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.933 2.422 . . . . 0.0 113.213 -178.737 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 074 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.12 169.12 22.99 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 122.384 2.056 . . . . 0.0 112.415 -179.998 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.661 ' CG2' HG22 ' A' ' 66' ' ' THR . 40.2 t -114.03 136.5 50.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.933 -179.764 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' B' B ' 237' ' ' CYS . . . . . 0.463 ' N ' HG21 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -67.24 128.48 36.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.008 -179.207 . . . . . . . . 3 3 . 1 . 074 nuclear build full ' B' B ' 238' ' ' TPO . . . . . 0.624 ' O2P' HG23 ' B' ' 240' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 074 nuclear build full ' B' B ' 239' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 50.9 Cg_exo -56.21 -31.7 84.86 Favored 'Trans proline' 0 N--CA 1.501 1.921 0 C-N-CA 123.227 2.618 . . . . 0.0 114.241 -178.59 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' B' B ' 240' ' ' THR . . . . . 0.624 HG23 ' O2P' ' B' ' 238' ' ' TPO . 44.8 p -79.52 -34.62 41.0 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.321 179.423 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.544 ' CE2' ' CZ ' ' B' ' 245' ' ' ARG . 78.9 t80 -57.9 -47.86 81.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.702 -179.572 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.427 HD23 HH21 ' B' ' 245' ' ' ARG . 72.0 mt -65.36 -43.16 91.68 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.005 0.431 . . . . 0.0 110.774 179.276 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -65.8 -39.43 90.91 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.463 -179.245 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -61.67 -47.23 86.27 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.962 -179.719 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.93 HH22 HG22 ' A' ' 91' ' ' ILE . 78.1 mtm180 -65.95 -37.99 87.44 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.39 -179.275 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -59.57 -42.17 91.84 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.994 0.426 . . . . 0.0 111.006 179.703 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 81.2 p -68.95 -42.98 75.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.664 0.745 . . . . 0.0 109.112 178.981 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' B' B ' 248' ' ' GLN . . . . . 0.603 ' O ' HD23 ' B' ' 252' ' ' LEU . 94.7 mt-30 -62.97 -37.92 89.03 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.783 179.749 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.513 HG23 ' O ' ' B' ' 245' ' ' ARG . 55.1 t -60.86 -44.79 98.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.112 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -60.25 -23.52 64.15 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.577 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -93.05 -9.42 39.74 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.065 179.572 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.603 HD23 ' O ' ' B' ' 248' ' ' GLN . 2.9 mm? -74.72 154.0 38.6 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.424 0.63 . . . . 0.0 111.263 179.83 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -69.07 171.16 8.64 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.053 179.437 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -76.48 4.83 8.31 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.139 0.495 . . . . 0.0 109.945 -179.876 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -85.42 -88.12 0.12 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.126 178.799 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.5 ' O ' ' NZ ' ' A' ' 11' ' ' LYS . 97.6 m-20 58.42 28.1 16.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.868 -179.272 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -59.4 -29.76 67.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.461 -0.791 . . . . 0.0 112.487 -178.16 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.547 ' O ' ' C ' ' B' ' 259' ' ' ASP . 48.9 p-10 -115.28 3.76 14.31 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.263 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.547 ' C ' ' O ' ' B' ' 258' ' ' ASP . 35.5 t0 23.85 -94.05 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.18 0 O-C-N 124.403 1.065 . . . . 0.0 109.516 -179.208 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.47 ' N ' ' O ' ' B' ' 258' ' ' ASP . 99.0 mt-10 -149.1 17.13 0.96 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.235 178.878 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.444 HD12 ' CG2' ' A' ' 9' ' ' THR . 70.5 mt -112.88 134.89 54.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -179.999 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 48.8 t -126.51 134.35 66.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.122 179.47 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -94.79 120.94 35.84 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.155 0.502 . . . . 0.0 110.993 -179.457 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' B' B ' 264' ' ' LYS . . . . . 0.441 ' HG3' HH22 ' A' ' 38' ' ' ARG . 88.2 tttt -62.93 -45.7 91.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.016 179.414 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 5.7 mm100 -97.68 152.7 38.29 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.336 -179.803 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -69.88 148.98 65.51 Favored 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 122.906 2.404 . . . . 0.0 113.305 -179.279 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 18.7 pt . . . . . 0 N--CA 1.462 0.146 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.313 178.9 . . . . . . . . 0 0 . 1 . 075 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo . . . . . 0 N--CA 1.492 1.398 0 CA-C-O 121.054 0.356 . . . . 0.0 111.798 . . . . . . . . . 0 0 . 1 . 075 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 59.6 p -70.13 -40.56 74.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.451 -179.462 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.603 ' HD2' HD13 ' A' ' 53' ' ' ILE . 91.5 mtt-85 -92.49 129.77 38.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.071 -177.941 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -136.47 141.99 43.54 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.362 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.643 ' CD1' HD11 ' A' ' 22' ' ' LEU . 26.1 mt -116.48 142.12 47.29 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.87 179.207 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.7 t -114.76 129.32 71.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.138 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.431 HG21 ' OD2' ' B' ' 259' ' ' ASP . 1.3 m -94.57 118.54 31.84 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -177.725 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.734 HD12 ' OG ' ' A' ' 94' ' ' SER . 91.0 mt -81.39 143.58 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.804 179.587 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 69.9 mttt -87.51 160.73 18.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.374 178.671 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.57 HH21 ' HG3' ' B' ' 245' ' ' ARG . 81.3 mtp180 -56.18 -33.14 64.99 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.693 -178.76 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 99.8 p -79.82 -8.29 59.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.311 -179.314 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.64 39.75 5.82 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 179.831 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 37.1 t -123.15 133.96 67.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.237 0.542 . . . . 0.0 111.261 -179.454 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -68.9 123.23 20.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.128 179.905 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -115.38 -125.31 3.92 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.507 -179.577 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -74.32 150.08 41.13 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.139 1.893 . . . . 0.0 112.363 -179.342 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -107.21 150.91 26.11 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.9 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.437 ' CD2' HD11 ' A' ' 37' ' ' ILE . 54.8 t80 -119.24 90.98 43.11 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.286 -178.585 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -63.94 130.82 28.69 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.509 2.14 . . . . 0.0 111.36 178.708 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.643 HD11 ' CD1' ' A' ' 7' ' ' LEU . 95.1 mt -96.05 122.37 38.81 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.738 -179.671 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.401 ' H ' HE22 ' B' ' 265' ' ' GLN . 11.4 p -121.87 -26.38 4.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.126 179.284 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.3 mt -78.3 143.72 36.73 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.054 179.008 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.0 p -69.93 -13.82 62.42 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.307 -179.389 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.443 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 20.3 m -127.75 130.39 48.68 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 120.599 -0.441 . . . . 0.0 110.905 179.452 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.8 t -126.67 119.03 25.98 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.595 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' A' ' 36' ' ' ASP . 52.9 tp -117.57 124.35 48.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.901 0.382 . . . . 0.0 111.667 -178.776 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.822 ' CE2' HD12 ' A' ' 37' ' ' ILE . 4.7 m-85 -100.39 142.55 31.71 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 178.768 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 155.55 -177.14 32.86 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 119.972 -1.109 . . . . 0.0 112.265 178.709 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.61 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 87.8 mtm-85 -75.34 -32.18 60.81 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.139 0.495 . . . . 0.0 110.007 179.388 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.546 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -53.0 146.5 18.22 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.112 -178.434 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.499 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.2 tp -66.88 -41.57 87.83 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.158 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.499 ' N ' HG23 ' A' ' 33' ' ' ILE . 78.2 mm-40 -54.07 -19.55 5.06 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.758 179.818 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.546 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 38.6 m -60.67 124.61 20.93 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.072 179.917 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.443 ' OD2' ' O ' ' A' ' 26' ' ' THR . 56.1 m-20 -59.11 -32.41 69.81 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -179.793 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.822 HD12 ' CE2' ' A' ' 29' ' ' PHE . 85.5 mt -124.04 120.82 60.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 175.724 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -108.43 136.0 48.79 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.209 -0.596 . . . . 0.0 111.242 -179.189 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.432 HG22 ' H ' ' A' ' 41' ' ' LEU . 76.8 mt -115.67 132.0 66.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.99 -179.879 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -80.31 25.62 0.39 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.124 -178.476 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.482 HD21 ' OE1' ' B' ' 260' ' ' GLU . 36.2 mt -99.04 129.14 30.22 Favored Pre-proline 0 C--N 1.328 -0.333 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.266 179.332 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.45 -13.53 33.03 Favored 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 122.184 1.922 . . . . 0.0 112.798 -179.638 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.424 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 0.7 OUTLIER -91.58 1.25 8.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.499 -0.48 . . . . 0.0 111.75 -179.542 . . . . . . . . 3 3 . 1 . 075 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.61 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 66.0 t -93.22 132.32 37.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.352 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.551 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 0.3 OUTLIER -61.69 164.7 5.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.241 0.543 . . . . 0.0 111.551 -178.585 . . . . . . . . 3 3 . 1 . 075 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.473 ' CG ' ' NH2' ' A' ' 31' ' ' ARG . 96.6 mttt -61.99 -45.08 95.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.825 -179.142 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.589 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.2 mt-30 -110.53 -12.34 14.38 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-O 121.519 0.676 . . . . 0.0 109.548 179.315 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.551 ' H ' ' HB3' ' A' ' 45' ' ' SER . 25.1 t60 28.8 -75.45 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.219 -1.355 . . . . 0.0 114.255 179.277 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.589 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.43 135.87 46.37 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -177.688 . . . . . . . . 3 3 . 1 . 075 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -126.78 130.49 50.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.616 179.36 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 98.3 mt -115.22 133.31 61.86 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.135 179.537 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -112.48 122.47 47.81 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.309 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.603 HD13 ' HD2' ' A' ' 5' ' ' ARG . 94.7 mt -104.13 113.57 41.41 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 C-N-CA 119.726 -0.79 . . . . 0.0 111.943 -179.004 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.441 ' C ' ' N ' ' A' ' 56' ' ' GLN . 89.9 m-70 -113.5 141.21 47.4 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.592 179.274 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 54' ' ' HIS . 94.8 mt-10 -40.67 -31.87 0.18 Allowed 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -179.365 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.441 ' N ' ' C ' ' A' ' 54' ' ' HIS . 54.7 mt-30 -63.4 -67.75 0.4 Allowed 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.359 -0.837 . . . . 0.0 108.78 178.623 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.464 ' OE1' ' N ' ' A' ' 58' ' ' ALA . 1.4 mm-40 -154.99 -174.77 5.12 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.785 0.803 . . . . 0.0 112.611 -179.285 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.464 ' N ' ' OE1' ' A' ' 57' ' ' GLU . . . -109.65 119.54 39.71 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 114.457 -1.247 . . . . 0.0 108.198 177.689 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.2 mt -110.48 130.12 64.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.842 0.353 . . . . 0.0 111.823 -178.467 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.562 ' HB2' HD11 ' A' ' 82' ' ' LEU . 28.0 tp -97.05 128.24 43.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.464 179.88 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -113.43 138.77 49.61 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.535 179.746 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -96.44 111.09 23.31 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -179.233 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -104.5 -8.49 19.04 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.762 178.698 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.7 t -75.23 104.61 5.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.765 0.316 . . . . 0.0 110.303 179.281 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 94.7 p -87.59 -8.33 56.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.021 0.439 . . . . 0.0 110.331 179.843 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.408 ' HB ' ' ND2' ' A' ' 67' ' ' ASN . 0.2 OUTLIER -101.94 -37.26 8.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.207 -179.213 . . . . . . . . 3 3 . 1 . 075 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.413 ' OD1' HG23 ' B' ' 236' ' ' VAL . 6.3 m-80 -145.07 98.87 4.68 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.489 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -57.29 145.84 85.3 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 121.8 1.667 . . . . 0.0 112.258 -178.782 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.912 ' O ' HG22 ' A' ' 76' ' ' ILE . 28.8 m -67.7 137.34 55.44 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.291 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -102.42 140.78 36.24 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.399 179.576 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 55.7 t -130.95 133.22 63.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.675 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 54.59 30.51 13.32 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.671 -178.922 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.98 23.97 73.12 Favored Glycine 0 CA--C 1.534 1.27 0 CA-C-N 115.307 -0.861 . . . . 0.0 112.711 179.001 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 58.5 m -139.09 145.65 39.77 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 117.522 0.661 . . . . 0.0 110.742 179.478 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.421 ' H ' HG22 ' A' ' 75' ' ' VAL . 7.9 m -71.03 142.74 15.21 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-O 121.138 0.494 . . . . 0.0 111.87 -179.351 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.912 HG22 ' O ' ' A' ' 69' ' ' THR . 6.7 tt -109.54 92.35 2.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.196 179.155 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -65.89 -34.98 79.37 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.746 -179.685 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.478 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 0.2 OUTLIER -126.04 175.06 3.44 Favored Pre-proline 0 N--CA 1.464 0.259 0 C-N-CA 120.414 -0.515 . . . . 0.0 111.481 -179.578 . . . . . . . . 3 3 . 1 . 075 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.421 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 35.5 Cg_exo -57.68 140.98 95.28 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.509 2.139 . . . . 0.0 112.396 -179.881 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 72.1 t -137.43 137.83 45.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.181 -179.671 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 91.9 mtm-85 -74.29 132.02 41.7 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.713 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.562 HD11 ' HB2' ' A' ' 60' ' ' LEU . 97.8 mt -87.95 139.27 30.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.174 0.512 . . . . 0.0 111.852 -178.72 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -129.63 154.18 47.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.487 -179.43 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -57.0 120.69 8.4 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.84 0.353 . . . . 0.0 111.462 -179.29 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.15 -16.48 27.43 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.651 -0.58 . . . . 0.0 111.651 179.299 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -69.94 136.99 51.15 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.105 0.478 . . . . 0.0 110.276 179.812 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 53.3 t -111.88 132.07 61.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.169 -178.936 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.1 mt -99.1 130.94 47.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.559 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.5 m -122.82 126.41 47.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.293 0.568 . . . . 0.0 111.816 -178.387 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.488 ' O ' ' N ' ' A' ' 93' ' ' ARG . 96.2 mt -113.31 124.18 69.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.291 178.164 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.456 ' C ' ' O ' ' A' ' 90' ' ' ILE . 48.5 mm 35.03 -98.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.796 -179.533 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.578 ' OD2' ' NE ' ' B' ' 245' ' ' ARG . 85.3 m-20 -110.44 5.14 21.16 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -179.517 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.572 ' CZ ' ' O ' ' B' ' 259' ' ' ASP . 84.6 mtt-85 -120.39 145.48 47.13 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.943 -179.129 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.734 ' OG ' HD12 ' A' ' 10' ' ' ILE . 33.5 p -140.64 152.87 45.74 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.199 0.523 . . . . 0.0 111.196 179.789 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -123.95 123.17 39.81 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.841 179.592 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -80.6 129.19 34.37 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.287 -179.87 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.599 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 86.8 t80 -96.15 125.45 40.68 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.792 0.33 . . . . 0.0 111.267 -179.645 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -130.85 123.17 28.44 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 121.064 0.459 . . . . 0.0 111.532 -179.882 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -111.5 112.69 24.61 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.445 179.845 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 . . . . . 0 C--N 1.331 -0.212 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.743 -179.68 . . . . . . . . 0 0 . 1 . 075 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 3.5 p . . . . . 0 N--CA 1.455 -0.216 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 . . . . . . . . . 0 0 . 1 . 075 nuclear build full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -57.16 139.53 52.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.009 0.433 . . . . 0.0 110.889 -179.166 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 075 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -121.97 38.66 4.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.684 -179.604 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -119.28 -173.84 15.6 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 111.404 -0.679 . . . . 0.0 111.404 -179.715 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.87 155.57 68.17 Favored 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 123.021 2.481 . . . . 0.0 112.611 -179.913 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 075 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.52 172.91 15.21 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 122.748 2.299 . . . . 0.0 112.213 179.079 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.413 HG23 ' OD1' ' A' ' 67' ' ' ASN . 2.7 p -118.99 137.14 53.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.557 -179.729 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 3.0 t -68.87 127.55 33.52 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.514 -179.74 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' B' B ' 238' ' ' TPO . . . . . 0.494 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 075 nuclear build full ' B' B ' 239' ' ' PRO . . . . . 0.494 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 32.6 Cg_exo -59.72 -24.59 76.2 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.758 2.305 . . . . 0.0 112.446 -179.825 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 97.8 m -73.21 -44.89 58.96 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.271 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.424 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 86.5 t80 -57.88 -45.77 85.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.855 -179.493 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.53 ' CD2' ' OD1' ' A' ' 92' ' ' ASP . 97.2 mt -63.46 -41.08 98.63 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 120.746 -0.381 . . . . 0.0 110.466 -179.634 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -60.28 -42.89 96.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.351 -179.476 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -64.04 -39.9 95.13 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.353 -179.997 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.714 ' O ' HG23 ' B' ' 249' ' ' VAL . 57.9 ttm-85 -59.49 -44.13 93.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.862 -179.978 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -60.8 -42.95 98.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.039 0.447 . . . . 0.0 111.033 -179.472 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 67.8 p -69.68 -44.12 71.1 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.608 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' B' B ' 248' ' ' GLN . . . . . 0.602 ' O ' ' N ' ' B' ' 252' ' ' LEU . 66.3 tp60 -59.19 -39.2 81.85 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.474 179.758 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.714 HG23 ' O ' ' B' ' 245' ' ' ARG . 73.4 t -60.98 -46.42 96.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.495 179.682 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -62.57 -31.87 72.76 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.14 0.495 . . . . 0.0 109.899 179.331 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -91.02 -18.84 23.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.115 179.603 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.602 ' N ' ' O ' ' B' ' 248' ' ' GLN . 57.4 tp -70.64 135.89 48.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.014 0.435 . . . . 0.0 110.952 -179.169 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -99.22 136.24 39.46 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.414 -179.822 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -70.21 -22.0 62.96 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.866 -0.607 . . . . 0.0 109.756 178.691 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -66.01 -8.69 24.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.447 -179.419 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.649 ' O ' ' N ' ' B' ' 258' ' ' ASP . 42.5 p-10 -96.38 -7.99 33.62 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.343 179.667 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' B' B ' 257' ' ' LYS . . . . . 0.431 ' C ' ' O ' ' B' ' 256' ' ' ASP . 62.7 mttp 33.44 24.4 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.299 179.599 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.649 ' N ' ' O ' ' B' ' 256' ' ' ASP . 45.1 t0 -102.68 110.51 22.47 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.557 -179.582 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.572 ' O ' ' CZ ' ' A' ' 93' ' ' ARG . 50.8 p-10 -102.24 18.7 20.27 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.809 -179.079 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.482 ' OE1' HD21 ' A' ' 41' ' ' LEU . 99.4 mt-10 65.54 10.32 6.56 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 179.341 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 65.7 mt -111.74 134.97 52.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.915 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 42.2 t -125.35 132.76 70.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.909 0.385 . . . . 0.0 110.467 179.464 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -98.6 121.02 40.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.938 -178.648 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -69.21 -47.1 65.74 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.276 -179.368 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' B' B ' 265' ' ' GLN . . . . . 0.401 HE22 ' H ' ' A' ' 23' ' ' SER . 0.4 OUTLIER -67.31 165.69 26.67 Favored Pre-proline 0 N--CA 1.464 0.266 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.904 -179.237 . . . . . . . . 3 3 . 1 . 075 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -62.42 143.58 93.65 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.472 2.115 . . . . 0.0 111.603 179.217 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 19.8 tt . . . . . 0 N--CA 1.446 -0.649 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.056 -179.413 . . . . . . . . 0 0 . 1 . 076 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo . . . . . 0 N--CA 1.499 1.805 0 N-CA-C 111.705 -0.152 . . . . 0.0 111.705 . . . . . . . . . 0 0 . 1 . 076 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 95.9 m -74.31 -45.01 50.19 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.396 -0.521 . . . . 0.0 111.598 -179.597 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.6 mtt85 -93.63 125.69 38.39 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.538 -178.145 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -124.19 140.5 52.9 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.015 -179.4 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.643 HD11 ' HB3' ' A' ' 95' ' ' PHE . 38.0 tp -113.66 131.34 56.19 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.792 179.704 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.401 ' O ' HG23 ' A' ' 8' ' ' VAL . 19.2 m -110.55 130.73 63.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 121.13 0.491 . . . . 0.0 111.334 -179.393 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.1 m -78.45 141.97 37.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.297 -179.182 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.5 mm -109.97 136.43 45.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.033 177.296 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -91.42 154.77 18.93 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.435 179.54 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.477 ' CD ' ' OD2' ' A' ' 92' ' ' ASP . 89.1 mtm180 -54.56 -27.23 37.3 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.301 -179.684 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 91.8 p -80.48 -7.37 59.15 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.926 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.19 39.65 7.82 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 179.938 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.9 t -125.15 137.54 57.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -178.835 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -69.96 127.49 33.04 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.086 179.827 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -113.6 -127.51 4.6 Favored Glycine 0 CA--C 1.54 1.606 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 179.735 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -75.36 154.19 40.63 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 122.345 2.03 . . . . 0.0 112.311 -179.51 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 64.3 m170 -109.37 140.65 42.8 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.234 0.54 . . . . 0.0 111.888 -178.267 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.589 ' CD2' HD11 ' A' ' 37' ' ' ILE . 25.7 t80 -112.66 106.14 55.64 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.918 179.771 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -74.59 126.23 10.08 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 121.635 1.557 . . . . 0.0 111.563 -179.538 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.452 ' CD2' ' SG ' ' A' ' 27' ' ' CYS . 87.7 mt -82.8 52.66 2.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.899 0.38 . . . . 0.0 110.905 -179.263 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.6 t -64.66 -27.61 69.04 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.929 179.607 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.526 HD11 ' HG2' ' B' ' 265' ' ' GLN . 94.6 mt -79.11 142.96 35.97 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.705 179.568 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 44.0 t -63.67 -18.47 64.01 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 121.17 -0.212 . . . . 0.0 111.422 -179.341 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 40.7 m -131.13 131.6 44.23 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.867 -179.321 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.452 ' SG ' ' CD2' ' A' ' 22' ' ' LEU . 4.0 t -124.15 115.24 20.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.197 178.908 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.431 ' O ' ' N ' ' A' ' 36' ' ' ASP . 53.1 tp -112.26 122.79 48.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.162 0.506 . . . . 0.0 111.825 -178.849 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.765 ' CE2' HD12 ' A' ' 37' ' ' ILE . 5.4 m-85 -102.28 139.42 37.91 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.403 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 167.09 -171.56 41.9 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 118.699 -1.715 . . . . 0.0 113.513 179.304 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.563 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 36.7 ttp-105 -89.57 -31.54 17.54 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 114.549 -0.826 . . . . 0.0 109.377 179.585 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.46 151.62 39.48 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.767 -0.533 . . . . 0.0 111.767 -179.465 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.564 ' CD1' ' CZ ' ' A' ' 38' ' ' ARG . 39.5 mm -63.31 -44.41 99.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 121.106 0.479 . . . . 0.0 110.314 -179.965 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -52.95 -18.98 2.25 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.628 -179.208 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.55 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 78.6 m -62.78 128.19 34.77 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.247 -179.882 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 28' ' ' LEU . 62.2 m-20 -59.41 -31.3 69.14 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -179.56 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.765 HD12 ' CE2' ' A' ' 29' ' ' PHE . 93.3 mt -124.81 116.02 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.59 177.683 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.564 ' CZ ' ' CD1' ' A' ' 33' ' ' ILE . 83.7 mtp180 -99.25 137.63 37.5 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.928 -178.48 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.609 HD13 ' HE ' ' A' ' 93' ' ' ARG . 96.6 mt -119.82 129.02 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 121.335 0.588 . . . . 0.0 110.166 179.044 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -68.92 23.64 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.402 -178.156 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.787 HD12 ' CZ ' ' A' ' 93' ' ' ARG . 36.6 mt -106.0 129.68 24.2 Favored Pre-proline 0 C--N 1.324 -0.527 0 C-N-CA 120.015 -0.674 . . . . 0.0 111.247 -179.451 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.69 -10.4 25.04 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 C-N-CA 122.085 1.857 . . . . 0.0 112.589 179.714 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.495 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 5.2 m -91.55 1.42 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.213 179.183 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.563 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 51.4 t -90.83 136.01 25.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.03 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.3 m -71.78 168.34 18.03 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.492 0.663 . . . . 0.0 111.461 -178.783 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.55 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 97.9 mttt -60.15 -42.03 94.04 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.832 -1.077 . . . . 0.0 111.454 -179.257 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.665 ' O ' ' N ' ' A' ' 49' ' ' CYS . 87.2 mt-30 -116.29 -17.68 10.7 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 123.246 0.341 . . . . 0.0 110.976 179.789 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 31.6 t60 34.58 -74.81 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -179.691 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.665 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.29 137.44 46.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.326 0.584 . . . . 0.0 112.455 -178.831 . . . . . . . . 3 3 . 1 . 076 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -128.96 133.14 47.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.011 -179.749 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 88.2 mt -116.62 134.44 60.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.384 179.89 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -115.54 123.48 48.61 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 177.719 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 76.4 mt -103.75 114.11 42.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.287 -178.954 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.595 ' O ' ' N ' ' A' ' 56' ' ' GLN . 92.6 m-70 -111.8 141.75 45.02 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.007 179.233 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.48 ' OE1' ' N ' ' A' ' 55' ' ' GLU . 56.0 mp0 -39.47 -24.12 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.495 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.595 ' N ' ' O ' ' A' ' 54' ' ' HIS . 58.1 tt0 -67.95 -69.25 0.33 Allowed 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.177 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.732 ' CB ' ' HE ' ' A' ' 81' ' ' ARG . 2.8 tp10 -158.02 -163.11 1.25 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.334 179.914 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -115.98 125.42 52.48 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.012 -0.995 . . . . 0.0 108.531 178.347 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.4 mt -113.76 129.91 68.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.848 -178.413 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.43 HD11 ' SG ' ' A' ' 49' ' ' CYS . 50.5 tp -94.11 126.62 39.45 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.483 179.761 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -112.67 136.61 52.04 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.246 179.798 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -98.63 108.75 21.51 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.134 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -100.11 -11.24 20.67 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.432 179.473 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.1 t -69.64 103.35 2.09 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.596 179.106 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.0 p -84.51 -12.47 54.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.288 0.566 . . . . 0.0 109.548 178.856 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.19 -37.27 9.76 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.756 179.956 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.473 ' HB3' HD11 ' A' ' 91' ' ' ILE . 23.3 m-80 -144.18 90.27 6.79 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.847 179.741 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -56.23 146.33 72.3 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.21 1.94 . . . . 0.0 112.264 -179.862 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 56.8 m -73.32 144.02 46.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.159 179.913 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -102.97 141.04 36.44 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.694 179.639 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.8 t -130.34 134.67 62.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.553 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 53.71 34.73 19.58 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.27 -179.431 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.29 29.4 70.27 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.499 179.217 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.9 t -143.64 136.75 27.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 117.355 0.577 . . . . 0.0 110.783 179.314 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.8 p -70.72 139.96 19.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.692 -179.401 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.914 HD13 ' O ' ' A' ' 76' ' ' ILE . 0.0 OUTLIER -132.76 125.56 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.931 179.31 . . . . . . . . 3 3 . 1 . 076 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -97.73 -9.27 26.95 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.755 -179.382 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.84 ' O ' HD11 ' A' ' 76' ' ' ILE . 0.4 OUTLIER -125.19 170.33 9.42 Favored Pre-proline 0 N--CA 1.469 0.482 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.162 -179.431 . . . . . . . . 3 3 . 1 . 076 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -61.41 143.29 97.52 Favored 'Trans proline' 0 N--CA 1.501 1.915 0 C-N-CA 122.442 2.095 . . . . 0.0 113.271 -179.601 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 42.7 t -136.21 136.9 48.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.329 178.403 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.732 ' HE ' ' CB ' ' A' ' 57' ' ' GLU . 72.1 ttt180 -75.63 131.95 40.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.872 179.98 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 82' ' ' LEU . 96.6 mt -84.89 136.73 33.51 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.369 0.604 . . . . 0.0 112.417 -178.369 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -125.73 149.21 48.71 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.494 179.495 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.469 ' CG ' ' H ' ' A' ' 99' ' ' ASN . 5.3 t-160 -54.48 113.81 1.43 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.837 0.351 . . . . 0.0 110.989 -179.934 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.3 -15.67 25.06 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.018 178.938 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -68.3 137.22 54.5 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.099 -0.64 . . . . 0.0 109.403 179.534 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 23.3 t -110.04 134.26 52.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.868 -178.728 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 86.2 mt -103.76 129.42 55.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.1 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.9 m -116.36 129.35 56.2 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.515 -178.958 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.58 ' O ' ' N ' ' A' ' 93' ' ' ARG . 94.3 mt -119.65 128.85 75.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.53 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.531 HD13 ' HB3' ' B' ' 237' ' ' CYS . 94.5 mt -20.41 95.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -178.984 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.477 ' OD2' ' CD ' ' A' ' 12' ' ' ARG . 5.2 t0 90.07 -22.12 0.11 Allowed 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 177.985 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.787 ' CZ ' HD12 ' A' ' 41' ' ' LEU . 14.7 mtm-85 -130.58 145.84 51.97 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.235 -179.69 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.8 p -138.01 155.79 48.49 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.038 0.447 . . . . 0.0 110.781 -179.361 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.643 ' HB3' HD11 ' A' ' 7' ' ' LEU . 81.6 m-85 -131.65 129.44 40.81 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.643 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.49 ' O ' HD12 ' A' ' 7' ' ' LEU . 44.4 ttm180 -96.83 136.34 37.51 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 119.836 -0.745 . . . . 0.0 110.229 179.83 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -89.68 125.48 35.28 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.682 -179.724 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -125.65 127.3 46.07 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.5 -179.366 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.469 ' H ' ' CG ' ' A' ' 84' ' ' HIS . 55.5 t-20 -102.35 109.89 21.69 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.199 179.601 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 . . . . . 0 C--N 1.326 -0.419 0 CA-C-O 120.884 0.373 . . . . 0.0 110.433 179.989 . . . . . . . . 0 0 . 1 . 076 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 27.0 m . . . . . 0 N--CA 1.461 0.092 0 CA-C-O 120.943 0.401 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 076 nuclear build full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -82.31 -1.64 50.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.033 -179.117 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 076 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -141.34 18.94 2.23 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.868 179.832 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -131.27 -176.05 14.26 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 111.419 -0.672 . . . . 0.0 111.419 -179.666 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -71.94 164.56 35.28 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 123.432 2.755 . . . . 0.0 112.252 179.834 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.519 ' O2P' HG21 ' B' ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 076 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -70.08 169.89 18.24 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.055 1.837 . . . . 0.0 111.923 179.509 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 6.6 p -115.19 137.28 49.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.762 -179.893 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' B' B ' 237' ' ' CYS . . . . . 0.531 ' HB3' HD13 ' A' ' 91' ' ' ILE . 5.7 t -80.24 126.93 31.75 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 120.876 0.37 . . . . 0.0 110.958 -178.52 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' B' B ' 238' ' ' TPO . . . . . 0.476 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 076 nuclear build full ' B' B ' 239' ' ' PRO . . . . . 0.476 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 37.6 Cg_exo -58.44 -26.04 76.15 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.95 2.433 . . . . 0.0 112.292 -179.473 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 94.6 m -75.51 -42.75 51.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.043 0.449 . . . . 0.0 110.352 178.813 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.576 ' HZ ' HD22 ' A' ' 41' ' ' LEU . 60.2 t80 -57.54 -47.34 82.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.761 -179.832 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.437 HD21 HG23 ' A' ' 91' ' ' ILE . 90.1 mt -63.72 -41.19 98.1 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.086 0.47 . . . . 0.0 109.781 179.439 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -60.93 -41.31 95.95 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.873 179.789 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 73.6 ttt-85 -63.05 -43.23 99.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.668 -179.78 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.598 ' O ' HG23 ' B' ' 249' ' ' VAL . 24.0 mmt180 -59.9 -43.27 94.91 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.55 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.48 -41.93 98.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.818 179.215 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 11.8 t -65.73 -44.05 87.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.725 0.774 . . . . 0.0 108.957 179.512 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -60.89 -37.5 82.42 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.938 -179.447 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.598 HG23 ' O ' ' B' ' 245' ' ' ARG . 62.7 t -63.77 -46.1 95.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.614 179.647 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -61.38 -27.14 68.31 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.828 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -89.86 -10.84 43.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.574 179.24 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.463 ' O ' ' O ' ' B' ' 249' ' ' VAL . 40.3 tp -116.77 115.11 24.97 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.717 178.579 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' B' B ' 253' ' ' ASN . . . . . 0.507 ' C ' ' H ' ' B' ' 255' ' ' ASP . 5.4 m-80 -78.39 -159.74 0.18 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.414 0.626 . . . . 0.0 111.711 -179.228 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -49.69 -6.8 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.561 -178.887 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' B' B ' 255' ' ' ASP . . . . . 0.507 ' H ' ' C ' ' B' ' 253' ' ' ASN . 96.0 m-20 -63.41 -11.85 26.3 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.686 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.651 ' O ' ' N ' ' B' ' 258' ' ' ASP . 22.3 t70 -47.05 -28.89 1.86 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.348 179.474 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' B' B ' 257' ' ' LYS . . . . . 0.505 ' C ' ' O ' ' B' ' 256' ' ' ASP . 98.5 mttt -26.17 -35.16 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 O-C-N 123.353 0.408 . . . . 0.0 111.03 -179.137 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.651 ' N ' ' O ' ' B' ' 256' ' ' ASP . 44.1 p-10 -104.2 59.83 0.72 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 177.371 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.571 ' N ' ' O ' ' B' ' 256' ' ' ASP . 47.5 p30 -47.09 -115.71 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.592 -177.904 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.535 ' OE1' HD21 ' A' ' 41' ' ' LEU . 99.7 mt-10 -147.55 23.52 1.13 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.546 -179.648 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 65.9 mt -113.9 133.8 58.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.852 -179.856 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 43.5 t -126.91 134.23 66.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.508 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' B' B ' 263' ' ' PHE . . . . . 0.643 ' CD2' HG21 ' B' ' 267' ' ' ILE . 78.9 m-85 -97.38 123.65 41.28 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.137 0.494 . . . . 0.0 111.495 -178.255 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -64.07 -41.49 97.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.572 179.697 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' B' B ' 265' ' ' GLN . . . . . 0.526 ' HG2' HD11 ' A' ' 24' ' ' LEU . 2.8 mp0 -105.53 173.14 3.43 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.547 -178.956 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -57.26 150.78 55.97 Favored 'Trans proline' 0 N--CA 1.502 1.973 0 C-N-CA 122.824 2.349 . . . . 0.0 114.219 -179.614 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' B' B ' 267' ' ' ILE . . . . . 0.643 HG21 ' CD2' ' B' ' 263' ' ' PHE . 41.4 pt . . . . . 0 C--O 1.232 0.16 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.501 179.823 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 N--CA 1.492 1.428 0 CA-C-O 120.903 0.293 . . . . 0.0 112.381 . . . . . . . . . 0 0 . 1 . 077 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.9 m -73.34 -44.72 58.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.663 -179.872 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.505 ' NH1' ' CG2' ' A' ' 53' ' ' ILE . 85.0 mtt85 -89.57 134.21 34.23 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.355 -178.549 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -134.82 144.3 47.53 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.292 179.982 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.69 HD11 HD11 ' A' ' 22' ' ' LEU . 85.1 mt -114.94 135.65 53.98 Favored 'General case' 0 C--N 1.334 -0.097 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.635 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 76.7 t -111.83 130.36 65.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.562 -0.455 . . . . 0.0 109.994 -179.363 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.1 m -80.3 140.24 36.25 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -178.132 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.519 HD12 ' HB3' ' A' ' 94' ' ' SER . 96.6 mt -106.13 132.47 53.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 176.673 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.661 ' C ' HH22 ' A' ' 93' ' ' ARG . 97.3 mttt -86.25 154.2 21.45 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.189 0.518 . . . . 0.0 109.729 179.134 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.648 ' N ' HH22 ' A' ' 93' ' ' ARG . 84.9 mtp180 -56.15 -28.8 59.39 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.186 -179.263 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 86.1 p -80.7 -8.83 59.77 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.641 179.747 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.55 33.17 8.72 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.721 -0.551 . . . . 0.0 111.721 179.367 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 54.3 t -119.82 135.33 60.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.784 0.326 . . . . 0.0 110.414 179.818 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -65.03 125.99 26.65 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.776 179.81 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -111.19 -133.33 6.26 Favored Glycine 0 CA--C 1.539 1.575 0 C-N-CA 120.722 -0.752 . . . . 0.0 111.942 -179.184 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.85 151.88 40.86 Favored 'Trans proline' 0 N--CA 1.499 1.827 0 C-N-CA 122.571 2.181 . . . . 0.0 113.037 -178.624 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -106.02 147.87 28.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.363 179.508 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.632 ' CD2' HD11 ' A' ' 37' ' ' ILE . 35.2 t80 -117.26 95.24 46.96 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.353 -179.571 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -64.15 127.32 19.01 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 122.613 2.209 . . . . 0.0 111.96 -179.468 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.69 HD11 HD11 ' A' ' 7' ' ' LEU . 93.3 mt -85.61 83.33 7.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.086 0.469 . . . . 0.0 111.357 -179.485 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 92.2 p -88.17 -14.17 39.3 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.488 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.651 HD11 ' HG2' ' B' ' 265' ' ' GLN . 66.9 mt -95.52 138.39 33.26 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.091 -179.688 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 27.5 t -64.37 -17.67 63.94 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.058 -179.742 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 46.8 m -128.67 129.53 45.94 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.563 179.582 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.9 t -121.38 115.63 23.29 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.128 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.404 ' O ' ' N ' ' A' ' 36' ' ' ASP . 53.9 tp -113.38 122.02 46.11 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.466 -178.857 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.816 ' CE2' HD12 ' A' ' 37' ' ' ILE . 18.3 m-85 -100.07 141.34 33.03 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.455 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 169.35 -161.08 34.56 Favored Glycine 0 C--O 1.226 -0.392 0 C-N-CA 119.541 -1.314 . . . . 0.0 112.467 179.238 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 29.5 ttp85 -108.0 -9.84 15.59 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -178.372 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -89.21 170.62 37.66 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.798 -178.714 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.469 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.7 tp -66.88 -41.45 87.66 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 O-C-N 122.759 -0.259 . . . . 0.0 110.562 179.861 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.469 ' N ' HG23 ' A' ' 33' ' ' ILE . 72.3 mm-40 -54.27 -26.66 30.3 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.055 0.455 . . . . 0.0 110.721 -179.19 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.548 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 79.2 m -64.2 121.31 13.92 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.485 -179.982 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 28' ' ' LEU . 87.4 m-20 -59.7 -28.2 67.09 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.342 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.816 HD12 ' CE2' ' A' ' 29' ' ' PHE . 89.4 mt -127.08 123.04 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.175 177.726 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 -104.24 136.05 44.57 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.242 -179.595 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.443 ' C ' ' H ' ' A' ' 41' ' ' LEU . 97.4 mt -117.5 128.93 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.912 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -72.39 34.0 0.06 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.244 -178.199 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.531 ' CD2' ' CZ ' ' B' ' 245' ' ' ARG . 32.2 mt -102.87 126.5 32.43 Favored Pre-proline 0 C--N 1.322 -0.624 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.428 179.339 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -73.03 -7.12 20.17 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.147 1.898 . . . . 0.0 112.655 -179.418 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.7 m -102.99 13.23 7.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.499 179.394 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 29.1 t -99.76 133.26 43.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.172 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 33.2 t -72.49 175.05 6.61 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.439 0.638 . . . . 0.0 112.538 -178.329 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.548 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 61.0 mttp -65.18 -40.64 94.54 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.797 -179.455 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.659 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.1 mt-30 -112.86 -18.06 12.36 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.211 -179.853 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 23.9 t60 32.73 -74.48 0.0 OUTLIER 'General case' 0 C--O 1.236 0.357 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 179.882 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.659 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.48 134.0 46.73 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.998 0.428 . . . . 0.0 111.594 -179.578 . . . . . . . . 3 3 . 1 . 077 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -125.77 130.36 51.29 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.465 179.183 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.6 mt -117.43 134.01 62.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.226 179.611 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -114.52 131.03 56.79 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.396 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.505 ' CG2' ' NH1' ' A' ' 5' ' ' ARG . 48.3 mm -99.45 120.29 48.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.46 -178.449 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.462 ' O ' ' C ' ' A' ' 55' ' ' GLU . 94.0 m-70 -119.73 132.36 55.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.262 179.103 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.462 ' C ' ' O ' ' A' ' 54' ' ' HIS . 98.4 mt-10 -40.31 -37.17 0.62 Allowed 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.728 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.456 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 84.3 mt-30 -62.76 -67.25 0.44 Allowed 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.379 179.028 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.457 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 6.1 tp10 -151.03 -166.62 2.58 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.2 -179.039 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.457 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -125.48 135.71 52.59 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 -179.957 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.9 mt -119.04 131.49 71.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -178.311 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.431 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 32.7 tp -97.94 125.93 43.09 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 114.827 -1.079 . . . . 0.0 108.846 178.471 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -112.71 136.79 51.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.743 -179.058 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 26.0 t30 -96.31 105.61 17.7 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.788 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.422 ' CD2' ' OE1' ' A' ' 47' ' ' GLN . 27.0 m-85 -96.48 -9.21 30.21 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.066 178.613 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.515 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 42.2 t -73.83 100.22 3.41 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.477 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.9 m -83.18 -16.61 45.94 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.383 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.464 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.3 OUTLIER -87.42 -38.95 15.68 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.252 -179.782 . . . . . . . . 3 3 . 1 . 077 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.515 ' O ' ' OG ' ' A' ' 64' ' ' SER . 77.4 m-20 -146.62 98.73 4.17 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.343 -179.86 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.38 147.78 55.09 Favored 'Trans proline' 0 N--CA 1.501 1.961 0 C-N-CA 122.392 2.062 . . . . 0.0 113.688 -179.423 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 89.1 m -71.41 136.09 47.55 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.695 179.1 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -98.88 140.89 32.38 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.642 -179.722 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.455 ' CG1' ' OD1' ' A' ' 86' ' ' ASP . 71.5 t -129.43 134.71 63.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.07 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 51.28 34.78 12.17 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.604 -0.838 . . . . 0.0 109.655 -179.773 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.23 30.11 69.78 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.933 179.64 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.6 p -142.22 133.7 26.59 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.469 -179.693 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -67.6 142.37 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.309 -179.964 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.465 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 2.9 pt -119.02 121.27 66.39 Favored 'Isoleucine or valine' 0 C--N 1.343 0.285 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.109 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -87.2 -24.09 24.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.401 -179.894 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -127.04 172.98 5.81 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.907 -179.585 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.51 144.1 99.5 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 122.434 2.09 . . . . 0.0 112.58 179.514 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.7 t -132.16 138.57 52.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.737 178.922 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -73.31 131.17 41.6 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.442 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 97.3 mt -84.26 135.49 34.31 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.079 0.466 . . . . 0.0 111.536 -179.912 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -127.12 149.58 49.88 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.811 179.796 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.438 ' ND1' ' N ' ' A' ' 99' ' ' ASN . 6.7 t60 -55.6 116.63 3.01 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.423 179.819 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.1 -18.77 23.45 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 -179.416 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.455 ' OD1' ' CG1' ' A' ' 71' ' ' VAL . 36.4 t70 -66.81 132.28 47.71 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.535 0.207 . . . . 0.0 110.449 179.151 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.611 HG22 ' HG2' ' A' ' 96' ' ' ARG . 53.4 t -106.86 132.19 54.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.194 -178.927 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 80.0 mt -101.33 129.79 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 177.914 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.3 m -120.42 126.09 49.58 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.531 0.681 . . . . 0.0 112.353 -178.875 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.599 ' O ' ' N ' ' A' ' 93' ' ' ARG . 91.7 mt -113.18 133.26 59.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 177.746 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.526 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 68.0 mt -30.9 102.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 O-C-N 123.112 0.257 . . . . 0.0 111.66 -178.759 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 4.8 t70 87.67 -22.18 0.15 Allowed 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 178.743 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.661 HH22 ' C ' ' A' ' 11' ' ' LYS . 2.0 mmp_? -127.73 139.62 52.57 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.564 -179.337 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.519 ' HB3' HD12 ' A' ' 10' ' ' ILE . 34.7 t -141.1 148.66 40.48 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.929 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.421 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 82.4 m-85 -129.19 130.47 46.38 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.397 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.611 ' HG2' HG22 ' A' ' 87' ' ' VAL . 99.9 mtt180 -89.03 134.36 34.02 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.325 -179.488 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.506 ' CZ ' ' OD1' ' A' ' 99' ' ' ASN . 91.1 t80 -94.45 124.52 38.53 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.142 -179.991 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -139.2 123.96 18.58 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.513 -179.173 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.506 ' OD1' ' CZ ' ' A' ' 97' ' ' TYR . 79.5 m-20 -87.96 134.33 33.75 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.621 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 . . . . . 0 N--CA 1.463 0.189 0 CA-C-O 120.749 0.309 . . . . 0.0 110.505 -179.701 . . . . . . . . 0 0 . 1 . 077 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 CA--C 1.534 0.339 0 CA-C-O 120.663 0.268 . . . . 0.0 111.224 . . . . . . . . . 0 0 . 1 . 077 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.552 ' C ' ' H ' ' B' ' 231' ' ' GLN . 93.0 m-20 -72.67 142.14 48.26 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.766 0.317 . . . . 0.0 111.65 -179.428 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 077 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.552 ' H ' ' C ' ' B' ' 229' ' ' ASP . 72.4 mt-30 -130.73 50.89 2.17 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.34 -178.969 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -120.7 -171.75 14.46 Favored Glycine 0 CA--C 1.537 1.451 0 N-CA-C 111.843 -0.503 . . . . 0.0 111.843 -179.341 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.74 162.74 41.13 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 123.613 2.876 . . . . 0.0 113.25 -179.793 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.464 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 077 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -77.79 146.5 23.68 Favored 'Trans proline' 0 C--N 1.315 -1.205 0 C-N-CA 121.736 1.624 . . . . 0.0 112.909 -178.792 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 25.0 t -60.05 138.64 20.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.766 -179.808 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' B' B ' 237' ' ' CYS . . . . . 0.506 ' HB2' HD13 ' A' ' 91' ' ' ILE . 4.1 t -71.63 129.3 38.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.562 -179.659 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' B' B ' 238' ' ' TPO . . . . . 0.457 ' O2P' HG23 ' B' ' 240' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 077 nuclear build full ' B' B ' 239' ' ' PRO . . . . . 0.425 ' HD2' ' P ' ' B' ' 238' ' ' TPO . 41.0 Cg_exo -54.18 -24.14 32.4 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 122.415 2.076 . . . . 0.0 113.576 179.909 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' B' B ' 240' ' ' THR . . . . . 0.457 HG23 ' O2P' ' B' ' 238' ' ' TPO . 17.2 p -73.54 -41.25 63.25 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 119.836 -0.746 . . . . 0.0 109.268 177.981 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.505 ' CZ ' ' NE ' ' B' ' 245' ' ' ARG . 75.7 t80 -56.86 -47.37 80.56 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.752 -179.415 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.42 ' HA ' HD23 ' B' ' 242' ' ' LEU . 90.7 mt -67.08 -40.14 86.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.515 179.172 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -63.4 -43.06 98.6 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.399 -178.653 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -61.72 -42.57 99.12 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.093 0.473 . . . . 0.0 110.637 179.69 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.531 ' CZ ' ' CD2' ' A' ' 41' ' ' LEU . 95.6 mtt-85 -64.0 -39.05 93.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.12 -179.637 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.02 -39.01 93.46 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.061 179.495 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 32.8 t -67.55 -42.18 83.08 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.22 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' B' B ' 248' ' ' GLN . . . . . 0.531 ' O ' ' N ' ' B' ' 252' ' ' LEU . 61.7 tt0 -58.24 -36.77 73.71 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.903 179.205 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' B' ' 252' ' ' LEU . 41.3 t -64.31 -45.26 96.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.501 179.259 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -58.65 -27.98 65.26 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.024 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -100.58 -9.41 22.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.741 178.999 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.531 ' N ' ' O ' ' B' ' 248' ' ' GLN . 42.7 tp -124.0 125.38 44.47 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.63 179.896 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' B' B ' 253' ' ' ASN . . . . . 0.665 ' O ' ' N ' ' B' ' 255' ' ' ASP . 0.2 OUTLIER -159.4 -80.47 0.05 Allowed 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.286 . . . . . . . . 3 3 . 1 . 077 nuclear build full ' B' B ' 254' ' ' ASP . . . . . 0.476 ' O ' ' C ' ' B' ' 255' ' ' ASP . 91.8 m-20 -31.81 -25.94 0.0 OUTLIER 'General case' 0 C--O 1.231 0.114 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.051 -178.521 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' B' B ' 255' ' ' ASP . . . . . 0.665 ' N ' ' O ' ' B' ' 253' ' ' ASN . 34.8 t70 -32.5 -38.96 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 110.425 -0.213 . . . . 0.0 110.425 -179.795 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.586 ' CB ' ' O ' ' B' ' 255' ' ' ASP . 26.7 t0 98.2 -133.55 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 O-C-N 124.105 0.878 . . . . 0.0 111.115 178.976 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' B' B ' 257' ' ' LYS . . . . . 0.404 ' H ' ' CG ' ' B' ' 256' ' ' ASP . 98.9 mttt -88.46 -165.34 1.3 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.745 -179.46 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 61.58 51.43 4.04 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -178.529 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' B' B ' 259' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -83.08 73.19 10.08 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.757 -178.915 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 60.23 13.1 3.69 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 178.117 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.421 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 64.6 mt -119.26 132.35 69.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.398 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 56.1 t -126.9 135.9 62.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.366 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' B' B ' 263' ' ' PHE . . . . . 0.695 ' CD2' HG21 ' B' ' 267' ' ' ILE . 69.4 m-85 -99.32 120.22 39.21 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.901 -177.885 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -65.48 -43.48 90.09 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.571 0.701 . . . . 0.0 109.916 179.451 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' B' B ' 265' ' ' GLN . . . . . 0.651 ' HG2' HD11 ' A' ' 24' ' ' LEU . 2.5 mp0 -100.78 172.6 4.36 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.255 -178.951 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.0 150.05 66.85 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 121.985 1.79 . . . . 0.0 112.599 179.742 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' B' B ' 267' ' ' ILE . . . . . 0.695 HG21 ' CD2' ' B' ' 263' ' ' PHE . 42.5 pt . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.741 178.996 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo . . . . . 0 N--CA 1.489 1.232 0 N-CA-C 110.952 -0.441 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 078 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 46.1 m -101.76 -47.28 4.66 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.78 -179.043 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.574 ' NH1' HG23 ' A' ' 53' ' ' ILE . 99.1 mtt180 -99.79 127.03 45.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.517 -179.016 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.595 HH21 ' CE1' ' A' ' 19' ' ' HIS . 83.2 mtp180 -129.3 148.67 51.25 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.877 -179.075 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.432 HD11 HD11 ' A' ' 22' ' ' LEU . 99.6 mt -112.87 142.23 45.77 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.557 178.872 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.543 HG11 HH21 ' A' ' 96' ' ' ARG . 72.8 t -116.24 128.38 73.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.59 -0.444 . . . . 0.0 109.996 179.855 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 m -81.57 141.09 34.06 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.456 0.646 . . . . 0.0 112.674 -178.293 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.465 HD12 ' HB2' ' A' ' 94' ' ' SER . 83.1 mt -113.93 135.93 52.02 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.056 178.133 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.6 mttp -86.91 158.29 19.34 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.101 178.792 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.629 ' CD ' HH21 ' B' ' 245' ' ' ARG . 89.3 mtm180 -58.75 -27.46 64.98 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.193 -179.86 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 99.0 p -83.56 -8.87 59.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.825 179.771 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.43 37.73 6.49 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.863 179.819 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.1 t -118.76 131.3 71.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-O 120.835 0.35 . . . . 0.0 111.11 179.811 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -75.72 124.34 27.1 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.671 179.83 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -113.41 -122.52 3.88 Favored Glycine 0 CA--C 1.543 1.806 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.721 -179.84 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -76.4 155.54 36.58 Favored 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 123.043 2.495 . . . . 0.0 112.267 -178.702 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.614 ' CE1' ' HG3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -117.67 149.28 40.98 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.829 . . . . . . . . 3 3 . 1 . 078 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.47 ' CD2' HD11 ' A' ' 37' ' ' ILE . 37.7 t80 -115.5 100.49 53.64 Favored Pre-proline 0 N--CA 1.468 0.438 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.748 -177.658 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.614 ' HG3' ' CE1' ' A' ' 19' ' ' HIS . 3.0 Cg_exo -65.04 129.96 24.47 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 121.367 1.378 . . . . 0.0 111.557 179.48 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.432 HD11 HD11 ' A' ' 7' ' ' LEU . 90.6 mt -83.85 71.32 10.47 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.834 -179.896 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 80.6 p -78.66 -15.27 58.69 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.754 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.574 HD11 ' HG2' ' B' ' 265' ' ' GLN . 80.3 mt -93.64 140.78 29.23 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.211 -179.866 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 80.4 p -66.64 -17.51 64.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.959 -179.72 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.484 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 94.9 m -130.7 132.77 45.57 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.907 179.69 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.8 t -125.26 116.65 22.31 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.015 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 44.1 tp -114.16 129.02 56.63 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 121.169 -0.213 . . . . 0.0 111.181 -178.506 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.675 ' CE2' HD12 ' A' ' 37' ' ' ILE . 13.9 m-85 -109.25 140.8 42.43 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.285 179.649 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 156.78 -178.35 33.26 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 119.932 -1.128 . . . . 0.0 112.069 178.603 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.6 ' NH2' ' O ' ' B' ' 233' ' ' PRO . 43.7 mtm180 -74.72 -27.12 60.24 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.457 178.773 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.465 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -57.58 148.38 34.61 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.406 -177.771 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.466 HG23 ' N ' ' A' ' 34' ' ' GLU . 11.1 tp -66.9 -41.47 87.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.097 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.466 ' N ' HG23 ' A' ' 33' ' ' ILE . 92.8 mt-10 -52.49 -21.82 4.16 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.744 178.767 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.465 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 13.8 m -64.85 120.73 13.07 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.597 -179.492 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.484 ' OD2' ' O ' ' A' ' 26' ' ' THR . 99.4 m-20 -54.89 -25.21 27.43 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.316 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.675 HD12 ' CE2' ' A' ' 29' ' ' PHE . 96.8 mt -130.73 124.78 57.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.229 176.837 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 40.4 ttp180 -115.73 139.24 50.34 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.973 -179.386 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.453 HG12 HG23 ' B' ' 261' ' ' ILE . 89.2 mt -117.88 133.47 64.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.704 -178.927 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -73.49 20.38 0.09 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.106 -178.527 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' A' ' 41' ' ' LEU . 30.3 mt -91.2 128.41 47.47 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.924 179.488 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.14 -6.55 19.12 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 122.757 2.305 . . . . 0.0 113.143 -179.118 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.599 HG21 ' CE2' ' B' ' 241' ' ' PHE . 27.2 m -105.23 4.9 10.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.91 179.615 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.518 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 19.8 t -85.91 133.16 30.29 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.931 178.853 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.3 m -64.27 157.96 24.6 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.199 -179.496 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.411 ' HG2' ' H ' ' A' ' 47' ' ' GLN . 10.4 ptmt -60.71 -46.34 90.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.476 -178.815 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.695 ' O ' ' N ' ' A' ' 49' ' ' CYS . 78.6 mt-30 -113.39 -12.31 13.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.553 179.578 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.403 ' CE1' ' HG ' ' A' ' 64' ' ' SER . 24.1 t60 28.36 -70.27 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 179.712 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.695 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -146.67 149.57 33.72 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.699 0.762 . . . . 0.0 112.522 -179.064 . . . . . . . . 3 3 . 1 . 078 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -139.07 131.12 27.94 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.517 -1.22 . . . . 0.0 111.237 179.945 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.6 mt -106.41 135.25 45.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.796 179.875 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -112.76 135.72 53.18 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.062 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.574 HG23 ' NH1' ' A' ' 5' ' ' ARG . 38.8 mm -101.08 124.8 54.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 119.744 -0.782 . . . . 0.0 110.877 -179.646 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.437 ' O ' ' N ' ' A' ' 56' ' ' GLN . 95.6 m-70 -128.45 133.42 48.52 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.41 178.902 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 54' ' ' HIS . 97.8 mt-10 -39.97 -29.98 0.08 Allowed 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 120.492 -0.483 . . . . 0.0 109.761 -179.154 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.437 ' N ' ' O ' ' A' ' 54' ' ' HIS . 69.8 tp60 -64.91 -67.37 0.44 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.041 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.442 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 9.6 tp10 -155.3 -152.05 0.38 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.92 -179.572 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.458 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -127.74 134.72 49.53 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.576 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.1 mt -120.99 132.71 69.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.027 -0.669 . . . . 0.0 112.306 -178.274 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.404 ' HB2' HD21 ' A' ' 82' ' ' LEU . 21.1 tp -101.57 128.05 48.01 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.897 -179.558 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -110.95 136.85 49.35 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.733 -179.973 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -97.09 107.69 20.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.206 0.527 . . . . 0.0 111.745 -179.813 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -98.9 -10.29 23.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.2 179.676 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.403 ' HG ' ' CE1' ' A' ' 48' ' ' HIS . 0.3 OUTLIER -78.09 101.66 7.09 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.28 -179.179 . . . . . . . . 3 3 . 1 . 078 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.7 m -83.15 -43.41 16.22 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.187 0.518 . . . . 0.0 110.363 178.958 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.59 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -61.49 -46.83 88.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.858 -179.042 . . . . . . . . 3 3 . 1 . 078 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.435 HD21 ' HA ' ' B' ' 236' ' ' VAL . 64.7 m-80 -133.52 93.81 20.77 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.617 -179.724 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.559 ' HB2' HG13 ' A' ' 75' ' ' VAL . 53.1 Cg_exo -52.11 140.3 50.8 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.222 1.948 . . . . 0.0 112.819 -179.325 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.499 ' HB ' HD11 ' A' ' 76' ' ' ILE . 8.1 m -69.79 146.25 51.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.622 179.281 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.504 ' OE1' HG22 ' A' ' 75' ' ' VAL . 81.5 mm-40 -109.7 141.5 42.2 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.121 -179.765 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.451 ' O ' ' N ' ' A' ' 74' ' ' SER . 3.6 p -129.94 135.55 60.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.901 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 49.13 31.5 3.53 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -179.043 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.04 29.12 65.26 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.638 -179.429 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.451 ' N ' ' O ' ' A' ' 71' ' ' VAL . 22.3 m -139.61 139.46 36.75 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 120.454 -0.498 . . . . 0.0 112.046 179.99 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.559 HG13 ' HB2' ' A' ' 68' ' ' PRO . 58.7 t -61.14 137.37 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.018 -179.706 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.499 HD11 ' HB ' ' A' ' 69' ' ' THR . 1.4 pt -117.34 72.53 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 120.661 -0.415 . . . . 0.0 109.927 178.498 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.486 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 21.3 p-10 -61.59 -27.6 68.76 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.689 179.974 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -112.89 159.48 34.37 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.431 178.979 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.84 144.42 88.49 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.014 1.809 . . . . 0.0 112.329 179.776 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 51.4 t -131.84 138.89 51.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.88 -179.57 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -73.82 130.87 40.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.296 179.447 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.404 HD21 ' HB2' ' A' ' 60' ' ' LEU . 96.8 mt -80.85 135.48 35.94 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.592 0.711 . . . . 0.0 111.569 -178.97 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -128.11 151.15 49.54 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.955 179.028 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.607 ' CE1' ' H ' ' A' ' 99' ' ' ASN . 7.0 t60 -55.03 117.25 3.29 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.938 -178.847 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 113.32 -15.18 22.83 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.089 179.4 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -70.0 133.31 47.1 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 117.139 0.47 . . . . 0.0 110.7 -179.921 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.5 p -108.91 137.31 41.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.674 -179.469 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 88.2 mt -104.96 129.81 57.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 177.908 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.5 m -121.42 129.34 52.94 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -177.45 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.414 ' N ' ' O ' ' A' ' 93' ' ' ARG . 89.2 mt -116.63 122.95 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 114.306 -1.315 . . . . 0.0 109.151 178.335 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.49 HD12 ' CB ' ' B' ' 237' ' ' CYS . 38.8 mm 40.05 -98.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.064 -179.562 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -117.68 17.0 14.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.213 0.53 . . . . 0.0 109.978 -179.787 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.414 ' O ' ' N ' ' A' ' 90' ' ' ILE . 39.3 ttm180 -130.26 144.05 51.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.176 -179.671 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.465 ' HB2' HD12 ' A' ' 10' ' ' ILE . 36.7 m -140.62 158.9 43.3 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.793 0.806 . . . . 0.0 111.855 -179.494 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -128.35 123.24 33.42 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.304 179.434 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.543 HH21 HG11 ' A' ' 8' ' ' VAL . 95.2 mtm-85 -86.24 135.59 33.5 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.957 -179.407 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -93.33 122.8 36.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.826 178.745 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.4 ' HG3' ' CE1' ' A' ' 84' ' ' HIS . 80.4 tt0 -125.72 126.29 44.38 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.252 -178.907 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.607 ' H ' ' CE1' ' A' ' 84' ' ' HIS . 28.9 t-20 -109.02 107.35 17.67 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.725 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 . . . . . 0 C--N 1.323 -0.552 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.671 -179.044 . . . . . . . . 0 0 . 1 . 078 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 54.4 t . . . . . 0 N--CA 1.465 0.32 0 CA-C-O 120.958 0.409 . . . . 0.0 110.763 . . . . . . . . . 0 0 . 1 . 078 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.496 ' O ' ' CB ' ' B' ' 230' ' ' SEP . 47.5 p30 -98.8 176.16 5.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.557 -179.091 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' B' B ' 230' ' ' SEP . . . . . 0.496 ' CB ' ' O ' ' B' ' 229' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 078 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 62.0 56.47 2.3 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 121.096 0.474 . . . . 0.0 110.218 -179.33 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -98.53 -173.16 32.26 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 179.929 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' B' B ' 233' ' ' PRO . . . . . 0.6 ' O ' ' NH2' ' A' ' 31' ' ' ARG . 57.6 Cg_endo -67.83 154.6 72.6 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.559 2.172 . . . . 0.0 112.468 -179.394 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.472 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 078 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.44 142.65 54.93 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 121.948 1.765 . . . . 0.0 111.937 179.646 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.59 ' CG2' HG22 ' A' ' 66' ' ' THR . 52.5 t -77.95 131.86 33.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.215 -178.545 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' B' B ' 237' ' ' CYS . . . . . 0.49 ' CB ' HD12 ' A' ' 91' ' ' ILE . 2.5 t -75.66 127.43 33.05 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.99 179.224 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' B' B ' 238' ' ' TPO . . . . . 0.435 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 078 nuclear build full ' B' B ' 239' ' ' PRO . . . . . 0.435 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 32.1 Cg_exo -59.41 -25.46 78.61 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.503 2.136 . . . . 0.0 112.471 -179.566 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' B' B ' 240' ' ' THR . . . . . 0.422 ' OG1' ' O3P' ' B' ' 238' ' ' TPO . 27.5 m -72.74 -46.02 55.64 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.296 178.545 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.599 ' CE2' HG21 ' A' ' 43' ' ' VAL . 71.6 t80 -58.21 -45.7 87.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.743 -179.243 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 88.9 mt -64.35 -42.53 96.18 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 120.829 0.347 . . . . 0.0 111.003 179.345 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -62.9 -43.23 99.35 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.289 -178.68 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 87.8 mtm180 -63.29 -42.03 99.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.986 0.422 . . . . 0.0 110.631 -179.005 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.629 HH21 ' CD ' ' A' ' 12' ' ' ARG . 75.9 mtp180 -61.52 -42.07 98.27 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.255 179.955 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -64.56 -40.2 95.13 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.379 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 15.3 t -65.56 -44.96 85.16 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.558 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' B' B ' 248' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' B' ' 252' ' ' LEU . 5.7 tp-100 -60.21 -37.89 81.67 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.025 -179.945 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.438 HG23 ' O ' ' B' ' 245' ' ' ARG . 37.4 t -62.87 -43.67 99.06 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-O 120.811 0.338 . . . . 0.0 110.52 178.93 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -62.07 -34.48 76.36 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.147 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -91.37 -9.2 45.69 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.754 179.046 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.593 HD11 ' OD2' ' B' ' 256' ' ' ASP . 48.8 tp -72.78 131.06 41.83 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.985 0.421 . . . . 0.0 110.946 -179.518 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' B' B ' 253' ' ' ASN . . . . . 0.467 ' C ' ' H ' ' B' ' 255' ' ' ASP . 71.6 m-20 -95.67 154.96 16.95 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.466 179.255 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -56.39 -7.38 0.38 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.133 0.492 . . . . 0.0 109.976 179.389 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' B' B ' 255' ' ' ASP . . . . . 0.467 ' H ' ' C ' ' B' ' 253' ' ' ASN . 99.3 m-20 -63.91 -19.33 65.01 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.213 -179.863 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.593 ' OD2' HD11 ' B' ' 252' ' ' LEU . 94.5 m-20 -102.94 32.29 3.77 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.082 179.886 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -65.68 -6.63 12.01 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.467 179.022 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.566 ' O ' ' CG ' ' B' ' 259' ' ' ASP . 50.8 m-20 -63.29 -41.84 99.02 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.861 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.664 ' CG ' ' H ' ' B' ' 261' ' ' ILE . 11.0 p-10 106.03 -158.02 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.622 0 C-N-CA 124.242 1.017 . . . . 0.0 110.145 179.112 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.552 ' OE2' ' CZ ' ' A' ' 12' ' ' ARG . 98.3 mt-10 -138.15 10.65 2.8 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 114.034 -1.439 . . . . 0.0 107.661 178.842 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.664 ' H ' ' CG ' ' B' ' 259' ' ' ASP . 2.8 mt -116.0 140.84 36.02 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.537 -179.795 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 62.3 t -127.81 136.21 60.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.376 179.354 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' B' B ' 263' ' ' PHE . . . . . 0.691 ' CD2' HG21 ' B' ' 267' ' ' ILE . 68.3 m-85 -99.59 124.64 44.98 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.395 0.616 . . . . 0.0 111.615 -178.271 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -62.09 -40.79 97.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.744 179.572 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' B' B ' 265' ' ' GLN . . . . . 0.574 ' HG2' HD11 ' A' ' 24' ' ' LEU . 0.8 OUTLIER -107.05 173.6 3.02 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 114.838 -1.073 . . . . 0.0 110.232 -179.336 . . . . . . . . 3 3 . 1 . 078 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.77 150.45 62.38 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 122.63 2.22 . . . . 0.0 113.535 -179.63 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' B' B ' 267' ' ' ILE . . . . . 0.691 HG21 ' CD2' ' B' ' 263' ' ' PHE . 41.1 pt . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.813 179.576 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo . . . . . 0 N--CA 1.495 1.569 0 CA-C-O 120.647 0.186 . . . . 0.0 112.138 . . . . . . . . . 0 0 . 1 . 079 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.2 t -142.39 36.55 1.5 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.186 0.517 . . . . 0.0 110.397 179.305 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.702 HH12 HG23 ' A' ' 53' ' ' ILE . 99.9 mtt180 -88.7 139.08 30.83 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.506 -179.822 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.7 mtm180 -130.97 136.21 48.34 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.429 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.921 HD11 HD11 ' A' ' 22' ' ' LEU . 83.3 mt -112.47 138.9 48.56 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-O 120.778 0.323 . . . . 0.0 110.624 179.515 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 43.5 t -112.34 128.36 69.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.25 178.988 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.576 HG21 ' HZ ' ' B' ' 263' ' ' PHE . 74.8 p -83.14 138.94 33.46 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.49 0.662 . . . . 0.0 112.023 -178.815 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.0 mm -105.66 134.07 48.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.656 179.38 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.4 mttt -86.79 153.86 21.36 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.054 178.266 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 91.8 mtm180 -57.22 -25.87 59.77 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.446 -0.502 . . . . 0.0 109.968 -179.556 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.1 m -79.48 -10.48 59.81 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.771 179.158 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.64 40.09 7.9 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.066 -1.213 . . . . 0.0 110.066 -178.946 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.8 t -120.48 131.08 73.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 114.996 -0.602 . . . . 0.0 109.894 -179.992 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -71.38 125.24 26.49 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.18 179.679 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -120.64 -120.85 2.8 Favored Glycine 0 CA--C 1.54 1.643 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.214 -179.23 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.87 145.26 40.18 Favored 'Trans proline' 0 N--CA 1.503 2.087 0 C-N-CA 122.848 2.365 . . . . 0.0 114.307 -177.769 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -110.65 129.17 55.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.011 -179.784 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.645 ' CD2' HD11 ' A' ' 37' ' ' ILE . 47.8 t80 -100.1 102.38 17.71 Favored Pre-proline 0 N--CA 1.465 0.323 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.817 -179.995 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -78.21 139.09 16.57 Favored 'Trans proline' 0 C--N 1.314 -1.242 0 C-N-CA 121.608 1.538 . . . . 0.0 111.957 -179.45 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.921 HD11 HD11 ' A' ' 7' ' ' LEU . 87.8 mt -101.39 130.26 47.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.255 0.55 . . . . 0.0 111.498 -179.109 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 45.1 p -139.54 4.03 2.14 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.875 177.725 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.1 mt -107.35 151.25 25.75 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.332 -179.654 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 m -62.93 -24.29 67.79 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.369 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 87.1 m -133.97 135.42 43.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.428 0.632 . . . . 0.0 111.948 -179.483 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.595 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 3.1 t -126.19 117.19 22.58 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 177.769 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.736 HD13 ' HD3' ' A' ' 50' ' ' LYS . 49.2 tp -115.41 131.31 56.97 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.807 -176.842 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.765 ' CE2' HD12 ' A' ' 37' ' ' ILE . 11.2 m-85 -107.44 128.48 54.52 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.719 -179.913 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 165.01 -176.18 40.8 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 119.918 -1.134 . . . . 0.0 113.549 178.14 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 48.6 mtm180 -74.67 -31.91 62.07 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.746 0.308 . . . . 0.0 110.63 179.129 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.526 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -51.14 145.45 11.68 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.033 -178.568 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.417 HD13 ' HA ' ' A' ' 33' ' ' ILE . 32.4 mm -65.78 -43.87 93.26 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.102 0 CA-C-O 120.81 0.338 . . . . 0.0 110.913 179.305 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -55.64 -23.51 28.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.028 0.442 . . . . 0.0 109.831 -179.682 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.526 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 35.2 m -54.46 126.61 24.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.287 -179.369 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.408 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 54.8 m-20 -61.35 -33.22 73.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.872 -179.459 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.765 HD12 ' CE2' ' A' ' 29' ' ' PHE . 77.9 mt -126.54 122.87 61.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 177.38 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 39.6 mtm180 -106.23 137.63 43.83 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -179.602 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.718 ' CG2' HD12 ' A' ' 41' ' ' LEU . 80.3 mt -117.42 125.9 74.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.918 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -71.34 29.33 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.894 -178.604 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.718 HD12 ' CG2' ' A' ' 39' ' ' ILE . 13.0 mt -100.73 127.61 32.02 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.955 -179.942 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.07 -9.17 24.15 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.096 1.864 . . . . 0.0 112.722 -179.385 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.551 HG21 ' CE2' ' B' ' 241' ' ' PHE . 18.1 m -99.07 7.86 8.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.089 -0.644 . . . . 0.0 111.301 -179.723 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 42.8 t -91.86 135.88 25.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.799 178.677 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.7 m -68.94 166.97 16.76 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.207 -179.476 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -61.21 -42.57 98.83 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.208 -0.906 . . . . 0.0 111.045 -179.055 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.627 ' O ' ' N ' ' A' ' 49' ' ' CYS . 12.5 mm100 -115.57 -26.84 7.33 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 123.853 0.721 . . . . 0.0 109.825 -179.518 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.44 ' O ' ' OG ' ' A' ' 64' ' ' SER . 21.3 t60 44.95 -74.86 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.493 179.556 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.627 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -134.81 139.59 45.21 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.703 -179.195 . . . . . . . . 3 3 . 1 . 079 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.736 ' HD3' HD13 ' A' ' 28' ' ' LEU . 21.7 ttpt -130.61 129.52 42.83 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.0 179.007 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 91.5 mt -107.56 130.47 59.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.34 179.615 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -114.52 123.15 48.65 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 177.598 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.702 HG23 HH12 ' A' ' 5' ' ' ARG . 95.3 mt -103.04 115.91 45.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 119.816 -0.753 . . . . 0.0 111.626 -179.195 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.52 ' O ' ' N ' ' A' ' 56' ' ' GLN . 84.7 m-70 -113.24 141.19 47.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.162 179.551 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.1 tt0 -39.97 -26.13 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.446 0.641 . . . . 0.0 109.528 -178.827 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.52 ' N ' ' O ' ' A' ' 54' ' ' HIS . 63.2 tt0 -68.13 -67.98 0.42 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.816 -1.083 . . . . 0.0 109.628 179.104 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -157.58 -168.48 2.58 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.607 -179.426 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -107.5 127.09 53.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.615 179.24 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.1 mt -120.28 129.67 75.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.213 0.53 . . . . 0.0 111.979 -179.618 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.543 ' HB2' HD11 ' A' ' 82' ' ' LEU . 23.5 tp -101.42 128.51 47.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.152 -179.907 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -113.8 138.57 50.09 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.882 -179.296 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.56 HD21 ' CA ' ' A' ' 68' ' ' PRO . 55.3 t-20 -100.39 108.34 20.33 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.825 0.345 . . . . 0.0 111.649 -179.934 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -98.03 -9.45 25.99 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.538 -179.89 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -78.82 117.11 19.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.971 0.415 . . . . 0.0 111.107 -179.818 . . . . . . . . 3 3 . 1 . 079 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.7 p -101.2 -14.6 17.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.64 179.351 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.912 HG22 HG22 ' B' ' 236' ' ' VAL . 0.2 OUTLIER -88.73 -44.44 10.55 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.346 0.593 . . . . 0.0 109.421 -179.596 . . . . . . . . 3 3 . 1 . 079 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -138.85 95.47 9.69 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.137 -0.938 . . . . 0.0 108.584 178.286 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.56 ' CA ' HD21 ' A' ' 62' ' ' ASN . 37.5 Cg_endo -66.4 150.11 84.52 Favored 'Trans proline' 0 C--N 1.316 -1.156 0 C-N-CA 121.18 1.253 . . . . 0.0 113.029 -177.918 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.439 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 5.3 m -72.13 140.26 48.76 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.949 -179.401 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -103.33 140.9 36.81 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.514 178.547 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.495 ' CG2' ' OD1' ' A' ' 86' ' ' ASP . 5.6 p -128.48 135.5 62.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.043 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 48.37 31.03 2.54 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 119.415 -0.914 . . . . 0.0 108.629 -178.628 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.08 24.73 73.01 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.683 -179.583 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.459 ' N ' ' O ' ' A' ' 71' ' ' VAL . 35.9 t -136.24 139.55 42.81 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.94 0.37 . . . . 0.0 111.11 -179.711 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 79.3 t -68.02 140.7 18.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.169 179.807 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.9 pt -111.77 70.97 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 120.927 0.394 . . . . 0.0 110.437 179.021 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -54.95 -32.72 61.67 Favored 'General case' 0 N--CA 1.461 0.096 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.313 179.578 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -118.88 163.05 28.11 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.96 179.399 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -59.46 144.57 99.37 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.886 1.724 . . . . 0.0 112.829 -179.158 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.0 m -138.14 138.39 43.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.176 -179.68 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -73.12 129.08 37.27 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 120.646 -0.422 . . . . 0.0 109.919 179.47 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.543 HD11 ' HB2' ' A' ' 60' ' ' LEU . 94.6 mt -80.51 141.27 35.32 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.994 0.426 . . . . 0.0 110.631 179.717 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.438 ' HG2' ' N ' ' A' ' 84' ' ' HIS . 88.3 tttt -136.03 157.78 46.01 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.952 -179.56 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.612 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 6.2 t60 -57.3 118.41 5.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.924 0.392 . . . . 0.0 110.834 -179.36 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.68 -7.67 29.89 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -179.989 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.495 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 50.5 t0 -74.76 124.88 27.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.023 0.439 . . . . 0.0 110.115 179.316 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.547 HG22 ' HG2' ' A' ' 96' ' ' ARG . 75.0 t -108.02 131.36 58.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.658 -178.685 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 80.3 mt -99.47 130.67 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.341 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.2 m -118.46 124.78 48.45 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.409 0.623 . . . . 0.0 112.494 -179.121 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.491 HD12 ' HE1' ' A' ' 95' ' ' PHE . 96.9 mt -114.0 124.68 70.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 177.902 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.524 HG22 ' NH2' ' B' ' 245' ' ' ARG . 34.5 mm 36.09 -99.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 -178.764 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.509 ' CG ' ' NH2' ' B' ' 245' ' ' ARG . 37.7 p-10 -116.08 14.01 15.93 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.247 179.425 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.531 ' CZ ' ' O ' ' B' ' 259' ' ' ASP . 84.7 mtt-85 -121.96 145.52 48.04 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.282 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 73.7 m -136.72 154.96 50.45 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.009 179.766 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.491 ' HE1' HD12 ' A' ' 90' ' ' ILE . 79.7 m-85 -126.59 120.65 30.11 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.333 179.378 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.547 ' HG2' HG22 ' A' ' 87' ' ' VAL . 99.6 mtt180 -85.42 136.58 33.39 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.39 -178.936 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -98.18 122.81 41.8 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.302 -179.521 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -134.76 129.33 34.47 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.275 0.56 . . . . 0.0 112.004 -179.601 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.612 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 13.3 p30 -132.78 169.67 16.38 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.762 179.399 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 . . . . . 0 C--N 1.324 -0.517 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.354 -179.769 . . . . . . . . 0 0 . 1 . 079 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 12.0 t . . . . . 0 N--CA 1.453 -0.285 0 CA-C-O 120.819 0.343 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 079 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.622 ' O ' ' C ' ' B' ' 230' ' ' SEP . 52.6 t0 -95.02 110.61 22.51 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.047 179.187 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' B' B ' 230' ' ' SEP . . . . . 0.622 ' C ' ' O ' ' B' ' 229' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 079 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.579 ' N ' ' O ' ' B' ' 229' ' ' ASP . 10.2 mt-30 82.42 52.52 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.815 -179.522 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' B' B ' 232' ' ' GLY . . . . . 0.601 ' N ' ' O ' ' B' ' 229' ' ' ASP . . . -97.32 -149.28 25.19 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.899 -0.881 . . . . 0.0 110.899 -179.565 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -58.98 148.34 85.53 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 123.046 2.498 . . . . 0.0 111.787 179.3 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.402 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 079 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -70.23 147.71 60.47 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 121.814 1.676 . . . . 0.0 112.372 179.95 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.912 HG22 HG22 ' A' ' 66' ' ' THR . 11.4 t -85.4 129.26 38.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.127 -179.568 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -73.58 127.11 31.84 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.59 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' B' B ' 238' ' ' TPO . . . . . 0.425 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 079 nuclear build full ' B' B ' 239' ' ' PRO . . . . . 0.425 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 32.1 Cg_exo -58.28 -27.48 81.06 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.532 2.155 . . . . 0.0 113.222 -178.367 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 23.4 m -74.17 -44.6 52.88 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.273 179.008 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.551 ' CE2' HG21 ' A' ' 43' ' ' VAL . 89.1 t80 -56.35 -46.92 79.77 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.634 -179.436 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.75 HD23 HH21 ' B' ' 245' ' ' ARG . 93.3 mt -63.02 -42.27 99.75 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.846 0.355 . . . . 0.0 110.634 179.869 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -67.6 -40.24 84.75 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -179.425 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -60.97 -45.0 96.53 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.328 -178.832 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.75 HH21 HD23 ' B' ' 242' ' ' LEU . 60.5 mtm180 -65.36 -38.55 90.42 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.626 -0.429 . . . . 0.0 111.513 -179.662 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -61.49 -41.15 96.84 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.41 -179.845 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 62.9 m -64.91 -41.07 95.89 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.052 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' B' B ' 248' ' ' GLN . . . . . 0.433 ' O ' ' N ' ' B' ' 252' ' ' LEU . 58.3 tt0 -62.13 -37.48 85.3 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.797 179.882 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 27.3 t -63.83 -45.68 96.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.255 179.359 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -59.81 -28.31 67.35 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.211 -0.596 . . . . 0.0 109.521 179.282 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -95.14 -8.73 35.59 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.322 179.558 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' B' ' 248' ' ' GLN . 40.6 tp -77.46 136.86 38.4 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.595 -178.656 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -88.17 135.37 33.47 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.349 179.762 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' B' B ' 254' ' ' ASP . . . . . 0.577 ' OD1' ' N ' ' B' ' 255' ' ' ASP . 23.3 p-10 -65.91 -24.71 66.89 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.773 0.32 . . . . 0.0 111.255 -179.176 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' B' B ' 255' ' ' ASP . . . . . 0.577 ' N ' ' OD1' ' B' ' 254' ' ' ASP . 45.7 p-10 -65.44 -1.65 2.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.71 -178.701 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.637 ' O ' ' N ' ' B' ' 258' ' ' ASP . 89.1 m-20 -87.55 -19.81 27.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.143 0.497 . . . . 0.0 110.062 179.454 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 3.2 tttm 37.16 20.53 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.652 179.605 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.637 ' N ' ' O ' ' B' ' 256' ' ' ASP . 51.9 t0 -92.43 108.05 19.67 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.686 -179.878 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.531 ' O ' ' CZ ' ' A' ' 93' ' ' ARG . 35.3 p-10 -85.12 1.71 46.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.584 -178.344 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 70.76 7.52 6.24 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.352 0.596 . . . . 0.0 110.275 179.195 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.452 HD13 ' CE2' ' A' ' 95' ' ' PHE . 81.3 mt -114.42 136.8 49.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.324 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 88.1 t -124.51 132.0 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 120.816 -0.353 . . . . 0.0 110.424 -179.202 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' B' B ' 263' ' ' PHE . . . . . 0.576 ' HZ ' HG21 ' A' ' 9' ' ' THR . 48.2 m-85 -96.93 118.55 33.59 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.192 0.52 . . . . 0.0 112.193 -178.18 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -67.2 -46.01 75.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.553 179.057 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 62.6 mm-40 -91.77 160.78 35.51 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.622 -178.168 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -62.51 154.3 65.51 Favored 'Trans proline' 0 N--CA 1.501 1.942 0 C-N-CA 122.664 2.243 . . . . 0.0 111.082 179.11 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.1 pt . . . . . 0 CA--C 1.519 -0.238 0 CA-C-O 121.497 0.665 . . . . 0.0 112.139 -178.771 . . . . . . . . 0 0 . 1 . 080 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo . . . . . 0 N--CA 1.494 1.531 0 CA-C-O 121.217 0.424 . . . . 0.0 112.672 . . . . . . . . . 0 0 . 1 . 080 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.699 HG23 ' O ' ' A' ' 100' ' ' GLU . 74.1 m -64.17 -44.6 91.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.195 -179.406 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.661 ' NH1' ' HB2' ' A' ' 58' ' ' ALA . 95.5 mtt-85 -93.62 118.12 30.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.718 0.294 . . . . 0.0 111.205 -178.671 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.8 mtp180 -133.51 138.16 45.98 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.397 -0.521 . . . . 0.0 111.509 179.468 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.738 HD12 ' O ' ' A' ' 96' ' ' ARG . 35.8 tp -113.85 133.62 55.31 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.331 179.876 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.621 HG22 ' ND1' ' A' ' 19' ' ' HIS . 47.4 t -109.69 130.96 61.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.865 0.364 . . . . 0.0 110.106 -179.966 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.452 HG23 HH21 ' A' ' 93' ' ' ARG . 1.5 m -88.33 115.65 25.98 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.092 -0.503 . . . . 0.0 112.046 -178.698 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.652 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 95.4 mt -84.04 141.5 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.245 178.712 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -94.78 157.17 16.06 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.332 0.586 . . . . 0.0 111.812 179.526 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.584 ' NH2' ' CD1' ' B' ' 252' ' ' LEU . 89.9 mtm180 -57.85 -27.67 63.44 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.459 -178.92 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.0 t -75.72 -16.36 60.16 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.449 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.22 26.88 11.52 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -179.441 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 49.7 t -117.26 133.59 63.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.75 0.31 . . . . 0.0 110.632 179.865 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -75.47 138.56 41.68 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 178.835 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.5 -113.94 1.69 Allowed Glycine 0 CA--C 1.534 1.237 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.316 -179.292 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -72.1 143.01 39.29 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.18 1.92 . . . . 0.0 113.015 -178.415 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.621 ' ND1' HG22 ' A' ' 8' ' ' VAL . 6.2 m-70 -102.76 143.35 32.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.028 179.863 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.627 ' CD2' HD11 ' A' ' 37' ' ' ILE . 45.5 t80 -117.08 92.43 39.36 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.297 -179.49 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -60.8 127.49 22.65 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.162 1.908 . . . . 0.0 111.755 179.965 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.6 mt -90.01 51.01 1.96 Allowed 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.739 -0.384 . . . . 0.0 111.126 -179.156 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.6 p -63.33 -20.14 65.24 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.21 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.568 HD11 ' OE1' ' B' ' 265' ' ' GLN . 79.3 mt -81.45 141.89 33.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.501 179.266 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.9 m -66.51 -20.44 66.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.665 -178.742 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 83.9 m -129.32 131.01 46.84 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.048 0.451 . . . . 0.0 111.332 179.551 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.8 t -127.08 123.34 36.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.804 178.898 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 40.8 tp -120.32 127.46 52.37 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.36 -178.782 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.744 ' CE2' HD12 ' A' ' 37' ' ' ILE . 11.2 m-85 -104.36 130.77 52.21 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.773 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 178.37 -159.24 24.48 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 111.424 -0.671 . . . . 0.0 111.424 -179.771 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 29.3 ptt-85 -108.48 -15.88 14.34 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.955 -179.87 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -77.0 165.59 53.58 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.017 -178.852 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.418 HD13 ' HA ' ' A' ' 33' ' ' ILE . 30.9 mm -64.5 -43.07 96.86 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.843 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.9 mp0 -52.27 -29.14 21.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.168 -179.887 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 58.6 m -60.88 121.08 11.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.846 179.831 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -55.36 -29.35 58.23 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.958 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.744 HD12 ' CE2' ' A' ' 29' ' ' PHE . 99.3 mt -129.49 124.43 59.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.247 -0.888 . . . . 0.0 108.868 177.505 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 45.7 mtm180 -101.8 134.25 45.27 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.703 -179.905 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.739 HG21 HD12 ' A' ' 41' ' ' LEU . 92.1 mt -119.37 129.04 75.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.813 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -70.24 35.19 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.921 -178.88 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.875 ' O ' HG12 ' A' ' 44' ' ' VAL . 23.6 mt -103.65 115.93 62.74 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.267 -179.75 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -74.64 -7.78 19.78 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.145 1.896 . . . . 0.0 111.771 -179.847 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.9 m -100.36 8.2 8.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.59 179.843 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.875 HG12 ' O ' ' A' ' 41' ' ' LEU . 8.5 p -96.72 140.86 16.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.455 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.0 m -70.98 166.63 20.89 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.336 0.589 . . . . 0.0 111.612 -178.728 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -63.38 -40.84 98.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.01 -179.696 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.582 ' O ' ' N ' ' A' ' 49' ' ' CYS . 87.7 mt-30 -116.93 -6.65 11.45 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.405 -179.89 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.478 ' C ' ' O ' ' A' ' 47' ' ' GLN . 13.1 t60 15.21 -74.88 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -179.568 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.582 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -125.48 130.15 51.22 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.885 -0.726 . . . . 0.0 112.061 -178.435 . . . . . . . . 3 3 . 1 . 080 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -127.67 126.42 41.92 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.102 179.979 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 83.5 mt -110.23 133.56 55.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.912 -179.309 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -115.18 126.54 54.71 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.497 178.931 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.3 mm -97.84 113.3 32.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 119.675 -0.81 . . . . 0.0 111.085 -179.694 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.437 ' O ' ' C ' ' A' ' 55' ' ' GLU . 97.4 m-70 -114.85 136.3 53.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.432 179.114 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 54' ' ' HIS . 98.4 mt-10 -40.31 -38.68 0.83 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.42 -0.512 . . . . 0.0 109.741 -179.428 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.495 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 50.8 tt0 -62.34 -66.43 0.54 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.035 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.495 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 4.0 tp10 -155.58 -169.42 3.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.334 -179.377 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.661 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -114.52 129.42 56.66 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.61 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 93.9 mt -115.4 131.83 66.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.408 0.623 . . . . 0.0 111.913 -178.796 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.496 HD22 ' CD1' ' A' ' 88' ' ' ILE . 28.2 tp -100.61 130.8 46.72 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.196 179.994 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -111.3 131.52 55.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.819 -179.343 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 62.6 t-20 -94.74 106.16 18.13 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.819 0.343 . . . . 0.0 111.429 -179.673 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -97.52 -7.74 30.71 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.178 -179.683 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.8 p -84.06 108.21 16.86 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 119.997 -0.681 . . . . 0.0 111.3 -179.334 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 89.6 p -91.27 -16.25 27.87 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.783 178.874 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.583 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -86.23 -42.53 13.72 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.128 179.95 . . . . . . . . 3 3 . 1 . 080 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -139.82 97.64 8.02 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.085 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -56.08 143.22 84.54 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 121.974 1.782 . . . . 0.0 112.781 -178.501 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.5 m -69.83 138.25 52.45 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.349 178.588 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -102.73 140.29 37.2 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.272 0.558 . . . . 0.0 111.091 -179.561 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.0 p -133.14 135.66 56.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.92 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 50.09 31.79 5.26 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.361 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.13 26.51 68.38 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.769 179.91 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.6 t -140.6 138.23 34.27 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 117.266 0.533 . . . . 0.0 111.929 -179.546 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.417 ' H ' HG22 ' A' ' 75' ' ' VAL . 2.6 m -72.39 141.94 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.789 179.374 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.9 pt -113.68 94.16 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.203 0.525 . . . . 0.0 111.148 179.461 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -65.35 -29.05 69.74 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.752 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -122.12 165.02 22.18 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.219 179.909 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.14 152.28 81.6 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.647 2.231 . . . . 0.0 112.6 -179.819 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.3 m -143.33 143.46 24.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.466 -179.424 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -72.01 133.33 45.25 Favored 'General case' 0 C--O 1.231 0.098 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.036 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.468 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 98.1 mt -82.34 141.57 32.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.026 0.441 . . . . 0.0 111.564 -179.487 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -131.38 151.9 51.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.425 179.682 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.531 ' HD1' ' C ' ' A' ' 99' ' ' ASN . 7.4 t60 -54.37 117.7 3.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.712 0.291 . . . . 0.0 110.813 -179.785 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.5 -15.43 27.15 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.196 -0.526 . . . . 0.0 111.821 179.515 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -67.4 134.46 51.48 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.345 -0.542 . . . . 0.0 110.545 -179.741 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.468 HG22 ' HG2' ' A' ' 96' ' ' ARG . 74.3 t -109.74 135.91 47.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.244 -178.225 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.496 ' CD1' HD22 ' A' ' 60' ' ' LEU . 6.5 mm -99.26 128.74 50.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.761 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.4 m -119.98 121.22 38.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.686 0.755 . . . . 0.0 111.976 -178.989 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.567 ' O ' ' N ' ' A' ' 93' ' ' ARG . 96.2 mt -115.87 127.75 73.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.002 178.667 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.537 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 72.5 mt -18.64 99.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -178.763 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.537 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 2.6 t70 88.68 -21.96 0.14 Allowed 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 178.031 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.652 ' NH2' ' O ' ' A' ' 10' ' ' ILE . 8.0 mmm180 -130.06 146.02 51.7 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.0 -179.609 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.6 t -139.45 148.83 43.28 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.991 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.553 ' HB3' HD11 ' A' ' 7' ' ' LEU . 58.3 m-85 -126.92 122.14 33.75 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 -179.992 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.738 ' O ' HD12 ' A' ' 7' ' ' LEU . 79.0 mtp85 -82.07 130.31 35.05 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.89 0.376 . . . . 0.0 111.249 -179.184 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.63 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 82.8 t80 -96.23 124.92 40.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.554 179.498 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -122.39 127.04 49.22 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.6 179.852 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.531 ' C ' ' HD1' ' A' ' 84' ' ' HIS . 61.6 t-20 -127.01 108.61 11.09 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.217 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.699 ' O ' HG23 ' A' ' 4' ' ' THR . 95.7 mt-10 . . . . . 0 C--N 1.332 -0.16 0 CA-C-O 120.967 0.413 . . . . 0.0 111.075 -178.866 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' B' B ' 228' ' ' VAL . . . . . 0.545 HG13 ' N ' ' B' ' 229' ' ' ASP . 11.0 p . . . . . 0 CA--C 1.528 0.126 0 CA-C-O 120.676 0.274 . . . . 0.0 111.217 . . . . . . . . . 1 1 . 1 . 080 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.545 ' N ' HG13 ' B' ' 228' ' ' VAL . 66.5 t0 56.58 -125.06 1.91 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.215 -179.093 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' B' B ' 230' ' ' SEP . . . . . 0.493 ' N ' ' OD1' ' B' ' 229' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 080 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.476 ' O ' ' O ' ' B' ' 232' ' ' GLY . 75.1 mt-30 -141.33 -5.22 1.1 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.027 -179.075 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' B' B ' 232' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' B' ' 231' ' ' GLN . . . -52.68 -158.68 0.01 OUTLIER Glycine 0 CA--C 1.532 1.122 0 CA-C-N 116.413 -0.358 . . . . 0.0 112.407 -179.144 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -64.88 157.5 56.3 Favored 'Trans proline' 0 N--CA 1.5 1.86 0 C-N-CA 123.559 2.839 . . . . 0.0 112.789 -179.73 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.532 HG21 ' O1P' ' B' ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 080 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -73.71 170.93 18.85 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 122.386 2.057 . . . . 0.0 113.015 -179.559 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.583 ' CG2' HG22 ' A' ' 66' ' ' THR . 25.6 t -110.28 133.37 55.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.998 -179.396 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.6 t -77.42 130.71 37.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.867 -179.902 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' B' B ' 238' ' ' TPO . . . . . 0.415 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 080 nuclear build full ' B' B ' 239' ' ' PRO . . . . . 0.415 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 31.8 Cg_exo -57.72 -24.5 63.59 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 122.569 2.179 . . . . 0.0 111.926 -179.546 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 16.8 m -73.74 -44.92 54.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.203 0.525 . . . . 0.0 110.29 178.357 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -58.17 -45.54 87.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.873 -178.724 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.411 ' HA ' HD23 ' B' ' 242' ' ' LEU . 94.0 mt -63.64 -39.76 95.16 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.328 -0.549 . . . . 0.0 109.575 179.568 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -62.04 -42.75 99.51 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.258 179.988 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -64.89 -40.64 95.42 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.126 -179.713 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.783 ' CZ ' HD21 ' A' ' 41' ' ' LEU . 13.6 mmm180 -61.05 -38.92 87.88 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.298 -178.778 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -65.06 -38.82 92.05 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.38 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 30.4 m -62.39 -45.8 91.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.497 178.475 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -61.08 -35.35 76.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.457 -179.739 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 24.2 t -60.42 -45.0 97.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.39 -0.524 . . . . 0.0 109.697 179.423 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -59.75 -30.23 68.7 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.52 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -82.9 -12.4 57.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.413 179.495 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.584 ' CD1' ' NH2' ' A' ' 12' ' ' ARG . 93.6 mt -110.03 -176.8 3.09 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.708 179.778 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 30.3 p30 -141.95 173.01 11.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.068 -179.745 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -69.77 -18.3 63.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.57 179.537 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -67.95 -9.2 43.38 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.4 -179.472 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -82.14 81.06 8.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.089 0.471 . . . . 0.0 110.501 -179.855 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -66.56 -7.36 19.63 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.908 -178.818 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.695 ' O ' ' N ' ' B' ' 260' ' ' GLU . 89.0 m-20 -102.35 -0.87 32.02 Favored 'General case' 0 C--O 1.224 -0.264 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.541 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.551 ' O ' ' NH1' ' A' ' 93' ' ' ARG . 64.9 t0 -12.99 67.45 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 114.84 -1.073 . . . . 0.0 113.529 -178.867 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.695 ' N ' ' O ' ' B' ' 258' ' ' ASP . 50.4 mm-40 60.83 1.98 0.49 Allowed 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 177.365 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.543 HD11 ' CZ ' ' A' ' 93' ' ' ARG . 4.6 mm -110.46 130.78 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-N 119.113 0.87 . . . . 0.0 109.945 179.537 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 53.5 t -124.48 131.77 72.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.032 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -99.73 122.51 42.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.064 0.459 . . . . 0.0 111.613 -178.257 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -63.85 -46.78 83.46 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.358 0.599 . . . . 0.0 110.135 179.927 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' B' B ' 265' ' ' GLN . . . . . 0.568 ' OE1' HD11 ' A' ' 24' ' ' LEU . 1.5 mm-40 -97.55 157.34 34.92 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.654 -179.367 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -60.3 145.23 99.02 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.893 2.395 . . . . 0.0 113.059 -179.647 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 14.5 pt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.178 179.483 . . . . . . . . 0 0 . 1 . 081 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo . . . . . 0 N--CA 1.491 1.347 0 CA-C-O 120.992 0.33 . . . . 0.0 112.356 . . . . . . . . . 0 0 . 1 . 081 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.6 p -108.53 -34.75 6.66 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.5 179.033 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.566 ' NH1' ' HB2' ' A' ' 58' ' ' ALA . 96.1 mtt-85 -91.99 118.7 31.02 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.274 -179.882 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -128.29 129.78 46.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.926 0.394 . . . . 0.0 111.56 -179.476 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.537 HD11 ' HB3' ' A' ' 95' ' ' PHE . 33.9 tp -112.91 130.06 56.25 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.581 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.8 t -109.06 134.29 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-O 120.835 0.35 . . . . 0.0 110.795 -179.39 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.409 HG23 ' CD1' ' B' ' 261' ' ' ILE . 3.7 m -91.96 120.93 33.07 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.502 -178.521 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.495 ' CD1' ' OD1' ' A' ' 16' ' ' ASP . 49.4 mm -82.15 138.68 19.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.539 179.651 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -91.6 159.65 15.79 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 121.331 0.586 . . . . 0.0 111.561 179.115 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.57 ' NH2' ' OE1' ' B' ' 248' ' ' GLN . 77.3 mtp180 -54.72 -33.07 60.53 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.32 -179.109 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.8 p -78.4 -12.78 60.03 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.76 -179.594 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.59 13.56 40.65 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.973 178.899 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.3 m -109.71 141.49 24.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.317 179.947 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.495 ' OD1' ' CD1' ' A' ' 10' ' ' ILE . 86.4 m-20 -73.6 139.26 45.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.56 -179.327 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.43 -117.33 1.96 Allowed Glycine 0 CA--C 1.535 1.295 0 C-N-CA 120.383 -0.913 . . . . 0.0 111.638 179.94 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.17 143.28 43.74 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 122.096 1.864 . . . . 0.0 113.319 -178.73 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -106.85 157.6 17.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.402 -179.861 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.465 ' CD2' HD11 ' A' ' 37' ' ' ILE . 48.3 t80 -131.52 102.19 15.44 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.773 179.918 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.08 132.73 17.09 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 121.728 1.619 . . . . 0.0 112.061 -179.037 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.9 mt -83.36 55.4 3.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.901 0.381 . . . . 0.0 111.46 -178.535 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 52.4 p -68.04 -25.39 65.34 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.558 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.0 mt -80.65 139.65 36.09 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.539 -0.755 . . . . 0.0 108.966 179.083 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 80.3 p -65.5 -19.38 65.91 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.408 -179.224 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.52 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 44.6 m -131.95 131.49 42.67 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.175 -179.446 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.1 t -125.15 117.18 23.32 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.711 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.549 HD21 ' HG3' ' A' ' 47' ' ' GLN . 52.0 tp -113.93 126.06 54.73 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.915 -179.6 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.676 ' CE2' HD12 ' A' ' 37' ' ' ILE . 7.8 m-85 -104.7 141.09 37.08 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.944 179.465 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 153.34 -174.24 32.03 Favored Glycine 0 N--CA 1.469 0.864 0 C-N-CA 120.288 -0.958 . . . . 0.0 112.328 178.481 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.714 ' NE ' HG21 ' B' ' 228' ' ' VAL . 80.7 mtm-85 -77.39 -32.51 54.89 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-O 120.93 0.395 . . . . 0.0 110.842 -179.982 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.485 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -46.04 144.63 3.65 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 -179.057 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.513 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.0 tp -65.96 -41.41 89.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-O 120.883 0.373 . . . . 0.0 110.056 179.667 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.513 ' N ' HG23 ' A' ' 33' ' ' ILE . 79.4 mm-40 -57.63 -15.65 8.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.861 -179.845 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 80.2 m -56.87 124.4 18.42 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.587 -179.628 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.52 ' OD2' ' O ' ' A' ' 26' ' ' THR . 57.0 m-20 -60.2 -33.15 71.83 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 179.443 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.676 HD12 ' CE2' ' A' ' 29' ' ' PHE . 87.1 mt -127.57 120.33 54.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 176.346 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 76.8 ttt-85 -105.85 135.53 47.11 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.352 -177.923 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.628 HG21 HD12 ' A' ' 41' ' ' LEU . 94.5 mt -117.32 130.09 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 121.045 0.45 . . . . 0.0 110.888 -179.537 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -81.09 30.62 0.33 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.496 -179.216 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.708 ' O ' HG12 ' A' ' 44' ' ' VAL . 20.8 mt -91.32 112.8 55.94 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.758 179.262 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -57.38 -14.24 15.43 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.347 2.032 . . . . 0.0 113.343 179.636 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.48 HG21 ' CE2' ' B' ' 241' ' ' PHE . 2.4 m -103.78 11.15 8.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.748 -178.988 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.708 HG12 ' O ' ' A' ' 41' ' ' LEU . 6.0 p -98.56 138.39 23.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.018 179.629 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.0 m -68.91 167.87 14.8 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.616 0.722 . . . . 0.0 111.983 -179.138 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -63.02 -43.79 97.75 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 114.768 -1.106 . . . . 0.0 111.997 -178.394 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.649 ' O ' ' N ' ' A' ' 49' ' ' CYS . 21.6 mp0 -110.74 -14.55 14.0 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.935 0.398 . . . . 0.0 110.035 179.966 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 25.7 t60 32.45 -75.31 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.083 -0.962 . . . . 0.0 113.551 179.633 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.649 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.82 137.82 45.3 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -178.594 . . . . . . . . 3 3 . 1 . 081 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -125.02 131.83 53.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.016 179.599 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 88.3 mt -114.12 130.54 68.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.337 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -117.98 121.35 40.42 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.422 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 86.3 mt -103.82 116.04 46.86 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-O 121.572 0.701 . . . . 0.0 111.649 -178.854 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.454 ' O ' ' N ' ' A' ' 56' ' ' GLN . 53.0 m-70 -111.84 146.08 38.31 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.864 -179.837 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 54' ' ' HIS . 95.5 mt-10 -39.83 -30.45 0.08 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.128 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.465 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 89.6 mt-30 -63.97 -68.74 0.32 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.991 179.213 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.507 ' HG2' ' HE ' ' A' ' 81' ' ' ARG . 4.6 tp10 -159.13 -161.82 0.99 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.668 179.401 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.566 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -116.63 122.31 44.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.578 179.158 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 91.4 mt -113.59 130.48 67.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.266 0.555 . . . . 0.0 112.132 -178.926 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.599 ' HB2' HD21 ' A' ' 82' ' ' LEU . 48.3 tp -92.37 125.39 37.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.15 179.47 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.416 ' ND1' ' HB3' ' A' ' 79' ' ' PRO . 97.6 m-70 -111.36 136.28 50.71 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.635 0.255 . . . . 0.0 110.921 179.73 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.607 HD22 ' HA ' ' A' ' 68' ' ' PRO . 50.0 t30 -97.76 104.48 16.51 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.133 179.114 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -95.99 -8.87 32.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.026 179.447 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.25 101.01 2.73 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.941 179.423 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.9 p -84.58 -10.17 57.64 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.438 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.733 HG22 HG12 ' B' ' 236' ' ' VAL . 0.2 OUTLIER -97.39 -44.3 6.92 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.881 179.519 . . . . . . . . 3 3 . 1 . 081 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.448 HD21 ' HA ' ' B' ' 236' ' ' VAL . 74.8 m-20 -137.45 91.62 14.05 Favored Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.57 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.607 ' HA ' HD22 ' A' ' 62' ' ' ASN . 51.1 Cg_exo -53.68 144.29 54.02 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.422 2.081 . . . . 0.0 112.46 -179.055 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.4 m -72.17 138.29 47.53 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.786 179.164 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -100.98 141.22 34.19 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.36 -179.867 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 54.5 t -130.3 134.27 62.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.101 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 52.13 32.48 10.56 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.13 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.93 29.72 66.7 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.781 179.68 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.7 m -139.02 130.65 27.35 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.521 -0.472 . . . . 0.0 111.425 -179.599 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.42 ' H ' HG12 ' A' ' 75' ' ' VAL . 0.1 OUTLIER -69.56 138.26 22.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.619 179.844 . . . . . . . . 3 3 . 1 . 081 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.544 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 1.2 pt -118.54 112.39 37.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-O 121.37 0.605 . . . . 0.0 111.501 -179.763 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -80.32 -20.52 44.09 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.583 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -121.55 160.2 47.25 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.394 179.741 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.416 ' HB3' ' ND1' ' A' ' 61' ' ' HIS . 30.6 Cg_endo -61.99 148.49 93.05 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.901 1.734 . . . . 0.0 112.444 179.69 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 76.9 t -130.35 138.13 54.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.021 -179.469 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.507 ' HE ' ' HG2' ' A' ' 57' ' ' GLU . 72.5 ttt180 -70.77 129.48 39.21 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.713 178.948 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.599 HD21 ' HB2' ' A' ' 60' ' ' LEU . 95.4 mt -80.68 135.29 36.0 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.309 0.576 . . . . 0.0 111.276 -179.921 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -133.06 151.75 52.01 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.51 -179.912 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.552 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 4.6 t60 -52.04 116.44 2.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.168 -179.16 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.16 -14.79 36.73 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 121.234 -0.508 . . . . 0.0 111.953 179.551 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -68.89 134.94 50.28 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.953 -179.512 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.9 t -114.13 132.68 62.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.647 -178.207 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.5 mt -100.54 131.81 47.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.317 -0.856 . . . . 0.0 108.79 178.888 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.9 m -120.91 124.2 44.35 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.343 0.592 . . . . 0.0 112.064 -178.431 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.578 ' O ' ' N ' ' A' ' 92' ' ' ASP . 82.2 mt -111.15 122.59 65.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 178.099 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.612 HD12 ' CB ' ' B' ' 237' ' ' CYS . 43.8 mm 36.89 -92.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.02 -179.471 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.588 ' CB ' ' HE ' ' B' ' 245' ' ' ARG . 59.2 t0 -121.48 7.46 10.09 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.881 0.372 . . . . 0.0 111.296 179.649 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.735 ' NH1' HH22 ' B' ' 245' ' ' ARG . 48.5 mmt-85 -111.59 135.01 52.76 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.101 178.9 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.6 m -133.5 148.18 51.67 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.96 179.466 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.537 ' HB3' HD11 ' A' ' 7' ' ' LEU . 67.2 m-85 -124.81 124.66 42.59 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.429 -179.684 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.535 ' O ' HD12 ' A' ' 7' ' ' LEU . 77.1 mtp85 -86.99 131.75 33.99 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 119.687 -0.805 . . . . 0.0 110.976 -179.109 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.511 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 71.2 t80 -96.62 125.55 41.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.492 179.674 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -126.26 123.16 37.5 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.382 179.835 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.552 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 63.7 t-20 -107.66 109.78 21.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.078 179.371 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 . . . . . 0 C--N 1.329 -0.3 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.758 . . . . . . . . 0 0 . 1 . 081 nuclear build full ' B' B ' 228' ' ' VAL . . . . . 0.714 HG21 ' NE ' ' A' ' 31' ' ' ARG . 7.9 p . . . . . 0 C--O 1.233 0.189 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 . . . . . . . . . 1 1 . 1 . 081 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' B' ' 230' ' ' SEP . 83.9 m-20 -92.5 0.61 57.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.9 -179.752 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' B' B ' 230' ' ' SEP . . . . . 0.581 ' H2 ' HG22 ' B' ' 228' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 081 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.435 ' OE1' ' O ' ' B' ' 230' ' ' SEP . 29.0 mm100 -127.87 31.87 5.04 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.463 178.849 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -110.62 -158.58 16.15 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.69 -179.269 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.93 151.11 59.46 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 123.309 2.673 . . . . 0.0 112.895 179.681 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.483 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 081 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -79.91 130.52 8.56 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.377 2.051 . . . . 0.0 113.621 -178.846 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.733 HG12 HG22 ' A' ' 66' ' ' THR . 1.2 m -68.86 147.84 12.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.079 -178.876 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' B' B ' 237' ' ' CYS . . . . . 0.612 ' CB ' HD12 ' A' ' 91' ' ' ILE . 4.3 t -79.15 128.28 33.09 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.897 -179.966 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 081 nuclear build full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -55.76 -28.68 68.04 Favored 'Trans proline' 0 N--CA 1.5 1.893 0 C-N-CA 123.249 2.633 . . . . 0.0 112.772 -179.149 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 51.6 m -70.91 -45.72 63.79 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.864 179.239 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.48 ' CE2' HG21 ' A' ' 43' ' ' VAL . 68.5 t80 -58.4 -46.5 86.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.523 -178.928 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' B' ' 242' ' ' LEU . 82.8 mt -63.11 -41.79 99.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.277 -179.061 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -67.0 -38.67 86.44 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.113 -179.652 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -61.61 -43.91 97.98 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.313 179.539 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.735 HH22 ' NH1' ' A' ' 93' ' ' ARG . 37.9 mtp85 -61.38 -40.98 96.31 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.018 -179.881 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -60.89 -41.19 95.54 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 178.122 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 48.0 t -62.87 -44.27 96.57 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 177.916 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' B' B ' 248' ' ' GLN . . . . . 0.57 ' OE1' ' NH2' ' A' ' 12' ' ' ARG . 87.5 mt-30 -60.02 -37.15 78.9 Favored 'General case' 0 CA--C 1.523 -0.074 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.051 179.598 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.443 HG22 ' HB3' ' A' ' 12' ' ' ARG . 55.8 t -61.62 -43.82 97.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.663 179.689 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -65.51 -35.7 81.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.25 179.097 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -82.45 -13.54 56.57 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.903 179.9 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.457 ' CD1' ' NH1' ' A' ' 12' ' ' ARG . 61.4 mt -101.42 -174.49 2.61 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.293 0.568 . . . . 0.0 111.199 179.874 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -142.98 176.69 8.89 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.947 178.987 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' B' B ' 254' ' ' ASP . . . . . 0.428 ' N ' ' OD1' ' B' ' 254' ' ' ASP . 35.5 p-10 -69.79 -1.5 9.44 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.33 0.586 . . . . 0.0 109.44 179.871 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' B' B ' 255' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' B' ' 257' ' ' LYS . 35.7 t70 -66.66 -25.85 66.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.934 178.928 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.432 ' O ' ' OD1' ' B' ' 259' ' ' ASP . 66.8 t0 -69.01 59.0 0.1 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.0 0.429 . . . . 0.0 110.316 -179.074 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' B' B ' 257' ' ' LYS . . . . . 0.428 ' N ' ' O ' ' B' ' 255' ' ' ASP . 88.7 tttt -55.63 -17.12 4.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.641 -179.62 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -61.81 -51.94 66.23 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 119.997 -0.681 . . . . 0.0 109.677 179.724 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.544 ' C ' HH21 ' A' ' 93' ' ' ARG . 2.5 m-20 65.3 10.23 6.31 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.619 -179.594 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 60.88 18.42 8.75 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 121.078 -0.249 . . . . 0.0 110.915 179.788 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.409 ' CD1' HG23 ' A' ' 9' ' ' THR . 66.8 mt -123.13 132.91 70.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.891 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 55.6 t -125.84 134.08 67.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.888 0.375 . . . . 0.0 110.631 -179.932 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -96.17 117.67 31.2 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.155 0.503 . . . . 0.0 110.968 -179.25 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -66.88 -45.48 77.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.89 179.555 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.85 157.82 37.43 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.309 -179.61 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -64.49 150.42 88.27 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 C-N-CA 123.006 2.471 . . . . 0.0 112.436 -179.892 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 30.3 pt . . . . . 0 C--N 1.328 -0.369 0 CA-C-O 121.247 0.546 . . . . 0.0 111.048 179.762 . . . . . . . . 0 0 . 1 . 082 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo . . . . . 0 N--CA 1.493 1.48 0 CA-C-O 120.88 0.283 . . . . 0.0 112.156 . . . . . . . . . 0 0 . 1 . 082 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.1 m -112.28 -66.32 1.09 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.073 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 86.0 mtt85 -89.6 129.68 36.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.041 179.318 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -128.4 141.77 51.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.071 0.462 . . . . 0.0 111.545 -179.93 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.75 HD12 ' O ' ' A' ' 96' ' ' ARG . 28.1 tp -114.44 130.46 56.72 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.354 179.696 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 52.3 t -106.04 129.26 59.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.554 -0.459 . . . . 0.0 110.474 -179.429 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.577 HG21 ' HZ ' ' B' ' 263' ' ' PHE . 77.6 p -81.89 140.79 33.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.458 -178.243 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.57 HD12 ' OG ' ' A' ' 94' ' ' SER . 96.6 mt -110.88 136.41 47.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.098 178.653 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.1 mttm -87.96 160.08 18.05 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.36 179.224 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.517 ' HD3' HH21 ' B' ' 245' ' ' ARG . 89.7 mtm180 -58.44 -29.41 66.11 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.962 -179.259 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 87.1 p -81.24 -7.28 59.54 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.005 179.936 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.0 35.72 6.64 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 179.696 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.6 t -119.03 132.44 68.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.693 0.282 . . . . 0.0 111.076 -179.978 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -77.45 135.56 38.28 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.637 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -128.11 -114.04 1.78 Allowed Glycine 0 CA--C 1.535 1.31 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.052 -179.098 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.517 ' O ' ' OG1' ' A' ' 9' ' ' THR . 61.4 Cg_endo -72.24 145.71 44.27 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 122.445 2.097 . . . . 0.0 113.378 -178.657 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -108.79 129.52 55.38 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.384 179.776 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.827 ' CD2' HD11 ' A' ' 37' ' ' ILE . 51.8 t80 -98.63 99.85 8.34 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.604 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.514 ' HD2' HG22 ' B' ' 267' ' ' ILE . 73.9 Cg_endo -73.76 134.4 20.02 Favored 'Trans proline' 0 C--N 1.315 -1.229 0 C-N-CA 121.12 1.214 . . . . 0.0 111.099 -179.347 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.9 mt -94.15 118.42 31.53 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.547 -178.982 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.4 p -125.03 -4.36 7.49 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.509 179.328 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.552 HD11 ' OE1' ' B' ' 265' ' ' GLN . 49.8 mt -104.47 148.77 26.09 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.545 -179.032 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.36 -22.43 66.26 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.11 -178.906 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 88.0 m -128.34 130.06 47.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.282 0.563 . . . . 0.0 111.76 -179.433 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.628 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -127.96 121.75 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.878 178.565 . . . . . . . . 3 3 . 1 . 082 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.671 HD12 ' O ' ' A' ' 49' ' ' CYS . 53.7 tp -123.87 124.16 42.03 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -177.649 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.628 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 46.5 m-85 -97.4 141.28 30.67 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.091 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 168.69 -164.44 38.05 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.109 -1.044 . . . . 0.0 112.423 179.582 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.509 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 33.9 ttp-105 -96.99 -28.91 13.95 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.684 -0.758 . . . . 0.0 110.186 -179.611 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.9 162.08 53.99 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.777 -178.439 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.464 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.0 tp -64.47 -39.45 85.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.056 -0.572 . . . . 0.0 110.153 179.342 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.464 ' N ' HG23 ' A' ' 33' ' ' ILE . 80.1 mm-40 -53.31 -28.08 26.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.435 -179.643 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.3 m -64.37 116.71 6.34 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.434 -179.969 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.527 ' OD1' ' O ' ' A' ' 28' ' ' LEU . 12.5 p-10 -58.02 -26.24 62.18 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.539 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.827 HD11 ' CD2' ' A' ' 20' ' ' PHE . 34.6 mm -122.33 113.96 40.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.361 177.636 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -105.36 136.67 44.47 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.784 179.479 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.485 ' C ' ' H ' ' A' ' 41' ' ' LEU . 91.3 mt -119.61 132.13 70.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.36 -0.836 . . . . 0.0 108.976 179.603 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -71.29 29.4 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.669 -178.808 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.713 HD21 HH22 ' B' ' 245' ' ' ARG . 31.4 mt -91.1 122.73 66.1 Favored Pre-proline 0 C--N 1.323 -0.549 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.037 179.805 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.44 -7.47 20.95 Favored 'Trans proline' 0 N--CA 1.49 1.298 0 C-N-CA 122.12 1.88 . . . . 0.0 111.64 -179.161 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.2 m -107.54 9.97 9.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.844 -179.164 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.628 HG12 ' O ' ' A' ' 41' ' ' LEU . 9.6 p -92.16 141.85 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.061 179.835 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.0 m -71.26 159.43 34.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.714 0.769 . . . . 0.0 112.215 -178.659 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -61.89 -39.72 92.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.814 -1.084 . . . . 0.0 110.797 -179.602 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.595 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.3 mt-30 -117.14 -8.76 11.13 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.678 0.275 . . . . 0.0 111.047 179.445 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.466 ' C ' ' O ' ' A' ' 47' ' ' GLN . 24.3 t60 16.19 -73.88 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 114.633 1.345 . . . . 0.0 114.633 -178.527 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.671 ' O ' HD12 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -130.8 134.64 47.03 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 119.966 -0.693 . . . . 0.0 112.72 -177.724 . . . . . . . . 3 3 . 1 . 082 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -126.02 131.16 52.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.638 179.742 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.9 mt -116.0 133.38 62.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.166 0.508 . . . . 0.0 110.728 179.649 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -118.67 122.58 42.87 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.371 -0.832 . . . . 0.0 108.774 179.051 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 92.1 mt -105.2 116.09 48.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.561 0.696 . . . . 0.0 111.653 -178.974 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.439 ' O ' ' C ' ' A' ' 55' ' ' GLU . 87.6 m-70 -114.42 144.78 42.75 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.604 -179.848 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 54' ' ' HIS . 92.1 mt-10 -39.77 -33.11 0.17 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.318 -0.553 . . . . 0.0 109.911 -179.037 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.449 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 82.7 mt-30 -61.73 -68.38 0.32 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.788 179.227 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.449 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 4.5 tp10 -158.2 -166.35 1.92 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.393 -179.492 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.424 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -110.1 130.13 55.59 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.921 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.5 mt -119.4 129.07 75.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.226 0.536 . . . . 0.0 112.24 -178.549 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.652 ' HB2' HD11 ' A' ' 82' ' ' LEU . 17.4 tp -99.27 126.25 45.06 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.216 179.535 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -113.22 137.1 51.97 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.928 -179.886 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.506 ' ND2' ' O ' ' A' ' 76' ' ' ILE . 22.3 p-10 -100.66 111.19 23.39 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.992 0.425 . . . . 0.0 111.929 -179.246 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -102.61 -6.84 22.33 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.352 179.73 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.44 100.12 6.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.81 0.338 . . . . 0.0 111.579 -179.476 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.9 p -75.6 -32.17 60.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.207 178.288 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.4 m -65.25 -49.24 70.39 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.108 -179.069 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -145.4 103.95 4.32 Favored Pre-proline 0 N--CA 1.466 0.348 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.831 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -54.68 145.14 61.44 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 121.446 1.43 . . . . 0.0 112.004 -179.096 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.9 m -68.8 138.73 55.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.867 178.872 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -99.32 139.98 34.17 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.991 -179.764 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 55.0 t -134.38 134.47 54.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.735 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.573 ' ND2' ' OD1' ' A' ' 86' ' ' ASP . 74.1 m-20 53.8 32.12 14.34 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.611 -179.5 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.65 28.34 63.4 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.736 179.251 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.5 m -147.98 144.85 28.26 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 117.74 0.77 . . . . 0.0 111.734 179.902 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.404 ' H ' HG22 ' A' ' 75' ' ' VAL . 2.4 m -75.88 139.54 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.435 179.247 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.506 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 4.5 pt -104.99 101.61 12.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.411 0.624 . . . . 0.0 111.319 -179.912 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -65.01 -34.86 79.45 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.808 179.431 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.457 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.7 OUTLIER -126.15 178.52 1.48 Allowed Pre-proline 0 CA--C 1.53 0.176 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.52 179.803 . . . . . . . . 3 3 . 1 . 082 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.457 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 21.7 Cg_exo -63.26 146.89 94.13 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 C-N-CA 122.826 2.351 . . . . 0.0 112.174 -179.899 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.5 p -141.64 140.96 30.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.067 179.668 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -72.6 129.86 39.25 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.121 179.41 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.652 HD11 ' HB2' ' A' ' 60' ' ' LEU . 93.0 mt -86.63 135.84 33.26 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.344 -179.926 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -126.83 155.0 43.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.811 -179.554 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.498 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 6.1 t60 -53.96 116.64 2.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.441 -179.597 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.55 -14.48 27.41 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -179.509 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.573 ' OD1' ' ND2' ' A' ' 72' ' ' ASN . 26.2 t70 -69.12 129.7 40.62 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 179.551 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.0 t -109.24 135.64 47.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.312 -178.761 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 89.3 mt -103.43 132.29 50.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.25 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.843 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.0 m -122.15 127.59 50.26 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.762 0.791 . . . . 0.0 112.799 -178.342 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.55 ' O ' ' N ' ' A' ' 93' ' ' ARG . 97.4 mt -121.26 122.94 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 114.369 -1.287 . . . . 0.0 108.492 177.953 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.56 HG23 HD21 ' B' ' 242' ' ' LEU . 56.6 mt -3.74 95.62 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -179.77 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.629 ' CG ' ' HE ' ' B' ' 245' ' ' ARG . 1.4 t70 78.73 -13.42 0.97 Allowed 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 177.69 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.564 ' HD2' HD11 ' B' ' 261' ' ' ILE . 1.6 tpp180 -130.78 139.41 50.22 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.628 -179.192 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.57 ' OG ' HD12 ' A' ' 10' ' ' ILE . 14.9 p -140.15 157.08 46.18 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.283 0.563 . . . . 0.0 111.436 -179.204 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.519 ' HB3' HD11 ' A' ' 7' ' ' LEU . 65.2 m-85 -130.04 125.97 36.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.207 -179.584 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.75 ' O ' HD12 ' A' ' 7' ' ' LEU . 99.9 mtt180 -88.78 132.19 34.73 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.945 -179.231 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -96.94 125.43 41.36 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.498 -179.811 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -127.2 119.73 27.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.082 179.114 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.498 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 58.9 t-20 -105.04 114.31 28.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.504 179.583 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 . . . . . 0 C--N 1.328 -0.365 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.184 179.588 . . . . . . . . 0 0 . 1 . 082 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 17.5 m . . . . . 0 N--CA 1.455 -0.207 0 CA-C-O 120.745 0.307 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 082 nuclear build full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -68.32 154.98 40.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.565 -179.425 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' B' B ' 230' ' ' SEP . . . . . 0.462 ' HA ' ' HE ' ' A' ' 31' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 082 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -119.95 27.78 8.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.872 179.752 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -114.39 -152.68 10.58 Favored Glycine 0 CA--C 1.536 1.388 0 N-CA-C 111.832 -0.507 . . . . 0.0 111.832 -179.363 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -75.49 162.18 36.26 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 123.127 2.551 . . . . 0.0 113.211 -179.097 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 082 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -57.89 150.07 65.82 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 C-N-CA 122.674 2.249 . . . . 0.0 113.282 179.584 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 6.0 p -97.1 132.8 40.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.11 179.641 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 10.7 t -55.84 111.96 1.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.201 -179.221 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' B' B ' 238' ' ' TPO . . . . . 0.518 HG22 ' H ' ' B' ' 241' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 082 nuclear build full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -50.83 -26.97 19.11 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 121.993 1.795 . . . . 0.0 112.592 -179.826 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 42.5 p -74.37 -36.62 63.56 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.577 -0.449 . . . . 0.0 109.793 178.762 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.611 ' CZ ' ' NH1' ' B' ' 245' ' ' ARG . 85.9 t80 -59.39 -48.04 83.15 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.261 -179.153 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.56 HD21 HG23 ' A' ' 91' ' ' ILE . 94.3 mt -64.64 -42.28 95.56 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.445 -179.892 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -69.37 -42.13 75.6 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.867 -179.439 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 62.2 ttp180 -61.87 -46.66 88.43 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.703 -178.799 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.713 HH22 HD21 ' A' ' 41' ' ' LEU . 10.7 ptm85 -71.47 -38.89 71.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.292 -179.476 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -61.54 -39.99 93.05 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.504 179.737 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 23.0 t -69.35 -42.77 74.83 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.289 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 64.1 tp60 -58.21 -40.14 80.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.838 179.758 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.664 HG23 ' O ' ' B' ' 245' ' ' ARG . 89.0 t -67.43 -43.78 87.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.698 179.826 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -57.51 -28.72 63.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.563 -179.879 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -105.95 10.61 32.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.625 179.297 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 46.0 tp -91.44 137.63 32.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.227 -179.76 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' B' B ' 253' ' ' ASN . . . . . 0.536 ' C ' ' H ' ' B' ' 255' ' ' ASP . 19.4 t-20 -88.42 158.58 18.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.04 0.448 . . . . 0.0 111.078 -179.983 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -61.38 4.12 0.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.637 179.528 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' B' B ' 255' ' ' ASP . . . . . 0.536 ' H ' ' C ' ' B' ' 253' ' ' ASN . 99.2 m-20 -60.08 -20.9 60.4 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.813 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -95.91 35.21 1.43 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.356 179.186 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -60.07 -9.57 3.34 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.453 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -62.8 -42.71 99.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.321 179.718 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.618 ' C ' ' H ' ' B' ' 261' ' ' ILE . 35.5 t0 80.87 118.57 0.05 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.422 0.63 . . . . 0.0 111.58 179.957 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -54.24 10.91 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.645 -179.636 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.618 ' H ' ' C ' ' B' ' 259' ' ' ASP . 54.9 mt -103.84 134.65 44.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.75 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 77.7 t -123.18 132.37 71.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.43 -179.163 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' B' B ' 263' ' ' PHE . . . . . 0.577 ' HZ ' HG21 ' A' ' 9' ' ' THR . 45.7 m-85 -95.03 111.92 23.67 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.88 -177.677 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -61.93 -45.52 93.32 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.33 179.19 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' B' B ' 265' ' ' GLN . . . . . 0.552 ' OE1' HD11 ' A' ' 24' ' ' LEU . 1.8 mm-40 -98.99 156.77 35.12 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.308 -179.472 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.28 152.94 71.77 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 123.158 2.572 . . . . 0.0 113.427 -178.866 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' B' B ' 267' ' ' ILE . . . . . 0.514 HG22 ' HD2' ' A' ' 21' ' ' PRO . 26.3 pt . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.196 179.112 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo . . . . . 0 N--CA 1.489 1.233 0 CA-C-O 120.869 0.279 . . . . 0.0 111.777 . . . . . . . . . 0 0 . 1 . 083 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 67.3 p -109.51 -35.49 6.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.701 -179.705 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.894 ' NH1' ' HB2' ' A' ' 58' ' ' ALA . 94.0 mtt-85 -93.11 119.99 32.92 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.228 -179.286 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -131.14 139.25 49.76 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.436 179.937 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.62 HD11 ' HB3' ' A' ' 95' ' ' PHE . 46.9 tp -115.25 131.88 56.79 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.979 179.749 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 73.8 t -110.65 133.07 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.597 -178.759 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 m -84.42 143.23 29.56 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.717 0.77 . . . . 0.0 112.475 -179.094 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 50.6 mm -109.39 137.08 43.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 114.238 -1.346 . . . . 0.0 108.807 177.794 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -91.58 160.84 15.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.302 0.573 . . . . 0.0 111.127 179.877 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.457 HH21 ' HG3' ' B' ' 245' ' ' ARG . 82.0 mtp180 -54.1 -32.29 54.53 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.015 -178.949 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 97.7 p -81.64 -6.27 58.85 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.281 -179.958 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.03 38.2 6.92 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -179.869 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.5 t -123.74 133.73 68.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.02 0.438 . . . . 0.0 110.519 179.964 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.481 ' O ' ' OD1' ' A' ' 16' ' ' ASP . 50.8 p-10 -80.19 136.9 36.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.292 179.695 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -131.76 -110.63 1.3 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 120.3 -0.953 . . . . 0.0 112.169 -179.613 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.17 144.08 41.24 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.288 1.992 . . . . 0.0 113.25 -178.608 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -109.06 148.79 30.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.372 179.909 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.521 ' CD2' HD11 ' A' ' 37' ' ' ILE . 35.5 t80 -118.48 94.69 47.72 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.633 -179.262 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -60.69 126.57 20.15 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 121.926 1.751 . . . . 0.0 111.638 179.653 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 63.5 mt -91.18 47.81 1.44 Allowed 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -178.576 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.9 m -66.28 -16.77 64.3 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.701 179.629 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.602 HD11 ' OE1' ' B' ' 265' ' ' GLN . 94.2 mt -78.43 141.3 38.4 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.163 179.496 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 94.3 p -61.17 -21.98 64.29 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.756 -0.657 . . . . 0.0 112.054 -178.488 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 44.5 m -137.42 136.45 37.83 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 120.397 -0.521 . . . . 0.0 112.081 -179.435 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.2 t -129.43 122.6 29.72 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.035 178.315 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.431 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 47.6 tp -117.08 130.63 56.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.197 -179.23 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.739 ' CE2' HD12 ' A' ' 37' ' ' ILE . 7.9 m-85 -107.41 125.67 51.51 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.562 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 172.72 178.64 42.94 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 120.297 -0.954 . . . . 0.0 112.303 179.831 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.652 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 81.2 mtm-85 -77.6 -31.48 53.0 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.016 179.362 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -52.49 150.2 9.29 Favored Glycine 0 N--CA 1.464 0.553 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 -178.872 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.484 HG23 ' N ' ' A' ' 34' ' ' GLU . 8.8 tp -66.76 -42.77 89.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.815 -179.514 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.484 ' N ' HG23 ' A' ' 33' ' ' ILE . 83.8 tt0 -53.44 -18.28 2.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.386 179.406 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.9 m -62.38 127.05 29.5 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.537 -179.742 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.431 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 55.9 m-20 -61.09 -31.64 71.31 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -179.459 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.739 HD12 ' CE2' ' A' ' 29' ' ' PHE . 98.5 mt -126.14 120.98 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 176.539 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.479 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 83.7 mtp180 -100.41 128.55 46.44 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.739 -178.951 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.405 HG22 ' H ' ' A' ' 41' ' ' LEU . 89.5 mt -112.94 128.08 69.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.205 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -80.93 26.74 0.41 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.976 -0.557 . . . . 0.0 112.382 -177.432 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.774 HD11 ' NE ' ' A' ' 93' ' ' ARG . 68.4 mt -94.98 131.73 29.64 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.185 179.263 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.93 -12.1 31.91 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.098 1.865 . . . . 0.0 112.897 -179.676 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.5 m -98.27 12.67 5.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.278 -179.796 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.652 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 14.3 t -100.89 130.86 49.59 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 C-N-CA 120.577 -0.449 . . . . 0.0 109.893 178.695 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.6 t -71.38 173.42 7.87 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.448 0.642 . . . . 0.0 112.125 -178.559 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.6 mttp -64.51 -41.39 96.46 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.89 179.919 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.588 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.2 mt-30 -116.45 -7.32 11.69 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 121.111 -0.235 . . . . 0.0 111.338 -179.566 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.474 ' C ' ' O ' ' A' ' 47' ' ' GLN . 14.9 t60 15.91 -74.88 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -178.695 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.588 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -129.24 133.27 47.44 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.088 -0.645 . . . . 0.0 112.341 -178.335 . . . . . . . . 3 3 . 1 . 083 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -128.47 131.15 48.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.293 179.763 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.4 mt -117.35 133.67 63.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.008 -179.697 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.453 ' OE2' ' CE1' ' A' ' 54' ' ' HIS . 81.7 tt0 -112.41 133.26 54.6 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.51 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.545 HD12 ' HD3' ' A' ' 5' ' ' ARG . 46.4 mm -101.96 124.28 55.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.448 0.642 . . . . 0.0 111.661 -178.637 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.57 ' O ' ' N ' ' A' ' 56' ' ' GLN . 96.9 m-70 -124.92 132.35 53.31 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.488 178.747 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.47 ' C ' ' O ' ' A' ' 54' ' ' HIS . 77.9 tt0 -39.79 -25.34 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.894 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.57 ' N ' ' O ' ' A' ' 54' ' ' HIS . 91.3 mt-30 -66.59 -68.34 0.38 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.018 178.018 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.464 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 5.3 tp10 -158.71 -160.75 0.9 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.209 179.942 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.894 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -118.69 127.89 54.0 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.224 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.7 mt -115.65 129.56 71.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.476 0.655 . . . . 0.0 111.523 -178.927 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.8 tp -96.62 128.86 43.96 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.383 -179.62 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -110.63 132.89 53.8 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.764 179.82 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -94.47 103.95 15.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.299 -179.391 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -97.07 -7.9 31.62 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.741 -0.383 . . . . 0.0 111.015 179.209 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.487 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 12.9 t -72.17 100.92 2.67 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-O 120.779 0.323 . . . . 0.0 110.169 179.256 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.7 p -82.99 -13.85 55.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.874 179.641 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.496 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.2 OUTLIER -96.27 -38.3 10.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.181 -179.534 . . . . . . . . 3 3 . 1 . 083 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.488 HD21 ' HA ' ' B' ' 236' ' ' VAL . 76.1 m-20 -143.11 101.23 5.28 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.772 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.429 ' HB2' HG23 ' A' ' 75' ' ' VAL . 31.5 Cg_exo -58.01 146.39 87.55 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 121.509 1.473 . . . . 0.0 112.436 179.951 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.7 m -73.61 143.53 46.31 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.906 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -104.37 140.94 37.19 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.041 -179.355 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 43.9 t -132.26 135.54 57.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.372 -0.831 . . . . 0.0 108.82 179.562 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 52.8 26.95 4.91 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -179.235 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.28 29.1 62.72 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.651 -179.634 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.3 m -142.46 140.47 31.92 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.865 0.365 . . . . 0.0 110.827 179.875 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.446 ' H ' HG12 ' A' ' 75' ' ' VAL . 0.2 OUTLIER -73.22 142.75 14.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.013 -179.21 . . . . . . . . 3 3 . 1 . 083 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.467 HG21 HG11 ' A' ' 80' ' ' VAL . 7.5 pt -109.88 92.62 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-O 121.224 0.535 . . . . 0.0 110.911 179.115 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -63.95 -30.95 71.99 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.715 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -121.31 169.49 8.99 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.362 179.865 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -59.06 144.89 99.18 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 121.918 1.745 . . . . 0.0 111.751 179.429 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.467 HG11 HG21 ' A' ' 76' ' ' ILE . 8.2 p -135.21 140.94 44.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.108 0.48 . . . . 0.0 111.445 -179.627 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.455 HH21 ' CE ' ' A' ' 83' ' ' LYS . 62.7 ttp180 -78.2 132.64 37.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.881 179.085 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.429 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 91.8 mt -87.67 137.12 32.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.933 -178.541 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.455 ' CE ' HH21 ' A' ' 81' ' ' ARG . 99.2 mttt -124.86 151.23 45.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.432 179.532 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.495 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 6.8 t60 -54.62 121.3 8.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.771 -179.377 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.28 -18.99 35.2 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.034 -0.827 . . . . 0.0 111.034 -179.942 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -69.05 136.69 52.74 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.551 -0.46 . . . . 0.0 109.86 179.735 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.0 t -113.24 133.53 58.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.543 -178.305 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 89.2 mt -98.32 133.72 39.54 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.684 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 97.4 m -123.2 127.67 48.96 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 119.605 -0.838 . . . . 0.0 112.36 -179.195 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.612 ' O ' ' N ' ' A' ' 93' ' ' ARG . 96.8 mt -116.45 129.64 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 114.123 -1.399 . . . . 0.0 108.41 178.418 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.527 HD13 ' HB2' ' B' ' 237' ' ' CYS . 79.4 mt -18.98 101.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 O-C-N 123.744 0.652 . . . . 0.0 112.279 -179.246 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.496 ' OD1' ' NE ' ' B' ' 245' ' ' ARG . 73.8 m-20 80.37 -18.27 0.51 Allowed 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 178.919 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.774 ' NE ' HD11 ' A' ' 41' ' ' LEU . 59.4 mtt-85 -129.51 141.59 50.96 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.61 179.93 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 30.7 p -138.27 152.83 48.92 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.169 0.509 . . . . 0.0 110.027 179.901 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.62 ' HB3' HD11 ' A' ' 7' ' ' LEU . 65.9 m-85 -128.79 121.93 29.41 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.623 -179.563 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.537 ' O ' HD12 ' A' ' 7' ' ' LEU . 43.8 ttm180 -80.52 128.78 33.99 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.711 -0.395 . . . . 0.0 111.2 -179.705 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.592 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 89.4 t80 -94.62 124.97 38.97 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.597 179.632 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -127.66 122.84 34.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.937 0.399 . . . . 0.0 111.32 -179.89 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.495 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 61.6 t-20 -106.89 107.49 18.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.085 179.095 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 . . . . . 0 C--N 1.331 -0.208 0 CA-C-O 120.861 0.363 . . . . 0.0 110.888 -179.604 . . . . . . . . 0 0 . 1 . 083 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.669 0.271 . . . . 0.0 111.321 . . . . . . . . . 1 1 . 1 . 083 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.634 ' O ' ' N ' ' B' ' 231' ' ' GLN . 51.9 t0 -98.32 105.75 17.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.781 -179.62 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 083 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.634 ' N ' ' O ' ' B' ' 229' ' ' ASP . 6.0 mt-30 -57.34 -51.52 69.04 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.96 -178.995 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' B' B ' 232' ' ' GLY . . . . . 0.504 ' O ' ' NH2' ' A' ' 31' ' ' ARG . . . -38.13 161.7 0.01 OUTLIER Glycine 0 CA--C 1.528 0.901 0 N-CA-C 111.743 -0.543 . . . . 0.0 111.743 -179.709 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -74.0 161.24 41.56 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 123.683 2.922 . . . . 0.0 112.99 179.648 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.496 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 083 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -79.46 140.69 15.33 Favored 'Trans proline' 0 C--N 1.3 -1.998 0 C-N-CA 121.757 1.638 . . . . 0.0 112.71 -179.011 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.488 ' HA ' HD21 ' A' ' 67' ' ' ASN . 53.1 t -57.46 141.99 13.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.456 179.687 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' B' B ' 237' ' ' CYS . . . . . 0.527 ' HB2' HD13 ' A' ' 91' ' ' ILE . 17.4 t -63.49 128.58 36.48 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.782 -179.263 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 083 nuclear build full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -58.28 -22.76 59.18 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.176 1.917 . . . . 0.0 112.851 -179.835 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 54.6 m -74.05 -44.22 55.03 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 121.029 0.443 . . . . 0.0 109.849 178.198 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -56.84 -47.12 81.08 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.894 -178.989 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.434 HD23 ' OD1' ' A' ' 92' ' ' ASP . 97.1 mt -66.99 -40.82 87.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.734 179.541 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -60.73 -43.19 98.18 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.854 -179.812 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -60.43 -42.86 96.95 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.505 179.739 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.605 ' O ' HG23 ' B' ' 249' ' ' VAL . 71.7 ttp85 -61.64 -40.61 95.52 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.604 -0.439 . . . . 0.0 111.253 -179.524 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -60.54 -40.16 90.53 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.46 -179.718 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 80.8 p -69.85 -42.22 73.85 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.058 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' B' B ' 248' ' ' GLN . . . . . 0.455 ' CB ' HH22 ' A' ' 12' ' ' ARG . 87.4 mt-30 -63.55 -32.41 73.86 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.209 179.778 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.605 HG23 ' O ' ' B' ' 245' ' ' ARG . 54.9 t -64.39 -45.45 95.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 120.113 -0.635 . . . . 0.0 109.64 178.477 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -58.72 -31.03 67.91 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.811 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -92.11 -9.74 41.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.843 179.162 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' B' ' 248' ' ' GLN . 35.9 tp -78.63 148.66 33.13 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.274 0.559 . . . . 0.0 111.278 -179.327 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -96.88 123.86 40.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.713 179.362 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -53.32 -27.99 26.1 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.594 -179.431 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -71.67 3.25 4.2 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.674 179.676 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -61.36 146.75 47.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.248 0.547 . . . . 0.0 110.906 -179.861 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -135.1 157.65 46.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.947 179.573 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.615 ' O ' ' N ' ' B' ' 260' ' ' GLU . 1.1 t0 62.47 48.01 4.79 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -178.794 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.477 ' C ' ' OE1' ' B' ' 260' ' ' GLU . 43.6 p-10 -55.75 65.96 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.176 -178.314 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.615 ' N ' ' O ' ' B' ' 258' ' ' ASP . 52.8 mp0 59.07 6.97 0.75 Allowed 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 179.044 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 67.0 mt -113.98 132.17 63.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.202 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 53.2 t -127.12 131.43 70.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.786 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -93.07 120.66 33.61 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.222 0.534 . . . . 0.0 110.335 -178.49 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -64.82 -44.94 88.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.989 -179.416 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' B' B ' 265' ' ' GLN . . . . . 0.602 ' OE1' HD11 ' A' ' 24' ' ' LEU . 1.4 mm-40 -99.74 158.56 31.9 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.786 -179.221 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -65.16 153.82 76.47 Favored 'Trans proline' 0 N--CA 1.503 2.039 0 C-N-CA 123.278 2.652 . . . . 0.0 111.846 -179.979 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 47.0 pt . . . . . 0 C--O 1.232 0.153 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -178.514 . . . . . . . . 0 0 . 1 . 084 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo . . . . . 0 N--CA 1.489 1.254 0 N-CA-C 111.24 -0.331 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 084 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.5 m -91.08 -42.38 10.53 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.223 0.535 . . . . 0.0 110.351 179.815 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.3 mtt85 -91.8 129.35 37.78 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.433 -178.728 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.5 mtt85 -130.83 138.0 49.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.276 -179.973 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.545 HD11 ' HB3' ' A' ' 95' ' ' PHE . 39.4 tp -115.11 128.35 56.16 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.619 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.3 m -109.49 132.49 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 121.155 0.502 . . . . 0.0 111.413 -179.078 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.409 ' HG1' ' HE2' ' A' ' 95' ' ' PHE . 2.7 m -80.36 138.56 36.7 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.246 -179.437 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.612 HD12 ' OG ' ' A' ' 94' ' ' SER . 96.5 mt -107.83 138.23 35.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.695 177.715 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -89.14 155.97 19.1 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.014 0.435 . . . . 0.0 109.849 178.434 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.575 HH11 ' CZ ' ' A' ' 93' ' ' ARG . 72.7 mtp85 -58.05 -24.17 57.37 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.429 -179.04 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.2 p -82.47 -8.63 59.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.037 0.446 . . . . 0.0 110.16 178.982 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.76 36.16 6.94 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -179.834 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.6 t -121.88 133.5 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.801 0.334 . . . . 0.0 111.069 -179.993 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 17' ' ' GLY . 61.6 t0 -78.43 132.58 37.38 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.236 179.397 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.461 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -125.72 -113.56 1.92 Allowed Glycine 0 CA--C 1.537 1.458 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.954 -179.736 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -71.68 143.9 43.0 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 122.324 2.016 . . . . 0.0 113.298 -178.568 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.541 ' O ' ' CD1' ' B' ' 267' ' ' ILE . 0.3 OUTLIER -111.29 135.81 51.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.135 0.493 . . . . 0.0 111.119 -179.89 . . . . . . . . 3 3 . 1 . 084 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -105.81 105.76 54.25 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.405 179.976 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -74.31 129.49 13.04 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 121.33 1.353 . . . . 0.0 111.911 -178.899 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 74.5 mt -83.97 47.04 1.25 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.859 -178.777 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.0 p -64.08 -21.57 66.58 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.969 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.478 HD11 ' OE1' ' B' ' 265' ' ' GLN . 79.3 mt -83.31 143.71 30.19 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.007 179.796 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.7 t -64.14 -21.73 66.66 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.947 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.415 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 56.2 m -135.63 135.54 40.28 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.181 -0.608 . . . . 0.0 112.369 -179.012 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.574 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 16.9 t -127.9 119.83 26.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.324 178.4 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.441 HD12 ' O ' ' A' ' 49' ' ' CYS . 49.1 tp -118.07 130.89 56.41 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.229 -178.546 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.621 ' CE2' HD12 ' A' ' 37' ' ' ILE . 5.5 m-85 -108.53 140.78 41.38 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.2 179.852 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 152.21 -176.28 30.55 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.249 178.393 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.695 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 76.8 mtm-85 -75.89 -32.23 59.57 Favored 'General case' 0 C--N 1.338 0.068 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.197 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.582 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -48.08 143.37 7.04 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 -178.471 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.512 ' CD1' ' CZ ' ' A' ' 38' ' ' ARG . 32.2 mm -65.79 -43.91 93.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.647 179.803 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -54.28 -17.74 3.25 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.789 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.582 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 39.4 m -60.16 121.47 11.99 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.218 179.851 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.415 ' OD2' ' O ' ' A' ' 26' ' ' THR . 99.0 m-20 -60.69 -28.64 68.77 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.238 -179.264 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.621 HD12 ' CE2' ' A' ' 29' ' ' PHE . 96.7 mt -126.13 120.54 57.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 176.798 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.512 ' CZ ' ' CD1' ' A' ' 33' ' ' ILE . 84.0 mtp180 -103.99 132.53 50.15 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.938 -178.199 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.581 HG21 HD12 ' A' ' 41' ' ' LEU . 84.8 mt -121.49 130.79 74.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 121.03 0.443 . . . . 0.0 109.961 179.491 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -78.44 41.5 0.4 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.232 -178.495 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.581 HD12 HG21 ' A' ' 39' ' ' ILE . 77.8 mt -105.88 104.99 51.71 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.44 179.41 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -57.61 -15.39 20.22 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.117 1.878 . . . . 0.0 112.148 179.532 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.461 HG21 ' CE2' ' B' ' 241' ' ' PHE . 35.0 m -91.11 4.89 6.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.237 -179.632 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.695 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 24.9 t -104.18 140.32 22.62 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.354 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.128 180.0 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.4 ' HA ' HG21 ' B' ' 234' ' ' TPO . 18.4 m -71.05 168.09 17.84 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.284 0.564 . . . . 0.0 112.276 -179.236 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -61.8 -39.29 91.2 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.271 -179.678 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.643 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.6 mt-30 -111.17 -19.43 12.7 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.904 179.813 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.3 t60 35.85 -75.86 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 179.015 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.643 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.83 134.45 46.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.266 0.555 . . . . 0.0 112.106 -177.871 . . . . . . . . 3 3 . 1 . 084 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -127.43 131.71 50.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.458 179.668 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 98.0 mt -118.03 133.88 63.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.175 179.933 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -117.69 134.37 54.96 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.102 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 48.3 mm -98.56 119.71 46.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.831 179.819 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.483 ' O ' ' N ' ' A' ' 56' ' ' GLN . 98.4 m-70 -123.85 135.53 53.8 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.137 -179.989 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 54' ' ' HIS . 92.8 mt-10 -41.28 -25.97 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -179.396 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.483 ' N ' ' O ' ' A' ' 54' ' ' HIS . 47.9 tt0 -67.3 -68.87 0.35 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.75 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -156.95 -163.44 1.41 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.399 179.094 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.412 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -108.92 126.09 52.71 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 177.47 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.9 mt -114.9 129.52 70.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.243 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.621 ' HB2' HD11 ' A' ' 82' ' ' LEU . 26.1 tp -100.14 129.2 46.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.135 179.634 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -113.24 135.56 53.7 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.877 -179.713 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -94.35 104.7 16.67 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.403 179.708 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -96.75 -10.78 26.06 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.194 179.397 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.4 t -68.18 101.47 1.18 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.046 179.653 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.5 p -84.35 -7.22 59.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.066 0.46 . . . . 0.0 110.024 179.895 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.822 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.2 OUTLIER -103.44 -43.85 5.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.836 -179.131 . . . . . . . . 3 3 . 1 . 084 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.424 ' OD1' HG13 ' B' ' 236' ' ' VAL . 64.2 m-20 -140.23 99.39 7.25 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.646 -179.769 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.591 ' HB2' HG13 ' A' ' 75' ' ' VAL . 52.9 Cg_exo -55.19 145.95 62.7 Favored 'Trans proline' 0 N--CA 1.5 1.904 0 C-N-CA 122.359 2.039 . . . . 0.0 113.236 -179.348 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.2 m -73.11 137.96 45.52 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.869 178.796 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -99.24 140.77 32.91 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.517 179.82 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 55.9 t -128.82 135.34 62.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.685 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 52.04 31.44 8.76 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.124 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.8 28.18 69.42 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.489 179.921 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.1 p -140.69 139.22 34.71 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 120.774 -0.371 . . . . 0.0 111.48 -179.735 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.591 HG13 ' HB2' ' A' ' 68' ' ' PRO . 38.8 t -70.37 138.32 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.16 -179.6 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.7 pt -112.73 96.68 4.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.1 178.321 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -66.65 -26.14 66.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.189 -179.76 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.437 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.3 OUTLIER -130.93 178.55 1.68 Allowed Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.312 -179.086 . . . . . . . . 3 3 . 1 . 084 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.437 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 36.1 Cg_exo -59.99 146.27 96.38 Favored 'Trans proline' 0 N--CA 1.505 2.155 0 C-N-CA 123.09 2.527 . . . . 0.0 112.802 -179.775 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.6 p -144.37 141.65 24.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.634 179.984 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -78.89 133.95 36.93 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.52 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.621 HD11 ' HB2' ' A' ' 60' ' ' LEU . 89.0 mt -91.18 140.44 29.8 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.991 0.424 . . . . 0.0 111.522 -179.074 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -128.2 157.5 40.68 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.981 179.165 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.452 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 5.8 t60 -53.99 115.71 2.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.523 -178.553 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.3 -10.65 26.52 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.142 179.16 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -67.67 135.34 52.65 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.018 -179.836 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.58 HG22 ' HG2' ' A' ' 96' ' ' ARG . 48.9 t -109.44 126.57 66.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.43 -179.665 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 84.8 mt -100.42 131.25 48.31 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 178.514 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 75.3 m -122.84 129.1 51.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.715 0.769 . . . . 0.0 112.584 -178.189 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.462 ' O ' ' C ' ' A' ' 91' ' ' ILE . 95.0 mt -116.53 128.07 73.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 114.493 -1.23 . . . . 0.0 108.621 178.537 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.462 ' C ' ' O ' ' A' ' 90' ' ' ILE . 42.4 mm 34.02 -99.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.166 -179.428 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.504 ' O ' ' OD1' ' A' ' 92' ' ' ASP . 61.7 t0 -115.55 16.49 16.55 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 120.94 0.4 . . . . 0.0 110.847 -179.576 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.58 HH21 ' CD ' ' B' ' 260' ' ' GLU . 73.1 mtt-85 -127.93 144.5 51.1 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.67 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.612 ' OG ' HD12 ' A' ' 10' ' ' ILE . 12.6 p -140.92 156.81 46.01 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.391 0.615 . . . . 0.0 111.637 -179.551 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.545 ' HB3' HD11 ' A' ' 7' ' ' LEU . 61.1 m-85 -132.54 133.58 43.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.412 179.617 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.58 ' HG2' HG22 ' A' ' 87' ' ' VAL . 70.4 mtp85 -98.48 137.78 36.66 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 119.881 -0.727 . . . . 0.0 110.361 179.906 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 93.9 t80 -93.24 122.99 36.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.689 -179.881 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.408 ' HG3' ' CE1' ' A' ' 84' ' ' HIS . 84.4 tt0 -123.93 119.48 29.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.166 179.397 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.452 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 47.5 t-20 -104.22 113.81 27.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.64 180.0 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.182 179.813 . . . . . . . . 0 0 . 1 . 084 nuclear build full ' B' B ' 228' ' ' VAL . . . . . 0.563 HG12 ' H ' ' B' ' 231' ' ' GLN . 86.2 t . . . . . 0 N--CA 1.456 -0.173 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 . . . . . . . . . 1 1 . 1 . 084 nuclear build full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 57.56 32.12 21.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.218 178.971 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 084 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.563 ' H ' HG12 ' B' ' 228' ' ' VAL . 28.6 mm100 -136.87 30.83 2.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.577 179.759 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -142.76 177.99 21.44 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.671 -0.571 . . . . 0.0 111.671 -179.366 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.76 163.19 37.82 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 123.933 3.088 . . . . 0.0 112.47 -179.921 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.822 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 084 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -78.13 141.59 18.68 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 C-N-CA 121.87 1.713 . . . . 0.0 112.288 -179.758 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.433 ' CG2' HG22 ' A' ' 66' ' ' THR . 54.7 t -60.58 140.53 18.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.383 -179.541 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 6.5 t -67.29 131.64 46.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.235 -179.747 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 084 nuclear build full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -50.77 -22.55 9.96 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 122.171 1.914 . . . . 0.0 112.962 179.826 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 40.9 p -75.95 -40.27 54.35 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.289 -0.564 . . . . 0.0 109.909 178.441 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.561 ' CZ ' ' NE ' ' B' ' 245' ' ' ARG . 81.6 t80 -57.3 -48.04 79.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.415 -179.626 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.424 ' HA ' HD23 ' B' ' 242' ' ' LEU . 89.4 mt -65.91 -42.09 90.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.018 179.964 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -67.94 -39.87 83.39 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.798 -179.463 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -60.88 -46.63 89.88 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.444 -179.154 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.859 ' O ' HG23 ' B' ' 249' ' ' VAL . 94.0 mtt-85 -67.78 -38.53 83.51 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.615 179.806 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -60.78 -40.28 91.99 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.101 -179.45 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 9.7 t -65.53 -45.62 82.73 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.656 0.741 . . . . 0.0 109.56 177.911 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -64.91 -31.44 72.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.539 -179.914 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.859 HG23 ' O ' ' B' ' 245' ' ' ARG . 93.8 t -68.54 -46.81 79.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.966 0.412 . . . . 0.0 110.538 179.363 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -59.89 -25.11 64.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.587 179.765 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -96.98 5.34 50.63 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.408 178.844 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.701 HD11 ' OD2' ' B' ' 256' ' ' ASP . 37.3 tp -106.77 130.29 54.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.055 0.455 . . . . 0.0 111.113 -178.966 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -60.56 146.42 45.18 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.814 -179.22 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -70.62 -16.93 62.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.154 179.921 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -78.54 -1.48 34.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.454 -179.352 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.701 ' OD2' HD11 ' B' ' 252' ' ' LEU . 84.7 m-20 -85.41 89.4 7.67 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.716 -179.903 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -72.38 179.73 3.31 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.796 -0.361 . . . . 0.0 110.454 -179.896 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 58.24 67.93 0.89 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -179.097 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.531 ' CG ' HH12 ' A' ' 93' ' ' ARG . 34.2 t0 -80.61 62.84 4.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.095 -179.667 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.58 ' CD ' HH21 ' A' ' 93' ' ' ARG . 94.8 mt-10 65.1 13.41 8.68 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.898 179.149 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 68.2 mt -113.77 131.05 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.34 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 40.4 t -128.46 135.86 61.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.829 0.347 . . . . 0.0 111.308 -179.076 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -97.24 119.01 34.97 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.221 0.534 . . . . 0.0 111.651 -179.31 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -62.98 -46.45 87.62 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.986 178.984 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' B' B ' 265' ' ' GLN . . . . . 0.478 ' OE1' HD11 ' A' ' 24' ' ' LEU . 3.6 mm-40 -90.15 156.39 46.38 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.191 -179.554 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -60.17 142.59 98.63 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 C-N-CA 122.226 1.951 . . . . 0.0 112.183 -179.845 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' B' B ' 267' ' ' ILE . . . . . 0.541 ' CD1' ' O ' ' A' ' 19' ' ' HIS . 3.9 tt . . . . . 0 C--N 1.325 -0.494 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.946 -179.72 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo . . . . . 0 N--CA 1.495 1.591 0 CA-C-O 120.554 0.147 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 085 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.454 HG22 ' OD1' ' A' ' 99' ' ' ASN . 22.1 m -73.75 -46.62 44.69 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -179.493 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.457 ' CD ' ' OH ' ' A' ' 97' ' ' TYR . 82.0 mtt85 -102.04 134.34 45.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.832 0.349 . . . . 0.0 111.218 -178.782 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.471 HH21 ' CD ' ' A' ' 98' ' ' GLU . 36.8 ptt180 -142.48 157.42 44.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.866 179.722 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 74.0 mt -120.83 147.19 45.71 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.033 -179.811 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.7 t -116.21 126.77 73.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.377 178.658 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.3 m -78.66 138.48 38.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.487 0.661 . . . . 0.0 111.801 -178.692 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.6 mm -103.37 132.61 49.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.63 178.208 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -86.75 155.86 20.17 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.12 179.5 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.951 HH21 HD22 ' B' ' 252' ' ' LEU . 87.4 mtm180 -58.39 -30.28 66.69 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.052 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.6 t -74.62 -15.06 60.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.805 179.246 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.0 30.75 7.7 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 -179.431 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.1 t -119.09 133.99 64.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.94 0.4 . . . . 0.0 111.121 -179.964 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -74.75 136.98 41.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.838 178.981 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.51 -120.31 2.24 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 120.558 -0.829 . . . . 0.0 111.782 -179.905 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -73.54 152.84 49.09 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.173 1.915 . . . . 0.0 112.428 -179.111 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -114.1 156.07 24.84 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.015 179.471 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.558 ' CD2' HD11 ' A' ' 37' ' ' ILE . 37.3 t80 -119.97 104.04 44.63 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.451 -179.946 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.3 130.43 16.29 Favored 'Trans proline' 0 N--CA 1.488 1.19 0 C-N-CA 121.356 1.371 . . . . 0.0 112.59 -178.913 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.1 mt -83.88 45.7 1.11 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.749 -179.431 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.8 m -59.29 -28.73 67.02 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.666 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.691 HD11 ' HG2' ' B' ' 265' ' ' GLN . 78.3 mt -77.84 143.12 38.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.622 179.976 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 95.7 p -64.44 -21.08 66.54 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.219 -179.567 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 90.9 m -135.48 136.04 40.96 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.053 0.454 . . . . 0.0 112.153 -179.593 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.643 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 3.4 t -131.72 124.05 28.98 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.515 178.361 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.529 HD21 ' HG2' ' A' ' 47' ' ' GLN . 31.4 tp -116.36 130.49 56.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.934 -178.982 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.759 ' CE2' HD12 ' A' ' 37' ' ' ILE . 14.4 m-85 -107.34 141.07 39.28 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.436 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 160.21 -164.34 34.33 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 119.566 -1.302 . . . . 0.0 112.979 179.198 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.8 ttp85 -98.85 -32.11 11.51 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 114.977 -0.612 . . . . 0.0 111.88 -179.268 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -57.56 156.25 17.11 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.509 -1.037 . . . . 0.0 110.509 -179.795 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.584 ' O ' ' NE ' ' A' ' 38' ' ' ARG . 8.7 tp -63.97 -42.37 95.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 117.327 0.563 . . . . 0.0 112.235 -178.616 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.481 ' OE1' ' N ' ' A' ' 34' ' ' GLU . 57.9 mp0 -56.89 -17.41 9.38 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.267 -178.699 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.585 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 89.5 m -59.86 122.74 14.99 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.244 -0.583 . . . . 0.0 110.087 179.522 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.448 ' O ' ' CB ' ' B' ' 264' ' ' LYS . 71.5 m-20 -59.9 -31.18 69.57 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.273 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.759 HD12 ' CE2' ' A' ' 29' ' ' PHE . 94.6 mt -122.03 115.52 46.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 176.384 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.584 ' NE ' ' O ' ' A' ' 33' ' ' ILE . 74.5 mtt85 -104.43 138.22 41.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.006 -177.267 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.597 HG23 ' O ' ' B' ' 260' ' ' GLU . 80.1 mt -119.5 130.49 73.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.839 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -73.7 38.79 0.1 Allowed 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -177.867 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.723 HD13 HH21 ' A' ' 93' ' ' ARG . 39.7 mt -125.04 129.64 24.47 Favored Pre-proline 0 C--N 1.325 -0.487 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.938 179.771 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.06 -11.83 27.58 Favored 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 122.404 2.069 . . . . 0.0 113.392 -178.973 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.652 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 27.5 m -83.94 -4.32 8.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.411 179.549 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 40.8 t -87.38 133.13 30.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.209 179.578 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.5 t -65.25 161.16 19.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.779 -179.198 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.585 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 93.7 mttt -62.02 -44.35 96.9 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.485 -178.951 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.643 ' O ' ' N ' ' A' ' 49' ' ' CYS . 89.5 mt-30 -116.9 -18.23 10.22 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.921 0.391 . . . . 0.0 111.014 179.682 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 16.7 t60 33.66 -72.21 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 179.415 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.643 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.11 137.18 46.22 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -177.726 . . . . . . . . 3 3 . 1 . 085 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -125.32 126.78 45.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.686 179.176 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 88.0 mt -110.36 131.73 60.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.995 -179.933 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -115.38 131.29 56.98 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.925 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.1 mm -100.39 122.24 52.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.841 -179.312 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.454 ' O ' ' C ' ' A' ' 55' ' ' GLU . 97.1 m-70 -122.42 132.15 54.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.199 179.25 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 54' ' ' HIS . 76.6 mt-10 -40.68 -36.71 0.64 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -178.457 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.487 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 88.7 mt-30 -62.85 -66.7 0.5 Allowed 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.401 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.487 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 3.8 tp10 -153.74 -168.3 2.93 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.678 -179.658 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.448 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -118.4 132.87 56.24 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.099 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.1 mt -118.59 129.89 74.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.392 0.615 . . . . 0.0 111.956 -178.666 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.453 ' HB2' HD21 ' A' ' 82' ' ' LEU . 40.1 tp -95.13 129.07 42.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.046 179.997 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -113.76 136.12 53.21 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 179.956 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -97.41 107.64 20.19 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.988 0.423 . . . . 0.0 111.787 -179.582 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -98.65 -10.77 22.8 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.622 179.162 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.3 t -69.78 101.03 1.61 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.443 179.914 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 90.3 p -84.34 -14.27 50.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.972 0.415 . . . . 0.0 110.039 179.614 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.578 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -98.45 -40.8 8.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.161 -179.004 . . . . . . . . 3 3 . 1 . 085 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -137.09 93.79 13.0 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.053 -179.687 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -56.75 144.03 88.33 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.256 1.97 . . . . 0.0 112.226 -179.822 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 95.1 m -71.29 137.13 48.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.056 179.707 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -98.32 141.29 31.4 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.614 178.982 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 55.5 t -130.15 136.55 58.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.251 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 53.37 32.33 13.6 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.252 -179.691 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.11 27.5 72.86 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.48 -179.99 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.1 m -138.37 137.51 37.38 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.383 -179.634 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.403 ' O ' HG13 ' A' ' 75' ' ' VAL . 5.9 p -71.05 135.51 27.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.017 0.437 . . . . 0.0 111.897 -179.67 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.877 HD11 ' O ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -136.18 121.95 29.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.727 178.545 . . . . . . . . 3 3 . 1 . 085 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.7 p-10 -103.22 -5.02 23.56 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 120.801 -0.359 . . . . 0.0 111.475 -179.273 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.877 ' O ' HD11 ' A' ' 76' ' ' ILE . 21.4 mt-10 -116.13 151.49 46.71 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.747 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -60.35 146.23 97.03 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.016 1.811 . . . . 0.0 112.422 -179.12 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.6 m -141.32 147.26 22.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.325 -179.644 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -73.87 131.12 41.16 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 178.858 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.453 HD21 ' HB2' ' A' ' 60' ' ' LEU . 95.7 mt -78.46 134.76 37.3 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.257 179.965 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -124.9 148.83 48.12 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 178.848 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.415 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 6.1 t60 -55.1 121.42 8.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.393 -178.944 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.32 -19.13 34.86 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 179.975 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -67.61 134.79 51.82 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.385 179.919 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.544 HG22 ' HG2' ' A' ' 96' ' ' ARG . 47.5 t -110.04 132.48 58.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.811 -179.257 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 86.6 mt -101.33 132.16 47.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 178.697 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 55.7 m -124.89 124.1 41.34 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 119.953 -0.699 . . . . 0.0 112.054 -178.543 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.461 ' O ' ' C ' ' A' ' 91' ' ' ILE . 86.6 mt -109.74 127.84 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.058 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.734 HG22 ' N ' ' A' ' 92' ' ' ASP . 95.3 mt 37.32 -100.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.583 -179.149 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.734 ' N ' HG22 ' A' ' 91' ' ' ILE . 1.6 t70 -118.36 15.93 13.9 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.816 0.341 . . . . 0.0 110.963 -179.827 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.723 HH21 HD13 ' A' ' 41' ' ' LEU . 3.4 mtm105 -124.04 138.69 54.41 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.916 -179.588 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 47.0 t -137.7 151.85 48.65 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.917 -179.405 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.475 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 82.4 m-85 -127.21 123.33 36.35 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.582 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.544 ' HG2' HG22 ' A' ' 87' ' ' VAL . 99.6 mtt180 -82.85 135.98 34.77 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.048 -178.304 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.457 ' OH ' ' CD ' ' A' ' 5' ' ' ARG . 88.4 t80 -93.97 122.83 36.87 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.337 -179.854 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.471 ' CD ' HH21 ' A' ' 6' ' ' ARG . 76.1 tt0 -126.93 122.25 34.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.779 179.911 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.454 ' OD1' HG22 ' A' ' 4' ' ' THR . 62.0 t-20 -109.26 113.27 25.96 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.588 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.406 ' O ' HG23 ' A' ' 4' ' ' THR . 96.9 mt-10 . . . . . 0 C--N 1.33 -0.28 0 CA-C-O 120.974 0.416 . . . . 0.0 110.938 -179.189 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' B' B ' 228' ' ' VAL . . . . . 0.523 ' O ' ' O ' ' B' ' 229' ' ' ASP . 15.4 m . . . . . 0 CA--C 1.522 -0.107 0 CA-C-O 120.532 0.206 . . . . 0.0 111.029 . . . . . . . . . 1 1 . 1 . 085 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.587 ' C ' ' H ' ' B' ' 231' ' ' GLN . 97.4 m-20 57.11 129.89 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.247 -179.403 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 085 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.587 ' H ' ' C ' ' B' ' 229' ' ' ASP . 82.7 mt-30 -122.62 -17.37 6.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.513 0.673 . . . . 0.0 109.32 179.599 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' B' B ' 232' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' B' ' 231' ' ' GLN . . . -47.03 -173.39 0.01 OUTLIER Glycine 0 CA--C 1.525 0.702 0 CA-C-N 114.975 -1.011 . . . . 0.0 112.675 -178.974 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.31 161.61 43.92 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 123.489 2.793 . . . . 0.0 113.584 -179.25 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 085 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -60.54 131.83 40.11 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.077 1.851 . . . . 0.0 112.872 -179.753 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.578 ' CG2' HG22 ' A' ' 66' ' ' THR . 40.4 t -66.78 135.35 28.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.225 -0.898 . . . . 0.0 108.72 178.662 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 35.9 t -54.62 120.54 6.85 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.085 -179.027 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 085 nuclear build full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -57.46 -25.25 65.45 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.361 2.041 . . . . 0.0 112.199 179.018 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 24.7 m -73.34 -44.81 58.15 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.238 0.542 . . . . 0.0 109.552 178.286 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.652 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 83.4 t80 -56.67 -45.71 81.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.79 -179.963 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' B' ' 242' ' ' LEU . 88.8 mt -64.08 -41.65 97.24 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.559 179.871 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -60.69 -40.78 93.46 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.429 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -64.29 -42.32 96.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.423 179.094 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.604 HH11 ' CD ' ' A' ' 12' ' ' ARG . 58.1 ttm-85 -58.06 -42.9 86.48 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.168 -179.895 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -60.71 -39.94 90.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.167 -179.977 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 59.2 m -65.14 -44.49 88.46 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.025 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' B' B ' 248' ' ' GLN . . . . . 0.417 ' O ' ' N ' ' B' ' 252' ' ' LEU . 81.9 mt-30 -60.41 -37.45 80.9 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.802 -179.895 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 38.7 t -61.04 -46.44 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 C-N-CA 119.864 -0.734 . . . . 0.0 109.805 178.908 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -58.2 -30.29 66.35 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.528 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -90.56 -10.89 41.78 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.964 178.847 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.951 HD22 HH21 ' A' ' 12' ' ' ARG . 38.5 tp -79.14 138.99 38.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.779 -179.903 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -109.48 143.54 38.95 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.136 179.043 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -62.48 -21.77 65.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.104 0.478 . . . . 0.0 109.919 -179.378 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -67.99 -7.65 30.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.68 -179.455 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.412 ' C ' ' H ' ' B' ' 258' ' ' ASP . 68.3 t0 -98.51 81.59 2.74 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.281 179.086 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -73.23 19.12 0.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.889 -178.554 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.668 ' O ' ' N ' ' B' ' 260' ' ' GLU . 43.1 t0 -99.07 0.82 44.47 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 177.869 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.504 ' C ' ' H ' ' B' ' 261' ' ' ILE . 32.9 t70 6.09 51.58 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 114.272 -1.331 . . . . 0.0 113.4 179.487 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.668 ' N ' ' O ' ' B' ' 258' ' ' ASP . 51.7 mp0 54.12 1.25 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 179.398 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.504 ' H ' ' C ' ' B' ' 259' ' ' ASP . 75.4 mt -114.21 136.46 50.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.086 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' B' B ' 262' ' ' VAL . . . . . 0.405 ' N ' ' O ' ' A' ' 38' ' ' ARG . 50.2 t -128.18 137.92 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.86 0.362 . . . . 0.0 110.939 -179.565 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -100.86 122.64 43.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.117 0.484 . . . . 0.0 111.386 -179.117 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' B' B ' 264' ' ' LYS . . . . . 0.46 ' HG3' HH22 ' A' ' 38' ' ' ARG . 89.2 tttt -64.35 -45.88 85.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.309 179.238 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' B' B ' 265' ' ' GLN . . . . . 0.691 ' HG2' HD11 ' A' ' 24' ' ' LEU . 5.0 mp0 -99.82 163.63 18.07 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.976 -179.008 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.59 156.47 65.46 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.836 2.357 . . . . 0.0 111.459 178.916 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 37.6 pt . . . . . 0 C--N 1.325 -0.461 0 CA-C-O 121.267 0.556 . . . . 0.0 112.085 -178.832 . . . . . . . . 0 0 . 1 . 086 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo . . . . . 0 N--CA 1.491 1.327 0 CA-C-O 120.968 0.32 . . . . 0.0 112.034 . . . . . . . . . 0 0 . 1 . 086 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 t -123.56 29.07 6.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.854 -179.253 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.401 ' HD2' HD13 ' A' ' 53' ' ' ILE . 83.9 mtt85 -85.63 122.11 29.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.341 -179.589 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -126.73 137.46 53.25 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.537 179.847 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.537 HD11 ' HB3' ' A' ' 95' ' ' PHE . 30.6 tp -114.67 127.54 55.82 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.617 179.98 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.553 HG11 ' OD2' ' A' ' 16' ' ' ASP . 64.2 t -104.53 134.19 46.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.105 179.684 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.417 HG23 ' CD1' ' B' ' 261' ' ' ILE . 2.8 m -94.42 118.93 32.38 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.247 0.546 . . . . 0.0 112.141 -178.516 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.612 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 95.3 mt -83.02 141.8 14.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.999 179.541 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.461 ' HA ' HH22 ' A' ' 93' ' ' ARG . 98.0 mttt -88.44 159.26 18.07 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 178.856 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.602 HH12 ' CD ' ' B' ' 248' ' ' GLN . 84.5 mtp180 -57.22 -29.63 63.92 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 121.059 -0.257 . . . . 0.0 111.139 -178.764 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.4 m -81.18 -6.21 58.59 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.605 179.393 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.97 36.85 7.5 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 -179.557 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.3 t -119.1 132.64 68.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.836 0.351 . . . . 0.0 110.633 -179.535 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.553 ' OD2' HG11 ' A' ' 8' ' ' VAL . 68.4 t0 -76.21 130.81 38.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.65 -179.549 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.17 -116.08 1.87 Allowed Glycine 0 CA--C 1.539 1.579 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.737 -179.438 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.5 145.91 38.53 Favored 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 122.797 2.331 . . . . 0.0 113.867 -178.301 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -109.23 150.12 28.41 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.12 0.486 . . . . 0.0 110.807 179.544 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.518 ' CD2' HD11 ' A' ' 37' ' ' ILE . 30.8 t80 -120.42 106.06 40.79 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.02 179.577 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -73.21 125.91 10.66 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 C-N-CA 121.459 1.439 . . . . 0.0 112.137 -178.583 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.419 HD22 ' SG ' ' A' ' 27' ' ' CYS . 57.0 mt -88.27 43.5 1.13 Allowed 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.108 -178.796 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 80.0 p -66.24 -19.55 65.86 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.564 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 90.0 mt -73.46 142.71 46.83 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.678 179.575 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 71.5 p -59.41 -24.95 63.9 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.474 -179.135 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 39.1 m -136.93 134.05 36.35 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.918 -179.6 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.419 ' SG ' HD22 ' A' ' 22' ' ' LEU . 5.5 t -126.03 122.24 35.31 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.335 178.169 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.609 HD21 ' OE1' ' A' ' 47' ' ' GLN . 41.7 tp -118.09 129.79 55.76 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.478 -178.441 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.649 ' CE2' HD12 ' A' ' 37' ' ' ILE . 4.7 m-85 -108.29 139.57 42.8 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 123.425 0.453 . . . . 0.0 110.06 179.395 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 178.22 -170.34 42.44 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 178.861 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.527 ' NH2' ' O ' ' B' ' 233' ' ' PRO . 27.9 ptt-85 -100.11 -3.23 32.27 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.543 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -81.87 166.29 46.66 Favored Glycine 0 CA--C 1.52 0.371 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -179.326 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 19.3 tt -96.16 5.73 8.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.216 0.532 . . . . 0.0 110.308 179.969 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -95.64 -7.96 36.13 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.989 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.2 m -91.44 151.1 20.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.137 -179.94 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.419 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 55.1 m-20 -60.77 -32.36 71.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.186 -179.641 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.649 HD12 ' CE2' ' A' ' 29' ' ' PHE . 98.4 mt -128.12 127.29 67.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.463 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -113.42 136.85 52.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.894 -178.775 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 85.6 mt -118.34 130.64 72.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.685 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -73.02 35.43 0.08 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.29 -178.035 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.481 HD21 ' NH1' ' B' ' 245' ' ' ARG . 59.7 mt -109.97 129.07 24.34 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.017 -179.83 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.413 ' O ' ' HD2' ' B' ' 235' ' ' PRO . 60.9 Cg_endo -72.5 -6.86 19.85 Favored 'Trans proline' 0 N--CA 1.49 1.292 0 C-N-CA 122.314 2.009 . . . . 0.0 112.623 -179.798 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.447 HG21 ' CE2' ' B' ' 241' ' ' PHE . 6.1 m -102.41 7.21 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.035 179.368 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 37.1 t -93.3 134.11 32.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.817 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.9 m -68.14 160.37 29.16 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.639 0.733 . . . . 0.0 112.481 -178.782 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -63.56 -41.3 98.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.088 -179.445 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.641 ' O ' ' N ' ' A' ' 49' ' ' CYS . 98.3 mm-40 -113.84 -19.22 11.58 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.005 -179.971 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 21.7 t60 26.83 -74.65 0.0 OUTLIER 'General case' 0 C--O 1.235 0.335 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 179.969 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.641 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.19 134.48 46.53 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.6 0.714 . . . . 0.0 112.727 -178.206 . . . . . . . . 3 3 . 1 . 086 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -127.36 129.63 47.95 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.313 179.865 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 98.1 mt -113.92 132.25 63.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.438 179.859 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -111.19 126.38 54.8 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 178.088 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.401 HD13 ' HD2' ' A' ' 5' ' ' ARG . 82.2 mt -104.22 115.18 45.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.819 0.819 . . . . 0.0 111.952 -179.002 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.428 ' O ' ' C ' ' A' ' 55' ' ' GLU . 98.3 m-70 -117.55 142.57 47.03 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.265 -1.334 . . . . 0.0 110.165 179.844 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 54' ' ' HIS . 87.3 tt0 -40.5 -33.16 0.24 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.673 179.539 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.502 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 64.6 tp60 -61.72 -68.03 0.36 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.55 179.417 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.502 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 6.5 tp10 -156.41 -168.71 2.8 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.463 -178.641 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.442 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -110.46 126.81 54.73 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.412 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.8 mt -115.09 131.15 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -177.689 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.556 ' HB2' HD11 ' A' ' 82' ' ' LEU . 21.6 tp -101.59 127.78 48.15 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.769 179.862 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -110.92 135.58 51.24 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.737 179.876 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.466 ' ND2' ' O ' ' A' ' 76' ' ' ILE . 48.6 t-20 -94.92 104.5 16.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.296 -179.196 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -99.53 -9.65 23.04 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.307 179.729 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.05 102.75 1.69 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.478 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 81.6 p -88.91 -15.94 33.12 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.225 179.911 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.73 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.2 OUTLIER -90.97 -42.78 10.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.261 -179.805 . . . . . . . . 3 3 . 1 . 086 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.445 HD21 ' HA ' ' B' ' 236' ' ' VAL . 46.4 m-20 -141.2 103.45 6.1 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.483 -179.729 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -56.25 144.85 80.13 Favored 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 121.9 1.733 . . . . 0.0 113.188 -179.097 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.5 m -73.3 140.05 46.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.593 178.459 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -101.26 139.61 36.7 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.15 0.5 . . . . 0.0 111.532 -179.874 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.68 HG13 ' OD1' ' A' ' 86' ' ' ASP . 45.1 t -136.4 133.79 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.956 178.63 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 54.49 32.31 16.52 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.075 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.67 29.16 63.9 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-N 115.14 -0.936 . . . . 0.0 112.212 179.388 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 64.1 m -149.87 147.47 27.99 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 117.401 0.601 . . . . 0.0 111.674 -179.742 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.8 m -75.82 149.48 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.103 0.477 . . . . 0.0 111.733 -179.695 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.466 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 4.0 pt -120.97 97.94 5.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.663 179.312 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -69.25 -23.34 63.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.719 179.724 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -129.85 177.25 2.28 Favored Pre-proline 0 N--CA 1.469 0.506 0 C-N-CA 121.191 -0.203 . . . . 0.0 111.324 -179.84 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -61.02 146.7 97.41 Favored 'Trans proline' 0 N--CA 1.503 2.071 0 C-N-CA 123.042 2.495 . . . . 0.0 112.744 179.649 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.4 p -143.67 138.99 25.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.696 179.884 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 88.9 mtm180 -74.84 133.05 41.94 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.176 179.475 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.556 HD11 ' HB2' ' A' ' 60' ' ' LEU . 93.3 mt -89.23 129.09 35.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.963 0.411 . . . . 0.0 110.696 179.77 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -117.22 156.15 28.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.243 179.594 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -56.01 118.41 4.62 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.178 179.978 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.35 -17.42 18.99 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -179.775 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.68 ' OD1' HG13 ' A' ' 71' ' ' VAL . 54.3 t0 -65.63 127.57 32.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.256 0.55 . . . . 0.0 110.851 179.725 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.45 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 56.0 t -109.14 132.99 55.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.43 -179.226 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 77.2 mt -101.05 130.54 50.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.843 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 51.5 m -122.54 122.88 39.95 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.608 0.718 . . . . 0.0 112.221 -178.629 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.557 ' O ' ' N ' ' A' ' 93' ' ' ARG . 96.7 mt -113.9 124.66 70.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 114.642 -1.163 . . . . 0.0 108.592 178.24 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.5 HD12 ' CB ' ' B' ' 237' ' ' CYS . 46.3 mm 39.17 -96.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.323 -179.27 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.575 ' CB ' ' HE ' ' B' ' 245' ' ' ARG . 54.7 t0 -119.95 5.07 10.9 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.978 0.418 . . . . 0.0 110.742 -179.826 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.641 HH21 ' CD1' ' B' ' 261' ' ' ILE . 17.9 mmm180 -106.89 134.97 49.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.699 179.925 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 47.1 t -132.12 144.07 50.45 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.838 -179.872 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.537 ' HB3' HD11 ' A' ' 7' ' ' LEU . 79.7 m-85 -123.19 120.26 32.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.1 179.766 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.497 ' O ' HD12 ' A' ' 7' ' ' LEU . 44.2 ttm180 -84.47 127.35 33.98 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.142 -179.8 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.535 ' CZ ' ' OD1' ' A' ' 99' ' ' ASN . 88.9 t80 -95.73 129.05 43.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.462 179.854 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -142.66 128.63 19.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.973 0.416 . . . . 0.0 111.938 -179.445 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.535 ' OD1' ' CZ ' ' A' ' 97' ' ' TYR . 89.1 m-20 -109.75 105.33 14.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.987 179.228 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 . . . . . 0 C--O 1.233 0.203 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.225 -179.635 . . . . . . . . 0 0 . 1 . 086 nuclear build full ' B' B ' 228' ' ' VAL . . . . . 0.502 ' O ' HG12 ' B' ' 228' ' ' VAL . 45.8 t . . . . . 0 N--CA 1.453 -0.303 0 CA-C-O 120.731 0.3 . . . . 0.0 110.98 . . . . . . . . . 1 1 . 1 . 086 nuclear build full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -68.24 145.54 54.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.034 0.445 . . . . 0.0 111.277 -179.989 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 086 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -119.4 38.74 3.78 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.921 -179.152 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' B' B ' 232' ' ' GLY . . . . . 0.461 ' O ' ' NH2' ' A' ' 31' ' ' ARG . . . -117.14 -177.74 17.72 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.804 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' B' B ' 233' ' ' PRO . . . . . 0.527 ' O ' ' NH2' ' A' ' 31' ' ' ARG . 72.5 Cg_endo -72.5 161.69 43.46 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 123.674 2.916 . . . . 0.0 113.378 -179.502 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.73 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 086 nuclear build full ' B' B ' 235' ' ' PRO . . . . . 0.413 ' HD2' ' O ' ' A' ' 42' ' ' PRO . 81.5 Cg_endo -77.18 136.95 16.65 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.403 2.068 . . . . 0.0 113.095 -179.299 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.618 ' CG2' HG22 ' A' ' 66' ' ' THR . 55.6 t -67.75 136.02 27.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 114.612 -1.176 . . . . 0.0 111.803 -179.357 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' B' B ' 237' ' ' CYS . . . . . 0.5 ' CB ' HD12 ' A' ' 91' ' ' ILE . 1.9 t -81.44 128.36 33.79 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.644 178.774 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' B' B ' 238' ' ' TPO . . . . . 0.431 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 086 nuclear build full ' B' B ' 239' ' ' PRO . . . . . 0.431 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 51.7 Cg_exo -57.97 -28.56 83.52 Favored 'Trans proline' 0 N--CA 1.504 2.091 0 C-N-CA 123.456 2.77 . . . . 0.0 113.609 -179.674 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 37.2 m -72.28 -45.52 59.74 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.201 0.524 . . . . 0.0 110.341 179.135 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.447 ' CE2' HG21 ' A' ' 43' ' ' VAL . 81.0 t80 -56.61 -45.41 81.49 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.659 -179.733 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 98.6 mt -64.31 -41.31 96.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.31 179.82 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -64.99 -37.42 87.61 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.642 179.903 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -60.36 -43.41 96.57 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.616 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.671 ' O ' HG23 ' B' ' 249' ' ' VAL . 75.1 mtp85 -62.34 -37.48 85.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.75 -179.966 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -62.04 -41.37 98.05 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.238 179.809 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 10.2 t -65.63 -44.07 87.58 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.757 0.789 . . . . 0.0 108.932 177.812 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' B' B ' 248' ' ' GLN . . . . . 0.602 ' CD ' HH12 ' A' ' 12' ' ' ARG . 64.5 tt0 -62.11 -32.2 72.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.454 179.455 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.671 HG23 ' O ' ' B' ' 245' ' ' ARG . 55.6 t -61.99 -45.89 97.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 179.109 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -60.95 -31.19 70.75 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.609 179.032 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -91.63 -11.06 38.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.447 178.82 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' B' ' 248' ' ' GLN . 51.8 tp -75.86 141.22 42.46 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.123 0.487 . . . . 0.0 111.546 -179.302 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -100.42 142.96 31.18 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.286 179.753 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -64.47 -19.19 65.41 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.29 179.446 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -63.46 -10.45 17.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.379 -178.688 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.501 ' OD2' HD21 ' B' ' 252' ' ' LEU . 49.2 p-10 -81.84 64.24 6.45 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.346 -0.542 . . . . 0.0 109.934 179.645 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -56.83 -9.72 0.87 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.042 -179.026 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.475 ' O ' ' C ' ' B' ' 259' ' ' ASP . 83.5 m-20 -106.91 -0.36 23.27 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 177.45 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.475 ' C ' ' O ' ' B' ' 258' ' ' ASP . 0.6 OUTLIER 28.57 -102.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.043 -179.227 . . . . . . . . 3 3 . 1 . 086 nuclear build full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -140.66 17.89 2.35 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.156 179.703 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.641 ' CD1' HH21 ' A' ' 93' ' ' ARG . 39.7 mt -118.09 138.34 49.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -179.734 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 52.9 t -126.56 135.28 64.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.431 -179.847 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -98.23 118.62 35.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.135 0.493 . . . . 0.0 111.242 -178.903 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.86 -47.35 78.22 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.446 179.273 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -92.48 150.6 40.21 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.253 -179.22 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -66.44 147.76 83.04 Favored 'Trans proline' 0 N--CA 1.499 1.828 0 C-N-CA 123.169 2.579 . . . . 0.0 113.34 -179.488 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 19.7 pt . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.128 178.722 . . . . . . . . 0 0 . 1 . 087 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo . . . . . 0 N--CA 1.489 1.238 0 CA-C-O 120.856 0.273 . . . . 0.0 112.299 . . . . . . . . . 0 0 . 1 . 087 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.463 ' H ' ' NH1' ' A' ' 5' ' ' ARG . 6.6 p -108.7 -36.72 6.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.931 179.72 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.463 ' NH1' ' H ' ' A' ' 4' ' ' THR . 0.0 OUTLIER -94.45 119.95 33.95 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.247 0.546 . . . . 0.0 110.719 -179.894 . . . . . . . . 3 3 . 1 . 087 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.514 ' C ' HD22 ' A' ' 7' ' ' LEU . 83.9 mtp180 -133.48 143.57 48.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.309 179.107 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.581 HD12 ' HB3' ' A' ' 95' ' ' PHE . 3.1 mm? -112.32 127.48 56.0 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.416 179.067 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.616 HG13 ' NE2' ' A' ' 19' ' ' HIS . 86.9 t -98.77 125.67 52.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.058 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 m -76.84 138.08 39.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.473 0.654 . . . . 0.0 112.2 -178.923 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.611 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 48.1 mm -105.19 132.45 51.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.625 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -87.73 156.8 19.27 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.09 -0.644 . . . . 0.0 110.994 179.918 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.635 ' CZ ' HH11 ' B' ' 245' ' ' ARG . 73.2 mtp180 -54.02 -33.56 57.54 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.612 -179.286 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.7 m -78.73 -5.41 53.13 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.42 179.008 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.42 35.02 9.78 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -179.343 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.3 t -119.15 134.6 62.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.66 0.267 . . . . 0.0 110.284 -179.84 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.404 ' OD1' HD13 ' A' ' 10' ' ' ILE . 86.7 m-20 -76.15 137.97 40.42 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.862 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.25 -118.15 2.05 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.514 -179.176 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.43 147.9 47.47 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.215 1.943 . . . . 0.0 113.002 -178.217 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.616 ' NE2' HG13 ' A' ' 8' ' ' VAL . 64.7 m170 -105.45 132.76 51.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.236 179.577 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.629 ' CD2' HD11 ' A' ' 37' ' ' ILE . 35.5 t80 -104.61 97.52 12.58 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.115 179.784 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -71.37 129.11 15.42 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 121.326 1.351 . . . . 0.0 111.675 -179.859 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.451 HD22 ' HB2' ' A' ' 27' ' ' CYS . 49.6 mt -96.92 54.12 1.25 Allowed 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.421 -179.131 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 92.0 p -61.78 -17.94 57.97 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.855 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.458 HD11 ' HG2' ' B' ' 265' ' ' GLN . 76.7 mt -77.15 142.21 39.8 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.293 178.88 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.7 t -63.61 -20.83 65.99 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -178.866 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 72.1 m -132.92 133.43 43.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.137 0.494 . . . . 0.0 111.739 -179.652 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.567 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 9.6 t -126.34 119.09 26.43 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.493 179.291 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.618 HD21 ' OE1' ' A' ' 47' ' ' GLN . 34.0 tp -115.55 126.57 54.41 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.566 -0.453 . . . . 0.0 111.854 -178.084 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.833 ' CE2' HD12 ' A' ' 37' ' ' ILE . 10.5 m-85 -104.12 139.86 38.6 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.994 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 171.82 -171.83 44.33 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 119.812 -1.185 . . . . 0.0 112.063 179.738 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 31.2 ttp85 -100.26 -8.73 23.16 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.114 -0.543 . . . . 0.0 111.778 -179.444 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.451 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -88.78 167.31 34.83 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 120.688 -0.767 . . . . 0.0 111.284 -179.996 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.519 HG23 ' N ' ' A' ' 34' ' ' GLU . 9.9 tp -64.71 -42.06 93.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 O-C-N 122.551 -0.382 . . . . 0.0 110.975 -179.732 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.519 ' N ' HG23 ' A' ' 33' ' ' ILE . 93.0 mt-10 -53.7 -22.23 8.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.766 0.317 . . . . 0.0 111.047 -179.334 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 4.0 m -65.96 124.83 23.59 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.438 -179.873 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 28' ' ' LEU . 53.1 m-20 -60.31 -30.65 69.63 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.349 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.833 HD12 ' CE2' ' A' ' 29' ' ' PHE . 79.7 mt -123.93 121.41 62.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 176.825 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.468 HH12 ' HA ' ' B' ' 264' ' ' LYS . 89.2 mtm-85 -103.84 133.93 48.0 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.006 -178.228 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.419 ' C ' ' H ' ' A' ' 41' ' ' LEU . 97.9 mt -116.9 128.95 74.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.289 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -73.23 26.46 0.06 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.014 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.472 HD21 ' OE1' ' B' ' 260' ' ' GLU . 51.5 mt -95.64 127.44 41.6 Favored Pre-proline 0 C--N 1.324 -0.543 0 C-N-CA 120.478 -0.489 . . . . 0.0 109.921 179.022 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.91 -7.96 22.08 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 122.186 1.924 . . . . 0.0 111.964 -179.628 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.8 m -97.92 10.97 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.299 179.982 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 33.5 t -99.0 133.52 41.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-O 120.675 0.274 . . . . 0.0 110.846 179.467 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.0 m -74.45 170.69 15.17 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.255 0.55 . . . . 0.0 111.927 -178.934 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -64.53 -41.45 96.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.202 -179.301 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.618 ' OE1' HD21 ' A' ' 28' ' ' LEU . 97.8 mm-40 -109.58 -27.41 9.41 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.164 0.507 . . . . 0.0 110.025 -179.578 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.794 ' NE2' HG23 ' A' ' 90' ' ' ILE . 18.8 t60 38.94 -77.52 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.666 -1.152 . . . . 0.0 112.661 179.623 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.617 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.45 133.68 46.5 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.259 0.552 . . . . 0.0 111.114 -179.066 . . . . . . . . 3 3 . 1 . 087 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -128.76 131.45 47.84 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.494 -179.819 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 94.7 mt -116.88 133.21 64.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.183 0.516 . . . . 0.0 110.744 179.633 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -115.81 125.92 53.33 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.704 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 95.5 mt -105.02 113.67 42.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.482 0.658 . . . . 0.0 111.77 -178.938 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.475 ' O ' ' N ' ' A' ' 56' ' ' GLN . 90.7 m-70 -112.11 142.94 43.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.316 -179.883 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 54' ' ' HIS . 78.4 tt0 -40.9 -27.48 0.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.298 0.57 . . . . 0.0 109.897 -179.317 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.475 ' N ' ' O ' ' A' ' 54' ' ' HIS . 70.0 tp60 -65.86 -67.88 0.41 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.727 179.715 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.469 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 5.8 tp10 -158.12 -168.17 2.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.042 -0.527 . . . . 0.0 109.676 -179.257 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.469 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -108.87 122.63 47.6 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.909 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.0 mt -114.56 131.43 66.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -177.763 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.413 ' HB2' HD11 ' A' ' 82' ' ' LEU . 24.5 tp -103.07 127.22 50.41 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.216 -179.417 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -111.05 136.78 49.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.141 179.335 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.488 HD21 ' HA ' ' A' ' 68' ' ' PRO . 58.9 t-20 -97.92 106.95 19.33 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.693 -178.954 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -101.43 -7.3 23.01 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.471 179.606 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.472 ' OG ' ' O ' ' A' ' 48' ' ' HIS . 0.7 OUTLIER -74.36 99.48 3.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.484 -178.794 . . . . . . . . 3 3 . 1 . 087 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 76.7 p -81.08 -32.41 33.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.059 0.457 . . . . 0.0 109.863 179.337 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.757 HG21 ' O ' ' B' ' 234' ' ' TPO . 1.8 m -62.92 -49.97 72.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.683 -179.935 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.467 ' OD1' HG22 ' B' ' 236' ' ' VAL . 13.6 m-20 -144.15 106.33 4.83 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.933 -179.854 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.488 ' HA ' HD21 ' A' ' 62' ' ' ASN . 45.4 Cg_exo -54.08 146.89 46.2 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 121.923 1.748 . . . . 0.0 112.949 -179.231 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.4 m -74.98 138.95 42.6 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.924 178.885 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -101.78 140.67 35.75 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.95 179.841 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.665 HG13 ' OD1' ' A' ' 86' ' ' ASP . 64.8 t -131.8 133.17 61.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.052 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 53.74 32.39 14.69 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.007 -178.611 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.12 29.09 67.18 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.417 -179.73 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 4.9 p -145.42 140.4 27.6 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.953 -179.682 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.401 HG13 ' HB2' ' A' ' 68' ' ' PRO . 15.1 t -65.82 139.85 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.456 179.741 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.3 pt -110.2 78.13 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.089 0 CA-C-O 121.021 0.439 . . . . 0.0 110.214 178.587 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -57.59 -31.69 66.43 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.004 179.993 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -118.81 168.85 8.91 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.55 179.762 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.3 141.99 98.51 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.019 1.813 . . . . 0.0 111.941 179.607 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 61.2 t -135.78 136.57 50.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.188 -179.913 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -72.64 131.55 42.57 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.614 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.413 HD11 ' HB2' ' A' ' 60' ' ' LEU . 93.3 mt -83.25 138.59 33.53 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.761 -179.836 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -130.71 154.46 47.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.024 -179.661 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.414 ' CD2' ' C ' ' A' ' 84' ' ' HIS . 7.7 t60 -54.35 116.42 2.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.372 179.88 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.72 -19.15 31.23 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -179.846 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.665 ' OD1' HG13 ' A' ' 71' ' ' VAL . 45.5 t0 -65.54 126.95 29.93 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.144 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 52.8 t -109.94 134.55 51.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.432 -0.507 . . . . 0.0 111.312 -178.386 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 79.5 mt -100.96 130.17 50.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.172 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.514 HG23 ' OG ' ' A' ' 94' ' ' SER . 68.3 m -122.44 123.05 40.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.514 0.673 . . . . 0.0 111.545 -178.762 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.794 HG23 ' NE2' ' A' ' 48' ' ' HIS . 79.6 mt -107.08 121.02 59.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 178.382 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.49 ' C ' ' O ' ' A' ' 90' ' ' ILE . 96.7 mt 33.99 -91.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.818 -179.707 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.576 ' N ' ' O ' ' A' ' 90' ' ' ILE . 46.6 p-10 -118.49 2.7 11.82 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.899 0.381 . . . . 0.0 111.118 179.654 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.782 ' NH2' ' H ' ' A' ' 94' ' ' SER . 0.5 OUTLIER -111.87 132.49 54.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.31 -179.98 . . . . . . . . 3 3 . 1 . 087 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.782 ' H ' ' NH2' ' A' ' 93' ' ' ARG . 16.7 m -135.7 152.28 51.02 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.612 0.72 . . . . 0.0 112.019 -179.455 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.581 ' HB3' HD12 ' A' ' 7' ' ' LEU . 84.4 m-85 -129.67 126.29 37.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.901 179.06 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.504 ' O ' HD13 ' A' ' 7' ' ' LEU . 37.9 ttp-105 -88.11 133.33 34.02 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.612 179.662 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -93.42 125.77 38.2 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.926 -179.73 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -124.47 131.02 53.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.612 179.93 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 59.8 t-20 -120.5 83.62 2.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.042 -179.741 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.186 179.352 . . . . . . . . 0 0 . 1 . 087 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 58.3 t . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.851 0.358 . . . . 0.0 110.699 . . . . . . . . . 0 0 . 1 . 087 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.648 ' O ' ' N ' ' B' ' 231' ' ' GLN . 96.5 m-20 -87.76 151.56 22.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.596 -179.301 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 087 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.648 ' N ' ' O ' ' B' ' 229' ' ' ASP . 11.9 mm100 -65.7 -47.52 75.11 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.806 -179.849 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' B' B ' 232' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' B' ' 231' ' ' GLN . . . -33.71 153.36 0.01 OUTLIER Glycine 0 CA--C 1.534 1.257 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.235 -179.271 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.76 160.99 46.49 Favored 'Trans proline' 0 N--CA 1.499 1.84 0 C-N-CA 123.58 2.853 . . . . 0.0 112.497 179.403 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.757 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 087 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -60.65 138.1 77.65 Favored 'Trans proline' 0 C--N 1.301 -1.94 0 C-N-CA 121.961 1.774 . . . . 0.0 112.167 179.817 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.467 HG22 ' OD1' ' A' ' 67' ' ' ASN . 0.4 OUTLIER -60.58 137.61 22.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.074 179.817 . . . . . . . . 3 3 . 1 . 087 nuclear build full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 3.7 t -68.57 121.24 15.99 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.223 -178.701 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 087 nuclear build full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.27 -23.53 62.98 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 122.332 2.022 . . . . 0.0 111.888 179.778 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 98.3 m -72.91 -44.65 60.98 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.314 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.46 ' HZ ' HD22 ' A' ' 41' ' ' LEU . 81.1 t80 -57.99 -45.06 87.42 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.865 -179.415 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.401 ' HA ' HD23 ' B' ' 242' ' ' LEU . 97.1 mt -64.81 -40.9 95.97 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -179.426 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -61.22 -42.89 99.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.786 179.964 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -63.21 -39.43 94.6 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.44 -0.504 . . . . 0.0 109.682 179.946 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.65 ' O ' HG23 ' B' ' 249' ' ' VAL . 14.5 tpp180 -59.04 -42.42 90.22 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 179.604 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -60.4 -43.03 97.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.403 179.131 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 16.5 t -65.1 -44.88 87.39 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.948 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' B' B ' 248' ' ' GLN . . . . . 0.492 ' HB3' HH22 ' A' ' 12' ' ' ARG . 87.6 mt-30 -60.84 -32.84 72.23 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.465 -179.825 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.65 HG23 ' O ' ' B' ' 245' ' ' ARG . 54.1 t -62.96 -46.2 96.93 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.046 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -59.86 -28.34 67.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.794 178.949 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -95.86 -11.89 26.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.872 179.764 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.491 ' N ' ' O ' ' B' ' 248' ' ' GLN . 47.7 tp -73.68 145.02 45.57 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.986 -179.714 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -102.96 135.01 45.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.006 0.431 . . . . 0.0 110.61 179.726 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -63.12 -27.26 69.26 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.042 -179.867 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 -65.71 1.17 1.37 Allowed 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -178.674 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -99.15 85.78 3.3 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.494 -0.482 . . . . 0.0 111.266 -179.929 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -78.92 7.55 7.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.761 0.315 . . . . 0.0 111.42 -179.015 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.503 ' O ' ' C ' ' B' ' 259' ' ' ASP . 95.2 m-20 -106.27 -6.54 18.35 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 177.532 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.503 ' C ' ' O ' ' B' ' 258' ' ' ASP . 34.9 t0 22.01 -102.38 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 113.669 -1.605 . . . . 0.0 110.53 -179.676 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.568 ' OE2' ' NH1' ' A' ' 12' ' ' ARG . 92.7 mt-10 -136.57 15.38 3.16 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.292 179.213 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.589 HD11 ' CZ ' ' A' ' 93' ' ' ARG . 59.1 mt -116.53 134.12 60.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.958 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' B' B ' 262' ' ' VAL . . . . . 0.433 HG11 ' NH2' ' A' ' 38' ' ' ARG . 52.9 t -126.5 134.03 67.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.946 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -93.95 117.86 30.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.479 0.657 . . . . 0.0 111.97 -178.412 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' B' B ' 264' ' ' LYS . . . . . 0.468 ' HA ' HH12 ' A' ' 38' ' ' ARG . 87.5 tttt -63.34 -43.86 96.51 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.981 179.128 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' B' B ' 265' ' ' GLN . . . . . 0.458 ' HG2' HD11 ' A' ' 24' ' ' LEU . 9.3 mp0 -100.65 157.43 33.74 Favored Pre-proline 0 N--CA 1.449 -0.492 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.548 -179.686 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -70.2 143.57 49.13 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 C-N-CA 122.847 2.364 . . . . 0.0 113.312 -179.157 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 29.5 pt . . . . . 0 N--CA 1.451 -0.378 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.072 178.564 . . . . . . . . 0 0 . 1 . 088 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo . . . . . 0 N--CA 1.493 1.471 0 CA-C-O 120.732 0.222 . . . . 0.0 111.931 . . . . . . . . . 0 0 . 1 . 088 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 37.2 p -115.17 -54.64 2.54 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.3 -179.715 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.703 ' NH2' HG21 ' A' ' 53' ' ' ILE . 82.6 mtm-85 -99.71 134.93 41.89 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.902 -179.366 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -138.82 144.9 39.51 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 120.222 -0.591 . . . . 0.0 111.626 -179.859 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.4 mt -108.73 140.62 41.88 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.003 178.58 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.4 t -112.54 129.21 68.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.616 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.471 HG23 HD12 ' B' ' 261' ' ' ILE . 1.8 m -93.45 117.77 30.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.272 0.558 . . . . 0.0 112.299 -178.049 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.5 mt -83.07 143.04 12.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.785 179.582 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -95.94 164.31 12.77 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.967 179.498 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.458 ' HG3' ' NH1' ' A' ' 93' ' ' ARG . 82.7 mtp180 -58.36 -30.09 66.49 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.281 -179.366 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.541 ' OG ' HG22 ' A' ' 15' ' ' VAL . 88.0 p -73.25 -15.08 61.43 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.229 179.561 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.93 11.09 44.3 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -179.869 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.541 HG22 ' OG ' ' A' ' 13' ' ' SER . 11.4 m -112.02 138.73 39.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.956 0.408 . . . . 0.0 110.484 179.931 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.419 ' O ' ' OD1' ' A' ' 16' ' ' ASP . 54.2 p-10 -80.19 146.85 31.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.006 179.446 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.21 -106.09 1.01 Allowed Glycine 0 CA--C 1.537 1.447 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 179.822 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.1 146.92 37.39 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 122.963 2.442 . . . . 0.0 112.248 -179.994 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -112.97 153.18 28.43 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.194 179.901 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.641 ' CD2' HD11 ' A' ' 37' ' ' ILE . 62.5 t80 -117.53 89.21 31.59 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.665 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -61.3 132.62 42.12 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.556 2.171 . . . . 0.0 111.089 179.914 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.7 mt -87.97 82.23 7.29 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.653 -178.847 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 86.0 p -86.59 -11.14 52.32 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 178.379 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.67 HD11 ' HG2' ' B' ' 265' ' ' GLN . 63.4 mt -101.92 144.06 31.03 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.526 -179.186 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.1 m -67.86 -21.2 65.19 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.779 0.323 . . . . 0.0 111.199 -179.724 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 63.1 m -127.52 133.31 49.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.708 179.619 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.653 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 9.8 t -129.78 122.13 28.2 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.463 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 49.8 tp -118.08 132.5 56.35 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.149 -178.246 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.653 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 38.0 m-85 -110.49 142.46 42.22 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.8 0.334 . . . . 0.0 110.197 179.837 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 150.13 -176.16 28.89 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 179.406 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 46.6 mtm180 -77.76 -31.68 52.19 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.64 179.605 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.578 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -47.8 149.37 3.27 Favored Glycine 0 N--CA 1.466 0.688 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 -179.012 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.448 HD12 ' HD3' ' A' ' 38' ' ' ARG . 11.0 tp -68.58 -41.04 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.583 -179.918 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.442 ' N ' HG23 ' A' ' 33' ' ' ILE . 78.2 mm-40 -55.07 -21.98 14.51 Favored 'General case' 0 C--O 1.231 0.096 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -179.995 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.578 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 19.0 m -57.34 113.01 1.57 Allowed 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.771 178.812 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -58.36 -26.72 63.47 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 -179.99 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.641 HD11 ' CD2' ' A' ' 20' ' ' PHE . 50.5 mm -122.4 113.48 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.476 177.289 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.448 ' HD3' HD12 ' A' ' 33' ' ' ILE . 42.2 mtm180 -98.02 131.63 44.27 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.829 -179.662 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.504 HG21 HD12 ' A' ' 41' ' ' LEU . 99.2 mt -118.17 131.25 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 121.465 0.65 . . . . 0.0 111.31 179.79 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -79.79 32.39 0.25 Allowed 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.159 -178.631 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.71 ' O ' HG12 ' A' ' 44' ' ' VAL . 31.9 mt -98.22 121.56 56.73 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.484 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -72.33 -13.0 27.92 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 121.552 1.501 . . . . 0.0 111.499 -179.823 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.2 m -96.2 7.73 7.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.505 -179.451 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.71 HG12 ' O ' ' A' ' 41' ' ' LEU . 5.0 p -101.86 142.5 16.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.533 179.958 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.8 m -71.95 170.35 13.95 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.363 0.602 . . . . 0.0 111.129 -179.391 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -63.81 -41.2 97.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.986 -179.764 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.637 ' O ' ' N ' ' A' ' 49' ' ' CYS . 87.7 mt-30 -108.96 -9.92 15.08 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 121.086 -0.246 . . . . 0.0 110.994 -179.958 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.594 ' ND1' HG23 ' A' ' 44' ' ' VAL . 30.0 t60 31.41 -76.32 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 179.635 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.637 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.51 137.37 45.58 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.132 0.491 . . . . 0.0 111.685 -178.472 . . . . . . . . 3 3 . 1 . 088 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -123.75 131.56 53.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.899 178.733 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.5 mt -116.05 133.46 62.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.197 -179.109 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -117.85 125.63 50.89 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.02 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.703 HG21 ' NH2' ' A' ' 5' ' ' ARG . 67.7 mt -103.29 116.6 47.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 C-N-CA 119.853 -0.739 . . . . 0.0 111.207 -179.488 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.503 ' O ' ' N ' ' A' ' 56' ' ' GLN . 6.3 m-70 -111.72 135.8 51.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.182 179.637 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.0 mm-40 -41.51 -26.58 0.07 Allowed 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.477 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.503 ' N ' ' O ' ' A' ' 54' ' ' HIS . 82.4 mt-30 -68.39 -68.55 0.38 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.215 178.679 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.447 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 5.2 tp10 -151.0 -178.3 6.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.557 -179.357 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.447 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -102.41 128.7 48.89 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.554 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 40.9 mm -111.89 126.57 69.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.886 -178.117 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.627 ' HB2' HD11 ' A' ' 82' ' ' LEU . 23.0 tp -101.37 124.24 46.75 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.923 178.878 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -114.81 137.04 52.42 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.419 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -102.21 108.28 19.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.03 0.443 . . . . 0.0 111.288 179.49 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -94.43 -3.03 50.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.805 179.298 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.8 t -82.31 100.98 10.26 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.446 -0.501 . . . . 0.0 110.081 179.521 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.9 m -82.76 -17.2 45.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.62 179.954 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.752 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.2 OUTLIER -87.52 -36.09 17.8 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.376 -179.338 . . . . . . . . 3 3 . 1 . 088 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -146.05 100.58 4.22 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.873 -179.54 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -57.81 144.09 94.25 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 121.736 1.624 . . . . 0.0 112.708 -179.336 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 37.2 m -70.21 134.55 48.17 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.171 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -96.08 141.1 29.87 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.635 -178.909 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.5 t -134.32 134.07 55.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.321 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 53.49 31.89 13.09 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 119.84 -0.744 . . . . 0.0 109.023 -179.104 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.04 25.68 72.98 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.26 179.852 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 37.8 t -141.72 143.57 33.6 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 117.297 0.549 . . . . 0.0 111.528 -179.993 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.8 m -76.69 139.13 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.884 179.984 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.414 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 1.1 pt -104.08 104.05 16.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.622 179.106 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.428 ' C ' ' OE1' ' A' ' 78' ' ' GLU . 57.9 m-20 -63.24 -35.88 81.8 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-O 121.191 0.519 . . . . 0.0 109.911 179.964 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.428 ' OE1' ' C ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -125.79 177.95 1.7 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.345 -179.128 . . . . . . . . 3 3 . 1 . 088 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.418 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 34.6 Cg_exo -60.48 142.64 98.5 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 122.302 2.001 . . . . 0.0 111.914 179.966 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 42.9 t -132.7 138.19 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 120.946 0.403 . . . . 0.0 111.665 179.722 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -75.32 132.83 41.25 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.679 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.627 HD11 ' HB2' ' A' ' 60' ' ' LEU . 86.1 mt -87.41 137.2 32.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.326 0.584 . . . . 0.0 111.318 -179.121 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -126.02 151.85 46.54 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.321 -179.704 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.455 ' ND1' ' N ' ' A' ' 99' ' ' ASN . 9.1 t60 -55.12 122.98 12.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.227 0.537 . . . . 0.0 111.246 -178.973 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 103.35 -13.22 54.89 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.143 -179.657 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -70.72 139.06 51.04 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 117.079 0.44 . . . . 0.0 110.696 179.687 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.427 ' O ' HG13 ' A' ' 87' ' ' VAL . 8.7 p -111.69 135.81 49.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.411 -0.515 . . . . 0.0 111.841 -178.996 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 81.2 mt -102.4 128.99 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 177.606 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.783 HG23 ' OG ' ' A' ' 94' ' ' SER . 95.3 m -123.93 125.07 43.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.702 0.763 . . . . 0.0 111.759 -178.438 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.63 ' O ' ' N ' ' A' ' 93' ' ' ARG . 96.1 mt -113.99 121.65 66.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 114.547 -1.206 . . . . 0.0 108.062 178.324 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.555 ' C ' ' O ' ' A' ' 90' ' ' ILE . 66.5 mt -3.44 95.31 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -179.833 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.427 ' CB ' ' NH1' ' B' ' 245' ' ' ARG . 2.0 t0 77.83 -20.3 0.39 Allowed 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 178.18 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.754 ' HE ' ' CD1' ' B' ' 261' ' ' ILE . 6.8 tpt180 -120.31 130.08 54.29 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 110.465 -0.198 . . . . 0.0 110.465 -178.372 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.783 ' OG ' HG23 ' A' ' 89' ' ' THR . 64.3 m -134.62 151.11 50.83 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -178.486 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.481 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 82.9 m-85 -122.63 120.74 34.62 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.308 178.551 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 37.7 ttp-105 -87.86 134.95 33.59 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 119.914 -0.715 . . . . 0.0 110.727 -179.652 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -96.93 123.86 40.75 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.124 -178.14 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -125.12 120.26 30.9 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.234 179.415 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.461 ' O ' ' C ' ' A' ' 100' ' ' GLU . 15.9 t-20 -103.11 109.48 21.06 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.507 -179.225 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.461 ' C ' ' O ' ' A' ' 99' ' ' ASN . 76.9 tt0 . . . . . 0 CA--C 1.517 -0.312 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.73 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 2.4 t . . . . . 0 CA--C 1.528 0.129 0 CA-C-O 120.572 0.225 . . . . 0.0 110.794 . . . . . . . . . 0 0 . 1 . 088 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.591 ' C ' ' H ' ' B' ' 231' ' ' GLN . 75.7 m-20 -67.36 138.73 56.96 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.214 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 088 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.591 ' H ' ' C ' ' B' ' 229' ' ' ASP . 99.3 mm-40 -105.72 -24.66 12.47 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.162 0.506 . . . . 0.0 110.368 179.681 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' B' B ' 232' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' B' ' 229' ' ' ASP . . . -33.35 158.82 0.01 OUTLIER Glycine 0 CA--C 1.531 1.037 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.459 -179.142 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -71.49 161.4 45.57 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 123.581 2.854 . . . . 0.0 111.591 179.565 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.752 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 088 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -75.0 141.86 27.16 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 121.946 1.764 . . . . 0.0 113.388 -179.844 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.467 ' CG2' HG22 ' A' ' 66' ' ' THR . 60.5 t -60.82 137.61 22.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.48 179.667 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' B' B ' 237' ' ' CYS . . . . . 0.535 ' HB2' HD13 ' A' ' 91' ' ' ILE . 2.7 t -64.61 134.42 54.29 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.038 -179.559 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' B' B ' 238' ' ' TPO . . . . . 0.407 ' O3P' ' OG1' ' B' ' 240' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 088 nuclear build full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -55.42 -22.54 34.51 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.534 2.156 . . . . 0.0 112.241 -179.959 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' B' B ' 240' ' ' THR . . . . . 0.407 ' OG1' ' O3P' ' B' ' 238' ' ' TPO . 86.2 m -72.24 -44.05 63.46 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.439 0.638 . . . . 0.0 109.417 178.485 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.406 ' CZ ' ' HD2' ' B' ' 245' ' ' ARG . 72.2 t80 -58.47 -51.01 71.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.324 -178.624 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.475 HD21 HG23 ' A' ' 91' ' ' ILE . 97.2 mt -63.51 -42.04 98.49 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.183 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -64.29 -42.24 96.49 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -178.734 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -62.2 -41.8 98.7 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.344 -179.591 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.438 ' O ' HG23 ' B' ' 249' ' ' VAL . 83.5 mtp180 -63.21 -39.32 94.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.636 -178.495 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -62.01 -38.46 88.73 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.016 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 21.0 m -65.49 -42.61 91.97 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.499 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' B' B ' 248' ' ' GLN . . . . . 0.471 ' O ' ' N ' ' B' ' 252' ' ' LEU . 87.2 mt-30 -62.33 -32.92 73.75 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.156 179.705 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.438 HG23 ' O ' ' B' ' 245' ' ' ARG . 53.1 t -61.18 -45.93 97.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 120.121 -0.632 . . . . 0.0 109.419 178.74 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -59.24 -29.3 67.43 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.229 179.343 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -96.48 -9.35 29.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.083 179.228 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.471 ' N ' ' O ' ' B' ' 248' ' ' GLN . 35.3 tp -75.59 142.82 42.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.669 -178.601 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -100.44 141.02 33.87 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.256 179.354 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -65.04 -20.38 66.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.463 0.649 . . . . 0.0 110.522 -179.134 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -63.06 -9.59 11.0 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.247 -179.957 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 46.2 p-10 -65.01 149.1 50.44 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.069 0.462 . . . . 0.0 110.707 179.984 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' B' B ' 257' ' ' LYS . . . . . 0.55 ' O ' ' N ' ' B' ' 259' ' ' ASP . 99.0 mttt -134.86 153.7 51.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.74 179.983 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.53 ' O ' ' C ' ' B' ' 259' ' ' ASP . 87.0 m-20 45.49 15.83 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -179.409 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.55 ' N ' ' O ' ' B' ' 257' ' ' LYS . 29.2 t70 -2.36 -77.21 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.041 -0.982 . . . . 0.0 112.137 -178.948 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -133.7 9.21 3.92 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.838 -179.4 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.754 ' CD1' ' HE ' ' A' ' 93' ' ' ARG . 64.9 mt -117.6 134.36 61.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -179.883 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 47.8 t -123.4 130.65 74.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.162 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -93.47 117.07 29.63 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.272 0.558 . . . . 0.0 111.106 -177.924 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -64.48 -46.6 82.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.687 -179.781 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' B' B ' 265' ' ' GLN . . . . . 0.67 ' HG2' HD11 ' A' ' 24' ' ' LEU . 0.8 OUTLIER -92.49 165.78 18.59 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.069 -178.465 . . . . . . . . 3 3 . 1 . 088 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -69.07 148.01 68.6 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 122.122 1.882 . . . . 0.0 112.739 -178.93 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 32.1 pt . . . . . 0 C--N 1.321 -0.646 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.15 -179.876 . . . . . . . . 0 0 . 1 . 089 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo . . . . . 0 N--CA 1.495 1.575 0 CA-C-O 121.116 0.382 . . . . 0.0 112.774 . . . . . . . . . 0 0 . 1 . 089 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.0 p -89.17 -39.48 13.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.294 179.509 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.55 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 80.5 mtp85 -87.69 126.73 35.14 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.064 -179.465 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -129.62 133.53 47.19 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.013 -179.863 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.514 HD11 ' HB3' ' A' ' 95' ' ' PHE . 35.1 tp -117.1 128.38 55.08 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.748 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.6 m -106.16 136.09 41.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.419 -179.768 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.516 HG23 HD12 ' B' ' 261' ' ' ILE . 1.8 m -95.29 117.84 30.99 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.142 -0.936 . . . . 0.0 112.589 -178.589 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.7 mt -84.65 145.59 7.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.386 179.02 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -96.4 162.3 13.55 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.95 0.405 . . . . 0.0 110.773 179.315 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.882 HH21 HD22 ' B' ' 252' ' ' LEU . 87.6 mtm180 -58.45 -27.38 64.32 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.558 -178.636 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 89.3 p -81.82 -9.77 59.52 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.093 -0.643 . . . . 0.0 109.697 179.646 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.3 36.75 6.47 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.61 179.8 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.3 t -118.38 132.37 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-O 120.787 0.327 . . . . 0.0 111.42 179.993 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -69.64 124.48 24.06 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.862 179.274 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -116.08 -128.89 4.34 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.271 -178.937 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -70.61 148.07 58.76 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.031 1.821 . . . . 0.0 112.816 -178.623 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -106.51 144.87 32.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.814 -179.572 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.757 ' CD2' HD11 ' A' ' 37' ' ' ILE . 34.6 t80 -112.25 100.98 51.19 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.321 179.862 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.414 ' CD ' ' O ' ' B' ' 267' ' ' ILE . 57.8 Cg_endo -75.79 128.82 11.15 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 121.47 1.446 . . . . 0.0 111.42 -179.632 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 88.0 mt -83.8 81.17 8.88 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.855 -178.871 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 87.8 p -86.01 -13.7 46.72 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.987 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 73.8 mt -100.03 145.36 28.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.422 -179.967 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 54.2 p -68.56 -15.77 63.64 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.506 -178.804 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.517 HG23 ' OE2' ' A' ' 52' ' ' GLU . 85.6 m -128.61 131.48 48.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.237 0.541 . . . . 0.0 111.778 -179.691 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.9 t -128.11 122.15 31.34 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.304 178.543 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.8 tp -115.27 130.58 56.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.956 0.408 . . . . 0.0 111.002 -179.074 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.522 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 44.8 m-85 -111.36 140.47 45.92 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.796 179.718 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 152.64 -168.4 31.63 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 120.886 -0.673 . . . . 0.0 111.504 179.394 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.578 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 49.5 ptt85 -118.29 17.27 13.92 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 122.76 -0.259 . . . . 0.0 111.034 179.901 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.629 ' O ' ' N ' ' A' ' 34' ' ' GLU . . . -88.05 32.96 4.16 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.814 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.65 ' C ' ' H ' ' A' ' 35' ' ' CYS . 2.0 tt 52.03 -62.09 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 123.28 0.632 . . . . 0.0 112.587 -179.609 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.629 ' N ' ' O ' ' A' ' 32' ' ' GLY . 72.0 tt0 -52.26 2.21 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 O-C-N 121.974 -0.454 . . . . 0.0 110.899 -178.934 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.65 ' H ' ' C ' ' A' ' 33' ' ' ILE . 3.9 m -82.77 133.81 35.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.891 0.377 . . . . 0.0 111.027 179.82 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -61.88 -26.81 68.37 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.88 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.757 HD11 ' CD2' ' A' ' 20' ' ' PHE . 49.0 mm -123.41 117.09 50.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 177.267 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.411 ' NH1' HG13 ' A' ' 33' ' ' ILE . 82.1 mtt180 -100.33 132.92 45.43 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.85 -179.133 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.721 HG21 HD12 ' A' ' 41' ' ' LEU . 80.9 mt -120.31 130.98 73.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.469 -0.493 . . . . 0.0 110.446 -179.727 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -79.11 33.97 0.23 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.507 -179.046 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.721 HD12 HG21 ' A' ' 39' ' ' ILE . 17.9 mt -102.06 108.74 57.85 Favored Pre-proline 0 C--N 1.326 -0.427 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.78 -179.974 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -57.56 -13.81 14.91 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.21 1.94 . . . . 0.0 112.406 179.159 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.6 m -97.31 9.7 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.858 -179.893 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.578 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 15.7 t -102.17 135.88 37.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.092 0.473 . . . . 0.0 110.957 -179.744 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.53 162.23 21.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.204 -179.12 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -62.89 -42.42 99.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.702 -179.392 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.595 ' O ' ' N ' ' A' ' 49' ' ' CYS . 87.6 mt-30 -112.34 -2.58 14.76 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.916 0.389 . . . . 0.0 110.579 178.882 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.456 ' C ' ' O ' ' A' ' 47' ' ' GLN . 14.8 t60 15.88 -73.51 0.0 OUTLIER 'General case' 0 C--O 1.235 0.29 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -179.287 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.595 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.91 134.69 44.9 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.331 -0.548 . . . . 0.0 112.094 -178.127 . . . . . . . . 3 3 . 1 . 089 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -127.41 132.36 50.13 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.399 179.793 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.2 mt -115.93 133.24 62.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.977 0.417 . . . . 0.0 111.432 -179.491 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.517 ' OE2' HG23 ' A' ' 26' ' ' THR . 70.8 mm-40 -117.41 127.93 54.52 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.428 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 93.0 mt -105.53 118.36 52.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 119.941 -0.703 . . . . 0.0 112.231 -179.089 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.454 ' O ' ' N ' ' A' ' 56' ' ' GLN . 92.9 m-70 -116.39 144.01 44.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.692 -179.522 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 54' ' ' HIS . 95.3 mt-10 -40.28 -29.69 0.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.857 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.483 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 53.4 tt0 -63.87 -68.31 0.36 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.411 178.733 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.483 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 5.5 tp10 -160.09 -159.44 0.71 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.047 179.371 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.442 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -116.04 124.97 51.79 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.213 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.5 mt -116.69 132.43 66.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.243 0.545 . . . . 0.0 112.22 -178.329 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.1 tp -100.54 129.03 46.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.319 -179.971 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -110.22 135.65 50.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.704 -179.66 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.414 HD21 ' HA ' ' A' ' 68' ' ' PRO . 47.2 t-20 -95.95 105.22 17.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.729 -179.247 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -98.0 -5.74 33.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.815 179.086 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.23 101.39 3.98 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.702 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.6 p -87.37 -11.13 50.2 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.699 -179.877 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.823 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.2 OUTLIER -101.1 -36.08 9.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.169 -179.272 . . . . . . . . 3 3 . 1 . 089 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 60.2 m-80 -142.78 97.72 5.87 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.664 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.414 ' HA ' HD21 ' A' ' 62' ' ' ASN . 32.6 Cg_exo -55.92 146.08 70.21 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 122.299 2.0 . . . . 0.0 113.633 -178.358 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.3 m -69.23 133.19 47.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.023 178.641 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -97.78 141.78 30.37 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.224 -0.59 . . . . 0.0 111.347 -179.287 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.3 p -133.46 133.58 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.801 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 50.64 32.96 7.43 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 119.921 -0.712 . . . . 0.0 109.219 -179.321 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.21 29.27 62.62 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.943 179.788 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.5 m -142.33 135.31 28.55 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.233 -0.587 . . . . 0.0 111.962 -179.727 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.431 ' H ' HG22 ' A' ' 75' ' ' VAL . 0.5 OUTLIER -72.84 139.23 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.471 179.277 . . . . . . . . 3 3 . 1 . 089 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.547 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 1.1 pt -107.07 111.81 37.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-O 121.719 0.771 . . . . 0.0 111.023 179.721 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -67.3 -31.98 72.64 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.993 179.303 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.615 ' N ' ' OE1' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -133.13 -179.19 1.0 Allowed Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.847 -179.322 . . . . . . . . 3 3 . 1 . 089 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.496 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 31.3 Cg_exo -60.77 146.72 96.92 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 122.973 2.449 . . . . 0.0 113.08 179.828 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.9 m -137.4 140.53 41.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.857 179.018 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 52.3 ttp180 -73.15 129.96 39.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.317 179.3 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.0 mt -81.92 140.82 33.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.374 0.607 . . . . 0.0 111.694 -179.227 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.66 152.23 51.62 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.94 179.599 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -56.85 121.11 9.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.991 0.424 . . . . 0.0 110.916 -179.477 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.61 -18.75 37.46 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 179.924 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -67.48 135.57 53.27 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.963 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.4 t -113.71 132.73 61.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.329 -177.671 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.9 mt -96.52 129.3 46.78 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 177.801 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 43.1 m -121.71 124.96 45.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.622 0.725 . . . . 0.0 112.133 -178.0 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.527 ' O ' ' C ' ' A' ' 91' ' ' ILE . 95.4 mt -113.07 128.84 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 114.708 -1.133 . . . . 0.0 107.987 178.404 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.527 ' C ' ' O ' ' A' ' 90' ' ' ILE . 61.3 mt -20.88 102.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -178.673 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.461 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 5.1 m-20 87.17 -23.72 0.13 Allowed 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 177.881 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 90' ' ' ILE . 17.3 mmm-85 -129.24 144.6 51.28 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.413 179.926 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.5 t -140.24 152.87 46.29 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.249 0.547 . . . . 0.0 110.814 179.979 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.573 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 51.7 m-85 -123.2 122.06 37.47 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.985 -179.768 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.439 ' O ' HD12 ' A' ' 7' ' ' LEU . 42.7 ttm180 -88.49 130.98 35.08 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 119.655 -0.818 . . . . 0.0 109.959 179.591 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.55 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 41.0 t80 -93.83 127.71 39.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.168 -179.941 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -123.94 122.29 37.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.689 179.56 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -97.25 116.11 28.85 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.32 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.103 -179.07 . . . . . . . . 0 0 . 1 . 089 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 9.2 p . . . . . 0 C--O 1.232 0.144 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 089 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.593 ' O ' ' N ' ' B' ' 231' ' ' GLN . 52.0 t0 -88.23 116.15 26.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.101 -179.162 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' B' B ' 230' ' ' SEP . . . . . 0.419 ' C ' ' O ' ' B' ' 229' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 089 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.593 ' N ' ' O ' ' B' ' 229' ' ' ASP . 90.5 mm-40 -113.89 -21.57 10.56 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.373 179.387 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' B' B ' 232' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' B' ' 229' ' ' ASP . . . -40.86 170.79 0.01 OUTLIER Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 -179.916 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.41 161.63 44.95 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 123.464 2.776 . . . . 0.0 112.961 -179.421 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.823 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 089 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -76.42 139.4 20.69 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.141 1.894 . . . . 0.0 114.27 -179.078 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.49 ' CG2' HG22 ' A' ' 66' ' ' THR . 55.4 t -65.38 142.07 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.301 179.529 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 3.5 t -71.1 136.1 48.04 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.378 179.892 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' B' B ' 238' ' ' TPO . . . . . 0.414 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 089 nuclear build full ' B' B ' 239' ' ' PRO . . . . . 0.414 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 41.8 Cg_exo -57.6 -28.41 81.13 Favored 'Trans proline' 0 N--CA 1.499 1.817 0 C-N-CA 123.193 2.596 . . . . 0.0 113.07 -179.305 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 30.4 m -68.62 -46.69 68.59 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.077 0.465 . . . . 0.0 110.031 178.73 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -59.52 -46.31 89.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.483 -178.607 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 84.7 mt -63.72 -42.65 97.88 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -178.907 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -65.56 -40.02 92.34 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.406 -0.517 . . . . 0.0 111.093 -178.931 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 63.7 ttm-85 -63.62 -44.12 94.86 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.441 -0.503 . . . . 0.0 109.849 179.649 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' B' B ' 245' ' ' ARG . . . . . . . . . . . . . 70.6 ttp85 -61.28 -42.53 98.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.757 -179.928 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -59.17 -37.95 78.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.019 -179.675 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 49.0 m -68.92 -41.66 77.84 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 177.454 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' B' B ' 248' ' ' GLN . . . . . 0.447 ' O ' ' N ' ' B' ' 252' ' ' LEU . 70.2 tp60 -61.16 -38.38 86.26 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.515 179.954 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 38.6 t -62.15 -46.02 97.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.119 179.232 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -60.84 -25.77 66.88 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.149 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -95.52 -10.52 29.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.927 179.112 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.882 HD22 HH21 ' A' ' 12' ' ' ARG . 56.2 tp -76.7 140.18 40.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.817 -179.26 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -100.48 139.54 36.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.019 178.708 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -67.56 -22.62 65.39 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.911 -179.882 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -69.38 -5.86 26.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.419 -179.773 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -84.1 76.09 10.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.251 179.677 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -66.81 0.78 2.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.312 -179.398 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.535 ' O ' ' C ' ' B' ' 259' ' ' ASP . 97.4 m-20 -98.17 1.28 47.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.61 0.243 . . . . 0.0 110.39 178.538 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.535 ' C ' ' O ' ' B' ' 258' ' ' ASP . 31.9 p-10 11.93 -118.89 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 O-C-N 124.082 0.864 . . . . 0.0 111.989 179.951 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.593 ' OE2' ' NH1' ' A' ' 12' ' ' ARG . 98.1 mt-10 -130.32 5.19 4.8 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.186 -179.871 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.573 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 81.1 mt -116.41 138.06 48.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.86 0.362 . . . . 0.0 110.18 179.972 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 43.9 t -127.07 136.44 60.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.363 179.739 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -97.72 118.02 33.33 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.249 0.547 . . . . 0.0 110.979 -178.748 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -64.7 -46.53 81.94 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.599 179.509 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' B' B ' 265' ' ' GLN . . . . . 0.413 ' CB ' ' CD ' ' B' ' 266' ' ' PRO . 1.1 mm-40 -98.73 177.74 1.5 Allowed Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.467 -179.111 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' B' B ' 266' ' ' PRO . . . . . 0.413 ' CD ' ' CB ' ' B' ' 265' ' ' GLN . 38.8 Cg_exo -60.75 143.36 99.38 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.544 2.162 . . . . 0.0 113.193 -178.895 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' B' B ' 267' ' ' ILE . . . . . 0.414 ' O ' ' CD ' ' A' ' 21' ' ' PRO . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.314 179.296 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo . . . . . 0 N--CA 1.497 1.679 0 CA-C-O 120.746 0.227 . . . . 0.0 112.326 . . . . . . . . . 0 0 . 1 . 090 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.4 p -78.55 -30.54 46.98 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.503 179.465 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.668 ' NH1' ' HB2' ' A' ' 58' ' ' ALA . 93.6 mtt-85 -100.21 117.12 33.78 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.89 -179.092 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.471 HH12 ' HB2' ' A' ' 100' ' ' GLU . 32.3 ptt-85 -132.96 141.78 48.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.25 179.871 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.587 HD11 ' HB3' ' A' ' 95' ' ' PHE . 33.2 tp -118.24 136.18 53.82 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.899 -179.805 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.0 t -112.56 131.2 64.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 -179.784 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.469 ' CG2' HD12 ' B' ' 261' ' ' ILE . 12.8 m -91.08 113.62 25.93 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.548 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 84.6 mt -81.63 145.01 9.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.666 178.477 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -89.9 157.89 17.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.083 0.468 . . . . 0.0 111.066 178.949 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.648 ' NH1' HH11 ' B' ' 245' ' ' ARG . 90.4 mtm180 -58.61 -32.07 68.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.93 -179.454 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.5 m -75.64 -13.49 60.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.917 0.389 . . . . 0.0 110.381 179.675 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.06 35.54 5.51 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.363 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.4 t -121.66 133.17 68.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.849 0.357 . . . . 0.0 111.551 -179.12 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -72.43 122.62 21.54 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.767 179.415 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -114.63 -129.26 4.69 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.529 -179.354 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.49 156.18 54.42 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.301 2.001 . . . . 0.0 112.859 -178.969 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.539 ' CE1' ' HD3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -112.91 156.0 23.75 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.128 0.49 . . . . 0.0 110.762 -179.336 . . . . . . . . 3 3 . 1 . 090 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.443 ' CD2' HD11 ' A' ' 37' ' ' ILE . 39.0 t80 -126.19 104.39 25.72 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.517 -179.436 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.539 ' HD3' ' CE1' ' A' ' 19' ' ' HIS . 61.6 Cg_endo -74.01 132.8 17.29 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 C-N-CA 121.07 1.18 . . . . 0.0 111.472 -179.363 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.443 HD22 ' SG ' ' A' ' 27' ' ' CYS . 73.9 mt -89.98 49.97 1.8 Allowed 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.196 -178.351 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 93.9 p -63.13 -19.65 64.65 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.893 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.717 HD11 ' CD ' ' B' ' 265' ' ' GLN . 87.0 mt -77.48 140.2 39.76 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.069 179.592 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 77.9 p -61.57 -21.38 64.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.593 -178.973 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.488 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 20.8 m -136.27 135.7 39.21 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.786 -0.365 . . . . 0.0 111.304 -179.752 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.443 ' SG ' HD22 ' A' ' 22' ' ' LEU . 5.0 t -124.84 116.65 22.59 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.46 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.1 tp -113.73 127.8 56.17 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.906 0.384 . . . . 0.0 110.87 -179.052 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.785 ' CE2' HD12 ' A' ' 37' ' ' ILE . 9.6 m-85 -106.33 132.5 52.3 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.666 179.773 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 163.24 -173.53 39.41 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 119.724 -1.227 . . . . 0.0 112.879 179.144 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.635 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 87.3 mtm-85 -77.44 -31.02 53.65 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-O 120.907 0.384 . . . . 0.0 110.167 179.51 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.498 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -52.81 148.1 13.53 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.365 -178.075 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.461 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 8.2 tp -67.36 -40.6 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.417 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.461 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 79.5 mm-40 -54.45 -24.93 22.21 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.221 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 61.6 m -51.85 120.65 5.52 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.122 -179.786 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.488 ' OD2' ' O ' ' A' ' 26' ' ' THR . 68.0 m-20 -57.56 -27.3 62.54 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 179.932 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.785 HD12 ' CE2' ' A' ' 29' ' ' PHE . 84.4 mt -129.35 121.26 53.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.92 177.367 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 66.7 ttp85 -112.13 138.23 49.08 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.857 -179.177 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.833 HD13 ' NH1' ' A' ' 93' ' ' ARG . 78.0 mt -117.66 132.53 67.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.975 0.417 . . . . 0.0 110.312 -179.54 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -72.45 32.49 0.06 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.478 -178.168 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.933 HD12 HH21 ' A' ' 93' ' ' ARG . 78.7 mt -118.64 128.1 26.16 Favored Pre-proline 0 CA--C 1.535 0.392 0 C-N-CA 120.249 -0.58 . . . . 0.0 111.95 -179.722 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.85 -11.35 25.67 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 122.46 2.107 . . . . 0.0 113.222 -179.85 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.576 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 2.5 m -87.63 -5.58 10.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.344 179.403 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.635 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 55.3 t -84.51 133.17 29.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 177.541 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.455 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 0.4 OUTLIER -61.34 161.37 9.26 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.127 0.489 . . . . 0.0 111.265 -179.086 . . . . . . . . 3 3 . 1 . 090 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -61.99 -44.66 96.26 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.704 -178.988 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.604 ' O ' ' N ' ' A' ' 49' ' ' CYS . 95.1 mt-30 -113.94 -15.03 12.4 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.17 179.904 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.455 ' H ' ' HB3' ' A' ' 45' ' ' SER . 24.1 t60 31.35 -76.51 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 179.394 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.604 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.26 135.87 48.57 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.28 0.562 . . . . 0.0 112.193 -178.194 . . . . . . . . 3 3 . 1 . 090 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -128.16 126.84 41.85 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.246 179.534 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.4 mt -113.19 136.3 49.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.753 -179.659 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -115.62 132.84 56.51 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.917 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 51.5 mm -102.51 119.67 51.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.171 -0.612 . . . . 0.0 111.445 -178.948 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.451 ' O ' ' N ' ' A' ' 56' ' ' GLN . 96.5 m-70 -121.44 134.07 55.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.14 179.398 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 54' ' ' HIS . 81.0 tt0 -40.3 -29.82 0.09 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -179.765 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.451 ' N ' ' O ' ' A' ' 54' ' ' HIS . 60.0 tt0 -67.58 -67.29 0.47 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.544 179.083 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.427 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 5.3 tp10 -154.72 -161.56 1.23 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.125 -179.185 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.668 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -124.96 132.17 53.32 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.143 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.5 mt -116.99 129.21 73.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.175 0.512 . . . . 0.0 112.339 -179.097 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.526 ' HB2' HD11 ' A' ' 82' ' ' LEU . 34.7 tp -96.92 128.53 43.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.184 179.121 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -111.82 136.04 51.63 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.497 -179.58 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.416 HD21 ' HA ' ' A' ' 68' ' ' PRO . 58.2 t-20 -94.63 106.86 18.85 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.441 -179.671 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -99.87 -10.72 21.42 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.342 179.292 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.448 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 2.7 t -71.65 100.78 2.38 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.297 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.7 m -87.66 -19.27 27.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.083 0.468 . . . . 0.0 110.405 -179.858 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.404 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.2 OUTLIER -89.85 -43.0 10.92 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.105 179.809 . . . . . . . . 3 3 . 1 . 090 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.637 ' OD1' HG23 ' B' ' 236' ' ' VAL . 27.0 m-80 -133.23 91.94 26.29 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.497 179.994 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.44 ' HB2' HG13 ' A' ' 75' ' ' VAL . 41.5 Cg_exo -54.8 143.5 70.48 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.15 1.9 . . . . 0.0 112.702 -178.986 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.4 m -74.84 141.47 44.24 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.812 -1.086 . . . . 0.0 111.005 -179.781 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -104.32 142.05 35.24 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.396 179.527 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.493 ' CG2' ' OD1' ' A' ' 86' ' ' ASP . 4.9 p -128.55 134.13 65.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.207 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 46.65 34.7 2.6 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 -179.426 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.05 26.53 68.51 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.916 179.802 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.454 ' N ' ' O ' ' A' ' 71' ' ' VAL . 14.5 m -138.43 135.41 35.21 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 117.164 0.482 . . . . 0.0 111.499 179.928 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.44 HG13 ' HB2' ' A' ' 68' ' ' PRO . 43.3 t -64.72 136.36 26.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.422 179.965 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 pt -116.64 83.87 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.588 179.036 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -66.28 -22.26 66.3 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.88 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.486 ' CD ' ' H ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -118.45 163.43 25.46 Favored Pre-proline 0 C--N 1.333 -0.146 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.841 178.994 . . . . . . . . 3 3 . 1 . 090 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -67.93 152.0 77.46 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.65 2.234 . . . . 0.0 112.685 -179.685 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.6 m -144.3 146.22 20.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.597 -179.719 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 91.5 mtm180 -73.48 131.3 41.63 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.78 179.179 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.526 HD11 ' HB2' ' A' ' 60' ' ' LEU . 95.4 mt -84.06 133.72 34.64 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.016 0.436 . . . . 0.0 110.939 -179.696 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -130.68 157.03 43.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.763 179.879 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -58.13 117.51 4.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.903 0.382 . . . . 0.0 110.526 -179.72 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.77 -11.46 20.88 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -179.449 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.493 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 61.7 t0 -79.18 120.11 23.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.984 0.421 . . . . 0.0 110.185 179.586 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.8 t -108.21 130.79 60.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.92 -178.985 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.2 mt -94.73 132.18 39.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.108 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.9 m -116.61 127.16 54.21 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 121.53 0.681 . . . . 0.0 111.477 -179.831 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.47 ' O ' ' C ' ' A' ' 91' ' ' ILE . 96.6 mt -122.86 125.15 71.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.001 179.044 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.577 HG22 ' N ' ' A' ' 92' ' ' ASP . 87.4 mt 33.09 -101.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.155 -179.455 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.577 ' N ' HG22 ' A' ' 91' ' ' ILE . 56.9 t0 -109.69 14.98 23.11 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 121.067 -0.253 . . . . 0.0 111.615 -179.123 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.933 HH21 HD12 ' A' ' 41' ' ' LEU . 8.9 mtm105 -127.87 143.02 51.12 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.806 -179.449 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.3 m -134.8 148.48 50.2 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.945 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.587 ' HB3' HD11 ' A' ' 7' ' ' LEU . 75.9 m-85 -126.94 126.97 44.12 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.884 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.481 ' O ' HD12 ' A' ' 7' ' ' LEU . 99.8 mtt180 -89.77 131.04 35.93 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.812 179.857 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.587 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 88.9 t80 -97.99 129.2 44.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.938 0.399 . . . . 0.0 110.127 179.569 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -133.14 123.91 26.54 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.222 -179.514 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -117.32 105.62 12.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.818 -179.682 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.471 ' HB2' HH12 ' A' ' 6' ' ' ARG . 49.0 tt0 . . . . . 0 C--N 1.326 -0.451 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.716 179.86 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 54.4 t . . . . . 0 C--O 1.233 0.195 0 CA-C-O 120.676 0.274 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 090 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' A' ' 31' ' ' ARG . 91.0 m-20 -61.79 -42.75 99.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.964 -179.472 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 090 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -111.83 26.2 10.86 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.724 -178.198 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -119.16 -173.41 15.53 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -179.798 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -73.5 158.44 47.79 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 123.183 2.588 . . . . 0.0 112.428 179.988 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.404 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 090 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.91 172.74 13.98 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 122.285 1.99 . . . . 0.0 110.958 178.757 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.637 HG23 ' OD1' ' A' ' 67' ' ' ASN . 4.1 p -118.14 136.48 55.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 120.976 0.417 . . . . 0.0 111.026 -179.277 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 11.9 t -70.92 128.1 34.84 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.377 -179.939 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' B' B ' 238' ' ' TPO . . . . . 0.41 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 090 nuclear build full ' B' B ' 239' ' ' PRO . . . . . 0.41 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 46.9 Cg_exo -57.19 -25.42 64.28 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 123.02 2.48 . . . . 0.0 112.881 -179.461 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 36.2 m -73.58 -44.76 56.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.229 0.538 . . . . 0.0 109.837 178.224 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.576 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 47.7 t80 -57.28 -46.31 83.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.448 -179.413 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 97.9 mt -63.61 -41.2 98.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.919 0.39 . . . . 0.0 110.06 -179.871 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -62.75 -45.05 94.51 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.099 179.736 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' B' B ' 244' ' ' ARG . . . . . 0.502 ' O ' ' OG ' ' B' ' 247' ' ' SER . 73.6 ttt180 -65.03 -41.85 94.9 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.045 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.648 HH11 ' NH1' ' A' ' 12' ' ' ARG . 9.0 tpp180 -58.91 -43.95 91.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.543 -179.122 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -64.93 -42.05 95.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.122 0.487 . . . . 0.0 109.874 178.796 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' B' B ' 247' ' ' SER . . . . . 0.502 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 78.3 p -62.05 -46.32 89.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.037 179.774 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -62.61 -39.02 92.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.278 -179.575 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.452 HG23 ' O ' ' B' ' 245' ' ' ARG . 42.6 t -59.76 -45.41 94.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.303 -179.946 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -65.16 -32.81 74.68 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.435 0.636 . . . . 0.0 109.374 178.612 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -71.09 -19.51 62.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.753 -179.44 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 79.6 mt -66.9 122.65 18.18 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.903 -179.866 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' B' B ' 253' ' ' ASN . . . . . 0.595 ' ND2' ' OD1' ' B' ' 254' ' ' ASP . 2.1 p-10 -66.92 -42.98 84.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.064 -179.999 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' B' B ' 254' ' ' ASP . . . . . 0.595 ' OD1' ' ND2' ' B' ' 253' ' ' ASN . 99.3 m-20 -65.9 -11.12 44.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.084 -179.52 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' B' B ' 255' ' ' ASP . . . . . 0.448 ' CB ' ' O ' ' B' ' 254' ' ' ASP . 1.6 t0 80.07 26.89 0.32 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.402 -179.791 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.409 ' CB ' ' O ' ' B' ' 255' ' ' ASP . 4.5 t0 75.51 39.63 0.34 Allowed 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.253 179.339 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -64.64 -41.3 96.25 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.764 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.49 ' O ' ' O ' ' B' ' 259' ' ' ASP . 32.7 p-10 -115.75 96.6 5.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.491 178.586 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.49 ' O ' ' O ' ' B' ' 258' ' ' ASP . 63.4 t0 -53.46 -111.14 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.794 -178.92 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.674 ' OE1' HD21 ' A' ' 41' ' ' LEU . 95.7 mt-10 -152.17 27.43 0.6 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.555 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.469 HD12 ' CG2' ' A' ' 9' ' ' THR . 55.0 mt -111.12 139.91 32.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.554 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 58.9 t -128.25 135.71 61.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.129 179.765 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -97.41 120.8 38.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.252 0.549 . . . . 0.0 111.9 -178.178 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -63.88 -46.63 84.08 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.231 179.267 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' B' B ' 265' ' ' GLN . . . . . 0.717 ' CD ' HD11 ' A' ' 24' ' ' LEU . 2.7 mt-30 -94.01 161.78 28.77 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.903 -179.674 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.93 146.36 58.88 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 122.854 2.369 . . . . 0.0 112.768 -179.64 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 45.3 pt . . . . . 0 C--N 1.328 -0.342 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.679 . . . . . . . . 0 0 . 1 . 091 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo . . . . . 0 N--CA 1.494 1.524 0 CA-C-O 120.884 0.285 . . . . 0.0 111.626 . . . . . . . . . 0 0 . 1 . 091 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 68.2 p -99.37 -46.71 5.41 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.469 -179.587 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.8 mtt85 -93.08 129.19 39.13 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.37 -0.532 . . . . 0.0 109.589 -179.743 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -133.99 145.44 49.5 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 120.641 -0.423 . . . . 0.0 111.363 -179.476 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.402 HD11 HD11 ' A' ' 22' ' ' LEU . 66.0 mt -115.34 136.31 53.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.316 179.635 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.818 HG11 ' NH2' ' A' ' 96' ' ' ARG . 27.4 t -109.71 127.06 66.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.715 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.0 m -77.26 142.04 39.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.356 -178.493 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.631 HD12 ' OG ' ' A' ' 94' ' ' SER . 97.5 mt -110.43 134.15 53.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.871 177.261 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.412 ' NZ ' ' HA ' ' B' ' 257' ' ' LYS . 96.8 mttt -88.51 158.77 18.22 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.06 0.457 . . . . 0.0 110.815 179.99 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.433 ' NH2' ' HB3' ' B' ' 248' ' ' GLN . 82.1 mtp180 -57.25 -32.82 66.95 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.901 -178.824 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 65.2 m -77.31 -6.78 54.5 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.201 178.767 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.07 31.63 10.7 Favored Glycine 0 CA--C 1.519 0.302 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 -179.595 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.1 t -113.5 133.04 60.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.987 0.423 . . . . 0.0 111.451 -178.924 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.658 ' CG ' HH22 ' A' ' 96' ' ' ARG . 97.5 m-20 -74.03 137.03 43.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.874 179.651 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.47 -122.91 2.49 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 120.459 -0.877 . . . . 0.0 113.029 -178.633 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -71.78 149.93 55.12 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.463 2.109 . . . . 0.0 113.235 -177.965 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -111.29 127.39 55.61 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.688 179.962 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.743 ' CD2' HD11 ' A' ' 37' ' ' ILE . 55.9 t80 -99.29 105.55 33.49 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.854 179.903 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -75.82 135.29 17.45 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 121.112 1.208 . . . . 0.0 111.255 -179.516 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.402 HD11 HD11 ' A' ' 7' ' ' LEU . 96.5 mt -85.94 58.94 5.33 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.484 -178.528 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 90.8 p -64.17 -34.5 78.21 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.003 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 66.2 mt -75.77 144.94 41.13 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.53 179.423 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.8 m -68.63 -17.09 64.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.873 -178.624 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.483 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 58.1 m -133.22 134.22 43.73 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.666 -0.413 . . . . 0.0 112.024 -179.198 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.5 t -126.23 116.2 20.91 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.64 179.14 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.492 HD21 ' OE1' ' A' ' 47' ' ' GLN . 63.2 tp -113.2 128.9 56.62 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 121.006 -0.277 . . . . 0.0 111.087 -179.486 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.445 ' CE2' HG13 ' A' ' 37' ' ' ILE . 19.3 m-85 -107.1 129.04 54.88 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.783 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 172.46 -175.44 45.6 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.455 179.96 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.698 ' HD2' HG13 ' B' ' 228' ' ' VAL . 83.8 mtm-85 -80.28 -26.55 38.88 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.98 0.419 . . . . 0.0 110.33 179.363 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -55.44 144.45 33.29 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.132 -178.041 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.498 HG23 ' N ' ' A' ' 34' ' ' GLU . 11.1 tp -64.91 -41.77 93.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.17 0.509 . . . . 0.0 109.634 179.334 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.498 ' N ' HG23 ' A' ' 33' ' ' ILE . 17.3 pt-20 -57.19 -16.74 8.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.331 -179.874 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 45.8 m -66.21 134.01 51.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.204 0.526 . . . . 0.0 111.096 -178.84 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.483 ' OD2' ' O ' ' A' ' 26' ' ' THR . 60.9 m-20 -63.17 -36.34 83.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.316 -179.461 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.743 HD11 ' CD2' ' A' ' 20' ' ' PHE . 49.1 mm -121.14 117.4 52.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.483 177.693 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.43 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 81.4 mtp180 -107.2 134.7 49.91 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 120.374 -0.531 . . . . 0.0 111.018 -179.259 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 85.3 mt -120.92 131.34 73.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 120.126 -0.63 . . . . 0.0 109.711 178.916 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -77.84 24.93 0.21 Allowed 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -177.492 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 32.8 mt -94.23 132.61 28.84 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.973 179.433 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.57 -12.26 29.04 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.121 1.881 . . . . 0.0 113.584 -179.239 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.0 m -97.41 9.53 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 120.034 -0.666 . . . . 0.0 110.787 179.309 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.623 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 33.8 t -94.84 131.79 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 177.918 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.436 ' HB2' ' H ' ' A' ' 48' ' ' HIS . 5.9 m -76.1 173.49 11.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.579 0.704 . . . . 0.0 111.865 -178.755 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.563 ' NZ ' ' O ' ' B' ' 232' ' ' GLY . 62.7 mttp -64.75 -38.62 91.6 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.477 -179.862 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.649 ' O ' ' N ' ' A' ' 49' ' ' CYS . 93.8 mm-40 -113.34 -23.52 9.84 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.993 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.436 ' H ' ' HB2' ' A' ' 45' ' ' SER . 12.7 t60 34.26 -77.42 0.0 OUTLIER 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.63 179.978 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.649 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.72 135.74 47.08 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.981 0.42 . . . . 0.0 111.62 -179.385 . . . . . . . . 3 3 . 1 . 091 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -128.82 127.32 41.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.506 179.911 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 85.7 mt -111.6 132.85 59.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.599 -179.451 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -115.59 125.66 53.22 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.434 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.7 mt -107.3 115.13 47.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.029 -179.497 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.466 ' C ' ' N ' ' A' ' 56' ' ' GLN . 94.1 m-70 -112.45 144.75 41.37 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.771 -179.711 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 54' ' ' HIS . 94.9 mt-10 -41.62 -27.52 0.1 Allowed 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.152 -179.908 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.466 ' N ' ' C ' ' A' ' 54' ' ' HIS . 88.1 mt-30 -65.0 -68.89 0.33 Allowed 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.157 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -159.34 -164.9 1.46 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.954 179.489 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -108.97 130.75 55.47 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.608 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.4 mt -121.15 130.53 74.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -177.961 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.405 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 22.7 tp -101.15 126.93 47.9 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.66 179.514 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -109.77 135.71 50.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.697 178.726 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.625 ' C ' HD21 ' A' ' 62' ' ' ASN . 0.2 OUTLIER -98.14 103.71 15.68 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.76 -179.159 . . . . . . . . 3 3 . 1 . 091 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -98.86 -7.24 27.59 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -179.693 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 26.2 t -76.6 99.58 5.05 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.998 179.954 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.7 p -74.95 -38.46 61.72 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.993 0.425 . . . . 0.0 109.902 178.999 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.0 p -67.18 -39.35 86.39 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.538 179.859 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.454 ' O ' ' OG ' ' A' ' 64' ' ' SER . 46.3 m-20 -147.47 97.51 4.04 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.44 -179.277 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.45 ' HA ' HD22 ' A' ' 62' ' ' ASN . 37.3 Cg_exo -56.55 148.11 65.66 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 121.988 1.792 . . . . 0.0 112.574 179.544 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.3 m -74.36 137.43 42.78 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.36 179.718 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -99.03 140.12 33.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.427 179.827 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.517 ' HB ' HD11 ' A' ' 76' ' ' ILE . 25.2 t -130.49 134.69 61.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.65 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 53.12 35.94 21.06 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 120.127 -0.629 . . . . 0.0 109.399 -179.716 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 66.56 30.15 75.96 Favored Glycine 0 CA--C 1.523 0.557 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.204 179.484 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 83.4 p -138.44 125.86 21.84 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.625 -179.141 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.3 p -63.01 140.78 19.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.104 0.478 . . . . 0.0 111.57 -179.657 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.549 ' CG2' ' O ' ' A' ' 78' ' ' GLU . 97.1 mt -116.17 124.27 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.085 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.044 -179.883 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 30.6 p-10 -96.76 -24.58 15.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.974 179.198 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.549 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 2.5 mt-10 -129.54 169.91 12.12 Favored Pre-proline 0 N--CA 1.468 0.451 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.092 -179.055 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -56.8 143.25 91.3 Favored 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 121.994 1.796 . . . . 0.0 112.581 -179.95 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 78.0 t -136.4 138.22 47.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.756 179.975 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 85.4 mtt85 -74.17 134.68 42.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.629 179.199 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.1 mt -86.02 136.61 33.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.388 0.613 . . . . 0.0 111.393 -179.754 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -126.95 151.46 48.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.967 179.764 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.429 ' ND1' ' N ' ' A' ' 99' ' ' ASN . 7.8 t60 -56.58 120.14 7.27 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.963 0.411 . . . . 0.0 111.296 -179.447 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.7 -17.73 30.17 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 179.465 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -71.06 134.54 47.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.943 0.401 . . . . 0.0 110.47 -179.85 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.8 p -106.59 135.93 43.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.825 -178.859 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.9 mt -105.95 131.44 55.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 179.0 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 99.9 m -122.51 127.75 49.93 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -178.314 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.519 ' N ' ' O ' ' A' ' 93' ' ' ARG . 96.9 mt -112.67 132.27 61.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 177.428 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.579 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 2.5 mp -37.74 101.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.777 -178.766 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.579 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 37.5 t0 101.49 -30.94 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.732 0 O-C-N 124.225 0.953 . . . . 0.0 112.496 179.01 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 90' ' ' ILE . 36.0 mmt180 -128.99 143.18 50.79 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.951 -178.647 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.631 ' OG ' HD12 ' A' ' 10' ' ' ILE . 17.1 p -138.26 151.25 47.45 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.474 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -130.76 125.05 32.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.736 -179.351 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.818 ' NH2' HG11 ' A' ' 8' ' ' VAL . 92.8 mtm-85 -84.35 138.39 32.91 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.113 178.869 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -96.2 116.59 29.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.488 -179.392 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -120.64 122.59 40.83 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.777 0.322 . . . . 0.0 110.362 179.743 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.429 ' N ' ' ND1' ' A' ' 84' ' ' HIS . 21.5 t-20 -101.1 111.8 24.1 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.372 179.897 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 . . . . . 0 N--CA 1.466 0.369 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.102 -179.372 . . . . . . . . 0 0 . 1 . 091 nuclear build full ' B' B ' 228' ' ' VAL . . . . . 0.698 HG13 ' HD2' ' A' ' 31' ' ' ARG . 17.3 t . . . . . 0 CA--C 1.53 0.204 0 CA-C-O 120.756 0.312 . . . . 0.0 111.349 . . . . . . . . . 1 1 . 1 . 091 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.543 ' O ' ' CB ' ' B' ' 230' ' ' SEP . 79.7 m-20 -90.58 -5.36 56.0 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.593 178.986 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' B' B ' 230' ' ' SEP . . . . . 0.543 ' CB ' ' O ' ' B' ' 229' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 091 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -125.4 42.81 3.2 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.302 179.857 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' B' B ' 232' ' ' GLY . . . . . 0.563 ' O ' ' NZ ' ' A' ' 46' ' ' LYS . . . -118.35 -175.7 16.65 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -179.435 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.6 164.06 35.86 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 123.814 3.009 . . . . 0.0 113.33 -179.822 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.612 ' O2P' HG21 ' B' ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 091 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -77.3 152.3 30.52 Favored 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 122.408 2.072 . . . . 0.0 112.803 179.531 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.423 HG13 ' O ' ' B' ' 236' ' ' VAL . 8.9 p -80.44 124.64 38.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.277 179.969 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -61.64 122.1 14.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.608 -179.354 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 091 nuclear build full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.04 -19.66 33.81 Favored 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 121.855 1.703 . . . . 0.0 111.395 178.986 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 73.8 m -71.35 -45.53 62.71 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.194 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -57.89 -46.72 84.49 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.336 179.588 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.429 HD21 HG23 ' A' ' 91' ' ' ILE . 90.0 mt -64.58 -40.07 94.88 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.667 179.026 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -61.41 -40.81 95.77 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 120.778 0.323 . . . . 0.0 110.686 -179.979 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -60.04 -42.07 93.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.569 179.466 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.538 ' O ' HG23 ' B' ' 249' ' ' VAL . 67.9 ttp85 -59.92 -42.97 95.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.538 179.878 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -62.83 -41.66 99.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.211 -179.225 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 59.5 p -69.53 -41.55 75.83 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.879 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' B' B ' 248' ' ' GLN . . . . . 0.447 ' O ' ' N ' ' B' ' 252' ' ' LEU . 67.2 tp60 -60.95 -38.22 85.12 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.424 -179.937 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.538 HG23 ' O ' ' B' ' 245' ' ' ARG . 39.3 t -60.73 -47.19 94.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.547 179.543 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -62.17 -26.75 68.52 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.129 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -89.45 -15.31 33.44 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.307 -179.932 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.668 HD21 ' OD2' ' B' ' 256' ' ' ASP . 57.3 tp -122.83 115.84 22.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.374 179.178 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 174.38 30.35 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.707 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' B' B ' 254' ' ' ASP . . . . . 0.59 ' O ' ' CB ' ' B' ' 255' ' ' ASP . 75.9 m-20 -87.81 -4.61 58.86 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.093 -179.971 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' B' B ' 255' ' ' ASP . . . . . 0.59 ' CB ' ' O ' ' B' ' 254' ' ' ASP . 52.5 t0 111.11 64.73 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 O-C-N 124.459 1.1 . . . . 0.0 110.575 -179.703 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.668 ' OD2' HD21 ' B' ' 252' ' ' LEU . 50.9 p-10 -94.2 14.85 18.88 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.289 -179.559 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' B' B ' 257' ' ' LYS . . . . . 0.532 ' C ' ' O ' ' B' ' 256' ' ' ASP . 98.6 mttt 25.13 -120.16 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 O-C-N 123.553 0.533 . . . . 0.0 110.366 -179.991 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.476 ' C ' ' O ' ' B' ' 257' ' ' LYS . 86.4 m-20 -33.48 148.11 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.813 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.562 ' C ' ' H ' ' B' ' 261' ' ' ILE . 49.4 p30 -125.43 -169.41 1.99 Allowed 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.242 0.544 . . . . 0.0 110.953 -179.267 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.456 ' HB2' HH21 ' A' ' 93' ' ' ARG . 77.2 mt-10 -62.12 17.91 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.991 -178.734 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.562 ' H ' ' C ' ' B' ' 259' ' ' ASP . 83.2 mt -107.59 132.07 56.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.949 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 54.9 t -124.78 132.37 71.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.082 -179.947 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -94.3 118.35 31.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.052 -178.636 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -67.13 -44.8 78.93 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.606 179.276 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' B' B ' 265' ' ' GLN . . . . . 0.658 ' NE2' ' O ' ' B' ' 266' ' ' PRO . 0.0 OUTLIER -87.42 162.12 43.64 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.999 -179.621 . . . . . . . . 3 3 . 1 . 091 nuclear build full ' B' B ' 266' ' ' PRO . . . . . 0.658 ' O ' ' NE2' ' B' ' 265' ' ' GLN . 36.6 Cg_endo -62.15 144.07 95.32 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 121.974 1.783 . . . . 0.0 111.91 -179.85 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' B' B ' 267' ' ' ILE . . . . . 0.488 HG23 ' O ' ' B' ' 267' ' ' ILE . 11.8 tt . . . . . 0 C--N 1.322 -0.589 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.623 -178.925 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo . . . . . 0 N--CA 1.499 1.817 0 N-CA-C 111.825 -0.106 . . . . 0.0 111.825 . . . . . . . . . 0 0 . 1 . 092 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.6 m -96.65 -37.79 10.2 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.426 -179.881 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.612 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 95.3 mtt-85 -90.97 122.98 34.1 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.457 -179.665 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -133.08 140.21 47.55 Favored 'General case' 0 CA--C 1.522 -0.105 0 CA-C-O 121.246 0.546 . . . . 0.0 112.134 -179.65 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.567 HD11 ' HB3' ' A' ' 95' ' ' PHE . 37.3 tp -114.57 135.81 53.72 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.347 -179.883 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.8 t -111.66 130.1 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 120.683 0.278 . . . . 0.0 110.487 -179.735 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.446 HG23 ' CD1' ' B' ' 261' ' ' ILE . 1.8 m -88.93 118.47 28.67 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -177.837 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.562 HD12 ' OG ' ' A' ' 94' ' ' SER . 97.0 mt -83.32 139.07 18.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.37 178.935 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -88.97 160.46 17.12 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.981 179.275 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.504 ' NE ' ' NH2' ' B' ' 245' ' ' ARG . 84.4 mtp180 -56.3 -30.97 63.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.269 -179.27 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 84.3 p -79.22 -7.27 58.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.424 -179.803 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.61 28.08 22.81 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 -179.817 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.7 t -112.01 133.03 59.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.829 0.347 . . . . 0.0 110.629 -179.625 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -77.02 141.24 40.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.732 179.317 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -133.3 -114.91 1.56 Allowed Glycine 0 CA--C 1.536 1.396 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.64 -179.319 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -74.45 149.56 39.68 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.406 2.071 . . . . 0.0 113.324 -179.171 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -112.52 148.88 33.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.986 179.941 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.575 ' CD2' HD11 ' A' ' 37' ' ' ILE . 22.0 t80 -114.58 105.4 53.62 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.714 179.983 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.17 122.41 8.37 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 C-N-CA 121.123 1.215 . . . . 0.0 110.895 -179.678 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 74.2 mt -78.51 46.11 0.62 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.256 -0.578 . . . . 0.0 110.442 -179.2 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.9 p -59.53 -30.25 68.46 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.333 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.645 HD11 ' HG2' ' B' ' 265' ' ' GLN . 73.3 mt -72.86 142.91 47.96 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.996 179.532 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.5 m -62.94 -22.97 67.15 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.255 -179.382 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 86.3 m -135.43 137.89 42.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.504 -179.606 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.67 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 3.5 t -132.57 123.83 27.23 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.825 0.345 . . . . 0.0 110.266 178.227 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.442 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 41.0 tp -112.72 130.3 56.11 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.957 -179.228 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.724 ' CE2' HD12 ' A' ' 37' ' ' ILE . 6.9 m-85 -108.88 140.03 42.91 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.768 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 167.63 -169.05 40.98 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 118.84 -1.647 . . . . 0.0 113.436 179.203 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.451 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 36.9 ttp-105 -90.77 -28.47 18.23 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 114.53 -0.835 . . . . 0.0 110.537 -179.966 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.08 152.35 49.03 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.517 -179.344 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.635 ' O ' ' NE ' ' A' ' 38' ' ' ARG . 7.0 tp -66.42 -42.28 90.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.449 0.642 . . . . 0.0 110.273 179.506 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.542 ' N ' HG23 ' A' ' 33' ' ' ILE . 79.9 tt0 -54.62 -13.87 1.13 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.874 -178.925 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 83.4 m -67.58 133.32 49.21 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.497 179.801 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.442 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 51.3 m-20 -58.69 -32.34 69.05 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.473 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.724 HD12 ' CE2' ' A' ' 29' ' ' PHE . 92.4 mt -125.33 120.61 58.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 177.228 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.635 ' NE ' ' O ' ' A' ' 33' ' ' ILE . 71.0 mtt85 -107.01 135.84 47.88 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.064 -177.34 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.433 HG22 ' H ' ' A' ' 41' ' ' LEU . 89.4 mt -118.12 133.55 64.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.069 0.461 . . . . 0.0 110.593 179.019 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -75.16 23.42 0.1 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.966 -178.864 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.62 HD21 ' NH1' ' B' ' 245' ' ' ARG . 21.0 mt -92.23 123.77 61.58 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.248 178.831 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -71.99 -8.27 22.61 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 121.821 1.681 . . . . 0.0 112.713 -179.503 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.604 HG12 ' HB2' ' B' ' 235' ' ' PRO . 23.8 m -101.14 7.83 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.58 -179.736 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.451 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 21.0 t -91.12 137.19 22.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 120.394 -0.522 . . . . 0.0 109.838 179.674 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.43 ' O ' HG12 ' A' ' 44' ' ' VAL . 0.4 OUTLIER -65.66 164.78 13.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.167 0.508 . . . . 0.0 111.192 -179.451 . . . . . . . . 3 3 . 1 . 092 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -62.54 -44.53 96.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.221 -178.822 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.644 ' O ' ' N ' ' A' ' 49' ' ' CYS . 83.4 mt-30 -113.8 -20.59 11.06 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 123.526 0.516 . . . . 0.0 110.376 179.092 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.513 ' O ' ' OG ' ' A' ' 64' ' ' SER . 24.5 t60 35.52 -73.27 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 179.846 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.644 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -129.91 134.18 47.32 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -178.381 . . . . . . . . 3 3 . 1 . 092 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -125.74 129.95 50.51 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.41 178.67 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.2 mt -113.9 134.66 56.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.015 -179.421 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -119.08 124.93 48.1 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.917 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 94.2 mt -104.27 114.13 43.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.483 0.659 . . . . 0.0 111.447 -179.326 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.44 ' O ' ' C ' ' A' ' 55' ' ' GLU . 94.8 m-70 -114.26 142.23 46.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.638 -1.165 . . . . 0.0 109.93 -179.681 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 54' ' ' HIS . 97.5 mt-10 -40.11 -31.14 0.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -179.703 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.433 ' N ' ' O ' ' A' ' 54' ' ' HIS . 89.1 mt-30 -62.35 -67.98 0.37 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.491 178.604 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.423 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 4.8 tp10 -159.21 -162.98 1.13 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.902 179.742 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.543 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -114.19 127.24 55.8 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.009 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.6 mt -116.44 130.9 70.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.21 0.529 . . . . 0.0 112.369 -177.952 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 25.6 tp -98.62 130.29 45.15 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.464 179.442 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -116.58 137.52 52.12 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.548 -179.437 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.42 HD22 ' HA ' ' A' ' 68' ' ' PRO . 47.5 t30 -98.88 106.7 19.0 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.935 179.496 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -98.14 -7.24 29.88 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.001 178.453 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.513 ' OG ' ' O ' ' A' ' 48' ' ' HIS . 0.7 OUTLIER -70.29 100.93 1.8 Allowed 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.698 179.456 . . . . . . . . 3 3 . 1 . 092 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.3 m -86.05 -8.7 57.73 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.031 0.443 . . . . 0.0 110.268 179.917 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.764 HG22 HG12 ' B' ' 236' ' ' VAL . 0.2 OUTLIER -99.67 -39.52 8.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.226 179.817 . . . . . . . . 3 3 . 1 . 092 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 67.3 m-20 -142.63 93.79 6.82 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.111 179.569 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.42 ' HA ' HD22 ' A' ' 62' ' ' ASN . 42.4 Cg_exo -55.07 148.59 47.7 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 122.384 2.056 . . . . 0.0 112.13 -179.782 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.65 ' HB ' HD11 ' A' ' 76' ' ' ILE . 33.5 m -73.4 149.64 42.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.301 -179.761 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -114.11 140.56 48.4 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.405 -179.911 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.414 ' O ' ' N ' ' A' ' 74' ' ' SER . 4.2 p -128.78 134.8 63.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.671 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 48.8 30.49 2.68 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.086 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.09 27.9 67.55 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.569 -179.984 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.414 ' N ' ' O ' ' A' ' 71' ' ' VAL . 71.5 m -134.81 134.91 41.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.674 0.273 . . . . 0.0 110.434 179.935 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.5 p -68.51 145.19 13.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -178.748 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.65 HD11 ' HB ' ' A' ' 69' ' ' THR . 3.1 pt -122.36 86.08 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.839 179.801 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 46.4 p-10 -67.21 -21.89 65.74 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.846 0.355 . . . . 0.0 110.406 179.68 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -122.5 170.28 8.24 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.446 179.918 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -62.96 144.53 93.29 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 122.298 1.999 . . . . 0.0 112.21 -179.888 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.9 p -139.28 139.68 39.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.858 -179.831 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -74.71 132.88 42.01 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.791 -0.363 . . . . 0.0 110.449 179.452 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 97.7 mt -83.0 138.48 33.74 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.643 179.925 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -128.47 149.42 50.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.36 179.697 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -54.15 119.71 5.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.057 0.456 . . . . 0.0 111.105 -179.426 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.97 -15.73 36.73 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 179.208 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -70.15 137.56 51.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.836 0.35 . . . . 0.0 110.616 179.821 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.465 HG22 ' HG2' ' A' ' 96' ' ' ARG . 59.0 t -111.08 132.73 58.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.14 -178.728 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.3 mt -100.52 132.22 46.58 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.829 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.2 m -120.7 121.71 38.86 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 119.862 -0.735 . . . . 0.0 112.027 -179.136 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.535 ' N ' ' O ' ' A' ' 93' ' ' ARG . 97.4 mt -108.12 119.63 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 177.74 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.517 HG22 ' N ' ' A' ' 92' ' ' ASP . 91.7 mt 35.16 -96.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.486 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.633 ' OD2' ' NE ' ' B' ' 245' ' ' ARG . 31.5 p-10 -110.1 10.82 23.95 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -178.323 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.535 ' O ' ' N ' ' A' ' 90' ' ' ILE . 80.1 mtt-85 -130.04 145.56 51.67 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.624 -179.785 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.562 ' OG ' HD12 ' A' ' 10' ' ' ILE . 54.3 p -139.72 151.94 46.26 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.389 0.614 . . . . 0.0 110.133 179.392 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.567 ' HB3' HD11 ' A' ' 7' ' ' LEU . 54.8 m-85 -125.38 126.2 44.63 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.953 -179.924 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.465 ' HG2' HG22 ' A' ' 87' ' ' VAL . 99.7 mtt180 -85.57 131.94 34.27 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.971 -179.351 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.612 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 88.4 t80 -100.53 125.54 46.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.916 -179.659 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -145.1 132.79 20.99 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.066 0.46 . . . . 0.0 111.912 -179.961 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -96.84 140.67 31.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.714 179.57 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 . . . . . 0 C--N 1.324 -0.505 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.65 -178.718 . . . . . . . . 0 0 . 1 . 092 nuclear build full ' B' B ' 228' ' ' VAL . . . . . 0.537 ' O ' HG12 ' B' ' 228' ' ' VAL . 19.0 t . . . . . 0 C--O 1.234 0.238 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 . . . . . . . . . 1 1 . 1 . 092 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.523 ' O ' ' CB ' ' B' ' 230' ' ' SEP . 99.3 m-20 -76.98 -18.71 58.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.069 179.314 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' B' B ' 230' ' ' SEP . . . . . 0.523 ' CB ' ' O ' ' B' ' 229' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 092 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 169.68 36.64 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.784 179.886 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -126.23 -167.69 12.49 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.554 -179.525 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -61.85 156.84 46.32 Favored 'Trans proline' 0 C--N 1.299 -2.061 0 C-N-CA 123.929 3.086 . . . . 0.0 112.634 179.407 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 092 nuclear build full ' B' B ' 235' ' ' PRO . . . . . 0.604 ' HB2' HG12 ' A' ' 43' ' ' VAL . 31.5 Cg_exo -57.38 154.89 32.82 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.719 2.28 . . . . 0.0 112.357 179.653 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.764 HG12 HG22 ' A' ' 66' ' ' THR . 12.0 m -101.78 130.21 51.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.836 179.615 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.7 t -61.92 115.47 4.07 Favored 'General case' 0 CA--C 1.52 -0.19 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.198 -179.705 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 092 nuclear build full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -55.73 -25.48 51.51 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 122.196 1.931 . . . . 0.0 112.243 179.081 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 19.8 m -70.33 -43.14 70.87 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.096 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.496 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 76.8 t80 -57.94 -49.06 78.08 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.801 179.825 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 97.1 mt -63.66 -41.76 98.17 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.569 -179.193 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -65.12 -40.91 95.15 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -178.829 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -61.59 -43.77 98.24 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.183 -179.59 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.633 ' NE ' ' OD2' ' A' ' 92' ' ' ASP . 76.3 mtp85 -65.14 -40.49 94.49 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.765 -179.6 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -61.6 -39.55 91.65 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.008 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 14.4 t -65.14 -43.86 90.53 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.416 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' B' B ' 248' ' ' GLN . . . . . 0.444 ' O ' ' N ' ' B' ' 252' ' ' LEU . 55.9 tt0 -61.07 -37.83 84.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.254 179.689 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.572 HG23 ' O ' ' B' ' 245' ' ' ARG . 70.5 t -63.22 -44.14 99.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 120.526 -0.47 . . . . 0.0 109.833 178.768 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -58.28 -29.14 65.59 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.379 0.609 . . . . 0.0 109.374 179.143 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -96.96 -9.45 28.28 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.782 179.504 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.529 ' O ' ' O ' ' B' ' 249' ' ' VAL . 31.5 tp -124.47 121.53 35.12 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.801 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' B' B ' 253' ' ' ASN . . . . . 0.438 ' CB ' ' O ' ' B' ' 252' ' ' LEU . 2.1 m-20 167.49 24.91 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.421 -179.827 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' B' B ' 254' ' ' ASP . . . . . 0.459 ' O ' ' CB ' ' B' ' 255' ' ' ASP . 92.7 m-20 -61.47 -41.28 97.0 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.594 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' B' B ' 255' ' ' ASP . . . . . 0.459 ' CB ' ' O ' ' B' ' 254' ' ' ASP . 4.6 t0 154.31 73.28 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.187 -1.369 . . . . 0.0 108.238 179.756 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' B' ' 258' ' ' ASP . 63.8 t0 -97.08 92.47 6.07 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.688 -179.074 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -67.19 -8.06 28.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.35 -179.855 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.401 ' O ' ' OD1' ' B' ' 256' ' ' ASP . 97.6 m-20 -110.98 135.71 51.08 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.322 179.018 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.555 ' C ' ' H ' ' B' ' 261' ' ' ILE . 47.5 p30 -124.9 165.87 17.3 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.469 0.652 . . . . 0.0 110.208 179.83 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.429 ' HB2' ' NH2' ' A' ' 93' ' ' ARG . 98.3 mt-10 -61.61 17.48 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.034 -0.985 . . . . 0.0 112.467 -178.755 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.555 ' H ' ' C ' ' B' ' 259' ' ' ASP . 69.2 mt -108.91 134.69 50.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.848 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 59.1 t -128.88 134.79 63.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.918 0.39 . . . . 0.0 110.621 -179.684 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -97.21 122.08 39.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.661 -178.898 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' B' B ' 264' ' ' LYS . . . . . 0.481 ' HG3' HH22 ' A' ' 38' ' ' ARG . 86.9 tttt -66.81 -44.51 81.01 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.293 179.424 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' B' B ' 265' ' ' GLN . . . . . 0.645 ' HG2' HD11 ' A' ' 24' ' ' LEU . 9.7 mp0 -100.87 160.31 27.1 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.482 -177.935 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -62.3 151.38 82.81 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 123.423 2.748 . . . . 0.0 112.803 -179.336 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 40.8 pt . . . . . 0 C--N 1.33 -0.261 0 CA-C-O 121.844 0.83 . . . . 0.0 112.431 -178.722 . . . . . . . . 0 0 . 1 . 093 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo . . . . . 0 N--CA 1.496 1.639 0 N-CA-C 113.58 0.569 . . . . 0.0 113.58 . . . . . . . . . 0 0 . 1 . 093 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.7 m -65.24 -45.02 86.32 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.127 -179.715 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.603 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 96.3 mtt-85 -88.12 118.01 27.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.916 0.388 . . . . 0.0 110.743 -178.844 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.413 HH21 ' CE1' ' A' ' 19' ' ' HIS . 75.6 ttt180 -125.99 126.42 44.28 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.288 -179.499 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.627 HD12 ' O ' ' A' ' 96' ' ' ARG . 22.5 tp -109.13 130.98 55.49 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.467 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 76.5 t -106.82 127.46 62.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.355 179.97 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.5 m -80.23 144.75 32.66 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.375 0.607 . . . . 0.0 111.674 -179.047 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.64 HD12 ' OG ' ' A' ' 94' ' ' SER . 98.1 mt -116.1 138.41 46.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.235 178.451 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -91.26 156.36 17.87 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.361 179.013 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.437 ' NH2' ' OE2' ' B' ' 260' ' ' GLU . 89.9 mtm180 -60.02 -28.75 67.99 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.615 -179.852 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 84.0 p -74.3 -14.47 60.9 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.524 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.34 35.42 5.73 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 -179.699 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 49.6 t -120.55 130.95 73.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.747 0.308 . . . . 0.0 111.049 -179.797 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -77.08 138.28 39.44 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.632 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.17 -118.24 2.06 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.936 -179.301 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -69.85 148.07 63.71 Favored 'Trans proline' 0 N--CA 1.501 1.938 0 C-N-CA 122.317 2.011 . . . . 0.0 113.685 -178.468 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.413 ' CE1' HH21 ' A' ' 6' ' ' ARG . 0.9 OUTLIER -111.95 130.27 55.9 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.376 -179.863 . . . . . . . . 3 3 . 1 . 093 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.403 ' CD2' HD11 ' A' ' 37' ' ' ILE . 64.9 t80 -107.02 105.43 55.53 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.15 -179.108 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.05 135.17 22.59 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 120.717 0.944 . . . . 0.0 111.306 -179.9 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 74.9 mt -87.13 48.14 1.61 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.754 -178.899 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.9 m -60.46 -29.91 69.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.91 178.829 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 73.1 mt -71.12 143.42 50.6 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.372 -179.939 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.3 m -58.94 -25.99 64.0 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.918 -179.143 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 78.0 m -138.77 141.17 38.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.182 0.515 . . . . 0.0 111.431 -179.862 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.8 t -130.42 121.85 26.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.694 178.683 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 41.2 tp -117.12 126.61 53.09 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.63 -179.652 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.65 ' CE2' HD12 ' A' ' 37' ' ' ILE . 4.3 m-85 -101.92 125.78 48.68 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.441 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 172.12 178.39 42.33 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 119.75 -1.214 . . . . 0.0 113.016 179.624 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 45.8 mtm180 -73.33 -32.77 64.75 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.771 0.32 . . . . 0.0 111.308 179.01 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -48.9 147.02 5.75 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 -178.967 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.456 ' HA ' HH11 ' A' ' 38' ' ' ARG . 11.0 tp -67.02 -40.66 86.01 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 CA-C-O 121.249 0.547 . . . . 0.0 109.929 179.714 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.446 ' N ' HG23 ' A' ' 33' ' ' ILE . 50.1 tp10 -57.68 -19.83 29.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.387 -179.951 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 76.8 m -59.72 129.95 44.42 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.821 -179.399 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.41 ' O ' ' CB ' ' B' ' 264' ' ' LYS . 66.0 m-20 -61.82 -35.03 77.02 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 -179.589 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.65 HD12 ' CE2' ' A' ' 29' ' ' PHE . 93.6 mt -123.5 118.32 54.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 177.395 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.456 HH11 ' HA ' ' A' ' 33' ' ' ILE . 21.8 mtp85 -104.57 136.22 44.53 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.447 -178.375 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.425 ' C ' ' H ' ' A' ' 41' ' ' LEU . 94.0 mt -117.54 129.85 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 121.036 0.446 . . . . 0.0 110.595 -179.955 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.626 ' NE2' ' OD2' ' B' ' 258' ' ' ASP . 73.4 mt-30 -73.36 28.54 0.07 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.808 -178.42 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.627 ' CD1' ' HE ' ' A' ' 93' ' ' ARG . 49.0 mt -103.14 127.89 28.82 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 120.296 -0.561 . . . . 0.0 110.803 -179.985 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.9 -7.47 20.77 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.129 1.886 . . . . 0.0 112.673 -179.369 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.8 m -98.7 4.73 9.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 120.776 -0.369 . . . . 0.0 111.06 179.941 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.1 t -88.4 134.8 27.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.158 178.434 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.2 m -70.54 168.58 15.99 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.447 0.641 . . . . 0.0 111.93 -179.264 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -62.9 -43.67 98.17 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.285 -178.98 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.623 ' O ' ' N ' ' A' ' 49' ' ' CYS . 97.2 mt-30 -114.24 -25.03 8.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.575 179.472 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.6 t60 37.0 -77.21 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.076 -0.966 . . . . 0.0 113.023 179.064 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.623 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -127.39 132.86 50.07 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.228 0.537 . . . . 0.0 111.775 -178.279 . . . . . . . . 3 3 . 1 . 093 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -128.86 132.47 47.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.07 -179.578 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.1 mt -117.12 132.31 67.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.488 179.488 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -114.73 127.85 55.98 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.79 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.5 mm -100.27 111.81 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-O 121.105 0.479 . . . . 0.0 110.736 -179.22 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.448 ' O ' ' C ' ' A' ' 55' ' ' GLU . 88.6 m-70 -110.64 132.91 53.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.17 179.434 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 54' ' ' HIS . 76.9 tt0 -40.82 -32.17 0.21 Allowed 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.394 -179.945 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.409 ' N ' ' O ' ' A' ' 54' ' ' HIS . 98.4 mm-40 -69.16 -68.48 0.4 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.599 179.171 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -146.13 -178.59 6.21 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.706 0.765 . . . . 0.0 111.939 -178.354 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.55 ' HB2' ' NH2' ' A' ' 5' ' ' ARG . . . -116.16 122.0 43.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.788 178.206 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 94.0 mt -118.85 133.92 64.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.161 0.505 . . . . 0.0 111.825 -178.638 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 22.9 tp -98.25 131.53 44.51 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.718 -179.896 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -114.22 139.49 49.34 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 121.053 0.454 . . . . 0.0 111.448 -178.955 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 59.1 t-20 -98.31 106.12 18.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.822 -179.485 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -98.63 -12.23 21.3 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.728 179.379 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.0 t -70.69 103.43 2.55 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.533 179.892 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.4 p -88.97 -18.73 26.83 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.432 179.695 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.596 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -86.68 -44.27 11.96 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.285 . . . . . . . . 3 3 . 1 . 093 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -137.13 97.9 10.6 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.803 179.425 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -57.09 145.31 86.82 Favored 'Trans proline' 0 N--CA 1.499 1.82 0 C-N-CA 122.173 1.916 . . . . 0.0 113.014 -179.426 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.3 m -73.78 141.69 46.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.64 179.365 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -102.16 147.77 26.22 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.146 -179.637 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.546 ' CG2' ' OD1' ' A' ' 86' ' ' ASP . 4.3 p -128.04 136.04 61.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.88 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 47.75 31.59 2.26 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.226 -0.59 . . . . 0.0 109.653 -179.352 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.66 28.37 61.34 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.669 179.887 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 71' ' ' VAL . 58.3 m -140.35 141.57 35.64 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.192 -179.729 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 71.0 t -68.18 132.37 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.125 0 CA-C-O 121.358 0.599 . . . . 0.0 112.0 -179.131 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.58 100.3 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.72 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -87.07 -13.91 42.94 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.98 -178.717 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -117.02 164.96 16.7 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.967 -179.177 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -60.22 143.58 99.51 Favored 'Trans proline' 0 N--CA 1.501 1.956 0 C-N-CA 121.827 1.684 . . . . 0.0 111.613 -179.775 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.3 p -139.62 139.46 38.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.066 0.46 . . . . 0.0 110.782 -178.856 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -72.08 125.65 27.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.006 179.931 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.3 mt -77.95 137.25 38.22 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.269 0.557 . . . . 0.0 110.889 -179.894 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -134.96 152.8 52.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.993 -179.696 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -57.28 113.3 1.69 Allowed 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.347 -179.745 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.85 1.67 22.59 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 -179.843 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.546 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 67.7 t0 -86.16 122.96 30.9 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.596 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.412 HG22 ' HG2' ' A' ' 96' ' ' ARG . 28.0 t -105.7 134.27 47.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.791 -179.286 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.7 mt -105.26 132.61 51.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 178.453 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 37.4 m -121.02 125.45 47.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.484 0.659 . . . . 0.0 111.866 -178.901 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.401 ' O ' ' C ' ' A' ' 91' ' ' ILE . 84.8 mt -117.01 125.22 73.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.49 179.096 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.452 HG22 ' N ' ' A' ' 92' ' ' ASP . 44.5 mm 40.47 -105.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.586 -179.443 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.459 ' O ' ' OD1' ' A' ' 92' ' ' ASP . 56.5 t0 -114.86 19.55 15.79 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.921 0.391 . . . . 0.0 110.633 -179.679 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.627 ' HE ' ' CD1' ' A' ' 41' ' ' LEU . 73.7 mtt-85 -129.32 145.49 51.37 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 -179.856 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.64 ' OG ' HD12 ' A' ' 10' ' ' ILE . 11.4 p -140.94 157.4 45.41 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.241 -179.834 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.592 ' HB3' HD11 ' A' ' 7' ' ' LEU . 92.3 m-85 -131.09 124.96 31.92 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.055 -179.772 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.627 ' O ' HD12 ' A' ' 7' ' ' LEU . 99.8 mtt180 -90.82 136.31 33.16 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.531 -179.707 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.603 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 72.2 t80 -100.16 124.55 45.71 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.833 -179.574 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -141.13 132.08 26.06 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 121.256 0.55 . . . . 0.0 111.829 -179.908 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.435 ' ND2' ' OH ' ' A' ' 97' ' ' TYR . 97.9 m-20 -101.16 142.05 33.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.393 178.413 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 120.913 0.387 . . . . 0.0 111.068 -179.984 . . . . . . . . 0 0 . 1 . 093 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 18.1 m . . . . . 0 N--CA 1.455 -0.185 0 CA-C-O 120.808 0.337 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 093 nuclear build full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -47.48 166.37 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.559 -179.838 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' B' B ' 230' ' ' SEP . . . . . 0.47 ' O ' ' OE1' ' B' ' 231' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 093 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.47 ' OE1' ' O ' ' B' ' 230' ' ' SEP . 30.7 mm100 -139.41 38.95 2.07 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.708 0.289 . . . . 0.0 110.263 179.12 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -111.55 -154.52 12.91 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.106 -178.799 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -74.83 156.46 43.76 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 122.69 2.26 . . . . 0.0 112.788 -179.332 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.413 HG21 ' OG1' ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 093 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -72.88 171.14 18.05 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 121.858 1.705 . . . . 0.0 111.722 179.773 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.596 ' CG2' HG22 ' A' ' 66' ' ' THR . 25.6 t -113.36 134.1 57.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.787 -178.958 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 44.6 t -73.24 128.03 34.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.634 -179.905 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' B' B ' 238' ' ' TPO . . . . . 0.43 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 093 nuclear build full ' B' B ' 239' ' ' PRO . . . . . 0.43 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 31.5 Cg_exo -59.41 -27.02 83.91 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 123.005 2.47 . . . . 0.0 112.711 -179.188 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 71.6 m -73.67 -42.91 60.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.239 0.543 . . . . 0.0 109.757 178.008 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -57.0 -47.02 81.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.981 -179.186 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 89.2 mt -63.42 -40.06 96.16 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.66 -179.998 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.7 -40.5 96.95 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.742 -179.948 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -63.44 -42.53 98.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.227 0.537 . . . . 0.0 110.374 179.309 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.527 ' O ' HG23 ' B' ' 249' ' ' VAL . 21.9 mmt180 -59.36 -41.53 89.46 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.404 -179.125 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -65.35 -40.54 93.74 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.112 -0.635 . . . . 0.0 109.997 178.038 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 48.7 m -61.36 -46.82 88.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.261 178.703 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -62.56 -36.01 81.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.117 -179.724 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.527 HG23 ' O ' ' B' ' 245' ' ' ARG . 33.2 t -59.48 -46.17 93.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.92 -179.928 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -65.75 -36.47 83.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.47 0.652 . . . . 0.0 109.802 178.891 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -68.3 -21.5 64.78 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.496 -179.661 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.446 ' CD1' ' OD1' ' B' ' 256' ' ' ASP . 70.7 mt -72.1 120.61 17.94 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.738 -179.398 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 38.5 t-20 -68.14 -44.41 76.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.487 179.956 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' B' B ' 254' ' ' ASP . . . . . 0.488 ' O ' ' CB ' ' B' ' 255' ' ' ASP . 96.6 m-20 -65.46 -18.4 65.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.732 179.676 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' B' B ' 255' ' ' ASP . . . . . 0.488 ' CB ' ' O ' ' B' ' 254' ' ' ASP . 2.0 m-20 86.89 13.75 0.12 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.776 -179.323 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.487 ' CB ' ' O ' ' B' ' 255' ' ' ASP . 3.7 t0 82.03 48.01 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.285 -179.746 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -65.92 -37.9 87.28 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.509 179.053 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.626 ' OD2' ' NE2' ' A' ' 40' ' ' GLN . 28.7 t70 -55.98 -50.54 70.55 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.49 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.464 ' CB ' ' O ' ' B' ' 258' ' ' ASP . 12.5 t0 83.69 0.86 1.02 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.952 178.876 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.458 ' OE1' ' C ' ' B' ' 259' ' ' ASP . 53.3 mp0 59.66 4.2 0.52 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.11 0.414 . . . . 0.0 111.739 179.528 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.585 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 84.3 mt -110.18 133.26 56.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.927 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 55.3 t -127.31 131.13 70.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.444 0.64 . . . . 0.0 110.914 -179.347 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -93.61 122.73 36.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.219 -0.901 . . . . 0.0 112.165 -178.804 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' B' B ' 264' ' ' LYS . . . . . 0.41 ' CB ' ' O ' ' A' ' 36' ' ' ASP . 88.1 tttt -65.78 -46.74 77.59 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.306 179.929 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.98 160.99 45.3 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.285 -179.365 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -59.8 140.58 93.94 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.363 2.042 . . . . 0.0 111.905 179.278 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 3.4 tt . . . . . 0 C--N 1.321 -0.639 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.881 179.908 . . . . . . . . 0 0 . 1 . 094 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.528 ' C ' HG22 ' A' ' 4' ' ' THR . 95.3 Cg_endo . . . . . 0 N--CA 1.49 1.283 0 N-CA-C 112.685 0.225 . . . . 0.0 112.685 . . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.528 HG22 ' C ' ' A' ' 3' ' ' PRO . 1.8 t 148.94 -27.8 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 O-C-N 124.283 0.99 . . . . 0.0 110.281 179.021 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.484 ' HG3' HG23 ' A' ' 4' ' ' THR . 80.4 mtt85 -86.22 124.58 32.77 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.76 -179.526 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -133.6 141.31 47.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.244 0.545 . . . . 0.0 111.773 -179.228 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.57 HD11 ' HB3' ' A' ' 95' ' ' PHE . 42.8 tp -117.34 130.71 56.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.053 179.014 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 63.8 t -108.96 132.7 56.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.754 -179.226 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.519 ' CG2' HD12 ' B' ' 261' ' ' ILE . 23.0 m -92.35 111.59 23.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.795 -178.874 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.419 HD11 ' HG3' ' A' ' 96' ' ' ARG . 86.7 mt -78.69 147.89 6.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.373 179.142 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -92.12 158.34 16.24 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.329 178.101 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.447 ' NH1' HH11 ' B' ' 245' ' ' ARG . 87.9 mtm180 -57.85 -26.43 62.05 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.266 -178.492 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 97.9 p -80.61 -11.76 59.6 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 120.324 -0.551 . . . . 0.0 111.049 -179.876 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.98 24.22 13.43 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.409 178.777 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.4 m -116.89 136.56 53.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.281 179.037 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -65.91 126.41 28.43 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.423 -179.984 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -113.0 -128.64 4.95 Favored Glycine 0 CA--C 1.535 1.336 0 N-CA-C 111.381 -0.687 . . . . 0.0 111.381 -179.255 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -74.13 150.63 43.03 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 121.979 1.786 . . . . 0.0 111.951 -179.445 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -108.18 162.68 13.85 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.156 0.503 . . . . 0.0 110.604 -179.654 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -129.51 88.93 48.64 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.403 -179.051 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -61.44 131.08 34.38 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.464 2.109 . . . . 0.0 110.993 179.106 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 22' ' ' LEU . 87.7 mt -98.68 121.44 40.63 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 119.819 -0.752 . . . . 0.0 111.355 -178.559 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 82.8 p -114.84 -28.34 7.1 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.562 178.66 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.7 mt -78.59 145.74 34.58 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.856 -1.066 . . . . 0.0 109.952 179.799 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 57.1 m -71.65 -8.27 53.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 0.0 112.216 -178.558 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.5 m -135.59 135.84 40.59 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.331 -179.687 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.5 t -126.4 117.1 22.24 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.227 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.405 HD12 ' O ' ' A' ' 49' ' ' CYS . 55.0 tp -113.65 131.97 55.94 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.249 -178.362 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.676 ' CE2' HD12 ' A' ' 37' ' ' ILE . 4.9 m-85 -110.89 134.02 52.89 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.95 -179.655 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.29 -172.12 38.32 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 119.963 -1.113 . . . . 0.0 112.468 178.687 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.663 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 82.2 mtm-85 -83.28 -32.53 26.33 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.644 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -49.8 149.91 5.2 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -178.86 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.559 ' O ' ' NH2' ' A' ' 38' ' ' ARG . 36.5 mm -64.03 -43.28 97.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.33 -179.823 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -53.68 -21.61 7.35 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.943 -179.234 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 71.5 m -56.6 118.52 4.93 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.717 -179.695 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -57.13 -31.05 64.95 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.864 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.676 HD12 ' CE2' ' A' ' 29' ' ' PHE . 96.3 mt -123.56 117.08 50.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 176.734 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.559 ' NH2' ' O ' ' A' ' 33' ' ' ILE . 72.0 mtt85 -102.91 134.33 46.52 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.571 -177.928 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.664 HG21 HD12 ' A' ' 41' ' ' LEU . 78.7 mt -118.74 131.22 72.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.2 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -80.71 24.66 0.47 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.084 -178.652 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.664 HD12 HG21 ' A' ' 39' ' ' ILE . 27.8 mt -89.61 126.51 57.78 Favored Pre-proline 0 C--N 1.323 -0.579 0 C-N-CA 120.377 -0.529 . . . . 0.0 109.595 179.953 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -68.77 -13.0 36.05 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.258 1.972 . . . . 0.0 113.668 -179.158 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.462 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 2.9 m -99.83 6.47 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.925 179.969 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.663 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 24.1 t -90.52 132.1 36.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.988 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.506 ' OG ' ' N ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -64.79 169.38 5.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.219 0.533 . . . . 0.0 111.375 -178.674 . . . . . . . . 3 3 . 1 . 094 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -62.64 -44.88 95.16 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.292 -179.366 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.651 ' O ' ' N ' ' A' ' 49' ' ' CYS . 96.2 mt-30 -113.21 -13.05 13.02 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.424 178.983 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.506 ' N ' ' OG ' ' A' ' 45' ' ' SER . 14.7 t60 34.2 -75.97 0.0 OUTLIER 'General case' 0 C--O 1.235 0.29 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 179.066 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.651 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.81 136.74 47.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.173 0.511 . . . . 0.0 112.003 -178.773 . . . . . . . . 3 3 . 1 . 094 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -126.38 127.08 44.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.205 179.655 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 92.3 mt -110.85 134.07 54.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.313 -179.113 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -116.5 121.46 41.88 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.718 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.431 HD13 ' HD3' ' A' ' 5' ' ' ARG . 96.5 mt -107.15 112.57 40.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.139 -0.624 . . . . 0.0 111.653 -179.571 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.44 ' O ' ' C ' ' A' ' 55' ' ' GLU . 96.2 m-70 -111.52 144.66 40.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.847 179.936 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.2 tt0 -40.85 -32.26 0.21 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.308 -0.626 . . . . 0.0 109.308 -179.944 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.425 ' N ' ' C ' ' A' ' 54' ' ' HIS . 98.1 mt-30 -63.8 -68.15 0.37 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.452 178.805 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.438 ' CD ' ' CD ' ' A' ' 81' ' ' ARG . 14.7 pt-20 -157.4 -171.82 3.75 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.484 -178.626 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.26 123.33 49.09 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.679 179.51 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 84.2 mt -114.73 128.08 71.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 120.345 -0.542 . . . . 0.0 112.343 -178.93 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.556 ' HB2' HD11 ' A' ' 82' ' ' LEU . 47.3 tp -93.85 127.49 39.62 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.352 179.517 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -115.04 135.41 54.25 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 178.795 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -101.65 112.13 24.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.182 0.515 . . . . 0.0 111.576 -179.369 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -102.44 -7.08 22.25 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.749 179.784 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.36 100.7 3.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.368 179.899 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.2 m -84.98 -9.2 58.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.941 0.4 . . . . 0.0 109.928 179.678 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.92 -39.02 9.59 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.26 179.895 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -149.19 98.32 3.52 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.344 179.987 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -56.04 147.36 64.53 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 122.36 2.04 . . . . 0.0 112.713 179.968 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 38.1 m -69.64 138.78 53.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.088 178.872 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 89' ' ' THR . 83.7 mt-30 -101.02 139.67 36.39 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.161 179.795 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.437 HG22 HD13 ' A' ' 88' ' ' ILE . 18.2 t -131.36 135.97 58.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.356 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 28.4 m120 53.86 34.59 19.67 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.949 -179.733 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.23 30.38 71.72 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.031 179.251 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 41.0 m -143.63 134.88 25.83 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 117.105 0.453 . . . . 0.0 111.054 -179.907 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.4 ' H ' HG12 ' A' ' 75' ' ' VAL . 0.1 OUTLIER -68.99 137.77 23.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.505 179.897 . . . . . . . . 3 3 . 1 . 094 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.573 ' CG2' ' O ' ' A' ' 78' ' ' GLU . 97.2 mt -102.65 105.16 17.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.888 -179.634 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -67.55 -40.87 84.95 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.849 178.751 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.573 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 1.9 mt-10 -127.64 170.91 9.21 Favored Pre-proline 0 N--CA 1.469 0.482 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.147 -178.514 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -59.54 148.71 86.06 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.181 1.921 . . . . 0.0 112.133 179.983 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.7 m -147.39 148.84 16.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.179 0.514 . . . . 0.0 111.869 179.708 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.438 ' CD ' ' CD ' ' A' ' 57' ' ' GLU . 61.4 ttp180 -72.81 128.86 36.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.518 179.779 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.556 HD11 ' HB2' ' A' ' 60' ' ' LEU . 94.9 mt -85.32 135.94 33.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.142 0.496 . . . . 0.0 110.94 179.712 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -119.94 148.93 42.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.79 179.561 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 9.1 t-80 -51.41 123.16 9.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.673 -179.396 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.69 -14.95 49.64 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 179.878 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -67.12 139.09 57.5 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.4 -0.52 . . . . 0.0 109.639 179.507 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.427 HG22 ' HG2' ' A' ' 96' ' ' ARG . 72.6 t -109.99 134.22 52.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.394 -178.195 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.437 HD13 HG22 ' A' ' 71' ' ' VAL . 30.5 mm -90.71 127.28 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 177.492 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.509 ' N ' ' O ' ' A' ' 70' ' ' GLN . 31.6 m -119.74 123.36 43.55 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.467 0.651 . . . . 0.0 111.148 -178.652 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 92' ' ' ASP . 89.2 mt -118.08 126.03 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.314 179.5 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.501 HG22 ' N ' ' A' ' 92' ' ' ASP . 87.9 mt 37.1 -95.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.056 -179.956 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.501 ' N ' HG22 ' A' ' 91' ' ' ILE . 54.2 t0 -119.62 14.38 12.66 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.917 0.389 . . . . 0.0 111.453 -179.356 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.526 ' NE ' HD11 ' B' ' 261' ' ' ILE . 2.2 tpp180 -128.48 142.25 51.14 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.286 -179.555 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.0 m -133.45 150.08 51.76 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.428 0.632 . . . . 0.0 111.362 -179.847 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.57 ' HB3' HD11 ' A' ' 7' ' ' LEU . 89.1 m-85 -121.58 123.24 41.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.422 -0.808 . . . . 0.0 108.907 178.895 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.528 ' O ' HD12 ' A' ' 7' ' ' LEU . 99.7 mtt180 -81.33 126.68 31.88 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.52 -179.725 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.572 ' CE2' ' OD1' ' A' ' 99' ' ' ASN . 76.8 t80 -95.6 123.48 39.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.11 -179.193 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -126.24 115.88 20.41 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.118 179.061 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.572 ' OD1' ' CE2' ' A' ' 97' ' ' TYR . 86.1 m-20 -66.22 -43.35 86.94 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.94 -179.643 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 . . . . . 0 C--N 1.328 -0.358 0 CA-C-O 120.968 0.413 . . . . 0.0 111.097 179.991 . . . . . . . . 0 0 . 1 . 094 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 27.2 m . . . . . 0 N--CA 1.453 -0.317 0 CA-C-O 120.633 0.254 . . . . 0.0 110.543 . . . . . . . . . 0 0 . 1 . 094 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.521 ' C ' ' H ' ' B' ' 231' ' ' GLN . 90.6 m-20 -72.29 144.11 48.48 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.511 179.686 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' B' B ' 230' ' ' SEP . . . . . 0.461 ' N ' ' O2P' ' B' ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 094 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.521 ' H ' ' C ' ' B' ' 229' ' ' ASP . 74.9 mt-30 -130.36 39.59 3.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.609 179.637 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -115.01 -164.12 14.36 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 111.684 -0.567 . . . . 0.0 111.684 -178.726 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -72.88 160.6 45.68 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.823 2.349 . . . . 0.0 112.241 -179.658 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 094 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -73.19 170.53 19.62 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 121.718 1.612 . . . . 0.0 111.715 178.977 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 3.1 p -112.29 133.42 58.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.861 -179.498 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 5.6 t -67.19 123.09 19.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.892 179.834 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' B' B ' 238' ' ' TPO . . . . . 0.598 ' O3P' HG23 ' B' ' 240' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 094 nuclear build full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -55.64 -23.87 42.63 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 121.963 1.775 . . . . 0.0 111.989 179.004 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' B' B ' 240' ' ' THR . . . . . 0.598 HG23 ' O3P' ' B' ' 238' ' ' TPO . 4.6 p -75.93 -38.9 57.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 177.908 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.462 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 74.8 t80 -57.71 -46.61 84.14 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.837 -179.466 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' B' ' 242' ' ' LEU . 92.5 mt -64.67 -40.85 96.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.163 179.711 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -61.87 -43.48 98.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.379 179.565 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 63.4 ttm-85 -63.71 -42.96 97.89 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.366 179.431 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.618 ' O ' HG23 ' B' ' 249' ' ' VAL . 12.4 tpp180 -61.99 -44.6 96.4 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.117 -179.617 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -64.63 -38.97 92.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.453 178.712 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 69.7 p -68.22 -43.76 77.27 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.253 0.549 . . . . 0.0 109.795 179.057 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -58.76 -37.88 77.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.325 179.824 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.618 HG23 ' O ' ' B' ' 245' ' ' ARG . 77.0 t -64.43 -45.07 96.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.909 179.934 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -63.5 -26.97 68.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.39 179.662 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -95.6 -8.85 33.78 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.38 -179.728 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.423 ' CD2' ' NH2' ' A' ' 12' ' ' ARG . 31.4 tp -106.63 120.53 42.21 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.929 -179.934 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -54.29 149.09 10.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.285 0.564 . . . . 0.0 111.299 -179.122 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -68.01 -15.38 63.58 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.177 178.429 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -71.47 -1.2 12.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.27 179.88 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 42.3 p-10 -70.37 78.27 0.55 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.575 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -69.28 -10.85 59.75 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.916 -179.204 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -86.31 112.52 21.49 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.774 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.664 ' C ' ' H ' ' B' ' 261' ' ' ILE . 39.6 p-10 -101.58 127.83 48.12 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.393 0.616 . . . . 0.0 110.613 -179.492 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.441 ' HB2' HH22 ' A' ' 93' ' ' ARG . 90.6 mt-10 -55.19 9.66 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.026 -179.628 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.664 ' H ' ' C ' ' B' ' 259' ' ' ASP . 60.9 mt -106.62 137.24 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.877 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 69.8 t -127.54 134.48 65.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.031 -179.548 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -94.94 119.16 33.01 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.986 -177.367 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' B' B ' 264' ' ' LYS . . . . . 0.494 ' HG3' HH22 ' A' ' 38' ' ' ARG . 88.5 tttt -68.48 -44.63 74.35 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.252 179.612 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.69 156.98 49.9 Favored Pre-proline 0 C--O 1.236 0.353 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.374 -179.43 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -62.26 144.6 95.64 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.935 2.423 . . . . 0.0 112.713 -179.563 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 47.2 pt . . . . . 0 N--CA 1.455 -0.204 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.572 178.673 . . . . . . . . 0 0 . 1 . 095 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo . . . . . 0 N--CA 1.495 1.565 0 CA-C-O 120.852 0.272 . . . . 0.0 112.097 . . . . . . . . . 0 0 . 1 . 095 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.5 p -95.58 -43.74 7.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.17 -179.504 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.505 ' NH2' HG21 ' A' ' 53' ' ' ILE . 76.5 mtm-85 -88.58 125.05 34.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.315 -178.95 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -130.91 144.43 51.46 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.216 179.35 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.965 HD11 HD11 ' A' ' 22' ' ' LEU . 69.7 mt -117.24 141.12 48.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.442 179.761 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.5 t -113.37 127.61 70.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.784 179.652 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.421 ' CG2' HD12 ' B' ' 261' ' ' ILE . 4.9 m -82.76 135.14 35.07 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.233 -178.29 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.515 HD12 ' HB3' ' A' ' 94' ' ' SER . 98.9 mt -105.65 137.04 37.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.348 178.368 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.616 ' HZ2' ' CD ' ' B' ' 257' ' ' LYS . 27.6 mttm -89.69 161.03 16.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.042 0.449 . . . . 0.0 110.348 179.389 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.734 ' HE ' ' NZ ' ' B' ' 257' ' ' LYS . 87.7 mtm180 -54.55 -27.13 36.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.198 -179.018 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.4 m -82.71 -5.1 58.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.197 179.443 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.39 35.3 14.66 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 179.519 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.1 t -115.51 135.36 55.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.773 0.321 . . . . 0.0 110.474 -179.995 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -78.45 132.6 37.36 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.203 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -126.55 -114.95 1.94 Allowed Glycine 0 CA--C 1.537 1.416 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.967 -179.139 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -71.9 144.49 43.34 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 122.338 2.025 . . . . 0.0 112.631 -178.97 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.43 ' O ' HD11 ' B' ' 267' ' ' ILE . 0.2 OUTLIER -106.54 132.66 52.28 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.984 0.421 . . . . 0.0 110.701 -179.746 . . . . . . . . 3 3 . 1 . 095 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.685 ' CD2' HD11 ' A' ' 37' ' ' ILE . 56.0 t80 -101.18 102.35 20.31 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.44 -179.41 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -76.22 129.92 11.66 Favored 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 121.67 1.58 . . . . 0.0 111.789 -179.75 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.965 HD11 HD11 ' A' ' 7' ' ' LEU . 89.8 mt -87.41 80.28 8.18 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.165 -179.07 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.6 p -84.73 -9.92 57.75 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.437 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 66.6 mt -100.16 143.23 30.61 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.96 -179.676 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 93.1 p -65.56 -15.91 63.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.131 -178.642 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.488 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 33.4 m -130.13 130.74 45.17 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.864 -179.407 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.618 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 2.2 t -124.9 118.85 27.21 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.979 178.921 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.483 HD12 ' O ' ' A' ' 49' ' ' CYS . 54.8 tp -120.01 131.86 55.28 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.509 -178.142 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.618 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 54.8 m-85 -108.45 143.13 37.81 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.289 179.689 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 156.29 -151.04 22.51 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 179.156 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.666 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 84.2 mtm-85 -108.89 -23.45 11.72 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.634 179.326 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.469 ' N ' ' SG ' ' A' ' 35' ' ' CYS . . . -55.49 156.86 8.79 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 121.281 -0.485 . . . . 0.0 112.206 -178.584 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.506 HG23 ' N ' ' A' ' 34' ' ' GLU . 11.0 tp -65.69 -41.93 91.55 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 CA-C-O 120.986 0.422 . . . . 0.0 110.061 179.606 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.506 ' N ' HG23 ' A' ' 33' ' ' ILE . 96.4 mt-10 -60.11 -28.46 67.88 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.803 179.873 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.534 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 9.3 m -53.13 115.46 1.89 Allowed 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.071 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.488 ' OD2' ' O ' ' A' ' 26' ' ' THR . 99.5 m-20 -60.74 -26.71 67.39 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -179.245 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.685 HD11 ' CD2' ' A' ' 20' ' ' PHE . 47.5 mm -123.24 112.37 33.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.67 177.516 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -105.0 137.65 42.42 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.773 -179.832 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.489 ' CG2' HD12 ' A' ' 41' ' ' LEU . 98.2 mt -121.76 132.85 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.138 179.058 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -79.33 34.26 0.25 Allowed 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -177.588 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.582 ' CD1' ' HE ' ' A' ' 93' ' ' ARG . 9.7 mt -113.59 137.61 22.25 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.553 178.9 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.09 -10.79 29.1 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.836 2.358 . . . . 0.0 113.93 -178.138 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.435 HG21 ' CE2' ' B' ' 241' ' ' PHE . 27.4 m -95.51 3.34 9.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.223 -0.591 . . . . 0.0 111.206 -179.993 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.666 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 37.3 t -94.5 130.19 43.69 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.717 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.9 m -70.97 163.47 27.46 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -177.796 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.534 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 54.8 mttp -62.75 -41.62 99.29 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.486 -179.048 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.633 ' O ' ' N ' ' A' ' 49' ' ' CYS . 10.8 mm100 -113.98 -24.63 8.95 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.239 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 24.5 t60 35.26 -74.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 178.944 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.633 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.79 138.64 45.83 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -177.993 . . . . . . . . 3 3 . 1 . 095 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -128.6 127.83 43.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.789 179.817 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.8 mt -115.42 134.22 59.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.516 179.244 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -114.17 137.84 51.23 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.449 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.505 HG21 ' NH2' ' A' ' 5' ' ' ARG . 39.5 mm -98.15 120.01 46.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.307 0.575 . . . . 0.0 110.679 -179.367 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.454 ' O ' ' C ' ' A' ' 55' ' ' GLU . 38.0 m-70 -120.78 131.35 54.43 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.303 179.452 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 54' ' ' HIS . 99.5 mt-10 -40.07 -34.46 0.3 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -179.774 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -62.75 -66.85 0.48 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.845 -1.071 . . . . 0.0 108.953 178.358 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -160.05 -159.14 0.69 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.426 178.854 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.669 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -113.62 131.03 56.28 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.814 -0.355 . . . . 0.0 110.362 -179.938 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 37.6 mm -108.64 123.5 64.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.004 -179.25 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.413 HD22 ' CD1' ' A' ' 88' ' ' ILE . 38.9 tp -95.77 124.01 39.6 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.149 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -113.01 134.17 54.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.259 -179.547 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -95.33 104.65 16.55 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.951 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -99.26 -7.51 26.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.957 178.838 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.9 t -78.08 98.94 5.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.133 -179.175 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.8 m -77.64 -37.49 49.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.127 0.489 . . . . 0.0 109.955 178.599 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.467 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.1 OUTLIER -68.56 -40.45 80.61 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.458 -179.705 . . . . . . . . 3 3 . 1 . 095 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -146.68 96.98 4.33 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.963 -179.286 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -56.36 148.28 62.75 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.455 2.104 . . . . 0.0 112.467 179.505 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.4 m -74.68 143.06 44.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.313 -179.764 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -104.12 140.39 37.86 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.225 179.385 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.9 t -130.08 135.77 60.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.024 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 52.98 37.14 23.83 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.38 -179.898 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.29 29.53 74.4 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.095 179.204 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.3 t -144.94 136.05 24.94 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.481 -179.983 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.1 p -72.2 138.59 21.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.16 -179.256 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.894 HD13 ' O ' ' A' ' 76' ' ' ILE . 0.0 OUTLIER -133.6 126.76 52.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.96 179.289 . . . . . . . . 3 3 . 1 . 095 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -99.4 -9.76 23.07 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.658 -179.308 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.788 ' O ' HD11 ' A' ' 76' ' ' ILE . 1.2 pm0 -118.47 161.05 37.37 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 120.776 -0.37 . . . . 0.0 111.035 -179.18 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -57.54 143.77 93.8 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 121.613 1.542 . . . . 0.0 111.859 179.696 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.409 HG13 ' HB3' ' A' ' 60' ' ' LEU . 2.8 p -139.63 141.61 34.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.353 -179.462 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -78.39 134.12 37.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.394 -179.867 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.669 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 91.1 mt -93.46 139.36 30.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.241 0.543 . . . . 0.0 111.622 -179.269 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -126.06 155.93 40.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.997 179.765 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.423 ' ND1' ' N ' ' A' ' 99' ' ' ASN . 8.4 t60 -55.83 118.55 4.68 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.9 0.381 . . . . 0.0 110.235 -179.523 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.82 -17.1 27.9 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 -179.704 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -68.14 137.47 54.92 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.224 179.968 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.55 ' CG2' ' OG ' ' A' ' 94' ' ' SER . 7.7 p -111.55 134.18 54.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.061 0.457 . . . . 0.0 112.031 -178.557 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.413 ' CD1' HD22 ' A' ' 60' ' ' LEU . 47.5 mm -93.81 128.02 45.46 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.093 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 178.069 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 47.9 m -126.57 126.68 44.05 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -178.001 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.459 ' O ' ' C ' ' A' ' 91' ' ' ILE . 86.4 mt -116.07 126.63 73.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 114.225 -1.352 . . . . 0.0 108.259 178.57 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.476 HG22 ' N ' ' A' ' 92' ' ' ASP . 94.6 mt 35.71 -96.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 121.024 -0.271 . . . . 0.0 110.922 -179.593 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.476 ' N ' HG22 ' A' ' 91' ' ' ILE . 26.5 m-20 -120.11 17.28 12.43 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.86 0.362 . . . . 0.0 111.432 179.802 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.79 HH21 ' NH2' ' B' ' 245' ' ' ARG . 0.6 OUTLIER -124.71 138.22 54.3 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.845 . . . . . . . . 3 3 . 1 . 095 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.55 ' OG ' ' CG2' ' A' ' 87' ' ' VAL . 8.1 t -139.97 151.1 45.25 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 119.826 -0.75 . . . . 0.0 111.751 -179.055 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -122.69 122.51 38.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.561 178.734 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -87.2 134.12 33.57 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.315 -178.865 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -97.59 125.8 42.53 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.518 179.79 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -143.72 130.07 19.91 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.779 -179.908 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.423 ' N ' ' ND1' ' A' ' 84' ' ' HIS . 84.7 m-20 -89.61 112.64 23.92 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.411 179.112 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.616 -179.991 . . . . . . . . 0 0 . 1 . 095 nuclear build full ' B' B ' 228' ' ' VAL . . . . . 0.597 ' O ' ' N ' ' B' ' 230' ' ' SEP . 3.5 p . . . . . 0 N--CA 1.455 -0.187 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 . . . . . . . . . 1 1 . 1 . 095 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' B' ' 228' ' ' VAL . 62.6 t0 33.61 -86.27 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.235 179.763 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' B' B ' 230' ' ' SEP . . . . . 0.597 ' N ' ' O ' ' B' ' 228' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 095 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -122.01 51.75 1.32 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.922 -179.2 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -128.33 -177.57 14.93 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 -179.418 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -74.19 160.77 41.95 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 123.863 3.042 . . . . 0.0 113.5 -179.398 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.467 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 095 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -57.42 132.69 52.27 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 121.935 1.757 . . . . 0.0 111.969 -179.434 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 24.8 t -59.6 137.53 21.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.006 179.441 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.9 t -52.67 112.58 0.86 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.169 -179.324 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' B' B ' 238' ' ' TPO . . . . . 0.432 HG23 ' H ' ' B' ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 095 nuclear build full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -57.96 -24.73 66.64 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 121.741 1.627 . . . . 0.0 111.519 178.95 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 97.0 m -71.03 -45.35 64.05 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.967 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.435 ' CE2' HG21 ' A' ' 43' ' ' VAL . 89.6 t80 -58.38 -46.8 85.64 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.754 -179.601 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 92.6 mt -64.04 -42.1 97.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.878 -179.577 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -63.3 -43.21 98.51 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 120.871 -0.331 . . . . 0.0 111.076 -179.402 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -63.0 -40.11 96.79 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.699 179.8 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.79 ' NH2' HH21 ' A' ' 93' ' ' ARG . 61.2 ttm-85 -61.76 -44.54 96.69 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.084 179.574 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -62.52 -41.53 98.92 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.469 -179.618 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 57.9 m -66.97 -46.03 75.89 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.291 0.567 . . . . 0.0 110.521 179.122 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' B' B ' 248' ' ' GLN . . . . . 0.427 ' O ' ' HG ' ' B' ' 252' ' ' LEU . 86.2 mt-30 -62.92 -33.56 75.59 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.447 -179.46 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.729 HG23 ' O ' ' B' ' 245' ' ' ARG . 61.4 t -66.12 -45.2 90.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 121.19 0.519 . . . . 0.0 111.55 179.867 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -69.95 -20.82 63.31 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.984 -178.948 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -90.99 4.67 51.43 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.324 -178.983 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' B' ' 248' ' ' GLN . 36.4 mt -77.93 159.94 28.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.392 0.615 . . . . 0.0 112.349 -178.981 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' B' B ' 253' ' ' ASN . . . . . 0.547 ' OD1' ' N ' ' B' ' 254' ' ' ASP . 25.5 t-20 -75.7 176.45 7.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.594 178.864 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' B' B ' 254' ' ' ASP . . . . . 0.547 ' N ' ' OD1' ' B' ' 253' ' ' ASN . 88.6 m-20 -98.1 0.88 46.92 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -178.757 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' B' B ' 255' ' ' ASP . . . . . 0.507 ' O ' ' OD1' ' B' ' 256' ' ' ASP . 74.2 m-20 -148.66 43.73 1.0 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -178.437 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.507 ' OD1' ' O ' ' B' ' 255' ' ' ASP . 93.8 m-20 -138.75 -141.31 0.15 Allowed 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 119.715 -0.794 . . . . 0.0 111.865 178.909 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' B' B ' 257' ' ' LYS . . . . . 0.734 ' NZ ' ' HE ' ' A' ' 12' ' ' ARG . 82.2 tttt 62.7 110.05 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.174 0 O-C-N 121.896 -0.502 . . . . 0.0 112.048 179.986 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.505 ' O ' ' OD2' ' B' ' 259' ' ' ASP . 36.8 p-10 -85.78 -4.57 59.2 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.22 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.586 ' C ' ' H ' ' B' ' 261' ' ' ILE . 0.0 OUTLIER 80.87 111.88 0.07 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.624 -179.653 . . . . . . . . 3 3 . 1 . 095 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.438 ' OE1' ' N ' ' B' ' 260' ' ' GLU . 57.4 mp0 -57.64 11.92 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.012 -0.994 . . . . 0.0 112.261 -178.524 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.586 ' H ' ' C ' ' B' ' 259' ' ' ASP . 66.4 mt -106.01 134.35 47.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 178.123 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 72.0 t -123.71 132.27 71.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.26 0.552 . . . . 0.0 110.238 -178.812 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -95.18 117.4 30.18 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.543 -177.869 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' B' B ' 264' ' ' LYS . . . . . 0.427 ' NZ ' ' HA ' ' A' ' 34' ' ' GLU . 88.5 tttt -65.17 -45.77 83.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.572 179.745 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.26 158.9 71.34 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.144 -179.819 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -60.1 140.59 93.2 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 C-N-CA 122.237 1.958 . . . . 0.0 111.733 179.499 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' B' B ' 267' ' ' ILE . . . . . 0.469 HG23 ' O ' ' B' ' 267' ' ' ILE . 13.8 tt . . . . . 0 C--N 1.326 -0.414 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.156 -179.541 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo . . . . . 0 N--CA 1.498 1.745 0 N-CA-C 112.973 0.336 . . . . 0.0 112.973 . . . . . . . . . 0 0 . 1 . 096 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.6 m -135.75 -59.37 0.76 Allowed 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.707 -179.313 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.546 ' NH2' HG21 ' A' ' 53' ' ' ILE . 88.1 mtm-85 -94.87 131.57 40.62 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.936 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -142.86 151.54 41.18 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 119.958 -0.697 . . . . 0.0 112.305 179.933 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 80.3 mt -115.25 131.52 56.9 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.14 178.653 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 73.0 t -103.65 128.21 57.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.942 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.553 HG23 ' CD1' ' B' ' 261' ' ' ILE . 2.7 m -87.82 120.9 29.6 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -177.377 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 91.1 mt -82.18 134.92 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.659 178.462 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -88.37 160.73 17.46 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.4 0.619 . . . . 0.0 111.394 179.365 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.67 ' CG ' HH12 ' A' ' 93' ' ' ARG . 76.7 mtp180 -53.9 -40.98 67.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.921 -178.759 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.5 t -72.2 -11.11 60.58 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.024 179.892 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.25 35.31 5.3 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 -179.513 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.7 t -123.66 135.96 61.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.103 0.478 . . . . 0.0 111.914 -179.474 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -70.07 136.43 50.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.809 179.504 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -122.0 -125.34 3.11 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.919 -179.332 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.65 150.26 56.45 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 122.051 1.834 . . . . 0.0 113.222 -178.469 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 53.3 m170 -110.28 132.91 53.76 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.52 -179.251 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.444 ' CD2' HD11 ' A' ' 37' ' ' ILE . 25.1 t80 -102.12 100.73 15.99 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.301 -179.506 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -73.37 127.69 12.11 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 C-N-CA 121.421 1.414 . . . . 0.0 110.855 179.979 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 99.3 mt -79.99 55.58 2.16 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.816 -0.353 . . . . 0.0 111.886 -178.345 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 87.1 p -67.13 -22.21 65.8 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.508 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.649 HD11 ' HG2' ' B' ' 265' ' ' GLN . 69.9 mt -83.52 139.8 32.67 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.563 179.573 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.9 m -67.42 -18.6 65.17 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.429 -178.965 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 36.4 m -129.23 130.91 46.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.238 0.542 . . . . 0.0 111.918 -179.717 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.671 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.7 OUTLIER -125.62 118.33 25.45 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.65 178.735 . . . . . . . . 3 3 . 1 . 096 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.519 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 56.0 tp -119.79 125.69 49.21 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.522 -178.424 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.671 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 48.2 m-85 -101.76 128.07 48.26 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.492 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 177.5 -176.84 48.23 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.282 -0.961 . . . . 0.0 111.762 179.101 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.662 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 84.6 mtm-85 -82.39 -28.07 31.68 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.12 0.486 . . . . 0.0 110.242 179.75 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.61 155.02 41.63 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.282 -178.368 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.443 HD12 ' HD3' ' A' ' 38' ' ' ARG . 9.1 tp -65.98 -39.38 84.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.489 -0.355 . . . . 0.0 110.56 179.23 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.413 ' N ' HG23 ' A' ' 33' ' ' ILE . 71.0 mm-40 -55.17 -21.61 14.2 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.659 -179.795 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.8 m -64.03 119.86 10.93 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.088 -179.982 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.585 ' OD2' ' SG ' ' A' ' 27' ' ' CYS . 28.2 p-10 -54.26 -26.12 27.19 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.385 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.603 HD12 ' CE2' ' A' ' 29' ' ' PHE . 94.9 mt -130.59 123.61 55.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.29 -0.868 . . . . 0.0 108.879 178.043 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.443 ' HD3' HD12 ' A' ' 33' ' ' ILE . 20.9 mtm180 -109.3 137.63 46.88 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.761 -179.099 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 92.8 mt -118.65 131.62 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.936 179.293 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -77.89 31.64 0.17 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -177.877 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.568 HD21 ' OE1' ' B' ' 260' ' ' GLU . 34.7 mt -102.88 130.64 23.37 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.742 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.573 ' HA ' HG11 ' B' ' 228' ' ' VAL . 60.4 Cg_endo -73.53 -6.09 18.17 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 121.909 1.739 . . . . 0.0 112.534 -179.459 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.458 HG21 ' CE2' ' B' ' 241' ' ' PHE . 4.9 m -101.39 3.74 10.59 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.501 -179.686 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.662 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 34.3 t -90.57 133.48 32.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.632 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.453 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 0.6 OUTLIER -69.74 170.22 11.39 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.779 0.799 . . . . 0.0 112.753 -177.5 . . . . . . . . 3 3 . 1 . 096 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -64.04 -43.83 94.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.512 -179.324 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.636 ' O ' ' N ' ' A' ' 49' ' ' CYS . 90.5 mm-40 -111.69 -17.39 13.01 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.299 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.453 ' H ' ' HB3' ' A' ' 45' ' ' SER . 13.4 t60 32.56 -78.11 0.0 OUTLIER 'General case' 0 C--O 1.238 0.492 0 CA-C-N 114.686 -1.143 . . . . 0.0 112.985 179.765 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.636 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.66 135.97 46.16 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.482 -179.003 . . . . . . . . 3 3 . 1 . 096 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -125.89 131.4 52.36 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.702 179.003 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.1 mt -117.64 135.17 58.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.574 -179.967 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -114.18 135.57 53.89 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.669 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.546 HG21 ' NH2' ' A' ' 5' ' ' ARG . 46.0 mm -103.01 125.19 57.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.941 -179.398 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.473 ' O ' ' N ' ' A' ' 56' ' ' GLN . 33.3 m-70 -127.04 129.31 47.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.596 179.349 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' A' ' 54' ' ' HIS . 96.0 mt-10 -40.2 -29.74 0.08 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.216 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.473 ' N ' ' O ' ' A' ' 54' ' ' HIS . 88.3 mt-30 -67.08 -67.28 0.46 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.41 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -154.92 -168.1 2.78 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.707 -179.807 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.566 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -112.11 131.09 55.65 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.407 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.3 mm -108.66 125.2 65.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.869 -179.433 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 34.1 tp -99.44 126.3 45.33 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.258 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -115.76 137.61 51.92 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.579 -179.187 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -102.57 105.18 15.65 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.368 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -95.89 -4.28 43.84 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.513 178.997 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.52 104.45 15.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.553 -179.187 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.3 p -87.31 -35.89 18.17 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.698 179.124 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.6 -45.71 92.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.793 -179.714 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.41 ' OD1' HG23 ' B' ' 236' ' ' VAL . 2.9 m-80 -145.58 104.43 4.27 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.07 179.248 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -67.04 151.43 81.88 Favored 'Trans proline' 0 N--CA 1.491 1.332 0 C-N-CA 121.74 1.627 . . . . 0.0 113.287 -177.87 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.928 ' O ' HG22 ' A' ' 76' ' ' ILE . 33.9 m -70.79 146.93 49.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.598 179.95 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -110.87 139.92 45.77 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.758 -179.404 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 54.2 t -129.66 134.99 62.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.05 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 53.6 34.41 18.57 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.221 179.829 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.31 28.71 69.43 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.91 179.468 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.6 t -144.93 142.62 30.01 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 117.182 0.491 . . . . 0.0 110.986 179.758 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.4 m -68.97 143.71 14.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.496 -179.497 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.928 HG22 ' O ' ' A' ' 69' ' ' THR . 10.0 tt -111.67 90.92 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.92 -179.801 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -65.55 -35.25 80.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.115 179.52 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.477 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 5.0 mt-10 -124.67 164.74 28.99 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.387 -178.402 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.74 138.87 77.12 Favored 'Trans proline' 0 N--CA 1.501 1.954 0 C-N-CA 122.102 1.868 . . . . 0.0 112.874 -179.879 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 73.2 t -132.37 137.39 54.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.781 179.956 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 84.6 mtt85 -71.38 129.32 38.52 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.487 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.566 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 95.6 mt -82.75 137.36 34.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.164 0.507 . . . . 0.0 111.072 -179.876 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -128.09 152.35 48.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.593 -179.621 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.415 ' HD1' ' H ' ' A' ' 99' ' ' ASN . 7.7 t60 -55.86 117.77 3.99 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.431 179.948 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.85 -20.43 19.93 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 179.851 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -67.03 136.63 55.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.979 0.418 . . . . 0.0 110.216 179.948 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.1 t -109.43 133.87 53.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.684 -178.758 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 88.6 mt -102.86 129.93 53.75 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.514 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 178.275 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 61.5 m -123.41 128.43 49.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.799 0.809 . . . . 0.0 112.249 -178.014 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.678 ' O ' ' N ' ' A' ' 93' ' ' ARG . 93.9 mt -116.53 132.86 64.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.077 178.7 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.517 ' C ' ' O ' ' A' ' 90' ' ' ILE . 51.0 mt -22.5 98.82 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.067 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.573 ' CG ' ' HE ' ' B' ' 245' ' ' ARG . 0.7 OUTLIER 80.08 -17.57 0.57 Allowed 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 178.354 . . . . . . . . 3 3 . 1 . 096 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.678 ' N ' ' O ' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -122.52 132.64 54.42 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 119.64 -0.219 . . . . 0.0 110.868 -179.747 . . . . . . . . 3 3 . 1 . 096 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.1 t -136.28 146.88 47.16 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 118.488 0.586 . . . . 0.0 111.129 -179.781 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -125.74 122.06 35.19 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.647 179.593 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -84.43 134.85 34.45 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.399 -179.249 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -97.82 126.43 43.18 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.492 -179.598 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -143.12 128.38 18.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.644 179.827 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.539 ' O ' ' OD1' ' A' ' 99' ' ' ASN . 29.0 p30 -118.06 136.76 53.36 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 121.483 0.658 . . . . 0.0 111.343 -179.898 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 C--N 1.325 -0.492 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.211 -179.75 . . . . . . . . 0 0 . 1 . 096 nuclear build full ' B' B ' 228' ' ' VAL . . . . . 0.573 HG11 ' HA ' ' A' ' 42' ' ' PRO . 53.6 t . . . . . 0 C--O 1.234 0.258 0 CA-C-O 120.728 0.299 . . . . 0.0 111.016 . . . . . . . . . 1 1 . 1 . 096 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' B' ' 228' ' ' VAL . 83.5 m-20 39.21 -106.75 0.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.741 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' B' B ' 230' ' ' SEP . . . . . 0.415 ' O1P' ' O ' ' B' ' 229' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 096 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -139.18 29.05 2.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.017 -179.112 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -106.39 -158.01 21.79 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -179.611 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -58.43 151.97 57.7 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 C-N-CA 123.168 2.579 . . . . 0.0 113.041 -179.951 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.424 ' O2P' HG21 ' B' ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 096 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -77.4 172.7 15.47 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.343 2.028 . . . . 0.0 111.927 -179.939 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.41 HG23 ' OD1' ' A' ' 67' ' ' ASN . 3.8 p -113.7 132.65 62.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.095 -179.719 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' B' B ' 237' ' ' CYS . . . . . 0.427 ' HB2' HD13 ' A' ' 91' ' ' ILE . 1.0 OUTLIER -66.27 121.41 15.17 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 120.248 -0.581 . . . . 0.0 109.493 179.943 . . . . . . . . 3 3 . 1 . 096 nuclear build full ' B' B ' 238' ' ' TPO . . . . . 0.541 ' P ' ' OG1' ' B' ' 240' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 096 nuclear build full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -54.61 -24.27 36.09 Favored 'Trans proline' 0 N--CA 1.49 1.284 0 C-N-CA 121.941 1.761 . . . . 0.0 111.349 -179.792 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' B' B ' 240' ' ' THR . . . . . 0.541 ' OG1' ' P ' ' B' ' 238' ' ' TPO . 2.5 p -74.35 -39.75 62.58 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 177.784 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.458 ' CE2' HG21 ' A' ' 43' ' ' VAL . 71.0 t80 -58.04 -47.46 83.03 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.047 -179.264 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.465 HD21 HG23 ' A' ' 91' ' ' ILE . 98.0 mt -64.66 -40.18 94.97 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.043 0.449 . . . . 0.0 110.07 -179.823 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -63.61 -44.0 95.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.795 179.567 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -61.54 -41.24 97.07 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.109 -179.855 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.715 ' O ' HG23 ' B' ' 249' ' ' VAL . 22.1 mmm180 -61.61 -40.37 94.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.348 -179.859 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -63.77 -42.43 97.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.801 0.334 . . . . 0.0 110.794 179.313 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 72.2 p -64.95 -43.19 93.51 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.729 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -62.36 -37.33 85.25 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.682 179.668 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.715 HG23 ' O ' ' B' ' 245' ' ' ARG . 79.3 t -65.75 -45.41 91.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.2 179.019 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -63.08 -30.67 71.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.861 179.876 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -90.75 -10.87 41.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.983 179.619 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.533 ' O ' ' O ' ' B' ' 249' ' ' VAL . 64.0 tp -121.75 118.51 29.25 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.594 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -177.8 39.54 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.08 -179.674 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' B' B ' 254' ' ' ASP . . . . . 0.586 ' O ' ' CB ' ' B' ' 255' ' ' ASP . 33.1 p-10 -95.14 1.81 54.92 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 178.927 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' B' B ' 255' ' ' ASP . . . . . 0.586 ' CB ' ' O ' ' B' ' 254' ' ' ASP . 64.6 t0 116.12 58.64 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 O-C-N 124.796 1.31 . . . . 0.0 109.994 -179.623 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.506 ' O ' ' OD1' ' B' ' 256' ' ' ASP . 55.8 p-10 -56.71 76.88 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.941 0.4 . . . . 0.0 110.206 -179.937 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' B' B ' 257' ' ' LYS . . . . . 0.586 ' N ' ' O ' ' B' ' 255' ' ' ASP . 98.2 mttt -63.65 -35.87 81.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.951 179.573 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -61.23 -68.13 0.34 Allowed 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.026 -179.223 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.598 ' OD1' ' N ' ' B' ' 261' ' ' ILE . 0.0 OUTLIER 69.57 129.68 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.495 0.664 . . . . 0.0 110.591 -179.224 . . . . . . . . 3 3 . 1 . 096 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.568 ' OE1' HD21 ' A' ' 41' ' ' LEU . 99.6 mt-10 -56.3 11.57 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.559 -1.201 . . . . 0.0 113.987 -177.808 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.598 ' N ' ' OD1' ' B' ' 259' ' ' ASP . 41.0 mt -109.66 133.11 55.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 119.881 -0.728 . . . . 0.0 109.111 178.824 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 44.1 t -127.8 135.5 62.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.541 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -100.22 123.64 44.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.249 0.547 . . . . 0.0 112.415 -177.6 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -63.98 -47.35 80.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.111 178.59 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' B' B ' 265' ' ' GLN . . . . . 0.649 ' HG2' HD11 ' A' ' 24' ' ' LEU . 6.0 mp0 -96.84 163.76 19.48 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.477 179.972 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -60.76 156.74 41.35 Favored 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 122.941 2.427 . . . . 0.0 111.982 178.72 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 10.6 pt . . . . . 0 N--CA 1.466 0.35 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.893 -178.224 . . . . . . . . 0 0 . 1 . 097 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo . . . . . 0 N--CA 1.499 1.801 0 N-CA-C 111.593 -0.195 . . . . 0.0 111.593 . . . . . . . . . 0 0 . 1 . 097 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.5 p -100.99 -46.56 5.05 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.858 0.361 . . . . 0.0 110.354 -179.765 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.776 HH12 HG23 ' A' ' 53' ' ' ILE . 99.9 mtt180 -94.11 132.28 38.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.747 179.213 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 91.6 mtm180 -134.07 141.93 47.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.015 -179.911 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.559 HD11 ' HB3' ' A' ' 95' ' ' PHE . 42.3 tp -111.94 131.27 55.49 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.122 179.416 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.666 HG11 ' OD2' ' A' ' 16' ' ' ASP . 61.7 t -107.07 130.27 59.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.382 179.832 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 m -92.84 115.06 27.77 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.437 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 88.6 mt -80.93 142.74 13.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.667 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.443 ' NZ ' ' HA ' ' B' ' 257' ' ' LYS . 97.6 mttt -84.81 156.04 21.52 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.562 178.823 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.424 ' HG3' ' NH2' ' B' ' 245' ' ' ARG . 58.0 ttp180 -58.16 -35.85 72.16 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.069 -179.795 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.1 t -68.21 -21.59 64.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.988 0.423 . . . . 0.0 110.13 178.638 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.57 29.02 4.6 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 111.156 -0.777 . . . . 0.0 111.156 179.993 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.8 t -117.78 132.9 66.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.869 0.366 . . . . 0.0 111.152 -179.804 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.666 ' OD2' HG11 ' A' ' 8' ' ' VAL . 63.5 t0 -79.29 130.83 35.85 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.67 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.462 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -129.93 -108.71 1.31 Allowed Glycine 0 CA--C 1.532 1.133 0 C-N-CA 119.707 -1.235 . . . . 0.0 112.221 -179.66 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.1 145.19 48.88 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.496 2.131 . . . . 0.0 113.81 -178.333 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.451 ' O ' ' CD1' ' B' ' 267' ' ' ILE . 0.2 OUTLIER -110.56 145.62 37.49 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.475 178.871 . . . . . . . . 3 3 . 1 . 097 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.421 ' CD2' HD11 ' A' ' 37' ' ' ILE . 54.0 t80 -113.99 92.21 25.14 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.856 -179.084 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.83 130.02 34.86 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 122.037 1.825 . . . . 0.0 111.189 -179.602 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.5 mt -87.73 84.71 7.03 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.314 -179.483 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 51.4 p -89.85 -10.44 45.33 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.164 179.486 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.77 HD11 ' CD ' ' B' ' 265' ' ' GLN . 59.4 mt -102.24 146.6 27.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.289 -179.723 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 52.4 p -68.84 -17.36 63.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.564 -179.614 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.48 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 30.5 m -128.87 130.73 47.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.873 0.368 . . . . 0.0 110.992 -179.437 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.8 t -126.03 119.28 27.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.718 178.844 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.478 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 42.8 tp -116.77 130.17 56.55 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.155 -178.098 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.721 ' CE2' HD12 ' A' ' 37' ' ' ILE . 10.1 m-85 -109.01 140.41 42.57 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.41 179.921 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 153.88 -177.24 31.47 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.316 -0.945 . . . . 0.0 112.431 177.969 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -71.13 -32.51 69.07 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 111.725 0.268 . . . . 0.0 111.725 179.336 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.453 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -50.38 140.27 19.46 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.812 -178.0 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.48 HG23 ' N ' ' A' ' 34' ' ' GLU . 11.0 tp -67.1 -41.87 87.6 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 C-N-CA 120.381 -0.527 . . . . 0.0 109.597 179.569 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.48 ' N ' HG23 ' A' ' 33' ' ' ILE . 77.3 tt0 -55.6 -16.98 4.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.226 179.457 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 24.1 m -66.63 136.26 55.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.119 -179.79 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.48 ' OD2' ' O ' ' A' ' 26' ' ' THR . 68.8 m-20 -61.53 -33.72 74.3 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -178.999 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.721 HD12 ' CE2' ' A' ' 29' ' ' PHE . 98.3 mt -125.05 119.67 56.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 177.188 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -104.64 133.11 50.04 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.774 -177.999 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 98.9 mt -119.36 129.13 75.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.587 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -76.39 29.63 0.12 Allowed 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -178.082 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 41' ' ' LEU . 30.4 mt -94.12 129.03 38.7 Favored Pre-proline 0 C--N 1.322 -0.613 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.91 -179.806 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -72.86 -10.34 24.72 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 122.58 2.187 . . . . 0.0 113.046 -178.996 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.521 HG21 ' CE2' ' B' ' 241' ' ' PHE . 29.4 m -109.66 4.19 9.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.589 179.804 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.449 ' O ' ' O ' ' A' ' 45' ' ' SER . 4.5 t -91.8 108.17 19.72 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 CA-C-O 121.454 0.645 . . . . 0.0 110.642 179.623 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.507 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 1.1 m -32.09 153.05 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.999 -1.0 . . . . 0.0 112.167 -179.523 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -62.0 -42.36 99.06 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 114.406 -1.27 . . . . 0.0 111.192 -179.104 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.698 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.7 mt-30 -113.1 -18.09 12.24 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.097 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.507 ' H ' ' HB3' ' A' ' 45' ' ' SER . 35.5 t60 31.83 -71.42 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 114.902 -1.045 . . . . 0.0 113.23 179.879 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.698 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.66 135.41 47.82 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.282 . . . . . . . . 3 3 . 1 . 097 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -127.82 131.72 49.52 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.507 179.098 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.7 mt -116.28 136.2 54.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.536 -179.576 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -120.55 125.25 47.32 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.619 178.877 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.776 HG23 HH12 ' A' ' 5' ' ' ARG . 96.4 mt -105.24 114.27 44.34 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 CA-C-O 121.363 0.602 . . . . 0.0 111.569 -179.839 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.572 ' O ' ' N ' ' A' ' 56' ' ' GLN . 93.8 m-70 -112.22 144.46 41.59 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.671 179.641 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.474 ' C ' ' O ' ' A' ' 54' ' ' HIS . 81.8 tt0 -38.83 -26.42 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.81 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.572 ' N ' ' O ' ' A' ' 54' ' ' HIS . 68.9 tp60 -69.62 -68.11 0.43 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.676 178.32 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -160.82 -165.21 1.33 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.551 -179.695 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.41 124.93 52.65 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.013 179.468 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 98.5 mt -113.57 129.22 69.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.245 0.545 . . . . 0.0 112.445 -179.042 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.478 ' HB2' HD21 ' A' ' 82' ' ' LEU . 51.1 tp -95.17 126.73 40.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.355 179.227 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.409 ' ND1' ' HB3' ' A' ' 79' ' ' PRO . 96.0 m-70 -113.94 135.93 53.45 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.402 -179.305 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -95.74 106.67 18.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.952 0.406 . . . . 0.0 111.897 -179.678 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -99.17 -9.52 23.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.602 179.095 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.45 102.93 3.32 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.489 179.785 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 99.1 p -87.45 -1.58 58.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.083 0.468 . . . . 0.0 109.92 179.445 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.679 HG21 ' O ' ' B' ' 234' ' ' TPO . 1.0 OUTLIER -112.11 -35.81 5.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.378 -179.916 . . . . . . . . 3 3 . 1 . 097 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 31.4 m-20 -144.27 90.42 6.69 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.607 179.675 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.38 147.1 48.24 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 123.108 2.539 . . . . 0.0 113.445 -178.298 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 58.8 m -71.85 130.41 40.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.32 179.609 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -98.91 143.57 29.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.771 179.637 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.0 t -131.67 133.22 61.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 179.161 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 54.04 33.62 18.03 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 119.491 -0.884 . . . . 0.0 109.286 179.489 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.34 28.73 69.34 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.235 179.627 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.1 m -139.27 133.0 30.65 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 117.439 0.619 . . . . 0.0 112.227 -179.854 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.453 ' H ' HG12 ' A' ' 75' ' ' VAL . 0.1 OUTLIER -72.28 137.91 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.213 179.75 . . . . . . . . 3 3 . 1 . 097 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.543 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 1.7 pt -119.07 115.85 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 121.194 0.521 . . . . 0.0 110.057 178.737 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -82.37 -18.5 41.83 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.165 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.622 ' CD ' ' H ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -124.89 164.71 29.67 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.875 -179.975 . . . . . . . . 3 3 . 1 . 097 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.409 ' HB3' ' ND1' ' A' ' 61' ' ' HIS . 33.6 Cg_endo -63.54 153.4 75.09 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 C-N-CA 122.789 2.326 . . . . 0.0 112.473 179.816 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.3 p -142.76 147.59 20.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.719 -179.259 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -78.65 129.95 35.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.746 179.294 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.478 HD21 ' HB2' ' A' ' 60' ' ' LEU . 91.0 mt -85.44 137.92 32.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.15 0.5 . . . . 0.0 111.257 -179.085 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -128.45 150.87 49.95 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.106 179.578 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.478 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 8.5 t60 -53.13 120.65 6.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.979 0.418 . . . . 0.0 111.156 -179.505 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.14 -20.82 23.28 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 179.746 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -67.56 136.03 53.88 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.053 0.454 . . . . 0.0 110.812 -179.814 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.1 t -116.53 132.18 66.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.058 -178.796 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 93.3 mt -92.6 131.77 38.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.291 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 54.5 m -123.47 124.71 43.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.8 0.809 . . . . 0.0 112.817 -178.41 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.492 ' O ' ' C ' ' A' ' 91' ' ' ILE . 96.5 mt -110.68 124.07 67.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.35 177.874 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.492 ' C ' ' O ' ' A' ' 90' ' ' ILE . 73.1 mt 33.98 -95.5 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.724 179.575 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' A' ' 90' ' ' ILE . 97.9 m-20 -113.72 9.52 17.75 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.557 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.759 ' HE ' HH22 ' B' ' 245' ' ' ARG . 97.5 mtt180 -125.08 144.25 50.51 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.513 -179.114 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.5 m -139.89 152.47 46.46 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.522 0.677 . . . . 0.0 111.388 -179.125 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.559 ' HB3' HD11 ' A' ' 7' ' ' LEU . 51.2 m-85 -125.62 121.98 35.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.572 179.81 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.51 ' O ' HD12 ' A' ' 7' ' ' LEU . 43.1 ttm180 -80.3 128.2 33.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.072 0.463 . . . . 0.0 111.639 -178.957 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -97.35 123.86 41.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.315 179.478 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -126.44 125.66 42.51 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.796 179.984 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.478 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 61.5 t-20 -114.26 113.79 25.08 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.255 179.443 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 . . . . . 0 N--CA 1.466 0.343 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.98 -179.632 . . . . . . . . 0 0 . 1 . 097 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 12.8 m . . . . . 0 N--CA 1.452 -0.365 0 CA-C-O 120.763 0.316 . . . . 0.0 110.703 . . . . . . . . . 0 0 . 1 . 097 nuclear build full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 49.6 p-10 -114.05 43.3 1.87 Allowed 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.445 -179.187 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' B' B ' 230' ' ' SEP . . . . . 0.512 ' O ' ' OE1' ' B' ' 231' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 097 nuclear build full ' B' B ' 231' ' ' GLN . . . . . 0.512 ' OE1' ' O ' ' B' ' 230' ' ' SEP . 1.3 tp60 -141.09 -48.23 0.41 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.93 179.778 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -84.09 159.3 35.6 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.052 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -66.92 140.89 56.52 Favored 'Trans proline' 0 C--N 1.297 -2.177 0 C-N-CA 122.739 2.293 . . . . 0.0 112.653 -179.37 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.679 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 097 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -75.83 148.17 31.81 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 C-N-CA 121.697 1.598 . . . . 0.0 112.453 179.133 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 53.7 t -63.35 136.4 26.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.088 179.942 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 4.2 t -70.53 134.64 47.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.446 -179.743 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' B' B ' 238' ' ' TPO . . . . . 0.437 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 097 nuclear build full ' B' B ' 239' ' ' PRO . . . . . 0.437 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 36.7 Cg_exo -57.26 -29.15 82.79 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 123.03 2.487 . . . . 0.0 112.472 -178.986 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 16.1 m -66.78 -45.12 79.46 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.35 0.595 . . . . 0.0 109.529 178.644 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.521 ' CE2' HG21 ' A' ' 43' ' ' VAL . 79.6 t80 -59.18 -46.13 89.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.034 -178.827 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 99.7 mt -64.58 -40.06 94.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.736 0.303 . . . . 0.0 111.332 -178.978 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 -62.95 -39.62 95.21 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.735 -179.289 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' B' B ' 244' ' ' ARG . . . . . 0.4 ' HE ' ' HA ' ' B' ' 241' ' ' PHE . 87.7 mtm180 -64.03 -42.19 97.17 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.334 179.942 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.759 HH22 ' HE ' ' A' ' 93' ' ' ARG . 75.9 mtp85 -61.12 -41.33 96.52 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.781 -179.196 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -62.75 -41.36 99.17 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.479 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 8.7 t -63.59 -45.67 89.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.364 177.979 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -60.14 -39.11 85.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.128 -179.378 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.495 HG23 ' O ' ' B' ' 245' ' ' ARG . 74.3 t -62.31 -43.88 98.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.256 -0.578 . . . . 0.0 110.274 179.643 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -63.61 -34.91 78.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.302 0.572 . . . . 0.0 109.78 179.116 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -80.12 -11.35 59.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.357 179.691 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' B' ' 252' ' ' LEU . 75.4 mt -110.52 -175.06 2.63 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.861 179.298 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' B' B ' 253' ' ' ASN . . . . . 0.516 ' CG ' ' N ' ' B' ' 254' ' ' ASP . 44.5 p-10 -125.62 -123.23 0.25 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.763 -179.869 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' B' B ' 254' ' ' ASP . . . . . 0.534 ' C ' ' H ' ' B' ' 256' ' ' ASP . 82.9 m-20 -79.1 4.03 15.8 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 178.634 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' B' B ' 255' ' ' ASP . . . . . 0.518 ' O ' ' O ' ' B' ' 256' ' ' ASP . 80.6 m-20 60.01 3.03 0.45 Allowed 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.291 -178.498 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.552 ' O ' ' C ' ' B' ' 257' ' ' LYS . 63.7 t0 47.13 109.74 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.694 -179.324 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' B' B ' 257' ' ' LYS . . . . . 0.552 ' C ' ' O ' ' B' ' 256' ' ' ASP . 98.9 mttt 13.29 -101.42 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 O-C-N 123.738 0.649 . . . . 0.0 111.559 179.983 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' B' ' 257' ' ' LYS . 89.0 m-20 -35.05 119.92 0.5 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.122 -179.729 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.576 ' CG ' ' H ' ' B' ' 260' ' ' GLU . 28.8 t70 -127.11 -174.22 3.1 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.055 0.455 . . . . 0.0 110.076 179.197 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.616 ' OE1' ' NH2' ' A' ' 93' ' ' ARG . 93.8 mt-10 -59.01 9.36 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.371 -178.762 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.566 ' H ' ' C ' ' B' ' 259' ' ' ASP . 59.5 mt -108.87 133.28 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.95 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 44.7 t -127.69 134.91 64.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.975 0.416 . . . . 0.0 111.109 -178.959 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -95.57 119.45 34.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.627 -178.767 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -64.79 -48.47 74.34 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.472 -179.517 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' B' B ' 265' ' ' GLN . . . . . 0.77 ' CD ' HD11 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -82.42 167.96 26.68 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.291 -179.236 . . . . . . . . 3 3 . 1 . 097 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.85 144.98 89.92 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 121.701 1.601 . . . . 0.0 111.904 -179.554 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' B' B ' 267' ' ' ILE . . . . . 0.451 ' CD1' ' O ' ' A' ' 19' ' ' HIS . 7.8 tt . . . . . 0 C--N 1.321 -0.635 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.302 -179.275 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo . . . . . 0 N--CA 1.498 1.774 0 CA-C-O 121.388 0.495 . . . . 0.0 113.235 . . . . . . . . . 0 0 . 1 . 098 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.9 p -108.92 -46.91 3.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.384 -179.966 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.728 ' NE ' HD13 ' A' ' 53' ' ' ILE . 89.6 mtm-85 -92.53 131.91 37.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.786 -179.398 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -133.01 141.93 48.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.011 0.434 . . . . 0.0 111.693 -179.927 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.486 HD12 ' O ' ' A' ' 96' ' ' ARG . 26.4 tp -114.92 130.0 56.82 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.787 179.729 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 56.1 t -106.58 128.95 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.288 -179.012 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.416 HG23 HD12 ' B' ' 261' ' ' ILE . 2.8 m -80.27 140.46 36.2 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.263 0.554 . . . . 0.0 111.365 -179.833 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.493 ' CD1' ' OD1' ' A' ' 16' ' ' ASP . 50.6 mm -113.19 137.95 44.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.549 179.609 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -90.66 156.71 17.91 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.716 179.367 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.409 ' HD3' ' NH1' ' B' ' 245' ' ' ARG . 90.0 mtm180 -59.36 -24.0 63.02 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.172 179.676 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 81.8 p -81.61 -10.92 59.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.069 0.461 . . . . 0.0 109.856 179.301 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.02 34.34 8.94 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 -179.975 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.2 t -118.06 131.75 69.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.742 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.493 ' OD1' ' CD1' ' A' ' 10' ' ' ILE . 89.4 m-20 -72.4 134.05 45.21 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.229 -0.589 . . . . 0.0 109.628 179.264 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -118.53 -125.37 3.46 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.48 -179.1 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.59 152.71 38.41 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.372 2.048 . . . . 0.0 112.537 -178.689 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 27.1 m-70 -102.71 154.61 18.99 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.907 0.384 . . . . 0.0 110.627 179.549 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.462 ' CD2' HD11 ' A' ' 37' ' ' ILE . 53.2 t80 -124.71 91.21 49.81 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.829 179.557 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -60.6 129.66 30.32 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.206 1.937 . . . . 0.0 111.719 179.872 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 90.6 mt -88.81 84.25 6.67 Favored 'General case' 0 N--CA 1.461 0.119 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.974 -179.302 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.2 p -86.21 -10.53 54.51 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.653 179.411 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.676 HD11 ' CD ' ' B' ' 265' ' ' GLN . 66.4 mt -102.14 145.77 28.89 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.094 -179.405 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 81.9 p -68.33 -15.9 63.74 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.045 0.45 . . . . 0.0 110.833 -179.257 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 46.3 m -128.47 132.43 48.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.674 -179.201 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.9 t -126.23 114.17 17.95 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.765 178.611 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.506 HD12 ' O ' ' A' ' 49' ' ' CYS . 57.6 tp -111.31 122.51 48.05 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.906 0.384 . . . . 0.0 111.413 -178.459 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.831 ' CE2' HD12 ' A' ' 37' ' ' ILE . 11.1 m-85 -101.95 142.56 33.06 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.404 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 156.04 -169.63 33.67 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 120.136 -1.031 . . . . 0.0 112.453 179.17 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 31.9 ttp85 -89.28 -32.5 17.35 Favored 'General case' 0 N--CA 1.461 0.096 0 CA-C-O 120.817 0.342 . . . . 0.0 110.824 -179.899 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.432 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -50.36 145.41 9.7 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 -179.879 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.416 HD13 ' HA ' ' A' ' 33' ' ' ILE . 35.7 mm -63.69 -43.93 98.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.555 -179.614 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -54.8 -18.14 4.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.473 179.778 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.432 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 51.2 m -62.1 128.55 36.68 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.162 179.944 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.452 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 61.7 m-20 -58.97 -30.7 68.13 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -178.9 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.831 HD12 ' CE2' ' A' ' 29' ' ' PHE . 79.4 mt -126.5 121.74 59.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 177.126 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 47.6 mtt180 -101.12 136.06 41.59 Favored 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.266 -178.724 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.407 ' C ' ' H ' ' A' ' 41' ' ' LEU . 91.7 mt -117.12 125.33 73.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.995 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -70.92 39.07 0.05 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.308 -177.686 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 41' ' ' LEU . 43.3 mt -112.69 125.17 30.37 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 120.556 -0.458 . . . . 0.0 109.796 179.16 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.56 -2.75 12.61 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.224 1.949 . . . . 0.0 112.61 -179.143 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.529 HG21 ' CE2' ' B' ' 241' ' ' PHE . 33.3 m -109.1 2.97 9.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.767 179.088 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.463 ' O ' ' O ' ' A' ' 45' ' ' SER . 2.7 t -89.72 109.7 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 120.703 0.287 . . . . 0.0 110.592 -179.865 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.58 ' OG ' ' N ' ' A' ' 48' ' ' HIS . 1.1 t -31.79 152.08 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.384 0.611 . . . . 0.0 111.775 -178.771 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -63.26 -43.0 99.21 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.04 -179.194 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.605 ' O ' ' N ' ' A' ' 49' ' ' CYS . 13.3 mm100 -108.9 -26.43 10.24 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.635 0.731 . . . . 0.0 109.113 179.205 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.58 ' N ' ' OG ' ' A' ' 45' ' ' SER . 36.5 t60 39.68 -74.46 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.257 -1.338 . . . . 0.0 113.681 179.471 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.605 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.54 136.44 46.62 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -177.985 . . . . . . . . 3 3 . 1 . 098 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -128.07 127.67 43.53 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.803 179.317 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.3 mt -108.85 133.78 52.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.297 179.838 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.455 ' CD ' ' NE2' ' A' ' 54' ' ' HIS . 82.1 tt0 -118.73 123.81 45.78 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.006 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.728 HD13 ' NE ' ' A' ' 5' ' ' ARG . 97.0 mt -106.85 116.0 49.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -178.565 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.53 ' O ' ' N ' ' A' ' 56' ' ' GLN . 96.9 m-70 -111.32 143.51 42.0 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.123 178.366 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.9 mm-40 -39.35 -26.85 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.278 0.561 . . . . 0.0 109.761 -179.841 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.53 ' N ' ' O ' ' A' ' 54' ' ' HIS . 47.2 tp60 -67.89 -68.3 0.4 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.262 178.918 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -158.92 -165.79 1.71 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.25 179.734 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.406 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -109.88 131.52 54.99 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.013 179.843 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 93.5 mt -121.41 132.31 70.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.233 0.54 . . . . 0.0 112.003 -179.09 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.546 HD22 HD12 ' A' ' 88' ' ' ILE . 37.0 tp -101.53 125.69 48.22 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.758 -179.175 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -110.81 135.97 50.57 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.636 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -97.94 105.34 17.47 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -178.123 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -98.28 -8.6 26.9 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.624 179.13 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -78.2 98.23 5.78 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.985 0.422 . . . . 0.0 110.557 -179.716 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.7 m -84.55 -33.94 23.34 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.886 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.447 HG22 ' HA ' ' B' ' 236' ' ' VAL . 1.4 m -64.41 -50.64 66.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.843 179.64 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -136.28 96.74 12.34 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.831 -179.752 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.499 ' HB2' HG23 ' A' ' 75' ' ' VAL . 43.0 Cg_exo -55.29 143.43 75.95 Favored 'Trans proline' 0 N--CA 1.499 1.822 0 C-N-CA 122.151 1.901 . . . . 0.0 112.856 -178.822 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 18.2 m -72.06 140.34 48.92 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.406 179.93 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -104.01 140.35 37.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.438 -179.96 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.689 HG13 ' OD1' ' A' ' 86' ' ' ASP . 49.3 t -130.1 137.09 57.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.907 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 54.05 32.55 15.83 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.267 -0.573 . . . . 0.0 109.791 -179.643 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.22 29.18 72.13 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.05 179.623 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 49.8 m -141.28 135.65 30.84 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.163 -179.996 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.499 HG23 ' HB2' ' A' ' 68' ' ' PRO . 2.4 p -70.86 136.32 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 121.181 0.515 . . . . 0.0 111.681 -179.303 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.878 HD13 ' O ' ' A' ' 76' ' ' ILE . 0.0 OUTLIER -132.68 125.25 52.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.837 179.77 . . . . . . . . 3 3 . 1 . 098 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -99.32 -9.02 24.08 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.121 -179.713 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.847 ' O ' HD11 ' A' ' 76' ' ' ILE . 16.3 mt-10 -119.6 156.72 53.3 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.299 -179.082 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -62.52 148.15 93.76 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.48 2.12 . . . . 0.0 112.702 -179.951 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.5 m -143.76 145.4 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.427 -179.608 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 87.3 mtm-85 -73.35 130.2 39.66 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.529 179.349 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.497 HD11 ' HB2' ' A' ' 60' ' ' LEU . 96.0 mt -85.35 140.69 30.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.278 0.561 . . . . 0.0 111.274 -179.682 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -133.62 157.51 45.57 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.256 -179.661 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -58.81 117.19 4.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.242 -179.664 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.65 -1.29 29.06 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 -179.365 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.689 ' OD1' HG13 ' A' ' 71' ' ' VAL . 60.7 t0 -86.17 125.36 33.46 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.027 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.409 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 9.5 p -103.38 135.37 41.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 C-N-CA 120.461 -0.495 . . . . 0.0 111.543 -178.875 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.546 HD12 HD22 ' A' ' 60' ' ' LEU . 33.2 mm -96.14 128.28 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 177.789 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 36.3 m -122.79 121.55 36.56 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 119.688 -0.805 . . . . 0.0 113.08 -178.27 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.481 HD12 ' HE1' ' A' ' 95' ' ' PHE . 93.3 mt -110.36 124.79 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 114.624 -1.171 . . . . 0.0 108.623 177.672 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.593 HG22 ' NH2' ' B' ' 245' ' ' ARG . 61.1 mt 33.54 -99.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 121.034 -0.267 . . . . 0.0 111.195 179.7 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.506 ' O ' ' OD1' ' A' ' 92' ' ' ASP . 59.3 t0 -112.98 15.61 19.61 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.489 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.526 HH21 ' CD ' ' B' ' 260' ' ' GLU . 87.3 mtt-85 -129.32 140.61 51.34 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.128 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 75.2 m -137.17 154.73 50.16 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 119.958 -0.697 . . . . 0.0 111.585 -179.491 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.481 ' HE1' HD12 ' A' ' 90' ' ' ILE . 78.4 m-85 -125.17 121.43 34.16 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.209 179.689 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.486 ' O ' HD12 ' A' ' 7' ' ' LEU . 79.1 mtp85 -85.82 134.05 33.94 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.617 -179.685 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -93.53 123.76 37.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.736 -179.825 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -125.09 119.24 28.05 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.778 -179.769 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -99.74 110.03 22.44 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.266 -179.754 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.466 0.337 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.359 179.725 . . . . . . . . 0 0 . 1 . 098 nuclear build full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 33.0 m . . . . . 0 CA--C 1.531 0.214 0 CA-C-O 121.006 0.431 . . . . 0.0 110.396 . . . . . . . . . 0 0 . 1 . 098 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.509 ' O ' ' CB ' ' B' ' 230' ' ' SEP . 55.8 m-20 -63.9 -34.47 78.04 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.422 179.858 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' B' B ' 230' ' ' SEP . . . . . 0.509 ' CB ' ' O ' ' B' ' 229' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 098 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 75.0 mm-40 -113.89 59.17 0.67 Allowed 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 179.192 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -154.57 127.9 2.21 Favored Glycine 0 CA--C 1.535 1.292 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 -179.812 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -50.63 132.74 36.88 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 121.883 1.722 . . . . 0.0 112.55 -179.45 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.692 ' P ' ' H ' ' B' ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 098 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -75.35 151.6 38.17 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 122.554 2.169 . . . . 0.0 112.69 179.494 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.447 ' HA ' HG22 ' A' ' 66' ' ' THR . 3.3 p -69.22 138.11 22.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.558 -0.747 . . . . 0.0 111.275 -178.841 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.5 t -81.66 134.03 35.43 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.168 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' B' B ' 238' ' ' TPO . . . . . 0.472 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 098 nuclear build full ' B' B ' 239' ' ' PRO . . . . . 0.472 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 47.7 Cg_exo -57.97 -30.2 89.11 Favored 'Trans proline' 0 N--CA 1.502 2.001 0 C-N-CA 123.771 2.98 . . . . 0.0 113.189 -179.641 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 89.4 m -72.21 -44.75 62.5 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.396 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.529 ' CE2' HG21 ' A' ' 43' ' ' VAL . 80.8 t80 -57.33 -46.5 83.18 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.072 -179.777 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.432 HD21 HG23 ' A' ' 91' ' ' ILE . 91.2 mt -64.19 -43.09 96.15 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 -179.936 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -65.52 -39.93 92.39 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.061 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 53.8 ttt85 -62.97 -46.22 88.73 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.354 -179.563 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.801 ' O ' HG23 ' B' ' 249' ' ' VAL . 45.4 mtm180 -66.97 -37.9 85.1 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.903 -179.801 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -60.43 -45.94 91.82 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.207 -179.423 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 11.6 t -64.78 -44.66 89.29 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.677 178.681 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -63.52 -32.22 73.61 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.868 179.884 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.801 HG23 ' O ' ' B' ' 245' ' ' ARG . 71.9 t -67.85 -43.07 86.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.286 -0.566 . . . . 0.0 109.644 179.46 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -62.5 -30.14 71.06 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.151 179.477 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -92.13 2.24 56.71 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.627 179.321 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.869 HD11 ' OD1' ' B' ' 256' ' ' ASP . 49.1 tp -110.66 125.14 53.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.466 -179.61 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' B' B ' 253' ' ' ASN . . . . . 0.513 ' ND2' ' CG ' ' B' ' 255' ' ' ASP . 12.5 p-10 -74.61 173.38 10.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.44 0.638 . . . . 0.0 111.872 -178.526 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -70.15 -5.0 24.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.224 -179.455 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' B' B ' 255' ' ' ASP . . . . . 0.552 ' OD1' ' N ' ' B' ' 256' ' ' ASP . 48.5 p-10 -58.06 -18.65 26.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.788 0.327 . . . . 0.0 110.192 -179.829 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.869 ' OD1' HD11 ' B' ' 252' ' ' LEU . 1.6 m-20 -79.95 48.46 0.97 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.124 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -63.03 -14.44 48.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.126 179.801 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -62.85 -43.5 98.63 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.182 179.763 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.63 ' C ' ' H ' ' B' ' 261' ' ' ILE . 66.6 t0 65.59 125.47 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.111 0.482 . . . . 0.0 110.532 -178.853 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.526 ' CD ' HH21 ' A' ' 93' ' ' ARG . 95.4 mt-10 -57.2 16.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.18 -179.102 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.63 ' H ' ' C ' ' B' ' 259' ' ' ASP . 74.0 mt -111.96 134.69 53.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.269 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 73.9 t -127.1 133.72 67.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.955 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -94.97 121.23 36.36 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.132 0.491 . . . . 0.0 111.483 -177.303 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -64.51 -43.99 92.34 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.956 179.606 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' B' B ' 265' ' ' GLN . . . . . 0.676 ' CD ' HD11 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -89.05 167.14 18.82 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.191 -178.068 . . . . . . . . 3 3 . 1 . 098 nuclear build full ' B' B ' 266' ' ' PRO . . . . . 0.443 ' C ' HD13 ' B' ' 267' ' ' ILE . 60.6 Cg_endo -70.77 149.27 60.21 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.744 2.296 . . . . 0.0 112.115 -179.885 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' B' B ' 267' ' ' ILE . . . . . 0.566 ' N ' HD13 ' B' ' 267' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.394 0 CA-C-O 121.594 0.712 . . . . 0.0 109.448 179.568 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo . . . . . 0 N--CA 1.499 1.796 0 CA-C-O 121.139 0.391 . . . . 0.0 113.001 . . . . . . . . . 0 0 . 1 . 099 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 36.1 p -70.62 -39.26 73.86 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.218 -179.292 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.633 ' NH1' ' HB2' ' A' ' 58' ' ' ALA . 94.6 mtt-85 -90.48 123.76 34.44 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.659 -0.417 . . . . 0.0 111.709 -178.034 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.7 mtm-85 -127.7 130.53 49.01 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 121.113 0.482 . . . . 0.0 110.497 179.155 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.627 HD11 ' HB3' ' A' ' 95' ' ' PHE . 51.7 tp -113.01 125.14 54.08 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.885 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.7 m -104.7 133.44 48.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.42 -178.94 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.9 m -83.03 143.81 30.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.771 -179.268 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.627 HD12 ' OG ' ' A' ' 94' ' ' SER . 97.2 mt -116.88 140.98 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.464 177.687 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -92.32 156.54 17.18 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.587 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.04 -15.87 37.24 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.779 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.6 p -77.16 -19.53 56.7 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.103 178.131 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.57 14.02 42.32 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.48 178.984 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.4 m -113.15 144.48 20.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.023 0.44 . . . . 0.0 111.101 -179.891 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 17' ' ' GLY . 61.9 t0 -80.1 130.47 35.27 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.999 -179.363 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.462 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -116.84 -122.55 3.35 Favored Glycine 0 CA--C 1.535 1.334 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 -179.803 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -71.97 151.77 56.67 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 121.737 1.625 . . . . 0.0 112.653 -178.913 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -108.28 151.65 25.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.989 0.423 . . . . 0.0 110.344 -179.508 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.854 ' CD2' HD11 ' A' ' 37' ' ' ILE . 49.2 t80 -120.09 96.91 49.4 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.478 -179.066 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.451 ' HD2' HG22 ' B' ' 267' ' ' ILE . 87.6 Cg_endo -75.57 137.26 20.28 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 121.024 1.15 . . . . 0.0 111.686 -179.252 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 22' ' ' LEU . 84.1 mt -99.21 120.76 40.05 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 119.884 -0.726 . . . . 0.0 111.848 -178.717 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.7 p -122.4 -0.46 9.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.64 178.366 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.424 HD11 ' CG ' ' B' ' 265' ' ' GLN . 63.6 mt -105.85 149.34 26.6 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.994 -179.054 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.3 p -69.39 -21.0 63.81 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.984 -179.397 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 42.8 m -128.8 131.96 47.82 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.056 -179.829 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.486 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -132.85 126.38 32.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.274 178.205 . . . . . . . . 3 3 . 1 . 099 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.755 HD21 ' OE1' ' A' ' 47' ' ' GLN . 33.3 tp -122.23 133.23 54.71 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.973 -178.056 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.505 ' O ' ' O ' ' A' ' 47' ' ' GLN . 51.0 m-85 -106.06 138.19 42.68 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.323 -0.853 . . . . 0.0 108.925 178.808 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 155.04 -172.85 33.38 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 120.381 -0.914 . . . . 0.0 111.731 179.181 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.42 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 46.7 mtm105 -81.32 -31.27 33.61 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -179.467 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.506 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -48.06 148.36 4.05 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.706 -179.004 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.555 HG23 ' N ' ' A' ' 34' ' ' GLU . 9.9 tp -65.79 -43.45 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 120.695 0.283 . . . . 0.0 111.037 179.733 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.555 ' N ' HG23 ' A' ' 33' ' ' ILE . 81.8 tt0 -59.39 -18.38 38.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.416 -179.736 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 33.4 m -57.84 126.81 29.02 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.739 -179.327 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -62.59 -33.9 75.9 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.523 -179.606 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.854 HD11 ' CD2' ' A' ' 20' ' ' PHE . 40.6 mm -119.87 111.33 32.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 177.312 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.419 ' NH2' ' O3P' ' B' ' 230' ' ' SEP . 85.2 mtp180 -99.23 132.45 44.54 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 120.681 -0.407 . . . . 0.0 110.225 -179.403 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.578 HG23 ' NH1' ' A' ' 93' ' ' ARG . 80.7 mt -122.71 131.76 72.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.803 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.614 ' O ' HG11 ' B' ' 228' ' ' VAL . 50.1 mt-30 -82.31 32.95 0.4 Allowed 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -177.859 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.665 HD21 ' NH2' ' A' ' 93' ' ' ARG . 70.3 mt -96.1 131.11 29.49 Favored Pre-proline 0 N--CA 1.469 0.483 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.121 178.992 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -73.4 -14.46 25.23 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.169 1.913 . . . . 0.0 112.156 179.672 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.583 HG21 ' CE2' ' B' ' 241' ' ' PHE . 21.3 m -93.07 7.14 5.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.602 179.931 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.42 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 24.3 t -101.37 134.46 41.57 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.482 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.5 m -71.84 168.14 18.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.282 0.563 . . . . 0.0 111.14 -179.131 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -60.91 -39.15 88.26 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.114 -178.98 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.755 ' OE1' HD21 ' A' ' 28' ' ' LEU . 13.4 mm100 -112.47 -18.07 12.52 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.619 0.247 . . . . 0.0 110.725 -179.828 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 23.3 t60 36.66 -75.9 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 179.634 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.772 ' SG ' HD11 ' A' ' 60' ' ' LEU . 0.1 OUTLIER -136.68 139.19 41.8 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.796 -178.581 . . . . . . . . 3 3 . 1 . 099 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -124.65 139.11 54.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.848 179.572 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.617 HD11 HD12 ' A' ' 82' ' ' LEU . 17.3 tt -128.95 138.29 54.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.143 179.959 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -117.22 137.84 52.1 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.015 179.144 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.7 mm -103.36 124.26 57.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.514 0.673 . . . . 0.0 111.159 -179.318 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.474 ' O ' ' N ' ' A' ' 56' ' ' GLN . 50.3 m-70 -125.41 132.15 52.81 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.17 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.473 ' C ' ' O ' ' A' ' 54' ' ' HIS . 97.7 mt-10 -39.59 -30.56 0.07 Allowed 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.125 -178.8 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.474 ' N ' ' O ' ' A' ' 54' ' ' HIS . 98.6 mt-30 -65.37 -69.9 0.27 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.264 179.33 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -154.88 -159.47 0.95 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.691 -179.777 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.633 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -119.71 137.9 53.63 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.864 0.364 . . . . 0.0 110.601 -179.84 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.3 mm -111.61 120.6 62.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.11 179.936 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.772 HD11 ' SG ' ' A' ' 49' ' ' CYS . 48.7 tp -98.22 126.04 43.53 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.248 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -113.34 136.14 53.09 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.817 -179.412 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.477 HD21 ' HA ' ' A' ' 68' ' ' PRO . 61.2 t-20 -96.21 109.8 22.21 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.98 0.419 . . . . 0.0 111.683 179.915 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -102.38 -9.41 20.33 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.343 179.4 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.22 98.8 9.58 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.821 0.343 . . . . 0.0 111.185 -179.296 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.3 p -78.77 -38.5 38.44 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.967 0.413 . . . . 0.0 109.959 178.729 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.538 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.2 OUTLIER -64.41 -44.57 90.83 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.647 -179.488 . . . . . . . . 3 3 . 1 . 099 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.431 ' CG ' ' H ' ' B' ' 237' ' ' CYS . 89.9 m-20 -139.41 89.56 12.03 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.188 179.897 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.529 ' HB2' HG13 ' A' ' 75' ' ' VAL . 46.4 Cg_exo -54.14 145.59 53.17 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.427 2.085 . . . . 0.0 112.449 -179.675 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.5 m -75.91 143.81 41.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.907 -179.175 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -103.88 142.84 33.7 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.658 179.994 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.48 ' CG2' ' OD1' ' A' ' 86' ' ' ASP . 4.5 p -131.33 135.47 59.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.198 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 51.92 28.95 5.57 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -179.576 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.86 27.45 64.71 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.319 179.995 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.415 ' N ' ' O ' ' A' ' 71' ' ' VAL . 25.5 m -139.9 140.5 36.46 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.86 -179.498 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.529 HG13 ' HB2' ' A' ' 68' ' ' PRO . 51.1 t -68.42 136.96 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -179.309 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.3 pt -110.74 79.68 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.226 0 CA-C-O 121.118 0.485 . . . . 0.0 111.491 179.188 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -61.13 -31.76 71.46 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.918 179.326 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.581 ' OE1' ' N ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -114.84 159.6 36.79 Favored Pre-proline 0 CA--C 1.517 -0.305 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.766 . . . . . . . . 3 3 . 1 . 099 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -62.49 144.51 94.78 Favored 'Trans proline' 0 C--N 1.294 -2.341 0 C-N-CA 122.462 2.108 . . . . 0.0 111.72 -179.343 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 44.1 t -135.09 138.21 49.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.94 -179.151 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -74.63 137.65 42.39 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.831 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.617 HD12 HD11 ' A' ' 51' ' ' ILE . 93.3 mt -91.46 141.0 29.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.177 0.513 . . . . 0.0 112.349 -178.782 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -129.91 154.42 47.34 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.076 179.293 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -53.03 117.21 2.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.71 -179.565 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.38 -22.03 12.42 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 179.56 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 87' ' ' VAL . 59.4 t0 -62.76 130.27 44.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.259 0.552 . . . . 0.0 111.292 -179.873 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.588 HG22 ' HG2' ' A' ' 96' ' ' ARG . 61.7 t -105.65 133.05 51.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.231 -179.247 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 86.4 mt -103.12 128.74 55.82 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.639 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.8 m -119.06 129.01 54.86 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -178.422 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.674 ' O ' ' N ' ' A' ' 93' ' ' ARG . 98.6 mt -115.84 133.96 60.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 113.974 -1.466 . . . . 0.0 107.826 177.121 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.615 HG23 HD21 ' B' ' 242' ' ' LEU . 77.5 mt -19.12 94.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.028 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.42 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 0.4 OUTLIER 80.34 -13.22 0.96 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 177.771 . . . . . . . . 3 3 . 1 . 099 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.674 ' N ' ' O ' ' A' ' 90' ' ' ILE . 88.2 mtt180 -128.4 137.92 52.1 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.564 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.627 ' OG ' HD12 ' A' ' 10' ' ' ILE . 62.6 p -139.27 156.7 46.88 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.396 0.617 . . . . 0.0 110.697 -179.549 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.627 ' HB3' HD11 ' A' ' 7' ' ' LEU . 78.0 m-85 -130.63 127.33 38.73 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.496 -0.775 . . . . 0.0 108.995 179.596 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.588 ' HG2' HG22 ' A' ' 87' ' ' VAL . 99.5 mtt180 -94.91 138.15 33.05 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.832 -179.514 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.58 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 83.1 t80 -96.71 126.1 41.64 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.876 -179.087 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -124.81 119.73 29.72 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.828 179.521 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.464 ' O ' ' C ' ' A' ' 100' ' ' GLU . 59.7 t-20 -102.67 107.77 18.8 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.124 -179.462 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 99' ' ' ASN . 81.4 tt0 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.274 179.282 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' B' B ' 228' ' ' VAL . . . . . 0.614 HG11 ' O ' ' A' ' 40' ' ' GLN . 32.6 m . . . . . 0 N--CA 1.454 -0.262 0 CA-C-O 120.618 0.247 . . . . 0.0 110.799 . . . . . . . . . 1 1 . 1 . 099 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.419 ' O ' ' CB ' ' B' ' 230' ' ' SEP . 95.9 m-20 -89.28 1.53 55.61 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.424 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' B' B ' 230' ' ' SEP . . . . . 0.419 ' CB ' ' O ' ' B' ' 229' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 099 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 174.87 39.12 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.731 179.9 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -121.88 -176.53 15.2 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.604 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.11 155.88 66.73 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 123.09 2.527 . . . . 0.0 112.632 -179.706 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.538 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 099 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -57.59 132.12 48.49 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 123.044 2.496 . . . . 0.0 113.654 179.338 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 38.8 t -61.77 137.47 23.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.461 179.213 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' B' B ' 237' ' ' CYS . . . . . 0.431 ' H ' ' CG ' ' A' ' 67' ' ' ASN . 0.7 OUTLIER -53.5 112.16 0.85 Allowed 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.263 -178.902 . . . . . . . . 3 3 . 1 . 099 nuclear build full ' B' B ' 238' ' ' TPO . . . . . 0.405 ' H ' HG23 ' B' ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 099 nuclear build full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -56.38 -24.27 51.08 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 121.833 1.688 . . . . 0.0 111.601 179.678 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 94.7 m -72.89 -46.05 54.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.952 179.095 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.583 ' CE2' HG21 ' A' ' 43' ' ' VAL . 76.1 t80 -59.33 -45.63 90.83 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.579 -178.528 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.615 HD21 HG23 ' A' ' 91' ' ' ILE . 77.4 mt -65.32 -44.31 88.22 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.992 -179.178 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -62.48 -41.01 98.49 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.558 -179.098 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -63.84 -46.33 85.55 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.311 -179.251 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' B' B ' 245' ' ' ARG . . . . . . . . . . . . . 57.1 ttm-85 -64.82 -42.95 94.57 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.133 -179.246 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' B' B ' 246' ' ' LYS . . . . . 0.401 ' O ' HG12 ' B' ' 249' ' ' VAL . 98.3 mttt -63.27 -39.11 93.68 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.37 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 38.7 t -63.53 -44.98 92.64 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.674 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -58.61 -37.23 75.42 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.815 -179.687 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.401 HG12 ' O ' ' B' ' 246' ' ' LYS . 0.3 OUTLIER -69.2 -40.18 80.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.896 179.839 . . . . . . . . 3 3 . 1 . 099 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -60.63 -35.07 75.29 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.803 0.335 . . . . 0.0 111.031 -179.687 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -98.69 10.4 41.2 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.686 -178.973 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 61.4 tp -116.55 129.12 56.0 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.992 0.425 . . . . 0.0 110.254 179.66 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' B' B ' 253' ' ' ASN . . . . . 0.603 ' C ' ' H ' ' B' ' 255' ' ' ASP . 24.5 m-80 -74.2 173.72 9.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.229 0.537 . . . . 0.0 111.686 -178.896 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 52.6 p-10 -54.76 4.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.393 -179.55 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' B' B ' 255' ' ' ASP . . . . . 0.603 ' H ' ' C ' ' B' ' 253' ' ' ASN . 44.8 p-10 -65.85 -20.92 66.41 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 120.854 0.359 . . . . 0.0 110.826 -179.659 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.714 ' O ' ' N ' ' B' ' 258' ' ' ASP . 45.0 p-10 -51.68 -21.02 2.35 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.182 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' B' B ' 257' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' B' ' 256' ' ' ASP . 86.7 tttt -20.88 -35.1 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.089 -0.96 . . . . 0.0 112.526 -179.239 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.714 ' N ' ' O ' ' B' ' 256' ' ' ASP . 88.4 m-20 -56.11 -48.73 75.64 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 119.646 -0.822 . . . . 0.0 108.833 179.465 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.609 ' C ' ' H ' ' B' ' 261' ' ' ILE . 43.8 t0 72.37 116.36 0.05 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.544 178.816 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.538 ' OE1' ' N ' ' B' ' 260' ' ' GLU . 56.8 mp0 -62.6 15.61 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.551 -179.462 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.609 ' H ' ' C ' ' B' ' 259' ' ' ASP . 72.1 mt -109.81 137.98 39.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.705 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 55.2 t -127.42 134.45 65.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 C-N-CA 120.202 -0.599 . . . . 0.0 111.239 -178.506 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -93.7 118.01 30.83 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.379 -178.861 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -67.02 -46.94 72.94 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.61 179.751 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' B' B ' 265' ' ' GLN . . . . . 0.424 ' CG ' HD11 ' A' ' 24' ' ' LEU . 5.0 mp0 -81.6 162.64 57.43 Favored Pre-proline 0 CA--C 1.514 -0.422 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.934 -178.785 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.9 144.49 58.84 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 121.617 1.545 . . . . 0.0 111.643 179.088 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' B' B ' 267' ' ' ILE . . . . . 0.451 HG22 ' HD2' ' A' ' 21' ' ' PRO . 43.3 pt . . . . . 0 C--N 1.32 -0.717 0 CA-C-O 121.386 0.613 . . . . 0.0 109.43 178.553 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo . . . . . 0 N--CA 1.494 1.548 0 CA-C-O 120.709 0.212 . . . . 0.0 111.667 . . . . . . . . . 0 0 . 1 . 100 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.0 p -86.74 -38.22 17.14 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.943 179.407 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.733 ' NH1' ' HB2' ' A' ' 58' ' ' ALA . 92.2 mtt-85 -92.47 124.08 36.25 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.268 -179.177 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -130.15 139.57 50.86 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.551 -179.877 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.511 HD11 ' HB3' ' A' ' 95' ' ' PHE . 33.5 tp -115.95 130.91 57.03 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.274 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.674 HG12 ' CD2' ' A' ' 19' ' ' HIS . 33.3 m -111.25 134.32 53.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 C-N-CA 120.744 -0.383 . . . . 0.0 110.77 -179.779 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.5 m -95.02 117.87 30.89 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -177.817 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.664 HD12 ' OG ' ' A' ' 94' ' ' SER . 97.6 mt -80.94 144.27 10.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.13 178.443 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -92.64 163.8 13.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.755 178.8 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.644 ' CZ ' HH11 ' B' ' 245' ' ' ARG . 83.1 mtp180 -55.47 -30.54 60.77 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.885 -179.191 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 95.8 p -79.95 -7.58 58.86 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 120.666 -0.413 . . . . 0.0 111.521 -179.983 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.39 35.11 8.16 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.853 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.6 t -121.46 133.62 67.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.86 0.362 . . . . 0.0 110.626 -179.671 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -73.95 135.48 43.23 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 178.788 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.5 -116.95 1.93 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 120.412 -0.899 . . . . 0.0 111.699 -179.603 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -68.37 142.13 53.65 Favored 'Trans proline' 0 N--CA 1.49 1.276 0 C-N-CA 121.593 1.528 . . . . 0.0 112.545 -178.665 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.674 ' CD2' HG12 ' A' ' 8' ' ' VAL . 49.4 m170 -106.15 142.68 35.43 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.269 -179.377 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.544 ' CD2' HD11 ' A' ' 37' ' ' ILE . 37.6 t80 -113.32 93.32 26.01 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.272 -179.673 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -62.45 126.82 19.28 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 121.713 1.608 . . . . 0.0 110.387 179.7 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.6 mt -86.75 51.75 2.32 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.406 -178.719 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 88.9 p -61.67 -23.64 66.22 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.198 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.506 HD11 ' CD ' ' B' ' 265' ' ' GLN . 92.6 mt -77.61 139.03 39.45 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.264 179.36 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 99.3 p -66.4 -16.86 64.41 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.837 -178.461 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 61.8 m -138.83 138.44 37.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.565 0.222 . . . . 0.0 110.669 179.998 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.682 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -138.2 133.53 33.36 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.987 0.423 . . . . 0.0 110.69 179.205 . . . . . . . . 3 3 . 1 . 100 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.56 HD21 ' HG2' ' A' ' 47' ' ' GLN . 34.7 tp -123.04 131.45 53.71 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.745 -178.056 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.728 ' CE2' HD12 ' A' ' 37' ' ' ILE . 8.2 m-85 -107.2 141.95 37.69 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.115 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 158.5 -175.66 35.56 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.92 179.169 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.846 ' NE ' HG11 ' B' ' 228' ' ' VAL . 86.8 mtm-85 -74.94 -27.34 60.16 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 122.659 -0.318 . . . . 0.0 110.928 -179.935 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.566 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -59.14 138.05 49.83 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.154 -177.925 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.449 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.0 tp -66.51 -41.56 88.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.721 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.449 ' N ' HG23 ' A' ' 33' ' ' ILE . 84.4 tt0 -51.93 -19.0 1.55 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.376 178.854 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.566 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 13.8 m -67.91 137.77 55.48 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.568 179.209 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -60.74 -33.77 73.42 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -179.251 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.728 HD12 ' CE2' ' A' ' 29' ' ' PHE . 96.8 mt -127.26 124.72 64.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.247 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.431 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 78.4 ttt-85 -109.34 134.23 52.07 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.115 -178.579 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 82.0 mt -116.45 130.59 71.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.929 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -78.82 26.04 0.25 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.792 -178.056 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.739 HD21 ' OE1' ' B' ' 260' ' ' GLU . 31.5 mt -95.37 125.96 47.86 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.977 179.947 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.69 -14.33 33.06 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.555 2.17 . . . . 0.0 113.056 -179.786 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.598 HG23 HD13 ' A' ' 91' ' ' ILE . 15.3 m -93.83 6.05 6.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.92 0.39 . . . . 0.0 110.7 -179.698 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.599 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 57.5 t -100.71 134.57 40.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.429 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.529 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 0.2 OUTLIER -66.07 167.71 9.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.165 0.507 . . . . 0.0 112.023 -178.658 . . . . . . . . 3 3 . 1 . 100 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -60.21 -42.67 95.62 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.664 -179.676 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.728 ' O ' ' N ' ' A' ' 49' ' ' CYS . 85.0 mt-30 -111.64 -12.15 13.93 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.463 179.675 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.529 ' H ' ' HB3' ' A' ' 45' ' ' SER . 27.7 t60 32.94 -68.17 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -179.852 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.728 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -142.87 143.87 32.25 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.202 -0.599 . . . . 0.0 112.152 -179.464 . . . . . . . . 3 3 . 1 . 100 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -125.18 137.62 54.14 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.832 179.436 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.51 HD11 HD12 ' A' ' 82' ' ' LEU . 19.8 tt -125.09 138.08 55.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.072 0.463 . . . . 0.0 110.128 -179.724 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -122.8 135.07 54.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.284 -179.463 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.521 HD13 ' HD2' ' A' ' 5' ' ' ARG . 96.7 mt -109.88 117.04 53.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.61 0.719 . . . . 0.0 111.949 -179.602 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.555 ' O ' ' N ' ' A' ' 56' ' ' GLN . 94.9 m-70 -116.37 142.52 46.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.475 -1.239 . . . . 0.0 110.351 -179.981 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 54' ' ' HIS . 80.8 mm-40 -39.88 -24.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.993 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.555 ' N ' ' O ' ' A' ' 54' ' ' HIS . 59.5 tt0 -69.47 -67.57 0.47 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.272 178.613 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.494 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 6.0 tp10 -161.12 -158.87 0.61 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.23 179.237 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.733 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -114.39 125.06 53.42 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.816 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.2 mt -114.12 130.91 67.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.129 0.49 . . . . 0.0 111.883 -178.447 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.507 HD11 ' SG ' ' A' ' 49' ' ' CYS . 56.5 tp -99.85 129.05 45.9 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.717 -179.391 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -113.59 136.72 52.5 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.542 179.65 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.407 ' ND2' ' HB3' ' A' ' 68' ' ' PRO . 29.9 t30 -95.28 108.79 20.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.04 0.447 . . . . 0.0 111.777 -179.962 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -98.78 -8.51 25.83 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.739 179.182 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.7 t -81.2 105.84 12.72 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.263 179.721 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.7 p -87.36 -20.36 26.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.244 0.545 . . . . 0.0 109.668 179.567 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.492 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.3 OUTLIER -86.32 -33.58 20.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.196 -179.642 . . . . . . . . 3 3 . 1 . 100 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.4 HD21 ' HA ' ' B' ' 236' ' ' VAL . 74.7 m-80 -150.84 93.95 3.64 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.17 179.926 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.726 ' HB2' HG13 ' A' ' 75' ' ' VAL . 32.2 Cg_exo -56.73 149.29 60.38 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.165 1.91 . . . . 0.0 112.009 -179.801 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 51.9 m -73.57 137.41 44.31 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.04 178.846 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -98.0 141.16 31.3 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.59 -179.768 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 51.8 t -126.45 134.11 67.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.21 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 51.65 33.18 10.35 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.974 -0.69 . . . . 0.0 109.416 -179.099 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.66 29.97 69.06 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.659 179.81 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.4 m -140.6 135.37 31.69 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 117.001 0.401 . . . . 0.0 111.142 -179.912 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.726 HG13 ' HB2' ' A' ' 68' ' ' PRO . 55.7 t -69.1 136.74 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.725 -179.606 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.55 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 1.1 pt -104.96 100.4 10.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-O 121.361 0.6 . . . . 0.0 110.677 178.959 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -65.45 -35.47 81.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.311 179.166 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -123.66 175.99 2.48 Favored Pre-proline 0 CA--C 1.536 0.404 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.548 -179.008 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.01 145.34 96.74 Favored 'Trans proline' 0 N--CA 1.501 1.926 0 C-N-CA 122.575 2.183 . . . . 0.0 111.954 -179.443 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.5 m -136.01 138.93 46.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.995 0.426 . . . . 0.0 112.14 -179.235 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -76.36 133.14 40.03 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 178.819 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.51 HD12 HD11 ' A' ' 51' ' ' ILE . 89.9 mt -89.43 136.01 33.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.413 0.625 . . . . 0.0 112.009 -178.589 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -121.26 148.61 44.06 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.742 179.014 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -54.49 123.04 11.84 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.931 0.396 . . . . 0.0 110.279 -179.577 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.13 -20.28 31.07 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.67 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -66.11 137.62 57.17 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.728 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.449 HG22 ' HG2' ' A' ' 96' ' ' ARG . 55.2 t -112.6 133.16 59.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.521 -178.368 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 92.2 mt -99.22 130.68 47.82 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 178.7 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 65.9 m -122.45 124.91 44.71 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.067 -0.653 . . . . 0.0 112.067 -178.735 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.549 HD12 ' HE1' ' A' ' 95' ' ' PHE . 77.0 mt -109.53 121.5 62.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.255 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.598 HD13 HG23 ' A' ' 43' ' ' VAL . 77.4 mt 35.24 -97.76 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.493 -179.867 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.562 ' OD2' ' NE ' ' B' ' 245' ' ' ARG . 42.0 p-10 -110.73 7.68 22.24 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.666 0.269 . . . . 0.0 111.633 -179.219 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.539 ' CZ ' ' O ' ' B' ' 259' ' ' ASP . 85.6 mtt-85 -124.01 144.4 49.85 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.667 179.916 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.664 ' OG ' HD12 ' A' ' 10' ' ' ILE . 32.7 p -137.9 151.02 47.59 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.49 0.662 . . . . 0.0 111.056 179.553 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.549 ' HE1' HD12 ' A' ' 90' ' ' ILE . 35.1 m-85 -124.01 122.11 37.04 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.324 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.449 ' HG2' HG22 ' A' ' 87' ' ' VAL . 74.7 mtp85 -87.85 135.22 33.49 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.851 -178.658 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.571 ' HH ' ' HG2' ' A' ' 5' ' ' ARG . 89.7 t80 -99.25 125.16 44.81 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.629 -179.669 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -143.77 125.46 15.03 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.475 179.472 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.538 ' OD1' ' CZ ' ' A' ' 97' ' ' TYR . 95.4 m-20 -99.67 138.65 36.46 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.567 179.705 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 . . . . . 0 C--N 1.328 -0.327 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.803 . . . . . . . . 0 0 . 1 . 100 nuclear build full ' B' B ' 228' ' ' VAL . . . . . 0.846 HG11 ' NE ' ' A' ' 31' ' ' ARG . 61.6 t . . . . . 0 N--CA 1.448 -0.551 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 . . . . . . . . . 1 1 . 1 . 100 nuclear build full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -84.29 59.2 5.24 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.596 -179.458 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' B' B ' 230' ' ' SEP . . . . . 0.443 ' H2 ' HG12 ' B' ' 228' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 100 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -144.62 77.29 1.53 Allowed 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.091 179.651 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' B' B ' 232' ' ' GLY . . . . . 0.663 ' N ' HG13 ' B' ' 228' ' ' VAL . . . -128.16 -173.3 13.42 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 121.026 -0.607 . . . . 0.0 111.795 -179.583 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -65.45 154.69 72.54 Favored 'Trans proline' 0 N--CA 1.499 1.85 0 C-N-CA 123.628 2.885 . . . . 0.0 112.638 -179.864 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' B' B ' 234' ' ' TPO . . . . . 0.492 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 100 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -55.74 129.24 33.95 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.501 2.134 . . . . 0.0 113.342 -179.761 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' B' B ' 236' ' ' VAL . . . . . 0.461 HG22 HG22 ' A' ' 66' ' ' THR . 71.4 t -58.25 131.09 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.013 -179.806 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 4.5 t -51.81 113.35 0.97 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.644 -179.539 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 100 nuclear build full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.04 -20.34 44.99 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.039 1.826 . . . . 0.0 111.945 179.536 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 29.3 m -72.72 -45.76 57.12 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.079 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' B' B ' 241' ' ' PHE . . . . . 0.481 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 79.4 t80 -58.69 -45.97 88.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.729 -179.872 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.403 ' HA ' HD23 ' B' ' 242' ' ' LEU . 82.1 mt -64.41 -39.04 93.08 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.012 0.434 . . . . 0.0 110.28 -179.899 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -64.08 -39.94 95.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.16 -179.239 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -62.47 -41.42 98.75 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.987 0.422 . . . . 0.0 110.212 179.831 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' B' B ' 245' ' ' ARG . . . . . 0.811 ' O ' HG23 ' B' ' 249' ' ' VAL . 14.9 tpp180 -60.86 -42.38 97.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.081 -179.735 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.39 -42.87 98.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.727 179.738 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 43.8 p -65.37 -44.01 88.94 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.834 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' B' B ' 248' ' ' GLN . . . . . 0.619 ' O ' ' N ' ' B' ' 252' ' ' LEU . 84.5 mt-30 -64.42 -34.48 78.27 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.919 179.737 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.811 HG23 ' O ' ' B' ' 245' ' ' ARG . 79.7 t -60.99 -45.65 98.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 C-N-CA 120.271 -0.572 . . . . 0.0 109.919 179.788 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -65.62 -27.77 68.63 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.121 179.109 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -95.42 -13.88 24.26 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.014 -179.863 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' B' B ' 252' ' ' LEU . . . . . 0.619 ' N ' ' O ' ' B' ' 248' ' ' GLN . 46.4 tp -91.81 127.42 37.26 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.52 0.676 . . . . 0.0 111.576 -178.874 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -73.41 -147.78 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.512 -178.947 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -93.3 3.15 56.1 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.697 179.133 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' B' B ' 255' ' ' ASP . . . . . 0.568 ' C ' ' H ' ' B' ' 257' ' ' LYS . 98.0 m-20 -64.06 -12.29 37.52 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.208 -178.907 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 30.0 p-10 -65.49 37.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.878 0.371 . . . . 0.0 111.26 -179.854 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' B' B ' 257' ' ' LYS . . . . . 0.568 ' H ' ' C ' ' B' ' 255' ' ' ASP . 88.6 tttt -61.73 -40.64 95.81 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.457 -179.824 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.689 ' O ' ' N ' ' B' ' 260' ' ' GLU . 29.5 p-10 -94.7 9.26 39.57 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.87 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.539 ' O ' ' CZ ' ' A' ' 93' ' ' ARG . 55.2 p-10 8.1 48.32 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 113.917 -1.492 . . . . 0.0 113.507 179.622 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' B' B ' 260' ' ' GLU . . . . . 0.739 ' OE1' HD21 ' A' ' 41' ' ' LEU . 96.8 mt-10 60.05 9.07 1.66 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 178.782 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.463 ' N ' ' O ' ' B' ' 258' ' ' ASP . 75.7 mt -117.14 134.27 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 C-N-CA 120.544 -0.462 . . . . 0.0 109.911 179.587 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 45.8 t -127.06 133.61 67.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.066 179.549 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' B' B ' 263' ' ' PHE . . . . . 0.651 ' CD2' HG21 ' B' ' 267' ' ' ILE . 85.4 m-85 -98.76 122.15 41.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.088 0.471 . . . . 0.0 111.857 -178.499 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -66.17 -43.11 87.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.134 178.356 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' B' B ' 265' ' ' GLN . . . . . 0.506 ' CD ' HD11 ' A' ' 24' ' ' LEU . 0.9 OUTLIER -102.2 174.16 3.06 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.344 -179.699 . . . . . . . . 3 3 . 1 . 100 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -56.56 150.62 50.92 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 122.825 2.35 . . . . 0.0 113.765 179.76 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' B' B ' 267' ' ' ILE . . . . . 0.651 HG21 ' CD2' ' B' ' 263' ' ' PHE . 34.2 pt . . . . . 0 C--N 1.332 -0.165 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.164 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 65.7 p . . . . . 0 N--CA 1.462 0.149 0 CA-C-O 120.848 0.356 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.8 mtt85 -89.0 126.91 35.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.647 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -127.48 138.52 52.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.795 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.575 HD11 ' HB3' ' A' ' 95' ' ' PHE . 24.3 tp -117.21 131.63 56.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.023 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.2 t -108.98 131.9 58.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.681 0.276 . . . . 0.0 110.708 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.6 m -82.15 133.18 35.25 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.395 0.617 . . . . 0.0 112.206 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.526 HD12 ' HB2' ' A' ' 94' ' ' SER . 92.8 mt -103.78 137.61 31.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.619 177.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.426 ' HD3' HG23 ' A' ' 15' ' ' VAL . 50.0 mtpt -97.83 160.03 14.56 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.99 -178.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -58.14 -25.57 61.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.299 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.801 ' OG ' HG22 ' A' ' 15' ' ' VAL . 60.1 p -79.64 -13.69 59.32 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.582 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.81 19.73 33.44 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.002 -0.618 . . . . 0.0 111.772 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.801 HG22 ' OG ' ' A' ' 13' ' ' SER . 27.5 m -115.94 135.67 55.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -76.1 141.06 42.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.828 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -123.25 -118.17 2.41 Favored Glycine 0 CA--C 1.542 1.728 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.795 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -72.04 147.96 49.88 Favored 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 122.415 2.077 . . . . 0.0 112.8 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -108.06 150.07 27.64 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.172 0.51 . . . . 0.0 110.768 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.469 ' CD2' HD11 ' A' ' 37' ' ' ILE . 28.8 t80 -119.56 111.64 36.13 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.898 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.12 123.64 6.27 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.555 1.503 . . . . 0.0 111.259 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 82.1 mt -77.65 52.49 1.0 Allowed 'General case' 0 C--O 1.233 0.196 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.665 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.6 t -62.06 -42.16 98.9 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.101 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.6 mt -69.1 146.51 52.5 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 58.4 p -67.45 -16.57 64.3 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.496 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 90.2 m -131.23 133.89 45.91 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.414 -0.514 . . . . 0.0 111.542 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.8 t -124.33 116.05 21.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.446 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.46 HD21 ' HG2' ' A' ' 47' ' ' GLN . 56.9 tp -114.66 124.86 52.89 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.85 0.357 . . . . 0.0 111.422 -178.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.725 ' CE2' HD12 ' A' ' 37' ' ' ILE . 22.7 m-85 -104.5 141.31 36.61 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.518 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 156.59 -173.08 34.36 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.25 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.545 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 27.2 mtm180 -80.0 -27.74 39.55 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.055 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.532 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -56.18 137.78 46.58 Favored Glycine 0 CA--C 1.521 0.453 0 C-N-CA 120.186 -1.007 . . . . 0.0 110.695 -178.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.427 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.6 tp -65.18 -40.12 87.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.671 -0.412 . . . . 0.0 109.99 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.427 ' N ' HG23 ' A' ' 33' ' ' ILE . 74.0 tt0 -53.99 -13.54 0.81 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.256 179.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.532 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 37.8 m -71.24 138.25 49.3 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.513 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.496 ' OD2' ' O ' ' A' ' 26' ' ' THR . 56.0 m-20 -61.55 -34.28 75.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.443 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.725 HD12 ' CE2' ' A' ' 29' ' ' PHE . 94.2 mt -127.59 122.56 59.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 38' ' ' ARG . 13.2 ttp180 -111.86 137.25 50.07 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.418 -178.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 94.6 mt -120.63 130.31 74.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.402 HE21 ' HA ' ' B' ' 260' ' ' GLU . 26.9 pt20 -81.74 38.4 0.51 Allowed 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.607 ' CD1' ' CZ ' ' A' ' 93' ' ' ARG . 39.9 mt -103.08 132.72 20.86 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.91 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.89 -11.37 30.54 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.459 2.106 . . . . 0.0 113.214 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.456 HG21 ' CE2' ' B' ' 241' ' ' PHE . 28.1 m -96.32 4.56 9.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.898 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.545 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 44.1 t -96.23 133.97 35.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.975 0.417 . . . . 0.0 110.562 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.2 m -70.93 165.51 23.19 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.825 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.0 mttm -63.23 -39.18 93.87 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.661 -178.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.695 ' O ' ' N ' ' A' ' 49' ' ' CYS . 86.4 mt-30 -113.92 -16.08 12.25 Favored 'General case' 0 C--O 1.227 -0.128 0 O-C-N 123.31 0.381 . . . . 0.0 111.247 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 28.7 t60 34.26 -74.13 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.695 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.52 138.96 46.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.129 0.49 . . . . 0.0 111.962 -179.025 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -127.56 130.93 49.96 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.877 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.9 mt -114.62 132.81 62.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.602 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -118.65 123.27 44.54 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.8 mt -106.44 117.06 51.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.019 -0.672 . . . . 0.0 112.345 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.431 ' O ' ' C ' ' A' ' 55' ' ' GLU . 81.0 m-70 -114.15 145.17 42.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.233 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 54' ' ' HIS . 96.3 mt-10 -40.5 -31.8 0.17 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.339 0.59 . . . . 0.0 109.471 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.516 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 58.6 tt0 -63.9 -68.6 0.33 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.162 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.516 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 5.1 tp10 -157.38 -170.24 3.17 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.287 -178.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.445 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -109.45 125.97 53.0 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.6 mt -116.63 130.21 71.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.235 0.54 . . . . 0.0 111.857 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 19.4 tp -101.39 126.25 48.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.841 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -110.14 136.64 49.06 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.966 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.444 HD21 ' HA ' ' A' ' 68' ' ' PRO . 64.7 t-20 -96.48 105.48 17.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.684 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -97.63 -7.47 31.01 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.56 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 t -77.01 99.64 5.37 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.012 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.4 m -86.83 -18.18 31.6 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.468 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -88.88 -43.35 11.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.52 -179.898 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -135.31 91.64 18.73 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.803 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.444 ' HA ' HD21 ' A' ' 62' ' ' ASN . 47.3 Cg_exo -56.24 145.51 76.78 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.193 1.929 . . . . 0.0 113.408 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 18.9 m -79.39 137.17 37.19 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.84 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -102.0 141.37 34.95 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.017 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 93.1 t -132.21 134.33 59.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.465 HD21 ' CG ' ' A' ' 86' ' ' ASP . 75.1 m-20 50.92 32.87 7.89 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.219 0.533 . . . . 0.0 109.593 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.93 29.56 60.69 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.135 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 31.0 t -148.97 143.83 26.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 117.439 0.619 . . . . 0.0 111.335 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 62.1 t -69.38 143.16 15.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.465 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.1 pt -113.89 68.46 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.223 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -52.12 -27.69 15.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.662 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -120.74 169.57 8.6 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.549 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -60.28 143.14 99.51 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 122.354 2.036 . . . . 0.0 112.23 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.9 m -139.57 139.31 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-O 120.83 0.348 . . . . 0.0 111.223 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -75.51 131.82 40.34 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.445 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 92.3 mt -79.51 139.79 37.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.089 0.471 . . . . 0.0 111.086 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -127.87 144.9 51.09 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.748 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.481 ' CE1' ' H ' ' A' ' 99' ' ' ASN . 3.4 t-160 -54.54 117.67 3.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.924 0.392 . . . . 0.0 110.088 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.67 -14.75 27.06 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.074 -0.811 . . . . 0.0 111.074 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.465 ' CG ' HD21 ' A' ' 72' ' ' ASN . 17.3 m-20 -74.84 133.47 41.88 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.049 0.452 . . . . 0.0 110.316 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.557 HG22 ' HA ' ' A' ' 96' ' ' ARG . 49.4 t -112.38 133.68 57.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.676 -178.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 89.6 mt -93.09 129.99 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 177.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.461 HG23 ' OG ' ' A' ' 94' ' ' SER . 51.6 m -118.17 125.37 50.07 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.717 0.77 . . . . 0.0 112.43 -178.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.539 ' N ' ' O ' ' A' ' 93' ' ' ARG . 87.0 mt -116.62 123.08 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 114.505 -1.225 . . . . 0.0 108.505 178.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.656 HG22 ' N ' ' A' ' 92' ' ' ASP . 94.6 mt 33.24 -101.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.463 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.656 ' N ' HG22 ' A' ' 91' ' ' ILE . 82.6 m-20 -105.86 7.02 32.06 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.64 0.257 . . . . 0.0 111.599 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.607 ' CZ ' ' CD1' ' A' ' 41' ' ' LEU . 40.7 mtm-85 -125.07 142.21 51.63 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.716 -178.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.526 ' HB2' HD12 ' A' ' 10' ' ' ILE . 51.0 m -139.51 157.32 46.04 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.499 -0.481 . . . . 0.0 110.617 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.575 ' HB3' HD11 ' A' ' 7' ' ' LEU . 94.9 m-85 -125.96 120.47 30.45 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.655 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.557 ' HA ' HG22 ' A' ' 87' ' ' VAL . 44.4 ttm180 -80.35 127.08 31.96 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.251 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -92.56 125.7 37.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.805 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -121.6 127.41 50.85 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.263 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.481 ' H ' ' CE1' ' A' ' 84' ' ' HIS . 49.4 t-20 . . . . . 0 C--N 1.324 -0.54 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.654 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo . . . . . 0 N--CA 1.485 1.028 0 CA-C-O 121.651 0.605 . . . . 0.0 112.809 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.468 ' CG2' HG22 ' A' ' 66' ' ' THR . 53.5 t -57.79 142.83 12.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.659 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 5.1 t . . . . . 0 C--N 1.327 -0.396 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.29 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo . . . . . 0 N--CA 1.5 1.881 0 N-CA-C 112.838 0.284 . . . . 0.0 112.838 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 70.2 m -69.37 -47.17 65.09 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.526 -0.47 . . . . 0.0 109.787 178.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.456 ' CE2' HG21 ' A' ' 43' ' ' VAL . 71.2 t80 -59.97 -46.67 88.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.624 -179.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.407 ' HA ' HD23 ' B' ' 242' ' ' LEU . 94.5 mt -63.27 -41.29 99.01 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.821 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -65.18 -39.66 93.19 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.009 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -61.97 -41.8 98.41 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.074 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.528 ' NH2' ' CD2' ' A' ' 41' ' ' LEU . 24.9 mmt180 -63.3 -43.15 98.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.676 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -62.68 -41.98 99.39 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.482 -0.487 . . . . 0.0 109.863 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 5.3 t -65.15 -44.86 87.21 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 69.4 tp60 -57.43 -41.16 79.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.778 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--N 1.326 -0.415 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.91 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.471 ' OE1' HD21 ' A' ' 41' ' ' LEU . 98.2 mt-10 . . . . . 0 C--O 1.236 0.348 0 CA-C-O 120.697 0.284 . . . . 0.0 110.255 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 56.5 mt -112.74 134.5 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 53.4 t -122.86 133.32 69.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -96.84 119.54 35.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.243 0.544 . . . . 0.0 111.018 -178.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -67.34 -45.67 75.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.249 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.68 158.18 34.82 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.437 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -60.58 150.32 82.37 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 122.873 2.382 . . . . 0.0 112.478 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 42.9 pt . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 121.581 0.705 . . . . 0.0 111.587 -179.319 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.0 p . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.834 0.349 . . . . 0.0 110.707 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.747 ' NE ' HD13 ' A' ' 53' ' ' ILE . 89.2 mtm-85 -87.18 121.77 30.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.346 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -126.26 134.75 51.09 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.679 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.513 HD12 ' O ' ' A' ' 96' ' ' ARG . 36.4 tp -115.81 130.94 57.04 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.848 HG22 ' CD2' ' A' ' 19' ' ' HIS . 44.3 t -108.9 131.77 58.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.474 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 m -92.21 114.01 26.43 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 121.13 0.49 . . . . 0.0 111.819 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.427 HD12 ' HB3' ' A' ' 94' ' ' SER . 96.8 mt -81.32 146.09 7.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.151 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -92.71 157.7 16.31 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.825 HH12 HE21 ' B' ' 248' ' ' GLN . 87.8 mtm180 -59.91 -21.97 61.79 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.741 -0.383 . . . . 0.0 110.469 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.1 m -80.76 -12.01 59.52 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.1 35.51 8.11 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.9 t -120.72 134.31 64.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.667 0.27 . . . . 0.0 110.869 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -66.41 118.77 10.53 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.409 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -108.29 -130.84 6.31 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.196 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.03 148.34 39.88 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 122.546 2.164 . . . . 0.0 113.321 -178.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.848 ' CD2' HG22 ' A' ' 8' ' ' VAL . 65.0 m170 -104.03 140.0 38.36 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.115 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -111.7 97.87 38.89 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.505 -0.771 . . . . 0.0 108.958 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.432 ' HD2' HG22 ' B' ' 267' ' ' ILE . 57.1 Cg_endo -72.46 127.04 12.11 Favored 'Trans proline' 0 C--N 1.314 -1.24 0 C-N-CA 121.194 1.263 . . . . 0.0 110.922 -178.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.414 ' HA ' HD23 ' A' ' 22' ' ' LEU . 92.8 mt -84.51 81.33 8.89 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.625 0.726 . . . . 0.0 110.563 -178.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 91.1 p -86.72 -9.29 56.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.467 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.0 mt -102.6 145.35 29.77 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.008 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.6 t -65.09 -16.2 63.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.333 -178.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.07 132.63 42.0 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.972 0.415 . . . . 0.0 111.803 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.8 t -123.35 117.58 25.55 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.658 178.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.622 HD21 ' OE1' ' A' ' 47' ' ' GLN . 39.3 tp -115.55 127.4 55.24 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 120.702 0.287 . . . . 0.0 111.35 -178.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.71 ' CE2' HD12 ' A' ' 37' ' ' ILE . 8.4 m-85 -107.62 142.69 37.17 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.504 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 153.97 -170.36 32.58 Favored Glycine 0 N--CA 1.467 0.75 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.966 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.631 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 81.4 mtm-85 -84.0 -31.34 25.53 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.952 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.562 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -53.48 148.65 15.28 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.142 -178.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.532 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.1 tp -68.38 -42.82 84.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.801 0.334 . . . . 0.0 110.454 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.532 ' N ' HG23 ' A' ' 33' ' ' ILE . 51.6 tp10 -53.09 -19.89 3.23 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.562 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 5.3 m -66.8 124.95 24.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.821 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -59.5 -27.41 66.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.312 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.71 HD12 ' CE2' ' A' ' 29' ' ' PHE . 97.7 mt -128.45 121.14 54.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.831 178.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 74.1 mtm180 -100.4 135.45 41.82 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.492 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.79 HG21 ' CZ ' ' A' ' 93' ' ' ARG . 99.4 mt -119.99 131.8 71.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.458 0.647 . . . . 0.0 110.57 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -78.78 28.22 0.21 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.999 -1.0 . . . . 0.0 112.987 -178.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.657 ' O ' HG12 ' A' ' 44' ' ' VAL . 7.3 mt -105.97 104.69 50.48 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 120.539 -0.465 . . . . 0.0 109.804 178.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -53.84 -8.74 0.96 Allowed 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 122.417 2.078 . . . . 0.0 113.254 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.62 HG21 ' CE2' ' B' ' 241' ' ' PHE . 26.9 m -95.62 3.69 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.637 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.657 HG12 ' O ' ' A' ' 41' ' ' LEU . 5.9 p -95.45 138.23 21.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.46 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 0.5 OUTLIER -65.88 162.54 18.8 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.487 0.66 . . . . 0.0 111.527 -179.101 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt -62.94 -40.55 97.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.433 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.676 ' O ' ' N ' ' A' ' 49' ' ' CYS . 15.1 mm100 -109.47 -13.28 14.6 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.381 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.46 ' H ' ' HB3' ' A' ' 45' ' ' SER . 25.8 t60 35.88 -73.31 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.288 -0.869 . . . . 0.0 113.163 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.676 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -149.35 149.76 31.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.19 0.519 . . . . 0.0 111.661 -179.564 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -135.85 134.9 39.32 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.675 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 89.4 mt -105.81 133.39 50.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.024 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -111.71 120.37 41.79 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.747 HD13 ' NE ' ' A' ' 5' ' ' ARG . 91.3 mt -104.46 110.02 29.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.581 0.705 . . . . 0.0 111.613 -178.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.468 ' O ' ' N ' ' A' ' 56' ' ' GLN . 95.0 m-70 -112.19 144.37 41.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.644 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 54' ' ' HIS . 83.7 tt0 -41.18 -28.35 0.09 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.468 ' N ' ' O ' ' A' ' 54' ' ' HIS . 99.7 mm-40 -66.53 -68.82 0.34 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.151 178.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -158.75 -169.69 2.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.479 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -108.43 124.61 50.67 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.509 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 98.9 mt -115.58 129.32 72.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.084 0.468 . . . . 0.0 112.059 -178.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.451 HD11 ' SG ' ' A' ' 49' ' ' CYS . 43.9 tp -94.51 124.18 38.38 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.973 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -108.82 132.1 54.33 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.865 0.364 . . . . 0.0 110.019 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 33.5 t-20 -94.32 105.04 17.02 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.813 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -96.31 -6.56 37.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.033 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.2 t -85.58 97.58 10.16 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.199 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 77.5 p -78.09 -33.59 50.61 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 177.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.7 m -63.68 -46.25 86.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.817 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -142.48 95.98 6.41 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.777 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.49 144.45 62.47 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 121.877 1.718 . . . . 0.0 112.122 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 33.0 m -72.09 138.07 47.52 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.128 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -100.98 139.28 36.88 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.642 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 70.8 t -129.97 135.42 61.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 52.43 32.87 11.98 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 119.774 -0.77 . . . . 0.0 109.063 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.23 27.85 69.25 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.611 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 34.4 t -142.23 137.32 30.65 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 117.671 0.736 . . . . 0.0 111.91 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -69.18 143.6 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.511 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.562 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 1.2 pt -113.47 108.1 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 121.564 0.697 . . . . 0.0 110.553 178.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -70.8 -31.62 68.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.282 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.485 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -129.38 -179.35 0.98 Allowed Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.752 -179.588 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 24.7 Cg_exo -62.6 146.94 95.41 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 122.779 2.32 . . . . 0.0 112.061 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.8 p -140.12 141.69 33.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.019 0.438 . . . . 0.0 111.164 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -76.56 133.44 39.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.724 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 82' ' ' LEU . 98.3 mt -88.93 139.14 30.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.206 0.527 . . . . 0.0 111.501 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.405 ' N ' ' OD2' ' A' ' 86' ' ' ASP . 99.4 mttt -123.2 149.76 44.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.803 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.512 ' ND1' ' N ' ' A' ' 99' ' ' ASN . 8.1 t60 -54.39 121.92 9.33 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.125 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.8 -13.24 38.41 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.405 ' OD2' ' N ' ' A' ' 83' ' ' LYS . 84.3 m-20 -68.88 136.58 52.85 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.056 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.401 ' CG1' ' OG ' ' A' ' 94' ' ' SER . 70.3 t -109.14 131.56 59.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.422 -178.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 25.7 mm -93.37 129.58 43.62 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 178.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.0 m -120.42 123.88 44.1 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.104 -0.639 . . . . 0.0 112.205 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.669 ' CG2' HH12 ' A' ' 93' ' ' ARG . 94.9 mt -122.61 126.75 74.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.367 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.476 HG22 ' N ' ' A' ' 92' ' ' ASP . 47.9 mm 35.34 -105.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 121.041 -0.264 . . . . 0.0 111.246 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.477 ' OD1' ' CD2' ' B' ' 242' ' ' LEU . 87.8 m-20 -109.12 16.4 22.55 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.747 0.308 . . . . 0.0 111.064 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.79 ' CZ ' HG21 ' A' ' 39' ' ' ILE . 1.8 mtm105 -126.39 144.57 50.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.073 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.427 ' HB3' HD12 ' A' ' 10' ' ' ILE . 47.4 t -138.7 148.73 44.31 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 178.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.48 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 27.3 m-85 -125.6 125.11 42.63 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.659 -179.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.513 ' O ' HD12 ' A' ' 7' ' ' LEU . 78.4 mtp85 -85.91 128.02 34.74 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.433 -179.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.559 ' CZ ' ' OD1' ' A' ' 99' ' ' ASN . 92.0 t80 -95.41 127.17 41.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.945 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -138.67 124.6 19.96 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.222 -0.591 . . . . 0.0 111.969 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.559 ' OD1' ' CZ ' ' A' ' 97' ' ' TYR . 96.9 m-20 . . . . . 0 N--CA 1.463 0.217 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.107 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo . . . . . 0 N--CA 1.483 0.882 0 CA-C-O 121.826 0.678 . . . . 0.0 113.115 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -67.37 139.89 20.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.327 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 6.3 t . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.016 -179.941 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo . . . . . 0 N--CA 1.504 2.093 0 N-CA-C 113.842 0.67 . . . . 0.0 113.842 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 35.4 m -74.61 -43.21 56.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.314 0.578 . . . . 0.0 109.851 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.62 ' CE2' HG21 ' A' ' 43' ' ' VAL . 68.7 t80 -59.18 -45.96 89.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.926 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.477 ' CD2' ' OD1' ' A' ' 92' ' ' ASP . 81.6 mt -62.47 -41.73 98.99 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.777 -0.192 . . . . 0.0 111.382 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -65.86 -36.9 84.72 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.676 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -59.63 -42.85 93.63 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.686 ' NH1' HE22 ' B' ' 248' ' ' GLN . 2.4 mpt_? -60.64 -41.77 95.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.193 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -60.83 -40.45 92.82 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 16.5 m -64.26 -46.55 83.22 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.622 178.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . 0.825 HE21 HH12 ' A' ' 12' ' ' ARG . 27.1 mt-30 -61.62 -36.48 80.87 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.12 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . 0.401 HG23 ' O ' ' B' ' 245' ' ' ARG . 42.1 t . . . . . 0 C--N 1.329 -0.29 0 C-N-CA 120.347 -0.541 . . . . 0.0 110.099 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 57.8 mp0 . . . . . 0 CA--C 1.529 0.162 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 70.8 mt -117.36 134.28 61.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 54.2 t -127.74 135.06 64.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.295 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -95.28 117.69 30.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.217 0.532 . . . . 0.0 111.151 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -65.13 -44.18 89.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.08 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -91.55 150.43 41.1 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.658 -178.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -67.03 146.07 75.85 Favored 'Trans proline' 0 N--CA 1.497 1.678 0 C-N-CA 122.644 2.229 . . . . 0.0 112.697 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . 0.432 HG22 ' HD2' ' A' ' 21' ' ' PRO . 25.1 pt . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.114 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.9 p . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.511 0.196 . . . . 0.0 111.487 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 87.8 mtm-85 -104.38 125.79 50.91 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.076 0.465 . . . . 0.0 111.638 -178.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -134.04 138.67 45.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.922 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.585 HD12 ' O ' ' A' ' 96' ' ' ARG . 31.4 tp -113.29 129.62 56.48 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.438 HG12 ' CD2' ' A' ' 19' ' ' HIS . 30.6 m -107.58 133.52 52.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-O 121.085 0.469 . . . . 0.0 110.681 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.2 m -90.68 115.39 27.74 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.457 -0.792 . . . . 0.0 113.136 -177.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.4 mt -79.02 142.1 14.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 178.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -88.74 157.64 18.44 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.772 HH12 ' NE2' ' B' ' 248' ' ' GLN . 84.2 mtp180 -59.04 -33.07 70.33 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.021 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.7 t -69.91 -18.6 63.39 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.267 0.556 . . . . 0.0 109.849 178.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.82 34.75 4.24 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.6 t -124.95 134.16 67.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.13 0.49 . . . . 0.0 111.517 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -70.11 131.31 44.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.253 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -113.13 -128.04 4.8 Favored Glycine 0 CA--C 1.539 1.545 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.586 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -73.74 154.76 49.2 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.35 2.033 . . . . 0.0 112.625 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.498 ' O ' ' CG2' ' B' ' 267' ' ' ILE . 7.6 m170 -110.01 139.98 44.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.269 0.557 . . . . 0.0 111.177 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.433 ' CD2' HD11 ' A' ' 37' ' ' ILE . 27.9 t80 -108.6 99.38 33.27 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.014 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.87 128.14 15.51 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 121.19 1.26 . . . . 0.0 111.334 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 72.5 mt -79.06 47.86 0.81 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.301 -178.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 99.5 p -59.1 -24.87 63.32 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.672 HD11 ' HG2' ' B' ' 265' ' ' GLN . 71.0 mt -78.35 139.52 38.8 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.417 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.8 t -66.15 -18.45 65.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.354 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.479 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 85.1 m -133.02 135.17 45.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.813 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.8 t -127.06 115.34 19.03 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.417 HD12 ' O ' ' A' ' 49' ' ' CYS . 51.2 tp -114.93 129.88 56.8 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.195 0.522 . . . . 0.0 110.915 -178.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.849 ' CE2' HD12 ' A' ' 37' ' ' ILE . 14.3 m-85 -110.96 135.16 51.89 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.146 -0.933 . . . . 0.0 109.576 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 160.21 -172.06 36.59 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.704 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -81.2 -31.6 33.86 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.705 0.288 . . . . 0.0 110.998 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.529 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -54.9 150.31 18.75 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 111.714 -0.554 . . . . 0.0 111.714 -178.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.47 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.9 tp -66.44 -40.05 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-O 120.791 0.329 . . . . 0.0 110.158 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.47 ' N ' HG23 ' A' ' 33' ' ' ILE . 96.9 mt-10 -51.72 -27.87 13.27 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.338 -0.545 . . . . 0.0 109.542 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.529 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 14.2 m -57.16 110.99 0.93 Allowed 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.934 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.479 ' OD2' ' O ' ' A' ' 26' ' ' THR . 97.5 m-20 -51.18 -18.75 0.96 Allowed 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.849 HD12 ' CE2' ' A' ' 29' ' ' PHE . 76.2 mt -134.06 125.77 48.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.94 177.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 71.5 mtm180 -103.46 135.06 45.76 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.612 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 99.2 mt -117.17 129.1 74.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -77.25 25.48 0.17 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -177.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.526 HD21 ' NH1' ' B' ' 245' ' ' ARG . 67.2 mt -96.81 128.06 37.08 Favored Pre-proline 0 N--CA 1.466 0.35 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.554 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -73.22 -9.75 23.58 Favored 'Trans proline' 0 N--CA 1.487 1.132 0 C-N-CA 122.052 1.835 . . . . 0.0 112.848 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.439 HG23 HG13 ' A' ' 91' ' ' ILE . 28.9 m -96.71 4.2 9.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 120.758 0.313 . . . . 0.0 110.582 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 38.1 t -93.08 135.71 27.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.871 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.9 m -70.67 173.01 7.69 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.473 0.654 . . . . 0.0 111.584 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 40.7 mtmt -63.73 -41.66 98.02 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.527 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.614 ' O ' ' N ' ' A' ' 49' ' ' CYS . 86.1 mt-30 -114.52 -20.95 10.55 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.919 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 27.5 t60 37.75 -76.13 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 113.971 1.101 . . . . 0.0 113.971 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.614 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -128.78 133.27 48.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.926 0.393 . . . . 0.0 111.516 -178.621 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -125.66 127.95 47.07 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.31 178.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 94.5 mt -110.25 132.41 58.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -114.5 120.3 39.78 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.3 mt -102.93 114.94 43.95 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 C-N-CA 119.714 -0.794 . . . . 0.0 111.968 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.55 ' O ' ' N ' ' A' ' 56' ' ' GLN . 97.0 m-70 -112.57 141.16 46.66 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.221 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.469 ' C ' ' O ' ' A' ' 54' ' ' HIS . 95.1 mt-10 -39.73 -26.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 -178.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.55 ' N ' ' O ' ' A' ' 54' ' ' HIS . 84.6 mt-30 -66.05 -67.98 0.4 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.948 177.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -161.84 -158.27 0.53 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.479 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -116.71 129.76 56.32 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.575 0.226 . . . . 0.0 110.66 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 98.2 mt -119.55 131.59 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 121.046 0.451 . . . . 0.0 111.762 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.474 ' HB2' HD11 ' A' ' 82' ' ' LEU . 28.7 tp -99.27 129.34 45.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.977 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -116.48 138.22 51.55 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.825 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 38.2 p-10 -101.89 107.33 18.47 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.629 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -94.27 -11.61 29.82 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.896 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.3 p -77.19 100.75 5.9 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.286 178.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.7 p -73.43 -34.27 65.35 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.447 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.3 OUTLIER -71.11 -40.29 71.55 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.699 -179.987 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -144.07 90.95 6.63 Favored Pre-proline 0 N--CA 1.467 0.412 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -64.81 149.45 89.61 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 C-N-CA 120.988 1.126 . . . . 0.0 112.089 -179.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.8 m -71.11 151.51 44.4 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.386 0.612 . . . . 0.0 111.776 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -106.7 147.06 30.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.833 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.501 ' CG2' ' OD1' ' A' ' 86' ' ' ASP . 4.8 p -132.88 134.86 57.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 51.75 32.11 9.02 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.185 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.88 27.64 70.26 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.878 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 68.6 m -139.26 142.35 37.78 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.2 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.7 t -75.45 133.3 31.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.381 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.3 pt -101.84 102.12 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.516 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -64.1 -34.42 78.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.492 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.402 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 1.3 mt-10 -129.74 178.49 1.68 Allowed Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.79 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.402 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 31.3 Cg_exo -60.09 143.63 99.53 Favored 'Trans proline' 0 N--CA 1.504 2.09 0 C-N-CA 122.742 2.295 . . . . 0.0 112.469 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.5 p -135.91 138.46 47.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.371 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 83.3 mtm-85 -73.17 129.88 39.02 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.5 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.474 HD11 ' HB2' ' A' ' 60' ' ' LEU . 97.0 mt -83.77 137.41 33.74 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.161 -178.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -129.17 152.98 48.16 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.363 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.533 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 7.5 t60 -53.36 119.18 4.48 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.264 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.64 -14.46 29.73 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 87' ' ' VAL . 59.4 t0 -66.25 130.41 43.14 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.229 0.538 . . . . 0.0 110.623 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.599 HG22 ' HG2' ' A' ' 96' ' ' ARG . 71.1 t -109.27 130.85 61.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.001 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 87.6 mt -105.78 134.1 48.27 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.6 m -118.21 124.33 47.65 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 121.191 0.519 . . . . 0.0 111.64 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.576 ' N ' ' O ' ' A' ' 93' ' ' ARG . 97.4 mt -114.82 126.08 72.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.448 HG22 ' N ' ' A' ' 92' ' ' ASP . 36.2 mm 38.28 -109.3 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.697 -179.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.537 ' OD1' ' CD2' ' B' ' 242' ' ' LEU . 98.1 m-20 -107.77 14.61 25.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.501 0.667 . . . . 0.0 110.011 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.576 ' O ' ' N ' ' A' ' 90' ' ' ILE . 18.8 mtp85 -126.86 146.95 50.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.298 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 66.4 m -137.69 150.65 47.5 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 121.235 0.54 . . . . 0.0 110.778 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.541 ' CE1' HD12 ' A' ' 90' ' ' ILE . 89.0 m-85 -124.39 122.28 37.23 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.69 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.599 ' HG2' HG22 ' A' ' 87' ' ' VAL . 99.8 mtt180 -89.79 135.84 33.39 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 119.378 -0.929 . . . . 0.0 110.685 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -96.75 124.72 40.81 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.431 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -124.79 122.08 36.41 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.533 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 46.3 t30 . . . . . 0 C--N 1.333 -0.136 0 C-N-CA 120.671 -0.411 . . . . 0.0 111.257 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo . . . . . 0 N--CA 1.494 1.545 0 CA-C-O 121.835 0.681 . . . . 0.0 113.767 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.447 ' CG2' HG22 ' A' ' 66' ' ' THR . 24.0 t -67.99 135.08 29.16 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.921 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 16.0 t . . . . . 0 C--N 1.325 -0.482 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.391 179.839 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo . . . . . 0 N--CA 1.506 2.236 0 N-CA-C 113.905 0.694 . . . . 0.0 113.905 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 21.2 m -71.64 -45.93 60.55 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.202 0.525 . . . . 0.0 109.933 178.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.435 ' HZ ' HD22 ' A' ' 41' ' ' LEU . 45.9 t80 -58.09 -44.89 87.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.068 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.537 ' CD2' ' OD1' ' A' ' 92' ' ' ASP . 93.7 mt -62.21 -40.81 97.35 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.566 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -61.62 -45.17 95.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.362 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 -62.4 -43.07 99.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.733 0.301 . . . . 0.0 110.995 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.526 ' NH1' HD21 ' A' ' 41' ' ' LEU . 16.1 mmm180 -58.67 -44.88 90.34 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.76 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -63.27 -39.24 94.05 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.874 0.369 . . . . 0.0 110.175 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 38.8 t -65.48 -44.77 86.09 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 122.0 0.905 . . . . 0.0 109.137 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . 0.772 ' NE2' HH12 ' A' ' 12' ' ' ARG . 57.8 tt0 -59.62 -39.76 85.34 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.74 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 26.0 t . . . . . 0 CA--C 1.519 -0.25 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.659 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.472 ' OE1' ' NH1' ' B' ' 245' ' ' ARG . 98.5 mt-10 . . . . . 0 N--CA 1.465 0.299 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.449 HD11 ' NE ' ' A' ' 93' ' ' ARG . 78.7 mt -112.38 132.01 62.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 46.0 t -127.5 134.18 66.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.193 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -99.09 123.58 43.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.341 0.591 . . . . 0.0 110.897 -178.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -64.28 -40.6 96.3 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.414 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . 0.672 ' HG2' HD11 ' A' ' 24' ' ' LEU . 5.1 mp0 -95.81 164.67 18.21 Favored Pre-proline 0 N--CA 1.463 0.224 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.254 -178.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -61.27 145.13 98.81 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 122.283 1.989 . . . . 0.0 110.916 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . 0.498 ' CG2' ' O ' ' A' ' 19' ' ' HIS . 2.6 mt . . . . . 0 C--N 1.321 -0.657 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.425 -178.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.4 p . . . . . 0 CA--C 1.531 0.243 0 CA-C-O 120.79 0.329 . . . . 0.0 111.471 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.5 mtt85 -88.28 129.81 35.27 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.249 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -126.09 136.18 52.61 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.27 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.61 HD12 ' O ' ' A' ' 96' ' ' ARG . 30.6 tp -115.82 132.58 56.6 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.9 t -110.2 132.37 58.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.063 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 m -88.72 114.2 25.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.024 -0.534 . . . . 0.0 112.118 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.437 HD12 ' HB2' ' A' ' 94' ' ' SER . 95.5 mt -85.13 144.02 10.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -96.09 160.33 14.5 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.514 HH12 ' CD ' ' B' ' 260' ' ' GLU . 94.7 mtm-85 -62.38 -20.2 64.18 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.901 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.0 p -78.58 -16.25 57.63 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 120.592 -0.443 . . . . 0.0 109.909 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.41 17.72 30.56 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.369 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.0 m -115.14 135.63 54.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 117.191 0.496 . . . . 0.0 110.169 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -72.52 142.86 48.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.341 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -126.72 -117.72 2.14 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.499 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.63 146.77 44.26 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.161 1.907 . . . . 0.0 112.129 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.595 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -108.03 138.98 43.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.06 0.457 . . . . 0.0 110.909 -179.69 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.631 ' CE2' HD11 ' A' ' 37' ' ' ILE . 50.2 t80 -110.1 104.85 56.45 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.955 -178.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.83 130.19 14.29 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.211 1.274 . . . . 0.0 112.016 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.4 mt -83.74 60.27 5.65 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.603 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.3 t -62.83 -40.67 98.15 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 69.9 mt -71.6 144.1 49.59 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.149 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 92.3 p -69.41 -14.06 62.7 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.055 -0.521 . . . . 0.0 112.101 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.407 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 62.6 m -130.42 133.65 46.51 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.38 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.5 t -124.95 115.94 21.39 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 58.5 tp -113.56 130.26 56.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.911 0.386 . . . . 0.0 110.928 -178.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.522 ' O ' ' O ' ' A' ' 47' ' ' GLN . 59.2 m-85 -110.17 136.33 49.56 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.219 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 160.83 -174.26 37.45 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.284 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.581 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 82.3 mtm-85 -79.93 -30.48 39.98 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.552 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -53.4 149.18 13.67 Favored Glycine 0 N--CA 1.467 0.718 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.496 -177.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.539 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.5 tp -67.65 -43.24 86.93 Favored 'Isoleucine or valine' 0 C--N 1.341 0.2 0 CA-C-O 120.868 0.366 . . . . 0.0 111.008 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.539 ' N ' HG23 ' A' ' 33' ' ' ILE . 81.3 tt0 -56.09 -19.39 12.9 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.825 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.552 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 9.6 m -63.02 126.44 27.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.607 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.407 ' OD2' ' O ' ' A' ' 26' ' ' THR . 89.8 m-20 -61.41 -32.6 72.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.337 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.631 HD11 ' CE2' ' A' ' 20' ' ' PHE . 50.5 mm -123.38 114.58 42.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.195 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 38' ' ' ARG . 47.0 mtm180 -99.72 137.14 38.62 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 121.169 -0.212 . . . . 0.0 110.667 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 82.2 mt -120.06 131.27 72.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 120.184 -0.606 . . . . 0.0 111.093 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -73.22 28.31 0.06 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.332 -0.849 . . . . 0.0 113.001 -177.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.722 HD12 ' CZ ' ' A' ' 93' ' ' ARG . 65.9 mt -113.06 130.92 23.1 Favored Pre-proline 0 C--N 1.323 -0.564 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.692 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.84 -9.67 23.98 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 122.262 1.974 . . . . 0.0 112.184 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.488 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 13.1 m -90.86 2.6 7.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.026 0.441 . . . . 0.0 110.017 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.581 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 55.2 t -94.51 132.3 38.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.7 m -71.22 169.2 15.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.562 0.696 . . . . 0.0 111.932 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -62.46 -41.78 99.0 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.442 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.639 ' O ' ' N ' ' A' ' 49' ' ' CYS . 96.3 mt-30 -116.34 -15.26 10.99 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.281 0.363 . . . . 0.0 110.834 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.0 t60 31.08 -74.25 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.639 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.5 138.34 47.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.212 0.529 . . . . 0.0 112.126 -178.67 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -127.99 133.35 49.16 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.443 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.6 mt -118.25 133.94 63.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.026 0.441 . . . . 0.0 110.705 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.438 ' CD ' ' NE2' ' A' ' 54' ' ' HIS . 85.1 tt0 -121.03 124.07 43.93 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.0 mt -106.54 117.26 51.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.661 0.743 . . . . 0.0 112.914 -178.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.438 ' NE2' ' CD ' ' A' ' 52' ' ' GLU . 94.3 m-70 -110.66 143.3 41.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.098 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 54' ' ' HIS . 83.2 tt0 -40.39 -30.32 0.1 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.278 -0.569 . . . . 0.0 109.807 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.434 ' N ' ' O ' ' A' ' 54' ' ' HIS . 59.9 tt0 -64.11 -67.62 0.42 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -157.21 -169.44 2.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.071 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.458 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -110.75 125.95 54.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.767 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.6 mt -115.48 128.52 72.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.31 0.576 . . . . 0.0 111.933 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 24.9 tp -99.07 132.1 44.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.968 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -115.4 135.83 53.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.528 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.618 ' ND2' ' H ' ' A' ' 69' ' ' THR . 12.3 t-20 -97.17 108.58 21.34 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.929 0.395 . . . . 0.0 111.185 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -100.88 -8.57 22.43 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.263 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.7 t -74.64 98.84 3.5 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.092 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.2 m -74.51 -40.38 61.81 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.25 0.547 . . . . 0.0 110.236 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.537 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.3 OUTLIER -64.54 -43.38 94.16 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.264 -178.904 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -144.34 97.36 5.17 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.011 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.441 ' HA ' HD21 ' A' ' 62' ' ' ASN . 37.4 Cg_exo -57.25 149.4 64.54 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.977 1.785 . . . . 0.0 111.858 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.618 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 85.4 m -76.41 156.34 33.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.324 0.583 . . . . 0.0 110.933 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.46 ' N ' HG22 ' A' ' 69' ' ' THR . 88.0 mt-30 -114.84 139.36 49.82 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.61 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 55.3 t -128.42 136.23 60.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.54 ' ND2' ' OD1' ' A' ' 86' ' ' ASP . 82.2 m-20 53.25 33.36 15.29 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 119.777 -0.769 . . . . 0.0 109.1 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.04 27.38 73.93 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 115.106 -0.952 . . . . 0.0 112.032 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 74.3 m -141.56 136.37 31.02 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 117.29 0.545 . . . . 0.0 111.31 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.7 p -63.46 144.01 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.803 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.497 HG21 HG21 ' A' ' 80' ' ' VAL . 7.3 pt -118.78 90.96 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.091 0 CA-C-O 121.065 0.459 . . . . 0.0 110.538 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -67.46 -26.94 66.64 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.443 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -122.58 169.34 9.9 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.063 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.79 144.23 99.48 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.075 1.85 . . . . 0.0 111.773 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.497 HG21 HG21 ' A' ' 76' ' ' ILE . 3.3 m -136.47 138.43 46.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.22 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -73.88 134.48 43.25 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.498 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.458 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 95.7 mt -86.09 135.81 33.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.03 0.443 . . . . 0.0 111.324 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -127.79 148.33 50.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.502 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.479 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 5.3 t60 -48.86 116.16 1.54 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.081 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.01 -13.87 40.85 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.161 -0.775 . . . . 0.0 111.161 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.54 ' OD1' ' ND2' ' A' ' 72' ' ' ASN . 34.4 t70 -66.23 133.7 51.16 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 70.8 t -114.19 133.29 60.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.354 -0.538 . . . . 0.0 111.517 -178.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 71.1 mt -100.02 131.77 46.83 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.588 HG23 ' OG ' ' A' ' 94' ' ' SER . 89.4 m -123.97 125.9 45.39 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.83 -178.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.504 ' O ' ' N ' ' A' ' 92' ' ' ASP . 94.2 mt -112.5 123.65 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.591 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.47 HG22 ' N ' ' A' ' 92' ' ' ASP . 94.5 mt 38.61 -94.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.028 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 90' ' ' ILE . 52.1 t0 -121.71 16.35 11.08 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 120.941 -0.303 . . . . 0.0 111.564 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.722 ' CZ ' HD12 ' A' ' 41' ' ' LEU . 44.3 mtm-85 -128.43 139.05 52.56 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.588 ' OG ' HG23 ' A' ' 89' ' ' THR . 58.0 m -133.69 152.14 51.81 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 119.979 -0.689 . . . . 0.0 111.169 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.522 ' HB3' HD11 ' A' ' 7' ' ' LEU . 80.8 m-85 -123.85 121.74 36.16 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.088 178.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.61 ' O ' HD12 ' A' ' 7' ' ' LEU . 79.8 mtp85 -85.21 131.75 34.38 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.113 0.483 . . . . 0.0 111.304 -178.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -95.63 124.73 39.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.003 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -125.6 122.31 36.09 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.967 0.413 . . . . 0.0 110.702 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.479 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 55.3 t-20 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.957 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo . . . . . 0 N--CA 1.486 1.057 0 CA-C-O 121.474 0.531 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.537 ' CG2' HG22 ' A' ' 66' ' ' THR . 24.1 t -111.08 132.55 59.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.273 -179.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 40.1 t . . . . . 0 C--N 1.332 -0.188 0 CA-C-O 120.97 0.414 . . . . 0.0 110.046 179.639 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo . . . . . 0 N--CA 1.496 1.66 0 CA-C-O 120.795 0.248 . . . . 0.0 112.043 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 18.8 m -74.16 -44.35 53.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.316 0.579 . . . . 0.0 109.806 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.488 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 82.1 t80 -58.14 -46.55 85.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.0 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' B' ' 242' ' ' LEU . 95.0 mt -64.5 -39.62 94.12 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.154 0.502 . . . . 0.0 109.993 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -61.33 -41.7 97.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.577 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -60.9 -42.24 97.66 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.326 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.485 ' NH2' ' CE1' ' B' ' 241' ' ' PHE . 47.8 mmt-85 -61.17 -40.49 94.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.93 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -61.34 -39.27 89.96 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 24.0 m -65.76 -43.73 88.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -60.48 -37.65 81.73 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 114.511 -1.222 . . . . 0.0 110.426 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 46.8 t . . . . . 0 CA--C 1.531 0.229 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.051 179.003 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.524 ' OE1' HD21 ' A' ' 41' ' ' LEU . 97.5 mt-10 . . . . . 0 N--CA 1.462 0.143 0 CA-C-O 120.426 0.155 . . . . 0.0 111.053 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 61.5 mt -112.34 135.06 52.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 43.6 t -123.86 133.3 69.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.202 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -94.79 117.46 30.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.988 0.423 . . . . 0.0 110.976 -178.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . 0.422 ' HZ1' ' HA ' ' A' ' 34' ' ' GLU . 88.5 tttt -65.39 -47.01 77.81 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.275 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -82.34 160.89 61.31 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.201 -0.908 . . . . 0.0 110.257 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -60.37 141.65 96.18 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.162 1.908 . . . . 0.0 111.753 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . 0.552 HG23 ' O ' ' B' ' 267' ' ' ILE . 13.8 tt . . . . . 0 C--N 1.324 -0.532 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.919 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 35.3 p . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.734 0.302 . . . . 0.0 111.267 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.665 HH22 ' CB ' ' A' ' 99' ' ' ASN . 7.0 mmp_? -90.52 118.0 29.64 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -178.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.664 ' NH2' ' ND1' ' A' ' 19' ' ' HIS . 77.8 ttt-85 -127.36 127.23 43.9 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.696 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.929 HD11 HD11 ' A' ' 22' ' ' LEU . 77.6 mt -113.67 144.71 42.47 Favored 'General case' 0 C--N 1.339 0.139 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 51.2 t -121.12 130.94 74.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.47 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.1 m -81.37 142.17 33.28 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.579 0.704 . . . . 0.0 112.432 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.402 ' CD1' ' OD1' ' A' ' 16' ' ' ASP . 47.0 mm -108.59 134.35 50.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.62 177.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -90.15 156.58 18.24 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.998 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.679 ' NH1' ' NH2' ' B' ' 245' ' ' ARG . 88.8 mtm180 -58.85 -25.91 63.7 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.247 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.9 p -78.26 -10.11 59.52 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.78 37.85 9.14 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.7 t -122.1 134.3 65.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.674 0.273 . . . . 0.0 110.658 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.402 ' OD1' ' CD1' ' A' ' 10' ' ' ILE . 96.8 m-20 -71.4 133.39 45.9 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.34 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -122.41 -118.02 2.46 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 120.806 -0.711 . . . . 0.0 111.887 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -74.65 145.04 32.38 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.265 1.976 . . . . 0.0 112.812 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.664 ' ND1' ' NH2' ' A' ' 6' ' ' ARG . 17.9 m170 -101.73 140.69 35.67 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.66 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.493 ' CD2' HD11 ' A' ' 37' ' ' ILE . 40.1 t80 -114.42 97.03 45.1 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.441 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -79.67 139.22 14.01 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 121.836 1.691 . . . . 0.0 110.66 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.929 HD11 HD11 ' A' ' 7' ' ' LEU . 92.8 mt -101.43 124.08 46.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.747 0.784 . . . . 0.0 110.529 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.6 p -124.18 -1.31 8.22 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.261 -1.336 . . . . 0.0 108.683 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 42.2 mt -104.67 147.99 27.06 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 114.508 -1.224 . . . . 0.0 109.732 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 96.1 p -65.98 -17.26 64.56 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.345 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 85.2 m -132.37 133.77 44.36 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.246 0.546 . . . . 0.0 112.122 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.573 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 2.9 t -126.4 121.51 32.68 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.619 HD21 ' OE1' ' A' ' 47' ' ' GLN . 55.4 tp -120.9 132.22 54.84 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.824 0.345 . . . . 0.0 111.922 -177.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.692 ' CE2' HD12 ' A' ' 37' ' ' ILE . 8.9 m-85 -109.22 140.79 42.38 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 151.44 -177.78 29.17 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.447 178.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.492 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 46.0 mtm180 -74.19 -33.52 63.45 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.501 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -48.12 148.44 4.07 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.808 -0.71 . . . . 0.0 111.587 -178.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.515 HG23 ' N ' ' A' ' 34' ' ' GLU . 9.9 tp -66.53 -41.96 89.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-O 120.9 0.381 . . . . 0.0 110.438 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.515 ' N ' HG23 ' A' ' 33' ' ' ILE . 79.2 tt0 -58.55 -25.83 62.92 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 17.9 m -52.73 115.45 1.82 Allowed 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.448 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 63.5 m-20 -53.05 -25.0 11.1 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.538 -178.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.692 HD12 ' CE2' ' A' ' 29' ' ' PHE . 96.2 mt -129.71 122.06 54.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.503 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 83.8 mtp180 -106.06 135.53 47.35 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.015 0.435 . . . . 0.0 110.853 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 95.5 mt -118.09 129.55 74.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.059 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -73.73 34.24 0.08 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -177.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.76 HD11 ' NH1' ' A' ' 93' ' ' ARG . 55.9 mt -111.24 129.04 24.44 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.684 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.76 -10.25 24.76 Favored 'Trans proline' 0 N--CA 1.489 1.237 0 C-N-CA 122.445 2.096 . . . . 0.0 113.101 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.52 HG21 ' CE2' ' B' ' 241' ' ' PHE . 35.9 m -94.15 1.12 9.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.562 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.492 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 42.6 t -89.75 136.05 24.65 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.24 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.072 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.6 m -69.8 164.79 22.84 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.424 0.63 . . . . 0.0 111.297 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -62.65 -43.26 99.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.287 -179.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.619 ' OE1' HD21 ' A' ' 28' ' ' LEU . 92.7 mm-40 -111.34 -24.15 10.38 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.318 0.58 . . . . 0.0 110.002 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.0 t60 39.22 -78.05 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.251 -0.886 . . . . 0.0 113.382 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.594 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -129.53 133.73 47.39 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.385 0.612 . . . . 0.0 112.225 -178.663 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -126.83 132.44 50.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.307 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 93.7 mt -117.54 135.41 58.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.568 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.485 ' CD ' ' NE2' ' A' ' 54' ' ' HIS . 79.7 tt0 -120.48 124.62 45.87 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 84.9 mt -102.04 117.83 47.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.324 0.583 . . . . 0.0 111.57 -178.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.485 ' NE2' ' CD ' ' A' ' 52' ' ' GLU . 97.5 m-70 -112.94 141.01 47.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.258 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 54' ' ' HIS . 94.1 mt-10 -39.75 -28.85 0.05 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -178.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.49 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 58.1 tt0 -63.55 -67.67 0.41 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.301 178.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.49 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 3.7 tp10 -158.16 -164.43 1.5 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.336 -178.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -111.49 129.96 55.88 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.9 mt -118.87 128.09 75.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.386 0.612 . . . . 0.0 112.157 -178.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 28.1 tp -97.29 127.87 43.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.934 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -113.23 136.47 52.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.127 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.41 HD21 ' HA ' ' A' ' 68' ' ' PRO . 58.5 t-20 -97.12 104.61 16.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.188 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -96.51 -9.7 29.03 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 120.757 0.313 . . . . 0.0 110.747 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.15 101.44 1.85 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.101 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 79.0 p -87.73 -10.13 52.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.206 0.527 . . . . 0.0 109.591 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.653 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -100.92 -43.22 6.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.249 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.405 HD21 ' HA ' ' B' ' 236' ' ' VAL . 78.9 m-20 -135.85 94.86 14.31 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.025 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.486 ' HB2' HG23 ' A' ' 75' ' ' VAL . 50.4 Cg_exo -57.17 142.9 94.51 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 121.966 1.777 . . . . 0.0 113.014 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 95.9 m -74.49 144.1 44.3 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.401 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -104.88 139.47 39.57 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.056 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 68.8 t -131.02 133.11 63.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 53.65 32.11 13.92 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.149 -0.621 . . . . 0.0 110.065 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.45 26.88 68.9 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-N 115.606 -0.724 . . . . 0.0 112.129 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 43.4 t -142.68 139.93 31.37 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 117.36 0.58 . . . . 0.0 111.08 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.486 HG23 ' HB2' ' A' ' 68' ' ' PRO . 1.2 p -70.25 140.85 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.486 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.8 pt -113.96 90.72 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.82 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -68.43 -28.94 67.51 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.478 ' N ' ' CD ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -116.49 162.18 28.0 Favored Pre-proline 0 C--O 1.232 0.168 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.582 179.129 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -66.56 150.54 83.94 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.571 2.181 . . . . 0.0 112.466 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.4 m -141.78 141.76 29.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.142 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -70.52 129.92 40.49 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.077 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 82' ' ' LEU . 91.3 mt -79.64 140.17 37.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.175 0.512 . . . . 0.0 111.13 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -131.84 151.23 51.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.729 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.42 ' CE1' ' H ' ' A' ' 99' ' ' ASN . 6.1 t60 -53.78 120.14 5.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.052 0.453 . . . . 0.0 111.162 -179.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.81 -17.67 32.54 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -67.51 135.06 52.44 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 120.184 -0.607 . . . . 0.0 110.258 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.519 HG22 ' HG2' ' A' ' 96' ' ' ARG . 58.5 t -113.67 132.51 62.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.115 -178.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 84.5 mt -103.78 132.78 49.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 90.1 m -122.63 128.97 51.35 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.48 0.657 . . . . 0.0 112.646 -178.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.492 ' O ' ' N ' ' A' ' 93' ' ' ARG . 81.2 mt -113.91 126.02 71.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.499 178.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.458 ' C ' ' O ' ' A' ' 90' ' ' ILE . 41.2 mm 35.99 -98.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.746 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 90' ' ' ILE . 41.3 p-10 -116.13 12.11 15.44 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.04 0.448 . . . . 0.0 110.918 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.76 ' NH1' HD11 ' A' ' 41' ' ' LEU . 53.9 mtt85 -123.07 140.44 53.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.334 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 29.4 t -137.27 151.15 48.38 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 120.319 -0.553 . . . . 0.0 110.722 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.488 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 98.0 m-85 -123.6 122.21 37.57 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.519 ' HG2' HG22 ' A' ' 87' ' ' VAL . 99.5 mtt180 -84.65 136.35 33.79 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.167 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.61 ' CZ ' ' CZ ' ' A' ' 5' ' ' ARG . 60.0 t80 -94.48 118.02 31.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.742 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.412 ' HG3' ' CE1' ' A' ' 84' ' ' HIS . 79.8 tt0 -125.47 125.71 43.75 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 111.971 0.359 . . . . 0.0 111.971 -178.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.665 ' CB ' HH22 ' A' ' 5' ' ' ARG . 12.1 t-20 . . . . . 0 C--N 1.333 -0.142 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo . . . . . 0 N--CA 1.487 1.138 0 CA-C-O 121.499 0.541 . . . . 0.0 112.922 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.653 ' CG2' HG22 ' A' ' 66' ' ' THR . 54.9 t -64.71 139.82 20.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.716 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 7.3 t . . . . . 0 C--N 1.329 -0.312 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 179.188 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo . . . . . 0 N--CA 1.496 1.666 0 N-CA-C 112.83 0.281 . . . . 0.0 112.83 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 90.9 m -73.61 -45.19 54.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.546 0.689 . . . . 0.0 109.668 178.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.52 ' CE2' HG21 ' A' ' 43' ' ' VAL . 68.9 t80 -58.33 -46.22 86.61 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.622 -178.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 94.9 mt -62.67 -41.64 99.2 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 120.981 0.419 . . . . 0.0 110.481 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -59.29 -37.06 76.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.415 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -62.92 -43.4 98.91 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.012 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.752 ' NH2' HH22 ' A' ' 93' ' ' ARG . 26.5 mmm180 -58.59 -41.65 86.24 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -64.21 -43.22 95.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.349 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 27.9 t -64.08 -44.98 90.7 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -57.38 -40.31 77.93 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.29 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 54.3 t . . . . . 0 C--N 1.328 -0.358 0 C-N-CA 120.658 -0.417 . . . . 0.0 109.916 178.957 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.57 ' OE1' ' NH2' ' B' ' 245' ' ' ARG . 96.4 mt-10 . . . . . 0 N--CA 1.467 0.421 0 CA-C-O 120.793 0.33 . . . . 0.0 111.163 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.488 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 89.6 mt -109.78 133.08 56.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 41.5 t -124.32 133.71 68.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.945 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . 0.534 ' CD2' HG21 ' B' ' 267' ' ' ILE . 70.6 m-85 -98.77 121.29 40.53 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.299 0.571 . . . . 0.0 110.818 -178.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -65.92 -39.2 90.32 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.905 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . 0.414 ' CB ' ' CD ' ' B' ' 266' ' ' PRO . 0.6 OUTLIER -103.2 179.47 0.96 Allowed Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.099 -178.461 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . 0.414 ' CD ' ' CB ' ' B' ' 265' ' ' GLN . 24.4 Cg_exo -62.25 149.81 89.27 Favored 'Trans proline' 0 N--CA 1.498 1.742 0 C-N-CA 122.822 2.348 . . . . 0.0 113.536 -178.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . 0.534 HG21 ' CD2' ' B' ' 263' ' ' PHE . 15.8 pt . . . . . 0 N--CA 1.465 0.308 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.051 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.0 p . . . . . 0 CA--C 1.524 -0.027 0 CA-C-O 120.864 0.364 . . . . 0.0 110.373 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.728 HH12 ' HB2' ' A' ' 58' ' ' ALA . 94.3 mtt-85 -97.25 115.01 26.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.957 -178.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.61 HH21 ' CE1' ' A' ' 19' ' ' HIS . 73.5 ttt180 -128.24 130.8 48.49 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.667 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.563 HD11 ' HB3' ' A' ' 95' ' ' PHE . 34.2 tp -113.17 133.25 55.14 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.0 t -109.87 131.57 60.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.851 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.414 HG23 ' CD1' ' B' ' 261' ' ' ILE . 2.1 m -92.17 113.86 26.25 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.942 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.8 mt -79.15 143.69 12.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.901 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -87.99 159.37 18.33 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.153 0.502 . . . . 0.0 110.64 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.441 ' NH2' ' HB2' ' B' ' 248' ' ' GLN . 82.1 mtp180 -53.27 -32.42 48.46 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.066 -178.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 91.1 p -79.37 -7.39 58.33 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.954 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.15 31.96 11.25 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.7 t -117.86 132.71 66.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -75.11 138.91 42.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.556 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -131.94 -114.89 1.63 Allowed Glycine 0 CA--C 1.538 1.479 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.321 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -74.07 148.31 39.65 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.46 2.107 . . . . 0.0 112.56 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.61 ' CE1' HH21 ' A' ' 6' ' ' ARG . 0.0 OUTLIER -111.37 160.82 16.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.479 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.406 ' CD2' HD11 ' A' ' 37' ' ' ILE . 39.4 t80 -131.21 103.51 15.29 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.706 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.98 135.83 17.77 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 121.346 1.364 . . . . 0.0 111.627 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 64.7 mt -85.22 51.83 2.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.228 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.2 p -64.25 -24.85 67.81 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.7 mt -80.33 141.82 35.07 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.678 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.8 t -63.14 -20.73 65.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.563 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 94.4 m -134.88 135.64 41.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.106 0.479 . . . . 0.0 111.577 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.2 t -127.99 120.7 28.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.591 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.528 HD12 ' O ' ' A' ' 49' ' ' CYS . 56.3 tp -118.51 131.65 56.23 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.262 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.635 ' CE2' HD12 ' A' ' 37' ' ' ILE . 3.8 m-85 -108.83 141.78 40.38 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.291 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 158.15 -170.92 35.01 Favored Glycine 0 N--CA 1.469 0.894 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.219 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.578 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 81.9 mtm-85 -84.42 -27.91 27.24 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 122.447 -0.443 . . . . 0.0 110.821 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -54.66 146.07 27.19 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.051 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.406 HD13 ' HA ' ' A' ' 33' ' ' ILE . 31.2 mm -64.54 -43.57 96.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.014 0.435 . . . . 0.0 110.291 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -57.17 -19.86 23.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.048 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 81.7 m -62.77 131.97 50.65 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.491 -0.483 . . . . 0.0 110.171 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.456 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 64.8 m-20 -61.48 -34.79 76.06 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.222 -178.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.635 HD12 ' CE2' ' A' ' 29' ' ' PHE . 99.4 mt -125.16 125.88 70.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.413 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 44.4 mtm-85 -119.39 145.14 46.48 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.879 -177.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 80.9 mt -123.2 133.16 69.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.422 -178.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -75.88 25.64 0.12 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.973 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.744 HD11 ' CZ ' ' A' ' 93' ' ' ARG . 30.4 mt -96.81 129.41 32.78 Favored Pre-proline 0 C--N 1.324 -0.528 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.087 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.428 ' O ' ' HD2' ' B' ' 235' ' ' PRO . 42.8 Cg_endo -71.09 -13.09 31.1 Favored 'Trans proline' 0 N--CA 1.489 1.225 0 C-N-CA 122.029 1.819 . . . . 0.0 112.618 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.612 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 26.9 m -98.06 3.22 10.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.619 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.578 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 35.4 t -89.88 135.69 25.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.48 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 0.6 OUTLIER -65.15 160.62 20.86 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.373 0.606 . . . . 0.0 111.782 -178.864 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -62.46 -42.31 99.38 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.071 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.614 ' O ' ' N ' ' A' ' 49' ' ' CYS . 86.7 mt-30 -114.97 -14.4 11.87 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 123.609 0.568 . . . . 0.0 110.069 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.48 ' H ' ' HB3' ' A' ' 45' ' ' SER . 19.7 t60 31.1 -73.75 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.614 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.85 137.19 44.87 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -177.631 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -125.16 132.33 53.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.909 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.9 mt -118.57 133.03 66.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.832 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -119.99 127.38 52.57 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 177.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.402 HD13 ' CD ' ' A' ' 5' ' ' ARG . 86.7 mt -108.36 124.15 64.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -177.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.517 ' CD2' ' N ' ' A' ' 54' ' ' HIS . 2.7 m-70 -117.5 141.02 48.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.538 -1.21 . . . . 0.0 109.479 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 54' ' ' HIS . 96.3 mt-10 -39.91 -29.5 0.07 Allowed 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.993 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.458 ' N ' ' O ' ' A' ' 54' ' ' HIS . 69.0 tp60 -64.38 -65.93 0.61 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -158.5 -155.44 0.49 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.099 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.728 ' HB2' HH12 ' A' ' 5' ' ' ARG . . . -120.5 131.41 54.71 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.208 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.7 mm -112.58 123.62 68.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.668 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.474 ' HB2' HD11 ' A' ' 82' ' ' LEU . 30.9 tp -97.67 127.21 43.45 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -115.01 136.18 53.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.956 0.408 . . . . 0.0 110.847 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -97.29 106.22 18.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.48 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -98.74 -8.18 26.47 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.086 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.2 m -69.74 101.33 1.66 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 95.4 p -83.57 -13.23 54.88 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.123 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -91.35 -46.81 7.82 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.199 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -139.67 101.51 7.26 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.916 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.594 ' HB2' HG13 ' A' ' 75' ' ' VAL . 36.6 Cg_exo -57.07 147.66 73.82 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 121.986 1.791 . . . . 0.0 112.884 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.7 m -74.66 145.83 42.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.543 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -107.54 140.34 40.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.256 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.1 t -129.66 133.91 64.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 53.59 32.93 15.29 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 119.899 -0.72 . . . . 0.0 109.284 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.45 27.57 71.14 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.702 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 21.3 t -141.99 138.79 32.14 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 117.133 0.466 . . . . 0.0 112.003 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.594 HG13 ' HB2' ' A' ' 68' ' ' PRO . 48.3 t -68.76 140.3 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.143 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.483 HG21 HG11 ' A' ' 80' ' ' VAL . 4.9 pt -113.36 93.86 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-O 120.983 0.42 . . . . 0.0 110.808 178.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -65.04 -28.98 69.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.63 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.462 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.2 OUTLIER -126.34 178.96 1.3 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.178 -179.313 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.462 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 36.5 Cg_exo -59.36 143.05 99.85 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 122.68 2.253 . . . . 0.0 111.45 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.483 HG11 HG21 ' A' ' 76' ' ' ILE . 5.2 p -137.69 140.78 40.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.464 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.454 HH11 ' HD3' ' A' ' 81' ' ' ARG . 34.0 mmt-85 -79.29 129.4 34.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.221 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.474 HD11 ' HB2' ' A' ' 60' ' ' LEU . 98.4 mt -85.21 136.58 33.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.985 0.421 . . . . 0.0 111.381 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -125.85 152.2 45.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.459 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.407 ' CD2' ' C ' ' A' ' 84' ' ' HIS . 6.9 t60 -53.37 115.78 2.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.79 0.329 . . . . 0.0 110.422 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.7 -16.7 25.99 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -69.01 135.2 50.52 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.215 -0.594 . . . . 0.0 109.958 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.1 t -112.39 131.29 64.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.138 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 91.6 mt -94.62 131.37 41.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 25.6 m -122.79 128.18 50.11 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -177.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.474 ' O ' ' C ' ' A' ' 91' ' ' ILE . 79.5 mt -113.79 125.14 71.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.01 178.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.516 HG22 ' N ' ' A' ' 92' ' ' ASP . 97.9 mt 33.64 -96.36 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.074 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.593 ' OD1' ' NH1' ' A' ' 93' ' ' ARG . 47.9 p-10 -114.74 12.24 17.02 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.744 ' CZ ' HD11 ' A' ' 41' ' ' LEU . 70.6 mtt85 -124.62 140.05 53.3 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.683 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 56.6 m -136.09 151.1 49.46 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.45 0.643 . . . . 0.0 111.137 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.563 ' HB3' HD11 ' A' ' 7' ' ' LEU . 63.0 m-85 -121.95 120.74 35.3 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.851 179.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.526 ' O ' HD12 ' A' ' 7' ' ' LEU . 39.6 ttm180 -81.65 129.21 34.62 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.616 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.586 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 87.1 t80 -94.9 124.31 38.88 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.722 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -123.3 122.01 37.27 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.617 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.415 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 47.7 t30 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.373 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . 0.428 ' HD2' ' O ' ' A' ' 42' ' ' PRO . 26.8 Cg_exo . . . . . 0 N--CA 1.491 1.382 0 CA-C-O 121.532 0.555 . . . . 0.0 112.779 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -78.76 133.17 30.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.87 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . 0.451 ' SG ' HG23 ' A' ' 91' ' ' ILE . 34.7 t . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.963 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo . . . . . 0 N--CA 1.494 1.537 0 CA-C-O 120.551 0.146 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 79.8 m -74.38 -43.0 58.35 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.29 0.567 . . . . 0.0 109.62 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.612 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 73.6 t80 -55.54 -46.65 77.06 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.693 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 98.4 mt -64.75 -39.49 93.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.108 0.48 . . . . 0.0 110.331 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 51.2 tp10 -61.12 -42.52 98.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.761 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -63.72 -39.43 94.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.307 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.488 ' NH2' ' CE1' ' B' ' 241' ' ' PHE . 40.3 mmt-85 -61.74 -40.74 96.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.706 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -62.18 -41.38 98.28 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.412 -0.515 . . . . 0.0 109.95 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 37.3 t -65.04 -45.38 85.66 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . 0.441 ' HB2' ' NH2' ' A' ' 12' ' ' ARG . 74.8 mt-30 -61.2 -35.41 77.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.554 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . 0.47 HG23 ' O ' ' B' ' 245' ' ' ARG . 39.4 t . . . . . 0 C--N 1.33 -0.247 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.452 ' OE1' ' NH2' ' A' ' 93' ' ' ARG . 95.2 mt-10 . . . . . 0 CA--C 1.529 0.159 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.414 ' CD1' HG23 ' A' ' 9' ' ' THR . 76.5 mt -111.61 134.0 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 54.8 t -125.58 132.85 70.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.738 0.304 . . . . 0.0 111.098 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -98.33 120.36 38.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.312 0.577 . . . . 0.0 111.626 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -66.85 -44.61 80.58 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.203 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.42 159.2 30.13 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.033 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.02 154.4 67.39 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 123.051 2.501 . . . . 0.0 111.864 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 47.0 pt . . . . . 0 C--N 1.327 -0.393 0 CA-C-O 121.309 0.576 . . . . 0.0 111.819 -178.931 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.5 p . . . . . 0 CA--C 1.529 0.152 0 CA-C-O 120.901 0.381 . . . . 0.0 110.716 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.4 mtt85 -94.87 124.93 39.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.908 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -133.53 140.25 47.09 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.343 -0.543 . . . . 0.0 111.521 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.879 HD11 HD11 ' A' ' 22' ' ' LEU . 79.2 mt -113.0 138.45 49.86 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.502 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 54.7 t -112.78 131.34 64.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.3 m -85.38 136.32 33.51 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.595 0.712 . . . . 0.0 112.32 -178.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 95.0 mt -108.89 138.03 38.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.185 178.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -91.4 158.36 16.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.191 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.476 ' CD ' HH21 ' B' ' 245' ' ' ARG . 87.5 mtm180 -59.26 -23.51 62.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.044 0.45 . . . . 0.0 110.271 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.2 t -79.05 -16.83 56.26 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.358 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.05 36.62 5.93 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.6 t -119.46 134.18 63.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 121.191 0.519 . . . . 0.0 112.052 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.401 ' C ' ' OD1' ' A' ' 16' ' ' ASP . 60.5 t0 -76.96 120.1 21.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.38 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -115.48 -124.75 3.82 Favored Glycine 0 CA--C 1.539 1.583 0 C-N-CA 120.919 -0.657 . . . . 0.0 111.665 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.24 153.25 40.52 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.551 2.167 . . . . 0.0 113.192 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -111.61 156.58 21.58 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.029 0.442 . . . . 0.0 110.563 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.417 ' CD2' HD11 ' A' ' 37' ' ' ILE . 38.7 t80 -123.58 100.91 37.54 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.066 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.53 134.44 20.49 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 C-N-CA 121.344 1.363 . . . . 0.0 111.928 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.879 HD11 HD11 ' A' ' 7' ' ' LEU . 95.3 mt -88.55 71.74 8.86 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.844 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 89.2 p -79.9 -8.22 59.18 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.652 HD11 ' HG2' ' B' ' 265' ' ' GLN . 51.8 mt -97.4 142.5 29.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.801 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.9 p -66.2 -21.69 66.32 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.099 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 86.0 m -133.68 136.23 44.58 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.006 0.431 . . . . 0.0 110.775 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.559 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -134.81 129.53 34.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.486 178.632 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.51 HD12 ' O ' ' A' ' 49' ' ' CYS . 48.1 tp -119.71 131.22 55.34 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.745 -178.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.757 ' CE2' HD12 ' A' ' 37' ' ' ILE . 38.1 m-85 -104.98 140.78 37.68 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.702 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 149.3 -166.4 29.53 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 120.299 -0.953 . . . . 0.0 112.574 178.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 44.5 mtm180 -86.0 -32.01 21.72 Favored 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.415 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -49.33 151.16 3.84 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 -178.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.462 HG23 ' N ' ' A' ' 34' ' ' GLU . 11.3 tp -66.41 -40.5 86.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.462 ' N ' HG23 ' A' ' 33' ' ' ILE . 85.1 tt0 -54.8 -23.96 20.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.022 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.415 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 59.5 m -56.79 115.02 2.32 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.827 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -57.82 -21.41 42.09 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.757 HD12 ' CE2' ' A' ' 29' ' ' PHE . 97.6 mt -129.99 120.98 50.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.278 -0.874 . . . . 0.0 108.912 177.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 84.7 mtp180 -105.54 133.66 49.93 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.514 -179.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.0 mt -118.49 128.07 75.47 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -80.25 43.59 0.64 Allowed 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -177.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.971 HD11 ' NH1' ' A' ' 93' ' ' ARG . 59.0 mt -111.14 134.06 21.16 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.379 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.81 -9.76 21.2 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 122.223 1.948 . . . . 0.0 111.965 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.626 HG21 ' CE2' ' B' ' 241' ' ' PHE . 27.0 m -101.11 2.28 10.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.772 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 25.1 t -93.34 135.84 26.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.278 0.561 . . . . 0.0 109.945 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.4 m -68.25 159.94 30.24 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.377 -178.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -61.47 -42.46 98.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.928 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.675 ' O ' ' N ' ' A' ' 49' ' ' CYS . 82.9 mt-30 -114.58 -16.37 11.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.459 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.2 t60 32.81 -73.82 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.675 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -134.8 138.13 43.98 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -178.221 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -125.5 136.76 53.69 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.42 -0.809 . . . . 0.0 108.909 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.532 HG22 ' O ' ' A' ' 27' ' ' CYS . 14.9 tt -126.5 140.72 48.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.074 0.464 . . . . 0.0 110.89 -178.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -122.59 135.56 54.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.393 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.8 mt -110.6 114.62 47.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.283 0.564 . . . . 0.0 111.355 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.47 ' O ' ' N ' ' A' ' 56' ' ' GLN . 92.3 m-70 -115.76 143.89 44.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.571 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 54' ' ' HIS . 96.1 mt-10 -40.06 -29.36 0.07 Allowed 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.308 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.47 ' N ' ' O ' ' A' ' 54' ' ' HIS . 87.9 mt-30 -63.48 -69.66 0.26 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -160.57 -164.1 1.18 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.555 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -108.42 131.91 54.3 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.163 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 89.2 mt -122.0 132.27 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -178.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.553 HD11 ' SG ' ' A' ' 49' ' ' CYS . 57.9 tp -99.35 128.83 45.51 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.825 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -115.53 134.95 54.58 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -95.74 103.53 15.42 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -95.25 -8.25 36.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.427 178.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.44 98.42 8.88 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.989 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.9 p -79.57 -31.82 41.97 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.448 HG22 HG12 ' B' ' 236' ' ' VAL . 3.5 m -65.32 -49.08 70.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.917 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.479 HD21 ' HA ' ' B' ' 236' ' ' VAL . 73.8 m-20 -138.96 95.9 9.39 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.742 -179.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -54.04 144.32 58.0 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 121.901 1.734 . . . . 0.0 112.74 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.3 m -71.11 132.29 44.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.783 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -97.56 140.64 31.67 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.071 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.5 p -133.25 137.68 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 49.85 32.38 5.38 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.3 29.35 70.3 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.901 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 58.3 m -135.13 124.77 25.17 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 117.364 0.582 . . . . 0.0 112.086 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.7 m -69.27 137.0 25.12 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.526 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 1.6 pt -116.26 120.17 64.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 C-N-CA 120.659 -0.417 . . . . 0.0 110.726 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -85.29 -18.93 32.42 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.02 167.07 17.96 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.2 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.88 151.46 73.91 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.697 2.265 . . . . 0.0 112.807 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.5 m -141.2 148.81 20.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.193 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -79.09 133.7 36.76 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.331 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 97.0 mt -85.57 144.34 27.95 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.238 0.542 . . . . 0.0 111.304 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -128.47 151.1 49.79 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.913 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.5 ' ND1' ' N ' ' A' ' 99' ' ' ASN . 7.0 t60 -53.72 118.34 3.85 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.059 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.28 -17.33 31.61 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.994 -0.843 . . . . 0.0 110.994 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -67.16 135.38 53.43 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.227 0.537 . . . . 0.0 110.214 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.525 ' O ' HG13 ' A' ' 87' ' ' VAL . 12.5 p -113.54 133.47 59.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.877 -178.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.1 mt -99.67 131.7 46.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 177.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 98.6 m -122.91 125.67 45.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.642 0.735 . . . . 0.0 112.527 -178.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.591 ' O ' ' N ' ' A' ' 92' ' ' ASP . 96.6 mt -111.03 125.26 68.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 114.519 -1.218 . . . . 0.0 108.198 178.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.552 HD12 ' HB2' ' B' ' 237' ' ' CYS . 23.4 mm 35.17 -90.23 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -178.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.591 ' N ' ' O ' ' A' ' 90' ' ' ILE . 1.0 OUTLIER -125.44 5.81 7.65 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.14 0.495 . . . . 0.0 110.735 178.793 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.971 ' NH1' HD11 ' A' ' 41' ' ' LEU . 71.4 mtt85 -108.4 137.01 47.09 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.186 178.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 31.0 t -139.21 151.27 46.42 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.167 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.532 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 78.9 m-85 -124.81 126.02 44.94 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -87.06 135.99 33.08 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.99 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -97.82 123.0 41.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.358 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -139.62 130.69 26.42 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.158 -0.617 . . . . 0.0 112.069 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.5 ' N ' ' ND1' ' A' ' 84' ' ' HIS . 77.8 m-20 . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.626 178.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo . . . . . 0 N--CA 1.484 0.96 0 CA-C-O 121.038 0.349 . . . . 0.0 111.949 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.479 ' HA ' HD21 ' A' ' 67' ' ' ASN . 3.5 m -65.75 147.55 12.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . 0.552 ' HB2' HD12 ' A' ' 91' ' ' ILE . 8.5 t . . . . . 0 C--N 1.328 -0.354 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.246 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo . . . . . 0 N--CA 1.503 2.068 0 N-CA-C 113.254 0.444 . . . . 0.0 113.254 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 42.9 m -72.11 -43.39 64.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.051 0.453 . . . . 0.0 110.214 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.626 ' CE2' HG21 ' A' ' 43' ' ' VAL . 63.6 t80 -58.11 -46.76 85.0 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.097 -178.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 82.7 mt -63.79 -41.66 97.88 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.85 -39.67 90.99 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.565 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -61.74 -40.72 96.09 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.237 -0.585 . . . . 0.0 109.617 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.857 ' O ' HG23 ' B' ' 249' ' ' VAL . 77.9 mtp180 -63.35 -42.53 98.92 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.289 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -62.99 -41.06 99.46 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.382 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 33.5 p -67.62 -44.27 78.4 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.285 0.564 . . . . 0.0 109.905 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -63.49 -32.85 74.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.42 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . 0.857 HG23 ' O ' ' B' ' 245' ' ' ARG . 75.8 t . . . . . 0 C--N 1.328 -0.361 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 . . . . . 0 CA--C 1.529 0.14 0 CA-C-O 120.741 0.305 . . . . 0.0 111.371 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.532 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 75.6 mt -110.84 134.1 54.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 178.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 79.1 t -126.22 135.04 65.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.766 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -95.25 120.41 35.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.145 -178.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 40.5 tttp -65.33 -45.52 83.93 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.034 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . 0.652 ' HG2' HD11 ' A' ' 24' ' ' LEU . 2.9 mp0 -91.54 160.92 35.67 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.714 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.46 148.54 67.22 Favored 'Trans proline' 0 C--N 1.301 -1.923 0 C-N-CA 122.698 2.265 . . . . 0.0 112.829 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 42.7 pt . . . . . 0 C--N 1.332 -0.165 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.759 179.384 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.3 p . . . . . 0 CA--C 1.523 -0.066 0 CA-C-O 120.665 0.269 . . . . 0.0 110.834 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.582 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 93.5 mtt-85 -93.84 120.74 34.49 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.546 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -130.09 137.08 49.99 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.057 0.456 . . . . 0.0 111.782 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.621 HD11 ' HB3' ' A' ' 95' ' ' PHE . 43.8 tp -110.49 130.57 55.53 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.7 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 43.3 t -107.37 130.23 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 120.744 0.307 . . . . 0.0 110.72 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 m -90.91 116.4 28.69 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -177.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.625 HD12 ' OG ' ' A' ' 94' ' ' SER . 96.6 mt -83.72 142.89 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.21 178.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -93.32 157.85 16.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.265 0.555 . . . . 0.0 111.147 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.602 HH22 ' CG ' ' B' ' 248' ' ' GLN . 59.1 mtp180 -57.97 -31.9 67.34 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.232 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.4 p -71.59 -15.62 62.27 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.064 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.03 37.18 5.76 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 46.3 t -124.81 133.6 69.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.181 -0.509 . . . . 0.0 111.328 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -77.22 136.9 38.57 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.87 -120.25 2.22 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.486 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -71.53 151.52 58.98 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.273 1.982 . . . . 0.0 113.147 -178.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -108.01 158.59 17.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.178 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.55 ' CD2' HD11 ' A' ' 37' ' ' ILE . 53.0 t80 -129.22 94.98 31.99 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.22 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -57.93 124.9 17.05 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.038 1.825 . . . . 0.0 111.862 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 89.3 mt -87.39 46.94 1.43 Allowed 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.676 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.5 t -59.81 -20.21 55.42 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.692 HD11 ' HG2' ' B' ' 265' ' ' GLN . 71.7 mt -77.78 139.44 39.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.02 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.1 p -64.62 -20.98 66.59 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.906 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.5 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 28.2 m -132.45 132.98 43.3 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.716 -0.393 . . . . 0.0 110.769 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.2 t -124.98 117.92 25.09 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.3 tp -115.99 129.05 56.2 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.278 -178.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.68 ' CE2' HD12 ' A' ' 37' ' ' ILE . 4.9 m-85 -108.56 139.96 42.59 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.056 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.76 -178.11 29.24 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.479 178.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 31' ' ' ARG . 46.5 mtm180 -70.96 -33.3 70.33 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.685 0.278 . . . . 0.0 111.264 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.452 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -47.15 143.62 5.47 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.475 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.3 tp -67.1 -41.11 86.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.475 ' N ' HG23 ' A' ' 33' ' ' ILE . 79.7 mm-40 -55.79 -19.25 10.73 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.899 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.452 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 86.0 m -55.96 122.13 10.88 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.232 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.5 ' OD2' ' O ' ' A' ' 26' ' ' THR . 63.8 m-20 -58.15 -29.2 65.39 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.68 HD12 ' CE2' ' A' ' 29' ' ' PHE . 79.4 mt -128.38 119.09 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 176.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 68.8 ttp85 -106.47 135.85 47.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.319 -178.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.426 HG22 ' H ' ' A' ' 41' ' ' LEU . 95.1 mt -116.17 129.93 71.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-O 121.168 0.508 . . . . 0.0 110.853 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -75.92 25.46 0.12 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.415 -178.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.483 HD23 ' HA ' ' A' ' 41' ' ' LEU . 29.7 mt -92.22 128.85 43.47 Favored Pre-proline 0 C--N 1.326 -0.43 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.403 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.19 -8.21 21.7 Favored 'Trans proline' 0 C--N 1.316 -1.18 0 C-N-CA 122.083 1.856 . . . . 0.0 111.905 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.593 HG21 ' CE2' ' B' ' 241' ' ' PHE . 35.2 m -104.58 5.33 10.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.496 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.7 t -90.64 137.81 20.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.8 m -66.68 168.06 10.07 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.295 0.569 . . . . 0.0 112.035 -178.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -63.15 -45.71 90.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.237 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.651 ' O ' ' N ' ' A' ' 49' ' ' CYS . 86.9 mt-30 -115.02 -16.82 11.6 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.193 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.578 ' NE2' HG23 ' A' ' 90' ' ' ILE . 19.7 t60 35.97 -74.81 0.0 OUTLIER 'General case' 0 C--O 1.236 0.373 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 179.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.651 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.4 134.35 47.07 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -177.971 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -127.46 126.8 42.99 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.852 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.7 mt -111.52 134.26 54.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.332 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.493 ' CD ' ' NE2' ' A' ' 54' ' ' HIS . 82.7 tt0 -116.66 122.63 45.11 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 178.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 74.3 mt -103.46 118.7 50.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.008 -0.677 . . . . 0.0 112.276 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.56 ' O ' ' N ' ' A' ' 56' ' ' GLN . 99.3 m-70 -114.25 139.91 49.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.14 178.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.459 ' C ' ' O ' ' A' ' 54' ' ' HIS . 97.3 mt-10 -39.79 -25.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.465 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.56 ' N ' ' O ' ' A' ' 54' ' ' HIS . 60.4 tt0 -64.99 -67.55 0.43 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.712 ' CB ' ' HE ' ' A' ' 81' ' ' ARG . 4.7 tp10 -158.37 -159.14 0.77 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.104 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.406 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -118.25 128.36 54.61 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 87.7 mt -118.68 129.68 74.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.895 -178.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.629 ' HB2' HD11 ' A' ' 82' ' ' LEU . 26.7 tp -99.59 129.65 45.76 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.857 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -110.97 135.93 50.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.147 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.507 HD21 ' HB3' ' A' ' 68' ' ' PRO . 36.7 t-20 -97.26 109.45 22.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.835 0.35 . . . . 0.0 111.748 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -99.83 -9.66 22.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.692 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.9 t -78.74 119.81 22.5 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.106 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 95.2 p -101.04 -29.92 11.9 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.404 ' O ' ' OD1' ' A' ' 67' ' ' ASN . 0.6 OUTLIER -66.57 -42.06 87.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.608 178.67 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.404 ' OD1' ' O ' ' A' ' 66' ' ' THR . 1.4 m-20 -147.97 101.13 3.65 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.162 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.507 ' HB3' HD21 ' A' ' 62' ' ' ASN . 39.1 Cg_endo -66.2 154.22 75.0 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 121.624 1.549 . . . . 0.0 112.753 -178.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.1 m -75.24 149.9 38.75 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.612 -178.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -112.84 140.18 47.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.663 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 41.1 t -129.08 135.66 61.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.483 ' H ' HG13 ' A' ' 87' ' ' VAL . 89.6 m-20 52.22 31.81 9.76 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.42 25.81 71.76 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.893 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 63.4 m -136.78 135.94 38.47 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 120.324 -0.55 . . . . 0.0 112.031 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 43.5 t -66.63 135.84 27.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.233 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.0 pt -106.62 98.82 7.4 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.088 0 CA-C-O 121.322 0.582 . . . . 0.0 111.001 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -63.13 -33.26 75.07 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.39 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.498 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.2 OUTLIER -129.58 -178.71 0.85 Allowed Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.262 -179.531 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.498 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 31.5 Cg_exo -60.5 146.53 96.71 Favored 'Trans proline' 0 N--CA 1.504 2.1 0 C-N-CA 123.297 2.665 . . . . 0.0 112.459 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.4 p -140.01 139.65 36.69 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 CA-C-O 120.93 0.395 . . . . 0.0 111.626 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.712 ' HE ' ' CB ' ' A' ' 57' ' ' GLU . 70.5 ttt180 -75.34 127.65 33.63 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.687 178.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.629 HD11 ' HB2' ' A' ' 60' ' ' LEU . 92.4 mt -84.12 141.26 31.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.167 0.508 . . . . 0.0 111.206 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -130.73 149.36 52.41 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.882 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.471 ' ND1' ' N ' ' A' ' 99' ' ' ASN . 7.8 t60 -52.39 117.99 3.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.64 -179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.36 -16.97 34.61 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -66.37 139.72 58.04 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 121.213 0.53 . . . . 0.0 110.308 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.483 HG13 ' H ' ' A' ' 72' ' ' ASN . 7.4 p -111.09 133.01 58.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.869 -178.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.7 mt -101.14 129.65 51.81 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 76.8 m -124.48 122.29 37.22 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.642 0.734 . . . . 0.0 112.445 -178.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.578 HG23 ' NE2' ' A' ' 48' ' ' HIS . 76.5 mt -108.34 125.24 65.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.511 ' C ' ' O ' ' A' ' 90' ' ' ILE . 94.5 mt 34.73 -97.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.063 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.569 ' OD2' ' CZ ' ' B' ' 245' ' ' ARG . 54.4 p-10 -117.41 6.8 12.66 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.919 0.39 . . . . 0.0 111.196 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.57 ' N ' ' O ' ' A' ' 90' ' ' ILE . 23.1 mmt180 -110.53 134.27 52.53 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.625 ' OG ' HD12 ' A' ' 10' ' ' ILE . 71.6 p -137.55 150.95 47.89 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 119.661 -0.815 . . . . 0.0 110.429 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.621 ' HB3' HD11 ' A' ' 7' ' ' LEU . 82.9 m-85 -125.43 124.6 41.79 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.408 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.471 ' O ' HD12 ' A' ' 7' ' ' LEU . 69.4 mtp85 -87.12 134.11 33.55 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.316 -0.554 . . . . 0.0 110.951 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.601 ' OH ' ' ND2' ' A' ' 99' ' ' ASN . 92.6 t80 -99.25 126.67 45.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.15 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -143.5 125.98 15.8 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.967 0.413 . . . . 0.0 111.668 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.601 ' ND2' ' OH ' ' A' ' 97' ' ' TYR . 97.5 m-20 . . . . . 0 N--CA 1.464 0.266 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.308 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo . . . . . 0 N--CA 1.492 1.416 0 CA-C-O 121.391 0.496 . . . . 0.0 112.411 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.467 HG13 ' O ' ' B' ' 236' ' ' VAL . 14.6 p -87.2 127.81 40.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.22 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.6 t . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.662 -179.531 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo . . . . . 0 N--CA 1.494 1.526 0 CA-C-O 120.637 0.182 . . . . 0.0 111.819 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 20.4 m -68.14 -44.97 74.84 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 177.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.593 ' CE2' HG21 ' A' ' 43' ' ' VAL . 80.9 t80 -58.67 -45.62 89.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.144 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 84.0 mt -63.35 -41.66 98.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.917 0.389 . . . . 0.0 111.49 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -63.3 -42.07 99.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.151 -178.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 77.8 ttt-85 -61.44 -43.46 98.83 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.934 0.397 . . . . 0.0 110.572 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.569 ' CZ ' ' OD2' ' A' ' 92' ' ' ASP . 8.4 tpp85 -59.82 -42.4 93.45 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.849 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.98 -39.86 96.0 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 58.2 m -64.98 -44.28 89.82 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 177.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . 0.602 ' CG ' HH22 ' A' ' 12' ' ' ARG . 60.9 tt0 -58.67 -38.36 78.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.437 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 42.1 t . . . . . 0 C--N 1.329 -0.283 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.95 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.484 ' HB2' HH21 ' A' ' 93' ' ' ARG . 50.7 mp0 . . . . . 0 N--CA 1.467 0.383 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 53.2 mt -116.02 135.6 55.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 61.7 t -129.08 135.54 61.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.865 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -95.19 119.46 33.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.435 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . 0.433 ' HD3' HE22 ' B' ' 265' ' ' GLN . 88.2 tttt -64.63 -47.15 79.59 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.838 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . 0.692 ' HG2' HD11 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -93.67 159.15 35.39 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.038 -179.676 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -69.44 148.1 66.41 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.818 2.345 . . . . 0.0 112.754 -179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 44.8 pt . . . . . 0 C--N 1.326 -0.451 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.54 179.007 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.48 ' O ' ' O ' ' A' ' 99' ' ' ASN . 80.5 m . . . . . 0 CA--C 1.529 0.149 0 CA-C-O 120.731 0.3 . . . . 0.0 111.214 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.3 mtt85 -86.58 137.23 32.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.136 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -129.33 131.52 46.93 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.372 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.577 HD11 ' HB3' ' A' ' 95' ' ' PHE . 32.7 tp -109.64 131.66 54.85 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.4 t -113.27 131.17 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 121.172 0.511 . . . . 0.0 111.002 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.401 HG23 ' CD1' ' B' ' 261' ' ' ILE . 17.2 m -80.18 145.51 32.25 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.429 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.537 ' CD1' ' OD1' ' A' ' 16' ' ' ASP . 46.2 mm -112.83 136.24 49.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.579 177.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -88.3 151.74 22.42 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.771 HH11 ' NH2' ' A' ' 93' ' ' ARG . 79.0 mtm-85 -58.17 -21.8 48.77 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.175 -178.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 93.9 p -78.12 -10.9 59.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.767 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.98 31.8 11.67 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.184 -1.167 . . . . 0.0 110.184 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 51.2 t -118.34 132.64 67.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.796 0.332 . . . . 0.0 110.325 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.537 ' OD1' ' CD1' ' A' ' 10' ' ' ILE . 79.8 m-20 -75.85 137.51 40.51 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -130.89 -116.59 1.83 Allowed Glycine 0 CA--C 1.537 1.433 0 C-N-CA 120.364 -0.922 . . . . 0.0 112.597 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.63 146.84 44.39 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.337 2.025 . . . . 0.0 112.755 -178.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -109.21 155.15 21.43 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.012 0.435 . . . . 0.0 110.004 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.46 ' CD2' HD11 ' A' ' 37' ' ' ILE . 48.8 t80 -127.94 104.38 20.78 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.993 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.58 134.78 19.03 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 C-N-CA 121.371 1.381 . . . . 0.0 111.388 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 90.7 mt -87.23 59.61 5.66 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.374 -178.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 88.2 p -65.39 -33.08 75.12 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.8 mt -76.43 142.44 41.04 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.705 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 77.4 p -65.17 -17.6 64.61 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.417 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 92.0 m -135.31 136.96 41.99 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.725 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.0 t -128.12 119.73 25.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.056 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.666 HD21 ' HG2' ' A' ' 47' ' ' GLN . 38.6 tp -117.27 128.1 54.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.856 -178.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.668 ' CE2' HD12 ' A' ' 37' ' ' ILE . 4.7 m-85 -106.13 138.56 42.1 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 123.594 0.559 . . . . 0.0 109.834 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 160.8 -164.62 34.78 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.147 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.62 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 83.3 mtm-85 -86.82 -26.63 23.96 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.483 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.569 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -55.82 149.66 24.74 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-N 116.249 -0.432 . . . . 0.0 112.912 -178.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.513 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.5 tp -70.35 -42.77 78.67 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 CA-C-O 121.118 0.485 . . . . 0.0 109.823 178.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.513 ' N ' HG23 ' A' ' 33' ' ' ILE . 21.6 pt-20 -54.78 -20.15 7.91 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.498 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.569 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 13.3 m -61.63 128.15 34.9 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.205 -179.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.417 ' OD2' ' O ' ' A' ' 26' ' ' THR . 55.0 m-20 -61.88 -32.76 73.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.447 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.668 HD12 ' CE2' ' A' ' 29' ' ' PHE . 98.6 mt -128.62 125.51 63.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.692 178.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 70.8 mtm180 -106.57 138.17 43.25 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.931 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.687 HG21 HD12 ' A' ' 41' ' ' LEU . 94.2 mt -117.81 127.66 75.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -72.83 32.83 0.07 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.696 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.687 HD12 HG21 ' A' ' 39' ' ' ILE . 25.9 mt -98.44 120.99 58.08 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.667 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.1 -9.27 23.26 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.309 2.006 . . . . 0.0 112.45 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.645 HG23 HD13 ' A' ' 91' ' ' ILE . 12.1 m -103.5 10.71 8.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.664 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.62 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 11.0 t -100.8 138.1 26.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.5 m -69.91 172.17 8.19 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.577 0.703 . . . . 0.0 112.11 -178.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -63.98 -40.91 97.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.393 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.666 ' HG2' HD21 ' A' ' 28' ' ' LEU . 86.8 mt-30 -112.73 -20.03 11.8 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 123.172 0.295 . . . . 0.0 110.766 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 26.0 t60 37.12 -73.57 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.663 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.46 136.83 48.26 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.017 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -126.85 129.59 48.56 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.357 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.8 mt -115.01 133.75 60.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.584 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -115.2 128.68 56.32 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 52.0 mm -98.28 115.83 39.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.214 0.531 . . . . 0.0 110.959 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.486 ' O ' ' N ' ' A' ' 56' ' ' GLN . 97.2 m-70 -119.4 135.0 54.94 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.159 179.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 54' ' ' HIS . 51.6 tp10 -40.26 -28.69 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.041 -0.663 . . . . 0.0 109.375 -179.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.486 ' N ' ' O ' ' A' ' 54' ' ' HIS . 50.7 tt0 -65.39 -67.87 0.41 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.113 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.431 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 5.8 tp10 -158.8 -159.72 0.8 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.049 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.466 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -120.73 130.46 54.06 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.5 mt -116.92 128.8 74.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.191 0.519 . . . . 0.0 111.514 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.578 HD21 HG21 ' A' ' 69' ' ' THR . 22.6 tp -96.96 127.05 42.54 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.403 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -110.88 136.44 49.92 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.22 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -95.63 106.97 19.12 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.291 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -99.97 -12.03 20.11 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.31 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.44 100.44 10.72 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.779 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.8 m -73.31 -34.7 65.84 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.999 0.428 . . . . 0.0 110.491 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.71 -37.09 81.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.096 -179.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -145.05 92.37 5.73 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.171 -178.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.455 ' HB2' HG23 ' A' ' 75' ' ' VAL . 33.5 Cg_exo -56.65 146.42 76.53 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.205 1.937 . . . . 0.0 112.735 -178.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.578 HG21 HD21 ' A' ' 60' ' ' LEU . 3.3 m -72.84 136.96 45.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.61 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -102.43 140.15 37.09 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.668 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 51.7 t -131.78 133.25 61.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.581 ' ND2' ' OD1' ' A' ' 86' ' ' ASP . 83.8 m-20 53.01 32.16 12.34 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.488 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.99 28.29 64.9 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.905 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 66.1 m -142.71 138.95 30.91 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 117.048 0.424 . . . . 0.0 111.214 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.455 HG23 ' HB2' ' A' ' 68' ' ' PRO . 0.4 OUTLIER -71.39 141.47 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.399 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.1 pt -112.41 90.09 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.848 178.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -65.37 -26.97 68.25 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -121.63 168.09 12.07 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.544 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -56.51 142.46 89.69 Favored 'Trans proline' 0 N--CA 1.501 1.935 0 C-N-CA 122.312 2.008 . . . . 0.0 112.272 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.7 p -134.3 138.87 49.2 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 CA-C-O 121.072 0.463 . . . . 0.0 111.255 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -78.3 131.29 36.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.507 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.466 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 89.9 mt -83.14 131.22 35.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.261 0.553 . . . . 0.0 111.06 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -119.91 143.59 47.87 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.048 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -48.81 118.04 2.37 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.384 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.66 -12.84 42.58 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.581 ' OD1' ' ND2' ' A' ' 72' ' ' ASN . 26.3 t70 -69.71 132.2 45.76 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.3 t -108.27 133.53 52.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.19 -178.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 87.8 mt -102.21 131.79 49.55 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 54.1 m -120.89 127.4 51.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.535 0.683 . . . . 0.0 112.749 -178.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.486 ' O ' ' N ' ' A' ' 93' ' ' ARG . 88.9 mt -112.35 121.96 65.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.588 178.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.645 HD13 HG23 ' A' ' 43' ' ' VAL . 75.3 mt 31.71 -95.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.522 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 92' ' ' ASP . 38.7 p-10 -107.87 6.71 27.62 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -178.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.771 ' NH2' HH11 ' A' ' 12' ' ' ARG . 91.0 mtt-85 -129.98 147.95 51.78 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.458 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.3 t -136.77 154.18 50.63 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.626 0.727 . . . . 0.0 111.241 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.577 ' HB3' HD11 ' A' ' 7' ' ' LEU . 93.7 m-85 -125.46 120.93 32.33 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.893 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.474 ' O ' HD12 ' A' ' 7' ' ' LEU . 79.7 mtp85 -83.5 132.53 34.94 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.106 -0.638 . . . . 0.0 110.551 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -94.04 123.55 37.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.302 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -125.46 117.08 22.89 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.48 ' O ' ' O ' ' A' ' 4' ' ' THR . 7.2 t-20 . . . . . 0 C--N 1.326 -0.43 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.543 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo . . . . . 0 N--CA 1.485 1.009 0 CA-C-O 121.676 0.615 . . . . 0.0 113.032 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.484 HG13 ' O ' ' B' ' 236' ' ' VAL . 9.7 p -77.47 128.31 38.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.403 -178.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.425 179.926 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo . . . . . 0 N--CA 1.498 1.751 0 N-CA-C 113.057 0.368 . . . . 0.0 113.057 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . 0.405 HG22 ' NE ' ' B' ' 244' ' ' ARG . 18.6 m -72.88 -43.81 62.08 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.51 ' CE2' HG21 ' A' ' 43' ' ' VAL . 85.5 t80 -58.14 -46.72 85.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.577 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.467 HD21 ' CG2' ' A' ' 91' ' ' ILE . 87.4 mt -65.16 -41.91 94.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.973 0.416 . . . . 0.0 110.988 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 50.3 tp10 -65.22 -44.82 87.03 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.065 -179.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . 0.405 ' NE ' HG22 ' B' ' 240' ' ' THR . 88.6 mtm180 -64.34 -44.1 92.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.049 0.452 . . . . 0.0 111.046 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.593 ' NH1' ' OE2' ' B' ' 260' ' ' GLU . 54.5 ttm-85 -65.53 -41.06 93.52 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.709 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -60.86 -36.78 80.04 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 40.2 t -66.11 -43.24 87.76 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 177.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 67.4 tp60 -61.04 -36.46 79.61 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.286 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . 0.478 ' CG2' ' HE ' ' A' ' 12' ' ' ARG . 47.5 t . . . . . 0 CA--C 1.519 -0.225 0 CA-C-O 120.959 0.409 . . . . 0.0 109.988 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.593 ' OE2' ' NH1' ' B' ' 245' ' ' ARG . 97.7 mt-10 . . . . . 0 CA--C 1.523 -0.073 0 CA-C-O 120.973 0.416 . . . . 0.0 110.361 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.527 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 85.0 mt -115.25 135.15 56.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.569 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 45.5 t -125.83 133.7 68.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.082 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -98.95 120.71 39.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.555 0.693 . . . . 0.0 112.421 -177.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -67.29 -41.59 85.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.623 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.12 159.39 29.53 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.576 -178.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -61.01 153.76 61.74 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 123.128 2.552 . . . . 0.0 112.598 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 45.4 pt . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.872 -179.347 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.553 ' O ' ' O ' ' A' ' 99' ' ' ASN . 25.0 m . . . . . 0 C--O 1.227 -0.116 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.7 mtt85 -92.94 138.54 31.39 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.632 -178.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -133.42 141.83 48.04 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.729 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.715 HD11 HD11 ' A' ' 22' ' ' LEU . 65.7 mt -116.57 139.04 50.93 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.6 t -110.81 132.61 58.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 C-N-CA 120.349 -0.541 . . . . 0.0 110.158 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 m -91.58 116.79 29.16 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -177.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.6 mt -84.11 142.51 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.057 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -94.85 155.82 16.62 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.272 0.558 . . . . 0.0 111.266 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.523 ' CD ' ' NH2' ' B' ' 245' ' ' ARG . 83.4 mtm180 -59.05 -32.15 69.5 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.159 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 93.9 p -70.49 -22.51 62.64 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.49 30.05 5.73 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.329 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.3 t -118.04 131.03 71.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.107 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -78.26 138.64 38.72 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.89 -113.83 1.48 Allowed Glycine 0 CA--C 1.53 0.988 0 C-N-CA 120.041 -1.076 . . . . 0.0 112.426 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.6 149.42 55.31 Favored 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 121.953 1.769 . . . . 0.0 112.006 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -114.51 144.65 43.01 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.094 0.473 . . . . 0.0 110.304 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.53 ' CD2' HD11 ' A' ' 37' ' ' ILE . 33.8 t80 -105.87 102.74 40.67 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.344 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -77.74 132.6 12.1 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 121.95 1.766 . . . . 0.0 111.415 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.715 HD11 HD11 ' A' ' 7' ' ' LEU . 95.9 mt -84.56 76.63 10.16 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -177.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 61.5 p -79.9 -12.17 59.76 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 177.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.638 HD11 ' HG2' ' B' ' 265' ' ' GLN . 44.5 mt -102.61 146.81 27.62 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.521 -178.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -68.89 -15.31 63.46 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.832 0.348 . . . . 0.0 111.397 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.454 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 92.1 m -132.48 134.96 45.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.017 0.437 . . . . 0.0 111.295 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.448 ' HB2' HD22 ' A' ' 22' ' ' LEU . 5.1 t -127.3 118.91 25.12 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.05 178.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.503 HD21 ' HG2' ' A' ' 47' ' ' GLN . 33.6 tp -118.2 125.51 50.32 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.814 -178.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.756 ' CE2' HD12 ' A' ' 37' ' ' ILE . 5.1 m-85 -102.61 135.94 43.34 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 123.669 0.606 . . . . 0.0 109.679 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 154.91 -179.9 30.61 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 120.353 -0.927 . . . . 0.0 112.568 179.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 47.1 mtm180 -70.9 -33.48 70.59 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 122.653 -0.322 . . . . 0.0 111.552 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.551 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -43.94 140.18 3.52 Favored Glycine 0 N--CA 1.464 0.553 0 N-CA-C 111.306 -0.717 . . . . 0.0 111.306 -178.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.553 HG23 ' N ' ' A' ' 34' ' ' GLU . 9.7 tp -65.51 -41.99 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.553 ' N ' HG23 ' A' ' 33' ' ' ILE . 50.6 tp10 -56.92 -18.82 14.77 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.805 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.551 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 20.2 m -62.54 128.06 34.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.29 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.454 ' OD2' ' O ' ' A' ' 26' ' ' THR . 95.5 m-20 -60.4 -28.97 68.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.621 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.756 HD12 ' CE2' ' A' ' 29' ' ' PHE . 92.1 mt -128.32 118.56 48.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 177.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.513 ' CZ ' HD12 ' A' ' 33' ' ' ILE . 80.6 mtp180 -104.97 138.12 41.67 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.463 -178.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 88.6 mt -120.32 129.35 75.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 120.536 -0.465 . . . . 0.0 110.318 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -73.79 34.63 0.09 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.143 -178.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.572 ' CD1' ' NH2' ' A' ' 93' ' ' ARG . 32.3 mt -109.25 129.54 23.79 Favored Pre-proline 0 C--N 1.326 -0.435 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.06 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.12 -9.11 21.77 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 C-N-CA 121.975 1.784 . . . . 0.0 112.634 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.572 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 27.6 m -96.74 -0.67 10.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.627 0.251 . . . . 0.0 110.866 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 37.2 t -87.95 136.93 22.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.0 m -69.7 167.54 16.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.294 0.568 . . . . 0.0 111.553 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -64.46 -42.17 96.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.446 -178.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.656 ' O ' ' N ' ' A' ' 49' ' ' CYS . 86.5 mt-30 -115.13 -19.51 10.82 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.384 178.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 24.6 t60 37.3 -76.5 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.656 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -129.1 133.24 47.58 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.27 0.557 . . . . 0.0 111.722 -178.649 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -125.12 126.2 44.94 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.231 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 98.3 mt -112.86 134.55 55.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.578 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.454 ' CD ' ' NE2' ' A' ' 54' ' ' HIS . 84.6 tt0 -122.29 127.06 49.4 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.43 122.95 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 CA-C-O 121.754 0.788 . . . . 0.0 112.754 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.55 ' O ' ' N ' ' A' ' 56' ' ' GLN . 98.0 m-70 -114.02 139.42 49.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.388 -1.278 . . . . 0.0 109.308 179.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.473 ' C ' ' O ' ' A' ' 54' ' ' HIS . 83.3 tt0 -38.96 -26.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.55 ' N ' ' O ' ' A' ' 54' ' ' HIS . 91.2 mt-30 -67.36 -67.64 0.44 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.871 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.452 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 3.3 tp10 -155.2 -165.18 1.95 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.826 -179.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.41 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -114.33 133.38 55.72 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.527 178.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.2 mt -121.72 127.54 75.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.005 0.431 . . . . 0.0 111.561 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.571 ' HB2' HD11 ' A' ' 82' ' ' LEU . 28.9 tp -100.26 127.43 46.55 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.223 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.401 ' CE1' ' HB3' ' A' ' 79' ' ' PRO . 98.8 m-70 -113.53 138.71 49.75 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.041 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.495 ' ND2' ' H ' ' A' ' 69' ' ' THR . 8.6 t-20 -100.65 108.78 20.75 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.389 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -100.88 -9.82 21.25 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.335 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -75.98 99.15 4.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.098 0.475 . . . . 0.0 110.307 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.8 t -73.04 -36.52 66.96 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.519 0.676 . . . . 0.0 109.354 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.5 m -65.31 -48.14 74.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.81 -1.086 . . . . 0.0 111.789 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.454 ' OD1' HG23 ' B' ' 236' ' ' VAL . 3.0 m-20 -142.81 95.11 6.37 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.546 -178.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.591 ' HB2' HG13 ' A' ' 75' ' ' VAL . 43.3 Cg_exo -55.17 146.78 57.93 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 122.18 1.92 . . . . 0.0 112.287 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.495 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 59.0 m -74.57 140.45 44.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.284 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -99.18 142.51 30.57 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.647 179.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 54.5 t -131.12 134.73 61.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 51.07 30.25 5.32 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 119.321 -0.951 . . . . 0.0 108.601 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.07 26.13 69.5 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.221 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.4 p -137.85 137.34 38.02 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.98 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.591 HG13 ' HB2' ' A' ' 68' ' ' PRO . 25.7 t -70.99 136.07 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.312 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.4 pt -109.4 93.99 2.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.729 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -67.81 -29.43 68.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.087 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -125.46 174.65 3.73 Favored Pre-proline 0 CA--C 1.536 0.419 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.172 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.401 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 27.4 Cg_exo -61.36 144.58 98.48 Favored 'Trans proline' 0 N--CA 1.501 1.936 0 C-N-CA 122.871 2.38 . . . . 0.0 112.745 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.7 m -144.03 143.06 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.352 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 92.4 mtt-85 -75.36 129.88 38.1 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.61 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.571 HD11 ' HB2' ' A' ' 60' ' ' LEU . 88.1 mt -83.77 139.24 32.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.705 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -126.9 151.16 48.8 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.489 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.495 ' C ' ' CD2' ' A' ' 84' ' ' HIS . 6.1 t60 -58.06 122.39 12.93 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.91 0.385 . . . . 0.0 110.388 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.49 -13.67 32.97 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.574 -0.61 . . . . 0.0 111.574 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -75.0 136.82 41.24 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.728 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.3 t -108.28 131.98 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.068 -178.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.7 mt -97.09 132.07 42.44 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.448 HG23 ' OG ' ' A' ' 94' ' ' SER . 84.5 m -124.68 126.7 46.13 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -177.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.426 ' O ' ' C ' ' A' ' 91' ' ' ILE . 93.2 mt -114.79 122.03 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.593 HG22 ' N ' ' A' ' 92' ' ' ASP . 89.7 mt 36.29 -103.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.593 ' N ' HG22 ' A' ' 91' ' ' ILE . 88.3 m-20 -103.77 9.02 37.22 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -178.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.626 HH21 ' CZ ' ' B' ' 245' ' ' ARG . 2.5 ptp85 -132.46 148.16 52.39 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.509 -0.477 . . . . 0.0 111.194 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.448 ' OG ' HG23 ' A' ' 89' ' ' THR . 65.2 m -135.15 152.33 51.5 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.349 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -119.32 121.56 39.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.25 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -81.56 131.05 35.26 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 119.821 -0.751 . . . . 0.0 111.391 -179.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -93.24 120.28 33.34 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.247 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -136.4 122.29 20.02 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.727 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.553 ' O ' ' O ' ' A' ' 4' ' ' THR . 90.6 m-20 . . . . . 0 N--CA 1.455 -0.176 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 178.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo . . . . . 0 N--CA 1.491 1.335 0 CA-C-O 121.68 0.616 . . . . 0.0 112.83 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.454 HG23 ' OD1' ' A' ' 67' ' ' ASN . 0.5 OUTLIER -73.12 137.65 22.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 114.559 -1.2 . . . . 0.0 109.713 179.412 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.33 -0.276 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.444 -179.245 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo . . . . . 0 N--CA 1.495 1.606 0 N-CA-C 112.986 0.341 . . . . 0.0 112.986 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 40.1 p -73.99 -39.46 63.65 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.572 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 81.7 t80 -57.45 -45.7 84.44 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.427 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.49 HD23 ' OD2' ' A' ' 92' ' ' ASP . 90.9 mt -62.89 -40.16 96.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.991 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.77 -43.02 97.64 Favored 'General case' 0 CA--C 1.522 -0.105 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.794 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -61.4 -42.82 99.34 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.839 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.626 ' CZ ' HH21 ' A' ' 93' ' ' ARG . 70.6 mtp85 -61.3 -43.89 98.12 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.484 0.549 . . . . 0.0 112.484 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -62.87 -39.61 94.96 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.099 -0.64 . . . . 0.0 109.298 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 39.7 t -67.23 -46.56 73.43 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.025 178.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -59.27 -37.21 77.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.36 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . 0.451 HG23 ' O ' ' B' ' 245' ' ' ARG . 40.7 t . . . . . 0 C--N 1.33 -0.268 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.798 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.436 ' OE2' ' NH1' ' A' ' 12' ' ' ARG . 97.3 mt-10 . . . . . 0 CA--C 1.54 0.569 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 82.6 mt -117.61 132.88 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 43.2 t -126.97 135.35 63.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.495 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -96.91 120.58 37.52 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.194 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -65.48 -46.11 81.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.539 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . 0.638 ' HG2' HD11 ' A' ' 24' ' ' LEU . 3.3 mp0 -96.9 164.95 16.85 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.277 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -64.32 152.58 80.83 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.351 2.034 . . . . 0.0 111.91 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 42.6 pt . . . . . 0 C--N 1.328 -0.328 0 CA-C-O 121.307 0.575 . . . . 0.0 112.103 -178.553 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.7 p . . . . . 0 CA--C 1.529 0.159 0 CA-C-O 120.823 0.344 . . . . 0.0 111.258 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.494 ' NH2' HG21 ' A' ' 53' ' ' ILE . 88.0 mtm-85 -86.09 127.49 34.7 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -128.48 144.28 51.12 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.83 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 1.061 HD11 HD11 ' A' ' 22' ' ' LEU . 82.0 mt -113.89 142.62 45.89 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.5 t -114.14 126.76 71.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.0 m -77.4 140.68 39.95 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.505 0.669 . . . . 0.0 111.52 -178.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.446 ' HB ' ' H ' ' A' ' 94' ' ' SER . 49.2 mm -109.95 135.31 49.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.088 178.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -94.6 158.29 15.6 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.339 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -57.9 -20.97 41.06 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.89 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.7 p -81.23 -11.65 59.33 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.969 179.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.23 16.55 57.29 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-N 116.086 -0.506 . . . . 0.0 113.094 178.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.5 m -109.05 147.31 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 117.434 0.617 . . . . 0.0 111.533 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.431 ' C ' ' OD1' ' A' ' 16' ' ' ASP . 58.9 t0 -69.74 126.42 29.67 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.18 -178.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.402 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -115.86 -132.35 5.06 Favored Glycine 0 CA--C 1.542 1.751 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -74.18 153.36 46.06 Favored 'Trans proline' 0 N--CA 1.5 1.868 0 C-N-CA 122.509 2.139 . . . . 0.0 112.952 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -109.7 162.51 14.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.006 0.431 . . . . 0.0 110.615 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.427 ' CD2' HD11 ' A' ' 37' ' ' ILE . 38.0 t80 -132.43 106.76 13.24 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.047 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -73.58 127.37 11.66 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 121.903 1.736 . . . . 0.0 112.603 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 1.061 HD11 HD11 ' A' ' 7' ' ' LEU . 95.5 mt -92.05 48.26 1.41 Allowed 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.8 p -64.82 -13.05 54.45 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 119.559 -0.856 . . . . 0.0 109.222 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.616 HD11 ' OE1' ' B' ' 265' ' ' GLN . 75.4 mt -81.29 141.6 33.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.222 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 87.8 p -62.19 -21.65 65.27 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.971 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 57.6 m -139.54 138.84 36.63 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 119.827 -0.749 . . . . 0.0 112.164 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.509 ' HB2' HD22 ' A' ' 22' ' ' LEU . 5.7 t -128.6 123.92 34.57 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.849 178.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.6 tp -117.43 128.18 54.76 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.979 -178.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.791 ' CE2' HD12 ' A' ' 37' ' ' ILE . 4.4 m-85 -107.35 139.61 41.56 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.703 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 155.8 -173.37 33.84 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.196 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.629 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 83.9 mtm-85 -79.79 -31.03 40.76 Favored 'General case' 0 CA--C 1.527 0.079 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.561 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -52.38 146.08 16.52 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 121.003 -0.618 . . . . 0.0 111.695 -178.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.43 HD13 ' CZ ' ' A' ' 38' ' ' ARG . 33.2 mm -63.8 -43.61 97.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.877 0.37 . . . . 0.0 110.078 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -53.0 -18.11 1.82 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.989 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.561 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 59.6 m -61.18 123.39 17.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.982 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -60.18 -31.73 70.4 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.791 HD12 ' CE2' ' A' ' 29' ' ' PHE . 81.0 mt -124.65 119.33 55.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 176.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.43 ' CZ ' HD13 ' A' ' 33' ' ' ILE . 84.3 mtp180 -102.41 137.31 40.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.723 -178.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.471 HG22 ' H ' ' A' ' 41' ' ' LEU . 98.2 mt -122.99 131.62 72.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.521 179.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -80.3 26.0 0.38 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.529 -178.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.471 ' H ' HG22 ' A' ' 39' ' ' ILE . 34.8 mt -90.11 132.62 35.48 Favored Pre-proline 0 C--N 1.325 -0.477 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.377 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -71.4 -12.65 29.88 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 121.904 1.736 . . . . 0.0 111.53 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.532 HG21 ' CE2' ' B' ' 241' ' ' PHE . 3.6 m -102.14 7.59 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.629 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 11.4 t -93.51 129.95 43.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.28 168.04 6.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.272 0.558 . . . . 0.0 110.894 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -63.25 -43.32 98.32 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.1 -178.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.626 ' O ' ' N ' ' A' ' 49' ' ' CYS . 86.3 mt-30 -111.18 -11.83 14.19 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.55 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 18.6 t60 30.23 -76.68 0.0 OUTLIER 'General case' 0 C--O 1.237 0.402 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.626 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.95 136.04 47.04 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.266 0.555 . . . . 0.0 112.061 -178.549 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -127.38 127.09 43.62 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.064 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 95.8 mt -111.6 133.13 58.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.208 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -114.4 131.69 56.49 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.494 HG21 ' NH2' ' A' ' 5' ' ' ARG . 45.5 mm -103.51 115.37 45.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.296 0.57 . . . . 0.0 111.269 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.426 ' O ' ' C ' ' A' ' 55' ' ' GLU . 93.2 m-70 -117.04 137.57 52.16 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.959 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 54' ' ' HIS . 80.1 mm-40 -40.18 -35.39 0.39 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.256 0.551 . . . . 0.0 109.777 -179.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.478 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 98.5 mm-40 -64.13 -67.11 0.46 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.983 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.478 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 6.1 tp10 -155.64 -166.08 2.14 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.534 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.455 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -119.88 127.93 53.17 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 91.3 mt -116.02 130.54 70.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.11 0.481 . . . . 0.0 111.496 -178.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.562 ' HB2' HD11 ' A' ' 82' ' ' LEU . 19.6 tp -96.88 127.36 42.78 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.145 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -110.58 136.19 50.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.803 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.612 ' ND2' ' H ' ' A' ' 69' ' ' THR . 20.5 t-20 -97.15 111.66 23.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.856 0.36 . . . . 0.0 111.575 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.444 ' CD2' ' OE1' ' A' ' 47' ' ' GLN . 32.8 m-85 -99.8 -8.22 24.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.667 178.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.8 t -70.59 99.26 1.62 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 88.3 p -85.08 -6.12 59.32 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.324 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.534 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -102.04 -38.04 7.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.286 179.782 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -144.68 97.49 5.0 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.032 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.4 147.71 55.62 Favored 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 122.504 2.136 . . . . 0.0 113.376 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.612 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 11.1 m -72.08 138.06 47.55 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.56 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -101.54 139.04 37.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.533 179.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.477 ' HB ' HD11 ' A' ' 76' ' ' ILE . 25.5 t -130.5 134.17 62.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 54.94 32.46 18.01 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.288 0.566 . . . . 0.0 109.696 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.13 27.35 70.36 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.895 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.8 m -138.06 131.66 30.95 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.785 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -67.47 142.42 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 121.101 0.476 . . . . 0.0 111.123 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.525 ' CG2' ' O ' ' A' ' 78' ' ' GLU . 75.1 mt -114.51 123.79 70.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.845 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -96.14 -24.09 16.45 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.981 179.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.525 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 3.7 mm-40 -129.27 172.42 7.16 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.785 -178.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -60.6 146.49 96.98 Favored 'Trans proline' 0 N--CA 1.501 1.943 0 C-N-CA 122.285 1.99 . . . . 0.0 112.652 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.491 HG11 HD13 ' A' ' 76' ' ' ILE . 4.1 p -140.15 144.97 26.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.209 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -77.85 129.66 35.68 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.157 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.562 HD11 ' HB2' ' A' ' 60' ' ' LEU . 96.9 mt -86.56 135.94 33.25 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.249 0.547 . . . . 0.0 111.107 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -131.1 154.25 48.49 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.629 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.433 ' ND1' ' N ' ' A' ' 99' ' ' ASN . 8.2 t60 -53.44 117.37 3.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.626 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 113.87 -25.38 10.9 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.1 -0.572 . . . . 0.0 112.157 178.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -66.8 137.0 56.3 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.871 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 68.4 t -113.38 132.68 61.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.7 -178.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.0 mt -93.4 130.79 41.9 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 N-CA-C 107.994 -1.114 . . . . 0.0 107.994 178.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 51.4 m -118.52 128.26 54.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.639 0.733 . . . . 0.0 112.575 -178.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.458 ' O ' ' C ' ' A' ' 91' ' ' ILE . 95.3 mt -118.03 124.63 73.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.682 178.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.504 HD12 ' CB ' ' B' ' 237' ' ' CYS . 42.6 mm 34.14 -95.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.944 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 90' ' ' ILE . 47.9 t0 -117.65 15.36 14.53 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.727 0.298 . . . . 0.0 111.336 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.571 ' NH2' ' OE1' ' B' ' 260' ' ' GLU . 55.6 mtt85 -127.13 143.44 51.27 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.09 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.446 ' H ' ' HB ' ' A' ' 10' ' ' ILE . 38.2 m -135.69 154.53 51.25 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.531 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.594 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 91.8 m-85 -127.56 121.58 30.98 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -88.58 133.62 34.12 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.984 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -93.07 122.98 36.0 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.166 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -124.51 118.81 27.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.838 0.351 . . . . 0.0 110.294 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.433 ' N ' ' ND1' ' A' ' 84' ' ' HIS . 58.5 t-20 . . . . . 0 C--N 1.33 -0.265 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo . . . . . 0 N--CA 1.484 0.954 0 CA-C-O 121.038 0.349 . . . . 0.0 111.712 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.534 ' CG2' HG22 ' A' ' 66' ' ' THR . 27.9 t -112.84 133.6 58.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.375 -179.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . 0.504 ' CB ' HD12 ' A' ' 91' ' ' ILE . 2.3 t . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.438 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo . . . . . 0 N--CA 1.499 1.796 0 N-CA-C 113.795 0.652 . . . . 0.0 113.795 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . 0.407 ' HB ' ' NH1' ' B' ' 244' ' ' ARG . 18.1 p -76.04 -42.57 47.33 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.735 178.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.532 ' CE2' HG21 ' A' ' 43' ' ' VAL . 83.8 t80 -58.08 -45.0 87.87 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.837 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' B' ' 242' ' ' LEU . 95.6 mt -64.54 -41.87 96.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.781 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -63.95 -36.92 85.53 Favored 'General case' 0 C--N 1.334 -0.093 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.38 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' B' ' 244' ' ' ARG . 78.2 mtt85 -61.74 -43.25 99.21 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.628 -0.429 . . . . 0.0 109.981 179.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.575 ' O ' HG23 ' B' ' 249' ' ' VAL . 24.8 mmt180 -63.2 -41.88 99.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.427 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -63.53 -39.36 94.23 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 11.2 t -64.28 -46.59 83.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.129 178.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -61.42 -35.87 78.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.611 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . 0.575 HG23 ' O ' ' B' ' 245' ' ' ARG . 77.3 t . . . . . 0 C--N 1.328 -0.328 0 CA-C-O 120.903 0.382 . . . . 0.0 110.188 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.571 ' OE1' ' NH2' ' A' ' 93' ' ' ARG . 96.0 mt-10 . . . . . 0 CA--C 1.53 0.179 0 CA-C-O 120.611 0.244 . . . . 0.0 111.461 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.594 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 68.5 mt -107.77 134.5 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 178.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 77.3 t -128.07 136.76 59.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.369 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -95.49 118.18 31.74 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.296 0.57 . . . . 0.0 111.499 -178.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -65.05 -44.02 90.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.289 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . 0.616 ' OE1' HD11 ' A' ' 24' ' ' LEU . 10.4 mm-40 -96.73 154.01 38.53 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.57 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -61.65 146.24 96.94 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.326 2.017 . . . . 0.0 112.355 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 45.6 pt . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.872 -179.637 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 96.4 m . . . . . 0 CA--C 1.521 -0.172 0 CA-C-O 120.769 0.318 . . . . 0.0 111.382 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.6 mtt85 -87.51 129.74 34.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.436 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -133.93 139.55 46.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.611 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.734 HD12 ' O ' ' A' ' 96' ' ' ARG . 34.5 tp -114.59 129.2 56.65 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.764 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.7 t -108.19 131.11 59.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.29 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.8 m -81.76 148.23 29.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.287 0.565 . . . . 0.0 111.711 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.427 HD12 ' HB3' ' A' ' 94' ' ' SER . 92.6 mt -117.93 138.06 49.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 114.979 -1.01 . . . . 0.0 108.74 178.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -91.14 160.73 15.41 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.045 0.45 . . . . 0.0 111.408 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.54 HH12 ' CD ' ' B' ' 248' ' ' GLN . 89.9 mtm180 -58.63 -28.82 66.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.781 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.5 p -78.41 -7.61 57.56 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.636 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.67 33.17 9.38 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -178.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.5 t -123.78 135.27 64.02 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 CA-C-O 121.385 0.612 . . . . 0.0 111.55 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -76.27 138.11 40.34 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.547 179.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -126.29 -121.62 2.5 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 111.404 -0.678 . . . . 0.0 111.404 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.24 152.92 45.47 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.281 1.988 . . . . 0.0 112.829 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -110.34 153.81 24.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.16 0.505 . . . . 0.0 110.658 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.8 ' CD2' HD11 ' A' ' 37' ' ' ILE . 43.8 t80 -122.58 94.9 47.26 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.335 -179.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -59.36 127.03 22.47 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 121.349 1.366 . . . . 0.0 111.254 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.4 mt -84.77 50.17 1.86 Allowed 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.448 -178.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 72.4 m -60.86 -33.83 73.67 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.2 0.524 . . . . 0.0 109.845 179.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.702 HD11 ' HG2' ' B' ' 265' ' ' GLN . 66.7 mt -69.97 139.96 52.91 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.369 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.0 t -65.69 -18.83 65.61 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.405 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.9 m -134.51 133.53 40.45 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.246 -0.582 . . . . 0.0 111.444 -178.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.2 t -129.54 120.37 25.24 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.313 0.578 . . . . 0.0 110.249 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.525 HD12 ' O ' ' A' ' 49' ' ' CYS . 48.4 tp -117.37 131.74 56.72 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.994 -178.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.462 ' O ' ' O ' ' A' ' 47' ' ' GLN . 37.3 m-85 -109.7 140.5 43.5 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.848 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 153.86 -175.49 32.14 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 120.783 -0.723 . . . . 0.0 111.686 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 45.0 mtm180 -75.15 -32.29 61.27 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.609 0.242 . . . . 0.0 111.428 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.589 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -45.04 140.04 4.76 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.468 HG23 ' N ' ' A' ' 34' ' ' GLU . 7.1 tp -66.91 -41.07 87.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.374 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.468 ' N ' HG23 ' A' ' 33' ' ' ILE . 51.6 tp10 -61.41 -15.73 39.66 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.205 0.526 . . . . 0.0 110.149 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.589 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 8.8 m -61.17 131.62 51.05 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.289 -0.564 . . . . 0.0 109.752 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -60.67 -33.43 72.82 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.8 HD11 ' CD2' ' A' ' 20' ' ' PHE . 44.1 mm -121.4 115.12 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.061 177.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.474 ' NH2' HG11 ' B' ' 262' ' ' VAL . 88.3 mtm-85 -100.72 133.08 45.71 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.828 HG23 ' NH1' ' A' ' 93' ' ' ARG . 96.2 mt -119.24 129.8 74.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.689 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -74.92 24.14 0.09 Allowed 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -177.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.753 HD21 ' NH2' ' A' ' 93' ' ' ARG . 95.6 mt -97.87 126.71 39.64 Favored Pre-proline 0 C--N 1.324 -0.512 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.384 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -70.97 -9.67 26.13 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.682 2.254 . . . . 0.0 113.232 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.554 HG21 ' CE2' ' B' ' 241' ' ' PHE . 27.1 m -97.71 5.33 9.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.393 -179.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.4 t -94.96 136.79 25.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.692 0.282 . . . . 0.0 110.38 179.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.492 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 1.2 t -67.52 165.62 16.44 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.164 0.507 . . . . 0.0 110.857 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 41.1 mtmt -62.51 -41.99 99.21 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.36 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.605 ' O ' ' N ' ' A' ' 49' ' ' CYS . 84.2 mt-30 -111.46 -17.72 13.02 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.954 0.407 . . . . 0.0 111.111 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.492 ' H ' ' HB3' ' A' ' 45' ' ' SER . 26.8 t60 34.06 -75.92 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.605 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.81 136.94 49.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.321 0.581 . . . . 0.0 112.559 -177.785 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -127.09 129.0 47.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.979 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 93.5 mt -114.83 133.31 61.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.43 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -117.1 126.98 53.67 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 77.5 mt -108.81 113.78 45.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.705 0.765 . . . . 0.0 111.714 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.582 ' O ' ' N ' ' A' ' 56' ' ' GLN . 86.4 m-70 -114.27 146.79 40.0 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.806 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 54' ' ' HIS . 57.7 mp0 -40.58 -22.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.653 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.582 ' N ' ' O ' ' A' ' 54' ' ' HIS . 14.8 mm100 -72.57 -69.38 0.41 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -160.58 -164.89 1.3 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.191 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.493 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -109.8 124.26 50.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.663 179.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.6 mt -113.5 130.02 68.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.026 0.441 . . . . 0.0 111.751 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.719 HD22 ' CD1' ' A' ' 88' ' ' ILE . 25.6 tp -99.76 128.3 45.87 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.011 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -113.15 136.04 53.15 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.147 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -93.48 107.97 19.73 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.642 0.258 . . . . 0.0 111.67 -178.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -101.19 -11.51 19.48 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.714 179.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.6 t -72.45 98.43 2.27 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.9 t -82.69 -17.33 44.84 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.806 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.481 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -93.32 -43.21 8.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.287 -178.766 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -133.31 97.35 16.35 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -57.62 144.33 92.88 Favored 'Trans proline' 0 N--CA 1.5 1.894 0 C-N-CA 122.183 1.922 . . . . 0.0 113.224 -178.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.6 m -72.51 150.01 43.6 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.372 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -114.42 141.25 47.9 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.482 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.687 HG13 ' OD1' ' A' ' 86' ' ' ASP . 44.6 t -127.72 134.1 66.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 54.84 32.02 16.85 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.139 -0.625 . . . . 0.0 110.12 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.12 23.28 77.99 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.124 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.7 t -138.33 143.95 40.16 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 117.011 0.405 . . . . 0.0 110.99 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 44.2 t -67.08 132.33 32.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.502 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.426 HG12 ' O ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -118.56 79.29 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.426 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -65.96 -21.35 66.41 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.117 -178.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.426 ' O ' HG12 ' A' ' 76' ' ' ILE . 0.6 OUTLIER -110.35 159.95 30.2 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -179.562 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.41 145.87 92.83 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 C-N-CA 121.148 1.232 . . . . 0.0 111.196 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.42 145.73 21.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 89.9 mtm180 -75.29 132.05 40.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.795 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.493 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 92.0 mt -80.77 141.27 34.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.066 0.46 . . . . 0.0 110.927 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -129.02 149.84 50.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.779 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.471 ' C ' ' CD2' ' A' ' 84' ' ' HIS . 7.7 t60 -54.67 119.91 5.99 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.376 -0.529 . . . . 0.0 110.57 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.07 -8.32 41.94 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.687 ' OD1' HG13 ' A' ' 71' ' ' VAL . 45.6 t0 -71.62 127.54 32.9 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.516 HG22 ' HG2' ' A' ' 96' ' ' ARG . 76.6 t -105.56 134.62 46.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.401 -178.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.719 ' CD1' HD22 ' A' ' 60' ' ' LEU . 11.6 mm -98.16 128.55 49.49 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.7 m -122.48 129.06 51.61 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.841 0.829 . . . . 0.0 112.875 -178.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.476 ' O ' ' C ' ' A' ' 91' ' ' ILE . 74.1 mt -121.01 127.03 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 114.445 -1.252 . . . . 0.0 108.429 178.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.476 ' C ' ' O ' ' A' ' 90' ' ' ILE . 37.5 mm 35.91 -99.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 C-N-CA 120.576 -0.449 . . . . 0.0 110.252 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.504 ' O ' ' OD1' ' A' ' 92' ' ' ASP . 39.0 t0 -118.07 17.6 14.03 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.989 0.424 . . . . 0.0 110.91 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.828 ' NH1' HG23 ' A' ' 39' ' ' ILE . 97.7 mtt180 -125.67 142.17 51.65 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.759 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.45 ' OG ' ' CG1' ' A' ' 87' ' ' VAL . 16.6 t -140.12 152.85 46.44 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 120.184 -0.607 . . . . 0.0 110.781 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.518 ' HB3' HD11 ' A' ' 7' ' ' LEU . 76.4 m-85 -126.07 125.12 42.07 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.617 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.734 ' O ' HD12 ' A' ' 7' ' ' LEU . 99.6 mtt180 -88.03 134.09 33.82 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 120.351 -0.539 . . . . 0.0 111.605 -178.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -97.64 125.92 42.66 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.858 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -131.03 124.28 30.56 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.216 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 45.5 p-10 . . . . . 0 N--CA 1.466 0.339 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.841 -179.844 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo . . . . . 0 N--CA 1.485 1.005 0 CA-C-O 121.201 0.417 . . . . 0.0 112.765 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.481 ' CG2' HG22 ' A' ' 66' ' ' THR . 39.8 t -67.78 136.56 26.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.72 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 10.4 t . . . . . 0 CA--C 1.52 -0.206 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.594 -179.795 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo . . . . . 0 N--CA 1.494 1.533 0 CA-C-O 120.596 0.165 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 24.7 m -71.41 -42.95 67.68 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.554 ' CE2' HG21 ' A' ' 43' ' ' VAL . 87.8 t80 -58.33 -46.61 85.88 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.221 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 88.0 mt -62.97 -41.17 99.46 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.491 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -61.34 -38.76 88.08 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.408 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -63.79 -42.77 97.67 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.419 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -60.88 -40.27 92.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.259 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -64.17 -38.45 91.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.863 0.364 . . . . 0.0 110.763 179.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 80.8 p -68.61 -40.56 80.37 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . 0.54 ' CD ' HH12 ' A' ' 12' ' ' ARG . 59.8 tt0 -60.53 -38.27 83.9 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.442 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 24.4 t . . . . . 0 N--CA 1.452 -0.335 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.986 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.535 ' OE1' ' NH2' ' A' ' 93' ' ' ARG . 91.1 mt-10 . . . . . 0 N--CA 1.464 0.242 0 CA-C-O 120.485 0.183 . . . . 0.0 111.347 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 64.6 mt -108.59 141.45 23.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . 0.474 HG11 ' NH2' ' A' ' 38' ' ' ARG . 54.3 t -127.27 135.62 62.93 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 CA-C-O 121.065 0.459 . . . . 0.0 110.957 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -98.81 124.06 43.44 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.519 -178.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . 0.4 ' HB3' ' NE2' ' B' ' 265' ' ' GLN . 88.6 tttt -64.69 -47.1 79.61 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.705 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . 0.749 ' N ' HE21 ' B' ' 265' ' ' GLN . 0.0 OUTLIER -96.74 159.1 32.42 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.547 -179.344 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -68.05 143.51 60.19 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 122.998 2.465 . . . . 0.0 113.395 -179.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 47.9 pt . . . . . 0 C--N 1.326 -0.438 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.535 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.8 m . . . . . 0 CA--C 1.522 -0.116 0 CA-C-O 121.399 0.619 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.591 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 93.9 mtt-85 -92.39 130.81 37.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.309 -178.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.593 ' HE ' ' CE1' ' A' ' 19' ' ' HIS . 85.6 mtp180 -128.7 141.4 51.34 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.106 0.479 . . . . 0.0 111.343 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.491 HD12 ' O ' ' A' ' 96' ' ' ARG . 41.7 tp -117.8 136.46 53.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.065 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.7 t -114.26 130.01 69.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 CA-C-O 120.775 0.321 . . . . 0.0 111.353 -178.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 m -94.87 116.16 28.37 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.553 -178.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 66.9 mt -84.93 150.93 3.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.99 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -92.93 161.15 14.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.714 0.292 . . . . 0.0 110.358 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.776 HH11 HH11 ' B' ' 245' ' ' ARG . 91.0 mtm180 -57.22 -29.3 63.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.917 -179.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 75.4 p -77.28 -11.09 59.79 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.831 -0.347 . . . . 0.0 110.818 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.88 29.28 11.95 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.1 t -114.49 133.69 59.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.735 0.303 . . . . 0.0 110.668 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' A' ' 17' ' ' GLY . 64.8 t0 -69.34 127.64 33.77 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.809 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.409 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -119.31 -123.67 3.19 Favored Glycine 0 CA--C 1.537 1.42 0 C-N-CA 121.083 -0.579 . . . . 0.0 112.166 -179.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -74.34 149.08 39.45 Favored 'Trans proline' 0 N--CA 1.497 1.709 0 C-N-CA 122.492 2.128 . . . . 0.0 113.338 -178.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.593 ' CE1' ' HE ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -109.28 151.72 26.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.902 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.488 ' CD2' HD11 ' A' ' 37' ' ' ILE . 65.1 t80 -121.29 104.5 40.57 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.906 -178.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.437 ' O ' ' NE2' ' B' ' 265' ' ' GLN . 60.2 Cg_endo -77.48 127.37 8.9 Favored 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 121.767 1.645 . . . . 0.0 111.722 -179.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.433 HD13 HD11 ' A' ' 53' ' ' ILE . 79.3 mt -77.23 80.36 3.75 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.369 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.736 ' H ' HE22 ' B' ' 265' ' ' GLN . 66.4 p -82.91 -10.99 58.54 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.8 mt -108.07 148.93 29.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.574 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 94.7 p -72.19 -13.4 61.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.845 -178.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 29.0 m -129.57 131.34 46.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.185 0.517 . . . . 0.0 110.777 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.684 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -128.0 119.64 25.88 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.579 179.191 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.507 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 49.2 tp -120.02 125.29 47.99 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.737 -178.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.684 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 19.5 m-85 -98.96 124.36 43.86 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -176.98 -156.77 16.53 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 119.894 -1.146 . . . . 0.0 112.503 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.622 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 84.7 mtm-85 -107.9 -24.31 11.69 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 120.354 -0.539 . . . . 0.0 110.599 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.28 165.06 36.06 Favored Glycine 0 CA--C 1.524 0.644 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.135 -178.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.455 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.5 tp -67.14 -40.01 84.34 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 CA-C-N 115.529 -0.336 . . . . 0.0 110.713 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.455 ' N ' HG23 ' A' ' 33' ' ' ILE . 93.1 mt-10 -57.62 -32.64 67.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.533 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 68.9 m -49.52 116.18 1.64 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.936 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.572 ' OD1' ' N ' ' A' ' 37' ' ' ILE . 6.6 p-10 -58.16 -29.65 65.76 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.595 HD12 ' CE2' ' A' ' 29' ' ' PHE . 80.2 mt -129.23 117.11 42.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 177.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -101.28 138.74 37.9 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.871 0.367 . . . . 0.0 111.459 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.471 HG22 ' H ' ' A' ' 41' ' ' LEU . 91.6 mt -119.71 130.6 73.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.473 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.431 ' OE1' ' OE1' ' B' ' 260' ' ' GLU . 73.8 mt-30 -73.53 21.9 0.08 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.396 -178.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.941 HD11 ' NH1' ' A' ' 93' ' ' ARG . 20.1 mt -90.65 123.52 64.94 Favored Pre-proline 0 C--N 1.326 -0.426 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.165 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.31 -8.52 22.02 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 121.671 1.581 . . . . 0.0 112.128 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.4 m -101.42 4.77 10.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 C-N-CA 120.43 -0.508 . . . . 0.0 111.451 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.622 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 38.0 t -96.72 106.77 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.297 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.533 ' O ' ' O ' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -33.84 162.91 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.963 0.887 . . . . 0.0 112.385 -179.143 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -61.66 -41.06 97.0 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.354 -1.294 . . . . 0.0 111.461 -178.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.616 ' O ' ' N ' ' A' ' 49' ' ' CYS . 89.7 mm-40 -109.57 -17.45 13.73 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 123.728 0.642 . . . . 0.0 110.303 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.466 ' O ' ' OG ' ' A' ' 64' ' ' SER . 19.1 t60 36.87 -78.51 0.0 OUTLIER 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.072 -0.967 . . . . 0.0 113.02 -179.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.616 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -135.93 139.75 43.5 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.616 -178.588 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -126.41 131.68 51.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.843 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 87.9 mt -115.38 131.91 66.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.176 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -118.07 129.36 55.51 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.433 HD11 HD13 ' A' ' 22' ' ' LEU . 96.9 mt -110.49 121.85 64.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.548 0.689 . . . . 0.0 112.852 -178.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.464 ' O ' ' C ' ' A' ' 55' ' ' GLU . 97.3 m-70 -116.49 140.33 49.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.406 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 54' ' ' HIS . 92.1 mt-10 -39.92 -30.32 0.08 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.462 ' N ' ' O ' ' A' ' 54' ' ' HIS . 88.4 mt-30 -64.57 -68.79 0.33 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.798 178.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -152.21 -171.45 3.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.404 0.621 . . . . 0.0 110.748 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -111.91 124.63 52.78 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.507 178.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 91.0 mt -114.21 131.22 66.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.179 0.514 . . . . 0.0 112.128 -178.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.456 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 16.2 tp -104.1 129.6 51.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.191 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -115.2 138.09 51.31 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.167 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.616 ' ND2' ' H ' ' A' ' 69' ' ' THR . 23.3 t-20 -102.02 110.6 22.6 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.965 179.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -98.4 -5.35 32.8 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.157 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.466 ' OG ' ' O ' ' A' ' 48' ' ' HIS . 1.4 m -71.64 100.64 2.34 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.277 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.7 m -84.11 -20.48 32.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.119 0.485 . . . . 0.0 109.963 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.718 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -90.76 -40.85 11.58 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.619 -179.457 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -138.94 95.16 9.7 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.872 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.41 ' HB2' HG13 ' A' ' 75' ' ' VAL . 35.8 Cg_exo -57.77 143.65 95.0 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 122.287 1.991 . . . . 0.0 112.552 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.616 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 4.5 m -77.08 154.79 32.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.58 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.402 ' N ' ' CG2' ' A' ' 69' ' ' THR . 75.3 mt-30 -114.87 140.45 48.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.921 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 50.6 t -128.43 135.72 61.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 50.27 33.56 7.55 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.38 28.41 67.9 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.775 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.4 t -142.47 139.45 31.56 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.173 -0.611 . . . . 0.0 112.197 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.41 HG13 ' HB2' ' A' ' 68' ' ' PRO . 40.7 t -67.51 137.54 24.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.282 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 10.9 pt -108.6 81.33 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.154 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -60.85 -33.54 73.22 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.542 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.471 ' N ' ' CD ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -117.05 165.4 15.54 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.873 179.754 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.54 142.39 98.82 Favored 'Trans proline' 0 N--CA 1.502 1.979 0 C-N-CA 122.346 2.031 . . . . 0.0 112.162 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.5 m -135.6 138.17 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-O 120.961 0.41 . . . . 0.0 111.904 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.7 mtm180 -72.39 131.18 42.27 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.7 mt -80.02 136.61 36.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.266 0.555 . . . . 0.0 111.436 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -126.41 146.79 49.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.935 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.696 ' CE1' ' H ' ' A' ' 99' ' ' ASN . 3.5 t-160 -54.41 121.88 9.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.146 0.498 . . . . 0.0 110.909 -178.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.73 -10.84 38.37 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -71.86 136.71 47.06 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.49 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.468 ' O ' HG13 ' A' ' 87' ' ' VAL . 9.7 p -114.12 132.21 63.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.182 -178.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 69.1 mt -101.65 132.9 46.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 53.0 m -118.65 128.72 54.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.686 0.755 . . . . 0.0 112.121 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.567 HD12 ' HE1' ' A' ' 95' ' ' PHE . 98.1 mt -118.81 131.26 72.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 177.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.51 HG23 HD21 ' B' ' 242' ' ' LEU . 88.9 mt -24.43 98.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.547 ' OD1' ' CD2' ' B' ' 242' ' ' LEU . 2.7 m-20 89.01 -15.78 0.31 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 177.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.941 ' NH1' HD11 ' A' ' 41' ' ' LEU . 69.6 mtt85 -132.5 141.89 48.97 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.159 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.6 t -135.98 149.98 49.07 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.567 ' HE1' HD12 ' A' ' 90' ' ' ILE . 36.7 m-85 -126.57 123.63 38.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.785 -179.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.491 ' O ' HD12 ' A' ' 7' ' ' LEU . 42.7 ttm180 -84.42 129.09 34.9 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.599 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.591 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 87.8 t80 -91.78 124.67 36.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.137 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -123.76 132.42 53.8 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.737 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.696 ' H ' ' CE1' ' A' ' 84' ' ' HIS . 41.5 t-20 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.137 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo . . . . . 0 N--CA 1.488 1.173 0 CA-C-O 121.151 0.396 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.718 ' CG2' HG22 ' A' ' 66' ' ' THR . 44.1 t -112.61 132.5 61.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.644 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . 0.448 ' CB ' HD13 ' A' ' 91' ' ' ILE . 2.5 t . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.159 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo . . . . . 0 N--CA 1.501 1.945 0 N-CA-C 113.611 0.581 . . . . 0.0 113.611 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 19.0 p -82.76 -38.9 22.58 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.347 -0.541 . . . . 0.0 109.886 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -57.9 -46.48 84.87 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.726 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.547 ' CD2' ' OD1' ' A' ' 92' ' ' ASP . 97.3 mt -66.23 -42.43 88.64 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.386 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -63.39 -43.27 98.04 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.996 -178.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -63.43 -43.32 97.8 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.858 0.361 . . . . 0.0 111.04 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.776 HH11 HH11 ' A' ' 12' ' ' ARG . 58.0 ttm-85 -61.4 -42.28 98.47 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.797 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -63.17 -37.85 88.85 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.205 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 67.3 m -67.46 -43.8 80.15 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 177.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 63.5 tp60 -59.58 -39.85 85.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.979 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . 0.544 HG23 ' O ' ' B' ' 245' ' ' ARG . 77.6 t . . . . . 0 C--N 1.331 -0.231 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.582 ' CG ' HH21 ' A' ' 93' ' ' ARG . 49.9 mm-40 . . . . . 0 CA--C 1.531 0.215 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 89.4 mt -110.1 135.09 50.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 69.2 t -127.5 132.06 69.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.927 0.394 . . . . 0.0 110.204 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . 0.478 ' HB2' HD11 ' B' ' 267' ' ' ILE . 72.7 m-85 -96.35 120.7 37.13 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.241 0.543 . . . . 0.0 111.493 -178.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -67.96 -41.35 82.59 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.417 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . 0.736 HE22 ' H ' ' A' ' 23' ' ' SER . 0.0 OUTLIER -93.59 161.41 30.54 Favored Pre-proline 0 N--CA 1.463 0.202 0 CA-C-N 116.62 -0.263 . . . . 0.0 111.419 -177.797 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -59.31 143.55 99.7 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.227 1.951 . . . . 0.0 111.181 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . 0.55 ' CG2' ' O ' ' A' ' 19' ' ' HIS . 2.1 mt . . . . . 0 N--CA 1.449 -0.477 0 C-N-CA 120.304 -0.559 . . . . 0.0 110.55 -178.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.1 m . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.977 0.417 . . . . 0.0 110.665 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.652 ' NH1' HG23 ' A' ' 53' ' ' ILE . 99.8 mtt180 -98.56 135.38 40.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.037 -179.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -137.89 150.4 47.06 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.498 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 86.2 mt -116.5 139.22 50.71 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.455 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.413 HG11 ' OD2' ' A' ' 16' ' ' ASP . 65.5 t -110.92 127.98 67.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.457 ' CG2' HD12 ' B' ' 261' ' ' ILE . 54.8 m -79.04 142.06 36.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.387 0.613 . . . . 0.0 112.386 -178.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.418 HD12 ' HB3' ' A' ' 94' ' ' SER . 96.9 mt -114.17 135.88 52.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.467 176.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -86.91 160.01 18.85 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 90.9 mtm180 -57.84 -29.31 64.86 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.578 -178.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 42.8 m -80.81 -9.49 59.81 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.712 0.291 . . . . 0.0 110.928 179.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.68 40.67 5.58 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.6 t -121.09 133.02 69.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.919 0.39 . . . . 0.0 110.74 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.413 ' OD2' HG11 ' A' ' 8' ' ' VAL . 65.7 t0 -75.19 125.45 28.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.154 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -120.54 -121.01 2.82 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.062 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -74.89 150.78 39.25 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.464 2.109 . . . . 0.0 112.777 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.97 155.85 22.1 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.548 ' CD2' HD11 ' A' ' 37' ' ' ILE . 64.0 t80 -122.29 93.24 48.65 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.2 -179.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.467 ' O ' ' NE2' ' B' ' 265' ' ' GLN . 27.3 Cg_exo -61.66 130.47 31.62 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.159 1.906 . . . . 0.0 111.74 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 22' ' ' LEU . 96.7 mt -85.79 82.22 8.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.426 0.631 . . . . 0.0 110.396 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.7 p -86.78 -8.14 57.62 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.002 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 42.7 mt -108.08 147.99 30.42 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.964 -178.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.9 t -65.39 -18.25 65.17 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -178.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 21.6 m -136.65 136.96 39.56 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.463 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.7 t -129.73 123.4 30.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.514 178.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 52.5 tp -116.69 129.69 56.28 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.037 0.446 . . . . 0.0 111.642 -178.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.763 ' CE2' HD12 ' A' ' 37' ' ' ILE . 3.2 m-85 -109.16 144.47 37.18 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.99 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 146.97 -170.12 27.94 Favored Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.764 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 31' ' ' ARG . 47.9 mtm180 -78.53 -32.3 47.91 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.491 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -50.83 146.77 9.15 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.63 -178.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.488 HG23 ' N ' ' A' ' 34' ' ' GLU . 7.6 tp -67.17 -41.78 87.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.488 ' N ' HG23 ' A' ' 33' ' ' ILE . 70.3 mm-40 -53.33 -17.65 1.98 Allowed 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.813 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 59.8 m -62.27 121.42 13.11 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.749 -179.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -57.83 -29.71 65.15 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.763 HD12 ' CE2' ' A' ' 29' ' ' PHE . 92.5 mt -128.23 121.93 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.107 176.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.431 ' CZ ' HD12 ' A' ' 33' ' ' ILE . 81.9 mtp180 -106.97 137.94 44.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.092 -178.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.613 ' CG2' HD12 ' A' ' 41' ' ' LEU . 95.5 mt -120.53 129.32 75.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -78.2 26.99 0.2 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.613 HD12 ' CG2' ' A' ' 39' ' ' ILE . 9.4 mt -92.73 126.84 50.33 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.808 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.79 -12.41 30.89 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.499 2.133 . . . . 0.0 113.632 -179.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.656 HG21 ' CE2' ' B' ' 241' ' ' PHE . 35.2 m -99.92 5.83 9.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.791 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.7 t -89.32 136.61 23.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.986 179.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.2 m -67.84 161.33 26.48 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.52 0.676 . . . . 0.0 111.548 -178.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -61.65 -42.99 99.67 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.112 -178.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.603 ' O ' ' N ' ' A' ' 49' ' ' CYS . 95.5 mt-30 -115.72 -6.26 12.13 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 123.652 0.595 . . . . 0.0 111.064 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.463 ' C ' ' O ' ' A' ' 47' ' ' GLN . 15.2 t60 15.9 -73.43 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 -178.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.603 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -128.48 132.67 48.38 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.483 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -126.85 126.57 43.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.179 179.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 85.6 mt -106.71 130.32 58.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.048 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -116.81 119.83 36.62 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.652 HG23 ' NH1' ' A' ' 5' ' ' ARG . 97.5 mt -103.62 116.55 47.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.02 -0.672 . . . . 0.0 112.285 -178.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.551 ' O ' ' N ' ' A' ' 56' ' ' GLN . 87.0 m-70 -114.88 142.91 45.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.303 179.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.4 mm-40 -39.52 -26.35 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -178.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.551 ' N ' ' O ' ' A' ' 54' ' ' HIS . 77.7 mt-30 -69.47 -68.73 0.39 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.891 178.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.409 ' CD ' ' N ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -157.68 -166.13 1.93 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.321 -179.174 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.59 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -112.9 130.2 56.2 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.2 mt -119.8 130.78 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 29.0 tp -100.14 125.83 46.32 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.291 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -107.53 137.57 45.32 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.575 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -99.92 106.95 18.82 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -99.35 -5.35 29.8 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.662 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.521 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 23.1 t -86.77 99.88 12.11 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 120.401 -0.52 . . . . 0.0 112.014 -178.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.5 m -73.68 -37.6 65.17 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 177.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.7 p -65.66 -36.24 83.09 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.636 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.521 ' O ' ' OG ' ' A' ' 64' ' ' SER . 36.3 m-80 -153.05 97.92 2.8 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.547 -179.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -59.28 147.01 92.87 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.063 1.842 . . . . 0.0 112.758 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 60.4 m -65.62 133.58 51.46 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 177.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -96.82 141.55 29.88 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.223 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.741 ' HB ' HD11 ' A' ' 76' ' ' ILE . 5.2 p -129.66 134.67 62.93 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 50.96 32.97 8.08 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 119.694 -0.802 . . . . 0.0 109.15 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.05 28.53 66.38 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.443 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.2 t -140.24 139.43 35.58 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 117.308 0.554 . . . . 0.0 110.743 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -68.05 144.1 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 120.903 0.382 . . . . 0.0 111.48 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.741 HD11 ' HB ' ' A' ' 71' ' ' VAL . 85.9 mt -106.28 108.73 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.693 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -76.18 -39.17 55.48 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.1 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.511 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 1.5 mt-10 -128.64 172.99 6.11 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.737 -178.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -57.54 143.57 94.29 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 122.16 1.907 . . . . 0.0 112.57 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.1 t -133.0 138.03 52.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.425 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -74.32 131.35 41.07 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 178.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.527 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 96.4 mt -82.84 136.73 34.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.982 0.42 . . . . 0.0 111.491 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -132.61 154.95 49.55 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.301 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.405 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 5.2 t60 -54.94 117.28 3.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.894 0.378 . . . . 0.0 111.596 -179.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.39 -14.03 30.51 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.525 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 52.5 t0 -69.44 127.8 34.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.089 0.471 . . . . 0.0 110.445 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.461 HG22 ' HG2' ' A' ' 96' ' ' ARG . 72.5 t -108.79 132.64 56.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.359 -178.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.1 mt -102.48 131.13 51.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 89.7 m -119.49 129.49 54.74 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.643 0.735 . . . . 0.0 112.119 -178.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.623 ' O ' ' N ' ' A' ' 93' ' ' ARG . 92.0 mt -118.35 133.08 66.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 114.615 -1.175 . . . . 0.0 108.769 178.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.543 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 70.3 mt -20.77 91.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.656 ' CG ' ' HE ' ' B' ' 245' ' ' ARG . 21.3 t0 93.36 -21.73 0.07 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 177.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.623 ' N ' ' O ' ' A' ' 90' ' ' ILE . 87.8 mtt-85 -130.4 146.01 51.9 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.103 -0.639 . . . . 0.0 111.029 -179.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.418 ' HB3' HD12 ' A' ' 10' ' ' ILE . 32.7 t -138.9 151.77 47.21 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.149 0.5 . . . . 0.0 110.317 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.638 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 91.6 m-85 -125.65 127.27 46.02 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.461 ' HG2' HG22 ' A' ' 87' ' ' VAL . 99.8 mtt180 -89.06 138.02 31.79 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.745 -179.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -94.91 119.37 33.34 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.512 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -123.18 120.96 34.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.852 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.405 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 64.1 t-20 . . . . . 0 C--N 1.325 -0.476 0 C-N-CA 120.679 -0.409 . . . . 0.0 110.141 179.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo . . . . . 0 N--CA 1.495 1.608 0 CA-C-O 121.333 0.472 . . . . 0.0 112.982 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.441 HG13 ' O ' ' B' ' 236' ' ' VAL . 10.7 p -78.39 128.87 38.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.254 178.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . 0.517 ' HB2' HD13 ' A' ' 91' ' ' ILE . 1.8 t . . . . . 0 C--N 1.328 -0.339 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.184 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo . . . . . 0 N--CA 1.491 1.377 0 CA-C-O 120.711 0.213 . . . . 0.0 111.981 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 20.0 m -68.72 -46.89 67.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.442 0.639 . . . . 0.0 109.774 178.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.744 ' CD2' ' NH1' ' B' ' 245' ' ' ARG . 77.2 t80 -58.65 -44.0 89.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.767 -179.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 1.046 HD23 HH22 ' B' ' 245' ' ' ARG . 60.6 mt -61.34 -43.87 98.14 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.214 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -64.69 -37.7 88.49 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -62.68 -47.2 84.69 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.632 -178.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 1.046 HH22 HD23 ' B' ' 242' ' ' LEU . 27.8 mtm-85 -63.93 -37.55 87.84 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.773 -179.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -62.49 -41.2 98.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.809 0.338 . . . . 0.0 110.443 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 76.7 p -66.16 -41.12 90.82 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -62.08 -38.98 90.88 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.111 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . 0.457 HG23 ' O ' ' B' ' 245' ' ' ARG . 52.5 t . . . . . 0 N--CA 1.451 -0.4 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 . . . . . 0 C--O 1.231 0.124 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.638 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 66.7 mt -107.32 133.6 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 56.5 t -125.86 132.94 70.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.109 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -96.23 118.78 33.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.401 0.62 . . . . 0.0 111.969 -177.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -66.23 -44.65 83.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.767 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . 0.467 ' NE2' ' O ' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -95.83 156.15 37.6 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.09 -179.462 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -64.93 144.21 82.03 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 C-N-CA 122.674 2.249 . . . . 0.0 112.926 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 47.3 pt . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.912 179.463 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.0 p . . . . . 0 CA--C 1.528 0.129 0 CA-C-O 120.912 0.387 . . . . 0.0 110.851 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.763 ' NH1' ' HB2' ' A' ' 58' ' ' ALA . 96.8 mtt-85 -90.24 122.39 33.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.87 -178.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -130.69 138.08 49.85 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.918 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 1.032 HD11 HD11 ' A' ' 22' ' ' LEU . 83.3 mt -115.26 139.42 49.97 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.57 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.6 t -112.1 127.65 69.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.452 HG23 ' CD1' ' B' ' 261' ' ' ILE . 4.3 m -87.62 111.83 21.67 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.234 0.54 . . . . 0.0 111.43 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 90.9 mt -82.82 145.52 8.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.717 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -92.0 158.19 16.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.783 0.325 . . . . 0.0 110.754 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -58.01 -24.75 59.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.529 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.2 m -80.94 -10.05 59.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.033 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.07 39.81 6.81 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.1 t -123.31 134.62 65.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.849 0.356 . . . . 0.0 111.328 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' A' ' 17' ' ' GLY . 62.6 t0 -73.93 127.24 32.36 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.931 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.428 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -123.8 -122.73 2.73 Favored Glycine 0 CA--C 1.542 1.746 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.217 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.95 148.63 45.75 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 122.671 2.247 . . . . 0.0 113.626 -178.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -107.39 154.83 20.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.166 0.508 . . . . 0.0 110.832 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -130.76 103.2 16.03 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.582 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -78.05 138.62 16.49 Favored 'Trans proline' 0 N--CA 1.488 1.191 0 C-N-CA 121.911 1.74 . . . . 0.0 112.635 -179.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 1.032 HD11 HD11 ' A' ' 7' ' ' LEU . 94.0 mt -92.65 54.42 2.24 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.225 -0.443 . . . . 0.0 112.188 -178.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.6 p -59.67 -29.03 67.78 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.749 HD11 HE21 ' B' ' 265' ' ' GLN . 63.1 mt -75.43 142.11 43.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.609 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.32 -16.65 64.22 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -178.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 30.3 m -140.5 140.29 35.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.021 0.438 . . . . 0.0 111.16 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.617 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -136.28 134.2 37.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.382 178.545 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 47.5 tp -121.73 127.38 50.63 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.214 -178.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.82 ' CE2' HD12 ' A' ' 37' ' ' ILE . 21.0 m-85 -101.86 131.99 47.89 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.663 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.62 -177.79 38.61 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 120.274 -0.965 . . . . 0.0 112.285 179.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.671 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 73.0 mtm-85 -77.9 -31.95 51.47 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.764 0.316 . . . . 0.0 110.554 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.435 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -52.45 149.21 10.34 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -178.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.514 HG23 ' N ' ' A' ' 34' ' ' GLU . 8.1 tp -66.44 -42.04 89.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 C-N-CA 120.759 -0.377 . . . . 0.0 110.272 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.514 ' N ' HG23 ' A' ' 33' ' ' ILE . 80.0 mm-40 -53.16 -18.87 2.5 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.435 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 57.1 m -63.25 121.88 14.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.533 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -57.94 -29.41 65.14 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.82 HD12 ' CE2' ' A' ' 29' ' ' PHE . 93.4 mt -122.64 119.78 59.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 176.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.457 ' HD3' HD12 ' A' ' 33' ' ' ILE . 87.9 mtm-85 -104.0 133.67 48.56 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.355 -178.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.45 HG22 ' H ' ' A' ' 41' ' ' LEU . 98.9 mt -117.53 129.36 74.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.148 0.499 . . . . 0.0 110.24 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -77.92 24.1 0.24 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.857 -177.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.769 HD12 ' CZ ' ' A' ' 93' ' ' ARG . 38.3 mt -105.02 128.24 27.1 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.912 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.47 -12.93 30.02 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.434 2.089 . . . . 0.0 113.309 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.589 HG21 ' CE2' ' B' ' 241' ' ' PHE . 25.5 m -88.45 -2.21 8.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.871 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.671 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 55.8 t -92.86 134.55 30.39 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.255 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 178.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.451 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 0.6 OUTLIER -65.1 162.04 17.74 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.291 0.567 . . . . 0.0 111.793 -178.766 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -59.86 -43.6 94.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.19 -178.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.67 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.5 mt-30 -111.5 -18.08 12.93 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.451 ' H ' ' HB3' ' A' ' 45' ' ' SER . 19.5 t60 32.59 -71.93 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.467 -1.242 . . . . 0.0 114.108 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.67 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.19 136.21 45.53 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.296 0.57 . . . . 0.0 112.263 -177.847 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -125.68 135.76 52.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.333 178.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.578 HD11 HD12 ' A' ' 82' ' ' LEU . 18.0 tt -124.29 136.39 60.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.03 0.443 . . . . 0.0 110.14 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -122.46 132.57 54.41 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.981 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.55 HD13 ' HD2' ' A' ' 5' ' ' ARG . 95.6 mt -106.99 112.25 39.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.823 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.501 ' O ' ' N ' ' A' ' 56' ' ' GLN . 81.4 m-70 -112.92 145.96 39.83 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.156 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' A' ' 54' ' ' HIS . 99.1 mt-10 -40.2 -27.02 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.894 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.501 ' N ' ' O ' ' A' ' 54' ' ' HIS . 85.7 mt-30 -67.04 -68.92 0.34 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.608 178.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -158.68 -168.22 2.35 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.209 0.528 . . . . 0.0 110.945 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.763 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -104.04 120.74 41.72 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 177.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.6 mt -110.99 128.89 67.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.588 HD11 ' SG ' ' A' ' 49' ' ' CYS . 56.5 tp -97.82 129.78 44.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.682 179.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -114.86 136.95 52.54 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.731 0.3 . . . . 0.0 111.147 -179.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -94.35 106.55 18.53 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -102.75 -10.18 19.37 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.311 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.5 t -74.27 101.59 4.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.381 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 92.2 p -82.61 -12.69 57.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.01 0.434 . . . . 0.0 110.035 179.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.15 -35.64 9.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.434 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -145.33 92.75 5.54 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.39 -179.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.548 ' HB2' HG13 ' A' ' 75' ' ' VAL . 45.1 Cg_exo -55.57 146.19 65.67 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 122.648 2.232 . . . . 0.0 112.721 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 61.8 m -77.03 138.65 39.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.585 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -102.68 141.15 35.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.088 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.4 t -129.79 135.18 61.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 52.42 32.13 10.77 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.2 24.72 70.48 Favored Glycine 0 CA--C 1.535 1.281 0 CA-C-N 115.131 -0.941 . . . . 0.0 112.885 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 47.6 t -141.66 140.85 33.33 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 118.053 0.927 . . . . 0.0 112.057 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.548 HG13 ' HB2' ' A' ' 68' ' ' PRO . 43.0 t -68.03 139.43 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.343 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.2 pt -114.59 89.36 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.25 178.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -63.72 -24.0 67.6 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -123.62 166.74 17.36 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.128 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -65.55 150.64 86.43 Favored 'Trans proline' 0 N--CA 1.5 1.86 0 C-N-CA 122.845 2.364 . . . . 0.0 113.441 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 29.7 m -143.1 143.92 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.59 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -75.27 138.56 41.95 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 178.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.578 HD12 HD11 ' A' ' 51' ' ' ILE . 92.0 mt -96.67 134.83 39.42 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.249 0.547 . . . . 0.0 111.571 -178.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -121.45 157.3 30.88 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.769 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -55.46 120.71 7.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.354 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.38 -19.3 26.93 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -68.14 135.94 52.91 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.307 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 42.2 t -114.6 133.54 60.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.524 -178.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.404 ' O ' ' OG ' ' A' ' 94' ' ' SER . 80.9 mt -100.61 132.49 46.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.248 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.6 m -125.56 130.09 51.02 Favored 'General case' 0 C--N 1.334 -0.097 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -179.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.49 HG22 HG12 ' A' ' 91' ' ' ILE . 84.0 mt -119.32 127.59 75.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.28 178.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.808 HG22 ' NH2' ' B' ' 245' ' ' ARG . 36.0 mm 42.26 -97.82 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -178.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.515 ' CB ' HH22 ' B' ' 245' ' ' ARG . 48.0 t0 -126.85 23.92 6.57 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.283 0.564 . . . . 0.0 110.02 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.769 ' CZ ' HD12 ' A' ' 41' ' ' LEU . 54.5 mtm-85 -126.45 139.75 53.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.001 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.404 ' OG ' ' O ' ' A' ' 88' ' ' ILE . 15.9 t -139.75 150.57 44.94 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.223 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -118.83 119.38 34.21 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 96' ' ' ARG . 39.2 ttp-105 -82.23 130.58 35.13 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.33 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.517 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 61.6 t80 -97.74 124.85 42.25 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.059 0.456 . . . . 0.0 111.271 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -128.52 123.65 34.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.523 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 . . . . . 0 C--N 1.329 -0.317 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.361 179.891 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo . . . . . 0 N--CA 1.491 1.328 0 CA-C-O 121.959 0.733 . . . . 0.0 112.95 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 4.0 p -65.25 136.55 26.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 114.572 -1.195 . . . . 0.0 110.446 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 20.2 t . . . . . 0 C--N 1.327 -0.412 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.214 -179.764 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo . . . . . 0 N--CA 1.5 1.86 0 N-CA-C 112.595 0.19 . . . . 0.0 112.595 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 19.5 m -70.28 -45.29 66.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.657 0.742 . . . . 0.0 109.038 178.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.589 ' CE2' HG21 ' A' ' 43' ' ' VAL . 87.7 t80 -58.15 -43.94 87.62 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.585 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 1.041 HD23 HH21 ' B' ' 245' ' ' ARG . 75.8 mt -61.76 -41.96 98.37 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.767 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.44 -39.28 91.88 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.49 -179.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -60.02 -45.71 91.9 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.566 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 1.041 HH21 HD23 ' B' ' 242' ' ' LEU . 64.3 mtm180 -63.3 -38.22 90.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.468 -179.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.3 -39.08 91.79 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 120.101 -0.64 . . . . 0.0 109.652 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 18.0 m -63.98 -44.15 93.56 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -60.23 -35.84 76.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.517 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 38.0 t . . . . . 0 N--CA 1.453 -0.286 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.572 179.717 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.61 ' OE1' HD11 ' A' ' 41' ' ' LEU . 97.8 mt-10 . . . . . 0 CA--C 1.534 0.358 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.452 ' CD1' HG23 ' A' ' 9' ' ' THR . 66.1 mt -114.57 134.8 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 41.2 t -127.57 136.2 61.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -95.5 117.24 30.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.171 0.51 . . . . 0.0 110.865 -178.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -63.65 -47.11 82.64 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.448 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . 0.749 HE21 HD11 ' A' ' 24' ' ' LEU . 4.2 mm100 -96.63 154.42 38.47 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.853 -178.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.29 147.65 59.93 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 123.015 2.477 . . . . 0.0 113.639 -178.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 29.9 pt . . . . . 0 C--N 1.33 -0.244 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.203 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 69.6 p . . . . . 0 N--CA 1.463 0.19 0 CA-C-O 120.719 0.295 . . . . 0.0 111.507 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.1 mtt85 -87.74 120.24 28.86 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.264 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -124.22 135.86 53.75 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.134 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.555 HD12 ' O ' ' A' ' 96' ' ' ARG . 33.2 tp -116.05 131.91 56.81 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.605 -0.438 . . . . 0.0 109.853 179.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 53.8 t -109.04 132.55 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.328 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 m -88.68 112.57 23.28 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.958 0.409 . . . . 0.0 112.043 -178.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.738 HD12 ' OG ' ' A' ' 94' ' ' SER . 79.4 mt -80.75 141.85 14.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -97.42 160.87 14.07 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.021 0.439 . . . . 0.0 109.852 178.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -59.69 -19.86 52.52 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.983 -179.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.5 t -78.71 -16.48 57.2 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.282 178.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.85 24.49 22.88 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.5 m -119.77 135.83 58.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -70.89 139.46 50.77 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.238 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -125.1 -121.99 2.59 Favored Glycine 0 CA--C 1.534 1.246 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.4 148.14 54.03 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 121.869 1.712 . . . . 0.0 112.888 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -108.34 143.85 36.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.29 0.567 . . . . 0.0 111.139 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.452 ' CD2' HD11 ' A' ' 37' ' ' ILE . 39.6 t80 -114.68 98.82 50.55 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.358 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.55 132.01 18.29 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 121.101 1.2 . . . . 0.0 111.359 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.418 HD22 ' HB2' ' A' ' 27' ' ' CYS . 80.2 mt -84.5 56.12 3.68 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.07 -178.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.423 ' OG ' ' NE2' ' B' ' 265' ' ' GLN . 79.8 p -64.48 -22.39 66.95 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.445 ' HG ' HE22 ' B' ' 265' ' ' GLN . 92.1 mt -84.96 141.91 30.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.545 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 45.3 t -61.8 -18.1 58.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.524 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.514 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 33.5 m -133.93 132.93 40.82 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.593 -0.443 . . . . 0.0 112.008 -179.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.418 ' HB2' HD22 ' A' ' 22' ' ' LEU . 4.5 t -122.09 114.59 21.11 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.47 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 53.8 tp -113.95 131.37 56.34 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.523 -178.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.684 ' CE2' HD12 ' A' ' 37' ' ' ILE . 12.5 m-85 -109.76 127.18 54.46 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.051 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 173.63 -173.6 45.86 Favored Glycine 0 N--CA 1.474 1.199 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.492 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.649 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 85.9 mtm-85 -86.29 -26.72 24.79 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.463 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.547 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -58.31 154.52 25.01 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.99 -178.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.514 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.5 tp -66.57 -41.81 88.97 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-O 120.746 0.308 . . . . 0.0 111.002 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.514 ' N ' HG23 ' A' ' 33' ' ' ILE . 83.1 tt0 -57.63 -20.27 32.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.776 -179.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.547 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 7.5 m -60.69 129.41 41.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.234 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.514 ' OD2' ' O ' ' A' ' 26' ' ' THR . 54.3 m-20 -61.93 -34.35 75.93 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.684 HD12 ' CE2' ' A' ' 29' ' ' PHE . 87.9 mt -126.3 121.39 58.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 178.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.437 ' NH1' HD12 ' A' ' 33' ' ' ILE . 83.5 mtp180 -103.53 134.28 47.15 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.631 -178.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 89.9 mt -117.34 129.72 73.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.074 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -78.47 39.35 0.33 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -177.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.547 HD12 ' NH2' ' A' ' 93' ' ' ARG . 75.9 mt -119.94 137.72 26.12 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.844 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -72.78 -11.93 26.15 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 122.608 2.206 . . . . 0.0 112.455 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.8 m -92.04 4.15 7.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.517 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.649 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 48.0 t -98.69 130.35 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.3 m -73.05 172.32 11.24 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.747 0.784 . . . . 0.0 112.642 -178.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -64.63 -40.32 95.26 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.091 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.649 ' O ' ' N ' ' A' ' 49' ' ' CYS . 84.0 mm-40 -114.12 -19.25 11.43 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.921 0.391 . . . . 0.0 110.345 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.7 t60 31.37 -77.41 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.649 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -128.05 133.25 49.06 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.605 -178.931 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -129.2 128.84 44.15 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.401 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 85.9 mt -114.04 133.15 60.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.416 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -113.53 125.07 53.79 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.9 mm -93.99 123.98 46.29 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 121.602 0.715 . . . . 0.0 112.088 -178.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.425 ' O ' ' C ' ' A' ' 55' ' ' GLU . 96.5 m-70 -124.75 131.03 53.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.386 178.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 54' ' ' HIS . 47.9 tp10 -42.73 -32.2 0.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -64.12 -67.57 0.42 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.213 -0.903 . . . . 0.0 108.914 178.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.545 ' OE2' ' CD ' ' A' ' 81' ' ' ARG . 0.2 OUTLIER -152.3 -175.36 5.23 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.639 179.808 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.55 129.04 56.63 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.704 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.4 mt -116.77 131.55 69.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -178.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.506 ' HB2' HD21 ' A' ' 82' ' ' LEU . 50.1 tp -94.38 125.69 39.18 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.322 178.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -110.33 132.52 54.1 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.11 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.427 ' ND2' ' O ' ' A' ' 76' ' ' ILE . 41.5 t30 -94.05 106.23 18.21 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.25 0.548 . . . . 0.0 111.705 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -100.57 -9.45 21.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.397 179.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.0 t -76.75 98.18 4.71 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 120.036 -0.666 . . . . 0.0 109.831 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.4 p -74.99 -32.82 61.75 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.377 178.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.28 -43.24 57.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.461 -179.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.496 ' OD1' HG13 ' B' ' 236' ' ' VAL . 71.9 m-20 -140.57 97.77 7.34 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -55.51 145.01 71.39 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.295 1.997 . . . . 0.0 112.532 -178.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 13.2 m -71.79 137.15 47.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.157 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -101.02 140.73 34.91 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.666 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.7 p -135.17 136.08 51.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 50.11 30.93 4.52 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.96 28.86 65.88 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.972 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.4 m -135.3 124.55 24.6 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.826 -179.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.6 m -71.87 140.75 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.427 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 46.2 pt -121.0 141.88 39.56 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-O 121.203 0.525 . . . . 0.0 111.281 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 21.5 p-10 -104.29 -14.32 15.84 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 178.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -128.66 166.77 22.36 Favored Pre-proline 0 CA--C 1.528 0.098 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.148 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -64.12 146.88 91.35 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 122.673 2.249 . . . . 0.0 112.772 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.7 t -133.95 140.47 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.837 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.545 ' CD ' ' OE2' ' A' ' 57' ' ' GLU . 88.6 mtm180 -71.95 128.99 37.49 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.659 -0.417 . . . . 0.0 110.952 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.506 HD21 ' HB2' ' A' ' 60' ' ' LEU . 92.8 mt -84.37 131.23 34.72 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.341 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -124.53 153.2 42.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.702 178.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.401 ' ND1' ' N ' ' A' ' 99' ' ' ASN . 12.4 t60 -56.94 122.52 12.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.956 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.22 -19.96 33.74 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.05 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -66.27 139.26 58.06 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.501 HG22 ' HG2' ' A' ' 96' ' ' ARG . 77.1 t -112.03 129.99 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.326 -178.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.2 mt -95.66 131.21 43.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 42.3 m -120.69 124.53 45.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.494 0.664 . . . . 0.0 111.82 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.447 HG22 HG12 ' A' ' 91' ' ' ILE . 86.0 mt -119.57 121.06 65.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.173 179.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.484 HG22 ' N ' ' A' ' 92' ' ' ASP . 36.0 mm 52.45 -112.51 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -178.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.484 ' N ' HG22 ' A' ' 91' ' ' ILE . 56.6 t0 -116.25 24.25 11.53 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.337 0.589 . . . . 0.0 110.371 179.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.547 ' NH2' HD12 ' A' ' 41' ' ' LEU . 47.5 mtm-85 -131.26 146.72 52.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.224 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.738 ' OG ' HD12 ' A' ' 10' ' ' ILE . 23.3 p -140.65 158.58 43.78 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.318 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.544 ' HB3' HD11 ' A' ' 7' ' ' LEU . 73.0 m-85 -126.37 124.24 39.78 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.238 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.555 ' O ' HD12 ' A' ' 7' ' ' LEU . 79.8 mtp85 -85.14 127.68 34.35 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 121.075 0.464 . . . . 0.0 111.053 -179.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -96.09 125.64 40.77 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.885 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -130.5 122.38 27.53 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.428 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.401 ' N ' ' ND1' ' A' ' 84' ' ' HIS . 49.2 t-20 . . . . . 0 C--N 1.331 -0.215 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.967 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo . . . . . 0 N--CA 1.485 1.015 0 CA-C-O 121.417 0.507 . . . . 0.0 112.263 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.496 HG13 ' OD1' ' A' ' 67' ' ' ASN . 76.3 t -59.09 139.85 18.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.215 -179.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . 0.603 ' SG ' ' CD1' ' B' ' 241' ' ' PHE . 4.9 t . . . . . 0 C--N 1.331 -0.211 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo . . . . . 0 N--CA 1.5 1.863 0 N-CA-C 113.222 0.431 . . . . 0.0 113.222 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 98.7 m -73.27 -45.72 54.05 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.631 0.729 . . . . 0.0 109.541 178.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.603 ' CD1' ' SG ' ' B' ' 237' ' ' CYS . 54.4 t80 -57.31 -45.63 84.02 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.102 -178.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' B' ' 242' ' ' LEU . 89.0 mt -65.24 -42.23 93.53 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -61.67 -38.75 88.93 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.404 -0.519 . . . . 0.0 110.357 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . 0.534 ' O ' ' OG ' ' B' ' 247' ' ' SER . 82.7 mtp180 -64.12 -40.72 96.79 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.544 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.449 ' NH2' ' CD2' ' A' ' 41' ' ' LEU . 22.0 mmt180 -64.73 -41.4 95.98 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.382 -179.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.46 -38.05 88.27 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . 0.534 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 77.8 p -67.46 -42.78 82.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.441 179.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -61.56 -36.2 79.95 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.838 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 34.9 t . . . . . 0 C--N 1.326 -0.447 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.358 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.503 ' N ' ' OE1' ' B' ' 260' ' ' GLU . 44.5 mp0 . . . . . 0 C--O 1.223 -0.335 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 74.5 mt -118.62 133.67 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 75.5 t -129.25 137.19 57.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.987 0.423 . . . . 0.0 110.884 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -97.31 119.56 36.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.595 -178.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -67.87 -45.89 73.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.364 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . 0.445 HE22 ' HG ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -92.57 156.17 41.47 Favored Pre-proline 0 C--N 1.332 -0.16 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.049 -179.006 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -63.65 148.28 92.32 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.995 2.464 . . . . 0.0 112.17 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 33.9 pt . . . . . 0 C--N 1.326 -0.439 0 CA-C-O 121.416 0.627 . . . . 0.0 111.185 -179.535 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 63.3 p . . . . . 0 C--O 1.232 0.147 0 CA-C-O 121.027 0.442 . . . . 0.0 110.308 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 86.0 mtt85 -97.43 132.42 43.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.219 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -134.37 145.31 48.85 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.844 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.479 HD11 HD11 ' A' ' 22' ' ' LEU . 87.5 mt -114.07 142.95 45.55 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.049 179.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.584 HG22 ' CD2' ' A' ' 19' ' ' HIS . 42.9 t -115.82 129.9 71.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 m -90.74 119.32 30.87 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.485 0.66 . . . . 0.0 112.776 -177.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.1 mm -81.33 135.48 24.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.496 178.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.425 ' HB2' ' H ' ' A' ' 15' ' ' VAL . 95.7 mttt -85.86 156.3 20.6 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.792 179.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.427 ' NE ' ' HD2' ' B' ' 245' ' ' ARG . 83.7 mtp180 -58.36 -34.61 70.85 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.3 p -70.25 -18.88 63.15 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.202 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.65 34.38 5.78 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.425 ' H ' ' HB2' ' A' ' 11' ' ' LYS . 43.0 t -121.15 133.09 68.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 114.992 -0.604 . . . . 0.0 110.922 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -73.26 136.38 44.59 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -135.52 -114.56 1.4 Allowed Glycine 0 CA--C 1.534 1.276 0 C-N-CA 119.752 -1.213 . . . . 0.0 112.827 -179.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.67 144.09 43.5 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.33 2.02 . . . . 0.0 113.653 -177.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.584 ' CD2' HG22 ' A' ' 8' ' ' VAL . 63.8 m170 -107.9 137.94 45.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.678 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.494 ' CD2' HD11 ' A' ' 37' ' ' ILE . 26.1 t80 -106.12 96.51 13.32 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.6 134.59 22.51 Favored 'Trans proline' 0 C--N 1.315 -1.231 0 C-N-CA 121.283 1.322 . . . . 0.0 110.745 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.479 HD11 HD11 ' A' ' 7' ' ' LEU . 95.9 mt -86.06 74.16 10.14 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.663 -178.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.1 p -79.6 -10.24 59.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.41 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.1 mt -105.86 148.0 28.06 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.108 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.2 t -68.22 -16.16 63.86 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.5 m -134.41 136.97 43.69 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.419 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.664 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 4.1 t -131.69 124.47 29.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.923 178.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.479 HD21 ' OE1' ' A' ' 47' ' ' GLN . 47.7 tp -118.38 129.61 55.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.532 -178.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.744 ' CE2' HD12 ' A' ' 37' ' ' ILE . 6.8 m-85 -106.06 134.72 48.74 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.422 179.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 156.5 -177.91 33.24 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 120.451 -0.88 . . . . 0.0 112.322 179.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 45.5 mtm105 -75.1 -32.44 61.42 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.48 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -50.34 150.85 5.25 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.778 -178.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.534 HG23 ' N ' ' A' ' 34' ' ' GLU . 9.8 tp -66.11 -41.66 89.9 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-O 121.021 0.439 . . . . 0.0 110.1 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.534 ' N ' HG23 ' A' ' 33' ' ' ILE . 97.7 mt-10 -56.07 -24.3 39.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.806 -179.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.48 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 32.0 m -55.8 117.2 3.44 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.685 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -57.37 -29.15 63.8 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.744 HD12 ' CE2' ' A' ' 29' ' ' PHE . 98.7 mt -125.64 118.66 52.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.417 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 84.1 mtp180 -104.06 136.73 43.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.689 -178.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.522 HD13 ' NH1' ' A' ' 93' ' ' ARG . 97.6 mt -118.08 129.82 73.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 121.29 0.567 . . . . 0.0 110.771 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -74.96 35.19 0.1 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 114.975 -1.011 . . . . 0.0 113.092 -177.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.685 ' CD1' ' HE ' ' A' ' 93' ' ' ARG . 28.3 mt -118.94 130.93 24.56 Favored Pre-proline 0 C--N 1.323 -0.561 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.457 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.476 ' O ' ' HD2' ' B' ' 235' ' ' PRO . 44.2 Cg_endo -67.84 -18.97 47.23 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.379 2.052 . . . . 0.0 113.454 -179.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 241' ' ' PHE . 34.2 m -83.87 -0.08 5.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.836 -0.345 . . . . 0.0 110.896 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 56.8 t -88.08 133.0 31.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.926 0.393 . . . . 0.0 110.124 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.9 m -67.89 162.49 24.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.426 0.631 . . . . 0.0 111.325 -179.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -60.88 -41.53 96.19 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.591 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.629 ' O ' ' N ' ' A' ' 49' ' ' CYS . 97.9 mm-40 -115.33 -25.32 8.04 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.436 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.8 t60 36.54 -76.07 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.629 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.53 134.04 46.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.37 0.605 . . . . 0.0 112.177 -178.091 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -126.8 131.62 51.22 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.196 179.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 91.6 mt -115.41 133.32 62.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.507 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -119.34 126.55 51.7 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 89.1 mt -106.38 118.18 53.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.555 0.693 . . . . 0.0 111.83 -179.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.453 ' O ' ' N ' ' A' ' 56' ' ' GLN . 86.5 m-70 -113.86 142.66 45.82 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.331 179.366 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 54' ' ' HIS . 80.0 mm-40 -40.21 -29.46 0.08 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.453 ' N ' ' O ' ' A' ' 54' ' ' HIS . 88.5 mt-30 -63.7 -66.98 0.47 Allowed 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.439 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 5.5 tp10 -158.36 -163.32 1.26 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.138 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.454 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -112.8 129.16 56.53 Favored 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.1 mt -119.29 128.88 75.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.385 0.612 . . . . 0.0 112.145 -178.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.4 tp -97.79 126.58 43.22 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.054 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -110.97 136.36 50.09 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.843 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -97.33 104.44 16.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.575 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -99.07 -10.06 23.07 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.891 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.52 99.03 3.48 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.248 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.7 m -73.55 -39.82 64.44 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.377 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.825 HG22 HG22 ' B' ' 236' ' ' VAL . 0.2 OUTLIER -63.66 -47.46 81.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.818 -178.707 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.505 ' OD1' HG13 ' B' ' 236' ' ' VAL . 2.2 m-20 -142.9 99.03 5.6 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.653 ' HB2' HG13 ' A' ' 75' ' ' VAL . 51.7 Cg_exo -53.38 148.35 33.66 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.361 2.04 . . . . 0.0 113.26 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.5 m -69.32 139.54 54.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.862 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -100.33 141.93 32.5 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.431 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.495 ' CG2' ' OD1' ' A' ' 86' ' ' ASP . 8.5 p -130.79 135.17 60.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 44.99 33.71 1.09 Allowed 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.082 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.05 29.28 62.93 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.837 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.485 ' N ' ' O ' ' A' ' 71' ' ' VAL . 15.8 m -140.65 139.43 34.82 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 120.576 -0.449 . . . . 0.0 111.239 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.653 HG13 ' HB2' ' A' ' 68' ' ' PRO . 29.2 t -72.59 137.93 22.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.243 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.0 pt -109.38 91.99 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.707 178.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -65.41 -30.29 71.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.56 179.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -122.86 168.7 11.37 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.458 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -60.71 148.87 90.3 Favored 'Trans proline' 0 N--CA 1.501 1.917 0 C-N-CA 122.41 2.073 . . . . 0.0 112.26 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.6 p -142.72 142.89 26.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.42 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.7 mtm180 -75.58 131.43 39.99 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.454 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 93.0 mt -78.42 140.33 38.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.128 0.49 . . . . 0.0 111.471 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -128.4 148.13 50.69 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.534 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -55.36 117.21 3.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.213 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.07 -8.71 31.38 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.495 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 60.6 t0 -73.7 128.18 34.81 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.73 0.3 . . . . 0.0 110.441 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.457 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 48.3 t -109.9 132.64 57.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.463 -178.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.8 mt -105.37 134.01 48.06 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 97.6 m -121.53 126.65 49.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.33 0.586 . . . . 0.0 111.898 -178.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.412 ' CG2' HH12 ' A' ' 93' ' ' ARG . 97.8 mt -115.71 124.81 72.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 177.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.4 mm 40.81 -101.66 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 -178.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -118.39 23.56 11.47 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.096 0.475 . . . . 0.0 110.615 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.685 ' HE ' ' CD1' ' A' ' 41' ' ' LEU . 7.9 mtm105 -128.2 146.5 50.71 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.095 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.1 t -137.06 147.16 45.96 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.469 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -120.13 121.0 37.83 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -84.87 135.07 34.24 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.344 -178.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -95.16 120.36 35.25 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.524 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -122.26 123.8 42.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.319 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 62.5 t-20 . . . . . 0 C--N 1.33 -0.282 0 CA-C-O 120.832 0.348 . . . . 0.0 110.576 179.818 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . 0.476 ' HD2' ' O ' ' A' ' 42' ' ' PRO . 31.3 Cg_exo . . . . . 0 N--CA 1.488 1.199 0 CA-C-O 121.756 0.648 . . . . 0.0 112.726 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.825 HG22 HG22 ' A' ' 66' ' ' THR . 25.5 t -68.56 133.66 31.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 114.572 -1.195 . . . . 0.0 109.406 179.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.403 0 C-N-CA 120.218 -0.593 . . . . 0.0 110.199 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo . . . . . 0 N--CA 1.493 1.447 0 CA-C-O 120.948 0.312 . . . . 0.0 111.76 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 21.4 m -74.21 -46.2 43.35 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.79 177.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.442 ' CE2' HG21 ' A' ' 43' ' ' VAL . 70.9 t80 -57.84 -44.87 86.77 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.276 -179.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 79.2 mt -63.76 -39.76 95.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.406 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -60.34 -42.42 95.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.317 -0.401 . . . . 0.0 109.96 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -65.67 -39.47 91.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.203 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.427 ' HD2' ' NE ' ' A' ' 12' ' ' ARG . 3.1 tpp85 -57.5 -43.69 84.38 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -64.4 -41.52 96.6 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 68.1 m -60.93 -45.51 94.39 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . 0.423 ' OE1' ' NH2' ' A' ' 12' ' ' ARG . 86.3 mt-30 -62.53 -34.21 76.45 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.339 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 19.0 t . . . . . 0 CA--C 1.519 -0.234 0 C-N-CA 120.409 -0.516 . . . . 0.0 109.92 179.544 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 . . . . . 0 CA--C 1.53 0.19 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 59.3 mt -116.35 132.19 66.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 42.9 t -125.3 134.42 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.094 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -95.54 118.01 31.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.296 0.569 . . . . 0.0 111.038 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -65.02 -44.24 89.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.463 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -100.84 157.83 32.96 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.039 -178.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.23 153.47 69.7 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.777 2.318 . . . . 0.0 111.883 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 41.9 pt . . . . . 0 C--N 1.328 -0.355 0 CA-C-O 121.65 0.738 . . . . 0.0 111.995 -178.877 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.543 HG22 ' OD1' ' A' ' 99' ' ' ASN . 19.2 m . . . . . 0 N--CA 1.467 0.393 0 CA-C-O 120.666 0.27 . . . . 0.0 111.14 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.595 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 95.2 mtt-85 -97.76 112.31 24.26 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.556 -179.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 60.7 ttp180 -124.73 131.5 53.45 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.862 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.659 HD11 ' HB3' ' A' ' 95' ' ' PHE . 43.8 tp -109.32 132.63 53.94 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 37.1 t -109.81 131.41 60.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.809 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.473 ' CG2' HD12 ' B' ' 261' ' ' ILE . 18.6 m -91.45 113.49 25.77 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -177.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.63 HD12 ' OG ' ' A' ' 94' ' ' SER . 97.0 mt -81.91 143.59 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.648 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -89.79 158.42 17.51 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.039 0.447 . . . . 0.0 110.97 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -57.28 -32.21 66.39 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.994 -178.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.4 p -79.76 -7.9 58.92 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.419 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.82 40.29 4.99 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.2 t -122.59 131.16 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 O-C-N 122.753 -0.263 . . . . 0.0 111.446 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -73.59 134.29 43.7 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -126.97 -123.52 2.65 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.036 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -74.37 153.16 44.94 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 122.362 2.042 . . . . 0.0 112.167 -178.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.571 ' O ' ' CG2' ' B' ' 267' ' ' ILE . 0.2 OUTLIER -108.16 159.88 16.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.971 0.415 . . . . 0.0 110.842 -179.516 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.602 ' CD2' HD11 ' A' ' 37' ' ' ILE . 43.8 t80 -128.38 92.3 41.55 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.64 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.23 125.55 18.84 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.026 1.817 . . . . 0.0 111.292 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.484 HD22 ' SG ' ' A' ' 27' ' ' CYS . 93.1 mt -87.92 42.25 1.04 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.896 0.379 . . . . 0.0 111.404 -178.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.7 t -59.37 -23.35 62.49 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.678 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.0 mt -76.62 143.9 39.87 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 82.2 p -66.66 -20.31 65.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.676 -178.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.512 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 93.8 m -128.74 128.96 45.06 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.379 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.484 ' SG ' HD22 ' A' ' 22' ' ' LEU . 6.5 t -121.94 112.57 18.46 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.666 HD21 ' OE1' ' A' ' 47' ' ' GLN . 52.6 tp -113.47 126.07 54.92 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.233 -177.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.712 ' CE2' HD12 ' A' ' 37' ' ' ILE . 6.6 m-85 -106.44 136.66 45.8 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.454 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 160.37 -173.11 36.91 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.284 -0.96 . . . . 0.0 112.421 178.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.571 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 39.3 mtm180 -79.38 -29.21 41.99 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.575 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -61.89 151.03 45.09 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.523 -177.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 78.2 mt -64.87 -42.92 96.15 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.337 0 CA-C-N 115.564 -0.318 . . . . 0.0 110.916 179.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -52.64 -26.03 12.49 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 119.657 -0.817 . . . . 0.0 108.893 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.575 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 11.4 m -57.81 118.74 5.63 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.295 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.512 ' OD2' ' O ' ' A' ' 26' ' ' THR . 98.5 m-20 -56.09 -24.07 37.9 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.712 HD12 ' CE2' ' A' ' 29' ' ' PHE . 96.9 mt -131.66 122.75 50.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.838 178.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.4 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 32.2 mtm180 -107.71 140.47 40.71 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.016 0.436 . . . . 0.0 111.5 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 78.0 mt -121.04 128.79 76.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -70.57 32.3 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -177.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.568 ' CD1' ' CZ ' ' A' ' 93' ' ' ARG . 64.7 mt -110.79 133.68 21.15 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.956 -179.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.7 -8.92 24.07 Favored 'Trans proline' 0 N--CA 1.501 1.959 0 C-N-CA 123.478 2.785 . . . . 0.0 113.863 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.6 m -101.13 2.65 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.032 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.571 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 18.4 t -89.54 100.98 11.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.649 -179.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.521 ' O ' ' O ' ' A' ' 44' ' ' VAL . 3.6 t -34.99 164.29 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.936 -179.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -63.59 -43.55 96.61 Favored 'General case' 0 C--O 1.238 0.447 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.776 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.666 ' OE1' HD21 ' A' ' 28' ' ' LEU . 94.5 mm-40 -111.21 -23.51 10.81 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.007 0.432 . . . . 0.0 110.421 -179.285 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.457 ' NE2' HG23 ' A' ' 90' ' ' ILE . 16.5 t60 41.29 -78.3 0.0 OUTLIER 'General case' 0 C--O 1.24 0.576 0 CA-C-N 115.421 -0.808 . . . . 0.0 112.679 179.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.609 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.45 136.93 48.37 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.914 -178.861 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -129.81 129.51 44.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.181 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 89.0 mt -114.61 138.41 44.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.313 -179.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -118.0 122.51 43.4 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 89.3 mt -103.47 114.09 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 C-N-CA 120.104 -0.639 . . . . 0.0 111.285 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.5 ' O ' ' N ' ' A' ' 56' ' ' GLN . 96.6 m-70 -111.41 139.9 46.44 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.828 179.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 54' ' ' HIS . 81.2 tt0 -39.56 -28.43 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.5 ' N ' ' O ' ' A' ' 54' ' ' HIS . 99.6 mm-40 -64.19 -68.14 0.38 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.164 178.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -157.98 -168.02 2.39 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.865 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.561 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -112.54 128.4 56.34 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.24 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 87.6 mt -118.64 129.89 74.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 121.175 0.512 . . . . 0.0 111.963 -178.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 25.1 tp -96.31 128.38 43.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.671 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -113.13 138.57 49.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.295 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.603 HD21 ' CB ' ' A' ' 68' ' ' PRO . 61.1 t-20 -99.8 107.01 18.95 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -98.68 -8.03 26.86 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.803 0.335 . . . . 0.0 110.444 179.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.05 100.68 12.33 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.781 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.6 p -88.31 -30.34 19.67 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.215 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.594 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -63.7 -46.37 85.78 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.317 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -142.49 101.89 5.55 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 115.174 -0.921 . . . . 0.0 108.693 178.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.603 ' CB ' HD21 ' A' ' 62' ' ' ASN . 60.0 Cg_endo -69.44 152.25 70.97 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.097 1.865 . . . . 0.0 114.032 -177.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.961 ' O ' HG22 ' A' ' 76' ' ' ILE . 11.4 m -70.94 145.57 50.03 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.286 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -106.82 143.61 34.66 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.7 179.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.505 ' CG2' ' OD1' ' A' ' 86' ' ' ASP . 6.3 p -131.67 136.26 57.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 48.5 32.27 3.29 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.85 27.52 68.77 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.341 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 71' ' ' VAL . 31.3 m -137.67 133.2 33.98 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.322 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 54.7 t -60.97 136.52 24.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.858 0.361 . . . . 0.0 110.57 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.961 HG22 ' O ' ' A' ' 69' ' ' THR . 14.0 tt -103.1 89.73 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.892 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -63.43 -35.84 81.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.746 179.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.505 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 0.8 OUTLIER -128.69 167.52 19.05 Favored Pre-proline 0 N--CA 1.464 0.233 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.372 -179.214 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -56.74 141.78 91.93 Favored 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 122.27 1.98 . . . . 0.0 112.674 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 73.0 t -131.72 137.8 54.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.617 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 83.1 mtt85 -70.24 129.16 38.61 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 97.0 mt -82.53 137.12 34.7 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.456 -0.497 . . . . 0.0 111.394 -178.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -129.29 152.73 48.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.107 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.53 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 7.2 t60 -54.19 118.34 3.99 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.734 0.302 . . . . 0.0 110.428 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.73 -13.15 24.95 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.505 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 59.8 t0 -71.43 128.41 35.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.845 0.355 . . . . 0.0 110.464 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.405 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 69.3 t -110.83 129.05 66.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.674 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 93.8 mt -97.28 132.58 41.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 94.0 m -122.8 127.74 49.51 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 120.026 -0.67 . . . . 0.0 112.553 -178.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.525 HG22 HG12 ' A' ' 91' ' ' ILE . 82.2 mt -120.31 125.37 74.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 114.944 -1.026 . . . . 0.0 108.26 178.245 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.525 HG12 HG22 ' A' ' 90' ' ' ILE . 25.1 mm 43.22 -116.33 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -178.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.419 ' HB2' ' HE ' ' B' ' 245' ' ' ARG . 94.3 m-20 -102.74 14.47 31.87 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.854 0.359 . . . . 0.0 110.849 178.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.819 HH11 ' NH2' ' B' ' 245' ' ' ARG . 37.2 mtm-85 -123.37 145.13 49.0 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.427 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.63 ' OG ' HD12 ' A' ' 10' ' ' ILE . 38.3 p -140.99 151.86 44.46 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 120.687 -0.405 . . . . 0.0 109.927 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.659 ' HB3' HD11 ' A' ' 7' ' ' LEU . 82.7 m-85 -120.07 121.65 39.34 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.51 ' O ' HD12 ' A' ' 7' ' ' LEU . 79.6 mtp85 -81.56 130.3 35.0 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.471 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.595 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 86.7 t80 -96.62 123.05 40.17 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.198 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -127.41 131.62 50.26 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.007 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.543 ' OD1' HG22 ' A' ' 4' ' ' THR . 64.9 t-20 . . . . . 0 CA--C 1.52 -0.206 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.412 -179.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo . . . . . 0 N--CA 1.486 1.076 0 CA-C-O 121.21 0.421 . . . . 0.0 112.17 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.594 ' CG2' HG22 ' A' ' 66' ' ' THR . 41.1 t -70.13 133.02 32.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.441 -178.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 4.8 t . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.751 179.059 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo . . . . . 0 N--CA 1.497 1.713 0 N-CA-C 113.419 0.507 . . . . 0.0 113.419 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 96.6 m -74.03 -44.65 53.65 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.307 -0.557 . . . . 0.0 109.579 178.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.414 ' HZ ' HD22 ' A' ' 41' ' ' LEU . 82.4 t80 -59.71 -46.54 88.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.263 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.425 ' HA ' HD23 ' B' ' 242' ' ' LEU . 88.3 mt -63.87 -42.36 97.54 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.092 0.472 . . . . 0.0 110.569 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -61.81 -38.89 89.81 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.255 -179.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . 0.469 ' HE ' HE21 ' B' ' 248' ' ' GLN . 76.6 ttt180 -62.36 -44.75 95.74 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.4 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.819 ' NH2' HH11 ' A' ' 93' ' ' ARG . 72.6 mtp85 -61.18 -39.7 91.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.894 -179.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -63.67 -41.74 98.14 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 120.375 -0.53 . . . . 0.0 109.683 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 62.6 m -66.17 -45.36 81.17 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . 0.469 HE21 ' HE ' ' B' ' 244' ' ' ARG . 85.6 mt-30 -58.03 -39.3 78.04 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.879 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . 0.436 HG23 ' O ' ' B' ' 245' ' ' ARG . 54.7 t . . . . . 0 C--N 1.33 -0.282 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.633 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 . . . . . 0 C--O 1.231 0.116 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.473 HD12 ' CG2' ' A' ' 9' ' ' THR . 74.6 mt -103.22 136.64 34.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 72.0 t -125.96 135.76 62.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.45 0.643 . . . . 0.0 111.359 -178.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -97.46 116.55 29.88 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.781 -178.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -67.58 -39.6 84.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.505 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.56 159.46 32.57 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.344 -178.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . 0.414 ' C ' HD13 ' B' ' 267' ' ' ILE . 37.9 Cg_endo -61.2 147.61 95.15 Favored 'Trans proline' 0 C--N 1.302 -1.891 0 C-N-CA 122.27 1.98 . . . . 0.0 111.925 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . 0.571 ' CG2' ' O ' ' A' ' 19' ' ' HIS . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.904 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.627 HG22 ' OD1' ' A' ' 99' ' ' ASN . 16.6 m . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.59 0.233 . . . . 0.0 111.1 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.65 ' NE ' HD13 ' A' ' 53' ' ' ILE . 91.5 mtm-85 -95.91 117.46 30.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.012 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -128.31 134.92 49.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.864 0.364 . . . . 0.0 110.251 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.633 HD12 ' O ' ' A' ' 96' ' ' ARG . 24.2 tp -113.87 132.85 55.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.989 -179.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.652 HG22 ' CD2' ' A' ' 19' ' ' HIS . 51.5 t -108.49 130.86 60.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.424 HG23 ' CD1' ' B' ' 261' ' ' ILE . 2.7 m -90.79 121.34 32.58 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.356 0.598 . . . . 0.0 112.124 -178.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 98.2 mt -89.18 141.06 14.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.23 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -91.03 162.87 14.52 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.711 HH22 ' NE2' ' B' ' 248' ' ' GLN . 87.4 mtm180 -55.83 -27.56 52.04 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.075 -178.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 92.6 p -84.87 -6.26 59.34 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.791 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.51 42.17 7.49 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.436 -1.065 . . . . 0.0 110.436 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.2 t -118.57 132.99 66.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.797 0.332 . . . . 0.0 110.996 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.545 ' CG ' ' HE2' ' A' ' 19' ' ' HIS . 63.9 t0 -74.17 120.24 19.47 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.872 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -117.37 -120.76 3.12 Favored Glycine 0 CA--C 1.539 1.582 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.748 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -74.34 147.45 37.07 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 122.413 2.075 . . . . 0.0 112.703 -179.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.652 ' CD2' HG22 ' A' ' 8' ' ' VAL . 65.2 m170 -109.66 143.87 38.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.083 0.468 . . . . 0.0 110.818 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.731 ' CD2' HD11 ' A' ' 37' ' ' ILE . 30.1 t80 -112.28 104.14 55.81 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.71 -178.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -74.02 128.18 12.06 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 121.34 1.36 . . . . 0.0 111.106 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.3 mt -85.07 47.32 1.39 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.811 -177.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 97.2 p -59.07 -28.44 66.47 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.3 mt -74.29 141.78 45.26 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.8 m -70.95 -16.29 62.64 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.972 -0.291 . . . . 0.0 111.724 -178.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.9 m -134.07 135.88 43.58 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.97 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.676 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 2.4 t -131.05 123.05 27.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.945 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.3 tp -117.51 130.24 56.31 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.686 0.279 . . . . 0.0 110.92 -178.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.676 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 59.3 m-85 -108.02 143.63 36.45 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.823 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 147.84 -177.61 25.99 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.035 178.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 46.6 mtm180 -70.83 -32.67 69.79 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.924 0.392 . . . . 0.0 111.042 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.535 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -48.67 143.92 7.56 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 -178.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.538 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.8 tp -66.22 -41.59 89.49 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.151 0 CA-C-O 121.046 0.45 . . . . 0.0 110.078 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.538 ' N ' HG23 ' A' ' 33' ' ' ILE . 97.9 mt-10 -54.88 -22.1 13.67 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.519 179.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.535 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 50.0 m -56.73 118.39 4.85 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.348 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -59.54 -26.89 65.74 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.731 HD11 ' CD2' ' A' ' 20' ' ' PHE . 47.5 mm -123.54 108.54 21.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 176.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -102.28 132.95 47.92 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.843 -177.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 84.0 mt -123.42 131.51 73.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.571 HE21 ' CA ' ' B' ' 260' ' ' GLU . 2.5 pp0? -88.56 43.71 1.15 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 119.626 -0.83 . . . . 0.0 112.558 -178.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.983 HD11 ' NH1' ' A' ' 93' ' ' ARG . 36.6 mt -95.36 128.87 36.83 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.27 178.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -70.78 -13.34 32.04 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 122.095 1.863 . . . . 0.0 113.534 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 18.6 m -100.61 5.67 10.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.028 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 34.5 t -95.7 139.07 19.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.123 0.487 . . . . 0.0 111.086 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.87 166.04 11.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.548 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -63.87 -44.12 94.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.003 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.625 ' O ' ' N ' ' A' ' 49' ' ' CYS . 98.2 mt-30 -113.4 -12.08 13.04 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.885 0.374 . . . . 0.0 111.049 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 26.1 t60 34.48 -74.77 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 178.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.625 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -135.53 139.54 44.04 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.405 0.622 . . . . 0.0 112.095 -177.938 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -127.66 131.09 49.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.78 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.8 mt -113.24 132.95 60.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.107 179.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.464 ' CD ' ' NE2' ' A' ' 54' ' ' HIS . 83.4 tt0 -117.89 123.32 45.57 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.65 HD13 ' NE ' ' A' ' 5' ' ' ARG . 85.1 mt -107.22 117.11 52.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 119.968 -0.693 . . . . 0.0 112.559 -178.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.464 ' NE2' ' CD ' ' A' ' 52' ' ' GLU . 97.7 m-70 -110.93 139.67 46.06 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.968 178.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.5 tt0 -40.77 -32.55 0.23 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.5 -0.48 . . . . 0.0 109.802 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -66.3 -65.97 0.61 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.99 -173.23 4.43 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.098 0.475 . . . . 0.0 111.797 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.84 129.22 56.61 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.698 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 91.3 mt -118.14 130.87 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 121.609 0.719 . . . . 0.0 112.76 -178.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.543 HD22 ' CD1' ' A' ' 88' ' ' ILE . 43.1 tp -98.69 128.06 44.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.456 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -115.06 136.03 53.56 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.948 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.448 HD21 ' CA ' ' A' ' 68' ' ' PRO . 64.0 t-20 -97.32 104.72 16.77 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.25 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -96.44 -11.66 25.31 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.865 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.503 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 85.1 p -74.71 98.4 3.44 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.098 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.8 m -78.67 -32.85 47.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.345 179.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.489 HG22 HG22 ' B' ' 236' ' ' VAL . 0.2 OUTLIER -75.19 -42.72 55.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.595 -179.225 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.503 ' O ' ' OG ' ' A' ' 64' ' ' SER . 79.5 m-20 -135.88 95.06 14.07 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.919 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.448 ' CA ' HD21 ' A' ' 62' ' ' ASN . 40.1 Cg_exo -54.92 143.33 72.77 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.383 2.055 . . . . 0.0 113.242 -178.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.464 ' HB ' HD11 ' A' ' 76' ' ' ILE . 12.2 m -70.94 152.87 43.18 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.309 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -115.54 141.24 48.33 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.535 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.547 ' CG2' ' OD1' ' A' ' 86' ' ' ASP . 4.4 p -130.9 137.51 55.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 49.26 32.16 4.17 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.05 28.79 69.8 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.959 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.464 ' N ' ' O ' ' A' ' 71' ' ' VAL . 9.0 t -140.24 137.3 34.16 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.914 0.388 . . . . 0.0 111.363 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.437 HG13 ' HB2' ' A' ' 68' ' ' PRO . 40.7 t -64.9 135.97 27.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.673 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.464 HD11 ' HB ' ' A' ' 69' ' ' THR . 11.9 pt -110.49 77.93 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.12 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.318 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -59.93 -33.02 71.33 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -112.9 159.35 34.84 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.785 178.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.55 154.27 71.97 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.413 2.075 . . . . 0.0 111.67 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.0 m -148.15 149.02 15.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.873 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -73.1 132.15 42.95 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-O 120.983 0.42 . . . . 0.0 110.449 179.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.408 HD21 ' HB2' ' A' ' 60' ' ' LEU . 97.6 mt -80.95 140.97 34.95 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.198 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -133.63 154.6 50.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.767 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -55.15 116.46 2.81 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.259 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.17 -18.39 18.58 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.547 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 56.9 t0 -66.08 123.36 19.67 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.271 0.557 . . . . 0.0 109.508 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.502 ' CG2' ' OG ' ' A' ' 94' ' ' SER . 7.4 p -104.37 132.94 49.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.078 -178.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.543 ' CD1' HD22 ' A' ' 60' ' ' LEU . 29.4 mm -92.48 130.47 41.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 178.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.6 m -121.96 126.44 48.6 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 119.364 -0.934 . . . . 0.0 112.9 -178.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.517 ' O ' ' C ' ' A' ' 91' ' ' ILE . 98.0 mt -120.39 127.69 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 113.988 -1.46 . . . . 0.0 107.996 177.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.553 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 44.0 mt -21.21 101.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 O-C-N 123.612 0.57 . . . . 0.0 112.243 -179.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.553 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 11.3 t0 89.87 -19.81 0.16 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 177.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.983 ' NH1' HD11 ' A' ' 41' ' ' LEU . 71.7 mtt85 -131.44 139.85 49.48 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.806 -178.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.502 ' OG ' ' CG2' ' A' ' 87' ' ' VAL . 15.8 t -135.04 146.91 49.43 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 120.894 0.378 . . . . 0.0 110.09 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.592 ' HB3' HD11 ' A' ' 7' ' ' LEU . 72.7 m-85 -123.78 124.52 42.87 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.752 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.633 ' O ' HD12 ' A' ' 7' ' ' LEU . 99.8 mtt180 -88.29 133.47 34.05 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 119.568 -0.853 . . . . 0.0 110.932 -179.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -95.28 124.34 39.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.875 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -123.12 127.62 48.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.421 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.627 ' OD1' HG22 ' A' ' 4' ' ' THR . 62.6 t-20 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.385 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo . . . . . 0 N--CA 1.492 1.386 0 CA-C-O 121.306 0.461 . . . . 0.0 112.635 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.489 HG22 HG22 ' A' ' 66' ' ' THR . 72.8 t -66.2 133.26 31.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.818 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 2.0 t . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.113 179.651 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo . . . . . 0 N--CA 1.495 1.598 0 CA-C-O 120.64 0.184 . . . . 0.0 112.263 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 98.9 m -67.25 -48.0 69.08 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.453 ' HZ ' HD22 ' A' ' 41' ' ' LEU . 88.9 t80 -59.31 -47.57 84.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.13 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.486 HD21 HG23 ' A' ' 91' ' ' ILE . 85.9 mt -65.36 -40.13 93.18 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.14 -179.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -62.16 -42.4 99.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.896 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 79.2 ttt-85 -61.19 -42.48 98.65 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.078 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.417 ' O ' HG23 ' B' ' 249' ' ' VAL . 22.5 mmt180 -62.72 -42.33 99.6 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.749 -179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -62.11 -43.12 99.53 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 54.3 m -65.35 -44.05 88.93 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . 0.711 ' NE2' HH22 ' A' ' 12' ' ' ARG . 57.0 tt0 -57.26 -41.29 79.4 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.521 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . 0.417 HG23 ' O ' ' B' ' 245' ' ' ARG . 55.1 t . . . . . 0 C--N 1.331 -0.232 0 CA-C-O 120.75 0.309 . . . . 0.0 110.649 179.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.605 ' CB ' HH21 ' A' ' 93' ' ' ARG . 51.1 mp0 . . . . . 0 C--O 1.237 0.437 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.424 ' CD1' HG23 ' A' ' 9' ' ' THR . 78.1 mt -110.81 136.21 47.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 76.7 t -122.91 131.19 73.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.999 0.428 . . . . 0.0 110.254 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -94.23 117.48 30.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.202 0.525 . . . . 0.0 110.958 -178.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.32 -44.81 90.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.543 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.75 160.36 28.07 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.801 -179.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -57.07 152.87 41.8 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.987 2.458 . . . . 0.0 111.716 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 39.8 pt . . . . . 0 C--N 1.327 -0.383 0 CA-C-O 121.622 0.725 . . . . 0.0 111.978 -178.921 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.503 ' O ' ' O ' ' A' ' 99' ' ' ASN . 2.9 m . . . . . 0 CA--C 1.529 0.16 0 CA-C-O 120.795 0.331 . . . . 0.0 111.318 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.746 ' HE ' HD13 ' A' ' 53' ' ' ILE . 82.5 mtm-85 -89.98 130.68 36.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.958 -179.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -131.06 148.04 52.69 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.155 0.502 . . . . 0.0 111.921 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.762 HD11 HD11 ' A' ' 22' ' ' LEU . 94.1 mt -115.4 141.7 47.68 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.257 179.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.9 t -113.14 128.22 70.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.7 m -91.69 113.73 26.08 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.681 HD12 ' OG ' ' A' ' 94' ' ' SER . 96.8 mt -77.58 138.77 19.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -86.32 157.04 19.99 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.425 179.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -58.01 -30.84 66.41 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.782 -179.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 87.0 p -78.55 -9.74 59.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.871 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.56 34.78 6.81 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.756 -0.937 . . . . 0.0 110.756 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 52.3 t -121.51 133.84 66.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.574 0.226 . . . . 0.0 110.813 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.403 ' C ' ' OD1' ' A' ' 16' ' ' ASP . 62.3 t0 -66.24 120.15 12.75 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.934 0.397 . . . . 0.0 110.383 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -104.43 -136.12 8.7 Favored Glycine 0 CA--C 1.535 1.337 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.374 -178.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.97 151.54 45.15 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.581 2.187 . . . . 0.0 112.693 -178.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -107.85 128.93 55.04 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.965 -179.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.835 ' CD2' HD11 ' A' ' 37' ' ' ILE . 59.8 t80 -97.67 106.36 32.83 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.053 -178.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.85 128.13 9.87 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 121.703 1.602 . . . . 0.0 111.405 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.762 HD11 HD11 ' A' ' 7' ' ' LEU . 97.5 mt -83.39 84.0 7.67 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.381 -0.528 . . . . 0.0 111.552 -178.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 57.2 p -83.44 -13.66 54.27 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.516 HD11 ' CD ' ' B' ' 265' ' ' GLN . 58.6 mt -99.55 142.57 30.85 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.963 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 27.1 m -69.48 -10.44 58.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.646 -178.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 29.2 m -132.16 132.56 43.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.757 0.313 . . . . 0.0 110.57 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.6 t -128.1 123.68 35.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.508 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.456 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 54.7 tp -117.45 131.67 56.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.017 -179.058 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.423 ' CE2' HG13 ' A' ' 37' ' ' ILE . 32.1 m-85 -110.33 135.91 50.32 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 155.81 -164.38 32.18 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 120.367 -0.921 . . . . 0.0 112.328 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.62 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 47.6 ptt85 -119.18 19.54 12.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.651 -0.275 . . . . 0.0 110.352 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.63 ' O ' ' N ' ' A' ' 34' ' ' GLU . . . -88.32 29.74 5.53 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.588 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 1.7 tp 55.63 -61.85 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 O-C-N 123.849 0.382 . . . . 0.0 111.163 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.63 ' N ' ' O ' ' A' ' 32' ' ' GLY . 49.8 tp10 -50.46 -9.64 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.415 0.626 . . . . 0.0 109.514 179.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.551 ' H ' ' C ' ' A' ' 33' ' ' ILE . 35.1 m -65.42 124.74 23.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.39 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.456 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 60.5 m-20 -60.34 -31.66 70.51 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.835 HD11 ' CD2' ' A' ' 20' ' ' PHE . 42.6 mm -118.95 114.08 43.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 177.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.758 HH22 ' NZ ' ' B' ' 264' ' ' LYS . 77.3 mtt85 -103.64 136.09 43.99 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.448 -177.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.668 HD13 ' HE ' ' A' ' 93' ' ' ARG . 97.8 mt -122.58 132.23 71.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 121.006 0.432 . . . . 0.0 110.439 179.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -77.27 33.0 0.15 Allowed 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -176.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.71 HD12 ' CZ ' ' A' ' 93' ' ' ARG . 47.4 mt -109.81 134.75 20.54 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 120.091 -0.643 . . . . 0.0 111.546 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.55 -8.23 21.36 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.456 2.104 . . . . 0.0 113.517 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.562 HG21 ' CE2' ' B' ' 241' ' ' PHE . 27.6 m -100.56 3.23 10.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.468 179.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.62 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 37.2 t -88.96 132.74 32.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.482 -0.487 . . . . 0.0 109.713 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.8 t -66.02 155.86 35.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.498 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.516 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 40.3 mtmt -63.04 -40.76 98.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.027 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.646 ' O ' ' N ' ' A' ' 49' ' ' CYS . 87.5 mt-30 -115.94 -7.57 11.96 Favored 'General case' 0 N--CA 1.464 0.23 0 O-C-N 123.319 0.387 . . . . 0.0 111.334 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.469 ' C ' ' O ' ' A' ' 47' ' ' GLN . 17.0 t60 15.7 -71.4 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -178.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.646 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.46 133.42 45.15 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -178.49 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -125.36 129.02 49.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.784 178.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 90.5 mt -115.1 134.86 56.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.042 0.449 . . . . 0.0 111.732 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.443 ' CD ' ' NE2' ' A' ' 54' ' ' HIS . 81.5 tt0 -117.59 126.15 52.05 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.746 HD13 ' HE ' ' A' ' 5' ' ' ARG . 94.9 mt -108.14 118.87 56.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 113.086 0.772 . . . . 0.0 113.086 -178.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.443 ' NE2' ' CD ' ' A' ' 52' ' ' GLU . 98.4 m-70 -111.23 138.28 47.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.015 178.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 54' ' ' HIS . 78.6 tt0 -40.72 -33.87 0.33 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -179.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -63.79 -67.14 0.45 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.696 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.51 ' OE2' ' CD ' ' A' ' 81' ' ' ARG . 0.1 OUTLIER -148.56 -178.97 6.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.203 0.525 . . . . 0.0 111.519 -179.373 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -106.51 126.47 52.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.189 178.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 86.6 mt -116.9 128.6 74.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.429 0.633 . . . . 0.0 112.351 -178.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.623 ' HB2' HD11 ' A' ' 82' ' ' LEU . 24.8 tp -99.85 130.57 46.06 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.499 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -112.61 132.9 54.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.098 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 63.9 t-20 -92.16 106.77 18.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.353 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -98.25 -7.57 28.91 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.44 102.06 4.33 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.039 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.5 m -89.42 -6.52 56.48 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.553 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -102.2 -40.14 6.92 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.126 -179.894 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 56.9 m-20 -142.69 99.04 5.72 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.107 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.531 ' HB2' HG13 ' A' ' 75' ' ' VAL . 51.9 Cg_exo -55.36 146.2 63.25 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.286 1.991 . . . . 0.0 113.546 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.9 m -76.01 144.95 40.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.837 178.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -105.63 139.16 40.64 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.795 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 54.9 t -130.1 134.44 62.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 52.67 33.78 14.54 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.6 27.91 71.8 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.233 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 68.2 m -142.77 138.26 30.32 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 117.626 0.713 . . . . 0.0 111.853 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.531 HG13 ' HB2' ' A' ' 68' ' ' PRO . 3.4 t -68.12 140.8 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.853 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.5 pt -114.16 105.99 19.79 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.063 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.67 178.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 20.5 p-10 -74.37 -26.54 60.18 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.131 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.442 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.3 OUTLIER -130.4 178.52 1.69 Allowed Pre-proline 0 C--N 1.33 -0.258 0 C-N-CA 120.866 -0.333 . . . . 0.0 110.62 -179.794 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 31.2 Cg_exo -59.91 141.87 97.42 Favored 'Trans proline' 0 N--CA 1.502 1.985 0 C-N-CA 122.687 2.258 . . . . 0.0 113.158 -179.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 47.1 t -133.77 135.92 54.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.725 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.51 ' CD ' ' OE2' ' A' ' 57' ' ' GLU . 88.9 mtm180 -71.91 132.98 45.11 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.623 HD11 ' HB2' ' A' ' 60' ' ' LEU . 96.1 mt -86.86 136.82 32.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.257 0.551 . . . . 0.0 111.615 -178.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -121.31 148.79 43.85 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.613 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.439 ' CD2' ' C ' ' A' ' 84' ' ' HIS . 7.9 t60 -58.55 125.76 24.73 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.029 0.442 . . . . 0.0 110.291 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.57 -17.44 42.91 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.809 -0.917 . . . . 0.0 110.809 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -67.74 140.39 56.72 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.101 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.537 ' O ' HG13 ' A' ' 87' ' ' VAL . 12.1 p -112.33 127.96 69.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.476 -178.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 88.0 mt -92.81 130.59 41.67 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 177.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.1 m -125.85 128.9 48.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.975 0.893 . . . . 0.0 113.111 -178.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.546 ' O ' ' C ' ' A' ' 91' ' ' ILE . 95.9 mt -114.44 137.81 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 114.004 -1.453 . . . . 0.0 108.217 178.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.546 ' C ' ' O ' ' A' ' 90' ' ' ILE . 87.4 mt 17.02 -85.74 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 O-C-N 123.645 0.591 . . . . 0.0 111.771 -178.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.499 ' N ' ' O ' ' A' ' 90' ' ' ILE . 53.9 t0 -121.63 14.33 10.97 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 120.315 -0.554 . . . . 0.0 112.023 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.71 ' CZ ' HD12 ' A' ' 41' ' ' LEU . 45.1 mtm-85 -129.31 140.75 51.3 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.642 -0.423 . . . . 0.0 109.974 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.681 ' OG ' HD12 ' A' ' 10' ' ' ILE . 55.0 p -139.14 153.96 48.04 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.124 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -127.13 126.84 43.6 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.746 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -84.34 129.36 34.88 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.85 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.557 ' CE2' ' OD1' ' A' ' 99' ' ' ASN . 88.8 t80 -89.63 123.86 34.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.951 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -134.12 113.24 11.85 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.076 0.465 . . . . 0.0 111.146 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.557 ' OD1' ' CE2' ' A' ' 97' ' ' TYR . 99.1 m-20 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.152 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 N--CA 1.487 1.14 0 CA-C-O 121.588 0.578 . . . . 0.0 113.098 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.553 ' CG2' HG22 ' A' ' 66' ' ' THR . 55.0 t -65.22 137.14 25.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 114.585 -1.189 . . . . 0.0 111.156 -179.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . 0.497 ' SG ' HG23 ' A' ' 91' ' ' ILE . 5.9 t . . . . . 0 C--N 1.331 -0.214 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo . . . . . 0 N--CA 1.492 1.425 0 CA-C-O 120.443 0.101 . . . . 0.0 112.266 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 21.9 p -74.18 -41.19 61.85 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 121.188 0.518 . . . . 0.0 109.835 178.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.562 ' CE2' HG21 ' A' ' 43' ' ' VAL . 84.5 t80 -58.22 -45.56 87.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.964 -179.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 89.1 mt -64.18 -40.46 96.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.658 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -61.81 -40.55 95.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.027 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 80.4 mtt85 -62.16 -42.52 99.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.168 0.509 . . . . 0.0 109.994 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.923 ' O ' HG23 ' B' ' 249' ' ' VAL . 78.0 mtp85 -61.98 -41.95 98.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.657 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -61.92 -43.32 99.09 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.274 -0.57 . . . . 0.0 110.398 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 46.9 t -65.97 -45.22 82.48 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -63.43 -34.49 77.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.012 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . 0.923 HG23 ' O ' ' B' ' 245' ' ' ARG . 59.8 t . . . . . 0 C--N 1.33 -0.278 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.127 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.585 ' OE1' HD21 ' A' ' 41' ' ' LEU . 97.1 mt-10 . . . . . 0 N--CA 1.457 -0.077 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 61.6 mt -109.33 132.41 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 75.2 t -127.87 137.08 58.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.282 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . 0.578 ' CD2' HD13 ' B' ' 267' ' ' ILE . 67.1 m-85 -98.61 120.48 39.11 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.052 -177.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . 0.758 ' NZ ' HH22 ' A' ' 38' ' ' ARG . 64.6 tttp -65.18 -48.07 74.73 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.924 178.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . 0.516 ' CD ' HD11 ' A' ' 24' ' ' LEU . 0.4 OUTLIER -85.5 172.04 9.48 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.281 -178.809 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -58.08 143.98 95.62 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.343 2.029 . . . . 0.0 112.943 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . 0.578 HD13 ' CD2' ' B' ' 263' ' ' PHE . 18.5 tt . . . . . 0 N--CA 1.448 -0.569 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.361 179.216 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.9 p . . . . . 0 N--CA 1.456 -0.136 0 CA-C-O 120.874 0.369 . . . . 0.0 111.014 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.688 ' NH2' HG21 ' A' ' 53' ' ' ILE . 91.4 mtm-85 -99.76 124.43 45.02 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.02 -178.641 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -133.74 144.81 49.32 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.261 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.562 HD11 HD11 ' A' ' 22' ' ' LEU . 69.4 mt -111.73 138.96 47.61 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.855 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.8 t -112.29 125.88 69.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.3 m -74.93 138.65 42.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.916 -178.693 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.614 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 98.5 mt -109.89 132.86 56.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.547 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -90.38 157.25 17.71 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.479 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.53 ' NH1' ' CD ' ' B' ' 260' ' ' GLU . 93.2 mtm-85 -61.31 -23.49 65.75 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.048 -179.28 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.5 m -76.08 -16.6 59.89 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.552 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.06 33.26 7.03 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.596 -1.001 . . . . 0.0 110.596 -179.331 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 37.0 t -117.64 131.82 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-O 120.573 0.225 . . . . 0.0 111.499 -179.521 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -74.02 136.65 43.14 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 178.376 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -130.46 -119.95 2.17 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.308 -179.169 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -72.95 150.16 48.46 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 122.464 2.109 . . . . 0.0 112.646 -178.748 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -112.38 156.96 21.63 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.306 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.625 ' CD2' HD11 ' A' ' 37' ' ' ILE . 46.9 t80 -123.13 103.99 35.67 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.143 -179.261 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -71.49 127.24 13.01 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 121.622 1.548 . . . . 0.0 111.929 -179.414 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.562 HD11 HD11 ' A' ' 7' ' ' LEU . 98.3 mt -84.31 48.83 1.55 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -178.295 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 94.3 p -61.35 -24.33 66.38 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.728 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.672 HD11 ' NE2' ' B' ' 265' ' ' GLN . 73.3 mt -77.36 139.76 39.81 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.667 179.485 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 91.8 p -66.18 -18.96 65.67 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.165 -179.302 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.428 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 40.4 m -132.8 132.83 42.63 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.024 -179.777 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.46 ' HB2' HD22 ' A' ' 22' ' ' LEU . 3.7 t -125.27 118.33 25.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.847 178.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.423 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 39.7 tp -116.82 128.55 55.38 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.055 -178.646 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.713 ' CE2' HD12 ' A' ' 37' ' ' ILE . 4.5 m-85 -107.58 141.06 39.62 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.158 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 158.13 -168.76 34.65 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 120.033 -1.079 . . . . 0.0 112.615 179.016 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.6 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 86.5 mtm-85 -81.23 -31.1 33.99 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-O 121.005 0.431 . . . . 0.0 110.185 179.687 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.485 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -50.56 142.07 16.37 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 115.745 -0.662 . . . . 0.0 112.39 -177.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.477 HD13 ' CZ ' ' A' ' 38' ' ' ARG . 38.8 mm -65.67 -43.65 93.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.276 0.56 . . . . 0.0 109.492 179.087 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.3 tp10 -57.8 -19.38 28.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.973 -179.637 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 34.9 m -59.69 130.9 49.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.42 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.428 ' OD2' ' O ' ' A' ' 26' ' ' THR . 54.6 m-20 -60.78 -33.83 73.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.838 -179.351 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.713 HD12 ' CE2' ' A' ' 29' ' ' PHE . 89.7 mt -127.84 120.66 54.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 177.48 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.477 ' CZ ' HD13 ' A' ' 33' ' ' ILE . 81.4 mtp180 -103.12 137.02 41.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.824 -178.722 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 98.4 mt -118.26 127.55 75.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.805 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -73.16 31.92 0.07 Allowed 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -177.405 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.872 HD21 ' OE1' ' B' ' 260' ' ' GLU . 88.2 mt -108.45 132.09 21.34 Favored Pre-proline 0 C--N 1.325 -0.482 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.012 179.657 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.37 -9.79 23.38 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.459 2.106 . . . . 0.0 112.797 179.742 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.2 m -95.03 2.62 9.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.512 -0.475 . . . . 0.0 109.801 179.51 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.6 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 21.0 t -88.57 131.6 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.602 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.632 ' OG ' ' N ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -66.42 167.48 10.57 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.325 0.583 . . . . 0.0 111.798 -177.897 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -61.37 -45.84 92.68 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.423 -178.746 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.622 ' O ' ' N ' ' A' ' 49' ' ' CYS . 86.1 mt-30 -113.62 -15.71 12.47 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.557 178.825 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.632 ' N ' ' OG ' ' A' ' 45' ' ' SER . 16.8 t60 34.93 -76.61 0.0 OUTLIER 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.067 -0.969 . . . . 0.0 113.604 179.765 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.622 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -129.56 134.41 47.72 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.367 0.603 . . . . 0.0 112.294 -178.433 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -125.67 132.23 52.46 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.845 178.67 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.2 mt -116.46 134.26 60.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.927 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -117.83 122.97 44.78 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.562 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.688 HG21 ' NH2' ' A' ' 5' ' ' ARG . 72.7 mt -105.27 115.8 47.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.419 0.628 . . . . 0.0 111.476 -178.861 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.46 ' O ' ' N ' ' A' ' 56' ' ' GLN . 87.2 m-70 -114.79 144.86 42.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.816 -1.083 . . . . 0.0 109.868 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.8 mm-40 -40.84 -27.15 0.05 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.07 0.462 . . . . 0.0 110.156 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.46 ' N ' ' O ' ' A' ' 54' ' ' HIS . 86.9 mm-40 -68.96 -67.61 0.46 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.151 179.094 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -158.99 -166.37 1.83 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.37 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.34 129.35 55.77 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.195 -179.853 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 90.0 mt -120.48 130.18 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 121.166 0.508 . . . . 0.0 112.338 -178.85 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.412 ' HB2' HD11 ' A' ' 82' ' ' LEU . 36.0 tp -97.71 129.25 44.77 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.156 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -114.61 136.41 53.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.206 179.677 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -97.42 104.87 16.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.97 0.414 . . . . 0.0 111.614 -179.613 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -94.2 -10.5 32.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.68 178.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.8 t -76.95 102.94 6.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.225 179.237 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 88.8 p -86.76 -8.7 57.13 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.574 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.82 HG22 HG22 ' B' ' 236' ' ' VAL . 0.2 OUTLIER -95.84 -37.91 10.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.117 0.484 . . . . 0.0 110.019 179.966 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -146.2 95.57 4.71 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.961 179.879 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.0 148.57 76.03 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 122.363 2.042 . . . . 0.0 112.526 -179.652 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 57.1 m -70.29 141.23 52.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.469 179.197 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -98.53 146.71 25.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.562 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.754 ' HB ' HD11 ' A' ' 76' ' ' ILE . 6.1 p -130.55 135.99 59.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.2 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 48.3 32.37 3.14 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 -179.694 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.12 29.57 62.34 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 111.414 -0.674 . . . . 0.0 111.414 -179.836 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.415 ' N ' ' O ' ' A' ' 71' ' ' VAL . 15.0 m -138.87 136.32 35.43 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.817 0.308 . . . . 0.0 111.052 -179.62 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.8 p -64.38 143.81 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 120.931 0.396 . . . . 0.0 111.835 -179.194 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.754 HD11 ' HB ' ' A' ' 71' ' ' VAL . 95.5 mt -107.64 103.51 15.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.036 179.672 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -64.58 -41.84 96.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.519 179.082 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.527 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.4 OUTLIER -137.38 -177.46 0.71 Allowed Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.456 -178.362 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.506 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 35.7 Cg_exo -58.69 145.71 94.71 Favored 'Trans proline' 0 N--CA 1.5 1.885 0 C-N-CA 122.838 2.359 . . . . 0.0 112.779 -179.598 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.3 m -144.48 147.25 19.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.556 179.808 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -77.53 131.82 38.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.807 178.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.412 HD11 ' HB2' ' A' ' 60' ' ' LEU . 96.0 mt -84.76 140.52 31.19 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.08 0.467 . . . . 0.0 111.482 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -129.32 151.36 50.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.646 179.58 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.426 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 5.2 t60 -54.42 120.87 7.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.482 -179.656 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.82 -13.8 41.66 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 -179.269 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.513 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 55.1 t0 -70.05 126.38 29.53 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.363 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 71.4 t -103.88 135.02 43.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.625 -178.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 84.7 mt -103.91 129.52 55.92 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.769 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 87.5 m -124.53 124.69 42.81 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 119.861 -0.736 . . . . 0.0 112.675 -178.269 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.582 ' O ' ' N ' ' A' ' 93' ' ' ARG . 98.4 mt -111.93 131.54 63.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 114.697 -1.138 . . . . 0.0 107.944 177.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.671 HD13 ' HB2' ' B' ' 237' ' ' CYS . 66.0 mt -21.9 97.61 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.585 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.502 ' CG ' ' NE ' ' B' ' 245' ' ' ARG . 3.3 m-20 89.2 -24.9 0.08 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 178.098 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.614 ' NH2' ' O ' ' A' ' 10' ' ' ILE . 6.2 mmm180 -124.15 140.05 53.34 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.532 -179.288 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.498 ' HB3' HD12 ' A' ' 10' ' ' ILE . 46.0 t -141.22 151.59 43.89 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.768 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -128.24 123.14 33.44 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.267 179.323 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -80.08 134.09 36.16 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.289 179.22 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -94.83 123.69 38.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.669 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.404 ' HG3' ' CE1' ' A' ' 84' ' ' HIS . 79.5 tt0 -124.63 122.19 36.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.785 -179.874 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.426 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 59.9 t-20 . . . . . 0 C--N 1.33 -0.244 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.038 179.61 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo . . . . . 0 N--CA 1.493 1.478 0 N-CA-C 113.759 0.638 . . . . 0.0 113.759 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.82 HG22 HG22 ' A' ' 66' ' ' THR . 19.0 t -78.21 131.5 34.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.019 179.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . 0.671 ' HB2' HD13 ' A' ' 91' ' ' ILE . 3.3 t . . . . . 0 C--N 1.33 -0.25 0 CA-C-O 120.807 0.337 . . . . 0.0 111.268 -179.353 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo . . . . . 0 N--CA 1.494 1.552 0 N-CA-C 113.306 0.464 . . . . 0.0 113.306 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 6.7 p -77.29 -38.25 51.15 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 120.187 -0.605 . . . . 0.0 109.528 177.94 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -58.63 -45.47 89.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.327 179.78 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.588 HD23 ' HE ' ' B' ' 245' ' ' ARG . 95.3 mt -62.6 -41.54 99.03 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 121.161 0.505 . . . . 0.0 110.537 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -67.9 -38.4 82.92 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.571 -179.645 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -61.12 -48.02 83.57 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.502 -178.593 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.588 ' HE ' HD23 ' B' ' 242' ' ' LEU . 52.0 ptt85 -64.64 -37.37 87.36 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.613 -179.303 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -61.21 -39.72 91.28 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.294 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 14.0 t -66.75 -42.3 86.42 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.364 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -58.07 -39.88 79.6 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.853 179.674 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 42.9 t . . . . . 0 CA--C 1.52 -0.21 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.918 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.872 ' OE1' HD21 ' A' ' 41' ' ' LEU . 97.6 mt-10 . . . . . 0 N--CA 1.462 0.163 0 CA-C-O 120.519 0.2 . . . . 0.0 110.84 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 47.6 mt -115.37 137.92 47.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -179.555 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 55.3 t -127.23 133.93 67.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.897 179.223 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -97.31 122.6 40.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.051 0.453 . . . . 0.0 111.348 -178.411 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -66.18 -44.08 85.04 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.359 179.568 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . 0.672 ' NE2' HD11 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -99.87 170.0 7.32 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.554 -178.723 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.77 154.56 67.56 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.414 2.076 . . . . 0.0 112.017 -179.83 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 45.0 pt . . . . . 0 C--N 1.328 -0.362 0 CA-C-O 121.484 0.659 . . . . 0.0 111.936 -179.147 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 37.1 m . . . . . 0 CA--C 1.52 -0.2 0 CA-C-O 121.017 0.437 . . . . 0.0 110.667 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.58 ' NH1' ' HB2' ' A' ' 58' ' ' ALA . 95.9 mtt-85 -90.76 125.4 35.69 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.749 -178.425 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -134.73 143.93 47.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.871 -179.243 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.717 HD11 HD11 ' A' ' 22' ' ' LEU . 73.1 mt -116.75 142.06 47.41 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.775 179.667 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.7 t -117.19 128.31 74.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.968 0.413 . . . . 0.0 110.279 179.536 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.2 m -74.68 140.8 44.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.354 0.597 . . . . 0.0 112.325 -179.187 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.631 HD12 ' OG ' ' A' ' 94' ' ' SER . 90.0 mt -112.47 134.06 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.838 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -91.6 158.08 16.63 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.193 0.52 . . . . 0.0 111.77 -179.311 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.76 HH11 HH11 ' B' ' 245' ' ' ARG . 86.4 mtm180 -58.21 -30.99 66.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.505 -178.952 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.5 p -78.15 -10.2 59.52 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.601 178.96 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.81 36.17 7.42 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 179.951 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.5 t -118.07 132.74 67.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.01 0.433 . . . . 0.0 111.579 -179.615 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -73.22 128.86 36.68 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.003 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -125.45 -120.68 2.46 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 120.139 -1.029 . . . . 0.0 112.709 -178.797 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -72.01 146.67 47.53 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 122.242 1.962 . . . . 0.0 112.517 -178.202 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -108.71 147.33 32.11 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.94 179.372 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.526 ' CD2' HD11 ' A' ' 37' ' ' ILE . 29.3 t80 -116.87 102.8 52.87 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.578 -179.375 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.61 133.84 17.75 Favored 'Trans proline' 0 N--CA 1.486 1.049 0 C-N-CA 121.122 1.215 . . . . 0.0 110.504 -179.357 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.717 HD11 HD11 ' A' ' 7' ' ' LEU . 92.3 mt -87.64 62.87 7.27 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.723 -177.822 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 80.6 p -70.71 -21.0 62.61 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 177.79 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.698 HD11 ' HG2' ' B' ' 265' ' ' GLN . 71.0 mt -85.03 138.34 32.5 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.339 -179.61 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -62.4 -20.9 64.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.612 -179.12 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.1 m -134.17 135.49 43.11 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.821 -179.827 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.661 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -129.88 122.92 29.57 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.187 178.883 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.531 HD21 ' OE1' ' A' ' 47' ' ' GLN . 35.0 tp -120.98 126.8 50.87 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.7 -178.688 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.661 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 36.3 m-85 -99.74 127.16 45.88 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.134 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -176.39 -156.16 14.77 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.499 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -115.46 -17.67 11.17 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 117.174 0.487 . . . . 0.0 110.415 179.13 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.23 161.88 47.35 Favored Glycine 0 CA--C 1.519 0.337 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -179.656 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.526 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.8 tp -66.04 -41.63 90.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.408 179.585 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.526 ' N ' HG23 ' A' ' 33' ' ' ILE . 15.0 pt-20 -56.86 -22.77 39.41 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.801 -179.727 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.7 m -63.23 126.3 26.96 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.874 0.369 . . . . 0.0 110.706 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.611 ' OD1' ' N ' ' A' ' 37' ' ' ILE . 11.0 p-10 -61.97 -28.89 69.87 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.096 -179.316 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.611 ' N ' ' OD1' ' A' ' 36' ' ' ASP . 97.5 mt -130.55 122.42 52.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 177.724 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 75.0 mtm180 -103.82 136.24 43.88 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.198 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.572 HG21 HD12 ' A' ' 41' ' ' LEU . 97.2 mt -117.66 129.23 74.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.857 179.748 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -70.52 32.4 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.814 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.58 HD23 ' NH2' ' B' ' 245' ' ' ARG . 43.4 mt -110.33 121.77 40.52 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 120.446 -0.502 . . . . 0.0 109.668 179.043 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.02 -1.47 10.92 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.244 1.963 . . . . 0.0 112.351 -178.809 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.433 HG23 HG13 ' A' ' 91' ' ' ILE . 18.3 m -99.2 6.73 9.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.323 179.813 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.499 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 29.6 t -89.96 133.94 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.25 178.797 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.479 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 0.6 OUTLIER -67.04 159.56 28.43 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.02 0.438 . . . . 0.0 110.551 179.514 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -61.77 -39.16 90.67 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.273 -178.817 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.606 ' O ' ' N ' ' A' ' 49' ' ' CYS . 96.3 mm-40 -111.53 -18.22 12.88 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.46 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.479 ' H ' ' HB3' ' A' ' 45' ' ' SER . 19.4 t60 29.96 -78.85 0.0 OUTLIER 'General case' 0 C--O 1.236 0.377 0 CA-C-N 114.716 -1.129 . . . . 0.0 113.124 -179.683 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.606 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -129.47 134.21 47.69 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.914 -179.342 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -125.66 128.49 47.91 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.223 179.364 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 93.0 mt -114.54 133.31 61.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.787 -179.849 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -113.27 133.68 54.98 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.807 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.562 HD12 ' CD ' ' A' ' 5' ' ' ARG . 47.9 mm -103.14 114.5 42.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.558 -179.462 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.44 ' O ' ' C ' ' A' ' 55' ' ' GLU . 95.0 m-70 -115.47 132.8 56.51 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.473 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 54' ' ' HIS . 95.4 mt-10 -40.47 -34.13 0.32 Allowed 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 121.195 0.522 . . . . 0.0 109.92 -178.673 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -62.75 -67.32 0.43 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.233 179.418 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -152.43 -164.38 1.94 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.333 -179.63 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.58 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -127.28 131.18 50.56 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.011 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 91.7 mt -112.32 129.9 67.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.255 0.55 . . . . 0.0 112.205 -178.237 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.548 ' HB2' HD21 ' A' ' 82' ' ' LEU . 44.3 tp -94.46 120.22 34.37 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.224 179.028 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -107.85 135.05 49.9 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.962 0.41 . . . . 0.0 111.336 -178.823 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -96.14 104.91 16.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.246 179.627 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -99.31 -10.84 21.82 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.614 179.549 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.4 t -69.61 100.87 1.52 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.538 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.9 p -85.01 -15.96 42.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.038 0.447 . . . . 0.0 109.924 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.586 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -90.24 -46.13 8.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.752 -179.852 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.459 HD21 ' HA ' ' B' ' 236' ' ' VAL . 65.5 m-20 -135.08 97.71 13.38 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.283 -0.872 . . . . 0.0 109.456 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.502 ' HB2' HG13 ' A' ' 75' ' ' VAL . 41.2 Cg_exo -56.74 144.64 86.22 Favored 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 122.501 2.134 . . . . 0.0 113.612 -178.838 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.0 m -75.36 140.39 43.0 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.264 178.756 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -104.3 141.42 36.34 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.321 179.938 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.641 HG13 ' OD1' ' A' ' 86' ' ' ASP . 53.0 t -131.92 135.29 58.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.739 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 51.92 31.96 9.26 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -178.399 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.31 27.48 69.79 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.095 -179.924 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.5 p -140.39 140.83 35.57 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 117.608 0.704 . . . . 0.0 111.696 179.776 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.502 HG13 ' HB2' ' A' ' 68' ' ' PRO . 41.5 t -68.87 135.83 27.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.041 179.451 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.478 HG21 HG21 ' A' ' 80' ' ' VAL . 7.4 pt -113.34 82.22 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.974 0.416 . . . . 0.0 110.696 178.588 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -61.62 -24.69 66.87 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.441 179.885 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -118.79 167.36 11.88 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.997 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -62.46 145.54 95.6 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 122.386 2.058 . . . . 0.0 112.568 179.63 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.478 HG21 HG21 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -139.34 140.01 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 120.822 0.344 . . . . 0.0 110.996 179.291 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -74.77 133.18 42.01 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.456 179.519 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.548 HD21 ' HB2' ' A' ' 60' ' ' LEU . 95.6 mt -79.23 134.9 36.66 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.196 0.522 . . . . 0.0 110.92 -179.596 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -129.52 150.18 50.98 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.385 179.479 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -52.32 113.63 1.1 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.501 -179.852 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.29 -11.16 19.69 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.641 ' OD1' HG13 ' A' ' 71' ' ' VAL . 52.4 t0 -68.96 123.6 21.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.205 0.526 . . . . 0.0 110.998 -179.713 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.6 t -108.94 130.89 61.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.71 -179.572 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 83.9 mt -104.46 133.2 49.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.726 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 82.8 m -120.61 129.45 53.74 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.6 0.714 . . . . 0.0 112.491 -178.53 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.464 ' O ' ' N ' ' A' ' 93' ' ' ARG . 89.5 mt -121.13 122.59 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 114.501 -1.227 . . . . 0.0 108.1 178.235 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.433 HG13 HG23 ' A' ' 43' ' ' VAL . 36.8 mm 40.73 -112.45 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.016 -178.831 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.42 ' OD1' HD22 ' B' ' 242' ' ' LEU . 97.6 m-20 -103.16 10.88 37.62 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.544 0.211 . . . . 0.0 111.05 179.079 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.673 ' CZ ' HD11 ' B' ' 261' ' ' ILE . 6.5 mmm180 -120.76 143.97 48.53 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.674 -179.123 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.631 ' OG ' HD12 ' A' ' 10' ' ' ILE . 39.1 p -142.26 155.76 45.25 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.904 0.383 . . . . 0.0 110.838 -179.96 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -128.0 124.99 38.56 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.273 179.35 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -86.95 133.67 33.57 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.505 0.193 . . . . 0.0 110.827 -179.737 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.54 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 69.6 t80 -93.96 123.79 37.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.893 179.886 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -123.85 128.83 50.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.42 -179.923 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 . . . . . 0 C--N 1.326 -0.447 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.147 178.992 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo . . . . . 0 N--CA 1.49 1.28 0 CA-C-O 121.485 0.535 . . . . 0.0 112.784 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.586 ' CG2' HG22 ' A' ' 66' ' ' THR . 27.8 t -72.08 137.29 23.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.782 -179.771 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 8.0 t . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.175 -179.628 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo . . . . . 0 N--CA 1.499 1.829 0 CA-C-O 120.881 0.284 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 99.8 m -73.04 -45.16 59.13 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.714 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -55.17 -45.31 75.74 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.875 -179.575 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.42 HD22 ' OD1' ' A' ' 92' ' ' ASP . 89.6 mt -63.11 -42.6 99.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.791 -179.185 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -65.3 -42.18 93.32 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.368 -179.024 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -61.98 -44.88 95.8 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.167 0.508 . . . . 0.0 110.509 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.76 HH11 HH11 ' A' ' 12' ' ' ARG . 49.5 ttm-85 -64.78 -41.49 95.81 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.682 -179.345 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -60.74 -38.17 84.26 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.708 0.29 . . . . 0.0 110.532 179.398 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 88.3 p -69.29 -40.56 77.65 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.528 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -58.64 -37.53 76.13 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.66 178.78 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 54.1 t . . . . . 0 CA--C 1.528 0.105 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.262 178.824 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.455 ' C ' HD13 ' B' ' 261' ' ' ILE . 47.4 mm-40 . . . . . 0 CA--C 1.544 0.727 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.673 HD11 ' CZ ' ' A' ' 93' ' ' ARG . 2.7 mm -114.05 133.28 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-N 119.334 0.97 . . . . 0.0 110.223 178.854 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 52.6 t -126.5 133.23 69.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.159 178.894 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -100.41 122.02 42.47 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.191 0.52 . . . . 0.0 111.266 -178.637 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -63.3 -47.62 81.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.222 179.432 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . 0.698 ' HG2' HD11 ' A' ' 24' ' ' LEU . 4.1 mp0 -96.47 161.57 26.38 Favored Pre-proline 0 N--CA 1.453 -0.314 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.474 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.98 150.18 37.87 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 123.035 2.49 . . . . 0.0 112.585 -178.877 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 28.5 pt . . . . . 0 C--N 1.325 -0.497 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.248 178.926 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.8 p . . . . . 0 C--O 1.231 0.105 0 CA-C-O 121.013 0.435 . . . . 0.0 110.108 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.803 ' NH1' ' HB2' ' A' ' 58' ' ' ALA . 94.6 mtt-85 -98.02 113.53 25.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.136 -179.585 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -127.62 138.18 52.77 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.92 0.39 . . . . 0.0 111.331 -179.711 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.527 HD12 ' O ' ' A' ' 96' ' ' ARG . 42.3 tp -117.41 129.94 56.17 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.586 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.1 t -106.15 130.8 57.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.911 -179.536 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 m -92.2 114.81 27.45 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.253 -179.635 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.2 mt -80.96 145.66 8.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.516 179.359 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -88.13 161.69 17.16 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.076 0.465 . . . . 0.0 111.169 -179.866 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.708 HH11 ' NH2' ' A' ' 93' ' ' ARG . 58.0 mtp85 -55.21 -32.59 62.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.458 -179.445 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 42.9 t -80.74 -6.67 58.77 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.859 179.502 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.57 33.86 12.72 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -179.527 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.8 t -114.16 132.75 62.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.724 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 63.0 t0 -65.31 120.69 13.23 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.865 -179.448 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -107.88 -133.56 7.12 Favored Glycine 0 CA--C 1.536 1.366 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 -179.279 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.73 149.88 49.26 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 122.106 1.87 . . . . 0.0 112.341 -179.21 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -105.78 139.23 40.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.891 0.377 . . . . 0.0 109.991 179.493 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.775 ' CD2' HD11 ' A' ' 37' ' ' ILE . 24.6 t80 -111.45 103.5 55.1 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.684 -179.614 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.69 132.16 16.91 Favored 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 121.437 1.425 . . . . 0.0 111.972 -179.216 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 75.5 mt -87.5 45.98 1.33 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.887 -178.728 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 79.2 p -65.22 -17.82 64.81 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.276 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.5 mt -81.38 143.0 32.48 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.27 178.518 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.0 t -64.8 -23.65 67.3 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -178.872 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 66.3 m -135.03 136.87 42.44 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.56 -179.505 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.8 t -130.02 121.78 27.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.066 178.924 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.443 HD21 ' NE2' ' A' ' 47' ' ' GLN . 59.6 tp -116.78 127.65 54.54 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.579 -179.269 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.671 ' CE2' HD12 ' A' ' 37' ' ' ILE . 7.6 m-85 -104.86 141.3 36.77 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.291 178.915 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 156.33 -174.24 34.15 Favored Glycine 0 N--CA 1.469 0.867 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.415 178.922 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.636 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 83.2 mtm-85 -78.62 -29.3 45.86 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.168 179.56 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.553 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -54.47 148.98 19.94 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.643 -178.759 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.509 HG23 ' N ' ' A' ' 34' ' ' GLU . 11.1 tp -67.78 -40.81 84.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.084 0.469 . . . . 0.0 110.023 179.512 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.509 ' N ' HG23 ' A' ' 33' ' ' ILE . 80.1 mm-40 -54.4 -21.8 10.69 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.773 179.546 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.553 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 58.8 m -55.64 118.62 4.68 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.93 179.553 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -55.89 -29.69 60.38 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 179.936 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.775 HD11 ' CD2' ' A' ' 20' ' ' PHE . 73.0 mt -128.48 120.55 53.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.36 176.226 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 78.2 ttt-85 -108.35 137.26 46.61 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.602 -177.898 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.786 HG21 HD12 ' A' ' 41' ' ' LEU . 96.2 mt -121.45 132.09 71.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.4 -179.54 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -80.94 32.21 0.32 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -177.962 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.786 HD12 HG21 ' A' ' 39' ' ' ILE . 16.4 mt -97.2 133.54 23.87 Favored Pre-proline 0 C--N 1.32 -0.691 0 C-N-CA 120.049 -0.661 . . . . 0.0 110.711 -179.938 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.12 -10.41 25.88 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 122.364 2.043 . . . . 0.0 112.221 -179.746 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.556 HG21 ' CE2' ' B' ' 241' ' ' PHE . 32.2 m -105.47 4.05 10.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.269 -179.384 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.636 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 17.4 t -88.77 131.15 36.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 177.714 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.77 163.16 19.87 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.082 0.467 . . . . 0.0 110.812 -178.858 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -61.38 -40.9 96.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.013 -178.8 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.608 ' O ' ' N ' ' A' ' 49' ' ' CYS . 12.3 mm100 -110.31 -17.0 13.6 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 123.573 0.546 . . . . 0.0 110.299 -179.852 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 21.7 t60 33.09 -75.73 0.0 OUTLIER 'General case' 0 C--O 1.239 0.525 0 CA-C-N 114.943 -1.026 . . . . 0.0 113.634 -179.601 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.608 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -135.48 139.77 44.3 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -178.299 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -127.57 133.52 49.76 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.633 179.707 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.0 mt -119.04 134.14 63.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.082 -179.855 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -116.63 127.75 54.75 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.065 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.3 mt -109.46 111.52 36.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.473 0.654 . . . . 0.0 111.218 -179.756 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.548 ' O ' ' N ' ' A' ' 56' ' ' GLN . 94.8 m-70 -110.51 143.18 41.25 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.801 -1.09 . . . . 0.0 108.984 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.557 ' OE1' ' N ' ' A' ' 55' ' ' GLU . 55.1 mp0 -40.65 -24.44 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.853 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.548 ' N ' ' O ' ' A' ' 54' ' ' HIS . 88.8 mm-40 -68.16 -69.26 0.33 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.07 179.044 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.445 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 5.5 tp10 -158.91 -168.31 2.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.987 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.803 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -109.73 126.09 53.36 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.099 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.29 130.25 70.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.467 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.497 ' HB2' HD21 ' A' ' 82' ' ' LEU . 26.6 tp -98.66 130.21 45.16 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.429 179.724 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -117.47 137.65 52.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.857 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.58 HD21 ' CB ' ' A' ' 68' ' ' PRO . 64.1 t-20 -98.08 104.68 16.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.08 179.805 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -96.27 -7.28 35.88 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.864 179.342 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.38 100.81 10.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.984 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.1 m -87.08 -37.69 17.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.677 179.75 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.583 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -61.08 -44.11 97.86 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.418 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -141.23 101.23 6.24 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.119 179.415 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.58 ' CB ' HD21 ' A' ' 62' ' ' ASN . 44.5 Cg_endo -67.76 152.32 77.76 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 121.676 1.584 . . . . 0.0 113.602 -178.242 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.5 m -77.38 149.11 35.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.775 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -111.99 140.53 46.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.345 179.404 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.5 t -128.5 136.32 60.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.598 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 53.65 32.97 15.52 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.225 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.98 25.93 74.88 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.437 -179.759 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 66.7 m -141.14 141.78 34.12 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 117.114 0.457 . . . . 0.0 111.856 -179.564 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 75.2 t -67.91 139.14 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.687 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 9.2 pt -111.2 82.63 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-O 121.126 0.488 . . . . 0.0 111.049 178.55 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -62.56 -32.79 73.82 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.98 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -113.95 156.95 43.21 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.834 178.676 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.6 152.39 80.55 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.18 1.92 . . . . 0.0 111.582 178.928 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.1 m -146.89 149.0 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 121.28 0.562 . . . . 0.0 112.03 179.89 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -72.4 133.68 45.02 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.871 179.678 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.497 HD21 ' HB2' ' A' ' 60' ' ' LEU . 96.4 mt -77.26 137.94 39.11 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.098 0.475 . . . . 0.0 110.767 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -128.56 147.12 50.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.514 179.535 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.523 ' HD1' ' C ' ' A' ' 99' ' ' ASN . 6.8 t60 -56.06 118.99 5.17 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.579 -179.525 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.27 -20.04 23.9 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -179.801 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -66.44 131.18 45.49 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.595 179.305 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.6 t -114.86 131.35 67.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.159 -178.501 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 84.6 mt -95.05 133.75 34.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.725 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.0 m -120.7 128.38 52.9 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.62 0.724 . . . . 0.0 112.574 -178.833 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.543 ' O ' ' N ' ' A' ' 92' ' ' ASP . 97.5 mt -115.06 123.4 70.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 114.559 -1.2 . . . . 0.0 108.664 178.54 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.457 ' CG2' ' CZ ' ' B' ' 245' ' ' ARG . 32.2 mm 38.71 -93.25 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.35 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.78 ' H ' ' NH1' ' B' ' 245' ' ' ARG . 16.9 t0 -125.97 20.16 7.68 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.011 0.434 . . . . 0.0 110.86 179.139 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.754 ' CZ ' HD11 ' A' ' 41' ' ' LEU . 75.5 mtt85 -124.85 142.57 51.35 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.351 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 30.2 p -139.61 154.73 47.64 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.96 179.763 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.505 ' HE1' HD12 ' A' ' 90' ' ' ILE . 17.1 m-85 -125.16 121.96 35.72 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.035 179.54 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.527 ' O ' HD12 ' A' ' 7' ' ' LEU . 39.1 ttp-105 -85.08 130.67 34.57 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.125 -0.63 . . . . 0.0 110.713 -179.256 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.63 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 87.7 t80 -94.66 123.67 38.24 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.962 -179.556 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -121.41 122.88 40.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.962 179.647 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.523 ' C ' ' HD1' ' A' ' 84' ' ' HIS . 54.7 t-20 . . . . . 0 C--N 1.328 -0.37 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.976 179.001 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 N--CA 1.491 1.38 0 N-CA-C 113.997 0.73 . . . . 0.0 113.997 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.583 ' CG2' HG22 ' A' ' 66' ' ' THR . 39.4 t -76.0 133.62 30.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 114.781 -1.1 . . . . 0.0 110.998 -179.454 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 7.6 t . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.675 179.367 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo . . . . . 0 N--CA 1.496 1.63 0 N-CA-C 112.671 0.219 . . . . 0.0 112.671 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 97.2 m -74.08 -42.52 60.04 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.857 0.361 . . . . 0.0 110.161 178.664 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.556 ' CE2' HG21 ' A' ' 43' ' ' VAL . 64.1 t80 -58.02 -45.75 86.41 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -179.54 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 87.2 mt -62.61 -40.86 98.3 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.177 179.964 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -61.52 -39.72 92.04 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.713 179.609 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . 0.45 ' HE ' ' HA ' ' B' ' 241' ' ' PHE . 88.7 mtm180 -62.08 -40.38 95.62 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.77 179.69 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.78 ' NH1' ' H ' ' A' ' 92' ' ' ASP . 89.4 mtt180 -60.1 -42.48 94.79 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.224 179.084 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -64.23 -42.79 96.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.016 0.436 . . . . 0.0 110.488 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 35.8 p -63.86 -44.86 91.85 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.73 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -58.58 -40.29 82.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.965 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . 0.489 HG23 ' O ' ' B' ' 245' ' ' ARG . 55.3 t . . . . . 0 C--N 1.327 -0.372 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.267 -179.885 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.514 ' OE1' ' NH2' ' A' ' 93' ' ' ARG . 94.6 mt-10 . . . . . 0 CA--C 1.531 0.236 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 68.6 mt -108.24 132.16 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.757 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 53.4 t -128.25 134.39 65.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.805 -178.609 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -99.54 121.92 41.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.51 0.671 . . . . 0.0 111.176 -178.955 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -67.06 -44.88 79.0 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.902 178.874 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -92.76 150.63 39.91 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.706 -178.235 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.84 143.98 47.1 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 122.86 2.373 . . . . 0.0 112.581 179.999 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 33.3 pt . . . . . 0 C--N 1.33 -0.265 0 CA-C-O 121.04 0.448 . . . . 0.0 110.7 179.209 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.2 p . . . . . 0 C--O 1.231 0.122 0 CA-C-O 121.165 0.507 . . . . 0.0 110.064 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.624 ' NH1' ' HB2' ' A' ' 58' ' ' ALA . 96.3 mtt-85 -89.47 124.5 34.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.922 -179.858 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -134.43 139.39 45.52 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.287 -0.565 . . . . 0.0 112.322 -179.342 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.445 HD11 HD11 ' A' ' 22' ' ' LEU . 75.7 mt -113.55 143.56 44.33 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.072 178.718 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.536 HG22 ' CD2' ' A' ' 19' ' ' HIS . 70.3 t -117.03 128.93 74.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.224 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.4 ' O ' HG22 ' A' ' 9' ' ' THR . 1.5 m -92.87 113.87 26.26 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.132 0.492 . . . . 0.0 112.076 -178.436 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 86.8 mt -79.19 143.86 11.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.784 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -89.54 161.6 16.12 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.223 0.535 . . . . 0.0 110.9 179.64 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.771 HH12 ' NE2' ' B' ' 248' ' ' GLN . 80.9 mtp180 -58.19 -33.41 69.23 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.802 -179.326 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.7 t -76.02 -13.11 60.23 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.706 179.218 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.39 35.05 5.83 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 -178.878 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.0 t -119.04 132.42 68.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.092 0.472 . . . . 0.0 110.966 -179.9 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.48 ' OD1' ' CG1' ' A' ' 8' ' ' VAL . 43.6 t0 -68.5 124.98 25.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.749 179.581 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -117.58 -126.41 3.72 Favored Glycine 0 CA--C 1.541 1.673 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.225 -178.916 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.29 147.88 42.76 Favored 'Trans proline' 0 N--CA 1.504 2.107 0 C-N-CA 122.741 2.294 . . . . 0.0 114.523 -177.808 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.536 ' CD2' HG22 ' A' ' 8' ' ' VAL . 60.1 m170 -104.77 144.73 31.34 Favored 'General case' 0 C--N 1.335 -0.059 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.08 179.37 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.473 ' CD2' HD11 ' A' ' 37' ' ' ILE . 72.1 t80 -121.82 105.44 37.99 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.996 -179.579 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -75.63 132.84 15.02 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 C-N-CA 121.682 1.588 . . . . 0.0 112.292 -179.14 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.445 HD11 HD11 ' A' ' 7' ' ' LEU . 89.6 mt -81.3 54.73 2.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.834 0.349 . . . . 0.0 110.935 -179.253 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.431 ' HB3' HE22 ' B' ' 265' ' ' GLN . 38.7 t -59.8 -37.58 79.53 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.877 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 66.0 mt -74.02 141.6 45.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.666 179.519 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 m -66.76 -15.23 63.41 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.075 -0.512 . . . . 0.0 112.271 -178.029 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.49 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 40.4 m -136.24 137.87 41.24 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.017 0.437 . . . . 0.0 110.724 179.504 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.668 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 4.3 t -131.58 122.87 26.81 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.908 179.65 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.501 HD21 ' HG2' ' A' ' 47' ' ' GLN . 42.4 tp -119.77 128.16 53.47 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.896 -178.98 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.668 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 14.1 m-85 -104.23 140.33 38.0 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.179 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.95 -171.79 38.81 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 119.647 -1.263 . . . . 0.0 112.764 179.1 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.623 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 85.4 mtm-85 -80.37 -28.08 38.07 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.418 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.55 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -60.68 141.22 48.06 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.3 -0.476 . . . . 0.0 112.287 -178.168 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.492 HG23 ' N ' ' A' ' 34' ' ' GLU . 11.0 tp -66.06 -41.43 89.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.095 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.492 ' N ' HG23 ' A' ' 33' ' ' ILE . 82.5 tt0 -54.52 -16.41 2.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.125 179.839 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.55 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 33.5 m -66.01 135.93 55.35 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.265 179.862 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.49 ' OD2' ' O ' ' A' ' 26' ' ' THR . 56.0 m-20 -61.42 -33.32 73.51 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.38 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.651 HD12 ' CE2' ' A' ' 29' ' ' PHE . 93.4 mt -127.66 122.46 59.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 177.17 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 76.8 ttt-85 -111.26 137.99 48.29 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.607 -178.317 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.452 HG22 ' H ' ' A' ' 41' ' ' LEU . 92.9 mt -119.11 131.87 70.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.846 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -75.13 20.69 0.13 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.686 -178.693 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.538 HD11 ' CZ ' ' A' ' 93' ' ' ARG . 22.7 mt -93.52 124.44 57.21 Favored Pre-proline 0 C--N 1.321 -0.66 0 C-N-CA 120.261 -0.575 . . . . 0.0 111.105 -179.449 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.47 -14.25 27.79 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 C-N-CA 121.901 1.734 . . . . 0.0 112.375 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 18.0 m -88.67 0.62 7.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.135 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.623 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 72.6 t -95.33 136.11 27.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.186 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.4 m -69.39 171.16 9.09 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.322 0.582 . . . . 0.0 111.699 -178.749 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -61.84 -42.11 98.63 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.671 -178.13 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.679 ' O ' ' N ' ' A' ' 49' ' ' CYS . 87.8 mt-30 -113.75 -14.99 12.51 Favored 'General case' 0 CA--C 1.521 -0.155 0 O-C-N 123.365 0.416 . . . . 0.0 110.337 179.873 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 30.1 t60 33.44 -73.11 0.0 OUTLIER 'General case' 0 C--O 1.236 0.393 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 179.654 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.679 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.68 135.35 45.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.06 0.457 . . . . 0.0 111.921 -178.649 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -123.85 128.66 49.82 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.389 179.3 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.4 mt -115.16 134.46 58.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.351 -179.686 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.453 ' CD ' ' NE2' ' A' ' 54' ' ' HIS . 83.9 tt0 -120.01 128.29 53.4 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.782 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.437 HD13 ' HD2' ' A' ' 5' ' ' ARG . 97.0 mt -108.18 118.8 56.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.471 0.653 . . . . 0.0 112.611 -178.549 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.545 ' O ' ' N ' ' A' ' 56' ' ' GLN . 99.0 m-70 -115.3 141.23 48.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.326 178.859 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.6 mm-40 -40.12 -25.94 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.906 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.545 ' N ' ' O ' ' A' ' 54' ' ' HIS . 85.9 mt-30 -65.71 -68.3 0.38 Allowed 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.2 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -159.94 -162.77 1.04 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.905 179.614 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.624 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -114.29 126.44 55.03 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.398 179.147 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.7 mt -112.68 127.9 69.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.441 0.638 . . . . 0.0 111.95 -178.923 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 40.1 tp -95.44 128.85 42.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.955 -179.74 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -115.33 135.8 53.77 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.549 -179.748 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.4 ' OD1' ' C ' ' A' ' 62' ' ' ASN . 51.1 t-20 -95.12 106.22 18.21 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.897 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -100.86 -10.05 21.05 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 179.279 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.3 t -78.85 100.61 7.26 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.269 -179.619 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.4 p -76.95 -33.84 57.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.042 0.448 . . . . 0.0 110.636 178.918 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.82 -40.65 65.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.485 -178.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -141.29 93.52 7.96 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.163 -179.726 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.06 145.67 51.94 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.344 2.029 . . . . 0.0 113.053 -179.488 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.2 m -72.65 139.54 47.39 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.338 179.533 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -102.89 139.77 38.03 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.662 179.641 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.648 HG13 ' OD1' ' A' ' 86' ' ' ASP . 75.3 t -133.46 134.43 56.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.097 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.4 m120 54.79 26.92 8.18 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -178.397 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.53 24.13 66.05 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-N 115.039 -0.982 . . . . 0.0 112.048 179.585 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.2 t -138.48 140.4 39.2 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 117.371 0.585 . . . . 0.0 111.28 179.695 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.47 ' H ' HG12 ' A' ' 75' ' ' VAL . 0.2 OUTLIER -70.99 140.38 18.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.183 179.918 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.2 pt -115.42 91.95 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.122 179.941 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -66.87 -25.72 66.54 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.653 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.19 162.19 27.41 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.505 179.484 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.13 154.16 66.53 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.62 2.213 . . . . 0.0 112.247 179.899 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.9 m -145.65 148.62 17.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.833 -179.781 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.2 mtm-85 -75.65 134.83 40.5 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.158 179.531 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 90.0 mt -89.7 134.02 34.37 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.138 0.495 . . . . 0.0 111.161 -179.677 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -125.1 156.62 37.99 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.052 179.143 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.414 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 4.2 t60 -54.1 120.02 5.87 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.546 -0.461 . . . . 0.0 111.089 -178.701 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.07 -15.65 28.11 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 179.797 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.648 ' OD1' HG13 ' A' ' 71' ' ' VAL . 59.1 t0 -65.41 128.21 34.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.882 0.372 . . . . 0.0 110.422 179.988 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.53 HG22 ' HG2' ' A' ' 96' ' ' ARG . 53.6 t -112.13 130.93 64.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.291 -179.382 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.7 mt -101.64 134.02 43.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.383 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 76.9 m -124.33 129.22 50.34 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -178.53 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.585 ' O ' ' N ' ' A' ' 92' ' ' ASP . 95.0 mt -112.18 126.67 69.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 114.516 -1.22 . . . . 0.0 108.159 177.57 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.527 HG23 ' SG ' ' B' ' 237' ' ' CYS . 45.4 mm 40.19 -92.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 C-N-CA 120.269 -0.572 . . . . 0.0 109.716 -179.257 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.585 ' N ' ' O ' ' A' ' 90' ' ' ILE . 0.7 OUTLIER -129.43 20.48 5.69 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.928 0.395 . . . . 0.0 110.87 179.732 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.717 ' HE ' HH12 ' B' ' 245' ' ' ARG . 98.5 mtt180 -124.31 142.09 51.54 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.326 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 75.6 m -137.55 151.36 48.31 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.203 -179.725 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.455 ' HE1' HD12 ' A' ' 90' ' ' ILE . 62.6 m-85 -121.95 122.33 39.13 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.534 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.53 ' HG2' HG22 ' A' ' 87' ' ' VAL . 98.2 mtt180 -84.95 133.96 34.26 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 119.638 -0.825 . . . . 0.0 111.375 -178.581 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -95.8 120.08 35.43 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.158 179.532 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -122.31 119.67 31.8 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.263 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.414 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 64.8 t-20 . . . . . 0 C--N 1.326 -0.453 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.333 179.7 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo . . . . . 0 N--CA 1.486 1.05 0 CA-C-O 120.933 0.306 . . . . 0.0 111.607 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 4.9 p -116.85 132.75 65.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.328 -179.664 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . 0.527 ' SG ' HG23 ' A' ' 91' ' ' ILE . 45.9 t . . . . . 0 N--CA 1.465 0.294 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.532 -179.256 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo . . . . . 0 N--CA 1.498 1.736 0 N-CA-C 113.53 0.55 . . . . 0.0 113.53 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 5.2 p -73.29 -41.6 63.39 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.026 -0.669 . . . . 0.0 109.305 178.28 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.445 ' HZ ' HD22 ' A' ' 41' ' ' LEU . 57.9 t80 -58.24 -46.65 85.56 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.12 -179.524 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.424 ' HA ' HD23 ' B' ' 242' ' ' LEU . 94.4 mt -62.79 -40.45 97.35 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.605 -179.674 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -63.9 -37.37 87.14 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.271 179.545 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -62.4 -41.75 98.91 Favored 'General case' 0 C--N 1.334 -0.1 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.488 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.841 ' O ' HG23 ' B' ' 249' ' ' VAL . 60.9 ttm-85 -58.07 -44.19 87.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.006 -179.495 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -63.33 -40.4 97.22 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.029 0.442 . . . . 0.0 110.759 -179.475 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 41.8 m -69.0 -46.13 68.81 Favored 'General case' 0 C--N 1.334 -0.104 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.65 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . 0.771 ' NE2' HH12 ' A' ' 12' ' ' ARG . 59.5 tt0 -61.78 -36.94 82.52 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.818 -179.55 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . 0.841 HG23 ' O ' ' B' ' 245' ' ' ARG . 75.4 t . . . . . 0 N--CA 1.453 -0.288 0 C-N-CA 120.257 -0.577 . . . . 0.0 109.513 179.42 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.637 ' OE1' ' NH2' ' A' ' 93' ' ' ARG . 95.1 mt-10 . . . . . 0 N--CA 1.462 0.137 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 79.4 mt -106.78 132.31 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 177.589 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 47.6 t -126.4 133.09 69.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 120.904 0.383 . . . . 0.0 111.014 -179.15 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -97.88 124.13 42.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.12 -179.297 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -69.36 -45.42 69.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.261 179.457 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . 0.431 HE22 ' HB3' ' A' ' 23' ' ' SER . 0.0 OUTLIER -93.22 155.79 40.73 Favored Pre-proline 0 CA--C 1.521 -0.16 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.201 -179.428 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.85 144.26 70.18 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 122.584 2.189 . . . . 0.0 113.052 -179.664 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 45.0 pt . . . . . 0 C--N 1.331 -0.206 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.87 178.835 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.0 p . . . . . 0 CA--C 1.521 -0.156 0 CA-C-O 120.976 0.417 . . . . 0.0 110.505 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.3 mtt85 -100.12 123.42 44.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.171 -179.616 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -130.01 144.35 51.29 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.685 -179.84 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 83.9 mt -113.18 135.45 53.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.392 179.045 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.6 m -110.79 132.06 60.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-O 120.95 0.405 . . . . 0.0 110.019 179.254 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.7 m -79.97 142.53 34.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.495 -0.775 . . . . 0.0 113.044 -178.193 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.478 HD12 ' HB3' ' A' ' 94' ' ' SER . 96.5 mt -112.15 136.67 47.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.024 176.611 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -90.32 158.94 16.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.842 0.353 . . . . 0.0 110.432 179.754 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -58.45 -30.92 67.3 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.088 -178.875 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.3 p -76.44 -11.58 59.91 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.199 179.594 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.08 35.57 6.02 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -179.635 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 54.0 t -120.14 132.04 70.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.935 0.398 . . . . 0.0 110.816 -179.81 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -81.21 138.41 35.81 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.805 179.624 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -133.42 -116.15 1.68 Allowed Glycine 0 CA--C 1.538 1.517 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.124 -179.718 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.36 153.1 61.35 Favored 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 122.473 2.116 . . . . 0.0 112.849 -178.83 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -116.04 161.68 18.52 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.604 -179.832 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.509 ' CD2' HD11 ' A' ' 37' ' ' ILE . 34.2 t80 -122.88 91.84 49.5 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.417 -179.563 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -59.96 127.63 23.96 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 121.957 1.772 . . . . 0.0 110.564 179.346 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.6 mt -82.02 57.56 3.56 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.566 -0.454 . . . . 0.0 111.233 -179.002 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 89.8 p -67.84 -22.97 65.12 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.576 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 80.2 mt -83.63 138.9 33.13 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.233 179.79 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 92.9 p -64.22 -18.09 64.19 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.03 -179.48 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.495 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 88.0 m -134.37 134.82 42.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.985 179.91 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.666 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 1.4 t -128.21 118.11 22.75 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.235 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.5 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 40.8 tp -117.47 128.73 55.27 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.22 -177.699 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.783 ' CE2' HD12 ' A' ' 37' ' ' ILE . 19.8 m-85 -104.89 135.8 45.57 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.657 179.045 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 164.22 178.62 37.86 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 120.283 -0.961 . . . . 0.0 112.778 179.034 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.424 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 42.3 mtm180 -75.44 -31.1 60.2 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.903 0.382 . . . . 0.0 110.503 178.654 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -50.48 144.86 10.58 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.19 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.455 HG23 ' N ' ' A' ' 34' ' ' GLU . 8.6 tp -66.92 -41.05 87.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.908 -179.585 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.455 ' N ' HG23 ' A' ' 33' ' ' ILE . 84.8 tt0 -58.03 -20.83 41.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.869 0.366 . . . . 0.0 110.813 -179.92 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 62.4 m -57.63 131.52 50.48 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.878 -179.512 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.5 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 56.0 m-20 -60.25 -33.56 72.47 Favored 'General case' 0 C--N 1.334 -0.097 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -178.781 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.783 HD12 ' CE2' ' A' ' 29' ' ' PHE . 84.8 mt -126.12 123.8 64.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 176.65 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.493 HH21 HG11 ' B' ' 262' ' ' VAL . 84.2 mtm-85 -105.45 135.04 47.58 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.439 -0.505 . . . . 0.0 110.609 -178.246 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 95.8 mt -118.78 131.02 72.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 120.304 -0.559 . . . . 0.0 111.36 -179.82 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -75.45 32.26 0.11 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.52 -0.763 . . . . 0.0 112.318 -178.794 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.72 HD21 ' OE1' ' B' ' 260' ' ' GLU . 61.0 mt -106.18 127.07 29.02 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.65 179.378 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.33 -8.49 22.79 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 122.406 2.071 . . . . 0.0 113.117 -179.42 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.5 m -95.38 6.77 7.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.39 179.737 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.424 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 36.1 t -96.86 135.36 31.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.331 179.475 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.493 ' HB2' ' H ' ' A' ' 48' ' ' HIS . 4.1 m -73.02 173.68 8.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.205 -178.883 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -63.02 -40.35 97.49 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.819 179.476 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.64 ' O ' ' N ' ' A' ' 49' ' ' CYS . 9.8 mm100 -113.24 -23.3 10.02 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.974 -0.291 . . . . 0.0 110.519 -179.712 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.493 ' H ' ' HB2' ' A' ' 45' ' ' SER . 20.4 t60 43.58 -77.69 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.894 -179.735 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.64 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -134.03 136.97 44.41 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.991 -179.517 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -125.77 133.13 52.16 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.485 179.75 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 98.6 mt -115.98 131.43 68.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.058 179.945 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.587 ' OE2' ' NE2' ' A' ' 54' ' ' HIS . 79.4 tt0 -118.11 125.73 50.85 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.765 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 86.2 mt -108.06 123.17 63.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.896 0.855 . . . . 0.0 112.992 -177.826 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.587 ' NE2' ' OE2' ' A' ' 52' ' ' GLU . 98.5 m-70 -117.57 136.92 52.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 113.989 -1.459 . . . . 0.0 109.056 178.902 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 54' ' ' HIS . 96.2 mt-10 -41.18 -32.23 0.26 Allowed 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.156 -0.617 . . . . 0.0 109.89 -179.571 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -64.22 -67.93 0.39 Allowed 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.291 -0.564 . . . . 0.0 109.893 179.224 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.569 ' CG ' ' H ' ' A' ' 58' ' ' ALA . 52.9 tt0 -150.56 -179.35 7.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.863 -178.593 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.569 ' H ' ' CG ' ' A' ' 57' ' ' GLU . . . -108.83 131.86 54.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.052 -179.697 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.8 mt -119.85 129.5 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -178.33 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.487 HD11 ' SG ' ' A' ' 49' ' ' CYS . 38.6 tp -97.39 129.03 44.67 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.041 -0.982 . . . . 0.0 110.051 179.47 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -115.92 136.32 53.15 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 179.595 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.628 HD21 ' CB ' ' A' ' 68' ' ' PRO . 62.7 t-20 -100.32 105.24 16.74 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 120.965 0.412 . . . . 0.0 111.134 -179.477 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -97.52 -9.57 26.85 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.229 179.855 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.87 98.55 7.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.021 0.438 . . . . 0.0 110.271 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.4 t -76.27 -42.65 44.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.844 179.396 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.405 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.3 OUTLIER -61.28 -45.43 94.52 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.293 -178.68 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.41 HD21 ' HA ' ' B' ' 236' ' ' VAL . 37.2 m-80 -139.36 94.84 9.4 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 115.503 -0.771 . . . . 0.0 108.958 -179.503 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.628 ' CB ' HD21 ' A' ' 62' ' ' ASN . 35.6 Cg_endo -64.86 150.52 88.01 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 121.528 1.485 . . . . 0.0 112.507 -178.173 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.8 m -73.01 142.11 47.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.7 -178.883 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -99.51 148.04 24.68 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.788 179.84 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.407 ' O ' HG13 ' A' ' 71' ' ' VAL . 5.6 p -132.61 135.47 57.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.239 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 50.85 33.02 7.91 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.455 -179.861 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.69 27.69 70.5 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -179.442 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 10.4 t -138.12 139.42 39.43 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.462 -179.501 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 77.8 t -69.22 134.0 30.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.031 0.443 . . . . 0.0 111.636 -179.715 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.16 95.58 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.482 179.266 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -81.92 -16.62 49.95 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.666 -179.209 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -110.01 156.91 39.21 Favored Pre-proline 0 C--O 1.222 -0.372 0 C-N-CA 121.099 -0.241 . . . . 0.0 110.481 -179.733 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -64.57 145.98 88.26 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.369 2.046 . . . . 0.0 112.669 -179.807 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.9 m -147.61 148.08 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.106 -179.463 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 91.2 mtm180 -73.97 132.36 42.33 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.403 179.391 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 82' ' ' LEU . 77.8 mt -79.39 141.2 37.09 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.996 0.427 . . . . 0.0 111.417 179.693 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -132.75 151.29 52.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.775 179.55 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.536 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 5.5 t60 -56.23 116.82 3.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.024 -179.801 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.92 -14.32 26.55 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.061 179.235 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -74.48 134.97 42.26 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.229 179.867 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.47 HG22 ' HG2' ' A' ' 96' ' ' ARG . 59.0 t -108.07 132.13 56.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.749 -178.891 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 88.8 mt -104.99 131.87 53.12 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.769 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 65.2 m -120.78 130.01 53.83 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 119.745 -0.782 . . . . 0.0 112.778 -177.96 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.597 ' O ' ' N ' ' A' ' 93' ' ' ARG . 96.6 mt -114.58 131.19 67.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 114.29 -1.323 . . . . 0.0 108.611 178.335 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.677 HG22 HH22 ' B' ' 245' ' ' ARG . 95.6 mt -20.38 95.26 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -179.565 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.554 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 10.5 t0 90.42 -23.55 0.09 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 178.084 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.597 ' N ' ' O ' ' A' ' 90' ' ' ILE . 88.2 mtt-85 -130.0 147.02 51.71 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.03 -179.621 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.478 ' HB3' HD12 ' A' ' 10' ' ' ILE . 38.7 t -139.1 152.27 47.37 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.384 0.611 . . . . 0.0 110.598 -179.911 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.568 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 91.2 m-85 -125.07 121.36 34.08 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.649 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.47 ' HG2' HG22 ' A' ' 87' ' ' VAL . 99.9 mtt180 -87.51 140.27 29.69 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 119.453 -0.899 . . . . 0.0 109.976 -179.561 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -96.65 123.17 40.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.031 -178.292 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -126.03 120.77 31.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.781 179.711 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.536 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 64.4 t-20 . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.259 179.817 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo . . . . . 0 N--CA 1.489 1.244 0 N-CA-C 113.722 0.624 . . . . 0.0 113.722 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.41 ' HA ' HD21 ' A' ' 67' ' ' ASN . 50.1 t -64.42 132.46 30.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.036 179.231 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.324 -0.511 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.063 -179.693 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo . . . . . 0 N--CA 1.499 1.835 0 N-CA-C 113.009 0.35 . . . . 0.0 113.009 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 86.0 m -74.84 -45.99 39.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.949 0.404 . . . . 0.0 110.881 179.234 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.641 ' CE2' ' CZ ' ' B' ' 245' ' ' ARG . 57.2 t80 -58.37 -48.31 81.0 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.033 -178.31 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.451 HD23 ' NH2' ' B' ' 245' ' ' ARG . 44.7 mt -64.73 -42.62 95.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.252 0.548 . . . . 0.0 110.757 179.681 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -62.99 -43.09 99.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.016 -178.72 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -61.55 -45.56 93.65 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.692 -179.041 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.677 HH22 HG22 ' A' ' 91' ' ' ILE . 89.7 mtm180 -63.86 -37.05 85.96 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.904 -178.771 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.7 -39.7 92.42 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.305 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 70.2 m -63.49 -44.09 95.38 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.606 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 93.9 mm-40 -61.11 -37.11 81.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.281 -179.779 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 47.1 t . . . . . 0 C--N 1.327 -0.39 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.914 179.792 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.72 ' OE1' HD21 ' A' ' 41' ' ' LEU . 95.5 mt-10 . . . . . 0 CA--C 1.523 -0.085 0 CA-C-O 121.446 0.641 . . . . 0.0 109.694 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.568 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 82.6 mt -115.91 133.55 61.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.79 179.951 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . 0.493 HG11 HH21 ' A' ' 38' ' ' ARG . 55.0 t -126.6 133.13 69.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.979 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -96.12 121.95 38.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.204 0.526 . . . . 0.0 111.219 -178.53 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . 0.443 ' CB ' ' O ' ' A' ' 36' ' ' ASP . 87.6 tttt -63.78 -43.45 96.34 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.477 179.551 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.24 160.14 31.37 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.327 -179.398 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -61.17 145.42 98.74 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.686 2.257 . . . . 0.0 111.031 178.464 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . 0.868 ' O ' HD13 ' B' ' 267' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.49 0 C-N-CA 120.151 -0.62 . . . . 0.0 111.28 -179.415 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.55 ' O ' ' O ' ' A' ' 99' ' ' ASN . 2.4 t . . . . . 0 N--CA 1.474 0.743 0 CA-C-O 120.6 0.238 . . . . 0.0 110.592 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.499 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 92.9 mtt-85 -86.08 130.54 34.5 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.635 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -135.0 142.38 46.43 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.536 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.8 mt -111.7 132.74 54.41 Favored 'General case' 0 CA--C 1.523 -0.076 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.29 179.405 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.6 t -109.01 125.89 66.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.988 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.1 m -77.17 140.94 40.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.679 -178.779 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.554 HD12 ' HB2' ' A' ' 94' ' ' SER . 97.3 mt -110.27 135.19 50.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.125 178.578 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.404 ' HA ' HH12 ' A' ' 93' ' ' ARG . 81.7 mttt -90.68 159.51 16.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.202 0.525 . . . . 0.0 110.947 -179.809 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.607 HH11 ' NH1' ' B' ' 245' ' ' ARG . 91.1 mtm180 -56.95 -29.35 63.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.601 -178.546 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.3 p -81.44 -8.49 59.74 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.279 -179.734 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.29 33.27 7.74 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 179.676 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.7 t -120.38 134.7 63.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.572 0.225 . . . . 0.0 111.518 -179.59 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -72.4 136.4 46.07 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.105 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -124.84 -119.41 2.39 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.679 -179.893 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.62 148.3 36.93 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 122.52 2.147 . . . . 0.0 113.318 -178.989 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -109.55 138.31 46.1 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.515 179.853 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.721 ' CD2' HD11 ' A' ' 37' ' ' ILE . 29.9 t80 -111.54 104.04 55.69 Favored Pre-proline 0 N--CA 1.469 0.477 0 N-CA-C 110.056 -0.349 . . . . 0.0 110.056 -179.746 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -76.15 138.43 20.34 Favored 'Trans proline' 0 N--CA 1.489 1.235 0 C-N-CA 121.949 1.766 . . . . 0.0 112.217 -179.133 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.431 HD22 ' HB2' ' A' ' 27' ' ' CYS . 93.4 mt -88.83 92.06 9.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.143 0.497 . . . . 0.0 111.106 -178.878 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 88.6 p -93.55 -8.07 42.36 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.728 179.017 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 67.3 mt -109.58 150.07 28.74 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.859 -179.424 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.9 m -68.97 -16.39 63.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.734 0.302 . . . . 0.0 111.311 -179.148 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 78.4 m -128.59 132.01 48.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.058 0.456 . . . . 0.0 111.464 -179.766 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.631 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 5.2 t -128.1 119.19 24.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.451 178.816 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.573 HD12 ' O ' ' A' ' 49' ' ' CYS . 31.6 tp -117.68 130.34 56.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.41 -178.496 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.751 ' CE2' HD12 ' A' ' 37' ' ' ILE . 17.5 m-85 -107.72 137.23 46.1 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.666 179.441 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 156.91 -177.48 33.79 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 120.384 -0.912 . . . . 0.0 112.425 178.899 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.405 ' HD2' HH11 ' A' ' 31' ' ' ARG . 46.3 mtm180 -74.91 -32.55 61.84 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.581 0.229 . . . . 0.0 111.48 179.202 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.489 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -53.04 145.68 20.58 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.264 -178.514 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.51 HG23 ' N ' ' A' ' 34' ' ' GLU . 11.1 tp -66.36 -41.93 89.71 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-O 120.856 0.36 . . . . 0.0 110.204 179.873 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.51 ' N ' HG23 ' A' ' 33' ' ' ILE . 49.9 tp10 -52.3 -22.1 4.16 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.605 179.511 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.489 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 9.9 m -65.46 126.03 26.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.064 -179.791 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -57.67 -27.5 62.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.023 -179.551 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.751 HD12 ' CE2' ' A' ' 29' ' ' PHE . 78.7 mt -130.26 123.71 56.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.484 178.295 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 75.2 mtm180 -101.61 135.33 43.31 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.317 179.979 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.589 HG21 HD12 ' A' ' 41' ' ' LEU . 97.3 mt -117.56 129.58 73.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.131 0.491 . . . . 0.0 109.97 179.068 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -74.24 29.1 0.08 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.205 -178.952 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.589 HD12 HG21 ' A' ' 39' ' ' ILE . 26.9 mt -93.72 121.36 64.75 Favored Pre-proline 0 CA--C 1.533 0.303 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.204 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.4 -8.45 20.73 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 121.779 1.653 . . . . 0.0 111.676 -179.642 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 m -102.53 9.88 8.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.906 -179.981 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.415 HG12 ' O ' ' A' ' 45' ' ' SER . 10.9 t -96.59 141.36 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 121.077 0.465 . . . . 0.0 110.595 179.324 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.415 ' O ' HG12 ' A' ' 44' ' ' VAL . 12.8 m -71.64 165.59 23.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.517 -179.24 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -62.17 -40.83 97.34 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.665 -179.426 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.634 ' O ' ' N ' ' A' ' 49' ' ' CYS . 85.7 mt-30 -113.59 -25.0 8.93 Favored 'General case' 0 C--O 1.226 -0.133 0 CA-C-O 121.102 0.477 . . . . 0.0 110.27 -179.907 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.8 t60 37.08 -76.01 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 179.405 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.634 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -127.34 133.54 50.07 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.243 0.544 . . . . 0.0 112.187 -178.128 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -130.88 129.18 41.95 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.051 179.993 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 94.4 mt -113.07 133.8 57.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.561 179.842 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -118.94 126.96 52.98 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.641 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.2 mt -104.67 113.72 42.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.049 -0.66 . . . . 0.0 111.215 -179.398 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.559 ' O ' ' N ' ' A' ' 56' ' ' GLN . 95.3 m-70 -113.4 145.4 41.19 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.569 179.789 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 54' ' ' HIS . 77.3 tt0 -39.85 -24.59 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -179.694 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.559 ' N ' ' O ' ' A' ' 54' ' ' HIS . 87.0 mt-30 -71.14 -68.69 0.42 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.222 178.9 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.496 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 2.5 tp10 -158.62 -169.17 2.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.234 0.54 . . . . 0.0 111.025 -178.962 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -105.71 121.89 44.94 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 177.961 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.7 mt -114.66 129.42 70.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.223 0.535 . . . . 0.0 112.093 -178.443 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 29.5 tp -96.64 127.48 42.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.47 179.706 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -112.01 135.32 52.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.857 0.36 . . . . 0.0 110.404 -179.821 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.473 HD21 ' HA ' ' A' ' 68' ' ' PRO . 10.7 t-20 -93.46 106.5 18.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.635 -179.847 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -98.38 -12.57 21.29 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.72 179.056 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 t -73.98 100.51 3.58 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.204 179.749 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.2 p -86.09 -20.76 28.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.897 0.38 . . . . 0.0 110.761 179.768 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.607 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -85.62 -44.65 12.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.213 -179.612 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.404 ' OD1' HG13 ' B' ' 236' ' ' VAL . 22.5 m-80 -135.1 94.17 16.3 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.175 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.473 ' HA ' HD21 ' A' ' 62' ' ' ASN . 41.7 Cg_exo -55.38 145.11 69.31 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.393 2.062 . . . . 0.0 113.57 -178.435 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.469 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 53.1 m -74.03 142.59 45.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.332 179.176 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -104.6 140.97 37.24 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.663 179.765 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.711 HG13 ' OD1' ' A' ' 86' ' ' ASP . 53.0 t -128.52 131.46 68.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.83 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 51.09 32.03 7.26 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.149 -0.621 . . . . 0.0 109.489 -179.06 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.56 26.33 67.9 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.861 179.749 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.9 p -136.78 133.93 36.5 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 122.451 -0.44 . . . . 0.0 111.061 -179.989 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -68.03 138.12 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.494 179.821 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.9 pt -116.28 92.34 2.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.659 179.729 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -68.2 -20.89 64.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.075 0.464 . . . . 0.0 109.841 178.933 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.86 168.2 11.96 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.726 -179.533 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.65 152.43 69.9 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.778 2.319 . . . . 0.0 112.255 179.601 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.4 p -143.09 145.11 23.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.866 -179.742 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.8 mtm-85 -73.24 128.16 34.7 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.483 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 82' ' ' LEU . 95.7 mt -80.4 137.37 36.52 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.203 -179.345 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -130.6 153.42 48.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.429 179.767 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -58.17 118.87 5.93 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.011 0.434 . . . . 0.0 110.505 -179.542 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.59 -7.24 26.22 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.746 -0.941 . . . . 0.0 110.746 -179.472 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.711 ' OD1' HG13 ' A' ' 71' ' ' VAL . 52.2 t0 -81.12 123.85 28.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.092 0.472 . . . . 0.0 110.365 179.792 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 42.9 t -104.05 134.17 46.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.648 -179.162 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.1 mt -103.32 129.94 54.39 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 178.104 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.434 HG23 ' OG ' ' A' ' 94' ' ' SER . 29.4 m -119.08 128.09 53.99 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.531 0.682 . . . . 0.0 111.832 -178.616 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.459 HD12 ' HE1' ' A' ' 95' ' ' PHE . 94.6 mt -118.1 125.29 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.954 179.295 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.411 ' C ' ' O ' ' A' ' 90' ' ' ILE . 38.2 mm 38.36 -105.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.991 -179.117 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.54 ' CG ' ' NE ' ' B' ' 245' ' ' ARG . 1.1 p30 -108.24 12.07 26.84 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -178.808 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.625 ' HE ' HD11 ' B' ' 261' ' ' ILE . 53.4 mtp85 -132.91 147.9 52.29 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.068 179.616 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.554 ' HB2' HD12 ' A' ' 10' ' ' ILE . 38.1 m -138.8 158.27 44.53 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.233 -179.064 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.463 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 78.9 m-85 -125.89 122.95 37.53 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.354 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 79.4 mtp85 -81.35 135.53 35.69 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.491 179.471 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.499 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 80.6 t80 -95.15 122.07 37.44 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.997 179.952 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -134.64 119.96 18.97 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.999 -179.257 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.55 ' O ' ' O ' ' A' ' 4' ' ' THR . 91.9 m-20 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.758 179.381 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo . . . . . 0 N--CA 1.49 1.295 0 CA-C-O 121.467 0.528 . . . . 0.0 112.944 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.607 ' CG2' HG22 ' A' ' 66' ' ' THR . 74.3 t -76.22 132.72 32.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.898 -179.381 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 37.5 t . . . . . 0 C--N 1.331 -0.22 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.776 -179.728 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo . . . . . 0 N--CA 1.499 1.795 0 N-CA-C 113.189 0.419 . . . . 0.0 113.189 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 21.8 m -73.18 -45.58 55.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.261 0.553 . . . . 0.0 109.89 178.829 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -58.59 -47.23 85.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.362 -179.381 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' B' ' 242' ' ' LEU . 98.8 mt -66.53 -39.79 88.78 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.832 0.348 . . . . 0.0 111.251 -179.805 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 51.5 tp10 -62.87 -45.09 94.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.171 -179.372 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -62.09 -40.8 97.08 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.258 0.552 . . . . 0.0 109.915 179.807 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.607 ' NH1' HH11 ' A' ' 12' ' ' ARG . 56.2 ttm-85 -60.13 -42.98 95.99 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.423 -179.229 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -62.23 -38.46 89.3 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.563 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 47.8 t -64.8 -44.21 90.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.433 177.849 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -60.94 -36.32 79.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.344 179.933 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 22.3 t . . . . . 0 N--CA 1.454 -0.228 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.932 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 . . . . . 0 N--CA 1.463 0.224 0 CA-C-O 121.223 0.535 . . . . 0.0 110.065 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.625 HD11 ' HE ' ' A' ' 93' ' ' ARG . 58.6 mt -115.3 147.22 18.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.73 179.52 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 78.7 t -128.91 136.38 59.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.39 179.468 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -98.18 120.92 39.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.259 0.552 . . . . 0.0 111.567 -178.74 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -68.55 -46.2 70.11 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.783 -179.684 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -96.37 176.65 2.05 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.055 -178.715 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -59.54 146.13 96.02 Favored 'Trans proline' 0 N--CA 1.5 1.879 0 C-N-CA 122.644 2.229 . . . . 0.0 113.252 -178.938 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 1.1 tt . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.451 -179.829 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.4 p . . . . . 0 N--CA 1.462 0.164 0 CA-C-O 120.609 0.242 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.2 mtt85 -97.2 127.23 42.98 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.783 -178.679 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 94.5 mtm-85 -129.6 135.44 48.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.993 179.816 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.595 HD11 ' HB3' ' A' ' 95' ' ' PHE . 39.9 tp -108.79 134.11 51.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.301 -179.47 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 54.9 t -114.98 130.7 69.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.128 -179.704 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.1 m -79.51 142.29 35.93 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.81 -179.605 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.622 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 90.0 mt -109.32 135.51 48.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.39 -0.823 . . . . 0.0 108.857 177.769 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.68 ' CA ' HH22 ' A' ' 93' ' ' ARG . 97.4 mttt -87.25 153.68 21.3 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.766 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.581 ' NH1' ' OE2' ' B' ' 260' ' ' GLU . 88.8 mtm180 -58.11 -23.81 56.33 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.414 -0.515 . . . . 0.0 110.474 -179.357 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.0 m -80.38 -10.72 59.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.385 179.524 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.67 30.28 9.19 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 179.644 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.9 t -121.21 132.12 71.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.795 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -73.55 140.01 46.01 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.362 179.418 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -122.42 -121.46 2.72 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 121.031 -0.604 . . . . 0.0 111.916 -179.041 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.05 149.74 53.16 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 122.094 1.863 . . . . 0.0 112.489 -179.059 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.56 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -109.95 140.44 43.94 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.925 -179.092 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.565 ' CD2' HD11 ' A' ' 37' ' ' ILE . 33.9 t80 -112.86 104.71 55.97 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.614 -178.807 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -72.63 131.36 17.2 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.103 1.202 . . . . 0.0 111.579 -178.488 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 92.2 mt -86.21 48.68 1.65 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.926 -178.189 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.6 p -65.33 -22.31 66.8 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.918 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.8 mt -80.28 141.47 35.49 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.018 179.965 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.7 m -62.48 -21.6 65.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.985 -179.206 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 74.7 m -138.15 135.77 36.04 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.693 -179.404 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.0 t -126.73 122.09 33.87 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 177.888 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.65 HD21 ' HG2' ' A' ' 47' ' ' GLN . 44.1 tp -118.01 127.35 53.72 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.104 0.478 . . . . 0.0 111.163 -178.386 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.763 ' CE2' HD12 ' A' ' 37' ' ' ILE . 9.3 m-85 -105.36 132.45 51.53 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.904 179.83 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.79 -175.93 39.13 Favored Glycine 0 N--CA 1.467 0.749 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.158 179.425 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.601 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 78.9 mtm-85 -77.73 -30.12 51.51 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.873 0.368 . . . . 0.0 110.338 179.262 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -50.62 149.2 6.78 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.923 -0.471 . . . . 0.0 111.923 -178.208 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.472 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.9 tp -67.05 -40.57 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.458 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.472 ' N ' HG23 ' A' ' 33' ' ' ILE . 96.5 mt-10 -57.2 -25.4 58.98 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.885 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.439 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 47.7 m -53.59 118.41 3.88 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.995 179.824 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.468 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 55.3 m-20 -58.56 -28.26 65.35 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.155 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.763 HD12 ' CE2' ' A' ' 29' ' ' PHE . 90.4 mt -129.0 124.62 61.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 176.494 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -107.72 136.6 47.19 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.636 -178.61 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.407 HG23 ' O ' ' B' ' 260' ' ' GLU . 92.5 mt -118.0 130.31 73.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 179.501 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -73.44 30.54 0.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.441 -177.747 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.42 ' HA ' HD23 ' A' ' 41' ' ' LEU . 82.3 mt -100.85 127.85 31.23 Favored Pre-proline 0 C--N 1.326 -0.417 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.521 179.865 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.24 -8.09 20.49 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 122.267 1.978 . . . . 0.0 111.77 179.636 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.558 HG23 HD13 ' A' ' 91' ' ' ILE . 16.4 m -100.21 6.37 9.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.008 -179.776 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.601 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 9.4 t -97.25 138.0 23.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 179.151 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.7 m -68.75 165.16 20.15 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.502 0.668 . . . . 0.0 111.496 -178.882 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.439 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 9.6 mtmt -61.94 -40.06 94.21 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.825 -179.459 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.65 ' HG2' HD21 ' A' ' 28' ' ' LEU . 85.8 mt-30 -118.06 -20.28 8.75 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.91 0.386 . . . . 0.0 111.322 179.742 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 33.7 t60 32.57 -73.97 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 178.887 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.639 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -124.83 131.52 53.43 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.157 0.503 . . . . 0.0 112.213 -178.305 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -126.82 127.89 45.7 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.229 179.914 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.1 mt -113.48 131.13 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.532 179.883 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.569 ' OE2' ' NE2' ' A' ' 54' ' ' HIS . 81.2 tt0 -118.34 128.06 54.29 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.742 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 88.6 mt -106.87 117.14 52.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 121.597 0.713 . . . . 0.0 112.19 -178.017 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.569 ' NE2' ' OE2' ' A' ' 52' ' ' GLU . 96.6 m-70 -112.24 141.11 46.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.628 179.759 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 54' ' ' HIS . 96.9 mt-10 -40.44 -29.92 0.1 Allowed 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.381 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' ' 54' ' ' HIS . 89.0 mt-30 -67.33 -67.1 0.48 Allowed 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.461 178.654 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.531 ' OE1' ' N ' ' A' ' 58' ' ' ALA . 1.3 mm-40 -155.49 -177.28 6.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.486 0.66 . . . . 0.0 112.212 -178.263 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.531 ' N ' ' OE1' ' A' ' 57' ' ' GLU . . . -106.38 118.85 37.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.456 178.585 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 94.2 mt -110.63 131.57 61.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.541 0.686 . . . . 0.0 111.804 -178.775 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 23.8 tp -98.99 128.69 45.19 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.59 179.519 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -115.27 135.84 53.73 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.021 -179.773 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.666 ' ND2' ' H ' ' A' ' 69' ' ' THR . 13.4 t-20 -97.76 108.49 21.22 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.423 179.859 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -96.82 -8.06 32.02 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.649 179.413 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 6.7 t -71.19 97.83 1.6 Allowed 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.343 179.808 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.0 m -74.15 -43.29 57.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.292 0.568 . . . . 0.0 110.068 178.819 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.531 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.3 OUTLIER -65.04 -43.23 93.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.808 -178.82 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.427 ' O ' ' OG ' ' A' ' 64' ' ' SER . 36.7 m-20 -140.16 99.95 7.2 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.189 -179.386 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.507 ' HB2' HG13 ' A' ' 75' ' ' VAL . 44.0 Cg_exo -56.77 146.29 78.55 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 122.281 1.987 . . . . 0.0 112.871 -179.593 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.666 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 10.3 m -75.28 142.6 43.28 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.419 179.391 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -104.65 138.44 40.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.64 179.694 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 72.2 t -128.74 134.14 65.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.464 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 52.4 34.86 16.0 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.346 -179.425 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.86 26.47 69.07 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.541 179.212 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 41.8 m -146.46 141.29 26.95 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 117.563 0.681 . . . . 0.0 112.031 179.93 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.507 HG13 ' HB2' ' A' ' 68' ' ' PRO . 6.9 t -68.56 138.11 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.454 179.764 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.5 pt -113.48 89.09 1.23 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-O 121.158 0.504 . . . . 0.0 111.147 178.739 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -65.51 -27.2 68.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.567 179.114 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -120.01 166.08 16.08 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.067 -179.723 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.76 144.32 99.47 Favored 'Trans proline' 0 N--CA 1.501 1.936 0 C-N-CA 122.581 2.187 . . . . 0.0 112.197 -179.72 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.5 m -136.92 138.25 46.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.999 179.767 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.9 mtm180 -73.25 132.74 43.5 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.259 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.1 mt -81.5 133.79 35.44 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.113 -179.051 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -125.88 149.57 48.59 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.834 179.96 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -52.6 112.51 0.84 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.156 0.503 . . . . 0.0 111.062 -179.268 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.6 -11.43 25.69 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.799 179.233 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -70.36 132.48 45.71 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 117.289 0.545 . . . . 0.0 110.679 -179.823 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.0 t -108.16 132.69 55.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.929 -178.877 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.7 mt -104.32 130.92 54.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.759 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 87.0 m -122.8 123.59 41.39 Favored 'General case' 0 CA--C 1.523 -0.086 0 CA-C-O 121.628 0.728 . . . . 0.0 112.003 -178.83 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.549 ' O ' ' N ' ' A' ' 93' ' ' ARG . 78.9 mt -110.91 123.93 67.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.658 178.852 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.558 HD13 HG23 ' A' ' 43' ' ' VAL . 96.8 mt 31.78 -95.63 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.896 179.044 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 92' ' ' ASP . 24.1 p-10 -114.29 7.51 16.47 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.517 -179.763 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.68 HH22 ' CA ' ' A' ' 11' ' ' LYS . 1.7 mmp_? -119.41 137.22 53.9 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.651 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 44.9 t -138.26 150.17 46.42 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.234 179.951 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.595 ' HB3' HD11 ' A' ' 7' ' ' LEU . 83.4 m-85 -129.22 134.14 47.85 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.839 179.581 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.416 ' O ' HD12 ' A' ' 7' ' ' LEU . 39.5 ttm180 -95.05 134.05 38.16 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.353 -179.406 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -93.51 121.54 35.03 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.914 -179.541 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -134.41 127.39 31.48 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 120.453 -0.499 . . . . 0.0 112.071 -179.915 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 . . . . . 0 C--N 1.333 -0.118 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.875 179.395 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo . . . . . 0 N--CA 1.486 1.076 0 CA-C-O 121.782 0.659 . . . . 0.0 112.662 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.531 ' CG2' HG22 ' A' ' 66' ' ' THR . 30.5 t -64.86 131.42 30.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 114.429 -1.26 . . . . 0.0 109.856 -179.76 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 2.0 t . . . . . 0 C--N 1.327 -0.379 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.88 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo . . . . . 0 N--CA 1.5 1.867 0 CA-C-O 120.695 0.206 . . . . 0.0 112.208 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 23.6 m -73.29 -44.11 59.75 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.818 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.703 ' CD1' ' NH2' ' B' ' 245' ' ' ARG . 77.2 t80 -57.57 -46.41 84.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.839 -179.63 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 91.6 mt -63.09 -40.65 98.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.424 0.63 . . . . 0.0 110.143 -179.945 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -62.4 -41.41 98.64 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.158 -179.663 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . 0.43 ' O ' ' OG ' ' B' ' 247' ' ' SER . 94.4 mtt-85 -61.44 -43.16 99.36 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.882 0.372 . . . . 0.0 111.039 -179.465 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.703 ' NH2' ' CD1' ' B' ' 241' ' ' PHE . 0.3 OUTLIER -61.24 -38.27 86.04 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.834 -179.921 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.11 -39.13 91.46 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.492 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . 0.43 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 64.5 p -68.81 -41.41 78.7 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.293 178.164 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -58.86 -38.57 79.07 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.899 179.014 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 48.5 t . . . . . 0 N--CA 1.451 -0.411 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.003 179.297 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.581 ' OE2' ' NH1' ' A' ' 12' ' ' ARG . 98.7 mt-10 . . . . . 0 CA--C 1.537 0.475 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.495 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 80.1 mt -115.58 134.71 57.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.422 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 40.3 t -127.69 132.87 68.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.529 179.014 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -97.11 120.14 36.92 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.213 -179.46 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -63.98 -46.27 85.35 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.508 179.148 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -97.99 151.96 37.81 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.565 -179.42 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -66.99 146.84 78.81 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.929 2.42 . . . . 0.0 113.055 -178.932 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 27.5 pt . . . . . 0 C--N 1.327 -0.387 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.514 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 69.5 p . . . . . 0 C--O 1.233 0.198 0 CA-C-O 121.029 0.443 . . . . 0.0 110.583 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.823 HH12 ' HB2' ' A' ' 58' ' ' ALA . 94.5 mtt-85 -91.89 113.4 25.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.458 -179.321 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -126.31 133.72 51.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.379 -179.747 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.563 HD11 ' HB3' ' A' ' 95' ' ' PHE . 31.8 tp -113.62 133.85 55.05 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.781 -179.816 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.9 t -110.21 129.22 65.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.868 0.366 . . . . 0.0 111.116 -179.425 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.466 HG23 ' CD1' ' B' ' 261' ' ' ILE . 3.8 m -83.43 137.44 33.91 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.084 -178.864 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.561 HD12 ' HB2' ' A' ' 94' ' ' SER . 96.6 mt -104.64 135.65 41.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.583 177.623 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -88.97 158.9 17.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.569 179.916 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.624 ' CD ' HH22 ' A' ' 93' ' ' ARG . 77.5 mtp180 -56.5 -29.27 61.61 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.076 179.881 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.9 m -79.25 -7.79 58.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.847 179.599 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.96 28.97 24.43 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -179.21 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.3 t -113.7 132.67 62.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.505 -0.347 . . . . 0.0 110.467 -179.695 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -77.61 138.71 39.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.407 179.944 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -133.87 -119.66 2.01 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 120.348 -0.93 . . . . 0.0 112.748 -179.141 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -66.44 143.12 68.3 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.144 1.896 . . . . 0.0 113.499 -177.828 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.435 ' O ' ' CD1' ' B' ' 267' ' ' ILE . 0.6 OUTLIER -108.04 130.56 55.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.576 -179.728 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.524 ' CD2' HD11 ' A' ' 37' ' ' ILE . 41.7 t80 -101.26 107.65 51.46 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.304 -179.181 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -74.64 128.9 12.16 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 121.753 1.636 . . . . 0.0 111.679 -179.562 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 86.6 mt -86.43 51.24 2.17 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -178.063 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.7 p -62.41 -22.37 66.11 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.456 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.74 HD11 ' HG2' ' B' ' 265' ' ' GLN . 64.6 mt -79.15 137.95 37.68 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.209 179.043 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 81.0 p -66.57 -17.46 64.83 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.925 -179.424 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.433 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 86.4 m -129.98 131.03 45.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.066 0.46 . . . . 0.0 111.046 179.616 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.6 t -123.54 115.25 21.21 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.292 178.155 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.797 HD21 ' OE1' ' A' ' 47' ' ' GLN . 43.8 tp -112.01 124.55 52.64 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.928 -179.219 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.756 ' CE2' HD12 ' A' ' 37' ' ' ILE . 3.9 m-85 -106.42 143.51 34.44 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.763 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 157.49 -170.55 34.59 Favored Glycine 0 C--O 1.225 -0.408 0 C-N-CA 120.005 -1.093 . . . . 0.0 111.715 178.852 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.0 ttp85 -87.49 -27.41 22.67 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.84 -0.18 . . . . 0.0 111.212 -179.903 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.564 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -59.19 151.13 35.71 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 179.99 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.482 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.5 tp -66.24 -40.41 86.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.218 -0.593 . . . . 0.0 110.298 179.854 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.482 ' N ' HG23 ' A' ' 33' ' ' ILE . 79.4 mm-40 -53.98 -15.68 1.52 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.353 -179.884 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.564 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 34.1 m -64.48 123.63 19.72 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 120.162 -0.615 . . . . 0.0 109.394 179.631 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.433 ' OD2' ' O ' ' A' ' 26' ' ' THR . 98.6 m-20 -56.95 -25.0 57.06 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -179.501 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.756 HD12 ' CE2' ' A' ' 29' ' ' PHE . 99.0 mt -129.82 120.83 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.367 176.761 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.538 ' NH2' HG21 ' B' ' 262' ' ' VAL . 68.9 ttp85 -108.22 133.94 51.76 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.791 -178.648 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 97.6 mt -116.31 130.08 71.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.875 -179.825 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -75.24 34.59 0.11 Allowed 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -178.205 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.432 HD22 ' HZ ' ' B' ' 241' ' ' PHE . 57.8 mt -110.84 127.55 26.75 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.753 179.651 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.81 -8.45 22.39 Favored 'Trans proline' 0 N--CA 1.498 1.742 0 C-N-CA 122.684 2.256 . . . . 0.0 114.063 -179.024 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.2 m -100.61 1.8 10.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.317 179.711 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.487 ' O ' ' O ' ' A' ' 45' ' ' SER . 91.2 t -97.26 103.35 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.034 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.487 ' O ' ' O ' ' A' ' 44' ' ' VAL . 12.5 t -32.71 157.54 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.785 0.803 . . . . 0.0 111.961 -178.688 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -64.25 -38.38 90.83 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.963 -179.695 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.797 ' OE1' HD21 ' A' ' 28' ' ' LEU . 95.6 mm-40 -113.22 -6.67 13.6 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 123.474 0.484 . . . . 0.0 111.055 -179.015 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.605 ' CD2' ' HG1' ' A' ' 69' ' ' THR . 20.8 t60 14.28 -71.66 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 -178.982 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.577 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.3 136.06 45.22 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -177.352 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -125.99 125.56 42.87 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.69 178.827 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.6 mt -110.72 132.79 58.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.978 179.894 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.418 ' CD ' ' CE1' ' A' ' 54' ' ' HIS . 75.6 tt0 -115.64 124.78 51.78 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.487 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.6 mt -103.16 120.68 53.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 119.913 -0.715 . . . . 0.0 112.422 -178.309 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.592 ' O ' ' N ' ' A' ' 56' ' ' GLN . 2.4 m-70 -114.91 138.4 50.86 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.084 178.723 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.462 ' C ' ' O ' ' A' ' 54' ' ' HIS . 96.5 mt-10 -39.86 -23.88 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 -179.655 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.592 ' N ' ' O ' ' A' ' 54' ' ' HIS . 66.2 tp60 -68.49 -67.93 0.43 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.142 178.257 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -159.2 -163.38 1.2 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.74 -179.529 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.823 ' HB2' HH12 ' A' ' 5' ' ' ARG . . . -109.42 131.7 54.82 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.401 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 41.2 mm -112.23 125.08 69.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.068 -178.801 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.433 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 28.9 tp -100.43 125.63 46.73 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.805 0.336 . . . . 0.0 110.097 -179.849 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -115.68 136.96 52.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.157 179.456 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.758 ' ND2' ' H ' ' A' ' 69' ' ' THR . 14.6 t-20 -100.54 106.73 18.28 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.4 -179.856 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -97.58 -6.93 32.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.587 179.462 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.48 100.6 0.87 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.886 179.563 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.2 m -83.25 -14.95 52.11 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.276 -0.569 . . . . 0.0 109.677 179.374 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.5 -43.5 9.65 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.594 179.964 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.652 ' HB3' HD11 ' A' ' 91' ' ' ILE . 44.0 m-20 -146.97 101.66 3.88 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.452 -179.485 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.49 ' HA ' HD21 ' A' ' 62' ' ' ASN . 32.5 Cg_exo -56.04 150.53 46.97 Favored 'Trans proline' 0 N--CA 1.499 1.824 0 C-N-CA 122.664 2.243 . . . . 0.0 113.998 -178.795 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.758 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 11.3 m -71.57 136.99 47.68 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.794 178.987 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.556 ' O ' ' N ' ' A' ' 89' ' ' THR . 70.2 mt-30 -99.64 146.04 26.92 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.597 179.947 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.721 ' HB ' HD11 ' A' ' 76' ' ' ILE . 4.1 p -133.75 139.73 48.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.499 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 48.24 33.13 3.5 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -179.63 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.23 29.79 65.96 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.299 -179.549 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.442 ' N ' ' O ' ' A' ' 71' ' ' VAL . 18.2 t -140.67 137.32 33.46 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.975 -179.199 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.44 HG13 ' HB2' ' A' ' 68' ' ' PRO . 38.9 t -66.76 139.09 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.375 -179.321 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.721 HD11 ' HB ' ' A' ' 71' ' ' VAL . 89.8 mt -107.64 116.21 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.528 179.055 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 24.5 p-10 -87.75 -33.54 18.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.661 0.267 . . . . 0.0 111.064 179.274 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.455 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 5.0 pt-20 -128.88 174.05 4.95 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.949 -179.292 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -58.8 144.48 98.35 Favored 'Trans proline' 0 N--CA 1.501 1.929 0 C-N-CA 122.305 2.003 . . . . 0.0 112.513 -179.4 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.6 p -141.6 144.26 26.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.308 0.575 . . . . 0.0 111.689 179.747 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -77.6 132.98 38.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.095 179.611 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.543 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 91.2 mt -88.02 140.26 29.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.922 0.392 . . . . 0.0 111.146 -179.451 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -129.69 154.45 47.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.576 -179.87 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -54.46 117.81 3.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.038 0.447 . . . . 0.0 110.654 -179.502 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.81 -16.73 30.72 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 -179.396 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.544 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 45.3 t0 -69.94 126.52 29.94 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.185 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 49.7 t -102.5 135.58 38.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.006 -178.981 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 28.3 mm -92.59 129.03 43.77 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.605 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 177.485 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.654 HG23 ' OG ' ' A' ' 94' ' ' SER . 98.8 m -121.23 125.15 46.4 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 122.031 0.919 . . . . 0.0 112.597 -178.245 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.591 ' O ' ' N ' ' A' ' 93' ' ' ARG . 97.0 mt -117.38 132.47 67.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 113.993 -1.458 . . . . 0.0 107.924 177.919 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.652 HD11 ' HB3' ' A' ' 67' ' ' ASN . 69.7 mt -26.78 104.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 O-C-N 123.448 0.467 . . . . 0.0 111.257 -179.225 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.509 ' CG ' ' NE ' ' B' ' 245' ' ' ARG . 90.9 m-20 79.37 -16.51 0.66 Allowed 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 179.147 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.624 HH22 ' CD ' ' A' ' 12' ' ' ARG . 23.5 mtt85 -130.62 137.36 49.59 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.661 -0.415 . . . . 0.0 110.84 179.028 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.654 ' OG ' HG23 ' A' ' 89' ' ' THR . 48.2 m -138.82 152.42 47.85 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.156 0.503 . . . . 0.0 109.888 -179.989 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.563 ' HB3' HD11 ' A' ' 7' ' ' LEU . 79.1 m-85 -126.16 122.95 37.13 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.094 -179.61 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.531 ' O ' HD12 ' A' ' 7' ' ' LEU . 99.6 mtt180 -83.69 132.05 34.9 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.82 -179.59 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.611 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 72.5 t80 -96.87 127.16 42.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.691 -179.525 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -124.94 120.95 33.07 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.271 179.533 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 59.4 t-20 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.044 179.988 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo . . . . . 0 N--CA 1.488 1.201 0 CA-C-O 121.582 0.576 . . . . 0.0 112.358 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 36.8 t -63.06 141.67 17.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.226 179.511 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.464 0.249 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.193 -179.72 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo . . . . . 0 N--CA 1.498 1.769 0 N-CA-C 112.834 0.282 . . . . 0.0 112.834 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 18.8 m -72.15 -44.96 62.3 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.212 0.529 . . . . 0.0 109.897 178.618 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.432 ' HZ ' HD22 ' A' ' 41' ' ' LEU . 87.5 t80 -55.92 -47.13 78.08 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.6 -179.439 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.437 ' CD2' ' OD1' ' A' ' 92' ' ' ASP . 93.3 mt -65.39 -41.49 93.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.776 -179.653 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -60.59 -40.68 92.64 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.738 -179.242 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -61.76 -42.44 98.99 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.785 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.716 ' O ' HG23 ' B' ' 249' ' ' VAL . 70.4 ttp85 -60.77 -43.56 97.88 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.559 -179.739 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.98 -42.11 97.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.986 0.422 . . . . 0.0 109.957 -179.548 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 73.9 m -66.64 -45.09 80.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.542 0.687 . . . . 0.0 109.292 178.303 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . 0.448 ' HG2' HH22 ' A' ' 12' ' ' ARG . 68.8 tp60 -59.84 -35.44 74.75 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.325 -179.992 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . 0.716 HG23 ' O ' ' B' ' 245' ' ' ARG . 71.4 t . . . . . 0 C--N 1.33 -0.273 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.063 179.887 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 . . . . . 0 CA--C 1.533 0.291 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.466 ' CD1' HG23 ' A' ' 9' ' ' THR . 73.1 mt -109.87 132.86 56.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.183 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . 0.538 HG21 ' NH2' ' A' ' 38' ' ' ARG . 54.9 t -123.18 131.57 72.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.187 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -94.46 119.93 33.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.038 0.447 . . . . 0.0 111.723 -178.576 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -63.29 -48.45 78.08 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.899 179.74 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . 0.74 ' HG2' HD11 ' A' ' 24' ' ' LEU . 1.2 mp0 -89.34 160.3 42.71 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.609 -179.067 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -60.04 140.64 93.61 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.194 1.93 . . . . 0.0 111.727 179.867 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . 0.435 ' CD1' ' O ' ' A' ' 19' ' ' HIS . 3.2 tt . . . . . 0 C--N 1.324 -0.508 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.169 -179.249 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.6 m . . . . . 0 C--O 1.234 0.257 0 CA-C-O 120.945 0.402 . . . . 0.0 110.464 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.547 ' NH2' HG21 ' A' ' 53' ' ' ILE . 87.0 mtm-85 -100.51 131.51 46.38 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.026 -179.209 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -130.87 154.37 48.14 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.202 0.525 . . . . 0.0 111.995 -179.364 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.722 HD11 HD11 ' A' ' 22' ' ' LEU . 87.1 mt -119.96 141.93 49.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.625 179.387 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 45.9 t -115.53 129.83 71.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.787 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.0 m -88.46 111.98 22.42 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.426 0.631 . . . . 0.0 112.079 -178.14 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 35.5 mm -79.57 142.86 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.215 178.539 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -95.28 160.47 14.52 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.414 0.626 . . . . 0.0 111.189 -179.547 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.466 HH22 ' HB2' ' B' ' 248' ' ' GLN . 82.7 mtp180 -58.84 -27.53 65.21 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.94 179.41 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 93.8 p -74.11 -18.48 60.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.0 178.833 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.67 21.2 12.85 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-N 116.213 -0.449 . . . . 0.0 112.134 179.266 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.0 p -125.57 139.72 50.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.977 0.417 . . . . 0.0 110.189 179.897 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.447 ' OD1' ' N ' ' A' ' 16' ' ' ASP . 33.4 p-10 -84.72 149.14 25.99 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.463 -179.696 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -138.54 -97.85 0.42 Allowed Glycine 0 CA--C 1.53 1.021 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.768 -179.817 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.84 141.39 27.08 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.198 1.932 . . . . 0.0 112.395 -179.087 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -106.95 146.67 30.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.985 0.421 . . . . 0.0 110.375 -179.482 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -114.74 98.63 50.18 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.334 -179.931 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.32 133.52 14.75 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.872 1.715 . . . . 0.0 112.069 -178.411 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.722 HD11 HD11 ' A' ' 7' ' ' LEU . 92.2 mt -87.71 86.27 7.16 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.062 -178.806 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 89.5 p -83.65 -11.34 57.38 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.566 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.1 mt -109.15 154.86 21.74 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.378 -179.697 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 59.9 m -79.56 -8.53 59.23 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -178.648 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.477 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 24.2 m -126.43 129.14 48.14 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.827 -179.637 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.1 t -123.78 114.52 20.01 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.991 178.505 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.581 HD21 ' HG2' ' A' ' 47' ' ' GLN . 45.4 tp -112.25 128.49 56.27 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.451 -178.39 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.732 ' CE2' HD12 ' A' ' 37' ' ' ILE . 7.0 m-85 -110.36 130.9 55.46 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.482 -179.953 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 165.2 -176.65 40.84 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.411 178.692 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.639 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 81.5 mtm-85 -75.51 -30.96 59.98 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 122.483 -0.422 . . . . 0.0 112.032 -179.346 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -54.6 143.66 31.41 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 121.387 -0.435 . . . . 0.0 112.181 -178.131 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.48 HG23 ' N ' ' A' ' 34' ' ' GLU . 11.1 tp -64.43 -41.09 91.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.252 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.48 ' N ' HG23 ' A' ' 33' ' ' ILE . 80.8 tt0 -54.44 -15.95 2.0 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.357 179.5 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.7 m -69.16 133.13 47.59 Favored 'General case' 0 N--CA 1.461 0.1 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.989 -179.319 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.477 ' OD2' ' O ' ' A' ' 26' ' ' THR . 91.2 m-20 -59.95 -31.2 69.65 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.922 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.732 HD12 ' CE2' ' A' ' 29' ' ' PHE . 98.8 mt -126.68 124.59 65.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 177.008 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.429 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 70.1 ttt180 -110.64 133.49 53.27 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.54 -178.566 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 94.6 mt -118.17 131.4 71.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 121.073 0.463 . . . . 0.0 110.736 -179.148 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -75.89 32.79 0.12 Allowed 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -178.168 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.745 HD12 ' CZ ' ' A' ' 93' ' ' ARG . 52.9 mt -113.45 128.19 25.97 Favored Pre-proline 0 N--CA 1.471 0.581 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.306 179.571 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.84 -15.03 29.86 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.239 1.959 . . . . 0.0 113.269 -179.034 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.665 HG23 ' O ' ' B' ' 235' ' ' PRO . 2.9 p -86.05 -1.41 7.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.103 179.729 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.741 HG12 ' O ' ' A' ' 41' ' ' LEU . 5.3 p -95.1 139.28 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.958 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.463 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 0.5 OUTLIER -68.79 171.91 7.18 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.563 0.697 . . . . 0.0 112.456 -178.09 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 44.7 mttm -64.26 -45.36 88.45 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.592 -179.369 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.662 ' O ' ' N ' ' A' ' 49' ' ' CYS . 84.6 mt-30 -113.05 -12.75 13.16 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.781 -179.607 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.463 ' H ' ' HB3' ' A' ' 45' ' ' SER . 21.3 t60 33.86 -75.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.238 -0.892 . . . . 0.0 113.385 179.52 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.662 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.2 134.77 46.8 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.759 -178.466 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -127.67 127.55 43.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.422 179.769 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 92.8 mt -109.73 133.06 56.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.868 -179.635 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -115.72 117.47 30.35 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.012 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.547 HG21 ' NH2' ' A' ' 5' ' ' ARG . 90.1 mt -101.1 112.72 34.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 119.972 -0.691 . . . . 0.0 111.328 -178.691 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.427 ' O ' ' C ' ' A' ' 55' ' ' GLU . 92.7 m-70 -110.05 141.06 43.41 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.483 -1.235 . . . . 0.0 109.561 -179.685 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 54' ' ' HIS . 99.2 mt-10 -41.23 -36.05 0.71 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.234 0.54 . . . . 0.0 109.693 -179.895 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -60.38 -66.23 0.56 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.371 179.637 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -154.0 -174.01 4.8 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.13 -179.369 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.56 123.18 48.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.292 179.152 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.9 mt -117.42 131.42 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -178.679 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 24.2 tp -100.76 127.87 47.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.209 179.267 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -109.22 135.48 50.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.054 179.817 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.403 HD21 ' CA ' ' A' ' 68' ' ' PRO . 61.1 t-20 -96.71 108.34 20.96 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.999 0.428 . . . . 0.0 111.261 -179.263 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -101.25 -7.29 23.19 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.668 179.855 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.7 t -76.71 97.79 4.57 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.883 -179.877 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.1 p -78.39 -33.01 49.11 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.092 179.113 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.39 -44.47 51.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.044 -179.213 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.439 HD21 ' HA ' ' B' ' 236' ' ' VAL . 79.0 m-20 -139.54 94.78 9.24 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.082 -179.693 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.568 ' HB2' HG13 ' A' ' 75' ' ' VAL . 54.2 Cg_exo -54.48 147.23 48.59 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.522 2.148 . . . . 0.0 113.465 -179.725 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 59.3 m -77.05 149.06 35.83 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.115 179.095 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -110.08 141.06 43.46 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.711 -179.61 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.688 HG13 ' OD1' ' A' ' 86' ' ' ASP . 55.0 t -132.37 135.48 57.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.316 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.426 ' ND2' HG12 ' A' ' 71' ' ' VAL . 74.6 m-80 52.99 33.34 14.51 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -178.711 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.6 28.98 70.17 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.153 179.495 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.2 t -143.74 142.83 31.12 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 117.037 0.419 . . . . 0.0 111.138 179.51 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.568 HG13 ' HB2' ' A' ' 68' ' ' PRO . 52.9 t -68.0 138.64 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.066 -0.516 . . . . 0.0 112.062 -179.193 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.409 HG21 HG11 ' A' ' 80' ' ' VAL . 2.6 pt -112.46 92.75 2.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-O 121.274 0.559 . . . . 0.0 109.899 178.369 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -63.98 -28.45 69.82 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.628 -179.743 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.439 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.8 OUTLIER -130.81 179.46 1.34 Allowed Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.801 -179.67 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.439 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 31.9 Cg_exo -60.58 146.19 97.48 Favored 'Trans proline' 0 N--CA 1.501 1.951 0 C-N-CA 123.137 2.558 . . . . 0.0 113.244 179.898 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.409 HG11 HG21 ' A' ' 76' ' ' ILE . 2.7 p -140.4 137.95 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.381 179.484 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 68.2 ttp85 -73.12 129.07 37.25 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.904 -0.319 . . . . 0.0 110.77 179.925 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 97.4 mt -81.2 139.58 35.44 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.355 0.598 . . . . 0.0 110.946 179.936 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -136.71 152.19 50.09 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.352 -179.748 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -52.15 114.82 1.45 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.927 0.394 . . . . 0.0 110.366 -179.797 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.81 -18.34 22.13 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.034 -0.827 . . . . 0.0 111.034 -179.718 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.688 ' OD1' HG13 ' A' ' 71' ' ' VAL . 53.3 t0 -66.21 129.49 40.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.276 0.56 . . . . 0.0 110.021 179.153 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.501 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 9.3 p -109.16 133.91 52.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.687 -179.051 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.1 mt -99.88 129.47 50.47 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.204 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.6 m -123.58 127.74 48.72 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.699 0.761 . . . . 0.0 112.761 -178.456 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.483 ' O ' ' N ' ' A' ' 93' ' ' ARG . 96.5 mt -117.37 125.82 74.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 114.44 -1.255 . . . . 0.0 108.551 177.626 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.555 HG22 ' N ' ' A' ' 92' ' ' ASP . 82.4 mt 36.55 -103.3 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.929 179.949 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.555 ' N ' HG22 ' A' ' 91' ' ' ILE . 89.8 m-20 -109.32 7.82 25.32 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.571 179.715 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.745 ' CZ ' HD12 ' A' ' 41' ' ' LEU . 40.9 mtm-85 -121.94 140.85 51.94 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -179.208 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.5 t -138.03 152.26 48.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.297 0.57 . . . . 0.0 111.091 -179.698 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -121.99 120.96 35.92 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.417 179.081 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 53.6 ttt85 -84.87 129.98 34.73 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.871 -179.197 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -93.74 122.84 36.61 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.208 -179.242 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -123.0 124.19 42.58 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.88 179.967 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 63.2 t-20 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.055 -179.711 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . 0.665 ' O ' HG23 ' A' ' 43' ' ' VAL . 56.9 Cg_endo . . . . . 0 N--CA 1.493 1.451 0 CA-C-O 121.138 0.391 . . . . 0.0 112.667 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.439 ' HA ' HD21 ' A' ' 67' ' ' ASN . 24.4 t -57.74 137.33 20.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.798 -179.61 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 7.0 t . . . . . 0 C--N 1.327 -0.376 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.257 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo . . . . . 0 N--CA 1.49 1.317 0 CA-C-O 120.338 0.057 . . . . 0.0 112.159 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 91.3 m -73.57 -47.52 40.0 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-O 121.132 0.492 . . . . 0.0 109.732 178.894 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.48 ' CZ ' HG11 ' A' ' 43' ' ' VAL . 69.0 t80 -59.83 -45.66 91.69 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.71 -179.29 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 91.9 mt -64.5 -40.56 95.87 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.86 0.362 . . . . 0.0 110.887 -179.728 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -60.14 -42.11 94.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.351 -179.2 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . 0.511 ' O ' ' OG ' ' B' ' 247' ' ' SER . 89.4 mtm180 -65.3 -39.29 92.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.594 179.276 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.505 ' NH2' HH11 ' A' ' 93' ' ' ARG . 16.8 mmm180 -60.72 -43.66 97.57 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.863 -178.471 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -63.92 -40.19 95.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.208 0.528 . . . . 0.0 109.819 179.353 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . 0.511 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 67.9 p -64.03 -44.72 91.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.625 179.182 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . 0.466 ' HB2' HH22 ' A' ' 12' ' ' ARG . 87.3 mt-30 -61.1 -33.79 73.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.68 179.665 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 55.4 t . . . . . 0 C--N 1.332 -0.185 0 C-N-CA 120.259 -0.577 . . . . 0.0 109.754 179.139 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.471 ' OE1' HD21 ' A' ' 41' ' ' LEU . 97.4 mt-10 . . . . . 0 CA--C 1.522 -0.102 0 CA-C-O 120.472 0.177 . . . . 0.0 110.916 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 66.8 mt -115.96 135.35 56.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.765 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 72.7 t -127.39 135.39 63.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.113 179.543 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -96.84 118.18 32.71 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.396 0.617 . . . . 0.0 110.769 -179.163 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -66.85 -46.72 74.18 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.066 -179.917 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -75.31 168.5 27.09 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.588 -179.083 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -64.64 144.17 83.45 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 121.356 1.371 . . . . 0.0 111.024 179.275 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 10.6 tt . . . . . 0 C--N 1.322 -0.613 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.534 -178.936 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.4 m . . . . . 0 N--CA 1.463 0.185 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.96 ' NE ' HD13 ' A' ' 53' ' ' ILE . 86.2 mtm-85 -90.83 130.68 36.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.068 0.461 . . . . 0.0 111.328 -178.407 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.661 ' C ' HD12 ' A' ' 7' ' ' LEU . 99.8 mtt180 -135.41 143.0 45.74 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.966 179.677 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.661 HD12 ' C ' ' A' ' 6' ' ' ARG . 10.9 mp -120.08 139.33 52.71 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.93 0.395 . . . . 0.0 110.937 179.773 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.598 HG22 ' CD2' ' A' ' 19' ' ' HIS . 46.5 t -111.88 132.02 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.102 -179.729 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.411 HG23 HD12 ' B' ' 261' ' ' ILE . 9.0 m -84.21 139.37 32.43 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -178.286 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.2 mm -108.31 135.11 48.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.821 177.324 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -90.8 159.93 16.03 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 177.802 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.534 HH11 ' HB2' ' B' ' 245' ' ' ARG . 90.9 mtm180 -56.2 -20.98 20.41 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.149 -179.42 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.9 m -83.62 -13.16 54.92 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.12 179.876 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.25 31.49 11.75 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.102 179.634 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.1 m -118.78 142.54 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 120.982 0.42 . . . . 0.0 111.77 -179.793 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -73.21 119.12 17.01 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.237 -179.151 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -110.96 -128.21 5.3 Favored Glycine 0 CA--C 1.54 1.654 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 -179.752 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -74.8 149.53 37.83 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 122.538 2.159 . . . . 0.0 113.209 -178.854 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.598 ' CD2' HG22 ' A' ' 8' ' ' VAL . 47.8 m170 -101.72 143.55 31.52 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.126 -179.665 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.764 ' CD2' HD11 ' A' ' 37' ' ' ILE . 39.0 t80 -113.42 92.52 23.48 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.192 179.53 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.463 ' HD2' HG22 ' B' ' 267' ' ' ILE . 94.4 Cg_endo -77.67 138.19 16.87 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 121.878 1.719 . . . . 0.0 111.767 -179.415 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 82.9 mt -101.65 125.54 48.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.454 0.645 . . . . 0.0 111.465 -179.007 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 82.9 p -120.34 -1.03 10.28 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.329 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.589 HD12 ' CD ' ' B' ' 265' ' ' GLN . 45.4 mt -111.37 152.83 26.86 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 114.402 -1.272 . . . . 0.0 109.398 -178.921 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.9 m -77.27 -11.76 59.87 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -177.818 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 20.7 m -127.31 130.92 50.4 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 120.131 -0.628 . . . . 0.0 112.03 -179.617 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.5 t -126.15 117.97 24.24 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.851 178.841 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.538 HD21 ' OE1' ' A' ' 47' ' ' GLN . 31.9 tp -113.57 134.97 54.4 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 120.838 0.351 . . . . 0.0 111.215 -178.851 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.511 ' O ' ' O ' ' A' ' 47' ' ' GLN . 79.0 m-85 -112.44 135.82 52.68 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.682 179.244 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 165.39 -164.94 37.56 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 120.617 -0.801 . . . . 0.0 111.422 179.784 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 31.1 ptt-85 -103.41 -26.19 12.99 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.544 -0.462 . . . . 0.0 111.24 179.996 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -50.29 158.55 1.71 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 179.859 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.564 ' O ' ' NH2' ' A' ' 38' ' ' ARG . 7.9 tp -66.94 -41.87 88.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 117.644 0.722 . . . . 0.0 110.588 -179.22 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.448 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 80.4 tt0 -60.13 -19.68 54.72 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 -178.914 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.408 ' HA ' HD23 ' A' ' 28' ' ' LEU . 55.8 m -59.84 130.98 49.42 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.276 -0.57 . . . . 0.0 111.002 -179.238 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.565 ' CG ' ' NE2' ' B' ' 265' ' ' GLN . 74.2 m-20 -61.5 -32.65 72.69 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.907 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.764 HD11 ' CD2' ' A' ' 20' ' ' PHE . 46.6 mm -119.83 112.84 38.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.102 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.564 ' NH2' ' O ' ' A' ' 33' ' ' ILE . 74.0 mtt85 -98.95 131.16 45.22 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.579 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.642 HD13 ' HD2' ' A' ' 93' ' ' ARG . 91.8 mt -121.76 132.13 71.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.882 0.373 . . . . 0.0 110.711 -178.265 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -75.46 33.02 0.11 Allowed 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -177.664 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.683 HD12 ' CZ ' ' A' ' 93' ' ' ARG . 88.5 mt -115.19 123.76 31.21 Favored Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 120.261 -0.575 . . . . 0.0 110.159 179.138 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.95 -7.21 19.68 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.291 1.994 . . . . 0.0 113.427 -178.986 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.9 m -87.26 1.24 6.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 119.791 -0.763 . . . . 0.0 109.129 178.69 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.63 HG12 ' O ' ' A' ' 41' ' ' LEU . 2.4 p -96.29 138.39 21.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.262 178.533 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.449 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 3.7 t -75.22 173.36 10.93 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.592 0.71 . . . . 0.0 111.86 -178.348 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 43.6 mttp -64.13 -41.77 97.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.043 179.954 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.647 ' O ' ' N ' ' A' ' 49' ' ' CYS . 10.7 mm100 -109.72 -20.69 12.72 Favored 'General case' 0 C--N 1.334 -0.068 0 CA-C-O 120.766 0.317 . . . . 0.0 110.952 -179.691 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.449 ' H ' ' HB3' ' A' ' 45' ' ' SER . 15.1 t60 37.54 -77.81 0.0 OUTLIER 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.647 -179.862 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.647 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.65 135.31 45.76 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.331 0.586 . . . . 0.0 111.581 -179.337 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -126.02 131.83 52.12 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.157 179.844 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 99.2 mt -118.27 133.45 65.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.267 179.912 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.491 ' OE2' ' NE2' ' A' ' 61' ' ' HIS . 21.8 pt-20 -116.62 128.43 55.38 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.48 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.96 HD13 ' NE ' ' A' ' 5' ' ' ARG . 83.4 mt -107.53 114.92 47.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.506 -178.074 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.522 ' O ' ' N ' ' A' ' 56' ' ' GLN . 99.5 m-70 -113.28 144.7 42.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.983 179.894 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 54' ' ' HIS . 84.6 tt0 -39.62 -27.58 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -179.717 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.522 ' N ' ' O ' ' A' ' 54' ' ' HIS . 89.1 mt-30 -65.66 -68.99 0.32 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.534 178.798 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -161.25 -161.83 0.85 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.92 0.39 . . . . 0.0 111.073 179.23 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.431 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -111.35 125.15 53.55 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.781 179.42 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.7 mt -113.91 128.34 70.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.997 0.427 . . . . 0.0 111.39 -179.076 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.454 ' HB2' HD11 ' A' ' 82' ' ' LEU . 27.1 tp -98.19 128.35 44.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.928 -179.798 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.491 ' NE2' ' OE2' ' A' ' 52' ' ' GLU . 99.6 m-70 -116.3 138.11 51.59 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.711 -179.268 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -103.13 105.36 15.65 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 179.944 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -96.94 -4.41 40.01 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.93 178.988 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.65 100.83 11.1 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.044 179.355 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.2 m -87.64 -14.47 39.93 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.089 179.852 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.471 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -85.71 -41.19 15.35 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.499 -179.849 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -144.2 95.05 5.64 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.486 179.702 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -64.65 150.86 87.51 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 121.28 1.32 . . . . 0.0 112.988 -178.483 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.6 m -72.73 137.45 45.93 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.829 -179.705 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -97.2 140.19 32.05 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.506 -0.478 . . . . 0.0 109.842 178.997 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.457 ' O ' ' N ' ' A' ' 74' ' ' SER . 7.3 p -129.43 135.95 60.47 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.504 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.131 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 48.86 29.83 2.46 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -178.78 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 76.11 25.07 67.29 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-N 115.045 -0.98 . . . . 0.0 112.18 179.94 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 71' ' ' VAL . 12.9 t -137.37 139.16 40.59 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 117.383 0.591 . . . . 0.0 111.733 -179.874 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.4 m -73.57 138.32 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.055 179.985 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.569 HG21 HG21 ' A' ' 80' ' ' VAL . 7.6 pt -105.15 94.25 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 121.184 0.516 . . . . 0.0 111.274 179.611 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -65.33 -33.62 76.4 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.226 179.285 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -121.16 167.35 13.42 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.404 -179.129 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -60.32 142.81 99.03 Favored 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 121.842 1.695 . . . . 0.0 112.104 -179.304 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.569 HG21 HG21 ' A' ' 76' ' ' ILE . 24.2 m -137.04 137.57 46.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.094 0.473 . . . . 0.0 110.834 179.237 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -71.56 133.09 45.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.947 179.705 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.454 HD11 ' HB2' ' A' ' 60' ' ' LEU . 92.8 mt -85.74 139.59 31.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.219 0.533 . . . . 0.0 110.604 179.872 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -123.97 151.23 43.89 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.319 179.824 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.439 ' ND1' ' N ' ' A' ' 99' ' ' ASN . 5.6 t60 -57.56 122.64 13.19 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.653 -179.67 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.47 -15.84 35.05 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 179.616 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -69.27 137.74 53.32 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.415 -179.766 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 40.6 t -110.17 130.56 63.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.964 0.411 . . . . 0.0 110.829 -179.239 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 88.0 mt -98.71 130.64 47.26 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 178.373 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 94.5 m -123.14 124.54 43.3 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 119.816 -0.754 . . . . 0.0 112.187 -178.866 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.496 ' O ' ' C ' ' A' ' 91' ' ' ILE . 92.1 mt -115.46 130.89 69.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.129 178.284 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.579 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 84.7 mt -15.68 98.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -178.059 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.453 ' OD1' ' NE ' ' B' ' 245' ' ' ARG . 23.7 m-20 85.23 -22.11 0.21 Allowed 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 177.617 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.683 ' CZ ' HD12 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -130.59 144.1 51.19 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.985 -179.676 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 66.8 p -137.96 153.97 49.41 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.177 0.513 . . . . 0.0 110.072 -179.859 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.667 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 81.8 m-85 -125.15 122.73 37.92 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.481 179.792 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -84.69 132.16 34.49 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.619 -179.627 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.619 ' CZ ' ' OD1' ' A' ' 99' ' ' ASN . 88.0 t80 -97.12 123.93 41.01 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.775 -179.525 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -134.49 127.52 31.58 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.673 179.954 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.619 ' OD1' ' CZ ' ' A' ' 97' ' ' TYR . 70.1 m-20 . . . . . 0 N--CA 1.467 0.378 0 CA-C-O 120.916 0.389 . . . . 0.0 110.854 179.296 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo . . . . . 0 N--CA 1.491 1.331 0 CA-C-O 121.159 0.399 . . . . 0.0 112.899 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.471 ' CG2' HG22 ' A' ' 66' ' ' THR . 78.6 t -61.48 139.4 20.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.184 -179.591 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . 0.466 ' HB2' HD13 ' A' ' 91' ' ' ILE . 3.8 t . . . . . 0 C--N 1.33 -0.242 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.279 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo . . . . . 0 N--CA 1.498 1.745 0 CA-C-O 120.744 0.227 . . . . 0.0 112.455 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 28.4 m -69.07 -48.83 61.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.234 0.54 . . . . 0.0 110.194 178.557 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -60.15 -46.64 88.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.788 -178.62 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.421 ' CD2' ' OD1' ' A' ' 92' ' ' ASP . 97.3 mt -63.92 -41.19 97.72 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.761 -0.375 . . . . 0.0 111.964 -178.59 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -66.32 -39.96 89.62 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.167 -179.635 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -62.18 -48.96 77.74 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.162 -0.615 . . . . 0.0 112.274 -178.754 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.534 ' HB2' HH11 ' A' ' 12' ' ' ARG . 3.9 ppt_? -65.72 -37.61 86.89 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.074 -178.515 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . 0.439 ' N ' ' HG3' ' B' ' 245' ' ' ARG . 36.7 ttmt -62.73 -40.44 97.22 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.519 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 50.5 m -65.73 -41.79 91.81 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.945 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -56.79 -39.47 74.16 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.934 179.486 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 58.1 t . . . . . 0 N--CA 1.452 -0.343 0 CA-C-O 121.079 0.466 . . . . 0.0 110.201 179.206 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.566 ' OE1' HD21 ' A' ' 41' ' ' LEU . 97.6 mt-10 . . . . . 0 CA--C 1.523 -0.086 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.667 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 58.2 mt -114.77 137.51 47.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.947 -179.865 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 48.8 t -124.43 133.95 68.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.883 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -93.01 117.3 29.91 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.768 -178.262 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -67.33 -44.88 78.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.623 179.411 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . 0.589 ' CD ' HD12 ' A' ' 24' ' ' LEU . 33.6 mt-30 -88.84 152.41 48.69 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.039 -178.957 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -62.22 141.36 87.75 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.44 2.093 . . . . 0.0 113.259 179.878 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . 0.463 HG22 ' HD2' ' A' ' 21' ' ' PRO . 20.5 pt . . . . . 0 N--CA 1.463 0.209 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.827 179.026 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.7 p . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.852 0.358 . . . . 0.0 110.675 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.5 mtt85 -99.46 131.49 45.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.014 -179.731 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -135.66 144.71 46.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.343 179.27 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 83.2 mt -112.13 141.19 46.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.125 179.007 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 31.1 t -114.84 129.13 71.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.576 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.473 ' CG2' HD12 ' B' ' 261' ' ' ILE . 5.1 m -92.07 114.99 27.68 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -177.943 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.478 HD12 ' OG ' ' A' ' 94' ' ' SER . 96.7 mt -81.68 144.73 9.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.543 178.205 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.9 mttt -94.48 162.27 13.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.892 0.377 . . . . 0.0 110.436 179.221 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -57.89 -30.04 65.53 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.531 -178.969 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.562 ' OG ' HG22 ' A' ' 15' ' ' VAL . 78.2 p -76.28 -20.56 57.22 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.649 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.7 32.62 4.4 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.903 179.649 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.562 HG22 ' OG ' ' A' ' 13' ' ' SER . 6.7 m -128.07 134.47 65.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.881 0.372 . . . . 0.0 110.85 179.399 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -71.45 139.01 49.48 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.321 179.276 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -127.08 -118.1 2.15 Favored Glycine 0 CA--C 1.536 1.345 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -179.89 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.02 147.7 43.7 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 121.951 1.768 . . . . 0.0 112.619 -179.331 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -111.52 153.54 26.06 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.779 179.801 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -122.45 94.01 48.06 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.199 -178.598 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.52 127.99 25.67 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.145 1.897 . . . . 0.0 111.601 179.426 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.415 ' HA ' HD23 ' A' ' 22' ' ' LEU . 95.9 mt -82.77 56.42 3.39 Favored 'General case' 0 CA--C 1.522 -0.134 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.949 -179.733 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 91.9 p -62.74 -16.16 56.41 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.028 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.664 HD11 ' HG2' ' B' ' 265' ' ' GLN . 56.4 mt -91.92 143.15 26.79 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 114.761 -1.108 . . . . 0.0 110.676 -179.794 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.9 m -69.1 -17.02 63.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.697 -179.303 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.2 m -134.61 137.52 43.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.048 -179.874 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.615 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.6 OUTLIER -130.82 124.23 30.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.012 178.554 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.572 HD21 ' HG2' ' A' ' 47' ' ' GLN . 52.4 tp -118.36 128.72 54.91 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.966 0.412 . . . . 0.0 112.03 -177.758 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.615 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 60.5 m-85 -103.49 124.25 48.4 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.951 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 176.35 -178.23 47.74 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 119.822 -1.18 . . . . 0.0 112.965 179.449 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 46.2 mtm180 -80.05 -28.53 39.22 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.807 0.337 . . . . 0.0 110.6 179.034 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -54.66 143.35 32.22 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 -178.985 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.3 mm -64.92 -43.17 96.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.177 0.513 . . . . 0.0 109.816 179.166 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -55.91 -20.3 15.36 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.086 -179.851 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 38.5 m -63.95 131.05 46.49 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.509 -179.918 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 37' ' ' ILE . 6.6 p-10 -59.47 -30.39 68.5 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.838 -178.956 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.535 ' N ' ' OD1' ' A' ' 36' ' ' ASP . 96.5 mt -126.14 121.43 59.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.528 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 77.1 ttt-85 -110.51 136.89 48.95 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.061 -178.377 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.723 HG21 HD12 ' A' ' 41' ' ' LEU . 82.9 mt -119.61 131.35 72.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.922 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -75.56 24.0 0.12 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.246 -179.1 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.723 HD12 HG21 ' A' ' 39' ' ' ILE . 24.6 mt -89.31 122.96 68.09 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.365 179.808 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.73 -14.86 30.17 Favored 'Trans proline' 0 N--CA 1.488 1.177 0 C-N-CA 121.783 1.655 . . . . 0.0 112.594 -179.72 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.624 HG21 ' CE2' ' B' ' 241' ' ' PHE . 1.1 m -93.65 3.41 8.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.087 179.913 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.451 HG12 ' O ' ' A' ' 45' ' ' SER . 25.0 t -89.44 137.02 22.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 120.441 -0.504 . . . . 0.0 109.945 179.069 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.451 ' O ' HG12 ' A' ' 44' ' ' VAL . 2.3 m -68.61 171.98 6.87 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.568 0.699 . . . . 0.0 111.504 -179.596 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -63.4 -43.58 97.15 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.659 -179.802 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.623 ' O ' ' N ' ' A' ' 49' ' ' CYS . 89.9 mt-30 -116.94 -20.53 9.36 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.805 179.904 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.3 t60 36.21 -78.58 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 179.491 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.623 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -125.89 133.82 51.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.217 0.532 . . . . 0.0 112.194 -178.847 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -126.51 129.91 49.56 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.688 179.827 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.6 mt -113.71 132.91 61.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.984 0.421 . . . . 0.0 110.419 179.01 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.461 ' OE2' ' CE1' ' A' ' 54' ' ' HIS . 83.4 tt0 -118.08 125.35 50.14 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 178.62 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 93.4 mt -108.63 123.04 64.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.808 0.813 . . . . 0.0 112.855 -178.155 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.554 ' O ' ' N ' ' A' ' 56' ' ' GLN . 98.0 m-70 -115.85 139.05 50.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.258 -1.337 . . . . 0.0 109.285 179.143 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.482 ' C ' ' O ' ' A' ' 54' ' ' HIS . 83.5 tt0 -39.99 -26.25 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -179.666 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.554 ' N ' ' O ' ' A' ' 54' ' ' HIS . 91.5 mt-30 -64.46 -68.97 0.31 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.027 177.812 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -159.7 -161.89 0.96 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.578 179.81 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -118.41 131.79 56.27 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.517 179.99 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.0 mt -117.57 129.21 74.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-O 121.387 0.613 . . . . 0.0 111.727 -179.301 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.546 ' HB2' HD11 ' A' ' 82' ' ' LEU . 28.2 tp -98.68 127.31 44.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.338 -179.782 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -111.79 135.48 52.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.21 179.858 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.41 HD21 ' CA ' ' A' ' 68' ' ' PRO . 62.7 t-20 -94.77 106.99 19.01 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.42 179.995 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -99.38 -10.38 22.33 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 179.53 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.446 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 7.4 t -76.22 98.62 4.49 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.727 -179.565 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.9 p -80.71 -35.16 33.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.143 0.497 . . . . 0.0 109.768 178.671 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.5 m -65.16 -49.65 69.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.692 179.859 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.446 ' O ' ' OG ' ' A' ' 64' ' ' SER . 0.6 OUTLIER -136.57 96.35 12.17 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.461 179.535 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.48 ' HB2' HG13 ' A' ' 75' ' ' VAL . 32.5 Cg_exo -55.38 144.73 71.15 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.105 1.87 . . . . 0.0 112.082 -179.204 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.7 m -73.76 146.81 44.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.332 179.831 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -110.29 141.25 43.54 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.782 179.955 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 42.0 t -127.92 134.27 65.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.426 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.2 m120 52.54 30.53 8.6 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -179.447 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.65 25.47 69.85 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.74 179.792 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 58.3 m -136.52 138.48 41.38 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.452 -179.642 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.48 HG13 ' HB2' ' A' ' 68' ' ' PRO . 44.4 t -68.94 138.28 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.433 179.982 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.9 pt -116.19 85.88 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.202 179.502 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.524 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 15.4 p-10 -66.47 -26.57 67.25 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.538 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -114.04 159.54 35.83 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.333 179.7 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -66.75 149.45 83.61 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.772 2.315 . . . . 0.0 111.822 179.278 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.2 m -141.45 144.42 26.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.692 -179.427 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -71.68 130.72 41.85 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.281 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.546 HD11 ' HB2' ' A' ' 60' ' ' LEU . 96.9 mt -81.89 138.82 34.95 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.096 0.474 . . . . 0.0 111.93 -178.738 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -130.91 151.65 51.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.715 179.585 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -57.0 121.1 9.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.893 0.378 . . . . 0.0 111.145 -179.228 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.13 -17.28 19.68 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 179.48 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -71.4 134.68 46.83 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.269 0.557 . . . . 0.0 111.082 -179.784 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 68.1 t -111.02 133.86 55.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.713 -179.361 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 79.1 mt -103.58 133.4 47.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.366 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 84.8 m -121.59 131.24 54.01 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.789 0.804 . . . . 0.0 112.589 -178.53 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 76.5 mt -123.47 126.46 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 114.29 -1.323 . . . . 0.0 108.783 179.247 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.469 HG22 ' N ' ' A' ' 92' ' ' ASP . 44.9 mm 43.42 -107.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.002 -179.253 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.562 ' HB3' ' HE ' ' B' ' 245' ' ' ARG . 45.7 t0 -114.89 16.59 17.22 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.943 0.402 . . . . 0.0 111.048 -179.795 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 17.4 mtp180 -130.78 148.22 52.54 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.067 179.4 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.478 ' OG ' HD12 ' A' ' 10' ' ' ILE . 19.4 p -138.64 157.35 46.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.966 0.412 . . . . 0.0 110.839 -179.23 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.574 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 66.7 m-85 -124.0 121.62 35.73 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.563 179.086 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -80.2 131.67 35.74 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.306 -179.78 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -96.62 121.28 38.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.955 -179.865 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -121.49 122.87 40.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.118 -179.89 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 60.4 t-20 . . . . . 0 CA--C 1.521 -0.152 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.324 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo . . . . . 0 N--CA 1.494 1.532 0 CA-C-O 121.026 0.344 . . . . 0.0 112.38 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.411 ' O ' HG13 ' B' ' 236' ' ' VAL . 4.4 p -101.72 129.5 52.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.945 179.381 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 53.2 t . . . . . 0 C--N 1.325 -0.462 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.143 -179.341 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo . . . . . 0 N--CA 1.498 1.753 0 CA-C-O 120.732 0.222 . . . . 0.0 112.589 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 96.3 m -73.5 -46.75 46.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.48 179.3 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.624 ' CE2' HG21 ' A' ' 43' ' ' VAL . 72.2 t80 -59.91 -45.35 92.84 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.588 -179.123 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' B' ' 242' ' ' LEU . 93.9 mt -64.71 -39.25 93.33 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.018 0.437 . . . . 0.0 110.218 179.397 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -61.75 -42.83 99.48 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.339 -179.368 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -62.37 -40.67 97.21 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.231 179.903 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.63 ' NH1' HD21 ' A' ' 41' ' ' LEU . 77.6 mtp85 -60.84 -41.97 96.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.166 -179.943 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.22 -40.8 98.49 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 179.247 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 10.9 t -65.26 -46.71 79.44 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.855 178.448 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -60.12 -39.11 85.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.247 -179.549 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . 0.443 HG23 ' O ' ' B' ' 245' ' ' ARG . 45.3 t . . . . . 0 C--N 1.327 -0.398 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.291 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 . . . . . 0 N--CA 1.461 0.086 0 CA-C-O 120.706 0.289 . . . . 0.0 110.7 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.574 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 78.5 mt -101.89 137.58 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 178.312 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 64.6 t -126.64 134.3 66.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.79 -178.95 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -96.73 119.54 35.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.111 0.481 . . . . 0.0 111.231 -178.672 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -64.66 -40.66 95.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.454 179.532 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . 0.757 ' N ' HE21 ' B' ' 265' ' ' GLN . 0.0 OUTLIER -101.96 160.82 25.3 Favored Pre-proline 0 N--CA 1.464 0.247 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.431 -179.242 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -70.94 145.76 51.13 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 122.595 2.197 . . . . 0.0 113.221 -179.105 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.4 pt . . . . . 0 C--N 1.326 -0.434 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.197 178.86 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.7 p . . . . . 0 N--CA 1.452 -0.359 0 CA-C-O 121.282 0.563 . . . . 0.0 109.636 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.596 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 92.4 mtt-85 -88.17 131.49 34.71 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.951 -179.526 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.5 mtp180 -133.27 141.03 47.8 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 120.312 -0.555 . . . . 0.0 112.389 -179.274 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.609 HD11 ' HB3' ' A' ' 95' ' ' PHE . 40.0 tp -117.42 132.97 56.47 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.243 179.488 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.589 HG22 ' CD2' ' A' ' 19' ' ' HIS . 53.0 t -108.37 131.07 59.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.897 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.407 ' CG2' HD12 ' B' ' 261' ' ' ILE . 1.7 m -93.71 117.45 30.1 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.346 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.489 ' CD1' ' OD1' ' A' ' 16' ' ' ASP . 48.3 mm -82.27 143.28 12.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.645 179.649 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -90.97 160.48 15.62 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 177.701 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.409 ' CG ' ' NH1' ' A' ' 93' ' ' ARG . 83.4 mtm180 -57.0 -24.48 53.93 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.962 -178.442 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 68.6 p -83.9 -8.26 59.23 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.922 179.754 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.21 35.12 9.03 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 179.887 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 32.2 t -117.3 132.49 66.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 -179.997 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.489 ' OD1' ' CD1' ' A' ' 10' ' ' ILE . 92.4 m-20 -70.04 133.46 47.23 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.656 -0.418 . . . . 0.0 109.952 179.762 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -126.03 -122.26 2.57 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.593 -179.547 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -72.91 145.92 41.18 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.002 1.801 . . . . 0.0 112.575 -179.036 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.589 ' CD2' HG22 ' A' ' 8' ' ' VAL . 54.5 m170 -107.83 143.44 36.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.132 0.491 . . . . 0.0 111.126 -179.331 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.533 ' CD2' HD11 ' A' ' 37' ' ' ILE . 25.8 t80 -115.04 93.96 36.8 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.069 -179.207 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -56.79 124.4 16.15 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 121.896 1.731 . . . . 0.0 111.681 179.136 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.7 mt -87.79 41.73 1.01 Allowed 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.384 -179.781 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.8 p -64.7 -20.44 66.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.788 179.594 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.8 mt -74.04 142.09 45.73 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.568 179.778 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 73.8 p -61.42 -25.15 67.02 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.362 -179.21 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 45.3 m -134.69 134.33 40.97 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.221 -0.592 . . . . 0.0 111.534 179.917 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.692 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -128.37 120.2 26.51 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.069 178.345 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.522 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 43.4 tp -120.03 124.96 47.18 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.999 -177.02 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.692 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 38.8 m-85 -101.37 140.83 35.12 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.23 179.282 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 158.67 -173.58 35.67 Favored Glycine 0 N--CA 1.464 0.536 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.156 178.269 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.63 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 72.2 mtm-85 -83.29 -30.74 27.33 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.876 0.37 . . . . 0.0 110.21 179.895 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.561 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -56.29 152.08 21.15 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 121.126 -0.559 . . . . 0.0 111.728 -178.26 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.578 HD12 ' HD3' ' A' ' 38' ' ' ARG . 7.1 tp -66.7 -40.51 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.677 179.958 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.418 ' N ' HG23 ' A' ' 33' ' ' ILE . 96.9 mt-10 -53.69 -21.39 6.92 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.293 179.972 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.561 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 4.2 m -63.88 115.78 5.17 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.118 -179.974 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.594 ' OD1' ' N ' ' A' ' 37' ' ' ILE . 39.2 p-10 -50.97 -24.59 3.79 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.758 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.673 HD12 ' CE2' ' A' ' 29' ' ' PHE . 94.2 mt -130.67 123.49 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.223 178.062 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.578 ' HD3' HD12 ' A' ' 33' ' ' ILE . 88.2 mtm-85 -103.97 134.66 46.88 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.4 -0.52 . . . . 0.0 109.801 -179.434 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.717 HG21 HD12 ' A' ' 41' ' ' LEU . 98.1 mt -117.91 130.54 72.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.064 0.459 . . . . 0.0 109.796 -179.809 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -79.23 30.37 0.22 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.201 -179.043 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.717 HD12 HG21 ' A' ' 39' ' ' ILE . 33.9 mt -94.8 123.24 58.44 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.476 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.99 -10.76 26.59 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 121.856 1.704 . . . . 0.0 112.047 -179.386 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.6 m -100.51 8.31 8.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.771 -179.211 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.63 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 42.2 t -100.63 136.75 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.459 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.448 ' HB2' ' H ' ' A' ' 48' ' ' HIS . 2.7 m -67.66 169.47 9.4 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.317 0.579 . . . . 0.0 111.478 -179.179 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -62.26 -40.35 95.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.455 -179.474 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.697 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.1 mt-30 -114.59 -11.19 12.42 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 123.348 0.405 . . . . 0.0 111.357 -179.933 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.448 ' H ' ' HB2' ' A' ' 45' ' ' SER . 22.8 t60 31.86 -73.45 0.0 OUTLIER 'General case' 0 C--O 1.237 0.423 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 179.649 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.697 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -134.95 139.5 44.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.284 0.564 . . . . 0.0 112.324 -178.621 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -125.42 128.68 48.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.049 179.323 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 94.6 mt -115.45 133.3 62.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.016 -179.552 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -115.5 127.25 55.17 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.859 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.563 HD13 ' HD2' ' A' ' 5' ' ' ARG . 75.9 mt -108.36 111.99 38.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.95 -179.386 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.538 ' O ' ' N ' ' A' ' 56' ' ' GLN . 82.3 m-70 -110.8 143.94 40.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.541 -179.598 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 54' ' ' HIS . 96.9 mt-10 -41.06 -24.84 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.532 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.538 ' N ' ' O ' ' A' ' 54' ' ' HIS . 94.2 mm-40 -68.8 -68.8 0.37 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.463 178.712 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.595 ' CB ' ' HE ' ' A' ' 81' ' ' ARG . 5.1 tp10 -159.17 -167.76 2.16 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.328 179.895 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.539 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -110.67 125.33 53.34 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.937 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.14 129.54 71.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.353 0.596 . . . . 0.0 112.391 -177.757 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.5 HD11 ' SG ' ' A' ' 49' ' ' CYS . 49.3 tp -94.72 123.45 38.17 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.38 -179.431 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -111.68 136.47 50.87 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.362 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -97.94 105.41 17.55 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.734 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -96.08 -7.32 36.44 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.682 178.976 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 10.1 t -79.46 100.8 7.85 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.279 178.798 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.0 m -84.74 -17.77 37.26 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.084 0.469 . . . . 0.0 110.025 179.577 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.05 -36.61 15.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.602 -179.845 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.437 ' O ' ' OG ' ' A' ' 64' ' ' SER . 79.5 m-20 -144.12 95.24 5.64 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.398 179.765 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.96 146.78 85.49 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.128 1.885 . . . . 0.0 112.658 -179.098 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.5 m -70.71 134.89 47.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.278 178.792 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -99.71 139.77 34.89 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.57 179.989 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 31.4 t -130.49 135.93 59.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 178.706 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 53.42 31.72 12.63 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -178.613 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.37 29.5 70.04 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.152 -179.866 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 81.1 p -137.63 130.5 30.16 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 120.446 -0.502 . . . . 0.0 111.999 -179.283 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.4 t -63.7 141.43 18.16 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.935 179.581 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.584 ' CG2' ' O ' ' A' ' 78' ' ' GLU . 96.3 mt -112.14 111.15 34.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.352 179.511 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -76.31 -34.34 59.04 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.801 179.579 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.584 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.1 OUTLIER -131.51 178.13 1.9 Allowed Pre-proline 0 N--CA 1.468 0.445 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.874 -179.734 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 35.5 Cg_exo -57.13 141.5 94.31 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 122.522 2.148 . . . . 0.0 112.739 -179.079 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.4 t -133.19 138.07 52.17 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.132 179.75 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.595 ' HE ' ' CB ' ' A' ' 57' ' ' GLU . 73.3 ttt180 -74.62 131.46 40.94 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.633 179.28 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.425 HD21 ' HB2' ' A' ' 60' ' ' LEU . 91.2 mt -87.25 140.97 29.01 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.16 0.505 . . . . 0.0 112.272 -178.645 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -134.4 156.12 49.09 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.406 179.59 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.573 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 6.3 t60 -56.77 120.17 7.41 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.868 0.366 . . . . 0.0 111.44 -179.359 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.33 -21.23 22.25 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.52 179.316 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -65.84 135.54 54.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.254 0.55 . . . . 0.0 110.341 -179.788 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.2 t -113.37 133.79 58.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.233 -178.213 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.7 mt -98.35 130.17 47.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.678 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 55.1 m -120.02 124.64 46.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.531 0.682 . . . . 0.0 112.26 -178.818 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.482 HG22 HG12 ' A' ' 91' ' ' ILE . 93.3 mt -115.54 124.0 71.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.091 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.548 HG23 ' SG ' ' B' ' 237' ' ' CYS . 27.5 mm 43.89 -106.49 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -178.812 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.608 ' OD1' ' NH2' ' B' ' 245' ' ' ARG . 40.6 p-10 -114.93 12.73 16.9 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.076 0.465 . . . . 0.0 110.473 179.273 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.515 ' CD ' HD11 ' B' ' 261' ' ' ILE . 6.1 ttp180 -120.39 143.62 48.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.577 179.732 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 38.2 t -137.7 152.83 49.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.353 0.596 . . . . 0.0 111.371 -178.76 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.609 ' HB3' HD11 ' A' ' 7' ' ' LEU . 46.5 m-85 -120.42 120.73 36.8 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.803 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.483 ' O ' HD12 ' A' ' 7' ' ' LEU . 99.7 mtt180 -84.04 131.69 34.79 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.363 -178.562 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.596 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 84.0 t80 -94.26 124.2 38.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.65 179.813 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -129.92 123.26 30.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.009 0.433 . . . . 0.0 111.638 -179.702 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.573 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 65.0 t-20 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.841 179.121 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 N--CA 1.487 1.097 0 CA-C-O 121.283 0.451 . . . . 0.0 112.889 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.435 ' HA ' HD21 ' A' ' 67' ' ' ASN . 31.3 t -59.63 134.78 24.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.794 -179.672 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . 0.548 ' SG ' HG23 ' A' ' 91' ' ' ILE . 8.6 t . . . . . 0 C--N 1.328 -0.359 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -179.861 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo . . . . . 0 N--CA 1.492 1.428 0 CA-C-O 120.444 0.102 . . . . 0.0 112.165 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 76.0 m -72.88 -44.46 61.28 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 178.337 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.464 ' CE2' ' HD2' ' B' ' 245' ' ' ARG . 63.3 t80 -58.75 -47.64 83.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.29 -179.465 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' B' ' 242' ' ' LEU . 89.2 mt -64.59 -42.49 95.55 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -179.386 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -65.52 -38.72 90.49 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.521 -0.472 . . . . 0.0 111.136 -179.08 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -61.77 -44.08 97.59 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.855 179.78 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.608 ' NH2' ' OD1' ' A' ' 92' ' ' ASP . 82.2 mtp180 -63.16 -37.66 88.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.089 -179.028 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.82 -39.4 91.65 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.359 -0.537 . . . . 0.0 109.99 179.225 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 61.9 m -67.49 -43.79 80.1 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.571 0.701 . . . . 0.0 109.516 178.274 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -60.82 -37.35 81.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.699 -179.863 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . 0.456 HG23 ' O ' ' B' ' 245' ' ' ARG . 50.0 t . . . . . 0 N--CA 1.447 -0.587 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.185 179.61 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.418 ' HB2' ' NH2' ' A' ' 93' ' ' ARG . 96.5 mt-10 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 121.0 0.429 . . . . 0.0 110.408 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.515 HD11 ' CD ' ' A' ' 93' ' ' ARG . 74.0 mt -112.93 137.64 45.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.684 179.978 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . 0.496 HG11 ' NH2' ' A' ' 38' ' ' ARG . 41.3 t -126.86 134.15 66.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.906 0.384 . . . . 0.0 110.579 179.891 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . 0.44 ' CD2' HG21 ' B' ' 267' ' ' ILE . 84.0 m-85 -97.55 122.26 40.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.979 0.418 . . . . 0.0 111.961 -178.528 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . 0.451 ' HA ' HH12 ' A' ' 38' ' ' ARG . 87.4 tttt -62.56 -44.9 95.2 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.663 179.578 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -99.52 164.97 15.59 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.01 179.977 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.72 153.13 51.63 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.392 2.062 . . . . 0.0 112.099 179.567 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . 0.485 HG22 ' HD1' ' A' ' 20' ' ' PHE . 36.4 pt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.089 -178.576 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 51.0 p . . . . . 0 CA--C 1.522 -0.127 0 CA-C-O 120.902 0.382 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.933 ' NH1' HG23 ' A' ' 53' ' ' ILE . 99.2 mtt180 -99.52 129.73 45.71 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.556 -178.78 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -129.23 143.08 50.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.495 -179.726 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.524 HD11 HD11 ' A' ' 22' ' ' LEU . 90.9 mt -113.29 136.37 52.82 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.697 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 50.0 t -112.94 131.92 63.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.839 -0.345 . . . . 0.0 110.303 -179.384 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.428 ' CG2' HD12 ' B' ' 261' ' ' ILE . 5.2 m -90.07 115.88 27.67 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 -177.722 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.47 HD12 ' HB2' ' A' ' 94' ' ' SER . 96.8 mt -85.09 142.22 13.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.292 178.153 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -91.42 159.98 15.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.97 0.414 . . . . 0.0 110.515 179.36 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 88.9 mtm180 -58.05 -29.53 65.45 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.792 -179.229 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.1 p -76.75 -17.3 59.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.86 0.362 . . . . 0.0 110.544 179.471 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.93 32.75 5.5 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -179.679 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.4 t -121.35 132.46 70.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.054 0.454 . . . . 0.0 111.106 -179.994 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -78.23 138.44 38.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.667 178.883 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.7 -115.72 1.67 Allowed Glycine 0 CA--C 1.533 1.162 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.467 179.936 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.11 148.56 56.63 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 121.841 1.694 . . . . 0.0 112.433 -179.392 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.467 ' CD2' ' C ' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -113.13 158.05 20.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.016 0.436 . . . . 0.0 109.921 179.701 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.747 ' CD2' HD11 ' A' ' 37' ' ' ILE . 48.1 t80 -120.53 101.31 46.32 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.164 -179.044 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -75.2 131.41 14.04 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.016 1.811 . . . . 0.0 111.891 -179.617 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.524 HD11 HD11 ' A' ' 7' ' ' LEU . 83.8 mt -86.71 85.32 7.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.158 0.504 . . . . 0.0 112.043 -178.486 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 92.6 p -89.01 -9.68 50.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.194 178.058 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 47.2 mt -104.45 148.12 26.81 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.071 -179.816 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.5 m -70.83 -16.23 62.7 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.498 -179.463 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.421 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 55.8 m -131.31 134.11 46.03 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.752 -179.916 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.6 t -129.63 120.54 25.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.955 178.179 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.464 HD11 ' HB3' ' A' ' 47' ' ' GLN . 35.3 tp -116.4 129.82 56.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.887 -179.078 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.528 ' O ' ' O ' ' A' ' 47' ' ' GLN . 9.8 m-85 -108.95 139.11 44.26 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.697 179.904 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 151.94 -178.71 29.05 Favored Glycine 0 N--CA 1.47 0.925 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.161 178.316 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.412 ' HD2' HH11 ' A' ' 31' ' ' ARG . 46.9 mtm180 -67.14 -33.29 75.12 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 179.381 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.54 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -46.78 131.8 12.29 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 -178.812 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.521 HG23 ' N ' ' A' ' 34' ' ' GLU . 9.3 tp -64.79 -42.03 93.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 O-C-N 122.434 -0.451 . . . . 0.0 110.024 179.387 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.521 ' N ' HG23 ' A' ' 33' ' ' ILE . 7.9 pt-20 -56.4 -13.01 1.93 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.228 179.292 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.54 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 31.3 m -70.16 139.15 52.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.595 -179.301 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.461 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 57.2 m-20 -63.77 -34.74 78.58 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.329 -179.505 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.747 HD11 ' CD2' ' A' ' 20' ' ' PHE . 40.6 mm -122.22 112.82 36.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 177.978 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.415 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 15.9 ttp180 -101.83 130.88 48.38 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.596 -178.636 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.675 HG21 HD12 ' A' ' 41' ' ' LEU . 93.2 mt -118.68 131.85 70.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.157 -179.395 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -76.03 32.45 0.12 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.606 -179.528 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.942 HD11 HH21 ' A' ' 93' ' ' ARG . 20.3 mt -95.55 118.46 66.14 Favored Pre-proline 0 CA--C 1.534 0.355 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.507 179.499 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -73.36 -11.4 24.7 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 121.908 1.739 . . . . 0.0 111.985 -179.922 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.1 m -95.39 5.26 8.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.207 179.431 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.446 HG12 ' O ' ' A' ' 45' ' ' SER . 5.0 t -98.69 139.84 19.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.577 -179.464 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.446 ' O ' HG12 ' A' ' 44' ' ' VAL . 75.3 m -68.73 175.18 3.71 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.682 0.753 . . . . 0.0 111.315 -179.589 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -65.12 -43.17 92.82 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.958 -179.699 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.616 ' O ' ' N ' ' A' ' 49' ' ' CYS . 81.9 mt-30 -113.77 -12.72 12.72 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.542 -179.682 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.9 t60 38.7 -76.89 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 178.873 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.616 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -135.58 140.32 44.56 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.252 0.548 . . . . 0.0 111.812 -178.657 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -125.51 132.65 52.58 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.788 179.891 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.5 mt -116.42 134.1 60.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.918 179.49 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.438 ' CG ' ' NE2' ' A' ' 54' ' ' HIS . 47.2 tp10 -119.96 128.6 53.73 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.369 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.933 HG23 ' NH1' ' A' ' 5' ' ' ARG . 96.8 mt -105.57 123.54 60.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.591 0.71 . . . . 0.0 112.159 -178.678 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.569 ' O ' ' N ' ' A' ' 56' ' ' GLN . 3.3 m-70 -120.54 139.9 52.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.452 -179.752 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.467 ' C ' ' O ' ' A' ' 54' ' ' HIS . 83.9 tt0 -39.3 -25.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.73 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' A' ' 54' ' ' HIS . 67.9 tp60 -69.11 -68.2 0.42 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.096 178.301 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.479 ' HA ' HH22 ' A' ' 5' ' ' ARG . 8.8 pt-20 -160.03 -157.52 0.56 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.708 179.64 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.406 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -113.73 132.3 55.87 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.505 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.448 ' CG2' ' NE2' ' A' ' 61' ' ' HIS . 45.5 mm -111.08 127.54 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 121.051 -0.26 . . . . 0.0 111.636 -178.65 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.435 ' HB3' HG13 ' A' ' 80' ' ' VAL . 28.8 tp -103.51 125.3 49.99 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.955 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.448 ' NE2' ' CG2' ' A' ' 59' ' ' ILE . 97.9 m-70 -118.37 139.49 51.3 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.486 -179.211 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.421 ' ND2' ' H ' ' A' ' 69' ' ' THR . 12.6 t-20 -102.7 107.86 18.91 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.596 179.741 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -94.83 -7.8 39.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.66 179.142 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.09 99.7 11.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.856 0.36 . . . . 0.0 110.878 -179.861 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.6 p -77.39 -32.91 55.15 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.885 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.7 m -63.55 -49.35 73.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.221 -179.405 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -136.55 91.92 15.6 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.957 -179.626 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.56 ' HB2' HG13 ' A' ' 75' ' ' VAL . 52.4 Cg_exo -54.77 143.55 69.99 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.157 1.904 . . . . 0.0 112.568 -179.599 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.421 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 15.8 m -74.71 138.07 42.51 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.839 179.246 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -100.12 140.48 34.28 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.271 179.636 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.453 ' O ' ' N ' ' A' ' 74' ' ' SER . 5.1 p -131.59 136.42 57.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 178.939 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 48.35 31.98 3.0 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -178.675 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.84 29.48 63.05 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.437 -179.831 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.453 ' N ' ' O ' ' A' ' 71' ' ' VAL . 19.5 m -140.34 133.5 29.56 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 120.58 -0.448 . . . . 0.0 112.112 -179.479 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.56 HG13 ' HB2' ' A' ' 68' ' ' PRO . 7.0 t -70.43 139.06 20.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.475 179.152 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.429 HG21 HG11 ' A' ' 80' ' ' VAL . 3.7 pt -112.26 94.37 3.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.117 0.484 . . . . 0.0 111.266 179.814 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -65.22 -29.08 69.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.974 178.956 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.0 176.1 2.85 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.392 -179.979 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -59.93 144.08 99.51 Favored 'Trans proline' 0 N--CA 1.5 1.899 0 C-N-CA 122.515 2.143 . . . . 0.0 112.591 -179.776 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.435 HG13 ' HB3' ' A' ' 60' ' ' LEU . 7.1 p -136.7 141.26 41.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.521 179.679 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -81.02 130.21 34.91 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.473 179.377 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.5 mt -83.61 141.3 31.64 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.039 0.447 . . . . 0.0 111.642 -179.791 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -130.75 151.16 51.49 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.909 179.171 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.405 ' CE1' ' H ' ' A' ' 99' ' ' ASN . 4.3 t60 -52.12 118.66 3.65 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.001 0.429 . . . . 0.0 111.587 -178.637 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.03 -13.57 37.53 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 179.455 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -67.99 135.37 52.23 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.19 179.831 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.4 t -112.44 133.29 58.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.81 -178.205 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 92.8 mt -104.53 132.35 51.36 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.643 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 58.8 m -119.39 128.0 53.66 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.325 -0.55 . . . . 0.0 112.112 -178.766 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 98.2 mt -122.08 124.83 72.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.846 178.588 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.402 HG22 ' N ' ' A' ' 92' ' ' ASP . 26.0 mm 41.45 -114.99 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 121.068 -0.253 . . . . 0.0 110.629 -178.837 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.402 ' N ' HG22 ' A' ' 91' ' ' ILE . 93.4 m-20 -101.56 12.94 36.38 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.767 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.942 HH21 HD11 ' A' ' 41' ' ' LEU . 11.4 mtm180 -131.46 149.07 52.67 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.382 -179.497 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.47 ' HB2' HD12 ' A' ' 10' ' ' ILE . 71.7 m -135.49 154.15 51.51 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.008 0.432 . . . . 0.0 111.337 -179.631 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.452 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 85.1 m-85 -120.49 120.52 36.12 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.539 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 78.1 mtp85 -85.22 136.79 33.37 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 120.308 -0.557 . . . . 0.0 111.059 -179.238 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 92.2 t80 -96.5 118.81 33.79 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.402 -179.625 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -122.7 122.95 40.0 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.755 0.312 . . . . 0.0 111.0 179.549 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.405 ' H ' ' CE1' ' A' ' 84' ' ' HIS . 52.7 t-20 . . . . . 0 C--O 1.231 0.097 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.717 179.733 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 N--CA 1.49 1.294 0 N-CA-C 113.652 0.597 . . . . 0.0 113.652 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -68.48 140.27 19.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.648 -179.74 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 19.4 t . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.734 -179.858 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo . . . . . 0 N--CA 1.498 1.775 0 N-CA-C 113.431 0.512 . . . . 0.0 113.431 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 59.5 m -73.9 -43.51 58.24 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.18 0.514 . . . . 0.0 109.698 178.358 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -58.93 -45.81 89.49 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.558 -179.243 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' B' ' 242' ' ' LEU . 91.1 mt -64.77 -40.87 95.99 Favored 'General case' 0 CA--C 1.521 -0.161 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.192 -179.429 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -59.96 -40.72 89.99 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.05 -179.638 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 62.0 ttp180 -62.39 -43.32 99.11 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.792 0.33 . . . . 0.0 110.794 179.786 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.594 ' NH1' ' OE1' ' B' ' 248' ' ' GLN . 1.9 mpt_? -59.32 -43.73 92.64 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.111 -179.307 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.7 -40.96 98.77 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.838 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 65.6 m -64.38 -45.21 88.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.411 0.624 . . . . 0.0 109.327 178.194 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . 0.594 ' OE1' ' NH1' ' B' ' 245' ' ' ARG . 80.4 mt-30 -60.36 -37.38 80.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.116 -179.81 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . 0.47 HG23 ' O ' ' B' ' 245' ' ' ARG . 48.7 t . . . . . 0 C--N 1.328 -0.364 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.325 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.498 ' OE1' ' NH2' ' A' ' 93' ' ' ARG . 93.6 mt-10 . . . . . 0 N--CA 1.463 0.186 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.452 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 81.0 mt -109.77 131.97 59.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.194 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 40.4 t -124.06 132.67 70.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.348 -179.807 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -94.42 117.23 29.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.104 0.478 . . . . 0.0 111.108 -178.509 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -67.87 -46.59 71.28 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.513 179.949 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.17 163.43 23.44 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.223 -178.96 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -60.33 149.59 85.0 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.177 1.918 . . . . 0.0 112.031 179.857 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.3 pt . . . . . 0 C--N 1.328 -0.344 0 CA-C-O 121.485 0.66 . . . . 0.0 111.886 -178.396 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 CA--C 1.517 -0.29 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 87.2 mtm-85 -93.5 111.3 22.94 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.098 0.475 . . . . 0.0 110.392 -179.372 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.481 ' NH2' ' ND1' ' A' ' 19' ' ' HIS . 79.5 ttt180 -127.44 131.22 50.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.184 -179.776 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.545 HD11 HD21 ' A' ' 22' ' ' LEU . 80.0 mt -110.12 135.64 50.6 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.832 179.952 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.82 HG21 ' NH2' ' A' ' 96' ' ' ARG . 89.0 t -106.74 120.38 57.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.479 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.601 HG21 ' HZ ' ' B' ' 263' ' ' PHE . 70.0 p -77.45 140.81 39.91 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.576 0.703 . . . . 0.0 110.99 -179.05 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 51.0 mm -103.76 130.18 54.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.619 -179.791 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.462 ' HA ' HH12 ' A' ' 93' ' ' ARG . 95.9 mttt -83.98 154.99 23.01 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.889 178.001 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.543 HH22 ' CB ' ' B' ' 248' ' ' GLN . 75.8 mtp180 -56.61 -34.3 67.09 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.532 -179.214 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 67.4 m -76.76 -6.13 50.98 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.428 179.093 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.32 32.09 10.92 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.529 179.482 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.0 t -113.53 132.25 62.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.794 0.331 . . . . 0.0 110.639 -179.998 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -73.13 136.28 44.81 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.503 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -130.75 -115.98 1.78 Allowed Glycine 0 CA--C 1.534 1.279 0 C-N-CA 120.18 -1.009 . . . . 0.0 112.886 -178.855 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.81 143.18 45.1 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 122.24 1.96 . . . . 0.0 112.937 -177.952 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.596 ' NE2' HG13 ' A' ' 8' ' ' VAL . 57.4 m170 -110.29 123.08 49.15 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.446 179.591 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.566 ' CD2' HD11 ' A' ' 37' ' ' ILE . 43.1 t80 -98.04 109.07 50.1 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.907 -179.513 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -79.03 139.09 14.95 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 121.344 1.363 . . . . 0.0 111.707 179.373 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.545 HD21 HD11 ' A' ' 7' ' ' LEU . 74.3 mt -91.66 50.13 1.67 Allowed 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.205 -178.967 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.8 t -63.82 -17.44 63.12 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 119.45 -0.9 . . . . 0.0 108.692 178.968 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.76 HD11 ' HG2' ' B' ' 265' ' ' GLN . 46.2 mt -78.65 138.45 38.32 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.875 179.951 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.15 -23.05 65.27 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.608 -179.274 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 94.5 m -133.78 134.91 43.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.561 179.147 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.447 ' SG ' HD22 ' A' ' 22' ' ' LEU . 6.1 t -124.37 118.43 26.71 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.536 179.008 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.483 HD21 ' HG2' ' A' ' 47' ' ' GLN . 44.4 tp -115.49 131.63 56.87 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.224 0.535 . . . . 0.0 111.78 -178.421 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.706 ' CE2' HD12 ' A' ' 37' ' ' ILE . 2.3 m-85 -111.2 138.96 46.99 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.572 179.865 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 150.85 179.21 26.4 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.539 178.68 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 45.7 mtm180 -70.22 -33.04 71.19 Favored 'General case' 0 C--O 1.227 -0.123 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 179.795 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.616 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -51.32 148.05 9.21 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.193 -179.065 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.413 HG23 ' N ' ' A' ' 34' ' ' GLU . 11.0 tp -67.5 -39.72 83.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.217 -0.593 . . . . 0.0 109.508 179.54 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.413 ' N ' HG23 ' A' ' 33' ' ' ILE . 98.4 mt-10 -53.06 -21.55 4.79 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.261 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.616 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 48.3 m -55.84 118.51 4.66 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.706 -179.597 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -59.72 -32.79 70.86 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -179.924 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.706 HD12 ' CE2' ' A' ' 29' ' ' PHE . 91.1 mt -123.5 120.96 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 176.256 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -109.04 135.33 50.38 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.949 -177.326 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.456 HG21 HD12 ' A' ' 41' ' ' LEU . 95.1 mt -119.87 130.27 74.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.618 -179.652 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -75.17 25.67 0.1 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.473 -179.099 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.456 HD12 HG21 ' A' ' 39' ' ' ILE . 24.3 mt -88.9 123.26 67.97 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.184 -179.915 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -73.28 -10.15 23.87 Favored 'Trans proline' 0 N--CA 1.49 1.285 0 C-N-CA 121.877 1.718 . . . . 0.0 112.548 179.714 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.51 HG21 ' CE2' ' B' ' 241' ' ' PHE . 30.0 m -97.97 8.26 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.114 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.555 179.442 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 25.5 t -101.26 139.56 22.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.449 179.068 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.1 m -74.11 171.85 12.8 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.061 0.458 . . . . 0.0 111.444 -178.974 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.6 mttp -61.37 -42.46 98.75 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.245 -178.778 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.62 ' O ' ' N ' ' A' ' 49' ' ' CYS . 95.5 mt-30 -112.81 -15.96 12.83 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.575 0.226 . . . . 0.0 111.162 -179.163 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 18.5 t60 37.25 -75.64 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 179.071 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.62 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.76 137.82 48.34 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.266 0.555 . . . . 0.0 111.366 -177.661 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -129.71 134.05 47.41 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.156 -179.983 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.4 mt -118.34 135.57 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.682 -179.688 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -112.78 127.84 56.26 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.638 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.4 mm -100.55 125.76 54.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 119.674 -0.81 . . . . 0.0 110.712 -179.668 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.456 ' O ' ' N ' ' A' ' 56' ' ' GLN . 94.7 m-70 -130.35 136.22 48.87 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.307 179.806 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 54' ' ' HIS . 42.7 tt0 -40.74 -28.85 0.08 Allowed 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.217 -0.593 . . . . 0.0 109.845 -179.272 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.456 ' N ' ' O ' ' A' ' 54' ' ' HIS . 55.0 tt0 -65.99 -68.28 0.38 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.301 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -158.37 -164.55 1.5 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.801 179.737 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -118.3 135.13 54.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.983 0.42 . . . . 0.0 110.394 179.775 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.05 130.27 74.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.564 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.599 ' HB2' HD21 ' A' ' 82' ' ' LEU . 50.1 tp -93.17 126.69 38.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.546 178.923 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -113.91 134.32 54.89 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.236 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 31.5 t30 -97.59 104.27 16.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.955 -179.481 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -96.44 -9.69 29.22 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.677 178.86 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.2 m -72.19 98.17 2.1 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.693 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.5 p -77.34 -36.1 54.15 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.705 0.765 . . . . 0.0 109.231 178.644 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.8 m -65.23 -48.57 72.83 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.387 -1.279 . . . . 0.0 110.78 -179.147 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -142.04 100.76 5.87 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.201 -179.128 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.18 145.75 85.11 Favored 'Trans proline' 0 N--CA 1.5 1.872 0 C-N-CA 122.022 1.815 . . . . 0.0 111.858 -179.564 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.3 m -72.49 141.87 48.56 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.199 0.523 . . . . 0.0 110.548 -179.642 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -101.0 141.61 33.64 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.805 -179.606 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.532 ' HB ' HD11 ' A' ' 76' ' ' ILE . 23.5 t -131.27 136.52 57.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 177.25 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 54.04 31.41 13.6 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -178.795 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.85 24.01 76.83 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.004 179.65 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 44.1 t -134.99 137.26 42.85 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.325 0.583 . . . . 0.0 111.527 -179.737 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.3 t -68.04 139.87 20.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.076 -179.544 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.585 ' CG2' ' O ' ' A' ' 78' ' ' GLU . 95.9 mt -113.88 116.77 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.986 179.407 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -90.74 -24.15 20.47 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.712 179.054 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.585 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.2 OUTLIER -128.9 168.18 16.91 Favored Pre-proline 0 C--O 1.222 -0.388 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.879 -178.669 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -66.28 148.02 84.09 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 122.463 2.109 . . . . 0.0 112.7 -179.941 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.1 m -141.18 151.93 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.164 179.976 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -78.53 129.23 34.6 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.485 179.345 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.599 HD21 ' HB2' ' A' ' 60' ' ' LEU . 95.9 mt -82.42 140.56 33.37 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.931 0.396 . . . . 0.0 110.736 -179.114 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -129.92 151.94 49.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.552 179.745 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.447 ' C ' ' CD2' ' A' ' 84' ' ' HIS . 7.5 t60 -56.5 119.98 6.96 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.165 -178.89 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.17 -18.13 23.79 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 121.155 -0.545 . . . . 0.0 111.767 179.128 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -69.51 133.23 47.44 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.331 179.912 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.0 t -107.76 136.9 41.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.45 -178.6 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 95.3 mt -103.07 129.1 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 178.167 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 96.2 m -120.33 127.32 52.23 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 119.913 -0.715 . . . . 0.0 112.025 -178.532 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.526 ' O ' ' N ' ' A' ' 93' ' ' ARG . 90.7 mt -116.5 134.86 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 CA-C-N 115.023 -0.989 . . . . 0.0 108.961 178.229 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.507 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 47.1 mt -29.13 97.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.415 -178.807 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.507 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 1.4 m-20 92.05 -22.4 0.08 Allowed 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 112.872 0.694 . . . . 0.0 112.872 178.047 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.745 HH21 ' CD1' ' B' ' 261' ' ' ILE . 25.2 mmm180 -131.04 143.73 50.92 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.17 -179.734 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 43.2 t -138.38 152.25 48.24 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.975 0.417 . . . . 0.0 110.421 -179.901 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -127.26 123.36 36.29 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.353 179.659 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.82 ' NH2' HG21 ' A' ' 8' ' ' VAL . 38.3 ttp-105 -90.31 135.58 33.59 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.487 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 81.4 t80 -98.93 127.89 44.96 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -178.489 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -134.0 120.68 20.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.28 179.552 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.44 ' OD1' ' ND1' ' A' ' 84' ' ' HIS . 43.1 p-10 . . . . . 0 C--N 1.332 -0.168 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.338 -179.949 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo . . . . . 0 N--CA 1.489 1.213 0 N-CA-C 113.936 0.706 . . . . 0.0 113.936 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.19 139.62 20.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.7 179.854 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . 0.421 ' HB2' HD13 ' A' ' 91' ' ' ILE . 4.0 t . . . . . 0 C--N 1.323 -0.582 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.569 -178.575 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo . . . . . 0 N--CA 1.496 1.646 0 N-CA-C 112.735 0.244 . . . . 0.0 112.735 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 2.8 m -74.78 -43.65 53.66 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 177.898 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.57 ' CZ ' ' NH2' ' B' ' 245' ' ' ARG . 79.0 t80 -58.36 -46.91 85.39 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.499 -179.374 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 95.9 mt -67.78 -39.3 84.07 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.058 179.384 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 73.3 tt0 -61.07 -41.56 96.86 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.539 179.906 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . 0.625 ' NH1' ' NE2' ' B' ' 248' ' ' GLN . 78.4 ttt-85 -64.12 -40.98 97.36 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.245 0.545 . . . . 0.0 109.653 179.538 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.645 ' O ' HG23 ' B' ' 249' ' ' VAL . 10.1 tpp180 -57.33 -42.7 82.42 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.054 -179.525 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.48 -41.45 98.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.445 179.824 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 47.1 t -63.27 -45.07 93.2 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.468 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . 0.625 ' NE2' ' NH1' ' B' ' 244' ' ' ARG . 84.6 mt-30 -60.67 -32.53 71.73 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.473 179.655 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . 0.645 HG23 ' O ' ' B' ' 245' ' ' ARG . 72.5 t . . . . . 0 N--CA 1.451 -0.381 0 C-N-CA 119.977 -0.689 . . . . 0.0 109.477 179.52 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 . . . . . 0 N--CA 1.467 0.389 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.745 ' CD1' HH21 ' A' ' 93' ' ' ARG . 66.0 mt -112.97 133.93 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.254 179.888 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 45.9 t -124.18 132.63 71.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.743 178.918 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . 0.601 ' HZ ' HG21 ' A' ' 9' ' ' THR . 49.2 m-85 -97.13 118.66 34.04 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.377 0.608 . . . . 0.0 111.909 -178.131 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -62.41 -44.19 97.02 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.767 178.813 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . 0.76 ' HG2' HD11 ' A' ' 24' ' ' LEU . 1.6 mp0 -84.55 162.31 51.13 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.366 -179.809 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -65.59 144.96 80.69 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.095 1.863 . . . . 0.0 112.44 179.9 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.536 0.435 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.551 -179.896 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 72.3 p . . . . . 0 C--O 1.234 0.265 0 CA-C-O 120.914 0.388 . . . . 0.0 110.446 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.8 mtt85 -88.57 132.0 34.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.554 179.718 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 19.5 ptp180 -139.02 148.67 43.72 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 120.029 -0.668 . . . . 0.0 111.717 179.877 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.594 HD11 HD11 ' A' ' 22' ' ' LEU . 67.1 mt -115.26 144.8 43.18 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.766 179.676 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.463 HG22 ' CD2' ' A' ' 19' ' ' HIS . 48.6 t -117.37 124.83 73.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.475 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.1 m -73.73 138.12 44.44 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.927 0.394 . . . . 0.0 111.846 -179.079 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.693 HD12 ' OG ' ' A' ' 94' ' ' SER . 78.8 mt -111.31 137.11 45.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.377 178.079 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -92.76 155.11 17.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.663 179.868 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.855 HH11 HH11 ' B' ' 245' ' ' ARG . 90.6 mtm180 -58.1 -23.73 55.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.505 -179.126 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.8 p -81.97 -10.15 59.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.1 0.476 . . . . 0.0 109.736 179.031 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.55 34.58 7.83 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 -179.819 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.6 t -122.45 133.31 69.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.706 0.288 . . . . 0.0 110.903 -179.959 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -74.99 141.06 44.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.861 179.844 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.04 -118.96 2.13 Favored Glycine 0 CA--C 1.542 1.727 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.369 -179.309 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.11 145.53 44.55 Favored 'Trans proline' 0 N--CA 1.501 1.918 0 C-N-CA 122.517 2.145 . . . . 0.0 114.065 -177.932 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.463 ' CD2' HG22 ' A' ' 8' ' ' VAL . 57.8 m170 -105.56 139.08 40.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.248 179.842 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.503 ' CD2' HD11 ' A' ' 37' ' ' ILE . 31.2 t80 -112.15 104.6 56.12 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 108.957 -0.756 . . . . 0.0 108.957 179.505 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -75.47 133.42 15.88 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 C-N-CA 121.404 1.403 . . . . 0.0 110.772 -178.983 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.594 HD11 HD11 ' A' ' 7' ' ' LEU . 97.2 mt -87.81 59.18 5.25 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 119.879 -0.728 . . . . 0.0 111.784 -178.187 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.2 p -67.61 -21.13 65.41 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.473 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.549 ' CD1' ' NE2' ' B' ' 265' ' ' GLN . 70.2 mt -84.01 140.69 31.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.628 -179.686 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 77.7 p -62.56 -21.31 65.49 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.78 -179.507 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.505 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 65.5 m -131.94 132.82 43.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.848 0.356 . . . . 0.0 111.748 -179.234 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.551 ' HB2' HD22 ' A' ' 22' ' ' LEU . 7.1 t -124.86 118.51 26.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.302 178.242 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 45.5 tp -115.95 128.45 55.76 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.439 -178.908 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.744 ' CE2' HD12 ' A' ' 37' ' ' ILE . 6.3 m-85 -106.51 136.0 47.04 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.335 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 159.02 -169.64 35.29 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 119.727 -1.225 . . . . 0.0 112.402 178.854 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.422 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 42.1 mtm180 -87.34 -31.1 20.34 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.418 179.376 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.416 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -50.82 148.18 7.89 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -179.735 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 36.9 mm -63.98 -43.73 97.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 O-C-N 122.611 -0.346 . . . . 0.0 111.046 -179.409 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -53.69 -18.12 2.8 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.82 -179.511 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.416 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 70.3 m -59.68 123.47 17.04 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 121.13 0.49 . . . . 0.0 111.189 -179.449 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.505 ' OD2' ' O ' ' A' ' 26' ' ' THR . 71.1 m-20 -60.77 -29.95 69.73 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.804 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.744 HD12 ' CE2' ' A' ' 29' ' ' PHE . 95.6 mt -127.17 123.95 63.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.241 -0.89 . . . . 0.0 108.822 177.492 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' A' ' 38' ' ' ARG . 26.8 mtm180 -107.18 138.11 43.99 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.283 -179.107 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 95.9 mt -119.26 128.63 75.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.445 -179.911 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -73.16 30.72 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.123 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.584 HD21 ' OE1' ' B' ' 260' ' ' GLU . 94.0 mt -108.19 128.31 25.95 Favored Pre-proline 0 N--CA 1.464 0.257 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.649 179.137 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.75 -8.87 21.99 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.488 2.125 . . . . 0.0 112.107 179.953 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.7 m -93.13 4.22 7.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 121.209 0.528 . . . . 0.0 110.274 179.293 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.422 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 20.4 t -95.13 133.7 35.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.512 -0.767 . . . . 0.0 108.941 178.332 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.2 t -70.41 170.52 11.78 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.287 0.565 . . . . 0.0 111.506 -178.266 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 52.2 mttp -62.97 -42.57 99.87 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.132 -179.444 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.607 ' O ' ' N ' ' A' ' 49' ' ' CYS . 87.1 mt-30 -114.49 -22.9 9.59 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 123.436 0.46 . . . . 0.0 110.709 -179.808 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.3 t60 37.13 -75.83 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 179.502 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.607 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -128.36 134.04 48.77 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.101 0.477 . . . . 0.0 111.955 -177.817 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -128.87 136.94 51.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.608 -179.932 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.7 mt -121.93 135.94 60.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.978 -179.932 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -113.85 127.1 55.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.634 178.973 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 48.8 mm -96.1 114.3 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-O 121.174 0.512 . . . . 0.0 111.555 -179.522 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.463 ' O ' ' N ' ' A' ' 56' ' ' GLN . 94.6 m-70 -117.54 134.61 54.68 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.622 178.684 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.478 ' H ' ' CD ' ' A' ' 55' ' ' GLU . 57.6 mp0 -39.72 -29.72 0.06 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -179.718 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.463 ' N ' ' O ' ' A' ' 54' ' ' HIS . 87.7 mt-30 -66.55 -67.87 0.42 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.545 178.735 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.11 -165.18 1.77 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.698 -179.275 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -120.28 129.46 54.04 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.569 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.4 mt -114.05 130.66 67.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -178.493 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.424 ' HB2' HD11 ' A' ' 82' ' ' LEU . 51.2 tp -94.59 124.54 38.69 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.884 179.585 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -112.84 137.6 50.94 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.099 -179.232 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.558 ' ND2' ' O ' ' A' ' 76' ' ' ILE . 50.7 p-10 -98.33 104.57 16.61 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.866 -179.841 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -93.88 -7.28 43.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.162 0.506 . . . . 0.0 109.825 178.328 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.4 t -75.21 100.9 4.45 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.013 179.531 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.9 m -87.46 -9.31 54.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.234 -179.962 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.573 HG22 HG22 ' B' ' 236' ' ' VAL . 0.2 OUTLIER -96.16 -41.92 8.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.09 0.472 . . . . 0.0 109.829 -179.85 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 40.9 m-20 -140.59 101.29 6.65 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.746 179.586 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -56.02 143.32 83.54 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 121.996 1.797 . . . . 0.0 112.24 -179.466 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 92.4 m -70.78 138.33 50.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.27 178.763 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -98.3 139.63 33.79 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.058 -179.999 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.407 HG21 HD23 ' A' ' 60' ' ' LEU . 55.5 t -133.5 132.38 57.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.288 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 53.22 34.31 17.31 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.612 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.5 29.02 66.51 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 114.958 -1.019 . . . . 0.0 112.53 179.928 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 47.3 t -145.72 142.42 28.94 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.924 179.763 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.0 m -74.75 140.24 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.515 179.278 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.587 HG22 HG21 ' A' ' 80' ' ' VAL . 4.6 pt -105.34 98.91 7.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.618 0.723 . . . . 0.0 109.901 178.781 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -63.86 -34.66 78.44 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.573 -179.705 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.458 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 1.2 mt-10 -128.9 -178.78 0.85 Allowed Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.748 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.458 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 25.0 Cg_exo -61.42 142.43 95.49 Favored 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 122.192 1.928 . . . . 0.0 113.03 -178.813 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.587 HG21 HG22 ' A' ' 76' ' ' ILE . 78.0 t -132.72 137.53 53.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.159 179.736 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -75.99 128.51 35.2 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.576 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.424 HD11 ' HB2' ' A' ' 60' ' ' LEU . 96.6 mt -84.01 136.43 34.05 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.99 -179.702 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -120.53 149.94 41.63 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.767 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.539 ' ND1' ' N ' ' A' ' 99' ' ' ASN . 6.1 t60 -55.31 123.88 15.25 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.995 -178.603 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.05 -13.55 52.46 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.513 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -71.24 136.91 48.22 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.49 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.4 p -105.5 140.42 23.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.776 -0.37 . . . . 0.0 111.38 -178.815 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 72.1 mt -108.25 130.81 60.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.092 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 53.5 m -126.39 128.8 47.6 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -177.355 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 91.4 mt -112.66 121.67 65.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 114.228 -1.351 . . . . 0.0 107.354 177.197 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.622 HG22 ' N ' ' A' ' 92' ' ' ASP . 97.0 mt 35.57 -99.01 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.751 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.622 ' N ' HG22 ' A' ' 91' ' ' ILE . 94.5 m-20 -110.38 8.62 23.37 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -178.982 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.505 HH21 HG13 ' B' ' 261' ' ' ILE . 50.3 mtp85 -127.12 144.26 51.07 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -179.846 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.693 ' OG ' HD12 ' A' ' 10' ' ' ILE . 19.4 p -141.28 159.28 42.54 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.37 0.605 . . . . 0.0 112.217 -178.458 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.661 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 87.9 m-85 -129.24 125.01 35.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.084 178.231 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -82.12 135.16 35.34 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 119.769 -0.773 . . . . 0.0 110.49 179.967 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -97.2 122.92 40.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.323 0.582 . . . . 0.0 111.091 -179.271 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -124.31 117.16 23.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.533 179.455 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.539 ' N ' ' ND1' ' A' ' 84' ' ' HIS . 64.7 t-20 . . . . . 0 C--N 1.322 -0.619 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.704 -179.747 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo . . . . . 0 N--CA 1.488 1.17 0 CA-C-O 121.42 0.508 . . . . 0.0 112.067 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.573 HG22 HG22 ' A' ' 66' ' ' THR . 53.3 t -62.61 135.42 27.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.559 179.666 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 14.9 t . . . . . 0 CA--C 1.518 -0.259 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.413 -179.511 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo . . . . . 0 N--CA 1.495 1.597 0 N-CA-C 112.476 0.145 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 17.4 p -73.65 -40.74 63.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.017 0.436 . . . . 0.0 110.006 178.371 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -56.6 -46.53 80.8 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.871 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.442 HD23 ' OD2' ' A' ' 92' ' ' ASP . 93.6 mt -62.57 -43.52 98.6 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.941 -179.335 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -64.73 -40.01 94.61 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.07 -178.861 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . 0.47 ' O ' ' OG ' ' B' ' 247' ' ' SER . 95.0 mtt-85 -64.51 -42.01 96.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.218 0.532 . . . . 0.0 110.071 179.649 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.855 HH11 HH11 ' A' ' 12' ' ' ARG . 25.0 ttm-85 -61.79 -42.19 98.68 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.765 -179.339 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -61.56 -36.4 80.51 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.809 0.337 . . . . 0.0 110.285 179.113 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . 0.47 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 78.6 p -69.94 -40.39 75.52 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 177.958 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -57.61 -40.18 78.55 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.024 179.324 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 56.9 t . . . . . 0 C--N 1.327 -0.376 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 178.627 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.584 ' OE1' HD21 ' A' ' 41' ' ' LEU . 96.9 mt-10 . . . . . 0 N--CA 1.466 0.327 0 CA-C-O 120.759 0.314 . . . . 0.0 111.187 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.661 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 71.6 mt -116.93 135.2 58.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.609 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 50.0 t -123.78 132.32 71.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.541 179.309 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -95.57 119.52 34.21 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.264 0.554 . . . . 0.0 111.781 -178.234 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -64.9 -45.3 86.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.354 179.769 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . 0.549 ' NE2' ' CD1' ' A' ' 24' ' ' LEU . 0.3 OUTLIER -100.78 163.96 17.07 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.284 -179.831 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -61.41 156.86 43.93 Favored 'Trans proline' 0 N--CA 1.503 2.051 0 C-N-CA 122.992 2.462 . . . . 0.0 113.062 -179.604 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 25.9 pt . . . . . 0 N--CA 1.465 0.285 0 CA-C-O 121.312 0.577 . . . . 0.0 111.775 -178.986 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.7 m . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.897 0.379 . . . . 0.0 111.477 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.608 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 85.1 mtt-85 -100.25 148.75 24.31 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.492 -177.995 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -134.55 141.68 46.76 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.516 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 98.5 mt -113.8 139.74 48.88 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 178.73 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 67.9 t -113.89 129.46 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.407 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 m -93.22 116.62 29.19 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.402 0.62 . . . . 0.0 112.516 -178.258 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 81.7 mt -85.67 147.66 5.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.111 179.149 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.464 ' HD2' HG23 ' A' ' 15' ' ' VAL . 94.8 mttt -93.61 157.87 15.97 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.479 179.092 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.595 ' NH2' ' OE2' ' B' ' 260' ' ' GLU . 91.1 mtm180 -60.98 -27.56 68.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.304 -0.407 . . . . 0.0 109.997 179.859 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.558 ' OG ' HG22 ' A' ' 15' ' ' VAL . 91.1 p -70.6 -22.69 62.52 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.755 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.73 6.94 37.27 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-N 115.72 -0.673 . . . . 0.0 113.699 178.576 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.558 HG22 ' OG ' ' A' ' 13' ' ' SER . 17.8 m -104.82 142.92 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 117.995 0.898 . . . . 0.0 111.568 -179.693 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 17' ' ' GLY . 61.8 t0 -69.15 127.85 34.55 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.063 -179.397 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.437 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -115.72 -127.94 4.26 Favored Glycine 0 CA--C 1.535 1.325 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 -179.814 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.93 155.88 38.78 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.483 2.122 . . . . 0.0 112.788 -178.872 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -112.78 158.78 19.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.985 0.421 . . . . 0.0 111.191 -178.591 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.554 ' CD2' HD11 ' A' ' 37' ' ' ILE . 39.0 t80 -128.35 98.61 25.69 Favored Pre-proline 0 N--CA 1.467 0.403 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.578 -179.727 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.441 ' HD2' HG22 ' B' ' 267' ' ' ILE . 73.6 Cg_endo -74.28 139.57 26.48 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 121.587 1.525 . . . . 0.0 112.508 -178.905 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.441 HD13 HD11 ' A' ' 53' ' ' ILE . 80.2 mt -88.33 86.01 6.99 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.203 -179.331 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 59.7 p -86.39 -7.95 58.04 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.515 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.0 mt -108.69 148.82 29.86 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.041 -179.184 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.3 m -68.73 -15.06 63.4 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.127 -179.117 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 57.0 m -130.02 134.63 47.54 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.452 -0.499 . . . . 0.0 112.143 -179.975 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.7 t -127.96 118.76 24.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.914 178.573 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.525 HD12 ' O ' ' A' ' 49' ' ' CYS . 57.3 tp -118.46 130.8 56.15 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 120.954 0.406 . . . . 0.0 111.031 -179.056 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.816 ' CE2' HD12 ' A' ' 37' ' ' ILE . 18.3 m-85 -110.25 141.6 42.99 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.988 -179.893 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 153.67 -174.88 32.19 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.883 178.795 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 45.1 mtm180 -74.82 -32.53 61.98 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 122.704 -0.291 . . . . 0.0 111.722 179.348 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.594 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -58.14 149.57 34.59 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.579 -177.714 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.431 ' C ' ' N ' ' A' ' 35' ' ' CYS . 82.4 mt -66.37 -43.06 91.49 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 178.247 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -49.9 -25.28 3.07 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.222 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.594 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 3.6 m -65.69 115.01 5.4 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.723 179.47 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -52.76 -21.09 3.71 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.166 -178.135 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.816 HD12 ' CE2' ' A' ' 29' ' ' PHE . 85.4 mt -131.4 123.92 53.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.657 177.809 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 47.3 mtm180 -107.3 138.5 43.38 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.836 -179.865 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 1.028 HG21 ' NH1' ' A' ' 93' ' ' ARG . 63.9 mt -120.56 132.44 70.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.419 -0.512 . . . . 0.0 110.48 179.762 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -75.41 24.08 0.11 Allowed 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -178.068 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.747 HD12 ' CZ ' ' A' ' 93' ' ' ARG . 25.7 mt -105.48 128.67 26.09 Favored Pre-proline 0 C--N 1.323 -0.56 0 C-N-CA 119.591 -0.844 . . . . 0.0 109.855 179.341 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.07 -10.27 25.75 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.523 2.149 . . . . 0.0 112.566 -178.773 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.8 m -87.11 -0.21 7.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.622 179.927 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.459 HG21 HH12 ' A' ' 93' ' ' ARG . 48.0 t -91.38 131.64 37.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.131 0.491 . . . . 0.0 111.006 -179.223 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.05 160.64 20.54 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.987 179.77 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 28.2 mtmt -59.93 -42.54 94.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.702 -178.839 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.629 ' O ' ' N ' ' A' ' 49' ' ' CYS . 12.4 mm100 -111.49 -16.52 13.28 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 123.481 0.488 . . . . 0.0 110.048 -179.549 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.2 t60 35.62 -76.37 0.0 OUTLIER 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.076 -0.966 . . . . 0.0 113.348 -179.763 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.629 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -137.09 140.18 41.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.941 0.401 . . . . 0.0 111.799 -178.622 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -127.01 131.91 50.89 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.511 179.728 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.9 mt -114.87 135.93 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-O 121.098 0.475 . . . . 0.0 110.738 179.54 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -113.75 125.55 54.23 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.067 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.441 HD11 HD13 ' A' ' 22' ' ' LEU . 93.9 mt -108.2 113.62 44.36 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.461 -179.856 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.582 ' O ' ' N ' ' A' ' 56' ' ' GLN . 91.5 m-70 -115.42 141.36 48.15 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.125 179.974 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.467 ' C ' ' O ' ' A' ' 54' ' ' HIS . 84.1 tt0 -38.92 -25.18 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 120.293 -0.563 . . . . 0.0 109.527 -179.109 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.582 ' N ' ' O ' ' A' ' 54' ' ' HIS . 57.3 tt0 -67.51 -67.31 0.47 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.386 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -160.65 -163.66 1.11 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.193 -179.586 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.79 127.16 55.9 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.577 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 89.2 mt -113.89 128.76 70.67 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 CA-C-O 121.297 0.57 . . . . 0.0 111.688 -179.228 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 43.4 tp -97.39 126.91 42.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.883 -179.975 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -114.7 138.01 51.22 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.962 179.105 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.555 ' ND2' ' H ' ' A' ' 69' ' ' THR . 16.8 t-20 -101.12 109.62 21.53 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.067 0.461 . . . . 0.0 111.602 -179.564 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -94.89 -4.59 46.65 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.254 179.108 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.0 t -90.42 101.06 13.79 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.728 -179.712 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.4 p -87.59 -24.21 24.06 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.388 -0.525 . . . . 0.0 109.996 178.087 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.58 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.3 OUTLIER -69.74 -43.29 72.61 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.6 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.432 HD21 ' HA ' ' B' ' 236' ' ' VAL . 31.4 m-80 -142.97 100.9 5.36 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.69 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -66.28 150.85 84.52 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.264 1.309 . . . . 0.0 113.532 -177.831 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.555 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 33.7 m -69.93 137.95 51.96 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.912 179.555 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -101.38 142.43 32.79 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.662 179.906 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.716 ' HB ' HD11 ' A' ' 76' ' ' ILE . 5.0 p -129.5 137.2 57.47 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.14 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 49.57 32.8 5.18 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.583 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.51 27.85 64.65 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.057 -179.903 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 62.8 m -141.06 138.8 33.86 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 117.549 0.675 . . . . 0.0 112.098 -179.473 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.4 m -65.62 137.45 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.527 179.734 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.716 HD11 ' HB ' ' A' ' 71' ' ' VAL . 96.2 mt -99.57 96.39 4.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.594 179.856 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -65.15 -41.49 94.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.853 0.359 . . . . 0.0 110.867 179.645 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.497 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.1 OUTLIER -126.72 166.05 24.65 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.492 -179.343 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -57.24 143.32 93.87 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.174 1.916 . . . . 0.0 112.565 -179.052 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.6 t -133.32 137.49 53.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.654 -179.894 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 87.7 mtm-85 -68.98 134.43 49.48 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.535 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.441 HD23 ' HA ' ' A' ' 82' ' ' LEU . 80.3 mt -81.08 137.28 36.0 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.472 0.653 . . . . 0.0 111.589 -179.22 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -125.64 147.08 49.44 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.656 179.724 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.482 ' ND1' ' N ' ' A' ' 99' ' ' ASN . 4.8 t60 -57.19 124.97 20.67 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.578 -179.318 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.73 -24.22 26.03 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -179.151 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.544 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 41.4 t0 -64.57 134.48 54.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.991 0.424 . . . . 0.0 110.198 179.347 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.544 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 9.9 p -110.9 132.9 58.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.509 -178.157 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 79.0 mt -99.09 130.18 48.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.857 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 17.7 m -116.85 123.73 47.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.514 0.673 . . . . 0.0 111.405 179.895 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.634 ' O ' ' N ' ' A' ' 93' ' ' ARG . 96.8 mt -117.36 129.04 74.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.062 178.306 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.494 ' C ' ' O ' ' A' ' 90' ' ' ILE . 85.5 mt -14.97 96.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -178.876 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 79.06 -11.23 1.24 Allowed 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 177.963 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 1.028 ' NH1' HG21 ' A' ' 39' ' ' ILE . 17.7 mtm180 -130.95 134.28 46.59 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.349 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.2 m -133.81 147.95 51.28 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.6 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.407 ' HE1' HD12 ' A' ' 90' ' ' ILE . 54.7 m-85 -122.81 120.13 32.62 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.549 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.429 ' NE ' ' OE2' ' A' ' 98' ' ' GLU . 37.8 ttp-105 -79.97 130.92 35.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.061 0.458 . . . . 0.0 110.989 -179.362 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.608 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 46.0 t80 -98.5 122.97 42.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.413 -179.704 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.429 ' OE2' ' NE ' ' A' ' 96' ' ' ARG . 96.3 mt-10 -139.07 129.31 25.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.188 0.518 . . . . 0.0 111.333 179.832 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.509 ' OD1' ' OH ' ' A' ' 97' ' ' TYR . 91.4 m-20 . . . . . 0 C--N 1.324 -0.543 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.356 179.734 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo . . . . . 0 N--CA 1.487 1.139 0 CA-C-O 121.226 0.427 . . . . 0.0 111.843 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.58 ' CG2' HG22 ' A' ' 66' ' ' THR . 37.7 t -112.73 134.07 56.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.83 179.871 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . 0.413 ' HB2' HD13 ' A' ' 91' ' ' ILE . 3.7 t . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.553 -179.539 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo . . . . . 0 N--CA 1.489 1.255 0 N-CA-C 111.622 -0.184 . . . . 0.0 111.622 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 18.5 m -71.92 -46.78 56.39 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 120.606 -0.437 . . . . 0.0 110.421 179.092 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.5 ' CZ ' ' NH1' ' B' ' 245' ' ' ARG . 80.5 t80 -58.7 -45.73 88.86 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.616 -178.846 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 93.9 mt -64.16 -40.16 95.55 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.04 -179.178 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -60.98 -45.16 95.92 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.489 -179.689 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -66.91 -38.67 86.65 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.598 179.744 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.603 ' CA ' ' HE ' ' B' ' 245' ' ' ARG . 0.0 OUTLIER -60.11 -44.62 94.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.97 -179.029 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.59 -40.77 97.8 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.353 0.597 . . . . 0.0 109.473 179.117 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 26.8 m -60.44 -45.74 92.57 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.44 179.226 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . 0.579 HE22 ' NH2' ' B' ' 245' ' ' ARG . 74.1 mt-30 -58.23 -37.93 75.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.416 179.793 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 54.6 t . . . . . 0 C--N 1.329 -0.287 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.013 179.35 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.595 ' OE2' ' NH2' ' A' ' 12' ' ' ARG . 56.6 mp0 . . . . . 0 C--O 1.225 -0.231 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 . . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 66.3 mt -112.77 135.45 52.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.671 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 55.1 t -130.16 134.88 62.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.124 0.488 . . . . 0.0 111.048 -178.657 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -95.06 118.81 32.5 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.551 0.691 . . . . 0.0 111.277 -178.503 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -66.01 -47.52 74.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.159 179.424 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -89.06 151.45 46.92 Favored Pre-proline 0 N--CA 1.449 -0.494 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.185 -178.981 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.9 149.46 72.32 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.919 2.412 . . . . 0.0 112.838 179.747 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . 0.441 HG22 ' HD2' ' A' ' 21' ' ' PRO . 44.1 pt . . . . . 0 C--N 1.33 -0.262 0 CA-C-O 121.313 0.578 . . . . 0.0 110.09 179.042 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.0 p . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.883 0.373 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.547 ' NE ' HD13 ' A' ' 53' ' ' ILE . 88.6 mtm-85 -90.26 126.4 35.83 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.28 179.913 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -129.79 135.37 48.35 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.095 0.474 . . . . 0.0 111.032 179.826 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.698 HD12 ' O ' ' A' ' 96' ' ' ARG . 29.5 tp -115.3 133.82 55.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.136 -179.38 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 45.0 t -109.15 131.98 58.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.407 -179.95 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 m -90.99 118.39 30.34 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.34 0.59 . . . . 0.0 112.541 -178.408 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.469 HD12 ' HB2' ' A' ' 94' ' ' SER . 97.0 mt -85.85 142.14 13.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.536 179.248 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -89.31 160.68 16.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.027 0.441 . . . . 0.0 110.919 179.262 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.593 HH11 HH11 ' B' ' 245' ' ' ARG . 90.5 mtm180 -55.94 -33.07 64.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.662 -178.902 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.6 t -77.75 -8.54 58.12 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.234 179.837 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.92 31.14 9.49 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -179.924 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.0 t -116.8 132.69 65.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.857 0.36 . . . . 0.0 110.081 179.681 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 45.4 p-10 -84.19 142.8 30.06 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.978 179.612 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -133.89 -108.05 1.02 Allowed Glycine 0 CA--C 1.532 1.098 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.733 -179.531 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -73.29 148.57 43.91 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 122.347 2.032 . . . . 0.0 112.028 -179.454 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -111.94 147.58 35.57 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.149 -179.844 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -115.05 104.72 53.73 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.981 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.42 133.14 15.63 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.164 1.242 . . . . 0.0 110.992 -178.81 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 82.9 mt -87.61 51.76 2.31 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -177.51 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.5 m -59.28 -34.1 71.87 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.879 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.538 HD11 ' HG2' ' B' ' 265' ' ' GLN . 60.9 mt -71.62 144.75 49.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.45 -179.845 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.6 m -68.18 -16.38 63.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.415 -179.355 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.448 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 95.5 m -133.77 134.42 42.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.834 0.35 . . . . 0.0 111.664 -179.806 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.9 t -125.78 116.66 21.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.902 178.424 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 58.2 tp -113.71 127.83 56.18 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.794 -178.924 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.609 ' CE2' HD12 ' A' ' 37' ' ' ILE . 9.4 m-85 -106.93 139.23 41.67 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.851 179.65 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 146.5 -175.93 25.67 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 120.982 -0.628 . . . . 0.0 111.622 178.972 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 31' ' ' ARG . 47.6 mtm180 -75.46 -33.72 60.88 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -179.851 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.505 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -44.45 142.95 2.75 Favored Glycine 0 C--O 1.223 -0.535 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 -178.465 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.416 HD13 ' CZ ' ' A' ' 38' ' ' ARG . 32.5 mm -62.6 -43.13 98.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 117.194 0.497 . . . . 0.0 110.033 179.957 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -54.81 -20.73 9.24 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.51 -0.476 . . . . 0.0 109.865 179.551 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.505 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 60.0 m -56.63 119.61 6.4 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-O 120.968 0.413 . . . . 0.0 111.141 -179.47 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.448 ' OD2' ' O ' ' A' ' 26' ' ' THR . 80.0 m-20 -58.09 -26.63 62.81 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -179.817 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.609 HD12 ' CE2' ' A' ' 29' ' ' PHE . 95.1 mt -129.18 118.97 47.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.235 177.381 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.416 ' CZ ' HD13 ' A' ' 33' ' ' ILE . 84.7 mtp180 -103.34 133.5 48.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.634 -179.106 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.423 HG21 HD12 ' A' ' 41' ' ' LEU . 83.6 mt -118.13 129.94 73.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 120.511 -0.475 . . . . 0.0 110.021 179.744 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -75.24 36.71 0.12 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.85 -178.057 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.723 ' O ' HG12 ' A' ' 44' ' ' VAL . 70.0 mt -111.74 119.32 44.98 Favored Pre-proline 0 C--N 1.325 -0.457 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.061 -179.678 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -71.29 -12.77 30.27 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 121.835 1.69 . . . . 0.0 112.824 -179.987 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.706 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 31.1 m -86.76 -3.51 8.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.949 -0.301 . . . . 0.0 110.716 179.657 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.723 HG12 ' O ' ' A' ' 41' ' ' LEU . 3.3 p -96.62 146.76 6.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.103 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.9 m -74.65 166.14 24.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.469 0.652 . . . . 0.0 112.519 -178.478 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 45.6 mttp -63.23 -40.05 96.34 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.03 -0.987 . . . . 0.0 111.737 179.975 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.669 ' O ' ' N ' ' A' ' 49' ' ' CYS . 89.7 mt-30 -113.36 -19.83 11.58 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.385 179.858 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.0 t60 34.83 -75.93 0.0 OUTLIER 'General case' 0 C--O 1.234 0.274 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 179.048 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.669 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.1 134.45 47.36 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.248 0.547 . . . . 0.0 112.253 -178.948 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -127.01 128.65 46.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.257 179.021 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.3 mt -111.56 133.74 56.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.189 179.845 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -116.79 126.55 53.26 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.463 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.547 HD13 ' NE ' ' A' ' 5' ' ' ARG . 84.8 mt -106.15 112.91 41.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.404 -179.067 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.504 ' O ' ' N ' ' A' ' 56' ' ' GLN . 95.0 m-70 -112.78 144.03 43.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.399 179.54 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 54' ' ' HIS . 84.1 tt0 -39.9 -27.21 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.358 -0.537 . . . . 0.0 109.992 -178.839 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.504 ' N ' ' O ' ' A' ' 54' ' ' HIS . 75.8 mt-30 -69.08 -66.99 0.51 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.949 179.132 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -157.92 -169.2 2.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.347 -179.11 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -111.85 125.32 53.89 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.741 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.5 mt -114.73 132.05 65.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -178.203 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.494 ' HB2' HD21 ' A' ' 82' ' ' LEU . 44.0 tp -94.8 122.54 37.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.8 179.266 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -109.08 136.35 48.73 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.159 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.475 HD21 ' HA ' ' A' ' 68' ' ' PRO . 63.5 t-20 -97.54 109.54 22.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.068 0.461 . . . . 0.0 112.241 -178.422 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.405 ' CD2' ' OE1' ' A' ' 47' ' ' GLN . 28.3 m-85 -100.91 -9.87 21.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.121 179.326 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.7 t -76.22 98.62 4.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.805 0.336 . . . . 0.0 110.844 -179.389 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 34.2 t -79.09 -40.79 30.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.323 0.582 . . . . 0.0 109.744 178.683 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.613 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -64.75 -47.02 79.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.02 -179.112 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 42.3 m-20 -136.97 97.91 10.77 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.452 179.894 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.475 ' HA ' HD21 ' A' ' 62' ' ' ASN . 36.2 Cg_exo -56.45 145.05 81.55 Favored 'Trans proline' 0 N--CA 1.494 1.5 0 C-N-CA 121.799 1.666 . . . . 0.0 112.612 -179.121 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.3 m -73.83 140.01 45.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.393 -179.992 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -104.59 141.79 35.79 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.749 -179.188 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.509 ' CG1' ' OD1' ' A' ' 86' ' ' ASP . 55.3 t -130.96 136.23 58.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.491 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 52.26 33.3 12.33 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -179.394 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.58 29.48 72.88 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.284 179.726 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.7 p -141.66 136.65 31.11 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.714 -0.395 . . . . 0.0 110.867 -179.974 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.414 HG13 ' HB2' ' A' ' 68' ' ' PRO . 78.6 t -66.01 135.82 27.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.087 -179.907 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.08 96.65 3.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.409 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -84.56 -16.69 41.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.536 -0.757 . . . . 0.0 112.014 -178.583 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -111.47 162.6 20.3 Favored Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.557 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -58.96 142.24 99.1 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 121.45 1.433 . . . . 0.0 111.693 179.684 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.5 p -140.48 139.1 35.89 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 CA-C-O 120.957 0.408 . . . . 0.0 110.758 179.814 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.635 HH21 ' CE ' ' A' ' 83' ' ' LYS . 61.9 ttp180 -73.39 127.71 33.44 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.461 179.616 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.494 HD21 ' HB2' ' A' ' 60' ' ' LEU . 98.2 mt -78.78 138.16 38.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.79 -180.0 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.635 ' CE ' HH21 ' A' ' 81' ' ' ARG . 97.7 mttt -130.29 151.93 50.26 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.342 179.237 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.643 ' HD1' ' CG ' ' A' ' 99' ' ' ASN . 3.7 t-160 -55.59 120.95 8.02 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.287 -179.334 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.08 -15.06 36.89 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -179.58 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.509 ' OD1' ' CG1' ' A' ' 71' ' ' VAL . 35.2 t70 -68.79 126.54 30.07 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.312 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.9 t -109.51 127.09 66.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.578 -178.922 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 90.7 mt -93.27 133.54 34.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.896 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 53.7 m -124.19 123.08 39.5 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.592 0.71 . . . . 0.0 112.387 -178.555 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.451 ' N ' ' O ' ' A' ' 93' ' ' ARG . 93.1 mt -107.91 124.27 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 177.498 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.707 HD12 HH22 ' A' ' 93' ' ' ARG . 93.9 mt 39.47 -98.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.171 -178.445 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.613 ' OD1' ' NH1' ' A' ' 93' ' ' ARG . 28.9 p-10 -119.71 16.54 12.76 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.015 0.436 . . . . 0.0 110.837 179.365 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.707 HH22 HD12 ' A' ' 91' ' ' ILE . 45.0 mtm-85 -120.0 138.12 53.68 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.765 179.877 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.469 ' HB2' HD12 ' A' ' 10' ' ' ILE . 66.9 m -137.44 152.41 49.55 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 119.886 -0.726 . . . . 0.0 111.283 -179.871 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.533 ' HB3' HD11 ' A' ' 7' ' ' LEU . 74.6 m-85 -123.79 121.45 35.45 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.098 179.413 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.698 ' O ' HD12 ' A' ' 7' ' ' LEU . 99.8 mtt180 -81.95 129.08 34.67 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.75 -179.045 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -99.0 126.99 44.82 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.832 179.876 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -137.22 127.88 26.98 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.653 179.996 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.643 ' CG ' ' HD1' ' A' ' 84' ' ' HIS . 41.2 p30 . . . . . 0 N--CA 1.463 0.223 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.532 -179.965 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo . . . . . 0 N--CA 1.49 1.314 0 CA-C-O 121.212 0.422 . . . . 0.0 112.657 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.613 ' CG2' HG22 ' A' ' 66' ' ' THR . 31.4 t -64.09 135.5 27.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.391 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-O 121.093 0.473 . . . . 0.0 110.805 -178.741 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo . . . . . 0 N--CA 1.492 1.389 0 CA-C-O 120.495 0.123 . . . . 0.0 111.806 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 52.0 m -73.03 -46.19 53.38 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.05 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.706 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 71.3 t80 -56.6 -48.15 78.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.757 -179.793 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 85.8 mt -66.18 -43.6 86.4 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -179.887 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -65.48 -45.14 84.8 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.447 -178.228 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -62.68 -44.53 96.02 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.435 179.626 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.593 HH11 HH11 ' A' ' 12' ' ' ARG . 52.2 ttm-85 -63.56 -44.09 95.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.98 -179.627 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -63.97 -36.89 85.45 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.554 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 32.7 m -64.08 -43.78 94.38 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.47 178.022 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -61.64 -34.59 75.96 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.877 -179.962 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 43.4 t . . . . . 0 C--N 1.332 -0.192 0 C-N-CA 120.774 -0.371 . . . . 0.0 110.232 179.098 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.481 ' OE1' HD21 ' A' ' 41' ' ' LEU . 99.1 mt-10 . . . . . 0 CA--C 1.527 0.069 0 CA-C-O 120.66 0.267 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 66.9 mt -109.69 134.56 51.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 178.945 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 61.9 t -125.23 133.88 68.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.746 -179.311 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -94.43 118.95 32.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.043 -178.986 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -68.2 -41.16 81.79 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.281 179.392 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . 0.538 ' HG2' HD11 ' A' ' 24' ' ' LEU . 4.6 mp0 -103.56 163.69 16.92 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.814 -178.878 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -62.27 153.27 71.26 Favored 'Trans proline' 0 N--CA 1.5 1.856 0 C-N-CA 123.202 2.601 . . . . 0.0 113.08 -179.429 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 42.5 pt . . . . . 0 C--N 1.33 -0.253 0 CA-C-O 121.693 0.759 . . . . 0.0 112.328 -179.02 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.7 m . . . . . 0 CA--C 1.531 0.234 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.524 ' NE ' ' HB2' ' A' ' 58' ' ' ALA . 85.7 mtt85 -97.76 137.22 36.97 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.918 0.389 . . . . 0.0 111.997 -177.494 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.529 ' C ' HD22 ' A' ' 7' ' ' LEU . 89.4 mtm180 -137.62 145.98 43.41 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.518 179.576 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.717 HD21 HD11 ' A' ' 22' ' ' LEU . 3.0 mm? -112.96 141.54 46.68 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.94 178.395 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.0 t -114.09 127.02 71.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.852 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.531 ' CG2' HD12 ' B' ' 261' ' ' ILE . 50.0 m -78.64 139.68 38.51 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -177.998 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.485 HD12 ' CB ' ' A' ' 94' ' ' SER . 99.6 mt -109.22 136.47 45.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.185 177.494 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -88.8 158.46 18.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.006 0.431 . . . . 0.0 110.926 179.942 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.504 ' CD ' HH11 ' B' ' 245' ' ' ARG . 86.3 mtm180 -57.16 -30.59 64.59 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.801 -178.611 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 88.6 p -80.93 -7.07 59.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.192 179.988 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.88 34.44 6.85 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.692 179.527 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.2 t -119.64 132.73 68.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.748 0.308 . . . . 0.0 111.111 -179.988 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -74.84 138.23 42.39 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.73 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -131.65 -118.89 2.02 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 120.533 -0.842 . . . . 0.0 112.616 -178.939 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -73.79 149.12 42.32 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.414 2.076 . . . . 0.0 113.066 -178.427 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -110.58 157.46 19.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.697 -179.962 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.971 ' CD2' HD11 ' A' ' 37' ' ' ILE . 35.2 t80 -124.64 99.83 35.36 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.924 -179.553 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -74.81 135.52 19.58 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 121.374 1.383 . . . . 0.0 112.48 -179.499 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.717 HD11 HD21 ' A' ' 7' ' ' LEU . 80.5 mt -87.65 81.98 7.54 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 120.872 0.367 . . . . 0.0 111.093 -179.24 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.474 ' OG ' ' NE2' ' B' ' 265' ' ' GLN . 77.9 p -86.33 -8.68 57.51 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.164 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.5 mt -103.82 146.22 28.96 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.611 179.917 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.6 m -67.81 -14.82 63.27 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -179.219 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 39.7 m -131.03 132.6 45.06 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.694 -179.948 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.435 ' HB2' HD22 ' A' ' 22' ' ' LEU . 5.1 t -126.96 120.21 28.55 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.653 178.835 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.446 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 35.1 tp -117.22 130.86 56.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.779 0.323 . . . . 0.0 111.42 -178.561 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.446 ' O ' ' O ' ' A' ' 47' ' ' GLN . 54.1 m-85 -107.43 133.44 51.94 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.615 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 179.42 -173.46 45.39 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.186 -1.007 . . . . 0.0 112.718 -179.967 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.2 ttp-105 -93.75 -23.4 18.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.234 -0.483 . . . . 0.0 110.349 179.746 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.467 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -72.2 163.96 54.49 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.932 -179.095 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.59 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.4 tp -68.17 -43.25 85.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.948 0.404 . . . . 0.0 111.582 -179.846 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.59 ' N ' HG23 ' A' ' 33' ' ' ILE . 52.1 tp10 -54.19 -19.81 5.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.862 -178.594 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.467 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 3.5 m -67.77 129.01 38.59 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.275 -179.777 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.446 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 66.0 m-20 -61.58 -33.84 74.58 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.961 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.971 HD11 ' CD2' ' A' ' 20' ' ' PHE . 36.9 mm -120.11 116.6 50.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.097 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.56 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 83.2 mtp180 -105.63 134.85 48.07 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.681 -178.404 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 78.6 mt -121.13 129.13 75.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.35 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -77.22 27.72 0.15 Allowed 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -177.921 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.741 HD21 ' OE1' ' B' ' 260' ' ' GLU . 78.9 mt -99.09 139.18 20.81 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.121 179.55 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.45 -14.73 20.1 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.492 2.128 . . . . 0.0 112.277 -179.395 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.1 m -91.19 7.87 4.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.534 179.868 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 55.6 t -100.36 132.11 46.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.359 179.09 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.4 m -74.11 170.32 15.73 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.768 0.794 . . . . 0.0 111.655 -179.52 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -64.83 -38.54 91.32 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.093 179.799 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.642 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.0 mt-30 -114.74 -19.2 11.15 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.167 179.875 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 14.8 t60 32.61 -76.58 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 179.805 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.642 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.82 134.16 46.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.3 0.571 . . . . 0.0 112.066 -178.662 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -125.34 132.55 52.82 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.189 179.08 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.8 mt -116.46 133.78 61.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.986 -179.563 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -113.87 123.76 50.58 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.513 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.407 HD11 HD13 ' A' ' 22' ' ' LEU . 96.6 mt -105.87 111.6 35.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.659 -179.484 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.458 ' O ' ' N ' ' A' ' 56' ' ' GLN . 81.4 m-70 -113.77 142.85 45.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.313 179.834 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 54' ' ' HIS . 99.2 mt-10 -40.67 -28.46 0.07 Allowed 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.266 -0.574 . . . . 0.0 109.826 -179.771 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.488 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 95.1 mt-30 -63.78 -68.55 0.34 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.546 178.866 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.488 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 3.4 tp10 -157.24 -168.32 2.58 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.585 -179.671 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.524 ' HB2' ' NE ' ' A' ' 5' ' ' ARG . . . -110.12 124.71 52.02 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 178.473 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 98.0 mt -115.83 130.28 70.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.283 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 47.1 tp -97.98 127.98 44.26 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.249 179.258 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -114.94 138.24 51.06 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.467 -179.995 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.47 HD21 ' CA ' ' A' ' 68' ' ' PRO . 57.8 t-20 -98.69 106.83 19.15 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.903 0.383 . . . . 0.0 111.961 -179.692 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -102.33 -9.5 20.29 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.032 179.406 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.38 100.14 4.35 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.173 -179.932 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 85.0 p -84.24 -32.11 24.65 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.341 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.501 HG22 HG12 ' B' ' 236' ' ' VAL . 1.7 m -64.43 -51.46 63.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.699 -179.745 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.552 ' HB3' HD11 ' A' ' 91' ' ' ILE . 55.5 m-80 -138.79 95.96 9.58 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.673 179.825 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.47 ' CA ' HD21 ' A' ' 62' ' ' ASN . 52.0 Cg_exo -55.0 146.7 56.46 Favored 'Trans proline' 0 N--CA 1.499 1.809 0 C-N-CA 122.286 1.99 . . . . 0.0 113.328 -178.957 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 44.3 m -75.06 145.16 42.58 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.289 -179.984 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -108.11 143.37 36.95 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.808 -179.733 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.435 ' O ' ' N ' ' A' ' 74' ' ' SER . 5.4 p -131.99 135.97 57.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.77 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 49.16 33.17 4.69 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.238 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.69 29.09 69.92 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.317 -179.577 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 71' ' ' VAL . 66.8 m -138.65 136.06 35.51 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.906 0.353 . . . . 0.0 111.161 -179.616 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -66.32 141.75 17.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.176 -179.806 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.2 pt -118.71 78.99 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.677 179.107 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -63.34 -24.02 67.67 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.768 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -116.84 158.71 43.14 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.838 179.559 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -64.97 148.62 89.81 Favored 'Trans proline' 0 N--CA 1.5 1.884 0 C-N-CA 122.859 2.373 . . . . 0.0 113.044 -179.6 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 65.9 t -138.41 138.99 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.088 179.815 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -69.33 132.11 45.89 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 178.817 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 90.0 mt -78.85 138.38 38.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.304 0.574 . . . . 0.0 111.113 -179.985 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -132.36 150.14 52.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.075 179.949 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.453 ' ND1' ' N ' ' A' ' 99' ' ' ASN . 4.9 t60 -58.17 119.12 6.29 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.874 0.369 . . . . 0.0 110.401 -179.674 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.51 -23.04 16.19 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 -179.66 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 87' ' ' VAL . 57.7 t0 -67.93 132.11 46.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.029 0.442 . . . . 0.0 110.939 179.736 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.526 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 50.0 t -110.63 132.15 59.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.512 -179.038 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 87.3 mt -95.75 131.26 43.01 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 177.957 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 44.6 m -121.99 128.97 52.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.989 0.899 . . . . 0.0 113.314 -177.244 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.626 ' O ' ' N ' ' A' ' 93' ' ' ARG . 97.9 mt -116.42 129.94 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-N 113.926 -1.488 . . . . 0.0 108.379 178.453 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.552 HD11 ' HB3' ' A' ' 67' ' ' ASN . 70.4 mt -21.49 98.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.415 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.566 ' OD2' ' NH1' ' B' ' 245' ' ' ARG . 0.8 OUTLIER 88.46 -23.8 0.11 Allowed 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 178.171 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.626 ' N ' ' O ' ' A' ' 90' ' ' ILE . 83.4 mtt-85 -128.35 145.02 51.2 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.273 -179.53 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.485 ' CB ' HD12 ' A' ' 10' ' ' ILE . 11.3 t -140.7 153.76 46.08 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.325 0.583 . . . . 0.0 110.576 -179.9 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.647 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 95.8 m-85 -124.96 121.49 34.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.464 179.363 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -81.6 131.68 35.28 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.342 -179.937 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.584 ' CZ ' ' OD1' ' A' ' 99' ' ' ASN . 85.8 t80 -94.66 126.22 39.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.691 -179.647 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -136.4 128.59 29.84 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 120.572 -0.451 . . . . 0.0 112.001 -179.531 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.584 ' OD1' ' CZ ' ' A' ' 97' ' ' TYR . 93.7 m-20 . . . . . 0 CA--C 1.531 0.219 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.827 179.083 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo . . . . . 0 N--CA 1.494 1.505 0 N-CA-C 114.474 0.913 . . . . 0.0 114.474 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.501 HG12 HG22 ' A' ' 66' ' ' THR . 26.8 m -72.43 143.35 14.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 114.279 -1.328 . . . . 0.0 109.174 179.34 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 10.3 t . . . . . 0 C--N 1.322 -0.599 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.705 -179.028 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo . . . . . 0 N--CA 1.494 1.518 0 CA-C-O 120.607 0.169 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 99.3 m -73.22 -45.09 58.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.905 0.384 . . . . 0.0 111.023 179.376 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -57.08 -47.84 80.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.251 -179.29 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 87.1 mt -63.5 -42.56 98.5 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.412 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -63.67 -41.88 98.12 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.892 -179.547 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 62.9 ttm-85 -64.31 -44.21 92.29 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.009 0.433 . . . . 0.0 110.422 179.938 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.603 ' NH2' HD13 ' A' ' 41' ' ' LEU . 4.0 tpp85 -61.43 -42.9 99.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.773 -179.61 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -59.48 -40.09 85.81 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.825 0.345 . . . . 0.0 110.271 -179.734 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 78.0 p -70.31 -39.88 74.55 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.816 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 63.7 tp60 -59.25 -38.53 80.3 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.699 179.823 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 38.3 t . . . . . 0 C--N 1.332 -0.18 0 CA-C-O 120.734 0.302 . . . . 0.0 110.35 179.029 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.741 ' OE1' HD21 ' A' ' 41' ' ' LEU . 98.2 mt-10 . . . . . 0 N--CA 1.465 0.312 0 CA-C-O 120.767 0.318 . . . . 0.0 110.173 . . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.647 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 67.6 mt -114.11 134.19 57.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.655 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 44.4 t -124.99 134.53 66.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.168 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -96.17 117.72 31.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.275 0.559 . . . . 0.0 111.578 -178.222 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -65.96 -46.29 78.66 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.163 179.611 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . 0.474 ' NE2' ' OG ' ' A' ' 23' ' ' SER . 0.0 OUTLIER -96.0 155.51 38.2 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.336 -179.192 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -64.31 148.86 90.99 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 123.212 2.608 . . . . 0.0 113.42 -179.222 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 47.1 pt . . . . . 0 C--N 1.332 -0.157 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.761 178.693 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.8 p . . . . . 0 N--CA 1.456 -0.164 0 CA-C-O 121.096 0.474 . . . . 0.0 110.549 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.716 ' NH1' ' HB2' ' A' ' 58' ' ' ALA . 99.9 mtt180 -98.84 135.34 40.44 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.212 -179.736 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.497 ' NE ' ' OE1' ' A' ' 98' ' ' GLU . 33.4 ptt180 -140.85 155.44 46.34 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.27 -0.572 . . . . 0.0 112.034 -179.569 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 78.5 mt -118.91 145.19 45.94 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.747 179.703 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.6 t -114.43 129.88 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 178.177 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.413 ' CG2' HD12 ' B' ' 261' ' ' ILE . 22.4 m -91.64 118.27 30.49 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -177.553 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.43 HD12 ' HB2' ' A' ' 94' ' ' SER . 98.1 mt -84.67 142.87 12.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.436 178.284 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -94.99 167.89 11.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.845 0.355 . . . . 0.0 110.942 179.566 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.457 ' HG2' HH11 ' B' ' 245' ' ' ARG . 83.5 mtm180 -56.49 -32.44 65.02 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.465 -178.407 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.486 ' OG ' HG13 ' B' ' 249' ' ' VAL . 3.5 m -80.25 -7.61 59.09 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.47 179.893 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.71 39.83 6.98 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 -179.545 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.3 t -119.58 130.85 73.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.959 0.409 . . . . 0.0 110.869 -179.403 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -77.16 136.68 38.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.558 179.305 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -137.59 -114.86 1.32 Allowed Glycine 0 CA--C 1.535 1.297 0 C-N-CA 120.2 -1.0 . . . . 0.0 111.746 -179.9 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -71.92 149.0 52.62 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.088 1.859 . . . . 0.0 112.502 -178.994 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -113.45 157.6 21.75 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.793 179.932 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.599 ' CD2' HD11 ' A' ' 37' ' ' ILE . 34.1 t80 -118.13 97.71 50.94 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.487 179.864 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -74.17 131.76 15.74 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 121.39 1.393 . . . . 0.0 111.342 -179.328 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 82.0 mt -83.51 80.63 9.04 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.632 -178.791 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 87.9 p -84.55 -11.15 56.6 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.867 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 67.5 mt -107.16 149.18 27.96 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.191 -179.885 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 28.5 t -67.88 -15.79 63.78 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.811 -179.408 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.531 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 58.8 m -127.16 130.04 49.01 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.594 -0.442 . . . . 0.0 112.181 -179.192 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.7 t -123.76 113.46 18.61 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 177.799 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.456 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 41.0 tp -115.68 131.09 57.04 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.619 -178.232 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.745 ' CE2' HD12 ' A' ' 37' ' ' ILE . 6.9 m-85 -108.51 131.1 55.16 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.706 179.796 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 166.59 -175.25 41.99 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 119.934 -1.127 . . . . 0.0 112.862 179.386 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.503 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 76.4 mtm-85 -80.1 -32.11 39.17 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-O 120.876 0.369 . . . . 0.0 110.594 179.95 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.563 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -51.3 146.23 11.4 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.512 -178.147 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.549 HD13 ' CZ ' ' A' ' 38' ' ' ARG . 36.9 mm -64.44 -43.46 96.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.74 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -54.91 -21.24 10.93 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.633 -179.769 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.563 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 17.2 m -59.08 129.07 40.37 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.155 0.503 . . . . 0.0 110.521 -179.672 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.531 ' OD2' ' O ' ' A' ' 26' ' ' THR . 59.0 m-20 -60.9 -33.35 72.99 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.457 -179.109 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.745 HD12 ' CE2' ' A' ' 29' ' ' PHE . 89.4 mt -125.97 119.78 55.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 177.998 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.549 ' CZ ' HD13 ' A' ' 33' ' ' ILE . 83.3 mtp180 -103.75 137.84 41.22 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.889 -178.497 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 90.3 mt -121.08 131.76 72.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.267 179.551 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -75.24 26.35 0.1 Allowed 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -178.319 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.587 ' CD1' ' CZ ' ' A' ' 93' ' ' ARG . 81.9 mt -102.2 131.74 22.27 Favored Pre-proline 0 C--N 1.326 -0.42 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.301 179.947 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.69 -13.18 27.05 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 122.292 1.995 . . . . 0.0 112.47 -179.535 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.525 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 3.8 m -92.81 2.04 8.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.159 -179.621 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.503 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 38.0 t -91.7 133.8 32.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 177.875 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.0 m -72.64 175.0 6.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.501 0.667 . . . . 0.0 111.586 -178.285 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -63.35 -42.58 98.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.736 -179.787 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.629 ' O ' ' N ' ' A' ' 49' ' ' CYS . 89.0 mt-30 -116.98 -17.01 10.48 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.426 0.454 . . . . 0.0 111.335 -179.948 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.1 t60 34.05 -76.52 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 179.665 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.629 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -127.8 135.1 49.63 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.225 0.536 . . . . 0.0 112.222 -178.766 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -126.74 133.08 50.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.896 179.476 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.3 mt -119.37 132.04 70.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.63 179.107 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -115.21 126.09 54.14 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.944 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.48 HD12 HH11 ' A' ' 5' ' ' ARG . 47.4 mm -93.68 122.66 45.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.326 0.584 . . . . 0.0 111.356 -178.029 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.463 ' O ' ' C ' ' A' ' 55' ' ' GLU . 11.0 m-70 -117.76 127.42 53.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.168 179.104 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' A' ' 54' ' ' HIS . 97.5 mt-10 -40.96 -31.33 0.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.967 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.428 ' N ' ' C ' ' A' ' 54' ' ' HIS . 85.7 mt-30 -67.0 -67.61 0.44 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.664 178.046 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -149.77 -172.79 4.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.157 -179.63 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.716 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -115.01 132.19 56.68 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.951 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 47.6 mm -113.21 128.11 70.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 120.493 -0.483 . . . . 0.0 112.022 -178.286 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.42 ' HB2' HD11 ' A' ' 82' ' ' LEU . 22.9 tp -98.65 126.61 44.3 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.545 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -117.92 139.09 51.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.739 0.304 . . . . 0.0 110.595 -179.724 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.577 ' ND2' ' H ' ' A' ' 69' ' ' THR . 16.0 t-20 -101.58 113.93 27.51 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.85 0.357 . . . . 0.0 111.493 -179.728 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -102.45 -7.92 21.54 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.653 179.878 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.42 99.16 11.01 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.423 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.9 m -76.25 -32.31 58.79 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.246 0.546 . . . . 0.0 109.938 179.064 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.0 m -63.48 -45.97 88.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.598 -179.309 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -142.93 93.15 6.73 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.597 179.208 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -56.93 148.89 64.8 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.056 1.837 . . . . 0.0 111.859 -179.721 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.967 ' O ' HG22 ' A' ' 76' ' ' ILE . 41.7 m -70.66 156.43 39.48 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.106 -179.589 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.413 ' N ' HG22 ' A' ' 69' ' ' THR . 86.7 mt-30 -114.6 140.98 48.36 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.915 179.683 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.642 HG13 ' OD1' ' A' ' 86' ' ' ASP . 55.6 t -130.21 135.68 60.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.762 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 52.81 32.38 12.19 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 119.857 -0.737 . . . . 0.0 109.359 -179.142 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.25 29.17 68.84 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.511 179.99 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 11.3 p -142.03 140.15 32.55 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.286 179.965 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.2 p -63.0 143.27 15.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.698 -179.433 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.967 HG22 ' O ' ' A' ' 69' ' ' THR . 10.5 tt -113.88 87.28 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.577 -179.849 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 20.5 p-10 -66.4 -33.03 74.79 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.952 179.891 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.418 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 2.7 mt-10 -124.65 167.41 15.96 Favored Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.27 -179.053 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -60.3 144.87 99.5 Favored 'Trans proline' 0 N--CA 1.502 2.001 0 C-N-CA 122.582 2.188 . . . . 0.0 112.891 179.647 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.1 m -138.77 152.81 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 CA-C-O 121.618 0.723 . . . . 0.0 111.962 178.665 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -79.45 127.31 31.95 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.835 179.548 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.42 HD11 ' HB2' ' A' ' 60' ' ' LEU . 98.1 mt -83.41 129.49 34.99 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.28 0.562 . . . . 0.0 110.434 -179.623 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -121.91 150.45 41.96 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.283 -179.881 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.428 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 6.1 t60 -49.63 118.35 2.75 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.955 -179.397 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.15 -20.35 28.55 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 179.685 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.642 ' OD1' HG13 ' A' ' 71' ' ' VAL . 56.7 t0 -61.54 132.49 53.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.17 0.509 . . . . 0.0 110.437 179.864 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.503 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 56.7 t -109.48 129.75 63.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.278 -179.03 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.8 mt -98.09 131.56 44.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.613 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.455 HG23 ' OG ' ' A' ' 94' ' ' SER . 74.7 m -126.05 127.92 46.6 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.624 0.726 . . . . 0.0 112.405 -178.42 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.569 ' O ' ' N ' ' A' ' 92' ' ' ASP . 97.8 mt -110.13 125.4 67.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.009 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.894 HD12 HH22 ' A' ' 93' ' ' ARG . 88.6 mt 40.0 -91.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 120.584 -0.447 . . . . 0.0 110.315 -178.7 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.569 ' N ' ' O ' ' A' ' 90' ' ' ILE . 33.9 t70 -128.06 20.05 6.43 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.04 0.448 . . . . 0.0 111.238 -179.776 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.894 HH22 HD12 ' A' ' 91' ' ' ILE . 45.8 mtm-85 -126.65 140.41 52.43 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.541 -179.798 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.455 ' OG ' HG23 ' A' ' 89' ' ' THR . 57.4 m -138.89 153.31 48.27 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 119.602 -0.839 . . . . 0.0 112.2 -179.154 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -121.92 122.44 39.4 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.705 178.864 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -81.55 130.11 34.93 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 119.884 -0.726 . . . . 0.0 110.449 -179.108 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -94.27 124.24 38.17 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.272 -179.283 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.497 ' OE1' ' NE ' ' A' ' 6' ' ' ARG . 80.3 tt0 -124.5 123.44 40.13 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.97 179.868 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.428 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 64.0 t-20 . . . . . 0 N--CA 1.463 0.193 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.668 -179.959 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo . . . . . 0 N--CA 1.484 0.925 0 CA-C-O 120.947 0.311 . . . . 0.0 111.59 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 5.9 p -113.91 133.2 60.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.799 179.704 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . 0.461 ' HG ' ' HD2' ' B' ' 241' ' ' PHE . 4.6 t . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.48 -178.923 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo . . . . . 0 N--CA 1.495 1.584 0 CA-C-O 120.621 0.176 . . . . 0.0 112.003 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 94.4 m -71.88 -45.84 59.91 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.147 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.525 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 83.3 t80 -58.79 -47.05 86.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.101 -179.376 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.407 ' HA ' HD23 ' B' ' 242' ' ' LEU . 95.3 mt -63.56 -41.1 98.42 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -179.046 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -63.12 -38.87 92.91 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.967 -179.792 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -63.49 -41.85 98.56 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.126 0.489 . . . . 0.0 110.002 179.613 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.633 ' NH2' ' NH1' ' A' ' 93' ' ' ARG . 62.4 ttm-85 -60.05 -44.72 94.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.008 -179.168 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -64.77 -40.05 94.62 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.752 179.467 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 66.6 m -63.77 -45.42 89.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.499 179.509 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -60.7 -39.47 88.65 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.259 -179.461 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . 0.486 HG13 ' OG ' ' A' ' 13' ' ' SER . 21.0 t . . . . . 0 N--CA 1.452 -0.351 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.445 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 . . . . . 0 CA--C 1.531 0.247 0 CA-C-O 120.481 0.181 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.413 HD12 ' CG2' ' A' ' 9' ' ' THR . 73.5 mt -106.39 138.73 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.783 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 54.1 t -129.05 136.66 59.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.274 -178.765 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -97.4 117.12 30.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.318 0.58 . . . . 0.0 111.126 -179.397 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 43.3 tttp -67.05 -43.41 82.8 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.502 178.99 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 53.8 mm-40 -94.0 155.2 40.43 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.721 -179.014 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -61.31 154.1 60.82 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.103 1.869 . . . . 0.0 111.036 178.561 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 40.3 pt . . . . . 0 C--N 1.324 -0.539 0 CA-C-O 121.702 0.763 . . . . 0.0 112.372 -178.328 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 68.5 p . . . . . 0 CA--C 1.521 -0.152 0 CA-C-O 120.787 0.327 . . . . 0.0 110.58 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.871 ' NH1' HG23 ' A' ' 53' ' ' ILE . 99.9 mtt180 -94.72 130.73 41.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.941 179.924 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -128.27 137.85 52.16 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.424 179.514 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.56 HD11 ' HB3' ' A' ' 95' ' ' PHE . 45.0 tp -106.88 130.88 54.49 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.47 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.6 t -110.04 129.31 65.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.475 -178.991 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.412 ' O ' HG22 ' A' ' 9' ' ' THR . 1.8 m -90.9 111.9 23.52 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.461 -178.971 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.7 mt -83.13 148.03 5.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.599 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -94.15 168.6 10.83 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.383 0.611 . . . . 0.0 111.434 179.705 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.446 ' HD3' HH12 ' A' ' 93' ' ' ARG . 87.9 mtm180 -58.06 -29.74 65.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.886 -179.038 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.8 p -80.54 -6.24 57.93 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.687 179.796 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.04 23.6 37.6 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.163 179.159 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.1 m -109.54 140.86 26.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.535 179.742 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.41 ' C ' ' OD1' ' A' ' 16' ' ' ASP . 57.3 t0 -69.32 122.75 19.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.682 -179.6 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -108.74 -131.91 6.49 Favored Glycine 0 CA--C 1.538 1.506 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 -179.344 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -74.71 153.95 43.64 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.342 2.028 . . . . 0.0 112.031 -179.258 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -109.15 155.92 20.45 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.148 -179.536 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.439 ' CD2' HD11 ' A' ' 37' ' ' ILE . 57.2 t80 -126.12 92.28 46.13 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.477 179.927 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.94 126.72 22.53 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 121.865 1.71 . . . . 0.0 111.551 -179.789 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.2 mt -80.02 54.3 1.88 Allowed 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 120.808 0.337 . . . . 0.0 110.708 -179.351 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.6 t -62.46 -40.62 97.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.802 179.587 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 46.8 mt -70.54 144.49 51.29 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.178 -179.77 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.6 t -66.01 -17.84 64.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.444 -178.84 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.549 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 50.2 m -132.53 134.13 44.61 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.996 -179.777 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.647 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 2.7 t -127.66 116.81 20.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.111 0.481 . . . . 0.0 109.798 178.585 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.617 HD21 ' OE1' ' A' ' 47' ' ' GLN . 44.7 tp -114.82 130.14 56.82 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.631 -178.291 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.778 ' CE2' HD12 ' A' ' 37' ' ' ILE . 27.1 m-85 -108.7 139.18 43.86 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.171 -179.894 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.87 -175.38 30.65 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.405 178.574 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.6 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 81.5 mtm-85 -74.04 -32.96 63.54 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.911 0.386 . . . . 0.0 110.868 -179.961 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.428 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -46.86 139.8 7.46 Favored Glycine 0 N--CA 1.465 0.584 0 N-CA-C 111.554 -0.619 . . . . 0.0 111.554 -178.582 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.547 ' CD1' ' CZ ' ' A' ' 38' ' ' ARG . 36.3 mm -64.99 -44.71 96.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.805 0.336 . . . . 0.0 110.975 -179.951 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -57.98 -13.91 5.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.45 -179.173 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.428 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 60.0 m -63.02 131.23 47.91 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.524 -179.877 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.549 ' OD2' ' O ' ' A' ' 26' ' ' THR . 58.9 m-20 -61.24 -30.79 70.66 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.288 -179.326 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.778 HD12 ' CE2' ' A' ' 29' ' ' PHE . 77.9 mt -128.44 119.34 50.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.019 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.547 ' CZ ' ' CD1' ' A' ' 33' ' ' ILE . 83.8 mtp180 -100.04 135.54 41.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.518 -179.052 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.561 HG21 HD12 ' A' ' 41' ' ' LEU . 95.2 mt -121.28 128.96 76.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.55 -0.46 . . . . 0.0 109.907 179.98 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -79.36 31.26 0.22 Allowed 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -178.318 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.561 HD12 HG21 ' A' ' 39' ' ' ILE . 13.2 mt -97.85 128.48 33.92 Favored Pre-proline 0 CA--C 1.535 0.366 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.763 179.544 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -72.51 -12.69 27.27 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.487 2.125 . . . . 0.0 113.272 -179.276 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.439 HG21 ' CE2' ' B' ' 241' ' ' PHE . 27.1 m -100.29 6.99 9.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.316 -0.554 . . . . 0.0 110.432 179.525 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.6 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 32.0 t -95.43 134.99 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.934 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.67 164.47 19.2 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.502 0.668 . . . . 0.0 111.94 -178.691 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -63.56 -42.31 98.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.056 -179.375 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.638 ' O ' ' N ' ' A' ' 49' ' ' CYS . 95.3 mm-40 -109.2 -23.04 11.81 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.591 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.473 ' O ' ' OG ' ' A' ' 64' ' ' SER . 17.1 t60 38.18 -76.04 0.0 OUTLIER 'General case' 0 C--O 1.235 0.336 0 CA-C-N 114.621 -1.172 . . . . 0.0 113.086 179.135 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.638 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.59 136.79 45.13 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.347 -0.541 . . . . 0.0 112.04 -178.218 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -128.17 130.39 47.98 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.394 179.431 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 95.8 mt -112.36 133.36 58.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.043 -179.934 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 73.3 tt0 -116.92 125.32 51.29 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.864 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.871 HG23 ' NH1' ' A' ' 5' ' ' ARG . 91.8 mt -104.33 123.81 58.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.666 0.746 . . . . 0.0 112.913 -177.796 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.494 ' O ' ' N ' ' A' ' 56' ' ' GLN . 2.0 m-70 -118.21 137.19 53.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.506 -1.225 . . . . 0.0 109.437 179.06 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.466 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.9 mm-40 -39.38 -29.57 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -179.508 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.494 ' N ' ' O ' ' A' ' 54' ' ' HIS . 98.6 mm-40 -65.22 -66.52 0.53 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.955 178.656 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -157.49 -166.03 1.93 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.198 -179.65 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.499 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -108.95 130.79 55.46 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.699 179.129 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 37.1 mm -112.43 125.84 69.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.902 -179.473 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.1 tp -99.72 123.41 43.95 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.723 0.297 . . . . 0.0 110.53 -179.888 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -111.23 134.6 52.69 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.152 179.853 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.408 ' ND2' ' O ' ' A' ' 76' ' ' ILE . 46.6 p-10 -99.89 108.3 20.51 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 121.0 0.429 . . . . 0.0 111.537 -179.845 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -97.52 -9.65 26.72 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.7 -179.937 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.473 ' OG ' ' O ' ' A' ' 48' ' ' HIS . 0.3 OUTLIER -77.25 99.88 5.64 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 120.95 0.405 . . . . 0.0 110.764 -179.689 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 86.5 p -79.08 -31.44 44.37 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.875 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.588 HG22 HG12 ' B' ' 236' ' ' VAL . 3.6 m -64.41 -47.99 77.08 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.764 -179.796 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -147.61 99.17 3.85 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.25 -179.699 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -56.27 149.66 53.93 Favored 'Trans proline' 0 N--CA 1.499 1.794 0 C-N-CA 122.117 1.878 . . . . 0.0 113.215 -178.489 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 50.3 m -68.06 138.7 56.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.174 178.849 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -100.45 144.54 29.33 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.731 -179.745 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.697 ' HB ' HD11 ' A' ' 76' ' ' ILE . 5.1 p -131.21 136.28 58.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.167 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 51.12 30.93 6.01 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -178.967 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.41 26.2 70.76 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.936 -179.86 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 71' ' ' VAL . 12.0 t -135.65 137.8 42.21 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.194 0.521 . . . . 0.0 111.534 -179.511 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.5 t -66.68 136.43 26.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.813 -179.784 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.697 HD11 ' HB ' ' A' ' 71' ' ' VAL . 97.0 mt -101.27 100.86 11.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.561 179.383 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -64.44 -41.15 96.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.875 179.872 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.515 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.9 OUTLIER -132.54 -178.07 0.79 Allowed Pre-proline 0 N--CA 1.464 0.227 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.346 -178.656 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 31.3 Cg_exo -59.38 143.8 99.6 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.49 2.127 . . . . 0.0 111.642 -179.815 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.2 p -141.01 147.65 22.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-O 121.186 0.517 . . . . 0.0 112.078 -179.041 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -79.7 128.16 33.08 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.283 179.27 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.499 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 96.0 mt -83.33 139.15 33.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.22 -179.84 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.484 ' N ' ' OD2' ' A' ' 86' ' ' ASP . 99.2 mttt -128.81 153.67 47.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.795 179.166 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.538 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 3.6 t-160 -55.54 119.4 5.6 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.892 0.377 . . . . 0.0 110.383 -179.661 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.0 -13.66 31.65 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.687 179.606 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.523 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 2.4 p30 -72.06 133.2 45.11 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.406 -0.517 . . . . 0.0 109.894 179.564 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 45.7 t -109.21 130.12 62.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.583 -178.309 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 89.4 mt -98.21 131.29 45.56 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 178.401 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.6 m -119.27 127.91 53.67 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.951 0.882 . . . . 0.0 112.628 -178.066 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.587 ' O ' ' N ' ' A' ' 93' ' ' ARG . 98.4 mt -115.28 134.11 59.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.471 178.496 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.617 HD13 ' HB2' ' B' ' 237' ' ' CYS . 53.9 mt -31.73 100.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 O-C-N 123.028 0.205 . . . . 0.0 111.295 -179.857 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.488 ' HB2' ' O ' ' A' ' 91' ' ' ILE . 83.8 m-20 86.67 -16.11 0.42 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.132 0.973 . . . . 0.0 113.259 179.169 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.587 ' N ' ' O ' ' A' ' 90' ' ' ILE . 81.1 mmt-85 -130.43 141.53 50.53 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.902 179.517 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.5 m -139.02 148.58 43.6 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.611 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.56 ' HB3' HD11 ' A' ' 7' ' ' LEU . 18.8 m-85 -126.8 125.37 41.59 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.544 -179.804 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 96' ' ' ARG . 49.0 ttt85 -84.5 131.18 34.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.885 0.374 . . . . 0.0 110.893 -179.647 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -94.73 122.2 37.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.917 -179.781 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -124.1 120.73 33.22 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.637 -179.679 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.538 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 43.9 t-20 . . . . . 0 C--N 1.332 -0.17 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.199 179.364 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo . . . . . 0 N--CA 1.49 1.319 0 CA-C-O 121.631 0.596 . . . . 0.0 113.289 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.588 HG12 HG22 ' A' ' 66' ' ' THR . 35.1 m -76.44 135.42 26.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 114.66 -1.154 . . . . 0.0 109.989 179.799 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . 0.617 ' HB2' HD13 ' A' ' 91' ' ' ILE . 5.1 t . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.403 -178.732 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo . . . . . 0 N--CA 1.492 1.387 0 CA-C-O 120.922 0.301 . . . . 0.0 111.579 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 60.4 m -75.27 -43.01 53.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.599 177.445 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.439 ' CE2' HG21 ' A' ' 43' ' ' VAL . 90.1 t80 -59.18 -45.11 91.9 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.031 -179.949 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.518 HD21 HG23 ' A' ' 91' ' ' ILE . 98.2 mt -63.8 -39.32 93.95 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.091 0.472 . . . . 0.0 110.124 179.899 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -62.25 -41.71 98.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.768 179.985 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -62.36 -37.2 84.77 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.178 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.593 ' NH2' ' OE1' ' B' ' 248' ' ' GLN . 0.0 OUTLIER -58.5 -43.14 88.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.875 179.684 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -61.16 -38.48 86.6 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.587 -0.524 . . . . 0.0 109.587 178.95 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 38.0 t -64.1 -43.08 96.43 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 177.601 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . 0.593 ' OE1' ' NH2' ' B' ' 245' ' ' ARG . 36.7 mt-30 -58.49 -37.9 76.53 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.419 179.881 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 38.5 t . . . . . 0 N--CA 1.454 -0.238 0 C-N-CA 120.546 -0.461 . . . . 0.0 110.345 179.859 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.411 ' HB2' ' NH2' ' A' ' 93' ' ' ARG . 95.5 mt-10 . . . . . 0 N--CA 1.462 0.161 0 N-CA-C 111.366 0.136 . . . . 0.0 111.366 . . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.503 HD11 ' HD2' ' A' ' 93' ' ' ARG . 82.8 mt -111.47 132.28 60.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.838 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 54.9 t -127.98 136.03 61.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.149 -179.873 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -96.99 121.97 39.46 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.41 0.624 . . . . 0.0 111.258 -179.029 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -66.25 -46.16 78.07 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.037 179.473 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . 0.521 ' OE1' ' O ' ' B' ' 266' ' ' PRO . 0.0 OUTLIER -94.8 157.22 37.18 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.036 -179.418 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . 0.521 ' O ' ' OE1' ' B' ' 265' ' ' GLN . 57.2 Cg_endo -65.72 145.26 80.73 Favored 'Trans proline' 0 N--CA 1.5 1.882 0 C-N-CA 123.15 2.566 . . . . 0.0 113.118 -178.852 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 43.9 pt . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.224 178.95 . . . . . . . . 0 0 . 1 . 041 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 34.2 p . . . . . 0 N--CA 1.456 -0.148 0 CA-C-O 120.975 0.417 . . . . 0.0 110.528 . . . . . . . . . 0 0 . 1 . 041 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.619 ' NE ' ' OH ' ' A' ' 97' ' ' TYR . 83.5 mtp180 -85.17 129.89 34.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.155 -179.418 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.602 ' NH2' ' ND1' ' A' ' 19' ' ' HIS . 79.5 ttt180 -124.42 131.38 53.5 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -178.783 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.429 HD11 ' HB3' ' A' ' 95' ' ' PHE . 40.3 tp -109.81 132.36 54.22 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.208 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.7 t -109.79 128.45 65.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.467 -178.952 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.442 HG23 ' CD1' ' B' ' 261' ' ' ILE . 1.6 m -89.93 115.04 26.93 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.565 -179.429 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.666 HD12 ' OG ' ' A' ' 94' ' ' SER . 97.4 mt -79.87 140.14 17.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.151 179.393 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -89.93 160.41 16.43 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.182 0.515 . . . . 0.0 111.046 179.071 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.597 ' NH2' ' N ' ' B' ' 249' ' ' VAL . 73.5 mtp180 -57.52 -31.96 66.57 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.779 -179.757 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 99.7 p -77.38 -11.59 59.86 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.634 -179.634 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.93 31.68 9.72 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 -179.682 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.7 t -115.86 133.37 62.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.432 -0.384 . . . . 0.0 110.427 -179.68 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.436 ' C ' ' OD1' ' A' ' 16' ' ' ASP . 49.0 t0 -62.02 120.33 10.61 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.6 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -103.31 -134.81 8.42 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 120.892 -0.67 . . . . 0.0 111.808 -178.7 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -75.14 150.7 37.94 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.526 2.151 . . . . 0.0 112.534 -178.945 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.602 ' ND1' ' NH2' ' A' ' 6' ' ' ARG . 0.6 OUTLIER -108.51 131.08 55.18 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.64 -179.541 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.558 ' CD2' HD11 ' A' ' 37' ' ' ILE . 37.8 t80 -100.84 100.38 12.59 Favored Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.347 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.28 134.74 21.45 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 121.095 1.197 . . . . 0.0 111.581 -178.303 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 68.2 mt -99.38 124.17 44.28 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.627 0.727 . . . . 0.0 111.574 -178.118 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.6 p -137.09 -19.7 1.27 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.404 -1.271 . . . . 0.0 109.284 178.714 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.652 HD11 ' CD ' ' B' ' 265' ' ' GLN . 58.7 mt -79.15 144.92 34.02 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.355 179.41 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 90.9 p -61.82 -21.3 64.5 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -178.248 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.441 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 53.9 m -135.08 134.79 40.69 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.213 -0.595 . . . . 0.0 112.561 -178.618 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.9 t -124.81 116.23 21.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.602 178.119 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.666 HD12 ' O ' ' A' ' 49' ' ' CYS . 49.6 tp -116.73 132.86 56.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.957 0.408 . . . . 0.0 112.042 -178.337 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.714 ' CE2' HD12 ' A' ' 37' ' ' ILE . 10.8 m-85 -110.49 140.6 44.6 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.233 178.973 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 154.13 -176.29 32.06 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.044 178.735 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.646 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 80.2 mtm-85 -75.48 -30.72 59.99 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 120.956 0.407 . . . . 0.0 110.111 179.562 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.556 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -51.06 145.07 11.69 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.848 -178.608 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.488 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.7 tp -68.12 -41.0 83.86 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 120.872 0.368 . . . . 0.0 110.095 179.271 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.488 ' N ' HG23 ' A' ' 33' ' ' ILE . 80.6 tt0 -55.67 -22.09 21.36 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.47 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.556 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 19.0 m -58.82 121.41 11.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.837 179.369 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.441 ' OD2' ' O ' ' A' ' 26' ' ' THR . 96.2 m-20 -58.65 -25.05 62.36 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -178.767 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.714 HD12 ' CE2' ' A' ' 29' ' ' PHE . 82.1 mt -131.21 122.74 51.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.565 177.27 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.441 ' HD3' HD12 ' A' ' 33' ' ' ILE . 60.6 mtm180 -101.08 134.22 44.41 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.491 179.658 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.4 mt -116.47 127.87 73.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.484 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -74.66 28.21 0.09 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.23 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.595 HD21 ' OE1' ' B' ' 260' ' ' GLU . 40.7 mt -98.31 129.54 30.34 Favored Pre-proline 0 CA--C 1.538 0.508 0 C-N-CA 119.924 -0.711 . . . . 0.0 110.737 179.922 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.59 -7.53 20.35 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.607 2.205 . . . . 0.0 112.072 -179.523 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.4 m -102.06 6.79 9.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.112 -179.355 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.646 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 17.4 t -95.08 136.43 26.17 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.268 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.864 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.5 m -69.43 167.48 16.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.054 0.454 . . . . 0.0 111.147 -179.384 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 47.3 mttp -63.5 -38.6 91.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.966 -179.53 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.676 ' O ' ' N ' ' A' ' 49' ' ' CYS . 91.7 mm-40 -113.66 -17.99 12.0 Favored 'General case' 0 C--O 1.223 -0.338 0 O-C-N 123.474 0.484 . . . . 0.0 111.371 -179.159 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 23.2 t60 29.63 -74.97 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.52 0.934 . . . . 0.0 113.52 -179.608 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.676 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.11 133.83 46.0 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.427 0.632 . . . . 0.0 112.402 -178.287 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -128.55 128.37 44.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.2 179.537 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 85.2 mt -109.47 132.37 57.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.422 179.667 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -114.63 124.24 51.33 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.11 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.567 HD13 ' NH1' ' A' ' 5' ' ' ARG . 64.5 mt -107.46 116.59 51.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 120.02 -0.672 . . . . 0.0 112.727 -177.661 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.455 ' O ' ' C ' ' A' ' 55' ' ' GLU . 97.4 m-70 -111.49 139.26 47.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.905 178.654 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 54' ' ' HIS . 84.0 tt0 -41.21 -30.05 0.15 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 119.926 -0.709 . . . . 0.0 109.306 -179.943 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.431 ' N ' ' O ' ' A' ' 54' ' ' HIS . 84.8 mt-30 -61.08 -68.09 0.34 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.622 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -156.19 -174.04 4.77 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.1 -179.772 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.597 ' HB1' HH22 ' A' ' 5' ' ' ARG . . . -108.32 125.3 51.54 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.022 179.732 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.1 mt -119.23 130.77 73.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.369 0.604 . . . . 0.0 112.471 -178.55 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.587 ' HB2' HD11 ' A' ' 82' ' ' LEU . 18.4 tp -97.86 127.94 44.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.367 179.503 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -109.0 134.81 51.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.891 179.621 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.447 HD21 ' CA ' ' A' ' 68' ' ' PRO . 64.5 t-20 -94.49 105.49 17.46 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.39 -178.866 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -98.75 -8.28 26.28 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.689 179.497 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.6 m -71.52 101.93 2.58 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.304 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 89.7 p -87.84 -24.13 23.8 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.107 179.821 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.508 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -78.27 -42.1 32.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.312 0.577 . . . . 0.0 109.769 179.323 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 36.7 m-20 -143.13 99.31 5.46 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.875 -179.498 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.447 ' CA ' HD21 ' A' ' 62' ' ' ASN . 52.7 Cg_exo -54.77 148.17 46.95 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.197 1.931 . . . . 0.0 113.41 -179.578 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.1 m -75.04 142.07 43.81 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.293 179.457 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -108.2 139.9 42.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.928 179.688 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.681 HG13 ' OD1' ' A' ' 86' ' ' ASP . 54.8 t -131.75 135.33 59.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.579 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 51.81 31.72 8.63 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.28 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.51 25.06 68.79 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-N 114.957 -1.02 . . . . 0.0 112.132 179.743 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 66.1 m -142.93 142.52 31.71 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 117.725 0.762 . . . . 0.0 112.57 -179.576 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.8 t -69.85 142.08 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.312 179.424 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.3 pt -110.98 77.08 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.478 179.221 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -52.55 -29.56 26.14 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.4 179.943 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.56 171.25 6.34 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.145 179.366 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -60.63 148.44 91.4 Favored 'Trans proline' 0 N--CA 1.499 1.84 0 C-N-CA 122.276 1.984 . . . . 0.0 111.832 179.631 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.8 p -138.15 140.83 39.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.995 0.426 . . . . 0.0 111.625 -179.391 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.9 mtm180 -75.12 128.53 35.73 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.025 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.587 HD11 ' HB2' ' A' ' 60' ' ' LEU . 91.5 mt -84.4 138.96 32.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.958 0.409 . . . . 0.0 111.054 -179.449 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -131.83 155.63 47.46 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.583 179.987 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.598 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 5.7 t60 -56.92 115.13 2.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.446 179.944 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.3 -12.49 26.15 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 -179.462 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.681 ' OD1' HG13 ' A' ' 71' ' ' VAL . 58.7 t0 -70.01 129.79 40.41 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 179.615 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.464 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 60.9 t -110.96 131.82 61.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.228 -179.237 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 94.4 mt -97.63 129.79 47.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.379 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 77.7 m -120.46 125.71 48.59 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.69 0.757 . . . . 0.0 112.777 -178.231 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.464 ' O ' ' C ' ' A' ' 91' ' ' ILE . 95.7 mt -112.2 123.47 67.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.347 178.079 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.608 HG22 ' N ' ' A' ' 92' ' ' ASP . 96.0 mt 34.33 -98.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 121.201 -0.2 . . . . 0.0 110.972 -178.883 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.608 ' N ' HG22 ' A' ' 91' ' ' ILE . 50.1 p-10 -114.43 15.03 17.97 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.913 0.387 . . . . 0.0 111.544 -179.99 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.442 HH21 ' CD ' ' B' ' 260' ' ' GLU . 84.6 mtt-85 -124.89 142.48 51.43 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.765 179.058 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.666 ' OG ' HD12 ' A' ' 10' ' ' ILE . 53.8 p -141.0 154.43 46.02 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.715 179.549 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.429 ' HB3' HD11 ' A' ' 7' ' ' LEU . 47.9 m-85 -124.32 125.46 44.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.555 179.757 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.425 ' O ' HD12 ' A' ' 7' ' ' LEU . 79.4 mtp85 -88.48 132.4 34.5 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.83 -179.494 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.619 ' OH ' ' NE ' ' A' ' 5' ' ' ARG . 88.3 t80 -95.21 127.87 41.6 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.197 -179.609 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -131.24 116.43 17.64 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.303 -179.613 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.598 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 61.9 t-20 . . . . . 0 N--CA 1.464 0.243 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.963 -179.806 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo . . . . . 0 N--CA 1.486 1.043 0 CA-C-O 121.624 0.594 . . . . 0.0 113.44 . . . . . . . . . 0 0 . 1 . 041 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.508 ' CG2' HG22 ' A' ' 66' ' ' THR . 53.7 t -63.91 136.32 26.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.542 -179.355 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 14.8 t . . . . . 0 C--N 1.332 -0.187 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.764 . . . . . . . . 0 0 . 1 . 041 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo . . . . . 0 N--CA 1.493 1.473 0 CA-C-O 120.656 0.19 . . . . 0.0 111.986 . . . . . . . . . 0 0 . 1 . 041 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 19.9 m -68.3 -44.42 75.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.321 0.581 . . . . 0.0 109.67 178.001 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.419 ' HZ ' HD22 ' A' ' 41' ' ' LEU . 89.0 t80 -58.47 -47.26 84.62 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.411 -179.296 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 93.8 mt -63.32 -40.68 97.99 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.146 -179.501 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -64.42 -41.25 96.71 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.115 -179.42 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -62.0 -41.86 98.52 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.016 -179.653 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.587 ' CZ ' ' OD2' ' A' ' 92' ' ' ASP . 8.2 tpp85 -61.28 -42.02 97.94 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.277 179.595 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . 0.47 ' O ' HG12 ' B' ' 249' ' ' VAL . 98.4 mttt -61.39 -41.38 97.04 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.412 179.891 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 58.5 m -68.75 -41.91 78.27 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.305 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . 0.448 ' HB3' HH22 ' A' ' 12' ' ' ARG . 62.1 tt0 -61.1 -39.67 90.84 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.119 -179.422 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . 0.597 ' N ' ' NH2' ' A' ' 12' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.465 0.297 0 C-N-CA 119.932 -0.707 . . . . 0.0 109.25 179.165 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.595 ' OE1' HD21 ' A' ' 41' ' ' LEU . 97.0 mt-10 . . . . . 0 CA--C 1.535 0.402 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 . . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.442 ' CD1' HG23 ' A' ' 9' ' ' THR . 65.0 mt -118.4 133.44 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 120.604 -0.438 . . . . 0.0 109.839 179.703 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 49.6 t -128.46 135.91 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 120.786 0.327 . . . . 0.0 110.836 -179.693 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -97.42 119.64 36.32 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.298 0.57 . . . . 0.0 112.156 -178.641 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -64.93 -45.37 86.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.292 178.552 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . 0.652 ' CD ' HD11 ' A' ' 24' ' ' LEU . 2.0 mm-40 -89.9 157.84 45.48 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.393 -179.002 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -60.71 144.15 99.5 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 C-N-CA 122.055 1.837 . . . . 0.0 111.139 179.173 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . 0.498 ' CD1' ' O ' ' A' ' 19' ' ' HIS . 2.5 tt . . . . . 0 C--N 1.324 -0.514 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.549 -178.555 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.7 p . . . . . 0 C--O 1.232 0.164 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 . . . . . . . . . 0 0 . 1 . 042 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.4 mtm-85 -93.4 121.61 34.97 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.282 -178.725 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.695 HH21 ' CG ' ' A' ' 19' ' ' HIS . 80.5 ttt180 -130.23 132.01 45.78 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.757 -179.566 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.569 HD12 ' O ' ' A' ' 96' ' ' ARG . 26.0 tp -112.84 133.33 54.88 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -179.928 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.6 t -110.49 131.98 60.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 121.071 -0.251 . . . . 0.0 110.903 -179.492 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 m -93.24 114.38 26.84 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.317 0.58 . . . . 0.0 112.026 -178.713 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 98.2 mt -83.73 146.63 6.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.712 178.538 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -90.49 158.77 16.86 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.903 0.382 . . . . 0.0 110.028 179.063 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.47 HH11 ' HD2' ' B' ' 245' ' ' ARG . 89.7 mtm180 -57.55 -25.54 60.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.03 -179.608 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 90.3 p -79.94 -10.67 59.8 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.838 179.56 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.59 34.69 7.74 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 -179.738 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.3 t -121.03 135.28 61.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.988 0.423 . . . . 0.0 111.381 -179.681 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -74.06 123.49 24.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.278 179.39 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -118.36 -119.97 2.95 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 120.894 -0.67 . . . . 0.0 111.724 -179.327 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -76.21 149.81 32.37 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.137 1.891 . . . . 0.0 111.549 -179.321 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.695 ' CG ' HH21 ' A' ' 6' ' ' ARG . 0.3 OUTLIER -111.79 156.66 21.61 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.787 179.93 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.608 ' CD2' HD11 ' A' ' 37' ' ' ILE . 58.1 t80 -121.76 101.97 42.06 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.03 -179.025 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -73.72 129.59 13.72 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 121.515 1.476 . . . . 0.0 111.359 -179.907 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 93.7 mt -82.12 52.64 2.04 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 120.779 0.324 . . . . 0.0 111.745 -178.567 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.401 ' OG ' ' OE1' ' B' ' 265' ' ' GLN . 91.5 p -62.69 -17.67 61.04 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.415 0.626 . . . . 0.0 109.947 179.22 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.0 mt -90.38 142.17 28.0 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.605 -179.545 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.1 m -66.08 -20.04 66.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.256 -179.847 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.5 m -130.41 131.96 45.51 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.516 -179.816 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.6 t -124.77 116.44 22.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.368 178.655 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 36' ' ' ASP . 50.9 tp -114.41 125.35 53.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.85 -178.753 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.52 ' O ' ' O ' ' A' ' 47' ' ' GLN . 6.9 m-85 -108.11 142.1 38.81 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.789 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 163.86 -165.98 37.24 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.197 -1.002 . . . . 0.0 112.336 178.71 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 28.8 ttp-105 -91.48 -31.0 16.14 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.8 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.576 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -60.75 156.63 31.68 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -179.659 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.617 HD12 ' CD ' ' A' ' 38' ' ' ARG . 5.7 tp -69.06 -39.27 79.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.872 -179.988 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.416 ' N ' HG23 ' A' ' 33' ' ' ILE . 95.8 mt-10 -52.41 -23.46 6.07 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.969 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.576 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 6.1 m -61.25 118.84 7.39 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.118 -179.586 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.549 ' N ' ' O ' ' A' ' 28' ' ' LEU . 99.0 m-20 -58.53 -25.02 61.99 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.448 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.608 HD11 ' CD2' ' A' ' 20' ' ' PHE . 47.5 mm -123.63 108.57 21.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 177.021 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.617 ' CD ' HD12 ' A' ' 33' ' ' ILE . 45.0 mtm180 -100.36 135.08 42.34 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -177.969 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.756 HG21 ' CZ ' ' A' ' 93' ' ' ARG . 96.8 mt -122.03 132.46 70.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.401 0.62 . . . . 0.0 111.477 -178.851 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -68.84 13.37 0.1 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 114.929 -1.032 . . . . 0.0 112.974 -178.579 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.985 HD12 HH21 ' A' ' 93' ' ' ARG . 17.5 mt -94.18 124.87 54.57 Favored Pre-proline 0 C--N 1.32 -0.712 0 C-N-CA 118.973 -1.091 . . . . 0.0 110.166 179.87 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -73.91 -8.97 21.92 Favored 'Trans proline' 0 C--N 1.315 -1.207 0 C-N-CA 122.165 1.91 . . . . 0.0 111.715 179.939 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.0 m -90.29 -0.1 8.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.193 179.302 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.712 HG12 ' O ' ' A' ' 41' ' ' LEU . 4.0 p -91.03 139.32 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-O 121.123 0.487 . . . . 0.0 110.205 -179.986 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.8 t -68.88 161.86 27.77 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.226 0.536 . . . . 0.0 111.354 -178.768 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.468 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 79.9 mttt -61.22 -42.37 98.49 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.614 -178.383 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.672 ' O ' ' N ' ' A' ' 49' ' ' CYS . 90.1 mt-30 -115.44 -12.45 11.7 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 121.061 -0.256 . . . . 0.0 111.246 179.512 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.55 ' CD2' ' HG1' ' A' ' 69' ' ' THR . 20.1 t60 30.76 -73.37 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 179.49 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.672 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -135.56 140.51 44.72 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 119.91 -0.716 . . . . 0.0 112.324 -178.6 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -129.24 130.7 46.59 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.769 179.876 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.7 mt -111.83 131.96 61.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.989 179.717 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -113.34 124.56 52.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.863 179.032 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 48.3 mm -99.45 108.17 22.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.533 -179.895 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.458 ' O ' ' C ' ' A' ' 55' ' ' GLU . 94.7 m-70 -106.48 133.21 51.51 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.681 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 54' ' ' HIS . 95.7 mt-10 -42.32 -31.17 0.37 Allowed 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 119.585 -0.846 . . . . 0.0 108.974 -179.599 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.416 ' N ' ' C ' ' A' ' 54' ' ' HIS . 88.2 mt-30 -67.99 -68.83 0.36 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.759 178.831 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -146.86 176.16 10.1 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.13 0.491 . . . . 0.0 111.603 -179.128 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -111.33 123.2 49.73 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.678 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 93.1 mt -117.06 135.25 58.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -177.631 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.554 ' HB2' HD11 ' A' ' 82' ' ' LEU . 24.9 tp -100.59 125.64 46.98 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.876 -179.932 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -111.34 137.4 49.14 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.197 -179.539 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.422 HD21 ' HA ' ' A' ' 68' ' ' PRO . 64.0 t-20 -98.66 106.22 18.47 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.243 179.478 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -97.26 -10.68 25.29 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 179.865 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.98 106.86 3.36 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 179.955 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 85.7 p -91.88 -15.04 28.69 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.166 -0.613 . . . . 0.0 110.03 179.229 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.495 HG22 HG23 ' B' ' 236' ' ' VAL . 0.2 OUTLIER -93.2 -46.12 7.55 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.567 -179.83 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -132.48 92.93 26.33 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.729 179.724 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.441 ' HB2' HG13 ' A' ' 75' ' ' VAL . 52.4 Cg_exo -56.15 140.89 87.87 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.226 1.95 . . . . 0.0 112.821 -179.378 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.55 ' HG1' ' CD2' ' A' ' 48' ' ' HIS . 86.9 m -72.5 140.32 48.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.388 179.143 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -101.71 140.65 35.72 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.943 178.896 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.445 ' CG1' ' OD1' ' A' ' 86' ' ' ASP . 75.1 t -134.04 133.11 56.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.436 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.59 ' ND2' ' OD1' ' A' ' 86' ' ' ASP . 89.1 m-20 53.8 33.08 16.15 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 119.909 -0.716 . . . . 0.0 109.128 -179.264 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.63 28.68 68.86 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.077 179.587 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 43.3 t -145.61 143.94 30.16 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 117.242 0.521 . . . . 0.0 111.615 179.942 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.441 HG13 ' HB2' ' A' ' 68' ' ' PRO . 50.9 t -70.28 135.19 28.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.024 179.744 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 9.1 pt -108.36 70.47 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.16 179.048 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -56.17 -30.65 62.52 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.949 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.32 157.75 37.22 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.487 178.605 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -64.05 149.59 90.13 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.314 2.009 . . . . 0.0 112.202 -179.841 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.7 m -139.03 142.93 32.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.202 -179.645 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 60.2 ttp180 -72.69 125.32 27.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.394 179.25 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.554 HD11 ' HB2' ' A' ' 60' ' ' LEU . 98.0 mt -77.33 138.7 39.5 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.362 0.601 . . . . 0.0 110.779 179.299 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -136.35 155.15 50.46 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.93 -179.411 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -55.83 113.16 1.38 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.358 -179.647 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.79 -6.76 22.16 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 121.169 -0.539 . . . . 0.0 111.767 179.977 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.59 ' OD1' ' ND2' ' A' ' 72' ' ' ASN . 37.9 t0 -76.73 124.34 27.53 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.249 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 45.8 t -108.12 129.5 62.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.328 -178.476 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 81.9 mt -97.13 132.2 42.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.842 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.9 m -116.41 126.23 53.15 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.072 0.463 . . . . 0.0 111.605 -179.448 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.416 ' CG2' HH12 ' A' ' 93' ' ' ARG . 87.8 mt -122.2 123.14 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.465 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.418 HG22 ' N ' ' A' ' 92' ' ' ASP . 45.0 mm 40.31 -106.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 121.065 -0.254 . . . . 0.0 110.506 -179.609 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.562 ' O ' ' OD1' ' A' ' 92' ' ' ASP . 66.3 t0 -110.48 18.93 19.28 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.06 0.457 . . . . 0.0 110.677 -179.863 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.985 HH21 HD12 ' A' ' 41' ' ' LEU . 8.5 mtm105 -125.44 142.95 51.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.369 -179.985 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 75.2 m -134.43 147.36 50.42 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 120.355 -0.538 . . . . 0.0 109.713 178.296 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.481 ' HB3' HD11 ' A' ' 7' ' ' LEU . 61.2 m-85 -125.28 124.29 41.31 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.931 -179.566 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.569 ' O ' HD12 ' A' ' 7' ' ' LEU . 99.9 mtt180 -90.58 131.76 36.11 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.292 -179.116 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -93.4 123.76 36.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.372 179.269 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -120.04 126.48 50.9 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.213 -179.855 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 . . . . . 0 C--N 1.331 -0.212 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.612 179.732 . . . . . . . . 0 0 . 1 . 042 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo . . . . . 0 N--CA 1.491 1.346 0 CA-C-O 121.334 0.473 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 042 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.495 HG23 HG22 ' A' ' 66' ' ' THR . 39.4 t -61.81 138.59 22.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.271 -179.757 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 10.4 t . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.433 -179.428 . . . . . . . . 0 0 . 1 . 042 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo . . . . . 0 N--CA 1.495 1.607 0 N-CA-C 112.945 0.325 . . . . 0.0 112.945 . . . . . . . . . 0 0 . 1 . 042 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 2.9 p -73.65 -40.67 63.55 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.908 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -57.25 -46.9 82.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.115 179.976 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' B' ' 242' ' ' LEU . 95.7 mt -64.12 -41.4 97.25 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.884 -179.758 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -62.1 -39.72 93.43 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.757 -179.457 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -63.0 -41.3 99.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.889 0.376 . . . . 0.0 110.688 179.407 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.47 ' HD2' HH11 ' A' ' 12' ' ' ARG . 22.7 mmt180 -62.61 -39.01 92.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.026 -179.605 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.32 -39.58 93.5 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.007 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 46.1 t -64.75 -45.01 88.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.488 177.629 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -60.4 -38.15 83.07 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.793 -179.348 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 40.3 t . . . . . 0 N--CA 1.448 -0.533 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.514 -179.791 . . . . . . . . 0 0 . 1 . 042 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.57 ' N ' ' OE1' ' B' ' 260' ' ' GLU . 44.1 mp0 . . . . . 0 C--O 1.226 -0.146 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 . . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 44.6 mt -114.48 134.58 56.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.609 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . 0.403 HG11 ' NH2' ' A' ' 38' ' ' ARG . 74.0 t -126.4 130.77 71.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.114 0.483 . . . . 0.0 110.18 179.6 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -90.62 116.38 28.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.467 -178.403 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -64.91 -44.41 89.67 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.18 179.688 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . 0.401 ' OE1' ' OG ' ' A' ' 23' ' ' SER . 0.0 OUTLIER -92.97 156.34 40.56 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.421 -179.144 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -61.74 145.66 97.18 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.843 2.362 . . . . 0.0 112.146 -179.944 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 27.2 pt . . . . . 0 C--N 1.321 -0.65 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.99 -179.695 . . . . . . . . 0 0 . 1 . 043 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.0 p . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.948 0.404 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 043 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.488 ' NH2' HG21 ' A' ' 53' ' ' ILE . 90.9 mtm-85 -98.7 124.98 43.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.489 -179.624 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 88.6 mtm-85 -129.0 137.85 51.59 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.903 -179.995 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.573 HD12 ' O ' ' A' ' 96' ' ' ARG . 33.9 tp -109.96 129.52 55.65 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.986 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 52.8 t -109.76 131.15 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 120.942 0.401 . . . . 0.0 110.662 -179.463 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.432 HG23 ' CD1' ' B' ' 261' ' ' ILE . 2.8 m -79.78 140.33 36.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.449 -179.097 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.436 ' CD1' ' OD1' ' A' ' 16' ' ' ASP . 50.6 mm -108.69 135.52 47.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.509 177.505 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.7 mttm -86.86 156.4 19.87 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.258 179.185 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.496 ' CD ' ' OD2' ' A' ' 92' ' ' ASP . 89.3 mtm180 -57.1 -29.57 63.63 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.64 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.4 t -78.11 -14.54 59.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.674 179.303 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.75 35.57 5.83 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.208 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.1 t -119.98 130.45 74.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.963 0.411 . . . . 0.0 110.958 -179.623 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.436 ' OD1' ' CD1' ' A' ' 10' ' ' ILE . 97.7 m-20 -72.25 136.36 46.3 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.193 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -127.85 -122.74 2.54 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 120.533 -0.841 . . . . 0.0 111.971 -178.887 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -74.12 151.03 43.69 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.33 2.02 . . . . 0.0 112.779 -178.616 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -110.76 149.79 30.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.621 -179.712 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.426 ' CD2' HD11 ' A' ' 37' ' ' ILE . 69.3 t80 -122.19 102.7 39.91 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.475 -179.395 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.43 134.41 22.54 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.551 1.501 . . . . 0.0 112.105 -178.485 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 91.1 mt -81.62 56.53 3.02 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.129 -179.285 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.0 p -68.09 -23.09 64.89 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.142 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.5 mt -86.21 142.26 28.73 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.599 178.737 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 70.3 p -67.8 -16.17 63.98 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.484 -179.108 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.504 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 66.8 m -133.17 135.29 45.03 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.489 179.973 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.676 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 2.1 t -127.85 114.94 17.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.068 178.675 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.503 HD21 ' HG2' ' A' ' 47' ' ' GLN . 46.1 tp -110.96 128.16 55.74 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.588 -178.873 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.676 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 35.1 m-85 -104.75 137.57 42.35 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.788 178.933 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 158.55 -171.29 35.29 Favored Glycine 0 N--CA 1.471 1.022 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.809 179.091 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.591 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 83.2 mtm-85 -86.82 -29.61 22.13 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.442 -179.67 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -54.3 157.96 5.93 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 -178.355 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.432 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.9 tp -68.89 -40.26 80.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 O-C-N 122.639 -0.33 . . . . 0.0 110.539 179.65 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.432 ' N ' HG23 ' A' ' 33' ' ' ILE . 94.6 mt-10 -57.05 -25.68 59.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.284 -179.825 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.418 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 75.9 m -50.84 115.07 1.34 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.349 179.709 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.504 ' OD2' ' O ' ' A' ' 26' ' ' THR . 94.2 m-20 -58.57 -31.86 68.39 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -179.594 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.655 HD12 ' CE2' ' A' ' 29' ' ' PHE . 95.2 mt -126.13 122.22 61.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 176.381 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 50.3 mtm180 -105.6 138.85 41.12 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.168 -0.613 . . . . 0.0 112.484 -178.721 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 90.5 mt -122.94 129.28 75.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.937 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -77.33 29.47 0.15 Allowed 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -177.894 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.434 ' HA ' HD23 ' A' ' 41' ' ' LEU . 78.5 mt -90.96 122.11 67.12 Favored Pre-proline 0 C--N 1.323 -0.581 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.671 179.455 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.7 -7.91 22.09 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 122.032 1.821 . . . . 0.0 112.061 -179.252 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.6 m -101.56 5.98 10.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.024 179.673 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.591 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 54.3 t -107.0 114.19 45.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.63 179.682 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.8 t -42.75 170.88 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 122.208 1.004 . . . . 0.0 113.303 -178.208 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.418 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 50.3 mttp -63.21 -40.32 97.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.475 -1.238 . . . . 0.0 112.003 -179.763 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.637 ' O ' ' N ' ' A' ' 49' ' ' CYS . 89.0 mt-30 -112.61 -13.34 13.31 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.217 -179.604 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.475 ' ND1' HG13 ' A' ' 44' ' ' VAL . 34.6 t60 36.73 -74.88 0.0 OUTLIER 'General case' 0 C--O 1.237 0.407 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 179.132 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.637 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -134.84 139.63 45.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.141 -178.336 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -128.94 132.77 47.66 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.603 179.927 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 95.5 mt -117.07 134.48 60.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.38 179.892 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -121.54 127.62 51.16 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.467 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.488 HG21 ' NH2' ' A' ' 5' ' ' ARG . 95.8 mt -102.22 118.32 48.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.368 0.604 . . . . 0.0 112.283 -178.473 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.536 ' O ' ' N ' ' A' ' 56' ' ' GLN . 1.9 m-70 -112.89 139.86 48.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.264 178.992 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.9 mm-40 -39.91 -26.48 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -179.586 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.536 ' N ' ' O ' ' A' ' 54' ' ' HIS . 88.5 mt-30 -65.08 -67.32 0.45 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.086 -0.961 . . . . 0.0 108.662 178.028 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -160.9 -162.7 0.95 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.806 0.336 . . . . 0.0 111.377 179.733 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.486 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -106.45 127.46 53.31 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.617 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 44.4 mm -110.51 125.96 67.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.432 -178.781 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 35.7 tp -99.82 126.84 45.99 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.615 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -117.12 136.71 52.8 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.614 0.245 . . . . 0.0 111.377 -179.328 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.505 HD21 ' CB ' ' A' ' 68' ' ' PRO . 48.5 t30 -98.33 106.41 18.69 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.384 179.573 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -98.59 -8.58 26.18 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 179.664 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.2 t -81.07 98.85 8.18 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.274 -179.799 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.4 t -77.87 -39.61 42.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.243 0.544 . . . . 0.0 109.651 178.238 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.498 HG22 HG23 ' B' ' 236' ' ' VAL . 0.3 OUTLIER -63.09 -46.33 87.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.745 -179.49 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.462 ' HB3' HD11 ' A' ' 91' ' ' ILE . 89.2 m-20 -137.23 93.86 12.76 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.26 -179.809 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.505 ' CB ' HD21 ' A' ' 62' ' ' ASN . 39.2 Cg_endo -64.57 148.76 90.56 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.4 1.4 . . . . 0.0 112.733 -177.76 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.432 HG22 ' N ' ' A' ' 70' ' ' GLN . 89.2 m -75.42 153.62 37.57 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.6 -179.29 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.432 ' N ' HG22 ' A' ' 69' ' ' THR . 88.8 mt-30 -115.47 140.59 49.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.852 -179.572 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 50.4 t -129.46 136.15 59.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.679 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 52.32 32.55 11.19 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.522 0.677 . . . . 0.0 109.484 -179.784 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.06 25.04 74.61 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 114.909 -1.041 . . . . 0.0 112.523 178.973 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.8 t -139.31 141.38 37.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 117.444 0.622 . . . . 0.0 110.631 179.131 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 68.7 t -66.4 136.32 26.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.628 -179.559 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.1 pt -108.32 80.06 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.102 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.474 178.963 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -63.93 -31.63 72.88 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.361 0.601 . . . . 0.0 109.744 179.396 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -111.35 155.83 42.16 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.362 179.024 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -63.52 147.43 93.11 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 122.309 2.006 . . . . 0.0 112.209 -179.707 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.3 m -140.25 145.24 26.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.267 0.556 . . . . 0.0 111.534 -179.884 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -74.4 135.64 42.41 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.171 179.79 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.486 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 96.2 mt -81.02 134.19 35.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.921 0.391 . . . . 0.0 111.134 -179.552 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -128.49 149.29 50.65 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.778 179.119 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -52.01 118.3 3.36 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.873 0.368 . . . . 0.0 111.164 -178.669 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.42 -15.27 30.02 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.184 -0.767 . . . . 0.0 111.184 -179.844 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -69.6 131.93 45.42 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.681 179.975 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.43 HG22 ' HG2' ' A' ' 96' ' ' ARG . 71.4 t -113.78 133.85 58.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.94 -178.531 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.8 mt -102.91 132.87 48.16 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.985 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 96.7 m -120.35 126.91 51.68 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 120.027 -0.669 . . . . 0.0 111.669 -179.497 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.583 ' O ' ' N ' ' A' ' 93' ' ' ARG . 89.4 mt -116.07 130.37 70.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.329 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.556 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 84.5 mt -20.93 94.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -178.202 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.556 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 12.9 t0 94.44 -24.78 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 177.847 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.951 ' HE ' HD11 ' B' ' 261' ' ' ILE . 18.2 mtp85 -131.22 146.67 52.41 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.819 -179.949 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 93.9 p -140.04 156.28 46.68 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.95 0.405 . . . . 0.0 110.251 179.739 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.541 ' HB3' HD11 ' A' ' 7' ' ' LEU . 73.9 m-85 -130.64 128.21 40.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.234 -179.631 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.573 ' O ' HD12 ' A' ' 7' ' ' LEU . 73.7 mtp85 -89.43 134.69 33.98 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.503 -179.606 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -95.37 124.55 39.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.515 179.698 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -125.23 127.8 47.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.488 -179.9 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 59.8 t-20 . . . . . 0 C--N 1.331 -0.203 0 CA-C-O 120.82 0.343 . . . . 0.0 110.686 179.999 . . . . . . . . 0 0 . 1 . 043 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo . . . . . 0 N--CA 1.491 1.376 0 CA-C-O 121.469 0.529 . . . . 0.0 112.998 . . . . . . . . . 0 0 . 1 . 043 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.498 HG23 HG22 ' A' ' 66' ' ' THR . 55.3 t -60.56 138.31 21.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.279 -179.958 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 2.0 t . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.066 179.821 . . . . . . . . 0 0 . 1 . 043 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo . . . . . 0 N--CA 1.491 1.356 0 N-CA-C 112.379 0.107 . . . . 0.0 112.379 . . . . . . . . . 0 0 . 1 . 043 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 99.2 m -73.33 -46.07 51.5 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.042 178.513 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -58.3 -47.3 84.12 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.907 -178.47 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' B' ' 242' ' ' LEU . 95.7 mt -63.8 -42.6 97.68 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.719 -0.393 . . . . 0.0 111.8 -179.392 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -65.48 -44.06 88.28 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.183 -179.197 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . 0.533 ' NH1' ' OE1' ' B' ' 248' ' ' GLN . 71.0 ttp85 -65.06 -43.49 92.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.999 0.428 . . . . 0.0 110.3 179.16 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.541 ' O ' HG23 ' B' ' 249' ' ' VAL . 14.5 tpp180 -61.68 -43.81 98.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.542 -179.604 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -65.49 -38.17 88.98 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.046 178.845 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 47.1 t -63.62 -45.15 91.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.464 179.257 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . 0.533 ' OE1' ' NH1' ' B' ' 244' ' ' ARG . 26.1 mt-30 -61.75 -36.13 80.12 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.758 -179.431 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . 0.541 HG23 ' O ' ' B' ' 245' ' ' ARG . 77.5 t . . . . . 0 C--N 1.327 -0.391 0 CA-C-O 121.025 0.44 . . . . 0.0 110.458 179.197 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 . . . . . 0 N--CA 1.454 -0.255 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 . . . . . . . . . 0 0 . 1 . 043 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.951 HD11 ' HE ' ' A' ' 93' ' ' ARG . 60.9 mt -107.2 134.01 50.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.691 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 62.3 t -126.56 131.69 71.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.454 -179.545 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -95.06 120.52 35.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.693 -178.361 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -65.46 -45.24 84.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.659 179.137 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.5 152.77 47.73 Favored Pre-proline 0 C--O 1.231 0.117 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.606 -179.107 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -64.04 141.86 78.71 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.494 2.129 . . . . 0.0 112.116 -179.876 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.1 pt . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.818 179.052 . . . . . . . . 0 0 . 1 . 044 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.469 ' O ' ' O ' ' A' ' 99' ' ' ASN . 26.8 m . . . . . 0 N--CA 1.46 0.071 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 . . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.6 mtt85 -92.49 137.26 32.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.229 -178.208 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.7 mtt85 -130.5 139.62 50.51 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.187 -0.46 . . . . 0.0 112.032 -179.655 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.642 HD12 ' O ' ' A' ' 96' ' ' ARG . 27.3 tp -113.42 130.84 56.21 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.479 179.862 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.5 ' CG1' ' OD1' ' A' ' 16' ' ' ASP . 41.0 t -109.43 129.61 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.215 -178.867 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.9 m -80.2 145.31 32.33 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.797 -178.798 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.7 mt -116.19 137.64 49.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 114.66 -1.155 . . . . 0.0 109.42 178.244 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.1 mttt -88.43 160.21 17.64 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.402 179.854 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.625 ' HG3' HH11 ' A' ' 93' ' ' ARG . 90.0 mtm180 -57.82 -32.33 67.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.428 -179.329 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.1 t -79.82 -5.87 56.24 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.356 179.358 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.45 38.17 7.25 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.933 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.5 t -115.0 132.57 63.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.298 0.57 . . . . 0.0 111.324 -179.799 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.5 ' OD1' ' CG1' ' A' ' 8' ' ' VAL . 67.1 t0 -77.15 122.84 25.57 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.106 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -118.3 -120.1 2.97 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.173 -178.509 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -74.46 152.56 43.81 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.317 2.011 . . . . 0.0 112.395 -178.893 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -111.17 147.74 34.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.057 0.456 . . . . 0.0 110.18 179.913 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.463 ' CD2' HD11 ' A' ' 37' ' ' ILE . 70.3 t80 -117.54 101.68 52.35 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.075 -179.255 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -73.08 136.54 24.87 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.279 1.32 . . . . 0.0 111.696 -179.592 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.0 mt -86.57 65.78 9.18 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.527 -178.307 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.594 ' OG ' ' NE2' ' B' ' 265' ' ' GLN . 18.0 p -68.8 -22.43 64.26 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.693 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 76.2 mt -87.53 142.19 28.05 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.378 179.977 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 61.4 p -66.21 -15.6 63.3 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.658 -179.322 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.507 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 35.6 m -133.02 134.04 43.89 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.988 0.423 . . . . 0.0 110.902 -179.558 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.8 t -126.56 118.13 24.24 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.275 179.911 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.449 HD21 ' HG2' ' A' ' 47' ' ' GLN . 44.6 tp -116.87 128.96 55.76 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.05 -179.071 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.71 ' CE2' HD12 ' A' ' 37' ' ' ILE . 5.8 m-85 -105.94 131.02 53.75 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.868 179.717 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.8 179.9 37.65 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 120.253 -0.975 . . . . 0.0 112.368 179.267 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.471 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 45.3 mtm105 -73.39 -32.53 64.51 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 179.573 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.567 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -48.44 149.28 3.97 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -178.548 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.534 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.4 tp -68.06 -41.99 84.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.339 0.59 . . . . 0.0 110.109 179.676 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.534 ' N ' HG23 ' A' ' 33' ' ' ILE . 80.8 tt0 -56.74 -20.71 23.46 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.386 -179.823 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.567 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 14.8 m -58.12 128.41 37.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.129 -179.819 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.507 ' OD2' ' O ' ' A' ' 26' ' ' THR . 54.0 m-20 -62.4 -33.47 74.82 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.127 -179.712 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.71 HD12 ' CE2' ' A' ' 29' ' ' PHE . 93.2 mt -125.55 118.57 52.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 177.45 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.533 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 82.9 mtp180 -103.36 139.65 38.49 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.137 -178.762 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.418 ' C ' ' H ' ' A' ' 41' ' ' LEU . 80.5 mt -121.54 129.28 75.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.37 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -74.58 34.93 0.1 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.737 -178.367 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.452 ' HA ' HD23 ' A' ' 41' ' ' LEU . 38.2 mt -102.35 122.66 45.78 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.63 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.1 -6.11 18.45 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 122.415 2.077 . . . . 0.0 112.729 -178.802 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.522 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 2.9 m -107.3 6.26 9.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.328 -179.749 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.48 ' O ' ' O ' ' A' ' 45' ' ' SER . 11.8 t -98.27 110.42 25.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.296 0.569 . . . . 0.0 110.693 -179.673 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.48 ' O ' ' O ' ' A' ' 44' ' ' VAL . 1.2 t -33.85 160.25 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.112 -0.949 . . . . 0.0 112.266 -178.94 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -62.04 -42.01 98.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.107 -179.416 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.653 ' O ' ' N ' ' A' ' 49' ' ' CYS . 90.0 mt-30 -114.75 -17.7 11.54 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.696 179.659 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 29.5 t60 35.98 -72.59 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 179.293 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.653 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.71 137.86 47.05 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.067 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -126.84 128.62 46.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.557 179.401 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.3 mt -116.67 135.19 57.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.73 0.3 . . . . 0.0 110.231 179.202 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -113.23 136.79 52.35 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.232 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.8 mm -104.19 124.24 58.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.078 -179.245 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.444 ' O ' ' C ' ' A' ' 55' ' ' GLU . 97.4 m-70 -128.63 135.76 49.75 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.967 179.348 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 54' ' ' HIS . 51.7 tp10 -40.26 -30.37 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.022 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.463 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 92.2 mt-30 -66.34 -67.89 0.41 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.255 178.266 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.52 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 8.3 tp10 -157.93 -158.07 0.7 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.726 -179.352 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.52 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -124.2 130.93 53.38 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.738 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.2 mt -119.55 130.67 73.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.188 0.518 . . . . 0.0 111.48 -179.109 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.493 ' HB2' HD11 ' A' ' 82' ' ' LEU . 25.1 tp -95.71 132.23 41.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.845 -179.753 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -117.02 137.38 52.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.075 179.519 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 62.5 t-20 -95.45 106.44 18.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.046 -178.508 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -97.15 -13.54 22.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.972 179.201 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.12 101.21 4.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.46 179.869 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.6 m -87.2 -16.53 35.06 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.118 179.628 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.472 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -87.8 -45.64 10.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.16 179.453 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -135.96 95.67 13.54 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.373 -179.988 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.539 ' HB2' HG23 ' A' ' 75' ' ' VAL . 50.0 Cg_exo -55.16 142.8 77.15 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.227 1.951 . . . . 0.0 113.124 -179.934 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.96 ' O ' HG22 ' A' ' 76' ' ' ILE . 5.3 m -70.41 140.85 52.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.008 179.181 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -102.1 140.72 36.01 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.507 -0.477 . . . . 0.0 109.953 179.57 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 51.8 t -129.78 134.64 62.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.52 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 50.28 32.84 6.61 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -179.585 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.37 25.7 67.6 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.628 179.532 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 29.6 t -140.74 141.23 34.89 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 117.606 0.703 . . . . 0.0 111.207 179.573 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.539 HG23 ' HB2' ' A' ' 68' ' ' PRO . 0.5 OUTLIER -68.19 140.46 19.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.191 -179.878 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.96 HG22 ' O ' ' A' ' 69' ' ' THR . 9.4 tt -106.74 94.03 2.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.43 179.59 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.5 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 16.2 p-10 -68.24 -34.33 76.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.43 179.844 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.462 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 0.1 OUTLIER -130.65 174.88 4.15 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.115 -178.838 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -61.0 142.89 98.86 Favored 'Trans proline' 0 N--CA 1.501 1.954 0 C-N-CA 122.678 2.252 . . . . 0.0 112.775 -179.615 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.2 m -140.33 143.67 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.402 179.857 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -75.05 126.65 31.47 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.812 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.493 HD11 ' HB2' ' A' ' 60' ' ' LEU . 96.6 mt -79.42 139.26 37.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.917 -179.677 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -126.36 150.12 48.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.445 179.956 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -58.03 121.34 10.37 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.13 -179.561 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.84 -13.82 26.91 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -179.711 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -68.58 134.69 50.36 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.421 179.841 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.543 HG22 ' HG2' ' A' ' 96' ' ' ARG . 74.2 t -108.65 131.84 58.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.68 -178.794 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 83.0 mt -105.6 132.09 53.41 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.1 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.926 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 94.5 m -121.0 125.64 47.88 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 120.305 -0.558 . . . . 0.0 112.044 -178.261 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.454 ' O ' ' C ' ' A' ' 91' ' ' ILE . 92.4 mt -119.05 124.88 73.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 178.716 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.454 ' C ' ' O ' ' A' ' 90' ' ' ILE . 45.0 mm 35.17 -107.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.729 -178.761 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.454 ' N ' HG22 ' A' ' 91' ' ' ILE . 31.3 p-10 -106.04 12.07 30.82 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.385 -179.825 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.625 HH11 ' HG3' ' A' ' 12' ' ' ARG . 19.6 mmm180 -125.85 144.12 50.79 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.593 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 26.4 t -137.59 155.52 49.11 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.896 -179.858 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.516 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 87.2 m-85 -130.13 130.96 45.45 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.559 -0.292 . . . . 0.0 110.739 179.889 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.642 ' O ' HD12 ' A' ' 7' ' ' LEU . 97.8 mtt180 -94.65 134.1 37.59 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.157 179.441 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -97.63 126.51 42.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.853 179.727 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -134.88 125.69 27.27 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.177 179.849 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.469 ' O ' ' O ' ' A' ' 4' ' ' THR . 91.1 m-20 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.512 178.849 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo . . . . . 0 N--CA 1.49 1.29 0 CA-C-O 121.348 0.478 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 044 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.472 ' CG2' HG22 ' A' ' 66' ' ' THR . 47.6 t -76.05 131.42 34.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.107 -0.951 . . . . 0.0 112.009 -178.334 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 4.0 t . . . . . 0 CA--C 1.518 -0.283 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 178.165 . . . . . . . . 0 0 . 1 . 044 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo . . . . . 0 N--CA 1.497 1.707 0 N-CA-C 112.694 0.229 . . . . 0.0 112.694 . . . . . . . . . 0 0 . 1 . 044 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 86.3 m -73.56 -44.09 58.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.224 0.535 . . . . 0.0 109.61 178.259 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.717 ' CE1' ' NE ' ' B' ' 245' ' ' ARG . 53.4 t80 -56.85 -46.93 81.42 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.705 -178.911 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 95.7 mt -64.01 -40.57 96.63 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 121.076 0.465 . . . . 0.0 110.517 -179.856 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -64.1 -39.9 95.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.649 -179.303 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 44.2 ttm180 -60.84 -44.77 96.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.876 0.369 . . . . 0.0 110.209 -179.69 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.717 ' NE ' ' CE1' ' B' ' 241' ' ' PHE . 2.2 mtm-85 -63.26 -40.67 98.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.011 179.858 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.36 -41.42 98.83 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.268 179.117 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 31.3 t -65.93 -45.88 80.25 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.464 0.65 . . . . 0.0 109.674 178.959 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -63.43 -34.53 77.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.261 -179.792 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . 0.696 HG23 ' O ' ' B' ' 245' ' ' ARG . 51.7 t . . . . . 0 C--N 1.327 -0.405 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.687 179.743 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 CA--C 1.529 0.17 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 . . . . . . . . . 0 0 . 1 . 044 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.53 HD11 ' HE ' ' A' ' 93' ' ' ARG . 73.3 mt -109.78 140.44 28.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.913 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 78.7 t -128.34 136.38 60.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.865 -178.904 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -97.93 121.01 39.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.362 0.601 . . . . 0.0 111.71 -179.027 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -66.26 -42.79 88.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.194 179.479 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . 0.594 ' NE2' ' OG ' ' A' ' 23' ' ' SER . 0.0 OUTLIER -99.44 161.64 23.9 Favored Pre-proline 0 N--CA 1.465 0.322 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.274 -178.73 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -60.95 149.69 87.56 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.531 2.154 . . . . 0.0 112.14 178.875 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 44.5 pt . . . . . 0 C--N 1.331 -0.201 0 CA-C-O 121.534 0.683 . . . . 0.0 112.295 -179.091 . . . . . . . . 0 0 . 1 . 045 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.1 p . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.746 0.308 . . . . 0.0 110.663 . . . . . . . . . 0 0 . 1 . 045 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.819 ' NE ' HD13 ' A' ' 53' ' ' ILE . 87.7 mtm-85 -98.06 121.6 40.18 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.595 -179.711 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.442 ' C ' HD22 ' A' ' 7' ' ' LEU . 99.7 mtt180 -129.98 137.9 50.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.072 179.839 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.455 ' CD2' ' N ' ' A' ' 7' ' ' LEU . 1.1 mm? -111.12 135.37 51.74 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.512 179.416 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.673 HG22 ' CD2' ' A' ' 19' ' ' HIS . 55.0 t -111.09 126.41 68.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.642 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 m -82.86 112.83 20.03 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.124 -178.337 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 98.1 mt -81.83 139.78 17.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.914 179.242 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -90.44 153.37 20.45 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.286 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.569 ' NH1' ' OD2' ' A' ' 92' ' ' ASP . 30.2 mtp85 -59.75 -26.46 65.69 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.709 179.82 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.3 p -72.53 -19.0 61.59 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.993 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.74 31.3 6.09 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 -179.646 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 51.9 t -121.06 132.37 70.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.928 0.394 . . . . 0.0 111.02 -179.814 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -76.85 139.87 40.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.062 179.262 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -130.9 -115.11 1.7 Allowed Glycine 0 CA--C 1.538 1.524 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.165 -179.378 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -70.21 144.89 52.95 Favored 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 122.2 1.933 . . . . 0.0 113.054 -178.538 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.673 ' CD2' HG22 ' A' ' 8' ' ' VAL . 59.0 m170 -109.14 135.15 50.74 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.586 -179.543 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.921 ' CD2' HD11 ' A' ' 37' ' ' ILE . 65.0 t80 -106.92 102.57 43.31 Favored Pre-proline 0 N--CA 1.467 0.385 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.043 -179.149 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.47 132.49 16.23 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 121.422 1.414 . . . . 0.0 111.971 -179.986 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 22' ' ' LEU . 73.3 mt -85.8 58.48 5.07 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -178.745 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 86.5 p -66.76 -17.31 64.8 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 178.842 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.511 HD11 ' HG2' ' B' ' 265' ' ' GLN . 62.1 mt -86.68 139.67 30.54 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.475 -179.76 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.4 t -63.6 -18.61 64.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.717 -179.905 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.15 140.93 36.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.626 -179.19 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.666 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -137.37 132.57 33.73 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.093 178.875 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.526 HD12 ' O ' ' A' ' 49' ' ' CYS . 56.3 tp -125.45 123.16 38.64 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.805 -179.067 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.666 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 46.5 m-85 -95.82 141.33 29.4 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.811 179.683 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 147.44 -176.8 26.11 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.066 178.685 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 31' ' ' ARG . 45.5 mtm180 -70.8 -33.11 70.38 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 179.285 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.577 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -42.62 140.31 2.24 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -179.35 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 33' ' ' ILE . 11.0 tp -67.0 -39.29 83.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.936 -179.694 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -58.81 -20.58 51.58 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.189 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.577 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 66.8 m -50.24 119.9 4.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.971 179.632 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -61.75 -31.77 71.98 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 179.736 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.921 HD11 ' CD2' ' A' ' 20' ' ' PHE . 27.1 mm -120.85 105.0 16.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 177.044 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.443 HH12 ' HG2' ' A' ' 40' ' ' GLN . 68.2 ttp85 -98.21 135.98 39.08 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.559 -178.457 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.712 HG23 ' NH1' ' A' ' 93' ' ' ARG . 94.5 mt -121.58 131.59 72.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.902 -179.683 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.443 ' HG2' HH12 ' A' ' 38' ' ' ARG . 74.5 mt-30 -78.26 31.78 0.18 Allowed 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -177.693 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.771 ' O ' HG12 ' A' ' 44' ' ' VAL . 87.1 mt -96.34 122.93 56.4 Favored Pre-proline 0 C--N 1.326 -0.454 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.727 179.586 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.08 -8.29 21.92 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 122.261 1.974 . . . . 0.0 112.601 -179.361 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.445 HG12 ' HG2' ' B' ' 235' ' ' PRO . 35.5 m -102.17 4.76 10.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.191 179.997 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.771 HG12 ' O ' ' A' ' 41' ' ' LEU . 6.0 p -97.32 150.3 4.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.348 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.2 163.43 27.85 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.805 0.812 . . . . 0.0 112.186 -178.869 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.9 mtmt -63.76 -38.1 89.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.131 -179.558 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.621 ' O ' ' N ' ' A' ' 49' ' ' CYS . 10.4 mm100 -110.58 -20.33 12.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.024 0.44 . . . . 0.0 109.967 179.897 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.534 ' NE2' HG23 ' A' ' 90' ' ' ILE . 22.8 t60 38.3 -77.32 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 179.021 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.763 ' SG ' HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -134.73 137.73 43.73 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.42 -0.512 . . . . 0.0 112.085 -178.038 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -123.65 131.57 53.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.886 179.225 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.439 HD11 HD12 ' A' ' 82' ' ' LEU . 16.2 tt -120.13 134.62 63.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.716 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -120.75 128.42 52.9 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.35 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.819 HD13 ' NE ' ' A' ' 5' ' ' ARG . 78.4 mt -106.43 122.37 60.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 119.774 -0.77 . . . . 0.0 112.262 -178.754 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.51 ' CD2' ' N ' ' A' ' 54' ' ' HIS . 2.4 m-70 -114.42 137.95 51.18 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.785 179.666 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.466 ' C ' ' O ' ' A' ' 54' ' ' HIS . 97.7 mt-10 -40.93 -29.77 0.11 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.75 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.452 ' N ' ' C ' ' A' ' 54' ' ' HIS . 59.4 tt0 -64.31 -68.21 0.37 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.798 178.294 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -156.82 -168.31 2.63 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.202 -179.853 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -105.52 133.23 50.61 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.532 -179.747 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 41.4 mm -118.86 125.55 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 120.511 -0.475 . . . . 0.0 111.502 -179.491 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.763 HD11 ' SG ' ' A' ' 49' ' ' CYS . 57.3 tp -104.65 130.48 52.66 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.836 -179.954 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.9 m-70 -121.55 140.41 52.26 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.741 179.923 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.729 ' ND2' ' H ' ' A' ' 69' ' ' THR . 25.2 t-20 -104.62 110.77 23.21 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.892 0.377 . . . . 0.0 111.957 179.743 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -96.66 -4.33 41.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.417 179.18 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.44 100.65 9.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.518 179.97 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 86.5 p -84.87 -29.11 25.53 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.285 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.42 ' O ' ' OD1' ' A' ' 67' ' ' ASN . 2.1 m -64.3 -49.27 72.43 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.078 179.388 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.625 ' OD1' HG23 ' B' ' 236' ' ' VAL . 2.7 m-20 -145.75 100.37 4.33 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.563 179.623 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.405 ' HA ' HD21 ' A' ' 62' ' ' ASN . 36.7 Cg_endo -64.79 153.23 78.88 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 121.308 1.338 . . . . 0.0 112.038 -178.933 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.729 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 28.3 m -75.14 150.41 38.76 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.642 -179.5 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -108.48 141.18 40.74 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.933 179.307 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.719 HG13 ' OD1' ' A' ' 86' ' ' ASP . 48.8 t -128.2 134.4 65.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.309 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 53.66 31.4 12.63 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -178.622 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.76 29.16 67.82 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.051 179.522 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 67.0 m -139.67 138.52 36.12 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 117.076 0.438 . . . . 0.0 111.213 -179.967 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.7 t -69.94 133.98 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.707 179.527 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.3 pt -101.38 94.14 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 CA-C-O 121.241 0.543 . . . . 0.0 110.506 179.338 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -63.95 -34.47 78.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.123 179.714 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -124.44 172.64 5.6 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.922 179.978 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.61 143.21 99.72 Favored 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 122.151 1.901 . . . . 0.0 112.549 -179.709 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 48.1 t -131.36 138.97 51.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.075 179.905 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 95.8 mtm-85 -76.38 128.82 35.59 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.777 179.174 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.609 HD11 ' HB2' ' A' ' 60' ' ' LEU . 93.7 mt -86.04 134.04 33.87 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.245 0.545 . . . . 0.0 111.277 -179.333 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -124.45 154.41 40.51 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.244 178.954 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.579 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 4.5 t60 -53.63 118.9 4.27 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.32 -179.504 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.44 -11.66 28.31 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.823 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.719 ' OD1' HG13 ' A' ' 71' ' ' VAL . 50.2 t0 -71.73 126.09 28.82 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.407 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 43.7 t -107.86 129.08 62.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.493 -179.203 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 94.3 mt -94.29 132.52 38.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.315 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.8 m -123.47 123.26 40.24 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.49 0.662 . . . . 0.0 112.572 -178.775 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.534 HG23 ' NE2' ' A' ' 48' ' ' HIS . 90.0 mt -109.51 123.82 65.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.197 177.845 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.487 ' C ' ' O ' ' A' ' 90' ' ' ILE . 86.8 mt 35.2 -96.82 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.509 -0.477 . . . . 0.0 110.613 179.746 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.569 ' OD2' ' NH1' ' A' ' 12' ' ' ARG . 20.8 p-10 -115.03 12.19 16.65 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.736 179.999 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.712 ' NH1' HG23 ' A' ' 39' ' ' ILE . 98.9 mtt180 -124.02 142.13 51.44 Favored 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.444 179.938 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 38.9 t -138.5 147.62 43.38 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.583 179.834 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.449 ' HE1' HD12 ' A' ' 90' ' ' ILE . 85.7 m-85 -121.78 120.64 35.21 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.095 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -79.7 131.79 36.04 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.343 -178.656 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -95.41 122.18 37.86 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.606 179.855 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -124.56 124.57 42.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.706 -179.708 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.579 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 59.0 t-20 . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.213 -179.929 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . 0.445 ' HG2' HG12 ' A' ' 43' ' ' VAL . 61.7 Cg_endo . . . . . 0 N--CA 1.486 1.051 0 CA-C-O 121.714 0.631 . . . . 0.0 112.799 . . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.625 HG23 ' OD1' ' A' ' 67' ' ' ASN . 1.0 OUTLIER -64.44 136.9 25.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.01 -179.473 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . 0.43 ' SG ' HG23 ' A' ' 91' ' ' ILE . 7.7 t . . . . . 0 C--N 1.332 -0.186 0 CA-C-O 120.843 0.354 . . . . 0.0 110.488 -179.079 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo . . . . . 0 N--CA 1.495 1.578 0 N-CA-C 112.866 0.295 . . . . 0.0 112.866 . . . . . . . . . 0 0 . 1 . 045 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 35.8 p -75.47 -40.69 57.07 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.316 -0.553 . . . . 0.0 109.704 178.603 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.466 ' HZ ' HD22 ' A' ' 41' ' ' LEU . 83.3 t80 -57.17 -47.36 81.42 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.677 -179.592 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.42 ' HA ' HD23 ' B' ' 242' ' ' LEU . 91.6 mt -62.65 -41.11 98.87 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.635 179.93 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -65.26 -41.49 94.2 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.76 -179.29 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 80.9 mtt85 -62.18 -43.04 99.72 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.093 179.495 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.708 ' NH2' HH21 ' A' ' 93' ' ' ARG . 24.1 mmm180 -61.19 -39.76 91.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.082 -178.622 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.43 -38.71 90.8 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 179.057 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 71.1 m -62.9 -43.66 98.19 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 177.413 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -59.15 -36.6 75.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.194 179.761 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . 0.428 HG23 HH21 ' A' ' 12' ' ' ARG . 63.3 t . . . . . 0 N--CA 1.453 -0.297 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.393 179.646 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.627 ' OE1' ' NH2' ' A' ' 93' ' ' ARG . 98.3 mt-10 . . . . . 0 CA--C 1.531 0.214 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 . . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 77.9 mt -118.31 133.84 63.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 177.225 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 68.3 t -126.24 133.04 69.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.381 -178.494 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . 0.558 ' CD2' HG21 ' B' ' 267' ' ' ILE . 62.1 m-85 -93.42 116.64 29.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.802 -179.307 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -64.49 -42.33 95.94 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.207 179.212 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . 0.511 ' HG2' HD11 ' A' ' 24' ' ' LEU . 1.1 mp0 -101.84 169.77 7.26 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.875 -179.398 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -62.29 149.68 89.81 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 121.752 1.635 . . . . 0.0 113.495 -179.281 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . 0.558 HG21 ' CD2' ' B' ' 263' ' ' PHE . 19.8 pt . . . . . 0 N--CA 1.462 0.151 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.912 -179.175 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.6 p . . . . . 0 CA--C 1.521 -0.137 0 CA-C-O 120.619 0.247 . . . . 0.0 111.311 . . . . . . . . . 0 0 . 1 . 046 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.89 ' NH1' HG23 ' A' ' 53' ' ' ILE . 99.6 mtt180 -96.52 122.08 39.04 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.094 -179.417 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -128.35 142.61 51.07 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.184 0.516 . . . . 0.0 111.339 -179.14 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.61 HD11 ' HB3' ' A' ' 95' ' ' PHE . 45.2 tp -113.38 133.09 55.34 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.304 -179.362 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.0 t -109.01 131.11 60.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.32 -179.617 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.469 HG23 ' CD1' ' B' ' 261' ' ' ILE . 1.5 m -92.3 115.55 28.18 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.514 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.414 HD12 ' HB3' ' A' ' 94' ' ' SER . 98.4 mt -83.13 145.43 8.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.242 179.014 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -91.44 162.08 14.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.163 0.506 . . . . 0.0 110.863 178.928 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.572 ' NH1' ' OE2' ' B' ' 260' ' ' GLU . 88.6 mtm180 -57.95 -30.07 65.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.792 -179.638 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.2 m -78.35 -8.61 58.63 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.813 0.339 . . . . 0.0 110.591 179.759 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.3 29.38 12.51 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -179.89 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.8 t -120.02 133.72 65.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.841 0.353 . . . . 0.0 110.075 179.95 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.488 ' O ' ' OD1' ' A' ' 16' ' ' ASP . 43.3 p30 -79.7 141.59 36.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.553 -179.978 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -128.42 -112.29 1.65 Allowed Glycine 0 CA--C 1.535 1.327 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 -179.923 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -75.02 150.05 37.51 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 122.627 2.218 . . . . 0.0 112.978 -179.329 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -111.24 148.97 31.69 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.415 179.694 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.471 ' CD2' HD11 ' A' ' 37' ' ' ILE . 34.7 t80 -117.44 104.58 49.67 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.66 -179.817 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.83 131.43 15.76 Favored 'Trans proline' 0 N--CA 1.489 1.229 0 C-N-CA 121.371 1.381 . . . . 0.0 111.942 -178.905 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 83.4 mt -88.97 46.03 1.35 Allowed 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.082 -178.67 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -55.99 -32.01 63.55 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.668 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.622 HD11 ' HG2' ' B' ' 265' ' ' GLN . 69.4 mt -69.75 142.78 53.2 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.654 179.436 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 97.8 p -63.5 -16.86 61.91 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.327 -178.917 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.5 m -145.15 145.42 31.36 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.694 -0.403 . . . . 0.0 110.845 179.61 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.677 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -136.54 127.82 28.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.662 179.327 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.519 HD13 ' HD3' ' A' ' 50' ' ' LYS . 40.0 tp -114.39 123.92 50.68 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -178.156 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.677 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 54.3 m-85 -97.39 133.59 41.78 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.987 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 177.09 -177.7 48.25 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 119.533 -1.318 . . . . 0.0 112.871 179.609 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 23.6 ttp85 -89.25 -23.79 22.25 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.946 -0.627 . . . . 0.0 110.994 179.944 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.71 152.16 45.59 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 -179.823 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.541 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.6 tp -64.12 -41.26 91.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.104 0.478 . . . . 0.0 110.195 179.45 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.541 ' N ' HG23 ' A' ' 33' ' ' ILE . 83.1 tt0 -51.37 -17.49 0.77 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.972 -179.764 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 24.0 m -75.08 139.08 42.55 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.493 179.986 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.502 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 57.1 m-20 -61.13 -32.81 72.5 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 -179.445 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.673 HD12 ' CE2' ' A' ' 29' ' ' PHE . 94.2 mt -123.03 116.98 50.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 177.44 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.1 ttp180 -103.95 131.95 50.68 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.397 -178.425 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.8 HD13 ' CZ ' ' A' ' 93' ' ' ARG . 80.0 mt -117.34 132.26 67.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.086 0.47 . . . . 0.0 110.012 -179.41 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -76.71 30.93 0.13 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.77 -177.857 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.677 HD22 HH22 ' B' ' 245' ' ' ARG . 33.3 mt -103.2 131.84 21.72 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.727 179.247 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.96 -10.01 24.22 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.531 2.154 . . . . 0.0 112.642 -179.519 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.434 HG21 ' CE2' ' B' ' 241' ' ' PHE . 22.1 m -97.62 7.22 8.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.872 -179.989 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.499 ' CG2' ' NH2' ' A' ' 93' ' ' ARG . 28.6 t -95.09 134.61 31.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.202 179.236 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.3 t -73.44 171.16 13.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.409 0.623 . . . . 0.0 111.54 -179.152 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -63.5 -42.88 98.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.8 -179.053 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.652 ' O ' ' N ' ' A' ' 49' ' ' CYS . 98.3 mt-30 -113.89 -21.19 10.76 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.384 -179.612 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.0 t60 41.04 -74.94 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.957 179.621 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.828 ' SG ' HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -140.29 141.75 35.75 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.537 -179.201 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.519 ' HD3' HD13 ' A' ' 28' ' ' LEU . 29.1 ttpt -128.02 133.03 49.08 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.639 178.795 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.411 HD11 HD12 ' A' ' 82' ' ' LEU . 18.5 tt -112.06 134.46 54.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -179.872 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -118.15 132.81 56.31 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 -179.875 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.89 HG23 ' NH1' ' A' ' 5' ' ' ARG . 98.3 mt -112.21 117.89 56.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.664 0.745 . . . . 0.0 112.613 -179.135 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.452 ' O ' ' N ' ' A' ' 56' ' ' GLN . 91.4 m-70 -116.65 139.63 50.31 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.211 178.808 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 54' ' ' HIS . 82.6 tt0 -40.13 -30.0 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.252 0.548 . . . . 0.0 109.634 -179.295 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.477 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 60.1 tt0 -65.34 -68.21 0.38 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.053 179.118 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.477 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 3.4 tp10 -154.15 -172.95 4.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.833 -178.976 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.554 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -107.24 130.02 54.8 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.827 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.6 mt -120.05 129.65 75.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.437 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.828 HD11 ' SG ' ' A' ' 49' ' ' CYS . 45.2 tp -100.17 127.88 46.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.209 179.532 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -114.97 137.79 51.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.502 -179.877 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.699 ' ND2' ' H ' ' A' ' 69' ' ' THR . 28.9 t-20 -100.27 108.24 20.26 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.755 0.312 . . . . 0.0 111.825 179.802 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -99.21 -7.39 26.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.995 179.454 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.36 102.22 13.81 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.733 0.301 . . . . 0.0 111.112 -179.742 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.1 m -83.99 -27.69 28.25 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.643 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.3 m -64.24 -48.66 74.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.604 179.769 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.499 ' OD1' HG22 ' B' ' 236' ' ' VAL . 56.8 m-80 -140.13 95.31 8.47 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.02 -179.899 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.498 ' HB2' HG13 ' A' ' 75' ' ' VAL . 46.4 Cg_exo -56.78 144.6 86.73 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.173 1.915 . . . . 0.0 112.534 -179.765 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.699 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 18.3 m -75.79 141.79 42.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.473 179.248 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -103.57 140.98 36.8 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.523 -179.73 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 55.7 t -129.57 132.44 66.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.966 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 51.38 31.72 7.58 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.184 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.9 28.13 63.29 Favored Glycine 0 CA--C 1.534 1.25 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.088 179.636 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 35.0 t -142.35 141.65 32.36 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 117.274 0.537 . . . . 0.0 111.451 179.945 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.498 HG13 ' HB2' ' A' ' 68' ' ' PRO . 54.1 t -69.79 141.5 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.109 179.946 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.48 HD13 HD23 ' A' ' 60' ' ' LEU . 5.1 pt -116.22 75.83 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.557 179.233 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -65.67 -26.22 67.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.84 0.352 . . . . 0.0 110.26 179.832 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -112.18 160.98 28.08 Favored Pre-proline 0 CA--C 1.532 0.26 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.376 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.8 140.24 94.24 Favored 'Trans proline' 0 N--CA 1.499 1.827 0 C-N-CA 121.46 1.44 . . . . 0.0 111.994 179.852 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.3 t -133.61 136.32 54.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.999 179.944 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -74.9 130.44 39.41 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 178.764 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.451 HD11 ' HB2' ' A' ' 60' ' ' LEU . 95.0 mt -84.1 140.64 31.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.161 0.505 . . . . 0.0 111.611 -179.607 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -129.33 151.24 50.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.371 179.69 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -54.69 119.0 4.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.704 -179.225 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.66 -13.33 35.47 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 179.873 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -68.85 134.22 49.36 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.337 -0.545 . . . . 0.0 109.762 179.631 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.449 HG22 ' HG2' ' A' ' 96' ' ' ARG . 54.3 t -109.38 132.23 58.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.139 -178.425 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 81.6 mt -103.82 131.06 53.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.844 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.5 m -118.72 125.73 50.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.468 0.651 . . . . 0.0 111.823 -179.607 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.522 ' O ' ' N ' ' A' ' 93' ' ' ARG . 89.3 mt -118.1 123.7 72.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.535 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.473 HG22 ' N ' ' A' ' 92' ' ' ASP . 46.7 mm 40.78 -108.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.205 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.473 ' N ' HG22 ' A' ' 91' ' ' ILE . 45.5 t0 -111.28 12.68 21.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.253 0.549 . . . . 0.0 110.132 178.829 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.8 ' CZ ' HD13 ' A' ' 39' ' ' ILE . 18.8 mtm105 -112.28 139.6 47.7 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.862 179.715 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.414 ' HB3' HD12 ' A' ' 10' ' ' ILE . 37.4 t -135.54 145.54 47.13 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.775 178.976 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.61 ' HB3' HD11 ' A' ' 7' ' ' LEU . 46.1 m-85 -124.15 122.6 38.26 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.87 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.476 ' O ' HD12 ' A' ' 7' ' ' LEU . 99.7 mtt180 -86.35 132.74 33.89 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.2 -0.6 . . . . 0.0 111.387 -179.324 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.516 ' CZ ' ' OD1' ' A' ' 99' ' ' ASN . 93.8 t80 -95.5 124.16 39.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.969 179.485 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -139.81 127.18 21.38 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.257 -0.577 . . . . 0.0 111.51 -179.161 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.516 ' OD1' ' CZ ' ' A' ' 97' ' ' TYR . 92.3 m-20 . . . . . 0 CA--C 1.529 0.144 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.977 -179.754 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo . . . . . 0 N--CA 1.494 1.528 0 N-CA-C 114.41 0.888 . . . . 0.0 114.41 . . . . . . . . . 0 0 . 1 . 046 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.499 HG22 ' OD1' ' A' ' 67' ' ' ASN . 0.5 OUTLIER -69.28 137.73 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 114.38 -1.282 . . . . 0.0 110.445 179.991 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 6.8 t . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.384 -179.687 . . . . . . . . 0 0 . 1 . 046 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo . . . . . 0 N--CA 1.503 2.043 0 N-CA-C 114.31 0.85 . . . . 0.0 114.31 . . . . . . . . . 0 0 . 1 . 046 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 7.7 p -74.76 -38.89 62.08 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.154 -0.619 . . . . 0.0 110.02 179.071 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.485 ' CZ ' ' NH2' ' B' ' 245' ' ' ARG . 66.6 t80 -58.71 -45.3 89.85 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.696 -179.294 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 95.6 mt -64.91 -40.66 95.42 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.838 0.351 . . . . 0.0 111.209 179.681 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -64.33 -44.06 92.71 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.088 -179.025 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 62.8 ttm-85 -60.49 -42.53 96.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.264 0.554 . . . . 0.0 109.886 179.556 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.677 HH22 HD22 ' A' ' 41' ' ' LEU . 48.5 ttm-85 -60.62 -43.18 97.78 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.127 -178.965 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.02 -38.64 89.44 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.35 -179.516 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 15.6 t -65.91 -42.99 89.46 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 177.536 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 69.2 tp60 -59.4 -38.02 79.5 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.61 179.845 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 43.3 t . . . . . 0 C--N 1.331 -0.213 0 C-N-CA 120.614 -0.435 . . . . 0.0 109.873 179.315 . . . . . . . . 0 0 . 1 . 046 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.672 ' O ' HG23 ' A' ' 39' ' ' ILE . 97.0 mt-10 . . . . . 0 CA--C 1.529 0.138 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 . . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.469 ' CD1' HG23 ' A' ' 9' ' ' THR . 64.5 mt -118.4 134.01 63.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.078 -179.743 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 40.7 t -128.24 134.85 64.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.996 -179.705 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -96.03 119.0 33.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.554 -178.904 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -65.22 -44.46 88.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.924 178.871 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . 0.622 ' HG2' HD11 ' A' ' 24' ' ' LEU . 4.4 mp0 -97.35 158.38 33.28 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.382 -179.728 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -69.53 145.74 59.42 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 123.022 2.481 . . . . 0.0 113.398 -179.264 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 48.6 pt . . . . . 0 C--N 1.332 -0.155 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.434 179.061 . . . . . . . . 0 0 . 1 . 047 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 77.0 p . . . . . 0 C--O 1.232 0.177 0 CA-C-O 121.032 0.444 . . . . 0.0 110.439 . . . . . . . . . 0 0 . 1 . 047 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.4 mtt85 -96.46 119.59 35.22 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.784 179.875 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.9 mtm180 -132.85 141.42 48.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.936 0.398 . . . . 0.0 111.323 -179.292 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.846 HD11 HD11 ' A' ' 22' ' ' LEU . 64.0 mt -114.35 142.37 46.41 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.669 -179.375 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 76.6 t -117.05 130.55 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.651 178.833 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.8 m -87.28 113.58 23.13 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -178.163 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.489 HD12 ' HB2' ' A' ' 94' ' ' SER . 95.1 mt -80.9 140.05 17.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.404 177.781 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -88.21 155.42 19.77 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 178.36 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.693 HH12 ' NH1' ' B' ' 245' ' ' ARG . 75.1 mtp85 -59.29 -26.5 65.01 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.235 -178.899 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.0 m -76.9 -18.75 58.1 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.034 0.445 . . . . 0.0 110.667 179.328 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.08 33.99 4.73 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.196 -1.161 . . . . 0.0 110.196 -179.718 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.2 t -124.13 129.91 73.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.478 0.18 . . . . 0.0 110.533 179.991 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -73.3 138.02 45.19 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.439 179.265 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -125.96 -117.03 2.13 Favored Glycine 0 CA--C 1.541 1.688 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.323 -179.298 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -75.95 147.67 30.77 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 122.765 2.31 . . . . 0.0 112.384 -178.505 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -108.36 148.66 29.78 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.414 179.913 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.487 ' CD2' HD11 ' A' ' 37' ' ' ILE . 31.7 t80 -118.69 101.28 50.72 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.284 -179.876 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.31 135.04 23.92 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.012 1.808 . . . . 0.0 111.629 -179.266 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.846 HD11 HD11 ' A' ' 7' ' ' LEU . 95.6 mt -91.03 49.49 1.65 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.069 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 34.4 t -61.71 -19.1 62.02 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.508 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.734 HD11 ' HG2' ' B' ' 265' ' ' GLN . 80.7 mt -80.14 138.0 36.83 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.057 -179.895 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.1 m -64.76 -19.79 66.0 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.994 -179.486 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.505 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 39.0 m -135.45 135.2 40.34 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.618 -179.405 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.683 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 5.4 t -130.38 120.75 24.76 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.163 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.513 HD21 ' OE1' ' A' ' 47' ' ' GLN . 62.8 tp -118.99 128.77 54.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.308 -178.723 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.743 ' CE2' HD12 ' A' ' 37' ' ' ILE . 3.9 m-85 -105.05 142.59 34.56 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -179.875 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 146.83 -174.36 26.69 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.887 178.587 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 31' ' ' ARG . 46.3 mtm180 -74.03 -33.03 63.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 179.42 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.504 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -41.85 144.81 0.8 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 -179.05 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.556 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.3 tp -67.42 -41.86 86.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 O-C-N 122.219 -0.577 . . . . 0.0 109.824 179.483 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.556 ' N ' HG23 ' A' ' 33' ' ' ILE . 76.4 mm-40 -58.15 -23.3 54.78 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.178 179.374 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.504 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 57.4 m -50.9 118.24 3.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.077 179.969 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.505 ' OD2' ' O ' ' A' ' 26' ' ' THR . 57.6 m-20 -57.52 -30.6 65.29 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.817 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.743 HD12 ' CE2' ' A' ' 29' ' ' PHE . 87.8 mt -125.15 118.86 54.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.239 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -104.74 134.74 47.39 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.913 -178.962 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 95.7 mt -114.57 127.23 72.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 121.2 0.524 . . . . 0.0 110.788 179.294 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -70.74 39.37 0.05 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.289 -0.869 . . . . 0.0 113.115 -178.322 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.808 HD11 ' NH2' ' A' ' 93' ' ' ARG . 79.3 mt -117.02 130.99 24.21 Favored Pre-proline 0 C--N 1.326 -0.449 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.369 179.738 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -72.7 -9.19 23.58 Favored 'Trans proline' 0 N--CA 1.489 1.235 0 C-N-CA 122.122 1.881 . . . . 0.0 112.162 179.522 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.458 HG21 ' CE2' ' B' ' 241' ' ' PHE . 28.0 m -99.11 1.98 10.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.894 179.808 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.3 t -86.92 134.93 26.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.268 0.556 . . . . 0.0 110.315 179.412 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.8 m -65.06 160.02 21.95 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.742 -178.987 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -63.72 -43.63 95.98 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.276 -179.085 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.636 ' O ' ' N ' ' A' ' 49' ' ' CYS . 12.1 mm100 -112.75 -23.43 10.17 Favored 'General case' 0 C--O 1.227 -0.123 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.424 179.929 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.3 t60 37.14 -76.75 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.078 -0.964 . . . . 0.0 112.932 179.855 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.636 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.0 136.1 47.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.337 0.589 . . . . 0.0 112.28 -178.539 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -125.39 129.09 49.2 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.781 179.683 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 93.8 mt -114.11 133.71 59.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.181 178.781 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -115.25 128.89 56.43 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.532 179.013 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 51.8 mm -99.0 118.66 45.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.989 -179.807 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.435 ' O ' ' C ' ' A' ' 55' ' ' GLU . 99.5 m-70 -120.31 135.09 55.13 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.33 179.646 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 54' ' ' HIS . 82.6 tt0 -40.46 -32.03 0.18 Allowed 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -179.675 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.434 ' N ' ' C ' ' A' ' 54' ' ' HIS . 88.7 mt-30 -67.53 -68.48 0.38 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.041 179.236 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.479 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 5.1 tp10 -153.84 -167.05 2.55 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.369 -179.067 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.479 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -119.44 130.4 55.25 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.435 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 99.5 mt -117.97 131.16 71.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.634 0.731 . . . . 0.0 111.981 -178.433 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.7 tp -99.78 127.53 45.93 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.213 179.624 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -110.16 133.64 53.01 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.208 -178.881 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 61.4 t-20 -93.25 104.57 16.74 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.948 179.889 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -100.93 -11.93 19.35 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 120.995 -0.282 . . . . 0.0 111.594 179.812 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 m -68.29 99.78 0.96 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.421 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 87.9 p -85.38 -10.11 56.7 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.525 -179.774 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.548 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -100.19 -43.12 6.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.117 179.88 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -133.84 95.61 17.17 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.991 -179.709 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.0 141.2 86.72 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.395 2.063 . . . . 0.0 112.882 -179.735 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.2 m -74.07 136.63 43.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.283 179.174 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -100.6 139.31 36.47 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.212 179.362 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.7 t -131.62 133.37 61.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 178.76 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 54.52 32.68 17.34 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -178.844 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.3 27.22 72.02 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.115 179.487 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 28.5 t -141.29 136.96 32.11 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 117.377 0.589 . . . . 0.0 111.501 -179.966 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -70.06 138.58 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.862 179.652 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.3 pt -114.08 91.57 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 121.208 0.528 . . . . 0.0 111.401 179.664 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -66.49 -26.86 67.38 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.823 178.494 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.495 ' N ' ' OE1' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -119.21 162.07 33.66 Favored Pre-proline 0 N--CA 1.465 0.295 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.81 179.71 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.29 151.09 86.84 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.694 2.263 . . . . 0.0 112.388 -179.388 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 36.0 m -142.05 148.69 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.107 0 CA-C-O 121.273 0.559 . . . . 0.0 112.107 -179.483 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -75.86 127.54 33.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.018 178.865 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 82' ' ' LEU . 92.9 mt -75.55 140.06 42.5 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.488 179.609 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -130.51 146.08 51.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.2 179.515 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.592 ' HD1' ' C ' ' A' ' 99' ' ' ASN . 7.2 t60 -51.4 119.62 4.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.133 -179.178 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.81 -12.19 49.8 Favored Glycine 0 CA--C 1.522 0.51 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.938 179.463 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -69.66 137.22 51.99 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.316 -0.553 . . . . 0.0 110.204 179.705 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.492 ' O ' HG13 ' A' ' 87' ' ' VAL . 8.7 p -106.89 134.86 47.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.876 -178.667 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 93.4 mt -103.27 129.48 55.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 177.696 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 47.5 m -123.98 124.81 43.4 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.577 0.704 . . . . 0.0 112.783 -178.171 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.425 ' O ' ' N ' ' A' ' 92' ' ' ASP . 94.0 mt -111.6 124.2 68.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.005 178.102 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.621 HG22 ' NH2' ' B' ' 245' ' ' ARG . 64.4 mt 39.36 -96.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.987 -179.201 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.49 ' CB ' ' NH2' ' B' ' 245' ' ' ARG . 52.8 t0 -120.51 18.15 12.08 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.792 0.33 . . . . 0.0 111.888 -178.791 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.832 HH22 ' NH1' ' B' ' 245' ' ' ARG . 1.1 ptp85 -131.25 144.29 51.19 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.067 178.679 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.489 ' HB2' HD12 ' A' ' 10' ' ' ILE . 38.1 m -136.14 152.83 51.23 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.298 0.571 . . . . 0.0 111.232 -179.913 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.419 ' HE1' HD12 ' A' ' 90' ' ' ILE . 65.1 m-85 -122.95 122.09 37.71 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.629 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 45.2 ttm180 -78.95 131.77 36.47 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.216 -178.726 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -95.93 119.62 34.75 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.76 179.924 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.41 ' HG3' ' CE1' ' A' ' 84' ' ' HIS . 79.7 tt0 -122.5 122.21 38.39 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.262 -179.969 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.592 ' C ' ' HD1' ' A' ' 84' ' ' HIS . 59.4 t-20 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.615 -179.651 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . 0.446 ' HG2' HG12 ' A' ' 43' ' ' VAL . 76.5 Cg_endo . . . . . 0 N--CA 1.489 1.21 0 CA-C-O 121.316 0.465 . . . . 0.0 113.156 . . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.548 ' CG2' HG22 ' A' ' 66' ' ' THR . 67.9 t -66.93 133.27 31.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.771 179.836 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.332 -0.188 0 CA-C-O 121.036 0.445 . . . . 0.0 110.555 -179.468 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo . . . . . 0 N--CA 1.491 1.35 0 CA-C-O 120.488 0.12 . . . . 0.0 112.018 . . . . . . . . . 0 0 . 1 . 047 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 2.8 m -75.96 -42.39 48.64 Favored 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.532 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.458 ' CE2' HG21 ' A' ' 43' ' ' VAL . 79.9 t80 -58.16 -46.11 86.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.143 -179.788 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.704 HD23 HH21 ' B' ' 245' ' ' ARG . 92.9 mt -63.82 -41.95 97.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.171 0.51 . . . . 0.0 110.851 179.874 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -63.04 -43.0 99.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.979 -179.092 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -61.51 -43.89 98.04 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.271 179.935 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.832 ' NH1' HH22 ' A' ' 93' ' ' ARG . 75.6 mtm180 -63.54 -40.04 95.99 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.881 -178.926 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -61.31 -39.01 88.91 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.263 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 13.5 t -65.91 -45.37 82.18 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.711 0.767 . . . . 0.0 109.496 178.051 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -62.17 -33.63 74.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.558 179.872 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . 0.512 HG23 ' O ' ' B' ' 245' ' ' ARG . 54.0 t . . . . . 0 N--CA 1.452 -0.338 0 C-N-CA 119.986 -0.686 . . . . 0.0 109.335 178.761 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 53.5 mp0 . . . . . 0 N--CA 1.463 0.188 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 . . . . . . . . . 0 0 . 1 . 047 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 56.6 mt -119.29 130.2 74.26 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 177.89 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 54.1 t -122.69 133.83 67.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.427 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -95.27 122.14 37.66 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.263 0.554 . . . . 0.0 110.685 -178.7 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -62.53 -46.06 90.11 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.564 -179.889 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . 0.734 ' HG2' HD11 ' A' ' 24' ' ' LEU . 3.2 mp0 -94.85 160.71 30.58 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.82 -179.403 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.41 147.49 58.83 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.478 2.119 . . . . 0.0 112.94 -179.695 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 47.9 pt . . . . . 0 N--CA 1.466 0.346 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.666 179.13 . . . . . . . . 0 0 . 1 . 048 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 121.008 0.433 . . . . 0.0 110.481 . . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.571 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 94.9 mtt-85 -98.6 122.09 41.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.128 -179.381 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.578 ' NH2' ' OE2' ' A' ' 98' ' ' GLU . 33.6 ptt-85 -146.01 158.38 43.87 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.103 -0.639 . . . . 0.0 112.009 179.937 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.3 mt -118.86 144.85 46.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.261 179.604 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.826 HG13 ' NE2' ' A' ' 19' ' ' HIS . 67.0 t -114.31 125.46 71.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.568 -0.453 . . . . 0.0 109.903 179.446 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.2 m -74.21 134.16 42.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.019 0.438 . . . . 0.0 111.313 -179.689 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.662 HD12 ' OG ' ' A' ' 94' ' ' SER . 97.0 mt -104.0 133.98 46.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.759 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -86.71 154.25 21.11 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.279 -0.568 . . . . 0.0 109.881 179.307 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 89.9 mtm180 -54.99 -27.74 46.44 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.581 -178.983 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.4 m -81.1 -5.67 57.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.759 0.314 . . . . 0.0 110.589 179.809 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.82 34.09 9.35 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 -179.959 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.8 t -121.08 135.59 60.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.86 0.362 . . . . 0.0 110.91 -179.852 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.463 ' O ' ' OD1' ' A' ' 16' ' ' ASP . 48.7 p-10 -75.97 133.36 40.47 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.459 179.727 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -121.39 -121.15 2.76 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.794 -179.327 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.48 147.24 40.78 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.131 1.888 . . . . 0.0 112.8 -178.871 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.826 ' NE2' HG13 ' A' ' 8' ' ' VAL . 62.0 m170 -109.76 143.37 39.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.635 -179.664 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.588 ' CE2' HD11 ' A' ' 37' ' ' ILE . 37.3 t80 -112.52 99.83 48.4 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.849 -179.717 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -70.6 131.51 20.18 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 C-N-CA 120.912 1.075 . . . . 0.0 110.787 -179.638 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 75.8 mt -85.39 77.36 9.95 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 120.261 -0.575 . . . . 0.0 110.784 -178.749 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 97.3 p -85.56 -10.61 55.68 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.077 178.744 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 52.2 mt -102.57 146.19 28.51 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.312 -179.047 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 94.9 p -65.91 -20.02 66.07 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -178.488 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 27.6 m -133.25 133.06 42.18 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.481 -0.487 . . . . 0.0 111.359 -179.777 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.0 t -122.71 116.84 24.44 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.589 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 56.8 tp -113.61 129.37 56.57 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -177.673 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.499 ' O ' ' O ' ' A' ' 47' ' ' GLN . 72.6 m-85 -109.77 131.51 55.0 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.449 179.804 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 160.46 -173.41 37.02 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.882 179.072 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.627 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 75.9 mtm-85 -80.89 -28.52 35.9 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.243 179.364 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.553 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -46.35 146.41 3.16 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -178.645 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.49 HG23 ' N ' ' A' ' 34' ' ' GLU . 9.9 tp -67.72 -41.91 85.78 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 CA-C-O 120.843 0.354 . . . . 0.0 110.285 179.823 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.49 ' N ' HG23 ' A' ' 33' ' ' ILE . 81.7 tt0 -59.03 -21.34 58.92 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.462 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.553 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 22.4 m -55.84 123.46 14.32 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.401 -179.96 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -62.08 -30.96 71.36 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.397 -179.71 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.588 HD11 ' CE2' ' A' ' 20' ' ' PHE . 47.1 mm -124.61 121.13 60.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.17 178.649 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.417 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 60.0 mtm180 -108.81 137.25 47.05 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 120.279 -0.569 . . . . 0.0 111.386 -179.977 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 89.6 mt -121.19 129.31 75.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.047 179.349 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -74.89 32.34 0.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -177.941 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.484 HD23 ' HA ' ' A' ' 41' ' ' LEU . 25.8 mt -98.27 129.07 31.47 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.317 179.272 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -73.14 -5.32 16.97 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 122.317 2.012 . . . . 0.0 112.368 -179.941 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.628 HG23 HD13 ' A' ' 91' ' ' ILE . 27.9 m -107.63 8.71 9.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.356 179.81 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.627 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 13.7 t -95.15 137.6 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.601 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.7 m -69.05 167.28 16.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.479 0.657 . . . . 0.0 112.381 -178.095 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.3 mttp -63.99 -41.65 97.45 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.033 -179.577 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.639 ' O ' ' N ' ' A' ' 49' ' ' CYS . 96.2 mt-30 -115.62 -25.24 7.93 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.098 0.475 . . . . 0.0 110.245 179.864 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.825 ' NE2' HG23 ' A' ' 90' ' ' ILE . 32.1 t60 38.39 -72.44 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 178.912 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.639 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -134.83 139.26 44.93 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -177.967 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.9 ttpp -132.95 133.95 43.88 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.539 178.827 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 92.3 mt -113.27 135.7 51.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.883 179.683 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.408 ' CD ' ' NE2' ' A' ' 54' ' ' HIS . 79.8 tt0 -117.32 132.12 56.67 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.255 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.1 mm -103.6 118.55 50.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.403 -0.519 . . . . 0.0 112.295 -177.924 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.434 ' O ' ' C ' ' A' ' 55' ' ' GLU . 97.9 m-70 -117.66 134.22 55.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.11 178.052 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 54' ' ' HIS . 84.6 tt0 -40.15 -35.47 0.4 Allowed 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.038 -179.085 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -64.27 -66.7 0.51 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.945 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -150.43 -167.96 2.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.286 -179.718 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -119.2 134.61 55.11 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.536 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 98.0 mt -120.2 130.77 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 121.385 0.612 . . . . 0.0 112.615 -178.729 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 21.7 tp -98.72 128.44 44.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.084 179.624 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -109.84 134.62 51.85 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.051 -179.346 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.527 HD21 ' CA ' ' A' ' 68' ' ' PRO . 62.7 t-20 -95.65 104.62 16.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.802 -178.848 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -97.19 -10.46 25.82 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.373 179.535 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 10.3 t -78.01 98.93 5.88 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.666 -179.477 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.2 m -76.09 -40.26 53.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.249 0.547 . . . . 0.0 110.055 178.509 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.37 -41.35 85.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.451 -179.671 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.628 ' OD1' HG23 ' B' ' 236' ' ' VAL . 59.8 m-20 -140.51 93.29 8.81 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.718 -179.895 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.551 ' HB2' HG13 ' A' ' 75' ' ' VAL . 40.6 Cg_exo -56.56 147.55 69.15 Favored 'Trans proline' 0 N--CA 1.498 1.784 0 C-N-CA 122.551 2.167 . . . . 0.0 113.029 -179.064 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.406 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 3.9 m -72.25 136.83 46.44 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.472 179.227 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -100.43 141.56 33.11 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.578 179.49 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.571 HG13 ' OD1' ' A' ' 86' ' ' ASP . 56.1 t -128.54 135.97 61.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.236 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 50.97 31.87 6.79 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.464 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.94 29.27 63.18 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.028 179.569 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 12.1 p -141.34 141.0 33.87 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 117.139 0.469 . . . . 0.0 111.412 179.878 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.551 HG13 ' HB2' ' A' ' 68' ' ' PRO . 53.5 t -74.76 136.5 25.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-O 121.115 0.483 . . . . 0.0 111.74 -179.854 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.958 HD13 ' O ' ' A' ' 76' ' ' ILE . 0.0 OUTLIER -137.15 119.45 19.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.824 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.401 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 38.3 p-10 -101.17 -0.42 36.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.922 -178.038 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.91 ' O ' HD11 ' A' ' 76' ' ' ILE . 5.2 pt-20 -119.93 165.09 18.87 Favored Pre-proline 0 C--N 1.331 -0.225 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.256 179.965 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.98 141.86 96.36 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 121.747 1.632 . . . . 0.0 111.866 179.772 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.7 p -140.21 140.31 35.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.725 -179.879 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -78.96 130.3 35.41 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.961 179.542 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 82' ' ' LEU . 96.8 mt -78.87 140.19 38.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.01 0.433 . . . . 0.0 110.728 179.96 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -129.7 149.38 51.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.329 179.978 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.441 ' C ' ' CD2' ' A' ' 84' ' ' HIS . 7.3 t60 -55.62 116.6 2.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.012 0.434 . . . . 0.0 110.885 -179.168 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.44 -16.41 37.88 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -179.751 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.571 ' OD1' HG13 ' A' ' 71' ' ' VAL . 53.7 t0 -67.68 131.07 44.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.717 0.294 . . . . 0.0 110.231 179.314 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.542 HG22 ' HG2' ' A' ' 96' ' ' ARG . 76.7 t -104.92 135.54 42.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.937 0.399 . . . . 0.0 111.298 -178.8 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 88.4 mt -104.13 130.28 55.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.443 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.8 m -122.53 123.58 41.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.828 0.823 . . . . 0.0 112.836 -178.884 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.825 HG23 ' NE2' ' A' ' 48' ' ' HIS . 86.9 mt -109.38 125.95 66.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 114.236 -1.347 . . . . 0.0 108.281 178.274 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.68 HG22 ' N ' ' A' ' 92' ' ' ASP . 97.8 mt 29.42 -101.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.932 0.396 . . . . 0.0 111.578 -179.165 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.68 ' N ' HG22 ' A' ' 91' ' ' ILE . 35.6 p-10 -105.54 11.42 32.45 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.137 -179.035 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.877 ' NE ' HD11 ' B' ' 261' ' ' ILE . 8.7 mtp85 -130.2 145.2 51.71 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.045 -179.55 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.662 ' OG ' HD12 ' A' ' 10' ' ' ILE . 21.1 p -140.64 153.24 45.95 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.178 0.513 . . . . 0.0 110.699 179.747 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -129.77 127.41 40.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.953 179.814 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.542 ' HG2' HG22 ' A' ' 87' ' ' VAL . 99.9 mtt180 -82.9 133.64 35.11 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.376 -0.529 . . . . 0.0 110.182 179.979 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.571 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 85.0 t80 -94.61 126.21 39.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.485 -179.24 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.578 ' OE2' ' NH2' ' A' ' 6' ' ' ARG . 82.5 tt0 -135.5 118.88 16.77 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.823 179.546 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.42 ' C ' ' OD1' ' A' ' 99' ' ' ASN . 55.5 p30 . . . . . 0 C--N 1.333 -0.136 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.67 -179.998 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo . . . . . 0 N--CA 1.486 1.047 0 CA-C-O 121.509 0.545 . . . . 0.0 111.971 . . . . . . . . . 0 0 . 1 . 048 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.628 HG23 ' OD1' ' A' ' 67' ' ' ASN . 4.8 p -64.73 141.51 18.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.548 -179.606 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . 0.465 ' SG ' ' CD2' ' B' ' 241' ' ' PHE . 2.8 t . . . . . 0 C--N 1.333 -0.113 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.217 -179.594 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo . . . . . 0 N--CA 1.495 1.607 0 CA-C-O 120.825 0.26 . . . . 0.0 112.062 . . . . . . . . . 0 0 . 1 . 048 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 87.8 m -64.34 -46.42 83.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.433 0.635 . . . . 0.0 109.317 178.771 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.474 ' HZ ' HD22 ' A' ' 41' ' ' LEU . 85.4 t80 -58.02 -47.5 82.87 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.546 -179.378 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.4 ' HA ' HD23 ' B' ' 242' ' ' LEU . 96.9 mt -62.8 -41.92 99.49 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.89 -178.584 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -65.09 -39.02 92.58 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.224 -179.271 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . 0.431 ' O ' ' OG ' ' B' ' 247' ' ' SER . 99.5 mtt180 -63.41 -40.24 96.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.085 0.469 . . . . 0.0 109.835 179.884 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . . . . . . . . . 71.2 ttp85 -61.21 -43.16 99.32 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.845 -179.505 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.37 -40.62 97.05 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.321 -179.652 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 79.4 p -64.51 -42.84 95.55 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.726 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -61.66 -39.12 90.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.193 -179.991 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 54.3 t . . . . . 0 N--CA 1.456 -0.157 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.303 179.059 . . . . . . . . 0 0 . 1 . 048 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.475 ' OE1' HD21 ' A' ' 41' ' ' LEU . 99.2 mt-10 . . . . . 0 CA--C 1.534 0.363 0 N-CA-C 115.316 1.598 . . . . 0.0 115.316 . . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.877 HD11 ' NE ' ' A' ' 93' ' ' ARG . 74.2 mt -118.21 132.89 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 119.434 1.016 . . . . 0.0 109.274 178.388 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 55.9 t -125.11 135.21 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-O 120.932 0.396 . . . . 0.0 111.191 -179.625 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -98.79 119.12 37.01 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.278 0.561 . . . . 0.0 110.581 -179.761 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -66.24 -43.89 85.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.045 179.934 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -103.13 157.98 32.68 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.355 -179.1 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -63.89 155.54 63.45 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 122.949 2.432 . . . . 0.0 112.703 -179.833 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.0 pt . . . . . 0 C--N 1.331 -0.217 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.117 -178.745 . . . . . . . . 0 0 . 1 . 049 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.1 p . . . . . 0 C--O 1.233 0.201 0 CA-C-O 120.591 0.234 . . . . 0.0 111.035 . . . . . . . . . 0 0 . 1 . 049 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.607 ' HG2' ' HH ' ' A' ' 97' ' ' TYR . 85.6 mtt85 -83.71 123.12 29.52 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.26 -179.865 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -127.45 136.52 51.92 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.23 -179.404 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.524 HD11 ' HB3' ' A' ' 95' ' ' PHE . 25.3 tp -112.67 130.6 55.99 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.836 -179.755 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.561 HG22 ' CE1' ' A' ' 19' ' ' HIS . 47.0 t -108.07 129.15 62.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.914 -179.479 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.0 m -81.05 143.83 32.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.471 0.653 . . . . 0.0 111.921 -179.606 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.8 mm -111.81 135.15 51.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.613 178.729 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -89.9 157.27 17.95 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.01 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.49 HH11 ' CD ' ' B' ' 245' ' ' ARG . 84.5 mtm180 -58.6 -22.57 56.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.059 -179.466 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.615 ' OG ' HG13 ' B' ' 249' ' ' VAL . 5.2 m -85.08 -9.45 57.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.991 -179.63 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.49 40.24 6.47 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.189 -0.765 . . . . 0.0 111.189 179.716 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 54.6 t -125.89 135.36 64.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.726 0.298 . . . . 0.0 111.627 -179.265 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.441 ' CG ' ' HE2' ' A' ' 19' ' ' HIS . 62.8 t0 -67.68 124.55 23.59 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.163 179.115 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -115.62 -124.8 3.81 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 120.959 -0.639 . . . . 0.0 111.863 -179.18 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -75.82 146.61 30.0 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.31 2.006 . . . . 0.0 113.334 -178.688 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.561 ' CE1' HG22 ' A' ' 8' ' ' VAL . 59.4 m170 -106.1 142.17 36.23 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.563 -179.935 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.414 ' CD2' HD11 ' A' ' 37' ' ' ILE . 44.0 t80 -117.74 106.85 45.35 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.096 179.977 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.29 127.49 12.71 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 121.541 1.494 . . . . 0.0 112.03 -178.382 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 56.3 mt -89.01 43.92 1.18 Allowed 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.35 -178.361 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 65.3 p -67.54 -19.85 65.34 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.554 -0.458 . . . . 0.0 109.849 179.381 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.9 mt -74.39 144.06 44.54 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.61 179.954 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 92.8 p -58.07 -26.08 62.08 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.035 -178.39 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 97.8 m -141.22 138.63 33.44 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.206 -0.598 . . . . 0.0 111.839 -179.113 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.655 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 2.5 t -128.77 121.7 28.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.053 178.393 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.555 HD12 ' O ' ' A' ' 49' ' ' CYS . 52.1 tp -119.74 129.33 54.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.377 -178.167 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.731 ' CE2' HD12 ' A' ' 37' ' ' ILE . 3.0 m-85 -104.68 137.17 42.9 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.473 179.495 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 163.55 -167.46 37.74 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.419 178.883 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.636 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 86.3 mtm-85 -88.05 -27.99 21.64 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.767 0.318 . . . . 0.0 110.263 179.97 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.408 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -55.64 149.87 23.36 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 121.133 -0.556 . . . . 0.0 111.837 -178.168 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.543 ' CD1' ' NH1' ' A' ' 38' ' ' ARG . 10.5 tp -68.09 -41.6 84.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 CA-C-O 120.864 0.364 . . . . 0.0 110.518 179.92 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.467 ' N ' HG23 ' A' ' 33' ' ' ILE . 83.0 tt0 -57.4 -23.34 48.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.226 0.536 . . . . 0.0 110.099 179.77 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.408 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 33.3 m -56.0 126.12 24.47 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.185 179.683 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.436 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 55.0 m-20 -61.04 -33.14 72.82 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.602 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.731 HD12 ' CE2' ' A' ' 29' ' ' PHE . 94.8 mt -123.98 121.9 63.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 177.314 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.543 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 83.1 mtp180 -109.84 139.1 45.29 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.405 -178.544 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 97.4 mt -120.36 130.58 74.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.987 179.004 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.419 ' NE2' ' HA ' ' B' ' 260' ' ' GLU . 19.9 pt20 -79.75 35.67 0.31 Allowed 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -177.768 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.781 HD12 ' CZ ' ' A' ' 93' ' ' ARG . 60.5 mt -112.95 135.17 21.67 Favored Pre-proline 0 C--N 1.328 -0.328 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.112 178.191 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.67 -9.78 26.49 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.629 2.22 . . . . 0.0 113.22 -178.717 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.694 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 1.8 m -96.52 2.0 10.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.444 -179.828 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.636 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 53.2 t -88.3 131.96 34.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.614 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.403 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 1.6 m -63.99 158.39 22.57 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.159 0.504 . . . . 0.0 111.328 -179.106 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -61.42 -42.08 98.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.663 -179.086 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.612 ' O ' ' N ' ' A' ' 49' ' ' CYS . 10.8 mm100 -115.43 -20.23 10.35 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.919 179.677 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.403 ' H ' ' HB3' ' A' ' 45' ' ' SER . 20.5 t60 33.21 -74.54 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 179.082 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.612 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -129.54 133.94 47.49 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -177.608 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -123.93 133.07 53.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.663 179.284 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 98.1 mt -119.49 134.38 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.679 -179.218 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -115.92 127.99 55.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.402 179.154 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.3 mm -100.49 109.86 26.15 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 CA-C-O 121.251 0.548 . . . . 0.0 110.861 -179.481 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.445 ' O ' ' C ' ' A' ' 55' ' ' GLU . 97.8 m-70 -111.36 135.22 52.22 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.512 179.247 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 54' ' ' HIS . 93.1 mt-10 -41.8 -34.32 0.63 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -179.396 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 73.5 tp60 -63.72 -67.2 0.45 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.373 178.572 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -155.68 -169.52 3.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.691 -179.829 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -117.47 129.94 56.14 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.592 -179.729 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 87.9 mt -117.51 130.51 72.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 121.324 0.583 . . . . 0.0 112.416 -178.902 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.5 ' HB2' HD21 ' A' ' 82' ' ' LEU . 50.5 tp -95.27 129.19 42.49 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.931 179.81 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -115.19 133.44 56.03 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.799 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.722 ' ND2' ' H ' ' A' ' 69' ' ' THR . 11.3 t-20 -96.57 108.3 20.87 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.266 -179.684 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -97.51 -7.02 32.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.256 179.532 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.585 ' OG ' ' ND2' ' A' ' 62' ' ' ASN . 78.7 p -76.25 97.93 4.31 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.306 179.579 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.3 m -80.39 -32.95 37.49 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.2 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.1 m -65.55 -48.07 73.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.293 179.597 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.583 ' OD1' HG23 ' B' ' 236' ' ' VAL . 1.5 m-20 -137.72 102.02 8.68 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.032 -179.663 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.451 ' HA ' HD21 ' A' ' 62' ' ' ASN . 32.4 Cg_exo -55.14 146.05 61.62 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 121.752 1.635 . . . . 0.0 112.326 -179.85 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.722 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 10.2 m -74.68 140.64 44.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.595 179.075 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -104.61 139.02 40.07 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.14 179.673 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 56.4 t -132.02 132.96 61.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.879 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 54.38 33.48 18.66 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.025 -0.67 . . . . 0.0 109.622 -179.391 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.7 29.29 65.7 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.77 178.921 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.1 t -148.08 140.39 24.3 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 117.492 0.646 . . . . 0.0 111.342 179.342 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.428 ' H ' HG12 ' A' ' 75' ' ' VAL . 0.2 OUTLIER -68.65 144.0 14.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.379 -179.485 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.1 pt -118.19 94.35 3.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 121.034 0.445 . . . . 0.0 110.585 179.068 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.58 ' OD1' ' N ' ' A' ' 78' ' ' GLU . 37.0 p-10 -69.4 -23.96 63.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.281 179.727 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.58 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 2.6 mt-10 -124.28 170.04 9.53 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.459 179.656 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -60.73 147.27 95.51 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 122.485 2.123 . . . . 0.0 112.601 179.283 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 29.3 m -138.32 138.71 42.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.473 179.626 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.575 HH21 ' CE ' ' A' ' 83' ' ' LYS . 61.7 ttp180 -72.8 130.44 40.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.632 179.281 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.5 HD21 ' HB2' ' A' ' 60' ' ' LEU . 97.0 mt -81.58 136.02 35.57 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.015 0.436 . . . . 0.0 111.7 -179.386 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.575 ' CE ' HH21 ' A' ' 81' ' ' ARG . 99.1 mttt -129.05 149.0 51.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.409 179.426 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.444 ' CD2' ' C ' ' A' ' 84' ' ' HIS . 7.2 t60 -54.58 116.81 2.88 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.162 179.897 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 113.09 -15.35 23.28 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.572 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -67.96 135.67 52.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.29 0.567 . . . . 0.0 110.672 -179.569 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.513 HG22 ' HG2' ' A' ' 96' ' ' ARG . 77.0 t -112.48 131.57 63.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.752 -178.652 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 81.0 mt -104.29 131.14 53.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.081 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 38.8 m -123.26 128.24 49.7 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -177.807 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.427 ' O ' ' C ' ' A' ' 91' ' ' ILE . 91.4 mt -115.76 124.17 71.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.051 178.679 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.624 HG23 ' SG ' ' B' ' 237' ' ' CYS . 76.6 mt 39.72 -100.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.445 179.989 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.601 ' OD1' ' NH1' ' A' ' 93' ' ' ARG . 24.2 p-10 -116.21 13.4 15.68 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.779 0.323 . . . . 0.0 111.482 -179.919 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.781 ' CZ ' HD12 ' A' ' 41' ' ' LEU . 57.0 mtm-85 -125.07 143.45 50.91 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.878 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.2 t -138.75 156.18 47.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.628 0.728 . . . . 0.0 111.887 -179.413 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.524 ' HB3' HD11 ' A' ' 7' ' ' LEU . 86.5 m-85 -128.32 124.62 36.93 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.454 179.294 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.513 ' HG2' HG22 ' A' ' 87' ' ' VAL . 99.6 mtt180 -89.6 134.54 34.08 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.951 -0.7 . . . . 0.0 110.959 -179.316 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.607 ' HH ' ' HG2' ' A' ' 5' ' ' ARG . 85.7 t80 -98.0 123.27 41.93 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.046 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -141.11 126.91 19.14 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.093 -179.617 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.471 ' OD1' ' CZ ' ' A' ' 97' ' ' TYR . 95.0 m-20 . . . . . 0 N--CA 1.462 0.153 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.434 179.214 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo . . . . . 0 N--CA 1.49 1.276 0 CA-C-O 121.506 0.544 . . . . 0.0 112.015 . . . . . . . . . 0 0 . 1 . 049 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.583 HG23 ' OD1' ' A' ' 67' ' ' ASN . 8.2 p -109.9 135.07 50.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.248 -179.767 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . 0.624 ' SG ' HG23 ' A' ' 91' ' ' ILE . 19.9 t . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.289 -179.426 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo . . . . . 0 N--CA 1.494 1.543 0 CA-C-O 120.854 0.272 . . . . 0.0 111.884 . . . . . . . . . 0 0 . 1 . 049 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 77.6 m -73.3 -46.69 48.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.566 178.834 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.694 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 57.5 t80 -58.19 -45.84 86.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.693 -178.999 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.446 ' HA ' HD23 ' B' ' 242' ' ' LEU . 78.4 mt -64.27 -40.46 96.02 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.478 179.85 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -61.67 -40.63 95.63 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.951 0.405 . . . . 0.0 110.206 179.922 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -61.8 -43.1 99.52 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.628 179.601 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.605 ' NH2' HD22 ' A' ' 41' ' ' LEU . 40.0 mmt-85 -62.19 -39.79 93.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.605 -179.514 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.08 -40.2 96.96 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.238 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 11.2 t -62.84 -44.06 97.15 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 177.693 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -60.0 -38.11 81.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.785 -179.917 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . 0.615 HG13 ' OG ' ' A' ' 13' ' ' SER . 25.0 t . . . . . 0 C--N 1.327 -0.374 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.797 179.724 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.569 ' OE1' HD11 ' A' ' 41' ' ' LEU . 98.5 mt-10 . . . . . 0 CA--C 1.52 -0.174 0 CA-C-O 121.029 0.443 . . . . 0.0 110.037 . . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 66.7 mt -113.3 141.12 30.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.303 -178.799 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 56.0 t -127.63 134.04 66.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.329 -179.812 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -99.43 122.92 43.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.441 0.639 . . . . 0.0 111.238 -179.208 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . 0.408 ' NZ ' ' HA ' ' A' ' 34' ' ' GLU . 88.2 tttt -64.78 -44.88 88.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.42 179.772 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -98.5 155.29 36.98 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.796 -178.901 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.74 149.71 83.6 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.776 2.318 . . . . 0.0 111.791 179.202 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 25.1 pt . . . . . 0 C--N 1.325 -0.481 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.271 -179.425 . . . . . . . . 0 0 . 1 . 050 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 74.8 p . . . . . 0 N--CA 1.461 0.098 0 CA-C-O 120.929 0.395 . . . . 0.0 111.218 . . . . . . . . . 0 0 . 1 . 050 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.664 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 93.7 mtt-85 -92.72 126.22 37.7 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.305 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 89.6 mtm-85 -134.5 151.45 51.14 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.247 0.546 . . . . 0.0 112.255 -179.075 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.42 ' CD1' HD21 ' A' ' 22' ' ' LEU . 85.5 mt -119.16 146.97 44.71 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.875 -179.55 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.0 t -118.55 129.79 74.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.816 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.535 HG22 HH21 ' A' ' 93' ' ' ARG . 53.5 m -89.07 112.74 23.76 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -178.126 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.49 HD12 ' OG ' ' A' ' 94' ' ' SER . 95.8 mt -83.64 143.13 12.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 177.748 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.1 tttm -92.33 167.64 11.86 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.108 -0.637 . . . . 0.0 111.063 -179.735 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.601 ' NH1' ' OE2' ' B' ' 260' ' ' GLU . 90.5 mtm180 -58.25 -31.54 67.52 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.517 -179.165 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 90.5 p -83.35 -6.13 59.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.962 0.41 . . . . 0.0 110.024 179.136 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.2 39.78 7.23 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.89 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.1 t -117.26 134.19 61.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.029 0.442 . . . . 0.0 111.617 -179.198 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -73.09 116.68 13.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.702 -179.839 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -110.95 -124.24 4.57 Favored Glycine 0 CA--C 1.54 1.596 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 179.416 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.93 147.58 39.19 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 122.41 2.073 . . . . 0.0 113.518 -179.219 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.551 ' O ' ' CD1' ' B' ' 267' ' ' ILE . 0.4 OUTLIER -110.59 131.01 55.42 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.234 179.333 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.584 ' CD2' HD11 ' A' ' 37' ' ' ILE . 24.7 t80 -99.58 101.01 12.04 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.533 -179.098 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.97 135.63 23.55 Favored 'Trans proline' 0 C--N 1.315 -1.204 0 C-N-CA 121.332 1.355 . . . . 0.0 111.36 -179.69 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.575 HD13 HD11 ' A' ' 53' ' ' ILE . 79.8 mt -85.95 76.58 9.82 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.965 -178.542 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 95.5 p -82.67 -10.34 58.97 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.757 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.701 HD11 ' HG2' ' B' ' 265' ' ' GLN . 59.2 mt -102.16 146.02 28.55 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.611 -179.682 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.8 m -66.19 -14.8 62.46 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.929 -0.308 . . . . 0.0 111.514 -179.255 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.426 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 75.0 m -135.49 136.48 41.29 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.912 0.387 . . . . 0.0 111.875 -179.539 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.411 ' HB2' HD22 ' A' ' 22' ' ' LEU . 12.2 t -126.2 117.18 22.57 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.911 178.626 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.563 HD21 ' OE1' ' A' ' 47' ' ' GLN . 58.4 tp -113.57 127.88 56.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.602 0.239 . . . . 0.0 110.861 -179.171 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.823 ' CE2' HD12 ' A' ' 37' ' ' ILE . 6.0 m-85 -107.4 141.81 38.21 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.741 179.473 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 149.64 -178.5 27.1 Favored Glycine 0 N--CA 1.467 0.751 0 C-N-CA 120.175 -1.012 . . . . 0.0 112.418 178.676 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.479 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 45.8 mtm180 -73.56 -32.92 64.43 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 179.787 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.535 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -50.13 141.68 15.36 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 120.474 -0.87 . . . . 0.0 111.317 -178.579 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.571 ' CD1' ' CZ ' ' A' ' 38' ' ' ARG . 34.4 mm -63.17 -43.62 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-O 120.874 0.369 . . . . 0.0 110.029 179.529 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -53.81 -19.25 4.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.962 179.806 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.535 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 39.6 m -61.6 129.27 40.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.396 -179.923 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.426 ' OD2' ' O ' ' A' ' 26' ' ' THR . 91.4 m-20 -60.73 -30.38 69.94 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.645 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.823 HD12 ' CE2' ' A' ' 29' ' ' PHE . 82.7 mt -126.93 119.96 54.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.482 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.571 ' CZ ' ' CD1' ' A' ' 33' ' ' ILE . 82.0 mtp180 -99.95 133.75 43.87 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.029 -178.822 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.744 HG21 HD12 ' A' ' 41' ' ' LEU . 96.8 mt -118.44 128.81 75.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-O 121.131 0.491 . . . . 0.0 110.339 179.991 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -76.67 26.87 0.13 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.253 -178.683 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.744 HD12 HG21 ' A' ' 39' ' ' ILE . 26.3 mt -94.84 124.76 53.56 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.554 179.731 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.88 -10.84 26.88 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 122.371 2.047 . . . . 0.0 112.542 -179.443 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.54 HG21 ' CE2' ' B' ' 241' ' ' PHE . 4.1 m -100.86 8.88 8.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.941 0.4 . . . . 0.0 111.27 179.996 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.479 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 21.9 t -97.44 136.31 28.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.329 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.3 m -70.45 170.45 11.97 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.635 0.731 . . . . 0.0 111.921 -178.467 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -62.28 -41.41 98.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.039 -179.144 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.607 ' O ' ' N ' ' A' ' 49' ' ' CYS . 13.9 mm100 -110.91 -20.95 12.26 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.265 0.555 . . . . 0.0 110.403 -179.849 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.408 ' NE2' HG23 ' A' ' 90' ' ' ILE . 11.0 t60 39.74 -78.34 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.006 -0.997 . . . . 0.0 113.209 179.087 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.607 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.16 137.69 46.32 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.216 0.531 . . . . 0.0 111.791 -178.886 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -129.15 135.36 48.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.217 179.661 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.6 mt -121.27 136.95 56.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.142 -179.11 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -117.01 123.89 47.99 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.755 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.575 HD11 HD13 ' A' ' 22' ' ' LEU . 96.4 mt -102.37 116.05 45.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.528 0.68 . . . . 0.0 111.521 -178.714 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.492 ' O ' ' N ' ' A' ' 56' ' ' GLN . 90.8 m-70 -117.67 144.57 45.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.143 179.932 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 54' ' ' HIS . 80.7 tt0 -39.2 -29.16 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -179.626 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.492 ' N ' ' O ' ' A' ' 54' ' ' HIS . 86.5 mt-30 -66.59 -68.59 0.36 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.733 178.944 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.44 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 6.1 tp10 -157.65 -158.99 0.79 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.562 -179.67 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.44 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -118.42 128.77 54.94 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.064 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.9 mt -118.38 129.3 74.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.304 0.573 . . . . 0.0 112.248 -178.477 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 49.2 tp -95.31 129.19 42.53 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.584 -179.954 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -114.23 134.71 54.73 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.154 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.681 HD21 ' CB ' ' A' ' 68' ' ' PRO . 63.7 t-20 -97.84 105.8 18.0 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -178.078 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -98.24 -8.55 27.12 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.911 179.568 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.3 t -81.06 99.23 8.37 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.694 0.283 . . . . 0.0 110.983 179.684 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.4 t -83.99 -32.74 24.81 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.804 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.6 m -61.29 -47.46 85.85 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.918 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -144.17 108.62 4.96 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.714 178.587 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.681 ' CB ' HD21 ' A' ' 62' ' ' ASN . 40.1 Cg_endo -68.6 152.64 74.56 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 121.535 1.49 . . . . 0.0 113.019 -178.473 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.9 m -70.66 138.97 51.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.22 -179.636 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -101.76 140.28 36.26 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.833 -179.682 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.567 ' CG2' HD11 ' A' ' 76' ' ' ILE . 12.9 t -134.89 136.29 52.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 178.13 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 56.91 33.51 23.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.993 0.425 . . . . 0.0 110.064 -179.581 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.97 30.64 67.66 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.173 179.219 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 36.0 m -148.18 146.39 28.7 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 117.359 0.58 . . . . 0.0 111.348 -179.661 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.4 m -72.78 147.36 10.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-O 121.015 0.436 . . . . 0.0 111.002 -179.703 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.567 HD11 ' CG2' ' A' ' 71' ' ' VAL . 98.3 mt -107.2 107.21 22.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.406 -179.474 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -66.09 -42.25 89.58 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.64 179.233 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.545 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.4 OUTLIER -136.71 -177.55 0.72 Allowed Pre-proline 0 N--CA 1.466 0.346 0 CA-C-O 120.666 0.269 . . . . 0.0 111.298 -178.737 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.509 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 45.2 Cg_exo -58.69 145.22 96.57 Favored 'Trans proline' 0 N--CA 1.5 1.895 0 C-N-CA 122.842 2.361 . . . . 0.0 113.199 -179.753 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.8 m -143.76 143.07 24.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.985 179.634 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.46 ' HE ' ' HE2' ' A' ' 83' ' ' LYS . 59.6 ttp180 -76.25 133.59 40.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.107 179.449 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 82' ' ' LEU . 98.4 mt -82.35 143.87 30.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.151 0.501 . . . . 0.0 111.675 -179.153 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.46 ' HE2' ' HE ' ' A' ' 81' ' ' ARG . 73.3 mmtt -132.72 151.68 51.92 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.489 179.556 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.418 ' CE1' ' H ' ' A' ' 99' ' ' ASN . 5.4 t60 -56.26 117.8 4.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.421 -178.847 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.67 -18.58 24.58 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 111.189 -0.765 . . . . 0.0 111.189 179.527 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -69.61 135.08 49.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.163 0.506 . . . . 0.0 110.554 -179.899 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 49.7 t -110.16 132.78 57.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.91 -179.178 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.439 ' HA ' HG22 ' A' ' 71' ' ' VAL . 97.1 mt -101.12 130.22 50.89 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 177.676 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 49.6 m -120.1 126.42 50.71 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 119.876 -0.73 . . . . 0.0 112.209 -178.663 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.591 ' O ' ' N ' ' A' ' 93' ' ' ARG . 99.1 mt -114.78 129.91 70.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 114.798 -1.092 . . . . 0.0 108.25 177.993 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.504 HG23 HD21 ' B' ' 242' ' ' LEU . 75.6 mt -23.04 95.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -178.612 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.501 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 3.8 m-20 92.88 -27.19 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 178.551 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.666 ' NE ' HD11 ' B' ' 261' ' ' ILE . 7.9 mmm180 -125.93 143.21 51.18 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.418 -179.3 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.49 ' OG ' HD12 ' A' ' 10' ' ' ILE . 87.0 p -138.81 154.36 48.46 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.6 -0.44 . . . . 0.0 109.995 179.345 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -129.12 126.79 40.1 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.32 -179.539 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 96' ' ' ARG . 41.7 ttp-105 -90.91 135.69 33.57 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.661 -0.415 . . . . 0.0 110.429 -179.605 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.664 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 89.1 t80 -92.39 121.34 33.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.905 -179.759 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -121.63 123.43 41.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.831 -179.568 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.418 ' H ' ' CE1' ' A' ' 84' ' ' HIS . 60.3 t-20 . . . . . 0 C--N 1.333 -0.118 0 CA-C-O 120.921 0.391 . . . . 0.0 110.285 179.923 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo . . . . . 0 N--CA 1.485 1.023 0 CA-C-O 121.413 0.506 . . . . 0.0 112.708 . . . . . . . . . 0 0 . 1 . 050 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 2.1 p -107.72 132.4 55.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.058 179.071 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 3.2 t . . . . . 0 C--N 1.329 -0.305 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.03 -179.282 . . . . . . . . 0 0 . 1 . 050 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo . . . . . 0 N--CA 1.502 2.003 0 N-CA-C 113.078 0.376 . . . . 0.0 113.078 . . . . . . . . . 0 0 . 1 . 050 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 98.9 m -74.47 -46.39 39.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.064 0.459 . . . . 0.0 110.357 178.894 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.54 ' CE2' HG21 ' A' ' 43' ' ' VAL . 88.1 t80 -59.63 -45.34 92.26 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.82 -178.8 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.504 HD21 HG23 ' A' ' 91' ' ' ILE . 89.9 mt -65.79 -39.96 91.47 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 119.86 -0.736 . . . . 0.0 110.563 179.398 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -60.67 -41.84 95.86 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.854 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -65.81 -37.58 86.64 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.314 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.475 HH11 ' NH1' ' A' ' 12' ' ' ARG . 10.7 tpp180 -62.62 -44.52 96.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.334 -179.68 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -63.08 -36.62 84.19 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.978 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 10.2 t -63.53 -44.65 93.6 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.629 177.974 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 66.6 mm-40 -57.83 -37.63 74.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.919 -179.952 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 C--N 1.326 -0.426 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.576 178.934 . . . . . . . . 0 0 . 1 . 050 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.601 ' OE2' ' NH1' ' A' ' 12' ' ' ARG . 92.4 mt-10 . . . . . 0 N--CA 1.448 -0.528 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 . . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.666 HD11 ' NE ' ' A' ' 93' ' ' ARG . 3.0 mm -112.72 131.36 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 114.31 -1.314 . . . . 0.0 109.407 -179.109 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 39.2 t -124.95 132.31 71.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.629 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -98.56 122.05 41.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.2 0.524 . . . . 0.0 111.889 -178.302 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -65.06 -45.9 83.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.694 179.326 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . 0.701 ' HG2' HD11 ' A' ' 24' ' ' LEU . 2.9 mp0 -92.47 163.9 24.75 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.436 -179.882 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.86 146.92 92.23 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.21 1.94 . . . . 0.0 112.56 -179.89 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . 0.551 ' CD1' ' O ' ' A' ' 19' ' ' HIS . 4.9 tt . . . . . 0 C--N 1.323 -0.582 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.246 -179.607 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.1 m . . . . . 0 C--O 1.237 0.411 0 CA-C-O 120.813 0.34 . . . . 0.0 111.745 . . . . . . . . . 0 0 . 1 . 051 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.658 ' NH1' HG23 ' A' ' 53' ' ' ILE . 90.0 mtt180 -91.4 138.66 31.4 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.949 -178.011 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -139.0 147.23 41.87 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 179.761 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.551 HD12 ' O ' ' A' ' 96' ' ' ARG . 42.4 tp -117.82 133.61 55.76 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.258 179.241 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 53.7 t -110.8 132.02 60.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.265 -178.668 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.444 HG23 ' CD1' ' B' ' 261' ' ' ILE . 4.7 m -96.6 115.84 28.1 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.874 -179.249 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 87.2 mt -83.41 150.96 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.578 179.888 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.403 ' HB2' ' H ' ' A' ' 15' ' ' VAL . 72.8 mmtt -86.17 154.09 21.58 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 178.527 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.533 ' NH2' ' OE2' ' B' ' 260' ' ' GLU . 87.7 mtm180 -58.22 -25.47 61.7 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.373 179.776 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.2 m -79.49 -8.25 59.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.843 179.84 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.01 31.84 8.89 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -179.893 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.403 ' H ' ' HB2' ' A' ' 11' ' ' LYS . 23.8 t -118.65 133.64 64.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.611 0.243 . . . . 0.0 110.898 -179.949 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -72.89 133.02 44.22 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.524 -0.546 . . . . 0.0 109.524 179.141 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -127.54 -118.63 2.17 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 120.403 -0.903 . . . . 0.0 111.931 -179.54 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -76.17 149.06 31.62 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.56 2.173 . . . . 0.0 112.593 -179.028 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -110.81 151.08 28.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.339 0.59 . . . . 0.0 111.246 -179.432 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.402 ' HB2' ' CE1' ' B' ' 263' ' ' PHE . 40.4 t80 -112.54 91.75 17.87 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.304 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.518 ' HD2' HG22 ' B' ' 267' ' ' ILE . 59.8 Cg_endo -71.47 133.53 22.64 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 121.226 1.284 . . . . 0.0 111.269 -178.329 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.594 ' O ' ' CB ' ' A' ' 23' ' ' SER . 72.0 mt -73.45 -149.56 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.976 -178.429 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.594 ' CB ' ' O ' ' A' ' 22' ' ' LEU . 6.9 p 135.98 -40.16 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -179.181 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.3 mt -77.52 142.84 38.86 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.55 -1.204 . . . . 0.0 109.769 179.746 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 m -65.26 -17.13 64.25 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -178.766 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.1 m -133.86 133.56 41.69 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.619 0.599 . . . . 0.0 112.619 -179.2 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.662 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.4 OUTLIER -126.15 119.44 27.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.185 178.146 . . . . . . . . 3 3 . 1 . 051 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.512 HD21 ' OE1' ' A' ' 47' ' ' GLN . 36.7 tp -119.7 128.07 53.45 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.826 -178.391 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.705 ' CE2' HD12 ' A' ' 37' ' ' ILE . 25.1 m-85 -100.73 128.18 46.88 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.262 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -173.35 -165.04 29.61 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 120.057 -1.068 . . . . 0.0 112.876 -179.79 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.499 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 38.0 ttp-105 -105.75 -8.5 17.78 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.169 -0.515 . . . . 0.0 111.694 -179.138 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -91.52 170.05 33.49 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.66 -178.865 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.52 HG23 ' N ' ' A' ' 34' ' ' GLU . 11.0 tp -68.45 -41.7 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 115.638 -0.281 . . . . 0.0 111.301 -179.884 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.52 ' N ' HG23 ' A' ' 33' ' ' ILE . 48.8 tt0 -56.76 -29.46 62.62 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.458 -179.429 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.9 m -63.5 129.94 42.28 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.479 -179.975 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.426 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 57.0 m-20 -60.51 -31.3 70.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.383 -178.768 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.705 HD12 ' CE2' ' A' ' 29' ' ' PHE . 97.6 mt -127.25 118.65 50.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 178.258 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.492 ' CZ ' HD12 ' A' ' 33' ' ' ILE . 59.9 mtm180 -102.29 137.2 40.86 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.57 179.9 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.819 HD13 ' NH1' ' A' ' 93' ' ' ARG . 75.8 mt -119.38 131.94 70.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.617 -179.583 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -67.2 18.82 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -177.934 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.702 HD12 HH21 ' A' ' 93' ' ' ARG . 15.5 mt -104.64 127.73 28.34 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.87 179.96 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.67 -5.89 17.8 Favored 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 122.368 2.046 . . . . 0.0 112.326 -179.737 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.543 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 11.0 m -91.8 5.51 6.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.065 179.462 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.499 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 54.7 t -96.51 135.52 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.882 178.885 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.2 m -74.27 167.99 20.51 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.747 0.784 . . . . 0.0 112.951 -178.377 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.7 mtmt -64.13 -37.97 89.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.689 179.588 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.612 ' O ' ' N ' ' A' ' 49' ' ' CYS . 92.1 mm-40 -115.16 -32.26 5.75 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.135 0.493 . . . . 0.0 110.103 -179.984 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 18.7 t60 41.74 -77.2 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.764 179.636 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.612 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.37 134.74 47.38 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.793 -178.916 . . . . . . . . 3 3 . 1 . 051 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -126.05 129.25 48.79 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.359 -179.972 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 95.5 mt -114.89 131.98 65.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.208 -179.736 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -116.93 125.8 52.0 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.552 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.658 HG23 ' NH1' ' A' ' 5' ' ' ARG . 98.0 mt -106.73 114.5 46.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 119.975 -0.69 . . . . 0.0 112.022 -178.585 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.426 ' O ' ' C ' ' A' ' 55' ' ' GLU . 86.2 m-70 -113.27 146.32 39.55 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.719 179.804 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 54' ' ' HIS . 52.8 tp10 -40.66 -33.39 0.28 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.527 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -61.39 -68.94 0.27 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.744 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -161.35 -160.58 0.73 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.145 178.723 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.11 128.15 56.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.365 -179.926 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 91.2 mt -116.59 129.88 72.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.036 0.446 . . . . 0.0 111.892 -179.013 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.575 ' HB2' HD11 ' A' ' 82' ' ' LEU . 28.5 tp -100.0 130.39 46.16 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.896 -179.14 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -115.92 136.17 53.29 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.718 179.849 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -97.09 106.54 18.89 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -178.994 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -100.58 -7.47 24.01 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.213 178.73 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.99 100.97 7.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.187 179.789 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.3 m -88.47 -10.92 47.42 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.999 179.606 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.593 HG22 HG23 ' B' ' 236' ' ' VAL . 0.2 OUTLIER -91.98 -43.6 9.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.284 -179.724 . . . . . . . . 3 3 . 1 . 051 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.446 ' OD1' HG22 ' B' ' 236' ' ' VAL . 80.1 m-20 -140.05 101.26 7.03 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.08 -179.877 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -56.7 143.11 90.83 Favored 'Trans proline' 0 N--CA 1.501 1.929 0 C-N-CA 122.297 1.998 . . . . 0.0 113.355 -179.312 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.939 ' O ' HG22 ' A' ' 76' ' ' ILE . 2.9 m -72.27 140.35 48.57 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.096 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 89' ' ' THR . 72.8 mt-30 -104.57 140.35 38.12 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.327 -0.549 . . . . 0.0 111.39 -179.005 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.465 HG22 HD13 ' A' ' 88' ' ' ILE . 55.8 t -131.61 133.43 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.982 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 54.21 33.06 17.25 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.976 179.947 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.5 24.29 70.89 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.993 178.932 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.7 t -142.79 143.52 32.21 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 117.585 0.692 . . . . 0.0 111.058 179.844 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.401 HG22 ' H ' ' A' ' 75' ' ' VAL . 2.5 m -69.22 144.11 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.311 179.945 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.939 HG22 ' O ' ' A' ' 69' ' ' THR . 8.2 tt -106.42 91.39 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.259 179.191 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -64.11 -37.27 86.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.966 179.925 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.486 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 3.5 mt-10 -126.89 168.7 13.85 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.254 -179.044 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -59.74 145.38 98.31 Favored 'Trans proline' 0 N--CA 1.501 1.912 0 C-N-CA 122.042 1.828 . . . . 0.0 112.705 -179.56 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.2 m -145.48 151.58 14.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.801 178.922 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -78.83 132.94 37.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.762 179.552 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.575 HD11 ' HB2' ' A' ' 60' ' ' LEU . 96.1 mt -89.39 140.92 29.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.16 0.505 . . . . 0.0 111.281 -179.681 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -123.13 151.94 41.61 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.852 179.351 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.405 ' CE1' ' HG3' ' A' ' 98' ' ' GLU . 6.5 t60 -53.82 121.69 8.45 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.403 -179.861 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.15 -13.99 37.01 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -179.888 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -68.71 135.59 51.55 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.575 -0.45 . . . . 0.0 109.937 179.671 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.495 ' CG1' ' OG ' ' A' ' 94' ' ' SER . 91.4 t -107.06 132.28 54.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.213 -179.024 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.465 HD13 HG22 ' A' ' 71' ' ' VAL . 45.2 mm -91.05 128.28 42.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.768 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.526 ' N ' ' O ' ' A' ' 70' ' ' GLN . 63.5 m -124.26 123.35 40.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.505 0.669 . . . . 0.0 112.531 -178.02 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.443 ' O ' ' C ' ' A' ' 91' ' ' ILE . 85.1 mt -121.55 129.06 75.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.432 179.295 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.553 HG22 ' N ' ' A' ' 92' ' ' ASP . 95.8 mt 34.2 -99.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.454 -179.797 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.553 ' N ' HG22 ' A' ' 91' ' ' ILE . 36.7 t0 -114.05 16.87 18.1 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.703 0.287 . . . . 0.0 111.33 -179.216 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.819 ' NH1' HD13 ' A' ' 39' ' ' ILE . 4.8 mtm105 -124.71 139.18 54.09 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.812 -179.298 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.495 ' OG ' ' CG1' ' A' ' 87' ' ' VAL . 41.7 t -132.72 141.81 48.74 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.103 0.478 . . . . 0.0 110.128 179.606 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.494 ' HB3' HD11 ' A' ' 7' ' ' LEU . 27.2 m-85 -125.06 123.26 39.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.886 -179.993 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.551 ' O ' HD12 ' A' ' 7' ' ' LEU . 99.6 mtt180 -82.53 126.42 32.25 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.508 -179.855 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.585 ' CE2' ' OD1' ' A' ' 99' ' ' ASN . 74.7 t80 -90.59 124.27 34.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.658 179.607 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.405 ' HG3' ' CE1' ' A' ' 84' ' ' HIS . 82.0 tt0 -128.52 113.5 15.56 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.801 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.585 ' OD1' ' CE2' ' A' ' 97' ' ' TYR . 87.2 m-20 . . . . . 0 C--N 1.327 -0.41 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.544 179.961 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo . . . . . 0 N--CA 1.491 1.331 0 CA-C-O 121.531 0.555 . . . . 0.0 113.159 . . . . . . . . . 0 0 . 1 . 051 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.593 HG23 HG22 ' A' ' 66' ' ' THR . 1.8 t -61.03 138.9 21.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.306 -179.882 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.243 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.288 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo . . . . . 0 N--CA 1.497 1.733 0 N-CA-C 112.7 0.231 . . . . 0.0 112.7 . . . . . . . . . 0 0 . 1 . 051 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 25.9 m -74.52 -42.6 58.61 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.073 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.543 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 73.1 t80 -57.17 -47.41 81.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.585 -179.219 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 91.0 mt -65.31 -39.47 92.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.039 0.447 . . . . 0.0 110.206 179.634 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -62.35 -41.25 98.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.757 -179.615 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -64.33 -40.78 96.58 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.65 179.85 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.435 HH11 ' HD3' ' B' ' 245' ' ' ARG . 25.9 mmt180 -61.37 -42.69 99.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.33 -179.354 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.4 -39.76 95.36 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.304 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 11.0 t -66.04 -45.89 79.77 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.849 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -55.11 -40.87 70.96 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.693 179.996 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 44.3 t . . . . . 0 C--N 1.332 -0.175 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.857 . . . . . . . . 0 0 . 1 . 051 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.533 ' OE2' ' NH2' ' A' ' 12' ' ' ARG . 53.5 mp0 . . . . . 0 C--O 1.226 -0.174 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 . . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.444 ' CD1' HG23 ' A' ' 9' ' ' THR . 64.5 mt -111.7 134.28 54.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.48 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 77.1 t -128.02 135.27 63.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.761 -179.225 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . 0.402 ' CE1' ' HB2' ' A' ' 20' ' ' PHE . 42.3 m-85 -96.53 119.25 34.67 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.072 -178.224 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -66.42 -46.82 75.23 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.156 178.976 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.37 156.2 51.17 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.859 -178.543 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -62.23 149.19 91.54 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 C-N-CA 122.46 2.107 . . . . 0.0 111.071 179.261 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . 0.518 HG22 ' HD2' ' A' ' 21' ' ' PRO . 30.1 pt . . . . . 0 C--N 1.325 -0.489 0 CA-C-O 121.47 0.652 . . . . 0.0 111.964 -178.42 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 69.1 p . . . . . 0 N--CA 1.455 -0.214 0 CA-C-O 120.919 0.39 . . . . 0.0 110.556 . . . . . . . . . 0 0 . 1 . 052 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.5 mtt85 -94.2 132.76 38.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.248 -179.808 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.502 HH21 ' CD ' ' A' ' 98' ' ' GLU . 39.5 ptt180 -143.57 153.43 42.55 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 120.311 -0.556 . . . . 0.0 111.784 -179.943 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 68.5 mt -117.98 138.71 52.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.817 -179.757 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.703 HG11 ' NH2' ' A' ' 96' ' ' ARG . 26.6 t -112.03 130.3 65.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.524 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.427 ' HG1' ' HE2' ' A' ' 95' ' ' PHE . 3.5 m -79.27 141.24 37.23 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -178.389 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.73 HD11 ' NH1' ' A' ' 96' ' ' ARG . 47.9 mm -106.2 132.4 53.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.096 -0.957 . . . . 0.0 109.035 177.547 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -87.74 154.42 20.58 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.406 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.442 ' HG2' HH12 ' B' ' 245' ' ' ARG . 80.8 mtm180 -57.78 -23.67 53.46 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -178.806 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.4 m -82.89 -9.5 59.28 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.623 179.653 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.27 32.58 10.34 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -179.746 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.1 t -120.53 132.09 71.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.875 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.605 ' CG ' HH22 ' A' ' 96' ' ' ARG . 98.2 m-20 -69.8 137.96 52.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.438 -179.649 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -124.77 -121.23 2.54 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.28 -179.093 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -75.93 146.62 29.66 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.578 2.185 . . . . 0.0 113.192 -178.486 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -106.65 143.69 34.39 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.154 0.502 . . . . 0.0 110.461 179.754 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.529 ' CD2' HD11 ' A' ' 37' ' ' ILE . 33.7 t80 -112.35 96.22 34.63 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.371 -179.707 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -68.89 129.35 18.36 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 121.369 1.379 . . . . 0.0 112.332 -178.422 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 94.4 mt -83.88 78.05 9.79 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.114 0.483 . . . . 0.0 111.052 -178.922 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.7 p -82.29 -13.14 57.45 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.176 178.93 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.2 mt -102.86 148.22 25.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.428 -179.312 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 80.0 p -69.95 -14.78 62.87 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.568 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 58.3 m -129.48 131.48 46.69 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.315 -179.985 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.3 t -124.55 112.7 17.15 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 178.63 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.499 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 40.6 tp -110.01 124.58 51.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.524 -178.749 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.734 ' CE2' HD12 ' A' ' 37' ' ' ILE . 5.5 m-85 -104.76 140.77 37.59 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.175 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -179.97 -176.08 47.12 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.001 -1.095 . . . . 0.0 112.428 179.507 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 31' ' ' ARG . 37.2 ttp180 -91.27 -10.01 43.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.928 0.394 . . . . 0.0 109.959 -179.933 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.434 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -93.86 154.53 21.64 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.763 -179.652 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.468 HG23 ' N ' ' A' ' 34' ' ' GLU . 11.3 tp -66.92 -40.84 86.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 179.435 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.468 ' N ' HG23 ' A' ' 33' ' ' ILE . 80.9 tt0 -46.92 -16.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.478 -179.968 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.435 ' N ' ' C ' ' A' ' 33' ' ' ILE . 2.8 m -83.19 145.14 29.34 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.764 -179.983 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.499 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 54.8 m-20 -58.85 -32.81 69.77 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -179.539 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.734 HD12 ' CE2' ' A' ' 29' ' ' PHE . 85.3 mt -129.04 124.54 60.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.314 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 36.0 ttp180 -108.47 138.71 44.32 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.541 -0.464 . . . . 0.0 111.228 -179.514 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 98.3 mt -121.23 132.54 70.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.125 0.488 . . . . 0.0 110.418 -179.915 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -76.38 29.19 0.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.35 -178.803 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.489 HD22 ' HZ ' ' B' ' 241' ' ' PHE . 38.2 mt -98.72 128.87 31.35 Favored Pre-proline 0 C--N 1.324 -0.523 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.476 179.736 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.89 -9.59 22.44 Favored 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 122.135 1.89 . . . . 0.0 111.345 179.316 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.5 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 31.4 m -97.43 5.5 9.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.804 -179.917 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 24.8 t -96.46 133.12 38.96 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-O 121.134 0.492 . . . . 0.0 110.058 179.272 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 28.7 m -72.21 160.93 31.6 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.944 -179.291 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.27 -39.31 89.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.832 -178.891 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.534 ' O ' ' N ' ' A' ' 49' ' ' CYS . 99.4 mm-40 -111.45 -9.81 14.21 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.903 0.382 . . . . 0.0 110.966 -179.549 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.606 ' CG ' ' HG ' ' A' ' 64' ' ' SER . 15.1 t60 15.36 -76.05 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -178.16 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.534 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.65 135.09 46.64 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 -177.613 . . . . . . . . 3 3 . 1 . 052 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -128.55 128.73 44.83 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.648 179.57 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.9 mt -112.84 133.5 58.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.364 179.796 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -116.81 125.27 51.34 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.34 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 87.5 mt -107.27 113.56 43.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.62 0.724 . . . . 0.0 111.812 -179.117 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.433 ' C ' ' N ' ' A' ' 56' ' ' GLN . 86.7 m-70 -109.68 141.77 41.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.442 -179.941 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 54' ' ' HIS . 94.3 mt-10 -42.72 -28.35 0.23 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.729 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.487 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 86.7 mt-30 -65.0 -69.44 0.29 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.642 178.791 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.487 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 4.4 tp10 -154.79 -174.56 5.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.762 -179.064 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -108.62 127.92 54.39 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.252 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 91.6 mt -119.18 132.17 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -178.512 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.618 HD22 ' CD1' ' A' ' 88' ' ' ILE . 26.1 tp -100.85 129.58 46.74 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.693 178.934 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -114.35 137.72 51.45 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.787 -179.601 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -98.42 104.28 16.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.266 -0.424 . . . . 0.0 112.11 -179.568 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -101.22 -5.31 25.72 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.518 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.606 ' HG ' ' CG ' ' A' ' 48' ' ' HIS . 0.2 OUTLIER -77.03 99.51 5.33 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.917 -179.844 . . . . . . . . 3 3 . 1 . 052 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.0 m -78.74 -31.72 46.43 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.311 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.62 ' O ' HG12 ' B' ' 236' ' ' VAL . 6.5 m -63.45 -49.0 75.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.596 -179.808 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.449 HD21 ' HA ' ' B' ' 236' ' ' VAL . 49.7 m-80 -150.61 100.93 3.1 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.002 -179.487 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -52.34 149.1 23.74 Favored 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 122.468 2.112 . . . . 0.0 112.843 -179.823 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 31.3 m -72.83 137.07 45.5 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.774 179.877 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -100.15 142.02 32.19 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.098 -179.972 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.418 ' O ' ' OG ' ' A' ' 74' ' ' SER . 54.6 t -130.36 134.04 63.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.932 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 51.59 33.01 9.88 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 119.684 -0.806 . . . . 0.0 109.497 179.99 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.68 29.51 67.5 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.344 179.402 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 24.0 p -140.92 133.49 28.6 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 117.486 0.643 . . . . 0.0 111.424 -179.96 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.1 t -69.93 139.18 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.092 179.978 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.55 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 1.2 pt -108.63 107.41 22.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.454 0.645 . . . . 0.0 111.213 179.551 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.432 ' O ' ' OE1' ' A' ' 78' ' ' GLU . 58.3 m-20 -65.64 -33.87 76.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.851 179.051 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.513 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.1 OUTLIER -128.45 -177.72 0.68 Allowed Pre-proline 0 N--CA 1.465 0.282 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.318 179.988 . . . . . . . . 3 3 . 1 . 052 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.513 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 39.7 Cg_exo -61.56 145.08 98.07 Favored 'Trans proline' 0 N--CA 1.499 1.822 0 C-N-CA 122.705 2.27 . . . . 0.0 112.441 179.75 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.2 t -133.21 136.55 54.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.587 179.426 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -73.24 131.19 41.66 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.161 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.441 HD11 ' HB2' ' A' ' 60' ' ' LEU . 90.3 mt -87.46 136.65 32.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.035 0.445 . . . . 0.0 111.279 -179.006 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.537 ' N ' ' OD2' ' A' ' 86' ' ' ASP . 99.2 mttt -125.36 152.26 45.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.953 -179.929 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.498 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 6.1 t60 -52.08 114.73 1.41 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.829 -179.317 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.95 -12.09 29.42 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 179.634 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.537 ' OD2' ' N ' ' A' ' 83' ' ' LYS . 97.5 m-20 -69.98 137.71 51.67 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.086 179.767 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 88.6 t -111.41 134.15 54.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.418 -178.573 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.618 ' CD1' HD22 ' A' ' 60' ' ' LEU . 37.5 mm -93.31 126.53 45.73 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 178.291 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 51.2 m -125.4 127.44 46.57 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.944 0.878 . . . . 0.0 113.08 -178.125 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.531 ' O ' ' C ' ' A' ' 91' ' ' ILE . 89.0 mt -111.76 133.95 55.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 113.933 -1.485 . . . . 0.0 108.043 178.739 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.531 ' C ' ' O ' ' A' ' 90' ' ' ILE . 74.3 mt 16.17 -83.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 O-C-N 123.65 0.594 . . . . 0.0 112.171 -177.333 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' A' ' 90' ' ' ILE . 46.6 t0 -120.7 8.18 10.59 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.593 -179.515 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.757 ' NH1' HH22 ' B' ' 245' ' ' ARG . 2.4 tpp180 -124.65 137.92 54.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.085 -179.784 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 91.0 p -140.79 158.7 43.58 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.577 0.703 . . . . 0.0 112.343 -178.711 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.512 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 87.3 m-85 -130.05 128.8 42.68 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.483 179.573 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.73 ' NH1' HD11 ' A' ' 10' ' ' ILE . 92.4 mtm-85 -87.55 132.97 33.86 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 119.591 -0.844 . . . . 0.0 111.168 -179.812 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -95.48 125.15 39.89 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.46 179.369 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.502 ' CD ' HH21 ' A' ' 6' ' ' ARG . 83.4 tt0 -126.52 121.68 33.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.623 179.931 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.498 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 64.7 t-20 . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.996 179.764 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo . . . . . 0 N--CA 1.482 0.821 0 CA-C-O 121.376 0.49 . . . . 0.0 112.892 . . . . . . . . . 0 0 . 1 . 052 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.62 HG12 ' O ' ' A' ' 66' ' ' THR . 24.8 m -65.67 153.31 8.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.602 -179.263 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 8.6 t . . . . . 0 C--N 1.328 -0.337 0 CA-C-O 121.214 0.531 . . . . 0.0 111.122 -178.629 . . . . . . . . 0 0 . 1 . 052 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo . . . . . 0 N--CA 1.498 1.769 0 N-CA-C 112.826 0.279 . . . . 0.0 112.826 . . . . . . . . . 0 0 . 1 . 052 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 84.2 m -74.21 -40.21 62.6 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.202 0.525 . . . . 0.0 109.595 178.017 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.5 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 92.1 t80 -58.5 -48.06 82.04 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.751 -179.227 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' B' ' 242' ' ' LEU . 86.9 mt -63.5 -42.27 98.53 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 120.858 0.361 . . . . 0.0 111.32 179.86 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -66.17 -36.72 83.83 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.451 -179.471 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -61.24 -44.06 97.86 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.454 -0.499 . . . . 0.0 109.808 179.416 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.757 HH22 ' NH1' ' A' ' 93' ' ' ARG . 2.9 mtt-85 -59.9 -41.13 90.97 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.871 0.367 . . . . 0.0 110.432 179.776 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -61.77 -43.05 99.62 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.354 179.505 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 10.5 t -64.26 -45.41 88.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.284 0.564 . . . . 0.0 109.687 178.958 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 28.7 mm100 -62.01 -35.69 79.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.977 -179.363 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . 0.457 HG23 ' O ' ' B' ' 245' ' ' ARG . 44.8 t . . . . . 0 C--N 1.331 -0.22 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.677 179.357 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 . . . . . 0 CA--C 1.531 0.245 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 . . . . . . . . . 0 0 . 1 . 052 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.56 HD11 ' HD2' ' A' ' 93' ' ' ARG . 75.1 mt -118.23 131.37 71.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.061 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 53.6 t -125.23 132.37 71.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.575 179.81 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -96.18 115.75 27.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.2 -178.927 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -65.53 -46.7 78.57 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.747 179.289 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -87.25 150.39 49.27 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.13 -178.957 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.13 142.98 63.26 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.327 2.018 . . . . 0.0 112.254 -179.745 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 44.5 pt . . . . . 0 C--N 1.327 -0.396 0 CA-C-O 121.148 0.499 . . . . 0.0 109.841 179.114 . . . . . . . . 0 0 . 1 . 053 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.0 p . . . . . 0 N--CA 1.456 -0.173 0 CA-C-O 120.953 0.406 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 053 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.968 ' NH2' HD11 ' A' ' 53' ' ' ILE . 15.0 mtm180 -93.69 128.84 40.08 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.564 -179.086 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.7 mtp180 -126.94 139.15 53.27 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.155 0.502 . . . . 0.0 111.456 179.74 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.578 HD11 ' HB3' ' A' ' 95' ' ' PHE . 32.3 tp -112.51 132.83 54.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.057 -179.6 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.0 t -109.45 129.68 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.822 0.344 . . . . 0.0 110.648 179.982 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.475 HG23 ' CD1' ' B' ' 261' ' ' ILE . 3.8 m -86.28 111.93 20.91 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.715 -179.368 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 79.5 mt -80.42 142.76 13.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.15 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -93.56 159.02 15.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.992 0.425 . . . . 0.0 111.587 179.994 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.425 ' HB3' HG21 ' B' ' 249' ' ' VAL . 89.9 mtm180 -59.12 -29.8 67.66 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.417 179.682 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.4 m -75.51 -15.41 60.4 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.43 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.8 31.83 7.18 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -179.86 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.7 t -119.66 131.17 72.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.835 0.35 . . . . 0.0 110.911 -179.496 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -74.96 139.42 42.98 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.436 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.84 -115.57 1.65 Allowed Glycine 0 CA--C 1.534 1.227 0 C-N-CA 120.118 -1.039 . . . . 0.0 112.11 -179.355 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.71 146.68 43.65 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.264 1.976 . . . . 0.0 112.909 -178.717 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -109.77 146.9 34.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.031 -179.622 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.764 ' CD2' HD11 ' A' ' 37' ' ' ILE . 40.3 t80 -117.27 101.29 53.03 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.584 -179.813 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -72.47 127.35 12.44 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 121.714 1.61 . . . . 0.0 111.546 -178.743 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.606 HD13 ' NH2' ' A' ' 5' ' ' ARG . 62.6 mt -78.02 52.29 1.06 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.985 -178.555 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.6 p -61.83 -33.28 73.87 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.398 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 68.6 mt -74.06 141.87 45.69 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.818 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 94.7 p -67.07 -16.61 64.45 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.879 0.371 . . . . 0.0 110.814 -179.35 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 56.4 m -130.83 132.46 45.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.962 -179.992 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.661 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 2.6 t -128.25 120.04 26.38 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.828 179.471 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.667 HD21 ' OE1' ' A' ' 47' ' ' GLN . 27.6 tp -120.15 130.98 54.85 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.541 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.661 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 35.6 m-85 -108.15 144.29 35.75 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.826 179.92 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 149.23 -178.92 26.44 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 120.928 -0.654 . . . . 0.0 112.074 177.929 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.413 ' HD2' HH11 ' A' ' 31' ' ' ARG . 45.6 mtm180 -69.72 -32.88 71.68 Favored 'General case' 0 CA--C 1.522 -0.119 0 CA-C-O 120.936 0.398 . . . . 0.0 111.256 178.76 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.562 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -52.78 135.68 38.26 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -178.813 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.435 ' C ' ' N ' ' A' ' 35' ' ' CYS . 80.1 mt -63.89 -43.45 97.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.48 179.419 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -51.48 -18.9 1.2 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.406 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.562 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 13.9 m -68.79 129.13 39.04 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.718 179.037 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -60.42 -28.63 68.42 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.689 -179.103 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.764 HD11 ' CD2' ' A' ' 20' ' ' PHE . 48.2 mm -122.5 116.0 47.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.9 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -100.79 131.44 46.68 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.678 -179.39 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.629 HG21 HD12 ' A' ' 41' ' ' LEU . 91.8 mt -119.52 130.36 74.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.205 -0.598 . . . . 0.0 109.798 -179.549 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -78.04 27.81 0.18 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.207 -178.594 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.712 ' O ' HG12 ' A' ' 44' ' ' VAL . 16.0 mt -95.3 110.73 52.1 Favored Pre-proline 0 C--N 1.325 -0.483 0 C-N-CA 120.592 -0.443 . . . . 0.0 109.827 179.769 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -56.55 -12.05 7.79 Favored 'Trans proline' 0 N--CA 1.499 1.809 0 C-N-CA 122.115 1.877 . . . . 0.0 113.223 -179.266 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.471 HG23 HG13 ' A' ' 91' ' ' ILE . 6.6 m -102.64 9.14 9.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -178.888 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.712 HG12 ' O ' ' A' ' 41' ' ' LEU . 8.8 p -103.3 106.59 20.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.021 179.894 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.532 ' O ' ' O ' ' A' ' 44' ' ' VAL . 0.4 OUTLIER -34.05 167.08 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 114.911 -1.04 . . . . 0.0 113.122 -178.109 . . . . . . . . 3 3 . 1 . 053 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -62.37 -42.82 99.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.471 -178.723 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.667 ' OE1' HD21 ' A' ' 28' ' ' LEU . 88.0 mm-40 -111.97 -20.03 12.14 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.421 -179.445 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.463 ' NE2' HG23 ' A' ' 90' ' ' ILE . 24.6 t60 36.55 -75.26 0.0 OUTLIER 'General case' 0 C--O 1.236 0.361 0 CA-C-N 114.89 -1.05 . . . . 0.0 113.493 179.685 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.66 ' O ' HD12 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -133.27 135.91 45.21 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.759 -178.118 . . . . . . . . 3 3 . 1 . 053 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -128.56 134.82 48.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.776 179.809 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.0 mt -117.05 132.73 65.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.21 179.701 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -118.56 127.24 53.43 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.647 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.968 HD11 ' NH2' ' A' ' 5' ' ' ARG . 86.7 mt -102.72 116.27 46.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.487 0.66 . . . . 0.0 111.593 -179.562 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.448 ' O ' ' C ' ' A' ' 55' ' ' GLU . 79.6 m-70 -111.83 139.04 47.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.114 -179.921 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 54' ' ' HIS . 97.6 mt-10 -40.55 -34.69 0.38 Allowed 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.654 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -60.73 -67.96 0.35 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.832 178.599 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -155.63 -171.89 3.94 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.286 0.565 . . . . 0.0 111.571 -179.03 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.18 128.17 54.81 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.668 179.18 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.4 mt -125.48 133.53 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -178.77 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.415 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 16.5 tp -97.89 131.68 44.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.138 179.024 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -113.35 136.2 53.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.959 179.992 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -97.97 104.1 16.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.37 -179.921 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -95.99 -8.7 33.0 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.17 179.636 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.09 109.58 7.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.933 0.397 . . . . 0.0 111.364 -179.579 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.7 p -90.44 -18.07 26.05 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.07 179.022 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.8 HG22 HG22 ' B' ' 236' ' ' VAL . 0.2 OUTLIER -87.91 -40.88 13.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.221 -179.901 . . . . . . . . 3 3 . 1 . 053 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -145.67 99.1 4.45 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.47 -179.766 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -57.86 147.49 81.02 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 122.049 1.833 . . . . 0.0 112.779 179.99 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.0 m -68.08 137.17 54.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.884 179.519 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -98.52 143.62 28.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.977 179.353 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.773 ' HB ' HD11 ' A' ' 76' ' ' ILE . 5.1 p -130.82 137.9 54.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.342 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 50.58 31.84 6.11 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.946 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.91 28.68 68.29 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.355 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.414 ' N ' ' O ' ' A' ' 71' ' ' VAL . 14.8 t -137.97 135.29 35.86 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.846 0.355 . . . . 0.0 111.357 -179.726 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.4 p -61.73 143.03 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.914 -179.207 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.773 HD11 ' HB ' ' A' ' 71' ' ' VAL . 96.5 mt -108.3 106.01 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.931 -179.855 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -68.74 -42.04 78.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.428 179.067 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.55 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.7 OUTLIER -135.01 -179.92 1.21 Allowed Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.522 -178.774 . . . . . . . . 3 3 . 1 . 053 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.473 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 32.1 Cg_exo -57.48 146.94 81.25 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.631 2.221 . . . . 0.0 112.699 -179.595 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 18.2 m -139.67 142.81 31.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.48 -179.315 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.538 HH21 ' CE ' ' A' ' 83' ' ' LYS . 61.2 ttp180 -76.07 131.28 39.37 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.579 179.013 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.3 mt -80.61 135.5 36.07 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-O 121.148 0.499 . . . . 0.0 111.69 -179.413 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.538 ' CE ' HH21 ' A' ' 81' ' ' ARG . 99.0 mttt -129.07 150.57 50.41 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.868 178.937 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.481 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 6.3 t60 -55.3 115.72 2.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.831 0.348 . . . . 0.0 111.748 -179.172 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.24 -18.75 18.09 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.936 -0.65 . . . . 0.0 111.595 179.016 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -69.52 136.37 51.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.34 0.591 . . . . 0.0 110.608 179.913 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.8 t -114.5 131.24 67.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.04 -179.014 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 92.8 mt -97.23 132.26 42.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.645 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.8 m -118.55 124.92 48.71 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.338 -178.544 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.474 ' O ' ' N ' ' A' ' 92' ' ' ASP . 78.0 mt -112.38 126.96 69.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.134 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.743 HG22 ' NH2' ' B' ' 245' ' ' ARG . 33.8 mm 38.74 -97.09 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -178.749 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.546 ' CB ' HH22 ' B' ' 245' ' ' ARG . 44.2 t0 -123.09 17.45 10.0 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.097 0.475 . . . . 0.0 110.494 178.883 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.454 ' HG3' HD11 ' A' ' 41' ' ' LEU . 29.7 mmm-85 -122.96 138.78 54.59 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.855 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.3 m -135.04 151.59 50.92 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.87 -179.248 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.578 ' HB3' HD11 ' A' ' 7' ' ' LEU . 88.6 m-85 -122.62 120.83 34.9 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.246 179.271 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.52 ' O ' HD12 ' A' ' 7' ' ' LEU . 38.9 ttp-105 -81.16 130.55 35.07 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.831 -179.671 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -97.69 125.55 42.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.035 -179.917 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -128.15 129.25 46.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.327 -179.956 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.481 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 60.5 t-20 . . . . . 0 N--CA 1.464 0.227 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.778 -179.411 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo . . . . . 0 N--CA 1.485 0.972 0 CA-C-O 121.179 0.408 . . . . 0.0 111.846 . . . . . . . . . 0 0 . 1 . 053 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.8 HG22 HG22 ' A' ' 66' ' ' THR . 15.7 t -98.84 128.38 50.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.206 -179.744 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 5.7 t . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.548 -179.848 . . . . . . . . 0 0 . 1 . 053 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo . . . . . 0 N--CA 1.495 1.577 0 N-CA-C 113.115 0.39 . . . . 0.0 113.115 . . . . . . . . . 0 0 . 1 . 053 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 96.0 m -72.88 -45.66 57.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.288 0.566 . . . . 0.0 109.779 179.123 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.433 ' CE2' ' NE ' ' B' ' 245' ' ' ARG . 80.3 t80 -57.38 -44.42 84.42 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.968 -179.722 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.491 HD23 HH21 ' B' ' 245' ' ' ARG . 97.0 mt -63.51 -41.83 98.5 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.641 -179.796 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -66.31 -37.23 84.91 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.707 0.289 . . . . 0.0 111.108 -179.497 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 78.2 ttt-85 -63.1 -47.62 82.07 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.636 -179.429 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.743 ' NH2' HG22 ' A' ' 91' ' ' ILE . 55.9 mtm180 -65.53 -39.3 91.62 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.621 -179.585 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -59.79 -40.3 87.85 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.325 179.991 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 28.2 m -68.22 -42.83 79.19 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.5 0.667 . . . . 0.0 109.587 178.301 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -62.54 -36.26 82.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.862 179.731 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . 0.671 HG23 ' O ' ' B' ' 245' ' ' ARG . 95.0 t . . . . . 0 N--CA 1.451 -0.387 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.961 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 . . . . . 0 CA--C 1.536 0.432 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 . . . . . . . . . 0 0 . 1 . 053 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.475 ' CD1' HG23 ' A' ' 9' ' ' THR . 76.7 mt -112.18 134.6 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 119.101 0.864 . . . . 0.0 109.571 178.814 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 40.4 t -127.74 134.11 66.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.993 -179.74 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -94.33 115.14 27.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.662 -179.016 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -66.3 -46.92 75.31 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.628 179.78 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.09 155.16 43.19 Favored Pre-proline 0 N--CA 1.454 -0.267 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.708 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -63.0 141.77 85.24 Favored 'Trans proline' 0 C--N 1.302 -1.906 0 C-N-CA 122.86 2.373 . . . . 0.0 113.085 179.965 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 37.4 pt . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.607 178.355 . . . . . . . . 0 0 . 1 . 054 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.489 ' O ' ' O ' ' A' ' 99' ' ' ASN . 23.8 m . . . . . 0 N--CA 1.464 0.258 0 N-CA-C 111.787 0.292 . . . . 0.0 111.787 . . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.522 ' CZ ' HG23 ' A' ' 53' ' ' ILE . 86.2 mtt85 -82.31 134.24 35.26 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.906 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -131.14 139.06 49.74 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 120.266 -0.573 . . . . 0.0 111.984 -179.075 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 34.2 mt -115.75 133.65 55.81 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.958 179.948 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.606 HG22 ' CD2' ' A' ' 19' ' ' HIS . 76.3 t -107.25 127.61 62.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.349 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 m -91.01 114.75 27.35 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 112.943 0.719 . . . . 0.0 112.943 -177.31 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.743 HD12 ' OG ' ' A' ' 94' ' ' SER . 92.6 mt -80.99 141.9 14.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.645 179.242 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -90.43 159.54 16.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.063 0.458 . . . . 0.0 110.748 179.157 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.516 HH22 ' HB2' ' B' ' 248' ' ' GLN . 81.3 mtp180 -58.77 -32.75 69.58 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.405 -179.426 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.7 p -74.45 -13.62 60.73 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.584 179.674 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.26 29.91 7.28 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -179.745 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.3 t -117.58 130.17 72.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.721 0.296 . . . . 0.0 111.205 -179.494 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -73.62 139.26 45.37 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 177.773 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.2 -112.8 1.43 Allowed Glycine 0 CA--C 1.53 0.978 0 C-N-CA 120.161 -1.018 . . . . 0.0 112.232 -179.088 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -73.45 144.8 36.91 Favored 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 122.138 1.892 . . . . 0.0 113.009 -178.524 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.606 ' CD2' HG22 ' A' ' 8' ' ' VAL . 66.1 m170 -104.0 135.58 45.26 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.453 179.662 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.876 ' CD2' HD11 ' A' ' 37' ' ' ILE . 47.4 t80 -106.07 91.97 6.05 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.024 -179.274 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -72.95 139.27 29.83 Favored 'Trans proline' 0 N--CA 1.488 1.193 0 C-N-CA 121.634 1.556 . . . . 0.0 111.352 -179.33 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 86.2 mt -101.31 124.03 46.36 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.423 -178.592 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 65.3 p -117.37 -8.93 10.99 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.602 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 54.9 mt -101.73 149.78 23.81 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.587 -179.083 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 97.3 p -70.18 -12.14 61.39 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.27 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.434 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 41.9 m -132.35 133.98 44.64 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.257 -0.577 . . . . 0.0 111.89 -179.544 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 10.0 t -125.25 116.46 22.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.323 -0.853 . . . . 0.0 108.901 178.384 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.705 HD21 ' OE1' ' A' ' 47' ' ' GLN . 52.1 tp -116.88 132.8 56.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.997 -178.04 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.499 ' O ' ' O ' ' A' ' 47' ' ' GLN . 42.1 m-85 -110.16 136.67 49.02 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.366 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 164.48 -166.79 38.04 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 120.111 -1.042 . . . . 0.0 112.344 179.541 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.645 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 85.4 mtm-85 -89.27 -29.03 19.5 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 115.606 -0.297 . . . . 0.0 110.462 179.581 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.461 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -57.23 153.1 23.49 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 121.273 -0.489 . . . . 0.0 112.715 -177.73 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.525 ' CD1' ' NH1' ' A' ' 38' ' ' ARG . 9.4 tp -66.55 -41.87 89.12 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 N-CA-C 110.356 -0.238 . . . . 0.0 110.356 179.389 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.488 ' N ' HG23 ' A' ' 33' ' ' ILE . 50.9 tp10 -56.49 -27.07 56.16 Favored 'General case' 0 N--CA 1.461 0.124 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.647 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.461 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 19.3 m -54.54 122.75 11.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.693 179.701 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.462 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 55.5 m-20 -60.87 -33.35 72.95 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -179.566 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.876 HD11 ' CD2' ' A' ' 20' ' ' PHE . 44.0 mm -119.1 109.91 28.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 177.792 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.525 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 84.9 mtp180 -98.21 134.83 40.71 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -179.097 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 98.1 mt -120.42 132.34 70.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.028 -179.922 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -76.11 29.11 0.11 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.498 -0.773 . . . . 0.0 112.113 -178.495 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.57 HD12 ' CZ ' ' A' ' 93' ' ' ARG . 44.9 mt -106.12 130.07 23.56 Favored Pre-proline 0 CA--C 1.534 0.348 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.448 178.973 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.25 -12.65 25.49 Favored 'Trans proline' 0 N--CA 1.49 1.268 0 C-N-CA 122.448 2.099 . . . . 0.0 112.736 -179.455 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.479 HG21 ' CE2' ' B' ' 241' ' ' PHE . 30.7 m -92.57 -0.61 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.695 179.851 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.645 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 46.1 t -86.71 132.83 31.36 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.452 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.014 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.6 m -70.15 167.96 16.67 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.331 0.586 . . . . 0.0 111.22 -178.588 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt -62.64 -40.55 97.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.703 -178.872 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.705 ' OE1' HD21 ' A' ' 28' ' ' LEU . 95.4 mm-40 -115.38 -20.9 10.09 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.928 0.394 . . . . 0.0 110.483 -179.568 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.3 t60 34.05 -74.52 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -179.947 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.652 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.99 136.92 46.33 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -177.97 . . . . . . . . 3 3 . 1 . 054 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -128.23 132.2 48.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.861 179.558 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.9 mt -116.59 134.09 61.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.69 179.901 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -111.21 129.01 56.09 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.957 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.522 HG23 ' CZ ' ' A' ' 5' ' ' ARG . 47.9 mm -100.16 118.6 47.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.304 0.573 . . . . 0.0 111.253 -179.138 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.452 ' O ' ' C ' ' A' ' 55' ' ' GLU . 98.0 m-70 -119.86 130.79 55.04 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.915 179.296 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' A' ' 54' ' ' HIS . 81.8 tt0 -40.83 -31.35 0.16 Allowed 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -179.866 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.458 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 98.4 mm-40 -64.82 -67.76 0.41 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.94 178.649 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.459 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 5.5 tp10 -153.49 -170.51 3.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.0 -179.481 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.459 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -118.43 128.41 54.59 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.513 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.0 mt -114.51 130.67 68.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.134 0.492 . . . . 0.0 112.23 -178.732 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.525 ' HB2' HD11 ' A' ' 82' ' ' LEU . 26.7 tp -99.56 128.88 45.68 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.471 179.996 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -112.7 136.7 51.98 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.742 179.649 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.539 HD21 ' CA ' ' A' ' 68' ' ' PRO . 59.5 t-20 -95.96 110.32 22.55 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.403 -178.763 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -103.94 -7.92 20.03 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 179.84 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.559 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 97.9 p -81.37 98.48 8.21 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.18 -179.419 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.3 m -74.64 -38.86 62.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.449 0.642 . . . . 0.0 109.482 178.427 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p -65.46 -39.21 91.74 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.342 -179.629 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.559 ' O ' ' OG ' ' A' ' 64' ' ' SER . 54.2 m-80 -146.18 92.79 5.2 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.424 -179.53 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.539 ' CA ' HD21 ' A' ' 62' ' ' ASN . 46.8 Cg_exo -54.22 145.98 52.14 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.541 2.16 . . . . 0.0 111.873 -179.072 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.442 ' HB ' HD11 ' A' ' 76' ' ' ILE . 17.7 m -70.87 150.6 45.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.956 179.665 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -117.23 140.16 49.88 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.777 -179.768 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 48.9 t -130.92 134.86 61.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.353 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 51.79 32.32 9.44 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -179.37 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.27 27.06 68.86 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.957 179.688 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.9 t -140.15 138.05 34.9 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 117.359 0.579 . . . . 0.0 111.599 179.864 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.479 HG13 ' HB2' ' A' ' 68' ' ' PRO . 10.9 t -68.67 140.68 18.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.685 179.958 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.442 HD11 ' HB ' ' A' ' 69' ' ' THR . 7.0 pt -112.08 84.33 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.949 179.403 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -61.91 -32.17 72.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.449 179.532 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -118.46 168.21 10.01 Favored Pre-proline 0 CA--C 1.531 0.249 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.534 179.587 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.71 145.09 99.09 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 122.205 1.936 . . . . 0.0 112.52 179.965 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.2 p -138.9 140.0 39.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.986 179.652 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.6 mtm-85 -73.25 131.46 41.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.846 179.243 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.525 HD11 ' HB2' ' A' ' 60' ' ' LEU . 95.8 mt -84.95 137.57 33.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.114 0.483 . . . . 0.0 111.58 -179.136 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -126.95 151.06 49.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.563 179.028 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.462 ' C ' ' CD2' ' A' ' 84' ' ' HIS . 4.9 t60 -56.94 123.28 14.56 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.849 -179.736 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.26 -21.76 28.29 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 179.592 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -69.24 138.47 53.99 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.023 0.44 . . . . 0.0 110.513 179.784 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.2 t -111.75 131.1 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.85 -177.928 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.7 mt -93.01 134.32 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.117 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 94.5 m -126.55 126.5 43.78 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 119.933 -0.707 . . . . 0.0 112.492 -179.026 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.577 ' O ' ' N ' ' A' ' 92' ' ' ASP . 89.6 mt -110.48 125.66 67.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.085 -0.961 . . . . 0.0 108.695 178.367 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.518 HD12 HH22 ' A' ' 93' ' ' ARG . 89.2 mt 38.85 -91.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.113 -179.087 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.577 ' N ' ' O ' ' A' ' 90' ' ' ILE . 42.7 t0 -126.8 21.17 7.0 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.385 179.82 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.632 ' NH1' HH12 ' B' ' 245' ' ' ARG . 50.4 mtm-85 -129.01 143.39 50.85 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.321 -179.607 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.743 ' OG ' HD12 ' A' ' 10' ' ' ILE . 28.9 p -139.61 153.87 47.45 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 119.796 -0.762 . . . . 0.0 111.729 179.634 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -123.38 121.6 36.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.623 178.439 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -74.24 126.57 30.91 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.373 -179.534 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.49 ' CE2' ' OD1' ' A' ' 99' ' ' ASN . 92.0 t80 -94.51 121.42 36.04 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.929 0.395 . . . . 0.0 110.719 -179.972 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.449 ' HG3' ' CE1' ' A' ' 84' ' ' HIS . 84.7 tt0 -131.63 116.57 17.54 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.725 -179.959 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.49 ' OD1' ' CE2' ' A' ' 97' ' ' TYR . 91.5 m-20 . . . . . 0 C--N 1.33 -0.244 0 CA-C-O 120.974 0.416 . . . . 0.0 111.044 179.905 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo . . . . . 0 N--CA 1.489 1.231 0 CA-C-O 121.706 0.628 . . . . 0.0 112.814 . . . . . . . . . 0 0 . 1 . 054 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.541 HG13 ' O ' ' B' ' 236' ' ' VAL . 13.1 p -79.5 125.29 38.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.716 179.26 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.9 t . . . . . 0 C--N 1.331 -0.226 0 C-N-CA 120.502 -0.479 . . . . 0.0 109.845 -179.795 . . . . . . . . 0 0 . 1 . 054 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo . . . . . 0 N--CA 1.491 1.371 0 N-CA-C 111.284 -0.314 . . . . 0.0 111.284 . . . . . . . . . 0 0 . 1 . 054 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 79.8 m -74.79 -43.85 52.59 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 177.764 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.479 ' CE2' HG21 ' A' ' 43' ' ' VAL . 88.3 t80 -57.52 -46.54 83.69 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.994 -179.584 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 92.5 mt -64.0 -41.62 97.42 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.259 -179.938 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.8 -39.5 87.77 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.99 -179.901 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . 0.499 ' O ' ' OG ' ' B' ' 247' ' ' SER . 62.8 ttp180 -60.51 -43.97 96.5 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.943 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.632 HH12 ' NH1' ' A' ' 93' ' ' ARG . 79.3 mtp180 -61.77 -40.1 93.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.553 -179.508 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.21 -38.22 85.81 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 120.504 -0.478 . . . . 0.0 109.853 179.127 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . 0.499 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 80.2 p -68.62 -42.57 77.9 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 178.389 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . 0.516 ' HB2' HH22 ' A' ' 12' ' ' ARG . 82.5 mt-30 -61.89 -35.59 78.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.536 179.568 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 22.5 t . . . . . 0 C--N 1.33 -0.25 0 CA-C-O 120.941 0.401 . . . . 0.0 110.159 179.221 . . . . . . . . 0 0 . 1 . 054 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 . . . . . 0 CA--C 1.537 0.451 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 . . . . . . . . . 0 0 . 1 . 054 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 60.0 mt -110.42 137.19 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 120.516 -0.474 . . . . 0.0 109.867 179.722 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 44.7 t -126.89 134.63 65.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.731 179.465 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -94.14 117.25 29.84 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.462 -178.85 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -67.93 -47.99 67.17 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.15 -179.985 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -82.62 157.99 66.36 Favored Pre-proline 0 CA--C 1.516 -0.354 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.681 -179.123 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.82 138.54 49.01 Favored 'Trans proline' 0 C--N 1.301 -1.933 0 C-N-CA 122.5 2.133 . . . . 0.0 112.641 179.586 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 1.4 pt . . . . . 0 C--N 1.325 -0.491 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.259 178.522 . . . . . . . . 0 0 . 1 . 055 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 78.9 p . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.933 0.397 . . . . 0.0 110.73 . . . . . . . . . 0 0 . 1 . 055 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.787 ' NH1' ' HB2' ' A' ' 58' ' ' ALA . 96.0 mtt-85 -96.24 117.77 31.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.594 -179.53 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.596 ' HE ' ' CE1' ' A' ' 19' ' ' HIS . 85.6 mtp180 -131.37 139.02 49.4 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.054 0.454 . . . . 0.0 111.601 179.877 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.628 HD12 ' O ' ' A' ' 96' ' ' ARG . 37.1 tp -114.26 128.88 56.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.486 179.519 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 64.4 t -108.68 131.6 58.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.694 -0.403 . . . . 0.0 110.026 -179.684 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.403 HG21 HD12 ' B' ' 261' ' ' ILE . 18.3 m -82.56 152.23 26.06 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.601 0.715 . . . . 0.0 112.181 -178.714 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.413 HD12 ' HB3' ' A' ' 94' ' ' SER . 96.5 mt -120.08 140.2 44.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.101 177.46 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 73.0 mttt -89.05 157.12 18.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.17 0.509 . . . . 0.0 110.501 179.551 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.562 ' NH2' ' O ' ' B' ' 245' ' ' ARG . 79.3 mtp180 -56.35 -31.03 63.39 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.665 -179.758 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.3 m -77.83 -9.33 58.99 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.764 -0.375 . . . . 0.0 110.339 179.589 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.83 38.98 5.35 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 179.878 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.4 t -124.09 133.42 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 120.92 0.39 . . . . 0.0 111.64 -179.692 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -76.71 138.66 40.12 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.078 178.939 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -134.47 -116.43 1.65 Allowed Glycine 0 CA--C 1.538 1.508 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.965 -179.521 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.95 152.09 45.95 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 122.499 2.133 . . . . 0.0 113.096 -179.163 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.596 ' CE1' ' HE ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -116.14 158.77 22.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.935 0.397 . . . . 0.0 110.48 179.904 . . . . . . . . 3 3 . 1 . 055 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.663 ' CD2' HD11 ' A' ' 37' ' ' ILE . 36.9 t80 -124.15 108.38 29.9 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.589 -179.382 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -75.58 127.95 10.67 Favored 'Trans proline' 0 N--CA 1.488 1.201 0 C-N-CA 121.605 1.537 . . . . 0.0 111.361 -179.196 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 61.6 mt -82.86 49.41 1.5 Allowed 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.137 -178.808 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.6 t -63.1 -32.5 73.9 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 178.75 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.49 ' HG ' HE22 ' B' ' 265' ' ' GLN . 68.5 mt -70.77 142.25 51.4 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.831 179.711 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.5 m -63.87 -22.96 67.16 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.507 -179.289 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.3 m -133.27 133.93 43.27 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.953 -179.761 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.676 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 3.0 t -127.14 114.87 18.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.81 179.664 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.588 HD21 ' OE1' ' A' ' 47' ' ' GLN . 54.2 tp -111.55 125.69 54.19 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.228 -178.741 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.676 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 18.4 m-85 -100.69 128.51 46.71 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 177.93 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 179.26 -155.86 17.01 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 120.027 -1.082 . . . . 0.0 112.309 -179.588 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.599 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 81.8 mtm-85 -109.98 -25.23 10.37 Favored 'General case' 0 N--CA 1.46 0.067 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.074 179.902 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.48 161.29 21.92 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.194 -0.763 . . . . 0.0 111.194 -179.13 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.508 HD12 ' NH1' ' A' ' 38' ' ' ARG . 10.9 tp -67.38 -39.44 82.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.949 0.404 . . . . 0.0 110.418 179.959 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.427 ' N ' HG23 ' A' ' 33' ' ' ILE . 97.7 mt-10 -57.48 -31.58 66.11 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.109 -179.981 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.3 m -50.81 120.64 4.97 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.022 179.803 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -60.71 -33.4 72.83 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.406 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.663 HD11 ' CD2' ' A' ' 20' ' ' PHE . 96.4 mt -124.94 116.92 48.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.395 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.508 ' NH1' HD12 ' A' ' 33' ' ' ILE . 83.9 mtp180 -103.31 137.26 41.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.507 -177.927 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.644 HG21 HD12 ' A' ' 41' ' ' LEU . 92.7 mt -120.22 131.34 72.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.534 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -73.83 25.98 0.07 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.651 -178.234 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.644 HD12 HG21 ' A' ' 39' ' ' ILE . 15.1 mt -101.68 122.95 45.84 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.647 179.947 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.9 -8.68 21.57 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 122.295 1.997 . . . . 0.0 112.144 -179.753 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.2 m -92.91 0.74 9.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.656 179.325 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.599 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 93.7 t -98.27 103.47 14.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.858 179.449 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.538 ' O ' ' O ' ' A' ' 44' ' ' VAL . 1.4 t -34.11 162.11 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.451 0.643 . . . . 0.0 112.022 -178.846 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -60.69 -41.85 95.97 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.019 -0.992 . . . . 0.0 112.175 -178.371 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.588 ' OE1' HD21 ' A' ' 28' ' ' LEU . 90.8 mm-40 -107.67 -18.04 13.94 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.556 0.693 . . . . 0.0 109.902 179.589 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.0 t60 37.22 -78.16 0.0 OUTLIER 'General case' 0 C--O 1.239 0.53 0 CA-C-N 114.541 -1.209 . . . . 0.0 113.738 179.901 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.584 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -134.54 139.23 45.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.115 0.483 . . . . 0.0 112.072 -178.455 . . . . . . . . 3 3 . 1 . 055 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -129.15 125.26 36.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.555 179.594 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.5 mt -109.32 133.79 53.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.102 179.863 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.458 ' CD ' ' NE2' ' A' ' 54' ' ' HIS . 74.5 tt0 -113.17 126.37 55.37 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.324 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.8 mm -98.63 118.61 45.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.325 0.583 . . . . 0.0 112.141 -178.201 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.492 ' O ' ' N ' ' A' ' 56' ' ' GLN . 96.5 m-70 -119.46 132.22 55.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.375 178.411 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.469 ' C ' ' O ' ' A' ' 54' ' ' HIS . 76.0 tt0 -40.72 -28.37 0.07 Allowed 'General case' 0 CA--C 1.518 -0.25 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.719 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.492 ' N ' ' O ' ' A' ' 54' ' ' HIS . 86.0 mt-30 -66.41 -68.47 0.37 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.329 178.387 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.491 ' CB ' ' HE ' ' A' ' 81' ' ' ARG . 1.4 pt-20 -156.12 -168.81 2.86 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.843 -179.307 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.787 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -114.52 128.66 56.45 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.039 179.474 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.2 mt -116.85 127.94 74.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.2 0.524 . . . . 0.0 111.157 -179.748 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.2 tp -95.92 129.18 43.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.507 -179.69 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -115.68 136.32 53.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.984 179.636 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.699 ' ND2' ' H ' ' A' ' 69' ' ' THR . 12.8 t-20 -99.4 110.53 23.01 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.121 179.935 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -99.59 -8.38 24.56 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 120.856 0.36 . . . . 0.0 110.55 179.365 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.0 t -76.17 99.05 4.57 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.063 179.964 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 45.9 t -75.09 -44.59 46.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.663 0.744 . . . . 0.0 109.527 178.463 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.683 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -62.83 -43.36 98.99 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.495 -1.23 . . . . 0.0 111.021 -179.17 . . . . . . . . 3 3 . 1 . 055 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -143.39 97.07 5.65 Favored Pre-proline 0 N--CA 1.468 0.436 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.216 -179.792 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.414 ' HB2' HG13 ' A' ' 75' ' ' VAL . 31.5 Cg_exo -57.84 146.3 86.75 Favored 'Trans proline' 0 N--CA 1.499 1.844 0 C-N-CA 122.294 1.996 . . . . 0.0 112.963 179.553 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.699 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 29.1 m -69.34 137.05 52.58 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.068 178.927 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -98.69 140.16 33.32 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.548 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.622 ' HB ' HD11 ' A' ' 76' ' ' ILE . 25.2 t -132.96 137.12 54.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.359 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 54.61 33.59 19.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.136 0.494 . . . . 0.0 109.914 -179.34 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.73 30.24 66.42 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.952 179.473 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.2 m -145.16 140.35 27.9 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 117.464 0.632 . . . . 0.0 112.193 -179.505 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.414 HG13 ' HB2' ' A' ' 68' ' ' PRO . 25.2 t -70.44 136.23 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.677 179.944 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.622 HD11 ' HB ' ' A' ' 71' ' ' VAL . 88.6 mt -107.81 117.69 53.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.495 179.943 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -89.16 -29.13 19.55 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.68 178.928 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.562 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.0 OUTLIER -126.03 166.61 20.49 Favored Pre-proline 0 N--CA 1.467 0.401 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.122 -178.947 . . . . . . . . 3 3 . 1 . 055 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.07 148.96 91.36 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 122.469 2.112 . . . . 0.0 112.354 -179.946 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.2 m -141.41 151.55 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 121.354 0.597 . . . . 0.0 112.605 -179.559 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.491 ' HE ' ' CB ' ' A' ' 57' ' ' GLU . 74.6 ttt180 -78.13 128.31 33.6 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.543 179.066 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.482 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 96.9 mt -81.64 134.03 35.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.119 0.485 . . . . 0.0 111.229 -179.625 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -128.39 152.12 48.56 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.117 179.265 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -53.8 117.76 3.42 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.489 -179.535 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.62 -3.41 27.71 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -179.248 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.499 ' OD1' HG13 ' A' ' 71' ' ' VAL . 45.7 t0 -80.34 121.29 25.49 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.083 -0.339 . . . . 0.0 110.083 179.628 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.497 HG22 ' HG2' ' A' ' 96' ' ' ARG . 74.5 t -108.43 132.68 55.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.042 -178.249 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.436 HG23 ' CG2' ' A' ' 69' ' ' THR . 84.8 mt -99.11 131.98 45.35 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.682 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.3 m -115.93 125.04 52.05 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.345 0.593 . . . . 0.0 111.061 -179.179 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.468 ' O ' ' C ' ' A' ' 91' ' ' ILE . 92.0 mt -118.85 123.31 71.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.898 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.609 HD12 ' CB ' ' B' ' 237' ' ' CYS . 46.7 mm 35.13 -104.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.972 -179.727 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.505 ' N ' HG22 ' A' ' 91' ' ' ILE . 37.1 p-10 -105.91 11.11 32.13 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -179.555 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.558 HH21 ' CG ' ' B' ' 260' ' ' GLU . 86.0 mtt-85 -127.58 147.31 50.34 Favored 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.193 -179.426 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.413 ' HB3' HD12 ' A' ' 10' ' ' ILE . 29.0 t -137.18 153.22 50.5 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.079 0.466 . . . . 0.0 110.331 179.271 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.602 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 93.6 m-85 -126.64 129.14 47.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.426 179.76 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.628 ' O ' HD12 ' A' ' 7' ' ' LEU . 99.9 mtt180 -94.15 135.07 35.92 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.26 -179.003 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.561 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 83.8 t80 -99.91 124.2 44.97 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.357 179.912 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -124.89 127.53 47.25 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.728 179.508 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 63.5 t-20 . . . . . 0 C--N 1.331 -0.222 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.171 179.436 . . . . . . . . 0 0 . 1 . 055 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo . . . . . 0 N--CA 1.484 0.958 0 CA-C-O 121.02 0.342 . . . . 0.0 111.936 . . . . . . . . . 0 0 . 1 . 055 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.683 ' CG2' HG22 ' A' ' 66' ' ' THR . 37.0 t -114.08 133.4 60.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.751 179.952 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . 0.609 ' CB ' HD12 ' A' ' 91' ' ' ILE . 2.6 t . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.668 179.43 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo . . . . . 0 N--CA 1.492 1.4 0 N-CA-C 112.571 0.181 . . . . 0.0 112.571 . . . . . . . . . 0 0 . 1 . 055 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 99.2 m -73.21 -46.02 52.81 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.375 0.607 . . . . 0.0 109.709 178.067 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -57.65 -45.36 85.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.485 -179.433 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 95.8 mt -64.17 -41.4 97.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.548 -179.25 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -63.19 -41.5 99.2 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.225 -179.951 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -62.49 -43.44 98.82 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.976 0.417 . . . . 0.0 110.055 179.533 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.562 ' O ' ' NH2' ' A' ' 12' ' ' ARG . 24.4 mmt180 -61.26 -43.02 99.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.64 -179.473 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.66 -38.99 92.49 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.803 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 11.1 t -64.72 -46.22 83.2 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 177.696 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . 0.459 ' HB2' HH22 ' A' ' 12' ' ' ARG . 83.6 mt-30 -60.39 -37.74 81.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.123 179.709 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . 0.508 HG23 ' O ' ' B' ' 245' ' ' ARG . 61.9 t . . . . . 0 CA--C 1.519 -0.22 0 C-N-CA 120.217 -0.593 . . . . 0.0 109.744 179.898 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.558 ' CG ' HH21 ' A' ' 93' ' ' ARG . 97.6 mt-10 . . . . . 0 C--O 1.231 0.121 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 . . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.602 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 60.3 mt -111.11 138.07 40.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.867 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 48.6 t -128.55 136.08 60.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.682 0.277 . . . . 0.0 110.296 179.502 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -99.2 122.03 41.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.276 0.56 . . . . 0.0 111.791 -178.465 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -65.71 -44.3 86.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.021 179.233 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . 0.49 HE22 ' HG ' ' A' ' 24' ' ' LEU . 0.3 OUTLIER -103.77 162.14 20.86 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.737 -178.831 . . . . . . . . 3 3 . 1 . 055 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -60.75 152.79 67.02 Favored 'Trans proline' 0 N--CA 1.499 1.836 0 C-N-CA 123.17 2.58 . . . . 0.0 112.702 179.376 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 40.1 pt . . . . . 0 C--N 1.327 -0.39 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.55 -179.844 . . . . . . . . 0 0 . 1 . 056 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 52.9 p . . . . . 0 CA--C 1.517 -0.318 0 CA-C-O 121.142 0.496 . . . . 0.0 111.016 . . . . . . . . . 0 0 . 1 . 056 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.5 mtt85 -100.43 122.06 42.56 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.972 -178.919 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -132.14 142.08 49.35 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.173 179.909 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.498 HD12 ' O ' ' A' ' 96' ' ' ARG . 40.0 tp -114.68 125.25 53.52 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.493 179.494 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.4 HG12 ' CD2' ' A' ' 19' ' ' HIS . 32.0 m -104.85 132.82 50.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.701 -179.413 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.446 ' HG1' ' HE2' ' A' ' 95' ' ' PHE . 3.1 m -79.68 142.83 35.16 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.386 -179.119 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.622 HD12 ' OG ' ' A' ' 94' ' ' SER . 86.0 mt -111.49 135.94 49.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 177.492 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -89.2 157.73 18.15 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.627 179.291 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.439 ' HD3' HH22 ' A' ' 93' ' ' ARG . 87.8 mtm180 -57.2 -26.57 60.88 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.151 -179.191 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 44.9 m -80.48 -12.53 59.54 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 179.541 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.23 35.89 5.87 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.955 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.6 t -124.21 133.56 68.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 120.803 0.335 . . . . 0.0 110.793 -179.101 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -72.26 130.33 40.54 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.546 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -119.98 -122.68 3.03 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.282 -178.826 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.58 145.17 51.65 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 121.357 1.372 . . . . 0.0 112.402 -179.458 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.4 ' CD2' HG12 ' A' ' 8' ' ' VAL . 61.6 m170 -103.72 140.34 37.73 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.642 -179.975 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.473 ' CD2' HD11 ' A' ' 37' ' ' ILE . 59.3 t80 -114.39 96.19 42.16 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.073 -179.466 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -59.28 125.88 19.27 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.93 1.754 . . . . 0.0 112.497 -179.01 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 89.0 mt -85.62 44.91 1.14 Allowed 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.533 -179.893 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 66.3 p -60.17 -30.69 69.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.979 0.419 . . . . 0.0 109.943 179.57 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 68.5 mt -72.54 144.98 47.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.22 178.987 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.09 -20.64 65.83 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.568 -178.343 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.499 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 23.0 m -133.05 136.95 46.25 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.655 -179.321 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.595 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 3.7 t -129.43 118.36 22.03 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.794 178.052 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.544 HD12 ' O ' ' A' ' 49' ' ' CYS . 49.5 tp -114.55 130.61 56.78 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.173 -178.859 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.711 ' CE2' HD12 ' A' ' 37' ' ' ILE . 9.1 m-85 -109.21 138.28 45.81 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.195 -0.911 . . . . 0.0 108.91 179.174 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.42 -166.72 36.67 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.145 179.105 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.574 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 81.7 mtm-85 -89.81 -29.62 18.52 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 179.8 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.562 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -52.96 148.77 12.28 Favored Glycine 0 CA--C 1.521 0.458 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.314 -179.413 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.522 HG23 ' N ' ' A' ' 34' ' ' GLU . 11.1 tp -66.01 -39.83 85.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.874 0.369 . . . . 0.0 110.191 -179.98 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.522 ' N ' HG23 ' A' ' 33' ' ' ILE . 78.3 mm-40 -58.78 -21.99 57.13 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.217 -178.373 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.562 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 14.3 m -56.86 121.05 8.96 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.829 -179.804 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.499 ' OD2' ' O ' ' A' ' 26' ' ' THR . 95.3 m-20 -57.93 -26.06 61.72 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.17 179.807 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.711 HD12 ' CE2' ' A' ' 29' ' ' PHE . 86.3 mt -130.06 122.08 53.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 176.848 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.466 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 83.9 mtp180 -105.6 135.15 47.54 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.358 -178.737 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.9 mt -119.97 129.56 75.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.945 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -75.74 24.65 0.12 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -177.771 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.563 ' CD2' ' NH2' ' B' ' 245' ' ' ARG . 34.0 mt -92.49 125.55 55.58 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 119.841 -0.744 . . . . 0.0 110.848 179.667 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -72.62 -8.93 23.31 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.048 1.832 . . . . 0.0 112.558 -179.151 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.6 m -101.55 5.13 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.393 -179.648 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.574 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 40.7 t -99.09 106.65 19.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.152 -179.843 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.551 ' O ' ' O ' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -31.96 162.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.554 -178.762 . . . . . . . . 3 3 . 1 . 056 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -59.22 -47.39 85.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.3 -178.933 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.63 ' O ' ' N ' ' A' ' 49' ' ' CYS . 98.4 mt-30 -107.25 -12.44 15.36 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.491 0.662 . . . . 0.0 110.071 179.592 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.464 ' H ' ' HB3' ' A' ' 45' ' ' SER . 20.0 t60 37.99 -75.51 0.0 OUTLIER 'General case' 0 C--O 1.239 0.539 0 CA-C-N 114.812 -1.085 . . . . 0.0 113.765 179.744 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.63 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -139.1 140.72 38.06 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.584 -178.664 . . . . . . . . 3 3 . 1 . 056 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -128.04 127.61 43.47 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.893 179.51 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 91.4 mt -110.16 135.02 50.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.319 -179.951 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -117.97 128.42 54.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.513 178.149 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 94.2 mt -111.95 117.73 55.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.498 0.666 . . . . 0.0 111.603 -179.225 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.588 ' O ' ' N ' ' A' ' 56' ' ' GLN . 89.3 m-70 -117.59 144.86 44.73 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.94 179.63 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 54' ' ' HIS . 80.0 mm-40 -38.94 -23.91 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.215 -0.594 . . . . 0.0 109.928 -179.825 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.588 ' N ' ' O ' ' A' ' 54' ' ' HIS . 56.3 tt0 -67.76 -68.78 0.36 Allowed 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.267 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -161.66 -158.27 0.54 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.034 179.337 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.504 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -112.81 131.43 55.7 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.059 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 80.0 mt -120.78 131.03 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 121.061 0.457 . . . . 0.0 112.231 -179.354 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.719 HD22 HD12 ' A' ' 88' ' ' ILE . 28.8 tp -102.29 131.43 48.88 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.635 -179.376 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -112.81 133.44 54.8 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.593 179.132 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.631 HD21 ' CB ' ' A' ' 68' ' ' PRO . 57.4 t-20 -95.0 107.84 19.89 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -178.675 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -98.75 -11.58 21.75 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.401 179.693 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.9 t -84.1 100.26 11.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.236 179.593 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.6 p -83.55 -40.7 18.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.528 0.68 . . . . 0.0 109.393 179.298 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.67 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -60.64 -43.15 97.89 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.012 -0.994 . . . . 0.0 109.986 -179.984 . . . . . . . . 3 3 . 1 . 056 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -141.41 97.32 6.8 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.088 178.695 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.631 ' CB ' HD21 ' A' ' 62' ' ' ASN . 52.9 Cg_endo -66.4 152.73 80.28 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 121.932 1.754 . . . . 0.0 113.165 -178.19 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.843 ' O ' HG22 ' A' ' 76' ' ' ILE . 18.5 m -73.98 153.99 39.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.572 -179.25 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.47 ' O ' ' N ' ' A' ' 89' ' ' THR . 74.0 mt-30 -113.82 140.09 48.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.527 178.947 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.4 t -128.63 135.42 62.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.344 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.428 ' H ' HG13 ' A' ' 87' ' ' VAL . 84.9 m-20 52.07 32.94 11.11 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -178.96 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.02 28.23 68.91 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.783 179.707 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 69.9 m -140.6 140.53 35.11 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.997 179.884 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 52.1 t -65.23 136.87 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.589 179.827 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.843 HG22 ' O ' ' A' ' 69' ' ' THR . 7.5 tt -104.57 89.64 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.779 178.793 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -63.88 -35.19 79.83 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.722 -179.483 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.47 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 1.7 mt-10 -128.02 168.46 15.33 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.803 -179.475 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.84 143.75 80.07 Favored 'Trans proline' 0 N--CA 1.501 1.967 0 C-N-CA 122.282 1.988 . . . . 0.0 112.815 -178.747 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.48 HG12 HD12 ' A' ' 76' ' ' ILE . 4.7 p -139.87 142.95 31.18 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 121.329 0.585 . . . . 0.0 111.782 179.571 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -75.17 133.65 41.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.701 179.782 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.522 HD11 ' HB2' ' A' ' 60' ' ' LEU . 56.9 mt -92.5 134.33 35.07 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.801 -179.098 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.518 ' O ' ' OD2' ' A' ' 86' ' ' ASP . 99.8 mttt -120.14 153.07 36.72 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.904 -179.825 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.489 ' HD1' ' C ' ' A' ' 99' ' ' ASN . 9.3 t60 -51.1 119.13 3.71 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.243 -179.317 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.89 -14.61 34.38 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -179.614 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.518 ' OD2' ' O ' ' A' ' 83' ' ' LYS . 2.1 p30 -69.28 131.1 44.33 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.15 179.422 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.428 HG13 ' H ' ' A' ' 72' ' ' ASN . 13.5 p -105.31 140.55 22.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.56 -179.198 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.719 HD12 HD22 ' A' ' 60' ' ' LEU . 38.6 mm -102.99 128.94 55.45 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 177.851 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.47 ' N ' ' O ' ' A' ' 70' ' ' GLN . 41.1 m -121.91 130.21 53.16 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -177.654 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.532 ' O ' ' N ' ' A' ' 93' ' ' ARG . 97.5 mt -115.9 129.74 71.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 113.881 -1.509 . . . . 0.0 107.398 177.442 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.688 HG21 ' SG ' ' B' ' 237' ' ' CYS . 23.5 mt -31.74 107.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.022 0.439 . . . . 0.0 111.118 -178.37 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.513 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 2.2 t70 88.89 -25.66 0.08 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 178.691 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 90' ' ' ILE . 55.6 mtt85 -130.09 139.85 50.89 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 121.329 -0.149 . . . . 0.0 110.618 -178.658 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.622 ' OG ' HD12 ' A' ' 10' ' ' ILE . 34.0 p -142.51 158.56 43.55 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.222 0.534 . . . . 0.0 110.474 -179.997 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.463 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 59.1 m-85 -132.06 133.65 44.61 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.79 179.414 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.507 ' HG3' HD11 ' A' ' 10' ' ' ILE . 78.3 mtp85 -95.75 136.89 35.57 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 119.767 -0.773 . . . . 0.0 109.988 179.0 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -95.46 125.7 40.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.227 -179.116 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -122.09 122.19 38.69 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.265 179.062 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.489 ' C ' ' HD1' ' A' ' 84' ' ' HIS . 49.4 t-20 . . . . . 0 C--N 1.324 -0.507 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.708 -179.976 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo . . . . . 0 N--CA 1.492 1.425 0 N-CA-C 111.702 -0.153 . . . . 0.0 111.702 . . . . . . . . . 0 0 . 1 . 056 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.67 ' CG2' HG22 ' A' ' 66' ' ' THR . 25.6 t -110.3 133.2 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-O 120.949 0.404 . . . . 0.0 110.505 -179.509 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . 0.688 ' SG ' HG21 ' A' ' 91' ' ' ILE . 3.5 t . . . . . 0 CA--C 1.515 -0.403 0 CA-C-O 121.157 0.503 . . . . 0.0 110.608 -179.643 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo . . . . . 0 N--CA 1.491 1.379 0 N-CA-C 112.605 0.194 . . . . 0.0 112.605 . . . . . . . . . 0 0 . 1 . 056 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 99.9 m -72.73 -43.97 62.28 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.628 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.453 ' HD2' ' HG ' ' B' ' 237' ' ' CYS . 82.7 t80 -56.91 -47.68 80.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.264 -179.679 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.447 HD21 HG23 ' A' ' 91' ' ' ILE . 92.7 mt -62.61 -41.2 98.85 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.927 -179.173 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -63.63 -40.0 95.76 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.517 -0.473 . . . . 0.0 109.749 179.886 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . 0.537 ' O ' ' OG ' ' B' ' 247' ' ' SER . 72.9 ttt180 -59.84 -43.6 94.53 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.176 179.35 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.563 ' NH2' ' CD2' ' A' ' 41' ' ' LEU . 22.2 mmt180 -62.44 -41.41 98.7 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.675 -179.279 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.71 -39.06 90.16 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.261 0.553 . . . . 0.0 109.769 179.658 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . 0.537 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 57.6 p -67.15 -42.87 83.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.141 178.306 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -61.33 -35.84 78.52 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.028 179.789 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 49.8 t . . . . . 0 C--N 1.328 -0.347 0 O-C-N 121.595 -0.691 . . . . 0.0 110.118 178.638 . . . . . . . . 0 0 . 1 . 056 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.475 ' OE1' ' NH2' ' A' ' 93' ' ' ARG . 96.6 mt-10 . . . . . 0 CA--C 1.531 0.231 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 . . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.463 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 82.7 mt -112.06 130.95 64.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.821 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 60.8 t -126.4 134.34 66.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.16 -179.434 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -94.95 119.81 34.11 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.329 0.585 . . . . 0.0 110.975 -179.334 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.99 -43.92 97.45 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.071 179.48 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -100.98 155.31 36.45 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.619 -179.227 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -68.43 143.98 59.77 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 123.099 2.533 . . . . 0.0 113.659 -179.029 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 43.6 pt . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.047 178.35 . . . . . . . . 0 0 . 1 . 057 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.8 p . . . . . 0 CA--C 1.528 0.131 0 CA-C-O 120.756 0.312 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 057 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.78 ' NH1' ' HB2' ' A' ' 58' ' ' ALA . 95.7 mtt-85 -97.65 115.51 28.05 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.09 -178.877 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.6 mtt85 -129.44 138.54 51.51 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.997 0.427 . . . . 0.0 111.897 -179.874 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.603 HD11 ' HB3' ' A' ' 95' ' ' PHE . 32.5 tp -115.01 136.89 52.62 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.999 179.29 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 53.9 t -112.91 132.22 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.606 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 m -94.91 117.69 30.56 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.821 0.675 . . . . 0.0 112.821 -178.136 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 95.6 mt -82.97 143.71 11.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.85 179.569 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -90.6 159.89 16.21 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.042 178.419 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.601 HH12 ' CD ' ' B' ' 260' ' ' GLU . 55.0 mtm-85 -58.51 -28.29 65.28 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.403 -179.397 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.6 p -77.87 -8.6 58.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.876 0.37 . . . . 0.0 110.457 179.907 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.68 34.05 8.08 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.94 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.6 t -118.91 132.8 67.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.866 0.365 . . . . 0.0 111.065 -179.81 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -72.07 136.03 46.48 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.315 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -127.7 -121.77 2.45 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 120.541 -0.837 . . . . 0.0 111.94 -179.135 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -73.12 149.57 46.5 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.313 2.009 . . . . 0.0 112.865 -178.601 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -106.45 152.9 23.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.638 179.868 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.65 ' CD2' HD11 ' A' ' 37' ' ' ILE . 30.1 t80 -121.36 92.92 48.78 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.017 179.789 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -59.51 125.95 19.33 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.636 1.558 . . . . 0.0 110.713 -179.595 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.2 mt -90.83 45.83 1.28 Allowed 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.558 -178.242 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 94.5 p -60.53 -23.4 64.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.216 0.532 . . . . 0.0 109.635 179.545 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.7 mt -77.1 144.44 38.5 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.323 179.494 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.7 m -67.81 -18.75 64.94 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -178.373 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 59.3 m -134.72 135.16 41.75 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.671 -179.559 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.6 t -127.2 119.47 26.48 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.059 178.871 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.481 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 35.9 tp -113.45 128.12 56.34 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 121.178 -0.209 . . . . 0.0 111.537 -178.609 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.731 ' CE2' HD12 ' A' ' 37' ' ' ILE . 13.5 m-85 -107.69 130.48 54.92 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.532 179.181 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -176.26 -171.3 39.89 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.707 179.883 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.558 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 39.7 ttp-105 -93.9 -9.31 37.6 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.249 -0.476 . . . . 0.0 111.298 -179.422 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.485 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -93.93 158.88 23.44 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.671 -178.651 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.448 HG23 ' N ' ' A' ' 34' ' ' GLU . 11.1 tp -66.81 -40.22 85.41 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 115.078 -0.561 . . . . 0.0 110.496 179.82 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.448 ' N ' HG23 ' A' ' 33' ' ' ILE . 85.2 tt0 -53.15 -22.43 6.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.035 0.445 . . . . 0.0 110.053 -179.695 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 2.7 m -71.52 139.31 49.46 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.762 179.839 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.481 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 99.6 m-20 -60.8 -31.26 70.64 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.145 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.731 HD12 ' CE2' ' A' ' 29' ' ' PHE . 84.5 mt -129.27 120.33 50.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.489 177.34 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 77.2 ttt-85 -107.41 135.1 49.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.843 -178.981 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 99.7 mt -117.45 130.72 71.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.902 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -73.65 34.98 0.08 Allowed 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -177.588 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.691 ' CD1' ' HE ' ' A' ' 93' ' ' ARG . 37.6 mt -114.41 132.18 22.94 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.582 179.478 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.47 -12.01 26.87 Favored 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 122.574 2.182 . . . . 0.0 112.997 -179.036 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.438 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 19.2 m -88.11 0.9 6.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.416 179.743 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.648 HG22 HH22 ' A' ' 93' ' ' ARG . 55.7 t -90.54 131.77 36.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.156 179.331 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 46.4 t -70.75 165.31 23.32 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.345 -179.107 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 70.2 mttt -61.9 -39.97 93.83 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.142 -179.26 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.679 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.9 mt-30 -120.5 -21.54 6.76 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.046 179.772 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 16.6 t60 36.15 -75.05 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 178.991 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.679 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -128.52 132.66 48.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.104 0.478 . . . . 0.0 111.677 -178.891 . . . . . . . . 3 3 . 1 . 057 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -128.51 125.25 37.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.138 179.234 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.0 mt -107.07 133.38 51.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.526 -179.529 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.417 ' CD ' ' NE2' ' A' ' 54' ' ' HIS . 82.4 tt0 -117.24 126.06 52.15 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.562 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.5 119.72 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -177.625 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.553 ' O ' ' N ' ' A' ' 56' ' ' GLN . 97.4 m-70 -114.46 141.28 47.89 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.628 178.813 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 54' ' ' HIS . 58.8 mp0 -40.71 -24.46 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.801 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.553 ' N ' ' O ' ' A' ' 54' ' ' HIS . 99.8 mm-40 -71.86 -69.16 0.41 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.548 178.848 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.452 ' OE2' ' NE ' ' A' ' 81' ' ' ARG . 2.3 pt-20 -152.61 -174.71 5.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.294 0.568 . . . . 0.0 111.602 -178.95 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.78 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -110.47 130.18 55.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.672 179.156 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 86.2 mt -121.08 131.04 74.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.162 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 24.0 tp -100.01 129.16 46.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.318 179.442 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -113.51 135.38 53.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.149 179.573 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.466 HD21 ' HA ' ' A' ' 68' ' ' PRO . 9.1 t-20 -95.09 105.62 17.56 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.866 -0.333 . . . . 0.0 111.338 -179.988 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -98.07 -6.96 30.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.209 178.847 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.422 ' HB2' HD21 ' A' ' 62' ' ' ASN . 1.0 OUTLIER -69.36 102.28 1.72 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.401 179.846 . . . . . . . . 3 3 . 1 . 057 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.6 p -89.51 -6.51 56.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.788 0.328 . . . . 0.0 110.484 179.397 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.64 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -101.28 -42.12 6.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.332 0.587 . . . . 0.0 109.637 179.928 . . . . . . . . 3 3 . 1 . 057 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.427 HD21 ' HA ' ' B' ' 236' ' ' VAL . 69.8 m-20 -141.21 99.87 6.45 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.668 -179.919 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.466 ' HA ' HD21 ' A' ' 62' ' ' ASN . 48.8 Cg_exo -55.53 146.44 63.87 Favored 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 122.595 2.197 . . . . 0.0 112.982 -179.282 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.458 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 48.3 m -72.67 139.17 47.12 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.167 179.278 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -105.88 140.45 38.89 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.754 -179.589 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.652 HG13 ' OD1' ' A' ' 86' ' ' ASP . 54.9 t -132.23 132.9 60.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.041 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 52.91 32.93 13.44 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.049 -0.66 . . . . 0.0 109.332 -179.079 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.75 27.98 69.87 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.892 179.858 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 28.9 p -141.02 140.78 34.34 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 117.206 0.503 . . . . 0.0 111.22 179.895 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.401 HG13 ' HB2' ' A' ' 68' ' ' PRO . 13.4 t -72.4 142.48 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.804 -179.79 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.46 HG22 HG21 ' A' ' 80' ' ' VAL . 3.9 pt -115.67 88.69 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.66 178.967 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -63.67 -25.64 68.3 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.361 179.396 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.52 173.62 4.3 Favored Pre-proline 0 C--O 1.233 0.221 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.959 -179.704 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -61.66 142.37 94.14 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.401 2.067 . . . . 0.0 111.812 179.349 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.46 HG21 HG22 ' A' ' 76' ' ' ILE . 79.2 t -135.38 136.7 50.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.615 179.631 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.452 ' NE ' ' OE2' ' A' ' 57' ' ' GLU . 84.0 mtp180 -73.99 131.91 41.87 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.768 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.2 mt -82.45 139.94 33.68 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.954 0.407 . . . . 0.0 110.939 -179.38 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -131.12 151.35 51.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.698 -179.836 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.612 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 4.1 t60 -54.06 114.94 1.79 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.391 179.982 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.81 -6.39 29.42 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 -179.382 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.652 ' OD1' HG13 ' A' ' 71' ' ' VAL . 26.7 t0 -79.4 125.28 29.33 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.306 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 42.6 t -110.03 130.54 63.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.604 -178.341 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 95.6 mt -92.46 130.62 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.804 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 25.7 m -121.65 126.75 49.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.449 0.643 . . . . 0.0 112.277 -178.124 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.73 HG21 HH12 ' A' ' 93' ' ' ARG . 70.8 mt -121.69 127.54 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.442 178.977 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.489 HG22 ' N ' ' A' ' 92' ' ' ASP . 82.9 mt 38.59 -101.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.629 -179.511 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.489 ' N ' HG22 ' A' ' 91' ' ' ILE . 26.5 t70 -115.88 15.72 16.28 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 120.666 -0.413 . . . . 0.0 111.693 -179.183 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.73 HH12 HG21 ' A' ' 90' ' ' ILE . 4.5 ptt85 -131.64 146.32 52.13 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.839 179.125 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 53.0 m -139.24 155.48 47.74 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.572 -179.388 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.603 ' HB3' HD11 ' A' ' 7' ' ' LEU . 61.4 m-85 -122.22 121.04 35.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.657 179.775 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.518 ' O ' HD12 ' A' ' 7' ' ' LEU . 42.4 ttm180 -83.7 130.95 34.97 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.878 0.371 . . . . 0.0 111.59 -178.872 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.641 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 76.6 t80 -96.37 123.62 40.08 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.23 -179.47 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -123.53 126.29 46.44 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.895 179.801 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.612 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 59.7 t-20 . . . . . 0 N--CA 1.464 0.231 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.243 179.43 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo . . . . . 0 N--CA 1.491 1.361 0 CA-C-O 121.519 0.55 . . . . 0.0 113.406 . . . . . . . . . 0 0 . 1 . 057 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.64 ' CG2' HG22 ' A' ' 66' ' ' THR . 31.2 t -65.29 136.6 26.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.864 179.102 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 5.7 t . . . . . 0 C--N 1.327 -0.41 0 C-N-CA 120.626 -0.429 . . . . 0.0 110.099 -179.685 . . . . . . . . 0 0 . 1 . 057 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo . . . . . 0 N--CA 1.494 1.506 0 N-CA-C 112.609 0.196 . . . . 0.0 112.609 . . . . . . . . . 0 0 . 1 . 057 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 96.2 m -73.33 -44.9 58.03 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.515 0.674 . . . . 0.0 109.334 178.551 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.502 ' HZ ' HD22 ' A' ' 41' ' ' LEU . 80.8 t80 -56.11 -44.8 79.43 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.826 -179.861 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 92.1 mt -62.81 -40.86 98.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 179.818 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -64.42 -39.94 94.8 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.419 -179.26 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 59.8 ttm-85 -60.01 -44.86 94.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.044 0.45 . . . . 0.0 109.962 179.781 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.474 HH21 ' HG2' ' A' ' 12' ' ' ARG . 58.1 mtp180 -63.32 -41.55 98.93 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.749 -179.823 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -62.85 -40.76 98.46 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.239 -0.585 . . . . 0.0 109.806 179.376 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 38.5 t -64.38 -45.05 89.4 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 122.052 0.929 . . . . 0.0 108.679 178.167 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -59.52 -37.28 77.93 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.41 -179.973 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 21.8 t . . . . . 0 C--N 1.33 -0.267 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.753 . . . . . . . . 0 0 . 1 . 057 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.601 ' CD ' HH12 ' A' ' 12' ' ' ARG . 53.5 mp0 . . . . . 0 N--CA 1.461 0.119 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 . . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 69.4 mt -108.58 135.53 47.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.738 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 55.0 t -127.45 134.0 66.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.947 0.404 . . . . 0.0 110.896 -178.384 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -97.38 119.75 36.48 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.557 -179.331 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.85 -43.84 94.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.924 179.038 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -95.79 153.78 39.24 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.362 -179.598 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.85 147.05 80.13 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 123.087 2.525 . . . . 0.0 113.288 -179.273 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.4 pt . . . . . 0 C--N 1.331 -0.223 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.678 178.455 . . . . . . . . 0 0 . 1 . 058 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 50.0 p . . . . . 0 N--CA 1.453 -0.277 0 CA-C-O 121.238 0.542 . . . . 0.0 110.25 . . . . . . . . . 0 0 . 1 . 058 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.485 ' HD2' HD13 ' A' ' 53' ' ' ILE . 84.9 mtt85 -89.39 122.27 32.45 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.493 -179.449 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.436 ' HE ' ' CE1' ' A' ' 19' ' ' HIS . 83.7 mtp180 -124.79 139.44 53.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.24 -179.922 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.579 HD12 ' O ' ' A' ' 96' ' ' ARG . 29.4 tp -116.39 132.83 56.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.133 -179.4 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.892 HG11 ' NH2' ' A' ' 96' ' ' ARG . 67.6 t -108.18 130.19 61.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.36 -179.676 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.601 HG21 ' HZ ' ' B' ' 263' ' ' PHE . 59.2 p -91.28 114.22 26.69 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.455 0.645 . . . . 0.0 112.485 -178.83 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.435 HD12 ' HB3' ' A' ' 94' ' ' SER . 95.5 mt -79.71 140.9 16.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.396 178.953 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -87.69 158.19 18.89 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.15 0.5 . . . . 0.0 111.008 179.179 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.592 ' NH1' ' OE2' ' B' ' 260' ' ' GLU . 81.3 mtp180 -58.3 -31.03 67.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.554 -179.305 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 93.2 p -74.82 -12.79 60.47 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.933 179.275 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.34 25.93 10.57 Favored Glycine 0 CA--C 1.531 1.045 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -179.566 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.2 t -119.27 134.98 61.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.695 0.283 . . . . 0.0 110.541 179.981 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.657 ' CG ' HH22 ' A' ' 96' ' ' ARG . 90.6 m-20 -67.6 139.23 56.86 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.426 -179.837 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -127.04 -123.71 2.66 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.068 -179.023 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.43 146.34 44.51 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 122.321 2.014 . . . . 0.0 113.184 -178.426 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.61 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -111.08 131.01 55.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.094 0.473 . . . . 0.0 111.049 -179.561 . . . . . . . . 3 3 . 1 . 058 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.545 ' CD2' HD11 ' A' ' 37' ' ' ILE . 25.2 t80 -101.35 107.7 51.93 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.014 -179.602 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -73.64 127.45 11.68 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 121.129 1.219 . . . . 0.0 111.645 -179.748 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.9 mt -87.87 50.58 2.02 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.139 -178.769 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 97.4 p -65.97 -19.07 65.74 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.051 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.605 HD11 ' HG2' ' B' ' 265' ' ' GLN . 68.0 mt -79.03 140.57 37.9 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.283 179.848 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.7 t -62.43 -25.5 68.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.866 179.916 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 66.0 m -129.79 130.96 46.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.193 -179.768 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.61 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 8.6 t -129.3 124.17 33.69 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.605 178.903 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.576 HD21 ' HG2' ' A' ' 47' ' ' GLN . 42.8 tp -119.28 132.05 55.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.928 0.394 . . . . 0.0 111.184 -178.747 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.771 ' CE2' HD12 ' A' ' 37' ' ' ILE . 10.0 m-85 -108.97 139.98 43.09 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.022 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 167.76 -155.7 26.77 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 119.942 -1.123 . . . . 0.0 112.069 179.846 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.538 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 37.6 ttp-105 -111.2 -21.64 11.8 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.88 -0.16 . . . . 0.0 110.855 -179.459 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.458 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -73.77 163.59 54.69 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.553 -179.161 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.514 ' CD1' ' NH1' ' A' ' 38' ' ' ARG . 46.2 mm -64.52 -45.67 94.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 O-C-N 122.746 -0.267 . . . . 0.0 110.944 -179.876 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -49.78 -21.95 1.27 Allowed 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.503 179.962 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.572 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 4.8 m -67.75 121.87 16.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.11 -179.513 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -59.41 -25.9 64.7 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.757 -179.494 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.771 HD12 ' CE2' ' A' ' 29' ' ' PHE . 98.1 mt -128.77 124.16 60.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.086 177.64 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.514 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 56.6 mtm180 -110.34 141.43 43.38 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 120.634 -0.427 . . . . 0.0 111.237 -179.704 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.658 HD13 ' HE ' ' A' ' 93' ' ' ARG . 81.0 mt -121.17 132.65 70.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.034 179.916 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -74.75 29.81 0.09 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.569 -177.762 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.712 HD12 ' CZ ' ' A' ' 93' ' ' ARG . 51.5 mt -109.34 133.55 20.77 Favored Pre-proline 0 C--N 1.325 -0.494 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.643 -179.559 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.2 -12.92 25.74 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.741 2.294 . . . . 0.0 112.016 179.598 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.4 m -88.61 3.71 5.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.069 179.448 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.538 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 55.1 t -98.99 130.88 47.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 C-N-CA 120.434 -0.507 . . . . 0.0 109.699 178.432 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 75.6 m -70.74 172.62 8.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.632 -179.077 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.572 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 10.5 mttm -63.79 -41.87 97.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.259 179.939 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.658 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.2 mt-30 -117.48 -16.15 10.21 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 123.337 0.398 . . . . 0.0 111.732 -179.315 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.42 ' NE2' HG23 ' A' ' 90' ' ' ILE . 17.5 t60 33.78 -72.58 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 179.081 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.658 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -135.99 140.32 43.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.067 0.461 . . . . 0.0 112.036 -178.752 . . . . . . . . 3 3 . 1 . 058 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -126.63 135.51 51.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.556 179.918 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 92.3 mt -121.52 134.17 65.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.013 -179.483 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -116.14 127.34 54.75 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.849 179.036 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.485 HD13 ' HD2' ' A' ' 5' ' ' ARG . 82.1 mt -106.57 113.27 42.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 119.853 -0.739 . . . . 0.0 112.288 -179.606 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.426 ' O ' ' C ' ' A' ' 55' ' ' GLU . 98.0 m-70 -113.25 143.89 43.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.742 179.426 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 54' ' ' HIS . 41.3 tt0 -40.9 -30.68 0.14 Allowed 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.028 -0.669 . . . . 0.0 109.4 -179.407 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.47 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 85.7 mt-30 -60.79 -68.88 0.26 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.37 179.131 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.47 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 4.2 tp10 -157.91 -164.95 1.63 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.809 179.775 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.437 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -111.59 126.77 55.36 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 178.317 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 94.4 mt -115.36 131.56 67.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.247 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.443 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 22.0 tp -101.05 131.24 47.04 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.835 179.773 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -114.26 134.71 54.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.499 -179.779 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 56.6 t-20 -92.84 105.06 17.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.933 0.397 . . . . 0.0 111.434 -179.309 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -101.82 -9.56 20.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.277 179.417 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.92 98.2 10.21 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.717 -179.581 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.5 m -76.69 -38.41 54.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.359 0.599 . . . . 0.0 109.854 178.996 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.418 ' O ' HG22 ' B' ' 236' ' ' VAL . 0.2 OUTLIER -62.49 -44.66 95.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.832 -178.688 . . . . . . . . 3 3 . 1 . 058 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.464 HD21 ' HA ' ' B' ' 236' ' ' VAL . 85.4 m-20 -139.16 95.86 9.21 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.624 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -54.8 144.29 66.79 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 121.787 1.658 . . . . 0.0 112.542 -179.038 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 97.0 m -73.42 138.38 45.19 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.625 178.76 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -99.96 137.81 37.91 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.272 179.881 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.663 HG13 ' OD1' ' A' ' 86' ' ' ASP . 54.2 t -131.89 133.21 61.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 178.517 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 53.71 32.1 14.06 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.218 -179.121 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.4 27.66 67.38 Favored Glycine 0 CA--C 1.536 1.38 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.225 179.691 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 58.6 m -144.35 140.45 29.11 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 117.319 0.56 . . . . 0.0 111.657 -179.964 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.444 ' H ' HG22 ' A' ' 75' ' ' VAL . 4.6 m -74.28 146.8 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.748 179.515 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.8 pt -116.43 98.5 6.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.262 0.553 . . . . 0.0 111.549 179.837 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -67.14 -26.58 66.74 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 178.465 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.31 166.36 17.51 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.602 -179.868 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -64.22 150.5 88.18 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.684 2.256 . . . . 0.0 112.183 179.249 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.4 m -141.63 141.99 29.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.347 -179.482 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -74.91 135.22 41.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.966 179.18 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.437 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 98.2 mt -83.82 137.53 33.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.236 0.541 . . . . 0.0 110.838 -179.631 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -129.27 154.85 46.42 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.808 179.974 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -56.99 116.19 3.06 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.843 -178.901 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.06 -12.8 29.06 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -179.743 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.663 ' OD1' HG13 ' A' ' 71' ' ' VAL . 43.6 t0 -67.78 128.47 36.59 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.963 0.411 . . . . 0.0 110.283 179.651 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.411 ' O ' HG13 ' A' ' 87' ' ' VAL . 9.3 p -109.11 134.87 49.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.559 -179.053 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 81.2 mt -106.8 131.17 57.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.275 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.8 m -119.9 123.67 44.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.446 0.641 . . . . 0.0 111.479 -179.033 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.549 HD12 ' CE1' ' A' ' 95' ' ' PHE . 84.8 mt -116.74 124.47 72.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.914 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.402 HG22 ' N ' ' A' ' 92' ' ' ASP . 44.8 mm 44.61 -103.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.773 -179.607 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.664 ' OD1' ' NH1' ' A' ' 93' ' ' ARG . 12.3 p-10 -117.49 17.58 14.5 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.995 0.426 . . . . 0.0 110.488 -179.803 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.712 ' CZ ' HD12 ' A' ' 41' ' ' LEU . 34.2 mtm-85 -127.1 142.68 51.46 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.024 -179.366 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.435 ' HB3' HD12 ' A' ' 10' ' ' ILE . 41.2 t -135.25 150.26 50.02 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.564 -179.826 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.549 ' CE1' HD12 ' A' ' 90' ' ' ILE . 19.2 m-85 -124.97 124.02 41.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.581 -179.892 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.892 ' NH2' HG11 ' A' ' 8' ' ' VAL . 89.8 mtm-85 -85.66 128.41 34.77 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.932 -178.915 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -92.12 124.53 36.28 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.193 179.083 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -127.69 118.55 24.03 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.549 -179.547 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 61.4 t-20 . . . . . 0 C--N 1.326 -0.431 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.009 179.589 . . . . . . . . 0 0 . 1 . 058 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo . . . . . 0 N--CA 1.483 0.874 0 CA-C-O 121.66 0.608 . . . . 0.0 113.019 . . . . . . . . . 0 0 . 1 . 058 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.464 ' HA ' HD21 ' A' ' 67' ' ' ASN . 17.5 t -57.56 141.09 15.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.485 -179.597 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 16.5 t . . . . . 0 C--N 1.332 -0.154 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.455 . . . . . . . . 0 0 . 1 . 058 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo . . . . . 0 N--CA 1.498 1.758 0 N-CA-C 113.057 0.368 . . . . 0.0 113.057 . . . . . . . . . 0 0 . 1 . 058 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 13.7 p -73.96 -39.2 63.9 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.218 179.044 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.42 ' HZ ' HD22 ' A' ' 41' ' ' LEU . 68.3 t80 -57.42 -46.34 83.65 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.357 -179.872 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.457 HD22 ' NH2' ' B' ' 245' ' ' ARG . 94.9 mt -63.45 -40.76 98.0 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.215 179.95 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -58.18 -41.77 84.64 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.14 179.558 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -64.34 -38.8 92.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.447 179.844 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.494 ' NE ' ' CB ' ' A' ' 92' ' ' ASP . 10.1 ttm180 -57.8 -44.93 86.65 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.56 -179.511 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -61.65 -41.23 97.23 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.758 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 10.2 t -63.8 -45.97 87.25 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.323 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . 0.443 ' HG2' HH12 ' A' ' 12' ' ' ARG . 67.0 tp60 -58.51 -41.15 84.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.688 -1.142 . . . . 0.0 111.406 -179.531 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 55.0 t . . . . . 0 C--N 1.332 -0.158 0 C-N-CA 120.559 -0.457 . . . . 0.0 109.792 179.897 . . . . . . . . 0 0 . 1 . 058 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.592 ' OE2' ' NH1' ' A' ' 12' ' ' ARG . 95.7 mt-10 . . . . . 0 N--CA 1.464 0.239 0 N-CA-C 113.982 1.105 . . . . 0.0 113.982 . . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 73.9 mt -109.41 134.11 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 118.644 0.656 . . . . 0.0 109.691 179.684 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 56.1 t -123.9 131.94 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.052 -179.532 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . 0.601 ' HZ ' HG21 ' A' ' 9' ' ' THR . 51.2 m-85 -98.77 120.64 39.56 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.21 0.528 . . . . 0.0 111.174 -178.683 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -63.05 -48.3 79.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.332 -179.681 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . 0.605 ' HG2' HD11 ' A' ' 24' ' ' LEU . 6.0 mp0 -88.78 161.86 40.3 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.029 -179.068 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -62.28 143.54 94.13 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.276 1.984 . . . . 0.0 112.279 -179.963 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . 0.428 ' CD1' ' O ' ' A' ' 19' ' ' HIS . 4.2 tt . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.877 -179.647 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 73.8 p . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.99 0.424 . . . . 0.0 110.409 . . . . . . . . . 0 0 . 1 . 059 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.738 ' NE ' HD13 ' A' ' 53' ' ' ILE . 89.9 mtm-85 -91.24 125.75 36.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.151 -179.75 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 86.5 mtm-85 -131.43 137.14 48.52 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.849 179.522 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.551 HD12 ' O ' ' A' ' 96' ' ' ARG . 40.8 tp -113.32 131.38 55.97 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.983 -179.905 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.6 t -109.07 131.71 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 120.947 0.403 . . . . 0.0 110.984 -179.586 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.426 ' O ' HG22 ' A' ' 9' ' ' THR . 1.8 m -90.65 112.64 24.45 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.748 -179.341 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.7 mt -79.72 144.67 10.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.405 178.646 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -90.6 158.32 17.03 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.142 0.496 . . . . 0.0 110.588 179.17 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.749 HH12 ' NE2' ' B' ' 248' ' ' GLN . 87.2 mtm180 -58.39 -28.39 65.13 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.727 -178.846 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 93.6 p -80.36 -11.22 59.73 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.473 179.795 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.55 31.34 7.16 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.108 179.212 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.1 t -122.61 133.45 68.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.789 0.328 . . . . 0.0 110.729 179.623 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -73.64 138.64 44.93 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.207 179.479 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.66 -118.34 1.93 Allowed Glycine 0 CA--C 1.534 1.225 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.764 -179.899 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.42 146.14 55.29 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 121.912 1.741 . . . . 0.0 112.332 -179.112 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -110.83 158.54 18.58 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.157 0.503 . . . . 0.0 110.649 -179.337 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -125.74 102.0 29.32 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.617 -179.491 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -69.8 128.56 16.16 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 121.279 1.32 . . . . 0.0 111.468 -178.947 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.8 mt -85.72 49.48 1.78 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.543 -178.183 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 92.2 p -61.55 -24.93 66.97 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.055 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.619 HD11 ' HG2' ' B' ' 265' ' ' GLN . 65.7 mt -78.64 141.27 38.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.076 179.779 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 91.9 p -65.33 -19.99 66.2 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.811 179.962 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.409 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 61.8 m -130.28 131.46 45.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.6 -178.852 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.2 t -125.0 112.71 16.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.429 178.385 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.685 HD21 ' OE1' ' A' ' 47' ' ' GLN . 54.7 tp -109.36 127.74 54.57 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.923 -178.593 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.82 ' CE2' HD12 ' A' ' 37' ' ' ILE . 2.5 m-85 -110.07 143.41 40.16 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.745 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 150.98 -166.82 30.5 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.233 178.468 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.531 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 46.2 mtm105 -82.62 -30.98 29.07 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 179.946 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.544 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -50.84 139.08 24.31 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 120.556 -0.83 . . . . 0.0 111.298 -178.854 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.451 HD13 ' HD2' ' A' ' 38' ' ' ARG . 31.3 mm -63.92 -43.79 97.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 121.064 0.459 . . . . 0.0 110.332 179.396 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -55.72 -14.41 2.25 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.132 179.879 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.544 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 56.6 m -64.43 135.2 55.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.93 179.954 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.409 ' OD2' ' O ' ' A' ' 26' ' ' THR . 58.5 m-20 -61.23 -33.84 74.15 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.646 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.82 HD12 ' CE2' ' A' ' 29' ' ' PHE . 88.2 mt -127.32 122.58 60.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 177.471 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.451 ' HD2' HD13 ' A' ' 33' ' ' ILE . 77.5 ttt-85 -111.42 138.6 47.71 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.516 -178.187 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 83.8 mt -119.86 131.48 72.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-O 120.88 0.371 . . . . 0.0 110.409 -179.89 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -78.06 33.82 0.19 Allowed 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 -178.49 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.529 ' CD1' ' CZ ' ' A' ' 93' ' ' ARG . 33.4 mt -109.09 131.86 21.56 Favored Pre-proline 0 C--N 1.325 -0.461 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.293 -179.651 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.79 -15.41 29.94 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.392 2.061 . . . . 0.0 112.874 -179.681 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.55 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 19.2 m -90.27 1.01 8.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.281 179.592 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.531 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 45.3 t -93.25 133.74 33.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.061 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.9 m -71.53 164.09 26.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.4 0.619 . . . . 0.0 112.02 -178.609 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -63.73 -43.3 96.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.187 -178.834 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.685 ' OE1' HD21 ' A' ' 28' ' ' LEU . 93.1 mm-40 -111.95 -17.88 12.78 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.966 0.412 . . . . 0.0 110.148 -179.791 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 14.9 t60 30.66 -76.15 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 179.908 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.623 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.52 137.25 47.09 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -178.43 . . . . . . . . 3 3 . 1 . 059 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -128.69 126.69 40.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.876 179.809 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 91.8 mt -108.71 133.71 52.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.129 0.49 . . . . 0.0 110.738 179.868 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.448 ' OE2' ' CE1' ' A' ' 54' ' ' HIS . 81.0 tt0 -118.23 123.83 46.42 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.354 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.738 HD13 ' NE ' ' A' ' 5' ' ' ARG . 92.5 mt -107.5 119.25 56.78 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 CA-C-O 122.013 0.911 . . . . 0.0 112.858 -178.531 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.461 ' O ' ' C ' ' A' ' 55' ' ' GLU . 98.7 m-70 -108.02 134.14 51.34 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 113.871 -1.513 . . . . 0.0 108.865 179.075 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.461 ' C ' ' O ' ' A' ' 54' ' ' HIS . 97.3 mt-10 -42.5 -33.13 0.63 Allowed 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.524 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.408 ' N ' ' C ' ' A' ' 54' ' ' HIS . 78.6 mt-30 -64.53 -68.33 0.36 Allowed 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.071 -0.968 . . . . 0.0 108.835 177.722 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -143.82 179.12 7.36 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.562 0.696 . . . . 0.0 112.404 -178.567 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.9 120.59 41.96 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.095 178.429 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.7 mt -118.34 133.03 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.994 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.523 ' HB2' HD11 ' A' ' 82' ' ' LEU . 15.7 tp -99.29 129.45 45.51 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.317 179.487 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -110.8 136.89 49.16 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.559 -179.945 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -98.9 106.97 19.29 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.007 0.432 . . . . 0.0 111.905 -179.052 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -100.21 -6.06 26.67 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.779 179.402 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.7 99.18 8.06 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.376 -179.667 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.7 p -88.53 -20.42 25.12 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.738 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.451 HG22 HG12 ' B' ' 236' ' ' VAL . 2.6 m -74.18 -50.91 17.22 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.467 179.189 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.49 HD21 ' HA ' ' B' ' 236' ' ' VAL . 72.2 m-20 -137.43 99.42 9.66 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 114.698 -1.137 . . . . 0.0 108.923 179.766 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -54.0 144.62 56.18 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 121.954 1.769 . . . . 0.0 113.403 -178.762 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 26.8 m -72.12 139.87 48.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.493 178.581 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -105.1 140.53 38.13 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.166 -0.614 . . . . 0.0 110.648 179.932 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.2 p -134.06 134.22 55.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.707 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 51.6 31.89 8.33 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -179.065 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.92 27.39 68.91 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.887 -179.751 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.7 t -139.07 136.73 35.55 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 117.497 0.649 . . . . 0.0 111.804 -179.839 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.5 m -73.75 143.25 13.87 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.151 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.048 179.667 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.559 ' CG2' HG21 ' A' ' 80' ' ' VAL . 9.9 pt -117.07 100.61 10.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.411 0.624 . . . . 0.0 111.028 179.795 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -71.0 -21.97 62.22 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.072 179.46 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.438 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.3 OUTLIER -130.19 177.21 2.31 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.736 179.78 . . . . . . . . 3 3 . 1 . 059 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.438 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 36.7 Cg_exo -59.96 142.32 98.24 Favored 'Trans proline' 0 N--CA 1.5 1.906 0 C-N-CA 122.865 2.377 . . . . 0.0 112.708 -179.335 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.559 HG21 ' CG2' ' A' ' 76' ' ' ILE . 61.4 t -133.03 139.32 49.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.065 179.602 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.546 HH21 ' CE ' ' A' ' 83' ' ' LYS . 62.5 ttp180 -76.61 126.73 31.49 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.955 179.043 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.523 HD11 ' HB2' ' A' ' 60' ' ' LEU . 94.4 mt -82.78 138.45 34.0 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.942 0.401 . . . . 0.0 111.703 -179.285 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.546 ' CE ' HH21 ' A' ' 81' ' ' ARG . 99.3 mttt -128.38 150.95 49.89 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.035 179.712 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -55.43 122.31 10.92 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.068 0.461 . . . . 0.0 111.174 -179.18 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.96 -16.64 42.73 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 -179.894 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -65.82 136.54 56.32 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.62 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 42.0 t -114.5 132.76 62.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.427 -178.364 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 91.6 mt -95.51 131.43 42.33 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.43 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.7 m -123.98 124.96 43.74 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.6 0.714 . . . . 0.0 112.634 -178.319 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.5 ' O ' ' N ' ' A' ' 92' ' ' ASP . 93.7 mt -113.15 125.91 70.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 114.695 -1.139 . . . . 0.0 108.427 178.432 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.591 HD12 HH22 ' A' ' 93' ' ' ARG . 73.9 mt 39.5 -94.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 C-N-CA 120.716 -0.393 . . . . 0.0 110.53 -179.458 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.517 ' O ' ' OD1' ' A' ' 92' ' ' ASP . 62.3 t0 -124.94 19.0 8.49 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.071 0.463 . . . . 0.0 110.905 -179.78 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.676 ' NH1' ' NH2' ' B' ' 245' ' ' ARG . 58.0 mtm-85 -127.62 141.98 51.48 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.472 -179.841 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 25.8 p -139.27 154.2 47.91 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 119.59 -0.844 . . . . 0.0 111.426 -179.798 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.535 ' HB3' HD11 ' A' ' 7' ' ' LEU . 63.8 m-85 -123.22 121.79 36.77 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.078 179.702 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.551 ' O ' HD12 ' A' ' 7' ' ' LEU . 44.8 ttm180 -80.14 127.65 32.57 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.953 -179.148 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -95.1 125.13 39.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.111 -179.825 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -124.87 121.62 35.06 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.636 179.651 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.012 179.453 . . . . . . . . 0 0 . 1 . 059 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 N--CA 1.482 0.818 0 CA-C-O 121.501 0.542 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 059 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.49 ' HA ' HD21 ' A' ' 67' ' ' ASN . 10.9 m -67.39 147.75 12.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.191 -178.919 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 3.0 t . . . . . 0 C--N 1.323 -0.546 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.847 179.891 . . . . . . . . 0 0 . 1 . 059 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo . . . . . 0 N--CA 1.498 1.787 0 N-CA-C 113.585 0.571 . . . . 0.0 113.585 . . . . . . . . . 0 0 . 1 . 059 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 97.3 m -73.61 -44.21 57.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.179 0.514 . . . . 0.0 109.844 179.074 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.55 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 90.6 t80 -58.31 -46.11 86.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.652 -179.516 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 94.7 mt -63.54 -40.13 96.2 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.852 0.358 . . . . 0.0 110.284 -179.834 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 51.9 tp10 -60.77 -43.73 97.65 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.496 -179.749 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -60.04 -41.74 92.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.175 0.512 . . . . 0.0 109.841 179.548 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.676 ' NH2' ' NH1' ' A' ' 93' ' ' ARG . 61.3 ttm-85 -60.04 -44.75 94.46 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.718 -179.544 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -61.87 -40.9 96.98 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.056 0.455 . . . . 0.0 110.141 -179.719 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 61.4 m -66.94 -44.01 81.73 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 177.949 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . 0.749 ' NE2' HH12 ' A' ' 12' ' ' ARG . 59.0 tt0 -60.87 -37.8 83.38 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.201 179.867 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . 0.444 HG23 ' O ' ' B' ' 245' ' ' ARG . 53.6 t . . . . . 0 N--CA 1.455 -0.177 0 C-N-CA 119.926 -0.709 . . . . 0.0 110.037 -179.966 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 . . . . . 0 N--CA 1.465 0.319 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 . . . . . . . . . 0 0 . 1 . 059 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 75.2 mt -113.11 134.9 54.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 179.065 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 59.2 t -124.22 133.27 69.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.924 0.392 . . . . 0.0 110.842 -179.564 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -96.48 118.5 33.11 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.141 0.496 . . . . 0.0 110.928 -179.424 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -65.32 -47.95 74.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.857 -179.945 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . 0.619 ' HG2' HD11 ' A' ' 24' ' ' LEU . 1.3 mp0 -95.15 164.84 18.22 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.143 -178.436 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -64.34 149.63 89.78 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 122.91 2.406 . . . . 0.0 112.696 -179.575 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 47.7 pt . . . . . 0 C--N 1.33 -0.243 0 CA-C-O 121.366 0.603 . . . . 0.0 111.436 -179.851 . . . . . . . . 0 0 . 1 . 060 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.2 m . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.915 0.388 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 060 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.1 mtt85 -90.08 136.45 33.04 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.657 -178.559 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -127.59 137.35 52.55 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.787 179.482 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.65 HD11 ' HB3' ' A' ' 95' ' ' PHE . 40.6 tp -115.67 134.0 55.48 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.651 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.0 t -111.76 130.98 64.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -179.799 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.459 ' CG2' HD12 ' B' ' 261' ' ' ILE . 4.2 m -90.45 111.76 23.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.393 0.616 . . . . 0.0 112.09 -178.644 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 95.2 mt -79.97 142.13 14.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.703 178.64 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -91.42 159.97 15.7 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.021 0.439 . . . . 0.0 111.368 -179.832 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 91.3 mtm180 -57.68 -29.38 64.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.282 -179.68 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.7 t -80.69 -11.01 59.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.339 179.557 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.63 34.82 6.42 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.356 -0.697 . . . . 0.0 111.356 -179.985 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.4 t -121.65 131.33 73.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.604 0.24 . . . . 0.0 110.696 179.531 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -73.27 135.7 44.49 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.146 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -124.82 -117.08 2.21 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.145 -179.288 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -73.62 144.55 35.83 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.153 1.902 . . . . 0.0 113.056 -178.581 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.424 ' O ' ' CG2' ' B' ' 267' ' ' ILE . 6.3 m170 -102.63 149.36 24.51 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.93 179.602 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -127.22 104.37 22.44 Favored Pre-proline 0 CA--C 1.536 0.437 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.538 -178.759 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.51 ' O ' ' NE2' ' B' ' 265' ' ' GLN . 61.5 Cg_endo -75.25 134.91 17.98 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.359 1.373 . . . . 0.0 112.433 -179.399 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 68.2 mt -88.98 54.27 2.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.341 -178.714 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.3 p -61.21 -20.53 62.89 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.984 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 80.8 mt -84.91 141.08 30.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.451 179.165 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.9 p -67.81 -15.9 63.85 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -178.595 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.513 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 85.6 m -132.52 134.72 45.35 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.071 179.905 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.7 t -127.8 115.78 19.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.226 179.409 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.495 HD21 ' HG2' ' A' ' 47' ' ' GLN . 43.1 tp -114.5 128.68 56.46 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.487 -178.991 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.622 ' CE2' HD12 ' A' ' 37' ' ' ILE . 3.4 m-85 -107.11 136.48 46.88 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.205 179.297 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 163.7 -175.87 39.85 Favored Glycine 0 N--CA 1.467 0.766 0 C-N-CA 120.094 -1.05 . . . . 0.0 112.591 178.88 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.626 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 84.1 mtm-85 -72.34 -30.2 64.52 Favored 'General case' 0 CA--C 1.522 -0.111 0 CA-C-O 121.035 0.445 . . . . 0.0 110.06 179.311 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.511 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -55.77 138.78 43.91 Favored Glycine 0 CA--C 1.523 0.54 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.401 -177.98 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.435 HG23 ' N ' ' A' ' 34' ' ' GLU . 9.4 tp -69.09 -41.15 81.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.84 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.435 ' N ' HG23 ' A' ' 33' ' ' ILE . 52.3 tp10 -54.04 -18.24 3.41 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 178.767 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.511 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 18.7 m -66.81 139.18 57.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.577 -179.769 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.513 ' OD2' ' O ' ' A' ' 26' ' ' THR . 60.5 m-20 -62.47 -34.73 77.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.613 -179.13 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.622 HD12 ' CE2' ' A' ' 29' ' ' PHE . 96.8 mt -127.18 120.84 56.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 177.796 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 51.3 ttt180 -108.39 133.94 51.87 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.26 -179.026 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 79.5 mt -117.49 133.93 62.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.439 -179.657 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -79.45 29.91 0.23 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.466 -178.096 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 41' ' ' LEU . 24.1 mt -98.49 125.82 41.57 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.915 179.39 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.94 -9.07 24.13 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.369 2.046 . . . . 0.0 113.326 -178.749 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.578 HG21 ' CE2' ' B' ' 241' ' ' PHE . 22.0 m -98.94 7.34 8.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.633 -179.797 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.626 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 53.6 t -96.7 135.75 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.809 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.0 m -70.01 171.33 9.68 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.114 0.483 . . . . 0.0 111.638 -179.234 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -61.67 -41.55 97.69 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.405 -179.044 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.633 ' O ' ' N ' ' A' ' 49' ' ' CYS . 97.1 mt-30 -112.5 -18.88 12.31 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 123.384 0.428 . . . . 0.0 110.757 -179.92 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 16.0 t60 36.93 -76.23 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 179.513 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.633 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.12 136.23 48.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.317 0.58 . . . . 0.0 112.121 -178.856 . . . . . . . . 3 3 . 1 . 060 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -126.27 127.98 46.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.259 179.623 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 95.5 mt -116.29 134.36 59.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.998 -179.916 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -114.71 140.3 48.97 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.331 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 50.1 mm -107.66 120.41 58.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.185 -0.606 . . . . 0.0 111.821 -179.11 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.422 ' O ' ' N ' ' A' ' 56' ' ' GLN . 98.5 m-70 -123.68 133.36 53.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.661 178.488 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 54' ' ' HIS . 98.7 mt-10 -39.56 -31.81 0.11 Allowed 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.415 -0.514 . . . . 0.0 109.938 -178.261 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.422 ' N ' ' O ' ' A' ' 54' ' ' HIS . 85.9 mt-30 -63.2 -67.82 0.39 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.476 178.894 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.424 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 7.1 tp10 -152.22 -153.54 0.49 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.529 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.432 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -131.71 134.14 45.59 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.644 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.3 mt -119.14 130.61 73.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -178.262 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.684 HD22 ' CD1' ' A' ' 88' ' ' ILE . 26.3 tp -95.7 127.46 41.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.754 179.201 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -114.4 138.23 50.82 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.596 -179.409 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.428 ' C ' ' OD1' ' A' ' 62' ' ' ASN . 55.6 t-20 -96.08 106.2 18.35 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -178.54 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -101.56 -12.16 18.7 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.947 0.403 . . . . 0.0 110.038 178.425 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.13 104.78 3.72 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.369 179.613 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.5 p -88.29 -19.49 26.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.164 0.506 . . . . 0.0 109.831 179.648 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.66 -44.49 12.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.783 -179.874 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 -140.62 98.3 7.18 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.181 -179.715 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -54.91 143.99 69.51 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.279 1.986 . . . . 0.0 112.673 -179.614 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.1 m -70.28 136.57 49.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.117 179.32 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -101.72 141.1 35.1 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.442 179.937 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.686 HG13 ' OD1' ' A' ' 86' ' ' ASP . 51.6 t -126.15 136.21 61.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.649 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 51.27 33.61 10.06 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -179.821 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.41 28.42 71.27 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.162 -179.968 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.5 t -140.18 138.34 35.08 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.259 -179.727 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 64.1 t -69.3 131.82 33.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.896 -179.34 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.3 100.39 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.765 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -84.33 -16.42 43.02 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.972 -179.013 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.23 160.82 29.82 Favored Pre-proline 0 C--O 1.219 -0.524 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.238 179.866 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -58.24 142.27 97.24 Favored 'Trans proline' 0 N--CA 1.502 1.989 0 C-N-CA 121.932 1.755 . . . . 0.0 112.968 -179.151 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.3 p -142.15 141.08 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 120.996 0.427 . . . . 0.0 111.459 179.575 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -74.52 131.05 40.67 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.41 179.492 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.432 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 96.7 mt -83.46 136.86 34.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.171 0.51 . . . . 0.0 110.96 -179.984 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -128.22 151.2 49.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.152 -179.785 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.459 ' ND1' ' OD1' ' A' ' 99' ' ' ASN . 4.6 t60 -53.45 120.21 5.8 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.383 -179.209 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.13 -15.7 27.92 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -179.34 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.686 ' OD1' HG13 ' A' ' 71' ' ' VAL . 65.4 t0 -73.75 124.9 26.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.007 0.432 . . . . 0.0 110.245 179.753 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.448 HG22 ' HA ' ' A' ' 96' ' ' ARG . 26.2 t -104.57 133.38 48.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.127 -178.953 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.684 ' CD1' HD22 ' A' ' 60' ' ' LEU . 33.1 mm -90.08 130.91 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.1 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.5 m -121.56 126.28 48.76 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -177.84 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.524 ' O ' ' N ' ' A' ' 92' ' ' ASP . 91.9 mt -115.75 125.3 72.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.843 178.612 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.518 HG23 ' SG ' ' B' ' 237' ' ' CYS . 42.1 mm 35.66 -93.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.974 179.261 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 90' ' ' ILE . 28.1 t70 -122.85 19.29 10.18 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.745 0.307 . . . . 0.0 111.294 -179.711 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.499 ' HG3' HH22 ' B' ' 245' ' ' ARG . 99.1 mtt180 -129.75 145.22 51.56 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.443 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 60.8 p -140.63 157.04 46.04 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 119.634 -0.826 . . . . 0.0 111.35 -179.95 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.65 ' HB3' HD11 ' A' ' 7' ' ' LEU . 46.6 m-85 -125.87 122.13 35.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.894 179.893 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.509 ' O ' HD12 ' A' ' 7' ' ' LEU . 52.2 ttt85 -82.49 128.5 34.34 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.582 -179.757 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -96.54 127.79 42.86 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.739 179.871 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -134.22 124.52 26.1 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.639 179.888 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.459 ' OD1' ' ND1' ' A' ' 84' ' ' HIS . 46.6 p30 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.71 -179.863 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo . . . . . 0 N--CA 1.485 1.024 0 CA-C-O 121.173 0.406 . . . . 0.0 112.562 . . . . . . . . . 0 0 . 1 . 060 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.487 HG13 ' O ' ' B' ' 236' ' ' VAL . 3.0 p -101.55 125.95 55.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.722 -179.814 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . 0.518 ' SG ' HG23 ' A' ' 91' ' ' ILE . 32.1 t . . . . . 0 N--CA 1.453 -0.314 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.533 179.689 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo . . . . . 0 N--CA 1.494 1.533 0 CA-C-O 120.75 0.229 . . . . 0.0 111.801 . . . . . . . . . 0 0 . 1 . 060 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 96.7 m -71.95 -43.89 64.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.582 0.706 . . . . 0.0 109.334 178.13 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.578 ' CE2' HG21 ' A' ' 43' ' ' VAL . 80.8 t80 -57.85 -46.15 85.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.172 -179.44 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 89.0 mt -63.73 -42.19 97.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.541 -179.634 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -64.85 -40.01 94.48 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.412 -179.254 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -61.71 -44.98 95.89 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.073 -179.458 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.499 HH22 ' HG3' ' A' ' 93' ' ' ARG . 79.9 mtp180 -63.2 -40.42 97.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.36 -179.475 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.95 -39.69 95.4 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.924 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 75.2 m -64.06 -45.03 90.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.35 177.942 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 -61.58 -37.31 83.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.786 -179.761 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 39.1 t . . . . . 0 C--N 1.332 -0.17 0 C-N-CA 119.951 -0.699 . . . . 0.0 109.263 178.644 . . . . . . . . 0 0 . 1 . 060 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 . . . . . 0 CA--C 1.53 0.196 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 . . . . . . . . . 0 0 . 1 . 060 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.459 HD12 ' CG2' ' A' ' 9' ' ' THR . 95.7 mt -103.76 137.42 32.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 177.909 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 69.2 t -125.38 132.44 71.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 120.421 -0.511 . . . . 0.0 110.544 -178.715 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -97.71 122.61 40.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.2 0.524 . . . . 0.0 111.734 -178.365 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -69.26 -42.8 75.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.551 179.899 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . 0.51 ' NE2' ' O ' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -88.06 161.21 44.41 Favored Pre-proline 0 CA--C 1.518 -0.269 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.933 -178.328 . . . . . . . . 3 3 . 1 . 060 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -59.23 145.68 97.0 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 121.973 1.782 . . . . 0.0 109.924 178.633 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . 0.424 ' CG2' ' O ' ' A' ' 19' ' ' HIS . 4.3 mt . . . . . 0 C--N 1.326 -0.443 0 C-N-CA 119.946 -0.702 . . . . 0.0 110.953 -178.081 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 26.0 m . . . . . 0 N--CA 1.463 0.177 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 . . . . . . . . . 0 0 . 1 . 061 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.724 ' NH1' ' HB2' ' A' ' 58' ' ' ALA . 99.8 mtt180 -98.33 136.34 38.64 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.21 -177.667 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.1 mtm-85 -138.25 150.19 46.45 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.808 -179.807 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.633 HD11 HD11 ' A' ' 22' ' ' LEU . 84.5 mt -115.0 143.43 45.2 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.744 -179.908 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.4 t -115.97 127.66 73.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.338 179.07 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 m -77.85 134.16 38.02 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.647 0.737 . . . . 0.0 112.156 -178.888 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.515 ' CD1' ' OD1' ' A' ' 16' ' ' ASP . 50.5 mm -104.47 134.23 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 114.653 -1.158 . . . . 0.0 107.943 177.086 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -96.67 159.81 14.73 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.197 0.522 . . . . 0.0 111.103 -179.246 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.421 ' CB ' HG21 ' B' ' 249' ' ' VAL . 84.7 mtt-85 -57.52 -31.1 65.71 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.111 -178.84 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.421 ' OG ' HG22 ' A' ' 15' ' ' VAL . 80.2 p -72.97 -15.15 61.55 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.808 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.7 17.04 46.42 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.647 179.948 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.421 HG22 ' OG ' ' A' ' 13' ' ' SER . 4.3 m -108.15 139.72 29.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.127 0.489 . . . . 0.0 110.632 -179.845 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.515 ' OD1' ' CD1' ' A' ' 10' ' ' ILE . 99.0 m-20 -76.76 138.5 39.95 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.953 179.849 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -128.48 -117.72 2.04 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 120.193 -1.003 . . . . 0.0 111.653 -179.774 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -74.73 151.58 41.16 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.6 2.2 . . . . 0.0 112.635 -179.126 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -111.17 144.32 40.5 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.265 179.28 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.561 ' CD2' HD11 ' A' ' 37' ' ' ILE . 38.8 t80 -108.28 94.64 13.76 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.582 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.83 137.3 29.4 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 121.169 1.246 . . . . 0.0 111.855 -178.795 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.633 HD11 HD11 ' A' ' 7' ' ' LEU . 97.9 mt -93.18 107.75 19.5 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.144 0.497 . . . . 0.0 111.419 -178.755 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 94.4 p -111.53 -6.34 14.43 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.348 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 70.7 mt -104.32 146.69 28.44 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.764 -179.739 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 83.8 p -66.32 -16.56 64.14 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.75 -178.754 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 29.8 m -132.9 134.16 44.22 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.939 -179.43 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.629 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 9.2 t -127.39 120.77 29.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.881 178.839 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.444 HD21 ' OE1' ' A' ' 47' ' ' GLN . 32.0 tp -118.5 128.46 54.61 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.788 0.328 . . . . 0.0 111.38 -178.428 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.74 ' CE2' HD12 ' A' ' 37' ' ' ILE . 14.5 m-85 -105.15 140.15 38.75 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.561 179.12 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 153.38 -179.58 29.63 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 119.944 -1.122 . . . . 0.0 112.637 178.537 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.499 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 45.3 mtm180 -70.04 -33.05 71.47 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.03 0.443 . . . . 0.0 110.637 178.516 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.57 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -52.96 141.31 29.44 Favored Glycine 0 CA--C 1.521 0.449 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.95 -178.401 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.648 HG23 ' NH2' ' A' ' 38' ' ' ARG . 78.7 mt -63.05 -43.05 98.8 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.162 178.974 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.406 ' HA ' ' NZ ' ' B' ' 264' ' ' LYS . 97.2 mt-10 -51.1 -18.85 0.93 Allowed 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.403 -0.519 . . . . 0.0 109.666 179.67 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.57 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 23.0 m -67.26 122.58 18.18 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.163 -179.527 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -57.05 -22.86 42.39 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -179.534 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.74 HD12 ' CE2' ' A' ' 29' ' ' PHE . 84.2 mt -130.98 118.28 40.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.987 177.904 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.648 ' NH2' HG23 ' A' ' 33' ' ' ILE . 57.4 mtt180 -99.74 133.5 44.0 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.29 -179.022 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 97.4 mt -116.81 126.93 74.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 120.417 -0.513 . . . . 0.0 109.999 179.339 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -75.27 42.64 0.2 Allowed 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -177.104 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.686 HD21 ' OE1' ' B' ' 260' ' ' GLU . 85.4 mt -118.43 131.48 24.22 Favored Pre-proline 0 C--N 1.326 -0.451 0 C-N-CA 120.521 -0.472 . . . . 0.0 111.098 179.657 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.41 -10.32 23.81 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 122.235 1.957 . . . . 0.0 111.892 179.786 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.443 HG21 ' CE2' ' B' ' 241' ' ' PHE . 19.4 m -96.02 2.69 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.056 179.724 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.499 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 37.3 t -99.44 104.02 15.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.916 0.388 . . . . 0.0 111.262 -179.621 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.471 ' O ' ' O ' ' A' ' 44' ' ' VAL . 5.0 m -37.92 161.35 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.301 0.572 . . . . 0.0 111.108 -179.797 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.3 mttp -63.5 -38.71 92.18 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.82 -179.096 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.599 ' O ' ' N ' ' A' ' 49' ' ' CYS . 96.2 mm-40 -108.9 -25.53 10.71 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.264 0.554 . . . . 0.0 110.417 -179.482 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.411 ' NE2' HG23 ' A' ' 90' ' ' ILE . 18.2 t60 38.67 -76.33 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 179.467 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.599 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.57 135.41 46.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.132 0.492 . . . . 0.0 112.018 -178.162 . . . . . . . . 3 3 . 1 . 061 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -130.14 131.0 45.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.808 179.89 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 91.1 mt -115.53 136.03 53.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.222 179.65 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -118.82 128.9 54.9 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.412 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.52 HG23 ' NH1' ' A' ' 5' ' ' ARG . 97.0 mt -105.67 114.26 44.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.626 -179.508 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.558 ' O ' ' N ' ' A' ' 56' ' ' GLN . 79.7 m-70 -112.22 143.53 43.12 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.336 179.385 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.459 ' C ' ' O ' ' A' ' 54' ' ' HIS . 98.5 mt-10 -40.09 -25.48 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -179.699 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.558 ' N ' ' O ' ' A' ' 54' ' ' HIS . 82.8 mt-30 -67.73 -68.96 0.35 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.407 178.519 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.452 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 4.1 tp10 -160.4 -162.91 1.02 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.724 179.957 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.724 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -111.19 124.41 52.16 Favored 'General case' 0 N--CA 1.461 0.119 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.326 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 79.4 mt -116.58 131.15 70.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.802 -178.36 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.3 tp -96.86 129.83 44.24 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.487 179.836 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -113.13 133.48 55.01 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.235 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.443 ' ND2' ' H ' ' A' ' 69' ' ' THR . 9.6 t-20 -96.26 108.48 20.98 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.496 -179.374 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -99.75 -9.53 22.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.425 179.896 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.9 t -74.17 100.56 3.7 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.508 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.4 m -84.17 -22.7 30.88 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.428 -179.767 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.519 HG22 HG22 ' B' ' 236' ' ' VAL . 0.2 OUTLIER -78.34 -43.72 27.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.147 0.498 . . . . 0.0 110.222 179.993 . . . . . . . . 3 3 . 1 . 061 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.415 ' OD1' ' O ' ' A' ' 66' ' ' THR . 22.8 m-20 -140.88 100.41 6.57 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.749 -179.833 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.583 ' HB2' HG13 ' A' ' 75' ' ' VAL . 32.1 Cg_exo -57.48 147.24 79.56 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 121.954 1.77 . . . . 0.0 112.438 -179.656 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.443 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 10.3 m -74.61 151.74 39.33 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.182 179.234 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -111.23 140.67 45.6 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.267 179.932 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.699 HG13 ' OD1' ' A' ' 86' ' ' ASP . 55.8 t -129.99 134.39 62.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.962 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 52.08 32.0 9.72 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -179.024 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.89 29.12 67.59 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.528 -179.834 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.7 m -141.82 138.5 32.24 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.583 -179.64 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.583 HG13 ' HB2' ' A' ' 68' ' ' PRO . 40.5 t -68.22 140.5 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.208 -179.275 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 9.2 pt -113.0 92.18 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 121.272 0.558 . . . . 0.0 110.164 178.306 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -64.83 -29.37 70.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.98 -179.779 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.423 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.8 OUTLIER -125.28 177.78 1.74 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.986 179.383 . . . . . . . . 3 3 . 1 . 061 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.423 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 36.0 Cg_exo -60.43 145.68 98.24 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 122.527 2.152 . . . . 0.0 112.097 179.814 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.8 p -137.73 141.22 39.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-O 121.166 0.507 . . . . 0.0 111.365 -179.778 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 45.3 ttm180 -79.88 131.97 35.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.711 179.68 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 89.3 mt -84.54 138.39 32.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.899 -179.043 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -130.84 152.57 50.03 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.75 179.065 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -55.88 119.09 5.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.84 0.352 . . . . 0.0 110.817 -179.451 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.57 -9.0 35.01 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.824 -0.911 . . . . 0.0 110.824 -179.675 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.699 ' OD1' HG13 ' A' ' 71' ' ' VAL . 61.0 t0 -75.61 126.58 31.28 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.727 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 39.9 t -107.35 131.07 58.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.788 -179.032 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 87.4 mt -97.0 131.51 43.62 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.396 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.9 m -122.46 125.38 45.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.566 0.698 . . . . 0.0 112.033 -178.429 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.455 ' O ' ' C ' ' A' ' 91' ' ' ILE . 95.7 mt -113.25 124.35 69.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.471 178.912 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.668 HG23 ' SG ' ' B' ' 237' ' ' CYS . 95.0 mt 35.09 -99.95 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 121.166 -0.213 . . . . 0.0 110.527 -178.612 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.518 ' N ' HG22 ' A' ' 91' ' ' ILE . 42.8 t0 -116.41 20.22 14.3 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.025 0.441 . . . . 0.0 110.929 179.745 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.626 ' CZ ' ' CD1' ' A' ' 41' ' ' LEU . 29.9 mtm-85 -130.13 142.34 50.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.473 -179.783 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 30.2 t -140.48 152.4 45.59 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.637 -179.037 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -123.31 122.0 37.24 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.157 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -83.98 134.13 34.66 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.827 -179.496 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -92.81 120.82 33.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.579 179.807 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -123.2 116.54 23.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.018 179.735 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 . . . . . 0 C--N 1.329 -0.305 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.329 179.768 . . . . . . . . 0 0 . 1 . 061 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo . . . . . 0 N--CA 1.488 1.182 0 CA-C-O 121.032 0.347 . . . . 0.0 111.707 . . . . . . . . . 0 0 . 1 . 061 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.519 HG22 HG22 ' A' ' 66' ' ' THR . 42.7 t -61.35 136.36 24.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.628 179.612 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . 0.668 ' SG ' HG23 ' A' ' 91' ' ' ILE . 14.9 t . . . . . 0 C--N 1.328 -0.343 0 C-N-CA 120.493 -0.483 . . . . 0.0 109.737 -179.787 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo . . . . . 0 N--CA 1.499 1.802 0 N-CA-C 113.25 0.442 . . . . 0.0 113.25 . . . . . . . . . 0 0 . 1 . 061 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 20.7 m -72.93 -49.2 30.95 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.299 -0.561 . . . . 0.0 110.091 179.16 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.443 ' CE2' HG21 ' A' ' 43' ' ' VAL . 82.2 t80 -58.08 -47.49 83.01 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.324 -179.066 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 86.8 mt -64.48 -42.18 96.04 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -179.177 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -65.54 -39.36 91.65 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.201 -0.6 . . . . 0.0 111.099 -179.539 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -61.84 -42.88 99.57 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.167 -0.613 . . . . 0.0 109.591 179.784 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -63.07 -41.23 99.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.717 -179.846 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -62.1 -42.66 99.45 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.45 0.643 . . . . 0.0 109.89 179.41 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 67.3 p -67.83 -43.99 78.27 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.245 -0.888 . . . . 0.0 109.129 178.652 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -61.39 -39.49 90.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.388 179.882 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . 0.421 HG21 ' CB ' ' A' ' 12' ' ' ARG . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.087 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.872 179.674 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.686 ' OE1' HD21 ' A' ' 41' ' ' LEU . 96.7 mt-10 . . . . . 0 CA--C 1.531 0.242 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 . . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 80.8 mt -119.46 132.33 69.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.35 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 51.1 t -126.79 135.61 63.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.021 0.439 . . . . 0.0 110.874 -179.69 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -94.59 117.44 30.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.186 0.517 . . . . 0.0 110.78 -179.176 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . 0.406 ' NZ ' ' HA ' ' A' ' 34' ' ' GLU . 88.8 tttt -70.53 -44.23 67.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.79 -179.69 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -94.68 162.18 26.39 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.771 -179.032 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -59.94 151.74 69.52 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.9 2.4 . . . . 0.0 111.588 179.364 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 47.8 pt . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 121.44 0.638 . . . . 0.0 111.827 -178.708 . . . . . . . . 0 0 . 1 . 062 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 30.3 p . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 120.951 0.405 . . . . 0.0 110.629 . . . . . . . . . 0 0 . 1 . 062 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.631 ' NH1' ' HB2' ' A' ' 58' ' ' ALA . 93.7 mtt-85 -91.68 131.2 37.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.819 -179.27 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -135.23 144.62 47.0 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.452 179.312 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.855 HD11 HD11 ' A' ' 22' ' ' LEU . 69.3 mt -119.64 146.46 45.54 Favored 'General case' 0 CA--C 1.527 0.083 0 CA-C-O 121.025 0.44 . . . . 0.0 111.451 -179.389 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.2 t -117.87 129.79 73.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.584 178.9 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.426 HG23 ' CD1' ' B' ' 261' ' ' ILE . 1.9 m -91.35 114.46 27.0 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.933 0.397 . . . . 0.0 111.067 -179.631 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 92.9 mt -81.11 144.66 10.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.282 179.508 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.456 ' HB2' ' H ' ' A' ' 15' ' ' VAL . 71.3 mmtt -84.78 150.76 24.83 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.339 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.613 HH11 HH11 ' B' ' 245' ' ' ARG . 87.8 mtm180 -58.28 -24.99 61.26 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -179.888 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.447 ' HA ' HG11 ' B' ' 249' ' ' VAL . 28.1 t -76.73 -13.03 60.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.876 178.738 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.97 35.27 6.82 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 179.946 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.456 ' H ' ' HB2' ' A' ' 11' ' ' LYS . 48.0 t -121.39 135.6 61.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.734 0.302 . . . . 0.0 110.888 -179.861 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -71.29 118.67 14.38 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.886 179.384 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -111.38 -126.43 4.87 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 120.976 -0.631 . . . . 0.0 111.751 -179.017 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.63 148.68 42.38 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.236 1.958 . . . . 0.0 112.196 -179.239 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -105.77 154.57 20.3 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.647 179.801 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.832 ' CD2' HD11 ' A' ' 37' ' ' ILE . 51.5 t80 -122.44 92.37 49.01 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.1 -179.33 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -74.16 139.92 27.3 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 121.331 1.354 . . . . 0.0 111.557 -179.517 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.855 HD11 HD11 ' A' ' 7' ' ' LEU . 81.3 mt -102.54 125.29 49.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.22 0.533 . . . . 0.0 111.798 -178.176 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 61.6 p -121.71 -2.73 9.31 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.381 -0.827 . . . . 0.0 108.806 178.292 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.9 mt -104.82 147.17 28.02 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.154 -179.203 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 90.6 p -68.63 -17.15 64.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.001 -178.912 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 44.2 m -128.53 131.78 48.27 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.365 0.603 . . . . 0.0 111.997 -179.121 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.683 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -128.52 121.6 29.22 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.188 178.896 . . . . . . . . 3 3 . 1 . 062 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.516 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 42.8 tp -120.76 126.43 50.13 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -178.208 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.683 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 66.0 m-85 -103.08 145.14 30.35 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 178.616 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 155.64 -169.87 33.49 Favored Glycine 0 C--N 1.321 -0.27 0 C-N-CA 119.886 -1.15 . . . . 0.0 112.273 178.611 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 31' ' ' ARG . 33.2 ttp-105 -86.64 -31.11 21.28 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -179.624 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -57.09 152.09 25.24 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-N 116.217 -0.447 . . . . 0.0 112.168 -178.977 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.421 ' CD1' ' CZ ' ' A' ' 38' ' ' ARG . 37.5 mm -63.93 -44.04 97.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-O 120.766 0.317 . . . . 0.0 110.93 179.93 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -55.74 -17.5 6.14 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.095 -179.075 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 83.2 m -64.05 119.65 10.53 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.662 -179.71 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.589 ' OD2' ' SG ' ' A' ' 27' ' ' CYS . 12.0 p-10 -56.54 -24.07 44.26 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.97 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.832 HD11 ' CD2' ' A' ' 20' ' ' PHE . 45.2 mm -126.17 116.33 45.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.1 -0.955 . . . . 0.0 108.761 176.803 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.421 ' CZ ' ' CD1' ' A' ' 33' ' ' ILE . 84.5 mtp180 -100.97 132.24 46.48 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -179.195 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.6 mt -123.08 131.53 73.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.173 0.511 . . . . 0.0 111.058 -179.341 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -81.75 35.18 0.41 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.642 -178.628 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.749 HD11 ' NE ' ' A' ' 93' ' ' ARG . 40.3 mt -100.17 115.72 65.21 Favored Pre-proline 0 C--N 1.325 -0.494 0 C-N-CA 120.388 -0.525 . . . . 0.0 110.391 179.502 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -56.22 -15.4 14.42 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 121.944 1.763 . . . . 0.0 112.421 178.794 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.445 HG23 HG13 ' A' ' 91' ' ' ILE . 25.9 m -98.24 8.32 7.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.556 -179.583 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.7 t -99.21 132.51 44.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.103 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.2 m -71.96 169.06 16.7 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.585 0.707 . . . . 0.0 111.775 -178.829 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -64.78 -40.69 95.67 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.671 -1.15 . . . . 0.0 111.457 -179.076 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.602 ' O ' ' N ' ' A' ' 49' ' ' CYS . 93.7 mm-40 -106.91 -23.86 12.22 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.259 0.552 . . . . 0.0 110.036 179.821 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.6 t60 38.17 -78.46 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.144 -0.935 . . . . 0.0 112.975 179.487 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.602 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.1 OUTLIER -135.36 137.0 41.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.226 0.536 . . . . 0.0 111.767 -178.428 . . . . . . . . 3 3 . 1 . 062 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -124.74 128.22 48.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.603 179.155 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 82.4 mt -111.07 131.49 62.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.852 179.303 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -114.29 132.49 56.15 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.371 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.41 HD12 ' CD ' ' A' ' 5' ' ' ARG . 43.4 mm -103.33 114.32 42.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 120.161 -0.616 . . . . 0.0 111.106 -179.278 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.449 ' O ' ' C ' ' A' ' 55' ' ' GLU . 96.9 m-70 -116.71 137.17 52.39 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.633 179.195 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 54' ' ' HIS . 80.2 mm-40 -39.95 -35.73 0.39 Allowed 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.057 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -60.27 -68.63 0.28 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.013 178.804 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.582 ' OE2' ' NH1' ' A' ' 81' ' ' ARG . 9.5 pt-20 -160.37 -158.46 0.62 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.327 178.88 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.631 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -120.95 133.96 55.29 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.764 0.316 . . . . 0.0 110.917 -179.648 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 87.6 mt -116.83 131.4 69.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.3 0.571 . . . . 0.0 112.457 -178.837 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.495 HD23 HD13 ' A' ' 76' ' ' ILE . 37.5 tp -95.22 126.91 40.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.695 179.833 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -116.0 134.34 55.07 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.668 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -98.96 105.23 17.35 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.787 -179.369 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -96.83 -7.89 32.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.301 179.134 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.96 99.47 6.85 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.069 0.461 . . . . 0.0 110.627 179.906 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 91.5 p -78.39 -33.09 49.04 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.945 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.2 m -66.9 -46.09 75.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.072 -179.351 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.447 HD21 ' HA ' ' B' ' 236' ' ' VAL . 35.2 m-80 -146.05 97.27 4.51 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.835 -179.118 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.536 ' HB2' HG13 ' A' ' 75' ' ' VAL . 51.5 Cg_exo -54.6 146.67 52.58 Favored 'Trans proline' 0 N--CA 1.501 1.958 0 C-N-CA 122.625 2.217 . . . . 0.0 113.585 -179.965 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 93.4 m -72.14 138.74 47.91 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.463 178.669 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -102.35 140.73 36.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.092 -179.918 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.473 ' HB ' HD11 ' A' ' 76' ' ' ILE . 5.6 t -131.36 139.69 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.118 178.568 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 8.9 m120 52.36 32.4 11.04 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.346 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.09 30.23 65.64 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.51 179.185 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.7 m -146.2 143.76 29.47 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 117.659 0.729 . . . . 0.0 111.798 -179.825 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.536 HG13 ' HB2' ' A' ' 68' ' ' PRO . 74.8 t -69.8 138.35 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.235 -179.376 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.536 ' CG2' ' O ' ' A' ' 78' ' ' GLU . 95.6 mt -105.15 100.31 10.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.569 179.744 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -65.94 -39.56 90.58 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.599 179.57 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.536 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.1 OUTLIER -129.63 177.48 2.16 Favored Pre-proline 0 N--CA 1.466 0.374 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.405 -178.989 . . . . . . . . 3 3 . 1 . 062 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.423 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 33.8 Cg_exo -58.93 145.05 98.53 Favored 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 122.56 2.173 . . . . 0.0 112.54 -179.45 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.4 p -142.68 141.32 27.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.508 -179.778 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.582 ' NH1' ' OE2' ' A' ' 57' ' ' GLU . 93.9 mtt-85 -73.85 133.09 43.12 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.613 -179.507 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.447 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 94.3 mt -87.15 139.24 30.77 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.356 0.598 . . . . 0.0 111.76 -179.17 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -130.89 155.36 46.88 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.727 -179.566 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -56.22 118.51 4.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.803 0.335 . . . . 0.0 110.229 -179.748 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.31 -12.52 26.13 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.367 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.46 ' OD1' HG13 ' A' ' 71' ' ' VAL . 48.1 t0 -68.99 128.19 35.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.851 0.358 . . . . 0.0 110.605 179.762 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.429 HG22 ' HG2' ' A' ' 96' ' ' ARG . 53.6 t -109.81 131.84 59.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.78 -178.81 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.4 mm -94.65 127.79 46.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.091 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 53.1 m -118.14 124.93 49.21 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.881 -179.558 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.444 ' O ' ' C ' ' A' ' 91' ' ' ILE . 96.0 mt -122.19 126.18 73.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.26 179.321 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.445 HG13 HG23 ' A' ' 43' ' ' VAL . 31.8 mm 35.87 -109.55 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.01 -179.464 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.411 ' N ' HG22 ' A' ' 91' ' ' ILE . 86.6 m-20 -103.1 11.59 36.94 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.755 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.749 ' NE ' HD11 ' A' ' 41' ' ' LEU . 17.4 ptp180 -130.88 147.25 52.51 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.827 179.822 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 29.8 t -137.07 152.75 50.4 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.736 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.407 ' HE1' HD12 ' A' ' 90' ' ' ILE . 80.5 m-85 -121.35 121.47 37.72 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.73 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.429 ' HG2' HG22 ' A' ' 87' ' ' VAL . 99.3 mtt180 -85.18 129.54 34.78 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.004 -0.679 . . . . 0.0 110.515 -179.112 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.494 ' OH ' ' ND2' ' A' ' 99' ' ' ASN . 24.3 t80 -97.37 122.83 40.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.093 0.473 . . . . 0.0 110.236 179.869 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -121.86 123.26 41.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.062 179.849 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.494 ' ND2' ' OH ' ' A' ' 97' ' ' TYR . 20.6 t-20 . . . . . 0 C--N 1.327 -0.401 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.888 -179.51 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo . . . . . 0 N--CA 1.494 1.517 0 CA-C-O 122.292 0.872 . . . . 0.0 114.041 . . . . . . . . . 0 0 . 1 . 062 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.447 ' HA ' HD21 ' A' ' 67' ' ' ASN . 0.3 OUTLIER -75.1 139.38 19.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 113.939 -1.482 . . . . 0.0 111.017 -179.244 . . . . . . . . 3 3 . 1 . 062 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.9 t . . . . . 0 C--O 1.232 0.152 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.225 -179.975 . . . . . . . . 0 0 . 1 . 062 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo . . . . . 0 N--CA 1.496 1.619 0 N-CA-C 113.164 0.409 . . . . 0.0 113.164 . . . . . . . . . 0 0 . 1 . 062 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 16.7 m -73.14 -47.27 45.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.258 0.551 . . . . 0.0 110.434 179.385 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -57.88 -46.81 84.32 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.633 -178.932 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 96.7 mt -63.55 -42.32 98.37 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.669 -179.241 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -66.1 -39.1 89.71 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.338 -179.668 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . 0.535 ' NH1' ' OE1' ' B' ' 248' ' ' GLN . 78.4 ttt-85 -59.83 -45.72 91.52 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.953 -179.593 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.613 HH11 HH11 ' A' ' 12' ' ' ARG . 95.6 mtt-85 -65.81 -37.14 85.45 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.483 -179.5 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -60.28 -40.65 91.16 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.817 179.667 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 78.2 p -69.97 -43.02 72.36 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.108 0.48 . . . . 0.0 110.103 178.948 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . 0.535 ' OE1' ' NH1' ' B' ' 244' ' ' ARG . 88.0 mt-30 -64.19 -36.69 84.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.321 -179.768 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . 0.562 HG23 ' O ' ' B' ' 245' ' ' ARG . 60.4 t . . . . . 0 C--N 1.329 -0.299 0 C-N-CA 120.356 -0.538 . . . . 0.0 109.912 179.444 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.587 ' CD ' HH12 ' B' ' 245' ' ' ARG . 97.0 mt-10 . . . . . 0 CA--C 1.537 0.457 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 . . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.426 ' CD1' HG23 ' A' ' 9' ' ' THR . 69.8 mt -118.43 132.37 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 178.079 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 52.3 t -124.89 132.74 70.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.232 179.46 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -93.42 117.11 29.68 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.135 0.493 . . . . 0.0 110.897 -178.259 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -67.4 -45.97 74.61 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.393 -179.87 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 25.6 mm100 -88.6 153.34 50.25 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.887 -178.729 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -61.28 147.19 96.25 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.448 2.099 . . . . 0.0 112.253 179.362 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.4 pt . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.282 -179.329 . . . . . . . . 0 0 . 1 . 063 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 46.0 p . . . . . 0 N--CA 1.471 0.599 0 CA-C-O 121.238 0.542 . . . . 0.0 110.368 . . . . . . . . . 0 0 . 1 . 063 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.8 mtt85 -85.92 131.05 34.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.324 -179.592 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -129.09 139.41 52.0 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.348 179.975 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.581 HD12 ' O ' ' A' ' 96' ' ' ARG . 32.7 tp -116.49 133.31 56.16 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.836 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 70.7 t -112.42 131.06 64.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.068 0.461 . . . . 0.0 110.174 -179.293 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.8 m -80.99 144.5 31.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.769 0.795 . . . . 0.0 112.472 -178.236 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.534 ' CD1' ' OD1' ' A' ' 16' ' ' ASP . 48.5 mm -111.86 135.78 50.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.54 178.389 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -93.48 157.95 15.96 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.318 0.58 . . . . 0.0 110.31 178.433 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.486 ' HD3' HH21 ' B' ' 245' ' ' ARG . 88.5 mtm180 -58.02 -23.49 54.42 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.435 -179.514 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 87.7 p -80.08 -13.13 59.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.329 179.913 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.19 20.06 34.07 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.56 179.228 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.4 m -115.65 138.21 46.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.166 179.301 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.534 ' OD1' ' CD1' ' A' ' 10' ' ' ILE . 83.1 m-20 -70.3 139.97 52.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.11 -179.91 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -126.22 -120.21 2.37 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 121.063 -0.589 . . . . 0.0 111.634 -179.638 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.38 146.1 39.33 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.018 1.812 . . . . 0.0 113.117 -178.621 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -104.82 145.64 30.1 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.09 179.468 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.465 ' CD2' HD11 ' A' ' 37' ' ' ILE . 61.3 t80 -119.45 103.5 46.67 Favored Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.496 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -73.64 130.06 14.34 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 121.617 1.544 . . . . 0.0 112.588 -178.433 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.2 mt -85.87 57.05 4.25 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.104 -178.666 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.59 -33.07 74.22 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.479 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.7 mt -74.91 142.5 44.01 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.139 179.791 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.59 -14.98 63.37 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.186 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.529 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 54.4 m -132.13 132.13 42.96 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.842 -179.798 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.5 t -124.57 117.16 23.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.804 178.683 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.472 HD11 ' HB3' ' A' ' 47' ' ' GLN . 32.6 tp -115.44 126.23 54.08 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.447 -178.96 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.81 ' CE2' HD12 ' A' ' 37' ' ' ILE . 4.8 m-85 -107.11 138.92 42.39 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.831 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.13 -168.78 37.29 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 120.071 -1.061 . . . . 0.0 112.577 179.424 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.711 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 83.9 mtm-85 -82.54 -26.68 32.24 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.744 0.307 . . . . 0.0 110.585 -179.753 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.474 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -61.69 134.62 47.13 Favored Glycine 0 N--CA 1.466 0.644 0 C-N-CA 121.354 -0.45 . . . . 0.0 112.349 -178.018 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.449 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.7 tp -62.79 -41.43 92.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.101 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.449 ' N ' HG23 ' A' ' 33' ' ' ILE . 83.8 tt0 -51.87 -16.09 0.64 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.883 179.137 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.474 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 40.8 m -70.54 142.4 51.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.751 179.709 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.529 ' OD2' ' O ' ' A' ' 26' ' ' THR . 59.1 m-20 -60.96 -34.08 74.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.703 -179.736 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.81 HD12 ' CE2' ' A' ' 29' ' ' PHE . 85.1 mt -129.89 124.31 58.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.031 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 70.6 ttp85 -109.63 138.45 45.98 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.18 -179.407 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.495 ' CG2' HD12 ' A' ' 41' ' ' LEU . 97.7 mt -116.6 131.36 69.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.687 -179.433 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -74.82 30.78 0.09 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -178.083 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.616 ' CD1' ' CZ ' ' A' ' 93' ' ' ARG . 17.3 mt -110.36 129.81 23.55 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 120.132 -0.627 . . . . 0.0 111.954 179.921 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.48 -10.38 26.76 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.567 2.178 . . . . 0.0 112.971 -179.878 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.628 HG21 ' CE2' ' B' ' 241' ' ' PHE . 11.7 m -95.83 -1.88 10.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 121.056 -0.258 . . . . 0.0 111.407 -179.827 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.711 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 53.4 t -87.24 135.85 24.34 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.54 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.994 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.525 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 0.6 OUTLIER -62.55 162.39 10.49 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.248 0.547 . . . . 0.0 111.551 -179.183 . . . . . . . . 3 3 . 1 . 063 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -62.57 -45.1 94.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.857 -178.861 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.642 ' O ' ' N ' ' A' ' 49' ' ' CYS . 85.8 mt-30 -113.81 -12.69 12.69 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 123.937 0.773 . . . . 0.0 110.243 179.397 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.525 ' H ' ' HB3' ' A' ' 45' ' ' SER . 10.3 t60 31.01 -72.7 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 179.305 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.642 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.5 135.26 46.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.396 0.617 . . . . 0.0 112.196 -178.233 . . . . . . . . 3 3 . 1 . 063 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -126.92 128.85 47.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.054 179.307 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.2 mt -115.18 134.54 57.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.971 -179.808 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -111.98 131.35 55.45 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.039 179.036 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 51.5 mm -101.55 110.4 28.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 120.144 -0.622 . . . . 0.0 111.015 179.617 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.465 ' O ' ' C ' ' A' ' 55' ' ' GLU . 97.7 m-70 -113.54 135.33 54.01 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.267 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.465 ' C ' ' O ' ' A' ' 54' ' ' HIS . 93.2 mt-10 -41.2 -32.0 0.25 Allowed 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -179.998 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.454 ' N ' ' C ' ' A' ' 54' ' ' HIS . 99.8 mm-40 -65.23 -68.26 0.38 Allowed 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.638 178.402 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.484 ' HG3' ' NE ' ' A' ' 81' ' ' ARG . 1.0 OUTLIER -155.13 -171.84 3.96 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.539 0.685 . . . . 0.0 111.499 -179.638 . . . . . . . . 3 3 . 1 . 063 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -115.24 122.53 46.27 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.477 178.781 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.0 mt -114.55 133.58 60.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.258 0.551 . . . . 0.0 111.675 -178.423 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 21.5 tp -97.6 128.3 44.22 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.779 -179.751 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -110.45 133.61 53.12 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.09 179.689 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.431 HD21 ' HA ' ' A' ' 68' ' ' PRO . 60.8 t-20 -90.88 106.98 18.89 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.193 -179.589 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -97.95 -11.08 23.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.376 179.202 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 54.1 p -74.15 100.74 3.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.043 0.449 . . . . 0.0 110.923 179.82 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.1 p -86.2 -14.26 44.47 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.249 179.542 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.72 -42.98 8.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.954 -179.886 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.462 ' O ' ' OG ' ' A' ' 64' ' ' SER . 34.4 m-80 -136.93 99.3 10.18 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.369 179.887 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.431 ' HA ' HD21 ' A' ' 62' ' ' ASN . 49.2 Cg_exo -54.39 143.86 64.13 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.15 1.9 . . . . 0.0 112.985 -179.585 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.3 m -77.16 141.5 40.11 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.824 179.192 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -107.3 138.8 42.82 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.435 0.636 . . . . 0.0 110.821 179.975 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 66.8 t -131.4 135.07 60.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.494 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 53.84 32.35 14.89 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.035 -0.666 . . . . 0.0 110.398 -179.469 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.18 29.63 66.29 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.8 178.296 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 73.3 m -146.51 138.2 24.64 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.496 -0.482 . . . . 0.0 111.05 179.302 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -69.42 144.26 14.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.974 179.739 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.8 pt -119.14 95.09 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.133 179.048 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 78' ' ' GLU . 49.0 p-10 -71.09 -24.01 62.23 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.254 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.491 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 5.5 mt-10 -118.92 163.96 23.49 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.745 179.545 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -62.23 150.1 88.17 Favored 'Trans proline' 0 N--CA 1.501 1.943 0 C-N-CA 122.656 2.237 . . . . 0.0 112.483 179.78 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.0 p -140.54 143.87 28.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-O 121.478 0.656 . . . . 0.0 112.352 -179.003 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.484 ' NE ' ' HG3' ' A' ' 57' ' ' GLU . 68.2 ttt180 -73.33 126.79 30.95 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.558 179.245 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.0 mt -82.13 132.43 35.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.956 0.407 . . . . 0.0 110.955 -179.623 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -123.57 149.22 45.55 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.706 179.284 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -52.44 121.01 6.22 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.962 -179.249 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.01 -13.67 45.02 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.529 -0.629 . . . . 0.0 111.529 179.676 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -71.21 139.22 50.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.954 0.407 . . . . 0.0 111.095 -179.939 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.7 t -117.92 130.18 73.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.468 -178.5 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 92.7 mt -94.0 131.93 39.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.225 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.8 m -115.91 127.6 55.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.307 0.575 . . . . 0.0 112.252 -178.568 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.511 ' O ' ' C ' ' A' ' 91' ' ' ILE . 93.5 mt -125.87 124.8 67.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.176 178.346 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.537 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 72.2 mt -3.61 89.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -179.856 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.537 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 8.9 t0 86.84 -15.44 0.44 Allowed 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 177.158 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.751 ' NH1' HH22 ' B' ' 245' ' ' ARG . 23.3 mtm-85 -131.27 145.82 52.05 Favored 'General case' 0 CA--C 1.512 -0.519 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.698 -179.127 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.8 p -138.0 156.13 48.15 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 121.134 0.493 . . . . 0.0 110.164 179.567 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.56 ' HB3' HD11 ' A' ' 7' ' ' LEU . 91.2 m-85 -130.08 122.12 27.71 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.536 -179.292 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.581 ' O ' HD12 ' A' ' 7' ' ' LEU . 44.5 ttm180 -84.66 128.62 34.7 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 120.446 -0.502 . . . . 0.0 111.202 -179.616 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 92.9 t80 -91.88 125.33 36.54 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.616 179.947 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -126.5 121.22 31.73 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.807 179.539 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 . . . . . 0 C--N 1.329 -0.292 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.393 . . . . . . . . 0 0 . 1 . 063 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo . . . . . 0 N--CA 1.492 1.392 0 CA-C-O 121.028 0.345 . . . . 0.0 111.787 . . . . . . . . . 0 0 . 1 . 063 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 2.4 p -114.03 135.74 52.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.129 179.746 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . 0.463 ' HB2' HD13 ' A' ' 91' ' ' ILE . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 121.18 0.514 . . . . 0.0 110.071 -179.878 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo . . . . . 0 N--CA 1.49 1.287 0 N-CA-C 112.257 0.06 . . . . 0.0 112.257 . . . . . . . . . 0 0 . 1 . 063 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 27.4 p -77.08 -39.67 48.92 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.24 178.274 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.628 ' CE2' HG21 ' A' ' 43' ' ' VAL . 80.2 t80 -58.99 -47.04 86.58 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.934 -179.798 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 80.2 mt -67.27 -39.63 86.08 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.127 179.033 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -65.22 -40.88 94.69 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.824 -178.903 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 78.1 ttt-85 -63.01 -43.67 98.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 120.431 -0.507 . . . . 0.0 110.557 -179.553 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.751 HH22 ' NH1' ' A' ' 93' ' ' ARG . 85.6 mtp180 -64.53 -37.32 87.15 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.678 -178.894 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.27 -40.15 96.59 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.095 178.811 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 44.6 t -64.07 -44.18 93.18 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.701 0.763 . . . . 0.0 109.211 178.499 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -62.41 -36.32 81.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.263 179.727 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . 0.601 HG23 ' O ' ' B' ' 245' ' ' ARG . 60.0 t . . . . . 0 C--N 1.327 -0.382 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.307 179.708 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 . . . . . 0 C--O 1.227 -0.127 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 . . . . . . . . . 0 0 . 1 . 063 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.516 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 64.1 mt -108.46 135.13 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.735 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 78.4 t -127.98 136.45 60.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.913 0.387 . . . . 0.0 109.961 -179.684 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -99.68 121.11 40.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.42 -178.398 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -66.52 -45.51 79.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.932 179.217 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.41 152.2 47.21 Favored Pre-proline 0 CA--C 1.52 -0.199 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.283 -179.448 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -62.5 140.51 82.21 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.754 2.303 . . . . 0.0 112.234 -179.831 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 41.8 pt . . . . . 0 C--N 1.322 -0.599 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.01 179.14 . . . . . . . . 0 0 . 1 . 064 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 60.1 p . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.858 0.361 . . . . 0.0 110.642 . . . . . . . . . 0 0 . 1 . 064 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.9 mtt85 -90.65 126.84 36.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.505 -179.676 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -135.95 146.43 47.27 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.384 -0.526 . . . . 0.0 111.688 -179.646 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.858 HD11 HD11 ' A' ' 22' ' ' LEU . 73.3 mt -114.41 142.83 45.85 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.021 179.358 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.2 t -118.31 130.34 73.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.195 179.686 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 50.0 m -79.22 135.44 36.79 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.294 0.569 . . . . 0.0 111.956 -178.843 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.6 mt -112.51 138.11 42.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.301 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -91.71 157.15 17.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.089 0.471 . . . . 0.0 111.507 -179.009 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 85.7 mtm-85 -58.27 -24.42 59.36 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.6 -178.623 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 86.2 p -84.78 -7.92 59.02 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.261 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.44 38.8 6.53 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.82 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.9 t -122.14 134.54 65.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.897 0.38 . . . . 0.0 111.416 -179.709 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -77.09 122.53 25.1 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.705 179.824 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -114.75 -122.85 3.68 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.657 -179.435 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.38 148.99 34.56 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.406 2.071 . . . . 0.0 112.914 -178.985 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -103.97 153.8 20.4 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.919 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.465 ' CD2' HD11 ' A' ' 37' ' ' ILE . 47.0 t80 -124.23 91.15 49.96 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.245 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.0 139.71 36.5 Favored 'Trans proline' 0 C--N 1.315 -1.191 0 C-N-CA 121.253 1.302 . . . . 0.0 111.785 -179.299 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.858 HD11 HD11 ' A' ' 7' ' ' LEU . 83.1 mt -101.23 122.53 43.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.265 0.555 . . . . 0.0 111.187 -178.866 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.6 p -117.76 -6.74 11.05 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.47 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 67.2 mt -102.79 148.31 25.77 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.555 -179.623 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.9 m -72.53 -14.49 61.66 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.438 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.417 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 31.5 m -127.92 129.42 46.81 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.411 -179.799 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.2 t -123.91 119.34 29.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.272 178.268 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.5 tp -116.3 130.23 56.67 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.94 0.4 . . . . 0.0 111.355 -178.084 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.786 ' CE2' HD12 ' A' ' 37' ' ' ILE . 5.7 m-85 -109.4 138.98 44.94 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.011 -179.897 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 148.08 -171.83 28.48 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.081 178.944 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.412 ' HD2' HH11 ' A' ' 31' ' ' ARG . 47.6 mtm180 -79.1 -32.75 44.74 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 -179.919 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.557 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -45.32 147.63 1.85 Allowed Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 -178.751 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 36.2 mm -63.88 -43.51 97.82 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 CA-C-O 120.921 0.391 . . . . 0.0 110.149 179.958 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -56.87 -21.25 28.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.955 -179.654 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.557 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 59.7 m -52.87 115.16 1.69 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.133 -179.667 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.417 ' OD2' ' O ' ' A' ' 26' ' ' THR . 79.3 m-20 -57.16 -21.6 34.07 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -179.697 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.786 HD12 ' CE2' ' A' ' 29' ' ' PHE . 98.9 mt -132.25 122.24 47.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.124 -0.943 . . . . 0.0 109.334 177.037 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -104.77 135.94 45.22 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 -179.791 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.412 HD13 ' HE ' ' A' ' 93' ' ' ARG . 95.1 mt -115.26 127.72 72.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.615 -179.99 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -69.94 40.08 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -177.361 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.64 ' CD1' ' NH1' ' A' ' 93' ' ' ARG . 20.5 mt -124.18 132.32 24.29 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.957 -179.934 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.08 -7.2 19.57 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.679 2.252 . . . . 0.0 112.931 -179.509 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.492 HG21 ' CE2' ' B' ' 241' ' ' PHE . 17.2 m -99.8 2.25 10.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.685 179.53 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 29.4 t -87.94 136.54 22.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.345 179.526 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.2 m -65.9 157.2 31.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.182 0.515 . . . . 0.0 111.179 -179.659 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -62.74 -43.65 98.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.161 -178.888 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.638 ' O ' ' N ' ' A' ' 49' ' ' CYS . 96.7 mt-30 -113.99 -15.0 12.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.957 0.408 . . . . 0.0 110.511 179.677 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 18.3 t60 28.38 -74.86 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 178.875 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.638 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -128.23 133.96 48.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.258 0.552 . . . . 0.0 112.436 -178.666 . . . . . . . . 3 3 . 1 . 064 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -127.63 131.05 49.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.122 179.17 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.4 mt -115.39 133.63 61.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.894 -179.56 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -113.84 123.01 48.77 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.345 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.0 mt -105.62 113.8 43.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.448 0.642 . . . . 0.0 111.778 -178.662 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.422 ' O ' ' N ' ' A' ' 56' ' ' GLN . 82.2 m-70 -114.6 144.44 43.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.592 179.783 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 54' ' ' HIS . 78.2 mm-40 -41.07 -29.5 0.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.02 -179.02 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.422 ' N ' ' O ' ' A' ' 54' ' ' HIS . 95.7 mt-30 -64.73 -68.93 0.32 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.031 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.1 -166.1 1.99 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.061 179.86 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.42 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -113.29 127.89 56.29 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.324 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.5 mt -115.52 127.88 72.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.098 0.475 . . . . 0.0 111.795 -179.211 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.541 ' HB2' HD11 ' A' ' 82' ' ' LEU . 24.8 tp -97.42 126.95 42.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.043 179.596 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -111.2 135.33 51.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.858 179.925 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.563 ' ND2' ' H ' ' A' ' 69' ' ' THR . 22.0 t-20 -98.83 106.9 19.22 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.974 -179.705 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -95.09 -6.64 41.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.534 178.994 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.5 t -71.65 99.84 2.18 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.493 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 79.0 p -87.21 -16.52 35.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.275 179.823 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.495 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -90.72 -42.82 10.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.278 -179.806 . . . . . . . . 3 3 . 1 . 064 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.405 HD21 ' HA ' ' B' ' 236' ' ' VAL . 56.8 m-20 -139.25 97.96 8.42 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.983 -179.802 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -56.67 146.0 78.95 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 122.321 2.014 . . . . 0.0 113.156 -179.435 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.563 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 2.9 m -76.68 149.95 36.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.59 179.492 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -110.77 140.03 45.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.154 -179.653 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.666 HG13 ' OD1' ' A' ' 86' ' ' ASP . 60.6 t -131.09 135.3 60.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.386 -0.824 . . . . 0.0 108.87 179.624 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 51.59 33.35 10.51 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 119.834 -0.747 . . . . 0.0 109.103 -179.835 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.3 25.96 71.65 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.066 179.531 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 67.6 m -142.18 139.91 32.22 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 117.503 0.651 . . . . 0.0 111.561 179.948 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -68.13 143.91 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.185 179.897 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.475 HG21 HG21 ' A' ' 80' ' ' VAL . 5.4 pt -116.05 94.38 3.08 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-O 121.166 0.507 . . . . 0.0 110.479 179.111 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -67.21 -25.83 66.31 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.739 179.762 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.478 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.1 OUTLIER -129.98 179.73 1.24 Allowed Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.818 -179.876 . . . . . . . . 3 3 . 1 . 064 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.478 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 23.8 Cg_exo -62.06 146.83 96.02 Favored 'Trans proline' 0 N--CA 1.5 1.878 0 C-N-CA 123.087 2.524 . . . . 0.0 112.703 -179.379 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.475 HG21 HG21 ' A' ' 76' ' ' ILE . 2.4 m -142.41 137.97 29.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.813 -179.748 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 85.2 mtt85 -73.33 129.35 37.83 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.258 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.541 HD11 ' HB2' ' A' ' 60' ' ' LEU . 95.3 mt -83.17 137.6 33.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.942 0.401 . . . . 0.0 110.493 179.987 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -131.49 156.7 45.2 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.614 -179.883 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.585 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 3.6 t-160 -59.07 118.64 6.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.029 0.442 . . . . 0.0 110.115 -179.899 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.12 -8.0 35.61 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 -179.046 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.666 ' OD1' HG13 ' A' ' 71' ' ' VAL . 64.4 t0 -77.2 126.99 31.84 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.478 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 13.0 p -107.16 137.47 37.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.471 -178.897 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 83.3 mt -103.9 128.22 57.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.502 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.5 m -123.17 126.56 47.23 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 121.624 0.726 . . . . 0.0 112.82 -178.243 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.474 ' O ' ' C ' ' A' ' 91' ' ' ILE . 97.9 mt -117.51 126.88 74.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.988 178.547 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.542 HG22 ' N ' ' A' ' 92' ' ' ASP . 96.8 mt 32.79 -98.73 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.669 -179.499 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.542 ' N ' HG22 ' A' ' 91' ' ' ILE . 97.6 m-20 -112.13 12.1 20.45 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -179.84 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.64 ' NH1' ' CD1' ' A' ' 41' ' ' LEU . 39.6 mtm-85 -126.19 142.55 51.48 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 120.984 -0.287 . . . . 0.0 110.441 -179.499 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 43.7 t -138.55 149.57 45.46 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.706 179.92 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.624 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 96.8 m-85 -121.0 121.2 37.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.038 178.558 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 55.3 ttt85 -84.45 131.03 34.71 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.546 -0.462 . . . . 0.0 109.766 -179.774 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -90.38 122.52 33.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.402 -179.753 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -124.24 120.64 32.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.843 0.354 . . . . 0.0 110.836 179.893 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.585 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 62.8 t-20 . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.221 179.688 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo . . . . . 0 N--CA 1.486 1.054 0 CA-C-O 121.248 0.436 . . . . 0.0 112.331 . . . . . . . . . 0 0 . 1 . 064 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.495 ' CG2' HG22 ' A' ' 66' ' ' THR . 49.8 t -65.5 135.68 27.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.714 -179.623 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.7 t . . . . . 0 CA--C 1.52 -0.191 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.723 . . . . . . . . 0 0 . 1 . 064 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo . . . . . 0 N--CA 1.5 1.867 0 N-CA-C 113.668 0.603 . . . . 0.0 113.668 . . . . . . . . . 0 0 . 1 . 064 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 39.8 p -73.47 -38.59 65.39 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.977 179.182 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.492 ' CE2' HG21 ' A' ' 43' ' ' VAL . 77.6 t80 -58.09 -48.14 81.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.845 -179.004 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.402 HD22 ' OD1' ' A' ' 92' ' ' ASP . 98.0 mt -67.71 -42.36 82.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.884 0.373 . . . . 0.0 111.674 -179.687 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -63.25 -45.16 92.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.884 -178.62 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -63.53 -43.82 96.05 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.841 0.353 . . . . 0.0 111.141 -179.527 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.445 ' O ' HG23 ' B' ' 249' ' ' VAL . 48.5 ttm-85 -65.27 -41.9 93.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.469 -179.334 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -63.4 -39.02 93.36 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.179 179.159 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 20.3 m -65.12 -42.64 93.74 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 177.895 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 63.6 tp60 -59.63 -35.41 74.31 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.53 -1.213 . . . . 0.0 110.179 179.493 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . 0.445 HG23 ' O ' ' B' ' 245' ' ' ARG . 49.9 t . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.873 0.368 . . . . 0.0 110.227 178.926 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 . . . . . 0 N--CA 1.455 -0.181 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 064 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.624 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 70.6 mt -115.47 134.48 58.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.168 179.94 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 54.6 t -124.16 132.91 70.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.725 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -94.54 119.02 32.57 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.387 0.613 . . . . 0.0 111.612 -177.88 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -66.83 -46.48 74.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.287 179.68 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -72.85 166.44 43.05 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.181 -179.25 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -64.26 141.26 74.65 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 121.569 1.513 . . . . 0.0 111.282 179.878 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 11.9 tt . . . . . 0 C--N 1.324 -0.517 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.34 -178.869 . . . . . . . . 0 0 . 1 . 065 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.408 ' OG1' ' N ' ' A' ' 5' ' ' ARG . 6.6 p . . . . . 0 CA--C 1.518 -0.256 0 CA-C-O 121.302 0.572 . . . . 0.0 110.326 . . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.408 ' N ' ' OG1' ' A' ' 4' ' ' THR . 85.3 mtt85 -94.21 128.24 40.54 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.816 -179.885 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -132.86 144.33 50.12 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.389 -0.525 . . . . 0.0 111.354 -179.345 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 79.9 mt -115.41 145.59 42.4 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.669 179.633 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.641 HG22 ' CD2' ' A' ' 19' ' ' HIS . 49.7 t -118.48 130.18 73.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.855 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 m -90.66 117.04 29.0 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.308 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.595 HD12 ' OG ' ' A' ' 94' ' ' SER . 96.0 mt -86.94 142.36 13.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.305 177.724 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -95.16 169.73 9.89 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.869 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.411 ' NH1' ' HB3' ' B' ' 248' ' ' GLN . 88.9 mtm180 -56.96 -29.6 63.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.8 -178.784 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.6 t -81.11 -7.35 59.54 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.757 179.295 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.27 40.19 8.67 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 -178.892 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.8 t -116.64 134.06 61.32 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.076 0 CA-C-O 120.832 0.349 . . . . 0.0 111.602 -178.713 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.468 ' C ' ' OD1' ' A' ' 16' ' ' ASP . 39.4 t0 -77.64 124.36 27.84 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.138 179.448 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -124.09 -115.56 2.16 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 120.655 -0.784 . . . . 0.0 111.408 179.94 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -72.95 144.21 37.94 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.153 1.902 . . . . 0.0 113.621 -178.808 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.641 ' CD2' HG22 ' A' ' 8' ' ' VAL . 50.9 m170 -106.05 142.41 35.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.275 179.781 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.435 ' HD1' HG22 ' B' ' 267' ' ' ILE . 45.5 t80 -114.2 93.02 29.12 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.221 -179.571 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -69.07 135.15 31.31 Favored 'Trans proline' 0 N--CA 1.488 1.187 0 C-N-CA 121.51 1.474 . . . . 0.0 111.668 -179.537 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.474 HD22 ' HB2' ' A' ' 27' ' ' CYS . 92.4 mt -84.84 80.31 9.32 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.187 -178.699 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 85.6 p -82.33 -10.85 58.93 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.078 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 58.0 mt -103.85 144.66 31.21 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.401 -179.202 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.8 t -67.5 -14.84 63.29 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.968 -179.856 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.548 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 89.2 m -131.38 133.69 45.52 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 120.696 -0.401 . . . . 0.0 111.395 -179.809 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.595 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 13.2 t -125.27 116.14 21.48 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.632 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.531 HD12 ' O ' ' A' ' 49' ' ' CYS . 43.4 tp -115.23 131.29 56.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.29 -178.161 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.607 ' CE2' HD12 ' A' ' 37' ' ' ILE . 23.3 m-85 -109.38 136.91 48.04 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.632 178.943 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 154.22 -177.19 31.76 Favored Glycine 0 C--O 1.221 -0.677 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.778 178.804 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.477 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 46.4 mtm180 -77.47 -31.08 53.48 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.646 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.508 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -51.33 150.55 6.85 Favored Glycine 0 N--CA 1.465 0.582 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.395 -178.327 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.551 HG23 ' N ' ' A' ' 34' ' ' GLU . 11.0 tp -66.44 -41.62 89.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.646 0.26 . . . . 0.0 110.533 179.967 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.551 ' N ' HG23 ' A' ' 33' ' ' ILE . 81.0 mm-40 -55.72 -24.23 33.61 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.347 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.508 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 39.0 m -53.3 118.04 3.51 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.823 179.971 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.548 ' OD2' ' O ' ' A' ' 26' ' ' THR . 93.2 m-20 -59.14 -27.99 66.15 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.855 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.607 HD12 ' CE2' ' A' ' 29' ' ' PHE . 97.9 mt -127.53 119.12 51.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 176.479 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.472 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 82.9 mtp180 -102.2 134.82 44.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.901 0.382 . . . . 0.0 111.901 -178.439 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.0 mt -122.02 130.05 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.114 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.693 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -82.93 34.36 0.45 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.001 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.715 HD11 ' CZ ' ' A' ' 93' ' ' ARG . 31.3 mt -95.65 129.03 35.71 Favored Pre-proline 0 C--N 1.325 -0.477 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.33 179.458 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.17 -12.16 27.62 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 C-N-CA 122.218 1.945 . . . . 0.0 112.361 -179.616 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.4 m -98.08 5.73 9.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.872 0.368 . . . . 0.0 110.495 -179.949 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.477 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 37.4 t -98.82 135.11 35.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.414 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.43 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 6.9 t -70.34 174.68 5.37 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.229 0.538 . . . . 0.0 111.233 -179.031 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 50.4 mttp -64.03 -41.01 97.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.1 -179.926 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.628 ' O ' ' N ' ' A' ' 49' ' ' CYS . 85.6 mt-30 -112.85 -20.08 11.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.919 -179.272 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.43 ' H ' ' HB3' ' A' ' 45' ' ' SER . 28.2 t60 39.17 -76.8 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 179.751 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.628 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.2 133.46 46.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.306 -178.548 . . . . . . . . 3 3 . 1 . 065 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -127.35 130.57 49.69 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.541 179.34 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 86.2 mt -115.98 134.86 57.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.812 -179.826 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.516 ' CD ' ' NE2' ' A' ' 54' ' ' HIS . 74.6 tt0 -120.47 125.8 48.81 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.791 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 93.9 mt -106.56 119.08 55.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.567 0.698 . . . . 0.0 112.26 -179.009 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.516 ' NE2' ' CD ' ' A' ' 52' ' ' GLU . 99.6 m-70 -112.36 140.34 47.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.605 -1.179 . . . . 0.0 108.959 178.961 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.9 mm-40 -40.78 -28.02 0.07 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 -179.86 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.462 ' N ' ' O ' ' A' ' 54' ' ' HIS . 82.3 mt-30 -65.88 -68.04 0.4 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.434 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -154.14 -171.51 3.9 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.382 -179.613 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.454 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -110.16 128.99 55.78 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.497 -0.556 . . . . 0.0 109.497 179.021 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 98.0 mt -119.02 130.96 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -178.752 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 32.1 tp -99.33 131.7 45.17 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.003 179.277 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -114.55 136.44 53.02 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.072 179.197 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -97.81 111.09 23.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.187 0.518 . . . . 0.0 111.651 -179.543 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -104.8 -10.37 17.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.484 179.91 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.4 101.46 12.02 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.491 -179.813 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 77.8 p -76.19 -35.57 59.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.257 0.551 . . . . 0.0 109.903 179.244 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.01 -43.02 99.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.285 -178.827 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -147.25 99.77 3.9 Favored Pre-proline 0 C--N 1.317 -0.834 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.484 -179.034 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -57.55 146.46 84.02 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 C-N-CA 121.783 1.656 . . . . 0.0 112.681 -178.78 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 18.2 m -70.24 136.17 49.68 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.351 178.316 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -96.94 143.9 27.37 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.171 -0.612 . . . . 0.0 111.229 -179.162 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.696 ' HB ' HD11 ' A' ' 76' ' ' ILE . 5.4 p -129.5 133.88 64.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.837 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 49.17 30.12 2.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.157 0.503 . . . . 0.0 109.952 -179.331 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 78.2 27.47 57.85 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.393 179.064 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.6 t -138.0 139.59 39.73 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.997 0.398 . . . . 0.0 110.46 179.739 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -67.78 142.29 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.846 179.907 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.696 HD11 ' HB ' ' A' ' 71' ' ' VAL . 96.6 mt -101.72 103.72 15.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.936 -179.742 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -67.63 -40.97 84.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.989 179.028 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.528 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.6 OUTLIER -134.68 179.37 1.4 Allowed Pre-proline 0 CA--C 1.53 0.186 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.727 -178.35 . . . . . . . . 3 3 . 1 . 065 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.467 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 31.8 Cg_exo -59.37 144.59 99.36 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 122.804 2.336 . . . . 0.0 112.648 -179.585 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.8 m -143.1 141.24 26.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.995 -179.806 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 91.7 mtm180 -71.68 131.39 43.09 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.526 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.454 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 96.4 mt -80.19 139.99 36.51 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.838 0.351 . . . . 0.0 110.978 -179.538 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -131.44 150.2 52.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.426 -179.903 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -55.92 123.09 13.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.908 0.385 . . . . 0.0 110.982 -179.304 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.12 -14.19 48.42 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 -179.472 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.48 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 64.9 t0 -71.4 129.75 39.6 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.028 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.447 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 95.0 t -109.36 130.55 62.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.265 -178.819 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.4 mt -97.0 131.57 43.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.984 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 63.9 m -127.97 127.63 43.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.713 0.768 . . . . 0.0 113.002 -178.512 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.607 ' O ' ' N ' ' A' ' 92' ' ' ASP . 82.2 mt -107.03 123.06 61.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 177.682 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.437 ' C ' ' O ' ' A' ' 90' ' ' ILE . 70.3 mt 38.87 -88.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 120.511 -0.475 . . . . 0.0 110.646 -179.467 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.607 ' N ' ' O ' ' A' ' 90' ' ' ILE . 32.4 t70 -128.18 16.17 6.69 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -179.746 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.715 ' CZ ' HD11 ' A' ' 41' ' ' LEU . 98.3 mtt180 -123.01 139.91 53.59 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.115 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.595 ' OG ' HD12 ' A' ' 10' ' ' ILE . 31.7 p -138.84 151.87 47.37 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 119.23 -0.988 . . . . 0.0 112.011 -179.684 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -122.1 121.61 37.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.554 -1.203 . . . . 0.0 108.364 178.958 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -83.56 133.32 34.87 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.176 -0.609 . . . . 0.0 111.48 -178.52 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -96.83 122.47 39.82 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.234 -179.615 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -123.67 124.58 43.08 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.864 179.947 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 62.9 t-20 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.787 179.478 . . . . . . . . 0 0 . 1 . 065 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 N--CA 1.487 1.104 0 CA-C-O 121.785 0.66 . . . . 0.0 113.307 . . . . . . . . . 0 0 . 1 . 065 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.42 HG13 ' O ' ' B' ' 236' ' ' VAL . 12.2 p -58.35 135.73 22.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.135 -179.642 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 10.0 t . . . . . 0 C--N 1.329 -0.311 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.742 -179.502 . . . . . . . . 0 0 . 1 . 065 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo . . . . . 0 N--CA 1.502 1.999 0 N-CA-C 114.085 0.764 . . . . 0.0 114.085 . . . . . . . . . 0 0 . 1 . 065 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 97.4 m -67.45 -47.09 71.15 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.379 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.489 ' HZ ' HD22 ' A' ' 41' ' ' LEU . 91.7 t80 -57.93 -46.21 85.4 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.335 -179.459 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 87.6 mt -65.43 -38.83 91.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.842 0.353 . . . . 0.0 110.64 179.962 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -60.77 -41.11 94.83 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.077 0.465 . . . . 0.0 110.044 -179.98 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 62.0 ttp180 -61.45 -43.17 99.34 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.195 179.877 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.658 HH12 ' HE ' ' A' ' 93' ' ' ARG . 76.0 mtp85 -60.07 -42.09 93.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.866 -179.689 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.29 -41.34 96.81 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.28 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 8.6 t -63.4 -46.13 87.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.738 178.381 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . 0.411 ' HB3' ' NH1' ' A' ' 12' ' ' ARG . 83.2 mt-30 -59.33 -38.45 80.35 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.808 -178.989 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 25.1 t . . . . . 0 N--CA 1.455 -0.207 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.677 178.846 . . . . . . . . 0 0 . 1 . 065 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.544 ' OE1' ' NH2' ' A' ' 93' ' ' ARG . 97.8 mt-10 . . . . . 0 N--CA 1.456 -0.155 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 . . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 76.3 mt -114.51 128.98 71.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.178 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 54.4 t -126.85 133.9 67.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.137 0.494 . . . . 0.0 110.973 -179.203 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . 0.673 ' CD2' HG21 ' B' ' 267' ' ' ILE . 54.9 m-85 -96.38 120.36 36.54 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.99 -179.299 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -64.07 -42.72 96.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.533 0.682 . . . . 0.0 110.045 179.24 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . 0.569 ' N ' HE21 ' B' ' 265' ' ' GLN . 0.0 OUTLIER -103.26 171.52 5.09 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.006 -178.604 . . . . . . . . 3 3 . 1 . 065 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -54.52 149.73 37.79 Favored 'Trans proline' 0 N--CA 1.501 1.953 0 C-N-CA 123.143 2.562 . . . . 0.0 114.154 -179.728 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . 0.673 HG21 ' CD2' ' B' ' 263' ' ' PHE . 33.0 pt . . . . . 0 C--O 1.232 0.178 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.001 179.907 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 68.2 p . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.952 0.406 . . . . 0.0 110.543 . . . . . . . . . 0 0 . 1 . 066 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.809 ' NH1' ' HB2' ' A' ' 58' ' ' ALA . 95.1 mtt-85 -95.5 122.11 37.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.128 -179.644 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.411 ' NE ' ' OE1' ' A' ' 98' ' ' GLU . 31.1 ptt180 -138.48 145.34 40.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.072 0.463 . . . . 0.0 111.298 -179.86 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.618 HD12 ' O ' ' A' ' 96' ' ' ARG . 36.9 tp -118.93 136.47 54.05 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.359 179.007 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.81 HG22 ' CD2' ' A' ' 19' ' ' HIS . 41.0 t -110.35 131.6 60.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.822 -178.548 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.5 m -93.47 114.73 27.19 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.156 0.503 . . . . 0.0 112.12 -179.144 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 45.7 mm -79.63 144.93 10.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.611 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -90.52 158.92 16.77 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.181 178.595 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.55 ' NE ' ' NH2' ' B' ' 245' ' ' ARG . 84.7 mtp180 -54.87 -27.84 45.6 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.801 -178.825 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 85.9 p -79.19 -10.71 59.89 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 120.876 -0.329 . . . . 0.0 111.626 179.982 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.69 33.36 7.96 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 -179.223 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.6 t -120.6 134.61 63.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.87 0.367 . . . . 0.0 110.969 -179.531 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -71.22 129.28 38.49 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.818 179.58 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -125.35 -121.53 2.54 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.527 -179.076 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.21 144.62 42.13 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.16 1.907 . . . . 0.0 113.019 -178.104 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.81 ' CD2' HG22 ' A' ' 8' ' ' VAL . 59.2 m170 -104.22 145.78 29.73 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.647 -179.443 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.726 ' CD2' HD11 ' A' ' 37' ' ' ILE . 34.7 t80 -116.21 91.37 32.19 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.992 -179.924 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -60.35 125.36 17.26 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 121.779 1.652 . . . . 0.0 111.135 179.52 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 22' ' ' LEU . 96.0 mt -84.48 50.51 1.9 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.292 -178.762 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.4 p -61.21 -23.69 65.8 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.962 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.602 HD11 ' OE1' ' B' ' 265' ' ' GLN . 64.3 mt -83.53 141.84 31.33 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.173 -179.832 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.2 m -67.25 -17.84 64.97 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.834 -178.696 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.74 133.73 40.23 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.252 -0.579 . . . . 0.0 112.029 -178.977 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.5 t -128.19 119.96 26.29 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.25 179.207 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.459 HD23 ' HA ' ' A' ' 35' ' ' CYS . 38.5 tp -111.75 128.54 56.12 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.88 -178.938 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.478 ' O ' ' O ' ' A' ' 47' ' ' GLN . 57.6 m-85 -108.35 134.86 50.57 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.329 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 156.83 -170.7 34.25 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 119.904 -1.141 . . . . 0.0 112.449 179.344 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.603 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 10.4 mtp180 -85.6 -31.45 22.61 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -179.779 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -51.45 155.45 3.77 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 -178.648 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.649 HD12 ' NH1' ' A' ' 38' ' ' ARG . 1.1 tp -66.16 -42.69 91.66 Favored 'Isoleucine or valine' 0 C--N 1.34 0.195 0 CA-C-N 117.149 0.475 . . . . 0.0 111.01 -179.707 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.474 ' N ' HG23 ' A' ' 33' ' ' ILE . 73.6 mm-40 -58.06 -16.82 14.27 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.409 -179.64 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.459 ' HA ' HD23 ' A' ' 28' ' ' LEU . 68.6 m -59.8 120.34 9.36 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.838 -179.485 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.431 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 56.5 m-20 -60.89 -32.27 71.73 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.73 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.726 HD11 ' CD2' ' A' ' 20' ' ' PHE . 48.9 mm -120.13 113.77 41.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.554 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.649 ' NH1' HD12 ' A' ' 33' ' ' ILE . 77.4 mtt180 -101.06 132.77 46.33 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.028 -0.669 . . . . 0.0 111.287 -177.876 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 95.9 mt -123.73 129.85 74.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.283 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.442 HE21 ' HA ' ' B' ' 260' ' ' GLU . 2.4 pm0 -83.56 43.74 0.92 Allowed 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -176.98 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.578 ' CD1' ' CZ ' ' A' ' 93' ' ' ARG . 39.9 mt -109.4 126.58 28.91 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 120.403 -0.519 . . . . 0.0 111.781 179.885 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -68.86 -13.84 37.63 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.174 1.916 . . . . 0.0 112.779 179.709 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.467 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 25.2 m -90.68 4.43 6.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.891 0.377 . . . . 0.0 110.701 179.996 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.603 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 54.7 t -107.03 136.43 42.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.23 -179.698 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.3 m -70.68 168.31 16.8 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.527 0.68 . . . . 0.0 111.281 -179.386 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.5 mttm -62.07 -38.77 90.06 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.109 -179.293 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.708 ' O ' ' N ' ' A' ' 49' ' ' CYS . 99.0 mt-30 -109.58 -14.98 14.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.532 -179.077 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.543 ' NE2' HG23 ' A' ' 90' ' ' ILE . 23.5 t60 37.13 -72.75 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -179.836 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.708 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -151.69 151.92 32.09 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.997 179.943 . . . . . . . . 3 3 . 1 . 066 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -138.36 143.57 39.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.96 -179.96 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.8 mt -114.39 133.06 61.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.483 179.934 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -114.67 124.58 52.18 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.494 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.4 mt -105.89 118.59 53.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -177.356 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.423 ' O ' ' C ' ' A' ' 55' ' ' GLU . 97.7 m-70 -112.97 138.43 49.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.267 -1.333 . . . . 0.0 108.718 178.055 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 54' ' ' HIS . 94.8 mt-10 -39.47 -35.67 0.31 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.186 0.517 . . . . 0.0 109.807 -178.822 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -60.26 -68.17 0.32 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.649 179.071 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.522 ' CD ' ' NH1' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -151.99 -171.26 3.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.11 0.481 . . . . 0.0 111.063 179.523 . . . . . . . . 3 3 . 1 . 066 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.809 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -110.04 129.15 55.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.398 179.505 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.4 mt -116.84 129.14 73.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.234 0.54 . . . . 0.0 112.39 -178.555 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.459 ' HB2' HD11 ' A' ' 82' ' ' LEU . 25.4 tp -98.38 128.29 44.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.439 179.669 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -112.84 134.61 54.27 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.151 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.681 HD21 ' CB ' ' A' ' 68' ' ' PRO . 61.6 t-20 -98.4 109.59 22.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.925 -178.429 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -98.71 -3.89 34.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.094 179.726 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.1 t -92.8 110.36 21.8 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.085 -179.274 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 56.3 p -93.59 -28.75 15.85 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.577 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.447 ' O ' ' OD1' ' A' ' 67' ' ' ASN . 0.3 OUTLIER -65.52 -43.68 89.29 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.834 179.734 . . . . . . . . 3 3 . 1 . 066 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.456 HD21 ' HA ' ' B' ' 236' ' ' VAL . 33.2 m-20 -149.2 103.91 3.33 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.884 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.681 ' CB ' HD21 ' A' ' 62' ' ' ASN . 68.0 Cg_endo -71.03 158.21 55.83 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 121.657 1.571 . . . . 0.0 113.337 -177.424 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.1 m -73.04 140.03 46.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.296 179.656 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.45 ' O ' ' N ' ' A' ' 89' ' ' THR . 89.3 mt-30 -102.76 142.42 33.94 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.34 -179.507 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.688 ' HB ' HD11 ' A' ' 76' ' ' ILE . 8.9 p -132.04 138.63 52.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.766 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 50.39 31.81 5.78 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 -179.616 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.68 30.03 64.63 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.493 179.962 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 65.6 m -140.7 136.35 32.53 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 117.151 0.475 . . . . 0.0 111.847 -179.235 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.417 HG13 ' HG2' ' A' ' 68' ' ' PRO . 19.8 t -63.8 137.2 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.732 179.758 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.688 HD11 ' HB ' ' A' ' 71' ' ' VAL . 92.6 mt -101.91 110.87 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 178.631 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 18.6 p-10 -75.45 -37.15 60.52 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.13 179.546 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.551 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.8 OUTLIER -133.15 -177.95 0.78 Allowed Pre-proline 0 N--CA 1.465 0.316 0 CA-C-O 120.895 0.379 . . . . 0.0 111.823 -178.938 . . . . . . . . 3 3 . 1 . 066 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.516 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 32.5 Cg_exo -59.51 144.78 99.33 Favored 'Trans proline' 0 N--CA 1.499 1.822 0 C-N-CA 122.84 2.36 . . . . 0.0 112.545 -179.653 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 23.5 m -142.22 141.39 28.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.566 -179.627 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.522 ' NH1' ' CD ' ' A' ' 57' ' ' GLU . 96.7 mtt-85 -74.97 136.71 41.31 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.785 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.459 HD11 ' HB2' ' A' ' 60' ' ' LEU . 97.7 mt -92.31 136.43 33.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.461 0.648 . . . . 0.0 111.173 -179.579 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.407 ' HG2' ' N ' ' A' ' 84' ' ' HIS . 88.5 tttt -125.31 155.53 40.08 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.824 179.965 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.407 ' N ' ' HG2' ' A' ' 83' ' ' LYS . 10.4 t60 -57.43 121.88 11.28 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.954 -179.451 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.21 -22.44 20.59 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.962 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.566 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 64.9 t0 -64.32 131.27 46.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.712 0.292 . . . . 0.0 110.835 179.656 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.503 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 39.7 t -108.88 130.86 61.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.906 -179.463 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.5 mt -91.46 128.88 42.93 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.165 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.45 ' N ' ' O ' ' A' ' 70' ' ' GLN . 53.3 m -123.78 125.51 44.85 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.677 0.751 . . . . 0.0 112.002 -178.853 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.543 HG23 ' NE2' ' A' ' 48' ' ' HIS . 95.2 mt -115.97 123.0 70.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.588 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.703 HD12 HH22 ' A' ' 93' ' ' ARG . 96.6 mt 43.53 -102.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.934 -178.768 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.643 ' N ' HG22 ' A' ' 91' ' ' ILE . 46.0 p-10 -118.39 14.67 13.8 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.166 0.508 . . . . 0.0 110.972 179.938 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.703 HH22 HD12 ' A' ' 91' ' ' ILE . 51.2 mtm-85 -122.57 143.76 49.53 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.533 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 29.0 p -139.63 153.01 47.23 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 119.499 -0.881 . . . . 0.0 111.732 -179.137 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.482 ' HB3' HD11 ' A' ' 7' ' ' LEU . 60.2 m-85 -122.51 120.78 34.87 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 114.786 -1.097 . . . . 0.0 108.686 178.906 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.618 ' O ' HD12 ' A' ' 7' ' ' LEU . 44.4 ttm180 -82.85 128.7 34.66 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.144 -0.622 . . . . 0.0 111.455 -178.657 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.549 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 83.3 t80 -97.78 127.95 44.08 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.92 179.736 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.411 ' OE1' ' NE ' ' A' ' 6' ' ' ARG . 98.2 mt-10 -130.7 123.78 30.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.048 179.637 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 63.8 t-20 . . . . . 0 C--N 1.327 -0.386 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.028 . . . . . . . . 0 0 . 1 . 066 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo . . . . . 0 N--CA 1.49 1.304 0 CA-C-O 121.798 0.666 . . . . 0.0 113.494 . . . . . . . . . 0 0 . 1 . 066 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.456 ' HA ' HD21 ' A' ' 67' ' ' ASN . 23.0 t -57.44 140.81 15.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.843 -179.067 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 49.0 t . . . . . 0 C--N 1.331 -0.211 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.599 . . . . . . . . 0 0 . 1 . 066 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo . . . . . 0 N--CA 1.498 1.767 0 N-CA-C 113.406 0.502 . . . . 0.0 113.406 . . . . . . . . . 0 0 . 1 . 066 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . 0.737 HG22 ' NH1' ' B' ' 244' ' ' ARG . 16.9 m -73.13 -47.7 41.83 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 119.953 -0.699 . . . . 0.0 109.394 178.972 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.495 ' HZ ' HD22 ' A' ' 41' ' ' LEU . 87.7 t80 -57.49 -44.84 85.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.192 179.911 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 92.9 mt -65.32 -39.1 92.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.811 179.816 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -62.87 -42.15 99.65 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.296 -179.053 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . 0.737 ' NH1' HG22 ' B' ' 240' ' ' THR . 95.1 mtm-85 -62.84 -42.23 99.65 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.231 -179.429 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.57 ' NE ' ' OD2' ' A' ' 92' ' ' ASP . 77.2 mtp85 -63.54 -40.57 97.37 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.5 -0.48 . . . . 0.0 112.095 -179.33 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.42 -38.84 88.56 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 120.205 -0.598 . . . . 0.0 109.682 179.658 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 70.7 p -67.17 -42.5 84.16 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 177.959 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 75.5 mm-40 -62.7 -33.1 74.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.757 179.641 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 37.5 t . . . . . 0 N--CA 1.453 -0.308 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.978 179.583 . . . . . . . . 0 0 . 1 . 066 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.442 ' HA ' HE21 ' A' ' 40' ' ' GLN . 35.3 tp10 . . . . . 0 CA--C 1.534 0.335 0 N-CA-C 111.552 0.205 . . . . 0.0 111.552 . . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 63.5 mt -111.97 135.85 49.98 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 CA-C-O 120.811 0.339 . . . . 0.0 110.517 -179.719 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 38.2 t -127.63 134.2 66.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.053 179.447 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -96.69 121.02 38.07 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.991 0.424 . . . . 0.0 111.544 -178.597 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -65.15 -48.09 74.76 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.711 179.583 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . 0.602 ' OE1' HD11 ' A' ' 24' ' ' LEU . 3.8 mm-40 -95.63 157.87 35.37 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.286 -178.891 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -64.47 154.67 70.48 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 123.209 2.606 . . . . 0.0 112.575 178.987 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 36.0 pt . . . . . 0 C--N 1.332 -0.156 0 CA-C-O 121.594 0.711 . . . . 0.0 112.401 -179.346 . . . . . . . . 0 0 . 1 . 067 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.9 p . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.739 0.304 . . . . 0.0 111.414 . . . . . . . . . 0 0 . 1 . 067 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.693 ' NE ' ' CZ ' ' A' ' 97' ' ' TYR . 2.6 mmp_? -90.9 118.2 30.11 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.781 -178.805 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.6 mtp180 -129.08 137.1 51.06 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.202 0.525 . . . . 0.0 111.541 179.522 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.644 HD12 ' O ' ' A' ' 96' ' ' ARG . 22.6 tp -114.49 131.05 56.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.268 179.807 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 76.6 t -108.91 130.89 61.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.072 -179.602 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.6 m -77.71 142.93 38.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.683 -179.341 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.439 ' CD1' ' OD1' ' A' ' 16' ' ' ASP . 50.4 mm -111.11 136.16 48.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.954 178.85 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -89.91 155.64 18.99 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.53 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.54 ' HD3' HH21 ' B' ' 245' ' ' ARG . 89.7 mtm180 -59.78 -24.45 64.1 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.039 -178.951 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.4 p -82.97 -6.97 59.7 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.447 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.77 38.11 7.65 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 179.691 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.6 t -122.84 133.63 68.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.662 0.267 . . . . 0.0 110.565 179.533 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.439 ' OD1' ' CD1' ' A' ' 10' ' ' ILE . 90.9 m-20 -73.7 135.15 43.66 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.271 179.64 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -124.84 -121.57 2.57 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 120.596 -0.811 . . . . 0.0 111.897 -179.633 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.59 145.32 41.69 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.139 1.892 . . . . 0.0 112.888 -178.709 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -104.56 143.76 32.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.711 179.995 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.887 ' CD2' HD11 ' A' ' 37' ' ' ILE . 38.7 t80 -115.36 107.21 49.69 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.19 179.374 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -74.78 127.5 10.89 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 121.373 1.382 . . . . 0.0 111.758 -179.159 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 82.2 mt -84.12 48.81 1.53 Allowed 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.29 -179.383 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 93.6 p -60.72 -25.36 66.37 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.467 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.582 HD11 ' HG2' ' B' ' 265' ' ' GLN . 66.8 mt -76.04 139.02 41.24 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.383 179.986 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.2 m -63.21 -19.25 64.35 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.286 -179.489 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.467 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 22.8 m -136.81 135.0 37.58 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.478 -179.723 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.9 t -126.43 118.49 25.08 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.058 0.456 . . . . 0.0 110.182 178.104 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.523 HD12 ' O ' ' A' ' 49' ' ' CYS . 53.5 tp -114.17 132.42 56.09 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.121 -179.016 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.515 ' O ' ' O ' ' A' ' 47' ' ' GLN . 34.1 m-85 -112.04 137.34 50.2 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.376 -179.341 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 152.93 -177.96 30.3 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.304 179.17 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 45.4 mtm180 -70.6 -32.03 69.25 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 179.772 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.568 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -51.79 148.04 10.64 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 121.133 -0.556 . . . . 0.0 112.477 -178.084 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.526 HG23 ' N ' ' A' ' 34' ' ' GLU . 11.0 tp -66.71 -41.47 88.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 120.886 0.374 . . . . 0.0 110.152 179.315 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.526 ' N ' HG23 ' A' ' 33' ' ' ILE . 77.5 tt0 -57.33 -24.08 52.83 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.497 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.568 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 16.5 m -56.6 120.36 7.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.93 179.343 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.467 ' OD2' ' O ' ' A' ' 26' ' ' THR . 95.7 m-20 -61.87 -25.5 67.58 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.537 0.684 . . . . 0.0 109.155 -179.692 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.887 HD11 ' CD2' ' A' ' 20' ' ' PHE . 39.5 mm -126.88 117.11 46.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.888 178.848 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.419 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 62.0 mtm180 -104.1 135.24 45.96 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.614 -179.871 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.2 mt -120.13 127.95 75.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.521 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -75.05 34.58 0.1 Allowed 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -177.108 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.616 HD11 ' HE ' ' A' ' 93' ' ' ARG . 96.2 mt -103.37 127.88 28.71 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.986 179.588 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.79 -9.83 24.23 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.491 2.128 . . . . 0.0 112.197 -179.915 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.573 HG21 ' CE2' ' B' ' 241' ' ' PHE . 15.8 m -96.77 9.96 6.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.613 179.818 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.438 HG12 ' O ' ' A' ' 45' ' ' SER . 20.1 t -103.31 135.72 39.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.428 179.71 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.438 ' O ' HG12 ' A' ' 44' ' ' VAL . 13.2 m -70.04 170.15 11.98 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.357 0.599 . . . . 0.0 111.048 -179.895 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -64.3 -40.16 95.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.698 -179.685 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.616 ' O ' ' N ' ' A' ' 49' ' ' CYS . 69.5 mm-40 -110.07 -25.07 10.42 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.131 0.491 . . . . 0.0 110.676 -179.158 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.512 ' NE2' HG23 ' A' ' 90' ' ' ILE . 20.5 t60 40.08 -74.69 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 179.119 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.616 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.48 136.86 45.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.406 0.622 . . . . 0.0 112.396 -177.834 . . . . . . . . 3 3 . 1 . 067 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -127.1 128.05 45.61 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.938 179.011 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.8 mt -116.85 134.59 59.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.84 -179.737 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -115.75 135.8 53.68 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.662 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 49.9 mm -102.08 114.2 40.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 120.169 -0.613 . . . . 0.0 110.62 -179.945 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -115.4 134.39 55.14 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.078 179.01 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -42.13 -32.9 0.51 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.01 -179.487 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -63.04 -66.23 0.57 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.739 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -157.69 -160.33 0.92 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.131 179.671 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.511 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -121.29 133.83 55.14 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.561 -179.926 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.9 mt -118.27 128.48 75.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.266 0.555 . . . . 0.0 112.099 -179.265 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.4 tp -95.69 125.01 39.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.623 179.575 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -112.02 136.06 51.85 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.69 0.281 . . . . 0.0 110.444 -179.794 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.76 ' ND2' ' H ' ' A' ' 69' ' ' THR . 21.2 t-20 -97.88 107.7 20.24 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.529 -179.808 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -98.66 -10.65 22.95 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.222 179.37 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.73 97.96 7.53 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.233 179.954 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.0 p -71.67 -32.56 68.01 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.78 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.0 m -64.0 -47.07 81.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.504 -178.956 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -141.99 97.41 6.42 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.888 -178.984 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.447 ' HA ' HD21 ' A' ' 62' ' ' ASN . 37.9 Cg_exo -56.06 146.76 68.09 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.009 1.806 . . . . 0.0 111.63 179.696 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.76 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 6.7 m -73.91 146.16 44.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.291 0.567 . . . . 0.0 111.151 -179.698 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -104.81 140.9 37.43 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.996 179.791 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.485 ' O ' ' OG ' ' A' ' 74' ' ' SER . 43.0 t -129.02 135.53 61.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.214 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 51.94 33.48 11.77 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.209 -0.596 . . . . 0.0 109.533 -179.733 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.33 29.84 71.71 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.431 179.703 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.485 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 16.5 p -141.55 136.14 30.83 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.754 0.311 . . . . 0.0 110.895 179.987 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.1 p -68.42 139.14 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 CA-C-O 121.083 0.468 . . . . 0.0 111.678 -179.753 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.7 109.45 21.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.092 179.492 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -90.46 -17.55 26.93 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.845 -179.201 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -116.01 164.88 16.2 Favored Pre-proline 0 N--CA 1.469 0.505 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.824 179.77 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -56.78 142.97 91.93 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 C-N-CA 121.59 1.526 . . . . 0.0 111.562 179.296 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.0 p -139.9 138.91 38.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.983 0.42 . . . . 0.0 110.989 -178.909 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.2 mtm180 -77.94 133.03 38.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.482 -179.982 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.511 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 93.4 mt -86.72 139.84 30.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.143 0.497 . . . . 0.0 111.074 -179.445 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -133.31 155.51 49.3 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.697 -179.501 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.496 ' CE1' ' O ' ' A' ' 99' ' ' ASN . 3.4 t-160 -55.36 113.3 1.36 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.899 -179.458 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.66 -17.54 18.12 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 121.068 -0.587 . . . . 0.0 111.921 179.475 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -70.94 133.3 46.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.998 0.428 . . . . 0.0 110.371 -179.901 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.47 ' O ' HG13 ' A' ' 87' ' ' VAL . 14.2 p -107.87 132.76 54.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.008 -179.217 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 91.3 mt -97.68 130.3 46.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.372 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 51.6 m -122.14 126.23 47.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.735 0.779 . . . . 0.0 112.561 -178.417 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.512 HG23 ' NE2' ' A' ' 48' ' ' HIS . 80.7 mt -113.04 120.07 62.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 114.509 -1.223 . . . . 0.0 108.186 178.661 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.57 ' CD1' HG23 ' A' ' 43' ' ' VAL . 57.1 mt 38.09 -92.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.715 -0.221 . . . . 0.0 111.144 -179.533 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 90' ' ' ILE . 10.3 t0 -119.35 14.75 12.95 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.572 -179.254 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.616 ' HE ' HD11 ' A' ' 41' ' ' LEU . 79.6 mtt-85 -128.89 146.73 50.86 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.148 179.726 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.418 ' OG ' ' CG2' ' A' ' 87' ' ' VAL . 12.8 t -139.45 153.98 47.67 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.651 0.739 . . . . 0.0 111.701 -179.73 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.533 ' HB3' HD11 ' A' ' 7' ' ' LEU . 96.7 m-85 -126.65 121.88 33.39 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.109 179.061 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.644 ' O ' HD12 ' A' ' 7' ' ' LEU . 99.6 mtt180 -82.42 131.29 35.22 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.226 -178.944 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.693 ' CZ ' ' NE ' ' A' ' 5' ' ' ARG . 67.5 t80 -92.25 121.39 33.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.031 179.95 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.463 ' C ' ' NH2' ' A' ' 5' ' ' ARG . 93.5 mt-10 -126.57 131.37 51.55 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -177.886 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.632 ' CG ' HH12 ' A' ' 5' ' ' ARG . 63.1 t-20 . . . . . 0 C--N 1.333 -0.119 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.179 178.591 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo . . . . . 0 N--CA 1.483 0.909 0 CA-C-O 121.222 0.426 . . . . 0.0 112.621 . . . . . . . . . 0 0 . 1 . 067 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 31.4 m -59.25 142.74 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.618 -179.72 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 2.4 t . . . . . 0 C--N 1.322 -0.604 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.789 179.926 . . . . . . . . 0 0 . 1 . 067 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo . . . . . 0 N--CA 1.494 1.548 0 N-CA-C 113.039 0.361 . . . . 0.0 113.039 . . . . . . . . . 0 0 . 1 . 067 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 26.2 p -74.16 -40.02 62.85 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 120.421 -0.511 . . . . 0.0 109.696 178.401 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.573 ' CE2' HG21 ' A' ' 43' ' ' VAL . 70.0 t80 -59.96 -46.67 88.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.109 -179.358 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' B' ' 242' ' ' LEU . 90.6 mt -65.25 -41.43 94.32 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -179.561 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -65.47 -40.62 93.37 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.422 -179.374 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . 0.431 ' O ' ' OG ' ' B' ' 247' ' ' SER . 82.3 mtp180 -62.04 -42.71 99.46 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.52 -179.886 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.54 HH21 ' HD3' ' A' ' 12' ' ' ARG . 85.3 mtp180 -65.9 -39.95 91.07 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.579 -179.912 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -62.16 -40.81 97.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.167 0.508 . . . . 0.0 110.106 178.887 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 73.5 p -66.19 -41.69 89.85 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.463 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -61.27 -36.19 79.36 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.116 179.431 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 27.8 t . . . . . 0 C--N 1.326 -0.449 0 C-N-CA 120.166 -0.614 . . . . 0.0 109.49 178.769 . . . . . . . . 0 0 . 1 . 067 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.4 ' HB2' ' NH2' ' A' ' 93' ' ' ARG . 94.4 mt-10 . . . . . 0 N--CA 1.462 0.152 0 CA-C-O 120.558 0.218 . . . . 0.0 110.954 . . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.49 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 68.2 mt -115.62 136.99 50.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -179.312 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 55.2 t -124.89 132.56 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 121.102 0.477 . . . . 0.0 110.769 -179.837 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -94.6 118.45 31.71 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.875 -179.101 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -64.23 -46.53 83.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.273 179.974 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . 0.582 ' HG2' HD11 ' A' ' 24' ' ' LEU . 0.8 OUTLIER -97.2 158.79 32.67 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.417 -179.3 . . . . . . . . 3 3 . 1 . 067 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -65.94 149.2 86.44 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 123.486 2.791 . . . . 0.0 113.664 -179.716 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 42.3 pt . . . . . 0 CA--C 1.529 0.163 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.3 179.014 . . . . . . . . 0 0 . 1 . 068 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.7 m . . . . . 0 N--CA 1.457 -0.079 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 . . . . . . . . . 0 0 . 1 . 068 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 86.0 mtt85 -90.57 127.54 36.29 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -177.677 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.5 mtp180 -127.88 136.84 51.94 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.207 179.982 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.616 HD11 ' HB3' ' A' ' 95' ' ' PHE . 43.3 tp -114.79 135.2 54.45 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 179.55 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.768 HG11 ' NH2' ' A' ' 96' ' ' ARG . 29.8 t -113.85 129.65 69.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.281 -179.404 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.4 m -93.61 112.61 24.53 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -178.209 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.587 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 97.0 mt -78.22 144.4 11.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 177.419 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.488 ' HA ' HH22 ' A' ' 93' ' ' ARG . 96.6 mttt -91.83 165.99 12.97 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 119.841 -0.744 . . . . 0.0 109.915 178.584 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.775 HH11 HH11 ' B' ' 245' ' ' ARG . 86.2 mtm180 -57.51 -27.95 63.03 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.635 -178.769 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.7 m -79.21 -10.47 59.83 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.433 -179.522 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.61 25.66 19.99 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.018 179.551 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.5 m -117.58 138.83 46.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.597 179.803 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.43 ' OD1' HG13 ' A' ' 8' ' ' VAL . 67.1 t0 -64.56 127.36 31.21 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.059 -179.717 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -114.88 -128.55 4.51 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 121.146 -0.55 . . . . 0.0 112.054 -179.062 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -75.67 148.84 33.28 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.416 2.077 . . . . 0.0 112.29 -179.14 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -102.77 165.37 11.1 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.6 -179.933 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.565 ' CD2' HD11 ' A' ' 37' ' ' ILE . 42.3 t80 -139.57 103.74 7.06 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.325 -179.778 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -72.45 126.7 11.81 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 121.446 1.431 . . . . 0.0 111.566 -178.757 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.6 HD22 ' SG ' ' A' ' 27' ' ' CYS . 69.2 mt -85.27 50.75 2.01 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.722 -178.924 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 99.1 p -60.4 -28.63 68.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.1 179.778 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.1 mt -74.61 143.12 44.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.359 -179.732 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 91.5 p -63.91 -17.39 63.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.907 -178.484 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.405 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 31.9 m -133.55 133.54 42.24 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.135 179.857 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.6 ' SG ' HD22 ' A' ' 22' ' ' LEU . 5.4 t -124.81 116.72 22.73 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.443 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.434 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 36.0 tp -113.98 126.26 54.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.139 -179.218 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.764 ' CE2' HD12 ' A' ' 37' ' ' ILE . 12.7 m-85 -104.88 137.96 41.86 Favored 'General case' 0 C--N 1.334 -0.091 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.652 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 175.57 -174.21 46.71 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 119.95 -1.119 . . . . 0.0 112.011 179.66 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 27.9 ttp85 -91.59 -16.12 27.59 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.623 -0.288 . . . . 0.0 111.263 179.843 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -81.7 154.35 34.1 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 121.068 -0.587 . . . . 0.0 111.782 -179.43 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.498 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.5 tp -66.46 -41.67 89.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.754 0.311 . . . . 0.0 110.459 179.436 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.498 ' N ' HG23 ' A' ' 33' ' ' ILE . 80.7 tt0 -50.3 -18.65 0.65 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.912 0.387 . . . . 0.0 110.106 -179.613 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.425 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 82.3 m -73.83 140.72 45.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.207 179.685 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.434 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 94.6 m-20 -60.48 -32.78 71.74 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -179.552 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.764 HD12 ' CE2' ' A' ' 29' ' ' PHE . 84.1 mt -126.95 122.5 60.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 176.559 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 67.8 ttp85 -106.36 133.56 50.86 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.461 -179.476 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.415 HG22 ' HG ' ' A' ' 41' ' ' LEU . 79.7 mt -114.37 131.71 65.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.71 -179.55 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -74.5 25.37 0.08 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.962 -178.281 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.634 HD21 ' OE1' ' B' ' 260' ' ' GLU . 50.5 mt -100.29 128.21 31.08 Favored Pre-proline 0 C--N 1.326 -0.427 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.407 179.144 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -73.1 -9.2 23.18 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.347 2.031 . . . . 0.0 111.858 179.678 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.2 m -92.18 5.46 6.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.656 179.829 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 36.1 t -96.84 131.8 42.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.2 179.574 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.409 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 7.9 t -70.17 173.02 7.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.26 -179.052 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.425 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 64.2 mttp -62.77 -42.21 99.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.814 -179.529 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.65 ' O ' ' N ' ' A' ' 49' ' ' CYS . 99.5 mt-30 -114.33 -18.23 11.61 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.203 -179.399 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.409 ' H ' ' HB3' ' A' ' 45' ' ' SER . 20.4 t60 35.14 -76.53 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 179.8 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.65 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.42 134.58 47.22 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.157 0.503 . . . . 0.0 111.956 -178.521 . . . . . . . . 3 3 . 1 . 068 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -127.16 134.07 50.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.849 -179.966 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.6 mt -119.68 133.42 66.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.96 -179.749 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -108.77 127.48 54.04 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.591 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.7 mm -101.35 115.44 43.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 119.995 -0.682 . . . . 0.0 111.33 -178.726 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.469 ' O ' ' C ' ' A' ' 55' ' ' GLU . 95.8 m-70 -119.1 134.13 55.38 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.731 179.155 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.469 ' C ' ' O ' ' A' ' 54' ' ' HIS . 84.9 tt0 -40.75 -30.71 0.13 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.91 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.453 ' N ' ' C ' ' A' ' 54' ' ' HIS . 94.1 mm-40 -66.19 -68.63 0.36 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.034 178.705 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.53 ' OE1' ' CZ ' ' A' ' 81' ' ' ARG . 2.0 pt-20 -153.92 -172.99 4.41 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.334 -178.823 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -116.46 128.0 55.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.622 179.313 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.2 mt -115.8 130.48 70.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.296 0.57 . . . . 0.0 112.023 -178.279 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 23.4 tp -97.43 129.03 44.68 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.09 179.876 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -113.19 137.04 52.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.882 -179.644 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 62.0 t-20 -93.56 105.62 17.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.468 -179.132 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -101.96 -10.59 19.65 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.324 179.319 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.479 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 60.4 p -72.99 102.41 3.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.603 179.742 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.7 p -82.11 -19.0 41.02 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.677 179.742 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.575 HG22 HG22 ' B' ' 236' ' ' VAL . 0.2 OUTLIER -86.98 -41.29 14.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.001 -179.077 . . . . . . . . 3 3 . 1 . 068 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.479 ' O ' ' OG ' ' A' ' 64' ' ' SER . 47.3 m-20 -143.32 106.93 5.18 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.36 -179.47 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -56.49 143.4 87.8 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 121.606 1.537 . . . . 0.0 112.142 -179.927 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.8 m -69.85 137.35 51.65 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.726 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -97.82 138.34 35.33 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.997 -179.761 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.9 t -133.93 134.52 55.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.994 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 9.9 m120 52.97 30.03 8.76 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 -178.836 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.34 27.49 69.71 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.134 -179.513 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.4 t -140.48 138.82 34.93 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.906 0.384 . . . . 0.0 111.756 -179.606 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.458 ' H ' HG22 ' A' ' 75' ' ' VAL . 6.2 m -73.82 141.69 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.996 -179.97 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 10.3 pt -108.36 96.39 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 121.238 0.542 . . . . 0.0 111.462 179.67 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -64.39 -35.62 81.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.777 179.263 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -121.48 171.77 5.72 Favored Pre-proline 0 CA--C 1.533 0.301 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.989 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -60.08 147.25 93.84 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.165 1.91 . . . . 0.0 111.917 179.854 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.9 p -139.2 141.99 34.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.376 0.608 . . . . 0.0 111.755 -179.512 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.53 ' CZ ' ' OE1' ' A' ' 57' ' ' GLU . 79.5 ttt180 -74.78 128.66 36.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.176 179.224 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.434 HD23 ' HA ' ' A' ' 82' ' ' LEU . 95.2 mt -79.91 135.35 36.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.026 0.441 . . . . 0.0 110.897 -179.888 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -124.47 147.79 48.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.733 179.203 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.557 ' ND1' ' OD1' ' A' ' 99' ' ' ASN . 10.5 t60 -53.36 122.48 9.71 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.005 -179.074 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.93 -16.91 42.54 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.976 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -66.76 135.25 53.69 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.483 -0.487 . . . . 0.0 109.821 179.77 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 53.2 t -109.84 131.93 59.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.011 -178.305 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.1 mt -98.98 130.93 47.14 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.426 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.1 m -121.29 127.52 51.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.632 0.729 . . . . 0.0 112.226 -178.722 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.646 ' O ' ' N ' ' A' ' 93' ' ' ARG . 97.6 mt -119.93 125.21 74.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 178.001 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.525 ' C ' ' O ' ' A' ' 90' ' ' ILE . 62.2 mt -11.15 97.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -178.129 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 78.17 -9.71 1.47 Allowed 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 177.938 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.734 HH12 ' N ' ' A' ' 12' ' ' ARG . 20.0 mmm180 -130.09 133.07 46.42 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.669 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.486 ' OG ' HD12 ' A' ' 10' ' ' ILE . 89.0 p -138.54 153.5 48.73 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.176 179.299 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.616 ' HB3' HD11 ' A' ' 7' ' ' LEU . 55.6 m-85 -130.03 132.23 46.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.268 -179.324 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.768 ' NH2' HG11 ' A' ' 8' ' ' VAL . 92.0 mtm-85 -88.51 130.39 35.24 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.539 -179.825 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -95.58 126.49 40.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.502 -179.452 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -134.8 118.13 16.69 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.192 179.489 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.557 ' OD1' ' ND1' ' A' ' 84' ' ' HIS . 53.4 p-10 . . . . . 0 C--N 1.332 -0.175 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.336 -179.489 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo . . . . . 0 N--CA 1.494 1.535 0 N-CA-C 114.032 0.743 . . . . 0.0 114.032 . . . . . . . . . 0 0 . 1 . 068 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.575 HG22 HG22 ' A' ' 66' ' ' THR . 68.0 t -63.65 135.42 27.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.483 179.097 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . 0.424 ' SG ' HD11 ' B' ' 242' ' ' LEU . 2.0 t . . . . . 0 C--N 1.328 -0.367 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.294 -179.842 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo . . . . . 0 N--CA 1.496 1.619 0 CA-C-O 120.63 0.179 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 068 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 21.6 p -76.37 -45.63 31.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.897 0.379 . . . . 0.0 110.39 179.035 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -58.9 -48.41 81.53 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.32 -178.742 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.424 HD11 ' SG ' ' B' ' 237' ' ' CYS . 80.1 mt -65.45 -42.11 92.69 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.09 -179.892 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -61.28 -43.64 98.53 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.555 -178.87 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 77.0 ttt-85 -63.41 -43.68 96.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.903 0.382 . . . . 0.0 111.312 -179.14 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.775 HH11 HH11 ' A' ' 12' ' ' ARG . 52.8 ttm-85 -64.08 -40.52 96.43 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.862 -179.262 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -60.13 -36.99 78.74 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.744 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 20.2 m -66.15 -42.8 88.54 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 177.189 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . 0.536 ' CD ' HH12 ' A' ' 12' ' ' ARG . 56.7 tt0 -60.27 -34.36 73.61 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.097 179.662 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 55.7 t . . . . . 0 N--CA 1.454 -0.234 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.118 178.974 . . . . . . . . 0 0 . 1 . 068 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.634 ' OE1' HD21 ' A' ' 41' ' ' LEU . 95.9 mt-10 . . . . . 0 CA--C 1.531 0.242 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 . . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.665 ' CD1' HH21 ' A' ' 93' ' ' ARG . 42.5 mt -110.17 138.3 38.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.101 -179.811 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 43.0 t -125.61 132.33 71.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.005 0.431 . . . . 0.0 110.221 179.262 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -96.39 120.52 36.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.877 -178.94 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -66.01 -47.32 74.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.387 -179.315 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.8 151.99 44.22 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.445 -179.018 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -64.55 147.71 90.34 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.754 2.303 . . . . 0.0 112.31 179.613 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.1 pt . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.448 179.82 . . . . . . . . 0 0 . 1 . 069 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 99.2 m . . . . . 0 N--CA 1.461 0.112 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 . . . . . . . . . 0 0 . 1 . 069 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.504 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 95.5 mtt-85 -88.04 128.85 35.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.671 -178.579 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -129.33 140.37 51.42 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 120.471 -0.492 . . . . 0.0 112.13 -179.242 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.505 HD11 ' CB ' ' A' ' 95' ' ' PHE . 34.0 tp -116.25 134.38 54.97 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.843 178.966 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.3 t -110.78 130.83 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.016 -179.945 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.421 HG23 ' CD1' ' B' ' 261' ' ' ILE . 1.4 m -94.14 116.86 29.32 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.678 -178.77 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.649 HD12 ' OG ' ' A' ' 94' ' ' SER . 96.8 mt -80.18 143.55 12.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.32 179.061 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -91.22 158.88 16.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.022 0.439 . . . . 0.0 110.268 178.637 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.838 HH12 ' NE2' ' B' ' 248' ' ' GLN . 80.9 mtp180 -58.2 -32.07 67.93 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.539 -179.854 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.2 m -77.23 -9.95 59.11 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.006 -179.947 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.71 33.67 7.33 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.446 -0.662 . . . . 0.0 111.446 179.877 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.0 t -119.57 134.22 63.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.733 0.301 . . . . 0.0 110.79 -179.823 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -63.17 122.41 16.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.26 179.942 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -106.89 -139.58 9.38 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.553 -179.266 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.79 155.49 62.43 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.215 1.944 . . . . 0.0 112.082 -179.164 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -107.29 146.8 31.06 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.975 -179.05 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.692 ' CD2' HD11 ' A' ' 37' ' ' ILE . 23.6 t80 -115.16 101.68 54.52 Favored Pre-proline 0 CA--C 1.536 0.437 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.898 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.72 131.78 17.7 Favored 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 121.398 1.399 . . . . 0.0 111.475 -179.392 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 83.4 mt -86.48 52.44 2.5 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 119.961 -0.695 . . . . 0.0 111.197 -178.44 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.8 p -61.8 -29.87 70.43 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.797 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.431 HD11 ' CD ' ' B' ' 265' ' ' GLN . 67.5 mt -79.06 142.45 36.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.187 179.757 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 72.6 p -66.39 -20.17 66.0 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.969 -0.293 . . . . 0.0 111.713 -179.494 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.416 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 53.2 m -127.04 128.9 47.03 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.292 0.568 . . . . 0.0 112.011 -179.633 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.454 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 11.8 t -123.57 113.54 18.85 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.774 178.697 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.565 ' O ' ' N ' ' A' ' 36' ' ' ASP . 63.4 tp -110.42 125.33 53.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.185 0.517 . . . . 0.0 110.786 -179.555 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.862 ' CE2' HD12 ' A' ' 37' ' ' ILE . 4.5 m-85 -107.06 140.02 40.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.282 179.583 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 170.38 -160.22 32.88 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.377 179.388 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 27.4 ptt-85 -107.22 -8.92 16.25 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.411 179.817 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.478 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -85.37 167.24 40.93 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.286 -179.945 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.569 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.9 tp -67.29 -42.41 87.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.719 0.295 . . . . 0.0 110.779 -179.814 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.569 ' N ' HG23 ' A' ' 33' ' ' ILE . 78.4 mm-40 -53.14 -25.55 13.76 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.144 0.497 . . . . 0.0 110.021 -178.908 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.478 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 3.7 m -62.38 124.21 20.32 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.402 179.521 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.565 ' N ' ' O ' ' A' ' 28' ' ' LEU . 63.7 m-20 -58.54 -29.03 66.02 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -179.055 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.862 HD12 ' CE2' ' A' ' 29' ' ' PHE . 93.6 mt -126.56 122.32 60.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 176.237 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 72.0 ttp85 -106.57 135.81 47.44 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.116 -178.511 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 98.6 mt -115.68 129.1 72.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.009 -179.573 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -74.09 31.5 0.08 Allowed 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 -177.918 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.507 ' CG ' HH21 ' A' ' 93' ' ' ARG . 86.2 mt -107.49 135.88 19.67 Favored Pre-proline 0 C--N 1.323 -0.559 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.888 179.539 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.56 -10.13 24.89 Favored 'Trans proline' 0 C--N 1.315 -1.216 0 C-N-CA 122.067 1.845 . . . . 0.0 111.428 179.215 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.526 HG21 ' CE2' ' B' ' 241' ' ' PHE . 9.7 m -97.22 6.62 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.216 -179.936 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.0 t -92.78 128.48 44.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.045 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 41.2 t -66.71 172.76 3.96 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.51 0.671 . . . . 0.0 111.628 -178.59 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -65.83 -43.24 89.12 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.96 -179.631 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.628 ' O ' ' N ' ' A' ' 49' ' ' CYS . 86.8 mt-30 -119.36 -5.34 10.37 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.847 -179.002 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.503 ' C ' ' O ' ' A' ' 47' ' ' GLN . 17.8 t60 14.05 -73.37 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 -178.852 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.628 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -126.08 129.53 49.29 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 119.716 -0.793 . . . . 0.0 112.876 -179.069 . . . . . . . . 3 3 . 1 . 069 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -126.58 128.66 47.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.013 178.508 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.2 mt -116.41 134.3 60.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.685 -179.292 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -112.18 122.12 46.86 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.603 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 95.7 mt -101.8 116.49 45.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 119.543 -0.863 . . . . 0.0 111.847 -178.638 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.485 ' O ' ' N ' ' A' ' 56' ' ' GLN . 94.1 m-70 -114.19 141.52 47.43 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.922 -179.828 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 54' ' ' HIS . 51.7 mp0 -40.15 -29.37 0.07 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 179.852 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.485 ' N ' ' O ' ' A' ' 54' ' ' HIS . 56.1 tt0 -65.34 -68.14 0.39 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.241 -0.89 . . . . 0.0 108.997 178.192 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.488 ' OE1' ' O ' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -159.53 -166.28 1.74 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.257 0.551 . . . . 0.0 111.868 -179.531 . . . . . . . . 3 3 . 1 . 069 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.488 ' O ' ' OE1' ' A' ' 57' ' ' GLU . . . -112.88 125.48 54.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.313 179.633 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 99.0 mt -116.08 129.55 72.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -177.924 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.45 ' HB2' HD11 ' A' ' 82' ' ' LEU . 50.9 tp -96.3 128.87 43.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.642 179.706 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -111.57 135.31 52.33 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.74 179.722 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -100.57 106.84 18.39 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -178.749 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -99.89 -1.44 37.36 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.994 179.031 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.46 100.04 12.46 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.404 -179.553 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.0 p -81.7 -15.16 55.35 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.214 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.92 -35.57 14.65 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.213 -179.86 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.491 ' HB3' HD11 ' A' ' 91' ' ' ILE . 11.1 m-80 -150.7 89.0 4.47 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.24 -179.815 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -57.12 148.9 66.46 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.68 2.253 . . . . 0.0 112.717 -179.665 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 38.1 m -71.99 138.37 47.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.324 179.327 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -96.63 144.54 26.58 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.101 -179.664 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.711 ' HB ' HD11 ' A' ' 76' ' ' ILE . 3.9 p -127.87 135.74 62.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.956 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 8.3 m120 48.71 31.46 3.06 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.287 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.56 27.44 63.29 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.686 179.87 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 71' ' ' VAL . 21.1 t -136.67 134.53 37.36 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.998 0.399 . . . . 0.0 110.907 179.784 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.4 ' H ' HG12 ' A' ' 75' ' ' VAL . 0.2 OUTLIER -60.64 143.95 13.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.342 -179.911 . . . . . . . . 3 3 . 1 . 069 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.711 HD11 ' HB ' ' A' ' 71' ' ' VAL . 97.2 mt -107.97 102.93 14.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.456 179.565 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -64.92 -42.31 94.81 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.716 0.294 . . . . 0.0 111.556 179.365 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.536 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.3 OUTLIER -133.67 -179.41 1.06 Allowed Pre-proline 0 CA--C 1.532 0.28 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.597 -178.581 . . . . . . . . 3 3 . 1 . 069 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.471 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 52.3 Cg_exo -55.18 138.05 78.25 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 122.331 2.021 . . . . 0.0 112.779 -178.687 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 72.7 t -134.48 136.68 52.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.792 -179.576 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -73.84 135.49 43.43 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.608 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.45 HD11 ' HB2' ' A' ' 60' ' ' LEU . 97.4 mt -84.89 137.56 33.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.284 0.564 . . . . 0.0 111.466 -179.225 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -126.74 151.04 48.72 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.219 -179.963 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.475 ' HD1' ' H ' ' A' ' 99' ' ' ASN . 15.0 t60 -60.46 125.76 24.92 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.041 0.448 . . . . 0.0 110.774 -179.43 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.11 -17.88 47.18 Favored Glycine 0 CA--C 1.519 0.289 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.516 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 87' ' ' VAL . 66.4 t0 -72.52 133.05 44.59 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.041 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.512 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 33.6 t -109.36 133.3 54.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.1 0.476 . . . . 0.0 110.998 -179.119 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.4 mt -93.33 131.46 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 178.841 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.3 m -122.44 124.54 43.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.495 0.664 . . . . 0.0 112.311 -178.321 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.575 ' O ' ' N ' ' A' ' 93' ' ' ARG . 98.0 mt -117.84 133.46 64.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.752 178.725 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.491 HD11 ' HB3' ' A' ' 67' ' ' ASN . 80.8 mt -23.7 97.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -178.614 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.473 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 3.2 m-20 89.73 -20.07 0.16 Allowed 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.801 1.038 . . . . 0.0 113.801 177.792 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.603 ' NH2' ' OE1' ' B' ' 260' ' ' GLU . 54.3 mtt-85 -130.33 140.81 50.62 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.6 -179.114 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.649 ' OG ' HD12 ' A' ' 10' ' ' ILE . 11.2 p -137.53 150.71 47.73 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.712 0.291 . . . . 0.0 110.241 -179.931 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.541 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 15.4 m-85 -129.53 123.78 32.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.077 -179.038 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.447 ' HA ' HG22 ' A' ' 87' ' ' VAL . 42.9 ttm180 -79.37 127.7 32.42 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.137 0.494 . . . . 0.0 111.337 -179.464 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.504 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 67.9 t80 -94.26 127.68 40.27 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.997 -179.707 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -141.26 116.96 10.33 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.702 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.475 ' H ' ' HD1' ' A' ' 84' ' ' HIS . 52.4 p30 . . . . . 0 C--N 1.331 -0.234 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.48 179.72 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo . . . . . 0 N--CA 1.481 0.754 0 CA-C-O 121.241 0.434 . . . . 0.0 112.082 . . . . . . . . . 0 0 . 1 . 069 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 2.9 p -115.18 133.64 60.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.914 179.864 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . 0.465 ' CB ' HD13 ' A' ' 91' ' ' ILE . 2.3 t . . . . . 0 C--N 1.326 -0.448 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.635 -179.418 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo . . . . . 0 N--CA 1.496 1.645 0 N-CA-C 113.175 0.413 . . . . 0.0 113.175 . . . . . . . . . 0 0 . 1 . 069 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 14.5 m -69.11 -45.68 69.59 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.582 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.526 ' CE2' HG21 ' A' ' 43' ' ' VAL . 64.8 t80 -57.3 -45.93 83.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.364 -179.327 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 90.6 mt -64.53 -41.37 96.41 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -179.91 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -64.09 -39.11 93.35 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.967 -178.95 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -61.82 -41.64 98.03 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.544 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.603 ' O ' HG23 ' B' ' 249' ' ' VAL . 71.3 ttp85 -60.9 -42.51 98.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.981 179.847 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.18 -40.59 90.52 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.097 -179.506 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 68.6 m -68.07 -42.99 79.61 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.481 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . 0.838 ' NE2' HH12 ' A' ' 12' ' ' ARG . 56.0 tt0 -62.37 -38.07 88.13 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.61 -179.18 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . 0.603 HG23 ' O ' ' B' ' 245' ' ' ARG . 77.8 t . . . . . 0 N--CA 1.454 -0.267 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.108 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.603 ' OE1' ' NH2' ' A' ' 93' ' ' ARG . 90.8 mt-10 . . . . . 0 N--CA 1.456 -0.163 0 CA-C-O 121.237 0.541 . . . . 0.0 110.702 . . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.421 ' CD1' HG23 ' A' ' 9' ' ' THR . 50.5 mt -107.87 139.42 29.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.762 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 61.1 t -126.73 135.27 64.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.511 -179.741 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -98.97 121.54 41.05 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.302 0.572 . . . . 0.0 111.089 -178.833 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -64.66 -46.72 81.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.952 179.913 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . 0.431 ' CD ' HD11 ' A' ' 24' ' ' LEU . 21.7 mm-40 -93.15 150.09 38.57 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.956 -179.269 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.7 148.54 65.7 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.549 2.166 . . . . 0.0 112.678 -179.869 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.3 pt . . . . . 0 C--N 1.327 -0.39 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.535 179.589 . . . . . . . . 0 0 . 1 . 070 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 41.4 p . . . . . 0 CA--C 1.523 -0.076 0 CA-C-O 120.78 0.324 . . . . 0.0 110.699 . . . . . . . . . 0 0 . 1 . 070 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.816 ' NE ' HD13 ' A' ' 53' ' ' ILE . 89.7 mtm-85 -88.66 123.68 33.35 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.751 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -130.79 138.48 49.93 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -178.393 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.565 HD11 HD11 ' A' ' 22' ' ' LEU . 68.2 mt -112.98 133.52 54.9 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.088 178.645 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 66.4 t -108.77 128.37 64.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.415 179.672 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.465 ' CG2' HD12 ' B' ' 261' ' ' ILE . 11.9 m -92.17 114.45 27.0 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.729 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.563 HD12 ' OG ' ' A' ' 94' ' ' SER . 96.4 mt -78.39 141.88 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.766 178.605 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.74 155.37 20.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.316 179.827 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -57.57 -31.96 66.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.682 -179.515 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.0 p -78.21 -8.3 58.16 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.146 0.498 . . . . 0.0 110.61 -179.877 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.76 38.2 6.21 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 -179.547 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 52.9 t -121.52 132.74 70.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.716 -0.393 . . . . 0.0 111.153 -179.49 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -68.54 116.61 9.28 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.795 -0.816 . . . . 0.0 108.795 179.53 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -107.53 -131.32 6.58 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.994 -178.975 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.58 149.45 61.7 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 121.945 1.763 . . . . 0.0 112.816 -178.63 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -106.85 145.0 32.68 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.598 179.351 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -115.17 96.45 45.41 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.184 -178.805 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.3 134.03 20.27 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.337 1.358 . . . . 0.0 112.311 -179.048 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.565 HD11 HD11 ' A' ' 7' ' ' LEU . 95.5 mt -84.54 83.02 8.15 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.017 -179.172 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 24.3 p -87.31 -12.03 47.73 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.535 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 58.9 mt -99.47 142.41 30.98 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.178 -179.732 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 77.9 p -66.82 -14.92 63.21 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.283 -178.953 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.0 m -130.73 131.98 45.08 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.973 0.416 . . . . 0.0 111.147 -179.721 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.498 ' HB2' HD22 ' A' ' 22' ' ' LEU . 9.9 t -125.71 119.44 28.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.453 178.992 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.439 HD21 ' HG2' ' A' ' 47' ' ' GLN . 50.5 tp -116.15 131.11 57.03 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.837 0.351 . . . . 0.0 111.408 -178.27 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.697 ' CE2' HD12 ' A' ' 37' ' ' ILE . 10.8 m-85 -108.8 143.29 38.16 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.63 179.704 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 156.74 -152.98 24.32 Favored Glycine 0 C--O 1.223 -0.536 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.262 179.448 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.539 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 32.9 mtm180 -108.0 -26.48 10.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.806 0.336 . . . . 0.0 110.414 179.251 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.562 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -58.29 155.39 22.95 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 121.205 -0.521 . . . . 0.0 111.917 -178.639 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.432 HD13 ' HA ' ' A' ' 33' ' ' ILE . 35.9 mm -63.4 -42.56 96.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.753 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -55.06 -29.6 57.85 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.147 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.562 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 5.7 m -53.99 113.82 1.37 Allowed 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.085 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -59.08 -23.93 62.49 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -178.558 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.697 HD12 ' CE2' ' A' ' 29' ' ' PHE . 91.1 mt -128.4 121.95 56.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 177.197 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.432 ' O ' ' N ' ' B' ' 262' ' ' VAL . 43.4 mtm180 -110.64 136.81 49.17 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.359 -179.151 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.63 HD13 ' HE ' ' A' ' 93' ' ' ARG . 93.3 mt -115.66 128.91 72.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.688 179.397 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -71.71 33.72 0.06 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.704 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.713 HD12 ' CZ ' ' A' ' 93' ' ' ARG . 41.6 mt -115.39 131.57 23.54 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 120.189 -0.604 . . . . 0.0 111.14 179.739 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.4 ' O ' ' HD2' ' B' ' 235' ' ' PRO . 57.0 Cg_endo -71.26 -15.11 31.69 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.345 2.03 . . . . 0.0 113.321 -179.637 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.553 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 26.2 m -84.25 -0.49 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-O 121.009 0.433 . . . . 0.0 110.534 179.61 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.539 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 66.4 t -94.65 133.07 36.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.6 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 38.4 t -71.85 170.73 13.05 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.465 0.65 . . . . 0.0 111.962 -178.335 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.558 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 51.7 mttp -62.48 -40.43 96.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.424 -179.874 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.695 ' O ' ' N ' ' A' ' 49' ' ' CYS . 86.2 mt-30 -119.55 -15.01 9.06 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 123.239 0.337 . . . . 0.0 111.65 -179.249 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.6 t60 32.41 -71.91 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 179.534 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.695 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -134.44 137.34 43.91 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.952 -178.582 . . . . . . . . 3 3 . 1 . 070 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -127.41 131.04 50.36 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.045 179.416 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.6 mt -116.74 135.32 57.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.441 -179.606 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -117.28 124.76 49.79 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.765 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.816 HD13 ' NE ' ' A' ' 5' ' ' ARG . 80.9 mt -104.72 115.75 47.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.724 0.773 . . . . 0.0 112.096 -178.788 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.588 ' O ' ' N ' ' A' ' 56' ' ' GLN . 96.9 m-70 -112.59 141.59 46.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.547 -1.206 . . . . 0.0 108.844 179.129 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 54' ' ' HIS . 50.6 tp10 -39.36 -24.57 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -179.336 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.588 ' N ' ' O ' ' A' ' 54' ' ' HIS . 49.8 tt0 -64.93 -68.2 0.38 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.123 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.93 -155.15 0.4 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.484 178.476 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.431 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -116.86 126.04 52.43 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.711 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 99.2 mt -114.92 131.09 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 121.152 0.501 . . . . 0.0 112.064 -178.628 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.52 ' HB2' HD11 ' A' ' 82' ' ' LEU . 23.9 tp -101.5 129.29 47.54 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.389 -179.451 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -113.23 136.0 53.21 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.577 -179.896 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.449 HD21 ' HA ' ' A' ' 68' ' ' PRO . 41.0 t30 -95.87 105.34 17.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.559 179.998 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -99.12 -10.11 22.95 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.803 179.56 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.41 98.49 11.04 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.865 179.709 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.8 m -75.55 -30.29 59.67 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.407 178.998 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.598 ' CG2' HG12 ' B' ' 236' ' ' VAL . 5.4 m -61.01 -45.42 94.88 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.856 -179.296 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.2 m-20 -144.07 102.18 4.84 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.982 -179.659 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.449 ' HA ' HD21 ' A' ' 62' ' ' ASN . 32.4 Cg_exo -56.39 146.01 75.81 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 121.479 1.452 . . . . 0.0 112.343 179.554 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.7 m -73.07 144.39 47.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.144 179.17 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -102.8 138.68 39.37 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.491 179.399 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.433 HG22 HG12 ' A' ' 88' ' ' ILE . 52.2 t -132.78 131.63 59.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.185 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 54.3 34.12 19.83 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.131 -0.628 . . . . 0.0 109.978 -179.43 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.52 25.56 72.2 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.647 178.901 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 29.1 t -145.55 142.49 29.21 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 117.524 0.662 . . . . 0.0 111.34 179.751 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.404 HG12 ' H ' ' A' ' 75' ' ' VAL . 0.2 OUTLIER -73.2 141.63 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.838 179.749 . . . . . . . . 3 3 . 1 . 070 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 11.4 pt -108.13 98.51 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-O 121.43 0.633 . . . . 0.0 110.888 179.0 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -66.23 -32.06 73.26 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.322 179.406 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -123.61 172.84 5.1 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.454 -179.283 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.63 146.72 94.53 Favored 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 122.468 2.112 . . . . 0.0 112.276 179.927 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.7 p -139.97 140.39 35.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.137 0.494 . . . . 0.0 111.304 -179.86 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -75.39 131.94 40.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.573 179.691 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.52 HD11 ' HB2' ' A' ' 60' ' ' LEU . 93.2 mt -87.27 138.39 31.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.274 0.559 . . . . 0.0 111.449 -179.645 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -130.1 156.43 44.55 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.665 179.368 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.552 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 4.7 t60 -59.86 123.83 18.25 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.604 -179.574 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.84 -13.86 45.64 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.877 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -69.7 136.99 51.72 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.472 -0.491 . . . . 0.0 109.864 179.728 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 50.7 t -113.61 130.64 67.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.837 -178.797 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.433 HG12 HG22 ' A' ' 71' ' ' VAL . 98.7 mt -103.84 133.33 48.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.734 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 95.8 m -128.58 129.89 46.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.907 0.861 . . . . 0.0 113.217 -178.379 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.465 ' O ' ' N ' ' A' ' 92' ' ' ASP . 92.8 mt -113.2 124.96 70.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.106 -1.406 . . . . 0.0 107.918 178.135 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.452 ' C ' ' O ' ' A' ' 90' ' ' ILE . 52.6 mt 34.68 -94.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.73 -178.719 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.623 ' OD1' ' NH1' ' A' ' 93' ' ' ARG . 31.5 p-10 -116.79 10.3 14.19 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.927 -179.754 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.713 ' CZ ' HD12 ' A' ' 41' ' ' LEU . 53.4 mtm-85 -122.39 139.43 53.85 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -179.581 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.563 ' OG ' HD12 ' A' ' 10' ' ' ILE . 58.5 p -140.31 155.33 46.86 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.961 -179.78 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -124.67 121.96 36.18 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.501 179.711 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -81.18 132.54 35.36 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 119.651 -0.819 . . . . 0.0 110.249 -179.901 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.626 ' OH ' ' ND2' ' A' ' 99' ' ' ASN . 87.2 t80 -102.02 124.98 48.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.494 -178.873 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -140.49 127.7 21.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.045 179.148 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.626 ' ND2' ' OH ' ' A' ' 97' ' ' TYR . 94.3 m-20 . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.166 178.996 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . 0.4 ' HD2' ' O ' ' A' ' 42' ' ' PRO . 31.6 Cg_exo . . . . . 0 N--CA 1.487 1.109 0 CA-C-O 121.914 0.714 . . . . 0.0 112.26 . . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.598 HG12 ' CG2' ' A' ' 66' ' ' THR . 3.6 m -66.76 138.69 22.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 114.552 -1.204 . . . . 0.0 110.263 -178.996 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.5 t . . . . . 0 C--N 1.323 -0.556 0 C-N-CA 120.392 -0.523 . . . . 0.0 109.7 179.918 . . . . . . . . 0 0 . 1 . 070 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_exo . . . . . 0 N--CA 1.498 1.779 0 CA-C-O 120.69 0.204 . . . . 0.0 112.137 . . . . . . . . . 0 0 . 1 . 070 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 71.4 m -68.88 -44.77 72.6 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.004 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.713 ' CD1' ' NH2' ' B' ' 245' ' ' ARG . 62.7 t80 -58.07 -46.1 86.0 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.503 -179.4 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.417 ' HA ' HD23 ' B' ' 242' ' ' LEU . 71.9 mt -62.11 -41.04 97.82 Favored 'General case' 0 N--CA 1.462 0.127 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 179.972 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.83 -39.36 93.45 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.208 -179.471 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -59.47 -44.24 93.06 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.659 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.713 ' NH2' ' CD1' ' B' ' 241' ' ' PHE . 0.6 OUTLIER -62.22 -40.9 97.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.44 179.423 . . . . . . . . 3 3 . 1 . 070 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -61.98 -43.74 98.2 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.477 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 38.9 t -63.13 -44.19 96.25 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.529 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -61.35 -33.66 73.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.355 179.764 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . 0.521 HG23 ' O ' ' B' ' 245' ' ' ARG . 51.3 t . . . . . 0 C--N 1.333 -0.132 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.013 179.548 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 . . . . . 0 N--CA 1.455 -0.176 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 . . . . . . . . . 0 0 . 1 . 070 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.465 HD12 ' CG2' ' A' ' 9' ' ' THR . 73.6 mt -109.57 132.88 56.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.335 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . 0.432 ' N ' ' O ' ' A' ' 38' ' ' ARG . 53.7 t -124.37 133.19 70.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.605 -178.775 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -98.91 121.59 41.07 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.135 0.493 . . . . 0.0 111.936 -178.382 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -65.59 -44.04 87.84 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.621 179.417 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.23 158.51 83.85 Favored Pre-proline 0 CA--C 1.517 -0.312 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.828 -179.102 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -57.79 139.47 90.41 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 C-N-CA 122.2 1.933 . . . . 0.0 111.302 179.444 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 19.1 tt . . . . . 0 N--CA 1.441 -0.876 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.206 -179.313 . . . . . . . . 0 0 . 1 . 071 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 99' ' ' ASN . 2.5 t . . . . . 0 N--CA 1.454 -0.237 0 CA-C-O 120.986 0.422 . . . . 0.0 109.881 . . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.66 HH11 ' HH ' ' A' ' 97' ' ' TYR . 94.9 mtt-85 -81.64 135.7 35.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.038 179.894 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.4 mtp180 -130.54 140.37 50.47 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 121.504 0.669 . . . . 0.0 112.469 -178.63 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.613 HD12 ' O ' ' A' ' 96' ' ' ARG . 44.4 tp -117.16 133.56 55.85 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.154 179.391 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.2 t -109.33 130.97 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.264 -178.752 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.44 HG23 ' CD1' ' B' ' 261' ' ' ILE . 9.7 m -89.96 115.59 27.37 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 121.316 0.579 . . . . 0.0 112.357 -178.842 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.424 HD12 ' HB2' ' A' ' 94' ' ' SER . 94.1 mt -83.9 143.37 11.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.641 178.725 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -86.95 155.0 20.37 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.4 178.364 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.759 HH11 HH11 ' B' ' 245' ' ' ARG . 91.1 mtm180 -52.92 -26.99 16.73 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.848 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 91.6 p -81.36 -6.26 58.72 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.292 179.309 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.63 36.95 9.91 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.322 -179.267 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 36.1 t -120.62 137.09 55.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.953 0.406 . . . . 0.0 111.453 -178.883 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -76.56 121.26 22.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.149 -179.504 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -117.18 -123.79 3.44 Favored Glycine 0 CA--C 1.542 1.739 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -179.786 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -74.8 148.88 36.89 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 122.48 2.12 . . . . 0.0 113.134 -179.359 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -102.96 165.97 10.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.293 179.03 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.678 ' CD2' HD11 ' A' ' 37' ' ' ILE . 52.8 t80 -134.63 97.44 14.23 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.206 -179.248 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.79 122.66 10.81 Favored 'Trans proline' 0 N--CA 1.501 1.943 0 C-N-CA 122.441 2.094 . . . . 0.0 112.694 -179.896 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.6 mt -83.94 49.53 1.65 Allowed 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 121.126 -0.23 . . . . 0.0 111.375 -179.477 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 91.6 p -65.23 -22.55 66.89 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.051 0.453 . . . . 0.0 109.789 179.396 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 80.5 mt -77.58 139.48 39.54 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.991 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.81 -17.52 63.19 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.223 -0.444 . . . . 0.0 112.047 -178.28 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 86.2 m -133.26 133.97 43.34 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.444 -179.613 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.7 t -122.98 114.79 20.88 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.107 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.518 HD21 ' HG2' ' A' ' 47' ' ' GLN . 31.4 tp -111.09 128.43 55.88 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.489 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.52 ' O ' ' O ' ' A' ' 47' ' ' GLN . 55.8 m-85 -108.44 137.05 47.05 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.939 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 165.77 -170.94 40.79 Favored Glycine 0 C--O 1.224 -0.52 0 C-N-CA 119.833 -1.175 . . . . 0.0 112.555 179.786 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 37.4 ttp85 -90.19 -30.04 17.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.078 -0.561 . . . . 0.0 111.489 179.843 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.495 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -57.26 155.25 17.92 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.714 -0.555 . . . . 0.0 111.714 -179.226 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.527 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.2 tp -66.71 -42.43 89.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.594 -179.704 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.527 ' N ' HG23 ' A' ' 33' ' ' ILE . 16.2 pt-20 -58.95 -13.42 6.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.362 -179.418 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.577 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 6.6 m -68.27 128.54 36.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.979 0.418 . . . . 0.0 110.414 -179.507 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.445 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 61.9 m-20 -60.18 -32.84 71.45 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.469 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.678 HD11 ' CD2' ' A' ' 20' ' ' PHE . 47.1 mm -119.59 111.29 32.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 177.275 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 88.4 mtm-85 -100.47 133.57 44.7 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.722 -178.327 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.426 HD13 ' HE ' ' A' ' 93' ' ' ARG . 96.7 mt -118.91 129.64 74.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.317 0.58 . . . . 0.0 109.813 178.839 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -72.44 33.82 0.06 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.221 -0.9 . . . . 0.0 112.782 -177.381 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.553 ' CD1' ' CZ ' ' A' ' 93' ' ' ARG . 49.6 mt -110.48 133.23 21.19 Favored Pre-proline 0 N--CA 1.468 0.44 0 C-N-CA 119.81 -0.756 . . . . 0.0 111.834 -179.855 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -71.35 -9.38 25.2 Favored 'Trans proline' 0 N--CA 1.488 1.164 0 C-N-CA 122.363 2.042 . . . . 0.0 113.107 -179.11 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.1 m -102.6 6.11 10.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.018 179.864 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 24.1 t -90.91 133.7 31.86 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.956 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.3 m -68.46 158.07 34.52 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.127 -178.83 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.577 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 9.2 mtmp? -63.39 -39.29 94.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.24 -179.506 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.652 ' O ' ' N ' ' A' ' 49' ' ' CYS . 97.9 mt-30 -114.13 -21.43 10.51 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-O 120.885 0.374 . . . . 0.0 110.318 179.559 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.4 t60 33.06 -74.17 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -179.711 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.652 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -129.82 133.28 46.85 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.121 0.486 . . . . 0.0 111.909 -179.001 . . . . . . . . 3 3 . 1 . 071 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -125.27 126.67 45.51 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.809 179.668 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 94.8 mt -113.4 132.51 62.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.606 -179.766 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -112.3 134.87 53.6 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 178.74 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 49.8 mm -104.43 112.86 39.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.752 -179.471 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.443 ' C ' ' N ' ' A' ' 56' ' ' GLN . 97.5 m-70 -116.07 135.36 54.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.944 179.163 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.533 ' H ' ' CD ' ' A' ' 55' ' ' GLU . 53.8 mp0 -41.2 -29.6 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.546 0.689 . . . . 0.0 109.454 -179.58 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.443 ' N ' ' C ' ' A' ' 54' ' ' HIS . 24.4 mt-30 -67.83 -67.75 0.44 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.394 178.526 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.462 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 4.3 tp10 -155.51 -168.46 2.83 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.742 -179.404 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.462 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -116.09 124.47 50.48 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.388 179.121 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.8 mt -110.52 128.8 66.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 120.867 0.365 . . . . 0.0 111.936 -178.928 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.53 ' HB2' HD11 ' A' ' 82' ' ' LEU . 32.2 tp -94.97 124.56 39.09 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.875 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -110.09 134.24 52.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.958 -179.392 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -93.08 108.41 20.0 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.227 -179.234 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -103.36 -11.62 17.77 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.516 179.331 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.474 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 2.1 t -73.77 99.0 3.05 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.452 -179.676 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.5 t -77.22 -43.01 35.14 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.102 0.477 . . . . 0.0 110.552 178.691 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.1 p -66.8 -39.76 87.85 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.865 -179.001 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.474 ' O ' ' OG ' ' A' ' 64' ' ' SER . 39.6 m-80 -142.84 97.43 5.88 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.672 -179.361 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.547 ' HB2' HG23 ' A' ' 75' ' ' VAL . 51.6 Cg_exo -54.2 144.21 60.25 Favored 'Trans proline' 0 N--CA 1.502 2.005 0 C-N-CA 122.636 2.224 . . . . 0.0 113.5 -179.813 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 16.4 m -69.65 134.85 49.19 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.547 178.413 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -102.62 138.49 39.46 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.054 -0.658 . . . . 0.0 109.987 179.71 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 75.9 t -131.44 133.97 61.35 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.473 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.831 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 53.91 33.75 17.96 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -178.767 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.54 29.46 72.92 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.335 -179.666 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 73.4 m -141.11 136.14 31.63 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.007 0.432 . . . . 0.0 111.577 -179.633 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.547 HG23 ' HB2' ' A' ' 68' ' ' PRO . 1.3 p -68.74 142.51 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.681 179.929 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.7 pt -119.46 88.28 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.139 178.729 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -68.01 -26.23 65.79 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.411 0.624 . . . . 0.0 109.588 178.329 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -113.8 159.07 37.23 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 114.935 -1.029 . . . . 0.0 109.889 179.532 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.32 155.1 71.9 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.147 1.898 . . . . 0.0 111.5 179.916 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.0 m -149.65 146.51 16.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.874 -179.222 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.6 mtm-85 -72.19 131.53 42.89 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.366 179.494 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.53 HD11 ' HB2' ' A' ' 60' ' ' LEU . 99.7 mt -82.63 139.09 33.95 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.423 0.63 . . . . 0.0 110.255 179.75 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -124.34 150.17 45.78 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.221 -179.906 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.516 ' C ' ' CD2' ' A' ' 84' ' ' HIS . 5.9 t60 -63.25 126.04 26.11 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 119.719 -0.793 . . . . 0.0 109.495 -179.764 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.07 -18.94 33.2 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.207 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -69.16 143.26 54.12 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.428 179.586 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.4 p -112.57 134.81 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.781 -178.528 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 85.9 mt -103.06 131.15 52.0 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.526 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 53.6 m -121.18 127.85 51.9 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.616 0.722 . . . . 0.0 112.312 -179.106 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.453 ' O ' ' N ' ' A' ' 92' ' ' ASP . 98.0 mt -121.05 128.32 76.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.211 179.886 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.445 ' C ' ' O ' ' A' ' 90' ' ' ILE . 39.4 mm 39.26 -98.58 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.685 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.534 ' O ' ' OD1' ' A' ' 92' ' ' ASP . 65.5 t0 -125.04 23.07 7.85 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.546 0.688 . . . . 0.0 110.642 179.387 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.553 ' CZ ' ' CD1' ' A' ' 41' ' ' LEU . 38.0 mtm-85 -129.52 142.44 50.77 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.147 -0.933 . . . . 0.0 108.865 179.862 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.424 ' HB2' HD12 ' A' ' 10' ' ' ILE . 58.8 m -135.21 151.22 50.42 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.031 -179.414 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.596 ' HB3' HD11 ' A' ' 7' ' ' LEU . 58.4 m-85 -126.93 120.42 29.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.594 179.179 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.613 ' O ' HD12 ' A' ' 7' ' ' LEU . 99.5 mtt180 -83.12 129.55 35.03 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.151 -0.619 . . . . 0.0 110.644 179.846 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.66 ' HH ' HH11 ' A' ' 5' ' ' ARG . 93.8 t80 -94.38 126.85 39.9 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.814 179.748 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -142.82 122.46 13.32 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.015 0.436 . . . . 0.0 111.274 -179.879 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.472 ' O ' ' O ' ' A' ' 4' ' ' THR . 86.8 m-20 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.502 179.813 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo . . . . . 0 N--CA 1.489 1.226 0 CA-C-O 121.448 0.52 . . . . 0.0 112.929 . . . . . . . . . 0 0 . 1 . 071 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 14.7 p -62.28 134.95 27.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.49 -179.869 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 7.4 t . . . . . 0 C--N 1.329 -0.298 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.541 . . . . . . . . 0 0 . 1 . 071 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo . . . . . 0 N--CA 1.493 1.443 0 CA-C-O 120.947 0.311 . . . . 0.0 111.427 . . . . . . . . . 0 0 . 1 . 071 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 95.6 m -68.47 -45.23 72.97 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.352 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.538 ' HZ ' HD22 ' A' ' 41' ' ' LEU . 82.3 t80 -58.59 -48.6 80.42 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.182 179.737 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 86.8 mt -64.69 -42.0 95.62 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.916 0.389 . . . . 0.0 110.971 -179.917 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -66.04 -47.06 75.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.282 -179.287 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -62.55 -41.85 99.16 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.167 -179.743 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.759 HH11 HH11 ' A' ' 12' ' ' ARG . 52.1 ttm-85 -64.17 -39.45 94.03 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.188 -179.727 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -59.28 -38.44 80.16 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.361 0.601 . . . . 0.0 109.468 179.923 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 15.9 m -67.14 -42.21 84.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.778 177.974 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -64.04 -31.14 72.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.46 179.881 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 55.6 t . . . . . 0 N--CA 1.456 -0.138 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.065 178.513 . . . . . . . . 0 0 . 1 . 071 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.526 ' OE1' HD21 ' A' ' 41' ' ' LEU . 99.2 mt-10 . . . . . 0 N--CA 1.452 -0.354 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 . . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.44 ' CD1' HG23 ' A' ' 9' ' ' THR . 66.3 mt -107.94 136.41 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 177.845 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 55.2 t -127.59 135.34 63.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.88 -178.618 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -94.74 117.16 29.69 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.907 -178.744 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -64.5 -46.11 84.37 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.264 179.935 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.68 158.24 36.95 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.657 -179.53 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -61.24 147.43 95.63 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 C-N-CA 123.041 2.494 . . . . 0.0 112.609 179.47 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.4 pt . . . . . 0 C--N 1.326 -0.427 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.073 -179.783 . . . . . . . . 0 0 . 1 . 072 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.4 p . . . . . 0 CA--C 1.531 0.224 0 CA-C-O 120.598 0.237 . . . . 0.0 111.501 . . . . . . . . . 0 0 . 1 . 072 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.728 ' NE ' HD13 ' A' ' 53' ' ' ILE . 91.7 mtm-85 -100.72 115.5 30.41 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 121.031 -0.268 . . . . 0.0 110.761 -179.57 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -131.65 141.23 49.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.277 0.56 . . . . 0.0 111.427 179.769 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.564 HD11 ' HB3' ' A' ' 95' ' ' PHE . 36.4 tp -114.47 127.7 55.95 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.413 179.908 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.575 HG13 ' CD2' ' A' ' 19' ' ' HIS . 75.8 t -103.15 127.86 56.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.521 -0.471 . . . . 0.0 110.268 -179.406 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 m -92.85 114.45 27.01 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 121.113 0.482 . . . . 0.0 111.398 -179.52 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.442 HD12 ' HB2' ' A' ' 94' ' ' SER . 85.9 mt -80.86 146.78 6.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.419 179.746 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -90.3 154.17 19.91 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 177.811 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.48 ' NH1' ' OD2' ' A' ' 92' ' ' ASP . 38.4 mtp85 -58.04 -28.71 64.75 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.547 -179.245 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 86.0 p -74.81 -14.9 60.74 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.606 -0.437 . . . . 0.0 110.142 178.949 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.54 36.44 4.84 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 -179.518 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.6 t -123.72 133.78 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-O 120.848 0.356 . . . . 0.0 111.68 -179.447 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -66.02 125.87 26.83 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.364 179.512 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -117.28 -126.98 3.83 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.458 -178.951 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -73.76 147.33 39.61 Favored 'Trans proline' 0 N--CA 1.5 1.874 0 C-N-CA 122.604 2.203 . . . . 0.0 112.955 -178.446 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.575 ' CD2' HG13 ' A' ' 8' ' ' VAL . 62.7 m170 -109.23 132.17 54.37 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.913 0.387 . . . . 0.0 110.705 -179.955 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.462 ' CD2' HD11 ' A' ' 37' ' ' ILE . 32.1 t80 -102.22 105.42 42.76 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.936 -179.893 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -74.93 128.66 11.72 Favored 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 121.464 1.443 . . . . 0.0 111.529 -179.418 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 64.9 mt -89.99 44.17 1.19 Allowed 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.387 -178.472 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 84.8 p -59.23 -21.94 60.31 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.408 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 73.6 mt -76.92 146.05 37.82 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.326 179.836 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.0 m -64.24 -23.18 67.21 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.23 -178.981 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 61.2 m -136.26 136.45 39.84 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.897 -179.039 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.1 t -128.01 120.05 26.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.062 179.063 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.404 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 57.4 tp -114.81 132.34 56.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.641 0.258 . . . . 0.0 111.112 -178.749 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.754 ' CE2' HD12 ' A' ' 37' ' ' ILE . 5.9 m-85 -111.92 139.8 47.11 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.902 179.715 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.44 -167.56 30.84 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 120.564 -0.826 . . . . 0.0 112.164 178.755 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.542 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 45.8 mtm180 -84.5 -32.0 24.19 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.867 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.572 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -49.49 143.69 9.65 Favored Glycine 0 CA--C 1.519 0.323 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 -178.662 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.49 HD12 ' HD2' ' A' ' 38' ' ' ARG . 7.0 tp -65.99 -41.1 89.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 120.248 -0.581 . . . . 0.0 109.932 179.995 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.443 ' N ' HG23 ' A' ' 33' ' ' ILE . 82.5 tt0 -54.71 -20.48 8.42 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.228 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.572 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 34.2 m -59.65 126.54 28.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.924 -179.834 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.404 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 56.1 m-20 -59.83 -31.98 70.24 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.249 0.547 . . . . 0.0 109.547 -179.623 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.754 HD12 ' CE2' ' A' ' 29' ' ' PHE . 97.4 mt -123.83 116.56 48.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.148 177.761 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.49 ' HD2' HD12 ' A' ' 33' ' ' ILE . 25.9 mtp85 -100.86 132.39 46.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.434 -178.197 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.796 HG21 ' NH2' ' A' ' 93' ' ' ARG . 92.8 mt -121.7 131.11 73.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.987 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.413 ' H ' ' HG2' ' A' ' 40' ' ' GLN . 13.5 pt20 -79.53 34.16 0.26 Allowed 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -177.849 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.959 HD12 HH21 ' A' ' 93' ' ' ARG . 23.6 mt -104.76 127.88 27.96 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.895 178.92 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -73.42 -9.49 23.03 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 122.303 2.002 . . . . 0.0 112.277 -179.997 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.0 m -91.73 1.09 8.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.73 0.3 . . . . 0.0 110.677 179.798 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.542 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 42.8 t -98.35 138.02 24.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.989 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 64.0 m -72.38 170.58 13.91 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.101 0.477 . . . . 0.0 111.364 -178.794 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -62.48 -41.41 98.77 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.884 -179.099 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.626 ' O ' ' N ' ' A' ' 49' ' ' CYS . 89.6 mt-30 -111.44 -18.5 12.85 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.631 0.253 . . . . 0.0 111.489 -179.698 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.49 ' NE2' HG23 ' A' ' 90' ' ' ILE . 12.6 t60 36.61 -77.06 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 179.262 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.626 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.66 136.08 47.41 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.067 0.461 . . . . 0.0 111.559 -178.475 . . . . . . . . 3 3 . 1 . 072 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -129.45 132.17 46.89 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.477 179.774 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.7 mt -115.13 134.31 58.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.855 -179.745 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -116.65 124.22 49.22 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.783 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.728 HD13 ' NE ' ' A' ' 5' ' ' ARG . 98.0 mt -107.25 114.69 46.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.483 -179.668 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.459 ' O ' ' N ' ' A' ' 56' ' ' GLN . 89.5 m-70 -114.22 145.95 41.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.831 179.924 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 54' ' ' HIS . 53.4 tp10 -40.7 -28.63 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.603 -179.819 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.459 ' N ' ' O ' ' A' ' 54' ' ' HIS . 84.1 mt-30 -63.53 -68.79 0.32 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.962 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.467 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 6.1 tp10 -159.9 -163.48 1.15 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.996 179.379 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.467 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -110.3 127.49 55.04 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.659 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.7 mt -117.22 130.2 72.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.371 0.605 . . . . 0.0 112.099 -178.911 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.8 tp -99.17 129.12 45.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.292 -179.74 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -114.53 137.48 51.81 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.618 179.975 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.438 HD21 ' HA ' ' A' ' 68' ' ' PRO . 54.1 t30 -97.61 107.55 20.08 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.374 -179.757 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -98.9 -10.1 23.29 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 179.918 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.2 t -74.98 102.71 4.9 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.548 179.429 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.7 p -82.28 -17.7 44.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.98 0.419 . . . . 0.0 110.382 179.764 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.513 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -91.24 -39.96 11.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.009 -179.102 . . . . . . . . 3 3 . 1 . 072 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.469 ' OD1' HG13 ' B' ' 236' ' ' VAL . 71.2 m-20 -140.65 94.52 8.22 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.555 -179.936 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.504 ' HB2' HG13 ' A' ' 75' ' ' VAL . 32.2 Cg_exo -57.01 146.34 80.91 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.005 1.804 . . . . 0.0 112.028 -179.404 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.1 m -72.93 137.48 45.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.496 179.967 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -100.76 141.27 33.87 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.104 -179.827 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 46.0 t -127.2 136.95 59.24 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.155 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 51.29 32.31 8.13 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.714 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.96 29.92 68.52 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 -179.965 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.3 p -140.25 134.76 31.52 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 120.641 -0.423 . . . . 0.0 111.644 -179.3 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.504 HG13 ' HB2' ' A' ' 68' ' ' PRO . 52.9 t -67.8 132.89 32.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-O 121.248 0.547 . . . . 0.0 110.929 179.708 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.13 111.39 25.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.807 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -96.25 -10.62 27.54 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.734 -0.387 . . . . 0.0 111.772 -178.592 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -117.25 158.12 45.36 Favored Pre-proline 0 C--N 1.329 -0.3 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.627 -179.412 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -56.12 142.49 86.31 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 121.919 1.746 . . . . 0.0 112.216 179.522 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 18.9 m -144.57 139.96 23.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.623 179.306 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 89.3 mtm-85 -72.91 133.07 44.22 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.876 0.37 . . . . 0.0 110.176 179.758 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.441 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 93.7 mt -81.45 138.98 35.48 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.169 -179.434 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -126.78 148.91 49.89 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.466 179.429 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.423 ' ND1' ' N ' ' A' ' 99' ' ' ASN . 12.4 t60 -58.48 124.89 21.14 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.886 0.374 . . . . 0.0 111.209 -178.667 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.07 -20.96 34.69 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.444 -0.662 . . . . 0.0 111.444 179.967 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -66.87 138.44 57.32 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 120.491 -0.483 . . . . 0.0 110.023 179.731 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.507 HG22 ' HG2' ' A' ' 96' ' ' ARG . 79.5 t -110.36 132.69 58.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.25 -178.747 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 82.5 mt -100.63 132.6 45.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.324 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 93.7 m -120.82 125.52 47.76 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.032 -0.667 . . . . 0.0 112.172 -178.203 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.49 HG23 ' NE2' ' A' ' 48' ' ' HIS . 96.2 mt -116.25 123.96 71.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.019 -0.991 . . . . 0.0 108.61 178.694 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.541 HG22 ' N ' ' A' ' 92' ' ' ASP . 48.8 mm 39.72 -106.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.618 -179.318 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.541 ' N ' HG22 ' A' ' 91' ' ' ILE . 32.8 p-10 -110.1 13.09 23.34 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.787 0.327 . . . . 0.0 111.698 -179.346 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.959 HH21 HD12 ' A' ' 41' ' ' LEU . 9.5 mtm105 -118.51 140.4 49.94 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.198 179.732 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.442 ' HB2' HD12 ' A' ' 10' ' ' ILE . 17.0 m -128.88 144.8 51.28 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.006 179.007 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.564 ' HB3' HD11 ' A' ' 7' ' ' LEU . 41.7 m-85 -126.73 123.53 37.69 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.497 -179.782 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.507 ' HG2' HG22 ' A' ' 87' ' ' VAL . 99.7 mtt180 -85.95 128.49 34.85 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 119.953 -0.699 . . . . 0.0 109.721 -179.754 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -93.98 127.98 40.07 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 120.897 0.38 . . . . 0.0 110.495 -179.995 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -126.56 128.79 47.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.56 -179.323 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.423 ' N ' ' ND1' ' A' ' 84' ' ' HIS . 43.8 t30 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.538 179.485 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 N--CA 1.488 1.184 0 CA-C-O 121.071 0.363 . . . . 0.0 112.763 . . . . . . . . . 0 0 . 1 . 072 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.513 ' CG2' HG22 ' A' ' 66' ' ' THR . 77.5 t -59.83 134.98 24.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.664 -179.625 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 4.5 t . . . . . 0 C--N 1.327 -0.412 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.493 -179.117 . . . . . . . . 0 0 . 1 . 072 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo . . . . . 0 N--CA 1.489 1.207 0 N-CA-C 111.736 -0.14 . . . . 0.0 111.736 . . . . . . . . . 0 0 . 1 . 072 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 73.5 m -75.07 -45.36 41.97 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 176.956 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -57.07 -47.52 80.8 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.265 -179.106 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' B' ' 242' ' ' LEU . 93.0 mt -66.07 -39.85 90.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.15 -179.611 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -62.4 -42.18 99.23 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.577 -179.257 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -63.39 -42.0 98.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.019 0.438 . . . . 0.0 110.058 179.523 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.533 ' CA ' ' HE ' ' B' ' 245' ' ' ARG . 0.0 OUTLIER -63.19 -43.15 99.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.81 -179.348 . . . . . . . . 3 3 . 1 . 072 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.76 -37.71 87.7 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.66 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 39.0 t -64.71 -42.61 95.13 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 177.29 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -59.26 -36.88 76.31 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.073 179.997 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . 0.459 HG23 HH21 ' A' ' 12' ' ' ARG . 46.3 t . . . . . 0 C--O 1.23 0.057 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.129 178.829 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.599 ' O ' HG23 ' A' ' 39' ' ' ILE . 93.5 mt-10 . . . . . 0 N--CA 1.453 -0.32 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 . . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 16.8 mt -115.84 135.85 54.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.51 -179.627 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 45.2 t -127.23 133.72 67.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.537 179.272 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -96.37 119.93 35.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.151 0.5 . . . . 0.0 111.711 -178.638 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -65.45 -44.51 87.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.335 178.964 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -100.25 157.35 33.97 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.979 -179.171 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.4 157.51 54.22 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.945 2.43 . . . . 0.0 112.0 178.763 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 45.3 pt . . . . . 0 C--N 1.33 -0.258 0 CA-C-O 121.336 0.588 . . . . 0.0 112.306 -178.868 . . . . . . . . 0 0 . 1 . 073 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.4 t . . . . . 0 C--O 1.235 0.291 0 CA-C-O 120.843 0.354 . . . . 0.0 110.145 . . . . . . . . . 0 0 . 1 . 073 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -94.07 123.1 37.23 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.918 -179.57 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 -128.23 137.14 51.89 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.214 -179.903 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.6 HD11 ' HB3' ' A' ' 95' ' ' PHE . 39.6 tp -112.87 130.98 55.91 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.845 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 66.7 t -109.53 130.99 61.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.325 -179.439 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 m -90.87 118.56 30.37 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.163 -178.765 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.598 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 96.0 mt -81.63 140.54 16.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.063 179.282 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.483 ' HA ' HH22 ' A' ' 93' ' ' ARG . 41.5 mmtt -83.71 158.91 21.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.955 0.407 . . . . 0.0 110.058 178.89 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.58 ' N ' HH12 ' A' ' 93' ' ' ARG . 85.4 mtp180 -57.74 -35.48 70.76 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.12 -178.646 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.4 t -76.08 -8.52 57.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.739 0.304 . . . . 0.0 111.414 -179.787 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.66 35.07 5.76 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 -179.184 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.6 t -121.84 132.9 69.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.785 0.326 . . . . 0.0 111.189 -179.72 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -77.71 137.12 38.31 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.313 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.95 -118.34 2.03 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 120.617 -0.802 . . . . 0.0 111.492 -179.63 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.53 151.96 48.03 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.216 1.944 . . . . 0.0 112.274 -179.25 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.459 ' CD2' ' C ' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -117.1 156.62 27.28 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.309 179.814 . . . . . . . . 3 3 . 1 . 073 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.457 ' CD2' HD11 ' A' ' 37' ' ' ILE . 49.1 t80 -124.04 107.03 30.83 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.924 -179.13 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.24 135.16 22.2 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 121.546 1.497 . . . . 0.0 111.961 -179.282 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.461 HD22 ' SG ' ' A' ' 27' ' ' CYS . 62.2 mt -96.44 40.95 1.12 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.166 -178.512 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.8 p -63.07 -18.47 63.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.146 0.498 . . . . 0.0 109.957 179.541 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.9 mt -75.53 149.49 38.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.504 179.219 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 26.3 m -62.99 -25.52 68.42 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.494 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.478 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 95.7 m -139.25 139.66 37.48 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 120.1 -0.64 . . . . 0.0 112.541 -179.59 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.461 ' SG ' HD22 ' A' ' 22' ' ' LEU . 4.0 t -128.09 116.63 20.27 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.852 179.027 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.571 HD21 ' OE1' ' A' ' 47' ' ' GLN . 54.9 tp -113.81 128.91 56.6 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.84 0.352 . . . . 0.0 110.976 -179.073 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.791 ' CE2' HD12 ' A' ' 37' ' ' ILE . 5.1 m-85 -108.07 137.04 46.75 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.171 -179.511 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 152.54 -172.79 31.67 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.216 -0.992 . . . . 0.0 112.267 178.756 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 48.1 mtm180 -76.98 -32.57 57.35 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 179.851 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.498 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -48.23 144.95 6.2 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 120.674 -0.775 . . . . 0.0 111.263 -178.693 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.491 HG23 ' N ' ' A' ' 34' ' ' GLU . 9.9 tp -65.64 -41.16 89.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.824 0.345 . . . . 0.0 110.12 -179.99 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.491 ' N ' HG23 ' A' ' 33' ' ' ILE . 80.3 mm-40 -57.06 -19.54 19.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.959 -179.987 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 62.8 m -56.05 122.69 12.23 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.703 -179.751 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.478 ' OD2' ' O ' ' A' ' 26' ' ' THR . 56.0 m-20 -58.88 -30.72 67.97 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -179.947 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.791 HD12 ' CE2' ' A' ' 29' ' ' PHE . 85.6 mt -127.01 120.51 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.361 177.333 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 84.4 mtp180 -102.46 135.15 44.59 Favored 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.472 -179.354 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 97.1 mt -116.12 126.31 73.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.145 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -75.05 30.62 0.09 Allowed 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -177.87 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.418 ' HA ' HD23 ' A' ' 41' ' ' LEU . 45.9 mt -98.27 126.22 40.57 Favored Pre-proline 0 C--N 1.325 -0.49 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.3 179.259 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -72.4 -8.22 22.27 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 C-N-CA 122.315 2.01 . . . . 0.0 112.853 -179.719 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.575 HG21 ' CE2' ' B' ' 241' ' ' PHE . 27.5 m -101.73 6.32 10.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.069 0.462 . . . . 0.0 110.422 179.52 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.1 t -91.01 137.41 21.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.431 178.747 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.8 m -68.72 169.24 11.63 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.613 0.72 . . . . 0.0 112.214 -178.332 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -62.78 -43.93 97.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.177 -179.041 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.586 ' O ' ' N ' ' A' ' 49' ' ' CYS . 95.2 mm-40 -113.65 -25.75 8.56 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.95 -179.532 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.1 t60 40.42 -78.74 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.878 -1.056 . . . . 0.0 113.43 179.661 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.586 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -129.05 136.03 49.72 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.025 . . . . . . . . 3 3 . 1 . 073 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -129.53 126.82 39.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.798 -179.931 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.1 mt -112.04 134.72 53.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.341 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -119.77 127.67 53.02 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.624 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 83.6 mt -105.67 121.52 58.02 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 CA-C-O 121.694 0.759 . . . . 0.0 111.609 -178.904 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.548 ' O ' ' N ' ' A' ' 56' ' ' GLN . 92.5 m-70 -117.11 142.81 46.52 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.105 -179.504 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 54' ' ' HIS . 92.4 mt-10 -39.0 -26.75 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -179.295 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.548 ' N ' ' O ' ' A' ' 54' ' ' HIS . 87.7 mt-30 -68.63 -67.39 0.47 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.679 179.045 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.493 ' CD ' HH21 ' A' ' 81' ' ' ARG . 5.3 tp10 -159.66 -156.98 0.54 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.221 179.802 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -120.88 131.17 54.24 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.039 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 93.5 mt -120.77 131.22 73.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.031 0.443 . . . . 0.0 112.027 -178.455 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 34.7 tp -94.48 125.2 38.98 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.042 179.566 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -111.21 138.22 47.93 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.16 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.653 HD21 ' CB ' ' A' ' 68' ' ' PRO . 63.5 t-20 -101.74 107.82 19.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.43 . . . . 0.0 112.013 -178.53 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -99.33 -9.87 23.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.43 -179.991 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.49 99.93 9.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.691 0.281 . . . . 0.0 110.295 -179.634 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.2 p -82.34 -35.9 27.42 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.963 179.811 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.543 HG22 HG22 ' B' ' 236' ' ' VAL . 0.3 OUTLIER -61.69 -48.19 81.9 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.182 0.515 . . . . 0.0 109.902 -179.517 . . . . . . . . 3 3 . 1 . 073 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -139.63 100.63 7.45 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.683 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.653 ' CB ' HD21 ' A' ' 62' ' ' ASN . 44.7 Cg_endo -66.9 151.22 82.64 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 121.56 1.507 . . . . 0.0 113.662 -177.79 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.928 ' O ' HG22 ' A' ' 76' ' ' ILE . 16.6 m -68.38 144.02 54.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.116 -179.835 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -103.73 140.6 37.38 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.85 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.9 p -129.27 135.85 60.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.621 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 49.83 34.34 7.58 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.628 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.04 28.19 70.83 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.529 -179.838 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.0 m -139.64 139.69 36.76 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.796 -179.421 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.3 t -68.56 135.93 27.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 120.909 0.385 . . . . 0.0 111.231 179.661 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.928 HG22 ' O ' ' A' ' 69' ' ' THR . 9.6 tt -105.45 96.56 4.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.332 179.906 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -64.57 -35.59 81.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.67 179.736 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.518 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 0.0 OUTLIER -133.55 177.22 2.36 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 120.596 -0.441 . . . . 0.0 111.722 -179.157 . . . . . . . . 3 3 . 1 . 073 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.433 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 48.8 Cg_exo -56.22 141.72 87.84 Favored 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 122.842 2.362 . . . . 0.0 112.944 -179.661 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 42.1 t -134.58 141.26 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.027 -179.636 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.493 HH21 ' CD ' ' A' ' 57' ' ' GLU . 60.2 ttt180 -74.03 122.83 23.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.022 178.353 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 82' ' ' LEU . 98.5 mt -75.02 140.44 43.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.174 0.511 . . . . 0.0 111.3 -179.144 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -133.17 147.7 52.06 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.58 179.701 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.516 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 7.8 t60 -52.66 114.4 1.38 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.316 179.38 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 113.85 -14.67 21.82 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.179 -0.769 . . . . 0.0 111.179 179.997 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -69.42 131.32 44.59 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.028 179.684 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.405 HG22 ' HG3' ' A' ' 96' ' ' ARG . 66.8 t -110.55 129.4 65.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.369 -178.95 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 89.7 mt -101.71 133.9 43.78 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.51 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.556 HG23 ' OG ' ' A' ' 94' ' ' SER . 66.5 m -121.71 121.85 38.23 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.583 0.706 . . . . 0.0 111.529 -179.135 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.632 ' O ' ' N ' ' A' ' 93' ' ' ARG . 86.6 mt -110.32 128.98 66.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.533 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.647 HD13 ' HB2' ' B' ' 237' ' ' CYS . 61.8 mt -15.42 92.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -178.519 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.539 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 2.7 t70 88.73 -22.33 0.13 Allowed 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 177.595 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.632 ' N ' ' O ' ' A' ' 90' ' ' ILE . 19.6 mmm180 -122.94 138.74 54.59 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.789 -0.365 . . . . 0.0 110.349 -179.603 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.556 ' OG ' HG23 ' A' ' 89' ' ' THR . 69.4 m -134.88 150.0 50.38 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.707 179.688 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.6 ' HB3' HD11 ' A' ' 7' ' ' LEU . 55.3 m-85 -127.56 121.35 30.39 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.361 -179.917 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.575 ' O ' HD12 ' A' ' 7' ' ' LEU . 42.1 ttp-105 -84.77 133.51 34.35 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.906 0.384 . . . . 0.0 110.257 -179.834 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -94.3 121.34 35.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.199 -179.327 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -127.56 123.08 34.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.616 179.971 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.516 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 7.8 p-10 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.047 179.4 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo . . . . . 0 N--CA 1.497 1.691 0 CA-C-O 120.967 0.319 . . . . 0.0 112.7 . . . . . . . . . 0 0 . 1 . 073 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.543 HG22 HG22 ' A' ' 66' ' ' THR . 28.3 t -89.48 131.08 37.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.038 178.89 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . 0.647 ' HB2' HD13 ' A' ' 91' ' ' ILE . 8.0 t . . . . . 0 C--N 1.325 -0.474 0 CA-C-O 120.984 0.421 . . . . 0.0 110.965 -179.264 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo . . . . . 0 N--CA 1.493 1.46 0 CA-C-O 120.687 0.203 . . . . 0.0 111.712 . . . . . . . . . 0 0 . 1 . 073 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 3.1 m -74.05 -41.8 61.22 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 177.259 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.575 ' CE2' HG21 ' A' ' 43' ' ' VAL . 87.7 t80 -57.49 -47.24 82.44 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.238 -179.69 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 99.3 mt -65.55 -39.87 92.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.778 -179.787 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -61.28 -42.05 97.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.425 -179.801 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -62.0 -43.41 98.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.64 179.512 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.417 ' NH1' ' OE1' ' B' ' 248' ' ' GLN . 2.6 mpt_? -60.33 -40.74 91.7 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.292 -179.927 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -63.5 -43.01 98.49 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.375 0.607 . . . . 0.0 109.76 179.089 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 72.3 m -62.71 -44.38 96.37 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.646 179.094 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . 0.417 ' OE1' ' NH1' ' B' ' 245' ' ' ARG . 86.5 mt-30 -61.11 -36.68 80.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.572 -179.887 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 22.9 t . . . . . 0 C--N 1.33 -0.273 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.139 179.301 . . . . . . . . 0 0 . 1 . 073 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.412 ' N ' ' CD ' ' B' ' 260' ' ' GLU . 1.3 pm0 . . . . . 0 C--O 1.226 -0.162 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 . . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.565 HD11 ' HE ' ' A' ' 93' ' ' ARG . 60.1 mt -118.67 131.69 70.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.146 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 50.8 t -128.88 134.81 63.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.057 -179.515 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -94.45 119.92 33.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.174 0.511 . . . . 0.0 111.206 -178.582 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.26 -44.72 94.35 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.507 179.56 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -102.19 159.93 27.91 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.408 -179.086 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -65.88 161.45 39.37 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.602 2.201 . . . . 0.0 111.723 179.68 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.4 pt . . . . . 0 C--N 1.33 -0.258 0 CA-C-O 121.435 0.636 . . . . 0.0 111.952 -179.03 . . . . . . . . 0 0 . 1 . 074 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 54.2 m . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.836 0.351 . . . . 0.0 110.494 . . . . . . . . . 0 0 . 1 . 074 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.507 ' NH2' ' O ' ' A' ' 22' ' ' LEU . 82.9 mtm-85 -81.72 132.61 35.29 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.41 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 91.0 mtm-85 -127.1 131.42 50.84 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.295 -179.768 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.7 HD12 ' O ' ' A' ' 96' ' ' ARG . 29.8 tp -117.22 126.24 52.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.409 179.348 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.678 HG12 ' CD2' ' A' ' 19' ' ' HIS . 35.8 m -101.3 133.65 43.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.903 -179.277 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.444 ' CG2' HD12 ' B' ' 261' ' ' ILE . 9.7 m -92.2 113.87 26.26 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.072 -178.874 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.463 HD12 ' OG ' ' A' ' 94' ' ' SER . 96.3 mt -81.78 144.53 10.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.683 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -101.02 164.02 12.01 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.618 179.965 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.487 ' HB3' HG21 ' B' ' 249' ' ' VAL . 87.4 mtm180 -59.35 -31.56 69.31 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.569 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.1 t -70.35 -20.59 62.97 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.484 179.239 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.39 17.3 20.24 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.727 179.36 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.5 m -110.23 135.49 49.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.991 0.424 . . . . 0.0 111.198 -179.733 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 17' ' ' GLY . 64.0 t0 -76.55 135.75 39.28 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.029 179.602 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.511 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -126.63 -114.03 1.88 Allowed Glycine 0 CA--C 1.537 1.428 0 C-N-CA 120.361 -0.924 . . . . 0.0 111.961 -179.897 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.91 147.64 50.06 Favored 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 122.434 2.089 . . . . 0.0 113.488 -178.678 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.678 ' CD2' HG12 ' A' ' 8' ' ' VAL . 12.3 m170 -109.83 142.1 41.58 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.148 179.325 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.424 ' CD2' HD11 ' A' ' 37' ' ' ILE . 27.4 t80 -113.32 106.14 54.75 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.041 -179.829 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.62 129.46 13.67 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 121.419 1.413 . . . . 0.0 111.831 -179.432 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.507 ' O ' ' NH2' ' A' ' 5' ' ' ARG . 25.8 mt -94.77 39.94 1.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.858 -178.556 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.9 t -63.12 -15.82 57.99 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.405 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.8 mt -73.7 145.36 45.27 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.327 179.891 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 86.6 p -58.44 -26.38 63.26 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.049 -178.42 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 87.3 m -141.41 139.99 33.56 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.487 -179.584 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.665 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 6.6 t -129.29 119.88 24.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.668 178.856 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.619 HD21 ' OE1' ' A' ' 47' ' ' GLN . 50.1 tp -114.7 130.49 56.83 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.373 -178.422 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.837 ' CE2' HD12 ' A' ' 37' ' ' ILE . 7.0 m-85 -107.68 141.02 39.84 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.807 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 153.39 -171.39 32.27 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 119.95 -1.119 . . . . 0.0 112.538 179.053 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.5 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 45.0 mtm180 -85.8 -32.57 21.72 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 111.497 0.184 . . . . 0.0 111.497 179.564 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -47.36 150.05 2.55 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 -178.977 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.545 ' O ' ' NH2' ' A' ' 38' ' ' ARG . 8.2 tp -64.54 -41.52 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 O-C-N 122.442 -0.446 . . . . 0.0 110.574 -179.579 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.543 ' N ' HG23 ' A' ' 33' ' ' ILE . 95.5 mt-10 -59.08 -18.82 38.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.898 -179.315 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 71.4 m -57.11 118.94 5.53 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.119 -179.869 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -56.4 -29.89 62.1 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.328 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.837 HD12 ' CE2' ' A' ' 29' ' ' PHE . 75.1 mt -124.37 118.81 54.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 177.01 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.545 ' NH2' ' O ' ' A' ' 33' ' ' ILE . 72.0 mtt85 -103.86 134.38 47.25 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.469 -178.427 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.728 ' CG2' HD12 ' A' ' 41' ' ' LEU . 77.6 mt -117.96 129.61 74.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.877 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -76.84 29.99 0.13 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.749 -178.974 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.728 HD12 ' CG2' ' A' ' 39' ' ' ILE . 7.3 mt -99.66 127.14 34.87 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.188 179.902 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.16 -13.27 31.05 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.278 1.986 . . . . 0.0 113.438 -179.202 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.463 HG21 ' N ' ' B' ' 237' ' ' CYS . 1.4 p -96.13 5.06 8.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.114 179.73 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.5 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 42.4 t -88.68 133.45 30.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.275 179.431 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.438 ' O ' HG12 ' A' ' 44' ' ' VAL . 0.6 OUTLIER -66.15 162.69 19.21 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.213 0.53 . . . . 0.0 110.576 179.965 . . . . . . . . 3 3 . 1 . 074 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -60.6 -42.14 96.2 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.944 -178.512 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.619 ' OE1' HD21 ' A' ' 28' ' ' LEU . 97.6 mm-40 -109.33 -16.07 14.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.11 179.837 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.6 t60 34.88 -77.82 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.686 -179.316 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.615 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.11 136.64 45.95 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.113 0.483 . . . . 0.0 111.364 -178.931 . . . . . . . . 3 3 . 1 . 074 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -127.86 129.54 47.08 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.867 179.855 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.8 mt -112.18 133.03 59.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.14 179.663 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.505 ' OE2' ' CE1' ' A' ' 54' ' ' HIS . 81.7 tt0 -115.61 124.03 49.92 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.048 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 48.4 mm -96.33 117.61 40.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.155 0.502 . . . . 0.0 111.886 -178.345 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.505 ' CE1' ' OE2' ' A' ' 52' ' ' GLU . 95.8 m-70 -115.42 132.52 56.59 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.116 179.065 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 54' ' ' HIS . 96.9 mt-10 -42.54 -30.16 0.33 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.375 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.457 ' N ' ' C ' ' A' ' 54' ' ' HIS . 59.3 tt0 -67.09 -68.37 0.38 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.602 178.216 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -151.16 -174.83 4.93 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.475 0.655 . . . . 0.0 111.905 -179.66 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.35 122.16 46.54 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.978 178.372 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 98.5 mt -117.2 132.35 67.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -178.505 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.1 tp -98.76 130.16 45.21 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.173 179.302 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -110.35 135.43 51.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.785 179.585 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 64.2 t-20 -95.31 105.97 17.97 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.915 179.983 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -98.34 -9.81 24.8 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.581 179.52 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.1 m -72.99 100.63 3.02 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 178.988 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.2 p -87.11 -21.55 25.93 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.114 179.95 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.661 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -86.72 -44.86 11.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.215 -179.73 . . . . . . . . 3 3 . 1 . 074 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -132.34 93.14 26.35 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.285 179.75 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -56.25 142.71 87.18 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.45 2.1 . . . . 0.0 112.84 -178.6 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 45.6 m -75.74 152.99 37.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.819 179.607 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -116.08 140.67 49.04 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.835 -179.278 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.736 HG13 ' OD1' ' A' ' 86' ' ' ASP . 55.6 t -129.25 134.5 63.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.336 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 53.29 33.41 15.5 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -179.163 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.9 28.62 70.32 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.696 179.944 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 45.0 t -141.65 140.05 33.16 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 117.04 0.42 . . . . 0.0 111.39 -179.972 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.1 t -66.66 136.38 26.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.685 -179.86 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.7 pt -111.88 79.19 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.617 179.276 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -62.27 -26.94 68.67 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.355 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.08 162.04 26.27 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.837 179.187 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.41 146.43 89.66 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.544 2.163 . . . . 0.0 111.561 179.724 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.7 m -137.77 142.95 34.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.17 0.51 . . . . 0.0 111.555 -179.6 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -72.32 127.52 32.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.585 -179.759 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 82' ' ' LEU . 96.0 mt -78.52 139.19 38.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.185 0.517 . . . . 0.0 111.185 -179.596 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -135.72 150.06 49.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.209 -178.68 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -53.35 113.21 1.07 Allowed 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.73 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.32 -10.89 26.43 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -179.784 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.736 ' OD1' HG13 ' A' ' 71' ' ' VAL . 49.0 t0 -74.19 127.24 32.44 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.41 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.47 ' O ' HG13 ' A' ' 87' ' ' VAL . 13.1 p -108.78 132.64 56.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.639 -178.493 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 94.9 mt -98.66 130.37 47.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.11 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.1 m -117.38 127.25 53.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.725 0.774 . . . . 0.0 112.177 -178.669 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.595 ' O ' ' N ' ' A' ' 93' ' ' ARG . 94.7 mt -116.39 132.86 64.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 114.46 -1.245 . . . . 0.0 108.436 178.536 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.93 HG22 HH22 ' B' ' 245' ' ' ARG . 89.1 mt -25.64 99.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 -179.098 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.534 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 6.9 t0 90.06 -21.88 0.12 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 178.08 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.595 ' N ' ' O ' ' A' ' 90' ' ' ILE . 63.2 mtt85 -131.27 146.09 52.16 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.215 -179.289 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.463 ' OG ' HD12 ' A' ' 10' ' ' ILE . 44.8 p -140.67 154.56 46.44 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.026 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.502 ' HE1' HD12 ' A' ' 90' ' ' ILE . 56.5 m-85 -128.26 128.51 44.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.033 -179.825 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.7 ' O ' HD12 ' A' ' 7' ' ' LEU . 99.4 mtt180 -94.81 135.07 36.74 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 119.461 -0.896 . . . . 0.0 110.66 -179.948 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.461 ' CE2' ' OD1' ' A' ' 99' ' ' ASN . 88.0 t80 -95.04 125.89 40.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.707 -179.705 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.521 ' N ' ' OE1' ' A' ' 98' ' ' GLU . 55.7 mp0 -134.94 126.94 29.64 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.423 -179.652 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.461 ' OD1' ' CE2' ' A' ' 97' ' ' TYR . 98.3 m-20 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.867 179.122 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo . . . . . 0 N--CA 1.492 1.39 0 CA-C-O 120.966 0.319 . . . . 0.0 112.415 . . . . . . . . . 0 0 . 1 . 074 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.661 ' CG2' HG22 ' A' ' 66' ' ' THR . 40.2 t -114.03 136.5 50.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.933 -179.764 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . 0.463 ' N ' HG21 ' A' ' 43' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.008 -179.207 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo . . . . . 0 N--CA 1.501 1.921 0 N-CA-C 114.241 0.824 . . . . 0.0 114.241 . . . . . . . . . 0 0 . 1 . 074 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 44.8 p -79.52 -34.62 41.0 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.321 179.423 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.544 ' CE2' ' CZ ' ' B' ' 245' ' ' ARG . 78.9 t80 -57.9 -47.86 81.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.702 -179.572 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.427 HD23 HH21 ' B' ' 245' ' ' ARG . 72.0 mt -65.36 -43.16 91.68 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.005 0.431 . . . . 0.0 110.774 179.276 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -65.8 -39.43 90.91 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.463 -179.245 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -61.67 -47.23 86.27 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.962 -179.719 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.93 HH22 HG22 ' A' ' 91' ' ' ILE . 78.1 mtm180 -65.95 -37.99 87.44 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.39 -179.275 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -59.57 -42.17 91.84 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.994 0.426 . . . . 0.0 111.006 179.703 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 81.2 p -68.95 -42.98 75.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.664 0.745 . . . . 0.0 109.112 178.981 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -62.97 -37.92 89.03 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.783 179.749 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . 0.513 HG23 ' O ' ' B' ' 245' ' ' ARG . 55.1 t . . . . . 0 N--CA 1.454 -0.261 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.112 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.446 ' OE1' ' NH2' ' A' ' 93' ' ' ARG . 99.0 mt-10 . . . . . 0 N--CA 1.455 -0.2 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 . . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.444 HD12 ' CG2' ' A' ' 9' ' ' THR . 70.5 mt -112.88 134.89 54.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -179.999 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 48.8 t -126.51 134.35 66.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.122 179.47 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -94.79 120.94 35.84 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.155 0.502 . . . . 0.0 110.993 -179.457 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . 0.441 ' HG3' HH22 ' A' ' 38' ' ' ARG . 88.2 tttt -62.93 -45.7 91.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.016 179.414 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 5.7 mm100 -97.68 152.7 38.29 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.336 -179.803 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -69.88 148.98 65.51 Favored 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 122.906 2.404 . . . . 0.0 113.305 -179.279 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 18.7 pt . . . . . 0 N--CA 1.462 0.146 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.313 178.9 . . . . . . . . 0 0 . 1 . 075 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 59.6 p . . . . . 0 N--CA 1.463 0.219 0 CA-C-O 120.904 0.383 . . . . 0.0 111.451 . . . . . . . . . 0 0 . 1 . 075 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.603 ' HD2' HD13 ' A' ' 53' ' ' ILE . 91.5 mtt-85 -92.49 129.77 38.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.071 -177.941 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -136.47 141.99 43.54 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.362 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.643 ' CD1' HD11 ' A' ' 22' ' ' LEU . 26.1 mt -116.48 142.12 47.29 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.87 179.207 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.7 t -114.76 129.32 71.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.138 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 m -94.57 118.54 31.84 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -177.725 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.734 HD12 ' OG ' ' A' ' 94' ' ' SER . 91.0 mt -81.39 143.58 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.804 179.587 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 69.9 mttt -87.51 160.73 18.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.374 178.671 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.57 HH21 ' HG3' ' B' ' 245' ' ' ARG . 81.3 mtp180 -56.18 -33.14 64.99 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.693 -178.76 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 99.8 p -79.82 -8.29 59.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.311 -179.314 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.64 39.75 5.82 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 179.831 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 37.1 t -123.15 133.96 67.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.237 0.542 . . . . 0.0 111.261 -179.454 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -68.9 123.23 20.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.128 179.905 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -115.38 -125.31 3.92 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.507 -179.577 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -74.32 150.08 41.13 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.139 1.893 . . . . 0.0 112.363 -179.342 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -107.21 150.91 26.11 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.9 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.437 ' CD2' HD11 ' A' ' 37' ' ' ILE . 54.8 t80 -119.24 90.98 43.11 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.286 -178.585 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -63.94 130.82 28.69 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.509 2.14 . . . . 0.0 111.36 178.708 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.643 HD11 ' CD1' ' A' ' 7' ' ' LEU . 95.1 mt -96.05 122.37 38.81 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.738 -179.671 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.401 ' H ' HE22 ' B' ' 265' ' ' GLN . 11.4 p -121.87 -26.38 4.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.126 179.284 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.3 mt -78.3 143.72 36.73 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.054 179.008 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.0 p -69.93 -13.82 62.42 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.307 -179.389 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.443 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 20.3 m -127.75 130.39 48.68 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 120.599 -0.441 . . . . 0.0 110.905 179.452 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.8 t -126.67 119.03 25.98 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.595 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' A' ' 36' ' ' ASP . 52.9 tp -117.57 124.35 48.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.901 0.382 . . . . 0.0 111.667 -178.776 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.822 ' CE2' HD12 ' A' ' 37' ' ' ILE . 4.7 m-85 -100.39 142.55 31.71 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 178.768 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 155.55 -177.14 32.86 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 119.972 -1.109 . . . . 0.0 112.265 178.709 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.61 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 87.8 mtm-85 -75.34 -32.18 60.81 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.139 0.495 . . . . 0.0 110.007 179.388 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.546 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -53.0 146.5 18.22 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.112 -178.434 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.499 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.2 tp -66.88 -41.57 87.83 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.158 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.499 ' N ' HG23 ' A' ' 33' ' ' ILE . 78.2 mm-40 -54.07 -19.55 5.06 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.758 179.818 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.546 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 38.6 m -60.67 124.61 20.93 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.072 179.917 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.443 ' OD2' ' O ' ' A' ' 26' ' ' THR . 56.1 m-20 -59.11 -32.41 69.81 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -179.793 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.822 HD12 ' CE2' ' A' ' 29' ' ' PHE . 85.5 mt -124.04 120.82 60.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 175.724 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -108.43 136.0 48.79 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.209 -0.596 . . . . 0.0 111.242 -179.189 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.432 HG22 ' H ' ' A' ' 41' ' ' LEU . 76.8 mt -115.67 132.0 66.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.99 -179.879 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -80.31 25.62 0.39 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.124 -178.476 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.482 HD21 ' OE1' ' B' ' 260' ' ' GLU . 36.2 mt -99.04 129.14 30.22 Favored Pre-proline 0 C--N 1.328 -0.333 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.266 179.332 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.45 -13.53 33.03 Favored 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 122.184 1.922 . . . . 0.0 112.798 -179.638 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.424 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 0.7 OUTLIER -91.58 1.25 8.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.499 -0.48 . . . . 0.0 111.75 -179.542 . . . . . . . . 3 3 . 1 . 075 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.61 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 66.0 t -93.22 132.32 37.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.352 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.551 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 0.3 OUTLIER -61.69 164.7 5.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.241 0.543 . . . . 0.0 111.551 -178.585 . . . . . . . . 3 3 . 1 . 075 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.473 ' CG ' ' NH2' ' A' ' 31' ' ' ARG . 96.6 mttt -61.99 -45.08 95.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.825 -179.142 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.589 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.2 mt-30 -110.53 -12.34 14.38 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-O 121.519 0.676 . . . . 0.0 109.548 179.315 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.551 ' H ' ' HB3' ' A' ' 45' ' ' SER . 25.1 t60 28.8 -75.45 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.219 -1.355 . . . . 0.0 114.255 179.277 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.589 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.43 135.87 46.37 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -177.688 . . . . . . . . 3 3 . 1 . 075 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -126.78 130.49 50.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.616 179.36 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 98.3 mt -115.22 133.31 61.86 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.135 179.537 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -112.48 122.47 47.81 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.309 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.603 HD13 ' HD2' ' A' ' 5' ' ' ARG . 94.7 mt -104.13 113.57 41.41 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 C-N-CA 119.726 -0.79 . . . . 0.0 111.943 -179.004 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.441 ' C ' ' N ' ' A' ' 56' ' ' GLN . 89.9 m-70 -113.5 141.21 47.4 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.592 179.274 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 54' ' ' HIS . 94.8 mt-10 -40.67 -31.87 0.18 Allowed 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -179.365 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.441 ' N ' ' C ' ' A' ' 54' ' ' HIS . 54.7 mt-30 -63.4 -67.75 0.4 Allowed 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.359 -0.837 . . . . 0.0 108.78 178.623 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.464 ' OE1' ' N ' ' A' ' 58' ' ' ALA . 1.4 mm-40 -154.99 -174.77 5.12 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.785 0.803 . . . . 0.0 112.611 -179.285 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.464 ' N ' ' OE1' ' A' ' 57' ' ' GLU . . . -109.65 119.54 39.71 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 114.457 -1.247 . . . . 0.0 108.198 177.689 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.2 mt -110.48 130.12 64.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.842 0.353 . . . . 0.0 111.823 -178.467 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.562 ' HB2' HD11 ' A' ' 82' ' ' LEU . 28.0 tp -97.05 128.24 43.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.464 179.88 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -113.43 138.77 49.61 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.535 179.746 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -96.44 111.09 23.31 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -179.233 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -104.5 -8.49 19.04 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.762 178.698 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.7 t -75.23 104.61 5.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.765 0.316 . . . . 0.0 110.303 179.281 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 94.7 p -87.59 -8.33 56.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.021 0.439 . . . . 0.0 110.331 179.843 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.408 ' HB ' ' ND2' ' A' ' 67' ' ' ASN . 0.2 OUTLIER -101.94 -37.26 8.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.207 -179.213 . . . . . . . . 3 3 . 1 . 075 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.413 ' OD1' HG23 ' B' ' 236' ' ' VAL . 6.3 m-80 -145.07 98.87 4.68 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.489 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -57.29 145.84 85.3 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 121.8 1.667 . . . . 0.0 112.258 -178.782 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.912 ' O ' HG22 ' A' ' 76' ' ' ILE . 28.8 m -67.7 137.34 55.44 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.291 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -102.42 140.78 36.24 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.399 179.576 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 55.7 t -130.95 133.22 63.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.675 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 54.59 30.51 13.32 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.671 -178.922 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.98 23.97 73.12 Favored Glycine 0 CA--C 1.534 1.27 0 CA-C-N 115.307 -0.861 . . . . 0.0 112.711 179.001 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 58.5 m -139.09 145.65 39.77 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 117.522 0.661 . . . . 0.0 110.742 179.478 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.421 ' H ' HG22 ' A' ' 75' ' ' VAL . 7.9 m -71.03 142.74 15.21 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-O 121.138 0.494 . . . . 0.0 111.87 -179.351 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.912 HG22 ' O ' ' A' ' 69' ' ' THR . 6.7 tt -109.54 92.35 2.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.196 179.155 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -65.89 -34.98 79.37 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.746 -179.685 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.478 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 0.2 OUTLIER -126.04 175.06 3.44 Favored Pre-proline 0 N--CA 1.464 0.259 0 C-N-CA 120.414 -0.515 . . . . 0.0 111.481 -179.578 . . . . . . . . 3 3 . 1 . 075 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.421 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 35.5 Cg_exo -57.68 140.98 95.28 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.509 2.139 . . . . 0.0 112.396 -179.881 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 72.1 t -137.43 137.83 45.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.181 -179.671 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 91.9 mtm-85 -74.29 132.02 41.7 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.713 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.562 HD11 ' HB2' ' A' ' 60' ' ' LEU . 97.8 mt -87.95 139.27 30.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.174 0.512 . . . . 0.0 111.852 -178.72 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -129.63 154.18 47.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.487 -179.43 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -57.0 120.69 8.4 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.84 0.353 . . . . 0.0 111.462 -179.29 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.15 -16.48 27.43 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.651 -0.58 . . . . 0.0 111.651 179.299 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -69.94 136.99 51.15 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.105 0.478 . . . . 0.0 110.276 179.812 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 53.3 t -111.88 132.07 61.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.169 -178.936 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.1 mt -99.1 130.94 47.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.559 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.5 m -122.82 126.41 47.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.293 0.568 . . . . 0.0 111.816 -178.387 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.488 ' O ' ' N ' ' A' ' 93' ' ' ARG . 96.2 mt -113.31 124.18 69.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.291 178.164 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.456 ' C ' ' O ' ' A' ' 90' ' ' ILE . 48.5 mm 35.03 -98.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.796 -179.533 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.578 ' OD2' ' NE ' ' B' ' 245' ' ' ARG . 85.3 m-20 -110.44 5.14 21.16 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -179.517 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.498 ' NH2' ' HD2' ' A' ' 12' ' ' ARG . 84.6 mtt-85 -120.39 145.48 47.13 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.943 -179.129 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.734 ' OG ' HD12 ' A' ' 10' ' ' ILE . 33.5 p -140.64 152.87 45.74 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.199 0.523 . . . . 0.0 111.196 179.789 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -123.95 123.17 39.81 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.841 179.592 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -80.6 129.19 34.37 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.287 -179.87 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.599 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 86.8 t80 -96.15 125.45 40.68 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.792 0.33 . . . . 0.0 111.267 -179.645 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -130.85 123.17 28.44 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 121.064 0.459 . . . . 0.0 111.532 -179.882 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 . . . . . 0 C--N 1.327 -0.386 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.445 179.845 . . . . . . . . 0 0 . 1 . 075 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo . . . . . 0 N--CA 1.49 1.312 0 CA-C-O 121.028 0.345 . . . . 0.0 112.213 . . . . . . . . . 0 0 . 1 . 075 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.413 HG23 ' OD1' ' A' ' 67' ' ' ASN . 2.7 p -118.99 137.14 53.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.557 -179.729 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 3.0 t . . . . . 0 C--N 1.332 -0.171 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.514 -179.74 . . . . . . . . 0 0 . 1 . 075 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo . . . . . 0 N--CA 1.494 1.541 0 CA-C-O 120.547 0.144 . . . . 0.0 112.446 . . . . . . . . . 0 0 . 1 . 075 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 97.8 m -73.21 -44.89 58.96 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.271 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.424 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 86.5 t80 -57.88 -45.77 85.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.855 -179.493 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.53 ' CD2' ' OD1' ' A' ' 92' ' ' ASP . 97.2 mt -63.46 -41.08 98.63 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 120.746 -0.381 . . . . 0.0 110.466 -179.634 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -60.28 -42.89 96.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.351 -179.476 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -64.04 -39.9 95.13 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.353 -179.997 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.714 ' O ' HG23 ' B' ' 249' ' ' VAL . 57.9 ttm-85 -59.49 -44.13 93.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.862 -179.978 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -60.8 -42.95 98.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.039 0.447 . . . . 0.0 111.033 -179.472 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 67.8 p -69.68 -44.12 71.1 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.608 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . 0.462 ' HG2' HH22 ' A' ' 12' ' ' ARG . 66.3 tp60 -59.19 -39.2 81.85 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.474 179.758 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . 0.714 HG23 ' O ' ' B' ' 245' ' ' ARG . 73.4 t . . . . . 0 C--N 1.332 -0.161 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.495 179.682 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.482 ' OE1' HD21 ' A' ' 41' ' ' LEU . 99.4 mt-10 . . . . . 0 N--CA 1.463 0.197 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 . . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 65.7 mt -111.74 134.97 52.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.915 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 42.2 t -125.35 132.76 70.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.909 0.385 . . . . 0.0 110.467 179.464 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -98.6 121.02 40.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.938 -178.648 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -69.21 -47.1 65.74 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.276 -179.368 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . 0.401 HE22 ' H ' ' A' ' 23' ' ' SER . 0.4 OUTLIER -67.31 165.69 26.67 Favored Pre-proline 0 N--CA 1.464 0.266 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.904 -179.237 . . . . . . . . 3 3 . 1 . 075 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -62.42 143.58 93.65 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.472 2.115 . . . . 0.0 111.603 179.217 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 19.8 tt . . . . . 0 N--CA 1.446 -0.649 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.056 -179.413 . . . . . . . . 0 0 . 1 . 076 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 95.9 m . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.692 0.282 . . . . 0.0 111.598 . . . . . . . . . 0 0 . 1 . 076 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.6 mtt85 -93.63 125.69 38.39 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.538 -178.145 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -124.19 140.5 52.9 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.015 -179.4 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.643 HD11 ' HB3' ' A' ' 95' ' ' PHE . 38.0 tp -113.66 131.34 56.19 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.792 179.704 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.401 ' O ' HG23 ' A' ' 8' ' ' VAL . 19.2 m -110.55 130.73 63.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 121.13 0.491 . . . . 0.0 111.334 -179.393 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.1 m -78.45 141.97 37.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.297 -179.182 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.5 mm -109.97 136.43 45.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.033 177.296 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -91.42 154.77 18.93 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.435 179.54 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.477 ' CD ' ' OD2' ' A' ' 92' ' ' ASP . 89.1 mtm180 -54.56 -27.23 37.3 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.301 -179.684 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 91.8 p -80.48 -7.37 59.15 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.926 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.19 39.65 7.82 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 179.938 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.9 t -125.15 137.54 57.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -178.835 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -69.96 127.49 33.04 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.086 179.827 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -113.6 -127.51 4.6 Favored Glycine 0 CA--C 1.54 1.606 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 179.735 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -75.36 154.19 40.63 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 122.345 2.03 . . . . 0.0 112.311 -179.51 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 64.3 m170 -109.37 140.65 42.8 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.234 0.54 . . . . 0.0 111.888 -178.267 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.589 ' CD2' HD11 ' A' ' 37' ' ' ILE . 25.7 t80 -112.66 106.14 55.64 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.918 179.771 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -74.59 126.23 10.08 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 121.635 1.557 . . . . 0.0 111.563 -179.538 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.452 ' CD2' ' SG ' ' A' ' 27' ' ' CYS . 87.7 mt -82.8 52.66 2.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.899 0.38 . . . . 0.0 110.905 -179.263 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.6 t -64.66 -27.61 69.04 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.929 179.607 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.526 HD11 ' HG2' ' B' ' 265' ' ' GLN . 94.6 mt -79.11 142.96 35.97 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.705 179.568 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 44.0 t -63.67 -18.47 64.01 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 121.17 -0.212 . . . . 0.0 111.422 -179.341 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 40.7 m -131.13 131.6 44.23 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.867 -179.321 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.452 ' SG ' ' CD2' ' A' ' 22' ' ' LEU . 4.0 t -124.15 115.24 20.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.197 178.908 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.431 ' O ' ' N ' ' A' ' 36' ' ' ASP . 53.1 tp -112.26 122.79 48.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.162 0.506 . . . . 0.0 111.825 -178.849 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.765 ' CE2' HD12 ' A' ' 37' ' ' ILE . 5.4 m-85 -102.28 139.42 37.91 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.403 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 167.09 -171.56 41.9 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 118.699 -1.715 . . . . 0.0 113.513 179.304 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.563 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 36.7 ttp-105 -89.57 -31.54 17.54 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 114.549 -0.826 . . . . 0.0 109.377 179.585 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.46 151.62 39.48 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.767 -0.533 . . . . 0.0 111.767 -179.465 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.564 ' CD1' ' CZ ' ' A' ' 38' ' ' ARG . 39.5 mm -63.31 -44.41 99.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 121.106 0.479 . . . . 0.0 110.314 -179.965 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -52.95 -18.98 2.25 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.628 -179.208 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.55 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 78.6 m -62.78 128.19 34.77 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.247 -179.882 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 28' ' ' LEU . 62.2 m-20 -59.41 -31.3 69.14 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -179.56 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.765 HD12 ' CE2' ' A' ' 29' ' ' PHE . 93.3 mt -124.81 116.02 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.59 177.683 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.564 ' CZ ' ' CD1' ' A' ' 33' ' ' ILE . 83.7 mtp180 -99.25 137.63 37.5 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.928 -178.48 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.609 HD13 ' HE ' ' A' ' 93' ' ' ARG . 96.6 mt -119.82 129.02 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 121.335 0.588 . . . . 0.0 110.166 179.044 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -68.92 23.64 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.402 -178.156 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.787 HD12 ' CZ ' ' A' ' 93' ' ' ARG . 36.6 mt -106.0 129.68 24.2 Favored Pre-proline 0 C--N 1.324 -0.527 0 C-N-CA 120.015 -0.674 . . . . 0.0 111.247 -179.451 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.69 -10.4 25.04 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 C-N-CA 122.085 1.857 . . . . 0.0 112.589 179.714 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.495 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 5.2 m -91.55 1.42 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.213 179.183 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.563 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 51.4 t -90.83 136.01 25.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.03 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.3 m -71.78 168.34 18.03 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.492 0.663 . . . . 0.0 111.461 -178.783 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.55 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 97.9 mttt -60.15 -42.03 94.04 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.832 -1.077 . . . . 0.0 111.454 -179.257 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.665 ' O ' ' N ' ' A' ' 49' ' ' CYS . 87.2 mt-30 -116.29 -17.68 10.7 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 123.246 0.341 . . . . 0.0 110.976 179.789 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 31.6 t60 34.58 -74.81 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -179.691 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.665 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.29 137.44 46.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.326 0.584 . . . . 0.0 112.455 -178.831 . . . . . . . . 3 3 . 1 . 076 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -128.96 133.14 47.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.011 -179.749 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 88.2 mt -116.62 134.44 60.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.384 179.89 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -115.54 123.48 48.61 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 177.719 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 76.4 mt -103.75 114.11 42.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.287 -178.954 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.595 ' O ' ' N ' ' A' ' 56' ' ' GLN . 92.6 m-70 -111.8 141.75 45.02 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.007 179.233 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.48 ' OE1' ' N ' ' A' ' 55' ' ' GLU . 56.0 mp0 -39.47 -24.12 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.495 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.595 ' N ' ' O ' ' A' ' 54' ' ' HIS . 58.1 tt0 -67.95 -69.25 0.33 Allowed 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.177 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.732 ' CB ' ' HE ' ' A' ' 81' ' ' ARG . 2.8 tp10 -158.02 -163.11 1.25 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.334 179.914 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -115.98 125.42 52.48 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.012 -0.995 . . . . 0.0 108.531 178.347 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.4 mt -113.76 129.91 68.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.848 -178.413 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.43 HD11 ' SG ' ' A' ' 49' ' ' CYS . 50.5 tp -94.11 126.62 39.45 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.483 179.761 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -112.67 136.61 52.04 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.246 179.798 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -98.63 108.75 21.51 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.134 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -100.11 -11.24 20.67 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.432 179.473 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.1 t -69.64 103.35 2.09 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.596 179.106 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.0 p -84.51 -12.47 54.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.288 0.566 . . . . 0.0 109.548 178.856 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.19 -37.27 9.76 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.756 179.956 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.473 ' HB3' HD11 ' A' ' 91' ' ' ILE . 23.3 m-80 -144.18 90.27 6.79 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.847 179.741 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -56.23 146.33 72.3 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.21 1.94 . . . . 0.0 112.264 -179.862 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 56.8 m -73.32 144.02 46.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.159 179.913 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -102.97 141.04 36.44 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.694 179.639 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.8 t -130.34 134.67 62.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.553 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 53.71 34.73 19.58 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.27 -179.431 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.29 29.4 70.27 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.499 179.217 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.9 t -143.64 136.75 27.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 117.355 0.577 . . . . 0.0 110.783 179.314 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.8 p -70.72 139.96 19.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.692 -179.401 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.914 HD13 ' O ' ' A' ' 76' ' ' ILE . 0.0 OUTLIER -132.76 125.56 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.931 179.31 . . . . . . . . 3 3 . 1 . 076 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -97.73 -9.27 26.95 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.755 -179.382 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.84 ' O ' HD11 ' A' ' 76' ' ' ILE . 0.4 OUTLIER -125.19 170.33 9.42 Favored Pre-proline 0 N--CA 1.469 0.482 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.162 -179.431 . . . . . . . . 3 3 . 1 . 076 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -61.41 143.29 97.52 Favored 'Trans proline' 0 N--CA 1.501 1.915 0 C-N-CA 122.442 2.095 . . . . 0.0 113.271 -179.601 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 42.7 t -136.21 136.9 48.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.329 178.403 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.732 ' HE ' ' CB ' ' A' ' 57' ' ' GLU . 72.1 ttt180 -75.63 131.95 40.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.872 179.98 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 82' ' ' LEU . 96.6 mt -84.89 136.73 33.51 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.369 0.604 . . . . 0.0 112.417 -178.369 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -125.73 149.21 48.71 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.494 179.495 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.469 ' CG ' ' H ' ' A' ' 99' ' ' ASN . 5.3 t-160 -54.48 113.81 1.43 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.837 0.351 . . . . 0.0 110.989 -179.934 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.3 -15.67 25.06 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.018 178.938 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -68.3 137.22 54.5 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.099 -0.64 . . . . 0.0 109.403 179.534 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 23.3 t -110.04 134.26 52.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.868 -178.728 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 86.2 mt -103.76 129.42 55.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.1 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.9 m -116.36 129.35 56.2 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.515 -178.958 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.58 ' O ' ' N ' ' A' ' 93' ' ' ARG . 94.3 mt -119.65 128.85 75.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.53 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.531 HD13 ' HB3' ' B' ' 237' ' ' CYS . 94.5 mt -20.41 95.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -178.984 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.477 ' OD2' ' CD ' ' A' ' 12' ' ' ARG . 5.2 t0 90.07 -22.12 0.11 Allowed 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 177.985 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.787 ' CZ ' HD12 ' A' ' 41' ' ' LEU . 14.7 mtm-85 -130.58 145.84 51.97 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.235 -179.69 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.8 p -138.01 155.79 48.49 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.038 0.447 . . . . 0.0 110.781 -179.361 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.643 ' HB3' HD11 ' A' ' 7' ' ' LEU . 81.6 m-85 -131.65 129.44 40.81 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.643 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.49 ' O ' HD12 ' A' ' 7' ' ' LEU . 44.4 ttm180 -96.83 136.34 37.51 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 119.836 -0.745 . . . . 0.0 110.229 179.83 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -89.68 125.48 35.28 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.682 -179.724 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -125.65 127.3 46.07 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.5 -179.366 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.469 ' H ' ' CG ' ' A' ' 84' ' ' HIS . 55.5 t-20 . . . . . 0 N--CA 1.463 0.225 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.199 179.601 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo . . . . . 0 N--CA 1.486 1.069 0 CA-C-O 121.187 0.411 . . . . 0.0 111.923 . . . . . . . . . 0 0 . 1 . 076 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 6.6 p -115.19 137.28 49.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.762 -179.893 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . 0.531 ' HB3' HD13 ' A' ' 91' ' ' ILE . 5.7 t . . . . . 0 CA--C 1.52 -0.189 0 CA-C-O 120.876 0.37 . . . . 0.0 110.958 -178.52 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo . . . . . 0 N--CA 1.494 1.506 0 CA-C-O 120.518 0.132 . . . . 0.0 112.292 . . . . . . . . . 0 0 . 1 . 076 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 94.6 m -75.51 -42.75 51.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.043 0.449 . . . . 0.0 110.352 178.813 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.576 ' HZ ' HD22 ' A' ' 41' ' ' LEU . 60.2 t80 -57.54 -47.34 82.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.761 -179.832 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.437 HD21 HG23 ' A' ' 91' ' ' ILE . 90.1 mt -63.72 -41.19 98.1 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.086 0.47 . . . . 0.0 109.781 179.439 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -60.93 -41.31 95.95 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.873 179.789 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 73.6 ttt-85 -63.05 -43.23 99.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.668 -179.78 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.598 ' O ' HG23 ' B' ' 249' ' ' VAL . 24.0 mmt180 -59.9 -43.27 94.91 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.55 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.48 -41.93 98.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.818 179.215 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 11.8 t -65.73 -44.05 87.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.725 0.774 . . . . 0.0 108.957 179.512 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -60.89 -37.5 82.42 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.938 -179.447 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . 0.598 HG23 ' O ' ' B' ' 245' ' ' ARG . 62.7 t . . . . . 0 C--N 1.33 -0.272 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.614 179.647 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.535 ' OE1' HD21 ' A' ' 41' ' ' LEU . 99.7 mt-10 . . . . . 0 N--CA 1.462 0.151 0 CA-C-O 120.891 0.377 . . . . 0.0 110.546 . . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 65.9 mt -113.9 133.8 58.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.852 -179.856 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 43.5 t -126.91 134.23 66.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.508 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . 0.643 ' CD2' HG21 ' B' ' 267' ' ' ILE . 78.9 m-85 -97.38 123.65 41.28 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.137 0.494 . . . . 0.0 111.495 -178.255 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -64.07 -41.49 97.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.572 179.697 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . 0.526 ' HG2' HD11 ' A' ' 24' ' ' LEU . 0.6 OUTLIER -105.53 173.14 3.43 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.547 -178.956 . . . . . . . . 3 3 . 1 . 076 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -57.26 150.78 55.97 Favored 'Trans proline' 0 N--CA 1.502 1.973 0 C-N-CA 122.824 2.349 . . . . 0.0 114.219 -179.614 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . 0.643 HG21 ' CD2' ' B' ' 263' ' ' PHE . 41.4 pt . . . . . 0 C--O 1.232 0.16 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.501 179.823 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.9 m . . . . . 0 N--CA 1.465 0.289 0 CA-C-O 121.076 0.465 . . . . 0.0 111.663 . . . . . . . . . 0 0 . 1 . 077 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.505 ' NH1' ' CG2' ' A' ' 53' ' ' ILE . 85.0 mtt85 -89.57 134.21 34.23 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.355 -178.549 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -134.82 144.3 47.53 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.292 179.982 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.69 HD11 HD11 ' A' ' 22' ' ' LEU . 85.1 mt -114.94 135.65 53.98 Favored 'General case' 0 C--N 1.334 -0.097 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.635 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 76.7 t -111.83 130.36 65.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.562 -0.455 . . . . 0.0 109.994 -179.363 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.1 m -80.3 140.24 36.25 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -178.132 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.519 HD12 ' HB3' ' A' ' 94' ' ' SER . 96.6 mt -106.13 132.47 53.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 176.673 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.661 ' C ' HH22 ' A' ' 93' ' ' ARG . 97.3 mttt -86.25 154.2 21.45 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.189 0.518 . . . . 0.0 109.729 179.134 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.648 ' N ' HH22 ' A' ' 93' ' ' ARG . 84.9 mtp180 -56.15 -28.8 59.39 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.186 -179.263 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 86.1 p -80.7 -8.83 59.77 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.641 179.747 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.55 33.17 8.72 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.721 -0.551 . . . . 0.0 111.721 179.367 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 54.3 t -119.82 135.33 60.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.784 0.326 . . . . 0.0 110.414 179.818 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -65.03 125.99 26.65 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.776 179.81 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -111.19 -133.33 6.26 Favored Glycine 0 CA--C 1.539 1.575 0 C-N-CA 120.722 -0.752 . . . . 0.0 111.942 -179.184 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.85 151.88 40.86 Favored 'Trans proline' 0 N--CA 1.499 1.827 0 C-N-CA 122.571 2.181 . . . . 0.0 113.037 -178.624 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.594 ' H ' ' CD2' ' A' ' 19' ' ' HIS . 0.1 OUTLIER -106.02 147.87 28.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.363 179.508 . . . . . . . . 3 3 . 1 . 077 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.632 ' CD2' HD11 ' A' ' 37' ' ' ILE . 35.2 t80 -117.26 95.24 46.96 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.353 -179.571 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -64.15 127.32 19.01 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 122.613 2.209 . . . . 0.0 111.96 -179.468 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.69 HD11 HD11 ' A' ' 7' ' ' LEU . 93.3 mt -85.61 83.33 7.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.086 0.469 . . . . 0.0 111.357 -179.485 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 92.2 p -88.17 -14.17 39.3 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.488 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.651 HD11 ' HG2' ' B' ' 265' ' ' GLN . 66.9 mt -95.52 138.39 33.26 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.091 -179.688 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 27.5 t -64.37 -17.67 63.94 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.058 -179.742 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 46.8 m -128.67 129.53 45.94 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.563 179.582 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.9 t -121.38 115.63 23.29 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.128 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.404 ' O ' ' N ' ' A' ' 36' ' ' ASP . 53.9 tp -113.38 122.02 46.11 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.466 -178.857 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.816 ' CE2' HD12 ' A' ' 37' ' ' ILE . 18.3 m-85 -100.07 141.34 33.03 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.455 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 169.35 -161.08 34.56 Favored Glycine 0 C--O 1.226 -0.392 0 C-N-CA 119.541 -1.314 . . . . 0.0 112.467 179.238 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 29.5 ttp85 -108.0 -9.84 15.59 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -178.372 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -89.21 170.62 37.66 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.798 -178.714 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.469 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.7 tp -66.88 -41.45 87.66 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 O-C-N 122.759 -0.259 . . . . 0.0 110.562 179.861 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.469 ' N ' HG23 ' A' ' 33' ' ' ILE . 72.3 mm-40 -54.27 -26.66 30.3 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.055 0.455 . . . . 0.0 110.721 -179.19 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.548 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 79.2 m -64.2 121.31 13.92 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.485 -179.982 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 28' ' ' LEU . 87.4 m-20 -59.7 -28.2 67.09 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.342 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.816 HD12 ' CE2' ' A' ' 29' ' ' PHE . 89.4 mt -127.08 123.04 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.175 177.726 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 -104.24 136.05 44.57 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.242 -179.595 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.443 ' C ' ' H ' ' A' ' 41' ' ' LEU . 97.4 mt -117.5 128.93 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.912 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -72.39 34.0 0.06 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.244 -178.199 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.531 ' CD2' ' CZ ' ' B' ' 245' ' ' ARG . 32.2 mt -102.87 126.5 32.43 Favored Pre-proline 0 C--N 1.322 -0.624 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.428 179.339 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -73.03 -7.12 20.17 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.147 1.898 . . . . 0.0 112.655 -179.418 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.7 m -102.99 13.23 7.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.499 179.394 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 29.1 t -99.76 133.26 43.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.172 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 33.2 t -72.49 175.05 6.61 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.439 0.638 . . . . 0.0 112.538 -178.329 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.548 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 61.0 mttp -65.18 -40.64 94.54 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.797 -179.455 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.659 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.1 mt-30 -112.86 -18.06 12.36 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.211 -179.853 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 23.9 t60 32.73 -74.48 0.0 OUTLIER 'General case' 0 C--O 1.236 0.357 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 179.882 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.659 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.48 134.0 46.73 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.998 0.428 . . . . 0.0 111.594 -179.578 . . . . . . . . 3 3 . 1 . 077 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -125.77 130.36 51.29 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.465 179.183 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.6 mt -117.43 134.01 62.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.226 179.611 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -114.52 131.03 56.79 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.396 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.505 ' CG2' ' NH1' ' A' ' 5' ' ' ARG . 48.3 mm -99.45 120.29 48.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.46 -178.449 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.462 ' O ' ' C ' ' A' ' 55' ' ' GLU . 94.0 m-70 -119.73 132.36 55.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.262 179.103 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.462 ' C ' ' O ' ' A' ' 54' ' ' HIS . 98.4 mt-10 -40.31 -37.17 0.62 Allowed 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.728 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.456 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 84.3 mt-30 -62.76 -67.25 0.44 Allowed 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.379 179.028 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.457 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 6.1 tp10 -151.03 -166.62 2.58 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.2 -179.039 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.457 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -125.48 135.71 52.59 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 -179.957 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.9 mt -119.04 131.49 71.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -178.311 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.431 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 32.7 tp -97.94 125.93 43.09 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 114.827 -1.079 . . . . 0.0 108.846 178.471 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -112.71 136.79 51.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.743 -179.058 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 26.0 t30 -96.31 105.61 17.7 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.788 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.422 ' CD2' ' OE1' ' A' ' 47' ' ' GLN . 27.0 m-85 -96.48 -9.21 30.21 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.066 178.613 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.515 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 42.2 t -73.83 100.22 3.41 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.477 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.9 m -83.18 -16.61 45.94 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.383 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.42 -38.95 15.68 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.252 -179.782 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.515 ' O ' ' OG ' ' A' ' 64' ' ' SER . 77.4 m-20 -146.62 98.73 4.17 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.343 -179.86 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.38 147.78 55.09 Favored 'Trans proline' 0 N--CA 1.501 1.961 0 C-N-CA 122.392 2.062 . . . . 0.0 113.688 -179.423 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 89.1 m -71.41 136.09 47.55 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.695 179.1 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -98.88 140.89 32.38 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.642 -179.722 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.455 ' CG1' ' OD1' ' A' ' 86' ' ' ASP . 71.5 t -129.43 134.71 63.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.07 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 51.28 34.78 12.17 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.604 -0.838 . . . . 0.0 109.655 -179.773 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.23 30.11 69.78 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.933 179.64 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.6 p -142.22 133.7 26.59 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.469 -179.693 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -67.6 142.37 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.309 -179.964 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.465 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 2.9 pt -119.02 121.27 66.39 Favored 'Isoleucine or valine' 0 C--N 1.343 0.285 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.109 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -87.2 -24.09 24.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.401 -179.894 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -127.04 172.98 5.81 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.907 -179.585 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.51 144.1 99.5 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 122.434 2.09 . . . . 0.0 112.58 179.514 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.7 t -132.16 138.57 52.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.737 178.922 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -73.31 131.17 41.6 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.442 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 97.3 mt -84.26 135.49 34.31 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.079 0.466 . . . . 0.0 111.536 -179.912 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -127.12 149.58 49.88 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.811 179.796 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.438 ' ND1' ' N ' ' A' ' 99' ' ' ASN . 6.7 t60 -55.6 116.63 3.01 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.423 179.819 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.1 -18.77 23.45 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 -179.416 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.455 ' OD1' ' CG1' ' A' ' 71' ' ' VAL . 36.4 t70 -66.81 132.28 47.71 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.535 0.207 . . . . 0.0 110.449 179.151 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.611 HG22 ' HG2' ' A' ' 96' ' ' ARG . 53.4 t -106.86 132.19 54.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.194 -178.927 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 80.0 mt -101.33 129.79 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 177.914 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.3 m -120.42 126.09 49.58 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.531 0.681 . . . . 0.0 112.353 -178.875 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.599 ' O ' ' N ' ' A' ' 93' ' ' ARG . 91.7 mt -113.18 133.26 59.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 177.746 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.526 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 68.0 mt -30.9 102.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 O-C-N 123.112 0.257 . . . . 0.0 111.66 -178.759 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 4.8 t70 87.67 -22.18 0.15 Allowed 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 178.743 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.661 HH22 ' C ' ' A' ' 11' ' ' LYS . 2.0 mmp_? -127.73 139.62 52.57 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.564 -179.337 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.519 ' HB3' HD12 ' A' ' 10' ' ' ILE . 34.7 t -141.1 148.66 40.48 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.929 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.421 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 82.4 m-85 -129.19 130.47 46.38 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.397 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.611 ' HG2' HG22 ' A' ' 87' ' ' VAL . 99.9 mtt180 -89.03 134.36 34.02 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.325 -179.488 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.506 ' CZ ' ' OD1' ' A' ' 99' ' ' ASN . 91.1 t80 -94.45 124.52 38.53 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.142 -179.991 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -139.2 123.96 18.58 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.513 -179.173 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.506 ' OD1' ' CZ ' ' A' ' 97' ' ' TYR . 79.5 m-20 . . . . . 0 C--N 1.328 -0.339 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.621 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo . . . . . 0 N--CA 1.487 1.112 0 CA-C-O 121.77 0.654 . . . . 0.0 112.909 . . . . . . . . . 0 0 . 1 . 077 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 25.0 t -60.05 138.64 20.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.766 -179.808 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . 0.506 ' HB2' HD13 ' A' ' 91' ' ' ILE . 4.1 t . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.562 -179.659 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo . . . . . 0 N--CA 1.497 1.731 0 N-CA-C 113.576 0.568 . . . . 0.0 113.576 . . . . . . . . . 0 0 . 1 . 077 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 17.2 p -73.54 -41.25 63.25 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 119.836 -0.746 . . . . 0.0 109.268 177.981 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.505 ' CZ ' ' NE ' ' B' ' 245' ' ' ARG . 75.7 t80 -56.86 -47.37 80.56 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.752 -179.415 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.42 ' HA ' HD23 ' B' ' 242' ' ' LEU . 90.7 mt -67.08 -40.14 86.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.515 179.172 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -63.4 -43.06 98.6 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.399 -178.653 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -61.72 -42.57 99.12 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.093 0.473 . . . . 0.0 110.637 179.69 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.531 ' CZ ' ' CD2' ' A' ' 41' ' ' LEU . 95.6 mtt-85 -64.0 -39.05 93.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.12 -179.637 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.02 -39.01 93.46 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.061 179.495 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 32.8 t -67.55 -42.18 83.08 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.22 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -58.24 -36.77 73.71 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.903 179.205 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 41.3 t . . . . . 0 N--CA 1.453 -0.321 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.501 179.259 . . . . . . . . 0 0 . 1 . 077 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 . . . . . 0 N--CA 1.464 0.235 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 . . . . . . . . . 0 0 . 1 . 077 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.421 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 64.6 mt -119.26 132.35 69.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.398 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 56.1 t -126.9 135.9 62.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.366 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . 0.695 ' CD2' HG21 ' B' ' 267' ' ' ILE . 69.4 m-85 -99.32 120.22 39.21 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.901 -177.885 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -65.48 -43.48 90.09 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.571 0.701 . . . . 0.0 109.916 179.451 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . 0.651 ' HG2' HD11 ' A' ' 24' ' ' LEU . 2.5 mp0 -100.78 172.6 4.36 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.255 -178.951 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.0 150.05 66.85 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 121.985 1.79 . . . . 0.0 112.599 179.742 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . 0.695 HG21 ' CD2' ' B' ' 263' ' ' PHE . 42.5 pt . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.741 178.996 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 46.1 m . . . . . 0 N--CA 1.455 -0.211 0 CA-C-O 121.129 0.49 . . . . 0.0 110.78 . . . . . . . . . 0 0 . 1 . 078 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.574 ' NH1' HG23 ' A' ' 53' ' ' ILE . 99.1 mtt180 -99.79 127.03 45.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.517 -179.016 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.842 ' HE ' ' CE1' ' A' ' 19' ' ' HIS . 83.2 mtp180 -129.3 148.67 51.25 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.877 -179.075 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.432 HD11 HD11 ' A' ' 22' ' ' LEU . 99.6 mt -112.87 142.23 45.77 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.557 178.872 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.543 HG11 HH21 ' A' ' 96' ' ' ARG . 72.8 t -116.24 128.38 73.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.59 -0.444 . . . . 0.0 109.996 179.855 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 m -81.57 141.09 34.06 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.456 0.646 . . . . 0.0 112.674 -178.293 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.465 HD12 ' HB2' ' A' ' 94' ' ' SER . 83.1 mt -113.93 135.93 52.02 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.056 178.133 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.6 mttp -86.91 158.29 19.34 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.101 178.792 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.629 ' CD ' HH21 ' B' ' 245' ' ' ARG . 89.3 mtm180 -58.75 -27.46 64.98 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.193 -179.86 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 99.0 p -83.56 -8.87 59.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.825 179.771 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.43 37.73 6.49 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.863 179.819 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.1 t -118.76 131.3 71.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-O 120.835 0.35 . . . . 0.0 111.11 179.811 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -75.72 124.34 27.1 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.671 179.83 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -113.41 -122.52 3.88 Favored Glycine 0 CA--C 1.543 1.806 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.721 -179.84 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -76.4 155.54 36.58 Favored 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 123.043 2.495 . . . . 0.0 112.267 -178.702 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.842 ' CE1' ' HE ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -117.67 149.28 40.98 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.829 . . . . . . . . 3 3 . 1 . 078 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.47 ' CD2' HD11 ' A' ' 37' ' ' ILE . 37.7 t80 -115.5 100.49 53.64 Favored Pre-proline 0 N--CA 1.468 0.438 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.748 -177.658 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.406 ' HG3' ' NE2' ' A' ' 19' ' ' HIS . 3.0 Cg_exo -65.04 129.96 24.47 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 121.367 1.378 . . . . 0.0 111.557 179.48 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.432 HD11 HD11 ' A' ' 7' ' ' LEU . 90.6 mt -83.85 71.32 10.47 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.834 -179.896 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 80.6 p -78.66 -15.27 58.69 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.754 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.574 HD11 ' HG2' ' B' ' 265' ' ' GLN . 80.3 mt -93.64 140.78 29.23 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.211 -179.866 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 80.4 p -66.64 -17.51 64.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.959 -179.72 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.484 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 94.9 m -130.7 132.77 45.57 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.907 179.69 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.8 t -125.26 116.65 22.31 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.015 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 44.1 tp -114.16 129.02 56.63 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 121.169 -0.213 . . . . 0.0 111.181 -178.506 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.675 ' CE2' HD12 ' A' ' 37' ' ' ILE . 13.9 m-85 -109.25 140.8 42.43 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.285 179.649 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 156.78 -178.35 33.26 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 119.932 -1.128 . . . . 0.0 112.069 178.603 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.518 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 43.7 mtm180 -74.72 -27.12 60.24 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.457 178.773 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.465 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -57.58 148.38 34.61 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.406 -177.771 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.466 HG23 ' N ' ' A' ' 34' ' ' GLU . 11.1 tp -66.9 -41.47 87.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.097 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.466 ' N ' HG23 ' A' ' 33' ' ' ILE . 92.8 mt-10 -52.49 -21.82 4.16 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.744 178.767 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.465 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 13.8 m -64.85 120.73 13.07 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.597 -179.492 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.484 ' OD2' ' O ' ' A' ' 26' ' ' THR . 99.4 m-20 -54.89 -25.21 27.43 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.316 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.675 HD12 ' CE2' ' A' ' 29' ' ' PHE . 96.8 mt -130.73 124.78 57.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.229 176.837 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 40.4 ttp180 -115.73 139.24 50.34 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.973 -179.386 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.453 HG12 HG23 ' B' ' 261' ' ' ILE . 89.2 mt -117.88 133.47 64.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.704 -178.927 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -73.49 20.38 0.09 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.106 -178.527 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' A' ' 41' ' ' LEU . 30.3 mt -91.2 128.41 47.47 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.924 179.488 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.14 -6.55 19.12 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 122.757 2.305 . . . . 0.0 113.143 -179.118 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.599 HG21 ' CE2' ' B' ' 241' ' ' PHE . 27.2 m -105.23 4.9 10.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.91 179.615 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.518 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 19.8 t -85.91 133.16 30.29 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.931 178.853 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.3 m -64.27 157.96 24.6 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.199 -179.496 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.411 ' HG2' ' H ' ' A' ' 47' ' ' GLN . 10.4 ptmt -60.71 -46.34 90.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.476 -178.815 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.695 ' O ' ' N ' ' A' ' 49' ' ' CYS . 78.6 mt-30 -113.39 -12.31 13.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.553 179.578 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.403 ' CE1' ' HG ' ' A' ' 64' ' ' SER . 24.1 t60 28.36 -70.27 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 179.712 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.695 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -146.67 149.57 33.72 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.699 0.762 . . . . 0.0 112.522 -179.064 . . . . . . . . 3 3 . 1 . 078 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -139.07 131.12 27.94 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.517 -1.22 . . . . 0.0 111.237 179.945 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.6 mt -106.41 135.25 45.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.796 179.875 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -112.76 135.72 53.18 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.062 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.574 HG23 ' NH1' ' A' ' 5' ' ' ARG . 38.8 mm -101.08 124.8 54.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 119.744 -0.782 . . . . 0.0 110.877 -179.646 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.437 ' O ' ' N ' ' A' ' 56' ' ' GLN . 95.6 m-70 -128.45 133.42 48.52 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.41 178.902 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 54' ' ' HIS . 97.8 mt-10 -39.97 -29.98 0.08 Allowed 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 120.492 -0.483 . . . . 0.0 109.761 -179.154 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.437 ' N ' ' O ' ' A' ' 54' ' ' HIS . 69.8 tp60 -64.91 -67.37 0.44 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.041 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.442 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 9.6 tp10 -155.3 -152.05 0.38 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.92 -179.572 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.458 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -127.74 134.72 49.53 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.576 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.1 mt -120.99 132.71 69.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.027 -0.669 . . . . 0.0 112.306 -178.274 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.404 ' HB2' HD21 ' A' ' 82' ' ' LEU . 21.1 tp -101.57 128.05 48.01 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.897 -179.558 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -110.95 136.85 49.35 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.733 -179.973 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -97.09 107.69 20.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.206 0.527 . . . . 0.0 111.745 -179.813 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -98.9 -10.29 23.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.2 179.676 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.403 ' HG ' ' CE1' ' A' ' 48' ' ' HIS . 0.3 OUTLIER -78.09 101.66 7.09 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.28 -179.179 . . . . . . . . 3 3 . 1 . 078 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.7 m -83.15 -43.41 16.22 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.187 0.518 . . . . 0.0 110.363 178.958 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.59 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -61.49 -46.83 88.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.858 -179.042 . . . . . . . . 3 3 . 1 . 078 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.435 HD21 ' HA ' ' B' ' 236' ' ' VAL . 64.7 m-80 -133.52 93.81 20.77 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.617 -179.724 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.559 ' HB2' HG13 ' A' ' 75' ' ' VAL . 53.1 Cg_exo -52.11 140.3 50.8 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.222 1.948 . . . . 0.0 112.819 -179.325 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.499 ' HB ' HD11 ' A' ' 76' ' ' ILE . 8.1 m -69.79 146.25 51.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.622 179.281 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.504 ' OE1' HG22 ' A' ' 75' ' ' VAL . 81.5 mm-40 -109.7 141.5 42.2 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.121 -179.765 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.451 ' O ' ' N ' ' A' ' 74' ' ' SER . 3.6 p -129.94 135.55 60.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.901 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 49.13 31.5 3.53 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -179.043 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.04 29.12 65.26 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.638 -179.429 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.451 ' N ' ' O ' ' A' ' 71' ' ' VAL . 22.3 m -139.61 139.46 36.75 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 120.454 -0.498 . . . . 0.0 112.046 179.99 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.559 HG13 ' HB2' ' A' ' 68' ' ' PRO . 58.7 t -61.14 137.37 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.018 -179.706 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.499 HD11 ' HB ' ' A' ' 69' ' ' THR . 1.4 pt -117.34 72.53 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 120.661 -0.415 . . . . 0.0 109.927 178.498 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.486 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 21.3 p-10 -61.59 -27.6 68.76 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.689 179.974 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -112.89 159.48 34.37 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.431 178.979 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.84 144.42 88.49 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.014 1.809 . . . . 0.0 112.329 179.776 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 51.4 t -131.84 138.89 51.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.88 -179.57 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -73.82 130.87 40.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.296 179.447 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.404 HD21 ' HB2' ' A' ' 60' ' ' LEU . 96.8 mt -80.85 135.48 35.94 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.592 0.711 . . . . 0.0 111.569 -178.97 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -128.11 151.15 49.54 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.955 179.028 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.607 ' CE1' ' H ' ' A' ' 99' ' ' ASN . 7.0 t60 -55.03 117.25 3.29 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.938 -178.847 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 113.32 -15.18 22.83 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.089 179.4 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -70.0 133.31 47.1 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 117.139 0.47 . . . . 0.0 110.7 -179.921 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.5 p -108.91 137.31 41.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.674 -179.469 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 88.2 mt -104.96 129.81 57.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 177.908 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.5 m -121.42 129.34 52.94 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -177.45 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.414 ' N ' ' O ' ' A' ' 93' ' ' ARG . 89.2 mt -116.63 122.95 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 114.306 -1.315 . . . . 0.0 109.151 178.335 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.49 HD12 ' CB ' ' B' ' 237' ' ' CYS . 38.8 mm 40.05 -98.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.064 -179.562 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -117.68 17.0 14.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.213 0.53 . . . . 0.0 109.978 -179.787 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.414 ' O ' ' N ' ' A' ' 90' ' ' ILE . 39.3 ttm180 -130.26 144.05 51.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.176 -179.671 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.465 ' HB2' HD12 ' A' ' 10' ' ' ILE . 36.7 m -140.62 158.9 43.3 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.793 0.806 . . . . 0.0 111.855 -179.494 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -128.35 123.24 33.42 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.304 179.434 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.543 HH21 HG11 ' A' ' 8' ' ' VAL . 95.2 mtm-85 -86.24 135.59 33.5 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.957 -179.407 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -93.33 122.8 36.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.826 178.745 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.4 ' HG3' ' CE1' ' A' ' 84' ' ' HIS . 80.4 tt0 -125.72 126.29 44.38 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.252 -178.907 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.607 ' H ' ' CE1' ' A' ' 84' ' ' HIS . 28.9 t-20 . . . . . 0 C--N 1.332 -0.195 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.725 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo . . . . . 0 N--CA 1.49 1.303 0 CA-C-O 121.11 0.379 . . . . 0.0 111.937 . . . . . . . . . 0 0 . 1 . 078 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.59 ' CG2' HG22 ' A' ' 66' ' ' THR . 52.5 t -77.95 131.86 33.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.215 -178.545 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . 0.49 ' CB ' HD12 ' A' ' 91' ' ' ILE . 2.5 t . . . . . 0 N--CA 1.463 0.211 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.99 179.224 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo . . . . . 0 N--CA 1.491 1.344 0 N-CA-C 112.471 0.143 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 078 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 27.5 m -72.74 -46.02 55.64 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.296 178.545 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.599 ' CE2' HG21 ' A' ' 43' ' ' VAL . 71.6 t80 -58.21 -45.7 87.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.743 -179.243 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 88.9 mt -64.35 -42.53 96.18 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 120.829 0.347 . . . . 0.0 111.003 179.345 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -62.9 -43.23 99.35 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.289 -178.68 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 87.8 mtm180 -63.29 -42.03 99.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.986 0.422 . . . . 0.0 110.631 -179.005 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.629 HH21 ' CD ' ' A' ' 12' ' ' ARG . 75.9 mtp180 -61.52 -42.07 98.27 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.255 179.955 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -64.56 -40.2 95.13 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.379 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 15.3 t -65.56 -44.96 85.16 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.558 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -60.21 -37.89 81.67 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.025 -179.945 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . 0.438 HG23 ' O ' ' B' ' 245' ' ' ARG . 37.4 t . . . . . 0 N--CA 1.462 0.169 0 CA-C-O 120.811 0.338 . . . . 0.0 110.52 178.93 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.552 ' OE2' ' CZ ' ' A' ' 12' ' ' ARG . 98.3 mt-10 . . . . . 0 N--CA 1.444 -0.725 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 . . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.453 HG23 HG12 ' A' ' 39' ' ' ILE . 2.8 mt -116.0 140.84 36.02 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.537 -179.795 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 62.3 t -127.81 136.21 60.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.376 179.354 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . 0.691 ' CD2' HG21 ' B' ' 267' ' ' ILE . 68.3 m-85 -99.59 124.64 44.98 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.395 0.616 . . . . 0.0 111.615 -178.271 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -62.09 -40.79 97.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.744 179.572 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . 0.574 ' HG2' HD11 ' A' ' 24' ' ' LEU . 0.8 OUTLIER -107.05 173.6 3.02 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 114.838 -1.073 . . . . 0.0 110.232 -179.336 . . . . . . . . 3 3 . 1 . 078 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.77 150.45 62.38 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 122.63 2.22 . . . . 0.0 113.535 -179.63 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . 0.691 HG21 ' CD2' ' B' ' 263' ' ' PHE . 41.1 pt . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.813 179.576 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.2 t . . . . . 0 N--CA 1.462 0.146 0 CA-C-O 121.186 0.517 . . . . 0.0 110.397 . . . . . . . . . 0 0 . 1 . 079 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.702 HH12 HG23 ' A' ' 53' ' ' ILE . 99.9 mtt180 -88.7 139.08 30.83 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.506 -179.822 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.7 mtm180 -130.97 136.21 48.34 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.429 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.921 HD11 HD11 ' A' ' 22' ' ' LEU . 83.3 mt -112.47 138.9 48.56 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-O 120.778 0.323 . . . . 0.0 110.624 179.515 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 43.5 t -112.34 128.36 69.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.25 178.988 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.576 HG21 ' HZ ' ' B' ' 263' ' ' PHE . 74.8 p -83.14 138.94 33.46 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.49 0.662 . . . . 0.0 112.023 -178.815 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.0 mm -105.66 134.07 48.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.656 179.38 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.4 mttt -86.79 153.86 21.36 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.054 178.266 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 91.8 mtm180 -57.22 -25.87 59.77 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.446 -0.502 . . . . 0.0 109.968 -179.556 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.1 m -79.48 -10.48 59.81 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.771 179.158 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.64 40.09 7.9 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.066 -1.213 . . . . 0.0 110.066 -178.946 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.8 t -120.48 131.08 73.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 114.996 -0.602 . . . . 0.0 109.894 -179.992 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -71.38 125.24 26.49 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.18 179.679 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -120.64 -120.85 2.8 Favored Glycine 0 CA--C 1.54 1.643 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.214 -179.23 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.87 145.26 40.18 Favored 'Trans proline' 0 N--CA 1.503 2.087 0 C-N-CA 122.848 2.365 . . . . 0.0 114.307 -177.769 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -110.65 129.17 55.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.011 -179.784 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.645 ' CD2' HD11 ' A' ' 37' ' ' ILE . 47.8 t80 -100.1 102.38 17.71 Favored Pre-proline 0 N--CA 1.465 0.323 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.817 -179.995 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -78.21 139.09 16.57 Favored 'Trans proline' 0 C--N 1.314 -1.242 0 C-N-CA 121.608 1.538 . . . . 0.0 111.957 -179.45 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.921 HD11 HD11 ' A' ' 7' ' ' LEU . 87.8 mt -101.39 130.26 47.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.255 0.55 . . . . 0.0 111.498 -179.109 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 45.1 p -139.54 4.03 2.14 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.875 177.725 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.1 mt -107.35 151.25 25.75 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.332 -179.654 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 m -62.93 -24.29 67.79 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.369 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 87.1 m -133.97 135.42 43.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.428 0.632 . . . . 0.0 111.948 -179.483 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.595 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 3.1 t -126.19 117.19 22.58 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 177.769 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.736 HD13 ' HD3' ' A' ' 50' ' ' LYS . 49.2 tp -115.41 131.31 56.97 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.807 -176.842 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.765 ' CE2' HD12 ' A' ' 37' ' ' ILE . 11.2 m-85 -107.44 128.48 54.52 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.719 -179.913 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 165.01 -176.18 40.8 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 119.918 -1.134 . . . . 0.0 113.549 178.14 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 48.6 mtm180 -74.67 -31.91 62.07 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.746 0.308 . . . . 0.0 110.63 179.129 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.526 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -51.14 145.45 11.68 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.033 -178.568 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.417 HD13 ' HA ' ' A' ' 33' ' ' ILE . 32.4 mm -65.78 -43.87 93.26 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.102 0 CA-C-O 120.81 0.338 . . . . 0.0 110.913 179.305 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -55.64 -23.51 28.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.028 0.442 . . . . 0.0 109.831 -179.682 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.526 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 35.2 m -54.46 126.61 24.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.287 -179.369 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.408 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 54.8 m-20 -61.35 -33.22 73.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.872 -179.459 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.765 HD12 ' CE2' ' A' ' 29' ' ' PHE . 77.9 mt -126.54 122.87 61.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 177.38 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 39.6 mtm180 -106.23 137.63 43.83 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -179.602 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.718 ' CG2' HD12 ' A' ' 41' ' ' LEU . 80.3 mt -117.42 125.9 74.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.918 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -71.34 29.33 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.894 -178.604 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.718 HD12 ' CG2' ' A' ' 39' ' ' ILE . 13.0 mt -100.73 127.61 32.02 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.955 -179.942 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.07 -9.17 24.15 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.096 1.864 . . . . 0.0 112.722 -179.385 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.551 HG21 ' CE2' ' B' ' 241' ' ' PHE . 18.1 m -99.07 7.86 8.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.089 -0.644 . . . . 0.0 111.301 -179.723 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 42.8 t -91.86 135.88 25.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.799 178.677 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.7 m -68.94 166.97 16.76 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.207 -179.476 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -61.21 -42.57 98.83 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.208 -0.906 . . . . 0.0 111.045 -179.055 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.627 ' O ' ' N ' ' A' ' 49' ' ' CYS . 12.5 mm100 -115.57 -26.84 7.33 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 123.853 0.721 . . . . 0.0 109.825 -179.518 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.44 ' O ' ' OG ' ' A' ' 64' ' ' SER . 21.3 t60 44.95 -74.86 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.493 179.556 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.627 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -134.81 139.59 45.21 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.703 -179.195 . . . . . . . . 3 3 . 1 . 079 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.736 ' HD3' HD13 ' A' ' 28' ' ' LEU . 21.7 ttpt -130.61 129.52 42.83 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.0 179.007 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 91.5 mt -107.56 130.47 59.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.34 179.615 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -114.52 123.15 48.65 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 177.598 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.702 HG23 HH12 ' A' ' 5' ' ' ARG . 95.3 mt -103.04 115.91 45.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 119.816 -0.753 . . . . 0.0 111.626 -179.195 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.52 ' O ' ' N ' ' A' ' 56' ' ' GLN . 84.7 m-70 -113.24 141.19 47.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.162 179.551 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.1 tt0 -39.97 -26.13 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.446 0.641 . . . . 0.0 109.528 -178.827 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.52 ' N ' ' O ' ' A' ' 54' ' ' HIS . 63.2 tt0 -68.13 -67.98 0.42 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.816 -1.083 . . . . 0.0 109.628 179.104 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -157.58 -168.48 2.58 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.607 -179.426 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -107.5 127.09 53.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.615 179.24 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.1 mt -120.28 129.67 75.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.213 0.53 . . . . 0.0 111.979 -179.618 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.543 ' HB2' HD11 ' A' ' 82' ' ' LEU . 23.5 tp -101.42 128.51 47.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.152 -179.907 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -113.8 138.57 50.09 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.882 -179.296 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.56 HD21 ' CA ' ' A' ' 68' ' ' PRO . 55.3 t-20 -100.39 108.34 20.33 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.825 0.345 . . . . 0.0 111.649 -179.934 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -98.03 -9.45 25.99 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.538 -179.89 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -78.82 117.11 19.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.971 0.415 . . . . 0.0 111.107 -179.818 . . . . . . . . 3 3 . 1 . 079 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.7 p -101.2 -14.6 17.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.64 179.351 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.912 HG22 HG22 ' B' ' 236' ' ' VAL . 0.2 OUTLIER -88.73 -44.44 10.55 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.346 0.593 . . . . 0.0 109.421 -179.596 . . . . . . . . 3 3 . 1 . 079 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -138.85 95.47 9.69 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.137 -0.938 . . . . 0.0 108.584 178.286 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.56 ' CA ' HD21 ' A' ' 62' ' ' ASN . 37.5 Cg_endo -66.4 150.11 84.52 Favored 'Trans proline' 0 C--N 1.316 -1.156 0 C-N-CA 121.18 1.253 . . . . 0.0 113.029 -177.918 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.439 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 5.3 m -72.13 140.26 48.76 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.949 -179.401 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -103.33 140.9 36.81 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.514 178.547 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.495 ' CG2' ' OD1' ' A' ' 86' ' ' ASP . 5.6 p -128.48 135.5 62.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.043 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 48.37 31.03 2.54 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 119.415 -0.914 . . . . 0.0 108.629 -178.628 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.08 24.73 73.01 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.683 -179.583 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.459 ' N ' ' O ' ' A' ' 71' ' ' VAL . 35.9 t -136.24 139.55 42.81 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.94 0.37 . . . . 0.0 111.11 -179.711 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 79.3 t -68.02 140.7 18.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.169 179.807 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.9 pt -111.77 70.97 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 120.927 0.394 . . . . 0.0 110.437 179.021 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -54.95 -32.72 61.67 Favored 'General case' 0 N--CA 1.461 0.096 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.313 179.578 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -118.88 163.05 28.11 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.96 179.399 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -59.46 144.57 99.37 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.886 1.724 . . . . 0.0 112.829 -179.158 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.0 m -138.14 138.39 43.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.176 -179.68 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -73.12 129.08 37.27 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 120.646 -0.422 . . . . 0.0 109.919 179.47 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.543 HD11 ' HB2' ' A' ' 60' ' ' LEU . 94.6 mt -80.51 141.27 35.32 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.994 0.426 . . . . 0.0 110.631 179.717 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.438 ' HG2' ' N ' ' A' ' 84' ' ' HIS . 88.3 tttt -136.03 157.78 46.01 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.952 -179.56 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.612 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 6.2 t60 -57.3 118.41 5.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.924 0.392 . . . . 0.0 110.834 -179.36 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.68 -7.67 29.89 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -179.989 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.495 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 50.5 t0 -74.76 124.88 27.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.023 0.439 . . . . 0.0 110.115 179.316 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.547 HG22 ' HG2' ' A' ' 96' ' ' ARG . 75.0 t -108.02 131.36 58.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.658 -178.685 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 80.3 mt -99.47 130.67 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.341 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.2 m -118.46 124.78 48.45 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.409 0.623 . . . . 0.0 112.494 -179.121 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.491 HD12 ' HE1' ' A' ' 95' ' ' PHE . 96.9 mt -114.0 124.68 70.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 177.902 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.524 HG22 ' NH2' ' B' ' 245' ' ' ARG . 34.5 mm 36.09 -99.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 -178.764 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.509 ' CG ' ' NH2' ' B' ' 245' ' ' ARG . 37.7 p-10 -116.08 14.01 15.93 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.247 179.425 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.432 ' O ' ' N ' ' A' ' 90' ' ' ILE . 84.7 mtt-85 -121.96 145.52 48.04 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.282 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 73.7 m -136.72 154.96 50.45 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.009 179.766 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.491 ' HE1' HD12 ' A' ' 90' ' ' ILE . 79.7 m-85 -126.59 120.65 30.11 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.333 179.378 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.547 ' HG2' HG22 ' A' ' 87' ' ' VAL . 99.6 mtt180 -85.42 136.58 33.39 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.39 -178.936 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -98.18 122.81 41.8 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.302 -179.521 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -134.76 129.33 34.47 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.275 0.56 . . . . 0.0 112.004 -179.601 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.612 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 13.3 p30 . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.762 179.399 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo . . . . . 0 N--CA 1.488 1.205 0 CA-C-O 121.291 0.454 . . . . 0.0 112.372 . . . . . . . . . 0 0 . 1 . 079 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.912 HG22 HG22 ' A' ' 66' ' ' THR . 11.4 t -85.4 129.26 38.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.127 -179.568 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.243 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.59 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo . . . . . 0 N--CA 1.493 1.446 0 N-CA-C 113.222 0.432 . . . . 0.0 113.222 . . . . . . . . . 0 0 . 1 . 079 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 23.4 m -74.17 -44.6 52.88 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.273 179.008 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.551 ' CE2' HG21 ' A' ' 43' ' ' VAL . 89.1 t80 -56.35 -46.92 79.77 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.634 -179.436 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.75 HD23 HH21 ' B' ' 245' ' ' ARG . 93.3 mt -63.02 -42.27 99.75 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.846 0.355 . . . . 0.0 110.634 179.869 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -67.6 -40.24 84.75 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -179.425 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -60.97 -45.0 96.53 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.328 -178.832 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.75 HH21 HD23 ' B' ' 242' ' ' LEU . 60.5 mtm180 -65.36 -38.55 90.42 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.626 -0.429 . . . . 0.0 111.513 -179.662 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -61.49 -41.15 96.84 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.41 -179.845 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 62.9 m -64.91 -41.07 95.89 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.052 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -62.13 -37.48 85.3 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.797 179.882 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 27.3 t . . . . . 0 N--CA 1.456 -0.156 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.255 179.359 . . . . . . . . 0 0 . 1 . 079 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 . . . . . 0 C--O 1.233 0.225 0 CA-C-O 121.352 0.596 . . . . 0.0 110.275 . . . . . . . . . 0 0 . 1 . 079 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.452 HD13 ' CE2' ' A' ' 95' ' ' PHE . 81.3 mt -114.42 136.8 49.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.324 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 88.1 t -124.51 132.0 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 120.816 -0.353 . . . . 0.0 110.424 -179.202 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . 0.576 ' HZ ' HG21 ' A' ' 9' ' ' THR . 48.2 m-85 -96.93 118.55 33.59 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.192 0.52 . . . . 0.0 112.193 -178.18 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -67.2 -46.01 75.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.553 179.057 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 62.6 mm-40 -91.77 160.78 35.51 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.622 -178.168 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -62.51 154.3 65.51 Favored 'Trans proline' 0 N--CA 1.501 1.942 0 C-N-CA 122.664 2.243 . . . . 0.0 111.082 179.11 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.1 pt . . . . . 0 CA--C 1.519 -0.238 0 CA-C-O 121.497 0.665 . . . . 0.0 112.139 -178.771 . . . . . . . . 0 0 . 1 . 080 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 74.1 m . . . . . 0 N--CA 1.457 -0.12 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 . . . . . . . . . 0 0 . 1 . 080 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.661 ' NH1' ' HB2' ' A' ' 58' ' ' ALA . 95.5 mtt-85 -93.62 118.12 30.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.718 0.294 . . . . 0.0 111.205 -178.671 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.8 mtp180 -133.51 138.16 45.98 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.397 -0.521 . . . . 0.0 111.509 179.468 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.738 HD12 ' O ' ' A' ' 96' ' ' ARG . 35.8 tp -113.85 133.62 55.31 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.331 179.876 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.82 HG22 ' CD2' ' A' ' 19' ' ' HIS . 47.4 t -109.69 130.96 61.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.865 0.364 . . . . 0.0 110.106 -179.966 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.452 HG23 HH21 ' A' ' 93' ' ' ARG . 1.5 m -88.33 115.65 25.98 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.092 -0.503 . . . . 0.0 112.046 -178.698 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.652 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 95.4 mt -84.04 141.5 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.245 178.712 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -94.78 157.17 16.06 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.332 0.586 . . . . 0.0 111.812 179.526 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.473 ' CD ' ' OD2' ' A' ' 92' ' ' ASP . 89.9 mtm180 -57.85 -27.67 63.44 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.459 -178.92 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.0 t -75.72 -16.36 60.16 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.449 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.22 26.88 11.52 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -179.441 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 49.7 t -117.26 133.59 63.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.75 0.31 . . . . 0.0 110.632 179.865 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -75.47 138.56 41.68 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 178.835 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.5 -113.94 1.69 Allowed Glycine 0 CA--C 1.534 1.237 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.316 -179.292 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -72.1 143.01 39.29 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.18 1.92 . . . . 0.0 113.015 -178.415 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.82 ' CD2' HG22 ' A' ' 8' ' ' VAL . 55.0 m170 -102.76 143.35 32.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.028 179.863 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.627 ' CD2' HD11 ' A' ' 37' ' ' ILE . 45.5 t80 -117.08 92.43 39.36 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.297 -179.49 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -60.8 127.49 22.65 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.162 1.908 . . . . 0.0 111.755 179.965 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.6 mt -90.01 51.01 1.96 Allowed 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.739 -0.384 . . . . 0.0 111.126 -179.156 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.6 p -63.33 -20.14 65.24 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.21 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.711 HD11 ' NE2' ' B' ' 265' ' ' GLN . 79.3 mt -81.45 141.89 33.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.501 179.266 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.9 m -66.51 -20.44 66.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.665 -178.742 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 83.9 m -129.32 131.01 46.84 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.048 0.451 . . . . 0.0 111.332 179.551 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.8 t -127.08 123.34 36.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.804 178.898 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 40.8 tp -120.32 127.46 52.37 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.36 -178.782 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.744 ' CE2' HD12 ' A' ' 37' ' ' ILE . 11.2 m-85 -104.36 130.77 52.21 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.773 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 178.37 -159.24 24.48 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 111.424 -0.671 . . . . 0.0 111.424 -179.771 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 29.3 ptt-85 -108.48 -15.88 14.34 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.955 -179.87 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -77.0 165.59 53.58 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.017 -178.852 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.418 HD13 ' HA ' ' A' ' 33' ' ' ILE . 30.9 mm -64.5 -43.07 96.86 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.843 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.9 mp0 -52.27 -29.14 21.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.168 -179.887 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 58.6 m -60.88 121.08 11.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.846 179.831 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -55.36 -29.35 58.23 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.958 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.744 HD12 ' CE2' ' A' ' 29' ' ' PHE . 99.3 mt -129.49 124.43 59.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.247 -0.888 . . . . 0.0 108.868 177.505 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 45.7 mtm180 -101.8 134.25 45.27 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.703 -179.905 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.739 HG21 HD12 ' A' ' 41' ' ' LEU . 92.1 mt -119.37 129.04 75.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.813 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -70.24 35.19 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.921 -178.88 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.875 ' O ' HG12 ' A' ' 44' ' ' VAL . 23.6 mt -103.65 115.93 62.74 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.267 -179.75 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -74.64 -7.78 19.78 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.145 1.896 . . . . 0.0 111.771 -179.847 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.9 m -100.36 8.2 8.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.59 179.843 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.875 HG12 ' O ' ' A' ' 41' ' ' LEU . 8.5 p -96.72 140.86 16.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.455 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.0 m -70.98 166.63 20.89 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.336 0.589 . . . . 0.0 111.612 -178.728 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -63.38 -40.84 98.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.01 -179.696 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.582 ' O ' ' N ' ' A' ' 49' ' ' CYS . 87.7 mt-30 -116.93 -6.65 11.45 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.405 -179.89 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.478 ' C ' ' O ' ' A' ' 47' ' ' GLN . 13.1 t60 15.21 -74.88 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -179.568 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.582 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -125.48 130.15 51.22 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.885 -0.726 . . . . 0.0 112.061 -178.435 . . . . . . . . 3 3 . 1 . 080 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -127.67 126.42 41.92 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.102 179.979 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 83.5 mt -110.23 133.56 55.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.912 -179.309 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -115.18 126.54 54.71 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.497 178.931 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.3 mm -97.84 113.3 32.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 119.675 -0.81 . . . . 0.0 111.085 -179.694 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.437 ' O ' ' C ' ' A' ' 55' ' ' GLU . 97.4 m-70 -114.85 136.3 53.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.432 179.114 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 54' ' ' HIS . 98.4 mt-10 -40.31 -38.68 0.83 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.42 -0.512 . . . . 0.0 109.741 -179.428 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.495 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 50.8 tt0 -62.34 -66.43 0.54 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.035 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.495 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 4.0 tp10 -155.58 -169.42 3.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.334 -179.377 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.661 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -114.52 129.42 56.66 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.61 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 93.9 mt -115.4 131.83 66.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.408 0.623 . . . . 0.0 111.913 -178.796 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.496 HD22 ' CD1' ' A' ' 88' ' ' ILE . 28.2 tp -100.61 130.8 46.72 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.196 179.994 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -111.3 131.52 55.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.819 -179.343 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 62.6 t-20 -94.74 106.16 18.13 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.819 0.343 . . . . 0.0 111.429 -179.673 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -97.52 -7.74 30.71 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.178 -179.683 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.8 p -84.06 108.21 16.86 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 119.997 -0.681 . . . . 0.0 111.3 -179.334 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 89.6 p -91.27 -16.25 27.87 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.783 178.874 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.583 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -86.23 -42.53 13.72 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.128 179.95 . . . . . . . . 3 3 . 1 . 080 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -139.82 97.64 8.02 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.085 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -56.08 143.22 84.54 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 121.974 1.782 . . . . 0.0 112.781 -178.501 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.5 m -69.83 138.25 52.45 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.349 178.588 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -102.73 140.29 37.2 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.272 0.558 . . . . 0.0 111.091 -179.561 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.0 p -133.14 135.66 56.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.92 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 50.09 31.79 5.26 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.361 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.13 26.51 68.38 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.769 179.91 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.6 t -140.6 138.23 34.27 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 117.266 0.533 . . . . 0.0 111.929 -179.546 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.417 ' H ' HG22 ' A' ' 75' ' ' VAL . 2.6 m -72.39 141.94 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.789 179.374 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.9 pt -113.68 94.16 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.203 0.525 . . . . 0.0 111.148 179.461 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -65.35 -29.05 69.74 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.752 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -122.12 165.02 22.18 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.219 179.909 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.14 152.28 81.6 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.647 2.231 . . . . 0.0 112.6 -179.819 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.3 m -143.33 143.46 24.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.466 -179.424 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -72.01 133.33 45.25 Favored 'General case' 0 C--O 1.231 0.098 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.036 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.468 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 98.1 mt -82.34 141.57 32.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.026 0.441 . . . . 0.0 111.564 -179.487 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -131.38 151.9 51.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.425 179.682 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.531 ' HD1' ' C ' ' A' ' 99' ' ' ASN . 7.4 t60 -54.37 117.7 3.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.712 0.291 . . . . 0.0 110.813 -179.785 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.5 -15.43 27.15 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.196 -0.526 . . . . 0.0 111.821 179.515 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -67.4 134.46 51.48 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.345 -0.542 . . . . 0.0 110.545 -179.741 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.468 HG22 ' HG2' ' A' ' 96' ' ' ARG . 74.3 t -109.74 135.91 47.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.244 -178.225 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.496 ' CD1' HD22 ' A' ' 60' ' ' LEU . 6.5 mm -99.26 128.74 50.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.761 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.4 m -119.98 121.22 38.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.686 0.755 . . . . 0.0 111.976 -178.989 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.567 ' O ' ' N ' ' A' ' 93' ' ' ARG . 96.2 mt -115.87 127.75 73.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.002 178.667 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.537 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 72.5 mt -18.64 99.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -178.763 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.537 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 2.6 t70 88.68 -21.96 0.14 Allowed 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 178.031 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.652 ' NH2' ' O ' ' A' ' 10' ' ' ILE . 8.0 mmm180 -130.06 146.02 51.7 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.0 -179.609 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.6 t -139.45 148.83 43.28 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.991 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.553 ' HB3' HD11 ' A' ' 7' ' ' LEU . 58.3 m-85 -126.92 122.14 33.75 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 -179.992 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.738 ' O ' HD12 ' A' ' 7' ' ' LEU . 79.0 mtp85 -82.07 130.31 35.05 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.89 0.376 . . . . 0.0 111.249 -179.184 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.63 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 82.8 t80 -96.23 124.92 40.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.554 179.498 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -122.39 127.04 49.22 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.6 179.852 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.531 ' C ' ' HD1' ' A' ' 84' ' ' HIS . 61.6 t-20 . . . . . 0 C--N 1.328 -0.342 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.217 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo . . . . . 0 N--CA 1.489 1.235 0 CA-C-O 121.357 0.482 . . . . 0.0 113.015 . . . . . . . . . 0 0 . 1 . 080 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.583 ' CG2' HG22 ' A' ' 66' ' ' THR . 25.6 t -110.28 133.37 55.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.998 -179.396 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.6 t . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.867 -179.902 . . . . . . . . 0 0 . 1 . 080 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo . . . . . 0 N--CA 1.493 1.495 0 CA-C-O 120.769 0.237 . . . . 0.0 111.926 . . . . . . . . . 0 0 . 1 . 080 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 16.8 m -73.74 -44.92 54.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.203 0.525 . . . . 0.0 110.29 178.357 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -58.17 -45.54 87.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.873 -178.724 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.411 ' HA ' HD23 ' B' ' 242' ' ' LEU . 94.0 mt -63.64 -39.76 95.16 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.328 -0.549 . . . . 0.0 109.575 179.568 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -62.04 -42.75 99.51 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.258 179.988 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -64.89 -40.64 95.42 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.126 -179.713 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.783 ' CZ ' HD21 ' A' ' 41' ' ' LEU . 13.6 mmm180 -61.05 -38.92 87.88 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.298 -178.778 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -65.06 -38.82 92.05 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.38 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 30.4 m -62.39 -45.8 91.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.497 178.475 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -61.08 -35.35 76.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.457 -179.739 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 24.2 t . . . . . 0 C--N 1.328 -0.342 0 C-N-CA 120.39 -0.524 . . . . 0.0 109.697 179.423 . . . . . . . . 0 0 . 1 . 080 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.443 ' C ' HD13 ' B' ' 261' ' ' ILE . 50.4 mm-40 . . . . . 0 CA--C 1.54 0.584 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 . . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.543 HD11 ' CZ ' ' A' ' 93' ' ' ARG . 4.6 mm -110.46 130.78 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-N 119.113 0.87 . . . . 0.0 109.945 179.537 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 53.5 t -124.48 131.77 72.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.032 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -99.73 122.51 42.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.064 0.459 . . . . 0.0 111.613 -178.257 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -63.85 -46.78 83.46 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.358 0.599 . . . . 0.0 110.135 179.927 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . 0.711 ' NE2' HD11 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -97.55 157.34 34.92 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.654 -179.367 . . . . . . . . 3 3 . 1 . 080 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -60.3 145.23 99.02 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.893 2.395 . . . . 0.0 113.059 -179.647 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 14.5 pt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.178 179.483 . . . . . . . . 0 0 . 1 . 081 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.6 p . . . . . 0 N--CA 1.45 -0.461 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 081 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.566 ' NH1' ' HB2' ' A' ' 58' ' ' ALA . 96.1 mtt-85 -91.99 118.7 31.02 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.274 -179.882 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -128.29 129.78 46.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.926 0.394 . . . . 0.0 111.56 -179.476 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.537 HD11 ' HB3' ' A' ' 95' ' ' PHE . 33.9 tp -112.91 130.06 56.25 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.581 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.8 t -109.06 134.29 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-O 120.835 0.35 . . . . 0.0 110.795 -179.39 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.409 HG23 ' CD1' ' B' ' 261' ' ' ILE . 3.7 m -91.96 120.93 33.07 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.502 -178.521 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.495 ' CD1' ' OD1' ' A' ' 16' ' ' ASP . 49.4 mm -82.15 138.68 19.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.539 179.651 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -91.6 159.65 15.79 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 121.331 0.586 . . . . 0.0 111.561 179.115 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.57 ' NH2' ' OE1' ' B' ' 248' ' ' GLN . 77.3 mtp180 -54.72 -33.07 60.53 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.32 -179.109 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.8 p -78.4 -12.78 60.03 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.76 -179.594 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.59 13.56 40.65 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.973 178.899 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.3 m -109.71 141.49 24.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.317 179.947 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.495 ' OD1' ' CD1' ' A' ' 10' ' ' ILE . 86.4 m-20 -73.6 139.26 45.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.56 -179.327 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.43 -117.33 1.96 Allowed Glycine 0 CA--C 1.535 1.295 0 C-N-CA 120.383 -0.913 . . . . 0.0 111.638 179.94 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.17 143.28 43.74 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 122.096 1.864 . . . . 0.0 113.319 -178.73 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -106.85 157.6 17.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.402 -179.861 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.465 ' CD2' HD11 ' A' ' 37' ' ' ILE . 48.3 t80 -131.52 102.19 15.44 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.773 179.918 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.08 132.73 17.09 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 121.728 1.619 . . . . 0.0 112.061 -179.037 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.9 mt -83.36 55.4 3.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.901 0.381 . . . . 0.0 111.46 -178.535 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 52.4 p -68.04 -25.39 65.34 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.558 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.0 mt -80.65 139.65 36.09 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.539 -0.755 . . . . 0.0 108.966 179.083 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 80.3 p -65.5 -19.38 65.91 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.408 -179.224 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.52 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 44.6 m -131.95 131.49 42.67 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.175 -179.446 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.1 t -125.15 117.18 23.32 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.711 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.549 HD21 ' HG3' ' A' ' 47' ' ' GLN . 52.0 tp -113.93 126.06 54.73 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.915 -179.6 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.676 ' CE2' HD12 ' A' ' 37' ' ' ILE . 7.8 m-85 -104.7 141.09 37.08 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.944 179.465 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 153.34 -174.24 32.03 Favored Glycine 0 N--CA 1.469 0.864 0 C-N-CA 120.288 -0.958 . . . . 0.0 112.328 178.481 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.628 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 80.7 mtm-85 -77.39 -32.51 54.89 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-O 120.93 0.395 . . . . 0.0 110.842 -179.982 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.485 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -46.04 144.63 3.65 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 -179.057 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.513 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.0 tp -65.96 -41.41 89.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-O 120.883 0.373 . . . . 0.0 110.056 179.667 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.513 ' N ' HG23 ' A' ' 33' ' ' ILE . 79.4 mm-40 -57.63 -15.65 8.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.861 -179.845 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 80.2 m -56.87 124.4 18.42 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.587 -179.628 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.52 ' OD2' ' O ' ' A' ' 26' ' ' THR . 57.0 m-20 -60.2 -33.15 71.83 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 179.443 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.676 HD12 ' CE2' ' A' ' 29' ' ' PHE . 87.1 mt -127.57 120.33 54.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 176.346 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 76.8 ttt-85 -105.85 135.53 47.11 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.352 -177.923 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.628 HG21 HD12 ' A' ' 41' ' ' LEU . 94.5 mt -117.32 130.09 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 121.045 0.45 . . . . 0.0 110.888 -179.537 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -81.09 30.62 0.33 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.496 -179.216 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.708 ' O ' HG12 ' A' ' 44' ' ' VAL . 20.8 mt -91.32 112.8 55.94 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.758 179.262 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -57.38 -14.24 15.43 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.347 2.032 . . . . 0.0 113.343 179.636 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.48 HG21 ' CE2' ' B' ' 241' ' ' PHE . 2.4 m -103.78 11.15 8.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.748 -178.988 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.708 HG12 ' O ' ' A' ' 41' ' ' LEU . 6.0 p -98.56 138.39 23.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.018 179.629 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.0 m -68.91 167.87 14.8 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.616 0.722 . . . . 0.0 111.983 -179.138 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -63.02 -43.79 97.75 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 114.768 -1.106 . . . . 0.0 111.997 -178.394 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.649 ' O ' ' N ' ' A' ' 49' ' ' CYS . 21.6 mp0 -110.74 -14.55 14.0 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.935 0.398 . . . . 0.0 110.035 179.966 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 25.7 t60 32.45 -75.31 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.083 -0.962 . . . . 0.0 113.551 179.633 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.649 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.82 137.82 45.3 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -178.594 . . . . . . . . 3 3 . 1 . 081 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -125.02 131.83 53.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.016 179.599 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 88.3 mt -114.12 130.54 68.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.337 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -117.98 121.35 40.42 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.422 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 86.3 mt -103.82 116.04 46.86 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-O 121.572 0.701 . . . . 0.0 111.649 -178.854 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.454 ' O ' ' N ' ' A' ' 56' ' ' GLN . 53.0 m-70 -111.84 146.08 38.31 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.864 -179.837 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 54' ' ' HIS . 95.5 mt-10 -39.83 -30.45 0.08 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.128 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.465 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 89.6 mt-30 -63.97 -68.74 0.32 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.991 179.213 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.507 ' HG2' ' HE ' ' A' ' 81' ' ' ARG . 4.6 tp10 -159.13 -161.82 0.99 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.668 179.401 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.566 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -116.63 122.31 44.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.578 179.158 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 91.4 mt -113.59 130.48 67.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.266 0.555 . . . . 0.0 112.132 -178.926 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.599 ' HB2' HD21 ' A' ' 82' ' ' LEU . 48.3 tp -92.37 125.39 37.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.15 179.47 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.416 ' ND1' ' HB3' ' A' ' 79' ' ' PRO . 97.6 m-70 -111.36 136.28 50.71 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.635 0.255 . . . . 0.0 110.921 179.73 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.705 ' ND2' ' H ' ' A' ' 69' ' ' THR . 8.1 t-20 -97.76 104.48 16.51 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.133 179.114 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -95.99 -8.87 32.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.026 179.447 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.25 101.01 2.73 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.941 179.423 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.9 p -84.58 -10.17 57.64 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.438 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.733 HG22 HG12 ' B' ' 236' ' ' VAL . 0.2 OUTLIER -97.39 -44.3 6.92 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.881 179.519 . . . . . . . . 3 3 . 1 . 081 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.448 HD21 ' HA ' ' B' ' 236' ' ' VAL . 74.8 m-20 -137.45 91.62 14.05 Favored Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.57 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.464 ' HA ' HD21 ' A' ' 62' ' ' ASN . 51.1 Cg_exo -53.68 144.29 54.02 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.422 2.081 . . . . 0.0 112.46 -179.055 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.705 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 20.4 m -72.17 138.29 47.53 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.786 179.164 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -100.98 141.22 34.19 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.36 -179.867 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 54.5 t -130.3 134.27 62.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.101 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 52.13 32.48 10.56 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.13 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.93 29.72 66.7 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.781 179.68 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.7 m -139.02 130.65 27.35 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.521 -0.472 . . . . 0.0 111.425 -179.599 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.42 ' H ' HG12 ' A' ' 75' ' ' VAL . 0.1 OUTLIER -69.56 138.26 22.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.619 179.844 . . . . . . . . 3 3 . 1 . 081 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.544 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 1.2 pt -118.54 112.39 37.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-O 121.37 0.605 . . . . 0.0 111.501 -179.763 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -80.32 -20.52 44.09 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.583 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -121.55 160.2 47.25 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.394 179.741 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.416 ' HB3' ' ND1' ' A' ' 61' ' ' HIS . 30.6 Cg_endo -61.99 148.49 93.05 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.901 1.734 . . . . 0.0 112.444 179.69 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 76.9 t -130.35 138.13 54.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.021 -179.469 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.507 ' HE ' ' HG2' ' A' ' 57' ' ' GLU . 72.5 ttt180 -70.77 129.48 39.21 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.713 178.948 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.599 HD21 ' HB2' ' A' ' 60' ' ' LEU . 95.4 mt -80.68 135.29 36.0 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.309 0.576 . . . . 0.0 111.276 -179.921 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -133.06 151.75 52.01 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.51 -179.912 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.552 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 4.6 t60 -52.04 116.44 2.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.168 -179.16 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.16 -14.79 36.73 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 121.234 -0.508 . . . . 0.0 111.953 179.551 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -68.89 134.94 50.28 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.953 -179.512 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.9 t -114.13 132.68 62.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.647 -178.207 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.5 mt -100.54 131.81 47.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.317 -0.856 . . . . 0.0 108.79 178.888 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.9 m -120.91 124.2 44.35 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.343 0.592 . . . . 0.0 112.064 -178.431 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.578 ' O ' ' N ' ' A' ' 92' ' ' ASP . 82.2 mt -111.15 122.59 65.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 178.099 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.612 HD12 ' CB ' ' B' ' 237' ' ' CYS . 43.8 mm 36.89 -92.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.02 -179.471 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.588 ' CB ' ' HE ' ' B' ' 245' ' ' ARG . 59.2 t0 -121.48 7.46 10.09 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.881 0.372 . . . . 0.0 111.296 179.649 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.735 ' NH1' HH22 ' B' ' 245' ' ' ARG . 48.5 mmt-85 -111.59 135.01 52.76 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.101 178.9 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.6 m -133.5 148.18 51.67 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.96 179.466 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.537 ' HB3' HD11 ' A' ' 7' ' ' LEU . 67.2 m-85 -124.81 124.66 42.59 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.429 -179.684 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.535 ' O ' HD12 ' A' ' 7' ' ' LEU . 77.1 mtp85 -86.99 131.75 33.99 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 119.687 -0.805 . . . . 0.0 110.976 -179.109 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.511 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 71.2 t80 -96.62 125.55 41.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.492 179.674 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -126.26 123.16 37.5 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.382 179.835 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.552 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 63.7 t-20 . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.078 179.371 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo . . . . . 0 N--CA 1.487 1.146 0 CA-C-O 121.71 0.629 . . . . 0.0 113.621 . . . . . . . . . 0 0 . 1 . 081 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.733 HG12 HG22 ' A' ' 66' ' ' THR . 1.2 m -68.86 147.84 12.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.079 -178.876 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . 0.612 ' CB ' HD12 ' A' ' 91' ' ' ILE . 4.3 t . . . . . 0 N--CA 1.466 0.359 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.897 -179.966 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo . . . . . 0 N--CA 1.5 1.893 0 N-CA-C 112.772 0.258 . . . . 0.0 112.772 . . . . . . . . . 0 0 . 1 . 081 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 51.6 m -70.91 -45.72 63.79 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.864 179.239 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.48 ' CE2' HG21 ' A' ' 43' ' ' VAL . 68.5 t80 -58.4 -46.5 86.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.523 -178.928 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' B' ' 242' ' ' LEU . 82.8 mt -63.11 -41.79 99.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.277 -179.061 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -67.0 -38.67 86.44 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.113 -179.652 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -61.61 -43.91 97.98 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.313 179.539 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.735 HH22 ' NH1' ' A' ' 93' ' ' ARG . 37.9 mtp85 -61.38 -40.98 96.31 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.018 -179.881 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -60.89 -41.19 95.54 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 178.122 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 48.0 t -62.87 -44.27 96.57 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 177.916 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . 0.57 ' OE1' ' NH2' ' A' ' 12' ' ' ARG . 87.5 mt-30 -60.02 -37.15 78.9 Favored 'General case' 0 CA--C 1.523 -0.074 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.051 179.598 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . 0.443 HG22 ' HB3' ' A' ' 12' ' ' ARG . 55.8 t . . . . . 0 C--N 1.33 -0.252 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.663 179.689 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 . . . . . 0 N--CA 1.462 0.155 0 CA-C-O 120.574 0.226 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 081 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.409 ' CD1' HG23 ' A' ' 9' ' ' THR . 66.8 mt -123.13 132.91 70.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.891 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 55.6 t -125.84 134.08 67.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.888 0.375 . . . . 0.0 110.631 -179.932 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -96.17 117.67 31.2 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.155 0.503 . . . . 0.0 110.968 -179.25 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -66.88 -45.48 77.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.89 179.555 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . 0.439 ' OE1' ' CZ ' ' A' ' 20' ' ' PHE . 0.3 OUTLIER -93.85 157.82 37.43 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.309 -179.61 . . . . . . . . 3 3 . 1 . 081 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -64.49 150.42 88.27 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 C-N-CA 123.006 2.471 . . . . 0.0 112.436 -179.892 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 30.3 pt . . . . . 0 C--N 1.328 -0.369 0 CA-C-O 121.247 0.546 . . . . 0.0 111.048 179.762 . . . . . . . . 0 0 . 1 . 082 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.1 m . . . . . 0 C--O 1.233 0.191 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 . . . . . . . . . 0 0 . 1 . 082 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 86.0 mtt85 -89.6 129.68 36.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.041 179.318 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -128.4 141.77 51.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.071 0.462 . . . . 0.0 111.545 -179.93 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.75 HD12 ' O ' ' A' ' 96' ' ' ARG . 28.1 tp -114.44 130.46 56.72 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.354 179.696 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 52.3 t -106.04 129.26 59.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.554 -0.459 . . . . 0.0 110.474 -179.429 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.577 HG21 ' HZ ' ' B' ' 263' ' ' PHE . 77.6 p -81.89 140.79 33.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.458 -178.243 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.57 HD12 ' OG ' ' A' ' 94' ' ' SER . 96.6 mt -110.88 136.41 47.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.098 178.653 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.1 mttm -87.96 160.08 18.05 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.36 179.224 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.517 ' HD3' HH21 ' B' ' 245' ' ' ARG . 89.7 mtm180 -58.44 -29.41 66.11 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.962 -179.259 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 87.1 p -81.24 -7.28 59.54 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.005 179.936 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.0 35.72 6.64 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 179.696 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.6 t -119.03 132.44 68.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.693 0.282 . . . . 0.0 111.076 -179.978 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -77.45 135.56 38.28 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.637 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -128.11 -114.04 1.78 Allowed Glycine 0 CA--C 1.535 1.31 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.052 -179.098 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.517 ' O ' ' OG1' ' A' ' 9' ' ' THR . 61.4 Cg_endo -72.24 145.71 44.27 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 122.445 2.097 . . . . 0.0 113.378 -178.657 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -108.79 129.52 55.38 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.384 179.776 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.827 ' CD2' HD11 ' A' ' 37' ' ' ILE . 51.8 t80 -98.63 99.85 8.34 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.604 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.514 ' HD2' HG22 ' B' ' 267' ' ' ILE . 73.9 Cg_endo -73.76 134.4 20.02 Favored 'Trans proline' 0 C--N 1.315 -1.229 0 C-N-CA 121.12 1.214 . . . . 0.0 111.099 -179.347 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.9 mt -94.15 118.42 31.53 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.547 -178.982 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.4 p -125.03 -4.36 7.49 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.509 179.328 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.552 HD11 ' OE1' ' B' ' 265' ' ' GLN . 49.8 mt -104.47 148.77 26.09 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.545 -179.032 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.36 -22.43 66.26 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.11 -178.906 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 88.0 m -128.34 130.06 47.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.282 0.563 . . . . 0.0 111.76 -179.433 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.628 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -127.96 121.75 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.878 178.565 . . . . . . . . 3 3 . 1 . 082 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.671 HD12 ' O ' ' A' ' 49' ' ' CYS . 53.7 tp -123.87 124.16 42.03 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -177.649 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.628 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 46.5 m-85 -97.4 141.28 30.67 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.091 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 168.69 -164.44 38.05 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.109 -1.044 . . . . 0.0 112.423 179.582 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.509 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 33.9 ttp-105 -96.99 -28.91 13.95 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.684 -0.758 . . . . 0.0 110.186 -179.611 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.9 162.08 53.99 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.777 -178.439 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.464 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.0 tp -64.47 -39.45 85.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.056 -0.572 . . . . 0.0 110.153 179.342 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.464 ' N ' HG23 ' A' ' 33' ' ' ILE . 80.1 mm-40 -53.31 -28.08 26.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.435 -179.643 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.3 m -64.37 116.71 6.34 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.434 -179.969 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.527 ' OD1' ' O ' ' A' ' 28' ' ' LEU . 12.5 p-10 -58.02 -26.24 62.18 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.539 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.827 HD11 ' CD2' ' A' ' 20' ' ' PHE . 34.6 mm -122.33 113.96 40.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.361 177.636 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -105.36 136.67 44.47 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.784 179.479 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.485 ' C ' ' H ' ' A' ' 41' ' ' LEU . 91.3 mt -119.61 132.13 70.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.36 -0.836 . . . . 0.0 108.976 179.603 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -71.29 29.4 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.669 -178.808 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.713 HD21 HH22 ' B' ' 245' ' ' ARG . 31.4 mt -91.1 122.73 66.1 Favored Pre-proline 0 C--N 1.323 -0.549 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.037 179.805 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.44 -7.47 20.95 Favored 'Trans proline' 0 N--CA 1.49 1.298 0 C-N-CA 122.12 1.88 . . . . 0.0 111.64 -179.161 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.2 m -107.54 9.97 9.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.844 -179.164 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.628 HG12 ' O ' ' A' ' 41' ' ' LEU . 9.6 p -92.16 141.85 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.061 179.835 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.0 m -71.26 159.43 34.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.714 0.769 . . . . 0.0 112.215 -178.659 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -61.89 -39.72 92.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.814 -1.084 . . . . 0.0 110.797 -179.602 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.595 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.3 mt-30 -117.14 -8.76 11.13 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.678 0.275 . . . . 0.0 111.047 179.445 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.466 ' C ' ' O ' ' A' ' 47' ' ' GLN . 24.3 t60 16.19 -73.88 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 114.633 1.345 . . . . 0.0 114.633 -178.527 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.671 ' O ' HD12 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -130.8 134.64 47.03 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 119.966 -0.693 . . . . 0.0 112.72 -177.724 . . . . . . . . 3 3 . 1 . 082 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -126.02 131.16 52.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.638 179.742 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.9 mt -116.0 133.38 62.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.166 0.508 . . . . 0.0 110.728 179.649 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -118.67 122.58 42.87 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.371 -0.832 . . . . 0.0 108.774 179.051 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 92.1 mt -105.2 116.09 48.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.561 0.696 . . . . 0.0 111.653 -178.974 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.439 ' O ' ' C ' ' A' ' 55' ' ' GLU . 87.6 m-70 -114.42 144.78 42.75 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.604 -179.848 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 54' ' ' HIS . 92.1 mt-10 -39.77 -33.11 0.17 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.318 -0.553 . . . . 0.0 109.911 -179.037 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.449 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 82.7 mt-30 -61.73 -68.38 0.32 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.788 179.227 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.449 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 4.5 tp10 -158.2 -166.35 1.92 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.393 -179.492 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.424 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -110.1 130.13 55.59 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.921 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.5 mt -119.4 129.07 75.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.226 0.536 . . . . 0.0 112.24 -178.549 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.652 ' HB2' HD11 ' A' ' 82' ' ' LEU . 17.4 tp -99.27 126.25 45.06 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.216 179.535 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -113.22 137.1 51.97 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.928 -179.886 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.506 ' ND2' ' O ' ' A' ' 76' ' ' ILE . 22.3 p-10 -100.66 111.19 23.39 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.992 0.425 . . . . 0.0 111.929 -179.246 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -102.61 -6.84 22.33 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.352 179.73 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.44 100.12 6.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.81 0.338 . . . . 0.0 111.579 -179.476 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.9 p -75.6 -32.17 60.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.207 178.288 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.4 m -65.25 -49.24 70.39 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.108 -179.069 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -145.4 103.95 4.32 Favored Pre-proline 0 N--CA 1.466 0.348 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.831 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -54.68 145.14 61.44 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 121.446 1.43 . . . . 0.0 112.004 -179.096 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.9 m -68.8 138.73 55.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.867 178.872 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -99.32 139.98 34.17 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.991 -179.764 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 55.0 t -134.38 134.47 54.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.735 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.573 ' ND2' ' OD1' ' A' ' 86' ' ' ASP . 74.1 m-20 53.8 32.12 14.34 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.611 -179.5 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.65 28.34 63.4 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.736 179.251 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.5 m -147.98 144.85 28.26 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 117.74 0.77 . . . . 0.0 111.734 179.902 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.404 ' H ' HG22 ' A' ' 75' ' ' VAL . 2.4 m -75.88 139.54 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.435 179.247 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.506 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 4.5 pt -104.99 101.61 12.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.411 0.624 . . . . 0.0 111.319 -179.912 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -65.01 -34.86 79.45 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.808 179.431 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.457 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.7 OUTLIER -126.15 178.52 1.48 Allowed Pre-proline 0 CA--C 1.53 0.176 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.52 179.803 . . . . . . . . 3 3 . 1 . 082 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.457 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 21.7 Cg_exo -63.26 146.89 94.13 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 C-N-CA 122.826 2.351 . . . . 0.0 112.174 -179.899 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.5 p -141.64 140.96 30.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.067 179.668 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -72.6 129.86 39.25 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.121 179.41 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.652 HD11 ' HB2' ' A' ' 60' ' ' LEU . 93.0 mt -86.63 135.84 33.26 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.344 -179.926 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -126.83 155.0 43.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.811 -179.554 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.498 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 6.1 t60 -53.96 116.64 2.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.441 -179.597 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.55 -14.48 27.41 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -179.509 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.573 ' OD1' ' ND2' ' A' ' 72' ' ' ASN . 26.2 t70 -69.12 129.7 40.62 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 179.551 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.0 t -109.24 135.64 47.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.312 -178.761 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 89.3 mt -103.43 132.29 50.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.25 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.843 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.0 m -122.15 127.59 50.26 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.762 0.791 . . . . 0.0 112.799 -178.342 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.55 ' O ' ' N ' ' A' ' 93' ' ' ARG . 97.4 mt -121.26 122.94 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 114.369 -1.287 . . . . 0.0 108.492 177.953 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.56 HG23 HD21 ' B' ' 242' ' ' LEU . 56.6 mt -3.74 95.62 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -179.77 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.629 ' CG ' ' HE ' ' B' ' 245' ' ' ARG . 1.4 t70 78.73 -13.42 0.97 Allowed 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 177.69 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.564 ' HD2' HD11 ' B' ' 261' ' ' ILE . 1.6 tpp180 -130.78 139.41 50.22 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.628 -179.192 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.57 ' OG ' HD12 ' A' ' 10' ' ' ILE . 14.9 p -140.15 157.08 46.18 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.283 0.563 . . . . 0.0 111.436 -179.204 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.519 ' HB3' HD11 ' A' ' 7' ' ' LEU . 65.2 m-85 -130.04 125.97 36.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.207 -179.584 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.75 ' O ' HD12 ' A' ' 7' ' ' LEU . 99.9 mtt180 -88.78 132.19 34.73 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.945 -179.231 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -96.94 125.43 41.36 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.498 -179.811 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -127.2 119.73 27.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.082 179.114 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.498 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 58.9 t-20 . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.504 179.583 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo . . . . . 0 N--CA 1.494 1.543 0 CA-C-O 121.573 0.572 . . . . 0.0 113.282 . . . . . . . . . 0 0 . 1 . 082 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 6.0 p -97.1 132.8 40.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.11 179.641 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 10.7 t . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.201 -179.221 . . . . . . . . 0 0 . 1 . 082 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo . . . . . 0 N--CA 1.494 1.542 0 N-CA-C 112.592 0.189 . . . . 0.0 112.592 . . . . . . . . . 0 0 . 1 . 082 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 42.5 p -74.37 -36.62 63.56 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.577 -0.449 . . . . 0.0 109.793 178.762 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.611 ' CZ ' ' NH1' ' B' ' 245' ' ' ARG . 85.9 t80 -59.39 -48.04 83.15 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.261 -179.153 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.56 HD21 HG23 ' A' ' 91' ' ' ILE . 94.3 mt -64.64 -42.28 95.56 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.445 -179.892 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -69.37 -42.13 75.6 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.867 -179.439 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 62.2 ttp180 -61.87 -46.66 88.43 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.703 -178.799 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.713 HH22 HD21 ' A' ' 41' ' ' LEU . 10.7 ptm85 -71.47 -38.89 71.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.292 -179.476 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -61.54 -39.99 93.05 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.504 179.737 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 23.0 t -69.35 -42.77 74.83 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.289 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 64.1 tp60 -58.21 -40.14 80.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.838 179.758 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . 0.664 HG23 ' O ' ' B' ' 245' ' ' ARG . 89.0 t . . . . . 0 N--CA 1.452 -0.348 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.698 179.826 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 . . . . . 0 N--CA 1.461 0.119 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 . . . . . . . . . 0 0 . 1 . 082 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.564 HD11 ' HD2' ' A' ' 93' ' ' ARG . 54.9 mt -103.84 134.65 44.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.75 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 77.7 t -123.18 132.37 71.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.43 -179.163 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . 0.577 ' HZ ' HG21 ' A' ' 9' ' ' THR . 45.7 m-85 -95.03 111.92 23.67 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.88 -177.677 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -61.93 -45.52 93.32 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.33 179.19 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . 0.552 ' OE1' HD11 ' A' ' 24' ' ' LEU . 1.8 mm-40 -98.99 156.77 35.12 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.308 -179.472 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.28 152.94 71.77 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 123.158 2.572 . . . . 0.0 113.427 -178.866 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . 0.514 HG22 ' HD2' ' A' ' 21' ' ' PRO . 26.3 pt . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.196 179.112 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 67.3 p . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.917 0.389 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 083 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.894 ' NH1' ' HB2' ' A' ' 58' ' ' ALA . 94.0 mtt-85 -93.11 119.99 32.92 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.228 -179.286 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -131.14 139.25 49.76 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.436 179.937 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.62 HD11 ' HB3' ' A' ' 95' ' ' PHE . 46.9 tp -115.25 131.88 56.79 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.979 179.749 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 73.8 t -110.65 133.07 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.597 -178.759 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 m -84.42 143.23 29.56 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.717 0.77 . . . . 0.0 112.475 -179.094 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 50.6 mm -109.39 137.08 43.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 114.238 -1.346 . . . . 0.0 108.807 177.794 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -91.58 160.84 15.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.302 0.573 . . . . 0.0 111.127 179.877 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.457 HH21 ' HG3' ' B' ' 245' ' ' ARG . 82.0 mtp180 -54.1 -32.29 54.53 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.015 -178.949 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 97.7 p -81.64 -6.27 58.85 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.281 -179.958 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.03 38.2 6.92 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -179.869 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.5 t -123.74 133.73 68.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.02 0.438 . . . . 0.0 110.519 179.964 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.481 ' O ' ' OD1' ' A' ' 16' ' ' ASP . 50.8 p-10 -80.19 136.9 36.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.292 179.695 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -131.76 -110.63 1.3 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 120.3 -0.953 . . . . 0.0 112.169 -179.613 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.17 144.08 41.24 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.288 1.992 . . . . 0.0 113.25 -178.608 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -109.06 148.79 30.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.372 179.909 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.521 ' CD2' HD11 ' A' ' 37' ' ' ILE . 35.5 t80 -118.48 94.69 47.72 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.633 -179.262 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -60.69 126.57 20.15 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 121.926 1.751 . . . . 0.0 111.638 179.653 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 63.5 mt -91.18 47.81 1.44 Allowed 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -178.576 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.9 m -66.28 -16.77 64.3 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.701 179.629 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.752 HD11 ' NE2' ' B' ' 265' ' ' GLN . 94.2 mt -78.43 141.3 38.4 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.163 179.496 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 94.3 p -61.17 -21.98 64.29 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.756 -0.657 . . . . 0.0 112.054 -178.488 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 44.5 m -137.42 136.45 37.83 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 120.397 -0.521 . . . . 0.0 112.081 -179.435 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.2 t -129.43 122.6 29.72 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.035 178.315 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.431 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 47.6 tp -117.08 130.63 56.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.197 -179.23 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.739 ' CE2' HD12 ' A' ' 37' ' ' ILE . 7.9 m-85 -107.41 125.67 51.51 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.562 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 172.72 178.64 42.94 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 120.297 -0.954 . . . . 0.0 112.303 179.831 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.652 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 81.2 mtm-85 -77.6 -31.48 53.0 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.016 179.362 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -52.49 150.2 9.29 Favored Glycine 0 N--CA 1.464 0.553 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 -178.872 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.484 HG23 ' N ' ' A' ' 34' ' ' GLU . 8.8 tp -66.76 -42.77 89.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.815 -179.514 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.484 ' N ' HG23 ' A' ' 33' ' ' ILE . 83.8 tt0 -53.44 -18.28 2.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.386 179.406 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.9 m -62.38 127.05 29.5 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.537 -179.742 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.431 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 55.9 m-20 -61.09 -31.64 71.31 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -179.459 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.739 HD12 ' CE2' ' A' ' 29' ' ' PHE . 98.5 mt -126.14 120.98 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 176.539 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.479 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 83.7 mtp180 -100.41 128.55 46.44 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.739 -178.951 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.405 HG22 ' H ' ' A' ' 41' ' ' LEU . 89.5 mt -112.94 128.08 69.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.205 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -80.93 26.74 0.41 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.976 -0.557 . . . . 0.0 112.382 -177.432 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.774 HD11 ' NE ' ' A' ' 93' ' ' ARG . 68.4 mt -94.98 131.73 29.64 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.185 179.263 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.93 -12.1 31.91 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.098 1.865 . . . . 0.0 112.897 -179.676 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.5 m -98.27 12.67 5.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.278 -179.796 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.652 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 14.3 t -100.89 130.86 49.59 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 C-N-CA 120.577 -0.449 . . . . 0.0 109.893 178.695 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.6 t -71.38 173.42 7.87 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.448 0.642 . . . . 0.0 112.125 -178.559 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.6 mttp -64.51 -41.39 96.46 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.89 179.919 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.588 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.2 mt-30 -116.45 -7.32 11.69 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 121.111 -0.235 . . . . 0.0 111.338 -179.566 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.474 ' C ' ' O ' ' A' ' 47' ' ' GLN . 14.9 t60 15.91 -74.88 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -178.695 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.588 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -129.24 133.27 47.44 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.088 -0.645 . . . . 0.0 112.341 -178.335 . . . . . . . . 3 3 . 1 . 083 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -128.47 131.15 48.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.293 179.763 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.4 mt -117.35 133.67 63.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.008 -179.697 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.453 ' OE2' ' CE1' ' A' ' 54' ' ' HIS . 81.7 tt0 -112.41 133.26 54.6 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.51 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.545 HD12 ' HD3' ' A' ' 5' ' ' ARG . 46.4 mm -101.96 124.28 55.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.448 0.642 . . . . 0.0 111.661 -178.637 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.57 ' O ' ' N ' ' A' ' 56' ' ' GLN . 96.9 m-70 -124.92 132.35 53.31 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.488 178.747 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.47 ' C ' ' O ' ' A' ' 54' ' ' HIS . 77.9 tt0 -39.79 -25.34 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.894 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.57 ' N ' ' O ' ' A' ' 54' ' ' HIS . 91.3 mt-30 -66.59 -68.34 0.38 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.018 178.018 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.464 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 5.3 tp10 -158.71 -160.75 0.9 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.209 179.942 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.894 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -118.69 127.89 54.0 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.224 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.7 mt -115.65 129.56 71.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.476 0.655 . . . . 0.0 111.523 -178.927 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.8 tp -96.62 128.86 43.96 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.383 -179.62 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -110.63 132.89 53.8 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.764 179.82 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -94.47 103.95 15.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.299 -179.391 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -97.07 -7.9 31.62 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.741 -0.383 . . . . 0.0 111.015 179.209 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.487 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 12.9 t -72.17 100.92 2.67 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-O 120.779 0.323 . . . . 0.0 110.169 179.256 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.7 p -82.99 -13.85 55.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.874 179.641 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.415 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -96.27 -38.3 10.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.181 -179.534 . . . . . . . . 3 3 . 1 . 083 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.488 HD21 ' HA ' ' B' ' 236' ' ' VAL . 76.1 m-20 -143.11 101.23 5.28 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.772 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.429 ' HB2' HG23 ' A' ' 75' ' ' VAL . 31.5 Cg_exo -58.01 146.39 87.55 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 121.509 1.473 . . . . 0.0 112.436 179.951 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.7 m -73.61 143.53 46.31 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.906 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -104.37 140.94 37.19 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.041 -179.355 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 43.9 t -132.26 135.54 57.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.372 -0.831 . . . . 0.0 108.82 179.562 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 14.0 m120 52.8 26.95 4.91 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -179.235 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.28 29.1 62.72 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.651 -179.634 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.3 m -142.46 140.47 31.92 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.865 0.365 . . . . 0.0 110.827 179.875 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.446 ' H ' HG12 ' A' ' 75' ' ' VAL . 0.2 OUTLIER -73.22 142.75 14.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.013 -179.21 . . . . . . . . 3 3 . 1 . 083 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.467 HG21 HG11 ' A' ' 80' ' ' VAL . 7.5 pt -109.88 92.62 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-O 121.224 0.535 . . . . 0.0 110.911 179.115 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -63.95 -30.95 71.99 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.715 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -121.31 169.49 8.99 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.362 179.865 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -59.06 144.89 99.18 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 121.918 1.745 . . . . 0.0 111.751 179.429 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.467 HG11 HG21 ' A' ' 76' ' ' ILE . 8.2 p -135.21 140.94 44.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.108 0.48 . . . . 0.0 111.445 -179.627 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.455 HH21 ' CE ' ' A' ' 83' ' ' LYS . 62.7 ttp180 -78.2 132.64 37.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.881 179.085 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.429 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 91.8 mt -87.67 137.12 32.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.933 -178.541 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.455 ' CE ' HH21 ' A' ' 81' ' ' ARG . 99.2 mttt -124.86 151.23 45.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.432 179.532 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.495 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 6.8 t60 -54.62 121.3 8.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.771 -179.377 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.28 -18.99 35.2 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.034 -0.827 . . . . 0.0 111.034 -179.942 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -69.05 136.69 52.74 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.551 -0.46 . . . . 0.0 109.86 179.735 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.0 t -113.24 133.53 58.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.543 -178.305 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 89.2 mt -98.32 133.72 39.54 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.684 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 97.4 m -123.2 127.67 48.96 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 119.605 -0.838 . . . . 0.0 112.36 -179.195 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.612 ' O ' ' N ' ' A' ' 93' ' ' ARG . 96.8 mt -116.45 129.64 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 114.123 -1.399 . . . . 0.0 108.41 178.418 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.527 HD13 ' HB2' ' B' ' 237' ' ' CYS . 79.4 mt -18.98 101.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 O-C-N 123.744 0.652 . . . . 0.0 112.279 -179.246 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.496 ' OD1' ' NE ' ' B' ' 245' ' ' ARG . 73.8 m-20 80.37 -18.27 0.51 Allowed 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 178.919 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.774 ' NE ' HD11 ' A' ' 41' ' ' LEU . 59.4 mtt-85 -129.51 141.59 50.96 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.61 179.93 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 30.7 p -138.27 152.83 48.92 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.169 0.509 . . . . 0.0 110.027 179.901 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.62 ' HB3' HD11 ' A' ' 7' ' ' LEU . 65.9 m-85 -128.79 121.93 29.41 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.623 -179.563 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.537 ' O ' HD12 ' A' ' 7' ' ' LEU . 43.8 ttm180 -80.52 128.78 33.99 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.711 -0.395 . . . . 0.0 111.2 -179.705 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.592 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 89.4 t80 -94.62 124.97 38.97 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.597 179.632 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -127.66 122.84 34.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.937 0.399 . . . . 0.0 111.32 -179.89 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.495 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 61.6 t-20 . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.085 179.095 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo . . . . . 0 N--CA 1.487 1.105 0 CA-C-O 121.266 0.444 . . . . 0.0 112.71 . . . . . . . . . 0 0 . 1 . 083 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.488 ' HA ' HD21 ' A' ' 67' ' ' ASN . 53.1 t -57.46 141.99 13.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.456 179.687 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . 0.527 ' HB2' HD13 ' A' ' 91' ' ' ILE . 17.4 t . . . . . 0 C--N 1.328 -0.345 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.782 -179.263 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo . . . . . 0 N--CA 1.496 1.641 0 N-CA-C 112.851 0.289 . . . . 0.0 112.851 . . . . . . . . . 0 0 . 1 . 083 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 54.6 m -74.05 -44.22 55.03 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 121.029 0.443 . . . . 0.0 109.849 178.198 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -56.84 -47.12 81.08 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.894 -178.989 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.434 HD23 ' OD1' ' A' ' 92' ' ' ASP . 97.1 mt -66.99 -40.82 87.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.734 179.541 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -60.73 -43.19 98.18 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.854 -179.812 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -60.43 -42.86 96.95 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.505 179.739 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.605 ' O ' HG23 ' B' ' 249' ' ' VAL . 71.7 ttp85 -61.64 -40.61 95.52 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.604 -0.439 . . . . 0.0 111.253 -179.524 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -60.54 -40.16 90.53 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.46 -179.718 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 80.8 p -69.85 -42.22 73.85 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.058 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . 0.455 ' CB ' HH22 ' A' ' 12' ' ' ARG . 87.4 mt-30 -63.55 -32.41 73.86 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.209 179.778 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . 0.605 HG23 ' O ' ' B' ' 245' ' ' ARG . 54.9 t . . . . . 0 C--O 1.233 0.232 0 C-N-CA 120.113 -0.635 . . . . 0.0 109.64 178.477 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 52.8 mp0 . . . . . 0 CA--C 1.518 -0.279 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 . . . . . . . . . 0 0 . 1 . 083 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 67.0 mt -113.98 132.17 63.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.202 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 53.2 t -127.12 131.43 70.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.786 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -93.07 120.66 33.61 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.222 0.534 . . . . 0.0 110.335 -178.49 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -64.82 -44.94 88.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.989 -179.416 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . 0.752 ' NE2' HD11 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -99.74 158.56 31.9 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.786 -179.221 . . . . . . . . 3 3 . 1 . 083 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -65.16 153.82 76.47 Favored 'Trans proline' 0 N--CA 1.503 2.039 0 C-N-CA 123.278 2.652 . . . . 0.0 111.846 -179.979 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 47.0 pt . . . . . 0 C--O 1.232 0.153 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -178.514 . . . . . . . . 0 0 . 1 . 084 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.5 m . . . . . 0 N--CA 1.454 -0.23 0 CA-C-O 121.223 0.535 . . . . 0.0 110.351 . . . . . . . . . 0 0 . 1 . 084 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.3 mtt85 -91.8 129.35 37.78 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.433 -178.728 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.5 mtt85 -130.83 138.0 49.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.276 -179.973 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.545 HD11 ' HB3' ' A' ' 95' ' ' PHE . 39.4 tp -115.11 128.35 56.16 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.619 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.3 m -109.49 132.49 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 121.155 0.502 . . . . 0.0 111.413 -179.078 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.409 ' HG1' ' HE2' ' A' ' 95' ' ' PHE . 2.7 m -80.36 138.56 36.7 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.246 -179.437 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.612 HD12 ' OG ' ' A' ' 94' ' ' SER . 96.5 mt -107.83 138.23 35.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.695 177.715 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -89.14 155.97 19.1 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.014 0.435 . . . . 0.0 109.849 178.434 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.575 HH11 ' CZ ' ' A' ' 93' ' ' ARG . 72.7 mtp85 -58.05 -24.17 57.37 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.429 -179.04 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.2 p -82.47 -8.63 59.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.037 0.446 . . . . 0.0 110.16 178.982 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.76 36.16 6.94 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -179.834 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.6 t -121.88 133.5 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.801 0.334 . . . . 0.0 111.069 -179.993 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 17' ' ' GLY . 61.6 t0 -78.43 132.58 37.38 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.236 179.397 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.461 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -125.72 -113.56 1.92 Allowed Glycine 0 CA--C 1.537 1.458 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.954 -179.736 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -71.68 143.9 43.0 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 122.324 2.016 . . . . 0.0 113.298 -178.568 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.541 ' O ' ' CD1' ' B' ' 267' ' ' ILE . 0.3 OUTLIER -111.29 135.81 51.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.135 0.493 . . . . 0.0 111.119 -179.89 . . . . . . . . 3 3 . 1 . 084 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -105.81 105.76 54.25 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.405 179.976 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -74.31 129.49 13.04 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 121.33 1.353 . . . . 0.0 111.911 -178.899 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 74.5 mt -83.97 47.04 1.25 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.859 -178.777 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.0 p -64.08 -21.57 66.58 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.969 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.478 HD11 ' OE1' ' B' ' 265' ' ' GLN . 79.3 mt -83.31 143.71 30.19 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.007 179.796 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.7 t -64.14 -21.73 66.66 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.947 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.415 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 56.2 m -135.63 135.54 40.28 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.181 -0.608 . . . . 0.0 112.369 -179.012 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.574 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 16.9 t -127.9 119.83 26.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.324 178.4 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.441 HD12 ' O ' ' A' ' 49' ' ' CYS . 49.1 tp -118.07 130.89 56.41 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.229 -178.546 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.621 ' CE2' HD12 ' A' ' 37' ' ' ILE . 5.5 m-85 -108.53 140.78 41.38 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.2 179.852 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 152.21 -176.28 30.55 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.249 178.393 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.695 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 76.8 mtm-85 -75.89 -32.23 59.57 Favored 'General case' 0 C--N 1.338 0.068 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.197 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.582 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -48.08 143.37 7.04 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 -178.471 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.512 ' CD1' ' CZ ' ' A' ' 38' ' ' ARG . 32.2 mm -65.79 -43.91 93.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.647 179.803 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -54.28 -17.74 3.25 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.789 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.582 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 39.4 m -60.16 121.47 11.99 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.218 179.851 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.415 ' OD2' ' O ' ' A' ' 26' ' ' THR . 99.0 m-20 -60.69 -28.64 68.77 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.238 -179.264 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.621 HD12 ' CE2' ' A' ' 29' ' ' PHE . 96.7 mt -126.13 120.54 57.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 176.798 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.512 ' CZ ' ' CD1' ' A' ' 33' ' ' ILE . 84.0 mtp180 -103.99 132.53 50.15 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.938 -178.199 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.581 HG21 HD12 ' A' ' 41' ' ' LEU . 84.8 mt -121.49 130.79 74.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 121.03 0.443 . . . . 0.0 109.961 179.491 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -78.44 41.5 0.4 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.232 -178.495 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.581 HD12 HG21 ' A' ' 39' ' ' ILE . 77.8 mt -105.88 104.99 51.71 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.44 179.41 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -57.61 -15.39 20.22 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.117 1.878 . . . . 0.0 112.148 179.532 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.461 HG21 ' CE2' ' B' ' 241' ' ' PHE . 35.0 m -91.11 4.89 6.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.237 -179.632 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.695 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 24.9 t -104.18 140.32 22.62 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.354 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.128 180.0 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.4 m -71.05 168.09 17.84 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.284 0.564 . . . . 0.0 112.276 -179.236 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -61.8 -39.29 91.2 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.271 -179.678 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.643 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.6 mt-30 -111.17 -19.43 12.7 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.904 179.813 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.3 t60 35.85 -75.86 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 179.015 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.643 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.83 134.45 46.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.266 0.555 . . . . 0.0 112.106 -177.871 . . . . . . . . 3 3 . 1 . 084 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -127.43 131.71 50.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.458 179.668 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 98.0 mt -118.03 133.88 63.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.175 179.933 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -117.69 134.37 54.96 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.102 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 48.3 mm -98.56 119.71 46.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.831 179.819 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.483 ' O ' ' N ' ' A' ' 56' ' ' GLN . 98.4 m-70 -123.85 135.53 53.8 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.137 -179.989 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 54' ' ' HIS . 92.8 mt-10 -41.28 -25.97 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -179.396 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.483 ' N ' ' O ' ' A' ' 54' ' ' HIS . 47.9 tt0 -67.3 -68.87 0.35 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.75 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -156.95 -163.44 1.41 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.399 179.094 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.412 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -108.92 126.09 52.71 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 177.47 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.9 mt -114.9 129.52 70.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.243 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.621 ' HB2' HD11 ' A' ' 82' ' ' LEU . 26.1 tp -100.14 129.2 46.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.135 179.634 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -113.24 135.56 53.7 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.877 -179.713 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -94.35 104.7 16.67 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.403 179.708 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -96.75 -10.78 26.06 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.194 179.397 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.4 t -68.18 101.47 1.18 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.046 179.653 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.5 p -84.35 -7.22 59.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.066 0.46 . . . . 0.0 110.024 179.895 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.433 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -103.44 -43.85 5.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.836 -179.131 . . . . . . . . 3 3 . 1 . 084 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.424 ' OD1' HG13 ' B' ' 236' ' ' VAL . 64.2 m-20 -140.23 99.39 7.25 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.646 -179.769 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.591 ' HB2' HG13 ' A' ' 75' ' ' VAL . 52.9 Cg_exo -55.19 145.95 62.7 Favored 'Trans proline' 0 N--CA 1.5 1.904 0 C-N-CA 122.359 2.039 . . . . 0.0 113.236 -179.348 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.2 m -73.11 137.96 45.52 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.869 178.796 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -99.24 140.77 32.91 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.517 179.82 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 55.9 t -128.82 135.34 62.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.685 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 52.04 31.44 8.76 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.124 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.8 28.18 69.42 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.489 179.921 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.1 p -140.69 139.22 34.71 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 120.774 -0.371 . . . . 0.0 111.48 -179.735 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.591 HG13 ' HB2' ' A' ' 68' ' ' PRO . 38.8 t -70.37 138.32 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.16 -179.6 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.7 pt -112.73 96.68 4.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.1 178.321 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -66.65 -26.14 66.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.189 -179.76 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.437 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.3 OUTLIER -130.93 178.55 1.68 Allowed Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.312 -179.086 . . . . . . . . 3 3 . 1 . 084 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.437 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 36.1 Cg_exo -59.99 146.27 96.38 Favored 'Trans proline' 0 N--CA 1.505 2.155 0 C-N-CA 123.09 2.527 . . . . 0.0 112.802 -179.775 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.6 p -144.37 141.65 24.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.634 179.984 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -78.89 133.95 36.93 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.52 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.621 HD11 ' HB2' ' A' ' 60' ' ' LEU . 89.0 mt -91.18 140.44 29.8 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.991 0.424 . . . . 0.0 111.522 -179.074 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -128.2 157.5 40.68 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.981 179.165 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.452 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 5.8 t60 -53.99 115.71 2.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.523 -178.553 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.3 -10.65 26.52 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.142 179.16 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -67.67 135.34 52.65 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.018 -179.836 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.58 HG22 ' HG2' ' A' ' 96' ' ' ARG . 48.9 t -109.44 126.57 66.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.43 -179.665 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 84.8 mt -100.42 131.25 48.31 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 178.514 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 75.3 m -122.84 129.1 51.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.715 0.769 . . . . 0.0 112.584 -178.189 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.462 ' O ' ' C ' ' A' ' 91' ' ' ILE . 95.0 mt -116.53 128.07 73.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 114.493 -1.23 . . . . 0.0 108.621 178.537 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.462 ' C ' ' O ' ' A' ' 90' ' ' ILE . 42.4 mm 34.02 -99.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.166 -179.428 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.504 ' O ' ' OD1' ' A' ' 92' ' ' ASP . 61.7 t0 -115.55 16.49 16.55 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 120.94 0.4 . . . . 0.0 110.847 -179.576 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.58 HH21 ' CD ' ' B' ' 260' ' ' GLU . 73.1 mtt-85 -127.93 144.5 51.1 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.67 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.612 ' OG ' HD12 ' A' ' 10' ' ' ILE . 12.6 p -140.92 156.81 46.01 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.391 0.615 . . . . 0.0 111.637 -179.551 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.545 ' HB3' HD11 ' A' ' 7' ' ' LEU . 61.1 m-85 -132.54 133.58 43.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.412 179.617 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.58 ' HG2' HG22 ' A' ' 87' ' ' VAL . 70.4 mtp85 -98.48 137.78 36.66 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 119.881 -0.727 . . . . 0.0 110.361 179.906 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 93.9 t80 -93.24 122.99 36.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.689 -179.881 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.408 ' HG3' ' CE1' ' A' ' 84' ' ' HIS . 84.4 tt0 -123.93 119.48 29.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.166 179.397 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.452 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 47.5 t-20 . . . . . 0 C--N 1.327 -0.412 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.64 180.0 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo . . . . . 0 N--CA 1.483 0.87 0 CA-C-O 121.324 0.468 . . . . 0.0 112.288 . . . . . . . . . 0 0 . 1 . 084 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.433 ' CG2' HG22 ' A' ' 66' ' ' THR . 54.7 t -60.58 140.53 18.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.383 -179.541 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 6.5 t . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.235 -179.747 . . . . . . . . 0 0 . 1 . 084 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo . . . . . 0 N--CA 1.494 1.542 0 N-CA-C 112.962 0.331 . . . . 0.0 112.962 . . . . . . . . . 0 0 . 1 . 084 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 40.9 p -75.95 -40.27 54.35 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.289 -0.564 . . . . 0.0 109.909 178.441 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.561 ' CZ ' ' NE ' ' B' ' 245' ' ' ARG . 81.6 t80 -57.3 -48.04 79.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.415 -179.626 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.424 ' HA ' HD23 ' B' ' 242' ' ' LEU . 89.4 mt -65.91 -42.09 90.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.018 179.964 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -67.94 -39.87 83.39 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.798 -179.463 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -60.88 -46.63 89.88 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.444 -179.154 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.859 ' O ' HG23 ' B' ' 249' ' ' VAL . 94.0 mtt-85 -67.78 -38.53 83.51 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.615 179.806 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -60.78 -40.28 91.99 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.101 -179.45 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 9.7 t -65.53 -45.62 82.73 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.656 0.741 . . . . 0.0 109.56 177.911 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -64.91 -31.44 72.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.539 -179.914 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . 0.859 HG23 ' O ' ' B' ' 245' ' ' ARG . 93.8 t . . . . . 0 C--N 1.331 -0.212 0 CA-C-O 120.966 0.412 . . . . 0.0 110.538 179.363 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.58 ' CD ' HH21 ' A' ' 93' ' ' ARG . 94.8 mt-10 . . . . . 0 N--CA 1.463 0.224 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 . . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 68.2 mt -113.77 131.05 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.34 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 40.4 t -128.46 135.86 61.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.829 0.347 . . . . 0.0 111.308 -179.076 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -97.24 119.01 34.97 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.221 0.534 . . . . 0.0 111.651 -179.31 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -62.98 -46.45 87.62 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.986 178.984 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . 0.478 ' OE1' HD11 ' A' ' 24' ' ' LEU . 3.6 mm-40 -90.15 156.39 46.38 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.191 -179.554 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -60.17 142.59 98.63 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 C-N-CA 122.226 1.951 . . . . 0.0 112.183 -179.845 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . 0.541 ' CD1' ' O ' ' A' ' 19' ' ' HIS . 3.9 tt . . . . . 0 C--N 1.325 -0.494 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.946 -179.72 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.454 HG22 ' OD1' ' A' ' 99' ' ' ASN . 22.1 m . . . . . 0 N--CA 1.463 0.176 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 . . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.457 ' CD ' ' OH ' ' A' ' 97' ' ' TYR . 82.0 mtt85 -102.04 134.34 45.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.832 0.349 . . . . 0.0 111.218 -178.782 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.471 HH21 ' CD ' ' A' ' 98' ' ' GLU . 36.8 ptt180 -142.48 157.42 44.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.866 179.722 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 74.0 mt -120.83 147.19 45.71 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.033 -179.811 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.7 t -116.21 126.77 73.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.377 178.658 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.3 m -78.66 138.48 38.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.487 0.661 . . . . 0.0 111.801 -178.692 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.6 mm -103.37 132.61 49.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.63 178.208 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -86.75 155.86 20.17 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.12 179.5 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.604 ' CD ' HH11 ' B' ' 245' ' ' ARG . 87.4 mtm180 -58.39 -30.28 66.69 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.052 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.6 t -74.62 -15.06 60.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.805 179.246 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.0 30.75 7.7 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 -179.431 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.1 t -119.09 133.99 64.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.94 0.4 . . . . 0.0 111.121 -179.964 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -74.75 136.98 41.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.838 178.981 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.51 -120.31 2.24 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 120.558 -0.829 . . . . 0.0 111.782 -179.905 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -73.54 152.84 49.09 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.173 1.915 . . . . 0.0 112.428 -179.111 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -114.1 156.07 24.84 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.015 179.471 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.558 ' CD2' HD11 ' A' ' 37' ' ' ILE . 37.3 t80 -119.97 104.04 44.63 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.451 -179.946 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.3 130.43 16.29 Favored 'Trans proline' 0 N--CA 1.488 1.19 0 C-N-CA 121.356 1.371 . . . . 0.0 112.59 -178.913 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.1 mt -83.88 45.7 1.11 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.749 -179.431 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.8 m -59.29 -28.73 67.02 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.666 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.691 HD11 ' HG2' ' B' ' 265' ' ' GLN . 78.3 mt -77.84 143.12 38.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.622 179.976 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 95.7 p -64.44 -21.08 66.54 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.219 -179.567 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 90.9 m -135.48 136.04 40.96 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.053 0.454 . . . . 0.0 112.153 -179.593 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.643 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 3.4 t -131.72 124.05 28.98 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.515 178.361 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.529 HD21 ' HG2' ' A' ' 47' ' ' GLN . 31.4 tp -116.36 130.49 56.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.934 -178.982 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.759 ' CE2' HD12 ' A' ' 37' ' ' ILE . 14.4 m-85 -107.34 141.07 39.28 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.436 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 160.21 -164.34 34.33 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 119.566 -1.302 . . . . 0.0 112.979 179.198 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.8 ttp85 -98.85 -32.11 11.51 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 114.977 -0.612 . . . . 0.0 111.88 -179.268 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -57.56 156.25 17.11 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.509 -1.037 . . . . 0.0 110.509 -179.795 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.584 ' O ' ' NE ' ' A' ' 38' ' ' ARG . 8.7 tp -63.97 -42.37 95.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 117.327 0.563 . . . . 0.0 112.235 -178.616 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.481 ' OE1' ' N ' ' A' ' 34' ' ' GLU . 57.9 mp0 -56.89 -17.41 9.38 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.267 -178.699 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.585 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 89.5 m -59.86 122.74 14.99 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.244 -0.583 . . . . 0.0 110.087 179.522 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.448 ' O ' ' CB ' ' B' ' 264' ' ' LYS . 71.5 m-20 -59.9 -31.18 69.57 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.273 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.759 HD12 ' CE2' ' A' ' 29' ' ' PHE . 94.6 mt -122.03 115.52 46.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 176.384 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.584 ' NE ' ' O ' ' A' ' 33' ' ' ILE . 74.5 mtt85 -104.43 138.22 41.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.006 -177.267 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.597 HG23 ' O ' ' B' ' 260' ' ' GLU . 80.1 mt -119.5 130.49 73.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.839 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -73.7 38.79 0.1 Allowed 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -177.867 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.723 HD13 HH21 ' A' ' 93' ' ' ARG . 39.7 mt -125.04 129.64 24.47 Favored Pre-proline 0 C--N 1.325 -0.487 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.938 179.771 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.06 -11.83 27.58 Favored 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 122.404 2.069 . . . . 0.0 113.392 -178.973 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.652 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 27.5 m -83.94 -4.32 8.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.411 179.549 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 40.8 t -87.38 133.13 30.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.209 179.578 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.5 t -65.25 161.16 19.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.779 -179.198 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.585 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 93.7 mttt -62.02 -44.35 96.9 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.485 -178.951 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.643 ' O ' ' N ' ' A' ' 49' ' ' CYS . 89.5 mt-30 -116.9 -18.23 10.22 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.921 0.391 . . . . 0.0 111.014 179.682 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 16.7 t60 33.66 -72.21 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 179.415 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.643 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.11 137.18 46.22 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -177.726 . . . . . . . . 3 3 . 1 . 085 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -125.32 126.78 45.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.686 179.176 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 88.0 mt -110.36 131.73 60.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.995 -179.933 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -115.38 131.29 56.98 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.925 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.1 mm -100.39 122.24 52.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.841 -179.312 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.454 ' O ' ' C ' ' A' ' 55' ' ' GLU . 97.1 m-70 -122.42 132.15 54.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.199 179.25 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 54' ' ' HIS . 76.6 mt-10 -40.68 -36.71 0.64 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -178.457 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.487 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 88.7 mt-30 -62.85 -66.7 0.5 Allowed 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.401 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.487 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 3.8 tp10 -153.74 -168.3 2.93 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.678 -179.658 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.448 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -118.4 132.87 56.24 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.099 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.1 mt -118.59 129.89 74.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.392 0.615 . . . . 0.0 111.956 -178.666 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.453 ' HB2' HD21 ' A' ' 82' ' ' LEU . 40.1 tp -95.13 129.07 42.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.046 179.997 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -113.76 136.12 53.21 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 179.956 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.612 ' ND2' ' H ' ' A' ' 69' ' ' THR . 17.1 t-20 -97.41 107.64 20.19 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.988 0.423 . . . . 0.0 111.787 -179.582 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -98.65 -10.77 22.8 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.622 179.162 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.3 t -69.78 101.03 1.61 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.443 179.914 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 90.3 p -84.34 -14.27 50.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.972 0.415 . . . . 0.0 110.039 179.614 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.578 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -98.45 -40.8 8.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.161 -179.004 . . . . . . . . 3 3 . 1 . 085 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -137.09 93.79 13.0 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.053 -179.687 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.462 ' HA ' HD21 ' A' ' 62' ' ' ASN . 32.1 Cg_exo -56.75 144.03 88.33 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.256 1.97 . . . . 0.0 112.226 -179.822 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.612 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 95.1 m -71.29 137.13 48.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.056 179.707 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -98.32 141.29 31.4 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.614 178.982 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 55.5 t -130.15 136.55 58.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.251 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 53.37 32.33 13.6 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.252 -179.691 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.11 27.5 72.86 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.48 -179.99 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.1 m -138.37 137.51 37.38 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.383 -179.634 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.403 ' O ' HG13 ' A' ' 75' ' ' VAL . 5.9 p -71.05 135.51 27.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.017 0.437 . . . . 0.0 111.897 -179.67 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.877 HD11 ' O ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -136.18 121.95 29.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.727 178.545 . . . . . . . . 3 3 . 1 . 085 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.7 p-10 -103.22 -5.02 23.56 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 120.801 -0.359 . . . . 0.0 111.475 -179.273 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.877 ' O ' HD11 ' A' ' 76' ' ' ILE . 21.4 mt-10 -116.13 151.49 46.71 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.747 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -60.35 146.23 97.03 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.016 1.811 . . . . 0.0 112.422 -179.12 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.6 m -141.32 147.26 22.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.325 -179.644 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -73.87 131.12 41.16 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 178.858 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.453 HD21 ' HB2' ' A' ' 60' ' ' LEU . 95.7 mt -78.46 134.76 37.3 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.257 179.965 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -124.9 148.83 48.12 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 178.848 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.415 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 6.1 t60 -55.1 121.42 8.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.393 -178.944 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.32 -19.13 34.86 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 179.975 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -67.61 134.79 51.82 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.385 179.919 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.544 HG22 ' HG2' ' A' ' 96' ' ' ARG . 47.5 t -110.04 132.48 58.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.811 -179.257 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 86.6 mt -101.33 132.16 47.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 178.697 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 55.7 m -124.89 124.1 41.34 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 119.953 -0.699 . . . . 0.0 112.054 -178.543 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.461 ' O ' ' C ' ' A' ' 91' ' ' ILE . 86.6 mt -109.74 127.84 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.058 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.734 HG22 ' N ' ' A' ' 92' ' ' ASP . 95.3 mt 37.32 -100.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.583 -179.149 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.734 ' N ' HG22 ' A' ' 91' ' ' ILE . 1.6 t70 -118.36 15.93 13.9 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.816 0.341 . . . . 0.0 110.963 -179.827 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.723 HH21 HD13 ' A' ' 41' ' ' LEU . 3.4 mtm105 -124.04 138.69 54.41 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.916 -179.588 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 47.0 t -137.7 151.85 48.65 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.917 -179.405 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.475 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 82.4 m-85 -127.21 123.33 36.35 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.582 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.544 ' HG2' HG22 ' A' ' 87' ' ' VAL . 99.6 mtt180 -82.85 135.98 34.77 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.048 -178.304 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.457 ' OH ' ' CD ' ' A' ' 5' ' ' ARG . 88.4 t80 -93.97 122.83 36.87 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.337 -179.854 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.471 ' CD ' HH21 ' A' ' 6' ' ' ARG . 76.1 tt0 -126.93 122.25 34.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.779 179.911 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.454 ' OD1' HG22 ' A' ' 4' ' ' THR . 62.0 t-20 . . . . . 0 C--N 1.327 -0.377 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.588 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo . . . . . 0 N--CA 1.49 1.293 0 CA-C-O 121.287 0.453 . . . . 0.0 112.872 . . . . . . . . . 0 0 . 1 . 085 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.578 ' CG2' HG22 ' A' ' 66' ' ' THR . 40.4 t -66.78 135.35 28.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.225 -0.898 . . . . 0.0 108.72 178.662 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 35.9 t . . . . . 0 C--N 1.323 -0.545 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.085 -179.027 . . . . . . . . 0 0 . 1 . 085 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo . . . . . 0 N--CA 1.496 1.665 0 CA-C-O 120.39 0.079 . . . . 0.0 112.199 . . . . . . . . . 0 0 . 1 . 085 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 24.7 m -73.34 -44.81 58.15 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.238 0.542 . . . . 0.0 109.552 178.286 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.652 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 83.4 t80 -56.67 -45.71 81.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.79 -179.963 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' B' ' 242' ' ' LEU . 88.8 mt -64.08 -41.65 97.24 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.559 179.871 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -60.69 -40.78 93.46 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.429 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -64.29 -42.32 96.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.423 179.094 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.604 HH11 ' CD ' ' A' ' 12' ' ' ARG . 58.1 ttm-85 -58.06 -42.9 86.48 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.168 -179.895 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -60.71 -39.94 90.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.167 -179.977 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 59.2 m -65.14 -44.49 88.46 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.025 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -60.41 -37.45 80.9 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.802 -179.895 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 38.7 t . . . . . 0 N--CA 1.452 -0.357 0 C-N-CA 119.864 -0.734 . . . . 0.0 109.805 178.908 . . . . . . . . 0 0 . 1 . 085 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.597 ' O ' HG23 ' A' ' 39' ' ' ILE . 51.7 mp0 . . . . . 0 CA--C 1.534 0.358 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 . . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.475 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 75.4 mt -114.21 136.46 50.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.086 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . 0.405 ' N ' ' O ' ' A' ' 38' ' ' ARG . 50.2 t -128.18 137.92 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.86 0.362 . . . . 0.0 110.939 -179.565 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -100.86 122.64 43.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.117 0.484 . . . . 0.0 111.386 -179.117 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . 0.46 ' HG3' HH22 ' A' ' 38' ' ' ARG . 89.2 tttt -64.35 -45.88 85.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.309 179.238 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . 0.691 ' HG2' HD11 ' A' ' 24' ' ' LEU . 5.0 mp0 -99.82 163.63 18.07 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.976 -179.008 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.59 156.47 65.46 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.836 2.357 . . . . 0.0 111.459 178.916 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 37.6 pt . . . . . 0 C--N 1.325 -0.461 0 CA-C-O 121.267 0.556 . . . . 0.0 112.085 -178.832 . . . . . . . . 0 0 . 1 . 086 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 C--O 1.233 0.229 0 CA-C-O 120.807 0.336 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 086 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.401 ' HD2' HD13 ' A' ' 53' ' ' ILE . 83.9 mtt85 -85.63 122.11 29.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.341 -179.589 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -126.73 137.46 53.25 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.537 179.847 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.537 HD11 ' HB3' ' A' ' 95' ' ' PHE . 30.6 tp -114.67 127.54 55.82 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.617 179.98 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.553 HG11 ' OD2' ' A' ' 16' ' ' ASP . 64.2 t -104.53 134.19 46.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.105 179.684 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.417 HG23 ' CD1' ' B' ' 261' ' ' ILE . 2.8 m -94.42 118.93 32.38 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.247 0.546 . . . . 0.0 112.141 -178.516 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.612 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 95.3 mt -83.02 141.8 14.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.999 179.541 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.461 ' HA ' HH22 ' A' ' 93' ' ' ARG . 98.0 mttt -88.44 159.26 18.07 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 178.856 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.602 HH12 ' CD ' ' B' ' 248' ' ' GLN . 84.5 mtp180 -57.22 -29.63 63.92 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 121.059 -0.257 . . . . 0.0 111.139 -178.764 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.4 m -81.18 -6.21 58.59 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.605 179.393 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.97 36.85 7.5 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 -179.557 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.3 t -119.1 132.64 68.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.836 0.351 . . . . 0.0 110.633 -179.535 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.553 ' OD2' HG11 ' A' ' 8' ' ' VAL . 68.4 t0 -76.21 130.81 38.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.65 -179.549 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.17 -116.08 1.87 Allowed Glycine 0 CA--C 1.539 1.579 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.737 -179.438 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.5 145.91 38.53 Favored 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 122.797 2.331 . . . . 0.0 113.867 -178.301 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -109.23 150.12 28.41 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.12 0.486 . . . . 0.0 110.807 179.544 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.518 ' CD2' HD11 ' A' ' 37' ' ' ILE . 30.8 t80 -120.42 106.06 40.79 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.02 179.577 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -73.21 125.91 10.66 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 C-N-CA 121.459 1.439 . . . . 0.0 112.137 -178.583 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.419 HD22 ' SG ' ' A' ' 27' ' ' CYS . 57.0 mt -88.27 43.5 1.13 Allowed 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.108 -178.796 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 80.0 p -66.24 -19.55 65.86 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.564 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 90.0 mt -73.46 142.71 46.83 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.678 179.575 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 71.5 p -59.41 -24.95 63.9 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.474 -179.135 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 39.1 m -136.93 134.05 36.35 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.918 -179.6 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.419 ' SG ' HD22 ' A' ' 22' ' ' LEU . 5.5 t -126.03 122.24 35.31 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.335 178.169 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.609 HD21 ' OE1' ' A' ' 47' ' ' GLN . 41.7 tp -118.09 129.79 55.76 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.478 -178.441 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.649 ' CE2' HD12 ' A' ' 37' ' ' ILE . 4.7 m-85 -108.29 139.57 42.8 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 123.425 0.453 . . . . 0.0 110.06 179.395 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 178.22 -170.34 42.44 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 178.861 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 27.9 ptt-85 -100.11 -3.23 32.27 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.543 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -81.87 166.29 46.66 Favored Glycine 0 CA--C 1.52 0.371 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -179.326 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 19.3 tt -96.16 5.73 8.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.216 0.532 . . . . 0.0 110.308 179.969 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -95.64 -7.96 36.13 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.989 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.2 m -91.44 151.1 20.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.137 -179.94 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.419 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 55.1 m-20 -60.77 -32.36 71.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.186 -179.641 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.649 HD12 ' CE2' ' A' ' 29' ' ' PHE . 98.4 mt -128.12 127.29 67.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.463 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -113.42 136.85 52.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.894 -178.775 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 85.6 mt -118.34 130.64 72.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.685 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -73.02 35.43 0.08 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.29 -178.035 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.481 HD21 ' NH1' ' B' ' 245' ' ' ARG . 59.7 mt -109.97 129.07 24.34 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.017 -179.83 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.413 ' O ' ' HD2' ' B' ' 235' ' ' PRO . 60.9 Cg_endo -72.5 -6.86 19.85 Favored 'Trans proline' 0 N--CA 1.49 1.292 0 C-N-CA 122.314 2.009 . . . . 0.0 112.623 -179.798 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.447 HG21 ' CE2' ' B' ' 241' ' ' PHE . 6.1 m -102.41 7.21 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.035 179.368 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 37.1 t -93.3 134.11 32.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.817 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.9 m -68.14 160.37 29.16 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.639 0.733 . . . . 0.0 112.481 -178.782 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -63.56 -41.3 98.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.088 -179.445 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.641 ' O ' ' N ' ' A' ' 49' ' ' CYS . 98.3 mm-40 -113.84 -19.22 11.58 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.005 -179.971 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 21.7 t60 26.83 -74.65 0.0 OUTLIER 'General case' 0 C--O 1.235 0.335 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 179.969 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.641 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.19 134.48 46.53 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.6 0.714 . . . . 0.0 112.727 -178.206 . . . . . . . . 3 3 . 1 . 086 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -127.36 129.63 47.95 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.313 179.865 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 98.1 mt -113.92 132.25 63.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.438 179.859 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -111.19 126.38 54.8 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 178.088 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.401 HD13 ' HD2' ' A' ' 5' ' ' ARG . 82.2 mt -104.22 115.18 45.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.819 0.819 . . . . 0.0 111.952 -179.002 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.428 ' O ' ' C ' ' A' ' 55' ' ' GLU . 98.3 m-70 -117.55 142.57 47.03 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.265 -1.334 . . . . 0.0 110.165 179.844 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 54' ' ' HIS . 87.3 tt0 -40.5 -33.16 0.24 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.673 179.539 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.502 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 64.6 tp60 -61.72 -68.03 0.36 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.55 179.417 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.502 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 6.5 tp10 -156.41 -168.71 2.8 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.463 -178.641 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.442 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -110.46 126.81 54.73 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.412 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.8 mt -115.09 131.15 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -177.689 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.556 ' HB2' HD11 ' A' ' 82' ' ' LEU . 21.6 tp -101.59 127.78 48.15 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.769 179.862 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -110.92 135.58 51.24 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.737 179.876 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.466 ' ND2' ' O ' ' A' ' 76' ' ' ILE . 48.6 t-20 -94.92 104.5 16.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.296 -179.196 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -99.53 -9.65 23.04 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.307 179.729 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.05 102.75 1.69 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.478 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 81.6 p -88.91 -15.94 33.12 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.225 179.911 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.618 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -90.97 -42.78 10.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.261 -179.805 . . . . . . . . 3 3 . 1 . 086 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.445 HD21 ' HA ' ' B' ' 236' ' ' VAL . 46.4 m-20 -141.2 103.45 6.1 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.483 -179.729 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -56.25 144.85 80.13 Favored 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 121.9 1.733 . . . . 0.0 113.188 -179.097 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.5 m -73.3 140.05 46.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.593 178.459 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -101.26 139.61 36.7 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.15 0.5 . . . . 0.0 111.532 -179.874 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.68 HG13 ' OD1' ' A' ' 86' ' ' ASP . 45.1 t -136.4 133.79 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.956 178.63 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 8.0 m120 54.49 32.31 16.52 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.075 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.67 29.16 63.9 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-N 115.14 -0.936 . . . . 0.0 112.212 179.388 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 64.1 m -149.87 147.47 27.99 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 117.401 0.601 . . . . 0.0 111.674 -179.742 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.8 m -75.82 149.48 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.103 0.477 . . . . 0.0 111.733 -179.695 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.466 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 4.0 pt -120.97 97.94 5.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.663 179.312 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -69.25 -23.34 63.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.719 179.724 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -129.85 177.25 2.28 Favored Pre-proline 0 N--CA 1.469 0.506 0 C-N-CA 121.191 -0.203 . . . . 0.0 111.324 -179.84 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -61.02 146.7 97.41 Favored 'Trans proline' 0 N--CA 1.503 2.071 0 C-N-CA 123.042 2.495 . . . . 0.0 112.744 179.649 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.4 p -143.67 138.99 25.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.696 179.884 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 88.9 mtm180 -74.84 133.05 41.94 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.176 179.475 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.556 HD11 ' HB2' ' A' ' 60' ' ' LEU . 93.3 mt -89.23 129.09 35.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.963 0.411 . . . . 0.0 110.696 179.77 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -117.22 156.15 28.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.243 179.594 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -56.01 118.41 4.62 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.178 179.978 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.35 -17.42 18.99 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -179.775 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.68 ' OD1' HG13 ' A' ' 71' ' ' VAL . 54.3 t0 -65.63 127.57 32.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.256 0.55 . . . . 0.0 110.851 179.725 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.45 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 56.0 t -109.14 132.99 55.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.43 -179.226 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 77.2 mt -101.05 130.54 50.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.843 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 51.5 m -122.54 122.88 39.95 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.608 0.718 . . . . 0.0 112.221 -178.629 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.557 ' O ' ' N ' ' A' ' 93' ' ' ARG . 96.7 mt -113.9 124.66 70.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 114.642 -1.163 . . . . 0.0 108.592 178.24 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.5 HD12 ' CB ' ' B' ' 237' ' ' CYS . 46.3 mm 39.17 -96.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.323 -179.27 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.575 ' CB ' ' HE ' ' B' ' 245' ' ' ARG . 54.7 t0 -119.95 5.07 10.9 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.978 0.418 . . . . 0.0 110.742 -179.826 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.641 HH21 ' CD1' ' B' ' 261' ' ' ILE . 17.9 mmm180 -106.89 134.97 49.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.699 179.925 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 47.1 t -132.12 144.07 50.45 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.838 -179.872 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.537 ' HB3' HD11 ' A' ' 7' ' ' LEU . 79.7 m-85 -123.19 120.26 32.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.1 179.766 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.497 ' O ' HD12 ' A' ' 7' ' ' LEU . 44.2 ttm180 -84.47 127.35 33.98 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.142 -179.8 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.535 ' CZ ' ' OD1' ' A' ' 99' ' ' ASN . 88.9 t80 -95.73 129.05 43.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.462 179.854 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -142.66 128.63 19.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.973 0.416 . . . . 0.0 111.938 -179.445 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.535 ' OD1' ' CZ ' ' A' ' 97' ' ' TYR . 89.1 m-20 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.987 179.228 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . 0.413 ' HD2' ' O ' ' A' ' 42' ' ' PRO . 81.5 Cg_endo . . . . . 0 N--CA 1.488 1.175 0 CA-C-O 121.568 0.57 . . . . 0.0 113.095 . . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.618 ' CG2' HG22 ' A' ' 66' ' ' THR . 55.6 t -67.75 136.02 27.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 114.612 -1.176 . . . . 0.0 111.803 -179.357 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . 0.5 ' CB ' HD12 ' A' ' 91' ' ' ILE . 1.9 t . . . . . 0 C--N 1.331 -0.22 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.644 178.774 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo . . . . . 0 N--CA 1.504 2.091 0 N-CA-C 113.609 0.58 . . . . 0.0 113.609 . . . . . . . . . 0 0 . 1 . 086 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 37.2 m -72.28 -45.52 59.74 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.201 0.524 . . . . 0.0 110.341 179.135 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.447 ' CE2' HG21 ' A' ' 43' ' ' VAL . 81.0 t80 -56.61 -45.41 81.49 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.659 -179.733 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 98.6 mt -64.31 -41.31 96.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.31 179.82 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -64.99 -37.42 87.61 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.642 179.903 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -60.36 -43.41 96.57 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.616 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.671 ' O ' HG23 ' B' ' 249' ' ' VAL . 75.1 mtp85 -62.34 -37.48 85.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.75 -179.966 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -62.04 -41.37 98.05 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.238 179.809 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 10.2 t -65.63 -44.07 87.58 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.757 0.789 . . . . 0.0 108.932 177.812 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . 0.602 ' CD ' HH12 ' A' ' 12' ' ' ARG . 64.5 tt0 -62.11 -32.2 72.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.454 179.455 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . 0.671 HG23 ' O ' ' B' ' 245' ' ' ARG . 55.6 t . . . . . 0 N--CA 1.456 -0.173 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 179.109 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 . . . . . 0 N--CA 1.462 0.168 0 CA-C-O 120.7 0.286 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 086 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.641 ' CD1' HH21 ' A' ' 93' ' ' ARG . 39.7 mt -118.09 138.34 49.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -179.734 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 52.9 t -126.56 135.28 64.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.431 -179.847 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -98.23 118.62 35.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.135 0.493 . . . . 0.0 111.242 -178.903 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.86 -47.35 78.22 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.446 179.273 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -92.48 150.6 40.21 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.253 -179.22 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -66.44 147.76 83.04 Favored 'Trans proline' 0 N--CA 1.499 1.828 0 C-N-CA 123.169 2.579 . . . . 0.0 113.34 -179.488 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 19.7 pt . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.128 178.722 . . . . . . . . 0 0 . 1 . 087 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.6 p . . . . . 0 C--O 1.236 0.361 0 CA-C-O 120.726 0.298 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 087 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.45 119.95 33.95 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.247 0.546 . . . . 0.0 110.719 -179.894 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.514 ' C ' HD22 ' A' ' 7' ' ' LEU . 83.9 mtp180 -133.48 143.57 48.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.309 179.107 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.581 HD12 ' HB3' ' A' ' 95' ' ' PHE . 3.1 mm? -112.32 127.48 56.0 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.416 179.067 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.616 HG13 ' NE2' ' A' ' 19' ' ' HIS . 86.9 t -98.77 125.67 52.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.058 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 m -76.84 138.08 39.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.473 0.654 . . . . 0.0 112.2 -178.923 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.611 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 48.1 mm -105.19 132.45 51.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.625 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -87.73 156.8 19.27 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.09 -0.644 . . . . 0.0 110.994 179.918 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.668 ' NH2' HE21 ' B' ' 248' ' ' GLN . 73.2 mtp180 -54.02 -33.56 57.54 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.612 -179.286 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.7 m -78.73 -5.41 53.13 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.42 179.008 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.42 35.02 9.78 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -179.343 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.3 t -119.15 134.6 62.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.66 0.267 . . . . 0.0 110.284 -179.84 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.404 ' OD1' HD13 ' A' ' 10' ' ' ILE . 86.7 m-20 -76.15 137.97 40.42 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.862 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.25 -118.15 2.05 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.514 -179.176 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.43 147.9 47.47 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.215 1.943 . . . . 0.0 113.002 -178.217 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.616 ' NE2' HG13 ' A' ' 8' ' ' VAL . 64.7 m170 -105.45 132.76 51.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.236 179.577 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.629 ' CD2' HD11 ' A' ' 37' ' ' ILE . 35.5 t80 -104.61 97.52 12.58 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.115 179.784 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -71.37 129.11 15.42 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 121.326 1.351 . . . . 0.0 111.675 -179.859 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.451 HD22 ' HB2' ' A' ' 27' ' ' CYS . 49.6 mt -96.92 54.12 1.25 Allowed 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.421 -179.131 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 92.0 p -61.78 -17.94 57.97 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.855 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.458 HD11 ' HG2' ' B' ' 265' ' ' GLN . 76.7 mt -77.15 142.21 39.8 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.293 178.88 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.7 t -63.61 -20.83 65.99 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -178.866 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 72.1 m -132.92 133.43 43.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.137 0.494 . . . . 0.0 111.739 -179.652 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.567 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 9.6 t -126.34 119.09 26.43 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.493 179.291 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.618 HD21 ' OE1' ' A' ' 47' ' ' GLN . 34.0 tp -115.55 126.57 54.41 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.566 -0.453 . . . . 0.0 111.854 -178.084 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.833 ' CE2' HD12 ' A' ' 37' ' ' ILE . 10.5 m-85 -104.12 139.86 38.6 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.994 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 171.82 -171.83 44.33 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 119.812 -1.185 . . . . 0.0 112.063 179.738 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 31.2 ttp85 -100.26 -8.73 23.16 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.114 -0.543 . . . . 0.0 111.778 -179.444 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.451 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -88.78 167.31 34.83 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 120.688 -0.767 . . . . 0.0 111.284 -179.996 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.519 HG23 ' N ' ' A' ' 34' ' ' GLU . 9.9 tp -64.71 -42.06 93.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 O-C-N 122.551 -0.382 . . . . 0.0 110.975 -179.732 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.519 ' N ' HG23 ' A' ' 33' ' ' ILE . 93.0 mt-10 -53.7 -22.23 8.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.766 0.317 . . . . 0.0 111.047 -179.334 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 4.0 m -65.96 124.83 23.59 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.438 -179.873 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 28' ' ' LEU . 53.1 m-20 -60.31 -30.65 69.63 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.349 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.833 HD12 ' CE2' ' A' ' 29' ' ' PHE . 79.7 mt -123.93 121.41 62.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 176.825 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.468 HH12 ' HA ' ' B' ' 264' ' ' LYS . 89.2 mtm-85 -103.84 133.93 48.0 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.006 -178.228 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.419 ' C ' ' H ' ' A' ' 41' ' ' LEU . 97.9 mt -116.9 128.95 74.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.289 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -73.23 26.46 0.06 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.014 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.472 HD21 ' OE1' ' B' ' 260' ' ' GLU . 51.5 mt -95.64 127.44 41.6 Favored Pre-proline 0 C--N 1.324 -0.543 0 C-N-CA 120.478 -0.489 . . . . 0.0 109.921 179.022 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.91 -7.96 22.08 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 122.186 1.924 . . . . 0.0 111.964 -179.628 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.8 m -97.92 10.97 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.299 179.982 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 33.5 t -99.0 133.52 41.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-O 120.675 0.274 . . . . 0.0 110.846 179.467 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.0 m -74.45 170.69 15.17 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.255 0.55 . . . . 0.0 111.927 -178.934 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -64.53 -41.45 96.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.202 -179.301 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.618 ' OE1' HD21 ' A' ' 28' ' ' LEU . 97.8 mm-40 -109.58 -27.41 9.41 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.164 0.507 . . . . 0.0 110.025 -179.578 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.794 ' NE2' HG23 ' A' ' 90' ' ' ILE . 18.8 t60 38.94 -77.52 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.666 -1.152 . . . . 0.0 112.661 179.623 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.617 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.45 133.68 46.5 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.259 0.552 . . . . 0.0 111.114 -179.066 . . . . . . . . 3 3 . 1 . 087 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -128.76 131.45 47.84 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.494 -179.819 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 94.7 mt -116.88 133.21 64.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.183 0.516 . . . . 0.0 110.744 179.633 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -115.81 125.92 53.33 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.704 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 95.5 mt -105.02 113.67 42.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.482 0.658 . . . . 0.0 111.77 -178.938 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.475 ' O ' ' N ' ' A' ' 56' ' ' GLN . 90.7 m-70 -112.11 142.94 43.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.316 -179.883 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 54' ' ' HIS . 78.4 tt0 -40.9 -27.48 0.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.298 0.57 . . . . 0.0 109.897 -179.317 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.475 ' N ' ' O ' ' A' ' 54' ' ' HIS . 70.0 tp60 -65.86 -67.88 0.41 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.727 179.715 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.469 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 5.8 tp10 -158.12 -168.17 2.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.042 -0.527 . . . . 0.0 109.676 -179.257 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.469 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -108.87 122.63 47.6 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.909 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.0 mt -114.56 131.43 66.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -177.763 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.413 ' HB2' HD11 ' A' ' 82' ' ' LEU . 24.5 tp -103.07 127.22 50.41 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.216 -179.417 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -111.05 136.78 49.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.141 179.335 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.488 HD21 ' HA ' ' A' ' 68' ' ' PRO . 58.9 t-20 -97.92 106.95 19.33 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.693 -178.954 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -101.43 -7.3 23.01 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.471 179.606 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.472 ' OG ' ' O ' ' A' ' 48' ' ' HIS . 0.7 OUTLIER -74.36 99.48 3.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.484 -178.794 . . . . . . . . 3 3 . 1 . 087 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 76.7 p -81.08 -32.41 33.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.059 0.457 . . . . 0.0 109.863 179.337 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.8 m -62.92 -49.97 72.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.683 -179.935 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.467 ' OD1' HG22 ' B' ' 236' ' ' VAL . 13.6 m-20 -144.15 106.33 4.83 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.933 -179.854 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.488 ' HA ' HD21 ' A' ' 62' ' ' ASN . 45.4 Cg_exo -54.08 146.89 46.2 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 121.923 1.748 . . . . 0.0 112.949 -179.231 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.4 m -74.98 138.95 42.6 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.924 178.885 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -101.78 140.67 35.75 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.95 179.841 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.665 HG13 ' OD1' ' A' ' 86' ' ' ASP . 64.8 t -131.8 133.17 61.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.052 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 53.74 32.39 14.69 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.007 -178.611 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.12 29.09 67.18 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.417 -179.73 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 4.9 p -145.42 140.4 27.6 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.953 -179.682 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.401 HG13 ' HB2' ' A' ' 68' ' ' PRO . 15.1 t -65.82 139.85 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.456 179.741 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.3 pt -110.2 78.13 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.089 0 CA-C-O 121.021 0.439 . . . . 0.0 110.214 178.587 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -57.59 -31.69 66.43 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.004 179.993 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -118.81 168.85 8.91 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.55 179.762 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.3 141.99 98.51 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.019 1.813 . . . . 0.0 111.941 179.607 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 61.2 t -135.78 136.57 50.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.188 -179.913 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -72.64 131.55 42.57 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.614 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.413 HD11 ' HB2' ' A' ' 60' ' ' LEU . 93.3 mt -83.25 138.59 33.53 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.761 -179.836 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -130.71 154.46 47.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.024 -179.661 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.414 ' CD2' ' C ' ' A' ' 84' ' ' HIS . 7.7 t60 -54.35 116.42 2.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.372 179.88 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.72 -19.15 31.23 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -179.846 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.665 ' OD1' HG13 ' A' ' 71' ' ' VAL . 45.5 t0 -65.54 126.95 29.93 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.144 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 52.8 t -109.94 134.55 51.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.432 -0.507 . . . . 0.0 111.312 -178.386 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 79.5 mt -100.96 130.17 50.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.172 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.514 HG23 ' OG ' ' A' ' 94' ' ' SER . 68.3 m -122.44 123.05 40.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.514 0.673 . . . . 0.0 111.545 -178.762 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.794 HG23 ' NE2' ' A' ' 48' ' ' HIS . 79.6 mt -107.08 121.02 59.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 178.382 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.49 ' C ' ' O ' ' A' ' 90' ' ' ILE . 96.7 mt 33.99 -91.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.818 -179.707 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.576 ' N ' ' O ' ' A' ' 90' ' ' ILE . 46.6 p-10 -118.49 2.7 11.82 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.899 0.381 . . . . 0.0 111.118 179.654 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.782 ' NH2' ' H ' ' A' ' 94' ' ' SER . 0.5 OUTLIER -111.87 132.49 54.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.31 -179.98 . . . . . . . . 3 3 . 1 . 087 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.782 ' H ' ' NH2' ' A' ' 93' ' ' ARG . 16.7 m -135.7 152.28 51.02 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.612 0.72 . . . . 0.0 112.019 -179.455 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.581 ' HB3' HD12 ' A' ' 7' ' ' LEU . 84.4 m-85 -129.67 126.29 37.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.901 179.06 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.504 ' O ' HD13 ' A' ' 7' ' ' LEU . 37.9 ttp-105 -88.11 133.33 34.02 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.612 179.662 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -93.42 125.77 38.2 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.926 -179.73 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -124.47 131.02 53.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.612 179.93 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 59.8 t-20 . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.042 -179.741 . . . . . . . . 0 0 . 1 . 087 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo . . . . . 0 N--CA 1.487 1.091 0 CA-C-O 121.37 0.487 . . . . 0.0 112.167 . . . . . . . . . 0 0 . 1 . 087 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.467 HG22 ' OD1' ' A' ' 67' ' ' ASN . 0.4 OUTLIER -60.58 137.61 22.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.074 179.817 . . . . . . . . 3 3 . 1 . 087 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 3.7 t . . . . . 0 C--N 1.331 -0.223 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.223 -178.701 . . . . . . . . 0 0 . 1 . 087 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo . . . . . 0 N--CA 1.498 1.768 0 CA-C-O 120.929 0.304 . . . . 0.0 111.888 . . . . . . . . . 0 0 . 1 . 087 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 98.3 m -72.91 -44.65 60.98 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.314 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.46 ' HZ ' HD22 ' A' ' 41' ' ' LEU . 81.1 t80 -57.99 -45.06 87.42 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.865 -179.415 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.401 ' HA ' HD23 ' B' ' 242' ' ' LEU . 97.1 mt -64.81 -40.9 95.97 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -179.426 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -61.22 -42.89 99.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.786 179.964 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -63.21 -39.43 94.6 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.44 -0.504 . . . . 0.0 109.682 179.946 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.65 ' O ' HG23 ' B' ' 249' ' ' VAL . 14.5 tpp180 -59.04 -42.42 90.22 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 179.604 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -60.4 -43.03 97.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.403 179.131 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 16.5 t -65.1 -44.88 87.39 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.948 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . 0.668 HE21 ' NH2' ' A' ' 12' ' ' ARG . 27.4 mt-30 -60.84 -32.84 72.23 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.465 -179.825 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . 0.65 HG23 ' O ' ' B' ' 245' ' ' ARG . 54.1 t . . . . . 0 CA--C 1.52 -0.183 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.046 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.568 ' OE2' ' NH1' ' A' ' 12' ' ' ARG . 92.7 mt-10 . . . . . 0 C--O 1.226 -0.145 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 . . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.589 HD11 ' CZ ' ' A' ' 93' ' ' ARG . 59.1 mt -116.53 134.12 60.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.958 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . 0.433 HG11 ' NH2' ' A' ' 38' ' ' ARG . 52.9 t -126.5 134.03 67.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.946 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -93.95 117.86 30.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.479 0.657 . . . . 0.0 111.97 -178.412 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . 0.468 ' HA ' HH12 ' A' ' 38' ' ' ARG . 87.5 tttt -63.34 -43.86 96.51 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.981 179.128 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . 0.458 ' HG2' HD11 ' A' ' 24' ' ' LEU . 9.3 mp0 -100.65 157.43 33.74 Favored Pre-proline 0 N--CA 1.449 -0.492 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.548 -179.686 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -70.2 143.57 49.13 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 C-N-CA 122.847 2.364 . . . . 0.0 113.312 -179.157 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 29.5 pt . . . . . 0 N--CA 1.451 -0.378 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.072 178.564 . . . . . . . . 0 0 . 1 . 088 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 37.2 p . . . . . 0 N--CA 1.462 0.137 0 CA-C-O 120.772 0.32 . . . . 0.0 111.3 . . . . . . . . . 0 0 . 1 . 088 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.703 ' NH2' HG21 ' A' ' 53' ' ' ILE . 82.6 mtm-85 -99.71 134.93 41.89 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.902 -179.366 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -138.82 144.9 39.51 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 120.222 -0.591 . . . . 0.0 111.626 -179.859 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.4 mt -108.73 140.62 41.88 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.003 178.58 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.4 t -112.54 129.21 68.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.616 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.471 HG23 HD12 ' B' ' 261' ' ' ILE . 1.8 m -93.45 117.77 30.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.272 0.558 . . . . 0.0 112.299 -178.049 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.5 mt -83.07 143.04 12.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.785 179.582 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -95.94 164.31 12.77 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.967 179.498 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.458 ' HG3' ' NH1' ' A' ' 93' ' ' ARG . 82.7 mtp180 -58.36 -30.09 66.49 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.281 -179.366 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.541 ' OG ' HG22 ' A' ' 15' ' ' VAL . 88.0 p -73.25 -15.08 61.43 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.229 179.561 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.93 11.09 44.3 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -179.869 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.541 HG22 ' OG ' ' A' ' 13' ' ' SER . 11.4 m -112.02 138.73 39.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.956 0.408 . . . . 0.0 110.484 179.931 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.419 ' O ' ' OD1' ' A' ' 16' ' ' ASP . 54.2 p-10 -80.19 146.85 31.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.006 179.446 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.21 -106.09 1.01 Allowed Glycine 0 CA--C 1.537 1.447 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 179.822 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.1 146.92 37.39 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 122.963 2.442 . . . . 0.0 112.248 -179.994 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -112.97 153.18 28.43 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.194 179.901 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.641 ' CD2' HD11 ' A' ' 37' ' ' ILE . 62.5 t80 -117.53 89.21 31.59 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.665 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -61.3 132.62 42.12 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.556 2.171 . . . . 0.0 111.089 179.914 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.7 mt -87.97 82.23 7.29 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.653 -178.847 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 86.0 p -86.59 -11.14 52.32 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 178.379 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.67 HD11 ' HG2' ' B' ' 265' ' ' GLN . 63.4 mt -101.92 144.06 31.03 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.526 -179.186 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.1 m -67.86 -21.2 65.19 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.779 0.323 . . . . 0.0 111.199 -179.724 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 63.1 m -127.52 133.31 49.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.708 179.619 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.653 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 9.8 t -129.78 122.13 28.2 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.463 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 49.8 tp -118.08 132.5 56.35 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.149 -178.246 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.653 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 38.0 m-85 -110.49 142.46 42.22 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.8 0.334 . . . . 0.0 110.197 179.837 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 150.13 -176.16 28.89 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 179.406 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 46.6 mtm180 -77.76 -31.68 52.19 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.64 179.605 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.578 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -47.8 149.37 3.27 Favored Glycine 0 N--CA 1.466 0.688 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 -179.012 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.448 HD12 ' HD3' ' A' ' 38' ' ' ARG . 11.0 tp -68.58 -41.04 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.583 -179.918 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.442 ' N ' HG23 ' A' ' 33' ' ' ILE . 78.2 mm-40 -55.07 -21.98 14.51 Favored 'General case' 0 C--O 1.231 0.096 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -179.995 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.578 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 19.0 m -57.34 113.01 1.57 Allowed 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.771 178.812 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -58.36 -26.72 63.47 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 -179.99 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.641 HD11 ' CD2' ' A' ' 20' ' ' PHE . 50.5 mm -122.4 113.48 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.476 177.289 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.448 ' HD3' HD12 ' A' ' 33' ' ' ILE . 42.2 mtm180 -98.02 131.63 44.27 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.829 -179.662 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.504 HG21 HD12 ' A' ' 41' ' ' LEU . 99.2 mt -118.17 131.25 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 121.465 0.65 . . . . 0.0 111.31 179.79 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -79.79 32.39 0.25 Allowed 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.159 -178.631 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.71 ' O ' HG12 ' A' ' 44' ' ' VAL . 31.9 mt -98.22 121.56 56.73 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.484 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -72.33 -13.0 27.92 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 121.552 1.501 . . . . 0.0 111.499 -179.823 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.2 m -96.2 7.73 7.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.505 -179.451 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.71 HG12 ' O ' ' A' ' 41' ' ' LEU . 5.0 p -101.86 142.5 16.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.533 179.958 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.8 m -71.95 170.35 13.95 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.363 0.602 . . . . 0.0 111.129 -179.391 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -63.81 -41.2 97.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.986 -179.764 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.637 ' O ' ' N ' ' A' ' 49' ' ' CYS . 87.7 mt-30 -108.96 -9.92 15.08 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 121.086 -0.246 . . . . 0.0 110.994 -179.958 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.594 ' ND1' HG23 ' A' ' 44' ' ' VAL . 30.0 t60 31.41 -76.32 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 179.635 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.637 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.51 137.37 45.58 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.132 0.491 . . . . 0.0 111.685 -178.472 . . . . . . . . 3 3 . 1 . 088 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -123.75 131.56 53.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.899 178.733 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.5 mt -116.05 133.46 62.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.197 -179.109 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -117.85 125.63 50.89 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.02 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.703 HG21 ' NH2' ' A' ' 5' ' ' ARG . 67.7 mt -103.29 116.6 47.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 C-N-CA 119.853 -0.739 . . . . 0.0 111.207 -179.488 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.503 ' O ' ' N ' ' A' ' 56' ' ' GLN . 6.3 m-70 -111.72 135.8 51.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.182 179.637 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.0 mm-40 -41.51 -26.58 0.07 Allowed 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.477 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.503 ' N ' ' O ' ' A' ' 54' ' ' HIS . 82.4 mt-30 -68.39 -68.55 0.38 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.215 178.679 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.447 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 5.2 tp10 -151.0 -178.3 6.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.557 -179.357 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.447 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -102.41 128.7 48.89 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.554 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 40.9 mm -111.89 126.57 69.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.886 -178.117 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.627 ' HB2' HD11 ' A' ' 82' ' ' LEU . 23.0 tp -101.37 124.24 46.75 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.923 178.878 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -114.81 137.04 52.42 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.419 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.691 ' ND2' ' H ' ' A' ' 69' ' ' THR . 21.5 t-20 -102.21 108.28 19.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.03 0.443 . . . . 0.0 111.288 179.49 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -94.43 -3.03 50.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.805 179.298 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.8 t -82.31 100.98 10.26 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.446 -0.501 . . . . 0.0 110.081 179.521 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.9 m -82.76 -17.2 45.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.62 179.954 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.467 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -87.52 -36.09 17.8 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.376 -179.338 . . . . . . . . 3 3 . 1 . 088 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -146.05 100.58 4.22 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.873 -179.54 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -57.81 144.09 94.25 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 121.736 1.624 . . . . 0.0 112.708 -179.336 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.691 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 37.2 m -70.21 134.55 48.17 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.171 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -96.08 141.1 29.87 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.635 -178.909 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.5 t -134.32 134.07 55.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.321 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 53.49 31.89 13.09 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 119.84 -0.744 . . . . 0.0 109.023 -179.104 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.04 25.68 72.98 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.26 179.852 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 37.8 t -141.72 143.57 33.6 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 117.297 0.549 . . . . 0.0 111.528 -179.993 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.8 m -76.69 139.13 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.884 179.984 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.414 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 1.1 pt -104.08 104.05 16.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.622 179.106 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.428 ' C ' ' OE1' ' A' ' 78' ' ' GLU . 57.9 m-20 -63.24 -35.88 81.8 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-O 121.191 0.519 . . . . 0.0 109.911 179.964 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.428 ' OE1' ' C ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -125.79 177.95 1.7 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.345 -179.128 . . . . . . . . 3 3 . 1 . 088 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.418 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 34.6 Cg_exo -60.48 142.64 98.5 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 122.302 2.001 . . . . 0.0 111.914 179.966 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 42.9 t -132.7 138.19 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 120.946 0.403 . . . . 0.0 111.665 179.722 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -75.32 132.83 41.25 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.679 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.627 HD11 ' HB2' ' A' ' 60' ' ' LEU . 86.1 mt -87.41 137.2 32.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.326 0.584 . . . . 0.0 111.318 -179.121 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -126.02 151.85 46.54 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.321 -179.704 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.455 ' ND1' ' N ' ' A' ' 99' ' ' ASN . 9.1 t60 -55.12 122.98 12.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.227 0.537 . . . . 0.0 111.246 -178.973 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 103.35 -13.22 54.89 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.143 -179.657 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -70.72 139.06 51.04 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 117.079 0.44 . . . . 0.0 110.696 179.687 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.427 ' O ' HG13 ' A' ' 87' ' ' VAL . 8.7 p -111.69 135.81 49.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.411 -0.515 . . . . 0.0 111.841 -178.996 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 81.2 mt -102.4 128.99 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 177.606 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.783 HG23 ' OG ' ' A' ' 94' ' ' SER . 95.3 m -123.93 125.07 43.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.702 0.763 . . . . 0.0 111.759 -178.438 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.63 ' O ' ' N ' ' A' ' 93' ' ' ARG . 96.1 mt -113.99 121.65 66.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 114.547 -1.206 . . . . 0.0 108.062 178.324 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.555 ' C ' ' O ' ' A' ' 90' ' ' ILE . 66.5 mt -3.44 95.31 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -179.833 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.427 ' CB ' ' NH1' ' B' ' 245' ' ' ARG . 2.0 t0 77.83 -20.3 0.39 Allowed 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 178.18 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.754 ' HE ' ' CD1' ' B' ' 261' ' ' ILE . 6.8 tpt180 -120.31 130.08 54.29 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 110.465 -0.198 . . . . 0.0 110.465 -178.372 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.783 ' OG ' HG23 ' A' ' 89' ' ' THR . 64.3 m -134.62 151.11 50.83 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -178.486 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.481 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 82.9 m-85 -122.63 120.74 34.62 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.308 178.551 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 37.7 ttp-105 -87.86 134.95 33.59 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 119.914 -0.715 . . . . 0.0 110.727 -179.652 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -96.93 123.86 40.75 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.124 -178.14 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -125.12 120.26 30.9 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.234 179.415 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.455 ' N ' ' ND1' ' A' ' 84' ' ' HIS . 15.9 t-20 . . . . . 0 N--CA 1.472 0.657 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.507 -179.225 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo . . . . . 0 N--CA 1.49 1.275 0 N-CA-C 113.388 0.495 . . . . 0.0 113.388 . . . . . . . . . 0 0 . 1 . 088 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.467 ' CG2' HG22 ' A' ' 66' ' ' THR . 60.5 t -60.82 137.61 22.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.48 179.667 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . 0.535 ' HB2' HD13 ' A' ' 91' ' ' ILE . 2.7 t . . . . . 0 C--N 1.321 -0.651 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.038 -179.559 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo . . . . . 0 N--CA 1.496 1.655 0 CA-C-O 120.775 0.24 . . . . 0.0 112.241 . . . . . . . . . 0 0 . 1 . 088 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 86.2 m -72.24 -44.05 63.46 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.439 0.638 . . . . 0.0 109.417 178.485 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.406 ' CZ ' ' HD2' ' B' ' 245' ' ' ARG . 72.2 t80 -58.47 -51.01 71.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.324 -178.624 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.475 HD21 HG23 ' A' ' 91' ' ' ILE . 97.2 mt -63.51 -42.04 98.49 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.183 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -64.29 -42.24 96.49 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -178.734 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -62.2 -41.8 98.7 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.344 -179.591 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.438 ' O ' HG23 ' B' ' 249' ' ' VAL . 83.5 mtp180 -63.21 -39.32 94.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.636 -178.495 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -62.01 -38.46 88.73 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.016 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 21.0 m -65.49 -42.61 91.97 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.499 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -62.33 -32.92 73.75 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.156 179.705 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . 0.438 HG23 ' O ' ' B' ' 245' ' ' ARG . 53.1 t . . . . . 0 N--CA 1.45 -0.439 0 C-N-CA 120.121 -0.632 . . . . 0.0 109.419 178.74 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 . . . . . 0 C--O 1.23 0.075 0 N-CA-C 111.838 0.311 . . . . 0.0 111.838 . . . . . . . . . 0 0 . 1 . 088 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.754 ' CD1' ' HE ' ' A' ' 93' ' ' ARG . 64.9 mt -117.6 134.36 61.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -179.883 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 47.8 t -123.4 130.65 74.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.162 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -93.47 117.07 29.63 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.272 0.558 . . . . 0.0 111.106 -177.924 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -64.48 -46.6 82.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.687 -179.781 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . 0.67 ' HG2' HD11 ' A' ' 24' ' ' LEU . 0.8 OUTLIER -92.49 165.78 18.59 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.069 -178.465 . . . . . . . . 3 3 . 1 . 088 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -69.07 148.01 68.6 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 122.122 1.882 . . . . 0.0 112.739 -178.93 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 32.1 pt . . . . . 0 C--N 1.321 -0.646 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.15 -179.876 . . . . . . . . 0 0 . 1 . 089 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.0 p . . . . . 0 N--CA 1.455 -0.183 0 CA-C-O 121.133 0.492 . . . . 0.0 110.294 . . . . . . . . . 0 0 . 1 . 089 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.55 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 80.5 mtp85 -87.69 126.73 35.14 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.064 -179.465 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -129.62 133.53 47.19 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.013 -179.863 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.514 HD11 ' HB3' ' A' ' 95' ' ' PHE . 35.1 tp -117.1 128.38 55.08 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.748 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.6 m -106.16 136.09 41.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.419 -179.768 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.516 HG23 HD12 ' B' ' 261' ' ' ILE . 1.8 m -95.29 117.84 30.99 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.142 -0.936 . . . . 0.0 112.589 -178.589 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.7 mt -84.65 145.59 7.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.386 179.02 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -96.4 162.3 13.55 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.95 0.405 . . . . 0.0 110.773 179.315 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.593 ' NH1' ' OE2' ' B' ' 260' ' ' GLU . 87.6 mtm180 -58.45 -27.38 64.32 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.558 -178.636 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 89.3 p -81.82 -9.77 59.52 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.093 -0.643 . . . . 0.0 109.697 179.646 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.3 36.75 6.47 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.61 179.8 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.3 t -118.38 132.37 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-O 120.787 0.327 . . . . 0.0 111.42 179.993 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -69.64 124.48 24.06 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.862 179.274 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -116.08 -128.89 4.34 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.271 -178.937 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -70.61 148.07 58.76 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.031 1.821 . . . . 0.0 112.816 -178.623 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -106.51 144.87 32.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.814 -179.572 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.757 ' CD2' HD11 ' A' ' 37' ' ' ILE . 34.6 t80 -112.25 100.98 51.19 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.321 179.862 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.414 ' CD ' ' O ' ' B' ' 267' ' ' ILE . 57.8 Cg_endo -75.79 128.82 11.15 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 121.47 1.446 . . . . 0.0 111.42 -179.632 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 88.0 mt -83.8 81.17 8.88 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.855 -178.871 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 87.8 p -86.01 -13.7 46.72 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.987 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 73.8 mt -100.03 145.36 28.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.422 -179.967 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 54.2 p -68.56 -15.77 63.64 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.506 -178.804 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.517 HG23 ' OE2' ' A' ' 52' ' ' GLU . 85.6 m -128.61 131.48 48.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.237 0.541 . . . . 0.0 111.778 -179.691 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.9 t -128.11 122.15 31.34 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.304 178.543 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.8 tp -115.27 130.58 56.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.956 0.408 . . . . 0.0 111.002 -179.074 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.522 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 44.8 m-85 -111.36 140.47 45.92 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.796 179.718 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 152.64 -168.4 31.63 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 120.886 -0.673 . . . . 0.0 111.504 179.394 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.578 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 49.5 ptt85 -118.29 17.27 13.92 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 122.76 -0.259 . . . . 0.0 111.034 179.901 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.629 ' O ' ' N ' ' A' ' 34' ' ' GLU . . . -88.05 32.96 4.16 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.814 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.65 ' C ' ' H ' ' A' ' 35' ' ' CYS . 2.0 tt 52.03 -62.09 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 123.28 0.632 . . . . 0.0 112.587 -179.609 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.629 ' N ' ' O ' ' A' ' 32' ' ' GLY . 72.0 tt0 -52.26 2.21 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 O-C-N 121.974 -0.454 . . . . 0.0 110.899 -178.934 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.65 ' H ' ' C ' ' A' ' 33' ' ' ILE . 3.9 m -82.77 133.81 35.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.891 0.377 . . . . 0.0 111.027 179.82 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -61.88 -26.81 68.37 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.88 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.757 HD11 ' CD2' ' A' ' 20' ' ' PHE . 49.0 mm -123.41 117.09 50.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 177.267 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.411 ' NH1' HG13 ' A' ' 33' ' ' ILE . 82.1 mtt180 -100.33 132.92 45.43 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.85 -179.133 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.721 HG21 HD12 ' A' ' 41' ' ' LEU . 80.9 mt -120.31 130.98 73.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.469 -0.493 . . . . 0.0 110.446 -179.727 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -79.11 33.97 0.23 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.507 -179.046 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.721 HD12 HG21 ' A' ' 39' ' ' ILE . 17.9 mt -102.06 108.74 57.85 Favored Pre-proline 0 C--N 1.326 -0.427 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.78 -179.974 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -57.56 -13.81 14.91 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.21 1.94 . . . . 0.0 112.406 179.159 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.6 m -97.31 9.7 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.858 -179.893 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.578 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 15.7 t -102.17 135.88 37.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.092 0.473 . . . . 0.0 110.957 -179.744 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.53 162.23 21.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.204 -179.12 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -62.89 -42.42 99.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.702 -179.392 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.595 ' O ' ' N ' ' A' ' 49' ' ' CYS . 87.6 mt-30 -112.34 -2.58 14.76 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.916 0.389 . . . . 0.0 110.579 178.882 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.456 ' C ' ' O ' ' A' ' 47' ' ' GLN . 14.8 t60 15.88 -73.51 0.0 OUTLIER 'General case' 0 C--O 1.235 0.29 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -179.287 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.595 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.91 134.69 44.9 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.331 -0.548 . . . . 0.0 112.094 -178.127 . . . . . . . . 3 3 . 1 . 089 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -127.41 132.36 50.13 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.399 179.793 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.2 mt -115.93 133.24 62.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.977 0.417 . . . . 0.0 111.432 -179.491 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.517 ' OE2' HG23 ' A' ' 26' ' ' THR . 70.8 mm-40 -117.41 127.93 54.52 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.428 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 93.0 mt -105.53 118.36 52.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 119.941 -0.703 . . . . 0.0 112.231 -179.089 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.454 ' O ' ' N ' ' A' ' 56' ' ' GLN . 92.9 m-70 -116.39 144.01 44.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.692 -179.522 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 54' ' ' HIS . 95.3 mt-10 -40.28 -29.69 0.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.857 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.483 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 53.4 tt0 -63.87 -68.31 0.36 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.411 178.733 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.483 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 5.5 tp10 -160.09 -159.44 0.71 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.047 179.371 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.442 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -116.04 124.97 51.79 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.213 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.5 mt -116.69 132.43 66.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.243 0.545 . . . . 0.0 112.22 -178.329 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.1 tp -100.54 129.03 46.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.319 -179.971 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -110.22 135.65 50.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.704 -179.66 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.414 HD21 ' HA ' ' A' ' 68' ' ' PRO . 47.2 t-20 -95.95 105.22 17.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.729 -179.247 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -98.0 -5.74 33.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.815 179.086 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.23 101.39 3.98 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.702 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.6 p -87.37 -11.13 50.2 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.699 -179.877 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.49 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -101.1 -36.08 9.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.169 -179.272 . . . . . . . . 3 3 . 1 . 089 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 60.2 m-80 -142.78 97.72 5.87 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.664 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.414 ' HA ' HD21 ' A' ' 62' ' ' ASN . 32.6 Cg_exo -55.92 146.08 70.21 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 122.299 2.0 . . . . 0.0 113.633 -178.358 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.3 m -69.23 133.19 47.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.023 178.641 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -97.78 141.78 30.37 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.224 -0.59 . . . . 0.0 111.347 -179.287 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.3 p -133.46 133.58 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.801 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 50.64 32.96 7.43 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 119.921 -0.712 . . . . 0.0 109.219 -179.321 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.21 29.27 62.62 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.943 179.788 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.5 m -142.33 135.31 28.55 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.233 -0.587 . . . . 0.0 111.962 -179.727 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.431 ' H ' HG22 ' A' ' 75' ' ' VAL . 0.5 OUTLIER -72.84 139.23 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.471 179.277 . . . . . . . . 3 3 . 1 . 089 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.547 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 1.1 pt -107.07 111.81 37.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-O 121.719 0.771 . . . . 0.0 111.023 179.721 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -67.3 -31.98 72.64 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.993 179.303 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.615 ' N ' ' OE1' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -133.13 -179.19 1.0 Allowed Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.847 -179.322 . . . . . . . . 3 3 . 1 . 089 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.496 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 31.3 Cg_exo -60.77 146.72 96.92 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 122.973 2.449 . . . . 0.0 113.08 179.828 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.9 m -137.4 140.53 41.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.857 179.018 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 52.3 ttp180 -73.15 129.96 39.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.317 179.3 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.0 mt -81.92 140.82 33.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.374 0.607 . . . . 0.0 111.694 -179.227 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.66 152.23 51.62 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.94 179.599 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -56.85 121.11 9.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.991 0.424 . . . . 0.0 110.916 -179.477 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.61 -18.75 37.46 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 179.924 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -67.48 135.57 53.27 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.963 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.4 t -113.71 132.73 61.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.329 -177.671 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.9 mt -96.52 129.3 46.78 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 177.801 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 43.1 m -121.71 124.96 45.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.622 0.725 . . . . 0.0 112.133 -178.0 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.527 ' O ' ' C ' ' A' ' 91' ' ' ILE . 95.4 mt -113.07 128.84 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 114.708 -1.133 . . . . 0.0 107.987 178.404 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.527 ' C ' ' O ' ' A' ' 90' ' ' ILE . 61.3 mt -20.88 102.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -178.673 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.461 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 5.1 m-20 87.17 -23.72 0.13 Allowed 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 177.881 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 90' ' ' ILE . 17.3 mmm-85 -129.24 144.6 51.28 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.413 179.926 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.5 t -140.24 152.87 46.29 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.249 0.547 . . . . 0.0 110.814 179.979 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.573 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 51.7 m-85 -123.2 122.06 37.47 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.985 -179.768 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.439 ' O ' HD12 ' A' ' 7' ' ' LEU . 42.7 ttm180 -88.49 130.98 35.08 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 119.655 -0.818 . . . . 0.0 109.959 179.591 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.55 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 41.0 t80 -93.83 127.71 39.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.168 -179.941 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -123.94 122.29 37.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.689 179.56 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 . . . . . 0 C--N 1.328 -0.368 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.32 . . . . . . . . 0 0 . 1 . 089 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo . . . . . 0 N--CA 1.492 1.409 0 N-CA-C 114.27 0.834 . . . . 0.0 114.27 . . . . . . . . . 0 0 . 1 . 089 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.49 ' CG2' HG22 ' A' ' 66' ' ' THR . 55.4 t -65.38 142.07 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.301 179.529 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 3.5 t . . . . . 0 N--CA 1.464 0.227 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.378 179.892 . . . . . . . . 0 0 . 1 . 089 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo . . . . . 0 N--CA 1.499 1.817 0 N-CA-C 113.07 0.373 . . . . 0.0 113.07 . . . . . . . . . 0 0 . 1 . 089 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 30.4 m -68.62 -46.69 68.59 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.077 0.465 . . . . 0.0 110.031 178.73 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -59.52 -46.31 89.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.483 -178.607 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 84.7 mt -63.72 -42.65 97.88 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -178.907 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -65.56 -40.02 92.34 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.406 -0.517 . . . . 0.0 111.093 -178.931 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 63.7 ttm-85 -63.62 -44.12 94.86 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.441 -0.503 . . . . 0.0 109.849 179.649 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . . . . . . . . . 70.6 ttp85 -61.28 -42.53 98.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.757 -179.928 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -59.17 -37.95 78.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.019 -179.675 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 49.0 m -68.92 -41.66 77.84 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 177.454 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 70.2 tp60 -61.16 -38.38 86.26 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.515 179.954 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 38.6 t . . . . . 0 C--N 1.331 -0.227 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.119 179.232 . . . . . . . . 0 0 . 1 . 089 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.593 ' OE2' ' NH1' ' A' ' 12' ' ' ARG . 98.1 mt-10 . . . . . 0 N--CA 1.461 0.108 0 CA-C-O 120.487 0.184 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.573 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 81.1 mt -116.41 138.06 48.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.86 0.362 . . . . 0.0 110.18 179.972 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 43.9 t -127.07 136.44 60.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.363 179.739 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -97.72 118.02 33.33 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.249 0.547 . . . . 0.0 110.979 -178.748 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -64.7 -46.53 81.94 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.599 179.509 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . 0.413 ' CB ' ' CD ' ' B' ' 266' ' ' PRO . 1.1 mm-40 -98.73 177.74 1.5 Allowed Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.467 -179.111 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . 0.413 ' CD ' ' CB ' ' B' ' 265' ' ' GLN . 38.8 Cg_exo -60.75 143.36 99.38 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.544 2.162 . . . . 0.0 113.193 -178.895 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . 0.414 ' O ' ' CD ' ' A' ' 21' ' ' PRO . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.314 179.296 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.4 p . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.786 0.327 . . . . 0.0 110.503 . . . . . . . . . 0 0 . 1 . 090 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.668 ' NH1' ' HB2' ' A' ' 58' ' ' ALA . 93.6 mtt-85 -100.21 117.12 33.78 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.89 -179.092 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 32.3 ptt-85 -132.96 141.78 48.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.25 179.871 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.587 HD11 ' HB3' ' A' ' 95' ' ' PHE . 33.2 tp -118.24 136.18 53.82 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.899 -179.805 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.0 t -112.56 131.2 64.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 -179.784 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.469 ' CG2' HD12 ' B' ' 261' ' ' ILE . 12.8 m -91.08 113.62 25.93 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.548 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 84.6 mt -81.63 145.01 9.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.666 178.477 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -89.9 157.89 17.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.083 0.468 . . . . 0.0 111.066 178.949 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.648 ' NH1' HH11 ' B' ' 245' ' ' ARG . 90.4 mtm180 -58.61 -32.07 68.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.93 -179.454 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.5 m -75.64 -13.49 60.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.917 0.389 . . . . 0.0 110.381 179.675 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.06 35.54 5.51 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.363 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.4 t -121.66 133.17 68.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.849 0.357 . . . . 0.0 111.551 -179.12 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -72.43 122.62 21.54 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.767 179.415 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -114.63 -129.26 4.69 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.529 -179.354 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.49 156.18 54.42 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.301 2.001 . . . . 0.0 112.859 -178.969 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.482 ' CD2' ' C ' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -112.91 156.0 23.75 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.128 0.49 . . . . 0.0 110.762 -179.336 . . . . . . . . 3 3 . 1 . 090 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.443 ' CD2' HD11 ' A' ' 37' ' ' ILE . 39.0 t80 -126.19 104.39 25.72 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.517 -179.436 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -74.01 132.8 17.29 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 C-N-CA 121.07 1.18 . . . . 0.0 111.472 -179.363 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.443 HD22 ' SG ' ' A' ' 27' ' ' CYS . 73.9 mt -89.98 49.97 1.8 Allowed 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.196 -178.351 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 93.9 p -63.13 -19.65 64.65 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.893 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.717 HD11 ' CD ' ' B' ' 265' ' ' GLN . 87.0 mt -77.48 140.2 39.76 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.069 179.592 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 77.9 p -61.57 -21.38 64.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.593 -178.973 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.488 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 20.8 m -136.27 135.7 39.21 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.786 -0.365 . . . . 0.0 111.304 -179.752 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.443 ' SG ' HD22 ' A' ' 22' ' ' LEU . 5.0 t -124.84 116.65 22.59 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.46 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.1 tp -113.73 127.8 56.17 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.906 0.384 . . . . 0.0 110.87 -179.052 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.785 ' CE2' HD12 ' A' ' 37' ' ' ILE . 9.6 m-85 -106.33 132.5 52.3 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.666 179.773 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 163.24 -173.53 39.41 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 119.724 -1.227 . . . . 0.0 112.879 179.144 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.635 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 87.3 mtm-85 -77.44 -31.02 53.65 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-O 120.907 0.384 . . . . 0.0 110.167 179.51 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.498 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -52.81 148.1 13.53 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.365 -178.075 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.461 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 8.2 tp -67.36 -40.6 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.417 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.461 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 79.5 mm-40 -54.45 -24.93 22.21 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.221 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 61.6 m -51.85 120.65 5.52 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.122 -179.786 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.488 ' OD2' ' O ' ' A' ' 26' ' ' THR . 68.0 m-20 -57.56 -27.3 62.54 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 179.932 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.785 HD12 ' CE2' ' A' ' 29' ' ' PHE . 84.4 mt -129.35 121.26 53.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.92 177.367 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 66.7 ttp85 -112.13 138.23 49.08 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.857 -179.177 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.833 HD13 ' NH1' ' A' ' 93' ' ' ARG . 78.0 mt -117.66 132.53 67.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.975 0.417 . . . . 0.0 110.312 -179.54 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -72.45 32.49 0.06 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.478 -178.168 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.933 HD12 HH21 ' A' ' 93' ' ' ARG . 78.7 mt -118.64 128.1 26.16 Favored Pre-proline 0 CA--C 1.535 0.392 0 C-N-CA 120.249 -0.58 . . . . 0.0 111.95 -179.722 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.85 -11.35 25.67 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 122.46 2.107 . . . . 0.0 113.222 -179.85 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.576 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 2.5 m -87.63 -5.58 10.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.344 179.403 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.635 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 55.3 t -84.51 133.17 29.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 177.541 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.455 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 0.4 OUTLIER -61.34 161.37 9.26 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.127 0.489 . . . . 0.0 111.265 -179.086 . . . . . . . . 3 3 . 1 . 090 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -61.99 -44.66 96.26 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.704 -178.988 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.604 ' O ' ' N ' ' A' ' 49' ' ' CYS . 95.1 mt-30 -113.94 -15.03 12.4 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.17 179.904 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.455 ' H ' ' HB3' ' A' ' 45' ' ' SER . 24.1 t60 31.35 -76.51 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 179.394 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.604 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.26 135.87 48.57 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.28 0.562 . . . . 0.0 112.193 -178.194 . . . . . . . . 3 3 . 1 . 090 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -128.16 126.84 41.85 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.246 179.534 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.4 mt -113.19 136.3 49.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.753 -179.659 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -115.62 132.84 56.51 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.917 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 51.5 mm -102.51 119.67 51.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.171 -0.612 . . . . 0.0 111.445 -178.948 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.451 ' O ' ' N ' ' A' ' 56' ' ' GLN . 96.5 m-70 -121.44 134.07 55.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.14 179.398 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 54' ' ' HIS . 81.0 tt0 -40.3 -29.82 0.09 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -179.765 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.451 ' N ' ' O ' ' A' ' 54' ' ' HIS . 60.0 tt0 -67.58 -67.29 0.47 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.544 179.083 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.427 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 5.3 tp10 -154.72 -161.56 1.23 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.125 -179.185 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.668 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -124.96 132.17 53.32 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.143 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.5 mt -116.99 129.21 73.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.175 0.512 . . . . 0.0 112.339 -179.097 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.526 ' HB2' HD11 ' A' ' 82' ' ' LEU . 34.7 tp -96.92 128.53 43.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.184 179.121 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -111.82 136.04 51.63 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.497 -179.58 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.416 HD21 ' HA ' ' A' ' 68' ' ' PRO . 58.2 t-20 -94.63 106.86 18.85 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.441 -179.671 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -99.87 -10.72 21.42 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.342 179.292 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.448 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 2.7 t -71.65 100.78 2.38 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.297 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.7 m -87.66 -19.27 27.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.083 0.468 . . . . 0.0 110.405 -179.858 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.85 -43.0 10.92 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.105 179.809 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.637 ' OD1' HG23 ' B' ' 236' ' ' VAL . 27.0 m-80 -133.23 91.94 26.29 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.497 179.994 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.44 ' HB2' HG13 ' A' ' 75' ' ' VAL . 41.5 Cg_exo -54.8 143.5 70.48 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.15 1.9 . . . . 0.0 112.702 -178.986 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.4 m -74.84 141.47 44.24 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.812 -1.086 . . . . 0.0 111.005 -179.781 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -104.32 142.05 35.24 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.396 179.527 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.493 ' CG2' ' OD1' ' A' ' 86' ' ' ASP . 4.9 p -128.55 134.13 65.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.207 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 46.65 34.7 2.6 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 -179.426 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.05 26.53 68.51 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.916 179.802 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.454 ' N ' ' O ' ' A' ' 71' ' ' VAL . 14.5 m -138.43 135.41 35.21 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 117.164 0.482 . . . . 0.0 111.499 179.928 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.44 HG13 ' HB2' ' A' ' 68' ' ' PRO . 43.3 t -64.72 136.36 26.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.422 179.965 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 pt -116.64 83.87 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.588 179.036 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -66.28 -22.26 66.3 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.88 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.486 ' CD ' ' H ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -118.45 163.43 25.46 Favored Pre-proline 0 C--N 1.333 -0.146 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.841 178.994 . . . . . . . . 3 3 . 1 . 090 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -67.93 152.0 77.46 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.65 2.234 . . . . 0.0 112.685 -179.685 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.6 m -144.3 146.22 20.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.597 -179.719 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 91.5 mtm180 -73.48 131.3 41.63 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.78 179.179 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.526 HD11 ' HB2' ' A' ' 60' ' ' LEU . 95.4 mt -84.06 133.72 34.64 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.016 0.436 . . . . 0.0 110.939 -179.696 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -130.68 157.03 43.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.763 179.879 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -58.13 117.51 4.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.903 0.382 . . . . 0.0 110.526 -179.72 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.77 -11.46 20.88 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -179.449 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.493 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 61.7 t0 -79.18 120.11 23.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.984 0.421 . . . . 0.0 110.185 179.586 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.8 t -108.21 130.79 60.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.92 -178.985 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.2 mt -94.73 132.18 39.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.108 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.9 m -116.61 127.16 54.21 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 121.53 0.681 . . . . 0.0 111.477 -179.831 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.47 ' O ' ' C ' ' A' ' 91' ' ' ILE . 96.6 mt -122.86 125.15 71.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.001 179.044 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.577 HG22 ' N ' ' A' ' 92' ' ' ASP . 87.4 mt 33.09 -101.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.155 -179.455 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.577 ' N ' HG22 ' A' ' 91' ' ' ILE . 56.9 t0 -109.69 14.98 23.11 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 121.067 -0.253 . . . . 0.0 111.615 -179.123 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.933 HH21 HD12 ' A' ' 41' ' ' LEU . 8.9 mtm105 -127.87 143.02 51.12 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.806 -179.449 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.3 m -134.8 148.48 50.2 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.945 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.587 ' HB3' HD11 ' A' ' 7' ' ' LEU . 75.9 m-85 -126.94 126.97 44.12 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.884 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.481 ' O ' HD12 ' A' ' 7' ' ' LEU . 99.8 mtt180 -89.77 131.04 35.93 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.812 179.857 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.587 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 88.9 t80 -97.99 129.2 44.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.938 0.399 . . . . 0.0 110.127 179.569 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -133.14 123.91 26.54 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.222 -179.514 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 54.3 t30 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.818 -179.682 . . . . . . . . 0 0 . 1 . 090 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo . . . . . 0 N--CA 1.486 1.072 0 N-CA-C 110.958 -0.439 . . . . 0.0 110.958 . . . . . . . . . 0 0 . 1 . 090 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.637 HG23 ' OD1' ' A' ' 67' ' ' ASN . 4.1 p -118.14 136.48 55.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 120.976 0.417 . . . . 0.0 111.026 -179.277 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 11.9 t . . . . . 0 CA--C 1.52 -0.197 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.377 -179.939 . . . . . . . . 0 0 . 1 . 090 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo . . . . . 0 N--CA 1.499 1.812 0 N-CA-C 112.881 0.3 . . . . 0.0 112.881 . . . . . . . . . 0 0 . 1 . 090 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 36.2 m -73.58 -44.76 56.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.229 0.538 . . . . 0.0 109.837 178.224 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.576 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 47.7 t80 -57.28 -46.31 83.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.448 -179.413 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 97.9 mt -63.61 -41.2 98.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.919 0.39 . . . . 0.0 110.06 -179.871 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -62.75 -45.05 94.51 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.099 179.736 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . 0.502 ' O ' ' OG ' ' B' ' 247' ' ' SER . 73.6 ttt180 -65.03 -41.85 94.9 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.045 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.648 HH11 ' NH1' ' A' ' 12' ' ' ARG . 9.0 tpp180 -58.91 -43.95 91.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.543 -179.122 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -64.93 -42.05 95.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.122 0.487 . . . . 0.0 109.874 178.796 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . 0.502 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 78.3 p -62.05 -46.32 89.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.037 179.774 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -62.61 -39.02 92.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.278 -179.575 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . 0.452 HG23 ' O ' ' B' ' 245' ' ' ARG . 42.6 t . . . . . 0 C--N 1.329 -0.32 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.303 -179.946 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.674 ' OE1' HD21 ' A' ' 41' ' ' LEU . 95.7 mt-10 . . . . . 0 C--O 1.228 -0.042 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 . . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.469 HD12 ' CG2' ' A' ' 9' ' ' THR . 55.0 mt -111.12 139.91 32.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.554 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 58.9 t -128.25 135.71 61.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.129 179.765 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -97.41 120.8 38.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.252 0.549 . . . . 0.0 111.9 -178.178 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -63.88 -46.63 84.08 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.231 179.267 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . 0.717 ' CD ' HD11 ' A' ' 24' ' ' LEU . 2.7 mt-30 -94.01 161.78 28.77 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.903 -179.674 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.93 146.36 58.88 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 122.854 2.369 . . . . 0.0 112.768 -179.64 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 45.3 pt . . . . . 0 C--N 1.328 -0.342 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.679 . . . . . . . . 0 0 . 1 . 091 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 68.2 p . . . . . 0 CA--C 1.516 -0.34 0 CA-C-O 121.017 0.437 . . . . 0.0 110.469 . . . . . . . . . 0 0 . 1 . 091 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.8 mtt85 -93.08 129.19 39.13 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.37 -0.532 . . . . 0.0 109.589 -179.743 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -133.99 145.44 49.5 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 120.641 -0.423 . . . . 0.0 111.363 -179.476 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.402 HD11 HD11 ' A' ' 22' ' ' LEU . 66.0 mt -115.34 136.31 53.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.316 179.635 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.818 HG11 ' NH2' ' A' ' 96' ' ' ARG . 27.4 t -109.71 127.06 66.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.715 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.0 m -77.26 142.04 39.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.356 -178.493 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.631 HD12 ' OG ' ' A' ' 94' ' ' SER . 97.5 mt -110.43 134.15 53.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.871 177.261 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -88.51 158.77 18.22 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.06 0.457 . . . . 0.0 110.815 179.99 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.433 ' NH2' ' HB3' ' B' ' 248' ' ' GLN . 82.1 mtp180 -57.25 -32.82 66.95 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.901 -178.824 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 65.2 m -77.31 -6.78 54.5 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.201 178.767 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.07 31.63 10.7 Favored Glycine 0 CA--C 1.519 0.302 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 -179.595 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.1 t -113.5 133.04 60.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.987 0.423 . . . . 0.0 111.451 -178.924 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.658 ' CG ' HH22 ' A' ' 96' ' ' ARG . 97.5 m-20 -74.03 137.03 43.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.874 179.651 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.47 -122.91 2.49 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 120.459 -0.877 . . . . 0.0 113.029 -178.633 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -71.78 149.93 55.12 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.463 2.109 . . . . 0.0 113.235 -177.965 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -111.29 127.39 55.61 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.688 179.962 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.743 ' CD2' HD11 ' A' ' 37' ' ' ILE . 55.9 t80 -99.29 105.55 33.49 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.854 179.903 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -75.82 135.29 17.45 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 121.112 1.208 . . . . 0.0 111.255 -179.516 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.402 HD11 HD11 ' A' ' 7' ' ' LEU . 96.5 mt -85.94 58.94 5.33 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.484 -178.528 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 90.8 p -64.17 -34.5 78.21 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.003 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 66.2 mt -75.77 144.94 41.13 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.53 179.423 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.8 m -68.63 -17.09 64.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.873 -178.624 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.483 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 58.1 m -133.22 134.22 43.73 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.666 -0.413 . . . . 0.0 112.024 -179.198 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.5 t -126.23 116.2 20.91 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.64 179.14 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.492 HD21 ' OE1' ' A' ' 47' ' ' GLN . 63.2 tp -113.2 128.9 56.62 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 121.006 -0.277 . . . . 0.0 111.087 -179.486 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.445 ' CE2' HG13 ' A' ' 37' ' ' ILE . 19.3 m-85 -107.1 129.04 54.88 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.783 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 172.46 -175.44 45.6 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.455 179.96 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.623 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 83.8 mtm-85 -80.28 -26.55 38.88 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.98 0.419 . . . . 0.0 110.33 179.363 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -55.44 144.45 33.29 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.132 -178.041 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.498 HG23 ' N ' ' A' ' 34' ' ' GLU . 11.1 tp -64.91 -41.77 93.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.17 0.509 . . . . 0.0 109.634 179.334 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.498 ' N ' HG23 ' A' ' 33' ' ' ILE . 17.3 pt-20 -57.19 -16.74 8.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.331 -179.874 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 45.8 m -66.21 134.01 51.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.204 0.526 . . . . 0.0 111.096 -178.84 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.483 ' OD2' ' O ' ' A' ' 26' ' ' THR . 60.9 m-20 -63.17 -36.34 83.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.316 -179.461 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.743 HD11 ' CD2' ' A' ' 20' ' ' PHE . 49.1 mm -121.14 117.4 52.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.483 177.693 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.43 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 81.4 mtp180 -107.2 134.7 49.91 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 120.374 -0.531 . . . . 0.0 111.018 -179.259 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 85.3 mt -120.92 131.34 73.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 120.126 -0.63 . . . . 0.0 109.711 178.916 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -77.84 24.93 0.21 Allowed 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -177.492 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 32.8 mt -94.23 132.61 28.84 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.973 179.433 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.57 -12.26 29.04 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.121 1.881 . . . . 0.0 113.584 -179.239 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.0 m -97.41 9.53 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 120.034 -0.666 . . . . 0.0 110.787 179.309 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.623 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 33.8 t -94.84 131.79 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 177.918 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.436 ' HB2' ' H ' ' A' ' 48' ' ' HIS . 5.9 m -76.1 173.49 11.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.579 0.704 . . . . 0.0 111.865 -178.755 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -64.75 -38.62 91.6 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.477 -179.862 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.649 ' O ' ' N ' ' A' ' 49' ' ' CYS . 93.8 mm-40 -113.34 -23.52 9.84 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.993 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.436 ' H ' ' HB2' ' A' ' 45' ' ' SER . 12.7 t60 34.26 -77.42 0.0 OUTLIER 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.63 179.978 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.649 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.72 135.74 47.08 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.981 0.42 . . . . 0.0 111.62 -179.385 . . . . . . . . 3 3 . 1 . 091 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -128.82 127.32 41.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.506 179.911 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 85.7 mt -111.6 132.85 59.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.599 -179.451 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -115.59 125.66 53.22 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.434 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.7 mt -107.3 115.13 47.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.029 -179.497 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.466 ' C ' ' N ' ' A' ' 56' ' ' GLN . 94.1 m-70 -112.45 144.75 41.37 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.771 -179.711 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 54' ' ' HIS . 94.9 mt-10 -41.62 -27.52 0.1 Allowed 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.152 -179.908 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.466 ' N ' ' C ' ' A' ' 54' ' ' HIS . 88.1 mt-30 -65.0 -68.89 0.33 Allowed 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.157 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -159.34 -164.9 1.46 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.954 179.489 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -108.97 130.75 55.47 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.608 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.4 mt -121.15 130.53 74.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -177.961 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.405 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 22.7 tp -101.15 126.93 47.9 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.66 179.514 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -109.77 135.71 50.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.697 178.726 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.64 HD21 ' CA ' ' A' ' 68' ' ' PRO . 56.2 t-20 -98.14 103.71 15.68 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.76 -179.159 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -98.86 -7.24 27.59 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -179.693 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 26.2 t -76.6 99.58 5.05 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.998 179.954 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.7 p -74.95 -38.46 61.72 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.993 0.425 . . . . 0.0 109.902 178.999 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.0 p -67.18 -39.35 86.39 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.538 179.859 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.454 ' O ' ' OG ' ' A' ' 64' ' ' SER . 46.3 m-20 -147.47 97.51 4.04 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.44 -179.277 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.64 ' CA ' HD21 ' A' ' 62' ' ' ASN . 37.3 Cg_exo -56.55 148.11 65.66 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 121.988 1.792 . . . . 0.0 112.574 179.544 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.545 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 8.3 m -74.36 137.43 42.78 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.36 179.718 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -99.03 140.12 33.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.427 179.827 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.517 ' HB ' HD11 ' A' ' 76' ' ' ILE . 25.2 t -130.49 134.69 61.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.65 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 53.12 35.94 21.06 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 120.127 -0.629 . . . . 0.0 109.399 -179.716 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 66.56 30.15 75.96 Favored Glycine 0 CA--C 1.523 0.557 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.204 179.484 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 83.4 p -138.44 125.86 21.84 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.625 -179.141 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.3 p -63.01 140.78 19.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.104 0.478 . . . . 0.0 111.57 -179.657 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.549 ' CG2' ' O ' ' A' ' 78' ' ' GLU . 97.1 mt -116.17 124.27 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.085 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.044 -179.883 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 30.6 p-10 -96.76 -24.58 15.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.974 179.198 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.549 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 2.5 mt-10 -129.54 169.91 12.12 Favored Pre-proline 0 N--CA 1.468 0.451 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.092 -179.055 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -56.8 143.25 91.3 Favored 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 121.994 1.796 . . . . 0.0 112.581 -179.95 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 78.0 t -136.4 138.22 47.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.756 179.975 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 85.4 mtt85 -74.17 134.68 42.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.629 179.199 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.1 mt -86.02 136.61 33.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.388 0.613 . . . . 0.0 111.393 -179.754 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -126.95 151.46 48.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.967 179.764 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.429 ' ND1' ' N ' ' A' ' 99' ' ' ASN . 7.8 t60 -56.58 120.14 7.27 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.963 0.411 . . . . 0.0 111.296 -179.447 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.7 -17.73 30.17 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 179.465 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -71.06 134.54 47.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.943 0.401 . . . . 0.0 110.47 -179.85 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.8 p -106.59 135.93 43.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.825 -178.859 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.9 mt -105.95 131.44 55.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 179.0 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 99.9 m -122.51 127.75 49.93 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -178.314 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.519 ' N ' ' O ' ' A' ' 93' ' ' ARG . 96.9 mt -112.67 132.27 61.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 177.428 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.579 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 2.5 mp -37.74 101.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.777 -178.766 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.579 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 37.5 t0 101.49 -30.94 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.732 0 O-C-N 124.225 0.953 . . . . 0.0 112.496 179.01 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 90' ' ' ILE . 36.0 mmt180 -128.99 143.18 50.79 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.951 -178.647 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.631 ' OG ' HD12 ' A' ' 10' ' ' ILE . 17.1 p -138.26 151.25 47.45 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.474 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -130.76 125.05 32.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.736 -179.351 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.818 ' NH2' HG11 ' A' ' 8' ' ' VAL . 92.8 mtm-85 -84.35 138.39 32.91 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.113 178.869 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -96.2 116.59 29.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.488 -179.392 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -120.64 122.59 40.83 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.777 0.322 . . . . 0.0 110.362 179.743 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.429 ' N ' ' ND1' ' A' ' 84' ' ' HIS . 21.5 t-20 . . . . . 0 C--N 1.327 -0.38 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.372 179.897 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo . . . . . 0 N--CA 1.491 1.334 0 CA-C-O 121.113 0.38 . . . . 0.0 112.803 . . . . . . . . . 0 0 . 1 . 091 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.423 HG13 ' O ' ' B' ' 236' ' ' VAL . 8.9 p -80.44 124.64 38.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.277 179.969 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.608 -179.354 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo . . . . . 0 N--CA 1.489 1.26 0 N-CA-C 111.395 -0.271 . . . . 0.0 111.395 . . . . . . . . . 0 0 . 1 . 091 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 73.8 m -71.35 -45.53 62.71 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.194 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -57.89 -46.72 84.49 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.336 179.588 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.429 HD21 HG23 ' A' ' 91' ' ' ILE . 90.0 mt -64.58 -40.07 94.88 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.667 179.026 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -61.41 -40.81 95.77 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 120.778 0.323 . . . . 0.0 110.686 -179.979 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -60.04 -42.07 93.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.569 179.466 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.538 ' O ' HG23 ' B' ' 249' ' ' VAL . 67.9 ttp85 -59.92 -42.97 95.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.538 179.878 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -62.83 -41.66 99.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.211 -179.225 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 59.5 p -69.53 -41.55 75.83 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.879 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . 0.433 ' HB3' ' NH2' ' A' ' 12' ' ' ARG . 67.2 tp60 -60.95 -38.22 85.12 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.424 -179.937 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . 0.538 HG23 ' O ' ' B' ' 245' ' ' ARG . 39.3 t . . . . . 0 C--N 1.331 -0.207 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.547 179.543 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.456 ' HB2' HH21 ' A' ' 93' ' ' ARG . 77.2 mt-10 . . . . . 0 C--O 1.226 -0.141 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 . . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.479 HD11 ' HD2' ' A' ' 93' ' ' ARG . 83.2 mt -107.59 132.07 56.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.949 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 54.9 t -124.78 132.37 71.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.082 -179.947 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -94.3 118.35 31.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.052 -178.636 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -67.13 -44.8 78.93 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.606 179.276 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . 0.508 ' OE1' ' O ' ' B' ' 266' ' ' PRO . 0.0 OUTLIER -87.42 162.12 43.64 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.999 -179.621 . . . . . . . . 3 3 . 1 . 091 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . 0.508 ' O ' ' OE1' ' B' ' 265' ' ' GLN . 36.6 Cg_endo -62.15 144.07 95.32 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 121.974 1.783 . . . . 0.0 111.91 -179.85 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . 0.488 HG23 ' O ' ' B' ' 267' ' ' ILE . 11.8 tt . . . . . 0 C--N 1.322 -0.589 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.623 -178.925 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.6 m . . . . . 0 N--CA 1.463 0.204 0 N-CA-C 111.426 0.158 . . . . 0.0 111.426 . . . . . . . . . 0 0 . 1 . 092 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.612 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 95.3 mtt-85 -90.97 122.98 34.1 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.457 -179.665 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -133.08 140.21 47.55 Favored 'General case' 0 CA--C 1.522 -0.105 0 CA-C-O 121.246 0.546 . . . . 0.0 112.134 -179.65 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.567 HD11 ' HB3' ' A' ' 95' ' ' PHE . 37.3 tp -114.57 135.81 53.72 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.347 -179.883 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.8 t -111.66 130.1 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 120.683 0.278 . . . . 0.0 110.487 -179.735 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.446 HG23 ' CD1' ' B' ' 261' ' ' ILE . 1.8 m -88.93 118.47 28.67 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -177.837 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.562 HD12 ' OG ' ' A' ' 94' ' ' SER . 97.0 mt -83.32 139.07 18.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.37 178.935 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -88.97 160.46 17.12 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.981 179.275 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.504 ' NE ' ' NH2' ' B' ' 245' ' ' ARG . 84.4 mtp180 -56.3 -30.97 63.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.269 -179.27 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 84.3 p -79.22 -7.27 58.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.424 -179.803 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.61 28.08 22.81 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 -179.817 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.7 t -112.01 133.03 59.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.829 0.347 . . . . 0.0 110.629 -179.625 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -77.02 141.24 40.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.732 179.317 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -133.3 -114.91 1.56 Allowed Glycine 0 CA--C 1.536 1.396 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.64 -179.319 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -74.45 149.56 39.68 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.406 2.071 . . . . 0.0 113.324 -179.171 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -112.52 148.88 33.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.986 179.941 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.575 ' CD2' HD11 ' A' ' 37' ' ' ILE . 22.0 t80 -114.58 105.4 53.62 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.714 179.983 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.17 122.41 8.37 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 C-N-CA 121.123 1.215 . . . . 0.0 110.895 -179.678 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 74.2 mt -78.51 46.11 0.62 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.256 -0.578 . . . . 0.0 110.442 -179.2 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.9 p -59.53 -30.25 68.46 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.333 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.645 HD11 ' HG2' ' B' ' 265' ' ' GLN . 73.3 mt -72.86 142.91 47.96 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.996 179.532 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.5 m -62.94 -22.97 67.15 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.255 -179.382 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 86.3 m -135.43 137.89 42.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.504 -179.606 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.67 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 3.5 t -132.57 123.83 27.23 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.825 0.345 . . . . 0.0 110.266 178.227 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.442 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 41.0 tp -112.72 130.3 56.11 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.957 -179.228 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.724 ' CE2' HD12 ' A' ' 37' ' ' ILE . 6.9 m-85 -108.88 140.03 42.91 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.768 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 167.63 -169.05 40.98 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 118.84 -1.647 . . . . 0.0 113.436 179.203 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.451 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 36.9 ttp-105 -90.77 -28.47 18.23 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 114.53 -0.835 . . . . 0.0 110.537 -179.966 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.08 152.35 49.03 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.517 -179.344 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.635 ' O ' ' NE ' ' A' ' 38' ' ' ARG . 7.0 tp -66.42 -42.28 90.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.449 0.642 . . . . 0.0 110.273 179.506 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.542 ' N ' HG23 ' A' ' 33' ' ' ILE . 79.9 tt0 -54.62 -13.87 1.13 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.874 -178.925 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 83.4 m -67.58 133.32 49.21 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.497 179.801 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.442 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 51.3 m-20 -58.69 -32.34 69.05 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.473 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.724 HD12 ' CE2' ' A' ' 29' ' ' PHE . 92.4 mt -125.33 120.61 58.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 177.228 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.635 ' NE ' ' O ' ' A' ' 33' ' ' ILE . 71.0 mtt85 -107.01 135.84 47.88 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.064 -177.34 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.433 HG22 ' H ' ' A' ' 41' ' ' LEU . 89.4 mt -118.12 133.55 64.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.069 0.461 . . . . 0.0 110.593 179.019 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -75.16 23.42 0.1 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.966 -178.864 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.62 HD21 ' NH1' ' B' ' 245' ' ' ARG . 21.0 mt -92.23 123.77 61.58 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.248 178.831 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -71.99 -8.27 22.61 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 121.821 1.681 . . . . 0.0 112.713 -179.503 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.604 HG12 ' HB2' ' B' ' 235' ' ' PRO . 23.8 m -101.14 7.83 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.58 -179.736 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.451 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 21.0 t -91.12 137.19 22.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 120.394 -0.522 . . . . 0.0 109.838 179.674 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.43 ' O ' HG12 ' A' ' 44' ' ' VAL . 0.4 OUTLIER -65.66 164.78 13.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.167 0.508 . . . . 0.0 111.192 -179.451 . . . . . . . . 3 3 . 1 . 092 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -62.54 -44.53 96.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.221 -178.822 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.644 ' O ' ' N ' ' A' ' 49' ' ' CYS . 83.4 mt-30 -113.8 -20.59 11.06 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 123.526 0.516 . . . . 0.0 110.376 179.092 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.513 ' O ' ' OG ' ' A' ' 64' ' ' SER . 24.5 t60 35.52 -73.27 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 179.846 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.644 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -129.91 134.18 47.32 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -178.381 . . . . . . . . 3 3 . 1 . 092 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -125.74 129.95 50.51 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.41 178.67 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.2 mt -113.9 134.66 56.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.015 -179.421 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -119.08 124.93 48.1 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.917 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 94.2 mt -104.27 114.13 43.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.483 0.659 . . . . 0.0 111.447 -179.326 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.44 ' O ' ' C ' ' A' ' 55' ' ' GLU . 94.8 m-70 -114.26 142.23 46.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.638 -1.165 . . . . 0.0 109.93 -179.681 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 54' ' ' HIS . 97.5 mt-10 -40.11 -31.14 0.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -179.703 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.433 ' N ' ' O ' ' A' ' 54' ' ' HIS . 89.1 mt-30 -62.35 -67.98 0.37 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.491 178.604 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.423 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 4.8 tp10 -159.21 -162.98 1.13 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.902 179.742 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.543 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -114.19 127.24 55.8 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.009 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.6 mt -116.44 130.9 70.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.21 0.529 . . . . 0.0 112.369 -177.952 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 25.6 tp -98.62 130.29 45.15 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.464 179.442 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -116.58 137.52 52.12 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.548 -179.437 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.67 ' ND2' ' H ' ' A' ' 69' ' ' THR . 16.1 t-20 -98.88 106.7 19.0 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.935 179.496 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -98.14 -7.24 29.88 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.001 178.453 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.513 ' OG ' ' O ' ' A' ' 48' ' ' HIS . 0.7 OUTLIER -70.29 100.93 1.8 Allowed 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.698 179.456 . . . . . . . . 3 3 . 1 . 092 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.3 m -86.05 -8.7 57.73 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.031 0.443 . . . . 0.0 110.268 179.917 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.764 HG22 HG12 ' B' ' 236' ' ' VAL . 0.2 OUTLIER -99.67 -39.52 8.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.226 179.817 . . . . . . . . 3 3 . 1 . 092 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 67.3 m-20 -142.63 93.79 6.82 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.111 179.569 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.49 ' HA ' HD21 ' A' ' 62' ' ' ASN . 42.4 Cg_exo -55.07 148.59 47.7 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 122.384 2.056 . . . . 0.0 112.13 -179.782 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.67 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 33.5 m -73.4 149.64 42.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.301 -179.761 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -114.11 140.56 48.4 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.405 -179.911 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.414 ' O ' ' N ' ' A' ' 74' ' ' SER . 4.2 p -128.78 134.8 63.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.671 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 48.8 30.49 2.68 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.086 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.09 27.9 67.55 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.569 -179.984 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.414 ' N ' ' O ' ' A' ' 71' ' ' VAL . 71.5 m -134.81 134.91 41.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.674 0.273 . . . . 0.0 110.434 179.935 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.5 p -68.51 145.19 13.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -178.748 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.65 HD11 ' HB ' ' A' ' 69' ' ' THR . 3.1 pt -122.36 86.08 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.839 179.801 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 46.4 p-10 -67.21 -21.89 65.74 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.846 0.355 . . . . 0.0 110.406 179.68 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -122.5 170.28 8.24 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.446 179.918 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -62.96 144.53 93.29 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 122.298 1.999 . . . . 0.0 112.21 -179.888 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.9 p -139.28 139.68 39.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.858 -179.831 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -74.71 132.88 42.01 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.791 -0.363 . . . . 0.0 110.449 179.452 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 97.7 mt -83.0 138.48 33.74 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.643 179.925 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -128.47 149.42 50.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.36 179.697 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -54.15 119.71 5.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.057 0.456 . . . . 0.0 111.105 -179.426 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.97 -15.73 36.73 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 179.208 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -70.15 137.56 51.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.836 0.35 . . . . 0.0 110.616 179.821 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.465 HG22 ' HG2' ' A' ' 96' ' ' ARG . 59.0 t -111.08 132.73 58.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.14 -178.728 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.3 mt -100.52 132.22 46.58 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.829 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.2 m -120.7 121.71 38.86 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 119.862 -0.735 . . . . 0.0 112.027 -179.136 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.535 ' N ' ' O ' ' A' ' 93' ' ' ARG . 97.4 mt -108.12 119.63 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 177.74 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.517 HG22 ' N ' ' A' ' 92' ' ' ASP . 91.7 mt 35.16 -96.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.486 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.633 ' OD2' ' NE ' ' B' ' 245' ' ' ARG . 31.5 p-10 -110.1 10.82 23.95 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -178.323 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.535 ' O ' ' N ' ' A' ' 90' ' ' ILE . 80.1 mtt-85 -130.04 145.56 51.67 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.624 -179.785 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.562 ' OG ' HD12 ' A' ' 10' ' ' ILE . 54.3 p -139.72 151.94 46.26 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.389 0.614 . . . . 0.0 110.133 179.392 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.567 ' HB3' HD11 ' A' ' 7' ' ' LEU . 54.8 m-85 -125.38 126.2 44.63 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.953 -179.924 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.465 ' HG2' HG22 ' A' ' 87' ' ' VAL . 99.7 mtt180 -85.57 131.94 34.27 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.971 -179.351 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.612 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 88.4 t80 -100.53 125.54 46.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.916 -179.659 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -145.1 132.79 20.99 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.066 0.46 . . . . 0.0 111.912 -179.961 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.714 179.57 . . . . . . . . 0 0 . 1 . 092 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . 0.604 ' HB2' HG12 ' A' ' 43' ' ' VAL . 31.5 Cg_exo . . . . . 0 N--CA 1.497 1.703 0 CA-C-O 120.837 0.265 . . . . 0.0 112.357 . . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.764 HG12 HG22 ' A' ' 66' ' ' THR . 12.0 m -101.78 130.21 51.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.836 179.615 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.7 t . . . . . 0 CA--C 1.52 -0.19 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.198 -179.705 . . . . . . . . 0 0 . 1 . 092 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo . . . . . 0 N--CA 1.495 1.575 0 CA-C-O 120.565 0.152 . . . . 0.0 112.243 . . . . . . . . . 0 0 . 1 . 092 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 19.8 m -70.33 -43.14 70.87 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.096 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.496 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 76.8 t80 -57.94 -49.06 78.08 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.801 179.825 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 97.1 mt -63.66 -41.76 98.17 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.569 -179.193 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -65.12 -40.91 95.15 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -178.829 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -61.59 -43.77 98.24 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.183 -179.59 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.633 ' NE ' ' OD2' ' A' ' 92' ' ' ASP . 76.3 mtp85 -65.14 -40.49 94.49 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.765 -179.6 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -61.6 -39.55 91.65 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.008 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 14.4 t -65.14 -43.86 90.53 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.416 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . 0.4 ' OE1' ' NH2' ' A' ' 12' ' ' ARG . 55.9 tt0 -61.07 -37.83 84.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.254 179.689 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . 0.572 HG23 ' O ' ' B' ' 245' ' ' ARG . 70.5 t . . . . . 0 N--CA 1.453 -0.287 0 C-N-CA 120.526 -0.47 . . . . 0.0 109.833 178.768 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.429 ' HB2' ' NH2' ' A' ' 93' ' ' ARG . 98.3 mt-10 . . . . . 0 CA--C 1.529 0.147 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 . . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.446 ' CD1' HG23 ' A' ' 9' ' ' THR . 69.2 mt -108.91 134.69 50.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.848 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 59.1 t -128.88 134.79 63.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.918 0.39 . . . . 0.0 110.621 -179.684 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -97.21 122.08 39.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.661 -178.898 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . 0.481 ' HG3' HH22 ' A' ' 38' ' ' ARG . 86.9 tttt -66.81 -44.51 81.01 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.293 179.424 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . 0.645 ' HG2' HD11 ' A' ' 24' ' ' LEU . 9.7 mp0 -100.87 160.31 27.1 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.482 -177.935 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -62.3 151.38 82.81 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 123.423 2.748 . . . . 0.0 112.803 -179.336 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 40.8 pt . . . . . 0 C--N 1.33 -0.261 0 CA-C-O 121.844 0.83 . . . . 0.0 112.431 -178.722 . . . . . . . . 0 0 . 1 . 093 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.7 m . . . . . 0 N--CA 1.463 0.192 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 . . . . . . . . . 0 0 . 1 . 093 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.603 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 96.3 mtt-85 -88.12 118.01 27.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.916 0.388 . . . . 0.0 110.743 -178.844 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.413 HH21 ' CE1' ' A' ' 19' ' ' HIS . 75.6 ttt180 -125.99 126.42 44.28 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.288 -179.499 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.627 HD12 ' O ' ' A' ' 96' ' ' ARG . 22.5 tp -109.13 130.98 55.49 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.467 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 76.5 t -106.82 127.46 62.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.355 179.97 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.5 m -80.23 144.75 32.66 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.375 0.607 . . . . 0.0 111.674 -179.047 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.64 HD12 ' OG ' ' A' ' 94' ' ' SER . 98.1 mt -116.1 138.41 46.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.235 178.451 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -91.26 156.36 17.87 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.361 179.013 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.437 ' NH2' ' OE2' ' B' ' 260' ' ' GLU . 89.9 mtm180 -60.02 -28.75 67.99 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.615 -179.852 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 84.0 p -74.3 -14.47 60.9 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.524 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.34 35.42 5.73 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 -179.699 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 49.6 t -120.55 130.95 73.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.747 0.308 . . . . 0.0 111.049 -179.797 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -77.08 138.28 39.44 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.632 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.17 -118.24 2.06 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.936 -179.301 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -69.85 148.07 63.71 Favored 'Trans proline' 0 N--CA 1.501 1.938 0 C-N-CA 122.317 2.011 . . . . 0.0 113.685 -178.468 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.413 ' CE1' HH21 ' A' ' 6' ' ' ARG . 0.9 OUTLIER -111.95 130.27 55.9 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.376 -179.863 . . . . . . . . 3 3 . 1 . 093 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.403 ' CD2' HD11 ' A' ' 37' ' ' ILE . 64.9 t80 -107.02 105.43 55.53 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.15 -179.108 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.05 135.17 22.59 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 120.717 0.944 . . . . 0.0 111.306 -179.9 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 74.9 mt -87.13 48.14 1.61 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.754 -178.899 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.9 m -60.46 -29.91 69.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.91 178.829 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 73.1 mt -71.12 143.42 50.6 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.372 -179.939 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.3 m -58.94 -25.99 64.0 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.918 -179.143 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 78.0 m -138.77 141.17 38.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.182 0.515 . . . . 0.0 111.431 -179.862 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.8 t -130.42 121.85 26.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.694 178.683 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 41.2 tp -117.12 126.61 53.09 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.63 -179.652 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.65 ' CE2' HD12 ' A' ' 37' ' ' ILE . 4.3 m-85 -101.92 125.78 48.68 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.441 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 172.12 178.39 42.33 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 119.75 -1.214 . . . . 0.0 113.016 179.624 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 45.8 mtm180 -73.33 -32.77 64.75 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.771 0.32 . . . . 0.0 111.308 179.01 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -48.9 147.02 5.75 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 -178.967 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.456 ' HA ' HH11 ' A' ' 38' ' ' ARG . 11.0 tp -67.02 -40.66 86.01 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 CA-C-O 121.249 0.547 . . . . 0.0 109.929 179.714 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.446 ' N ' HG23 ' A' ' 33' ' ' ILE . 50.1 tp10 -57.68 -19.83 29.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.387 -179.951 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 76.8 m -59.72 129.95 44.42 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.821 -179.399 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.41 ' O ' ' CB ' ' B' ' 264' ' ' LYS . 66.0 m-20 -61.82 -35.03 77.02 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 -179.589 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.65 HD12 ' CE2' ' A' ' 29' ' ' PHE . 93.6 mt -123.5 118.32 54.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 177.395 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.456 HH11 ' HA ' ' A' ' 33' ' ' ILE . 21.8 mtp85 -104.57 136.22 44.53 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.447 -178.375 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.425 ' C ' ' H ' ' A' ' 41' ' ' LEU . 94.0 mt -117.54 129.85 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 121.036 0.446 . . . . 0.0 110.595 -179.955 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -73.36 28.54 0.07 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.808 -178.42 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.627 ' CD1' ' HE ' ' A' ' 93' ' ' ARG . 49.0 mt -103.14 127.89 28.82 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 120.296 -0.561 . . . . 0.0 110.803 -179.985 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.9 -7.47 20.77 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.129 1.886 . . . . 0.0 112.673 -179.369 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.8 m -98.7 4.73 9.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 120.776 -0.369 . . . . 0.0 111.06 179.941 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.1 t -88.4 134.8 27.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.158 178.434 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.2 m -70.54 168.58 15.99 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.447 0.641 . . . . 0.0 111.93 -179.264 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -62.9 -43.67 98.17 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.285 -178.98 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.623 ' O ' ' N ' ' A' ' 49' ' ' CYS . 97.2 mt-30 -114.24 -25.03 8.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.575 179.472 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.6 t60 37.0 -77.21 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.076 -0.966 . . . . 0.0 113.023 179.064 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.623 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -127.39 132.86 50.07 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.228 0.537 . . . . 0.0 111.775 -178.279 . . . . . . . . 3 3 . 1 . 093 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -128.86 132.47 47.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.07 -179.578 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.1 mt -117.12 132.31 67.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.488 179.488 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -114.73 127.85 55.98 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.79 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.5 mm -100.27 111.81 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-O 121.105 0.479 . . . . 0.0 110.736 -179.22 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.448 ' O ' ' C ' ' A' ' 55' ' ' GLU . 88.6 m-70 -110.64 132.91 53.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.17 179.434 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 54' ' ' HIS . 76.9 tt0 -40.82 -32.17 0.21 Allowed 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.394 -179.945 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.409 ' N ' ' O ' ' A' ' 54' ' ' HIS . 98.4 mm-40 -69.16 -68.48 0.4 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.599 179.171 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -146.13 -178.59 6.21 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.706 0.765 . . . . 0.0 111.939 -178.354 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.55 ' HB2' ' NH2' ' A' ' 5' ' ' ARG . . . -116.16 122.0 43.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.788 178.206 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 94.0 mt -118.85 133.92 64.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.161 0.505 . . . . 0.0 111.825 -178.638 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 22.9 tp -98.25 131.53 44.51 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.718 -179.896 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -114.22 139.49 49.34 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 121.053 0.454 . . . . 0.0 111.448 -178.955 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 59.1 t-20 -98.31 106.12 18.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.822 -179.485 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -98.63 -12.23 21.3 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.728 179.379 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.0 t -70.69 103.43 2.55 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.533 179.892 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.4 p -88.97 -18.73 26.83 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.432 179.695 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.596 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -86.68 -44.27 11.96 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.285 . . . . . . . . 3 3 . 1 . 093 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -137.13 97.9 10.6 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.803 179.425 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -57.09 145.31 86.82 Favored 'Trans proline' 0 N--CA 1.499 1.82 0 C-N-CA 122.173 1.916 . . . . 0.0 113.014 -179.426 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.3 m -73.78 141.69 46.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.64 179.365 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -102.16 147.77 26.22 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.146 -179.637 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.546 ' CG2' ' OD1' ' A' ' 86' ' ' ASP . 4.3 p -128.04 136.04 61.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.88 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 47.75 31.59 2.26 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.226 -0.59 . . . . 0.0 109.653 -179.352 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.66 28.37 61.34 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.669 179.887 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 71' ' ' VAL . 58.3 m -140.35 141.57 35.64 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.192 -179.729 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 71.0 t -68.18 132.37 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.125 0 CA-C-O 121.358 0.599 . . . . 0.0 112.0 -179.131 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.58 100.3 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.72 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -87.07 -13.91 42.94 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.98 -178.717 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -117.02 164.96 16.7 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.967 -179.177 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -60.22 143.58 99.51 Favored 'Trans proline' 0 N--CA 1.501 1.956 0 C-N-CA 121.827 1.684 . . . . 0.0 111.613 -179.775 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.3 p -139.62 139.46 38.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.066 0.46 . . . . 0.0 110.782 -178.856 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -72.08 125.65 27.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.006 179.931 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.3 mt -77.95 137.25 38.22 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.269 0.557 . . . . 0.0 110.889 -179.894 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -134.96 152.8 52.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.993 -179.696 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -57.28 113.3 1.69 Allowed 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.347 -179.745 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.85 1.67 22.59 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 -179.843 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.546 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 67.7 t0 -86.16 122.96 30.9 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.596 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.412 HG22 ' HG2' ' A' ' 96' ' ' ARG . 28.0 t -105.7 134.27 47.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.791 -179.286 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.7 mt -105.26 132.61 51.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 178.453 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 37.4 m -121.02 125.45 47.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.484 0.659 . . . . 0.0 111.866 -178.901 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.401 ' O ' ' C ' ' A' ' 91' ' ' ILE . 84.8 mt -117.01 125.22 73.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.49 179.096 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.452 HG22 ' N ' ' A' ' 92' ' ' ASP . 44.5 mm 40.47 -105.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.586 -179.443 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.459 ' O ' ' OD1' ' A' ' 92' ' ' ASP . 56.5 t0 -114.86 19.55 15.79 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.921 0.391 . . . . 0.0 110.633 -179.679 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.627 ' HE ' ' CD1' ' A' ' 41' ' ' LEU . 73.7 mtt-85 -129.32 145.49 51.37 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 -179.856 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.64 ' OG ' HD12 ' A' ' 10' ' ' ILE . 11.4 p -140.94 157.4 45.41 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.241 -179.834 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.592 ' HB3' HD11 ' A' ' 7' ' ' LEU . 92.3 m-85 -131.09 124.96 31.92 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.055 -179.772 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.627 ' O ' HD12 ' A' ' 7' ' ' LEU . 99.8 mtt180 -90.82 136.31 33.16 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.531 -179.707 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.603 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 72.2 t80 -100.16 124.55 45.71 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.833 -179.574 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -141.13 132.08 26.06 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 121.256 0.55 . . . . 0.0 111.829 -179.908 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.435 ' ND2' ' OH ' ' A' ' 97' ' ' TYR . 97.9 m-20 . . . . . 0 C--N 1.327 -0.409 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.393 178.413 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo . . . . . 0 N--CA 1.484 0.917 0 CA-C-O 121.033 0.347 . . . . 0.0 111.722 . . . . . . . . . 0 0 . 1 . 093 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.596 ' CG2' HG22 ' A' ' 66' ' ' THR . 25.6 t -113.36 134.1 57.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.787 -178.958 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 44.6 t . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.634 -179.905 . . . . . . . . 0 0 . 1 . 093 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo . . . . . 0 N--CA 1.496 1.643 0 N-CA-C 112.711 0.235 . . . . 0.0 112.711 . . . . . . . . . 0 0 . 1 . 093 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 71.6 m -73.67 -42.91 60.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.239 0.543 . . . . 0.0 109.757 178.008 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -57.0 -47.02 81.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.981 -179.186 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 89.2 mt -63.42 -40.06 96.16 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.66 -179.998 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.7 -40.5 96.95 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.742 -179.948 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -63.44 -42.53 98.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.227 0.537 . . . . 0.0 110.374 179.309 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.527 ' O ' HG23 ' B' ' 249' ' ' VAL . 21.9 mmt180 -59.36 -41.53 89.46 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.404 -179.125 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -65.35 -40.54 93.74 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.112 -0.635 . . . . 0.0 109.997 178.038 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 48.7 m -61.36 -46.82 88.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.261 178.703 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -62.56 -36.01 81.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.117 -179.724 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . 0.527 HG23 ' O ' ' B' ' 245' ' ' ARG . 33.2 t . . . . . 0 C--N 1.329 -0.301 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.92 -179.928 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.457 ' HB2' ' CZ ' ' A' ' 93' ' ' ARG . 53.3 mp0 . . . . . 0 N--CA 1.47 0.542 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 . . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.585 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 84.3 mt -110.18 133.26 56.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.927 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 55.3 t -127.31 131.13 70.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.444 0.64 . . . . 0.0 110.914 -179.347 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -93.61 122.73 36.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.219 -0.901 . . . . 0.0 112.165 -178.804 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . 0.41 ' CB ' ' O ' ' A' ' 36' ' ' ASP . 88.1 tttt -65.78 -46.74 77.59 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.306 179.929 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.98 160.99 45.3 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.285 -179.365 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -59.8 140.58 93.94 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.363 2.042 . . . . 0.0 111.905 179.278 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 3.4 tt . . . . . 0 C--N 1.321 -0.639 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.881 179.908 . . . . . . . . 0 0 . 1 . 094 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.498 ' O ' ' O ' ' A' ' 99' ' ' ASN . 1.8 t . . . . . 0 N--CA 1.471 0.594 0 CA-C-O 121.027 0.442 . . . . 0.0 110.281 . . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.484 ' HG3' HG23 ' A' ' 4' ' ' THR . 80.4 mtt85 -86.22 124.58 32.77 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.76 -179.526 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -133.6 141.31 47.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.244 0.545 . . . . 0.0 111.773 -179.228 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.57 HD11 ' HB3' ' A' ' 95' ' ' PHE . 42.8 tp -117.34 130.71 56.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.053 179.014 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 63.8 t -108.96 132.7 56.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.754 -179.226 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.519 ' CG2' HD12 ' B' ' 261' ' ' ILE . 23.0 m -92.35 111.59 23.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.795 -178.874 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.419 HD11 ' HG3' ' A' ' 96' ' ' ARG . 86.7 mt -78.69 147.89 6.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.373 179.142 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -92.12 158.34 16.24 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.329 178.101 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.447 ' NH1' HH11 ' B' ' 245' ' ' ARG . 87.9 mtm180 -57.85 -26.43 62.05 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.266 -178.492 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 97.9 p -80.61 -11.76 59.6 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 120.324 -0.551 . . . . 0.0 111.049 -179.876 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.98 24.22 13.43 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.409 178.777 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.4 m -116.89 136.56 53.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.281 179.037 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -65.91 126.41 28.43 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.423 -179.984 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -113.0 -128.64 4.95 Favored Glycine 0 CA--C 1.535 1.336 0 N-CA-C 111.381 -0.687 . . . . 0.0 111.381 -179.255 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -74.13 150.63 43.03 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 121.979 1.786 . . . . 0.0 111.951 -179.445 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -108.18 162.68 13.85 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.156 0.503 . . . . 0.0 110.604 -179.654 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -129.51 88.93 48.64 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.403 -179.051 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -61.44 131.08 34.38 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.464 2.109 . . . . 0.0 110.993 179.106 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 22' ' ' LEU . 87.7 mt -98.68 121.44 40.63 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 119.819 -0.752 . . . . 0.0 111.355 -178.559 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 82.8 p -114.84 -28.34 7.1 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.562 178.66 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.7 mt -78.59 145.74 34.58 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.856 -1.066 . . . . 0.0 109.952 179.799 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 57.1 m -71.65 -8.27 53.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 0.0 112.216 -178.558 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.5 m -135.59 135.84 40.59 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.331 -179.687 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.5 t -126.4 117.1 22.24 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.227 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.405 HD12 ' O ' ' A' ' 49' ' ' CYS . 55.0 tp -113.65 131.97 55.94 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.249 -178.362 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.676 ' CE2' HD12 ' A' ' 37' ' ' ILE . 4.9 m-85 -110.89 134.02 52.89 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.95 -179.655 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.29 -172.12 38.32 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 119.963 -1.113 . . . . 0.0 112.468 178.687 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.663 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 82.2 mtm-85 -83.28 -32.53 26.33 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.644 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -49.8 149.91 5.2 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -178.86 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.559 ' O ' ' NH2' ' A' ' 38' ' ' ARG . 36.5 mm -64.03 -43.28 97.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.33 -179.823 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -53.68 -21.61 7.35 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.943 -179.234 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 71.5 m -56.6 118.52 4.93 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.717 -179.695 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -57.13 -31.05 64.95 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.864 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.676 HD12 ' CE2' ' A' ' 29' ' ' PHE . 96.3 mt -123.56 117.08 50.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 176.734 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.559 ' NH2' ' O ' ' A' ' 33' ' ' ILE . 72.0 mtt85 -102.91 134.33 46.52 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.571 -177.928 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.664 HG21 HD12 ' A' ' 41' ' ' LEU . 78.7 mt -118.74 131.22 72.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.2 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -80.71 24.66 0.47 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.084 -178.652 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.664 HD12 HG21 ' A' ' 39' ' ' ILE . 27.8 mt -89.61 126.51 57.78 Favored Pre-proline 0 C--N 1.323 -0.579 0 C-N-CA 120.377 -0.529 . . . . 0.0 109.595 179.953 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -68.77 -13.0 36.05 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.258 1.972 . . . . 0.0 113.668 -179.158 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.462 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 2.9 m -99.83 6.47 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.925 179.969 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.663 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 24.1 t -90.52 132.1 36.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.988 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.506 ' OG ' ' N ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -64.79 169.38 5.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.219 0.533 . . . . 0.0 111.375 -178.674 . . . . . . . . 3 3 . 1 . 094 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -62.64 -44.88 95.16 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.292 -179.366 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.651 ' O ' ' N ' ' A' ' 49' ' ' CYS . 96.2 mt-30 -113.21 -13.05 13.02 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.424 178.983 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.506 ' N ' ' OG ' ' A' ' 45' ' ' SER . 14.7 t60 34.2 -75.97 0.0 OUTLIER 'General case' 0 C--O 1.235 0.29 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 179.066 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.651 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.81 136.74 47.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.173 0.511 . . . . 0.0 112.003 -178.773 . . . . . . . . 3 3 . 1 . 094 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -126.38 127.08 44.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.205 179.655 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 92.3 mt -110.85 134.07 54.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.313 -179.113 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -116.5 121.46 41.88 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.718 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.431 HD13 ' HD3' ' A' ' 5' ' ' ARG . 96.5 mt -107.15 112.57 40.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.139 -0.624 . . . . 0.0 111.653 -179.571 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.44 ' O ' ' C ' ' A' ' 55' ' ' GLU . 96.2 m-70 -111.52 144.66 40.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.847 179.936 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.2 tt0 -40.85 -32.26 0.21 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.308 -0.626 . . . . 0.0 109.308 -179.944 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.425 ' N ' ' C ' ' A' ' 54' ' ' HIS . 98.1 mt-30 -63.8 -68.15 0.37 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.452 178.805 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.438 ' CD ' ' CD ' ' A' ' 81' ' ' ARG . 14.7 pt-20 -157.4 -171.82 3.75 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.484 -178.626 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.26 123.33 49.09 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.679 179.51 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 84.2 mt -114.73 128.08 71.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 120.345 -0.542 . . . . 0.0 112.343 -178.93 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.556 ' HB2' HD11 ' A' ' 82' ' ' LEU . 47.3 tp -93.85 127.49 39.62 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.352 179.517 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -115.04 135.41 54.25 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 178.795 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.676 ' ND2' ' H ' ' A' ' 69' ' ' THR . 16.0 t-20 -101.65 112.13 24.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.182 0.515 . . . . 0.0 111.576 -179.369 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -102.44 -7.08 22.25 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.749 179.784 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.36 100.7 3.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.368 179.899 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.2 m -84.98 -9.2 58.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.941 0.4 . . . . 0.0 109.928 179.678 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.92 -39.02 9.59 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.26 179.895 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -149.19 98.32 3.52 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.344 179.987 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.484 ' HA ' HD21 ' A' ' 62' ' ' ASN . 46.2 Cg_exo -56.04 147.36 64.53 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 122.36 2.04 . . . . 0.0 112.713 179.968 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.676 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 38.1 m -69.64 138.78 53.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.088 178.872 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 89' ' ' THR . 83.7 mt-30 -101.02 139.67 36.39 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.161 179.795 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.437 HG22 HD13 ' A' ' 88' ' ' ILE . 18.2 t -131.36 135.97 58.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.356 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 53.86 34.59 19.67 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.949 -179.733 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.23 30.38 71.72 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.031 179.251 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 41.0 m -143.63 134.88 25.83 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 117.105 0.453 . . . . 0.0 111.054 -179.907 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.4 ' H ' HG12 ' A' ' 75' ' ' VAL . 0.1 OUTLIER -68.99 137.77 23.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.505 179.897 . . . . . . . . 3 3 . 1 . 094 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.573 ' CG2' ' O ' ' A' ' 78' ' ' GLU . 97.2 mt -102.65 105.16 17.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.888 -179.634 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -67.55 -40.87 84.95 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.849 178.751 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.573 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 1.9 mt-10 -127.64 170.91 9.21 Favored Pre-proline 0 N--CA 1.469 0.482 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.147 -178.514 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -59.54 148.71 86.06 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.181 1.921 . . . . 0.0 112.133 179.983 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.7 m -147.39 148.84 16.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.179 0.514 . . . . 0.0 111.869 179.708 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.438 ' CD ' ' CD ' ' A' ' 57' ' ' GLU . 61.4 ttp180 -72.81 128.86 36.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.518 179.779 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.556 HD11 ' HB2' ' A' ' 60' ' ' LEU . 94.9 mt -85.32 135.94 33.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.142 0.496 . . . . 0.0 110.94 179.712 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -119.94 148.93 42.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.79 179.561 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.437 ' C ' ' CD2' ' A' ' 84' ' ' HIS . 5.8 t60 -51.41 123.16 9.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.673 -179.396 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.69 -14.95 49.64 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 179.878 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -67.12 139.09 57.5 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.4 -0.52 . . . . 0.0 109.639 179.507 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.427 HG22 ' HG2' ' A' ' 96' ' ' ARG . 72.6 t -109.99 134.22 52.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.394 -178.195 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.437 HD13 HG22 ' A' ' 71' ' ' VAL . 30.5 mm -90.71 127.28 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 177.492 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.509 ' N ' ' O ' ' A' ' 70' ' ' GLN . 31.6 m -119.74 123.36 43.55 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.467 0.651 . . . . 0.0 111.148 -178.652 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 92' ' ' ASP . 89.2 mt -118.08 126.03 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.314 179.5 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.501 HG22 ' N ' ' A' ' 92' ' ' ASP . 87.9 mt 37.1 -95.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.056 -179.956 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.501 ' N ' HG22 ' A' ' 91' ' ' ILE . 54.2 t0 -119.62 14.38 12.66 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.917 0.389 . . . . 0.0 111.453 -179.356 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.526 ' NE ' HD11 ' B' ' 261' ' ' ILE . 2.2 tpp180 -128.48 142.25 51.14 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.286 -179.555 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.0 m -133.45 150.08 51.76 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.428 0.632 . . . . 0.0 111.362 -179.847 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.57 ' HB3' HD11 ' A' ' 7' ' ' LEU . 89.1 m-85 -121.58 123.24 41.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.422 -0.808 . . . . 0.0 108.907 178.895 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.528 ' O ' HD12 ' A' ' 7' ' ' LEU . 99.7 mtt180 -81.33 126.68 31.88 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.52 -179.725 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.572 ' CE2' ' OD1' ' A' ' 99' ' ' ASN . 76.8 t80 -95.6 123.48 39.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.11 -179.193 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.414 ' HG3' ' CE1' ' A' ' 84' ' ' HIS . 84.2 tt0 -126.24 115.88 20.41 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.118 179.061 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.572 ' OD1' ' CE2' ' A' ' 97' ' ' TYR . 86.1 m-20 . . . . . 0 C--N 1.327 -0.401 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.94 -179.643 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo . . . . . 0 N--CA 1.482 0.836 0 CA-C-O 121.02 0.342 . . . . 0.0 111.715 . . . . . . . . . 0 0 . 1 . 094 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 3.1 p -112.29 133.42 58.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.861 -179.498 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 5.6 t . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.892 179.834 . . . . . . . . 0 0 . 1 . 094 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo . . . . . 0 N--CA 1.492 1.409 0 CA-C-O 120.529 0.137 . . . . 0.0 111.989 . . . . . . . . . 0 0 . 1 . 094 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 4.6 p -75.93 -38.9 57.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 177.908 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.462 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 74.8 t80 -57.71 -46.61 84.14 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.837 -179.466 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' B' ' 242' ' ' LEU . 92.5 mt -64.67 -40.85 96.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.163 179.711 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -61.87 -43.48 98.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.379 179.565 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 63.4 ttm-85 -63.71 -42.96 97.89 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.366 179.431 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.618 ' O ' HG23 ' B' ' 249' ' ' VAL . 12.4 tpp180 -61.99 -44.6 96.4 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.117 -179.617 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -64.63 -38.97 92.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.453 178.712 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 69.7 p -68.22 -43.76 77.27 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.253 0.549 . . . . 0.0 109.795 179.057 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -58.76 -37.88 77.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.325 179.824 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . 0.618 HG23 ' O ' ' B' ' 245' ' ' ARG . 77.0 t . . . . . 0 C--N 1.327 -0.406 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.909 179.934 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.441 ' HB2' HH22 ' A' ' 93' ' ' ARG . 90.6 mt-10 . . . . . 0 CA--C 1.529 0.15 0 CA-C-O 120.606 0.241 . . . . 0.0 111.026 . . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.526 HD11 ' NE ' ' A' ' 93' ' ' ARG . 60.9 mt -106.62 137.24 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.877 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 69.8 t -127.54 134.48 65.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.031 -179.548 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -94.94 119.16 33.01 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.986 -177.367 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . 0.494 ' HG3' HH22 ' A' ' 38' ' ' ARG . 88.5 tttt -68.48 -44.63 74.35 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.252 179.612 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.69 156.98 49.9 Favored Pre-proline 0 C--O 1.236 0.353 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.374 -179.43 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -62.26 144.6 95.64 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.935 2.423 . . . . 0.0 112.713 -179.563 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 47.2 pt . . . . . 0 N--CA 1.455 -0.204 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.572 178.673 . . . . . . . . 0 0 . 1 . 095 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.5 p . . . . . 0 C--O 1.231 0.095 0 CA-C-O 121.02 0.438 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 095 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.505 ' NH2' HG21 ' A' ' 53' ' ' ILE . 76.5 mtm-85 -88.58 125.05 34.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.315 -178.95 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -130.91 144.43 51.46 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.216 179.35 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.965 HD11 HD11 ' A' ' 22' ' ' LEU . 69.7 mt -117.24 141.12 48.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.442 179.761 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.5 t -113.37 127.61 70.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.784 179.652 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.421 ' CG2' HD12 ' B' ' 261' ' ' ILE . 4.9 m -82.76 135.14 35.07 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.233 -178.29 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.515 HD12 ' HB3' ' A' ' 94' ' ' SER . 98.9 mt -105.65 137.04 37.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.348 178.368 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.6 mttm -89.69 161.03 16.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.042 0.449 . . . . 0.0 110.348 179.389 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.507 ' CD ' HH11 ' B' ' 245' ' ' ARG . 87.7 mtm180 -54.55 -27.13 36.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.198 -179.018 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.4 m -82.71 -5.1 58.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.197 179.443 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.39 35.3 14.66 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 179.519 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.1 t -115.51 135.36 55.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.773 0.321 . . . . 0.0 110.474 -179.995 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -78.45 132.6 37.36 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.203 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -126.55 -114.95 1.94 Allowed Glycine 0 CA--C 1.537 1.416 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.967 -179.139 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -71.9 144.49 43.34 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 122.338 2.025 . . . . 0.0 112.631 -178.97 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.43 ' O ' HD11 ' B' ' 267' ' ' ILE . 0.2 OUTLIER -106.54 132.66 52.28 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.984 0.421 . . . . 0.0 110.701 -179.746 . . . . . . . . 3 3 . 1 . 095 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.685 ' CD2' HD11 ' A' ' 37' ' ' ILE . 56.0 t80 -101.18 102.35 20.31 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.44 -179.41 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -76.22 129.92 11.66 Favored 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 121.67 1.58 . . . . 0.0 111.789 -179.75 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.965 HD11 HD11 ' A' ' 7' ' ' LEU . 89.8 mt -87.41 80.28 8.18 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.165 -179.07 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.492 ' OG ' ' NE2' ' B' ' 265' ' ' GLN . 35.6 p -84.73 -9.92 57.75 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.437 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 66.6 mt -100.16 143.23 30.61 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.96 -179.676 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 93.1 p -65.56 -15.91 63.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.131 -178.642 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.488 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 33.4 m -130.13 130.74 45.17 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.864 -179.407 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.618 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 2.2 t -124.9 118.85 27.21 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.979 178.921 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.483 HD12 ' O ' ' A' ' 49' ' ' CYS . 54.8 tp -120.01 131.86 55.28 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.509 -178.142 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.618 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 54.8 m-85 -108.45 143.13 37.81 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.289 179.689 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 156.29 -151.04 22.51 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 179.156 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.666 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 84.2 mtm-85 -108.89 -23.45 11.72 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.634 179.326 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.469 ' N ' ' SG ' ' A' ' 35' ' ' CYS . . . -55.49 156.86 8.79 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 121.281 -0.485 . . . . 0.0 112.206 -178.584 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.506 HG23 ' N ' ' A' ' 34' ' ' GLU . 11.0 tp -65.69 -41.93 91.55 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 CA-C-O 120.986 0.422 . . . . 0.0 110.061 179.606 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.506 ' N ' HG23 ' A' ' 33' ' ' ILE . 96.4 mt-10 -60.11 -28.46 67.88 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.803 179.873 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.534 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 9.3 m -53.13 115.46 1.89 Allowed 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.071 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.488 ' OD2' ' O ' ' A' ' 26' ' ' THR . 99.5 m-20 -60.74 -26.71 67.39 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -179.245 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.685 HD11 ' CD2' ' A' ' 20' ' ' PHE . 47.5 mm -123.24 112.37 33.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.67 177.516 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -105.0 137.65 42.42 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.773 -179.832 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.489 ' CG2' HD12 ' A' ' 41' ' ' LEU . 98.2 mt -121.76 132.85 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.138 179.058 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -79.33 34.26 0.25 Allowed 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -177.588 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.582 ' CD1' ' HE ' ' A' ' 93' ' ' ARG . 9.7 mt -113.59 137.61 22.25 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.553 178.9 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.09 -10.79 29.1 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.836 2.358 . . . . 0.0 113.93 -178.138 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.435 HG21 ' CE2' ' B' ' 241' ' ' PHE . 27.4 m -95.51 3.34 9.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.223 -0.591 . . . . 0.0 111.206 -179.993 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.666 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 37.3 t -94.5 130.19 43.69 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.717 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.9 m -70.97 163.47 27.46 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -177.796 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.534 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 54.8 mttp -62.75 -41.62 99.29 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.486 -179.048 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.633 ' O ' ' N ' ' A' ' 49' ' ' CYS . 10.8 mm100 -113.98 -24.63 8.95 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.239 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 24.5 t60 35.26 -74.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 178.944 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.633 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.79 138.64 45.83 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -177.993 . . . . . . . . 3 3 . 1 . 095 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -128.6 127.83 43.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.789 179.817 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.8 mt -115.42 134.22 59.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.516 179.244 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -114.17 137.84 51.23 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.449 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.505 HG21 ' NH2' ' A' ' 5' ' ' ARG . 39.5 mm -98.15 120.01 46.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.307 0.575 . . . . 0.0 110.679 -179.367 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.454 ' O ' ' C ' ' A' ' 55' ' ' GLU . 38.0 m-70 -120.78 131.35 54.43 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.303 179.452 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 54' ' ' HIS . 99.5 mt-10 -40.07 -34.46 0.3 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -179.774 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -62.75 -66.85 0.48 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.845 -1.071 . . . . 0.0 108.953 178.358 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -160.05 -159.14 0.69 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.426 178.854 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.669 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -113.62 131.03 56.28 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.814 -0.355 . . . . 0.0 110.362 -179.938 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 37.6 mm -108.64 123.5 64.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.004 -179.25 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.413 HD22 ' CD1' ' A' ' 88' ' ' ILE . 38.9 tp -95.77 124.01 39.6 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.149 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -113.01 134.17 54.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.259 -179.547 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -95.33 104.65 16.55 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.951 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -99.26 -7.51 26.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.957 178.838 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.9 t -78.08 98.94 5.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.133 -179.175 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.8 m -77.64 -37.49 49.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.127 0.489 . . . . 0.0 109.955 178.599 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.56 -40.45 80.61 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.458 -179.705 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -146.68 96.98 4.33 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.963 -179.286 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -56.36 148.28 62.75 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.455 2.104 . . . . 0.0 112.467 179.505 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.4 m -74.68 143.06 44.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.313 -179.764 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -104.12 140.39 37.86 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.225 179.385 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.9 t -130.08 135.77 60.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.024 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 52.98 37.14 23.83 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.38 -179.898 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.29 29.53 74.4 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.095 179.204 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.3 t -144.94 136.05 24.94 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.481 -179.983 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.1 p -72.2 138.59 21.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.16 -179.256 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.894 HD13 ' O ' ' A' ' 76' ' ' ILE . 0.0 OUTLIER -133.6 126.76 52.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.96 179.289 . . . . . . . . 3 3 . 1 . 095 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -99.4 -9.76 23.07 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.658 -179.308 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.788 ' O ' HD11 ' A' ' 76' ' ' ILE . 1.2 pm0 -118.47 161.05 37.37 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 120.776 -0.37 . . . . 0.0 111.035 -179.18 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -57.54 143.77 93.8 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 121.613 1.542 . . . . 0.0 111.859 179.696 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.409 HG13 ' HB3' ' A' ' 60' ' ' LEU . 2.8 p -139.63 141.61 34.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.353 -179.462 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -78.39 134.12 37.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.394 -179.867 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.669 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 91.1 mt -93.46 139.36 30.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.241 0.543 . . . . 0.0 111.622 -179.269 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -126.06 155.93 40.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.997 179.765 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.423 ' ND1' ' N ' ' A' ' 99' ' ' ASN . 8.4 t60 -55.83 118.55 4.68 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.9 0.381 . . . . 0.0 110.235 -179.523 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.82 -17.1 27.9 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 -179.704 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -68.14 137.47 54.92 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.224 179.968 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.55 ' CG2' ' OG ' ' A' ' 94' ' ' SER . 7.7 p -111.55 134.18 54.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.061 0.457 . . . . 0.0 112.031 -178.557 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.413 ' CD1' HD22 ' A' ' 60' ' ' LEU . 47.5 mm -93.81 128.02 45.46 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.093 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 178.069 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 47.9 m -126.57 126.68 44.05 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -178.001 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.459 ' O ' ' C ' ' A' ' 91' ' ' ILE . 86.4 mt -116.07 126.63 73.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 114.225 -1.352 . . . . 0.0 108.259 178.57 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.476 HG22 ' N ' ' A' ' 92' ' ' ASP . 94.6 mt 35.71 -96.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 121.024 -0.271 . . . . 0.0 110.922 -179.593 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.476 ' N ' HG22 ' A' ' 91' ' ' ILE . 26.5 m-20 -120.11 17.28 12.43 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.86 0.362 . . . . 0.0 111.432 179.802 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.79 HH21 ' NH2' ' B' ' 245' ' ' ARG . 0.6 OUTLIER -124.71 138.22 54.3 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.845 . . . . . . . . 3 3 . 1 . 095 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.55 ' OG ' ' CG2' ' A' ' 87' ' ' VAL . 8.1 t -139.97 151.1 45.25 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 119.826 -0.75 . . . . 0.0 111.751 -179.055 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -122.69 122.51 38.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.561 178.734 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -87.2 134.12 33.57 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.315 -178.865 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -97.59 125.8 42.53 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.518 179.79 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -143.72 130.07 19.91 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.779 -179.908 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.423 ' N ' ' ND1' ' A' ' 84' ' ' HIS . 84.7 m-20 . . . . . 0 C--N 1.332 -0.18 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.411 179.112 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo . . . . . 0 N--CA 1.488 1.155 0 CA-C-O 121.082 0.367 . . . . 0.0 111.969 . . . . . . . . . 0 0 . 1 . 095 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 24.8 t -59.6 137.53 21.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.006 179.441 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.9 t . . . . . 0 C--N 1.325 -0.465 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.169 -179.324 . . . . . . . . 0 0 . 1 . 095 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo . . . . . 0 N--CA 1.492 1.433 0 N-CA-C 111.519 -0.224 . . . . 0.0 111.519 . . . . . . . . . 0 0 . 1 . 095 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 97.0 m -71.03 -45.35 64.05 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.967 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.435 ' CE2' HG21 ' A' ' 43' ' ' VAL . 89.6 t80 -58.38 -46.8 85.64 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.754 -179.601 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 92.6 mt -64.04 -42.1 97.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.878 -179.577 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -63.3 -43.21 98.51 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 120.871 -0.331 . . . . 0.0 111.076 -179.402 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -63.0 -40.11 96.79 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.699 179.8 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.79 ' NH2' HH21 ' A' ' 93' ' ' ARG . 61.2 ttm-85 -61.76 -44.54 96.69 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.084 179.574 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -62.52 -41.53 98.92 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.469 -179.618 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 57.9 m -66.97 -46.03 75.89 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.291 0.567 . . . . 0.0 110.521 179.122 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -62.92 -33.56 75.59 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.447 -179.46 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . 0.729 HG23 ' O ' ' B' ' 245' ' ' ARG . 61.4 t . . . . . 0 CA--C 1.532 0.259 0 CA-C-O 121.19 0.519 . . . . 0.0 111.55 179.867 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.55 ' N ' ' OE1' ' B' ' 260' ' ' GLU . 57.4 mp0 . . . . . 0 N--CA 1.461 0.109 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 . . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.421 HD12 ' CG2' ' A' ' 9' ' ' THR . 66.4 mt -106.01 134.35 47.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 178.123 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 72.0 t -123.71 132.27 71.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.26 0.552 . . . . 0.0 110.238 -178.812 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -95.18 117.4 30.18 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.543 -177.869 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . 0.427 ' NZ ' ' HA ' ' A' ' 34' ' ' GLU . 88.5 tttt -65.17 -45.77 83.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.572 179.745 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . 0.492 ' NE2' ' OG ' ' A' ' 23' ' ' SER . 0.0 OUTLIER -80.26 158.9 71.34 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.144 -179.819 . . . . . . . . 3 3 . 1 . 095 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -60.1 140.59 93.2 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 C-N-CA 122.237 1.958 . . . . 0.0 111.733 179.499 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . 0.469 HG23 ' O ' ' B' ' 267' ' ' ILE . 13.8 tt . . . . . 0 C--N 1.326 -0.414 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.156 -179.541 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.6 m . . . . . 0 C--O 1.231 0.107 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 . . . . . . . . . 0 0 . 1 . 096 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.546 ' NH2' HG21 ' A' ' 53' ' ' ILE . 88.1 mtm-85 -94.87 131.57 40.62 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.936 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -142.86 151.54 41.18 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 119.958 -0.697 . . . . 0.0 112.305 179.933 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 80.3 mt -115.25 131.52 56.9 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.14 178.653 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 73.0 t -103.65 128.21 57.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.942 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.553 HG23 ' CD1' ' B' ' 261' ' ' ILE . 2.7 m -87.82 120.9 29.6 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -177.377 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 91.1 mt -82.18 134.92 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.659 178.462 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -88.37 160.73 17.46 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.4 0.619 . . . . 0.0 111.394 179.365 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.67 ' CG ' HH12 ' A' ' 93' ' ' ARG . 76.7 mtp180 -53.9 -40.98 67.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.921 -178.759 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.5 t -72.2 -11.11 60.58 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.024 179.892 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.25 35.31 5.3 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 -179.513 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.7 t -123.66 135.96 61.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.103 0.478 . . . . 0.0 111.914 -179.474 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -70.07 136.43 50.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.809 179.504 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -122.0 -125.34 3.11 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.919 -179.332 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.65 150.26 56.45 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 122.051 1.834 . . . . 0.0 113.222 -178.469 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 53.3 m170 -110.28 132.91 53.76 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.52 -179.251 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.444 ' CD2' HD11 ' A' ' 37' ' ' ILE . 25.1 t80 -102.12 100.73 15.99 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.301 -179.506 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -73.37 127.69 12.11 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 C-N-CA 121.421 1.414 . . . . 0.0 110.855 179.979 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 99.3 mt -79.99 55.58 2.16 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.816 -0.353 . . . . 0.0 111.886 -178.345 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 87.1 p -67.13 -22.21 65.8 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.508 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.649 HD11 ' HG2' ' B' ' 265' ' ' GLN . 69.9 mt -83.52 139.8 32.67 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.563 179.573 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.9 m -67.42 -18.6 65.17 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.429 -178.965 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 36.4 m -129.23 130.91 46.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.238 0.542 . . . . 0.0 111.918 -179.717 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.671 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.7 OUTLIER -125.62 118.33 25.45 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.65 178.735 . . . . . . . . 3 3 . 1 . 096 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.519 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 56.0 tp -119.79 125.69 49.21 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.522 -178.424 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.671 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 48.2 m-85 -101.76 128.07 48.26 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.492 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 177.5 -176.84 48.23 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.282 -0.961 . . . . 0.0 111.762 179.101 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.662 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 84.6 mtm-85 -82.39 -28.07 31.68 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.12 0.486 . . . . 0.0 110.242 179.75 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.61 155.02 41.63 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.282 -178.368 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.443 HD12 ' HD3' ' A' ' 38' ' ' ARG . 9.1 tp -65.98 -39.38 84.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.489 -0.355 . . . . 0.0 110.56 179.23 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.413 ' N ' HG23 ' A' ' 33' ' ' ILE . 71.0 mm-40 -55.17 -21.61 14.2 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.659 -179.795 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.8 m -64.03 119.86 10.93 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.088 -179.982 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.585 ' OD2' ' SG ' ' A' ' 27' ' ' CYS . 28.2 p-10 -54.26 -26.12 27.19 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.385 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.603 HD12 ' CE2' ' A' ' 29' ' ' PHE . 94.9 mt -130.59 123.61 55.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.29 -0.868 . . . . 0.0 108.879 178.043 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.443 ' HD3' HD12 ' A' ' 33' ' ' ILE . 20.9 mtm180 -109.3 137.63 46.88 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.761 -179.099 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 92.8 mt -118.65 131.62 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.936 179.293 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -77.89 31.64 0.17 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -177.877 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.568 HD21 ' OE1' ' B' ' 260' ' ' GLU . 34.7 mt -102.88 130.64 23.37 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.742 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.53 -6.09 18.17 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 121.909 1.739 . . . . 0.0 112.534 -179.459 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.458 HG21 ' CE2' ' B' ' 241' ' ' PHE . 4.9 m -101.39 3.74 10.59 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.501 -179.686 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.662 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 34.3 t -90.57 133.48 32.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.632 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.453 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 0.6 OUTLIER -69.74 170.22 11.39 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.779 0.799 . . . . 0.0 112.753 -177.5 . . . . . . . . 3 3 . 1 . 096 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -64.04 -43.83 94.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.512 -179.324 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.636 ' O ' ' N ' ' A' ' 49' ' ' CYS . 90.5 mm-40 -111.69 -17.39 13.01 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.299 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.453 ' H ' ' HB3' ' A' ' 45' ' ' SER . 13.4 t60 32.56 -78.11 0.0 OUTLIER 'General case' 0 C--O 1.238 0.492 0 CA-C-N 114.686 -1.143 . . . . 0.0 112.985 179.765 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.636 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.66 135.97 46.16 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.482 -179.003 . . . . . . . . 3 3 . 1 . 096 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -125.89 131.4 52.36 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.702 179.003 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.1 mt -117.64 135.17 58.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.574 -179.967 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -114.18 135.57 53.89 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.669 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.546 HG21 ' NH2' ' A' ' 5' ' ' ARG . 46.0 mm -103.01 125.19 57.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.941 -179.398 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.473 ' O ' ' N ' ' A' ' 56' ' ' GLN . 33.3 m-70 -127.04 129.31 47.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.596 179.349 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' A' ' 54' ' ' HIS . 96.0 mt-10 -40.2 -29.74 0.08 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.216 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.473 ' N ' ' O ' ' A' ' 54' ' ' HIS . 88.3 mt-30 -67.08 -67.28 0.46 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.41 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -154.92 -168.1 2.78 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.707 -179.807 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.566 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -112.11 131.09 55.65 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.407 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.3 mm -108.66 125.2 65.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.869 -179.433 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 34.1 tp -99.44 126.3 45.33 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.258 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -115.76 137.61 51.92 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.579 -179.187 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -102.57 105.18 15.65 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.368 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -95.89 -4.28 43.84 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.513 178.997 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.52 104.45 15.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.553 -179.187 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.3 p -87.31 -35.89 18.17 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.698 179.124 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.6 -45.71 92.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.793 -179.714 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.41 ' OD1' HG23 ' B' ' 236' ' ' VAL . 2.9 m-80 -145.58 104.43 4.27 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.07 179.248 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -67.04 151.43 81.88 Favored 'Trans proline' 0 N--CA 1.491 1.332 0 C-N-CA 121.74 1.627 . . . . 0.0 113.287 -177.87 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.928 ' O ' HG22 ' A' ' 76' ' ' ILE . 33.9 m -70.79 146.93 49.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.598 179.95 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -110.87 139.92 45.77 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.758 -179.404 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 54.2 t -129.66 134.99 62.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.05 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 53.6 34.41 18.57 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.221 179.829 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.31 28.71 69.43 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.91 179.468 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.6 t -144.93 142.62 30.01 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 117.182 0.491 . . . . 0.0 110.986 179.758 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.4 m -68.97 143.71 14.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.496 -179.497 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.928 HG22 ' O ' ' A' ' 69' ' ' THR . 10.0 tt -111.67 90.92 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.92 -179.801 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -65.55 -35.25 80.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.115 179.52 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.477 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 5.0 mt-10 -124.67 164.74 28.99 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.387 -178.402 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.74 138.87 77.12 Favored 'Trans proline' 0 N--CA 1.501 1.954 0 C-N-CA 122.102 1.868 . . . . 0.0 112.874 -179.879 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 73.2 t -132.37 137.39 54.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.781 179.956 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 84.6 mtt85 -71.38 129.32 38.52 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.487 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.566 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 95.6 mt -82.75 137.36 34.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.164 0.507 . . . . 0.0 111.072 -179.876 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -128.09 152.35 48.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.593 -179.621 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.415 ' HD1' ' H ' ' A' ' 99' ' ' ASN . 7.7 t60 -55.86 117.77 3.99 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.431 179.948 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.85 -20.43 19.93 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 179.851 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -67.03 136.63 55.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.979 0.418 . . . . 0.0 110.216 179.948 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.1 t -109.43 133.87 53.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.684 -178.758 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 88.6 mt -102.86 129.93 53.75 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.514 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 178.275 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 61.5 m -123.41 128.43 49.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.799 0.809 . . . . 0.0 112.249 -178.014 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.678 ' O ' ' N ' ' A' ' 93' ' ' ARG . 93.9 mt -116.53 132.86 64.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.077 178.7 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.517 ' C ' ' O ' ' A' ' 90' ' ' ILE . 51.0 mt -22.5 98.82 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.067 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.573 ' CG ' ' HE ' ' B' ' 245' ' ' ARG . 0.7 OUTLIER 80.08 -17.57 0.57 Allowed 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 178.354 . . . . . . . . 3 3 . 1 . 096 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.678 ' N ' ' O ' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -122.52 132.64 54.42 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 119.64 -0.219 . . . . 0.0 110.868 -179.747 . . . . . . . . 3 3 . 1 . 096 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.1 t -136.28 146.88 47.16 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 118.488 0.586 . . . . 0.0 111.129 -179.781 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -125.74 122.06 35.19 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.647 179.593 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -84.43 134.85 34.45 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.399 -179.249 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -97.82 126.43 43.18 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.492 -179.598 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -143.12 128.38 18.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.644 179.827 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.539 ' O ' ' OD1' ' A' ' 99' ' ' ASN . 29.0 p30 . . . . . 0 C--N 1.333 -0.113 0 CA-C-O 121.483 0.658 . . . . 0.0 111.343 -179.898 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo . . . . . 0 N--CA 1.483 0.902 0 CA-C-O 121.084 0.369 . . . . 0.0 111.927 . . . . . . . . . 0 0 . 1 . 096 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.41 HG23 ' OD1' ' A' ' 67' ' ' ASN . 3.8 p -113.7 132.65 62.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.095 -179.719 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . 0.427 ' HB2' HD13 ' A' ' 91' ' ' ILE . 1.0 OUTLIER . . . . . 0 CA--C 1.515 -0.378 0 C-N-CA 120.248 -0.581 . . . . 0.0 109.493 179.943 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo . . . . . 0 N--CA 1.49 1.284 0 N-CA-C 111.349 -0.289 . . . . 0.0 111.349 . . . . . . . . . 0 0 . 1 . 096 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 2.5 p -74.35 -39.75 62.58 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 177.784 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.458 ' CE2' HG21 ' A' ' 43' ' ' VAL . 71.0 t80 -58.04 -47.46 83.03 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.047 -179.264 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.465 HD21 HG23 ' A' ' 91' ' ' ILE . 98.0 mt -64.66 -40.18 94.97 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.043 0.449 . . . . 0.0 110.07 -179.823 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -63.61 -44.0 95.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.795 179.567 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -61.54 -41.24 97.07 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.109 -179.855 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.715 ' O ' HG23 ' B' ' 249' ' ' VAL . 22.1 mmm180 -61.61 -40.37 94.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.348 -179.859 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -63.77 -42.43 97.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.801 0.334 . . . . 0.0 110.794 179.313 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 72.2 p -64.95 -43.19 93.51 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.729 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -62.36 -37.33 85.25 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.682 179.668 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . 0.715 HG23 ' O ' ' B' ' 245' ' ' ARG . 79.3 t . . . . . 0 N--CA 1.453 -0.29 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.2 179.019 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.568 ' OE1' HD21 ' A' ' 41' ' ' LEU . 99.6 mt-10 . . . . . 0 C--O 1.227 -0.11 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 . . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.553 ' CD1' HG23 ' A' ' 9' ' ' THR . 41.0 mt -109.66 133.11 55.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 119.881 -0.728 . . . . 0.0 109.111 178.824 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 44.1 t -127.8 135.5 62.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.541 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -100.22 123.64 44.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.249 0.547 . . . . 0.0 112.415 -177.6 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -63.98 -47.35 80.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.111 178.59 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . 0.649 ' HG2' HD11 ' A' ' 24' ' ' LEU . 6.0 mp0 -96.84 163.76 19.48 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.477 179.972 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -60.76 156.74 41.35 Favored 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 122.941 2.427 . . . . 0.0 111.982 178.72 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 10.6 pt . . . . . 0 N--CA 1.466 0.35 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.893 -178.224 . . . . . . . . 0 0 . 1 . 097 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.5 p . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.858 0.361 . . . . 0.0 110.354 . . . . . . . . . 0 0 . 1 . 097 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.776 HH12 HG23 ' A' ' 53' ' ' ILE . 99.9 mtt180 -94.11 132.28 38.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.747 179.213 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 91.6 mtm180 -134.07 141.93 47.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.015 -179.911 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.559 HD11 ' HB3' ' A' ' 95' ' ' PHE . 42.3 tp -111.94 131.27 55.49 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.122 179.416 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.666 HG11 ' OD2' ' A' ' 16' ' ' ASP . 61.7 t -107.07 130.27 59.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.382 179.832 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 m -92.84 115.06 27.77 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.437 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 88.6 mt -80.93 142.74 13.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.667 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -84.81 156.04 21.52 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.562 178.823 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.424 ' HG3' ' NH2' ' B' ' 245' ' ' ARG . 58.0 ttp180 -58.16 -35.85 72.16 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.069 -179.795 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.1 t -68.21 -21.59 64.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.988 0.423 . . . . 0.0 110.13 178.638 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.57 29.02 4.6 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 111.156 -0.777 . . . . 0.0 111.156 179.993 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.8 t -117.78 132.9 66.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.869 0.366 . . . . 0.0 111.152 -179.804 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.666 ' OD2' HG11 ' A' ' 8' ' ' VAL . 63.5 t0 -79.29 130.83 35.85 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.67 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.462 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -129.93 -108.71 1.31 Allowed Glycine 0 CA--C 1.532 1.133 0 C-N-CA 119.707 -1.235 . . . . 0.0 112.221 -179.66 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.1 145.19 48.88 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.496 2.131 . . . . 0.0 113.81 -178.333 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.451 ' O ' ' CD1' ' B' ' 267' ' ' ILE . 0.2 OUTLIER -110.56 145.62 37.49 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.475 178.871 . . . . . . . . 3 3 . 1 . 097 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.421 ' CD2' HD11 ' A' ' 37' ' ' ILE . 54.0 t80 -113.99 92.21 25.14 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.856 -179.084 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.83 130.02 34.86 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 122.037 1.825 . . . . 0.0 111.189 -179.602 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.5 mt -87.73 84.71 7.03 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.314 -179.483 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 51.4 p -89.85 -10.44 45.33 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.164 179.486 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.77 HD11 ' CD ' ' B' ' 265' ' ' GLN . 59.4 mt -102.24 146.6 27.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.289 -179.723 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 52.4 p -68.84 -17.36 63.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.564 -179.614 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.48 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 30.5 m -128.87 130.73 47.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.873 0.368 . . . . 0.0 110.992 -179.437 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.8 t -126.03 119.28 27.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.718 178.844 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.478 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 42.8 tp -116.77 130.17 56.55 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.155 -178.098 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.721 ' CE2' HD12 ' A' ' 37' ' ' ILE . 10.1 m-85 -109.01 140.41 42.57 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.41 179.921 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 153.88 -177.24 31.47 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.316 -0.945 . . . . 0.0 112.431 177.969 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -71.13 -32.51 69.07 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 111.725 0.268 . . . . 0.0 111.725 179.336 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.453 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -50.38 140.27 19.46 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.812 -178.0 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.48 HG23 ' N ' ' A' ' 34' ' ' GLU . 11.0 tp -67.1 -41.87 87.6 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 C-N-CA 120.381 -0.527 . . . . 0.0 109.597 179.569 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.48 ' N ' HG23 ' A' ' 33' ' ' ILE . 77.3 tt0 -55.6 -16.98 4.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.226 179.457 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 24.1 m -66.63 136.26 55.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.119 -179.79 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.48 ' OD2' ' O ' ' A' ' 26' ' ' THR . 68.8 m-20 -61.53 -33.72 74.3 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -178.999 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.721 HD12 ' CE2' ' A' ' 29' ' ' PHE . 98.3 mt -125.05 119.67 56.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 177.188 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -104.64 133.11 50.04 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.774 -177.999 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 98.9 mt -119.36 129.13 75.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.587 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -76.39 29.63 0.12 Allowed 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -178.082 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 41' ' ' LEU . 30.4 mt -94.12 129.03 38.7 Favored Pre-proline 0 C--N 1.322 -0.613 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.91 -179.806 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -72.86 -10.34 24.72 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 122.58 2.187 . . . . 0.0 113.046 -178.996 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.521 HG21 ' CE2' ' B' ' 241' ' ' PHE . 29.4 m -109.66 4.19 9.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.589 179.804 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.449 ' O ' ' O ' ' A' ' 45' ' ' SER . 4.5 t -91.8 108.17 19.72 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 CA-C-O 121.454 0.645 . . . . 0.0 110.642 179.623 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.507 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 1.1 m -32.09 153.05 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.999 -1.0 . . . . 0.0 112.167 -179.523 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -62.0 -42.36 99.06 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 114.406 -1.27 . . . . 0.0 111.192 -179.104 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.698 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.7 mt-30 -113.1 -18.09 12.24 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.097 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.507 ' H ' ' HB3' ' A' ' 45' ' ' SER . 35.5 t60 31.83 -71.42 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 114.902 -1.045 . . . . 0.0 113.23 179.879 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.698 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.66 135.41 47.82 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.282 . . . . . . . . 3 3 . 1 . 097 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -127.82 131.72 49.52 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.507 179.098 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.7 mt -116.28 136.2 54.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.536 -179.576 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -120.55 125.25 47.32 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.619 178.877 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.776 HG23 HH12 ' A' ' 5' ' ' ARG . 96.4 mt -105.24 114.27 44.34 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 CA-C-O 121.363 0.602 . . . . 0.0 111.569 -179.839 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.572 ' O ' ' N ' ' A' ' 56' ' ' GLN . 93.8 m-70 -112.22 144.46 41.59 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.671 179.641 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.474 ' C ' ' O ' ' A' ' 54' ' ' HIS . 81.8 tt0 -38.83 -26.42 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.81 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.572 ' N ' ' O ' ' A' ' 54' ' ' HIS . 68.9 tp60 -69.62 -68.11 0.43 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.676 178.32 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -160.82 -165.21 1.33 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.551 -179.695 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.41 124.93 52.65 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.013 179.468 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 98.5 mt -113.57 129.22 69.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.245 0.545 . . . . 0.0 112.445 -179.042 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.478 ' HB2' HD21 ' A' ' 82' ' ' LEU . 51.1 tp -95.17 126.73 40.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.355 179.227 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.409 ' ND1' ' HB3' ' A' ' 79' ' ' PRO . 96.0 m-70 -113.94 135.93 53.45 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.402 -179.305 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -95.74 106.67 18.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.952 0.406 . . . . 0.0 111.897 -179.678 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -99.17 -9.52 23.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.602 179.095 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.45 102.93 3.32 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.489 179.785 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 99.1 p -87.45 -1.58 58.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.083 0.468 . . . . 0.0 109.92 179.445 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -112.11 -35.81 5.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.378 -179.916 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 31.4 m-20 -144.27 90.42 6.69 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.607 179.675 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.38 147.1 48.24 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 123.108 2.539 . . . . 0.0 113.445 -178.298 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 58.8 m -71.85 130.41 40.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.32 179.609 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -98.91 143.57 29.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.771 179.637 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.0 t -131.67 133.22 61.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 179.161 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 54.04 33.62 18.03 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 119.491 -0.884 . . . . 0.0 109.286 179.489 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.34 28.73 69.34 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.235 179.627 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.1 m -139.27 133.0 30.65 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 117.439 0.619 . . . . 0.0 112.227 -179.854 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.453 ' H ' HG12 ' A' ' 75' ' ' VAL . 0.1 OUTLIER -72.28 137.91 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.213 179.75 . . . . . . . . 3 3 . 1 . 097 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.543 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 1.7 pt -119.07 115.85 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 121.194 0.521 . . . . 0.0 110.057 178.737 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -82.37 -18.5 41.83 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.165 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.622 ' CD ' ' H ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -124.89 164.71 29.67 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.875 -179.975 . . . . . . . . 3 3 . 1 . 097 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.409 ' HB3' ' ND1' ' A' ' 61' ' ' HIS . 33.6 Cg_endo -63.54 153.4 75.09 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 C-N-CA 122.789 2.326 . . . . 0.0 112.473 179.816 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.3 p -142.76 147.59 20.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.719 -179.259 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -78.65 129.95 35.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.746 179.294 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.478 HD21 ' HB2' ' A' ' 60' ' ' LEU . 91.0 mt -85.44 137.92 32.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.15 0.5 . . . . 0.0 111.257 -179.085 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -128.45 150.87 49.95 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.106 179.578 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.478 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 8.5 t60 -53.13 120.65 6.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.979 0.418 . . . . 0.0 111.156 -179.505 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.14 -20.82 23.28 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 179.746 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -67.56 136.03 53.88 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.053 0.454 . . . . 0.0 110.812 -179.814 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.1 t -116.53 132.18 66.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.058 -178.796 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 93.3 mt -92.6 131.77 38.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.291 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 54.5 m -123.47 124.71 43.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.8 0.809 . . . . 0.0 112.817 -178.41 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.492 ' O ' ' C ' ' A' ' 91' ' ' ILE . 96.5 mt -110.68 124.07 67.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.35 177.874 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.492 ' C ' ' O ' ' A' ' 90' ' ' ILE . 73.1 mt 33.98 -95.5 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.724 179.575 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' A' ' 90' ' ' ILE . 97.9 m-20 -113.72 9.52 17.75 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.557 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.759 ' HE ' HH22 ' B' ' 245' ' ' ARG . 97.5 mtt180 -125.08 144.25 50.51 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.513 -179.114 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.5 m -139.89 152.47 46.46 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.522 0.677 . . . . 0.0 111.388 -179.125 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.559 ' HB3' HD11 ' A' ' 7' ' ' LEU . 51.2 m-85 -125.62 121.98 35.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.572 179.81 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.51 ' O ' HD12 ' A' ' 7' ' ' LEU . 43.1 ttm180 -80.3 128.2 33.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.072 0.463 . . . . 0.0 111.639 -178.957 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -97.35 123.86 41.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.315 179.478 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -126.44 125.66 42.51 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.796 179.984 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.478 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 61.5 t-20 . . . . . 0 CA--C 1.53 0.193 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.255 179.443 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo . . . . . 0 N--CA 1.488 1.197 0 CA-C-O 121.32 0.467 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 097 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 53.7 t -63.35 136.4 26.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.088 179.942 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 4.2 t . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.446 -179.743 . . . . . . . . 0 0 . 1 . 097 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo . . . . . 0 N--CA 1.495 1.582 0 CA-C-O 120.63 0.179 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 097 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 16.1 m -66.78 -45.12 79.46 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.35 0.595 . . . . 0.0 109.529 178.644 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.521 ' CE2' HG21 ' A' ' 43' ' ' VAL . 79.6 t80 -59.18 -46.13 89.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.034 -178.827 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 99.7 mt -64.58 -40.06 94.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.736 0.303 . . . . 0.0 111.332 -178.978 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 -62.95 -39.62 95.21 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.735 -179.289 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . 0.4 ' HE ' ' HA ' ' B' ' 241' ' ' PHE . 87.7 mtm180 -64.03 -42.19 97.17 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.334 179.942 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.759 HH22 ' HE ' ' A' ' 93' ' ' ARG . 75.9 mtp85 -61.12 -41.33 96.52 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.781 -179.196 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -62.75 -41.36 99.17 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.479 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 8.7 t -63.59 -45.67 89.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.364 177.979 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -60.14 -39.11 85.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.128 -179.378 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . 0.495 HG23 ' O ' ' B' ' 245' ' ' ARG . 74.3 t . . . . . 0 C--N 1.329 -0.301 0 C-N-CA 120.256 -0.578 . . . . 0.0 110.274 179.643 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.616 ' OE1' ' NH2' ' A' ' 93' ' ' ARG . 93.8 mt-10 . . . . . 0 N--CA 1.464 0.265 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 . . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 59.5 mt -108.87 133.28 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.95 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 44.7 t -127.69 134.91 64.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.975 0.416 . . . . 0.0 111.109 -178.959 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -95.57 119.45 34.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.627 -178.767 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -64.79 -48.47 74.34 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.472 -179.517 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . 0.77 ' CD ' HD11 ' A' ' 24' ' ' LEU . 2.3 mt-30 -82.42 167.96 26.68 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.291 -179.236 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.85 144.98 89.92 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 121.701 1.601 . . . . 0.0 111.904 -179.554 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . 0.451 ' CD1' ' O ' ' A' ' 19' ' ' HIS . 7.8 tt . . . . . 0 C--N 1.321 -0.635 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.302 -179.275 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.9 p . . . . . 0 N--CA 1.462 0.158 0 CA-C-O 121.03 0.443 . . . . 0.0 110.384 . . . . . . . . . 0 0 . 1 . 098 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.728 ' NE ' HD13 ' A' ' 53' ' ' ILE . 89.6 mtm-85 -92.53 131.91 37.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.786 -179.398 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -133.01 141.93 48.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.011 0.434 . . . . 0.0 111.693 -179.927 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.486 HD12 ' O ' ' A' ' 96' ' ' ARG . 26.4 tp -114.92 130.0 56.82 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.787 179.729 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.496 HG22 ' CD2' ' A' ' 19' ' ' HIS . 56.1 t -106.58 128.95 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.288 -179.012 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.416 HG23 HD12 ' B' ' 261' ' ' ILE . 2.8 m -80.27 140.46 36.2 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.263 0.554 . . . . 0.0 111.365 -179.833 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.493 ' CD1' ' OD1' ' A' ' 16' ' ' ASP . 50.6 mm -113.19 137.95 44.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.549 179.609 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -90.66 156.71 17.91 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.716 179.367 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.409 ' HD3' ' NH1' ' B' ' 245' ' ' ARG . 90.0 mtm180 -59.36 -24.0 63.02 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.172 179.676 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 81.8 p -81.61 -10.92 59.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.069 0.461 . . . . 0.0 109.856 179.301 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.02 34.34 8.94 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 -179.975 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.2 t -118.06 131.75 69.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.742 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.493 ' OD1' ' CD1' ' A' ' 10' ' ' ILE . 89.4 m-20 -72.4 134.05 45.21 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.229 -0.589 . . . . 0.0 109.628 179.264 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -118.53 -125.37 3.46 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.48 -179.1 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.59 152.71 38.41 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.372 2.048 . . . . 0.0 112.537 -178.689 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.496 ' CD2' HG22 ' A' ' 8' ' ' VAL . 10.6 m80 -102.71 154.61 18.99 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.907 0.384 . . . . 0.0 110.627 179.549 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.462 ' CD2' HD11 ' A' ' 37' ' ' ILE . 53.2 t80 -124.71 91.21 49.81 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.829 179.557 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -60.6 129.66 30.32 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.206 1.937 . . . . 0.0 111.719 179.872 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 90.6 mt -88.81 84.25 6.67 Favored 'General case' 0 N--CA 1.461 0.119 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.974 -179.302 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.2 p -86.21 -10.53 54.51 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.653 179.411 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.676 HD11 ' CD ' ' B' ' 265' ' ' GLN . 66.4 mt -102.14 145.77 28.89 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.094 -179.405 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 81.9 p -68.33 -15.9 63.74 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.045 0.45 . . . . 0.0 110.833 -179.257 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 46.3 m -128.47 132.43 48.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.674 -179.201 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.9 t -126.23 114.17 17.95 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.765 178.611 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.506 HD12 ' O ' ' A' ' 49' ' ' CYS . 57.6 tp -111.31 122.51 48.05 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.906 0.384 . . . . 0.0 111.413 -178.459 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.831 ' CE2' HD12 ' A' ' 37' ' ' ILE . 11.1 m-85 -101.95 142.56 33.06 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.404 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 156.04 -169.63 33.67 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 120.136 -1.031 . . . . 0.0 112.453 179.17 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 31.9 ttp85 -89.28 -32.5 17.35 Favored 'General case' 0 N--CA 1.461 0.096 0 CA-C-O 120.817 0.342 . . . . 0.0 110.824 -179.899 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.432 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -50.36 145.41 9.7 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 -179.879 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.416 HD13 ' HA ' ' A' ' 33' ' ' ILE . 35.7 mm -63.69 -43.93 98.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.555 -179.614 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -54.8 -18.14 4.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.473 179.778 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.432 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 51.2 m -62.1 128.55 36.68 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.162 179.944 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.452 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 61.7 m-20 -58.97 -30.7 68.13 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -178.9 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.831 HD12 ' CE2' ' A' ' 29' ' ' PHE . 79.4 mt -126.5 121.74 59.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 177.126 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 47.6 mtt180 -101.12 136.06 41.59 Favored 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.266 -178.724 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.407 ' C ' ' H ' ' A' ' 41' ' ' LEU . 91.7 mt -117.12 125.33 73.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.995 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -70.92 39.07 0.05 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.308 -177.686 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 41' ' ' LEU . 43.3 mt -112.69 125.17 30.37 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 120.556 -0.458 . . . . 0.0 109.796 179.16 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.56 -2.75 12.61 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.224 1.949 . . . . 0.0 112.61 -179.143 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.529 HG21 ' CE2' ' B' ' 241' ' ' PHE . 33.3 m -109.1 2.97 9.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.767 179.088 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.463 ' O ' ' O ' ' A' ' 45' ' ' SER . 2.7 t -89.72 109.7 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 120.703 0.287 . . . . 0.0 110.592 -179.865 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.58 ' OG ' ' N ' ' A' ' 48' ' ' HIS . 1.1 t -31.79 152.08 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.384 0.611 . . . . 0.0 111.775 -178.771 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -63.26 -43.0 99.21 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.04 -179.194 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.605 ' O ' ' N ' ' A' ' 49' ' ' CYS . 13.3 mm100 -108.9 -26.43 10.24 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.635 0.731 . . . . 0.0 109.113 179.205 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.58 ' N ' ' OG ' ' A' ' 45' ' ' SER . 36.5 t60 39.68 -74.46 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.257 -1.338 . . . . 0.0 113.681 179.471 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.605 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.54 136.44 46.62 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -177.985 . . . . . . . . 3 3 . 1 . 098 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -128.07 127.67 43.53 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.803 179.317 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.3 mt -108.85 133.78 52.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.297 179.838 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.455 ' CD ' ' NE2' ' A' ' 54' ' ' HIS . 82.1 tt0 -118.73 123.81 45.78 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.006 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.728 HD13 ' NE ' ' A' ' 5' ' ' ARG . 97.0 mt -106.85 116.0 49.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -178.565 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.53 ' O ' ' N ' ' A' ' 56' ' ' GLN . 96.9 m-70 -111.32 143.51 42.0 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.123 178.366 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.9 mm-40 -39.35 -26.85 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.278 0.561 . . . . 0.0 109.761 -179.841 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.53 ' N ' ' O ' ' A' ' 54' ' ' HIS . 47.2 tp60 -67.89 -68.3 0.4 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.262 178.918 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -158.92 -165.79 1.71 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.25 179.734 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.406 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -109.88 131.52 54.99 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.013 179.843 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 93.5 mt -121.41 132.31 70.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.233 0.54 . . . . 0.0 112.003 -179.09 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.546 HD22 HD12 ' A' ' 88' ' ' ILE . 37.0 tp -101.53 125.69 48.22 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.758 -179.175 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -110.81 135.97 50.57 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.636 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -97.94 105.34 17.47 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -178.123 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -98.28 -8.6 26.9 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.624 179.13 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -78.2 98.23 5.78 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.985 0.422 . . . . 0.0 110.557 -179.716 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.7 m -84.55 -33.94 23.34 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.886 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.447 HG22 ' HA ' ' B' ' 236' ' ' VAL . 1.4 m -64.41 -50.64 66.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.843 179.64 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -136.28 96.74 12.34 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.831 -179.752 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.499 ' HB2' HG23 ' A' ' 75' ' ' VAL . 43.0 Cg_exo -55.29 143.43 75.95 Favored 'Trans proline' 0 N--CA 1.499 1.822 0 C-N-CA 122.151 1.901 . . . . 0.0 112.856 -178.822 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 18.2 m -72.06 140.34 48.92 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.406 179.93 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -104.01 140.35 37.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.438 -179.96 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.689 HG13 ' OD1' ' A' ' 86' ' ' ASP . 49.3 t -130.1 137.09 57.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.907 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.438 HD22 HG12 ' A' ' 87' ' ' VAL . 7.9 m120 54.05 32.55 15.83 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.267 -0.573 . . . . 0.0 109.791 -179.643 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.22 29.18 72.13 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.05 179.623 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 49.8 m -141.28 135.65 30.84 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.163 -179.996 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.499 HG23 ' HB2' ' A' ' 68' ' ' PRO . 2.4 p -70.86 136.32 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 121.181 0.515 . . . . 0.0 111.681 -179.303 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.878 HD13 ' O ' ' A' ' 76' ' ' ILE . 0.0 OUTLIER -132.68 125.25 52.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.837 179.77 . . . . . . . . 3 3 . 1 . 098 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -99.32 -9.02 24.08 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.121 -179.713 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.847 ' O ' HD11 ' A' ' 76' ' ' ILE . 16.3 mt-10 -119.6 156.72 53.3 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.299 -179.082 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -62.52 148.15 93.76 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.48 2.12 . . . . 0.0 112.702 -179.951 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.5 m -143.76 145.4 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.427 -179.608 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 87.3 mtm-85 -73.35 130.2 39.66 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.529 179.349 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.497 HD11 ' HB2' ' A' ' 60' ' ' LEU . 96.0 mt -85.35 140.69 30.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.278 0.561 . . . . 0.0 111.274 -179.682 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -133.62 157.51 45.57 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.256 -179.661 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -58.81 117.19 4.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.242 -179.664 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.65 -1.29 29.06 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 -179.365 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.689 ' OD1' HG13 ' A' ' 71' ' ' VAL . 60.7 t0 -86.17 125.36 33.46 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.027 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.438 HG12 HD22 ' A' ' 72' ' ' ASN . 9.5 p -103.38 135.37 41.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 C-N-CA 120.461 -0.495 . . . . 0.0 111.543 -178.875 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.546 HD12 HD22 ' A' ' 60' ' ' LEU . 33.2 mm -96.14 128.28 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 177.789 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 36.3 m -122.79 121.55 36.56 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 119.688 -0.805 . . . . 0.0 113.08 -178.27 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.481 HD12 ' HE1' ' A' ' 95' ' ' PHE . 93.3 mt -110.36 124.79 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 114.624 -1.171 . . . . 0.0 108.623 177.672 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.593 HG22 ' NH2' ' B' ' 245' ' ' ARG . 61.1 mt 33.54 -99.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 121.034 -0.267 . . . . 0.0 111.195 179.7 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.506 ' O ' ' OD1' ' A' ' 92' ' ' ASP . 59.3 t0 -112.98 15.61 19.61 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.489 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.526 HH21 ' CD ' ' B' ' 260' ' ' GLU . 87.3 mtt-85 -129.32 140.61 51.34 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.128 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 75.2 m -137.17 154.73 50.16 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 119.958 -0.697 . . . . 0.0 111.585 -179.491 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.481 ' HE1' HD12 ' A' ' 90' ' ' ILE . 78.4 m-85 -125.17 121.43 34.16 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.209 179.689 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.486 ' O ' HD12 ' A' ' 7' ' ' LEU . 79.1 mtp85 -85.82 134.05 33.94 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.617 -179.685 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -93.53 123.76 37.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.736 -179.825 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -125.09 119.24 28.05 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.778 -179.769 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 . . . . . 0 N--CA 1.469 0.482 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.266 -179.754 . . . . . . . . 0 0 . 1 . 098 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo . . . . . 0 N--CA 1.492 1.433 0 CA-C-O 121.462 0.526 . . . . 0.0 112.69 . . . . . . . . . 0 0 . 1 . 098 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.447 ' HA ' HG22 ' A' ' 66' ' ' THR . 3.3 p -69.22 138.11 22.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.558 -0.747 . . . . 0.0 111.275 -178.841 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.5 t . . . . . 0 CA--C 1.516 -0.33 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.168 . . . . . . . . 0 0 . 1 . 098 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo . . . . . 0 N--CA 1.502 2.001 0 N-CA-C 113.189 0.419 . . . . 0.0 113.189 . . . . . . . . . 0 0 . 1 . 098 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 89.4 m -72.21 -44.75 62.5 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.396 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.529 ' CE2' HG21 ' A' ' 43' ' ' VAL . 80.8 t80 -57.33 -46.5 83.18 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.072 -179.777 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.432 HD21 HG23 ' A' ' 91' ' ' ILE . 91.2 mt -64.19 -43.09 96.15 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 -179.936 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -65.52 -39.93 92.39 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.061 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 53.8 ttt85 -62.97 -46.22 88.73 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.354 -179.563 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.801 ' O ' HG23 ' B' ' 249' ' ' VAL . 45.4 mtm180 -66.97 -37.9 85.1 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.903 -179.801 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -60.43 -45.94 91.82 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.207 -179.423 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 11.6 t -64.78 -44.66 89.29 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.677 178.681 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -63.52 -32.22 73.61 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.868 179.884 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . 0.801 HG23 ' O ' ' B' ' 245' ' ' ARG . 71.9 t . . . . . 0 C--N 1.326 -0.443 0 C-N-CA 120.286 -0.566 . . . . 0.0 109.644 179.46 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.526 ' CD ' HH21 ' A' ' 93' ' ' ARG . 95.4 mt-10 . . . . . 0 CA--C 1.527 0.087 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 . . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.416 HD12 HG23 ' A' ' 9' ' ' THR . 74.0 mt -111.96 134.69 53.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.269 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 73.9 t -127.1 133.72 67.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.955 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -94.97 121.23 36.36 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.132 0.491 . . . . 0.0 111.483 -177.303 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -64.51 -43.99 92.34 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.956 179.606 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . 0.676 ' CD ' HD11 ' A' ' 24' ' ' LEU . 2.1 mt-30 -89.05 167.14 18.82 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.191 -178.068 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . 0.443 ' C ' HD13 ' B' ' 267' ' ' ILE . 60.6 Cg_endo -70.77 149.27 60.21 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.744 2.296 . . . . 0.0 112.115 -179.885 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . 0.566 ' N ' HD13 ' B' ' 267' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.394 0 CA-C-O 121.594 0.712 . . . . 0.0 109.448 179.568 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 36.1 p . . . . . 0 N--CA 1.465 0.314 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 . . . . . . . . . 0 0 . 1 . 099 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.633 ' NH1' ' HB2' ' A' ' 58' ' ' ALA . 94.6 mtt-85 -90.48 123.76 34.44 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.659 -0.417 . . . . 0.0 111.709 -178.034 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.7 mtm-85 -127.7 130.53 49.01 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 121.113 0.482 . . . . 0.0 110.497 179.155 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.627 HD11 ' HB3' ' A' ' 95' ' ' PHE . 51.7 tp -113.01 125.14 54.08 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.885 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.7 m -104.7 133.44 48.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.42 -178.94 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.9 m -83.03 143.81 30.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.771 -179.268 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.627 HD12 ' OG ' ' A' ' 94' ' ' SER . 97.2 mt -116.88 140.98 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.464 177.687 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -92.32 156.54 17.18 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.587 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.04 -15.87 37.24 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.779 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.6 p -77.16 -19.53 56.7 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.103 178.131 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.57 14.02 42.32 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.48 178.984 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.4 m -113.15 144.48 20.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.023 0.44 . . . . 0.0 111.101 -179.891 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 17' ' ' GLY . 61.9 t0 -80.1 130.47 35.27 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.999 -179.363 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.462 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -116.84 -122.55 3.35 Favored Glycine 0 CA--C 1.535 1.334 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 -179.803 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -71.97 151.77 56.67 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 121.737 1.625 . . . . 0.0 112.653 -178.913 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -108.28 151.65 25.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.989 0.423 . . . . 0.0 110.344 -179.508 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.854 ' CD2' HD11 ' A' ' 37' ' ' ILE . 49.2 t80 -120.09 96.91 49.4 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.478 -179.066 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.451 ' HD2' HG22 ' B' ' 267' ' ' ILE . 87.6 Cg_endo -75.57 137.26 20.28 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 121.024 1.15 . . . . 0.0 111.686 -179.252 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 22' ' ' LEU . 84.1 mt -99.21 120.76 40.05 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 119.884 -0.726 . . . . 0.0 111.848 -178.717 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.7 p -122.4 -0.46 9.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.64 178.366 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.424 HD11 ' CG ' ' B' ' 265' ' ' GLN . 63.6 mt -105.85 149.34 26.6 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.994 -179.054 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.3 p -69.39 -21.0 63.81 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.984 -179.397 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 42.8 m -128.8 131.96 47.82 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.056 -179.829 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.486 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -132.85 126.38 32.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.274 178.205 . . . . . . . . 3 3 . 1 . 099 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.755 HD21 ' OE1' ' A' ' 47' ' ' GLN . 33.3 tp -122.23 133.23 54.71 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.973 -178.056 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.505 ' O ' ' O ' ' A' ' 47' ' ' GLN . 51.0 m-85 -106.06 138.19 42.68 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.323 -0.853 . . . . 0.0 108.925 178.808 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 155.04 -172.85 33.38 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 120.381 -0.914 . . . . 0.0 111.731 179.181 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.42 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 46.7 mtm105 -81.32 -31.27 33.61 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -179.467 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.506 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -48.06 148.36 4.05 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.706 -179.004 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.555 HG23 ' N ' ' A' ' 34' ' ' GLU . 9.9 tp -65.79 -43.45 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 120.695 0.283 . . . . 0.0 111.037 179.733 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.555 ' N ' HG23 ' A' ' 33' ' ' ILE . 81.8 tt0 -59.39 -18.38 38.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.416 -179.736 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 33.4 m -57.84 126.81 29.02 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.739 -179.327 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.556 ' CG ' HE22 ' B' ' 265' ' ' GLN . 50.1 m-20 -62.59 -33.9 75.9 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.523 -179.606 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.854 HD11 ' CD2' ' A' ' 20' ' ' PHE . 40.6 mm -119.87 111.33 32.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 177.312 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.407 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 85.2 mtp180 -99.23 132.45 44.54 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 120.681 -0.407 . . . . 0.0 110.225 -179.403 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.578 HG23 ' NH1' ' A' ' 93' ' ' ARG . 80.7 mt -122.71 131.76 72.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.803 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -82.31 32.95 0.4 Allowed 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -177.859 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.665 HD21 ' NH2' ' A' ' 93' ' ' ARG . 70.3 mt -96.1 131.11 29.49 Favored Pre-proline 0 N--CA 1.469 0.483 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.121 178.992 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -73.4 -14.46 25.23 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.169 1.913 . . . . 0.0 112.156 179.672 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.583 HG21 ' CE2' ' B' ' 241' ' ' PHE . 21.3 m -93.07 7.14 5.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.602 179.931 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.42 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 24.3 t -101.37 134.46 41.57 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.482 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.5 m -71.84 168.14 18.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.282 0.563 . . . . 0.0 111.14 -179.131 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -60.91 -39.15 88.26 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.114 -178.98 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.755 ' OE1' HD21 ' A' ' 28' ' ' LEU . 13.4 mm100 -112.47 -18.07 12.52 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.619 0.247 . . . . 0.0 110.725 -179.828 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 23.3 t60 36.66 -75.9 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 179.634 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.772 ' SG ' HD11 ' A' ' 60' ' ' LEU . 0.1 OUTLIER -136.68 139.19 41.8 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.796 -178.581 . . . . . . . . 3 3 . 1 . 099 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -124.65 139.11 54.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.848 179.572 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.617 HD11 HD12 ' A' ' 82' ' ' LEU . 17.3 tt -128.95 138.29 54.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.143 179.959 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -117.22 137.84 52.1 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.015 179.144 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.7 mm -103.36 124.26 57.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.514 0.673 . . . . 0.0 111.159 -179.318 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.474 ' O ' ' N ' ' A' ' 56' ' ' GLN . 50.3 m-70 -125.41 132.15 52.81 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.17 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.473 ' C ' ' O ' ' A' ' 54' ' ' HIS . 97.7 mt-10 -39.59 -30.56 0.07 Allowed 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.125 -178.8 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.474 ' N ' ' O ' ' A' ' 54' ' ' HIS . 98.6 mt-30 -65.37 -69.9 0.27 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.264 179.33 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -154.88 -159.47 0.95 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.691 -179.777 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.633 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -119.71 137.9 53.63 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.864 0.364 . . . . 0.0 110.601 -179.84 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.3 mm -111.61 120.6 62.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.11 179.936 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.772 HD11 ' SG ' ' A' ' 49' ' ' CYS . 48.7 tp -98.22 126.04 43.53 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.248 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -113.34 136.14 53.09 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.817 -179.412 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.477 HD21 ' HA ' ' A' ' 68' ' ' PRO . 61.2 t-20 -96.21 109.8 22.21 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.98 0.419 . . . . 0.0 111.683 179.915 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -102.38 -9.41 20.33 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.343 179.4 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.22 98.8 9.58 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.821 0.343 . . . . 0.0 111.185 -179.296 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.3 p -78.77 -38.5 38.44 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.967 0.413 . . . . 0.0 109.959 178.729 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.41 -44.57 90.83 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.647 -179.488 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.431 ' CG ' ' H ' ' B' ' 237' ' ' CYS . 89.9 m-20 -139.41 89.56 12.03 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.188 179.897 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.529 ' HB2' HG13 ' A' ' 75' ' ' VAL . 46.4 Cg_exo -54.14 145.59 53.17 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.427 2.085 . . . . 0.0 112.449 -179.675 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.5 m -75.91 143.81 41.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.907 -179.175 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -103.88 142.84 33.7 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.658 179.994 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.48 ' CG2' ' OD1' ' A' ' 86' ' ' ASP . 4.5 p -131.33 135.47 59.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.198 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 51.92 28.95 5.57 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -179.576 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.86 27.45 64.71 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.319 179.995 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.415 ' N ' ' O ' ' A' ' 71' ' ' VAL . 25.5 m -139.9 140.5 36.46 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.86 -179.498 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.529 HG13 ' HB2' ' A' ' 68' ' ' PRO . 51.1 t -68.42 136.96 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -179.309 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.3 pt -110.74 79.68 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.226 0 CA-C-O 121.118 0.485 . . . . 0.0 111.491 179.188 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -61.13 -31.76 71.46 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.918 179.326 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.581 ' OE1' ' N ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -114.84 159.6 36.79 Favored Pre-proline 0 CA--C 1.517 -0.305 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.766 . . . . . . . . 3 3 . 1 . 099 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -62.49 144.51 94.78 Favored 'Trans proline' 0 C--N 1.294 -2.341 0 C-N-CA 122.462 2.108 . . . . 0.0 111.72 -179.343 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 44.1 t -135.09 138.21 49.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.94 -179.151 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -74.63 137.65 42.39 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.831 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.617 HD12 HD11 ' A' ' 51' ' ' ILE . 93.3 mt -91.46 141.0 29.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.177 0.513 . . . . 0.0 112.349 -178.782 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -129.91 154.42 47.34 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.076 179.293 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -53.03 117.21 2.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.71 -179.565 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.38 -22.03 12.42 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 179.56 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 87' ' ' VAL . 59.4 t0 -62.76 130.27 44.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.259 0.552 . . . . 0.0 111.292 -179.873 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.588 HG22 ' HG2' ' A' ' 96' ' ' ARG . 61.7 t -105.65 133.05 51.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.231 -179.247 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 86.4 mt -103.12 128.74 55.82 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.639 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.8 m -119.06 129.01 54.86 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -178.422 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.674 ' O ' ' N ' ' A' ' 93' ' ' ARG . 98.6 mt -115.84 133.96 60.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 113.974 -1.466 . . . . 0.0 107.826 177.121 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.615 HG23 HD21 ' B' ' 242' ' ' LEU . 77.5 mt -19.12 94.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.028 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.42 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 0.4 OUTLIER 80.34 -13.22 0.96 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 177.771 . . . . . . . . 3 3 . 1 . 099 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.674 ' N ' ' O ' ' A' ' 90' ' ' ILE . 88.2 mtt180 -128.4 137.92 52.1 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.564 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.627 ' OG ' HD12 ' A' ' 10' ' ' ILE . 62.6 p -139.27 156.7 46.88 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.396 0.617 . . . . 0.0 110.697 -179.549 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.627 ' HB3' HD11 ' A' ' 7' ' ' LEU . 78.0 m-85 -130.63 127.33 38.73 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.496 -0.775 . . . . 0.0 108.995 179.596 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.588 ' HG2' HG22 ' A' ' 87' ' ' VAL . 99.5 mtt180 -94.91 138.15 33.05 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.832 -179.514 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.58 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 83.1 t80 -96.71 126.1 41.64 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.876 -179.087 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -124.81 119.73 29.72 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.828 179.521 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 . . . . . 0 N--CA 1.464 0.242 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.124 -179.462 . . . . . . . . 0 0 . 1 . 099 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo . . . . . 0 N--CA 1.495 1.615 0 N-CA-C 113.654 0.598 . . . . 0.0 113.654 . . . . . . . . . 0 0 . 1 . 099 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 38.8 t -61.77 137.47 23.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.461 179.213 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . 0.431 ' H ' ' CG ' ' A' ' 67' ' ' ASN . 0.7 OUTLIER . . . . . 0 C--N 1.326 -0.452 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.263 -178.902 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo . . . . . 0 N--CA 1.49 1.305 0 N-CA-C 111.601 -0.192 . . . . 0.0 111.601 . . . . . . . . . 0 0 . 1 . 099 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 94.7 m -72.89 -46.05 54.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.952 179.095 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.583 ' CE2' HG21 ' A' ' 43' ' ' VAL . 76.1 t80 -59.33 -45.63 90.83 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.579 -178.528 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.615 HD21 HG23 ' A' ' 91' ' ' ILE . 77.4 mt -65.32 -44.31 88.22 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.992 -179.178 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -62.48 -41.01 98.49 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.558 -179.098 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -63.84 -46.33 85.55 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.311 -179.251 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . . . . . . . . . 57.1 ttm-85 -64.82 -42.95 94.57 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.133 -179.246 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . 0.401 ' O ' HG12 ' B' ' 249' ' ' VAL . 98.3 mttt -63.27 -39.11 93.68 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.37 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 38.7 t -63.53 -44.98 92.64 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.674 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -58.61 -37.23 75.42 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.815 -179.687 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . 0.401 HG12 ' O ' ' B' ' 246' ' ' LYS . 0.3 OUTLIER . . . . . 0 CA--C 1.533 0.291 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.896 179.839 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.61 ' N ' ' OE1' ' B' ' 260' ' ' GLU . 56.8 mp0 . . . . . 0 C--O 1.233 0.195 0 CA-C-O 121.146 0.498 . . . . 0.0 111.551 . . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 72.1 mt -109.81 137.98 39.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.705 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 55.2 t -127.42 134.45 65.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 C-N-CA 120.202 -0.599 . . . . 0.0 111.239 -178.506 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -93.7 118.01 30.83 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.379 -178.861 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -67.02 -46.94 72.94 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.61 179.751 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . 0.556 HE22 ' CG ' ' A' ' 36' ' ' ASP . 2.1 mp0 -81.6 162.64 57.43 Favored Pre-proline 0 CA--C 1.514 -0.422 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.934 -178.785 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.9 144.49 58.84 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 121.617 1.545 . . . . 0.0 111.643 179.088 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . 0.451 HG22 ' HD2' ' A' ' 21' ' ' PRO . 43.3 pt . . . . . 0 C--N 1.32 -0.717 0 CA-C-O 121.386 0.613 . . . . 0.0 109.43 178.553 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.0 p . . . . . 0 CA--C 1.528 0.107 0 CA-C-O 121.023 0.439 . . . . 0.0 109.943 . . . . . . . . . 0 0 . 1 . 100 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.733 ' NH1' ' HB2' ' A' ' 58' ' ' ALA . 92.2 mtt-85 -92.47 124.08 36.25 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.268 -179.177 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -130.15 139.57 50.86 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.551 -179.877 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.511 HD11 ' HB3' ' A' ' 95' ' ' PHE . 33.5 tp -115.95 130.91 57.03 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.274 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.674 HG12 ' CD2' ' A' ' 19' ' ' HIS . 33.3 m -111.25 134.32 53.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 C-N-CA 120.744 -0.383 . . . . 0.0 110.77 -179.779 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.5 m -95.02 117.87 30.89 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -177.817 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.664 HD12 ' OG ' ' A' ' 94' ' ' SER . 97.6 mt -80.94 144.27 10.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.13 178.443 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -92.64 163.8 13.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.755 178.8 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.644 ' CZ ' HH11 ' B' ' 245' ' ' ARG . 83.1 mtp180 -55.47 -30.54 60.77 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.885 -179.191 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 95.8 p -79.95 -7.58 58.86 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 120.666 -0.413 . . . . 0.0 111.521 -179.983 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.39 35.11 8.16 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.853 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.6 t -121.46 133.62 67.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.86 0.362 . . . . 0.0 110.626 -179.671 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -73.95 135.48 43.23 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 178.788 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.5 -116.95 1.93 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 120.412 -0.899 . . . . 0.0 111.699 -179.603 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -68.37 142.13 53.65 Favored 'Trans proline' 0 N--CA 1.49 1.276 0 C-N-CA 121.593 1.528 . . . . 0.0 112.545 -178.665 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.674 ' CD2' HG12 ' A' ' 8' ' ' VAL . 49.4 m170 -106.15 142.68 35.43 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.269 -179.377 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.544 ' CD2' HD11 ' A' ' 37' ' ' ILE . 37.6 t80 -113.32 93.32 26.01 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.272 -179.673 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -62.45 126.82 19.28 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 121.713 1.608 . . . . 0.0 110.387 179.7 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.6 mt -86.75 51.75 2.32 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.406 -178.719 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 88.9 p -61.67 -23.64 66.22 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.198 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.506 HD11 ' CD ' ' B' ' 265' ' ' GLN . 92.6 mt -77.61 139.03 39.45 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.264 179.36 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 99.3 p -66.4 -16.86 64.41 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.837 -178.461 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 61.8 m -138.83 138.44 37.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.565 0.222 . . . . 0.0 110.669 179.998 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.682 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -138.2 133.53 33.36 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.987 0.423 . . . . 0.0 110.69 179.205 . . . . . . . . 3 3 . 1 . 100 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.56 HD21 ' HG2' ' A' ' 47' ' ' GLN . 34.7 tp -123.04 131.45 53.71 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.745 -178.056 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.728 ' CE2' HD12 ' A' ' 37' ' ' ILE . 8.2 m-85 -107.2 141.95 37.69 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.115 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 158.5 -175.66 35.56 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.92 179.169 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.599 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 86.8 mtm-85 -74.94 -27.34 60.16 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 122.659 -0.318 . . . . 0.0 110.928 -179.935 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.566 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -59.14 138.05 49.83 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.154 -177.925 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.449 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.0 tp -66.51 -41.56 88.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.721 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.449 ' N ' HG23 ' A' ' 33' ' ' ILE . 84.4 tt0 -51.93 -19.0 1.55 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.376 178.854 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.566 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 13.8 m -67.91 137.77 55.48 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.568 179.209 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -60.74 -33.77 73.42 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -179.251 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.728 HD12 ' CE2' ' A' ' 29' ' ' PHE . 96.8 mt -127.26 124.72 64.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.247 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.431 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 78.4 ttt-85 -109.34 134.23 52.07 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.115 -178.579 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 82.0 mt -116.45 130.59 71.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.929 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -78.82 26.04 0.25 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.792 -178.056 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.739 HD21 ' OE1' ' B' ' 260' ' ' GLU . 31.5 mt -95.37 125.96 47.86 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.977 179.947 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.69 -14.33 33.06 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.555 2.17 . . . . 0.0 113.056 -179.786 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.598 HG23 HD13 ' A' ' 91' ' ' ILE . 15.3 m -93.83 6.05 6.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.92 0.39 . . . . 0.0 110.7 -179.698 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.599 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 57.5 t -100.71 134.57 40.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.429 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.529 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 0.2 OUTLIER -66.07 167.71 9.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.165 0.507 . . . . 0.0 112.023 -178.658 . . . . . . . . 3 3 . 1 . 100 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -60.21 -42.67 95.62 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.664 -179.676 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.728 ' O ' ' N ' ' A' ' 49' ' ' CYS . 85.0 mt-30 -111.64 -12.15 13.93 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.463 179.675 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.529 ' H ' ' HB3' ' A' ' 45' ' ' SER . 27.7 t60 32.94 -68.17 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -179.852 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.728 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -142.87 143.87 32.25 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.202 -0.599 . . . . 0.0 112.152 -179.464 . . . . . . . . 3 3 . 1 . 100 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -125.18 137.62 54.14 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.832 179.436 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.51 HD11 HD12 ' A' ' 82' ' ' LEU . 19.8 tt -125.09 138.08 55.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.072 0.463 . . . . 0.0 110.128 -179.724 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -122.8 135.07 54.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.284 -179.463 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.521 HD13 ' HD2' ' A' ' 5' ' ' ARG . 96.7 mt -109.88 117.04 53.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.61 0.719 . . . . 0.0 111.949 -179.602 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.555 ' O ' ' N ' ' A' ' 56' ' ' GLN . 94.9 m-70 -116.37 142.52 46.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.475 -1.239 . . . . 0.0 110.351 -179.981 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 54' ' ' HIS . 80.8 mm-40 -39.88 -24.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.993 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.555 ' N ' ' O ' ' A' ' 54' ' ' HIS . 59.5 tt0 -69.47 -67.57 0.47 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.272 178.613 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.494 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 6.0 tp10 -161.12 -158.87 0.61 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.23 179.237 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.733 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -114.39 125.06 53.42 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.816 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.2 mt -114.12 130.91 67.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.129 0.49 . . . . 0.0 111.883 -178.447 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.507 HD11 ' SG ' ' A' ' 49' ' ' CYS . 56.5 tp -99.85 129.05 45.9 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.717 -179.391 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -113.59 136.72 52.5 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.542 179.65 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.407 ' ND2' ' HB3' ' A' ' 68' ' ' PRO . 29.9 t30 -95.28 108.79 20.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.04 0.447 . . . . 0.0 111.777 -179.962 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -98.78 -8.51 25.83 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.739 179.182 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.7 t -81.2 105.84 12.72 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.263 179.721 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.7 p -87.36 -20.36 26.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.244 0.545 . . . . 0.0 109.668 179.567 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.461 HG22 HG22 ' B' ' 236' ' ' VAL . 0.3 OUTLIER -86.32 -33.58 20.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.196 -179.642 . . . . . . . . 3 3 . 1 . 100 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.4 HD21 ' HA ' ' B' ' 236' ' ' VAL . 74.7 m-80 -150.84 93.95 3.64 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.17 179.926 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.726 ' HB2' HG13 ' A' ' 75' ' ' VAL . 32.2 Cg_exo -56.73 149.29 60.38 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.165 1.91 . . . . 0.0 112.009 -179.801 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 51.9 m -73.57 137.41 44.31 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.04 178.846 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -98.0 141.16 31.3 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.59 -179.768 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 51.8 t -126.45 134.11 67.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.21 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 51.65 33.18 10.35 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.974 -0.69 . . . . 0.0 109.416 -179.099 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.66 29.97 69.06 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.659 179.81 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.4 m -140.6 135.37 31.69 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 117.001 0.401 . . . . 0.0 111.142 -179.912 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.726 HG13 ' HB2' ' A' ' 68' ' ' PRO . 55.7 t -69.1 136.74 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.725 -179.606 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.55 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 1.1 pt -104.96 100.4 10.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-O 121.361 0.6 . . . . 0.0 110.677 178.959 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -65.45 -35.47 81.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.311 179.166 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -123.66 175.99 2.48 Favored Pre-proline 0 CA--C 1.536 0.404 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.548 -179.008 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.01 145.34 96.74 Favored 'Trans proline' 0 N--CA 1.501 1.926 0 C-N-CA 122.575 2.183 . . . . 0.0 111.954 -179.443 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.5 m -136.01 138.93 46.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.995 0.426 . . . . 0.0 112.14 -179.235 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -76.36 133.14 40.03 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 178.819 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.51 HD12 HD11 ' A' ' 51' ' ' ILE . 89.9 mt -89.43 136.01 33.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.413 0.625 . . . . 0.0 112.009 -178.589 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -121.26 148.61 44.06 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.742 179.014 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -54.49 123.04 11.84 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.931 0.396 . . . . 0.0 110.279 -179.577 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.13 -20.28 31.07 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.67 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -66.11 137.62 57.17 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.728 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.449 HG22 ' HG2' ' A' ' 96' ' ' ARG . 55.2 t -112.6 133.16 59.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.521 -178.368 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 92.2 mt -99.22 130.68 47.82 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 178.7 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 65.9 m -122.45 124.91 44.71 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.067 -0.653 . . . . 0.0 112.067 -178.735 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.549 HD12 ' HE1' ' A' ' 95' ' ' PHE . 77.0 mt -109.53 121.5 62.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.255 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.598 HD13 HG23 ' A' ' 43' ' ' VAL . 77.4 mt 35.24 -97.76 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.493 -179.867 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.562 ' OD2' ' NE ' ' B' ' 245' ' ' ARG . 42.0 p-10 -110.73 7.68 22.24 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.666 0.269 . . . . 0.0 111.633 -179.219 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 90' ' ' ILE . 85.6 mtt-85 -124.01 144.4 49.85 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.667 179.916 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.664 ' OG ' HD12 ' A' ' 10' ' ' ILE . 32.7 p -137.9 151.02 47.59 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.49 0.662 . . . . 0.0 111.056 179.553 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.549 ' HE1' HD12 ' A' ' 90' ' ' ILE . 35.1 m-85 -124.01 122.11 37.04 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.324 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.449 ' HG2' HG22 ' A' ' 87' ' ' VAL . 74.7 mtp85 -87.85 135.22 33.49 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.851 -178.658 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.571 ' HH ' ' HG2' ' A' ' 5' ' ' ARG . 89.7 t80 -99.25 125.16 44.81 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.629 -179.669 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -143.77 125.46 15.03 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.475 179.472 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.538 ' OD1' ' CZ ' ' A' ' 97' ' ' TYR . 95.4 m-20 . . . . . 0 C--N 1.331 -0.225 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.567 179.705 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo . . . . . 0 N--CA 1.495 1.614 0 N-CA-C 113.342 0.478 . . . . 0.0 113.342 . . . . . . . . . 0 0 . 1 . 100 nuclear nobuild core ' B' B ' 236' ' ' VAL . . . . . 0.461 HG22 HG22 ' A' ' 66' ' ' THR . 71.4 t -58.25 131.09 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.013 -179.806 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 4.5 t . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.644 -179.539 . . . . . . . . 0 0 . 1 . 100 nuclear nobuild core ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo . . . . . 0 N--CA 1.494 1.558 0 CA-C-O 120.745 0.227 . . . . 0.0 111.945 . . . . . . . . . 0 0 . 1 . 100 nuclear nobuild core ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 29.3 m -72.72 -45.76 57.12 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.079 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' B' B ' 241' ' ' PHE . . . . . 0.481 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 79.4 t80 -58.69 -45.97 88.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.729 -179.872 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.403 ' HA ' HD23 ' B' ' 242' ' ' LEU . 82.1 mt -64.41 -39.04 93.08 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.012 0.434 . . . . 0.0 110.28 -179.899 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -64.08 -39.94 95.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.16 -179.239 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -62.47 -41.42 98.75 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.987 0.422 . . . . 0.0 110.212 179.831 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' B' B ' 245' ' ' ARG . . . . . 0.811 ' O ' HG23 ' B' ' 249' ' ' VAL . 14.9 tpp180 -60.86 -42.38 97.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.081 -179.735 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.39 -42.87 98.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.727 179.738 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 43.8 p -65.37 -44.01 88.94 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.834 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' B' B ' 248' ' ' GLN . . . . . 0.537 ' HB3' HH22 ' A' ' 12' ' ' ARG . 84.5 mt-30 -64.42 -34.48 78.27 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.919 179.737 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . 0.811 HG23 ' O ' ' B' ' 245' ' ' ARG . 79.7 t . . . . . 0 N--CA 1.455 -0.219 0 C-N-CA 120.271 -0.572 . . . . 0.0 109.919 179.788 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' B' B ' 260' ' ' GLU . . . . . 0.739 ' OE1' HD21 ' A' ' 41' ' ' LEU . 96.8 mt-10 . . . . . 0 CA--C 1.532 0.257 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 . . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 75.7 mt -117.14 134.27 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 C-N-CA 120.544 -0.462 . . . . 0.0 109.911 179.587 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 45.8 t -127.06 133.61 67.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.066 179.549 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' B' B ' 263' ' ' PHE . . . . . 0.651 ' CD2' HG21 ' B' ' 267' ' ' ILE . 85.4 m-85 -98.76 122.15 41.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.088 0.471 . . . . 0.0 111.857 -178.499 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -66.17 -43.11 87.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.134 178.356 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' B' B ' 265' ' ' GLN . . . . . 0.506 ' CD ' HD11 ' A' ' 24' ' ' LEU . 0.9 OUTLIER -102.2 174.16 3.06 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.344 -179.699 . . . . . . . . 3 3 . 1 . 100 nuclear nobuild core ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -56.56 150.62 50.92 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 122.825 2.35 . . . . 0.0 113.765 179.76 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . 0.651 HG21 ' CD2' ' B' ' 263' ' ' PHE . 34.2 pt . . . . . 0 C--N 1.332 -0.165 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.164 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo . . . . . 0 N--CA 1.493 1.476 0 CA-C-O 120.956 0.315 . . . . 0.0 112.25 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 65.7 p -88.87 -42.86 11.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.839 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.8 mtt85 -89.0 126.91 35.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.647 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -127.48 138.52 52.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.795 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.575 HD11 ' HB3' ' A' ' 95' ' ' PHE . 24.3 tp -117.21 131.63 56.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.023 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.2 t -108.98 131.9 58.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.681 0.276 . . . . 0.0 110.708 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.6 m -82.15 133.18 35.25 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.395 0.617 . . . . 0.0 112.206 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.526 HD12 ' HB2' ' A' ' 94' ' ' SER . 92.8 mt -103.78 137.61 31.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.619 177.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.426 ' HD3' HG23 ' A' ' 15' ' ' VAL . 50.0 mtpt -97.83 160.03 14.56 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.99 -178.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -58.14 -25.57 61.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.299 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.801 ' OG ' HG22 ' A' ' 15' ' ' VAL . 60.1 p -79.64 -13.69 59.32 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.582 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.81 19.73 33.44 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.002 -0.618 . . . . 0.0 111.772 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.801 HG22 ' OG ' ' A' ' 13' ' ' SER . 27.5 m -115.94 135.67 55.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -76.1 141.06 42.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.828 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -123.25 -118.17 2.41 Favored Glycine 0 CA--C 1.542 1.728 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.795 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -72.04 147.96 49.88 Favored 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 122.415 2.077 . . . . 0.0 112.8 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -108.06 150.07 27.64 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.172 0.51 . . . . 0.0 110.768 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.469 ' CD2' HD11 ' A' ' 37' ' ' ILE . 28.8 t80 -119.56 111.64 36.13 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.898 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.12 123.64 6.27 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.555 1.503 . . . . 0.0 111.259 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 82.1 mt -77.65 52.49 1.0 Allowed 'General case' 0 C--O 1.233 0.196 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.665 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.6 t -62.06 -42.16 98.9 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.101 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.6 mt -69.1 146.51 52.5 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 58.4 p -67.45 -16.57 64.3 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.496 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 90.2 m -131.23 133.89 45.91 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.414 -0.514 . . . . 0.0 111.542 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.8 t -124.33 116.05 21.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.446 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.46 HD21 ' HG2' ' A' ' 47' ' ' GLN . 56.9 tp -114.66 124.86 52.89 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.85 0.357 . . . . 0.0 111.422 -178.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.725 ' CE2' HD12 ' A' ' 37' ' ' ILE . 22.7 m-85 -104.5 141.31 36.61 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.518 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 156.59 -173.08 34.36 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.25 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.545 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 27.2 mtm180 -80.0 -27.74 39.55 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.055 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.532 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -56.18 137.78 46.58 Favored Glycine 0 CA--C 1.521 0.453 0 C-N-CA 120.186 -1.007 . . . . 0.0 110.695 -178.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.427 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.6 tp -65.18 -40.12 87.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.671 -0.412 . . . . 0.0 109.99 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.427 ' N ' HG23 ' A' ' 33' ' ' ILE . 74.0 tt0 -53.99 -13.54 0.81 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.256 179.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.532 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 37.8 m -71.24 138.25 49.3 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.513 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.496 ' OD2' ' O ' ' A' ' 26' ' ' THR . 56.0 m-20 -61.55 -34.28 75.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.443 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.725 HD12 ' CE2' ' A' ' 29' ' ' PHE . 94.2 mt -127.59 122.56 59.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 38' ' ' ARG . 13.2 ttp180 -111.86 137.25 50.07 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.418 -178.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 94.6 mt -120.63 130.31 74.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.402 HE21 ' HA ' ' B' ' 260' ' ' GLU . 26.9 pt20 -81.74 38.4 0.51 Allowed 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.607 ' CD1' ' CZ ' ' A' ' 93' ' ' ARG . 39.9 mt -103.08 132.72 20.86 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.91 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.89 -11.37 30.54 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.459 2.106 . . . . 0.0 113.214 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.456 HG21 ' CE2' ' B' ' 241' ' ' PHE . 28.1 m -96.32 4.56 9.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.898 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.545 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 44.1 t -96.23 133.97 35.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.975 0.417 . . . . 0.0 110.562 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.2 m -70.93 165.51 23.19 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.825 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.0 mttm -63.23 -39.18 93.87 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.661 -178.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.695 ' O ' ' N ' ' A' ' 49' ' ' CYS . 86.4 mt-30 -113.92 -16.08 12.25 Favored 'General case' 0 C--O 1.227 -0.128 0 O-C-N 123.31 0.381 . . . . 0.0 111.247 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 28.7 t60 34.26 -74.13 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.695 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.52 138.96 46.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.129 0.49 . . . . 0.0 111.962 -179.025 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -127.56 130.93 49.96 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.877 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.9 mt -114.62 132.81 62.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.602 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -118.65 123.27 44.54 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.8 mt -106.44 117.06 51.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.019 -0.672 . . . . 0.0 112.345 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.431 ' O ' ' C ' ' A' ' 55' ' ' GLU . 81.0 m-70 -114.15 145.17 42.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.233 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 54' ' ' HIS . 96.3 mt-10 -40.5 -31.8 0.17 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.339 0.59 . . . . 0.0 109.471 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.516 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 58.6 tt0 -63.9 -68.6 0.33 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.162 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.516 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 5.1 tp10 -157.38 -170.24 3.17 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.287 -178.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.445 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -109.45 125.97 53.0 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.6 mt -116.63 130.21 71.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.235 0.54 . . . . 0.0 111.857 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 19.4 tp -101.39 126.25 48.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.841 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -110.14 136.64 49.06 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.966 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.444 HD21 ' HA ' ' A' ' 68' ' ' PRO . 64.7 t-20 -96.48 105.48 17.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.684 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -97.63 -7.47 31.01 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.56 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 t -77.01 99.64 5.37 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.012 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.4 m -86.83 -18.18 31.6 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.874 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.2 OUTLIER -88.88 -43.35 11.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.52 -179.898 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -135.31 91.64 18.73 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.803 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.444 ' HA ' HD21 ' A' ' 62' ' ' ASN . 47.3 Cg_exo -56.24 145.51 76.78 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.193 1.929 . . . . 0.0 113.408 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 18.9 m -79.39 137.17 37.19 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.84 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -102.0 141.37 34.95 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.017 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 93.1 t -132.21 134.33 59.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.465 HD21 ' CG ' ' A' ' 86' ' ' ASP . 75.1 m-20 50.92 32.87 7.89 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.219 0.533 . . . . 0.0 109.593 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.93 29.56 60.69 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.135 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 31.0 t -148.97 143.83 26.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 117.439 0.619 . . . . 0.0 111.335 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 62.1 t -69.38 143.16 15.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.465 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.1 pt -113.89 68.46 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.223 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -52.12 -27.69 15.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.662 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -120.74 169.57 8.6 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.549 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -60.28 143.14 99.51 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 122.354 2.036 . . . . 0.0 112.23 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.9 m -139.57 139.31 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-O 120.83 0.348 . . . . 0.0 111.223 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -75.51 131.82 40.34 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.445 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 92.3 mt -79.51 139.79 37.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.089 0.471 . . . . 0.0 111.086 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -127.87 144.9 51.09 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.748 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.481 ' CE1' ' H ' ' A' ' 99' ' ' ASN . 3.4 t-160 -54.54 117.67 3.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.924 0.392 . . . . 0.0 110.088 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.67 -14.75 27.06 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.074 -0.811 . . . . 0.0 111.074 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.465 ' CG ' HD21 ' A' ' 72' ' ' ASN . 17.3 m-20 -74.84 133.47 41.88 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.049 0.452 . . . . 0.0 110.316 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.557 HG22 ' HA ' ' A' ' 96' ' ' ARG . 49.4 t -112.38 133.68 57.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.676 -178.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 89.6 mt -93.09 129.99 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 177.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.461 HG23 ' OG ' ' A' ' 94' ' ' SER . 51.6 m -118.17 125.37 50.07 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.717 0.77 . . . . 0.0 112.43 -178.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.539 ' N ' ' O ' ' A' ' 93' ' ' ARG . 87.0 mt -116.62 123.08 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 114.505 -1.225 . . . . 0.0 108.505 178.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.656 HG22 ' N ' ' A' ' 92' ' ' ASP . 94.6 mt 33.24 -101.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.463 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.656 ' N ' HG22 ' A' ' 91' ' ' ILE . 82.6 m-20 -105.86 7.02 32.06 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.64 0.257 . . . . 0.0 111.599 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.607 ' CZ ' ' CD1' ' A' ' 41' ' ' LEU . 40.7 mtm-85 -125.07 142.21 51.63 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.716 -178.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.526 ' HB2' HD12 ' A' ' 10' ' ' ILE . 51.0 m -139.51 157.32 46.04 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.499 -0.481 . . . . 0.0 110.617 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.575 ' HB3' HD11 ' A' ' 7' ' ' LEU . 94.9 m-85 -125.96 120.47 30.45 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.655 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.557 ' HA ' HG22 ' A' ' 87' ' ' VAL . 44.4 ttm180 -80.35 127.08 31.96 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.251 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -92.56 125.7 37.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.805 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -121.6 127.41 50.85 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.263 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.481 ' H ' ' CE1' ' A' ' 84' ' ' HIS . 49.4 t-20 -101.96 111.72 24.09 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.654 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 . . . . . 0 C--N 1.322 -0.591 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.749 179.84 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 44.1 t . . . . . 0 N--CA 1.465 0.306 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.533 ' C ' ' H ' ' B' ' 231' ' ' GLN . 81.0 m-20 -65.78 142.18 58.06 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.237 0.541 . . . . 0.0 111.743 -178.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.533 ' H ' ' C ' ' B' ' 229' ' ' ASP . 78.0 mt-30 -128.53 30.04 5.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.615 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -111.06 -152.5 12.57 Favored Glycine 0 CA--C 1.533 1.211 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -76.9 161.28 33.32 Favored 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 123.067 2.512 . . . . 0.0 113.342 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.874 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -70.56 134.09 25.54 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 121.418 1.412 . . . . 0.0 112.809 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.468 ' CG2' HG22 ' A' ' 66' ' ' THR . 53.5 t -57.79 142.83 12.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.659 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 5.1 t -71.82 129.89 39.74 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . 0.405 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . 0.405 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 52.5 Cg_exo -56.19 -29.22 74.63 Favored 'Trans proline' 0 N--CA 1.5 1.881 0 C-N-CA 123.011 2.474 . . . . 0.0 112.838 -178.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 70.2 m -69.37 -47.17 65.09 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.526 -0.47 . . . . 0.0 109.787 178.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.456 ' CE2' HG21 ' A' ' 43' ' ' VAL . 71.2 t80 -59.97 -46.67 88.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.624 -179.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.407 ' HA ' HD23 ' B' ' 242' ' ' LEU . 94.5 mt -63.27 -41.29 99.01 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.821 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -65.18 -39.66 93.19 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.009 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -61.97 -41.8 98.41 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.074 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.528 ' NH2' ' CD2' ' A' ' 41' ' ' LEU . 24.9 mmt180 -63.3 -43.15 98.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.676 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -62.68 -41.98 99.39 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.482 -0.487 . . . . 0.0 109.863 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 5.3 t -65.15 -44.86 87.21 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 69.4 tp60 -57.43 -41.16 79.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.778 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 21.5 t -61.52 -42.89 95.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -63.18 -34.76 78.32 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.669 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -79.24 -10.71 59.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.459 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 82.4 mt -102.87 -177.55 3.41 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.568 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . 0.55 ' O ' ' N ' ' B' ' 255' ' ' ASP . 67.7 m-80 -154.89 -164.54 1.82 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.831 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -45.44 -14.58 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.264 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . 0.55 ' N ' ' O ' ' B' ' 253' ' ' ASN . 97.5 m-20 -65.09 -12.17 47.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.948 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.659 ' O ' ' N ' ' B' ' 258' ' ' ASP . 94.7 m-20 -48.76 -34.44 12.22 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.924 179.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . 0.498 ' C ' ' O ' ' B' ' 256' ' ' ASP . 88.5 tttt -20.19 -41.38 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 O-C-N 123.928 0.767 . . . . 0.0 111.486 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.659 ' N ' ' O ' ' B' ' 256' ' ' ASP . 93.0 m-20 -100.12 62.19 1.11 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 177.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.539 ' N ' ' O ' ' B' ' 256' ' ' ASP . 41.7 m-20 -50.61 -113.67 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.845 -177.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.471 ' OE1' HD21 ' A' ' 41' ' ' LEU . 98.2 mt-10 -151.72 22.54 0.69 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.255 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 56.5 mt -112.74 134.5 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 53.4 t -122.86 133.32 69.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -96.84 119.54 35.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.243 0.544 . . . . 0.0 111.018 -178.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -67.34 -45.67 75.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.249 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.68 158.18 34.82 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.437 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -60.58 150.32 82.37 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 122.873 2.382 . . . . 0.0 112.478 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 42.9 pt . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 121.581 0.705 . . . . 0.0 111.587 -179.319 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo . . . . . 0 N--CA 1.496 1.647 0 CA-C-O 120.734 0.222 . . . . 0.0 111.808 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.0 p -106.8 -42.23 5.0 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.707 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.747 ' NE ' HD13 ' A' ' 53' ' ' ILE . 89.2 mtm-85 -87.18 121.77 30.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.346 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -126.26 134.75 51.09 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.679 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.513 HD12 ' O ' ' A' ' 96' ' ' ARG . 36.4 tp -115.81 130.94 57.04 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.848 HG22 ' CD2' ' A' ' 19' ' ' HIS . 44.3 t -108.9 131.77 58.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.474 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 m -92.21 114.01 26.43 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 121.13 0.49 . . . . 0.0 111.819 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.427 HD12 ' HB3' ' A' ' 94' ' ' SER . 96.8 mt -81.32 146.09 7.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.151 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -92.71 157.7 16.31 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 1.005 HH21 HD22 ' B' ' 252' ' ' LEU . 87.8 mtm180 -59.91 -21.97 61.79 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.741 -0.383 . . . . 0.0 110.469 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.1 m -80.76 -12.01 59.52 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.1 35.51 8.11 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.9 t -120.72 134.31 64.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.667 0.27 . . . . 0.0 110.869 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -66.41 118.77 10.53 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.409 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -108.29 -130.84 6.31 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.196 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.03 148.34 39.88 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 122.546 2.164 . . . . 0.0 113.321 -178.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.848 ' CD2' HG22 ' A' ' 8' ' ' VAL . 65.0 m170 -104.03 140.0 38.36 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.115 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -111.7 97.87 38.89 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.505 -0.771 . . . . 0.0 108.958 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.432 ' HD2' HG22 ' B' ' 267' ' ' ILE . 57.1 Cg_endo -72.46 127.04 12.11 Favored 'Trans proline' 0 C--N 1.314 -1.24 0 C-N-CA 121.194 1.263 . . . . 0.0 110.922 -178.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.414 ' HA ' HD23 ' A' ' 22' ' ' LEU . 92.8 mt -84.51 81.33 8.89 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.625 0.726 . . . . 0.0 110.563 -178.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 91.1 p -86.72 -9.29 56.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.467 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.0 mt -102.6 145.35 29.77 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.008 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.6 t -65.09 -16.2 63.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.333 -178.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.07 132.63 42.0 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.972 0.415 . . . . 0.0 111.803 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.8 t -123.35 117.58 25.55 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.658 178.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.622 HD21 ' OE1' ' A' ' 47' ' ' GLN . 39.3 tp -115.55 127.4 55.24 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 120.702 0.287 . . . . 0.0 111.35 -178.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.71 ' CE2' HD12 ' A' ' 37' ' ' ILE . 8.4 m-85 -107.62 142.69 37.17 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.504 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 153.97 -170.36 32.58 Favored Glycine 0 N--CA 1.467 0.75 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.966 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.631 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 81.4 mtm-85 -84.0 -31.34 25.53 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.952 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.562 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -53.48 148.65 15.28 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.142 -178.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.532 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.1 tp -68.38 -42.82 84.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.801 0.334 . . . . 0.0 110.454 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.532 ' N ' HG23 ' A' ' 33' ' ' ILE . 51.6 tp10 -53.09 -19.89 3.23 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.562 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 5.3 m -66.8 124.95 24.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.821 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -59.5 -27.41 66.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.312 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.71 HD12 ' CE2' ' A' ' 29' ' ' PHE . 97.7 mt -128.45 121.14 54.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.831 178.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 74.1 mtm180 -100.4 135.45 41.82 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.492 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.79 HG21 ' CZ ' ' A' ' 93' ' ' ARG . 99.4 mt -119.99 131.8 71.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.458 0.647 . . . . 0.0 110.57 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -78.78 28.22 0.21 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.999 -1.0 . . . . 0.0 112.987 -178.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.657 ' O ' HG12 ' A' ' 44' ' ' VAL . 7.3 mt -105.97 104.69 50.48 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 120.539 -0.465 . . . . 0.0 109.804 178.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -53.84 -8.74 0.96 Allowed 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 122.417 2.078 . . . . 0.0 113.254 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.62 HG21 ' CE2' ' B' ' 241' ' ' PHE . 26.9 m -95.62 3.69 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.637 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.657 HG12 ' O ' ' A' ' 41' ' ' LEU . 5.9 p -95.45 138.23 21.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.46 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 0.5 OUTLIER -65.88 162.54 18.8 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.487 0.66 . . . . 0.0 111.527 -179.101 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt -62.94 -40.55 97.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.433 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.676 ' O ' ' N ' ' A' ' 49' ' ' CYS . 15.1 mm100 -109.47 -13.28 14.6 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.381 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.46 ' H ' ' HB3' ' A' ' 45' ' ' SER . 25.8 t60 35.88 -73.31 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.288 -0.869 . . . . 0.0 113.163 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.676 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -149.35 149.76 31.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.19 0.519 . . . . 0.0 111.661 -179.564 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -135.85 134.9 39.32 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.675 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 89.4 mt -105.81 133.39 50.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.024 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -111.71 120.37 41.79 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.747 HD13 ' NE ' ' A' ' 5' ' ' ARG . 91.3 mt -104.46 110.02 29.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.581 0.705 . . . . 0.0 111.613 -178.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.468 ' O ' ' N ' ' A' ' 56' ' ' GLN . 95.0 m-70 -112.19 144.37 41.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.644 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 54' ' ' HIS . 83.7 tt0 -41.18 -28.35 0.09 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.468 ' N ' ' O ' ' A' ' 54' ' ' HIS . 99.7 mm-40 -66.53 -68.82 0.34 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.151 178.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -158.75 -169.69 2.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.479 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -108.43 124.61 50.67 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.509 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 98.9 mt -115.58 129.32 72.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.084 0.468 . . . . 0.0 112.059 -178.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.451 HD11 ' SG ' ' A' ' 49' ' ' CYS . 43.9 tp -94.51 124.18 38.38 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.973 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -108.82 132.1 54.33 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.865 0.364 . . . . 0.0 110.019 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 33.5 t-20 -94.32 105.04 17.02 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.813 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -96.31 -6.56 37.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.033 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.2 t -85.58 97.58 10.16 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.199 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 77.5 p -78.09 -33.59 50.61 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 177.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.694 HG21 ' O ' ' B' ' 234' ' ' TPO . 2.7 m -63.68 -46.25 86.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.817 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -142.48 95.98 6.41 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.777 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.49 144.45 62.47 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 121.877 1.718 . . . . 0.0 112.122 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 33.0 m -72.09 138.07 47.52 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.128 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -100.98 139.28 36.88 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.642 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 70.8 t -129.97 135.42 61.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 52.43 32.87 11.98 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 119.774 -0.77 . . . . 0.0 109.063 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.23 27.85 69.25 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.611 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 34.4 t -142.23 137.32 30.65 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 117.671 0.736 . . . . 0.0 111.91 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -69.18 143.6 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.511 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.562 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 1.2 pt -113.47 108.1 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 121.564 0.697 . . . . 0.0 110.553 178.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -70.8 -31.62 68.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.282 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.485 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -129.38 -179.35 0.98 Allowed Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.752 -179.588 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 24.7 Cg_exo -62.6 146.94 95.41 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 122.779 2.32 . . . . 0.0 112.061 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.8 p -140.12 141.69 33.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.019 0.438 . . . . 0.0 111.164 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -76.56 133.44 39.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.724 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 82' ' ' LEU . 98.3 mt -88.93 139.14 30.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.206 0.527 . . . . 0.0 111.501 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.405 ' N ' ' OD2' ' A' ' 86' ' ' ASP . 99.4 mttt -123.2 149.76 44.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.803 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.512 ' ND1' ' N ' ' A' ' 99' ' ' ASN . 8.1 t60 -54.39 121.92 9.33 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.125 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.8 -13.24 38.41 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.405 ' OD2' ' N ' ' A' ' 83' ' ' LYS . 84.3 m-20 -68.88 136.58 52.85 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.056 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.401 ' CG1' ' OG ' ' A' ' 94' ' ' SER . 70.3 t -109.14 131.56 59.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.422 -178.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 25.7 mm -93.37 129.58 43.62 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 178.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.0 m -120.42 123.88 44.1 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.104 -0.639 . . . . 0.0 112.205 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.669 ' CG2' HH12 ' A' ' 93' ' ' ARG . 94.9 mt -122.61 126.75 74.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.367 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.476 HG22 ' N ' ' A' ' 92' ' ' ASP . 47.9 mm 35.34 -105.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 121.041 -0.264 . . . . 0.0 111.246 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.477 ' OD1' ' CD2' ' B' ' 242' ' ' LEU . 87.8 m-20 -109.12 16.4 22.55 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.747 0.308 . . . . 0.0 111.064 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.79 ' CZ ' HG21 ' A' ' 39' ' ' ILE . 1.8 mtm105 -126.39 144.57 50.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.073 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.427 ' HB3' HD12 ' A' ' 10' ' ' ILE . 47.4 t -138.7 148.73 44.31 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 178.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.48 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 27.3 m-85 -125.6 125.11 42.63 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.659 -179.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.513 ' O ' HD12 ' A' ' 7' ' ' LEU . 78.4 mtp85 -85.91 128.02 34.74 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.433 -179.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.559 ' CZ ' ' OD1' ' A' ' 99' ' ' ASN . 92.0 t80 -95.41 127.17 41.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.945 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -138.67 124.6 19.96 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.222 -0.591 . . . . 0.0 111.969 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.559 ' OD1' ' CZ ' ' A' ' 97' ' ' TYR . 96.9 m-20 -100.83 107.21 18.69 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.107 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.492 ' O ' ' O ' ' A' ' 99' ' ' ASN . 46.3 tt0 . . . . . 0 C--N 1.327 -0.371 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.531 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 14.4 p . . . . . 0 CA--C 1.53 0.185 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.443 ' OD1' ' N ' ' B' ' 230' ' ' SEP . 67.1 t0 -45.64 128.37 8.37 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.982 0.42 . . . . 0.0 111.44 -179.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . 0.443 ' N ' ' OD1' ' B' ' 229' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.49 ' O ' ' O ' ' B' ' 232' ' ' GLY . 71.0 mt-30 -114.2 -27.38 7.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.155 0.502 . . . . 0.0 109.808 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . 0.49 ' O ' ' O ' ' B' ' 231' ' ' GLN . . . -45.44 -177.19 0.01 OUTLIER Glycine 0 CA--C 1.53 1.004 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.19 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -70.6 162.07 43.8 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 123.891 3.061 . . . . 0.0 113.136 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.694 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.22 138.22 24.75 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 121.679 1.586 . . . . 0.0 113.115 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -67.37 139.89 20.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.327 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 6.3 t -73.8 133.19 43.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.016 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . 0.441 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . 0.441 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 31.7 Cg_exo -60.1 -25.99 81.28 Favored 'Trans proline' 0 N--CA 1.504 2.093 0 C-N-CA 123.224 2.616 . . . . 0.0 113.842 -178.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 35.4 m -74.61 -43.21 56.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.314 0.578 . . . . 0.0 109.851 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.62 ' CE2' HG21 ' A' ' 43' ' ' VAL . 68.7 t80 -59.18 -45.96 89.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.926 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.477 ' CD2' ' OD1' ' A' ' 92' ' ' ASP . 81.6 mt -62.47 -41.73 98.99 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.777 -0.192 . . . . 0.0 111.382 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -65.86 -36.9 84.72 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.676 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -59.63 -42.85 93.63 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.686 ' NH1' HE22 ' B' ' 248' ' ' GLN . 2.4 mpt_? -60.64 -41.77 95.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.193 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -60.83 -40.45 92.82 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 16.5 m -64.26 -46.55 83.22 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.622 178.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . 0.825 HE21 HH12 ' A' ' 12' ' ' ARG . 27.1 mt-30 -61.62 -36.48 80.87 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.12 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.401 HG23 ' O ' ' B' ' 245' ' ' ARG . 42.1 t -61.11 -46.27 96.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.347 -0.541 . . . . 0.0 110.099 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -60.34 -28.98 68.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.962 0.41 . . . . 0.0 110.143 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -95.42 -13.68 24.43 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.794 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 1.005 HD22 HH21 ' A' ' 12' ' ' ARG . 46.9 tp -74.52 142.12 44.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.098 0.475 . . . . 0.0 111.865 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -101.06 140.04 35.91 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.523 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -64.35 -19.06 65.22 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.315 0.579 . . . . 0.0 109.527 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -65.58 -10.44 35.34 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.926 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.419 ' C ' ' H ' ' B' ' 258' ' ' ASP . 67.7 t0 -93.7 75.3 4.32 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.34 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -67.82 11.53 0.14 Allowed 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -178.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.661 ' O ' ' N ' ' B' ' 260' ' ' GLU . 91.9 m-20 -96.83 1.26 50.47 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.476 ' C ' ' O ' ' B' ' 258' ' ' ASP . 39.0 t70 4.92 54.25 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 114.393 -1.276 . . . . 0.0 113.284 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.661 ' N ' ' O ' ' B' ' 258' ' ' ASP . 57.8 mp0 55.46 4.37 0.1 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.513 ' N ' ' O ' ' B' ' 258' ' ' ASP . 70.8 mt -117.36 134.28 61.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 54.2 t -127.74 135.06 64.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.295 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -95.28 117.69 30.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.217 0.532 . . . . 0.0 111.151 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -65.13 -44.18 89.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.08 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -91.55 150.43 41.1 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.658 -178.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -67.03 146.07 75.85 Favored 'Trans proline' 0 N--CA 1.497 1.678 0 C-N-CA 122.644 2.229 . . . . 0.0 112.697 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . 0.432 HG22 ' HD2' ' A' ' 21' ' ' PRO . 25.1 pt . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.114 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo . . . . . 0 N--CA 1.497 1.728 0 CA-C-O 121.072 0.363 . . . . 0.0 113.005 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.9 p -110.34 -34.29 6.39 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 120.714 -0.395 . . . . 0.0 111.487 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 87.8 mtm-85 -104.38 125.79 50.91 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.076 0.465 . . . . 0.0 111.638 -178.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -134.04 138.67 45.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.922 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.585 HD12 ' O ' ' A' ' 96' ' ' ARG . 31.4 tp -113.29 129.62 56.48 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.438 HG12 ' CD2' ' A' ' 19' ' ' HIS . 30.6 m -107.58 133.52 52.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-O 121.085 0.469 . . . . 0.0 110.681 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.2 m -90.68 115.39 27.74 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.457 -0.792 . . . . 0.0 113.136 -177.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.4 mt -79.02 142.1 14.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 178.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -88.74 157.64 18.44 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.772 HH12 ' NE2' ' B' ' 248' ' ' GLN . 84.2 mtp180 -59.04 -33.07 70.33 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.021 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.7 t -69.91 -18.6 63.39 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.267 0.556 . . . . 0.0 109.849 178.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.82 34.75 4.24 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.6 t -124.95 134.16 67.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.13 0.49 . . . . 0.0 111.517 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -70.11 131.31 44.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.253 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -113.13 -128.04 4.8 Favored Glycine 0 CA--C 1.539 1.545 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.586 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -73.74 154.76 49.2 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.35 2.033 . . . . 0.0 112.625 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.498 ' O ' ' CG2' ' B' ' 267' ' ' ILE . 7.6 m170 -110.01 139.98 44.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.269 0.557 . . . . 0.0 111.177 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.433 ' CD2' HD11 ' A' ' 37' ' ' ILE . 27.9 t80 -108.6 99.38 33.27 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.014 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.87 128.14 15.51 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 121.19 1.26 . . . . 0.0 111.334 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 72.5 mt -79.06 47.86 0.81 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.301 -178.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 99.5 p -59.1 -24.87 63.32 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.672 HD11 ' HG2' ' B' ' 265' ' ' GLN . 71.0 mt -78.35 139.52 38.8 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.417 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.8 t -66.15 -18.45 65.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.354 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.479 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 85.1 m -133.02 135.17 45.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.813 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.8 t -127.06 115.34 19.03 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.417 HD12 ' O ' ' A' ' 49' ' ' CYS . 51.2 tp -114.93 129.88 56.8 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.195 0.522 . . . . 0.0 110.915 -178.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.849 ' CE2' HD12 ' A' ' 37' ' ' ILE . 14.3 m-85 -110.96 135.16 51.89 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.146 -0.933 . . . . 0.0 109.576 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 160.21 -172.06 36.59 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.704 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -81.2 -31.6 33.86 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.705 0.288 . . . . 0.0 110.998 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.529 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -54.9 150.31 18.75 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 111.714 -0.554 . . . . 0.0 111.714 -178.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.47 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.9 tp -66.44 -40.05 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-O 120.791 0.329 . . . . 0.0 110.158 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.47 ' N ' HG23 ' A' ' 33' ' ' ILE . 96.9 mt-10 -51.72 -27.87 13.27 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.338 -0.545 . . . . 0.0 109.542 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.529 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 14.2 m -57.16 110.99 0.93 Allowed 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.934 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.479 ' OD2' ' O ' ' A' ' 26' ' ' THR . 97.5 m-20 -51.18 -18.75 0.96 Allowed 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.849 HD12 ' CE2' ' A' ' 29' ' ' PHE . 76.2 mt -134.06 125.77 48.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.94 177.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 71.5 mtm180 -103.46 135.06 45.76 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.612 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 99.2 mt -117.17 129.1 74.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -77.25 25.48 0.17 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -177.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.526 HD21 ' NH1' ' B' ' 245' ' ' ARG . 67.2 mt -96.81 128.06 37.08 Favored Pre-proline 0 N--CA 1.466 0.35 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.554 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -73.22 -9.75 23.58 Favored 'Trans proline' 0 N--CA 1.487 1.132 0 C-N-CA 122.052 1.835 . . . . 0.0 112.848 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.439 HG23 HG13 ' A' ' 91' ' ' ILE . 28.9 m -96.71 4.2 9.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 120.758 0.313 . . . . 0.0 110.582 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 38.1 t -93.08 135.71 27.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.871 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.9 m -70.67 173.01 7.69 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.473 0.654 . . . . 0.0 111.584 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 40.7 mtmt -63.73 -41.66 98.02 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.527 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.614 ' O ' ' N ' ' A' ' 49' ' ' CYS . 86.1 mt-30 -114.52 -20.95 10.55 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.919 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 27.5 t60 37.75 -76.13 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 113.971 1.101 . . . . 0.0 113.971 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.614 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -128.78 133.27 48.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.926 0.393 . . . . 0.0 111.516 -178.621 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -125.66 127.95 47.07 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.31 178.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 94.5 mt -110.25 132.41 58.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -114.5 120.3 39.78 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.3 mt -102.93 114.94 43.95 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 C-N-CA 119.714 -0.794 . . . . 0.0 111.968 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.55 ' O ' ' N ' ' A' ' 56' ' ' GLN . 97.0 m-70 -112.57 141.16 46.66 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.221 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.469 ' C ' ' O ' ' A' ' 54' ' ' HIS . 95.1 mt-10 -39.73 -26.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 -178.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.55 ' N ' ' O ' ' A' ' 54' ' ' HIS . 84.6 mt-30 -66.05 -67.98 0.4 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.948 177.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -161.84 -158.27 0.53 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.479 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -116.71 129.76 56.32 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.575 0.226 . . . . 0.0 110.66 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 98.2 mt -119.55 131.59 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 121.046 0.451 . . . . 0.0 111.762 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.474 ' HB2' HD11 ' A' ' 82' ' ' LEU . 28.7 tp -99.27 129.34 45.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.977 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -116.48 138.22 51.55 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.825 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 38.2 p-10 -101.89 107.33 18.47 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.629 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -94.27 -11.61 29.82 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.896 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.3 p -77.19 100.75 5.9 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.286 178.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.7 p -73.43 -34.27 65.35 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.447 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.3 OUTLIER -71.11 -40.29 71.55 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.699 -179.987 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -144.07 90.95 6.63 Favored Pre-proline 0 N--CA 1.467 0.412 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -64.81 149.45 89.61 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 C-N-CA 120.988 1.126 . . . . 0.0 112.089 -179.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.8 m -71.11 151.51 44.4 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.386 0.612 . . . . 0.0 111.776 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -106.7 147.06 30.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.833 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.501 ' CG2' ' OD1' ' A' ' 86' ' ' ASP . 4.8 p -132.88 134.86 57.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 51.75 32.11 9.02 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.185 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.88 27.64 70.26 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.878 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 68.6 m -139.26 142.35 37.78 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.2 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.7 t -75.45 133.3 31.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.381 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.3 pt -101.84 102.12 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.516 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -64.1 -34.42 78.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.492 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.402 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 1.3 mt-10 -129.74 178.49 1.68 Allowed Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.79 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.402 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 31.3 Cg_exo -60.09 143.63 99.53 Favored 'Trans proline' 0 N--CA 1.504 2.09 0 C-N-CA 122.742 2.295 . . . . 0.0 112.469 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.5 p -135.91 138.46 47.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.371 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 83.3 mtm-85 -73.17 129.88 39.02 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.5 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.474 HD11 ' HB2' ' A' ' 60' ' ' LEU . 97.0 mt -83.77 137.41 33.74 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.161 -178.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -129.17 152.98 48.16 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.363 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.533 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 7.5 t60 -53.36 119.18 4.48 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.264 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.64 -14.46 29.73 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 87' ' ' VAL . 59.4 t0 -66.25 130.41 43.14 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.229 0.538 . . . . 0.0 110.623 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.599 HG22 ' HG2' ' A' ' 96' ' ' ARG . 71.1 t -109.27 130.85 61.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.001 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 87.6 mt -105.78 134.1 48.27 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.6 m -118.21 124.33 47.65 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 121.191 0.519 . . . . 0.0 111.64 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.576 ' N ' ' O ' ' A' ' 93' ' ' ARG . 97.4 mt -114.82 126.08 72.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.448 HG22 ' N ' ' A' ' 92' ' ' ASP . 36.2 mm 38.28 -109.3 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.697 -179.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.537 ' OD1' ' CD2' ' B' ' 242' ' ' LEU . 98.1 m-20 -107.77 14.61 25.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.501 0.667 . . . . 0.0 110.011 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.644 ' NH2' ' OD2' ' B' ' 259' ' ' ASP . 18.8 mtp85 -126.86 146.95 50.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.298 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 66.4 m -137.69 150.65 47.5 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 121.235 0.54 . . . . 0.0 110.778 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.541 ' CE1' HD12 ' A' ' 90' ' ' ILE . 89.0 m-85 -124.39 122.28 37.23 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.69 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.599 ' HG2' HG22 ' A' ' 87' ' ' VAL . 99.8 mtt180 -89.79 135.84 33.39 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 119.378 -0.929 . . . . 0.0 110.685 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -96.75 124.72 40.81 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.431 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -124.79 122.08 36.41 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.533 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 46.3 t30 -118.49 103.87 10.16 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.671 -0.411 . . . . 0.0 111.257 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 . . . . . 0 C--N 1.326 -0.44 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.806 179.415 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . 0.811 HG23 ' O ' ' B' ' 228' ' ' VAL . 30.4 m . . . . . 0 CA--C 1.521 -0.142 0 CA-C-O 120.988 0.423 . . . . 0.0 110.876 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.545 ' O ' ' CB ' ' B' ' 230' ' ' SEP . 42.0 p-10 -102.58 3.02 36.9 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.367 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . 0.591 ' O ' ' NE2' ' B' ' 231' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.591 ' NE2' ' O ' ' B' ' 230' ' ' SEP . 87.5 mm-40 -124.98 62.56 1.16 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.251 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -135.35 175.32 20.77 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.684 -178.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.22 160.48 49.7 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 123.396 2.731 . . . . 0.0 112.847 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.29 137.91 45.06 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.258 1.972 . . . . 0.0 113.767 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.447 ' CG2' HG22 ' A' ' 66' ' ' THR . 24.0 t -67.99 135.08 29.16 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.921 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 16.0 t -68.87 128.58 37.17 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.391 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . 0.426 ' O2P' ' OG1' ' B' ' 240' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . 0.42 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 51.0 Cg_exo -57.49 -26.86 73.72 Favored 'Trans proline' 0 N--CA 1.506 2.236 0 C-N-CA 123.517 2.811 . . . . 0.0 113.905 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . 0.426 ' OG1' ' O2P' ' B' ' 238' ' ' TPO . 21.2 m -71.64 -45.93 60.55 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.202 0.525 . . . . 0.0 109.933 178.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.435 ' HZ ' HD22 ' A' ' 41' ' ' LEU . 45.9 t80 -58.09 -44.89 87.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.068 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.537 ' CD2' ' OD1' ' A' ' 92' ' ' ASP . 93.7 mt -62.21 -40.81 97.35 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.566 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -61.62 -45.17 95.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.362 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 -62.4 -43.07 99.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.733 0.301 . . . . 0.0 110.995 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.526 ' NH1' HD21 ' A' ' 41' ' ' LEU . 16.1 mmm180 -58.67 -44.88 90.34 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.76 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -63.27 -39.24 94.05 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.874 0.369 . . . . 0.0 110.175 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 38.8 t -65.48 -44.77 86.09 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 122.0 0.905 . . . . 0.0 109.137 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . 0.772 ' NE2' HH12 ' A' ' 12' ' ' ARG . 57.8 tt0 -59.62 -39.76 85.34 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.74 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.444 ' HA ' HD12 ' B' ' 252' ' ' LEU . 26.0 t -59.93 -45.59 94.98 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -59.29 -27.74 66.12 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -86.2 -12.57 49.39 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.666 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.444 HD12 ' HA ' ' B' ' 249' ' ' VAL . 66.7 mt -77.51 148.72 35.15 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.401 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -77.41 163.96 25.91 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.353 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 51.7 p-10 -78.98 -7.88 58.44 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -108.13 20.1 19.12 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.737 -1.119 . . . . 0.0 110.31 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -60.11 136.48 58.03 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.391 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . 0.689 ' O ' ' N ' ' B' ' 259' ' ' ASP . 99.0 mttt -125.29 -137.68 0.27 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.318 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.61 ' C ' ' O ' ' B' ' 257' ' ' LYS . 99.1 m-20 -9.58 74.37 0.0 OUTLIER 'General case' 0 C--N 1.351 0.668 0 O-C-N 124.096 0.872 . . . . 0.0 109.944 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.689 ' N ' ' O ' ' B' ' 257' ' ' LYS . 51.2 p-10 -78.82 80.96 5.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.922 -176.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.472 ' OE1' ' NH1' ' B' ' 245' ' ' ARG . 98.5 mt-10 46.48 2.75 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.561 ' N ' ' O ' ' B' ' 259' ' ' ASP . 78.7 mt -112.38 132.01 62.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 46.0 t -127.5 134.18 66.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.193 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -99.09 123.58 43.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.341 0.591 . . . . 0.0 110.897 -178.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -64.28 -40.6 96.3 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.414 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . 0.672 ' HG2' HD11 ' A' ' 24' ' ' LEU . 5.1 mp0 -95.81 164.67 18.21 Favored Pre-proline 0 N--CA 1.463 0.224 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.254 -178.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -61.27 145.13 98.81 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 122.283 1.989 . . . . 0.0 110.916 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . 0.498 ' CG2' ' O ' ' A' ' 19' ' ' HIS . 2.6 mt . . . . . 0 C--N 1.321 -0.657 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.425 -178.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo . . . . . 0 N--CA 1.492 1.426 0 CA-C-O 120.932 0.305 . . . . 0.0 112.698 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.4 p -89.91 -45.24 9.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.471 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.5 mtt85 -88.28 129.81 35.27 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.249 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -126.09 136.18 52.61 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.27 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.61 HD12 ' O ' ' A' ' 96' ' ' ARG . 30.6 tp -115.82 132.58 56.6 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.9 t -110.2 132.37 58.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.063 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 m -88.72 114.2 25.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.024 -0.534 . . . . 0.0 112.118 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.437 HD12 ' HB2' ' A' ' 94' ' ' SER . 95.5 mt -85.13 144.02 10.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -96.09 160.33 14.5 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.514 HH12 ' CD ' ' B' ' 260' ' ' GLU . 94.7 mtm-85 -62.38 -20.2 64.18 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.901 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.0 p -78.58 -16.25 57.63 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 120.592 -0.443 . . . . 0.0 109.909 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.41 17.72 30.56 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.369 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.0 m -115.14 135.63 54.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 117.191 0.496 . . . . 0.0 110.169 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -72.52 142.86 48.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.341 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -126.72 -117.72 2.14 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.499 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.63 146.77 44.26 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.161 1.907 . . . . 0.0 112.129 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.595 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -108.03 138.98 43.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.06 0.457 . . . . 0.0 110.909 -179.69 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.631 ' CE2' HD11 ' A' ' 37' ' ' ILE . 50.2 t80 -110.1 104.85 56.45 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.955 -178.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.83 130.19 14.29 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.211 1.274 . . . . 0.0 112.016 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.4 mt -83.74 60.27 5.65 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.603 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.3 t -62.83 -40.67 98.15 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 69.9 mt -71.6 144.1 49.59 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.149 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 92.3 p -69.41 -14.06 62.7 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.055 -0.521 . . . . 0.0 112.101 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.407 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 62.6 m -130.42 133.65 46.51 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.38 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.5 t -124.95 115.94 21.39 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 58.5 tp -113.56 130.26 56.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.911 0.386 . . . . 0.0 110.928 -178.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.522 ' O ' ' O ' ' A' ' 47' ' ' GLN . 59.2 m-85 -110.17 136.33 49.56 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.219 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 160.83 -174.26 37.45 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.284 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.581 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 82.3 mtm-85 -79.93 -30.48 39.98 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.552 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -53.4 149.18 13.67 Favored Glycine 0 N--CA 1.467 0.718 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.496 -177.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.539 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.5 tp -67.65 -43.24 86.93 Favored 'Isoleucine or valine' 0 C--N 1.341 0.2 0 CA-C-O 120.868 0.366 . . . . 0.0 111.008 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.539 ' N ' HG23 ' A' ' 33' ' ' ILE . 81.3 tt0 -56.09 -19.39 12.9 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.825 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.552 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 9.6 m -63.02 126.44 27.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.607 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.407 ' OD2' ' O ' ' A' ' 26' ' ' THR . 89.8 m-20 -61.41 -32.6 72.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.337 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.631 HD11 ' CE2' ' A' ' 20' ' ' PHE . 50.5 mm -123.38 114.58 42.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.195 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 38' ' ' ARG . 47.0 mtm180 -99.72 137.14 38.62 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 121.169 -0.212 . . . . 0.0 110.667 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 82.2 mt -120.06 131.27 72.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 120.184 -0.606 . . . . 0.0 111.093 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -73.22 28.31 0.06 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.332 -0.849 . . . . 0.0 113.001 -177.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.722 HD12 ' CZ ' ' A' ' 93' ' ' ARG . 65.9 mt -113.06 130.92 23.1 Favored Pre-proline 0 C--N 1.323 -0.564 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.692 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.84 -9.67 23.98 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 122.262 1.974 . . . . 0.0 112.184 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.488 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 13.1 m -90.86 2.6 7.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.026 0.441 . . . . 0.0 110.017 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.581 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 55.2 t -94.51 132.3 38.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.7 m -71.22 169.2 15.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.562 0.696 . . . . 0.0 111.932 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -62.46 -41.78 99.0 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.442 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.639 ' O ' ' N ' ' A' ' 49' ' ' CYS . 96.3 mt-30 -116.34 -15.26 10.99 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.281 0.363 . . . . 0.0 110.834 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.0 t60 31.08 -74.25 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.639 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.5 138.34 47.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.212 0.529 . . . . 0.0 112.126 -178.67 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -127.99 133.35 49.16 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.443 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.6 mt -118.25 133.94 63.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.026 0.441 . . . . 0.0 110.705 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.438 ' CD ' ' NE2' ' A' ' 54' ' ' HIS . 85.1 tt0 -121.03 124.07 43.93 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.0 mt -106.54 117.26 51.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.661 0.743 . . . . 0.0 112.914 -178.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.438 ' NE2' ' CD ' ' A' ' 52' ' ' GLU . 94.3 m-70 -110.66 143.3 41.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.098 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 54' ' ' HIS . 83.2 tt0 -40.39 -30.32 0.1 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.278 -0.569 . . . . 0.0 109.807 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.434 ' N ' ' O ' ' A' ' 54' ' ' HIS . 59.9 tt0 -64.11 -67.62 0.42 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -157.21 -169.44 2.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.071 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.458 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -110.75 125.95 54.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.767 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.6 mt -115.48 128.52 72.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.31 0.576 . . . . 0.0 111.933 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 24.9 tp -99.07 132.1 44.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.968 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -115.4 135.83 53.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.528 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.618 ' ND2' ' H ' ' A' ' 69' ' ' THR . 12.3 t-20 -97.17 108.58 21.34 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.929 0.395 . . . . 0.0 111.185 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -100.88 -8.57 22.43 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.263 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.7 t -74.64 98.84 3.5 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.092 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.2 m -74.51 -40.38 61.81 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.25 0.547 . . . . 0.0 110.236 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.537 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.3 OUTLIER -64.54 -43.38 94.16 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.264 -178.904 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -144.34 97.36 5.17 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.011 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.441 ' HA ' HD21 ' A' ' 62' ' ' ASN . 37.4 Cg_exo -57.25 149.4 64.54 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.977 1.785 . . . . 0.0 111.858 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.618 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 85.4 m -76.41 156.34 33.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.324 0.583 . . . . 0.0 110.933 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.46 ' N ' HG22 ' A' ' 69' ' ' THR . 88.0 mt-30 -114.84 139.36 49.82 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.61 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 55.3 t -128.42 136.23 60.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.54 ' ND2' ' OD1' ' A' ' 86' ' ' ASP . 82.2 m-20 53.25 33.36 15.29 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 119.777 -0.769 . . . . 0.0 109.1 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.04 27.38 73.93 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 115.106 -0.952 . . . . 0.0 112.032 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 74.3 m -141.56 136.37 31.02 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 117.29 0.545 . . . . 0.0 111.31 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.7 p -63.46 144.01 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.803 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.497 HG21 HG21 ' A' ' 80' ' ' VAL . 7.3 pt -118.78 90.96 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.091 0 CA-C-O 121.065 0.459 . . . . 0.0 110.538 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -67.46 -26.94 66.64 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.443 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -122.58 169.34 9.9 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.063 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.79 144.23 99.48 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.075 1.85 . . . . 0.0 111.773 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.497 HG21 HG21 ' A' ' 76' ' ' ILE . 3.3 m -136.47 138.43 46.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.22 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -73.88 134.48 43.25 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.498 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.458 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 95.7 mt -86.09 135.81 33.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.03 0.443 . . . . 0.0 111.324 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -127.79 148.33 50.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.502 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.479 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 5.3 t60 -48.86 116.16 1.54 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.081 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.01 -13.87 40.85 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.161 -0.775 . . . . 0.0 111.161 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.54 ' OD1' ' ND2' ' A' ' 72' ' ' ASN . 34.4 t70 -66.23 133.7 51.16 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 70.8 t -114.19 133.29 60.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.354 -0.538 . . . . 0.0 111.517 -178.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 71.1 mt -100.02 131.77 46.83 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.588 HG23 ' OG ' ' A' ' 94' ' ' SER . 89.4 m -123.97 125.9 45.39 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.83 -178.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.504 ' O ' ' N ' ' A' ' 92' ' ' ASP . 94.2 mt -112.5 123.65 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.591 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.47 HG22 ' N ' ' A' ' 92' ' ' ASP . 94.5 mt 38.61 -94.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.028 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 90' ' ' ILE . 52.1 t0 -121.71 16.35 11.08 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 120.941 -0.303 . . . . 0.0 111.564 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.722 ' CZ ' HD12 ' A' ' 41' ' ' LEU . 44.3 mtm-85 -128.43 139.05 52.56 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.588 ' OG ' HG23 ' A' ' 89' ' ' THR . 58.0 m -133.69 152.14 51.81 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 119.979 -0.689 . . . . 0.0 111.169 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.522 ' HB3' HD11 ' A' ' 7' ' ' LEU . 80.8 m-85 -123.85 121.74 36.16 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.088 178.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.61 ' O ' HD12 ' A' ' 7' ' ' LEU . 79.8 mtp85 -85.21 131.75 34.38 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.113 0.483 . . . . 0.0 111.304 -178.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -95.63 124.73 39.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.003 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -125.6 122.31 36.09 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.967 0.413 . . . . 0.0 110.702 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.479 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 55.3 t-20 -104.38 105.56 15.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.957 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.854 179.585 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . 0.569 ' O ' ' CB ' ' B' ' 229' ' ' ASP . 34.0 m . . . . . 0 N--CA 1.455 -0.187 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.569 ' CB ' ' O ' ' B' ' 228' ' ' VAL . 22.1 t0 95.55 158.04 0.02 OUTLIER 'General case' 0 C--O 1.237 0.42 0 O-C-N 123.768 0.668 . . . . 0.0 111.282 179.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 170.41 23.88 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.614 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -115.89 -167.89 15.12 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 111.518 -0.633 . . . . 0.0 111.518 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.52 159.5 53.35 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.694 2.263 . . . . 0.0 112.48 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.509 ' O2P' HG21 ' B' ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -74.29 172.47 15.99 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 122.417 2.078 . . . . 0.0 112.478 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.537 ' CG2' HG22 ' A' ' 66' ' ' THR . 24.1 t -111.08 132.55 59.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.273 -179.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 40.1 t -61.73 120.65 11.06 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.97 0.414 . . . . 0.0 110.046 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -56.67 -22.37 43.72 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 121.757 1.638 . . . . 0.0 112.043 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 18.8 m -74.16 -44.35 53.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.316 0.579 . . . . 0.0 109.806 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.488 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 82.1 t80 -58.14 -46.55 85.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.0 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' B' ' 242' ' ' LEU . 95.0 mt -64.5 -39.62 94.12 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.154 0.502 . . . . 0.0 109.993 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -61.33 -41.7 97.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.577 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -60.9 -42.24 97.66 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.326 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.485 ' NH2' ' CE1' ' B' ' 241' ' ' PHE . 47.8 mmt-85 -61.17 -40.49 94.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.93 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -61.34 -39.27 89.96 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 24.0 m -65.76 -43.73 88.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -60.48 -37.65 81.73 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 114.511 -1.222 . . . . 0.0 110.426 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 46.8 t -61.73 -46.39 96.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.051 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -60.46 -27.52 67.61 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 121.272 0.558 . . . . 0.0 109.793 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -86.16 -11.82 51.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.917 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.567 ' O ' ' CB ' ' B' ' 253' ' ' ASN . 90.7 mt -114.7 -174.5 2.5 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.823 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . 0.567 ' CB ' ' O ' ' B' ' 252' ' ' LEU . 0.3 OUTLIER 91.39 27.4 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.116 179.889 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . 0.582 ' O ' ' CB ' ' B' ' 255' ' ' ASP . 96.6 m-20 -92.91 -6.87 47.63 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.798 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . 0.582 ' CB ' ' O ' ' B' ' 254' ' ' ASP . 32.1 t0 106.28 58.05 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 O-C-N 124.04 0.837 . . . . 0.0 108.839 -178.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.579 ' O ' ' C ' ' B' ' 257' ' ' LYS . 54.6 p-10 -120.23 19.07 12.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.124 -178.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . 0.6 ' O ' ' N ' ' B' ' 259' ' ' ASP . 99.2 mttt 20.52 -89.24 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.41 0.444 . . . . 0.0 110.729 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' B' ' 256' ' ' ASP . 94.6 m-20 -27.11 87.76 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 O-C-N 123.647 0.592 . . . . 0.0 110.105 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.6 ' N ' ' O ' ' B' ' 257' ' ' LYS . 87.7 m-20 -87.06 -93.09 0.1 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.235 -179.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.524 ' OE1' HD21 ' A' ' 41' ' ' LEU . 97.5 mt-10 -141.46 9.47 2.03 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.053 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 61.5 mt -112.34 135.06 52.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 43.6 t -123.86 133.3 69.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.202 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -94.79 117.46 30.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.988 0.423 . . . . 0.0 110.976 -178.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . 0.422 ' HZ1' ' HA ' ' A' ' 34' ' ' GLU . 88.5 tttt -65.39 -47.01 77.81 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.275 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -82.34 160.89 61.31 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.201 -0.908 . . . . 0.0 110.257 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -60.37 141.65 96.18 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.162 1.908 . . . . 0.0 111.753 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . 0.552 HG23 ' O ' ' B' ' 267' ' ' ILE . 13.8 tt . . . . . 0 C--N 1.324 -0.532 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.919 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo . . . . . 0 N--CA 1.489 1.238 0 CA-C-O 120.875 0.281 . . . . 0.0 111.829 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 35.3 p -66.73 -35.38 79.98 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.267 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.665 HH22 ' CB ' ' A' ' 99' ' ' ASN . 7.0 mmp_? -90.52 118.0 29.64 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -178.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.664 ' NH2' ' ND1' ' A' ' 19' ' ' HIS . 77.8 ttt-85 -127.36 127.23 43.9 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.696 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.929 HD11 HD11 ' A' ' 22' ' ' LEU . 77.6 mt -113.67 144.71 42.47 Favored 'General case' 0 C--N 1.339 0.139 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 51.2 t -121.12 130.94 74.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.47 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.407 HG21 ' OD2' ' B' ' 259' ' ' ASP . 16.1 m -81.37 142.17 33.28 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.579 0.704 . . . . 0.0 112.432 -178.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.402 ' CD1' ' OD1' ' A' ' 16' ' ' ASP . 47.0 mm -108.59 134.35 50.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.62 177.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -90.15 156.58 18.24 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.998 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.679 ' NH1' ' NH2' ' B' ' 245' ' ' ARG . 88.8 mtm180 -58.85 -25.91 63.7 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.247 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.9 p -78.26 -10.11 59.52 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.78 37.85 9.14 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.7 t -122.1 134.3 65.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.674 0.273 . . . . 0.0 110.658 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.402 ' OD1' ' CD1' ' A' ' 10' ' ' ILE . 96.8 m-20 -71.4 133.39 45.9 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.34 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -122.41 -118.02 2.46 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 120.806 -0.711 . . . . 0.0 111.887 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -74.65 145.04 32.38 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.265 1.976 . . . . 0.0 112.812 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.664 ' ND1' ' NH2' ' A' ' 6' ' ' ARG . 17.9 m170 -101.73 140.69 35.67 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.66 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.493 ' CD2' HD11 ' A' ' 37' ' ' ILE . 40.1 t80 -114.42 97.03 45.1 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.441 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -79.67 139.22 14.01 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 121.836 1.691 . . . . 0.0 110.66 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.929 HD11 HD11 ' A' ' 7' ' ' LEU . 92.8 mt -101.43 124.08 46.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.747 0.784 . . . . 0.0 110.529 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.6 p -124.18 -1.31 8.22 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.261 -1.336 . . . . 0.0 108.683 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 42.2 mt -104.67 147.99 27.06 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 114.508 -1.224 . . . . 0.0 109.732 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 96.1 p -65.98 -17.26 64.56 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.345 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 85.2 m -132.37 133.77 44.36 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.246 0.546 . . . . 0.0 112.122 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.573 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 2.9 t -126.4 121.51 32.68 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.619 HD21 ' OE1' ' A' ' 47' ' ' GLN . 55.4 tp -120.9 132.22 54.84 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.824 0.345 . . . . 0.0 111.922 -177.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.692 ' CE2' HD12 ' A' ' 37' ' ' ILE . 8.9 m-85 -109.22 140.79 42.38 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 151.44 -177.78 29.17 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.447 178.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.492 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 46.0 mtm180 -74.19 -33.52 63.45 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.501 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -48.12 148.44 4.07 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.808 -0.71 . . . . 0.0 111.587 -178.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.515 HG23 ' N ' ' A' ' 34' ' ' GLU . 9.9 tp -66.53 -41.96 89.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-O 120.9 0.381 . . . . 0.0 110.438 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.515 ' N ' HG23 ' A' ' 33' ' ' ILE . 79.2 tt0 -58.55 -25.83 62.92 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 17.9 m -52.73 115.45 1.82 Allowed 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.448 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 63.5 m-20 -53.05 -25.0 11.1 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.538 -178.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.692 HD12 ' CE2' ' A' ' 29' ' ' PHE . 96.2 mt -129.71 122.06 54.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.503 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 83.8 mtp180 -106.06 135.53 47.35 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.015 0.435 . . . . 0.0 110.853 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 95.5 mt -118.09 129.55 74.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.059 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -73.73 34.24 0.08 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -177.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.76 HD11 ' NH1' ' A' ' 93' ' ' ARG . 55.9 mt -111.24 129.04 24.44 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.684 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.76 -10.25 24.76 Favored 'Trans proline' 0 N--CA 1.489 1.237 0 C-N-CA 122.445 2.096 . . . . 0.0 113.101 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.52 HG21 ' CE2' ' B' ' 241' ' ' PHE . 35.9 m -94.15 1.12 9.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.562 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.492 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 42.6 t -89.75 136.05 24.65 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.24 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.072 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.6 m -69.8 164.79 22.84 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.424 0.63 . . . . 0.0 111.297 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -62.65 -43.26 99.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.287 -179.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.619 ' OE1' HD21 ' A' ' 28' ' ' LEU . 92.7 mm-40 -111.34 -24.15 10.38 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.318 0.58 . . . . 0.0 110.002 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.0 t60 39.22 -78.05 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.251 -0.886 . . . . 0.0 113.382 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.594 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -129.53 133.73 47.39 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.385 0.612 . . . . 0.0 112.225 -178.663 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -126.83 132.44 50.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.307 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 93.7 mt -117.54 135.41 58.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.568 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.485 ' CD ' ' NE2' ' A' ' 54' ' ' HIS . 79.7 tt0 -120.48 124.62 45.87 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 84.9 mt -102.04 117.83 47.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.324 0.583 . . . . 0.0 111.57 -178.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.485 ' NE2' ' CD ' ' A' ' 52' ' ' GLU . 97.5 m-70 -112.94 141.01 47.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.258 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 54' ' ' HIS . 94.1 mt-10 -39.75 -28.85 0.05 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -178.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.49 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 58.1 tt0 -63.55 -67.67 0.41 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.301 178.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.49 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 3.7 tp10 -158.16 -164.43 1.5 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.336 -178.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -111.49 129.96 55.88 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.9 mt -118.87 128.09 75.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.386 0.612 . . . . 0.0 112.157 -178.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 28.1 tp -97.29 127.87 43.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.934 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -113.23 136.47 52.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.127 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.41 HD21 ' HA ' ' A' ' 68' ' ' PRO . 58.5 t-20 -97.12 104.61 16.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.188 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -96.51 -9.7 29.03 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 120.757 0.313 . . . . 0.0 110.747 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.15 101.44 1.85 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.101 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 79.0 p -87.73 -10.13 52.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.206 0.527 . . . . 0.0 109.591 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.828 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.2 OUTLIER -100.92 -43.22 6.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.249 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.405 HD21 ' HA ' ' B' ' 236' ' ' VAL . 78.9 m-20 -135.85 94.86 14.31 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.025 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.486 ' HB2' HG23 ' A' ' 75' ' ' VAL . 50.4 Cg_exo -57.17 142.9 94.51 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 121.966 1.777 . . . . 0.0 113.014 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 95.9 m -74.49 144.1 44.3 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.401 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -104.88 139.47 39.57 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.056 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 68.8 t -131.02 133.11 63.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 53.65 32.11 13.92 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.149 -0.621 . . . . 0.0 110.065 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.45 26.88 68.9 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-N 115.606 -0.724 . . . . 0.0 112.129 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 43.4 t -142.68 139.93 31.37 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 117.36 0.58 . . . . 0.0 111.08 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.486 HG23 ' HB2' ' A' ' 68' ' ' PRO . 1.2 p -70.25 140.85 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.486 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.8 pt -113.96 90.72 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.82 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -68.43 -28.94 67.51 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.478 ' N ' ' CD ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -116.49 162.18 28.0 Favored Pre-proline 0 C--O 1.232 0.168 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.582 179.129 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -66.56 150.54 83.94 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.571 2.181 . . . . 0.0 112.466 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.4 m -141.78 141.76 29.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.142 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -70.52 129.92 40.49 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.077 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 82' ' ' LEU . 91.3 mt -79.64 140.17 37.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.175 0.512 . . . . 0.0 111.13 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -131.84 151.23 51.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.729 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.42 ' CE1' ' H ' ' A' ' 99' ' ' ASN . 6.1 t60 -53.78 120.14 5.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.052 0.453 . . . . 0.0 111.162 -179.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.81 -17.67 32.54 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -67.51 135.06 52.44 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 120.184 -0.607 . . . . 0.0 110.258 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.519 HG22 ' HG2' ' A' ' 96' ' ' ARG . 58.5 t -113.67 132.51 62.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.115 -178.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 84.5 mt -103.78 132.78 49.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 90.1 m -122.63 128.97 51.35 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.48 0.657 . . . . 0.0 112.646 -178.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.492 ' O ' ' N ' ' A' ' 93' ' ' ARG . 81.2 mt -113.91 126.02 71.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.499 178.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.458 ' C ' ' O ' ' A' ' 90' ' ' ILE . 41.2 mm 35.99 -98.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.746 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 90' ' ' ILE . 41.3 p-10 -116.13 12.11 15.44 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.04 0.448 . . . . 0.0 110.918 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.76 ' NH1' HD11 ' A' ' 41' ' ' LEU . 53.9 mtt85 -123.07 140.44 53.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.334 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 29.4 t -137.27 151.15 48.38 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 120.319 -0.553 . . . . 0.0 110.722 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.488 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 98.0 m-85 -123.6 122.21 37.57 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.519 ' HG2' HG22 ' A' ' 87' ' ' VAL . 99.5 mtt180 -84.65 136.35 33.79 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.167 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.61 ' CZ ' ' CZ ' ' A' ' 5' ' ' ARG . 60.0 t80 -94.48 118.02 31.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.742 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.412 ' HG3' ' CE1' ' A' ' 84' ' ' HIS . 79.8 tt0 -125.47 125.71 43.75 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 111.971 0.359 . . . . 0.0 111.971 -178.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.665 ' CB ' HH22 ' A' ' 5' ' ' ARG . 12.1 t-20 -96.46 131.5 42.98 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 . . . . . 0 C--N 1.323 -0.587 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.956 -178.996 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . 0.616 ' O ' ' N ' ' B' ' 230' ' ' SEP . 14.4 t . . . . . 0 CA--C 1.513 -0.457 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.528 ' C ' ' O ' ' B' ' 228' ' ' VAL . 61.9 t0 15.1 -78.7 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.129 0 O-C-N 124.66 1.225 . . . . 0.0 111.23 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . 0.616 ' N ' ' O ' ' B' ' 228' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.525 ' O ' ' O ' ' B' ' 232' ' ' GLY . 0.2 OUTLIER -116.48 -26.83 6.95 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.887 -179.007 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . 0.525 ' O ' ' O ' ' B' ' 231' ' ' GLN . . . -40.22 173.63 0.01 OUTLIER Glycine 0 CA--C 1.528 0.86 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.098 -178.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.42 161.94 43.89 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 123.91 3.074 . . . . 0.0 112.741 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.828 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.65 133.82 19.33 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 121.891 1.727 . . . . 0.0 112.922 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.653 ' CG2' HG22 ' A' ' 66' ' ' THR . 54.9 t -64.71 139.82 20.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.716 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 7.3 t -73.62 132.18 42.5 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . 0.44 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . 0.44 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 35.5 Cg_exo -57.97 -27.45 79.15 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 122.877 2.385 . . . . 0.0 112.83 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 90.9 m -73.61 -45.19 54.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.546 0.689 . . . . 0.0 109.668 178.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.52 ' CE2' HG21 ' A' ' 43' ' ' VAL . 68.9 t80 -58.33 -46.22 86.61 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.622 -178.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 94.9 mt -62.67 -41.64 99.2 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 120.981 0.419 . . . . 0.0 110.481 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -59.29 -37.06 76.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.415 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -62.92 -43.4 98.91 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.012 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.752 ' NH2' HH22 ' A' ' 93' ' ' ARG . 26.5 mmm180 -58.59 -41.65 86.24 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -64.21 -43.22 95.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.349 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 27.9 t -64.08 -44.98 90.7 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . 0.587 ' O ' ' N ' ' B' ' 252' ' ' LEU . 87.2 mt-30 -57.38 -40.31 77.93 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.29 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.457 ' O ' ' O ' ' B' ' 252' ' ' LEU . 54.3 t -62.82 -42.91 98.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 120.658 -0.417 . . . . 0.0 109.916 178.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -61.37 -36.42 80.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.2 0.524 . . . . 0.0 109.625 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -90.81 -11.3 39.8 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.063 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.587 ' N ' ' O ' ' B' ' 248' ' ' GLN . 37.3 tp -124.22 109.87 13.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.067 179.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . 0.609 ' ND2' ' O ' ' B' ' 253' ' ' ASN . 0.2 OUTLIER -177.47 12.79 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 178.781 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . 0.417 ' O ' ' CB ' ' B' ' 255' ' ' ASP . 34.7 t70 -62.92 -44.34 96.33 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 119.519 -0.873 . . . . 0.0 109.513 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . 0.464 ' CG ' ' O ' ' B' ' 255' ' ' ASP . 4.3 t0 156.27 66.3 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.495 -1.229 . . . . 0.0 107.74 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.46 ' C ' ' H ' ' B' ' 258' ' ' ASP . 46.5 t0 -105.76 98.47 8.16 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.873 -178.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -66.2 8.29 0.23 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.352 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.46 ' H ' ' C ' ' B' ' 256' ' ' ASP . 59.6 t0 -91.22 106.19 18.33 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.407 ' OD2' HG21 ' A' ' 9' ' ' THR . 53.6 p-10 -102.46 17.51 23.41 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -177.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.57 ' OE1' ' NH2' ' B' ' 245' ' ' ARG . 96.4 mt-10 62.87 7.64 2.71 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.25 0.477 . . . . 0.0 111.163 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.488 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 89.6 mt -109.78 133.08 56.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 41.5 t -124.32 133.71 68.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.945 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . 0.534 ' CD2' HG21 ' B' ' 267' ' ' ILE . 70.6 m-85 -98.77 121.29 40.53 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.299 0.571 . . . . 0.0 110.818 -178.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -65.92 -39.2 90.32 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.905 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . 0.414 ' CB ' ' CD ' ' B' ' 266' ' ' PRO . 0.6 OUTLIER -103.2 179.47 0.96 Allowed Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.099 -178.461 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . 0.414 ' CD ' ' CB ' ' B' ' 265' ' ' GLN . 24.4 Cg_exo -62.25 149.81 89.27 Favored 'Trans proline' 0 N--CA 1.498 1.742 0 C-N-CA 122.822 2.348 . . . . 0.0 113.536 -178.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . 0.534 HG21 ' CD2' ' B' ' 263' ' ' PHE . 15.8 pt . . . . . 0 N--CA 1.465 0.308 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.051 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo . . . . . 0 N--CA 1.495 1.606 0 CA-C-O 121.17 0.404 . . . . 0.0 113.063 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.0 p -100.86 -23.16 14.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.373 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.728 HH12 ' HB2' ' A' ' 58' ' ' ALA . 94.3 mtt-85 -97.25 115.01 26.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.957 -178.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.61 HH21 ' CE1' ' A' ' 19' ' ' HIS . 73.5 ttt180 -128.24 130.8 48.49 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.667 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.563 HD11 ' HB3' ' A' ' 95' ' ' PHE . 34.2 tp -113.17 133.25 55.14 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.0 t -109.87 131.57 60.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.851 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.414 HG23 ' CD1' ' B' ' 261' ' ' ILE . 2.1 m -92.17 113.86 26.25 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.942 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.8 mt -79.15 143.69 12.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.901 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -87.99 159.37 18.33 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.153 0.502 . . . . 0.0 110.64 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.441 ' NH2' ' HB2' ' B' ' 248' ' ' GLN . 82.1 mtp180 -53.27 -32.42 48.46 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.066 -178.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 91.1 p -79.37 -7.39 58.33 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.954 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.15 31.96 11.25 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.7 t -117.86 132.71 66.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -75.11 138.91 42.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.556 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -131.94 -114.89 1.63 Allowed Glycine 0 CA--C 1.538 1.479 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.321 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -74.07 148.31 39.65 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.46 2.107 . . . . 0.0 112.56 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.61 ' CE1' HH21 ' A' ' 6' ' ' ARG . 0.0 OUTLIER -111.37 160.82 16.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.479 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.406 ' CD2' HD11 ' A' ' 37' ' ' ILE . 39.4 t80 -131.21 103.51 15.29 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.706 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.98 135.83 17.77 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 121.346 1.364 . . . . 0.0 111.627 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 64.7 mt -85.22 51.83 2.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.228 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.2 p -64.25 -24.85 67.81 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.7 mt -80.33 141.82 35.07 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.678 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.8 t -63.14 -20.73 65.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.563 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 94.4 m -134.88 135.64 41.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.106 0.479 . . . . 0.0 111.577 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.2 t -127.99 120.7 28.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.591 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.528 HD12 ' O ' ' A' ' 49' ' ' CYS . 56.3 tp -118.51 131.65 56.23 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.262 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.635 ' CE2' HD12 ' A' ' 37' ' ' ILE . 3.8 m-85 -108.83 141.78 40.38 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.291 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 158.15 -170.92 35.01 Favored Glycine 0 N--CA 1.469 0.894 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.219 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.578 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 81.9 mtm-85 -84.42 -27.91 27.24 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 122.447 -0.443 . . . . 0.0 110.821 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -54.66 146.07 27.19 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.051 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.406 HD13 ' HA ' ' A' ' 33' ' ' ILE . 31.2 mm -64.54 -43.57 96.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.014 0.435 . . . . 0.0 110.291 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -57.17 -19.86 23.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.048 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 81.7 m -62.77 131.97 50.65 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.491 -0.483 . . . . 0.0 110.171 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.456 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 64.8 m-20 -61.48 -34.79 76.06 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.222 -178.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.635 HD12 ' CE2' ' A' ' 29' ' ' PHE . 99.4 mt -125.16 125.88 70.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.413 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 44.4 mtm-85 -119.39 145.14 46.48 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.879 -177.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 80.9 mt -123.2 133.16 69.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.422 -178.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -75.88 25.64 0.12 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.973 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.744 HD11 ' CZ ' ' A' ' 93' ' ' ARG . 30.4 mt -96.81 129.41 32.78 Favored Pre-proline 0 C--N 1.324 -0.528 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.087 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.545 ' HB3' HG11 ' B' ' 228' ' ' VAL . 42.8 Cg_endo -71.09 -13.09 31.1 Favored 'Trans proline' 0 N--CA 1.489 1.225 0 C-N-CA 122.029 1.819 . . . . 0.0 112.618 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.612 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 26.9 m -98.06 3.22 10.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.619 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.578 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 35.4 t -89.88 135.69 25.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.48 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 0.6 OUTLIER -65.15 160.62 20.86 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.373 0.606 . . . . 0.0 111.782 -178.864 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -62.46 -42.31 99.38 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.071 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.614 ' O ' ' N ' ' A' ' 49' ' ' CYS . 86.7 mt-30 -114.97 -14.4 11.87 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 123.609 0.568 . . . . 0.0 110.069 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.48 ' H ' ' HB3' ' A' ' 45' ' ' SER . 19.7 t60 31.1 -73.75 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.614 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.85 137.19 44.87 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -177.631 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -125.16 132.33 53.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.909 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.9 mt -118.57 133.03 66.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.832 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -119.99 127.38 52.57 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 177.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.402 HD13 ' CD ' ' A' ' 5' ' ' ARG . 86.7 mt -108.36 124.15 64.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -177.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.517 ' CD2' ' N ' ' A' ' 54' ' ' HIS . 2.7 m-70 -117.5 141.02 48.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.538 -1.21 . . . . 0.0 109.479 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 54' ' ' HIS . 96.3 mt-10 -39.91 -29.5 0.07 Allowed 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.993 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.458 ' N ' ' O ' ' A' ' 54' ' ' HIS . 69.0 tp60 -64.38 -65.93 0.61 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -158.5 -155.44 0.49 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.099 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.728 ' HB2' HH12 ' A' ' 5' ' ' ARG . . . -120.5 131.41 54.71 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.208 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.7 mm -112.58 123.62 68.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.668 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.474 ' HB2' HD11 ' A' ' 82' ' ' LEU . 30.9 tp -97.67 127.21 43.45 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -115.01 136.18 53.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.956 0.408 . . . . 0.0 110.847 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -97.29 106.22 18.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.48 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -98.74 -8.18 26.47 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.086 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.2 m -69.74 101.33 1.66 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 95.4 p -83.57 -13.23 54.88 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.123 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.623 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.3 OUTLIER -91.35 -46.81 7.82 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.199 -179.95 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -139.67 101.51 7.26 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.916 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.594 ' HB2' HG13 ' A' ' 75' ' ' VAL . 36.6 Cg_exo -57.07 147.66 73.82 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 121.986 1.791 . . . . 0.0 112.884 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.7 m -74.66 145.83 42.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.543 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -107.54 140.34 40.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.256 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.1 t -129.66 133.91 64.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 53.59 32.93 15.29 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 119.899 -0.72 . . . . 0.0 109.284 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.45 27.57 71.14 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.702 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 21.3 t -141.99 138.79 32.14 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 117.133 0.466 . . . . 0.0 112.003 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.594 HG13 ' HB2' ' A' ' 68' ' ' PRO . 48.3 t -68.76 140.3 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.143 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.483 HG21 HG11 ' A' ' 80' ' ' VAL . 4.9 pt -113.36 93.86 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-O 120.983 0.42 . . . . 0.0 110.808 178.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -65.04 -28.98 69.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.63 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.462 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.2 OUTLIER -126.34 178.96 1.3 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.178 -179.313 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.462 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 36.5 Cg_exo -59.36 143.05 99.85 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 122.68 2.253 . . . . 0.0 111.45 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.483 HG11 HG21 ' A' ' 76' ' ' ILE . 5.2 p -137.69 140.78 40.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.464 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.454 HH11 ' HD3' ' A' ' 81' ' ' ARG . 34.0 mmt-85 -79.29 129.4 34.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.221 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.474 HD11 ' HB2' ' A' ' 60' ' ' LEU . 98.4 mt -85.21 136.58 33.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.985 0.421 . . . . 0.0 111.381 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -125.85 152.2 45.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.459 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.407 ' CD2' ' C ' ' A' ' 84' ' ' HIS . 6.9 t60 -53.37 115.78 2.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.79 0.329 . . . . 0.0 110.422 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.7 -16.7 25.99 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -69.01 135.2 50.52 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.215 -0.594 . . . . 0.0 109.958 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.1 t -112.39 131.29 64.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.138 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 91.6 mt -94.62 131.37 41.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 25.6 m -122.79 128.18 50.11 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -177.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.474 ' O ' ' C ' ' A' ' 91' ' ' ILE . 79.5 mt -113.79 125.14 71.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.01 178.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.516 HG22 ' N ' ' A' ' 92' ' ' ASP . 97.9 mt 33.64 -96.36 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.074 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.593 ' OD1' ' NH1' ' A' ' 93' ' ' ARG . 47.9 p-10 -114.74 12.24 17.02 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.744 ' CZ ' HD11 ' A' ' 41' ' ' LEU . 70.6 mtt85 -124.62 140.05 53.3 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.683 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 56.6 m -136.09 151.1 49.46 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.45 0.643 . . . . 0.0 111.137 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.563 ' HB3' HD11 ' A' ' 7' ' ' LEU . 63.0 m-85 -121.95 120.74 35.3 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.851 179.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.526 ' O ' HD12 ' A' ' 7' ' ' LEU . 39.6 ttm180 -81.65 129.21 34.62 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.616 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.586 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 87.1 t80 -94.9 124.31 38.88 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.722 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -123.3 122.01 37.27 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.617 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.415 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 47.7 t30 -125.53 115.83 20.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.373 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 . . . . . 0 C--N 1.329 -0.313 0 CA-C-O 120.771 0.32 . . . . 0.0 110.541 -179.875 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . 0.545 HG11 ' HB3' ' A' ' 42' ' ' PRO . 3.7 t . . . . . 0 CA--C 1.517 -0.294 0 CA-C-O 121.204 0.526 . . . . 0.0 111.541 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.609 ' C ' ' H ' ' B' ' 231' ' ' GLN . 98.0 m-20 58.76 88.23 0.07 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.682 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . 0.6 ' O ' ' NE2' ' B' ' 231' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.609 ' H ' ' C ' ' B' ' 229' ' ' ASP . 95.5 mm-40 -137.32 51.0 1.96 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -116.25 -173.98 17.32 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.251 -0.74 . . . . 0.0 111.251 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.09 158.82 56.34 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.8 2.333 . . . . 0.0 112.517 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.623 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . 0.428 ' HD2' ' O ' ' A' ' 42' ' ' PRO . 26.8 Cg_exo -60.03 141.49 96.44 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.911 2.407 . . . . 0.0 112.779 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -78.76 133.17 30.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.87 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . 0.451 ' SG ' HG23 ' A' ' 91' ' ' ILE . 34.7 t -68.18 126.39 29.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.963 -179.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -59.38 -23.54 70.67 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.63 2.22 . . . . 0.0 112.458 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 79.8 m -74.38 -43.0 58.35 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.29 0.567 . . . . 0.0 109.62 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.612 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 73.6 t80 -55.54 -46.65 77.06 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.693 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 98.4 mt -64.75 -39.49 93.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.108 0.48 . . . . 0.0 110.331 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 51.2 tp10 -61.12 -42.52 98.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.761 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -63.72 -39.43 94.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.307 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.488 ' NH2' ' CE1' ' B' ' 241' ' ' PHE . 40.3 mmt-85 -61.74 -40.74 96.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.706 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -62.18 -41.38 98.28 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.412 -0.515 . . . . 0.0 109.95 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 37.3 t -65.04 -45.38 85.66 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . 0.441 ' HB2' ' NH2' ' A' ' 12' ' ' ARG . 74.8 mt-30 -61.2 -35.41 77.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.554 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.47 HG23 ' O ' ' B' ' 245' ' ' ARG . 39.4 t -60.34 -45.75 96.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -59.07 -27.38 65.48 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -86.47 -10.11 54.86 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.097 178.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.413 ' O ' ' CB ' ' B' ' 253' ' ' ASN . 96.2 mt -117.52 -176.19 2.97 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.61 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . 0.587 ' ND2' ' O ' ' B' ' 253' ' ' ASN . 0.2 OUTLIER 79.62 14.49 0.98 Allowed 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.11 179.509 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' B' ' 255' ' ' ASP . 96.8 m-20 -65.57 -31.0 71.81 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . 0.478 ' O ' ' CB ' ' B' ' 256' ' ' ASP . 91.3 m-20 -137.61 -80.94 0.36 Allowed 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.668 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.478 ' CB ' ' O ' ' B' ' 255' ' ' ASP . 1.9 p30 154.24 116.97 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -178.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . 0.559 ' O ' ' C ' ' B' ' 258' ' ' ASP . 62.2 pttt -174.32 151.87 1.68 Allowed 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.514 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.559 ' C ' ' O ' ' B' ' 257' ' ' LYS . 66.7 t0 -6.31 119.48 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 O-C-N 124.344 1.027 . . . . 0.0 111.449 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . . . . . . . . . 46.3 p-10 -105.55 61.19 0.67 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.26 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.452 ' OE1' ' NH2' ' A' ' 93' ' ' ARG . 95.2 mt-10 62.74 9.46 3.6 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.414 ' CD1' HG23 ' A' ' 9' ' ' THR . 76.5 mt -111.61 134.0 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 54.8 t -125.58 132.85 70.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.738 0.304 . . . . 0.0 111.098 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -98.33 120.36 38.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.312 0.577 . . . . 0.0 111.626 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -66.85 -44.61 80.58 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.203 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.42 159.2 30.13 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.033 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.02 154.4 67.39 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 123.051 2.501 . . . . 0.0 111.864 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 47.0 pt . . . . . 0 C--N 1.327 -0.393 0 CA-C-O 121.309 0.576 . . . . 0.0 111.819 -178.931 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo . . . . . 0 N--CA 1.493 1.472 0 CA-C-O 120.961 0.317 . . . . 0.0 112.401 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.5 p -87.04 -36.01 18.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.716 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.4 mtt85 -94.87 124.93 39.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.908 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -133.53 140.25 47.09 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.343 -0.543 . . . . 0.0 111.521 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.879 HD11 HD11 ' A' ' 22' ' ' LEU . 79.2 mt -113.0 138.45 49.86 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.502 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 54.7 t -112.78 131.34 64.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.3 m -85.38 136.32 33.51 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.595 0.712 . . . . 0.0 112.32 -178.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 95.0 mt -108.89 138.03 38.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.185 178.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -91.4 158.36 16.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.191 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.774 ' HE ' ' HZ2' ' B' ' 257' ' ' LYS . 87.5 mtm180 -59.26 -23.51 62.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.044 0.45 . . . . 0.0 110.271 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.2 t -79.05 -16.83 56.26 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.358 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.05 36.62 5.93 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.6 t -119.46 134.18 63.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 121.191 0.519 . . . . 0.0 112.052 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.401 ' C ' ' OD1' ' A' ' 16' ' ' ASP . 60.5 t0 -76.96 120.1 21.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.38 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -115.48 -124.75 3.82 Favored Glycine 0 CA--C 1.539 1.583 0 C-N-CA 120.919 -0.657 . . . . 0.0 111.665 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.24 153.25 40.52 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.551 2.167 . . . . 0.0 113.192 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -111.61 156.58 21.58 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.029 0.442 . . . . 0.0 110.563 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.417 ' CD2' HD11 ' A' ' 37' ' ' ILE . 38.7 t80 -123.58 100.91 37.54 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.066 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.53 134.44 20.49 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 C-N-CA 121.344 1.363 . . . . 0.0 111.928 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.879 HD11 HD11 ' A' ' 7' ' ' LEU . 95.3 mt -88.55 71.74 8.86 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.844 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 89.2 p -79.9 -8.22 59.18 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.652 HD11 ' HG2' ' B' ' 265' ' ' GLN . 51.8 mt -97.4 142.5 29.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.801 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.9 p -66.2 -21.69 66.32 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.099 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 86.0 m -133.68 136.23 44.58 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.006 0.431 . . . . 0.0 110.775 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.559 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -134.81 129.53 34.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.486 178.632 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.51 HD12 ' O ' ' A' ' 49' ' ' CYS . 48.1 tp -119.71 131.22 55.34 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.745 -178.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.757 ' CE2' HD12 ' A' ' 37' ' ' ILE . 38.1 m-85 -104.98 140.78 37.68 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.702 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 149.3 -166.4 29.53 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 120.299 -0.953 . . . . 0.0 112.574 178.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 44.5 mtm180 -86.0 -32.01 21.72 Favored 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.415 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -49.33 151.16 3.84 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 -178.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.462 HG23 ' N ' ' A' ' 34' ' ' GLU . 11.3 tp -66.41 -40.5 86.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.462 ' N ' HG23 ' A' ' 33' ' ' ILE . 85.1 tt0 -54.8 -23.96 20.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.022 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.415 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 59.5 m -56.79 115.02 2.32 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.827 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -57.82 -21.41 42.09 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.757 HD12 ' CE2' ' A' ' 29' ' ' PHE . 97.6 mt -129.99 120.98 50.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.278 -0.874 . . . . 0.0 108.912 177.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 84.7 mtp180 -105.54 133.66 49.93 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.514 -179.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.0 mt -118.49 128.07 75.47 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -80.25 43.59 0.64 Allowed 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -177.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.971 HD11 ' NH1' ' A' ' 93' ' ' ARG . 59.0 mt -111.14 134.06 21.16 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.379 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.81 -9.76 21.2 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 122.223 1.948 . . . . 0.0 111.965 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.626 HG21 ' CE2' ' B' ' 241' ' ' PHE . 27.0 m -101.11 2.28 10.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.772 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 25.1 t -93.34 135.84 26.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.278 0.561 . . . . 0.0 109.945 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.4 m -68.25 159.94 30.24 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.377 -178.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -61.47 -42.46 98.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.928 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.675 ' O ' ' N ' ' A' ' 49' ' ' CYS . 82.9 mt-30 -114.58 -16.37 11.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.459 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.2 t60 32.81 -73.82 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.675 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -134.8 138.13 43.98 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -178.221 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -125.5 136.76 53.69 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.42 -0.809 . . . . 0.0 108.909 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.532 HG22 ' O ' ' A' ' 27' ' ' CYS . 14.9 tt -126.5 140.72 48.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.074 0.464 . . . . 0.0 110.89 -178.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -122.59 135.56 54.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.393 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.8 mt -110.6 114.62 47.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.283 0.564 . . . . 0.0 111.355 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.47 ' O ' ' N ' ' A' ' 56' ' ' GLN . 92.3 m-70 -115.76 143.89 44.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.571 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 54' ' ' HIS . 96.1 mt-10 -40.06 -29.36 0.07 Allowed 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.308 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.47 ' N ' ' O ' ' A' ' 54' ' ' HIS . 87.9 mt-30 -63.48 -69.66 0.26 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -160.57 -164.1 1.18 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.555 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -108.42 131.91 54.3 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.163 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 89.2 mt -122.0 132.27 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -178.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.553 HD11 ' SG ' ' A' ' 49' ' ' CYS . 57.9 tp -99.35 128.83 45.51 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.825 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -115.53 134.95 54.58 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -95.74 103.53 15.42 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -95.25 -8.25 36.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.427 178.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.44 98.42 8.88 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.989 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.9 p -79.57 -31.82 41.97 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.747 HG21 ' O ' ' B' ' 234' ' ' TPO . 3.5 m -65.32 -49.08 70.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.917 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.479 HD21 ' HA ' ' B' ' 236' ' ' VAL . 73.8 m-20 -138.96 95.9 9.39 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.742 -179.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -54.04 144.32 58.0 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 121.901 1.734 . . . . 0.0 112.74 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.3 m -71.11 132.29 44.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.783 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -97.56 140.64 31.67 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.071 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.5 p -133.25 137.68 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 49.85 32.38 5.38 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.3 29.35 70.3 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.901 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 58.3 m -135.13 124.77 25.17 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 117.364 0.582 . . . . 0.0 112.086 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.7 m -69.27 137.0 25.12 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.526 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 1.6 pt -116.26 120.17 64.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 C-N-CA 120.659 -0.417 . . . . 0.0 110.726 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -85.29 -18.93 32.42 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.02 167.07 17.96 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.2 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.88 151.46 73.91 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.697 2.265 . . . . 0.0 112.807 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.5 m -141.2 148.81 20.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.193 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -79.09 133.7 36.76 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.331 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 97.0 mt -85.57 144.34 27.95 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.238 0.542 . . . . 0.0 111.304 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -128.47 151.1 49.79 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.913 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.5 ' ND1' ' N ' ' A' ' 99' ' ' ASN . 7.0 t60 -53.72 118.34 3.85 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.059 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.28 -17.33 31.61 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.994 -0.843 . . . . 0.0 110.994 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -67.16 135.38 53.43 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.227 0.537 . . . . 0.0 110.214 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.525 ' O ' HG13 ' A' ' 87' ' ' VAL . 12.5 p -113.54 133.47 59.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.877 -178.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.1 mt -99.67 131.7 46.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 177.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 98.6 m -122.91 125.67 45.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.642 0.735 . . . . 0.0 112.527 -178.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.591 ' O ' ' N ' ' A' ' 92' ' ' ASP . 96.6 mt -111.03 125.26 68.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 114.519 -1.218 . . . . 0.0 108.198 178.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.552 HD12 ' HB2' ' B' ' 237' ' ' CYS . 23.4 mm 35.17 -90.23 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -178.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.591 ' N ' ' O ' ' A' ' 90' ' ' ILE . 1.0 OUTLIER -125.44 5.81 7.65 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.14 0.495 . . . . 0.0 110.735 178.793 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.971 ' NH1' HD11 ' A' ' 41' ' ' LEU . 71.4 mtt85 -108.4 137.01 47.09 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.186 178.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 31.0 t -139.21 151.27 46.42 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.167 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.532 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 78.9 m-85 -124.81 126.02 44.94 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -87.06 135.99 33.08 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.99 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -97.82 123.0 41.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.358 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -139.62 130.69 26.42 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.158 -0.617 . . . . 0.0 112.069 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.5 ' N ' ' ND1' ' A' ' 84' ' ' HIS . 77.8 m-20 -97.79 127.21 43.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.626 178.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 . . . . . 0 C--N 1.324 -0.519 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.922 -179.975 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . 0.449 ' O ' ' C ' ' B' ' 229' ' ' ASP . 33.3 m . . . . . 0 N--CA 1.455 -0.206 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.449 ' C ' ' O ' ' B' ' 228' ' ' VAL . 67.1 t0 -34.33 -83.6 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.501 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -134.65 54.12 1.96 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.084 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -117.23 -169.22 14.92 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.559 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -65.83 153.41 78.26 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 123.598 2.865 . . . . 0.0 112.7 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.747 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -77.63 141.19 19.47 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 C-N-CA 121.815 1.677 . . . . 0.0 111.949 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.479 ' HA ' HD21 ' A' ' 67' ' ' ASN . 3.5 m -65.75 147.55 12.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . 0.552 ' HB2' HD12 ' A' ' 91' ' ' ILE . 8.5 t -67.7 133.26 48.99 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.246 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.1 -29.94 85.05 Favored 'Trans proline' 0 N--CA 1.503 2.068 0 C-N-CA 123.019 2.479 . . . . 0.0 113.254 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 42.9 m -72.11 -43.39 64.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.051 0.453 . . . . 0.0 110.214 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.626 ' CE2' HG21 ' A' ' 43' ' ' VAL . 63.6 t80 -58.11 -46.76 85.0 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.097 -178.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 82.7 mt -63.79 -41.66 97.88 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.85 -39.67 90.99 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.565 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -61.74 -40.72 96.09 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.237 -0.585 . . . . 0.0 109.617 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.857 ' O ' HG23 ' B' ' 249' ' ' VAL . 77.9 mtp180 -63.35 -42.53 98.92 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.289 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -62.99 -41.06 99.46 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.382 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 33.5 p -67.62 -44.27 78.4 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.285 0.564 . . . . 0.0 109.905 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -63.49 -32.85 74.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.42 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.857 HG23 ' O ' ' B' ' 245' ' ' ARG . 75.8 t -62.34 -45.75 98.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -61.45 -28.09 69.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.45 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -85.39 -10.45 56.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.81 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.492 ' O ' ' O ' ' B' ' 249' ' ' VAL . 96.2 mt -120.63 108.91 14.6 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.467 177.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . 0.589 ' ND2' ' O ' ' B' ' 253' ' ' ASN . 0.3 OUTLIER 178.88 18.7 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 121.116 -0.233 . . . . 0.0 111.018 179.475 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -63.32 -42.69 99.02 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.057 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . 0.57 ' O ' ' CB ' ' B' ' 256' ' ' ASP . 36.4 t0 170.21 63.29 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.758 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.57 ' CB ' ' O ' ' B' ' 255' ' ' ASP . 63.1 m-20 109.28 129.24 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 O-C-N 124.446 1.091 . . . . 0.0 110.72 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . 0.774 ' HZ2' ' HE ' ' A' ' 12' ' ' ARG . 11.7 ptmt -106.13 28.3 7.8 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.36 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.449 ' C ' ' O ' ' B' ' 257' ' ' LYS . 87.3 m-20 41.59 64.63 1.0 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -178.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.637 ' C ' ' H ' ' B' ' 261' ' ' ILE . 50.6 p-10 -32.67 114.42 0.16 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.676 -178.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -61.9 19.33 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.711 -1.131 . . . . 0.0 111.371 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.637 ' H ' ' C ' ' B' ' 259' ' ' ASP . 75.6 mt -110.84 134.1 54.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 178.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 79.1 t -126.22 135.04 65.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.766 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -95.25 120.41 35.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.145 -178.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 40.5 tttp -65.33 -45.52 83.93 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.034 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . 0.652 ' HG2' HD11 ' A' ' 24' ' ' LEU . 2.9 mp0 -91.54 160.92 35.67 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.714 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.46 148.54 67.22 Favored 'Trans proline' 0 C--N 1.301 -1.923 0 C-N-CA 122.698 2.265 . . . . 0.0 112.829 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 42.7 pt . . . . . 0 C--N 1.332 -0.165 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.759 179.384 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.42 ' HG2' HH21 ' A' ' 6' ' ' ARG . 91.7 Cg_endo . . . . . 0 N--CA 1.492 1.431 0 N-CA-C 112.899 0.307 . . . . 0.0 112.899 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.3 p -122.22 -40.06 2.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.834 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.582 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 93.5 mtt-85 -93.84 120.74 34.49 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.546 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.557 ' NH1' ' OE2' ' A' ' 100' ' ' GLU . 99.5 mtt180 -130.09 137.08 49.99 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.057 0.456 . . . . 0.0 111.782 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.621 HD11 ' HB3' ' A' ' 95' ' ' PHE . 43.8 tp -110.49 130.57 55.53 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.7 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 43.3 t -107.37 130.23 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 120.744 0.307 . . . . 0.0 110.72 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 m -90.91 116.4 28.69 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -177.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.625 HD12 ' OG ' ' A' ' 94' ' ' SER . 96.6 mt -83.72 142.89 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.21 178.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -93.32 157.85 16.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.265 0.555 . . . . 0.0 111.147 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.602 HH22 ' CG ' ' B' ' 248' ' ' GLN . 59.1 mtp180 -57.97 -31.9 67.34 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.232 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.4 p -71.59 -15.62 62.27 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.064 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.03 37.18 5.76 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 46.3 t -124.81 133.6 69.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.181 -0.509 . . . . 0.0 111.328 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -77.22 136.9 38.57 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.87 -120.25 2.22 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.486 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -71.53 151.52 58.98 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.273 1.982 . . . . 0.0 113.147 -178.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -108.01 158.59 17.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.178 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.55 ' CD2' HD11 ' A' ' 37' ' ' ILE . 53.0 t80 -129.22 94.98 31.99 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.22 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -57.93 124.9 17.05 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.038 1.825 . . . . 0.0 111.862 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 89.3 mt -87.39 46.94 1.43 Allowed 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.676 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.5 t -59.81 -20.21 55.42 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.692 HD11 ' HG2' ' B' ' 265' ' ' GLN . 71.7 mt -77.78 139.44 39.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.02 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.1 p -64.62 -20.98 66.59 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.906 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.5 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 28.2 m -132.45 132.98 43.3 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.716 -0.393 . . . . 0.0 110.769 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.2 t -124.98 117.92 25.09 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.3 tp -115.99 129.05 56.2 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.278 -178.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.68 ' CE2' HD12 ' A' ' 37' ' ' ILE . 4.9 m-85 -108.56 139.96 42.59 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.056 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.76 -178.11 29.24 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.479 178.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 31' ' ' ARG . 46.5 mtm180 -70.96 -33.3 70.33 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.685 0.278 . . . . 0.0 111.264 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.452 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -47.15 143.62 5.47 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.475 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.3 tp -67.1 -41.11 86.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.475 ' N ' HG23 ' A' ' 33' ' ' ILE . 79.7 mm-40 -55.79 -19.25 10.73 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.899 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.452 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 86.0 m -55.96 122.13 10.88 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.232 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.5 ' OD2' ' O ' ' A' ' 26' ' ' THR . 63.8 m-20 -58.15 -29.2 65.39 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.68 HD12 ' CE2' ' A' ' 29' ' ' PHE . 79.4 mt -128.38 119.09 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 176.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 68.8 ttp85 -106.47 135.85 47.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.319 -178.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.426 HG22 ' H ' ' A' ' 41' ' ' LEU . 95.1 mt -116.17 129.93 71.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-O 121.168 0.508 . . . . 0.0 110.853 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -75.92 25.46 0.12 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.415 -178.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.483 HD23 ' HA ' ' A' ' 41' ' ' LEU . 29.7 mt -92.22 128.85 43.47 Favored Pre-proline 0 C--N 1.326 -0.43 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.403 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.19 -8.21 21.7 Favored 'Trans proline' 0 C--N 1.316 -1.18 0 C-N-CA 122.083 1.856 . . . . 0.0 111.905 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.593 HG21 ' CE2' ' B' ' 241' ' ' PHE . 35.2 m -104.58 5.33 10.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.496 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.7 t -90.64 137.81 20.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.8 m -66.68 168.06 10.07 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.295 0.569 . . . . 0.0 112.035 -178.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -63.15 -45.71 90.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.237 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.651 ' O ' ' N ' ' A' ' 49' ' ' CYS . 86.9 mt-30 -115.02 -16.82 11.6 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.193 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.578 ' NE2' HG23 ' A' ' 90' ' ' ILE . 19.7 t60 35.97 -74.81 0.0 OUTLIER 'General case' 0 C--O 1.236 0.373 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 179.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.651 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.4 134.35 47.07 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -177.971 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -127.46 126.8 42.99 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.852 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.7 mt -111.52 134.26 54.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.332 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.493 ' CD ' ' NE2' ' A' ' 54' ' ' HIS . 82.7 tt0 -116.66 122.63 45.11 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 178.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 74.3 mt -103.46 118.7 50.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.008 -0.677 . . . . 0.0 112.276 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.56 ' O ' ' N ' ' A' ' 56' ' ' GLN . 99.3 m-70 -114.25 139.91 49.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.14 178.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.459 ' C ' ' O ' ' A' ' 54' ' ' HIS . 97.3 mt-10 -39.79 -25.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.465 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.56 ' N ' ' O ' ' A' ' 54' ' ' HIS . 60.4 tt0 -64.99 -67.55 0.43 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.712 ' CB ' ' HE ' ' A' ' 81' ' ' ARG . 4.7 tp10 -158.37 -159.14 0.77 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.104 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.406 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -118.25 128.36 54.61 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 87.7 mt -118.68 129.68 74.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.895 -178.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.629 ' HB2' HD11 ' A' ' 82' ' ' LEU . 26.7 tp -99.59 129.65 45.76 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.857 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -110.97 135.93 50.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.147 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.507 HD21 ' HB3' ' A' ' 68' ' ' PRO . 36.7 t-20 -97.26 109.45 22.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.835 0.35 . . . . 0.0 111.748 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -99.83 -9.66 22.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.692 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.9 t -78.74 119.81 22.5 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.106 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 95.2 p -101.04 -29.92 11.9 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.404 ' O ' ' OD1' ' A' ' 67' ' ' ASN . 0.6 OUTLIER -66.57 -42.06 87.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.608 178.67 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.404 ' OD1' ' O ' ' A' ' 66' ' ' THR . 1.4 m-20 -147.97 101.13 3.65 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.162 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.507 ' HB3' HD21 ' A' ' 62' ' ' ASN . 39.1 Cg_endo -66.2 154.22 75.0 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 121.624 1.549 . . . . 0.0 112.753 -178.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.1 m -75.24 149.9 38.75 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.612 -178.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -112.84 140.18 47.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.663 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 41.1 t -129.08 135.66 61.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.483 ' H ' HG13 ' A' ' 87' ' ' VAL . 89.6 m-20 52.22 31.81 9.76 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.42 25.81 71.76 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.893 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 63.4 m -136.78 135.94 38.47 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 120.324 -0.55 . . . . 0.0 112.031 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 43.5 t -66.63 135.84 27.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.233 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.0 pt -106.62 98.82 7.4 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.088 0 CA-C-O 121.322 0.582 . . . . 0.0 111.001 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -63.13 -33.26 75.07 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.39 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.498 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.2 OUTLIER -129.58 -178.71 0.85 Allowed Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.262 -179.531 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.498 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 31.5 Cg_exo -60.5 146.53 96.71 Favored 'Trans proline' 0 N--CA 1.504 2.1 0 C-N-CA 123.297 2.665 . . . . 0.0 112.459 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.4 p -140.01 139.65 36.69 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 CA-C-O 120.93 0.395 . . . . 0.0 111.626 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.712 ' HE ' ' CB ' ' A' ' 57' ' ' GLU . 70.5 ttt180 -75.34 127.65 33.63 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.687 178.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.629 HD11 ' HB2' ' A' ' 60' ' ' LEU . 92.4 mt -84.12 141.26 31.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.167 0.508 . . . . 0.0 111.206 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -130.73 149.36 52.41 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.882 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.471 ' ND1' ' N ' ' A' ' 99' ' ' ASN . 7.8 t60 -52.39 117.99 3.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.64 -179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.36 -16.97 34.61 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -66.37 139.72 58.04 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 121.213 0.53 . . . . 0.0 110.308 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.483 HG13 ' H ' ' A' ' 72' ' ' ASN . 7.4 p -111.09 133.01 58.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.869 -178.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.7 mt -101.14 129.65 51.81 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 76.8 m -124.48 122.29 37.22 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.642 0.734 . . . . 0.0 112.445 -178.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.578 HG23 ' NE2' ' A' ' 48' ' ' HIS . 76.5 mt -108.34 125.24 65.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.511 ' C ' ' O ' ' A' ' 90' ' ' ILE . 94.5 mt 34.73 -97.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.063 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.569 ' OD2' ' CZ ' ' B' ' 245' ' ' ARG . 54.4 p-10 -117.41 6.8 12.66 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.919 0.39 . . . . 0.0 111.196 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.595 ' NH2' ' O ' ' B' ' 259' ' ' ASP . 23.1 mmt180 -110.53 134.27 52.53 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.625 ' OG ' HD12 ' A' ' 10' ' ' ILE . 71.6 p -137.55 150.95 47.89 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 119.661 -0.815 . . . . 0.0 110.429 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.621 ' HB3' HD11 ' A' ' 7' ' ' LEU . 82.9 m-85 -125.43 124.6 41.79 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.408 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.471 ' O ' HD12 ' A' ' 7' ' ' LEU . 69.4 mtp85 -87.12 134.11 33.55 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.316 -0.554 . . . . 0.0 110.951 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.601 ' OH ' ' ND2' ' A' ' 99' ' ' ASN . 92.6 t80 -99.25 126.67 45.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.15 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -143.5 125.98 15.8 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.967 0.413 . . . . 0.0 111.668 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.601 ' ND2' ' OH ' ' A' ' 97' ' ' TYR . 97.5 m-20 -104.61 127.73 52.43 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.308 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.557 ' OE2' ' NH1' ' A' ' 6' ' ' ARG . 96.8 mt-10 . . . . . 0 C--N 1.33 -0.269 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 43.1 t . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.943 0.402 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.597 ' O ' ' C ' ' B' ' 230' ' ' SEP . 59.6 t0 -89.85 110.84 21.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.953 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . 0.597 ' C ' ' O ' ' B' ' 229' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.484 ' N ' ' O ' ' B' ' 229' ' ' ASP . 33.7 mm-40 77.49 52.45 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.858 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' B' ' 229' ' ' ASP . . . -99.72 -124.69 5.29 Favored Glycine 0 CA--C 1.534 1.243 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -77.56 157.04 32.33 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 122.551 2.167 . . . . 0.0 112.867 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -58.68 145.71 94.69 Favored 'Trans proline' 0 C--N 1.301 -1.956 0 C-N-CA 122.443 2.095 . . . . 0.0 112.411 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.467 HG13 ' O ' ' B' ' 236' ' ' VAL . 14.6 p -87.2 127.81 40.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.22 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.6 t -59.98 118.86 6.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.662 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -55.84 -22.97 39.89 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.845 1.697 . . . . 0.0 111.819 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 20.4 m -68.14 -44.97 74.84 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 177.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.593 ' CE2' HG21 ' A' ' 43' ' ' VAL . 80.9 t80 -58.67 -45.62 89.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.144 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 84.0 mt -63.35 -41.66 98.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.917 0.389 . . . . 0.0 111.49 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -63.3 -42.07 99.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.151 -178.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 77.8 ttt-85 -61.44 -43.46 98.83 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.934 0.397 . . . . 0.0 110.572 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.569 ' CZ ' ' OD2' ' A' ' 92' ' ' ASP . 8.4 tpp85 -59.82 -42.4 93.45 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.849 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.98 -39.86 96.0 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 58.2 m -64.98 -44.28 89.82 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 177.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . 0.602 ' CG ' HH22 ' A' ' 12' ' ' ARG . 60.9 tt0 -58.67 -38.36 78.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.437 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 42.1 t -61.79 -44.11 98.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -58.33 -29.79 66.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.645 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -97.88 -11.47 23.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.962 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.896 HD11 ' OD2' ' B' ' 256' ' ' ASP . 38.6 tp -120.89 110.92 16.89 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.44 -179.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 176.99 40.69 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . 0.595 ' O ' ' CB ' ' B' ' 255' ' ' ASP . 81.3 m-20 -93.72 -4.21 50.87 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.202 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . 0.595 ' CB ' ' O ' ' B' ' 254' ' ' ASP . 61.1 t0 111.57 60.62 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 O-C-N 124.478 1.111 . . . . 0.0 110.45 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.896 ' OD2' HD11 ' B' ' 252' ' ' LEU . 95.4 m-20 -72.73 -66.3 0.68 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.504 0.668 . . . . 0.0 109.628 178.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . 0.434 ' CB ' ' O ' ' B' ' 256' ' ' ASP . 34.4 tttt 80.87 -5.04 1.72 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.323 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.709 ' O ' ' N ' ' B' ' 260' ' ' GLU . 50.6 p-10 -98.42 6.02 47.61 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 177.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.595 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 7.3 p30 -0.36 53.39 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 113.437 -1.71 . . . . 0.0 113.993 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.709 ' N ' ' O ' ' B' ' 258' ' ' ASP . 50.7 mp0 50.39 7.56 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.422 ' H ' ' C ' ' B' ' 259' ' ' ASP . 53.2 mt -116.02 135.6 55.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 61.7 t -129.08 135.54 61.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.865 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -95.19 119.46 33.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.435 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . 0.433 ' HD3' HE22 ' B' ' 265' ' ' GLN . 88.2 tttt -64.63 -47.15 79.59 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.838 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . 0.692 ' HG2' HD11 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -93.67 159.15 35.39 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.038 -179.676 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -69.44 148.1 66.41 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.818 2.345 . . . . 0.0 112.754 -179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 44.8 pt . . . . . 0 C--N 1.326 -0.451 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.54 179.007 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo . . . . . 0 N--CA 1.497 1.711 0 CA-C-O 120.882 0.284 . . . . 0.0 112.241 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.48 ' O ' ' O ' ' A' ' 99' ' ' ASN . 80.5 m -100.52 -56.33 2.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.214 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.3 mtt85 -86.58 137.23 32.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.136 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -129.33 131.52 46.93 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.372 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.577 HD11 ' HB3' ' A' ' 95' ' ' PHE . 32.7 tp -109.64 131.66 54.85 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.4 t -113.27 131.17 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 121.172 0.511 . . . . 0.0 111.002 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.401 HG23 ' CD1' ' B' ' 261' ' ' ILE . 17.2 m -80.18 145.51 32.25 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.429 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.537 ' CD1' ' OD1' ' A' ' 16' ' ' ASP . 46.2 mm -112.83 136.24 49.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.579 177.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -88.3 151.74 22.42 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.771 HH11 ' NH2' ' A' ' 93' ' ' ARG . 79.0 mtm-85 -58.17 -21.8 48.77 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.175 -178.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 93.9 p -78.12 -10.9 59.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.767 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.98 31.8 11.67 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.184 -1.167 . . . . 0.0 110.184 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 51.2 t -118.34 132.64 67.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.796 0.332 . . . . 0.0 110.325 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.537 ' OD1' ' CD1' ' A' ' 10' ' ' ILE . 79.8 m-20 -75.85 137.51 40.51 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -130.89 -116.59 1.83 Allowed Glycine 0 CA--C 1.537 1.433 0 C-N-CA 120.364 -0.922 . . . . 0.0 112.597 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.63 146.84 44.39 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.337 2.025 . . . . 0.0 112.755 -178.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -109.21 155.15 21.43 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.012 0.435 . . . . 0.0 110.004 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.46 ' CD2' HD11 ' A' ' 37' ' ' ILE . 48.8 t80 -127.94 104.38 20.78 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.993 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.58 134.78 19.03 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 C-N-CA 121.371 1.381 . . . . 0.0 111.388 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 90.7 mt -87.23 59.61 5.66 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.374 -178.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 88.2 p -65.39 -33.08 75.12 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.8 mt -76.43 142.44 41.04 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.705 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 77.4 p -65.17 -17.6 64.61 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.417 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 92.0 m -135.31 136.96 41.99 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.725 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.0 t -128.12 119.73 25.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.056 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.666 HD21 ' HG2' ' A' ' 47' ' ' GLN . 38.6 tp -117.27 128.1 54.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.856 -178.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.668 ' CE2' HD12 ' A' ' 37' ' ' ILE . 4.7 m-85 -106.13 138.56 42.1 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 123.594 0.559 . . . . 0.0 109.834 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 160.8 -164.62 34.78 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.147 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.62 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 83.3 mtm-85 -86.82 -26.63 23.96 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.483 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.569 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -55.82 149.66 24.74 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-N 116.249 -0.432 . . . . 0.0 112.912 -178.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.513 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.5 tp -70.35 -42.77 78.67 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 CA-C-O 121.118 0.485 . . . . 0.0 109.823 178.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.513 ' N ' HG23 ' A' ' 33' ' ' ILE . 21.6 pt-20 -54.78 -20.15 7.91 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.498 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.569 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 13.3 m -61.63 128.15 34.9 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.205 -179.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.417 ' OD2' ' O ' ' A' ' 26' ' ' THR . 55.0 m-20 -61.88 -32.76 73.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.447 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.668 HD12 ' CE2' ' A' ' 29' ' ' PHE . 98.6 mt -128.62 125.51 63.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.692 178.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 70.8 mtm180 -106.57 138.17 43.25 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.931 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.687 HG21 HD12 ' A' ' 41' ' ' LEU . 94.2 mt -117.81 127.66 75.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -72.83 32.83 0.07 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.696 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.687 HD12 HG21 ' A' ' 39' ' ' ILE . 25.9 mt -98.44 120.99 58.08 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.667 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.1 -9.27 23.26 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.309 2.006 . . . . 0.0 112.45 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.645 HG23 HD13 ' A' ' 91' ' ' ILE . 12.1 m -103.5 10.71 8.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.664 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.62 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 11.0 t -100.8 138.1 26.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.5 m -69.91 172.17 8.19 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.577 0.703 . . . . 0.0 112.11 -178.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -63.98 -40.91 97.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.393 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.666 ' HG2' HD21 ' A' ' 28' ' ' LEU . 86.8 mt-30 -112.73 -20.03 11.8 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 123.172 0.295 . . . . 0.0 110.766 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 26.0 t60 37.12 -73.57 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.663 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.46 136.83 48.26 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.017 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -126.85 129.59 48.56 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.357 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.8 mt -115.01 133.75 60.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.584 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -115.2 128.68 56.32 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 52.0 mm -98.28 115.83 39.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.214 0.531 . . . . 0.0 110.959 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.486 ' O ' ' N ' ' A' ' 56' ' ' GLN . 97.2 m-70 -119.4 135.0 54.94 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.159 179.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 54' ' ' HIS . 51.6 tp10 -40.26 -28.69 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.041 -0.663 . . . . 0.0 109.375 -179.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.486 ' N ' ' O ' ' A' ' 54' ' ' HIS . 50.7 tt0 -65.39 -67.87 0.41 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.113 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.431 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 5.8 tp10 -158.8 -159.72 0.8 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.049 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.466 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -120.73 130.46 54.06 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.5 mt -116.92 128.8 74.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.191 0.519 . . . . 0.0 111.514 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.578 HD21 HG21 ' A' ' 69' ' ' THR . 22.6 tp -96.96 127.05 42.54 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.403 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -110.88 136.44 49.92 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.22 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -95.63 106.97 19.12 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.291 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -99.97 -12.03 20.11 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.31 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.44 100.44 10.72 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.779 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.8 m -73.31 -34.7 65.84 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.999 0.428 . . . . 0.0 110.491 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.71 -37.09 81.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.096 -179.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -145.05 92.37 5.73 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.171 -178.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.455 ' HB2' HG23 ' A' ' 75' ' ' VAL . 33.5 Cg_exo -56.65 146.42 76.53 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.205 1.937 . . . . 0.0 112.735 -178.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.578 HG21 HD21 ' A' ' 60' ' ' LEU . 3.3 m -72.84 136.96 45.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.61 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -102.43 140.15 37.09 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.668 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 51.7 t -131.78 133.25 61.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.581 ' ND2' ' OD1' ' A' ' 86' ' ' ASP . 83.8 m-20 53.01 32.16 12.34 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.488 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.99 28.29 64.9 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.905 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 66.1 m -142.71 138.95 30.91 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 117.048 0.424 . . . . 0.0 111.214 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.455 HG23 ' HB2' ' A' ' 68' ' ' PRO . 0.4 OUTLIER -71.39 141.47 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.399 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.1 pt -112.41 90.09 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.848 178.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -65.37 -26.97 68.25 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -121.63 168.09 12.07 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.544 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -56.51 142.46 89.69 Favored 'Trans proline' 0 N--CA 1.501 1.935 0 C-N-CA 122.312 2.008 . . . . 0.0 112.272 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.7 p -134.3 138.87 49.2 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 CA-C-O 121.072 0.463 . . . . 0.0 111.255 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -78.3 131.29 36.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.507 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.466 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 89.9 mt -83.14 131.22 35.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.261 0.553 . . . . 0.0 111.06 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -119.91 143.59 47.87 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.048 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -48.81 118.04 2.37 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.384 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.66 -12.84 42.58 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.581 ' OD1' ' ND2' ' A' ' 72' ' ' ASN . 26.3 t70 -69.71 132.2 45.76 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.3 t -108.27 133.53 52.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.19 -178.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 87.8 mt -102.21 131.79 49.55 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 54.1 m -120.89 127.4 51.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.535 0.683 . . . . 0.0 112.749 -178.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.486 ' O ' ' N ' ' A' ' 93' ' ' ARG . 88.9 mt -112.35 121.96 65.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.588 178.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.645 HD13 HG23 ' A' ' 43' ' ' VAL . 75.3 mt 31.71 -95.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.522 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 92' ' ' ASP . 38.7 p-10 -107.87 6.71 27.62 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -178.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.771 ' NH2' HH11 ' A' ' 12' ' ' ARG . 91.0 mtt-85 -129.98 147.95 51.78 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.458 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.3 t -136.77 154.18 50.63 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.626 0.727 . . . . 0.0 111.241 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.577 ' HB3' HD11 ' A' ' 7' ' ' LEU . 93.7 m-85 -125.46 120.93 32.33 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.893 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.474 ' O ' HD12 ' A' ' 7' ' ' LEU . 79.7 mtp85 -83.5 132.53 34.94 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.106 -0.638 . . . . 0.0 110.551 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -94.04 123.55 37.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.302 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -125.46 117.08 22.89 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.48 ' O ' ' O ' ' A' ' 4' ' ' THR . 7.2 t-20 -64.27 -41.87 96.72 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.543 -178.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 . . . . . 0 C--N 1.332 -0.19 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.375 -179.758 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.455 -0.193 0 CA-C-O 120.747 0.308 . . . . 0.0 110.767 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -68.58 141.36 55.49 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.056 0.455 . . . . 0.0 111.292 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -125.94 36.47 4.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.732 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -110.14 -175.75 20.84 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.21 160.42 49.65 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 122.895 2.397 . . . . 0.0 111.889 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.12 147.21 47.99 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 121.672 1.582 . . . . 0.0 113.032 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.484 HG13 ' O ' ' B' ' 236' ' ' VAL . 9.7 p -77.47 128.31 38.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.403 -178.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.8 t -72.78 124.12 24.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.425 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.81 -22.36 67.76 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.646 2.231 . . . . 0.0 113.057 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . 0.405 HG22 ' NE ' ' B' ' 244' ' ' ARG . 18.6 m -72.88 -43.81 62.08 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.51 ' CE2' HG21 ' A' ' 43' ' ' VAL . 85.5 t80 -58.14 -46.72 85.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.577 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.467 HD21 ' CG2' ' A' ' 91' ' ' ILE . 87.4 mt -65.16 -41.91 94.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.973 0.416 . . . . 0.0 110.988 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 50.3 tp10 -65.22 -44.82 87.03 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.065 -179.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . 0.405 ' NE ' HG22 ' B' ' 240' ' ' THR . 88.6 mtm180 -64.34 -44.1 92.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.049 0.452 . . . . 0.0 111.046 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.593 ' NH1' ' OE2' ' B' ' 260' ' ' GLU . 54.5 ttm-85 -65.53 -41.06 93.52 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.709 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -60.86 -36.78 80.04 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 40.2 t -66.11 -43.24 87.76 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 177.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . 0.554 ' O ' ' N ' ' B' ' 252' ' ' LEU . 67.4 tp60 -61.04 -36.46 79.61 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.286 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.478 ' CG2' ' HE ' ' A' ' 12' ' ' ARG . 47.5 t -62.78 -45.74 98.1 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 CA-C-O 120.959 0.409 . . . . 0.0 109.988 179.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -62.92 -23.67 67.48 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.505 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -101.6 -8.7 21.61 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.189 178.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.554 ' N ' ' O ' ' B' ' 248' ' ' GLN . 37.9 tp -76.58 154.61 34.29 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.533 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -55.9 160.28 2.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.691 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . 0.409 ' N ' ' OD1' ' B' ' 254' ' ' ASP . 36.9 p-10 -80.91 5.97 14.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.441 0.639 . . . . 0.0 109.497 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -83.08 -88.62 0.09 Allowed 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.525 ' OD1' ' CD2' ' B' ' 252' ' ' LEU . 71.4 m-20 60.51 31.05 20.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.12 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.28 -36.61 84.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.971 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.494 ' O ' ' C ' ' B' ' 259' ' ' ASP . 92.4 m-20 -103.25 -2.06 27.84 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.588 ' CG ' ' H ' ' B' ' 260' ' ' GLU . 8.3 p-10 27.39 -101.95 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 113.928 -1.487 . . . . 0.0 109.728 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.593 ' OE2' ' NH1' ' B' ' 245' ' ' ARG . 97.7 mt-10 -144.13 19.39 1.76 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.361 179.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.527 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 85.0 mt -115.25 135.15 56.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.569 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 45.5 t -125.83 133.7 68.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.082 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -98.95 120.71 39.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.555 0.693 . . . . 0.0 112.421 -177.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -67.29 -41.59 85.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.623 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.12 159.39 29.53 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.576 -178.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -61.01 153.76 61.74 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 123.128 2.552 . . . . 0.0 112.598 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 45.4 pt . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.872 -179.347 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo . . . . . 0 N--CA 1.496 1.667 0 N-CA-C 110.854 -0.479 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.553 ' O ' ' O ' ' A' ' 99' ' ' ASN . 25.0 m -73.71 -46.0 48.78 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -178.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.7 mtt85 -92.94 138.54 31.39 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.632 -178.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -133.42 141.83 48.04 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.729 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.715 HD11 HD11 ' A' ' 22' ' ' LEU . 65.7 mt -116.57 139.04 50.93 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.6 t -110.81 132.61 58.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 C-N-CA 120.349 -0.541 . . . . 0.0 110.158 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 m -91.58 116.79 29.16 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -177.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.6 mt -84.11 142.51 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.057 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -94.85 155.82 16.62 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.272 0.558 . . . . 0.0 111.266 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.799 ' NH2' HD23 ' B' ' 252' ' ' LEU . 83.4 mtm180 -59.05 -32.15 69.5 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.159 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 93.9 p -70.49 -22.51 62.64 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.49 30.05 5.73 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.329 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.3 t -118.04 131.03 71.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.107 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -78.26 138.64 38.72 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.89 -113.83 1.48 Allowed Glycine 0 CA--C 1.53 0.988 0 C-N-CA 120.041 -1.076 . . . . 0.0 112.426 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.6 149.42 55.31 Favored 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 121.953 1.769 . . . . 0.0 112.006 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -114.51 144.65 43.01 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.094 0.473 . . . . 0.0 110.304 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.53 ' CD2' HD11 ' A' ' 37' ' ' ILE . 33.8 t80 -105.87 102.74 40.67 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.344 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -77.74 132.6 12.1 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 121.95 1.766 . . . . 0.0 111.415 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.715 HD11 HD11 ' A' ' 7' ' ' LEU . 95.9 mt -84.56 76.63 10.16 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -177.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 61.5 p -79.9 -12.17 59.76 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 177.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.638 HD11 ' HG2' ' B' ' 265' ' ' GLN . 44.5 mt -102.61 146.81 27.62 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.521 -178.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -68.89 -15.31 63.46 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.832 0.348 . . . . 0.0 111.397 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.454 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 92.1 m -132.48 134.96 45.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.017 0.437 . . . . 0.0 111.295 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.448 ' HB2' HD22 ' A' ' 22' ' ' LEU . 5.1 t -127.3 118.91 25.12 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.05 178.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.503 HD21 ' HG2' ' A' ' 47' ' ' GLN . 33.6 tp -118.2 125.51 50.32 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.814 -178.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.756 ' CE2' HD12 ' A' ' 37' ' ' ILE . 5.1 m-85 -102.61 135.94 43.34 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 123.669 0.606 . . . . 0.0 109.679 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 154.91 -179.9 30.61 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 120.353 -0.927 . . . . 0.0 112.568 179.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.465 ' NH1' ' O ' ' B' ' 229' ' ' ASP . 47.1 mtm180 -70.9 -33.48 70.59 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 122.653 -0.322 . . . . 0.0 111.552 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.551 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -43.94 140.18 3.52 Favored Glycine 0 N--CA 1.464 0.553 0 N-CA-C 111.306 -0.717 . . . . 0.0 111.306 -178.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.553 HG23 ' N ' ' A' ' 34' ' ' GLU . 9.7 tp -65.51 -41.99 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.553 ' N ' HG23 ' A' ' 33' ' ' ILE . 50.6 tp10 -56.92 -18.82 14.77 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.805 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.551 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 20.2 m -62.54 128.06 34.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.29 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.454 ' OD2' ' O ' ' A' ' 26' ' ' THR . 95.5 m-20 -60.4 -28.97 68.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.621 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.756 HD12 ' CE2' ' A' ' 29' ' ' PHE . 92.1 mt -128.32 118.56 48.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 177.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.513 ' CZ ' HD12 ' A' ' 33' ' ' ILE . 80.6 mtp180 -104.97 138.12 41.67 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.463 -178.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 88.6 mt -120.32 129.35 75.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 120.536 -0.465 . . . . 0.0 110.318 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -73.79 34.63 0.09 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.143 -178.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.572 ' CD1' ' NH2' ' A' ' 93' ' ' ARG . 32.3 mt -109.25 129.54 23.79 Favored Pre-proline 0 C--N 1.326 -0.435 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.06 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.12 -9.11 21.77 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 C-N-CA 121.975 1.784 . . . . 0.0 112.634 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.572 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 27.6 m -96.74 -0.67 10.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.627 0.251 . . . . 0.0 110.866 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 37.2 t -87.95 136.93 22.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.0 m -69.7 167.54 16.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.294 0.568 . . . . 0.0 111.553 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -64.46 -42.17 96.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.446 -178.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.656 ' O ' ' N ' ' A' ' 49' ' ' CYS . 86.5 mt-30 -115.13 -19.51 10.82 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.384 178.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 24.6 t60 37.3 -76.5 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.656 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -129.1 133.24 47.58 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.27 0.557 . . . . 0.0 111.722 -178.649 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -125.12 126.2 44.94 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.231 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 98.3 mt -112.86 134.55 55.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.578 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.454 ' CD ' ' NE2' ' A' ' 54' ' ' HIS . 84.6 tt0 -122.29 127.06 49.4 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.43 122.95 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 CA-C-O 121.754 0.788 . . . . 0.0 112.754 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.55 ' O ' ' N ' ' A' ' 56' ' ' GLN . 98.0 m-70 -114.02 139.42 49.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.388 -1.278 . . . . 0.0 109.308 179.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.473 ' C ' ' O ' ' A' ' 54' ' ' HIS . 83.3 tt0 -38.96 -26.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.55 ' N ' ' O ' ' A' ' 54' ' ' HIS . 91.2 mt-30 -67.36 -67.64 0.44 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.871 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.452 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 3.3 tp10 -155.2 -165.18 1.95 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.826 -179.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.41 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -114.33 133.38 55.72 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.527 178.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.2 mt -121.72 127.54 75.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.005 0.431 . . . . 0.0 111.561 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.571 ' HB2' HD11 ' A' ' 82' ' ' LEU . 28.9 tp -100.26 127.43 46.55 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.223 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.401 ' CE1' ' HB3' ' A' ' 79' ' ' PRO . 98.8 m-70 -113.53 138.71 49.75 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.041 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.495 ' ND2' ' H ' ' A' ' 69' ' ' THR . 8.6 t-20 -100.65 108.78 20.75 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.389 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -100.88 -9.82 21.25 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.335 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -75.98 99.15 4.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.098 0.475 . . . . 0.0 110.307 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.8 t -73.04 -36.52 66.96 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.519 0.676 . . . . 0.0 109.354 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.704 HG21 ' O ' ' B' ' 234' ' ' TPO . 1.5 m -65.31 -48.14 74.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.81 -1.086 . . . . 0.0 111.789 -178.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.454 ' OD1' HG23 ' B' ' 236' ' ' VAL . 3.0 m-20 -142.81 95.11 6.37 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.546 -178.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.591 ' HB2' HG13 ' A' ' 75' ' ' VAL . 43.3 Cg_exo -55.17 146.78 57.93 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 122.18 1.92 . . . . 0.0 112.287 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.495 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 59.0 m -74.57 140.45 44.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.284 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -99.18 142.51 30.57 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.647 179.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 54.5 t -131.12 134.73 61.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 51.07 30.25 5.32 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 119.321 -0.951 . . . . 0.0 108.601 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.07 26.13 69.5 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.221 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.4 p -137.85 137.34 38.02 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.98 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.591 HG13 ' HB2' ' A' ' 68' ' ' PRO . 25.7 t -70.99 136.07 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.312 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.4 pt -109.4 93.99 2.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.729 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -67.81 -29.43 68.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.087 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -125.46 174.65 3.73 Favored Pre-proline 0 CA--C 1.536 0.419 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.172 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.401 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 27.4 Cg_exo -61.36 144.58 98.48 Favored 'Trans proline' 0 N--CA 1.501 1.936 0 C-N-CA 122.871 2.38 . . . . 0.0 112.745 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.7 m -144.03 143.06 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.352 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 92.4 mtt-85 -75.36 129.88 38.1 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.61 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.571 HD11 ' HB2' ' A' ' 60' ' ' LEU . 88.1 mt -83.77 139.24 32.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.705 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -126.9 151.16 48.8 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.489 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.495 ' C ' ' CD2' ' A' ' 84' ' ' HIS . 6.1 t60 -58.06 122.39 12.93 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.91 0.385 . . . . 0.0 110.388 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.49 -13.67 32.97 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.574 -0.61 . . . . 0.0 111.574 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -75.0 136.82 41.24 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.728 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.3 t -108.28 131.98 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.068 -178.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.7 mt -97.09 132.07 42.44 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.448 HG23 ' OG ' ' A' ' 94' ' ' SER . 84.5 m -124.68 126.7 46.13 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -177.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.426 ' O ' ' C ' ' A' ' 91' ' ' ILE . 93.2 mt -114.79 122.03 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.593 HG22 ' N ' ' A' ' 92' ' ' ASP . 89.7 mt 36.29 -103.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.593 ' N ' HG22 ' A' ' 91' ' ' ILE . 88.3 m-20 -103.77 9.02 37.22 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -178.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.626 HH21 ' CZ ' ' B' ' 245' ' ' ARG . 2.5 ptp85 -132.46 148.16 52.39 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.509 -0.477 . . . . 0.0 111.194 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.448 ' OG ' HG23 ' A' ' 89' ' ' THR . 65.2 m -135.15 152.33 51.5 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.349 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -119.32 121.56 39.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.25 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -81.56 131.05 35.26 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 119.821 -0.751 . . . . 0.0 111.391 -179.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -93.24 120.28 33.34 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.247 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -136.4 122.29 20.02 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.727 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.553 ' O ' ' O ' ' A' ' 4' ' ' THR . 90.6 m-20 -63.59 -40.77 97.79 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 178.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.606 179.243 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 34.1 m . . . . . 0 N--CA 1.453 -0.299 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.465 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 75.4 m-20 -71.24 130.71 42.13 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.209 0.528 . . . . 0.0 110.868 -178.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . 0.569 ' P ' ' H ' ' B' ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.437 ' H ' ' C ' ' B' ' 229' ' ' ASP . 75.0 mt-30 -123.9 35.19 4.89 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.988 -1.006 . . . . 0.0 109.449 178.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -114.36 -177.87 19.05 Favored Glycine 0 CA--C 1.533 1.17 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.45 161.11 44.78 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 123.399 2.733 . . . . 0.0 113.04 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.704 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -61.5 138.7 77.62 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.637 2.225 . . . . 0.0 112.83 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.454 HG23 ' OD1' ' A' ' 67' ' ' ASN . 0.5 OUTLIER -73.12 137.65 22.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 114.559 -1.2 . . . . 0.0 109.713 179.412 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.8 t -52.39 116.18 2.13 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.444 -179.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -50.7 -26.48 17.43 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.543 2.162 . . . . 0.0 112.986 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 40.1 p -73.99 -39.46 63.65 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.572 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 81.7 t80 -57.45 -45.7 84.44 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.427 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.49 HD23 ' OD2' ' A' ' 92' ' ' ASP . 90.9 mt -62.89 -40.16 96.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.991 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.77 -43.02 97.64 Favored 'General case' 0 CA--C 1.522 -0.105 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.794 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -61.4 -42.82 99.34 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.839 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.626 ' CZ ' HH21 ' A' ' 93' ' ' ARG . 70.6 mtp85 -61.3 -43.89 98.12 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.484 0.549 . . . . 0.0 112.484 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -62.87 -39.61 94.96 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.099 -0.64 . . . . 0.0 109.298 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 39.7 t -67.23 -46.56 73.43 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.025 178.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . 0.633 ' O ' ' N ' ' B' ' 252' ' ' LEU . 73.4 mt-30 -59.27 -37.21 77.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.36 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.451 HG23 ' O ' ' B' ' 245' ' ' ARG . 40.7 t -62.79 -46.19 96.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.798 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -58.15 -29.75 65.82 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -96.64 -16.1 21.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.499 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.799 HD23 ' NH2' ' A' ' 12' ' ' ARG . 63.4 tp -123.13 111.36 16.42 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 178.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . 0.596 ' ND2' ' O ' ' B' ' 253' ' ' ASN . 0.5 OUTLIER 179.49 24.3 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.669 179.188 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -99.45 -3.92 32.59 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . 0.406 ' C ' ' H ' ' B' ' 257' ' ' LYS . 67.7 t0 -177.54 55.06 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.586 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.574 ' N ' ' OD1' ' B' ' 256' ' ' ASP . 6.1 p-10 -78.26 31.6 0.18 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.892 0.377 . . . . 0.0 111.035 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . 0.406 ' H ' ' C ' ' B' ' 255' ' ' ASP . 98.5 mttt -60.74 -29.54 69.45 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.744 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.685 ' O ' ' N ' ' B' ' 260' ' ' GLU . 23.3 p-10 -99.82 3.0 44.5 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.977 0.418 . . . . 0.0 110.351 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.451 ' C ' ' O ' ' B' ' 258' ' ' ASP . 48.9 p30 1.12 54.13 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 114.52 -1.218 . . . . 0.0 114.128 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.685 ' N ' ' O ' ' B' ' 258' ' ' ASP . 97.3 mt-10 55.22 9.91 0.39 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 178.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 82.6 mt -117.61 132.88 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 43.2 t -126.97 135.35 63.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.495 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -96.91 120.58 37.52 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.194 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -65.48 -46.11 81.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.539 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . 0.638 ' HG2' HD11 ' A' ' 24' ' ' LEU . 3.3 mp0 -96.9 164.95 16.85 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.277 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -64.32 152.58 80.83 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.351 2.034 . . . . 0.0 111.91 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 42.6 pt . . . . . 0 C--N 1.328 -0.328 0 CA-C-O 121.307 0.575 . . . . 0.0 112.103 -178.553 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo . . . . . 0 N--CA 1.494 1.504 0 N-CA-C 111.459 -0.247 . . . . 0.0 111.459 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.7 p -127.79 26.36 5.88 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.814 -0.354 . . . . 0.0 111.258 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.494 ' NH2' HG21 ' A' ' 53' ' ' ILE . 88.0 mtm-85 -86.09 127.49 34.7 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -128.48 144.28 51.12 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.83 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 1.061 HD11 HD11 ' A' ' 22' ' ' LEU . 82.0 mt -113.89 142.62 45.89 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.5 t -114.14 126.76 71.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.0 m -77.4 140.68 39.95 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.505 0.669 . . . . 0.0 111.52 -178.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.446 ' HB ' ' H ' ' A' ' 94' ' ' SER . 49.2 mm -109.95 135.31 49.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.088 178.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -94.6 158.29 15.6 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.339 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -57.9 -20.97 41.06 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.89 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.7 p -81.23 -11.65 59.33 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.969 179.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.23 16.55 57.29 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-N 116.086 -0.506 . . . . 0.0 113.094 178.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.5 m -109.05 147.31 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 117.434 0.617 . . . . 0.0 111.533 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.431 ' C ' ' OD1' ' A' ' 16' ' ' ASP . 58.9 t0 -69.74 126.42 29.67 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.18 -178.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.402 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -115.86 -132.35 5.06 Favored Glycine 0 CA--C 1.542 1.751 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -74.18 153.36 46.06 Favored 'Trans proline' 0 N--CA 1.5 1.868 0 C-N-CA 122.509 2.139 . . . . 0.0 112.952 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -109.7 162.51 14.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.006 0.431 . . . . 0.0 110.615 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.427 ' CD2' HD11 ' A' ' 37' ' ' ILE . 38.0 t80 -132.43 106.76 13.24 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.047 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -73.58 127.37 11.66 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 121.903 1.736 . . . . 0.0 112.603 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 1.061 HD11 HD11 ' A' ' 7' ' ' LEU . 95.5 mt -92.05 48.26 1.41 Allowed 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.8 p -64.82 -13.05 54.45 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 119.559 -0.856 . . . . 0.0 109.222 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.616 HD11 ' OE1' ' B' ' 265' ' ' GLN . 75.4 mt -81.29 141.6 33.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.222 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 87.8 p -62.19 -21.65 65.27 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.971 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 57.6 m -139.54 138.84 36.63 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 119.827 -0.749 . . . . 0.0 112.164 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.509 ' HB2' HD22 ' A' ' 22' ' ' LEU . 5.7 t -128.6 123.92 34.57 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.849 178.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.6 tp -117.43 128.18 54.76 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.979 -178.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.791 ' CE2' HD12 ' A' ' 37' ' ' ILE . 4.4 m-85 -107.35 139.61 41.56 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.703 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 155.8 -173.37 33.84 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.196 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.629 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 83.9 mtm-85 -79.79 -31.03 40.76 Favored 'General case' 0 CA--C 1.527 0.079 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.561 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -52.38 146.08 16.52 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 121.003 -0.618 . . . . 0.0 111.695 -178.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.43 HD13 ' CZ ' ' A' ' 38' ' ' ARG . 33.2 mm -63.8 -43.61 97.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.877 0.37 . . . . 0.0 110.078 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -53.0 -18.11 1.82 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.989 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.561 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 59.6 m -61.18 123.39 17.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.982 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -60.18 -31.73 70.4 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.791 HD12 ' CE2' ' A' ' 29' ' ' PHE . 81.0 mt -124.65 119.33 55.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 176.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.43 ' CZ ' HD13 ' A' ' 33' ' ' ILE . 84.3 mtp180 -102.41 137.31 40.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.723 -178.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.471 HG22 ' H ' ' A' ' 41' ' ' LEU . 98.2 mt -122.99 131.62 72.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.521 179.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -80.3 26.0 0.38 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.529 -178.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.471 ' H ' HG22 ' A' ' 39' ' ' ILE . 34.8 mt -90.11 132.62 35.48 Favored Pre-proline 0 C--N 1.325 -0.477 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.377 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -71.4 -12.65 29.88 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 121.904 1.736 . . . . 0.0 111.53 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.532 HG21 ' CE2' ' B' ' 241' ' ' PHE . 3.6 m -102.14 7.59 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.629 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 11.4 t -93.51 129.95 43.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.28 168.04 6.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.272 0.558 . . . . 0.0 110.894 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -63.25 -43.32 98.32 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.1 -178.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.626 ' O ' ' N ' ' A' ' 49' ' ' CYS . 86.3 mt-30 -111.18 -11.83 14.19 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.55 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 18.6 t60 30.23 -76.68 0.0 OUTLIER 'General case' 0 C--O 1.237 0.402 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.626 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.95 136.04 47.04 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.266 0.555 . . . . 0.0 112.061 -178.549 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -127.38 127.09 43.62 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.064 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 95.8 mt -111.6 133.13 58.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.208 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -114.4 131.69 56.49 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.494 HG21 ' NH2' ' A' ' 5' ' ' ARG . 45.5 mm -103.51 115.37 45.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.296 0.57 . . . . 0.0 111.269 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.426 ' O ' ' C ' ' A' ' 55' ' ' GLU . 93.2 m-70 -117.04 137.57 52.16 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.959 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 54' ' ' HIS . 80.1 mm-40 -40.18 -35.39 0.39 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.256 0.551 . . . . 0.0 109.777 -179.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.478 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 98.5 mm-40 -64.13 -67.11 0.46 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.983 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.478 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 6.1 tp10 -155.64 -166.08 2.14 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.534 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.455 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -119.88 127.93 53.17 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 91.3 mt -116.02 130.54 70.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.11 0.481 . . . . 0.0 111.496 -178.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.562 ' HB2' HD11 ' A' ' 82' ' ' LEU . 19.6 tp -96.88 127.36 42.78 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.145 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -110.58 136.19 50.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.803 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.612 ' ND2' ' H ' ' A' ' 69' ' ' THR . 20.5 t-20 -97.15 111.66 23.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.856 0.36 . . . . 0.0 111.575 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.444 ' CD2' ' OE1' ' A' ' 47' ' ' GLN . 32.8 m-85 -99.8 -8.22 24.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.667 178.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.8 t -70.59 99.26 1.62 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 88.3 p -85.08 -6.12 59.32 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.324 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.534 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -102.04 -38.04 7.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.286 179.782 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -144.68 97.49 5.0 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.032 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.4 147.71 55.62 Favored 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 122.504 2.136 . . . . 0.0 113.376 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.612 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 11.1 m -72.08 138.06 47.55 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.56 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -101.54 139.04 37.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.533 179.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.477 ' HB ' HD11 ' A' ' 76' ' ' ILE . 25.5 t -130.5 134.17 62.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 54.94 32.46 18.01 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.288 0.566 . . . . 0.0 109.696 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.13 27.35 70.36 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.895 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.8 m -138.06 131.66 30.95 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.785 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -67.47 142.42 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 121.101 0.476 . . . . 0.0 111.123 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.525 ' CG2' ' O ' ' A' ' 78' ' ' GLU . 75.1 mt -114.51 123.79 70.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.845 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -96.14 -24.09 16.45 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.981 179.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.525 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 3.7 mm-40 -129.27 172.42 7.16 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.785 -178.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -60.6 146.49 96.98 Favored 'Trans proline' 0 N--CA 1.501 1.943 0 C-N-CA 122.285 1.99 . . . . 0.0 112.652 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.491 HG11 HD13 ' A' ' 76' ' ' ILE . 4.1 p -140.15 144.97 26.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.209 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -77.85 129.66 35.68 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.157 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.562 HD11 ' HB2' ' A' ' 60' ' ' LEU . 96.9 mt -86.56 135.94 33.25 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.249 0.547 . . . . 0.0 111.107 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -131.1 154.25 48.49 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.629 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.433 ' ND1' ' N ' ' A' ' 99' ' ' ASN . 8.2 t60 -53.44 117.37 3.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.626 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 113.87 -25.38 10.9 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.1 -0.572 . . . . 0.0 112.157 178.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -66.8 137.0 56.3 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.871 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 68.4 t -113.38 132.68 61.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.7 -178.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.0 mt -93.4 130.79 41.9 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 N-CA-C 107.994 -1.114 . . . . 0.0 107.994 178.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 51.4 m -118.52 128.26 54.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.639 0.733 . . . . 0.0 112.575 -178.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.458 ' O ' ' C ' ' A' ' 91' ' ' ILE . 95.3 mt -118.03 124.63 73.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.682 178.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.504 HD12 ' CB ' ' B' ' 237' ' ' CYS . 42.6 mm 34.14 -95.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.944 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 90' ' ' ILE . 47.9 t0 -117.65 15.36 14.53 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.727 0.298 . . . . 0.0 111.336 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.571 ' NH2' ' OE1' ' B' ' 260' ' ' GLU . 55.6 mtt85 -127.13 143.44 51.27 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.09 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.446 ' H ' ' HB ' ' A' ' 10' ' ' ILE . 38.2 m -135.69 154.53 51.25 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.531 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.594 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 91.8 m-85 -127.56 121.58 30.98 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -88.58 133.62 34.12 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.984 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -93.07 122.98 36.0 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.166 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -124.51 118.81 27.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.838 0.351 . . . . 0.0 110.294 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.433 ' N ' ' ND1' ' A' ' 84' ' ' HIS . 58.5 t-20 -100.19 102.65 14.0 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.641 -178.557 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 47.5 t . . . . . 0 N--CA 1.45 -0.465 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.474 ' C ' ' H ' ' B' ' 231' ' ' GLN . 87.3 m-20 -68.97 143.84 54.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.513 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . 0.466 ' N ' ' O3P' ' B' ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.474 ' H ' ' C ' ' B' ' 229' ' ' ASP . 75.0 mt-30 -130.16 33.34 4.37 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.5 -179.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -109.15 -157.7 18.09 Favored Glycine 0 CA--C 1.531 1.072 0 N-CA-C 111.582 -0.607 . . . . 0.0 111.582 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -77.86 160.2 30.81 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 123.002 2.468 . . . . 0.0 112.831 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -77.57 172.93 14.98 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.602 2.201 . . . . 0.0 111.712 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.534 ' CG2' HG22 ' A' ' 66' ' ' THR . 27.9 t -112.84 133.6 58.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.375 -179.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . 0.504 ' CB ' HD12 ' A' ' 91' ' ' ILE . 2.3 t -78.17 121.46 24.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.438 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . 0.552 ' P ' ' HG1' ' B' ' 240' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . 0.441 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 42.3 Cg_exo -57.77 -24.98 66.46 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 122.995 2.463 . . . . 0.0 113.795 -179.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . 0.552 ' HG1' ' P ' ' B' ' 238' ' ' TPO . 18.1 p -76.04 -42.57 47.33 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.735 178.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.532 ' CE2' HG21 ' A' ' 43' ' ' VAL . 83.8 t80 -58.08 -45.0 87.87 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.837 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' B' ' 242' ' ' LEU . 95.6 mt -64.54 -41.87 96.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.781 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -63.95 -36.92 85.53 Favored 'General case' 0 C--N 1.334 -0.093 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.38 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' B' ' 244' ' ' ARG . 78.2 mtt85 -61.74 -43.25 99.21 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.628 -0.429 . . . . 0.0 109.981 179.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.575 ' O ' HG23 ' B' ' 249' ' ' VAL . 24.8 mmt180 -63.2 -41.88 99.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.427 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -63.53 -39.36 94.23 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 11.2 t -64.28 -46.59 83.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.129 178.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -61.42 -35.87 78.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.611 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.575 HG23 ' O ' ' B' ' 245' ' ' ARG . 77.3 t -64.92 -44.23 96.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.903 0.382 . . . . 0.0 110.188 179.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -60.22 -33.88 72.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.564 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -95.61 -5.51 42.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.305 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.469 ' O ' ' O ' ' B' ' 249' ' ' VAL . 54.5 tp -119.79 120.19 35.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.502 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -70.92 -179.86 2.43 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.916 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' B' ' 254' ' ' ASP . 36.3 p-10 -91.37 2.34 56.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.707 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -70.44 -9.45 56.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.979 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.47 ' OD1' ' OD1' ' B' ' 258' ' ' ASP . 25.9 t0 -84.33 90.17 7.51 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.134 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -81.56 7.23 12.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.546 -178.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.524 ' O ' ' C ' ' B' ' 259' ' ' ASP . 12.7 p-10 -82.8 23.07 0.84 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.683 ' C ' ' H ' ' B' ' 261' ' ' ILE . 38.0 p30 -19.68 124.91 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 123.99 0.806 . . . . 0.0 111.603 -179.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.571 ' OE1' ' NH2' ' A' ' 93' ' ' ARG . 96.0 mt-10 -52.71 7.78 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.461 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.683 ' H ' ' C ' ' B' ' 259' ' ' ASP . 68.5 mt -107.77 134.5 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 178.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 77.3 t -128.07 136.76 59.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.369 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -95.49 118.18 31.74 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.296 0.57 . . . . 0.0 111.499 -178.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -65.05 -44.02 90.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.289 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . 0.616 ' OE1' HD11 ' A' ' 24' ' ' LEU . 10.4 mm-40 -96.73 154.01 38.53 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.57 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -61.65 146.24 96.94 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.326 2.017 . . . . 0.0 112.355 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 45.6 pt . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.872 -179.637 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo . . . . . 0 N--CA 1.494 1.556 0 CA-C-O 120.645 0.185 . . . . 0.0 112.171 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 96.4 m -96.61 -45.05 6.87 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.382 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.6 mtt85 -87.51 129.74 34.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.436 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -133.93 139.55 46.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.611 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.734 HD12 ' O ' ' A' ' 96' ' ' ARG . 34.5 tp -114.59 129.2 56.65 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.764 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.7 t -108.19 131.11 59.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.29 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.8 m -81.76 148.23 29.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.287 0.565 . . . . 0.0 111.711 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.427 HD12 ' HB3' ' A' ' 94' ' ' SER . 92.6 mt -117.93 138.06 49.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 114.979 -1.01 . . . . 0.0 108.74 178.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -91.14 160.73 15.41 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.045 0.45 . . . . 0.0 111.408 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.54 HH12 ' CD ' ' B' ' 248' ' ' GLN . 89.9 mtm180 -58.63 -28.82 66.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.781 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.5 p -78.41 -7.61 57.56 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.636 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.67 33.17 9.38 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -178.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.5 t -123.78 135.27 64.02 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 CA-C-O 121.385 0.612 . . . . 0.0 111.55 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -76.27 138.11 40.34 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.547 179.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -126.29 -121.62 2.5 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 111.404 -0.678 . . . . 0.0 111.404 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.24 152.92 45.47 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.281 1.988 . . . . 0.0 112.829 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -110.34 153.81 24.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.16 0.505 . . . . 0.0 110.658 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.8 ' CD2' HD11 ' A' ' 37' ' ' ILE . 43.8 t80 -122.58 94.9 47.26 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.335 -179.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -59.36 127.03 22.47 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 121.349 1.366 . . . . 0.0 111.254 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.4 mt -84.77 50.17 1.86 Allowed 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.448 -178.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 72.4 m -60.86 -33.83 73.67 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.2 0.524 . . . . 0.0 109.845 179.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.702 HD11 ' HG2' ' B' ' 265' ' ' GLN . 66.7 mt -69.97 139.96 52.91 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.369 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.0 t -65.69 -18.83 65.61 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.405 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.9 m -134.51 133.53 40.45 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.246 -0.582 . . . . 0.0 111.444 -178.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.2 t -129.54 120.37 25.24 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.313 0.578 . . . . 0.0 110.249 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.525 HD12 ' O ' ' A' ' 49' ' ' CYS . 48.4 tp -117.37 131.74 56.72 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.994 -178.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.462 ' O ' ' O ' ' A' ' 47' ' ' GLN . 37.3 m-85 -109.7 140.5 43.5 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.848 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 153.86 -175.49 32.14 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 120.783 -0.723 . . . . 0.0 111.686 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 45.0 mtm180 -75.15 -32.29 61.27 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.609 0.242 . . . . 0.0 111.428 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.589 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -45.04 140.04 4.76 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.468 HG23 ' N ' ' A' ' 34' ' ' GLU . 7.1 tp -66.91 -41.07 87.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.374 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.468 ' N ' HG23 ' A' ' 33' ' ' ILE . 51.6 tp10 -61.41 -15.73 39.66 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.205 0.526 . . . . 0.0 110.149 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.589 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 8.8 m -61.17 131.62 51.05 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.289 -0.564 . . . . 0.0 109.752 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -60.67 -33.43 72.82 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.8 HD11 ' CD2' ' A' ' 20' ' ' PHE . 44.1 mm -121.4 115.12 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.061 177.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.474 ' NH2' HG11 ' B' ' 262' ' ' VAL . 88.3 mtm-85 -100.72 133.08 45.71 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.828 HG23 ' NH1' ' A' ' 93' ' ' ARG . 96.2 mt -119.24 129.8 74.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.689 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -74.92 24.14 0.09 Allowed 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -177.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.753 HD21 ' NH2' ' A' ' 93' ' ' ARG . 95.6 mt -97.87 126.71 39.64 Favored Pre-proline 0 C--N 1.324 -0.512 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.384 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -70.97 -9.67 26.13 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.682 2.254 . . . . 0.0 113.232 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.554 HG21 ' CE2' ' B' ' 241' ' ' PHE . 27.1 m -97.71 5.33 9.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.393 -179.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.4 t -94.96 136.79 25.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.692 0.282 . . . . 0.0 110.38 179.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.492 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 1.2 t -67.52 165.62 16.44 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.164 0.507 . . . . 0.0 110.857 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 41.1 mtmt -62.51 -41.99 99.21 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.36 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.605 ' O ' ' N ' ' A' ' 49' ' ' CYS . 84.2 mt-30 -111.46 -17.72 13.02 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.954 0.407 . . . . 0.0 111.111 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.492 ' H ' ' HB3' ' A' ' 45' ' ' SER . 26.8 t60 34.06 -75.92 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.605 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.81 136.94 49.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.321 0.581 . . . . 0.0 112.559 -177.785 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -127.09 129.0 47.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.979 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 93.5 mt -114.83 133.31 61.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.43 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -117.1 126.98 53.67 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 77.5 mt -108.81 113.78 45.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.705 0.765 . . . . 0.0 111.714 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.582 ' O ' ' N ' ' A' ' 56' ' ' GLN . 86.4 m-70 -114.27 146.79 40.0 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.806 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 54' ' ' HIS . 57.7 mp0 -40.58 -22.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.653 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.582 ' N ' ' O ' ' A' ' 54' ' ' HIS . 14.8 mm100 -72.57 -69.38 0.41 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -160.58 -164.89 1.3 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.191 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.493 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -109.8 124.26 50.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.663 179.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.6 mt -113.5 130.02 68.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.026 0.441 . . . . 0.0 111.751 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.719 HD22 ' CD1' ' A' ' 88' ' ' ILE . 25.6 tp -99.76 128.3 45.87 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.011 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -113.15 136.04 53.15 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.147 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -93.48 107.97 19.73 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.642 0.258 . . . . 0.0 111.67 -178.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -101.19 -11.51 19.48 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.714 179.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.6 t -72.45 98.43 2.27 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.9 t -82.69 -17.33 44.84 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.806 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.481 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -93.32 -43.21 8.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.287 -178.766 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -133.31 97.35 16.35 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -57.62 144.33 92.88 Favored 'Trans proline' 0 N--CA 1.5 1.894 0 C-N-CA 122.183 1.922 . . . . 0.0 113.224 -178.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.6 m -72.51 150.01 43.6 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.372 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -114.42 141.25 47.9 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.482 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.687 HG13 ' OD1' ' A' ' 86' ' ' ASP . 44.6 t -127.72 134.1 66.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 54.84 32.02 16.85 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.139 -0.625 . . . . 0.0 110.12 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.12 23.28 77.99 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.124 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.7 t -138.33 143.95 40.16 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 117.011 0.405 . . . . 0.0 110.99 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 44.2 t -67.08 132.33 32.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.502 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.426 HG12 ' O ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -118.56 79.29 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.426 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -65.96 -21.35 66.41 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.117 -178.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.426 ' O ' HG12 ' A' ' 76' ' ' ILE . 0.6 OUTLIER -110.35 159.95 30.2 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -179.562 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.41 145.87 92.83 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 C-N-CA 121.148 1.232 . . . . 0.0 111.196 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.42 145.73 21.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 89.9 mtm180 -75.29 132.05 40.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.795 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.493 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 92.0 mt -80.77 141.27 34.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.066 0.46 . . . . 0.0 110.927 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -129.02 149.84 50.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.779 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.471 ' C ' ' CD2' ' A' ' 84' ' ' HIS . 7.7 t60 -54.67 119.91 5.99 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.376 -0.529 . . . . 0.0 110.57 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.07 -8.32 41.94 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.687 ' OD1' HG13 ' A' ' 71' ' ' VAL . 45.6 t0 -71.62 127.54 32.9 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.516 HG22 ' HG2' ' A' ' 96' ' ' ARG . 76.6 t -105.56 134.62 46.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.401 -178.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.719 ' CD1' HD22 ' A' ' 60' ' ' LEU . 11.6 mm -98.16 128.55 49.49 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.7 m -122.48 129.06 51.61 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.841 0.829 . . . . 0.0 112.875 -178.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.476 ' O ' ' C ' ' A' ' 91' ' ' ILE . 74.1 mt -121.01 127.03 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 114.445 -1.252 . . . . 0.0 108.429 178.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.476 ' C ' ' O ' ' A' ' 90' ' ' ILE . 37.5 mm 35.91 -99.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 C-N-CA 120.576 -0.449 . . . . 0.0 110.252 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.504 ' O ' ' OD1' ' A' ' 92' ' ' ASP . 39.0 t0 -118.07 17.6 14.03 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.989 0.424 . . . . 0.0 110.91 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.828 ' NH1' HG23 ' A' ' 39' ' ' ILE . 97.7 mtt180 -125.67 142.17 51.65 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.759 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.45 ' OG ' ' CG1' ' A' ' 87' ' ' VAL . 16.6 t -140.12 152.85 46.44 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 120.184 -0.607 . . . . 0.0 110.781 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.518 ' HB3' HD11 ' A' ' 7' ' ' LEU . 76.4 m-85 -126.07 125.12 42.07 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.617 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.734 ' O ' HD12 ' A' ' 7' ' ' LEU . 99.6 mtt180 -88.03 134.09 33.82 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 120.351 -0.539 . . . . 0.0 111.605 -178.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -97.64 125.92 42.66 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.858 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -131.03 124.28 30.56 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.216 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 45.5 p-10 -102.52 9.94 39.19 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.841 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 . . . . . 0 C--N 1.323 -0.544 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.905 179.649 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 78.3 t . . . . . 0 CA--C 1.529 0.141 0 CA-C-O 120.577 0.227 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.439 ' C ' ' H ' ' B' ' 231' ' ' GLN . 86.6 m-20 -98.6 -4.1 34.74 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.81 0.338 . . . . 0.0 110.434 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . 0.65 ' O ' ' NE2' ' B' ' 231' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.65 ' NE2' ' O ' ' B' ' 230' ' ' SEP . 92.3 mm-40 -135.63 39.83 2.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.363 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -110.38 -162.51 18.61 Favored Glycine 0 CA--C 1.521 0.441 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.736 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -70.94 156.08 60.91 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 123.465 2.777 . . . . 0.0 112.176 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -78.12 140.22 17.62 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 121.768 1.645 . . . . 0.0 112.765 -179.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.481 ' CG2' HG22 ' A' ' 66' ' ' THR . 39.8 t -67.78 136.56 26.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.72 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 10.4 t -62.55 126.81 28.62 Favored 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.594 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -57.77 -23.15 56.89 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 121.921 1.747 . . . . 0.0 112.5 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 24.7 m -71.41 -42.95 67.68 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.554 ' CE2' HG21 ' A' ' 43' ' ' VAL . 87.8 t80 -58.33 -46.61 85.88 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.221 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 88.0 mt -62.97 -41.17 99.46 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.491 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -61.34 -38.76 88.08 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.408 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -63.79 -42.77 97.67 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.419 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -60.88 -40.27 92.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.259 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -64.17 -38.45 91.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.863 0.364 . . . . 0.0 110.763 179.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 80.8 p -68.61 -40.56 80.37 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . 0.54 ' CD ' HH12 ' A' ' 12' ' ' ARG . 59.8 tt0 -60.53 -38.27 83.9 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.442 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 24.4 t -63.04 -44.96 99.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -59.96 -27.62 66.97 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.72 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -96.59 -12.44 23.97 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.748 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.443 ' N ' ' O ' ' B' ' 248' ' ' GLN . 54.3 tp -124.39 115.66 21.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.305 178.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 171.63 23.0 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.042 178.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' B' ' 255' ' ' ASP . 29.2 p-10 -65.89 -46.4 78.5 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . 0.538 ' N ' ' OD1' ' B' ' 254' ' ' ASP . 24.6 p-10 170.38 64.41 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.551 179.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -120.33 99.48 6.6 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 120.551 -0.459 . . . . 0.0 111.725 -178.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . 0.597 ' O ' ' N ' ' B' ' 259' ' ' ASP . 98.8 mttt -65.76 -84.14 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.98 0.419 . . . . 0.0 110.161 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.583 ' O ' ' N ' ' B' ' 260' ' ' GLU . 97.4 m-20 -33.97 -28.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.476 -178.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.597 ' N ' ' O ' ' B' ' 257' ' ' LYS . 61.3 t0 45.86 -79.3 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.448 178.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.583 ' N ' ' O ' ' B' ' 258' ' ' ASP . 91.1 mt-10 -148.22 10.42 0.88 Allowed 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.347 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 64.6 mt -108.59 141.45 23.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . 0.474 HG11 ' NH2' ' A' ' 38' ' ' ARG . 54.3 t -127.27 135.62 62.93 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 CA-C-O 121.065 0.459 . . . . 0.0 110.957 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -98.81 124.06 43.44 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.519 -178.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . 0.4 ' HB3' ' NE2' ' B' ' 265' ' ' GLN . 88.6 tttt -64.69 -47.1 79.61 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.705 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . 0.749 ' N ' HE21 ' B' ' 265' ' ' GLN . 0.0 OUTLIER -96.74 159.1 32.42 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.547 -179.344 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -68.05 143.51 60.19 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 122.998 2.465 . . . . 0.0 113.395 -179.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 47.9 pt . . . . . 0 C--N 1.326 -0.438 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.535 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo . . . . . 0 N--CA 1.496 1.654 0 CA-C-O 120.588 0.162 . . . . 0.0 111.874 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.8 m -100.84 -55.47 2.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.399 0.619 . . . . 0.0 110.137 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.591 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 93.9 mtt-85 -92.39 130.81 37.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.309 -178.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.593 ' HE ' ' CE1' ' A' ' 19' ' ' HIS . 85.6 mtp180 -128.7 141.4 51.34 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.106 0.479 . . . . 0.0 111.343 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.491 HD12 ' O ' ' A' ' 96' ' ' ARG . 41.7 tp -117.8 136.46 53.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.065 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.7 t -114.26 130.01 69.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 CA-C-O 120.775 0.321 . . . . 0.0 111.353 -178.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 m -94.87 116.16 28.37 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.553 -178.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 66.9 mt -84.93 150.93 3.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.99 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -92.93 161.15 14.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.714 0.292 . . . . 0.0 110.358 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.776 HH11 HH11 ' B' ' 245' ' ' ARG . 91.0 mtm180 -57.22 -29.3 63.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.917 -179.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 75.4 p -77.28 -11.09 59.79 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.831 -0.347 . . . . 0.0 110.818 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.88 29.28 11.95 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.1 t -114.49 133.69 59.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.735 0.303 . . . . 0.0 110.668 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' A' ' 17' ' ' GLY . 64.8 t0 -69.34 127.64 33.77 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.809 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.409 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -119.31 -123.67 3.19 Favored Glycine 0 CA--C 1.537 1.42 0 C-N-CA 121.083 -0.579 . . . . 0.0 112.166 -179.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -74.34 149.08 39.45 Favored 'Trans proline' 0 N--CA 1.497 1.709 0 C-N-CA 122.492 2.128 . . . . 0.0 113.338 -178.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.593 ' CE1' ' HE ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -109.28 151.72 26.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.902 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.488 ' CD2' HD11 ' A' ' 37' ' ' ILE . 65.1 t80 -121.29 104.5 40.57 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.906 -178.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.437 ' O ' ' NE2' ' B' ' 265' ' ' GLN . 60.2 Cg_endo -77.48 127.37 8.9 Favored 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 121.767 1.645 . . . . 0.0 111.722 -179.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.433 HD13 HD11 ' A' ' 53' ' ' ILE . 79.3 mt -77.23 80.36 3.75 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.369 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.736 ' H ' HE22 ' B' ' 265' ' ' GLN . 66.4 p -82.91 -10.99 58.54 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.8 mt -108.07 148.93 29.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.574 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 94.7 p -72.19 -13.4 61.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.845 -178.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 29.0 m -129.57 131.34 46.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.185 0.517 . . . . 0.0 110.777 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.684 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -128.0 119.64 25.88 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.579 179.191 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.507 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 49.2 tp -120.02 125.29 47.99 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.737 -178.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.684 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 19.5 m-85 -98.96 124.36 43.86 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -176.98 -156.77 16.53 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 119.894 -1.146 . . . . 0.0 112.503 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.622 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 84.7 mtm-85 -107.9 -24.31 11.69 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 120.354 -0.539 . . . . 0.0 110.599 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.28 165.06 36.06 Favored Glycine 0 CA--C 1.524 0.644 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.135 -178.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.455 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.5 tp -67.14 -40.01 84.34 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 CA-C-N 115.529 -0.336 . . . . 0.0 110.713 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.455 ' N ' HG23 ' A' ' 33' ' ' ILE . 93.1 mt-10 -57.62 -32.64 67.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.533 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 68.9 m -49.52 116.18 1.64 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.936 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.572 ' OD1' ' N ' ' A' ' 37' ' ' ILE . 6.6 p-10 -58.16 -29.65 65.76 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.595 HD12 ' CE2' ' A' ' 29' ' ' PHE . 80.2 mt -129.23 117.11 42.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 177.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -101.28 138.74 37.9 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.871 0.367 . . . . 0.0 111.459 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.471 HG22 ' H ' ' A' ' 41' ' ' LEU . 91.6 mt -119.71 130.6 73.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.473 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.431 ' OE1' ' OE1' ' B' ' 260' ' ' GLU . 73.8 mt-30 -73.53 21.9 0.08 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.396 -178.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.941 HD11 ' NH1' ' A' ' 93' ' ' ARG . 20.1 mt -90.65 123.52 64.94 Favored Pre-proline 0 C--N 1.326 -0.426 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.165 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.31 -8.52 22.02 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 121.671 1.581 . . . . 0.0 112.128 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.4 m -101.42 4.77 10.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 C-N-CA 120.43 -0.508 . . . . 0.0 111.451 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.622 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 38.0 t -96.72 106.77 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.297 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.533 ' O ' ' O ' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -33.84 162.91 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.963 0.887 . . . . 0.0 112.385 -179.143 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.45 ' CE ' ' O ' ' B' ' 232' ' ' GLY . 96.3 mttt -61.66 -41.06 97.0 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.354 -1.294 . . . . 0.0 111.461 -178.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.616 ' O ' ' N ' ' A' ' 49' ' ' CYS . 89.7 mm-40 -109.57 -17.45 13.73 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 123.728 0.642 . . . . 0.0 110.303 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.466 ' O ' ' OG ' ' A' ' 64' ' ' SER . 19.1 t60 36.87 -78.51 0.0 OUTLIER 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.072 -0.967 . . . . 0.0 113.02 -179.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.616 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -135.93 139.75 43.5 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.616 -178.588 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -126.41 131.68 51.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.843 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 87.9 mt -115.38 131.91 66.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.176 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -118.07 129.36 55.51 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.433 HD11 HD13 ' A' ' 22' ' ' LEU . 96.9 mt -110.49 121.85 64.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.548 0.689 . . . . 0.0 112.852 -178.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.464 ' O ' ' C ' ' A' ' 55' ' ' GLU . 97.3 m-70 -116.49 140.33 49.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.406 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 54' ' ' HIS . 92.1 mt-10 -39.92 -30.32 0.08 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.462 ' N ' ' O ' ' A' ' 54' ' ' HIS . 88.4 mt-30 -64.57 -68.79 0.33 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.798 178.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -152.21 -171.45 3.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.404 0.621 . . . . 0.0 110.748 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -111.91 124.63 52.78 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.507 178.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 91.0 mt -114.21 131.22 66.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.179 0.514 . . . . 0.0 112.128 -178.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.456 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 16.2 tp -104.1 129.6 51.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.191 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -115.2 138.09 51.31 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.167 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.616 ' ND2' ' H ' ' A' ' 69' ' ' THR . 23.3 t-20 -102.02 110.6 22.6 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.965 179.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -98.4 -5.35 32.8 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.157 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.466 ' OG ' ' O ' ' A' ' 48' ' ' HIS . 1.4 m -71.64 100.64 2.34 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.277 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.7 m -84.11 -20.48 32.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.119 0.485 . . . . 0.0 109.963 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.718 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -90.76 -40.85 11.58 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.619 -179.457 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -138.94 95.16 9.7 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.872 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.41 ' HB2' HG13 ' A' ' 75' ' ' VAL . 35.8 Cg_exo -57.77 143.65 95.0 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 122.287 1.991 . . . . 0.0 112.552 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.616 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 4.5 m -77.08 154.79 32.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.58 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.402 ' N ' ' CG2' ' A' ' 69' ' ' THR . 75.3 mt-30 -114.87 140.45 48.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.921 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 50.6 t -128.43 135.72 61.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 50.27 33.56 7.55 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.38 28.41 67.9 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.775 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.4 t -142.47 139.45 31.56 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.173 -0.611 . . . . 0.0 112.197 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.41 HG13 ' HB2' ' A' ' 68' ' ' PRO . 40.7 t -67.51 137.54 24.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.282 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 10.9 pt -108.6 81.33 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.154 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -60.85 -33.54 73.22 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.542 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.471 ' N ' ' CD ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -117.05 165.4 15.54 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.873 179.754 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.54 142.39 98.82 Favored 'Trans proline' 0 N--CA 1.502 1.979 0 C-N-CA 122.346 2.031 . . . . 0.0 112.162 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.5 m -135.6 138.17 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-O 120.961 0.41 . . . . 0.0 111.904 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.7 mtm180 -72.39 131.18 42.27 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.7 mt -80.02 136.61 36.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.266 0.555 . . . . 0.0 111.436 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -126.41 146.79 49.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.935 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.696 ' CE1' ' H ' ' A' ' 99' ' ' ASN . 3.5 t-160 -54.41 121.88 9.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.146 0.498 . . . . 0.0 110.909 -178.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.73 -10.84 38.37 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -71.86 136.71 47.06 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.49 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.468 ' O ' HG13 ' A' ' 87' ' ' VAL . 9.7 p -114.12 132.21 63.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.182 -178.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 69.1 mt -101.65 132.9 46.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 53.0 m -118.65 128.72 54.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.686 0.755 . . . . 0.0 112.121 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.567 HD12 ' HE1' ' A' ' 95' ' ' PHE . 98.1 mt -118.81 131.26 72.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 177.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.51 HG23 HD21 ' B' ' 242' ' ' LEU . 88.9 mt -24.43 98.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.547 ' OD1' ' CD2' ' B' ' 242' ' ' LEU . 2.7 m-20 89.01 -15.78 0.31 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 177.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.941 ' NH1' HD11 ' A' ' 41' ' ' LEU . 69.6 mtt85 -132.5 141.89 48.97 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.159 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.6 t -135.98 149.98 49.07 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.567 ' HE1' HD12 ' A' ' 90' ' ' ILE . 36.7 m-85 -126.57 123.63 38.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.785 -179.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.491 ' O ' HD12 ' A' ' 7' ' ' LEU . 42.7 ttm180 -84.42 129.09 34.9 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.599 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.591 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 87.8 t80 -91.78 124.67 36.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.137 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -123.76 132.42 53.8 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.737 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.696 ' H ' ' CE1' ' A' ' 84' ' ' HIS . 41.5 t-20 -115.09 115.06 26.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.137 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 121.11 0.481 . . . . 0.0 110.281 179.926 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 121.134 0.492 . . . . 0.0 110.613 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.553 ' O ' ' CB ' ' B' ' 230' ' ' SEP . 98.0 m-20 -97.39 -12.07 23.19 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.503 179.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . 0.553 ' CB ' ' O ' ' B' ' 229' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -167.85 62.06 0.07 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.382 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . 0.45 ' O ' ' CE ' ' A' ' 46' ' ' LYS . . . -98.17 -140.77 11.61 Favored Glycine 0 CA--C 1.535 1.311 0 N-CA-C 110.926 -0.869 . . . . 0.0 110.926 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -76.09 160.13 36.8 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.29 1.993 . . . . 0.0 112.8 -179.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.416 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -69.8 167.78 23.5 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.144 1.896 . . . . 0.0 112.45 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.718 ' CG2' HG22 ' A' ' 66' ' ' THR . 44.1 t -112.61 132.5 61.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.644 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . 0.448 ' CB ' HD13 ' A' ' 91' ' ' ILE . 2.5 t -72.03 133.47 45.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.159 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . 0.566 ' P ' ' OG1' ' B' ' 240' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 31.4 Cg_exo -59.28 -23.43 69.78 Favored 'Trans proline' 0 N--CA 1.501 1.945 0 C-N-CA 123.289 2.659 . . . . 0.0 113.611 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . 0.566 ' OG1' ' P ' ' B' ' 238' ' ' TPO . 19.0 p -82.76 -38.9 22.58 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.347 -0.541 . . . . 0.0 109.886 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -57.9 -46.48 84.87 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.726 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.547 ' CD2' ' OD1' ' A' ' 92' ' ' ASP . 97.3 mt -66.23 -42.43 88.64 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.386 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -63.39 -43.27 98.04 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.996 -178.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -63.43 -43.32 97.8 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.858 0.361 . . . . 0.0 111.04 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.776 HH11 HH11 ' A' ' 12' ' ' ARG . 58.0 ttm-85 -61.4 -42.28 98.47 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.797 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -63.17 -37.85 88.85 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.205 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 67.3 m -67.46 -43.8 80.15 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 177.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 63.5 tp60 -59.58 -39.85 85.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.979 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.544 HG23 ' O ' ' B' ' 245' ' ' ARG . 77.6 t -62.51 -44.18 99.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -61.18 -25.04 66.75 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -82.19 -8.6 59.65 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.41 178.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.546 ' CD1' ' NH2' ' A' ' 12' ' ' ARG . 85.7 mt -100.49 -179.75 4.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.82 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . 0.493 ' N ' ' OD1' ' B' ' 253' ' ' ASN . 7.1 p-10 -153.2 -170.96 3.77 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.836 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -49.63 -11.55 0.06 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.224 -178.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . 0.489 ' OD1' ' OD1' ' B' ' 253' ' ' ASN . 44.4 p-10 -84.11 7.83 17.53 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.408 ' N ' ' O ' ' B' ' 253' ' ' ASN . 53.8 p-10 -72.29 39.94 0.08 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.251 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . 0.482 ' H ' ' C ' ' B' ' 255' ' ' ASP . 98.8 mttt -69.91 153.12 43.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.87 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' B' ' 260' ' ' GLU . 99.7 m-20 59.58 55.99 3.84 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -178.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.423 ' O ' ' OD1' ' B' ' 259' ' ' ASP . 43.5 p30 -58.45 58.13 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.043 -0.981 . . . . 0.0 112.907 -177.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.582 ' CG ' HH21 ' A' ' 93' ' ' ARG . 49.9 mm-40 63.64 5.51 2.23 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 177.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 89.4 mt -110.1 135.09 50.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 69.2 t -127.5 132.06 69.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.927 0.394 . . . . 0.0 110.204 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . 0.478 ' HB2' HD11 ' B' ' 267' ' ' ILE . 72.7 m-85 -96.35 120.7 37.13 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.241 0.543 . . . . 0.0 111.493 -178.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -67.96 -41.35 82.59 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.417 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . 0.736 HE22 ' H ' ' A' ' 23' ' ' SER . 0.0 OUTLIER -93.59 161.41 30.54 Favored Pre-proline 0 N--CA 1.463 0.202 0 CA-C-N 116.62 -0.263 . . . . 0.0 111.419 -177.797 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -59.31 143.55 99.7 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.227 1.951 . . . . 0.0 111.181 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . 0.55 ' CG2' ' O ' ' A' ' 19' ' ' HIS . 2.1 mt . . . . . 0 N--CA 1.449 -0.477 0 C-N-CA 120.304 -0.559 . . . . 0.0 110.55 -178.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo . . . . . 0 N--CA 1.491 1.378 0 CA-C-O 120.946 0.311 . . . . 0.0 112.294 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.1 m -126.74 -63.05 1.1 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.665 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.652 ' NH1' HG23 ' A' ' 53' ' ' ILE . 99.8 mtt180 -98.56 135.38 40.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.037 -179.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -137.89 150.4 47.06 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.498 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 86.2 mt -116.5 139.22 50.71 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.455 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.413 HG11 ' OD2' ' A' ' 16' ' ' ASP . 65.5 t -110.92 127.98 67.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.457 ' CG2' HD12 ' B' ' 261' ' ' ILE . 54.8 m -79.04 142.06 36.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.387 0.613 . . . . 0.0 112.386 -178.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.418 HD12 ' HB3' ' A' ' 94' ' ' SER . 96.9 mt -114.17 135.88 52.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.467 176.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -86.91 160.01 18.85 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.546 ' NH2' HD22 ' B' ' 252' ' ' LEU . 90.9 mtm180 -57.84 -29.31 64.86 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.578 -178.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 42.8 m -80.81 -9.49 59.81 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.712 0.291 . . . . 0.0 110.928 179.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.68 40.67 5.58 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.6 t -121.09 133.02 69.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.919 0.39 . . . . 0.0 110.74 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.413 ' OD2' HG11 ' A' ' 8' ' ' VAL . 65.7 t0 -75.19 125.45 28.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.154 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -120.54 -121.01 2.82 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.062 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -74.89 150.78 39.25 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.464 2.109 . . . . 0.0 112.777 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.97 155.85 22.1 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.548 ' CD2' HD11 ' A' ' 37' ' ' ILE . 64.0 t80 -122.29 93.24 48.65 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.2 -179.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.467 ' O ' ' NE2' ' B' ' 265' ' ' GLN . 27.3 Cg_exo -61.66 130.47 31.62 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.159 1.906 . . . . 0.0 111.74 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 22' ' ' LEU . 96.7 mt -85.79 82.22 8.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.426 0.631 . . . . 0.0 110.396 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.7 p -86.78 -8.14 57.62 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.002 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 42.7 mt -108.08 147.99 30.42 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.964 -178.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.9 t -65.39 -18.25 65.17 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -178.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 21.6 m -136.65 136.96 39.56 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.463 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.7 t -129.73 123.4 30.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.514 178.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 52.5 tp -116.69 129.69 56.28 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.037 0.446 . . . . 0.0 111.642 -178.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.763 ' CE2' HD12 ' A' ' 37' ' ' ILE . 3.2 m-85 -109.16 144.47 37.18 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.99 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 146.97 -170.12 27.94 Favored Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.764 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 31' ' ' ARG . 47.9 mtm180 -78.53 -32.3 47.91 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.491 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -50.83 146.77 9.15 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.63 -178.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.488 HG23 ' N ' ' A' ' 34' ' ' GLU . 7.6 tp -67.17 -41.78 87.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.488 ' N ' HG23 ' A' ' 33' ' ' ILE . 70.3 mm-40 -53.33 -17.65 1.98 Allowed 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.813 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 59.8 m -62.27 121.42 13.11 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.749 -179.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -57.83 -29.71 65.15 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.763 HD12 ' CE2' ' A' ' 29' ' ' PHE . 92.5 mt -128.23 121.93 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.107 176.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.431 ' CZ ' HD12 ' A' ' 33' ' ' ILE . 81.9 mtp180 -106.97 137.94 44.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.092 -178.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.613 ' CG2' HD12 ' A' ' 41' ' ' LEU . 95.5 mt -120.53 129.32 75.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -78.2 26.99 0.2 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.613 HD12 ' CG2' ' A' ' 39' ' ' ILE . 9.4 mt -92.73 126.84 50.33 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.808 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.79 -12.41 30.89 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.499 2.133 . . . . 0.0 113.632 -179.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.656 HG21 ' CE2' ' B' ' 241' ' ' PHE . 35.2 m -99.92 5.83 9.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.791 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.7 t -89.32 136.61 23.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.986 179.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.2 m -67.84 161.33 26.48 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.52 0.676 . . . . 0.0 111.548 -178.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -61.65 -42.99 99.67 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.112 -178.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.603 ' O ' ' N ' ' A' ' 49' ' ' CYS . 95.5 mt-30 -115.72 -6.26 12.13 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 123.652 0.595 . . . . 0.0 111.064 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.463 ' C ' ' O ' ' A' ' 47' ' ' GLN . 15.2 t60 15.9 -73.43 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 -178.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.603 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -128.48 132.67 48.38 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.483 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -126.85 126.57 43.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.179 179.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 85.6 mt -106.71 130.32 58.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.048 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -116.81 119.83 36.62 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.652 HG23 ' NH1' ' A' ' 5' ' ' ARG . 97.5 mt -103.62 116.55 47.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.02 -0.672 . . . . 0.0 112.285 -178.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.551 ' O ' ' N ' ' A' ' 56' ' ' GLN . 87.0 m-70 -114.88 142.91 45.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.303 179.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.4 mm-40 -39.52 -26.35 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -178.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.551 ' N ' ' O ' ' A' ' 54' ' ' HIS . 77.7 mt-30 -69.47 -68.73 0.39 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.891 178.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.409 ' CD ' ' N ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -157.68 -166.13 1.93 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.321 -179.174 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.59 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -112.9 130.2 56.2 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.2 mt -119.8 130.78 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 29.0 tp -100.14 125.83 46.32 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.291 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -107.53 137.57 45.32 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.575 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -99.92 106.95 18.82 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -99.35 -5.35 29.8 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.662 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.521 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 23.1 t -86.77 99.88 12.11 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 120.401 -0.52 . . . . 0.0 112.014 -178.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.5 m -73.68 -37.6 65.17 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 177.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.7 p -65.66 -36.24 83.09 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.636 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.521 ' O ' ' OG ' ' A' ' 64' ' ' SER . 36.3 m-80 -153.05 97.92 2.8 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.547 -179.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -59.28 147.01 92.87 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.063 1.842 . . . . 0.0 112.758 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 60.4 m -65.62 133.58 51.46 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 177.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -96.82 141.55 29.88 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.223 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.741 ' HB ' HD11 ' A' ' 76' ' ' ILE . 5.2 p -129.66 134.67 62.93 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 50.96 32.97 8.08 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 119.694 -0.802 . . . . 0.0 109.15 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.05 28.53 66.38 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.443 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.2 t -140.24 139.43 35.58 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 117.308 0.554 . . . . 0.0 110.743 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -68.05 144.1 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 120.903 0.382 . . . . 0.0 111.48 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.741 HD11 ' HB ' ' A' ' 71' ' ' VAL . 85.9 mt -106.28 108.73 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.693 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -76.18 -39.17 55.48 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.1 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.511 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 1.5 mt-10 -128.64 172.99 6.11 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.737 -178.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -57.54 143.57 94.29 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 122.16 1.907 . . . . 0.0 112.57 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.1 t -133.0 138.03 52.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.425 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -74.32 131.35 41.07 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 178.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.527 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 96.4 mt -82.84 136.73 34.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.982 0.42 . . . . 0.0 111.491 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -132.61 154.95 49.55 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.301 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.405 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 5.2 t60 -54.94 117.28 3.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.894 0.378 . . . . 0.0 111.596 -179.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.39 -14.03 30.51 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.525 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 52.5 t0 -69.44 127.8 34.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.089 0.471 . . . . 0.0 110.445 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.461 HG22 ' HG2' ' A' ' 96' ' ' ARG . 72.5 t -108.79 132.64 56.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.359 -178.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.1 mt -102.48 131.13 51.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 89.7 m -119.49 129.49 54.74 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.643 0.735 . . . . 0.0 112.119 -178.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.623 ' O ' ' N ' ' A' ' 93' ' ' ARG . 92.0 mt -118.35 133.08 66.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 114.615 -1.175 . . . . 0.0 108.769 178.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.543 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 70.3 mt -20.77 91.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.656 ' CG ' ' HE ' ' B' ' 245' ' ' ARG . 21.3 t0 93.36 -21.73 0.07 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 177.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.623 ' N ' ' O ' ' A' ' 90' ' ' ILE . 87.8 mtt-85 -130.4 146.01 51.9 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.103 -0.639 . . . . 0.0 111.029 -179.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.418 ' HB3' HD12 ' A' ' 10' ' ' ILE . 32.7 t -138.9 151.77 47.21 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.149 0.5 . . . . 0.0 110.317 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.638 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 91.6 m-85 -125.65 127.27 46.02 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.461 ' HG2' HG22 ' A' ' 87' ' ' VAL . 99.8 mtt180 -89.06 138.02 31.79 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.745 -179.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -94.91 119.37 33.34 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.512 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -123.18 120.96 34.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.852 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.405 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 64.1 t-20 -104.65 112.99 26.29 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.679 -0.409 . . . . 0.0 110.141 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 . . . . . 0 C--N 1.328 -0.361 0 CA-C-O 120.943 0.402 . . . . 0.0 110.012 179.861 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . 0.513 ' O ' ' O ' ' B' ' 229' ' ' ASP . 52.2 t . . . . . 0 N--CA 1.453 -0.289 0 CA-C-O 120.72 0.295 . . . . 0.0 110.638 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.513 ' O ' ' O ' ' B' ' 228' ' ' VAL . 83.1 m-20 39.68 -166.65 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.212 0.53 . . . . 0.0 110.529 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . 0.451 ' O1P' ' N ' ' B' ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -167.79 73.73 0.12 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.917 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -104.47 -156.85 23.62 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -63.73 155.08 65.57 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 123.156 2.57 . . . . 0.0 112.244 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.53 141.99 97.79 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.688 2.259 . . . . 0.0 112.982 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.441 HG13 ' O ' ' B' ' 236' ' ' VAL . 10.7 p -78.39 128.87 38.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.254 178.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . 0.517 ' HB2' HD13 ' A' ' 91' ' ' ILE . 1.8 t -60.76 119.82 8.91 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.184 -179.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -56.3 -24.92 53.87 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 122.219 1.946 . . . . 0.0 111.981 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 20.0 m -68.72 -46.89 67.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.442 0.639 . . . . 0.0 109.774 178.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.744 ' CD2' ' NH1' ' B' ' 245' ' ' ARG . 77.2 t80 -58.65 -44.0 89.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.767 -179.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 1.046 HD23 HH22 ' B' ' 245' ' ' ARG . 60.6 mt -61.34 -43.87 98.14 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.214 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -64.69 -37.7 88.49 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -62.68 -47.2 84.69 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.632 -178.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 1.046 HH22 HD23 ' B' ' 242' ' ' LEU . 27.8 mtm-85 -63.93 -37.55 87.84 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.773 -179.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -62.49 -41.2 98.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.809 0.338 . . . . 0.0 110.443 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 76.7 p -66.16 -41.12 90.82 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -62.08 -38.98 90.88 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.111 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.457 HG23 ' O ' ' B' ' 245' ' ' ARG . 52.5 t -62.0 -43.87 98.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -61.23 -28.09 68.91 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -87.51 -8.32 56.53 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.684 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.546 HD22 ' NH2' ' A' ' 12' ' ' ARG . 2.6 tp -102.81 -178.71 3.75 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.116 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 23.0 p30 -143.05 169.87 16.77 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.339 0.59 . . . . 0.0 112.142 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -71.43 -20.9 62.05 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.417 179.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -70.11 -10.32 58.37 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.768 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.443 ' OD2' HD21 ' B' ' 252' ' ' LEU . 62.8 t0 -85.93 83.33 7.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.42 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -82.79 6.51 17.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.543 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.466 ' O ' ' C ' ' B' ' 259' ' ' ASP . 98.3 m-20 -87.09 30.94 0.73 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.588 ' C ' ' H ' ' B' ' 261' ' ' ILE . 50.9 p-10 -31.4 141.05 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.869 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -59.45 12.89 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.075 -178.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.638 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 66.7 mt -107.32 133.6 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 56.5 t -125.86 132.94 70.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.109 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -96.23 118.78 33.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.401 0.62 . . . . 0.0 111.969 -177.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -66.23 -44.65 83.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.767 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . 0.467 ' NE2' ' O ' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -95.83 156.15 37.6 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.09 -179.462 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -64.93 144.21 82.03 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 C-N-CA 122.674 2.249 . . . . 0.0 112.926 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 47.3 pt . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.912 179.463 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo . . . . . 0 N--CA 1.494 1.52 0 CA-C-O 120.984 0.326 . . . . 0.0 112.746 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.0 p -93.22 -37.9 11.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.851 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.763 ' NH1' ' HB2' ' A' ' 58' ' ' ALA . 96.8 mtt-85 -90.24 122.39 33.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.87 -178.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -130.69 138.08 49.85 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.918 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 1.032 HD11 HD11 ' A' ' 22' ' ' LEU . 83.3 mt -115.26 139.42 49.97 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.57 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.6 t -112.1 127.65 69.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.452 HG23 ' CD1' ' B' ' 261' ' ' ILE . 4.3 m -87.62 111.83 21.67 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.234 0.54 . . . . 0.0 111.43 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 90.9 mt -82.82 145.52 8.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.717 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -92.0 158.19 16.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.783 0.325 . . . . 0.0 110.754 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.447 HH21 HD22 ' B' ' 252' ' ' LEU . 90.1 mtm180 -58.01 -24.75 59.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.529 -179.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.2 m -80.94 -10.05 59.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.033 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.07 39.81 6.81 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.1 t -123.31 134.62 65.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.849 0.356 . . . . 0.0 111.328 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' A' ' 17' ' ' GLY . 62.6 t0 -73.93 127.24 32.36 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.931 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.428 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -123.8 -122.73 2.73 Favored Glycine 0 CA--C 1.542 1.746 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.217 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.95 148.63 45.75 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 122.671 2.247 . . . . 0.0 113.626 -178.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -107.39 154.83 20.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.166 0.508 . . . . 0.0 110.832 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -130.76 103.2 16.03 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.582 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -78.05 138.62 16.49 Favored 'Trans proline' 0 N--CA 1.488 1.191 0 C-N-CA 121.911 1.74 . . . . 0.0 112.635 -179.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 1.032 HD11 HD11 ' A' ' 7' ' ' LEU . 94.0 mt -92.65 54.42 2.24 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.225 -0.443 . . . . 0.0 112.188 -178.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.6 p -59.67 -29.03 67.78 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.749 HD11 HE21 ' B' ' 265' ' ' GLN . 63.1 mt -75.43 142.11 43.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.609 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.32 -16.65 64.22 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -178.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 30.3 m -140.5 140.29 35.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.021 0.438 . . . . 0.0 111.16 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.617 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -136.28 134.2 37.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.382 178.545 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 47.5 tp -121.73 127.38 50.63 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.214 -178.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.82 ' CE2' HD12 ' A' ' 37' ' ' ILE . 21.0 m-85 -101.86 131.99 47.89 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.663 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.62 -177.79 38.61 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 120.274 -0.965 . . . . 0.0 112.285 179.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.671 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 73.0 mtm-85 -77.9 -31.95 51.47 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.764 0.316 . . . . 0.0 110.554 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.435 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -52.45 149.21 10.34 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -178.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.514 HG23 ' N ' ' A' ' 34' ' ' GLU . 8.1 tp -66.44 -42.04 89.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 C-N-CA 120.759 -0.377 . . . . 0.0 110.272 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.514 ' N ' HG23 ' A' ' 33' ' ' ILE . 80.0 mm-40 -53.16 -18.87 2.5 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.435 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 57.1 m -63.25 121.88 14.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.533 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -57.94 -29.41 65.14 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.82 HD12 ' CE2' ' A' ' 29' ' ' PHE . 93.4 mt -122.64 119.78 59.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 176.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.457 ' HD3' HD12 ' A' ' 33' ' ' ILE . 87.9 mtm-85 -104.0 133.67 48.56 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.355 -178.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.45 HG22 ' H ' ' A' ' 41' ' ' LEU . 98.9 mt -117.53 129.36 74.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.148 0.499 . . . . 0.0 110.24 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -77.92 24.1 0.24 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.857 -177.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.769 HD12 ' CZ ' ' A' ' 93' ' ' ARG . 38.3 mt -105.02 128.24 27.1 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.912 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.47 -12.93 30.02 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.434 2.089 . . . . 0.0 113.309 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.589 HG21 ' CE2' ' B' ' 241' ' ' PHE . 25.5 m -88.45 -2.21 8.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.871 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.671 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 55.8 t -92.86 134.55 30.39 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.255 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 178.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.451 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 0.6 OUTLIER -65.1 162.04 17.74 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.291 0.567 . . . . 0.0 111.793 -178.766 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -59.86 -43.6 94.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.19 -178.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.67 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.5 mt-30 -111.5 -18.08 12.93 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.451 ' H ' ' HB3' ' A' ' 45' ' ' SER . 19.5 t60 32.59 -71.93 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.467 -1.242 . . . . 0.0 114.108 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.67 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.19 136.21 45.53 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.296 0.57 . . . . 0.0 112.263 -177.847 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -125.68 135.76 52.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.333 178.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.578 HD11 HD12 ' A' ' 82' ' ' LEU . 18.0 tt -124.29 136.39 60.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.03 0.443 . . . . 0.0 110.14 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -122.46 132.57 54.41 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.981 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.55 HD13 ' HD2' ' A' ' 5' ' ' ARG . 95.6 mt -106.99 112.25 39.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.823 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.501 ' O ' ' N ' ' A' ' 56' ' ' GLN . 81.4 m-70 -112.92 145.96 39.83 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.156 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' A' ' 54' ' ' HIS . 99.1 mt-10 -40.2 -27.02 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.894 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.501 ' N ' ' O ' ' A' ' 54' ' ' HIS . 85.7 mt-30 -67.04 -68.92 0.34 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.608 178.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -158.68 -168.22 2.35 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.209 0.528 . . . . 0.0 110.945 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.763 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -104.04 120.74 41.72 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 177.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.6 mt -110.99 128.89 67.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.588 HD11 ' SG ' ' A' ' 49' ' ' CYS . 56.5 tp -97.82 129.78 44.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.682 179.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -114.86 136.95 52.54 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.731 0.3 . . . . 0.0 111.147 -179.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -94.35 106.55 18.53 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -102.75 -10.18 19.37 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.311 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.5 t -74.27 101.59 4.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.381 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 92.2 p -82.61 -12.69 57.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.01 0.434 . . . . 0.0 110.035 179.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.503 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.0 OUTLIER -101.15 -35.64 9.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.434 -179.625 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -145.33 92.75 5.54 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.39 -179.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.548 ' HB2' HG13 ' A' ' 75' ' ' VAL . 45.1 Cg_exo -55.57 146.19 65.67 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 122.648 2.232 . . . . 0.0 112.721 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 61.8 m -77.03 138.65 39.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.585 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -102.68 141.15 35.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.088 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.4 t -129.79 135.18 61.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 52.42 32.13 10.77 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.2 24.72 70.48 Favored Glycine 0 CA--C 1.535 1.281 0 CA-C-N 115.131 -0.941 . . . . 0.0 112.885 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 47.6 t -141.66 140.85 33.33 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 118.053 0.927 . . . . 0.0 112.057 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.548 HG13 ' HB2' ' A' ' 68' ' ' PRO . 43.0 t -68.03 139.43 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.343 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.2 pt -114.59 89.36 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.25 178.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -63.72 -24.0 67.6 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -123.62 166.74 17.36 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.128 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -65.55 150.64 86.43 Favored 'Trans proline' 0 N--CA 1.5 1.86 0 C-N-CA 122.845 2.364 . . . . 0.0 113.441 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 29.7 m -143.1 143.92 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.59 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -75.27 138.56 41.95 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 178.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.578 HD12 HD11 ' A' ' 51' ' ' ILE . 92.0 mt -96.67 134.83 39.42 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.249 0.547 . . . . 0.0 111.571 -178.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -121.45 157.3 30.88 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.769 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -55.46 120.71 7.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.354 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.38 -19.3 26.93 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -68.14 135.94 52.91 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.307 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 42.2 t -114.6 133.54 60.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.524 -178.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.404 ' O ' ' OG ' ' A' ' 94' ' ' SER . 80.9 mt -100.61 132.49 46.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.248 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.6 m -125.56 130.09 51.02 Favored 'General case' 0 C--N 1.334 -0.097 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -179.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.49 HG22 HG12 ' A' ' 91' ' ' ILE . 84.0 mt -119.32 127.59 75.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.28 178.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.808 HG22 ' NH2' ' B' ' 245' ' ' ARG . 36.0 mm 42.26 -97.82 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -178.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.515 ' CB ' HH22 ' B' ' 245' ' ' ARG . 48.0 t0 -126.85 23.92 6.57 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.283 0.564 . . . . 0.0 110.02 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.769 ' CZ ' HD12 ' A' ' 41' ' ' LEU . 54.5 mtm-85 -126.45 139.75 53.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.001 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.404 ' OG ' ' O ' ' A' ' 88' ' ' ILE . 15.9 t -139.75 150.57 44.94 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.223 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -118.83 119.38 34.21 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 96' ' ' ARG . 39.2 ttp-105 -82.23 130.58 35.13 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.33 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.517 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 61.6 t80 -97.74 124.85 42.25 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.059 0.456 . . . . 0.0 111.271 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -128.52 123.65 34.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.523 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 -100.15 109.52 21.79 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.361 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.857 -179.932 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . 0.511 ' O ' HG12 ' B' ' 228' ' ' VAL . 98.6 t . . . . . 0 N--CA 1.457 -0.108 0 CA-C-O 120.697 0.284 . . . . 0.0 111.145 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.553 ' OD1' ' N ' ' B' ' 232' ' ' GLY . 51.9 p-10 -156.56 176.17 13.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.768 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -124.03 40.38 3.74 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . 0.553 ' N ' ' OD1' ' B' ' 229' ' ' ASP . . . -114.54 -173.13 17.91 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.956 -178.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -61.81 156.84 46.09 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 123.506 2.804 . . . . 0.0 112.675 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.503 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -63.95 135.68 49.0 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 121.335 1.357 . . . . 0.0 112.95 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 4.0 p -65.25 136.55 26.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 114.572 -1.195 . . . . 0.0 110.446 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 20.2 t -64.2 123.1 18.22 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.214 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . 0.402 ' O3P' ' OG1' ' B' ' 240' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -55.55 -23.51 40.11 Favored 'Trans proline' 0 N--CA 1.5 1.86 0 C-N-CA 122.283 1.989 . . . . 0.0 112.595 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . 0.402 ' OG1' ' O3P' ' B' ' 238' ' ' TPO . 19.5 m -70.28 -45.29 66.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.657 0.742 . . . . 0.0 109.038 178.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.589 ' CE2' HG21 ' A' ' 43' ' ' VAL . 87.7 t80 -58.15 -43.94 87.62 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.585 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 1.041 HD23 HH21 ' B' ' 245' ' ' ARG . 75.8 mt -61.76 -41.96 98.37 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.767 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.44 -39.28 91.88 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.49 -179.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -60.02 -45.71 91.9 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.566 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 1.041 HH21 HD23 ' B' ' 242' ' ' LEU . 64.3 mtm180 -63.3 -38.22 90.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.468 -179.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.3 -39.08 91.79 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 120.101 -0.64 . . . . 0.0 109.652 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 18.0 m -63.98 -44.15 93.56 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . 0.446 ' O ' ' N ' ' B' ' 252' ' ' LEU . 84.6 mt-30 -60.23 -35.84 76.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.517 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 38.0 t -62.07 -46.44 96.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.572 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -60.19 -30.08 69.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.21 0.528 . . . . 0.0 109.594 179.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -91.76 -10.4 40.12 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.515 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.447 HD22 HH21 ' A' ' 12' ' ' ARG . 63.9 tp -75.54 144.11 42.09 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.06 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -98.06 130.12 44.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.377 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . 0.546 ' C ' ' H ' ' B' ' 256' ' ' ASP . 38.7 t70 -62.59 -32.59 73.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.892 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -58.6 3.01 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.733 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.546 ' H ' ' C ' ' B' ' 254' ' ' ASP . 62.2 t0 -121.59 104.21 9.47 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.754 0.311 . . . . 0.0 110.846 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . 0.591 ' O ' ' N ' ' B' ' 259' ' ' ASP . 99.8 mttt -66.64 -85.77 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.38 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.528 ' C ' ' O ' ' B' ' 257' ' ' LYS . 65.0 t0 -14.02 79.06 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 O-C-N 124.077 0.861 . . . . 0.0 111.494 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.591 ' N ' ' O ' ' B' ' 257' ' ' LYS . 42.8 t0 -91.03 79.43 5.82 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.567 -179.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.61 ' OE1' HD11 ' A' ' 41' ' ' LEU . 97.8 mt-10 56.05 2.44 0.08 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 178.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.452 ' CD1' HG23 ' A' ' 9' ' ' THR . 66.1 mt -114.57 134.8 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 41.2 t -127.57 136.2 61.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -95.5 117.24 30.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.171 0.51 . . . . 0.0 110.865 -178.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -63.65 -47.11 82.64 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.448 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . 0.749 HE21 HD11 ' A' ' 24' ' ' LEU . 4.2 mm100 -96.63 154.42 38.47 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.853 -178.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.29 147.65 59.93 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 123.015 2.477 . . . . 0.0 113.639 -178.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 29.9 pt . . . . . 0 C--N 1.33 -0.244 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.203 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo . . . . . 0 N--CA 1.497 1.683 0 N-CA-C 112.847 0.287 . . . . 0.0 112.847 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 69.6 p -125.89 -47.43 1.66 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.507 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.1 mtt85 -87.74 120.24 28.86 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.264 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -124.22 135.86 53.75 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.134 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.555 HD12 ' O ' ' A' ' 96' ' ' ARG . 33.2 tp -116.05 131.91 56.81 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.605 -0.438 . . . . 0.0 109.853 179.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 53.8 t -109.04 132.55 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.328 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 m -88.68 112.57 23.28 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.958 0.409 . . . . 0.0 112.043 -178.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.738 HD12 ' OG ' ' A' ' 94' ' ' SER . 79.4 mt -80.75 141.85 14.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -97.42 160.87 14.07 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.021 0.439 . . . . 0.0 109.852 178.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -59.69 -19.86 52.52 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.983 -179.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.5 t -78.71 -16.48 57.2 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.282 178.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.85 24.49 22.88 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.5 m -119.77 135.83 58.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -70.89 139.46 50.77 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.238 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -125.1 -121.99 2.59 Favored Glycine 0 CA--C 1.534 1.246 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.4 148.14 54.03 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 121.869 1.712 . . . . 0.0 112.888 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -108.34 143.85 36.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.29 0.567 . . . . 0.0 111.139 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.452 ' CD2' HD11 ' A' ' 37' ' ' ILE . 39.6 t80 -114.68 98.82 50.55 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.358 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.55 132.01 18.29 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 121.101 1.2 . . . . 0.0 111.359 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.418 HD22 ' HB2' ' A' ' 27' ' ' CYS . 80.2 mt -84.5 56.12 3.68 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.07 -178.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.423 ' OG ' ' NE2' ' B' ' 265' ' ' GLN . 79.8 p -64.48 -22.39 66.95 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.445 ' HG ' HE22 ' B' ' 265' ' ' GLN . 92.1 mt -84.96 141.91 30.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.545 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 45.3 t -61.8 -18.1 58.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.524 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.514 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 33.5 m -133.93 132.93 40.82 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.593 -0.443 . . . . 0.0 112.008 -179.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.418 ' HB2' HD22 ' A' ' 22' ' ' LEU . 4.5 t -122.09 114.59 21.11 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.47 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 53.8 tp -113.95 131.37 56.34 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.523 -178.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.684 ' CE2' HD12 ' A' ' 37' ' ' ILE . 12.5 m-85 -109.76 127.18 54.46 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.051 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 173.63 -173.6 45.86 Favored Glycine 0 N--CA 1.474 1.199 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.492 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.649 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 85.9 mtm-85 -86.29 -26.72 24.79 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.463 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.547 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -58.31 154.52 25.01 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.99 -178.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.514 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.5 tp -66.57 -41.81 88.97 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-O 120.746 0.308 . . . . 0.0 111.002 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.514 ' N ' HG23 ' A' ' 33' ' ' ILE . 83.1 tt0 -57.63 -20.27 32.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.776 -179.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.547 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 7.5 m -60.69 129.41 41.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.234 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.514 ' OD2' ' O ' ' A' ' 26' ' ' THR . 54.3 m-20 -61.93 -34.35 75.93 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.684 HD12 ' CE2' ' A' ' 29' ' ' PHE . 87.9 mt -126.3 121.39 58.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 178.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.437 ' NH1' HD12 ' A' ' 33' ' ' ILE . 83.5 mtp180 -103.53 134.28 47.15 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.631 -178.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 89.9 mt -117.34 129.72 73.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.074 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -78.47 39.35 0.33 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -177.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.547 HD12 ' NH2' ' A' ' 93' ' ' ARG . 75.9 mt -119.94 137.72 26.12 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.844 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -72.78 -11.93 26.15 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 122.608 2.206 . . . . 0.0 112.455 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.8 m -92.04 4.15 7.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.517 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.649 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 48.0 t -98.69 130.35 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.3 m -73.05 172.32 11.24 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.747 0.784 . . . . 0.0 112.642 -178.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -64.63 -40.32 95.26 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.091 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.649 ' O ' ' N ' ' A' ' 49' ' ' CYS . 84.0 mm-40 -114.12 -19.25 11.43 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.921 0.391 . . . . 0.0 110.345 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.7 t60 31.37 -77.41 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.649 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -128.05 133.25 49.06 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.605 -178.931 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -129.2 128.84 44.15 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.401 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 85.9 mt -114.04 133.15 60.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.416 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -113.53 125.07 53.79 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.9 mm -93.99 123.98 46.29 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 121.602 0.715 . . . . 0.0 112.088 -178.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.425 ' O ' ' C ' ' A' ' 55' ' ' GLU . 96.5 m-70 -124.75 131.03 53.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.386 178.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 54' ' ' HIS . 47.9 tp10 -42.73 -32.2 0.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -64.12 -67.57 0.42 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.213 -0.903 . . . . 0.0 108.914 178.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.545 ' OE2' ' CD ' ' A' ' 81' ' ' ARG . 0.2 OUTLIER -152.3 -175.36 5.23 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.639 179.808 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.55 129.04 56.63 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.704 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.4 mt -116.77 131.55 69.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -178.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.506 ' HB2' HD21 ' A' ' 82' ' ' LEU . 50.1 tp -94.38 125.69 39.18 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.322 178.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -110.33 132.52 54.1 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.11 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.427 ' ND2' ' O ' ' A' ' 76' ' ' ILE . 41.5 t30 -94.05 106.23 18.21 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.25 0.548 . . . . 0.0 111.705 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -100.57 -9.45 21.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.397 179.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.0 t -76.75 98.18 4.71 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 120.036 -0.666 . . . . 0.0 109.831 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.4 p -74.99 -32.82 61.75 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.377 178.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.924 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.2 OUTLIER -74.28 -43.24 57.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.461 -179.085 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.496 ' OD1' HG13 ' B' ' 236' ' ' VAL . 71.9 m-20 -140.57 97.77 7.34 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -55.51 145.01 71.39 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.295 1.997 . . . . 0.0 112.532 -178.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 13.2 m -71.79 137.15 47.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.157 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -101.02 140.73 34.91 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.666 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.7 p -135.17 136.08 51.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 50.11 30.93 4.52 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.96 28.86 65.88 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.972 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.4 m -135.3 124.55 24.6 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.826 -179.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.6 m -71.87 140.75 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.427 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 46.2 pt -121.0 141.88 39.56 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-O 121.203 0.525 . . . . 0.0 111.281 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 21.5 p-10 -104.29 -14.32 15.84 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 178.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -128.66 166.77 22.36 Favored Pre-proline 0 CA--C 1.528 0.098 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.148 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -64.12 146.88 91.35 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 122.673 2.249 . . . . 0.0 112.772 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.7 t -133.95 140.47 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.837 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.545 ' CD ' ' OE2' ' A' ' 57' ' ' GLU . 88.6 mtm180 -71.95 128.99 37.49 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.659 -0.417 . . . . 0.0 110.952 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.506 HD21 ' HB2' ' A' ' 60' ' ' LEU . 92.8 mt -84.37 131.23 34.72 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.341 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -124.53 153.2 42.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.702 178.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.401 ' ND1' ' N ' ' A' ' 99' ' ' ASN . 12.4 t60 -56.94 122.52 12.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.956 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.22 -19.96 33.74 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.05 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -66.27 139.26 58.06 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.501 HG22 ' HG2' ' A' ' 96' ' ' ARG . 77.1 t -112.03 129.99 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.326 -178.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.2 mt -95.66 131.21 43.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 42.3 m -120.69 124.53 45.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.494 0.664 . . . . 0.0 111.82 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.447 HG22 HG12 ' A' ' 91' ' ' ILE . 86.0 mt -119.57 121.06 65.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.173 179.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.484 HG22 ' N ' ' A' ' 92' ' ' ASP . 36.0 mm 52.45 -112.51 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -178.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.484 ' N ' HG22 ' A' ' 91' ' ' ILE . 56.6 t0 -116.25 24.25 11.53 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.337 0.589 . . . . 0.0 110.371 179.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.547 ' NH2' HD12 ' A' ' 41' ' ' LEU . 47.5 mtm-85 -131.26 146.72 52.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.224 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.738 ' OG ' HD12 ' A' ' 10' ' ' ILE . 23.3 p -140.65 158.58 43.78 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.318 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.544 ' HB3' HD11 ' A' ' 7' ' ' LEU . 73.0 m-85 -126.37 124.24 39.78 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.238 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.555 ' O ' HD12 ' A' ' 7' ' ' LEU . 79.8 mtp85 -85.14 127.68 34.35 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 121.075 0.464 . . . . 0.0 111.053 -179.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -96.09 125.64 40.77 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.885 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -130.5 122.38 27.53 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.428 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.401 ' N ' ' ND1' ' A' ' 84' ' ' HIS . 49.2 t-20 -111.05 90.62 3.38 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.967 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.401 ' OE2' ' CE1' ' A' ' 84' ' ' HIS . 96.0 mt-10 . . . . . 0 C--N 1.331 -0.213 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.777 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . 0.435 ' O ' ' N ' ' B' ' 230' ' ' SEP . 33.5 m . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' B' ' 228' ' ' VAL . 93.7 m-20 36.66 -96.85 0.02 OUTLIER 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.583 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . 0.435 ' N ' ' O ' ' B' ' 228' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -136.05 66.14 1.51 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.754 -178.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -132.51 -177.88 15.19 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.108 -0.567 . . . . 0.0 112.136 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.77 160.86 48.06 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 123.62 2.88 . . . . 0.0 112.982 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.924 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.39 142.93 37.95 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 121.284 1.323 . . . . 0.0 112.263 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.496 HG13 ' OD1' ' A' ' 67' ' ' ASN . 76.3 t -59.09 139.85 18.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.215 -179.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . 0.603 ' SG ' ' CD1' ' B' ' 241' ' ' PHE . 4.9 t -72.36 133.32 44.88 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . 0.472 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . 0.472 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 32.7 Cg_exo -60.67 -25.0 80.03 Favored 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 123.119 2.546 . . . . 0.0 113.222 -179.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 98.7 m -73.27 -45.72 54.05 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.631 0.729 . . . . 0.0 109.541 178.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.603 ' CD1' ' SG ' ' B' ' 237' ' ' CYS . 54.4 t80 -57.31 -45.63 84.02 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.102 -178.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' B' ' 242' ' ' LEU . 89.0 mt -65.24 -42.23 93.53 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -61.67 -38.75 88.93 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.404 -0.519 . . . . 0.0 110.357 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . 0.534 ' O ' ' OG ' ' B' ' 247' ' ' SER . 82.7 mtp180 -64.12 -40.72 96.79 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.544 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.449 ' NH2' ' CD2' ' A' ' 41' ' ' LEU . 22.0 mmt180 -64.73 -41.4 95.98 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.382 -179.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.46 -38.05 88.27 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . 0.534 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 77.8 p -67.46 -42.78 82.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.441 179.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . 0.482 ' O ' ' N ' ' B' ' 252' ' ' LEU . 86.7 mt-30 -61.56 -36.2 79.95 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.838 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 34.9 t -65.76 -43.72 93.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -58.61 -29.85 66.8 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.155 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -105.8 -5.11 20.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.543 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' B' ' 248' ' ' GLN . 51.5 tp -111.03 115.65 29.82 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.047 0.451 . . . . 0.0 110.142 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . 0.403 HD22 ' HA ' ' B' ' 253' ' ' ASN . 8.9 m120 -52.54 155.53 2.14 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.495 -178.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -74.55 -8.66 57.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.396 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . 0.409 ' OD1' ' C ' ' B' ' 255' ' ' ASP . 47.1 p-10 -86.66 1.54 51.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.328 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.481 ' CG ' ' O ' ' B' ' 256' ' ' ASP . 18.7 p-10 -69.78 91.81 0.65 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.375 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -70.85 162.54 29.06 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 58.79 71.72 0.57 Allowed 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -178.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.466 ' OD1' ' OE1' ' B' ' 260' ' ' GLU . 37.1 t0 -87.86 77.09 8.6 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.43 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.503 ' N ' ' OE1' ' B' ' 260' ' ' GLU . 44.5 mp0 57.52 6.03 0.37 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 178.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 74.5 mt -118.62 133.67 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 75.5 t -129.25 137.19 57.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.987 0.423 . . . . 0.0 110.884 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -97.31 119.56 36.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.595 -178.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -67.87 -45.89 73.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.364 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . 0.445 HE22 ' HG ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -92.57 156.17 41.47 Favored Pre-proline 0 C--N 1.332 -0.16 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.049 -179.006 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -63.65 148.28 92.32 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.995 2.464 . . . . 0.0 112.17 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 33.9 pt . . . . . 0 C--N 1.326 -0.439 0 CA-C-O 121.416 0.627 . . . . 0.0 111.185 -179.535 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo . . . . . 0 N--CA 1.497 1.7 0 CA-C-O 121.179 0.408 . . . . 0.0 112.986 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 63.3 p -104.19 -48.43 3.87 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.308 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 86.0 mtt85 -97.43 132.42 43.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.219 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -134.37 145.31 48.85 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.844 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.479 HD11 HD11 ' A' ' 22' ' ' LEU . 87.5 mt -114.07 142.95 45.55 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.049 179.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.584 HG22 ' CD2' ' A' ' 19' ' ' HIS . 42.9 t -115.82 129.9 71.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 m -90.74 119.32 30.87 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.485 0.66 . . . . 0.0 112.776 -177.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.1 mm -81.33 135.48 24.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.496 178.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.425 ' HB2' ' H ' ' A' ' 15' ' ' VAL . 95.7 mttt -85.86 156.3 20.6 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.792 179.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.427 ' NE ' ' HD2' ' B' ' 245' ' ' ARG . 83.7 mtp180 -58.36 -34.61 70.85 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.3 p -70.25 -18.88 63.15 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.202 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.65 34.38 5.78 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.425 ' H ' ' HB2' ' A' ' 11' ' ' LYS . 43.0 t -121.15 133.09 68.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 114.992 -0.604 . . . . 0.0 110.922 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -73.26 136.38 44.59 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -135.52 -114.56 1.4 Allowed Glycine 0 CA--C 1.534 1.276 0 C-N-CA 119.752 -1.213 . . . . 0.0 112.827 -179.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.67 144.09 43.5 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.33 2.02 . . . . 0.0 113.653 -177.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.584 ' CD2' HG22 ' A' ' 8' ' ' VAL . 63.8 m170 -107.9 137.94 45.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.678 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.494 ' CD2' HD11 ' A' ' 37' ' ' ILE . 26.1 t80 -106.12 96.51 13.32 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.6 134.59 22.51 Favored 'Trans proline' 0 C--N 1.315 -1.231 0 C-N-CA 121.283 1.322 . . . . 0.0 110.745 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.479 HD11 HD11 ' A' ' 7' ' ' LEU . 95.9 mt -86.06 74.16 10.14 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.663 -178.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.1 p -79.6 -10.24 59.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.41 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.1 mt -105.86 148.0 28.06 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.108 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.2 t -68.22 -16.16 63.86 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.5 m -134.41 136.97 43.69 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.419 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.664 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 4.1 t -131.69 124.47 29.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.923 178.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.479 HD21 ' OE1' ' A' ' 47' ' ' GLN . 47.7 tp -118.38 129.61 55.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.532 -178.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.744 ' CE2' HD12 ' A' ' 37' ' ' ILE . 6.8 m-85 -106.06 134.72 48.74 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.422 179.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 156.5 -177.91 33.24 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 120.451 -0.88 . . . . 0.0 112.322 179.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 45.5 mtm105 -75.1 -32.44 61.42 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.48 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -50.34 150.85 5.25 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.778 -178.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.534 HG23 ' N ' ' A' ' 34' ' ' GLU . 9.8 tp -66.11 -41.66 89.9 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-O 121.021 0.439 . . . . 0.0 110.1 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.534 ' N ' HG23 ' A' ' 33' ' ' ILE . 97.7 mt-10 -56.07 -24.3 39.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.806 -179.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.48 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 32.0 m -55.8 117.2 3.44 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.685 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -57.37 -29.15 63.8 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.744 HD12 ' CE2' ' A' ' 29' ' ' PHE . 98.7 mt -125.64 118.66 52.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.417 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 84.1 mtp180 -104.06 136.73 43.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.689 -178.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.522 HD13 ' NH1' ' A' ' 93' ' ' ARG . 97.6 mt -118.08 129.82 73.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 121.29 0.567 . . . . 0.0 110.771 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -74.96 35.19 0.1 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 114.975 -1.011 . . . . 0.0 113.092 -177.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.685 ' CD1' ' HE ' ' A' ' 93' ' ' ARG . 28.3 mt -118.94 130.93 24.56 Favored Pre-proline 0 C--N 1.323 -0.561 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.457 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.476 ' O ' ' HD2' ' B' ' 235' ' ' PRO . 44.2 Cg_endo -67.84 -18.97 47.23 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.379 2.052 . . . . 0.0 113.454 -179.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 241' ' ' PHE . 34.2 m -83.87 -0.08 5.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.836 -0.345 . . . . 0.0 110.896 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 56.8 t -88.08 133.0 31.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.926 0.393 . . . . 0.0 110.124 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.9 m -67.89 162.49 24.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.426 0.631 . . . . 0.0 111.325 -179.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -60.88 -41.53 96.19 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.591 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.629 ' O ' ' N ' ' A' ' 49' ' ' CYS . 97.9 mm-40 -115.33 -25.32 8.04 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.436 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.8 t60 36.54 -76.07 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.629 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.53 134.04 46.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.37 0.605 . . . . 0.0 112.177 -178.091 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -126.8 131.62 51.22 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.196 179.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 91.6 mt -115.41 133.32 62.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.507 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -119.34 126.55 51.7 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 89.1 mt -106.38 118.18 53.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.555 0.693 . . . . 0.0 111.83 -179.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.453 ' O ' ' N ' ' A' ' 56' ' ' GLN . 86.5 m-70 -113.86 142.66 45.82 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.331 179.366 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 54' ' ' HIS . 80.0 mm-40 -40.21 -29.46 0.08 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.453 ' N ' ' O ' ' A' ' 54' ' ' HIS . 88.5 mt-30 -63.7 -66.98 0.47 Allowed 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.439 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 5.5 tp10 -158.36 -163.32 1.26 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.138 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.454 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -112.8 129.16 56.53 Favored 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.1 mt -119.29 128.88 75.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.385 0.612 . . . . 0.0 112.145 -178.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.4 tp -97.79 126.58 43.22 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.054 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -110.97 136.36 50.09 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.843 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -97.33 104.44 16.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.575 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -99.07 -10.06 23.07 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.891 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.52 99.03 3.48 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.248 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.7 m -73.55 -39.82 64.44 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.377 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.825 HG22 HG22 ' B' ' 236' ' ' VAL . 0.2 OUTLIER -63.66 -47.46 81.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.818 -178.707 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.505 ' OD1' HG13 ' B' ' 236' ' ' VAL . 2.2 m-20 -142.9 99.03 5.6 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.653 ' HB2' HG13 ' A' ' 75' ' ' VAL . 51.7 Cg_exo -53.38 148.35 33.66 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.361 2.04 . . . . 0.0 113.26 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.5 m -69.32 139.54 54.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.862 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -100.33 141.93 32.5 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.431 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.495 ' CG2' ' OD1' ' A' ' 86' ' ' ASP . 8.5 p -130.79 135.17 60.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 44.99 33.71 1.09 Allowed 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.082 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.05 29.28 62.93 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.837 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.485 ' N ' ' O ' ' A' ' 71' ' ' VAL . 15.8 m -140.65 139.43 34.82 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 120.576 -0.449 . . . . 0.0 111.239 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.653 HG13 ' HB2' ' A' ' 68' ' ' PRO . 29.2 t -72.59 137.93 22.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.243 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.0 pt -109.38 91.99 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.707 178.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -65.41 -30.29 71.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.56 179.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -122.86 168.7 11.37 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.458 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -60.71 148.87 90.3 Favored 'Trans proline' 0 N--CA 1.501 1.917 0 C-N-CA 122.41 2.073 . . . . 0.0 112.26 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.6 p -142.72 142.89 26.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.42 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.7 mtm180 -75.58 131.43 39.99 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.454 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 93.0 mt -78.42 140.33 38.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.128 0.49 . . . . 0.0 111.471 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -128.4 148.13 50.69 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.534 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -55.36 117.21 3.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.213 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.07 -8.71 31.38 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.495 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 60.6 t0 -73.7 128.18 34.81 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.73 0.3 . . . . 0.0 110.441 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.457 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 48.3 t -109.9 132.64 57.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.463 -178.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.8 mt -105.37 134.01 48.06 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 97.6 m -121.53 126.65 49.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.33 0.586 . . . . 0.0 111.898 -178.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.412 ' CG2' HH12 ' A' ' 93' ' ' ARG . 97.8 mt -115.71 124.81 72.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 177.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.4 mm 40.81 -101.66 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 -178.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -118.39 23.56 11.47 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.096 0.475 . . . . 0.0 110.615 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.685 ' HE ' ' CD1' ' A' ' 41' ' ' LEU . 7.9 mtm105 -128.2 146.5 50.71 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.095 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.1 t -137.06 147.16 45.96 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.469 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -120.13 121.0 37.83 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -84.87 135.07 34.24 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.344 -178.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -95.16 120.36 35.25 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.524 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -122.26 123.8 42.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.319 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 62.5 t-20 -105.88 115.71 30.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.832 0.348 . . . . 0.0 110.576 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.029 -179.621 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 53.6 t . . . . . 0 C--O 1.231 0.093 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.458 ' O ' ' CB ' ' B' ' 230' ' ' SEP . 53.0 p30 -108.47 176.48 5.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.234 179.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . 0.63 ' O ' ' NE2' ' B' ' 231' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.63 ' NE2' ' O ' ' B' ' 230' ' ' SEP . 99.8 mm-40 -149.64 68.76 1.02 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 121.114 -0.234 . . . . 0.0 110.914 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -118.14 177.88 16.66 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.517 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -66.04 151.87 82.77 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 123.228 2.618 . . . . 0.0 112.194 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.45 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . 0.476 ' HD2' ' O ' ' A' ' 42' ' ' PRO . 31.3 Cg_exo -57.96 137.05 78.94 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 121.84 1.694 . . . . 0.0 112.726 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.825 HG22 HG22 ' A' ' 66' ' ' THR . 25.5 t -68.56 133.66 31.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 114.572 -1.195 . . . . 0.0 109.406 179.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -59.71 118.79 6.55 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.218 -0.593 . . . . 0.0 110.199 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . 0.404 HG23 ' O ' ' B' ' 236' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -59.49 -20.38 56.55 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.543 2.162 . . . . 0.0 111.76 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 21.4 m -74.21 -46.2 43.35 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.79 177.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.442 ' CE2' HG21 ' A' ' 43' ' ' VAL . 70.9 t80 -57.84 -44.87 86.77 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.276 -179.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 79.2 mt -63.76 -39.76 95.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.406 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -60.34 -42.42 95.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.317 -0.401 . . . . 0.0 109.96 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -65.67 -39.47 91.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.203 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.427 ' HD2' ' NE ' ' A' ' 12' ' ' ARG . 3.1 tpp85 -57.5 -43.69 84.38 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -64.4 -41.52 96.6 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 68.1 m -60.93 -45.51 94.39 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . 0.423 ' OE1' ' NH2' ' A' ' 12' ' ' ARG . 86.3 mt-30 -62.53 -34.21 76.45 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.339 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 19.0 t -60.25 -45.74 95.77 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 C-N-CA 120.409 -0.516 . . . . 0.0 109.92 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -62.31 -35.0 77.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.284 0.564 . . . . 0.0 109.899 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -79.56 -16.27 56.22 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.725 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 87.1 mt -122.29 111.58 17.09 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.547 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . 0.421 ' O ' ' CG ' ' B' ' 253' ' ' ASN . 13.9 t-20 -175.57 29.26 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 120.499 -0.48 . . . . 0.0 111.684 179.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . 0.543 ' O ' ' CB ' ' B' ' 255' ' ' ASP . 80.6 m-20 -97.0 -2.65 43.04 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.044 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . 0.543 ' CB ' ' O ' ' B' ' 254' ' ' ASP . 4.8 p-10 105.08 59.35 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 O-C-N 124.271 0.982 . . . . 0.0 109.88 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.567 ' O ' ' CB ' ' B' ' 257' ' ' LYS . 96.3 m-20 -73.6 -70.99 0.34 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.8 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . 0.567 ' CB ' ' O ' ' B' ' 256' ' ' ASP . 70.9 tttt 96.72 167.22 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.334 -178.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.608 ' O ' ' N ' ' B' ' 260' ' ' GLU . 74.0 m-20 56.61 38.12 29.34 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -177.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -49.96 77.22 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.536 -1.211 . . . . 0.0 111.43 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.608 ' N ' ' O ' ' B' ' 258' ' ' ASP . 56.0 mm-40 54.92 5.23 0.09 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.085 -0.961 . . . . 0.0 112.788 178.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 59.3 mt -116.35 132.19 66.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 42.9 t -125.3 134.42 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.094 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -95.54 118.01 31.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.296 0.569 . . . . 0.0 111.038 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -65.02 -44.24 89.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.463 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -100.84 157.83 32.96 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.039 -178.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.23 153.47 69.7 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.777 2.318 . . . . 0.0 111.883 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 41.9 pt . . . . . 0 C--N 1.328 -0.355 0 CA-C-O 121.65 0.738 . . . . 0.0 111.995 -178.877 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo . . . . . 0 N--CA 1.493 1.456 0 N-CA-C 110.884 -0.468 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.789 HG23 ' O ' ' A' ' 100' ' ' GLU . 19.2 m -62.04 -43.39 98.93 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.14 -178.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.595 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 95.2 mtt-85 -97.76 112.31 24.26 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.556 -179.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 60.7 ttp180 -124.73 131.5 53.45 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.862 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.659 HD11 ' HB3' ' A' ' 95' ' ' PHE . 43.8 tp -109.32 132.63 53.94 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 37.1 t -109.81 131.41 60.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.809 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.473 ' CG2' HD12 ' B' ' 261' ' ' ILE . 18.6 m -91.45 113.49 25.77 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -177.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.63 HD12 ' OG ' ' A' ' 94' ' ' SER . 97.0 mt -81.91 143.59 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.648 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -89.79 158.42 17.51 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.039 0.447 . . . . 0.0 110.97 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.519 ' NH2' ' CD2' ' B' ' 252' ' ' LEU . 89.0 mtm180 -57.28 -32.21 66.39 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.994 -178.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.4 p -79.76 -7.9 58.92 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.419 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.82 40.29 4.99 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.2 t -122.59 131.16 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 O-C-N 122.753 -0.263 . . . . 0.0 111.446 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -73.59 134.29 43.7 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -126.97 -123.52 2.65 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.036 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -74.37 153.16 44.94 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 122.362 2.042 . . . . 0.0 112.167 -178.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.571 ' O ' ' CG2' ' B' ' 267' ' ' ILE . 0.2 OUTLIER -108.16 159.88 16.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.971 0.415 . . . . 0.0 110.842 -179.516 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.602 ' CD2' HD11 ' A' ' 37' ' ' ILE . 43.8 t80 -128.38 92.3 41.55 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.64 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.23 125.55 18.84 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.026 1.817 . . . . 0.0 111.292 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.484 HD22 ' SG ' ' A' ' 27' ' ' CYS . 93.1 mt -87.92 42.25 1.04 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.896 0.379 . . . . 0.0 111.404 -178.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.7 t -59.37 -23.35 62.49 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.678 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.0 mt -76.62 143.9 39.87 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 82.2 p -66.66 -20.31 65.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.676 -178.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.512 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 93.8 m -128.74 128.96 45.06 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.379 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.484 ' SG ' HD22 ' A' ' 22' ' ' LEU . 6.5 t -121.94 112.57 18.46 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.666 HD21 ' OE1' ' A' ' 47' ' ' GLN . 52.6 tp -113.47 126.07 54.92 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.233 -177.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.712 ' CE2' HD12 ' A' ' 37' ' ' ILE . 6.6 m-85 -106.44 136.66 45.8 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.454 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 160.37 -173.11 36.91 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.284 -0.96 . . . . 0.0 112.421 178.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.571 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 39.3 mtm180 -79.38 -29.21 41.99 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.575 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -61.89 151.03 45.09 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.523 -177.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 78.2 mt -64.87 -42.92 96.15 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.337 0 CA-C-N 115.564 -0.318 . . . . 0.0 110.916 179.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -52.64 -26.03 12.49 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 119.657 -0.817 . . . . 0.0 108.893 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.575 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 11.4 m -57.81 118.74 5.63 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.295 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.512 ' OD2' ' O ' ' A' ' 26' ' ' THR . 98.5 m-20 -56.09 -24.07 37.9 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.712 HD12 ' CE2' ' A' ' 29' ' ' PHE . 96.9 mt -131.66 122.75 50.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.838 178.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.4 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 32.2 mtm180 -107.71 140.47 40.71 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.016 0.436 . . . . 0.0 111.5 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 78.0 mt -121.04 128.79 76.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -70.57 32.3 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -177.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.568 ' CD1' ' CZ ' ' A' ' 93' ' ' ARG . 64.7 mt -110.79 133.68 21.15 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.956 -179.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.7 -8.92 24.07 Favored 'Trans proline' 0 N--CA 1.501 1.959 0 C-N-CA 123.478 2.785 . . . . 0.0 113.863 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.6 m -101.13 2.65 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.032 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.571 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 18.4 t -89.54 100.98 11.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.649 -179.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.521 ' O ' ' O ' ' A' ' 44' ' ' VAL . 3.6 t -34.99 164.29 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.936 -179.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -63.59 -43.55 96.61 Favored 'General case' 0 C--O 1.238 0.447 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.776 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.666 ' OE1' HD21 ' A' ' 28' ' ' LEU . 94.5 mm-40 -111.21 -23.51 10.81 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.007 0.432 . . . . 0.0 110.421 -179.285 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.457 ' NE2' HG23 ' A' ' 90' ' ' ILE . 16.5 t60 41.29 -78.3 0.0 OUTLIER 'General case' 0 C--O 1.24 0.576 0 CA-C-N 115.421 -0.808 . . . . 0.0 112.679 179.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.609 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.45 136.93 48.37 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.914 -178.861 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -129.81 129.51 44.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.181 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 89.0 mt -114.61 138.41 44.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.313 -179.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -118.0 122.51 43.4 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 89.3 mt -103.47 114.09 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 C-N-CA 120.104 -0.639 . . . . 0.0 111.285 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.5 ' O ' ' N ' ' A' ' 56' ' ' GLN . 96.6 m-70 -111.41 139.9 46.44 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.828 179.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 54' ' ' HIS . 81.2 tt0 -39.56 -28.43 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.5 ' N ' ' O ' ' A' ' 54' ' ' HIS . 99.6 mm-40 -64.19 -68.14 0.38 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.164 178.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -157.98 -168.02 2.39 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.865 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.561 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -112.54 128.4 56.34 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.24 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 87.6 mt -118.64 129.89 74.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 121.175 0.512 . . . . 0.0 111.963 -178.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 25.1 tp -96.31 128.38 43.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.671 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -113.13 138.57 49.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.295 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.603 HD21 ' CB ' ' A' ' 68' ' ' PRO . 61.1 t-20 -99.8 107.01 18.95 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -98.68 -8.03 26.86 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.803 0.335 . . . . 0.0 110.444 179.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.05 100.68 12.33 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.781 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.6 p -88.31 -30.34 19.67 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.215 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.636 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.2 OUTLIER -63.7 -46.37 85.78 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.317 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -142.49 101.89 5.55 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 115.174 -0.921 . . . . 0.0 108.693 178.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.603 ' CB ' HD21 ' A' ' 62' ' ' ASN . 60.0 Cg_endo -69.44 152.25 70.97 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.097 1.865 . . . . 0.0 114.032 -177.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.961 ' O ' HG22 ' A' ' 76' ' ' ILE . 11.4 m -70.94 145.57 50.03 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.286 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -106.82 143.61 34.66 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.7 179.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.505 ' CG2' ' OD1' ' A' ' 86' ' ' ASP . 6.3 p -131.67 136.26 57.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 48.5 32.27 3.29 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.85 27.52 68.77 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.341 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 71' ' ' VAL . 31.3 m -137.67 133.2 33.98 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.322 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 54.7 t -60.97 136.52 24.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.858 0.361 . . . . 0.0 110.57 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.961 HG22 ' O ' ' A' ' 69' ' ' THR . 14.0 tt -103.1 89.73 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.892 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -63.43 -35.84 81.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.746 179.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.505 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 0.8 OUTLIER -128.69 167.52 19.05 Favored Pre-proline 0 N--CA 1.464 0.233 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.372 -179.214 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -56.74 141.78 91.93 Favored 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 122.27 1.98 . . . . 0.0 112.674 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 73.0 t -131.72 137.8 54.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.617 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 83.1 mtt85 -70.24 129.16 38.61 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 97.0 mt -82.53 137.12 34.7 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.456 -0.497 . . . . 0.0 111.394 -178.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -129.29 152.73 48.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.107 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.53 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 7.2 t60 -54.19 118.34 3.99 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.734 0.302 . . . . 0.0 110.428 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.73 -13.15 24.95 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.505 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 59.8 t0 -71.43 128.41 35.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.845 0.355 . . . . 0.0 110.464 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.405 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 69.3 t -110.83 129.05 66.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.674 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 93.8 mt -97.28 132.58 41.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 94.0 m -122.8 127.74 49.51 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 120.026 -0.67 . . . . 0.0 112.553 -178.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.525 HG22 HG12 ' A' ' 91' ' ' ILE . 82.2 mt -120.31 125.37 74.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 114.944 -1.026 . . . . 0.0 108.26 178.245 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.525 HG12 HG22 ' A' ' 90' ' ' ILE . 25.1 mm 43.22 -116.33 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -178.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.419 ' HB2' ' HE ' ' B' ' 245' ' ' ARG . 94.3 m-20 -102.74 14.47 31.87 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.854 0.359 . . . . 0.0 110.849 178.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.819 HH11 ' NH2' ' B' ' 245' ' ' ARG . 37.2 mtm-85 -123.37 145.13 49.0 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.427 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.63 ' OG ' HD12 ' A' ' 10' ' ' ILE . 38.3 p -140.99 151.86 44.46 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 120.687 -0.405 . . . . 0.0 109.927 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.659 ' HB3' HD11 ' A' ' 7' ' ' LEU . 82.7 m-85 -120.07 121.65 39.34 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.51 ' O ' HD12 ' A' ' 7' ' ' LEU . 79.6 mtp85 -81.56 130.3 35.0 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.471 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.595 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 86.7 t80 -96.62 123.05 40.17 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.198 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -127.41 131.62 50.26 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.007 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.543 ' OD1' HG22 ' A' ' 4' ' ' THR . 64.9 t-20 -126.46 121.21 31.75 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.412 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.789 ' O ' HG23 ' A' ' 4' ' ' THR . 86.5 mt-10 . . . . . 0 C--N 1.323 -0.568 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.655 178.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . 0.464 HG23 ' N ' ' B' ' 229' ' ' ASP . 26.1 m . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.643 0.258 . . . . 0.0 110.801 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.464 ' N ' HG23 ' B' ' 228' ' ' VAL . 52.2 p-10 -85.56 171.18 11.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.698 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . 0.551 ' OG ' ' N ' ' B' ' 231' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.551 ' N ' ' OG ' ' B' ' 230' ' ' SEP . 25.4 mp0 -148.65 65.49 1.06 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.884 0.373 . . . . 0.0 110.864 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . 0.468 ' C ' HH12 ' A' ' 31' ' ' ARG . . . -111.21 177.3 19.04 Favored Glycine 0 CA--C 1.532 1.1 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 -179.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.06 160.41 50.03 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 123.163 2.576 . . . . 0.0 112.705 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.636 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.9 141.72 30.55 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 122.211 1.941 . . . . 0.0 112.17 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.594 ' CG2' HG22 ' A' ' 66' ' ' THR . 41.1 t -70.13 133.02 32.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.441 -178.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 4.8 t -72.19 134.79 45.87 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.751 179.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -58.67 -25.59 75.93 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 123.143 2.562 . . . . 0.0 113.419 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 96.6 m -74.03 -44.65 53.65 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.307 -0.557 . . . . 0.0 109.579 178.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.414 ' HZ ' HD22 ' A' ' 41' ' ' LEU . 82.4 t80 -59.71 -46.54 88.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.263 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.425 ' HA ' HD23 ' B' ' 242' ' ' LEU . 88.3 mt -63.87 -42.36 97.54 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.092 0.472 . . . . 0.0 110.569 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -61.81 -38.89 89.81 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.255 -179.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . 0.469 ' HE ' HE21 ' B' ' 248' ' ' GLN . 76.6 ttt180 -62.36 -44.75 95.74 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.4 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.819 ' NH2' HH11 ' A' ' 93' ' ' ARG . 72.6 mtp85 -61.18 -39.7 91.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.894 -179.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -63.67 -41.74 98.14 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 120.375 -0.53 . . . . 0.0 109.683 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 62.6 m -66.17 -45.36 81.17 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . 0.674 ' O ' HD13 ' B' ' 252' ' ' LEU . 85.6 mt-30 -58.03 -39.3 78.04 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.879 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.436 HG23 ' O ' ' B' ' 245' ' ' ARG . 54.7 t -64.05 -45.32 96.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.633 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -65.73 -28.9 69.39 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.795 0.331 . . . . 0.0 110.772 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -89.29 -11.06 44.58 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.132 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.715 HD23 ' CB ' ' B' ' 256' ' ' ASP . 3.0 mp -88.11 173.26 8.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.983 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . 0.554 ' O ' ' N ' ' B' ' 255' ' ' ASP . 39.7 m-80 -153.35 -174.13 4.83 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.14 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -44.01 -14.29 0.02 OUTLIER 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.929 0.395 . . . . 0.0 111.164 -178.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' B' ' 253' ' ' ASN . 25.5 p-10 -76.29 -5.76 48.46 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.747 179.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.715 ' CB ' HD23 ' B' ' 252' ' ' LEU . 42.0 p-10 -103.75 13.09 33.78 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 120.739 0.304 . . . . 0.0 110.185 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -66.45 -11.67 53.21 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.112 178.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.494 ' O ' ' OD2' ' B' ' 259' ' ' ASP . 34.6 t70 -58.51 -44.85 89.62 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' B' ' 261' ' ' ILE . 0.0 OUTLIER 80.73 116.58 0.06 Allowed 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.99 179.501 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -63.44 10.71 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.107 -178.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.538 ' N ' ' OD1' ' B' ' 259' ' ' ASP . 74.6 mt -103.22 136.64 34.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 72.0 t -125.96 135.76 62.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.45 0.643 . . . . 0.0 111.359 -178.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -97.46 116.55 29.88 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.781 -178.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -67.58 -39.6 84.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.505 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.56 159.46 32.57 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.344 -178.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . 0.414 ' C ' HD13 ' B' ' 267' ' ' ILE . 37.9 Cg_endo -61.2 147.61 95.15 Favored 'Trans proline' 0 C--N 1.302 -1.891 0 C-N-CA 122.27 1.98 . . . . 0.0 111.925 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . 0.571 ' CG2' ' O ' ' A' ' 19' ' ' HIS . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.904 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo . . . . . 0 N--CA 1.493 1.48 0 CA-C-O 120.82 0.258 . . . . 0.0 112.375 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.627 HG22 ' OD1' ' A' ' 99' ' ' ASN . 16.6 m -62.16 -44.87 95.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.1 -179.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.65 ' NE ' HD13 ' A' ' 53' ' ' ILE . 91.5 mtm-85 -95.91 117.46 30.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.012 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -128.31 134.92 49.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.864 0.364 . . . . 0.0 110.251 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.633 HD12 ' O ' ' A' ' 96' ' ' ARG . 24.2 tp -113.87 132.85 55.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.989 -179.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.652 HG22 ' CD2' ' A' ' 19' ' ' HIS . 51.5 t -108.49 130.86 60.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.424 HG23 ' CD1' ' B' ' 261' ' ' ILE . 2.7 m -90.79 121.34 32.58 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.356 0.598 . . . . 0.0 112.124 -178.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 98.2 mt -89.18 141.06 14.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.23 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -91.03 162.87 14.52 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.711 HH22 ' NE2' ' B' ' 248' ' ' GLN . 87.4 mtm180 -55.83 -27.56 52.04 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.075 -178.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 92.6 p -84.87 -6.26 59.34 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.791 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.51 42.17 7.49 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.436 -1.065 . . . . 0.0 110.436 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.2 t -118.57 132.99 66.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.797 0.332 . . . . 0.0 110.996 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.545 ' CG ' ' HE2' ' A' ' 19' ' ' HIS . 63.9 t0 -74.17 120.24 19.47 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.872 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -117.37 -120.76 3.12 Favored Glycine 0 CA--C 1.539 1.582 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.748 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -74.34 147.45 37.07 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 122.413 2.075 . . . . 0.0 112.703 -179.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.652 ' CD2' HG22 ' A' ' 8' ' ' VAL . 65.2 m170 -109.66 143.87 38.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.083 0.468 . . . . 0.0 110.818 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.731 ' CD2' HD11 ' A' ' 37' ' ' ILE . 30.1 t80 -112.28 104.14 55.81 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.71 -178.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -74.02 128.18 12.06 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 121.34 1.36 . . . . 0.0 111.106 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.3 mt -85.07 47.32 1.39 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.811 -177.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 97.2 p -59.07 -28.44 66.47 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.3 mt -74.29 141.78 45.26 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.8 m -70.95 -16.29 62.64 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.972 -0.291 . . . . 0.0 111.724 -178.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.9 m -134.07 135.88 43.58 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.97 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.676 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 2.4 t -131.05 123.05 27.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.945 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.3 tp -117.51 130.24 56.31 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.686 0.279 . . . . 0.0 110.92 -178.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.676 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 59.3 m-85 -108.02 143.63 36.45 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.823 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 147.84 -177.61 25.99 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.035 178.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 46.6 mtm180 -70.83 -32.67 69.79 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.924 0.392 . . . . 0.0 111.042 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.535 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -48.67 143.92 7.56 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 -178.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.538 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.8 tp -66.22 -41.59 89.49 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.151 0 CA-C-O 121.046 0.45 . . . . 0.0 110.078 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.538 ' N ' HG23 ' A' ' 33' ' ' ILE . 97.9 mt-10 -54.88 -22.1 13.67 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.519 179.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.535 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 50.0 m -56.73 118.39 4.85 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.348 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -59.54 -26.89 65.74 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.731 HD11 ' CD2' ' A' ' 20' ' ' PHE . 47.5 mm -123.54 108.54 21.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 176.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -102.28 132.95 47.92 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.843 -177.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 84.0 mt -123.42 131.51 73.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.571 HE21 ' CA ' ' B' ' 260' ' ' GLU . 2.5 pp0? -88.56 43.71 1.15 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 119.626 -0.83 . . . . 0.0 112.558 -178.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.983 HD11 ' NH1' ' A' ' 93' ' ' ARG . 36.6 mt -95.36 128.87 36.83 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.27 178.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -70.78 -13.34 32.04 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 122.095 1.863 . . . . 0.0 113.534 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 18.6 m -100.61 5.67 10.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.028 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 34.5 t -95.7 139.07 19.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.123 0.487 . . . . 0.0 111.086 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.87 166.04 11.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.548 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -63.87 -44.12 94.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.003 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.625 ' O ' ' N ' ' A' ' 49' ' ' CYS . 98.2 mt-30 -113.4 -12.08 13.04 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.885 0.374 . . . . 0.0 111.049 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 26.1 t60 34.48 -74.77 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 178.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.625 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -135.53 139.54 44.04 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.405 0.622 . . . . 0.0 112.095 -177.938 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -127.66 131.09 49.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.78 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.8 mt -113.24 132.95 60.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.107 179.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.464 ' CD ' ' NE2' ' A' ' 54' ' ' HIS . 83.4 tt0 -117.89 123.32 45.57 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.65 HD13 ' NE ' ' A' ' 5' ' ' ARG . 85.1 mt -107.22 117.11 52.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 119.968 -0.693 . . . . 0.0 112.559 -178.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.464 ' NE2' ' CD ' ' A' ' 52' ' ' GLU . 97.7 m-70 -110.93 139.67 46.06 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.968 178.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.5 tt0 -40.77 -32.55 0.23 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.5 -0.48 . . . . 0.0 109.802 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -66.3 -65.97 0.61 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.99 -173.23 4.43 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.098 0.475 . . . . 0.0 111.797 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.84 129.22 56.61 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.698 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 91.3 mt -118.14 130.87 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 121.609 0.719 . . . . 0.0 112.76 -178.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.543 HD22 ' CD1' ' A' ' 88' ' ' ILE . 43.1 tp -98.69 128.06 44.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.456 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -115.06 136.03 53.56 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.948 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.448 HD21 ' CA ' ' A' ' 68' ' ' PRO . 64.0 t-20 -97.32 104.72 16.77 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.25 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -96.44 -11.66 25.31 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.865 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.503 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 85.1 p -74.71 98.4 3.44 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.098 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.8 m -78.67 -32.85 47.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.345 179.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.589 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.2 OUTLIER -75.19 -42.72 55.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.595 -179.225 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.503 ' O ' ' OG ' ' A' ' 64' ' ' SER . 79.5 m-20 -135.88 95.06 14.07 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.919 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.448 ' CA ' HD21 ' A' ' 62' ' ' ASN . 40.1 Cg_exo -54.92 143.33 72.77 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.383 2.055 . . . . 0.0 113.242 -178.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.464 ' HB ' HD11 ' A' ' 76' ' ' ILE . 12.2 m -70.94 152.87 43.18 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.309 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -115.54 141.24 48.33 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.535 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.547 ' CG2' ' OD1' ' A' ' 86' ' ' ASP . 4.4 p -130.9 137.51 55.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 49.26 32.16 4.17 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.05 28.79 69.8 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.959 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.464 ' N ' ' O ' ' A' ' 71' ' ' VAL . 9.0 t -140.24 137.3 34.16 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.914 0.388 . . . . 0.0 111.363 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.437 HG13 ' HB2' ' A' ' 68' ' ' PRO . 40.7 t -64.9 135.97 27.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.673 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.464 HD11 ' HB ' ' A' ' 69' ' ' THR . 11.9 pt -110.49 77.93 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.12 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.318 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -59.93 -33.02 71.33 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -112.9 159.35 34.84 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.785 178.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.55 154.27 71.97 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.413 2.075 . . . . 0.0 111.67 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.0 m -148.15 149.02 15.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.873 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -73.1 132.15 42.95 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-O 120.983 0.42 . . . . 0.0 110.449 179.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.408 HD21 ' HB2' ' A' ' 60' ' ' LEU . 97.6 mt -80.95 140.97 34.95 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.198 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -133.63 154.6 50.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.767 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -55.15 116.46 2.81 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.259 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.17 -18.39 18.58 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.547 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 56.9 t0 -66.08 123.36 19.67 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.271 0.557 . . . . 0.0 109.508 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.502 ' CG2' ' OG ' ' A' ' 94' ' ' SER . 7.4 p -104.37 132.94 49.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.078 -178.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.543 ' CD1' HD22 ' A' ' 60' ' ' LEU . 29.4 mm -92.48 130.47 41.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 178.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.6 m -121.96 126.44 48.6 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 119.364 -0.934 . . . . 0.0 112.9 -178.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.517 ' O ' ' C ' ' A' ' 91' ' ' ILE . 98.0 mt -120.39 127.69 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 113.988 -1.46 . . . . 0.0 107.996 177.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.553 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 44.0 mt -21.21 101.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 O-C-N 123.612 0.57 . . . . 0.0 112.243 -179.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.553 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 11.3 t0 89.87 -19.81 0.16 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 177.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.983 ' NH1' HD11 ' A' ' 41' ' ' LEU . 71.7 mtt85 -131.44 139.85 49.48 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.806 -178.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.502 ' OG ' ' CG2' ' A' ' 87' ' ' VAL . 15.8 t -135.04 146.91 49.43 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 120.894 0.378 . . . . 0.0 110.09 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.592 ' HB3' HD11 ' A' ' 7' ' ' LEU . 72.7 m-85 -123.78 124.52 42.87 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.752 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.633 ' O ' HD12 ' A' ' 7' ' ' LEU . 99.8 mtt180 -88.29 133.47 34.05 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 119.568 -0.853 . . . . 0.0 110.932 -179.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -95.28 124.34 39.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.875 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -123.12 127.62 48.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.421 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.627 ' OD1' HG22 ' A' ' 4' ' ' THR . 62.6 t-20 -130.22 112.36 13.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.385 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.4 ' O ' ' O ' ' A' ' 99' ' ' ASN . 82.6 tt0 . . . . . 0 C--N 1.33 -0.246 0 CA-C-O 120.897 0.379 . . . . 0.0 110.05 -179.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 CA--C 1.528 0.114 0 CA-C-O 120.827 0.346 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.508 ' O ' ' N ' ' B' ' 231' ' ' GLN . 75.9 m-20 -70.57 140.29 51.68 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.508 ' N ' ' O ' ' B' ' 229' ' ' ASP . 4.3 mt-30 -46.26 -47.27 18.17 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.136 -179.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' B' ' 231' ' ' GLN . . . -36.71 165.64 0.01 OUTLIER Glycine 0 CA--C 1.529 0.958 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.463 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.04 162.97 40.21 Favored 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 124.384 3.39 . . . . 0.0 112.813 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.589 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.44 141.63 42.93 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 121.902 1.735 . . . . 0.0 112.635 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.489 HG22 HG22 ' A' ' 66' ' ' THR . 72.8 t -66.2 133.26 31.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.818 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 2.0 t -74.88 135.6 41.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.113 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . 0.466 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . 0.466 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 33.1 Cg_exo -59.17 -24.01 71.91 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.728 2.285 . . . . 0.0 112.263 -179.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 98.9 m -67.25 -48.0 69.08 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.453 ' HZ ' HD22 ' A' ' 41' ' ' LEU . 88.9 t80 -59.31 -47.57 84.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.13 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.486 HD21 HG23 ' A' ' 91' ' ' ILE . 85.9 mt -65.36 -40.13 93.18 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.14 -179.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -62.16 -42.4 99.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.896 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 79.2 ttt-85 -61.19 -42.48 98.65 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.078 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.417 ' O ' HG23 ' B' ' 249' ' ' VAL . 22.5 mmt180 -62.72 -42.33 99.6 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.749 -179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -62.11 -43.12 99.53 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 54.3 m -65.35 -44.05 88.93 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . 0.711 ' NE2' HH22 ' A' ' 12' ' ' ARG . 57.0 tt0 -57.26 -41.29 79.4 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.521 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.417 HG23 ' O ' ' B' ' 245' ' ' ARG . 55.1 t -65.51 -43.83 94.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.75 0.309 . . . . 0.0 110.649 179.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -55.33 -29.8 59.01 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -87.3 -3.78 59.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.856 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.4 ' HA ' HD23 ' B' ' 252' ' ' LEU . 94.9 mt -123.62 116.2 22.72 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.968 178.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -61.5 -174.96 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.019 0.438 . . . . 0.0 111.345 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -62.47 -13.33 29.04 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.18 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -70.98 -14.92 62.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.853 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.406 ' CG ' ' N ' ' B' ' 257' ' ' LYS . 38.9 t70 38.09 -114.99 0.14 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.71 179.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . 0.491 ' O ' ' OD1' ' B' ' 259' ' ' ASP . 55.8 pttt 178.22 -130.94 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.39 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.584 ' OD1' ' N ' ' B' ' 259' ' ' ASP . 43.7 p-10 -65.23 -26.73 68.24 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.361 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.584 ' N ' ' OD1' ' B' ' 258' ' ' ASP . 1.1 m-20 89.98 12.58 0.06 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.582 179.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.605 ' CB ' HH21 ' A' ' 93' ' ' ARG . 51.1 mp0 56.28 -3.0 0.03 OUTLIER 'General case' 0 C--O 1.237 0.437 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 178.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.53 ' H ' ' C ' ' B' ' 259' ' ' ASP . 78.1 mt -110.81 136.21 47.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 76.7 t -122.91 131.19 73.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.999 0.428 . . . . 0.0 110.254 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -94.23 117.48 30.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.202 0.525 . . . . 0.0 110.958 -178.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.32 -44.81 90.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.543 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.75 160.36 28.07 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.801 -179.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -57.07 152.87 41.8 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.987 2.458 . . . . 0.0 111.716 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 39.8 pt . . . . . 0 C--N 1.327 -0.383 0 CA-C-O 121.622 0.725 . . . . 0.0 111.978 -178.921 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo . . . . . 0 N--CA 1.501 1.929 0 CA-C-O 121.105 0.377 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.503 ' O ' ' O ' ' A' ' 99' ' ' ASN . 2.9 m -93.18 -53.83 3.96 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.318 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.746 ' HE ' HD13 ' A' ' 53' ' ' ILE . 82.5 mtm-85 -89.98 130.68 36.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.958 -179.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -131.06 148.04 52.69 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.155 0.502 . . . . 0.0 111.921 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.762 HD11 HD11 ' A' ' 22' ' ' LEU . 94.1 mt -115.4 141.7 47.68 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.257 179.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.9 t -113.14 128.22 70.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.7 m -91.69 113.73 26.08 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.681 HD12 ' OG ' ' A' ' 94' ' ' SER . 96.8 mt -77.58 138.77 19.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -86.32 157.04 19.99 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.425 179.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -58.01 -30.84 66.41 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.782 -179.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 87.0 p -78.55 -9.74 59.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.871 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.56 34.78 6.81 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.756 -0.937 . . . . 0.0 110.756 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 52.3 t -121.51 133.84 66.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.574 0.226 . . . . 0.0 110.813 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.403 ' C ' ' OD1' ' A' ' 16' ' ' ASP . 62.3 t0 -66.24 120.15 12.75 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.934 0.397 . . . . 0.0 110.383 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -104.43 -136.12 8.7 Favored Glycine 0 CA--C 1.535 1.337 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.374 -178.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.97 151.54 45.15 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.581 2.187 . . . . 0.0 112.693 -178.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -107.85 128.93 55.04 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.965 -179.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.835 ' CD2' HD11 ' A' ' 37' ' ' ILE . 59.8 t80 -97.67 106.36 32.83 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.053 -178.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.85 128.13 9.87 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 121.703 1.602 . . . . 0.0 111.405 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.762 HD11 HD11 ' A' ' 7' ' ' LEU . 97.5 mt -83.39 84.0 7.67 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.381 -0.528 . . . . 0.0 111.552 -178.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 57.2 p -83.44 -13.66 54.27 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.516 HD11 ' CD ' ' B' ' 265' ' ' GLN . 58.6 mt -99.55 142.57 30.85 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.963 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 27.1 m -69.48 -10.44 58.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.646 -178.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 29.2 m -132.16 132.56 43.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.757 0.313 . . . . 0.0 110.57 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.6 t -128.1 123.68 35.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.508 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.456 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 54.7 tp -117.45 131.67 56.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.017 -179.058 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.423 ' CE2' HG13 ' A' ' 37' ' ' ILE . 32.1 m-85 -110.33 135.91 50.32 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 155.81 -164.38 32.18 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 120.367 -0.921 . . . . 0.0 112.328 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.62 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 47.6 ptt85 -119.18 19.54 12.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.651 -0.275 . . . . 0.0 110.352 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.63 ' O ' ' N ' ' A' ' 34' ' ' GLU . . . -88.32 29.74 5.53 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.588 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 1.7 tp 55.63 -61.85 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 O-C-N 123.849 0.382 . . . . 0.0 111.163 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.63 ' N ' ' O ' ' A' ' 32' ' ' GLY . 49.8 tp10 -50.46 -9.64 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.415 0.626 . . . . 0.0 109.514 179.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.551 ' H ' ' C ' ' A' ' 33' ' ' ILE . 35.1 m -65.42 124.74 23.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.39 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.456 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 60.5 m-20 -60.34 -31.66 70.51 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.835 HD11 ' CD2' ' A' ' 20' ' ' PHE . 42.6 mm -118.95 114.08 43.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 177.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.758 HH22 ' NZ ' ' B' ' 264' ' ' LYS . 77.3 mtt85 -103.64 136.09 43.99 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.448 -177.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.668 HD13 ' HE ' ' A' ' 93' ' ' ARG . 97.8 mt -122.58 132.23 71.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 121.006 0.432 . . . . 0.0 110.439 179.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -77.27 33.0 0.15 Allowed 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -176.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.71 HD12 ' CZ ' ' A' ' 93' ' ' ARG . 47.4 mt -109.81 134.75 20.54 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 120.091 -0.643 . . . . 0.0 111.546 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.55 -8.23 21.36 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.456 2.104 . . . . 0.0 113.517 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.562 HG21 ' CE2' ' B' ' 241' ' ' PHE . 27.6 m -100.56 3.23 10.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.468 179.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.62 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 37.2 t -88.96 132.74 32.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.482 -0.487 . . . . 0.0 109.713 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.8 t -66.02 155.86 35.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.498 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.516 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 40.3 mtmt -63.04 -40.76 98.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.027 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.646 ' O ' ' N ' ' A' ' 49' ' ' CYS . 87.5 mt-30 -115.94 -7.57 11.96 Favored 'General case' 0 N--CA 1.464 0.23 0 O-C-N 123.319 0.387 . . . . 0.0 111.334 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.469 ' C ' ' O ' ' A' ' 47' ' ' GLN . 17.0 t60 15.7 -71.4 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -178.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.646 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.46 133.42 45.15 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -178.49 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -125.36 129.02 49.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.784 178.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 90.5 mt -115.1 134.86 56.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.042 0.449 . . . . 0.0 111.732 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.443 ' CD ' ' NE2' ' A' ' 54' ' ' HIS . 81.5 tt0 -117.59 126.15 52.05 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.746 HD13 ' HE ' ' A' ' 5' ' ' ARG . 94.9 mt -108.14 118.87 56.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 113.086 0.772 . . . . 0.0 113.086 -178.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.443 ' NE2' ' CD ' ' A' ' 52' ' ' GLU . 98.4 m-70 -111.23 138.28 47.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.015 178.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 54' ' ' HIS . 78.6 tt0 -40.72 -33.87 0.33 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -179.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -63.79 -67.14 0.45 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.696 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.51 ' OE2' ' CD ' ' A' ' 81' ' ' ARG . 0.1 OUTLIER -148.56 -178.97 6.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.203 0.525 . . . . 0.0 111.519 -179.373 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -106.51 126.47 52.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.189 178.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 86.6 mt -116.9 128.6 74.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.429 0.633 . . . . 0.0 112.351 -178.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.623 ' HB2' HD11 ' A' ' 82' ' ' LEU . 24.8 tp -99.85 130.57 46.06 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.499 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -112.61 132.9 54.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.098 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 63.9 t-20 -92.16 106.77 18.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.353 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -98.25 -7.57 28.91 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.44 102.06 4.33 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.039 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.5 m -89.42 -6.52 56.48 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.831 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.2 OUTLIER -102.2 -40.14 6.92 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.126 -179.894 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 56.9 m-20 -142.69 99.04 5.72 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.107 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.531 ' HB2' HG13 ' A' ' 75' ' ' VAL . 51.9 Cg_exo -55.36 146.2 63.25 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.286 1.991 . . . . 0.0 113.546 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.9 m -76.01 144.95 40.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.837 178.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -105.63 139.16 40.64 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.795 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 54.9 t -130.1 134.44 62.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 52.67 33.78 14.54 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.6 27.91 71.8 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.233 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 68.2 m -142.77 138.26 30.32 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 117.626 0.713 . . . . 0.0 111.853 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.531 HG13 ' HB2' ' A' ' 68' ' ' PRO . 3.4 t -68.12 140.8 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.853 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.5 pt -114.16 105.99 19.79 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.063 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.67 178.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 20.5 p-10 -74.37 -26.54 60.18 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.131 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.442 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.3 OUTLIER -130.4 178.52 1.69 Allowed Pre-proline 0 C--N 1.33 -0.258 0 C-N-CA 120.866 -0.333 . . . . 0.0 110.62 -179.794 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 31.2 Cg_exo -59.91 141.87 97.42 Favored 'Trans proline' 0 N--CA 1.502 1.985 0 C-N-CA 122.687 2.258 . . . . 0.0 113.158 -179.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 47.1 t -133.77 135.92 54.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.725 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.51 ' CD ' ' OE2' ' A' ' 57' ' ' GLU . 88.9 mtm180 -71.91 132.98 45.11 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.623 HD11 ' HB2' ' A' ' 60' ' ' LEU . 96.1 mt -86.86 136.82 32.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.257 0.551 . . . . 0.0 111.615 -178.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -121.31 148.79 43.85 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.613 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.439 ' CD2' ' C ' ' A' ' 84' ' ' HIS . 7.9 t60 -58.55 125.76 24.73 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.029 0.442 . . . . 0.0 110.291 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.57 -17.44 42.91 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.809 -0.917 . . . . 0.0 110.809 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -67.74 140.39 56.72 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.101 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.537 ' O ' HG13 ' A' ' 87' ' ' VAL . 12.1 p -112.33 127.96 69.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.476 -178.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 88.0 mt -92.81 130.59 41.67 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 177.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.1 m -125.85 128.9 48.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.975 0.893 . . . . 0.0 113.111 -178.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.546 ' O ' ' C ' ' A' ' 91' ' ' ILE . 95.9 mt -114.44 137.81 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 114.004 -1.453 . . . . 0.0 108.217 178.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.546 ' C ' ' O ' ' A' ' 90' ' ' ILE . 87.4 mt 17.02 -85.74 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 O-C-N 123.645 0.591 . . . . 0.0 111.771 -178.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.499 ' N ' ' O ' ' A' ' 90' ' ' ILE . 53.9 t0 -121.63 14.33 10.97 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 120.315 -0.554 . . . . 0.0 112.023 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.71 ' CZ ' HD12 ' A' ' 41' ' ' LEU . 45.1 mtm-85 -129.31 140.75 51.3 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.642 -0.423 . . . . 0.0 109.974 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.681 ' OG ' HD12 ' A' ' 10' ' ' ILE . 55.0 p -139.14 153.96 48.04 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.124 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -127.13 126.84 43.6 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.746 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -84.34 129.36 34.88 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.85 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.557 ' CE2' ' OD1' ' A' ' 99' ' ' ASN . 88.8 t80 -89.63 123.86 34.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.951 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -134.12 113.24 11.85 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.076 0.465 . . . . 0.0 111.146 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.557 ' OD1' ' CE2' ' A' ' 97' ' ' TYR . 99.1 m-20 -68.17 -40.42 82.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.152 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.91 -179.542 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 39.0 t . . . . . 0 N--CA 1.456 -0.127 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 45.1 t0 61.98 -173.5 0.14 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.074 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . 0.598 ' O ' ' NE2' ' B' ' 231' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.598 ' NE2' ' O ' ' B' ' 230' ' ' SEP . 99.0 mm-40 -145.41 75.64 1.44 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.03 179.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -123.26 -174.08 14.18 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 120.986 -0.626 . . . . 0.0 111.754 -178.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . 0.606 ' O ' ' NH2' ' A' ' 31' ' ' ARG . 87.9 Cg_endo -73.66 155.22 49.65 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 123.415 2.743 . . . . 0.0 112.85 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.831 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.46 136.47 33.87 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 121.735 1.624 . . . . 0.0 113.098 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.553 ' CG2' HG22 ' A' ' 66' ' ' THR . 55.0 t -65.22 137.14 25.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 114.585 -1.189 . . . . 0.0 111.156 -179.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . 0.497 ' SG ' HG23 ' A' ' 91' ' ' ILE . 5.9 t -63.68 125.05 23.03 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -52.6 -23.02 18.41 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.934 1.756 . . . . 0.0 112.266 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 21.9 p -74.18 -41.19 61.85 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 121.188 0.518 . . . . 0.0 109.835 178.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.562 ' CE2' HG21 ' A' ' 43' ' ' VAL . 84.5 t80 -58.22 -45.56 87.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.964 -179.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 89.1 mt -64.18 -40.46 96.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.658 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -61.81 -40.55 95.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.027 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 80.4 mtt85 -62.16 -42.52 99.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.168 0.509 . . . . 0.0 109.994 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.923 ' O ' HG23 ' B' ' 249' ' ' VAL . 78.0 mtp85 -61.98 -41.95 98.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.657 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -61.92 -43.32 99.09 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.274 -0.57 . . . . 0.0 110.398 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 46.9 t -65.97 -45.22 82.48 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -63.43 -34.49 77.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.012 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.923 HG23 ' O ' ' B' ' 245' ' ' ARG . 59.8 t -61.06 -47.03 95.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.127 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -65.52 -29.71 70.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.788 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -78.12 -13.95 59.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.471 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 99.0 mt -114.44 115.08 26.71 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.971 0.415 . . . . 0.0 110.528 178.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . 0.567 ' O ' ' N ' ' B' ' 255' ' ' ASP . 1.6 m-80 -83.47 -157.35 0.24 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.534 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -47.31 -5.74 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.565 -179.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' B' ' 253' ' ' ASN . 44.7 p-10 -70.95 -1.89 13.44 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.272 0.558 . . . . 0.0 109.9 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.657 ' O ' ' N ' ' B' ' 258' ' ' ASP . 93.8 m-20 -58.61 -33.09 69.62 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . 0.501 ' C ' ' O ' ' B' ' 256' ' ' ASP . 87.8 tttt -25.06 -36.33 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 O-C-N 124.211 0.945 . . . . 0.0 110.951 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.657 ' N ' ' O ' ' B' ' 256' ' ' ASP . 96.6 m-20 -86.99 44.86 1.21 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.591 ' N ' ' O ' ' B' ' 256' ' ' ASP . 48.3 p30 -48.15 144.54 3.72 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.526 0.679 . . . . 0.0 111.952 -178.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.585 ' OE1' HD21 ' A' ' 41' ' ' LEU . 97.1 mt-10 -61.93 20.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.588 -1.187 . . . . 0.0 112.495 -178.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.553 ' H ' ' C ' ' B' ' 259' ' ' ASP . 61.6 mt -109.33 132.41 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 75.2 t -127.87 137.08 58.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.282 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . 0.578 ' CD2' HD13 ' B' ' 267' ' ' ILE . 67.1 m-85 -98.61 120.48 39.11 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.052 -177.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . 0.758 ' NZ ' HH22 ' A' ' 38' ' ' ARG . 64.6 tttp -65.18 -48.07 74.73 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.924 178.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . 0.516 ' CD ' HD11 ' A' ' 24' ' ' LEU . 0.4 OUTLIER -85.5 172.04 9.48 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.281 -178.809 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -58.08 143.98 95.62 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.343 2.029 . . . . 0.0 112.943 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . 0.578 HD13 ' CD2' ' B' ' 263' ' ' PHE . 18.5 tt . . . . . 0 N--CA 1.448 -0.569 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.361 179.216 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo . . . . . 0 N--CA 1.49 1.294 0 CA-C-O 120.743 0.226 . . . . 0.0 111.616 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.9 p -78.07 -36.48 48.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.014 179.641 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.688 ' NH2' HG21 ' A' ' 53' ' ' ILE . 91.4 mtm-85 -99.76 124.43 45.02 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.02 -178.641 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -133.74 144.81 49.32 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.261 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.562 HD11 HD11 ' A' ' 22' ' ' LEU . 69.4 mt -111.73 138.96 47.61 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.855 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.8 t -112.29 125.88 69.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.3 m -74.93 138.65 42.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.916 -178.693 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.614 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 98.5 mt -109.89 132.86 56.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.547 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -90.38 157.25 17.71 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.479 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.53 ' NH1' ' CD ' ' B' ' 260' ' ' GLU . 93.2 mtm-85 -61.31 -23.49 65.75 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.048 -179.28 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.5 m -76.08 -16.6 59.89 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.552 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.06 33.26 7.03 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.596 -1.001 . . . . 0.0 110.596 -179.331 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 37.0 t -117.64 131.82 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-O 120.573 0.225 . . . . 0.0 111.499 -179.521 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -74.02 136.65 43.14 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 178.376 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -130.46 -119.95 2.17 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.308 -179.169 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -72.95 150.16 48.46 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 122.464 2.109 . . . . 0.0 112.646 -178.748 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -112.38 156.96 21.63 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.306 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.625 ' CD2' HD11 ' A' ' 37' ' ' ILE . 46.9 t80 -123.13 103.99 35.67 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.143 -179.261 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -71.49 127.24 13.01 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 121.622 1.548 . . . . 0.0 111.929 -179.414 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.562 HD11 HD11 ' A' ' 7' ' ' LEU . 98.3 mt -84.31 48.83 1.55 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -178.295 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 94.3 p -61.35 -24.33 66.38 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.728 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.672 HD11 ' NE2' ' B' ' 265' ' ' GLN . 73.3 mt -77.36 139.76 39.81 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.667 179.485 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 91.8 p -66.18 -18.96 65.67 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.165 -179.302 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.428 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 40.4 m -132.8 132.83 42.63 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.024 -179.777 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.46 ' HB2' HD22 ' A' ' 22' ' ' LEU . 3.7 t -125.27 118.33 25.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.847 178.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.423 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 39.7 tp -116.82 128.55 55.38 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.055 -178.646 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.713 ' CE2' HD12 ' A' ' 37' ' ' ILE . 4.5 m-85 -107.58 141.06 39.62 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.158 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 158.13 -168.76 34.65 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 120.033 -1.079 . . . . 0.0 112.615 179.016 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.6 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 86.5 mtm-85 -81.23 -31.1 33.99 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-O 121.005 0.431 . . . . 0.0 110.185 179.687 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.485 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -50.56 142.07 16.37 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 115.745 -0.662 . . . . 0.0 112.39 -177.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.477 HD13 ' CZ ' ' A' ' 38' ' ' ARG . 38.8 mm -65.67 -43.65 93.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.276 0.56 . . . . 0.0 109.492 179.087 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.3 tp10 -57.8 -19.38 28.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.973 -179.637 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 34.9 m -59.69 130.9 49.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.42 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.428 ' OD2' ' O ' ' A' ' 26' ' ' THR . 54.6 m-20 -60.78 -33.83 73.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.838 -179.351 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.713 HD12 ' CE2' ' A' ' 29' ' ' PHE . 89.7 mt -127.84 120.66 54.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 177.48 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.477 ' CZ ' HD13 ' A' ' 33' ' ' ILE . 81.4 mtp180 -103.12 137.02 41.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.824 -178.722 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 98.4 mt -118.26 127.55 75.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.805 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -73.16 31.92 0.07 Allowed 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -177.405 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.872 HD21 ' OE1' ' B' ' 260' ' ' GLU . 88.2 mt -108.45 132.09 21.34 Favored Pre-proline 0 C--N 1.325 -0.482 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.012 179.657 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.37 -9.79 23.38 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.459 2.106 . . . . 0.0 112.797 179.742 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.2 m -95.03 2.62 9.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.512 -0.475 . . . . 0.0 109.801 179.51 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.6 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 21.0 t -88.57 131.6 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.602 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.632 ' OG ' ' N ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -66.42 167.48 10.57 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.325 0.583 . . . . 0.0 111.798 -177.897 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -61.37 -45.84 92.68 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.423 -178.746 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.622 ' O ' ' N ' ' A' ' 49' ' ' CYS . 86.1 mt-30 -113.62 -15.71 12.47 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.557 178.825 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.632 ' N ' ' OG ' ' A' ' 45' ' ' SER . 16.8 t60 34.93 -76.61 0.0 OUTLIER 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.067 -0.969 . . . . 0.0 113.604 179.765 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.622 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -129.56 134.41 47.72 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.367 0.603 . . . . 0.0 112.294 -178.433 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -125.67 132.23 52.46 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.845 178.67 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.2 mt -116.46 134.26 60.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.927 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -117.83 122.97 44.78 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.562 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.688 HG21 ' NH2' ' A' ' 5' ' ' ARG . 72.7 mt -105.27 115.8 47.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.419 0.628 . . . . 0.0 111.476 -178.861 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.46 ' O ' ' N ' ' A' ' 56' ' ' GLN . 87.2 m-70 -114.79 144.86 42.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.816 -1.083 . . . . 0.0 109.868 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.8 mm-40 -40.84 -27.15 0.05 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.07 0.462 . . . . 0.0 110.156 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.46 ' N ' ' O ' ' A' ' 54' ' ' HIS . 86.9 mm-40 -68.96 -67.61 0.46 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.151 179.094 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -158.99 -166.37 1.83 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.37 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.34 129.35 55.77 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.195 -179.853 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 90.0 mt -120.48 130.18 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 121.166 0.508 . . . . 0.0 112.338 -178.85 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.412 ' HB2' HD11 ' A' ' 82' ' ' LEU . 36.0 tp -97.71 129.25 44.77 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.156 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -114.61 136.41 53.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.206 179.677 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -97.42 104.87 16.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.97 0.414 . . . . 0.0 111.614 -179.613 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -94.2 -10.5 32.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.68 178.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.8 t -76.95 102.94 6.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.225 179.237 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 88.8 p -86.76 -8.7 57.13 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.574 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.82 HG22 HG22 ' B' ' 236' ' ' VAL . 0.2 OUTLIER -95.84 -37.91 10.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.117 0.484 . . . . 0.0 110.019 179.966 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -146.2 95.57 4.71 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.961 179.879 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.0 148.57 76.03 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 122.363 2.042 . . . . 0.0 112.526 -179.652 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 57.1 m -70.29 141.23 52.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.469 179.197 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -98.53 146.71 25.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.562 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.754 ' HB ' HD11 ' A' ' 76' ' ' ILE . 6.1 p -130.55 135.99 59.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.2 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 48.3 32.37 3.14 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 -179.694 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.12 29.57 62.34 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 111.414 -0.674 . . . . 0.0 111.414 -179.836 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.415 ' N ' ' O ' ' A' ' 71' ' ' VAL . 15.0 m -138.87 136.32 35.43 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.817 0.308 . . . . 0.0 111.052 -179.62 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.8 p -64.38 143.81 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 120.931 0.396 . . . . 0.0 111.835 -179.194 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.754 HD11 ' HB ' ' A' ' 71' ' ' VAL . 95.5 mt -107.64 103.51 15.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.036 179.672 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -64.58 -41.84 96.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.519 179.082 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.527 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.4 OUTLIER -137.38 -177.46 0.71 Allowed Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.456 -178.362 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.506 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 35.7 Cg_exo -58.69 145.71 94.71 Favored 'Trans proline' 0 N--CA 1.5 1.885 0 C-N-CA 122.838 2.359 . . . . 0.0 112.779 -179.598 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.3 m -144.48 147.25 19.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.556 179.808 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -77.53 131.82 38.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.807 178.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.412 HD11 ' HB2' ' A' ' 60' ' ' LEU . 96.0 mt -84.76 140.52 31.19 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.08 0.467 . . . . 0.0 111.482 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -129.32 151.36 50.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.646 179.58 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.426 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 5.2 t60 -54.42 120.87 7.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.482 -179.656 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.82 -13.8 41.66 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 -179.269 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.513 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 55.1 t0 -70.05 126.38 29.53 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.363 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 71.4 t -103.88 135.02 43.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.625 -178.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 84.7 mt -103.91 129.52 55.92 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.769 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 87.5 m -124.53 124.69 42.81 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 119.861 -0.736 . . . . 0.0 112.675 -178.269 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.582 ' O ' ' N ' ' A' ' 93' ' ' ARG . 98.4 mt -111.93 131.54 63.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 114.697 -1.138 . . . . 0.0 107.944 177.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.671 HD13 ' HB2' ' B' ' 237' ' ' CYS . 66.0 mt -21.9 97.61 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.585 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.502 ' CG ' ' NE ' ' B' ' 245' ' ' ARG . 3.3 m-20 89.2 -24.9 0.08 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 178.098 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.614 ' NH2' ' O ' ' A' ' 10' ' ' ILE . 6.2 mmm180 -124.15 140.05 53.34 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.532 -179.288 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.498 ' HB3' HD12 ' A' ' 10' ' ' ILE . 46.0 t -141.22 151.59 43.89 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.768 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -128.24 123.14 33.44 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.267 179.323 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -80.08 134.09 36.16 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.289 179.22 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -94.83 123.69 38.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.669 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.404 ' HG3' ' CE1' ' A' ' 84' ' ' HIS . 79.5 tt0 -124.63 122.19 36.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.785 -179.874 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.426 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 59.9 t-20 -106.52 104.18 13.81 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.038 179.61 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 . . . . . 0 C--N 1.328 -0.341 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.035 179.795 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.766 0.317 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -86.48 120.2 27.55 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.64 -179.765 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 -126.19 45.78 2.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.401 -179.496 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -116.94 -174.57 17.21 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 121.061 -0.59 . . . . 0.0 111.736 -179.458 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.11 162.04 41.75 Favored 'Trans proline' 0 N--CA 1.497 1.678 0 C-N-CA 123.712 2.941 . . . . 0.0 113.002 -179.739 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.471 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.78 147.71 56.89 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.081 1.854 . . . . 0.0 113.759 -179.404 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.82 HG22 HG22 ' A' ' 66' ' ' THR . 19.0 t -78.21 131.5 34.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.019 179.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . 0.671 ' HB2' HD13 ' A' ' 91' ' ' ILE . 3.3 t -60.35 126.41 27.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.807 0.337 . . . . 0.0 111.268 -179.353 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . 0.531 ' P ' ' OG1' ' B' ' 240' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -60.75 -23.53 76.58 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.813 2.342 . . . . 0.0 113.306 -179.171 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . 0.531 ' OG1' ' P ' ' B' ' 238' ' ' TPO . 6.7 p -77.29 -38.25 51.15 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 120.187 -0.605 . . . . 0.0 109.528 177.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -58.63 -45.47 89.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.327 179.78 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.588 HD23 ' HE ' ' B' ' 245' ' ' ARG . 95.3 mt -62.6 -41.54 99.03 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 121.161 0.505 . . . . 0.0 110.537 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -67.9 -38.4 82.92 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.571 -179.645 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -61.12 -48.02 83.57 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.502 -178.593 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.588 ' HE ' HD23 ' B' ' 242' ' ' LEU . 52.0 ptt85 -64.64 -37.37 87.36 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.613 -179.303 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -61.21 -39.72 91.28 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.294 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 14.0 t -66.75 -42.3 86.42 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.364 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -58.07 -39.88 79.6 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.853 179.674 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.447 ' HA ' HD12 ' B' ' 252' ' ' LEU . 42.9 t -59.64 -45.42 94.29 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.21 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.918 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -63.35 -23.64 67.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.056 178.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -87.66 -12.74 44.56 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.821 -179.624 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.447 HD12 ' HA ' ' B' ' 249' ' ' VAL . 78.1 mt -71.16 148.34 47.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.129 0.49 . . . . 0.0 110.645 179.364 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -173.02 39.25 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.687 179.751 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . 0.549 ' O ' ' CB ' ' B' ' 255' ' ' ASP . 46.5 p-10 -99.03 -3.03 35.76 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.067 179.109 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . 0.579 ' O ' ' CB ' ' B' ' 256' ' ' ASP . 48.2 p-10 129.51 -25.67 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.792 0 O-C-N 124.668 1.23 . . . . 0.0 109.936 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.579 ' CB ' ' O ' ' B' ' 255' ' ' ASP . 28.2 t0 105.01 13.34 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 O-C-N 124.157 0.91 . . . . 0.0 110.726 -179.815 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -108.71 161.0 15.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.117 179.784 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 64.04 55.44 1.54 Allowed 'General case' 0 C--O 1.231 0.126 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.553 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.579 ' CG ' ' H ' ' B' ' 260' ' ' GLU . 17.1 p-10 -65.76 -99.4 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.639 -179.0 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.872 ' OE1' HD21 ' A' ' 41' ' ' LEU . 97.6 mt-10 -145.05 16.88 1.57 Allowed 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 121.079 -0.248 . . . . 0.0 110.84 -179.66 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 47.6 mt -115.37 137.92 47.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -179.555 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 55.3 t -127.23 133.93 67.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.897 179.223 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -97.31 122.6 40.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.051 0.453 . . . . 0.0 111.348 -178.411 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -66.18 -44.08 85.04 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.359 179.568 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . 0.672 ' NE2' HD11 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -99.87 170.0 7.32 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.554 -178.723 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.77 154.56 67.56 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.414 2.076 . . . . 0.0 112.017 -179.83 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 45.0 pt . . . . . 0 C--N 1.328 -0.362 0 CA-C-O 121.484 0.659 . . . . 0.0 111.936 -179.147 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo . . . . . 0 N--CA 1.494 1.516 0 CA-C-O 120.678 0.199 . . . . 0.0 111.996 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.417 HG23 ' O ' ' A' ' 100' ' ' GLU . 37.1 m -99.42 -43.16 6.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.017 0.437 . . . . 0.0 110.667 179.227 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.58 ' NH1' ' HB2' ' A' ' 58' ' ' ALA . 95.9 mtt-85 -90.76 125.4 35.69 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.749 -178.425 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -134.73 143.93 47.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.871 -179.243 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.717 HD11 HD11 ' A' ' 22' ' ' LEU . 73.1 mt -116.75 142.06 47.41 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.775 179.667 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.7 t -117.19 128.31 74.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.968 0.413 . . . . 0.0 110.279 179.536 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.2 m -74.68 140.8 44.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.354 0.597 . . . . 0.0 112.325 -179.187 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.631 HD12 ' OG ' ' A' ' 94' ' ' SER . 90.0 mt -112.47 134.06 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.838 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.415 ' NZ ' ' HA ' ' B' ' 257' ' ' LYS . 97.3 mttt -91.6 158.08 16.63 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.193 0.52 . . . . 0.0 111.77 -179.311 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.855 ' NH2' HD23 ' B' ' 252' ' ' LEU . 86.4 mtm180 -58.21 -30.99 66.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.505 -178.952 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.5 p -78.15 -10.2 59.52 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.601 178.96 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.81 36.17 7.42 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 179.951 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.5 t -118.07 132.74 67.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.01 0.433 . . . . 0.0 111.579 -179.615 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -73.22 128.86 36.68 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.003 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -125.45 -120.68 2.46 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 120.139 -1.029 . . . . 0.0 112.709 -178.797 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -72.01 146.67 47.53 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 122.242 1.962 . . . . 0.0 112.517 -178.202 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -108.71 147.33 32.11 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.94 179.372 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.526 ' CD2' HD11 ' A' ' 37' ' ' ILE . 29.3 t80 -116.87 102.8 52.87 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.578 -179.375 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.61 133.84 17.75 Favored 'Trans proline' 0 N--CA 1.486 1.049 0 C-N-CA 121.122 1.215 . . . . 0.0 110.504 -179.357 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.717 HD11 HD11 ' A' ' 7' ' ' LEU . 92.3 mt -87.64 62.87 7.27 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.723 -177.822 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 80.6 p -70.71 -21.0 62.61 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 177.79 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.698 HD11 ' HG2' ' B' ' 265' ' ' GLN . 71.0 mt -85.03 138.34 32.5 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.339 -179.61 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -62.4 -20.9 64.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.612 -179.12 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.1 m -134.17 135.49 43.11 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.821 -179.827 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.661 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -129.88 122.92 29.57 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.187 178.883 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.531 HD21 ' OE1' ' A' ' 47' ' ' GLN . 35.0 tp -120.98 126.8 50.87 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.7 -178.688 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.661 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 36.3 m-85 -99.74 127.16 45.88 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.134 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -176.39 -156.16 14.77 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.499 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -115.46 -17.67 11.17 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 117.174 0.487 . . . . 0.0 110.415 179.13 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.23 161.88 47.35 Favored Glycine 0 CA--C 1.519 0.337 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -179.656 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.526 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.8 tp -66.04 -41.63 90.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.408 179.585 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.526 ' N ' HG23 ' A' ' 33' ' ' ILE . 15.0 pt-20 -56.86 -22.77 39.41 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.801 -179.727 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.7 m -63.23 126.3 26.96 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.874 0.369 . . . . 0.0 110.706 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.611 ' OD1' ' N ' ' A' ' 37' ' ' ILE . 11.0 p-10 -61.97 -28.89 69.87 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.096 -179.316 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.611 ' N ' ' OD1' ' A' ' 36' ' ' ASP . 97.5 mt -130.55 122.42 52.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 177.724 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 75.0 mtm180 -103.82 136.24 43.88 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.198 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.572 HG21 HD12 ' A' ' 41' ' ' LEU . 97.2 mt -117.66 129.23 74.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.857 179.748 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -70.52 32.4 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.814 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.58 HD23 ' NH2' ' B' ' 245' ' ' ARG . 43.4 mt -110.33 121.77 40.52 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 120.446 -0.502 . . . . 0.0 109.668 179.043 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.02 -1.47 10.92 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.244 1.963 . . . . 0.0 112.351 -178.809 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.433 HG23 HG13 ' A' ' 91' ' ' ILE . 18.3 m -99.2 6.73 9.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.323 179.813 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.499 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 29.6 t -89.96 133.94 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.25 178.797 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.479 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 0.6 OUTLIER -67.04 159.56 28.43 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.02 0.438 . . . . 0.0 110.551 179.514 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -61.77 -39.16 90.67 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.273 -178.817 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.606 ' O ' ' N ' ' A' ' 49' ' ' CYS . 96.3 mm-40 -111.53 -18.22 12.88 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.46 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.479 ' H ' ' HB3' ' A' ' 45' ' ' SER . 19.4 t60 29.96 -78.85 0.0 OUTLIER 'General case' 0 C--O 1.236 0.377 0 CA-C-N 114.716 -1.129 . . . . 0.0 113.124 -179.683 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.606 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -129.47 134.21 47.69 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.914 -179.342 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -125.66 128.49 47.91 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.223 179.364 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 93.0 mt -114.54 133.31 61.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.787 -179.849 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -113.27 133.68 54.98 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.807 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.562 HD12 ' CD ' ' A' ' 5' ' ' ARG . 47.9 mm -103.14 114.5 42.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.558 -179.462 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.44 ' O ' ' C ' ' A' ' 55' ' ' GLU . 95.0 m-70 -115.47 132.8 56.51 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.473 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 54' ' ' HIS . 95.4 mt-10 -40.47 -34.13 0.32 Allowed 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 121.195 0.522 . . . . 0.0 109.92 -178.673 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -62.75 -67.32 0.43 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.233 179.418 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -152.43 -164.38 1.94 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.333 -179.63 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.58 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -127.28 131.18 50.56 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.011 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 91.7 mt -112.32 129.9 67.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.255 0.55 . . . . 0.0 112.205 -178.237 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.548 ' HB2' HD21 ' A' ' 82' ' ' LEU . 44.3 tp -94.46 120.22 34.37 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.224 179.028 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -107.85 135.05 49.9 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.962 0.41 . . . . 0.0 111.336 -178.823 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -96.14 104.91 16.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.246 179.627 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -99.31 -10.84 21.82 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.614 179.549 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.4 t -69.61 100.87 1.52 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.538 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.9 p -85.01 -15.96 42.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.038 0.447 . . . . 0.0 109.924 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.586 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -90.24 -46.13 8.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.752 -179.852 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.459 HD21 ' HA ' ' B' ' 236' ' ' VAL . 65.5 m-20 -135.08 97.71 13.38 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.283 -0.872 . . . . 0.0 109.456 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.502 ' HB2' HG13 ' A' ' 75' ' ' VAL . 41.2 Cg_exo -56.74 144.64 86.22 Favored 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 122.501 2.134 . . . . 0.0 113.612 -178.838 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.0 m -75.36 140.39 43.0 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.264 178.756 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -104.3 141.42 36.34 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.321 179.938 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.641 HG13 ' OD1' ' A' ' 86' ' ' ASP . 53.0 t -131.92 135.29 58.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.739 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 51.92 31.96 9.26 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -178.399 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.31 27.48 69.79 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.095 -179.924 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.5 p -140.39 140.83 35.57 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 117.608 0.704 . . . . 0.0 111.696 179.776 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.502 HG13 ' HB2' ' A' ' 68' ' ' PRO . 41.5 t -68.87 135.83 27.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.041 179.451 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.478 HG21 HG21 ' A' ' 80' ' ' VAL . 7.4 pt -113.34 82.22 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.974 0.416 . . . . 0.0 110.696 178.588 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -61.62 -24.69 66.87 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.441 179.885 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -118.79 167.36 11.88 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.997 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -62.46 145.54 95.6 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 122.386 2.058 . . . . 0.0 112.568 179.63 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.478 HG21 HG21 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -139.34 140.01 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 120.822 0.344 . . . . 0.0 110.996 179.291 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -74.77 133.18 42.01 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.456 179.519 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.548 HD21 ' HB2' ' A' ' 60' ' ' LEU . 95.6 mt -79.23 134.9 36.66 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.196 0.522 . . . . 0.0 110.92 -179.596 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -129.52 150.18 50.98 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.385 179.479 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -52.32 113.63 1.1 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.501 -179.852 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.29 -11.16 19.69 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.641 ' OD1' HG13 ' A' ' 71' ' ' VAL . 52.4 t0 -68.96 123.6 21.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.205 0.526 . . . . 0.0 110.998 -179.713 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.6 t -108.94 130.89 61.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.71 -179.572 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 83.9 mt -104.46 133.2 49.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.726 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 82.8 m -120.61 129.45 53.74 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.6 0.714 . . . . 0.0 112.491 -178.53 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.464 ' O ' ' N ' ' A' ' 93' ' ' ARG . 89.5 mt -121.13 122.59 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 114.501 -1.227 . . . . 0.0 108.1 178.235 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.433 HG13 HG23 ' A' ' 43' ' ' VAL . 36.8 mm 40.73 -112.45 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.016 -178.831 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.42 ' OD1' HD22 ' B' ' 242' ' ' LEU . 97.6 m-20 -103.16 10.88 37.62 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.544 0.211 . . . . 0.0 111.05 179.079 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.673 ' CZ ' HD11 ' B' ' 261' ' ' ILE . 6.5 mmm180 -120.76 143.97 48.53 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.674 -179.123 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.631 ' OG ' HD12 ' A' ' 10' ' ' ILE . 39.1 p -142.26 155.76 45.25 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.904 0.383 . . . . 0.0 110.838 -179.96 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -128.0 124.99 38.56 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.273 179.35 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -86.95 133.67 33.57 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.505 0.193 . . . . 0.0 110.827 -179.737 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.54 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 69.6 t80 -93.96 123.79 37.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.893 179.886 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -123.85 128.83 50.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.42 -179.923 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -103.53 106.62 17.18 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.147 178.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.417 ' O ' HG23 ' A' ' 4' ' ' THR . 81.6 tt0 . . . . . 0 C--N 1.331 -0.231 0 CA-C-O 120.819 0.342 . . . . 0.0 110.877 -179.934 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . 0.79 ' C ' ' H2 ' ' B' ' 230' ' ' SEP . 55.3 t . . . . . 0 CA--C 1.533 0.297 0 CA-C-O 120.743 0.306 . . . . 0.0 111.445 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.434 ' C ' ' H ' ' B' ' 231' ' ' GLN . 93.8 m-20 41.8 13.11 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 179.542 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . 0.79 ' H2 ' ' C ' ' B' ' 228' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.515 ' O ' ' O ' ' B' ' 232' ' ' GLY . 7.6 mt-30 -120.46 -10.9 9.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.183 0.516 . . . . 0.0 110.648 -179.866 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . 0.515 ' O ' ' O ' ' B' ' 231' ' ' GLN . . . -39.91 -179.34 0.01 OUTLIER Glycine 0 CA--C 1.533 1.18 0 CA-C-N 115.097 -0.956 . . . . 0.0 113.901 -178.419 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.66 162.02 42.4 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 124.344 3.363 . . . . 0.0 112.62 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.416 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -65.99 135.57 41.36 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 121.66 1.574 . . . . 0.0 112.784 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.586 ' CG2' HG22 ' A' ' 66' ' ' THR . 27.8 t -72.08 137.29 23.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.782 -179.771 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 8.0 t -69.06 127.38 32.9 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.175 -179.628 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -56.67 -25.53 60.4 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 122.378 2.052 . . . . 0.0 112.51 179.626 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 99.8 m -73.04 -45.16 59.13 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.714 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -55.17 -45.31 75.74 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.875 -179.575 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.42 HD22 ' OD1' ' A' ' 92' ' ' ASP . 89.6 mt -63.11 -42.6 99.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.791 -179.185 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -65.3 -42.18 93.32 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.368 -179.024 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -61.98 -44.88 95.8 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.167 0.508 . . . . 0.0 110.509 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.76 HH11 HH11 ' A' ' 12' ' ' ARG . 49.5 ttm-85 -64.78 -41.49 95.81 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.682 -179.345 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -60.74 -38.17 84.26 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.708 0.29 . . . . 0.0 110.532 179.398 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 88.3 p -69.29 -40.56 77.65 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.528 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -58.64 -37.53 76.13 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.66 178.78 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.517 ' O ' ' O ' ' B' ' 252' ' ' LEU . 54.1 t -63.96 -45.79 95.85 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.262 178.824 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -56.08 -24.14 38.17 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.055 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -98.65 -8.81 25.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.075 179.493 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.855 HD23 ' NH2' ' A' ' 12' ' ' ARG . 61.8 tp -125.54 116.53 21.91 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.448 177.886 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -179.66 15.08 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 119.66 -0.816 . . . . 0.0 112.879 179.474 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . 0.401 ' O ' ' CB ' ' B' ' 255' ' ' ASP . 38.8 t70 -61.19 -44.67 96.91 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 178.827 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . 0.471 ' O ' ' CG ' ' B' ' 255' ' ' ASP . 1.3 t70 164.56 69.8 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.589 -1.187 . . . . 0.0 108.632 179.921 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.645 ' OD2' HD21 ' B' ' 252' ' ' LEU . 51.5 t0 -86.19 81.45 8.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.697 -179.515 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . 0.415 ' HA ' ' NZ ' ' A' ' 11' ' ' LYS . 99.0 mttt -65.11 -9.42 22.5 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.059 -178.292 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.658 ' O ' ' N ' ' B' ' 260' ' ' GLU . 17.8 p-10 -114.66 16.26 17.53 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.363 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.587 ' O ' ' NH1' ' A' ' 93' ' ' ARG . 39.4 t0 -24.58 76.23 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 114.404 -1.271 . . . . 0.0 113.045 -179.106 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.658 ' N ' ' O ' ' B' ' 258' ' ' ASP . 47.4 mm-40 59.46 6.44 0.79 Allowed 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 177.606 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.673 HD11 ' CZ ' ' A' ' 93' ' ' ARG . 2.7 mm -114.05 133.28 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-N 119.334 0.97 . . . . 0.0 110.223 178.854 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 52.6 t -126.5 133.23 69.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.159 178.894 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -100.41 122.02 42.47 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.191 0.52 . . . . 0.0 111.266 -178.637 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -63.3 -47.62 81.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.222 179.432 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . 0.698 ' HG2' HD11 ' A' ' 24' ' ' LEU . 4.1 mp0 -96.47 161.57 26.38 Favored Pre-proline 0 N--CA 1.453 -0.314 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.474 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.98 150.18 37.87 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 123.035 2.49 . . . . 0.0 112.585 -178.877 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 28.5 pt . . . . . 0 C--N 1.325 -0.497 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.248 178.926 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo . . . . . 0 N--CA 1.5 1.865 0 CA-C-O 120.86 0.275 . . . . 0.0 112.709 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.8 p -113.49 -30.63 6.79 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.108 179.14 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.803 ' NH1' ' HB2' ' A' ' 58' ' ' ALA . 94.6 mtt-85 -98.02 113.53 25.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.136 -179.585 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -127.62 138.18 52.77 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.92 0.39 . . . . 0.0 111.331 -179.711 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.527 HD12 ' O ' ' A' ' 96' ' ' ARG . 42.3 tp -117.41 129.94 56.17 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.586 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.1 t -106.15 130.8 57.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.911 -179.536 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 m -92.2 114.81 27.45 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.253 -179.635 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.2 mt -80.96 145.66 8.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.516 179.359 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -88.13 161.69 17.16 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.076 0.465 . . . . 0.0 111.169 -179.866 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.708 HH11 ' NH2' ' A' ' 93' ' ' ARG . 58.0 mtp85 -55.21 -32.59 62.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.458 -179.445 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 42.9 t -80.74 -6.67 58.77 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.859 179.502 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.57 33.86 12.72 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -179.527 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.8 t -114.16 132.75 62.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.724 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 63.0 t0 -65.31 120.69 13.23 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.865 -179.448 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -107.88 -133.56 7.12 Favored Glycine 0 CA--C 1.536 1.366 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 -179.279 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.73 149.88 49.26 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 122.106 1.87 . . . . 0.0 112.341 -179.21 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -105.78 139.23 40.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.891 0.377 . . . . 0.0 109.991 179.493 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.775 ' CD2' HD11 ' A' ' 37' ' ' ILE . 24.6 t80 -111.45 103.5 55.1 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.684 -179.614 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.69 132.16 16.91 Favored 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 121.437 1.425 . . . . 0.0 111.972 -179.216 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 75.5 mt -87.5 45.98 1.33 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.887 -178.728 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 79.2 p -65.22 -17.82 64.81 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.276 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.5 mt -81.38 143.0 32.48 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.27 178.518 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.0 t -64.8 -23.65 67.3 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -178.872 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 66.3 m -135.03 136.87 42.44 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.56 -179.505 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.8 t -130.02 121.78 27.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.066 178.924 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.443 HD21 ' NE2' ' A' ' 47' ' ' GLN . 59.6 tp -116.78 127.65 54.54 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.579 -179.269 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.671 ' CE2' HD12 ' A' ' 37' ' ' ILE . 7.6 m-85 -104.86 141.3 36.77 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.291 178.915 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 156.33 -174.24 34.15 Favored Glycine 0 N--CA 1.469 0.867 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.415 178.922 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.636 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 83.2 mtm-85 -78.62 -29.3 45.86 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.168 179.56 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.553 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -54.47 148.98 19.94 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.643 -178.759 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.509 HG23 ' N ' ' A' ' 34' ' ' GLU . 11.1 tp -67.78 -40.81 84.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.084 0.469 . . . . 0.0 110.023 179.512 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.509 ' N ' HG23 ' A' ' 33' ' ' ILE . 80.1 mm-40 -54.4 -21.8 10.69 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.773 179.546 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.553 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 58.8 m -55.64 118.62 4.68 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.93 179.553 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -55.89 -29.69 60.38 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 179.936 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.775 HD11 ' CD2' ' A' ' 20' ' ' PHE . 73.0 mt -128.48 120.55 53.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.36 176.226 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 78.2 ttt-85 -108.35 137.26 46.61 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.602 -177.898 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.786 HG21 HD12 ' A' ' 41' ' ' LEU . 96.2 mt -121.45 132.09 71.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.4 -179.54 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -80.94 32.21 0.32 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -177.962 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.786 HD12 HG21 ' A' ' 39' ' ' ILE . 16.4 mt -97.2 133.54 23.87 Favored Pre-proline 0 C--N 1.32 -0.691 0 C-N-CA 120.049 -0.661 . . . . 0.0 110.711 -179.938 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.12 -10.41 25.88 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 122.364 2.043 . . . . 0.0 112.221 -179.746 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.556 HG21 ' CE2' ' B' ' 241' ' ' PHE . 32.2 m -105.47 4.05 10.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.269 -179.384 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.636 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 17.4 t -88.77 131.15 36.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 177.714 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.77 163.16 19.87 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.082 0.467 . . . . 0.0 110.812 -178.858 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -61.38 -40.9 96.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.013 -178.8 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.608 ' O ' ' N ' ' A' ' 49' ' ' CYS . 12.3 mm100 -110.31 -17.0 13.6 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 123.573 0.546 . . . . 0.0 110.299 -179.852 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 21.7 t60 33.09 -75.73 0.0 OUTLIER 'General case' 0 C--O 1.239 0.525 0 CA-C-N 114.943 -1.026 . . . . 0.0 113.634 -179.601 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.608 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -135.48 139.77 44.3 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -178.299 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -127.57 133.52 49.76 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.633 179.707 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.0 mt -119.04 134.14 63.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.082 -179.855 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -116.63 127.75 54.75 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.065 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.3 mt -109.46 111.52 36.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.473 0.654 . . . . 0.0 111.218 -179.756 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.548 ' O ' ' N ' ' A' ' 56' ' ' GLN . 94.8 m-70 -110.51 143.18 41.25 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.801 -1.09 . . . . 0.0 108.984 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.557 ' OE1' ' N ' ' A' ' 55' ' ' GLU . 55.1 mp0 -40.65 -24.44 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.853 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.548 ' N ' ' O ' ' A' ' 54' ' ' HIS . 88.8 mm-40 -68.16 -69.26 0.33 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.07 179.044 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.445 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 5.5 tp10 -158.91 -168.31 2.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.987 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.803 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -109.73 126.09 53.36 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.099 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.29 130.25 70.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.467 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.497 ' HB2' HD21 ' A' ' 82' ' ' LEU . 26.6 tp -98.66 130.21 45.16 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.429 179.724 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -117.47 137.65 52.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.857 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.58 HD21 ' CB ' ' A' ' 68' ' ' PRO . 64.1 t-20 -98.08 104.68 16.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.08 179.805 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -96.27 -7.28 35.88 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.864 179.342 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.38 100.81 10.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.984 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.1 m -87.08 -37.69 17.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.677 179.75 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.583 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -61.08 -44.11 97.86 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.418 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -141.23 101.23 6.24 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.119 179.415 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.58 ' CB ' HD21 ' A' ' 62' ' ' ASN . 44.5 Cg_endo -67.76 152.32 77.76 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 121.676 1.584 . . . . 0.0 113.602 -178.242 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.5 m -77.38 149.11 35.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.775 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -111.99 140.53 46.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.345 179.404 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.5 t -128.5 136.32 60.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.598 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 53.65 32.97 15.52 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.225 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.98 25.93 74.88 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.437 -179.759 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 66.7 m -141.14 141.78 34.12 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 117.114 0.457 . . . . 0.0 111.856 -179.564 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 75.2 t -67.91 139.14 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.687 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 9.2 pt -111.2 82.63 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-O 121.126 0.488 . . . . 0.0 111.049 178.55 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -62.56 -32.79 73.82 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.98 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -113.95 156.95 43.21 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.834 178.676 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.6 152.39 80.55 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.18 1.92 . . . . 0.0 111.582 178.928 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.1 m -146.89 149.0 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 121.28 0.562 . . . . 0.0 112.03 179.89 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -72.4 133.68 45.02 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.871 179.678 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.497 HD21 ' HB2' ' A' ' 60' ' ' LEU . 96.4 mt -77.26 137.94 39.11 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.098 0.475 . . . . 0.0 110.767 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -128.56 147.12 50.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.514 179.535 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.523 ' HD1' ' C ' ' A' ' 99' ' ' ASN . 6.8 t60 -56.06 118.99 5.17 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.579 -179.525 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.27 -20.04 23.9 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -179.801 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -66.44 131.18 45.49 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.595 179.305 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.6 t -114.86 131.35 67.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.159 -178.501 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 84.6 mt -95.05 133.75 34.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.725 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.0 m -120.7 128.38 52.9 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.62 0.724 . . . . 0.0 112.574 -178.833 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.543 ' O ' ' N ' ' A' ' 92' ' ' ASP . 97.5 mt -115.06 123.4 70.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 114.559 -1.2 . . . . 0.0 108.664 178.54 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.457 ' CG2' ' CZ ' ' B' ' 245' ' ' ARG . 32.2 mm 38.71 -93.25 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.35 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.78 ' H ' ' NH1' ' B' ' 245' ' ' ARG . 16.9 t0 -125.97 20.16 7.68 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.011 0.434 . . . . 0.0 110.86 179.139 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.754 ' CZ ' HD11 ' A' ' 41' ' ' LEU . 75.5 mtt85 -124.85 142.57 51.35 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.351 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 30.2 p -139.61 154.73 47.64 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.96 179.763 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.505 ' HE1' HD12 ' A' ' 90' ' ' ILE . 17.1 m-85 -125.16 121.96 35.72 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.035 179.54 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.527 ' O ' HD12 ' A' ' 7' ' ' LEU . 39.1 ttp-105 -85.08 130.67 34.57 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.125 -0.63 . . . . 0.0 110.713 -179.256 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.63 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 87.7 t80 -94.66 123.67 38.24 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.962 -179.556 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -121.41 122.88 40.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.962 179.647 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.523 ' C ' ' HD1' ' A' ' 84' ' ' HIS . 54.7 t-20 -117.72 110.8 18.29 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.976 179.001 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 . . . . . 0 C--N 1.328 -0.368 0 CA-C-O 121.008 0.432 . . . . 0.0 110.763 -179.241 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 29.0 m . . . . . 0 N--CA 1.455 -0.223 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.468 ' C ' ' H ' ' B' ' 231' ' ' GLN . 88.6 m-20 -68.11 142.24 55.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.112 -179.545 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.468 ' H ' ' C ' ' B' ' 229' ' ' ASP . 75.8 mt-30 -127.81 26.49 5.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.255 -179.631 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -114.32 -157.12 11.85 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 120.711 -0.756 . . . . 0.0 111.818 -178.882 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.78 151.27 71.93 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 123.755 2.97 . . . . 0.0 113.555 -179.294 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.495 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.91 141.84 49.96 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.14 1.893 . . . . 0.0 113.997 -178.183 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.583 ' CG2' HG22 ' A' ' 66' ' ' THR . 39.4 t -76.0 133.62 30.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 114.781 -1.1 . . . . 0.0 110.998 -179.454 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 7.6 t -75.31 129.58 37.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.675 179.367 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -56.13 -27.6 66.09 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 122.889 2.393 . . . . 0.0 112.671 -179.643 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 97.2 m -74.08 -42.52 60.04 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.857 0.361 . . . . 0.0 110.161 178.664 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.556 ' CE2' HG21 ' A' ' 43' ' ' VAL . 64.1 t80 -58.02 -45.75 86.41 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -179.54 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 87.2 mt -62.61 -40.86 98.3 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.177 179.964 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -61.52 -39.72 92.04 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.713 179.609 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . 0.45 ' HE ' ' HA ' ' B' ' 241' ' ' PHE . 88.7 mtm180 -62.08 -40.38 95.62 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.77 179.69 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.78 ' NH1' ' H ' ' A' ' 92' ' ' ASP . 89.4 mtt180 -60.1 -42.48 94.79 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.224 179.084 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -64.23 -42.79 96.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.016 0.436 . . . . 0.0 110.488 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 35.8 p -63.86 -44.86 91.85 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.73 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -58.58 -40.29 82.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.965 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.489 HG23 ' O ' ' B' ' 245' ' ' ARG . 55.3 t -62.09 -44.0 98.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.267 -179.885 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -64.34 -33.77 76.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.677 178.837 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -76.26 -13.13 60.17 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.839 179.191 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 67.5 mt -104.23 -178.39 3.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.128 178.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -118.95 151.21 38.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.795 179.699 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -65.18 -20.0 66.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.887 -179.641 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 42.0 p-10 -82.64 18.94 1.39 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.762 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -70.53 93.78 0.93 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.403 0.62 . . . . 0.0 111.066 -179.289 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -66.18 -31.28 72.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.01 -0.995 . . . . 0.0 112.564 179.962 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -103.57 129.66 50.84 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.995 0.426 . . . . 0.0 110.908 -179.766 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.65 ' OD1' ' N ' ' B' ' 260' ' ' GLU . 35.7 t0 -125.3 158.97 32.85 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.555 0.693 . . . . 0.0 109.928 179.621 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.65 ' N ' ' OD1' ' B' ' 259' ' ' ASP . 94.6 mt-10 -56.84 13.02 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.684 -1.144 . . . . 0.0 112.11 -179.354 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.597 ' H ' ' C ' ' B' ' 259' ' ' ASP . 68.6 mt -108.24 132.16 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.757 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 53.4 t -128.25 134.39 65.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.805 -178.609 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -99.54 121.92 41.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.51 0.671 . . . . 0.0 111.176 -178.955 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -67.06 -44.88 79.0 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.902 178.874 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -92.76 150.63 39.91 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.706 -178.235 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.84 143.98 47.1 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 122.86 2.373 . . . . 0.0 112.581 179.999 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 33.3 pt . . . . . 0 C--N 1.33 -0.265 0 CA-C-O 121.04 0.448 . . . . 0.0 110.7 179.209 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo . . . . . 0 N--CA 1.496 1.628 0 CA-C-O 120.783 0.243 . . . . 0.0 112.564 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.2 p -122.67 -52.27 1.91 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.064 179.013 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.624 ' NH1' ' HB2' ' A' ' 58' ' ' ALA . 96.3 mtt-85 -89.47 124.5 34.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.922 -179.858 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -134.43 139.39 45.52 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.287 -0.565 . . . . 0.0 112.322 -179.342 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.445 HD11 HD11 ' A' ' 22' ' ' LEU . 75.7 mt -113.55 143.56 44.33 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.072 178.718 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.536 HG22 ' CD2' ' A' ' 19' ' ' HIS . 70.3 t -117.03 128.93 74.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.224 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.4 ' O ' HG22 ' A' ' 9' ' ' THR . 1.5 m -92.87 113.87 26.26 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.132 0.492 . . . . 0.0 112.076 -178.436 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 86.8 mt -79.19 143.86 11.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.784 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -89.54 161.6 16.12 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.223 0.535 . . . . 0.0 110.9 179.64 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.771 HH12 ' NE2' ' B' ' 248' ' ' GLN . 80.9 mtp180 -58.19 -33.41 69.23 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.802 -179.326 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.7 t -76.02 -13.11 60.23 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.706 179.218 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.39 35.05 5.83 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 -178.878 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.0 t -119.04 132.42 68.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.092 0.472 . . . . 0.0 110.966 -179.9 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.48 ' OD1' ' CG1' ' A' ' 8' ' ' VAL . 43.6 t0 -68.5 124.98 25.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.749 179.581 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -117.58 -126.41 3.72 Favored Glycine 0 CA--C 1.541 1.673 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.225 -178.916 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.29 147.88 42.76 Favored 'Trans proline' 0 N--CA 1.504 2.107 0 C-N-CA 122.741 2.294 . . . . 0.0 114.523 -177.808 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.536 ' CD2' HG22 ' A' ' 8' ' ' VAL . 60.1 m170 -104.77 144.73 31.34 Favored 'General case' 0 C--N 1.335 -0.059 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.08 179.37 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.473 ' CD2' HD11 ' A' ' 37' ' ' ILE . 72.1 t80 -121.82 105.44 37.99 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.996 -179.579 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -75.63 132.84 15.02 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 C-N-CA 121.682 1.588 . . . . 0.0 112.292 -179.14 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.445 HD11 HD11 ' A' ' 7' ' ' LEU . 89.6 mt -81.3 54.73 2.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.834 0.349 . . . . 0.0 110.935 -179.253 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.431 ' HB3' HE22 ' B' ' 265' ' ' GLN . 38.7 t -59.8 -37.58 79.53 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.877 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 66.0 mt -74.02 141.6 45.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.666 179.519 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 m -66.76 -15.23 63.41 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.075 -0.512 . . . . 0.0 112.271 -178.029 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.49 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 40.4 m -136.24 137.87 41.24 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.017 0.437 . . . . 0.0 110.724 179.504 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.668 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 4.3 t -131.58 122.87 26.81 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.908 179.65 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.501 HD21 ' HG2' ' A' ' 47' ' ' GLN . 42.4 tp -119.77 128.16 53.47 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.896 -178.98 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.668 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 14.1 m-85 -104.23 140.33 38.0 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.179 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.95 -171.79 38.81 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 119.647 -1.263 . . . . 0.0 112.764 179.1 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.623 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 85.4 mtm-85 -80.37 -28.08 38.07 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.418 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.55 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -60.68 141.22 48.06 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.3 -0.476 . . . . 0.0 112.287 -178.168 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.492 HG23 ' N ' ' A' ' 34' ' ' GLU . 11.0 tp -66.06 -41.43 89.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.095 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.492 ' N ' HG23 ' A' ' 33' ' ' ILE . 82.5 tt0 -54.52 -16.41 2.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.125 179.839 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.55 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 33.5 m -66.01 135.93 55.35 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.265 179.862 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.49 ' OD2' ' O ' ' A' ' 26' ' ' THR . 56.0 m-20 -61.42 -33.32 73.51 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.38 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.651 HD12 ' CE2' ' A' ' 29' ' ' PHE . 93.4 mt -127.66 122.46 59.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 177.17 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 76.8 ttt-85 -111.26 137.99 48.29 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.607 -178.317 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.452 HG22 ' H ' ' A' ' 41' ' ' LEU . 92.9 mt -119.11 131.87 70.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.846 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -75.13 20.69 0.13 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.686 -178.693 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.538 HD11 ' CZ ' ' A' ' 93' ' ' ARG . 22.7 mt -93.52 124.44 57.21 Favored Pre-proline 0 C--N 1.321 -0.66 0 C-N-CA 120.261 -0.575 . . . . 0.0 111.105 -179.449 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.47 -14.25 27.79 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 C-N-CA 121.901 1.734 . . . . 0.0 112.375 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 18.0 m -88.67 0.62 7.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.135 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.623 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 72.6 t -95.33 136.11 27.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.186 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.4 m -69.39 171.16 9.09 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.322 0.582 . . . . 0.0 111.699 -178.749 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -61.84 -42.11 98.63 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.671 -178.13 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.679 ' O ' ' N ' ' A' ' 49' ' ' CYS . 87.8 mt-30 -113.75 -14.99 12.51 Favored 'General case' 0 CA--C 1.521 -0.155 0 O-C-N 123.365 0.416 . . . . 0.0 110.337 179.873 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 30.1 t60 33.44 -73.11 0.0 OUTLIER 'General case' 0 C--O 1.236 0.393 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 179.654 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.679 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.68 135.35 45.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.06 0.457 . . . . 0.0 111.921 -178.649 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -123.85 128.66 49.82 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.389 179.3 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.4 mt -115.16 134.46 58.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.351 -179.686 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.453 ' CD ' ' NE2' ' A' ' 54' ' ' HIS . 83.9 tt0 -120.01 128.29 53.4 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.782 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.437 HD13 ' HD2' ' A' ' 5' ' ' ARG . 97.0 mt -108.18 118.8 56.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.471 0.653 . . . . 0.0 112.611 -178.549 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.545 ' O ' ' N ' ' A' ' 56' ' ' GLN . 99.0 m-70 -115.3 141.23 48.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.326 178.859 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.6 mm-40 -40.12 -25.94 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.906 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.545 ' N ' ' O ' ' A' ' 54' ' ' HIS . 85.9 mt-30 -65.71 -68.3 0.38 Allowed 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.2 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -159.94 -162.77 1.04 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.905 179.614 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.624 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -114.29 126.44 55.03 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.398 179.147 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.7 mt -112.68 127.9 69.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.441 0.638 . . . . 0.0 111.95 -178.923 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 40.1 tp -95.44 128.85 42.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.955 -179.74 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -115.33 135.8 53.77 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.549 -179.748 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.4 ' OD1' ' C ' ' A' ' 62' ' ' ASN . 51.1 t-20 -95.12 106.22 18.21 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.897 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -100.86 -10.05 21.05 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 179.279 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.3 t -78.85 100.61 7.26 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.269 -179.619 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.4 p -76.95 -33.84 57.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.042 0.448 . . . . 0.0 110.636 178.918 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.82 -40.65 65.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.485 -178.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -141.29 93.52 7.96 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.163 -179.726 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.06 145.67 51.94 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.344 2.029 . . . . 0.0 113.053 -179.488 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.2 m -72.65 139.54 47.39 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.338 179.533 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -102.89 139.77 38.03 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.662 179.641 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.648 HG13 ' OD1' ' A' ' 86' ' ' ASP . 75.3 t -133.46 134.43 56.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.097 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.4 m120 54.79 26.92 8.18 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -178.397 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.53 24.13 66.05 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-N 115.039 -0.982 . . . . 0.0 112.048 179.585 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.2 t -138.48 140.4 39.2 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 117.371 0.585 . . . . 0.0 111.28 179.695 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.47 ' H ' HG12 ' A' ' 75' ' ' VAL . 0.2 OUTLIER -70.99 140.38 18.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.183 179.918 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.2 pt -115.42 91.95 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.122 179.941 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -66.87 -25.72 66.54 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.653 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.19 162.19 27.41 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.505 179.484 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.13 154.16 66.53 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.62 2.213 . . . . 0.0 112.247 179.899 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.9 m -145.65 148.62 17.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.833 -179.781 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.2 mtm-85 -75.65 134.83 40.5 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.158 179.531 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 90.0 mt -89.7 134.02 34.37 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.138 0.495 . . . . 0.0 111.161 -179.677 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -125.1 156.62 37.99 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.052 179.143 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.414 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 4.2 t60 -54.1 120.02 5.87 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.546 -0.461 . . . . 0.0 111.089 -178.701 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.07 -15.65 28.11 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 179.797 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.648 ' OD1' HG13 ' A' ' 71' ' ' VAL . 59.1 t0 -65.41 128.21 34.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.882 0.372 . . . . 0.0 110.422 179.988 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.53 HG22 ' HG2' ' A' ' 96' ' ' ARG . 53.6 t -112.13 130.93 64.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.291 -179.382 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.7 mt -101.64 134.02 43.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.383 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 76.9 m -124.33 129.22 50.34 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -178.53 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.585 ' O ' ' N ' ' A' ' 92' ' ' ASP . 95.0 mt -112.18 126.67 69.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 114.516 -1.22 . . . . 0.0 108.159 177.57 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.527 HG23 ' SG ' ' B' ' 237' ' ' CYS . 45.4 mm 40.19 -92.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 C-N-CA 120.269 -0.572 . . . . 0.0 109.716 -179.257 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.585 ' N ' ' O ' ' A' ' 90' ' ' ILE . 0.7 OUTLIER -129.43 20.48 5.69 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.928 0.395 . . . . 0.0 110.87 179.732 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.717 ' HE ' HH12 ' B' ' 245' ' ' ARG . 98.5 mtt180 -124.31 142.09 51.54 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.326 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 75.6 m -137.55 151.36 48.31 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.203 -179.725 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.455 ' HE1' HD12 ' A' ' 90' ' ' ILE . 62.6 m-85 -121.95 122.33 39.13 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.534 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.53 ' HG2' HG22 ' A' ' 87' ' ' VAL . 98.2 mtt180 -84.95 133.96 34.26 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 119.638 -0.825 . . . . 0.0 111.375 -178.581 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -95.8 120.08 35.43 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.158 179.532 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -122.31 119.67 31.8 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.263 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.414 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 64.8 t-20 -102.11 114.12 27.98 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.333 179.7 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 . . . . . 0 C--N 1.326 -0.425 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.834 179.469 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 28.3 m . . . . . 0 N--CA 1.453 -0.306 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.513 ' C ' ' H ' ' B' ' 231' ' ' GLN . 77.6 m-20 -72.56 141.03 48.43 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.699 179.785 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . 0.44 ' C ' ' CD ' ' B' ' 231' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.513 ' H ' ' C ' ' B' ' 229' ' ' ASP . 16.5 mp0 -136.86 31.28 2.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.599 179.608 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -115.02 -161.62 13.35 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -179.547 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -60.84 150.93 80.69 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 123.456 2.771 . . . . 0.0 112.685 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.661 ' O2P' HG21 ' B' ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -74.62 172.04 16.99 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 122.262 1.975 . . . . 0.0 111.607 178.704 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 4.9 p -116.85 132.75 65.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.328 -179.664 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . 0.527 ' SG ' HG23 ' A' ' 91' ' ' ILE . 45.9 t -69.9 126.24 29.11 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.532 -179.256 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . 0.538 ' P ' ' HG1' ' B' ' 240' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . 0.477 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 35.8 Cg_exo -58.22 -25.9 74.07 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 C-N-CA 122.876 2.384 . . . . 0.0 113.53 -178.993 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . 0.538 ' HG1' ' P ' ' B' ' 238' ' ' TPO . 5.2 p -73.29 -41.6 63.39 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.026 -0.669 . . . . 0.0 109.305 178.28 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.445 ' HZ ' HD22 ' A' ' 41' ' ' LEU . 57.9 t80 -58.24 -46.65 85.56 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.12 -179.524 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.424 ' HA ' HD23 ' B' ' 242' ' ' LEU . 94.4 mt -62.79 -40.45 97.35 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.605 -179.674 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -63.9 -37.37 87.14 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.271 179.545 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -62.4 -41.75 98.91 Favored 'General case' 0 C--N 1.334 -0.1 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.488 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.841 ' O ' HG23 ' B' ' 249' ' ' VAL . 60.9 ttm-85 -58.07 -44.19 87.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.006 -179.495 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -63.33 -40.4 97.22 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.029 0.442 . . . . 0.0 110.759 -179.475 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 41.8 m -69.0 -46.13 68.81 Favored 'General case' 0 C--N 1.334 -0.104 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.65 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . 0.771 ' NE2' HH12 ' A' ' 12' ' ' ARG . 59.5 tt0 -61.78 -36.94 82.52 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.818 -179.55 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.841 HG23 ' O ' ' B' ' 245' ' ' ARG . 75.4 t -61.12 -45.47 98.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 120.257 -0.577 . . . . 0.0 109.513 179.42 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -59.53 -29.69 68.07 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.806 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -91.96 -15.21 28.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.609 178.886 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.53 ' N ' ' O ' ' B' ' 248' ' ' GLN . 40.7 tp -75.07 139.56 42.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.442 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -103.07 136.74 42.31 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.39 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -67.04 -23.72 65.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.823 -179.616 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 49.6 p-10 -75.98 -0.27 20.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.099 -179.2 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.455 ' O ' ' C ' ' B' ' 257' ' ' LYS . 90.3 m-20 -93.32 -2.96 54.31 Favored 'General case' 0 C--N 1.334 -0.099 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.403 179.175 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . 0.564 ' O ' ' C ' ' B' ' 258' ' ' ASP . 88.1 tttt 32.82 -103.19 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.441 -179.699 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.564 ' C ' ' O ' ' B' ' 257' ' ' LYS . 99.3 m-20 -17.66 87.15 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.587 0.708 . . . . 0.0 110.652 -179.308 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' B' ' 257' ' ' LYS . 23.3 p-10 -86.78 59.41 5.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.576 -1.193 . . . . 0.0 112.078 -178.481 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.637 ' OE1' ' NH2' ' A' ' 93' ' ' ARG . 95.1 mt-10 62.54 4.72 1.43 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.317 -0.401 . . . . 0.0 112.035 179.15 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 79.4 mt -106.78 132.31 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 177.589 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 47.6 t -126.4 133.09 69.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 120.904 0.383 . . . . 0.0 111.014 -179.15 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -97.88 124.13 42.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.12 -179.297 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -69.36 -45.42 69.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.261 179.457 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . 0.431 HE22 ' HB3' ' A' ' 23' ' ' SER . 0.0 OUTLIER -93.22 155.79 40.73 Favored Pre-proline 0 CA--C 1.521 -0.16 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.201 -179.428 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.85 144.26 70.18 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 122.584 2.189 . . . . 0.0 113.052 -179.664 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 45.0 pt . . . . . 0 C--N 1.331 -0.206 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.87 178.835 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo . . . . . 0 N--CA 1.494 1.552 0 CA-C-O 120.825 0.261 . . . . 0.0 112.064 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.0 p -107.72 -46.59 3.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.976 0.417 . . . . 0.0 110.505 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.3 mtt85 -100.12 123.42 44.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.171 -179.616 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -130.01 144.35 51.29 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.685 -179.84 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 83.9 mt -113.18 135.45 53.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.392 179.045 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.6 m -110.79 132.06 60.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-O 120.95 0.405 . . . . 0.0 110.019 179.254 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.7 m -79.97 142.53 34.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.495 -0.775 . . . . 0.0 113.044 -178.193 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.478 HD12 ' HB3' ' A' ' 94' ' ' SER . 96.5 mt -112.15 136.67 47.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.024 176.611 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -90.32 158.94 16.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.842 0.353 . . . . 0.0 110.432 179.754 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -58.45 -30.92 67.3 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.088 -178.875 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.3 p -76.44 -11.58 59.91 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.199 179.594 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.08 35.57 6.02 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -179.635 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 54.0 t -120.14 132.04 70.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.935 0.398 . . . . 0.0 110.816 -179.81 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -81.21 138.41 35.81 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.805 179.624 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -133.42 -116.15 1.68 Allowed Glycine 0 CA--C 1.538 1.517 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.124 -179.718 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.36 153.1 61.35 Favored 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 122.473 2.116 . . . . 0.0 112.849 -178.83 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -116.04 161.68 18.52 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.604 -179.832 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.509 ' CD2' HD11 ' A' ' 37' ' ' ILE . 34.2 t80 -122.88 91.84 49.5 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.417 -179.563 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -59.96 127.63 23.96 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 121.957 1.772 . . . . 0.0 110.564 179.346 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.6 mt -82.02 57.56 3.56 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.566 -0.454 . . . . 0.0 111.233 -179.002 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 89.8 p -67.84 -22.97 65.12 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.576 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 80.2 mt -83.63 138.9 33.13 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.233 179.79 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 92.9 p -64.22 -18.09 64.19 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.03 -179.48 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.495 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 88.0 m -134.37 134.82 42.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.985 179.91 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.666 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 1.4 t -128.21 118.11 22.75 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.235 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.5 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 40.8 tp -117.47 128.73 55.27 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.22 -177.699 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.783 ' CE2' HD12 ' A' ' 37' ' ' ILE . 19.8 m-85 -104.89 135.8 45.57 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.657 179.045 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 164.22 178.62 37.86 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 120.283 -0.961 . . . . 0.0 112.778 179.034 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.424 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 42.3 mtm180 -75.44 -31.1 60.2 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.903 0.382 . . . . 0.0 110.503 178.654 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -50.48 144.86 10.58 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.19 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.455 HG23 ' N ' ' A' ' 34' ' ' GLU . 8.6 tp -66.92 -41.05 87.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.908 -179.585 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.455 ' N ' HG23 ' A' ' 33' ' ' ILE . 84.8 tt0 -58.03 -20.83 41.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.869 0.366 . . . . 0.0 110.813 -179.92 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 62.4 m -57.63 131.52 50.48 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.878 -179.512 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.5 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 56.0 m-20 -60.25 -33.56 72.47 Favored 'General case' 0 C--N 1.334 -0.097 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -178.781 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.783 HD12 ' CE2' ' A' ' 29' ' ' PHE . 84.8 mt -126.12 123.8 64.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 176.65 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.493 HH21 HG11 ' B' ' 262' ' ' VAL . 84.2 mtm-85 -105.45 135.04 47.58 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.439 -0.505 . . . . 0.0 110.609 -178.246 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 95.8 mt -118.78 131.02 72.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 120.304 -0.559 . . . . 0.0 111.36 -179.82 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -75.45 32.26 0.11 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.52 -0.763 . . . . 0.0 112.318 -178.794 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.72 HD21 ' OE1' ' B' ' 260' ' ' GLU . 61.0 mt -106.18 127.07 29.02 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.65 179.378 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.33 -8.49 22.79 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 122.406 2.071 . . . . 0.0 113.117 -179.42 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.5 m -95.38 6.77 7.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.39 179.737 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.424 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 36.1 t -96.86 135.36 31.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.331 179.475 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.493 ' HB2' ' H ' ' A' ' 48' ' ' HIS . 4.1 m -73.02 173.68 8.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.205 -178.883 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -63.02 -40.35 97.49 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.819 179.476 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.64 ' O ' ' N ' ' A' ' 49' ' ' CYS . 9.8 mm100 -113.24 -23.3 10.02 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.974 -0.291 . . . . 0.0 110.519 -179.712 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.493 ' H ' ' HB2' ' A' ' 45' ' ' SER . 20.4 t60 43.58 -77.69 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.894 -179.735 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.64 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -134.03 136.97 44.41 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.991 -179.517 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -125.77 133.13 52.16 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.485 179.75 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 98.6 mt -115.98 131.43 68.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.058 179.945 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.587 ' OE2' ' NE2' ' A' ' 54' ' ' HIS . 79.4 tt0 -118.11 125.73 50.85 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.765 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 86.2 mt -108.06 123.17 63.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.896 0.855 . . . . 0.0 112.992 -177.826 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.587 ' NE2' ' OE2' ' A' ' 52' ' ' GLU . 98.5 m-70 -117.57 136.92 52.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 113.989 -1.459 . . . . 0.0 109.056 178.902 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 54' ' ' HIS . 96.2 mt-10 -41.18 -32.23 0.26 Allowed 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.156 -0.617 . . . . 0.0 109.89 -179.571 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -64.22 -67.93 0.39 Allowed 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.291 -0.564 . . . . 0.0 109.893 179.224 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.569 ' CG ' ' H ' ' A' ' 58' ' ' ALA . 52.9 tt0 -150.56 -179.35 7.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.863 -178.593 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.569 ' H ' ' CG ' ' A' ' 57' ' ' GLU . . . -108.83 131.86 54.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.052 -179.697 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.8 mt -119.85 129.5 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -178.33 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.487 HD11 ' SG ' ' A' ' 49' ' ' CYS . 38.6 tp -97.39 129.03 44.67 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.041 -0.982 . . . . 0.0 110.051 179.47 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -115.92 136.32 53.15 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 179.595 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.628 HD21 ' CB ' ' A' ' 68' ' ' PRO . 62.7 t-20 -100.32 105.24 16.74 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 120.965 0.412 . . . . 0.0 111.134 -179.477 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -97.52 -9.57 26.85 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.229 179.855 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.87 98.55 7.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.021 0.438 . . . . 0.0 110.271 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.4 t -76.27 -42.65 44.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.844 179.396 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.405 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.3 OUTLIER -61.28 -45.43 94.52 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.293 -178.68 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.41 HD21 ' HA ' ' B' ' 236' ' ' VAL . 37.2 m-80 -139.36 94.84 9.4 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 115.503 -0.771 . . . . 0.0 108.958 -179.503 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.628 ' CB ' HD21 ' A' ' 62' ' ' ASN . 35.6 Cg_endo -64.86 150.52 88.01 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 121.528 1.485 . . . . 0.0 112.507 -178.173 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.8 m -73.01 142.11 47.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.7 -178.883 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -99.51 148.04 24.68 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.788 179.84 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.407 ' O ' HG13 ' A' ' 71' ' ' VAL . 5.6 p -132.61 135.47 57.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.239 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 50.85 33.02 7.91 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.455 -179.861 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.69 27.69 70.5 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -179.442 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 10.4 t -138.12 139.42 39.43 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.462 -179.501 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 77.8 t -69.22 134.0 30.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.031 0.443 . . . . 0.0 111.636 -179.715 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.16 95.58 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.482 179.266 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -81.92 -16.62 49.95 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.666 -179.209 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -110.01 156.91 39.21 Favored Pre-proline 0 C--O 1.222 -0.372 0 C-N-CA 121.099 -0.241 . . . . 0.0 110.481 -179.733 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -64.57 145.98 88.26 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.369 2.046 . . . . 0.0 112.669 -179.807 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.9 m -147.61 148.08 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.106 -179.463 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 91.2 mtm180 -73.97 132.36 42.33 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.403 179.391 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 82' ' ' LEU . 77.8 mt -79.39 141.2 37.09 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.996 0.427 . . . . 0.0 111.417 179.693 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -132.75 151.29 52.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.775 179.55 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.536 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 5.5 t60 -56.23 116.82 3.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.024 -179.801 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.92 -14.32 26.55 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.061 179.235 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -74.48 134.97 42.26 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.229 179.867 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.47 HG22 ' HG2' ' A' ' 96' ' ' ARG . 59.0 t -108.07 132.13 56.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.749 -178.891 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 88.8 mt -104.99 131.87 53.12 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.769 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 65.2 m -120.78 130.01 53.83 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 119.745 -0.782 . . . . 0.0 112.778 -177.96 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.597 ' O ' ' N ' ' A' ' 93' ' ' ARG . 96.6 mt -114.58 131.19 67.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 114.29 -1.323 . . . . 0.0 108.611 178.335 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.677 HG22 HH22 ' B' ' 245' ' ' ARG . 95.6 mt -20.38 95.26 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -179.565 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.554 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 10.5 t0 90.42 -23.55 0.09 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 178.084 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.597 ' N ' ' O ' ' A' ' 90' ' ' ILE . 88.2 mtt-85 -130.0 147.02 51.71 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.03 -179.621 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.478 ' HB3' HD12 ' A' ' 10' ' ' ILE . 38.7 t -139.1 152.27 47.37 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.384 0.611 . . . . 0.0 110.598 -179.911 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.568 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 91.2 m-85 -125.07 121.36 34.08 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.649 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.47 ' HG2' HG22 ' A' ' 87' ' ' VAL . 99.9 mtt180 -87.51 140.27 29.69 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 119.453 -0.899 . . . . 0.0 109.976 -179.561 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -96.65 123.17 40.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.031 -178.292 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -126.03 120.77 31.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.781 179.711 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.536 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 64.4 t-20 -108.36 113.92 27.37 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.259 179.817 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.0 tp10 . . . . . 0 C--N 1.327 -0.405 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.58 -179.571 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 54.6 t . . . . . 0 N--CA 1.449 -0.482 0 CA-C-O 120.924 0.393 . . . . 0.0 109.946 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.434 ' C ' ' OD1' ' B' ' 229' ' ' ASP . 49.8 p30 -100.55 173.99 6.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.675 -179.813 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . 0.596 ' O ' ' NE2' ' B' ' 231' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.596 ' NE2' ' O ' ' B' ' 230' ' ' SEP . 97.0 mm-40 -140.82 62.08 1.49 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.405 -179.724 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -119.95 179.53 16.54 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -179.677 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.69 159.89 49.66 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 123.582 2.855 . . . . 0.0 113.127 -179.838 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.44 145.33 47.49 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 121.996 1.797 . . . . 0.0 113.722 -179.176 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.41 ' HA ' HD21 ' A' ' 67' ' ' ASN . 50.1 t -64.42 132.46 30.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.036 179.231 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -67.62 137.55 55.72 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.063 -179.693 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -57.71 -25.81 70.04 Favored 'Trans proline' 0 N--CA 1.499 1.835 0 C-N-CA 123.023 2.482 . . . . 0.0 113.009 -179.665 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 86.0 m -74.84 -45.99 39.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.949 0.404 . . . . 0.0 110.881 179.234 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.641 ' CE2' ' CZ ' ' B' ' 245' ' ' ARG . 57.2 t80 -58.37 -48.31 81.0 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.033 -178.31 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.451 HD23 ' NH2' ' B' ' 245' ' ' ARG . 44.7 mt -64.73 -42.62 95.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.252 0.548 . . . . 0.0 110.757 179.681 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -62.99 -43.09 99.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.016 -178.72 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -61.55 -45.56 93.65 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.692 -179.041 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.677 HH22 HG22 ' A' ' 91' ' ' ILE . 89.7 mtm180 -63.86 -37.05 85.96 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.904 -178.771 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.7 -39.7 92.42 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.305 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 70.2 m -63.49 -44.09 95.38 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.606 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 93.9 mm-40 -61.11 -37.11 81.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.281 -179.779 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 47.1 t -62.22 -44.61 99.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.914 179.792 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -61.37 -27.14 68.31 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.564 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 -82.85 -14.62 53.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.828 179.254 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 94.3 mt -101.21 -179.83 4.15 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.307 178.543 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . 0.589 ' O ' ' N ' ' B' ' 255' ' ' ASP . 18.3 m-80 -150.8 -173.07 4.37 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.838 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . 0.53 ' C ' ' H ' ' B' ' 256' ' ' ASP . 14.9 t70 -43.57 -15.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.237 -179.719 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . 0.589 ' N ' ' O ' ' B' ' 253' ' ' ASN . 87.8 m-20 -73.52 16.39 0.2 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.308 0.575 . . . . 0.0 109.707 179.371 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.751 ' O ' ' O ' ' B' ' 257' ' ' LYS . 94.3 m-20 -60.52 -36.4 78.3 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.544 -179.772 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . 0.751 ' O ' ' O ' ' B' ' 256' ' ' ASP . 99.0 mttt -2.1 138.8 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.113 0 O-C-N 124.604 1.19 . . . . 0.0 112.221 -179.425 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.533 ' O ' ' C ' ' B' ' 259' ' ' ASP . 98.8 m-20 59.1 -3.14 0.09 Allowed 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.634 ' H ' ' C ' ' B' ' 257' ' ' LYS . 0.1 OUTLIER 15.55 -90.37 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.021 179.902 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.72 ' OE1' HD21 ' A' ' 41' ' ' LEU . 95.5 mt-10 -146.7 18.66 1.3 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.446 0.641 . . . . 0.0 109.694 179.07 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.568 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 82.6 mt -115.91 133.55 61.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.79 179.951 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . 0.493 HG11 HH21 ' A' ' 38' ' ' ARG . 55.0 t -126.6 133.13 69.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.979 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -96.12 121.95 38.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.204 0.526 . . . . 0.0 111.219 -178.53 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . 0.443 ' CB ' ' O ' ' A' ' 36' ' ' ASP . 87.6 tttt -63.78 -43.45 96.34 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.477 179.551 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.24 160.14 31.37 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.327 -179.398 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -61.17 145.42 98.74 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.686 2.257 . . . . 0.0 111.031 178.464 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . 0.868 ' O ' HD13 ' B' ' 267' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.49 0 C-N-CA 120.151 -0.62 . . . . 0.0 111.28 -179.415 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.554 ' C ' HG22 ' A' ' 4' ' ' THR . 52.9 Cg_endo . . . . . 0 N--CA 1.491 1.348 0 N-CA-C 111.969 -0.051 . . . . 0.0 111.969 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.554 HG22 ' C ' ' A' ' 3' ' ' PRO . 2.4 t 143.42 -7.86 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 O-C-N 124.269 0.981 . . . . 0.0 110.592 179.421 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.499 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 92.9 mtt-85 -86.08 130.54 34.5 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.635 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -135.0 142.38 46.43 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.536 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.8 mt -111.7 132.74 54.41 Favored 'General case' 0 CA--C 1.523 -0.076 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.29 179.405 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.6 t -109.01 125.89 66.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.988 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.1 m -77.17 140.94 40.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.679 -178.779 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.554 HD12 ' HB2' ' A' ' 94' ' ' SER . 97.3 mt -110.27 135.19 50.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.125 178.578 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.404 ' HA ' HH12 ' A' ' 93' ' ' ARG . 81.7 mttt -90.68 159.51 16.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.202 0.525 . . . . 0.0 110.947 -179.809 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.607 HH11 ' NH1' ' B' ' 245' ' ' ARG . 91.1 mtm180 -56.95 -29.35 63.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.601 -178.546 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.3 p -81.44 -8.49 59.74 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.279 -179.734 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.29 33.27 7.74 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 179.676 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.7 t -120.38 134.7 63.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.572 0.225 . . . . 0.0 111.518 -179.59 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -72.4 136.4 46.07 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.105 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -124.84 -119.41 2.39 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.679 -179.893 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.62 148.3 36.93 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 122.52 2.147 . . . . 0.0 113.318 -178.989 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -109.55 138.31 46.1 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.515 179.853 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.721 ' CD2' HD11 ' A' ' 37' ' ' ILE . 29.9 t80 -111.54 104.04 55.69 Favored Pre-proline 0 N--CA 1.469 0.477 0 N-CA-C 110.056 -0.349 . . . . 0.0 110.056 -179.746 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -76.15 138.43 20.34 Favored 'Trans proline' 0 N--CA 1.489 1.235 0 C-N-CA 121.949 1.766 . . . . 0.0 112.217 -179.133 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.431 HD22 ' HB2' ' A' ' 27' ' ' CYS . 93.4 mt -88.83 92.06 9.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.143 0.497 . . . . 0.0 111.106 -178.878 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 88.6 p -93.55 -8.07 42.36 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.728 179.017 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 67.3 mt -109.58 150.07 28.74 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.859 -179.424 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.9 m -68.97 -16.39 63.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.734 0.302 . . . . 0.0 111.311 -179.148 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 78.4 m -128.59 132.01 48.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.058 0.456 . . . . 0.0 111.464 -179.766 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.631 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 5.2 t -128.1 119.19 24.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.451 178.816 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.573 HD12 ' O ' ' A' ' 49' ' ' CYS . 31.6 tp -117.68 130.34 56.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.41 -178.496 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.751 ' CE2' HD12 ' A' ' 37' ' ' ILE . 17.5 m-85 -107.72 137.23 46.1 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.666 179.441 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 156.91 -177.48 33.79 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 120.384 -0.912 . . . . 0.0 112.425 178.899 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.405 ' HD2' HH11 ' A' ' 31' ' ' ARG . 46.3 mtm180 -74.91 -32.55 61.84 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.581 0.229 . . . . 0.0 111.48 179.202 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.489 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -53.04 145.68 20.58 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.264 -178.514 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.51 HG23 ' N ' ' A' ' 34' ' ' GLU . 11.1 tp -66.36 -41.93 89.71 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-O 120.856 0.36 . . . . 0.0 110.204 179.873 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.51 ' N ' HG23 ' A' ' 33' ' ' ILE . 49.9 tp10 -52.3 -22.1 4.16 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.605 179.511 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.489 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 9.9 m -65.46 126.03 26.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.064 -179.791 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -57.67 -27.5 62.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.023 -179.551 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.751 HD12 ' CE2' ' A' ' 29' ' ' PHE . 78.7 mt -130.26 123.71 56.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.484 178.295 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 75.2 mtm180 -101.61 135.33 43.31 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.317 179.979 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.589 HG21 HD12 ' A' ' 41' ' ' LEU . 97.3 mt -117.56 129.58 73.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.131 0.491 . . . . 0.0 109.97 179.068 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -74.24 29.1 0.08 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.205 -178.952 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.589 HD12 HG21 ' A' ' 39' ' ' ILE . 26.9 mt -93.72 121.36 64.75 Favored Pre-proline 0 CA--C 1.533 0.303 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.204 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.4 -8.45 20.73 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 121.779 1.653 . . . . 0.0 111.676 -179.642 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 m -102.53 9.88 8.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.906 -179.981 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.415 HG12 ' O ' ' A' ' 45' ' ' SER . 10.9 t -96.59 141.36 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 121.077 0.465 . . . . 0.0 110.595 179.324 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.415 ' O ' HG12 ' A' ' 44' ' ' VAL . 12.8 m -71.64 165.59 23.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.517 -179.24 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -62.17 -40.83 97.34 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.665 -179.426 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.634 ' O ' ' N ' ' A' ' 49' ' ' CYS . 85.7 mt-30 -113.59 -25.0 8.93 Favored 'General case' 0 C--O 1.226 -0.133 0 CA-C-O 121.102 0.477 . . . . 0.0 110.27 -179.907 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.8 t60 37.08 -76.01 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 179.405 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.634 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -127.34 133.54 50.07 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.243 0.544 . . . . 0.0 112.187 -178.128 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -130.88 129.18 41.95 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.051 179.993 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 94.4 mt -113.07 133.8 57.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.561 179.842 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -118.94 126.96 52.98 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.641 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.2 mt -104.67 113.72 42.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.049 -0.66 . . . . 0.0 111.215 -179.398 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.559 ' O ' ' N ' ' A' ' 56' ' ' GLN . 95.3 m-70 -113.4 145.4 41.19 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.569 179.789 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 54' ' ' HIS . 77.3 tt0 -39.85 -24.59 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -179.694 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.559 ' N ' ' O ' ' A' ' 54' ' ' HIS . 87.0 mt-30 -71.14 -68.69 0.42 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.222 178.9 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.496 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 2.5 tp10 -158.62 -169.17 2.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.234 0.54 . . . . 0.0 111.025 -178.962 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -105.71 121.89 44.94 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 177.961 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.7 mt -114.66 129.42 70.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.223 0.535 . . . . 0.0 112.093 -178.443 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 29.5 tp -96.64 127.48 42.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.47 179.706 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -112.01 135.32 52.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.857 0.36 . . . . 0.0 110.404 -179.821 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.473 HD21 ' HA ' ' A' ' 68' ' ' PRO . 10.7 t-20 -93.46 106.5 18.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.635 -179.847 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -98.38 -12.57 21.29 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.72 179.056 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 t -73.98 100.51 3.58 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.204 179.749 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.2 p -86.09 -20.76 28.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.897 0.38 . . . . 0.0 110.761 179.768 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.607 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -85.62 -44.65 12.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.213 -179.612 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.404 ' OD1' HG13 ' B' ' 236' ' ' VAL . 22.5 m-80 -135.1 94.17 16.3 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.175 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.473 ' HA ' HD21 ' A' ' 62' ' ' ASN . 41.7 Cg_exo -55.38 145.11 69.31 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.393 2.062 . . . . 0.0 113.57 -178.435 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.469 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 53.1 m -74.03 142.59 45.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.332 179.176 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -104.6 140.97 37.24 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.663 179.765 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.711 HG13 ' OD1' ' A' ' 86' ' ' ASP . 53.0 t -128.52 131.46 68.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.83 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 51.09 32.03 7.26 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.149 -0.621 . . . . 0.0 109.489 -179.06 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.56 26.33 67.9 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.861 179.749 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.9 p -136.78 133.93 36.5 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 122.451 -0.44 . . . . 0.0 111.061 -179.989 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -68.03 138.12 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.494 179.821 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.9 pt -116.28 92.34 2.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.659 179.729 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -68.2 -20.89 64.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.075 0.464 . . . . 0.0 109.841 178.933 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.86 168.2 11.96 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.726 -179.533 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.65 152.43 69.9 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.778 2.319 . . . . 0.0 112.255 179.601 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.4 p -143.09 145.11 23.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.866 -179.742 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.8 mtm-85 -73.24 128.16 34.7 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.483 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 82' ' ' LEU . 95.7 mt -80.4 137.37 36.52 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.203 -179.345 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -130.6 153.42 48.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.429 179.767 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -58.17 118.87 5.93 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.011 0.434 . . . . 0.0 110.505 -179.542 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.59 -7.24 26.22 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.746 -0.941 . . . . 0.0 110.746 -179.472 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.711 ' OD1' HG13 ' A' ' 71' ' ' VAL . 52.2 t0 -81.12 123.85 28.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.092 0.472 . . . . 0.0 110.365 179.792 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 42.9 t -104.05 134.17 46.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.648 -179.162 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.1 mt -103.32 129.94 54.39 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 178.104 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.434 HG23 ' OG ' ' A' ' 94' ' ' SER . 29.4 m -119.08 128.09 53.99 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.531 0.682 . . . . 0.0 111.832 -178.616 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.459 HD12 ' HE1' ' A' ' 95' ' ' PHE . 94.6 mt -118.1 125.29 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.954 179.295 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.411 ' C ' ' O ' ' A' ' 90' ' ' ILE . 38.2 mm 38.36 -105.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.991 -179.117 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.54 ' CG ' ' NE ' ' B' ' 245' ' ' ARG . 1.1 p30 -108.24 12.07 26.84 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -178.808 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.625 ' HE ' HD11 ' B' ' 261' ' ' ILE . 53.4 mtp85 -132.91 147.9 52.29 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.068 179.616 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.554 ' HB2' HD12 ' A' ' 10' ' ' ILE . 38.1 m -138.8 158.27 44.53 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.233 -179.064 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.463 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 78.9 m-85 -125.89 122.95 37.53 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.354 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 79.4 mtp85 -81.35 135.53 35.69 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.491 179.471 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.499 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 80.6 t80 -95.15 122.07 37.44 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.997 179.952 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -134.64 119.96 18.97 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.999 -179.257 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.55 ' O ' ' O ' ' A' ' 4' ' ' THR . 91.9 m-20 -65.92 -40.33 91.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.758 179.381 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 . . . . . 0 C--N 1.326 -0.417 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.475 -179.274 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . 0.736 ' O ' HG12 ' B' ' 228' ' ' VAL . 48.6 t . . . . . 0 CA--C 1.533 0.306 0 CA-C-O 120.62 0.248 . . . . 0.0 110.937 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.506 ' C ' ' H ' ' B' ' 231' ' ' GLN . 90.0 m-20 -67.03 143.11 56.95 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.725 0.298 . . . . 0.0 111.726 -179.333 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.506 ' H ' ' C ' ' B' ' 229' ' ' ASP . 11.8 mp0 -111.96 -26.69 8.76 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.231 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' B' ' 231' ' ' GLN . . . -36.55 164.84 0.01 OUTLIER Glycine 0 CA--C 1.526 0.754 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.899 -179.499 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.3 162.4 41.68 Favored 'Trans proline' 0 C--N 1.301 -1.957 0 C-N-CA 123.777 2.984 . . . . 0.0 112.925 179.758 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -70.91 143.53 45.53 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 121.726 1.617 . . . . 0.0 112.944 -179.067 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.607 ' CG2' HG22 ' A' ' 66' ' ' THR . 74.3 t -76.22 132.72 32.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.898 -179.381 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 37.5 t -72.52 132.87 44.39 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.776 -179.728 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -58.24 -23.87 64.49 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 122.951 2.434 . . . . 0.0 113.189 179.915 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 21.8 m -73.18 -45.58 55.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.261 0.553 . . . . 0.0 109.89 178.829 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -58.59 -47.23 85.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.362 -179.381 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' B' ' 242' ' ' LEU . 98.8 mt -66.53 -39.79 88.78 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.832 0.348 . . . . 0.0 111.251 -179.805 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 51.5 tp10 -62.87 -45.09 94.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.171 -179.372 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -62.09 -40.8 97.08 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.258 0.552 . . . . 0.0 109.915 179.807 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.607 ' NH1' HH11 ' A' ' 12' ' ' ARG . 56.2 ttm-85 -60.13 -42.98 95.99 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.423 -179.229 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -62.23 -38.46 89.3 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.563 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 47.8 t -64.8 -44.21 90.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.433 177.849 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -60.94 -36.32 79.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.344 179.933 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 22.3 t -61.89 -45.1 99.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.932 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -61.63 -28.83 69.65 Favored 'General case' 0 C--O 1.231 0.092 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.83 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -85.13 -9.08 58.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.533 178.924 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.557 ' O ' ' CB ' ' B' ' 253' ' ' ASN . 2.0 mp -108.2 -175.76 2.87 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.888 179.385 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . 0.557 ' CB ' ' O ' ' B' ' 252' ' ' LEU . 0.3 OUTLIER 89.75 26.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.033 179.659 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . 0.541 ' O ' ' CB ' ' B' ' 255' ' ' ASP . 31.5 t70 -66.5 -39.26 88.6 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.671 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . 0.541 ' CB ' ' O ' ' B' ' 254' ' ' ASP . 46.0 m-20 138.01 73.6 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 O-C-N 124.605 1.19 . . . . 0.0 109.486 179.821 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' B' ' 257' ' ' LYS . 40.8 t0 -161.26 141.52 10.9 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.414 179.969 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . 0.462 ' N ' ' OD1' ' B' ' 256' ' ' ASP . 88.4 tttt -61.11 -103.82 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.499 -0.48 . . . . 0.0 109.906 179.708 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 19.7 t0 43.02 75.09 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.074 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.582 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 40.9 p-10 -81.79 14.22 2.8 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.686 -177.507 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 69.29 -3.12 1.64 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.223 0.535 . . . . 0.0 110.065 179.643 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.625 HD11 ' HE ' ' A' ' 93' ' ' ARG . 58.6 mt -115.3 147.22 18.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.73 179.52 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 78.7 t -128.91 136.38 59.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.39 179.468 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -98.18 120.92 39.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.259 0.552 . . . . 0.0 111.567 -178.74 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -68.55 -46.2 70.11 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.783 -179.684 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -96.37 176.65 2.05 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.055 -178.715 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -59.54 146.13 96.02 Favored 'Trans proline' 0 N--CA 1.5 1.879 0 C-N-CA 122.644 2.229 . . . . 0.0 113.252 -178.938 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 1.1 tt . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.451 -179.829 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo . . . . . 0 N--CA 1.498 1.742 0 CA-C-O 120.515 0.131 . . . . 0.0 111.848 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.4 p -91.55 -36.83 13.48 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.873 179.721 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.2 mtt85 -97.2 127.23 42.98 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.783 -178.679 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 94.5 mtm-85 -129.6 135.44 48.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.993 179.816 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.595 HD11 ' HB3' ' A' ' 95' ' ' PHE . 39.9 tp -108.79 134.11 51.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.301 -179.47 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 54.9 t -114.98 130.7 69.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.128 -179.704 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.1 m -79.51 142.29 35.93 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.81 -179.605 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.622 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 90.0 mt -109.32 135.51 48.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.39 -0.823 . . . . 0.0 108.857 177.769 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.68 ' CA ' HH22 ' A' ' 93' ' ' ARG . 97.4 mttt -87.25 153.68 21.3 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.766 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.581 ' NH1' ' OE2' ' B' ' 260' ' ' GLU . 88.8 mtm180 -58.11 -23.81 56.33 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.414 -0.515 . . . . 0.0 110.474 -179.357 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.0 m -80.38 -10.72 59.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.385 179.524 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.67 30.28 9.19 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 179.644 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.9 t -121.21 132.12 71.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.795 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -73.55 140.01 46.01 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.362 179.418 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -122.42 -121.46 2.72 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 121.031 -0.604 . . . . 0.0 111.916 -179.041 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.05 149.74 53.16 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 122.094 1.863 . . . . 0.0 112.489 -179.059 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.56 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -109.95 140.44 43.94 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.925 -179.092 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.565 ' CD2' HD11 ' A' ' 37' ' ' ILE . 33.9 t80 -112.86 104.71 55.97 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.614 -178.807 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -72.63 131.36 17.2 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.103 1.202 . . . . 0.0 111.579 -178.488 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 92.2 mt -86.21 48.68 1.65 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.926 -178.189 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.6 p -65.33 -22.31 66.8 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.918 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.8 mt -80.28 141.47 35.49 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.018 179.965 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.7 m -62.48 -21.6 65.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.985 -179.206 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 74.7 m -138.15 135.77 36.04 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.693 -179.404 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.0 t -126.73 122.09 33.87 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 177.888 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.65 HD21 ' HG2' ' A' ' 47' ' ' GLN . 44.1 tp -118.01 127.35 53.72 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.104 0.478 . . . . 0.0 111.163 -178.386 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.763 ' CE2' HD12 ' A' ' 37' ' ' ILE . 9.3 m-85 -105.36 132.45 51.53 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.904 179.83 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.79 -175.93 39.13 Favored Glycine 0 N--CA 1.467 0.749 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.158 179.425 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.601 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 78.9 mtm-85 -77.73 -30.12 51.51 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.873 0.368 . . . . 0.0 110.338 179.262 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -50.62 149.2 6.78 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.923 -0.471 . . . . 0.0 111.923 -178.208 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.472 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.9 tp -67.05 -40.57 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.458 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.472 ' N ' HG23 ' A' ' 33' ' ' ILE . 96.5 mt-10 -57.2 -25.4 58.98 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.885 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.439 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 47.7 m -53.59 118.41 3.88 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.995 179.824 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.468 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 55.3 m-20 -58.56 -28.26 65.35 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.155 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.763 HD12 ' CE2' ' A' ' 29' ' ' PHE . 90.4 mt -129.0 124.62 61.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 176.494 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -107.72 136.6 47.19 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.636 -178.61 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.407 HG23 ' O ' ' B' ' 260' ' ' GLU . 92.5 mt -118.0 130.31 73.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 179.501 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -73.44 30.54 0.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.441 -177.747 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.42 ' HA ' HD23 ' A' ' 41' ' ' LEU . 82.3 mt -100.85 127.85 31.23 Favored Pre-proline 0 C--N 1.326 -0.417 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.521 179.865 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.24 -8.09 20.49 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 122.267 1.978 . . . . 0.0 111.77 179.636 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.558 HG23 HD13 ' A' ' 91' ' ' ILE . 16.4 m -100.21 6.37 9.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.008 -179.776 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.601 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 9.4 t -97.25 138.0 23.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 179.151 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.7 m -68.75 165.16 20.15 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.502 0.668 . . . . 0.0 111.496 -178.882 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.439 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 9.6 mtmt -61.94 -40.06 94.21 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.825 -179.459 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.65 ' HG2' HD21 ' A' ' 28' ' ' LEU . 85.8 mt-30 -118.06 -20.28 8.75 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.91 0.386 . . . . 0.0 111.322 179.742 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 33.7 t60 32.57 -73.97 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 178.887 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.639 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -124.83 131.52 53.43 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.157 0.503 . . . . 0.0 112.213 -178.305 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -126.82 127.89 45.7 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.229 179.914 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.1 mt -113.48 131.13 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.532 179.883 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.569 ' OE2' ' NE2' ' A' ' 54' ' ' HIS . 81.2 tt0 -118.34 128.06 54.29 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.742 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 88.6 mt -106.87 117.14 52.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 121.597 0.713 . . . . 0.0 112.19 -178.017 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.569 ' NE2' ' OE2' ' A' ' 52' ' ' GLU . 96.6 m-70 -112.24 141.11 46.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.628 179.759 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 54' ' ' HIS . 96.9 mt-10 -40.44 -29.92 0.1 Allowed 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.381 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' ' 54' ' ' HIS . 89.0 mt-30 -67.33 -67.1 0.48 Allowed 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.461 178.654 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.531 ' OE1' ' N ' ' A' ' 58' ' ' ALA . 1.3 mm-40 -155.49 -177.28 6.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.486 0.66 . . . . 0.0 112.212 -178.263 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.531 ' N ' ' OE1' ' A' ' 57' ' ' GLU . . . -106.38 118.85 37.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.456 178.585 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 94.2 mt -110.63 131.57 61.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.541 0.686 . . . . 0.0 111.804 -178.775 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 23.8 tp -98.99 128.69 45.19 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.59 179.519 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -115.27 135.84 53.73 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.021 -179.773 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.666 ' ND2' ' H ' ' A' ' 69' ' ' THR . 13.4 t-20 -97.76 108.49 21.22 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.423 179.859 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -96.82 -8.06 32.02 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.649 179.413 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 6.7 t -71.19 97.83 1.6 Allowed 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.343 179.808 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.0 m -74.15 -43.29 57.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.292 0.568 . . . . 0.0 110.068 178.819 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.531 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.3 OUTLIER -65.04 -43.23 93.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.808 -178.82 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.427 ' O ' ' OG ' ' A' ' 64' ' ' SER . 36.7 m-20 -140.16 99.95 7.2 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.189 -179.386 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.507 ' HB2' HG13 ' A' ' 75' ' ' VAL . 44.0 Cg_exo -56.77 146.29 78.55 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 122.281 1.987 . . . . 0.0 112.871 -179.593 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.666 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 10.3 m -75.28 142.6 43.28 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.419 179.391 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -104.65 138.44 40.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.64 179.694 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 72.2 t -128.74 134.14 65.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.464 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 52.4 34.86 16.0 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.346 -179.425 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.86 26.47 69.07 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.541 179.212 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 41.8 m -146.46 141.29 26.95 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 117.563 0.681 . . . . 0.0 112.031 179.93 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.507 HG13 ' HB2' ' A' ' 68' ' ' PRO . 6.9 t -68.56 138.11 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.454 179.764 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.5 pt -113.48 89.09 1.23 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-O 121.158 0.504 . . . . 0.0 111.147 178.739 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -65.51 -27.2 68.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.567 179.114 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -120.01 166.08 16.08 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.067 -179.723 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.76 144.32 99.47 Favored 'Trans proline' 0 N--CA 1.501 1.936 0 C-N-CA 122.581 2.187 . . . . 0.0 112.197 -179.72 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.5 m -136.92 138.25 46.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.999 179.767 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.9 mtm180 -73.25 132.74 43.5 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.259 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.1 mt -81.5 133.79 35.44 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.113 -179.051 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -125.88 149.57 48.59 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.834 179.96 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -52.6 112.51 0.84 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.156 0.503 . . . . 0.0 111.062 -179.268 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.6 -11.43 25.69 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.799 179.233 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -70.36 132.48 45.71 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 117.289 0.545 . . . . 0.0 110.679 -179.823 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.0 t -108.16 132.69 55.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.929 -178.877 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.7 mt -104.32 130.92 54.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.759 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 87.0 m -122.8 123.59 41.39 Favored 'General case' 0 CA--C 1.523 -0.086 0 CA-C-O 121.628 0.728 . . . . 0.0 112.003 -178.83 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.549 ' O ' ' N ' ' A' ' 93' ' ' ARG . 78.9 mt -110.91 123.93 67.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.658 178.852 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.558 HD13 HG23 ' A' ' 43' ' ' VAL . 96.8 mt 31.78 -95.63 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.896 179.044 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 92' ' ' ASP . 24.1 p-10 -114.29 7.51 16.47 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.517 -179.763 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.68 HH22 ' CA ' ' A' ' 11' ' ' LYS . 1.7 mmp_? -119.41 137.22 53.9 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.651 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 44.9 t -138.26 150.17 46.42 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.234 179.951 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.595 ' HB3' HD11 ' A' ' 7' ' ' LEU . 83.4 m-85 -129.22 134.14 47.85 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.839 179.581 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.416 ' O ' HD12 ' A' ' 7' ' ' LEU . 39.5 ttm180 -95.05 134.05 38.16 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.353 -179.406 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -93.51 121.54 35.03 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.914 -179.541 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -134.41 127.39 31.48 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 120.453 -0.499 . . . . 0.0 112.071 -179.915 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -94.24 170.33 9.59 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.875 179.395 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 . . . . . 0 C--N 1.329 -0.324 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.365 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 67.3 t . . . . . 0 N--CA 1.451 -0.386 0 CA-C-O 120.727 0.299 . . . . 0.0 111.312 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.461 ' O ' ' CD ' ' B' ' 231' ' ' GLN . 97.6 m-20 -45.3 98.62 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.018 0.437 . . . . 0.0 112.167 -179.396 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . 0.447 ' C ' ' O ' ' B' ' 229' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.461 ' CD ' ' O ' ' B' ' 229' ' ' ASP . 1.0 OUTLIER -148.62 -57.83 0.22 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.961 0.41 . . . . 0.0 109.961 179.163 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' B' ' 231' ' ' GLN . . . -42.79 170.44 0.01 OUTLIER Glycine 0 CA--C 1.525 0.658 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.891 -179.472 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -68.95 164.7 32.69 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 C-N-CA 124.341 3.361 . . . . 0.0 112.242 179.631 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.48 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.69 137.36 72.7 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 122.106 1.871 . . . . 0.0 112.662 -179.534 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.531 ' CG2' HG22 ' A' ' 66' ' ' THR . 30.5 t -64.86 131.42 30.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 114.429 -1.26 . . . . 0.0 109.856 -179.76 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 2.0 t -62.54 122.15 15.06 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.88 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -56.57 -22.02 41.25 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 122.081 1.854 . . . . 0.0 112.208 -179.045 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 23.6 m -73.29 -44.11 59.75 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.818 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.703 ' CD1' ' NH2' ' B' ' 245' ' ' ARG . 77.2 t80 -57.57 -46.41 84.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.839 -179.63 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 91.6 mt -63.09 -40.65 98.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.424 0.63 . . . . 0.0 110.143 -179.945 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -62.4 -41.41 98.64 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.158 -179.663 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . 0.43 ' O ' ' OG ' ' B' ' 247' ' ' SER . 94.4 mtt-85 -61.44 -43.16 99.36 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.882 0.372 . . . . 0.0 111.039 -179.465 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.703 ' NH2' ' CD1' ' B' ' 241' ' ' PHE . 0.3 OUTLIER -61.24 -38.27 86.04 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.834 -179.921 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.11 -39.13 91.46 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.492 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . 0.43 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 64.5 p -68.81 -41.41 78.7 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.293 178.164 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -58.86 -38.57 79.07 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.899 179.014 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 48.5 t -61.78 -44.68 99.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.003 179.297 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -58.29 -28.05 64.62 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.08 179.331 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -93.37 -8.04 43.0 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.752 178.985 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.461 ' HG ' ' H ' ' B' ' 253' ' ' ASN . 5.0 tp -100.33 179.59 4.41 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.205 0.526 . . . . 0.0 110.953 -179.475 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . 0.489 ' ND2' ' OD2' ' B' ' 255' ' ' ASP . 16.1 p30 -140.66 172.38 12.79 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.099 179.861 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . 0.482 ' N ' ' OD1' ' B' ' 254' ' ' ASP . 27.7 p-10 -67.89 -4.2 12.12 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.764 0.316 . . . . 0.0 110.845 -179.593 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . 0.489 ' OD2' ' ND2' ' B' ' 253' ' ' ASN . 95.4 m-20 -66.95 -16.7 64.51 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.097 179.859 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 50.2 p-10 -73.08 57.71 0.47 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.358 -178.87 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.73 -11.52 18.06 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 121.104 -0.238 . . . . 0.0 111.313 -179.729 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.687 ' O ' ' N ' ' B' ' 260' ' ' GLU . 88.3 m-20 -97.15 -0.01 47.67 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 177.54 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.476 ' C ' ' O ' ' B' ' 258' ' ' ASP . 50.1 p-10 0.83 57.04 0.0 OUTLIER 'General case' 0 C--O 1.221 -0.409 0 O-C-N 124.932 1.395 . . . . 0.0 113.073 -179.921 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.687 ' N ' ' O ' ' B' ' 258' ' ' ASP . 98.7 mt-10 58.19 6.99 0.59 Allowed 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 178.509 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.495 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 80.1 mt -115.58 134.71 57.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.422 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 40.3 t -127.69 132.87 68.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.529 179.014 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -97.11 120.14 36.92 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.213 -179.46 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -63.98 -46.27 85.35 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.508 179.148 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -97.99 151.96 37.81 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.565 -179.42 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -66.99 146.84 78.81 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.929 2.42 . . . . 0.0 113.055 -178.932 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 27.5 pt . . . . . 0 C--N 1.327 -0.387 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.514 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo . . . . . 0 N--CA 1.486 1.062 0 N-CA-C 111.343 -0.291 . . . . 0.0 111.343 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 69.5 p -70.13 -35.72 74.29 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.583 -179.905 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.823 HH12 ' HB2' ' A' ' 58' ' ' ALA . 94.5 mtt-85 -91.89 113.4 25.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.458 -179.321 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -126.31 133.72 51.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.379 -179.747 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.563 HD11 ' HB3' ' A' ' 95' ' ' PHE . 31.8 tp -113.62 133.85 55.05 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.781 -179.816 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.9 t -110.21 129.22 65.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.868 0.366 . . . . 0.0 111.116 -179.425 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.466 HG23 ' CD1' ' B' ' 261' ' ' ILE . 3.8 m -83.43 137.44 33.91 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.084 -178.864 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.561 HD12 ' HB2' ' A' ' 94' ' ' SER . 96.6 mt -104.64 135.65 41.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.583 177.623 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -88.97 158.9 17.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.569 179.916 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.624 ' CD ' HH22 ' A' ' 93' ' ' ARG . 77.5 mtp180 -56.5 -29.27 61.61 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.076 179.881 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.9 m -79.25 -7.79 58.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.847 179.599 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.96 28.97 24.43 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -179.21 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.3 t -113.7 132.67 62.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.505 -0.347 . . . . 0.0 110.467 -179.695 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -77.61 138.71 39.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.407 179.944 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -133.87 -119.66 2.01 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 120.348 -0.93 . . . . 0.0 112.748 -179.141 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -66.44 143.12 68.3 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.144 1.896 . . . . 0.0 113.499 -177.828 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.435 ' O ' ' CD1' ' B' ' 267' ' ' ILE . 0.6 OUTLIER -108.04 130.56 55.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.576 -179.728 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.524 ' CD2' HD11 ' A' ' 37' ' ' ILE . 41.7 t80 -101.26 107.65 51.46 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.304 -179.181 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -74.64 128.9 12.16 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 121.753 1.636 . . . . 0.0 111.679 -179.562 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 86.6 mt -86.43 51.24 2.17 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -178.063 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.7 p -62.41 -22.37 66.11 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.456 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.74 HD11 ' HG2' ' B' ' 265' ' ' GLN . 64.6 mt -79.15 137.95 37.68 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.209 179.043 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 81.0 p -66.57 -17.46 64.83 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.925 -179.424 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.433 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 86.4 m -129.98 131.03 45.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.066 0.46 . . . . 0.0 111.046 179.616 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.6 t -123.54 115.25 21.21 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.292 178.155 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.797 HD21 ' OE1' ' A' ' 47' ' ' GLN . 43.8 tp -112.01 124.55 52.64 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.928 -179.219 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.756 ' CE2' HD12 ' A' ' 37' ' ' ILE . 3.9 m-85 -106.42 143.51 34.44 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.763 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 157.49 -170.55 34.59 Favored Glycine 0 C--O 1.225 -0.408 0 C-N-CA 120.005 -1.093 . . . . 0.0 111.715 178.852 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.0 ttp85 -87.49 -27.41 22.67 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.84 -0.18 . . . . 0.0 111.212 -179.903 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.564 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -59.19 151.13 35.71 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 179.99 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.482 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.5 tp -66.24 -40.41 86.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.218 -0.593 . . . . 0.0 110.298 179.854 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.482 ' N ' HG23 ' A' ' 33' ' ' ILE . 79.4 mm-40 -53.98 -15.68 1.52 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.353 -179.884 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.564 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 34.1 m -64.48 123.63 19.72 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 120.162 -0.615 . . . . 0.0 109.394 179.631 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.433 ' OD2' ' O ' ' A' ' 26' ' ' THR . 98.6 m-20 -56.95 -25.0 57.06 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -179.501 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.756 HD12 ' CE2' ' A' ' 29' ' ' PHE . 99.0 mt -129.82 120.83 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.367 176.761 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.538 ' NH2' HG21 ' B' ' 262' ' ' VAL . 68.9 ttp85 -108.22 133.94 51.76 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.791 -178.648 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 97.6 mt -116.31 130.08 71.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.875 -179.825 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -75.24 34.59 0.11 Allowed 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -178.205 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.432 HD22 ' HZ ' ' B' ' 241' ' ' PHE . 57.8 mt -110.84 127.55 26.75 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.753 179.651 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.81 -8.45 22.39 Favored 'Trans proline' 0 N--CA 1.498 1.742 0 C-N-CA 122.684 2.256 . . . . 0.0 114.063 -179.024 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.2 m -100.61 1.8 10.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.317 179.711 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.487 ' O ' ' O ' ' A' ' 45' ' ' SER . 91.2 t -97.26 103.35 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.034 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.561 ' HA ' HG21 ' B' ' 234' ' ' TPO . 12.5 t -32.71 157.54 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.785 0.803 . . . . 0.0 111.961 -178.688 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -64.25 -38.38 90.83 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.963 -179.695 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.797 ' OE1' HD21 ' A' ' 28' ' ' LEU . 95.6 mm-40 -113.22 -6.67 13.6 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 123.474 0.484 . . . . 0.0 111.055 -179.015 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.605 ' CD2' ' HG1' ' A' ' 69' ' ' THR . 20.8 t60 14.28 -71.66 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 -178.982 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.577 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.3 136.06 45.22 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -177.352 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -125.99 125.56 42.87 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.69 178.827 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.6 mt -110.72 132.79 58.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.978 179.894 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.418 ' CD ' ' CE1' ' A' ' 54' ' ' HIS . 75.6 tt0 -115.64 124.78 51.78 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.487 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.6 mt -103.16 120.68 53.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 119.913 -0.715 . . . . 0.0 112.422 -178.309 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.592 ' O ' ' N ' ' A' ' 56' ' ' GLN . 2.4 m-70 -114.91 138.4 50.86 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.084 178.723 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.462 ' C ' ' O ' ' A' ' 54' ' ' HIS . 96.5 mt-10 -39.86 -23.88 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 -179.655 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.592 ' N ' ' O ' ' A' ' 54' ' ' HIS . 66.2 tp60 -68.49 -67.93 0.43 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.142 178.257 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -159.2 -163.38 1.2 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.74 -179.529 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.823 ' HB2' HH12 ' A' ' 5' ' ' ARG . . . -109.42 131.7 54.82 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.401 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 41.2 mm -112.23 125.08 69.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.068 -178.801 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.433 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 28.9 tp -100.43 125.63 46.73 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.805 0.336 . . . . 0.0 110.097 -179.849 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -115.68 136.96 52.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.157 179.456 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.758 ' ND2' ' H ' ' A' ' 69' ' ' THR . 14.6 t-20 -100.54 106.73 18.28 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.4 -179.856 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -97.58 -6.93 32.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.587 179.462 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.48 100.6 0.87 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.886 179.563 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.2 m -83.25 -14.95 52.11 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.276 -0.569 . . . . 0.0 109.677 179.374 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.85 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.2 OUTLIER -91.5 -43.5 9.65 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.594 179.964 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.652 ' HB3' HD11 ' A' ' 91' ' ' ILE . 44.0 m-20 -146.97 101.66 3.88 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.452 -179.485 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.49 ' HA ' HD21 ' A' ' 62' ' ' ASN . 32.5 Cg_exo -56.04 150.53 46.97 Favored 'Trans proline' 0 N--CA 1.499 1.824 0 C-N-CA 122.664 2.243 . . . . 0.0 113.998 -178.795 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.758 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 11.3 m -71.57 136.99 47.68 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.794 178.987 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.556 ' O ' ' N ' ' A' ' 89' ' ' THR . 70.2 mt-30 -99.64 146.04 26.92 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.597 179.947 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.721 ' HB ' HD11 ' A' ' 76' ' ' ILE . 4.1 p -133.75 139.73 48.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.499 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 48.24 33.13 3.5 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -179.63 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.23 29.79 65.96 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.299 -179.549 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.442 ' N ' ' O ' ' A' ' 71' ' ' VAL . 18.2 t -140.67 137.32 33.46 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.975 -179.199 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.44 HG13 ' HB2' ' A' ' 68' ' ' PRO . 38.9 t -66.76 139.09 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.375 -179.321 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.721 HD11 ' HB ' ' A' ' 71' ' ' VAL . 89.8 mt -107.64 116.21 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.528 179.055 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 24.5 p-10 -87.75 -33.54 18.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.661 0.267 . . . . 0.0 111.064 179.274 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.455 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 5.0 pt-20 -128.88 174.05 4.95 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.949 -179.292 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -58.8 144.48 98.35 Favored 'Trans proline' 0 N--CA 1.501 1.929 0 C-N-CA 122.305 2.003 . . . . 0.0 112.513 -179.4 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.6 p -141.6 144.26 26.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.308 0.575 . . . . 0.0 111.689 179.747 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -77.6 132.98 38.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.095 179.611 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.543 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 91.2 mt -88.02 140.26 29.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.922 0.392 . . . . 0.0 111.146 -179.451 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -129.69 154.45 47.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.576 -179.87 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -54.46 117.81 3.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.038 0.447 . . . . 0.0 110.654 -179.502 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.81 -16.73 30.72 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 -179.396 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.544 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 45.3 t0 -69.94 126.52 29.94 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.185 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 49.7 t -102.5 135.58 38.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.006 -178.981 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 28.3 mm -92.59 129.03 43.77 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.605 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 177.485 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.654 HG23 ' OG ' ' A' ' 94' ' ' SER . 98.8 m -121.23 125.15 46.4 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 122.031 0.919 . . . . 0.0 112.597 -178.245 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.591 ' O ' ' N ' ' A' ' 93' ' ' ARG . 97.0 mt -117.38 132.47 67.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 113.993 -1.458 . . . . 0.0 107.924 177.919 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.652 HD11 ' HB3' ' A' ' 67' ' ' ASN . 69.7 mt -26.78 104.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 O-C-N 123.448 0.467 . . . . 0.0 111.257 -179.225 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.509 ' CG ' ' NE ' ' B' ' 245' ' ' ARG . 90.9 m-20 79.37 -16.51 0.66 Allowed 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 179.147 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.624 HH22 ' CD ' ' A' ' 12' ' ' ARG . 23.5 mtt85 -130.62 137.36 49.59 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.661 -0.415 . . . . 0.0 110.84 179.028 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.654 ' OG ' HG23 ' A' ' 89' ' ' THR . 48.2 m -138.82 152.42 47.85 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.156 0.503 . . . . 0.0 109.888 -179.989 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.563 ' HB3' HD11 ' A' ' 7' ' ' LEU . 79.1 m-85 -126.16 122.95 37.13 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.094 -179.61 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.531 ' O ' HD12 ' A' ' 7' ' ' LEU . 99.6 mtt180 -83.69 132.05 34.9 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.82 -179.59 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.611 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 72.5 t80 -96.87 127.16 42.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.691 -179.525 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -124.94 120.95 33.07 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.271 179.533 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 59.4 t-20 -116.82 110.11 17.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.044 179.988 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 . . . . . 0 C--N 1.331 -0.225 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.004 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 47.6 t . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.776 0.322 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.535 ' C ' ' H ' ' B' ' 231' ' ' GLN . 98.9 m-20 -74.13 145.64 44.14 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.875 0.369 . . . . 0.0 111.152 179.675 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.535 ' H ' ' C ' ' B' ' 229' ' ' ASP . 0.7 OUTLIER -115.84 -25.55 7.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.075 0.464 . . . . 0.0 110.625 179.898 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' B' ' 231' ' ' GLN . . . -41.01 172.14 0.01 OUTLIER Glycine 0 CA--C 1.527 0.814 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.416 -179.089 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.24 163.84 35.57 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 124.248 3.299 . . . . 0.0 112.731 179.73 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.85 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -79.52 142.97 16.74 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 121.645 1.563 . . . . 0.0 112.358 179.537 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 36.8 t -63.06 141.67 17.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.226 179.511 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 2.2 t -71.99 132.67 44.61 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.193 -179.72 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . 0.401 ' O3P' ' OG1' ' B' ' 240' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -57.5 -25.36 66.24 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 122.874 2.383 . . . . 0.0 112.834 -179.814 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . 0.401 ' OG1' ' O3P' ' B' ' 238' ' ' TPO . 18.8 m -72.15 -44.96 62.3 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.212 0.529 . . . . 0.0 109.897 178.618 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.432 ' HZ ' HD22 ' A' ' 41' ' ' LEU . 87.5 t80 -55.92 -47.13 78.08 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.6 -179.439 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.437 ' CD2' ' OD1' ' A' ' 92' ' ' ASP . 93.3 mt -65.39 -41.49 93.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.776 -179.653 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -60.59 -40.68 92.64 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.738 -179.242 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -61.76 -42.44 98.99 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.785 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.716 ' O ' HG23 ' B' ' 249' ' ' VAL . 70.4 ttp85 -60.77 -43.56 97.88 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.559 -179.739 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.98 -42.11 97.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.986 0.422 . . . . 0.0 109.957 -179.548 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 73.9 m -66.64 -45.09 80.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.542 0.687 . . . . 0.0 109.292 178.303 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . 0.451 ' O ' ' N ' ' B' ' 252' ' ' LEU . 68.8 tp60 -59.84 -35.44 74.75 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.325 -179.992 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.716 HG23 ' O ' ' B' ' 245' ' ' ARG . 71.4 t -63.05 -47.58 91.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.063 179.887 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -60.85 -28.81 69.11 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 121.445 0.641 . . . . 0.0 109.404 179.685 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -90.7 -11.91 38.26 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.982 178.986 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.451 ' N ' ' O ' ' B' ' 248' ' ' GLN . 46.0 tp -76.51 145.55 39.05 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.581 -179.499 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -100.79 130.97 46.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.81 179.368 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . 0.476 ' C ' ' H ' ' B' ' 256' ' ' ASP . 37.8 t70 -63.44 -33.5 75.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.734 179.783 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -61.86 3.91 0.14 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.929 -179.726 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.476 ' H ' ' C ' ' B' ' 254' ' ' ASP . 27.9 t0 -93.71 86.39 5.13 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 120.24 -0.584 . . . . 0.0 110.781 -179.515 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -71.18 7.12 1.36 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.165 179.701 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.433 ' H ' ' C ' ' B' ' 256' ' ' ASP . 22.0 t0 -128.77 97.57 4.71 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.113 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.541 ' CG ' ' NH2' ' A' ' 93' ' ' ARG . 46.0 t0 -88.95 -90.69 0.13 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.339 -0.545 . . . . 0.0 111.23 -178.793 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -149.09 16.92 0.95 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.807 -179.186 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.466 ' CD1' HG23 ' A' ' 9' ' ' THR . 73.1 mt -109.87 132.86 56.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.183 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . 0.538 HG21 ' NH2' ' A' ' 38' ' ' ARG . 54.9 t -123.18 131.57 72.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.187 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -94.46 119.93 33.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.038 0.447 . . . . 0.0 111.723 -178.576 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -63.29 -48.45 78.08 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.899 179.74 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . 0.74 ' HG2' HD11 ' A' ' 24' ' ' LEU . 1.2 mp0 -89.34 160.3 42.71 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.609 -179.067 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -60.04 140.64 93.61 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.194 1.93 . . . . 0.0 111.727 179.867 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . 0.435 ' CD1' ' O ' ' A' ' 19' ' ' HIS . 3.2 tt . . . . . 0 C--N 1.324 -0.508 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.169 -179.249 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo . . . . . 0 N--CA 1.496 1.62 0 CA-C-O 120.574 0.156 . . . . 0.0 111.805 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.6 m -104.6 -55.92 2.27 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.945 0.402 . . . . 0.0 110.464 179.459 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.547 ' NH2' HG21 ' A' ' 53' ' ' ILE . 87.0 mtm-85 -100.51 131.51 46.38 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.026 -179.209 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -130.87 154.37 48.14 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.202 0.525 . . . . 0.0 111.995 -179.364 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.722 HD11 HD11 ' A' ' 22' ' ' LEU . 87.1 mt -119.96 141.93 49.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.625 179.387 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 45.9 t -115.53 129.83 71.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.787 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.0 m -88.46 111.98 22.42 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.426 0.631 . . . . 0.0 112.079 -178.14 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 35.5 mm -79.57 142.86 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.215 178.539 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -95.28 160.47 14.52 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.414 0.626 . . . . 0.0 111.189 -179.547 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.466 HH22 ' HB2' ' B' ' 248' ' ' GLN . 82.7 mtp180 -58.84 -27.53 65.21 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.94 179.41 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 93.8 p -74.11 -18.48 60.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.0 178.833 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.67 21.2 12.85 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-N 116.213 -0.449 . . . . 0.0 112.134 179.266 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.0 p -125.57 139.72 50.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.977 0.417 . . . . 0.0 110.189 179.897 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.447 ' OD1' ' N ' ' A' ' 16' ' ' ASP . 33.4 p-10 -84.72 149.14 25.99 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.463 -179.696 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -138.54 -97.85 0.42 Allowed Glycine 0 CA--C 1.53 1.021 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.768 -179.817 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.84 141.39 27.08 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.198 1.932 . . . . 0.0 112.395 -179.087 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -106.95 146.67 30.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.985 0.421 . . . . 0.0 110.375 -179.482 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -114.74 98.63 50.18 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.334 -179.931 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.32 133.52 14.75 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.872 1.715 . . . . 0.0 112.069 -178.411 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.722 HD11 HD11 ' A' ' 7' ' ' LEU . 92.2 mt -87.71 86.27 7.16 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.062 -178.806 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 89.5 p -83.65 -11.34 57.38 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.566 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.1 mt -109.15 154.86 21.74 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.378 -179.697 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 59.9 m -79.56 -8.53 59.23 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -178.648 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.477 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 24.2 m -126.43 129.14 48.14 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.827 -179.637 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.1 t -123.78 114.52 20.01 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.991 178.505 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.581 HD21 ' HG2' ' A' ' 47' ' ' GLN . 45.4 tp -112.25 128.49 56.27 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.451 -178.39 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.732 ' CE2' HD12 ' A' ' 37' ' ' ILE . 7.0 m-85 -110.36 130.9 55.46 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.482 -179.953 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 165.2 -176.65 40.84 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.411 178.692 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.639 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 81.5 mtm-85 -75.51 -30.96 59.98 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 122.483 -0.422 . . . . 0.0 112.032 -179.346 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -54.6 143.66 31.41 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 121.387 -0.435 . . . . 0.0 112.181 -178.131 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.48 HG23 ' N ' ' A' ' 34' ' ' GLU . 11.1 tp -64.43 -41.09 91.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.252 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.48 ' N ' HG23 ' A' ' 33' ' ' ILE . 80.8 tt0 -54.44 -15.95 2.0 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.357 179.5 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.7 m -69.16 133.13 47.59 Favored 'General case' 0 N--CA 1.461 0.1 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.989 -179.319 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.477 ' OD2' ' O ' ' A' ' 26' ' ' THR . 91.2 m-20 -59.95 -31.2 69.65 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.922 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.732 HD12 ' CE2' ' A' ' 29' ' ' PHE . 98.8 mt -126.68 124.59 65.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 177.008 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.429 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 70.1 ttt180 -110.64 133.49 53.27 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.54 -178.566 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 94.6 mt -118.17 131.4 71.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 121.073 0.463 . . . . 0.0 110.736 -179.148 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -75.89 32.79 0.12 Allowed 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -178.168 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.745 HD12 ' CZ ' ' A' ' 93' ' ' ARG . 52.9 mt -113.45 128.19 25.97 Favored Pre-proline 0 N--CA 1.471 0.581 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.306 179.571 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.84 -15.03 29.86 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.239 1.959 . . . . 0.0 113.269 -179.034 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.665 HG23 ' O ' ' B' ' 235' ' ' PRO . 2.9 p -86.05 -1.41 7.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.103 179.729 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.741 HG12 ' O ' ' A' ' 41' ' ' LEU . 5.3 p -95.1 139.28 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.958 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.463 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 0.5 OUTLIER -68.79 171.91 7.18 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.563 0.697 . . . . 0.0 112.456 -178.09 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.561 ' NZ ' ' O ' ' B' ' 231' ' ' GLN . 44.7 mttm -64.26 -45.36 88.45 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.592 -179.369 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.662 ' O ' ' N ' ' A' ' 49' ' ' CYS . 84.6 mt-30 -113.05 -12.75 13.16 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.781 -179.607 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.463 ' H ' ' HB3' ' A' ' 45' ' ' SER . 21.3 t60 33.86 -75.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.238 -0.892 . . . . 0.0 113.385 179.52 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.662 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.2 134.77 46.8 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.759 -178.466 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -127.67 127.55 43.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.422 179.769 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 92.8 mt -109.73 133.06 56.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.868 -179.635 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -115.72 117.47 30.35 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.012 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.547 HG21 ' NH2' ' A' ' 5' ' ' ARG . 90.1 mt -101.1 112.72 34.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 119.972 -0.691 . . . . 0.0 111.328 -178.691 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.427 ' O ' ' C ' ' A' ' 55' ' ' GLU . 92.7 m-70 -110.05 141.06 43.41 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.483 -1.235 . . . . 0.0 109.561 -179.685 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 54' ' ' HIS . 99.2 mt-10 -41.23 -36.05 0.71 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.234 0.54 . . . . 0.0 109.693 -179.895 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -60.38 -66.23 0.56 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.371 179.637 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -154.0 -174.01 4.8 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.13 -179.369 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.56 123.18 48.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.292 179.152 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.9 mt -117.42 131.42 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -178.679 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 24.2 tp -100.76 127.87 47.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.209 179.267 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -109.22 135.48 50.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.054 179.817 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.403 HD21 ' CA ' ' A' ' 68' ' ' PRO . 61.1 t-20 -96.71 108.34 20.96 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.999 0.428 . . . . 0.0 111.261 -179.263 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -101.25 -7.29 23.19 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.668 179.855 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.7 t -76.71 97.79 4.57 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.883 -179.877 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.1 p -78.39 -33.01 49.11 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.092 179.113 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.39 -44.47 51.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.044 -179.213 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.439 HD21 ' HA ' ' B' ' 236' ' ' VAL . 79.0 m-20 -139.54 94.78 9.24 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.082 -179.693 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.568 ' HB2' HG13 ' A' ' 75' ' ' VAL . 54.2 Cg_exo -54.48 147.23 48.59 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.522 2.148 . . . . 0.0 113.465 -179.725 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 59.3 m -77.05 149.06 35.83 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.115 179.095 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -110.08 141.06 43.46 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.711 -179.61 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.688 HG13 ' OD1' ' A' ' 86' ' ' ASP . 55.0 t -132.37 135.48 57.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.316 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.426 ' ND2' HG12 ' A' ' 71' ' ' VAL . 74.6 m-80 52.99 33.34 14.51 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -178.711 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.6 28.98 70.17 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.153 179.495 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.2 t -143.74 142.83 31.12 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 117.037 0.419 . . . . 0.0 111.138 179.51 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.568 HG13 ' HB2' ' A' ' 68' ' ' PRO . 52.9 t -68.0 138.64 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.066 -0.516 . . . . 0.0 112.062 -179.193 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.409 HG21 HG11 ' A' ' 80' ' ' VAL . 2.6 pt -112.46 92.75 2.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-O 121.274 0.559 . . . . 0.0 109.899 178.369 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -63.98 -28.45 69.82 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.628 -179.743 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.439 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.8 OUTLIER -130.81 179.46 1.34 Allowed Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.801 -179.67 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.439 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 31.9 Cg_exo -60.58 146.19 97.48 Favored 'Trans proline' 0 N--CA 1.501 1.951 0 C-N-CA 123.137 2.558 . . . . 0.0 113.244 179.898 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.409 HG11 HG21 ' A' ' 76' ' ' ILE . 2.7 p -140.4 137.95 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.381 179.484 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 68.2 ttp85 -73.12 129.07 37.25 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.904 -0.319 . . . . 0.0 110.77 179.925 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 97.4 mt -81.2 139.58 35.44 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.355 0.598 . . . . 0.0 110.946 179.936 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -136.71 152.19 50.09 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.352 -179.748 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -52.15 114.82 1.45 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.927 0.394 . . . . 0.0 110.366 -179.797 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.81 -18.34 22.13 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.034 -0.827 . . . . 0.0 111.034 -179.718 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.688 ' OD1' HG13 ' A' ' 71' ' ' VAL . 53.3 t0 -66.21 129.49 40.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.276 0.56 . . . . 0.0 110.021 179.153 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.501 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 9.3 p -109.16 133.91 52.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.687 -179.051 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.1 mt -99.88 129.47 50.47 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.204 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.6 m -123.58 127.74 48.72 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.699 0.761 . . . . 0.0 112.761 -178.456 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.483 ' O ' ' N ' ' A' ' 93' ' ' ARG . 96.5 mt -117.37 125.82 74.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 114.44 -1.255 . . . . 0.0 108.551 177.626 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.555 HG22 ' N ' ' A' ' 92' ' ' ASP . 82.4 mt 36.55 -103.3 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.929 179.949 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.555 ' N ' HG22 ' A' ' 91' ' ' ILE . 89.8 m-20 -109.32 7.82 25.32 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.571 179.715 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.745 ' CZ ' HD12 ' A' ' 41' ' ' LEU . 40.9 mtm-85 -121.94 140.85 51.94 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -179.208 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.5 t -138.03 152.26 48.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.297 0.57 . . . . 0.0 111.091 -179.698 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -121.99 120.96 35.92 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.417 179.081 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 53.6 ttt85 -84.87 129.98 34.73 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.871 -179.197 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -93.74 122.84 36.61 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.208 -179.242 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -123.0 124.19 42.58 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.88 179.967 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 63.2 t-20 -105.42 102.78 12.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.055 -179.711 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 . . . . . 0 C--N 1.328 -0.357 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.785 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 88.8 t . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.77 0.319 . . . . 0.0 110.615 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.589 ' O ' ' CB ' ' B' ' 230' ' ' SEP . 85.4 m-20 -88.34 -2.02 58.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.799 179.64 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . 0.589 ' CB ' ' O ' ' B' ' 229' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.561 ' O ' ' NZ ' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -150.28 7.59 0.6 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.005 -179.873 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . 0.511 ' O ' ' O ' ' B' ' 231' ' ' GLN . . . -48.27 -166.58 0.01 OUTLIER Glycine 0 CA--C 1.531 1.041 0 CA-C-N 116.527 -0.306 . . . . 0.0 112.748 -179.029 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -60.37 152.96 63.5 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 123.806 3.004 . . . . 0.0 112.998 -179.186 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . 0.665 ' O ' HG23 ' A' ' 43' ' ' VAL . 56.9 Cg_endo -74.44 130.88 14.35 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.446 1.431 . . . . 0.0 112.667 179.574 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.439 ' HA ' HD21 ' A' ' 67' ' ' ASN . 24.4 t -57.74 137.33 20.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.798 -179.61 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 7.0 t -65.8 122.57 17.61 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.257 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . 0.477 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . 0.477 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 34.0 Cg_exo -59.3 -24.51 74.59 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.558 2.172 . . . . 0.0 112.159 -179.612 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 91.3 m -73.57 -47.52 40.0 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-O 121.132 0.492 . . . . 0.0 109.732 178.894 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.48 ' CZ ' HG11 ' A' ' 43' ' ' VAL . 69.0 t80 -59.83 -45.66 91.69 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.71 -179.29 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 91.9 mt -64.5 -40.56 95.87 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.86 0.362 . . . . 0.0 110.887 -179.728 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -60.14 -42.11 94.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.351 -179.2 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . 0.511 ' O ' ' OG ' ' B' ' 247' ' ' SER . 89.4 mtm180 -65.3 -39.29 92.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.594 179.276 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.505 ' NH2' HH11 ' A' ' 93' ' ' ARG . 16.8 mmm180 -60.72 -43.66 97.57 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.863 -178.471 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -63.92 -40.19 95.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.208 0.528 . . . . 0.0 109.819 179.353 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . 0.511 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 67.9 p -64.03 -44.72 91.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.625 179.182 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . 0.466 ' HB2' HH22 ' A' ' 12' ' ' ARG . 87.3 mt-30 -61.1 -33.79 73.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.68 179.665 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 55.4 t -63.38 -44.86 99.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 120.259 -0.577 . . . . 0.0 109.754 179.139 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -64.4 -28.64 69.82 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.129 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -84.76 -13.53 50.94 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.792 179.959 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 86.4 mt -103.35 -179.42 3.95 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.3 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -118.83 149.22 41.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.888 0.375 . . . . 0.0 110.877 179.981 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -65.99 -19.15 65.76 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.556 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -81.7 10.33 6.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.786 179.797 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -79.01 92.42 4.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.258 0.551 . . . . 0.0 109.771 179.665 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -67.61 -12.9 61.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.135 -0.938 . . . . 0.0 112.052 -178.632 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -126.14 101.96 7.0 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.211 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.587 ' CG ' ' H ' ' B' ' 260' ' ' GLU . 19.7 p-10 -89.57 -92.22 0.13 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.143 -179.563 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.587 ' H ' ' CG ' ' B' ' 259' ' ' ASP . 97.4 mt-10 -147.35 20.76 1.2 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.916 -179.994 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 66.8 mt -115.96 135.35 56.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.765 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 72.7 t -127.39 135.39 63.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.113 179.543 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -96.84 118.18 32.71 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.396 0.617 . . . . 0.0 110.769 -179.163 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -66.85 -46.72 74.18 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.066 -179.917 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -75.31 168.5 27.09 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.588 -179.083 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -64.64 144.17 83.45 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 121.356 1.371 . . . . 0.0 111.024 179.275 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 10.6 tt . . . . . 0 C--N 1.322 -0.613 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.534 -178.936 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo . . . . . 0 N--CA 1.499 1.814 0 CA-C-O 120.805 0.252 . . . . 0.0 112.325 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.4 m -71.82 -44.52 63.76 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.136 -179.65 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.96 ' NE ' HD13 ' A' ' 53' ' ' ILE . 86.2 mtm-85 -90.83 130.68 36.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.068 0.461 . . . . 0.0 111.328 -178.407 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.661 ' C ' HD12 ' A' ' 7' ' ' LEU . 99.8 mtt180 -135.41 143.0 45.74 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.966 179.677 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.661 HD12 ' C ' ' A' ' 6' ' ' ARG . 10.9 mp -120.08 139.33 52.71 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.93 0.395 . . . . 0.0 110.937 179.773 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.598 HG22 ' CD2' ' A' ' 19' ' ' HIS . 46.5 t -111.88 132.02 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.102 -179.729 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.411 HG23 HD12 ' B' ' 261' ' ' ILE . 9.0 m -84.21 139.37 32.43 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -178.286 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.2 mm -108.31 135.11 48.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.821 177.324 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.607 ' HZ3' ' HB3' ' B' ' 256' ' ' ASP . 96.4 mttt -90.8 159.93 16.03 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 177.802 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.534 HH11 ' HB2' ' B' ' 245' ' ' ARG . 90.9 mtm180 -56.2 -20.98 20.41 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.149 -179.42 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.9 m -83.62 -13.16 54.92 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.12 179.876 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.25 31.49 11.75 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.102 179.634 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.1 m -118.78 142.54 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 120.982 0.42 . . . . 0.0 111.77 -179.793 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -73.21 119.12 17.01 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.237 -179.151 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -110.96 -128.21 5.3 Favored Glycine 0 CA--C 1.54 1.654 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 -179.752 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -74.8 149.53 37.83 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 122.538 2.159 . . . . 0.0 113.209 -178.854 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.598 ' CD2' HG22 ' A' ' 8' ' ' VAL . 47.8 m170 -101.72 143.55 31.52 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.126 -179.665 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.764 ' CD2' HD11 ' A' ' 37' ' ' ILE . 39.0 t80 -113.42 92.52 23.48 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.192 179.53 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.463 ' HD2' HG22 ' B' ' 267' ' ' ILE . 94.4 Cg_endo -77.67 138.19 16.87 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 121.878 1.719 . . . . 0.0 111.767 -179.415 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 82.9 mt -101.65 125.54 48.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.454 0.645 . . . . 0.0 111.465 -179.007 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 82.9 p -120.34 -1.03 10.28 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.329 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.589 HD12 ' CD ' ' B' ' 265' ' ' GLN . 45.4 mt -111.37 152.83 26.86 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 114.402 -1.272 . . . . 0.0 109.398 -178.921 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.9 m -77.27 -11.76 59.87 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -177.818 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 20.7 m -127.31 130.92 50.4 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 120.131 -0.628 . . . . 0.0 112.03 -179.617 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.5 t -126.15 117.97 24.24 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.851 178.841 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.538 HD21 ' OE1' ' A' ' 47' ' ' GLN . 31.9 tp -113.57 134.97 54.4 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 120.838 0.351 . . . . 0.0 111.215 -178.851 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.511 ' O ' ' O ' ' A' ' 47' ' ' GLN . 79.0 m-85 -112.44 135.82 52.68 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.682 179.244 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 165.39 -164.94 37.56 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 120.617 -0.801 . . . . 0.0 111.422 179.784 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.614 ' NH2' ' O ' ' B' ' 232' ' ' GLY . 31.1 ptt-85 -103.41 -26.19 12.99 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.544 -0.462 . . . . 0.0 111.24 179.996 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -50.29 158.55 1.71 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 179.859 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.564 ' O ' ' NH2' ' A' ' 38' ' ' ARG . 7.9 tp -66.94 -41.87 88.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 117.644 0.722 . . . . 0.0 110.588 -179.22 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.448 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 80.4 tt0 -60.13 -19.68 54.72 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 -178.914 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.408 ' HA ' HD23 ' A' ' 28' ' ' LEU . 55.8 m -59.84 130.98 49.42 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.276 -0.57 . . . . 0.0 111.002 -179.238 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.565 ' CG ' ' NE2' ' B' ' 265' ' ' GLN . 74.2 m-20 -61.5 -32.65 72.69 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.907 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.764 HD11 ' CD2' ' A' ' 20' ' ' PHE . 46.6 mm -119.83 112.84 38.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.102 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.564 ' NH2' ' O ' ' A' ' 33' ' ' ILE . 74.0 mtt85 -98.95 131.16 45.22 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.579 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.642 HD13 ' HD2' ' A' ' 93' ' ' ARG . 91.8 mt -121.76 132.13 71.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.882 0.373 . . . . 0.0 110.711 -178.265 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -75.46 33.02 0.11 Allowed 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -177.664 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.683 HD12 ' CZ ' ' A' ' 93' ' ' ARG . 88.5 mt -115.19 123.76 31.21 Favored Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 120.261 -0.575 . . . . 0.0 110.159 179.138 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.95 -7.21 19.68 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.291 1.994 . . . . 0.0 113.427 -178.986 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.9 m -87.26 1.24 6.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 119.791 -0.763 . . . . 0.0 109.129 178.69 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.63 HG12 ' O ' ' A' ' 41' ' ' LEU . 2.4 p -96.29 138.39 21.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.262 178.533 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.449 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 3.7 t -75.22 173.36 10.93 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.592 0.71 . . . . 0.0 111.86 -178.348 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 43.6 mttp -64.13 -41.77 97.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.043 179.954 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.647 ' O ' ' N ' ' A' ' 49' ' ' CYS . 10.7 mm100 -109.72 -20.69 12.72 Favored 'General case' 0 C--N 1.334 -0.068 0 CA-C-O 120.766 0.317 . . . . 0.0 110.952 -179.691 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.449 ' H ' ' HB3' ' A' ' 45' ' ' SER . 15.1 t60 37.54 -77.81 0.0 OUTLIER 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.647 -179.862 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.647 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.65 135.31 45.76 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.331 0.586 . . . . 0.0 111.581 -179.337 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -126.02 131.83 52.12 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.157 179.844 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 99.2 mt -118.27 133.45 65.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.267 179.912 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.491 ' OE2' ' NE2' ' A' ' 61' ' ' HIS . 21.8 pt-20 -116.62 128.43 55.38 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.48 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.96 HD13 ' NE ' ' A' ' 5' ' ' ARG . 83.4 mt -107.53 114.92 47.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.506 -178.074 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.522 ' O ' ' N ' ' A' ' 56' ' ' GLN . 99.5 m-70 -113.28 144.7 42.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.983 179.894 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 54' ' ' HIS . 84.6 tt0 -39.62 -27.58 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -179.717 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.522 ' N ' ' O ' ' A' ' 54' ' ' HIS . 89.1 mt-30 -65.66 -68.99 0.32 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.534 178.798 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -161.25 -161.83 0.85 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.92 0.39 . . . . 0.0 111.073 179.23 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.431 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -111.35 125.15 53.55 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.781 179.42 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.7 mt -113.91 128.34 70.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.997 0.427 . . . . 0.0 111.39 -179.076 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.454 ' HB2' HD11 ' A' ' 82' ' ' LEU . 27.1 tp -98.19 128.35 44.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.928 -179.798 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.491 ' NE2' ' OE2' ' A' ' 52' ' ' GLU . 99.6 m-70 -116.3 138.11 51.59 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.711 -179.268 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -103.13 105.36 15.65 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 179.944 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -96.94 -4.41 40.01 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.93 178.988 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.65 100.83 11.1 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.044 179.355 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.2 m -87.64 -14.47 39.93 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.089 179.852 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.895 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.2 OUTLIER -85.71 -41.19 15.35 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.499 -179.849 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -144.2 95.05 5.64 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.486 179.702 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -64.65 150.86 87.51 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 121.28 1.32 . . . . 0.0 112.988 -178.483 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.6 m -72.73 137.45 45.93 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.829 -179.705 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -97.2 140.19 32.05 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.506 -0.478 . . . . 0.0 109.842 178.997 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.457 ' O ' ' N ' ' A' ' 74' ' ' SER . 7.3 p -129.43 135.95 60.47 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.504 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.131 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 48.86 29.83 2.46 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -178.78 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 76.11 25.07 67.29 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-N 115.045 -0.98 . . . . 0.0 112.18 179.94 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 71' ' ' VAL . 12.9 t -137.37 139.16 40.59 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 117.383 0.591 . . . . 0.0 111.733 -179.874 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.4 m -73.57 138.32 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.055 179.985 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.569 HG21 HG21 ' A' ' 80' ' ' VAL . 7.6 pt -105.15 94.25 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 121.184 0.516 . . . . 0.0 111.274 179.611 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -65.33 -33.62 76.4 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.226 179.285 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -121.16 167.35 13.42 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.404 -179.129 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -60.32 142.81 99.03 Favored 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 121.842 1.695 . . . . 0.0 112.104 -179.304 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.569 HG21 HG21 ' A' ' 76' ' ' ILE . 24.2 m -137.04 137.57 46.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.094 0.473 . . . . 0.0 110.834 179.237 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -71.56 133.09 45.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.947 179.705 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.454 HD11 ' HB2' ' A' ' 60' ' ' LEU . 92.8 mt -85.74 139.59 31.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.219 0.533 . . . . 0.0 110.604 179.872 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -123.97 151.23 43.89 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.319 179.824 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.439 ' ND1' ' N ' ' A' ' 99' ' ' ASN . 5.6 t60 -57.56 122.64 13.19 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.653 -179.67 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.47 -15.84 35.05 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 179.616 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -69.27 137.74 53.32 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.415 -179.766 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 40.6 t -110.17 130.56 63.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.964 0.411 . . . . 0.0 110.829 -179.239 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 88.0 mt -98.71 130.64 47.26 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 178.373 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 94.5 m -123.14 124.54 43.3 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 119.816 -0.754 . . . . 0.0 112.187 -178.866 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.496 ' O ' ' C ' ' A' ' 91' ' ' ILE . 92.1 mt -115.46 130.89 69.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.129 178.284 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.579 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 84.7 mt -15.68 98.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -178.059 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.453 ' OD1' ' NE ' ' B' ' 245' ' ' ARG . 23.7 m-20 85.23 -22.11 0.21 Allowed 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 177.617 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.683 ' CZ ' HD12 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -130.59 144.1 51.19 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.985 -179.676 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 66.8 p -137.96 153.97 49.41 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.177 0.513 . . . . 0.0 110.072 -179.859 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.667 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 81.8 m-85 -125.15 122.73 37.92 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.481 179.792 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -84.69 132.16 34.49 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.619 -179.627 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.619 ' CZ ' ' OD1' ' A' ' 99' ' ' ASN . 88.0 t80 -97.12 123.93 41.01 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.775 -179.525 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -134.49 127.52 31.58 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.673 179.954 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.619 ' OD1' ' CZ ' ' A' ' 97' ' ' TYR . 70.1 m-20 -103.32 128.09 50.48 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.916 0.389 . . . . 0.0 110.854 179.296 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.403 ' OE2' ' CZ ' ' A' ' 6' ' ' ARG . 95.9 mt-10 . . . . . 0 N--CA 1.464 0.24 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.126 -179.935 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 59.8 t . . . . . 0 N--CA 1.455 -0.199 0 CA-C-O 120.727 0.299 . . . . 0.0 111.538 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.547 ' O ' ' NE2' ' B' ' 231' ' ' GLN . 75.6 m-20 -60.85 151.21 30.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.151 0.5 . . . . 0.0 110.944 -179.773 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . 0.46 ' CB ' ' NE2' ' B' ' 231' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.547 ' NE2' ' O ' ' B' ' 229' ' ' ASP . 0.0 OUTLIER 179.16 61.9 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.443 179.529 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . 0.614 ' O ' ' NH2' ' A' ' 31' ' ' ARG . . . -132.68 161.44 24.02 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.905 -179.877 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -76.27 157.64 37.42 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 123.539 2.826 . . . . 0.0 112.49 179.031 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.895 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.53 136.05 16.99 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.438 2.092 . . . . 0.0 112.899 179.293 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.471 ' CG2' HG22 ' A' ' 66' ' ' THR . 78.6 t -61.48 139.4 20.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.184 -179.591 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . 0.466 ' HB2' HD13 ' A' ' 91' ' ' ILE . 3.8 t -67.86 136.06 53.49 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.279 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . 0.422 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . 0.422 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 45.2 Cg_exo -57.42 -27.46 76.08 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.979 2.452 . . . . 0.0 112.455 -179.918 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . 0.416 ' OG1' ' O2P' ' B' ' 238' ' ' TPO . 28.4 m -69.07 -48.83 61.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.234 0.54 . . . . 0.0 110.194 178.557 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -60.15 -46.64 88.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.788 -178.62 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.421 ' CD2' ' OD1' ' A' ' 92' ' ' ASP . 97.3 mt -63.92 -41.19 97.72 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.761 -0.375 . . . . 0.0 111.964 -178.59 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -66.32 -39.96 89.62 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.167 -179.635 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -62.18 -48.96 77.74 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.162 -0.615 . . . . 0.0 112.274 -178.754 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.534 ' HB2' HH11 ' A' ' 12' ' ' ARG . 3.9 ppt_? -65.72 -37.61 86.89 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.074 -178.515 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . 0.439 ' N ' ' HG3' ' B' ' 245' ' ' ARG . 36.7 ttmt -62.73 -40.44 97.22 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.519 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 50.5 m -65.73 -41.79 91.81 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.945 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -56.79 -39.47 74.16 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.934 179.486 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 58.1 t -63.18 -45.51 98.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-O 121.079 0.466 . . . . 0.0 110.201 179.206 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -64.96 -36.12 83.35 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.853 179.08 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -80.87 -6.96 59.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.987 179.585 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.492 HD11 ' HD3' ' B' ' 257' ' ' LYS . 31.7 tp -63.45 135.72 57.11 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.268 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . 0.562 ' C ' HD22 ' B' ' 253' ' ' ASN . 0.3 OUTLIER -73.73 -46.06 48.27 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -176.967 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . 0.509 ' OD1' ' ND2' ' B' ' 253' ' ' ASN . 81.6 m-20 -96.32 3.32 53.06 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.479 -0.488 . . . . 0.0 109.936 -179.569 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . 0.522 ' O ' ' CG ' ' B' ' 256' ' ' ASP . 84.4 m-20 54.23 23.21 4.1 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.769 179.371 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.607 ' HB3' ' HZ3' ' A' ' 11' ' ' LYS . 7.8 m-20 178.03 -66.77 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 179.776 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . 0.492 ' HD3' HD11 ' B' ' 252' ' ' LEU . 13.3 ptmt 28.36 -110.41 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.715 -178.823 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -94.54 146.72 23.91 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.101 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.543 ' CG ' ' H ' ' B' ' 260' ' ' GLU . 33.1 t0 -91.37 -141.14 0.17 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.204 0.526 . . . . 0.0 110.763 -179.839 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.566 ' OE1' HD21 ' A' ' 41' ' ' LEU . 97.6 mt-10 -139.34 13.76 2.58 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.755 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.667 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 58.2 mt -114.77 137.51 47.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.947 -179.865 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 48.8 t -124.43 133.95 68.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.883 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -93.01 117.3 29.91 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.768 -178.262 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -67.33 -44.88 78.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.623 179.411 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . 0.589 ' CD ' HD12 ' A' ' 24' ' ' LEU . 33.6 mt-30 -88.84 152.41 48.69 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.039 -178.957 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -62.22 141.36 87.75 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.44 2.093 . . . . 0.0 113.259 179.878 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . 0.463 HG22 ' HD2' ' A' ' 21' ' ' PRO . 20.5 pt . . . . . 0 N--CA 1.463 0.209 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.827 179.026 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.474 ' HG2' ' HE ' ' A' ' 6' ' ' ARG . 43.1 Cg_endo . . . . . 0 N--CA 1.494 1.558 0 CA-C-O 120.918 0.299 . . . . 0.0 112.498 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.7 p -100.01 -44.11 6.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.675 -179.754 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.5 mtt85 -99.46 131.49 45.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.014 -179.731 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.474 ' HE ' ' HG2' ' A' ' 3' ' ' PRO . 99.5 mtt180 -135.66 144.71 46.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.343 179.27 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 83.2 mt -112.13 141.19 46.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.125 179.007 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 31.1 t -114.84 129.13 71.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.576 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.473 ' CG2' HD12 ' B' ' 261' ' ' ILE . 5.1 m -92.07 114.99 27.68 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -177.943 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.478 HD12 ' OG ' ' A' ' 94' ' ' SER . 96.7 mt -81.68 144.73 9.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.543 178.205 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.9 mttt -94.48 162.27 13.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.892 0.377 . . . . 0.0 110.436 179.221 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.554 ' NH2' ' CD1' ' B' ' 252' ' ' LEU . 86.8 mtm180 -57.89 -30.04 65.53 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.531 -178.969 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.562 ' OG ' HG22 ' A' ' 15' ' ' VAL . 78.2 p -76.28 -20.56 57.22 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.649 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.7 32.62 4.4 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.903 179.649 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.562 HG22 ' OG ' ' A' ' 13' ' ' SER . 6.7 m -128.07 134.47 65.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.881 0.372 . . . . 0.0 110.85 179.399 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -71.45 139.01 49.48 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.321 179.276 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -127.08 -118.1 2.15 Favored Glycine 0 CA--C 1.536 1.345 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -179.89 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.02 147.7 43.7 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 121.951 1.768 . . . . 0.0 112.619 -179.331 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -111.52 153.54 26.06 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.779 179.801 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -122.45 94.01 48.06 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.199 -178.598 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.52 127.99 25.67 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.145 1.897 . . . . 0.0 111.601 179.426 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.415 ' HA ' HD23 ' A' ' 22' ' ' LEU . 95.9 mt -82.77 56.42 3.39 Favored 'General case' 0 CA--C 1.522 -0.134 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.949 -179.733 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 91.9 p -62.74 -16.16 56.41 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.028 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.664 HD11 ' HG2' ' B' ' 265' ' ' GLN . 56.4 mt -91.92 143.15 26.79 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 114.761 -1.108 . . . . 0.0 110.676 -179.794 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.9 m -69.1 -17.02 63.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.697 -179.303 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.2 m -134.61 137.52 43.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.048 -179.874 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.615 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.6 OUTLIER -130.82 124.23 30.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.012 178.554 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.572 HD21 ' HG2' ' A' ' 47' ' ' GLN . 52.4 tp -118.36 128.72 54.91 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.966 0.412 . . . . 0.0 112.03 -177.758 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.615 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 60.5 m-85 -103.49 124.25 48.4 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.951 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 176.35 -178.23 47.74 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 119.822 -1.18 . . . . 0.0 112.965 179.449 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 46.2 mtm180 -80.05 -28.53 39.22 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.807 0.337 . . . . 0.0 110.6 179.034 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -54.66 143.35 32.22 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 -178.985 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.3 mm -64.92 -43.17 96.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.177 0.513 . . . . 0.0 109.816 179.166 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -55.91 -20.3 15.36 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.086 -179.851 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 38.5 m -63.95 131.05 46.49 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.509 -179.918 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 37' ' ' ILE . 6.6 p-10 -59.47 -30.39 68.5 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.838 -178.956 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.535 ' N ' ' OD1' ' A' ' 36' ' ' ASP . 96.5 mt -126.14 121.43 59.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.528 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 77.1 ttt-85 -110.51 136.89 48.95 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.061 -178.377 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.723 HG21 HD12 ' A' ' 41' ' ' LEU . 82.9 mt -119.61 131.35 72.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.922 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -75.56 24.0 0.12 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.246 -179.1 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.723 HD12 HG21 ' A' ' 39' ' ' ILE . 24.6 mt -89.31 122.96 68.09 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.365 179.808 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.73 -14.86 30.17 Favored 'Trans proline' 0 N--CA 1.488 1.177 0 C-N-CA 121.783 1.655 . . . . 0.0 112.594 -179.72 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.624 HG21 ' CE2' ' B' ' 241' ' ' PHE . 1.1 m -93.65 3.41 8.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.087 179.913 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.451 HG12 ' O ' ' A' ' 45' ' ' SER . 25.0 t -89.44 137.02 22.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 120.441 -0.504 . . . . 0.0 109.945 179.069 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.451 ' O ' HG12 ' A' ' 44' ' ' VAL . 2.3 m -68.61 171.98 6.87 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.568 0.699 . . . . 0.0 111.504 -179.596 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -63.4 -43.58 97.15 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.659 -179.802 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.623 ' O ' ' N ' ' A' ' 49' ' ' CYS . 89.9 mt-30 -116.94 -20.53 9.36 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.805 179.904 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.3 t60 36.21 -78.58 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 179.491 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.623 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -125.89 133.82 51.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.217 0.532 . . . . 0.0 112.194 -178.847 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -126.51 129.91 49.56 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.688 179.827 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.6 mt -113.71 132.91 61.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.984 0.421 . . . . 0.0 110.419 179.01 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.461 ' OE2' ' CE1' ' A' ' 54' ' ' HIS . 83.4 tt0 -118.08 125.35 50.14 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 178.62 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 93.4 mt -108.63 123.04 64.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.808 0.813 . . . . 0.0 112.855 -178.155 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.554 ' O ' ' N ' ' A' ' 56' ' ' GLN . 98.0 m-70 -115.85 139.05 50.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.258 -1.337 . . . . 0.0 109.285 179.143 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.482 ' C ' ' O ' ' A' ' 54' ' ' HIS . 83.5 tt0 -39.99 -26.25 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -179.666 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.554 ' N ' ' O ' ' A' ' 54' ' ' HIS . 91.5 mt-30 -64.46 -68.97 0.31 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.027 177.812 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -159.7 -161.89 0.96 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.578 179.81 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -118.41 131.79 56.27 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.517 179.99 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.0 mt -117.57 129.21 74.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-O 121.387 0.613 . . . . 0.0 111.727 -179.301 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.546 ' HB2' HD11 ' A' ' 82' ' ' LEU . 28.2 tp -98.68 127.31 44.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.338 -179.782 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -111.79 135.48 52.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.21 179.858 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.41 HD21 ' CA ' ' A' ' 68' ' ' PRO . 62.7 t-20 -94.77 106.99 19.01 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.42 179.995 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -99.38 -10.38 22.33 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 179.53 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.446 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 7.4 t -76.22 98.62 4.49 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.727 -179.565 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.9 p -80.71 -35.16 33.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.143 0.497 . . . . 0.0 109.768 178.671 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.5 m -65.16 -49.65 69.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.692 179.859 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.446 ' O ' ' OG ' ' A' ' 64' ' ' SER . 0.6 OUTLIER -136.57 96.35 12.17 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.461 179.535 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.48 ' HB2' HG13 ' A' ' 75' ' ' VAL . 32.5 Cg_exo -55.38 144.73 71.15 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.105 1.87 . . . . 0.0 112.082 -179.204 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.7 m -73.76 146.81 44.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.332 179.831 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -110.29 141.25 43.54 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.782 179.955 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 42.0 t -127.92 134.27 65.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.426 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.2 m120 52.54 30.53 8.6 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -179.447 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.65 25.47 69.85 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.74 179.792 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 58.3 m -136.52 138.48 41.38 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.452 -179.642 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.48 HG13 ' HB2' ' A' ' 68' ' ' PRO . 44.4 t -68.94 138.28 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.433 179.982 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.9 pt -116.19 85.88 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.202 179.502 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.524 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 15.4 p-10 -66.47 -26.57 67.25 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.538 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -114.04 159.54 35.83 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.333 179.7 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -66.75 149.45 83.61 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.772 2.315 . . . . 0.0 111.822 179.278 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.2 m -141.45 144.42 26.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.692 -179.427 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -71.68 130.72 41.85 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.281 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.546 HD11 ' HB2' ' A' ' 60' ' ' LEU . 96.9 mt -81.89 138.82 34.95 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.096 0.474 . . . . 0.0 111.93 -178.738 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -130.91 151.65 51.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.715 179.585 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -57.0 121.1 9.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.893 0.378 . . . . 0.0 111.145 -179.228 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.13 -17.28 19.68 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 179.48 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -71.4 134.68 46.83 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.269 0.557 . . . . 0.0 111.082 -179.784 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 68.1 t -111.02 133.86 55.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.713 -179.361 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 79.1 mt -103.58 133.4 47.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.366 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 84.8 m -121.59 131.24 54.01 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.789 0.804 . . . . 0.0 112.589 -178.53 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 76.5 mt -123.47 126.46 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 114.29 -1.323 . . . . 0.0 108.783 179.247 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.469 HG22 ' N ' ' A' ' 92' ' ' ASP . 44.9 mm 43.42 -107.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.002 -179.253 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.562 ' HB3' ' HE ' ' B' ' 245' ' ' ARG . 45.7 t0 -114.89 16.59 17.22 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.943 0.402 . . . . 0.0 111.048 -179.795 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.422 HH22 ' HB2' ' B' ' 259' ' ' ASP . 17.4 mtp180 -130.78 148.22 52.54 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.067 179.4 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.478 ' OG ' HD12 ' A' ' 10' ' ' ILE . 19.4 p -138.64 157.35 46.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.966 0.412 . . . . 0.0 110.839 -179.23 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.574 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 66.7 m-85 -124.0 121.62 35.73 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.563 179.086 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -80.2 131.67 35.74 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.306 -179.78 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -96.62 121.28 38.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.955 -179.865 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -121.49 122.87 40.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.118 -179.89 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 60.4 t-20 -112.27 104.36 12.54 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.324 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 . . . . . 0 C--N 1.326 -0.43 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.583 -179.893 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.462 0.158 0 CA-C-O 120.944 0.402 . . . . 0.0 111.102 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.542 ' C ' ' H ' ' B' ' 231' ' ' GLN . 99.0 m-20 -70.56 142.39 51.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.186 179.536 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . 0.642 ' P ' ' H ' ' B' ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.542 ' H ' ' C ' ' B' ' 229' ' ' ASP . 77.2 mt-30 -135.43 26.57 3.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.12 179.664 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -111.3 -140.9 8.4 Favored Glycine 0 CA--C 1.539 1.54 0 N-CA-C 111.636 -0.586 . . . . 0.0 111.636 -179.618 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -77.32 161.61 31.73 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.742 2.295 . . . . 0.0 113.209 -178.943 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -60.6 152.07 71.23 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 122.95 2.433 . . . . 0.0 112.38 179.714 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.411 ' O ' HG13 ' B' ' 236' ' ' VAL . 4.4 p -101.72 129.5 52.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.945 179.381 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 53.2 t -73.65 130.79 40.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.143 -179.341 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -57.48 -24.18 59.91 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 122.824 2.349 . . . . 0.0 112.589 179.77 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 96.3 m -73.5 -46.75 46.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.48 179.3 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.624 ' CE2' HG21 ' A' ' 43' ' ' VAL . 72.2 t80 -59.91 -45.35 92.84 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.588 -179.123 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' B' ' 242' ' ' LEU . 93.9 mt -64.71 -39.25 93.33 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.018 0.437 . . . . 0.0 110.218 179.397 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -61.75 -42.83 99.48 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.339 -179.368 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -62.37 -40.67 97.21 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.231 179.903 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.63 ' NH1' HD21 ' A' ' 41' ' ' LEU . 77.6 mtp85 -60.84 -41.97 96.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.166 -179.943 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.22 -40.8 98.49 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 179.247 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 10.9 t -65.26 -46.71 79.44 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.855 178.448 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -60.12 -39.11 85.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.247 -179.549 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.443 HG23 ' O ' ' B' ' 245' ' ' ARG . 45.3 t -60.81 -44.21 97.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.291 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -64.83 -30.83 71.85 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.479 179.252 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -83.24 -11.92 57.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.586 -179.775 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.554 ' CD1' ' NH2' ' A' ' 12' ' ' ARG . 77.2 mt -96.04 178.55 5.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.07 0.462 . . . . 0.0 110.091 179.05 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . 0.567 ' O ' ' N ' ' B' ' 255' ' ' ASP . 8.7 p-10 -155.56 -170.49 3.45 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.108 179.668 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . 0.407 ' C ' ' O ' ' B' ' 253' ' ' ASN . 28.7 t70 -39.39 -22.32 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.234 0.54 . . . . 0.0 110.515 -179.706 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' B' ' 253' ' ' ASN . 95.7 m-20 -63.42 -11.07 20.27 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.045 179.666 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' B' ' 253' ' ' ASN . 18.6 p-10 -80.25 20.84 0.64 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.351 -179.957 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -58.9 -28.88 66.6 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.003 179.957 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -80.15 130.44 35.23 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 177.938 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.658 ' C ' ' H ' ' B' ' 261' ' ' ILE . 49.2 p-10 -103.39 128.9 50.4 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.37 0.605 . . . . 0.0 111.314 -178.858 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -54.93 5.41 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.7 179.026 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.658 ' H ' ' C ' ' B' ' 259' ' ' ASP . 78.5 mt -101.89 137.58 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 178.312 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 64.6 t -126.64 134.3 66.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.79 -178.95 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -96.73 119.54 35.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.111 0.481 . . . . 0.0 111.231 -178.672 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -64.66 -40.66 95.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.454 179.532 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . 0.757 ' N ' HE21 ' B' ' 265' ' ' GLN . 0.0 OUTLIER -101.96 160.82 25.3 Favored Pre-proline 0 N--CA 1.464 0.247 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.431 -179.242 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -70.94 145.76 51.13 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 122.595 2.197 . . . . 0.0 113.221 -179.105 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.4 pt . . . . . 0 C--N 1.326 -0.434 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.197 178.86 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo . . . . . 0 N--CA 1.494 1.507 0 CA-C-O 121.191 0.413 . . . . 0.0 112.998 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.7 p -125.7 28.85 6.1 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.636 179.373 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.596 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 92.4 mtt-85 -88.17 131.49 34.71 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.951 -179.526 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.5 mtp180 -133.27 141.03 47.8 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 120.312 -0.555 . . . . 0.0 112.389 -179.274 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.609 HD11 ' HB3' ' A' ' 95' ' ' PHE . 40.0 tp -117.42 132.97 56.47 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.243 179.488 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.589 HG22 ' CD2' ' A' ' 19' ' ' HIS . 53.0 t -108.37 131.07 59.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.897 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.407 ' CG2' HD12 ' B' ' 261' ' ' ILE . 1.7 m -93.71 117.45 30.1 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.346 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.489 ' CD1' ' OD1' ' A' ' 16' ' ' ASP . 48.3 mm -82.27 143.28 12.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.645 179.649 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -90.97 160.48 15.62 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 177.701 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.409 ' CG ' ' NH1' ' A' ' 93' ' ' ARG . 83.4 mtm180 -57.0 -24.48 53.93 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.962 -178.442 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 68.6 p -83.9 -8.26 59.23 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.922 179.754 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.21 35.12 9.03 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 179.887 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 32.2 t -117.3 132.49 66.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 -179.997 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.489 ' OD1' ' CD1' ' A' ' 10' ' ' ILE . 92.4 m-20 -70.04 133.46 47.23 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.656 -0.418 . . . . 0.0 109.952 179.762 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -126.03 -122.26 2.57 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.593 -179.547 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -72.91 145.92 41.18 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.002 1.801 . . . . 0.0 112.575 -179.036 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.589 ' CD2' HG22 ' A' ' 8' ' ' VAL . 54.5 m170 -107.83 143.44 36.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.132 0.491 . . . . 0.0 111.126 -179.331 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.533 ' CD2' HD11 ' A' ' 37' ' ' ILE . 25.8 t80 -115.04 93.96 36.8 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.069 -179.207 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -56.79 124.4 16.15 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 121.896 1.731 . . . . 0.0 111.681 179.136 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.7 mt -87.79 41.73 1.01 Allowed 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.384 -179.781 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.8 p -64.7 -20.44 66.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.788 179.594 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.8 mt -74.04 142.09 45.73 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.568 179.778 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 73.8 p -61.42 -25.15 67.02 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.362 -179.21 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 45.3 m -134.69 134.33 40.97 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.221 -0.592 . . . . 0.0 111.534 179.917 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.692 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -128.37 120.2 26.51 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.069 178.345 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.522 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 43.4 tp -120.03 124.96 47.18 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.999 -177.02 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.692 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 38.8 m-85 -101.37 140.83 35.12 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.23 179.282 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 158.67 -173.58 35.67 Favored Glycine 0 N--CA 1.464 0.536 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.156 178.269 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.63 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 72.2 mtm-85 -83.29 -30.74 27.33 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.876 0.37 . . . . 0.0 110.21 179.895 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.561 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -56.29 152.08 21.15 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 121.126 -0.559 . . . . 0.0 111.728 -178.26 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.578 HD12 ' HD3' ' A' ' 38' ' ' ARG . 7.1 tp -66.7 -40.51 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.677 179.958 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.418 ' N ' HG23 ' A' ' 33' ' ' ILE . 96.9 mt-10 -53.69 -21.39 6.92 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.293 179.972 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.561 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 4.2 m -63.88 115.78 5.17 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.118 -179.974 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.594 ' OD1' ' N ' ' A' ' 37' ' ' ILE . 39.2 p-10 -50.97 -24.59 3.79 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.758 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.673 HD12 ' CE2' ' A' ' 29' ' ' PHE . 94.2 mt -130.67 123.49 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.223 178.062 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.578 ' HD3' HD12 ' A' ' 33' ' ' ILE . 88.2 mtm-85 -103.97 134.66 46.88 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.4 -0.52 . . . . 0.0 109.801 -179.434 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.717 HG21 HD12 ' A' ' 41' ' ' LEU . 98.1 mt -117.91 130.54 72.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.064 0.459 . . . . 0.0 109.796 -179.809 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -79.23 30.37 0.22 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.201 -179.043 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.717 HD12 HG21 ' A' ' 39' ' ' ILE . 33.9 mt -94.8 123.24 58.44 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.476 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.99 -10.76 26.59 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 121.856 1.704 . . . . 0.0 112.047 -179.386 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.6 m -100.51 8.31 8.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.771 -179.211 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.63 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 42.2 t -100.63 136.75 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.459 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.448 ' HB2' ' H ' ' A' ' 48' ' ' HIS . 2.7 m -67.66 169.47 9.4 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.317 0.579 . . . . 0.0 111.478 -179.179 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -62.26 -40.35 95.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.455 -179.474 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.697 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.1 mt-30 -114.59 -11.19 12.42 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 123.348 0.405 . . . . 0.0 111.357 -179.933 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.448 ' H ' ' HB2' ' A' ' 45' ' ' SER . 22.8 t60 31.86 -73.45 0.0 OUTLIER 'General case' 0 C--O 1.237 0.423 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 179.649 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.697 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -134.95 139.5 44.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.284 0.564 . . . . 0.0 112.324 -178.621 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -125.42 128.68 48.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.049 179.323 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 94.6 mt -115.45 133.3 62.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.016 -179.552 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -115.5 127.25 55.17 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.859 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.563 HD13 ' HD2' ' A' ' 5' ' ' ARG . 75.9 mt -108.36 111.99 38.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.95 -179.386 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.538 ' O ' ' N ' ' A' ' 56' ' ' GLN . 82.3 m-70 -110.8 143.94 40.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.541 -179.598 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 54' ' ' HIS . 96.9 mt-10 -41.06 -24.84 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.532 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.538 ' N ' ' O ' ' A' ' 54' ' ' HIS . 94.2 mm-40 -68.8 -68.8 0.37 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.463 178.712 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.595 ' CB ' ' HE ' ' A' ' 81' ' ' ARG . 5.1 tp10 -159.17 -167.76 2.16 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.328 179.895 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.539 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -110.67 125.33 53.34 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.937 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.14 129.54 71.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.353 0.596 . . . . 0.0 112.391 -177.757 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.5 HD11 ' SG ' ' A' ' 49' ' ' CYS . 49.3 tp -94.72 123.45 38.17 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.38 -179.431 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -111.68 136.47 50.87 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.362 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -97.94 105.41 17.55 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.734 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -96.08 -7.32 36.44 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.682 178.976 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 10.1 t -79.46 100.8 7.85 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.279 178.798 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.0 m -84.74 -17.77 37.26 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.084 0.469 . . . . 0.0 110.025 179.577 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.461 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.3 OUTLIER -89.05 -36.61 15.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.602 -179.845 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.437 ' O ' ' OG ' ' A' ' 64' ' ' SER . 79.5 m-20 -144.12 95.24 5.64 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.398 179.765 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.96 146.78 85.49 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.128 1.885 . . . . 0.0 112.658 -179.098 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.5 m -70.71 134.89 47.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.278 178.792 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -99.71 139.77 34.89 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.57 179.989 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 31.4 t -130.49 135.93 59.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 178.706 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 53.42 31.72 12.63 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -178.613 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.37 29.5 70.04 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.152 -179.866 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 81.1 p -137.63 130.5 30.16 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 120.446 -0.502 . . . . 0.0 111.999 -179.283 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.4 t -63.7 141.43 18.16 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.935 179.581 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.584 ' CG2' ' O ' ' A' ' 78' ' ' GLU . 96.3 mt -112.14 111.15 34.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.352 179.511 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -76.31 -34.34 59.04 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.801 179.579 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.584 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.1 OUTLIER -131.51 178.13 1.9 Allowed Pre-proline 0 N--CA 1.468 0.445 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.874 -179.734 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 35.5 Cg_exo -57.13 141.5 94.31 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 122.522 2.148 . . . . 0.0 112.739 -179.079 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.4 t -133.19 138.07 52.17 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.132 179.75 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.595 ' HE ' ' CB ' ' A' ' 57' ' ' GLU . 73.3 ttt180 -74.62 131.46 40.94 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.633 179.28 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.425 HD21 ' HB2' ' A' ' 60' ' ' LEU . 91.2 mt -87.25 140.97 29.01 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.16 0.505 . . . . 0.0 112.272 -178.645 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -134.4 156.12 49.09 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.406 179.59 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.573 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 6.3 t60 -56.77 120.17 7.41 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.868 0.366 . . . . 0.0 111.44 -179.359 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.33 -21.23 22.25 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.52 179.316 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -65.84 135.54 54.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.254 0.55 . . . . 0.0 110.341 -179.788 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.2 t -113.37 133.79 58.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.233 -178.213 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.7 mt -98.35 130.17 47.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.678 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 55.1 m -120.02 124.64 46.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.531 0.682 . . . . 0.0 112.26 -178.818 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.482 HG22 HG12 ' A' ' 91' ' ' ILE . 93.3 mt -115.54 124.0 71.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.091 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.548 HG23 ' SG ' ' B' ' 237' ' ' CYS . 27.5 mm 43.89 -106.49 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -178.812 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.608 ' OD1' ' NH2' ' B' ' 245' ' ' ARG . 40.6 p-10 -114.93 12.73 16.9 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.076 0.465 . . . . 0.0 110.473 179.273 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.515 ' CD ' HD11 ' B' ' 261' ' ' ILE . 6.1 ttp180 -120.39 143.62 48.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.577 179.732 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 38.2 t -137.7 152.83 49.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.353 0.596 . . . . 0.0 111.371 -178.76 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.609 ' HB3' HD11 ' A' ' 7' ' ' LEU . 46.5 m-85 -120.42 120.73 36.8 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.803 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.483 ' O ' HD12 ' A' ' 7' ' ' LEU . 99.7 mtt180 -84.04 131.69 34.79 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.363 -178.562 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.596 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 84.0 t80 -94.26 124.2 38.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.65 179.813 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -129.92 123.26 30.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.009 0.433 . . . . 0.0 111.638 -179.702 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.573 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 65.0 t-20 -112.56 110.95 21.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.841 179.121 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 99' ' ' ASN . 79.3 mm-40 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.819 0.342 . . . . 0.0 110.48 -179.357 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . 0.413 ' O ' HG22 ' B' ' 228' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.453 -0.3 0 CA-C-O 121.25 0.548 . . . . 0.0 110.925 . . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.626 ' C ' ' H ' ' B' ' 231' ' ' GLN . 68.4 t0 -161.08 78.73 0.59 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.544 179.454 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . 0.623 ' O ' ' NE2' ' B' ' 231' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.626 ' H ' ' C ' ' B' ' 229' ' ' ASP . 88.1 mm-40 -131.57 76.77 1.73 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.392 -179.931 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . 0.527 ' O ' ' NH2' ' A' ' 31' ' ' ARG . . . -136.48 172.38 22.5 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.029 -179.476 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.48 159.84 48.15 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 123.983 3.122 . . . . 0.0 113.112 -179.832 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.461 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.15 140.37 27.92 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 121.903 1.735 . . . . 0.0 112.889 -178.933 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.435 ' HA ' HD21 ' A' ' 67' ' ' ASN . 31.3 t -59.63 134.78 24.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.794 -179.672 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . 0.548 ' SG ' HG23 ' A' ' 91' ' ' ILE . 8.6 t -62.03 129.78 42.47 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -179.861 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -60.38 -20.77 64.79 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 121.912 1.742 . . . . 0.0 112.165 179.801 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 76.0 m -72.88 -44.46 61.28 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 178.337 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.464 ' CE2' ' HD2' ' B' ' 245' ' ' ARG . 63.3 t80 -58.75 -47.64 83.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.29 -179.465 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' B' ' 242' ' ' LEU . 89.2 mt -64.59 -42.49 95.55 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -179.386 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -65.52 -38.72 90.49 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.521 -0.472 . . . . 0.0 111.136 -179.08 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -61.77 -44.08 97.59 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.855 179.78 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.608 ' NH2' ' OD1' ' A' ' 92' ' ' ASP . 82.2 mtp180 -63.16 -37.66 88.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.089 -179.028 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.82 -39.4 91.65 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.359 -0.537 . . . . 0.0 109.99 179.225 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 61.9 m -67.49 -43.79 80.1 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.571 0.701 . . . . 0.0 109.516 178.274 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -60.82 -37.35 81.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.699 -179.863 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.456 HG23 ' O ' ' B' ' 245' ' ' ARG . 50.0 t -63.91 -44.7 98.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.185 179.61 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -59.29 -26.35 64.89 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.341 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -95.24 -7.1 39.94 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.153 178.666 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 58.0 tp -78.54 149.44 33.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.503 -179.44 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -103.7 142.14 34.86 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.083 179.221 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . 0.405 ' C ' ' H ' ' B' ' 256' ' ' ASP . 99.8 m-20 -64.82 -21.72 66.84 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.821 0.343 . . . . 0.0 111.082 -179.229 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -63.4 -5.48 3.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.21 0.529 . . . . 0.0 109.81 179.557 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.572 ' OD1' ' N ' ' B' ' 257' ' ' LYS . 55.5 t0 -66.64 147.95 52.57 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.636 -179.844 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . 0.572 ' N ' ' OD1' ' B' ' 256' ' ' ASP . 99.0 mttt -139.5 159.33 42.41 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.395 179.47 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.527 ' O ' ' C ' ' B' ' 259' ' ' ASP . 13.4 m-20 46.2 16.24 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.058 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.544 ' N ' ' C ' ' B' ' 257' ' ' LYS . 36.2 t0 5.52 -80.96 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 114.477 -1.238 . . . . 0.0 112.037 -179.468 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.418 ' HB2' ' NH2' ' A' ' 93' ' ' ARG . 96.5 mt-10 -141.67 13.14 2.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.0 0.429 . . . . 0.0 110.408 179.518 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.515 HD11 ' CD ' ' A' ' 93' ' ' ARG . 74.0 mt -112.93 137.64 45.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.684 179.978 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . 0.496 HG11 ' NH2' ' A' ' 38' ' ' ARG . 41.3 t -126.86 134.15 66.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.906 0.384 . . . . 0.0 110.579 179.891 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . 0.44 ' CD2' HG21 ' B' ' 267' ' ' ILE . 84.0 m-85 -97.55 122.26 40.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.979 0.418 . . . . 0.0 111.961 -178.528 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . 0.451 ' HA ' HH12 ' A' ' 38' ' ' ARG . 87.4 tttt -62.56 -44.9 95.2 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.663 179.578 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -99.52 164.97 15.59 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.01 179.977 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.72 153.13 51.63 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.392 2.062 . . . . 0.0 112.099 179.567 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . 0.485 HG22 ' HD1' ' A' ' 20' ' ' PHE . 36.4 pt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.089 -178.576 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.495 ' HG2' HH21 ' A' ' 6' ' ' ARG . 73.2 Cg_endo . . . . . 0 N--CA 1.495 1.566 0 CA-C-O 120.71 0.213 . . . . 0.0 112.468 . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 51.0 p -116.87 -52.05 2.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.858 179.89 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.933 ' NH1' HG23 ' A' ' 53' ' ' ILE . 99.2 mtt180 -99.52 129.73 45.71 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.556 -178.78 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.495 HH21 ' HG2' ' A' ' 3' ' ' PRO . 99.8 mtt180 -129.23 143.08 50.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.495 -179.726 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.524 HD11 HD11 ' A' ' 22' ' ' LEU . 90.9 mt -113.29 136.37 52.82 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.697 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 50.0 t -112.94 131.92 63.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.839 -0.345 . . . . 0.0 110.303 -179.384 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.428 ' CG2' HD12 ' B' ' 261' ' ' ILE . 5.2 m -90.07 115.88 27.67 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 -177.722 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.47 HD12 ' HB2' ' A' ' 94' ' ' SER . 96.8 mt -85.09 142.22 13.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.292 178.153 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -91.42 159.98 15.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.97 0.414 . . . . 0.0 110.515 179.36 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 88.9 mtm180 -58.05 -29.53 65.45 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.792 -179.229 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.1 p -76.75 -17.3 59.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.86 0.362 . . . . 0.0 110.544 179.471 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.93 32.75 5.5 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -179.679 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.4 t -121.35 132.46 70.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.054 0.454 . . . . 0.0 111.106 -179.994 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -78.23 138.44 38.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.667 178.883 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.7 -115.72 1.67 Allowed Glycine 0 CA--C 1.533 1.162 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.467 179.936 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.11 148.56 56.63 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 121.841 1.694 . . . . 0.0 112.433 -179.392 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.467 ' CD2' ' C ' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -113.13 158.05 20.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.016 0.436 . . . . 0.0 109.921 179.701 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.747 ' CD2' HD11 ' A' ' 37' ' ' ILE . 48.1 t80 -120.53 101.31 46.32 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.164 -179.044 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -75.2 131.41 14.04 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.016 1.811 . . . . 0.0 111.891 -179.617 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.524 HD11 HD11 ' A' ' 7' ' ' LEU . 83.8 mt -86.71 85.32 7.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.158 0.504 . . . . 0.0 112.043 -178.486 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 92.6 p -89.01 -9.68 50.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.194 178.058 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 47.2 mt -104.45 148.12 26.81 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.071 -179.816 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.5 m -70.83 -16.23 62.7 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.498 -179.463 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.421 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 55.8 m -131.31 134.11 46.03 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.752 -179.916 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.6 t -129.63 120.54 25.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.955 178.179 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.464 HD11 ' HB3' ' A' ' 47' ' ' GLN . 35.3 tp -116.4 129.82 56.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.887 -179.078 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.528 ' O ' ' O ' ' A' ' 47' ' ' GLN . 9.8 m-85 -108.95 139.11 44.26 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.697 179.904 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 151.94 -178.71 29.05 Favored Glycine 0 N--CA 1.47 0.925 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.161 178.316 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.412 ' HD2' HH11 ' A' ' 31' ' ' ARG . 46.9 mtm180 -67.14 -33.29 75.12 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 179.381 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.54 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -46.78 131.8 12.29 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 -178.812 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.521 HG23 ' N ' ' A' ' 34' ' ' GLU . 9.3 tp -64.79 -42.03 93.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 O-C-N 122.434 -0.451 . . . . 0.0 110.024 179.387 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.521 ' N ' HG23 ' A' ' 33' ' ' ILE . 7.9 pt-20 -56.4 -13.01 1.93 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.228 179.292 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.54 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 31.3 m -70.16 139.15 52.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.595 -179.301 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.461 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 57.2 m-20 -63.77 -34.74 78.58 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.329 -179.505 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.747 HD11 ' CD2' ' A' ' 20' ' ' PHE . 40.6 mm -122.22 112.82 36.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 177.978 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.415 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 15.9 ttp180 -101.83 130.88 48.38 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.596 -178.636 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.675 HG21 HD12 ' A' ' 41' ' ' LEU . 93.2 mt -118.68 131.85 70.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.157 -179.395 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -76.03 32.45 0.12 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.606 -179.528 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.942 HD11 HH21 ' A' ' 93' ' ' ARG . 20.3 mt -95.55 118.46 66.14 Favored Pre-proline 0 CA--C 1.534 0.355 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.507 179.499 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -73.36 -11.4 24.7 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 121.908 1.739 . . . . 0.0 111.985 -179.922 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.1 m -95.39 5.26 8.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.207 179.431 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.446 HG12 ' O ' ' A' ' 45' ' ' SER . 5.0 t -98.69 139.84 19.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.577 -179.464 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.446 ' O ' HG12 ' A' ' 44' ' ' VAL . 75.3 m -68.73 175.18 3.71 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.682 0.753 . . . . 0.0 111.315 -179.589 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -65.12 -43.17 92.82 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.958 -179.699 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.616 ' O ' ' N ' ' A' ' 49' ' ' CYS . 81.9 mt-30 -113.77 -12.72 12.72 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.542 -179.682 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.9 t60 38.7 -76.89 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 178.873 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.616 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -135.58 140.32 44.56 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.252 0.548 . . . . 0.0 111.812 -178.657 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -125.51 132.65 52.58 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.788 179.891 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.5 mt -116.42 134.1 60.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.918 179.49 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.438 ' CG ' ' NE2' ' A' ' 54' ' ' HIS . 47.2 tp10 -119.96 128.6 53.73 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.369 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.933 HG23 ' NH1' ' A' ' 5' ' ' ARG . 96.8 mt -105.57 123.54 60.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.591 0.71 . . . . 0.0 112.159 -178.678 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.569 ' O ' ' N ' ' A' ' 56' ' ' GLN . 3.3 m-70 -120.54 139.9 52.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.452 -179.752 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.467 ' C ' ' O ' ' A' ' 54' ' ' HIS . 83.9 tt0 -39.3 -25.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.73 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' A' ' 54' ' ' HIS . 67.9 tp60 -69.11 -68.2 0.42 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.096 178.301 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.479 ' HA ' HH22 ' A' ' 5' ' ' ARG . 8.8 pt-20 -160.03 -157.52 0.56 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.708 179.64 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.406 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -113.73 132.3 55.87 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.505 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.448 ' CG2' ' NE2' ' A' ' 61' ' ' HIS . 45.5 mm -111.08 127.54 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 121.051 -0.26 . . . . 0.0 111.636 -178.65 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.435 ' HB3' HG13 ' A' ' 80' ' ' VAL . 28.8 tp -103.51 125.3 49.99 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.955 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.448 ' NE2' ' CG2' ' A' ' 59' ' ' ILE . 97.9 m-70 -118.37 139.49 51.3 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.486 -179.211 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.421 ' ND2' ' H ' ' A' ' 69' ' ' THR . 12.6 t-20 -102.7 107.86 18.91 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.596 179.741 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -94.83 -7.8 39.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.66 179.142 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.09 99.7 11.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.856 0.36 . . . . 0.0 110.878 -179.861 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.6 p -77.39 -32.91 55.15 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.885 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.783 HG21 ' O ' ' B' ' 234' ' ' TPO . 4.7 m -63.55 -49.35 73.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.221 -179.405 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -136.55 91.92 15.6 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.957 -179.626 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.56 ' HB2' HG13 ' A' ' 75' ' ' VAL . 52.4 Cg_exo -54.77 143.55 69.99 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.157 1.904 . . . . 0.0 112.568 -179.599 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.421 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 15.8 m -74.71 138.07 42.51 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.839 179.246 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -100.12 140.48 34.28 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.271 179.636 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.453 ' O ' ' N ' ' A' ' 74' ' ' SER . 5.1 p -131.59 136.42 57.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 178.939 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 48.35 31.98 3.0 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -178.675 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.84 29.48 63.05 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.437 -179.831 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.453 ' N ' ' O ' ' A' ' 71' ' ' VAL . 19.5 m -140.34 133.5 29.56 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 120.58 -0.448 . . . . 0.0 112.112 -179.479 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.56 HG13 ' HB2' ' A' ' 68' ' ' PRO . 7.0 t -70.43 139.06 20.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.475 179.152 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.429 HG21 HG11 ' A' ' 80' ' ' VAL . 3.7 pt -112.26 94.37 3.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.117 0.484 . . . . 0.0 111.266 179.814 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -65.22 -29.08 69.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.974 178.956 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.0 176.1 2.85 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.392 -179.979 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -59.93 144.08 99.51 Favored 'Trans proline' 0 N--CA 1.5 1.899 0 C-N-CA 122.515 2.143 . . . . 0.0 112.591 -179.776 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.435 HG13 ' HB3' ' A' ' 60' ' ' LEU . 7.1 p -136.7 141.26 41.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.521 179.679 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -81.02 130.21 34.91 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.473 179.377 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.5 mt -83.61 141.3 31.64 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.039 0.447 . . . . 0.0 111.642 -179.791 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -130.75 151.16 51.49 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.909 179.171 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.405 ' CE1' ' H ' ' A' ' 99' ' ' ASN . 4.3 t60 -52.12 118.66 3.65 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.001 0.429 . . . . 0.0 111.587 -178.637 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.03 -13.57 37.53 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 179.455 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -67.99 135.37 52.23 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.19 179.831 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.4 t -112.44 133.29 58.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.81 -178.205 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 92.8 mt -104.53 132.35 51.36 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.643 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 58.8 m -119.39 128.0 53.66 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.325 -0.55 . . . . 0.0 112.112 -178.766 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 98.2 mt -122.08 124.83 72.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.846 178.588 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.402 HG22 ' N ' ' A' ' 92' ' ' ASP . 26.0 mm 41.45 -114.99 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 121.068 -0.253 . . . . 0.0 110.629 -178.837 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.402 ' N ' HG22 ' A' ' 91' ' ' ILE . 93.4 m-20 -101.56 12.94 36.38 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.767 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.942 HH21 HD11 ' A' ' 41' ' ' LEU . 11.4 mtm180 -131.46 149.07 52.67 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.382 -179.497 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.47 ' HB2' HD12 ' A' ' 10' ' ' ILE . 71.7 m -135.49 154.15 51.51 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.008 0.432 . . . . 0.0 111.337 -179.631 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.452 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 85.1 m-85 -120.49 120.52 36.12 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.539 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 78.1 mtp85 -85.22 136.79 33.37 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 120.308 -0.557 . . . . 0.0 111.059 -179.238 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 92.2 t80 -96.5 118.81 33.79 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.402 -179.625 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -122.7 122.95 40.0 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.755 0.312 . . . . 0.0 111.0 179.549 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.405 ' H ' ' CE1' ' A' ' 84' ' ' HIS . 52.7 t-20 -101.54 101.9 12.55 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.717 179.733 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.042 179.413 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.152 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.501 ' O ' ' CB ' ' B' ' 230' ' ' SEP . 52.2 m-20 -64.61 -35.72 81.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.289 -179.825 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . 0.501 ' CB ' ' O ' ' B' ' 229' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.555 ' O ' ' O ' ' B' ' 232' ' ' GLY . 1.3 pt20 -140.04 0.14 1.72 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.99 179.997 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . 0.555 ' O ' ' O ' ' B' ' 231' ' ' GLN . . . -51.21 -153.07 0.01 OUTLIER Glycine 0 CA--C 1.532 1.111 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.088 -179.347 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -75.02 162.07 37.67 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 122.884 2.389 . . . . 0.0 113.053 -178.929 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.783 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.64 139.0 22.2 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.238 1.959 . . . . 0.0 113.652 -178.782 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -68.48 140.27 19.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.648 -179.74 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 19.4 t -69.51 135.98 50.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.734 -179.858 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . 0.453 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . 0.453 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 50.0 Cg_exo -58.48 -28.86 86.83 Favored 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 123.322 2.681 . . . . 0.0 113.431 -179.294 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 59.5 m -73.9 -43.51 58.24 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.18 0.514 . . . . 0.0 109.698 178.358 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -58.93 -45.81 89.49 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.558 -179.243 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' B' ' 242' ' ' LEU . 91.1 mt -64.77 -40.87 95.99 Favored 'General case' 0 CA--C 1.521 -0.161 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.192 -179.429 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -59.96 -40.72 89.99 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.05 -179.638 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 62.0 ttp180 -62.39 -43.32 99.11 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.792 0.33 . . . . 0.0 110.794 179.786 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.594 ' NH1' ' OE1' ' B' ' 248' ' ' GLN . 1.9 mpt_? -59.32 -43.73 92.64 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.111 -179.307 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.7 -40.96 98.77 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.838 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 65.6 m -64.38 -45.21 88.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.411 0.624 . . . . 0.0 109.327 178.194 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . 0.594 ' OE1' ' NH1' ' B' ' 245' ' ' ARG . 80.4 mt-30 -60.36 -37.38 80.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.116 -179.81 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.47 HG23 ' O ' ' B' ' 245' ' ' ARG . 48.7 t -60.34 -45.21 96.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.325 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -60.68 -27.27 67.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.535 178.595 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -85.18 -11.57 54.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.573 179.933 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.726 HD22 ' OD2' ' B' ' 256' ' ' ASP . 96.3 mt -111.22 -179.37 3.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.344 179.398 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . 0.543 ' OD1' ' N ' ' B' ' 256' ' ' ASP . 46.2 p30 -138.33 171.48 14.32 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.219 0.533 . . . . 0.0 111.42 -179.753 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -68.37 -21.76 64.69 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.788 179.837 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -81.84 -6.76 59.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.089 179.921 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.726 ' OD2' HD22 ' B' ' 252' ' ' LEU . 66.2 t0 -88.23 94.68 9.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.923 0.392 . . . . 0.0 110.39 179.951 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -76.73 -176.65 3.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.906 -178.69 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' B' ' 260' ' ' GLU . 90.3 m-20 62.09 50.42 4.03 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.879 -179.138 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . . . . . . . . . 46.4 p30 -63.21 63.69 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.699 -179.574 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.553 ' N ' ' O ' ' B' ' 258' ' ' ASP . 93.6 mt-10 59.35 5.6 0.63 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.215 179.574 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.452 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 81.0 mt -109.77 131.97 59.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.194 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 40.4 t -124.06 132.67 70.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.348 -179.807 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -94.42 117.23 29.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.104 0.478 . . . . 0.0 111.108 -178.509 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -67.87 -46.59 71.28 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.513 179.949 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.17 163.43 23.44 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.223 -178.96 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -60.33 149.59 85.0 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.177 1.918 . . . . 0.0 112.031 179.857 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.3 pt . . . . . 0 C--N 1.328 -0.344 0 CA-C-O 121.485 0.66 . . . . 0.0 111.886 -178.396 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo . . . . . 0 N--CA 1.49 1.296 0 CA-C-O 120.956 0.315 . . . . 0.0 111.455 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.1 p -115.32 -27.31 7.27 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.209 179.305 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 87.2 mtm-85 -93.5 111.3 22.94 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.098 0.475 . . . . 0.0 110.392 -179.372 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.481 ' NH2' ' ND1' ' A' ' 19' ' ' HIS . 79.5 ttt180 -127.44 131.22 50.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.184 -179.776 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.545 HD11 HD21 ' A' ' 22' ' ' LEU . 80.0 mt -110.12 135.64 50.6 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.832 179.952 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.82 HG21 ' NH2' ' A' ' 96' ' ' ARG . 89.0 t -106.74 120.38 57.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.479 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.601 HG21 ' HZ ' ' B' ' 263' ' ' PHE . 70.0 p -77.45 140.81 39.91 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.576 0.703 . . . . 0.0 110.99 -179.05 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 51.0 mm -103.76 130.18 54.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.619 -179.791 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.462 ' HA ' HH12 ' A' ' 93' ' ' ARG . 95.9 mttt -83.98 154.99 23.01 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.889 178.001 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.543 HH22 ' CB ' ' B' ' 248' ' ' GLN . 75.8 mtp180 -56.61 -34.3 67.09 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.532 -179.214 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 67.4 m -76.76 -6.13 50.98 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.428 179.093 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.32 32.09 10.92 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.529 179.482 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.0 t -113.53 132.25 62.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.794 0.331 . . . . 0.0 110.639 -179.998 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -73.13 136.28 44.81 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.503 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -130.75 -115.98 1.78 Allowed Glycine 0 CA--C 1.534 1.279 0 C-N-CA 120.18 -1.009 . . . . 0.0 112.886 -178.855 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.81 143.18 45.1 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 122.24 1.96 . . . . 0.0 112.937 -177.952 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.596 ' NE2' HG13 ' A' ' 8' ' ' VAL . 57.4 m170 -110.29 123.08 49.15 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.446 179.591 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.566 ' CD2' HD11 ' A' ' 37' ' ' ILE . 43.1 t80 -98.04 109.07 50.1 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.907 -179.513 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -79.03 139.09 14.95 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 121.344 1.363 . . . . 0.0 111.707 179.373 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.545 HD21 HD11 ' A' ' 7' ' ' LEU . 74.3 mt -91.66 50.13 1.67 Allowed 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.205 -178.967 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.8 t -63.82 -17.44 63.12 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 119.45 -0.9 . . . . 0.0 108.692 178.968 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.76 HD11 ' HG2' ' B' ' 265' ' ' GLN . 46.2 mt -78.65 138.45 38.32 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.875 179.951 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.15 -23.05 65.27 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.608 -179.274 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 94.5 m -133.78 134.91 43.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.561 179.147 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.447 ' SG ' HD22 ' A' ' 22' ' ' LEU . 6.1 t -124.37 118.43 26.71 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.536 179.008 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.483 HD21 ' HG2' ' A' ' 47' ' ' GLN . 44.4 tp -115.49 131.63 56.87 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.224 0.535 . . . . 0.0 111.78 -178.421 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.706 ' CE2' HD12 ' A' ' 37' ' ' ILE . 2.3 m-85 -111.2 138.96 46.99 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.572 179.865 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 150.85 179.21 26.4 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.539 178.68 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 45.7 mtm180 -70.22 -33.04 71.19 Favored 'General case' 0 C--O 1.227 -0.123 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 179.795 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.616 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -51.32 148.05 9.21 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.193 -179.065 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.413 HG23 ' N ' ' A' ' 34' ' ' GLU . 11.0 tp -67.5 -39.72 83.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.217 -0.593 . . . . 0.0 109.508 179.54 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.413 ' N ' HG23 ' A' ' 33' ' ' ILE . 98.4 mt-10 -53.06 -21.55 4.79 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.261 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.616 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 48.3 m -55.84 118.51 4.66 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.706 -179.597 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -59.72 -32.79 70.86 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -179.924 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.706 HD12 ' CE2' ' A' ' 29' ' ' PHE . 91.1 mt -123.5 120.96 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 176.256 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -109.04 135.33 50.38 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.949 -177.326 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.456 HG21 HD12 ' A' ' 41' ' ' LEU . 95.1 mt -119.87 130.27 74.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.618 -179.652 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -75.17 25.67 0.1 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.473 -179.099 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.456 HD12 HG21 ' A' ' 39' ' ' ILE . 24.3 mt -88.9 123.26 67.97 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.184 -179.915 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -73.28 -10.15 23.87 Favored 'Trans proline' 0 N--CA 1.49 1.285 0 C-N-CA 121.877 1.718 . . . . 0.0 112.548 179.714 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.51 HG21 ' CE2' ' B' ' 241' ' ' PHE . 30.0 m -97.97 8.26 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.114 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.555 179.442 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 25.5 t -101.26 139.56 22.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.449 179.068 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.1 m -74.11 171.85 12.8 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.061 0.458 . . . . 0.0 111.444 -178.974 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.6 mttp -61.37 -42.46 98.75 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.245 -178.778 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.62 ' O ' ' N ' ' A' ' 49' ' ' CYS . 95.5 mt-30 -112.81 -15.96 12.83 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.575 0.226 . . . . 0.0 111.162 -179.163 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 18.5 t60 37.25 -75.64 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 179.071 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.62 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.76 137.82 48.34 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.266 0.555 . . . . 0.0 111.366 -177.661 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -129.71 134.05 47.41 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.156 -179.983 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.4 mt -118.34 135.57 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.682 -179.688 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -112.78 127.84 56.26 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.638 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.4 mm -100.55 125.76 54.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 119.674 -0.81 . . . . 0.0 110.712 -179.668 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.456 ' O ' ' N ' ' A' ' 56' ' ' GLN . 94.7 m-70 -130.35 136.22 48.87 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.307 179.806 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 54' ' ' HIS . 42.7 tt0 -40.74 -28.85 0.08 Allowed 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.217 -0.593 . . . . 0.0 109.845 -179.272 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.456 ' N ' ' O ' ' A' ' 54' ' ' HIS . 55.0 tt0 -65.99 -68.28 0.38 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.301 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -158.37 -164.55 1.5 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.801 179.737 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -118.3 135.13 54.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.983 0.42 . . . . 0.0 110.394 179.775 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.05 130.27 74.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.564 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.599 ' HB2' HD21 ' A' ' 82' ' ' LEU . 50.1 tp -93.17 126.69 38.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.546 178.923 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -113.91 134.32 54.89 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.236 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 31.5 t30 -97.59 104.27 16.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.955 -179.481 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -96.44 -9.69 29.22 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.677 178.86 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.2 m -72.19 98.17 2.1 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.693 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.5 p -77.34 -36.1 54.15 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.705 0.765 . . . . 0.0 109.231 178.644 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.653 HG21 ' O ' ' B' ' 234' ' ' TPO . 1.8 m -65.23 -48.57 72.83 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.387 -1.279 . . . . 0.0 110.78 -179.147 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -142.04 100.76 5.87 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.201 -179.128 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.18 145.75 85.11 Favored 'Trans proline' 0 N--CA 1.5 1.872 0 C-N-CA 122.022 1.815 . . . . 0.0 111.858 -179.564 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.3 m -72.49 141.87 48.56 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.199 0.523 . . . . 0.0 110.548 -179.642 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -101.0 141.61 33.64 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.805 -179.606 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.532 ' HB ' HD11 ' A' ' 76' ' ' ILE . 23.5 t -131.27 136.52 57.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 177.25 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 54.04 31.41 13.6 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -178.795 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.85 24.01 76.83 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.004 179.65 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 44.1 t -134.99 137.26 42.85 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.325 0.583 . . . . 0.0 111.527 -179.737 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.3 t -68.04 139.87 20.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.076 -179.544 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.585 ' CG2' ' O ' ' A' ' 78' ' ' GLU . 95.9 mt -113.88 116.77 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.986 179.407 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -90.74 -24.15 20.47 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.712 179.054 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.585 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.2 OUTLIER -128.9 168.18 16.91 Favored Pre-proline 0 C--O 1.222 -0.388 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.879 -178.669 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -66.28 148.02 84.09 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 122.463 2.109 . . . . 0.0 112.7 -179.941 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.1 m -141.18 151.93 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.164 179.976 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -78.53 129.23 34.6 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.485 179.345 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.599 HD21 ' HB2' ' A' ' 60' ' ' LEU . 95.9 mt -82.42 140.56 33.37 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.931 0.396 . . . . 0.0 110.736 -179.114 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -129.92 151.94 49.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.552 179.745 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.447 ' C ' ' CD2' ' A' ' 84' ' ' HIS . 7.5 t60 -56.5 119.98 6.96 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.165 -178.89 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.17 -18.13 23.79 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 121.155 -0.545 . . . . 0.0 111.767 179.128 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -69.51 133.23 47.44 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.331 179.912 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.0 t -107.76 136.9 41.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.45 -178.6 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 95.3 mt -103.07 129.1 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 178.167 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 96.2 m -120.33 127.32 52.23 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 119.913 -0.715 . . . . 0.0 112.025 -178.532 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.526 ' O ' ' N ' ' A' ' 93' ' ' ARG . 90.7 mt -116.5 134.86 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 CA-C-N 115.023 -0.989 . . . . 0.0 108.961 178.229 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.507 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 47.1 mt -29.13 97.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.415 -178.807 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.507 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 1.4 m-20 92.05 -22.4 0.08 Allowed 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 112.872 0.694 . . . . 0.0 112.872 178.047 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.745 HH21 ' CD1' ' B' ' 261' ' ' ILE . 25.2 mmm180 -131.04 143.73 50.92 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.17 -179.734 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 43.2 t -138.38 152.25 48.24 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.975 0.417 . . . . 0.0 110.421 -179.901 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -127.26 123.36 36.29 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.353 179.659 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.82 ' NH2' HG21 ' A' ' 8' ' ' VAL . 38.3 ttp-105 -90.31 135.58 33.59 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.487 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 81.4 t80 -98.93 127.89 44.96 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -178.489 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -134.0 120.68 20.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.28 179.552 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.44 ' OD1' ' ND1' ' A' ' 84' ' ' HIS . 43.1 p-10 -96.22 3.3 53.23 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.338 -179.949 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.092 179.661 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 34.8 m . . . . . 0 CA--C 1.521 -0.165 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.424 ' C ' ' H ' ' B' ' 231' ' ' GLN . 67.9 t0 -87.26 117.08 25.78 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.581 -0.447 . . . . 0.0 110.125 -179.968 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.424 ' H ' ' C ' ' B' ' 229' ' ' ASP . 20.6 mp0 -126.33 41.86 3.43 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.204 179.539 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -117.14 -177.02 17.71 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.101 -0.571 . . . . 0.0 111.749 -179.604 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -66.67 156.55 65.23 Favored 'Trans proline' 0 N--CA 1.5 1.896 0 C-N-CA 123.312 2.675 . . . . 0.0 112.817 179.499 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.653 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.08 140.22 34.1 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 121.467 1.445 . . . . 0.0 113.936 -178.79 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.19 139.62 20.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.7 179.854 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . 0.421 ' HB2' HD13 ' A' ' 91' ' ' ILE . 4.0 t -62.61 125.25 23.31 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.569 -178.575 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -62.81 -21.08 72.77 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.489 2.126 . . . . 0.0 112.735 -178.61 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 2.8 m -74.78 -43.65 53.66 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 177.898 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.57 ' CZ ' ' NH2' ' B' ' 245' ' ' ARG . 79.0 t80 -58.36 -46.91 85.39 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.499 -179.374 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 95.9 mt -67.78 -39.3 84.07 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.058 179.384 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 73.3 tt0 -61.07 -41.56 96.86 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.539 179.906 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . 0.625 ' NH1' ' NE2' ' B' ' 248' ' ' GLN . 78.4 ttt-85 -64.12 -40.98 97.36 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.245 0.545 . . . . 0.0 109.653 179.538 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.645 ' O ' HG23 ' B' ' 249' ' ' VAL . 10.1 tpp180 -57.33 -42.7 82.42 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.054 -179.525 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.48 -41.45 98.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.445 179.824 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 47.1 t -63.27 -45.07 93.2 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.468 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . 0.625 ' NE2' ' NH1' ' B' ' 244' ' ' ARG . 84.6 mt-30 -60.67 -32.53 71.73 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.473 179.655 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.645 HG23 ' O ' ' B' ' 245' ' ' ARG . 72.5 t -62.29 -45.98 97.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 119.977 -0.689 . . . . 0.0 109.477 179.52 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -58.69 -29.71 66.84 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.441 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -91.43 -12.14 35.62 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.494 179.043 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.491 ' N ' ' O ' ' B' ' 248' ' ' GLN . 55.1 tp -73.83 136.32 43.5 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.915 0.388 . . . . 0.0 111.12 -179.123 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -99.27 124.28 44.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.211 -179.543 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -63.33 -33.43 75.51 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.331 0.586 . . . . 0.0 109.912 178.558 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -61.34 2.55 0.15 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.638 -179.223 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.669 ' O ' ' N ' ' B' ' 258' ' ' ASP . 88.4 m-20 -96.78 -8.04 32.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.192 0.52 . . . . 0.0 109.738 179.16 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt 37.46 15.52 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.101 179.572 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.669 ' N ' ' O ' ' B' ' 256' ' ' ASP . 49.2 t0 -138.1 108.12 6.37 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.613 -179.509 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.449 ' CB ' ' NH1' ' A' ' 93' ' ' ARG . 80.8 m-20 -87.37 -90.11 0.12 Allowed 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.241 -0.584 . . . . 0.0 111.384 179.631 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -146.49 20.58 1.34 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 119.794 -0.762 . . . . 0.0 112.357 -179.243 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.745 ' CD1' HH21 ' A' ' 93' ' ' ARG . 66.0 mt -112.97 133.93 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.254 179.888 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 45.9 t -124.18 132.63 71.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.743 178.918 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . 0.601 ' HZ ' HG21 ' A' ' 9' ' ' THR . 49.2 m-85 -97.13 118.66 34.04 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.377 0.608 . . . . 0.0 111.909 -178.131 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -62.41 -44.19 97.02 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.767 178.813 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . 0.76 ' HG2' HD11 ' A' ' 24' ' ' LEU . 1.6 mp0 -84.55 162.31 51.13 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.366 -179.809 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -65.59 144.96 80.69 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.095 1.863 . . . . 0.0 112.44 179.9 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.536 0.435 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.551 -179.896 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo . . . . . 0 N--CA 1.495 1.595 0 CA-C-O 120.822 0.259 . . . . 0.0 112.236 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 72.3 p -108.07 -52.81 2.71 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.446 -179.7 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.8 mtt85 -88.57 132.0 34.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.554 179.718 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 19.5 ptp180 -139.02 148.67 43.72 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 120.029 -0.668 . . . . 0.0 111.717 179.877 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.594 HD11 HD11 ' A' ' 22' ' ' LEU . 67.1 mt -115.26 144.8 43.18 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.766 179.676 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.463 HG22 ' CD2' ' A' ' 19' ' ' HIS . 48.6 t -117.37 124.83 73.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.475 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.1 m -73.73 138.12 44.44 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.927 0.394 . . . . 0.0 111.846 -179.079 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.693 HD12 ' OG ' ' A' ' 94' ' ' SER . 78.8 mt -111.31 137.11 45.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.377 178.079 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -92.76 155.11 17.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.663 179.868 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.855 HH11 HH11 ' B' ' 245' ' ' ARG . 90.6 mtm180 -58.1 -23.73 55.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.505 -179.126 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.8 p -81.97 -10.15 59.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.1 0.476 . . . . 0.0 109.736 179.031 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.55 34.58 7.83 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 -179.819 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.6 t -122.45 133.31 69.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.706 0.288 . . . . 0.0 110.903 -179.959 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -74.99 141.06 44.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.861 179.844 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.04 -118.96 2.13 Favored Glycine 0 CA--C 1.542 1.727 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.369 -179.309 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.11 145.53 44.55 Favored 'Trans proline' 0 N--CA 1.501 1.918 0 C-N-CA 122.517 2.145 . . . . 0.0 114.065 -177.932 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.463 ' CD2' HG22 ' A' ' 8' ' ' VAL . 57.8 m170 -105.56 139.08 40.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.248 179.842 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.503 ' CD2' HD11 ' A' ' 37' ' ' ILE . 31.2 t80 -112.15 104.6 56.12 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 108.957 -0.756 . . . . 0.0 108.957 179.505 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -75.47 133.42 15.88 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 C-N-CA 121.404 1.403 . . . . 0.0 110.772 -178.983 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.594 HD11 HD11 ' A' ' 7' ' ' LEU . 97.2 mt -87.81 59.18 5.25 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 119.879 -0.728 . . . . 0.0 111.784 -178.187 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.2 p -67.61 -21.13 65.41 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.473 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.549 ' CD1' ' NE2' ' B' ' 265' ' ' GLN . 70.2 mt -84.01 140.69 31.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.628 -179.686 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 77.7 p -62.56 -21.31 65.49 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.78 -179.507 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.505 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 65.5 m -131.94 132.82 43.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.848 0.356 . . . . 0.0 111.748 -179.234 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.551 ' HB2' HD22 ' A' ' 22' ' ' LEU . 7.1 t -124.86 118.51 26.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.302 178.242 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 45.5 tp -115.95 128.45 55.76 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.439 -178.908 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.744 ' CE2' HD12 ' A' ' 37' ' ' ILE . 6.3 m-85 -106.51 136.0 47.04 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.335 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 159.02 -169.64 35.29 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 119.727 -1.225 . . . . 0.0 112.402 178.854 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.529 HH12 ' CA ' ' B' ' 232' ' ' GLY . 42.1 mtm180 -87.34 -31.1 20.34 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.418 179.376 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.416 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -50.82 148.18 7.89 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -179.735 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.566 HD11 ' P ' ' B' ' 230' ' ' SEP . 36.9 mm -63.98 -43.73 97.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 O-C-N 122.611 -0.346 . . . . 0.0 111.046 -179.409 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -53.69 -18.12 2.8 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.82 -179.511 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.416 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 70.3 m -59.68 123.47 17.04 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 121.13 0.49 . . . . 0.0 111.189 -179.449 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.505 ' OD2' ' O ' ' A' ' 26' ' ' THR . 71.1 m-20 -60.77 -29.95 69.73 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.804 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.744 HD12 ' CE2' ' A' ' 29' ' ' PHE . 95.6 mt -127.17 123.95 63.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.241 -0.89 . . . . 0.0 108.822 177.492 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' A' ' 38' ' ' ARG . 26.8 mtm180 -107.18 138.11 43.99 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.283 -179.107 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 95.9 mt -119.26 128.63 75.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.445 -179.911 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -73.16 30.72 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.123 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.584 HD21 ' OE1' ' B' ' 260' ' ' GLU . 94.0 mt -108.19 128.31 25.95 Favored Pre-proline 0 N--CA 1.464 0.257 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.649 179.137 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.75 -8.87 21.99 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.488 2.125 . . . . 0.0 112.107 179.953 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.7 m -93.13 4.22 7.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 121.209 0.528 . . . . 0.0 110.274 179.293 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.422 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 20.4 t -95.13 133.7 35.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.512 -0.767 . . . . 0.0 108.941 178.332 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.2 t -70.41 170.52 11.78 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.287 0.565 . . . . 0.0 111.506 -178.266 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 52.2 mttp -62.97 -42.57 99.87 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.132 -179.444 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.607 ' O ' ' N ' ' A' ' 49' ' ' CYS . 87.1 mt-30 -114.49 -22.9 9.59 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 123.436 0.46 . . . . 0.0 110.709 -179.808 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.3 t60 37.13 -75.83 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 179.502 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.607 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -128.36 134.04 48.77 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.101 0.477 . . . . 0.0 111.955 -177.817 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -128.87 136.94 51.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.608 -179.932 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.7 mt -121.93 135.94 60.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.978 -179.932 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -113.85 127.1 55.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.634 178.973 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 48.8 mm -96.1 114.3 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-O 121.174 0.512 . . . . 0.0 111.555 -179.522 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.463 ' O ' ' N ' ' A' ' 56' ' ' GLN . 94.6 m-70 -117.54 134.61 54.68 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.622 178.684 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.478 ' H ' ' CD ' ' A' ' 55' ' ' GLU . 57.6 mp0 -39.72 -29.72 0.06 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -179.718 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.463 ' N ' ' O ' ' A' ' 54' ' ' HIS . 87.7 mt-30 -66.55 -67.87 0.42 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.545 178.735 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.11 -165.18 1.77 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.698 -179.275 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -120.28 129.46 54.04 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.569 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.4 mt -114.05 130.66 67.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -178.493 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.424 ' HB2' HD11 ' A' ' 82' ' ' LEU . 51.2 tp -94.59 124.54 38.69 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.884 179.585 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -112.84 137.6 50.94 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.099 -179.232 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.558 ' ND2' ' O ' ' A' ' 76' ' ' ILE . 50.7 p-10 -98.33 104.57 16.61 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.866 -179.841 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -93.88 -7.28 43.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.162 0.506 . . . . 0.0 109.825 178.328 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.4 t -75.21 100.9 4.45 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.013 179.531 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.9 m -87.46 -9.31 54.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.234 -179.962 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.573 HG22 HG22 ' B' ' 236' ' ' VAL . 0.2 OUTLIER -96.16 -41.92 8.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.09 0.472 . . . . 0.0 109.829 -179.85 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 40.9 m-20 -140.59 101.29 6.65 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.746 179.586 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -56.02 143.32 83.54 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 121.996 1.797 . . . . 0.0 112.24 -179.466 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 92.4 m -70.78 138.33 50.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.27 178.763 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -98.3 139.63 33.79 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.058 -179.999 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.407 HG21 HD23 ' A' ' 60' ' ' LEU . 55.5 t -133.5 132.38 57.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.288 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 53.22 34.31 17.31 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.612 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.5 29.02 66.51 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 114.958 -1.019 . . . . 0.0 112.53 179.928 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 47.3 t -145.72 142.42 28.94 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.924 179.763 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.0 m -74.75 140.24 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.515 179.278 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.587 HG22 HG21 ' A' ' 80' ' ' VAL . 4.6 pt -105.34 98.91 7.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.618 0.723 . . . . 0.0 109.901 178.781 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -63.86 -34.66 78.44 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.573 -179.705 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.458 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 1.2 mt-10 -128.9 -178.78 0.85 Allowed Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.748 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.458 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 25.0 Cg_exo -61.42 142.43 95.49 Favored 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 122.192 1.928 . . . . 0.0 113.03 -178.813 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.587 HG21 HG22 ' A' ' 76' ' ' ILE . 78.0 t -132.72 137.53 53.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.159 179.736 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -75.99 128.51 35.2 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.576 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.424 HD11 ' HB2' ' A' ' 60' ' ' LEU . 96.6 mt -84.01 136.43 34.05 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.99 -179.702 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -120.53 149.94 41.63 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.767 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.539 ' ND1' ' N ' ' A' ' 99' ' ' ASN . 6.1 t60 -55.31 123.88 15.25 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.995 -178.603 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.05 -13.55 52.46 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.513 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -71.24 136.91 48.22 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.49 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.4 p -105.5 140.42 23.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.776 -0.37 . . . . 0.0 111.38 -178.815 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 72.1 mt -108.25 130.81 60.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.092 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 53.5 m -126.39 128.8 47.6 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -177.355 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 91.4 mt -112.66 121.67 65.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 114.228 -1.351 . . . . 0.0 107.354 177.197 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.622 HG22 ' N ' ' A' ' 92' ' ' ASP . 97.0 mt 35.57 -99.01 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.751 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.622 ' N ' HG22 ' A' ' 91' ' ' ILE . 94.5 m-20 -110.38 8.62 23.37 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -178.982 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.505 HH21 HG13 ' B' ' 261' ' ' ILE . 50.3 mtp85 -127.12 144.26 51.07 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -179.846 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.693 ' OG ' HD12 ' A' ' 10' ' ' ILE . 19.4 p -141.28 159.28 42.54 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.37 0.605 . . . . 0.0 112.217 -178.458 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.661 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 87.9 m-85 -129.24 125.01 35.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.084 178.231 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -82.12 135.16 35.34 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 119.769 -0.773 . . . . 0.0 110.49 179.967 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -97.2 122.92 40.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.323 0.582 . . . . 0.0 111.091 -179.271 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -124.31 117.16 23.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.533 179.455 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.539 ' N ' ' ND1' ' A' ' 84' ' ' HIS . 64.7 t-20 -93.81 120.18 33.74 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.704 -179.747 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 70.6 tt0 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.032 179.792 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . 0.432 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 3.3 m . . . . . 0 C--O 1.237 0.404 0 CA-C-O 120.607 0.242 . . . . 0.0 110.938 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.552 ' O ' ' CB ' ' B' ' 230' ' ' SEP . 28.8 t0 -74.96 89.2 2.38 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.898 -178.27 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . 0.566 ' P ' HD11 ' A' ' 33' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.58 50.83 1.85 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.192 -179.948 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . 0.529 ' CA ' HH12 ' A' ' 31' ' ' ARG . . . -108.03 -173.25 21.88 Favored Glycine 0 CA--C 1.533 1.201 0 N-CA-C 111.689 -0.564 . . . . 0.0 111.689 179.429 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . 0.482 ' O ' ' NH2' ' A' ' 31' ' ' ARG . 85.0 Cg_endo -77.54 162.76 30.19 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 123.815 3.01 . . . . 0.0 112.485 179.843 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -57.43 137.97 83.97 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 121.946 1.764 . . . . 0.0 112.067 179.059 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.573 HG22 HG22 ' A' ' 66' ' ' THR . 53.3 t -62.61 135.42 27.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.559 179.666 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 14.9 t -56.58 118.22 4.63 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.413 -179.511 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . 0.485 ' O3P' HG23 ' B' ' 240' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.71 -26.64 47.94 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.553 2.169 . . . . 0.0 112.476 179.91 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . 0.485 HG23 ' O3P' ' B' ' 238' ' ' TPO . 17.4 p -73.65 -40.74 63.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.017 0.436 . . . . 0.0 110.006 178.371 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -56.6 -46.53 80.8 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.871 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.442 HD23 ' OD2' ' A' ' 92' ' ' ASP . 93.6 mt -62.57 -43.52 98.6 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.941 -179.335 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -64.73 -40.01 94.61 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.07 -178.861 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . 0.47 ' O ' ' OG ' ' B' ' 247' ' ' SER . 95.0 mtt-85 -64.51 -42.01 96.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.218 0.532 . . . . 0.0 110.071 179.649 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.855 HH11 HH11 ' A' ' 12' ' ' ARG . 25.0 ttm-85 -61.79 -42.19 98.68 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.765 -179.339 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -61.56 -36.4 80.51 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.809 0.337 . . . . 0.0 110.285 179.113 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . 0.47 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 78.6 p -69.94 -40.39 75.52 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 177.958 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -57.61 -40.18 78.55 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.024 179.324 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 56.9 t -61.8 -44.94 99.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 178.627 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -59.23 -27.56 65.87 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.212 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -84.26 -11.6 56.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.928 179.449 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.494 HD22 ' NH2' ' A' ' 12' ' ' ARG . 3.5 mp -108.88 171.49 7.4 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.427 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . 0.658 ' C ' ' H ' ' B' ' 255' ' ' ASP . 0.5 OUTLIER -176.21 -142.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.932 179.661 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . 0.551 ' H ' ' CG ' ' B' ' 253' ' ' ASN . 52.8 p30 -50.53 5.71 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.026 -178.716 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . 0.658 ' H ' ' C ' ' B' ' 253' ' ' ASN . 99.6 m-20 -38.02 -30.26 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.299 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.577 ' CB ' ' O ' ' B' ' 255' ' ' ASP . 39.4 t0 105.98 -128.62 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 O-C-N 124.192 0.932 . . . . 0.0 111.722 178.509 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -94.35 -158.72 0.65 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.005 -178.868 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 63.89 37.39 9.61 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.731 -179.66 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.486 ' OD2' ' NH1' ' A' ' 93' ' ' ARG . 67.1 t0 -57.83 -96.59 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.738 179.007 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.584 ' OE1' HD21 ' A' ' 41' ' ' LEU . 96.9 mt-10 -139.02 15.91 2.64 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.187 178.969 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.661 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 71.6 mt -116.93 135.2 58.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.609 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 50.0 t -123.78 132.32 71.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.541 179.309 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -95.57 119.52 34.21 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.264 0.554 . . . . 0.0 111.781 -178.234 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -64.9 -45.3 86.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.354 179.769 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . 0.549 ' NE2' ' CD1' ' A' ' 24' ' ' LEU . 0.3 OUTLIER -100.78 163.96 17.07 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.284 -179.831 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -61.41 156.86 43.93 Favored 'Trans proline' 0 N--CA 1.503 2.051 0 C-N-CA 122.992 2.462 . . . . 0.0 113.062 -179.604 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 25.9 pt . . . . . 0 N--CA 1.465 0.285 0 CA-C-O 121.312 0.577 . . . . 0.0 111.775 -178.986 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo . . . . . 0 N--CA 1.499 1.825 0 CA-C-O 120.697 0.207 . . . . 0.0 112.071 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.405 HG23 ' OE2' ' A' ' 100' ' ' GLU . 10.7 m -74.91 -50.97 15.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.897 0.379 . . . . 0.0 111.477 -179.932 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.608 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 85.1 mtt-85 -100.25 148.75 24.31 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.492 -177.995 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -134.55 141.68 46.76 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.516 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 98.5 mt -113.8 139.74 48.88 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 178.73 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 67.9 t -113.89 129.46 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.407 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 m -93.22 116.62 29.19 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.402 0.62 . . . . 0.0 112.516 -178.258 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 81.7 mt -85.67 147.66 5.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.111 179.149 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.464 ' HD2' HG23 ' A' ' 15' ' ' VAL . 94.8 mttt -93.61 157.87 15.97 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.479 179.092 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.595 ' NH2' ' OE2' ' B' ' 260' ' ' GLU . 91.1 mtm180 -60.98 -27.56 68.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.304 -0.407 . . . . 0.0 109.997 179.859 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.558 ' OG ' HG22 ' A' ' 15' ' ' VAL . 91.1 p -70.6 -22.69 62.52 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.755 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.73 6.94 37.27 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-N 115.72 -0.673 . . . . 0.0 113.699 178.576 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.558 HG22 ' OG ' ' A' ' 13' ' ' SER . 17.8 m -104.82 142.92 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 117.995 0.898 . . . . 0.0 111.568 -179.693 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 17' ' ' GLY . 61.8 t0 -69.15 127.85 34.55 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.063 -179.397 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.437 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -115.72 -127.94 4.26 Favored Glycine 0 CA--C 1.535 1.325 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 -179.814 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.93 155.88 38.78 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.483 2.122 . . . . 0.0 112.788 -178.872 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -112.78 158.78 19.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.985 0.421 . . . . 0.0 111.191 -178.591 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.554 ' CD2' HD11 ' A' ' 37' ' ' ILE . 39.0 t80 -128.35 98.61 25.69 Favored Pre-proline 0 N--CA 1.467 0.403 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.578 -179.727 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.441 ' HD2' HG22 ' B' ' 267' ' ' ILE . 73.6 Cg_endo -74.28 139.57 26.48 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 121.587 1.525 . . . . 0.0 112.508 -178.905 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.441 HD13 HD11 ' A' ' 53' ' ' ILE . 80.2 mt -88.33 86.01 6.99 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.203 -179.331 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 59.7 p -86.39 -7.95 58.04 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.515 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.0 mt -108.69 148.82 29.86 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.041 -179.184 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.3 m -68.73 -15.06 63.4 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.127 -179.117 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 57.0 m -130.02 134.63 47.54 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.452 -0.499 . . . . 0.0 112.143 -179.975 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.7 t -127.96 118.76 24.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.914 178.573 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.525 HD12 ' O ' ' A' ' 49' ' ' CYS . 57.3 tp -118.46 130.8 56.15 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 120.954 0.406 . . . . 0.0 111.031 -179.056 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.816 ' CE2' HD12 ' A' ' 37' ' ' ILE . 18.3 m-85 -110.25 141.6 42.99 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.988 -179.893 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 153.67 -174.88 32.19 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.883 178.795 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 45.1 mtm180 -74.82 -32.53 61.98 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 122.704 -0.291 . . . . 0.0 111.722 179.348 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.594 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -58.14 149.57 34.59 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.579 -177.714 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.431 ' C ' ' N ' ' A' ' 35' ' ' CYS . 82.4 mt -66.37 -43.06 91.49 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 178.247 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -49.9 -25.28 3.07 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.222 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.594 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 3.6 m -65.69 115.01 5.4 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.723 179.47 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -52.76 -21.09 3.71 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.166 -178.135 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.816 HD12 ' CE2' ' A' ' 29' ' ' PHE . 85.4 mt -131.4 123.92 53.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.657 177.809 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 47.3 mtm180 -107.3 138.5 43.38 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.836 -179.865 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 1.028 HG21 ' NH1' ' A' ' 93' ' ' ARG . 63.9 mt -120.56 132.44 70.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.419 -0.512 . . . . 0.0 110.48 179.762 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -75.41 24.08 0.11 Allowed 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -178.068 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.747 HD12 ' CZ ' ' A' ' 93' ' ' ARG . 25.7 mt -105.48 128.67 26.09 Favored Pre-proline 0 C--N 1.323 -0.56 0 C-N-CA 119.591 -0.844 . . . . 0.0 109.855 179.341 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.07 -10.27 25.75 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.523 2.149 . . . . 0.0 112.566 -178.773 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.8 m -87.11 -0.21 7.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.622 179.927 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.459 HG21 HH12 ' A' ' 93' ' ' ARG . 48.0 t -91.38 131.64 37.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.131 0.491 . . . . 0.0 111.006 -179.223 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.05 160.64 20.54 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.987 179.77 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 28.2 mtmt -59.93 -42.54 94.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.702 -178.839 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.629 ' O ' ' N ' ' A' ' 49' ' ' CYS . 12.4 mm100 -111.49 -16.52 13.28 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 123.481 0.488 . . . . 0.0 110.048 -179.549 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.2 t60 35.62 -76.37 0.0 OUTLIER 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.076 -0.966 . . . . 0.0 113.348 -179.763 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.629 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -137.09 140.18 41.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.941 0.401 . . . . 0.0 111.799 -178.622 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -127.01 131.91 50.89 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.511 179.728 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.9 mt -114.87 135.93 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-O 121.098 0.475 . . . . 0.0 110.738 179.54 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -113.75 125.55 54.23 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.067 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.441 HD11 HD13 ' A' ' 22' ' ' LEU . 93.9 mt -108.2 113.62 44.36 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.461 -179.856 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.582 ' O ' ' N ' ' A' ' 56' ' ' GLN . 91.5 m-70 -115.42 141.36 48.15 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.125 179.974 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.467 ' C ' ' O ' ' A' ' 54' ' ' HIS . 84.1 tt0 -38.92 -25.18 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 120.293 -0.563 . . . . 0.0 109.527 -179.109 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.582 ' N ' ' O ' ' A' ' 54' ' ' HIS . 57.3 tt0 -67.51 -67.31 0.47 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.386 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -160.65 -163.66 1.11 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.193 -179.586 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.79 127.16 55.9 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.577 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 89.2 mt -113.89 128.76 70.67 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 CA-C-O 121.297 0.57 . . . . 0.0 111.688 -179.228 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 43.4 tp -97.39 126.91 42.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.883 -179.975 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -114.7 138.01 51.22 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.962 179.105 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.555 ' ND2' ' H ' ' A' ' 69' ' ' THR . 16.8 t-20 -101.12 109.62 21.53 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.067 0.461 . . . . 0.0 111.602 -179.564 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -94.89 -4.59 46.65 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.254 179.108 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.0 t -90.42 101.06 13.79 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.728 -179.712 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.4 p -87.59 -24.21 24.06 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.388 -0.525 . . . . 0.0 109.996 178.087 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.58 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.3 OUTLIER -69.74 -43.29 72.61 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.6 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.432 HD21 ' HA ' ' B' ' 236' ' ' VAL . 31.4 m-80 -142.97 100.9 5.36 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.69 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -66.28 150.85 84.52 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.264 1.309 . . . . 0.0 113.532 -177.831 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.555 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 33.7 m -69.93 137.95 51.96 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.912 179.555 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -101.38 142.43 32.79 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.662 179.906 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.716 ' HB ' HD11 ' A' ' 76' ' ' ILE . 5.0 p -129.5 137.2 57.47 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.14 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 49.57 32.8 5.18 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.583 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.51 27.85 64.65 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.057 -179.903 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 62.8 m -141.06 138.8 33.86 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 117.549 0.675 . . . . 0.0 112.098 -179.473 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.4 m -65.62 137.45 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.527 179.734 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.716 HD11 ' HB ' ' A' ' 71' ' ' VAL . 96.2 mt -99.57 96.39 4.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.594 179.856 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -65.15 -41.49 94.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.853 0.359 . . . . 0.0 110.867 179.645 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.497 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.1 OUTLIER -126.72 166.05 24.65 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.492 -179.343 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -57.24 143.32 93.87 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.174 1.916 . . . . 0.0 112.565 -179.052 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.6 t -133.32 137.49 53.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.654 -179.894 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 87.7 mtm-85 -68.98 134.43 49.48 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.535 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.441 HD23 ' HA ' ' A' ' 82' ' ' LEU . 80.3 mt -81.08 137.28 36.0 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.472 0.653 . . . . 0.0 111.589 -179.22 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -125.64 147.08 49.44 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.656 179.724 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.482 ' ND1' ' N ' ' A' ' 99' ' ' ASN . 4.8 t60 -57.19 124.97 20.67 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.578 -179.318 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.73 -24.22 26.03 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -179.151 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.544 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 41.4 t0 -64.57 134.48 54.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.991 0.424 . . . . 0.0 110.198 179.347 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.544 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 9.9 p -110.9 132.9 58.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.509 -178.157 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 79.0 mt -99.09 130.18 48.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.857 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 17.7 m -116.85 123.73 47.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.514 0.673 . . . . 0.0 111.405 179.895 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.634 ' O ' ' N ' ' A' ' 93' ' ' ARG . 96.8 mt -117.36 129.04 74.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.062 178.306 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.494 ' C ' ' O ' ' A' ' 90' ' ' ILE . 85.5 mt -14.97 96.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -178.876 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 79.06 -11.23 1.24 Allowed 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 177.963 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 1.028 ' NH1' HG21 ' A' ' 39' ' ' ILE . 17.7 mtm180 -130.95 134.28 46.59 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.349 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.2 m -133.81 147.95 51.28 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.6 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.407 ' HE1' HD12 ' A' ' 90' ' ' ILE . 54.7 m-85 -122.81 120.13 32.62 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.549 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.429 ' NE ' ' OE2' ' A' ' 98' ' ' GLU . 37.8 ttp-105 -79.97 130.92 35.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.061 0.458 . . . . 0.0 110.989 -179.362 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.608 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 46.0 t80 -98.5 122.97 42.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.413 -179.704 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.429 ' OE2' ' NE ' ' A' ' 96' ' ' ARG . 96.3 mt-10 -139.07 129.31 25.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.188 0.518 . . . . 0.0 111.333 179.832 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.509 ' OD1' ' OH ' ' A' ' 97' ' ' TYR . 91.4 m-20 -91.32 141.04 29.2 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.356 179.734 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.405 ' OE2' HG23 ' A' ' 4' ' ' THR . 80.2 mm-40 . . . . . 0 C--N 1.325 -0.467 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.656 179.5 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . 0.499 ' O ' ' OD1' ' B' ' 229' ' ' ASP . 70.5 t . . . . . 0 N--CA 1.453 -0.309 0 CA-C-O 121.0 0.429 . . . . 0.0 110.139 . . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.499 ' OD1' ' O ' ' B' ' 228' ' ' VAL . 68.5 m-20 -164.93 174.69 10.26 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.934 -179.919 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -144.04 46.97 1.43 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.377 -179.724 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -112.64 -159.44 14.23 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.474 -0.651 . . . . 0.0 111.474 -178.826 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.84 158.2 53.48 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 122.554 2.169 . . . . 0.0 113.163 -179.381 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.528 HG21 ' O1P' ' B' ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -64.71 169.24 11.81 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.711 2.274 . . . . 0.0 111.843 178.703 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.58 ' CG2' HG22 ' A' ' 66' ' ' THR . 37.7 t -112.73 134.07 56.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.83 179.871 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . 0.413 ' HB2' HD13 ' A' ' 91' ' ' ILE . 3.7 t -52.32 112.98 0.9 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.553 -179.539 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . 0.404 ' O3P' ' OG1' ' B' ' 240' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -58.71 -22.27 60.26 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 C-N-CA 121.162 1.241 . . . . 0.0 111.622 178.855 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . 0.404 ' OG1' ' O3P' ' B' ' 238' ' ' TPO . 18.5 m -71.92 -46.78 56.39 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 120.606 -0.437 . . . . 0.0 110.421 179.092 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.5 ' CZ ' ' NH1' ' B' ' 245' ' ' ARG . 80.5 t80 -58.7 -45.73 88.86 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.616 -178.846 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 93.9 mt -64.16 -40.16 95.55 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.04 -179.178 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -60.98 -45.16 95.92 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.489 -179.689 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -66.91 -38.67 86.65 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.598 179.744 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.603 ' CA ' ' HE ' ' B' ' 245' ' ' ARG . 0.0 OUTLIER -60.11 -44.62 94.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.97 -179.029 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.59 -40.77 97.8 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.353 0.597 . . . . 0.0 109.473 179.117 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 26.8 m -60.44 -45.74 92.57 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.44 179.226 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . 0.579 HE22 ' NH2' ' B' ' 245' ' ' ARG . 74.1 mt-30 -58.23 -37.93 75.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.416 179.793 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.778 HG22 ' NZ ' ' B' ' 257' ' ' LYS . 54.6 t -61.41 -46.57 96.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.013 179.35 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -57.96 -27.97 63.91 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.84 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -86.45 -12.56 48.68 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.107 179.871 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.542 ' O ' ' CB ' ' B' ' 253' ' ' ASN . 92.5 mt -109.76 -176.67 3.07 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.085 178.58 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . 0.542 ' CB ' ' O ' ' B' ' 252' ' ' LEU . 0.2 OUTLIER 84.42 20.9 0.13 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.884 -179.414 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -66.35 -41.96 88.79 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.116 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . 0.482 ' O ' ' OD1' ' B' ' 256' ' ' ASP . 52.2 m-20 -111.86 -80.97 0.59 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.219 179.287 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.482 ' OD1' ' O ' ' B' ' 255' ' ' ASP . 98.1 m-20 -142.3 3.35 1.53 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.198 -179.742 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . 0.778 ' NZ ' HG22 ' B' ' 249' ' ' VAL . 74.6 tttt 60.55 116.27 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 120.216 -0.593 . . . . 0.0 109.428 -179.151 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.419 ' O ' ' CB ' ' B' ' 259' ' ' ASP . 96.5 m-20 -61.61 -36.64 81.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.712 -178.456 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.612 ' C ' ' H ' ' B' ' 261' ' ' ILE . 27.4 t0 81.36 112.03 0.06 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.187 -178.924 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.595 ' OE2' ' NH2' ' A' ' 12' ' ' ARG . 56.6 mp0 -58.88 19.85 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.279 -179.56 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.612 ' H ' ' C ' ' B' ' 259' ' ' ASP . 66.3 mt -112.77 135.45 52.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.671 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 55.1 t -130.16 134.88 62.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.124 0.488 . . . . 0.0 111.048 -178.657 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -95.06 118.81 32.5 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.551 0.691 . . . . 0.0 111.277 -178.503 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -66.01 -47.52 74.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.159 179.424 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -89.06 151.45 46.92 Favored Pre-proline 0 N--CA 1.449 -0.494 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.185 -178.981 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.9 149.46 72.32 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.919 2.412 . . . . 0.0 112.838 179.747 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . 0.441 HG22 ' HD2' ' A' ' 21' ' ' PRO . 44.1 pt . . . . . 0 C--N 1.33 -0.262 0 CA-C-O 121.313 0.578 . . . . 0.0 110.09 179.042 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 N--CA 1.489 1.227 0 CA-C-O 120.691 0.205 . . . . 0.0 111.883 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.0 p -103.13 -43.14 5.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.41 -179.892 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.547 ' NE ' HD13 ' A' ' 53' ' ' ILE . 88.6 mtm-85 -90.26 126.4 35.83 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.28 179.913 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -129.79 135.37 48.35 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.095 0.474 . . . . 0.0 111.032 179.826 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.698 HD12 ' O ' ' A' ' 96' ' ' ARG . 29.5 tp -115.3 133.82 55.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.136 -179.38 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 45.0 t -109.15 131.98 58.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.407 -179.95 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 m -90.99 118.39 30.34 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.34 0.59 . . . . 0.0 112.541 -178.408 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.469 HD12 ' HB2' ' A' ' 94' ' ' SER . 97.0 mt -85.85 142.14 13.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.536 179.248 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.555 ' NZ ' ' O ' ' B' ' 256' ' ' ASP . 97.8 mttt -89.31 160.68 16.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.027 0.441 . . . . 0.0 110.919 179.262 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.593 HH11 HH11 ' B' ' 245' ' ' ARG . 90.5 mtm180 -55.94 -33.07 64.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.662 -178.902 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.6 t -77.75 -8.54 58.12 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.234 179.837 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.92 31.14 9.49 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -179.924 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.0 t -116.8 132.69 65.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.857 0.36 . . . . 0.0 110.081 179.681 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 45.4 p-10 -84.19 142.8 30.06 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.978 179.612 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -133.89 -108.05 1.02 Allowed Glycine 0 CA--C 1.532 1.098 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.733 -179.531 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -73.29 148.57 43.91 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 122.347 2.032 . . . . 0.0 112.028 -179.454 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -111.94 147.58 35.57 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.149 -179.844 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -115.05 104.72 53.73 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.981 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.42 133.14 15.63 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.164 1.242 . . . . 0.0 110.992 -178.81 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 82.9 mt -87.61 51.76 2.31 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -177.51 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.5 m -59.28 -34.1 71.87 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.879 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.538 HD11 ' HG2' ' B' ' 265' ' ' GLN . 60.9 mt -71.62 144.75 49.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.45 -179.845 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.6 m -68.18 -16.38 63.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.415 -179.355 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.448 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 95.5 m -133.77 134.42 42.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.834 0.35 . . . . 0.0 111.664 -179.806 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.9 t -125.78 116.66 21.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.902 178.424 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 58.2 tp -113.71 127.83 56.18 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.794 -178.924 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.609 ' CE2' HD12 ' A' ' 37' ' ' ILE . 9.4 m-85 -106.93 139.23 41.67 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.851 179.65 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 146.5 -175.93 25.67 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 120.982 -0.628 . . . . 0.0 111.622 178.972 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 31' ' ' ARG . 47.6 mtm180 -75.46 -33.72 60.88 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -179.851 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.505 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -44.45 142.95 2.75 Favored Glycine 0 C--O 1.223 -0.535 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 -178.465 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.416 HD13 ' CZ ' ' A' ' 38' ' ' ARG . 32.5 mm -62.6 -43.13 98.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 117.194 0.497 . . . . 0.0 110.033 179.957 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -54.81 -20.73 9.24 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.51 -0.476 . . . . 0.0 109.865 179.551 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.505 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 60.0 m -56.63 119.61 6.4 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-O 120.968 0.413 . . . . 0.0 111.141 -179.47 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.448 ' OD2' ' O ' ' A' ' 26' ' ' THR . 80.0 m-20 -58.09 -26.63 62.81 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -179.817 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.609 HD12 ' CE2' ' A' ' 29' ' ' PHE . 95.1 mt -129.18 118.97 47.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.235 177.381 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.416 ' CZ ' HD13 ' A' ' 33' ' ' ILE . 84.7 mtp180 -103.34 133.5 48.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.634 -179.106 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.423 HG21 HD12 ' A' ' 41' ' ' LEU . 83.6 mt -118.13 129.94 73.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 120.511 -0.475 . . . . 0.0 110.021 179.744 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -75.24 36.71 0.12 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.85 -178.057 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.723 ' O ' HG12 ' A' ' 44' ' ' VAL . 70.0 mt -111.74 119.32 44.98 Favored Pre-proline 0 C--N 1.325 -0.457 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.061 -179.678 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -71.29 -12.77 30.27 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 121.835 1.69 . . . . 0.0 112.824 -179.987 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.706 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 31.1 m -86.76 -3.51 8.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.949 -0.301 . . . . 0.0 110.716 179.657 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.723 HG12 ' O ' ' A' ' 41' ' ' LEU . 3.3 p -96.62 146.76 6.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.103 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.9 m -74.65 166.14 24.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.469 0.652 . . . . 0.0 112.519 -178.478 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 45.6 mttp -63.23 -40.05 96.34 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.03 -0.987 . . . . 0.0 111.737 179.975 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.669 ' O ' ' N ' ' A' ' 49' ' ' CYS . 89.7 mt-30 -113.36 -19.83 11.58 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.385 179.858 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.0 t60 34.83 -75.93 0.0 OUTLIER 'General case' 0 C--O 1.234 0.274 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 179.048 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.669 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.1 134.45 47.36 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.248 0.547 . . . . 0.0 112.253 -178.948 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -127.01 128.65 46.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.257 179.021 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.3 mt -111.56 133.74 56.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.189 179.845 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -116.79 126.55 53.26 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.463 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.547 HD13 ' NE ' ' A' ' 5' ' ' ARG . 84.8 mt -106.15 112.91 41.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.404 -179.067 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.504 ' O ' ' N ' ' A' ' 56' ' ' GLN . 95.0 m-70 -112.78 144.03 43.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.399 179.54 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 54' ' ' HIS . 84.1 tt0 -39.9 -27.21 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.358 -0.537 . . . . 0.0 109.992 -178.839 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.504 ' N ' ' O ' ' A' ' 54' ' ' HIS . 75.8 mt-30 -69.08 -66.99 0.51 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.949 179.132 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -157.92 -169.2 2.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.347 -179.11 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -111.85 125.32 53.89 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.741 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.5 mt -114.73 132.05 65.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -178.203 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.494 ' HB2' HD21 ' A' ' 82' ' ' LEU . 44.0 tp -94.8 122.54 37.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.8 179.266 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -109.08 136.35 48.73 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.159 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.475 HD21 ' HA ' ' A' ' 68' ' ' PRO . 63.5 t-20 -97.54 109.54 22.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.068 0.461 . . . . 0.0 112.241 -178.422 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.405 ' CD2' ' OE1' ' A' ' 47' ' ' GLN . 28.3 m-85 -100.91 -9.87 21.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.121 179.326 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.7 t -76.22 98.62 4.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.805 0.336 . . . . 0.0 110.844 -179.389 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 34.2 t -79.09 -40.79 30.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.323 0.582 . . . . 0.0 109.744 178.683 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.784 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.2 OUTLIER -64.75 -47.02 79.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.02 -179.112 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 42.3 m-20 -136.97 97.91 10.77 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.452 179.894 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.475 ' HA ' HD21 ' A' ' 62' ' ' ASN . 36.2 Cg_exo -56.45 145.05 81.55 Favored 'Trans proline' 0 N--CA 1.494 1.5 0 C-N-CA 121.799 1.666 . . . . 0.0 112.612 -179.121 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.3 m -73.83 140.01 45.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.393 -179.992 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -104.59 141.79 35.79 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.749 -179.188 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.509 ' CG1' ' OD1' ' A' ' 86' ' ' ASP . 55.3 t -130.96 136.23 58.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.491 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 52.26 33.3 12.33 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -179.394 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.58 29.48 72.88 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.284 179.726 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.7 p -141.66 136.65 31.11 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.714 -0.395 . . . . 0.0 110.867 -179.974 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.414 HG13 ' HB2' ' A' ' 68' ' ' PRO . 78.6 t -66.01 135.82 27.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.087 -179.907 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.08 96.65 3.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.409 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -84.56 -16.69 41.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.536 -0.757 . . . . 0.0 112.014 -178.583 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -111.47 162.6 20.3 Favored Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.557 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -58.96 142.24 99.1 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 121.45 1.433 . . . . 0.0 111.693 179.684 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.5 p -140.48 139.1 35.89 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 CA-C-O 120.957 0.408 . . . . 0.0 110.758 179.814 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.635 HH21 ' CE ' ' A' ' 83' ' ' LYS . 61.9 ttp180 -73.39 127.71 33.44 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.461 179.616 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.494 HD21 ' HB2' ' A' ' 60' ' ' LEU . 98.2 mt -78.78 138.16 38.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.79 -180.0 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.635 ' CE ' HH21 ' A' ' 81' ' ' ARG . 97.7 mttt -130.29 151.93 50.26 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.342 179.237 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.643 ' HD1' ' CG ' ' A' ' 99' ' ' ASN . 3.7 t-160 -55.59 120.95 8.02 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.287 -179.334 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.08 -15.06 36.89 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -179.58 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.509 ' OD1' ' CG1' ' A' ' 71' ' ' VAL . 35.2 t70 -68.79 126.54 30.07 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.312 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.9 t -109.51 127.09 66.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.578 -178.922 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 90.7 mt -93.27 133.54 34.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.896 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 53.7 m -124.19 123.08 39.5 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.592 0.71 . . . . 0.0 112.387 -178.555 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.451 ' N ' ' O ' ' A' ' 93' ' ' ARG . 93.1 mt -107.91 124.27 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 177.498 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.707 HD12 HH22 ' A' ' 93' ' ' ARG . 93.9 mt 39.47 -98.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.171 -178.445 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.613 ' OD1' ' NH1' ' A' ' 93' ' ' ARG . 28.9 p-10 -119.71 16.54 12.76 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.015 0.436 . . . . 0.0 110.837 179.365 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.707 HH22 HD12 ' A' ' 91' ' ' ILE . 45.0 mtm-85 -120.0 138.12 53.68 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.765 179.877 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.469 ' HB2' HD12 ' A' ' 10' ' ' ILE . 66.9 m -137.44 152.41 49.55 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 119.886 -0.726 . . . . 0.0 111.283 -179.871 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.533 ' HB3' HD11 ' A' ' 7' ' ' LEU . 74.6 m-85 -123.79 121.45 35.45 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.098 179.413 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.698 ' O ' HD12 ' A' ' 7' ' ' LEU . 99.8 mtt180 -81.95 129.08 34.67 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.75 -179.045 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -99.0 126.99 44.82 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.832 179.876 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -137.22 127.88 26.98 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.653 179.996 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.643 ' CG ' ' HD1' ' A' ' 84' ' ' HIS . 41.2 p30 -82.54 -145.58 0.07 Allowed 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.532 -179.965 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.415 ' N ' ' OD1' ' A' ' 99' ' ' ASN . 22.5 pt-20 . . . . . 0 C--N 1.331 -0.233 0 CA-C-O 121.05 0.452 . . . . 0.0 111.11 -179.189 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 4.7 p . . . . . 0 CA--C 1.53 0.203 0 N-CA-C 111.475 0.176 . . . . 0.0 111.475 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.479 ' C ' ' H ' ' B' ' 231' ' ' GLN . 79.7 m-20 -61.1 139.24 58.13 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.347 -179.786 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.479 ' H ' ' C ' ' B' ' 229' ' ' ASP . 88.3 mm-40 -132.2 48.84 2.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.906 179.986 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -118.22 -170.74 15.04 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -179.468 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -76.72 161.65 33.47 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 123.655 2.903 . . . . 0.0 113.279 -179.355 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.784 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -58.31 132.7 50.41 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.32 2.013 . . . . 0.0 112.657 179.511 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.613 ' CG2' HG22 ' A' ' 66' ' ' THR . 31.4 t -64.09 135.5 27.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.391 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -57.19 122.51 12.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.093 0.473 . . . . 0.0 110.805 -178.741 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -59.22 -21.45 60.0 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 121.844 1.696 . . . . 0.0 111.806 178.776 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 52.0 m -73.03 -46.19 53.38 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.05 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.706 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 71.3 t80 -56.6 -48.15 78.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.757 -179.793 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 85.8 mt -66.18 -43.6 86.4 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -179.887 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -65.48 -45.14 84.8 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.447 -178.228 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -62.68 -44.53 96.02 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.435 179.626 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.593 HH11 HH11 ' A' ' 12' ' ' ARG . 52.2 ttm-85 -63.56 -44.09 95.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.98 -179.627 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -63.97 -36.89 85.45 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.554 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 32.7 m -64.08 -43.78 94.38 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.47 178.022 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -61.64 -34.59 75.96 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.877 -179.962 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 43.4 t -63.94 -45.46 96.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 120.774 -0.371 . . . . 0.0 110.232 179.098 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -64.54 -29.77 70.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.273 0.559 . . . . 0.0 109.649 179.208 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -89.78 -7.32 54.67 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.303 -179.701 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 49.6 tp -67.88 144.61 55.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.917 -179.52 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . 0.492 ' ND2' ' O ' ' B' ' 253' ' ' ASN . 1.5 t-20 -153.77 29.03 0.47 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.07 -179.794 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . 0.561 ' O ' ' CB ' ' B' ' 255' ' ' ASP . 80.8 m-20 -96.26 3.83 52.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.453 -0.794 . . . . 0.0 108.994 178.851 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . 0.561 ' CB ' ' O ' ' B' ' 254' ' ' ASP . 4.8 t70 93.26 -23.66 0.06 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.564 -178.743 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.555 ' O ' ' NZ ' ' A' ' 11' ' ' LYS . 8.0 t0 77.34 13.53 1.96 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.281 -179.965 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . 0.424 ' HA ' ' HZ3' ' A' ' 11' ' ' LYS . 97.2 mttt -67.64 -37.63 82.72 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.098 0.475 . . . . 0.0 111.068 178.345 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -88.81 122.28 32.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.763 179.744 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.668 ' C ' ' H ' ' B' ' 261' ' ' ILE . 43.8 p30 -114.25 143.49 44.76 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.579 0.704 . . . . 0.0 110.694 -179.704 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.481 ' OE1' HD21 ' A' ' 41' ' ' LEU . 99.1 mt-10 -59.93 15.99 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.626 -1.17 . . . . 0.0 111.186 -179.804 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.668 ' H ' ' C ' ' B' ' 259' ' ' ASP . 66.9 mt -109.69 134.56 51.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 178.945 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 61.9 t -125.23 133.88 68.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.746 -179.311 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -94.43 118.95 32.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.043 -178.986 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -68.2 -41.16 81.79 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.281 179.392 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . 0.538 ' HG2' HD11 ' A' ' 24' ' ' LEU . 4.6 mp0 -103.56 163.69 16.92 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.814 -178.878 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -62.27 153.27 71.26 Favored 'Trans proline' 0 N--CA 1.5 1.856 0 C-N-CA 123.202 2.601 . . . . 0.0 113.08 -179.429 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 42.5 pt . . . . . 0 C--N 1.33 -0.253 0 CA-C-O 121.693 0.759 . . . . 0.0 112.328 -179.02 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo . . . . . 0 N--CA 1.496 1.62 0 CA-C-O 120.762 0.234 . . . . 0.0 112.395 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.7 m -74.78 -47.98 27.92 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.965 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.524 ' NE ' ' HB2' ' A' ' 58' ' ' ALA . 85.7 mtt85 -97.76 137.22 36.97 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.918 0.389 . . . . 0.0 111.997 -177.494 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.569 ' NE ' ' OE2' ' A' ' 100' ' ' GLU . 89.4 mtm180 -137.62 145.98 43.41 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.518 179.576 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.717 HD21 HD11 ' A' ' 22' ' ' LEU . 3.0 mm? -112.96 141.54 46.68 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.94 178.395 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.0 t -114.09 127.02 71.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.852 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.531 ' CG2' HD12 ' B' ' 261' ' ' ILE . 50.0 m -78.64 139.68 38.51 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -177.998 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.485 HD12 ' CB ' ' A' ' 94' ' ' SER . 99.6 mt -109.22 136.47 45.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.185 177.494 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -88.8 158.46 18.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.006 0.431 . . . . 0.0 110.926 179.942 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.945 HH21 HD22 ' B' ' 252' ' ' LEU . 86.3 mtm180 -57.16 -30.59 64.59 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.801 -178.611 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 88.6 p -80.93 -7.07 59.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.192 179.988 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.88 34.44 6.85 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.692 179.527 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.2 t -119.64 132.73 68.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.748 0.308 . . . . 0.0 111.111 -179.988 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -74.84 138.23 42.39 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.73 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -131.65 -118.89 2.02 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 120.533 -0.842 . . . . 0.0 112.616 -178.939 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -73.79 149.12 42.32 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.414 2.076 . . . . 0.0 113.066 -178.427 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -110.58 157.46 19.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.697 -179.962 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.971 ' CD2' HD11 ' A' ' 37' ' ' ILE . 35.2 t80 -124.64 99.83 35.36 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.924 -179.553 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -74.81 135.52 19.58 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 121.374 1.383 . . . . 0.0 112.48 -179.499 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.717 HD11 HD21 ' A' ' 7' ' ' LEU . 80.5 mt -87.65 81.98 7.54 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 120.872 0.367 . . . . 0.0 111.093 -179.24 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.474 ' OG ' ' NE2' ' B' ' 265' ' ' GLN . 77.9 p -86.33 -8.68 57.51 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.164 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.5 mt -103.82 146.22 28.96 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.611 179.917 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.6 m -67.81 -14.82 63.27 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -179.219 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 39.7 m -131.03 132.6 45.06 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.694 -179.948 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.435 ' HB2' HD22 ' A' ' 22' ' ' LEU . 5.1 t -126.96 120.21 28.55 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.653 178.835 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.446 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 35.1 tp -117.22 130.86 56.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.779 0.323 . . . . 0.0 111.42 -178.561 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.446 ' O ' ' O ' ' A' ' 47' ' ' GLN . 54.1 m-85 -107.43 133.44 51.94 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.615 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 179.42 -173.46 45.39 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.186 -1.007 . . . . 0.0 112.718 -179.967 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.2 ttp-105 -93.75 -23.4 18.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.234 -0.483 . . . . 0.0 110.349 179.746 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.467 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -72.2 163.96 54.49 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.932 -179.095 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.59 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.4 tp -68.17 -43.25 85.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.948 0.404 . . . . 0.0 111.582 -179.846 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.59 ' N ' HG23 ' A' ' 33' ' ' ILE . 52.1 tp10 -54.19 -19.81 5.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.862 -178.594 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.467 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 3.5 m -67.77 129.01 38.59 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.275 -179.777 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.446 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 66.0 m-20 -61.58 -33.84 74.58 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.961 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.971 HD11 ' CD2' ' A' ' 20' ' ' PHE . 36.9 mm -120.11 116.6 50.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.097 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.56 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 83.2 mtp180 -105.63 134.85 48.07 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.681 -178.404 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 78.6 mt -121.13 129.13 75.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.35 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -77.22 27.72 0.15 Allowed 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -177.921 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.741 HD21 ' OE1' ' B' ' 260' ' ' GLU . 78.9 mt -99.09 139.18 20.81 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.121 179.55 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.45 -14.73 20.1 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.492 2.128 . . . . 0.0 112.277 -179.395 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.1 m -91.19 7.87 4.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.534 179.868 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 55.6 t -100.36 132.11 46.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.359 179.09 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.4 m -74.11 170.32 15.73 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.768 0.794 . . . . 0.0 111.655 -179.52 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -64.83 -38.54 91.32 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.093 179.799 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.642 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.0 mt-30 -114.74 -19.2 11.15 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.167 179.875 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 14.8 t60 32.61 -76.58 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 179.805 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.642 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.82 134.16 46.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.3 0.571 . . . . 0.0 112.066 -178.662 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -125.34 132.55 52.82 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.189 179.08 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.8 mt -116.46 133.78 61.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.986 -179.563 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -113.87 123.76 50.58 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.513 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.407 HD11 HD13 ' A' ' 22' ' ' LEU . 96.6 mt -105.87 111.6 35.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.659 -179.484 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.458 ' O ' ' N ' ' A' ' 56' ' ' GLN . 81.4 m-70 -113.77 142.85 45.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.313 179.834 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 54' ' ' HIS . 99.2 mt-10 -40.67 -28.46 0.07 Allowed 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.266 -0.574 . . . . 0.0 109.826 -179.771 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.488 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 95.1 mt-30 -63.78 -68.55 0.34 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.546 178.866 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.488 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 3.4 tp10 -157.24 -168.32 2.58 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.585 -179.671 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.524 ' HB2' ' NE ' ' A' ' 5' ' ' ARG . . . -110.12 124.71 52.02 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 178.473 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 98.0 mt -115.83 130.28 70.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.283 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 47.1 tp -97.98 127.98 44.26 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.249 179.258 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -114.94 138.24 51.06 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.467 -179.995 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.47 HD21 ' CA ' ' A' ' 68' ' ' PRO . 57.8 t-20 -98.69 106.83 19.15 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.903 0.383 . . . . 0.0 111.961 -179.692 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -102.33 -9.5 20.29 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.032 179.406 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.38 100.14 4.35 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.173 -179.932 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 85.0 p -84.24 -32.11 24.65 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.341 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.755 HG21 ' O ' ' B' ' 234' ' ' TPO . 1.7 m -64.43 -51.46 63.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.699 -179.745 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.552 ' HB3' HD11 ' A' ' 91' ' ' ILE . 55.5 m-80 -138.79 95.96 9.58 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.673 179.825 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.47 ' CA ' HD21 ' A' ' 62' ' ' ASN . 52.0 Cg_exo -55.0 146.7 56.46 Favored 'Trans proline' 0 N--CA 1.499 1.809 0 C-N-CA 122.286 1.99 . . . . 0.0 113.328 -178.957 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 44.3 m -75.06 145.16 42.58 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.289 -179.984 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -108.11 143.37 36.95 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.808 -179.733 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.435 ' O ' ' N ' ' A' ' 74' ' ' SER . 5.4 p -131.99 135.97 57.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.77 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 49.16 33.17 4.69 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.238 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.69 29.09 69.92 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.317 -179.577 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 71' ' ' VAL . 66.8 m -138.65 136.06 35.51 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.906 0.353 . . . . 0.0 111.161 -179.616 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -66.32 141.75 17.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.176 -179.806 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.2 pt -118.71 78.99 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.677 179.107 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -63.34 -24.02 67.67 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.768 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -116.84 158.71 43.14 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.838 179.559 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -64.97 148.62 89.81 Favored 'Trans proline' 0 N--CA 1.5 1.884 0 C-N-CA 122.859 2.373 . . . . 0.0 113.044 -179.6 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 65.9 t -138.41 138.99 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.088 179.815 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -69.33 132.11 45.89 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 178.817 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 90.0 mt -78.85 138.38 38.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.304 0.574 . . . . 0.0 111.113 -179.985 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -132.36 150.14 52.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.075 179.949 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.453 ' ND1' ' N ' ' A' ' 99' ' ' ASN . 4.9 t60 -58.17 119.12 6.29 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.874 0.369 . . . . 0.0 110.401 -179.674 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.51 -23.04 16.19 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 -179.66 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 87' ' ' VAL . 57.7 t0 -67.93 132.11 46.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.029 0.442 . . . . 0.0 110.939 179.736 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.526 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 50.0 t -110.63 132.15 59.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.512 -179.038 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 87.3 mt -95.75 131.26 43.01 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 177.957 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 44.6 m -121.99 128.97 52.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.989 0.899 . . . . 0.0 113.314 -177.244 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.626 ' O ' ' N ' ' A' ' 93' ' ' ARG . 97.9 mt -116.42 129.94 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-N 113.926 -1.488 . . . . 0.0 108.379 178.453 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.552 HD11 ' HB3' ' A' ' 67' ' ' ASN . 70.4 mt -21.49 98.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.415 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.566 ' OD2' ' NH1' ' B' ' 245' ' ' ARG . 0.8 OUTLIER 88.46 -23.8 0.11 Allowed 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 178.171 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.649 HH22 ' CG ' ' B' ' 259' ' ' ASP . 83.4 mtt-85 -128.35 145.02 51.2 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.273 -179.53 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.485 ' CB ' HD12 ' A' ' 10' ' ' ILE . 11.3 t -140.7 153.76 46.08 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.325 0.583 . . . . 0.0 110.576 -179.9 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.647 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 95.8 m-85 -124.96 121.49 34.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.464 179.363 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -81.6 131.68 35.28 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.342 -179.937 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.584 ' CZ ' ' OD1' ' A' ' 99' ' ' ASN . 85.8 t80 -94.66 126.22 39.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.691 -179.647 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -136.4 128.59 29.84 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 120.572 -0.451 . . . . 0.0 112.001 -179.531 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.584 ' OD1' ' CZ ' ' A' ' 97' ' ' TYR . 93.7 m-20 -96.04 136.0 37.06 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.827 179.083 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.569 ' OE2' ' NE ' ' A' ' 6' ' ' ARG . 96.9 mt-10 . . . . . 0 N--CA 1.464 0.229 0 CA-C-O 120.889 0.376 . . . . 0.0 111.369 -179.482 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 28.4 m . . . . . 0 N--CA 1.45 -0.429 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.438 ' C ' ' H ' ' B' ' 231' ' ' GLN . 99.2 m-20 -68.36 148.21 51.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.033 0.444 . . . . 0.0 111.365 -179.232 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.438 ' H ' ' C ' ' B' ' 229' ' ' ASP . 74.9 mt-30 -128.18 36.24 4.32 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.678 -179.638 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -116.85 -161.87 12.5 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.602 -178.514 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -60.88 153.18 65.11 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 123.858 3.039 . . . . 0.0 112.401 -179.835 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.755 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -65.68 138.56 54.45 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.739 1.626 . . . . 0.0 114.474 -178.954 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.501 HG12 HG22 ' A' ' 66' ' ' THR . 26.8 m -72.43 143.35 14.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 114.279 -1.328 . . . . 0.0 109.174 179.34 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 10.3 t -72.24 129.31 38.13 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.705 -179.028 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . 0.431 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . 0.431 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 39.0 Cg_exo -57.26 -26.92 72.61 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.755 2.303 . . . . 0.0 112.493 -179.252 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 99.3 m -73.22 -45.09 58.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.905 0.384 . . . . 0.0 111.023 179.376 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -57.08 -47.84 80.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.251 -179.29 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 87.1 mt -63.5 -42.56 98.5 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.412 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -63.67 -41.88 98.12 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.892 -179.547 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 62.9 ttm-85 -64.31 -44.21 92.29 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.009 0.433 . . . . 0.0 110.422 179.938 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.603 ' NH2' HD13 ' A' ' 41' ' ' LEU . 4.0 tpp85 -61.43 -42.9 99.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.773 -179.61 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -59.48 -40.09 85.81 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.825 0.345 . . . . 0.0 110.271 -179.734 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 78.0 p -70.31 -39.88 74.55 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.816 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . 0.416 ' O ' ' N ' ' B' ' 252' ' ' LEU . 63.7 tp60 -59.25 -38.53 80.3 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.699 179.823 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 38.3 t -62.34 -46.91 95.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.734 0.302 . . . . 0.0 110.35 179.029 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -58.67 -26.7 64.07 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.254 0.55 . . . . 0.0 109.831 179.708 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -96.69 -12.07 24.3 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.531 179.727 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.945 HD22 HH21 ' A' ' 12' ' ' ARG . 40.7 tp -73.3 140.2 46.62 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.746 -179.289 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -95.54 129.98 42.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.345 178.855 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . 0.532 ' N ' ' OD1' ' B' ' 254' ' ' ASP . 12.9 p-10 -61.39 -19.54 62.02 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.849 -179.249 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -64.63 1.14 0.89 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.968 -179.682 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.72 ' OD2' HD11 ' B' ' 252' ' ' LEU . 55.2 p-10 -91.79 69.88 5.61 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.31 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -64.99 1.76 0.87 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.316 -178.963 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.48 ' O ' ' C ' ' B' ' 259' ' ' ASP . 96.2 m-20 -113.23 0.63 14.94 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 177.799 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.649 ' CG ' HH22 ' A' ' 93' ' ' ARG . 66.6 t0 21.86 -96.99 0.0 OUTLIER 'General case' 0 C--O 1.233 0.199 0 CA-C-N 113.869 -1.514 . . . . 0.0 110.976 -179.674 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.741 ' OE1' HD21 ' A' ' 41' ' ' LEU . 98.2 mt-10 -141.09 14.46 2.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.767 0.318 . . . . 0.0 110.173 178.958 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.647 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 67.6 mt -114.11 134.19 57.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.655 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 44.4 t -124.99 134.53 66.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.168 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -96.17 117.72 31.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.275 0.559 . . . . 0.0 111.578 -178.222 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -65.96 -46.29 78.66 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.163 179.611 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . 0.474 ' NE2' ' OG ' ' A' ' 23' ' ' SER . 0.0 OUTLIER -96.0 155.51 38.2 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.336 -179.192 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -64.31 148.86 90.99 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 123.212 2.608 . . . . 0.0 113.42 -179.222 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 47.1 pt . . . . . 0 C--N 1.332 -0.157 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.761 178.693 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo . . . . . 0 N--CA 1.491 1.346 0 CA-C-O 120.699 0.208 . . . . 0.0 112.158 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.8 p -89.24 -50.67 6.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.096 0.474 . . . . 0.0 110.549 179.927 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.716 ' NH1' ' HB2' ' A' ' 58' ' ' ALA . 99.9 mtt180 -98.84 135.34 40.44 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.212 -179.736 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.497 ' NE ' ' OE1' ' A' ' 98' ' ' GLU . 33.4 ptt180 -140.85 155.44 46.34 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.27 -0.572 . . . . 0.0 112.034 -179.569 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 78.5 mt -118.91 145.19 45.94 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.747 179.703 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.6 t -114.43 129.88 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 178.177 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.413 ' CG2' HD12 ' B' ' 261' ' ' ILE . 22.4 m -91.64 118.27 30.49 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -177.553 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.43 HD12 ' HB2' ' A' ' 94' ' ' SER . 98.1 mt -84.67 142.87 12.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.436 178.284 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.601 ' NZ ' ' CB ' ' B' ' 256' ' ' ASP . 98.3 mttt -94.99 167.89 11.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.845 0.355 . . . . 0.0 110.942 179.566 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.586 ' NH2' ' CD1' ' B' ' 252' ' ' LEU . 83.5 mtm180 -56.49 -32.44 65.02 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.465 -178.407 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.486 ' OG ' HG13 ' B' ' 249' ' ' VAL . 3.5 m -80.25 -7.61 59.09 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.47 179.893 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.71 39.83 6.98 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 -179.545 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.609 HG21 ' OD1' ' B' ' 254' ' ' ASP . 40.3 t -119.58 130.85 73.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.959 0.409 . . . . 0.0 110.869 -179.403 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -77.16 136.68 38.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.558 179.305 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -137.59 -114.86 1.32 Allowed Glycine 0 CA--C 1.535 1.297 0 C-N-CA 120.2 -1.0 . . . . 0.0 111.746 -179.9 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -71.92 149.0 52.62 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.088 1.859 . . . . 0.0 112.502 -178.994 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -113.45 157.6 21.75 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.793 179.932 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.599 ' CD2' HD11 ' A' ' 37' ' ' ILE . 34.1 t80 -118.13 97.71 50.94 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.487 179.864 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -74.17 131.76 15.74 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 121.39 1.393 . . . . 0.0 111.342 -179.328 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 82.0 mt -83.51 80.63 9.04 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.632 -178.791 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 87.9 p -84.55 -11.15 56.6 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.867 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 67.5 mt -107.16 149.18 27.96 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.191 -179.885 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 28.5 t -67.88 -15.79 63.78 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.811 -179.408 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.531 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 58.8 m -127.16 130.04 49.01 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.594 -0.442 . . . . 0.0 112.181 -179.192 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.7 t -123.76 113.46 18.61 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 177.799 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.456 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 41.0 tp -115.68 131.09 57.04 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.619 -178.232 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.745 ' CE2' HD12 ' A' ' 37' ' ' ILE . 6.9 m-85 -108.51 131.1 55.16 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.706 179.796 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 166.59 -175.25 41.99 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 119.934 -1.127 . . . . 0.0 112.862 179.386 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.503 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 76.4 mtm-85 -80.1 -32.11 39.17 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-O 120.876 0.369 . . . . 0.0 110.594 179.95 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.563 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -51.3 146.23 11.4 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.512 -178.147 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.549 HD13 ' CZ ' ' A' ' 38' ' ' ARG . 36.9 mm -64.44 -43.46 96.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.74 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -54.91 -21.24 10.93 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.633 -179.769 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.563 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 17.2 m -59.08 129.07 40.37 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.155 0.503 . . . . 0.0 110.521 -179.672 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.531 ' OD2' ' O ' ' A' ' 26' ' ' THR . 59.0 m-20 -60.9 -33.35 72.99 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.457 -179.109 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.745 HD12 ' CE2' ' A' ' 29' ' ' PHE . 89.4 mt -125.97 119.78 55.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 177.998 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.549 ' CZ ' HD13 ' A' ' 33' ' ' ILE . 83.3 mtp180 -103.75 137.84 41.22 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.889 -178.497 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 90.3 mt -121.08 131.76 72.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.267 179.551 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -75.24 26.35 0.1 Allowed 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -178.319 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.587 ' CD1' ' CZ ' ' A' ' 93' ' ' ARG . 81.9 mt -102.2 131.74 22.27 Favored Pre-proline 0 C--N 1.326 -0.42 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.301 179.947 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.69 -13.18 27.05 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 122.292 1.995 . . . . 0.0 112.47 -179.535 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.525 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 3.8 m -92.81 2.04 8.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.159 -179.621 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.503 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 38.0 t -91.7 133.8 32.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 177.875 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.0 m -72.64 175.0 6.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.501 0.667 . . . . 0.0 111.586 -178.285 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -63.35 -42.58 98.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.736 -179.787 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.629 ' O ' ' N ' ' A' ' 49' ' ' CYS . 89.0 mt-30 -116.98 -17.01 10.48 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.426 0.454 . . . . 0.0 111.335 -179.948 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.1 t60 34.05 -76.52 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 179.665 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.629 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -127.8 135.1 49.63 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.225 0.536 . . . . 0.0 112.222 -178.766 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -126.74 133.08 50.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.896 179.476 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.3 mt -119.37 132.04 70.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.63 179.107 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -115.21 126.09 54.14 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.944 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.48 HD12 HH11 ' A' ' 5' ' ' ARG . 47.4 mm -93.68 122.66 45.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.326 0.584 . . . . 0.0 111.356 -178.029 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.463 ' O ' ' C ' ' A' ' 55' ' ' GLU . 11.0 m-70 -117.76 127.42 53.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.168 179.104 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' A' ' 54' ' ' HIS . 97.5 mt-10 -40.96 -31.33 0.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.967 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.428 ' N ' ' C ' ' A' ' 54' ' ' HIS . 85.7 mt-30 -67.0 -67.61 0.44 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.664 178.046 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -149.77 -172.79 4.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.157 -179.63 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.716 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -115.01 132.19 56.68 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.951 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 47.6 mm -113.21 128.11 70.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 120.493 -0.483 . . . . 0.0 112.022 -178.286 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.42 ' HB2' HD11 ' A' ' 82' ' ' LEU . 22.9 tp -98.65 126.61 44.3 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.545 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -117.92 139.09 51.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.739 0.304 . . . . 0.0 110.595 -179.724 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.577 ' ND2' ' H ' ' A' ' 69' ' ' THR . 16.0 t-20 -101.58 113.93 27.51 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.85 0.357 . . . . 0.0 111.493 -179.728 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -102.45 -7.92 21.54 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.653 179.878 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.42 99.16 11.01 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.423 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.9 m -76.25 -32.31 58.79 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.246 0.546 . . . . 0.0 109.938 179.064 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.0 m -63.48 -45.97 88.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.598 -179.309 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -142.93 93.15 6.73 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.597 179.208 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -56.93 148.89 64.8 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.056 1.837 . . . . 0.0 111.859 -179.721 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.967 ' O ' HG22 ' A' ' 76' ' ' ILE . 41.7 m -70.66 156.43 39.48 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.106 -179.589 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.413 ' N ' HG22 ' A' ' 69' ' ' THR . 86.7 mt-30 -114.6 140.98 48.36 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.915 179.683 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.642 HG13 ' OD1' ' A' ' 86' ' ' ASP . 55.6 t -130.21 135.68 60.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.762 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 52.81 32.38 12.19 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 119.857 -0.737 . . . . 0.0 109.359 -179.142 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.25 29.17 68.84 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.511 179.99 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 11.3 p -142.03 140.15 32.55 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.286 179.965 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.2 p -63.0 143.27 15.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.698 -179.433 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.967 HG22 ' O ' ' A' ' 69' ' ' THR . 10.5 tt -113.88 87.28 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.577 -179.849 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 20.5 p-10 -66.4 -33.03 74.79 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.952 179.891 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.418 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 2.7 mt-10 -124.65 167.41 15.96 Favored Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.27 -179.053 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -60.3 144.87 99.5 Favored 'Trans proline' 0 N--CA 1.502 2.001 0 C-N-CA 122.582 2.188 . . . . 0.0 112.891 179.647 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.1 m -138.77 152.81 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 CA-C-O 121.618 0.723 . . . . 0.0 111.962 178.665 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -79.45 127.31 31.95 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.835 179.548 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.42 HD11 ' HB2' ' A' ' 60' ' ' LEU . 98.1 mt -83.41 129.49 34.99 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.28 0.562 . . . . 0.0 110.434 -179.623 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -121.91 150.45 41.96 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.283 -179.881 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.428 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 6.1 t60 -49.63 118.35 2.75 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.955 -179.397 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.15 -20.35 28.55 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 179.685 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.642 ' OD1' HG13 ' A' ' 71' ' ' VAL . 56.7 t0 -61.54 132.49 53.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.17 0.509 . . . . 0.0 110.437 179.864 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.503 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 56.7 t -109.48 129.75 63.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.278 -179.03 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.8 mt -98.09 131.56 44.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.613 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.455 HG23 ' OG ' ' A' ' 94' ' ' SER . 74.7 m -126.05 127.92 46.6 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.624 0.726 . . . . 0.0 112.405 -178.42 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.569 ' O ' ' N ' ' A' ' 92' ' ' ASP . 97.8 mt -110.13 125.4 67.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.009 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.894 HD12 HH22 ' A' ' 93' ' ' ARG . 88.6 mt 40.0 -91.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 120.584 -0.447 . . . . 0.0 110.315 -178.7 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.569 ' N ' ' O ' ' A' ' 90' ' ' ILE . 33.9 t70 -128.06 20.05 6.43 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.04 0.448 . . . . 0.0 111.238 -179.776 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.894 HH22 HD12 ' A' ' 91' ' ' ILE . 45.8 mtm-85 -126.65 140.41 52.43 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.541 -179.798 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.455 ' OG ' HG23 ' A' ' 89' ' ' THR . 57.4 m -138.89 153.31 48.27 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 119.602 -0.839 . . . . 0.0 112.2 -179.154 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -121.92 122.44 39.4 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.705 178.864 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -81.55 130.11 34.93 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 119.884 -0.726 . . . . 0.0 110.449 -179.108 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -94.27 124.24 38.17 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.272 -179.283 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.497 ' OE1' ' NE ' ' A' ' 6' ' ' ARG . 80.3 tt0 -124.5 123.44 40.13 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.97 179.868 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.428 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 64.0 t-20 -107.71 114.07 27.79 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.668 -179.959 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 . . . . . 0 C--O 1.233 0.202 0 CA-C-O 121.035 0.445 . . . . 0.0 110.679 -179.624 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . 0.473 HG21 ' NH2' ' A' ' 31' ' ' ARG . 2.1 p . . . . . 0 CA--C 1.517 -0.305 0 CA-C-O 120.957 0.408 . . . . 0.0 110.598 . . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -61.0 -104.72 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.927 179.67 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -156.28 39.58 0.35 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 120.955 0.407 . . . . 0.0 111.045 -179.531 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -105.37 -139.94 10.0 Favored Glycine 0 CA--C 1.534 1.252 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -179.984 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -75.46 153.47 39.67 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 122.327 2.018 . . . . 0.0 112.22 -179.366 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.574 HG21 ' O1P' ' B' ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -76.5 172.0 17.03 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.312 2.008 . . . . 0.0 111.59 178.918 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 5.9 p -113.91 133.2 60.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.799 179.704 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . 0.461 ' HG ' ' HD2' ' B' ' 241' ' ' PHE . 4.6 t -72.35 129.9 39.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.48 -178.923 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . 0.454 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . 0.454 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 37.2 Cg_exo -58.94 -22.25 62.13 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.862 2.375 . . . . 0.0 112.003 179.863 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 94.4 m -71.88 -45.84 59.91 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.147 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.525 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 83.3 t80 -58.79 -47.05 86.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.101 -179.376 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.407 ' HA ' HD23 ' B' ' 242' ' ' LEU . 95.3 mt -63.56 -41.1 98.42 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -179.046 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -63.12 -38.87 92.91 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.967 -179.792 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -63.49 -41.85 98.56 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.126 0.489 . . . . 0.0 110.002 179.613 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.633 ' NH2' ' NH1' ' A' ' 93' ' ' ARG . 62.4 ttm-85 -60.05 -44.72 94.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.008 -179.168 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -64.77 -40.05 94.62 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.752 179.467 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 66.6 m -63.77 -45.42 89.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.499 179.509 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -60.7 -39.47 88.65 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.259 -179.461 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.486 HG13 ' OG ' ' A' ' 13' ' ' SER . 21.0 t -60.6 -44.1 96.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.445 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -61.84 -34.49 76.06 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.632 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -75.47 -9.67 58.77 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 178.374 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.586 ' CD1' ' NH2' ' A' ' 12' ' ' ARG . 96.3 mt -113.39 -175.15 2.61 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.834 178.925 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . 0.416 ' OD1' ' N ' ' B' ' 253' ' ' ASN . 19.6 p-10 -137.83 177.67 7.7 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.139 0.495 . . . . 0.0 110.629 -179.929 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . 0.609 ' OD1' HG21 ' A' ' 15' ' ' VAL . 35.9 t70 -63.84 -16.22 60.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.67 -179.722 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . 0.502 ' O ' ' O ' ' B' ' 256' ' ' ASP . 99.3 m-20 -60.62 -3.77 0.78 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.174 -179.373 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.601 ' CB ' ' NZ ' ' A' ' 11' ' ' LYS . 4.0 p30 43.19 -176.1 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.878 0.371 . . . . 0.0 111.332 179.159 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . 0.543 ' O ' ' C ' ' B' ' 258' ' ' ASP . 16.1 ptmt -176.31 124.78 0.18 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.318 179.849 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.543 ' C ' ' O ' ' B' ' 257' ' ' LYS . 82.1 m-20 14.95 57.75 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.864 -179.506 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.636 ' C ' ' H ' ' B' ' 261' ' ' ILE . 44.2 p-10 -19.96 129.53 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.657 0.741 . . . . 0.0 112.427 -179.327 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -50.95 1.93 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.209 179.537 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.636 ' H ' ' C ' ' B' ' 259' ' ' ASP . 73.5 mt -106.39 138.73 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.783 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 54.1 t -129.05 136.66 59.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.274 -178.765 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -97.4 117.12 30.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.318 0.58 . . . . 0.0 111.126 -179.397 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 43.3 tttp -67.05 -43.41 82.8 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.502 178.99 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 53.8 mm-40 -94.0 155.2 40.43 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.721 -179.014 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -61.31 154.1 60.82 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.103 1.869 . . . . 0.0 111.036 178.561 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 40.3 pt . . . . . 0 C--N 1.324 -0.539 0 CA-C-O 121.702 0.763 . . . . 0.0 112.372 -178.328 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo . . . . . 0 N--CA 1.496 1.624 0 CA-C-O 120.748 0.228 . . . . 0.0 112.114 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 68.5 p -101.14 -48.59 4.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.58 -179.968 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.871 ' NH1' HG23 ' A' ' 53' ' ' ILE . 99.9 mtt180 -94.72 130.73 41.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.941 179.924 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -128.27 137.85 52.16 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.424 179.514 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.56 HD11 ' HB3' ' A' ' 95' ' ' PHE . 45.0 tp -106.88 130.88 54.49 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.47 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.6 t -110.04 129.31 65.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.475 -178.991 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.412 ' O ' HG22 ' A' ' 9' ' ' THR . 1.8 m -90.9 111.9 23.52 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.461 -178.971 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.7 mt -83.13 148.03 5.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.599 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -94.15 168.6 10.83 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.383 0.611 . . . . 0.0 111.434 179.705 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.801 HH21 HD22 ' B' ' 252' ' ' LEU . 87.9 mtm180 -58.06 -29.74 65.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.886 -179.038 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.8 p -80.54 -6.24 57.93 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.687 179.796 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.04 23.6 37.6 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.163 179.159 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.1 m -109.54 140.86 26.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.535 179.742 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.41 ' C ' ' OD1' ' A' ' 16' ' ' ASP . 57.3 t0 -69.32 122.75 19.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.682 -179.6 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -108.74 -131.91 6.49 Favored Glycine 0 CA--C 1.538 1.506 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 -179.344 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -74.71 153.95 43.64 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.342 2.028 . . . . 0.0 112.031 -179.258 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -109.15 155.92 20.45 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.148 -179.536 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.439 ' CD2' HD11 ' A' ' 37' ' ' ILE . 57.2 t80 -126.12 92.28 46.13 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.477 179.927 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.94 126.72 22.53 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 121.865 1.71 . . . . 0.0 111.551 -179.789 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.2 mt -80.02 54.3 1.88 Allowed 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 120.808 0.337 . . . . 0.0 110.708 -179.351 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.6 t -62.46 -40.62 97.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.802 179.587 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 46.8 mt -70.54 144.49 51.29 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.178 -179.77 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.6 t -66.01 -17.84 64.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.444 -178.84 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.549 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 50.2 m -132.53 134.13 44.61 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.996 -179.777 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.647 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 2.7 t -127.66 116.81 20.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.111 0.481 . . . . 0.0 109.798 178.585 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.617 HD21 ' OE1' ' A' ' 47' ' ' GLN . 44.7 tp -114.82 130.14 56.82 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.631 -178.291 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.778 ' CE2' HD12 ' A' ' 37' ' ' ILE . 27.1 m-85 -108.7 139.18 43.86 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.171 -179.894 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.87 -175.38 30.65 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.405 178.574 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.6 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 81.5 mtm-85 -74.04 -32.96 63.54 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.911 0.386 . . . . 0.0 110.868 -179.961 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.428 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -46.86 139.8 7.46 Favored Glycine 0 N--CA 1.465 0.584 0 N-CA-C 111.554 -0.619 . . . . 0.0 111.554 -178.582 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.547 ' CD1' ' CZ ' ' A' ' 38' ' ' ARG . 36.3 mm -64.99 -44.71 96.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.805 0.336 . . . . 0.0 110.975 -179.951 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -57.98 -13.91 5.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.45 -179.173 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.428 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 60.0 m -63.02 131.23 47.91 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.524 -179.877 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.549 ' OD2' ' O ' ' A' ' 26' ' ' THR . 58.9 m-20 -61.24 -30.79 70.66 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.288 -179.326 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.778 HD12 ' CE2' ' A' ' 29' ' ' PHE . 77.9 mt -128.44 119.34 50.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.019 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.547 ' CZ ' ' CD1' ' A' ' 33' ' ' ILE . 83.8 mtp180 -100.04 135.54 41.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.518 -179.052 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.561 HG21 HD12 ' A' ' 41' ' ' LEU . 95.2 mt -121.28 128.96 76.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.55 -0.46 . . . . 0.0 109.907 179.98 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -79.36 31.26 0.22 Allowed 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -178.318 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.561 HD12 HG21 ' A' ' 39' ' ' ILE . 13.2 mt -97.85 128.48 33.92 Favored Pre-proline 0 CA--C 1.535 0.366 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.763 179.544 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -72.51 -12.69 27.27 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.487 2.125 . . . . 0.0 113.272 -179.276 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.439 HG21 ' CE2' ' B' ' 241' ' ' PHE . 27.1 m -100.29 6.99 9.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.316 -0.554 . . . . 0.0 110.432 179.525 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.6 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 32.0 t -95.43 134.99 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.934 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.67 164.47 19.2 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.502 0.668 . . . . 0.0 111.94 -178.691 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -63.56 -42.31 98.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.056 -179.375 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.638 ' O ' ' N ' ' A' ' 49' ' ' CYS . 95.3 mm-40 -109.2 -23.04 11.81 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.591 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.473 ' O ' ' OG ' ' A' ' 64' ' ' SER . 17.1 t60 38.18 -76.04 0.0 OUTLIER 'General case' 0 C--O 1.235 0.336 0 CA-C-N 114.621 -1.172 . . . . 0.0 113.086 179.135 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.638 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.59 136.79 45.13 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.347 -0.541 . . . . 0.0 112.04 -178.218 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -128.17 130.39 47.98 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.394 179.431 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 95.8 mt -112.36 133.36 58.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.043 -179.934 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 73.3 tt0 -116.92 125.32 51.29 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.864 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.871 HG23 ' NH1' ' A' ' 5' ' ' ARG . 91.8 mt -104.33 123.81 58.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.666 0.746 . . . . 0.0 112.913 -177.796 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.494 ' O ' ' N ' ' A' ' 56' ' ' GLN . 2.0 m-70 -118.21 137.19 53.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.506 -1.225 . . . . 0.0 109.437 179.06 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.466 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.9 mm-40 -39.38 -29.57 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -179.508 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.494 ' N ' ' O ' ' A' ' 54' ' ' HIS . 98.6 mm-40 -65.22 -66.52 0.53 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.955 178.656 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -157.49 -166.03 1.93 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.198 -179.65 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.499 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -108.95 130.79 55.46 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.699 179.129 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 37.1 mm -112.43 125.84 69.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.902 -179.473 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.1 tp -99.72 123.41 43.95 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.723 0.297 . . . . 0.0 110.53 -179.888 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -111.23 134.6 52.69 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.152 179.853 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.408 ' ND2' ' O ' ' A' ' 76' ' ' ILE . 46.6 p-10 -99.89 108.3 20.51 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 121.0 0.429 . . . . 0.0 111.537 -179.845 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -97.52 -9.65 26.72 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.7 -179.937 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.473 ' OG ' ' O ' ' A' ' 48' ' ' HIS . 0.3 OUTLIER -77.25 99.88 5.64 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 120.95 0.405 . . . . 0.0 110.764 -179.689 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 86.5 p -79.08 -31.44 44.37 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.875 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.588 HG22 HG12 ' B' ' 236' ' ' VAL . 3.6 m -64.41 -47.99 77.08 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.764 -179.796 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -147.61 99.17 3.85 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.25 -179.699 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -56.27 149.66 53.93 Favored 'Trans proline' 0 N--CA 1.499 1.794 0 C-N-CA 122.117 1.878 . . . . 0.0 113.215 -178.489 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 50.3 m -68.06 138.7 56.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.174 178.849 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -100.45 144.54 29.33 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.731 -179.745 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.697 ' HB ' HD11 ' A' ' 76' ' ' ILE . 5.1 p -131.21 136.28 58.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.167 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 51.12 30.93 6.01 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -178.967 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.41 26.2 70.76 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.936 -179.86 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 71' ' ' VAL . 12.0 t -135.65 137.8 42.21 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.194 0.521 . . . . 0.0 111.534 -179.511 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.5 t -66.68 136.43 26.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.813 -179.784 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.697 HD11 ' HB ' ' A' ' 71' ' ' VAL . 97.0 mt -101.27 100.86 11.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.561 179.383 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -64.44 -41.15 96.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.875 179.872 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.515 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.9 OUTLIER -132.54 -178.07 0.79 Allowed Pre-proline 0 N--CA 1.464 0.227 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.346 -178.656 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 31.3 Cg_exo -59.38 143.8 99.6 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.49 2.127 . . . . 0.0 111.642 -179.815 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.2 p -141.01 147.65 22.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-O 121.186 0.517 . . . . 0.0 112.078 -179.041 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -79.7 128.16 33.08 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.283 179.27 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.499 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 96.0 mt -83.33 139.15 33.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.22 -179.84 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.484 ' N ' ' OD2' ' A' ' 86' ' ' ASP . 99.2 mttt -128.81 153.67 47.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.795 179.166 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.538 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 3.6 t-160 -55.54 119.4 5.6 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.892 0.377 . . . . 0.0 110.383 -179.661 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.0 -13.66 31.65 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.687 179.606 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.523 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 2.4 p30 -72.06 133.2 45.11 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.406 -0.517 . . . . 0.0 109.894 179.564 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 45.7 t -109.21 130.12 62.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.583 -178.309 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 89.4 mt -98.21 131.29 45.56 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 178.401 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.6 m -119.27 127.91 53.67 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.951 0.882 . . . . 0.0 112.628 -178.066 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.587 ' O ' ' N ' ' A' ' 93' ' ' ARG . 98.4 mt -115.28 134.11 59.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.471 178.496 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.617 HD13 ' HB2' ' B' ' 237' ' ' CYS . 53.9 mt -31.73 100.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 O-C-N 123.028 0.205 . . . . 0.0 111.295 -179.857 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.488 ' HB2' ' O ' ' A' ' 91' ' ' ILE . 83.8 m-20 86.67 -16.11 0.42 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.132 0.973 . . . . 0.0 113.259 179.169 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.587 ' N ' ' O ' ' A' ' 90' ' ' ILE . 81.1 mmt-85 -130.43 141.53 50.53 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.902 179.517 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.5 m -139.02 148.58 43.6 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.611 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.56 ' HB3' HD11 ' A' ' 7' ' ' LEU . 18.8 m-85 -126.8 125.37 41.59 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.544 -179.804 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 96' ' ' ARG . 49.0 ttt85 -84.5 131.18 34.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.885 0.374 . . . . 0.0 110.893 -179.647 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -94.73 122.2 37.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.917 -179.781 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -124.1 120.73 33.22 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.637 -179.679 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.538 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 43.9 t-20 -108.54 112.56 24.99 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.199 179.364 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 C--N 1.327 -0.404 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.281 -179.96 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 2.3 p . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.518 ' C ' ' H ' ' B' ' 231' ' ' GLN . 86.8 m-20 -67.58 144.33 55.64 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.742 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . 0.408 ' O1P' ' N ' ' B' ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.518 ' H ' ' C ' ' B' ' 229' ' ' ASP . 74.9 mt-30 -128.68 29.49 5.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.484 -179.571 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -110.78 -156.59 14.72 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.89 -179.414 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -75.36 161.56 37.51 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 123.369 2.712 . . . . 0.0 113.505 -178.972 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -76.32 143.66 25.28 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 122.375 2.05 . . . . 0.0 113.289 -179.37 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.588 HG12 HG22 ' A' ' 66' ' ' THR . 35.1 m -76.44 135.42 26.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 114.66 -1.154 . . . . 0.0 109.989 179.799 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . 0.617 ' HB2' HD13 ' A' ' 91' ' ' ILE . 5.1 t -67.81 128.01 34.9 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.403 -178.732 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . 0.411 HG23 ' H ' ' B' ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.82 -19.07 52.54 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.379 2.053 . . . . 0.0 111.579 -179.706 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 60.4 m -75.27 -43.01 53.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.599 177.445 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.439 ' CE2' HG21 ' A' ' 43' ' ' VAL . 90.1 t80 -59.18 -45.11 91.9 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.031 -179.949 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.518 HD21 HG23 ' A' ' 91' ' ' ILE . 98.2 mt -63.8 -39.32 93.95 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.091 0.472 . . . . 0.0 110.124 179.899 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -62.25 -41.71 98.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.768 179.985 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -62.36 -37.2 84.77 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.178 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.593 ' NH2' ' OE1' ' B' ' 248' ' ' GLN . 0.0 OUTLIER -58.5 -43.14 88.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.875 179.684 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -61.16 -38.48 86.6 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.587 -0.524 . . . . 0.0 109.587 178.95 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 38.0 t -64.1 -43.08 96.43 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 177.601 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . 0.593 ' OE1' ' NH2' ' B' ' 245' ' ' ARG . 36.7 mt-30 -58.49 -37.9 76.53 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.419 179.881 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 38.5 t -61.11 -46.72 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 120.546 -0.461 . . . . 0.0 110.345 179.859 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -58.89 -29.22 66.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.027 0.441 . . . . 0.0 109.837 179.503 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -91.87 -8.64 45.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.489 179.429 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.801 HD22 HH21 ' A' ' 12' ' ' ARG . 63.2 tp -77.33 139.42 39.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.64 -179.2 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -101.67 124.76 47.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.129 -0.942 . . . . 0.0 110.398 179.453 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . 0.47 ' C ' ' H ' ' B' ' 256' ' ' ASP . 95.6 m-20 -61.22 -35.48 77.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.443 -179.645 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -64.92 -0.4 1.52 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.556 179.699 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.47 ' H ' ' C ' ' B' ' 254' ' ' ASP . 42.0 t0 -107.03 96.51 6.48 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.564 179.255 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . 0.484 ' O ' ' C ' ' B' ' 258' ' ' ASP . 98.7 mttt -69.96 -81.65 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.582 -179.667 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.484 ' C ' ' O ' ' B' ' 257' ' ' LYS . 84.5 m-20 -28.31 112.78 0.07 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.693 -178.942 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.598 ' C ' ' H ' ' B' ' 261' ' ' ILE . 30.3 t0 -116.94 -177.12 3.12 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.309 0.575 . . . . 0.0 110.299 -179.502 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.429 ' H ' ' CG ' ' B' ' 259' ' ' ASP . 95.5 mt-10 -56.24 5.78 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.366 -179.501 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.598 ' H ' ' C ' ' B' ' 259' ' ' ASP . 82.8 mt -111.47 132.28 60.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.838 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 54.9 t -127.98 136.03 61.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.149 -179.873 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -96.99 121.97 39.46 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.41 0.624 . . . . 0.0 111.258 -179.029 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -66.25 -46.16 78.07 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.037 179.473 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . 0.521 ' OE1' ' O ' ' B' ' 266' ' ' PRO . 0.0 OUTLIER -94.8 157.22 37.18 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.036 -179.418 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . 0.521 ' O ' ' OE1' ' B' ' 265' ' ' GLN . 57.2 Cg_endo -65.72 145.26 80.73 Favored 'Trans proline' 0 N--CA 1.5 1.882 0 C-N-CA 123.15 2.566 . . . . 0.0 113.118 -178.852 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 43.9 pt . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.224 178.95 . . . . . . . . 0 0 . 1 . 041 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo . . . . . 0 N--CA 1.494 1.525 0 CA-C-O 120.931 0.305 . . . . 0.0 111.85 . . . . . . . . . 0 0 . 1 . 041 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 34.2 p -128.43 26.82 5.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.528 -179.855 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.619 ' NE ' ' OH ' ' A' ' 97' ' ' TYR . 83.5 mtp180 -85.17 129.89 34.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.155 -179.418 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.602 ' NH2' ' ND1' ' A' ' 19' ' ' HIS . 79.5 ttt180 -124.42 131.38 53.5 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -178.783 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.429 HD11 ' HB3' ' A' ' 95' ' ' PHE . 40.3 tp -109.81 132.36 54.22 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.208 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.7 t -109.79 128.45 65.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.467 -178.952 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.442 HG23 ' CD1' ' B' ' 261' ' ' ILE . 1.6 m -89.93 115.04 26.93 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.565 -179.429 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.666 HD12 ' OG ' ' A' ' 94' ' ' SER . 97.4 mt -79.87 140.14 17.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.151 179.393 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -89.93 160.41 16.43 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.182 0.515 . . . . 0.0 111.046 179.071 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.597 ' NH2' ' N ' ' B' ' 249' ' ' VAL . 73.5 mtp180 -57.52 -31.96 66.57 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.779 -179.757 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 99.7 p -77.38 -11.59 59.86 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.634 -179.634 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.93 31.68 9.72 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 -179.682 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.7 t -115.86 133.37 62.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.432 -0.384 . . . . 0.0 110.427 -179.68 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.436 ' C ' ' OD1' ' A' ' 16' ' ' ASP . 49.0 t0 -62.02 120.33 10.61 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.6 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -103.31 -134.81 8.42 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 120.892 -0.67 . . . . 0.0 111.808 -178.7 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -75.14 150.7 37.94 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.526 2.151 . . . . 0.0 112.534 -178.945 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.602 ' ND1' ' NH2' ' A' ' 6' ' ' ARG . 0.6 OUTLIER -108.51 131.08 55.18 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.64 -179.541 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.558 ' CD2' HD11 ' A' ' 37' ' ' ILE . 37.8 t80 -100.84 100.38 12.59 Favored Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.347 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.28 134.74 21.45 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 121.095 1.197 . . . . 0.0 111.581 -178.303 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 68.2 mt -99.38 124.17 44.28 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.627 0.727 . . . . 0.0 111.574 -178.118 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.6 p -137.09 -19.7 1.27 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.404 -1.271 . . . . 0.0 109.284 178.714 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.652 HD11 ' CD ' ' B' ' 265' ' ' GLN . 58.7 mt -79.15 144.92 34.02 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.355 179.41 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 90.9 p -61.82 -21.3 64.5 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -178.248 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.441 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 53.9 m -135.08 134.79 40.69 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.213 -0.595 . . . . 0.0 112.561 -178.618 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.9 t -124.81 116.23 21.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.602 178.119 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.666 HD12 ' O ' ' A' ' 49' ' ' CYS . 49.6 tp -116.73 132.86 56.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.957 0.408 . . . . 0.0 112.042 -178.337 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.714 ' CE2' HD12 ' A' ' 37' ' ' ILE . 10.8 m-85 -110.49 140.6 44.6 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.233 178.973 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 154.13 -176.29 32.06 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.044 178.735 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.646 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 80.2 mtm-85 -75.48 -30.72 59.99 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 120.956 0.407 . . . . 0.0 110.111 179.562 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.556 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -51.06 145.07 11.69 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.848 -178.608 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.488 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.7 tp -68.12 -41.0 83.86 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 120.872 0.368 . . . . 0.0 110.095 179.271 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.488 ' N ' HG23 ' A' ' 33' ' ' ILE . 80.6 tt0 -55.67 -22.09 21.36 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.47 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.556 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 19.0 m -58.82 121.41 11.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.837 179.369 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.441 ' OD2' ' O ' ' A' ' 26' ' ' THR . 96.2 m-20 -58.65 -25.05 62.36 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -178.767 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.714 HD12 ' CE2' ' A' ' 29' ' ' PHE . 82.1 mt -131.21 122.74 51.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.565 177.27 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.441 ' HD3' HD12 ' A' ' 33' ' ' ILE . 60.6 mtm180 -101.08 134.22 44.41 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.491 179.658 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.4 mt -116.47 127.87 73.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.484 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -74.66 28.21 0.09 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.23 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.595 HD21 ' OE1' ' B' ' 260' ' ' GLU . 40.7 mt -98.31 129.54 30.34 Favored Pre-proline 0 CA--C 1.538 0.508 0 C-N-CA 119.924 -0.711 . . . . 0.0 110.737 179.922 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.59 -7.53 20.35 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.607 2.205 . . . . 0.0 112.072 -179.523 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.4 m -102.06 6.79 9.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.112 -179.355 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.646 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 17.4 t -95.08 136.43 26.17 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.268 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.864 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.5 m -69.43 167.48 16.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.054 0.454 . . . . 0.0 111.147 -179.384 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 47.3 mttp -63.5 -38.6 91.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.966 -179.53 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.676 ' O ' ' N ' ' A' ' 49' ' ' CYS . 91.7 mm-40 -113.66 -17.99 12.0 Favored 'General case' 0 C--O 1.223 -0.338 0 O-C-N 123.474 0.484 . . . . 0.0 111.371 -179.159 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 23.2 t60 29.63 -74.97 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.52 0.934 . . . . 0.0 113.52 -179.608 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.676 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.11 133.83 46.0 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.427 0.632 . . . . 0.0 112.402 -178.287 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -128.55 128.37 44.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.2 179.537 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 85.2 mt -109.47 132.37 57.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.422 179.667 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -114.63 124.24 51.33 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.11 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.567 HD13 ' NH1' ' A' ' 5' ' ' ARG . 64.5 mt -107.46 116.59 51.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 120.02 -0.672 . . . . 0.0 112.727 -177.661 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.455 ' O ' ' C ' ' A' ' 55' ' ' GLU . 97.4 m-70 -111.49 139.26 47.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.905 178.654 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 54' ' ' HIS . 84.0 tt0 -41.21 -30.05 0.15 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 119.926 -0.709 . . . . 0.0 109.306 -179.943 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.431 ' N ' ' O ' ' A' ' 54' ' ' HIS . 84.8 mt-30 -61.08 -68.09 0.34 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.622 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -156.19 -174.04 4.77 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.1 -179.772 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.597 ' HB1' HH22 ' A' ' 5' ' ' ARG . . . -108.32 125.3 51.54 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.022 179.732 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.1 mt -119.23 130.77 73.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.369 0.604 . . . . 0.0 112.471 -178.55 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.587 ' HB2' HD11 ' A' ' 82' ' ' LEU . 18.4 tp -97.86 127.94 44.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.367 179.503 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -109.0 134.81 51.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.891 179.621 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.447 HD21 ' CA ' ' A' ' 68' ' ' PRO . 64.5 t-20 -94.49 105.49 17.46 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.39 -178.866 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -98.75 -8.28 26.28 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.689 179.497 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.6 m -71.52 101.93 2.58 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.304 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 89.7 p -87.84 -24.13 23.8 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.107 179.821 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.856 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.2 OUTLIER -78.27 -42.1 32.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.312 0.577 . . . . 0.0 109.769 179.323 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 36.7 m-20 -143.13 99.31 5.46 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.875 -179.498 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.447 ' CA ' HD21 ' A' ' 62' ' ' ASN . 52.7 Cg_exo -54.77 148.17 46.95 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.197 1.931 . . . . 0.0 113.41 -179.578 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.1 m -75.04 142.07 43.81 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.293 179.457 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -108.2 139.9 42.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.928 179.688 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.681 HG13 ' OD1' ' A' ' 86' ' ' ASP . 54.8 t -131.75 135.33 59.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.579 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 51.81 31.72 8.63 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.28 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.51 25.06 68.79 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-N 114.957 -1.02 . . . . 0.0 112.132 179.743 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 66.1 m -142.93 142.52 31.71 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 117.725 0.762 . . . . 0.0 112.57 -179.576 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.8 t -69.85 142.08 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.312 179.424 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.3 pt -110.98 77.08 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.478 179.221 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -52.55 -29.56 26.14 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.4 179.943 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.56 171.25 6.34 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.145 179.366 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -60.63 148.44 91.4 Favored 'Trans proline' 0 N--CA 1.499 1.84 0 C-N-CA 122.276 1.984 . . . . 0.0 111.832 179.631 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.8 p -138.15 140.83 39.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.995 0.426 . . . . 0.0 111.625 -179.391 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.9 mtm180 -75.12 128.53 35.73 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.025 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.587 HD11 ' HB2' ' A' ' 60' ' ' LEU . 91.5 mt -84.4 138.96 32.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.958 0.409 . . . . 0.0 111.054 -179.449 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -131.83 155.63 47.46 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.583 179.987 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.598 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 5.7 t60 -56.92 115.13 2.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.446 179.944 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.3 -12.49 26.15 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 -179.462 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.681 ' OD1' HG13 ' A' ' 71' ' ' VAL . 58.7 t0 -70.01 129.79 40.41 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 179.615 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.464 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 60.9 t -110.96 131.82 61.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.228 -179.237 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 94.4 mt -97.63 129.79 47.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.379 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 77.7 m -120.46 125.71 48.59 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.69 0.757 . . . . 0.0 112.777 -178.231 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.464 ' O ' ' C ' ' A' ' 91' ' ' ILE . 95.7 mt -112.2 123.47 67.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.347 178.079 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.608 HG22 ' N ' ' A' ' 92' ' ' ASP . 96.0 mt 34.33 -98.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 121.201 -0.2 . . . . 0.0 110.972 -178.883 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.608 ' N ' HG22 ' A' ' 91' ' ' ILE . 50.1 p-10 -114.43 15.03 17.97 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.913 0.387 . . . . 0.0 111.544 -179.99 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.442 HH21 ' CD ' ' B' ' 260' ' ' GLU . 84.6 mtt-85 -124.89 142.48 51.43 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.765 179.058 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.666 ' OG ' HD12 ' A' ' 10' ' ' ILE . 53.8 p -141.0 154.43 46.02 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.715 179.549 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.429 ' HB3' HD11 ' A' ' 7' ' ' LEU . 47.9 m-85 -124.32 125.46 44.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.555 179.757 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.425 ' O ' HD12 ' A' ' 7' ' ' LEU . 79.4 mtp85 -88.48 132.4 34.5 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.83 -179.494 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.619 ' OH ' ' NE ' ' A' ' 5' ' ' ARG . 88.3 t80 -95.21 127.87 41.6 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.197 -179.609 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -131.24 116.43 17.64 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.303 -179.613 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.598 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 61.9 t-20 -109.71 111.01 22.21 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.963 -179.806 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 . . . . . 0 C--N 1.331 -0.224 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.656 -179.598 . . . . . . . . 0 0 . 1 . 041 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 37.3 t . . . . . 0 C--O 1.232 0.165 0 N-CA-C 111.542 0.201 . . . . 0.0 111.542 . . . . . . . . . 0 0 . 1 . 041 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -65.12 141.73 58.61 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.404 0.621 . . . . 0.0 111.368 -178.92 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 041 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -121.88 40.14 3.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.301 -179.069 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -122.08 -179.26 15.91 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.679 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.48 161.14 47.08 Favored 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 123.575 2.85 . . . . 0.0 112.697 179.861 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.856 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -77.19 142.46 21.59 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 121.656 1.57 . . . . 0.0 113.44 -179.331 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.508 ' CG2' HG22 ' A' ' 66' ' ' THR . 53.7 t -63.91 136.32 26.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.542 -179.355 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 14.8 t -57.64 123.51 15.89 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.764 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 041 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.15 -27.22 36.36 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.913 1.742 . . . . 0.0 111.986 179.519 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 19.9 m -68.3 -44.42 75.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.321 0.581 . . . . 0.0 109.67 178.001 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.419 ' HZ ' HD22 ' A' ' 41' ' ' LEU . 89.0 t80 -58.47 -47.26 84.62 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.411 -179.296 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 93.8 mt -63.32 -40.68 97.99 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.146 -179.501 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -64.42 -41.25 96.71 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.115 -179.42 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -62.0 -41.86 98.52 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.016 -179.653 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.587 ' CZ ' ' OD2' ' A' ' 92' ' ' ASP . 8.2 tpp85 -61.28 -42.02 97.94 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.277 179.595 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . 0.47 ' O ' HG12 ' B' ' 249' ' ' VAL . 98.4 mttt -61.39 -41.38 97.04 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.412 179.891 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 58.5 m -68.75 -41.91 78.27 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.305 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . 0.621 ' O ' ' N ' ' B' ' 252' ' ' LEU . 62.1 tt0 -61.1 -39.67 90.84 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.119 -179.422 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.597 ' N ' ' NH2' ' A' ' 12' ' ' ARG . 0.3 OUTLIER -64.68 -39.02 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 119.932 -0.707 . . . . 0.0 109.25 179.165 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -60.37 -32.0 70.87 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.067 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -100.12 -11.54 20.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.859 178.82 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.629 HD13 ' N ' ' B' ' 253' ' ' ASN . 0.9 OUTLIER -122.3 113.83 19.95 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.127 179.994 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . 0.629 ' N ' HD13 ' B' ' 252' ' ' LEU . 9.9 t-20 175.31 42.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.796 179.952 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . 0.588 ' O ' ' CB ' ' B' ' 255' ' ' ASP . 38.3 p-10 -93.4 2.18 56.6 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.381 179.941 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . 0.588 ' CB ' ' O ' ' B' ' 254' ' ' ASP . 61.5 t0 113.51 57.98 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 O-C-N 124.492 1.12 . . . . 0.0 109.956 -179.775 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -86.88 79.22 8.86 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.802 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -64.28 -4.8 4.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.071 -178.943 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.74 ' O ' ' N ' ' B' ' 260' ' ' GLU . 95.7 m-20 -94.72 -2.36 51.26 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.138 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.463 ' C ' ' O ' ' B' ' 258' ' ' ASP . 48.7 p30 0.1 54.13 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 114.32 -1.309 . . . . 0.0 113.161 -179.807 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.74 ' N ' ' O ' ' B' ' 258' ' ' ASP . 97.0 mt-10 59.09 8.16 0.98 Allowed 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 178.97 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.442 ' CD1' HG23 ' A' ' 9' ' ' THR . 65.0 mt -118.4 133.44 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 120.604 -0.438 . . . . 0.0 109.839 179.703 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 49.6 t -128.46 135.91 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 120.786 0.327 . . . . 0.0 110.836 -179.693 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -97.42 119.64 36.32 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.298 0.57 . . . . 0.0 112.156 -178.641 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -64.93 -45.37 86.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.292 178.552 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . 0.652 ' CD ' HD11 ' A' ' 24' ' ' LEU . 2.0 mm-40 -89.9 157.84 45.48 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.393 -179.002 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -60.71 144.15 99.5 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 C-N-CA 122.055 1.837 . . . . 0.0 111.139 179.173 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . 0.498 ' CD1' ' O ' ' A' ' 19' ' ' HIS . 2.5 tt . . . . . 0 C--N 1.324 -0.514 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.549 -178.555 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo . . . . . 0 N--CA 1.499 1.848 0 CA-C-O 121.118 0.383 . . . . 0.0 112.608 . . . . . . . . . 0 0 . 1 . 042 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.7 p -117.19 -35.13 4.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.061 -178.592 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.4 mtm-85 -93.4 121.61 34.97 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.282 -178.725 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.695 HH21 ' CG ' ' A' ' 19' ' ' HIS . 80.5 ttt180 -130.23 132.01 45.78 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.757 -179.566 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.569 HD12 ' O ' ' A' ' 96' ' ' ARG . 26.0 tp -112.84 133.33 54.88 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -179.928 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.6 t -110.49 131.98 60.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 121.071 -0.251 . . . . 0.0 110.903 -179.492 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 m -93.24 114.38 26.84 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.317 0.58 . . . . 0.0 112.026 -178.713 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 98.2 mt -83.73 146.63 6.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.712 178.538 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -90.49 158.77 16.86 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.903 0.382 . . . . 0.0 110.028 179.063 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.616 HH21 HD22 ' B' ' 252' ' ' LEU . 89.7 mtm180 -57.55 -25.54 60.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.03 -179.608 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 90.3 p -79.94 -10.67 59.8 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.838 179.56 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.59 34.69 7.74 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 -179.738 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.3 t -121.03 135.28 61.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.988 0.423 . . . . 0.0 111.381 -179.681 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -74.06 123.49 24.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.278 179.39 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -118.36 -119.97 2.95 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 120.894 -0.67 . . . . 0.0 111.724 -179.327 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -76.21 149.81 32.37 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.137 1.891 . . . . 0.0 111.549 -179.321 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.695 ' CG ' HH21 ' A' ' 6' ' ' ARG . 0.3 OUTLIER -111.79 156.66 21.61 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.787 179.93 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.608 ' CD2' HD11 ' A' ' 37' ' ' ILE . 58.1 t80 -121.76 101.97 42.06 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.03 -179.025 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -73.72 129.59 13.72 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 121.515 1.476 . . . . 0.0 111.359 -179.907 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 93.7 mt -82.12 52.64 2.04 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 120.779 0.324 . . . . 0.0 111.745 -178.567 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.401 ' OG ' ' OE1' ' B' ' 265' ' ' GLN . 91.5 p -62.69 -17.67 61.04 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.415 0.626 . . . . 0.0 109.947 179.22 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.0 mt -90.38 142.17 28.0 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.605 -179.545 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.1 m -66.08 -20.04 66.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.256 -179.847 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.5 m -130.41 131.96 45.51 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.516 -179.816 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.6 t -124.77 116.44 22.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.368 178.655 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 36' ' ' ASP . 50.9 tp -114.41 125.35 53.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.85 -178.753 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.52 ' O ' ' O ' ' A' ' 47' ' ' GLN . 6.9 m-85 -108.11 142.1 38.81 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.789 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 163.86 -165.98 37.24 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.197 -1.002 . . . . 0.0 112.336 178.71 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.472 ' NH2' ' O ' ' B' ' 232' ' ' GLY . 28.8 ttp-105 -91.48 -31.0 16.14 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.8 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.576 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -60.75 156.63 31.68 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -179.659 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.617 HD12 ' CD ' ' A' ' 38' ' ' ARG . 5.7 tp -69.06 -39.27 79.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.872 -179.988 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.416 ' N ' HG23 ' A' ' 33' ' ' ILE . 95.8 mt-10 -52.41 -23.46 6.07 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.969 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.576 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 6.1 m -61.25 118.84 7.39 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.118 -179.586 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.549 ' N ' ' O ' ' A' ' 28' ' ' LEU . 99.0 m-20 -58.53 -25.02 61.99 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.448 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.608 HD11 ' CD2' ' A' ' 20' ' ' PHE . 47.5 mm -123.63 108.57 21.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 177.021 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.617 ' CD ' HD12 ' A' ' 33' ' ' ILE . 45.0 mtm180 -100.36 135.08 42.34 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -177.969 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.756 HG21 ' CZ ' ' A' ' 93' ' ' ARG . 96.8 mt -122.03 132.46 70.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.401 0.62 . . . . 0.0 111.477 -178.851 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -68.84 13.37 0.1 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 114.929 -1.032 . . . . 0.0 112.974 -178.579 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.985 HD12 HH21 ' A' ' 93' ' ' ARG . 17.5 mt -94.18 124.87 54.57 Favored Pre-proline 0 C--N 1.32 -0.712 0 C-N-CA 118.973 -1.091 . . . . 0.0 110.166 179.87 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -73.91 -8.97 21.92 Favored 'Trans proline' 0 C--N 1.315 -1.207 0 C-N-CA 122.165 1.91 . . . . 0.0 111.715 179.939 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.0 m -90.29 -0.1 8.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.193 179.302 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.712 HG12 ' O ' ' A' ' 41' ' ' LEU . 4.0 p -91.03 139.32 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-O 121.123 0.487 . . . . 0.0 110.205 -179.986 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.8 t -68.88 161.86 27.77 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.226 0.536 . . . . 0.0 111.354 -178.768 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.468 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 79.9 mttt -61.22 -42.37 98.49 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.614 -178.383 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.672 ' O ' ' N ' ' A' ' 49' ' ' CYS . 90.1 mt-30 -115.44 -12.45 11.7 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 121.061 -0.256 . . . . 0.0 111.246 179.512 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.55 ' CD2' ' HG1' ' A' ' 69' ' ' THR . 20.1 t60 30.76 -73.37 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 179.49 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.672 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -135.56 140.51 44.72 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 119.91 -0.716 . . . . 0.0 112.324 -178.6 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -129.24 130.7 46.59 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.769 179.876 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.7 mt -111.83 131.96 61.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.989 179.717 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -113.34 124.56 52.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.863 179.032 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 48.3 mm -99.45 108.17 22.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.533 -179.895 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.458 ' O ' ' C ' ' A' ' 55' ' ' GLU . 94.7 m-70 -106.48 133.21 51.51 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.681 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 54' ' ' HIS . 95.7 mt-10 -42.32 -31.17 0.37 Allowed 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 119.585 -0.846 . . . . 0.0 108.974 -179.599 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.416 ' N ' ' C ' ' A' ' 54' ' ' HIS . 88.2 mt-30 -67.99 -68.83 0.36 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.759 178.831 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -146.86 176.16 10.1 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.13 0.491 . . . . 0.0 111.603 -179.128 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -111.33 123.2 49.73 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.678 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 93.1 mt -117.06 135.25 58.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -177.631 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.554 ' HB2' HD11 ' A' ' 82' ' ' LEU . 24.9 tp -100.59 125.64 46.98 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.876 -179.932 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -111.34 137.4 49.14 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.197 -179.539 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.422 HD21 ' HA ' ' A' ' 68' ' ' PRO . 64.0 t-20 -98.66 106.22 18.47 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.243 179.478 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -97.26 -10.68 25.29 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 179.865 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.98 106.86 3.36 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 179.955 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 85.7 p -91.88 -15.04 28.69 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.166 -0.613 . . . . 0.0 110.03 179.229 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.707 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.2 OUTLIER -93.2 -46.12 7.55 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.567 -179.83 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -132.48 92.93 26.33 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.729 179.724 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.441 ' HB2' HG13 ' A' ' 75' ' ' VAL . 52.4 Cg_exo -56.15 140.89 87.87 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.226 1.95 . . . . 0.0 112.821 -179.378 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.55 ' HG1' ' CD2' ' A' ' 48' ' ' HIS . 86.9 m -72.5 140.32 48.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.388 179.143 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -101.71 140.65 35.72 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.943 178.896 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.445 ' CG1' ' OD1' ' A' ' 86' ' ' ASP . 75.1 t -134.04 133.11 56.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.436 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.59 ' ND2' ' OD1' ' A' ' 86' ' ' ASP . 89.1 m-20 53.8 33.08 16.15 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 119.909 -0.716 . . . . 0.0 109.128 -179.264 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.63 28.68 68.86 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.077 179.587 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 43.3 t -145.61 143.94 30.16 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 117.242 0.521 . . . . 0.0 111.615 179.942 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.441 HG13 ' HB2' ' A' ' 68' ' ' PRO . 50.9 t -70.28 135.19 28.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.024 179.744 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 9.1 pt -108.36 70.47 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.16 179.048 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -56.17 -30.65 62.52 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.949 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.32 157.75 37.22 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.487 178.605 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -64.05 149.59 90.13 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.314 2.009 . . . . 0.0 112.202 -179.841 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.7 m -139.03 142.93 32.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.202 -179.645 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 60.2 ttp180 -72.69 125.32 27.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.394 179.25 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.554 HD11 ' HB2' ' A' ' 60' ' ' LEU . 98.0 mt -77.33 138.7 39.5 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.362 0.601 . . . . 0.0 110.779 179.299 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -136.35 155.15 50.46 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.93 -179.411 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -55.83 113.16 1.38 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.358 -179.647 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.79 -6.76 22.16 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 121.169 -0.539 . . . . 0.0 111.767 179.977 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.59 ' OD1' ' ND2' ' A' ' 72' ' ' ASN . 37.9 t0 -76.73 124.34 27.53 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.249 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 45.8 t -108.12 129.5 62.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.328 -178.476 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 81.9 mt -97.13 132.2 42.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.842 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.9 m -116.41 126.23 53.15 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.072 0.463 . . . . 0.0 111.605 -179.448 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.416 ' CG2' HH12 ' A' ' 93' ' ' ARG . 87.8 mt -122.2 123.14 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.465 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.418 HG22 ' N ' ' A' ' 92' ' ' ASP . 45.0 mm 40.31 -106.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 121.065 -0.254 . . . . 0.0 110.506 -179.609 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.562 ' O ' ' OD1' ' A' ' 92' ' ' ASP . 66.3 t0 -110.48 18.93 19.28 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.06 0.457 . . . . 0.0 110.677 -179.863 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.985 HH21 HD12 ' A' ' 41' ' ' LEU . 8.5 mtm105 -125.44 142.95 51.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.369 -179.985 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 75.2 m -134.43 147.36 50.42 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 120.355 -0.538 . . . . 0.0 109.713 178.296 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.481 ' HB3' HD11 ' A' ' 7' ' ' LEU . 61.2 m-85 -125.28 124.29 41.31 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.931 -179.566 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.569 ' O ' HD12 ' A' ' 7' ' ' LEU . 99.9 mtt180 -90.58 131.76 36.11 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.292 -179.116 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -93.4 123.76 36.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.372 179.269 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -120.04 126.48 50.9 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.213 -179.855 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -113.77 -163.7 0.88 Allowed 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.612 179.732 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 . . . . . 0 N--CA 1.465 0.307 0 CA-C-O 120.871 0.367 . . . . 0.0 110.342 179.885 . . . . . . . . 0 0 . 1 . 042 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . 0.657 ' O ' HG13 ' B' ' 228' ' ' VAL . 10.0 p . . . . . 0 CA--C 1.531 0.222 0 CA-C-O 121.193 0.521 . . . . 0.0 111.213 . . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.416 ' O ' ' OD1' ' B' ' 229' ' ' ASP . 56.5 t0 -112.33 22.0 15.16 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.521 179.69 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . 0.573 ' O ' ' NE2' ' B' ' 231' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.573 ' NE2' ' O ' ' B' ' 230' ' ' SEP . 1.0 OUTLIER 158.2 -23.77 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.592 0.557 . . . . 0.0 111.215 179.995 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . 0.472 ' O ' ' NH2' ' A' ' 31' ' ' ARG . . . -52.07 -163.46 0.01 OUTLIER Glycine 0 CA--C 1.533 1.203 0 C-N-CA 121.238 -0.506 . . . . 0.0 112.181 -178.63 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -65.06 161.0 38.92 Favored 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 124.149 3.233 . . . . 0.0 112.908 -179.512 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.707 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -68.94 133.8 28.03 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 121.598 1.532 . . . . 0.0 112.513 -179.206 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.495 HG23 HG22 ' A' ' 66' ' ' THR . 39.4 t -61.81 138.59 22.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.271 -179.757 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 10.4 t -63.9 130.34 43.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.433 -179.428 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . 0.643 ' O2P' HG23 ' B' ' 240' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -59.36 -24.88 76.39 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 122.975 2.45 . . . . 0.0 112.945 -180.0 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . 0.643 HG23 ' O2P' ' B' ' 238' ' ' TPO . 2.9 p -73.65 -40.67 63.55 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.908 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -57.25 -46.9 82.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.115 179.976 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' B' ' 242' ' ' LEU . 95.7 mt -64.12 -41.4 97.25 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.884 -179.758 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -62.1 -39.72 93.43 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.757 -179.457 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -63.0 -41.3 99.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.889 0.376 . . . . 0.0 110.688 179.407 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.47 ' HD2' HH11 ' A' ' 12' ' ' ARG . 22.7 mmt180 -62.61 -39.01 92.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.026 -179.605 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.32 -39.58 93.5 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.007 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 46.1 t -64.75 -45.01 88.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.488 177.629 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . 0.547 ' O ' ' N ' ' B' ' 252' ' ' LEU . 84.8 mt-30 -60.4 -38.15 83.07 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.793 -179.348 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 40.3 t -61.79 -45.67 98.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.514 -179.791 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -60.45 -28.48 68.34 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.566 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -98.6 -8.81 25.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.974 179.172 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.616 HD22 HH21 ' A' ' 12' ' ' ARG . 36.9 tp -76.2 144.36 40.52 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.962 -179.109 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -99.52 136.96 38.69 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.77 179.163 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -67.12 -21.01 65.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.221 -179.559 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 39.2 p-10 -75.45 -0.36 19.81 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.335 -179.135 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.426 ' O ' ' C ' ' B' ' 257' ' ' LYS . 88.5 m-20 -93.07 -7.46 45.57 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.818 0.342 . . . . 0.0 110.104 179.212 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . 0.559 ' O ' ' C ' ' B' ' 258' ' ' ASP . 99.4 mttt 35.34 -104.94 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.237 179.947 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.559 ' C ' ' O ' ' B' ' 257' ' ' LYS . 64.7 t0 -8.54 80.1 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 O-C-N 123.912 0.757 . . . . 0.0 111.626 179.523 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' B' ' 257' ' ' LYS . 66.3 t0 -82.69 72.92 9.76 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.829 -178.852 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.57 ' N ' ' OE1' ' B' ' 260' ' ' GLU . 44.1 mp0 56.41 5.84 0.22 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 178.426 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 44.6 mt -114.48 134.58 56.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.609 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . 0.403 HG11 ' NH2' ' A' ' 38' ' ' ARG . 74.0 t -126.4 130.77 71.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.114 0.483 . . . . 0.0 110.18 179.6 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -90.62 116.38 28.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.467 -178.403 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -64.91 -44.41 89.67 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.18 179.688 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . 0.401 ' OE1' ' OG ' ' A' ' 23' ' ' SER . 0.0 OUTLIER -92.97 156.34 40.56 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.421 -179.144 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -61.74 145.66 97.18 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.843 2.362 . . . . 0.0 112.146 -179.944 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 27.2 pt . . . . . 0 C--N 1.321 -0.65 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.99 -179.695 . . . . . . . . 0 0 . 1 . 043 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo . . . . . 0 N--CA 1.494 1.52 0 CA-C-O 120.907 0.295 . . . . 0.0 111.743 . . . . . . . . . 0 0 . 1 . 043 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.0 p -118.95 -43.07 2.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.815 -179.607 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.488 ' NH2' HG21 ' A' ' 53' ' ' ILE . 90.9 mtm-85 -98.7 124.98 43.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.489 -179.624 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 88.6 mtm-85 -129.0 137.85 51.59 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.903 -179.995 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.573 HD12 ' O ' ' A' ' 96' ' ' ARG . 33.9 tp -109.96 129.52 55.65 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.986 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 52.8 t -109.76 131.15 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 120.942 0.401 . . . . 0.0 110.662 -179.463 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.432 HG23 ' CD1' ' B' ' 261' ' ' ILE . 2.8 m -79.78 140.33 36.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.449 -179.097 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.436 ' CD1' ' OD1' ' A' ' 16' ' ' ASP . 50.6 mm -108.69 135.52 47.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.509 177.505 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.448 ' HZ3' ' HB2' ' B' ' 259' ' ' ASP . 47.7 mttm -86.86 156.4 19.87 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.258 179.185 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.805 ' H ' ' NZ ' ' B' ' 257' ' ' LYS . 89.3 mtm180 -57.1 -29.57 63.63 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.64 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.4 t -78.11 -14.54 59.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.674 179.303 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.75 35.57 5.83 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.208 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.1 t -119.98 130.45 74.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.963 0.411 . . . . 0.0 110.958 -179.623 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.436 ' OD1' ' CD1' ' A' ' 10' ' ' ILE . 97.7 m-20 -72.25 136.36 46.3 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.193 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -127.85 -122.74 2.54 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 120.533 -0.841 . . . . 0.0 111.971 -178.887 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -74.12 151.03 43.69 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.33 2.02 . . . . 0.0 112.779 -178.616 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -110.76 149.79 30.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.621 -179.712 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.426 ' CD2' HD11 ' A' ' 37' ' ' ILE . 69.3 t80 -122.19 102.7 39.91 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.475 -179.395 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.43 134.41 22.54 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.551 1.501 . . . . 0.0 112.105 -178.485 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 91.1 mt -81.62 56.53 3.02 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.129 -179.285 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.0 p -68.09 -23.09 64.89 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.142 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.5 mt -86.21 142.26 28.73 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.599 178.737 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 70.3 p -67.8 -16.17 63.98 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.484 -179.108 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.504 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 66.8 m -133.17 135.29 45.03 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.489 179.973 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.676 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 2.1 t -127.85 114.94 17.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.068 178.675 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.503 HD21 ' HG2' ' A' ' 47' ' ' GLN . 46.1 tp -110.96 128.16 55.74 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.588 -178.873 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.676 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 35.1 m-85 -104.75 137.57 42.35 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.788 178.933 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 158.55 -171.29 35.29 Favored Glycine 0 N--CA 1.471 1.022 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.809 179.091 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.591 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 83.2 mtm-85 -86.82 -29.61 22.13 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.442 -179.67 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -54.3 157.96 5.93 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 -178.355 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.432 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.9 tp -68.89 -40.26 80.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 O-C-N 122.639 -0.33 . . . . 0.0 110.539 179.65 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.432 ' N ' HG23 ' A' ' 33' ' ' ILE . 94.6 mt-10 -57.05 -25.68 59.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.284 -179.825 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.418 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 75.9 m -50.84 115.07 1.34 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.349 179.709 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.504 ' OD2' ' O ' ' A' ' 26' ' ' THR . 94.2 m-20 -58.57 -31.86 68.39 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -179.594 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.655 HD12 ' CE2' ' A' ' 29' ' ' PHE . 95.2 mt -126.13 122.22 61.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 176.381 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 50.3 mtm180 -105.6 138.85 41.12 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.168 -0.613 . . . . 0.0 112.484 -178.721 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 90.5 mt -122.94 129.28 75.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.937 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -77.33 29.47 0.15 Allowed 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -177.894 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.434 ' HA ' HD23 ' A' ' 41' ' ' LEU . 78.5 mt -90.96 122.11 67.12 Favored Pre-proline 0 C--N 1.323 -0.581 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.671 179.455 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.7 -7.91 22.09 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 122.032 1.821 . . . . 0.0 112.061 -179.252 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.6 m -101.56 5.98 10.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.024 179.673 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.591 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 54.3 t -107.0 114.19 45.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.63 179.682 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.8 t -42.75 170.88 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 122.208 1.004 . . . . 0.0 113.303 -178.208 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.418 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 50.3 mttp -63.21 -40.32 97.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.475 -1.238 . . . . 0.0 112.003 -179.763 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.637 ' O ' ' N ' ' A' ' 49' ' ' CYS . 89.0 mt-30 -112.61 -13.34 13.31 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.217 -179.604 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.475 ' ND1' HG13 ' A' ' 44' ' ' VAL . 34.6 t60 36.73 -74.88 0.0 OUTLIER 'General case' 0 C--O 1.237 0.407 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 179.132 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.637 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -134.84 139.63 45.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.141 -178.336 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -128.94 132.77 47.66 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.603 179.927 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 95.5 mt -117.07 134.48 60.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.38 179.892 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -121.54 127.62 51.16 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.467 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.488 HG21 ' NH2' ' A' ' 5' ' ' ARG . 95.8 mt -102.22 118.32 48.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.368 0.604 . . . . 0.0 112.283 -178.473 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.536 ' O ' ' N ' ' A' ' 56' ' ' GLN . 1.9 m-70 -112.89 139.86 48.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.264 178.992 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.9 mm-40 -39.91 -26.48 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -179.586 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.536 ' N ' ' O ' ' A' ' 54' ' ' HIS . 88.5 mt-30 -65.08 -67.32 0.45 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.086 -0.961 . . . . 0.0 108.662 178.028 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -160.9 -162.7 0.95 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.806 0.336 . . . . 0.0 111.377 179.733 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.486 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -106.45 127.46 53.31 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.617 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 44.4 mm -110.51 125.96 67.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.432 -178.781 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 35.7 tp -99.82 126.84 45.99 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.615 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -117.12 136.71 52.8 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.614 0.245 . . . . 0.0 111.377 -179.328 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.505 HD21 ' CB ' ' A' ' 68' ' ' PRO . 48.5 t30 -98.33 106.41 18.69 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.384 179.573 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -98.59 -8.58 26.18 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 179.664 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.2 t -81.07 98.85 8.18 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.274 -179.799 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.4 t -77.87 -39.61 42.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.243 0.544 . . . . 0.0 109.651 178.238 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.736 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.3 OUTLIER -63.09 -46.33 87.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.745 -179.49 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.462 ' HB3' HD11 ' A' ' 91' ' ' ILE . 89.2 m-20 -137.23 93.86 12.76 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.26 -179.809 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.505 ' CB ' HD21 ' A' ' 62' ' ' ASN . 39.2 Cg_endo -64.57 148.76 90.56 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.4 1.4 . . . . 0.0 112.733 -177.76 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.432 HG22 ' N ' ' A' ' 70' ' ' GLN . 89.2 m -75.42 153.62 37.57 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.6 -179.29 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.432 ' N ' HG22 ' A' ' 69' ' ' THR . 88.8 mt-30 -115.47 140.59 49.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.852 -179.572 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 50.4 t -129.46 136.15 59.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.679 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 52.32 32.55 11.19 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.522 0.677 . . . . 0.0 109.484 -179.784 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.06 25.04 74.61 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 114.909 -1.041 . . . . 0.0 112.523 178.973 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.8 t -139.31 141.38 37.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 117.444 0.622 . . . . 0.0 110.631 179.131 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 68.7 t -66.4 136.32 26.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.628 -179.559 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.1 pt -108.32 80.06 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.102 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.474 178.963 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -63.93 -31.63 72.88 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.361 0.601 . . . . 0.0 109.744 179.396 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -111.35 155.83 42.16 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.362 179.024 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -63.52 147.43 93.11 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 122.309 2.006 . . . . 0.0 112.209 -179.707 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.3 m -140.25 145.24 26.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.267 0.556 . . . . 0.0 111.534 -179.884 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -74.4 135.64 42.41 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.171 179.79 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.486 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 96.2 mt -81.02 134.19 35.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.921 0.391 . . . . 0.0 111.134 -179.552 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -128.49 149.29 50.65 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.778 179.119 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -52.01 118.3 3.36 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.873 0.368 . . . . 0.0 111.164 -178.669 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.42 -15.27 30.02 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.184 -0.767 . . . . 0.0 111.184 -179.844 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -69.6 131.93 45.42 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.681 179.975 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.43 HG22 ' HG2' ' A' ' 96' ' ' ARG . 71.4 t -113.78 133.85 58.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.94 -178.531 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.8 mt -102.91 132.87 48.16 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.985 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 96.7 m -120.35 126.91 51.68 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 120.027 -0.669 . . . . 0.0 111.669 -179.497 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.583 ' O ' ' N ' ' A' ' 93' ' ' ARG . 89.4 mt -116.07 130.37 70.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.329 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.556 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 84.5 mt -20.93 94.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -178.202 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.556 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 12.9 t0 94.44 -24.78 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 177.847 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.951 ' HE ' HD11 ' B' ' 261' ' ' ILE . 18.2 mtp85 -131.22 146.67 52.41 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.819 -179.949 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 93.9 p -140.04 156.28 46.68 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.95 0.405 . . . . 0.0 110.251 179.739 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.541 ' HB3' HD11 ' A' ' 7' ' ' LEU . 73.9 m-85 -130.64 128.21 40.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.234 -179.631 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.573 ' O ' HD12 ' A' ' 7' ' ' LEU . 73.7 mtp85 -89.43 134.69 33.98 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.503 -179.606 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -95.37 124.55 39.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.515 179.698 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -125.23 127.8 47.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.488 -179.9 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 59.8 t-20 -125.63 114.62 18.94 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.82 0.343 . . . . 0.0 110.686 179.999 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.646 -179.955 . . . . . . . . 0 0 . 1 . 043 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 27.8 m . . . . . 0 N--CA 1.454 -0.27 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 043 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.536 ' O ' ' CB ' ' B' ' 230' ' ' SEP . 46.8 p-10 -102.04 15.89 27.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.351 -179.422 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . 0.551 ' O ' ' NE2' ' B' ' 231' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.551 ' NE2' ' O ' ' B' ' 230' ' ' SEP . 90.7 mm-40 -125.03 63.05 1.15 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.697 179.239 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -131.96 -177.96 15.22 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.405 -179.281 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.16 161.56 40.53 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 123.404 2.736 . . . . 0.0 112.64 -179.889 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.736 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.19 135.77 23.32 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 121.319 1.346 . . . . 0.0 112.998 -179.094 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.498 HG23 HG22 ' A' ' 66' ' ' THR . 55.3 t -60.56 138.31 21.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.279 -179.958 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 2.0 t -70.55 133.41 46.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.066 179.821 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 043 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -58.59 -23.21 64.04 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.482 2.122 . . . . 0.0 112.379 -179.748 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 99.2 m -73.33 -46.07 51.5 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.042 178.513 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -58.3 -47.3 84.12 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.907 -178.47 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' B' ' 242' ' ' LEU . 95.7 mt -63.8 -42.6 97.68 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.719 -0.393 . . . . 0.0 111.8 -179.392 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -65.48 -44.06 88.28 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.183 -179.197 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . 0.533 ' NH1' ' OE1' ' B' ' 248' ' ' GLN . 71.0 ttp85 -65.06 -43.49 92.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.999 0.428 . . . . 0.0 110.3 179.16 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.541 ' O ' HG23 ' B' ' 249' ' ' VAL . 14.5 tpp180 -61.68 -43.81 98.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.542 -179.604 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -65.49 -38.17 88.98 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.046 178.845 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 47.1 t -63.62 -45.15 91.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.464 179.257 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . 0.533 ' OE1' ' NH1' ' B' ' 244' ' ' ARG . 26.1 mt-30 -61.75 -36.13 80.12 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.758 -179.431 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.541 HG23 ' O ' ' B' ' 245' ' ' ARG . 77.5 t -64.35 -46.31 93.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.025 0.44 . . . . 0.0 110.458 179.197 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -63.68 -32.5 74.01 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.223 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -81.54 -7.57 59.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.482 178.774 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 39.2 tp -105.41 113.8 27.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.936 179.482 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -47.81 145.24 2.94 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.042 -178.367 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -62.62 -30.06 71.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.433 179.64 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . 0.417 ' OD1' ' C ' ' B' ' 255' ' ' ASP . 39.0 p-10 -87.07 9.01 21.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.308 179.752 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.504 ' O ' ' HB2' ' B' ' 257' ' ' LYS . 60.2 t0 -132.63 116.49 16.72 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.945 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . 0.805 ' NZ ' ' H ' ' A' ' 12' ' ' ARG . 86.0 tttt 165.95 97.97 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.458 0 O-C-N 124.063 0.852 . . . . 0.0 109.641 179.379 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' B' ' 258' ' ' ASP . 19.3 p-10 -69.19 -6.77 30.95 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.699 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.637 ' C ' ' H ' ' B' ' 261' ' ' ILE . 46.0 t0 74.44 106.78 0.07 Allowed 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.422 -179.478 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -57.56 12.51 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.303 -1.317 . . . . 0.0 111.982 -179.088 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.951 HD11 ' HE ' ' A' ' 93' ' ' ARG . 60.9 mt -107.2 134.01 50.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.691 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 62.3 t -126.56 131.69 71.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.454 -179.545 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -95.06 120.52 35.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.693 -178.361 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -65.46 -45.24 84.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.659 179.137 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.5 152.77 47.73 Favored Pre-proline 0 C--O 1.231 0.117 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.606 -179.107 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -64.04 141.86 78.71 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.494 2.129 . . . . 0.0 112.116 -179.876 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.1 pt . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.818 179.052 . . . . . . . . 0 0 . 1 . 044 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo . . . . . 0 N--CA 1.495 1.602 0 CA-C-O 121.083 0.368 . . . . 0.0 111.858 . . . . . . . . . 0 0 . 1 . 044 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.469 ' O ' ' O ' ' A' ' 99' ' ' ASN . 26.8 m -73.24 -46.46 50.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.299 -178.96 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.6 mtt85 -92.49 137.26 32.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.229 -178.208 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.7 mtt85 -130.5 139.62 50.51 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.187 -0.46 . . . . 0.0 112.032 -179.655 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.642 HD12 ' O ' ' A' ' 96' ' ' ARG . 27.3 tp -113.42 130.84 56.21 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.479 179.862 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.5 ' CG1' ' OD1' ' A' ' 16' ' ' ASP . 41.0 t -109.43 129.61 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.215 -178.867 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.9 m -80.2 145.31 32.33 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.797 -178.798 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.7 mt -116.19 137.64 49.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 114.66 -1.155 . . . . 0.0 109.42 178.244 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.429 ' CE ' ' OD1' ' B' ' 259' ' ' ASP . 60.1 mttt -88.43 160.21 17.64 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.402 179.854 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.625 ' HG3' HH11 ' A' ' 93' ' ' ARG . 90.0 mtm180 -57.82 -32.33 67.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.428 -179.329 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.1 t -79.82 -5.87 56.24 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.356 179.358 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.45 38.17 7.25 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.933 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.5 t -115.0 132.57 63.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.298 0.57 . . . . 0.0 111.324 -179.799 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.5 ' OD1' ' CG1' ' A' ' 8' ' ' VAL . 67.1 t0 -77.15 122.84 25.57 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.106 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -118.3 -120.1 2.97 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.173 -178.509 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -74.46 152.56 43.81 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.317 2.011 . . . . 0.0 112.395 -178.893 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -111.17 147.74 34.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.057 0.456 . . . . 0.0 110.18 179.913 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.463 ' CD2' HD11 ' A' ' 37' ' ' ILE . 70.3 t80 -117.54 101.68 52.35 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.075 -179.255 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -73.08 136.54 24.87 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.279 1.32 . . . . 0.0 111.696 -179.592 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.0 mt -86.57 65.78 9.18 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.527 -178.307 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.594 ' OG ' ' NE2' ' B' ' 265' ' ' GLN . 18.0 p -68.8 -22.43 64.26 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.693 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 76.2 mt -87.53 142.19 28.05 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.378 179.977 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 61.4 p -66.21 -15.6 63.3 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.658 -179.322 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.507 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 35.6 m -133.02 134.04 43.89 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.988 0.423 . . . . 0.0 110.902 -179.558 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.8 t -126.56 118.13 24.24 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.275 179.911 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.449 HD21 ' HG2' ' A' ' 47' ' ' GLN . 44.6 tp -116.87 128.96 55.76 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.05 -179.071 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.71 ' CE2' HD12 ' A' ' 37' ' ' ILE . 5.8 m-85 -105.94 131.02 53.75 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.868 179.717 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.8 179.9 37.65 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 120.253 -0.975 . . . . 0.0 112.368 179.267 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.471 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 45.3 mtm105 -73.39 -32.53 64.51 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 179.573 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.567 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -48.44 149.28 3.97 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -178.548 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.534 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.4 tp -68.06 -41.99 84.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.339 0.59 . . . . 0.0 110.109 179.676 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.534 ' N ' HG23 ' A' ' 33' ' ' ILE . 80.8 tt0 -56.74 -20.71 23.46 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.386 -179.823 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.567 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 14.8 m -58.12 128.41 37.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.129 -179.819 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.507 ' OD2' ' O ' ' A' ' 26' ' ' THR . 54.0 m-20 -62.4 -33.47 74.82 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.127 -179.712 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.71 HD12 ' CE2' ' A' ' 29' ' ' PHE . 93.2 mt -125.55 118.57 52.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 177.45 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.533 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 82.9 mtp180 -103.36 139.65 38.49 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.137 -178.762 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.418 ' C ' ' H ' ' A' ' 41' ' ' LEU . 80.5 mt -121.54 129.28 75.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.37 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -74.58 34.93 0.1 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.737 -178.367 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.452 ' HA ' HD23 ' A' ' 41' ' ' LEU . 38.2 mt -102.35 122.66 45.78 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.63 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.1 -6.11 18.45 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 122.415 2.077 . . . . 0.0 112.729 -178.802 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.522 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 2.9 m -107.3 6.26 9.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.328 -179.749 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.48 ' O ' ' O ' ' A' ' 45' ' ' SER . 11.8 t -98.27 110.42 25.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.296 0.569 . . . . 0.0 110.693 -179.673 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.48 ' O ' ' O ' ' A' ' 44' ' ' VAL . 1.2 t -33.85 160.25 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.112 -0.949 . . . . 0.0 112.266 -178.94 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -62.04 -42.01 98.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.107 -179.416 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.653 ' O ' ' N ' ' A' ' 49' ' ' CYS . 90.0 mt-30 -114.75 -17.7 11.54 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.696 179.659 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 29.5 t60 35.98 -72.59 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 179.293 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.653 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.71 137.86 47.05 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.067 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -126.84 128.62 46.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.557 179.401 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.3 mt -116.67 135.19 57.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.73 0.3 . . . . 0.0 110.231 179.202 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -113.23 136.79 52.35 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.232 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.8 mm -104.19 124.24 58.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.078 -179.245 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.444 ' O ' ' C ' ' A' ' 55' ' ' GLU . 97.4 m-70 -128.63 135.76 49.75 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.967 179.348 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 54' ' ' HIS . 51.7 tp10 -40.26 -30.37 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.022 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.463 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 92.2 mt-30 -66.34 -67.89 0.41 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.255 178.266 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.52 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 8.3 tp10 -157.93 -158.07 0.7 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.726 -179.352 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.52 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -124.2 130.93 53.38 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.738 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.2 mt -119.55 130.67 73.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.188 0.518 . . . . 0.0 111.48 -179.109 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.493 ' HB2' HD11 ' A' ' 82' ' ' LEU . 25.1 tp -95.71 132.23 41.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.845 -179.753 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -117.02 137.38 52.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.075 179.519 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 62.5 t-20 -95.45 106.44 18.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.046 -178.508 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -97.15 -13.54 22.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.972 179.201 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.12 101.21 4.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.46 179.869 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.6 m -87.2 -16.53 35.06 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.118 179.628 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.472 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -87.8 -45.64 10.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.16 179.453 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -135.96 95.67 13.54 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.373 -179.988 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.539 ' HB2' HG23 ' A' ' 75' ' ' VAL . 50.0 Cg_exo -55.16 142.8 77.15 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.227 1.951 . . . . 0.0 113.124 -179.934 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.96 ' O ' HG22 ' A' ' 76' ' ' ILE . 5.3 m -70.41 140.85 52.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.008 179.181 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -102.1 140.72 36.01 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.507 -0.477 . . . . 0.0 109.953 179.57 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 51.8 t -129.78 134.64 62.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.52 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 50.28 32.84 6.61 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -179.585 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.37 25.7 67.6 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.628 179.532 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 29.6 t -140.74 141.23 34.89 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 117.606 0.703 . . . . 0.0 111.207 179.573 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.539 HG23 ' HB2' ' A' ' 68' ' ' PRO . 0.5 OUTLIER -68.19 140.46 19.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.191 -179.878 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.96 HG22 ' O ' ' A' ' 69' ' ' THR . 9.4 tt -106.74 94.03 2.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.43 179.59 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.5 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 16.2 p-10 -68.24 -34.33 76.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.43 179.844 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.462 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 0.1 OUTLIER -130.65 174.88 4.15 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.115 -178.838 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -61.0 142.89 98.86 Favored 'Trans proline' 0 N--CA 1.501 1.954 0 C-N-CA 122.678 2.252 . . . . 0.0 112.775 -179.615 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.2 m -140.33 143.67 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.402 179.857 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -75.05 126.65 31.47 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.812 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.493 HD11 ' HB2' ' A' ' 60' ' ' LEU . 96.6 mt -79.42 139.26 37.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.917 -179.677 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -126.36 150.12 48.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.445 179.956 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -58.03 121.34 10.37 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.13 -179.561 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.84 -13.82 26.91 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -179.711 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -68.58 134.69 50.36 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.421 179.841 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.543 HG22 ' HG2' ' A' ' 96' ' ' ARG . 74.2 t -108.65 131.84 58.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.68 -178.794 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 83.0 mt -105.6 132.09 53.41 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.1 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.926 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 94.5 m -121.0 125.64 47.88 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 120.305 -0.558 . . . . 0.0 112.044 -178.261 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.454 ' O ' ' C ' ' A' ' 91' ' ' ILE . 92.4 mt -119.05 124.88 73.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 178.716 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.454 ' C ' ' O ' ' A' ' 90' ' ' ILE . 45.0 mm 35.17 -107.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.729 -178.761 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.454 ' N ' HG22 ' A' ' 91' ' ' ILE . 31.3 p-10 -106.04 12.07 30.82 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.385 -179.825 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.625 HH11 ' HG3' ' A' ' 12' ' ' ARG . 19.6 mmm180 -125.85 144.12 50.79 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.593 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 26.4 t -137.59 155.52 49.11 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.896 -179.858 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.516 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 87.2 m-85 -130.13 130.96 45.45 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.559 -0.292 . . . . 0.0 110.739 179.889 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.642 ' O ' HD12 ' A' ' 7' ' ' LEU . 97.8 mtt180 -94.65 134.1 37.59 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.157 179.441 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -97.63 126.51 42.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.853 179.727 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -134.88 125.69 27.27 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.177 179.849 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.469 ' O ' ' O ' ' A' ' 4' ' ' THR . 91.1 m-20 -63.74 -41.37 98.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.512 178.849 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 . . . . . 0 C--N 1.331 -0.204 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.414 -179.719 . . . . . . . . 0 0 . 1 . 044 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.458 -0.061 0 CA-C-O 120.826 0.346 . . . . 0.0 111.107 . . . . . . . . . 0 0 . 1 . 044 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.605 ' O ' ' N ' ' B' ' 231' ' ' GLN . 95.5 m-20 -89.47 147.59 23.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.014 -178.767 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 044 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.605 ' N ' ' O ' ' B' ' 229' ' ' ASP . 0.3 OUTLIER -114.54 57.38 0.71 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.671 -179.019 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -123.04 166.06 15.52 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.082 -0.58 . . . . 0.0 111.687 -179.828 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -73.79 158.33 46.85 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 123.823 3.015 . . . . 0.0 112.472 179.511 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.456 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -72.01 145.2 44.33 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.243 1.962 . . . . 0.0 112.501 179.879 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.472 ' CG2' HG22 ' A' ' 66' ' ' THR . 47.6 t -76.05 131.42 34.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.107 -0.951 . . . . 0.0 112.009 -178.334 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 4.0 t -76.95 128.02 33.77 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 178.165 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . 0.465 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . 0.465 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 34.3 Cg_exo -59.14 -26.46 81.81 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.764 2.31 . . . . 0.0 112.694 -179.857 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 86.3 m -73.56 -44.09 58.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.224 0.535 . . . . 0.0 109.61 178.259 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.717 ' CE1' ' NE ' ' B' ' 245' ' ' ARG . 53.4 t80 -56.85 -46.93 81.42 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.705 -178.911 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 95.7 mt -64.01 -40.57 96.63 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 121.076 0.465 . . . . 0.0 110.517 -179.856 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -64.1 -39.9 95.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.649 -179.303 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 44.2 ttm180 -60.84 -44.77 96.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.876 0.369 . . . . 0.0 110.209 -179.69 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.717 ' NE ' ' CE1' ' B' ' 241' ' ' PHE . 2.2 mtm-85 -63.26 -40.67 98.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.011 179.858 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.36 -41.42 98.83 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.268 179.117 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 31.3 t -65.93 -45.88 80.25 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.464 0.65 . . . . 0.0 109.674 178.959 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -63.43 -34.53 77.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.261 -179.792 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.696 HG23 ' O ' ' B' ' 245' ' ' ARG . 51.7 t -63.66 -45.08 98.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.687 179.743 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -65.51 -26.54 67.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.101 0.476 . . . . 0.0 110.254 179.203 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -96.22 -9.35 30.62 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.983 -179.357 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.912 HD22 ' OD2' ' B' ' 256' ' ' ASP . 13.3 mt -83.09 143.78 30.33 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -179.346 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . 0.598 ' O ' ' N ' ' B' ' 255' ' ' ASP . 12.9 t-20 -101.96 161.68 13.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.685 178.926 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . 0.431 ' H ' ' ND2' ' B' ' 253' ' ' ASN . 39.1 t70 -42.47 -8.61 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -179.084 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . 0.598 ' N ' ' O ' ' B' ' 253' ' ' ASN . 95.8 m-20 -61.58 -12.82 17.27 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.86 -179.334 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.912 ' OD2' HD22 ' B' ' 252' ' ' LEU . 89.5 m-20 -93.42 15.13 16.54 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 120.719 0.295 . . . . 0.0 110.424 179.362 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . 0.461 ' O ' ' OD1' ' B' ' 259' ' ' ASP . 88.8 tttt -58.49 -19.77 39.98 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.354 -179.923 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.456 ' O ' ' CB ' ' B' ' 259' ' ' ASP . 90.7 m-20 -60.65 -41.72 95.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.73 179.107 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.639 ' C ' ' H ' ' B' ' 261' ' ' ILE . 0.6 OUTLIER 82.88 114.16 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.473 179.263 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -51.64 6.88 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.9 -179.36 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.639 ' H ' ' C ' ' B' ' 259' ' ' ASP . 73.3 mt -109.78 140.44 28.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.913 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 78.7 t -128.34 136.38 60.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.865 -178.904 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -97.93 121.01 39.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.362 0.601 . . . . 0.0 111.71 -179.027 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -66.26 -42.79 88.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.194 179.479 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . 0.594 ' NE2' ' OG ' ' A' ' 23' ' ' SER . 0.0 OUTLIER -99.44 161.64 23.9 Favored Pre-proline 0 N--CA 1.465 0.322 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.274 -178.73 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -60.95 149.69 87.56 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.531 2.154 . . . . 0.0 112.14 178.875 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 44.5 pt . . . . . 0 C--N 1.331 -0.201 0 CA-C-O 121.534 0.683 . . . . 0.0 112.295 -179.091 . . . . . . . . 0 0 . 1 . 045 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.422 ' HG2' HH21 ' A' ' 6' ' ' ARG . 59.7 Cg_endo . . . . . 0 N--CA 1.491 1.382 0 CA-C-O 120.778 0.241 . . . . 0.0 111.924 . . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.1 p -115.5 -36.05 4.4 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.663 -179.8 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.819 ' NE ' HD13 ' A' ' 53' ' ' ILE . 87.7 mtm-85 -98.06 121.6 40.18 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.595 -179.711 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.442 ' C ' HD22 ' A' ' 7' ' ' LEU . 99.7 mtt180 -129.98 137.9 50.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.072 179.839 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.455 ' CD2' ' N ' ' A' ' 7' ' ' LEU . 1.1 mm? -111.12 135.37 51.74 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.512 179.416 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.673 HG22 ' CD2' ' A' ' 19' ' ' HIS . 55.0 t -111.09 126.41 68.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.642 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 m -82.86 112.83 20.03 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.124 -178.337 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 98.1 mt -81.83 139.78 17.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.914 179.242 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -90.44 153.37 20.45 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.286 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.569 ' NH1' ' OD2' ' A' ' 92' ' ' ASP . 30.2 mtp85 -59.75 -26.46 65.69 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.709 179.82 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.3 p -72.53 -19.0 61.59 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.993 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.74 31.3 6.09 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 -179.646 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 51.9 t -121.06 132.37 70.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.928 0.394 . . . . 0.0 111.02 -179.814 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -76.85 139.87 40.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.062 179.262 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -130.9 -115.11 1.7 Allowed Glycine 0 CA--C 1.538 1.524 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.165 -179.378 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -70.21 144.89 52.95 Favored 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 122.2 1.933 . . . . 0.0 113.054 -178.538 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.673 ' CD2' HG22 ' A' ' 8' ' ' VAL . 59.0 m170 -109.14 135.15 50.74 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.586 -179.543 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.921 ' CD2' HD11 ' A' ' 37' ' ' ILE . 65.0 t80 -106.92 102.57 43.31 Favored Pre-proline 0 N--CA 1.467 0.385 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.043 -179.149 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.47 132.49 16.23 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 121.422 1.414 . . . . 0.0 111.971 -179.986 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 22' ' ' LEU . 73.3 mt -85.8 58.48 5.07 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -178.745 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 86.5 p -66.76 -17.31 64.8 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 178.842 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.511 HD11 ' HG2' ' B' ' 265' ' ' GLN . 62.1 mt -86.68 139.67 30.54 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.475 -179.76 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.4 t -63.6 -18.61 64.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.717 -179.905 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.15 140.93 36.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.626 -179.19 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.666 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -137.37 132.57 33.73 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.093 178.875 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.526 HD12 ' O ' ' A' ' 49' ' ' CYS . 56.3 tp -125.45 123.16 38.64 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.805 -179.067 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.666 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 46.5 m-85 -95.82 141.33 29.4 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.811 179.683 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 147.44 -176.8 26.11 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.066 178.685 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 31' ' ' ARG . 45.5 mtm180 -70.8 -33.11 70.38 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 179.285 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.577 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -42.62 140.31 2.24 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -179.35 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 33' ' ' ILE . 11.0 tp -67.0 -39.29 83.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.936 -179.694 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -58.81 -20.58 51.58 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.189 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.577 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 66.8 m -50.24 119.9 4.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.971 179.632 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -61.75 -31.77 71.98 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 179.736 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.921 HD11 ' CD2' ' A' ' 20' ' ' PHE . 27.1 mm -120.85 105.0 16.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 177.044 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.443 HH12 ' HG2' ' A' ' 40' ' ' GLN . 68.2 ttp85 -98.21 135.98 39.08 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.559 -178.457 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.712 HG23 ' NH1' ' A' ' 93' ' ' ARG . 94.5 mt -121.58 131.59 72.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.902 -179.683 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.443 ' HG2' HH12 ' A' ' 38' ' ' ARG . 74.5 mt-30 -78.26 31.78 0.18 Allowed 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -177.693 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.771 ' O ' HG12 ' A' ' 44' ' ' VAL . 87.1 mt -96.34 122.93 56.4 Favored Pre-proline 0 C--N 1.326 -0.454 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.727 179.586 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.08 -8.29 21.92 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 122.261 1.974 . . . . 0.0 112.601 -179.361 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.445 HG12 ' HG2' ' B' ' 235' ' ' PRO . 35.5 m -102.17 4.76 10.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.191 179.997 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.771 HG12 ' O ' ' A' ' 41' ' ' LEU . 6.0 p -97.32 150.3 4.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.348 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.2 163.43 27.85 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.805 0.812 . . . . 0.0 112.186 -178.869 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.9 mtmt -63.76 -38.1 89.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.131 -179.558 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.621 ' O ' ' N ' ' A' ' 49' ' ' CYS . 10.4 mm100 -110.58 -20.33 12.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.024 0.44 . . . . 0.0 109.967 179.897 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.534 ' NE2' HG23 ' A' ' 90' ' ' ILE . 22.8 t60 38.3 -77.32 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 179.021 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.763 ' SG ' HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -134.73 137.73 43.73 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.42 -0.512 . . . . 0.0 112.085 -178.038 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -123.65 131.57 53.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.886 179.225 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.439 HD11 HD12 ' A' ' 82' ' ' LEU . 16.2 tt -120.13 134.62 63.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.716 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -120.75 128.42 52.9 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.35 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.819 HD13 ' NE ' ' A' ' 5' ' ' ARG . 78.4 mt -106.43 122.37 60.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 119.774 -0.77 . . . . 0.0 112.262 -178.754 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.51 ' CD2' ' N ' ' A' ' 54' ' ' HIS . 2.4 m-70 -114.42 137.95 51.18 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.785 179.666 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.466 ' C ' ' O ' ' A' ' 54' ' ' HIS . 97.7 mt-10 -40.93 -29.77 0.11 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.75 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.452 ' N ' ' C ' ' A' ' 54' ' ' HIS . 59.4 tt0 -64.31 -68.21 0.37 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.798 178.294 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -156.82 -168.31 2.63 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.202 -179.853 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -105.52 133.23 50.61 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.532 -179.747 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 41.4 mm -118.86 125.55 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 120.511 -0.475 . . . . 0.0 111.502 -179.491 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.763 HD11 ' SG ' ' A' ' 49' ' ' CYS . 57.3 tp -104.65 130.48 52.66 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.836 -179.954 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.9 m-70 -121.55 140.41 52.26 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.741 179.923 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.729 ' ND2' ' H ' ' A' ' 69' ' ' THR . 25.2 t-20 -104.62 110.77 23.21 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.892 0.377 . . . . 0.0 111.957 179.743 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -96.66 -4.33 41.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.417 179.18 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.44 100.65 9.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.518 179.97 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 86.5 p -84.87 -29.11 25.53 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.285 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.637 HG21 ' O ' ' B' ' 234' ' ' TPO . 2.1 m -64.3 -49.27 72.43 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.078 179.388 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.625 ' OD1' HG23 ' B' ' 236' ' ' VAL . 2.7 m-20 -145.75 100.37 4.33 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.563 179.623 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.405 ' HA ' HD21 ' A' ' 62' ' ' ASN . 36.7 Cg_endo -64.79 153.23 78.88 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 121.308 1.338 . . . . 0.0 112.038 -178.933 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.729 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 28.3 m -75.14 150.41 38.76 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.642 -179.5 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -108.48 141.18 40.74 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.933 179.307 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.719 HG13 ' OD1' ' A' ' 86' ' ' ASP . 48.8 t -128.2 134.4 65.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.309 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 53.66 31.4 12.63 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -178.622 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.76 29.16 67.82 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.051 179.522 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 67.0 m -139.67 138.52 36.12 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 117.076 0.438 . . . . 0.0 111.213 -179.967 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.7 t -69.94 133.98 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.707 179.527 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.3 pt -101.38 94.14 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 CA-C-O 121.241 0.543 . . . . 0.0 110.506 179.338 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -63.95 -34.47 78.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.123 179.714 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -124.44 172.64 5.6 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.922 179.978 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.61 143.21 99.72 Favored 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 122.151 1.901 . . . . 0.0 112.549 -179.709 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 48.1 t -131.36 138.97 51.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.075 179.905 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 95.8 mtm-85 -76.38 128.82 35.59 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.777 179.174 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.609 HD11 ' HB2' ' A' ' 60' ' ' LEU . 93.7 mt -86.04 134.04 33.87 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.245 0.545 . . . . 0.0 111.277 -179.333 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -124.45 154.41 40.51 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.244 178.954 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.579 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 4.5 t60 -53.63 118.9 4.27 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.32 -179.504 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.44 -11.66 28.31 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.823 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.719 ' OD1' HG13 ' A' ' 71' ' ' VAL . 50.2 t0 -71.73 126.09 28.82 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.407 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 43.7 t -107.86 129.08 62.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.493 -179.203 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 94.3 mt -94.29 132.52 38.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.315 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.8 m -123.47 123.26 40.24 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.49 0.662 . . . . 0.0 112.572 -178.775 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.534 HG23 ' NE2' ' A' ' 48' ' ' HIS . 90.0 mt -109.51 123.82 65.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.197 177.845 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.487 ' C ' ' O ' ' A' ' 90' ' ' ILE . 86.8 mt 35.2 -96.82 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.509 -0.477 . . . . 0.0 110.613 179.746 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.569 ' OD2' ' NH1' ' A' ' 12' ' ' ARG . 20.8 p-10 -115.03 12.19 16.65 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.736 179.999 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.712 ' NH1' HG23 ' A' ' 39' ' ' ILE . 98.9 mtt180 -124.02 142.13 51.44 Favored 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.444 179.938 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 38.9 t -138.5 147.62 43.38 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.583 179.834 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.449 ' HE1' HD12 ' A' ' 90' ' ' ILE . 85.7 m-85 -121.78 120.64 35.21 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.095 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -79.7 131.79 36.04 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.343 -178.656 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -95.41 122.18 37.86 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.606 179.855 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -124.56 124.57 42.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.706 -179.708 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.579 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 59.0 t-20 -118.29 116.34 26.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.213 -179.929 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 . . . . . 0 C--N 1.332 -0.157 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.271 -179.549 . . . . . . . . 0 0 . 1 . 045 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 2.3 m . . . . . 0 CA--C 1.529 0.163 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 . . . . . . . . . 0 0 . 1 . 045 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -62.16 -47.55 84.04 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.226 0.536 . . . . 0.0 110.146 -179.896 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . 0.506 ' C ' ' H ' ' B' ' 232' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -75.22 38.99 0.14 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.81 -179.817 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . 0.506 ' H ' ' C ' ' B' ' 230' ' ' SEP . . . -127.06 -179.89 16.02 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 179.978 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -72.43 161.13 45.11 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 123.624 2.883 . . . . 0.0 113.732 -179.531 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.637 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . 0.445 ' HG2' HG12 ' A' ' 43' ' ' VAL . 61.7 Cg_endo -72.04 140.58 34.85 Favored 'Trans proline' 0 C--N 1.301 -1.971 0 C-N-CA 121.24 1.293 . . . . 0.0 112.799 -179.352 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.625 HG23 ' OD1' ' A' ' 67' ' ' ASN . 1.0 OUTLIER -64.44 136.9 25.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.01 -179.473 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . 0.43 ' SG ' HG23 ' A' ' 91' ' ' ILE . 7.7 t -60.34 126.67 28.34 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.843 0.354 . . . . 0.0 110.488 -179.079 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . 0.604 ' O1P' HG23 ' B' ' 240' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -56.24 -23.04 43.54 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.111 1.874 . . . . 0.0 112.866 179.768 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . 0.604 HG23 ' O1P' ' B' ' 238' ' ' TPO . 35.8 p -75.47 -40.69 57.07 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.316 -0.553 . . . . 0.0 109.704 178.603 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.466 ' HZ ' HD22 ' A' ' 41' ' ' LEU . 83.3 t80 -57.17 -47.36 81.42 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.677 -179.592 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.42 ' HA ' HD23 ' B' ' 242' ' ' LEU . 91.6 mt -62.65 -41.11 98.87 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.635 179.93 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -65.26 -41.49 94.2 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.76 -179.29 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 80.9 mtt85 -62.18 -43.04 99.72 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.093 179.495 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.708 ' NH2' HH21 ' A' ' 93' ' ' ARG . 24.1 mmm180 -61.19 -39.76 91.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.082 -178.622 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.43 -38.71 90.8 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 179.057 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 71.1 m -62.9 -43.66 98.19 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 177.413 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -59.15 -36.6 75.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.194 179.761 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.428 HG23 HH21 ' A' ' 12' ' ' ARG . 63.3 t -61.59 -45.82 97.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.393 179.646 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -59.39 -30.53 68.5 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.586 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -90.47 -9.79 46.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.883 179.103 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 54.1 tp -78.66 144.23 35.57 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.566 179.641 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -107.3 141.51 38.52 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.891 178.521 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -61.45 -32.14 72.11 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.892 0.377 . . . . 0.0 110.798 -179.61 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -71.49 -1.32 12.88 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.593 -179.222 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.483 ' O ' ' C ' ' B' ' 257' ' ' LYS . 93.2 m-20 -88.59 -5.33 58.24 Favored 'General case' 0 N--CA 1.462 0.133 0 C-N-CA 120.709 -0.397 . . . . 0.0 110.638 179.923 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . 0.559 ' O ' ' C ' ' B' ' 258' ' ' ASP . 86.4 tttt 32.41 -106.35 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.331 179.917 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.559 ' C ' ' O ' ' B' ' 257' ' ' LYS . 99.4 m-20 -14.27 99.54 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 O-C-N 123.724 0.64 . . . . 0.0 111.138 -179.975 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . . . . . . . . . 49.9 p-10 -99.33 57.54 1.05 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.006 -178.62 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.627 ' OE1' ' NH2' ' A' ' 93' ' ' ARG . 98.3 mt-10 61.83 17.56 8.95 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 178.317 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 77.9 mt -118.31 133.84 63.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 177.225 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 68.3 t -126.24 133.04 69.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.381 -178.494 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . 0.558 ' CD2' HG21 ' B' ' 267' ' ' ILE . 62.1 m-85 -93.42 116.64 29.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.802 -179.307 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -64.49 -42.33 95.94 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.207 179.212 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . 0.511 ' HG2' HD11 ' A' ' 24' ' ' LEU . 1.1 mp0 -101.84 169.77 7.26 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.875 -179.398 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -62.29 149.68 89.81 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 121.752 1.635 . . . . 0.0 113.495 -179.281 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . 0.558 HG21 ' CD2' ' B' ' 263' ' ' PHE . 19.8 pt . . . . . 0 N--CA 1.462 0.151 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.912 -179.175 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo . . . . . 0 N--CA 1.493 1.494 0 N-CA-C 111.73 -0.142 . . . . 0.0 111.73 . . . . . . . . . 0 0 . 1 . 046 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.6 p -99.1 -44.42 6.29 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.311 -179.352 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.89 ' NH1' HG23 ' A' ' 53' ' ' ILE . 99.6 mtt180 -96.52 122.08 39.04 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.094 -179.417 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -128.35 142.61 51.07 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.184 0.516 . . . . 0.0 111.339 -179.14 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.61 HD11 ' HB3' ' A' ' 95' ' ' PHE . 45.2 tp -113.38 133.09 55.34 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.304 -179.362 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.0 t -109.01 131.11 60.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.32 -179.617 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.469 HG23 ' CD1' ' B' ' 261' ' ' ILE . 1.5 m -92.3 115.55 28.18 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.514 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.414 HD12 ' HB3' ' A' ' 94' ' ' SER . 98.4 mt -83.13 145.43 8.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.242 179.014 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -91.44 162.08 14.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.163 0.506 . . . . 0.0 110.863 178.928 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.983 HH21 HD22 ' B' ' 252' ' ' LEU . 88.6 mtm180 -57.95 -30.07 65.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.792 -179.638 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.2 m -78.35 -8.61 58.63 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.813 0.339 . . . . 0.0 110.591 179.759 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.3 29.38 12.51 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -179.89 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.8 t -120.02 133.72 65.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.841 0.353 . . . . 0.0 110.075 179.95 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.488 ' O ' ' OD1' ' A' ' 16' ' ' ASP . 43.3 p30 -79.7 141.59 36.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.553 -179.978 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -128.42 -112.29 1.65 Allowed Glycine 0 CA--C 1.535 1.327 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 -179.923 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -75.02 150.05 37.51 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 122.627 2.218 . . . . 0.0 112.978 -179.329 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -111.24 148.97 31.69 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.415 179.694 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.471 ' CD2' HD11 ' A' ' 37' ' ' ILE . 34.7 t80 -117.44 104.58 49.67 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.66 -179.817 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.83 131.43 15.76 Favored 'Trans proline' 0 N--CA 1.489 1.229 0 C-N-CA 121.371 1.381 . . . . 0.0 111.942 -178.905 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 83.4 mt -88.97 46.03 1.35 Allowed 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.082 -178.67 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -55.99 -32.01 63.55 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.668 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.622 HD11 ' HG2' ' B' ' 265' ' ' GLN . 69.4 mt -69.75 142.78 53.2 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.654 179.436 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 97.8 p -63.5 -16.86 61.91 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.327 -178.917 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.5 m -145.15 145.42 31.36 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.694 -0.403 . . . . 0.0 110.845 179.61 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.677 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -136.54 127.82 28.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.662 179.327 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.519 HD13 ' HD3' ' A' ' 50' ' ' LYS . 40.0 tp -114.39 123.92 50.68 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -178.156 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.677 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 54.3 m-85 -97.39 133.59 41.78 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.987 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 177.09 -177.7 48.25 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 119.533 -1.318 . . . . 0.0 112.871 179.609 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.727 ' NH1' ' H ' ' B' ' 231' ' ' GLN . 23.6 ttp85 -89.25 -23.79 22.25 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.946 -0.627 . . . . 0.0 110.994 179.944 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.71 152.16 45.59 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 -179.823 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.541 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.6 tp -64.12 -41.26 91.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.104 0.478 . . . . 0.0 110.195 179.45 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.541 ' N ' HG23 ' A' ' 33' ' ' ILE . 83.1 tt0 -51.37 -17.49 0.77 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.972 -179.764 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 24.0 m -75.08 139.08 42.55 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.493 179.986 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.502 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 57.1 m-20 -61.13 -32.81 72.5 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 -179.445 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.673 HD12 ' CE2' ' A' ' 29' ' ' PHE . 94.2 mt -123.03 116.98 50.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 177.44 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.1 ttp180 -103.95 131.95 50.68 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.397 -178.425 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.8 HD13 ' CZ ' ' A' ' 93' ' ' ARG . 80.0 mt -117.34 132.26 67.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.086 0.47 . . . . 0.0 110.012 -179.41 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -76.71 30.93 0.13 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.77 -177.857 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.677 HD22 HH22 ' B' ' 245' ' ' ARG . 33.3 mt -103.2 131.84 21.72 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.727 179.247 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.96 -10.01 24.22 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.531 2.154 . . . . 0.0 112.642 -179.519 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.434 HG21 ' CE2' ' B' ' 241' ' ' PHE . 22.1 m -97.62 7.22 8.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.872 -179.989 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.499 ' CG2' ' NH2' ' A' ' 93' ' ' ARG . 28.6 t -95.09 134.61 31.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.202 179.236 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.3 t -73.44 171.16 13.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.409 0.623 . . . . 0.0 111.54 -179.152 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -63.5 -42.88 98.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.8 -179.053 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.652 ' O ' ' N ' ' A' ' 49' ' ' CYS . 98.3 mt-30 -113.89 -21.19 10.76 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.384 -179.612 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.0 t60 41.04 -74.94 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.957 179.621 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.828 ' SG ' HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -140.29 141.75 35.75 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.537 -179.201 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.519 ' HD3' HD13 ' A' ' 28' ' ' LEU . 29.1 ttpt -128.02 133.03 49.08 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.639 178.795 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.411 HD11 HD12 ' A' ' 82' ' ' LEU . 18.5 tt -112.06 134.46 54.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -179.872 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -118.15 132.81 56.31 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 -179.875 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.89 HG23 ' NH1' ' A' ' 5' ' ' ARG . 98.3 mt -112.21 117.89 56.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.664 0.745 . . . . 0.0 112.613 -179.135 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.452 ' O ' ' N ' ' A' ' 56' ' ' GLN . 91.4 m-70 -116.65 139.63 50.31 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.211 178.808 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 54' ' ' HIS . 82.6 tt0 -40.13 -30.0 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.252 0.548 . . . . 0.0 109.634 -179.295 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.477 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 60.1 tt0 -65.34 -68.21 0.38 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.053 179.118 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.477 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 3.4 tp10 -154.15 -172.95 4.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.833 -178.976 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.554 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -107.24 130.02 54.8 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.827 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.6 mt -120.05 129.65 75.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.437 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.828 HD11 ' SG ' ' A' ' 49' ' ' CYS . 45.2 tp -100.17 127.88 46.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.209 179.532 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -114.97 137.79 51.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.502 -179.877 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.699 ' ND2' ' H ' ' A' ' 69' ' ' THR . 28.9 t-20 -100.27 108.24 20.26 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.755 0.312 . . . . 0.0 111.825 179.802 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -99.21 -7.39 26.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.995 179.454 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.36 102.22 13.81 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.733 0.301 . . . . 0.0 111.112 -179.742 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.1 m -83.99 -27.69 28.25 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.643 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.769 HG21 ' O ' ' B' ' 234' ' ' TPO . 3.3 m -64.24 -48.66 74.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.604 179.769 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.499 ' OD1' HG22 ' B' ' 236' ' ' VAL . 56.8 m-80 -140.13 95.31 8.47 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.02 -179.899 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.498 ' HB2' HG13 ' A' ' 75' ' ' VAL . 46.4 Cg_exo -56.78 144.6 86.73 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.173 1.915 . . . . 0.0 112.534 -179.765 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.699 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 18.3 m -75.79 141.79 42.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.473 179.248 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -103.57 140.98 36.8 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.523 -179.73 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 55.7 t -129.57 132.44 66.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.966 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 51.38 31.72 7.58 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.184 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.9 28.13 63.29 Favored Glycine 0 CA--C 1.534 1.25 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.088 179.636 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 35.0 t -142.35 141.65 32.36 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 117.274 0.537 . . . . 0.0 111.451 179.945 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.498 HG13 ' HB2' ' A' ' 68' ' ' PRO . 54.1 t -69.79 141.5 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.109 179.946 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.48 HD13 HD23 ' A' ' 60' ' ' LEU . 5.1 pt -116.22 75.83 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.557 179.233 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -65.67 -26.22 67.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.84 0.352 . . . . 0.0 110.26 179.832 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -112.18 160.98 28.08 Favored Pre-proline 0 CA--C 1.532 0.26 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.376 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.8 140.24 94.24 Favored 'Trans proline' 0 N--CA 1.499 1.827 0 C-N-CA 121.46 1.44 . . . . 0.0 111.994 179.852 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.3 t -133.61 136.32 54.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.999 179.944 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -74.9 130.44 39.41 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 178.764 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.451 HD11 ' HB2' ' A' ' 60' ' ' LEU . 95.0 mt -84.1 140.64 31.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.161 0.505 . . . . 0.0 111.611 -179.607 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -129.33 151.24 50.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.371 179.69 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -54.69 119.0 4.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.704 -179.225 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.66 -13.33 35.47 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 179.873 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -68.85 134.22 49.36 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.337 -0.545 . . . . 0.0 109.762 179.631 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.449 HG22 ' HG2' ' A' ' 96' ' ' ARG . 54.3 t -109.38 132.23 58.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.139 -178.425 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 81.6 mt -103.82 131.06 53.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.844 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.5 m -118.72 125.73 50.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.468 0.651 . . . . 0.0 111.823 -179.607 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.522 ' O ' ' N ' ' A' ' 93' ' ' ARG . 89.3 mt -118.1 123.7 72.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.535 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.473 HG22 ' N ' ' A' ' 92' ' ' ASP . 46.7 mm 40.78 -108.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.205 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.473 ' N ' HG22 ' A' ' 91' ' ' ILE . 45.5 t0 -111.28 12.68 21.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.253 0.549 . . . . 0.0 110.132 178.829 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.8 ' CZ ' HD13 ' A' ' 39' ' ' ILE . 18.8 mtm105 -112.28 139.6 47.7 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.862 179.715 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.414 ' HB3' HD12 ' A' ' 10' ' ' ILE . 37.4 t -135.54 145.54 47.13 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.775 178.976 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.61 ' HB3' HD11 ' A' ' 7' ' ' LEU . 46.1 m-85 -124.15 122.6 38.26 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.87 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.476 ' O ' HD12 ' A' ' 7' ' ' LEU . 99.7 mtt180 -86.35 132.74 33.89 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.2 -0.6 . . . . 0.0 111.387 -179.324 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.516 ' CZ ' ' OD1' ' A' ' 99' ' ' ASN . 93.8 t80 -95.5 124.16 39.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.969 179.485 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -139.81 127.18 21.38 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.257 -0.577 . . . . 0.0 111.51 -179.161 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.516 ' OD1' ' CZ ' ' A' ' 97' ' ' TYR . 92.3 m-20 -102.97 139.91 37.92 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.977 -179.754 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.448 179.462 . . . . . . . . 0 0 . 1 . 046 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 18.8 m . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.601 0.238 . . . . 0.0 111.259 . . . . . . . . . 0 0 . 1 . 046 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' B' ' 231' ' ' GLN . 64.2 t0 -62.07 116.94 5.36 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.211 179.925 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . 0.497 ' O ' ' CB ' ' B' ' 231' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.727 ' H ' ' NH1' ' A' ' 31' ' ' ARG . 4.0 mt-30 153.26 -21.34 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 O-C-N 123.723 0.639 . . . . 0.0 110.421 179.122 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' B' ' 231' ' ' GLN . . . -51.26 -160.58 0.01 OUTLIER Glycine 0 CA--C 1.529 0.928 0 CA-C-N 115.78 -0.646 . . . . 0.0 112.129 -179.283 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -61.29 153.3 66.39 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 123.759 2.972 . . . . 0.0 112.947 -179.769 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.769 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -71.77 141.24 37.05 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.368 2.045 . . . . 0.0 114.41 -178.752 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.499 HG22 ' OD1' ' A' ' 67' ' ' ASN . 0.5 OUTLIER -69.28 137.73 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 114.38 -1.282 . . . . 0.0 110.445 179.991 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 6.8 t -72.86 134.74 44.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.384 -179.687 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . 0.611 ' P ' ' HG1' ' B' ' 240' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . 0.414 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 44.3 Cg_exo -56.83 -29.5 81.47 Favored 'Trans proline' 0 N--CA 1.503 2.043 0 C-N-CA 123.484 2.789 . . . . 0.0 114.31 -178.81 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . 0.611 ' HG1' ' P ' ' B' ' 238' ' ' TPO . 7.7 p -74.76 -38.89 62.08 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.154 -0.619 . . . . 0.0 110.02 179.071 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.485 ' CZ ' ' NH2' ' B' ' 245' ' ' ARG . 66.6 t80 -58.71 -45.3 89.85 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.696 -179.294 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 95.6 mt -64.91 -40.66 95.42 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.838 0.351 . . . . 0.0 111.209 179.681 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -64.33 -44.06 92.71 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.088 -179.025 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 62.8 ttm-85 -60.49 -42.53 96.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.264 0.554 . . . . 0.0 109.886 179.556 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.677 HH22 HD22 ' A' ' 41' ' ' LEU . 48.5 ttm-85 -60.62 -43.18 97.78 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.127 -178.965 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.02 -38.64 89.44 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.35 -179.516 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 15.6 t -65.91 -42.99 89.46 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 177.536 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . 0.461 ' O ' ' N ' ' B' ' 252' ' ' LEU . 69.2 tp60 -59.4 -38.02 79.5 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.61 179.845 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 43.3 t -60.82 -46.01 96.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.614 -0.435 . . . . 0.0 109.873 179.315 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -60.46 -27.12 67.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.187 0.518 . . . . 0.0 109.748 179.376 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -94.95 -12.23 27.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.158 179.167 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.983 HD22 HH21 ' A' ' 12' ' ' ARG . 44.6 tp -73.4 137.57 44.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.695 -178.967 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -95.6 128.6 42.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.008 178.899 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -64.58 -23.28 67.22 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.979 -179.438 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 45.0 p-10 -75.42 0.78 15.83 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.636 -179.676 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.46 ' O ' ' C ' ' B' ' 257' ' ' LYS . 97.3 m-20 -89.87 -3.83 57.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.353 179.504 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . 0.608 ' O ' ' N ' ' B' ' 259' ' ' ASP . 86.6 tttt 34.34 -110.04 0.05 OUTLIER 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.015 -179.47 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.568 ' C ' ' O ' ' B' ' 257' ' ' LYS . 98.4 m-20 -12.57 79.26 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 O-C-N 123.885 0.741 . . . . 0.0 110.888 -179.889 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.608 ' N ' ' O ' ' B' ' 257' ' ' LYS . 58.9 t0 -84.62 83.09 8.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.534 -178.635 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.672 ' O ' HG23 ' A' ' 39' ' ' ILE . 97.0 mt-10 55.68 3.68 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.685 178.198 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.469 ' CD1' HG23 ' A' ' 9' ' ' THR . 64.5 mt -118.4 134.01 63.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.078 -179.743 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 40.7 t -128.24 134.85 64.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.996 -179.705 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -96.03 119.0 33.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.554 -178.904 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -65.22 -44.46 88.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.924 178.871 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . 0.622 ' HG2' HD11 ' A' ' 24' ' ' LEU . 4.4 mp0 -97.35 158.38 33.28 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.382 -179.728 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -69.53 145.74 59.42 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 123.022 2.481 . . . . 0.0 113.398 -179.264 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 48.6 pt . . . . . 0 C--N 1.332 -0.155 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.434 179.061 . . . . . . . . 0 0 . 1 . 047 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo . . . . . 0 N--CA 1.496 1.64 0 CA-C-O 120.766 0.236 . . . . 0.0 111.963 . . . . . . . . . 0 0 . 1 . 047 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 77.0 p -106.03 -39.44 5.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.439 -179.783 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.4 mtt85 -96.46 119.59 35.22 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.784 179.875 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.448 ' NH2' ' OE2' ' A' ' 100' ' ' GLU . 90.9 mtm180 -132.85 141.42 48.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.936 0.398 . . . . 0.0 111.323 -179.292 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.846 HD11 HD11 ' A' ' 22' ' ' LEU . 64.0 mt -114.35 142.37 46.41 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.669 -179.375 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 76.6 t -117.05 130.55 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.651 178.833 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.8 m -87.28 113.58 23.13 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -178.163 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.489 HD12 ' HB2' ' A' ' 94' ' ' SER . 95.1 mt -80.9 140.05 17.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.404 177.781 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -88.21 155.42 19.77 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 178.36 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.693 HH12 ' NH1' ' B' ' 245' ' ' ARG . 75.1 mtp85 -59.29 -26.5 65.01 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.235 -178.899 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.0 m -76.9 -18.75 58.1 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.034 0.445 . . . . 0.0 110.667 179.328 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.08 33.99 4.73 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.196 -1.161 . . . . 0.0 110.196 -179.718 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.2 t -124.13 129.91 73.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.478 0.18 . . . . 0.0 110.533 179.991 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -73.3 138.02 45.19 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.439 179.265 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -125.96 -117.03 2.13 Favored Glycine 0 CA--C 1.541 1.688 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.323 -179.298 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -75.95 147.67 30.77 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 122.765 2.31 . . . . 0.0 112.384 -178.505 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -108.36 148.66 29.78 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.414 179.913 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.487 ' CD2' HD11 ' A' ' 37' ' ' ILE . 31.7 t80 -118.69 101.28 50.72 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.284 -179.876 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.31 135.04 23.92 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.012 1.808 . . . . 0.0 111.629 -179.266 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.846 HD11 HD11 ' A' ' 7' ' ' LEU . 95.6 mt -91.03 49.49 1.65 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.069 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 34.4 t -61.71 -19.1 62.02 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.508 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.734 HD11 ' HG2' ' B' ' 265' ' ' GLN . 80.7 mt -80.14 138.0 36.83 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.057 -179.895 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.1 m -64.76 -19.79 66.0 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.994 -179.486 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.505 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 39.0 m -135.45 135.2 40.34 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.618 -179.405 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.683 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 5.4 t -130.38 120.75 24.76 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.163 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.513 HD21 ' OE1' ' A' ' 47' ' ' GLN . 62.8 tp -118.99 128.77 54.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.308 -178.723 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.743 ' CE2' HD12 ' A' ' 37' ' ' ILE . 3.9 m-85 -105.05 142.59 34.56 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -179.875 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 146.83 -174.36 26.69 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.887 178.587 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.429 ' NH2' ' O ' ' B' ' 233' ' ' PRO . 46.3 mtm180 -74.03 -33.03 63.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 179.42 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.504 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -41.85 144.81 0.8 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 -179.05 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.556 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.3 tp -67.42 -41.86 86.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 O-C-N 122.219 -0.577 . . . . 0.0 109.824 179.483 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.556 ' N ' HG23 ' A' ' 33' ' ' ILE . 76.4 mm-40 -58.15 -23.3 54.78 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.178 179.374 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.504 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 57.4 m -50.9 118.24 3.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.077 179.969 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.505 ' OD2' ' O ' ' A' ' 26' ' ' THR . 57.6 m-20 -57.52 -30.6 65.29 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.817 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.743 HD12 ' CE2' ' A' ' 29' ' ' PHE . 87.8 mt -125.15 118.86 54.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.239 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -104.74 134.74 47.39 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.913 -178.962 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 95.7 mt -114.57 127.23 72.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 121.2 0.524 . . . . 0.0 110.788 179.294 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -70.74 39.37 0.05 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.289 -0.869 . . . . 0.0 113.115 -178.322 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.808 HD11 ' NH2' ' A' ' 93' ' ' ARG . 79.3 mt -117.02 130.99 24.21 Favored Pre-proline 0 C--N 1.326 -0.449 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.369 179.738 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -72.7 -9.19 23.58 Favored 'Trans proline' 0 N--CA 1.489 1.235 0 C-N-CA 122.122 1.881 . . . . 0.0 112.162 179.522 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.458 HG21 ' CE2' ' B' ' 241' ' ' PHE . 28.0 m -99.11 1.98 10.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.894 179.808 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.3 t -86.92 134.93 26.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.268 0.556 . . . . 0.0 110.315 179.412 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.8 m -65.06 160.02 21.95 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.742 -178.987 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -63.72 -43.63 95.98 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.276 -179.085 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.636 ' O ' ' N ' ' A' ' 49' ' ' CYS . 12.1 mm100 -112.75 -23.43 10.17 Favored 'General case' 0 C--O 1.227 -0.123 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.424 179.929 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.3 t60 37.14 -76.75 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.078 -0.964 . . . . 0.0 112.932 179.855 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.636 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.0 136.1 47.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.337 0.589 . . . . 0.0 112.28 -178.539 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -125.39 129.09 49.2 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.781 179.683 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 93.8 mt -114.11 133.71 59.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.181 178.781 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -115.25 128.89 56.43 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.532 179.013 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 51.8 mm -99.0 118.66 45.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.989 -179.807 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.435 ' O ' ' C ' ' A' ' 55' ' ' GLU . 99.5 m-70 -120.31 135.09 55.13 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.33 179.646 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 54' ' ' HIS . 82.6 tt0 -40.46 -32.03 0.18 Allowed 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -179.675 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.434 ' N ' ' C ' ' A' ' 54' ' ' HIS . 88.7 mt-30 -67.53 -68.48 0.38 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.041 179.236 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.479 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 5.1 tp10 -153.84 -167.05 2.55 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.369 -179.067 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.479 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -119.44 130.4 55.25 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.435 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 99.5 mt -117.97 131.16 71.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.634 0.731 . . . . 0.0 111.981 -178.433 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.7 tp -99.78 127.53 45.93 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.213 179.624 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -110.16 133.64 53.01 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.208 -178.881 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 61.4 t-20 -93.25 104.57 16.74 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.948 179.889 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -100.93 -11.93 19.35 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 120.995 -0.282 . . . . 0.0 111.594 179.812 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 m -68.29 99.78 0.96 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.421 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 87.9 p -85.38 -10.11 56.7 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.525 -179.774 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.625 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.2 OUTLIER -100.19 -43.12 6.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.117 179.88 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -133.84 95.61 17.17 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.991 -179.709 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.0 141.2 86.72 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.395 2.063 . . . . 0.0 112.882 -179.735 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.2 m -74.07 136.63 43.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.283 179.174 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -100.6 139.31 36.47 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.212 179.362 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.7 t -131.62 133.37 61.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 178.76 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 54.52 32.68 17.34 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -178.844 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.3 27.22 72.02 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.115 179.487 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 28.5 t -141.29 136.96 32.11 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 117.377 0.589 . . . . 0.0 111.501 -179.966 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -70.06 138.58 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.862 179.652 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.3 pt -114.08 91.57 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 121.208 0.528 . . . . 0.0 111.401 179.664 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -66.49 -26.86 67.38 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.823 178.494 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.495 ' N ' ' OE1' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -119.21 162.07 33.66 Favored Pre-proline 0 N--CA 1.465 0.295 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.81 179.71 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.29 151.09 86.84 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.694 2.263 . . . . 0.0 112.388 -179.388 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 36.0 m -142.05 148.69 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.107 0 CA-C-O 121.273 0.559 . . . . 0.0 112.107 -179.483 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -75.86 127.54 33.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.018 178.865 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 82' ' ' LEU . 92.9 mt -75.55 140.06 42.5 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.488 179.609 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -130.51 146.08 51.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.2 179.515 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.592 ' HD1' ' C ' ' A' ' 99' ' ' ASN . 7.2 t60 -51.4 119.62 4.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.133 -179.178 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.81 -12.19 49.8 Favored Glycine 0 CA--C 1.522 0.51 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.938 179.463 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -69.66 137.22 51.99 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.316 -0.553 . . . . 0.0 110.204 179.705 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.492 ' O ' HG13 ' A' ' 87' ' ' VAL . 8.7 p -106.89 134.86 47.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.876 -178.667 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 93.4 mt -103.27 129.48 55.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 177.696 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 47.5 m -123.98 124.81 43.4 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.577 0.704 . . . . 0.0 112.783 -178.171 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.425 ' O ' ' N ' ' A' ' 92' ' ' ASP . 94.0 mt -111.6 124.2 68.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.005 178.102 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.621 HG22 ' NH2' ' B' ' 245' ' ' ARG . 64.4 mt 39.36 -96.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.987 -179.201 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.49 ' CB ' ' NH2' ' B' ' 245' ' ' ARG . 52.8 t0 -120.51 18.15 12.08 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.792 0.33 . . . . 0.0 111.888 -178.791 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.832 HH22 ' NH1' ' B' ' 245' ' ' ARG . 1.1 ptp85 -131.25 144.29 51.19 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.067 178.679 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.489 ' HB2' HD12 ' A' ' 10' ' ' ILE . 38.1 m -136.14 152.83 51.23 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.298 0.571 . . . . 0.0 111.232 -179.913 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.419 ' HE1' HD12 ' A' ' 90' ' ' ILE . 65.1 m-85 -122.95 122.09 37.71 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.629 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 45.2 ttm180 -78.95 131.77 36.47 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.216 -178.726 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -95.93 119.62 34.75 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.76 179.924 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.41 ' HG3' ' CE1' ' A' ' 84' ' ' HIS . 79.7 tt0 -122.5 122.21 38.39 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.262 -179.969 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.592 ' C ' ' HD1' ' A' ' 84' ' ' HIS . 59.4 t-20 -121.67 105.32 10.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.615 -179.651 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.448 ' OE2' ' NH2' ' A' ' 6' ' ' ARG . 96.1 mt-10 . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.493 178.625 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . 0.515 ' O ' ' CB ' ' B' ' 229' ' ' ASP . 86.7 t . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.759 0.314 . . . . 0.0 111.437 . . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' B' ' 230' ' ' SEP . 10.0 t0 83.81 55.38 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.938 179.424 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . 0.53 ' CB ' ' O ' ' B' ' 229' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.425 ' NE2' ' P ' ' B' ' 230' ' ' SEP . 2.7 mt-30 -145.36 61.31 1.29 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.61 179.446 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . 0.423 ' C ' HH12 ' A' ' 31' ' ' ARG . . . -110.91 -177.04 20.57 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.874 -179.132 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . 0.429 ' O ' ' NH2' ' A' ' 31' ' ' ARG . 65.4 Cg_endo -71.7 161.14 46.13 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.985 2.457 . . . . 0.0 112.635 -179.643 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.625 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . 0.446 ' HG2' HG12 ' A' ' 43' ' ' VAL . 76.5 Cg_endo -74.08 141.49 29.64 Favored 'Trans proline' 0 C--N 1.299 -2.046 0 C-N-CA 121.845 1.697 . . . . 0.0 113.156 -179.555 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.548 ' CG2' HG22 ' A' ' 66' ' ' THR . 67.9 t -66.93 133.27 31.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.771 179.836 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -64.35 131.63 47.81 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.036 0.445 . . . . 0.0 110.555 -179.468 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 047 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -62.11 -22.37 74.09 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.774 2.316 . . . . 0.0 112.018 179.707 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 2.8 m -75.96 -42.39 48.64 Favored 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.532 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.458 ' CE2' HG21 ' A' ' 43' ' ' VAL . 79.9 t80 -58.16 -46.11 86.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.143 -179.788 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.704 HD23 HH21 ' B' ' 245' ' ' ARG . 92.9 mt -63.82 -41.95 97.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.171 0.51 . . . . 0.0 110.851 179.874 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -63.04 -43.0 99.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.979 -179.092 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -61.51 -43.89 98.04 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.271 179.935 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.832 ' NH1' HH22 ' A' ' 93' ' ' ARG . 75.6 mtm180 -63.54 -40.04 95.99 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.881 -178.926 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -61.31 -39.01 88.91 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.263 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 13.5 t -65.91 -45.37 82.18 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.711 0.767 . . . . 0.0 109.496 178.051 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . 0.434 ' O ' ' N ' ' B' ' 252' ' ' LEU . 83.0 mt-30 -62.17 -33.63 74.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.558 179.872 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.512 HG23 ' O ' ' B' ' 245' ' ' ARG . 54.0 t -63.41 -44.43 98.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 119.986 -0.686 . . . . 0.0 109.335 178.761 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -60.91 -27.41 68.17 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.679 179.345 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -95.27 -10.93 28.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.173 179.474 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.434 ' N ' ' O ' ' B' ' 248' ' ' GLN . 44.5 tp -79.81 156.82 27.23 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.581 179.908 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . 0.419 ' N ' ' HG ' ' B' ' 252' ' ' LEU . 88.4 m-20 -109.91 139.95 44.42 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.196 179.436 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -66.52 -27.79 68.04 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.769 0.318 . . . . 0.0 111.076 179.984 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -68.71 -2.72 9.89 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.816 0.341 . . . . 0.0 110.847 179.732 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.43 ' O ' ' C ' ' B' ' 257' ' ' LYS . 96.0 m-20 -86.98 -4.81 59.21 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.533 179.929 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . 0.579 ' O ' ' C ' ' B' ' 258' ' ' ASP . 87.1 tttt 35.83 -109.66 0.05 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.38 -179.883 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.579 ' C ' ' O ' ' B' ' 257' ' ' LYS . 67.1 t0 -13.08 92.81 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 O-C-N 123.691 0.619 . . . . 0.0 111.088 -179.051 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.45 ' C ' ' OE1' ' B' ' 260' ' ' GLU . 39.8 p-10 -91.55 62.26 4.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.2 -179.168 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.45 ' OE1' ' C ' ' B' ' 259' ' ' ASP . 53.5 mp0 63.78 12.96 7.09 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.029 179.443 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 56.6 mt -119.29 130.2 74.26 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 177.89 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 54.1 t -122.69 133.83 67.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.427 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -95.27 122.14 37.66 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.263 0.554 . . . . 0.0 110.685 -178.7 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -62.53 -46.06 90.11 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.564 -179.889 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . 0.734 ' HG2' HD11 ' A' ' 24' ' ' LEU . 3.2 mp0 -94.85 160.71 30.58 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.82 -179.403 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.41 147.49 58.83 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.478 2.119 . . . . 0.0 112.94 -179.695 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 47.9 pt . . . . . 0 N--CA 1.466 0.346 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.666 179.13 . . . . . . . . 0 0 . 1 . 048 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo . . . . . 0 N--CA 1.495 1.597 0 CA-C-O 120.848 0.27 . . . . 0.0 112.701 . . . . . . . . . 0 0 . 1 . 048 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.25 -40.18 0.74 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.481 179.651 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.571 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 94.9 mtt-85 -98.6 122.09 41.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.128 -179.381 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.578 ' NH2' ' OE2' ' A' ' 98' ' ' GLU . 33.6 ptt-85 -146.01 158.38 43.87 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.103 -0.639 . . . . 0.0 112.009 179.937 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.3 mt -118.86 144.85 46.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.261 179.604 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.826 HG13 ' NE2' ' A' ' 19' ' ' HIS . 67.0 t -114.31 125.46 71.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.568 -0.453 . . . . 0.0 109.903 179.446 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.2 m -74.21 134.16 42.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.019 0.438 . . . . 0.0 111.313 -179.689 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.662 HD12 ' OG ' ' A' ' 94' ' ' SER . 97.0 mt -104.0 133.98 46.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.759 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -86.71 154.25 21.11 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.279 -0.568 . . . . 0.0 109.881 179.307 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.472 HH21 HD23 ' B' ' 252' ' ' LEU . 89.9 mtm180 -54.99 -27.74 46.44 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.581 -178.983 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.4 m -81.1 -5.67 57.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.759 0.314 . . . . 0.0 110.589 179.809 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.82 34.09 9.35 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 -179.959 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.8 t -121.08 135.59 60.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.86 0.362 . . . . 0.0 110.91 -179.852 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.463 ' O ' ' OD1' ' A' ' 16' ' ' ASP . 48.7 p-10 -75.97 133.36 40.47 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.459 179.727 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -121.39 -121.15 2.76 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.794 -179.327 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.48 147.24 40.78 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.131 1.888 . . . . 0.0 112.8 -178.871 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.826 ' NE2' HG13 ' A' ' 8' ' ' VAL . 62.0 m170 -109.76 143.37 39.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.635 -179.664 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.588 ' CE2' HD11 ' A' ' 37' ' ' ILE . 37.3 t80 -112.52 99.83 48.4 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.849 -179.717 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -70.6 131.51 20.18 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 C-N-CA 120.912 1.075 . . . . 0.0 110.787 -179.638 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 75.8 mt -85.39 77.36 9.95 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 120.261 -0.575 . . . . 0.0 110.784 -178.749 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 97.3 p -85.56 -10.61 55.68 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.077 178.744 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 52.2 mt -102.57 146.19 28.51 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.312 -179.047 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 94.9 p -65.91 -20.02 66.07 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -178.488 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 27.6 m -133.25 133.06 42.18 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.481 -0.487 . . . . 0.0 111.359 -179.777 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.0 t -122.71 116.84 24.44 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.589 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 56.8 tp -113.61 129.37 56.57 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -177.673 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.499 ' O ' ' O ' ' A' ' 47' ' ' GLN . 72.6 m-85 -109.77 131.51 55.0 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.449 179.804 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 160.46 -173.41 37.02 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.882 179.072 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.627 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 75.9 mtm-85 -80.89 -28.52 35.9 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.243 179.364 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.553 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -46.35 146.41 3.16 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -178.645 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.49 HG23 ' N ' ' A' ' 34' ' ' GLU . 9.9 tp -67.72 -41.91 85.78 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 CA-C-O 120.843 0.354 . . . . 0.0 110.285 179.823 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.49 ' N ' HG23 ' A' ' 33' ' ' ILE . 81.7 tt0 -59.03 -21.34 58.92 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.462 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.553 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 22.4 m -55.84 123.46 14.32 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.401 -179.96 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -62.08 -30.96 71.36 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.397 -179.71 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.588 HD11 ' CE2' ' A' ' 20' ' ' PHE . 47.1 mm -124.61 121.13 60.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.17 178.649 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.417 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 60.0 mtm180 -108.81 137.25 47.05 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 120.279 -0.569 . . . . 0.0 111.386 -179.977 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 89.6 mt -121.19 129.31 75.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.047 179.349 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -74.89 32.34 0.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -177.941 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.484 HD23 ' HA ' ' A' ' 41' ' ' LEU . 25.8 mt -98.27 129.07 31.47 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.317 179.272 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -73.14 -5.32 16.97 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 122.317 2.012 . . . . 0.0 112.368 -179.941 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.628 HG23 HD13 ' A' ' 91' ' ' ILE . 27.9 m -107.63 8.71 9.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.356 179.81 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.627 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 13.7 t -95.15 137.6 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.601 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.7 m -69.05 167.28 16.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.479 0.657 . . . . 0.0 112.381 -178.095 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.3 mttp -63.99 -41.65 97.45 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.033 -179.577 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.639 ' O ' ' N ' ' A' ' 49' ' ' CYS . 96.2 mt-30 -115.62 -25.24 7.93 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.098 0.475 . . . . 0.0 110.245 179.864 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.825 ' NE2' HG23 ' A' ' 90' ' ' ILE . 32.1 t60 38.39 -72.44 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 178.912 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.639 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -134.83 139.26 44.93 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -177.967 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.9 ttpp -132.95 133.95 43.88 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.539 178.827 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 92.3 mt -113.27 135.7 51.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.883 179.683 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.408 ' CD ' ' NE2' ' A' ' 54' ' ' HIS . 79.8 tt0 -117.32 132.12 56.67 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.255 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.1 mm -103.6 118.55 50.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.403 -0.519 . . . . 0.0 112.295 -177.924 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.434 ' O ' ' C ' ' A' ' 55' ' ' GLU . 97.9 m-70 -117.66 134.22 55.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.11 178.052 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 54' ' ' HIS . 84.6 tt0 -40.15 -35.47 0.4 Allowed 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.038 -179.085 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -64.27 -66.7 0.51 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.945 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -150.43 -167.96 2.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.286 -179.718 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -119.2 134.61 55.11 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.536 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 98.0 mt -120.2 130.77 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 121.385 0.612 . . . . 0.0 112.615 -178.729 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 21.7 tp -98.72 128.44 44.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.084 179.624 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -109.84 134.62 51.85 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.051 -179.346 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.527 HD21 ' CA ' ' A' ' 68' ' ' PRO . 62.7 t-20 -95.65 104.62 16.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.802 -178.848 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -97.19 -10.46 25.82 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.373 179.535 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 10.3 t -78.01 98.93 5.88 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.666 -179.477 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.2 m -76.09 -40.26 53.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.249 0.547 . . . . 0.0 110.055 178.509 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.37 -41.35 85.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.451 -179.671 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.628 ' OD1' HG23 ' B' ' 236' ' ' VAL . 59.8 m-20 -140.51 93.29 8.81 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.718 -179.895 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.551 ' HB2' HG13 ' A' ' 75' ' ' VAL . 40.6 Cg_exo -56.56 147.55 69.15 Favored 'Trans proline' 0 N--CA 1.498 1.784 0 C-N-CA 122.551 2.167 . . . . 0.0 113.029 -179.064 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.406 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 3.9 m -72.25 136.83 46.44 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.472 179.227 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -100.43 141.56 33.11 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.578 179.49 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.571 HG13 ' OD1' ' A' ' 86' ' ' ASP . 56.1 t -128.54 135.97 61.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.236 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 50.97 31.87 6.79 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.464 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.94 29.27 63.18 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.028 179.569 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 12.1 p -141.34 141.0 33.87 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 117.139 0.469 . . . . 0.0 111.412 179.878 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.551 HG13 ' HB2' ' A' ' 68' ' ' PRO . 53.5 t -74.76 136.5 25.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-O 121.115 0.483 . . . . 0.0 111.74 -179.854 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.958 HD13 ' O ' ' A' ' 76' ' ' ILE . 0.0 OUTLIER -137.15 119.45 19.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.824 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.401 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 38.3 p-10 -101.17 -0.42 36.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.922 -178.038 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.91 ' O ' HD11 ' A' ' 76' ' ' ILE . 5.2 pt-20 -119.93 165.09 18.87 Favored Pre-proline 0 C--N 1.331 -0.225 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.256 179.965 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.98 141.86 96.36 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 121.747 1.632 . . . . 0.0 111.866 179.772 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.7 p -140.21 140.31 35.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.725 -179.879 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -78.96 130.3 35.41 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.961 179.542 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 82' ' ' LEU . 96.8 mt -78.87 140.19 38.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.01 0.433 . . . . 0.0 110.728 179.96 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -129.7 149.38 51.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.329 179.978 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.441 ' C ' ' CD2' ' A' ' 84' ' ' HIS . 7.3 t60 -55.62 116.6 2.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.012 0.434 . . . . 0.0 110.885 -179.168 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.44 -16.41 37.88 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -179.751 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.571 ' OD1' HG13 ' A' ' 71' ' ' VAL . 53.7 t0 -67.68 131.07 44.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.717 0.294 . . . . 0.0 110.231 179.314 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.542 HG22 ' HG2' ' A' ' 96' ' ' ARG . 76.7 t -104.92 135.54 42.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.937 0.399 . . . . 0.0 111.298 -178.8 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 88.4 mt -104.13 130.28 55.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.443 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.8 m -122.53 123.58 41.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.828 0.823 . . . . 0.0 112.836 -178.884 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.825 HG23 ' NE2' ' A' ' 48' ' ' HIS . 86.9 mt -109.38 125.95 66.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 114.236 -1.347 . . . . 0.0 108.281 178.274 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.68 HG22 ' N ' ' A' ' 92' ' ' ASP . 97.8 mt 29.42 -101.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.932 0.396 . . . . 0.0 111.578 -179.165 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.68 ' N ' HG22 ' A' ' 91' ' ' ILE . 35.6 p-10 -105.54 11.42 32.45 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.137 -179.035 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.877 ' NE ' HD11 ' B' ' 261' ' ' ILE . 8.7 mtp85 -130.2 145.2 51.71 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.045 -179.55 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.662 ' OG ' HD12 ' A' ' 10' ' ' ILE . 21.1 p -140.64 153.24 45.95 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.178 0.513 . . . . 0.0 110.699 179.747 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -129.77 127.41 40.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.953 179.814 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.542 ' HG2' HG22 ' A' ' 87' ' ' VAL . 99.9 mtt180 -82.9 133.64 35.11 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.376 -0.529 . . . . 0.0 110.182 179.979 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.571 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 85.0 t80 -94.61 126.21 39.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.485 -179.24 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.578 ' OE2' ' NH2' ' A' ' 6' ' ' ARG . 82.5 tt0 -135.5 118.88 16.77 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.823 179.546 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.42 ' C ' ' OD1' ' A' ' 99' ' ' ASN . 55.5 p30 -104.31 6.5 35.33 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.67 -179.998 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.507 ' O ' ' OE2' ' A' ' 98' ' ' GLU . 82.2 tt0 . . . . . 0 C--N 1.327 -0.377 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.84 179.633 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 40.6 t . . . . . 0 N--CA 1.454 -0.272 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 . . . . . . . . . 0 0 . 1 . 048 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.439 ' C ' ' H ' ' B' ' 231' ' ' GLN . 97.8 m-20 -50.83 114.16 1.09 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.303 -179.452 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 048 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.439 ' H ' ' C ' ' B' ' 229' ' ' ASP . 99.5 mm-40 -101.48 -25.19 14.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.057 -179.871 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -68.91 153.29 52.87 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -179.161 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.76 132.58 17.36 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.764 2.31 . . . . 0.0 112.343 179.785 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.471 HG21 ' C ' ' A' ' 44' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -77.23 146.55 25.26 Favored 'Trans proline' 0 C--N 1.317 -1.089 0 C-N-CA 121.719 1.613 . . . . 0.0 111.971 177.303 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.628 HG23 ' OD1' ' A' ' 67' ' ' ASN . 4.8 p -64.73 141.51 18.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.548 -179.606 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . 0.465 ' SG ' ' CD2' ' B' ' 241' ' ' PHE . 2.8 t -70.27 130.46 42.06 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.217 -179.594 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 048 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.38 -29.11 56.87 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.53 2.154 . . . . 0.0 112.062 178.961 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 87.8 m -64.34 -46.42 83.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.433 0.635 . . . . 0.0 109.317 178.771 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.474 ' HZ ' HD22 ' A' ' 41' ' ' LEU . 85.4 t80 -58.02 -47.5 82.87 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.546 -179.378 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.4 ' HA ' HD23 ' B' ' 242' ' ' LEU . 96.9 mt -62.8 -41.92 99.49 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.89 -178.584 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -65.09 -39.02 92.58 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.224 -179.271 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . 0.431 ' O ' ' OG ' ' B' ' 247' ' ' SER . 99.5 mtt180 -63.41 -40.24 96.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.085 0.469 . . . . 0.0 109.835 179.884 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . . . . . . . . . 71.2 ttp85 -61.21 -43.16 99.32 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.845 -179.505 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.37 -40.62 97.05 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.321 -179.652 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 79.4 p -64.51 -42.84 95.55 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.726 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -61.66 -39.12 90.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.193 -179.991 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 54.3 t -64.32 -44.55 97.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.303 179.059 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -60.75 -34.06 73.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.314 179.975 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -89.95 -4.79 57.29 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.546 179.525 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.472 HD23 HH21 ' A' ' 12' ' ' ARG . 56.1 tp -113.89 112.96 24.19 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.984 0.421 . . . . 0.0 110.926 179.933 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . 0.477 ' C ' ' H ' ' B' ' 255' ' ' ASP . 28.3 m-80 -82.42 -162.9 0.62 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.108 -178.837 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 39.3 p-10 -54.22 -5.15 0.07 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.192 -178.907 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . 0.477 ' H ' ' C ' ' B' ' 253' ' ' ASN . 99.5 m-20 -63.62 -11.54 25.91 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.011 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.74 ' O ' ' N ' ' B' ' 258' ' ' ASP . 27.7 t70 -51.12 -31.17 18.5 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 114.749 -1.114 . . . . 0.0 112.014 -179.556 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . 0.499 ' C ' ' O ' ' B' ' 256' ' ' ASP . 98.6 mttt -7.86 -48.62 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.265 0 O-C-N 123.896 0.747 . . . . 0.0 112.682 -178.635 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.74 ' N ' ' O ' ' B' ' 256' ' ' ASP . 50.6 t0 -104.53 85.38 2.33 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 176.215 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.619 ' O ' ' NH1' ' A' ' 93' ' ' ARG . 26.6 t0 -96.11 72.86 2.93 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -175.825 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.475 ' OE1' HD21 ' A' ' 41' ' ' LEU . 99.2 mt-10 54.15 13.69 0.63 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 115.316 1.598 . . . . 0.0 115.316 176.11 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.877 HD11 ' NE ' ' A' ' 93' ' ' ARG . 74.2 mt -118.21 132.89 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 119.434 1.016 . . . . 0.0 109.274 178.388 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 55.9 t -125.11 135.21 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-O 120.932 0.396 . . . . 0.0 111.191 -179.625 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -98.79 119.12 37.01 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.278 0.561 . . . . 0.0 110.581 -179.761 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -66.24 -43.89 85.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.045 179.934 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -103.13 157.98 32.68 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.355 -179.1 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -63.89 155.54 63.45 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 122.949 2.432 . . . . 0.0 112.703 -179.833 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.0 pt . . . . . 0 C--N 1.331 -0.217 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.117 -178.745 . . . . . . . . 0 0 . 1 . 049 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo . . . . . 0 N--CA 1.494 1.551 0 CA-C-O 120.888 0.287 . . . . 0.0 111.944 . . . . . . . . . 0 0 . 1 . 049 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.1 p -117.41 24.94 10.79 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.035 -179.394 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.607 ' HG2' ' HH ' ' A' ' 97' ' ' TYR . 85.6 mtt85 -83.71 123.12 29.52 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.26 -179.865 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -127.45 136.52 51.92 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.23 -179.404 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.524 HD11 ' HB3' ' A' ' 95' ' ' PHE . 25.3 tp -112.67 130.6 55.99 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.836 -179.755 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.561 HG22 ' CE1' ' A' ' 19' ' ' HIS . 47.0 t -108.07 129.15 62.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.914 -179.479 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.0 m -81.05 143.83 32.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.471 0.653 . . . . 0.0 111.921 -179.606 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.8 mm -111.81 135.15 51.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.613 178.729 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.4 ' NZ ' ' HA ' ' B' ' 257' ' ' LYS . 98.2 mttt -89.9 157.27 17.95 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.01 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.514 ' NH2' ' CD1' ' B' ' 252' ' ' LEU . 84.5 mtm180 -58.6 -22.57 56.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.059 -179.466 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.615 ' OG ' HG13 ' B' ' 249' ' ' VAL . 5.2 m -85.08 -9.45 57.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.991 -179.63 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.49 40.24 6.47 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.189 -0.765 . . . . 0.0 111.189 179.716 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 54.6 t -125.89 135.36 64.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.726 0.298 . . . . 0.0 111.627 -179.265 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.441 ' CG ' ' HE2' ' A' ' 19' ' ' HIS . 62.8 t0 -67.68 124.55 23.59 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.163 179.115 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -115.62 -124.8 3.81 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 120.959 -0.639 . . . . 0.0 111.863 -179.18 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -75.82 146.61 30.0 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.31 2.006 . . . . 0.0 113.334 -178.688 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.561 ' CE1' HG22 ' A' ' 8' ' ' VAL . 59.4 m170 -106.1 142.17 36.23 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.563 -179.935 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.414 ' CD2' HD11 ' A' ' 37' ' ' ILE . 44.0 t80 -117.74 106.85 45.35 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.096 179.977 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.29 127.49 12.71 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 121.541 1.494 . . . . 0.0 112.03 -178.382 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 56.3 mt -89.01 43.92 1.18 Allowed 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.35 -178.361 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 65.3 p -67.54 -19.85 65.34 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.554 -0.458 . . . . 0.0 109.849 179.381 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.9 mt -74.39 144.06 44.54 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.61 179.954 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 92.8 p -58.07 -26.08 62.08 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.035 -178.39 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 97.8 m -141.22 138.63 33.44 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.206 -0.598 . . . . 0.0 111.839 -179.113 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.655 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 2.5 t -128.77 121.7 28.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.053 178.393 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.555 HD12 ' O ' ' A' ' 49' ' ' CYS . 52.1 tp -119.74 129.33 54.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.377 -178.167 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.731 ' CE2' HD12 ' A' ' 37' ' ' ILE . 3.0 m-85 -104.68 137.17 42.9 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.473 179.495 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 163.55 -167.46 37.74 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.419 178.883 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.636 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 86.3 mtm-85 -88.05 -27.99 21.64 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.767 0.318 . . . . 0.0 110.263 179.97 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.408 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -55.64 149.87 23.36 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 121.133 -0.556 . . . . 0.0 111.837 -178.168 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.543 ' CD1' ' NH1' ' A' ' 38' ' ' ARG . 10.5 tp -68.09 -41.6 84.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 CA-C-O 120.864 0.364 . . . . 0.0 110.518 179.92 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.467 ' N ' HG23 ' A' ' 33' ' ' ILE . 83.0 tt0 -57.4 -23.34 48.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.226 0.536 . . . . 0.0 110.099 179.77 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.408 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 33.3 m -56.0 126.12 24.47 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.185 179.683 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.436 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 55.0 m-20 -61.04 -33.14 72.82 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.602 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.731 HD12 ' CE2' ' A' ' 29' ' ' PHE . 94.8 mt -123.98 121.9 63.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 177.314 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.543 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 83.1 mtp180 -109.84 139.1 45.29 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.405 -178.544 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 97.4 mt -120.36 130.58 74.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.987 179.004 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.419 ' NE2' ' HA ' ' B' ' 260' ' ' GLU . 19.9 pt20 -79.75 35.67 0.31 Allowed 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -177.768 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.781 HD12 ' CZ ' ' A' ' 93' ' ' ARG . 60.5 mt -112.95 135.17 21.67 Favored Pre-proline 0 C--N 1.328 -0.328 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.112 178.191 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.67 -9.78 26.49 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.629 2.22 . . . . 0.0 113.22 -178.717 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.694 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 1.8 m -96.52 2.0 10.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.444 -179.828 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.636 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 53.2 t -88.3 131.96 34.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.614 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.403 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 1.6 m -63.99 158.39 22.57 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.159 0.504 . . . . 0.0 111.328 -179.106 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -61.42 -42.08 98.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.663 -179.086 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.612 ' O ' ' N ' ' A' ' 49' ' ' CYS . 10.8 mm100 -115.43 -20.23 10.35 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.919 179.677 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.403 ' H ' ' HB3' ' A' ' 45' ' ' SER . 20.5 t60 33.21 -74.54 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 179.082 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.612 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -129.54 133.94 47.49 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -177.608 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -123.93 133.07 53.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.663 179.284 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 98.1 mt -119.49 134.38 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.679 -179.218 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -115.92 127.99 55.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.402 179.154 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.3 mm -100.49 109.86 26.15 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 CA-C-O 121.251 0.548 . . . . 0.0 110.861 -179.481 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.445 ' O ' ' C ' ' A' ' 55' ' ' GLU . 97.8 m-70 -111.36 135.22 52.22 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.512 179.247 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 54' ' ' HIS . 93.1 mt-10 -41.8 -34.32 0.63 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -179.396 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 73.5 tp60 -63.72 -67.2 0.45 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.373 178.572 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -155.68 -169.52 3.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.691 -179.829 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -117.47 129.94 56.14 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.592 -179.729 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 87.9 mt -117.51 130.51 72.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 121.324 0.583 . . . . 0.0 112.416 -178.902 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.5 ' HB2' HD21 ' A' ' 82' ' ' LEU . 50.5 tp -95.27 129.19 42.49 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.931 179.81 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -115.19 133.44 56.03 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.799 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.722 ' ND2' ' H ' ' A' ' 69' ' ' THR . 11.3 t-20 -96.57 108.3 20.87 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.266 -179.684 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -97.51 -7.02 32.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.256 179.532 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.585 ' OG ' ' ND2' ' A' ' 62' ' ' ASN . 78.7 p -76.25 97.93 4.31 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.306 179.579 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.3 m -80.39 -32.95 37.49 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.2 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.516 HG21 ' O ' ' B' ' 234' ' ' TPO . 2.1 m -65.55 -48.07 73.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.293 179.597 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.583 ' OD1' HG23 ' B' ' 236' ' ' VAL . 1.5 m-20 -137.72 102.02 8.68 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.032 -179.663 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.451 ' HA ' HD21 ' A' ' 62' ' ' ASN . 32.4 Cg_exo -55.14 146.05 61.62 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 121.752 1.635 . . . . 0.0 112.326 -179.85 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.722 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 10.2 m -74.68 140.64 44.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.595 179.075 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -104.61 139.02 40.07 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.14 179.673 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 56.4 t -132.02 132.96 61.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.879 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 54.38 33.48 18.66 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.025 -0.67 . . . . 0.0 109.622 -179.391 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.7 29.29 65.7 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.77 178.921 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.1 t -148.08 140.39 24.3 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 117.492 0.646 . . . . 0.0 111.342 179.342 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.428 ' H ' HG12 ' A' ' 75' ' ' VAL . 0.2 OUTLIER -68.65 144.0 14.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.379 -179.485 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.1 pt -118.19 94.35 3.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 121.034 0.445 . . . . 0.0 110.585 179.068 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.58 ' OD1' ' N ' ' A' ' 78' ' ' GLU . 37.0 p-10 -69.4 -23.96 63.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.281 179.727 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.58 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 2.6 mt-10 -124.28 170.04 9.53 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.459 179.656 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -60.73 147.27 95.51 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 122.485 2.123 . . . . 0.0 112.601 179.283 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 29.3 m -138.32 138.71 42.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.473 179.626 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.575 HH21 ' CE ' ' A' ' 83' ' ' LYS . 61.7 ttp180 -72.8 130.44 40.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.632 179.281 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.5 HD21 ' HB2' ' A' ' 60' ' ' LEU . 97.0 mt -81.58 136.02 35.57 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.015 0.436 . . . . 0.0 111.7 -179.386 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.575 ' CE ' HH21 ' A' ' 81' ' ' ARG . 99.1 mttt -129.05 149.0 51.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.409 179.426 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.444 ' CD2' ' C ' ' A' ' 84' ' ' HIS . 7.2 t60 -54.58 116.81 2.88 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.162 179.897 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 113.09 -15.35 23.28 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.572 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -67.96 135.67 52.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.29 0.567 . . . . 0.0 110.672 -179.569 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.513 HG22 ' HG2' ' A' ' 96' ' ' ARG . 77.0 t -112.48 131.57 63.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.752 -178.652 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 81.0 mt -104.29 131.14 53.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.081 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 38.8 m -123.26 128.24 49.7 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -177.807 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.427 ' O ' ' C ' ' A' ' 91' ' ' ILE . 91.4 mt -115.76 124.17 71.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.051 178.679 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.624 HG23 ' SG ' ' B' ' 237' ' ' CYS . 76.6 mt 39.72 -100.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.445 179.989 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.601 ' OD1' ' NH1' ' A' ' 93' ' ' ARG . 24.2 p-10 -116.21 13.4 15.68 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.779 0.323 . . . . 0.0 111.482 -179.919 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.781 ' CZ ' HD12 ' A' ' 41' ' ' LEU . 57.0 mtm-85 -125.07 143.45 50.91 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.878 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.2 t -138.75 156.18 47.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.628 0.728 . . . . 0.0 111.887 -179.413 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.524 ' HB3' HD11 ' A' ' 7' ' ' LEU . 86.5 m-85 -128.32 124.62 36.93 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.454 179.294 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.513 ' HG2' HG22 ' A' ' 87' ' ' VAL . 99.6 mtt180 -89.6 134.54 34.08 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.951 -0.7 . . . . 0.0 110.959 -179.316 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.607 ' HH ' ' HG2' ' A' ' 5' ' ' ARG . 85.7 t80 -98.0 123.27 41.93 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.046 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -141.11 126.91 19.14 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.093 -179.617 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.471 ' OD1' ' CZ ' ' A' ' 97' ' ' TYR . 95.0 m-20 -101.44 108.16 19.67 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.434 179.214 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 . . . . . 0 C--N 1.328 -0.362 0 C-N-CA 119.868 -0.733 . . . . 0.0 110.271 179.598 . . . . . . . . 0 0 . 1 . 049 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . 0.434 HG12 ' H ' ' B' ' 229' ' ' ASP . 3.2 t . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.743 0.306 . . . . 0.0 110.458 . . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.519 ' C ' ' H ' ' B' ' 231' ' ' GLN . 30.4 p-10 -113.54 -2.37 13.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.824 179.931 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 049 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.519 ' H ' ' C ' ' B' ' 229' ' ' ASP . 0.0 OUTLIER -138.4 44.73 2.1 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.054 -179.268 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . 0.492 ' N ' ' OD1' ' B' ' 229' ' ' ASP . . . -118.18 -156.55 10.3 Favored Glycine 0 CA--C 1.532 1.116 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 179.909 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.23 160.95 44.14 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.735 2.29 . . . . 0.0 112.679 -179.548 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.516 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -51.86 156.71 6.6 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.682 2.255 . . . . 0.0 112.015 178.536 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.583 HG23 ' OD1' ' A' ' 67' ' ' ASN . 8.2 p -109.9 135.07 50.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.248 -179.767 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . 0.624 ' SG ' HG23 ' A' ' 91' ' ' ILE . 19.9 t -78.85 121.59 25.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.289 -179.426 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . 0.431 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . 0.431 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 32.2 Cg_exo -57.72 -24.58 63.93 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.668 2.245 . . . . 0.0 111.884 -179.091 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 77.6 m -73.3 -46.69 48.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.566 178.834 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.694 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 57.5 t80 -58.19 -45.84 86.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.693 -178.999 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.446 ' HA ' HD23 ' B' ' 242' ' ' LEU . 78.4 mt -64.27 -40.46 96.02 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.478 179.85 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -61.67 -40.63 95.63 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.951 0.405 . . . . 0.0 110.206 179.922 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -61.8 -43.1 99.52 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.628 179.601 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.605 ' NH2' HD22 ' A' ' 41' ' ' LEU . 40.0 mmt-85 -62.19 -39.79 93.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.605 -179.514 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.08 -40.2 96.96 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.238 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 11.2 t -62.84 -44.06 97.15 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 177.693 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -60.0 -38.11 81.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.785 -179.917 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.615 HG13 ' OG ' ' A' ' 13' ' ' SER . 25.0 t -61.7 -46.53 96.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.797 179.724 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -61.76 -26.84 68.32 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 179.253 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -88.02 -9.46 53.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.412 179.218 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.514 ' CD1' ' NH2' ' A' ' 12' ' ' ARG . 90.2 mt -114.16 106.83 14.83 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.187 179.919 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . 0.553 ' ND2' ' CG ' ' B' ' 255' ' ' ASP . 6.6 p-10 -61.35 179.83 0.2 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.896 0.379 . . . . 0.0 110.361 179.671 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -66.63 -11.42 53.58 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.01 -179.341 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . 0.567 ' O ' ' N ' ' B' ' 257' ' ' LYS . 15.7 p-10 -68.96 -8.12 41.61 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.96 -178.996 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -65.57 60.33 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.971 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . 0.567 ' N ' ' O ' ' B' ' 255' ' ' ASP . 84.9 tttt -64.71 -24.46 67.58 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.047 179.752 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.422 ' O ' ' O ' ' B' ' 259' ' ' ASP . 94.7 m-20 -108.19 81.62 1.51 Allowed 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 178.591 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.572 ' CG ' ' H ' ' B' ' 260' ' ' GLU . 38.6 p30 -53.77 -109.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.662 -178.862 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.572 ' H ' ' CG ' ' B' ' 259' ' ' ASP . 98.5 mt-10 -145.8 23.18 1.41 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.029 0.443 . . . . 0.0 110.037 179.983 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 66.7 mt -113.3 141.12 30.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.303 -178.799 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 56.0 t -127.63 134.04 66.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.329 -179.812 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -99.43 122.92 43.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.441 0.639 . . . . 0.0 111.238 -179.208 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . 0.408 ' NZ ' ' HA ' ' A' ' 34' ' ' GLU . 88.2 tttt -64.78 -44.88 88.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.42 179.772 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -98.5 155.29 36.98 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.796 -178.901 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.74 149.71 83.6 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.776 2.318 . . . . 0.0 111.791 179.202 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 25.1 pt . . . . . 0 C--N 1.325 -0.481 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.271 -179.425 . . . . . . . . 0 0 . 1 . 050 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo . . . . . 0 N--CA 1.493 1.461 0 N-CA-C 113.226 0.433 . . . . 0.0 113.226 . . . . . . . . . 0 0 . 1 . 050 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 74.8 p -105.02 -46.89 4.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.218 -179.398 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.664 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 93.7 mtt-85 -92.72 126.22 37.7 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.305 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 89.6 mtm-85 -134.5 151.45 51.14 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.247 0.546 . . . . 0.0 112.255 -179.075 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.42 ' CD1' HD21 ' A' ' 22' ' ' LEU . 85.5 mt -119.16 146.97 44.71 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.875 -179.55 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.0 t -118.55 129.79 74.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.816 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.535 HG22 HH21 ' A' ' 93' ' ' ARG . 53.5 m -89.07 112.74 23.76 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -178.126 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.49 HD12 ' OG ' ' A' ' 94' ' ' SER . 95.8 mt -83.64 143.13 12.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 177.748 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.1 tttm -92.33 167.64 11.86 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.108 -0.637 . . . . 0.0 111.063 -179.735 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.601 ' NH1' ' OE2' ' B' ' 260' ' ' GLU . 90.5 mtm180 -58.25 -31.54 67.52 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.517 -179.165 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 90.5 p -83.35 -6.13 59.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.962 0.41 . . . . 0.0 110.024 179.136 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.2 39.78 7.23 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.89 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.1 t -117.26 134.19 61.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.029 0.442 . . . . 0.0 111.617 -179.198 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -73.09 116.68 13.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.702 -179.839 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -110.95 -124.24 4.57 Favored Glycine 0 CA--C 1.54 1.596 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 179.416 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.93 147.58 39.19 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 122.41 2.073 . . . . 0.0 113.518 -179.219 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.551 ' O ' ' CD1' ' B' ' 267' ' ' ILE . 0.4 OUTLIER -110.59 131.01 55.42 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.234 179.333 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.584 ' CD2' HD11 ' A' ' 37' ' ' ILE . 24.7 t80 -99.58 101.01 12.04 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.533 -179.098 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.97 135.63 23.55 Favored 'Trans proline' 0 C--N 1.315 -1.204 0 C-N-CA 121.332 1.355 . . . . 0.0 111.36 -179.69 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.575 HD13 HD11 ' A' ' 53' ' ' ILE . 79.8 mt -85.95 76.58 9.82 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.965 -178.542 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 95.5 p -82.67 -10.34 58.97 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.757 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.701 HD11 ' HG2' ' B' ' 265' ' ' GLN . 59.2 mt -102.16 146.02 28.55 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.611 -179.682 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.8 m -66.19 -14.8 62.46 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.929 -0.308 . . . . 0.0 111.514 -179.255 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.426 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 75.0 m -135.49 136.48 41.29 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.912 0.387 . . . . 0.0 111.875 -179.539 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.411 ' HB2' HD22 ' A' ' 22' ' ' LEU . 12.2 t -126.2 117.18 22.57 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.911 178.626 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.563 HD21 ' OE1' ' A' ' 47' ' ' GLN . 58.4 tp -113.57 127.88 56.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.602 0.239 . . . . 0.0 110.861 -179.171 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.823 ' CE2' HD12 ' A' ' 37' ' ' ILE . 6.0 m-85 -107.4 141.81 38.21 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.741 179.473 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 149.64 -178.5 27.1 Favored Glycine 0 N--CA 1.467 0.751 0 C-N-CA 120.175 -1.012 . . . . 0.0 112.418 178.676 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.479 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 45.8 mtm180 -73.56 -32.92 64.43 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 179.787 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.535 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -50.13 141.68 15.36 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 120.474 -0.87 . . . . 0.0 111.317 -178.579 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.571 ' CD1' ' CZ ' ' A' ' 38' ' ' ARG . 34.4 mm -63.17 -43.62 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-O 120.874 0.369 . . . . 0.0 110.029 179.529 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -53.81 -19.25 4.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.962 179.806 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.535 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 39.6 m -61.6 129.27 40.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.396 -179.923 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.426 ' OD2' ' O ' ' A' ' 26' ' ' THR . 91.4 m-20 -60.73 -30.38 69.94 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.645 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.823 HD12 ' CE2' ' A' ' 29' ' ' PHE . 82.7 mt -126.93 119.96 54.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.482 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.571 ' CZ ' ' CD1' ' A' ' 33' ' ' ILE . 82.0 mtp180 -99.95 133.75 43.87 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.029 -178.822 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.744 HG21 HD12 ' A' ' 41' ' ' LEU . 96.8 mt -118.44 128.81 75.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-O 121.131 0.491 . . . . 0.0 110.339 179.991 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -76.67 26.87 0.13 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.253 -178.683 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.744 HD12 HG21 ' A' ' 39' ' ' ILE . 26.3 mt -94.84 124.76 53.56 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.554 179.731 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.88 -10.84 26.88 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 122.371 2.047 . . . . 0.0 112.542 -179.443 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.54 HG21 ' CE2' ' B' ' 241' ' ' PHE . 4.1 m -100.86 8.88 8.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.941 0.4 . . . . 0.0 111.27 179.996 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.479 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 21.9 t -97.44 136.31 28.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.329 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.3 m -70.45 170.45 11.97 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.635 0.731 . . . . 0.0 111.921 -178.467 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -62.28 -41.41 98.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.039 -179.144 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.607 ' O ' ' N ' ' A' ' 49' ' ' CYS . 13.9 mm100 -110.91 -20.95 12.26 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.265 0.555 . . . . 0.0 110.403 -179.849 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.408 ' NE2' HG23 ' A' ' 90' ' ' ILE . 11.0 t60 39.74 -78.34 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.006 -0.997 . . . . 0.0 113.209 179.087 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.607 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.16 137.69 46.32 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.216 0.531 . . . . 0.0 111.791 -178.886 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -129.15 135.36 48.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.217 179.661 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.6 mt -121.27 136.95 56.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.142 -179.11 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -117.01 123.89 47.99 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.755 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.575 HD11 HD13 ' A' ' 22' ' ' LEU . 96.4 mt -102.37 116.05 45.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.528 0.68 . . . . 0.0 111.521 -178.714 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.492 ' O ' ' N ' ' A' ' 56' ' ' GLN . 90.8 m-70 -117.67 144.57 45.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.143 179.932 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 54' ' ' HIS . 80.7 tt0 -39.2 -29.16 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -179.626 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.492 ' N ' ' O ' ' A' ' 54' ' ' HIS . 86.5 mt-30 -66.59 -68.59 0.36 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.733 178.944 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.44 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 6.1 tp10 -157.65 -158.99 0.79 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.562 -179.67 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.44 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -118.42 128.77 54.94 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.064 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.9 mt -118.38 129.3 74.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.304 0.573 . . . . 0.0 112.248 -178.477 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 49.2 tp -95.31 129.19 42.53 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.584 -179.954 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -114.23 134.71 54.73 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.154 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.681 HD21 ' CB ' ' A' ' 68' ' ' PRO . 63.7 t-20 -97.84 105.8 18.0 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -178.078 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -98.24 -8.55 27.12 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.911 179.568 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.3 t -81.06 99.23 8.37 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.694 0.283 . . . . 0.0 110.983 179.684 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.4 t -83.99 -32.74 24.81 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.804 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.6 m -61.29 -47.46 85.85 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.918 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -144.17 108.62 4.96 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.714 178.587 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.681 ' CB ' HD21 ' A' ' 62' ' ' ASN . 40.1 Cg_endo -68.6 152.64 74.56 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 121.535 1.49 . . . . 0.0 113.019 -178.473 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.9 m -70.66 138.97 51.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.22 -179.636 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -101.76 140.28 36.26 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.833 -179.682 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.567 ' CG2' HD11 ' A' ' 76' ' ' ILE . 12.9 t -134.89 136.29 52.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 178.13 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 56.91 33.51 23.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.993 0.425 . . . . 0.0 110.064 -179.581 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.97 30.64 67.66 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.173 179.219 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 36.0 m -148.18 146.39 28.7 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 117.359 0.58 . . . . 0.0 111.348 -179.661 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.4 m -72.78 147.36 10.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-O 121.015 0.436 . . . . 0.0 111.002 -179.703 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.567 HD11 ' CG2' ' A' ' 71' ' ' VAL . 98.3 mt -107.2 107.21 22.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.406 -179.474 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -66.09 -42.25 89.58 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.64 179.233 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.545 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.4 OUTLIER -136.71 -177.55 0.72 Allowed Pre-proline 0 N--CA 1.466 0.346 0 CA-C-O 120.666 0.269 . . . . 0.0 111.298 -178.737 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.509 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 45.2 Cg_exo -58.69 145.22 96.57 Favored 'Trans proline' 0 N--CA 1.5 1.895 0 C-N-CA 122.842 2.361 . . . . 0.0 113.199 -179.753 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.8 m -143.76 143.07 24.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.985 179.634 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.46 ' HE ' ' HE2' ' A' ' 83' ' ' LYS . 59.6 ttp180 -76.25 133.59 40.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.107 179.449 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 82' ' ' LEU . 98.4 mt -82.35 143.87 30.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.151 0.501 . . . . 0.0 111.675 -179.153 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.46 ' HE2' ' HE ' ' A' ' 81' ' ' ARG . 73.3 mmtt -132.72 151.68 51.92 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.489 179.556 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.418 ' CE1' ' H ' ' A' ' 99' ' ' ASN . 5.4 t60 -56.26 117.8 4.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.421 -178.847 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.67 -18.58 24.58 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 111.189 -0.765 . . . . 0.0 111.189 179.527 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -69.61 135.08 49.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.163 0.506 . . . . 0.0 110.554 -179.899 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 49.7 t -110.16 132.78 57.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.91 -179.178 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.439 ' HA ' HG22 ' A' ' 71' ' ' VAL . 97.1 mt -101.12 130.22 50.89 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 177.676 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 49.6 m -120.1 126.42 50.71 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 119.876 -0.73 . . . . 0.0 112.209 -178.663 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.591 ' O ' ' N ' ' A' ' 93' ' ' ARG . 99.1 mt -114.78 129.91 70.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 114.798 -1.092 . . . . 0.0 108.25 177.993 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.504 HG23 HD21 ' B' ' 242' ' ' LEU . 75.6 mt -23.04 95.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -178.612 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.501 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 3.8 m-20 92.88 -27.19 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 178.551 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.666 ' NE ' HD11 ' B' ' 261' ' ' ILE . 7.9 mmm180 -125.93 143.21 51.18 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.418 -179.3 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.49 ' OG ' HD12 ' A' ' 10' ' ' ILE . 87.0 p -138.81 154.36 48.46 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.6 -0.44 . . . . 0.0 109.995 179.345 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -129.12 126.79 40.1 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.32 -179.539 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 96' ' ' ARG . 41.7 ttp-105 -90.91 135.69 33.57 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.661 -0.415 . . . . 0.0 110.429 -179.605 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.664 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 89.1 t80 -92.39 121.34 33.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.905 -179.759 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -121.63 123.43 41.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.831 -179.568 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.418 ' H ' ' CE1' ' A' ' 84' ' ' HIS . 60.3 t-20 -105.28 118.31 36.22 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.921 0.391 . . . . 0.0 110.285 179.923 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 . . . . . 0 C--N 1.326 -0.42 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.492 -179.49 . . . . . . . . 0 0 . 1 . 050 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 47.1 t . . . . . 0 C--O 1.231 0.131 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 . . . . . . . . . 0 0 . 1 . 050 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' B' ' 231' ' ' GLN . 48.5 t0 -81.81 115.77 21.18 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.022 0.439 . . . . 0.0 110.556 -179.849 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 050 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.503 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 75.3 mt-30 -123.25 -26.13 4.35 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.25 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' B' ' 231' ' ' GLN . . . -52.1 -160.22 0.01 OUTLIER Glycine 0 CA--C 1.531 1.085 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.978 -179.679 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -72.89 160.89 45.05 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.944 2.43 . . . . 0.0 114.369 -178.551 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 050 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -74.78 168.8 24.02 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 121.931 1.754 . . . . 0.0 112.708 -179.783 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 2.1 p -107.72 132.4 55.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.058 179.071 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 3.2 t -79.19 133.44 36.71 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.03 -179.282 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . 0.419 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . 0.419 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 31.6 Cg_exo -59.0 -23.29 67.82 Favored 'Trans proline' 0 N--CA 1.502 2.003 0 C-N-CA 122.992 2.461 . . . . 0.0 113.078 -179.777 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 98.9 m -74.47 -46.39 39.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.064 0.459 . . . . 0.0 110.357 178.894 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.54 ' CE2' HG21 ' A' ' 43' ' ' VAL . 88.1 t80 -59.63 -45.34 92.26 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.82 -178.8 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.504 HD21 HG23 ' A' ' 91' ' ' ILE . 89.9 mt -65.79 -39.96 91.47 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 119.86 -0.736 . . . . 0.0 110.563 179.398 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -60.67 -41.84 95.86 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.854 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -65.81 -37.58 86.64 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.314 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.475 HH11 ' NH1' ' A' ' 12' ' ' ARG . 10.7 tpp180 -62.62 -44.52 96.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.334 -179.68 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -63.08 -36.62 84.19 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.978 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 10.2 t -63.53 -44.65 93.6 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.629 177.974 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 66.6 mm-40 -57.83 -37.63 74.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.919 -179.952 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 21.9 t -63.93 -45.21 97.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.576 178.934 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -59.61 -29.9 68.32 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.078 0.465 . . . . 0.0 110.262 -179.663 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -92.81 -7.17 47.15 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.116 179.613 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.494 HD22 HH21 ' A' ' 12' ' ' ARG . 38.5 tp -75.12 147.19 40.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.863 -179.558 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -105.07 132.24 51.56 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.213 -179.756 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . 0.475 ' N ' ' OD1' ' B' ' 254' ' ' ASP . 28.2 p-10 -65.13 -33.66 76.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.516 179.052 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . 0.475 ' N ' ' OD1' ' B' ' 254' ' ' ASP . 96.9 m-20 -69.51 -6.28 29.65 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.361 179.897 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.572 ' O ' ' N ' ' B' ' 258' ' ' ASP . 34.9 t70 -98.95 -44.19 6.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.379 0.609 . . . . 0.0 109.844 179.316 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' B' ' 259' ' ' ASP . 99.1 mttt 58.65 -72.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.244 -179.263 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.573 ' O ' ' CB ' ' B' ' 259' ' ' ASP . 90.3 m-20 38.71 -95.44 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -179.115 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.573 ' CB ' ' O ' ' B' ' 258' ' ' ASP . 30.2 p-10 116.95 -162.94 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.453 0 O-C-N 124.868 1.355 . . . . 0.0 108.564 179.263 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.601 ' OE2' ' NH1' ' A' ' 12' ' ' ARG . 92.4 mt-10 -137.74 16.21 2.89 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 177.486 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.666 HD11 ' NE ' ' A' ' 93' ' ' ARG . 3.0 mm -112.72 131.36 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 114.31 -1.314 . . . . 0.0 109.407 -179.109 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 39.2 t -124.95 132.31 71.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.629 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -98.56 122.05 41.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.2 0.524 . . . . 0.0 111.889 -178.302 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -65.06 -45.9 83.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.694 179.326 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . 0.701 ' HG2' HD11 ' A' ' 24' ' ' LEU . 2.9 mp0 -92.47 163.9 24.75 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.436 -179.882 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.86 146.92 92.23 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.21 1.94 . . . . 0.0 112.56 -179.89 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . 0.551 ' CD1' ' O ' ' A' ' 19' ' ' HIS . 4.9 tt . . . . . 0 C--N 1.323 -0.582 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.246 -179.607 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo . . . . . 0 N--CA 1.489 1.214 0 CA-C-O 121.094 0.372 . . . . 0.0 112.096 . . . . . . . . . 0 0 . 1 . 051 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.1 m -72.35 -44.02 63.21 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.745 -179.744 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.658 ' NH1' HG23 ' A' ' 53' ' ' ILE . 90.0 mtt180 -91.4 138.66 31.4 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.949 -178.011 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -139.0 147.23 41.87 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 179.761 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.551 HD12 ' O ' ' A' ' 96' ' ' ARG . 42.4 tp -117.82 133.61 55.76 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.258 179.241 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 53.7 t -110.8 132.02 60.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.265 -178.668 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.444 HG23 ' CD1' ' B' ' 261' ' ' ILE . 4.7 m -96.6 115.84 28.1 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.874 -179.249 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 87.2 mt -83.41 150.96 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.578 179.888 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.673 ' HZ3' ' HB2' ' B' ' 259' ' ' ASP . 72.8 mmtt -86.17 154.09 21.58 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 178.527 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.881 HH21 HD11 ' B' ' 252' ' ' LEU . 87.7 mtm180 -58.22 -25.47 61.7 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.373 179.776 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.2 m -79.49 -8.25 59.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.843 179.84 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.01 31.84 8.89 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -179.893 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.403 ' H ' ' HB2' ' A' ' 11' ' ' LYS . 23.8 t -118.65 133.64 64.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.611 0.243 . . . . 0.0 110.898 -179.949 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -72.89 133.02 44.22 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.524 -0.546 . . . . 0.0 109.524 179.141 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -127.54 -118.63 2.17 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 120.403 -0.903 . . . . 0.0 111.931 -179.54 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -76.17 149.06 31.62 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.56 2.173 . . . . 0.0 112.593 -179.028 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -110.81 151.08 28.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.339 0.59 . . . . 0.0 111.246 -179.432 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.402 ' HB2' ' CE1' ' B' ' 263' ' ' PHE . 40.4 t80 -112.54 91.75 17.87 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.304 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.518 ' HD2' HG22 ' B' ' 267' ' ' ILE . 59.8 Cg_endo -71.47 133.53 22.64 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 121.226 1.284 . . . . 0.0 111.269 -178.329 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.594 ' O ' ' CB ' ' A' ' 23' ' ' SER . 72.0 mt -73.45 -149.56 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.976 -178.429 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.594 ' CB ' ' O ' ' A' ' 22' ' ' LEU . 6.9 p 135.98 -40.16 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -179.181 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.3 mt -77.52 142.84 38.86 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.55 -1.204 . . . . 0.0 109.769 179.746 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 m -65.26 -17.13 64.25 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -178.766 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.1 m -133.86 133.56 41.69 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.619 0.599 . . . . 0.0 112.619 -179.2 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.662 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.4 OUTLIER -126.15 119.44 27.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.185 178.146 . . . . . . . . 3 3 . 1 . 051 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.512 HD21 ' OE1' ' A' ' 47' ' ' GLN . 36.7 tp -119.7 128.07 53.45 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.826 -178.391 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.705 ' CE2' HD12 ' A' ' 37' ' ' ILE . 25.1 m-85 -100.73 128.18 46.88 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.262 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -173.35 -165.04 29.61 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 120.057 -1.068 . . . . 0.0 112.876 -179.79 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.499 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 38.0 ttp-105 -105.75 -8.5 17.78 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.169 -0.515 . . . . 0.0 111.694 -179.138 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -91.52 170.05 33.49 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.66 -178.865 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.52 HG23 ' N ' ' A' ' 34' ' ' GLU . 11.0 tp -68.45 -41.7 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 115.638 -0.281 . . . . 0.0 111.301 -179.884 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.52 ' N ' HG23 ' A' ' 33' ' ' ILE . 48.8 tt0 -56.76 -29.46 62.62 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.458 -179.429 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.9 m -63.5 129.94 42.28 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.479 -179.975 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.426 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 57.0 m-20 -60.51 -31.3 70.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.383 -178.768 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.705 HD12 ' CE2' ' A' ' 29' ' ' PHE . 97.6 mt -127.25 118.65 50.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 178.258 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.492 ' CZ ' HD12 ' A' ' 33' ' ' ILE . 59.9 mtm180 -102.29 137.2 40.86 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.57 179.9 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.819 HD13 ' NH1' ' A' ' 93' ' ' ARG . 75.8 mt -119.38 131.94 70.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.617 -179.583 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -67.2 18.82 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -177.934 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.702 HD12 HH21 ' A' ' 93' ' ' ARG . 15.5 mt -104.64 127.73 28.34 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.87 179.96 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.67 -5.89 17.8 Favored 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 122.368 2.046 . . . . 0.0 112.326 -179.737 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.543 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 11.0 m -91.8 5.51 6.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.065 179.462 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.499 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 54.7 t -96.51 135.52 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.882 178.885 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.2 m -74.27 167.99 20.51 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.747 0.784 . . . . 0.0 112.951 -178.377 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.7 mtmt -64.13 -37.97 89.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.689 179.588 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.612 ' O ' ' N ' ' A' ' 49' ' ' CYS . 92.1 mm-40 -115.16 -32.26 5.75 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.135 0.493 . . . . 0.0 110.103 -179.984 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 18.7 t60 41.74 -77.2 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.764 179.636 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.612 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.37 134.74 47.38 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.793 -178.916 . . . . . . . . 3 3 . 1 . 051 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -126.05 129.25 48.79 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.359 -179.972 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 95.5 mt -114.89 131.98 65.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.208 -179.736 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -116.93 125.8 52.0 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.552 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.658 HG23 ' NH1' ' A' ' 5' ' ' ARG . 98.0 mt -106.73 114.5 46.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 119.975 -0.69 . . . . 0.0 112.022 -178.585 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.426 ' O ' ' C ' ' A' ' 55' ' ' GLU . 86.2 m-70 -113.27 146.32 39.55 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.719 179.804 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 54' ' ' HIS . 52.8 tp10 -40.66 -33.39 0.28 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.527 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -61.39 -68.94 0.27 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.744 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -161.35 -160.58 0.73 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.145 178.723 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.11 128.15 56.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.365 -179.926 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 91.2 mt -116.59 129.88 72.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.036 0.446 . . . . 0.0 111.892 -179.013 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.575 ' HB2' HD11 ' A' ' 82' ' ' LEU . 28.5 tp -100.0 130.39 46.16 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.896 -179.14 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -115.92 136.17 53.29 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.718 179.849 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -97.09 106.54 18.89 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -178.994 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -100.58 -7.47 24.01 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.213 178.73 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.99 100.97 7.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.187 179.789 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.3 m -88.47 -10.92 47.42 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.999 179.606 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.796 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.2 OUTLIER -91.98 -43.6 9.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.284 -179.724 . . . . . . . . 3 3 . 1 . 051 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.446 ' OD1' HG22 ' B' ' 236' ' ' VAL . 80.1 m-20 -140.05 101.26 7.03 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.08 -179.877 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -56.7 143.11 90.83 Favored 'Trans proline' 0 N--CA 1.501 1.929 0 C-N-CA 122.297 1.998 . . . . 0.0 113.355 -179.312 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.939 ' O ' HG22 ' A' ' 76' ' ' ILE . 2.9 m -72.27 140.35 48.57 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.096 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 89' ' ' THR . 72.8 mt-30 -104.57 140.35 38.12 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.327 -0.549 . . . . 0.0 111.39 -179.005 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.465 HG22 HD13 ' A' ' 88' ' ' ILE . 55.8 t -131.61 133.43 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.982 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 54.21 33.06 17.25 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.976 179.947 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.5 24.29 70.89 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.993 178.932 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.7 t -142.79 143.52 32.21 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 117.585 0.692 . . . . 0.0 111.058 179.844 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.401 HG22 ' H ' ' A' ' 75' ' ' VAL . 2.5 m -69.22 144.11 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.311 179.945 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.939 HG22 ' O ' ' A' ' 69' ' ' THR . 8.2 tt -106.42 91.39 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.259 179.191 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -64.11 -37.27 86.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.966 179.925 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.486 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 3.5 mt-10 -126.89 168.7 13.85 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.254 -179.044 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -59.74 145.38 98.31 Favored 'Trans proline' 0 N--CA 1.501 1.912 0 C-N-CA 122.042 1.828 . . . . 0.0 112.705 -179.56 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.2 m -145.48 151.58 14.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.801 178.922 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -78.83 132.94 37.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.762 179.552 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.575 HD11 ' HB2' ' A' ' 60' ' ' LEU . 96.1 mt -89.39 140.92 29.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.16 0.505 . . . . 0.0 111.281 -179.681 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -123.13 151.94 41.61 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.852 179.351 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.405 ' CE1' ' HG3' ' A' ' 98' ' ' GLU . 6.5 t60 -53.82 121.69 8.45 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.403 -179.861 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.15 -13.99 37.01 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -179.888 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -68.71 135.59 51.55 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.575 -0.45 . . . . 0.0 109.937 179.671 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.495 ' CG1' ' OG ' ' A' ' 94' ' ' SER . 91.4 t -107.06 132.28 54.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.213 -179.024 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.465 HD13 HG22 ' A' ' 71' ' ' VAL . 45.2 mm -91.05 128.28 42.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.768 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.526 ' N ' ' O ' ' A' ' 70' ' ' GLN . 63.5 m -124.26 123.35 40.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.505 0.669 . . . . 0.0 112.531 -178.02 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.443 ' O ' ' C ' ' A' ' 91' ' ' ILE . 85.1 mt -121.55 129.06 75.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.432 179.295 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.553 HG22 ' N ' ' A' ' 92' ' ' ASP . 95.8 mt 34.2 -99.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.454 -179.797 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.553 ' N ' HG22 ' A' ' 91' ' ' ILE . 36.7 t0 -114.05 16.87 18.1 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.703 0.287 . . . . 0.0 111.33 -179.216 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.819 ' NH1' HD13 ' A' ' 39' ' ' ILE . 4.8 mtm105 -124.71 139.18 54.09 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.812 -179.298 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.495 ' OG ' ' CG1' ' A' ' 87' ' ' VAL . 41.7 t -132.72 141.81 48.74 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.103 0.478 . . . . 0.0 110.128 179.606 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.494 ' HB3' HD11 ' A' ' 7' ' ' LEU . 27.2 m-85 -125.06 123.26 39.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.886 -179.993 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.551 ' O ' HD12 ' A' ' 7' ' ' LEU . 99.6 mtt180 -82.53 126.42 32.25 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.508 -179.855 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.585 ' CE2' ' OD1' ' A' ' 99' ' ' ASN . 74.7 t80 -90.59 124.27 34.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.658 179.607 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.405 ' HG3' ' CE1' ' A' ' 84' ' ' HIS . 82.0 tt0 -128.52 113.5 15.56 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.801 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.585 ' OD1' ' CE2' ' A' ' 97' ' ' TYR . 87.2 m-20 -66.42 -41.13 89.71 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.544 179.961 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.092 -179.244 . . . . . . . . 0 0 . 1 . 051 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . 0.638 ' O ' HG13 ' B' ' 228' ' ' VAL . 4.7 p . . . . . 0 CA--C 1.527 0.068 0 CA-C-O 121.215 0.531 . . . . 0.0 109.809 . . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.643 ' O ' ' N ' ' B' ' 231' ' ' GLN . 62.6 t0 -88.05 124.15 33.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.04 179.831 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . 0.407 ' O ' ' HB3' ' B' ' 231' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.643 ' N ' ' O ' ' B' ' 229' ' ' ASP . 5.7 pt20 156.8 -21.72 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.106 179.923 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . 0.509 ' O ' ' O ' ' B' ' 231' ' ' GLN . . . -48.89 -164.73 0.01 OUTLIER Glycine 0 CA--C 1.537 1.437 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.264 -179.417 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.51 158.72 55.14 Favored 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 122.863 2.375 . . . . 0.0 113.334 -178.989 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.796 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.3 140.92 38.03 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 121.655 1.57 . . . . 0.0 113.159 -178.943 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.593 HG23 HG22 ' A' ' 66' ' ' THR . 1.8 t -61.03 138.9 21.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.306 -179.882 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -66.08 128.95 38.12 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.288 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 051 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.77 -29.44 71.75 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 122.995 2.463 . . . . 0.0 112.7 179.974 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 25.9 m -74.52 -42.6 58.61 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.073 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.543 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 73.1 t80 -57.17 -47.41 81.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.585 -179.219 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 91.0 mt -65.31 -39.47 92.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.039 0.447 . . . . 0.0 110.206 179.634 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -62.35 -41.25 98.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.757 -179.615 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -64.33 -40.78 96.58 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.65 179.85 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.435 HH11 ' HD3' ' B' ' 245' ' ' ARG . 25.9 mmt180 -61.37 -42.69 99.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.33 -179.354 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.4 -39.76 95.36 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.304 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 11.0 t -66.04 -45.89 79.77 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.849 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -55.11 -40.87 70.96 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.693 179.996 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.506 ' HA ' HD12 ' B' ' 252' ' ' LEU . 44.3 t -60.96 -43.88 96.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.857 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -60.85 -26.59 67.47 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.539 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -86.62 -13.4 45.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.954 -179.557 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.881 HD11 HH21 ' A' ' 12' ' ' ARG . 69.0 mt -72.39 147.89 45.77 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.161 0.505 . . . . 0.0 110.454 179.472 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . 0.444 ' C ' ' H ' ' B' ' 255' ' ' ASP . 80.8 m-20 -73.48 174.86 7.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.012 179.583 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -65.84 0.84 1.57 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.843 179.563 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . 0.444 ' H ' ' C ' ' B' ' 253' ' ' ASN . 65.4 m-20 -89.34 -86.34 0.19 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.314 178.69 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.416 ' O ' ' NZ ' ' A' ' 11' ' ' LYS . 34.2 t0 64.13 26.74 13.97 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.907 -179.203 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . 0.423 ' C ' ' HZ1' ' A' ' 11' ' ' LYS . 99.6 mttt -80.47 -9.76 59.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.411 -179.546 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -70.99 -71.97 0.23 Allowed 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 120.531 -0.467 . . . . 0.0 109.885 179.093 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.673 ' HB2' ' HZ3' ' A' ' 11' ' ' LYS . 47.0 t0 72.72 124.88 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.311 0.577 . . . . 0.0 111.412 -179.867 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.533 ' OE2' ' NH2' ' A' ' 12' ' ' ARG . 53.5 mp0 -56.42 17.94 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.357 -179.433 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.639 ' H ' ' C ' ' B' ' 259' ' ' ASP . 64.5 mt -111.7 134.28 54.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.48 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 77.1 t -128.02 135.27 63.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.761 -179.225 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . 0.402 ' CE1' ' HB2' ' A' ' 20' ' ' PHE . 42.3 m-85 -96.53 119.25 34.67 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.072 -178.224 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -66.42 -46.82 75.23 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.156 178.976 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.37 156.2 51.17 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.859 -178.543 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -62.23 149.19 91.54 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 C-N-CA 122.46 2.107 . . . . 0.0 111.071 179.261 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . 0.518 HG22 ' HD2' ' A' ' 21' ' ' PRO . 30.1 pt . . . . . 0 C--N 1.325 -0.489 0 CA-C-O 121.47 0.652 . . . . 0.0 111.964 -178.42 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo . . . . . 0 N--CA 1.495 1.594 0 CA-C-O 120.823 0.259 . . . . 0.0 112.015 . . . . . . . . . 0 0 . 1 . 052 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 69.1 p -102.67 -47.84 4.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.556 179.904 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.5 mtt85 -94.2 132.76 38.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.248 -179.808 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.502 HH21 ' CD ' ' A' ' 98' ' ' GLU . 39.5 ptt180 -143.57 153.43 42.55 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 120.311 -0.556 . . . . 0.0 111.784 -179.943 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 68.5 mt -117.98 138.71 52.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.817 -179.757 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.703 HG11 ' NH2' ' A' ' 96' ' ' ARG . 26.6 t -112.03 130.3 65.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.524 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.427 ' HG1' ' HE2' ' A' ' 95' ' ' PHE . 3.5 m -79.27 141.24 37.23 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -178.389 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.73 HD11 ' NH1' ' A' ' 96' ' ' ARG . 47.9 mm -106.2 132.4 53.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.096 -0.957 . . . . 0.0 109.035 177.547 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -87.74 154.42 20.58 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.406 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.442 ' HG2' HH12 ' B' ' 245' ' ' ARG . 80.8 mtm180 -57.78 -23.67 53.46 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -178.806 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.4 m -82.89 -9.5 59.28 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.623 179.653 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.27 32.58 10.34 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -179.746 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.1 t -120.53 132.09 71.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.875 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.605 ' CG ' HH22 ' A' ' 96' ' ' ARG . 98.2 m-20 -69.8 137.96 52.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.438 -179.649 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -124.77 -121.23 2.54 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.28 -179.093 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -75.93 146.62 29.66 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.578 2.185 . . . . 0.0 113.192 -178.486 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -106.65 143.69 34.39 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.154 0.502 . . . . 0.0 110.461 179.754 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.529 ' CD2' HD11 ' A' ' 37' ' ' ILE . 33.7 t80 -112.35 96.22 34.63 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.371 -179.707 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -68.89 129.35 18.36 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 121.369 1.379 . . . . 0.0 112.332 -178.422 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 94.4 mt -83.88 78.05 9.79 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.114 0.483 . . . . 0.0 111.052 -178.922 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.7 p -82.29 -13.14 57.45 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.176 178.93 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.2 mt -102.86 148.22 25.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.428 -179.312 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 80.0 p -69.95 -14.78 62.87 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.568 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 58.3 m -129.48 131.48 46.69 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.315 -179.985 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.3 t -124.55 112.7 17.15 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 178.63 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.499 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 40.6 tp -110.01 124.58 51.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.524 -178.749 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.734 ' CE2' HD12 ' A' ' 37' ' ' ILE . 5.5 m-85 -104.76 140.77 37.59 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.175 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -179.97 -176.08 47.12 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.001 -1.095 . . . . 0.0 112.428 179.507 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 31' ' ' ARG . 37.2 ttp180 -91.27 -10.01 43.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.928 0.394 . . . . 0.0 109.959 -179.933 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.434 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -93.86 154.53 21.64 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.763 -179.652 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.468 HG23 ' N ' ' A' ' 34' ' ' GLU . 11.3 tp -66.92 -40.84 86.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 179.435 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.468 ' N ' HG23 ' A' ' 33' ' ' ILE . 80.9 tt0 -46.92 -16.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.478 -179.968 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.435 ' N ' ' C ' ' A' ' 33' ' ' ILE . 2.8 m -83.19 145.14 29.34 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.764 -179.983 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.499 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 54.8 m-20 -58.85 -32.81 69.77 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -179.539 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.734 HD12 ' CE2' ' A' ' 29' ' ' PHE . 85.3 mt -129.04 124.54 60.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.314 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 36.0 ttp180 -108.47 138.71 44.32 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.541 -0.464 . . . . 0.0 111.228 -179.514 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 98.3 mt -121.23 132.54 70.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.125 0.488 . . . . 0.0 110.418 -179.915 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -76.38 29.19 0.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.35 -178.803 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.489 HD22 ' HZ ' ' B' ' 241' ' ' PHE . 38.2 mt -98.72 128.87 31.35 Favored Pre-proline 0 C--N 1.324 -0.523 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.476 179.736 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.89 -9.59 22.44 Favored 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 122.135 1.89 . . . . 0.0 111.345 179.316 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.5 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 31.4 m -97.43 5.5 9.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.804 -179.917 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 24.8 t -96.46 133.12 38.96 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-O 121.134 0.492 . . . . 0.0 110.058 179.272 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.561 ' HA ' HG21 ' B' ' 234' ' ' TPO . 28.7 m -72.21 160.93 31.6 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.944 -179.291 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.27 -39.31 89.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.832 -178.891 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.534 ' O ' ' N ' ' A' ' 49' ' ' CYS . 99.4 mm-40 -111.45 -9.81 14.21 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.903 0.382 . . . . 0.0 110.966 -179.549 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.606 ' CG ' ' HG ' ' A' ' 64' ' ' SER . 15.1 t60 15.36 -76.05 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -178.16 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.534 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.65 135.09 46.64 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 -177.613 . . . . . . . . 3 3 . 1 . 052 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -128.55 128.73 44.83 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.648 179.57 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.9 mt -112.84 133.5 58.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.364 179.796 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -116.81 125.27 51.34 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.34 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 87.5 mt -107.27 113.56 43.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.62 0.724 . . . . 0.0 111.812 -179.117 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.433 ' C ' ' N ' ' A' ' 56' ' ' GLN . 86.7 m-70 -109.68 141.77 41.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.442 -179.941 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 54' ' ' HIS . 94.3 mt-10 -42.72 -28.35 0.23 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.729 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.487 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 86.7 mt-30 -65.0 -69.44 0.29 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.642 178.791 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.487 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 4.4 tp10 -154.79 -174.56 5.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.762 -179.064 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -108.62 127.92 54.39 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.252 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 91.6 mt -119.18 132.17 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -178.512 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.618 HD22 ' CD1' ' A' ' 88' ' ' ILE . 26.1 tp -100.85 129.58 46.74 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.693 178.934 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -114.35 137.72 51.45 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.787 -179.601 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -98.42 104.28 16.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.266 -0.424 . . . . 0.0 112.11 -179.568 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -101.22 -5.31 25.72 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.518 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.606 ' HG ' ' CG ' ' A' ' 48' ' ' HIS . 0.2 OUTLIER -77.03 99.51 5.33 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.917 -179.844 . . . . . . . . 3 3 . 1 . 052 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.0 m -78.74 -31.72 46.43 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.311 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.62 ' O ' HG12 ' B' ' 236' ' ' VAL . 6.5 m -63.45 -49.0 75.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.596 -179.808 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.449 HD21 ' HA ' ' B' ' 236' ' ' VAL . 49.7 m-80 -150.61 100.93 3.1 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.002 -179.487 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -52.34 149.1 23.74 Favored 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 122.468 2.112 . . . . 0.0 112.843 -179.823 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 31.3 m -72.83 137.07 45.5 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.774 179.877 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -100.15 142.02 32.19 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.098 -179.972 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.418 ' O ' ' OG ' ' A' ' 74' ' ' SER . 54.6 t -130.36 134.04 63.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.932 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 51.59 33.01 9.88 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 119.684 -0.806 . . . . 0.0 109.497 179.99 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.68 29.51 67.5 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.344 179.402 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 24.0 p -140.92 133.49 28.6 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 117.486 0.643 . . . . 0.0 111.424 -179.96 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.1 t -69.93 139.18 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.092 179.978 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.55 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 1.2 pt -108.63 107.41 22.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.454 0.645 . . . . 0.0 111.213 179.551 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.432 ' O ' ' OE1' ' A' ' 78' ' ' GLU . 58.3 m-20 -65.64 -33.87 76.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.851 179.051 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.513 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.1 OUTLIER -128.45 -177.72 0.68 Allowed Pre-proline 0 N--CA 1.465 0.282 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.318 179.988 . . . . . . . . 3 3 . 1 . 052 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.513 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 39.7 Cg_exo -61.56 145.08 98.07 Favored 'Trans proline' 0 N--CA 1.499 1.822 0 C-N-CA 122.705 2.27 . . . . 0.0 112.441 179.75 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.2 t -133.21 136.55 54.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.587 179.426 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -73.24 131.19 41.66 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.161 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.441 HD11 ' HB2' ' A' ' 60' ' ' LEU . 90.3 mt -87.46 136.65 32.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.035 0.445 . . . . 0.0 111.279 -179.006 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.537 ' N ' ' OD2' ' A' ' 86' ' ' ASP . 99.2 mttt -125.36 152.26 45.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.953 -179.929 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.498 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 6.1 t60 -52.08 114.73 1.41 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.829 -179.317 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.95 -12.09 29.42 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 179.634 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.537 ' OD2' ' N ' ' A' ' 83' ' ' LYS . 97.5 m-20 -69.98 137.71 51.67 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.086 179.767 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 88.6 t -111.41 134.15 54.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.418 -178.573 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.618 ' CD1' HD22 ' A' ' 60' ' ' LEU . 37.5 mm -93.31 126.53 45.73 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 178.291 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 51.2 m -125.4 127.44 46.57 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.944 0.878 . . . . 0.0 113.08 -178.125 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.531 ' O ' ' C ' ' A' ' 91' ' ' ILE . 89.0 mt -111.76 133.95 55.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 113.933 -1.485 . . . . 0.0 108.043 178.739 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.531 ' C ' ' O ' ' A' ' 90' ' ' ILE . 74.3 mt 16.17 -83.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 O-C-N 123.65 0.594 . . . . 0.0 112.171 -177.333 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' A' ' 90' ' ' ILE . 46.6 t0 -120.7 8.18 10.59 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.593 -179.515 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.757 ' NH1' HH22 ' B' ' 245' ' ' ARG . 2.4 tpp180 -124.65 137.92 54.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.085 -179.784 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 91.0 p -140.79 158.7 43.58 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.577 0.703 . . . . 0.0 112.343 -178.711 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.512 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 87.3 m-85 -130.05 128.8 42.68 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.483 179.573 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.73 ' NH1' HD11 ' A' ' 10' ' ' ILE . 92.4 mtm-85 -87.55 132.97 33.86 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 119.591 -0.844 . . . . 0.0 111.168 -179.812 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -95.48 125.15 39.89 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.46 179.369 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.502 ' CD ' HH21 ' A' ' 6' ' ' ARG . 83.4 tt0 -126.52 121.68 33.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.623 179.931 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.498 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 64.7 t-20 -100.54 107.13 18.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.996 179.764 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 . . . . . 0 C--N 1.326 -0.418 0 CA-C-O 120.908 0.385 . . . . 0.0 110.721 -179.687 . . . . . . . . 0 0 . 1 . 052 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 21.3 m . . . . . 0 N--CA 1.452 -0.354 0 CA-C-O 120.863 0.363 . . . . 0.0 110.453 . . . . . . . . . 0 0 . 1 . 052 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -66.48 131.19 45.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.98 -179.701 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 052 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -126.4 41.39 3.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.066 0.46 . . . . 0.0 110.187 179.743 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -118.82 -168.27 14.09 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.835 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -61.3 152.1 74.72 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 123.387 2.725 . . . . 0.0 112.643 179.856 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.561 HG21 ' HA ' ' A' ' 45' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -81.22 143.8 14.27 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.24 1.96 . . . . 0.0 112.892 -179.478 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.62 HG12 ' O ' ' A' ' 66' ' ' THR . 24.8 m -65.67 153.31 8.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.602 -179.263 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 8.6 t -60.03 120.99 10.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.214 0.531 . . . . 0.0 111.122 -178.629 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 052 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -60.64 -27.71 85.3 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 122.941 2.427 . . . . 0.0 112.826 -178.766 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 84.2 m -74.21 -40.21 62.6 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.202 0.525 . . . . 0.0 109.595 178.017 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.5 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 92.1 t80 -58.5 -48.06 82.04 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.751 -179.227 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' B' ' 242' ' ' LEU . 86.9 mt -63.5 -42.27 98.53 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 120.858 0.361 . . . . 0.0 111.32 179.86 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -66.17 -36.72 83.83 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.451 -179.471 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -61.24 -44.06 97.86 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.454 -0.499 . . . . 0.0 109.808 179.416 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.757 HH22 ' NH1' ' A' ' 93' ' ' ARG . 2.9 mtt-85 -59.9 -41.13 90.97 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.871 0.367 . . . . 0.0 110.432 179.776 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -61.77 -43.05 99.62 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.354 179.505 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 10.5 t -64.26 -45.41 88.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.284 0.564 . . . . 0.0 109.687 178.958 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 28.7 mm100 -62.01 -35.69 79.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.977 -179.363 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.457 HG23 ' O ' ' B' ' 245' ' ' ARG . 44.8 t -64.87 -46.06 93.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.677 179.357 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -62.13 -25.99 68.05 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.399 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -88.68 -11.22 45.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.811 179.697 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.532 HD11 ' CG ' ' B' ' 256' ' ' ASP . 48.8 tp -118.27 114.43 22.98 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.919 0.39 . . . . 0.0 111.777 -179.432 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -53.4 160.67 1.13 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.345 0.593 . . . . 0.0 111.685 -179.298 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -76.41 -21.74 55.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.017 178.748 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -92.44 7.25 43.87 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.389 -179.56 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.532 ' CG ' HD11 ' B' ' 252' ' ' LEU . 39.4 t0 -98.86 115.97 30.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.567 -179.728 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . 0.563 ' O ' ' CB ' ' B' ' 258' ' ' ASP . 97.8 mttt -73.3 160.58 31.64 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.675 179.416 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.563 ' CB ' ' O ' ' B' ' 257' ' ' LYS . 25.4 p-10 119.72 72.1 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 O-C-N 124.965 1.415 . . . . 0.0 108.336 -179.337 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . . . . . . . . . 38.3 p-10 -89.59 8.48 31.1 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.773 -178.22 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 62.61 20.39 11.97 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 179.931 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.56 HD11 ' HD2' ' A' ' 93' ' ' ARG . 75.1 mt -118.23 131.37 71.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.061 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 53.6 t -125.23 132.37 71.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.575 179.81 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -96.18 115.75 27.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.2 -178.927 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -65.53 -46.7 78.57 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.747 179.289 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -87.25 150.39 49.27 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.13 -178.957 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.13 142.98 63.26 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.327 2.018 . . . . 0.0 112.254 -179.745 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 44.5 pt . . . . . 0 C--N 1.327 -0.396 0 CA-C-O 121.148 0.499 . . . . 0.0 109.841 179.114 . . . . . . . . 0 0 . 1 . 053 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 N--CA 1.489 1.258 0 CA-C-O 120.891 0.288 . . . . 0.0 111.96 . . . . . . . . . 0 0 . 1 . 053 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.0 p -101.68 -50.32 3.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.038 -179.79 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.968 ' NH2' HD11 ' A' ' 53' ' ' ILE . 15.0 mtm180 -93.69 128.84 40.08 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.564 -179.086 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.7 mtp180 -126.94 139.15 53.27 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.155 0.502 . . . . 0.0 111.456 179.74 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.578 HD11 ' HB3' ' A' ' 95' ' ' PHE . 32.3 tp -112.51 132.83 54.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.057 -179.6 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.0 t -109.45 129.68 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.822 0.344 . . . . 0.0 110.648 179.982 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.475 HG23 ' CD1' ' B' ' 261' ' ' ILE . 3.8 m -86.28 111.93 20.91 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.715 -179.368 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 79.5 mt -80.42 142.76 13.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.15 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -93.56 159.02 15.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.992 0.425 . . . . 0.0 111.587 179.994 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.425 ' HB3' HG21 ' B' ' 249' ' ' VAL . 89.9 mtm180 -59.12 -29.8 67.66 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.417 179.682 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.4 m -75.51 -15.41 60.4 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.43 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.8 31.83 7.18 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -179.86 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.7 t -119.66 131.17 72.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.835 0.35 . . . . 0.0 110.911 -179.496 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -74.96 139.42 42.98 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.436 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.84 -115.57 1.65 Allowed Glycine 0 CA--C 1.534 1.227 0 C-N-CA 120.118 -1.039 . . . . 0.0 112.11 -179.355 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.71 146.68 43.65 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.264 1.976 . . . . 0.0 112.909 -178.717 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -109.77 146.9 34.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.031 -179.622 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.764 ' CD2' HD11 ' A' ' 37' ' ' ILE . 40.3 t80 -117.27 101.29 53.03 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.584 -179.813 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -72.47 127.35 12.44 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 121.714 1.61 . . . . 0.0 111.546 -178.743 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.606 HD13 ' NH2' ' A' ' 5' ' ' ARG . 62.6 mt -78.02 52.29 1.06 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.985 -178.555 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.6 p -61.83 -33.28 73.87 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.398 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 68.6 mt -74.06 141.87 45.69 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.818 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 94.7 p -67.07 -16.61 64.45 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.879 0.371 . . . . 0.0 110.814 -179.35 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 56.4 m -130.83 132.46 45.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.962 -179.992 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.661 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 2.6 t -128.25 120.04 26.38 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.828 179.471 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.667 HD21 ' OE1' ' A' ' 47' ' ' GLN . 27.6 tp -120.15 130.98 54.85 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.541 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.661 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 35.6 m-85 -108.15 144.29 35.75 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.826 179.92 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 149.23 -178.92 26.44 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 120.928 -0.654 . . . . 0.0 112.074 177.929 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.413 ' HD2' HH11 ' A' ' 31' ' ' ARG . 45.6 mtm180 -69.72 -32.88 71.68 Favored 'General case' 0 CA--C 1.522 -0.119 0 CA-C-O 120.936 0.398 . . . . 0.0 111.256 178.76 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.562 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -52.78 135.68 38.26 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -178.813 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.435 ' C ' ' N ' ' A' ' 35' ' ' CYS . 80.1 mt -63.89 -43.45 97.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.48 179.419 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -51.48 -18.9 1.2 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.406 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.562 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 13.9 m -68.79 129.13 39.04 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.718 179.037 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -60.42 -28.63 68.42 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.689 -179.103 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.764 HD11 ' CD2' ' A' ' 20' ' ' PHE . 48.2 mm -122.5 116.0 47.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.9 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -100.79 131.44 46.68 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.678 -179.39 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.629 HG21 HD12 ' A' ' 41' ' ' LEU . 91.8 mt -119.52 130.36 74.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.205 -0.598 . . . . 0.0 109.798 -179.549 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -78.04 27.81 0.18 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.207 -178.594 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.712 ' O ' HG12 ' A' ' 44' ' ' VAL . 16.0 mt -95.3 110.73 52.1 Favored Pre-proline 0 C--N 1.325 -0.483 0 C-N-CA 120.592 -0.443 . . . . 0.0 109.827 179.769 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.524 ' HB3' HG11 ' B' ' 228' ' ' VAL . 37.8 Cg_exo -56.55 -12.05 7.79 Favored 'Trans proline' 0 N--CA 1.499 1.809 0 C-N-CA 122.115 1.877 . . . . 0.0 113.223 -179.266 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.471 HG23 HG13 ' A' ' 91' ' ' ILE . 6.6 m -102.64 9.14 9.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -178.888 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.712 HG12 ' O ' ' A' ' 41' ' ' LEU . 8.8 p -103.3 106.59 20.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.021 179.894 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.532 ' O ' ' O ' ' A' ' 44' ' ' VAL . 0.4 OUTLIER -34.05 167.08 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 114.911 -1.04 . . . . 0.0 113.122 -178.109 . . . . . . . . 3 3 . 1 . 053 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -62.37 -42.82 99.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.471 -178.723 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.667 ' OE1' HD21 ' A' ' 28' ' ' LEU . 88.0 mm-40 -111.97 -20.03 12.14 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.421 -179.445 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.463 ' NE2' HG23 ' A' ' 90' ' ' ILE . 24.6 t60 36.55 -75.26 0.0 OUTLIER 'General case' 0 C--O 1.236 0.361 0 CA-C-N 114.89 -1.05 . . . . 0.0 113.493 179.685 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.66 ' O ' HD12 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -133.27 135.91 45.21 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.759 -178.118 . . . . . . . . 3 3 . 1 . 053 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -128.56 134.82 48.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.776 179.809 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.0 mt -117.05 132.73 65.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.21 179.701 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -118.56 127.24 53.43 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.647 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.968 HD11 ' NH2' ' A' ' 5' ' ' ARG . 86.7 mt -102.72 116.27 46.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.487 0.66 . . . . 0.0 111.593 -179.562 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.448 ' O ' ' C ' ' A' ' 55' ' ' GLU . 79.6 m-70 -111.83 139.04 47.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.114 -179.921 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 54' ' ' HIS . 97.6 mt-10 -40.55 -34.69 0.38 Allowed 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.654 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -60.73 -67.96 0.35 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.832 178.599 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -155.63 -171.89 3.94 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.286 0.565 . . . . 0.0 111.571 -179.03 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.18 128.17 54.81 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.668 179.18 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.4 mt -125.48 133.53 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -178.77 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.415 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 16.5 tp -97.89 131.68 44.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.138 179.024 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -113.35 136.2 53.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.959 179.992 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -97.97 104.1 16.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.37 -179.921 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -95.99 -8.7 33.0 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.17 179.636 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.09 109.58 7.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.933 0.397 . . . . 0.0 111.364 -179.579 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.7 p -90.44 -18.07 26.05 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.07 179.022 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.8 HG22 HG22 ' B' ' 236' ' ' VAL . 0.2 OUTLIER -87.91 -40.88 13.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.221 -179.901 . . . . . . . . 3 3 . 1 . 053 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -145.67 99.1 4.45 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.47 -179.766 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -57.86 147.49 81.02 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 122.049 1.833 . . . . 0.0 112.779 179.99 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.0 m -68.08 137.17 54.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.884 179.519 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -98.52 143.62 28.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.977 179.353 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.773 ' HB ' HD11 ' A' ' 76' ' ' ILE . 5.1 p -130.82 137.9 54.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.342 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 50.58 31.84 6.11 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.946 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.91 28.68 68.29 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.355 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.414 ' N ' ' O ' ' A' ' 71' ' ' VAL . 14.8 t -137.97 135.29 35.86 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.846 0.355 . . . . 0.0 111.357 -179.726 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.4 p -61.73 143.03 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.914 -179.207 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.773 HD11 ' HB ' ' A' ' 71' ' ' VAL . 96.5 mt -108.3 106.01 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.931 -179.855 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -68.74 -42.04 78.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.428 179.067 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.55 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.7 OUTLIER -135.01 -179.92 1.21 Allowed Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.522 -178.774 . . . . . . . . 3 3 . 1 . 053 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.473 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 32.1 Cg_exo -57.48 146.94 81.25 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.631 2.221 . . . . 0.0 112.699 -179.595 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 18.2 m -139.67 142.81 31.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.48 -179.315 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.538 HH21 ' CE ' ' A' ' 83' ' ' LYS . 61.2 ttp180 -76.07 131.28 39.37 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.579 179.013 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.3 mt -80.61 135.5 36.07 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-O 121.148 0.499 . . . . 0.0 111.69 -179.413 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.538 ' CE ' HH21 ' A' ' 81' ' ' ARG . 99.0 mttt -129.07 150.57 50.41 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.868 178.937 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.481 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 6.3 t60 -55.3 115.72 2.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.831 0.348 . . . . 0.0 111.748 -179.172 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.24 -18.75 18.09 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.936 -0.65 . . . . 0.0 111.595 179.016 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -69.52 136.37 51.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.34 0.591 . . . . 0.0 110.608 179.913 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.8 t -114.5 131.24 67.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.04 -179.014 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 92.8 mt -97.23 132.26 42.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.645 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.8 m -118.55 124.92 48.71 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.338 -178.544 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.474 ' O ' ' N ' ' A' ' 92' ' ' ASP . 78.0 mt -112.38 126.96 69.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.134 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.743 HG22 ' NH2' ' B' ' 245' ' ' ARG . 33.8 mm 38.74 -97.09 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -178.749 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.546 ' CB ' HH22 ' B' ' 245' ' ' ARG . 44.2 t0 -123.09 17.45 10.0 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.097 0.475 . . . . 0.0 110.494 178.883 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.527 ' NH1' ' O ' ' B' ' 259' ' ' ASP . 29.7 mmm-85 -122.96 138.78 54.59 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.855 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.3 m -135.04 151.59 50.92 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.87 -179.248 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.578 ' HB3' HD11 ' A' ' 7' ' ' LEU . 88.6 m-85 -122.62 120.83 34.9 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.246 179.271 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.52 ' O ' HD12 ' A' ' 7' ' ' LEU . 38.9 ttp-105 -81.16 130.55 35.07 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.831 -179.671 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -97.69 125.55 42.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.035 -179.917 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -128.15 129.25 46.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.327 -179.956 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.481 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 60.5 t-20 -118.03 112.95 20.92 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.778 -179.411 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 121.062 0.458 . . . . 0.0 110.586 179.559 . . . . . . . . 0 0 . 1 . 053 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . 0.524 HG11 ' HB3' ' A' ' 42' ' ' PRO . 15.3 m . . . . . 0 N--CA 1.446 -0.66 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 . . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.54 ' C ' ' H ' ' B' ' 231' ' ' GLN . 50.7 t0 -80.95 124.05 28.82 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.607 -179.577 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . 0.412 ' N ' ' O1P' ' B' ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.54 ' H ' ' C ' ' B' ' 229' ' ' ASP . 3.9 pt20 -140.63 31.54 1.86 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.256 0.55 . . . . 0.0 110.048 178.888 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -110.42 -159.07 16.77 Favored Glycine 0 CA--C 1.531 1.078 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 179.986 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -58.1 152.63 50.64 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 C-N-CA 123.573 2.848 . . . . 0.0 113.089 179.593 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.453 HG21 ' OG1' ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.25 160.03 42.9 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.61 1.54 . . . . 0.0 111.846 -179.787 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.8 HG22 HG22 ' A' ' 66' ' ' THR . 15.7 t -98.84 128.38 50.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.206 -179.744 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 5.7 t -69.96 126.96 31.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.548 -179.848 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 053 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -58.45 -25.37 73.36 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.963 2.442 . . . . 0.0 113.115 -178.769 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 96.0 m -72.88 -45.66 57.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.288 0.566 . . . . 0.0 109.779 179.123 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.433 ' CE2' ' NE ' ' B' ' 245' ' ' ARG . 80.3 t80 -57.38 -44.42 84.42 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.968 -179.722 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.491 HD23 HH21 ' B' ' 245' ' ' ARG . 97.0 mt -63.51 -41.83 98.5 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.641 -179.796 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -66.31 -37.23 84.91 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.707 0.289 . . . . 0.0 111.108 -179.497 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 78.2 ttt-85 -63.1 -47.62 82.07 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.636 -179.429 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.743 ' NH2' HG22 ' A' ' 91' ' ' ILE . 55.9 mtm180 -65.53 -39.3 91.62 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.621 -179.585 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -59.79 -40.3 87.85 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.325 179.991 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 28.2 m -68.22 -42.83 79.19 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.5 0.667 . . . . 0.0 109.587 178.301 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -62.54 -36.26 82.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.862 179.731 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.671 HG23 ' O ' ' B' ' 245' ' ' ARG . 95.0 t -65.63 -43.49 93.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.961 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -55.19 -26.19 37.58 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.025 179.502 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -86.22 2.28 47.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.714 177.937 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.468 ' N ' ' O ' ' B' ' 249' ' ' VAL . 97.8 mt -113.21 -175.49 2.68 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.332 -179.585 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 38.7 p30 -134.1 169.86 16.52 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.789 179.733 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -68.59 -18.25 64.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.583 179.287 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -74.91 0.46 15.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.089 -178.998 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -77.0 86.01 3.52 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.386 179.564 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -66.6 -8.15 25.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.698 -178.503 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -127.0 104.61 8.09 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.184 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.527 ' O ' ' NH1' ' A' ' 93' ' ' ARG . 63.4 t0 -121.93 86.9 2.66 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.116 -0.634 . . . . 0.0 112.53 -178.746 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 51.08 2.63 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 177.992 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.475 ' CD1' HG23 ' A' ' 9' ' ' THR . 76.7 mt -112.18 134.6 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 119.101 0.864 . . . . 0.0 109.571 178.814 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 40.4 t -127.74 134.11 66.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.993 -179.74 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -94.33 115.14 27.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.662 -179.016 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -66.3 -46.92 75.31 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.628 179.78 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.09 155.16 43.19 Favored Pre-proline 0 N--CA 1.454 -0.267 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.708 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -63.0 141.77 85.24 Favored 'Trans proline' 0 C--N 1.302 -1.906 0 C-N-CA 122.86 2.373 . . . . 0.0 113.085 179.965 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 37.4 pt . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.607 178.355 . . . . . . . . 0 0 . 1 . 054 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo . . . . . 0 N--CA 1.494 1.504 0 CA-C-O 120.888 0.287 . . . . 0.0 112.133 . . . . . . . . . 0 0 . 1 . 054 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.489 ' O ' ' O ' ' A' ' 99' ' ' ASN . 23.8 m -140.73 -84.22 0.21 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.787 -179.526 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.522 ' CZ ' HG23 ' A' ' 53' ' ' ILE . 86.2 mtt85 -82.31 134.24 35.26 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.906 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -131.14 139.06 49.74 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 120.266 -0.573 . . . . 0.0 111.984 -179.075 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 34.2 mt -115.75 133.65 55.81 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.958 179.948 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.606 HG22 ' CD2' ' A' ' 19' ' ' HIS . 76.3 t -107.25 127.61 62.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.349 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 m -91.01 114.75 27.35 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 112.943 0.719 . . . . 0.0 112.943 -177.31 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.743 HD12 ' OG ' ' A' ' 94' ' ' SER . 92.6 mt -80.99 141.9 14.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.645 179.242 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -90.43 159.54 16.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.063 0.458 . . . . 0.0 110.748 179.157 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.516 HH22 ' HB2' ' B' ' 248' ' ' GLN . 81.3 mtp180 -58.77 -32.75 69.58 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.405 -179.426 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.7 p -74.45 -13.62 60.73 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.584 179.674 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.26 29.91 7.28 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -179.745 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.3 t -117.58 130.17 72.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.721 0.296 . . . . 0.0 111.205 -179.494 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -73.62 139.26 45.37 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 177.773 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.2 -112.8 1.43 Allowed Glycine 0 CA--C 1.53 0.978 0 C-N-CA 120.161 -1.018 . . . . 0.0 112.232 -179.088 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -73.45 144.8 36.91 Favored 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 122.138 1.892 . . . . 0.0 113.009 -178.524 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.606 ' CD2' HG22 ' A' ' 8' ' ' VAL . 66.1 m170 -104.0 135.58 45.26 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.453 179.662 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.876 ' CD2' HD11 ' A' ' 37' ' ' ILE . 47.4 t80 -106.07 91.97 6.05 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.024 -179.274 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -72.95 139.27 29.83 Favored 'Trans proline' 0 N--CA 1.488 1.193 0 C-N-CA 121.634 1.556 . . . . 0.0 111.352 -179.33 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 86.2 mt -101.31 124.03 46.36 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.423 -178.592 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 65.3 p -117.37 -8.93 10.99 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.602 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 54.9 mt -101.73 149.78 23.81 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.587 -179.083 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 97.3 p -70.18 -12.14 61.39 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.27 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.434 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 41.9 m -132.35 133.98 44.64 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.257 -0.577 . . . . 0.0 111.89 -179.544 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 10.0 t -125.25 116.46 22.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.323 -0.853 . . . . 0.0 108.901 178.384 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.705 HD21 ' OE1' ' A' ' 47' ' ' GLN . 52.1 tp -116.88 132.8 56.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.997 -178.04 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.499 ' O ' ' O ' ' A' ' 47' ' ' GLN . 42.1 m-85 -110.16 136.67 49.02 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.366 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 164.48 -166.79 38.04 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 120.111 -1.042 . . . . 0.0 112.344 179.541 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.645 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 85.4 mtm-85 -89.27 -29.03 19.5 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 115.606 -0.297 . . . . 0.0 110.462 179.581 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.461 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -57.23 153.1 23.49 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 121.273 -0.489 . . . . 0.0 112.715 -177.73 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.525 ' CD1' ' NH1' ' A' ' 38' ' ' ARG . 9.4 tp -66.55 -41.87 89.12 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 N-CA-C 110.356 -0.238 . . . . 0.0 110.356 179.389 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.488 ' N ' HG23 ' A' ' 33' ' ' ILE . 50.9 tp10 -56.49 -27.07 56.16 Favored 'General case' 0 N--CA 1.461 0.124 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.647 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.461 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 19.3 m -54.54 122.75 11.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.693 179.701 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.462 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 55.5 m-20 -60.87 -33.35 72.95 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -179.566 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.876 HD11 ' CD2' ' A' ' 20' ' ' PHE . 44.0 mm -119.1 109.91 28.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 177.792 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.525 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 84.9 mtp180 -98.21 134.83 40.71 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -179.097 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 98.1 mt -120.42 132.34 70.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.028 -179.922 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -76.11 29.11 0.11 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.498 -0.773 . . . . 0.0 112.113 -178.495 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.57 HD12 ' CZ ' ' A' ' 93' ' ' ARG . 44.9 mt -106.12 130.07 23.56 Favored Pre-proline 0 CA--C 1.534 0.348 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.448 178.973 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.25 -12.65 25.49 Favored 'Trans proline' 0 N--CA 1.49 1.268 0 C-N-CA 122.448 2.099 . . . . 0.0 112.736 -179.455 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.479 HG21 ' CE2' ' B' ' 241' ' ' PHE . 30.7 m -92.57 -0.61 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.695 179.851 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.645 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 46.1 t -86.71 132.83 31.36 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.452 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.014 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.6 m -70.15 167.96 16.67 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.331 0.586 . . . . 0.0 111.22 -178.588 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt -62.64 -40.55 97.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.703 -178.872 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.705 ' OE1' HD21 ' A' ' 28' ' ' LEU . 95.4 mm-40 -115.38 -20.9 10.09 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.928 0.394 . . . . 0.0 110.483 -179.568 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.3 t60 34.05 -74.52 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -179.947 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.652 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.99 136.92 46.33 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -177.97 . . . . . . . . 3 3 . 1 . 054 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -128.23 132.2 48.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.861 179.558 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.9 mt -116.59 134.09 61.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.69 179.901 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -111.21 129.01 56.09 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.957 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.522 HG23 ' CZ ' ' A' ' 5' ' ' ARG . 47.9 mm -100.16 118.6 47.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.304 0.573 . . . . 0.0 111.253 -179.138 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.452 ' O ' ' C ' ' A' ' 55' ' ' GLU . 98.0 m-70 -119.86 130.79 55.04 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.915 179.296 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' A' ' 54' ' ' HIS . 81.8 tt0 -40.83 -31.35 0.16 Allowed 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -179.866 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.458 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 98.4 mm-40 -64.82 -67.76 0.41 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.94 178.649 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.459 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 5.5 tp10 -153.49 -170.51 3.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.0 -179.481 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.459 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -118.43 128.41 54.59 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.513 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.0 mt -114.51 130.67 68.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.134 0.492 . . . . 0.0 112.23 -178.732 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.525 ' HB2' HD11 ' A' ' 82' ' ' LEU . 26.7 tp -99.56 128.88 45.68 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.471 179.996 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -112.7 136.7 51.98 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.742 179.649 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.539 HD21 ' CA ' ' A' ' 68' ' ' PRO . 59.5 t-20 -95.96 110.32 22.55 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.403 -178.763 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -103.94 -7.92 20.03 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 179.84 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.559 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 97.9 p -81.37 98.48 8.21 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.18 -179.419 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.3 m -74.64 -38.86 62.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.449 0.642 . . . . 0.0 109.482 178.427 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p -65.46 -39.21 91.74 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.342 -179.629 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.559 ' O ' ' OG ' ' A' ' 64' ' ' SER . 54.2 m-80 -146.18 92.79 5.2 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.424 -179.53 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.539 ' CA ' HD21 ' A' ' 62' ' ' ASN . 46.8 Cg_exo -54.22 145.98 52.14 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.541 2.16 . . . . 0.0 111.873 -179.072 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.442 ' HB ' HD11 ' A' ' 76' ' ' ILE . 17.7 m -70.87 150.6 45.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.956 179.665 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -117.23 140.16 49.88 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.777 -179.768 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 48.9 t -130.92 134.86 61.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.353 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 51.79 32.32 9.44 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -179.37 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.27 27.06 68.86 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.957 179.688 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.9 t -140.15 138.05 34.9 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 117.359 0.579 . . . . 0.0 111.599 179.864 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.479 HG13 ' HB2' ' A' ' 68' ' ' PRO . 10.9 t -68.67 140.68 18.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.685 179.958 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.442 HD11 ' HB ' ' A' ' 69' ' ' THR . 7.0 pt -112.08 84.33 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.949 179.403 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -61.91 -32.17 72.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.449 179.532 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -118.46 168.21 10.01 Favored Pre-proline 0 CA--C 1.531 0.249 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.534 179.587 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.71 145.09 99.09 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 122.205 1.936 . . . . 0.0 112.52 179.965 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.2 p -138.9 140.0 39.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.986 179.652 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.6 mtm-85 -73.25 131.46 41.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.846 179.243 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.525 HD11 ' HB2' ' A' ' 60' ' ' LEU . 95.8 mt -84.95 137.57 33.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.114 0.483 . . . . 0.0 111.58 -179.136 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -126.95 151.06 49.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.563 179.028 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.462 ' C ' ' CD2' ' A' ' 84' ' ' HIS . 4.9 t60 -56.94 123.28 14.56 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.849 -179.736 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.26 -21.76 28.29 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 179.592 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -69.24 138.47 53.99 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.023 0.44 . . . . 0.0 110.513 179.784 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.2 t -111.75 131.1 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.85 -177.928 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.7 mt -93.01 134.32 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.117 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 94.5 m -126.55 126.5 43.78 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 119.933 -0.707 . . . . 0.0 112.492 -179.026 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.577 ' O ' ' N ' ' A' ' 92' ' ' ASP . 89.6 mt -110.48 125.66 67.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.085 -0.961 . . . . 0.0 108.695 178.367 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.518 HD12 HH22 ' A' ' 93' ' ' ARG . 89.2 mt 38.85 -91.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.113 -179.087 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.577 ' N ' ' O ' ' A' ' 90' ' ' ILE . 42.7 t0 -126.8 21.17 7.0 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.385 179.82 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.632 ' NH1' HH12 ' B' ' 245' ' ' ARG . 50.4 mtm-85 -129.01 143.39 50.85 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.321 -179.607 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.743 ' OG ' HD12 ' A' ' 10' ' ' ILE . 28.9 p -139.61 153.87 47.45 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 119.796 -0.762 . . . . 0.0 111.729 179.634 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -123.38 121.6 36.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.623 178.439 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -74.24 126.57 30.91 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.373 -179.534 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.49 ' CE2' ' OD1' ' A' ' 99' ' ' ASN . 92.0 t80 -94.51 121.42 36.04 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.929 0.395 . . . . 0.0 110.719 -179.972 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.449 ' HG3' ' CE1' ' A' ' 84' ' ' HIS . 84.7 tt0 -131.63 116.57 17.54 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.725 -179.959 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.49 ' OD1' ' CE2' ' A' ' 97' ' ' TYR . 91.5 m-20 -65.17 -42.44 93.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.974 0.416 . . . . 0.0 111.044 179.905 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.168 179.822 . . . . . . . . 0 0 . 1 . 054 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 56.0 t . . . . . 0 N--CA 1.454 -0.232 0 CA-C-O 120.75 0.31 . . . . 0.0 110.84 . . . . . . . . . 0 0 . 1 . 054 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.496 ' O ' ' OD1' ' B' ' 229' ' ' ASP . 66.6 t0 -170.22 -26.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.945 179.621 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . 0.552 ' O ' ' NE2' ' B' ' 231' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.552 ' NE2' ' O ' ' B' ' 230' ' ' SEP . 1.0 OUTLIER 160.57 40.76 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.201 -179.485 . . . . . . . . 3 3 . 1 . 054 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -121.95 -168.99 13.45 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 -179.611 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.35 157.15 57.48 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.822 2.348 . . . . 0.0 112.637 -179.852 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 054 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -61.06 144.79 99.48 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.207 1.938 . . . . 0.0 112.814 179.709 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.541 HG13 ' O ' ' B' ' 236' ' ' VAL . 13.1 p -79.5 125.29 38.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.716 179.26 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.9 t -57.37 120.67 8.6 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.502 -0.479 . . . . 0.0 109.845 -179.795 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 054 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.95 -19.55 48.5 Favored 'Trans proline' 0 N--CA 1.491 1.371 0 C-N-CA 122.209 1.939 . . . . 0.0 111.284 179.37 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 79.8 m -74.79 -43.85 52.59 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 177.764 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.479 ' CE2' HG21 ' A' ' 43' ' ' VAL . 88.3 t80 -57.52 -46.54 83.69 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.994 -179.584 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 92.5 mt -64.0 -41.62 97.42 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.259 -179.938 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.8 -39.5 87.77 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.99 -179.901 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . 0.499 ' O ' ' OG ' ' B' ' 247' ' ' SER . 62.8 ttp180 -60.51 -43.97 96.5 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.943 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.632 HH12 ' NH1' ' A' ' 93' ' ' ARG . 79.3 mtp180 -61.77 -40.1 93.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.553 -179.508 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.21 -38.22 85.81 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 120.504 -0.478 . . . . 0.0 109.853 179.127 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . 0.499 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 80.2 p -68.62 -42.57 77.9 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 178.389 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . 0.516 ' HB2' HH22 ' A' ' 12' ' ' ARG . 82.5 mt-30 -61.89 -35.59 78.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.536 179.568 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 22.5 t -60.64 -46.87 95.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.941 0.401 . . . . 0.0 110.159 179.221 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -62.93 -28.72 70.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.002 179.311 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -85.92 -15.9 40.21 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.896 179.902 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 83.5 mt -101.18 179.86 4.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.488 179.838 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -141.25 175.48 9.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.626 179.693 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -64.7 -10.14 25.02 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.925 -179.188 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -65.7 -16.42 63.74 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.844 0.354 . . . . 0.0 110.36 179.73 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.491 ' O ' ' OD1' ' B' ' 256' ' ' ASP . 48.6 p30 -72.06 51.0 0.22 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.457 179.501 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -56.62 -10.09 0.91 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.69 -178.761 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.66 ' O ' ' N ' ' B' ' 260' ' ' GLU . 96.1 m-20 -94.14 -2.24 52.99 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.947 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.476 ' C ' ' O ' ' B' ' 258' ' ' ASP . 36.2 p30 10.54 48.48 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 114.333 -1.303 . . . . 0.0 113.006 179.136 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.66 ' N ' ' O ' ' B' ' 258' ' ' ASP . 99.5 mt-10 59.44 -0.39 0.18 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 179.092 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.464 ' N ' ' O ' ' B' ' 258' ' ' ASP . 60.0 mt -110.42 137.19 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 120.516 -0.474 . . . . 0.0 109.867 179.722 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 44.7 t -126.89 134.63 65.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.731 179.465 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -94.14 117.25 29.84 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.462 -178.85 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -67.93 -47.99 67.17 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.15 -179.985 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -82.62 157.99 66.36 Favored Pre-proline 0 CA--C 1.516 -0.354 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.681 -179.123 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.82 138.54 49.01 Favored 'Trans proline' 0 C--N 1.301 -1.933 0 C-N-CA 122.5 2.133 . . . . 0.0 112.641 179.586 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 1.4 pt . . . . . 0 C--N 1.325 -0.491 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.259 178.522 . . . . . . . . 0 0 . 1 . 055 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 N--CA 1.489 1.229 0 CA-C-O 120.697 0.207 . . . . 0.0 111.789 . . . . . . . . . 0 0 . 1 . 055 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 78.9 p -137.92 -37.84 0.58 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.933 0.397 . . . . 0.0 110.73 -179.855 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.787 ' NH1' ' HB2' ' A' ' 58' ' ' ALA . 96.0 mtt-85 -96.24 117.77 31.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.594 -179.53 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.596 ' HE ' ' CE1' ' A' ' 19' ' ' HIS . 85.6 mtp180 -131.37 139.02 49.4 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.054 0.454 . . . . 0.0 111.601 179.877 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.628 HD12 ' O ' ' A' ' 96' ' ' ARG . 37.1 tp -114.26 128.88 56.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.486 179.519 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 64.4 t -108.68 131.6 58.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.694 -0.403 . . . . 0.0 110.026 -179.684 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.403 HG21 HD12 ' B' ' 261' ' ' ILE . 18.3 m -82.56 152.23 26.06 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.601 0.715 . . . . 0.0 112.181 -178.714 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.413 HD12 ' HB3' ' A' ' 94' ' ' SER . 96.5 mt -120.08 140.2 44.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.101 177.46 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 73.0 mttt -89.05 157.12 18.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.17 0.509 . . . . 0.0 110.501 179.551 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.562 ' NH2' ' O ' ' B' ' 245' ' ' ARG . 79.3 mtp180 -56.35 -31.03 63.39 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.665 -179.758 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.3 m -77.83 -9.33 58.99 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.764 -0.375 . . . . 0.0 110.339 179.589 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.83 38.98 5.35 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 179.878 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.4 t -124.09 133.42 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 120.92 0.39 . . . . 0.0 111.64 -179.692 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -76.71 138.66 40.12 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.078 178.939 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -134.47 -116.43 1.65 Allowed Glycine 0 CA--C 1.538 1.508 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.965 -179.521 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.95 152.09 45.95 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 122.499 2.133 . . . . 0.0 113.096 -179.163 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.596 ' CE1' ' HE ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -116.14 158.77 22.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.935 0.397 . . . . 0.0 110.48 179.904 . . . . . . . . 3 3 . 1 . 055 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.663 ' CD2' HD11 ' A' ' 37' ' ' ILE . 36.9 t80 -124.15 108.38 29.9 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.589 -179.382 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -75.58 127.95 10.67 Favored 'Trans proline' 0 N--CA 1.488 1.201 0 C-N-CA 121.605 1.537 . . . . 0.0 111.361 -179.196 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 61.6 mt -82.86 49.41 1.5 Allowed 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.137 -178.808 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.6 t -63.1 -32.5 73.9 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 178.75 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.49 ' HG ' HE22 ' B' ' 265' ' ' GLN . 68.5 mt -70.77 142.25 51.4 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.831 179.711 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.5 m -63.87 -22.96 67.16 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.507 -179.289 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.3 m -133.27 133.93 43.27 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.953 -179.761 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.676 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 3.0 t -127.14 114.87 18.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.81 179.664 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.588 HD21 ' OE1' ' A' ' 47' ' ' GLN . 54.2 tp -111.55 125.69 54.19 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.228 -178.741 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.676 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 18.4 m-85 -100.69 128.51 46.71 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 177.93 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 179.26 -155.86 17.01 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 120.027 -1.082 . . . . 0.0 112.309 -179.588 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.599 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 81.8 mtm-85 -109.98 -25.23 10.37 Favored 'General case' 0 N--CA 1.46 0.067 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.074 179.902 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.48 161.29 21.92 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.194 -0.763 . . . . 0.0 111.194 -179.13 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.508 HD12 ' NH1' ' A' ' 38' ' ' ARG . 10.9 tp -67.38 -39.44 82.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.949 0.404 . . . . 0.0 110.418 179.959 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.427 ' N ' HG23 ' A' ' 33' ' ' ILE . 97.7 mt-10 -57.48 -31.58 66.11 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.109 -179.981 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.3 m -50.81 120.64 4.97 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.022 179.803 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -60.71 -33.4 72.83 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.406 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.663 HD11 ' CD2' ' A' ' 20' ' ' PHE . 96.4 mt -124.94 116.92 48.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.395 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.508 ' NH1' HD12 ' A' ' 33' ' ' ILE . 83.9 mtp180 -103.31 137.26 41.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.507 -177.927 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.644 HG21 HD12 ' A' ' 41' ' ' LEU . 92.7 mt -120.22 131.34 72.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.534 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -73.83 25.98 0.07 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.651 -178.234 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.644 HD12 HG21 ' A' ' 39' ' ' ILE . 15.1 mt -101.68 122.95 45.84 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.647 179.947 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.9 -8.68 21.57 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 122.295 1.997 . . . . 0.0 112.144 -179.753 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.2 m -92.91 0.74 9.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.656 179.325 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.599 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 93.7 t -98.27 103.47 14.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.858 179.449 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.538 ' O ' ' O ' ' A' ' 44' ' ' VAL . 1.4 t -34.11 162.11 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.451 0.643 . . . . 0.0 112.022 -178.846 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -60.69 -41.85 95.97 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.019 -0.992 . . . . 0.0 112.175 -178.371 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.588 ' OE1' HD21 ' A' ' 28' ' ' LEU . 90.8 mm-40 -107.67 -18.04 13.94 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.556 0.693 . . . . 0.0 109.902 179.589 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.0 t60 37.22 -78.16 0.0 OUTLIER 'General case' 0 C--O 1.239 0.53 0 CA-C-N 114.541 -1.209 . . . . 0.0 113.738 179.901 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.584 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -134.54 139.23 45.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.115 0.483 . . . . 0.0 112.072 -178.455 . . . . . . . . 3 3 . 1 . 055 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -129.15 125.26 36.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.555 179.594 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.5 mt -109.32 133.79 53.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.102 179.863 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.458 ' CD ' ' NE2' ' A' ' 54' ' ' HIS . 74.5 tt0 -113.17 126.37 55.37 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.324 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.8 mm -98.63 118.61 45.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.325 0.583 . . . . 0.0 112.141 -178.201 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.492 ' O ' ' N ' ' A' ' 56' ' ' GLN . 96.5 m-70 -119.46 132.22 55.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.375 178.411 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.469 ' C ' ' O ' ' A' ' 54' ' ' HIS . 76.0 tt0 -40.72 -28.37 0.07 Allowed 'General case' 0 CA--C 1.518 -0.25 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.719 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.492 ' N ' ' O ' ' A' ' 54' ' ' HIS . 86.0 mt-30 -66.41 -68.47 0.37 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.329 178.387 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.491 ' CB ' ' HE ' ' A' ' 81' ' ' ARG . 1.4 pt-20 -156.12 -168.81 2.86 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.843 -179.307 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.787 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -114.52 128.66 56.45 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.039 179.474 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.2 mt -116.85 127.94 74.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.2 0.524 . . . . 0.0 111.157 -179.748 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.2 tp -95.92 129.18 43.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.507 -179.69 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -115.68 136.32 53.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.984 179.636 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.699 ' ND2' ' H ' ' A' ' 69' ' ' THR . 12.8 t-20 -99.4 110.53 23.01 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.121 179.935 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -99.59 -8.38 24.56 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 120.856 0.36 . . . . 0.0 110.55 179.365 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.0 t -76.17 99.05 4.57 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.063 179.964 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 45.9 t -75.09 -44.59 46.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.663 0.744 . . . . 0.0 109.527 178.463 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.683 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -62.83 -43.36 98.99 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.495 -1.23 . . . . 0.0 111.021 -179.17 . . . . . . . . 3 3 . 1 . 055 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -143.39 97.07 5.65 Favored Pre-proline 0 N--CA 1.468 0.436 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.216 -179.792 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.414 ' HB2' HG13 ' A' ' 75' ' ' VAL . 31.5 Cg_exo -57.84 146.3 86.75 Favored 'Trans proline' 0 N--CA 1.499 1.844 0 C-N-CA 122.294 1.996 . . . . 0.0 112.963 179.553 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.699 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 29.1 m -69.34 137.05 52.58 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.068 178.927 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -98.69 140.16 33.32 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.548 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.622 ' HB ' HD11 ' A' ' 76' ' ' ILE . 25.2 t -132.96 137.12 54.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.359 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 54.61 33.59 19.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.136 0.494 . . . . 0.0 109.914 -179.34 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.73 30.24 66.42 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.952 179.473 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.2 m -145.16 140.35 27.9 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 117.464 0.632 . . . . 0.0 112.193 -179.505 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.414 HG13 ' HB2' ' A' ' 68' ' ' PRO . 25.2 t -70.44 136.23 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.677 179.944 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.622 HD11 ' HB ' ' A' ' 71' ' ' VAL . 88.6 mt -107.81 117.69 53.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.495 179.943 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -89.16 -29.13 19.55 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.68 178.928 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.562 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.0 OUTLIER -126.03 166.61 20.49 Favored Pre-proline 0 N--CA 1.467 0.401 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.122 -178.947 . . . . . . . . 3 3 . 1 . 055 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.07 148.96 91.36 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 122.469 2.112 . . . . 0.0 112.354 -179.946 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.2 m -141.41 151.55 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 121.354 0.597 . . . . 0.0 112.605 -179.559 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.491 ' HE ' ' CB ' ' A' ' 57' ' ' GLU . 74.6 ttt180 -78.13 128.31 33.6 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.543 179.066 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.482 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 96.9 mt -81.64 134.03 35.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.119 0.485 . . . . 0.0 111.229 -179.625 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -128.39 152.12 48.56 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.117 179.265 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -53.8 117.76 3.42 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.489 -179.535 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.62 -3.41 27.71 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -179.248 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.499 ' OD1' HG13 ' A' ' 71' ' ' VAL . 45.7 t0 -80.34 121.29 25.49 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.083 -0.339 . . . . 0.0 110.083 179.628 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.497 HG22 ' HG2' ' A' ' 96' ' ' ARG . 74.5 t -108.43 132.68 55.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.042 -178.249 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.436 HG23 ' CG2' ' A' ' 69' ' ' THR . 84.8 mt -99.11 131.98 45.35 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.682 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.3 m -115.93 125.04 52.05 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.345 0.593 . . . . 0.0 111.061 -179.179 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.468 ' O ' ' C ' ' A' ' 91' ' ' ILE . 92.0 mt -118.85 123.31 71.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.898 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.609 HD12 ' CB ' ' B' ' 237' ' ' CYS . 46.7 mm 35.13 -104.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.972 -179.727 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.505 ' N ' HG22 ' A' ' 91' ' ' ILE . 37.1 p-10 -105.91 11.11 32.13 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -179.555 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.558 HH21 ' CG ' ' B' ' 260' ' ' GLU . 86.0 mtt-85 -127.58 147.31 50.34 Favored 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.193 -179.426 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.413 ' HB3' HD12 ' A' ' 10' ' ' ILE . 29.0 t -137.18 153.22 50.5 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.079 0.466 . . . . 0.0 110.331 179.271 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.602 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 93.6 m-85 -126.64 129.14 47.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.426 179.76 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.628 ' O ' HD12 ' A' ' 7' ' ' LEU . 99.9 mtt180 -94.15 135.07 35.92 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.26 -179.003 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.561 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 83.8 t80 -99.91 124.2 44.97 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.357 179.912 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -124.89 127.53 47.25 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.728 179.508 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.478 ' O ' ' O ' ' A' ' 100' ' ' GLU . 63.5 t-20 -106.86 103.51 12.95 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.171 179.436 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.478 ' O ' ' O ' ' A' ' 99' ' ' ASN . 82.3 tt0 . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.157 -179.521 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . 0.453 HG21 ' HE ' ' A' ' 31' ' ' ARG . 30.5 m . . . . . 0 N--CA 1.452 -0.366 0 CA-C-O 120.877 0.37 . . . . 0.0 110.78 . . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -87.87 3.31 48.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.524 -179.509 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . 0.531 ' O ' ' NE2' ' B' ' 231' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.531 ' NE2' ' O ' ' B' ' 230' ' ' SEP . 0.7 OUTLIER 159.17 27.99 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.376 -179.925 . . . . . . . . 3 3 . 1 . 055 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -119.24 -155.79 9.89 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.956 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.45 160.45 41.7 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 122.699 2.266 . . . . 0.0 113.083 -179.459 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 055 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -70.83 168.95 21.48 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 121.736 1.624 . . . . 0.0 111.936 179.453 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.683 ' CG2' HG22 ' A' ' 66' ' ' THR . 37.0 t -114.08 133.4 60.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.751 179.952 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . 0.609 ' CB ' HD12 ' A' ' 91' ' ' ILE . 2.6 t -73.25 124.17 25.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.668 179.43 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . 0.456 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . 0.456 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 31.6 Cg_exo -59.64 -24.76 76.62 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.511 2.141 . . . . 0.0 112.571 -179.663 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 99.2 m -73.21 -46.02 52.81 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.375 0.607 . . . . 0.0 109.709 178.067 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -57.65 -45.36 85.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.485 -179.433 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 95.8 mt -64.17 -41.4 97.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.548 -179.25 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -63.19 -41.5 99.2 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.225 -179.951 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -62.49 -43.44 98.82 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.976 0.417 . . . . 0.0 110.055 179.533 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.562 ' O ' ' NH2' ' A' ' 12' ' ' ARG . 24.4 mmt180 -61.26 -43.02 99.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.64 -179.473 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.66 -38.99 92.49 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.803 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 11.1 t -64.72 -46.22 83.2 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 177.696 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . 0.556 ' O ' ' N ' ' B' ' 252' ' ' LEU . 83.6 mt-30 -60.39 -37.74 81.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.123 179.709 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.508 HG23 ' O ' ' B' ' 245' ' ' ARG . 61.9 t -60.92 -45.65 97.91 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 C-N-CA 120.217 -0.593 . . . . 0.0 109.744 179.898 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -60.17 -27.31 67.01 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.908 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -95.1 -14.36 24.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.894 179.671 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.556 ' N ' ' O ' ' B' ' 248' ' ' GLN . 61.1 tp -72.17 138.8 47.88 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.983 0.42 . . . . 0.0 110.901 -179.807 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -94.07 128.79 40.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.704 179.995 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . 0.435 ' C ' ' H ' ' B' ' 256' ' ' ASP . 99.7 m-20 -66.25 -29.32 69.54 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.216 -179.891 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 31.2 p-10 -63.29 2.56 0.37 Allowed 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.973 -179.216 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.601 ' O ' ' N ' ' B' ' 258' ' ' ASP . 92.0 m-20 -87.31 -22.55 25.06 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.124 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 14.1 tttm 41.33 13.01 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.205 179.812 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.601 ' N ' ' O ' ' B' ' 256' ' ' ASP . 96.3 m-20 -131.4 103.41 6.42 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.096 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.557 ' CG ' ' H ' ' B' ' 260' ' ' GLU . 30.5 p-10 -71.14 -102.14 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.847 -178.458 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.558 ' CG ' HH21 ' A' ' 93' ' ' ARG . 97.6 mt-10 -148.49 18.37 1.05 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.771 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.602 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 60.3 mt -111.11 138.07 40.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.867 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 48.6 t -128.55 136.08 60.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.682 0.277 . . . . 0.0 110.296 179.502 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -99.2 122.03 41.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.276 0.56 . . . . 0.0 111.791 -178.465 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -65.71 -44.3 86.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.021 179.233 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . 0.49 HE22 ' HG ' ' A' ' 24' ' ' LEU . 0.3 OUTLIER -103.77 162.14 20.86 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.737 -178.831 . . . . . . . . 3 3 . 1 . 055 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -60.75 152.79 67.02 Favored 'Trans proline' 0 N--CA 1.499 1.836 0 C-N-CA 123.17 2.58 . . . . 0.0 112.702 179.376 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 40.1 pt . . . . . 0 C--N 1.327 -0.39 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.55 -179.844 . . . . . . . . 0 0 . 1 . 056 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo . . . . . 0 N--CA 1.487 1.088 0 N-CA-C 111.125 -0.375 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 056 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 52.9 p -78.44 -31.94 48.28 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.016 -179.265 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.5 mtt85 -100.43 122.06 42.56 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.972 -178.919 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -132.14 142.08 49.35 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.173 179.909 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.498 HD12 ' O ' ' A' ' 96' ' ' ARG . 40.0 tp -114.68 125.25 53.52 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.493 179.494 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.4 HG12 ' CD2' ' A' ' 19' ' ' HIS . 32.0 m -104.85 132.82 50.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.701 -179.413 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.446 ' HG1' ' HE2' ' A' ' 95' ' ' PHE . 3.1 m -79.68 142.83 35.16 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.386 -179.119 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.622 HD12 ' OG ' ' A' ' 94' ' ' SER . 86.0 mt -111.49 135.94 49.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 177.492 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -89.2 157.73 18.15 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.627 179.291 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.923 HH21 HD22 ' B' ' 252' ' ' LEU . 87.8 mtm180 -57.2 -26.57 60.88 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.151 -179.191 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 44.9 m -80.48 -12.53 59.54 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 179.541 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.23 35.89 5.87 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.955 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.6 t -124.21 133.56 68.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 120.803 0.335 . . . . 0.0 110.793 -179.101 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -72.26 130.33 40.54 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.546 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -119.98 -122.68 3.03 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.282 -178.826 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.58 145.17 51.65 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 121.357 1.372 . . . . 0.0 112.402 -179.458 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.4 ' CD2' HG12 ' A' ' 8' ' ' VAL . 61.6 m170 -103.72 140.34 37.73 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.642 -179.975 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.473 ' CD2' HD11 ' A' ' 37' ' ' ILE . 59.3 t80 -114.39 96.19 42.16 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.073 -179.466 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -59.28 125.88 19.27 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.93 1.754 . . . . 0.0 112.497 -179.01 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 89.0 mt -85.62 44.91 1.14 Allowed 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.533 -179.893 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 66.3 p -60.17 -30.69 69.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.979 0.419 . . . . 0.0 109.943 179.57 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 68.5 mt -72.54 144.98 47.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.22 178.987 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.09 -20.64 65.83 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.568 -178.343 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.499 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 23.0 m -133.05 136.95 46.25 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.655 -179.321 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.595 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 3.7 t -129.43 118.36 22.03 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.794 178.052 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.544 HD12 ' O ' ' A' ' 49' ' ' CYS . 49.5 tp -114.55 130.61 56.78 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.173 -178.859 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.711 ' CE2' HD12 ' A' ' 37' ' ' ILE . 9.1 m-85 -109.21 138.28 45.81 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.195 -0.911 . . . . 0.0 108.91 179.174 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.42 -166.72 36.67 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.145 179.105 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.574 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 81.7 mtm-85 -89.81 -29.62 18.52 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 179.8 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.562 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -52.96 148.77 12.28 Favored Glycine 0 CA--C 1.521 0.458 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.314 -179.413 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.522 HG23 ' N ' ' A' ' 34' ' ' GLU . 11.1 tp -66.01 -39.83 85.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.874 0.369 . . . . 0.0 110.191 -179.98 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.522 ' N ' HG23 ' A' ' 33' ' ' ILE . 78.3 mm-40 -58.78 -21.99 57.13 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.217 -178.373 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.562 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 14.3 m -56.86 121.05 8.96 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.829 -179.804 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.499 ' OD2' ' O ' ' A' ' 26' ' ' THR . 95.3 m-20 -57.93 -26.06 61.72 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.17 179.807 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.711 HD12 ' CE2' ' A' ' 29' ' ' PHE . 86.3 mt -130.06 122.08 53.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 176.848 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.466 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 83.9 mtp180 -105.6 135.15 47.54 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.358 -178.737 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.9 mt -119.97 129.56 75.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.945 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -75.74 24.65 0.12 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -177.771 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.563 ' CD2' ' NH2' ' B' ' 245' ' ' ARG . 34.0 mt -92.49 125.55 55.58 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 119.841 -0.744 . . . . 0.0 110.848 179.667 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -72.62 -8.93 23.31 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.048 1.832 . . . . 0.0 112.558 -179.151 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.6 m -101.55 5.13 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.393 -179.648 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.574 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 40.7 t -99.09 106.65 19.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.152 -179.843 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.551 ' O ' ' O ' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -31.96 162.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.554 -178.762 . . . . . . . . 3 3 . 1 . 056 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -59.22 -47.39 85.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.3 -178.933 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.63 ' O ' ' N ' ' A' ' 49' ' ' CYS . 98.4 mt-30 -107.25 -12.44 15.36 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.491 0.662 . . . . 0.0 110.071 179.592 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.464 ' H ' ' HB3' ' A' ' 45' ' ' SER . 20.0 t60 37.99 -75.51 0.0 OUTLIER 'General case' 0 C--O 1.239 0.539 0 CA-C-N 114.812 -1.085 . . . . 0.0 113.765 179.744 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.63 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -139.1 140.72 38.06 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.584 -178.664 . . . . . . . . 3 3 . 1 . 056 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -128.04 127.61 43.47 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.893 179.51 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 91.4 mt -110.16 135.02 50.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.319 -179.951 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -117.97 128.42 54.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.513 178.149 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 94.2 mt -111.95 117.73 55.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.498 0.666 . . . . 0.0 111.603 -179.225 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.588 ' O ' ' N ' ' A' ' 56' ' ' GLN . 89.3 m-70 -117.59 144.86 44.73 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.94 179.63 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 54' ' ' HIS . 80.0 mm-40 -38.94 -23.91 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.215 -0.594 . . . . 0.0 109.928 -179.825 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.588 ' N ' ' O ' ' A' ' 54' ' ' HIS . 56.3 tt0 -67.76 -68.78 0.36 Allowed 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.267 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -161.66 -158.27 0.54 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.034 179.337 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.504 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -112.81 131.43 55.7 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.059 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 80.0 mt -120.78 131.03 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 121.061 0.457 . . . . 0.0 112.231 -179.354 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.719 HD22 HD12 ' A' ' 88' ' ' ILE . 28.8 tp -102.29 131.43 48.88 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.635 -179.376 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -112.81 133.44 54.8 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.593 179.132 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.631 HD21 ' CB ' ' A' ' 68' ' ' PRO . 57.4 t-20 -95.0 107.84 19.89 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -178.675 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -98.75 -11.58 21.75 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.401 179.693 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.9 t -84.1 100.26 11.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.236 179.593 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.6 p -83.55 -40.7 18.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.528 0.68 . . . . 0.0 109.393 179.298 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.67 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -60.64 -43.15 97.89 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.012 -0.994 . . . . 0.0 109.986 -179.984 . . . . . . . . 3 3 . 1 . 056 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -141.41 97.32 6.8 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.088 178.695 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.631 ' CB ' HD21 ' A' ' 62' ' ' ASN . 52.9 Cg_endo -66.4 152.73 80.28 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 121.932 1.754 . . . . 0.0 113.165 -178.19 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.843 ' O ' HG22 ' A' ' 76' ' ' ILE . 18.5 m -73.98 153.99 39.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.572 -179.25 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.47 ' O ' ' N ' ' A' ' 89' ' ' THR . 74.0 mt-30 -113.82 140.09 48.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.527 178.947 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.4 t -128.63 135.42 62.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.344 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.428 ' H ' HG13 ' A' ' 87' ' ' VAL . 84.9 m-20 52.07 32.94 11.11 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -178.96 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.02 28.23 68.91 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.783 179.707 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 69.9 m -140.6 140.53 35.11 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.997 179.884 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 52.1 t -65.23 136.87 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.589 179.827 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.843 HG22 ' O ' ' A' ' 69' ' ' THR . 7.5 tt -104.57 89.64 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.779 178.793 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -63.88 -35.19 79.83 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.722 -179.483 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.47 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 1.7 mt-10 -128.02 168.46 15.33 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.803 -179.475 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.84 143.75 80.07 Favored 'Trans proline' 0 N--CA 1.501 1.967 0 C-N-CA 122.282 1.988 . . . . 0.0 112.815 -178.747 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.48 HG12 HD12 ' A' ' 76' ' ' ILE . 4.7 p -139.87 142.95 31.18 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 121.329 0.585 . . . . 0.0 111.782 179.571 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -75.17 133.65 41.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.701 179.782 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.522 HD11 ' HB2' ' A' ' 60' ' ' LEU . 56.9 mt -92.5 134.33 35.07 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.801 -179.098 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.518 ' O ' ' OD2' ' A' ' 86' ' ' ASP . 99.8 mttt -120.14 153.07 36.72 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.904 -179.825 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.489 ' HD1' ' C ' ' A' ' 99' ' ' ASN . 9.3 t60 -51.1 119.13 3.71 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.243 -179.317 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.89 -14.61 34.38 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -179.614 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.518 ' OD2' ' O ' ' A' ' 83' ' ' LYS . 2.1 p30 -69.28 131.1 44.33 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.15 179.422 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.428 HG13 ' H ' ' A' ' 72' ' ' ASN . 13.5 p -105.31 140.55 22.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.56 -179.198 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.719 HD12 HD22 ' A' ' 60' ' ' LEU . 38.6 mm -102.99 128.94 55.45 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 177.851 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.47 ' N ' ' O ' ' A' ' 70' ' ' GLN . 41.1 m -121.91 130.21 53.16 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -177.654 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.532 ' O ' ' N ' ' A' ' 93' ' ' ARG . 97.5 mt -115.9 129.74 71.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 113.881 -1.509 . . . . 0.0 107.398 177.442 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.688 HG21 ' SG ' ' B' ' 237' ' ' CYS . 23.5 mt -31.74 107.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.022 0.439 . . . . 0.0 111.118 -178.37 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.513 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 2.2 t70 88.89 -25.66 0.08 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 178.691 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 90' ' ' ILE . 55.6 mtt85 -130.09 139.85 50.89 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 121.329 -0.149 . . . . 0.0 110.618 -178.658 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.622 ' OG ' HD12 ' A' ' 10' ' ' ILE . 34.0 p -142.51 158.56 43.55 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.222 0.534 . . . . 0.0 110.474 -179.997 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.463 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 59.1 m-85 -132.06 133.65 44.61 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.79 179.414 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.507 ' HG3' HD11 ' A' ' 10' ' ' ILE . 78.3 mtp85 -95.75 136.89 35.57 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 119.767 -0.773 . . . . 0.0 109.988 179.0 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -95.46 125.7 40.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.227 -179.116 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -122.09 122.19 38.69 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.265 179.062 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.489 ' C ' ' HD1' ' A' ' 84' ' ' HIS . 49.4 t-20 -122.94 106.32 10.75 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.708 -179.976 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 121.059 0.457 . . . . 0.0 110.328 179.76 . . . . . . . . 0 0 . 1 . 056 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . 0.449 HG12 ' N ' ' B' ' 229' ' ' ASP . 6.2 t . . . . . 0 N--CA 1.451 -0.416 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 . . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' B' ' 231' ' ' GLN . 55.6 t0 -98.94 100.98 12.22 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.609 179.838 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 056 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.492 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 75.8 mt-30 -121.73 27.01 8.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.575 -179.718 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -111.1 -157.04 14.48 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 179.667 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -77.06 158.83 34.07 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 123.165 2.577 . . . . 0.0 112.456 -179.378 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 056 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.65 167.75 25.79 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.661 2.24 . . . . 0.0 111.702 -179.908 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.67 ' CG2' HG22 ' A' ' 66' ' ' THR . 25.6 t -110.3 133.2 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-O 120.949 0.404 . . . . 0.0 110.505 -179.509 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . 0.688 ' SG ' HG21 ' A' ' 91' ' ' ILE . 3.5 t -76.36 130.93 38.79 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.157 0.503 . . . . 0.0 110.608 -179.643 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . 0.463 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . 0.463 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 34.6 Cg_exo -57.81 -24.09 62.13 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 122.872 2.382 . . . . 0.0 112.605 -178.827 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 99.9 m -72.73 -43.97 62.28 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.628 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.453 ' HD2' ' HG ' ' B' ' 237' ' ' CYS . 82.7 t80 -56.91 -47.68 80.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.264 -179.679 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.447 HD21 HG23 ' A' ' 91' ' ' ILE . 92.7 mt -62.61 -41.2 98.85 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.927 -179.173 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -63.63 -40.0 95.76 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.517 -0.473 . . . . 0.0 109.749 179.886 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . 0.537 ' O ' ' OG ' ' B' ' 247' ' ' SER . 72.9 ttt180 -59.84 -43.6 94.53 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.176 179.35 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.563 ' NH2' ' CD2' ' A' ' 41' ' ' LEU . 22.2 mmt180 -62.44 -41.41 98.7 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.675 -179.279 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.71 -39.06 90.16 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.261 0.553 . . . . 0.0 109.769 179.658 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . 0.537 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 57.6 p -67.15 -42.87 83.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.141 178.306 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . 0.465 ' O ' ' N ' ' B' ' 252' ' ' LEU . 83.8 mt-30 -61.33 -35.84 78.52 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.028 179.789 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 49.8 t -60.84 -45.69 97.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 O-C-N 121.595 -0.691 . . . . 0.0 110.118 178.638 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -58.77 -27.38 64.92 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.383 -179.876 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -100.24 -7.33 24.78 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.024 179.014 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.923 HD22 HH21 ' A' ' 12' ' ' ARG . 35.5 tp -77.02 144.89 38.35 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.597 -179.705 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -113.65 148.0 37.09 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.35 179.154 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -66.4 -17.25 64.67 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.075 0.464 . . . . 0.0 110.139 179.347 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -66.58 -14.36 62.26 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.237 -179.528 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.401 ' C ' ' H ' ' B' ' 258' ' ' ASP . 64.2 t0 -95.32 76.91 3.41 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.995 0.426 . . . . 0.0 110.221 179.425 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -76.12 14.62 0.68 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.959 -178.988 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.676 ' O ' ' N ' ' B' ' 260' ' ' GLU . 88.0 m-20 -97.02 -4.73 39.16 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.186 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.48 ' C ' ' O ' ' B' ' 258' ' ' ASP . 53.7 p30 -1.83 59.9 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 113.858 -1.519 . . . . 0.0 113.476 179.766 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.676 ' N ' ' O ' ' B' ' 258' ' ' ASP . 96.6 mt-10 48.85 4.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 178.061 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.463 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 82.7 mt -112.06 130.95 64.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.821 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 60.8 t -126.4 134.34 66.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.16 -179.434 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -94.95 119.81 34.11 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.329 0.585 . . . . 0.0 110.975 -179.334 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.99 -43.92 97.45 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.071 179.48 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -100.98 155.31 36.45 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.619 -179.227 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -68.43 143.98 59.77 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 123.099 2.533 . . . . 0.0 113.659 -179.029 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 43.6 pt . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.047 178.35 . . . . . . . . 0 0 . 1 . 057 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo . . . . . 0 N--CA 1.493 1.468 0 CA-C-O 120.856 0.273 . . . . 0.0 112.28 . . . . . . . . . 0 0 . 1 . 057 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.8 p -84.4 -28.2 27.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.104 -179.605 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.78 ' NH1' ' HB2' ' A' ' 58' ' ' ALA . 95.7 mtt-85 -97.65 115.51 28.05 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.09 -178.877 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.456 HH12 ' HG3' ' A' ' 100' ' ' GLU . 84.6 mtt85 -129.44 138.54 51.51 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.997 0.427 . . . . 0.0 111.897 -179.874 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.603 HD11 ' HB3' ' A' ' 95' ' ' PHE . 32.5 tp -115.01 136.89 52.62 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.999 179.29 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 53.9 t -112.91 132.22 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.606 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 m -94.91 117.69 30.56 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.821 0.675 . . . . 0.0 112.821 -178.136 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 95.6 mt -82.97 143.71 11.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.85 179.569 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.477 ' NZ ' ' HA ' ' B' ' 257' ' ' LYS . 98.5 mttt -90.6 159.89 16.21 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.042 178.419 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.601 HH12 ' CD ' ' B' ' 260' ' ' GLU . 55.0 mtm-85 -58.51 -28.29 65.28 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.403 -179.397 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.6 p -77.87 -8.6 58.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.876 0.37 . . . . 0.0 110.457 179.907 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.68 34.05 8.08 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.94 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.6 t -118.91 132.8 67.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.866 0.365 . . . . 0.0 111.065 -179.81 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -72.07 136.03 46.48 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.315 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -127.7 -121.77 2.45 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 120.541 -0.837 . . . . 0.0 111.94 -179.135 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -73.12 149.57 46.5 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.313 2.009 . . . . 0.0 112.865 -178.601 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -106.45 152.9 23.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.638 179.868 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.65 ' CD2' HD11 ' A' ' 37' ' ' ILE . 30.1 t80 -121.36 92.92 48.78 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.017 179.789 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -59.51 125.95 19.33 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.636 1.558 . . . . 0.0 110.713 -179.595 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.2 mt -90.83 45.83 1.28 Allowed 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.558 -178.242 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 94.5 p -60.53 -23.4 64.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.216 0.532 . . . . 0.0 109.635 179.545 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.7 mt -77.1 144.44 38.5 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.323 179.494 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.7 m -67.81 -18.75 64.94 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -178.373 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 59.3 m -134.72 135.16 41.75 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.671 -179.559 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.6 t -127.2 119.47 26.48 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.059 178.871 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.481 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 35.9 tp -113.45 128.12 56.34 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 121.178 -0.209 . . . . 0.0 111.537 -178.609 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.731 ' CE2' HD12 ' A' ' 37' ' ' ILE . 13.5 m-85 -107.69 130.48 54.92 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.532 179.181 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -176.26 -171.3 39.89 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.707 179.883 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.558 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 39.7 ttp-105 -93.9 -9.31 37.6 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.249 -0.476 . . . . 0.0 111.298 -179.422 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.485 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -93.93 158.88 23.44 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.671 -178.651 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.448 HG23 ' N ' ' A' ' 34' ' ' GLU . 11.1 tp -66.81 -40.22 85.41 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 115.078 -0.561 . . . . 0.0 110.496 179.82 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.448 ' N ' HG23 ' A' ' 33' ' ' ILE . 85.2 tt0 -53.15 -22.43 6.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.035 0.445 . . . . 0.0 110.053 -179.695 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 2.7 m -71.52 139.31 49.46 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.762 179.839 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.481 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 99.6 m-20 -60.8 -31.26 70.64 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.145 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.731 HD12 ' CE2' ' A' ' 29' ' ' PHE . 84.5 mt -129.27 120.33 50.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.489 177.34 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 77.2 ttt-85 -107.41 135.1 49.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.843 -178.981 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 99.7 mt -117.45 130.72 71.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.902 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -73.65 34.98 0.08 Allowed 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -177.588 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.691 ' CD1' ' HE ' ' A' ' 93' ' ' ARG . 37.6 mt -114.41 132.18 22.94 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.582 179.478 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.47 -12.01 26.87 Favored 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 122.574 2.182 . . . . 0.0 112.997 -179.036 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.438 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 19.2 m -88.11 0.9 6.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.416 179.743 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.648 HG22 HH22 ' A' ' 93' ' ' ARG . 55.7 t -90.54 131.77 36.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.156 179.331 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 46.4 t -70.75 165.31 23.32 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.345 -179.107 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 70.2 mttt -61.9 -39.97 93.83 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.142 -179.26 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.679 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.9 mt-30 -120.5 -21.54 6.76 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.046 179.772 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 16.6 t60 36.15 -75.05 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 178.991 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.679 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -128.52 132.66 48.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.104 0.478 . . . . 0.0 111.677 -178.891 . . . . . . . . 3 3 . 1 . 057 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -128.51 125.25 37.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.138 179.234 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.0 mt -107.07 133.38 51.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.526 -179.529 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.417 ' CD ' ' NE2' ' A' ' 54' ' ' HIS . 82.4 tt0 -117.24 126.06 52.15 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.562 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.5 119.72 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -177.625 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.553 ' O ' ' N ' ' A' ' 56' ' ' GLN . 97.4 m-70 -114.46 141.28 47.89 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.628 178.813 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 54' ' ' HIS . 58.8 mp0 -40.71 -24.46 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.801 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.553 ' N ' ' O ' ' A' ' 54' ' ' HIS . 99.8 mm-40 -71.86 -69.16 0.41 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.548 178.848 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.452 ' OE2' ' NE ' ' A' ' 81' ' ' ARG . 2.3 pt-20 -152.61 -174.71 5.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.294 0.568 . . . . 0.0 111.602 -178.95 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.78 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -110.47 130.18 55.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.672 179.156 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 86.2 mt -121.08 131.04 74.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.162 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 24.0 tp -100.01 129.16 46.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.318 179.442 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -113.51 135.38 53.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.149 179.573 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.466 HD21 ' HA ' ' A' ' 68' ' ' PRO . 9.1 t-20 -95.09 105.62 17.56 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.866 -0.333 . . . . 0.0 111.338 -179.988 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -98.07 -6.96 30.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.209 178.847 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.422 ' HB2' HD21 ' A' ' 62' ' ' ASN . 1.0 OUTLIER -69.36 102.28 1.72 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.401 179.846 . . . . . . . . 3 3 . 1 . 057 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.6 p -89.51 -6.51 56.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.788 0.328 . . . . 0.0 110.484 179.397 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.839 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.2 OUTLIER -101.28 -42.12 6.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.332 0.587 . . . . 0.0 109.637 179.928 . . . . . . . . 3 3 . 1 . 057 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.427 HD21 ' HA ' ' B' ' 236' ' ' VAL . 69.8 m-20 -141.21 99.87 6.45 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.668 -179.919 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.466 ' HA ' HD21 ' A' ' 62' ' ' ASN . 48.8 Cg_exo -55.53 146.44 63.87 Favored 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 122.595 2.197 . . . . 0.0 112.982 -179.282 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.458 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 48.3 m -72.67 139.17 47.12 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.167 179.278 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -105.88 140.45 38.89 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.754 -179.589 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.652 HG13 ' OD1' ' A' ' 86' ' ' ASP . 54.9 t -132.23 132.9 60.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.041 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 52.91 32.93 13.44 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.049 -0.66 . . . . 0.0 109.332 -179.079 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.75 27.98 69.87 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.892 179.858 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 28.9 p -141.02 140.78 34.34 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 117.206 0.503 . . . . 0.0 111.22 179.895 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.401 HG13 ' HB2' ' A' ' 68' ' ' PRO . 13.4 t -72.4 142.48 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.804 -179.79 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.46 HG22 HG21 ' A' ' 80' ' ' VAL . 3.9 pt -115.67 88.69 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.66 178.967 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -63.67 -25.64 68.3 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.361 179.396 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.52 173.62 4.3 Favored Pre-proline 0 C--O 1.233 0.221 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.959 -179.704 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -61.66 142.37 94.14 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.401 2.067 . . . . 0.0 111.812 179.349 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.46 HG21 HG22 ' A' ' 76' ' ' ILE . 79.2 t -135.38 136.7 50.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.615 179.631 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.452 ' NE ' ' OE2' ' A' ' 57' ' ' GLU . 84.0 mtp180 -73.99 131.91 41.87 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.768 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.2 mt -82.45 139.94 33.68 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.954 0.407 . . . . 0.0 110.939 -179.38 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -131.12 151.35 51.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.698 -179.836 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.612 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 4.1 t60 -54.06 114.94 1.79 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.391 179.982 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.81 -6.39 29.42 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 -179.382 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.652 ' OD1' HG13 ' A' ' 71' ' ' VAL . 26.7 t0 -79.4 125.28 29.33 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.306 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 42.6 t -110.03 130.54 63.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.604 -178.341 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 95.6 mt -92.46 130.62 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.804 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 25.7 m -121.65 126.75 49.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.449 0.643 . . . . 0.0 112.277 -178.124 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.73 HG21 HH12 ' A' ' 93' ' ' ARG . 70.8 mt -121.69 127.54 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.442 178.977 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.489 HG22 ' N ' ' A' ' 92' ' ' ASP . 82.9 mt 38.59 -101.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.629 -179.511 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.489 ' N ' HG22 ' A' ' 91' ' ' ILE . 26.5 t70 -115.88 15.72 16.28 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 120.666 -0.413 . . . . 0.0 111.693 -179.183 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.73 HH12 HG21 ' A' ' 90' ' ' ILE . 4.5 ptt85 -131.64 146.32 52.13 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.839 179.125 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 53.0 m -139.24 155.48 47.74 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.572 -179.388 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.603 ' HB3' HD11 ' A' ' 7' ' ' LEU . 61.4 m-85 -122.22 121.04 35.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.657 179.775 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.518 ' O ' HD12 ' A' ' 7' ' ' LEU . 42.4 ttm180 -83.7 130.95 34.97 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.878 0.371 . . . . 0.0 111.59 -178.872 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.641 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 76.6 t80 -96.37 123.62 40.08 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.23 -179.47 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -123.53 126.29 46.44 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.895 179.801 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.612 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 59.7 t-20 -112.81 121.86 45.96 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.243 179.43 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.456 ' HG3' HH12 ' A' ' 6' ' ' ARG . 79.2 mm-40 . . . . . 0 C--N 1.329 -0.312 0 C-N-CA 120.646 -0.421 . . . . 0.0 110.824 -179.522 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 31.3 m . . . . . 0 N--CA 1.448 -0.57 0 CA-C-O 121.413 0.625 . . . . 0.0 111.489 . . . . . . . . . 0 0 . 1 . 057 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.664 ' O ' ' N ' ' B' ' 231' ' ' GLN . 60.4 t0 -88.67 117.31 27.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.459 -179.716 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . 0.554 ' O ' ' CB ' ' B' ' 231' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.664 ' N ' ' O ' ' B' ' 229' ' ' ASP . 25.0 mt-30 121.81 31.05 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 O-C-N 124.712 1.257 . . . . 0.0 109.964 179.916 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . 0.545 ' N ' HH21 ' A' ' 31' ' ' ARG . . . -98.96 -144.66 17.17 Favored Glycine 0 CA--C 1.534 1.276 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 179.443 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -58.68 150.0 73.04 Favored 'Trans proline' 0 N--CA 1.502 2.001 0 C-N-CA 122.755 2.303 . . . . 0.0 113.126 179.915 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.839 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -61.11 135.75 60.71 Favored 'Trans proline' 0 C--N 1.301 -1.965 0 C-N-CA 122.415 2.077 . . . . 0.0 113.406 -179.24 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.64 ' CG2' HG22 ' A' ' 66' ' ' THR . 31.2 t -65.29 136.6 26.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.864 179.102 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 5.7 t -60.1 121.63 12.38 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.626 -0.429 . . . . 0.0 110.099 -179.685 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 057 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.64 -24.47 70.62 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.224 1.949 . . . . 0.0 112.609 179.405 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 96.2 m -73.33 -44.9 58.03 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.515 0.674 . . . . 0.0 109.334 178.551 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.502 ' HZ ' HD22 ' A' ' 41' ' ' LEU . 80.8 t80 -56.11 -44.8 79.43 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.826 -179.861 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 92.1 mt -62.81 -40.86 98.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 179.818 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -64.42 -39.94 94.8 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.419 -179.26 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 59.8 ttm-85 -60.01 -44.86 94.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.044 0.45 . . . . 0.0 109.962 179.781 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.474 HH21 ' HG2' ' A' ' 12' ' ' ARG . 58.1 mtp180 -63.32 -41.55 98.93 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.749 -179.823 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -62.85 -40.76 98.46 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.239 -0.585 . . . . 0.0 109.806 179.376 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 38.5 t -64.38 -45.05 89.4 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 122.052 0.929 . . . . 0.0 108.679 178.167 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . 0.446 ' O ' ' N ' ' B' ' 252' ' ' LEU . 51.3 tt0 -59.52 -37.28 77.93 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.41 -179.973 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 21.8 t -59.31 -45.07 93.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.753 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -58.59 -30.5 67.25 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.726 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -90.4 -10.57 43.4 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.817 179.258 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.467 HD22 ' NH2' ' A' ' 12' ' ' ARG . 1.0 OUTLIER -115.5 -175.3 2.68 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.207 -179.882 . . . . . . . . 3 3 . 1 . 057 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . 0.416 ' H ' ' HG ' ' B' ' 252' ' ' LEU . 0.4 OUTLIER 73.89 18.23 3.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.803 0.335 . . . . 0.0 111.107 179.768 . . . . . . . . 3 3 . 1 . 057 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . 0.434 ' O ' ' HB2' ' B' ' 255' ' ' ASP . 56.0 m-20 -64.86 -38.48 91.11 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.56 178.92 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . 0.486 ' CG ' ' O ' ' B' ' 255' ' ' ASP . 14.2 t0 156.94 54.78 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.151 -0.931 . . . . 0.0 108.964 -179.47 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.504 ' O ' ' C ' ' B' ' 257' ' ' LYS . 51.6 p-10 -120.16 11.93 11.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.273 -179.295 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . 0.504 ' C ' ' O ' ' B' ' 256' ' ' ASP . 98.1 mttt 29.82 -95.12 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 O-C-N 123.603 0.564 . . . . 0.0 110.623 -179.139 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.476 ' C ' ' O ' ' B' ' 257' ' ' LYS . 89.4 m-20 -29.74 138.36 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.549 -179.9 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.584 ' C ' ' H ' ' B' ' 261' ' ' ILE . 53.1 p30 -126.62 -174.26 3.08 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.88 0.848 . . . . 0.0 111.837 -178.758 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.601 ' CD ' HH12 ' A' ' 12' ' ' ARG . 53.5 mp0 -56.16 9.57 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.164 -1.38 . . . . 0.0 112.345 -179.166 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.584 ' H ' ' C ' ' B' ' 259' ' ' ASP . 69.4 mt -108.58 135.53 47.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.738 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 55.0 t -127.45 134.0 66.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.947 0.404 . . . . 0.0 110.896 -178.384 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -97.38 119.75 36.48 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.557 -179.331 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.85 -43.84 94.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.924 179.038 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -95.79 153.78 39.24 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.362 -179.598 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.85 147.05 80.13 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 123.087 2.525 . . . . 0.0 113.288 -179.273 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.4 pt . . . . . 0 C--N 1.331 -0.223 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.678 178.455 . . . . . . . . 0 0 . 1 . 058 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo . . . . . 0 N--CA 1.492 1.391 0 CA-C-O 121.225 0.427 . . . . 0.0 112.769 . . . . . . . . . 0 0 . 1 . 058 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 50.0 p -102.68 -49.31 3.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.25 179.96 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.485 ' HD2' HD13 ' A' ' 53' ' ' ILE . 84.9 mtt85 -89.39 122.27 32.45 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.493 -179.449 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.436 ' HE ' ' CE1' ' A' ' 19' ' ' HIS . 83.7 mtp180 -124.79 139.44 53.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.24 -179.922 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.579 HD12 ' O ' ' A' ' 96' ' ' ARG . 29.4 tp -116.39 132.83 56.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.133 -179.4 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.892 HG11 ' NH2' ' A' ' 96' ' ' ARG . 67.6 t -108.18 130.19 61.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.36 -179.676 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.601 HG21 ' HZ ' ' B' ' 263' ' ' PHE . 59.2 p -91.28 114.22 26.69 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.455 0.645 . . . . 0.0 112.485 -178.83 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.435 HD12 ' HB3' ' A' ' 94' ' ' SER . 95.5 mt -79.71 140.9 16.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.396 178.953 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -87.69 158.19 18.89 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.15 0.5 . . . . 0.0 111.008 179.179 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.592 ' NH1' ' OE2' ' B' ' 260' ' ' GLU . 81.3 mtp180 -58.3 -31.03 67.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.554 -179.305 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 93.2 p -74.82 -12.79 60.47 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.933 179.275 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.34 25.93 10.57 Favored Glycine 0 CA--C 1.531 1.045 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -179.566 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.2 t -119.27 134.98 61.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.695 0.283 . . . . 0.0 110.541 179.981 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.657 ' CG ' HH22 ' A' ' 96' ' ' ARG . 90.6 m-20 -67.6 139.23 56.86 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.426 -179.837 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -127.04 -123.71 2.66 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.068 -179.023 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.43 146.34 44.51 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 122.321 2.014 . . . . 0.0 113.184 -178.426 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.61 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -111.08 131.01 55.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.094 0.473 . . . . 0.0 111.049 -179.561 . . . . . . . . 3 3 . 1 . 058 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.545 ' CD2' HD11 ' A' ' 37' ' ' ILE . 25.2 t80 -101.35 107.7 51.93 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.014 -179.602 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -73.64 127.45 11.68 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 121.129 1.219 . . . . 0.0 111.645 -179.748 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.9 mt -87.87 50.58 2.02 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.139 -178.769 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 97.4 p -65.97 -19.07 65.74 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.051 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.605 HD11 ' HG2' ' B' ' 265' ' ' GLN . 68.0 mt -79.03 140.57 37.9 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.283 179.848 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.7 t -62.43 -25.5 68.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.866 179.916 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 66.0 m -129.79 130.96 46.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.193 -179.768 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.61 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 8.6 t -129.3 124.17 33.69 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.605 178.903 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.576 HD21 ' HG2' ' A' ' 47' ' ' GLN . 42.8 tp -119.28 132.05 55.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.928 0.394 . . . . 0.0 111.184 -178.747 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.771 ' CE2' HD12 ' A' ' 37' ' ' ILE . 10.0 m-85 -108.97 139.98 43.09 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.022 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 167.76 -155.7 26.77 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 119.942 -1.123 . . . . 0.0 112.069 179.846 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.538 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 37.6 ttp-105 -111.2 -21.64 11.8 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.88 -0.16 . . . . 0.0 110.855 -179.459 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.458 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -73.77 163.59 54.69 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.553 -179.161 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.514 ' CD1' ' NH1' ' A' ' 38' ' ' ARG . 46.2 mm -64.52 -45.67 94.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 O-C-N 122.746 -0.267 . . . . 0.0 110.944 -179.876 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -49.78 -21.95 1.27 Allowed 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.503 179.962 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.572 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 4.8 m -67.75 121.87 16.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.11 -179.513 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -59.41 -25.9 64.7 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.757 -179.494 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.771 HD12 ' CE2' ' A' ' 29' ' ' PHE . 98.1 mt -128.77 124.16 60.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.086 177.64 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.514 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 56.6 mtm180 -110.34 141.43 43.38 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 120.634 -0.427 . . . . 0.0 111.237 -179.704 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.658 HD13 ' HE ' ' A' ' 93' ' ' ARG . 81.0 mt -121.17 132.65 70.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.034 179.916 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -74.75 29.81 0.09 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.569 -177.762 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.712 HD12 ' CZ ' ' A' ' 93' ' ' ARG . 51.5 mt -109.34 133.55 20.77 Favored Pre-proline 0 C--N 1.325 -0.494 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.643 -179.559 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.2 -12.92 25.74 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.741 2.294 . . . . 0.0 112.016 179.598 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.4 m -88.61 3.71 5.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.069 179.448 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.538 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 55.1 t -98.99 130.88 47.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 C-N-CA 120.434 -0.507 . . . . 0.0 109.699 178.432 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 75.6 m -70.74 172.62 8.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.632 -179.077 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.572 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 10.5 mttm -63.79 -41.87 97.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.259 179.939 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.658 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.2 mt-30 -117.48 -16.15 10.21 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 123.337 0.398 . . . . 0.0 111.732 -179.315 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.42 ' NE2' HG23 ' A' ' 90' ' ' ILE . 17.5 t60 33.78 -72.58 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 179.081 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.658 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -135.99 140.32 43.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.067 0.461 . . . . 0.0 112.036 -178.752 . . . . . . . . 3 3 . 1 . 058 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -126.63 135.51 51.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.556 179.918 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 92.3 mt -121.52 134.17 65.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.013 -179.483 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -116.14 127.34 54.75 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.849 179.036 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.485 HD13 ' HD2' ' A' ' 5' ' ' ARG . 82.1 mt -106.57 113.27 42.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 119.853 -0.739 . . . . 0.0 112.288 -179.606 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.426 ' O ' ' C ' ' A' ' 55' ' ' GLU . 98.0 m-70 -113.25 143.89 43.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.742 179.426 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 54' ' ' HIS . 41.3 tt0 -40.9 -30.68 0.14 Allowed 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.028 -0.669 . . . . 0.0 109.4 -179.407 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.47 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 85.7 mt-30 -60.79 -68.88 0.26 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.37 179.131 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.47 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 4.2 tp10 -157.91 -164.95 1.63 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.809 179.775 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.437 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -111.59 126.77 55.36 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 178.317 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 94.4 mt -115.36 131.56 67.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.247 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.443 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 22.0 tp -101.05 131.24 47.04 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.835 179.773 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -114.26 134.71 54.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.499 -179.779 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 56.6 t-20 -92.84 105.06 17.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.933 0.397 . . . . 0.0 111.434 -179.309 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -101.82 -9.56 20.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.277 179.417 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.92 98.2 10.21 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.717 -179.581 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.5 m -76.69 -38.41 54.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.359 0.599 . . . . 0.0 109.854 178.996 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.459 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.2 OUTLIER -62.49 -44.66 95.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.832 -178.688 . . . . . . . . 3 3 . 1 . 058 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.464 HD21 ' HA ' ' B' ' 236' ' ' VAL . 85.4 m-20 -139.16 95.86 9.21 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.624 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -54.8 144.29 66.79 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 121.787 1.658 . . . . 0.0 112.542 -179.038 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 97.0 m -73.42 138.38 45.19 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.625 178.76 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -99.96 137.81 37.91 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.272 179.881 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.663 HG13 ' OD1' ' A' ' 86' ' ' ASP . 54.2 t -131.89 133.21 61.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 178.517 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 53.71 32.1 14.06 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.218 -179.121 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.4 27.66 67.38 Favored Glycine 0 CA--C 1.536 1.38 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.225 179.691 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 58.6 m -144.35 140.45 29.11 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 117.319 0.56 . . . . 0.0 111.657 -179.964 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.444 ' H ' HG22 ' A' ' 75' ' ' VAL . 4.6 m -74.28 146.8 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.748 179.515 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.8 pt -116.43 98.5 6.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.262 0.553 . . . . 0.0 111.549 179.837 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -67.14 -26.58 66.74 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 178.465 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.31 166.36 17.51 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.602 -179.868 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -64.22 150.5 88.18 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.684 2.256 . . . . 0.0 112.183 179.249 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.4 m -141.63 141.99 29.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.347 -179.482 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -74.91 135.22 41.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.966 179.18 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.437 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 98.2 mt -83.82 137.53 33.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.236 0.541 . . . . 0.0 110.838 -179.631 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -129.27 154.85 46.42 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.808 179.974 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -56.99 116.19 3.06 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.843 -178.901 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.06 -12.8 29.06 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -179.743 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.663 ' OD1' HG13 ' A' ' 71' ' ' VAL . 43.6 t0 -67.78 128.47 36.59 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.963 0.411 . . . . 0.0 110.283 179.651 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.411 ' O ' HG13 ' A' ' 87' ' ' VAL . 9.3 p -109.11 134.87 49.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.559 -179.053 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 81.2 mt -106.8 131.17 57.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.275 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.8 m -119.9 123.67 44.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.446 0.641 . . . . 0.0 111.479 -179.033 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.549 HD12 ' CE1' ' A' ' 95' ' ' PHE . 84.8 mt -116.74 124.47 72.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.914 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.402 HG22 ' N ' ' A' ' 92' ' ' ASP . 44.8 mm 44.61 -103.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.773 -179.607 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.664 ' OD1' ' NH1' ' A' ' 93' ' ' ARG . 12.3 p-10 -117.49 17.58 14.5 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.995 0.426 . . . . 0.0 110.488 -179.803 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.712 ' CZ ' HD12 ' A' ' 41' ' ' LEU . 34.2 mtm-85 -127.1 142.68 51.46 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.024 -179.366 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.435 ' HB3' HD12 ' A' ' 10' ' ' ILE . 41.2 t -135.25 150.26 50.02 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.564 -179.826 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.549 ' CE1' HD12 ' A' ' 90' ' ' ILE . 19.2 m-85 -124.97 124.02 41.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.581 -179.892 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.892 ' NH2' HG11 ' A' ' 8' ' ' VAL . 89.8 mtm-85 -85.66 128.41 34.77 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.932 -178.915 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -92.12 124.53 36.28 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.193 179.083 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -127.69 118.55 24.03 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.549 -179.547 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 61.4 t-20 -103.37 104.01 14.07 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.009 179.589 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 . . . . . 0 C--N 1.333 -0.144 0 CA-C-O 120.863 0.364 . . . . 0.0 111.0 -179.252 . . . . . . . . 0 0 . 1 . 058 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . 0.471 ' O ' ' C ' ' B' ' 229' ' ' ASP . 27.7 m . . . . . 0 N--CA 1.451 -0.378 0 CA-C-O 120.697 0.284 . . . . 0.0 110.389 . . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.471 ' C ' ' O ' ' B' ' 228' ' ' VAL . 87.5 m-20 34.83 -111.44 0.06 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.076 -179.417 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 058 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.568 ' O ' ' NZ ' ' A' ' 46' ' ' LYS . 82.6 mt-30 -135.82 -5.74 2.18 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.335 -179.859 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . 0.493 ' N ' HH21 ' A' ' 31' ' ' ARG . . . -50.19 -171.99 0.01 OUTLIER Glycine 0 CA--C 1.527 0.825 0 C-N-CA 121.206 -0.521 . . . . 0.0 112.096 -178.852 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -65.7 160.88 41.37 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 123.519 2.813 . . . . 0.0 113.176 -179.617 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.459 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.87 140.28 31.65 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 121.169 1.246 . . . . 0.0 113.019 -178.878 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.464 ' HA ' HD21 ' A' ' 67' ' ' ASN . 17.5 t -57.56 141.09 15.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.485 -179.597 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 16.5 t -58.8 121.08 10.22 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.455 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . 0.592 ' O2P' HG23 ' B' ' 240' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.39 -29.21 57.49 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 122.447 2.098 . . . . 0.0 113.057 179.127 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . 0.592 HG23 ' O2P' ' B' ' 238' ' ' TPO . 13.7 p -73.96 -39.2 63.9 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.218 179.044 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.42 ' HZ ' HD22 ' A' ' 41' ' ' LEU . 68.3 t80 -57.42 -46.34 83.65 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.357 -179.872 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.457 HD22 ' NH2' ' B' ' 245' ' ' ARG . 94.9 mt -63.45 -40.76 98.0 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.215 179.95 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -58.18 -41.77 84.64 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.14 179.558 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -64.34 -38.8 92.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.447 179.844 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.494 ' NE ' ' CB ' ' A' ' 92' ' ' ASP . 10.1 ttm180 -57.8 -44.93 86.65 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.56 -179.511 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -61.65 -41.23 97.23 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.758 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 10.2 t -63.8 -45.97 87.25 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.323 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . 0.443 ' HG2' HH12 ' A' ' 12' ' ' ARG . 67.0 tp60 -58.51 -41.15 84.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.688 -1.142 . . . . 0.0 111.406 -179.531 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 55.0 t -59.85 -44.56 94.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 C-N-CA 120.559 -0.457 . . . . 0.0 109.792 179.897 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -60.27 -34.17 73.35 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.573 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -74.93 -14.15 60.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.369 179.295 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' B' ' 252' ' ' LEU . 97.7 mt -106.05 166.34 10.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.393 -179.968 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -127.47 160.68 30.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.146 -179.597 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -59.35 -26.98 65.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.949 179.785 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 40.7 p-10 -82.12 1.57 35.46 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.421 -179.119 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -60.25 146.03 45.23 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.193 0.52 . . . . 0.0 109.724 179.083 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -131.04 155.9 46.08 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.007 -179.562 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.508 ' O ' ' N ' ' B' ' 260' ' ' GLU . 94.3 m-20 61.16 50.83 4.68 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.549 0.69 . . . . 0.0 109.534 -178.705 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . . . . . . . . . 55.6 p-10 -58.02 69.0 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.629 -1.169 . . . . 0.0 112.32 -178.946 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.592 ' OE2' ' NH1' ' A' ' 12' ' ' ARG . 95.7 mt-10 60.01 3.43 0.5 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.982 1.105 . . . . 0.0 113.982 178.172 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 73.9 mt -109.41 134.11 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 118.644 0.656 . . . . 0.0 109.691 179.684 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 56.1 t -123.9 131.94 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.052 -179.532 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . 0.601 ' HZ ' HG21 ' A' ' 9' ' ' THR . 51.2 m-85 -98.77 120.64 39.56 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.21 0.528 . . . . 0.0 111.174 -178.683 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -63.05 -48.3 79.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.332 -179.681 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . 0.605 ' HG2' HD11 ' A' ' 24' ' ' LEU . 6.0 mp0 -88.78 161.86 40.3 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.029 -179.068 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -62.28 143.54 94.13 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.276 1.984 . . . . 0.0 112.279 -179.963 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . 0.428 ' CD1' ' O ' ' A' ' 19' ' ' HIS . 4.2 tt . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.877 -179.647 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo . . . . . 0 N--CA 1.492 1.412 0 CA-C-O 120.831 0.263 . . . . 0.0 112.142 . . . . . . . . . 0 0 . 1 . 059 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 73.8 p -102.6 -44.19 5.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.99 0.424 . . . . 0.0 110.409 179.641 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.738 ' NE ' HD13 ' A' ' 53' ' ' ILE . 89.9 mtm-85 -91.24 125.75 36.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.151 -179.75 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 86.5 mtm-85 -131.43 137.14 48.52 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.849 179.522 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.551 HD12 ' O ' ' A' ' 96' ' ' ARG . 40.8 tp -113.32 131.38 55.97 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.983 -179.905 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.6 t -109.07 131.71 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 120.947 0.403 . . . . 0.0 110.984 -179.586 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.426 ' O ' HG22 ' A' ' 9' ' ' THR . 1.8 m -90.65 112.64 24.45 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.748 -179.341 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.7 mt -79.72 144.67 10.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.405 178.646 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -90.6 158.32 17.03 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.142 0.496 . . . . 0.0 110.588 179.17 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 1.091 HH21 HD22 ' B' ' 252' ' ' LEU . 87.2 mtm180 -58.39 -28.39 65.13 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.727 -178.846 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 93.6 p -80.36 -11.22 59.73 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.473 179.795 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.55 31.34 7.16 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.108 179.212 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.1 t -122.61 133.45 68.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.789 0.328 . . . . 0.0 110.729 179.623 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -73.64 138.64 44.93 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.207 179.479 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.66 -118.34 1.93 Allowed Glycine 0 CA--C 1.534 1.225 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.764 -179.899 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.42 146.14 55.29 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 121.912 1.741 . . . . 0.0 112.332 -179.112 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -110.83 158.54 18.58 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.157 0.503 . . . . 0.0 110.649 -179.337 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -125.74 102.0 29.32 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.617 -179.491 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -69.8 128.56 16.16 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 121.279 1.32 . . . . 0.0 111.468 -178.947 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.8 mt -85.72 49.48 1.78 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.543 -178.183 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 92.2 p -61.55 -24.93 66.97 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.055 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.619 HD11 ' HG2' ' B' ' 265' ' ' GLN . 65.7 mt -78.64 141.27 38.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.076 179.779 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 91.9 p -65.33 -19.99 66.2 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.811 179.962 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.409 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 61.8 m -130.28 131.46 45.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.6 -178.852 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.2 t -125.0 112.71 16.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.429 178.385 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.685 HD21 ' OE1' ' A' ' 47' ' ' GLN . 54.7 tp -109.36 127.74 54.57 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.923 -178.593 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.82 ' CE2' HD12 ' A' ' 37' ' ' ILE . 2.5 m-85 -110.07 143.41 40.16 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.745 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 150.98 -166.82 30.5 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.233 178.468 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.531 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 46.2 mtm105 -82.62 -30.98 29.07 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 179.946 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.544 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -50.84 139.08 24.31 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 120.556 -0.83 . . . . 0.0 111.298 -178.854 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.451 HD13 ' HD2' ' A' ' 38' ' ' ARG . 31.3 mm -63.92 -43.79 97.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 121.064 0.459 . . . . 0.0 110.332 179.396 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -55.72 -14.41 2.25 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.132 179.879 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.544 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 56.6 m -64.43 135.2 55.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.93 179.954 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.409 ' OD2' ' O ' ' A' ' 26' ' ' THR . 58.5 m-20 -61.23 -33.84 74.15 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.646 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.82 HD12 ' CE2' ' A' ' 29' ' ' PHE . 88.2 mt -127.32 122.58 60.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 177.471 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.451 ' HD2' HD13 ' A' ' 33' ' ' ILE . 77.5 ttt-85 -111.42 138.6 47.71 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.516 -178.187 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 83.8 mt -119.86 131.48 72.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-O 120.88 0.371 . . . . 0.0 110.409 -179.89 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -78.06 33.82 0.19 Allowed 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 -178.49 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.529 ' CD1' ' CZ ' ' A' ' 93' ' ' ARG . 33.4 mt -109.09 131.86 21.56 Favored Pre-proline 0 C--N 1.325 -0.461 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.293 -179.651 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.79 -15.41 29.94 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.392 2.061 . . . . 0.0 112.874 -179.681 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.55 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 19.2 m -90.27 1.01 8.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.281 179.592 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.531 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 45.3 t -93.25 133.74 33.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.061 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.9 m -71.53 164.09 26.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.4 0.619 . . . . 0.0 112.02 -178.609 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -63.73 -43.3 96.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.187 -178.834 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.685 ' OE1' HD21 ' A' ' 28' ' ' LEU . 93.1 mm-40 -111.95 -17.88 12.78 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.966 0.412 . . . . 0.0 110.148 -179.791 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 14.9 t60 30.66 -76.15 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 179.908 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.623 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.52 137.25 47.09 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -178.43 . . . . . . . . 3 3 . 1 . 059 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -128.69 126.69 40.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.876 179.809 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 91.8 mt -108.71 133.71 52.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.129 0.49 . . . . 0.0 110.738 179.868 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.448 ' OE2' ' CE1' ' A' ' 54' ' ' HIS . 81.0 tt0 -118.23 123.83 46.42 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.354 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.738 HD13 ' NE ' ' A' ' 5' ' ' ARG . 92.5 mt -107.5 119.25 56.78 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 CA-C-O 122.013 0.911 . . . . 0.0 112.858 -178.531 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.461 ' O ' ' C ' ' A' ' 55' ' ' GLU . 98.7 m-70 -108.02 134.14 51.34 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 113.871 -1.513 . . . . 0.0 108.865 179.075 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.461 ' C ' ' O ' ' A' ' 54' ' ' HIS . 97.3 mt-10 -42.5 -33.13 0.63 Allowed 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.524 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.408 ' N ' ' C ' ' A' ' 54' ' ' HIS . 78.6 mt-30 -64.53 -68.33 0.36 Allowed 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.071 -0.968 . . . . 0.0 108.835 177.722 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -143.82 179.12 7.36 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.562 0.696 . . . . 0.0 112.404 -178.567 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.9 120.59 41.96 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.095 178.429 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.7 mt -118.34 133.03 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.994 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.523 ' HB2' HD11 ' A' ' 82' ' ' LEU . 15.7 tp -99.29 129.45 45.51 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.317 179.487 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -110.8 136.89 49.16 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.559 -179.945 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -98.9 106.97 19.29 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.007 0.432 . . . . 0.0 111.905 -179.052 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -100.21 -6.06 26.67 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.779 179.402 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.7 99.18 8.06 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.376 -179.667 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.7 p -88.53 -20.42 25.12 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.738 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.712 HG21 ' O ' ' B' ' 234' ' ' TPO . 2.6 m -74.18 -50.91 17.22 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.467 179.189 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.49 HD21 ' HA ' ' B' ' 236' ' ' VAL . 72.2 m-20 -137.43 99.42 9.66 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 114.698 -1.137 . . . . 0.0 108.923 179.766 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -54.0 144.62 56.18 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 121.954 1.769 . . . . 0.0 113.403 -178.762 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 26.8 m -72.12 139.87 48.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.493 178.581 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -105.1 140.53 38.13 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.166 -0.614 . . . . 0.0 110.648 179.932 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.2 p -134.06 134.22 55.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.707 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 51.6 31.89 8.33 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -179.065 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.92 27.39 68.91 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.887 -179.751 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.7 t -139.07 136.73 35.55 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 117.497 0.649 . . . . 0.0 111.804 -179.839 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.5 m -73.75 143.25 13.87 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.151 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.048 179.667 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.559 ' CG2' HG21 ' A' ' 80' ' ' VAL . 9.9 pt -117.07 100.61 10.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.411 0.624 . . . . 0.0 111.028 179.795 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -71.0 -21.97 62.22 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.072 179.46 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.438 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.3 OUTLIER -130.19 177.21 2.31 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.736 179.78 . . . . . . . . 3 3 . 1 . 059 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.438 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 36.7 Cg_exo -59.96 142.32 98.24 Favored 'Trans proline' 0 N--CA 1.5 1.906 0 C-N-CA 122.865 2.377 . . . . 0.0 112.708 -179.335 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.559 HG21 ' CG2' ' A' ' 76' ' ' ILE . 61.4 t -133.03 139.32 49.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.065 179.602 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.546 HH21 ' CE ' ' A' ' 83' ' ' LYS . 62.5 ttp180 -76.61 126.73 31.49 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.955 179.043 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.523 HD11 ' HB2' ' A' ' 60' ' ' LEU . 94.4 mt -82.78 138.45 34.0 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.942 0.401 . . . . 0.0 111.703 -179.285 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.546 ' CE ' HH21 ' A' ' 81' ' ' ARG . 99.3 mttt -128.38 150.95 49.89 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.035 179.712 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -55.43 122.31 10.92 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.068 0.461 . . . . 0.0 111.174 -179.18 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.96 -16.64 42.73 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 -179.894 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -65.82 136.54 56.32 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.62 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 42.0 t -114.5 132.76 62.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.427 -178.364 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 91.6 mt -95.51 131.43 42.33 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.43 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.7 m -123.98 124.96 43.74 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.6 0.714 . . . . 0.0 112.634 -178.319 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.5 ' O ' ' N ' ' A' ' 92' ' ' ASP . 93.7 mt -113.15 125.91 70.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 114.695 -1.139 . . . . 0.0 108.427 178.432 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.591 HD12 HH22 ' A' ' 93' ' ' ARG . 73.9 mt 39.5 -94.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 C-N-CA 120.716 -0.393 . . . . 0.0 110.53 -179.458 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.517 ' O ' ' OD1' ' A' ' 92' ' ' ASP . 62.3 t0 -124.94 19.0 8.49 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.071 0.463 . . . . 0.0 110.905 -179.78 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.676 ' NH1' ' NH2' ' B' ' 245' ' ' ARG . 58.0 mtm-85 -127.62 141.98 51.48 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.472 -179.841 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 25.8 p -139.27 154.2 47.91 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 119.59 -0.844 . . . . 0.0 111.426 -179.798 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.535 ' HB3' HD11 ' A' ' 7' ' ' LEU . 63.8 m-85 -123.22 121.79 36.77 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.078 179.702 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.551 ' O ' HD12 ' A' ' 7' ' ' LEU . 44.8 ttm180 -80.14 127.65 32.57 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.953 -179.148 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -95.1 125.13 39.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.111 -179.825 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -124.87 121.62 35.06 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.636 179.651 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -116.63 113.79 23.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.012 179.453 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.302 -179.305 . . . . . . . . 0 0 . 1 . 059 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . 0.717 ' O ' HG12 ' B' ' 228' ' ' VAL . 44.5 t . . . . . 0 N--CA 1.457 -0.123 0 CA-C-O 120.613 0.244 . . . . 0.0 110.844 . . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -60.71 -47.89 84.24 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.542 -179.984 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 059 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 9.0 mp0 -118.65 46.91 1.73 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.873 -178.733 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -126.82 -177.2 14.77 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.424 -179.974 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -66.79 153.86 76.48 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 123.37 2.714 . . . . 0.0 112.662 -179.814 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.712 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.88 139.1 17.22 Favored 'Trans proline' 0 C--N 1.302 -1.879 0 C-N-CA 121.863 1.709 . . . . 0.0 112.489 -179.74 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.49 ' HA ' HD21 ' A' ' 67' ' ' ASN . 10.9 m -67.39 147.75 12.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.191 -178.919 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 3.0 t -68.45 129.18 39.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.847 179.891 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . 0.432 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . 0.432 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 31.8 Cg_exo -58.97 -27.07 83.81 Favored 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 122.893 2.396 . . . . 0.0 113.585 -178.794 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 97.3 m -73.61 -44.21 57.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.179 0.514 . . . . 0.0 109.844 179.074 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.55 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 90.6 t80 -58.31 -46.11 86.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.652 -179.516 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 94.7 mt -63.54 -40.13 96.2 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.852 0.358 . . . . 0.0 110.284 -179.834 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 51.9 tp10 -60.77 -43.73 97.65 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.496 -179.749 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -60.04 -41.74 92.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.175 0.512 . . . . 0.0 109.841 179.548 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.676 ' NH2' ' NH1' ' A' ' 93' ' ' ARG . 61.3 ttm-85 -60.04 -44.75 94.46 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.718 -179.544 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -61.87 -40.9 96.98 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.056 0.455 . . . . 0.0 110.141 -179.719 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 61.4 m -66.94 -44.01 81.73 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 177.949 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . 0.749 ' NE2' HH12 ' A' ' 12' ' ' ARG . 59.0 tt0 -60.87 -37.8 83.38 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.201 179.867 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.444 HG23 ' O ' ' B' ' 245' ' ' ARG . 53.6 t -62.21 -45.97 97.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 C-N-CA 119.926 -0.709 . . . . 0.0 110.037 -179.966 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -58.77 -28.86 66.31 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.603 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -89.56 -14.76 34.39 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.52 179.355 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 1.091 HD22 HH21 ' A' ' 12' ' ' ARG . 64.2 tp -76.28 136.58 39.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.484 -179.237 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -104.19 144.04 32.12 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.956 178.988 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -64.62 -19.18 65.53 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.038 -179.722 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -65.58 -11.32 43.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.658 -179.889 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.497 ' C ' ' H ' ' B' ' 258' ' ' ASP . 85.3 m-20 -92.97 71.25 4.66 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.998 0.428 . . . . 0.0 110.48 179.228 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -66.43 13.16 0.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.621 -179.16 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.731 ' O ' ' N ' ' B' ' 260' ' ' GLU . 48.2 p-10 -101.61 1.34 37.67 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.033 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.457 ' C ' ' O ' ' B' ' 258' ' ' ASP . 56.0 p-10 4.7 49.72 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 O-C-N 124.477 1.11 . . . . 0.0 113.806 179.593 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.731 ' N ' ' O ' ' B' ' 258' ' ' ASP . 97.7 mt-10 58.67 4.25 0.36 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 178.764 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 75.2 mt -113.11 134.9 54.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 179.065 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 59.2 t -124.22 133.27 69.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.924 0.392 . . . . 0.0 110.842 -179.564 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -96.48 118.5 33.11 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.141 0.496 . . . . 0.0 110.928 -179.424 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -65.32 -47.95 74.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.857 -179.945 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . 0.619 ' HG2' HD11 ' A' ' 24' ' ' LEU . 1.3 mp0 -95.15 164.84 18.22 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.143 -178.436 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -64.34 149.63 89.78 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 122.91 2.406 . . . . 0.0 112.696 -179.575 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 47.7 pt . . . . . 0 C--N 1.33 -0.243 0 CA-C-O 121.366 0.603 . . . . 0.0 111.436 -179.851 . . . . . . . . 0 0 . 1 . 060 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo . . . . . 0 N--CA 1.494 1.546 0 CA-C-O 120.669 0.196 . . . . 0.0 112.355 . . . . . . . . . 0 0 . 1 . 060 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.2 m -76.04 -48.67 20.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.915 0.388 . . . . 0.0 111.065 179.341 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.1 mtt85 -90.08 136.45 33.04 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.657 -178.559 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -127.59 137.35 52.55 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.787 179.482 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.65 HD11 ' HB3' ' A' ' 95' ' ' PHE . 40.6 tp -115.67 134.0 55.48 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.651 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.0 t -111.76 130.98 64.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -179.799 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.459 ' CG2' HD12 ' B' ' 261' ' ' ILE . 4.2 m -90.45 111.76 23.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.393 0.616 . . . . 0.0 112.09 -178.644 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 95.2 mt -79.97 142.13 14.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.703 178.64 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -91.42 159.97 15.7 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.021 0.439 . . . . 0.0 111.368 -179.832 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 91.3 mtm180 -57.68 -29.38 64.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.282 -179.68 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.7 t -80.69 -11.01 59.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.339 179.557 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.63 34.82 6.42 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.356 -0.697 . . . . 0.0 111.356 -179.985 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.4 t -121.65 131.33 73.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.604 0.24 . . . . 0.0 110.696 179.531 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -73.27 135.7 44.49 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.146 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -124.82 -117.08 2.21 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.145 -179.288 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -73.62 144.55 35.83 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.153 1.902 . . . . 0.0 113.056 -178.581 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.424 ' O ' ' CG2' ' B' ' 267' ' ' ILE . 6.3 m170 -102.63 149.36 24.51 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.93 179.602 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -127.22 104.37 22.44 Favored Pre-proline 0 CA--C 1.536 0.437 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.538 -178.759 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.51 ' O ' ' NE2' ' B' ' 265' ' ' GLN . 61.5 Cg_endo -75.25 134.91 17.98 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.359 1.373 . . . . 0.0 112.433 -179.399 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 68.2 mt -88.98 54.27 2.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.341 -178.714 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.3 p -61.21 -20.53 62.89 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.984 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 80.8 mt -84.91 141.08 30.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.451 179.165 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.9 p -67.81 -15.9 63.85 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -178.595 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.513 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 85.6 m -132.52 134.72 45.35 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.071 179.905 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.7 t -127.8 115.78 19.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.226 179.409 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.495 HD21 ' HG2' ' A' ' 47' ' ' GLN . 43.1 tp -114.5 128.68 56.46 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.487 -178.991 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.622 ' CE2' HD12 ' A' ' 37' ' ' ILE . 3.4 m-85 -107.11 136.48 46.88 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.205 179.297 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 163.7 -175.87 39.85 Favored Glycine 0 N--CA 1.467 0.766 0 C-N-CA 120.094 -1.05 . . . . 0.0 112.591 178.88 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.626 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 84.1 mtm-85 -72.34 -30.2 64.52 Favored 'General case' 0 CA--C 1.522 -0.111 0 CA-C-O 121.035 0.445 . . . . 0.0 110.06 179.311 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.511 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -55.77 138.78 43.91 Favored Glycine 0 CA--C 1.523 0.54 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.401 -177.98 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.435 HG23 ' N ' ' A' ' 34' ' ' GLU . 9.4 tp -69.09 -41.15 81.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.84 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.435 ' N ' HG23 ' A' ' 33' ' ' ILE . 52.3 tp10 -54.04 -18.24 3.41 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 178.767 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.511 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 18.7 m -66.81 139.18 57.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.577 -179.769 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.513 ' OD2' ' O ' ' A' ' 26' ' ' THR . 60.5 m-20 -62.47 -34.73 77.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.613 -179.13 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.622 HD12 ' CE2' ' A' ' 29' ' ' PHE . 96.8 mt -127.18 120.84 56.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 177.796 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 51.3 ttt180 -108.39 133.94 51.87 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.26 -179.026 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 79.5 mt -117.49 133.93 62.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.439 -179.657 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -79.45 29.91 0.23 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.466 -178.096 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 41' ' ' LEU . 24.1 mt -98.49 125.82 41.57 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.915 179.39 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.94 -9.07 24.13 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.369 2.046 . . . . 0.0 113.326 -178.749 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.578 HG21 ' CE2' ' B' ' 241' ' ' PHE . 22.0 m -98.94 7.34 8.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.633 -179.797 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.626 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 53.6 t -96.7 135.75 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.809 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.0 m -70.01 171.33 9.68 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.114 0.483 . . . . 0.0 111.638 -179.234 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -61.67 -41.55 97.69 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.405 -179.044 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.633 ' O ' ' N ' ' A' ' 49' ' ' CYS . 97.1 mt-30 -112.5 -18.88 12.31 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 123.384 0.428 . . . . 0.0 110.757 -179.92 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 16.0 t60 36.93 -76.23 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 179.513 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.633 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.12 136.23 48.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.317 0.58 . . . . 0.0 112.121 -178.856 . . . . . . . . 3 3 . 1 . 060 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -126.27 127.98 46.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.259 179.623 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 95.5 mt -116.29 134.36 59.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.998 -179.916 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -114.71 140.3 48.97 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.331 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 50.1 mm -107.66 120.41 58.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.185 -0.606 . . . . 0.0 111.821 -179.11 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.422 ' O ' ' N ' ' A' ' 56' ' ' GLN . 98.5 m-70 -123.68 133.36 53.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.661 178.488 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 54' ' ' HIS . 98.7 mt-10 -39.56 -31.81 0.11 Allowed 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.415 -0.514 . . . . 0.0 109.938 -178.261 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.422 ' N ' ' O ' ' A' ' 54' ' ' HIS . 85.9 mt-30 -63.2 -67.82 0.39 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.476 178.894 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.424 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 7.1 tp10 -152.22 -153.54 0.49 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.529 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.432 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -131.71 134.14 45.59 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.644 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.3 mt -119.14 130.61 73.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -178.262 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.684 HD22 ' CD1' ' A' ' 88' ' ' ILE . 26.3 tp -95.7 127.46 41.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.754 179.201 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -114.4 138.23 50.82 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.596 -179.409 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.428 ' C ' ' OD1' ' A' ' 62' ' ' ASN . 55.6 t-20 -96.08 106.2 18.35 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -178.54 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -101.56 -12.16 18.7 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.947 0.403 . . . . 0.0 110.038 178.425 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.13 104.78 3.72 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.369 179.613 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.5 p -88.29 -19.49 26.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.164 0.506 . . . . 0.0 109.831 179.648 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.66 -44.49 12.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.783 -179.874 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 -140.62 98.3 7.18 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.181 -179.715 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -54.91 143.99 69.51 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.279 1.986 . . . . 0.0 112.673 -179.614 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.1 m -70.28 136.57 49.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.117 179.32 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -101.72 141.1 35.1 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.442 179.937 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.686 HG13 ' OD1' ' A' ' 86' ' ' ASP . 51.6 t -126.15 136.21 61.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.649 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 51.27 33.61 10.06 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -179.821 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.41 28.42 71.27 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.162 -179.968 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.5 t -140.18 138.34 35.08 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.259 -179.727 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 64.1 t -69.3 131.82 33.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.896 -179.34 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.3 100.39 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.765 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -84.33 -16.42 43.02 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.972 -179.013 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.23 160.82 29.82 Favored Pre-proline 0 C--O 1.219 -0.524 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.238 179.866 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -58.24 142.27 97.24 Favored 'Trans proline' 0 N--CA 1.502 1.989 0 C-N-CA 121.932 1.755 . . . . 0.0 112.968 -179.151 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.3 p -142.15 141.08 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 120.996 0.427 . . . . 0.0 111.459 179.575 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -74.52 131.05 40.67 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.41 179.492 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.432 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 96.7 mt -83.46 136.86 34.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.171 0.51 . . . . 0.0 110.96 -179.984 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -128.22 151.2 49.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.152 -179.785 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.459 ' ND1' ' OD1' ' A' ' 99' ' ' ASN . 4.6 t60 -53.45 120.21 5.8 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.383 -179.209 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.13 -15.7 27.92 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -179.34 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.686 ' OD1' HG13 ' A' ' 71' ' ' VAL . 65.4 t0 -73.75 124.9 26.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.007 0.432 . . . . 0.0 110.245 179.753 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.448 HG22 ' HA ' ' A' ' 96' ' ' ARG . 26.2 t -104.57 133.38 48.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.127 -178.953 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.684 ' CD1' HD22 ' A' ' 60' ' ' LEU . 33.1 mm -90.08 130.91 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.1 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.5 m -121.56 126.28 48.76 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -177.84 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.524 ' O ' ' N ' ' A' ' 92' ' ' ASP . 91.9 mt -115.75 125.3 72.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.843 178.612 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.518 HG23 ' SG ' ' B' ' 237' ' ' CYS . 42.1 mm 35.66 -93.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.974 179.261 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 90' ' ' ILE . 28.1 t70 -122.85 19.29 10.18 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.745 0.307 . . . . 0.0 111.294 -179.711 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.499 ' HG3' HH22 ' B' ' 245' ' ' ARG . 99.1 mtt180 -129.75 145.22 51.56 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.443 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 60.8 p -140.63 157.04 46.04 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 119.634 -0.826 . . . . 0.0 111.35 -179.95 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.65 ' HB3' HD11 ' A' ' 7' ' ' LEU . 46.6 m-85 -125.87 122.13 35.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.894 179.893 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.509 ' O ' HD12 ' A' ' 7' ' ' LEU . 52.2 ttt85 -82.49 128.5 34.34 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.582 -179.757 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -96.54 127.79 42.86 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.739 179.871 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -134.22 124.52 26.1 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.639 179.888 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.459 ' OD1' ' ND1' ' A' ' 84' ' ' HIS . 46.6 p30 -105.45 -146.86 0.39 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.71 -179.863 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.021 -179.307 . . . . . . . . 0 0 . 1 . 060 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . 0.681 ' O ' HG13 ' B' ' 228' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.461 0.093 0 CA-C-O 121.095 0.474 . . . . 0.0 109.745 . . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -69.89 139.44 53.0 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.589 -179.713 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 060 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -119.52 32.16 6.22 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.131 179.973 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -111.8 -170.78 18.73 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 -179.91 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -74.93 162.29 37.52 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 123.092 2.528 . . . . 0.0 112.416 179.943 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 060 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.67 170.53 18.06 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.274 1.982 . . . . 0.0 112.562 -179.965 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.487 HG13 ' O ' ' B' ' 236' ' ' VAL . 3.0 p -101.55 125.95 55.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.722 -179.814 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . 0.518 ' SG ' HG23 ' A' ' 91' ' ' ILE . 32.1 t -65.07 122.89 18.1 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.533 179.689 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 060 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -54.29 -22.32 26.05 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.203 1.935 . . . . 0.0 111.801 179.407 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 96.7 m -71.95 -43.89 64.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.582 0.706 . . . . 0.0 109.334 178.13 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.578 ' CE2' HG21 ' A' ' 43' ' ' VAL . 80.8 t80 -57.85 -46.15 85.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.172 -179.44 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 89.0 mt -63.73 -42.19 97.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.541 -179.634 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -64.85 -40.01 94.48 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.412 -179.254 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -61.71 -44.98 95.89 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.073 -179.458 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.499 HH22 ' HG3' ' A' ' 93' ' ' ARG . 79.9 mtp180 -63.2 -40.42 97.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.36 -179.475 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.95 -39.69 95.4 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.924 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 75.2 m -64.06 -45.03 90.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.35 177.942 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 -61.58 -37.31 83.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.786 -179.761 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 39.1 t -61.85 -43.74 97.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 C-N-CA 119.951 -0.699 . . . . 0.0 109.263 178.644 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -62.67 -28.23 69.79 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.571 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -83.57 -9.21 59.08 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.68 179.151 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 76.7 mt -101.09 -176.93 3.3 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.387 178.276 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -118.05 148.83 41.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.768 0.318 . . . . 0.0 111.376 -179.47 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -63.68 -25.2 68.1 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.241 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -79.2 13.23 1.94 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.531 -179.684 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -84.1 93.26 8.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.153 0.501 . . . . 0.0 109.963 -179.88 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -76.83 -9.28 58.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.859 -179.007 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -80.76 110.34 16.16 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.191 -0.603 . . . . 0.0 109.827 179.86 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.676 ' C ' ' H ' ' B' ' 261' ' ' ILE . 58.5 t0 -103.89 123.46 47.17 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.89 -179.143 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -54.56 11.66 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.814 -1.085 . . . . 0.0 111.9 179.893 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.676 ' H ' ' C ' ' B' ' 259' ' ' ASP . 95.7 mt -103.76 137.42 32.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 177.909 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 69.2 t -125.38 132.44 71.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 120.421 -0.511 . . . . 0.0 110.544 -178.715 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -97.71 122.61 40.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.2 0.524 . . . . 0.0 111.734 -178.365 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -69.26 -42.8 75.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.551 179.899 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . 0.51 ' NE2' ' O ' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -88.06 161.21 44.41 Favored Pre-proline 0 CA--C 1.518 -0.269 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.933 -178.328 . . . . . . . . 3 3 . 1 . 060 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -59.23 145.68 97.0 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 121.973 1.782 . . . . 0.0 109.924 178.633 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . 0.424 ' CG2' ' O ' ' A' ' 19' ' ' HIS . 4.3 mt . . . . . 0 C--N 1.326 -0.443 0 C-N-CA 119.946 -0.702 . . . . 0.0 110.953 -178.081 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo . . . . . 0 N--CA 1.491 1.365 0 CA-C-O 121.087 0.37 . . . . 0.0 112.636 . . . . . . . . . 0 0 . 1 . 061 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.595 HG23 ' O ' ' A' ' 100' ' ' GLU . 26.0 m -74.27 -45.19 49.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.214 -179.757 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.724 ' NH1' ' HB2' ' A' ' 58' ' ' ALA . 99.8 mtt180 -98.33 136.34 38.64 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.21 -177.667 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.434 HH22 ' HB2' ' A' ' 100' ' ' GLU . 85.1 mtm-85 -138.25 150.19 46.45 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.808 -179.807 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.633 HD11 HD11 ' A' ' 22' ' ' LEU . 84.5 mt -115.0 143.43 45.2 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.744 -179.908 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.4 t -115.97 127.66 73.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.338 179.07 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 m -77.85 134.16 38.02 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.647 0.737 . . . . 0.0 112.156 -178.888 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.515 ' CD1' ' OD1' ' A' ' 16' ' ' ASP . 50.5 mm -104.47 134.23 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 114.653 -1.158 . . . . 0.0 107.943 177.086 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.448 ' HZ1' ' C ' ' B' ' 257' ' ' LYS . 65.3 mttm -96.67 159.81 14.73 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.197 0.522 . . . . 0.0 111.103 -179.246 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.421 ' CB ' HG21 ' B' ' 249' ' ' VAL . 84.7 mtt-85 -57.52 -31.1 65.71 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.111 -178.84 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.421 ' OG ' HG22 ' A' ' 15' ' ' VAL . 80.2 p -72.97 -15.15 61.55 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.808 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.7 17.04 46.42 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.647 179.948 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.421 HG22 ' OG ' ' A' ' 13' ' ' SER . 4.3 m -108.15 139.72 29.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.127 0.489 . . . . 0.0 110.632 -179.845 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.515 ' OD1' ' CD1' ' A' ' 10' ' ' ILE . 99.0 m-20 -76.76 138.5 39.95 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.953 179.849 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -128.48 -117.72 2.04 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 120.193 -1.003 . . . . 0.0 111.653 -179.774 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -74.73 151.58 41.16 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.6 2.2 . . . . 0.0 112.635 -179.126 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -111.17 144.32 40.5 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.265 179.28 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.561 ' CD2' HD11 ' A' ' 37' ' ' ILE . 38.8 t80 -108.28 94.64 13.76 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.582 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.83 137.3 29.4 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 121.169 1.246 . . . . 0.0 111.855 -178.795 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.633 HD11 HD11 ' A' ' 7' ' ' LEU . 97.9 mt -93.18 107.75 19.5 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.144 0.497 . . . . 0.0 111.419 -178.755 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 94.4 p -111.53 -6.34 14.43 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.348 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 70.7 mt -104.32 146.69 28.44 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.764 -179.739 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 83.8 p -66.32 -16.56 64.14 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.75 -178.754 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 29.8 m -132.9 134.16 44.22 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.939 -179.43 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.629 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 9.2 t -127.39 120.77 29.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.881 178.839 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.444 HD21 ' OE1' ' A' ' 47' ' ' GLN . 32.0 tp -118.5 128.46 54.61 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.788 0.328 . . . . 0.0 111.38 -178.428 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.74 ' CE2' HD12 ' A' ' 37' ' ' ILE . 14.5 m-85 -105.15 140.15 38.75 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.561 179.12 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 153.38 -179.58 29.63 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 119.944 -1.122 . . . . 0.0 112.637 178.537 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.499 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 45.3 mtm180 -70.04 -33.05 71.47 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.03 0.443 . . . . 0.0 110.637 178.516 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.57 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -52.96 141.31 29.44 Favored Glycine 0 CA--C 1.521 0.449 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.95 -178.401 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.648 HG23 ' NH2' ' A' ' 38' ' ' ARG . 78.7 mt -63.05 -43.05 98.8 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.162 178.974 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.406 ' HA ' ' NZ ' ' B' ' 264' ' ' LYS . 97.2 mt-10 -51.1 -18.85 0.93 Allowed 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.403 -0.519 . . . . 0.0 109.666 179.67 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.57 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 23.0 m -67.26 122.58 18.18 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.163 -179.527 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -57.05 -22.86 42.39 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -179.534 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.74 HD12 ' CE2' ' A' ' 29' ' ' PHE . 84.2 mt -130.98 118.28 40.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.987 177.904 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.648 ' NH2' HG23 ' A' ' 33' ' ' ILE . 57.4 mtt180 -99.74 133.5 44.0 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.29 -179.022 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 97.4 mt -116.81 126.93 74.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 120.417 -0.513 . . . . 0.0 109.999 179.339 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -75.27 42.64 0.2 Allowed 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -177.104 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.686 HD21 ' OE1' ' B' ' 260' ' ' GLU . 85.4 mt -118.43 131.48 24.22 Favored Pre-proline 0 C--N 1.326 -0.451 0 C-N-CA 120.521 -0.472 . . . . 0.0 111.098 179.657 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.41 -10.32 23.81 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 122.235 1.957 . . . . 0.0 111.892 179.786 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.443 HG21 ' CE2' ' B' ' 241' ' ' PHE . 19.4 m -96.02 2.69 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.056 179.724 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.499 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 37.3 t -99.44 104.02 15.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.916 0.388 . . . . 0.0 111.262 -179.621 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.471 ' O ' ' O ' ' A' ' 44' ' ' VAL . 5.0 m -37.92 161.35 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.301 0.572 . . . . 0.0 111.108 -179.797 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.3 mttp -63.5 -38.71 92.18 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.82 -179.096 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.599 ' O ' ' N ' ' A' ' 49' ' ' CYS . 96.2 mm-40 -108.9 -25.53 10.71 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.264 0.554 . . . . 0.0 110.417 -179.482 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.411 ' NE2' HG23 ' A' ' 90' ' ' ILE . 18.2 t60 38.67 -76.33 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 179.467 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.599 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.57 135.41 46.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.132 0.492 . . . . 0.0 112.018 -178.162 . . . . . . . . 3 3 . 1 . 061 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -130.14 131.0 45.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.808 179.89 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 91.1 mt -115.53 136.03 53.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.222 179.65 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -118.82 128.9 54.9 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.412 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.52 HG23 ' NH1' ' A' ' 5' ' ' ARG . 97.0 mt -105.67 114.26 44.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.626 -179.508 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.558 ' O ' ' N ' ' A' ' 56' ' ' GLN . 79.7 m-70 -112.22 143.53 43.12 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.336 179.385 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.459 ' C ' ' O ' ' A' ' 54' ' ' HIS . 98.5 mt-10 -40.09 -25.48 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -179.699 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.558 ' N ' ' O ' ' A' ' 54' ' ' HIS . 82.8 mt-30 -67.73 -68.96 0.35 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.407 178.519 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.452 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 4.1 tp10 -160.4 -162.91 1.02 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.724 179.957 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.724 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -111.19 124.41 52.16 Favored 'General case' 0 N--CA 1.461 0.119 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.326 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 79.4 mt -116.58 131.15 70.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.802 -178.36 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.3 tp -96.86 129.83 44.24 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.487 179.836 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -113.13 133.48 55.01 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.235 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.443 ' ND2' ' H ' ' A' ' 69' ' ' THR . 9.6 t-20 -96.26 108.48 20.98 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.496 -179.374 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -99.75 -9.53 22.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.425 179.896 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.9 t -74.17 100.56 3.7 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.508 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.4 m -84.17 -22.7 30.88 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.428 -179.767 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.519 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.2 OUTLIER -78.34 -43.72 27.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.147 0.498 . . . . 0.0 110.222 179.993 . . . . . . . . 3 3 . 1 . 061 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.415 ' OD1' ' O ' ' A' ' 66' ' ' THR . 22.8 m-20 -140.88 100.41 6.57 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.749 -179.833 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.583 ' HB2' HG13 ' A' ' 75' ' ' VAL . 32.1 Cg_exo -57.48 147.24 79.56 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 121.954 1.77 . . . . 0.0 112.438 -179.656 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.443 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 10.3 m -74.61 151.74 39.33 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.182 179.234 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -111.23 140.67 45.6 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.267 179.932 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.699 HG13 ' OD1' ' A' ' 86' ' ' ASP . 55.8 t -129.99 134.39 62.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.962 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 52.08 32.0 9.72 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -179.024 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.89 29.12 67.59 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.528 -179.834 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.7 m -141.82 138.5 32.24 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.583 -179.64 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.583 HG13 ' HB2' ' A' ' 68' ' ' PRO . 40.5 t -68.22 140.5 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.208 -179.275 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 9.2 pt -113.0 92.18 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 121.272 0.558 . . . . 0.0 110.164 178.306 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -64.83 -29.37 70.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.98 -179.779 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.423 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.8 OUTLIER -125.28 177.78 1.74 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.986 179.383 . . . . . . . . 3 3 . 1 . 061 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.423 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 36.0 Cg_exo -60.43 145.68 98.24 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 122.527 2.152 . . . . 0.0 112.097 179.814 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.8 p -137.73 141.22 39.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-O 121.166 0.507 . . . . 0.0 111.365 -179.778 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 45.3 ttm180 -79.88 131.97 35.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.711 179.68 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 89.3 mt -84.54 138.39 32.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.899 -179.043 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -130.84 152.57 50.03 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.75 179.065 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -55.88 119.09 5.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.84 0.352 . . . . 0.0 110.817 -179.451 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.57 -9.0 35.01 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.824 -0.911 . . . . 0.0 110.824 -179.675 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.699 ' OD1' HG13 ' A' ' 71' ' ' VAL . 61.0 t0 -75.61 126.58 31.28 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.727 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 39.9 t -107.35 131.07 58.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.788 -179.032 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 87.4 mt -97.0 131.51 43.62 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.396 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.9 m -122.46 125.38 45.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.566 0.698 . . . . 0.0 112.033 -178.429 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.455 ' O ' ' C ' ' A' ' 91' ' ' ILE . 95.7 mt -113.25 124.35 69.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.471 178.912 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.668 HG23 ' SG ' ' B' ' 237' ' ' CYS . 95.0 mt 35.09 -99.95 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 121.166 -0.213 . . . . 0.0 110.527 -178.612 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.518 ' N ' HG22 ' A' ' 91' ' ' ILE . 42.8 t0 -116.41 20.22 14.3 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.025 0.441 . . . . 0.0 110.929 179.745 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.626 ' CZ ' ' CD1' ' A' ' 41' ' ' LEU . 29.9 mtm-85 -130.13 142.34 50.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.473 -179.783 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 30.2 t -140.48 152.4 45.59 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.637 -179.037 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -123.31 122.0 37.24 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.157 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -83.98 134.13 34.66 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.827 -179.496 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -92.81 120.82 33.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.579 179.807 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -123.2 116.54 23.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.018 179.735 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -105.48 107.63 18.71 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.329 179.768 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.595 ' O ' HG23 ' A' ' 4' ' ' THR . 86.7 tt0 . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.373 -179.334 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . 0.404 HG23 ' N ' ' B' ' 229' ' ' ASP . 27.6 m . . . . . 0 N--CA 1.451 -0.376 0 CA-C-O 120.855 0.36 . . . . 0.0 110.064 . . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.512 ' O ' ' CB ' ' B' ' 230' ' ' SEP . 85.4 m-20 53.61 32.69 14.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.4 178.85 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . 0.512 ' CB ' ' O ' ' B' ' 229' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.425 HE21 ' HB2' ' B' ' 230' ' ' SEP . 78.1 mm-40 -128.21 62.77 1.43 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.937 -179.002 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -122.39 170.63 15.2 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 -179.861 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -74.35 161.2 40.77 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 123.873 3.048 . . . . 0.0 111.966 179.814 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.519 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -61.69 139.02 78.56 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 121.877 1.718 . . . . 0.0 111.707 179.155 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.519 HG22 HG22 ' A' ' 66' ' ' THR . 42.7 t -61.35 136.36 24.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.628 179.612 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . 0.668 ' SG ' HG23 ' A' ' 91' ' ' ILE . 14.9 t -67.41 123.88 21.61 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.493 -0.483 . . . . 0.0 109.737 -179.787 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . 0.444 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . 0.444 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 51.0 Cg_exo -57.77 -28.35 81.7 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 123.158 2.572 . . . . 0.0 113.25 -179.837 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 20.7 m -72.93 -49.2 30.95 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.299 -0.561 . . . . 0.0 110.091 179.16 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.443 ' CE2' HG21 ' A' ' 43' ' ' VAL . 82.2 t80 -58.08 -47.49 83.01 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.324 -179.066 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 86.8 mt -64.48 -42.18 96.04 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -179.177 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -65.54 -39.36 91.65 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.201 -0.6 . . . . 0.0 111.099 -179.539 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -61.84 -42.88 99.57 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.167 -0.613 . . . . 0.0 109.591 179.784 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -63.07 -41.23 99.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.717 -179.846 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -62.1 -42.66 99.45 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.45 0.643 . . . . 0.0 109.89 179.41 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 67.3 p -67.83 -43.99 78.27 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.245 -0.888 . . . . 0.0 109.129 178.652 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -61.39 -39.49 90.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.388 179.882 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.444 ' C ' ' H ' ' B' ' 252' ' ' LEU . 0.4 OUTLIER -60.79 -42.1 91.04 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.872 179.674 . . . . . . . . 3 3 . 1 . 061 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -60.31 -33.09 71.88 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.271 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -81.57 -13.25 58.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.257 177.877 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.444 ' H ' ' C ' ' B' ' 249' ' ' VAL . 1.3 tp -110.94 -172.07 1.95 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.674 179.268 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' B' ' 252' ' ' LEU . 12.7 m120 80.91 32.55 0.14 Allowed 'General case' 0 N--CA 1.464 0.242 0 O-C-N 123.912 0.758 . . . . 0.0 111.138 -179.881 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . 0.44 ' N ' ' OD1' ' B' ' 254' ' ' ASP . 21.9 p-10 -63.03 -33.75 76.09 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.168 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . 0.529 ' O ' ' CB ' ' B' ' 256' ' ' ASP . 82.2 m-20 -115.15 -67.92 0.96 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.055 179.029 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.529 ' CB ' ' O ' ' B' ' 255' ' ' ASP . 4.3 m-20 96.81 39.9 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.429 -179.256 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . 0.448 ' C ' ' HZ1' ' A' ' 11' ' ' LYS . 71.5 mmtt -116.69 -22.14 8.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.627 -179.734 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.433 ' OD1' ' N ' ' B' ' 258' ' ' ASP . 30.0 p-10 -144.82 126.81 15.49 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.941 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -139.79 84.15 1.96 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 119.682 -0.807 . . . . 0.0 112.975 -179.046 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.686 ' OE1' HD21 ' A' ' 41' ' ' LEU . 96.7 mt-10 59.77 12.09 2.8 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 177.223 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 80.8 mt -119.46 132.33 69.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.35 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 51.1 t -126.79 135.61 63.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.021 0.439 . . . . 0.0 110.874 -179.69 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -94.59 117.44 30.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.186 0.517 . . . . 0.0 110.78 -179.176 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . 0.406 ' NZ ' ' HA ' ' A' ' 34' ' ' GLU . 88.8 tttt -70.53 -44.23 67.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.79 -179.69 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -94.68 162.18 26.39 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.771 -179.032 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -59.94 151.74 69.52 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.9 2.4 . . . . 0.0 111.588 179.364 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 47.8 pt . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 121.44 0.638 . . . . 0.0 111.827 -178.708 . . . . . . . . 0 0 . 1 . 062 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo . . . . . 0 N--CA 1.489 1.255 0 CA-C-O 120.745 0.227 . . . . 0.0 111.668 . . . . . . . . . 0 0 . 1 . 062 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 30.3 p -72.94 -40.76 65.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.629 -179.863 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.631 ' NH1' ' HB2' ' A' ' 58' ' ' ALA . 93.7 mtt-85 -91.68 131.2 37.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.819 -179.27 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -135.23 144.62 47.0 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.452 179.312 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.855 HD11 HD11 ' A' ' 22' ' ' LEU . 69.3 mt -119.64 146.46 45.54 Favored 'General case' 0 CA--C 1.527 0.083 0 CA-C-O 121.025 0.44 . . . . 0.0 111.451 -179.389 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.2 t -117.87 129.79 73.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.584 178.9 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.426 HG23 ' CD1' ' B' ' 261' ' ' ILE . 1.9 m -91.35 114.46 27.0 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.933 0.397 . . . . 0.0 111.067 -179.631 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 92.9 mt -81.11 144.66 10.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.282 179.508 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.456 ' HB2' ' H ' ' A' ' 15' ' ' VAL . 71.3 mmtt -84.78 150.76 24.83 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.339 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.613 HH11 HH11 ' B' ' 245' ' ' ARG . 87.8 mtm180 -58.28 -24.99 61.26 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -179.888 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.447 ' HA ' HG11 ' B' ' 249' ' ' VAL . 28.1 t -76.73 -13.03 60.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.876 178.738 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.97 35.27 6.82 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 179.946 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.456 ' H ' ' HB2' ' A' ' 11' ' ' LYS . 48.0 t -121.39 135.6 61.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.734 0.302 . . . . 0.0 110.888 -179.861 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -71.29 118.67 14.38 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.886 179.384 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -111.38 -126.43 4.87 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 120.976 -0.631 . . . . 0.0 111.751 -179.017 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.63 148.68 42.38 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.236 1.958 . . . . 0.0 112.196 -179.239 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -105.77 154.57 20.3 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.647 179.801 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.832 ' CD2' HD11 ' A' ' 37' ' ' ILE . 51.5 t80 -122.44 92.37 49.01 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.1 -179.33 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -74.16 139.92 27.3 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 121.331 1.354 . . . . 0.0 111.557 -179.517 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.855 HD11 HD11 ' A' ' 7' ' ' LEU . 81.3 mt -102.54 125.29 49.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.22 0.533 . . . . 0.0 111.798 -178.176 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 61.6 p -121.71 -2.73 9.31 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.381 -0.827 . . . . 0.0 108.806 178.292 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.9 mt -104.82 147.17 28.02 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.154 -179.203 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 90.6 p -68.63 -17.15 64.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.001 -178.912 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 44.2 m -128.53 131.78 48.27 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.365 0.603 . . . . 0.0 111.997 -179.121 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.683 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -128.52 121.6 29.22 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.188 178.896 . . . . . . . . 3 3 . 1 . 062 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.516 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 42.8 tp -120.76 126.43 50.13 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -178.208 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.683 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 66.0 m-85 -103.08 145.14 30.35 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 178.616 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 155.64 -169.87 33.49 Favored Glycine 0 C--N 1.321 -0.27 0 C-N-CA 119.886 -1.15 . . . . 0.0 112.273 178.611 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 31' ' ' ARG . 33.2 ttp-105 -86.64 -31.11 21.28 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -179.624 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -57.09 152.09 25.24 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-N 116.217 -0.447 . . . . 0.0 112.168 -178.977 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.421 ' CD1' ' CZ ' ' A' ' 38' ' ' ARG . 37.5 mm -63.93 -44.04 97.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-O 120.766 0.317 . . . . 0.0 110.93 179.93 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -55.74 -17.5 6.14 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.095 -179.075 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 83.2 m -64.05 119.65 10.53 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.662 -179.71 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.589 ' OD2' ' SG ' ' A' ' 27' ' ' CYS . 12.0 p-10 -56.54 -24.07 44.26 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.97 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.832 HD11 ' CD2' ' A' ' 20' ' ' PHE . 45.2 mm -126.17 116.33 45.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.1 -0.955 . . . . 0.0 108.761 176.803 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.421 ' CZ ' ' CD1' ' A' ' 33' ' ' ILE . 84.5 mtp180 -100.97 132.24 46.48 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -179.195 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.6 mt -123.08 131.53 73.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.173 0.511 . . . . 0.0 111.058 -179.341 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -81.75 35.18 0.41 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.642 -178.628 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.749 HD11 ' NE ' ' A' ' 93' ' ' ARG . 40.3 mt -100.17 115.72 65.21 Favored Pre-proline 0 C--N 1.325 -0.494 0 C-N-CA 120.388 -0.525 . . . . 0.0 110.391 179.502 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -56.22 -15.4 14.42 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 121.944 1.763 . . . . 0.0 112.421 178.794 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.445 HG23 HG13 ' A' ' 91' ' ' ILE . 25.9 m -98.24 8.32 7.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.556 -179.583 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.7 t -99.21 132.51 44.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.103 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.2 m -71.96 169.06 16.7 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.585 0.707 . . . . 0.0 111.775 -178.829 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -64.78 -40.69 95.67 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.671 -1.15 . . . . 0.0 111.457 -179.076 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.602 ' O ' ' N ' ' A' ' 49' ' ' CYS . 93.7 mm-40 -106.91 -23.86 12.22 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.259 0.552 . . . . 0.0 110.036 179.821 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.6 t60 38.17 -78.46 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.144 -0.935 . . . . 0.0 112.975 179.487 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.602 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.1 OUTLIER -135.36 137.0 41.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.226 0.536 . . . . 0.0 111.767 -178.428 . . . . . . . . 3 3 . 1 . 062 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -124.74 128.22 48.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.603 179.155 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 82.4 mt -111.07 131.49 62.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.852 179.303 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -114.29 132.49 56.15 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.371 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.41 HD12 ' CD ' ' A' ' 5' ' ' ARG . 43.4 mm -103.33 114.32 42.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 120.161 -0.616 . . . . 0.0 111.106 -179.278 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.449 ' O ' ' C ' ' A' ' 55' ' ' GLU . 96.9 m-70 -116.71 137.17 52.39 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.633 179.195 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 54' ' ' HIS . 80.2 mm-40 -39.95 -35.73 0.39 Allowed 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.057 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -60.27 -68.63 0.28 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.013 178.804 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.582 ' OE2' ' NH1' ' A' ' 81' ' ' ARG . 9.5 pt-20 -160.37 -158.46 0.62 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.327 178.88 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.631 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -120.95 133.96 55.29 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.764 0.316 . . . . 0.0 110.917 -179.648 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 87.6 mt -116.83 131.4 69.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.3 0.571 . . . . 0.0 112.457 -178.837 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.495 HD23 HD13 ' A' ' 76' ' ' ILE . 37.5 tp -95.22 126.91 40.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.695 179.833 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -116.0 134.34 55.07 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.668 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -98.96 105.23 17.35 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.787 -179.369 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -96.83 -7.89 32.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.301 179.134 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.96 99.47 6.85 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.069 0.461 . . . . 0.0 110.627 179.906 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 91.5 p -78.39 -33.09 49.04 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.945 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.597 HG21 ' O ' ' B' ' 234' ' ' TPO . 2.2 m -66.9 -46.09 75.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.072 -179.351 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.447 HD21 ' HA ' ' B' ' 236' ' ' VAL . 35.2 m-80 -146.05 97.27 4.51 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.835 -179.118 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.536 ' HB2' HG13 ' A' ' 75' ' ' VAL . 51.5 Cg_exo -54.6 146.67 52.58 Favored 'Trans proline' 0 N--CA 1.501 1.958 0 C-N-CA 122.625 2.217 . . . . 0.0 113.585 -179.965 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 93.4 m -72.14 138.74 47.91 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.463 178.669 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -102.35 140.73 36.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.092 -179.918 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.473 ' HB ' HD11 ' A' ' 76' ' ' ILE . 5.6 t -131.36 139.69 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.118 178.568 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 8.9 m120 52.36 32.4 11.04 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.346 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.09 30.23 65.64 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.51 179.185 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.7 m -146.2 143.76 29.47 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 117.659 0.729 . . . . 0.0 111.798 -179.825 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.536 HG13 ' HB2' ' A' ' 68' ' ' PRO . 74.8 t -69.8 138.35 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.235 -179.376 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.536 ' CG2' ' O ' ' A' ' 78' ' ' GLU . 95.6 mt -105.15 100.31 10.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.569 179.744 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -65.94 -39.56 90.58 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.599 179.57 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.536 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.1 OUTLIER -129.63 177.48 2.16 Favored Pre-proline 0 N--CA 1.466 0.374 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.405 -178.989 . . . . . . . . 3 3 . 1 . 062 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.423 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 33.8 Cg_exo -58.93 145.05 98.53 Favored 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 122.56 2.173 . . . . 0.0 112.54 -179.45 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.4 p -142.68 141.32 27.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.508 -179.778 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.582 ' NH1' ' OE2' ' A' ' 57' ' ' GLU . 93.9 mtt-85 -73.85 133.09 43.12 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.613 -179.507 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.447 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 94.3 mt -87.15 139.24 30.77 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.356 0.598 . . . . 0.0 111.76 -179.17 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -130.89 155.36 46.88 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.727 -179.566 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -56.22 118.51 4.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.803 0.335 . . . . 0.0 110.229 -179.748 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.31 -12.52 26.13 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.367 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.46 ' OD1' HG13 ' A' ' 71' ' ' VAL . 48.1 t0 -68.99 128.19 35.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.851 0.358 . . . . 0.0 110.605 179.762 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.429 HG22 ' HG2' ' A' ' 96' ' ' ARG . 53.6 t -109.81 131.84 59.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.78 -178.81 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.4 mm -94.65 127.79 46.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.091 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 53.1 m -118.14 124.93 49.21 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.881 -179.558 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.444 ' O ' ' C ' ' A' ' 91' ' ' ILE . 96.0 mt -122.19 126.18 73.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.26 179.321 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.445 HG13 HG23 ' A' ' 43' ' ' VAL . 31.8 mm 35.87 -109.55 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.01 -179.464 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.411 ' N ' HG22 ' A' ' 91' ' ' ILE . 86.6 m-20 -103.1 11.59 36.94 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.755 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.749 ' NE ' HD11 ' A' ' 41' ' ' LEU . 17.4 ptp180 -130.88 147.25 52.51 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.827 179.822 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 29.8 t -137.07 152.75 50.4 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.736 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.407 ' HE1' HD12 ' A' ' 90' ' ' ILE . 80.5 m-85 -121.35 121.47 37.72 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.73 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.429 ' HG2' HG22 ' A' ' 87' ' ' VAL . 99.3 mtt180 -85.18 129.54 34.78 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.004 -0.679 . . . . 0.0 110.515 -179.112 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.494 ' OH ' ' ND2' ' A' ' 99' ' ' ASN . 24.3 t80 -97.37 122.83 40.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.093 0.473 . . . . 0.0 110.236 179.869 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -121.86 123.26 41.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.062 179.849 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.494 ' ND2' ' OH ' ' A' ' 97' ' ' TYR . 20.6 t-20 -101.24 108.23 19.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.888 -179.51 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 . . . . . 0 C--N 1.329 -0.313 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.295 . . . . . . . . 0 0 . 1 . 062 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 54.7 t . . . . . 0 N--CA 1.455 -0.204 0 CA-C-O 120.87 0.367 . . . . 0.0 110.52 . . . . . . . . . 0 0 . 1 . 062 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.43 ' C ' ' H ' ' B' ' 231' ' ' GLN . 97.1 m-20 -73.29 141.94 47.17 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.515 179.834 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . 0.427 ' N ' ' O3P' ' B' ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.43 ' H ' ' C ' ' B' ' 229' ' ' ASP . 72.9 mt-30 -128.3 35.24 4.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.324 179.937 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -119.02 -164.53 12.82 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.487 -178.647 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.5 150.32 76.43 Favored 'Trans proline' 0 N--CA 1.501 1.95 0 C-N-CA 124.411 3.407 . . . . 0.0 113.618 -179.494 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.597 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.26 140.11 69.2 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.085 1.857 . . . . 0.0 114.041 -179.415 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.447 ' HA ' HD21 ' A' ' 67' ' ' ASN . 0.3 OUTLIER -75.1 139.38 19.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 113.939 -1.482 . . . . 0.0 111.017 -179.244 . . . . . . . . 3 3 . 1 . 062 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.9 t -75.89 125.05 28.35 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.225 -179.975 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 062 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -58.5 -25.26 73.33 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 122.833 2.355 . . . . 0.0 113.164 -179.233 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 16.7 m -73.14 -47.27 45.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.258 0.551 . . . . 0.0 110.434 179.385 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -57.88 -46.81 84.32 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.633 -178.932 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 96.7 mt -63.55 -42.32 98.37 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.669 -179.241 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -66.1 -39.1 89.71 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.338 -179.668 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . 0.535 ' NH1' ' OE1' ' B' ' 248' ' ' GLN . 78.4 ttt-85 -59.83 -45.72 91.52 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.953 -179.593 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.613 HH11 HH11 ' A' ' 12' ' ' ARG . 95.6 mtt-85 -65.81 -37.14 85.45 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.483 -179.5 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -60.28 -40.65 91.16 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.817 179.667 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 78.2 p -69.97 -43.02 72.36 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.108 0.48 . . . . 0.0 110.103 178.948 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . 0.535 ' OE1' ' NH1' ' B' ' 244' ' ' ARG . 88.0 mt-30 -64.19 -36.69 84.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.321 -179.768 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.562 HG23 ' O ' ' B' ' 245' ' ' ARG . 60.4 t -64.1 -45.79 95.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.356 -0.538 . . . . 0.0 109.912 179.444 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -64.22 -24.12 67.55 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 179.252 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -95.31 -4.02 46.3 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.946 -179.936 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 42.8 mt -109.48 129.14 55.57 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.989 0.423 . . . . 0.0 111.255 179.318 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -57.54 148.5 23.75 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.16 -179.623 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . 0.438 ' N ' ' OD1' ' B' ' 254' ' ' ASP . 32.2 p-10 -74.02 -10.13 59.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.2 179.704 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -87.38 2.97 48.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.278 -179.353 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -82.14 94.73 7.3 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.131 -0.627 . . . . 0.0 109.513 178.834 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . 0.455 ' HG2' ' H ' ' B' ' 258' ' ' ASP . 70.4 tttt -68.24 168.52 12.17 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.801 -179.063 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.455 ' H ' ' HG2' ' B' ' 257' ' ' LYS . 87.6 m-20 61.3 71.67 0.55 Allowed 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.39 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -85.59 72.69 10.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.417 -178.944 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.587 ' CD ' HH12 ' B' ' 245' ' ' ARG . 97.0 mt-10 57.45 10.63 0.99 Allowed 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 177.562 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.426 ' CD1' HG23 ' A' ' 9' ' ' THR . 69.8 mt -118.43 132.37 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 178.079 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 52.3 t -124.89 132.74 70.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.232 179.46 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -93.42 117.11 29.68 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.135 0.493 . . . . 0.0 110.897 -178.259 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -67.4 -45.97 74.61 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.393 -179.87 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 25.6 mm100 -88.6 153.34 50.25 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.887 -178.729 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -61.28 147.19 96.25 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.448 2.099 . . . . 0.0 112.253 179.362 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.4 pt . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.282 -179.329 . . . . . . . . 0 0 . 1 . 063 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo . . . . . 0 N--CA 1.506 2.258 0 N-CA-C 113.058 0.369 . . . . 0.0 113.058 . . . . . . . . . 0 0 . 1 . 063 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 46.0 p -102.44 -58.5 1.86 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.238 0.542 . . . . 0.0 110.368 178.867 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.8 mtt85 -85.92 131.05 34.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.324 -179.592 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -129.09 139.41 52.0 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.348 179.975 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.581 HD12 ' O ' ' A' ' 96' ' ' ARG . 32.7 tp -116.49 133.31 56.16 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.836 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 70.7 t -112.42 131.06 64.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.068 0.461 . . . . 0.0 110.174 -179.293 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.8 m -80.99 144.5 31.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.769 0.795 . . . . 0.0 112.472 -178.236 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.534 ' CD1' ' OD1' ' A' ' 16' ' ' ASP . 48.5 mm -111.86 135.78 50.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.54 178.389 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -93.48 157.95 15.96 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.318 0.58 . . . . 0.0 110.31 178.433 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.486 ' HD3' HH21 ' B' ' 245' ' ' ARG . 88.5 mtm180 -58.02 -23.49 54.42 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.435 -179.514 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 87.7 p -80.08 -13.13 59.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.329 179.913 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.19 20.06 34.07 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.56 179.228 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.4 m -115.65 138.21 46.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.166 179.301 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.534 ' OD1' ' CD1' ' A' ' 10' ' ' ILE . 83.1 m-20 -70.3 139.97 52.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.11 -179.91 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -126.22 -120.21 2.37 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 121.063 -0.589 . . . . 0.0 111.634 -179.638 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.38 146.1 39.33 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.018 1.812 . . . . 0.0 113.117 -178.621 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -104.82 145.64 30.1 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.09 179.468 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.465 ' CD2' HD11 ' A' ' 37' ' ' ILE . 61.3 t80 -119.45 103.5 46.67 Favored Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.496 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -73.64 130.06 14.34 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 121.617 1.544 . . . . 0.0 112.588 -178.433 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.2 mt -85.87 57.05 4.25 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.104 -178.666 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.59 -33.07 74.22 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.479 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.7 mt -74.91 142.5 44.01 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.139 179.791 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.59 -14.98 63.37 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.186 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.529 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 54.4 m -132.13 132.13 42.96 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.842 -179.798 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.5 t -124.57 117.16 23.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.804 178.683 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.472 HD11 ' HB3' ' A' ' 47' ' ' GLN . 32.6 tp -115.44 126.23 54.08 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.447 -178.96 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.81 ' CE2' HD12 ' A' ' 37' ' ' ILE . 4.8 m-85 -107.11 138.92 42.39 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.831 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.13 -168.78 37.29 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 120.071 -1.061 . . . . 0.0 112.577 179.424 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.711 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 83.9 mtm-85 -82.54 -26.68 32.24 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.744 0.307 . . . . 0.0 110.585 -179.753 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.474 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -61.69 134.62 47.13 Favored Glycine 0 N--CA 1.466 0.644 0 C-N-CA 121.354 -0.45 . . . . 0.0 112.349 -178.018 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.449 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.7 tp -62.79 -41.43 92.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.101 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.449 ' N ' HG23 ' A' ' 33' ' ' ILE . 83.8 tt0 -51.87 -16.09 0.64 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.883 179.137 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.474 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 40.8 m -70.54 142.4 51.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.751 179.709 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.529 ' OD2' ' O ' ' A' ' 26' ' ' THR . 59.1 m-20 -60.96 -34.08 74.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.703 -179.736 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.81 HD12 ' CE2' ' A' ' 29' ' ' PHE . 85.1 mt -129.89 124.31 58.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.031 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 70.6 ttp85 -109.63 138.45 45.98 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.18 -179.407 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.495 ' CG2' HD12 ' A' ' 41' ' ' LEU . 97.7 mt -116.6 131.36 69.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.687 -179.433 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -74.82 30.78 0.09 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -178.083 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.616 ' CD1' ' CZ ' ' A' ' 93' ' ' ARG . 17.3 mt -110.36 129.81 23.55 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 120.132 -0.627 . . . . 0.0 111.954 179.921 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.48 -10.38 26.76 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.567 2.178 . . . . 0.0 112.971 -179.878 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.628 HG21 ' CE2' ' B' ' 241' ' ' PHE . 11.7 m -95.83 -1.88 10.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 121.056 -0.258 . . . . 0.0 111.407 -179.827 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.711 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 53.4 t -87.24 135.85 24.34 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.54 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.994 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.525 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 0.6 OUTLIER -62.55 162.39 10.49 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.248 0.547 . . . . 0.0 111.551 -179.183 . . . . . . . . 3 3 . 1 . 063 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -62.57 -45.1 94.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.857 -178.861 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.642 ' O ' ' N ' ' A' ' 49' ' ' CYS . 85.8 mt-30 -113.81 -12.69 12.69 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 123.937 0.773 . . . . 0.0 110.243 179.397 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.525 ' H ' ' HB3' ' A' ' 45' ' ' SER . 10.3 t60 31.01 -72.7 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 179.305 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.642 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.5 135.26 46.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.396 0.617 . . . . 0.0 112.196 -178.233 . . . . . . . . 3 3 . 1 . 063 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -126.92 128.85 47.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.054 179.307 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.2 mt -115.18 134.54 57.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.971 -179.808 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -111.98 131.35 55.45 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.039 179.036 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 51.5 mm -101.55 110.4 28.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 120.144 -0.622 . . . . 0.0 111.015 179.617 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.465 ' O ' ' C ' ' A' ' 55' ' ' GLU . 97.7 m-70 -113.54 135.33 54.01 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.267 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.465 ' C ' ' O ' ' A' ' 54' ' ' HIS . 93.2 mt-10 -41.2 -32.0 0.25 Allowed 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -179.998 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.454 ' N ' ' C ' ' A' ' 54' ' ' HIS . 99.8 mm-40 -65.23 -68.26 0.38 Allowed 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.638 178.402 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.484 ' HG3' ' NE ' ' A' ' 81' ' ' ARG . 1.0 OUTLIER -155.13 -171.84 3.96 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.539 0.685 . . . . 0.0 111.499 -179.638 . . . . . . . . 3 3 . 1 . 063 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -115.24 122.53 46.27 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.477 178.781 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.0 mt -114.55 133.58 60.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.258 0.551 . . . . 0.0 111.675 -178.423 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 21.5 tp -97.6 128.3 44.22 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.779 -179.751 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -110.45 133.61 53.12 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.09 179.689 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.431 HD21 ' HA ' ' A' ' 68' ' ' PRO . 60.8 t-20 -90.88 106.98 18.89 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.193 -179.589 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -97.95 -11.08 23.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.376 179.202 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 54.1 p -74.15 100.74 3.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.043 0.449 . . . . 0.0 110.923 179.82 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.1 p -86.2 -14.26 44.47 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.249 179.542 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.585 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.2 OUTLIER -93.72 -42.98 8.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.954 -179.886 . . . . . . . . 3 3 . 1 . 063 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.462 ' O ' ' OG ' ' A' ' 64' ' ' SER . 34.4 m-80 -136.93 99.3 10.18 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.369 179.887 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.431 ' HA ' HD21 ' A' ' 62' ' ' ASN . 49.2 Cg_exo -54.39 143.86 64.13 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.15 1.9 . . . . 0.0 112.985 -179.585 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.3 m -77.16 141.5 40.11 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.824 179.192 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -107.3 138.8 42.82 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.435 0.636 . . . . 0.0 110.821 179.975 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 66.8 t -131.4 135.07 60.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.494 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 53.84 32.35 14.89 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.035 -0.666 . . . . 0.0 110.398 -179.469 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.18 29.63 66.29 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.8 178.296 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 73.3 m -146.51 138.2 24.64 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.496 -0.482 . . . . 0.0 111.05 179.302 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -69.42 144.26 14.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.974 179.739 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.8 pt -119.14 95.09 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.133 179.048 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 78' ' ' GLU . 49.0 p-10 -71.09 -24.01 62.23 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.254 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.491 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 5.5 mt-10 -118.92 163.96 23.49 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.745 179.545 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -62.23 150.1 88.17 Favored 'Trans proline' 0 N--CA 1.501 1.943 0 C-N-CA 122.656 2.237 . . . . 0.0 112.483 179.78 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.0 p -140.54 143.87 28.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-O 121.478 0.656 . . . . 0.0 112.352 -179.003 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.484 ' NE ' ' HG3' ' A' ' 57' ' ' GLU . 68.2 ttt180 -73.33 126.79 30.95 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.558 179.245 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.0 mt -82.13 132.43 35.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.956 0.407 . . . . 0.0 110.955 -179.623 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -123.57 149.22 45.55 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.706 179.284 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -52.44 121.01 6.22 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.962 -179.249 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.01 -13.67 45.02 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.529 -0.629 . . . . 0.0 111.529 179.676 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -71.21 139.22 50.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.954 0.407 . . . . 0.0 111.095 -179.939 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.7 t -117.92 130.18 73.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.468 -178.5 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 92.7 mt -94.0 131.93 39.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.225 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.8 m -115.91 127.6 55.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.307 0.575 . . . . 0.0 112.252 -178.568 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.511 ' O ' ' C ' ' A' ' 91' ' ' ILE . 93.5 mt -125.87 124.8 67.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.176 178.346 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.537 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 72.2 mt -3.61 89.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -179.856 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.537 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 8.9 t0 86.84 -15.44 0.44 Allowed 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 177.158 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.751 ' NH1' HH22 ' B' ' 245' ' ' ARG . 23.3 mtm-85 -131.27 145.82 52.05 Favored 'General case' 0 CA--C 1.512 -0.519 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.698 -179.127 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.8 p -138.0 156.13 48.15 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 121.134 0.493 . . . . 0.0 110.164 179.567 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.56 ' HB3' HD11 ' A' ' 7' ' ' LEU . 91.2 m-85 -130.08 122.12 27.71 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.536 -179.292 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.581 ' O ' HD12 ' A' ' 7' ' ' LEU . 44.5 ttm180 -84.66 128.62 34.7 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 120.446 -0.502 . . . . 0.0 111.202 -179.616 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 92.9 t80 -91.88 125.33 36.54 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.616 179.947 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -126.5 121.22 31.73 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.807 179.539 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.491 ' O ' ' O ' ' A' ' 100' ' ' GLU . 64.8 t-20 -98.45 107.15 19.53 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.393 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.491 ' O ' ' O ' ' A' ' 99' ' ' ASN . 95.6 mt-10 . . . . . 0 C--N 1.33 -0.265 0 C-N-CA 120.561 -0.455 . . . . 0.0 109.824 -179.239 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 60.2 t . . . . . 0 N--CA 1.456 -0.163 0 CA-C-O 120.776 0.322 . . . . 0.0 110.164 . . . . . . . . . 0 0 . 1 . 063 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -143.12 94.65 2.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.965 179.508 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 063 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -131.43 30.06 4.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.033 0.444 . . . . 0.0 110.026 179.672 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -124.84 -152.48 8.31 Favored Glycine 0 CA--C 1.534 1.219 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.436 -178.822 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.41 148.71 70.15 Favored 'Trans proline' 0 N--CA 1.5 1.872 0 C-N-CA 123.614 2.876 . . . . 0.0 113.173 -179.327 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.585 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -58.03 166.84 5.02 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.829 2.352 . . . . 0.0 111.787 179.102 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 2.4 p -114.03 135.74 52.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.129 179.746 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . 0.463 ' HB2' HD13 ' A' ' 91' ' ' ILE . 0.5 OUTLIER -68.73 123.14 20.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.18 0.514 . . . . 0.0 110.071 -179.878 . . . . . . . . 3 3 . 1 . 063 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 063 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -50.06 -20.15 4.9 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 121.983 1.789 . . . . 0.0 112.257 179.674 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 27.4 p -77.08 -39.67 48.92 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.24 178.274 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.628 ' CE2' HG21 ' A' ' 43' ' ' VAL . 80.2 t80 -58.99 -47.04 86.58 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.934 -179.798 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 80.2 mt -67.27 -39.63 86.08 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.127 179.033 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -65.22 -40.88 94.69 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.824 -178.903 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 78.1 ttt-85 -63.01 -43.67 98.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 120.431 -0.507 . . . . 0.0 110.557 -179.553 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.751 HH22 ' NH1' ' A' ' 93' ' ' ARG . 85.6 mtp180 -64.53 -37.32 87.15 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.678 -178.894 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.27 -40.15 96.59 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.095 178.811 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 44.6 t -64.07 -44.18 93.18 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.701 0.763 . . . . 0.0 109.211 178.499 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . 0.502 ' O ' ' N ' ' B' ' 252' ' ' LEU . 93.8 mm-40 -62.41 -36.32 81.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.263 179.727 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.601 HG23 ' O ' ' B' ' 245' ' ' ARG . 60.0 t -62.34 -46.47 96.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.307 179.708 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -63.42 -27.19 69.12 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.422 0.63 . . . . 0.0 109.568 179.125 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -94.44 -7.84 40.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.74 179.176 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.502 ' N ' ' O ' ' B' ' 248' ' ' GLN . 38.2 tp -108.09 126.85 53.24 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.329 0.585 . . . . 0.0 111.356 -179.233 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -57.94 142.33 46.64 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.924 -179.16 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -73.2 -8.31 55.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.678 179.188 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . 0.41 ' OD1' ' C ' ' B' ' 255' ' ' ASP . 40.3 p-10 -82.07 3.6 26.22 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.349 -179.05 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -80.24 90.54 5.53 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.867 179.702 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . 0.551 ' C ' ' H ' ' B' ' 259' ' ' ASP . 99.7 mttt -83.07 4.71 25.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.42 -178.399 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.544 ' O ' ' C ' ' B' ' 259' ' ' ASP . 87.1 m-20 -76.4 15.78 0.56 Allowed 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.441 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.667 ' C ' ' H ' ' B' ' 261' ' ' ILE . 51.1 p-10 -15.15 123.74 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.916 179.562 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -53.32 8.41 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.805 -179.189 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.667 ' H ' ' C ' ' B' ' 259' ' ' ASP . 64.1 mt -108.46 135.13 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.735 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 78.4 t -127.98 136.45 60.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.913 0.387 . . . . 0.0 109.961 -179.684 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -99.68 121.11 40.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.42 -178.398 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -66.52 -45.51 79.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.932 179.217 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.41 152.2 47.21 Favored Pre-proline 0 CA--C 1.52 -0.199 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.283 -179.448 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -62.5 140.51 82.21 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.754 2.303 . . . . 0.0 112.234 -179.831 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 41.8 pt . . . . . 0 C--N 1.322 -0.599 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.01 179.14 . . . . . . . . 0 0 . 1 . 064 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo . . . . . 0 N--CA 1.497 1.682 0 CA-C-O 120.905 0.294 . . . . 0.0 112.322 . . . . . . . . . 0 0 . 1 . 064 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 60.1 p -115.91 -46.23 2.84 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.642 179.76 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.9 mtt85 -90.65 126.84 36.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.505 -179.676 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -135.95 146.43 47.27 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.384 -0.526 . . . . 0.0 111.688 -179.646 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.858 HD11 HD11 ' A' ' 22' ' ' LEU . 73.3 mt -114.41 142.83 45.85 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.021 179.358 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.2 t -118.31 130.34 73.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.195 179.686 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 50.0 m -79.22 135.44 36.79 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.294 0.569 . . . . 0.0 111.956 -178.843 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.6 mt -112.51 138.11 42.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.301 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -91.71 157.15 17.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.089 0.471 . . . . 0.0 111.507 -179.009 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 85.7 mtm-85 -58.27 -24.42 59.36 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.6 -178.623 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 86.2 p -84.78 -7.92 59.02 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.261 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.44 38.8 6.53 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.82 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.9 t -122.14 134.54 65.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.897 0.38 . . . . 0.0 111.416 -179.709 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -77.09 122.53 25.1 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.705 179.824 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -114.75 -122.85 3.68 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.657 -179.435 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.38 148.99 34.56 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.406 2.071 . . . . 0.0 112.914 -178.985 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -103.97 153.8 20.4 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.919 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.465 ' CD2' HD11 ' A' ' 37' ' ' ILE . 47.0 t80 -124.23 91.15 49.96 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.245 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.0 139.71 36.5 Favored 'Trans proline' 0 C--N 1.315 -1.191 0 C-N-CA 121.253 1.302 . . . . 0.0 111.785 -179.299 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.858 HD11 HD11 ' A' ' 7' ' ' LEU . 83.1 mt -101.23 122.53 43.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.265 0.555 . . . . 0.0 111.187 -178.866 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.6 p -117.76 -6.74 11.05 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.47 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 67.2 mt -102.79 148.31 25.77 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.555 -179.623 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.9 m -72.53 -14.49 61.66 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.438 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.417 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 31.5 m -127.92 129.42 46.81 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.411 -179.799 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.2 t -123.91 119.34 29.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.272 178.268 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.5 tp -116.3 130.23 56.67 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.94 0.4 . . . . 0.0 111.355 -178.084 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.786 ' CE2' HD12 ' A' ' 37' ' ' ILE . 5.7 m-85 -109.4 138.98 44.94 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.011 -179.897 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 148.08 -171.83 28.48 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.081 178.944 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.412 ' HD2' HH11 ' A' ' 31' ' ' ARG . 47.6 mtm180 -79.1 -32.75 44.74 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 -179.919 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.557 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -45.32 147.63 1.85 Allowed Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 -178.751 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 36.2 mm -63.88 -43.51 97.82 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 CA-C-O 120.921 0.391 . . . . 0.0 110.149 179.958 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -56.87 -21.25 28.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.955 -179.654 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.557 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 59.7 m -52.87 115.16 1.69 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.133 -179.667 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.417 ' OD2' ' O ' ' A' ' 26' ' ' THR . 79.3 m-20 -57.16 -21.6 34.07 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -179.697 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.786 HD12 ' CE2' ' A' ' 29' ' ' PHE . 98.9 mt -132.25 122.24 47.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.124 -0.943 . . . . 0.0 109.334 177.037 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -104.77 135.94 45.22 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 -179.791 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.412 HD13 ' HE ' ' A' ' 93' ' ' ARG . 95.1 mt -115.26 127.72 72.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.615 -179.99 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -69.94 40.08 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -177.361 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.64 ' CD1' ' NH1' ' A' ' 93' ' ' ARG . 20.5 mt -124.18 132.32 24.29 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.957 -179.934 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.08 -7.2 19.57 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.679 2.252 . . . . 0.0 112.931 -179.509 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.492 HG21 ' CE2' ' B' ' 241' ' ' PHE . 17.2 m -99.8 2.25 10.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.685 179.53 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 29.4 t -87.94 136.54 22.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.345 179.526 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.2 m -65.9 157.2 31.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.182 0.515 . . . . 0.0 111.179 -179.659 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -62.74 -43.65 98.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.161 -178.888 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.638 ' O ' ' N ' ' A' ' 49' ' ' CYS . 96.7 mt-30 -113.99 -15.0 12.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.957 0.408 . . . . 0.0 110.511 179.677 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 18.3 t60 28.38 -74.86 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 178.875 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.638 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -128.23 133.96 48.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.258 0.552 . . . . 0.0 112.436 -178.666 . . . . . . . . 3 3 . 1 . 064 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -127.63 131.05 49.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.122 179.17 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.4 mt -115.39 133.63 61.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.894 -179.56 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -113.84 123.01 48.77 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.345 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.0 mt -105.62 113.8 43.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.448 0.642 . . . . 0.0 111.778 -178.662 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.422 ' O ' ' N ' ' A' ' 56' ' ' GLN . 82.2 m-70 -114.6 144.44 43.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.592 179.783 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 54' ' ' HIS . 78.2 mm-40 -41.07 -29.5 0.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.02 -179.02 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.422 ' N ' ' O ' ' A' ' 54' ' ' HIS . 95.7 mt-30 -64.73 -68.93 0.32 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.031 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.1 -166.1 1.99 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.061 179.86 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.42 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -113.29 127.89 56.29 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.324 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.5 mt -115.52 127.88 72.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.098 0.475 . . . . 0.0 111.795 -179.211 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.541 ' HB2' HD11 ' A' ' 82' ' ' LEU . 24.8 tp -97.42 126.95 42.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.043 179.596 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -111.2 135.33 51.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.858 179.925 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.563 ' ND2' ' H ' ' A' ' 69' ' ' THR . 22.0 t-20 -98.83 106.9 19.22 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.974 -179.705 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -95.09 -6.64 41.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.534 178.994 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.5 t -71.65 99.84 2.18 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.493 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 79.0 p -87.21 -16.52 35.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.275 179.823 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.789 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.2 OUTLIER -90.72 -42.82 10.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.278 -179.806 . . . . . . . . 3 3 . 1 . 064 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.405 HD21 ' HA ' ' B' ' 236' ' ' VAL . 56.8 m-20 -139.25 97.96 8.42 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.983 -179.802 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -56.67 146.0 78.95 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 122.321 2.014 . . . . 0.0 113.156 -179.435 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.563 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 2.9 m -76.68 149.95 36.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.59 179.492 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -110.77 140.03 45.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.154 -179.653 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.666 HG13 ' OD1' ' A' ' 86' ' ' ASP . 60.6 t -131.09 135.3 60.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.386 -0.824 . . . . 0.0 108.87 179.624 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 51.59 33.35 10.51 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 119.834 -0.747 . . . . 0.0 109.103 -179.835 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.3 25.96 71.65 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.066 179.531 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 67.6 m -142.18 139.91 32.22 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 117.503 0.651 . . . . 0.0 111.561 179.948 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -68.13 143.91 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.185 179.897 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.475 HG21 HG21 ' A' ' 80' ' ' VAL . 5.4 pt -116.05 94.38 3.08 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-O 121.166 0.507 . . . . 0.0 110.479 179.111 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -67.21 -25.83 66.31 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.739 179.762 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.478 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.1 OUTLIER -129.98 179.73 1.24 Allowed Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.818 -179.876 . . . . . . . . 3 3 . 1 . 064 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.478 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 23.8 Cg_exo -62.06 146.83 96.02 Favored 'Trans proline' 0 N--CA 1.5 1.878 0 C-N-CA 123.087 2.524 . . . . 0.0 112.703 -179.379 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.475 HG21 HG21 ' A' ' 76' ' ' ILE . 2.4 m -142.41 137.97 29.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.813 -179.748 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 85.2 mtt85 -73.33 129.35 37.83 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.258 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.541 HD11 ' HB2' ' A' ' 60' ' ' LEU . 95.3 mt -83.17 137.6 33.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.942 0.401 . . . . 0.0 110.493 179.987 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -131.49 156.7 45.2 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.614 -179.883 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.585 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 3.6 t-160 -59.07 118.64 6.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.029 0.442 . . . . 0.0 110.115 -179.899 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.12 -8.0 35.61 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 -179.046 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.666 ' OD1' HG13 ' A' ' 71' ' ' VAL . 64.4 t0 -77.2 126.99 31.84 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.478 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 13.0 p -107.16 137.47 37.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.471 -178.897 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 83.3 mt -103.9 128.22 57.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.502 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.5 m -123.17 126.56 47.23 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 121.624 0.726 . . . . 0.0 112.82 -178.243 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.474 ' O ' ' C ' ' A' ' 91' ' ' ILE . 97.9 mt -117.51 126.88 74.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.988 178.547 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.542 HG22 ' N ' ' A' ' 92' ' ' ASP . 96.8 mt 32.79 -98.73 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.669 -179.499 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.542 ' N ' HG22 ' A' ' 91' ' ' ILE . 97.6 m-20 -112.13 12.1 20.45 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -179.84 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.64 ' NH1' ' CD1' ' A' ' 41' ' ' LEU . 39.6 mtm-85 -126.19 142.55 51.48 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 120.984 -0.287 . . . . 0.0 110.441 -179.499 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 43.7 t -138.55 149.57 45.46 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.706 179.92 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.624 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 96.8 m-85 -121.0 121.2 37.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.038 178.558 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 55.3 ttt85 -84.45 131.03 34.71 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.546 -0.462 . . . . 0.0 109.766 -179.774 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -90.38 122.52 33.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.402 -179.753 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -124.24 120.64 32.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.843 0.354 . . . . 0.0 110.836 179.893 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.585 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 62.8 t-20 -110.69 112.43 24.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.221 179.688 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 . . . . . 0 C--N 1.329 -0.313 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.883 -179.769 . . . . . . . . 0 0 . 1 . 064 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 26.1 t . . . . . 0 CA--C 1.527 0.058 0 CA-C-O 120.542 0.211 . . . . 0.0 110.606 . . . . . . . . . 0 0 . 1 . 064 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.539 ' C ' ' H ' ' B' ' 231' ' ' GLN . 67.0 t0 -137.94 97.61 3.46 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.987 -179.749 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 064 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.539 ' H ' ' C ' ' B' ' 229' ' ' ASP . 2.6 mt-30 -115.31 -27.42 7.24 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.311 -179.429 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . 0.513 ' O ' ' O ' ' B' ' 231' ' ' GLN . . . -34.14 161.34 0.01 OUTLIER Glycine 0 CA--C 1.527 0.813 0 N-CA-C 111.798 -0.521 . . . . 0.0 111.798 -179.265 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.28 162.25 42.58 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 123.597 2.865 . . . . 0.0 112.451 179.993 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.789 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.08 142.01 30.4 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 C-N-CA 121.723 1.615 . . . . 0.0 112.331 179.582 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.495 ' CG2' HG22 ' A' ' 66' ' ' THR . 49.8 t -65.5 135.68 27.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.714 -179.623 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.7 t -66.69 130.56 43.58 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.723 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . 0.589 ' O2P' HG23 ' B' ' 240' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -53.63 -33.0 67.19 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 123.183 2.589 . . . . 0.0 113.668 179.677 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . 0.589 HG23 ' O2P' ' B' ' 238' ' ' TPO . 39.8 p -73.47 -38.59 65.39 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.977 179.182 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.492 ' CE2' HG21 ' A' ' 43' ' ' VAL . 77.6 t80 -58.09 -48.14 81.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.845 -179.004 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.402 HD22 ' OD1' ' A' ' 92' ' ' ASP . 98.0 mt -67.71 -42.36 82.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.884 0.373 . . . . 0.0 111.674 -179.687 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -63.25 -45.16 92.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.884 -178.62 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -63.53 -43.82 96.05 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.841 0.353 . . . . 0.0 111.141 -179.527 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.445 ' O ' HG23 ' B' ' 249' ' ' VAL . 48.5 ttm-85 -65.27 -41.9 93.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.469 -179.334 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -63.4 -39.02 93.36 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.179 179.159 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 20.3 m -65.12 -42.64 93.74 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 177.895 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 63.6 tp60 -59.63 -35.41 74.31 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.53 -1.213 . . . . 0.0 110.179 179.493 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.445 HG23 ' O ' ' B' ' 245' ' ' ARG . 49.9 t -64.22 -44.72 97.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-O 120.873 0.368 . . . . 0.0 110.227 178.926 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -64.01 -33.43 75.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.985 179.157 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -88.36 -5.45 58.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.438 179.4 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 36.6 tp -71.38 138.67 49.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.113 -179.498 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . 0.56 ' C ' ' H ' ' B' ' 255' ' ' ASP . 95.0 m-20 -38.1 154.3 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.25 -178.756 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' B' ' 254' ' ' ASP . 57.8 t0 -62.66 4.99 0.13 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.95 179.466 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . 0.56 ' H ' ' C ' ' B' ' 253' ' ' ASN . 90.8 m-20 -83.72 -84.21 0.14 Allowed 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.424 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' B' ' 253' ' ' ASN . 12.8 m-20 66.08 13.2 8.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.176 -179.459 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -65.16 -35.36 80.86 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.889 178.917 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -100.84 137.58 39.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.278 179.159 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.458 ' CG ' ' H ' ' B' ' 260' ' ' GLU . 33.3 p-10 -109.3 -118.43 0.28 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.177 0.513 . . . . 0.0 112.239 -178.604 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.458 ' H ' ' CG ' ' B' ' 259' ' ' ASP . 97.7 mt-10 -146.43 26.58 1.16 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.514 179.92 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.624 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 70.6 mt -115.47 134.48 58.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.168 179.94 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 54.6 t -124.16 132.91 70.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.725 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -94.54 119.02 32.57 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.387 0.613 . . . . 0.0 111.612 -177.88 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -66.83 -46.48 74.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.287 179.68 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -72.85 166.44 43.05 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.181 -179.25 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -64.26 141.26 74.65 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 121.569 1.513 . . . . 0.0 111.282 179.878 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 11.9 tt . . . . . 0 C--N 1.324 -0.517 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.34 -178.869 . . . . . . . . 0 0 . 1 . 065 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.41 ' HB2' ' HE ' ' A' ' 6' ' ' ARG . 35.1 Cg_exo . . . . . 0 N--CA 1.494 1.518 0 CA-C-O 121.003 0.335 . . . . 0.0 111.757 . . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.408 ' OG1' ' N ' ' A' ' 5' ' ' ARG . 6.6 p -115.56 -52.57 2.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.326 -179.802 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.408 ' N ' ' OG1' ' A' ' 4' ' ' THR . 85.3 mtt85 -94.21 128.24 40.54 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.816 -179.885 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.41 ' HE ' ' HB2' ' A' ' 3' ' ' PRO . 99.8 mtt180 -132.86 144.33 50.12 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.389 -0.525 . . . . 0.0 111.354 -179.345 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 79.9 mt -115.41 145.59 42.4 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.669 179.633 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.641 HG22 ' CD2' ' A' ' 19' ' ' HIS . 49.7 t -118.48 130.18 73.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.855 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 m -90.66 117.04 29.0 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.308 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.595 HD12 ' OG ' ' A' ' 94' ' ' SER . 96.0 mt -86.94 142.36 13.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.305 177.724 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.41 ' NZ ' ' HA ' ' B' ' 258' ' ' ASP . 68.1 mttm -95.16 169.73 9.89 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.869 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.411 ' NH1' ' HB3' ' B' ' 248' ' ' GLN . 88.9 mtm180 -56.96 -29.6 63.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.8 -178.784 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.6 t -81.11 -7.35 59.54 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.757 179.295 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.27 40.19 8.67 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 -178.892 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.8 t -116.64 134.06 61.32 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.076 0 CA-C-O 120.832 0.349 . . . . 0.0 111.602 -178.713 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.468 ' C ' ' OD1' ' A' ' 16' ' ' ASP . 39.4 t0 -77.64 124.36 27.84 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.138 179.448 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -124.09 -115.56 2.16 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 120.655 -0.784 . . . . 0.0 111.408 179.94 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -72.95 144.21 37.94 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.153 1.902 . . . . 0.0 113.621 -178.808 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.641 ' CD2' HG22 ' A' ' 8' ' ' VAL . 50.9 m170 -106.05 142.41 35.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.275 179.781 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.435 ' HD1' HG22 ' B' ' 267' ' ' ILE . 45.5 t80 -114.2 93.02 29.12 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.221 -179.571 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -69.07 135.15 31.31 Favored 'Trans proline' 0 N--CA 1.488 1.187 0 C-N-CA 121.51 1.474 . . . . 0.0 111.668 -179.537 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.474 HD22 ' HB2' ' A' ' 27' ' ' CYS . 92.4 mt -84.84 80.31 9.32 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.187 -178.699 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 85.6 p -82.33 -10.85 58.93 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.078 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 58.0 mt -103.85 144.66 31.21 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.401 -179.202 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.8 t -67.5 -14.84 63.29 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.968 -179.856 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.548 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 89.2 m -131.38 133.69 45.52 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 120.696 -0.401 . . . . 0.0 111.395 -179.809 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.595 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 13.2 t -125.27 116.14 21.48 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.632 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.531 HD12 ' O ' ' A' ' 49' ' ' CYS . 43.4 tp -115.23 131.29 56.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.29 -178.161 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.607 ' CE2' HD12 ' A' ' 37' ' ' ILE . 23.3 m-85 -109.38 136.91 48.04 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.632 178.943 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 154.22 -177.19 31.76 Favored Glycine 0 C--O 1.221 -0.677 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.778 178.804 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.497 ' NH1' ' O ' ' B' ' 229' ' ' ASP . 46.4 mtm180 -77.47 -31.08 53.48 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.646 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.508 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -51.33 150.55 6.85 Favored Glycine 0 N--CA 1.465 0.582 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.395 -178.327 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.551 HG23 ' N ' ' A' ' 34' ' ' GLU . 11.0 tp -66.44 -41.62 89.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.646 0.26 . . . . 0.0 110.533 179.967 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.551 ' N ' HG23 ' A' ' 33' ' ' ILE . 81.0 mm-40 -55.72 -24.23 33.61 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.347 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.508 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 39.0 m -53.3 118.04 3.51 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.823 179.971 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.548 ' OD2' ' O ' ' A' ' 26' ' ' THR . 93.2 m-20 -59.14 -27.99 66.15 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.855 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.607 HD12 ' CE2' ' A' ' 29' ' ' PHE . 97.9 mt -127.53 119.12 51.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 176.479 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.472 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 82.9 mtp180 -102.2 134.82 44.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.901 0.382 . . . . 0.0 111.901 -178.439 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.0 mt -122.02 130.05 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.114 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.693 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -82.93 34.36 0.45 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.001 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.715 HD11 ' CZ ' ' A' ' 93' ' ' ARG . 31.3 mt -95.65 129.03 35.71 Favored Pre-proline 0 C--N 1.325 -0.477 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.33 179.458 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.17 -12.16 27.62 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 C-N-CA 122.218 1.945 . . . . 0.0 112.361 -179.616 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.4 m -98.08 5.73 9.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.872 0.368 . . . . 0.0 110.495 -179.949 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.477 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 37.4 t -98.82 135.11 35.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.414 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.43 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 6.9 t -70.34 174.68 5.37 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.229 0.538 . . . . 0.0 111.233 -179.031 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 50.4 mttp -64.03 -41.01 97.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.1 -179.926 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.628 ' O ' ' N ' ' A' ' 49' ' ' CYS . 85.6 mt-30 -112.85 -20.08 11.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.919 -179.272 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.43 ' H ' ' HB3' ' A' ' 45' ' ' SER . 28.2 t60 39.17 -76.8 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 179.751 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.628 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.2 133.46 46.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.306 -178.548 . . . . . . . . 3 3 . 1 . 065 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -127.35 130.57 49.69 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.541 179.34 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 86.2 mt -115.98 134.86 57.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.812 -179.826 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.516 ' CD ' ' NE2' ' A' ' 54' ' ' HIS . 74.6 tt0 -120.47 125.8 48.81 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.791 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 93.9 mt -106.56 119.08 55.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.567 0.698 . . . . 0.0 112.26 -179.009 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.516 ' NE2' ' CD ' ' A' ' 52' ' ' GLU . 99.6 m-70 -112.36 140.34 47.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.605 -1.179 . . . . 0.0 108.959 178.961 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.9 mm-40 -40.78 -28.02 0.07 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 -179.86 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.462 ' N ' ' O ' ' A' ' 54' ' ' HIS . 82.3 mt-30 -65.88 -68.04 0.4 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.434 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -154.14 -171.51 3.9 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.382 -179.613 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.454 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -110.16 128.99 55.78 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.497 -0.556 . . . . 0.0 109.497 179.021 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 98.0 mt -119.02 130.96 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -178.752 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 32.1 tp -99.33 131.7 45.17 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.003 179.277 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -114.55 136.44 53.02 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.072 179.197 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -97.81 111.09 23.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.187 0.518 . . . . 0.0 111.651 -179.543 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -104.8 -10.37 17.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.484 179.91 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.4 101.46 12.02 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.491 -179.813 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 77.8 p -76.19 -35.57 59.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.257 0.551 . . . . 0.0 109.903 179.244 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.622 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.8 OUTLIER -63.01 -43.02 99.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.285 -178.827 . . . . . . . . 3 3 . 1 . 065 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -147.25 99.77 3.9 Favored Pre-proline 0 C--N 1.317 -0.834 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.484 -179.034 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -57.55 146.46 84.02 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 C-N-CA 121.783 1.656 . . . . 0.0 112.681 -178.78 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 18.2 m -70.24 136.17 49.68 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.351 178.316 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -96.94 143.9 27.37 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.171 -0.612 . . . . 0.0 111.229 -179.162 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.696 ' HB ' HD11 ' A' ' 76' ' ' ILE . 5.4 p -129.5 133.88 64.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.837 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 49.17 30.12 2.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.157 0.503 . . . . 0.0 109.952 -179.331 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 78.2 27.47 57.85 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.393 179.064 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.6 t -138.0 139.59 39.73 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.997 0.398 . . . . 0.0 110.46 179.739 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -67.78 142.29 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.846 179.907 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.696 HD11 ' HB ' ' A' ' 71' ' ' VAL . 96.6 mt -101.72 103.72 15.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.936 -179.742 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -67.63 -40.97 84.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.989 179.028 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.528 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.6 OUTLIER -134.68 179.37 1.4 Allowed Pre-proline 0 CA--C 1.53 0.186 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.727 -178.35 . . . . . . . . 3 3 . 1 . 065 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.467 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 31.8 Cg_exo -59.37 144.59 99.36 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 122.804 2.336 . . . . 0.0 112.648 -179.585 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.8 m -143.1 141.24 26.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.995 -179.806 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 91.7 mtm180 -71.68 131.39 43.09 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.526 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.454 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 96.4 mt -80.19 139.99 36.51 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.838 0.351 . . . . 0.0 110.978 -179.538 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -131.44 150.2 52.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.426 -179.903 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -55.92 123.09 13.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.908 0.385 . . . . 0.0 110.982 -179.304 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.12 -14.19 48.42 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 -179.472 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.48 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 64.9 t0 -71.4 129.75 39.6 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.028 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.447 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 95.0 t -109.36 130.55 62.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.265 -178.819 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.4 mt -97.0 131.57 43.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.984 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 63.9 m -127.97 127.63 43.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.713 0.768 . . . . 0.0 113.002 -178.512 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.607 ' O ' ' N ' ' A' ' 92' ' ' ASP . 82.2 mt -107.03 123.06 61.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 177.682 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.437 ' C ' ' O ' ' A' ' 90' ' ' ILE . 70.3 mt 38.87 -88.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 120.511 -0.475 . . . . 0.0 110.646 -179.467 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.607 ' N ' ' O ' ' A' ' 90' ' ' ILE . 32.4 t70 -128.18 16.17 6.69 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -179.746 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.715 ' CZ ' HD11 ' A' ' 41' ' ' LEU . 98.3 mtt180 -123.01 139.91 53.59 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.115 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.595 ' OG ' HD12 ' A' ' 10' ' ' ILE . 31.7 p -138.84 151.87 47.37 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 119.23 -0.988 . . . . 0.0 112.011 -179.684 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -122.1 121.61 37.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.554 -1.203 . . . . 0.0 108.364 178.958 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -83.56 133.32 34.87 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.176 -0.609 . . . . 0.0 111.48 -178.52 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -96.83 122.47 39.82 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.234 -179.615 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -123.67 124.58 43.08 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.864 179.947 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 62.9 t-20 -106.97 107.15 18.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.787 179.478 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 . . . . . 0 C--N 1.33 -0.272 0 C-N-CA 120.204 -0.598 . . . . 0.0 110.229 179.691 . . . . . . . . 0 0 . 1 . 065 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . 0.705 ' O ' HG12 ' B' ' 228' ' ' VAL . 29.5 t . . . . . 0 CA--C 1.53 0.182 0 N-CA-C 111.497 0.184 . . . . 0.0 111.497 . . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.497 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 88.6 m-20 -71.14 137.34 48.73 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.233 0.54 . . . . 0.0 111.05 -179.779 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . 0.537 ' C ' ' OE1' ' B' ' 231' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.537 ' OE1' ' C ' ' B' ' 230' ' ' SEP . 1.6 mp0 -124.65 46.14 2.38 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.13 178.677 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -125.4 179.99 15.96 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 -179.398 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.83 161.51 45.83 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 123.24 2.626 . . . . 0.0 113.448 -179.642 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.622 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.87 144.34 43.14 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 121.804 1.669 . . . . 0.0 113.307 -178.656 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.42 HG13 ' O ' ' B' ' 236' ' ' VAL . 12.2 p -58.35 135.73 22.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.135 -179.642 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 10.0 t -66.77 132.99 49.24 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.742 -179.502 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . 0.436 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . 0.436 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 31.9 Cg_exo -60.7 -27.92 85.64 Favored 'Trans proline' 0 N--CA 1.502 1.999 0 C-N-CA 123.131 2.554 . . . . 0.0 114.085 -178.769 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 97.4 m -67.45 -47.09 71.15 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.379 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.489 ' HZ ' HD22 ' A' ' 41' ' ' LEU . 91.7 t80 -57.93 -46.21 85.4 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.335 -179.459 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 87.6 mt -65.43 -38.83 91.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.842 0.353 . . . . 0.0 110.64 179.962 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -60.77 -41.11 94.83 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.077 0.465 . . . . 0.0 110.044 -179.98 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 62.0 ttp180 -61.45 -43.17 99.34 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.195 179.877 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.658 HH12 ' HE ' ' A' ' 93' ' ' ARG . 76.0 mtp85 -60.07 -42.09 93.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.866 -179.689 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.29 -41.34 96.81 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.28 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 8.6 t -63.4 -46.13 87.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.738 178.381 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . 0.411 ' HB3' ' NH1' ' A' ' 12' ' ' ARG . 83.2 mt-30 -59.33 -38.45 80.35 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.808 -178.989 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 25.1 t -59.61 -46.06 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.677 178.846 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -64.61 -31.81 73.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.085 0.469 . . . . 0.0 109.909 179.054 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -67.43 -19.91 65.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.641 -179.814 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 97.9 mt -66.2 134.65 53.16 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.109 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -101.63 -39.54 7.43 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.137 0.494 . . . . 0.0 110.441 179.534 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . 0.455 ' C ' ' N ' ' B' ' 256' ' ' ASP . 96.0 m-20 -67.78 -18.0 64.72 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.341 179.53 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 26.8 t0 56.99 12.14 1.14 Allowed 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -178.808 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.455 ' N ' ' C ' ' B' ' 254' ' ' ASP . 68.3 t0 -172.25 90.03 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.555 179.855 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . 0.522 ' O ' ' C ' ' B' ' 258' ' ' ASP . 88.5 tttt -156.97 138.21 13.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.449 -179.862 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.522 ' C ' ' O ' ' B' ' 257' ' ' LYS . 66.4 t0 -21.82 138.19 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 O-C-N 123.926 0.766 . . . . 0.0 110.6 -179.713 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.517 ' N ' ' OD1' ' B' ' 258' ' ' ASP . 20.4 p-10 -119.43 68.0 0.81 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -179.018 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.544 ' OE1' ' NH2' ' A' ' 93' ' ' ARG . 97.8 mt-10 58.68 22.61 10.12 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 177.559 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 76.3 mt -114.51 128.98 71.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.178 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 54.4 t -126.85 133.9 67.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.137 0.494 . . . . 0.0 110.973 -179.203 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . 0.673 ' CD2' HG21 ' B' ' 267' ' ' ILE . 54.9 m-85 -96.38 120.36 36.54 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.99 -179.299 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -64.07 -42.72 96.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.533 0.682 . . . . 0.0 110.045 179.24 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . 0.569 ' N ' HE21 ' B' ' 265' ' ' GLN . 0.0 OUTLIER -103.26 171.52 5.09 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.006 -178.604 . . . . . . . . 3 3 . 1 . 065 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -54.52 149.73 37.79 Favored 'Trans proline' 0 N--CA 1.501 1.953 0 C-N-CA 123.143 2.562 . . . . 0.0 114.154 -179.728 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . 0.673 HG21 ' CD2' ' B' ' 263' ' ' PHE . 33.0 pt . . . . . 0 C--O 1.232 0.178 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.001 179.907 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo . . . . . 0 N--CA 1.495 1.587 0 CA-C-O 120.861 0.275 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 066 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 68.2 p -119.0 -34.77 3.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.543 179.391 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.809 ' NH1' ' HB2' ' A' ' 58' ' ' ALA . 95.1 mtt-85 -95.5 122.11 37.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.128 -179.644 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.411 ' NE ' ' OE1' ' A' ' 98' ' ' GLU . 31.1 ptt180 -138.48 145.34 40.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.072 0.463 . . . . 0.0 111.298 -179.86 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.618 HD12 ' O ' ' A' ' 96' ' ' ARG . 36.9 tp -118.93 136.47 54.05 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.359 179.007 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.81 HG22 ' CD2' ' A' ' 19' ' ' HIS . 41.0 t -110.35 131.6 60.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.822 -178.548 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.5 m -93.47 114.73 27.19 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.156 0.503 . . . . 0.0 112.12 -179.144 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 45.7 mm -79.63 144.93 10.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.611 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -90.52 158.92 16.77 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.181 178.595 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.55 ' NE ' ' NH2' ' B' ' 245' ' ' ARG . 84.7 mtp180 -54.87 -27.84 45.6 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.801 -178.825 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 85.9 p -79.19 -10.71 59.89 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 120.876 -0.329 . . . . 0.0 111.626 179.982 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.69 33.36 7.96 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 -179.223 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.6 t -120.6 134.61 63.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.87 0.367 . . . . 0.0 110.969 -179.531 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -71.22 129.28 38.49 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.818 179.58 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -125.35 -121.53 2.54 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.527 -179.076 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.21 144.62 42.13 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.16 1.907 . . . . 0.0 113.019 -178.104 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.81 ' CD2' HG22 ' A' ' 8' ' ' VAL . 59.2 m170 -104.22 145.78 29.73 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.647 -179.443 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.726 ' CD2' HD11 ' A' ' 37' ' ' ILE . 34.7 t80 -116.21 91.37 32.19 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.992 -179.924 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -60.35 125.36 17.26 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 121.779 1.652 . . . . 0.0 111.135 179.52 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 22' ' ' LEU . 96.0 mt -84.48 50.51 1.9 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.292 -178.762 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.4 p -61.21 -23.69 65.8 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.962 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.602 HD11 ' OE1' ' B' ' 265' ' ' GLN . 64.3 mt -83.53 141.84 31.33 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.173 -179.832 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.2 m -67.25 -17.84 64.97 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.834 -178.696 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.74 133.73 40.23 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.252 -0.579 . . . . 0.0 112.029 -178.977 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.5 t -128.19 119.96 26.29 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.25 179.207 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.459 HD23 ' HA ' ' A' ' 35' ' ' CYS . 38.5 tp -111.75 128.54 56.12 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.88 -178.938 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.478 ' O ' ' O ' ' A' ' 47' ' ' GLN . 57.6 m-85 -108.35 134.86 50.57 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.329 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 156.83 -170.7 34.25 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 119.904 -1.141 . . . . 0.0 112.449 179.344 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.603 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 10.4 mtp180 -85.6 -31.45 22.61 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -179.779 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -51.45 155.45 3.77 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 -178.648 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.649 HD12 ' NH1' ' A' ' 38' ' ' ARG . 1.1 tp -66.16 -42.69 91.66 Favored 'Isoleucine or valine' 0 C--N 1.34 0.195 0 CA-C-N 117.149 0.475 . . . . 0.0 111.01 -179.707 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.474 ' N ' HG23 ' A' ' 33' ' ' ILE . 73.6 mm-40 -58.06 -16.82 14.27 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.409 -179.64 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.459 ' HA ' HD23 ' A' ' 28' ' ' LEU . 68.6 m -59.8 120.34 9.36 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.838 -179.485 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.431 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 56.5 m-20 -60.89 -32.27 71.73 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.73 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.726 HD11 ' CD2' ' A' ' 20' ' ' PHE . 48.9 mm -120.13 113.77 41.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.554 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.649 ' NH1' HD12 ' A' ' 33' ' ' ILE . 77.4 mtt180 -101.06 132.77 46.33 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.028 -0.669 . . . . 0.0 111.287 -177.876 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 95.9 mt -123.73 129.85 74.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.283 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.442 HE21 ' HA ' ' B' ' 260' ' ' GLU . 2.4 pm0 -83.56 43.74 0.92 Allowed 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -176.98 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.578 ' CD1' ' CZ ' ' A' ' 93' ' ' ARG . 39.9 mt -109.4 126.58 28.91 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 120.403 -0.519 . . . . 0.0 111.781 179.885 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -68.86 -13.84 37.63 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.174 1.916 . . . . 0.0 112.779 179.709 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.467 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 25.2 m -90.68 4.43 6.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.891 0.377 . . . . 0.0 110.701 179.996 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.603 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 54.7 t -107.03 136.43 42.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.23 -179.698 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.3 m -70.68 168.31 16.8 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.527 0.68 . . . . 0.0 111.281 -179.386 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.5 mttm -62.07 -38.77 90.06 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.109 -179.293 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.708 ' O ' ' N ' ' A' ' 49' ' ' CYS . 99.0 mt-30 -109.58 -14.98 14.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.532 -179.077 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.543 ' NE2' HG23 ' A' ' 90' ' ' ILE . 23.5 t60 37.13 -72.75 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -179.836 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.708 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -151.69 151.92 32.09 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.997 179.943 . . . . . . . . 3 3 . 1 . 066 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -138.36 143.57 39.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.96 -179.96 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.8 mt -114.39 133.06 61.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.483 179.934 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -114.67 124.58 52.18 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.494 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.4 mt -105.89 118.59 53.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -177.356 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.423 ' O ' ' C ' ' A' ' 55' ' ' GLU . 97.7 m-70 -112.97 138.43 49.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.267 -1.333 . . . . 0.0 108.718 178.055 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 54' ' ' HIS . 94.8 mt-10 -39.47 -35.67 0.31 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.186 0.517 . . . . 0.0 109.807 -178.822 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -60.26 -68.17 0.32 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.649 179.071 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.522 ' CD ' ' NH1' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -151.99 -171.26 3.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.11 0.481 . . . . 0.0 111.063 179.523 . . . . . . . . 3 3 . 1 . 066 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.809 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -110.04 129.15 55.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.398 179.505 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.4 mt -116.84 129.14 73.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.234 0.54 . . . . 0.0 112.39 -178.555 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.459 ' HB2' HD11 ' A' ' 82' ' ' LEU . 25.4 tp -98.38 128.29 44.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.439 179.669 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -112.84 134.61 54.27 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.151 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.681 HD21 ' CB ' ' A' ' 68' ' ' PRO . 61.6 t-20 -98.4 109.59 22.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.925 -178.429 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -98.71 -3.89 34.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.094 179.726 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.1 t -92.8 110.36 21.8 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.085 -179.274 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 56.3 p -93.59 -28.75 15.85 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.577 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.522 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.3 OUTLIER -65.52 -43.68 89.29 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.834 179.734 . . . . . . . . 3 3 . 1 . 066 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.456 HD21 ' HA ' ' B' ' 236' ' ' VAL . 33.2 m-20 -149.2 103.91 3.33 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.884 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.681 ' CB ' HD21 ' A' ' 62' ' ' ASN . 68.0 Cg_endo -71.03 158.21 55.83 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 121.657 1.571 . . . . 0.0 113.337 -177.424 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.1 m -73.04 140.03 46.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.296 179.656 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.45 ' O ' ' N ' ' A' ' 89' ' ' THR . 89.3 mt-30 -102.76 142.42 33.94 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.34 -179.507 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.688 ' HB ' HD11 ' A' ' 76' ' ' ILE . 8.9 p -132.04 138.63 52.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.766 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 50.39 31.81 5.78 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 -179.616 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.68 30.03 64.63 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.493 179.962 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 65.6 m -140.7 136.35 32.53 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 117.151 0.475 . . . . 0.0 111.847 -179.235 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.417 HG13 ' HG2' ' A' ' 68' ' ' PRO . 19.8 t -63.8 137.2 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.732 179.758 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.688 HD11 ' HB ' ' A' ' 71' ' ' VAL . 92.6 mt -101.91 110.87 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 178.631 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 18.6 p-10 -75.45 -37.15 60.52 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.13 179.546 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.551 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.8 OUTLIER -133.15 -177.95 0.78 Allowed Pre-proline 0 N--CA 1.465 0.316 0 CA-C-O 120.895 0.379 . . . . 0.0 111.823 -178.938 . . . . . . . . 3 3 . 1 . 066 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.516 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 32.5 Cg_exo -59.51 144.78 99.33 Favored 'Trans proline' 0 N--CA 1.499 1.822 0 C-N-CA 122.84 2.36 . . . . 0.0 112.545 -179.653 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 23.5 m -142.22 141.39 28.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.566 -179.627 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.522 ' NH1' ' CD ' ' A' ' 57' ' ' GLU . 96.7 mtt-85 -74.97 136.71 41.31 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.785 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.459 HD11 ' HB2' ' A' ' 60' ' ' LEU . 97.7 mt -92.31 136.43 33.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.461 0.648 . . . . 0.0 111.173 -179.579 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.407 ' HG2' ' N ' ' A' ' 84' ' ' HIS . 88.5 tttt -125.31 155.53 40.08 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.824 179.965 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.407 ' N ' ' HG2' ' A' ' 83' ' ' LYS . 10.4 t60 -57.43 121.88 11.28 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.954 -179.451 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.21 -22.44 20.59 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.962 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.566 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 64.9 t0 -64.32 131.27 46.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.712 0.292 . . . . 0.0 110.835 179.656 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.503 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 39.7 t -108.88 130.86 61.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.906 -179.463 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.5 mt -91.46 128.88 42.93 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.165 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.45 ' N ' ' O ' ' A' ' 70' ' ' GLN . 53.3 m -123.78 125.51 44.85 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.677 0.751 . . . . 0.0 112.002 -178.853 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.543 HG23 ' NE2' ' A' ' 48' ' ' HIS . 95.2 mt -115.97 123.0 70.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.588 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.703 HD12 HH22 ' A' ' 93' ' ' ARG . 96.6 mt 43.53 -102.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.934 -178.768 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.643 ' N ' HG22 ' A' ' 91' ' ' ILE . 46.0 p-10 -118.39 14.67 13.8 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.166 0.508 . . . . 0.0 110.972 179.938 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.703 HH22 HD12 ' A' ' 91' ' ' ILE . 51.2 mtm-85 -122.57 143.76 49.53 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.533 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 29.0 p -139.63 153.01 47.23 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 119.499 -0.881 . . . . 0.0 111.732 -179.137 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.482 ' HB3' HD11 ' A' ' 7' ' ' LEU . 60.2 m-85 -122.51 120.78 34.87 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 114.786 -1.097 . . . . 0.0 108.686 178.906 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.618 ' O ' HD12 ' A' ' 7' ' ' LEU . 44.4 ttm180 -82.85 128.7 34.66 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.144 -0.622 . . . . 0.0 111.455 -178.657 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.549 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 83.3 t80 -97.78 127.95 44.08 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.92 179.736 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.411 ' OE1' ' NE ' ' A' ' 6' ' ' ARG . 98.2 mt-10 -130.7 123.78 30.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.048 179.637 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 63.8 t-20 -113.74 100.08 8.19 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.028 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.428 -178.619 . . . . . . . . 0 0 . 1 . 066 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 1.9 t . . . . . 0 N--CA 1.462 0.147 0 CA-C-O 121.013 0.435 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 066 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.497 ' C ' ' H ' ' B' ' 231' ' ' GLN . 50.9 t0 -91.04 116.24 28.64 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.923 179.922 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . 0.442 ' HA ' ' HE ' ' A' ' 31' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.497 ' H ' ' C ' ' B' ' 229' ' ' ASP . 75.3 mt-30 -124.54 42.19 3.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.217 -179.454 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -131.24 -166.26 11.66 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.294 -179.144 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -59.96 151.93 68.23 Favored 'Trans proline' 0 N--CA 1.5 1.859 0 C-N-CA 124.174 3.25 . . . . 0.0 113.879 -179.304 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.522 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -66.83 139.95 53.83 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 121.083 1.189 . . . . 0.0 113.494 -178.625 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.456 ' HA ' HD21 ' A' ' 67' ' ' ASN . 23.0 t -57.44 140.81 15.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.843 -179.067 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 49.0 t -69.05 127.25 32.47 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.599 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . 0.447 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . 0.447 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 31.5 Cg_exo -58.57 -25.71 75.66 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 123.086 2.524 . . . . 0.0 113.406 -179.039 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . 0.737 HG22 ' NH1' ' B' ' 244' ' ' ARG . 16.9 m -73.13 -47.7 41.83 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 119.953 -0.699 . . . . 0.0 109.394 178.972 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.495 ' HZ ' HD22 ' A' ' 41' ' ' LEU . 87.7 t80 -57.49 -44.84 85.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.192 179.911 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 92.9 mt -65.32 -39.1 92.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.811 179.816 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -62.87 -42.15 99.65 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.296 -179.053 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . 0.737 ' NH1' HG22 ' B' ' 240' ' ' THR . 95.1 mtm-85 -62.84 -42.23 99.65 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.231 -179.429 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.57 ' NE ' ' OD2' ' A' ' 92' ' ' ASP . 77.2 mtp85 -63.54 -40.57 97.37 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.5 -0.48 . . . . 0.0 112.095 -179.33 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.42 -38.84 88.56 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 120.205 -0.598 . . . . 0.0 109.682 179.658 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 70.7 p -67.17 -42.5 84.16 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 177.959 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . 0.58 ' O ' ' N ' ' B' ' 252' ' ' LEU . 75.5 mm-40 -62.7 -33.1 74.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.757 179.641 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 37.5 t -63.23 -46.3 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.978 179.583 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -60.45 -29.13 68.83 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.997 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -92.77 -14.83 27.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.874 179.499 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.58 ' N ' ' O ' ' B' ' 248' ' ' GLN . 42.4 tp -76.32 147.45 38.15 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.991 0.424 . . . . 0.0 111.299 -179.602 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -98.65 131.09 45.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.558 179.464 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -65.66 -25.84 67.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.263 -179.515 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -84.03 5.29 26.38 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.162 -179.308 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -94.54 97.82 10.41 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.003 179.266 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -65.84 174.92 2.15 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -179.822 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 58.95 67.84 0.88 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -178.294 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.561 ' C ' ' H ' ' B' ' 261' ' ' ILE . 68.1 t0 -84.91 86.29 7.38 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.956 -179.14 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.442 ' HA ' HE21 ' A' ' 40' ' ' GLN . 35.3 tp10 60.73 -9.59 0.06 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.552 178.947 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.561 ' H ' ' C ' ' B' ' 259' ' ' ASP . 63.5 mt -111.97 135.85 49.98 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 CA-C-O 120.811 0.339 . . . . 0.0 110.517 -179.719 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 38.2 t -127.63 134.2 66.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.053 179.447 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -96.69 121.02 38.07 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.991 0.424 . . . . 0.0 111.544 -178.597 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -65.15 -48.09 74.76 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.711 179.583 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . 0.602 ' OE1' HD11 ' A' ' 24' ' ' LEU . 3.8 mm-40 -95.63 157.87 35.37 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.286 -178.891 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -64.47 154.67 70.48 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 123.209 2.606 . . . . 0.0 112.575 178.987 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 36.0 pt . . . . . 0 C--N 1.332 -0.156 0 CA-C-O 121.594 0.711 . . . . 0.0 112.401 -179.346 . . . . . . . . 0 0 . 1 . 067 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo . . . . . 0 N--CA 1.499 1.811 0 CA-C-O 121.096 0.373 . . . . 0.0 112.831 . . . . . . . . . 0 0 . 1 . 067 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.9 p -61.22 -44.8 96.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.414 -179.207 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.693 ' NE ' ' CZ ' ' A' ' 97' ' ' TYR . 2.6 mmp_? -90.9 118.2 30.11 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.781 -178.805 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.6 mtp180 -129.08 137.1 51.06 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.202 0.525 . . . . 0.0 111.541 179.522 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.644 HD12 ' O ' ' A' ' 96' ' ' ARG . 22.6 tp -114.49 131.05 56.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.268 179.807 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 76.6 t -108.91 130.89 61.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.072 -179.602 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.6 m -77.71 142.93 38.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.683 -179.341 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.439 ' CD1' ' OD1' ' A' ' 16' ' ' ASP . 50.4 mm -111.11 136.16 48.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.954 178.85 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -89.91 155.64 18.99 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.53 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.54 ' HD3' HH21 ' B' ' 245' ' ' ARG . 89.7 mtm180 -59.78 -24.45 64.1 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.039 -178.951 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.4 p -82.97 -6.97 59.7 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.447 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.77 38.11 7.65 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 179.691 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.6 t -122.84 133.63 68.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.662 0.267 . . . . 0.0 110.565 179.533 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.439 ' OD1' ' CD1' ' A' ' 10' ' ' ILE . 90.9 m-20 -73.7 135.15 43.66 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.271 179.64 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -124.84 -121.57 2.57 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 120.596 -0.811 . . . . 0.0 111.897 -179.633 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.59 145.32 41.69 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.139 1.892 . . . . 0.0 112.888 -178.709 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -104.56 143.76 32.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.711 179.995 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.887 ' CD2' HD11 ' A' ' 37' ' ' ILE . 38.7 t80 -115.36 107.21 49.69 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.19 179.374 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -74.78 127.5 10.89 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 121.373 1.382 . . . . 0.0 111.758 -179.159 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 82.2 mt -84.12 48.81 1.53 Allowed 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.29 -179.383 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 93.6 p -60.72 -25.36 66.37 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.467 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.582 HD11 ' HG2' ' B' ' 265' ' ' GLN . 66.8 mt -76.04 139.02 41.24 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.383 179.986 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.2 m -63.21 -19.25 64.35 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.286 -179.489 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.467 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 22.8 m -136.81 135.0 37.58 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.478 -179.723 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.9 t -126.43 118.49 25.08 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.058 0.456 . . . . 0.0 110.182 178.104 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.523 HD12 ' O ' ' A' ' 49' ' ' CYS . 53.5 tp -114.17 132.42 56.09 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.121 -179.016 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.515 ' O ' ' O ' ' A' ' 47' ' ' GLN . 34.1 m-85 -112.04 137.34 50.2 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.376 -179.341 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 152.93 -177.96 30.3 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.304 179.17 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 45.4 mtm180 -70.6 -32.03 69.25 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 179.772 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.568 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -51.79 148.04 10.64 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 121.133 -0.556 . . . . 0.0 112.477 -178.084 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.526 HG23 ' N ' ' A' ' 34' ' ' GLU . 11.0 tp -66.71 -41.47 88.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 120.886 0.374 . . . . 0.0 110.152 179.315 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.526 ' N ' HG23 ' A' ' 33' ' ' ILE . 77.5 tt0 -57.33 -24.08 52.83 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.497 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.568 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 16.5 m -56.6 120.36 7.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.93 179.343 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.467 ' OD2' ' O ' ' A' ' 26' ' ' THR . 95.7 m-20 -61.87 -25.5 67.58 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.537 0.684 . . . . 0.0 109.155 -179.692 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.887 HD11 ' CD2' ' A' ' 20' ' ' PHE . 39.5 mm -126.88 117.11 46.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.888 178.848 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.419 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 62.0 mtm180 -104.1 135.24 45.96 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.614 -179.871 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.2 mt -120.13 127.95 75.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.521 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -75.05 34.58 0.1 Allowed 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -177.108 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.616 HD11 ' HE ' ' A' ' 93' ' ' ARG . 96.2 mt -103.37 127.88 28.71 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.986 179.588 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.79 -9.83 24.23 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.491 2.128 . . . . 0.0 112.197 -179.915 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.573 HG21 ' CE2' ' B' ' 241' ' ' PHE . 15.8 m -96.77 9.96 6.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.613 179.818 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.438 HG12 ' O ' ' A' ' 45' ' ' SER . 20.1 t -103.31 135.72 39.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.428 179.71 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.438 ' O ' HG12 ' A' ' 44' ' ' VAL . 13.2 m -70.04 170.15 11.98 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.357 0.599 . . . . 0.0 111.048 -179.895 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -64.3 -40.16 95.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.698 -179.685 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.616 ' O ' ' N ' ' A' ' 49' ' ' CYS . 69.5 mm-40 -110.07 -25.07 10.42 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.131 0.491 . . . . 0.0 110.676 -179.158 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.512 ' NE2' HG23 ' A' ' 90' ' ' ILE . 20.5 t60 40.08 -74.69 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 179.119 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.616 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.48 136.86 45.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.406 0.622 . . . . 0.0 112.396 -177.834 . . . . . . . . 3 3 . 1 . 067 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -127.1 128.05 45.61 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.938 179.011 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.8 mt -116.85 134.59 59.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.84 -179.737 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -115.75 135.8 53.68 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.662 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 49.9 mm -102.08 114.2 40.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 120.169 -0.613 . . . . 0.0 110.62 -179.945 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -115.4 134.39 55.14 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.078 179.01 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -42.13 -32.9 0.51 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.01 -179.487 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -63.04 -66.23 0.57 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.739 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -157.69 -160.33 0.92 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.131 179.671 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.511 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -121.29 133.83 55.14 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.561 -179.926 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.9 mt -118.27 128.48 75.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.266 0.555 . . . . 0.0 112.099 -179.265 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.4 tp -95.69 125.01 39.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.623 179.575 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -112.02 136.06 51.85 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.69 0.281 . . . . 0.0 110.444 -179.794 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.76 ' ND2' ' H ' ' A' ' 69' ' ' THR . 21.2 t-20 -97.88 107.7 20.24 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.529 -179.808 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -98.66 -10.65 22.95 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.222 179.37 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.73 97.96 7.53 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.233 179.954 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.0 p -71.67 -32.56 68.01 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.78 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.836 HG21 ' O ' ' B' ' 234' ' ' TPO . 2.0 m -64.0 -47.07 81.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.504 -178.956 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -141.99 97.41 6.42 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.888 -178.984 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.447 ' HA ' HD21 ' A' ' 62' ' ' ASN . 37.9 Cg_exo -56.06 146.76 68.09 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.009 1.806 . . . . 0.0 111.63 179.696 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.76 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 6.7 m -73.91 146.16 44.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.291 0.567 . . . . 0.0 111.151 -179.698 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -104.81 140.9 37.43 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.996 179.791 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.485 ' O ' ' OG ' ' A' ' 74' ' ' SER . 43.0 t -129.02 135.53 61.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.214 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 51.94 33.48 11.77 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.209 -0.596 . . . . 0.0 109.533 -179.733 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.33 29.84 71.71 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.431 179.703 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.485 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 16.5 p -141.55 136.14 30.83 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.754 0.311 . . . . 0.0 110.895 179.987 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.1 p -68.42 139.14 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 CA-C-O 121.083 0.468 . . . . 0.0 111.678 -179.753 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.7 109.45 21.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.092 179.492 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -90.46 -17.55 26.93 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.845 -179.201 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -116.01 164.88 16.2 Favored Pre-proline 0 N--CA 1.469 0.505 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.824 179.77 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -56.78 142.97 91.93 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 C-N-CA 121.59 1.526 . . . . 0.0 111.562 179.296 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.0 p -139.9 138.91 38.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.983 0.42 . . . . 0.0 110.989 -178.909 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.2 mtm180 -77.94 133.03 38.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.482 -179.982 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.511 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 93.4 mt -86.72 139.84 30.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.143 0.497 . . . . 0.0 111.074 -179.445 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -133.31 155.51 49.3 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.697 -179.501 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.496 ' CE1' ' O ' ' A' ' 99' ' ' ASN . 3.4 t-160 -55.36 113.3 1.36 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.899 -179.458 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.66 -17.54 18.12 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 121.068 -0.587 . . . . 0.0 111.921 179.475 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -70.94 133.3 46.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.998 0.428 . . . . 0.0 110.371 -179.901 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.47 ' O ' HG13 ' A' ' 87' ' ' VAL . 14.2 p -107.87 132.76 54.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.008 -179.217 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 91.3 mt -97.68 130.3 46.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.372 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 51.6 m -122.14 126.23 47.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.735 0.779 . . . . 0.0 112.561 -178.417 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.512 HG23 ' NE2' ' A' ' 48' ' ' HIS . 80.7 mt -113.04 120.07 62.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 114.509 -1.223 . . . . 0.0 108.186 178.661 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.57 ' CD1' HG23 ' A' ' 43' ' ' VAL . 57.1 mt 38.09 -92.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.715 -0.221 . . . . 0.0 111.144 -179.533 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 90' ' ' ILE . 10.3 t0 -119.35 14.75 12.95 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.572 -179.254 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.616 ' HE ' HD11 ' A' ' 41' ' ' LEU . 79.6 mtt-85 -128.89 146.73 50.86 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.148 179.726 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.418 ' OG ' ' CG2' ' A' ' 87' ' ' VAL . 12.8 t -139.45 153.98 47.67 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.651 0.739 . . . . 0.0 111.701 -179.73 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.533 ' HB3' HD11 ' A' ' 7' ' ' LEU . 96.7 m-85 -126.65 121.88 33.39 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.109 179.061 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.644 ' O ' HD12 ' A' ' 7' ' ' LEU . 99.6 mtt180 -82.42 131.29 35.22 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.226 -178.944 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.693 ' CZ ' ' NE ' ' A' ' 5' ' ' ARG . 67.5 t80 -92.25 121.39 33.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.031 179.95 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.463 ' C ' ' NH2' ' A' ' 5' ' ' ARG . 93.5 mt-10 -126.57 131.37 51.55 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -177.886 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.632 ' CG ' HH12 ' A' ' 5' ' ' ARG . 63.1 t-20 -106.89 107.48 18.52 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.179 178.591 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 . . . . . 0 C--N 1.324 -0.51 0 C-N-CA 120.052 -0.659 . . . . 0.0 109.899 179.404 . . . . . . . . 0 0 . 1 . 067 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . 0.458 ' O ' ' N ' ' B' ' 231' ' ' GLN . 54.9 t . . . . . 0 N--CA 1.462 0.168 0 CA-C-O 120.997 0.427 . . . . 0.0 110.779 . . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.549 ' C ' ' H ' ' B' ' 231' ' ' GLN . 92.3 m-20 39.57 50.26 2.12 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.093 179.577 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 067 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.549 ' H ' ' C ' ' B' ' 229' ' ' ASP . 2.7 mp0 -113.88 60.47 0.66 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.684 0.278 . . . . 0.0 110.695 -179.833 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -134.05 173.42 21.32 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 -179.83 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.22 159.46 53.71 Favored 'Trans proline' 0 C--N 1.3 -2.006 0 C-N-CA 123.309 2.673 . . . . 0.0 112.002 179.794 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.836 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -73.38 138.83 27.95 Favored 'Trans proline' 0 C--N 1.302 -1.898 0 C-N-CA 121.915 1.744 . . . . 0.0 112.621 -179.784 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 31.4 m -59.25 142.74 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.618 -179.72 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 2.4 t -67.0 128.99 38.43 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.789 179.926 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . 0.628 ' O2P' HG23 ' B' ' 240' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -54.56 -23.94 34.31 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.289 1.992 . . . . 0.0 113.039 179.852 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . 0.628 HG23 ' O2P' ' B' ' 238' ' ' TPO . 26.2 p -74.16 -40.02 62.85 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 120.421 -0.511 . . . . 0.0 109.696 178.401 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.573 ' CE2' HG21 ' A' ' 43' ' ' VAL . 70.0 t80 -59.96 -46.67 88.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.109 -179.358 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' B' ' 242' ' ' LEU . 90.6 mt -65.25 -41.43 94.32 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -179.561 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -65.47 -40.62 93.37 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.422 -179.374 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . 0.431 ' O ' ' OG ' ' B' ' 247' ' ' SER . 82.3 mtp180 -62.04 -42.71 99.46 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.52 -179.886 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.54 HH21 ' HD3' ' A' ' 12' ' ' ARG . 85.3 mtp180 -65.9 -39.95 91.07 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.579 -179.912 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -62.16 -40.81 97.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.167 0.508 . . . . 0.0 110.106 178.887 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 73.5 p -66.19 -41.69 89.85 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.463 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -61.27 -36.19 79.36 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.116 179.431 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 27.8 t -60.84 -45.28 98.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 120.166 -0.614 . . . . 0.0 109.49 178.769 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -60.44 -27.83 67.81 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.687 179.332 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -89.22 -6.75 56.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.978 179.305 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 94.5 mt -116.32 112.94 22.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.919 178.661 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -65.21 178.97 0.79 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.492 -179.032 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 42.1 p-10 -71.69 -7.49 48.3 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.038 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -68.65 -15.23 63.46 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.75 -179.539 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -79.97 76.57 6.68 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.457 -179.203 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -71.19 -8.86 56.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.345 -179.659 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -112.45 80.83 1.38 Allowed 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.434 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.589 ' OD2' ' NH1' ' A' ' 93' ' ' ARG . 30.9 t0 -60.73 -103.43 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.41 -179.123 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.57 ' N ' ' OD1' ' B' ' 259' ' ' ASP . 94.4 mt-10 -151.05 25.95 0.72 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.954 -179.25 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.49 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 68.2 mt -115.62 136.99 50.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -179.312 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 55.2 t -124.89 132.56 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 121.102 0.477 . . . . 0.0 110.769 -179.837 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -94.6 118.45 31.71 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.875 -179.101 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -64.23 -46.53 83.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.273 179.974 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . 0.582 ' HG2' HD11 ' A' ' 24' ' ' LEU . 0.8 OUTLIER -97.2 158.79 32.67 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.417 -179.3 . . . . . . . . 3 3 . 1 . 067 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -65.94 149.2 86.44 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 123.486 2.791 . . . . 0.0 113.664 -179.716 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 42.3 pt . . . . . 0 CA--C 1.529 0.163 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.3 179.014 . . . . . . . . 0 0 . 1 . 068 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo . . . . . 0 N--CA 1.494 1.504 0 CA-C-O 120.833 0.264 . . . . 0.0 111.904 . . . . . . . . . 0 0 . 1 . 068 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.7 m -68.49 -45.37 72.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.039 -179.767 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 86.0 mtt85 -90.57 127.54 36.29 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -177.677 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.5 mtp180 -127.88 136.84 51.94 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.207 179.982 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.616 HD11 ' HB3' ' A' ' 95' ' ' PHE . 43.3 tp -114.79 135.2 54.45 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 179.55 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.768 HG11 ' NH2' ' A' ' 96' ' ' ARG . 29.8 t -113.85 129.65 69.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.281 -179.404 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.4 m -93.61 112.61 24.53 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -178.209 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.587 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 97.0 mt -78.22 144.4 11.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 177.419 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.488 ' HA ' HH22 ' A' ' 93' ' ' ARG . 96.6 mttt -91.83 165.99 12.97 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 119.841 -0.744 . . . . 0.0 109.915 178.584 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.87 HH21 HD22 ' B' ' 252' ' ' LEU . 86.2 mtm180 -57.51 -27.95 63.03 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.635 -178.769 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.7 m -79.21 -10.47 59.83 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.433 -179.522 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.61 25.66 19.99 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.018 179.551 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.5 m -117.58 138.83 46.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.597 179.803 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.43 ' OD1' HG13 ' A' ' 8' ' ' VAL . 67.1 t0 -64.56 127.36 31.21 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.059 -179.717 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -114.88 -128.55 4.51 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 121.146 -0.55 . . . . 0.0 112.054 -179.062 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -75.67 148.84 33.28 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.416 2.077 . . . . 0.0 112.29 -179.14 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -102.77 165.37 11.1 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.6 -179.933 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.565 ' CD2' HD11 ' A' ' 37' ' ' ILE . 42.3 t80 -139.57 103.74 7.06 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.325 -179.778 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -72.45 126.7 11.81 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 121.446 1.431 . . . . 0.0 111.566 -178.757 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.6 HD22 ' SG ' ' A' ' 27' ' ' CYS . 69.2 mt -85.27 50.75 2.01 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.722 -178.924 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 99.1 p -60.4 -28.63 68.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.1 179.778 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.1 mt -74.61 143.12 44.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.359 -179.732 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 91.5 p -63.91 -17.39 63.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.907 -178.484 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.405 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 31.9 m -133.55 133.54 42.24 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.135 179.857 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.6 ' SG ' HD22 ' A' ' 22' ' ' LEU . 5.4 t -124.81 116.72 22.73 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.443 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.434 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 36.0 tp -113.98 126.26 54.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.139 -179.218 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.764 ' CE2' HD12 ' A' ' 37' ' ' ILE . 12.7 m-85 -104.88 137.96 41.86 Favored 'General case' 0 C--N 1.334 -0.091 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.652 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 175.57 -174.21 46.71 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 119.95 -1.119 . . . . 0.0 112.011 179.66 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.553 HH12 ' H ' ' B' ' 231' ' ' GLN . 27.9 ttp85 -91.59 -16.12 27.59 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.623 -0.288 . . . . 0.0 111.263 179.843 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -81.7 154.35 34.1 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 121.068 -0.587 . . . . 0.0 111.782 -179.43 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.498 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.5 tp -66.46 -41.67 89.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.754 0.311 . . . . 0.0 110.459 179.436 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.498 ' N ' HG23 ' A' ' 33' ' ' ILE . 80.7 tt0 -50.3 -18.65 0.65 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.912 0.387 . . . . 0.0 110.106 -179.613 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.425 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 82.3 m -73.83 140.72 45.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.207 179.685 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.434 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 94.6 m-20 -60.48 -32.78 71.74 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -179.552 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.764 HD12 ' CE2' ' A' ' 29' ' ' PHE . 84.1 mt -126.95 122.5 60.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 176.559 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 67.8 ttp85 -106.36 133.56 50.86 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.461 -179.476 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.415 HG22 ' HG ' ' A' ' 41' ' ' LEU . 79.7 mt -114.37 131.71 65.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.71 -179.55 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -74.5 25.37 0.08 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.962 -178.281 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.634 HD21 ' OE1' ' B' ' 260' ' ' GLU . 50.5 mt -100.29 128.21 31.08 Favored Pre-proline 0 C--N 1.326 -0.427 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.407 179.144 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -73.1 -9.2 23.18 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.347 2.031 . . . . 0.0 111.858 179.678 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.2 m -92.18 5.46 6.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.656 179.829 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 36.1 t -96.84 131.8 42.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.2 179.574 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.409 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 7.9 t -70.17 173.02 7.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.26 -179.052 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.425 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 64.2 mttp -62.77 -42.21 99.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.814 -179.529 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.65 ' O ' ' N ' ' A' ' 49' ' ' CYS . 99.5 mt-30 -114.33 -18.23 11.61 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.203 -179.399 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.409 ' H ' ' HB3' ' A' ' 45' ' ' SER . 20.4 t60 35.14 -76.53 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 179.8 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.65 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.42 134.58 47.22 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.157 0.503 . . . . 0.0 111.956 -178.521 . . . . . . . . 3 3 . 1 . 068 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -127.16 134.07 50.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.849 -179.966 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.6 mt -119.68 133.42 66.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.96 -179.749 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -108.77 127.48 54.04 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.591 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.7 mm -101.35 115.44 43.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 119.995 -0.682 . . . . 0.0 111.33 -178.726 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.469 ' O ' ' C ' ' A' ' 55' ' ' GLU . 95.8 m-70 -119.1 134.13 55.38 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.731 179.155 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.469 ' C ' ' O ' ' A' ' 54' ' ' HIS . 84.9 tt0 -40.75 -30.71 0.13 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.91 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.453 ' N ' ' C ' ' A' ' 54' ' ' HIS . 94.1 mm-40 -66.19 -68.63 0.36 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.034 178.705 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.53 ' OE1' ' CZ ' ' A' ' 81' ' ' ARG . 2.0 pt-20 -153.92 -172.99 4.41 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.334 -178.823 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -116.46 128.0 55.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.622 179.313 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.2 mt -115.8 130.48 70.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.296 0.57 . . . . 0.0 112.023 -178.279 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 23.4 tp -97.43 129.03 44.68 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.09 179.876 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -113.19 137.04 52.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.882 -179.644 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 62.0 t-20 -93.56 105.62 17.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.468 -179.132 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -101.96 -10.59 19.65 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.324 179.319 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.479 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 60.4 p -72.99 102.41 3.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.603 179.742 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.7 p -82.11 -19.0 41.02 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.677 179.742 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.711 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.2 OUTLIER -86.98 -41.29 14.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.001 -179.077 . . . . . . . . 3 3 . 1 . 068 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.479 ' O ' ' OG ' ' A' ' 64' ' ' SER . 47.3 m-20 -143.32 106.93 5.18 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.36 -179.47 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -56.49 143.4 87.8 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 121.606 1.537 . . . . 0.0 112.142 -179.927 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.8 m -69.85 137.35 51.65 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.726 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -97.82 138.34 35.33 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.997 -179.761 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.9 t -133.93 134.52 55.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.994 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 9.9 m120 52.97 30.03 8.76 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 -178.836 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.34 27.49 69.71 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.134 -179.513 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.4 t -140.48 138.82 34.93 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.906 0.384 . . . . 0.0 111.756 -179.606 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.458 ' H ' HG22 ' A' ' 75' ' ' VAL . 6.2 m -73.82 141.69 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.996 -179.97 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 10.3 pt -108.36 96.39 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 121.238 0.542 . . . . 0.0 111.462 179.67 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -64.39 -35.62 81.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.777 179.263 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -121.48 171.77 5.72 Favored Pre-proline 0 CA--C 1.533 0.301 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.989 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -60.08 147.25 93.84 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.165 1.91 . . . . 0.0 111.917 179.854 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.9 p -139.2 141.99 34.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.376 0.608 . . . . 0.0 111.755 -179.512 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.53 ' CZ ' ' OE1' ' A' ' 57' ' ' GLU . 79.5 ttt180 -74.78 128.66 36.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.176 179.224 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.434 HD23 ' HA ' ' A' ' 82' ' ' LEU . 95.2 mt -79.91 135.35 36.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.026 0.441 . . . . 0.0 110.897 -179.888 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -124.47 147.79 48.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.733 179.203 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.557 ' ND1' ' OD1' ' A' ' 99' ' ' ASN . 10.5 t60 -53.36 122.48 9.71 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.005 -179.074 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.93 -16.91 42.54 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.976 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -66.76 135.25 53.69 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.483 -0.487 . . . . 0.0 109.821 179.77 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 53.2 t -109.84 131.93 59.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.011 -178.305 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.1 mt -98.98 130.93 47.14 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.426 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.1 m -121.29 127.52 51.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.632 0.729 . . . . 0.0 112.226 -178.722 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.646 ' O ' ' N ' ' A' ' 93' ' ' ARG . 97.6 mt -119.93 125.21 74.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 178.001 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.525 ' C ' ' O ' ' A' ' 90' ' ' ILE . 62.2 mt -11.15 97.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -178.129 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 78.17 -9.71 1.47 Allowed 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 177.938 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.734 HH12 ' N ' ' A' ' 12' ' ' ARG . 20.0 mmm180 -130.09 133.07 46.42 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.669 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.486 ' OG ' HD12 ' A' ' 10' ' ' ILE . 89.0 p -138.54 153.5 48.73 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.176 179.299 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.616 ' HB3' HD11 ' A' ' 7' ' ' LEU . 55.6 m-85 -130.03 132.23 46.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.268 -179.324 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.768 ' NH2' HG11 ' A' ' 8' ' ' VAL . 92.0 mtm-85 -88.51 130.39 35.24 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.539 -179.825 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -95.58 126.49 40.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.502 -179.452 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -134.8 118.13 16.69 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.192 179.489 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.557 ' OD1' ' ND1' ' A' ' 84' ' ' HIS . 53.4 p-10 -100.64 5.98 43.97 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.336 -179.489 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 . . . . . 0 C--N 1.327 -0.408 0 CA-C-O 121.196 0.522 . . . . 0.0 111.086 179.721 . . . . . . . . 0 0 . 1 . 068 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . 0.419 HG22 ' O ' ' B' ' 228' ' ' VAL . 5.5 p . . . . . 0 N--CA 1.457 -0.111 0 CA-C-O 120.827 0.346 . . . . 0.0 110.867 . . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.448 ' O ' ' OD1' ' B' ' 229' ' ' ASP . 52.2 p-10 -63.72 145.63 55.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.857 0.361 . . . . 0.0 110.372 -179.813 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . 0.407 ' O ' ' CB ' ' B' ' 231' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.553 ' H ' HH12 ' A' ' 31' ' ' ARG . 2.5 mt-30 162.3 -23.83 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 O-C-N 123.583 0.552 . . . . 0.0 110.439 179.727 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' B' ' 231' ' ' GLN . . . -48.33 -171.6 0.01 OUTLIER Glycine 0 CA--C 1.529 0.957 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.373 -179.063 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -64.34 154.6 70.45 Favored 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 123.674 2.916 . . . . 0.0 113.164 -179.44 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.711 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.58 135.47 60.87 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.396 2.064 . . . . 0.0 114.032 -178.379 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.575 HG22 HG22 ' A' ' 66' ' ' THR . 68.0 t -63.65 135.42 27.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.483 179.097 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . 0.424 ' SG ' HD11 ' B' ' 242' ' ' LEU . 2.0 t -46.08 110.25 0.25 Allowed 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.294 -179.842 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . 0.542 HG22 ' H ' ' B' ' 241' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.94 -22.93 19.66 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 122.04 1.826 . . . . 0.0 112.513 179.182 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 21.6 p -76.37 -45.63 31.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.897 0.379 . . . . 0.0 110.39 179.035 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.542 ' H ' HG22 ' B' ' 238' ' ' TPO . 85.4 t80 -58.9 -48.41 81.53 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.32 -178.742 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.424 HD11 ' SG ' ' B' ' 237' ' ' CYS . 80.1 mt -65.45 -42.11 92.69 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.09 -179.892 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -61.28 -43.64 98.53 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.555 -178.87 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 77.0 ttt-85 -63.41 -43.68 96.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.903 0.382 . . . . 0.0 111.312 -179.14 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.775 HH11 HH11 ' A' ' 12' ' ' ARG . 52.8 ttm-85 -64.08 -40.52 96.43 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.862 -179.262 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -60.13 -36.99 78.74 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.744 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 20.2 m -66.15 -42.8 88.54 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 177.189 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . 0.536 ' CD ' HH12 ' A' ' 12' ' ' ARG . 56.7 tt0 -60.27 -34.36 73.61 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.097 179.662 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 55.7 t -63.58 -46.91 93.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.118 178.974 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -58.69 -25.06 62.46 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 179.102 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -93.26 -10.3 36.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.314 178.732 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.87 HD22 HH21 ' A' ' 12' ' ' ARG . 55.8 tp -76.5 145.86 38.87 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.283 -179.58 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -106.58 141.44 37.86 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.981 179.797 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . 0.539 ' C ' ' H ' ' B' ' 256' ' ' ASP . 95.8 m-20 -63.46 -30.99 72.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.767 -179.704 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 44.5 p-10 -58.5 0.95 0.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.877 -179.137 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.539 ' H ' ' C ' ' B' ' 254' ' ' ASP . 94.4 m-20 -88.23 175.35 7.72 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.635 178.823 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . 0.693 ' O ' ' N ' ' B' ' 259' ' ' ASP . 98.4 mttt -147.31 -113.37 0.08 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.415 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.659 ' O ' ' N ' ' B' ' 260' ' ' GLU . 97.6 m-20 -33.72 -22.05 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.734 -178.885 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.693 ' N ' ' O ' ' B' ' 257' ' ' LYS . 28.0 t70 40.86 -72.54 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 113.248 0.832 . . . . 0.0 113.248 177.377 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.659 ' N ' ' O ' ' B' ' 258' ' ' ASP . 95.9 mt-10 -136.79 1.99 2.59 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -178.765 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.665 ' CD1' HH21 ' A' ' 93' ' ' ARG . 42.5 mt -110.17 138.3 38.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.101 -179.811 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 43.0 t -125.61 132.33 71.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.005 0.431 . . . . 0.0 110.221 179.262 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -96.39 120.52 36.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.877 -178.94 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -66.01 -47.32 74.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.387 -179.315 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.8 151.99 44.22 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.445 -179.018 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -64.55 147.71 90.34 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.754 2.303 . . . . 0.0 112.31 179.613 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.1 pt . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.448 179.82 . . . . . . . . 0 0 . 1 . 069 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 N--CA 1.494 1.529 0 N-CA-C 111.331 -0.296 . . . . 0.0 111.331 . . . . . . . . . 0 0 . 1 . 069 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 99.2 m -76.96 -46.69 23.17 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -179.55 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.504 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 95.5 mtt-85 -88.04 128.85 35.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.671 -178.579 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -129.33 140.37 51.42 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 120.471 -0.492 . . . . 0.0 112.13 -179.242 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.505 HD11 ' CB ' ' A' ' 95' ' ' PHE . 34.0 tp -116.25 134.38 54.97 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.843 178.966 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.3 t -110.78 130.83 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.016 -179.945 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.421 HG23 ' CD1' ' B' ' 261' ' ' ILE . 1.4 m -94.14 116.86 29.32 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.678 -178.77 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.649 HD12 ' OG ' ' A' ' 94' ' ' SER . 96.8 mt -80.18 143.55 12.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.32 179.061 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -91.22 158.88 16.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.022 0.439 . . . . 0.0 110.268 178.637 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.838 HH12 ' NE2' ' B' ' 248' ' ' GLN . 80.9 mtp180 -58.2 -32.07 67.93 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.539 -179.854 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.2 m -77.23 -9.95 59.11 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.006 -179.947 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.71 33.67 7.33 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.446 -0.662 . . . . 0.0 111.446 179.877 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.0 t -119.57 134.22 63.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.733 0.301 . . . . 0.0 110.79 -179.823 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -63.17 122.41 16.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.26 179.942 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -106.89 -139.58 9.38 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.553 -179.266 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.79 155.49 62.43 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.215 1.944 . . . . 0.0 112.082 -179.164 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -107.29 146.8 31.06 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.975 -179.05 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.692 ' CD2' HD11 ' A' ' 37' ' ' ILE . 23.6 t80 -115.16 101.68 54.52 Favored Pre-proline 0 CA--C 1.536 0.437 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.898 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.72 131.78 17.7 Favored 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 121.398 1.399 . . . . 0.0 111.475 -179.392 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 83.4 mt -86.48 52.44 2.5 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 119.961 -0.695 . . . . 0.0 111.197 -178.44 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.8 p -61.8 -29.87 70.43 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.797 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.431 HD11 ' CD ' ' B' ' 265' ' ' GLN . 67.5 mt -79.06 142.45 36.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.187 179.757 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 72.6 p -66.39 -20.17 66.0 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.969 -0.293 . . . . 0.0 111.713 -179.494 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.416 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 53.2 m -127.04 128.9 47.03 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.292 0.568 . . . . 0.0 112.011 -179.633 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.454 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 11.8 t -123.57 113.54 18.85 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.774 178.697 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.565 ' O ' ' N ' ' A' ' 36' ' ' ASP . 63.4 tp -110.42 125.33 53.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.185 0.517 . . . . 0.0 110.786 -179.555 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.862 ' CE2' HD12 ' A' ' 37' ' ' ILE . 4.5 m-85 -107.06 140.02 40.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.282 179.583 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 170.38 -160.22 32.88 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.377 179.388 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 27.4 ptt-85 -107.22 -8.92 16.25 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.411 179.817 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.478 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -85.37 167.24 40.93 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.286 -179.945 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.569 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.9 tp -67.29 -42.41 87.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.719 0.295 . . . . 0.0 110.779 -179.814 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.569 ' N ' HG23 ' A' ' 33' ' ' ILE . 78.4 mm-40 -53.14 -25.55 13.76 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.144 0.497 . . . . 0.0 110.021 -178.908 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.478 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 3.7 m -62.38 124.21 20.32 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.402 179.521 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.565 ' N ' ' O ' ' A' ' 28' ' ' LEU . 63.7 m-20 -58.54 -29.03 66.02 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -179.055 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.862 HD12 ' CE2' ' A' ' 29' ' ' PHE . 93.6 mt -126.56 122.32 60.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 176.237 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 72.0 ttp85 -106.57 135.81 47.44 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.116 -178.511 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 98.6 mt -115.68 129.1 72.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.009 -179.573 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -74.09 31.5 0.08 Allowed 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 -177.918 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.507 ' CG ' HH21 ' A' ' 93' ' ' ARG . 86.2 mt -107.49 135.88 19.67 Favored Pre-proline 0 C--N 1.323 -0.559 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.888 179.539 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.56 -10.13 24.89 Favored 'Trans proline' 0 C--N 1.315 -1.216 0 C-N-CA 122.067 1.845 . . . . 0.0 111.428 179.215 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.526 HG21 ' CE2' ' B' ' 241' ' ' PHE . 9.7 m -97.22 6.62 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.216 -179.936 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.0 t -92.78 128.48 44.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.045 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 41.2 t -66.71 172.76 3.96 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.51 0.671 . . . . 0.0 111.628 -178.59 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -65.83 -43.24 89.12 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.96 -179.631 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.628 ' O ' ' N ' ' A' ' 49' ' ' CYS . 86.8 mt-30 -119.36 -5.34 10.37 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.847 -179.002 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.503 ' C ' ' O ' ' A' ' 47' ' ' GLN . 17.8 t60 14.05 -73.37 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 -178.852 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.628 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -126.08 129.53 49.29 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 119.716 -0.793 . . . . 0.0 112.876 -179.069 . . . . . . . . 3 3 . 1 . 069 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -126.58 128.66 47.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.013 178.508 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.2 mt -116.41 134.3 60.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.685 -179.292 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -112.18 122.12 46.86 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.603 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 95.7 mt -101.8 116.49 45.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 119.543 -0.863 . . . . 0.0 111.847 -178.638 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.485 ' O ' ' N ' ' A' ' 56' ' ' GLN . 94.1 m-70 -114.19 141.52 47.43 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.922 -179.828 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 54' ' ' HIS . 51.7 mp0 -40.15 -29.37 0.07 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 179.852 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.485 ' N ' ' O ' ' A' ' 54' ' ' HIS . 56.1 tt0 -65.34 -68.14 0.39 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.241 -0.89 . . . . 0.0 108.997 178.192 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.488 ' OE1' ' O ' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -159.53 -166.28 1.74 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.257 0.551 . . . . 0.0 111.868 -179.531 . . . . . . . . 3 3 . 1 . 069 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.488 ' O ' ' OE1' ' A' ' 57' ' ' GLU . . . -112.88 125.48 54.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.313 179.633 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 99.0 mt -116.08 129.55 72.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -177.924 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.45 ' HB2' HD11 ' A' ' 82' ' ' LEU . 50.9 tp -96.3 128.87 43.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.642 179.706 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -111.57 135.31 52.33 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.74 179.722 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -100.57 106.84 18.39 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -178.749 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -99.89 -1.44 37.36 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.994 179.031 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.46 100.04 12.46 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.404 -179.553 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.0 p -81.7 -15.16 55.35 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.214 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.92 -35.57 14.65 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.213 -179.86 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.491 ' HB3' HD11 ' A' ' 91' ' ' ILE . 11.1 m-80 -150.7 89.0 4.47 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.24 -179.815 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -57.12 148.9 66.46 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.68 2.253 . . . . 0.0 112.717 -179.665 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 38.1 m -71.99 138.37 47.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.324 179.327 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -96.63 144.54 26.58 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.101 -179.664 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.711 ' HB ' HD11 ' A' ' 76' ' ' ILE . 3.9 p -127.87 135.74 62.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.956 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 8.3 m120 48.71 31.46 3.06 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.287 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.56 27.44 63.29 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.686 179.87 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 71' ' ' VAL . 21.1 t -136.67 134.53 37.36 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.998 0.399 . . . . 0.0 110.907 179.784 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.4 ' H ' HG12 ' A' ' 75' ' ' VAL . 0.2 OUTLIER -60.64 143.95 13.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.342 -179.911 . . . . . . . . 3 3 . 1 . 069 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.711 HD11 ' HB ' ' A' ' 71' ' ' VAL . 97.2 mt -107.97 102.93 14.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.456 179.565 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -64.92 -42.31 94.81 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.716 0.294 . . . . 0.0 111.556 179.365 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.536 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.3 OUTLIER -133.67 -179.41 1.06 Allowed Pre-proline 0 CA--C 1.532 0.28 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.597 -178.581 . . . . . . . . 3 3 . 1 . 069 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.471 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 52.3 Cg_exo -55.18 138.05 78.25 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 122.331 2.021 . . . . 0.0 112.779 -178.687 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 72.7 t -134.48 136.68 52.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.792 -179.576 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -73.84 135.49 43.43 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.608 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.45 HD11 ' HB2' ' A' ' 60' ' ' LEU . 97.4 mt -84.89 137.56 33.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.284 0.564 . . . . 0.0 111.466 -179.225 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -126.74 151.04 48.72 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.219 -179.963 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.475 ' HD1' ' H ' ' A' ' 99' ' ' ASN . 15.0 t60 -60.46 125.76 24.92 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.041 0.448 . . . . 0.0 110.774 -179.43 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.11 -17.88 47.18 Favored Glycine 0 CA--C 1.519 0.289 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.516 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 87' ' ' VAL . 66.4 t0 -72.52 133.05 44.59 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.041 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.512 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 33.6 t -109.36 133.3 54.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.1 0.476 . . . . 0.0 110.998 -179.119 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.4 mt -93.33 131.46 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 178.841 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.3 m -122.44 124.54 43.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.495 0.664 . . . . 0.0 112.311 -178.321 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.575 ' O ' ' N ' ' A' ' 93' ' ' ARG . 98.0 mt -117.84 133.46 64.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.752 178.725 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.491 HD11 ' HB3' ' A' ' 67' ' ' ASN . 80.8 mt -23.7 97.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -178.614 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.473 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 3.2 m-20 89.73 -20.07 0.16 Allowed 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.801 1.038 . . . . 0.0 113.801 177.792 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.603 ' NH2' ' OE1' ' B' ' 260' ' ' GLU . 54.3 mtt-85 -130.33 140.81 50.62 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.6 -179.114 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.649 ' OG ' HD12 ' A' ' 10' ' ' ILE . 11.2 p -137.53 150.71 47.73 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.712 0.291 . . . . 0.0 110.241 -179.931 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.541 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 15.4 m-85 -129.53 123.78 32.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.077 -179.038 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.447 ' HA ' HG22 ' A' ' 87' ' ' VAL . 42.9 ttm180 -79.37 127.7 32.42 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.137 0.494 . . . . 0.0 111.337 -179.464 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.504 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 67.9 t80 -94.26 127.68 40.27 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.997 -179.707 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -141.26 116.96 10.33 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.702 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 100' ' ' GLU . 52.4 p30 -71.85 -22.37 61.54 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.48 179.72 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.524 ' N ' ' OD1' ' A' ' 99' ' ' ASN . 96.7 mt-10 . . . . . 0 CA--C 1.53 0.204 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.736 179.798 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 15.2 m . . . . . 0 N--CA 1.448 -0.566 0 CA-C-O 120.932 0.396 . . . . 0.0 110.653 . . . . . . . . . 0 0 . 1 . 069 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 41.55 -108.38 0.09 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.258 -179.923 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 069 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.495 ' O ' ' O ' ' B' ' 232' ' ' GLY . 99.5 mm-40 -123.56 -22.86 4.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.693 -179.742 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' B' ' 231' ' ' GLN . . . -44.76 179.45 0.01 OUTLIER Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 -179.448 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.08 161.95 43.72 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 123.328 2.685 . . . . 0.0 112.762 179.976 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 069 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -75.03 171.16 18.86 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.019 1.813 . . . . 0.0 112.082 -179.841 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 2.9 p -115.18 133.64 60.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.914 179.864 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . 0.465 ' CB ' HD13 ' A' ' 91' ' ' ILE . 2.3 t -74.97 130.11 38.8 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.635 -179.418 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . 0.43 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . 0.43 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 40.7 Cg_exo -57.59 -28.55 81.71 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.849 2.366 . . . . 0.0 113.175 -179.411 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 14.5 m -69.11 -45.68 69.59 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.582 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.526 ' CE2' HG21 ' A' ' 43' ' ' VAL . 64.8 t80 -57.3 -45.93 83.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.364 -179.327 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 90.6 mt -64.53 -41.37 96.41 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -179.91 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -64.09 -39.11 93.35 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.967 -178.95 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -61.82 -41.64 98.03 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.544 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.603 ' O ' HG23 ' B' ' 249' ' ' VAL . 71.3 ttp85 -60.9 -42.51 98.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.981 179.847 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.18 -40.59 90.52 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.097 -179.506 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 68.6 m -68.07 -42.99 79.61 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.481 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . 0.838 ' NE2' HH12 ' A' ' 12' ' ' ARG . 56.0 tt0 -62.37 -38.07 88.13 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.61 -179.18 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.603 HG23 ' O ' ' B' ' 245' ' ' ARG . 77.8 t -60.4 -45.86 96.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.108 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -59.87 -26.75 66.12 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.636 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -83.88 -11.38 57.03 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.703 178.552 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.559 ' O ' ' CB ' ' B' ' 253' ' ' ASN . 97.0 mt -115.01 -173.92 2.4 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.624 179.554 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . 0.559 ' CB ' ' O ' ' B' ' 252' ' ' LEU . 0.3 OUTLIER 91.42 28.01 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.932 179.905 . . . . . . . . 3 3 . 1 . 069 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . 0.585 ' O ' ' CB ' ' B' ' 255' ' ' ASP . 24.0 p-10 -88.4 -6.01 57.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.355 179.534 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . 0.585 ' CB ' ' O ' ' B' ' 254' ' ' ASP . 51.3 t0 112.96 62.36 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 O-C-N 124.286 0.991 . . . . 0.0 110.904 179.636 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 37.2 p30 -98.41 -175.53 3.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.068 0.461 . . . . 0.0 110.865 179.871 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . 0.553 ' C ' ' H ' ' B' ' 259' ' ' ASP . 98.5 mttt -141.01 159.45 42.2 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.185 179.614 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.544 ' O ' ' N ' ' B' ' 260' ' ' GLU . 87.0 m-20 52.34 5.3 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.382 -179.9 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.553 ' H ' ' C ' ' B' ' 257' ' ' LYS . 1.6 p-10 28.55 -87.1 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.011 0.434 . . . . 0.0 111.789 -179.948 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.603 ' OE1' ' NH2' ' A' ' 93' ' ' ARG . 90.8 mt-10 -146.53 14.12 1.23 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.702 -179.95 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.421 ' CD1' HG23 ' A' ' 9' ' ' THR . 50.5 mt -107.87 139.42 29.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.762 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 61.1 t -126.73 135.27 64.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.511 -179.741 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -98.97 121.54 41.05 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.302 0.572 . . . . 0.0 111.089 -178.833 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -64.66 -46.72 81.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.952 179.913 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . 0.431 ' CD ' HD11 ' A' ' 24' ' ' LEU . 21.7 mm-40 -93.15 150.09 38.57 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.956 -179.269 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.7 148.54 65.7 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.549 2.166 . . . . 0.0 112.678 -179.869 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.3 pt . . . . . 0 C--N 1.327 -0.39 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.535 179.589 . . . . . . . . 0 0 . 1 . 070 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo . . . . . 0 N--CA 1.494 1.515 0 CA-C-O 120.678 0.199 . . . . 0.0 111.683 . . . . . . . . . 0 0 . 1 . 070 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 41.4 p -112.29 -44.46 3.39 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.699 -179.692 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.816 ' NE ' HD13 ' A' ' 53' ' ' ILE . 89.7 mtm-85 -88.66 123.68 33.35 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.751 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -130.79 138.48 49.93 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -178.393 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.565 HD11 HD11 ' A' ' 22' ' ' LEU . 68.2 mt -112.98 133.52 54.9 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.088 178.645 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 66.4 t -108.77 128.37 64.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.415 179.672 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.465 ' CG2' HD12 ' B' ' 261' ' ' ILE . 11.9 m -92.17 114.45 27.0 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.729 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.563 HD12 ' OG ' ' A' ' 94' ' ' SER . 96.4 mt -78.39 141.88 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.766 178.605 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.74 155.37 20.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.316 179.827 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -57.57 -31.96 66.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.682 -179.515 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.0 p -78.21 -8.3 58.16 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.146 0.498 . . . . 0.0 110.61 -179.877 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.76 38.2 6.21 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 -179.547 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 52.9 t -121.52 132.74 70.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.716 -0.393 . . . . 0.0 111.153 -179.49 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -68.54 116.61 9.28 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.795 -0.816 . . . . 0.0 108.795 179.53 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -107.53 -131.32 6.58 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.994 -178.975 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.58 149.45 61.7 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 121.945 1.763 . . . . 0.0 112.816 -178.63 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -106.85 145.0 32.68 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.598 179.351 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -115.17 96.45 45.41 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.184 -178.805 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.3 134.03 20.27 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.337 1.358 . . . . 0.0 112.311 -179.048 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.565 HD11 HD11 ' A' ' 7' ' ' LEU . 95.5 mt -84.54 83.02 8.15 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.017 -179.172 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 24.3 p -87.31 -12.03 47.73 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.535 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 58.9 mt -99.47 142.41 30.98 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.178 -179.732 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 77.9 p -66.82 -14.92 63.21 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.283 -178.953 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.0 m -130.73 131.98 45.08 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.973 0.416 . . . . 0.0 111.147 -179.721 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.498 ' HB2' HD22 ' A' ' 22' ' ' LEU . 9.9 t -125.71 119.44 28.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.453 178.992 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.439 HD21 ' HG2' ' A' ' 47' ' ' GLN . 50.5 tp -116.15 131.11 57.03 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.837 0.351 . . . . 0.0 111.408 -178.27 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.697 ' CE2' HD12 ' A' ' 37' ' ' ILE . 10.8 m-85 -108.8 143.29 38.16 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.63 179.704 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 156.74 -152.98 24.32 Favored Glycine 0 C--O 1.223 -0.536 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.262 179.448 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.539 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 32.9 mtm180 -108.0 -26.48 10.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.806 0.336 . . . . 0.0 110.414 179.251 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.562 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -58.29 155.39 22.95 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 121.205 -0.521 . . . . 0.0 111.917 -178.639 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.432 HD13 ' HA ' ' A' ' 33' ' ' ILE . 35.9 mm -63.4 -42.56 96.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.753 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -55.06 -29.6 57.85 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.147 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.562 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 5.7 m -53.99 113.82 1.37 Allowed 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.085 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -59.08 -23.93 62.49 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -178.558 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.697 HD12 ' CE2' ' A' ' 29' ' ' PHE . 91.1 mt -128.4 121.95 56.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 177.197 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.432 ' O ' ' N ' ' B' ' 262' ' ' VAL . 43.4 mtm180 -110.64 136.81 49.17 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.359 -179.151 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.63 HD13 ' HE ' ' A' ' 93' ' ' ARG . 93.3 mt -115.66 128.91 72.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.688 179.397 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -71.71 33.72 0.06 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.704 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.713 HD12 ' CZ ' ' A' ' 93' ' ' ARG . 41.6 mt -115.39 131.57 23.54 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 120.189 -0.604 . . . . 0.0 111.14 179.739 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.4 ' O ' ' HD2' ' B' ' 235' ' ' PRO . 57.0 Cg_endo -71.26 -15.11 31.69 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.345 2.03 . . . . 0.0 113.321 -179.637 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.553 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 26.2 m -84.25 -0.49 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-O 121.009 0.433 . . . . 0.0 110.534 179.61 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.539 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 66.4 t -94.65 133.07 36.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.6 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 38.4 t -71.85 170.73 13.05 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.465 0.65 . . . . 0.0 111.962 -178.335 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.558 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 51.7 mttp -62.48 -40.43 96.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.424 -179.874 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.695 ' O ' ' N ' ' A' ' 49' ' ' CYS . 86.2 mt-30 -119.55 -15.01 9.06 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 123.239 0.337 . . . . 0.0 111.65 -179.249 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.6 t60 32.41 -71.91 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 179.534 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.695 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -134.44 137.34 43.91 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.952 -178.582 . . . . . . . . 3 3 . 1 . 070 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -127.41 131.04 50.36 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.045 179.416 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.6 mt -116.74 135.32 57.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.441 -179.606 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -117.28 124.76 49.79 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.765 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.816 HD13 ' NE ' ' A' ' 5' ' ' ARG . 80.9 mt -104.72 115.75 47.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.724 0.773 . . . . 0.0 112.096 -178.788 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.588 ' O ' ' N ' ' A' ' 56' ' ' GLN . 96.9 m-70 -112.59 141.59 46.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.547 -1.206 . . . . 0.0 108.844 179.129 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 54' ' ' HIS . 50.6 tp10 -39.36 -24.57 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -179.336 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.588 ' N ' ' O ' ' A' ' 54' ' ' HIS . 49.8 tt0 -64.93 -68.2 0.38 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.123 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.93 -155.15 0.4 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.484 178.476 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.431 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -116.86 126.04 52.43 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.711 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 99.2 mt -114.92 131.09 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 121.152 0.501 . . . . 0.0 112.064 -178.628 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.52 ' HB2' HD11 ' A' ' 82' ' ' LEU . 23.9 tp -101.5 129.29 47.54 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.389 -179.451 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -113.23 136.0 53.21 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.577 -179.896 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.449 HD21 ' HA ' ' A' ' 68' ' ' PRO . 41.0 t30 -95.87 105.34 17.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.559 179.998 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -99.12 -10.11 22.95 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.803 179.56 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.41 98.49 11.04 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.865 179.709 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.8 m -75.55 -30.29 59.67 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.407 178.998 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.598 ' CG2' HG12 ' B' ' 236' ' ' VAL . 5.4 m -61.01 -45.42 94.88 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.856 -179.296 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.2 m-20 -144.07 102.18 4.84 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.982 -179.659 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.449 ' HA ' HD21 ' A' ' 62' ' ' ASN . 32.4 Cg_exo -56.39 146.01 75.81 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 121.479 1.452 . . . . 0.0 112.343 179.554 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.7 m -73.07 144.39 47.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.144 179.17 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -102.8 138.68 39.37 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.491 179.399 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.433 HG22 HG12 ' A' ' 88' ' ' ILE . 52.2 t -132.78 131.63 59.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.185 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 54.3 34.12 19.83 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.131 -0.628 . . . . 0.0 109.978 -179.43 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.52 25.56 72.2 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.647 178.901 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 29.1 t -145.55 142.49 29.21 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 117.524 0.662 . . . . 0.0 111.34 179.751 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.404 HG12 ' H ' ' A' ' 75' ' ' VAL . 0.2 OUTLIER -73.2 141.63 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.838 179.749 . . . . . . . . 3 3 . 1 . 070 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 11.4 pt -108.13 98.51 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-O 121.43 0.633 . . . . 0.0 110.888 179.0 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -66.23 -32.06 73.26 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.322 179.406 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -123.61 172.84 5.1 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.454 -179.283 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.63 146.72 94.53 Favored 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 122.468 2.112 . . . . 0.0 112.276 179.927 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.7 p -139.97 140.39 35.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.137 0.494 . . . . 0.0 111.304 -179.86 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -75.39 131.94 40.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.573 179.691 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.52 HD11 ' HB2' ' A' ' 60' ' ' LEU . 93.2 mt -87.27 138.39 31.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.274 0.559 . . . . 0.0 111.449 -179.645 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -130.1 156.43 44.55 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.665 179.368 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.552 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 4.7 t60 -59.86 123.83 18.25 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.604 -179.574 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.84 -13.86 45.64 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.877 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -69.7 136.99 51.72 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.472 -0.491 . . . . 0.0 109.864 179.728 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 50.7 t -113.61 130.64 67.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.837 -178.797 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.433 HG12 HG22 ' A' ' 71' ' ' VAL . 98.7 mt -103.84 133.33 48.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.734 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 95.8 m -128.58 129.89 46.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.907 0.861 . . . . 0.0 113.217 -178.379 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.465 ' O ' ' N ' ' A' ' 92' ' ' ASP . 92.8 mt -113.2 124.96 70.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.106 -1.406 . . . . 0.0 107.918 178.135 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.452 ' C ' ' O ' ' A' ' 90' ' ' ILE . 52.6 mt 34.68 -94.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.73 -178.719 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.623 ' OD1' ' NH1' ' A' ' 93' ' ' ARG . 31.5 p-10 -116.79 10.3 14.19 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.927 -179.754 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.713 ' CZ ' HD12 ' A' ' 41' ' ' LEU . 53.4 mtm-85 -122.39 139.43 53.85 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -179.581 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.563 ' OG ' HD12 ' A' ' 10' ' ' ILE . 58.5 p -140.31 155.33 46.86 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.961 -179.78 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -124.67 121.96 36.18 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.501 179.711 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -81.18 132.54 35.36 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 119.651 -0.819 . . . . 0.0 110.249 -179.901 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.626 ' OH ' ' ND2' ' A' ' 99' ' ' ASN . 87.2 t80 -102.02 124.98 48.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.494 -178.873 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -140.49 127.7 21.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.045 179.148 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.626 ' ND2' ' OH ' ' A' ' 97' ' ' TYR . 94.3 m-20 -107.83 142.25 38.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.166 178.996 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 . . . . . 0 C--N 1.328 -0.356 0 CA-C-O 121.043 0.449 . . . . 0.0 111.043 -179.851 . . . . . . . . 0 0 . 1 . 070 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . 0.467 ' O ' ' O ' ' B' ' 229' ' ' ASP . 89.8 t . . . . . 0 N--CA 1.463 0.206 0 CA-C-O 120.429 0.157 . . . . 0.0 110.784 . . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.477 ' C ' ' H ' ' B' ' 231' ' ' GLN . 95.6 m-20 55.89 118.8 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.463 179.324 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 070 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.477 ' H ' ' C ' ' B' ' 229' ' ' ASP . 69.7 mt-30 -132.37 49.83 2.29 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.325 -179.187 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -116.16 -171.41 16.18 Favored Glycine 0 CA--C 1.531 1.09 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 -179.468 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.12 161.12 45.58 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 123.336 2.691 . . . . 0.0 113.162 -179.766 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.565 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . 0.4 ' HD2' ' O ' ' A' ' 42' ' ' PRO . 31.6 Cg_exo -58.49 138.95 88.64 Favored 'Trans proline' 0 C--N 1.302 -1.89 0 C-N-CA 121.983 1.789 . . . . 0.0 112.26 179.735 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.598 HG12 ' CG2' ' A' ' 66' ' ' THR . 3.6 m -66.76 138.69 22.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 114.552 -1.204 . . . . 0.0 110.263 -178.996 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.5 t -59.05 114.97 2.85 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.392 -0.523 . . . . 0.0 109.7 179.918 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 070 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_exo -55.69 -25.62 51.82 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 122.177 1.918 . . . . 0.0 112.137 179.578 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 71.4 m -68.88 -44.77 72.6 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.004 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.713 ' CD1' ' NH2' ' B' ' 245' ' ' ARG . 62.7 t80 -58.07 -46.1 86.0 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.503 -179.4 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.417 ' HA ' HD23 ' B' ' 242' ' ' LEU . 71.9 mt -62.11 -41.04 97.82 Favored 'General case' 0 N--CA 1.462 0.127 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 179.972 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.83 -39.36 93.45 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.208 -179.471 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -59.47 -44.24 93.06 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.659 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.713 ' NH2' ' CD1' ' B' ' 241' ' ' PHE . 0.6 OUTLIER -62.22 -40.9 97.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.44 179.423 . . . . . . . . 3 3 . 1 . 070 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -61.98 -43.74 98.2 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.477 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 38.9 t -63.13 -44.19 96.25 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.529 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -61.35 -33.66 73.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.355 179.764 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.521 HG23 ' O ' ' B' ' 245' ' ' ARG . 51.3 t -63.12 -45.95 97.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.013 179.548 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -61.41 -28.56 69.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.689 178.932 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -89.16 -7.91 54.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.986 179.258 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.466 ' HG ' ' N ' ' B' ' 253' ' ' ASN . 33.3 tp -96.09 167.92 10.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.456 -179.766 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . 0.466 ' N ' ' HG ' ' B' ' 252' ' ' LEU . 97.7 m-20 -116.85 145.33 43.63 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.319 178.95 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -62.59 -32.24 73.2 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.328 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . 0.449 ' C ' ' OD1' ' B' ' 255' ' ' ASP . 39.1 p-10 -94.77 8.82 41.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.954 179.235 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.668 ' CG ' ' H ' ' B' ' 257' ' ' LYS . 25.4 p-10 -41.44 -94.39 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.014 -179.293 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . 0.668 ' H ' ' CG ' ' B' ' 256' ' ' ASP . 59.3 pttt 171.65 172.64 0.09 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.442 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.566 ' O ' ' O ' ' B' ' 257' ' ' LYS . 86.3 m-20 -27.28 151.97 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.23 0.538 . . . . 0.0 111.257 -178.854 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.572 ' C ' ' H ' ' B' ' 261' ' ' ILE . 24.9 p30 -101.01 -177.48 3.47 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.786 0.803 . . . . 0.0 111.388 -179.465 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -64.04 23.18 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.462 -1.244 . . . . 0.0 112.069 -178.139 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.572 ' H ' ' C ' ' B' ' 259' ' ' ASP . 73.6 mt -109.57 132.88 56.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.335 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . 0.432 ' N ' ' O ' ' A' ' 38' ' ' ARG . 53.7 t -124.37 133.19 70.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.605 -178.775 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -98.91 121.59 41.07 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.135 0.493 . . . . 0.0 111.936 -178.382 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -65.59 -44.04 87.84 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.621 179.417 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.23 158.51 83.85 Favored Pre-proline 0 CA--C 1.517 -0.312 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.828 -179.102 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -57.79 139.47 90.41 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 C-N-CA 122.2 1.933 . . . . 0.0 111.302 179.444 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 19.1 tt . . . . . 0 N--CA 1.441 -0.876 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.206 -179.313 . . . . . . . . 0 0 . 1 . 071 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo . . . . . 0 N--CA 1.495 1.567 0 CA-C-O 120.873 0.28 . . . . 0.0 112.015 . . . . . . . . . 0 0 . 1 . 071 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 99' ' ' ASN . 2.5 t -134.11 24.37 3.87 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.881 179.471 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.66 HH11 ' HH ' ' A' ' 97' ' ' TYR . 94.9 mtt-85 -81.64 135.7 35.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.038 179.894 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.4 mtp180 -130.54 140.37 50.47 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 121.504 0.669 . . . . 0.0 112.469 -178.63 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.613 HD12 ' O ' ' A' ' 96' ' ' ARG . 44.4 tp -117.16 133.56 55.85 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.154 179.391 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.2 t -109.33 130.97 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.264 -178.752 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.44 HG23 ' CD1' ' B' ' 261' ' ' ILE . 9.7 m -89.96 115.59 27.37 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 121.316 0.579 . . . . 0.0 112.357 -178.842 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.424 HD12 ' HB2' ' A' ' 94' ' ' SER . 94.1 mt -83.9 143.37 11.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.641 178.725 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -86.95 155.0 20.37 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.4 178.364 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.759 HH11 HH11 ' B' ' 245' ' ' ARG . 91.1 mtm180 -52.92 -26.99 16.73 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.848 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 91.6 p -81.36 -6.26 58.72 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.292 179.309 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.63 36.95 9.91 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.322 -179.267 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 36.1 t -120.62 137.09 55.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.953 0.406 . . . . 0.0 111.453 -178.883 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -76.56 121.26 22.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.149 -179.504 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -117.18 -123.79 3.44 Favored Glycine 0 CA--C 1.542 1.739 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -179.786 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -74.8 148.88 36.89 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 122.48 2.12 . . . . 0.0 113.134 -179.359 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -102.96 165.97 10.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.293 179.03 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.678 ' CD2' HD11 ' A' ' 37' ' ' ILE . 52.8 t80 -134.63 97.44 14.23 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.206 -179.248 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.79 122.66 10.81 Favored 'Trans proline' 0 N--CA 1.501 1.943 0 C-N-CA 122.441 2.094 . . . . 0.0 112.694 -179.896 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.6 mt -83.94 49.53 1.65 Allowed 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 121.126 -0.23 . . . . 0.0 111.375 -179.477 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 91.6 p -65.23 -22.55 66.89 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.051 0.453 . . . . 0.0 109.789 179.396 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 80.5 mt -77.58 139.48 39.54 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.991 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.81 -17.52 63.19 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.223 -0.444 . . . . 0.0 112.047 -178.28 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 86.2 m -133.26 133.97 43.34 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.444 -179.613 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.7 t -122.98 114.79 20.88 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.107 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.518 HD21 ' HG2' ' A' ' 47' ' ' GLN . 31.4 tp -111.09 128.43 55.88 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.489 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.52 ' O ' ' O ' ' A' ' 47' ' ' GLN . 55.8 m-85 -108.44 137.05 47.05 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.939 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 165.77 -170.94 40.79 Favored Glycine 0 C--O 1.224 -0.52 0 C-N-CA 119.833 -1.175 . . . . 0.0 112.555 179.786 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 37.4 ttp85 -90.19 -30.04 17.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.078 -0.561 . . . . 0.0 111.489 179.843 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.495 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -57.26 155.25 17.92 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.714 -0.555 . . . . 0.0 111.714 -179.226 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.527 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.2 tp -66.71 -42.43 89.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.594 -179.704 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.527 ' N ' HG23 ' A' ' 33' ' ' ILE . 16.2 pt-20 -58.95 -13.42 6.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.362 -179.418 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.577 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 6.6 m -68.27 128.54 36.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.979 0.418 . . . . 0.0 110.414 -179.507 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.445 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 61.9 m-20 -60.18 -32.84 71.45 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.469 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.678 HD11 ' CD2' ' A' ' 20' ' ' PHE . 47.1 mm -119.59 111.29 32.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 177.275 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 88.4 mtm-85 -100.47 133.57 44.7 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.722 -178.327 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.426 HD13 ' HE ' ' A' ' 93' ' ' ARG . 96.7 mt -118.91 129.64 74.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.317 0.58 . . . . 0.0 109.813 178.839 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -72.44 33.82 0.06 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.221 -0.9 . . . . 0.0 112.782 -177.381 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.553 ' CD1' ' CZ ' ' A' ' 93' ' ' ARG . 49.6 mt -110.48 133.23 21.19 Favored Pre-proline 0 N--CA 1.468 0.44 0 C-N-CA 119.81 -0.756 . . . . 0.0 111.834 -179.855 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -71.35 -9.38 25.2 Favored 'Trans proline' 0 N--CA 1.488 1.164 0 C-N-CA 122.363 2.042 . . . . 0.0 113.107 -179.11 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.1 m -102.6 6.11 10.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.018 179.864 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.542 ' O ' HG21 ' B' ' 234' ' ' TPO . 24.1 t -90.91 133.7 31.86 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.956 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.3 m -68.46 158.07 34.52 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.127 -178.83 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.577 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 9.2 mtmp? -63.39 -39.29 94.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.24 -179.506 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.652 ' O ' ' N ' ' A' ' 49' ' ' CYS . 97.9 mt-30 -114.13 -21.43 10.51 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-O 120.885 0.374 . . . . 0.0 110.318 179.559 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.4 t60 33.06 -74.17 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -179.711 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.652 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -129.82 133.28 46.85 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.121 0.486 . . . . 0.0 111.909 -179.001 . . . . . . . . 3 3 . 1 . 071 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -125.27 126.67 45.51 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.809 179.668 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 94.8 mt -113.4 132.51 62.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.606 -179.766 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -112.3 134.87 53.6 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 178.74 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 49.8 mm -104.43 112.86 39.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.752 -179.471 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.443 ' C ' ' N ' ' A' ' 56' ' ' GLN . 97.5 m-70 -116.07 135.36 54.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.944 179.163 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.533 ' H ' ' CD ' ' A' ' 55' ' ' GLU . 53.8 mp0 -41.2 -29.6 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.546 0.689 . . . . 0.0 109.454 -179.58 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.443 ' N ' ' C ' ' A' ' 54' ' ' HIS . 24.4 mt-30 -67.83 -67.75 0.44 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.394 178.526 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.462 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 4.3 tp10 -155.51 -168.46 2.83 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.742 -179.404 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.462 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -116.09 124.47 50.48 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.388 179.121 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.8 mt -110.52 128.8 66.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 120.867 0.365 . . . . 0.0 111.936 -178.928 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.53 ' HB2' HD11 ' A' ' 82' ' ' LEU . 32.2 tp -94.97 124.56 39.09 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.875 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -110.09 134.24 52.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.958 -179.392 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -93.08 108.41 20.0 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.227 -179.234 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -103.36 -11.62 17.77 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.516 179.331 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.474 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 2.1 t -73.77 99.0 3.05 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.452 -179.676 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.5 t -77.22 -43.01 35.14 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.102 0.477 . . . . 0.0 110.552 178.691 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.748 HG21 ' O ' ' B' ' 234' ' ' TPO . 17.1 p -66.8 -39.76 87.85 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.865 -179.001 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.474 ' O ' ' OG ' ' A' ' 64' ' ' SER . 39.6 m-80 -142.84 97.43 5.88 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.672 -179.361 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.547 ' HB2' HG23 ' A' ' 75' ' ' VAL . 51.6 Cg_exo -54.2 144.21 60.25 Favored 'Trans proline' 0 N--CA 1.502 2.005 0 C-N-CA 122.636 2.224 . . . . 0.0 113.5 -179.813 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 16.4 m -69.65 134.85 49.19 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.547 178.413 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -102.62 138.49 39.46 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.054 -0.658 . . . . 0.0 109.987 179.71 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 75.9 t -131.44 133.97 61.35 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.473 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.831 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 53.91 33.75 17.96 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -178.767 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.54 29.46 72.92 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.335 -179.666 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 73.4 m -141.11 136.14 31.63 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.007 0.432 . . . . 0.0 111.577 -179.633 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.547 HG23 ' HB2' ' A' ' 68' ' ' PRO . 1.3 p -68.74 142.51 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.681 179.929 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.7 pt -119.46 88.28 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.139 178.729 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -68.01 -26.23 65.79 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.411 0.624 . . . . 0.0 109.588 178.329 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -113.8 159.07 37.23 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 114.935 -1.029 . . . . 0.0 109.889 179.532 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.32 155.1 71.9 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.147 1.898 . . . . 0.0 111.5 179.916 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.0 m -149.65 146.51 16.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.874 -179.222 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.6 mtm-85 -72.19 131.53 42.89 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.366 179.494 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.53 HD11 ' HB2' ' A' ' 60' ' ' LEU . 99.7 mt -82.63 139.09 33.95 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.423 0.63 . . . . 0.0 110.255 179.75 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -124.34 150.17 45.78 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.221 -179.906 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.516 ' C ' ' CD2' ' A' ' 84' ' ' HIS . 5.9 t60 -63.25 126.04 26.11 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 119.719 -0.793 . . . . 0.0 109.495 -179.764 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.07 -18.94 33.2 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.207 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -69.16 143.26 54.12 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.428 179.586 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.4 p -112.57 134.81 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.781 -178.528 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 85.9 mt -103.06 131.15 52.0 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.526 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 53.6 m -121.18 127.85 51.9 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.616 0.722 . . . . 0.0 112.312 -179.106 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.453 ' O ' ' N ' ' A' ' 92' ' ' ASP . 98.0 mt -121.05 128.32 76.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.211 179.886 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.445 ' C ' ' O ' ' A' ' 90' ' ' ILE . 39.4 mm 39.26 -98.58 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.685 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.534 ' O ' ' OD1' ' A' ' 92' ' ' ASP . 65.5 t0 -125.04 23.07 7.85 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.546 0.688 . . . . 0.0 110.642 179.387 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.553 ' CZ ' ' CD1' ' A' ' 41' ' ' LEU . 38.0 mtm-85 -129.52 142.44 50.77 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.147 -0.933 . . . . 0.0 108.865 179.862 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.424 ' HB2' HD12 ' A' ' 10' ' ' ILE . 58.8 m -135.21 151.22 50.42 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.031 -179.414 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.596 ' HB3' HD11 ' A' ' 7' ' ' LEU . 58.4 m-85 -126.93 120.42 29.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.594 179.179 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.613 ' O ' HD12 ' A' ' 7' ' ' LEU . 99.5 mtt180 -83.12 129.55 35.03 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.151 -0.619 . . . . 0.0 110.644 179.846 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.66 ' HH ' HH11 ' A' ' 5' ' ' ARG . 93.8 t80 -94.38 126.85 39.9 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.814 179.748 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -142.82 122.46 13.32 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.015 0.436 . . . . 0.0 111.274 -179.879 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.472 ' O ' ' O ' ' A' ' 4' ' ' THR . 86.8 m-20 -61.63 -42.81 99.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.502 179.813 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 . . . . . 0 CA--C 1.531 0.215 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.299 179.355 . . . . . . . . 0 0 . 1 . 071 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 43.6 t . . . . . 0 N--CA 1.453 -0.32 0 CA-C-O 120.939 0.399 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 071 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.578 ' C ' ' H ' ' B' ' 231' ' ' GLN . 67.0 t0 -151.07 52.02 0.85 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.812 179.165 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 071 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.578 ' H ' ' C ' ' B' ' 229' ' ' ASP . 78.5 mm-40 -103.93 -23.77 13.32 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.099 0.476 . . . . 0.0 110.904 -179.491 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -62.38 117.51 11.64 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 111.209 -0.757 . . . . 0.0 111.209 -179.751 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.61 134.72 59.33 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 CA-C-N 119.352 1.576 . . . . 0.0 111.165 178.577 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.748 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -78.52 148.48 23.32 Favored 'Trans proline' 0 N--CA 1.489 1.226 0 C-N-CA 122.706 2.271 . . . . 0.0 112.929 179.004 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 14.7 p -62.28 134.95 27.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.49 -179.869 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 7.4 t -67.45 132.82 48.36 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.541 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . 0.426 HG23 ' H ' ' B' ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . 0.412 ' HD2' ' P ' ' B' ' 238' ' ' TPO . 44.5 Cg_exo -57.2 -25.51 64.81 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.329 2.019 . . . . 0.0 111.427 178.701 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 95.6 m -68.47 -45.23 72.97 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.352 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.538 ' HZ ' HD22 ' A' ' 41' ' ' LEU . 82.3 t80 -58.59 -48.6 80.42 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.182 179.737 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 86.8 mt -64.69 -42.0 95.62 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.916 0.389 . . . . 0.0 110.971 -179.917 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -66.04 -47.06 75.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.282 -179.287 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -62.55 -41.85 99.16 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.167 -179.743 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.759 HH11 HH11 ' A' ' 12' ' ' ARG . 52.1 ttm-85 -64.17 -39.45 94.03 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.188 -179.727 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -59.28 -38.44 80.16 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.361 0.601 . . . . 0.0 109.468 179.923 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 15.9 m -67.14 -42.21 84.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.778 177.974 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -64.04 -31.14 72.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.46 179.881 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.04 -45.33 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.065 178.513 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -62.29 -23.44 66.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.266 0.555 . . . . 0.0 109.794 179.94 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -97.92 -3.31 38.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.065 179.274 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.768 HD13 ' N ' ' B' ' 253' ' ' ASN . 1.7 tm? -87.8 126.54 35.07 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.941 0.4 . . . . 0.0 111.288 -178.353 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . 0.768 ' N ' HD13 ' B' ' 252' ' ' LEU . 82.9 m-20 -68.79 136.3 52.56 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.636 -179.556 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' B' ' 254' ' ' ASP . 22.8 p-10 -71.01 -26.1 62.97 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.092 179.446 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -65.16 0.23 1.42 Allowed 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.655 -179.812 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.502 ' O ' ' C ' ' B' ' 257' ' ' LYS . 78.9 m-20 -92.27 -3.64 55.18 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 120.219 -0.592 . . . . 0.0 109.659 179.502 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . 0.502 ' C ' ' O ' ' B' ' 256' ' ' ASP . 96.9 mttt 27.93 -101.94 0.01 OUTLIER 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.14 -179.58 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.483 ' C ' ' O ' ' B' ' 257' ' ' LYS . 82.1 m-20 -30.95 136.81 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.145 179.955 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.592 ' C ' ' H ' ' B' ' 261' ' ' ILE . 52.7 p30 -121.26 -172.9 2.5 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 122.086 0.946 . . . . 0.0 111.488 -179.186 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.526 ' OE1' HD21 ' A' ' 41' ' ' LEU . 99.2 mt-10 -58.65 12.96 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 113.891 -1.504 . . . . 0.0 112.021 -178.832 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.592 ' H ' ' C ' ' B' ' 259' ' ' ASP . 66.3 mt -107.94 136.41 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 177.845 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 55.2 t -127.59 135.34 63.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.88 -178.618 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -94.74 117.16 29.69 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.907 -178.744 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -64.5 -46.11 84.37 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.264 179.935 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.68 158.24 36.95 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.657 -179.53 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -61.24 147.43 95.63 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 C-N-CA 123.041 2.494 . . . . 0.0 112.609 179.47 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.4 pt . . . . . 0 C--N 1.326 -0.427 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.073 -179.783 . . . . . . . . 0 0 . 1 . 072 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo . . . . . 0 N--CA 1.491 1.375 0 N-CA-C 111.488 -0.235 . . . . 0.0 111.488 . . . . . . . . . 0 0 . 1 . 072 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.4 p -73.46 -34.54 65.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.501 -179.479 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.728 ' NE ' HD13 ' A' ' 53' ' ' ILE . 91.7 mtm-85 -100.72 115.5 30.41 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 121.031 -0.268 . . . . 0.0 110.761 -179.57 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -131.65 141.23 49.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.277 0.56 . . . . 0.0 111.427 179.769 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.564 HD11 ' HB3' ' A' ' 95' ' ' PHE . 36.4 tp -114.47 127.7 55.95 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.413 179.908 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.575 HG13 ' CD2' ' A' ' 19' ' ' HIS . 75.8 t -103.15 127.86 56.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.521 -0.471 . . . . 0.0 110.268 -179.406 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 m -92.85 114.45 27.01 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 121.113 0.482 . . . . 0.0 111.398 -179.52 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.442 HD12 ' HB2' ' A' ' 94' ' ' SER . 85.9 mt -80.86 146.78 6.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.419 179.746 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -90.3 154.17 19.91 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 177.811 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.48 ' NH1' ' OD2' ' A' ' 92' ' ' ASP . 38.4 mtp85 -58.04 -28.71 64.75 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.547 -179.245 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 86.0 p -74.81 -14.9 60.74 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.606 -0.437 . . . . 0.0 110.142 178.949 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.54 36.44 4.84 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 -179.518 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.6 t -123.72 133.78 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-O 120.848 0.356 . . . . 0.0 111.68 -179.447 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -66.02 125.87 26.83 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.364 179.512 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -117.28 -126.98 3.83 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.458 -178.951 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -73.76 147.33 39.61 Favored 'Trans proline' 0 N--CA 1.5 1.874 0 C-N-CA 122.604 2.203 . . . . 0.0 112.955 -178.446 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.575 ' CD2' HG13 ' A' ' 8' ' ' VAL . 62.7 m170 -109.23 132.17 54.37 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.913 0.387 . . . . 0.0 110.705 -179.955 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.462 ' CD2' HD11 ' A' ' 37' ' ' ILE . 32.1 t80 -102.22 105.42 42.76 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.936 -179.893 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -74.93 128.66 11.72 Favored 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 121.464 1.443 . . . . 0.0 111.529 -179.418 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 64.9 mt -89.99 44.17 1.19 Allowed 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.387 -178.472 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 84.8 p -59.23 -21.94 60.31 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.408 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 73.6 mt -76.92 146.05 37.82 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.326 179.836 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.0 m -64.24 -23.18 67.21 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.23 -178.981 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 61.2 m -136.26 136.45 39.84 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.897 -179.039 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.1 t -128.01 120.05 26.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.062 179.063 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.404 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 57.4 tp -114.81 132.34 56.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.641 0.258 . . . . 0.0 111.112 -178.749 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.754 ' CE2' HD12 ' A' ' 37' ' ' ILE . 5.9 m-85 -111.92 139.8 47.11 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.902 179.715 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.44 -167.56 30.84 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 120.564 -0.826 . . . . 0.0 112.164 178.755 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.542 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 45.8 mtm180 -84.5 -32.0 24.19 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.867 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.572 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -49.49 143.69 9.65 Favored Glycine 0 CA--C 1.519 0.323 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 -178.662 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.49 HD12 ' HD2' ' A' ' 38' ' ' ARG . 7.0 tp -65.99 -41.1 89.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 120.248 -0.581 . . . . 0.0 109.932 179.995 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.443 ' N ' HG23 ' A' ' 33' ' ' ILE . 82.5 tt0 -54.71 -20.48 8.42 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.228 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.572 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 34.2 m -59.65 126.54 28.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.924 -179.834 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.404 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 56.1 m-20 -59.83 -31.98 70.24 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.249 0.547 . . . . 0.0 109.547 -179.623 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.754 HD12 ' CE2' ' A' ' 29' ' ' PHE . 97.4 mt -123.83 116.56 48.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.148 177.761 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.49 ' HD2' HD12 ' A' ' 33' ' ' ILE . 25.9 mtp85 -100.86 132.39 46.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.434 -178.197 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.796 HG21 ' NH2' ' A' ' 93' ' ' ARG . 92.8 mt -121.7 131.11 73.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.987 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.413 ' H ' ' HG2' ' A' ' 40' ' ' GLN . 13.5 pt20 -79.53 34.16 0.26 Allowed 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -177.849 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.959 HD12 HH21 ' A' ' 93' ' ' ARG . 23.6 mt -104.76 127.88 27.96 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.895 178.92 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -73.42 -9.49 23.03 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 122.303 2.002 . . . . 0.0 112.277 -179.997 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.0 m -91.73 1.09 8.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.73 0.3 . . . . 0.0 110.677 179.798 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.542 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 42.8 t -98.35 138.02 24.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.989 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.508 ' OG ' HG21 ' B' ' 234' ' ' TPO . 64.0 m -72.38 170.58 13.91 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.101 0.477 . . . . 0.0 111.364 -178.794 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -62.48 -41.41 98.77 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.884 -179.099 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.626 ' O ' ' N ' ' A' ' 49' ' ' CYS . 89.6 mt-30 -111.44 -18.5 12.85 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.631 0.253 . . . . 0.0 111.489 -179.698 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.49 ' NE2' HG23 ' A' ' 90' ' ' ILE . 12.6 t60 36.61 -77.06 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 179.262 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.626 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.66 136.08 47.41 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.067 0.461 . . . . 0.0 111.559 -178.475 . . . . . . . . 3 3 . 1 . 072 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -129.45 132.17 46.89 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.477 179.774 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.7 mt -115.13 134.31 58.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.855 -179.745 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -116.65 124.22 49.22 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.783 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.728 HD13 ' NE ' ' A' ' 5' ' ' ARG . 98.0 mt -107.25 114.69 46.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.483 -179.668 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.459 ' O ' ' N ' ' A' ' 56' ' ' GLN . 89.5 m-70 -114.22 145.95 41.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.831 179.924 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 54' ' ' HIS . 53.4 tp10 -40.7 -28.63 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.603 -179.819 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.459 ' N ' ' O ' ' A' ' 54' ' ' HIS . 84.1 mt-30 -63.53 -68.79 0.32 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.962 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.467 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 6.1 tp10 -159.9 -163.48 1.15 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.996 179.379 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.467 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -110.3 127.49 55.04 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.659 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.7 mt -117.22 130.2 72.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.371 0.605 . . . . 0.0 112.099 -178.911 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.8 tp -99.17 129.12 45.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.292 -179.74 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -114.53 137.48 51.81 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.618 179.975 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.438 HD21 ' HA ' ' A' ' 68' ' ' PRO . 54.1 t30 -97.61 107.55 20.08 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.374 -179.757 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -98.9 -10.1 23.29 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 179.918 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.2 t -74.98 102.71 4.9 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.548 179.429 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.7 p -82.28 -17.7 44.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.98 0.419 . . . . 0.0 110.382 179.764 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.887 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.2 OUTLIER -91.24 -39.96 11.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.009 -179.102 . . . . . . . . 3 3 . 1 . 072 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.469 ' OD1' HG13 ' B' ' 236' ' ' VAL . 71.2 m-20 -140.65 94.52 8.22 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.555 -179.936 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.504 ' HB2' HG13 ' A' ' 75' ' ' VAL . 32.2 Cg_exo -57.01 146.34 80.91 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.005 1.804 . . . . 0.0 112.028 -179.404 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.1 m -72.93 137.48 45.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.496 179.967 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -100.76 141.27 33.87 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.104 -179.827 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 46.0 t -127.2 136.95 59.24 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.155 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 51.29 32.31 8.13 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.714 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.96 29.92 68.52 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 -179.965 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.3 p -140.25 134.76 31.52 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 120.641 -0.423 . . . . 0.0 111.644 -179.3 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.504 HG13 ' HB2' ' A' ' 68' ' ' PRO . 52.9 t -67.8 132.89 32.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-O 121.248 0.547 . . . . 0.0 110.929 179.708 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.13 111.39 25.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.807 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -96.25 -10.62 27.54 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.734 -0.387 . . . . 0.0 111.772 -178.592 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -117.25 158.12 45.36 Favored Pre-proline 0 C--N 1.329 -0.3 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.627 -179.412 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -56.12 142.49 86.31 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 121.919 1.746 . . . . 0.0 112.216 179.522 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 18.9 m -144.57 139.96 23.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.623 179.306 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 89.3 mtm-85 -72.91 133.07 44.22 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.876 0.37 . . . . 0.0 110.176 179.758 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.441 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 93.7 mt -81.45 138.98 35.48 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.169 -179.434 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -126.78 148.91 49.89 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.466 179.429 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.423 ' ND1' ' N ' ' A' ' 99' ' ' ASN . 12.4 t60 -58.48 124.89 21.14 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.886 0.374 . . . . 0.0 111.209 -178.667 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.07 -20.96 34.69 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.444 -0.662 . . . . 0.0 111.444 179.967 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -66.87 138.44 57.32 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 120.491 -0.483 . . . . 0.0 110.023 179.731 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.507 HG22 ' HG2' ' A' ' 96' ' ' ARG . 79.5 t -110.36 132.69 58.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.25 -178.747 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 82.5 mt -100.63 132.6 45.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.324 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 93.7 m -120.82 125.52 47.76 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.032 -0.667 . . . . 0.0 112.172 -178.203 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.49 HG23 ' NE2' ' A' ' 48' ' ' HIS . 96.2 mt -116.25 123.96 71.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.019 -0.991 . . . . 0.0 108.61 178.694 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.541 HG22 ' N ' ' A' ' 92' ' ' ASP . 48.8 mm 39.72 -106.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.618 -179.318 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.541 ' N ' HG22 ' A' ' 91' ' ' ILE . 32.8 p-10 -110.1 13.09 23.34 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.787 0.327 . . . . 0.0 111.698 -179.346 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.959 HH21 HD12 ' A' ' 41' ' ' LEU . 9.5 mtm105 -118.51 140.4 49.94 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.198 179.732 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.442 ' HB2' HD12 ' A' ' 10' ' ' ILE . 17.0 m -128.88 144.8 51.28 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.006 179.007 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.564 ' HB3' HD11 ' A' ' 7' ' ' LEU . 41.7 m-85 -126.73 123.53 37.69 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.497 -179.782 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.507 ' HG2' HG22 ' A' ' 87' ' ' VAL . 99.7 mtt180 -85.95 128.49 34.85 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 119.953 -0.699 . . . . 0.0 109.721 -179.754 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -93.98 127.98 40.07 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 120.897 0.38 . . . . 0.0 110.495 -179.995 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -126.56 128.79 47.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.56 -179.323 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.423 ' N ' ' ND1' ' A' ' 84' ' ' HIS . 43.8 t30 -135.24 104.27 5.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.538 179.485 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.1 tp10 . . . . . 0 C--N 1.328 -0.367 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -179.663 . . . . . . . . 0 0 . 1 . 072 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 34.7 m . . . . . 0 N--CA 1.454 -0.246 0 CA-C-O 121.171 0.51 . . . . 0.0 110.097 . . . . . . . . . 0 0 . 1 . 072 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.616 ' O ' ' N ' ' B' ' 231' ' ' GLN . 97.5 m-20 -60.83 140.25 57.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.741 -179.64 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . 0.46 ' C ' ' O ' ' B' ' 229' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.616 ' N ' ' O ' ' B' ' 229' ' ' ASP . 0.9 OUTLIER -169.6 43.74 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 121.378 0.608 . . . . 0.0 110.247 179.956 . . . . . . . . 3 3 . 1 . 072 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -132.79 163.14 24.2 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 179.987 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.84 156.89 56.18 Favored 'Trans proline' 0 N--CA 1.499 1.822 0 C-N-CA 123.828 3.019 . . . . 0.0 113.123 -179.964 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.887 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.71 138.93 30.0 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 C-N-CA 122.035 1.823 . . . . 0.0 112.763 179.253 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.513 ' CG2' HG22 ' A' ' 66' ' ' THR . 77.5 t -59.83 134.98 24.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.664 -179.625 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 4.5 t -51.91 126.9 19.55 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.493 -179.117 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 072 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.36 -18.47 64.83 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.462 2.108 . . . . 0.0 111.736 -179.683 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 73.5 m -75.07 -45.36 41.97 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 176.956 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -57.07 -47.52 80.8 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.265 -179.106 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' B' ' 242' ' ' LEU . 93.0 mt -66.07 -39.85 90.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.15 -179.611 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -62.4 -42.18 99.23 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.577 -179.257 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -63.39 -42.0 98.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.019 0.438 . . . . 0.0 110.058 179.523 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.533 ' CA ' ' HE ' ' B' ' 245' ' ' ARG . 0.0 OUTLIER -63.19 -43.15 99.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.81 -179.348 . . . . . . . . 3 3 . 1 . 072 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.76 -37.71 87.7 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.66 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 39.0 t -64.71 -42.61 95.13 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 177.29 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -59.26 -36.88 76.31 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.073 179.997 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.459 HG23 HH21 ' A' ' 12' ' ' ARG . 46.3 t -62.99 -45.25 99.36 Favored 'Isoleucine or valine' 0 C--O 1.23 0.057 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.129 178.829 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -57.71 -29.13 64.45 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.152 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -90.91 -9.97 44.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.288 179.393 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 53.0 tp -80.97 150.84 28.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.69 179.754 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -109.35 141.19 42.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.162 178.966 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -61.73 -29.06 69.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.835 0.35 . . . . 0.0 110.993 -179.65 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -65.09 1.24 1.02 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.255 -179.237 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.483 ' CG ' ' H ' ' B' ' 257' ' ' LYS . 32.6 t70 -89.4 -179.13 5.77 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 179.397 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . 0.607 ' O ' ' C ' ' B' ' 258' ' ' ASP . 97.8 mttt -145.32 -119.63 0.08 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.122 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.607 ' C ' ' O ' ' B' ' 257' ' ' LYS . 96.3 m-20 -7.26 78.17 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 O-C-N 123.741 0.651 . . . . 0.0 111.004 -179.951 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' B' ' 257' ' ' LYS . 61.2 t0 -83.3 85.9 7.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.41 0.624 . . . . 0.0 110.624 -179.138 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.599 ' O ' HG23 ' A' ' 39' ' ' ILE . 93.5 mt-10 56.14 -1.91 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.025 -0.988 . . . . 0.0 111.735 179.443 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.517 ' H ' ' C ' ' B' ' 259' ' ' ASP . 16.8 mt -115.84 135.85 54.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.51 -179.627 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 45.2 t -127.23 133.72 67.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.537 179.272 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -96.37 119.93 35.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.151 0.5 . . . . 0.0 111.711 -178.638 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -65.45 -44.51 87.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.335 178.964 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -100.25 157.35 33.97 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.979 -179.171 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.4 157.51 54.22 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.945 2.43 . . . . 0.0 112.0 178.763 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 45.3 pt . . . . . 0 C--N 1.33 -0.258 0 CA-C-O 121.336 0.588 . . . . 0.0 112.306 -178.868 . . . . . . . . 0 0 . 1 . 073 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo . . . . . 0 N--CA 1.496 1.638 0 CA-C-O 120.891 0.288 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 073 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.4 t -122.78 34.44 5.14 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.145 179.749 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -94.07 123.1 37.23 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.918 -179.57 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 -128.23 137.14 51.89 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.214 -179.903 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.6 HD11 ' HB3' ' A' ' 95' ' ' PHE . 39.6 tp -112.87 130.98 55.91 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.845 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 66.7 t -109.53 130.99 61.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.325 -179.439 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 m -90.87 118.56 30.37 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.163 -178.765 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.598 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 96.0 mt -81.63 140.54 16.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.063 179.282 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.577 ' NZ ' ' O ' ' B' ' 257' ' ' LYS . 41.5 mmtt -83.71 158.91 21.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.955 0.407 . . . . 0.0 110.058 178.89 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.58 ' N ' HH12 ' A' ' 93' ' ' ARG . 85.4 mtp180 -57.74 -35.48 70.76 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.12 -178.646 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.4 t -76.08 -8.52 57.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.739 0.304 . . . . 0.0 111.414 -179.787 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.66 35.07 5.76 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 -179.184 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.6 t -121.84 132.9 69.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.785 0.326 . . . . 0.0 111.189 -179.72 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -77.71 137.12 38.31 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.313 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.95 -118.34 2.03 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 120.617 -0.802 . . . . 0.0 111.492 -179.63 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.53 151.96 48.03 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.216 1.944 . . . . 0.0 112.274 -179.25 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.459 ' CD2' ' C ' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -117.1 156.62 27.28 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.309 179.814 . . . . . . . . 3 3 . 1 . 073 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.457 ' CD2' HD11 ' A' ' 37' ' ' ILE . 49.1 t80 -124.04 107.03 30.83 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.924 -179.13 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.24 135.16 22.2 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 121.546 1.497 . . . . 0.0 111.961 -179.282 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.461 HD22 ' SG ' ' A' ' 27' ' ' CYS . 62.2 mt -96.44 40.95 1.12 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.166 -178.512 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.8 p -63.07 -18.47 63.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.146 0.498 . . . . 0.0 109.957 179.541 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.9 mt -75.53 149.49 38.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.504 179.219 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 26.3 m -62.99 -25.52 68.42 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.494 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.478 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 95.7 m -139.25 139.66 37.48 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 120.1 -0.64 . . . . 0.0 112.541 -179.59 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.461 ' SG ' HD22 ' A' ' 22' ' ' LEU . 4.0 t -128.09 116.63 20.27 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.852 179.027 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.571 HD21 ' OE1' ' A' ' 47' ' ' GLN . 54.9 tp -113.81 128.91 56.6 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.84 0.352 . . . . 0.0 110.976 -179.073 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.791 ' CE2' HD12 ' A' ' 37' ' ' ILE . 5.1 m-85 -108.07 137.04 46.75 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.171 -179.511 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 152.54 -172.79 31.67 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.216 -0.992 . . . . 0.0 112.267 178.756 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 48.1 mtm180 -76.98 -32.57 57.35 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 179.851 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.498 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -48.23 144.95 6.2 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 120.674 -0.775 . . . . 0.0 111.263 -178.693 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.491 HG23 ' N ' ' A' ' 34' ' ' GLU . 9.9 tp -65.64 -41.16 89.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.824 0.345 . . . . 0.0 110.12 -179.99 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.491 ' N ' HG23 ' A' ' 33' ' ' ILE . 80.3 mm-40 -57.06 -19.54 19.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.959 -179.987 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 62.8 m -56.05 122.69 12.23 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.703 -179.751 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.478 ' OD2' ' O ' ' A' ' 26' ' ' THR . 56.0 m-20 -58.88 -30.72 67.97 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -179.947 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.791 HD12 ' CE2' ' A' ' 29' ' ' PHE . 85.6 mt -127.01 120.51 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.361 177.333 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 84.4 mtp180 -102.46 135.15 44.59 Favored 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.472 -179.354 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 97.1 mt -116.12 126.31 73.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.145 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -75.05 30.62 0.09 Allowed 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -177.87 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.418 ' HA ' HD23 ' A' ' 41' ' ' LEU . 45.9 mt -98.27 126.22 40.57 Favored Pre-proline 0 C--N 1.325 -0.49 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.3 179.259 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -72.4 -8.22 22.27 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 C-N-CA 122.315 2.01 . . . . 0.0 112.853 -179.719 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.575 HG21 ' CE2' ' B' ' 241' ' ' PHE . 27.5 m -101.73 6.32 10.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.069 0.462 . . . . 0.0 110.422 179.52 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.1 t -91.01 137.41 21.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.431 178.747 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.8 m -68.72 169.24 11.63 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.613 0.72 . . . . 0.0 112.214 -178.332 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -62.78 -43.93 97.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.177 -179.041 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.586 ' O ' ' N ' ' A' ' 49' ' ' CYS . 95.2 mm-40 -113.65 -25.75 8.56 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.95 -179.532 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.1 t60 40.42 -78.74 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.878 -1.056 . . . . 0.0 113.43 179.661 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.586 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -129.05 136.03 49.72 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.025 . . . . . . . . 3 3 . 1 . 073 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -129.53 126.82 39.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.798 -179.931 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.1 mt -112.04 134.72 53.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.341 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -119.77 127.67 53.02 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.624 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 83.6 mt -105.67 121.52 58.02 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 CA-C-O 121.694 0.759 . . . . 0.0 111.609 -178.904 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.548 ' O ' ' N ' ' A' ' 56' ' ' GLN . 92.5 m-70 -117.11 142.81 46.52 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.105 -179.504 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 54' ' ' HIS . 92.4 mt-10 -39.0 -26.75 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -179.295 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.548 ' N ' ' O ' ' A' ' 54' ' ' HIS . 87.7 mt-30 -68.63 -67.39 0.47 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.679 179.045 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.493 ' CD ' HH21 ' A' ' 81' ' ' ARG . 5.3 tp10 -159.66 -156.98 0.54 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.221 179.802 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -120.88 131.17 54.24 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.039 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 93.5 mt -120.77 131.22 73.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.031 0.443 . . . . 0.0 112.027 -178.455 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 34.7 tp -94.48 125.2 38.98 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.042 179.566 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -111.21 138.22 47.93 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.16 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.653 HD21 ' CB ' ' A' ' 68' ' ' PRO . 63.5 t-20 -101.74 107.82 19.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.43 . . . . 0.0 112.013 -178.53 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -99.33 -9.87 23.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.43 -179.991 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.49 99.93 9.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.691 0.281 . . . . 0.0 110.295 -179.634 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.2 p -82.34 -35.9 27.42 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.963 179.811 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.543 HG22 HG22 ' B' ' 236' ' ' VAL . 0.3 OUTLIER -61.69 -48.19 81.9 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.182 0.515 . . . . 0.0 109.902 -179.517 . . . . . . . . 3 3 . 1 . 073 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -139.63 100.63 7.45 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.683 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.653 ' CB ' HD21 ' A' ' 62' ' ' ASN . 44.7 Cg_endo -66.9 151.22 82.64 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 121.56 1.507 . . . . 0.0 113.662 -177.79 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.928 ' O ' HG22 ' A' ' 76' ' ' ILE . 16.6 m -68.38 144.02 54.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.116 -179.835 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -103.73 140.6 37.38 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.85 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.9 p -129.27 135.85 60.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.621 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 49.83 34.34 7.58 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.628 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.04 28.19 70.83 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.529 -179.838 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.0 m -139.64 139.69 36.76 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.796 -179.421 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.3 t -68.56 135.93 27.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 120.909 0.385 . . . . 0.0 111.231 179.661 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.928 HG22 ' O ' ' A' ' 69' ' ' THR . 9.6 tt -105.45 96.56 4.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.332 179.906 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -64.57 -35.59 81.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.67 179.736 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.518 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 0.0 OUTLIER -133.55 177.22 2.36 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 120.596 -0.441 . . . . 0.0 111.722 -179.157 . . . . . . . . 3 3 . 1 . 073 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.433 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 48.8 Cg_exo -56.22 141.72 87.84 Favored 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 122.842 2.362 . . . . 0.0 112.944 -179.661 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 42.1 t -134.58 141.26 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.027 -179.636 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.493 HH21 ' CD ' ' A' ' 57' ' ' GLU . 60.2 ttt180 -74.03 122.83 23.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.022 178.353 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 82' ' ' LEU . 98.5 mt -75.02 140.44 43.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.174 0.511 . . . . 0.0 111.3 -179.144 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -133.17 147.7 52.06 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.58 179.701 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.516 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 7.8 t60 -52.66 114.4 1.38 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.316 179.38 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 113.85 -14.67 21.82 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.179 -0.769 . . . . 0.0 111.179 179.997 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -69.42 131.32 44.59 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.028 179.684 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.405 HG22 ' HG3' ' A' ' 96' ' ' ARG . 66.8 t -110.55 129.4 65.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.369 -178.95 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 89.7 mt -101.71 133.9 43.78 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.51 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.556 HG23 ' OG ' ' A' ' 94' ' ' SER . 66.5 m -121.71 121.85 38.23 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.583 0.706 . . . . 0.0 111.529 -179.135 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.632 ' O ' ' N ' ' A' ' 93' ' ' ARG . 86.6 mt -110.32 128.98 66.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.533 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.647 HD13 ' HB2' ' B' ' 237' ' ' CYS . 61.8 mt -15.42 92.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -178.519 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.539 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 2.7 t70 88.73 -22.33 0.13 Allowed 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 177.595 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.632 ' N ' ' O ' ' A' ' 90' ' ' ILE . 19.6 mmm180 -122.94 138.74 54.59 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.789 -0.365 . . . . 0.0 110.349 -179.603 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.556 ' OG ' HG23 ' A' ' 89' ' ' THR . 69.4 m -134.88 150.0 50.38 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.707 179.688 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.6 ' HB3' HD11 ' A' ' 7' ' ' LEU . 55.3 m-85 -127.56 121.35 30.39 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.361 -179.917 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.575 ' O ' HD12 ' A' ' 7' ' ' LEU . 42.1 ttp-105 -84.77 133.51 34.35 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.906 0.384 . . . . 0.0 110.257 -179.834 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -94.3 121.34 35.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.199 -179.327 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -127.56 123.08 34.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.616 179.971 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.516 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 7.8 p-10 -134.55 130.2 36.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.047 179.4 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 . . . . . 0 C--N 1.33 -0.262 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.593 -179.376 . . . . . . . . 0 0 . 1 . 073 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 58.0 t . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 120.794 0.331 . . . . 0.0 110.587 . . . . . . . . . 0 0 . 1 . 073 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -63.6 -161.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.316 179.924 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 073 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -161.96 55.05 0.25 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.45 179.065 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -110.9 -152.62 12.77 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 -179.733 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -61.35 150.98 82.45 Favored 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 123.307 2.671 . . . . 0.0 112.889 -179.902 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.448 HG21 ' O1P' ' B' ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -60.2 146.12 97.03 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.768 2.312 . . . . 0.0 112.7 179.982 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.543 HG22 HG22 ' A' ' 66' ' ' THR . 28.3 t -89.48 131.08 37.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.038 178.89 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . 0.647 ' HB2' HD13 ' A' ' 91' ' ' ILE . 8.0 t -66.35 123.11 19.08 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.984 0.421 . . . . 0.0 110.965 -179.264 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 073 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -60.28 -20.47 62.63 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.251 1.967 . . . . 0.0 111.712 -179.432 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 3.1 m -74.05 -41.8 61.22 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 177.259 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.575 ' CE2' HG21 ' A' ' 43' ' ' VAL . 87.7 t80 -57.49 -47.24 82.44 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.238 -179.69 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 99.3 mt -65.55 -39.87 92.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.778 -179.787 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -61.28 -42.05 97.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.425 -179.801 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -62.0 -43.41 98.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.64 179.512 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.417 ' NH1' ' OE1' ' B' ' 248' ' ' GLN . 2.6 mpt_? -60.33 -40.74 91.7 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.292 -179.927 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -63.5 -43.01 98.49 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.375 0.607 . . . . 0.0 109.76 179.089 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 72.3 m -62.71 -44.38 96.37 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.646 179.094 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . 0.485 ' O ' ' N ' ' B' ' 252' ' ' LEU . 86.5 mt-30 -61.11 -36.68 80.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.572 -179.887 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 22.9 t -60.03 -44.77 95.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.139 179.301 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -65.18 -30.31 71.21 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.263 178.741 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -90.92 -13.47 33.48 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.221 -179.223 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.485 ' N ' ' O ' ' B' ' 248' ' ' GLN . 33.0 mt -85.6 171.17 11.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.008 0.433 . . . . 0.0 110.049 178.672 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . 0.583 ' O ' ' N ' ' B' ' 255' ' ' ASP . 69.5 m-80 -144.07 178.42 7.88 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.006 -179.559 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -46.09 -10.83 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.212 -179.895 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . 0.583 ' N ' ' O ' ' B' ' 253' ' ' ASN . 96.6 m-20 -70.74 -6.35 36.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.976 0.417 . . . . 0.0 110.085 178.668 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.404 ' C ' ' OD1' ' B' ' 256' ' ' ASP . 39.9 p-10 -97.17 16.81 18.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.797 -179.916 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . 0.577 ' O ' ' NZ ' ' A' ' 11' ' ' LYS . 88.4 tttt -58.3 -22.05 51.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.176 179.156 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.467 ' O ' ' OD1' ' B' ' 259' ' ' ASP . 91.5 m-20 -63.52 -44.43 94.29 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.428 -179.832 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.524 ' OD2' ' NZ ' ' A' ' 11' ' ' LYS . 4.0 p30 57.58 138.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.812 0.815 . . . . 0.0 110.965 -178.192 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.751 ' CD ' ' H ' ' B' ' 260' ' ' GLU . 1.3 pm0 -65.64 25.87 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.318 -1.31 . . . . 0.0 112.421 -178.359 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.565 HD11 ' HE ' ' A' ' 93' ' ' ARG . 60.1 mt -118.67 131.69 70.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.146 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 50.8 t -128.88 134.81 63.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.057 -179.515 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -94.45 119.92 33.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.174 0.511 . . . . 0.0 111.206 -178.582 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.26 -44.72 94.35 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.507 179.56 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -102.19 159.93 27.91 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.408 -179.086 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -65.88 161.45 39.37 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.602 2.201 . . . . 0.0 111.723 179.68 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.4 pt . . . . . 0 C--N 1.33 -0.258 0 CA-C-O 121.435 0.636 . . . . 0.0 111.952 -179.03 . . . . . . . . 0 0 . 1 . 074 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo . . . . . 0 N--CA 1.495 1.572 0 N-CA-C 112.999 0.346 . . . . 0.0 112.999 . . . . . . . . . 0 0 . 1 . 074 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 54.2 m -103.4 -58.61 1.85 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.494 179.306 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.507 ' NH2' ' O ' ' A' ' 22' ' ' LEU . 82.9 mtm-85 -81.72 132.61 35.29 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.41 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.412 HH22 ' HA ' ' A' ' 100' ' ' GLU . 91.0 mtm-85 -127.1 131.42 50.84 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.295 -179.768 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.7 HD12 ' O ' ' A' ' 96' ' ' ARG . 29.8 tp -117.22 126.24 52.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.409 179.348 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.678 HG12 ' CD2' ' A' ' 19' ' ' HIS . 35.8 m -101.3 133.65 43.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.903 -179.277 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.444 ' CG2' HD12 ' B' ' 261' ' ' ILE . 9.7 m -92.2 113.87 26.26 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.072 -178.874 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.463 HD12 ' OG ' ' A' ' 94' ' ' SER . 96.3 mt -81.78 144.53 10.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.683 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.5 ' NZ ' ' O ' ' B' ' 256' ' ' ASP . 66.8 mttm -101.02 164.02 12.01 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.618 179.965 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.487 ' HB3' HG21 ' B' ' 249' ' ' VAL . 87.4 mtm180 -59.35 -31.56 69.31 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.569 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.1 t -70.35 -20.59 62.97 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.484 179.239 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.39 17.3 20.24 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.727 179.36 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.5 m -110.23 135.49 49.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.991 0.424 . . . . 0.0 111.198 -179.733 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 17' ' ' GLY . 64.0 t0 -76.55 135.75 39.28 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.029 179.602 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.511 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -126.63 -114.03 1.88 Allowed Glycine 0 CA--C 1.537 1.428 0 C-N-CA 120.361 -0.924 . . . . 0.0 111.961 -179.897 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.91 147.64 50.06 Favored 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 122.434 2.089 . . . . 0.0 113.488 -178.678 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.678 ' CD2' HG12 ' A' ' 8' ' ' VAL . 12.3 m170 -109.83 142.1 41.58 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.148 179.325 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.424 ' CD2' HD11 ' A' ' 37' ' ' ILE . 27.4 t80 -113.32 106.14 54.75 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.041 -179.829 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.62 129.46 13.67 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 121.419 1.413 . . . . 0.0 111.831 -179.432 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.507 ' O ' ' NH2' ' A' ' 5' ' ' ARG . 25.8 mt -94.77 39.94 1.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.858 -178.556 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.9 t -63.12 -15.82 57.99 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.405 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.8 mt -73.7 145.36 45.27 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.327 179.891 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 86.6 p -58.44 -26.38 63.26 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.049 -178.42 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 87.3 m -141.41 139.99 33.56 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.487 -179.584 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.665 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 6.6 t -129.29 119.88 24.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.668 178.856 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.619 HD21 ' OE1' ' A' ' 47' ' ' GLN . 50.1 tp -114.7 130.49 56.83 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.373 -178.422 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.837 ' CE2' HD12 ' A' ' 37' ' ' ILE . 7.0 m-85 -107.68 141.02 39.84 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.807 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 153.39 -171.39 32.27 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 119.95 -1.119 . . . . 0.0 112.538 179.053 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.5 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 45.0 mtm180 -85.8 -32.57 21.72 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 111.497 0.184 . . . . 0.0 111.497 179.564 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -47.36 150.05 2.55 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 -178.977 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.545 ' O ' ' NH2' ' A' ' 38' ' ' ARG . 8.2 tp -64.54 -41.52 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 O-C-N 122.442 -0.446 . . . . 0.0 110.574 -179.579 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.543 ' N ' HG23 ' A' ' 33' ' ' ILE . 95.5 mt-10 -59.08 -18.82 38.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.898 -179.315 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 71.4 m -57.11 118.94 5.53 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.119 -179.869 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -56.4 -29.89 62.1 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.328 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.837 HD12 ' CE2' ' A' ' 29' ' ' PHE . 75.1 mt -124.37 118.81 54.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 177.01 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.545 ' NH2' ' O ' ' A' ' 33' ' ' ILE . 72.0 mtt85 -103.86 134.38 47.25 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.469 -178.427 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.728 ' CG2' HD12 ' A' ' 41' ' ' LEU . 77.6 mt -117.96 129.61 74.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.877 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -76.84 29.99 0.13 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.749 -178.974 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.728 HD12 ' CG2' ' A' ' 39' ' ' ILE . 7.3 mt -99.66 127.14 34.87 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.188 179.902 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.16 -13.27 31.05 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.278 1.986 . . . . 0.0 113.438 -179.202 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.463 HG21 ' N ' ' B' ' 237' ' ' CYS . 1.4 p -96.13 5.06 8.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.114 179.73 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.5 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 42.4 t -88.68 133.45 30.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.275 179.431 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.438 ' O ' HG12 ' A' ' 44' ' ' VAL . 0.6 OUTLIER -66.15 162.69 19.21 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.213 0.53 . . . . 0.0 110.576 179.965 . . . . . . . . 3 3 . 1 . 074 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.41 ' CE ' ' O ' ' B' ' 232' ' ' GLY . 96.4 mttt -60.6 -42.14 96.2 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.944 -178.512 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.619 ' OE1' HD21 ' A' ' 28' ' ' LEU . 97.6 mm-40 -109.33 -16.07 14.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.11 179.837 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.6 t60 34.88 -77.82 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.686 -179.316 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.615 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.11 136.64 45.95 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.113 0.483 . . . . 0.0 111.364 -178.931 . . . . . . . . 3 3 . 1 . 074 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -127.86 129.54 47.08 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.867 179.855 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.8 mt -112.18 133.03 59.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.14 179.663 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.505 ' OE2' ' CE1' ' A' ' 54' ' ' HIS . 81.7 tt0 -115.61 124.03 49.92 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.048 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 48.4 mm -96.33 117.61 40.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.155 0.502 . . . . 0.0 111.886 -178.345 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.505 ' CE1' ' OE2' ' A' ' 52' ' ' GLU . 95.8 m-70 -115.42 132.52 56.59 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.116 179.065 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 54' ' ' HIS . 96.9 mt-10 -42.54 -30.16 0.33 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.375 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.457 ' N ' ' C ' ' A' ' 54' ' ' HIS . 59.3 tt0 -67.09 -68.37 0.38 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.602 178.216 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -151.16 -174.83 4.93 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.475 0.655 . . . . 0.0 111.905 -179.66 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.35 122.16 46.54 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.978 178.372 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 98.5 mt -117.2 132.35 67.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -178.505 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.1 tp -98.76 130.16 45.21 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.173 179.302 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -110.35 135.43 51.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.785 179.585 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 64.2 t-20 -95.31 105.97 17.97 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.915 179.983 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -98.34 -9.81 24.8 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.581 179.52 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.1 m -72.99 100.63 3.02 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 178.988 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.2 p -87.11 -21.55 25.93 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.114 179.95 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.661 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -86.72 -44.86 11.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.215 -179.73 . . . . . . . . 3 3 . 1 . 074 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -132.34 93.14 26.35 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.285 179.75 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -56.25 142.71 87.18 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.45 2.1 . . . . 0.0 112.84 -178.6 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 45.6 m -75.74 152.99 37.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.819 179.607 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -116.08 140.67 49.04 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.835 -179.278 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.736 HG13 ' OD1' ' A' ' 86' ' ' ASP . 55.6 t -129.25 134.5 63.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.336 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 53.29 33.41 15.5 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -179.163 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.9 28.62 70.32 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.696 179.944 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 45.0 t -141.65 140.05 33.16 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 117.04 0.42 . . . . 0.0 111.39 -179.972 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.1 t -66.66 136.38 26.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.685 -179.86 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.7 pt -111.88 79.19 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.617 179.276 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -62.27 -26.94 68.67 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.355 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.08 162.04 26.27 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.837 179.187 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.41 146.43 89.66 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.544 2.163 . . . . 0.0 111.561 179.724 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.7 m -137.77 142.95 34.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.17 0.51 . . . . 0.0 111.555 -179.6 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -72.32 127.52 32.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.585 -179.759 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 82' ' ' LEU . 96.0 mt -78.52 139.19 38.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.185 0.517 . . . . 0.0 111.185 -179.596 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -135.72 150.06 49.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.209 -178.68 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -53.35 113.21 1.07 Allowed 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.73 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.32 -10.89 26.43 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -179.784 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.736 ' OD1' HG13 ' A' ' 71' ' ' VAL . 49.0 t0 -74.19 127.24 32.44 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.41 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.47 ' O ' HG13 ' A' ' 87' ' ' VAL . 13.1 p -108.78 132.64 56.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.639 -178.493 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 94.9 mt -98.66 130.37 47.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.11 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.1 m -117.38 127.25 53.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.725 0.774 . . . . 0.0 112.177 -178.669 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.595 ' O ' ' N ' ' A' ' 93' ' ' ARG . 94.7 mt -116.39 132.86 64.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 114.46 -1.245 . . . . 0.0 108.436 178.536 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.93 HG22 HH22 ' B' ' 245' ' ' ARG . 89.1 mt -25.64 99.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 -179.098 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.534 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 6.9 t0 90.06 -21.88 0.12 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 178.08 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.595 ' N ' ' O ' ' A' ' 90' ' ' ILE . 63.2 mtt85 -131.27 146.09 52.16 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.215 -179.289 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.463 ' OG ' HD12 ' A' ' 10' ' ' ILE . 44.8 p -140.67 154.56 46.44 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.026 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.502 ' HE1' HD12 ' A' ' 90' ' ' ILE . 56.5 m-85 -128.26 128.51 44.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.033 -179.825 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.7 ' O ' HD12 ' A' ' 7' ' ' LEU . 99.4 mtt180 -94.81 135.07 36.74 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 119.461 -0.896 . . . . 0.0 110.66 -179.948 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.461 ' CE2' ' OD1' ' A' ' 99' ' ' ASN . 88.0 t80 -95.04 125.89 40.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.707 -179.705 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.521 ' N ' ' OE1' ' A' ' 98' ' ' GLU . 55.7 mp0 -134.94 126.94 29.64 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.423 -179.652 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.461 ' OD1' ' CE2' ' A' ' 97' ' ' TYR . 98.3 m-20 -89.67 166.04 13.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.867 179.122 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.412 ' HA ' HH22 ' A' ' 6' ' ' ARG . 42.1 tt0 . . . . . 0 C--N 1.326 -0.451 0 CA-C-O 120.93 0.395 . . . . 0.0 110.834 -179.945 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . 0.444 HG13 ' HD2' ' A' ' 31' ' ' ARG . 67.1 t . . . . . 0 N--CA 1.455 -0.211 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 . . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.473 ' O ' ' CB ' ' B' ' 230' ' ' SEP . 96.2 m-20 -73.54 -23.4 59.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.968 -179.542 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . 0.473 ' CB ' ' O ' ' B' ' 229' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.445 ' H ' ' C ' ' B' ' 229' ' ' ASP . 1.2 pt20 -142.54 29.02 1.59 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.666 179.665 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . 0.41 ' O ' ' CE ' ' A' ' 46' ' ' LYS . . . -106.03 -134.52 7.82 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.777 -179.326 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -78.57 161.29 28.11 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.933 2.422 . . . . 0.0 113.213 -178.737 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 074 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.12 169.12 22.99 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 122.384 2.056 . . . . 0.0 112.415 -179.998 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.661 ' CG2' HG22 ' A' ' 66' ' ' THR . 40.2 t -114.03 136.5 50.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.933 -179.764 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . 0.463 ' N ' HG21 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -67.24 128.48 36.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.008 -179.207 . . . . . . . . 3 3 . 1 . 074 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . 0.624 ' O2P' HG23 ' B' ' 240' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 50.9 Cg_exo -56.21 -31.7 84.86 Favored 'Trans proline' 0 N--CA 1.501 1.921 0 C-N-CA 123.227 2.618 . . . . 0.0 114.241 -178.59 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . 0.624 HG23 ' O2P' ' B' ' 238' ' ' TPO . 44.8 p -79.52 -34.62 41.0 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.321 179.423 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.544 ' CE2' ' CZ ' ' B' ' 245' ' ' ARG . 78.9 t80 -57.9 -47.86 81.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.702 -179.572 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.427 HD23 HH21 ' B' ' 245' ' ' ARG . 72.0 mt -65.36 -43.16 91.68 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.005 0.431 . . . . 0.0 110.774 179.276 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -65.8 -39.43 90.91 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.463 -179.245 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -61.67 -47.23 86.27 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.962 -179.719 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.93 HH22 HG22 ' A' ' 91' ' ' ILE . 78.1 mtm180 -65.95 -37.99 87.44 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.39 -179.275 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -59.57 -42.17 91.84 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.994 0.426 . . . . 0.0 111.006 179.703 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 81.2 p -68.95 -42.98 75.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.664 0.745 . . . . 0.0 109.112 178.981 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . 0.603 ' O ' HD23 ' B' ' 252' ' ' LEU . 94.7 mt-30 -62.97 -37.92 89.03 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.783 179.749 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.513 HG23 ' O ' ' B' ' 245' ' ' ARG . 55.1 t -60.86 -44.79 98.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.112 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -60.25 -23.52 64.15 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.577 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -93.05 -9.42 39.74 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.065 179.572 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.603 HD23 ' O ' ' B' ' 248' ' ' GLN . 2.9 mm? -74.72 154.0 38.6 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.424 0.63 . . . . 0.0 111.263 179.83 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -69.07 171.16 8.64 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.053 179.437 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -76.48 4.83 8.31 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.139 0.495 . . . . 0.0 109.945 -179.876 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -85.42 -88.12 0.12 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.126 178.799 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.5 ' O ' ' NZ ' ' A' ' 11' ' ' LYS . 97.6 m-20 58.42 28.1 16.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.868 -179.272 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -59.4 -29.76 67.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.461 -0.791 . . . . 0.0 112.487 -178.16 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.547 ' O ' ' C ' ' B' ' 259' ' ' ASP . 48.9 p-10 -115.28 3.76 14.31 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.263 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.547 ' C ' ' O ' ' B' ' 258' ' ' ASP . 35.5 t0 23.85 -94.05 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.18 0 O-C-N 124.403 1.065 . . . . 0.0 109.516 -179.208 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.47 ' N ' ' O ' ' B' ' 258' ' ' ASP . 99.0 mt-10 -149.1 17.13 0.96 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.235 178.878 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.444 HD12 ' CG2' ' A' ' 9' ' ' THR . 70.5 mt -112.88 134.89 54.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -179.999 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 48.8 t -126.51 134.35 66.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.122 179.47 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -94.79 120.94 35.84 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.155 0.502 . . . . 0.0 110.993 -179.457 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . 0.441 ' HG3' HH22 ' A' ' 38' ' ' ARG . 88.2 tttt -62.93 -45.7 91.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.016 179.414 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 5.7 mm100 -97.68 152.7 38.29 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.336 -179.803 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -69.88 148.98 65.51 Favored 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 122.906 2.404 . . . . 0.0 113.305 -179.279 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 18.7 pt . . . . . 0 N--CA 1.462 0.146 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.313 178.9 . . . . . . . . 0 0 . 1 . 075 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo . . . . . 0 N--CA 1.492 1.398 0 CA-C-O 121.054 0.356 . . . . 0.0 111.798 . . . . . . . . . 0 0 . 1 . 075 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 59.6 p -70.13 -40.56 74.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.451 -179.462 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.603 ' HD2' HD13 ' A' ' 53' ' ' ILE . 91.5 mtt-85 -92.49 129.77 38.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.071 -177.941 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -136.47 141.99 43.54 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.362 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.643 ' CD1' HD11 ' A' ' 22' ' ' LEU . 26.1 mt -116.48 142.12 47.29 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.87 179.207 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.7 t -114.76 129.32 71.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.138 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.431 HG21 ' OD2' ' B' ' 259' ' ' ASP . 1.3 m -94.57 118.54 31.84 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -177.725 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.734 HD12 ' OG ' ' A' ' 94' ' ' SER . 91.0 mt -81.39 143.58 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.804 179.587 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 69.9 mttt -87.51 160.73 18.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.374 178.671 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.57 HH21 ' HG3' ' B' ' 245' ' ' ARG . 81.3 mtp180 -56.18 -33.14 64.99 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.693 -178.76 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 99.8 p -79.82 -8.29 59.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.311 -179.314 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.64 39.75 5.82 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 179.831 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 37.1 t -123.15 133.96 67.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.237 0.542 . . . . 0.0 111.261 -179.454 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -68.9 123.23 20.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.128 179.905 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -115.38 -125.31 3.92 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.507 -179.577 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -74.32 150.08 41.13 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.139 1.893 . . . . 0.0 112.363 -179.342 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -107.21 150.91 26.11 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.9 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.437 ' CD2' HD11 ' A' ' 37' ' ' ILE . 54.8 t80 -119.24 90.98 43.11 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.286 -178.585 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -63.94 130.82 28.69 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.509 2.14 . . . . 0.0 111.36 178.708 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.643 HD11 ' CD1' ' A' ' 7' ' ' LEU . 95.1 mt -96.05 122.37 38.81 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.738 -179.671 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.401 ' H ' HE22 ' B' ' 265' ' ' GLN . 11.4 p -121.87 -26.38 4.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.126 179.284 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.3 mt -78.3 143.72 36.73 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.054 179.008 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.0 p -69.93 -13.82 62.42 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.307 -179.389 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.443 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 20.3 m -127.75 130.39 48.68 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 120.599 -0.441 . . . . 0.0 110.905 179.452 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.8 t -126.67 119.03 25.98 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.595 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' A' ' 36' ' ' ASP . 52.9 tp -117.57 124.35 48.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.901 0.382 . . . . 0.0 111.667 -178.776 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.822 ' CE2' HD12 ' A' ' 37' ' ' ILE . 4.7 m-85 -100.39 142.55 31.71 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 178.768 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 155.55 -177.14 32.86 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 119.972 -1.109 . . . . 0.0 112.265 178.709 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.61 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 87.8 mtm-85 -75.34 -32.18 60.81 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.139 0.495 . . . . 0.0 110.007 179.388 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.546 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -53.0 146.5 18.22 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.112 -178.434 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.499 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.2 tp -66.88 -41.57 87.83 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.158 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.499 ' N ' HG23 ' A' ' 33' ' ' ILE . 78.2 mm-40 -54.07 -19.55 5.06 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.758 179.818 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.546 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 38.6 m -60.67 124.61 20.93 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.072 179.917 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.443 ' OD2' ' O ' ' A' ' 26' ' ' THR . 56.1 m-20 -59.11 -32.41 69.81 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -179.793 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.822 HD12 ' CE2' ' A' ' 29' ' ' PHE . 85.5 mt -124.04 120.82 60.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 175.724 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -108.43 136.0 48.79 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.209 -0.596 . . . . 0.0 111.242 -179.189 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.432 HG22 ' H ' ' A' ' 41' ' ' LEU . 76.8 mt -115.67 132.0 66.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.99 -179.879 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -80.31 25.62 0.39 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.124 -178.476 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.482 HD21 ' OE1' ' B' ' 260' ' ' GLU . 36.2 mt -99.04 129.14 30.22 Favored Pre-proline 0 C--N 1.328 -0.333 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.266 179.332 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.45 -13.53 33.03 Favored 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 122.184 1.922 . . . . 0.0 112.798 -179.638 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.424 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 0.7 OUTLIER -91.58 1.25 8.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.499 -0.48 . . . . 0.0 111.75 -179.542 . . . . . . . . 3 3 . 1 . 075 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.61 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 66.0 t -93.22 132.32 37.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.352 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.551 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 0.3 OUTLIER -61.69 164.7 5.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.241 0.543 . . . . 0.0 111.551 -178.585 . . . . . . . . 3 3 . 1 . 075 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.473 ' CG ' ' NH2' ' A' ' 31' ' ' ARG . 96.6 mttt -61.99 -45.08 95.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.825 -179.142 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.589 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.2 mt-30 -110.53 -12.34 14.38 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-O 121.519 0.676 . . . . 0.0 109.548 179.315 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.551 ' H ' ' HB3' ' A' ' 45' ' ' SER . 25.1 t60 28.8 -75.45 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.219 -1.355 . . . . 0.0 114.255 179.277 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.589 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.43 135.87 46.37 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -177.688 . . . . . . . . 3 3 . 1 . 075 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -126.78 130.49 50.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.616 179.36 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 98.3 mt -115.22 133.31 61.86 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.135 179.537 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -112.48 122.47 47.81 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.309 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.603 HD13 ' HD2' ' A' ' 5' ' ' ARG . 94.7 mt -104.13 113.57 41.41 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 C-N-CA 119.726 -0.79 . . . . 0.0 111.943 -179.004 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.441 ' C ' ' N ' ' A' ' 56' ' ' GLN . 89.9 m-70 -113.5 141.21 47.4 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.592 179.274 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 54' ' ' HIS . 94.8 mt-10 -40.67 -31.87 0.18 Allowed 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -179.365 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.441 ' N ' ' C ' ' A' ' 54' ' ' HIS . 54.7 mt-30 -63.4 -67.75 0.4 Allowed 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.359 -0.837 . . . . 0.0 108.78 178.623 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.464 ' OE1' ' N ' ' A' ' 58' ' ' ALA . 1.4 mm-40 -154.99 -174.77 5.12 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.785 0.803 . . . . 0.0 112.611 -179.285 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.464 ' N ' ' OE1' ' A' ' 57' ' ' GLU . . . -109.65 119.54 39.71 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 114.457 -1.247 . . . . 0.0 108.198 177.689 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.2 mt -110.48 130.12 64.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.842 0.353 . . . . 0.0 111.823 -178.467 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.562 ' HB2' HD11 ' A' ' 82' ' ' LEU . 28.0 tp -97.05 128.24 43.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.464 179.88 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -113.43 138.77 49.61 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.535 179.746 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -96.44 111.09 23.31 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -179.233 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -104.5 -8.49 19.04 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.762 178.698 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.7 t -75.23 104.61 5.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.765 0.316 . . . . 0.0 110.303 179.281 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 94.7 p -87.59 -8.33 56.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.021 0.439 . . . . 0.0 110.331 179.843 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.408 ' HB ' ' ND2' ' A' ' 67' ' ' ASN . 0.2 OUTLIER -101.94 -37.26 8.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.207 -179.213 . . . . . . . . 3 3 . 1 . 075 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.413 ' OD1' HG23 ' B' ' 236' ' ' VAL . 6.3 m-80 -145.07 98.87 4.68 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.489 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -57.29 145.84 85.3 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 121.8 1.667 . . . . 0.0 112.258 -178.782 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.912 ' O ' HG22 ' A' ' 76' ' ' ILE . 28.8 m -67.7 137.34 55.44 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.291 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -102.42 140.78 36.24 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.399 179.576 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 55.7 t -130.95 133.22 63.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.675 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 54.59 30.51 13.32 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.671 -178.922 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.98 23.97 73.12 Favored Glycine 0 CA--C 1.534 1.27 0 CA-C-N 115.307 -0.861 . . . . 0.0 112.711 179.001 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 58.5 m -139.09 145.65 39.77 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 117.522 0.661 . . . . 0.0 110.742 179.478 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.421 ' H ' HG22 ' A' ' 75' ' ' VAL . 7.9 m -71.03 142.74 15.21 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-O 121.138 0.494 . . . . 0.0 111.87 -179.351 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.912 HG22 ' O ' ' A' ' 69' ' ' THR . 6.7 tt -109.54 92.35 2.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.196 179.155 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -65.89 -34.98 79.37 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.746 -179.685 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.478 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 0.2 OUTLIER -126.04 175.06 3.44 Favored Pre-proline 0 N--CA 1.464 0.259 0 C-N-CA 120.414 -0.515 . . . . 0.0 111.481 -179.578 . . . . . . . . 3 3 . 1 . 075 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.421 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 35.5 Cg_exo -57.68 140.98 95.28 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.509 2.139 . . . . 0.0 112.396 -179.881 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 72.1 t -137.43 137.83 45.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.181 -179.671 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 91.9 mtm-85 -74.29 132.02 41.7 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.713 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.562 HD11 ' HB2' ' A' ' 60' ' ' LEU . 97.8 mt -87.95 139.27 30.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.174 0.512 . . . . 0.0 111.852 -178.72 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -129.63 154.18 47.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.487 -179.43 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -57.0 120.69 8.4 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.84 0.353 . . . . 0.0 111.462 -179.29 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.15 -16.48 27.43 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.651 -0.58 . . . . 0.0 111.651 179.299 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -69.94 136.99 51.15 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.105 0.478 . . . . 0.0 110.276 179.812 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 53.3 t -111.88 132.07 61.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.169 -178.936 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.1 mt -99.1 130.94 47.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.559 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.5 m -122.82 126.41 47.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.293 0.568 . . . . 0.0 111.816 -178.387 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.488 ' O ' ' N ' ' A' ' 93' ' ' ARG . 96.2 mt -113.31 124.18 69.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.291 178.164 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.456 ' C ' ' O ' ' A' ' 90' ' ' ILE . 48.5 mm 35.03 -98.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.796 -179.533 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.578 ' OD2' ' NE ' ' B' ' 245' ' ' ARG . 85.3 m-20 -110.44 5.14 21.16 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -179.517 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.572 ' CZ ' ' O ' ' B' ' 259' ' ' ASP . 84.6 mtt-85 -120.39 145.48 47.13 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.943 -179.129 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.734 ' OG ' HD12 ' A' ' 10' ' ' ILE . 33.5 p -140.64 152.87 45.74 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.199 0.523 . . . . 0.0 111.196 179.789 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -123.95 123.17 39.81 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.841 179.592 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -80.6 129.19 34.37 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.287 -179.87 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.599 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 86.8 t80 -96.15 125.45 40.68 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.792 0.33 . . . . 0.0 111.267 -179.645 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -130.85 123.17 28.44 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 121.064 0.459 . . . . 0.0 111.532 -179.882 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -111.5 112.69 24.61 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.445 179.845 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 . . . . . 0 C--N 1.331 -0.212 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.743 -179.68 . . . . . . . . 0 0 . 1 . 075 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 3.5 p . . . . . 0 N--CA 1.455 -0.216 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 . . . . . . . . . 0 0 . 1 . 075 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -57.16 139.53 52.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.009 0.433 . . . . 0.0 110.889 -179.166 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 075 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -121.97 38.66 4.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.684 -179.604 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -119.28 -173.84 15.6 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 111.404 -0.679 . . . . 0.0 111.404 -179.715 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.87 155.57 68.17 Favored 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 123.021 2.481 . . . . 0.0 112.611 -179.913 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 075 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.52 172.91 15.21 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 122.748 2.299 . . . . 0.0 112.213 179.079 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.413 HG23 ' OD1' ' A' ' 67' ' ' ASN . 2.7 p -118.99 137.14 53.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.557 -179.729 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 3.0 t -68.87 127.55 33.52 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.514 -179.74 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . 0.494 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . 0.494 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 32.6 Cg_exo -59.72 -24.59 76.2 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.758 2.305 . . . . 0.0 112.446 -179.825 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 97.8 m -73.21 -44.89 58.96 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.271 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.424 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 86.5 t80 -57.88 -45.77 85.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.855 -179.493 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.53 ' CD2' ' OD1' ' A' ' 92' ' ' ASP . 97.2 mt -63.46 -41.08 98.63 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 120.746 -0.381 . . . . 0.0 110.466 -179.634 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -60.28 -42.89 96.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.351 -179.476 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -64.04 -39.9 95.13 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.353 -179.997 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.714 ' O ' HG23 ' B' ' 249' ' ' VAL . 57.9 ttm-85 -59.49 -44.13 93.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.862 -179.978 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -60.8 -42.95 98.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.039 0.447 . . . . 0.0 111.033 -179.472 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 67.8 p -69.68 -44.12 71.1 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.608 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . 0.602 ' O ' ' N ' ' B' ' 252' ' ' LEU . 66.3 tp60 -59.19 -39.2 81.85 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.474 179.758 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.714 HG23 ' O ' ' B' ' 245' ' ' ARG . 73.4 t -60.98 -46.42 96.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.495 179.682 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -62.57 -31.87 72.76 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.14 0.495 . . . . 0.0 109.899 179.331 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -91.02 -18.84 23.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.115 179.603 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.602 ' N ' ' O ' ' B' ' 248' ' ' GLN . 57.4 tp -70.64 135.89 48.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.014 0.435 . . . . 0.0 110.952 -179.169 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -99.22 136.24 39.46 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.414 -179.822 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -70.21 -22.0 62.96 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.866 -0.607 . . . . 0.0 109.756 178.691 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -66.01 -8.69 24.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.447 -179.419 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.649 ' O ' ' N ' ' B' ' 258' ' ' ASP . 42.5 p-10 -96.38 -7.99 33.62 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.343 179.667 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . 0.431 ' C ' ' O ' ' B' ' 256' ' ' ASP . 62.7 mttp 33.44 24.4 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.299 179.599 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.649 ' N ' ' O ' ' B' ' 256' ' ' ASP . 45.1 t0 -102.68 110.51 22.47 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.557 -179.582 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.572 ' O ' ' CZ ' ' A' ' 93' ' ' ARG . 50.8 p-10 -102.24 18.7 20.27 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.809 -179.079 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.482 ' OE1' HD21 ' A' ' 41' ' ' LEU . 99.4 mt-10 65.54 10.32 6.56 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 179.341 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 65.7 mt -111.74 134.97 52.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.915 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 42.2 t -125.35 132.76 70.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.909 0.385 . . . . 0.0 110.467 179.464 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -98.6 121.02 40.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.938 -178.648 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -69.21 -47.1 65.74 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.276 -179.368 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . 0.401 HE22 ' H ' ' A' ' 23' ' ' SER . 0.4 OUTLIER -67.31 165.69 26.67 Favored Pre-proline 0 N--CA 1.464 0.266 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.904 -179.237 . . . . . . . . 3 3 . 1 . 075 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -62.42 143.58 93.65 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.472 2.115 . . . . 0.0 111.603 179.217 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 19.8 tt . . . . . 0 N--CA 1.446 -0.649 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.056 -179.413 . . . . . . . . 0 0 . 1 . 076 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo . . . . . 0 N--CA 1.499 1.805 0 N-CA-C 111.705 -0.152 . . . . 0.0 111.705 . . . . . . . . . 0 0 . 1 . 076 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 95.9 m -74.31 -45.01 50.19 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.396 -0.521 . . . . 0.0 111.598 -179.597 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.6 mtt85 -93.63 125.69 38.39 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.538 -178.145 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -124.19 140.5 52.9 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.015 -179.4 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.643 HD11 ' HB3' ' A' ' 95' ' ' PHE . 38.0 tp -113.66 131.34 56.19 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.792 179.704 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.401 ' O ' HG23 ' A' ' 8' ' ' VAL . 19.2 m -110.55 130.73 63.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 121.13 0.491 . . . . 0.0 111.334 -179.393 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.1 m -78.45 141.97 37.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.297 -179.182 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.5 mm -109.97 136.43 45.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.033 177.296 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -91.42 154.77 18.93 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.435 179.54 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.477 ' CD ' ' OD2' ' A' ' 92' ' ' ASP . 89.1 mtm180 -54.56 -27.23 37.3 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.301 -179.684 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 91.8 p -80.48 -7.37 59.15 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.926 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.19 39.65 7.82 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 179.938 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.9 t -125.15 137.54 57.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -178.835 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -69.96 127.49 33.04 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.086 179.827 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -113.6 -127.51 4.6 Favored Glycine 0 CA--C 1.54 1.606 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 179.735 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -75.36 154.19 40.63 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 122.345 2.03 . . . . 0.0 112.311 -179.51 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 64.3 m170 -109.37 140.65 42.8 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.234 0.54 . . . . 0.0 111.888 -178.267 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.589 ' CD2' HD11 ' A' ' 37' ' ' ILE . 25.7 t80 -112.66 106.14 55.64 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.918 179.771 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -74.59 126.23 10.08 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 121.635 1.557 . . . . 0.0 111.563 -179.538 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.452 ' CD2' ' SG ' ' A' ' 27' ' ' CYS . 87.7 mt -82.8 52.66 2.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.899 0.38 . . . . 0.0 110.905 -179.263 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.6 t -64.66 -27.61 69.04 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.929 179.607 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.526 HD11 ' HG2' ' B' ' 265' ' ' GLN . 94.6 mt -79.11 142.96 35.97 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.705 179.568 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 44.0 t -63.67 -18.47 64.01 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 121.17 -0.212 . . . . 0.0 111.422 -179.341 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 40.7 m -131.13 131.6 44.23 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.867 -179.321 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.452 ' SG ' ' CD2' ' A' ' 22' ' ' LEU . 4.0 t -124.15 115.24 20.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.197 178.908 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.431 ' O ' ' N ' ' A' ' 36' ' ' ASP . 53.1 tp -112.26 122.79 48.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.162 0.506 . . . . 0.0 111.825 -178.849 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.765 ' CE2' HD12 ' A' ' 37' ' ' ILE . 5.4 m-85 -102.28 139.42 37.91 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.403 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 167.09 -171.56 41.9 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 118.699 -1.715 . . . . 0.0 113.513 179.304 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.563 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 36.7 ttp-105 -89.57 -31.54 17.54 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 114.549 -0.826 . . . . 0.0 109.377 179.585 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.46 151.62 39.48 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.767 -0.533 . . . . 0.0 111.767 -179.465 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.564 ' CD1' ' CZ ' ' A' ' 38' ' ' ARG . 39.5 mm -63.31 -44.41 99.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 121.106 0.479 . . . . 0.0 110.314 -179.965 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -52.95 -18.98 2.25 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.628 -179.208 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.55 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 78.6 m -62.78 128.19 34.77 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.247 -179.882 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 28' ' ' LEU . 62.2 m-20 -59.41 -31.3 69.14 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -179.56 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.765 HD12 ' CE2' ' A' ' 29' ' ' PHE . 93.3 mt -124.81 116.02 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.59 177.683 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.564 ' CZ ' ' CD1' ' A' ' 33' ' ' ILE . 83.7 mtp180 -99.25 137.63 37.5 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.928 -178.48 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.609 HD13 ' HE ' ' A' ' 93' ' ' ARG . 96.6 mt -119.82 129.02 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 121.335 0.588 . . . . 0.0 110.166 179.044 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -68.92 23.64 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.402 -178.156 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.787 HD12 ' CZ ' ' A' ' 93' ' ' ARG . 36.6 mt -106.0 129.68 24.2 Favored Pre-proline 0 C--N 1.324 -0.527 0 C-N-CA 120.015 -0.674 . . . . 0.0 111.247 -179.451 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.69 -10.4 25.04 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 C-N-CA 122.085 1.857 . . . . 0.0 112.589 179.714 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.495 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 5.2 m -91.55 1.42 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.213 179.183 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.563 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 51.4 t -90.83 136.01 25.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.03 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.3 m -71.78 168.34 18.03 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.492 0.663 . . . . 0.0 111.461 -178.783 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.55 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 97.9 mttt -60.15 -42.03 94.04 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.832 -1.077 . . . . 0.0 111.454 -179.257 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.665 ' O ' ' N ' ' A' ' 49' ' ' CYS . 87.2 mt-30 -116.29 -17.68 10.7 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 123.246 0.341 . . . . 0.0 110.976 179.789 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 31.6 t60 34.58 -74.81 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -179.691 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.665 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.29 137.44 46.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.326 0.584 . . . . 0.0 112.455 -178.831 . . . . . . . . 3 3 . 1 . 076 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -128.96 133.14 47.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.011 -179.749 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 88.2 mt -116.62 134.44 60.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.384 179.89 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -115.54 123.48 48.61 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 177.719 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 76.4 mt -103.75 114.11 42.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.287 -178.954 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.595 ' O ' ' N ' ' A' ' 56' ' ' GLN . 92.6 m-70 -111.8 141.75 45.02 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.007 179.233 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.48 ' OE1' ' N ' ' A' ' 55' ' ' GLU . 56.0 mp0 -39.47 -24.12 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.495 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.595 ' N ' ' O ' ' A' ' 54' ' ' HIS . 58.1 tt0 -67.95 -69.25 0.33 Allowed 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.177 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.732 ' CB ' ' HE ' ' A' ' 81' ' ' ARG . 2.8 tp10 -158.02 -163.11 1.25 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.334 179.914 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -115.98 125.42 52.48 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.012 -0.995 . . . . 0.0 108.531 178.347 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.4 mt -113.76 129.91 68.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.848 -178.413 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.43 HD11 ' SG ' ' A' ' 49' ' ' CYS . 50.5 tp -94.11 126.62 39.45 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.483 179.761 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -112.67 136.61 52.04 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.246 179.798 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -98.63 108.75 21.51 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.134 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -100.11 -11.24 20.67 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.432 179.473 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.1 t -69.64 103.35 2.09 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.596 179.106 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.0 p -84.51 -12.47 54.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.288 0.566 . . . . 0.0 109.548 178.856 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.19 -37.27 9.76 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.756 179.956 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.473 ' HB3' HD11 ' A' ' 91' ' ' ILE . 23.3 m-80 -144.18 90.27 6.79 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.847 179.741 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -56.23 146.33 72.3 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.21 1.94 . . . . 0.0 112.264 -179.862 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 56.8 m -73.32 144.02 46.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.159 179.913 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -102.97 141.04 36.44 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.694 179.639 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.8 t -130.34 134.67 62.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.553 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 53.71 34.73 19.58 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.27 -179.431 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.29 29.4 70.27 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.499 179.217 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.9 t -143.64 136.75 27.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 117.355 0.577 . . . . 0.0 110.783 179.314 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.8 p -70.72 139.96 19.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.692 -179.401 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.914 HD13 ' O ' ' A' ' 76' ' ' ILE . 0.0 OUTLIER -132.76 125.56 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.931 179.31 . . . . . . . . 3 3 . 1 . 076 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -97.73 -9.27 26.95 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.755 -179.382 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.84 ' O ' HD11 ' A' ' 76' ' ' ILE . 0.4 OUTLIER -125.19 170.33 9.42 Favored Pre-proline 0 N--CA 1.469 0.482 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.162 -179.431 . . . . . . . . 3 3 . 1 . 076 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -61.41 143.29 97.52 Favored 'Trans proline' 0 N--CA 1.501 1.915 0 C-N-CA 122.442 2.095 . . . . 0.0 113.271 -179.601 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 42.7 t -136.21 136.9 48.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.329 178.403 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.732 ' HE ' ' CB ' ' A' ' 57' ' ' GLU . 72.1 ttt180 -75.63 131.95 40.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.872 179.98 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 82' ' ' LEU . 96.6 mt -84.89 136.73 33.51 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.369 0.604 . . . . 0.0 112.417 -178.369 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -125.73 149.21 48.71 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.494 179.495 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.469 ' CG ' ' H ' ' A' ' 99' ' ' ASN . 5.3 t-160 -54.48 113.81 1.43 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.837 0.351 . . . . 0.0 110.989 -179.934 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.3 -15.67 25.06 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.018 178.938 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -68.3 137.22 54.5 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.099 -0.64 . . . . 0.0 109.403 179.534 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 23.3 t -110.04 134.26 52.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.868 -178.728 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 86.2 mt -103.76 129.42 55.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.1 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.9 m -116.36 129.35 56.2 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.515 -178.958 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.58 ' O ' ' N ' ' A' ' 93' ' ' ARG . 94.3 mt -119.65 128.85 75.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.53 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.531 HD13 ' HB3' ' B' ' 237' ' ' CYS . 94.5 mt -20.41 95.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -178.984 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.477 ' OD2' ' CD ' ' A' ' 12' ' ' ARG . 5.2 t0 90.07 -22.12 0.11 Allowed 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 177.985 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.787 ' CZ ' HD12 ' A' ' 41' ' ' LEU . 14.7 mtm-85 -130.58 145.84 51.97 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.235 -179.69 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.8 p -138.01 155.79 48.49 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.038 0.447 . . . . 0.0 110.781 -179.361 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.643 ' HB3' HD11 ' A' ' 7' ' ' LEU . 81.6 m-85 -131.65 129.44 40.81 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.643 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.49 ' O ' HD12 ' A' ' 7' ' ' LEU . 44.4 ttm180 -96.83 136.34 37.51 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 119.836 -0.745 . . . . 0.0 110.229 179.83 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -89.68 125.48 35.28 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.682 -179.724 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -125.65 127.3 46.07 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.5 -179.366 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.469 ' H ' ' CG ' ' A' ' 84' ' ' HIS . 55.5 t-20 -102.35 109.89 21.69 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.199 179.601 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 . . . . . 0 C--N 1.326 -0.419 0 CA-C-O 120.884 0.373 . . . . 0.0 110.433 179.989 . . . . . . . . 0 0 . 1 . 076 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 27.0 m . . . . . 0 N--CA 1.461 0.092 0 CA-C-O 120.943 0.401 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 076 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -82.31 -1.64 50.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.033 -179.117 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 076 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -141.34 18.94 2.23 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.868 179.832 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -131.27 -176.05 14.26 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 111.419 -0.672 . . . . 0.0 111.419 -179.666 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -71.94 164.56 35.28 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 123.432 2.755 . . . . 0.0 112.252 179.834 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.519 ' O2P' HG21 ' B' ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -70.08 169.89 18.24 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.055 1.837 . . . . 0.0 111.923 179.509 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 6.6 p -115.19 137.28 49.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.762 -179.893 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . 0.531 ' HB3' HD13 ' A' ' 91' ' ' ILE . 5.7 t -80.24 126.93 31.75 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 120.876 0.37 . . . . 0.0 110.958 -178.52 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . 0.476 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . 0.476 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 37.6 Cg_exo -58.44 -26.04 76.15 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.95 2.433 . . . . 0.0 112.292 -179.473 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 94.6 m -75.51 -42.75 51.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.043 0.449 . . . . 0.0 110.352 178.813 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.576 ' HZ ' HD22 ' A' ' 41' ' ' LEU . 60.2 t80 -57.54 -47.34 82.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.761 -179.832 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.437 HD21 HG23 ' A' ' 91' ' ' ILE . 90.1 mt -63.72 -41.19 98.1 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.086 0.47 . . . . 0.0 109.781 179.439 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -60.93 -41.31 95.95 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.873 179.789 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 73.6 ttt-85 -63.05 -43.23 99.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.668 -179.78 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.598 ' O ' HG23 ' B' ' 249' ' ' VAL . 24.0 mmt180 -59.9 -43.27 94.91 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.55 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.48 -41.93 98.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.818 179.215 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 11.8 t -65.73 -44.05 87.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.725 0.774 . . . . 0.0 108.957 179.512 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -60.89 -37.5 82.42 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.938 -179.447 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.598 HG23 ' O ' ' B' ' 245' ' ' ARG . 62.7 t -63.77 -46.1 95.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.614 179.647 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -61.38 -27.14 68.31 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.828 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -89.86 -10.84 43.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.574 179.24 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.463 ' O ' ' O ' ' B' ' 249' ' ' VAL . 40.3 tp -116.77 115.11 24.97 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.717 178.579 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . 0.507 ' C ' ' H ' ' B' ' 255' ' ' ASP . 5.4 m-80 -78.39 -159.74 0.18 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.414 0.626 . . . . 0.0 111.711 -179.228 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -49.69 -6.8 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.561 -178.887 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . 0.507 ' H ' ' C ' ' B' ' 253' ' ' ASN . 96.0 m-20 -63.41 -11.85 26.3 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.686 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.651 ' O ' ' N ' ' B' ' 258' ' ' ASP . 22.3 t70 -47.05 -28.89 1.86 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.348 179.474 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . 0.505 ' C ' ' O ' ' B' ' 256' ' ' ASP . 98.5 mttt -26.17 -35.16 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 O-C-N 123.353 0.408 . . . . 0.0 111.03 -179.137 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.651 ' N ' ' O ' ' B' ' 256' ' ' ASP . 44.1 p-10 -104.2 59.83 0.72 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 177.371 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.571 ' N ' ' O ' ' B' ' 256' ' ' ASP . 47.5 p30 -47.09 -115.71 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.592 -177.904 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.535 ' OE1' HD21 ' A' ' 41' ' ' LEU . 99.7 mt-10 -147.55 23.52 1.13 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.546 -179.648 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 65.9 mt -113.9 133.8 58.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.852 -179.856 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 43.5 t -126.91 134.23 66.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.508 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . 0.643 ' CD2' HG21 ' B' ' 267' ' ' ILE . 78.9 m-85 -97.38 123.65 41.28 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.137 0.494 . . . . 0.0 111.495 -178.255 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -64.07 -41.49 97.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.572 179.697 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . 0.526 ' HG2' HD11 ' A' ' 24' ' ' LEU . 0.6 OUTLIER -105.53 173.14 3.43 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.547 -178.956 . . . . . . . . 3 3 . 1 . 076 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -57.26 150.78 55.97 Favored 'Trans proline' 0 N--CA 1.502 1.973 0 C-N-CA 122.824 2.349 . . . . 0.0 114.219 -179.614 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . 0.643 HG21 ' CD2' ' B' ' 263' ' ' PHE . 41.4 pt . . . . . 0 C--O 1.232 0.16 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.501 179.823 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 N--CA 1.492 1.428 0 CA-C-O 120.903 0.293 . . . . 0.0 112.381 . . . . . . . . . 0 0 . 1 . 077 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.9 m -73.34 -44.72 58.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.663 -179.872 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.505 ' NH1' ' CG2' ' A' ' 53' ' ' ILE . 85.0 mtt85 -89.57 134.21 34.23 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.355 -178.549 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -134.82 144.3 47.53 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.292 179.982 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.69 HD11 HD11 ' A' ' 22' ' ' LEU . 85.1 mt -114.94 135.65 53.98 Favored 'General case' 0 C--N 1.334 -0.097 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.635 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 76.7 t -111.83 130.36 65.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.562 -0.455 . . . . 0.0 109.994 -179.363 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.1 m -80.3 140.24 36.25 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -178.132 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.519 HD12 ' HB3' ' A' ' 94' ' ' SER . 96.6 mt -106.13 132.47 53.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 176.673 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.661 ' C ' HH22 ' A' ' 93' ' ' ARG . 97.3 mttt -86.25 154.2 21.45 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.189 0.518 . . . . 0.0 109.729 179.134 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.648 ' N ' HH22 ' A' ' 93' ' ' ARG . 84.9 mtp180 -56.15 -28.8 59.39 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.186 -179.263 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 86.1 p -80.7 -8.83 59.77 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.641 179.747 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.55 33.17 8.72 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.721 -0.551 . . . . 0.0 111.721 179.367 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 54.3 t -119.82 135.33 60.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.784 0.326 . . . . 0.0 110.414 179.818 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -65.03 125.99 26.65 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.776 179.81 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -111.19 -133.33 6.26 Favored Glycine 0 CA--C 1.539 1.575 0 C-N-CA 120.722 -0.752 . . . . 0.0 111.942 -179.184 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.85 151.88 40.86 Favored 'Trans proline' 0 N--CA 1.499 1.827 0 C-N-CA 122.571 2.181 . . . . 0.0 113.037 -178.624 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.594 ' H ' ' CD2' ' A' ' 19' ' ' HIS . 0.1 OUTLIER -106.02 147.87 28.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.363 179.508 . . . . . . . . 3 3 . 1 . 077 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.632 ' CD2' HD11 ' A' ' 37' ' ' ILE . 35.2 t80 -117.26 95.24 46.96 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.353 -179.571 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -64.15 127.32 19.01 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 122.613 2.209 . . . . 0.0 111.96 -179.468 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.69 HD11 HD11 ' A' ' 7' ' ' LEU . 93.3 mt -85.61 83.33 7.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.086 0.469 . . . . 0.0 111.357 -179.485 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 92.2 p -88.17 -14.17 39.3 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.488 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.651 HD11 ' HG2' ' B' ' 265' ' ' GLN . 66.9 mt -95.52 138.39 33.26 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.091 -179.688 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 27.5 t -64.37 -17.67 63.94 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.058 -179.742 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 46.8 m -128.67 129.53 45.94 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.563 179.582 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.9 t -121.38 115.63 23.29 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.128 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.404 ' O ' ' N ' ' A' ' 36' ' ' ASP . 53.9 tp -113.38 122.02 46.11 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.466 -178.857 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.816 ' CE2' HD12 ' A' ' 37' ' ' ILE . 18.3 m-85 -100.07 141.34 33.03 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.455 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 169.35 -161.08 34.56 Favored Glycine 0 C--O 1.226 -0.392 0 C-N-CA 119.541 -1.314 . . . . 0.0 112.467 179.238 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 29.5 ttp85 -108.0 -9.84 15.59 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -178.372 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -89.21 170.62 37.66 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.798 -178.714 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.469 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.7 tp -66.88 -41.45 87.66 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 O-C-N 122.759 -0.259 . . . . 0.0 110.562 179.861 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.469 ' N ' HG23 ' A' ' 33' ' ' ILE . 72.3 mm-40 -54.27 -26.66 30.3 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.055 0.455 . . . . 0.0 110.721 -179.19 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.548 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 79.2 m -64.2 121.31 13.92 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.485 -179.982 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 28' ' ' LEU . 87.4 m-20 -59.7 -28.2 67.09 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.342 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.816 HD12 ' CE2' ' A' ' 29' ' ' PHE . 89.4 mt -127.08 123.04 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.175 177.726 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 -104.24 136.05 44.57 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.242 -179.595 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.443 ' C ' ' H ' ' A' ' 41' ' ' LEU . 97.4 mt -117.5 128.93 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.912 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -72.39 34.0 0.06 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.244 -178.199 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.531 ' CD2' ' CZ ' ' B' ' 245' ' ' ARG . 32.2 mt -102.87 126.5 32.43 Favored Pre-proline 0 C--N 1.322 -0.624 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.428 179.339 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -73.03 -7.12 20.17 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.147 1.898 . . . . 0.0 112.655 -179.418 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.7 m -102.99 13.23 7.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.499 179.394 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 29.1 t -99.76 133.26 43.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.172 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 33.2 t -72.49 175.05 6.61 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.439 0.638 . . . . 0.0 112.538 -178.329 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.548 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 61.0 mttp -65.18 -40.64 94.54 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.797 -179.455 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.659 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.1 mt-30 -112.86 -18.06 12.36 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.211 -179.853 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 23.9 t60 32.73 -74.48 0.0 OUTLIER 'General case' 0 C--O 1.236 0.357 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 179.882 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.659 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.48 134.0 46.73 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.998 0.428 . . . . 0.0 111.594 -179.578 . . . . . . . . 3 3 . 1 . 077 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -125.77 130.36 51.29 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.465 179.183 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.6 mt -117.43 134.01 62.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.226 179.611 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -114.52 131.03 56.79 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.396 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.505 ' CG2' ' NH1' ' A' ' 5' ' ' ARG . 48.3 mm -99.45 120.29 48.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.46 -178.449 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.462 ' O ' ' C ' ' A' ' 55' ' ' GLU . 94.0 m-70 -119.73 132.36 55.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.262 179.103 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.462 ' C ' ' O ' ' A' ' 54' ' ' HIS . 98.4 mt-10 -40.31 -37.17 0.62 Allowed 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.728 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.456 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 84.3 mt-30 -62.76 -67.25 0.44 Allowed 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.379 179.028 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.457 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 6.1 tp10 -151.03 -166.62 2.58 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.2 -179.039 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.457 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -125.48 135.71 52.59 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 -179.957 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.9 mt -119.04 131.49 71.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -178.311 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.431 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 32.7 tp -97.94 125.93 43.09 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 114.827 -1.079 . . . . 0.0 108.846 178.471 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -112.71 136.79 51.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.743 -179.058 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 26.0 t30 -96.31 105.61 17.7 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.788 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.422 ' CD2' ' OE1' ' A' ' 47' ' ' GLN . 27.0 m-85 -96.48 -9.21 30.21 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.066 178.613 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.515 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 42.2 t -73.83 100.22 3.41 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.477 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.9 m -83.18 -16.61 45.94 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.383 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.464 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.3 OUTLIER -87.42 -38.95 15.68 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.252 -179.782 . . . . . . . . 3 3 . 1 . 077 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.515 ' O ' ' OG ' ' A' ' 64' ' ' SER . 77.4 m-20 -146.62 98.73 4.17 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.343 -179.86 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.38 147.78 55.09 Favored 'Trans proline' 0 N--CA 1.501 1.961 0 C-N-CA 122.392 2.062 . . . . 0.0 113.688 -179.423 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 89.1 m -71.41 136.09 47.55 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.695 179.1 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -98.88 140.89 32.38 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.642 -179.722 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.455 ' CG1' ' OD1' ' A' ' 86' ' ' ASP . 71.5 t -129.43 134.71 63.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.07 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 51.28 34.78 12.17 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.604 -0.838 . . . . 0.0 109.655 -179.773 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.23 30.11 69.78 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.933 179.64 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.6 p -142.22 133.7 26.59 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.469 -179.693 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -67.6 142.37 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.309 -179.964 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.465 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 2.9 pt -119.02 121.27 66.39 Favored 'Isoleucine or valine' 0 C--N 1.343 0.285 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.109 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -87.2 -24.09 24.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.401 -179.894 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -127.04 172.98 5.81 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.907 -179.585 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.51 144.1 99.5 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 122.434 2.09 . . . . 0.0 112.58 179.514 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.7 t -132.16 138.57 52.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.737 178.922 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -73.31 131.17 41.6 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.442 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 97.3 mt -84.26 135.49 34.31 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.079 0.466 . . . . 0.0 111.536 -179.912 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -127.12 149.58 49.88 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.811 179.796 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.438 ' ND1' ' N ' ' A' ' 99' ' ' ASN . 6.7 t60 -55.6 116.63 3.01 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.423 179.819 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.1 -18.77 23.45 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 -179.416 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.455 ' OD1' ' CG1' ' A' ' 71' ' ' VAL . 36.4 t70 -66.81 132.28 47.71 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.535 0.207 . . . . 0.0 110.449 179.151 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.611 HG22 ' HG2' ' A' ' 96' ' ' ARG . 53.4 t -106.86 132.19 54.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.194 -178.927 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 80.0 mt -101.33 129.79 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 177.914 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.3 m -120.42 126.09 49.58 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.531 0.681 . . . . 0.0 112.353 -178.875 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.599 ' O ' ' N ' ' A' ' 93' ' ' ARG . 91.7 mt -113.18 133.26 59.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 177.746 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.526 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 68.0 mt -30.9 102.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 O-C-N 123.112 0.257 . . . . 0.0 111.66 -178.759 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 4.8 t70 87.67 -22.18 0.15 Allowed 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 178.743 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.661 HH22 ' C ' ' A' ' 11' ' ' LYS . 2.0 mmp_? -127.73 139.62 52.57 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.564 -179.337 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.519 ' HB3' HD12 ' A' ' 10' ' ' ILE . 34.7 t -141.1 148.66 40.48 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.929 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.421 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 82.4 m-85 -129.19 130.47 46.38 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.397 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.611 ' HG2' HG22 ' A' ' 87' ' ' VAL . 99.9 mtt180 -89.03 134.36 34.02 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.325 -179.488 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.506 ' CZ ' ' OD1' ' A' ' 99' ' ' ASN . 91.1 t80 -94.45 124.52 38.53 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.142 -179.991 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -139.2 123.96 18.58 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.513 -179.173 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.506 ' OD1' ' CZ ' ' A' ' 97' ' ' TYR . 79.5 m-20 -87.96 134.33 33.75 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.621 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 . . . . . 0 N--CA 1.463 0.189 0 CA-C-O 120.749 0.309 . . . . 0.0 110.505 -179.701 . . . . . . . . 0 0 . 1 . 077 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 CA--C 1.534 0.339 0 CA-C-O 120.663 0.268 . . . . 0.0 111.224 . . . . . . . . . 0 0 . 1 . 077 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.552 ' C ' ' H ' ' B' ' 231' ' ' GLN . 93.0 m-20 -72.67 142.14 48.26 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.766 0.317 . . . . 0.0 111.65 -179.428 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 077 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.552 ' H ' ' C ' ' B' ' 229' ' ' ASP . 72.4 mt-30 -130.73 50.89 2.17 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.34 -178.969 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -120.7 -171.75 14.46 Favored Glycine 0 CA--C 1.537 1.451 0 N-CA-C 111.843 -0.503 . . . . 0.0 111.843 -179.341 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.74 162.74 41.13 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 123.613 2.876 . . . . 0.0 113.25 -179.793 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.464 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -77.79 146.5 23.68 Favored 'Trans proline' 0 C--N 1.315 -1.205 0 C-N-CA 121.736 1.624 . . . . 0.0 112.909 -178.792 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 25.0 t -60.05 138.64 20.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.766 -179.808 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . 0.506 ' HB2' HD13 ' A' ' 91' ' ' ILE . 4.1 t -71.63 129.3 38.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.562 -179.659 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . 0.457 ' O2P' HG23 ' B' ' 240' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . 0.425 ' HD2' ' P ' ' B' ' 238' ' ' TPO . 41.0 Cg_exo -54.18 -24.14 32.4 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 122.415 2.076 . . . . 0.0 113.576 179.909 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . 0.457 HG23 ' O2P' ' B' ' 238' ' ' TPO . 17.2 p -73.54 -41.25 63.25 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 119.836 -0.746 . . . . 0.0 109.268 177.981 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.505 ' CZ ' ' NE ' ' B' ' 245' ' ' ARG . 75.7 t80 -56.86 -47.37 80.56 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.752 -179.415 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.42 ' HA ' HD23 ' B' ' 242' ' ' LEU . 90.7 mt -67.08 -40.14 86.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.515 179.172 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -63.4 -43.06 98.6 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.399 -178.653 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -61.72 -42.57 99.12 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.093 0.473 . . . . 0.0 110.637 179.69 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.531 ' CZ ' ' CD2' ' A' ' 41' ' ' LEU . 95.6 mtt-85 -64.0 -39.05 93.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.12 -179.637 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.02 -39.01 93.46 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.061 179.495 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 32.8 t -67.55 -42.18 83.08 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.22 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . 0.531 ' O ' ' N ' ' B' ' 252' ' ' LEU . 61.7 tt0 -58.24 -36.77 73.71 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.903 179.205 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' B' ' 252' ' ' LEU . 41.3 t -64.31 -45.26 96.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.501 179.259 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -58.65 -27.98 65.26 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.024 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -100.58 -9.41 22.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.741 178.999 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.531 ' N ' ' O ' ' B' ' 248' ' ' GLN . 42.7 tp -124.0 125.38 44.47 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.63 179.896 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . 0.665 ' O ' ' N ' ' B' ' 255' ' ' ASP . 0.2 OUTLIER -159.4 -80.47 0.05 Allowed 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.286 . . . . . . . . 3 3 . 1 . 077 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . 0.476 ' O ' ' C ' ' B' ' 255' ' ' ASP . 91.8 m-20 -31.81 -25.94 0.0 OUTLIER 'General case' 0 C--O 1.231 0.114 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.051 -178.521 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . 0.665 ' N ' ' O ' ' B' ' 253' ' ' ASN . 34.8 t70 -32.5 -38.96 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 110.425 -0.213 . . . . 0.0 110.425 -179.795 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.586 ' CB ' ' O ' ' B' ' 255' ' ' ASP . 26.7 t0 98.2 -133.55 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 O-C-N 124.105 0.878 . . . . 0.0 111.115 178.976 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . 0.404 ' H ' ' CG ' ' B' ' 256' ' ' ASP . 98.9 mttt -88.46 -165.34 1.3 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.745 -179.46 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 61.58 51.43 4.04 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -178.529 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -83.08 73.19 10.08 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.757 -178.915 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 60.23 13.1 3.69 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 178.117 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.421 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 64.6 mt -119.26 132.35 69.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.398 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 56.1 t -126.9 135.9 62.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.366 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . 0.695 ' CD2' HG21 ' B' ' 267' ' ' ILE . 69.4 m-85 -99.32 120.22 39.21 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.901 -177.885 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -65.48 -43.48 90.09 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.571 0.701 . . . . 0.0 109.916 179.451 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . 0.651 ' HG2' HD11 ' A' ' 24' ' ' LEU . 2.5 mp0 -100.78 172.6 4.36 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.255 -178.951 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.0 150.05 66.85 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 121.985 1.79 . . . . 0.0 112.599 179.742 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . 0.695 HG21 ' CD2' ' B' ' 263' ' ' PHE . 42.5 pt . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.741 178.996 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo . . . . . 0 N--CA 1.489 1.232 0 N-CA-C 110.952 -0.441 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 078 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 46.1 m -101.76 -47.28 4.66 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.78 -179.043 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.574 ' NH1' HG23 ' A' ' 53' ' ' ILE . 99.1 mtt180 -99.79 127.03 45.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.517 -179.016 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.842 ' HE ' ' CE1' ' A' ' 19' ' ' HIS . 83.2 mtp180 -129.3 148.67 51.25 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.877 -179.075 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.432 HD11 HD11 ' A' ' 22' ' ' LEU . 99.6 mt -112.87 142.23 45.77 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.557 178.872 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.543 HG11 HH21 ' A' ' 96' ' ' ARG . 72.8 t -116.24 128.38 73.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.59 -0.444 . . . . 0.0 109.996 179.855 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 m -81.57 141.09 34.06 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.456 0.646 . . . . 0.0 112.674 -178.293 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.465 HD12 ' HB2' ' A' ' 94' ' ' SER . 83.1 mt -113.93 135.93 52.02 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.056 178.133 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.6 mttp -86.91 158.29 19.34 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.101 178.792 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.629 ' CD ' HH21 ' B' ' 245' ' ' ARG . 89.3 mtm180 -58.75 -27.46 64.98 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.193 -179.86 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 99.0 p -83.56 -8.87 59.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.825 179.771 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.43 37.73 6.49 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.863 179.819 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.1 t -118.76 131.3 71.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-O 120.835 0.35 . . . . 0.0 111.11 179.811 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -75.72 124.34 27.1 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.671 179.83 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -113.41 -122.52 3.88 Favored Glycine 0 CA--C 1.543 1.806 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.721 -179.84 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -76.4 155.54 36.58 Favored 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 123.043 2.495 . . . . 0.0 112.267 -178.702 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.842 ' CE1' ' HE ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -117.67 149.28 40.98 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.829 . . . . . . . . 3 3 . 1 . 078 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.47 ' CD2' HD11 ' A' ' 37' ' ' ILE . 37.7 t80 -115.5 100.49 53.64 Favored Pre-proline 0 N--CA 1.468 0.438 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.748 -177.658 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.406 ' HG3' ' NE2' ' A' ' 19' ' ' HIS . 3.0 Cg_exo -65.04 129.96 24.47 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 121.367 1.378 . . . . 0.0 111.557 179.48 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.432 HD11 HD11 ' A' ' 7' ' ' LEU . 90.6 mt -83.85 71.32 10.47 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.834 -179.896 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 80.6 p -78.66 -15.27 58.69 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.754 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.574 HD11 ' HG2' ' B' ' 265' ' ' GLN . 80.3 mt -93.64 140.78 29.23 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.211 -179.866 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 80.4 p -66.64 -17.51 64.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.959 -179.72 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.484 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 94.9 m -130.7 132.77 45.57 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.907 179.69 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.8 t -125.26 116.65 22.31 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.015 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 44.1 tp -114.16 129.02 56.63 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 121.169 -0.213 . . . . 0.0 111.181 -178.506 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.675 ' CE2' HD12 ' A' ' 37' ' ' ILE . 13.9 m-85 -109.25 140.8 42.43 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.285 179.649 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 156.78 -178.35 33.26 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 119.932 -1.128 . . . . 0.0 112.069 178.603 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.6 ' NH2' ' O ' ' B' ' 233' ' ' PRO . 43.7 mtm180 -74.72 -27.12 60.24 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.457 178.773 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.465 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -57.58 148.38 34.61 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.406 -177.771 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.466 HG23 ' N ' ' A' ' 34' ' ' GLU . 11.1 tp -66.9 -41.47 87.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.097 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.466 ' N ' HG23 ' A' ' 33' ' ' ILE . 92.8 mt-10 -52.49 -21.82 4.16 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.744 178.767 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.465 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 13.8 m -64.85 120.73 13.07 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.597 -179.492 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.484 ' OD2' ' O ' ' A' ' 26' ' ' THR . 99.4 m-20 -54.89 -25.21 27.43 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.316 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.675 HD12 ' CE2' ' A' ' 29' ' ' PHE . 96.8 mt -130.73 124.78 57.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.229 176.837 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 40.4 ttp180 -115.73 139.24 50.34 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.973 -179.386 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.453 HG12 HG23 ' B' ' 261' ' ' ILE . 89.2 mt -117.88 133.47 64.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.704 -178.927 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -73.49 20.38 0.09 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.106 -178.527 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' A' ' 41' ' ' LEU . 30.3 mt -91.2 128.41 47.47 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.924 179.488 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.14 -6.55 19.12 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 122.757 2.305 . . . . 0.0 113.143 -179.118 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.599 HG21 ' CE2' ' B' ' 241' ' ' PHE . 27.2 m -105.23 4.9 10.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.91 179.615 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.518 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 19.8 t -85.91 133.16 30.29 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.931 178.853 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.3 m -64.27 157.96 24.6 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.199 -179.496 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.411 ' HG2' ' H ' ' A' ' 47' ' ' GLN . 10.4 ptmt -60.71 -46.34 90.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.476 -178.815 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.695 ' O ' ' N ' ' A' ' 49' ' ' CYS . 78.6 mt-30 -113.39 -12.31 13.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.553 179.578 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.403 ' CE1' ' HG ' ' A' ' 64' ' ' SER . 24.1 t60 28.36 -70.27 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 179.712 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.695 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -146.67 149.57 33.72 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.699 0.762 . . . . 0.0 112.522 -179.064 . . . . . . . . 3 3 . 1 . 078 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -139.07 131.12 27.94 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.517 -1.22 . . . . 0.0 111.237 179.945 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.6 mt -106.41 135.25 45.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.796 179.875 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -112.76 135.72 53.18 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.062 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.574 HG23 ' NH1' ' A' ' 5' ' ' ARG . 38.8 mm -101.08 124.8 54.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 119.744 -0.782 . . . . 0.0 110.877 -179.646 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.437 ' O ' ' N ' ' A' ' 56' ' ' GLN . 95.6 m-70 -128.45 133.42 48.52 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.41 178.902 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 54' ' ' HIS . 97.8 mt-10 -39.97 -29.98 0.08 Allowed 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 120.492 -0.483 . . . . 0.0 109.761 -179.154 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.437 ' N ' ' O ' ' A' ' 54' ' ' HIS . 69.8 tp60 -64.91 -67.37 0.44 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.041 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.442 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 9.6 tp10 -155.3 -152.05 0.38 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.92 -179.572 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.458 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -127.74 134.72 49.53 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.576 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.1 mt -120.99 132.71 69.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.027 -0.669 . . . . 0.0 112.306 -178.274 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.404 ' HB2' HD21 ' A' ' 82' ' ' LEU . 21.1 tp -101.57 128.05 48.01 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.897 -179.558 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -110.95 136.85 49.35 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.733 -179.973 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -97.09 107.69 20.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.206 0.527 . . . . 0.0 111.745 -179.813 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -98.9 -10.29 23.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.2 179.676 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.403 ' HG ' ' CE1' ' A' ' 48' ' ' HIS . 0.3 OUTLIER -78.09 101.66 7.09 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.28 -179.179 . . . . . . . . 3 3 . 1 . 078 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.7 m -83.15 -43.41 16.22 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.187 0.518 . . . . 0.0 110.363 178.958 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.59 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -61.49 -46.83 88.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.858 -179.042 . . . . . . . . 3 3 . 1 . 078 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.435 HD21 ' HA ' ' B' ' 236' ' ' VAL . 64.7 m-80 -133.52 93.81 20.77 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.617 -179.724 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.559 ' HB2' HG13 ' A' ' 75' ' ' VAL . 53.1 Cg_exo -52.11 140.3 50.8 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.222 1.948 . . . . 0.0 112.819 -179.325 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.499 ' HB ' HD11 ' A' ' 76' ' ' ILE . 8.1 m -69.79 146.25 51.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.622 179.281 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.504 ' OE1' HG22 ' A' ' 75' ' ' VAL . 81.5 mm-40 -109.7 141.5 42.2 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.121 -179.765 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.451 ' O ' ' N ' ' A' ' 74' ' ' SER . 3.6 p -129.94 135.55 60.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.901 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 49.13 31.5 3.53 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -179.043 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.04 29.12 65.26 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.638 -179.429 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.451 ' N ' ' O ' ' A' ' 71' ' ' VAL . 22.3 m -139.61 139.46 36.75 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 120.454 -0.498 . . . . 0.0 112.046 179.99 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.559 HG13 ' HB2' ' A' ' 68' ' ' PRO . 58.7 t -61.14 137.37 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.018 -179.706 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.499 HD11 ' HB ' ' A' ' 69' ' ' THR . 1.4 pt -117.34 72.53 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 120.661 -0.415 . . . . 0.0 109.927 178.498 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.486 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 21.3 p-10 -61.59 -27.6 68.76 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.689 179.974 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -112.89 159.48 34.37 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.431 178.979 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.84 144.42 88.49 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.014 1.809 . . . . 0.0 112.329 179.776 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 51.4 t -131.84 138.89 51.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.88 -179.57 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -73.82 130.87 40.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.296 179.447 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.404 HD21 ' HB2' ' A' ' 60' ' ' LEU . 96.8 mt -80.85 135.48 35.94 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.592 0.711 . . . . 0.0 111.569 -178.97 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -128.11 151.15 49.54 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.955 179.028 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.607 ' CE1' ' H ' ' A' ' 99' ' ' ASN . 7.0 t60 -55.03 117.25 3.29 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.938 -178.847 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 113.32 -15.18 22.83 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.089 179.4 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -70.0 133.31 47.1 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 117.139 0.47 . . . . 0.0 110.7 -179.921 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.5 p -108.91 137.31 41.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.674 -179.469 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 88.2 mt -104.96 129.81 57.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 177.908 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.5 m -121.42 129.34 52.94 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -177.45 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.414 ' N ' ' O ' ' A' ' 93' ' ' ARG . 89.2 mt -116.63 122.95 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 114.306 -1.315 . . . . 0.0 109.151 178.335 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.49 HD12 ' CB ' ' B' ' 237' ' ' CYS . 38.8 mm 40.05 -98.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.064 -179.562 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -117.68 17.0 14.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.213 0.53 . . . . 0.0 109.978 -179.787 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.414 ' O ' ' N ' ' A' ' 90' ' ' ILE . 39.3 ttm180 -130.26 144.05 51.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.176 -179.671 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.465 ' HB2' HD12 ' A' ' 10' ' ' ILE . 36.7 m -140.62 158.9 43.3 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.793 0.806 . . . . 0.0 111.855 -179.494 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -128.35 123.24 33.42 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.304 179.434 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.543 HH21 HG11 ' A' ' 8' ' ' VAL . 95.2 mtm-85 -86.24 135.59 33.5 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.957 -179.407 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -93.33 122.8 36.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.826 178.745 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.4 ' HG3' ' CE1' ' A' ' 84' ' ' HIS . 80.4 tt0 -125.72 126.29 44.38 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.252 -178.907 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.607 ' H ' ' CE1' ' A' ' 84' ' ' HIS . 28.9 t-20 -109.02 107.35 17.67 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.725 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 . . . . . 0 C--N 1.323 -0.552 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.671 -179.044 . . . . . . . . 0 0 . 1 . 078 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 54.4 t . . . . . 0 N--CA 1.465 0.32 0 CA-C-O 120.958 0.409 . . . . 0.0 110.763 . . . . . . . . . 0 0 . 1 . 078 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.496 ' O ' ' CB ' ' B' ' 230' ' ' SEP . 47.5 p30 -98.8 176.16 5.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.557 -179.091 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . 0.496 ' CB ' ' O ' ' B' ' 229' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 62.0 56.47 2.3 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 121.096 0.474 . . . . 0.0 110.218 -179.33 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -98.53 -173.16 32.26 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 179.929 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . 0.6 ' O ' ' NH2' ' A' ' 31' ' ' ARG . 57.6 Cg_endo -67.83 154.6 72.6 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.559 2.172 . . . . 0.0 112.468 -179.394 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.472 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.44 142.65 54.93 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 121.948 1.765 . . . . 0.0 111.937 179.646 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.59 ' CG2' HG22 ' A' ' 66' ' ' THR . 52.5 t -77.95 131.86 33.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.215 -178.545 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . 0.49 ' CB ' HD12 ' A' ' 91' ' ' ILE . 2.5 t -75.66 127.43 33.05 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.99 179.224 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . 0.435 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . 0.435 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 32.1 Cg_exo -59.41 -25.46 78.61 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.503 2.136 . . . . 0.0 112.471 -179.566 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . 0.422 ' OG1' ' O3P' ' B' ' 238' ' ' TPO . 27.5 m -72.74 -46.02 55.64 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.296 178.545 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.599 ' CE2' HG21 ' A' ' 43' ' ' VAL . 71.6 t80 -58.21 -45.7 87.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.743 -179.243 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 88.9 mt -64.35 -42.53 96.18 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 120.829 0.347 . . . . 0.0 111.003 179.345 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -62.9 -43.23 99.35 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.289 -178.68 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 87.8 mtm180 -63.29 -42.03 99.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.986 0.422 . . . . 0.0 110.631 -179.005 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.629 HH21 ' CD ' ' A' ' 12' ' ' ARG . 75.9 mtp180 -61.52 -42.07 98.27 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.255 179.955 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -64.56 -40.2 95.13 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.379 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 15.3 t -65.56 -44.96 85.16 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.558 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' B' ' 252' ' ' LEU . 5.7 tp-100 -60.21 -37.89 81.67 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.025 -179.945 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.438 HG23 ' O ' ' B' ' 245' ' ' ARG . 37.4 t -62.87 -43.67 99.06 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-O 120.811 0.338 . . . . 0.0 110.52 178.93 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -62.07 -34.48 76.36 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.147 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -91.37 -9.2 45.69 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.754 179.046 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.593 HD11 ' OD2' ' B' ' 256' ' ' ASP . 48.8 tp -72.78 131.06 41.83 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.985 0.421 . . . . 0.0 110.946 -179.518 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . 0.467 ' C ' ' H ' ' B' ' 255' ' ' ASP . 71.6 m-20 -95.67 154.96 16.95 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.466 179.255 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -56.39 -7.38 0.38 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.133 0.492 . . . . 0.0 109.976 179.389 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . 0.467 ' H ' ' C ' ' B' ' 253' ' ' ASN . 99.3 m-20 -63.91 -19.33 65.01 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.213 -179.863 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.593 ' OD2' HD11 ' B' ' 252' ' ' LEU . 94.5 m-20 -102.94 32.29 3.77 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.082 179.886 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -65.68 -6.63 12.01 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.467 179.022 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.566 ' O ' ' CG ' ' B' ' 259' ' ' ASP . 50.8 m-20 -63.29 -41.84 99.02 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.861 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.664 ' CG ' ' H ' ' B' ' 261' ' ' ILE . 11.0 p-10 106.03 -158.02 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.622 0 C-N-CA 124.242 1.017 . . . . 0.0 110.145 179.112 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.552 ' OE2' ' CZ ' ' A' ' 12' ' ' ARG . 98.3 mt-10 -138.15 10.65 2.8 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 114.034 -1.439 . . . . 0.0 107.661 178.842 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.664 ' H ' ' CG ' ' B' ' 259' ' ' ASP . 2.8 mt -116.0 140.84 36.02 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.537 -179.795 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 62.3 t -127.81 136.21 60.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.376 179.354 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . 0.691 ' CD2' HG21 ' B' ' 267' ' ' ILE . 68.3 m-85 -99.59 124.64 44.98 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.395 0.616 . . . . 0.0 111.615 -178.271 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -62.09 -40.79 97.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.744 179.572 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . 0.574 ' HG2' HD11 ' A' ' 24' ' ' LEU . 0.8 OUTLIER -107.05 173.6 3.02 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 114.838 -1.073 . . . . 0.0 110.232 -179.336 . . . . . . . . 3 3 . 1 . 078 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.77 150.45 62.38 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 122.63 2.22 . . . . 0.0 113.535 -179.63 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . 0.691 HG21 ' CD2' ' B' ' 263' ' ' PHE . 41.1 pt . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.813 179.576 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo . . . . . 0 N--CA 1.495 1.569 0 CA-C-O 120.647 0.186 . . . . 0.0 112.138 . . . . . . . . . 0 0 . 1 . 079 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.2 t -142.39 36.55 1.5 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.186 0.517 . . . . 0.0 110.397 179.305 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.702 HH12 HG23 ' A' ' 53' ' ' ILE . 99.9 mtt180 -88.7 139.08 30.83 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.506 -179.822 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.7 mtm180 -130.97 136.21 48.34 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.429 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.921 HD11 HD11 ' A' ' 22' ' ' LEU . 83.3 mt -112.47 138.9 48.56 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-O 120.778 0.323 . . . . 0.0 110.624 179.515 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 43.5 t -112.34 128.36 69.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.25 178.988 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.576 HG21 ' HZ ' ' B' ' 263' ' ' PHE . 74.8 p -83.14 138.94 33.46 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.49 0.662 . . . . 0.0 112.023 -178.815 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.0 mm -105.66 134.07 48.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.656 179.38 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.4 mttt -86.79 153.86 21.36 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.054 178.266 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 91.8 mtm180 -57.22 -25.87 59.77 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.446 -0.502 . . . . 0.0 109.968 -179.556 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.1 m -79.48 -10.48 59.81 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.771 179.158 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.64 40.09 7.9 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.066 -1.213 . . . . 0.0 110.066 -178.946 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.8 t -120.48 131.08 73.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 114.996 -0.602 . . . . 0.0 109.894 -179.992 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -71.38 125.24 26.49 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.18 179.679 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -120.64 -120.85 2.8 Favored Glycine 0 CA--C 1.54 1.643 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.214 -179.23 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.87 145.26 40.18 Favored 'Trans proline' 0 N--CA 1.503 2.087 0 C-N-CA 122.848 2.365 . . . . 0.0 114.307 -177.769 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -110.65 129.17 55.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.011 -179.784 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.645 ' CD2' HD11 ' A' ' 37' ' ' ILE . 47.8 t80 -100.1 102.38 17.71 Favored Pre-proline 0 N--CA 1.465 0.323 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.817 -179.995 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -78.21 139.09 16.57 Favored 'Trans proline' 0 C--N 1.314 -1.242 0 C-N-CA 121.608 1.538 . . . . 0.0 111.957 -179.45 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.921 HD11 HD11 ' A' ' 7' ' ' LEU . 87.8 mt -101.39 130.26 47.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.255 0.55 . . . . 0.0 111.498 -179.109 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 45.1 p -139.54 4.03 2.14 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.875 177.725 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.1 mt -107.35 151.25 25.75 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.332 -179.654 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 m -62.93 -24.29 67.79 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.369 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 87.1 m -133.97 135.42 43.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.428 0.632 . . . . 0.0 111.948 -179.483 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.595 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 3.1 t -126.19 117.19 22.58 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 177.769 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.736 HD13 ' HD3' ' A' ' 50' ' ' LYS . 49.2 tp -115.41 131.31 56.97 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.807 -176.842 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.765 ' CE2' HD12 ' A' ' 37' ' ' ILE . 11.2 m-85 -107.44 128.48 54.52 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.719 -179.913 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 165.01 -176.18 40.8 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 119.918 -1.134 . . . . 0.0 113.549 178.14 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 48.6 mtm180 -74.67 -31.91 62.07 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.746 0.308 . . . . 0.0 110.63 179.129 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.526 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -51.14 145.45 11.68 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.033 -178.568 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.417 HD13 ' HA ' ' A' ' 33' ' ' ILE . 32.4 mm -65.78 -43.87 93.26 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.102 0 CA-C-O 120.81 0.338 . . . . 0.0 110.913 179.305 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -55.64 -23.51 28.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.028 0.442 . . . . 0.0 109.831 -179.682 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.526 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 35.2 m -54.46 126.61 24.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.287 -179.369 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.408 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 54.8 m-20 -61.35 -33.22 73.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.872 -179.459 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.765 HD12 ' CE2' ' A' ' 29' ' ' PHE . 77.9 mt -126.54 122.87 61.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 177.38 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 39.6 mtm180 -106.23 137.63 43.83 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -179.602 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.718 ' CG2' HD12 ' A' ' 41' ' ' LEU . 80.3 mt -117.42 125.9 74.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.918 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -71.34 29.33 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.894 -178.604 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.718 HD12 ' CG2' ' A' ' 39' ' ' ILE . 13.0 mt -100.73 127.61 32.02 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.955 -179.942 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.07 -9.17 24.15 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.096 1.864 . . . . 0.0 112.722 -179.385 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.551 HG21 ' CE2' ' B' ' 241' ' ' PHE . 18.1 m -99.07 7.86 8.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.089 -0.644 . . . . 0.0 111.301 -179.723 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 42.8 t -91.86 135.88 25.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.799 178.677 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.7 m -68.94 166.97 16.76 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.207 -179.476 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -61.21 -42.57 98.83 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.208 -0.906 . . . . 0.0 111.045 -179.055 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.627 ' O ' ' N ' ' A' ' 49' ' ' CYS . 12.5 mm100 -115.57 -26.84 7.33 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 123.853 0.721 . . . . 0.0 109.825 -179.518 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.44 ' O ' ' OG ' ' A' ' 64' ' ' SER . 21.3 t60 44.95 -74.86 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.493 179.556 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.627 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -134.81 139.59 45.21 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.703 -179.195 . . . . . . . . 3 3 . 1 . 079 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.736 ' HD3' HD13 ' A' ' 28' ' ' LEU . 21.7 ttpt -130.61 129.52 42.83 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.0 179.007 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 91.5 mt -107.56 130.47 59.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.34 179.615 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -114.52 123.15 48.65 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 177.598 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.702 HG23 HH12 ' A' ' 5' ' ' ARG . 95.3 mt -103.04 115.91 45.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 119.816 -0.753 . . . . 0.0 111.626 -179.195 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.52 ' O ' ' N ' ' A' ' 56' ' ' GLN . 84.7 m-70 -113.24 141.19 47.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.162 179.551 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.1 tt0 -39.97 -26.13 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.446 0.641 . . . . 0.0 109.528 -178.827 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.52 ' N ' ' O ' ' A' ' 54' ' ' HIS . 63.2 tt0 -68.13 -67.98 0.42 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.816 -1.083 . . . . 0.0 109.628 179.104 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -157.58 -168.48 2.58 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.607 -179.426 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -107.5 127.09 53.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.615 179.24 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.1 mt -120.28 129.67 75.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.213 0.53 . . . . 0.0 111.979 -179.618 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.543 ' HB2' HD11 ' A' ' 82' ' ' LEU . 23.5 tp -101.42 128.51 47.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.152 -179.907 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -113.8 138.57 50.09 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.882 -179.296 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.56 HD21 ' CA ' ' A' ' 68' ' ' PRO . 55.3 t-20 -100.39 108.34 20.33 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.825 0.345 . . . . 0.0 111.649 -179.934 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -98.03 -9.45 25.99 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.538 -179.89 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -78.82 117.11 19.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.971 0.415 . . . . 0.0 111.107 -179.818 . . . . . . . . 3 3 . 1 . 079 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.7 p -101.2 -14.6 17.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.64 179.351 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.912 HG22 HG22 ' B' ' 236' ' ' VAL . 0.2 OUTLIER -88.73 -44.44 10.55 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.346 0.593 . . . . 0.0 109.421 -179.596 . . . . . . . . 3 3 . 1 . 079 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -138.85 95.47 9.69 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.137 -0.938 . . . . 0.0 108.584 178.286 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.56 ' CA ' HD21 ' A' ' 62' ' ' ASN . 37.5 Cg_endo -66.4 150.11 84.52 Favored 'Trans proline' 0 C--N 1.316 -1.156 0 C-N-CA 121.18 1.253 . . . . 0.0 113.029 -177.918 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.439 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 5.3 m -72.13 140.26 48.76 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.949 -179.401 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -103.33 140.9 36.81 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.514 178.547 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.495 ' CG2' ' OD1' ' A' ' 86' ' ' ASP . 5.6 p -128.48 135.5 62.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.043 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 48.37 31.03 2.54 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 119.415 -0.914 . . . . 0.0 108.629 -178.628 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.08 24.73 73.01 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.683 -179.583 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.459 ' N ' ' O ' ' A' ' 71' ' ' VAL . 35.9 t -136.24 139.55 42.81 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.94 0.37 . . . . 0.0 111.11 -179.711 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 79.3 t -68.02 140.7 18.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.169 179.807 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.9 pt -111.77 70.97 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 120.927 0.394 . . . . 0.0 110.437 179.021 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -54.95 -32.72 61.67 Favored 'General case' 0 N--CA 1.461 0.096 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.313 179.578 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -118.88 163.05 28.11 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.96 179.399 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -59.46 144.57 99.37 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.886 1.724 . . . . 0.0 112.829 -179.158 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.0 m -138.14 138.39 43.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.176 -179.68 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -73.12 129.08 37.27 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 120.646 -0.422 . . . . 0.0 109.919 179.47 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.543 HD11 ' HB2' ' A' ' 60' ' ' LEU . 94.6 mt -80.51 141.27 35.32 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.994 0.426 . . . . 0.0 110.631 179.717 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.438 ' HG2' ' N ' ' A' ' 84' ' ' HIS . 88.3 tttt -136.03 157.78 46.01 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.952 -179.56 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.612 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 6.2 t60 -57.3 118.41 5.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.924 0.392 . . . . 0.0 110.834 -179.36 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.68 -7.67 29.89 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -179.989 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.495 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 50.5 t0 -74.76 124.88 27.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.023 0.439 . . . . 0.0 110.115 179.316 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.547 HG22 ' HG2' ' A' ' 96' ' ' ARG . 75.0 t -108.02 131.36 58.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.658 -178.685 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 80.3 mt -99.47 130.67 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.341 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.2 m -118.46 124.78 48.45 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.409 0.623 . . . . 0.0 112.494 -179.121 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.491 HD12 ' HE1' ' A' ' 95' ' ' PHE . 96.9 mt -114.0 124.68 70.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 177.902 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.524 HG22 ' NH2' ' B' ' 245' ' ' ARG . 34.5 mm 36.09 -99.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 -178.764 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.509 ' CG ' ' NH2' ' B' ' 245' ' ' ARG . 37.7 p-10 -116.08 14.01 15.93 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.247 179.425 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.531 ' CZ ' ' O ' ' B' ' 259' ' ' ASP . 84.7 mtt-85 -121.96 145.52 48.04 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.282 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 73.7 m -136.72 154.96 50.45 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.009 179.766 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.491 ' HE1' HD12 ' A' ' 90' ' ' ILE . 79.7 m-85 -126.59 120.65 30.11 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.333 179.378 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.547 ' HG2' HG22 ' A' ' 87' ' ' VAL . 99.6 mtt180 -85.42 136.58 33.39 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.39 -178.936 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -98.18 122.81 41.8 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.302 -179.521 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -134.76 129.33 34.47 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.275 0.56 . . . . 0.0 112.004 -179.601 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.612 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 13.3 p30 -132.78 169.67 16.38 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.762 179.399 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 . . . . . 0 C--N 1.324 -0.517 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.354 -179.769 . . . . . . . . 0 0 . 1 . 079 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 12.0 t . . . . . 0 N--CA 1.453 -0.285 0 CA-C-O 120.819 0.343 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 079 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.622 ' O ' ' C ' ' B' ' 230' ' ' SEP . 52.6 t0 -95.02 110.61 22.51 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.047 179.187 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . 0.622 ' C ' ' O ' ' B' ' 229' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.579 ' N ' ' O ' ' B' ' 229' ' ' ASP . 10.2 mt-30 82.42 52.52 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.815 -179.522 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . 0.601 ' N ' ' O ' ' B' ' 229' ' ' ASP . . . -97.32 -149.28 25.19 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.899 -0.881 . . . . 0.0 110.899 -179.565 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -58.98 148.34 85.53 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 123.046 2.498 . . . . 0.0 111.787 179.3 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.402 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -70.23 147.71 60.47 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 121.814 1.676 . . . . 0.0 112.372 179.95 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.912 HG22 HG22 ' A' ' 66' ' ' THR . 11.4 t -85.4 129.26 38.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.127 -179.568 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -73.58 127.11 31.84 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.59 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . 0.425 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . 0.425 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 32.1 Cg_exo -58.28 -27.48 81.06 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.532 2.155 . . . . 0.0 113.222 -178.367 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 23.4 m -74.17 -44.6 52.88 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.273 179.008 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.551 ' CE2' HG21 ' A' ' 43' ' ' VAL . 89.1 t80 -56.35 -46.92 79.77 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.634 -179.436 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.75 HD23 HH21 ' B' ' 245' ' ' ARG . 93.3 mt -63.02 -42.27 99.75 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.846 0.355 . . . . 0.0 110.634 179.869 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -67.6 -40.24 84.75 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -179.425 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -60.97 -45.0 96.53 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.328 -178.832 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.75 HH21 HD23 ' B' ' 242' ' ' LEU . 60.5 mtm180 -65.36 -38.55 90.42 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.626 -0.429 . . . . 0.0 111.513 -179.662 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -61.49 -41.15 96.84 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.41 -179.845 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 62.9 m -64.91 -41.07 95.89 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.052 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . 0.433 ' O ' ' N ' ' B' ' 252' ' ' LEU . 58.3 tt0 -62.13 -37.48 85.3 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.797 179.882 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 27.3 t -63.83 -45.68 96.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.255 179.359 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -59.81 -28.31 67.35 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.211 -0.596 . . . . 0.0 109.521 179.282 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -95.14 -8.73 35.59 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.322 179.558 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' B' ' 248' ' ' GLN . 40.6 tp -77.46 136.86 38.4 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.595 -178.656 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -88.17 135.37 33.47 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.349 179.762 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . 0.577 ' OD1' ' N ' ' B' ' 255' ' ' ASP . 23.3 p-10 -65.91 -24.71 66.89 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.773 0.32 . . . . 0.0 111.255 -179.176 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . 0.577 ' N ' ' OD1' ' B' ' 254' ' ' ASP . 45.7 p-10 -65.44 -1.65 2.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.71 -178.701 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.637 ' O ' ' N ' ' B' ' 258' ' ' ASP . 89.1 m-20 -87.55 -19.81 27.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.143 0.497 . . . . 0.0 110.062 179.454 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 3.2 tttm 37.16 20.53 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.652 179.605 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.637 ' N ' ' O ' ' B' ' 256' ' ' ASP . 51.9 t0 -92.43 108.05 19.67 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.686 -179.878 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.531 ' O ' ' CZ ' ' A' ' 93' ' ' ARG . 35.3 p-10 -85.12 1.71 46.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.584 -178.344 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 70.76 7.52 6.24 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.352 0.596 . . . . 0.0 110.275 179.195 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.452 HD13 ' CE2' ' A' ' 95' ' ' PHE . 81.3 mt -114.42 136.8 49.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.324 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 88.1 t -124.51 132.0 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 120.816 -0.353 . . . . 0.0 110.424 -179.202 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . 0.576 ' HZ ' HG21 ' A' ' 9' ' ' THR . 48.2 m-85 -96.93 118.55 33.59 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.192 0.52 . . . . 0.0 112.193 -178.18 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -67.2 -46.01 75.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.553 179.057 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 62.6 mm-40 -91.77 160.78 35.51 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.622 -178.168 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -62.51 154.3 65.51 Favored 'Trans proline' 0 N--CA 1.501 1.942 0 C-N-CA 122.664 2.243 . . . . 0.0 111.082 179.11 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 46.1 pt . . . . . 0 CA--C 1.519 -0.238 0 CA-C-O 121.497 0.665 . . . . 0.0 112.139 -178.771 . . . . . . . . 0 0 . 1 . 080 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo . . . . . 0 N--CA 1.494 1.531 0 CA-C-O 121.217 0.424 . . . . 0.0 112.672 . . . . . . . . . 0 0 . 1 . 080 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.699 HG23 ' O ' ' A' ' 100' ' ' GLU . 74.1 m -64.17 -44.6 91.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.195 -179.406 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.661 ' NH1' ' HB2' ' A' ' 58' ' ' ALA . 95.5 mtt-85 -93.62 118.12 30.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.718 0.294 . . . . 0.0 111.205 -178.671 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.8 mtp180 -133.51 138.16 45.98 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.397 -0.521 . . . . 0.0 111.509 179.468 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.738 HD12 ' O ' ' A' ' 96' ' ' ARG . 35.8 tp -113.85 133.62 55.31 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.331 179.876 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.82 HG22 ' CD2' ' A' ' 19' ' ' HIS . 47.4 t -109.69 130.96 61.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.865 0.364 . . . . 0.0 110.106 -179.966 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.452 HG23 HH21 ' A' ' 93' ' ' ARG . 1.5 m -88.33 115.65 25.98 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.092 -0.503 . . . . 0.0 112.046 -178.698 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.652 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 95.4 mt -84.04 141.5 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.245 178.712 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -94.78 157.17 16.06 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.332 0.586 . . . . 0.0 111.812 179.526 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.584 ' NH2' ' CD1' ' B' ' 252' ' ' LEU . 89.9 mtm180 -57.85 -27.67 63.44 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.459 -178.92 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.0 t -75.72 -16.36 60.16 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.449 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.22 26.88 11.52 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -179.441 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 49.7 t -117.26 133.59 63.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.75 0.31 . . . . 0.0 110.632 179.865 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -75.47 138.56 41.68 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 178.835 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.5 -113.94 1.69 Allowed Glycine 0 CA--C 1.534 1.237 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.316 -179.292 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -72.1 143.01 39.29 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.18 1.92 . . . . 0.0 113.015 -178.415 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.82 ' CD2' HG22 ' A' ' 8' ' ' VAL . 55.0 m170 -102.76 143.35 32.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.028 179.863 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.627 ' CD2' HD11 ' A' ' 37' ' ' ILE . 45.5 t80 -117.08 92.43 39.36 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.297 -179.49 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -60.8 127.49 22.65 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.162 1.908 . . . . 0.0 111.755 179.965 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.6 mt -90.01 51.01 1.96 Allowed 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.739 -0.384 . . . . 0.0 111.126 -179.156 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.6 p -63.33 -20.14 65.24 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.21 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.711 HD11 ' NE2' ' B' ' 265' ' ' GLN . 79.3 mt -81.45 141.89 33.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.501 179.266 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.9 m -66.51 -20.44 66.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.665 -178.742 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 83.9 m -129.32 131.01 46.84 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.048 0.451 . . . . 0.0 111.332 179.551 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.8 t -127.08 123.34 36.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.804 178.898 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 40.8 tp -120.32 127.46 52.37 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.36 -178.782 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.744 ' CE2' HD12 ' A' ' 37' ' ' ILE . 11.2 m-85 -104.36 130.77 52.21 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.773 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 178.37 -159.24 24.48 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 111.424 -0.671 . . . . 0.0 111.424 -179.771 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 29.3 ptt-85 -108.48 -15.88 14.34 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.955 -179.87 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -77.0 165.59 53.58 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.017 -178.852 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.418 HD13 ' HA ' ' A' ' 33' ' ' ILE . 30.9 mm -64.5 -43.07 96.86 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.843 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.9 mp0 -52.27 -29.14 21.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.168 -179.887 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 58.6 m -60.88 121.08 11.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.846 179.831 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -55.36 -29.35 58.23 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.958 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.744 HD12 ' CE2' ' A' ' 29' ' ' PHE . 99.3 mt -129.49 124.43 59.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.247 -0.888 . . . . 0.0 108.868 177.505 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 45.7 mtm180 -101.8 134.25 45.27 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.703 -179.905 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.739 HG21 HD12 ' A' ' 41' ' ' LEU . 92.1 mt -119.37 129.04 75.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.813 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -70.24 35.19 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.921 -178.88 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.875 ' O ' HG12 ' A' ' 44' ' ' VAL . 23.6 mt -103.65 115.93 62.74 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.267 -179.75 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -74.64 -7.78 19.78 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.145 1.896 . . . . 0.0 111.771 -179.847 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.9 m -100.36 8.2 8.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.59 179.843 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.875 HG12 ' O ' ' A' ' 41' ' ' LEU . 8.5 p -96.72 140.86 16.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.455 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.0 m -70.98 166.63 20.89 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.336 0.589 . . . . 0.0 111.612 -178.728 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -63.38 -40.84 98.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.01 -179.696 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.582 ' O ' ' N ' ' A' ' 49' ' ' CYS . 87.7 mt-30 -116.93 -6.65 11.45 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.405 -179.89 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.478 ' C ' ' O ' ' A' ' 47' ' ' GLN . 13.1 t60 15.21 -74.88 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -179.568 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.582 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -125.48 130.15 51.22 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.885 -0.726 . . . . 0.0 112.061 -178.435 . . . . . . . . 3 3 . 1 . 080 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -127.67 126.42 41.92 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.102 179.979 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 83.5 mt -110.23 133.56 55.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.912 -179.309 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -115.18 126.54 54.71 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.497 178.931 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.3 mm -97.84 113.3 32.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 119.675 -0.81 . . . . 0.0 111.085 -179.694 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.437 ' O ' ' C ' ' A' ' 55' ' ' GLU . 97.4 m-70 -114.85 136.3 53.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.432 179.114 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 54' ' ' HIS . 98.4 mt-10 -40.31 -38.68 0.83 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.42 -0.512 . . . . 0.0 109.741 -179.428 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.495 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 50.8 tt0 -62.34 -66.43 0.54 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.035 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.495 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 4.0 tp10 -155.58 -169.42 3.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.334 -179.377 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.661 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -114.52 129.42 56.66 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.61 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 93.9 mt -115.4 131.83 66.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.408 0.623 . . . . 0.0 111.913 -178.796 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.496 HD22 ' CD1' ' A' ' 88' ' ' ILE . 28.2 tp -100.61 130.8 46.72 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.196 179.994 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -111.3 131.52 55.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.819 -179.343 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 62.6 t-20 -94.74 106.16 18.13 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.819 0.343 . . . . 0.0 111.429 -179.673 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -97.52 -7.74 30.71 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.178 -179.683 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.8 p -84.06 108.21 16.86 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 119.997 -0.681 . . . . 0.0 111.3 -179.334 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 89.6 p -91.27 -16.25 27.87 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.783 178.874 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.583 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -86.23 -42.53 13.72 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.128 179.95 . . . . . . . . 3 3 . 1 . 080 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -139.82 97.64 8.02 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.085 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -56.08 143.22 84.54 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 121.974 1.782 . . . . 0.0 112.781 -178.501 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.5 m -69.83 138.25 52.45 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.349 178.588 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -102.73 140.29 37.2 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.272 0.558 . . . . 0.0 111.091 -179.561 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.0 p -133.14 135.66 56.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.92 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 50.09 31.79 5.26 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.361 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.13 26.51 68.38 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.769 179.91 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.6 t -140.6 138.23 34.27 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 117.266 0.533 . . . . 0.0 111.929 -179.546 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.417 ' H ' HG22 ' A' ' 75' ' ' VAL . 2.6 m -72.39 141.94 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.789 179.374 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.9 pt -113.68 94.16 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.203 0.525 . . . . 0.0 111.148 179.461 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -65.35 -29.05 69.74 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.752 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -122.12 165.02 22.18 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.219 179.909 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.14 152.28 81.6 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.647 2.231 . . . . 0.0 112.6 -179.819 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.3 m -143.33 143.46 24.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.466 -179.424 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -72.01 133.33 45.25 Favored 'General case' 0 C--O 1.231 0.098 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.036 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.468 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 98.1 mt -82.34 141.57 32.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.026 0.441 . . . . 0.0 111.564 -179.487 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -131.38 151.9 51.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.425 179.682 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.531 ' HD1' ' C ' ' A' ' 99' ' ' ASN . 7.4 t60 -54.37 117.7 3.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.712 0.291 . . . . 0.0 110.813 -179.785 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.5 -15.43 27.15 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.196 -0.526 . . . . 0.0 111.821 179.515 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -67.4 134.46 51.48 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.345 -0.542 . . . . 0.0 110.545 -179.741 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.468 HG22 ' HG2' ' A' ' 96' ' ' ARG . 74.3 t -109.74 135.91 47.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.244 -178.225 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.496 ' CD1' HD22 ' A' ' 60' ' ' LEU . 6.5 mm -99.26 128.74 50.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.761 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.4 m -119.98 121.22 38.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.686 0.755 . . . . 0.0 111.976 -178.989 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.567 ' O ' ' N ' ' A' ' 93' ' ' ARG . 96.2 mt -115.87 127.75 73.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.002 178.667 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.537 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 72.5 mt -18.64 99.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -178.763 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.537 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 2.6 t70 88.68 -21.96 0.14 Allowed 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 178.031 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.652 ' NH2' ' O ' ' A' ' 10' ' ' ILE . 8.0 mmm180 -130.06 146.02 51.7 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.0 -179.609 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.6 t -139.45 148.83 43.28 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.991 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.553 ' HB3' HD11 ' A' ' 7' ' ' LEU . 58.3 m-85 -126.92 122.14 33.75 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 -179.992 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.738 ' O ' HD12 ' A' ' 7' ' ' LEU . 79.0 mtp85 -82.07 130.31 35.05 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.89 0.376 . . . . 0.0 111.249 -179.184 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.63 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 82.8 t80 -96.23 124.92 40.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.554 179.498 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -122.39 127.04 49.22 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.6 179.852 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.531 ' C ' ' HD1' ' A' ' 84' ' ' HIS . 61.6 t-20 -127.01 108.61 11.09 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.217 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.699 ' O ' HG23 ' A' ' 4' ' ' THR . 95.7 mt-10 . . . . . 0 C--N 1.332 -0.16 0 CA-C-O 120.967 0.413 . . . . 0.0 111.075 -178.866 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . 0.545 HG13 ' N ' ' B' ' 229' ' ' ASP . 11.0 p . . . . . 0 CA--C 1.528 0.126 0 CA-C-O 120.676 0.274 . . . . 0.0 111.217 . . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.545 ' N ' HG13 ' B' ' 228' ' ' VAL . 66.5 t0 56.58 -125.06 1.91 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.215 -179.093 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . 0.493 ' N ' ' OD1' ' B' ' 229' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.476 ' O ' ' O ' ' B' ' 232' ' ' GLY . 75.1 mt-30 -141.33 -5.22 1.1 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.027 -179.075 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' B' ' 231' ' ' GLN . . . -52.68 -158.68 0.01 OUTLIER Glycine 0 CA--C 1.532 1.122 0 CA-C-N 116.413 -0.358 . . . . 0.0 112.407 -179.144 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -64.88 157.5 56.3 Favored 'Trans proline' 0 N--CA 1.5 1.86 0 C-N-CA 123.559 2.839 . . . . 0.0 112.789 -179.73 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.532 HG21 ' O1P' ' B' ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -73.71 170.93 18.85 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 122.386 2.057 . . . . 0.0 113.015 -179.559 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.583 ' CG2' HG22 ' A' ' 66' ' ' THR . 25.6 t -110.28 133.37 55.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.998 -179.396 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.6 t -77.42 130.71 37.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.867 -179.902 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . 0.415 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . 0.415 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 31.8 Cg_exo -57.72 -24.5 63.59 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 122.569 2.179 . . . . 0.0 111.926 -179.546 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 16.8 m -73.74 -44.92 54.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.203 0.525 . . . . 0.0 110.29 178.357 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -58.17 -45.54 87.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.873 -178.724 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.411 ' HA ' HD23 ' B' ' 242' ' ' LEU . 94.0 mt -63.64 -39.76 95.16 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.328 -0.549 . . . . 0.0 109.575 179.568 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -62.04 -42.75 99.51 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.258 179.988 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -64.89 -40.64 95.42 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.126 -179.713 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.783 ' CZ ' HD21 ' A' ' 41' ' ' LEU . 13.6 mmm180 -61.05 -38.92 87.88 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.298 -178.778 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -65.06 -38.82 92.05 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.38 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 30.4 m -62.39 -45.8 91.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.497 178.475 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -61.08 -35.35 76.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.457 -179.739 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 24.2 t -60.42 -45.0 97.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.39 -0.524 . . . . 0.0 109.697 179.423 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -59.75 -30.23 68.7 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.52 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -82.9 -12.4 57.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.413 179.495 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.584 ' CD1' ' NH2' ' A' ' 12' ' ' ARG . 93.6 mt -110.03 -176.8 3.09 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.708 179.778 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 30.3 p30 -141.95 173.01 11.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.068 -179.745 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -69.77 -18.3 63.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.57 179.537 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -67.95 -9.2 43.38 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.4 -179.472 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -82.14 81.06 8.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.089 0.471 . . . . 0.0 110.501 -179.855 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -66.56 -7.36 19.63 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.908 -178.818 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.695 ' O ' ' N ' ' B' ' 260' ' ' GLU . 89.0 m-20 -102.35 -0.87 32.02 Favored 'General case' 0 C--O 1.224 -0.264 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.541 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.551 ' O ' ' NH1' ' A' ' 93' ' ' ARG . 64.9 t0 -12.99 67.45 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 114.84 -1.073 . . . . 0.0 113.529 -178.867 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.695 ' N ' ' O ' ' B' ' 258' ' ' ASP . 50.4 mm-40 60.83 1.98 0.49 Allowed 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 177.365 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.543 HD11 ' CZ ' ' A' ' 93' ' ' ARG . 4.6 mm -110.46 130.78 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-N 119.113 0.87 . . . . 0.0 109.945 179.537 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 53.5 t -124.48 131.77 72.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.032 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -99.73 122.51 42.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.064 0.459 . . . . 0.0 111.613 -178.257 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -63.85 -46.78 83.46 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.358 0.599 . . . . 0.0 110.135 179.927 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . 0.711 ' NE2' HD11 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -97.55 157.34 34.92 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.654 -179.367 . . . . . . . . 3 3 . 1 . 080 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -60.3 145.23 99.02 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.893 2.395 . . . . 0.0 113.059 -179.647 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 14.5 pt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.178 179.483 . . . . . . . . 0 0 . 1 . 081 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo . . . . . 0 N--CA 1.491 1.347 0 CA-C-O 120.992 0.33 . . . . 0.0 112.356 . . . . . . . . . 0 0 . 1 . 081 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.6 p -108.53 -34.75 6.66 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.5 179.033 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.566 ' NH1' ' HB2' ' A' ' 58' ' ' ALA . 96.1 mtt-85 -91.99 118.7 31.02 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.274 -179.882 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -128.29 129.78 46.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.926 0.394 . . . . 0.0 111.56 -179.476 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.537 HD11 ' HB3' ' A' ' 95' ' ' PHE . 33.9 tp -112.91 130.06 56.25 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.581 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.8 t -109.06 134.29 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-O 120.835 0.35 . . . . 0.0 110.795 -179.39 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.409 HG23 ' CD1' ' B' ' 261' ' ' ILE . 3.7 m -91.96 120.93 33.07 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.502 -178.521 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.495 ' CD1' ' OD1' ' A' ' 16' ' ' ASP . 49.4 mm -82.15 138.68 19.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.539 179.651 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -91.6 159.65 15.79 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 121.331 0.586 . . . . 0.0 111.561 179.115 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.57 ' NH2' ' OE1' ' B' ' 248' ' ' GLN . 77.3 mtp180 -54.72 -33.07 60.53 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.32 -179.109 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.8 p -78.4 -12.78 60.03 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.76 -179.594 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.59 13.56 40.65 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.973 178.899 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.3 m -109.71 141.49 24.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.317 179.947 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.495 ' OD1' ' CD1' ' A' ' 10' ' ' ILE . 86.4 m-20 -73.6 139.26 45.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.56 -179.327 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.43 -117.33 1.96 Allowed Glycine 0 CA--C 1.535 1.295 0 C-N-CA 120.383 -0.913 . . . . 0.0 111.638 179.94 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.17 143.28 43.74 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 122.096 1.864 . . . . 0.0 113.319 -178.73 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -106.85 157.6 17.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.402 -179.861 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.465 ' CD2' HD11 ' A' ' 37' ' ' ILE . 48.3 t80 -131.52 102.19 15.44 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.773 179.918 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.08 132.73 17.09 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 121.728 1.619 . . . . 0.0 112.061 -179.037 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.9 mt -83.36 55.4 3.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.901 0.381 . . . . 0.0 111.46 -178.535 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 52.4 p -68.04 -25.39 65.34 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.558 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.0 mt -80.65 139.65 36.09 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.539 -0.755 . . . . 0.0 108.966 179.083 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 80.3 p -65.5 -19.38 65.91 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.408 -179.224 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.52 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 44.6 m -131.95 131.49 42.67 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.175 -179.446 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.1 t -125.15 117.18 23.32 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.711 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.549 HD21 ' HG3' ' A' ' 47' ' ' GLN . 52.0 tp -113.93 126.06 54.73 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.915 -179.6 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.676 ' CE2' HD12 ' A' ' 37' ' ' ILE . 7.8 m-85 -104.7 141.09 37.08 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.944 179.465 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 153.34 -174.24 32.03 Favored Glycine 0 N--CA 1.469 0.864 0 C-N-CA 120.288 -0.958 . . . . 0.0 112.328 178.481 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.714 ' NE ' HG21 ' B' ' 228' ' ' VAL . 80.7 mtm-85 -77.39 -32.51 54.89 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-O 120.93 0.395 . . . . 0.0 110.842 -179.982 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.485 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -46.04 144.63 3.65 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 -179.057 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.513 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.0 tp -65.96 -41.41 89.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-O 120.883 0.373 . . . . 0.0 110.056 179.667 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.513 ' N ' HG23 ' A' ' 33' ' ' ILE . 79.4 mm-40 -57.63 -15.65 8.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.861 -179.845 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 80.2 m -56.87 124.4 18.42 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.587 -179.628 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.52 ' OD2' ' O ' ' A' ' 26' ' ' THR . 57.0 m-20 -60.2 -33.15 71.83 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 179.443 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.676 HD12 ' CE2' ' A' ' 29' ' ' PHE . 87.1 mt -127.57 120.33 54.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 176.346 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 76.8 ttt-85 -105.85 135.53 47.11 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.352 -177.923 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.628 HG21 HD12 ' A' ' 41' ' ' LEU . 94.5 mt -117.32 130.09 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 121.045 0.45 . . . . 0.0 110.888 -179.537 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.456 ' NE2' ' OD2' ' B' ' 258' ' ' ASP . 49.8 mt-30 -81.09 30.62 0.33 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.496 -179.216 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.708 ' O ' HG12 ' A' ' 44' ' ' VAL . 20.8 mt -91.32 112.8 55.94 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.758 179.262 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -57.38 -14.24 15.43 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.347 2.032 . . . . 0.0 113.343 179.636 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.48 HG21 ' CE2' ' B' ' 241' ' ' PHE . 2.4 m -103.78 11.15 8.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.748 -178.988 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.708 HG12 ' O ' ' A' ' 41' ' ' LEU . 6.0 p -98.56 138.39 23.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.018 179.629 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.0 m -68.91 167.87 14.8 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.616 0.722 . . . . 0.0 111.983 -179.138 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -63.02 -43.79 97.75 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 114.768 -1.106 . . . . 0.0 111.997 -178.394 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.649 ' O ' ' N ' ' A' ' 49' ' ' CYS . 21.6 mp0 -110.74 -14.55 14.0 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.935 0.398 . . . . 0.0 110.035 179.966 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 25.7 t60 32.45 -75.31 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.083 -0.962 . . . . 0.0 113.551 179.633 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.649 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.82 137.82 45.3 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -178.594 . . . . . . . . 3 3 . 1 . 081 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -125.02 131.83 53.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.016 179.599 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 88.3 mt -114.12 130.54 68.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.337 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -117.98 121.35 40.42 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.422 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 86.3 mt -103.82 116.04 46.86 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-O 121.572 0.701 . . . . 0.0 111.649 -178.854 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.454 ' O ' ' N ' ' A' ' 56' ' ' GLN . 53.0 m-70 -111.84 146.08 38.31 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.864 -179.837 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 54' ' ' HIS . 95.5 mt-10 -39.83 -30.45 0.08 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.128 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.465 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 89.6 mt-30 -63.97 -68.74 0.32 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.991 179.213 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.507 ' HG2' ' HE ' ' A' ' 81' ' ' ARG . 4.6 tp10 -159.13 -161.82 0.99 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.668 179.401 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.566 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -116.63 122.31 44.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.578 179.158 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 91.4 mt -113.59 130.48 67.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.266 0.555 . . . . 0.0 112.132 -178.926 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.599 ' HB2' HD21 ' A' ' 82' ' ' LEU . 48.3 tp -92.37 125.39 37.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.15 179.47 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.416 ' ND1' ' HB3' ' A' ' 79' ' ' PRO . 97.6 m-70 -111.36 136.28 50.71 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.635 0.255 . . . . 0.0 110.921 179.73 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.705 ' ND2' ' H ' ' A' ' 69' ' ' THR . 8.1 t-20 -97.76 104.48 16.51 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.133 179.114 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -95.99 -8.87 32.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.026 179.447 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.25 101.01 2.73 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.941 179.423 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.9 p -84.58 -10.17 57.64 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.438 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.733 HG22 HG12 ' B' ' 236' ' ' VAL . 0.2 OUTLIER -97.39 -44.3 6.92 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.881 179.519 . . . . . . . . 3 3 . 1 . 081 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.448 HD21 ' HA ' ' B' ' 236' ' ' VAL . 74.8 m-20 -137.45 91.62 14.05 Favored Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.57 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.464 ' HA ' HD21 ' A' ' 62' ' ' ASN . 51.1 Cg_exo -53.68 144.29 54.02 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.422 2.081 . . . . 0.0 112.46 -179.055 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.705 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 20.4 m -72.17 138.29 47.53 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.786 179.164 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -100.98 141.22 34.19 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.36 -179.867 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 54.5 t -130.3 134.27 62.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.101 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 52.13 32.48 10.56 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.13 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.93 29.72 66.7 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.781 179.68 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.7 m -139.02 130.65 27.35 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.521 -0.472 . . . . 0.0 111.425 -179.599 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.42 ' H ' HG12 ' A' ' 75' ' ' VAL . 0.1 OUTLIER -69.56 138.26 22.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.619 179.844 . . . . . . . . 3 3 . 1 . 081 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.544 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 1.2 pt -118.54 112.39 37.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-O 121.37 0.605 . . . . 0.0 111.501 -179.763 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -80.32 -20.52 44.09 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.583 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -121.55 160.2 47.25 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.394 179.741 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.416 ' HB3' ' ND1' ' A' ' 61' ' ' HIS . 30.6 Cg_endo -61.99 148.49 93.05 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.901 1.734 . . . . 0.0 112.444 179.69 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 76.9 t -130.35 138.13 54.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.021 -179.469 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.507 ' HE ' ' HG2' ' A' ' 57' ' ' GLU . 72.5 ttt180 -70.77 129.48 39.21 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.713 178.948 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.599 HD21 ' HB2' ' A' ' 60' ' ' LEU . 95.4 mt -80.68 135.29 36.0 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.309 0.576 . . . . 0.0 111.276 -179.921 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -133.06 151.75 52.01 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.51 -179.912 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.552 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 4.6 t60 -52.04 116.44 2.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.168 -179.16 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.16 -14.79 36.73 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 121.234 -0.508 . . . . 0.0 111.953 179.551 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -68.89 134.94 50.28 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.953 -179.512 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.9 t -114.13 132.68 62.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.647 -178.207 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.5 mt -100.54 131.81 47.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.317 -0.856 . . . . 0.0 108.79 178.888 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.9 m -120.91 124.2 44.35 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.343 0.592 . . . . 0.0 112.064 -178.431 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.578 ' O ' ' N ' ' A' ' 92' ' ' ASP . 82.2 mt -111.15 122.59 65.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 178.099 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.612 HD12 ' CB ' ' B' ' 237' ' ' CYS . 43.8 mm 36.89 -92.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.02 -179.471 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.588 ' CB ' ' HE ' ' B' ' 245' ' ' ARG . 59.2 t0 -121.48 7.46 10.09 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.881 0.372 . . . . 0.0 111.296 179.649 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.735 ' NH1' HH22 ' B' ' 245' ' ' ARG . 48.5 mmt-85 -111.59 135.01 52.76 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.101 178.9 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.6 m -133.5 148.18 51.67 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.96 179.466 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.537 ' HB3' HD11 ' A' ' 7' ' ' LEU . 67.2 m-85 -124.81 124.66 42.59 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.429 -179.684 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.535 ' O ' HD12 ' A' ' 7' ' ' LEU . 77.1 mtp85 -86.99 131.75 33.99 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 119.687 -0.805 . . . . 0.0 110.976 -179.109 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.511 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 71.2 t80 -96.62 125.55 41.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.492 179.674 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -126.26 123.16 37.5 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.382 179.835 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.552 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 63.7 t-20 -107.66 109.78 21.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.078 179.371 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 . . . . . 0 C--N 1.329 -0.3 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.758 . . . . . . . . 0 0 . 1 . 081 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . 0.714 HG21 ' NE ' ' A' ' 31' ' ' ARG . 7.9 p . . . . . 0 C--O 1.233 0.189 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 . . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' B' ' 230' ' ' SEP . 83.9 m-20 -92.5 0.61 57.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.9 -179.752 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . 0.581 ' H2 ' HG22 ' B' ' 228' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.578 ' NE2' ' O ' ' B' ' 230' ' ' SEP . 93.8 mm-40 -127.87 31.87 5.04 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.463 178.849 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -110.62 -158.58 16.15 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.69 -179.269 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.93 151.11 59.46 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 123.309 2.673 . . . . 0.0 112.895 179.681 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.483 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -79.91 130.52 8.56 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.377 2.051 . . . . 0.0 113.621 -178.846 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.733 HG12 HG22 ' A' ' 66' ' ' THR . 1.2 m -68.86 147.84 12.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.079 -178.876 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . 0.612 ' CB ' HD12 ' A' ' 91' ' ' ILE . 4.3 t -79.15 128.28 33.09 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.897 -179.966 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 081 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -55.76 -28.68 68.04 Favored 'Trans proline' 0 N--CA 1.5 1.893 0 C-N-CA 123.249 2.633 . . . . 0.0 112.772 -179.149 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 51.6 m -70.91 -45.72 63.79 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.864 179.239 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.48 ' CE2' HG21 ' A' ' 43' ' ' VAL . 68.5 t80 -58.4 -46.5 86.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.523 -178.928 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' B' ' 242' ' ' LEU . 82.8 mt -63.11 -41.79 99.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.277 -179.061 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -67.0 -38.67 86.44 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.113 -179.652 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -61.61 -43.91 97.98 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.313 179.539 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.735 HH22 ' NH1' ' A' ' 93' ' ' ARG . 37.9 mtp85 -61.38 -40.98 96.31 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.018 -179.881 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -60.89 -41.19 95.54 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 178.122 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 48.0 t -62.87 -44.27 96.57 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 177.916 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . 0.57 ' OE1' ' NH2' ' A' ' 12' ' ' ARG . 87.5 mt-30 -60.02 -37.15 78.9 Favored 'General case' 0 CA--C 1.523 -0.074 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.051 179.598 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.443 HG22 ' HB3' ' A' ' 12' ' ' ARG . 55.8 t -61.62 -43.82 97.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.663 179.689 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -65.51 -35.7 81.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.25 179.097 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -82.45 -13.54 56.57 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.903 179.9 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.457 ' CD1' ' NH1' ' A' ' 12' ' ' ARG . 61.4 mt -101.42 -174.49 2.61 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.293 0.568 . . . . 0.0 111.199 179.874 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -142.98 176.69 8.89 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.947 178.987 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . 0.428 ' N ' ' OD1' ' B' ' 254' ' ' ASP . 35.5 p-10 -69.79 -1.5 9.44 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.33 0.586 . . . . 0.0 109.44 179.871 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' B' ' 257' ' ' LYS . 35.7 t70 -66.66 -25.85 66.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.934 178.928 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.432 ' O ' ' OD1' ' B' ' 259' ' ' ASP . 66.8 t0 -69.01 59.0 0.1 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.0 0.429 . . . . 0.0 110.316 -179.074 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . 0.428 ' N ' ' O ' ' B' ' 255' ' ' ASP . 88.7 tttt -55.63 -17.12 4.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.641 -179.62 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.456 ' OD2' ' NE2' ' A' ' 40' ' ' GLN . 39.2 t70 -61.81 -51.94 66.23 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 119.997 -0.681 . . . . 0.0 109.677 179.724 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.544 ' C ' HH21 ' A' ' 93' ' ' ARG . 2.5 m-20 65.3 10.23 6.31 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.619 -179.594 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 60.88 18.42 8.75 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 121.078 -0.249 . . . . 0.0 110.915 179.788 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.409 ' CD1' HG23 ' A' ' 9' ' ' THR . 66.8 mt -123.13 132.91 70.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.891 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 55.6 t -125.84 134.08 67.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.888 0.375 . . . . 0.0 110.631 -179.932 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -96.17 117.67 31.2 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.155 0.503 . . . . 0.0 110.968 -179.25 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -66.88 -45.48 77.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.89 179.555 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . 0.439 ' OE1' ' CZ ' ' A' ' 20' ' ' PHE . 0.3 OUTLIER -93.85 157.82 37.43 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.309 -179.61 . . . . . . . . 3 3 . 1 . 081 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -64.49 150.42 88.27 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 C-N-CA 123.006 2.471 . . . . 0.0 112.436 -179.892 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 30.3 pt . . . . . 0 C--N 1.328 -0.369 0 CA-C-O 121.247 0.546 . . . . 0.0 111.048 179.762 . . . . . . . . 0 0 . 1 . 082 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo . . . . . 0 N--CA 1.493 1.48 0 CA-C-O 120.88 0.283 . . . . 0.0 112.156 . . . . . . . . . 0 0 . 1 . 082 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.1 m -112.28 -66.32 1.09 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.073 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 86.0 mtt85 -89.6 129.68 36.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.041 179.318 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -128.4 141.77 51.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.071 0.462 . . . . 0.0 111.545 -179.93 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.75 HD12 ' O ' ' A' ' 96' ' ' ARG . 28.1 tp -114.44 130.46 56.72 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.354 179.696 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 52.3 t -106.04 129.26 59.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.554 -0.459 . . . . 0.0 110.474 -179.429 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.577 HG21 ' HZ ' ' B' ' 263' ' ' PHE . 77.6 p -81.89 140.79 33.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.458 -178.243 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.57 HD12 ' OG ' ' A' ' 94' ' ' SER . 96.6 mt -110.88 136.41 47.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.098 178.653 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.1 mttm -87.96 160.08 18.05 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.36 179.224 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.517 ' HD3' HH21 ' B' ' 245' ' ' ARG . 89.7 mtm180 -58.44 -29.41 66.11 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.962 -179.259 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 87.1 p -81.24 -7.28 59.54 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.005 179.936 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.0 35.72 6.64 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 179.696 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.6 t -119.03 132.44 68.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.693 0.282 . . . . 0.0 111.076 -179.978 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -77.45 135.56 38.28 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.637 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -128.11 -114.04 1.78 Allowed Glycine 0 CA--C 1.535 1.31 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.052 -179.098 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.517 ' O ' ' OG1' ' A' ' 9' ' ' THR . 61.4 Cg_endo -72.24 145.71 44.27 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 122.445 2.097 . . . . 0.0 113.378 -178.657 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -108.79 129.52 55.38 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.384 179.776 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.827 ' CD2' HD11 ' A' ' 37' ' ' ILE . 51.8 t80 -98.63 99.85 8.34 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.604 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.514 ' HD2' HG22 ' B' ' 267' ' ' ILE . 73.9 Cg_endo -73.76 134.4 20.02 Favored 'Trans proline' 0 C--N 1.315 -1.229 0 C-N-CA 121.12 1.214 . . . . 0.0 111.099 -179.347 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.9 mt -94.15 118.42 31.53 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.547 -178.982 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.4 p -125.03 -4.36 7.49 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.509 179.328 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.552 HD11 ' OE1' ' B' ' 265' ' ' GLN . 49.8 mt -104.47 148.77 26.09 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.545 -179.032 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.36 -22.43 66.26 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.11 -178.906 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 88.0 m -128.34 130.06 47.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.282 0.563 . . . . 0.0 111.76 -179.433 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.628 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -127.96 121.75 30.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.878 178.565 . . . . . . . . 3 3 . 1 . 082 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.671 HD12 ' O ' ' A' ' 49' ' ' CYS . 53.7 tp -123.87 124.16 42.03 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -177.649 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.628 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 46.5 m-85 -97.4 141.28 30.67 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.091 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 168.69 -164.44 38.05 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.109 -1.044 . . . . 0.0 112.423 179.582 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.509 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 33.9 ttp-105 -96.99 -28.91 13.95 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.684 -0.758 . . . . 0.0 110.186 -179.611 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.9 162.08 53.99 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.777 -178.439 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.464 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.0 tp -64.47 -39.45 85.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.056 -0.572 . . . . 0.0 110.153 179.342 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.464 ' N ' HG23 ' A' ' 33' ' ' ILE . 80.1 mm-40 -53.31 -28.08 26.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.435 -179.643 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.3 m -64.37 116.71 6.34 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.434 -179.969 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.527 ' OD1' ' O ' ' A' ' 28' ' ' LEU . 12.5 p-10 -58.02 -26.24 62.18 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.539 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.827 HD11 ' CD2' ' A' ' 20' ' ' PHE . 34.6 mm -122.33 113.96 40.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.361 177.636 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -105.36 136.67 44.47 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.784 179.479 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.485 ' C ' ' H ' ' A' ' 41' ' ' LEU . 91.3 mt -119.61 132.13 70.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.36 -0.836 . . . . 0.0 108.976 179.603 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -71.29 29.4 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.669 -178.808 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.713 HD21 HH22 ' B' ' 245' ' ' ARG . 31.4 mt -91.1 122.73 66.1 Favored Pre-proline 0 C--N 1.323 -0.549 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.037 179.805 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.44 -7.47 20.95 Favored 'Trans proline' 0 N--CA 1.49 1.298 0 C-N-CA 122.12 1.88 . . . . 0.0 111.64 -179.161 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.2 m -107.54 9.97 9.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.844 -179.164 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.628 HG12 ' O ' ' A' ' 41' ' ' LEU . 9.6 p -92.16 141.85 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.061 179.835 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.0 m -71.26 159.43 34.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.714 0.769 . . . . 0.0 112.215 -178.659 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -61.89 -39.72 92.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.814 -1.084 . . . . 0.0 110.797 -179.602 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.595 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.3 mt-30 -117.14 -8.76 11.13 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.678 0.275 . . . . 0.0 111.047 179.445 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.466 ' C ' ' O ' ' A' ' 47' ' ' GLN . 24.3 t60 16.19 -73.88 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 114.633 1.345 . . . . 0.0 114.633 -178.527 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.671 ' O ' HD12 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -130.8 134.64 47.03 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 119.966 -0.693 . . . . 0.0 112.72 -177.724 . . . . . . . . 3 3 . 1 . 082 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -126.02 131.16 52.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.638 179.742 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.9 mt -116.0 133.38 62.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.166 0.508 . . . . 0.0 110.728 179.649 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -118.67 122.58 42.87 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.371 -0.832 . . . . 0.0 108.774 179.051 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 92.1 mt -105.2 116.09 48.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.561 0.696 . . . . 0.0 111.653 -178.974 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.439 ' O ' ' C ' ' A' ' 55' ' ' GLU . 87.6 m-70 -114.42 144.78 42.75 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.604 -179.848 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 54' ' ' HIS . 92.1 mt-10 -39.77 -33.11 0.17 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.318 -0.553 . . . . 0.0 109.911 -179.037 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.449 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 82.7 mt-30 -61.73 -68.38 0.32 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.788 179.227 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.449 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 4.5 tp10 -158.2 -166.35 1.92 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.393 -179.492 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.424 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -110.1 130.13 55.59 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.921 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.5 mt -119.4 129.07 75.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.226 0.536 . . . . 0.0 112.24 -178.549 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.652 ' HB2' HD11 ' A' ' 82' ' ' LEU . 17.4 tp -99.27 126.25 45.06 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.216 179.535 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -113.22 137.1 51.97 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.928 -179.886 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.506 ' ND2' ' O ' ' A' ' 76' ' ' ILE . 22.3 p-10 -100.66 111.19 23.39 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.992 0.425 . . . . 0.0 111.929 -179.246 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -102.61 -6.84 22.33 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.352 179.73 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.44 100.12 6.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.81 0.338 . . . . 0.0 111.579 -179.476 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.9 p -75.6 -32.17 60.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.207 178.288 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.4 m -65.25 -49.24 70.39 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.108 -179.069 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -145.4 103.95 4.32 Favored Pre-proline 0 N--CA 1.466 0.348 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.831 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -54.68 145.14 61.44 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 121.446 1.43 . . . . 0.0 112.004 -179.096 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.9 m -68.8 138.73 55.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.867 178.872 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -99.32 139.98 34.17 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.991 -179.764 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 55.0 t -134.38 134.47 54.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.735 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.573 ' ND2' ' OD1' ' A' ' 86' ' ' ASP . 74.1 m-20 53.8 32.12 14.34 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.611 -179.5 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.65 28.34 63.4 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.736 179.251 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.5 m -147.98 144.85 28.26 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 117.74 0.77 . . . . 0.0 111.734 179.902 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.404 ' H ' HG22 ' A' ' 75' ' ' VAL . 2.4 m -75.88 139.54 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.435 179.247 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.506 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 4.5 pt -104.99 101.61 12.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.411 0.624 . . . . 0.0 111.319 -179.912 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -65.01 -34.86 79.45 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.808 179.431 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.457 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.7 OUTLIER -126.15 178.52 1.48 Allowed Pre-proline 0 CA--C 1.53 0.176 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.52 179.803 . . . . . . . . 3 3 . 1 . 082 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.457 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 21.7 Cg_exo -63.26 146.89 94.13 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 C-N-CA 122.826 2.351 . . . . 0.0 112.174 -179.899 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.5 p -141.64 140.96 30.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.067 179.668 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -72.6 129.86 39.25 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.121 179.41 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.652 HD11 ' HB2' ' A' ' 60' ' ' LEU . 93.0 mt -86.63 135.84 33.26 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.344 -179.926 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -126.83 155.0 43.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.811 -179.554 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.498 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 6.1 t60 -53.96 116.64 2.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.441 -179.597 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.55 -14.48 27.41 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -179.509 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.573 ' OD1' ' ND2' ' A' ' 72' ' ' ASN . 26.2 t70 -69.12 129.7 40.62 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 179.551 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.0 t -109.24 135.64 47.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.312 -178.761 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 89.3 mt -103.43 132.29 50.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.25 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.843 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.0 m -122.15 127.59 50.26 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.762 0.791 . . . . 0.0 112.799 -178.342 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.55 ' O ' ' N ' ' A' ' 93' ' ' ARG . 97.4 mt -121.26 122.94 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 114.369 -1.287 . . . . 0.0 108.492 177.953 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.56 HG23 HD21 ' B' ' 242' ' ' LEU . 56.6 mt -3.74 95.62 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -179.77 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.629 ' CG ' ' HE ' ' B' ' 245' ' ' ARG . 1.4 t70 78.73 -13.42 0.97 Allowed 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 177.69 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.564 ' HD2' HD11 ' B' ' 261' ' ' ILE . 1.6 tpp180 -130.78 139.41 50.22 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.628 -179.192 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.57 ' OG ' HD12 ' A' ' 10' ' ' ILE . 14.9 p -140.15 157.08 46.18 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.283 0.563 . . . . 0.0 111.436 -179.204 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.519 ' HB3' HD11 ' A' ' 7' ' ' LEU . 65.2 m-85 -130.04 125.97 36.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.207 -179.584 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.75 ' O ' HD12 ' A' ' 7' ' ' LEU . 99.9 mtt180 -88.78 132.19 34.73 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.945 -179.231 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -96.94 125.43 41.36 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.498 -179.811 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -127.2 119.73 27.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.082 179.114 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.498 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 58.9 t-20 -105.04 114.31 28.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.504 179.583 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 . . . . . 0 C--N 1.328 -0.365 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.184 179.588 . . . . . . . . 0 0 . 1 . 082 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 17.5 m . . . . . 0 N--CA 1.455 -0.207 0 CA-C-O 120.745 0.307 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 082 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -68.32 154.98 40.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.565 -179.425 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . 0.462 ' HA ' ' HE ' ' A' ' 31' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -119.95 27.78 8.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.872 179.752 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -114.39 -152.68 10.58 Favored Glycine 0 CA--C 1.536 1.388 0 N-CA-C 111.832 -0.507 . . . . 0.0 111.832 -179.363 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -75.49 162.18 36.26 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 123.127 2.551 . . . . 0.0 113.211 -179.097 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 082 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -57.89 150.07 65.82 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 C-N-CA 122.674 2.249 . . . . 0.0 113.282 179.584 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 6.0 p -97.1 132.8 40.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.11 179.641 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 10.7 t -55.84 111.96 1.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.201 -179.221 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . 0.518 HG22 ' H ' ' B' ' 241' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -50.83 -26.97 19.11 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 121.993 1.795 . . . . 0.0 112.592 -179.826 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 42.5 p -74.37 -36.62 63.56 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.577 -0.449 . . . . 0.0 109.793 178.762 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.611 ' CZ ' ' NH1' ' B' ' 245' ' ' ARG . 85.9 t80 -59.39 -48.04 83.15 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.261 -179.153 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.56 HD21 HG23 ' A' ' 91' ' ' ILE . 94.3 mt -64.64 -42.28 95.56 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.445 -179.892 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -69.37 -42.13 75.6 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.867 -179.439 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 62.2 ttp180 -61.87 -46.66 88.43 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.703 -178.799 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.713 HH22 HD21 ' A' ' 41' ' ' LEU . 10.7 ptm85 -71.47 -38.89 71.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.292 -179.476 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -61.54 -39.99 93.05 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.504 179.737 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 23.0 t -69.35 -42.77 74.83 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.289 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 64.1 tp60 -58.21 -40.14 80.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.838 179.758 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.664 HG23 ' O ' ' B' ' 245' ' ' ARG . 89.0 t -67.43 -43.78 87.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.698 179.826 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -57.51 -28.72 63.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.563 -179.879 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -105.95 10.61 32.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.625 179.297 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 46.0 tp -91.44 137.63 32.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.227 -179.76 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . 0.536 ' C ' ' H ' ' B' ' 255' ' ' ASP . 19.4 t-20 -88.42 158.58 18.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.04 0.448 . . . . 0.0 111.078 -179.983 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -61.38 4.12 0.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.637 179.528 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . 0.536 ' H ' ' C ' ' B' ' 253' ' ' ASN . 99.2 m-20 -60.08 -20.9 60.4 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.813 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -95.91 35.21 1.43 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.356 179.186 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -60.07 -9.57 3.34 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.453 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -62.8 -42.71 99.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.321 179.718 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.618 ' C ' ' H ' ' B' ' 261' ' ' ILE . 35.5 t0 80.87 118.57 0.05 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.422 0.63 . . . . 0.0 111.58 179.957 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -54.24 10.91 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.645 -179.636 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.618 ' H ' ' C ' ' B' ' 259' ' ' ASP . 54.9 mt -103.84 134.65 44.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.75 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 77.7 t -123.18 132.37 71.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.43 -179.163 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . 0.577 ' HZ ' HG21 ' A' ' 9' ' ' THR . 45.7 m-85 -95.03 111.92 23.67 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.88 -177.677 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -61.93 -45.52 93.32 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.33 179.19 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . 0.552 ' OE1' HD11 ' A' ' 24' ' ' LEU . 1.8 mm-40 -98.99 156.77 35.12 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.308 -179.472 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.28 152.94 71.77 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 123.158 2.572 . . . . 0.0 113.427 -178.866 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . 0.514 HG22 ' HD2' ' A' ' 21' ' ' PRO . 26.3 pt . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.196 179.112 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo . . . . . 0 N--CA 1.489 1.233 0 CA-C-O 120.869 0.279 . . . . 0.0 111.777 . . . . . . . . . 0 0 . 1 . 083 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 67.3 p -109.51 -35.49 6.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.701 -179.705 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.894 ' NH1' ' HB2' ' A' ' 58' ' ' ALA . 94.0 mtt-85 -93.11 119.99 32.92 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.228 -179.286 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -131.14 139.25 49.76 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.436 179.937 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.62 HD11 ' HB3' ' A' ' 95' ' ' PHE . 46.9 tp -115.25 131.88 56.79 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.979 179.749 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 73.8 t -110.65 133.07 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.597 -178.759 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 m -84.42 143.23 29.56 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.717 0.77 . . . . 0.0 112.475 -179.094 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 50.6 mm -109.39 137.08 43.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 114.238 -1.346 . . . . 0.0 108.807 177.794 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -91.58 160.84 15.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.302 0.573 . . . . 0.0 111.127 179.877 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.457 HH21 ' HG3' ' B' ' 245' ' ' ARG . 82.0 mtp180 -54.1 -32.29 54.53 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.015 -178.949 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 97.7 p -81.64 -6.27 58.85 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.281 -179.958 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.03 38.2 6.92 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -179.869 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.5 t -123.74 133.73 68.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.02 0.438 . . . . 0.0 110.519 179.964 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.481 ' O ' ' OD1' ' A' ' 16' ' ' ASP . 50.8 p-10 -80.19 136.9 36.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.292 179.695 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -131.76 -110.63 1.3 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 120.3 -0.953 . . . . 0.0 112.169 -179.613 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.17 144.08 41.24 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.288 1.992 . . . . 0.0 113.25 -178.608 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -109.06 148.79 30.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.372 179.909 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.521 ' CD2' HD11 ' A' ' 37' ' ' ILE . 35.5 t80 -118.48 94.69 47.72 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.633 -179.262 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -60.69 126.57 20.15 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 121.926 1.751 . . . . 0.0 111.638 179.653 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 63.5 mt -91.18 47.81 1.44 Allowed 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -178.576 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.9 m -66.28 -16.77 64.3 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.701 179.629 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.752 HD11 ' NE2' ' B' ' 265' ' ' GLN . 94.2 mt -78.43 141.3 38.4 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.163 179.496 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 94.3 p -61.17 -21.98 64.29 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.756 -0.657 . . . . 0.0 112.054 -178.488 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 44.5 m -137.42 136.45 37.83 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 120.397 -0.521 . . . . 0.0 112.081 -179.435 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.2 t -129.43 122.6 29.72 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.035 178.315 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.431 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 47.6 tp -117.08 130.63 56.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.197 -179.23 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.739 ' CE2' HD12 ' A' ' 37' ' ' ILE . 7.9 m-85 -107.41 125.67 51.51 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.562 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 172.72 178.64 42.94 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 120.297 -0.954 . . . . 0.0 112.303 179.831 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.652 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 81.2 mtm-85 -77.6 -31.48 53.0 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.016 179.362 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -52.49 150.2 9.29 Favored Glycine 0 N--CA 1.464 0.553 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 -178.872 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.484 HG23 ' N ' ' A' ' 34' ' ' GLU . 8.8 tp -66.76 -42.77 89.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.815 -179.514 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.484 ' N ' HG23 ' A' ' 33' ' ' ILE . 83.8 tt0 -53.44 -18.28 2.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.386 179.406 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.9 m -62.38 127.05 29.5 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.537 -179.742 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.431 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 55.9 m-20 -61.09 -31.64 71.31 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -179.459 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.739 HD12 ' CE2' ' A' ' 29' ' ' PHE . 98.5 mt -126.14 120.98 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 176.539 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.479 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 83.7 mtp180 -100.41 128.55 46.44 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.739 -178.951 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.405 HG22 ' H ' ' A' ' 41' ' ' LEU . 89.5 mt -112.94 128.08 69.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.205 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -80.93 26.74 0.41 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.976 -0.557 . . . . 0.0 112.382 -177.432 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.774 HD11 ' NE ' ' A' ' 93' ' ' ARG . 68.4 mt -94.98 131.73 29.64 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.185 179.263 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.93 -12.1 31.91 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.098 1.865 . . . . 0.0 112.897 -179.676 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.5 m -98.27 12.67 5.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.278 -179.796 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.652 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 14.3 t -100.89 130.86 49.59 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 C-N-CA 120.577 -0.449 . . . . 0.0 109.893 178.695 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.6 t -71.38 173.42 7.87 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.448 0.642 . . . . 0.0 112.125 -178.559 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.6 mttp -64.51 -41.39 96.46 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.89 179.919 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.588 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.2 mt-30 -116.45 -7.32 11.69 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 121.111 -0.235 . . . . 0.0 111.338 -179.566 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.474 ' C ' ' O ' ' A' ' 47' ' ' GLN . 14.9 t60 15.91 -74.88 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -178.695 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.588 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -129.24 133.27 47.44 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.088 -0.645 . . . . 0.0 112.341 -178.335 . . . . . . . . 3 3 . 1 . 083 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -128.47 131.15 48.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.293 179.763 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.4 mt -117.35 133.67 63.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.008 -179.697 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.453 ' OE2' ' CE1' ' A' ' 54' ' ' HIS . 81.7 tt0 -112.41 133.26 54.6 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.51 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.545 HD12 ' HD3' ' A' ' 5' ' ' ARG . 46.4 mm -101.96 124.28 55.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.448 0.642 . . . . 0.0 111.661 -178.637 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.57 ' O ' ' N ' ' A' ' 56' ' ' GLN . 96.9 m-70 -124.92 132.35 53.31 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.488 178.747 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.47 ' C ' ' O ' ' A' ' 54' ' ' HIS . 77.9 tt0 -39.79 -25.34 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.894 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.57 ' N ' ' O ' ' A' ' 54' ' ' HIS . 91.3 mt-30 -66.59 -68.34 0.38 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.018 178.018 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.464 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 5.3 tp10 -158.71 -160.75 0.9 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.209 179.942 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.894 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -118.69 127.89 54.0 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.224 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.7 mt -115.65 129.56 71.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.476 0.655 . . . . 0.0 111.523 -178.927 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.8 tp -96.62 128.86 43.96 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.383 -179.62 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -110.63 132.89 53.8 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.764 179.82 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -94.47 103.95 15.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.299 -179.391 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -97.07 -7.9 31.62 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.741 -0.383 . . . . 0.0 111.015 179.209 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.487 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 12.9 t -72.17 100.92 2.67 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-O 120.779 0.323 . . . . 0.0 110.169 179.256 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.7 p -82.99 -13.85 55.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.874 179.641 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.496 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.2 OUTLIER -96.27 -38.3 10.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.181 -179.534 . . . . . . . . 3 3 . 1 . 083 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.488 HD21 ' HA ' ' B' ' 236' ' ' VAL . 76.1 m-20 -143.11 101.23 5.28 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.772 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.429 ' HB2' HG23 ' A' ' 75' ' ' VAL . 31.5 Cg_exo -58.01 146.39 87.55 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 121.509 1.473 . . . . 0.0 112.436 179.951 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.7 m -73.61 143.53 46.31 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.906 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -104.37 140.94 37.19 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.041 -179.355 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 43.9 t -132.26 135.54 57.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.372 -0.831 . . . . 0.0 108.82 179.562 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 14.0 m120 52.8 26.95 4.91 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -179.235 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.28 29.1 62.72 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.651 -179.634 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.3 m -142.46 140.47 31.92 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.865 0.365 . . . . 0.0 110.827 179.875 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.446 ' H ' HG12 ' A' ' 75' ' ' VAL . 0.2 OUTLIER -73.22 142.75 14.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.013 -179.21 . . . . . . . . 3 3 . 1 . 083 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.467 HG21 HG11 ' A' ' 80' ' ' VAL . 7.5 pt -109.88 92.62 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-O 121.224 0.535 . . . . 0.0 110.911 179.115 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -63.95 -30.95 71.99 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.715 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -121.31 169.49 8.99 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.362 179.865 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -59.06 144.89 99.18 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 121.918 1.745 . . . . 0.0 111.751 179.429 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.467 HG11 HG21 ' A' ' 76' ' ' ILE . 8.2 p -135.21 140.94 44.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.108 0.48 . . . . 0.0 111.445 -179.627 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.455 HH21 ' CE ' ' A' ' 83' ' ' LYS . 62.7 ttp180 -78.2 132.64 37.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.881 179.085 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.429 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 91.8 mt -87.67 137.12 32.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.933 -178.541 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.455 ' CE ' HH21 ' A' ' 81' ' ' ARG . 99.2 mttt -124.86 151.23 45.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.432 179.532 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.495 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 6.8 t60 -54.62 121.3 8.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.771 -179.377 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.28 -18.99 35.2 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.034 -0.827 . . . . 0.0 111.034 -179.942 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -69.05 136.69 52.74 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.551 -0.46 . . . . 0.0 109.86 179.735 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.0 t -113.24 133.53 58.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.543 -178.305 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 89.2 mt -98.32 133.72 39.54 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.684 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 97.4 m -123.2 127.67 48.96 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 119.605 -0.838 . . . . 0.0 112.36 -179.195 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.612 ' O ' ' N ' ' A' ' 93' ' ' ARG . 96.8 mt -116.45 129.64 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 114.123 -1.399 . . . . 0.0 108.41 178.418 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.527 HD13 ' HB2' ' B' ' 237' ' ' CYS . 79.4 mt -18.98 101.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 O-C-N 123.744 0.652 . . . . 0.0 112.279 -179.246 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.496 ' OD1' ' NE ' ' B' ' 245' ' ' ARG . 73.8 m-20 80.37 -18.27 0.51 Allowed 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 178.919 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.774 ' NE ' HD11 ' A' ' 41' ' ' LEU . 59.4 mtt-85 -129.51 141.59 50.96 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.61 179.93 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 30.7 p -138.27 152.83 48.92 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.169 0.509 . . . . 0.0 110.027 179.901 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.62 ' HB3' HD11 ' A' ' 7' ' ' LEU . 65.9 m-85 -128.79 121.93 29.41 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.623 -179.563 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.537 ' O ' HD12 ' A' ' 7' ' ' LEU . 43.8 ttm180 -80.52 128.78 33.99 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.711 -0.395 . . . . 0.0 111.2 -179.705 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.592 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 89.4 t80 -94.62 124.97 38.97 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.597 179.632 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -127.66 122.84 34.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.937 0.399 . . . . 0.0 111.32 -179.89 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.495 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 61.6 t-20 -106.89 107.49 18.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.085 179.095 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 . . . . . 0 C--N 1.331 -0.208 0 CA-C-O 120.861 0.363 . . . . 0.0 110.888 -179.604 . . . . . . . . 0 0 . 1 . 083 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.669 0.271 . . . . 0.0 111.321 . . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.634 ' O ' ' N ' ' B' ' 231' ' ' GLN . 51.9 t0 -98.32 105.75 17.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.781 -179.62 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 083 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.634 ' N ' ' O ' ' B' ' 229' ' ' ASP . 6.0 mt-30 -57.34 -51.52 69.04 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.96 -178.995 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . 0.504 ' O ' ' NH2' ' A' ' 31' ' ' ARG . . . -38.13 161.7 0.01 OUTLIER Glycine 0 CA--C 1.528 0.901 0 N-CA-C 111.743 -0.543 . . . . 0.0 111.743 -179.709 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -74.0 161.24 41.56 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 123.683 2.922 . . . . 0.0 112.99 179.648 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.496 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -79.46 140.69 15.33 Favored 'Trans proline' 0 C--N 1.3 -1.998 0 C-N-CA 121.757 1.638 . . . . 0.0 112.71 -179.011 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.488 ' HA ' HD21 ' A' ' 67' ' ' ASN . 53.1 t -57.46 141.99 13.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.456 179.687 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . 0.527 ' HB2' HD13 ' A' ' 91' ' ' ILE . 17.4 t -63.49 128.58 36.48 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.782 -179.263 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 083 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -58.28 -22.76 59.18 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.176 1.917 . . . . 0.0 112.851 -179.835 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 54.6 m -74.05 -44.22 55.03 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 121.029 0.443 . . . . 0.0 109.849 178.198 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -56.84 -47.12 81.08 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.894 -178.989 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.434 HD23 ' OD1' ' A' ' 92' ' ' ASP . 97.1 mt -66.99 -40.82 87.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.734 179.541 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -60.73 -43.19 98.18 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.854 -179.812 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -60.43 -42.86 96.95 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.505 179.739 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.605 ' O ' HG23 ' B' ' 249' ' ' VAL . 71.7 ttp85 -61.64 -40.61 95.52 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.604 -0.439 . . . . 0.0 111.253 -179.524 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -60.54 -40.16 90.53 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.46 -179.718 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 80.8 p -69.85 -42.22 73.85 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.058 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . 0.455 ' CB ' HH22 ' A' ' 12' ' ' ARG . 87.4 mt-30 -63.55 -32.41 73.86 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.209 179.778 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.605 HG23 ' O ' ' B' ' 245' ' ' ARG . 54.9 t -64.39 -45.45 95.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 120.113 -0.635 . . . . 0.0 109.64 178.477 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -58.72 -31.03 67.91 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.811 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -92.11 -9.74 41.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.843 179.162 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' B' ' 248' ' ' GLN . 35.9 tp -78.63 148.66 33.13 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.274 0.559 . . . . 0.0 111.278 -179.327 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -96.88 123.86 40.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.713 179.362 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -53.32 -27.99 26.1 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.594 -179.431 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -71.67 3.25 4.2 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.674 179.676 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -61.36 146.75 47.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.248 0.547 . . . . 0.0 110.906 -179.861 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -135.1 157.65 46.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.947 179.573 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.615 ' O ' ' N ' ' B' ' 260' ' ' GLU . 1.1 t0 62.47 48.01 4.79 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -178.794 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.477 ' C ' ' OE1' ' B' ' 260' ' ' GLU . 43.6 p-10 -55.75 65.96 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.176 -178.314 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.615 ' N ' ' O ' ' B' ' 258' ' ' ASP . 52.8 mp0 59.07 6.97 0.75 Allowed 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 179.044 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 67.0 mt -113.98 132.17 63.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.202 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 53.2 t -127.12 131.43 70.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.786 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -93.07 120.66 33.61 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.222 0.534 . . . . 0.0 110.335 -178.49 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -64.82 -44.94 88.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.989 -179.416 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . 0.752 ' NE2' HD11 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -99.74 158.56 31.9 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.786 -179.221 . . . . . . . . 3 3 . 1 . 083 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -65.16 153.82 76.47 Favored 'Trans proline' 0 N--CA 1.503 2.039 0 C-N-CA 123.278 2.652 . . . . 0.0 111.846 -179.979 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 47.0 pt . . . . . 0 C--O 1.232 0.153 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -178.514 . . . . . . . . 0 0 . 1 . 084 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo . . . . . 0 N--CA 1.489 1.254 0 N-CA-C 111.24 -0.331 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 084 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.5 m -91.08 -42.38 10.53 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.223 0.535 . . . . 0.0 110.351 179.815 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.3 mtt85 -91.8 129.35 37.78 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.433 -178.728 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.5 mtt85 -130.83 138.0 49.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.276 -179.973 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.545 HD11 ' HB3' ' A' ' 95' ' ' PHE . 39.4 tp -115.11 128.35 56.16 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.619 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.3 m -109.49 132.49 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 121.155 0.502 . . . . 0.0 111.413 -179.078 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.409 ' HG1' ' HE2' ' A' ' 95' ' ' PHE . 2.7 m -80.36 138.56 36.7 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.246 -179.437 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.612 HD12 ' OG ' ' A' ' 94' ' ' SER . 96.5 mt -107.83 138.23 35.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.695 177.715 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -89.14 155.97 19.1 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.014 0.435 . . . . 0.0 109.849 178.434 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.575 HH11 ' CZ ' ' A' ' 93' ' ' ARG . 72.7 mtp85 -58.05 -24.17 57.37 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.429 -179.04 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.2 p -82.47 -8.63 59.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.037 0.446 . . . . 0.0 110.16 178.982 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.76 36.16 6.94 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -179.834 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.6 t -121.88 133.5 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.801 0.334 . . . . 0.0 111.069 -179.993 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 17' ' ' GLY . 61.6 t0 -78.43 132.58 37.38 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.236 179.397 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.461 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -125.72 -113.56 1.92 Allowed Glycine 0 CA--C 1.537 1.458 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.954 -179.736 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -71.68 143.9 43.0 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 122.324 2.016 . . . . 0.0 113.298 -178.568 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.541 ' O ' ' CD1' ' B' ' 267' ' ' ILE . 0.3 OUTLIER -111.29 135.81 51.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.135 0.493 . . . . 0.0 111.119 -179.89 . . . . . . . . 3 3 . 1 . 084 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -105.81 105.76 54.25 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.405 179.976 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -74.31 129.49 13.04 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 121.33 1.353 . . . . 0.0 111.911 -178.899 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 74.5 mt -83.97 47.04 1.25 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.859 -178.777 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.0 p -64.08 -21.57 66.58 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.969 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.478 HD11 ' OE1' ' B' ' 265' ' ' GLN . 79.3 mt -83.31 143.71 30.19 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.007 179.796 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.7 t -64.14 -21.73 66.66 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.947 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.415 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 56.2 m -135.63 135.54 40.28 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.181 -0.608 . . . . 0.0 112.369 -179.012 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.574 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 16.9 t -127.9 119.83 26.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.324 178.4 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.441 HD12 ' O ' ' A' ' 49' ' ' CYS . 49.1 tp -118.07 130.89 56.41 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.229 -178.546 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.621 ' CE2' HD12 ' A' ' 37' ' ' ILE . 5.5 m-85 -108.53 140.78 41.38 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.2 179.852 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 152.21 -176.28 30.55 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.249 178.393 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.695 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 76.8 mtm-85 -75.89 -32.23 59.57 Favored 'General case' 0 C--N 1.338 0.068 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.197 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.582 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -48.08 143.37 7.04 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 -178.471 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.512 ' CD1' ' CZ ' ' A' ' 38' ' ' ARG . 32.2 mm -65.79 -43.91 93.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.647 179.803 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -54.28 -17.74 3.25 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.789 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.582 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 39.4 m -60.16 121.47 11.99 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.218 179.851 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.415 ' OD2' ' O ' ' A' ' 26' ' ' THR . 99.0 m-20 -60.69 -28.64 68.77 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.238 -179.264 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.621 HD12 ' CE2' ' A' ' 29' ' ' PHE . 96.7 mt -126.13 120.54 57.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 176.798 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.512 ' CZ ' ' CD1' ' A' ' 33' ' ' ILE . 84.0 mtp180 -103.99 132.53 50.15 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.938 -178.199 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.581 HG21 HD12 ' A' ' 41' ' ' LEU . 84.8 mt -121.49 130.79 74.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 121.03 0.443 . . . . 0.0 109.961 179.491 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -78.44 41.5 0.4 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.232 -178.495 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.581 HD12 HG21 ' A' ' 39' ' ' ILE . 77.8 mt -105.88 104.99 51.71 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.44 179.41 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -57.61 -15.39 20.22 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.117 1.878 . . . . 0.0 112.148 179.532 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.461 HG21 ' CE2' ' B' ' 241' ' ' PHE . 35.0 m -91.11 4.89 6.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.237 -179.632 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.695 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 24.9 t -104.18 140.32 22.62 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.354 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.128 180.0 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.4 ' HA ' HG21 ' B' ' 234' ' ' TPO . 18.4 m -71.05 168.09 17.84 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.284 0.564 . . . . 0.0 112.276 -179.236 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -61.8 -39.29 91.2 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.271 -179.678 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.643 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.6 mt-30 -111.17 -19.43 12.7 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.904 179.813 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.3 t60 35.85 -75.86 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 179.015 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.643 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.83 134.45 46.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.266 0.555 . . . . 0.0 112.106 -177.871 . . . . . . . . 3 3 . 1 . 084 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -127.43 131.71 50.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.458 179.668 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 98.0 mt -118.03 133.88 63.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.175 179.933 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -117.69 134.37 54.96 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.102 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 48.3 mm -98.56 119.71 46.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.831 179.819 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.483 ' O ' ' N ' ' A' ' 56' ' ' GLN . 98.4 m-70 -123.85 135.53 53.8 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.137 -179.989 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 54' ' ' HIS . 92.8 mt-10 -41.28 -25.97 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -179.396 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.483 ' N ' ' O ' ' A' ' 54' ' ' HIS . 47.9 tt0 -67.3 -68.87 0.35 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.75 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -156.95 -163.44 1.41 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.399 179.094 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.412 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -108.92 126.09 52.71 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 177.47 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.9 mt -114.9 129.52 70.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.243 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.621 ' HB2' HD11 ' A' ' 82' ' ' LEU . 26.1 tp -100.14 129.2 46.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.135 179.634 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -113.24 135.56 53.7 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.877 -179.713 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -94.35 104.7 16.67 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.403 179.708 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -96.75 -10.78 26.06 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.194 179.397 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.4 t -68.18 101.47 1.18 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.046 179.653 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.5 p -84.35 -7.22 59.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.066 0.46 . . . . 0.0 110.024 179.895 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.822 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.2 OUTLIER -103.44 -43.85 5.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.836 -179.131 . . . . . . . . 3 3 . 1 . 084 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.424 ' OD1' HG13 ' B' ' 236' ' ' VAL . 64.2 m-20 -140.23 99.39 7.25 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.646 -179.769 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.591 ' HB2' HG13 ' A' ' 75' ' ' VAL . 52.9 Cg_exo -55.19 145.95 62.7 Favored 'Trans proline' 0 N--CA 1.5 1.904 0 C-N-CA 122.359 2.039 . . . . 0.0 113.236 -179.348 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.2 m -73.11 137.96 45.52 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.869 178.796 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -99.24 140.77 32.91 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.517 179.82 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 55.9 t -128.82 135.34 62.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.685 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 52.04 31.44 8.76 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.124 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.8 28.18 69.42 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.489 179.921 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.1 p -140.69 139.22 34.71 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 120.774 -0.371 . . . . 0.0 111.48 -179.735 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.591 HG13 ' HB2' ' A' ' 68' ' ' PRO . 38.8 t -70.37 138.32 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.16 -179.6 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.7 pt -112.73 96.68 4.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.1 178.321 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -66.65 -26.14 66.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.189 -179.76 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.437 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.3 OUTLIER -130.93 178.55 1.68 Allowed Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.312 -179.086 . . . . . . . . 3 3 . 1 . 084 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.437 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 36.1 Cg_exo -59.99 146.27 96.38 Favored 'Trans proline' 0 N--CA 1.505 2.155 0 C-N-CA 123.09 2.527 . . . . 0.0 112.802 -179.775 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.6 p -144.37 141.65 24.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.634 179.984 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -78.89 133.95 36.93 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.52 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.621 HD11 ' HB2' ' A' ' 60' ' ' LEU . 89.0 mt -91.18 140.44 29.8 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.991 0.424 . . . . 0.0 111.522 -179.074 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -128.2 157.5 40.68 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.981 179.165 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.452 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 5.8 t60 -53.99 115.71 2.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.523 -178.553 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.3 -10.65 26.52 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.142 179.16 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -67.67 135.34 52.65 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.018 -179.836 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.58 HG22 ' HG2' ' A' ' 96' ' ' ARG . 48.9 t -109.44 126.57 66.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.43 -179.665 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 84.8 mt -100.42 131.25 48.31 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 178.514 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 75.3 m -122.84 129.1 51.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.715 0.769 . . . . 0.0 112.584 -178.189 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.462 ' O ' ' C ' ' A' ' 91' ' ' ILE . 95.0 mt -116.53 128.07 73.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 114.493 -1.23 . . . . 0.0 108.621 178.537 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.462 ' C ' ' O ' ' A' ' 90' ' ' ILE . 42.4 mm 34.02 -99.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.166 -179.428 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.504 ' O ' ' OD1' ' A' ' 92' ' ' ASP . 61.7 t0 -115.55 16.49 16.55 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 120.94 0.4 . . . . 0.0 110.847 -179.576 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.58 HH21 ' CD ' ' B' ' 260' ' ' GLU . 73.1 mtt-85 -127.93 144.5 51.1 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.67 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.612 ' OG ' HD12 ' A' ' 10' ' ' ILE . 12.6 p -140.92 156.81 46.01 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.391 0.615 . . . . 0.0 111.637 -179.551 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.545 ' HB3' HD11 ' A' ' 7' ' ' LEU . 61.1 m-85 -132.54 133.58 43.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.412 179.617 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.58 ' HG2' HG22 ' A' ' 87' ' ' VAL . 70.4 mtp85 -98.48 137.78 36.66 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 119.881 -0.727 . . . . 0.0 110.361 179.906 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 93.9 t80 -93.24 122.99 36.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.689 -179.881 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.408 ' HG3' ' CE1' ' A' ' 84' ' ' HIS . 84.4 tt0 -123.93 119.48 29.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.166 179.397 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.452 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 47.5 t-20 -104.22 113.81 27.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.64 180.0 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.182 179.813 . . . . . . . . 0 0 . 1 . 084 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . 0.563 HG12 ' H ' ' B' ' 231' ' ' GLN . 86.2 t . . . . . 0 N--CA 1.456 -0.173 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 . . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 57.56 32.12 21.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.218 178.971 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . 0.456 ' O ' ' NE2' ' B' ' 231' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.563 ' H ' HG12 ' B' ' 228' ' ' VAL . 96.4 mm-40 -136.87 30.83 2.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.577 179.759 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -142.76 177.99 21.44 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.671 -0.571 . . . . 0.0 111.671 -179.366 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.76 163.19 37.82 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 123.933 3.088 . . . . 0.0 112.47 -179.921 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.822 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -78.13 141.59 18.68 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 C-N-CA 121.87 1.713 . . . . 0.0 112.288 -179.758 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.433 ' CG2' HG22 ' A' ' 66' ' ' THR . 54.7 t -60.58 140.53 18.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.383 -179.541 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 6.5 t -67.29 131.64 46.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.235 -179.747 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 084 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -50.77 -22.55 9.96 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 122.171 1.914 . . . . 0.0 112.962 179.826 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 40.9 p -75.95 -40.27 54.35 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.289 -0.564 . . . . 0.0 109.909 178.441 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.561 ' CZ ' ' NE ' ' B' ' 245' ' ' ARG . 81.6 t80 -57.3 -48.04 79.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.415 -179.626 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.424 ' HA ' HD23 ' B' ' 242' ' ' LEU . 89.4 mt -65.91 -42.09 90.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.018 179.964 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -67.94 -39.87 83.39 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.798 -179.463 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -60.88 -46.63 89.88 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.444 -179.154 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.859 ' O ' HG23 ' B' ' 249' ' ' VAL . 94.0 mtt-85 -67.78 -38.53 83.51 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.615 179.806 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -60.78 -40.28 91.99 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.101 -179.45 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 9.7 t -65.53 -45.62 82.73 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.656 0.741 . . . . 0.0 109.56 177.911 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -64.91 -31.44 72.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.539 -179.914 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.859 HG23 ' O ' ' B' ' 245' ' ' ARG . 93.8 t -68.54 -46.81 79.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.966 0.412 . . . . 0.0 110.538 179.363 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -59.89 -25.11 64.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.587 179.765 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -96.98 5.34 50.63 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.408 178.844 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.701 HD11 ' OD2' ' B' ' 256' ' ' ASP . 37.3 tp -106.77 130.29 54.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.055 0.455 . . . . 0.0 111.113 -178.966 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -60.56 146.42 45.18 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.814 -179.22 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -70.62 -16.93 62.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.154 179.921 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -78.54 -1.48 34.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.454 -179.352 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.701 ' OD2' HD11 ' B' ' 252' ' ' LEU . 84.7 m-20 -85.41 89.4 7.67 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.716 -179.903 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -72.38 179.73 3.31 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.796 -0.361 . . . . 0.0 110.454 -179.896 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 58.24 67.93 0.89 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -179.097 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.531 ' CG ' HH12 ' A' ' 93' ' ' ARG . 34.2 t0 -80.61 62.84 4.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.095 -179.667 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.58 ' CD ' HH21 ' A' ' 93' ' ' ARG . 94.8 mt-10 65.1 13.41 8.68 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.898 179.149 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 68.2 mt -113.77 131.05 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.34 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 40.4 t -128.46 135.86 61.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.829 0.347 . . . . 0.0 111.308 -179.076 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -97.24 119.01 34.97 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.221 0.534 . . . . 0.0 111.651 -179.31 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -62.98 -46.45 87.62 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.986 178.984 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . 0.478 ' OE1' HD11 ' A' ' 24' ' ' LEU . 3.6 mm-40 -90.15 156.39 46.38 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.191 -179.554 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -60.17 142.59 98.63 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 C-N-CA 122.226 1.951 . . . . 0.0 112.183 -179.845 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . 0.541 ' CD1' ' O ' ' A' ' 19' ' ' HIS . 3.9 tt . . . . . 0 C--N 1.325 -0.494 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.946 -179.72 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo . . . . . 0 N--CA 1.495 1.591 0 CA-C-O 120.554 0.147 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 085 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.454 HG22 ' OD1' ' A' ' 99' ' ' ASN . 22.1 m -73.75 -46.62 44.69 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -179.493 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.457 ' CD ' ' OH ' ' A' ' 97' ' ' TYR . 82.0 mtt85 -102.04 134.34 45.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.832 0.349 . . . . 0.0 111.218 -178.782 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.471 HH21 ' CD ' ' A' ' 98' ' ' GLU . 36.8 ptt180 -142.48 157.42 44.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.866 179.722 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 74.0 mt -120.83 147.19 45.71 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.033 -179.811 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.7 t -116.21 126.77 73.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.377 178.658 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.3 m -78.66 138.48 38.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.487 0.661 . . . . 0.0 111.801 -178.692 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.6 mm -103.37 132.61 49.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.63 178.208 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -86.75 155.86 20.17 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.12 179.5 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.951 HH21 HD22 ' B' ' 252' ' ' LEU . 87.4 mtm180 -58.39 -30.28 66.69 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.052 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.6 t -74.62 -15.06 60.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.805 179.246 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.0 30.75 7.7 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 -179.431 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.1 t -119.09 133.99 64.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.94 0.4 . . . . 0.0 111.121 -179.964 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -74.75 136.98 41.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.838 178.981 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.51 -120.31 2.24 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 120.558 -0.829 . . . . 0.0 111.782 -179.905 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -73.54 152.84 49.09 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.173 1.915 . . . . 0.0 112.428 -179.111 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -114.1 156.07 24.84 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.015 179.471 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.558 ' CD2' HD11 ' A' ' 37' ' ' ILE . 37.3 t80 -119.97 104.04 44.63 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.451 -179.946 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.3 130.43 16.29 Favored 'Trans proline' 0 N--CA 1.488 1.19 0 C-N-CA 121.356 1.371 . . . . 0.0 112.59 -178.913 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.1 mt -83.88 45.7 1.11 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.749 -179.431 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.8 m -59.29 -28.73 67.02 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.666 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.691 HD11 ' HG2' ' B' ' 265' ' ' GLN . 78.3 mt -77.84 143.12 38.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.622 179.976 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 95.7 p -64.44 -21.08 66.54 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.219 -179.567 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 90.9 m -135.48 136.04 40.96 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.053 0.454 . . . . 0.0 112.153 -179.593 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.643 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 3.4 t -131.72 124.05 28.98 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.515 178.361 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.529 HD21 ' HG2' ' A' ' 47' ' ' GLN . 31.4 tp -116.36 130.49 56.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.934 -178.982 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.759 ' CE2' HD12 ' A' ' 37' ' ' ILE . 14.4 m-85 -107.34 141.07 39.28 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.436 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 160.21 -164.34 34.33 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 119.566 -1.302 . . . . 0.0 112.979 179.198 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.8 ttp85 -98.85 -32.11 11.51 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 114.977 -0.612 . . . . 0.0 111.88 -179.268 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -57.56 156.25 17.11 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.509 -1.037 . . . . 0.0 110.509 -179.795 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.584 ' O ' ' NE ' ' A' ' 38' ' ' ARG . 8.7 tp -63.97 -42.37 95.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 117.327 0.563 . . . . 0.0 112.235 -178.616 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.481 ' OE1' ' N ' ' A' ' 34' ' ' GLU . 57.9 mp0 -56.89 -17.41 9.38 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.267 -178.699 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.585 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 89.5 m -59.86 122.74 14.99 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.244 -0.583 . . . . 0.0 110.087 179.522 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.448 ' O ' ' CB ' ' B' ' 264' ' ' LYS . 71.5 m-20 -59.9 -31.18 69.57 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.273 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.759 HD12 ' CE2' ' A' ' 29' ' ' PHE . 94.6 mt -122.03 115.52 46.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 176.384 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.584 ' NE ' ' O ' ' A' ' 33' ' ' ILE . 74.5 mtt85 -104.43 138.22 41.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.006 -177.267 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.597 HG23 ' O ' ' B' ' 260' ' ' GLU . 80.1 mt -119.5 130.49 73.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.839 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -73.7 38.79 0.1 Allowed 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -177.867 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.723 HD13 HH21 ' A' ' 93' ' ' ARG . 39.7 mt -125.04 129.64 24.47 Favored Pre-proline 0 C--N 1.325 -0.487 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.938 179.771 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.06 -11.83 27.58 Favored 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 122.404 2.069 . . . . 0.0 113.392 -178.973 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.652 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 27.5 m -83.94 -4.32 8.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.411 179.549 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 40.8 t -87.38 133.13 30.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.209 179.578 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.5 t -65.25 161.16 19.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.779 -179.198 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.585 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 93.7 mttt -62.02 -44.35 96.9 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.485 -178.951 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.643 ' O ' ' N ' ' A' ' 49' ' ' CYS . 89.5 mt-30 -116.9 -18.23 10.22 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.921 0.391 . . . . 0.0 111.014 179.682 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 16.7 t60 33.66 -72.21 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 179.415 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.643 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.11 137.18 46.22 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -177.726 . . . . . . . . 3 3 . 1 . 085 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -125.32 126.78 45.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.686 179.176 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 88.0 mt -110.36 131.73 60.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.995 -179.933 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -115.38 131.29 56.98 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.925 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.1 mm -100.39 122.24 52.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.841 -179.312 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.454 ' O ' ' C ' ' A' ' 55' ' ' GLU . 97.1 m-70 -122.42 132.15 54.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.199 179.25 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 54' ' ' HIS . 76.6 mt-10 -40.68 -36.71 0.64 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -178.457 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.487 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 88.7 mt-30 -62.85 -66.7 0.5 Allowed 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.401 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.487 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 3.8 tp10 -153.74 -168.3 2.93 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.678 -179.658 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.448 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -118.4 132.87 56.24 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.099 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.1 mt -118.59 129.89 74.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.392 0.615 . . . . 0.0 111.956 -178.666 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.453 ' HB2' HD21 ' A' ' 82' ' ' LEU . 40.1 tp -95.13 129.07 42.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.046 179.997 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -113.76 136.12 53.21 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 179.956 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.612 ' ND2' ' H ' ' A' ' 69' ' ' THR . 17.1 t-20 -97.41 107.64 20.19 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.988 0.423 . . . . 0.0 111.787 -179.582 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -98.65 -10.77 22.8 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.622 179.162 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.3 t -69.78 101.03 1.61 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.443 179.914 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 90.3 p -84.34 -14.27 50.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.972 0.415 . . . . 0.0 110.039 179.614 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.578 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -98.45 -40.8 8.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.161 -179.004 . . . . . . . . 3 3 . 1 . 085 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -137.09 93.79 13.0 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.053 -179.687 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.462 ' HA ' HD21 ' A' ' 62' ' ' ASN . 32.1 Cg_exo -56.75 144.03 88.33 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.256 1.97 . . . . 0.0 112.226 -179.822 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.612 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 95.1 m -71.29 137.13 48.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.056 179.707 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -98.32 141.29 31.4 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.614 178.982 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 55.5 t -130.15 136.55 58.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.251 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 53.37 32.33 13.6 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.252 -179.691 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.11 27.5 72.86 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.48 -179.99 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.1 m -138.37 137.51 37.38 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.383 -179.634 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.403 ' O ' HG13 ' A' ' 75' ' ' VAL . 5.9 p -71.05 135.51 27.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.017 0.437 . . . . 0.0 111.897 -179.67 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.877 HD11 ' O ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -136.18 121.95 29.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.727 178.545 . . . . . . . . 3 3 . 1 . 085 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.7 p-10 -103.22 -5.02 23.56 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 120.801 -0.359 . . . . 0.0 111.475 -179.273 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.877 ' O ' HD11 ' A' ' 76' ' ' ILE . 21.4 mt-10 -116.13 151.49 46.71 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.747 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -60.35 146.23 97.03 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.016 1.811 . . . . 0.0 112.422 -179.12 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.6 m -141.32 147.26 22.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.325 -179.644 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -73.87 131.12 41.16 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 178.858 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.453 HD21 ' HB2' ' A' ' 60' ' ' LEU . 95.7 mt -78.46 134.76 37.3 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.257 179.965 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -124.9 148.83 48.12 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 178.848 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.415 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 6.1 t60 -55.1 121.42 8.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.393 -178.944 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.32 -19.13 34.86 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 179.975 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -67.61 134.79 51.82 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.385 179.919 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.544 HG22 ' HG2' ' A' ' 96' ' ' ARG . 47.5 t -110.04 132.48 58.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.811 -179.257 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 86.6 mt -101.33 132.16 47.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 178.697 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 55.7 m -124.89 124.1 41.34 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 119.953 -0.699 . . . . 0.0 112.054 -178.543 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.461 ' O ' ' C ' ' A' ' 91' ' ' ILE . 86.6 mt -109.74 127.84 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.058 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.734 HG22 ' N ' ' A' ' 92' ' ' ASP . 95.3 mt 37.32 -100.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.583 -179.149 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.734 ' N ' HG22 ' A' ' 91' ' ' ILE . 1.6 t70 -118.36 15.93 13.9 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.816 0.341 . . . . 0.0 110.963 -179.827 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.723 HH21 HD13 ' A' ' 41' ' ' LEU . 3.4 mtm105 -124.04 138.69 54.41 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.916 -179.588 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 47.0 t -137.7 151.85 48.65 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.917 -179.405 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.475 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 82.4 m-85 -127.21 123.33 36.35 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.582 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.544 ' HG2' HG22 ' A' ' 87' ' ' VAL . 99.6 mtt180 -82.85 135.98 34.77 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.048 -178.304 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.457 ' OH ' ' CD ' ' A' ' 5' ' ' ARG . 88.4 t80 -93.97 122.83 36.87 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.337 -179.854 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.471 ' CD ' HH21 ' A' ' 6' ' ' ARG . 76.1 tt0 -126.93 122.25 34.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.779 179.911 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.454 ' OD1' HG22 ' A' ' 4' ' ' THR . 62.0 t-20 -109.26 113.27 25.96 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.588 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.406 ' O ' HG23 ' A' ' 4' ' ' THR . 96.9 mt-10 . . . . . 0 C--N 1.33 -0.28 0 CA-C-O 120.974 0.416 . . . . 0.0 110.938 -179.189 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . 0.523 ' O ' ' O ' ' B' ' 229' ' ' ASP . 15.4 m . . . . . 0 CA--C 1.522 -0.107 0 CA-C-O 120.532 0.206 . . . . 0.0 111.029 . . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.587 ' C ' ' H ' ' B' ' 231' ' ' GLN . 97.4 m-20 57.11 129.89 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.247 -179.403 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 085 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.587 ' H ' ' C ' ' B' ' 229' ' ' ASP . 82.7 mt-30 -122.62 -17.37 6.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.513 0.673 . . . . 0.0 109.32 179.599 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' B' ' 231' ' ' GLN . . . -47.03 -173.39 0.01 OUTLIER Glycine 0 CA--C 1.525 0.702 0 CA-C-N 114.975 -1.011 . . . . 0.0 112.675 -178.974 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.31 161.61 43.92 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 123.489 2.793 . . . . 0.0 113.584 -179.25 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 085 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -60.54 131.83 40.11 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.077 1.851 . . . . 0.0 112.872 -179.753 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.578 ' CG2' HG22 ' A' ' 66' ' ' THR . 40.4 t -66.78 135.35 28.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.225 -0.898 . . . . 0.0 108.72 178.662 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 35.9 t -54.62 120.54 6.85 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.085 -179.027 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 085 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -57.46 -25.25 65.45 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.361 2.041 . . . . 0.0 112.199 179.018 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 24.7 m -73.34 -44.81 58.15 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.238 0.542 . . . . 0.0 109.552 178.286 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.652 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 83.4 t80 -56.67 -45.71 81.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.79 -179.963 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' B' ' 242' ' ' LEU . 88.8 mt -64.08 -41.65 97.24 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.559 179.871 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -60.69 -40.78 93.46 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.429 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -64.29 -42.32 96.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.423 179.094 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.604 HH11 ' CD ' ' A' ' 12' ' ' ARG . 58.1 ttm-85 -58.06 -42.9 86.48 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.168 -179.895 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -60.71 -39.94 90.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.167 -179.977 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 59.2 m -65.14 -44.49 88.46 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.025 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . 0.417 ' O ' ' N ' ' B' ' 252' ' ' LEU . 81.9 mt-30 -60.41 -37.45 80.9 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.802 -179.895 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 38.7 t -61.04 -46.44 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 C-N-CA 119.864 -0.734 . . . . 0.0 109.805 178.908 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -58.2 -30.29 66.35 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.528 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -90.56 -10.89 41.78 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.964 178.847 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.951 HD22 HH21 ' A' ' 12' ' ' ARG . 38.5 tp -79.14 138.99 38.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.779 -179.903 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -109.48 143.54 38.95 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.136 179.043 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -62.48 -21.77 65.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.104 0.478 . . . . 0.0 109.919 -179.378 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -67.99 -7.65 30.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.68 -179.455 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.412 ' C ' ' H ' ' B' ' 258' ' ' ASP . 68.3 t0 -98.51 81.59 2.74 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.281 179.086 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -73.23 19.12 0.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.889 -178.554 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.668 ' O ' ' N ' ' B' ' 260' ' ' GLU . 43.1 t0 -99.07 0.82 44.47 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 177.869 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.504 ' C ' ' H ' ' B' ' 261' ' ' ILE . 32.9 t70 6.09 51.58 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 114.272 -1.331 . . . . 0.0 113.4 179.487 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.668 ' N ' ' O ' ' B' ' 258' ' ' ASP . 51.7 mp0 54.12 1.25 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 179.398 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.504 ' H ' ' C ' ' B' ' 259' ' ' ASP . 75.4 mt -114.21 136.46 50.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.086 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . 0.405 ' N ' ' O ' ' A' ' 38' ' ' ARG . 50.2 t -128.18 137.92 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.86 0.362 . . . . 0.0 110.939 -179.565 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -100.86 122.64 43.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.117 0.484 . . . . 0.0 111.386 -179.117 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . 0.46 ' HG3' HH22 ' A' ' 38' ' ' ARG . 89.2 tttt -64.35 -45.88 85.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.309 179.238 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . 0.691 ' HG2' HD11 ' A' ' 24' ' ' LEU . 5.0 mp0 -99.82 163.63 18.07 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.976 -179.008 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.59 156.47 65.46 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.836 2.357 . . . . 0.0 111.459 178.916 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 37.6 pt . . . . . 0 C--N 1.325 -0.461 0 CA-C-O 121.267 0.556 . . . . 0.0 112.085 -178.832 . . . . . . . . 0 0 . 1 . 086 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo . . . . . 0 N--CA 1.491 1.327 0 CA-C-O 120.968 0.32 . . . . 0.0 112.034 . . . . . . . . . 0 0 . 1 . 086 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 t -123.56 29.07 6.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.854 -179.253 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.401 ' HD2' HD13 ' A' ' 53' ' ' ILE . 83.9 mtt85 -85.63 122.11 29.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.341 -179.589 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -126.73 137.46 53.25 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.537 179.847 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.537 HD11 ' HB3' ' A' ' 95' ' ' PHE . 30.6 tp -114.67 127.54 55.82 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.617 179.98 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.553 HG11 ' OD2' ' A' ' 16' ' ' ASP . 64.2 t -104.53 134.19 46.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.105 179.684 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.417 HG23 ' CD1' ' B' ' 261' ' ' ILE . 2.8 m -94.42 118.93 32.38 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.247 0.546 . . . . 0.0 112.141 -178.516 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.612 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 95.3 mt -83.02 141.8 14.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.999 179.541 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.461 ' HA ' HH22 ' A' ' 93' ' ' ARG . 98.0 mttt -88.44 159.26 18.07 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 178.856 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.602 HH12 ' CD ' ' B' ' 248' ' ' GLN . 84.5 mtp180 -57.22 -29.63 63.92 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 121.059 -0.257 . . . . 0.0 111.139 -178.764 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.4 m -81.18 -6.21 58.59 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.605 179.393 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.97 36.85 7.5 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 -179.557 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.3 t -119.1 132.64 68.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.836 0.351 . . . . 0.0 110.633 -179.535 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.553 ' OD2' HG11 ' A' ' 8' ' ' VAL . 68.4 t0 -76.21 130.81 38.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.65 -179.549 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.17 -116.08 1.87 Allowed Glycine 0 CA--C 1.539 1.579 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.737 -179.438 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.5 145.91 38.53 Favored 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 122.797 2.331 . . . . 0.0 113.867 -178.301 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -109.23 150.12 28.41 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.12 0.486 . . . . 0.0 110.807 179.544 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.518 ' CD2' HD11 ' A' ' 37' ' ' ILE . 30.8 t80 -120.42 106.06 40.79 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.02 179.577 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -73.21 125.91 10.66 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 C-N-CA 121.459 1.439 . . . . 0.0 112.137 -178.583 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.419 HD22 ' SG ' ' A' ' 27' ' ' CYS . 57.0 mt -88.27 43.5 1.13 Allowed 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.108 -178.796 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 80.0 p -66.24 -19.55 65.86 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.564 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 90.0 mt -73.46 142.71 46.83 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.678 179.575 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 71.5 p -59.41 -24.95 63.9 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.474 -179.135 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 39.1 m -136.93 134.05 36.35 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.918 -179.6 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.419 ' SG ' HD22 ' A' ' 22' ' ' LEU . 5.5 t -126.03 122.24 35.31 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.335 178.169 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.609 HD21 ' OE1' ' A' ' 47' ' ' GLN . 41.7 tp -118.09 129.79 55.76 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.478 -178.441 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.649 ' CE2' HD12 ' A' ' 37' ' ' ILE . 4.7 m-85 -108.29 139.57 42.8 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 123.425 0.453 . . . . 0.0 110.06 179.395 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 178.22 -170.34 42.44 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 178.861 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.527 ' NH2' ' O ' ' B' ' 233' ' ' PRO . 27.9 ptt-85 -100.11 -3.23 32.27 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.543 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -81.87 166.29 46.66 Favored Glycine 0 CA--C 1.52 0.371 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -179.326 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 19.3 tt -96.16 5.73 8.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.216 0.532 . . . . 0.0 110.308 179.969 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -95.64 -7.96 36.13 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.989 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.2 m -91.44 151.1 20.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.137 -179.94 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.419 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 55.1 m-20 -60.77 -32.36 71.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.186 -179.641 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.649 HD12 ' CE2' ' A' ' 29' ' ' PHE . 98.4 mt -128.12 127.29 67.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.463 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -113.42 136.85 52.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.894 -178.775 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 85.6 mt -118.34 130.64 72.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.685 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -73.02 35.43 0.08 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.29 -178.035 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.481 HD21 ' NH1' ' B' ' 245' ' ' ARG . 59.7 mt -109.97 129.07 24.34 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.017 -179.83 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.413 ' O ' ' HD2' ' B' ' 235' ' ' PRO . 60.9 Cg_endo -72.5 -6.86 19.85 Favored 'Trans proline' 0 N--CA 1.49 1.292 0 C-N-CA 122.314 2.009 . . . . 0.0 112.623 -179.798 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.447 HG21 ' CE2' ' B' ' 241' ' ' PHE . 6.1 m -102.41 7.21 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.035 179.368 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 37.1 t -93.3 134.11 32.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.817 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.9 m -68.14 160.37 29.16 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.639 0.733 . . . . 0.0 112.481 -178.782 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -63.56 -41.3 98.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.088 -179.445 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.641 ' O ' ' N ' ' A' ' 49' ' ' CYS . 98.3 mm-40 -113.84 -19.22 11.58 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.005 -179.971 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 21.7 t60 26.83 -74.65 0.0 OUTLIER 'General case' 0 C--O 1.235 0.335 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 179.969 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.641 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.19 134.48 46.53 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.6 0.714 . . . . 0.0 112.727 -178.206 . . . . . . . . 3 3 . 1 . 086 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -127.36 129.63 47.95 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.313 179.865 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 98.1 mt -113.92 132.25 63.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.438 179.859 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -111.19 126.38 54.8 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 178.088 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.401 HD13 ' HD2' ' A' ' 5' ' ' ARG . 82.2 mt -104.22 115.18 45.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.819 0.819 . . . . 0.0 111.952 -179.002 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.428 ' O ' ' C ' ' A' ' 55' ' ' GLU . 98.3 m-70 -117.55 142.57 47.03 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.265 -1.334 . . . . 0.0 110.165 179.844 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 54' ' ' HIS . 87.3 tt0 -40.5 -33.16 0.24 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.673 179.539 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.502 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 64.6 tp60 -61.72 -68.03 0.36 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.55 179.417 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.502 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 6.5 tp10 -156.41 -168.71 2.8 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.463 -178.641 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.442 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -110.46 126.81 54.73 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.412 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.8 mt -115.09 131.15 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -177.689 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.556 ' HB2' HD11 ' A' ' 82' ' ' LEU . 21.6 tp -101.59 127.78 48.15 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.769 179.862 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -110.92 135.58 51.24 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.737 179.876 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.466 ' ND2' ' O ' ' A' ' 76' ' ' ILE . 48.6 t-20 -94.92 104.5 16.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.296 -179.196 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -99.53 -9.65 23.04 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.307 179.729 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.05 102.75 1.69 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.478 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 81.6 p -88.91 -15.94 33.12 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.225 179.911 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.73 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.2 OUTLIER -90.97 -42.78 10.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.261 -179.805 . . . . . . . . 3 3 . 1 . 086 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.445 HD21 ' HA ' ' B' ' 236' ' ' VAL . 46.4 m-20 -141.2 103.45 6.1 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.483 -179.729 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -56.25 144.85 80.13 Favored 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 121.9 1.733 . . . . 0.0 113.188 -179.097 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.5 m -73.3 140.05 46.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.593 178.459 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -101.26 139.61 36.7 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.15 0.5 . . . . 0.0 111.532 -179.874 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.68 HG13 ' OD1' ' A' ' 86' ' ' ASP . 45.1 t -136.4 133.79 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.956 178.63 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 8.0 m120 54.49 32.31 16.52 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.075 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.67 29.16 63.9 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-N 115.14 -0.936 . . . . 0.0 112.212 179.388 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 64.1 m -149.87 147.47 27.99 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 117.401 0.601 . . . . 0.0 111.674 -179.742 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.8 m -75.82 149.48 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.103 0.477 . . . . 0.0 111.733 -179.695 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.466 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 4.0 pt -120.97 97.94 5.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.663 179.312 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -69.25 -23.34 63.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.719 179.724 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -129.85 177.25 2.28 Favored Pre-proline 0 N--CA 1.469 0.506 0 C-N-CA 121.191 -0.203 . . . . 0.0 111.324 -179.84 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -61.02 146.7 97.41 Favored 'Trans proline' 0 N--CA 1.503 2.071 0 C-N-CA 123.042 2.495 . . . . 0.0 112.744 179.649 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.4 p -143.67 138.99 25.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.696 179.884 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 88.9 mtm180 -74.84 133.05 41.94 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.176 179.475 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.556 HD11 ' HB2' ' A' ' 60' ' ' LEU . 93.3 mt -89.23 129.09 35.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.963 0.411 . . . . 0.0 110.696 179.77 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -117.22 156.15 28.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.243 179.594 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -56.01 118.41 4.62 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.178 179.978 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.35 -17.42 18.99 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -179.775 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.68 ' OD1' HG13 ' A' ' 71' ' ' VAL . 54.3 t0 -65.63 127.57 32.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.256 0.55 . . . . 0.0 110.851 179.725 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.45 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 56.0 t -109.14 132.99 55.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.43 -179.226 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 77.2 mt -101.05 130.54 50.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.843 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 51.5 m -122.54 122.88 39.95 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.608 0.718 . . . . 0.0 112.221 -178.629 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.557 ' O ' ' N ' ' A' ' 93' ' ' ARG . 96.7 mt -113.9 124.66 70.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 114.642 -1.163 . . . . 0.0 108.592 178.24 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.5 HD12 ' CB ' ' B' ' 237' ' ' CYS . 46.3 mm 39.17 -96.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.323 -179.27 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.575 ' CB ' ' HE ' ' B' ' 245' ' ' ARG . 54.7 t0 -119.95 5.07 10.9 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.978 0.418 . . . . 0.0 110.742 -179.826 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.641 HH21 ' CD1' ' B' ' 261' ' ' ILE . 17.9 mmm180 -106.89 134.97 49.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.699 179.925 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 47.1 t -132.12 144.07 50.45 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.838 -179.872 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.537 ' HB3' HD11 ' A' ' 7' ' ' LEU . 79.7 m-85 -123.19 120.26 32.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.1 179.766 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.497 ' O ' HD12 ' A' ' 7' ' ' LEU . 44.2 ttm180 -84.47 127.35 33.98 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.142 -179.8 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.535 ' CZ ' ' OD1' ' A' ' 99' ' ' ASN . 88.9 t80 -95.73 129.05 43.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.462 179.854 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -142.66 128.63 19.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.973 0.416 . . . . 0.0 111.938 -179.445 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.535 ' OD1' ' CZ ' ' A' ' 97' ' ' TYR . 89.1 m-20 -109.75 105.33 14.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.987 179.228 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 . . . . . 0 C--O 1.233 0.203 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.225 -179.635 . . . . . . . . 0 0 . 1 . 086 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . 0.502 ' O ' HG12 ' B' ' 228' ' ' VAL . 45.8 t . . . . . 0 N--CA 1.453 -0.303 0 CA-C-O 120.731 0.3 . . . . 0.0 110.98 . . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -68.24 145.54 54.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.034 0.445 . . . . 0.0 111.277 -179.989 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 086 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -119.4 38.74 3.78 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.921 -179.152 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . 0.461 ' O ' ' NH2' ' A' ' 31' ' ' ARG . . . -117.14 -177.74 17.72 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.804 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . 0.527 ' O ' ' NH2' ' A' ' 31' ' ' ARG . 72.5 Cg_endo -72.5 161.69 43.46 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 123.674 2.916 . . . . 0.0 113.378 -179.502 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.73 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . 0.413 ' HD2' ' O ' ' A' ' 42' ' ' PRO . 81.5 Cg_endo -77.18 136.95 16.65 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.403 2.068 . . . . 0.0 113.095 -179.299 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.618 ' CG2' HG22 ' A' ' 66' ' ' THR . 55.6 t -67.75 136.02 27.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 114.612 -1.176 . . . . 0.0 111.803 -179.357 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . 0.5 ' CB ' HD12 ' A' ' 91' ' ' ILE . 1.9 t -81.44 128.36 33.79 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.644 178.774 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . 0.431 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . 0.431 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 51.7 Cg_exo -57.97 -28.56 83.52 Favored 'Trans proline' 0 N--CA 1.504 2.091 0 C-N-CA 123.456 2.77 . . . . 0.0 113.609 -179.674 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 37.2 m -72.28 -45.52 59.74 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.201 0.524 . . . . 0.0 110.341 179.135 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.447 ' CE2' HG21 ' A' ' 43' ' ' VAL . 81.0 t80 -56.61 -45.41 81.49 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.659 -179.733 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 98.6 mt -64.31 -41.31 96.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.31 179.82 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -64.99 -37.42 87.61 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.642 179.903 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -60.36 -43.41 96.57 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.616 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.671 ' O ' HG23 ' B' ' 249' ' ' VAL . 75.1 mtp85 -62.34 -37.48 85.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.75 -179.966 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -62.04 -41.37 98.05 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.238 179.809 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 10.2 t -65.63 -44.07 87.58 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.757 0.789 . . . . 0.0 108.932 177.812 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . 0.602 ' CD ' HH12 ' A' ' 12' ' ' ARG . 64.5 tt0 -62.11 -32.2 72.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.454 179.455 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.671 HG23 ' O ' ' B' ' 245' ' ' ARG . 55.6 t -61.99 -45.89 97.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 179.109 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -60.95 -31.19 70.75 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.609 179.032 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -91.63 -11.06 38.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.447 178.82 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' B' ' 248' ' ' GLN . 51.8 tp -75.86 141.22 42.46 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.123 0.487 . . . . 0.0 111.546 -179.302 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -100.42 142.96 31.18 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.286 179.753 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -64.47 -19.19 65.41 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.29 179.446 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -63.46 -10.45 17.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.379 -178.688 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.501 ' OD2' HD21 ' B' ' 252' ' ' LEU . 49.2 p-10 -81.84 64.24 6.45 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.346 -0.542 . . . . 0.0 109.934 179.645 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -56.83 -9.72 0.87 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.042 -179.026 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.475 ' O ' ' C ' ' B' ' 259' ' ' ASP . 83.5 m-20 -106.91 -0.36 23.27 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 177.45 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.475 ' C ' ' O ' ' B' ' 258' ' ' ASP . 0.6 OUTLIER 28.57 -102.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.043 -179.227 . . . . . . . . 3 3 . 1 . 086 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -140.66 17.89 2.35 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.156 179.703 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.641 ' CD1' HH21 ' A' ' 93' ' ' ARG . 39.7 mt -118.09 138.34 49.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -179.734 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 52.9 t -126.56 135.28 64.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.431 -179.847 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -98.23 118.62 35.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.135 0.493 . . . . 0.0 111.242 -178.903 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.86 -47.35 78.22 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.446 179.273 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -92.48 150.6 40.21 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.253 -179.22 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -66.44 147.76 83.04 Favored 'Trans proline' 0 N--CA 1.499 1.828 0 C-N-CA 123.169 2.579 . . . . 0.0 113.34 -179.488 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 19.7 pt . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.128 178.722 . . . . . . . . 0 0 . 1 . 087 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo . . . . . 0 N--CA 1.489 1.238 0 CA-C-O 120.856 0.273 . . . . 0.0 112.299 . . . . . . . . . 0 0 . 1 . 087 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.463 ' H ' ' NH1' ' A' ' 5' ' ' ARG . 6.6 p -108.7 -36.72 6.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.931 179.72 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.463 ' NH1' ' H ' ' A' ' 4' ' ' THR . 0.0 OUTLIER -94.45 119.95 33.95 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.247 0.546 . . . . 0.0 110.719 -179.894 . . . . . . . . 3 3 . 1 . 087 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.514 ' C ' HD22 ' A' ' 7' ' ' LEU . 83.9 mtp180 -133.48 143.57 48.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.309 179.107 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.581 HD12 ' HB3' ' A' ' 95' ' ' PHE . 3.1 mm? -112.32 127.48 56.0 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.416 179.067 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.616 HG13 ' NE2' ' A' ' 19' ' ' HIS . 86.9 t -98.77 125.67 52.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.058 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 m -76.84 138.08 39.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.473 0.654 . . . . 0.0 112.2 -178.923 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.611 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 48.1 mm -105.19 132.45 51.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.625 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -87.73 156.8 19.27 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.09 -0.644 . . . . 0.0 110.994 179.918 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.668 ' NH2' HE21 ' B' ' 248' ' ' GLN . 73.2 mtp180 -54.02 -33.56 57.54 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.612 -179.286 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.7 m -78.73 -5.41 53.13 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.42 179.008 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.42 35.02 9.78 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -179.343 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.3 t -119.15 134.6 62.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.66 0.267 . . . . 0.0 110.284 -179.84 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.404 ' OD1' HD13 ' A' ' 10' ' ' ILE . 86.7 m-20 -76.15 137.97 40.42 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.862 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.25 -118.15 2.05 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.514 -179.176 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.43 147.9 47.47 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.215 1.943 . . . . 0.0 113.002 -178.217 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.616 ' NE2' HG13 ' A' ' 8' ' ' VAL . 64.7 m170 -105.45 132.76 51.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.236 179.577 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.629 ' CD2' HD11 ' A' ' 37' ' ' ILE . 35.5 t80 -104.61 97.52 12.58 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.115 179.784 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -71.37 129.11 15.42 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 121.326 1.351 . . . . 0.0 111.675 -179.859 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.451 HD22 ' HB2' ' A' ' 27' ' ' CYS . 49.6 mt -96.92 54.12 1.25 Allowed 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.421 -179.131 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 92.0 p -61.78 -17.94 57.97 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.855 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.458 HD11 ' HG2' ' B' ' 265' ' ' GLN . 76.7 mt -77.15 142.21 39.8 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.293 178.88 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.7 t -63.61 -20.83 65.99 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -178.866 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 72.1 m -132.92 133.43 43.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.137 0.494 . . . . 0.0 111.739 -179.652 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.567 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 9.6 t -126.34 119.09 26.43 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.493 179.291 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.618 HD21 ' OE1' ' A' ' 47' ' ' GLN . 34.0 tp -115.55 126.57 54.41 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.566 -0.453 . . . . 0.0 111.854 -178.084 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.833 ' CE2' HD12 ' A' ' 37' ' ' ILE . 10.5 m-85 -104.12 139.86 38.6 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.994 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 171.82 -171.83 44.33 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 119.812 -1.185 . . . . 0.0 112.063 179.738 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 31.2 ttp85 -100.26 -8.73 23.16 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.114 -0.543 . . . . 0.0 111.778 -179.444 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.451 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -88.78 167.31 34.83 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 120.688 -0.767 . . . . 0.0 111.284 -179.996 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.519 HG23 ' N ' ' A' ' 34' ' ' GLU . 9.9 tp -64.71 -42.06 93.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 O-C-N 122.551 -0.382 . . . . 0.0 110.975 -179.732 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.519 ' N ' HG23 ' A' ' 33' ' ' ILE . 93.0 mt-10 -53.7 -22.23 8.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.766 0.317 . . . . 0.0 111.047 -179.334 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 4.0 m -65.96 124.83 23.59 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.438 -179.873 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 28' ' ' LEU . 53.1 m-20 -60.31 -30.65 69.63 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.349 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.833 HD12 ' CE2' ' A' ' 29' ' ' PHE . 79.7 mt -123.93 121.41 62.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 176.825 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.468 HH12 ' HA ' ' B' ' 264' ' ' LYS . 89.2 mtm-85 -103.84 133.93 48.0 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.006 -178.228 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.419 ' C ' ' H ' ' A' ' 41' ' ' LEU . 97.9 mt -116.9 128.95 74.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.289 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -73.23 26.46 0.06 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.014 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.472 HD21 ' OE1' ' B' ' 260' ' ' GLU . 51.5 mt -95.64 127.44 41.6 Favored Pre-proline 0 C--N 1.324 -0.543 0 C-N-CA 120.478 -0.489 . . . . 0.0 109.921 179.022 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.91 -7.96 22.08 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 122.186 1.924 . . . . 0.0 111.964 -179.628 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.8 m -97.92 10.97 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.299 179.982 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 33.5 t -99.0 133.52 41.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-O 120.675 0.274 . . . . 0.0 110.846 179.467 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.0 m -74.45 170.69 15.17 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.255 0.55 . . . . 0.0 111.927 -178.934 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -64.53 -41.45 96.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.202 -179.301 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.618 ' OE1' HD21 ' A' ' 28' ' ' LEU . 97.8 mm-40 -109.58 -27.41 9.41 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.164 0.507 . . . . 0.0 110.025 -179.578 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.794 ' NE2' HG23 ' A' ' 90' ' ' ILE . 18.8 t60 38.94 -77.52 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.666 -1.152 . . . . 0.0 112.661 179.623 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.617 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.45 133.68 46.5 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.259 0.552 . . . . 0.0 111.114 -179.066 . . . . . . . . 3 3 . 1 . 087 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -128.76 131.45 47.84 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.494 -179.819 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 94.7 mt -116.88 133.21 64.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.183 0.516 . . . . 0.0 110.744 179.633 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -115.81 125.92 53.33 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.704 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 95.5 mt -105.02 113.67 42.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.482 0.658 . . . . 0.0 111.77 -178.938 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.475 ' O ' ' N ' ' A' ' 56' ' ' GLN . 90.7 m-70 -112.11 142.94 43.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.316 -179.883 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 54' ' ' HIS . 78.4 tt0 -40.9 -27.48 0.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.298 0.57 . . . . 0.0 109.897 -179.317 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.475 ' N ' ' O ' ' A' ' 54' ' ' HIS . 70.0 tp60 -65.86 -67.88 0.41 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.727 179.715 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.469 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 5.8 tp10 -158.12 -168.17 2.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.042 -0.527 . . . . 0.0 109.676 -179.257 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.469 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -108.87 122.63 47.6 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.909 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.0 mt -114.56 131.43 66.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -177.763 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.413 ' HB2' HD11 ' A' ' 82' ' ' LEU . 24.5 tp -103.07 127.22 50.41 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.216 -179.417 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -111.05 136.78 49.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.141 179.335 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.488 HD21 ' HA ' ' A' ' 68' ' ' PRO . 58.9 t-20 -97.92 106.95 19.33 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.693 -178.954 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -101.43 -7.3 23.01 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.471 179.606 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.472 ' OG ' ' O ' ' A' ' 48' ' ' HIS . 0.7 OUTLIER -74.36 99.48 3.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.484 -178.794 . . . . . . . . 3 3 . 1 . 087 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 76.7 p -81.08 -32.41 33.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.059 0.457 . . . . 0.0 109.863 179.337 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.757 HG21 ' O ' ' B' ' 234' ' ' TPO . 1.8 m -62.92 -49.97 72.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.683 -179.935 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.467 ' OD1' HG22 ' B' ' 236' ' ' VAL . 13.6 m-20 -144.15 106.33 4.83 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.933 -179.854 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.488 ' HA ' HD21 ' A' ' 62' ' ' ASN . 45.4 Cg_exo -54.08 146.89 46.2 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 121.923 1.748 . . . . 0.0 112.949 -179.231 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.4 m -74.98 138.95 42.6 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.924 178.885 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -101.78 140.67 35.75 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.95 179.841 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.665 HG13 ' OD1' ' A' ' 86' ' ' ASP . 64.8 t -131.8 133.17 61.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.052 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 53.74 32.39 14.69 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.007 -178.611 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.12 29.09 67.18 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.417 -179.73 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 4.9 p -145.42 140.4 27.6 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.953 -179.682 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.401 HG13 ' HB2' ' A' ' 68' ' ' PRO . 15.1 t -65.82 139.85 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.456 179.741 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.3 pt -110.2 78.13 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.089 0 CA-C-O 121.021 0.439 . . . . 0.0 110.214 178.587 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -57.59 -31.69 66.43 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.004 179.993 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -118.81 168.85 8.91 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.55 179.762 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.3 141.99 98.51 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.019 1.813 . . . . 0.0 111.941 179.607 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 61.2 t -135.78 136.57 50.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.188 -179.913 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -72.64 131.55 42.57 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.614 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.413 HD11 ' HB2' ' A' ' 60' ' ' LEU . 93.3 mt -83.25 138.59 33.53 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.761 -179.836 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -130.71 154.46 47.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.024 -179.661 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.414 ' CD2' ' C ' ' A' ' 84' ' ' HIS . 7.7 t60 -54.35 116.42 2.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.372 179.88 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.72 -19.15 31.23 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -179.846 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.665 ' OD1' HG13 ' A' ' 71' ' ' VAL . 45.5 t0 -65.54 126.95 29.93 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.144 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 52.8 t -109.94 134.55 51.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.432 -0.507 . . . . 0.0 111.312 -178.386 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 79.5 mt -100.96 130.17 50.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.172 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.514 HG23 ' OG ' ' A' ' 94' ' ' SER . 68.3 m -122.44 123.05 40.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.514 0.673 . . . . 0.0 111.545 -178.762 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.794 HG23 ' NE2' ' A' ' 48' ' ' HIS . 79.6 mt -107.08 121.02 59.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 178.382 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.49 ' C ' ' O ' ' A' ' 90' ' ' ILE . 96.7 mt 33.99 -91.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.818 -179.707 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.576 ' N ' ' O ' ' A' ' 90' ' ' ILE . 46.6 p-10 -118.49 2.7 11.82 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.899 0.381 . . . . 0.0 111.118 179.654 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.782 ' NH2' ' H ' ' A' ' 94' ' ' SER . 0.5 OUTLIER -111.87 132.49 54.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.31 -179.98 . . . . . . . . 3 3 . 1 . 087 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.782 ' H ' ' NH2' ' A' ' 93' ' ' ARG . 16.7 m -135.7 152.28 51.02 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.612 0.72 . . . . 0.0 112.019 -179.455 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.581 ' HB3' HD12 ' A' ' 7' ' ' LEU . 84.4 m-85 -129.67 126.29 37.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.901 179.06 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.504 ' O ' HD13 ' A' ' 7' ' ' LEU . 37.9 ttp-105 -88.11 133.33 34.02 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.612 179.662 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -93.42 125.77 38.2 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.926 -179.73 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -124.47 131.02 53.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.612 179.93 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 59.8 t-20 -120.5 83.62 2.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.042 -179.741 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.186 179.352 . . . . . . . . 0 0 . 1 . 087 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 58.3 t . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.851 0.358 . . . . 0.0 110.699 . . . . . . . . . 0 0 . 1 . 087 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.648 ' O ' ' N ' ' B' ' 231' ' ' GLN . 96.5 m-20 -87.76 151.56 22.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.596 -179.301 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . 0.468 ' O1P' ' NE2' ' B' ' 231' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.648 ' N ' ' O ' ' B' ' 229' ' ' ASP . 39.2 mm-40 -65.7 -47.52 75.11 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.806 -179.849 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' B' ' 231' ' ' GLN . . . -33.71 153.36 0.01 OUTLIER Glycine 0 CA--C 1.534 1.257 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.235 -179.271 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.76 160.99 46.49 Favored 'Trans proline' 0 N--CA 1.499 1.84 0 C-N-CA 123.58 2.853 . . . . 0.0 112.497 179.403 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.757 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -60.65 138.1 77.65 Favored 'Trans proline' 0 C--N 1.301 -1.94 0 C-N-CA 121.961 1.774 . . . . 0.0 112.167 179.817 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.467 HG22 ' OD1' ' A' ' 67' ' ' ASN . 0.4 OUTLIER -60.58 137.61 22.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.074 179.817 . . . . . . . . 3 3 . 1 . 087 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 3.7 t -68.57 121.24 15.99 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.223 -178.701 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 087 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.27 -23.53 62.98 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 122.332 2.022 . . . . 0.0 111.888 179.778 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 98.3 m -72.91 -44.65 60.98 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.314 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.46 ' HZ ' HD22 ' A' ' 41' ' ' LEU . 81.1 t80 -57.99 -45.06 87.42 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.865 -179.415 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.401 ' HA ' HD23 ' B' ' 242' ' ' LEU . 97.1 mt -64.81 -40.9 95.97 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -179.426 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -61.22 -42.89 99.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.786 179.964 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -63.21 -39.43 94.6 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.44 -0.504 . . . . 0.0 109.682 179.946 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.65 ' O ' HG23 ' B' ' 249' ' ' VAL . 14.5 tpp180 -59.04 -42.42 90.22 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 179.604 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -60.4 -43.03 97.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.403 179.131 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 16.5 t -65.1 -44.88 87.39 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.948 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . 0.668 HE21 ' NH2' ' A' ' 12' ' ' ARG . 27.4 mt-30 -60.84 -32.84 72.23 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.465 -179.825 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.65 HG23 ' O ' ' B' ' 245' ' ' ARG . 54.1 t -62.96 -46.2 96.93 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.046 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -59.86 -28.34 67.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.794 178.949 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -95.86 -11.89 26.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.872 179.764 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.491 ' N ' ' O ' ' B' ' 248' ' ' GLN . 47.7 tp -73.68 145.02 45.57 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.986 -179.714 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -102.96 135.01 45.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.006 0.431 . . . . 0.0 110.61 179.726 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -63.12 -27.26 69.26 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.042 -179.867 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 -65.71 1.17 1.37 Allowed 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -178.674 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -99.15 85.78 3.3 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.494 -0.482 . . . . 0.0 111.266 -179.929 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -78.92 7.55 7.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.761 0.315 . . . . 0.0 111.42 -179.015 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.503 ' O ' ' C ' ' B' ' 259' ' ' ASP . 95.2 m-20 -106.27 -6.54 18.35 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 177.532 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.503 ' C ' ' O ' ' B' ' 258' ' ' ASP . 34.9 t0 22.01 -102.38 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 113.669 -1.605 . . . . 0.0 110.53 -179.676 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.568 ' OE2' ' NH1' ' A' ' 12' ' ' ARG . 92.7 mt-10 -136.57 15.38 3.16 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.292 179.213 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.589 HD11 ' CZ ' ' A' ' 93' ' ' ARG . 59.1 mt -116.53 134.12 60.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.958 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . 0.433 HG11 ' NH2' ' A' ' 38' ' ' ARG . 52.9 t -126.5 134.03 67.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.946 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -93.95 117.86 30.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.479 0.657 . . . . 0.0 111.97 -178.412 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . 0.468 ' HA ' HH12 ' A' ' 38' ' ' ARG . 87.5 tttt -63.34 -43.86 96.51 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.981 179.128 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . 0.458 ' HG2' HD11 ' A' ' 24' ' ' LEU . 9.3 mp0 -100.65 157.43 33.74 Favored Pre-proline 0 N--CA 1.449 -0.492 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.548 -179.686 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -70.2 143.57 49.13 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 C-N-CA 122.847 2.364 . . . . 0.0 113.312 -179.157 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 29.5 pt . . . . . 0 N--CA 1.451 -0.378 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.072 178.564 . . . . . . . . 0 0 . 1 . 088 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo . . . . . 0 N--CA 1.493 1.471 0 CA-C-O 120.732 0.222 . . . . 0.0 111.931 . . . . . . . . . 0 0 . 1 . 088 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 37.2 p -115.17 -54.64 2.54 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.3 -179.715 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.703 ' NH2' HG21 ' A' ' 53' ' ' ILE . 82.6 mtm-85 -99.71 134.93 41.89 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.902 -179.366 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -138.82 144.9 39.51 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 120.222 -0.591 . . . . 0.0 111.626 -179.859 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.4 mt -108.73 140.62 41.88 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.003 178.58 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.4 t -112.54 129.21 68.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.616 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.471 HG23 HD12 ' B' ' 261' ' ' ILE . 1.8 m -93.45 117.77 30.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.272 0.558 . . . . 0.0 112.299 -178.049 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.5 mt -83.07 143.04 12.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.785 179.582 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -95.94 164.31 12.77 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.967 179.498 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.458 ' HG3' ' NH1' ' A' ' 93' ' ' ARG . 82.7 mtp180 -58.36 -30.09 66.49 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.281 -179.366 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.541 ' OG ' HG22 ' A' ' 15' ' ' VAL . 88.0 p -73.25 -15.08 61.43 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.229 179.561 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.93 11.09 44.3 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -179.869 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.541 HG22 ' OG ' ' A' ' 13' ' ' SER . 11.4 m -112.02 138.73 39.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.956 0.408 . . . . 0.0 110.484 179.931 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.419 ' O ' ' OD1' ' A' ' 16' ' ' ASP . 54.2 p-10 -80.19 146.85 31.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.006 179.446 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.21 -106.09 1.01 Allowed Glycine 0 CA--C 1.537 1.447 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 179.822 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.1 146.92 37.39 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 122.963 2.442 . . . . 0.0 112.248 -179.994 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -112.97 153.18 28.43 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.194 179.901 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.641 ' CD2' HD11 ' A' ' 37' ' ' ILE . 62.5 t80 -117.53 89.21 31.59 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.665 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -61.3 132.62 42.12 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.556 2.171 . . . . 0.0 111.089 179.914 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.7 mt -87.97 82.23 7.29 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.653 -178.847 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 86.0 p -86.59 -11.14 52.32 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 178.379 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.67 HD11 ' HG2' ' B' ' 265' ' ' GLN . 63.4 mt -101.92 144.06 31.03 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.526 -179.186 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.1 m -67.86 -21.2 65.19 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.779 0.323 . . . . 0.0 111.199 -179.724 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 63.1 m -127.52 133.31 49.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.708 179.619 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.653 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 9.8 t -129.78 122.13 28.2 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.463 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 49.8 tp -118.08 132.5 56.35 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.149 -178.246 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.653 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 38.0 m-85 -110.49 142.46 42.22 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.8 0.334 . . . . 0.0 110.197 179.837 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 150.13 -176.16 28.89 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 179.406 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 46.6 mtm180 -77.76 -31.68 52.19 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.64 179.605 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.578 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -47.8 149.37 3.27 Favored Glycine 0 N--CA 1.466 0.688 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 -179.012 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.448 HD12 ' HD3' ' A' ' 38' ' ' ARG . 11.0 tp -68.58 -41.04 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.583 -179.918 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.442 ' N ' HG23 ' A' ' 33' ' ' ILE . 78.2 mm-40 -55.07 -21.98 14.51 Favored 'General case' 0 C--O 1.231 0.096 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -179.995 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.578 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 19.0 m -57.34 113.01 1.57 Allowed 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.771 178.812 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -58.36 -26.72 63.47 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 -179.99 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.641 HD11 ' CD2' ' A' ' 20' ' ' PHE . 50.5 mm -122.4 113.48 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.476 177.289 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.448 ' HD3' HD12 ' A' ' 33' ' ' ILE . 42.2 mtm180 -98.02 131.63 44.27 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.829 -179.662 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.504 HG21 HD12 ' A' ' 41' ' ' LEU . 99.2 mt -118.17 131.25 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 121.465 0.65 . . . . 0.0 111.31 179.79 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -79.79 32.39 0.25 Allowed 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.159 -178.631 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.71 ' O ' HG12 ' A' ' 44' ' ' VAL . 31.9 mt -98.22 121.56 56.73 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.484 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -72.33 -13.0 27.92 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 121.552 1.501 . . . . 0.0 111.499 -179.823 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.2 m -96.2 7.73 7.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.505 -179.451 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.71 HG12 ' O ' ' A' ' 41' ' ' LEU . 5.0 p -101.86 142.5 16.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.533 179.958 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.8 m -71.95 170.35 13.95 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.363 0.602 . . . . 0.0 111.129 -179.391 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -63.81 -41.2 97.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.986 -179.764 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.637 ' O ' ' N ' ' A' ' 49' ' ' CYS . 87.7 mt-30 -108.96 -9.92 15.08 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 121.086 -0.246 . . . . 0.0 110.994 -179.958 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.594 ' ND1' HG23 ' A' ' 44' ' ' VAL . 30.0 t60 31.41 -76.32 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 179.635 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.637 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.51 137.37 45.58 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.132 0.491 . . . . 0.0 111.685 -178.472 . . . . . . . . 3 3 . 1 . 088 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -123.75 131.56 53.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.899 178.733 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.5 mt -116.05 133.46 62.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.197 -179.109 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -117.85 125.63 50.89 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.02 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.703 HG21 ' NH2' ' A' ' 5' ' ' ARG . 67.7 mt -103.29 116.6 47.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 C-N-CA 119.853 -0.739 . . . . 0.0 111.207 -179.488 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.503 ' O ' ' N ' ' A' ' 56' ' ' GLN . 6.3 m-70 -111.72 135.8 51.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.182 179.637 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.0 mm-40 -41.51 -26.58 0.07 Allowed 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.477 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.503 ' N ' ' O ' ' A' ' 54' ' ' HIS . 82.4 mt-30 -68.39 -68.55 0.38 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.215 178.679 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.447 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 5.2 tp10 -151.0 -178.3 6.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.557 -179.357 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.447 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -102.41 128.7 48.89 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.554 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 40.9 mm -111.89 126.57 69.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.886 -178.117 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.627 ' HB2' HD11 ' A' ' 82' ' ' LEU . 23.0 tp -101.37 124.24 46.75 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.923 178.878 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -114.81 137.04 52.42 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.419 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.691 ' ND2' ' H ' ' A' ' 69' ' ' THR . 21.5 t-20 -102.21 108.28 19.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.03 0.443 . . . . 0.0 111.288 179.49 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -94.43 -3.03 50.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.805 179.298 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.8 t -82.31 100.98 10.26 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.446 -0.501 . . . . 0.0 110.081 179.521 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.9 m -82.76 -17.2 45.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.62 179.954 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.752 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.2 OUTLIER -87.52 -36.09 17.8 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.376 -179.338 . . . . . . . . 3 3 . 1 . 088 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -146.05 100.58 4.22 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.873 -179.54 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -57.81 144.09 94.25 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 121.736 1.624 . . . . 0.0 112.708 -179.336 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.691 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 37.2 m -70.21 134.55 48.17 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.171 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -96.08 141.1 29.87 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.635 -178.909 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.5 t -134.32 134.07 55.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.321 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 53.49 31.89 13.09 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 119.84 -0.744 . . . . 0.0 109.023 -179.104 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.04 25.68 72.98 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.26 179.852 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 37.8 t -141.72 143.57 33.6 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 117.297 0.549 . . . . 0.0 111.528 -179.993 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.8 m -76.69 139.13 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.884 179.984 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.414 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 1.1 pt -104.08 104.05 16.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.622 179.106 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.428 ' C ' ' OE1' ' A' ' 78' ' ' GLU . 57.9 m-20 -63.24 -35.88 81.8 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-O 121.191 0.519 . . . . 0.0 109.911 179.964 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.428 ' OE1' ' C ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -125.79 177.95 1.7 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.345 -179.128 . . . . . . . . 3 3 . 1 . 088 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.418 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 34.6 Cg_exo -60.48 142.64 98.5 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 122.302 2.001 . . . . 0.0 111.914 179.966 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 42.9 t -132.7 138.19 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 120.946 0.403 . . . . 0.0 111.665 179.722 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -75.32 132.83 41.25 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.679 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.627 HD11 ' HB2' ' A' ' 60' ' ' LEU . 86.1 mt -87.41 137.2 32.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.326 0.584 . . . . 0.0 111.318 -179.121 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -126.02 151.85 46.54 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.321 -179.704 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.455 ' ND1' ' N ' ' A' ' 99' ' ' ASN . 9.1 t60 -55.12 122.98 12.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.227 0.537 . . . . 0.0 111.246 -178.973 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 103.35 -13.22 54.89 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.143 -179.657 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -70.72 139.06 51.04 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 117.079 0.44 . . . . 0.0 110.696 179.687 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.427 ' O ' HG13 ' A' ' 87' ' ' VAL . 8.7 p -111.69 135.81 49.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.411 -0.515 . . . . 0.0 111.841 -178.996 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 81.2 mt -102.4 128.99 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 177.606 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.783 HG23 ' OG ' ' A' ' 94' ' ' SER . 95.3 m -123.93 125.07 43.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.702 0.763 . . . . 0.0 111.759 -178.438 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.63 ' O ' ' N ' ' A' ' 93' ' ' ARG . 96.1 mt -113.99 121.65 66.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 114.547 -1.206 . . . . 0.0 108.062 178.324 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.555 ' C ' ' O ' ' A' ' 90' ' ' ILE . 66.5 mt -3.44 95.31 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -179.833 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.427 ' CB ' ' NH1' ' B' ' 245' ' ' ARG . 2.0 t0 77.83 -20.3 0.39 Allowed 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 178.18 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.754 ' HE ' ' CD1' ' B' ' 261' ' ' ILE . 6.8 tpt180 -120.31 130.08 54.29 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 110.465 -0.198 . . . . 0.0 110.465 -178.372 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.783 ' OG ' HG23 ' A' ' 89' ' ' THR . 64.3 m -134.62 151.11 50.83 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -178.486 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.481 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 82.9 m-85 -122.63 120.74 34.62 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.308 178.551 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 37.7 ttp-105 -87.86 134.95 33.59 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 119.914 -0.715 . . . . 0.0 110.727 -179.652 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -96.93 123.86 40.75 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.124 -178.14 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -125.12 120.26 30.9 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.234 179.415 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.461 ' O ' ' C ' ' A' ' 100' ' ' GLU . 15.9 t-20 -103.11 109.48 21.06 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.507 -179.225 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.461 ' C ' ' O ' ' A' ' 99' ' ' ASN . 76.9 tt0 . . . . . 0 CA--C 1.517 -0.312 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.73 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 2.4 t . . . . . 0 CA--C 1.528 0.129 0 CA-C-O 120.572 0.225 . . . . 0.0 110.794 . . . . . . . . . 0 0 . 1 . 088 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.591 ' C ' ' H ' ' B' ' 231' ' ' GLN . 75.7 m-20 -67.36 138.73 56.96 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.214 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 088 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.591 ' H ' ' C ' ' B' ' 229' ' ' ASP . 99.3 mm-40 -105.72 -24.66 12.47 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.162 0.506 . . . . 0.0 110.368 179.681 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' B' ' 229' ' ' ASP . . . -33.35 158.82 0.01 OUTLIER Glycine 0 CA--C 1.531 1.037 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.459 -179.142 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -71.49 161.4 45.57 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 123.581 2.854 . . . . 0.0 111.591 179.565 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.752 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -75.0 141.86 27.16 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 121.946 1.764 . . . . 0.0 113.388 -179.844 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.467 ' CG2' HG22 ' A' ' 66' ' ' THR . 60.5 t -60.82 137.61 22.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.48 179.667 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . 0.535 ' HB2' HD13 ' A' ' 91' ' ' ILE . 2.7 t -64.61 134.42 54.29 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.038 -179.559 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . 0.407 ' O3P' ' OG1' ' B' ' 240' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -55.42 -22.54 34.51 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.534 2.156 . . . . 0.0 112.241 -179.959 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . 0.407 ' OG1' ' O3P' ' B' ' 238' ' ' TPO . 86.2 m -72.24 -44.05 63.46 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.439 0.638 . . . . 0.0 109.417 178.485 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.406 ' CZ ' ' HD2' ' B' ' 245' ' ' ARG . 72.2 t80 -58.47 -51.01 71.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.324 -178.624 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.475 HD21 HG23 ' A' ' 91' ' ' ILE . 97.2 mt -63.51 -42.04 98.49 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.183 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -64.29 -42.24 96.49 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -178.734 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -62.2 -41.8 98.7 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.344 -179.591 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.438 ' O ' HG23 ' B' ' 249' ' ' VAL . 83.5 mtp180 -63.21 -39.32 94.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.636 -178.495 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -62.01 -38.46 88.73 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.016 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 21.0 m -65.49 -42.61 91.97 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.499 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . 0.471 ' O ' ' N ' ' B' ' 252' ' ' LEU . 87.2 mt-30 -62.33 -32.92 73.75 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.156 179.705 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.438 HG23 ' O ' ' B' ' 245' ' ' ARG . 53.1 t -61.18 -45.93 97.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 120.121 -0.632 . . . . 0.0 109.419 178.74 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -59.24 -29.3 67.43 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.229 179.343 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -96.48 -9.35 29.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.083 179.228 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.471 ' N ' ' O ' ' B' ' 248' ' ' GLN . 35.3 tp -75.59 142.82 42.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.669 -178.601 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -100.44 141.02 33.87 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.256 179.354 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -65.04 -20.38 66.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.463 0.649 . . . . 0.0 110.522 -179.134 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -63.06 -9.59 11.0 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.247 -179.957 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 46.2 p-10 -65.01 149.1 50.44 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.069 0.462 . . . . 0.0 110.707 179.984 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . 0.55 ' O ' ' N ' ' B' ' 259' ' ' ASP . 99.0 mttt -134.86 153.7 51.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.74 179.983 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.53 ' O ' ' C ' ' B' ' 259' ' ' ASP . 87.0 m-20 45.49 15.83 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -179.409 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.55 ' N ' ' O ' ' B' ' 257' ' ' LYS . 29.2 t70 -2.36 -77.21 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.041 -0.982 . . . . 0.0 112.137 -178.948 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -133.7 9.21 3.92 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.838 -179.4 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.754 ' CD1' ' HE ' ' A' ' 93' ' ' ARG . 64.9 mt -117.6 134.36 61.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -179.883 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 47.8 t -123.4 130.65 74.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.162 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -93.47 117.07 29.63 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.272 0.558 . . . . 0.0 111.106 -177.924 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -64.48 -46.6 82.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.687 -179.781 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . 0.67 ' HG2' HD11 ' A' ' 24' ' ' LEU . 0.8 OUTLIER -92.49 165.78 18.59 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.069 -178.465 . . . . . . . . 3 3 . 1 . 088 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -69.07 148.01 68.6 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 122.122 1.882 . . . . 0.0 112.739 -178.93 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 32.1 pt . . . . . 0 C--N 1.321 -0.646 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.15 -179.876 . . . . . . . . 0 0 . 1 . 089 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo . . . . . 0 N--CA 1.495 1.575 0 CA-C-O 121.116 0.382 . . . . 0.0 112.774 . . . . . . . . . 0 0 . 1 . 089 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.0 p -89.17 -39.48 13.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.294 179.509 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.55 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 80.5 mtp85 -87.69 126.73 35.14 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.064 -179.465 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -129.62 133.53 47.19 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.013 -179.863 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.514 HD11 ' HB3' ' A' ' 95' ' ' PHE . 35.1 tp -117.1 128.38 55.08 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.748 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.6 m -106.16 136.09 41.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.419 -179.768 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.516 HG23 HD12 ' B' ' 261' ' ' ILE . 1.8 m -95.29 117.84 30.99 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.142 -0.936 . . . . 0.0 112.589 -178.589 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.7 mt -84.65 145.59 7.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.386 179.02 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -96.4 162.3 13.55 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.95 0.405 . . . . 0.0 110.773 179.315 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.882 HH21 HD22 ' B' ' 252' ' ' LEU . 87.6 mtm180 -58.45 -27.38 64.32 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.558 -178.636 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 89.3 p -81.82 -9.77 59.52 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.093 -0.643 . . . . 0.0 109.697 179.646 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.3 36.75 6.47 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.61 179.8 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.3 t -118.38 132.37 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-O 120.787 0.327 . . . . 0.0 111.42 179.993 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -69.64 124.48 24.06 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.862 179.274 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -116.08 -128.89 4.34 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.271 -178.937 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -70.61 148.07 58.76 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.031 1.821 . . . . 0.0 112.816 -178.623 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -106.51 144.87 32.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.814 -179.572 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.757 ' CD2' HD11 ' A' ' 37' ' ' ILE . 34.6 t80 -112.25 100.98 51.19 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.321 179.862 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.414 ' CD ' ' O ' ' B' ' 267' ' ' ILE . 57.8 Cg_endo -75.79 128.82 11.15 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 121.47 1.446 . . . . 0.0 111.42 -179.632 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 88.0 mt -83.8 81.17 8.88 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.855 -178.871 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 87.8 p -86.01 -13.7 46.72 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.987 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 73.8 mt -100.03 145.36 28.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.422 -179.967 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 54.2 p -68.56 -15.77 63.64 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.506 -178.804 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.517 HG23 ' OE2' ' A' ' 52' ' ' GLU . 85.6 m -128.61 131.48 48.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.237 0.541 . . . . 0.0 111.778 -179.691 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.9 t -128.11 122.15 31.34 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.304 178.543 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.8 tp -115.27 130.58 56.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.956 0.408 . . . . 0.0 111.002 -179.074 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.522 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 44.8 m-85 -111.36 140.47 45.92 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.796 179.718 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 152.64 -168.4 31.63 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 120.886 -0.673 . . . . 0.0 111.504 179.394 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.578 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 49.5 ptt85 -118.29 17.27 13.92 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 122.76 -0.259 . . . . 0.0 111.034 179.901 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.629 ' O ' ' N ' ' A' ' 34' ' ' GLU . . . -88.05 32.96 4.16 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.814 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.65 ' C ' ' H ' ' A' ' 35' ' ' CYS . 2.0 tt 52.03 -62.09 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 123.28 0.632 . . . . 0.0 112.587 -179.609 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.629 ' N ' ' O ' ' A' ' 32' ' ' GLY . 72.0 tt0 -52.26 2.21 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 O-C-N 121.974 -0.454 . . . . 0.0 110.899 -178.934 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.65 ' H ' ' C ' ' A' ' 33' ' ' ILE . 3.9 m -82.77 133.81 35.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.891 0.377 . . . . 0.0 111.027 179.82 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -61.88 -26.81 68.37 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.88 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.757 HD11 ' CD2' ' A' ' 20' ' ' PHE . 49.0 mm -123.41 117.09 50.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 177.267 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.411 ' NH1' HG13 ' A' ' 33' ' ' ILE . 82.1 mtt180 -100.33 132.92 45.43 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.85 -179.133 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.721 HG21 HD12 ' A' ' 41' ' ' LEU . 80.9 mt -120.31 130.98 73.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.469 -0.493 . . . . 0.0 110.446 -179.727 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -79.11 33.97 0.23 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.507 -179.046 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.721 HD12 HG21 ' A' ' 39' ' ' ILE . 17.9 mt -102.06 108.74 57.85 Favored Pre-proline 0 C--N 1.326 -0.427 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.78 -179.974 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -57.56 -13.81 14.91 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.21 1.94 . . . . 0.0 112.406 179.159 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.6 m -97.31 9.7 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.858 -179.893 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.578 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 15.7 t -102.17 135.88 37.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.092 0.473 . . . . 0.0 110.957 -179.744 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.53 162.23 21.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.204 -179.12 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -62.89 -42.42 99.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.702 -179.392 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.595 ' O ' ' N ' ' A' ' 49' ' ' CYS . 87.6 mt-30 -112.34 -2.58 14.76 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.916 0.389 . . . . 0.0 110.579 178.882 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.456 ' C ' ' O ' ' A' ' 47' ' ' GLN . 14.8 t60 15.88 -73.51 0.0 OUTLIER 'General case' 0 C--O 1.235 0.29 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -179.287 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.595 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.91 134.69 44.9 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.331 -0.548 . . . . 0.0 112.094 -178.127 . . . . . . . . 3 3 . 1 . 089 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -127.41 132.36 50.13 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.399 179.793 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.2 mt -115.93 133.24 62.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.977 0.417 . . . . 0.0 111.432 -179.491 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.517 ' OE2' HG23 ' A' ' 26' ' ' THR . 70.8 mm-40 -117.41 127.93 54.52 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.428 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 93.0 mt -105.53 118.36 52.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 119.941 -0.703 . . . . 0.0 112.231 -179.089 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.454 ' O ' ' N ' ' A' ' 56' ' ' GLN . 92.9 m-70 -116.39 144.01 44.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.692 -179.522 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 54' ' ' HIS . 95.3 mt-10 -40.28 -29.69 0.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.857 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.483 ' O ' ' OE1' ' A' ' 57' ' ' GLU . 53.4 tt0 -63.87 -68.31 0.36 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.411 178.733 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.483 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 5.5 tp10 -160.09 -159.44 0.71 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.047 179.371 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.442 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -116.04 124.97 51.79 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.213 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.5 mt -116.69 132.43 66.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.243 0.545 . . . . 0.0 112.22 -178.329 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.1 tp -100.54 129.03 46.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.319 -179.971 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -110.22 135.65 50.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.704 -179.66 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.414 HD21 ' HA ' ' A' ' 68' ' ' PRO . 47.2 t-20 -95.95 105.22 17.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.729 -179.247 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -98.0 -5.74 33.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.815 179.086 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.23 101.39 3.98 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.702 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.6 p -87.37 -11.13 50.2 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.699 -179.877 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.823 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.2 OUTLIER -101.1 -36.08 9.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.169 -179.272 . . . . . . . . 3 3 . 1 . 089 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 60.2 m-80 -142.78 97.72 5.87 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.664 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.414 ' HA ' HD21 ' A' ' 62' ' ' ASN . 32.6 Cg_exo -55.92 146.08 70.21 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 122.299 2.0 . . . . 0.0 113.633 -178.358 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.3 m -69.23 133.19 47.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.023 178.641 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -97.78 141.78 30.37 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.224 -0.59 . . . . 0.0 111.347 -179.287 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.3 p -133.46 133.58 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.801 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 50.64 32.96 7.43 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 119.921 -0.712 . . . . 0.0 109.219 -179.321 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.21 29.27 62.62 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.943 179.788 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.5 m -142.33 135.31 28.55 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.233 -0.587 . . . . 0.0 111.962 -179.727 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.431 ' H ' HG22 ' A' ' 75' ' ' VAL . 0.5 OUTLIER -72.84 139.23 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.471 179.277 . . . . . . . . 3 3 . 1 . 089 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.547 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 1.1 pt -107.07 111.81 37.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-O 121.719 0.771 . . . . 0.0 111.023 179.721 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -67.3 -31.98 72.64 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.993 179.303 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.615 ' N ' ' OE1' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -133.13 -179.19 1.0 Allowed Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.847 -179.322 . . . . . . . . 3 3 . 1 . 089 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.496 ' CD ' ' CB ' ' A' ' 78' ' ' GLU . 31.3 Cg_exo -60.77 146.72 96.92 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 122.973 2.449 . . . . 0.0 113.08 179.828 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.9 m -137.4 140.53 41.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.857 179.018 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 52.3 ttp180 -73.15 129.96 39.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.317 179.3 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.0 mt -81.92 140.82 33.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.374 0.607 . . . . 0.0 111.694 -179.227 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.66 152.23 51.62 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.94 179.599 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -56.85 121.11 9.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.991 0.424 . . . . 0.0 110.916 -179.477 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.61 -18.75 37.46 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 179.924 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -67.48 135.57 53.27 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.963 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.4 t -113.71 132.73 61.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.329 -177.671 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.9 mt -96.52 129.3 46.78 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 177.801 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 43.1 m -121.71 124.96 45.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.622 0.725 . . . . 0.0 112.133 -178.0 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.527 ' O ' ' C ' ' A' ' 91' ' ' ILE . 95.4 mt -113.07 128.84 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 114.708 -1.133 . . . . 0.0 107.987 178.404 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.527 ' C ' ' O ' ' A' ' 90' ' ' ILE . 61.3 mt -20.88 102.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -178.673 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.461 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 5.1 m-20 87.17 -23.72 0.13 Allowed 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 177.881 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 90' ' ' ILE . 17.3 mmm-85 -129.24 144.6 51.28 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.413 179.926 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.5 t -140.24 152.87 46.29 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.249 0.547 . . . . 0.0 110.814 179.979 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.573 ' CZ ' HD13 ' B' ' 261' ' ' ILE . 51.7 m-85 -123.2 122.06 37.47 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.985 -179.768 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.439 ' O ' HD12 ' A' ' 7' ' ' LEU . 42.7 ttm180 -88.49 130.98 35.08 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 119.655 -0.818 . . . . 0.0 109.959 179.591 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.55 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 41.0 t80 -93.83 127.71 39.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.168 -179.941 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -123.94 122.29 37.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.689 179.56 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -97.25 116.11 28.85 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.32 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.103 -179.07 . . . . . . . . 0 0 . 1 . 089 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 9.2 p . . . . . 0 C--O 1.232 0.144 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 089 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.593 ' O ' ' N ' ' B' ' 231' ' ' GLN . 52.0 t0 -88.23 116.15 26.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.101 -179.162 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . 0.419 ' C ' ' O ' ' B' ' 229' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.593 ' N ' ' O ' ' B' ' 229' ' ' ASP . 90.5 mm-40 -113.89 -21.57 10.56 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.373 179.387 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' B' ' 229' ' ' ASP . . . -40.86 170.79 0.01 OUTLIER Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 -179.916 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.41 161.63 44.95 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 123.464 2.776 . . . . 0.0 112.961 -179.421 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.823 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -76.42 139.4 20.69 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.141 1.894 . . . . 0.0 114.27 -179.078 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.49 ' CG2' HG22 ' A' ' 66' ' ' THR . 55.4 t -65.38 142.07 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.301 179.529 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 3.5 t -71.1 136.1 48.04 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.378 179.892 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . 0.414 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . 0.414 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 41.8 Cg_exo -57.6 -28.41 81.13 Favored 'Trans proline' 0 N--CA 1.499 1.817 0 C-N-CA 123.193 2.596 . . . . 0.0 113.07 -179.305 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 30.4 m -68.62 -46.69 68.59 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.077 0.465 . . . . 0.0 110.031 178.73 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -59.52 -46.31 89.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.483 -178.607 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 84.7 mt -63.72 -42.65 97.88 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -178.907 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -65.56 -40.02 92.34 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.406 -0.517 . . . . 0.0 111.093 -178.931 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 63.7 ttm-85 -63.62 -44.12 94.86 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.441 -0.503 . . . . 0.0 109.849 179.649 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . . . . . . . . . 70.6 ttp85 -61.28 -42.53 98.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.757 -179.928 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -59.17 -37.95 78.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.019 -179.675 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 49.0 m -68.92 -41.66 77.84 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 177.454 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . 0.447 ' O ' ' N ' ' B' ' 252' ' ' LEU . 70.2 tp60 -61.16 -38.38 86.26 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.515 179.954 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 38.6 t -62.15 -46.02 97.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.119 179.232 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -60.84 -25.77 66.88 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.149 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -95.52 -10.52 29.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.927 179.112 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.882 HD22 HH21 ' A' ' 12' ' ' ARG . 56.2 tp -76.7 140.18 40.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.817 -179.26 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -100.48 139.54 36.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.019 178.708 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -67.56 -22.62 65.39 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.911 -179.882 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -69.38 -5.86 26.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.419 -179.773 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -84.1 76.09 10.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.251 179.677 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -66.81 0.78 2.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.312 -179.398 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.535 ' O ' ' C ' ' B' ' 259' ' ' ASP . 97.4 m-20 -98.17 1.28 47.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.61 0.243 . . . . 0.0 110.39 178.538 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.535 ' C ' ' O ' ' B' ' 258' ' ' ASP . 31.9 p-10 11.93 -118.89 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 O-C-N 124.082 0.864 . . . . 0.0 111.989 179.951 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.593 ' OE2' ' NH1' ' A' ' 12' ' ' ARG . 98.1 mt-10 -130.32 5.19 4.8 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.186 -179.871 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.573 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 81.1 mt -116.41 138.06 48.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.86 0.362 . . . . 0.0 110.18 179.972 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 43.9 t -127.07 136.44 60.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.363 179.739 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -97.72 118.02 33.33 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.249 0.547 . . . . 0.0 110.979 -178.748 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -64.7 -46.53 81.94 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.599 179.509 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . 0.413 ' CB ' ' CD ' ' B' ' 266' ' ' PRO . 1.1 mm-40 -98.73 177.74 1.5 Allowed Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.467 -179.111 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . 0.413 ' CD ' ' CB ' ' B' ' 265' ' ' GLN . 38.8 Cg_exo -60.75 143.36 99.38 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.544 2.162 . . . . 0.0 113.193 -178.895 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . 0.414 ' O ' ' CD ' ' A' ' 21' ' ' PRO . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.314 179.296 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo . . . . . 0 N--CA 1.497 1.679 0 CA-C-O 120.746 0.227 . . . . 0.0 112.326 . . . . . . . . . 0 0 . 1 . 090 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.4 p -78.55 -30.54 46.98 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.503 179.465 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.668 ' NH1' ' HB2' ' A' ' 58' ' ' ALA . 93.6 mtt-85 -100.21 117.12 33.78 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.89 -179.092 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.471 HH12 ' HB2' ' A' ' 100' ' ' GLU . 32.3 ptt-85 -132.96 141.78 48.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.25 179.871 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.587 HD11 ' HB3' ' A' ' 95' ' ' PHE . 33.2 tp -118.24 136.18 53.82 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.899 -179.805 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.0 t -112.56 131.2 64.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 -179.784 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.469 ' CG2' HD12 ' B' ' 261' ' ' ILE . 12.8 m -91.08 113.62 25.93 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.548 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 84.6 mt -81.63 145.01 9.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.666 178.477 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -89.9 157.89 17.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.083 0.468 . . . . 0.0 111.066 178.949 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.648 ' NH1' HH11 ' B' ' 245' ' ' ARG . 90.4 mtm180 -58.61 -32.07 68.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.93 -179.454 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.5 m -75.64 -13.49 60.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.917 0.389 . . . . 0.0 110.381 179.675 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.06 35.54 5.51 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.363 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.4 t -121.66 133.17 68.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.849 0.357 . . . . 0.0 111.551 -179.12 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -72.43 122.62 21.54 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.767 179.415 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -114.63 -129.26 4.69 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.529 -179.354 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.49 156.18 54.42 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.301 2.001 . . . . 0.0 112.859 -178.969 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.482 ' CD2' ' C ' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -112.91 156.0 23.75 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.128 0.49 . . . . 0.0 110.762 -179.336 . . . . . . . . 3 3 . 1 . 090 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.443 ' CD2' HD11 ' A' ' 37' ' ' ILE . 39.0 t80 -126.19 104.39 25.72 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.517 -179.436 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -74.01 132.8 17.29 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 C-N-CA 121.07 1.18 . . . . 0.0 111.472 -179.363 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.443 HD22 ' SG ' ' A' ' 27' ' ' CYS . 73.9 mt -89.98 49.97 1.8 Allowed 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.196 -178.351 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 93.9 p -63.13 -19.65 64.65 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.893 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.717 HD11 ' CD ' ' B' ' 265' ' ' GLN . 87.0 mt -77.48 140.2 39.76 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.069 179.592 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 77.9 p -61.57 -21.38 64.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.593 -178.973 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.488 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 20.8 m -136.27 135.7 39.21 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.786 -0.365 . . . . 0.0 111.304 -179.752 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.443 ' SG ' HD22 ' A' ' 22' ' ' LEU . 5.0 t -124.84 116.65 22.59 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.46 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.1 tp -113.73 127.8 56.17 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.906 0.384 . . . . 0.0 110.87 -179.052 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.785 ' CE2' HD12 ' A' ' 37' ' ' ILE . 9.6 m-85 -106.33 132.5 52.3 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.666 179.773 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 163.24 -173.53 39.41 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 119.724 -1.227 . . . . 0.0 112.879 179.144 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.635 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 87.3 mtm-85 -77.44 -31.02 53.65 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-O 120.907 0.384 . . . . 0.0 110.167 179.51 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.498 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -52.81 148.1 13.53 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.365 -178.075 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.461 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 8.2 tp -67.36 -40.6 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.417 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.461 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 79.5 mm-40 -54.45 -24.93 22.21 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.221 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 61.6 m -51.85 120.65 5.52 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.122 -179.786 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.488 ' OD2' ' O ' ' A' ' 26' ' ' THR . 68.0 m-20 -57.56 -27.3 62.54 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 179.932 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.785 HD12 ' CE2' ' A' ' 29' ' ' PHE . 84.4 mt -129.35 121.26 53.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.92 177.367 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 66.7 ttp85 -112.13 138.23 49.08 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.857 -179.177 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.833 HD13 ' NH1' ' A' ' 93' ' ' ARG . 78.0 mt -117.66 132.53 67.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.975 0.417 . . . . 0.0 110.312 -179.54 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -72.45 32.49 0.06 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.478 -178.168 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.933 HD12 HH21 ' A' ' 93' ' ' ARG . 78.7 mt -118.64 128.1 26.16 Favored Pre-proline 0 CA--C 1.535 0.392 0 C-N-CA 120.249 -0.58 . . . . 0.0 111.95 -179.722 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.85 -11.35 25.67 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 122.46 2.107 . . . . 0.0 113.222 -179.85 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.576 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 2.5 m -87.63 -5.58 10.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.344 179.403 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.635 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 55.3 t -84.51 133.17 29.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 177.541 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.455 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 0.4 OUTLIER -61.34 161.37 9.26 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.127 0.489 . . . . 0.0 111.265 -179.086 . . . . . . . . 3 3 . 1 . 090 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -61.99 -44.66 96.26 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.704 -178.988 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.604 ' O ' ' N ' ' A' ' 49' ' ' CYS . 95.1 mt-30 -113.94 -15.03 12.4 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.17 179.904 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.455 ' H ' ' HB3' ' A' ' 45' ' ' SER . 24.1 t60 31.35 -76.51 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 179.394 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.604 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.26 135.87 48.57 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.28 0.562 . . . . 0.0 112.193 -178.194 . . . . . . . . 3 3 . 1 . 090 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -128.16 126.84 41.85 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.246 179.534 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.4 mt -113.19 136.3 49.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.753 -179.659 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -115.62 132.84 56.51 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.917 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 51.5 mm -102.51 119.67 51.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.171 -0.612 . . . . 0.0 111.445 -178.948 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.451 ' O ' ' N ' ' A' ' 56' ' ' GLN . 96.5 m-70 -121.44 134.07 55.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.14 179.398 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 54' ' ' HIS . 81.0 tt0 -40.3 -29.82 0.09 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -179.765 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.451 ' N ' ' O ' ' A' ' 54' ' ' HIS . 60.0 tt0 -67.58 -67.29 0.47 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.544 179.083 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.427 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 5.3 tp10 -154.72 -161.56 1.23 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.125 -179.185 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.668 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -124.96 132.17 53.32 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.143 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.5 mt -116.99 129.21 73.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.175 0.512 . . . . 0.0 112.339 -179.097 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.526 ' HB2' HD11 ' A' ' 82' ' ' LEU . 34.7 tp -96.92 128.53 43.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.184 179.121 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -111.82 136.04 51.63 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.497 -179.58 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.416 HD21 ' HA ' ' A' ' 68' ' ' PRO . 58.2 t-20 -94.63 106.86 18.85 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.441 -179.671 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -99.87 -10.72 21.42 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.342 179.292 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.448 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 2.7 t -71.65 100.78 2.38 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.297 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.7 m -87.66 -19.27 27.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.083 0.468 . . . . 0.0 110.405 -179.858 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.404 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.2 OUTLIER -89.85 -43.0 10.92 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.105 179.809 . . . . . . . . 3 3 . 1 . 090 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.637 ' OD1' HG23 ' B' ' 236' ' ' VAL . 27.0 m-80 -133.23 91.94 26.29 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.497 179.994 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.44 ' HB2' HG13 ' A' ' 75' ' ' VAL . 41.5 Cg_exo -54.8 143.5 70.48 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.15 1.9 . . . . 0.0 112.702 -178.986 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.4 m -74.84 141.47 44.24 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.812 -1.086 . . . . 0.0 111.005 -179.781 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -104.32 142.05 35.24 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.396 179.527 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.493 ' CG2' ' OD1' ' A' ' 86' ' ' ASP . 4.9 p -128.55 134.13 65.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.207 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 46.65 34.7 2.6 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 -179.426 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.05 26.53 68.51 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.916 179.802 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.454 ' N ' ' O ' ' A' ' 71' ' ' VAL . 14.5 m -138.43 135.41 35.21 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 117.164 0.482 . . . . 0.0 111.499 179.928 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.44 HG13 ' HB2' ' A' ' 68' ' ' PRO . 43.3 t -64.72 136.36 26.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.422 179.965 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 pt -116.64 83.87 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.588 179.036 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -66.28 -22.26 66.3 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.88 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.486 ' CD ' ' H ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -118.45 163.43 25.46 Favored Pre-proline 0 C--N 1.333 -0.146 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.841 178.994 . . . . . . . . 3 3 . 1 . 090 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -67.93 152.0 77.46 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.65 2.234 . . . . 0.0 112.685 -179.685 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.6 m -144.3 146.22 20.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.597 -179.719 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 91.5 mtm180 -73.48 131.3 41.63 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.78 179.179 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.526 HD11 ' HB2' ' A' ' 60' ' ' LEU . 95.4 mt -84.06 133.72 34.64 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.016 0.436 . . . . 0.0 110.939 -179.696 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -130.68 157.03 43.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.763 179.879 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -58.13 117.51 4.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.903 0.382 . . . . 0.0 110.526 -179.72 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.77 -11.46 20.88 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -179.449 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.493 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 61.7 t0 -79.18 120.11 23.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.984 0.421 . . . . 0.0 110.185 179.586 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.8 t -108.21 130.79 60.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.92 -178.985 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.2 mt -94.73 132.18 39.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.108 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.9 m -116.61 127.16 54.21 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 121.53 0.681 . . . . 0.0 111.477 -179.831 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.47 ' O ' ' C ' ' A' ' 91' ' ' ILE . 96.6 mt -122.86 125.15 71.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.001 179.044 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.577 HG22 ' N ' ' A' ' 92' ' ' ASP . 87.4 mt 33.09 -101.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.155 -179.455 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.577 ' N ' HG22 ' A' ' 91' ' ' ILE . 56.9 t0 -109.69 14.98 23.11 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 121.067 -0.253 . . . . 0.0 111.615 -179.123 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.933 HH21 HD12 ' A' ' 41' ' ' LEU . 8.9 mtm105 -127.87 143.02 51.12 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.806 -179.449 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.3 m -134.8 148.48 50.2 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.945 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.587 ' HB3' HD11 ' A' ' 7' ' ' LEU . 75.9 m-85 -126.94 126.97 44.12 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.884 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.481 ' O ' HD12 ' A' ' 7' ' ' LEU . 99.8 mtt180 -89.77 131.04 35.93 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.812 179.857 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.587 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 88.9 t80 -97.99 129.2 44.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.938 0.399 . . . . 0.0 110.127 179.569 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -133.14 123.91 26.54 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.222 -179.514 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -117.32 105.62 12.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.818 -179.682 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.471 ' HB2' HH12 ' A' ' 6' ' ' ARG . 49.0 tt0 . . . . . 0 C--N 1.326 -0.451 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.716 179.86 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 54.4 t . . . . . 0 C--O 1.233 0.195 0 CA-C-O 120.676 0.274 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 090 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' A' ' 31' ' ' ARG . 91.0 m-20 -61.79 -42.75 99.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.964 -179.472 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 090 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -111.83 26.2 10.86 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.724 -178.198 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -119.16 -173.41 15.53 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -179.798 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -73.5 158.44 47.79 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 123.183 2.588 . . . . 0.0 112.428 179.988 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.404 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.91 172.74 13.98 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 122.285 1.99 . . . . 0.0 110.958 178.757 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.637 HG23 ' OD1' ' A' ' 67' ' ' ASN . 4.1 p -118.14 136.48 55.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 120.976 0.417 . . . . 0.0 111.026 -179.277 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 11.9 t -70.92 128.1 34.84 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.377 -179.939 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . 0.41 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . 0.41 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 46.9 Cg_exo -57.19 -25.42 64.28 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 123.02 2.48 . . . . 0.0 112.881 -179.461 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 36.2 m -73.58 -44.76 56.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.229 0.538 . . . . 0.0 109.837 178.224 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.576 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 47.7 t80 -57.28 -46.31 83.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.448 -179.413 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 97.9 mt -63.61 -41.2 98.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.919 0.39 . . . . 0.0 110.06 -179.871 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -62.75 -45.05 94.51 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.099 179.736 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . 0.502 ' O ' ' OG ' ' B' ' 247' ' ' SER . 73.6 ttt180 -65.03 -41.85 94.9 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.045 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.648 HH11 ' NH1' ' A' ' 12' ' ' ARG . 9.0 tpp180 -58.91 -43.95 91.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.543 -179.122 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -64.93 -42.05 95.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.122 0.487 . . . . 0.0 109.874 178.796 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . 0.502 ' OG ' ' O ' ' B' ' 244' ' ' ARG . 78.3 p -62.05 -46.32 89.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.037 179.774 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -62.61 -39.02 92.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.278 -179.575 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.452 HG23 ' O ' ' B' ' 245' ' ' ARG . 42.6 t -59.76 -45.41 94.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.303 -179.946 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -65.16 -32.81 74.68 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.435 0.636 . . . . 0.0 109.374 178.612 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -71.09 -19.51 62.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.753 -179.44 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 79.6 mt -66.9 122.65 18.18 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.903 -179.866 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . 0.595 ' ND2' ' OD1' ' B' ' 254' ' ' ASP . 2.1 p-10 -66.92 -42.98 84.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.064 -179.999 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . 0.595 ' OD1' ' ND2' ' B' ' 253' ' ' ASN . 99.3 m-20 -65.9 -11.12 44.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.084 -179.52 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . 0.448 ' CB ' ' O ' ' B' ' 254' ' ' ASP . 1.6 t0 80.07 26.89 0.32 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.402 -179.791 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.409 ' CB ' ' O ' ' B' ' 255' ' ' ASP . 4.5 t0 75.51 39.63 0.34 Allowed 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.253 179.339 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -64.64 -41.3 96.25 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.764 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.49 ' O ' ' O ' ' B' ' 259' ' ' ASP . 32.7 p-10 -115.75 96.6 5.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.491 178.586 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.49 ' O ' ' O ' ' B' ' 258' ' ' ASP . 63.4 t0 -53.46 -111.14 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.794 -178.92 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.674 ' OE1' HD21 ' A' ' 41' ' ' LEU . 95.7 mt-10 -152.17 27.43 0.6 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.555 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.469 HD12 ' CG2' ' A' ' 9' ' ' THR . 55.0 mt -111.12 139.91 32.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.554 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 58.9 t -128.25 135.71 61.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.129 179.765 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -97.41 120.8 38.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.252 0.549 . . . . 0.0 111.9 -178.178 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -63.88 -46.63 84.08 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.231 179.267 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . 0.717 ' CD ' HD11 ' A' ' 24' ' ' LEU . 2.7 mt-30 -94.01 161.78 28.77 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.903 -179.674 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.93 146.36 58.88 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 122.854 2.369 . . . . 0.0 112.768 -179.64 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 45.3 pt . . . . . 0 C--N 1.328 -0.342 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.679 . . . . . . . . 0 0 . 1 . 091 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo . . . . . 0 N--CA 1.494 1.524 0 CA-C-O 120.884 0.285 . . . . 0.0 111.626 . . . . . . . . . 0 0 . 1 . 091 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 68.2 p -99.37 -46.71 5.41 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.469 -179.587 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.8 mtt85 -93.08 129.19 39.13 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.37 -0.532 . . . . 0.0 109.589 -179.743 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -133.99 145.44 49.5 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 120.641 -0.423 . . . . 0.0 111.363 -179.476 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.402 HD11 HD11 ' A' ' 22' ' ' LEU . 66.0 mt -115.34 136.31 53.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.316 179.635 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.818 HG11 ' NH2' ' A' ' 96' ' ' ARG . 27.4 t -109.71 127.06 66.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.715 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.0 m -77.26 142.04 39.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.356 -178.493 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.631 HD12 ' OG ' ' A' ' 94' ' ' SER . 97.5 mt -110.43 134.15 53.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.871 177.261 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.412 ' NZ ' ' HA ' ' B' ' 257' ' ' LYS . 96.8 mttt -88.51 158.77 18.22 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.06 0.457 . . . . 0.0 110.815 179.99 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.433 ' NH2' ' HB3' ' B' ' 248' ' ' GLN . 82.1 mtp180 -57.25 -32.82 66.95 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.901 -178.824 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 65.2 m -77.31 -6.78 54.5 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.201 178.767 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.07 31.63 10.7 Favored Glycine 0 CA--C 1.519 0.302 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 -179.595 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.1 t -113.5 133.04 60.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.987 0.423 . . . . 0.0 111.451 -178.924 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.658 ' CG ' HH22 ' A' ' 96' ' ' ARG . 97.5 m-20 -74.03 137.03 43.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.874 179.651 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.47 -122.91 2.49 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 120.459 -0.877 . . . . 0.0 113.029 -178.633 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -71.78 149.93 55.12 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.463 2.109 . . . . 0.0 113.235 -177.965 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -111.29 127.39 55.61 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.688 179.962 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.743 ' CD2' HD11 ' A' ' 37' ' ' ILE . 55.9 t80 -99.29 105.55 33.49 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.854 179.903 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -75.82 135.29 17.45 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 121.112 1.208 . . . . 0.0 111.255 -179.516 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.402 HD11 HD11 ' A' ' 7' ' ' LEU . 96.5 mt -85.94 58.94 5.33 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.484 -178.528 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 90.8 p -64.17 -34.5 78.21 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.003 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 66.2 mt -75.77 144.94 41.13 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.53 179.423 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.8 m -68.63 -17.09 64.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.873 -178.624 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.483 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 58.1 m -133.22 134.22 43.73 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.666 -0.413 . . . . 0.0 112.024 -179.198 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.5 t -126.23 116.2 20.91 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.64 179.14 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.492 HD21 ' OE1' ' A' ' 47' ' ' GLN . 63.2 tp -113.2 128.9 56.62 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 121.006 -0.277 . . . . 0.0 111.087 -179.486 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.445 ' CE2' HG13 ' A' ' 37' ' ' ILE . 19.3 m-85 -107.1 129.04 54.88 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.783 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 172.46 -175.44 45.6 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.455 179.96 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.698 ' HD2' HG13 ' B' ' 228' ' ' VAL . 83.8 mtm-85 -80.28 -26.55 38.88 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.98 0.419 . . . . 0.0 110.33 179.363 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -55.44 144.45 33.29 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.132 -178.041 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.498 HG23 ' N ' ' A' ' 34' ' ' GLU . 11.1 tp -64.91 -41.77 93.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.17 0.509 . . . . 0.0 109.634 179.334 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.498 ' N ' HG23 ' A' ' 33' ' ' ILE . 17.3 pt-20 -57.19 -16.74 8.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.331 -179.874 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 45.8 m -66.21 134.01 51.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.204 0.526 . . . . 0.0 111.096 -178.84 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.483 ' OD2' ' O ' ' A' ' 26' ' ' THR . 60.9 m-20 -63.17 -36.34 83.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.316 -179.461 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.743 HD11 ' CD2' ' A' ' 20' ' ' PHE . 49.1 mm -121.14 117.4 52.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.483 177.693 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.43 ' NH1' ' CD1' ' A' ' 33' ' ' ILE . 81.4 mtp180 -107.2 134.7 49.91 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 120.374 -0.531 . . . . 0.0 111.018 -179.259 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 85.3 mt -120.92 131.34 73.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 120.126 -0.63 . . . . 0.0 109.711 178.916 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -77.84 24.93 0.21 Allowed 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -177.492 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 32.8 mt -94.23 132.61 28.84 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.973 179.433 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.57 -12.26 29.04 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.121 1.881 . . . . 0.0 113.584 -179.239 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.0 m -97.41 9.53 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 120.034 -0.666 . . . . 0.0 110.787 179.309 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.623 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 33.8 t -94.84 131.79 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 177.918 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.436 ' HB2' ' H ' ' A' ' 48' ' ' HIS . 5.9 m -76.1 173.49 11.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.579 0.704 . . . . 0.0 111.865 -178.755 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.563 ' NZ ' ' O ' ' B' ' 232' ' ' GLY . 62.7 mttp -64.75 -38.62 91.6 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.477 -179.862 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.649 ' O ' ' N ' ' A' ' 49' ' ' CYS . 93.8 mm-40 -113.34 -23.52 9.84 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.993 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.436 ' H ' ' HB2' ' A' ' 45' ' ' SER . 12.7 t60 34.26 -77.42 0.0 OUTLIER 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.63 179.978 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.649 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.72 135.74 47.08 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.981 0.42 . . . . 0.0 111.62 -179.385 . . . . . . . . 3 3 . 1 . 091 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -128.82 127.32 41.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.506 179.911 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 85.7 mt -111.6 132.85 59.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.599 -179.451 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -115.59 125.66 53.22 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.434 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.7 mt -107.3 115.13 47.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.029 -179.497 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.466 ' C ' ' N ' ' A' ' 56' ' ' GLN . 94.1 m-70 -112.45 144.75 41.37 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.771 -179.711 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 54' ' ' HIS . 94.9 mt-10 -41.62 -27.52 0.1 Allowed 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.152 -179.908 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.466 ' N ' ' C ' ' A' ' 54' ' ' HIS . 88.1 mt-30 -65.0 -68.89 0.33 Allowed 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.157 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -159.34 -164.9 1.46 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.954 179.489 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -108.97 130.75 55.47 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.608 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.4 mt -121.15 130.53 74.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -177.961 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.405 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 22.7 tp -101.15 126.93 47.9 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.66 179.514 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -109.77 135.71 50.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.697 178.726 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.64 HD21 ' CA ' ' A' ' 68' ' ' PRO . 56.2 t-20 -98.14 103.71 15.68 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.76 -179.159 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -98.86 -7.24 27.59 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -179.693 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 26.2 t -76.6 99.58 5.05 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.998 179.954 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.7 p -74.95 -38.46 61.72 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.993 0.425 . . . . 0.0 109.902 178.999 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.0 p -67.18 -39.35 86.39 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.538 179.859 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.454 ' O ' ' OG ' ' A' ' 64' ' ' SER . 46.3 m-20 -147.47 97.51 4.04 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.44 -179.277 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.64 ' CA ' HD21 ' A' ' 62' ' ' ASN . 37.3 Cg_exo -56.55 148.11 65.66 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 121.988 1.792 . . . . 0.0 112.574 179.544 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.545 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 8.3 m -74.36 137.43 42.78 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.36 179.718 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -99.03 140.12 33.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.427 179.827 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.517 ' HB ' HD11 ' A' ' 76' ' ' ILE . 25.2 t -130.49 134.69 61.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.65 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 53.12 35.94 21.06 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 120.127 -0.629 . . . . 0.0 109.399 -179.716 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 66.56 30.15 75.96 Favored Glycine 0 CA--C 1.523 0.557 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.204 179.484 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 83.4 p -138.44 125.86 21.84 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.625 -179.141 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.3 p -63.01 140.78 19.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.104 0.478 . . . . 0.0 111.57 -179.657 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.549 ' CG2' ' O ' ' A' ' 78' ' ' GLU . 97.1 mt -116.17 124.27 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.085 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.044 -179.883 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 30.6 p-10 -96.76 -24.58 15.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.974 179.198 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.549 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 2.5 mt-10 -129.54 169.91 12.12 Favored Pre-proline 0 N--CA 1.468 0.451 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.092 -179.055 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -56.8 143.25 91.3 Favored 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 121.994 1.796 . . . . 0.0 112.581 -179.95 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 78.0 t -136.4 138.22 47.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.756 179.975 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 85.4 mtt85 -74.17 134.68 42.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.629 179.199 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.1 mt -86.02 136.61 33.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.388 0.613 . . . . 0.0 111.393 -179.754 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -126.95 151.46 48.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.967 179.764 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.429 ' ND1' ' N ' ' A' ' 99' ' ' ASN . 7.8 t60 -56.58 120.14 7.27 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.963 0.411 . . . . 0.0 111.296 -179.447 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.7 -17.73 30.17 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 179.465 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -71.06 134.54 47.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.943 0.401 . . . . 0.0 110.47 -179.85 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.8 p -106.59 135.93 43.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.825 -178.859 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.9 mt -105.95 131.44 55.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 179.0 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 99.9 m -122.51 127.75 49.93 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -178.314 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.519 ' N ' ' O ' ' A' ' 93' ' ' ARG . 96.9 mt -112.67 132.27 61.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 177.428 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.579 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 2.5 mp -37.74 101.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.777 -178.766 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.579 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 37.5 t0 101.49 -30.94 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.732 0 O-C-N 124.225 0.953 . . . . 0.0 112.496 179.01 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 90' ' ' ILE . 36.0 mmt180 -128.99 143.18 50.79 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.951 -178.647 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.631 ' OG ' HD12 ' A' ' 10' ' ' ILE . 17.1 p -138.26 151.25 47.45 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.474 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -130.76 125.05 32.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.736 -179.351 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.818 ' NH2' HG11 ' A' ' 8' ' ' VAL . 92.8 mtm-85 -84.35 138.39 32.91 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.113 178.869 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -96.2 116.59 29.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.488 -179.392 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -120.64 122.59 40.83 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.777 0.322 . . . . 0.0 110.362 179.743 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.429 ' N ' ' ND1' ' A' ' 84' ' ' HIS . 21.5 t-20 -101.1 111.8 24.1 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.372 179.897 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 . . . . . 0 N--CA 1.466 0.369 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.102 -179.372 . . . . . . . . 0 0 . 1 . 091 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . 0.698 HG13 ' HD2' ' A' ' 31' ' ' ARG . 17.3 t . . . . . 0 CA--C 1.53 0.204 0 CA-C-O 120.756 0.312 . . . . 0.0 111.349 . . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.543 ' O ' ' CB ' ' B' ' 230' ' ' SEP . 79.7 m-20 -90.58 -5.36 56.0 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.593 178.986 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . 0.543 ' CB ' ' O ' ' B' ' 229' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.446 ' NE2' ' P ' ' B' ' 230' ' ' SEP . 13.7 mt-30 -125.4 42.81 3.2 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.302 179.857 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . 0.563 ' O ' ' NZ ' ' A' ' 46' ' ' LYS . . . -118.35 -175.7 16.65 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -179.435 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.6 164.06 35.86 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 123.814 3.009 . . . . 0.0 113.33 -179.822 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.612 ' O2P' HG21 ' B' ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -77.3 152.3 30.52 Favored 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 122.408 2.072 . . . . 0.0 112.803 179.531 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.423 HG13 ' O ' ' B' ' 236' ' ' VAL . 8.9 p -80.44 124.64 38.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.277 179.969 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -61.64 122.1 14.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.608 -179.354 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 091 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.04 -19.66 33.81 Favored 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 121.855 1.703 . . . . 0.0 111.395 178.986 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 73.8 m -71.35 -45.53 62.71 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.194 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -57.89 -46.72 84.49 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.336 179.588 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.429 HD21 HG23 ' A' ' 91' ' ' ILE . 90.0 mt -64.58 -40.07 94.88 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.667 179.026 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -61.41 -40.81 95.77 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 120.778 0.323 . . . . 0.0 110.686 -179.979 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -60.04 -42.07 93.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.569 179.466 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.538 ' O ' HG23 ' B' ' 249' ' ' VAL . 67.9 ttp85 -59.92 -42.97 95.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.538 179.878 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -62.83 -41.66 99.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.211 -179.225 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 59.5 p -69.53 -41.55 75.83 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.879 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . 0.447 ' O ' ' N ' ' B' ' 252' ' ' LEU . 67.2 tp60 -60.95 -38.22 85.12 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.424 -179.937 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.538 HG23 ' O ' ' B' ' 245' ' ' ARG . 39.3 t -60.73 -47.19 94.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.547 179.543 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -62.17 -26.75 68.52 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.129 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -89.45 -15.31 33.44 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.307 -179.932 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.668 HD21 ' OD2' ' B' ' 256' ' ' ASP . 57.3 tp -122.83 115.84 22.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.374 179.178 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 174.38 30.35 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.707 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . 0.59 ' O ' ' CB ' ' B' ' 255' ' ' ASP . 75.9 m-20 -87.81 -4.61 58.86 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.093 -179.971 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . 0.59 ' CB ' ' O ' ' B' ' 254' ' ' ASP . 52.5 t0 111.11 64.73 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 O-C-N 124.459 1.1 . . . . 0.0 110.575 -179.703 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.668 ' OD2' HD21 ' B' ' 252' ' ' LEU . 50.9 p-10 -94.2 14.85 18.88 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.289 -179.559 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . 0.532 ' C ' ' O ' ' B' ' 256' ' ' ASP . 98.6 mttt 25.13 -120.16 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 O-C-N 123.553 0.533 . . . . 0.0 110.366 -179.991 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.476 ' C ' ' O ' ' B' ' 257' ' ' LYS . 86.4 m-20 -33.48 148.11 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.813 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.562 ' C ' ' H ' ' B' ' 261' ' ' ILE . 49.4 p30 -125.43 -169.41 1.99 Allowed 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.242 0.544 . . . . 0.0 110.953 -179.267 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.456 ' HB2' HH21 ' A' ' 93' ' ' ARG . 77.2 mt-10 -62.12 17.91 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.991 -178.734 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.562 ' H ' ' C ' ' B' ' 259' ' ' ASP . 83.2 mt -107.59 132.07 56.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.949 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 54.9 t -124.78 132.37 71.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.082 -179.947 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -94.3 118.35 31.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.052 -178.636 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -67.13 -44.8 78.93 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.606 179.276 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . 0.508 ' OE1' ' O ' ' B' ' 266' ' ' PRO . 0.0 OUTLIER -87.42 162.12 43.64 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.999 -179.621 . . . . . . . . 3 3 . 1 . 091 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . 0.508 ' O ' ' OE1' ' B' ' 265' ' ' GLN . 36.6 Cg_endo -62.15 144.07 95.32 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 121.974 1.783 . . . . 0.0 111.91 -179.85 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . 0.488 HG23 ' O ' ' B' ' 267' ' ' ILE . 11.8 tt . . . . . 0 C--N 1.322 -0.589 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.623 -178.925 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo . . . . . 0 N--CA 1.499 1.817 0 N-CA-C 111.825 -0.106 . . . . 0.0 111.825 . . . . . . . . . 0 0 . 1 . 092 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.6 m -96.65 -37.79 10.2 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.426 -179.881 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.612 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 95.3 mtt-85 -90.97 122.98 34.1 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.457 -179.665 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -133.08 140.21 47.55 Favored 'General case' 0 CA--C 1.522 -0.105 0 CA-C-O 121.246 0.546 . . . . 0.0 112.134 -179.65 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.567 HD11 ' HB3' ' A' ' 95' ' ' PHE . 37.3 tp -114.57 135.81 53.72 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.347 -179.883 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.8 t -111.66 130.1 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 120.683 0.278 . . . . 0.0 110.487 -179.735 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.446 HG23 ' CD1' ' B' ' 261' ' ' ILE . 1.8 m -88.93 118.47 28.67 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -177.837 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.562 HD12 ' OG ' ' A' ' 94' ' ' SER . 97.0 mt -83.32 139.07 18.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.37 178.935 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -88.97 160.46 17.12 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.981 179.275 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.504 ' NE ' ' NH2' ' B' ' 245' ' ' ARG . 84.4 mtp180 -56.3 -30.97 63.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.269 -179.27 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.468 ' HB3' HD21 ' B' ' 253' ' ' ASN . 84.3 p -79.22 -7.27 58.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.424 -179.803 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.61 28.08 22.81 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 -179.817 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.7 t -112.01 133.03 59.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.829 0.347 . . . . 0.0 110.629 -179.625 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -77.02 141.24 40.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.732 179.317 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -133.3 -114.91 1.56 Allowed Glycine 0 CA--C 1.536 1.396 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.64 -179.319 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -74.45 149.56 39.68 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.406 2.071 . . . . 0.0 113.324 -179.171 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -112.52 148.88 33.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.986 179.941 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.575 ' CD2' HD11 ' A' ' 37' ' ' ILE . 22.0 t80 -114.58 105.4 53.62 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.714 179.983 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.17 122.41 8.37 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 C-N-CA 121.123 1.215 . . . . 0.0 110.895 -179.678 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 74.2 mt -78.51 46.11 0.62 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.256 -0.578 . . . . 0.0 110.442 -179.2 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.9 p -59.53 -30.25 68.46 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.333 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.645 HD11 ' HG2' ' B' ' 265' ' ' GLN . 73.3 mt -72.86 142.91 47.96 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.996 179.532 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.5 m -62.94 -22.97 67.15 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.255 -179.382 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 86.3 m -135.43 137.89 42.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.504 -179.606 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.67 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 3.5 t -132.57 123.83 27.23 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.825 0.345 . . . . 0.0 110.266 178.227 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.442 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 41.0 tp -112.72 130.3 56.11 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.957 -179.228 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.724 ' CE2' HD12 ' A' ' 37' ' ' ILE . 6.9 m-85 -108.88 140.03 42.91 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.768 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 167.63 -169.05 40.98 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 118.84 -1.647 . . . . 0.0 113.436 179.203 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.451 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 36.9 ttp-105 -90.77 -28.47 18.23 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 114.53 -0.835 . . . . 0.0 110.537 -179.966 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.08 152.35 49.03 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.517 -179.344 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.635 ' O ' ' NE ' ' A' ' 38' ' ' ARG . 7.0 tp -66.42 -42.28 90.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.449 0.642 . . . . 0.0 110.273 179.506 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.542 ' N ' HG23 ' A' ' 33' ' ' ILE . 79.9 tt0 -54.62 -13.87 1.13 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.874 -178.925 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 83.4 m -67.58 133.32 49.21 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.497 179.801 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.442 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 51.3 m-20 -58.69 -32.34 69.05 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.473 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.724 HD12 ' CE2' ' A' ' 29' ' ' PHE . 92.4 mt -125.33 120.61 58.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 177.228 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.635 ' NE ' ' O ' ' A' ' 33' ' ' ILE . 71.0 mtt85 -107.01 135.84 47.88 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.064 -177.34 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.433 HG22 ' H ' ' A' ' 41' ' ' LEU . 89.4 mt -118.12 133.55 64.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.069 0.461 . . . . 0.0 110.593 179.019 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -75.16 23.42 0.1 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.966 -178.864 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.62 HD21 ' NH1' ' B' ' 245' ' ' ARG . 21.0 mt -92.23 123.77 61.58 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.248 178.831 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -71.99 -8.27 22.61 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 121.821 1.681 . . . . 0.0 112.713 -179.503 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.604 HG12 ' HB2' ' B' ' 235' ' ' PRO . 23.8 m -101.14 7.83 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.58 -179.736 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.451 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 21.0 t -91.12 137.19 22.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 120.394 -0.522 . . . . 0.0 109.838 179.674 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.43 ' O ' HG12 ' A' ' 44' ' ' VAL . 0.4 OUTLIER -65.66 164.78 13.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.167 0.508 . . . . 0.0 111.192 -179.451 . . . . . . . . 3 3 . 1 . 092 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -62.54 -44.53 96.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.221 -178.822 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.644 ' O ' ' N ' ' A' ' 49' ' ' CYS . 83.4 mt-30 -113.8 -20.59 11.06 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 123.526 0.516 . . . . 0.0 110.376 179.092 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.513 ' O ' ' OG ' ' A' ' 64' ' ' SER . 24.5 t60 35.52 -73.27 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 179.846 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.644 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -129.91 134.18 47.32 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -178.381 . . . . . . . . 3 3 . 1 . 092 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -125.74 129.95 50.51 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.41 178.67 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.2 mt -113.9 134.66 56.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.015 -179.421 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -119.08 124.93 48.1 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.917 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 94.2 mt -104.27 114.13 43.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.483 0.659 . . . . 0.0 111.447 -179.326 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.44 ' O ' ' C ' ' A' ' 55' ' ' GLU . 94.8 m-70 -114.26 142.23 46.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.638 -1.165 . . . . 0.0 109.93 -179.681 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 54' ' ' HIS . 97.5 mt-10 -40.11 -31.14 0.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -179.703 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.433 ' N ' ' O ' ' A' ' 54' ' ' HIS . 89.1 mt-30 -62.35 -67.98 0.37 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.491 178.604 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.423 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 4.8 tp10 -159.21 -162.98 1.13 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.902 179.742 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.543 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -114.19 127.24 55.8 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.009 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.6 mt -116.44 130.9 70.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.21 0.529 . . . . 0.0 112.369 -177.952 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 25.6 tp -98.62 130.29 45.15 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.464 179.442 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -116.58 137.52 52.12 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.548 -179.437 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.67 ' ND2' ' H ' ' A' ' 69' ' ' THR . 16.1 t-20 -98.88 106.7 19.0 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.935 179.496 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -98.14 -7.24 29.88 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.001 178.453 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.513 ' OG ' ' O ' ' A' ' 48' ' ' HIS . 0.7 OUTLIER -70.29 100.93 1.8 Allowed 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.698 179.456 . . . . . . . . 3 3 . 1 . 092 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.3 m -86.05 -8.7 57.73 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.031 0.443 . . . . 0.0 110.268 179.917 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.764 HG22 HG12 ' B' ' 236' ' ' VAL . 0.2 OUTLIER -99.67 -39.52 8.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.226 179.817 . . . . . . . . 3 3 . 1 . 092 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 67.3 m-20 -142.63 93.79 6.82 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.111 179.569 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.49 ' HA ' HD21 ' A' ' 62' ' ' ASN . 42.4 Cg_exo -55.07 148.59 47.7 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 122.384 2.056 . . . . 0.0 112.13 -179.782 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.67 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 33.5 m -73.4 149.64 42.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.301 -179.761 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -114.11 140.56 48.4 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.405 -179.911 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.414 ' O ' ' N ' ' A' ' 74' ' ' SER . 4.2 p -128.78 134.8 63.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.671 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 48.8 30.49 2.68 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.086 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.09 27.9 67.55 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.569 -179.984 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.414 ' N ' ' O ' ' A' ' 71' ' ' VAL . 71.5 m -134.81 134.91 41.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.674 0.273 . . . . 0.0 110.434 179.935 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.5 p -68.51 145.19 13.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -178.748 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.65 HD11 ' HB ' ' A' ' 69' ' ' THR . 3.1 pt -122.36 86.08 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.839 179.801 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 46.4 p-10 -67.21 -21.89 65.74 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.846 0.355 . . . . 0.0 110.406 179.68 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -122.5 170.28 8.24 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.446 179.918 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -62.96 144.53 93.29 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 122.298 1.999 . . . . 0.0 112.21 -179.888 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.9 p -139.28 139.68 39.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.858 -179.831 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -74.71 132.88 42.01 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.791 -0.363 . . . . 0.0 110.449 179.452 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 97.7 mt -83.0 138.48 33.74 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.643 179.925 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -128.47 149.42 50.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.36 179.697 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -54.15 119.71 5.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.057 0.456 . . . . 0.0 111.105 -179.426 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.97 -15.73 36.73 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 179.208 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -70.15 137.56 51.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.836 0.35 . . . . 0.0 110.616 179.821 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.465 HG22 ' HG2' ' A' ' 96' ' ' ARG . 59.0 t -111.08 132.73 58.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.14 -178.728 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 97.3 mt -100.52 132.22 46.58 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.829 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.2 m -120.7 121.71 38.86 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 119.862 -0.735 . . . . 0.0 112.027 -179.136 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.535 ' N ' ' O ' ' A' ' 93' ' ' ARG . 97.4 mt -108.12 119.63 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 177.74 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.517 HG22 ' N ' ' A' ' 92' ' ' ASP . 91.7 mt 35.16 -96.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.486 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.633 ' OD2' ' NE ' ' B' ' 245' ' ' ARG . 31.5 p-10 -110.1 10.82 23.95 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -178.323 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.535 ' O ' ' N ' ' A' ' 90' ' ' ILE . 80.1 mtt-85 -130.04 145.56 51.67 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.624 -179.785 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.562 ' OG ' HD12 ' A' ' 10' ' ' ILE . 54.3 p -139.72 151.94 46.26 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.389 0.614 . . . . 0.0 110.133 179.392 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.567 ' HB3' HD11 ' A' ' 7' ' ' LEU . 54.8 m-85 -125.38 126.2 44.63 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.953 -179.924 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.465 ' HG2' HG22 ' A' ' 87' ' ' VAL . 99.7 mtt180 -85.57 131.94 34.27 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.971 -179.351 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.612 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 88.4 t80 -100.53 125.54 46.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.916 -179.659 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -145.1 132.79 20.99 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.066 0.46 . . . . 0.0 111.912 -179.961 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -96.84 140.67 31.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.714 179.57 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 . . . . . 0 C--N 1.324 -0.505 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.65 -178.718 . . . . . . . . 0 0 . 1 . 092 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . 0.537 ' O ' HG12 ' B' ' 228' ' ' VAL . 19.0 t . . . . . 0 C--O 1.234 0.238 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 . . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.523 ' O ' ' CB ' ' B' ' 230' ' ' SEP . 99.3 m-20 -76.98 -18.71 58.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.069 179.314 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . 0.523 ' CB ' ' O ' ' B' ' 229' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 169.68 36.64 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.784 179.886 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -126.23 -167.69 12.49 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.554 -179.525 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -61.85 156.84 46.32 Favored 'Trans proline' 0 C--N 1.299 -2.061 0 C-N-CA 123.929 3.086 . . . . 0.0 112.634 179.407 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 092 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . 0.604 ' HB2' HG12 ' A' ' 43' ' ' VAL . 31.5 Cg_exo -57.38 154.89 32.82 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.719 2.28 . . . . 0.0 112.357 179.653 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.764 HG12 HG22 ' A' ' 66' ' ' THR . 12.0 m -101.78 130.21 51.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.836 179.615 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.7 t -61.92 115.47 4.07 Favored 'General case' 0 CA--C 1.52 -0.19 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.198 -179.705 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 092 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -55.73 -25.48 51.51 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 122.196 1.931 . . . . 0.0 112.243 179.081 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 19.8 m -70.33 -43.14 70.87 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.096 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.496 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 76.8 t80 -57.94 -49.06 78.08 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.801 179.825 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 97.1 mt -63.66 -41.76 98.17 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.569 -179.193 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -65.12 -40.91 95.15 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -178.829 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -61.59 -43.77 98.24 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.183 -179.59 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.633 ' NE ' ' OD2' ' A' ' 92' ' ' ASP . 76.3 mtp85 -65.14 -40.49 94.49 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.765 -179.6 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -61.6 -39.55 91.65 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.008 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 14.4 t -65.14 -43.86 90.53 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.416 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . 0.444 ' O ' ' N ' ' B' ' 252' ' ' LEU . 55.9 tt0 -61.07 -37.83 84.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.254 179.689 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.572 HG23 ' O ' ' B' ' 245' ' ' ARG . 70.5 t -63.22 -44.14 99.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 120.526 -0.47 . . . . 0.0 109.833 178.768 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -58.28 -29.14 65.59 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.379 0.609 . . . . 0.0 109.374 179.143 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -96.96 -9.45 28.28 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.782 179.504 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.529 ' O ' ' O ' ' B' ' 249' ' ' VAL . 31.5 tp -124.47 121.53 35.12 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.801 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . 0.468 HD21 ' HB3' ' A' ' 13' ' ' SER . 0.3 OUTLIER 167.49 24.91 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.421 -179.827 . . . . . . . . 3 3 . 1 . 092 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . 0.459 ' O ' ' CB ' ' B' ' 255' ' ' ASP . 92.7 m-20 -61.47 -41.28 97.0 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.594 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . 0.459 ' CB ' ' O ' ' B' ' 254' ' ' ASP . 4.6 t0 154.31 73.28 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.187 -1.369 . . . . 0.0 108.238 179.756 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' B' ' 258' ' ' ASP . 63.8 t0 -97.08 92.47 6.07 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.688 -179.074 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -67.19 -8.06 28.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.35 -179.855 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.401 ' O ' ' OD1' ' B' ' 256' ' ' ASP . 97.6 m-20 -110.98 135.71 51.08 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.322 179.018 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.555 ' C ' ' H ' ' B' ' 261' ' ' ILE . 47.5 p30 -124.9 165.87 17.3 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.469 0.652 . . . . 0.0 110.208 179.83 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.429 ' HB2' ' NH2' ' A' ' 93' ' ' ARG . 98.3 mt-10 -61.61 17.48 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.034 -0.985 . . . . 0.0 112.467 -178.755 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.555 ' H ' ' C ' ' B' ' 259' ' ' ASP . 69.2 mt -108.91 134.69 50.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.848 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 59.1 t -128.88 134.79 63.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.918 0.39 . . . . 0.0 110.621 -179.684 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -97.21 122.08 39.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.661 -178.898 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . 0.481 ' HG3' HH22 ' A' ' 38' ' ' ARG . 86.9 tttt -66.81 -44.51 81.01 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.293 179.424 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . 0.645 ' HG2' HD11 ' A' ' 24' ' ' LEU . 9.7 mp0 -100.87 160.31 27.1 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.482 -177.935 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -62.3 151.38 82.81 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 123.423 2.748 . . . . 0.0 112.803 -179.336 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 40.8 pt . . . . . 0 C--N 1.33 -0.261 0 CA-C-O 121.844 0.83 . . . . 0.0 112.431 -178.722 . . . . . . . . 0 0 . 1 . 093 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo . . . . . 0 N--CA 1.496 1.639 0 N-CA-C 113.58 0.569 . . . . 0.0 113.58 . . . . . . . . . 0 0 . 1 . 093 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.7 m -65.24 -45.02 86.32 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.127 -179.715 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.603 ' NH1' ' OH ' ' A' ' 97' ' ' TYR . 96.3 mtt-85 -88.12 118.01 27.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.916 0.388 . . . . 0.0 110.743 -178.844 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.413 HH21 ' CE1' ' A' ' 19' ' ' HIS . 75.6 ttt180 -125.99 126.42 44.28 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.288 -179.499 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.627 HD12 ' O ' ' A' ' 96' ' ' ARG . 22.5 tp -109.13 130.98 55.49 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.467 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 76.5 t -106.82 127.46 62.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.355 179.97 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.5 m -80.23 144.75 32.66 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.375 0.607 . . . . 0.0 111.674 -179.047 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.64 HD12 ' OG ' ' A' ' 94' ' ' SER . 98.1 mt -116.1 138.41 46.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.235 178.451 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -91.26 156.36 17.87 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.361 179.013 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.437 ' NH2' ' OE2' ' B' ' 260' ' ' GLU . 89.9 mtm180 -60.02 -28.75 67.99 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.615 -179.852 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 84.0 p -74.3 -14.47 60.9 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.524 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.34 35.42 5.73 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 -179.699 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 49.6 t -120.55 130.95 73.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.747 0.308 . . . . 0.0 111.049 -179.797 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -77.08 138.28 39.44 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.632 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.17 -118.24 2.06 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.936 -179.301 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -69.85 148.07 63.71 Favored 'Trans proline' 0 N--CA 1.501 1.938 0 C-N-CA 122.317 2.011 . . . . 0.0 113.685 -178.468 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.413 ' CE1' HH21 ' A' ' 6' ' ' ARG . 0.9 OUTLIER -111.95 130.27 55.9 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.376 -179.863 . . . . . . . . 3 3 . 1 . 093 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.403 ' CD2' HD11 ' A' ' 37' ' ' ILE . 64.9 t80 -107.02 105.43 55.53 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.15 -179.108 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.05 135.17 22.59 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 120.717 0.944 . . . . 0.0 111.306 -179.9 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 74.9 mt -87.13 48.14 1.61 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.754 -178.899 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.9 m -60.46 -29.91 69.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.91 178.829 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 73.1 mt -71.12 143.42 50.6 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.372 -179.939 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.3 m -58.94 -25.99 64.0 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.918 -179.143 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 78.0 m -138.77 141.17 38.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.182 0.515 . . . . 0.0 111.431 -179.862 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.8 t -130.42 121.85 26.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.694 178.683 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 41.2 tp -117.12 126.61 53.09 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.63 -179.652 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.65 ' CE2' HD12 ' A' ' 37' ' ' ILE . 4.3 m-85 -101.92 125.78 48.68 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.441 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 172.12 178.39 42.33 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 119.75 -1.214 . . . . 0.0 113.016 179.624 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 45.8 mtm180 -73.33 -32.77 64.75 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.771 0.32 . . . . 0.0 111.308 179.01 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -48.9 147.02 5.75 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 -178.967 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.456 ' HA ' HH11 ' A' ' 38' ' ' ARG . 11.0 tp -67.02 -40.66 86.01 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 CA-C-O 121.249 0.547 . . . . 0.0 109.929 179.714 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.446 ' N ' HG23 ' A' ' 33' ' ' ILE . 50.1 tp10 -57.68 -19.83 29.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.387 -179.951 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 76.8 m -59.72 129.95 44.42 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.821 -179.399 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.41 ' O ' ' CB ' ' B' ' 264' ' ' LYS . 66.0 m-20 -61.82 -35.03 77.02 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 -179.589 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.65 HD12 ' CE2' ' A' ' 29' ' ' PHE . 93.6 mt -123.5 118.32 54.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 177.395 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.456 HH11 ' HA ' ' A' ' 33' ' ' ILE . 21.8 mtp85 -104.57 136.22 44.53 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.447 -178.375 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.425 ' C ' ' H ' ' A' ' 41' ' ' LEU . 94.0 mt -117.54 129.85 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 121.036 0.446 . . . . 0.0 110.595 -179.955 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.626 ' NE2' ' OD2' ' B' ' 258' ' ' ASP . 73.4 mt-30 -73.36 28.54 0.07 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.808 -178.42 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.627 ' CD1' ' HE ' ' A' ' 93' ' ' ARG . 49.0 mt -103.14 127.89 28.82 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 120.296 -0.561 . . . . 0.0 110.803 -179.985 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.9 -7.47 20.77 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.129 1.886 . . . . 0.0 112.673 -179.369 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.8 m -98.7 4.73 9.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 120.776 -0.369 . . . . 0.0 111.06 179.941 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.1 t -88.4 134.8 27.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.158 178.434 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.2 m -70.54 168.58 15.99 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.447 0.641 . . . . 0.0 111.93 -179.264 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -62.9 -43.67 98.17 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.285 -178.98 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.623 ' O ' ' N ' ' A' ' 49' ' ' CYS . 97.2 mt-30 -114.24 -25.03 8.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.575 179.472 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.6 t60 37.0 -77.21 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.076 -0.966 . . . . 0.0 113.023 179.064 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.623 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -127.39 132.86 50.07 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.228 0.537 . . . . 0.0 111.775 -178.279 . . . . . . . . 3 3 . 1 . 093 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -128.86 132.47 47.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.07 -179.578 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.1 mt -117.12 132.31 67.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.488 179.488 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -114.73 127.85 55.98 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.79 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.5 mm -100.27 111.81 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-O 121.105 0.479 . . . . 0.0 110.736 -179.22 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.448 ' O ' ' C ' ' A' ' 55' ' ' GLU . 88.6 m-70 -110.64 132.91 53.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.17 179.434 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 54' ' ' HIS . 76.9 tt0 -40.82 -32.17 0.21 Allowed 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.394 -179.945 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.409 ' N ' ' O ' ' A' ' 54' ' ' HIS . 98.4 mm-40 -69.16 -68.48 0.4 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.599 179.171 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -146.13 -178.59 6.21 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.706 0.765 . . . . 0.0 111.939 -178.354 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.55 ' HB2' ' NH2' ' A' ' 5' ' ' ARG . . . -116.16 122.0 43.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.788 178.206 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 94.0 mt -118.85 133.92 64.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.161 0.505 . . . . 0.0 111.825 -178.638 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 22.9 tp -98.25 131.53 44.51 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.718 -179.896 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -114.22 139.49 49.34 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 121.053 0.454 . . . . 0.0 111.448 -178.955 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 59.1 t-20 -98.31 106.12 18.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.822 -179.485 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -98.63 -12.23 21.3 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.728 179.379 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.0 t -70.69 103.43 2.55 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.533 179.892 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.4 p -88.97 -18.73 26.83 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.432 179.695 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.596 HG22 ' CG2' ' B' ' 236' ' ' VAL . 0.2 OUTLIER -86.68 -44.27 11.96 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.285 . . . . . . . . 3 3 . 1 . 093 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -137.13 97.9 10.6 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.803 179.425 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -57.09 145.31 86.82 Favored 'Trans proline' 0 N--CA 1.499 1.82 0 C-N-CA 122.173 1.916 . . . . 0.0 113.014 -179.426 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.3 m -73.78 141.69 46.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.64 179.365 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -102.16 147.77 26.22 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.146 -179.637 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.546 ' CG2' ' OD1' ' A' ' 86' ' ' ASP . 4.3 p -128.04 136.04 61.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.88 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 47.75 31.59 2.26 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.226 -0.59 . . . . 0.0 109.653 -179.352 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.66 28.37 61.34 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.669 179.887 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 71' ' ' VAL . 58.3 m -140.35 141.57 35.64 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.192 -179.729 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 71.0 t -68.18 132.37 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.125 0 CA-C-O 121.358 0.599 . . . . 0.0 112.0 -179.131 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.58 100.3 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.72 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -87.07 -13.91 42.94 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.98 -178.717 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -117.02 164.96 16.7 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.967 -179.177 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -60.22 143.58 99.51 Favored 'Trans proline' 0 N--CA 1.501 1.956 0 C-N-CA 121.827 1.684 . . . . 0.0 111.613 -179.775 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.3 p -139.62 139.46 38.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.066 0.46 . . . . 0.0 110.782 -178.856 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -72.08 125.65 27.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.006 179.931 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.3 mt -77.95 137.25 38.22 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.269 0.557 . . . . 0.0 110.889 -179.894 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -134.96 152.8 52.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.993 -179.696 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -57.28 113.3 1.69 Allowed 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.347 -179.745 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.85 1.67 22.59 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 -179.843 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.546 ' OD1' ' CG2' ' A' ' 71' ' ' VAL . 67.7 t0 -86.16 122.96 30.9 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.596 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.412 HG22 ' HG2' ' A' ' 96' ' ' ARG . 28.0 t -105.7 134.27 47.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.791 -179.286 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 96.7 mt -105.26 132.61 51.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 178.453 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 37.4 m -121.02 125.45 47.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.484 0.659 . . . . 0.0 111.866 -178.901 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.401 ' O ' ' C ' ' A' ' 91' ' ' ILE . 84.8 mt -117.01 125.22 73.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.49 179.096 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.452 HG22 ' N ' ' A' ' 92' ' ' ASP . 44.5 mm 40.47 -105.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.586 -179.443 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.459 ' O ' ' OD1' ' A' ' 92' ' ' ASP . 56.5 t0 -114.86 19.55 15.79 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.921 0.391 . . . . 0.0 110.633 -179.679 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.627 ' HE ' ' CD1' ' A' ' 41' ' ' LEU . 73.7 mtt-85 -129.32 145.49 51.37 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 -179.856 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.64 ' OG ' HD12 ' A' ' 10' ' ' ILE . 11.4 p -140.94 157.4 45.41 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.241 -179.834 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.592 ' HB3' HD11 ' A' ' 7' ' ' LEU . 92.3 m-85 -131.09 124.96 31.92 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.055 -179.772 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.627 ' O ' HD12 ' A' ' 7' ' ' LEU . 99.8 mtt180 -90.82 136.31 33.16 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.531 -179.707 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.603 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 72.2 t80 -100.16 124.55 45.71 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.833 -179.574 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -141.13 132.08 26.06 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 121.256 0.55 . . . . 0.0 111.829 -179.908 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.435 ' ND2' ' OH ' ' A' ' 97' ' ' TYR . 97.9 m-20 -101.16 142.05 33.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.393 178.413 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 120.913 0.387 . . . . 0.0 111.068 -179.984 . . . . . . . . 0 0 . 1 . 093 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 18.1 m . . . . . 0 N--CA 1.455 -0.185 0 CA-C-O 120.808 0.337 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 093 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -47.48 166.37 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.559 -179.838 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . 0.624 ' O ' ' NE2' ' B' ' 231' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.624 ' NE2' ' O ' ' B' ' 230' ' ' SEP . 99.6 mm-40 -139.41 38.95 2.07 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.708 0.289 . . . . 0.0 110.263 179.12 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -111.55 -154.52 12.91 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.106 -178.799 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -74.83 156.46 43.76 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 122.69 2.26 . . . . 0.0 112.788 -179.332 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.413 HG21 ' OG1' ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -72.88 171.14 18.05 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 121.858 1.705 . . . . 0.0 111.722 179.773 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.596 ' CG2' HG22 ' A' ' 66' ' ' THR . 25.6 t -113.36 134.1 57.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.787 -178.958 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 44.6 t -73.24 128.03 34.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.634 -179.905 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . 0.43 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . 0.43 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 31.5 Cg_exo -59.41 -27.02 83.91 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 123.005 2.47 . . . . 0.0 112.711 -179.188 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 71.6 m -73.67 -42.91 60.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.239 0.543 . . . . 0.0 109.757 178.008 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -57.0 -47.02 81.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.981 -179.186 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 89.2 mt -63.42 -40.06 96.16 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.66 -179.998 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.7 -40.5 96.95 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.742 -179.948 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -63.44 -42.53 98.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.227 0.537 . . . . 0.0 110.374 179.309 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.527 ' O ' HG23 ' B' ' 249' ' ' VAL . 21.9 mmt180 -59.36 -41.53 89.46 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.404 -179.125 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -65.35 -40.54 93.74 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.112 -0.635 . . . . 0.0 109.997 178.038 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 48.7 m -61.36 -46.82 88.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.261 178.703 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -62.56 -36.01 81.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.117 -179.724 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.527 HG23 ' O ' ' B' ' 245' ' ' ARG . 33.2 t -59.48 -46.17 93.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.92 -179.928 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -65.75 -36.47 83.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.47 0.652 . . . . 0.0 109.802 178.891 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -68.3 -21.5 64.78 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.496 -179.661 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.446 ' CD1' ' OD1' ' B' ' 256' ' ' ASP . 70.7 mt -72.1 120.61 17.94 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.738 -179.398 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . 0.553 ' C ' HD22 ' B' ' 253' ' ' ASN . 0.4 OUTLIER -68.14 -44.41 76.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.487 179.956 . . . . . . . . 3 3 . 1 . 093 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . 0.488 ' O ' ' CB ' ' B' ' 255' ' ' ASP . 96.6 m-20 -65.46 -18.4 65.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.732 179.676 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . 0.488 ' CB ' ' O ' ' B' ' 254' ' ' ASP . 2.0 m-20 86.89 13.75 0.12 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.776 -179.323 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.487 ' CB ' ' O ' ' B' ' 255' ' ' ASP . 3.7 t0 82.03 48.01 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.285 -179.746 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -65.92 -37.9 87.28 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.509 179.053 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.626 ' OD2' ' NE2' ' A' ' 40' ' ' GLN . 28.7 t70 -55.98 -50.54 70.55 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.49 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.464 ' CB ' ' O ' ' B' ' 258' ' ' ASP . 12.5 t0 83.69 0.86 1.02 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.952 178.876 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.458 ' OE1' ' C ' ' B' ' 259' ' ' ASP . 53.3 mp0 59.66 4.2 0.52 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.11 0.414 . . . . 0.0 111.739 179.528 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.585 HD13 ' CZ ' ' A' ' 95' ' ' PHE . 84.3 mt -110.18 133.26 56.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.927 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 55.3 t -127.31 131.13 70.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.444 0.64 . . . . 0.0 110.914 -179.347 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -93.61 122.73 36.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.219 -0.901 . . . . 0.0 112.165 -178.804 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . 0.41 ' CB ' ' O ' ' A' ' 36' ' ' ASP . 88.1 tttt -65.78 -46.74 77.59 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.306 179.929 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.98 160.99 45.3 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.285 -179.365 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -59.8 140.58 93.94 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.363 2.042 . . . . 0.0 111.905 179.278 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 3.4 tt . . . . . 0 C--N 1.321 -0.639 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.881 179.908 . . . . . . . . 0 0 . 1 . 094 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.528 ' C ' HG22 ' A' ' 4' ' ' THR . 95.3 Cg_endo . . . . . 0 N--CA 1.49 1.283 0 N-CA-C 112.685 0.225 . . . . 0.0 112.685 . . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.528 HG22 ' C ' ' A' ' 3' ' ' PRO . 1.8 t 148.94 -27.8 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 O-C-N 124.283 0.99 . . . . 0.0 110.281 179.021 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.484 ' HG3' HG23 ' A' ' 4' ' ' THR . 80.4 mtt85 -86.22 124.58 32.77 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.76 -179.526 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -133.6 141.31 47.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.244 0.545 . . . . 0.0 111.773 -179.228 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.57 HD11 ' HB3' ' A' ' 95' ' ' PHE . 42.8 tp -117.34 130.71 56.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.053 179.014 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 63.8 t -108.96 132.7 56.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.754 -179.226 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.519 ' CG2' HD12 ' B' ' 261' ' ' ILE . 23.0 m -92.35 111.59 23.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.795 -178.874 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.419 HD11 ' HG3' ' A' ' 96' ' ' ARG . 86.7 mt -78.69 147.89 6.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.373 179.142 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -92.12 158.34 16.24 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.329 178.101 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.447 ' NH1' HH11 ' B' ' 245' ' ' ARG . 87.9 mtm180 -57.85 -26.43 62.05 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.266 -178.492 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 97.9 p -80.61 -11.76 59.6 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 120.324 -0.551 . . . . 0.0 111.049 -179.876 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.98 24.22 13.43 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.409 178.777 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.4 m -116.89 136.56 53.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.281 179.037 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -65.91 126.41 28.43 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.423 -179.984 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -113.0 -128.64 4.95 Favored Glycine 0 CA--C 1.535 1.336 0 N-CA-C 111.381 -0.687 . . . . 0.0 111.381 -179.255 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -74.13 150.63 43.03 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 121.979 1.786 . . . . 0.0 111.951 -179.445 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -108.18 162.68 13.85 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.156 0.503 . . . . 0.0 110.604 -179.654 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -129.51 88.93 48.64 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.403 -179.051 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -61.44 131.08 34.38 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.464 2.109 . . . . 0.0 110.993 179.106 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 22' ' ' LEU . 87.7 mt -98.68 121.44 40.63 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 119.819 -0.752 . . . . 0.0 111.355 -178.559 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 82.8 p -114.84 -28.34 7.1 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.562 178.66 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.7 mt -78.59 145.74 34.58 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.856 -1.066 . . . . 0.0 109.952 179.799 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 57.1 m -71.65 -8.27 53.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 0.0 112.216 -178.558 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.5 m -135.59 135.84 40.59 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.331 -179.687 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.5 t -126.4 117.1 22.24 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.227 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.405 HD12 ' O ' ' A' ' 49' ' ' CYS . 55.0 tp -113.65 131.97 55.94 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.249 -178.362 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.676 ' CE2' HD12 ' A' ' 37' ' ' ILE . 4.9 m-85 -110.89 134.02 52.89 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.95 -179.655 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.29 -172.12 38.32 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 119.963 -1.113 . . . . 0.0 112.468 178.687 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.663 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 82.2 mtm-85 -83.28 -32.53 26.33 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.644 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -49.8 149.91 5.2 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -178.86 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.559 ' O ' ' NH2' ' A' ' 38' ' ' ARG . 36.5 mm -64.03 -43.28 97.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.33 -179.823 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -53.68 -21.61 7.35 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.943 -179.234 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 71.5 m -56.6 118.52 4.93 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.717 -179.695 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -57.13 -31.05 64.95 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.864 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.676 HD12 ' CE2' ' A' ' 29' ' ' PHE . 96.3 mt -123.56 117.08 50.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 176.734 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.559 ' NH2' ' O ' ' A' ' 33' ' ' ILE . 72.0 mtt85 -102.91 134.33 46.52 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.571 -177.928 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.664 HG21 HD12 ' A' ' 41' ' ' LEU . 78.7 mt -118.74 131.22 72.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.2 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -80.71 24.66 0.47 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.084 -178.652 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.664 HD12 HG21 ' A' ' 39' ' ' ILE . 27.8 mt -89.61 126.51 57.78 Favored Pre-proline 0 C--N 1.323 -0.579 0 C-N-CA 120.377 -0.529 . . . . 0.0 109.595 179.953 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -68.77 -13.0 36.05 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.258 1.972 . . . . 0.0 113.668 -179.158 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.462 HG21 ' CZ ' ' B' ' 241' ' ' PHE . 2.9 m -99.83 6.47 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.925 179.969 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.663 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 24.1 t -90.52 132.1 36.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.988 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.506 ' OG ' ' N ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -64.79 169.38 5.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.219 0.533 . . . . 0.0 111.375 -178.674 . . . . . . . . 3 3 . 1 . 094 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -62.64 -44.88 95.16 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.292 -179.366 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.651 ' O ' ' N ' ' A' ' 49' ' ' CYS . 96.2 mt-30 -113.21 -13.05 13.02 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.424 178.983 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.506 ' N ' ' OG ' ' A' ' 45' ' ' SER . 14.7 t60 34.2 -75.97 0.0 OUTLIER 'General case' 0 C--O 1.235 0.29 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 179.066 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.651 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -131.81 136.74 47.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.173 0.511 . . . . 0.0 112.003 -178.773 . . . . . . . . 3 3 . 1 . 094 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -126.38 127.08 44.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.205 179.655 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 92.3 mt -110.85 134.07 54.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.313 -179.113 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -116.5 121.46 41.88 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.718 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.431 HD13 ' HD3' ' A' ' 5' ' ' ARG . 96.5 mt -107.15 112.57 40.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.139 -0.624 . . . . 0.0 111.653 -179.571 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.44 ' O ' ' C ' ' A' ' 55' ' ' GLU . 96.2 m-70 -111.52 144.66 40.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.847 179.936 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.2 tt0 -40.85 -32.26 0.21 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.308 -0.626 . . . . 0.0 109.308 -179.944 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.425 ' N ' ' C ' ' A' ' 54' ' ' HIS . 98.1 mt-30 -63.8 -68.15 0.37 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.452 178.805 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.438 ' CD ' ' CD ' ' A' ' 81' ' ' ARG . 14.7 pt-20 -157.4 -171.82 3.75 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.484 -178.626 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.26 123.33 49.09 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.679 179.51 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 84.2 mt -114.73 128.08 71.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 120.345 -0.542 . . . . 0.0 112.343 -178.93 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.556 ' HB2' HD11 ' A' ' 82' ' ' LEU . 47.3 tp -93.85 127.49 39.62 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.352 179.517 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -115.04 135.41 54.25 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 178.795 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.676 ' ND2' ' H ' ' A' ' 69' ' ' THR . 16.0 t-20 -101.65 112.13 24.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.182 0.515 . . . . 0.0 111.576 -179.369 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -102.44 -7.08 22.25 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.749 179.784 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.36 100.7 3.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.368 179.899 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.2 m -84.98 -9.2 58.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.941 0.4 . . . . 0.0 109.928 179.678 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.92 -39.02 9.59 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.26 179.895 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -149.19 98.32 3.52 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.344 179.987 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.484 ' HA ' HD21 ' A' ' 62' ' ' ASN . 46.2 Cg_exo -56.04 147.36 64.53 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 122.36 2.04 . . . . 0.0 112.713 179.968 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.676 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 38.1 m -69.64 138.78 53.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.088 178.872 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 89' ' ' THR . 83.7 mt-30 -101.02 139.67 36.39 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.161 179.795 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.437 HG22 HD13 ' A' ' 88' ' ' ILE . 18.2 t -131.36 135.97 58.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.356 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 53.86 34.59 19.67 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.949 -179.733 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.23 30.38 71.72 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.031 179.251 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 41.0 m -143.63 134.88 25.83 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 117.105 0.453 . . . . 0.0 111.054 -179.907 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.4 ' H ' HG12 ' A' ' 75' ' ' VAL . 0.1 OUTLIER -68.99 137.77 23.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.505 179.897 . . . . . . . . 3 3 . 1 . 094 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.573 ' CG2' ' O ' ' A' ' 78' ' ' GLU . 97.2 mt -102.65 105.16 17.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.888 -179.634 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -67.55 -40.87 84.95 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.849 178.751 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.573 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 1.9 mt-10 -127.64 170.91 9.21 Favored Pre-proline 0 N--CA 1.469 0.482 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.147 -178.514 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -59.54 148.71 86.06 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.181 1.921 . . . . 0.0 112.133 179.983 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.7 m -147.39 148.84 16.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.179 0.514 . . . . 0.0 111.869 179.708 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.438 ' CD ' ' CD ' ' A' ' 57' ' ' GLU . 61.4 ttp180 -72.81 128.86 36.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.518 179.779 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.556 HD11 ' HB2' ' A' ' 60' ' ' LEU . 94.9 mt -85.32 135.94 33.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.142 0.496 . . . . 0.0 110.94 179.712 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -119.94 148.93 42.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.79 179.561 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.437 ' C ' ' CD2' ' A' ' 84' ' ' HIS . 5.8 t60 -51.41 123.16 9.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.673 -179.396 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.69 -14.95 49.64 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 179.878 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -67.12 139.09 57.5 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.4 -0.52 . . . . 0.0 109.639 179.507 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.427 HG22 ' HG2' ' A' ' 96' ' ' ARG . 72.6 t -109.99 134.22 52.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.394 -178.195 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.437 HD13 HG22 ' A' ' 71' ' ' VAL . 30.5 mm -90.71 127.28 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 177.492 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.509 ' N ' ' O ' ' A' ' 70' ' ' GLN . 31.6 m -119.74 123.36 43.55 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.467 0.651 . . . . 0.0 111.148 -178.652 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 92' ' ' ASP . 89.2 mt -118.08 126.03 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.314 179.5 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.501 HG22 ' N ' ' A' ' 92' ' ' ASP . 87.9 mt 37.1 -95.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.056 -179.956 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.501 ' N ' HG22 ' A' ' 91' ' ' ILE . 54.2 t0 -119.62 14.38 12.66 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.917 0.389 . . . . 0.0 111.453 -179.356 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.526 ' NE ' HD11 ' B' ' 261' ' ' ILE . 2.2 tpp180 -128.48 142.25 51.14 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.286 -179.555 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.0 m -133.45 150.08 51.76 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.428 0.632 . . . . 0.0 111.362 -179.847 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.57 ' HB3' HD11 ' A' ' 7' ' ' LEU . 89.1 m-85 -121.58 123.24 41.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.422 -0.808 . . . . 0.0 108.907 178.895 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.528 ' O ' HD12 ' A' ' 7' ' ' LEU . 99.7 mtt180 -81.33 126.68 31.88 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.52 -179.725 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.572 ' CE2' ' OD1' ' A' ' 99' ' ' ASN . 76.8 t80 -95.6 123.48 39.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.11 -179.193 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.414 ' HG3' ' CE1' ' A' ' 84' ' ' HIS . 84.2 tt0 -126.24 115.88 20.41 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.118 179.061 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.572 ' OD1' ' CE2' ' A' ' 97' ' ' TYR . 86.1 m-20 -66.22 -43.35 86.94 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.94 -179.643 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 . . . . . 0 C--N 1.328 -0.358 0 CA-C-O 120.968 0.413 . . . . 0.0 111.097 179.991 . . . . . . . . 0 0 . 1 . 094 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 27.2 m . . . . . 0 N--CA 1.453 -0.317 0 CA-C-O 120.633 0.254 . . . . 0.0 110.543 . . . . . . . . . 0 0 . 1 . 094 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.521 ' C ' ' H ' ' B' ' 231' ' ' GLN . 90.6 m-20 -72.29 144.11 48.48 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.511 179.686 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . 0.461 ' N ' ' O2P' ' B' ' 230' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.521 ' H ' ' C ' ' B' ' 229' ' ' ASP . 74.9 mt-30 -130.36 39.59 3.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.609 179.637 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -115.01 -164.12 14.36 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 111.684 -0.567 . . . . 0.0 111.684 -178.726 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -72.88 160.6 45.68 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.823 2.349 . . . . 0.0 112.241 -179.658 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 094 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -73.19 170.53 19.62 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 121.718 1.612 . . . . 0.0 111.715 178.977 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 3.1 p -112.29 133.42 58.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.861 -179.498 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 5.6 t -67.19 123.09 19.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.892 179.834 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . 0.598 ' O3P' HG23 ' B' ' 240' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -55.64 -23.87 42.63 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 121.963 1.775 . . . . 0.0 111.989 179.004 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . 0.598 HG23 ' O3P' ' B' ' 238' ' ' TPO . 4.6 p -75.93 -38.9 57.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 177.908 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.462 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 74.8 t80 -57.71 -46.61 84.14 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.837 -179.466 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' B' ' 242' ' ' LEU . 92.5 mt -64.67 -40.85 96.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.163 179.711 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -61.87 -43.48 98.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.379 179.565 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 63.4 ttm-85 -63.71 -42.96 97.89 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.366 179.431 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.618 ' O ' HG23 ' B' ' 249' ' ' VAL . 12.4 tpp180 -61.99 -44.6 96.4 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.117 -179.617 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -64.63 -38.97 92.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.453 178.712 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 69.7 p -68.22 -43.76 77.27 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.253 0.549 . . . . 0.0 109.795 179.057 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -58.76 -37.88 77.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.325 179.824 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.618 HG23 ' O ' ' B' ' 245' ' ' ARG . 77.0 t -64.43 -45.07 96.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.909 179.934 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -63.5 -26.97 68.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.39 179.662 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -95.6 -8.85 33.78 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.38 -179.728 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.423 ' CD2' ' NH2' ' A' ' 12' ' ' ARG . 31.4 tp -106.63 120.53 42.21 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.929 -179.934 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -54.29 149.09 10.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.285 0.564 . . . . 0.0 111.299 -179.122 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -68.01 -15.38 63.58 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.177 178.429 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -71.47 -1.2 12.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.27 179.88 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 42.3 p-10 -70.37 78.27 0.55 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.575 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -69.28 -10.85 59.75 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.916 -179.204 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -86.31 112.52 21.49 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.774 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.664 ' C ' ' H ' ' B' ' 261' ' ' ILE . 39.6 p-10 -101.58 127.83 48.12 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.393 0.616 . . . . 0.0 110.613 -179.492 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.441 ' HB2' HH22 ' A' ' 93' ' ' ARG . 90.6 mt-10 -55.19 9.66 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.026 -179.628 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.664 ' H ' ' C ' ' B' ' 259' ' ' ASP . 60.9 mt -106.62 137.24 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.877 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 69.8 t -127.54 134.48 65.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.031 -179.548 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -94.94 119.16 33.01 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.986 -177.367 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . 0.494 ' HG3' HH22 ' A' ' 38' ' ' ARG . 88.5 tttt -68.48 -44.63 74.35 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.252 179.612 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.69 156.98 49.9 Favored Pre-proline 0 C--O 1.236 0.353 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.374 -179.43 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -62.26 144.6 95.64 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.935 2.423 . . . . 0.0 112.713 -179.563 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 47.2 pt . . . . . 0 N--CA 1.455 -0.204 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.572 178.673 . . . . . . . . 0 0 . 1 . 095 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo . . . . . 0 N--CA 1.495 1.565 0 CA-C-O 120.852 0.272 . . . . 0.0 112.097 . . . . . . . . . 0 0 . 1 . 095 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.5 p -95.58 -43.74 7.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.17 -179.504 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.505 ' NH2' HG21 ' A' ' 53' ' ' ILE . 76.5 mtm-85 -88.58 125.05 34.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.315 -178.95 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -130.91 144.43 51.46 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.216 179.35 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.965 HD11 HD11 ' A' ' 22' ' ' LEU . 69.7 mt -117.24 141.12 48.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.442 179.761 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.5 t -113.37 127.61 70.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.784 179.652 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.421 ' CG2' HD12 ' B' ' 261' ' ' ILE . 4.9 m -82.76 135.14 35.07 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.233 -178.29 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.515 HD12 ' HB3' ' A' ' 94' ' ' SER . 98.9 mt -105.65 137.04 37.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.348 178.368 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.616 ' HZ2' ' CD ' ' B' ' 257' ' ' LYS . 27.6 mttm -89.69 161.03 16.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.042 0.449 . . . . 0.0 110.348 179.389 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.734 ' HE ' ' NZ ' ' B' ' 257' ' ' LYS . 87.7 mtm180 -54.55 -27.13 36.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.198 -179.018 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.4 m -82.71 -5.1 58.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.197 179.443 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.39 35.3 14.66 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 179.519 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.1 t -115.51 135.36 55.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.773 0.321 . . . . 0.0 110.474 -179.995 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -78.45 132.6 37.36 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.203 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -126.55 -114.95 1.94 Allowed Glycine 0 CA--C 1.537 1.416 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.967 -179.139 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -71.9 144.49 43.34 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 122.338 2.025 . . . . 0.0 112.631 -178.97 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.43 ' O ' HD11 ' B' ' 267' ' ' ILE . 0.2 OUTLIER -106.54 132.66 52.28 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.984 0.421 . . . . 0.0 110.701 -179.746 . . . . . . . . 3 3 . 1 . 095 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.685 ' CD2' HD11 ' A' ' 37' ' ' ILE . 56.0 t80 -101.18 102.35 20.31 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.44 -179.41 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -76.22 129.92 11.66 Favored 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 121.67 1.58 . . . . 0.0 111.789 -179.75 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.965 HD11 HD11 ' A' ' 7' ' ' LEU . 89.8 mt -87.41 80.28 8.18 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.165 -179.07 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.492 ' OG ' ' NE2' ' B' ' 265' ' ' GLN . 35.6 p -84.73 -9.92 57.75 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.437 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 66.6 mt -100.16 143.23 30.61 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.96 -179.676 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 93.1 p -65.56 -15.91 63.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.131 -178.642 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.488 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 33.4 m -130.13 130.74 45.17 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.864 -179.407 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.618 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 2.2 t -124.9 118.85 27.21 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.979 178.921 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.483 HD12 ' O ' ' A' ' 49' ' ' CYS . 54.8 tp -120.01 131.86 55.28 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.509 -178.142 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.618 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 54.8 m-85 -108.45 143.13 37.81 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.289 179.689 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 156.29 -151.04 22.51 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 179.156 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.666 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 84.2 mtm-85 -108.89 -23.45 11.72 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.634 179.326 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.469 ' N ' ' SG ' ' A' ' 35' ' ' CYS . . . -55.49 156.86 8.79 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 121.281 -0.485 . . . . 0.0 112.206 -178.584 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.506 HG23 ' N ' ' A' ' 34' ' ' GLU . 11.0 tp -65.69 -41.93 91.55 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 CA-C-O 120.986 0.422 . . . . 0.0 110.061 179.606 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.506 ' N ' HG23 ' A' ' 33' ' ' ILE . 96.4 mt-10 -60.11 -28.46 67.88 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.803 179.873 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.534 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 9.3 m -53.13 115.46 1.89 Allowed 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.071 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.488 ' OD2' ' O ' ' A' ' 26' ' ' THR . 99.5 m-20 -60.74 -26.71 67.39 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -179.245 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.685 HD11 ' CD2' ' A' ' 20' ' ' PHE . 47.5 mm -123.24 112.37 33.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.67 177.516 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -105.0 137.65 42.42 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.773 -179.832 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.489 ' CG2' HD12 ' A' ' 41' ' ' LEU . 98.2 mt -121.76 132.85 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.138 179.058 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -79.33 34.26 0.25 Allowed 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -177.588 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.582 ' CD1' ' HE ' ' A' ' 93' ' ' ARG . 9.7 mt -113.59 137.61 22.25 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.553 178.9 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.09 -10.79 29.1 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.836 2.358 . . . . 0.0 113.93 -178.138 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.435 HG21 ' CE2' ' B' ' 241' ' ' PHE . 27.4 m -95.51 3.34 9.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.223 -0.591 . . . . 0.0 111.206 -179.993 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.666 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 37.3 t -94.5 130.19 43.69 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.717 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.9 m -70.97 163.47 27.46 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -177.796 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.534 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 54.8 mttp -62.75 -41.62 99.29 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.486 -179.048 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.633 ' O ' ' N ' ' A' ' 49' ' ' CYS . 10.8 mm100 -113.98 -24.63 8.95 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.239 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 24.5 t60 35.26 -74.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 178.944 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.633 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -133.79 138.64 45.83 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -177.993 . . . . . . . . 3 3 . 1 . 095 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -128.6 127.83 43.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.789 179.817 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.8 mt -115.42 134.22 59.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.516 179.244 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -114.17 137.84 51.23 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.449 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.505 HG21 ' NH2' ' A' ' 5' ' ' ARG . 39.5 mm -98.15 120.01 46.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.307 0.575 . . . . 0.0 110.679 -179.367 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.454 ' O ' ' C ' ' A' ' 55' ' ' GLU . 38.0 m-70 -120.78 131.35 54.43 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.303 179.452 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 54' ' ' HIS . 99.5 mt-10 -40.07 -34.46 0.3 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -179.774 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -62.75 -66.85 0.48 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.845 -1.071 . . . . 0.0 108.953 178.358 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -160.05 -159.14 0.69 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.426 178.854 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.669 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -113.62 131.03 56.28 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.814 -0.355 . . . . 0.0 110.362 -179.938 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 37.6 mm -108.64 123.5 64.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.004 -179.25 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.413 HD22 ' CD1' ' A' ' 88' ' ' ILE . 38.9 tp -95.77 124.01 39.6 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.149 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -113.01 134.17 54.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.259 -179.547 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -95.33 104.65 16.55 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.951 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -99.26 -7.51 26.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.957 178.838 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.9 t -78.08 98.94 5.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.133 -179.175 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.8 m -77.64 -37.49 49.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.127 0.489 . . . . 0.0 109.955 178.599 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.467 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.1 OUTLIER -68.56 -40.45 80.61 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.458 -179.705 . . . . . . . . 3 3 . 1 . 095 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -146.68 96.98 4.33 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.963 -179.286 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -56.36 148.28 62.75 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.455 2.104 . . . . 0.0 112.467 179.505 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.4 m -74.68 143.06 44.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.313 -179.764 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -104.12 140.39 37.86 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.225 179.385 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.9 t -130.08 135.77 60.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.024 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 52.98 37.14 23.83 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.38 -179.898 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.29 29.53 74.4 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.095 179.204 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.3 t -144.94 136.05 24.94 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.481 -179.983 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.1 p -72.2 138.59 21.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.16 -179.256 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.894 HD13 ' O ' ' A' ' 76' ' ' ILE . 0.0 OUTLIER -133.6 126.76 52.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.96 179.289 . . . . . . . . 3 3 . 1 . 095 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -99.4 -9.76 23.07 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.658 -179.308 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.788 ' O ' HD11 ' A' ' 76' ' ' ILE . 1.2 pm0 -118.47 161.05 37.37 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 120.776 -0.37 . . . . 0.0 111.035 -179.18 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -57.54 143.77 93.8 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 121.613 1.542 . . . . 0.0 111.859 179.696 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.409 HG13 ' HB3' ' A' ' 60' ' ' LEU . 2.8 p -139.63 141.61 34.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.353 -179.462 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -78.39 134.12 37.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.394 -179.867 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.669 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 91.1 mt -93.46 139.36 30.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.241 0.543 . . . . 0.0 111.622 -179.269 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -126.06 155.93 40.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.997 179.765 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.423 ' ND1' ' N ' ' A' ' 99' ' ' ASN . 8.4 t60 -55.83 118.55 4.68 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.9 0.381 . . . . 0.0 110.235 -179.523 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.82 -17.1 27.9 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 -179.704 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -68.14 137.47 54.92 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.224 179.968 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.55 ' CG2' ' OG ' ' A' ' 94' ' ' SER . 7.7 p -111.55 134.18 54.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.061 0.457 . . . . 0.0 112.031 -178.557 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.413 ' CD1' HD22 ' A' ' 60' ' ' LEU . 47.5 mm -93.81 128.02 45.46 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.093 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 178.069 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 47.9 m -126.57 126.68 44.05 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -178.001 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.459 ' O ' ' C ' ' A' ' 91' ' ' ILE . 86.4 mt -116.07 126.63 73.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 114.225 -1.352 . . . . 0.0 108.259 178.57 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.476 HG22 ' N ' ' A' ' 92' ' ' ASP . 94.6 mt 35.71 -96.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 121.024 -0.271 . . . . 0.0 110.922 -179.593 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.476 ' N ' HG22 ' A' ' 91' ' ' ILE . 26.5 m-20 -120.11 17.28 12.43 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.86 0.362 . . . . 0.0 111.432 179.802 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.79 HH21 ' NH2' ' B' ' 245' ' ' ARG . 0.6 OUTLIER -124.71 138.22 54.3 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.845 . . . . . . . . 3 3 . 1 . 095 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.55 ' OG ' ' CG2' ' A' ' 87' ' ' VAL . 8.1 t -139.97 151.1 45.25 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 119.826 -0.75 . . . . 0.0 111.751 -179.055 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -122.69 122.51 38.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.561 178.734 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -87.2 134.12 33.57 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.315 -178.865 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -97.59 125.8 42.53 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.518 179.79 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -143.72 130.07 19.91 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.779 -179.908 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.423 ' N ' ' ND1' ' A' ' 84' ' ' HIS . 84.7 m-20 -89.61 112.64 23.92 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.411 179.112 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.616 -179.991 . . . . . . . . 0 0 . 1 . 095 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . 0.597 ' O ' ' N ' ' B' ' 230' ' ' SEP . 3.5 p . . . . . 0 N--CA 1.455 -0.187 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 . . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' B' ' 228' ' ' VAL . 62.6 t0 33.61 -86.27 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.235 179.763 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . 0.597 ' N ' ' O ' ' B' ' 228' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -122.01 51.75 1.32 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.922 -179.2 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -128.33 -177.57 14.93 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 -179.418 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -74.19 160.77 41.95 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 123.863 3.042 . . . . 0.0 113.5 -179.398 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.467 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -57.42 132.69 52.27 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 121.935 1.757 . . . . 0.0 111.969 -179.434 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 24.8 t -59.6 137.53 21.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.006 179.441 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.9 t -52.67 112.58 0.86 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.169 -179.324 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . 0.432 HG23 ' H ' ' B' ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -57.96 -24.73 66.64 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 121.741 1.627 . . . . 0.0 111.519 178.95 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 97.0 m -71.03 -45.35 64.05 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.967 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.435 ' CE2' HG21 ' A' ' 43' ' ' VAL . 89.6 t80 -58.38 -46.8 85.64 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.754 -179.601 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 92.6 mt -64.04 -42.1 97.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.878 -179.577 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -63.3 -43.21 98.51 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 120.871 -0.331 . . . . 0.0 111.076 -179.402 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -63.0 -40.11 96.79 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.699 179.8 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.79 ' NH2' HH21 ' A' ' 93' ' ' ARG . 61.2 ttm-85 -61.76 -44.54 96.69 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.084 179.574 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -62.52 -41.53 98.92 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.469 -179.618 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 57.9 m -66.97 -46.03 75.89 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.291 0.567 . . . . 0.0 110.521 179.122 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . 0.427 ' O ' ' HG ' ' B' ' 252' ' ' LEU . 86.2 mt-30 -62.92 -33.56 75.59 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.447 -179.46 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.729 HG23 ' O ' ' B' ' 245' ' ' ARG . 61.4 t -66.12 -45.2 90.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 121.19 0.519 . . . . 0.0 111.55 179.867 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -69.95 -20.82 63.31 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.984 -178.948 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -90.99 4.67 51.43 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.324 -178.983 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' B' ' 248' ' ' GLN . 36.4 mt -77.93 159.94 28.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.392 0.615 . . . . 0.0 112.349 -178.981 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . 0.547 ' OD1' ' N ' ' B' ' 254' ' ' ASP . 25.5 t-20 -75.7 176.45 7.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.594 178.864 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . 0.547 ' N ' ' OD1' ' B' ' 253' ' ' ASN . 88.6 m-20 -98.1 0.88 46.92 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -178.757 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . 0.507 ' O ' ' OD1' ' B' ' 256' ' ' ASP . 74.2 m-20 -148.66 43.73 1.0 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -178.437 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.507 ' OD1' ' O ' ' B' ' 255' ' ' ASP . 93.8 m-20 -138.75 -141.31 0.15 Allowed 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 119.715 -0.794 . . . . 0.0 111.865 178.909 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . 0.734 ' NZ ' ' HE ' ' A' ' 12' ' ' ARG . 82.2 tttt 62.7 110.05 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.174 0 O-C-N 121.896 -0.502 . . . . 0.0 112.048 179.986 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.505 ' O ' ' OD2' ' B' ' 259' ' ' ASP . 36.8 p-10 -85.78 -4.57 59.2 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.22 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.586 ' C ' ' H ' ' B' ' 261' ' ' ILE . 0.0 OUTLIER 80.87 111.88 0.07 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.624 -179.653 . . . . . . . . 3 3 . 1 . 095 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.438 ' OE1' ' N ' ' B' ' 260' ' ' GLU . 57.4 mp0 -57.64 11.92 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.012 -0.994 . . . . 0.0 112.261 -178.524 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.586 ' H ' ' C ' ' B' ' 259' ' ' ASP . 66.4 mt -106.01 134.35 47.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 178.123 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 72.0 t -123.71 132.27 71.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.26 0.552 . . . . 0.0 110.238 -178.812 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -95.18 117.4 30.18 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.543 -177.869 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . 0.427 ' NZ ' ' HA ' ' A' ' 34' ' ' GLU . 88.5 tttt -65.17 -45.77 83.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.572 179.745 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . 0.492 ' NE2' ' OG ' ' A' ' 23' ' ' SER . 0.0 OUTLIER -80.26 158.9 71.34 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.144 -179.819 . . . . . . . . 3 3 . 1 . 095 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -60.1 140.59 93.2 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 C-N-CA 122.237 1.958 . . . . 0.0 111.733 179.499 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . 0.469 HG23 ' O ' ' B' ' 267' ' ' ILE . 13.8 tt . . . . . 0 C--N 1.326 -0.414 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.156 -179.541 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo . . . . . 0 N--CA 1.498 1.745 0 N-CA-C 112.973 0.336 . . . . 0.0 112.973 . . . . . . . . . 0 0 . 1 . 096 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.6 m -135.75 -59.37 0.76 Allowed 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.707 -179.313 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.546 ' NH2' HG21 ' A' ' 53' ' ' ILE . 88.1 mtm-85 -94.87 131.57 40.62 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.936 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -142.86 151.54 41.18 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 119.958 -0.697 . . . . 0.0 112.305 179.933 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 80.3 mt -115.25 131.52 56.9 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.14 178.653 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 73.0 t -103.65 128.21 57.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.942 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.553 HG23 ' CD1' ' B' ' 261' ' ' ILE . 2.7 m -87.82 120.9 29.6 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -177.377 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 91.1 mt -82.18 134.92 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.659 178.462 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -88.37 160.73 17.46 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.4 0.619 . . . . 0.0 111.394 179.365 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.67 ' CG ' HH12 ' A' ' 93' ' ' ARG . 76.7 mtp180 -53.9 -40.98 67.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.921 -178.759 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.5 t -72.2 -11.11 60.58 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.024 179.892 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.25 35.31 5.3 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 -179.513 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.7 t -123.66 135.96 61.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.103 0.478 . . . . 0.0 111.914 -179.474 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -70.07 136.43 50.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.809 179.504 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -122.0 -125.34 3.11 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.919 -179.332 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.65 150.26 56.45 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 122.051 1.834 . . . . 0.0 113.222 -178.469 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 53.3 m170 -110.28 132.91 53.76 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.52 -179.251 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.444 ' CD2' HD11 ' A' ' 37' ' ' ILE . 25.1 t80 -102.12 100.73 15.99 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.301 -179.506 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -73.37 127.69 12.11 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 C-N-CA 121.421 1.414 . . . . 0.0 110.855 179.979 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 99.3 mt -79.99 55.58 2.16 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.816 -0.353 . . . . 0.0 111.886 -178.345 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 87.1 p -67.13 -22.21 65.8 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.508 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.649 HD11 ' HG2' ' B' ' 265' ' ' GLN . 69.9 mt -83.52 139.8 32.67 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.563 179.573 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.9 m -67.42 -18.6 65.17 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.429 -178.965 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 36.4 m -129.23 130.91 46.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.238 0.542 . . . . 0.0 111.918 -179.717 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.671 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.7 OUTLIER -125.62 118.33 25.45 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.65 178.735 . . . . . . . . 3 3 . 1 . 096 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.519 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 56.0 tp -119.79 125.69 49.21 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.522 -178.424 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.671 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 48.2 m-85 -101.76 128.07 48.26 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.492 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 177.5 -176.84 48.23 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.282 -0.961 . . . . 0.0 111.762 179.101 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.662 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 84.6 mtm-85 -82.39 -28.07 31.68 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.12 0.486 . . . . 0.0 110.242 179.75 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.61 155.02 41.63 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.282 -178.368 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.443 HD12 ' HD3' ' A' ' 38' ' ' ARG . 9.1 tp -65.98 -39.38 84.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.489 -0.355 . . . . 0.0 110.56 179.23 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.413 ' N ' HG23 ' A' ' 33' ' ' ILE . 71.0 mm-40 -55.17 -21.61 14.2 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.659 -179.795 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.8 m -64.03 119.86 10.93 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.088 -179.982 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.585 ' OD2' ' SG ' ' A' ' 27' ' ' CYS . 28.2 p-10 -54.26 -26.12 27.19 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.385 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.603 HD12 ' CE2' ' A' ' 29' ' ' PHE . 94.9 mt -130.59 123.61 55.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.29 -0.868 . . . . 0.0 108.879 178.043 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.443 ' HD3' HD12 ' A' ' 33' ' ' ILE . 20.9 mtm180 -109.3 137.63 46.88 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.761 -179.099 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 92.8 mt -118.65 131.62 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.936 179.293 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -77.89 31.64 0.17 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -177.877 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.568 HD21 ' OE1' ' B' ' 260' ' ' GLU . 34.7 mt -102.88 130.64 23.37 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.742 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.573 ' HA ' HG11 ' B' ' 228' ' ' VAL . 60.4 Cg_endo -73.53 -6.09 18.17 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 121.909 1.739 . . . . 0.0 112.534 -179.459 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.458 HG21 ' CE2' ' B' ' 241' ' ' PHE . 4.9 m -101.39 3.74 10.59 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.501 -179.686 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.662 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 34.3 t -90.57 133.48 32.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.632 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.453 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 0.6 OUTLIER -69.74 170.22 11.39 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.779 0.799 . . . . 0.0 112.753 -177.5 . . . . . . . . 3 3 . 1 . 096 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -64.04 -43.83 94.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.512 -179.324 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.636 ' O ' ' N ' ' A' ' 49' ' ' CYS . 90.5 mm-40 -111.69 -17.39 13.01 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.299 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.453 ' H ' ' HB3' ' A' ' 45' ' ' SER . 13.4 t60 32.56 -78.11 0.0 OUTLIER 'General case' 0 C--O 1.238 0.492 0 CA-C-N 114.686 -1.143 . . . . 0.0 112.985 179.765 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.636 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.66 135.97 46.16 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.482 -179.003 . . . . . . . . 3 3 . 1 . 096 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -125.89 131.4 52.36 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.702 179.003 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.1 mt -117.64 135.17 58.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.574 -179.967 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -114.18 135.57 53.89 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.669 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.546 HG21 ' NH2' ' A' ' 5' ' ' ARG . 46.0 mm -103.01 125.19 57.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.941 -179.398 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.473 ' O ' ' N ' ' A' ' 56' ' ' GLN . 33.3 m-70 -127.04 129.31 47.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.596 179.349 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' A' ' 54' ' ' HIS . 96.0 mt-10 -40.2 -29.74 0.08 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.216 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.473 ' N ' ' O ' ' A' ' 54' ' ' HIS . 88.3 mt-30 -67.08 -67.28 0.46 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.41 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -154.92 -168.1 2.78 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.707 -179.807 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.566 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -112.11 131.09 55.65 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.407 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.3 mm -108.66 125.2 65.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.869 -179.433 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 34.1 tp -99.44 126.3 45.33 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.258 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -115.76 137.61 51.92 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.579 -179.187 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -102.57 105.18 15.65 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.368 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -95.89 -4.28 43.84 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.513 178.997 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.52 104.45 15.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.553 -179.187 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.3 p -87.31 -35.89 18.17 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.698 179.124 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.6 -45.71 92.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.793 -179.714 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.41 ' OD1' HG23 ' B' ' 236' ' ' VAL . 2.9 m-80 -145.58 104.43 4.27 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.07 179.248 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -67.04 151.43 81.88 Favored 'Trans proline' 0 N--CA 1.491 1.332 0 C-N-CA 121.74 1.627 . . . . 0.0 113.287 -177.87 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.928 ' O ' HG22 ' A' ' 76' ' ' ILE . 33.9 m -70.79 146.93 49.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.598 179.95 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -110.87 139.92 45.77 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.758 -179.404 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 54.2 t -129.66 134.99 62.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.05 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 53.6 34.41 18.57 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.221 179.829 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.31 28.71 69.43 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.91 179.468 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.6 t -144.93 142.62 30.01 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 117.182 0.491 . . . . 0.0 110.986 179.758 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.4 m -68.97 143.71 14.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.496 -179.497 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.928 HG22 ' O ' ' A' ' 69' ' ' THR . 10.0 tt -111.67 90.92 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.92 -179.801 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -65.55 -35.25 80.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.115 179.52 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.477 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 5.0 mt-10 -124.67 164.74 28.99 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.387 -178.402 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.74 138.87 77.12 Favored 'Trans proline' 0 N--CA 1.501 1.954 0 C-N-CA 122.102 1.868 . . . . 0.0 112.874 -179.879 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 73.2 t -132.37 137.39 54.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.781 179.956 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 84.6 mtt85 -71.38 129.32 38.52 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.487 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.566 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . 95.6 mt -82.75 137.36 34.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.164 0.507 . . . . 0.0 111.072 -179.876 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -128.09 152.35 48.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.593 -179.621 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.415 ' HD1' ' H ' ' A' ' 99' ' ' ASN . 7.7 t60 -55.86 117.77 3.99 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.431 179.948 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.85 -20.43 19.93 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 179.851 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -67.03 136.63 55.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.979 0.418 . . . . 0.0 110.216 179.948 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.1 t -109.43 133.87 53.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.684 -178.758 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 88.6 mt -102.86 129.93 53.75 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.514 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 178.275 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 61.5 m -123.41 128.43 49.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.799 0.809 . . . . 0.0 112.249 -178.014 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.678 ' O ' ' N ' ' A' ' 93' ' ' ARG . 93.9 mt -116.53 132.86 64.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.077 178.7 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.517 ' C ' ' O ' ' A' ' 90' ' ' ILE . 51.0 mt -22.5 98.82 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.067 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.573 ' CG ' ' HE ' ' B' ' 245' ' ' ARG . 0.7 OUTLIER 80.08 -17.57 0.57 Allowed 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 178.354 . . . . . . . . 3 3 . 1 . 096 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.678 ' N ' ' O ' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -122.52 132.64 54.42 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 119.64 -0.219 . . . . 0.0 110.868 -179.747 . . . . . . . . 3 3 . 1 . 096 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.1 t -136.28 146.88 47.16 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 118.488 0.586 . . . . 0.0 111.129 -179.781 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -125.74 122.06 35.19 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.647 179.593 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -84.43 134.85 34.45 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.399 -179.249 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -97.82 126.43 43.18 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.492 -179.598 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -143.12 128.38 18.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.644 179.827 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.539 ' O ' ' OD1' ' A' ' 99' ' ' ASN . 29.0 p30 -118.06 136.76 53.36 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 121.483 0.658 . . . . 0.0 111.343 -179.898 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 C--N 1.325 -0.492 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.211 -179.75 . . . . . . . . 0 0 . 1 . 096 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . 0.573 HG11 ' HA ' ' A' ' 42' ' ' PRO . 53.6 t . . . . . 0 C--O 1.234 0.258 0 CA-C-O 120.728 0.299 . . . . 0.0 111.016 . . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' B' ' 228' ' ' VAL . 83.5 m-20 39.21 -106.75 0.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.741 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . 0.415 ' O1P' ' O ' ' B' ' 229' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -139.18 29.05 2.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.017 -179.112 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -106.39 -158.01 21.79 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -179.611 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -58.43 151.97 57.7 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 C-N-CA 123.168 2.579 . . . . 0.0 113.041 -179.951 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.424 ' O2P' HG21 ' B' ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -77.4 172.7 15.47 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.343 2.028 . . . . 0.0 111.927 -179.939 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.41 HG23 ' OD1' ' A' ' 67' ' ' ASN . 3.8 p -113.7 132.65 62.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.095 -179.719 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . 0.427 ' HB2' HD13 ' A' ' 91' ' ' ILE . 1.0 OUTLIER -66.27 121.41 15.17 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 120.248 -0.581 . . . . 0.0 109.493 179.943 . . . . . . . . 3 3 . 1 . 096 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . 0.541 ' P ' ' OG1' ' B' ' 240' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -54.61 -24.27 36.09 Favored 'Trans proline' 0 N--CA 1.49 1.284 0 C-N-CA 121.941 1.761 . . . . 0.0 111.349 -179.792 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . 0.541 ' OG1' ' P ' ' B' ' 238' ' ' TPO . 2.5 p -74.35 -39.75 62.58 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 177.784 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.458 ' CE2' HG21 ' A' ' 43' ' ' VAL . 71.0 t80 -58.04 -47.46 83.03 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.047 -179.264 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.465 HD21 HG23 ' A' ' 91' ' ' ILE . 98.0 mt -64.66 -40.18 94.97 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.043 0.449 . . . . 0.0 110.07 -179.823 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -63.61 -44.0 95.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.795 179.567 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -61.54 -41.24 97.07 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.109 -179.855 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.715 ' O ' HG23 ' B' ' 249' ' ' VAL . 22.1 mmm180 -61.61 -40.37 94.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.348 -179.859 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -63.77 -42.43 97.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.801 0.334 . . . . 0.0 110.794 179.313 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 72.2 p -64.95 -43.19 93.51 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.729 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -62.36 -37.33 85.25 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.682 179.668 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.715 HG23 ' O ' ' B' ' 245' ' ' ARG . 79.3 t -65.75 -45.41 91.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.2 179.019 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -63.08 -30.67 71.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.861 179.876 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -90.75 -10.87 41.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.983 179.619 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.533 ' O ' ' O ' ' B' ' 249' ' ' VAL . 64.0 tp -121.75 118.51 29.25 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.594 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -177.8 39.54 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.08 -179.674 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . 0.586 ' O ' ' CB ' ' B' ' 255' ' ' ASP . 33.1 p-10 -95.14 1.81 54.92 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 178.927 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . 0.586 ' CB ' ' O ' ' B' ' 254' ' ' ASP . 64.6 t0 116.12 58.64 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 O-C-N 124.796 1.31 . . . . 0.0 109.994 -179.623 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.506 ' O ' ' OD1' ' B' ' 256' ' ' ASP . 55.8 p-10 -56.71 76.88 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.941 0.4 . . . . 0.0 110.206 -179.937 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . 0.586 ' N ' ' O ' ' B' ' 255' ' ' ASP . 98.2 mttt -63.65 -35.87 81.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.951 179.573 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -61.23 -68.13 0.34 Allowed 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.026 -179.223 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.598 ' OD1' ' N ' ' B' ' 261' ' ' ILE . 0.0 OUTLIER 69.57 129.68 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.495 0.664 . . . . 0.0 110.591 -179.224 . . . . . . . . 3 3 . 1 . 096 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.568 ' OE1' HD21 ' A' ' 41' ' ' LEU . 99.6 mt-10 -56.3 11.57 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.559 -1.201 . . . . 0.0 113.987 -177.808 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.598 ' N ' ' OD1' ' B' ' 259' ' ' ASP . 41.0 mt -109.66 133.11 55.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 119.881 -0.728 . . . . 0.0 109.111 178.824 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 44.1 t -127.8 135.5 62.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.541 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -100.22 123.64 44.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.249 0.547 . . . . 0.0 112.415 -177.6 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -63.98 -47.35 80.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.111 178.59 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . 0.649 ' HG2' HD11 ' A' ' 24' ' ' LEU . 6.0 mp0 -96.84 163.76 19.48 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.477 179.972 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -60.76 156.74 41.35 Favored 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 122.941 2.427 . . . . 0.0 111.982 178.72 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 10.6 pt . . . . . 0 N--CA 1.466 0.35 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.893 -178.224 . . . . . . . . 0 0 . 1 . 097 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo . . . . . 0 N--CA 1.499 1.801 0 N-CA-C 111.593 -0.195 . . . . 0.0 111.593 . . . . . . . . . 0 0 . 1 . 097 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.5 p -100.99 -46.56 5.05 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.858 0.361 . . . . 0.0 110.354 -179.765 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.776 HH12 HG23 ' A' ' 53' ' ' ILE . 99.9 mtt180 -94.11 132.28 38.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.747 179.213 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 91.6 mtm180 -134.07 141.93 47.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.015 -179.911 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.559 HD11 ' HB3' ' A' ' 95' ' ' PHE . 42.3 tp -111.94 131.27 55.49 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.122 179.416 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.666 HG11 ' OD2' ' A' ' 16' ' ' ASP . 61.7 t -107.07 130.27 59.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.382 179.832 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 m -92.84 115.06 27.77 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.437 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 88.6 mt -80.93 142.74 13.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.667 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.443 ' NZ ' ' HA ' ' B' ' 257' ' ' LYS . 97.6 mttt -84.81 156.04 21.52 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.562 178.823 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.424 ' HG3' ' NH2' ' B' ' 245' ' ' ARG . 58.0 ttp180 -58.16 -35.85 72.16 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.069 -179.795 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.1 t -68.21 -21.59 64.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.988 0.423 . . . . 0.0 110.13 178.638 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.57 29.02 4.6 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 111.156 -0.777 . . . . 0.0 111.156 179.993 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.8 t -117.78 132.9 66.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.869 0.366 . . . . 0.0 111.152 -179.804 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.666 ' OD2' HG11 ' A' ' 8' ' ' VAL . 63.5 t0 -79.29 130.83 35.85 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.67 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.462 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -129.93 -108.71 1.31 Allowed Glycine 0 CA--C 1.532 1.133 0 C-N-CA 119.707 -1.235 . . . . 0.0 112.221 -179.66 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.1 145.19 48.88 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.496 2.131 . . . . 0.0 113.81 -178.333 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.451 ' O ' ' CD1' ' B' ' 267' ' ' ILE . 0.2 OUTLIER -110.56 145.62 37.49 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.475 178.871 . . . . . . . . 3 3 . 1 . 097 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.421 ' CD2' HD11 ' A' ' 37' ' ' ILE . 54.0 t80 -113.99 92.21 25.14 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.856 -179.084 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.83 130.02 34.86 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 122.037 1.825 . . . . 0.0 111.189 -179.602 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.5 mt -87.73 84.71 7.03 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.314 -179.483 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 51.4 p -89.85 -10.44 45.33 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.164 179.486 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.77 HD11 ' CD ' ' B' ' 265' ' ' GLN . 59.4 mt -102.24 146.6 27.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.289 -179.723 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 52.4 p -68.84 -17.36 63.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.564 -179.614 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.48 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 30.5 m -128.87 130.73 47.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.873 0.368 . . . . 0.0 110.992 -179.437 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.8 t -126.03 119.28 27.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.718 178.844 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.478 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 42.8 tp -116.77 130.17 56.55 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.155 -178.098 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.721 ' CE2' HD12 ' A' ' 37' ' ' ILE . 10.1 m-85 -109.01 140.41 42.57 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.41 179.921 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 153.88 -177.24 31.47 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.316 -0.945 . . . . 0.0 112.431 177.969 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -71.13 -32.51 69.07 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 111.725 0.268 . . . . 0.0 111.725 179.336 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.453 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -50.38 140.27 19.46 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.812 -178.0 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.48 HG23 ' N ' ' A' ' 34' ' ' GLU . 11.0 tp -67.1 -41.87 87.6 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 C-N-CA 120.381 -0.527 . . . . 0.0 109.597 179.569 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.48 ' N ' HG23 ' A' ' 33' ' ' ILE . 77.3 tt0 -55.6 -16.98 4.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.226 179.457 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 24.1 m -66.63 136.26 55.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.119 -179.79 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.48 ' OD2' ' O ' ' A' ' 26' ' ' THR . 68.8 m-20 -61.53 -33.72 74.3 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -178.999 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.721 HD12 ' CE2' ' A' ' 29' ' ' PHE . 98.3 mt -125.05 119.67 56.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 177.188 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -104.64 133.11 50.04 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.774 -177.999 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 98.9 mt -119.36 129.13 75.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.587 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -76.39 29.63 0.12 Allowed 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -178.082 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 41' ' ' LEU . 30.4 mt -94.12 129.03 38.7 Favored Pre-proline 0 C--N 1.322 -0.613 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.91 -179.806 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -72.86 -10.34 24.72 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 122.58 2.187 . . . . 0.0 113.046 -178.996 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.521 HG21 ' CE2' ' B' ' 241' ' ' PHE . 29.4 m -109.66 4.19 9.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.589 179.804 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.449 ' O ' ' O ' ' A' ' 45' ' ' SER . 4.5 t -91.8 108.17 19.72 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 CA-C-O 121.454 0.645 . . . . 0.0 110.642 179.623 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.507 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 1.1 m -32.09 153.05 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.999 -1.0 . . . . 0.0 112.167 -179.523 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -62.0 -42.36 99.06 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 114.406 -1.27 . . . . 0.0 111.192 -179.104 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.698 ' O ' ' N ' ' A' ' 49' ' ' CYS . 88.7 mt-30 -113.1 -18.09 12.24 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.097 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.507 ' H ' ' HB3' ' A' ' 45' ' ' SER . 35.5 t60 31.83 -71.42 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 114.902 -1.045 . . . . 0.0 113.23 179.879 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.698 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -130.66 135.41 47.82 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.282 . . . . . . . . 3 3 . 1 . 097 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -127.82 131.72 49.52 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.507 179.098 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.7 mt -116.28 136.2 54.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.536 -179.576 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -120.55 125.25 47.32 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.619 178.877 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.776 HG23 HH12 ' A' ' 5' ' ' ARG . 96.4 mt -105.24 114.27 44.34 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 CA-C-O 121.363 0.602 . . . . 0.0 111.569 -179.839 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.572 ' O ' ' N ' ' A' ' 56' ' ' GLN . 93.8 m-70 -112.22 144.46 41.59 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.671 179.641 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.474 ' C ' ' O ' ' A' ' 54' ' ' HIS . 81.8 tt0 -38.83 -26.42 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.81 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.572 ' N ' ' O ' ' A' ' 54' ' ' HIS . 68.9 tp60 -69.62 -68.11 0.43 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.676 178.32 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -160.82 -165.21 1.33 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.551 -179.695 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.41 124.93 52.65 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.013 179.468 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 98.5 mt -113.57 129.22 69.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.245 0.545 . . . . 0.0 112.445 -179.042 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.478 ' HB2' HD21 ' A' ' 82' ' ' LEU . 51.1 tp -95.17 126.73 40.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.355 179.227 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.409 ' ND1' ' HB3' ' A' ' 79' ' ' PRO . 96.0 m-70 -113.94 135.93 53.45 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.402 -179.305 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -95.74 106.67 18.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.952 0.406 . . . . 0.0 111.897 -179.678 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -99.17 -9.52 23.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.602 179.095 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.45 102.93 3.32 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.489 179.785 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 99.1 p -87.45 -1.58 58.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.083 0.468 . . . . 0.0 109.92 179.445 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.679 HG21 ' O ' ' B' ' 234' ' ' TPO . 1.0 OUTLIER -112.11 -35.81 5.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.378 -179.916 . . . . . . . . 3 3 . 1 . 097 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 31.4 m-20 -144.27 90.42 6.69 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.607 179.675 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.38 147.1 48.24 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 123.108 2.539 . . . . 0.0 113.445 -178.298 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 58.8 m -71.85 130.41 40.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.32 179.609 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -98.91 143.57 29.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.771 179.637 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.0 t -131.67 133.22 61.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 179.161 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 54.04 33.62 18.03 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 119.491 -0.884 . . . . 0.0 109.286 179.489 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.34 28.73 69.34 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.235 179.627 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.1 m -139.27 133.0 30.65 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 117.439 0.619 . . . . 0.0 112.227 -179.854 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.453 ' H ' HG12 ' A' ' 75' ' ' VAL . 0.1 OUTLIER -72.28 137.91 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.213 179.75 . . . . . . . . 3 3 . 1 . 097 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.543 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 1.7 pt -119.07 115.85 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 121.194 0.521 . . . . 0.0 110.057 178.737 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -82.37 -18.5 41.83 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.165 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.622 ' CD ' ' H ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -124.89 164.71 29.67 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.875 -179.975 . . . . . . . . 3 3 . 1 . 097 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.409 ' HB3' ' ND1' ' A' ' 61' ' ' HIS . 33.6 Cg_endo -63.54 153.4 75.09 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 C-N-CA 122.789 2.326 . . . . 0.0 112.473 179.816 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.3 p -142.76 147.59 20.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.719 -179.259 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -78.65 129.95 35.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.746 179.294 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.478 HD21 ' HB2' ' A' ' 60' ' ' LEU . 91.0 mt -85.44 137.92 32.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.15 0.5 . . . . 0.0 111.257 -179.085 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -128.45 150.87 49.95 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.106 179.578 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.478 ' ND1' ' O ' ' A' ' 99' ' ' ASN . 8.5 t60 -53.13 120.65 6.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.979 0.418 . . . . 0.0 111.156 -179.505 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.14 -20.82 23.28 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 179.746 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -67.56 136.03 53.88 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.053 0.454 . . . . 0.0 110.812 -179.814 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.1 t -116.53 132.18 66.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.058 -178.796 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 93.3 mt -92.6 131.77 38.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.291 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 54.5 m -123.47 124.71 43.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.8 0.809 . . . . 0.0 112.817 -178.41 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.492 ' O ' ' C ' ' A' ' 91' ' ' ILE . 96.5 mt -110.68 124.07 67.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.35 177.874 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.492 ' C ' ' O ' ' A' ' 90' ' ' ILE . 73.1 mt 33.98 -95.5 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.724 179.575 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' A' ' 90' ' ' ILE . 97.9 m-20 -113.72 9.52 17.75 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.557 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.759 ' HE ' HH22 ' B' ' 245' ' ' ARG . 97.5 mtt180 -125.08 144.25 50.51 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.513 -179.114 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.5 m -139.89 152.47 46.46 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.522 0.677 . . . . 0.0 111.388 -179.125 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.559 ' HB3' HD11 ' A' ' 7' ' ' LEU . 51.2 m-85 -125.62 121.98 35.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.572 179.81 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.51 ' O ' HD12 ' A' ' 7' ' ' LEU . 43.1 ttm180 -80.3 128.2 33.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.072 0.463 . . . . 0.0 111.639 -178.957 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -97.35 123.86 41.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.315 179.478 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -126.44 125.66 42.51 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.796 179.984 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.478 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 61.5 t-20 -114.26 113.79 25.08 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.255 179.443 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 . . . . . 0 N--CA 1.466 0.343 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.98 -179.632 . . . . . . . . 0 0 . 1 . 097 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 12.8 m . . . . . 0 N--CA 1.452 -0.365 0 CA-C-O 120.763 0.316 . . . . 0.0 110.703 . . . . . . . . . 0 0 . 1 . 097 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 49.6 p-10 -114.05 43.3 1.87 Allowed 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.445 -179.187 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . 0.67 ' O ' ' NE2' ' B' ' 231' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.67 ' NE2' ' O ' ' B' ' 230' ' ' SEP . 0.0 OUTLIER -141.09 -48.23 0.41 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.93 179.778 . . . . . . . . 3 3 . 1 . 097 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -84.09 159.3 35.6 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.052 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -66.92 140.89 56.52 Favored 'Trans proline' 0 C--N 1.297 -2.177 0 C-N-CA 122.739 2.293 . . . . 0.0 112.653 -179.37 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.679 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -75.83 148.17 31.81 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 C-N-CA 121.697 1.598 . . . . 0.0 112.453 179.133 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 53.7 t -63.35 136.4 26.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.088 179.942 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 4.2 t -70.53 134.64 47.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.446 -179.743 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . 0.437 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . 0.437 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 36.7 Cg_exo -57.26 -29.15 82.79 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 123.03 2.487 . . . . 0.0 112.472 -178.986 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 16.1 m -66.78 -45.12 79.46 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.35 0.595 . . . . 0.0 109.529 178.644 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.521 ' CE2' HG21 ' A' ' 43' ' ' VAL . 79.6 t80 -59.18 -46.13 89.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.034 -178.827 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 99.7 mt -64.58 -40.06 94.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.736 0.303 . . . . 0.0 111.332 -178.978 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 -62.95 -39.62 95.21 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.735 -179.289 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . 0.4 ' HE ' ' HA ' ' B' ' 241' ' ' PHE . 87.7 mtm180 -64.03 -42.19 97.17 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.334 179.942 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.759 HH22 ' HE ' ' A' ' 93' ' ' ARG . 75.9 mtp85 -61.12 -41.33 96.52 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.781 -179.196 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -62.75 -41.36 99.17 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.479 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 8.7 t -63.59 -45.67 89.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.364 177.979 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -60.14 -39.11 85.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.128 -179.378 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.495 HG23 ' O ' ' B' ' 245' ' ' ARG . 74.3 t -62.31 -43.88 98.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.256 -0.578 . . . . 0.0 110.274 179.643 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -63.61 -34.91 78.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.302 0.572 . . . . 0.0 109.78 179.116 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -80.12 -11.35 59.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.357 179.691 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' B' ' 252' ' ' LEU . 75.4 mt -110.52 -175.06 2.63 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.861 179.298 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . 0.516 ' CG ' ' N ' ' B' ' 254' ' ' ASP . 44.5 p-10 -125.62 -123.23 0.25 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.763 -179.869 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . 0.534 ' C ' ' H ' ' B' ' 256' ' ' ASP . 82.9 m-20 -79.1 4.03 15.8 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 178.634 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . 0.518 ' O ' ' O ' ' B' ' 256' ' ' ASP . 80.6 m-20 60.01 3.03 0.45 Allowed 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.291 -178.498 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.552 ' O ' ' C ' ' B' ' 257' ' ' LYS . 63.7 t0 47.13 109.74 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.694 -179.324 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . 0.552 ' C ' ' O ' ' B' ' 256' ' ' ASP . 98.9 mttt 13.29 -101.42 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 O-C-N 123.738 0.649 . . . . 0.0 111.559 179.983 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' B' ' 257' ' ' LYS . 89.0 m-20 -35.05 119.92 0.5 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.122 -179.729 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.576 ' CG ' ' H ' ' B' ' 260' ' ' GLU . 28.8 t70 -127.11 -174.22 3.1 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.055 0.455 . . . . 0.0 110.076 179.197 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.616 ' OE1' ' NH2' ' A' ' 93' ' ' ARG . 93.8 mt-10 -59.01 9.36 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.371 -178.762 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.566 ' H ' ' C ' ' B' ' 259' ' ' ASP . 59.5 mt -108.87 133.28 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.95 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 44.7 t -127.69 134.91 64.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.975 0.416 . . . . 0.0 111.109 -178.959 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -95.57 119.45 34.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.627 -178.767 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -64.79 -48.47 74.34 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.472 -179.517 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . 0.77 ' CD ' HD11 ' A' ' 24' ' ' LEU . 2.3 mt-30 -82.42 167.96 26.68 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.291 -179.236 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.85 144.98 89.92 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 121.701 1.601 . . . . 0.0 111.904 -179.554 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . 0.451 ' CD1' ' O ' ' A' ' 19' ' ' HIS . 7.8 tt . . . . . 0 C--N 1.321 -0.635 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.302 -179.275 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo . . . . . 0 N--CA 1.498 1.774 0 CA-C-O 121.388 0.495 . . . . 0.0 113.235 . . . . . . . . . 0 0 . 1 . 098 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.9 p -108.92 -46.91 3.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.384 -179.966 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.728 ' NE ' HD13 ' A' ' 53' ' ' ILE . 89.6 mtm-85 -92.53 131.91 37.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.786 -179.398 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -133.01 141.93 48.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.011 0.434 . . . . 0.0 111.693 -179.927 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.486 HD12 ' O ' ' A' ' 96' ' ' ARG . 26.4 tp -114.92 130.0 56.82 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.787 179.729 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.496 HG22 ' CD2' ' A' ' 19' ' ' HIS . 56.1 t -106.58 128.95 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.288 -179.012 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.416 HG23 HD12 ' B' ' 261' ' ' ILE . 2.8 m -80.27 140.46 36.2 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.263 0.554 . . . . 0.0 111.365 -179.833 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.493 ' CD1' ' OD1' ' A' ' 16' ' ' ASP . 50.6 mm -113.19 137.95 44.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.549 179.609 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -90.66 156.71 17.91 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.716 179.367 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.409 ' HD3' ' NH1' ' B' ' 245' ' ' ARG . 90.0 mtm180 -59.36 -24.0 63.02 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.172 179.676 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 81.8 p -81.61 -10.92 59.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.069 0.461 . . . . 0.0 109.856 179.301 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.02 34.34 8.94 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 -179.975 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.2 t -118.06 131.75 69.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.742 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.493 ' OD1' ' CD1' ' A' ' 10' ' ' ILE . 89.4 m-20 -72.4 134.05 45.21 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.229 -0.589 . . . . 0.0 109.628 179.264 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -118.53 -125.37 3.46 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.48 -179.1 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.59 152.71 38.41 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.372 2.048 . . . . 0.0 112.537 -178.689 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.496 ' CD2' HG22 ' A' ' 8' ' ' VAL . 10.6 m80 -102.71 154.61 18.99 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.907 0.384 . . . . 0.0 110.627 179.549 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.462 ' CD2' HD11 ' A' ' 37' ' ' ILE . 53.2 t80 -124.71 91.21 49.81 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.829 179.557 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -60.6 129.66 30.32 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.206 1.937 . . . . 0.0 111.719 179.872 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 90.6 mt -88.81 84.25 6.67 Favored 'General case' 0 N--CA 1.461 0.119 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.974 -179.302 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.2 p -86.21 -10.53 54.51 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.653 179.411 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.676 HD11 ' CD ' ' B' ' 265' ' ' GLN . 66.4 mt -102.14 145.77 28.89 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.094 -179.405 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 81.9 p -68.33 -15.9 63.74 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.045 0.45 . . . . 0.0 110.833 -179.257 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 46.3 m -128.47 132.43 48.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.674 -179.201 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.9 t -126.23 114.17 17.95 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.765 178.611 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.506 HD12 ' O ' ' A' ' 49' ' ' CYS . 57.6 tp -111.31 122.51 48.05 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.906 0.384 . . . . 0.0 111.413 -178.459 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.831 ' CE2' HD12 ' A' ' 37' ' ' ILE . 11.1 m-85 -101.95 142.56 33.06 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.404 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 156.04 -169.63 33.67 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 120.136 -1.031 . . . . 0.0 112.453 179.17 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 31.9 ttp85 -89.28 -32.5 17.35 Favored 'General case' 0 N--CA 1.461 0.096 0 CA-C-O 120.817 0.342 . . . . 0.0 110.824 -179.899 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.432 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -50.36 145.41 9.7 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 -179.879 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.416 HD13 ' HA ' ' A' ' 33' ' ' ILE . 35.7 mm -63.69 -43.93 98.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.555 -179.614 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -54.8 -18.14 4.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.473 179.778 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.432 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 51.2 m -62.1 128.55 36.68 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.162 179.944 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.452 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 61.7 m-20 -58.97 -30.7 68.13 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -178.9 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.831 HD12 ' CE2' ' A' ' 29' ' ' PHE . 79.4 mt -126.5 121.74 59.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 177.126 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 47.6 mtt180 -101.12 136.06 41.59 Favored 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.266 -178.724 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.407 ' C ' ' H ' ' A' ' 41' ' ' LEU . 91.7 mt -117.12 125.33 73.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.995 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -70.92 39.07 0.05 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.308 -177.686 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 41' ' ' LEU . 43.3 mt -112.69 125.17 30.37 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 120.556 -0.458 . . . . 0.0 109.796 179.16 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.56 -2.75 12.61 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.224 1.949 . . . . 0.0 112.61 -179.143 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.529 HG21 ' CE2' ' B' ' 241' ' ' PHE . 33.3 m -109.1 2.97 9.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.767 179.088 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.463 ' O ' ' O ' ' A' ' 45' ' ' SER . 2.7 t -89.72 109.7 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 120.703 0.287 . . . . 0.0 110.592 -179.865 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.58 ' OG ' ' N ' ' A' ' 48' ' ' HIS . 1.1 t -31.79 152.08 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.384 0.611 . . . . 0.0 111.775 -178.771 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -63.26 -43.0 99.21 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.04 -179.194 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.605 ' O ' ' N ' ' A' ' 49' ' ' CYS . 13.3 mm100 -108.9 -26.43 10.24 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.635 0.731 . . . . 0.0 109.113 179.205 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.58 ' N ' ' OG ' ' A' ' 45' ' ' SER . 36.5 t60 39.68 -74.46 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.257 -1.338 . . . . 0.0 113.681 179.471 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.605 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -132.54 136.44 46.62 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -177.985 . . . . . . . . 3 3 . 1 . 098 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -128.07 127.67 43.53 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.803 179.317 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.3 mt -108.85 133.78 52.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.297 179.838 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.455 ' CD ' ' NE2' ' A' ' 54' ' ' HIS . 82.1 tt0 -118.73 123.81 45.78 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.006 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.728 HD13 ' NE ' ' A' ' 5' ' ' ARG . 97.0 mt -106.85 116.0 49.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -178.565 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.53 ' O ' ' N ' ' A' ' 56' ' ' GLN . 96.9 m-70 -111.32 143.51 42.0 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.123 178.366 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.9 mm-40 -39.35 -26.85 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.278 0.561 . . . . 0.0 109.761 -179.841 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.53 ' N ' ' O ' ' A' ' 54' ' ' HIS . 47.2 tp60 -67.89 -68.3 0.4 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.262 178.918 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -158.92 -165.79 1.71 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.25 179.734 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.406 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -109.88 131.52 54.99 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.013 179.843 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 93.5 mt -121.41 132.31 70.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.233 0.54 . . . . 0.0 112.003 -179.09 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.546 HD22 HD12 ' A' ' 88' ' ' ILE . 37.0 tp -101.53 125.69 48.22 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.758 -179.175 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -110.81 135.97 50.57 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.636 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -97.94 105.34 17.47 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -178.123 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -98.28 -8.6 26.9 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.624 179.13 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -78.2 98.23 5.78 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.985 0.422 . . . . 0.0 110.557 -179.716 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.7 m -84.55 -33.94 23.34 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.886 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.447 HG22 ' HA ' ' B' ' 236' ' ' VAL . 1.4 m -64.41 -50.64 66.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.843 179.64 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -136.28 96.74 12.34 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.831 -179.752 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.499 ' HB2' HG23 ' A' ' 75' ' ' VAL . 43.0 Cg_exo -55.29 143.43 75.95 Favored 'Trans proline' 0 N--CA 1.499 1.822 0 C-N-CA 122.151 1.901 . . . . 0.0 112.856 -178.822 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 18.2 m -72.06 140.34 48.92 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.406 179.93 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -104.01 140.35 37.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.438 -179.96 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.689 HG13 ' OD1' ' A' ' 86' ' ' ASP . 49.3 t -130.1 137.09 57.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.907 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.438 HD22 HG12 ' A' ' 87' ' ' VAL . 7.9 m120 54.05 32.55 15.83 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.267 -0.573 . . . . 0.0 109.791 -179.643 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.22 29.18 72.13 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.05 179.623 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 49.8 m -141.28 135.65 30.84 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.163 -179.996 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.499 HG23 ' HB2' ' A' ' 68' ' ' PRO . 2.4 p -70.86 136.32 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 121.181 0.515 . . . . 0.0 111.681 -179.303 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.878 HD13 ' O ' ' A' ' 76' ' ' ILE . 0.0 OUTLIER -132.68 125.25 52.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.837 179.77 . . . . . . . . 3 3 . 1 . 098 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -99.32 -9.02 24.08 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.121 -179.713 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.847 ' O ' HD11 ' A' ' 76' ' ' ILE . 16.3 mt-10 -119.6 156.72 53.3 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.299 -179.082 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -62.52 148.15 93.76 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.48 2.12 . . . . 0.0 112.702 -179.951 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.5 m -143.76 145.4 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.427 -179.608 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 87.3 mtm-85 -73.35 130.2 39.66 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.529 179.349 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.497 HD11 ' HB2' ' A' ' 60' ' ' LEU . 96.0 mt -85.35 140.69 30.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.278 0.561 . . . . 0.0 111.274 -179.682 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -133.62 157.51 45.57 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.256 -179.661 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -58.81 117.19 4.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.242 -179.664 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.65 -1.29 29.06 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 -179.365 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.689 ' OD1' HG13 ' A' ' 71' ' ' VAL . 60.7 t0 -86.17 125.36 33.46 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.027 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.438 HG12 HD22 ' A' ' 72' ' ' ASN . 9.5 p -103.38 135.37 41.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 C-N-CA 120.461 -0.495 . . . . 0.0 111.543 -178.875 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.546 HD12 HD22 ' A' ' 60' ' ' LEU . 33.2 mm -96.14 128.28 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 177.789 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 36.3 m -122.79 121.55 36.56 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 119.688 -0.805 . . . . 0.0 113.08 -178.27 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.481 HD12 ' HE1' ' A' ' 95' ' ' PHE . 93.3 mt -110.36 124.79 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 114.624 -1.171 . . . . 0.0 108.623 177.672 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.593 HG22 ' NH2' ' B' ' 245' ' ' ARG . 61.1 mt 33.54 -99.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 121.034 -0.267 . . . . 0.0 111.195 179.7 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.506 ' O ' ' OD1' ' A' ' 92' ' ' ASP . 59.3 t0 -112.98 15.61 19.61 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.489 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.526 HH21 ' CD ' ' B' ' 260' ' ' GLU . 87.3 mtt-85 -129.32 140.61 51.34 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.128 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 75.2 m -137.17 154.73 50.16 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 119.958 -0.697 . . . . 0.0 111.585 -179.491 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.481 ' HE1' HD12 ' A' ' 90' ' ' ILE . 78.4 m-85 -125.17 121.43 34.16 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.209 179.689 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.486 ' O ' HD12 ' A' ' 7' ' ' LEU . 79.1 mtp85 -85.82 134.05 33.94 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.617 -179.685 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -93.53 123.76 37.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.736 -179.825 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -125.09 119.24 28.05 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.778 -179.769 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -99.74 110.03 22.44 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.266 -179.754 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.466 0.337 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.359 179.725 . . . . . . . . 0 0 . 1 . 098 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . . . . . . . . . 33.0 m . . . . . 0 CA--C 1.531 0.214 0 CA-C-O 121.006 0.431 . . . . 0.0 110.396 . . . . . . . . . 0 0 . 1 . 098 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.509 ' O ' ' CB ' ' B' ' 230' ' ' SEP . 55.8 m-20 -63.9 -34.47 78.04 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.422 179.858 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . 0.509 ' CB ' ' O ' ' B' ' 229' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 75.0 mm-40 -113.89 59.17 0.67 Allowed 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 179.192 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -154.57 127.9 2.21 Favored Glycine 0 CA--C 1.535 1.292 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 -179.812 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -50.63 132.74 36.88 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 121.883 1.722 . . . . 0.0 112.55 -179.45 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.692 ' P ' ' H ' ' B' ' 234' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -75.35 151.6 38.17 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 122.554 2.169 . . . . 0.0 112.69 179.494 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.447 ' HA ' HG22 ' A' ' 66' ' ' THR . 3.3 p -69.22 138.11 22.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.558 -0.747 . . . . 0.0 111.275 -178.841 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 1.5 t -81.66 134.03 35.43 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.168 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . 0.472 ' CB ' ' CD ' ' B' ' 239' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . 0.472 ' CD ' ' CB ' ' B' ' 238' ' ' TPO . 47.7 Cg_exo -57.97 -30.2 89.11 Favored 'Trans proline' 0 N--CA 1.502 2.001 0 C-N-CA 123.771 2.98 . . . . 0.0 113.189 -179.641 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 89.4 m -72.21 -44.75 62.5 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.396 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.529 ' CE2' HG21 ' A' ' 43' ' ' VAL . 80.8 t80 -57.33 -46.5 83.18 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.072 -179.777 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.432 HD21 HG23 ' A' ' 91' ' ' ILE . 91.2 mt -64.19 -43.09 96.15 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 -179.936 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -65.52 -39.93 92.39 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.061 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 53.8 ttt85 -62.97 -46.22 88.73 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.354 -179.563 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.801 ' O ' HG23 ' B' ' 249' ' ' VAL . 45.4 mtm180 -66.97 -37.9 85.1 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.903 -179.801 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -60.43 -45.94 91.82 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.207 -179.423 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 11.6 t -64.78 -44.66 89.29 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.677 178.681 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -63.52 -32.22 73.61 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.868 179.884 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.801 HG23 ' O ' ' B' ' 245' ' ' ARG . 71.9 t -67.85 -43.07 86.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.286 -0.566 . . . . 0.0 109.644 179.46 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -62.5 -30.14 71.06 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.151 179.477 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -92.13 2.24 56.71 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.627 179.321 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.869 HD11 ' OD1' ' B' ' 256' ' ' ASP . 49.1 tp -110.66 125.14 53.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.466 -179.61 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . 0.513 ' ND2' ' CG ' ' B' ' 255' ' ' ASP . 12.5 p-10 -74.61 173.38 10.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.44 0.638 . . . . 0.0 111.872 -178.526 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -70.15 -5.0 24.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.224 -179.455 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . 0.552 ' OD1' ' N ' ' B' ' 256' ' ' ASP . 48.5 p-10 -58.06 -18.65 26.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.788 0.327 . . . . 0.0 110.192 -179.829 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.869 ' OD1' HD11 ' B' ' 252' ' ' LEU . 1.6 m-20 -79.95 48.46 0.97 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.124 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -63.03 -14.44 48.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.126 179.801 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -62.85 -43.5 98.63 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.182 179.763 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.63 ' C ' ' H ' ' B' ' 261' ' ' ILE . 66.6 t0 65.59 125.47 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.111 0.482 . . . . 0.0 110.532 -178.853 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.526 ' CD ' HH21 ' A' ' 93' ' ' ARG . 95.4 mt-10 -57.2 16.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.18 -179.102 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.63 ' H ' ' C ' ' B' ' 259' ' ' ASP . 74.0 mt -111.96 134.69 53.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.269 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 73.9 t -127.1 133.72 67.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.955 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -94.97 121.23 36.36 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.132 0.491 . . . . 0.0 111.483 -177.303 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -64.51 -43.99 92.34 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.956 179.606 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . 0.676 ' CD ' HD11 ' A' ' 24' ' ' LEU . 2.1 mt-30 -89.05 167.14 18.82 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.191 -178.068 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . 0.443 ' C ' HD13 ' B' ' 267' ' ' ILE . 60.6 Cg_endo -70.77 149.27 60.21 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.744 2.296 . . . . 0.0 112.115 -179.885 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . 0.566 ' N ' HD13 ' B' ' 267' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.394 0 CA-C-O 121.594 0.712 . . . . 0.0 109.448 179.568 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo . . . . . 0 N--CA 1.499 1.796 0 CA-C-O 121.139 0.391 . . . . 0.0 113.001 . . . . . . . . . 0 0 . 1 . 099 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 36.1 p -70.62 -39.26 73.86 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.218 -179.292 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.633 ' NH1' ' HB2' ' A' ' 58' ' ' ALA . 94.6 mtt-85 -90.48 123.76 34.44 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.659 -0.417 . . . . 0.0 111.709 -178.034 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.7 mtm-85 -127.7 130.53 49.01 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 121.113 0.482 . . . . 0.0 110.497 179.155 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.627 HD11 ' HB3' ' A' ' 95' ' ' PHE . 51.7 tp -113.01 125.14 54.08 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.885 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.7 m -104.7 133.44 48.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.42 -178.94 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.9 m -83.03 143.81 30.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.771 -179.268 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.627 HD12 ' OG ' ' A' ' 94' ' ' SER . 97.2 mt -116.88 140.98 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.464 177.687 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -92.32 156.54 17.18 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.587 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.04 -15.87 37.24 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.779 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.6 p -77.16 -19.53 56.7 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.103 178.131 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.57 14.02 42.32 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.48 178.984 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.4 m -113.15 144.48 20.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.023 0.44 . . . . 0.0 111.101 -179.891 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 17' ' ' GLY . 61.9 t0 -80.1 130.47 35.27 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.999 -179.363 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.462 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . -116.84 -122.55 3.35 Favored Glycine 0 CA--C 1.535 1.334 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 -179.803 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -71.97 151.77 56.67 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 121.737 1.625 . . . . 0.0 112.653 -178.913 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -108.28 151.65 25.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.989 0.423 . . . . 0.0 110.344 -179.508 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.854 ' CD2' HD11 ' A' ' 37' ' ' ILE . 49.2 t80 -120.09 96.91 49.4 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.478 -179.066 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.451 ' HD2' HG22 ' B' ' 267' ' ' ILE . 87.6 Cg_endo -75.57 137.26 20.28 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 121.024 1.15 . . . . 0.0 111.686 -179.252 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 22' ' ' LEU . 84.1 mt -99.21 120.76 40.05 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 119.884 -0.726 . . . . 0.0 111.848 -178.717 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.7 p -122.4 -0.46 9.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.64 178.366 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.424 HD11 ' CG ' ' B' ' 265' ' ' GLN . 63.6 mt -105.85 149.34 26.6 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.994 -179.054 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.3 p -69.39 -21.0 63.81 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.984 -179.397 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 42.8 m -128.8 131.96 47.82 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.056 -179.829 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.486 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -132.85 126.38 32.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.274 178.205 . . . . . . . . 3 3 . 1 . 099 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.755 HD21 ' OE1' ' A' ' 47' ' ' GLN . 33.3 tp -122.23 133.23 54.71 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.973 -178.056 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.505 ' O ' ' O ' ' A' ' 47' ' ' GLN . 51.0 m-85 -106.06 138.19 42.68 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.323 -0.853 . . . . 0.0 108.925 178.808 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 155.04 -172.85 33.38 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 120.381 -0.914 . . . . 0.0 111.731 179.181 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.42 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 46.7 mtm105 -81.32 -31.27 33.61 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -179.467 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.506 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -48.06 148.36 4.05 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.706 -179.004 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.555 HG23 ' N ' ' A' ' 34' ' ' GLU . 9.9 tp -65.79 -43.45 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 120.695 0.283 . . . . 0.0 111.037 179.733 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.555 ' N ' HG23 ' A' ' 33' ' ' ILE . 81.8 tt0 -59.39 -18.38 38.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.416 -179.736 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 33.4 m -57.84 126.81 29.02 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.739 -179.327 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.556 ' CG ' HE22 ' B' ' 265' ' ' GLN . 50.1 m-20 -62.59 -33.9 75.9 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.523 -179.606 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.854 HD11 ' CD2' ' A' ' 20' ' ' PHE . 40.6 mm -119.87 111.33 32.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 177.312 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.419 ' NH2' ' O3P' ' B' ' 230' ' ' SEP . 85.2 mtp180 -99.23 132.45 44.54 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 120.681 -0.407 . . . . 0.0 110.225 -179.403 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.578 HG23 ' NH1' ' A' ' 93' ' ' ARG . 80.7 mt -122.71 131.76 72.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.803 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.614 ' O ' HG11 ' B' ' 228' ' ' VAL . 50.1 mt-30 -82.31 32.95 0.4 Allowed 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -177.859 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.665 HD21 ' NH2' ' A' ' 93' ' ' ARG . 70.3 mt -96.1 131.11 29.49 Favored Pre-proline 0 N--CA 1.469 0.483 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.121 178.992 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -73.4 -14.46 25.23 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.169 1.913 . . . . 0.0 112.156 179.672 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.583 HG21 ' CE2' ' B' ' 241' ' ' PHE . 21.3 m -93.07 7.14 5.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.602 179.931 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.42 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 24.3 t -101.37 134.46 41.57 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.482 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.5 m -71.84 168.14 18.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.282 0.563 . . . . 0.0 111.14 -179.131 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -60.91 -39.15 88.26 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.114 -178.98 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.755 ' OE1' HD21 ' A' ' 28' ' ' LEU . 13.4 mm100 -112.47 -18.07 12.52 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.619 0.247 . . . . 0.0 110.725 -179.828 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 23.3 t60 36.66 -75.9 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 179.634 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.772 ' SG ' HD11 ' A' ' 60' ' ' LEU . 0.1 OUTLIER -136.68 139.19 41.8 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.796 -178.581 . . . . . . . . 3 3 . 1 . 099 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -124.65 139.11 54.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.848 179.572 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.617 HD11 HD12 ' A' ' 82' ' ' LEU . 17.3 tt -128.95 138.29 54.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.143 179.959 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -117.22 137.84 52.1 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.015 179.144 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.7 mm -103.36 124.26 57.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.514 0.673 . . . . 0.0 111.159 -179.318 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.474 ' O ' ' N ' ' A' ' 56' ' ' GLN . 50.3 m-70 -125.41 132.15 52.81 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.17 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.473 ' C ' ' O ' ' A' ' 54' ' ' HIS . 97.7 mt-10 -39.59 -30.56 0.07 Allowed 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.125 -178.8 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.474 ' N ' ' O ' ' A' ' 54' ' ' HIS . 98.6 mt-30 -65.37 -69.9 0.27 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.264 179.33 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -154.88 -159.47 0.95 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.691 -179.777 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.633 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -119.71 137.9 53.63 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.864 0.364 . . . . 0.0 110.601 -179.84 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.3 mm -111.61 120.6 62.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.11 179.936 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.772 HD11 ' SG ' ' A' ' 49' ' ' CYS . 48.7 tp -98.22 126.04 43.53 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.248 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -113.34 136.14 53.09 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.817 -179.412 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.477 HD21 ' HA ' ' A' ' 68' ' ' PRO . 61.2 t-20 -96.21 109.8 22.21 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.98 0.419 . . . . 0.0 111.683 179.915 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -102.38 -9.41 20.33 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.343 179.4 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.22 98.8 9.58 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.821 0.343 . . . . 0.0 111.185 -179.296 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.3 p -78.77 -38.5 38.44 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.967 0.413 . . . . 0.0 109.959 178.729 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.538 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.2 OUTLIER -64.41 -44.57 90.83 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.647 -179.488 . . . . . . . . 3 3 . 1 . 099 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.431 ' CG ' ' H ' ' B' ' 237' ' ' CYS . 89.9 m-20 -139.41 89.56 12.03 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.188 179.897 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.529 ' HB2' HG13 ' A' ' 75' ' ' VAL . 46.4 Cg_exo -54.14 145.59 53.17 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.427 2.085 . . . . 0.0 112.449 -179.675 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.5 m -75.91 143.81 41.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.907 -179.175 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -103.88 142.84 33.7 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.658 179.994 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.48 ' CG2' ' OD1' ' A' ' 86' ' ' ASP . 4.5 p -131.33 135.47 59.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.198 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 51.92 28.95 5.57 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -179.576 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 74.86 27.45 64.71 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.319 179.995 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.415 ' N ' ' O ' ' A' ' 71' ' ' VAL . 25.5 m -139.9 140.5 36.46 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.86 -179.498 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.529 HG13 ' HB2' ' A' ' 68' ' ' PRO . 51.1 t -68.42 136.96 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -179.309 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.3 pt -110.74 79.68 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.226 0 CA-C-O 121.118 0.485 . . . . 0.0 111.491 179.188 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -61.13 -31.76 71.46 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.918 179.326 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.581 ' OE1' ' N ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -114.84 159.6 36.79 Favored Pre-proline 0 CA--C 1.517 -0.305 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.766 . . . . . . . . 3 3 . 1 . 099 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -62.49 144.51 94.78 Favored 'Trans proline' 0 C--N 1.294 -2.341 0 C-N-CA 122.462 2.108 . . . . 0.0 111.72 -179.343 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 44.1 t -135.09 138.21 49.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.94 -179.151 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -74.63 137.65 42.39 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.831 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.617 HD12 HD11 ' A' ' 51' ' ' ILE . 93.3 mt -91.46 141.0 29.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.177 0.513 . . . . 0.0 112.349 -178.782 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -129.91 154.42 47.34 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.076 179.293 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -53.03 117.21 2.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.71 -179.565 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.38 -22.03 12.42 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 179.56 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 87' ' ' VAL . 59.4 t0 -62.76 130.27 44.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.259 0.552 . . . . 0.0 111.292 -179.873 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.588 HG22 ' HG2' ' A' ' 96' ' ' ARG . 61.7 t -105.65 133.05 51.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.231 -179.247 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 86.4 mt -103.12 128.74 55.82 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.639 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.8 m -119.06 129.01 54.86 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -178.422 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.674 ' O ' ' N ' ' A' ' 93' ' ' ARG . 98.6 mt -115.84 133.96 60.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 113.974 -1.466 . . . . 0.0 107.826 177.121 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.615 HG23 HD21 ' B' ' 242' ' ' LEU . 77.5 mt -19.12 94.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.028 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.42 ' CB ' ' O ' ' A' ' 91' ' ' ILE . 0.4 OUTLIER 80.34 -13.22 0.96 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 177.771 . . . . . . . . 3 3 . 1 . 099 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.674 ' N ' ' O ' ' A' ' 90' ' ' ILE . 88.2 mtt180 -128.4 137.92 52.1 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.564 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.627 ' OG ' HD12 ' A' ' 10' ' ' ILE . 62.6 p -139.27 156.7 46.88 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.396 0.617 . . . . 0.0 110.697 -179.549 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.627 ' HB3' HD11 ' A' ' 7' ' ' LEU . 78.0 m-85 -130.63 127.33 38.73 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.496 -0.775 . . . . 0.0 108.995 179.596 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.588 ' HG2' HG22 ' A' ' 87' ' ' VAL . 99.5 mtt180 -94.91 138.15 33.05 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.832 -179.514 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.58 ' OH ' ' NH1' ' A' ' 5' ' ' ARG . 83.1 t80 -96.71 126.1 41.64 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.876 -179.087 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -124.81 119.73 29.72 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.828 179.521 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.464 ' O ' ' C ' ' A' ' 100' ' ' GLU . 59.7 t-20 -102.67 107.77 18.8 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.124 -179.462 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 99' ' ' ASN . 81.4 tt0 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.274 179.282 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . 0.614 HG11 ' O ' ' A' ' 40' ' ' GLN . 32.6 m . . . . . 0 N--CA 1.454 -0.262 0 CA-C-O 120.618 0.247 . . . . 0.0 110.799 . . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.419 ' O ' ' CB ' ' B' ' 230' ' ' SEP . 95.9 m-20 -89.28 1.53 55.61 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.424 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . 0.419 ' CB ' ' O ' ' B' ' 229' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 174.87 39.12 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.731 179.9 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -121.88 -176.53 15.2 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.604 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.11 155.88 66.73 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 123.09 2.527 . . . . 0.0 112.632 -179.706 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.538 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -57.59 132.12 48.49 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 123.044 2.496 . . . . 0.0 113.654 179.338 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 38.8 t -61.77 137.47 23.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.461 179.213 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . 0.431 ' H ' ' CG ' ' A' ' 67' ' ' ASN . 0.7 OUTLIER -53.5 112.16 0.85 Allowed 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.263 -178.902 . . . . . . . . 3 3 . 1 . 099 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . 0.405 ' H ' HG23 ' B' ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -56.38 -24.27 51.08 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 121.833 1.688 . . . . 0.0 111.601 179.678 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 94.7 m -72.89 -46.05 54.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.952 179.095 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.583 ' CE2' HG21 ' A' ' 43' ' ' VAL . 76.1 t80 -59.33 -45.63 90.83 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.579 -178.528 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.615 HD21 HG23 ' A' ' 91' ' ' ILE . 77.4 mt -65.32 -44.31 88.22 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.992 -179.178 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -62.48 -41.01 98.49 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.558 -179.098 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -63.84 -46.33 85.55 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.311 -179.251 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . . . . . . . . . 57.1 ttm-85 -64.82 -42.95 94.57 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.133 -179.246 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . 0.401 ' O ' HG12 ' B' ' 249' ' ' VAL . 98.3 mttt -63.27 -39.11 93.68 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.37 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 38.7 t -63.53 -44.98 92.64 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.674 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -58.61 -37.23 75.42 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.815 -179.687 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.401 HG12 ' O ' ' B' ' 246' ' ' LYS . 0.3 OUTLIER -69.2 -40.18 80.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.896 179.839 . . . . . . . . 3 3 . 1 . 099 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -60.63 -35.07 75.29 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.803 0.335 . . . . 0.0 111.031 -179.687 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -98.69 10.4 41.2 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.686 -178.973 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . . . . . . . . . 61.4 tp -116.55 129.12 56.0 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.992 0.425 . . . . 0.0 110.254 179.66 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . 0.603 ' C ' ' H ' ' B' ' 255' ' ' ASP . 24.5 m-80 -74.2 173.72 9.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.229 0.537 . . . . 0.0 111.686 -178.896 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 52.6 p-10 -54.76 4.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.393 -179.55 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . 0.603 ' H ' ' C ' ' B' ' 253' ' ' ASN . 44.8 p-10 -65.85 -20.92 66.41 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 120.854 0.359 . . . . 0.0 110.826 -179.659 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.714 ' O ' ' N ' ' B' ' 258' ' ' ASP . 45.0 p-10 -51.68 -21.02 2.35 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.182 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' B' ' 256' ' ' ASP . 86.7 tttt -20.88 -35.1 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.089 -0.96 . . . . 0.0 112.526 -179.239 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.714 ' N ' ' O ' ' B' ' 256' ' ' ASP . 88.4 m-20 -56.11 -48.73 75.64 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 119.646 -0.822 . . . . 0.0 108.833 179.465 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.609 ' C ' ' H ' ' B' ' 261' ' ' ILE . 43.8 t0 72.37 116.36 0.05 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.544 178.816 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.538 ' OE1' ' N ' ' B' ' 260' ' ' GLU . 56.8 mp0 -62.6 15.61 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.551 -179.462 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.609 ' H ' ' C ' ' B' ' 259' ' ' ASP . 72.1 mt -109.81 137.98 39.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.705 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 55.2 t -127.42 134.45 65.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 C-N-CA 120.202 -0.599 . . . . 0.0 111.239 -178.506 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -93.7 118.01 30.83 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.379 -178.861 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -67.02 -46.94 72.94 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.61 179.751 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . 0.556 HE22 ' CG ' ' A' ' 36' ' ' ASP . 2.1 mp0 -81.6 162.64 57.43 Favored Pre-proline 0 CA--C 1.514 -0.422 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.934 -178.785 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.9 144.49 58.84 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 121.617 1.545 . . . . 0.0 111.643 179.088 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . 0.451 HG22 ' HD2' ' A' ' 21' ' ' PRO . 43.3 pt . . . . . 0 C--N 1.32 -0.717 0 CA-C-O 121.386 0.613 . . . . 0.0 109.43 178.553 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo . . . . . 0 N--CA 1.494 1.548 0 CA-C-O 120.709 0.212 . . . . 0.0 111.667 . . . . . . . . . 0 0 . 1 . 100 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.0 p -86.74 -38.22 17.14 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.943 179.407 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.733 ' NH1' ' HB2' ' A' ' 58' ' ' ALA . 92.2 mtt-85 -92.47 124.08 36.25 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.268 -179.177 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -130.15 139.57 50.86 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.551 -179.877 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.511 HD11 ' HB3' ' A' ' 95' ' ' PHE . 33.5 tp -115.95 130.91 57.03 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.274 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.674 HG12 ' CD2' ' A' ' 19' ' ' HIS . 33.3 m -111.25 134.32 53.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 C-N-CA 120.744 -0.383 . . . . 0.0 110.77 -179.779 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.5 m -95.02 117.87 30.89 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -177.817 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.664 HD12 ' OG ' ' A' ' 94' ' ' SER . 97.6 mt -80.94 144.27 10.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.13 178.443 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -92.64 163.8 13.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.755 178.8 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.644 ' CZ ' HH11 ' B' ' 245' ' ' ARG . 83.1 mtp180 -55.47 -30.54 60.77 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.885 -179.191 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 95.8 p -79.95 -7.58 58.86 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 120.666 -0.413 . . . . 0.0 111.521 -179.983 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.39 35.11 8.16 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.853 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.6 t -121.46 133.62 67.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.86 0.362 . . . . 0.0 110.626 -179.671 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -73.95 135.48 43.23 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 178.788 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.5 -116.95 1.93 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 120.412 -0.899 . . . . 0.0 111.699 -179.603 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -68.37 142.13 53.65 Favored 'Trans proline' 0 N--CA 1.49 1.276 0 C-N-CA 121.593 1.528 . . . . 0.0 112.545 -178.665 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.674 ' CD2' HG12 ' A' ' 8' ' ' VAL . 49.4 m170 -106.15 142.68 35.43 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.269 -179.377 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.544 ' CD2' HD11 ' A' ' 37' ' ' ILE . 37.6 t80 -113.32 93.32 26.01 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.272 -179.673 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -62.45 126.82 19.28 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 121.713 1.608 . . . . 0.0 110.387 179.7 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.6 mt -86.75 51.75 2.32 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.406 -178.719 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 88.9 p -61.67 -23.64 66.22 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.198 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.506 HD11 ' CD ' ' B' ' 265' ' ' GLN . 92.6 mt -77.61 139.03 39.45 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.264 179.36 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 99.3 p -66.4 -16.86 64.41 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.837 -178.461 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 61.8 m -138.83 138.44 37.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.565 0.222 . . . . 0.0 110.669 179.998 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.682 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -138.2 133.53 33.36 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.987 0.423 . . . . 0.0 110.69 179.205 . . . . . . . . 3 3 . 1 . 100 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.56 HD21 ' HG2' ' A' ' 47' ' ' GLN . 34.7 tp -123.04 131.45 53.71 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.745 -178.056 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.728 ' CE2' HD12 ' A' ' 37' ' ' ILE . 8.2 m-85 -107.2 141.95 37.69 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.115 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 38' ' ' ARG . . . 158.5 -175.66 35.56 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.92 179.169 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.846 ' NE ' HG11 ' B' ' 228' ' ' VAL . 86.8 mtm-85 -74.94 -27.34 60.16 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 122.659 -0.318 . . . . 0.0 110.928 -179.935 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.566 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -59.14 138.05 49.83 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.154 -177.925 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.449 HG23 ' N ' ' A' ' 34' ' ' GLU . 10.0 tp -66.51 -41.56 88.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.721 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.449 ' N ' HG23 ' A' ' 33' ' ' ILE . 84.4 tt0 -51.93 -19.0 1.55 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.376 178.854 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.566 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 13.8 m -67.91 137.77 55.48 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.568 179.209 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -60.74 -33.77 73.42 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -179.251 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.728 HD12 ' CE2' ' A' ' 29' ' ' PHE . 96.8 mt -127.26 124.72 64.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.247 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.431 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 78.4 ttt-85 -109.34 134.23 52.07 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.115 -178.579 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 82.0 mt -116.45 130.59 71.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.929 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -78.82 26.04 0.25 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.792 -178.056 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.739 HD21 ' OE1' ' B' ' 260' ' ' GLU . 31.5 mt -95.37 125.96 47.86 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.977 179.947 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.69 -14.33 33.06 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.555 2.17 . . . . 0.0 113.056 -179.786 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.598 HG23 HD13 ' A' ' 91' ' ' ILE . 15.3 m -93.83 6.05 6.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.92 0.39 . . . . 0.0 110.7 -179.698 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.599 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 57.5 t -100.71 134.57 40.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.429 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.529 ' HB3' ' H ' ' A' ' 48' ' ' HIS . 0.2 OUTLIER -66.07 167.71 9.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.165 0.507 . . . . 0.0 112.023 -178.658 . . . . . . . . 3 3 . 1 . 100 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -60.21 -42.67 95.62 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.664 -179.676 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.728 ' O ' ' N ' ' A' ' 49' ' ' CYS . 85.0 mt-30 -111.64 -12.15 13.93 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.463 179.675 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.529 ' H ' ' HB3' ' A' ' 45' ' ' SER . 27.7 t60 32.94 -68.17 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -179.852 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.728 ' N ' ' O ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -142.87 143.87 32.25 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.202 -0.599 . . . . 0.0 112.152 -179.464 . . . . . . . . 3 3 . 1 . 100 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -125.18 137.62 54.14 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.832 179.436 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.51 HD11 HD12 ' A' ' 82' ' ' LEU . 19.8 tt -125.09 138.08 55.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.072 0.463 . . . . 0.0 110.128 -179.724 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -122.8 135.07 54.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.284 -179.463 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.521 HD13 ' HD2' ' A' ' 5' ' ' ARG . 96.7 mt -109.88 117.04 53.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.61 0.719 . . . . 0.0 111.949 -179.602 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.555 ' O ' ' N ' ' A' ' 56' ' ' GLN . 94.9 m-70 -116.37 142.52 46.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.475 -1.239 . . . . 0.0 110.351 -179.981 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 54' ' ' HIS . 80.8 mm-40 -39.88 -24.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.993 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.555 ' N ' ' O ' ' A' ' 54' ' ' HIS . 59.5 tt0 -69.47 -67.57 0.47 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.272 178.613 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.494 ' OE1' ' O ' ' A' ' 56' ' ' GLN . 6.0 tp10 -161.12 -158.87 0.61 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.23 179.237 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.733 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . . . -114.39 125.06 53.42 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.816 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.2 mt -114.12 130.91 67.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.129 0.49 . . . . 0.0 111.883 -178.447 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.507 HD11 ' SG ' ' A' ' 49' ' ' CYS . 56.5 tp -99.85 129.05 45.9 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.717 -179.391 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -113.59 136.72 52.5 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.542 179.65 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.407 ' ND2' ' HB3' ' A' ' 68' ' ' PRO . 29.9 t30 -95.28 108.79 20.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.04 0.447 . . . . 0.0 111.777 -179.962 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -98.78 -8.51 25.83 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.739 179.182 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.7 t -81.2 105.84 12.72 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.263 179.721 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.7 p -87.36 -20.36 26.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.244 0.545 . . . . 0.0 109.668 179.567 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.492 HG21 ' O ' ' B' ' 234' ' ' TPO . 0.3 OUTLIER -86.32 -33.58 20.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.196 -179.642 . . . . . . . . 3 3 . 1 . 100 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.4 HD21 ' HA ' ' B' ' 236' ' ' VAL . 74.7 m-80 -150.84 93.95 3.64 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.17 179.926 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.726 ' HB2' HG13 ' A' ' 75' ' ' VAL . 32.2 Cg_exo -56.73 149.29 60.38 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.165 1.91 . . . . 0.0 112.009 -179.801 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 51.9 m -73.57 137.41 44.31 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.04 178.846 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -98.0 141.16 31.3 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.59 -179.768 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 51.8 t -126.45 134.11 67.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.21 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 51.65 33.18 10.35 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.974 -0.69 . . . . 0.0 109.416 -179.099 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.66 29.97 69.06 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.659 179.81 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.4 m -140.6 135.37 31.69 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 117.001 0.401 . . . . 0.0 111.142 -179.912 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.726 HG13 ' HB2' ' A' ' 68' ' ' PRO . 55.7 t -69.1 136.74 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.725 -179.606 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.55 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 1.1 pt -104.96 100.4 10.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-O 121.361 0.6 . . . . 0.0 110.677 178.959 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -65.45 -35.47 81.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.311 179.166 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -123.66 175.99 2.48 Favored Pre-proline 0 CA--C 1.536 0.404 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.548 -179.008 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.01 145.34 96.74 Favored 'Trans proline' 0 N--CA 1.501 1.926 0 C-N-CA 122.575 2.183 . . . . 0.0 111.954 -179.443 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.5 m -136.01 138.93 46.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.995 0.426 . . . . 0.0 112.14 -179.235 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -76.36 133.14 40.03 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 178.819 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.51 HD12 HD11 ' A' ' 51' ' ' ILE . 89.9 mt -89.43 136.01 33.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.413 0.625 . . . . 0.0 112.009 -178.589 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -121.26 148.61 44.06 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.742 179.014 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -54.49 123.04 11.84 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.931 0.396 . . . . 0.0 110.279 -179.577 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.13 -20.28 31.07 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.67 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -66.11 137.62 57.17 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.728 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.449 HG22 ' HG2' ' A' ' 96' ' ' ARG . 55.2 t -112.6 133.16 59.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.521 -178.368 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 92.2 mt -99.22 130.68 47.82 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 178.7 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 65.9 m -122.45 124.91 44.71 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.067 -0.653 . . . . 0.0 112.067 -178.735 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.549 HD12 ' HE1' ' A' ' 95' ' ' PHE . 77.0 mt -109.53 121.5 62.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.255 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.598 HD13 HG23 ' A' ' 43' ' ' VAL . 77.4 mt 35.24 -97.76 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.493 -179.867 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.562 ' OD2' ' NE ' ' B' ' 245' ' ' ARG . 42.0 p-10 -110.73 7.68 22.24 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.666 0.269 . . . . 0.0 111.633 -179.219 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.539 ' CZ ' ' O ' ' B' ' 259' ' ' ASP . 85.6 mtt-85 -124.01 144.4 49.85 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.667 179.916 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.664 ' OG ' HD12 ' A' ' 10' ' ' ILE . 32.7 p -137.9 151.02 47.59 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.49 0.662 . . . . 0.0 111.056 179.553 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.549 ' HE1' HD12 ' A' ' 90' ' ' ILE . 35.1 m-85 -124.01 122.11 37.04 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.324 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.449 ' HG2' HG22 ' A' ' 87' ' ' VAL . 74.7 mtp85 -87.85 135.22 33.49 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.851 -178.658 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.571 ' HH ' ' HG2' ' A' ' 5' ' ' ARG . 89.7 t80 -99.25 125.16 44.81 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.629 -179.669 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -143.77 125.46 15.03 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.475 179.472 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.538 ' OD1' ' CZ ' ' A' ' 97' ' ' TYR . 95.4 m-20 -99.67 138.65 36.46 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.567 179.705 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 . . . . . 0 C--N 1.328 -0.327 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.803 . . . . . . . . 0 0 . 1 . 100 nuclear nobuild full ' B' B ' 228' ' ' VAL . . . . . 0.846 HG11 ' NE ' ' A' ' 31' ' ' ARG . 61.6 t . . . . . 0 N--CA 1.448 -0.551 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 . . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -84.29 59.2 5.24 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.596 -179.458 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' B' B ' 230' ' ' SEP . . . . . 0.443 ' H2 ' HG12 ' B' ' 228' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.62 77.29 1.53 Allowed 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.091 179.651 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . 0.663 ' N ' HG13 ' B' ' 228' ' ' VAL . . . -128.16 -173.3 13.42 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 121.026 -0.607 . . . . 0.0 111.795 -179.583 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -65.45 154.69 72.54 Favored 'Trans proline' 0 N--CA 1.499 1.85 0 C-N-CA 123.628 2.885 . . . . 0.0 112.638 -179.864 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' B' B ' 234' ' ' TPO . . . . . 0.492 ' O ' HG21 ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -55.74 129.24 33.95 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.501 2.134 . . . . 0.0 113.342 -179.761 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . 0.461 HG22 HG22 ' A' ' 66' ' ' THR . 71.4 t -58.25 131.09 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.013 -179.806 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' B' B ' 237' ' ' CYS . . . . . . . . . . . . . 4.5 t -51.81 113.35 0.97 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.644 -179.539 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' B' B ' 238' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 100 nuclear nobuild full ' B' B ' 239' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.04 -20.34 44.99 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.039 1.826 . . . . 0.0 111.945 179.536 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' B' B ' 240' ' ' THR . . . . . . . . . . . . . 29.3 m -72.72 -45.76 57.12 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.079 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' B' B ' 241' ' ' PHE . . . . . 0.481 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 79.4 t80 -58.69 -45.97 88.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.729 -179.872 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.403 ' HA ' HD23 ' B' ' 242' ' ' LEU . 82.1 mt -64.41 -39.04 93.08 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.012 0.434 . . . . 0.0 110.28 -179.899 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -64.08 -39.94 95.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.16 -179.239 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' B' B ' 244' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -62.47 -41.42 98.75 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.987 0.422 . . . . 0.0 110.212 179.831 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' B' B ' 245' ' ' ARG . . . . . 0.811 ' O ' HG23 ' B' ' 249' ' ' VAL . 14.9 tpp180 -60.86 -42.38 97.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.081 -179.735 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.39 -42.87 98.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.727 179.738 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 43.8 p -65.37 -44.01 88.94 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.834 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' B' B ' 248' ' ' GLN . . . . . 0.619 ' O ' ' N ' ' B' ' 252' ' ' LEU . 84.5 mt-30 -64.42 -34.48 78.27 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.919 179.737 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.811 HG23 ' O ' ' B' ' 245' ' ' ARG . 79.7 t -60.99 -45.65 98.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 C-N-CA 120.271 -0.572 . . . . 0.0 109.919 179.788 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -65.62 -27.77 68.63 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.121 179.109 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -95.42 -13.88 24.26 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.014 -179.863 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' B' B ' 252' ' ' LEU . . . . . 0.619 ' N ' ' O ' ' B' ' 248' ' ' GLN . 46.4 tp -91.81 127.42 37.26 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.52 0.676 . . . . 0.0 111.576 -178.874 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -73.41 -147.78 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.512 -178.947 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -93.3 3.15 56.1 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.697 179.133 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' B' B ' 255' ' ' ASP . . . . . 0.568 ' C ' ' H ' ' B' ' 257' ' ' LYS . 98.0 m-20 -64.06 -12.29 37.52 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.208 -178.907 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 30.0 p-10 -65.49 37.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.878 0.371 . . . . 0.0 111.26 -179.854 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' B' B ' 257' ' ' LYS . . . . . 0.568 ' H ' ' C ' ' B' ' 255' ' ' ASP . 88.6 tttt -61.73 -40.64 95.81 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.457 -179.824 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.689 ' O ' ' N ' ' B' ' 260' ' ' GLU . 29.5 p-10 -94.7 9.26 39.57 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.87 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.539 ' O ' ' CZ ' ' A' ' 93' ' ' ARG . 55.2 p-10 8.1 48.32 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 113.917 -1.492 . . . . 0.0 113.507 179.622 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' B' B ' 260' ' ' GLU . . . . . 0.739 ' OE1' HD21 ' A' ' 41' ' ' LEU . 96.8 mt-10 60.05 9.07 1.66 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 178.782 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.463 ' N ' ' O ' ' B' ' 258' ' ' ASP . 75.7 mt -117.14 134.27 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 C-N-CA 120.544 -0.462 . . . . 0.0 109.911 179.587 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 45.8 t -127.06 133.61 67.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.066 179.549 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' B' B ' 263' ' ' PHE . . . . . 0.651 ' CD2' HG21 ' B' ' 267' ' ' ILE . 85.4 m-85 -98.76 122.15 41.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.088 0.471 . . . . 0.0 111.857 -178.499 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -66.17 -43.11 87.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.134 178.356 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' B' B ' 265' ' ' GLN . . . . . 0.506 ' CD ' HD11 ' A' ' 24' ' ' LEU . 0.9 OUTLIER -102.2 174.16 3.06 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.344 -179.699 . . . . . . . . 3 3 . 1 . 100 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -56.56 150.62 50.92 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 122.825 2.35 . . . . 0.0 113.765 179.76 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . 0.651 HG21 ' CD2' ' B' ' 263' ' ' PHE . 34.2 pt . . . . . 0 C--N 1.332 -0.165 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.164 179.153 . . . . . . . . 1 1 . 1 stop_ save_